Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"				"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	15.0	35.1	13.4	22.0	16.6	19.9	16.5	19.2	18.4	17.6	16.4	22.6	20.9	15.4	19.3	26.1	18.2	25.3	19.4	20.7	13.2	11.8	20.4	26.0	13.4	23.4	19.3	10.1	19.7	27.3	33.1	27.3	23.6	15.8	17.3	19.3	21.5	22.8	18.5	19.7	22.2	17.5	21.2	16.4	22.0	19.1	26.6	19.5	39.1	19.5	24.6	24.4	17.2	16.9	15.3	17.2	8.2	14.7	10.0	16.7	10.1	10.1	30.9	24.2	14.8	11.5	14.0	15.5	11.6	12.6	29.2	16.9	21.0	21.6	24.4	20.0	14.7	14.8	42.1	31.0	17.3	15.4	27.2	19.8	13.7	21.1	11.7	17.5	15.0	13.3	15.6	19.4	18.9	23.0	26.2	28.3	14.1	32.9	27.4	18.1	16.6	21.6	27.0	16.1	27.3	20.7	8.4	13.0	16.5	8.5	19.4	9.0	24.8	15.3	10.4	13.9	21.1	11.0	12.2	12.7	16.0	22.1	11.2	15.2	16.0	1.2	12.1	8.2	13.7	14.0	16.5	15.2	12.3	12.6	13.7	15.3	16.7	16.2	1.1	10.0	14.7	17.2	12.6	10.1	13.4	16.6	19.2	18.4	13.2	11.8	19.3	10.1	15.8	19.5
AAGAB	"FLJ11506, p34"	ENSG00000103591	"Alpha and gamma adaptin binding protein"	Q6PD74	15	67201033-67255195	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039371, HPA040174"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA039371: AB_10805476, HPA040174: AB_10805605"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (1.36e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavourable (9.48e-4)"	"unprognostic (1.53e-1)"	19.3	23.6	17.0	15.6	22.5	15.6	20.3	13.3	29.8	16.7	23.6	14.7	24.1	13.3	18.1	24.7	22.3	14.6	16.1	14.8	15.9	22.5	29.5	22.2	15.2	15.4	17.7	20.2	14.4	18.0	29.9	39.1	16.0	31.5	16.9	29.7	14.9	19.3	19.0	33.4	14.3	21.9	18.4	13.8	18.2	20.1	23.8	13.4	25.9	28.8	18.1	21.4	19.8	14.1	16.1	23.9	28.4	24.7	27.7	26.8	20.1	18.0	32.7	23.6	24.2	23.5	19.1	11.8	19.0	28.1	23.0	26.6	24.2	19.6	17.4	19.5	19.9	36.5	49.1	22.2	24.2	24.2	23.2	16.5	24.6	9.9	25.4	28.0	19.4	18.6	30.6	17.1	36.8	18.2	34.1	24.7	22.4	22.0	17.0	12.0	20.2	11.9	19.1	30.3	21.0	21.2	42.6	33.8	21.6	22.8	16.5	26.9	26.9	21.5	18.9	21.1	25.4	18.7	26.4	12.8	43.1	26.1	19.9	26.2	20.9	28.4	18.9	18.5	23.5	24.6	26.8	16.1	20.8	22.1	23.9	12.5	17.7	19.4	10.1	27.7	24.7	17.7	25.1	20.1	17.0	22.5	13.3	29.8	15.9	22.5	17.7	20.2	31.5	13.4
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 109.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	5.1	5.9	11.0	5.7	11.9	7.8	6.9	25.2	26.5	4.8	4.2	3.9	6.3	3.8	4.7	7.1	3.8	4.9	4.3	7.9	14.4	12.8	7.2	3.1	7.5	6.8	9.4	11.6	3.3	6.7	109.7	10.3	6.9	10.2	5.0	4.6	4.7	3.6	12.3	6.8	3.7	3.7	5.4	9.3	5.5	5.4	4.1	6.9	4.7	16.0	2.1	5.3	4.9	5.8	1.0	0.8	4.1	3.9	2.8	5.6	1.3	16.5	9.9	9.1	8.8	8.7	9.7	29.3	13.5	10.7	8.2	7.2	10.0	6.6	0.5	3.3	17.5	7.7	7.0	7.0	16.7	12.3	2.9	9.0	6.0	6.8	7.9	6.3	21.4	8.3	6.2	15.4	19.9	17.3	1.9	9.3	14.2	2.8	5.8	3.3	4.4	5.5	3.9	9.9	1.4	6.4	34.7	3.0	4.8	7.8	6.0	7.0	3.5	8.9	17.2	18.3	12.3	13.1	13.2	9.2	2.4	1.0	15.3	10.7	12.5	2.5	1.4	0.6	4.5	0.6	4.2	0.4	4.0	3.0	0.8	1.0	5.6	4.5	4.1	2.8	3.9	0.7	3.1	1.3	11.0	11.9	25.2	26.5	14.4	12.8	9.4	11.6	10.2	6.9
AAMDC	"C11orf67, CK067, FLJ21035, PTD015"	ENSG00000087884	"Adipogenesis associated Mth938 domain containing"	Q9H7C9	11	77821109-77918432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.8"	"Cell line enhanced"	"Detected in all"		"CACO-2: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037918, HPA037919"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037918: AB_2675737, HPA037919: AB_2675738"	"unprognostic (3.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (6.02e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.84e-2)"	18.8	42.2	7.5	7.5	11.4	5.2	16.2	10.9	8.6	13.8	15.8	9.5	16.9	10.1	18.0	9.5	12.4	13.4	11.8	35.0	7.5	6.4	12.8	15.5	11.8	3.5	13.0	6.8	14.3	18.1	6.9	11.1	7.9	9.9	12.6	8.3	10.0	16.7	14.5	155.8	13.0	13.6	21.0	15.3	7.4	14.2	14.4	13.1	6.5	14.1	15.7	5.0	14.4	17.0	8.1	13.2	43.3	11.9	13.7	18.0	6.4	7.6	6.3	9.8	7.0	28.7	20.0	2.7	12.7	8.7	11.6	14.5	72.2	11.6	5.2	12.4	21.4	4.3	14.7	8.5	13.9	11.9	11.9	5.0	10.9	13.2	14.2	2.8	4.5	26.6	5.9	12.2	6.5	34.3	5.7	8.4	24.4	9.1	5.9	11.1	4.6	10.7	5.7	16.8	5.0	15.3	4.6	3.5	13.1	16.2	7.0	9.0	10.9	5.6	35.7	12.3	6.7	23.2	4.2	9.1	14.2	9.5	4.7	4.6	6.8	43.3	11.9	12.3	6.1	6.6	7.8	7.0	11.9	10.0	12.7	8.1	10.4	7.8	6.9	13.7	6.4	13.2	18.0	6.4	7.5	11.4	10.9	8.6	7.5	6.4	13.0	6.8	9.9	13.1
AAMP		ENSG00000127837	"Angio associated migratory cell protein"	Q13685	2	218264123-218270257	"Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017717, HPA031868"	Approved		Supported	Microtubules,Cytosol				Microtubules	Cytosol	"CAB017717: , HPA031868: "	"unprognostic (1.57e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.39e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (4.94e-7)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.09e-2)"	36.3	40.4	41.2	35.5	49.1	15.9	36.7	40.8	48.5	36.5	48.5	30.8	48.3	38.7	38.2	34.1	50.0	40.1	50.2	39.7	37.3	35.7	38.2	49.8	28.8	29.0	39.0	51.4	53.1	59.2	44.0	37.9	40.4	40.8	39.3	37.2	28.7	43.9	41.4	47.8	42.6	39.0	42.8	32.8	32.2	51.4	50.9	36.5	27.8	46.6	33.6	32.1	39.9	34.6	30.2	50.9	15.7	53.2	27.2	31.6	41.8	32.1	27.1	19.2	26.4	29.9	20.8	36.9	22.4	35.7	43.4	32.3	57.9	25.3	16.0	33.1	28.6	24.4	39.0	34.1	34.4	26.3	49.4	36.7	27.8	65.6	41.5	34.3	24.3	26.2	39.9	45.4	39.8	25.2	49.5	21.2	28.5	47.4	30.0	58.2	32.0	19.0	22.4	25.5	28.7	26.7	41.3	25.1	23.8	15.0	33.7	32.8	26.7	26.8	21.7	32.1	21.2	20.8	26.9	27.5	49.3	27.3	30.3	22.4	20.8	15.7	44.2	14.9	28.8	53.2	29.3	27.3	25.4	26.1	50.9	30.2	31.6	28.8	7.0	27.2	50.2	29.7	27.2	41.8	41.2	49.1	40.8	48.5	37.3	35.7	39.0	51.4	40.8	36.5
AANAT	SNAT	ENSG00000129673	"Aralkylamine N-acetyltransferase"	Q16613	17	76453351-76470117	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Melatonin biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 27.7;testis: 8.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.5;SCLC-21H: 5.6;U-266/70: 4.5;U-266/84: 4.7;U-698: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA054321			Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA054321: "	"unprognostic (7.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.81e-7)"	"unprognostic (1.04e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.34e-2)"	0.3	0.2	1.2	3.8	0.8	2.7	0.3	1.3	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.4	1.8	0.3	1.2	1.5	0.3	0.3	0.3	3.3	1.7	0.7	0.4	0.3	0.0	0.9	0.3	1.9	0.3	0.0	27.7	0.3	0.3	1.8	3.3	0.7	0.3	1.2	2.2	0.2	8.2	0.3	0.3	0.8	0.3	0.3	0.9	0.3	1.3	1.3	2.2	0.1	1.8	0.2	0.0	0.9	4.5	0.7	0.5	0.0	0.1	0.5	0.0	0.4	0.3	0.1	0.1	3.2	3.7	0.5	0.0	1.1	0.0	0.0	0.3	0.0	1.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.9	0.4	0.5	0.1	0.1	1.2	0.4	0.2	0.2	1.9	0.0	0.1	5.6	0.4	0.1	0.2	1.5	2.8	0.7	0.0	0.0	1.8	0.2	0.1	4.5	4.7	6.6	1.2	0.4	0.8	2.0	0.1	2.2	0.2	0.0	0.0	0.6	0.1	0.0	0.0	1.3	0.0	0.2	0.6	1.8	0.0	1.3	0.1	0.0	1.2	0.8	1.3	0.9	1.2	1.5	1.7	0.7	1.9	0.3
AAR2	"bA234K24.2, C20orf4"	ENSG00000131043	"AAR2 splicing factor homolog"	Q9Y312	20	36236459-36270918	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034220, HPA048645"	Uncertain		Approved	Cytosol				Cytosol		"CAB034220: AB_1564205, HPA048645: "	"unprognostic (1.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.54e-3)"	"prognostic unfavourable (1.83e-6)"	"unprognostic (5.09e-2)"	"unprognostic (6.84e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	18.8	22.3	9.8	11.6	14.0	18.4	20.0	11.3	19.0	17.0	21.9	21.3	12.9	12.3	27.3	21.3	16.1	19.7	16.5	16.2	9.9	9.2	16.2	22.2	15.5	23.1	13.2	12.5	19.5	21.0	19.5	9.5	20.6	13.6	22.8	14.3	20.3	22.7	18.7	19.3	21.9	17.8	23.2	13.0	16.8	20.4	38.5	10.8	28.8	17.8	17.1	15.6	23.1	19.4	20.6	27.5	28.4	30.1	31.7	30.9	28.7	11.6	14.0	13.1	15.0	22.5	15.1	10.8	11.4	15.2	27.1	21.3	31.5	15.8	8.1	16.2	16.5	16.8	21.4	22.0	17.2	7.3	12.7	25.5	9.4	19.0	17.0	17.4	12.9	18.5	31.2	19.4	14.8	16.5	15.8	16.1	14.6	14.2	23.9	21.1	11.3	23.1	13.4	22.0	18.4	15.2	9.1	15.2	16.4	17.0	45.4	14.4	26.1	18.6	11.6	25.5	16.2	15.0	14.2	14.4	18.0	16.0	18.1	11.6	13.3	28.4	25.5	22.9	25.8	27.3	25.8	19.0	24.3	24.7	27.5	20.6	30.9	26.2	5.2	31.7	30.1	22.4	27.5	28.7	9.8	14.0	11.3	19.0	9.9	9.2	13.2	12.5	13.6	10.8
AARS	"AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase"	P49588	16	70252295-70289543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034261, HPA040870, HPA044223"	Supported		Enhanced	Cytosol			700000	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	22.8	25.3	28.0	19.6	34.8	5.9	22.6	36.4	54.0	22.3	18.4	30.6	21.4	16.8	22.0	33.9	14.5	20.4	14.1	20.9	29.5	31.7	25.5	36.4	19.5	17.9	40.3	40.5	18.7	45.4	61.2	23.1	21.0	37.5	23.2	17.5	17.3	30.1	30.0	25.2	14.1	14.4	28.4	33.2	16.7	21.1	12.2	32.7	10.3	42.1	10.6	20.9	17.7	26.9	13.4	11.6	3.9	13.3	21.3	13.4	11.6	22.9	38.7	10.7	39.6	25.0	22.7	25.8	18.2	25.3	23.0	29.1	31.7	31.0	26.1	24.5	18.3	26.9	30.9	24.8	32.4	11.8	11.1	25.7	16.4	28.1	66.2	15.4	15.4	26.8	37.5	44.2	99.0	22.8	32.7	34.5	17.2	52.0	16.5	18.1	20.0	22.3	31.6	6.7	57.0	15.7	11.8	13.3	11.4	50.6	11.9	44.8	37.3	33.9	15.0	17.0	16.5	16.8	15.1	48.7	31.9	48.1	29.1	24.1	33.2	3.9	8.6	3.9	12.6	12.7	12.8	13.4	10.9	12.1	11.6	11.4	13.1	13.4	1.3	21.3	13.3	7.9	8.4	11.6	28.0	34.8	36.4	54.0	29.5	31.7	40.3	40.5	37.5	32.7
AARSD1	MGC2744	ENSG00000266967	"Alanyl-tRNA synthetase domain containing 1"	Q9BTE6	17	42950526-42964498	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021408, HPA022869, HPA023714"	Supported		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (2.85e-3)"	"unprognostic (9.78e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (1.67e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.69e-3)"	11.2	13.5	16.2	9.9	20.5	9.1	13.7	20.5	25.2	13.2	10.5	11.9	14.3	8.3	15.6	14.8	12.6	13.9	12.7	21.7	14.8	15.7	13.6	16.0	8.0	10.2	14.1	21.7	18.2	29.6	16.7	12.4	9.5	19.2	12.5	11.7	13.1	16.6	13.0	41.1	10.1	8.1	15.6	11.1	9.7	11.3	58.4	9.5	8.8	14.4	20.6	14.4	10.0	10.0	17.2	18.4	2.3	15.1	14.5	16.3	9.2	14.0	19.4	15.1	15.0	18.4	17.7	11.4	15.4	13.0	17.9	12.0	16.8	11.9	38.3	0.7	16.0	12.0	20.8	23.1	20.6	12.8	16.4	15.0	21.0	9.0	24.2	29.7	8.4	16.0	12.6	12.4	31.5	14.5	27.3	8.1	17.0	8.0	29.4	21.0	10.3	9.7	19.4	30.9	39.2	17.7	13.3	19.5	12.2	7.3	7.6	19.5	20.7	24.7	13.5	18.5	16.7	9.4	21.3	12.8	16.3	23.6	12.3	18.3	19.7	2.3	10.6	0.8	12.3	15.1	16.2	15.4	12.9	14.6	17.1	17.2	16.3	15.7	0.3	14.5	12.6	18.4	12.2	9.2	16.2	20.5	20.5	25.2	14.8	15.7	14.1	21.7	19.2	9.5
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: "	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.0	0.0	2.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.1	0.0	6.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0
ABCA13	"FLJ33876, FLJ33951"	ENSG00000179869	"ATP binding cassette subfamily A member 13"		7	48171458-48647496	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.5;LHCN-M2: 3.6;U-2 OS: 10.2;U-266/84: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063601			Approved	Vesicles,Centrosome,Cytosol				Vesicles	"Centrosome, Cytosol"	"HPA063601: "	"unprognostic (8.97e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.03e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.2	0.1	0.3	1.0	35.4	0.7	0.0	1.1	1.2	0.3	0.4	0.0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0.0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0.0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0.0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.3	1.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.5	1.2	2.1	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.1	2.1	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.6	10.2	0.4	1.5	3.0	4.1	0.0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1.0	0.3	0.6	0.1	0.2	0.1	1.0	0.0	1.1	1.8	0.2	0.1	0.0	0.4	0.0
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;lung: 75.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.8;T-47d: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.3	6.2	12.9	3.4	15.3	1.6	7.0	21.9	30.8	3.0	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6.0	4.7	18.3	5.3	2.1	4.9	8.5	5.0	5.0	4.2	2.5	5.0	11.3	3.7	3.0	7.2	6.1	5.6	16.2	0.5	6.4	3.0	1.3	0.2	0.5	0.0	0.6	2.0	1.5	0.4	0.3	9.5	1.8	14.8	0.4	0.0	0.1	2.6	0.6	1.0	1.1	1.3	1.5	0.1	3.8	1.1	0.2	8.5	0.1	0.3	14.9	5.7	0.9	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	14.4	10.2	0.0	0.0	12.7	0.0	1.0	2.0	4.6	2.3	0.3	1.6	8.5	0.3	20.8	14.9	1.8	10.5	0.2	34.2	0.9	4.1	0.1	0.5	4.0	4.2	2.8	1.2	0.0	2.1	5.1	0.1	0.0	0.1	0.0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0.0	2.0	0.6	0.0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867292-68955392	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 16.2;ASC TERT1: 36.1;HSkMC: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	29.1	25.2	10.0	3.4	27.2	0.5	15.1	3.2	15.4	7.3	12.8	29.9	3.9	5.4	10.2	13.0	12.4	17.6	14.3	30.0	12.5	5.5	8.1	26.6	15.2	1.3	37.8	9.2	44.7	5.1	4.5	14.8	7.6	22.2	10.3	14.3	16.4	9.8	7.9	8.9	4.9	9.9	7.1	28.2	9.9	11.5	15.8	42.7	0.0	13.0	14.2	2.8	13.6	20.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	16.2	36.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	6.0	0.0	0.0	27.3	0.0	0.4	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.0	27.2	3.2	15.4	12.5	5.5	37.8	9.2	22.2	42.7
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 29.4;HEK 293: 9.0;HEL: 16.3;Hep G2: 8.1;RPTEC TERT1: 11.3;SH-SY5Y: 36.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"									"CAB001716, HPA002199"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Focal adhesion sites, Cytosol"		"CAB001716: , HPA002199: AB_1844428"	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favourable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favourable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	9.0	16.3	1.9	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.3	0.0	0.4	36.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168922938-169031322	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 47.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.0;NB-4: 1.6;PC-3: 1.0;THP-1: 2.5;TIME: 1.8;U-2197: 2.8"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	1.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209766-219219017	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"			22000	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: "	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavourable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavourable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.1	8.4	8.2	3.9	13.5	10.2	9.2	7.6	9.1	6.9	7.6	5.4	8.3	8.1	7.1	10.1	9.0	8.4	8.5	9.5	5.6	8.2	6.9	16.2	7.2	4.9	9.8	7.6	13.1	7.1	8.0	6.0	3.7	9.2	9.2	4.2	6.0	5.6	11.3	24.0	5.5	8.0	9.5	9.2	3.2	6.8	19.5	7.7	0.8	9.9	11.3	4.7	14.8	6.0	2.8	5.6	1.3	1.1	1.2	3.2	2.4	0.1	10.0	2.0	12.6	14.1	5.0	12.4	3.7	3.5	4.1	4.1	15.3	2.2	0.1	19.3	3.6	21.6	0.2	1.5	1.3	6.4	2.2	15.6	11.0	28.2	17.0	0.0	5.2	7.4	1.8	2.7	0.0	7.2	13.3	1.9	2.8	5.1	1.0	0.1	3.2	4.1	5.2	6.4	0.6	2.2	0.2	7.4	7.9	7.8	18.5	8.2	5.5	0.3	3.2	5.5	0.2	7.4	4.3	5.1	4.0	0.0	6.3	0.1	7.4	1.3	1.1	0.0	1.7	0.9	0.5	2.8	1.3	0.7	0.9	2.3	3.2	2.1	0.0	1.2	0.8	5.6	1.1	2.4	8.2	13.5	7.6	9.1	5.6	8.2	9.8	7.6	9.2	7.7
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;pancreas: 25.5;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	5	"A549: 4.6;AN3-CA: 3.7;SCLC-21H: 6.5"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: "	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	1.3	6.7	4.4	0.8	6.1	0.9	4.0	28.0	12.3	3.0	1.3	2.6	7.7	1.9	3.1	3.7	0.8	1.2	0.9	2.9	5.1	4.8	1.0	0.8	2.9	0.8	3.6	7.2	0.9	25.5	1.0	26.6	1.6	8.5	2.8	1.3	0.7	0.9	8.5	2.3	1.1	1.5	1.3	4.0	0.9	3.5	1.1	2.3	0.0	6.2	0.0	0.8	0.7	0.8	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	4.6	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.4	6.1	28.0	12.3	5.1	4.8	3.6	7.2	8.5	2.3
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797401-21942529	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.2;BJ hTERT+: 9.9;CACO-2: 15.7;HSkMC: 20.5;U-138 MG: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavourable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	21.6	4.7	5.5	2.6	5.4	1.2	25.8	1.5	8.6	12.4	6.8	4.8	5.1	3.0	15.3	6.3	9.1	9.5	9.6	26.2	5.7	2.6	5.6	31.1	6.2	2.7	2.9	4.2	11.8	5.8	1.7	2.7	2.8	5.5	7.0	1.6	10.8	4.8	8.4	33.2	3.3	4.1	17.1	4.9	3.5	9.1	3.4	4.2	0.1	6.3	14.5	1.2	9.5	8.4	1.6	0.9	1.8	0.8	0.5	0.9	0.0	0.6	0.1	7.3	0.2	17.2	7.8	0.2	4.0	9.9	4.4	2.2	15.7	0.6	0.3	0.8	0.4	0.2	0.0	0.0	4.6	0.2	0.1	0.3	0.5	0.2	0.0	0.3	0.4	20.5	0.0	4.4	1.6	0.0	0.2	0.9	0.2	0.9	0.1	0.2	1.0	0.4	0.3	0.2	0.2	0.0	0.8	0.3	1.2	0.2	0.3	0.1	0.8	0.2	0.2	17.1	1.2	1.4	5.2	0.7	0.8	0.3	4.2	0.2	0.3	0.9	0.5	0.4	0.9	0.4	0.6	0.7	0.7	0.7	0.2	1.6	0.6	0.8	1.8	0.5	0.8	0.9	0.4	0.0	5.5	5.4	1.5	8.6	5.7	2.6	2.9	4.2	5.5	4.2
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145097932-145129179	"Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol				Cytosol		"CAB012476: , HPA036846: "	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favourable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	27.5	19.4	17.5	23.3	23.7	17.5	25.3	21.0	23.2	20.8	16.5	17.7	14.7	14.4	19.5	15.8	28.5	19.4	16.4	19.5	19.5	18.0	23.1	40.1	17.3	27.3	22.1	15.5	28.2	34.2	23.0	31.7	21.2	26.0	18.4	21.1	11.0	19.0	15.1	33.1	19.9	14.1	20.7	22.1	29.0	16.7	21.2	20.7	36.5	20.1	29.7	29.5	26.0	19.0	9.9	13.2	1.0	8.8	10.4	18.2	9.9	26.4	13.9	21.5	14.8	18.7	27.1	21.1	29.0	21.0	35.4	25.0	20.9	25.2	43.5	9.4	25.8	17.8	32.0	37.8	48.0	24.2	18.8	24.5	10.4	18.5	24.7	56.4	19.8	20.0	26.5	37.4	52.9	37.9	49.2	32.6	37.7	15.9	54.0	18.9	17.7	32.2	28.8	25.9	31.1	26.6	17.7	26.9	13.2	17.7	30.1	20.8	17.9	22.1	25.0	35.1	21.6	24.4	35.0	29.2	46.6	46.5	21.5	49.3	38.8	1.0	6.7	0.7	9.2	8.8	18.2	9.9	11.1	11.1	13.2	9.2	15.6	12.9	0.6	10.4	8.1	7.4	12.4	9.9	17.5	23.7	21.0	23.2	19.5	18.0	22.1	15.5	26.0	20.7
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571376-30597179	"Plasma proteins, Predicted intracellular proteins"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol				Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	16.1	12.5	12.1	11.8	13.9	31.9	12.4	12.1	15.7	11.4	13.7	9.8	9.5	7.1	17.0	9.6	14.6	10.9	10.6	13.1	12.0	7.3	15.5	18.3	13.5	9.4	10.6	10.5	12.5	14.0	23.1	16.6	21.6	13.7	12.4	13.6	9.2	14.1	15.3	70.6	21.3	17.6	15.2	12.7	13.9	19.6	22.0	13.2	14.7	13.8	14.9	13.0	14.2	13.5	10.1	9.3	4.1	7.9	11.9	14.3	6.5	12.0	5.4	7.1	9.6	7.9	5.2	3.2	10.2	5.3	7.1	9.8	17.9	3.0	10.1	11.2	6.4	8.7	10.4	5.9	13.7	7.2	9.0	12.3	7.5	5.6	2.5	12.5	4.0	4.6	6.2	11.0	2.8	2.2	22.5	3.7	7.8	2.6	6.5	2.8	4.9	3.3	20.6	7.0	10.6	5.4	11.0	6.5	13.3	5.6	15.5	3.0	3.9	3.4	7.1	13.8	4.2	3.2	5.5	13.5	21.8	17.6	1.5	14.6	10.0	4.1	7.9	3.4	14.3	6.7	12.2	10.1	10.4	12.8	7.1	9.1	9.5	9.7	3.7	11.9	7.3	9.3	5.9	6.5	12.1	13.9	12.1	15.7	12.0	7.3	10.6	10.5	13.7	13.2
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000033050	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151212490-151227230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA020091, CAB020682, HPA021815, HPA030388"	Approved		Enhanced	Cytosol				Cytosol		"CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"	"unprognostic (6.80e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (9.52e-6)"	"unprognostic (1.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.84e-3)"	18.3	15.4	14.9	15.9	18.8	9.7	12.6	19.0	29.6	10.9	14.2	16.3	12.9	9.5	14.9	17.7	16.1	13.7	13.6	22.2	14.5	17.4	14.2	10.6	12.4	16.1	16.4	23.3	13.6	17.7	25.1	14.9	15.2	17.1	13.9	17.7	13.7	12.5	16.8	46.6	17.4	10.7	21.7	12.7	15.5	13.9	20.7	16.7	15.8	14.8	16.5	22.4	14.5	11.2	13.0	14.2	6.8	15.0	15.7	22.4	14.5	17.8	29.0	10.1	36.1	20.7	17.4	13.8	21.6	18.6	28.2	24.0	24.6	12.5	29.3	18.8	24.2	14.1	31.8	26.5	27.5	14.6	26.5	12.2	14.4	14.9	24.4	28.8	19.5	22.9	22.5	31.4	18.5	23.7	34.9	12.3	25.1	45.2	32.0	34.3	24.5	31.5	20.6	16.3	27.0	19.4	13.0	17.7	17.1	20.6	21.7	14.5	9.3	14.9	21.2	18.0	7.3	21.5	32.7	23.9	25.5	21.6	24.9	28.9	34.1	6.8	12.1	4.0	15.9	14.3	22.4	12.7	16.2	15.9	14.2	13.0	15.3	15.8	1.7	15.7	15.0	10.2	16.9	14.5	14.9	18.8	19.0	29.6	14.5	17.4	16.4	23.3	17.1	16.7
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000285292	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151207837-151227166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA020091, HPA021815, HPA030388"	Approved		Uncertain	Cytosol				Cytosol		"HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"																		7.9	4.3	4.4	6.5	6.4	2.4	6.1	4.2	10.8	5.5	5.4	5.4	4.0	3.6	5.7	3.3	6.1	5.8	4.3	4.5	4.1		6.2	5.2	5.8	6.1	5.0	8.3	4.0	6.0	10.8	2.7	4.1	5.7	4.1	5.2	4.4	2.9	5.8	20.3	5.6	3.1	6.0	3.1	5.9	3.3	7.2	5.6	5.2	4.9	5.5	6.8	4.8	3.3	8.5	11.3	8.7	9.8	10.0	24.2	13.4	12.5	11.6	8.9	18.6	10.3	12.0	4.9	18.0	9.9	8.6	11.3	9.2	10.2	19.3	13.6	16.5	9.9	14.1	14.1	18.1	7.7	4.2	12.0	9.4	5.5	18.6	24.0	4.6	11.3	9.8	20.4	17.6	14.9	26.1	8.8	15.3	9.6	26.1	0.9	8.1	9.3	8.6	9.9	20.1	3.9	10.2	3.5	9.6	19.9	10.8	7.9	5.8	10.1	13.9	8.3	2.3	12.8	20.3	12.2	12.9	22.5	15.8	19.3	7.6	8.7	9.8	2.3	10.3	7.1	24.2	8.5	14.4	12.6	11.3	8.4	12.7	12.0	0.7	10.0	5.5	6.8	12.7	13.4										
ABCF3	EST201864	ENSG00000161204	"ATP binding cassette subfamily F member 3"	Q9NUQ8	3	184186023-184194012	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036332	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA036332: AB_10603571"	"unprognostic (1.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.16e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.53e-2)"	13.0	47.0	18.9	10.6	19.7	12.4	12.7	23.0	27.2	15.3	12.1	15.4	33.8	13.1	13.5	11.1	16.1	15.0	10.8	22.9	15.4	16.8	16.5	22.3	12.1	12.7	15.4	15.1	17.8	19.7	41.6	17.9	16.0	19.8	13.3	11.8	15.5	21.4	30.1	33.8	15.2	12.8	10.8	12.3	14.9	13.3	12.6	18.6	8.8	15.4	14.4	14.2	12.5	13.8	16.1	16.4	13.9	19.4	14.5	25.4	21.5	21.9	13.6	7.8	15.0	22.7	12.8	15.4	15.9	17.8	21.7	17.0	23.2	8.8	13.2	32.3	17.1	21.1	12.1	16.8	11.3	16.9	11.6	11.4	11.9	13.6	19.2	12.8	11.7	18.8	15.5	15.3	15.3	15.5	10.5	16.0	15.3	26.4	12.5	8.2	11.8	18.8	12.6	13.0	22.3	11.9	13.3	13.5	7.8	16.5	31.8	14.7	43.0	11.2	15.1	11.6	12.7	18.2	23.6	18.2	17.5	17.1	18.1	12.8	14.2	5.3	18.6	13.9	22.7	19.4	23.5	16.0	20.1	18.7	16.4	16.1	25.4	20.5	9.3	14.5	19.1	10.1	17.2	21.5	18.9	19.7	23.0	27.2	15.4	16.8	15.4	15.1	19.8	18.6
ABHD13	"bA153I24.2, BEM46L1, C13orf6, FLJ14906"	ENSG00000139826	"Abhydrolase domain containing 13"	Q7L211	13	108218379-108234255	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032143, HPA032144"	Approved		Approved	Cytosol				Cytosol		"HPA032143: AB_2674178, HPA032144: AB_10602304"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.62e-2)"	13.6	12.5	13.8	14.3	14.2	26.7	14.9	17.0	15.5	13.6	17.0	6.8	14.5	13.8	16.3	21.0	15.2	13.5	13.8	12.9	11.7	10.4	12.5	20.1	15.4	14.8	10.1	10.4	13.2	12.4	9.6	14.1	16.5	11.1	13.0	15.0	10.5	14.7	18.1	12.9	12.7	16.7	13.7	10.1	20.0	13.9	8.9	8.2	26.4	15.4	11.3	14.5	13.3	18.6	8.5	8.9	19.2	10.4	11.8	11.8	10.1	9.0	3.8	10.1	5.6	7.9	9.4	4.9	8.9	9.0	7.9	9.4	5.7	8.6	7.6	9.4	6.9	8.3	7.5	10.4	12.6	10.2	6.6	9.3	5.4	5.7	7.9	19.2	11.5	9.7	9.9	6.2	8.0	9.3	5.0	4.3	8.1	3.7	9.3	8.1	4.7	4.5	8.0	7.2	4.4	11.1	8.1	7.7	9.6	4.7	7.9	9.6	7.4	17.9	9.6	5.6	5.8	6.6	6.0	8.5	6.7	8.4	13.3	12.1	10.2	8.7	10.4	19.2	8.0	9.5	11.8	8.5	10.9	9.5	8.9	8.1	10.5	8.7	11.3	11.8	8.4	6.7	10.2	10.1	13.8	14.2	17.0	15.5	11.7	10.4	10.1	10.4	11.1	8.2
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol			2600000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favourable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favourable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	40.0	34.2	6.2	19.8	7.5	11.4	25.2	10.7	7.0	21.9	33.6	8.6	32.1	30.3	19.6	21.7	27.7	22.0	32.9	12.2	6.2	5.8	42.6	78.4	21.5	35.1	7.8	7.3	29.5	45.0	14.2	15.2	11.4	6.7	30.9	20.2	29.1	39.4	35.0	11.7	16.0	58.7	22.6	8.9	23.3	18.7	11.2	6.2	26.0	35.3	15.2	32.5	24.6	16.9	24.9	15.5	12.5	9.4	9.9	27.2	14.0	10.1	8.7	0.7	10.2	28.4	25.3	2.6	4.0	4.8	7.5	8.7	6.4	20.2	11.5	3.2	14.1	5.1	6.3	5.8	5.7	15.6	6.8	18.0	7.5	25.1	15.3	10.1	18.6	32.7	20.1	7.6	10.3	9.1	10.4	18.3	14.4	9.9	4.4	7.7	0.9	22.2	11.4	1.4	51.6	13.6	4.2	4.3	4.6	10.2	19.1	32.6	27.5	6.9	8.5	4.0	18.8	9.0	2.4	23.4	10.9	4.7	8.6	32.3	6.9	12.5	9.4	4.2	18.3	7.6	27.2	24.9	23.0	22.4	15.5	18.7	23.4	21.3	0.8	9.9	4.8	11.3	16.3	14.0	6.2	7.5	10.7	7.0	6.2	5.8	7.8	7.3	6.7	6.2
ABHD15		ENSG00000168792	"Abhydrolase domain containing 15"	Q6UXT9	17	29560547-29567137	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA014470	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"			"Nucleoplasm, Cytosol"		"HPA014470: AB_1852993"	"unprognostic (1.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.45e-2)"	22.6	3.5	4.9	6.0	3.2	5.4	21.6	2.9	4.1	3.8	8.8	4.2	4.4	8.5	4.2	3.1	4.1	4.3	7.8	6.6	2.1	1.9	8.4	21.2	5.6	12.7	2.7	3.9	2.8	10.9	8.8	8.5	3.2	4.3	4.0	5.0	3.6	4.5	4.6	2.1	3.4	12.7	5.5	3.3	9.1	6.3	1.4	4.6	1.6	5.2	2.7	6.0	5.6	9.1	2.0	17.0	11.1	0.4	7.2	5.0	0.7	3.8	14.9	1.9	5.3	20.6	9.0	7.9	5.3	5.9	5.3	4.8	3.4	2.0	5.7	3.9	5.6	10.6	6.6	2.2	2.9	17.6	5.0	2.3	7.4	4.3	6.3	5.9	10.7	6.7	6.1	5.1	0.9	3.8	3.0	5.5	2.8	5.2	5.6	6.9	0.4	4.5	13.1	7.3	13.2	9.4	5.9	1.3	2.2	7.9	3.6	2.0	9.1	13.7	4.7	3.0	3.9	7.6	4.6	9.3	6.2	3.0	6.1	3.7	6.5	11.1	0.4	1.8	1.9	0.2	5.0	1.0	1.0	1.7	1.0	2.0	0.3	1.0	0.5	7.2	0.2	17.0	0.9	0.7	4.9	3.2	2.9	4.1	2.1	1.9	2.7	3.9	4.3	4.6
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2"	P08910	15	89087459-89202360	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEL: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 29.0;neutrophil: 22.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favourable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	13.2	24.8	14.8	9.5	19.3	15.6	11.7	25.2	23.4	10.7	16.1	12.0	6.5	23.4	18.2	34.7	9.0	12.1	32.2	24.5	12.2	11.3	11.8	76.4	22.2	11.2	11.1	14.8	13.1	28.3	11.2	18.1	5.6	19.8	22.9	9.6	22.6	11.8	10.0	19.3	7.5	18.5	11.4	8.3	14.2	35.8	42.9	7.6	7.7	8.6	8.1	12.1	13.5	10.4	1.1	3.0	29.0	7.0	4.7	3.5	2.5	8.0	15.5	3.8	4.1	7.5	10.2	2.1	5.4	16.2	5.2	4.9	3.9	14.0	2.3	6.3	6.7	10.7	8.4	6.6	7.3	12.0	3.8	83.5	3.6	2.9	3.9	5.7	19.7	5.2	4.7	18.5	11.9	6.3	7.4	7.2	14.2	3.3	3.5	1.4	1.7	4.6	5.1	8.0	17.4	6.9	12.6	6.6	9.9	10.3	4.9	8.6	5.4	4.5	9.6	18.3	6.2	6.6	13.6	5.9	11.7	2.7	14.9	5.3	14.2	3.1	5.6	29.0	1.6	4.8	0.9	1.1	1.5	1.5	3.0	1.1	1.4	1.5	22.7	4.7	7.0	2.4	3.5	2.5	14.8	19.3	25.2	23.4	12.2	11.3	11.1	14.8	19.8	7.6
ABI1	"ABI-1, E3B1, SSH3BP1"	ENSG00000136754	"Abl interactor 1"	Q8IZP0	10	26746593-26861087	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008375, HPA029973, HPA068407"	Approved		Enhanced	"Plasma membrane,Cell Junctions,Cytosol"			400000	"Plasma membrane, Cell Junctions"	Cytosol	"CAB008375: AB_592744, HPA029973: , HPA068407: "	"unprognostic (2.83e-3)"	"unprognostic (8.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	24.0	14.0	32.0	28.1	32.6	54.1	21.4	28.2	35.5	22.5	22.7	19.8	14.8	24.8	23.9	15.4	45.1	20.3	21.6	14.1	47.3	23.1	21.9	17.8	22.5	32.1	25.0	26.4	25.3	17.0	19.1	14.4	22.7	20.9	19.1	24.8	26.7	30.9	17.0	16.6	33.0	26.0	21.6	27.5	25.5	23.9	12.4	20.5	43.5	18.8	27.3	40.9	25.2	30.3	36.1	26.8	51.5	28.0	20.5	44.5	31.5	23.2	13.1	10.7	10.5	16.2	20.0	16.0	23.6	16.1	17.5	20.4	15.3	27.6	42.8	12.1	25.0	26.1	12.9	15.3	19.5	28.5	11.5	18.8	8.9	10.8	11.1	9.1	19.0	13.6	19.5	17.1	10.2	21.1	13.8	27.4	17.8	10.0	21.3	8.7	8.8	6.3	23.1	19.9	27.5	18.6	10.8	8.9	9.5	19.6	19.2	19.7	12.4	14.5	26.2	13.4	16.5	16.9	12.0	6.1	9.8	50.9	19.3	23.3	9.6	35.5	23.8	51.5	27.0	28.0	25.8	36.1	25.9	30.0	26.8	28.6	24.4	26.5	37.9	20.5	26.7	22.3	44.5	31.5	32.0	32.6	28.2	31.9	47.3	23.1	25.0	26.4	20.9	20.5
ABLIM1	"abLIM, LIMAB1, limatin"	ENSG00000099204	"Actin binding LIM protein 1"	O14639	10	114431113-114685003	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 43.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 84.9"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 43.9"	"Group enriched"	"Detected in many"	11	"B-cells: 14.8;NK-cells: 17.1;T-cells: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038951, HPA038952"	Approved		Supported	Cytosol				Cytosol		"HPA038951: AB_10673017, HPA038952: AB_10670915"	"unprognostic (2.25e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.23e-1)"	"prognostic favourable (2.72e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.87e-2)"	66.7	23.6	11.2	16.8	14.1	3.0	21.2	84.9	14.1	18.7	14.7	6.8	10.7	9.6	16.9	9.8	73.5	13.7	14.1	55.9	10.0	9.2	14.1	7.3	15.7	13.8	10.1	5.6	64.4	7.4	12.8	22.7	8.3	12.8	14.0	15.3	26.6	53.8	18.6	18.6	25.3	16.0	15.4	9.9	8.4	31.3	17.2	3.1	38.3	75.8	44.3	70.4	20.3	28.0	14.8	0.1	2.3	0.0	17.1	43.9	12.7	11.7	8.6	31.3	7.1	0.3	0.1	0.3	2.4	0.8	0.6	1.4	11.8	19.0	15.6	33.7	2.8	25.8	10.3	16.7	0.7	5.3	9.1	0.1	25.1	32.4	0.1	6.1	0.1	0.4	43.2	4.1	13.7	12.4	0.0	24.2	0.1	4.4	1.2	2.7	12.0	10.0	0.5	6.6	20.2	10.0	26.7	10.9	13.5	10.1	15.5	5.6	7.9	0.0	8.4	0.0	11.3	0.2	4.6	0.1	0.0	36.2	0.5	13.6	0.2	2.3	0.0	0.2	8.8	0.0	17.0	12.4	16.5	9.9	0.1	14.8	43.9	27.8	0.7	17.1	0.0	0.1	8.9	12.7	11.2	14.1	84.9	11.1	10.0	9.2	10.1	5.6	12.8	3.1
ABR	MDB	ENSG00000159842	"Active BCR-related"	Q12979	17	1003518-1229021	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 19.2;HEK 293: 10.4;LHCN-M2: 12.9;RPMI-8226: 11.0;TIME: 21.3;U-251 MG: 21.5;U-698: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"basophil: 8.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053618, HPA054824"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA053618: , HPA054824: "	"unprognostic (1.69e-1)"	"prognostic favourable (4.03e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.20e-3)"	"unprognostic (4.43e-3)"	"prognostic favourable (2.21e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.74e-2)"	12.9	5.8	31.8	18.0	28.7	6.0	5.8	7.0	43.6	6.6	19.9	12.0	2.3	9.4	7.9	4.0	11.0	6.1	6.7	26.6	24.0	16.9	6.8	4.0	9.3	6.9	14.1	27.0	3.9	5.0	8.3	6.0	7.2	11.3	4.6	21.6	19.4	23.7	3.4	2.9	5.9	11.9	25.1	8.1	8.1	13.6	3.8	11.3	2.9	7.0	2.3	18.0	7.2	7.4	0.3	0.7	8.9	0.8	0.0	0.8	0.0	0.5	0.6	0.2	0.0	0.9	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.0	19.2	0.3	0.1	0.1	2.1	0.0	0.4	5.9	10.4	0.0	0.2	0.0	0.4	2.3	6.8	0.2	0.0	0.1	6.8	0.0	0.0	0.0	12.9	0.8	0.0	2.6	0.1	0.1	0.1	0.0	11.0	0.1	0.2	0.2	0.3	0.1	0.0	1.0	6.0	3.0	21.3	0.1	0.2	2.1	21.5	0.0	0.2	15.7	1.0	4.2	0.4	8.9	0.3	1.0	0.2	0.8	0.4	0.1	0.3	0.0	0.7	0.3	0.0	0.3	0.9	0.0	0.4	0.0	0.8	0.0	31.8	28.7	7.0	43.6	24.0	16.9	14.1	27.0	11.3	11.3
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028682-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.9"	"Cell line enhanced"	"Detected in many"		"HL-60: 71.8;NB-4: 76.3;U-937: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol			7400000	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favourable (1.65e-6)"	12.2	4.2	12.0	25.5	10.1	23.1	22.1	1.8	19.0	6.5	28.4	2.4	10.6	22.6	10.3	43.8	23.5	6.0	10.9	7.9	15.1	7.1	29.0	26.8	14.0	39.0	5.5	10.3	5.1	9.5	10.3	9.3	12.9	4.8	8.2	26.9	4.3	19.9	9.7	2.3	12.8	35.5	7.1	5.1	45.6	13.7	20.1	5.0	60.2	13.2	19.2	26.0	23.0	9.0	17.1	37.2	30.5	82.9	24.6	48.8	51.8	11.0	5.9	15.2	14.2	6.0	9.5	16.6	8.8	6.3	6.6	13.7	13.1	12.9	0.0	16.1	8.7	16.8	13.3	19.0	7.8	29.3	24.6	43.1	3.3	4.5	8.8	71.8	19.8	8.5	16.0	8.9	7.4	34.8	5.4	15.1	19.0	23.2	44.7	76.3	18.2	11.6	28.9	9.4	3.4	17.9	32.7	34.0	3.7	6.0	16.8	27.5	6.7	53.9	25.8	4.3	3.6	8.8	15.6	8.2	23.4	3.0	5.4	74.2	12.5	30.5	31.7	18.9	29.8	55.8	46.1	15.3	48.8	38.1	33.8	17.1	47.7	44.3	8.6	24.6	82.9	37.2	43.5	51.8	12.0	10.1	1.8	19.0	15.1	7.1	5.5	10.3	4.8	5.0
ABRAXAS2	"ABRO1, Em:AC068896.4, FAM175B, KIAA0157"	ENSG00000165660	"Abraxas 2, BRISC complex subunit"	Q15018	10	124801785-124836670	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037591, HPA037592, HPA074089"	Approved		Supported	Cytosol				Cytosol		"HPA037591: AB_10671877, HPA037592: , HPA074089: "	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	18.4	17.3	16.1	13.1	16.5	14.3	17.0	16.3	20.5	15.6	14.8	10.6	8.1	13.7	16.0	13.3	17.9	13.9	11.2	13.2	15.1	14.5	18.6	19.9	12.5	15.4	13.1	14.4	15.1	11.8	17.5	13.9	17.7	15.9	13.5	14.5	8.5	14.9	13.5	32.2	19.1	20.8	14.4	16.1	20.3	13.2	11.1	12.1	23.9	20.5	16.0	17.4	16.2	16.2	12.2	13.9	18.5	15.2	7.8	12.2	7.7	14.0	9.6	10.4	14.2	13.5	13.4	9.0	14.6	23.0	17.4	16.2	7.7	13.6	15.8	12.4	15.7	15.9	16.3	13.7	18.5	13.7	11.3	12.0	8.0	9.6	17.3	20.5	12.6	14.7	16.7	17.1	31.1	13.1	12.5	10.9	14.1	9.2	15.7	18.4	8.9	9.0	12.7	11.0	9.6	12.8	7.2	7.2	13.2	11.6	11.2	15.7	9.2	14.2	11.3	9.4	7.5	10.9	17.3	11.4	10.6	15.3	12.3	10.2	6.6	18.5	11.4	10.4	8.9	15.2	12.2	12.1	10.3	12.1	13.9	12.2	11.2	12.1	4.6	7.8	12.0	9.4	11.9	7.7	16.1	16.5	16.3	20.5	15.1	14.5	13.1	14.4	15.9	12.1
ABTB1	"BPOZ, Btb3, BTBD21, EF1ABP"	ENSG00000114626	"Ankyrin repeat and BTB domain containing 1"	Q969K4	3	127672935-127680920	"Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 107.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035022, HPA035023"	Uncertain		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035022: AB_10669998, HPA035023: AB_10602104"	"unprognostic (6.76e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.55e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.92e-3)"	20.4	13.7	11.7	17.7	20.1	42.3	14.2	43.4	27.2	15.4	14.3	13.8	12.9	12.3	15.6	10.9	9.6	13.1	17.6	20.4	10.9	8.2	11.4	8.3	15.5	22.1	9.7	15.8	15.8	11.2	7.8	15.3	12.0	11.4	13.5	4.9	12.4	15.2	14.5	25.1	11.6	13.0	13.3	7.5	41.4	11.7	5.9	12.5	17.8	10.2	9.1	10.4	14.6	17.4	2.9	3.8	107.3	8.6	3.2	5.8	5.1	3.1	7.5	0.7	1.5	7.2	6.8	5.7	5.0	8.6	3.4	4.8	0.2	6.6	1.4	8.9	3.8	1.4	0.0	3.7	0.8	14.5	2.1	2.3	13.4	1.8	5.7	0.3	7.0	8.5	4.0	3.5	0.9	3.6	0.1	10.2	3.7	5.0	3.4	9.8	0.6	8.3	2.1	4.2	9.7	5.1	1.9	7.0	4.6	3.6	4.3	18.1	1.1	2.5	6.5	3.6	3.0	6.4	1.6	8.3	2.7	0.4	8.4	2.9	5.6	4.5	8.6	20.5	2.4	6.2	2.3	2.5	2.6	2.3	3.8	2.9	2.2	1.9	107.3	3.2	5.4	2.4	5.8	5.1	11.7	20.1	43.4	27.2	10.9	8.2	9.7	15.8	11.4	12.5
AC004922.1		ENSG00000284292			7	99325879-99394653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA004334	Uncertain		Approved	"Cell Junctions,Cytosol"				"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"																		6.0	5.2	4.2	9.4	6.2	6.9	7.8	3.2	9.1	5.3	6.6	4.6	5.6	13.8	5.8	3.8	5.3	5.0	4.5	4.9	7.1		4.1	6.3	4.6	8.1	3.2	6.0	3.9	6.4	3.0	4.1	5.2	6.2	5.0	3.1	4.9	3.3	5.4	4.6	2.4	9.6	4.2	3.0	6.5	7.0	3.9	3.2	2.9	6.0	6.4	4.4	4.6	4.1	7.9	13.0	18.1	16.3	5.1	11.9	18.0	4.1	3.9	0.4	1.0	0.5	2.8	5.0	3.3	1.8	3.0	3.1	7.1	5.8	4.4	10.8	3.4	2.8	1.2	3.7	0.6	2.1	7.4	2.5	2.9	1.9	0.9	2.7	3.1	2.6	1.1	3.1	1.2	4.3	3.8	4.0	2.1	7.8	4.8	1.2	2.6	11.8	2.1	1.1	1.5	0.6	2.0	1.1	1.0	2.8	4.6	8.3	2.1	1.7	2.9	4.8	2.6	7.1	4.2	0.0	2.2	4.7	2.9	4.1	5.7	9.2	15.5	18.1	7.1	16.3	5.1	7.3	7.0	6.9	13.0	7.9	6.1	6.1	13.9	5.1	15.0	8.9	11.9	18.0										
AC005324.3		ENSG00000251537			17	15571491-15651653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"esophagus: 23.3;tongue: 21.1;vagina: 17.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.5;HeLa: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023623, HPA066431"	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: "	"unprognostic (3.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.80e-11)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.09e-1)"	7.5	2.8	0.9	1.5	1.0	1.0	7.7	0.9	1.0	5.3	2.2	1.3	0.0	2.1	0.7	1.5	23.3	0.8	4.0	2.6	0.8	0.9	0.9	1.0	2.1	1.6	3.7	0.0	0.7	1.0	0.8	0.7	12.4	2.7	1.4	0.9	0.2	2.4	1.1	2.9	4.4	1.6	2.1	1.5	1.0	2.8	1.8	1.0	1.6	1.8	21.1	17.5	3.2	17.9	0.6	0.6	0.0	0.1	0.0	0.5	0.0	0.6	3.5	0.1	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	3.1	0.1	0.1	1.0	6.5	0.0	0.0	0.1	1.0	0.2	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.9	1.0	0.8	0.9	3.7	0.0	2.7	1.0
AC008403.1		ENSG00000268465			19	48465837-48472431	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.7;intestine: 3.6;testis: 4.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;LHCN-M2: 3.6;NB-4: 3.7;U-698: 5.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA060662			Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA060662: "																		0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.5	0.1	3.6			0.0	2.7	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.2		0.3	0.0	0.0	0.1	0.0		0.3	0.0		0.1	0.0	0.3	0.1	1.6	0.0	0.2	0.1	0.5	4.7			0.1		0.0	0.0	0.0	1.0	0.5	0.7	0.4	0.0	1.0	0.0	0.0	0.0	0.0	2.9	2.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.6	2.3	1.3	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.3	0.0	3.6	0.0	0.0	3.7	1.9	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.2	0.0	1.5	0.1	0.0	0.0	0.0	0.9	1.8	0.0	0.0	0.9	0.9	5.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.2	1.0	0.3	0.4	0.3	0.0	0.6	0.1	0.0	0.0	0.4	0.5	1.0	0.0										
AC008687.1		ENSG00000267335			19	49022953-49036895	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"pancreas: 8.2;pituitary gland: 19.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 7.2;U-251 MG: 10.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA038925	Uncertain		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA038925: "																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	8.2	0.0	19.9	0.5		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.9	0.2	0.1	0.2	0.0	1.8	0.0	0.0	0.1	0.3	0.1	1.2	0.0	0.3	0.0	1.0	0.0	0.0	0.6	0.2	0.9	0.0	0.9	0.1	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.5	0.2	0.0	0.0	0.1	1.2	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.4	0.1	0.5	0.2	0.4	0.0	2.6	2.3	0.6	10.4	0.5	2.4	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC008695.1		ENSG00000273217			5	131425891-131796983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A549: 6.9;HL-60: 1.3;HMC-1: 2.7;U-937: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 11.1"									"HPA037982, HPA037983"	Uncertain		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: "																		4.0	2.5	3.6	2.4	4.3	3.8	2.9	3.4	4.1	2.7	2.7	3.8	2.1	2.4	3.5	2.4	2.5	2.5	2.4	2.6	2.5	2.5	2.5	2.5	2.6	3.5	5.8	2.6	4.0	2.5	2.4	6.1	4.5	3.5	2.5	2.4	1.4	2.5	2.4	4.2	2.5	2.5	3.0	3.3	2.5	2.5	4.2	5.2	2.4	2.5	1.1	2.4	3.0	4.0	2.0	0.3	2.3	0.9	2.4	11.1	2.8	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	1.3	2.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	1.6	0.0	0.6	0.9	2.3	3.3	0.4	5.7	1.4	3.6	3.8	0.3	2.0	11.1	5.0	0.6	2.4	0.9	0.0	2.8	2.8	3.6	4.3	3.4	4.1	2.5	2.5	5.8	2.6	3.5	5.2
AC008878.3		ENSG00000268861			19	7382834-7472477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 7.7;bone marrow: 7.1;lymphoid tissue: 8.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.9;HL-60: 8.1;MOLT-4: 11.5;REH: 9.4;THP-1: 13.5;U-698: 10.7;U-937: 8.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042689, HPA071867"	Supported		Uncertain	Cytosol				Cytosol		"HPA042689: AB_10794385, HPA071867: "	"unprognostic (1.46e-1)"							"unprognostic (2.47e-2)"			"unprognostic (2.97e-1)"		"unprognostic (1.20e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.45e-4)"			0.0	1.2		4.3		7.1	0.0		0.0	0.0	0.5			0.0	0.9	0.1	1.5	0.0	2.1	0.0			0.2	0.0	1.0	8.6			0.0	0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0	0.6	0.0	2.3		4.9	0.0	0.0			0.7		4.8	2.4		7.4	1.4	7.7	3.3	0.1	4.2	1.4	0.0	0.2	0.5	0.0	1.3	0.3	0.0	0.0	1.1	0.0	0.3	0.0	0.0	17.9	0.0	4.4	0.0	2.4	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.3	8.1	7.2	2.7	0.1	0.1	2.2	1.0	0.0	0.0	3.6	0.0	11.5	3.0	0.0	0.0	9.4	0.1	3.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.1	0.3	0.1	0.0	0.1	0.0	10.7	0.3	8.4	0.0	0.9	1.7	7.7	2.7	1.9	1.5	7.4	3.6	1.8	1.1	6.7	4.2	1.4	4.3	0.1	3.3	1.4	1.7	1.4										
AC011005.1		ENSG00000230626			7	129126518-129130793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	8	"testis: 7.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.6;MCF7: 2.2;RT4: 1.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051993	Uncertain		Approved	Cytosol				Cytosol		"HPA051993: "	"unprognostic (2.03e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.36e-5)"	"unprognostic (3.43e-2)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	7.8			0.0		0.0	0.0		0.6	0.4	0.9	0.3	0.7	0.6	0.1	0.1	0.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.7	1.6	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.0	2.2	0.4	0.1	0.2	0.5	0.2	0.0	0.0	0.0	1.9	0.3	0.1	0.0	0.0	0.8	0.0	0.7	0.0	0.2	0.0	0.9	0.3	0.2	0.1	0.3	0.4	0.0	0.0	0.5	0.3	0.9	0.3	0.3	0.5	0.4	0.3	0.6	0.4	0.6	0.4	0.4	0.8	0.7	0.2	0.0	0.5	0.1										
AC012476.1		ENSG00000285396			15	40695129-40732158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	5	"lymphoid tissue: 19.5;testis: 16.7"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA039310	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA039310: "																		0.4	0.8	0.0	4.2	0.0	0.9	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.8	2.1	0.2	1.4	0.9	0.0		0.2	0.3	0.8	0.9	0.0	0.0	0.3	0.5	0.9	0.0	3.9	0.0	0.1	0.0	0.0	0.3	0.0	1.8	0.9	1.2	0.0	0.2	3.0	1.6	16.7	0.0	19.5	0.1	2.1	6.1	0.0	0.0	1.3	1.0	2.3	0.4	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.5	1.2	0.2	1.0	0.2	1.1	0.3	0.4	1.3	0.2	0.3	2.3	1.2	0.1	1.0	0.3	0.1										
AC023509.3		ENSG00000267281			12	53506688-53625979	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A549: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA003384	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (1.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.37e-4)"	"unprognostic (6.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.91e-2)"	"unprognostic (2.26e-7)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.77e-3)"	4.5	2.4	3.9	2.0	6.0	4.5	4.6	14.9	5.2	3.3	2.7	7.8	2.1	1.4	4.5	1.8	3.2	3.6	3.8	3.7	4.4	2.8	2.4	3.8	7.0	3.6	6.8	2.3	5.1	3.5	1.4	3.6	2.9	5.1	3.3	3.5	3.1	3.0	4.3	4.5	3.4	2.4	5.7	4.7	2.9	3.1	4.7	6.6	1.9	2.4	1.7	4.1	5.9	2.5	0.7	1.4	2.9	2.2	0.2	2.5	0.5	0.6	4.4	0.0	0.5	1.8	2.3	0.0	0.0	1.4	1.6	0.3	0.5	0.7	1.7	0.4	0.0	1.4	0.3	1.2	1.3	1.8	0.9	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.5	0.9	0.0	1.9	0.0	1.8	0.0	0.0	0.0	0.2	0.8	0.7	0.3	0.0	0.5	0.0	0.2	0.0	1.4	0.0	0.0	0.3	2.3	1.8	0.0	0.6	0.6	0.0	0.3	0.0	0.6	1.5	0.8	0.9	0.0	2.9	1.7	0.5	2.5	2.2	0.5	0.2	0.2	0.4	0.9	0.7	0.0	0.4	2.4	0.2	0.0	1.4	0.3	0.5	3.9	6.0	14.9	5.2	4.4	2.8	6.8	2.3	5.1	6.6
AC104662.2		ENSG00000281028			4	25160663-25277306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA004099	Uncertain		Uncertain	Cytosol				Cytosol		"HPA004099: AB_1855353"					"unprognostic (3.59e-2)"													1.7	2.3	6.7	5.5	11.1	6.7	3.7	9.7	9.3	2.0	4.1	4.3	5.0	7.8	1.7	2.5	5.4	3.5	1.6	1.5	7.3		2.8	10.1	4.0	4.4	10.0	2.4	1.5	1.8	2.9	14.9	2.8	7.1	1.1	5.4	2.1	4.5	2.5	1.8	0.0	6.0	2.6	11.3	2.5	3.6	9.2	10.6	6.1	5.3	1.6	5.3	3.1	4.8	2.1	2.0	7.5	1.9	1.4	4.3	0.9	5.2	3.6	4.3	2.4	3.1	6.0	4.1	8.7	9.0	11.3	12.0	4.0	7.4	13.3	2.1	11.3	2.8	9.2	3.8	6.8	5.8	2.6	6.2	9.0	3.7	0.6	12.2	3.6	3.1	0.7	4.5	4.5	3.9	4.2	15.5	3.5	6.0	10.6	0.9	3.6	2.4	6.2	11.9	5.8	2.7	9.7	5.0	1.0	3.6	1.2	2.6	2.9	1.7	7.3	6.2	1.8	2.9	5.2	10.4	11.8	18.8	5.4	6.5	4.5	7.5	1.9	6.2	2.4	1.8	1.6	2.1	2.4	2.3	1.4	1.9	1.8	2.1	3.2	1.4	1.3	2.0	4.3	0.9										
AC245033.1		ENSG00000260836			15	82536788-82573194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	5	"brain: 11.3"	"Cell line enriched"	"Detected in some"	5	"U-2197: 18.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055060	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	"Nucleoli, Cytosol"	"HPA055060: "									"unprognostic (2.91e-2)"									1.5	0.9	5.3	0.9	7.1	0.9	1.3	6.1	11.3	0.9	1.0	1.4	0.0	0.9	0.9	0.9	1.5	0.9	0.9	1.3	3.9	1.6	0.9	1.0	1.1	0.9	3.2	6.1	0.9	1.0	0.9	2.0	1.0	7.3	1.1	1.1	1.9	0.9	0.9	2.0	0.9	1.4	0.9	2.4	1.1	0.9	1.4	1.7	0.0	1.0	0.0	1.0	1.7	0.8	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.7	18.5	0.3	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.1	6.1	11.3	3.9	1.6	3.2	6.1	7.3	1.7
ACACA	"ACAC, ACC, ACC1"	ENSG00000278540	"Acetyl-CoA carboxylase alpha"	Q13085	17	37084988-37406818	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013715, HPA036650, HPA063018"	Approved		Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"				Cytosol	"Nucleoli fibrillar center, Actin filaments"	"CAB013715: , HPA036650: , HPA063018: "	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (8.81e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.89e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-2)"	10.7	4.8	5.6	2.5	7.7	3.0	18.5	6.0	11.5	5.3	4.2	6.9	12.7	3.8	4.5	11.7	9.2	3.8	3.6	2.3	4.9		3.0	5.8	7.3	3.5	6.3	4.6	4.3	2.3	13.6	7.9	2.6	6.1	12.2	5.1	4.8	4.6	14.4	11.3	5.4	2.5	7.8	4.2	2.3	3.9	5.5	5.7	2.0	4.2	4.5	5.0	4.3	4.6	4.4	3.2	1.3	4.1	2.0	3.9	2.0	14.6	3.0	17.9	18.8	25.0	24.7	6.2	6.6	9.3	6.8	12.4	11.9	2.5	2.0	5.4	10.5	15.2	3.3	22.3	10.7	5.8	9.8	11.7	7.7	12.1	4.0	6.3	2.4	19.9	13.0	18.1	13.5	12.0	27.9	1.4	1.0	12.4	6.7	9.7	13.6	9.7	10.3	11.3	2.7	16.2	16.7	20.3	8.0	11.8	5.5	5.2	11.1	7.2	10.6	5.8	9.3	8.1	1.6	3.9	4.7	18.3	5.3	5.3	8.0	1.1	2.8	0.3	2.3	4.1	2.1	2.7	2.5	2.7	3.2	4.4	3.9	2.7	1.3	2.0	2.7	2.4	3.2	2.0										
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol			19000000	"Nucleoli, Mitochondria"	"Nucleoplasm, Cytosol"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	32.7	69.2	22.8	18.2	21.1	15.1	24.1	19.8	18.4	21.1	44.0	16.5	26.7	51.7	17.4	19.7	31.5	14.2	24.4	118.2	20.2	12.2	35.2	90.0	17.3	9.8	18.5	16.8	15.5	67.8	31.5	32.3	40.2	20.9	22.1	24.2	20.0	27.4	29.0	132.3	20.3	51.2	25.0	15.7	21.9	28.7	11.5	18.6	14.6	29.6	36.9	21.2	22.4	31.8	8.3	32.0	37.9	29.0	11.6	14.9	20.0	33.2	31.9	13.1	18.0	56.6	20.8	24.8	24.5	34.1	28.0	17.4	12.9	30.2	17.8	20.5	51.4	25.7	8.8	26.8	24.8	56.5	9.0	9.5	22.7	19.6	27.2	9.0	24.8	23.2	24.6	23.4	36.9	25.1	12.2	21.8	44.9	12.6	9.4	10.9	6.2	12.6	13.1	14.5	42.4	62.2	30.4	3.5	8.6	34.6	44.0	20.1	20.2	13.9	25.0	24.8	18.6	12.5	23.9	20.4	9.5	0.9	45.6	16.0	18.0	6.8	29.0	37.9	13.5	18.0	12.4	8.3	10.9	14.9	32.0	7.6	8.3	10.2	6.3	11.6	12.0	26.0	9.7	20.0	22.8	21.1	19.8	18.4	20.2	12.2	18.5	16.8	20.9	18.6
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159760328-159779055	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 20.4;liver: 31.0"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 48.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Supported	Nucleoplasm,Cytosol			16000000	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favourable (1.12e-4)"	"prognostic unfavourable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	1.6	2.6	2.7	1.5	1.7	1.6	2.2	2.2	6.3	2.1	4.3			3.2	1.4	4.8	5.7	1.0	0.7	0.7	2.9	3.6	3.0	31.0	1.8	2.5	2.9		2.1	0.7	1.3	1.2	0.9		4.2	3.9		2.3	0.5	0.1	2.4	1.6	1.4	5.1	1.1	1.7	6.6			0.9		4.2	1.1	2.6	13.3	9.5	12.3	8.4	10.0	20.4	12.2	6.9	6.5	44.3	16.9	6.3	11.8	1.5	6.2	7.3	14.7	25.4	25.4	8.9	5.9	3.1	4.8	6.7	18.3	48.0	17.4	3.5	18.8	13.6	10.6	42.2	6.4	7.8	3.7	6.4	3.5	24.2	10.4	7.1	14.6	9.9	8.9	12.4	13.5	12.5	14.9	4.8	8.4	9.9	18.0	34.2	9.1	11.9	6.7	7.1	4.6	2.4	8.9	15.7	4.4	5.4	4.7	7.6	15.8	4.7	8.7	14.4	1.6	15.5	8.1	6.1	7.1	12.3	13.9	8.4	13.7	13.3	15.9	13.8	9.5	13.3	16.0	12.3	3.2	10.0	5.6	8.7	20.4	12.2										
ACBD6	MGC2404	ENSG00000230124	"Acyl-CoA binding domain containing 6"	Q9BR61	1	180269653-180502954	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028179, HPA028457"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA028179: AB_10601788, HPA028457: "	"unprognostic (3.12e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (4.02e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-1)"	6.5	7.5	7.3	9.7	7.7	9.1	7.1	17.4	8.1	8.0	5.2	6.5	9.6	5.8	8.6	7.6	5.4	6.0	7.1	8.9	6.6		6.8	5.5	6.8	11.2	6.1	7.9	10.5	9.7	6.8	10.5	11.3	5.8	6.8	5.0	6.5	7.2	7.6	9.5	6.3	5.2	7.8	4.0	6.8	6.1	18.2	7.3	8.1	8.1	7.7	7.1	7.6	6.9	11.5	14.5	2.7	13.3	16.4	10.9	7.7	20.9	15.6	13.5	9.9	9.4	16.4	28.1	9.7	19.5	16.8	15.3	22.0	15.4	18.5	20.1	9.5	15.1	9.9	17.9	10.7	14.0	19.2	14.6	14.1	12.5	24.2	24.9	13.2	14.8	25.5	10.5	16.5	18.8	22.8	15.1	13.5	19.0	21.3	23.6	14.8	7.4	21.5	11.2	35.5	14.3	10.9	21.2	27.0	12.9	21.7	12.9	22.8	18.7	15.1	12.6	15.1	15.4	20.8	31.9	16.5	42.1	13.8	15.4	14.9	1.9	8.4	2.7	9.3	13.3	10.7	11.5	8.0	7.9	14.5	8.8	10.0	10.9	0.6	16.4	10.0	11.8	7.4	7.7										
ACBD7	"bA455B2.2, FLJ38219"	ENSG00000176244	"Acyl-CoA binding domain containing 7"	Q8N6N7	10	15077523-15088776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 35.3"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 21.7;U-266/84: 16.3;U-698: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"olfactory region: 21.6"	"Low region specificity"	"Detected in all"			"HPA043326, HPA062478"			Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA043326: , HPA062478: "	"unprognostic (2.15e-1)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-3)"	"unprognostic (6.53e-3)"	"unprognostic (7.30e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.18e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.90e-2)"	1.1	1.1	25.0	1.5	27.1	3.9	8.3	12.9	35.3	1.1	1.4	9.3	0.0	2.5	1.4	2.7	1.7	4.4	1.7	1.2	25.3	9.8	1.4	1.7	1.4	2.1	15.0	16.2	1.7	1.5	1.5	0.7	1.3	14.0	1.5	1.6	0.0	4.7	1.4	2.0	3.0	1.9	1.3	6.6	1.6	1.8	5.9	11.7	2.9	4.2	0.0	1.7	1.4	0.5	1.7	1.5	3.8	0.6	2.1	1.1	0.2	2.6	0.6	10.5	5.0	0.6	0.5	1.2	0.7	0.6	1.9	3.2	2.9	3.2	2.4	3.6	2.4	0.6	6.2	1.9	2.7	5.4	8.5	2.6	0.8	1.6	0.1	0.5	1.1	0.1	0.2	0.7	0.1	2.6	2.0	2.9	2.1	8.3	21.7	2.3	5.2	1.9	11.7	3.7	5.7	1.2	1.0	8.6	5.2	2.6	5.9	1.1	8.5	0.7	0.7	0.4	5.8	1.0	2.2	8.2	16.3	18.7	1.7	0.5	0.7	3.8	0.6	0.8	1.1	0.6	0.9	1.3	0.6	0.6	0.3	1.7	1.1	1.1	3.7	2.1	0.5	1.5	0.5	0.2	25.0	27.1	12.9	21.8	25.3	9.8	15.0	16.2	14.0	11.7
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavourable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	32.4	44.4	34.6	46.6	36.2	57.6	32.5	45.7	41.8	36.6	30.1	39.1	35.2	28.5	52.9	32.2	39.3	34.6	33.3	29.7	33.1	28.3	34.9	35.5	28.8	41.1	34.4	27.7	43.9	34.5	51.1	48.3	37.0	33.7	35.4	34.6	31.5	33.0	38.3	43.8	38.1	35.1	40.1	35.0	52.9	34.0	34.5	40.6	44.2	38.5	27.1	45.9	30.5	47.8	6.9	6.8	13.4	4.9	9.7	5.5	2.7	23.2	24.0	37.9	30.7	23.7	19.1	38.1	26.0	18.4	31.4	25.7	31.8	27.4	43.2	15.4	21.5	25.7	52.4	29.7	32.3	30.3	23.2	38.0	25.4	43.7	13.6	41.2	33.8	22.3	18.4	32.2	27.1	27.4	35.0	17.3	23.7	29.1	46.7	40.7	42.6	23.0	42.4	29.5	23.0	26.1	41.1	25.3	18.6	34.5	22.6	20.5	18.6	33.4	28.0	21.5	21.6	20.4	24.0	18.4	20.7	44.8	19.2	31.3	23.3	4.1	4.9	5.6	5.5	4.5	4.4	4.4	3.7	4.2	4.1	6.9	5.1	4.6	13.4	9.7	3.7	6.8	3.8	2.7	34.6	36.2	45.7	41.8	33.1	28.3	34.4	27.7	33.7	40.6
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 96.2;salivary gland: 74.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 31.4;HEL: 10.0;SK-BR-3: 16.8;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 7.3;NK-cell: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.3;NK-cells: 2.2"	"Group enriched"	"Detected in many"	9	"amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6"	"Low region specificity"	"Detected in all"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA013819: AB_1846126, HPA073493: "	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	10.4	0.9	0.4	0.7	0.5	0.4	5.3	0.2	0.4	2.9	1.8	0.1	0.6	0.7	2.0	5.2	2.5	2.4	1.2	1.0	0.5	0.4	1.1	14.5	1.5	1.0	0.5	0.2	0.9	0.7	0.3	0.6	96.2	0.2	1.1	2.0	0.3	74.8	0.4	2.1	2.5	1.0	3.2	0.7	1.1	0.9	1.5	0.1	0.4	3.8	2.3	2.0	3.2	4.1	0.8	0.4	7.3	0.6	2.2	0.4	0.3	0.1	0.0	0.1	0.2	1.4	0.1	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	10.0	0.2	1.7	0.0	0.1	1.1	0.3	0.3	0.0	0.0	0.0	1.3	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	4.4	0.1	0.1	0.7	16.8	0.0	1.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	6.4	0.1	0.7	0.2	7.3	0.4	0.5	0.1	0.2	0.1	0.2	0.4	0.8	0.3	0.3	1.0	2.2	0.6	0.3	0.1	0.3	0.4	0.5	0.2	0.4	0.5	0.4	0.5	0.2	0.2	0.1
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866908-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			2100000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	38.3	24.0	16.7	26.2	22.9	19.1	35.7	21.5	29.1	22.9	22.2	25.1	18.0	30.7	27.0	24.9	23.2	23.7	28.2	18.4	18.3	33.7	37.8	22.2	23.3	27.4	23.1	17.9	19.0	30.6	27.1	19.5	26.7	49.0	41.3	23.2	15.6	25.4	19.6	10.9	19.6	29.6	27.2	26.2	24.5	24.6	20.7	21.4	32.0	21.3	18.2	24.6	20.3	21.3	16.1	23.9	25.2	26.3	16.0	23.9	21.4	23.2	79.1	37.4	32.2	57.8	54.3	34.4	32.7	35.8	41.2	51.8	40.1	26.8	37.8	21.0	45.8	37.0	48.2	56.0	34.5	34.0	46.1	21.6	45.6	41.7	26.9	34.9	28.3	43.1	16.9	72.4	14.6	43.4	26.6	30.2	34.1	23.7	57.4	19.6	24.3	14.4	37.7	45.2	48.4	42.2	41.4	70.4	38.7	23.3	73.0	25.0	43.5	33.4	46.6	32.2	26.5	32.3	53.6	17.7	22.5	35.9	54.4	27.1	26.1	18.9	20.7	25.2	23.8	22.1	22.5	16.1	19.0	21.3	23.9	13.8	14.6	16.1	10.7	16.0	26.3	13.9	23.9	21.4	16.7	22.9	21.5	27.7	18.3	33.7	23.1	17.9	49.0	21.4
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol			8000000	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favourable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	41.4	27.2	9.6	7.1	9.4	1.5	30.1	8.9	8.1	9.3	19.7	6.2	6.4	21.9	12.8	14.6	12.8	7.2	8.9	15.1	6.5	7.6	40.5	80.9	9.2	9.4	6.1	6.2	14.1	27.9	8.9	8.7	11.3	7.7	10.7	9.8	11.7	11.7	9.5	11.2	5.5	28.4	14.5	6.0	6.4	13.5	11.4	5.9	6.0	18.4	7.2	5.1	13.9	11.7	4.7	7.1	21.4	8.8	4.7	7.4	6.2	9.4	8.7	6.7	10.6	52.5	28.5	3.0	17.9	44.1	8.2	6.5	9.1	2.9	1.9	5.7	18.7	1.3	13.3	17.1	16.6	6.0	3.6	13.8	9.4	9.9	26.4	1.3	5.6	24.8	5.3	21.2	15.0	21.3	4.9	4.1	23.4	2.4	7.3	6.6	7.0	9.2	5.7	10.0	1.9	31.4	8.7	0.8	2.8	18.6	0.7	1.9	4.3	3.4	23.0	30.1	10.2	10.0	4.6	2.0	3.8	3.7	21.0	4.6	2.6	21.4	8.7	2.4	7.4	8.8	6.4	4.7	5.2	5.7	7.1	4.2	6.8	7.0	1.0	4.7	7.2	3.4	2.8	6.2	9.6	9.4	8.9	8.1	6.5	7.6	6.1	6.2	7.7	5.9
ACOT11	"BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1"	ENSG00000162390	"Acyl-CoA thioesterase 11"	Q8WXI4	1	54542257-54639192	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.5;HaCaT: 12.9;RT4: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041047	Enhanced		Supported	Cytosol				Cytosol		"HPA041047: "	"unprognostic (9.73e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (9.37e-4)"	"unprognostic (3.61e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.02e-1)"	"prognostic favourable (3.07e-8)"	"unprognostic (5.89e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.49e-3)"	1.3	4.1	5.7	1.9	7.3	3.0	1.2	3.7	8.6	3.7	10.9	9.6	10.0	28.2	3.6	5.2	14.8	2.7	4.0	22.2	5.9	2.6	15.1	1.2	1.7	1.5	3.1	9.5	4.6	3.0	9.4	18.8	1.4	11.1	3.9	9.5	22.0	9.4	4.5	6.8	2.6	22.5	14.6	6.2	1.3	9.0	6.6	3.9	0.0	10.1	5.7	2.7	9.1	5.5	1.3	1.3	8.3	1.3	0.9	0.9	0.6	4.4	2.9	1.5	0.9	0.6	1.4	2.3	2.6	0.3	0.9	0.7	4.3	11.5	1.0	4.4	2.2	12.9	0.6	2.3	0.5	2.6	1.1	10.7	4.1	1.8	0.2	1.2	1.8	1.4	2.6	0.4	1.1	2.3	0.6	1.6	3.0	1.4	0.6	1.8	2.4	0.6	0.9	7.7	1.0	1.0	27.0	3.0	3.0	1.2	1.0	0.5	1.2	3.4	2.4	2.1	1.8	1.3	1.0	1.8	0.9	1.1	0.9	8.0	0.9	2.0	1.3	8.3	0.8	0.7	0.7	0.7	0.7	0.5	1.3	1.3	0.9	0.9	2.8	0.9	0.9	0.9	0.6	0.6	5.7	7.3	3.7	8.6	5.9	2.6	3.1	9.5	11.1	3.9
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81330005-81394179	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 49.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;CACO-2: 2.4;Karpas-707: 1.8;SK-MEL-30: 4.1"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037723, HPA037724"			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037723: AB_10672606, HPA037724: "	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favourable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.2	49.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.4	0.1	0.0	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6394391	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 20.5;plasmacytoid DC: 19.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol			29000	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (2.31e-5)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	4.7	13.3	25.8	10.8	29.8	7.7	3.9	23.9	50.0	4.4	18.3	11.3	0.5	33.2	5.1	3.8	14.3	4.4	5.3	6.3	27.8	43.9	29.4	9.1	8.6	12.3	36.0	20.7	5.3	4.0	1.9	18.5	7.4	49.9	5.6	13.5	6.6	4.1	4.9	1.5	9.4	33.2	14.3	14.2	8.9	6.2	13.1	6.9	9.0	2.3	6.5	11.6	9.1	6.6	1.0	19.4	0.4	0.6	20.5	4.4	2.8	23.4	20.4	20.2	21.7	4.6	7.7	7.6	20.2	10.5	30.0	18.0	70.5	7.6	28.7	14.9	16.4	23.2	32.5	54.0	11.3	25.2	28.4	15.1	16.2	24.9	19.0	17.6	12.6	6.8	10.3	24.8	29.4	16.8	12.3	6.2	15.8	27.3	36.8	18.7	10.1	47.4	44.1	23.2	19.4	16.8	9.0	11.0	31.3	18.2	28.0	64.4	9.9	8.3	27.2	27.3	16.0	27.1	31.9	5.2	21.4	40.4	17.3	30.9	16.6	0.0	0.1	0.1	4.1	0.6	1.0	1.0	3.4	3.6	2.9	0.4	1.2	2.3	0.4	20.5	0.5	19.4	4.4	2.8	25.8	29.8	23.9	50.0	27.8	43.9	36.0	20.7	49.9	6.9
ACOT9	"ACATE2, CGI-16, MT-ACT48"	ENSG00000123130	"Acyl-CoA thioesterase 9"	Q9Y305	X	23702253-23766475	"Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035533	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035533: AB_10696506"	"unprognostic (5.69e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	19.1	15.9	6.3	14.1	7.7	10.5	29.2	6.5	13.6	15.4	16.3	5.4	17.6	11.5	21.2	16.1	12.0	14.5	15.5	35.7	5.7	7.7	12.8	15.5	23.6	36.0	7.3	8.6	13.4	16.6	9.1	7.8	13.3	12.7	12.8	12.7	13.9	16.3	23.0	28.8	10.4	12.5	35.7	13.8	15.8	15.0	7.1	4.5	3.8	15.1	11.4	9.7	15.9	14.4	5.5	16.4	11.1	26.5	6.0	10.0	8.4	26.4	18.1	7.9	17.4	13.0	14.8	4.0	21.0	18.3	20.9	20.3	16.0	24.0	1.3	13.5	23.4	16.2	9.9	26.8	29.1	6.2	15.1	9.0	19.0	11.6	17.5	3.5	11.4	13.1	18.3	24.4	27.8	30.4	5.7	9.1	22.5	9.2	4.8	8.5	11.5	22.1	5.1	30.1	11.2	24.7	9.9	1.5	7.6	22.8	9.6	13.5	10.8	4.6	28.2	17.4	11.6	25.2	11.4	2.2	5.2	0.1	12.9	3.5	14.7	9.1	16.1	11.1	5.6	22.2	7.6	5.5	7.0	6.3	16.4	4.6	2.3	5.3	8.4	6.0	26.5	2.8	10.0	8.4	6.3	7.7	6.5	13.6	5.7	7.7	7.3	8.6	12.7	4.5
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537319	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 70.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 12.2;ASC TERT1: 20.2;fHDF/TERT166: 6.6;Hep G2: 7.8;HSkMC: 13.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol			190000	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	4.0	5.3	1.9	3.8	2.5	0.1	3.4	1.6	2.1	4.4	10.2	2.7	9.5	10.0	9.0	6.2	3.8	4.4	4.8	8.8	2.4	1.4	17.1	70.5	2.8	0.7	2.0	1.7	5.1	2.9	3.8	3.0	1.4	4.0	7.2	3.4	11.4	3.0	5.9	4.2	1.7	13.7	10.6	2.5	0.9	2.6	4.0	2.0	1.0	7.7	2.7	1.6	5.4	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.2	20.2	3.5	2.3	0.2	0.0	0.3	0.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	1.8	0.0	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	1.6	2.1	2.4	1.4	2.0	1.7	4.0	2.0
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732573-111118222	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 29.7;lung: 20.8;placenta: 23.8"	"Group enriched"	"Detected in some"	4	"A-431: 8.9;RPMI-8226: 16.2;RT4: 20.8;U-266/70: 14.1"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035392: , HPA035393: "	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (6.48e-4)"	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0.0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1.0	0.6	4.1	1.1	0.7	0.6	0.3	8.9	0.0	0.2	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.2	0.1	0.1	1.0	0.0	0.0	0.0	0.2	3.1	0.2	0.4	0.2	0.0	0.1	0.2	0.1	0.9	0.0	0.1	0.0	1.4	1.4	0.1	3.2	0.7	0.4	3.1	0.4	0.1	0.1	16.2	0.0	20.8	2.0	0.4	0.1	0.4	0.1	0.2	0.9	0.3	0.2	0.4	0.2	0.1	14.1	3.6	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1.0	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016754	Approved		Approved	Nucleoplasm,Cytosol			3700000	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	22.3	59.7	38.0	20.8	40.3	38.0	33.0	27.9	43.7	23.1	29.7	27.4	24.4	31.1	25.2	36.2	24.8	29.5	26.9	27.4	34.6	33.7	42.1	54.8	24.7	29.4	31.5	34.6	33.7	53.0	28.4	43.9	39.7	39.7	27.0	32.8	28.5	46.0	23.8	35.4	21.6	34.5	24.2	28.6	28.1	34.2	38.3	21.2	33.0	32.5	32.8	29.8	22.7	20.3	33.9	20.3	17.3	23.0	35.3	41.0	33.1	17.6	26.4	41.1	22.6	18.7	18.7	33.5	21.5	22.9	21.5	19.1	36.1	17.8	11.1	16.8	20.1	17.4	39.9	23.3	19.4	27.0	40.7	32.5	23.9	79.1	25.9	36.9	18.7	19.0	21.3	20.1	24.9	24.4	32.8	21.7	25.4	24.0	39.7	35.7	49.7	29.8	26.3	41.8	25.4	33.6	25.3	44.9	44.5	13.4	31.7	43.0	18.8	19.8	20.1	23.7	15.8	19.5	32.4	29.5	58.6	34.7	28.1	32.0	27.9	17.3	19.8	17.1	30.1	22.7	39.7	33.9	34.3	34.4	17.7	31.1	41.0	39.7	3.5	35.3	23.0	20.3	35.6	33.1	38.0	40.3	27.9	43.7	34.6	33.7	31.5	34.6	39.7	21.2
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 117.9;lung: 151.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;RPMI-8226: 13.6;SK-MEL-30: 40.4;U-138 MG: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 51.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002584, HPA057655, HPA059463"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		3700000	Cytosol		"CAB002584: AB_564039, HPA057655: , HPA059463: "	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	117.9	2.8	0.9	21.1	1.1	1.4	7.7	0.7	1.0	11.9	10.2	1.2	2.1	7.7	7.7	6.5	12.1	3.5	9.1	6.8	0.9	0.4	28.0	16.3	151.9	30.8	1.0	1.0	13.2	8.7	0.2	1.6	9.2	1.2	6.4	8.7	19.1	8.6	2.8	3.0	10.4	15.6	3.3	1.9	20.7	15.0	3.5	0.7	9.2	2.2	8.2	18.4	11.4	10.1	51.4	13.9	16.8	9.4	2.6	16.0	8.1	3.2	0.4	0.0	0.0	0.2	0.0	14.3	0.4	9.6	0.0	0.0	0.0	0.1	0.4	0.6	2.8	0.1	0.0	1.4	0.0	3.6	0.3	0.1	0.0	1.7	0.5	0.0	0.2	0.0	1.1	0.1	0.0	0.0	10.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.1	0.7	13.6	0.0	0.1	0.2	0.3	0.0	0.0	40.4	0.0	0.1	0.3	38.0	0.4	0.7	0.1	0.2	1.8	0.2	7.8	0.0	1.2	0.0	9.4	16.8	4.1	9.1	2.1	51.4	6.4	4.7	1.7	23.5	8.3	4.7	2.6	2.6	8.7	13.9	16.0	8.1	0.9	1.1	0.7	1.0	0.9	0.4	1.0	1.0	1.2	0.7
ACSBG2	"BGR, DKFZp434K1635, PRTD-NY3"	ENSG00000130377	"Acyl-CoA synthetase bubblegum family member 2"	Q5FVE4	19	6135247-6193094	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 71.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;HEL: 3.4;Karpas-707: 2.6;MCF7: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA043421, HPA051013"	Enhanced		Uncertain	Cytosol				Cytosol		"HPA043421: AB_10794182, HPA051013: "	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.96e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.70e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.6	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.4	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ACSF2	"ACSMW, FLJ20920"	ENSG00000167107	"Acyl-CoA synthetase family member 2"	Q96CM8	17	50426158-50474845	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 60.0"	"Cell line enhanced"	"Detected in many"		"RT4: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024693	Enhanced		Approved	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Cytosol"	Microtubules	"HPA024693: "	"unprognostic (1.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.49e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.45e-2)"	"prognostic favourable (2.41e-4)"	13.2	37.6	4.8	7.7	4.4	1.1	16.3	2.0	4.0	8.4	19.1	4.0	30.3	9.2	3.5	15.4	6.7	4.3	7.2	12.9	5.6	2.0	60.0	15.0	9.0	3.7	3.7	2.8	9.4	3.4	2.6	1.7	14.1	3.9	12.4	7.4	7.6	10.1	33.3	28.4	9.7	22.4	4.5	3.5	4.5	8.0	4.5	3.6	3.5	30.6	6.6	5.9	13.0	7.6	7.8	13.8	11.9	6.2	1.2	4.3	2.1	9.6	3.1	2.6	6.2	27.4	5.0	15.3	2.3	3.4	5.0	9.8	12.2	18.4	6.0	5.1	2.8	5.8	1.8	11.3	6.0	7.5	4.4	10.3	1.5	21.7	4.6	1.3	9.6	22.1	17.4	6.4	0.8	6.8	1.2	3.4	5.4	11.6	3.1	4.1	0.4	4.6	7.8	1.9	15.1	1.6	37.5	8.5	4.6	4.5	6.8	4.7	6.0	8.8	5.1	9.1	2.8	1.3	0.7	6.1	1.2	3.1	3.8	6.5	0.5	0.0	2.5	11.9	1.8	6.2	1.6	7.8	1.3	1.8	13.8	1.9	0.6	0.8	0.4	1.2	5.4	5.2	4.3	2.1	4.8	4.4	2.0	4.0	5.6	2.0	3.7	2.8	3.9	3.6
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.4"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favourable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"	30.3	12.6	2.8	9.2	7.0	1.9	12.4	5.6	7.0	6.8	21.0	10.6	8.3	21.4	6.6	7.0	8.1	4.5	7.7	24.8	2.9	2.5	11.2	15.7	11.7	3.2	6.8	3.2	5.1	3.2	4.7	2.5	4.6	5.5	3.4	10.4	3.5	9.8	6.8	63.4	6.8	24.1	3.0	6.1	2.7	13.4	3.1	7.1	1.1	3.9	7.3	3.0	6.5	6.1	0.7	12.6	17.0	11.6	0.3	3.0	4.7	11.6	1.6	1.1	1.6	8.3	8.8	12.2	7.0	5.4	1.9	3.4	4.2	6.5	0.0	7.9	3.0	8.9	2.9	17.6	1.4	0.0	2.8	16.3	0.8	2.0	6.1	1.5	9.0	6.0	3.8	2.9	2.7	3.0	10.3	1.2	2.7	1.3	0.5	7.1	0.8	19.9	4.3	7.6	25.7	6.7	1.2	1.0	5.3	8.5	6.3	6.8	3.1	3.6	11.5	2.3	3.2	4.2	2.3	11.1	8.1	3.8	6.6	2.6	1.9	17.0	11.6	3.0	0.6	7.2	0.5	0.4	1.6	0.7	12.6	0.7	3.0	1.5	6.5	0.3	3.4	2.1	1.1	4.7	2.8	7.0	5.6	7.0	2.9	2.5	6.8	3.2	5.5	7.1
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562880-179588408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavourable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	18.8	17.9	9.9	23.4	16.8	8.7	21.3	8.7	9.6	16.8	21.3	15.3	15.6	14.5	24.8	16.4	23.2	16.3	14.9	24.2	8.7	7.4	19.6	18.6	14.6	17.4	16.7	5.4	24.8	20.9	13.7	23.4	20.1	13.7	17.7	23.5	10.4	19.0	17.4	12.8	19.4	19.8	16.1	14.8	19.3	16.7	47.5	17.0	46.1	21.9	20.4	23.8	18.7	22.7	17.5	19.8	8.0	16.1	14.5	22.4	13.8	46.1	14.0	34.9	18.4	13.3	14.6	27.4	18.6	14.5	34.8	29.5	31.5	22.7	36.1	33.5	17.5	21.3	30.4	22.9	43.4	35.8	25.4	29.6	15.5	23.8	15.3	36.7	18.5	10.2	23.5	22.5	19.0	19.8	23.0	20.7	25.0	31.6	32.1	22.7	30.9	31.4	30.2	29.2	66.8	27.5	18.7	28.7	20.5	28.7	28.8	28.8	56.1	30.2	14.9	24.9	21.5	25.5	56.2	13.5	20.1	55.5	13.8	39.0	27.3	3.3	11.3	8.0	15.1	14.3	20.0	17.5	17.5	17.4	19.8	13.7	19.2	19.4	1.5	14.5	16.1	11.2	22.4	13.8	9.9	16.8	8.7	9.6	8.7	7.4	16.7	5.4	13.7	17.0
ACTL8	CT57	ENSG00000117148	"Actin like 8"	Q9H568	1	17755313-17827063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	42	"testis: 23.6"	"Cell line enriched"	"Detected in some"	8	"U-266/84: 70.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027176			Approved	Cytosol				Cytosol		"HPA027176: AB_1844553"	"unprognostic (1.79e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (6.18e-2)"	"prognostic unfavourable (7.02e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.89e-1)"		"unprognostic (1.43e-1)"	"unprognostic (5.49e-2)"		"unprognostic (4.68e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.7	4.1	0.0	0.7	0.0	0.0	2.8	0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	70.7	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ACTN4	FSGS1	ENSG00000130402	"Actinin alpha 4"	O43707	19	38647649-38731583	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001873, HPA006035"	Supported		Approved	"Nuclear bodies,Actin filaments,Cytosol"			230000000	"Nuclear bodies, Actin filaments"	Cytosol	"HPA001873: AB_1078096, HPA006035: AB_1078095"	"unprognostic (1.03e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavourable (5.65e-4)"	"unprognostic (2.99e-1)"	"prognostic favourable (5.25e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.52e-2)"	38.3	39.2	19.2	30.1	24.4	28.1	34.1	16.6	26.6	45.2	47.9	31.8	23.4	51.0	70.1	22.2	61.4	37.9	41.5	25.0	19.6	16.2	48.4	34.1	39.5	17.7	27.8	18.7	33.6	34.1	17.8	21.0	65.9	21.8	33.7	22.4	29.2	41.4	35.4	16.0	40.4	69.4	54.0	32.9	40.8	34.3	13.4	24.6	11.6	29.2	30.5	42.9	40.3	41.1	2.6	8.5	12.9	5.7	17.5	9.7	5.6	44.3	90.6	13.3	6.3	7.7	9.4	26.4	20.2	27.2	30.1	24.2	32.5	34.5	9.8	48.6	45.1	21.3	8.0	31.9	9.0	24.2	8.4	13.9	41.8	28.1	16.9	10.2	17.3	15.5	10.6	26.2	17.6	18.5	16.2	10.6	22.9	23.2	3.3	6.8	9.4	21.5	9.9	12.4	5.2	32.5	46.5	9.9	5.8	36.6	29.2	13.3	12.0	12.2	31.5	34.4	16.7	16.4	67.1	4.8	10.8	8.1	30.4	10.8	61.5	4.5	5.1	10.9	9.7	5.7	7.8	2.4	4.5	9.7	4.6	2.6	0.8	3.3	12.9	17.5	4.6	8.5	7.1	5.6	19.2	24.4	16.6	26.6	19.6	16.2	27.8	18.7	21.8	24.6
ACTR2	ARP2	ENSG00000138071	"ARP2 actin related protein 2 homolog"	P61160	2	65227753-65271253	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005083, HPA015050"	Approved		Approved	Cytosol			76000000	Cytosol		"CAB005083: AB_2221848, HPA015050: AB_1844556"	"unprognostic (2.23e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (4.50e-4)"	"unprognostic (3.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.03e-2)"	31.7	22.3	40.0	58.1	46.1	41.0	24.9	38.5	53.8	24.9	39.3	19.2	16.1	29.1	23.9	18.9	39.5	17.8	26.0	28.9	39.5	35.6	25.8	30.3	32.0	63.1	36.8	39.4	20.9	19.3	19.8	19.6	31.2	30.2	21.1	40.2	16.0	26.7	19.3	28.8	21.2	33.1	29.7	42.6	56.6	29.6	13.7	28.1	59.6	20.9	19.4	69.2	31.9	25.2	21.2	44.9	54.9	53.2	21.3	25.2	59.3	35.8	30.2	28.8	30.8	30.7	41.8	30.1	50.8	39.1	39.2	27.3	33.8	29.4	79.5	26.0	55.3	27.1	24.8	35.2	64.2	45.9	20.8	87.9	21.4	31.7	35.0	82.4	102.8	36.0	27.6	43.7	42.2	48.1	37.3	29.0	64.9	26.5	43.0	43.1	24.0	21.8	46.7	37.4	33.1	44.8	46.8	14.8	24.2	33.0	37.6	34.8	23.2	55.2	64.2	43.3	26.4	28.3	55.4	22.4	20.5	113.1	37.2	80.7	48.9	54.3	38.9	45.3	23.6	51.5	25.2	21.2	21.2	22.1	44.9	18.0	16.7	23.3	54.9	21.3	53.2	16.8	23.5	59.3	40.0	46.1	38.5	53.8	39.5	35.6	36.8	39.4	30.2	28.1
ACTR6	"ARP6, FLJ13433"	ENSG00000075089	"ARP6 actin related protein 6 homolog"	Q9GZN1	12	100199122-100241865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038587, HPA038588"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038587: AB_10670781, HPA038588: AB_10672719"	"unprognostic (1.24e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (7.70e-9)"	"unprognostic (4.11e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.40e-2)"	7.6	8.0	12.6	6.6	13.8	5.6	20.5	14.8	20.2	10.3	9.9	10.2	6.9	7.5	8.6	7.2	10.4	9.6	5.9	8.1	15.2	15.7	12.3	12.5	8.2	11.6	13.8	15.4	9.9	5.9	15.8	14.0	11.6	21.2	11.0	10.6	6.7	7.7	12.2	8.3	6.8	9.2	8.3	12.8	9.6	7.3	13.9	14.6	13.4	9.6	5.8	11.9	11.6	8.6	6.1	6.1	4.6	5.8	7.9	10.9	6.6	17.8	7.0	9.0	10.9	8.9	11.0	18.3	5.0	8.8	8.4	5.8	5.0	5.3	9.4	7.0	7.9	5.8	13.0	8.2	15.3	8.9	11.8	5.8	7.2	5.4	9.7	8.8	5.9	6.5	10.0	7.1	9.2	11.4	10.0	3.8	11.6	3.9	11.7	9.9	8.7	8.8	7.3	8.7	11.0	11.3	10.3	7.8	13.7	9.2	19.6	9.0	12.8	8.5	5.7	5.1	3.8	6.8	5.4	6.3	16.1	12.1	3.6	5.8	7.5	3.8	2.8	4.6	8.0	5.8	9.9	6.0	8.8	7.5	4.1	6.1	10.9	10.0	2.1	7.9	4.5	6.1	7.7	6.6	12.6	13.8	14.8	20.2	15.2	15.7	13.8	15.4	21.2	14.6
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157875862	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: "	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (5.17e-4)"	18.9	9.2	18.0	10.0	12.7	1.6	38.7	15.3	12.2	25.2	14.4	7.4	8.4	8.9	24.8	26.8	11.0	16.6	20.5	18.8	18.7	8.6	21.7	18.9	22.5	15.1	10.4	7.9	18.5	12.3	11.3	17.0	14.2	12.3	16.8	10.5	14.3	18.1	13.6	15.6	12.8	11.5	29.2	12.3	9.2	11.8	8.8	10.9	7.5	34.0	14.6	6.9	16.1	32.5	1.4	2.4	3.8	2.6	1.9	10.0	1.6	2.1	4.2	4.9	6.4	25.0	26.1	6.9	15.1	25.2	12.1	13.0	3.3	4.7	0.0	7.0	16.4	5.9	3.5	8.2	13.1	14.5	3.0	8.6	2.5	4.8	19.8	0.6	10.2	32.6	15.6	24.9	31.8	13.2	3.1	2.4	15.3	3.7	0.1	0.2	7.4	7.7	1.4	6.6	1.8	15.8	7.9	4.4	5.4	5.8	3.3	20.7	1.7	2.3	19.0	18.5	6.1	9.1	5.7	1.6	1.2	0.1	19.0	0.5	19.9	3.8	2.6	0.2	1.1	1.7	1.2	1.4	7.8	2.5	1.8	0.8	3.1	1.5	0.8	1.9	2.3	2.4	10.0	1.6	18.0	12.7	15.3	12.2	18.7	8.6	10.4	7.9	12.3	10.9
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951667-51997078	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol				Cytosol		"CAB026126: , HPA063761: "	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	11.1	7.4	12.0	6.4	14.6	7.9	14.3	14.2	24.4	8.6	16.7	5.1	28.0	19.2	6.7	13.1	14.4	10.9	11.1	7.6	11.2	10.5	24.6	21.0	10.3	7.1	8.1	14.7	7.1	35.1	24.9	10.9	7.5	7.3	10.0	17.1	8.7	21.7	34.3	11.7	30.6	19.8	8.2	5.8	6.7	17.2	10.6	4.8	3.9	9.9	5.8	8.4	10.1	12.1	0.5	1.3	6.8	4.0	0.1	1.6	0.6	6.2	13.8	10.7	5.9	12.3	9.7	6.1	7.1	8.1	7.6	5.8	27.8	9.7	2.7	10.0	7.7	11.1	10.2	8.6	7.9	4.0	12.0	6.8	3.5	8.6	14.1	10.9	25.5	18.9	11.2	8.6	10.9	10.7	7.2	8.6	6.7	12.8	10.4	9.5	10.4	4.8	5.6	8.3	3.5	21.5	9.6	13.7	11.4	7.7	11.0	5.0	12.1	7.1	6.7	5.2	8.0	5.9	3.4	5.2	3.7	3.8	5.6	5.3	6.7	4.5	2.2	6.8	0.7	3.3	1.0	0.1	0.6	0.7	1.3	0.5	1.6	0.9	1.9	0.1	4.0	0.7	1.0	0.6	12.0	14.6	14.2	24.4	11.2	10.5	8.1	14.7	7.3	4.8
ACVR2A	"ACTRII, ACVR2"	ENSG00000121989	"Activin A receptor type 2A"	P27037	2	147844517-147930826	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 20.5;RH-30: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046997	Approved		Approved	Cytosol				Cytosol		"HPA046997: AB_10970077"	"unprognostic (4.55e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-3)"	"unprognostic (8.73e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.52e-1)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.99e-2)"	12.0	6.0	13.6	8.2	9.9	3.8	10.7	14.5	14.2	10.2	14.1	4.7	9.7	10.4	9.3	9.9	13.6	7.6	17.7	5.6	10.0	9.0	9.0	10.3	7.5	4.7	5.9	10.6	7.6	9.8	8.6	15.9	10.6	7.3	12.2	9.1	7.6	12.2	12.0	19.6	29.5	17.8	13.8	5.4	6.5	9.3	11.0	6.4	1.5	9.5	6.9	6.8	13.5	11.8	0.7	3.0	0.5	3.6	7.7	4.6	1.4	1.3	1.5	9.8	3.6	5.8	3.7	4.0	3.0	3.6	5.2	9.1	4.2	5.9	0.0	2.7	4.8	4.6	8.9	4.4	6.7	1.0	5.4	0.6	2.7	7.3	20.5	0.6	0.7	6.2	5.6	3.3	6.7	3.9	1.4	2.5	3.5	3.4	0.3	0.5	11.0	2.6	0.1	17.1	0.9	4.2	8.3	9.7	5.5	2.5	3.1	3.7	1.9	1.0	3.0	4.8	5.7	4.5	2.1	0.7	0.2	1.8	3.0	0.3	3.8	0.4	3.0	0.5	1.2	3.6	0.5	0.3	4.6	2.1	2.3	0.7	3.0	0.7	0.1	7.7	3.1	3.0	0.4	1.4	13.6	9.9	14.5	14.2	10.0	9.0	5.9	10.6	7.3	6.4
ACVR2B	ActR-IIB	ENSG00000114739	"Activin A receptor type 2B"	Q13705	3	38453851-38493142	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 16.6;NTERA-2: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007398, CAB025115, HPA040384"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"CAB025115: , HPA007398: , HPA040384: "	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.75e-1)"	2.8	7.4	5.5	4.6	7.9	1.1	5.5	13.2	7.5	5.2	3.4	7.2	4.5	2.8	4.7	5.1	2.5	5.6	3.3	3.9	5.9	5.4	5.3	5.4	6.9	2.2	5.9	5.4	8.3	6.1	11.3	5.1	16.0	6.5	3.9	3.6	5.0	4.6	4.2	15.9	2.4	2.8	4.6	4.7	3.1	4.0	9.1	9.1	12.8	4.8	1.7	2.2	4.2	10.3	0.3	0.3	0.5	0.2	0.5	1.6	0.3	0.8	1.4	16.6	1.4	0.6	0.4	8.9	0.3	0.5	0.3	0.7	2.4	1.1	0.1	1.3	0.4	1.0	6.3	1.0	0.9	2.4	4.1	4.2	2.6	3.5	0.8	3.0	1.6	0.7	0.9	0.5	1.8	1.1	7.0	1.4	0.3	1.3	5.1	1.9	20.5	0.7	1.7	5.5	1.0	1.1	2.0	3.9	6.8	0.5	2.5	2.2	1.4	4.0	0.9	0.6	2.7	0.4	1.4	4.0	5.4	0.9	0.6	2.5	1.1	0.5	0.1	0.1	0.4	0.2	0.6	0.2	1.0	0.5	0.0	0.3	1.6	1.5	0.3	0.5	0.2	0.3	0.7	0.3	5.5	7.9	13.2	7.0	5.9	5.4	5.9	5.4	6.5	9.1
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053221-75069483	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034944	Approved		Approved	Nucleoplasm,Cytosol			92000	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favourable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	8.7	27.4	23.0	13.9	20.4	12.7	16.2	24.0	25.2	10.6	14.9	14.8	14.3	11.3	10.2	26.9	11.6	21.4	7.1	10.8	19.9	30.2	12.2	5.2	10.9	17.6	28.7	19.3	9.1	7.0	8.9	38.2	10.4	24.4	10.0	19.8	9.4	9.7	12.9	22.3	24.4	11.3	11.4	27.5	10.9	14.0	16.7	22.9	8.3	20.2	10.3	19.0	7.5	12.0	10.6	7.6	12.3	6.6	10.0	17.8	5.1	24.6	13.6	19.6	12.0	8.0	9.3	10.9	14.2	5.5	14.4	20.6	13.7	27.8	27.3	8.7	5.9	22.3	12.9	6.3	23.7	39.6	15.9	17.7	35.8	9.7	4.7	11.1	18.5	5.1	9.1	20.0	10.3	19.0	13.9	33.0	19.0	16.9	24.9	20.8	6.0	13.7	20.0	25.9	12.7	20.4	13.1	36.0	14.6	9.7	6.6	22.0	14.7	11.0	8.9	9.9	18.4	19.9	15.2	7.9	15.9	28.6	15.1	13.1	10.6	3.9	2.2	12.3	8.6	4.3	9.7	10.0	14.5	9.9	3.8	10.6	12.2	11.3	0.9	10.0	6.6	7.6	17.8	5.1	23.0	20.4	24.0	25.2	19.9	30.2	28.7	19.3	24.4	22.9
ADA		ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0"	"Cell line enriched"	"Detected in many"	8	"MOLT-4: 197.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 64.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"			650000	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (6.77e-5)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	8.1	3.2	2.5	5.4	6.5	5.3	5.1	0.9	5.0	2.8	7.4	5.0	1.8	142.2	1.7	3.4	4.6	2.4	3.0	9.2	2.7	0.8	1.3	2.1	2.8	8.9	3.6	2.3	1.2	2.4	0.8	0.3	1.8	3.9	1.8	1.5	0.7	2.6	1.3	2.0	2.8	5.0	2.1	1.3	9.5	19.7	1.6	6.1	99.0	2.8	2.1	7.6	3.6	2.6	1.3	41.6	0.5	64.0	16.9	10.3	9.6	1.4	3.9	2.0	1.3	3.9	5.4	3.3	1.4	0.8	1.4	1.0	1.8	1.5	4.0	1.7	1.8	0.2	1.4	5.8	0.8	0.3	1.8	0.8	0.7	1.4	1.6	0.6	2.1	26.1	2.5	0.5	0.9	5.4	2.0	3.3	0.6	3.4	197.1	2.9	0.5	1.4	10.6	2.8	9.8	0.2	0.0	0.0	0.9	2.1	0.4	2.5	0.4	1.9	1.7	1.0	2.0	2.2	0.2	4.3	2.7	8.3	0.3	3.3	0.9	0.0	1.8	0.2	8.7	30.7	5.7	1.3	7.3	10.3	6.8	1.0	5.7	8.1	0.5	16.9	64.0	41.6	5.3	9.6	2.5	6.5	0.9	5.0	2.7	0.8	3.6	2.3	3.9	6.1
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9555792	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, CAB025906, HPA051575"	Approved		Supported	Cytosol	"Intracellular and membrane"		27000	Cytosol		"CAB025906: , HPA010738: AB_1078100, HPA051575: "	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (4.23e-5)"	18.6	11.0	13.6	15.4	13.8	21.9	14.7	20.4	15.5	14.0	11.7	13.8	8.3	8.7	14.2	15.8	18.7	10.7	17.4	13.4	11.2	12.4	12.4	7.8	24.7	15.0	11.6	11.7	18.1	9.6	10.9	11.9	29.0	11.2	8.2	9.4	10.6	12.5	9.8	12.3	16.7	11.1	13.9	14.3	21.4	8.9	17.4	12.3	14.7	12.5	13.9	20.3	12.3	14.4	7.0	7.7	16.0	10.2	6.0	7.9	6.0	7.7	12.7	13.4	13.9	26.5	19.8	24.2	8.1	13.8	9.4	13.9	11.2	18.7	22.1	11.8	10.2	14.2	9.9	17.2	12.9	8.8	9.9	11.3	9.6	9.9	37.5	11.0	12.7	22.1	17.4	15.0	29.1	23.5	15.3	8.5	10.0	7.3	8.3	11.1	11.1	5.2	9.6	13.2	10.5	12.5	12.9	7.9	19.8	9.1	11.1	19.3	5.7	14.2	18.8	16.7	8.7	11.7	15.4	11.1	10.0	19.2	13.8	7.1	19.8	16.0	9.8	7.6	6.1	10.2	7.9	7.0	5.0	5.1	7.7	5.1	4.5	4.6	11.8	6.0	9.5	4.3	5.7	6.0	13.6	13.8	20.4	13.1	11.2	12.4	11.6	11.7	11.2	12.3
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 21.7;EFO-21: 18.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"			Cytosol		"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.63e-5)"	47.4	1.1	0.2	1.7	0.3	0.1	14.5	0.1	0.8	3.4	3.8	0.8	3.0	0.6	3.7	9.8	3.8	9.3	9.1	12.6	0.4	0.3	9.1	0.4	6.6	5.6	0.8	0.2	7.0	1.6	0.9	1.0	16.4	1.3	3.7	2.1	10.9	1.0	1.3	1.6	4.1	3.1	6.9	1.4	1.9	4.9	2.4	0.6	0.7	9.8	2.5	0.8	8.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.4	36.0	21.7	0.0	1.3	2.5	0.5	0.1	0.2	0.6	0.0	18.1	0.1	3.3	0.3	0.3	0.1	0.0	0.8	0.0	1.6	0.0	0.3	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	2.7	0.0	2.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	1.9	0.0	0.0	0.3	4.3	3.4	1.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.8	0.2	1.3	0.6
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 157.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.5;BEWO: 62.2;HSkMC: 13.9;K-562: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;monocytes: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		47000000	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	14.4	2.4	0.8	8.9	1.4	2.2	13.2	0.7	1.1	11.0	8.2	1.5	3.9	2.2	9.7	8.1	19.7	11.1	6.6	10.7	1.0	0.2	3.4	14.9	13.3	2.3	1.4	0.4	14.5	1.8	0.2	1.3	157.1	3.4	9.4	2.4	19.1	5.7	2.3	21.1	5.4	6.0	17.4	2.2	3.9	8.9	3.3	1.1	0.8	3.8	15.5	4.8	19.1	15.9	0.0	0.5	2.3	3.5	0.0	0.1	0.6	6.5	0.1	0.1	1.2	6.0	29.5	62.2	6.3	5.6	3.8	2.2	0.5	2.5	0.0	1.3	4.3	3.3	0.2	0.9	1.5	0.5	0.1	1.8	0.7	2.6	4.8	0.0	0.9	13.9	0.2	0.9	2.1	0.0	19.9	0.1	0.6	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.2	2.0	4.9	0.0	1.4	3.4	1.1	0.2	1.8	2.6	0.1	0.5	0.1	1.4	0.2	1.2	0.1	0.0	1.6	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	3.5	0.0	0.0	0.6	0.8	1.4	0.7	1.1	1.0	0.2	1.4	0.4	3.4	1.1
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897901-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;intestine: 30.8"	"Cell line enhanced"	"Detected in many"		"A-431: 35.6;CAPAN-2: 25.7;HaCaT: 16.3;HMC-1: 24.6;THP-1: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	3.0	2.1	32.9	8.9	25.9	8.1	1.2	13.8	41.8	3.6	30.8	30.3	1.7	16.7	2.6	1.3	4.5	4.2	6.2	3.9	36.1	17.7	6.5	1.6	5.8	3.3	28.0	20.1	0.7	5.4	3.7	1.3	3.0	19.3	1.9	20.6	0.9	3.0	3.1	0.8	2.0	22.8	7.7	36.1	7.4	16.3	1.1	19.3	0.0	4.8	0.4	2.3	5.1	1.0	1.3	5.5	3.4	11.7	1.6	6.8	3.7	35.6	1.3	0.0	1.2	0.5	0.0	0.4	1.1	0.0	0.3	0.1	14.2	25.7	0.0	3.5	0.2	16.3	1.9	2.7	0.1	0.2	1.5	0.0	2.2	8.0	0.6	0.2	24.6	0.6	7.6	0.0	0.0	0.0	0.1	0.0	0.0	11.4	0.0	9.6	1.1	0.0	4.8	0.0	0.1	1.9	8.6	1.1	0.3	1.1	0.4	0.1	9.2	41.9	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	1.3	1.1	7.6	3.4	6.8	8.1	3.3	1.3	2.0	6.1	5.5	1.1	0.6	3.1	3.4	1.6	11.7	0.4	0.9	3.7	32.9	25.9	13.8	33.4	36.1	17.7	28.0	20.1	19.3	19.3
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase, RNA specific B1"	P78563	21	45073853-45226560	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 59.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.3;HHSteC: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavourable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	12.2	5.3	7.1	10.4	8.4	4.5	8.9	33.1	11.6	11.7	17.2	2.5	5.6	2.9	13.4	6.6	14.0	8.8	11.1	6.7	7.3	8.1	4.6	4.0	19.9	11.8	7.4	8.1	5.3	4.7	19.0	3.7	12.0	13.6	14.7	5.0	11.0	4.6	8.7	11.8	10.8	5.9	59.9	3.5	10.5	11.7	3.8	4.0	3.9	3.8	4.5	8.4	34.6	20.3	6.1	2.1	4.8	0.6	0.5	2.6	0.5	3.1	0.4	2.4	2.9	3.0	2.1	3.3	2.1	3.5	6.7	4.3	4.9	0.5	1.0	5.7	10.3	0.3	3.6	8.7	7.5	0.7	3.2	6.8	27.3	3.2	31.7	4.6	3.3	11.3	3.8	2.4	7.1	7.1	1.5	0.4	19.6	2.3	3.0	4.4	4.0	4.7	0.9	2.3	3.1	1.5	1.0	14.4	3.8	16.7	0.7	5.3	1.6	3.7	7.4	2.2	2.7	9.0	7.8	3.1	1.4	0.8	2.0	10.9	11.9	1.3	0.2	4.8	1.1	0.6	1.8	2.4	2.6	1.6	0.0	6.1	1.8	1.4	0.2	0.5	0.3	2.1	1.6	0.5	7.1	8.4	33.1	11.6	7.3	8.1	7.4	8.1	13.6	4.0
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase, tRNA specific 2"	Q7Z6V5	6	143422832-143450673	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	7.3	9.5	6.6	15.1	9.4	17.1	8.6	7.7	8.8	6.6	9.5	4.9	4.7	9.9	8.3	5.3	12.0	7.9	7.6	4.2	5.2	3.8	7.5	13.2	11.3	17.6	4.9	8.0	7.5	13.3	7.1	9.6	4.0	7.3	8.6	13.3	6.0	10.1	6.2	13.3	17.1	10.0	6.5	6.7	13.1	10.8	4.1	5.3	8.6	10.8	10.1	13.5	6.6	8.7	2.8	3.2	0.4	1.4	1.9	6.6	2.3	2.9	2.5	3.1	10.5	2.6	8.4	4.7	4.1	1.9	2.9	4.0	6.6	7.5	10.4	4.5	2.8	8.5	5.8	5.8	5.7	5.5	12.9	14.7	10.4	13.5	3.3	20.6	7.4	2.8	8.7	5.6	9.0	6.2	16.0	9.0	4.4	4.2	8.0	11.7	3.9	4.7	9.8	9.1	8.5	4.4	3.3	6.9	4.7	3.5	9.4	2.8	4.0	7.6	4.8	4.2	3.6	8.7	8.0	9.3	6.6	7.9	4.0	17.4	4.9	0.0	0.9	0.0	3.2	1.4	4.7	2.8	3.0	2.9	3.2	2.0	3.4	5.1	0.4	1.9	0.2	3.0	6.6	2.3	6.6	9.4	7.7	8.8	5.2	3.8	4.9	8.0	7.3	5.3
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140673153-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favourable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	12.3	10.6	15.3	11.3	16.6	8.8	13.4	15.4	27.0	12.3	15.1	26.3	13.2	8.8	10.3	11.4	18.0	20.0	10.3	10.2	16.6	18.2	12.3	12.5	12.8	15.6	19.5	13.1	14.5	22.8	21.4	12.7	19.9	18.2	14.4	13.2	10.7	16.8	14.0	12.5	25.8	13.0	10.9	24.0	13.6	13.0	7.6	13.3	20.6	25.1	9.9	16.2	13.4	18.9	8.2	12.0	3.2	5.0	5.1	7.3	2.2	15.9	11.5	2.7	12.7	10.0	11.4	16.4	8.3	10.1	8.7	5.8	10.5	11.3	21.4	12.6	5.8	13.2	13.8	9.4	2.6	15.8	14.2	4.5	4.5	5.1	13.9	3.0	11.3	9.5	28.9	4.9	6.9	7.4	7.9	10.5	3.1	19.9	22.4	7.4	4.0	12.5	17.7	0.1	10.4	4.7	16.0	10.8	7.5	11.4	16.6	11.4	14.7	6.1	7.8	10.9	3.8	18.0	16.0	7.3	11.2	15.8	16.0	12.1	12.9	0.0	3.7	3.2	5.4	5.0	4.9	8.2	4.8	5.3	5.7	4.2	7.3	4.7	0.1	5.1	3.0	12.0	6.0	2.2	15.3	16.6	15.4	27.0	16.6	18.2	19.5	13.1	18.2	13.3
ADCK5	FLJ35454	ENSG00000173137	"AarF domain containing kinase 5"	Q3MIX3	8	144373101-144393242	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025692, HPA028679"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA025692: AB_10599486, HPA028679: AB_10600226"	"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.31e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.90e-2)"	4.1	10.0	4.8	8.9	4.5	4.5	4.3	11.5	9.1	4.6	18.3	2.8	7.6	19.1	5.8	4.2	7.2	4.2	6.3	3.8	3.9	4.1	4.8	6.9	3.7	5.0	3.4	8.4	5.5	5.6	4.7	4.1	3.7	4.5	4.7	4.0	4.6	7.4	4.7	5.6	8.3	17.0	2.7	2.4	6.7	5.6	7.7	3.8	6.8	4.1	4.9	6.1	5.1	5.0	4.7	6.3	2.5	5.4	1.8	4.1	2.8	3.8	4.8	1.0	3.3	0.9	0.8	5.7	3.3	1.8	2.6	0.9	5.2	4.2	1.7	2.3	0.7	5.1	0.2	3.5	0.2	4.3	1.6	4.4	3.6	5.8	2.6	1.0	3.4	1.3	2.1	0.9	0.8	1.8	2.9	3.0	1.5	10.1	3.2	4.4	0.6	3.6	4.2	1.6	3.0	1.7	3.6	0.7	1.8	4.8	3.9	2.7	3.3	3.0	1.2	1.4	5.1	3.5	2.2	1.4	0.4	1.5	3.2	3.8	2.0	1.8	4.2	2.5	2.3	5.4	3.0	1.8	2.8	1.8	6.3	4.7	2.9	1.5	0.7	1.8	5.0	4.0	4.1	2.8	4.8	4.5	11.5	9.1	3.9	4.1	3.4	8.4	4.5	3.8
ADCY7	"AC7, KIAA0037"	ENSG00000121281	"Adenylate cyclase 7"	P51828	16	50246137-50318135	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 22.9;HMC-1: 63.9;RPMI-8226: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041218, HPA048241"	Uncertain		Approved	Cytosol				Cytosol		"HPA041218: , HPA048241: "	"unprognostic (1.98e-1)"	"prognostic unfavourable (5.31e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.59e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.52e-4)"	6.3	4.3	7.0	17.4	9.7	14.9	3.9	1.2	5.2	3.7	5.0	9.8	0.8	2.8	3.7	4.8	13.2	5.3	6.9	7.3	5.3	4.2	3.3	3.6	16.4	16.5	8.8	4.4	17.1	3.7	1.0	3.4	9.7	8.6	3.5	5.9	6.2	6.5	1.6	1.8	7.9	10.4	5.0	12.3	26.9	4.9	2.1	9.2	21.8	3.7	3.1	26.0	6.6	6.1	3.6	12.5	6.5	16.7	8.4	7.0	5.0	3.9	5.4	0.2	0.7	0.5	7.0	0.5	2.8	1.3	2.1	2.0	5.1	8.2	1.6	7.4	11.1	14.3	5.6	2.4	2.7	15.1	2.0	22.9	4.1	1.4	6.4	4.3	63.9	3.7	2.3	1.6	2.5	0.6	8.3	3.2	3.0	2.3	1.6	10.2	0.9	7.7	1.6	2.1	31.7	1.5	0.3	0.9	2.6	1.5	0.6	1.3	0.1	12.8	5.0	0.3	7.5	0.8	0.7	0.3	0.1	3.5	2.4	9.3	1.0	6.5	7.8	2.9	7.0	11.7	5.1	3.2	2.8	5.0	12.5	3.6	2.6	3.7	4.4	8.4	16.7	6.5	3.9	5.0	7.0	9.7	1.2	5.2	5.3	4.2	8.8	4.4	8.6	9.2
ADCY9	AC9	ENSG00000162104	"Adenylate cyclase 9"	O60503	16	3953387-4116185	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 36.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041328, HPA044225"	Approved		Approved	Cytosol				Cytosol		"HPA041328: , HPA044225: "	"unprognostic (1.78e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (5.24e-8)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-2)"	5.2	4.8	7.1	3.2	10.9	0.9	5.4	8.5	9.6	7.0	6.4	4.1	4.4	6.5	6.5	4.4	6.8	7.7	6.5	13.3	6.2	3.0	8.0	9.6	11.1	2.5	3.0	6.2	9.4	12.5	12.3	5.8	7.8	7.7	3.6	5.5	9.0	10.1	5.0	36.4	4.4	10.9	6.3	2.2	3.2	5.5	4.4	3.4	0.7	21.8	7.7	3.0	7.9	4.8	0.1	1.0	3.2	1.5	1.0	1.9	0.9	4.8	7.5	2.3	4.2	8.2	10.1	3.4	8.6	9.0	4.8	3.9	6.2	4.3	0.0	13.3	23.6	4.8	8.9	5.4	3.3	6.0	8.6	0.2	17.2	11.9	8.9	0.6	3.9	10.7	8.3	5.6	3.0	3.2	2.6	0.0	4.9	8.9	0.0	2.5	4.1	4.1	7.7	10.9	0.2	1.7	1.3	5.2	2.3	6.7	7.9	5.8	20.1	8.7	3.0	9.7	2.7	9.4	3.7	1.9	1.1	1.0	2.1	2.6	3.7	3.2	1.5	1.0	1.9	1.5	1.7	0.0	0.6	0.6	0.1	0.1	0.1	1.1	0.3	1.0	0.0	1.0	0.0	0.9	7.1	10.9	8.5	9.6	6.2	3.0	3.0	6.2	7.7	3.4
ADD2	ADDB	ENSG00000075340	"Adducin 2"	P35612	2	70607618-70768225	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 53.6;brain: 35.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 14.1;K-562: 18.5;NTERA-2: 36.5;RPMI-8226: 17.4;SCLC-21H: 18.1;U-251 MG: 19.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 4.7;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	20	"B-cells: 4.7;monocytes: 4.4;T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009796, HPA034509, HPA034510"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			66000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009796: AB_2223572, HPA034509: , HPA034510: "	"unprognostic (3.58e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.47e-7)"	"unprognostic (2.81e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-3)"	1.9	2.6	14.0	2.6	17.9	53.6	1.5	29.7	35.0	1.3	1.3	1.2	0.0	1.0	1.3	1.2	2.3	1.4	1.2	1.5	14.1	10.7	0.9	0.9	1.8	3.1	6.0	19.7	1.0	2.1	1.3	2.8	1.6	14.0	1.3	1.2	1.7	1.1	1.1	1.6	1.2	1.2	1.9	6.0	1.9	1.1	2.9	2.7	0.0	2.3	0.0	2.9	1.5	0.5	4.7	0.1	0.1	4.4	0.0	1.9	0.6	7.0	8.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.1	0.0	14.1	0.0	0.0	0.0	8.3	0.7	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.1	0.6	36.5	0.2	0.0	0.2	17.4	2.4	0.0	18.1	8.2	8.9	0.0	0.0	0.0	4.3	0.3	0.0	0.4	0.0	19.2	5.9	6.9	0.0	0.3	2.9	3.2	0.1	0.1	0.0	0.0	2.4	0.1	4.7	0.0	0.0	0.1	4.0	1.9	1.0	0.1	0.0	4.4	0.0	0.0	0.6	14.0	17.9	29.7	35.0	14.1	10.7	6.0	19.7	14.0	2.7
ADGRD1	"DKFZp434B1272, GPR133, PGR25"	ENSG00000111452	"Adhesion G protein-coupled receptor D1"	Q6QNK2	12	130953907-131141469	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 66.1"	"Cell line enhanced"	"Detected in some"		"BJ: 5.0;fHDF/TERT166: 5.7;HeLa: 10.3;HHSteC: 6.6;HMC-1: 14.2;U-2 OS: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 4.9"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.3"	"Low region specificity"	"Detected in all"			HPA042395	Uncertain		Approved	Nucleoplasm,Cytosol			600000	"Nucleoplasm, Cytosol"		"HPA042395: AB_10796906"	"unprognostic (3.21e-1)"	"unprognostic (1.49e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (9.27e-4)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.79e-5)"	"unprognostic (1.31e-3)"	"unprognostic (4.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-3)"	12.7	2.1	2.0	3.2	3.1	0.5	8.9	1.1	3.9	11.2	5.5	2.2	3.9	2.2	13.3	14.0	6.8	8.8	45.6	34.8	1.9	1.5	1.6	5.2	18.6	0.6	4.2	2.2	12.5	11.8	0.3	3.5	26.6	2.4	13.3	2.4	13.0	1.6	2.3	11.6	3.8	6.4	66.1	6.4	1.9	10.2	3.8	2.6	0.0	6.3	7.1	2.1	29.5	30.8	0.2	2.4	0.0	4.9	0.5	0.0	1.2	0.0	0.7	0.0	2.5	0.0	0.0	0.1	5.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.3	0.0	6.6	0.0	14.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.5	7.0	1.9	0.1	0.1	1.8	0.9	0.1	0.0	0.0	0.0	4.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.5	3.6	0.0	0.0	1.2	2.0	3.1	1.1	3.9	1.9	1.5	4.2	2.2	2.4	2.6
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732393-14778541	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Cell adhesion, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;lymphoid tissue: 38.9"	"Cell line enhanced"	"Detected in some"		"HEL: 10.1;HMC-1: 16.3;NB-4: 9.8;RPMI-8226: 7.2;U-937: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 24.2;monocytes: 28.7"									HPA055200			Uncertain	Vesicles,Cytosol				Vesicles	Cytosol	"HPA055200: "	"unprognostic (2.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.35e-6)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.01e-1)"	6.3	3.1	1.7	22.9	1.9	7.2	4.4	1.0	1.3	14.9	8.1	2.5	0.9	2.4	12.0	1.0	1.9	2.3	3.3	7.3	2.0	1.8	3.4	4.3	15.6	37.4	2.2	0.0	5.3	3.5	0.7	1.6	10.9	2.4	3.8	2.5	3.2	2.4	3.9	3.5	3.0	3.0	2.0	3.1	38.9	2.0	2.2	1.4	2.8	3.4	5.2	2.8	7.5	2.1	0.1	3.1	24.2	28.7	1.2	0.0	1.8	0.2	1.0	0.1	0.2	0.1	0.3	1.1	0.8	1.1	0.0	0.0	0.2	0.2	0.2	0.1	0.6	1.7	0.3	0.1	0.0	0.2	0.2	10.1	3.2	0.2	0.5	3.7	16.3	0.8	1.4	3.6	0.6	0.1	2.3	0.4	1.2	0.5	1.3	9.8	0.4	0.2	0.1	1.4	7.2	0.0	0.3	0.1	0.2	2.1	1.7	0.4	0.3	4.7	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.2	1.0	12.9	0.5	19.6	4.4	24.2	0.0	15.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	19.1	1.2	28.7	0.6	0.0	1.8	1.7	1.9	1.0	1.3	2.0	1.8	2.2	0.0	2.4	1.4
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA013707	Enhanced		Approved	Cytosol	"Secreted to blood"	10000000	930000	Cytosol		"HPA013707: AB_1846345"	"unprognostic (3.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (3.73e-5)"	"unprognostic (7.51e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (1.87e-6)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.41e-2)"	17.7	8.9	2.5	23.0	4.0	55.3	14.3	1.1	5.2	21.7	15.9	12.9	0.5	12.9	56.9	18.5	11.6	19.1	27.1	16.4	3.0	2.4	10.7	15.5	30.3	41.1	6.3	3.2	10.7	16.2	2.4	3.3	18.2	5.9	11.3	9.0	6.9	17.0	3.6	12.5	6.0	22.2	36.2	4.2	56.9	15.0	6.9	4.9	24.3	8.6	3.7	22.5	34.7	12.4	3.9	13.3	95.3	43.2	22.8	25.8	23.3	30.6	21.8	0.2	20.9	9.3	15.2	3.3	21.2	34.3	15.3	16.8	6.2	31.1	3.5	21.5	27.3	7.3	5.6	10.3	6.9	19.1	6.4	6.9	32.2	2.7	11.4	14.8	32.1	6.6	0.3	15.5	5.3	1.5	9.0	27.5	16.6	6.9	0.9	19.8	0.6	27.1	2.0	9.2	16.0	5.1	2.7	0.2	0.7	12.1	17.4	15.1	4.5	13.7	3.7	5.2	8.6	21.6	34.9	0.0	0.1	0.2	18.6	26.5	19.4	42.0	18.6	95.3	25.8	36.7	17.3	3.9	13.1	17.8	13.3	2.6	9.4	12.8	82.7	22.8	43.2	6.4	9.0	23.3	2.5	4.0	1.1	5.2	3.0	2.4	6.3	3.2	5.9	4.9
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989309-19122637	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 202.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.1;BEWO: 7.7;HeLa: 6.4;NTERA-2: 6.7;SH-SY5Y: 7.0;U-2197: 15.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"			7900000	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	4.4	0.3	0.4	0.9	0.2	0.2	2.8	0.1	0.2	0.8	1.0	0.1	6.6	0.2	0.5	202.4	0.9	6.9	1.4	1.8	0.6	0.6	0.7	0.9	1.7	3.1	0.2	0.2	0.9	0.9	24.8	1.9	0.6	0.3	3.2	0.2	1.6	9.6	0.8	0.6	0.3	1.4	0.6	0.2	1.2	3.5	4.7	0.2	2.7	1.8	0.6	1.9	1.1	1.5	0.1	0.2	0.9	0.6	0.0	0.2	0.0	0.2	6.1	0.0	0.0	0.1	0.9	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	6.4	0.2	0.9	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.2	0.0	1.0	0.0	2.3	6.7	2.0	0.0	0.1	4.4	0.0	1.2	2.3	7.0	1.5	0.1	0.0	0.1	0.1	0.1	0.2	0.4	15.3	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.9	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.6	0.1	0.0	0.0	0.4	0.2	0.1	0.2	0.6	0.6	0.2	0.2	0.3	0.2
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 10.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"			12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: , HPA060902: "	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 385.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"			16000000	"Plasma membrane, Cytosol"		"HPA047814: , HPA060902: "	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	385.0	56.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.1;HSkMC: 15.1"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"			9700000	"Plasma membrane, Cytosol"		"HPA047814: , HPA060902: "	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (4.55e-4)"	"prognostic favourable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.2	0.0	0.1	1.7	5.1	1.1	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.5	1.4	0.3	15.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.9	0.4	0.1	0.1	0.9	2.1	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1										
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 21.9"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol			5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favourable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.4	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.3	0.0	0.2	0.4	0.2	0.1	0.5	0.8	21.9	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.1	0.4	1.0	0.1	0.3	0.3	0.6	0.3	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.5	0.0	0.4	0.5	0.2	0.4	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	7	"ASC TERT1: 3.9;HaCaT: 4.4"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968192-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 25.2;HaCaT: 65.1;PC-3: 35.5;RT4: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.9;naive CD8 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	11	"T-cells: 3.9"					"Low region specificity"	"Detected in many"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol			580000	"Nucleoplasm, Cytosol"		"HPA026810: "																		123.4	9.5	15.7	21.4	6.1	1.5	109.7	1.6	8.4	44.3	65.3	6.8	21.6	66.2	25.3	34.6	24.3	34.7	29.9	24.8	17.3	6.1	20.3	10.3	32.5	5.4	10.5	9.3	54.7	12.6	7.2	11.7	8.7	7.2	38.6	7.0	23.6	41.5	38.8	30.5	23.7	69.5	19.8	9.6	10.0	12.2	12.5	9.9	1.2	29.7	38.6	8.3	39.5	41.6	0.0	0.3	0.0	0.3	0.0	3.9	0.6	25.2	0.3	0.0	0.0	2.1	12.4	1.7	8.8	9.5	0.0	0.0	0.9	3.2	0.0	0.3	10.8	65.1	0.0	2.1	0.1	0.9	0.0	0.0	2.7	0.2	1.2	0.0	0.4	0.3	4.1	0.0	5.8	3.6	0.1	3.5	0.3	3.1	0.1	0.6	0.1	35.5	0.1	0.0	0.3	0.4	45.2	1.6	0.1	3.0	13.5	0.1	16.7	0.3	9.6	0.3	2.0	1.7	0.0	0.5	0.4	0.0	0.7	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.3	0.0	3.9	2.8	0.0	0.0	0.0	0.0	0.2	0.6	15.7	6.1	1.6	7.9	17.3	6.1	10.5	9.3	7.2	9.9
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151185-74709303	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Purine salvage"	"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 71.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409"	Approved		Supported	Nucleoplasm,Cytosol			320000	"Nucleoplasm, Cytosol"		"CAB032876: AB_2242229, HPA038391: , HPA038409: AB_10675798"	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (1.93e-4)"	"prognostic favourable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	13.8	10.7	11.8	13.6	25.4	12.1	14.5	11.2	11.8	9.5	9.3	9.0	9.6	8.8	6.6	10.6	29.4	8.9	6.3	15.7	9.8	11.1	19.0	71.9	15.1	17.9	12.3	9.3	5.2	12.6	15.1	23.5	43.2	11.6	8.7	10.8	8.5	13.1	11.4	18.1	20.8	6.4	8.3	13.2	11.3	7.4	11.9	10.3	13.4	20.8	24.1	21.9	12.6	14.7	49.3	23.0	5.4	21.6	6.5	15.7	9.8	37.5	8.5	9.0	12.0	9.0	13.9	20.7	32.6	25.9	25.3	28.4	23.7	39.2	19.7	8.2	13.1	34.4	10.5	34.7	40.6	13.2	12.1	12.5	13.9	25.5	10.3	20.0	5.1	12.8	23.0	18.4	45.9	22.0	9.9	6.4	19.0	21.0	23.5	27.1	2.5	60.0	22.7	15.6	16.9	27.7	20.7	7.1	8.4	14.3	55.8	10.8	37.1	15.1	18.8	8.4	15.5	22.4	26.9	9.2	10.4	22.2	15.9	28.8	5.1	1.3	10.1	1.4	4.5	18.0	10.0	29.7	9.5	8.2	23.0	49.3	7.9	6.5	5.4	6.5	21.6	16.7	15.7	9.8	11.8	25.4	11.2	11.8	9.8	11.1	12.3	9.3	11.6	10.3
ADNP2	"KIAA0863, ZNF508"	ENSG00000101544	"ADNP homeobox 2"	Q6IQ32	18	80109031-80147523	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007126	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA007126: AB_1080729"	"unprognostic (4.93e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"prognostic favourable (6.39e-5)"	"unprognostic (8.64e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavourable (9.90e-4)"	"unprognostic (5.19e-2)"	11.3	8.8	9.1	7.6	10.4	40.5	10.9	8.4	12.5	7.7	8.6	14.4	7.1	10.8	10.2	13.5	12.5	10.0	11.1	10.2	9.8	7.0	8.4	11.3	10.3	11.6	8.0	10.4	12.7	10.4	12.7	12.4	11.4	10.4	9.2	8.2	12.6	9.1	8.9	4.0	16.5	9.7	13.1	10.1	8.7	11.2	24.4	6.7	14.3	10.1	8.1	10.4	11.3	10.8	2.4	2.3	1.7	3.0	1.4	4.4	1.5	11.1	8.7	18.3	13.4	4.1	5.9	13.8	8.2	9.2	9.7	12.2	8.1	5.7	0.1	3.1	6.4	10.2	17.7	10.4	10.5	10.1	8.8	15.7	6.7	8.9	7.6	22.9	17.5	6.1	9.8	9.9	13.4	9.7	15.1	16.6	5.6	7.8	21.0	4.7	12.4	10.2	7.9	20.4	7.9	5.8	14.9	12.4	16.0	9.2	9.0	6.3	8.8	17.4	6.4	11.5	28.8	4.8	8.9	6.0	10.9	23.1	7.7	9.6	7.7	0.0	1.1	0.7	3.4	1.7	2.4	2.4	4.4	2.9	0.6	1.1	2.4	4.1	1.7	1.4	3.0	2.3	2.1	1.5	9.1	10.4	8.4	12.5	9.8	7.0	8.0	10.4	10.4	6.7
ADORA2B		ENSG00000170425	"Adenosine A2b receptor"	P29275	17	15944917-15975746	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 56.7;hTERT-HME1: 21.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.8;myeloid DC: 8.4"	"Group enriched"	"Detected in many"	86	"dendritic cells: 8.4;granulocytes: 12.8;monocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073747			Uncertain	Cytosol				Cytosol		"HPA073747: "	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-9)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-1)"	1.5	1.5	7.6	4.5	9.1	1.6	1.8	7.3	8.7	2.9	15.3	2.4	0.0	0.8	1.7	1.5	11.1	2.2	3.8	1.2	6.6	3.0	0.6	0.7	4.1	1.0	1.9	5.4	0.6	2.8	0.4	1.9	9.0	5.2	1.7	12.8	10.5	1.9	0.7	0.7	10.4	1.6	2.8	3.9	0.7	2.6	0.7	2.6	0.1	0.6	4.4	4.5	6.8	5.6	0.0	8.4	12.8	4.5	0.0	0.0	1.5	11.2	6.2	0.2	0.2	2.0	3.9	0.2	2.1	9.7	6.3	7.9	2.9	11.8	1.5	2.7	1.9	17.7	2.7	16.2	8.5	3.2	6.2	10.9	2.0	4.3	7.9	0.0	56.7	2.3	6.9	9.0	21.2	3.2	0.5	0.0	6.2	2.9	0.7	2.2	0.6	8.8	0.0	0.1	0.0	6.5	3.0	0.3	0.4	4.8	1.2	2.9	0.0	1.7	2.6	2.3	6.0	6.3	10.1	0.9	0.0	0.0	9.0	0.0	3.1	12.8	4.0	2.6	0.0	4.5	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.4	0.0	2.3	0.1	0.0	1.5	7.6	9.1	7.3	8.7	6.6	3.0	1.9	5.4	5.2	2.6
ADRB2	"ADRB2R, ADRBR, B2AR, BAR"	ENSG00000169252	"Adrenoceptor beta 2"	P07550	5	148825245-148828687	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.0;hTERT-HME1: 25.0;PC-3: 10.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003431, HPA075322"	Uncertain		Uncertain	Cytosol				Cytosol		"HPA003431: AB_1845333, HPA075322: "	"unprognostic (2.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (3.15e-9)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	11.7	0.2	0.7	0.9	0.4	4.6	13.8	0.0	0.3	6.1	0.9			0.3	0.9	0.2	6.4	1.4	1.1	2.8	0.7	0.3	0.2	6.0	8.5	1.1	0.9		0.0	0.0	0.5	0.0	4.0		3.8	0.7		3.3	0.1	4.4	15.9	1.3	1.2	1.0	3.7	2.9	0.0			0.5		2.0	2.3	5.4	4.8	6.1	14.0	10.8	7.3	34.6	9.6	7.5	0.0	0.0	0.0	0.3	0.0	0.0	1.4	4.3	2.0	2.2	0.0	3.2	0.0	2.1	0.4	6.7	0.0	9.1	2.3	0.0	0.2	0.0	1.6	0.0	0.2	0.0	3.8	0.0	24.0	0.6	25.0	0.9	0.0	2.8	5.2	0.0	0.0	4.1	0.1	10.3	2.2	1.4	4.2	1.0	1.9	0.0	0.0	1.8	0.1	0.6	0.0	2.3	4.0	0.0	1.7	2.4	1.1	0.7	0.0	0.1	0.0	4.9	0.8	3.5	4.7	14.0	34.6	7.8	25.7	4.8	8.2	20.9	5.3	3.0	1.4	12.9	7.6	7.3	10.8	6.1	0.4	9.6										
ADRM1	"ARM1, GP110, Rpn13"	ENSG00000130706	"Adhesion regulating molecule 1"	Q16186	20	62302093-62308862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042266	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042266: AB_10794044"	"unprognostic (5.49e-2)"	"unprognostic (5.14e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (9.02e-6)"	"unprognostic (4.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.47e-2)"	22.9	22.9	14.8	23.4	16.8	30.5	17.0	24.1	29.3	14.7	16.9	18.8	12.4	24.0	19.9	15.3	23.9	14.0	20.4	24.6	14.6	15.1	21.7	54.5	15.7	22.1	15.5	13.4	17.2	34.9	9.5	13.4	27.6	21.4	14.8	7.9	14.8	21.0	18.3	86.6	26.4	19.5	17.3	15.4	23.5	20.1	30.0	10.1	23.8	16.4	29.1	29.4	17.3	14.6	79.2	67.2	69.4	78.0	51.7	77.6	70.9	33.7	37.8	10.6	22.6	10.2	7.5	28.9	22.3	15.2	41.9	16.8	112.7	35.8	18.2	40.8	12.7	38.2	13.4	32.8	12.9	21.2	27.3	44.1	27.4	59.4	17.2	22.7	42.1	9.4	20.2	27.3	10.9	16.2	32.2	19.9	9.6	45.4	28.5	44.6	36.0	56.5	23.0	18.7	28.8	11.2	25.4	19.0	23.7	24.1	38.3	26.8	26.6	25.1	23.7	41.9	44.4	40.8	44.7	42.5	33.4	24.3	44.1	22.9	30.3	48.3	66.3	69.4	66.0	78.0	58.9	79.2	59.8	62.7	67.2	75.5	45.1	51.4	62.2	51.7	65.0	62.7	77.6	70.9	14.8	16.8	24.1	29.3	14.6	15.1	15.5	13.4	21.4	10.1
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346500-40390463	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol			180000	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavourable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	9.3	11.6	5.0	13.7	8.5	11.2	9.0	6.8	10.1	7.9	9.5	7.3	4.4	6.0	10.8	9.4	9.7	9.0	6.9	14.6	4.5	4.7	12.0	17.3	6.8	17.6	4.9	4.9	10.5	21.8	5.4	9.1	9.5	5.1	7.1	9.7	9.2	14.7	6.4	79.0	6.2	9.4	10.7	4.9	14.5	9.6	10.9	4.4	18.8	8.4	23.6	15.5	9.5	7.4	15.3	28.8	11.0	22.7	19.8	34.0	24.6	21.0	24.9	21.4	30.5	14.5	20.4	24.8	19.3	19.1	41.8	32.0	41.1	12.4	61.3	16.4	22.3	15.9	47.7	31.0	43.0	16.3	44.9	27.8	28.1	37.8	30.3	90.4	23.4	21.9	17.6	36.7	39.0	30.9	32.8	26.9	31.2	23.5	27.9	32.3	34.9	26.6	42.6	45.0	43.5	26.9	16.7	13.8	13.6	23.0	12.7	36.5	17.6	28.6	20.4	22.4	41.5	19.7	36.9	25.6	44.6	47.0	18.6	33.6	21.8	11.0	19.3	7.8	16.2	22.7	22.8	15.3	34.0	21.7	28.8	14.9	27.0	20.8	1.9	19.8	20.2	14.9	34.0	24.6	5.0	8.5	6.8	10.1	4.5	4.7	4.9	4.9	5.1	4.4
ADSS		ENSG00000035687	"Adenylosuccinate synthase"	P30520	1	244408494-244452134	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Supported	"Plasma membrane,Cytosol"			620000	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.4	17.8	23.2	23.8	31.2	29.2	26.3	18.3	26.3	20.9	20.9	35.9	27.1	21.1	18.9	23.3	27.7	18.3	15.8	9.8	24.9	23.4	25.1	19.3	19.2	21.2	42.5	16.6	20.9	21.2	26.6	17.7	21.0	34.9	19.8	22.7	13.1	25.0	21.7	11.0	26.5	23.2	22.9	29.3	24.9	24.7	48.9	36.7	26.7	26.3	17.9	24.8	26.5	21.8	10.9	13.6	24.6	21.3	15.5	16.0	11.9	25.4	14.1	12.3	10.8	14.4	20.7	22.7	25.8	21.7	18.5	14.1	18.5	24.7	22.8	17.1	19.8	19.3	13.4	16.8	20.8	16.9	23.7	15.2	14.1	14.0	17.4	35.8	19.6	14.1	20.4	17.2	17.5	66.0	26.3	17.0	18.4	6.1	23.0	24.1	32.7	15.6	21.3	11.7	24.6	30.7	15.9	16.7	14.7	21.9	20.4	25.7	14.1	19.1	28.8	17.2	9.4	19.8	26.7	20.6	27.0	17.2	14.2	42.1	25.3	24.6	15.8	13.0	15.0	20.5	16.0	10.9	13.7	12.8	13.6	8.6	11.8	13.3	11.9	15.5	21.3	5.5	14.7	11.9	23.2	31.2	18.3	26.3	24.9	23.4	42.5	16.6	34.9	36.7
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;BJ: 46.1;BJ hTERT+: 30.4;fHDF/TERT166: 49.4;WM-115: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"		2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: , HPA063595: , HPA064970: "	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	35.0	12.4	0.2	46.1	30.4	5.2	1.1	0.0	0.0	1.2	5.1	49.4	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	2.3	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	16.6	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.2	0.1	3.3	8.1	0.0	21.4	0.1	0.0	0.2	0.2	24.3	0.1	0.0	28.3	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6
AFAP1	"AFAP, AFAP-110"	ENSG00000196526	"Actin filament associated protein 1"	Q8N556	4	7758714-7939926	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.0;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015642, CAB024712"	Enhanced		Supported	"Actin filaments,Focal adhesion sites,Cytosol"				"Actin filaments, Cytosol"	"Focal adhesion sites"	"CAB024712: , HPA015642: AB_1844632"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (8.18e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.44e-2)"	14.0	3.9	9.5	11.6	10.2	1.0	15.8	10.3	12.2	11.0	17.8	4.4	6.5	6.7	18.7	6.6	13.1	9.0	14.7	11.0	7.1	5.8	5.2	1.8	8.7	5.3	4.7	6.9	12.1	6.6	31.9	13.0	14.4	5.6	10.3	11.7	12.4	9.6	12.7	5.7	5.8	8.8	32.1	8.3	4.6	8.4	21.7	3.2	3.3	8.6	5.6	6.1	16.2	13.1	0.0	0.0	6.0	0.9	0.0	2.9	1.5	10.3	7.7	5.5	4.3	5.3	9.7	7.2	15.4	22.9	14.9	13.7	2.4	2.4	0.0	5.2	24.9	5.0	2.9	6.2	9.8	0.2	1.9	0.0	11.1	1.4	15.0	0.0	0.1	6.0	4.7	18.5	12.2	17.8	0.2	2.3	7.7	3.3	0.1	0.0	2.3	14.9	0.0	4.1	0.5	1.6	1.3	10.8	18.1	5.3	3.7	4.1	1.3	0.1	42.0	18.2	4.1	23.6	7.5	0.0	0.0	0.0	6.5	0.0	20.7	0.0	0.9	6.0	1.1	0.2	1.4	0.0	1.6	1.5	0.0	0.0	2.9	1.3	2.3	0.0	0.1	0.0	1.3	1.5	9.5	10.2	10.3	10.8	7.1	5.8	4.7	6.9	5.6	3.2
AFAP1L2	"Em:AC005383.4, FLJ14564, KIAA1914, XB130"	ENSG00000169129	"Actin filament associated protein 1 like 2"	Q8N4X5	10	114294824-114404756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 47.9"	"Cell line enhanced"	"Detected in some"		"A-431: 25.8;CAPAN-2: 27.9;EFO-21: 20.8;HaCaT: 35.5;RPMI-8226: 18.2;RPTEC TERT1: 21.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebellum: 169.5;olfactory region: 48.1"	HPA037843	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA037843: AB_10669990"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (3.76e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.55e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-1)"	4.5	1.7	9.0	5.9	6.3	0.3	7.1	24.7	8.8	12.9	7.1	5.3	30.5	2.4	22.3	9.7	5.9	13.8	3.6	2.9	7.8	7.1	9.1	1.2	3.2	2.4	8.0	6.7	9.3	8.2	35.1	1.8	10.6	5.5	7.9	3.2	8.1	4.2	28.4	1.8	5.7	4.0	11.1	5.7	39.9	4.1	1.5	6.5	3.4	47.9	7.5	4.3	3.7	14.0	4.0	0.3	0.4	0.0	0.8	4.0	1.4	25.8	3.8	3.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	27.9	0.0	20.8	0.2	35.5	0.0	9.7	0.0	0.5	0.0	0.0	0.2	0.0	1.1	0.0	1.0	0.0	10.5	2.9	2.6	0.1	0.0	0.0	0.0	1.0	0.6	0.0	0.2	0.2	0.3	0.3	18.2	21.9	0.2	0.1	0.1	0.8	0.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.6	3.8	2.7	2.8	0.0	4.0	0.9	2.2	0.4	0.8	0.0	0.3	4.0	1.4	9.0	6.3	24.7	8.5	7.8	7.1	8.0	6.7	5.5	6.5
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100142739	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.3;T-47d: 11.7;U-698: 34.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 16.2;naive B-cell: 27.5;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	16	"B-cells: 27.5;dendritic cells: 12.8"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: "	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.2	2.4	6.0	40.2	6.1	10.3	16.6	20.5	9.9	4.2	4.2	1.8	0.8	1.2	8.9	1.7	4.1	4.1	2.3	4.9	6.3	6.2	1.8	2.4	7.6	23.3	5.4	6.8	7.5	1.1	0.3	5.2	6.9	4.4	18.9	2.3	5.5	6.6	3.3	1.0	1.0	5.9	8.6	6.6	43.6	4.8	6.0	2.5	34.7	1.7	0.7	42.0	7.4	2.7	27.5	12.8	0.2	0.2	0.9	1.2	0.4	0.1	0.0	9.8	3.4	0.0	0.4	0.0	1.3	0.3	2.9	1.0	0.0	0.0	23.3	0.1	1.5	0.1	0.2	0.0	1.7	5.9	2.8	0.0	0.1	0.0	0.2	0.1	6.7	0.6	0.0	6.1	0.1	0.0	0.1	0.0	0.0	0.1	1.9	0.3	1.3	1.6	3.2	0.0	0.1	0.0	0.0	9.7	3.4	0.1	0.1	6.3	11.7	10.7	3.9	9.3	2.5	0.3	1.5	0.2	0.0	34.5	8.7	0.8	0.7	0.2	0.2	0.0	0.0	0.2	0.2	16.2	0.1	0.0	2.9	27.5	1.2	0.0	0.1	0.9	0.2	12.8	0.0	0.4	6.0	6.1	20.5	9.9	6.3	6.2	5.4	6.8	4.4	2.5
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294894-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	4.9	7.3	7.6	6.5	6.6	4.3	5.7	6.2	7.3	4.1	5.7	7.3	6.9	8.9	3.7	4.9	5.5	5.1	4.8	9.4	6.3	4.9	11.0	7.6	9.1	4.8	7.3	7.4	4.1	5.2	11.6	6.9	4.7	6.1	3.9	7.0	5.5	4.7	5.4	9.0	4.2	6.3	4.0	5.6	4.4	6.0	25.4	6.5	5.6	6.6	4.1	4.5	4.8	4.3	5.7	3.0	5.1	7.2	4.2	4.4	1.7	3.4	1.8	4.6	8.1	4.8	7.0	4.5	3.9	5.9	6.5	6.4	7.3	4.3	6.2	5.2	6.0	1.9	5.8	5.8	7.3	3.6	3.5	7.4	2.3	8.4	4.7	6.5	3.6	6.5	4.8	4.8	7.8	3.4	7.4	2.9	6.0	3.2	1.2	6.1	3.0	3.6	4.3	6.2	3.6	8.1	3.8	5.0	4.4	3.2	4.6	8.6	3.8	12.8	4.3	4.0	1.0	3.4	4.4	2.1	3.2	4.8	4.9	7.8	6.0	0.0	3.1	5.1	2.0	2.2	2.6	4.8	3.2	3.8	2.7	5.7	4.4	2.9	0.8	4.2	7.2	3.0	4.1	1.7	7.6	6.6	6.2	7.3	6.3	4.9	7.3	7.4	6.1	6.5
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Cell line enriched"	"Detected in some"	190	"Hep G2: 214.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	6000000	930000	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0
AFTPH	"FLJ20080, FLJ23793, MGC33965, Nbla10388"	ENSG00000119844	Aftiphilin	Q6ULP2	2	64524305-64593005	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034990, HPA034991"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"				Cytosol	"Golgi apparatus, Vesicles"	"HPA034990: AB_2674398, HPA034991: AB_10603577"	"unprognostic (7.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-2)"	"prognostic favourable (2.37e-5)"	"prognostic favourable (8.44e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.83e-4)"	12.4	14.8	18.0	25.8	20.0	11.4	20.8	29.8	22.9	14.9	20.1	9.5	16.7	14.1	12.9	28.6	20.7	14.7	16.9	13.5	15.6	14.5	34.8	20.3	18.7	20.7	12.8	21.4	13.1	19.4	26.8	22.6	9.8	16.3	22.3	21.5	9.8	18.5	17.4	12.2	21.8	19.0	14.7	12.2	17.1	20.0	15.1	16.7	20.0	16.0	9.9	24.7	16.5	20.9	16.4	11.8	21.4	10.2	4.9	9.0	4.2	14.0	9.3	7.0	8.4	9.0	7.7	11.6	8.1	12.2	13.4	10.1	10.7	10.7	20.9	8.0	10.0	11.5	12.0	11.3	17.5	20.3	6.6	10.0	5.9	12.5	9.6	19.0	17.2	3.8	24.1	8.6	19.8	10.4	7.4	19.1	8.2	8.0	10.2	23.3	6.4	7.0	8.4	11.2	13.6	24.1	15.2	12.9	6.5	8.6	19.6	16.6	11.8	14.6	8.9	10.0	11.6	8.4	9.0	21.6	12.8	32.3	7.6	21.7	11.0	21.4	6.9	11.6	5.8	6.7	6.9	16.4	7.3	7.0	9.0	14.8	7.0	5.6	12.1	4.9	10.2	11.8	9.0	4.2	18.0	20.0	29.8	22.9	15.6	14.5	12.8	21.4	16.3	16.7
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.9;lymphoid tissue: 18.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 17.6;Karpas-707: 17.2;RH-30: 43.0"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Group enriched"	"Detected in many"	4	"amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"				"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	3.8	1.8	34.3	11.8	40.2	8.1	0.7	48.2	55.9	0.6	2.1	1.2	0.0	2.0	1.5	0.9	1.6	0.8	2.8	4.3	37.6	8.9	1.2	0.8	2.2	13.5	6.3	3.1	1.2	2.4	1.7	1.2	1.7	2.5	1.0	1.2	0.7	4.5	0.9	8.3	2.1	2.2	0.8	2.1	10.0	2.1	0.9	0.7	18.8	0.9	1.5	16.6	2.9	0.6	1.9	1.4	6.3	1.2	2.3	6.3	1.7	3.0	4.4	8.6	2.5	0.0	0.0	4.9	2.0	0.4	0.0	0.2	0.5	2.8	7.7	0.6	0.0	1.9	0.0	0.0	0.0	8.4	1.3	8.5	0.7	1.4	0.0	8.7	17.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	5.2	15.4	5.6	1.4	4.6	6.4	43.0	5.5	0.0	2.5	2.4	8.9	1.1	1.5	1.8	1.1	6.2	4.7	2.4	4.0	4.5	1.5	7.3	4.3	3.9	4.3	5.8	4.0	6.0	0.8	1.0	4.8	1.2	5.1	1.9	4.8	5.1	1.4	1.6	2.0	3.0	6.3	2.3	0.7	1.2	6.3	1.7	34.3	40.2	48.2	35.4	37.6	8.9	6.3	3.1	2.5	0.7
AGBL3	"CCP3, MGC32955"	ENSG00000146856	"ATP/GTP binding protein like 3"	Q8NEM8	7	134986508-135147963	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020397, HPA024150"	Uncertain		Uncertain	"Nuclear speckles,Mitochondria,Cytosol"				"Nuclear speckles, Mitochondria, Cytosol"		"HPA020397: AB_2242453, HPA024150: AB_1844639"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.32e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.15e-4)"	"unprognostic (5.00e-3)"	"unprognostic (6.10e-4)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (4.02e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.11e-3)"	3.2	2.7	4.2	4.1	8.4	3.8	4.6	8.7	4.5	4.3	2.4	4.4	4.5	1.6	5.5	15.4	2.2	3.6	3.1	2.4	5.0	3.4	5.3	2.6	3.6	4.0	2.7	4.5	6.8	4.5	0.6	9.2	1.9	3.3	3.8	3.0	3.1	4.9	4.3	4.2	4.7	3.7	3.3	2.9	6.5	4.4	18.7	3.7	2.7	5.4	0.8	2.8	3.3	2.5	2.2	1.7	0.5	0.2	2.2	5.0	1.7	2.6	1.4	3.6	0.8	1.0	1.4	2.2	0.7	0.0	0.5	0.8	4.7	3.0	4.3	1.3	0.0	2.8	1.3	0.5	0.0	3.4	8.8	3.6	5.3	4.6	0.0	1.6	0.0	0.2	0.0	2.1	0.0	1.5	2.6	2.5	0.6	2.5	0.9	1.5	3.1	0.3	2.5	0.2	1.2	2.6	0.5	2.1	2.4	0.5	0.0	0.3	1.9	3.5	0.0	0.4	0.9	0.5	1.6	5.3	1.6	1.9	1.8	4.3	4.4	0.0	0.2	0.4	2.4	0.0	1.8	2.1	1.2	2.5	0.5	2.2	2.0	5.0	0.5	2.2	0.1	1.7	1.7	1.7	4.2	8.4	8.7	4.5	5.0	3.4	2.7	4.5	3.3	3.7
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 91.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"				"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	3.8	8.1	3.9	3.5	4.8	3.8	4.2	3.1	6.6	5.0	6.8	6.6	11.7	2.8	5.4	9.3	6.3	7.2	6.6	4.1	3.4	3.9	8.2	3.0	3.6	3.2	3.5	3.4	5.9	5.9	11.2	6.2	6.3	5.4	6.8	3.8	7.7	8.2	5.9	2.6	6.8	3.9	8.6	3.4	4.6	5.4	91.6	3.5	8.4	9.9	4.9	4.4	7.8	3.5	5.7	5.4	7.1	2.3	11.2	6.3	4.6	22.8	14.8	24.3	16.2	5.2	10.5	27.2	4.7	10.2	13.6	14.1	12.8	17.5	12.7	14.8	8.1	10.5	19.4	21.2	15.1	10.6	28.8	18.6	18.5	27.6	10.6	8.9	6.3	10.9	16.1	11.9	9.8	14.2	15.9	10.4	13.1	9.0	26.0	13.5	17.2	10.2	26.9	27.5	19.9	13.9	5.8	16.3	23.3	9.2	7.3	15.1	10.9	6.9	6.7	12.7	17.5	6.1	10.0	20.7	10.8	26.0	14.1	10.3	11.3	7.1	2.3	5.7	4.5	1.3	3.4	5.7	5.7	6.3	5.4	3.0	5.1	2.8	1.4	11.2	0.9	3.0	3.6	4.6	3.9	4.8	3.1	6.6	3.4	3.9	3.5	3.4	5.4	3.5
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			16000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: "	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	11.8	3.5	4.2	6.9	7.0	6.6	14.2	3.8	5.6	3.3	5.9	13.3	4.0	15.6	7.3	6.4	6.7	24.6	7.4	6.3	8.3	7.8	9.1	12.2	7.4	4.6	8.0	5.5	8.1	4.8	4.6	3.9	5.2	14.9	1.1	3.4	3.7	9.4	2.5	6.7	4.6	0.0	1.4	0.8	10.1	16.1	10.5	7.3	10.9	10.5	5.8	7.5	5.4	5.3	4.0	5.8	5.4	3.7	4.5	3.5	18.1	7.1	2.1	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020123-1056118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 45.6;EFO-21: 53.1;HaCaT: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		15000000	"Plasma membrane, Cytosol"		"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	10.2	2.8	13.0	5.3	12.4	2.9	8.3	2.3	24.0	11.3	8.5	20.5	8.9	9.8	8.2	14.5	8.8	11.4	37.2	8.1	10.9	8.3	36.0	9.3	18.1	2.3	9.3	7.0	7.6	25.2	5.7	5.0	11.0	12.7	8.7	2.5	13.6	26.5	10.8	4.7	18.6	11.2	3.9	7.7	7.2	14.1	7.5	8.1	6.4	27.0	9.5	7.6	13.7	6.2	0.0	0.1	0.0	0.5	0.0	1.1	0.1	26.5	16.5	3.2	10.7	0.5	0.7	28.8	13.4	4.3	9.0	5.5	13.9	45.6	0.5	53.1	2.0	46.2	1.1	16.5	1.0	1.0	6.3	0.0	21.6	14.5	3.9	0.3	5.4	2.4	7.2	2.8	6.2	1.5	5.5	0.1	0.7	21.8	0.2	3.8	6.9	12.0	4.2	6.3	4.0	15.8	11.8	0.8	6.4	27.3	29.6	26.0	26.0	2.0	23.5	11.1	39.3	1.5	10.8	0.3	0.2	0.9	7.0	2.4	2.9	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	13.0	12.4	2.3	22.0	10.9	8.3	9.3	7.0	12.7	8.1
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA041225, HPA044675"	Approved		Supported	Cytosol			3900000	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	15.3	18.6	11.7	15.4	15.0	17.0	24.3	6.3	16.4	25.1	30.0	14.7	18.4	24.6	20.2	23.9	43.4	26.6	22.4	26.0	12.0	12.8	52.2	99.8	19.1	18.1	16.0	10.6	39.1	72.0	15.7	15.0	44.5	13.2	26.9	20.2	14.4	32.4	18.3	48.2	14.8	20.4	18.8	15.7	17.9	22.2	33.3	13.4	25.0	52.8	31.0	29.2	18.2	20.5	9.1	24.1	2.3	26.0	4.6	7.4	11.4	36.8	48.4	20.5	36.2	24.0	25.8	23.6	15.2	21.8	33.9	27.0	130.7	31.9	57.5	27.1	19.4	42.4	48.3	85.2	21.8	7.6	29.3	69.4	24.1	84.1	25.8	32.3	22.8	53.4	38.8	21.0	33.9	23.1	33.7	14.6	17.9	39.1	42.2	30.6	26.3	47.2	31.7	52.2	40.4	30.3	26.3	35.6	23.7	30.3	36.0	50.4	54.1	30.1	14.6	29.5	31.4	14.8	28.6	21.8	31.9	34.6	21.7	20.0	15.7	2.3	13.7	0.4	4.1	26.0	6.7	9.1	6.0	5.3	21.1	7.8	6.6	7.4	1.1	4.6	16.5	24.1	6.7	11.4	11.7	15.0	6.3	16.4	12.0	12.8	16.0	10.6	13.2	13.4
AHCYL1	"IRBIT, PPP1R78, XPVKONA"	ENSG00000168710	"Adenosylhomocysteinase like 1"	O43865	1	109984686-110023741	"Predicted intracellular proteins"	"One-carbon metabolism"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042589	Approved		Supported	Cytosol				Cytosol		"HPA042589: AB_10793885"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (7.00e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-3)"	24.0	25.7	61.7	11.7	71.2	4.8	19.7	33.2	61.4	26.7	26.3	47.7	17.7	46.5	21.0	36.0	18.3	28.0	24.7	13.9	51.6	57.2	38.6	25.4	16.5	10.5	72.3	49.9	17.6	27.1	53.0	16.3	20.6	55.7	17.3	19.7	9.7	17.9	25.8	27.1	14.2	22.9	21.8	48.8	12.1	19.6	10.2	47.5	6.8	28.6	8.6	13.4	16.7	15.3	8.0	6.2	8.7	9.3	3.9	8.2	3.7	22.6	19.4	18.2	18.8	44.1	26.0	30.1	18.0	20.4	17.1	16.9	14.9	13.2	9.6	15.4	26.5	14.6	16.1	20.6	22.7	80.8	13.9	16.0	25.1	15.7	45.8	13.6	11.3	26.5	13.0	21.3	31.3	21.5	11.5	19.7	17.6	18.0	11.3	6.8	21.5	15.0	12.4	37.9	10.7	37.4	23.0	17.8	11.6	28.0	33.5	37.6	17.9	13.7	18.5	16.5	16.2	19.4	16.0	16.2	6.7	8.3	34.0	15.0	33.7	5.0	8.8	7.7	4.3	9.3	4.4	6.8	4.4	5.7	6.2	8.0	4.6	4.4	8.7	3.9	6.3	5.7	8.2	3.7	61.7	71.2	33.2	51.5	51.6	57.2	72.3	49.9	55.7	47.5
AHCYL2	KIAA0828	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 72.4"	"Cell line enriched"	"Detected in all"	8	"HDLM-2: 71.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favourable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favourable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	4.3	6.6	12.8	5.9	20.3	1.5	4.3	7.2	16.9	7.1	61.8	13.3	5.1	23.1	6.1	3.3	5.7	4.4	22.7	3.4	16.5	9.6	11.9	3.4	26.1	4.2	10.7	14.9	5.7	5.8	9.1	12.8	5.1	19.8	5.0	72.4	24.3	15.0	3.3	20.7	9.8	15.0	5.3	11.4	2.9	16.5	8.1	9.6	4.6	24.1	4.0	4.0	5.4	4.7	0.9	1.3	2.0	2.5	3.3	5.0	0.5	2.6	4.2	8.1	4.8	2.2	3.2	1.7	2.1	2.9	2.4	2.1	2.4	1.8	1.6	2.2	2.3	1.8	4.0	3.3	2.7	71.8	5.0	3.8	4.6	1.9	1.3	2.8	4.9	3.0	4.3	1.9	2.9	4.7	1.7	9.1	3.1	2.5	4.1	3.6	4.0	3.0	2.7	2.2	4.3	4.8	3.5	3.7	2.3	4.8	2.0	2.8	1.9	2.0	2.7	2.0	1.2	5.4	2.2	3.8	4.3	2.2	5.3	3.0	3.1	0.1	1.2	2.0	0.9	2.5	1.2	0.9	1.5	0.7	1.3	0.5	1.3	0.5	0.4	3.3	1.2	0.4	5.0	0.5	12.8	20.3	7.2	16.9	16.5	9.6	10.7	14.9	19.8	9.6
AHNAK	MGC5395	ENSG00000124942	"AHNAK nucleoprotein"	Q09666	11	62433542-62556235	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 84.9;fHDF/TERT166: 79.0;TIME: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019010, HPA019070, HPA026643"	Uncertain		Enhanced	"Plasma membrane,Cytosol"			950000	"Plasma membrane, Cytosol"		"HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.98e-3)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (3.47e-6)"	85.2	8.2	15.3	35.3	9.3	10.0	91.1	9.3	10.8	69.7	66.3	16.8	36.4	13.0	52.2	47.4	96.9	39.4	59.2	55.8	20.9	6.0	18.4	16.0	54.9	16.6	16.2	13.4	40.2	8.9	8.0	5.3	39.8	15.9	42.6	26.8	29.6	35.5	36.8	64.8	88.4	38.2	101.5	16.1	16.9	38.3	16.9	16.2	5.8	18.4	72.9	44.0	54.3	86.1	8.2	28.9	15.3	30.1	11.1	16.7	12.2	26.0	15.4	1.4	6.4	63.3	84.9	10.2	23.7	29.1	15.1	8.5	13.2	9.3	0.0	9.0	79.0	34.8	5.9	29.2	19.4	21.1	0.9	3.1	22.9	3.9	12.1	4.3	20.8	30.6	34.3	29.7	27.2	31.1	2.9	20.2	30.6	10.1	0.0	8.4	0.4	23.4	0.0	6.5	15.6	33.6	17.1	0.0	1.3	23.9	10.1	10.1	19.4	4.0	82.6	27.0	17.6	33.5	10.4	3.6	0.7	0.0	20.5	1.4	8.8	15.3	30.1	0.1	16.7	17.5	11.0	8.2	10.7	13.1	28.9	5.2	1.4	7.6	0.4	11.1	14.0	7.9	7.9	12.2	15.3	9.3	9.3	10.8	20.9	6.0	16.2	13.4	15.9	16.2
AHNAK2	C14orf78	ENSG00000185567	"AHNAK nucleoprotein 2"	Q8IVF2	14	104937244-104978357	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 131.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.1;ASC TERT1: 32.0;HBEC3-KT: 28.1;hTCEpi: 70.8;hTERT-HME1: 30.2;TIME: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"									"HPA000878, HPA002940, HPA004145, HPA020111"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA000878: , HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: "	"unprognostic (3.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.31e-3)"	"unprognostic (9.55e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (2.79e-5)"	"unprognostic (3.43e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavourable (4.05e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.23e-5)"	6.9	1.8	2.9	2.0	5.6	1.0	8.5	3.0	13.7	17.2	23.0	2.9	5.7	1.7	16.3	2.9	25.8	7.1	3.2	1.5	2.4	3.1	1.1	10.8	2.3	1.0	2.7	11.6	1.8	1.2	1.2	0.7	1.8	23.3	5.7	5.1	10.1	6.0	14.6	1.6	131.1	4.8	19.9	4.8	1.1	7.1	3.2	0.8	0.0	1.2	14.4	3.0	10.0	19.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	19.7	0.0	1.3	28.1	32.0	0.0	2.4	5.0	0.8	0.4	0.0	8.8	0.0	3.3	18.5	14.2	0.0	28.1	0.4	0.0	0.1	0.0	13.0	0.1	2.6	0.0	0.9	4.1	70.8	2.8	30.2	12.3	0.0	0.0	14.2	1.6	0.0	0.0	0.0	9.7	0.0	1.3	0.0	19.2	0.0	0.1	0.1	10.4	0.0	0.4	1.3	0.0	31.7	6.8	4.2	7.7	2.1	0.0	0.0	0.0	20.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.9	5.6	3.0	13.7	2.4	3.1	2.7	11.6	23.3	0.8
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.3;hTERT-HME1: 29.5;RT4: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.45e-2)"	23.1	12.2	2.5	13.2	3.5	19.8	19.1	1.6	3.5	14.6	14.0	5.7	8.7	8.5	11.9	10.1	14.2	11.2	22.2	14.8	3.2	2.2	7.3	23.9	26.4	20.0	6.5	2.5	21.3	6.8	4.5	3.8	69.6	3.7	21.4	8.9	10.9	11.1	8.5	5.2	16.6	13.7	12.1	4.8	15.6	13.3	6.8	4.0	7.1	12.4	7.9	12.3	26.7	26.6	1.1	9.3	5.6	7.6	3.1	2.9	2.0	3.0	2.5	1.0	0.0	7.7	5.3	0.4	6.3	9.2	2.9	4.3	3.1	6.8	0.0	1.9	9.3	8.5	0.6	5.8	7.8	0.1	1.4	1.8	3.2	2.7	14.5	3.0	4.5	7.2	28.3	11.2	29.5	9.8	0.2	0.0	13.3	1.6	0.0	4.8	0.8	4.0	0.0	0.0	0.1	9.4	24.3	0.9	0.0	4.7	5.2	4.6	3.6	1.0	1.6	1.2	0.0	16.1	0.0	1.3	0.0	0.0	20.6	11.9	20.2	0.7	7.6	5.6	0.7	3.6	1.1	0.8	2.6	1.4	9.3	1.1	1.5	1.1	0.8	3.1	1.3	2.2	2.9	2.0	2.5	3.5	1.6	3.5	3.2	2.2	6.5	2.5	3.7	4.0
AHRR	"AHH, AHHR, bHLHe77, KIAA1234"	ENSG00000063438	"Aryl-hydrocarbon receptor repressor"	A9YTQ3	5	304176-438291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 44.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 23.4;HMC-1: 35.1;NB-4: 42.2;WM-115: 24.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA021483			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021483: AB_1855110"	"unprognostic (2.06e-4)"	"unprognostic (3.48e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.33e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-6)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.55e-2)"	0.8	0.4	1.0	4.6	0.8	0.2	2.4	0.4	1.4	2.4	1.2	0.7	1.4	0.7	1.6	0.9	1.4	0.5	4.4	0.3	1.2	1.0	0.6	0.4	6.2	0.4	0.3	0.0	2.1	1.0	0.1	1.3	2.1	0.9	0.6	1.2	2.7	0.9	0.3	0.6	5.8	1.7	0.9	0.3	4.7	0.7	44.3	0.3	0.1	0.9	1.8	4.2	2.0	3.6	0.9	2.3	1.0	0.5	0.0	1.0	0.3	0.1	3.9	0.6	0.5	2.1	4.5	4.6	8.3	11.2	4.7	9.3	0.1	3.1	0.3	4.4	15.1	0.2	0.7	0.2	2.1	0.6	1.7	3.9	23.4	0.1	1.6	1.1	35.1	0.9	0.3	3.2	0.4	1.7	0.6	0.3	5.0	0.3	0.3	42.2	0.1	3.9	0.6	0.2	0.4	0.1	0.0	5.5	0.2	11.1	2.1	5.7	0.2	14.4	2.0	8.7	1.1	9.8	0.3	1.3	2.1	0.3	3.7	0.3	24.7	0.0	0.5	1.0	0.3	0.0	0.1	0.2	0.6	0.3	0.0	0.9	0.1	0.1	0.5	0.0	0.1	2.3	1.0	0.3	1.0	0.8	0.4	1.4	1.2	1.0	0.3	0.0	0.9	0.3
AHSA1	"Aha1, C14orf3, hAha1, p38"	ENSG00000100591	"Activator of HSP90 ATPase activity 1"	O95433	14	77457870-77469474	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000903, CAB006244"	Supported		Supported	Cytosol			28000	Cytosol		"CAB006244: AB_425858, HPA000903: AB_1078112"	"unprognostic (3.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavourable (5.04e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-1)"	23.7	39.3	37.8	26.9	44.4	20.7	58.9	33.1	52.1	25.7	27.9	22.6	28.9	21.0	31.7	34.9	27.2	56.4	18.6	47.8	38.2	38.2	31.5	28.4	21.9	29.4	61.8	29.7	30.3	25.4	32.0	37.0	34.9	50.1	32.0	34.9	11.5	24.7	35.3	48.5	20.8	20.7	40.0	42.5	21.5	22.8	40.5	54.3	26.0	37.6	24.5	40.3	24.8	177.1	44.3	36.6	34.5	45.1	42.3	42.3	26.9	33.4	66.2	18.1	23.7	28.1	20.3	31.9	25.0	19.8	39.3	29.5	49.6	29.0	62.4	19.6	24.4	38.4	65.4	32.0	43.8	24.8	38.9	29.4	33.0	59.8	20.8	18.6	42.5	17.9	42.8	26.4	12.9	37.0	36.3	20.1	24.5	92.1	45.6	35.3	31.5	69.8	36.8	21.5	31.1	30.9	34.9	28.0	30.8	23.1	51.8	21.4	31.6	25.6	19.2	21.3	30.3	23.8	35.5	20.3	40.8	47.9	30.9	37.2	23.4	32.6	28.2	34.5	37.8	39.0	42.3	44.3	34.8	38.7	36.6	34.3	40.0	40.1	20.2	42.3	45.1	34.1	40.0	26.9	37.8	44.4	33.1	52.1	38.2	38.2	61.8	29.7	50.1	54.3
AIDA	"C1orf80, FLJ12806"	ENSG00000186063	"Axin interactor, dorsalization associated"	Q96BJ3	1	222668013-222713210	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027935	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"				Cytosol	"Microtubules, Cytokinetic bridge"	"HPA027935: AB_10602226"	"unprognostic (2.33e-1)"	"prognostic unfavourable (7.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (4.37e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	37.7	20.7	22.6	20.2	28.1	9.8	33.7	19.8	20.4	28.7	32.6	13.3	20.1	13.7	22.3	32.7	31.5	17.9	22.7	43.2	21.6	23.8	27.9	27.6	30.5	25.0	25.2	17.0	25.4	21.0	16.4	22.5	26.0	25.7	29.6	20.5	13.7	16.1	24.9	20.2	14.9	19.5	33.3	27.5	24.9	19.7	23.1	22.5	21.1	30.5	13.5	27.9	42.0	39.7	14.2	6.7	4.4	4.4	3.3	9.1	3.8	17.8	13.8	16.5	17.6	46.9	44.3	18.1	33.6	36.1	24.1	22.3	15.7	15.4	9.6	17.1	39.7	11.1	20.3	22.2	29.5	14.3	7.4	12.2	16.6	15.0	24.7	14.9	7.2	26.9	20.0	28.7	27.8	29.3	18.3	13.6	45.2	6.6	9.7	9.2	41.1	29.7	10.6	46.4	14.0	27.9	12.2	10.9	18.3	22.5	13.4	20.4	10.9	9.4	23.2	32.6	16.1	31.5	39.6	10.2	19.1	8.7	30.2	9.4	31.9	4.4	2.6	2.6	5.7	4.0	4.9	13.7	7.3	6.2	2.4	14.2	7.6	5.8	1.5	3.3	4.4	6.7	9.1	3.8	22.6	28.1	19.8	20.4	21.6	23.8	25.2	17.0	25.7	22.5
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615184-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.2;lymphoid tissue: 99.3"	"Cell line enhanced"	"Detected in some"		"HEL: 25.4;HMC-1: 36.6;NB-4: 58.2;THP-1: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"classical monocyte: 67.4;intermediate monocyte: 104.8;myeloid DC: 35.9;neutrophil: 51.7;non-classical monocyte: 119.2"	"Group enriched"	"Detected in many"	33	"dendritic cells: 35.9;granulocytes: 51.7;monocytes: 119.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol				Cytosol		"HPA049234: , HPA062949: "	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	13.5	9.5	13.0	27.7	23.8	39.8	7.8	1.8	10.0	5.2	8.0	17.0	0.1	6.1	3.2	8.3	3.6	5.6	9.8	5.8	10.2	10.2	15.4	12.6	19.9	40.5	16.9	3.1	4.9	3.4	2.0	4.9	17.0	12.8	6.1	9.7	4.6	5.7	4.3	3.5	2.9	10.8	11.1	28.5	99.3	4.8	2.6	16.2	71.7	3.6	1.7	9.8	11.2	3.5	0.7	35.9	51.7	119.2	0.3	2.1	59.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	1.7	36.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	58.2	0.1	0.0	9.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.2	0.0	0.5	67.4	3.2	0.2	104.8	0.2	0.7	0.3	0.3	35.9	0.1	2.1	1.7	51.7	0.3	119.2	3.3	0.1	59.6	13.0	23.8	1.8	10.0	10.2	10.2	16.9	3.1	12.8	16.2
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor, mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"	Apoptosis	"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 41.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA028961: , HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.92e-4)"	32.9	7.8	3.1	6.6	5.9	1.3	41.9	5.0	3.7	3.5	9.0	2.1	22.1	7.6	4.5	9.6	9.1	4.0	7.6	19.7	2.8	4.1	10.2	18.2	8.1	4.0	2.9	2.4	7.5	3.6	3.9	3.1	5.2	3.5	6.4	5.9	9.2	5.8	15.2	9.1	2.8	9.9	7.8	3.7	5.9	6.5	3.1	2.1	1.0	10.8	6.4	7.3	11.8	15.7	3.4	0.7	1.5	1.0	7.8	3.5	1.2	8.6	15.1	0.4	3.9	9.1	3.4	0.1	3.5	8.6	7.2	8.1	11.6	16.8	1.2	8.9	4.8	9.4	4.3	1.2	2.0	16.9	0.7	0.0	8.9	56.6	19.6	0.0	2.2	4.6	2.8	11.5	2.4	3.2	6.6	7.5	3.7	11.0	0.3	0.4	1.5	4.9	0.2	1.4	4.1	3.8	6.4	1.3	0.3	6.4	5.6	9.8	0.2	2.4	3.9	0.1	8.9	5.3	10.1	5.6	10.4	2.4	4.8	0.3	4.7	1.5	0.9	1.0	3.5	0.8	3.1	3.4	1.2	3.0	0.7	2.9	1.7	2.7	1.0	7.8	1.0	0.5	2.4	1.2	3.1	5.9	5.0	3.7	2.8	4.1	2.9	2.4	3.5	2.1
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 44.7;lymphoid tissue: 43.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.1;HDLM-2: 43.3;Karpas-707: 17.2;U-266/70: 14.5;U-266/84: 10.9;U-87 MG: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"memory B-cell: 44.7;naive B-cell: 14.3"	"Lineage enriched"	"Detected in many"	9	"B-cells: 44.7"	"Low region specificity"	"Detected in all"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: "	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	0.7	0.3	1.3	28.2	0.9	0.4	0.6	0.5	0.6	0.4	1.9	0.1	0.0	0.7	0.2	0.2	4.1	0.5	1.1	0.5	1.2	0.6	0.9	0.8	2.0	24.1	0.5	0.2	0.6	0.3	0.0	8.8	0.4	0.5	0.7	1.0	0.5	1.9	0.0	0.2	0.3	12.8	0.2	2.6	43.8	1.3	1.4	1.4	1.4	0.7	0.6	25.9	4.0	0.5	44.7	1.2	4.7	2.4	0.0	3.3	1.4	5.2	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.5	0.4	0.3	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.3	43.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	2.8	0.0	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	14.5	10.9	0.2	13.4	1.1	2.2	4.2	2.4	0.0	0.6	2.1	1.7	44.7	1.6	1.1	1.2	14.3	0.1	0.4	4.7	0.0	2.2	0.0	3.3	1.4	1.3	0.9	0.5	0.6	1.2	0.6	0.5	0.2	0.5	1.4
AIMP1	"EMAP-2, EMAPII, p43, SCYE1"	ENSG00000164022	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 1"	Q12904	4	106315544-106349226	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis"	"Cytokine, RNA-binding, tRNA-binding"	Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017618, HPA018476"	Supported		Enhanced	Cytosol	"Secreted to blood"	6500000		Cytosol		"CAB017618: AB_2285445, HPA018476: AB_1848137"	"unprognostic (1.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	30.7	26.6	20.2	25.7	24.5	42.2	30.3	22.5	22.9	29.9	33.7	17.0	33.6	27.7	29.3	28.4	35.0	25.6	23.7	23.6	21.2	18.4	40.4	35.3	23.4	24.6	29.8	21.8	35.9	27.2	24.1	44.0	27.3	26.5	29.8	28.4	14.1	25.6	32.1	67.8	22.6	39.1	32.8	30.1	26.9	25.2	15.9	29.4	31.3	35.9	40.6	25.8	41.2	25.9	28.2	35.9	24.6	32.7	23.7	33.4	16.6	22.7	14.6	15.4	21.6	18.4	27.6	25.7	30.4	23.3	23.7	28.5	25.0	33.5	40.3	22.9	25.2	22.7	23.3	28.8	34.0	22.4	14.6	23.7	18.8	39.8	35.2	46.9	27.5	21.3	33.2	25.2	41.0	20.5	40.6	21.7	26.2	16.4	31.7	22.4	17.4	14.5	26.0	31.0	36.2	29.4	19.8	24.6	18.2	19.4	53.6	27.3	25.6	33.1	17.5	31.4	28.6	23.2	35.3	24.7	34.6	41.1	26.1	36.8	33.6	22.4	26.9	24.6	21.8	29.0	26.0	27.7	27.3	21.8	27.6	28.2	28.5	25.9	3.7	23.7	32.7	35.9	33.4	16.6	20.2	24.5	22.5	22.9	21.2	18.4	29.8	21.8	26.5	29.4
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009245-6023834	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol			8200	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favourable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (3.09e-4)"	10.2	11.2	6.3	6.9	7.3	5.3	11.2	5.3	11.0	5.6	14.9	10.2	7.1	22.8	8.9	10.8	11.2	7.7	8.7	17.7	6.5	5.8	18.6	30.7	6.8	15.1	6.8	8.2	7.5	9.6	12.3	4.5	9.0	7.6	6.1	12.2	6.6	13.6	9.0	66.1	10.3	21.0	9.8	7.2	9.4	7.5	20.4	5.1	9.3	12.9	28.4	9.1	8.2	6.6	19.0	37.3	13.8	30.0	17.8	17.7	16.1	26.2	29.8	10.1	14.5	10.7	11.8	34.6	14.9	10.0	24.6	18.3	32.6	17.5	32.4	14.1	15.3	29.3	34.2	22.4	15.3	10.4	26.0	17.9	17.6	24.3	33.3	25.1	16.2	18.1	33.2	22.1	36.3	18.2	25.0	10.7	17.8	41.7	10.9	45.7	41.2	21.7	24.4	22.5	27.3	35.8	12.3	20.3	19.2	15.0	30.5	20.4	28.5	20.5	15.3	14.1	35.0	23.3	32.5	13.7	20.8	27.9	11.8	35.9	22.7	13.8	25.0	7.6	17.7	30.0	15.0	19.0	12.2	14.0	37.3	13.3	12.2	12.8	2.5	17.8	22.1	23.9	13.0	16.1	6.3	7.3	5.3	11.0	6.5	5.8	6.8	8.2	7.6	5.1
AIP	"ARA9, FKBP16, XAP2"	ENSG00000110711	"Aryl hydrocarbon receptor interacting protein"	O00170	11	67483041-67491103	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033674, HPA050217, CAB069477"	Approved		Supported	Cytosol				Cytosol		"CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: "	"unprognostic (2.59e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.45e-2)"	23.1	30.5	30.7	31.1	32.6	25.1	29.0	30.3	34.2	27.8	38.5	26.6	24.2	23.7	30.6	24.2	30.8	25.0	28.6	34.7	28.0	25.4	28.0	20.7	24.7	55.2	34.2	24.6	45.5	23.0	18.2	22.0	23.6	27.1	36.2	14.6	21.4	25.0	28.1	26.5	15.9	25.0	29.8	30.2	37.9	22.9	18.2	30.4	34.6	38.0	16.6	33.5	33.1	60.6	56.5	49.8	36.9	38.0	37.6	80.0	41.7	20.5	23.9	13.8	13.2	17.7	17.8	10.5	13.0	16.3	22.5	16.5	37.4	20.5	36.7	31.8	14.3	16.7	15.5	13.6	8.6	53.6	16.8	22.2	26.1	22.2	18.4	22.2	39.0	21.2	12.9	19.9	13.0	11.4	12.6	22.1	14.6	39.4	47.2	54.8	13.0	30.7	21.0	20.9	32.4	15.6	12.3	21.8	21.8	16.8	12.0	51.2	16.2	22.6	18.8	19.8	19.3	29.0	11.9	18.1	24.8	28.7	27.1	17.4	15.2	36.9	28.9	31.0	49.5	33.4	53.5	56.5	58.5	57.9	43.1	48.7	53.2	50.8	19.0	37.6	38.0	49.8	80.0	41.7	30.7	32.6	30.3	34.2	28.0	25.4	34.2	24.6	27.1	30.4
AIPL1	LCA4	ENSG00000129221	"Aryl hydrocarbon receptor interacting protein like 1"	Q9NZN9	17	6393693-6435199	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"retina: 123.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.4;HeLa: 2.2"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026578	Enhanced		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA026578: "		"unprognostic (2.42e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.68e-3)"		"unprognostic (3.24e-1)"		"unprognostic (1.13e-3)"				"unprognostic (3.76e-1)"	"unprognostic (5.35e-2)"			0.1	0.1	1.4	0.4	0.3	2.9	0.1	0.5	0.8	0.2	0.1	0.1	0.1	0.0	0.1	0.3	1.1	0.0	0.3	0.1	0.6	0.5	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.0	0.8	0.1	0.1	0.1	0.0	123.7	2.3	0.1	0.1	2.4	0.1	0.1	0.1	1.0	0.2	3.3	0.1	0.2	0.4	0.1	0.2	0.1	0.1	1.0	1.1	2.2	0.7	1.1	0.6	0.0	0.2	2.0	0.6	0.2	0.1	0.1	0.5	0.0	0.4	0.1	0.7	0.1	0.2	0.4	0.2	0.0	5.4	0.2	0.2	0.3	0.3	0.4	0.6	2.2	0.6	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.5	0.3	0.1	1.1	1.7	0.2	0.0	0.0	0.1	1.4	0.2	0.3	1.1	0.4	0.0	0.3	0.0	0.0	0.4	0.3	0.6	0.4	0.4	0.2	0.1	0.9	0.6	0.2	0.9	0.7	0.6	0.6	0.3	0.3	0.6	0.3	0.1	0.3	1.0	0.3	0.4	2.2	1.1	0.5	1.1	0.4	0.0	1.4	0.3	0.5	0.5	0.6	0.5	0.5	0.1	0.1	0.1
AJM1	"ajm-1, C9orf172"	ENSG00000232434	"Apical junction component 1 homolog"	C9J069	9	136844415-136848801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;testis: 15.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 22.7"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.9;monocytes: 1.6;T-cells: 1.9"	"Low region specificity"	"Detected in all"							HPA021200	Uncertain		Approved	"Focal adhesion sites,Cytosol"				"Focal adhesion sites, Cytosol"		"HPA021200: AB_10601695"	"unprognostic (3.30e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.68e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.00e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.07e-3)"	"unprognostic (7.27e-2)"	1.1	1.9	4.6	1.3	6.3	1.4	1.1	22.7	7.9	1.1	4.0	1.1	1.1	3.3	1.2	1.1	1.1	0.3	1.1	1.2	4.4	3.1	1.1	1.1	1.1	1.1	2.1	1.1	1.1	7.6	1.1	5.2	1.1	1.1	2.6	1.1	1.1	2.0	2.2	3.9	1.5	4.3	1.1	1.3	3.6	2.3	15.0	1.1	1.1	1.1	1.1	1.1	2.6	1.1	0.2	3.9	0.1	1.6	0.2	1.9	0.8	3.6	2.9	0.4	1.1	0.5	0.4	4.8	2.9	0.5	0.4	0.2	1.0	2.0	2.2	2.5	0.8	4.1	0.4	1.1	0.0	5.7	2.2	0.6	5.5	0.8	1.6	1.3	4.1	0.9	1.4	0.5	0.3	0.2	3.4	1.5	0.7	4.1	0.4	4.5	1.1	3.8	2.7	0.9	7.2	0.8	0.7	7.3	2.6	1.9	7.5	3.9	5.9	2.8	3.1	5.0	3.4	1.7	1.7	6.5	4.4	0.8	8.7	4.5	1.2	0.0	1.6	0.1	1.9	1.0	0.4	0.2	0.5	0.9	1.5	0.0	0.2	0.9	0.1	0.2	1.5	3.9	0.1	0.8	4.6	6.3	22.7	6.8	4.4	3.1	2.1	1.1	1.1	1.1
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866480-127877743	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 84.5;skeletal muscle: 279.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol			32000000	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	7.7	9.2	19.6	3.7	18.8	6.5	3.9	9.8	17.3	10.5	8.6	18.1	12.2	5.2	3.4	17.3	9.0	84.5	12.0	60.4	17.6	18.5	6.3	10.7	18.7	2.2	16.4	15.3	12.3	4.6	5.6	7.1	2.9	17.5	5.2	10.8	7.0	13.4	15.7	279.0	3.4	2.6	6.3	11.5	5.6	5.8	9.8	11.1	0.0	10.5	61.5	4.0	4.4	4.4	1.2	3.4	2.8	0.4	1.4	1.5	1.2	15.2	6.6	8.4	11.5	20.5	41.8	7.7	10.6	10.7	18.9	11.5	4.8	9.7	0.4	11.6	21.8	22.0	0.0	11.8	7.6	2.4	7.3	2.2	18.9	8.4	11.5	0.0	0.3	31.7	23.0	14.0	10.2	25.2	8.9	0.6	21.4	14.5	0.0	0.3	3.0	20.4	0.4	8.5	3.3	12.6	1.1	13.7	8.5	28.0	16.1	8.1	12.9	9.1	20.8	13.2	5.4	46.5	10.1	1.0	0.1	0.0	16.6	0.0	9.2	0.9	0.4	0.4	1.5	0.3	1.1	0.3	0.6	1.1	0.1	1.2	0.3	1.1	2.8	1.4	0.4	3.4	0.3	1.2	19.6	18.8	9.8	17.3	17.6	18.5	16.4	15.3	17.5	11.1
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282051-77559969	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.7;BJ: 20.3;fHDF/TERT166: 23.1;LHCN-M2: 58.2;U-2 OS: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 10.9;naive CD4 T-cell: 14.2"	"Group enriched"	"Detected in many"	15	"dendritic cells: 10.9;T-cells: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: "	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favourable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.8	2.1	43.8	1.9	35.7	3.7	14.1	1.3	95.5	2.0	1.8	20.4	0.0	1.8	1.6	1.5	1.8	1.8	1.7	1.5	35.8	11.8	2.0	1.2	1.4	2.5	13.0	41.1	1.5	2.1	2.4	1.4	1.8	11.4	2.7	1.8	0.0	3.1	2.7	1.3	2.4	1.7	1.7	14.2	2.4	2.9	7.3	13.9	0.0	1.7	0.0	2.1	1.5	0.4	0.8	10.9	0.7	0.7	0.1	14.2	1.9	0.0	1.1	0.8	0.0	10.9	29.7	0.4	20.3	4.3	3.3	1.4	0.1	0.5	0.1	0.1	23.1	0.1	0.0	0.0	1.7	0.7	0.2	0.1	0.1	0.0	0.5	0.1	0.0	3.6	0.1	0.6	1.3	9.5	0.2	0.2	58.2	0.2	0.0	0.1	1.1	7.4	0.5	2.1	0.3	9.0	0.3	4.5	1.1	0.0	0.0	1.2	0.1	0.1	2.3	8.0	18.2	0.4	0.6	4.7	4.2	0.0	1.6	1.0	2.9	0.7	0.7	0.0	3.4	0.1	0.5	0.8	3.2	1.6	10.9	0.8	14.2	7.8	0.5	0.1	0.2	1.2	1.4	1.9	43.8	35.7	1.3	47.1	35.8	11.8	13.0	41.1	11.4	13.9
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"				"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	27.6	27.7	25.1	16.9	25.4	14.8	23.3	21.5	23.6	17.6	22.7	11.3	16.4	18.3	18.3	30.4	26.7	15.4	15.1	17.9	23.2	22.2	30.2	42.3	17.0	18.7	20.9	16.2	18.8	17.2	15.8	26.3	21.5	23.3	18.2	20.6	12.3	14.5	14.6	41.4	11.9	24.0	16.7	19.6	21.8	17.0	46.1	17.5	25.2	24.3	24.2	18.8	19.7	13.7	22.2	22.0	14.3	15.9	16.6	21.2	10.0	17.2	9.6	12.6	16.8	20.7	13.8	23.7	26.0	9.8	12.8	15.9	26.8	14.9	37.0	24.6	11.8	5.8	19.7	12.4	19.6	15.1	9.5	18.2	20.5	20.4	16.9	21.6	7.9	8.0	16.4	12.7	18.3	8.3	17.0	12.2	16.4	20.0	19.9	14.6	10.5	6.4	23.4	15.7	20.5	20.1	14.1	6.5	6.4	13.4	10.8	18.6	11.5	24.4	10.9	9.6	15.4	17.9	21.5	14.7	30.6	32.8	12.4	31.8	12.4	13.7	13.0	14.3	15.5	15.9	16.1	22.2	18.4	19.3	18.0	18.1	20.1	21.2	2.1	16.6	14.2	22.0	18.1	10.0	25.1	25.4	21.5	23.6	23.2	22.2	20.9	16.2	23.3	17.5
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	20.5	24.2	22.5	19.4	25.5	16.1	21.2	22.8	27.9	21.2	19.4	17.4	13.4	16.1	22.3	15.9	18.5	19.2	18.4	14.4	20.1	17.9	22.7	14.9	18.5	24.3	22.4	23.2	24.3	16.2	28.0	20.3	20.3	19.2	19.5	20.3	16.1	17.8	21.3	13.7	17.5	18.5	22.9	19.0	28.6	20.2	22.9	24.2	25.9	26.0	9.1	20.5	22.2	22.7	7.3	6.1	24.4	10.3	5.1	7.9	3.0	11.0	13.3	8.9	6.2	11.8	14.9	16.4	12.9	13.9	14.4	17.4	14.4	6.7	9.5	8.8	10.2	11.8	11.4	10.8	19.7	7.8	9.8	8.1	13.0	6.9	11.2	5.9	13.4	12.5	13.6	13.1	16.3	11.6	5.2	4.8	15.0	8.0	10.9	8.8	5.8	4.6	7.3	29.2	4.9	12.0	7.0	3.0	9.1	14.9	7.0	12.3	17.0	6.6	10.1	11.2	9.3	9.5	11.9	6.0	6.4	11.6	14.8	7.1	10.7	3.6	7.3	8.8	6.7	10.3	6.1	6.0	6.5	7.2	6.1	7.3	7.9	7.0	24.4	5.1	9.3	4.6	4.9	3.0	22.5	25.5	22.8	27.9	20.1	17.9	22.4	23.2	19.2	24.2
AKAP11	"AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11"	ENSG00000023516	"A-kinase anchoring protein 11"	Q9UKA4	13	42272153-42323267	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039089	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA039089: AB_10674279"	"unprognostic (6.43e-2)"	"prognostic unfavourable (9.26e-4)"	"unprognostic (4.91e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.49e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.10e-1)"	11.2	13.6	21.7	10.0	42.3	3.0	11.0	19.9	30.7	17.1	9.1	9.0	5.9	6.9	13.0	15.2	10.2	10.2	9.7	10.4	18.3	17.9	12.9	9.9	10.2	13.4	16.4	22.8	14.6	6.4	11.6	14.5	7.2	20.3	11.1	10.1	6.7	7.6	12.4	5.7	9.1	8.1	13.4	21.4	11.7	9.5	18.1	16.0	5.6	13.3	4.6	12.6	10.4	9.4	3.0	1.6	4.2	1.4	4.8	2.7	0.7	9.2	9.5	11.7	6.9	15.4	18.9	5.1	12.6	10.5	7.6	7.2	10.4	7.7	19.1	4.9	14.1	11.1	10.1	10.5	14.7	20.3	4.7	5.4	6.6	5.1	12.1	13.4	13.3	13.8	10.9	15.5	13.6	11.1	17.7	7.8	15.3	7.0	7.8	4.3	6.9	4.5	6.5	8.2	9.2	7.6	6.9	5.0	7.2	9.6	6.4	4.5	5.5	7.3	15.4	12.9	6.7	19.5	9.5	3.0	3.7	9.9	16.5	6.9	9.0	4.2	0.9	1.2	1.7	1.1	2.1	2.7	2.4	1.6	1.0	3.0	2.1	2.1	0.3	4.8	1.4	1.6	2.7	0.7	21.7	42.3	19.9	24.6	18.3	17.9	16.4	22.8	20.3	16.0
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239999-151358557	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 43.1;TIME: 42.9;U-251 MG: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	184	"basophil: 20.4"	"Lineage enriched"	"Detected in single"	184	"granulocytes: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			6400000	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavourable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	52.5	11.2	11.5	11.0	18.1	2.0	38.5	31.3	21.2	11.5	23.4	1.9	5.9	6.1	20.5	13.6	12.8	15.6	32.3	22.8	9.8	17.4	14.9	20.6	18.2	6.9	11.4	9.9	49.0	7.6	2.0	11.1	24.1	28.7	13.5	9.4	26.6	3.3	14.7	11.3	4.1	10.6	27.9	14.1	8.1	12.4	62.0	6.6	0.3	11.4	6.6	2.8	34.5	24.7	0.0	0.0	20.4	0.0	0.0	0.1	0.0	1.7	8.6	12.4	0.0	23.4	35.1	4.3	10.0	5.4	4.5	4.5	0.2	32.5	0.0	4.0	7.5	0.2	23.5	7.4	4.0	11.1	8.6	0.1	9.6	7.9	2.6	0.0	2.2	24.8	0.0	19.1	1.0	29.4	2.1	0.2	16.3	0.1	0.0	0.0	7.7	10.1	43.1	0.5	0.0	26.1	1.4	8.8	5.1	3.2	0.1	5.7	0.6	0.1	42.9	0.6	8.0	25.6	45.9	0.0	0.0	0.0	14.9	0.0	8.6	20.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.1	31.3	19.1	9.8	17.4	11.4	9.9	28.7	6.6
AKAP13	"AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB"	ENSG00000170776	"A-kinase anchoring protein 13"	Q12802	15	85380571-85749358	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019773	Approved		Supported	Cytosol				Cytosol		"HPA019773: AB_1844686"	"unprognostic (4.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.69e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.81e-3)"	35.9	11.1	7.2	32.5	9.3	23.7	17.1	1.9	7.8	24.6	13.6	8.4	23.0	7.8	57.8	24.5	16.1	16.3	22.1	40.5	8.8	6.1	10.9	14.0	54.9	40.1	9.0	5.5	20.0	26.4	8.0	40.5	22.5	12.4	16.7	10.4	17.2	17.8	26.5	35.8	17.0	21.0	37.4	13.7	42.9	17.8	15.0	7.1	36.0	26.0	18.7	38.6	24.6	18.2	19.3	27.1	61.4	19.4	27.7	35.4	11.0	4.6	10.2	7.4	2.7	11.2	12.5	4.1	3.8	8.1	3.3	3.2	3.9	3.8	21.4	5.4	6.5	9.5	8.1	3.4	3.2	15.7	4.1	28.1	6.9	2.9	6.2	5.6	56.6	9.1	9.1	4.1	14.0	8.8	1.8	10.2	5.0	2.2	8.1	4.3	4.7	4.2	5.8	7.4	7.8	5.3	9.4	4.7	8.5	10.1	2.9	5.2	2.1	4.8	10.0	4.0	2.8	2.4	3.7	16.1	10.1	17.1	2.4	18.7	3.1	61.4	17.8	46.3	35.4	14.9	19.7	19.3	23.7	26.2	10.3	19.2	20.1	22.1	29.0	27.7	19.4	27.1	18.8	11.0	7.2	9.3	1.9	7.8	8.8	6.1	9.0	5.5	12.4	7.1
AKAP17A	"721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y"	ENSG00000197976	"A-kinase anchoring protein 17A"	Q02040	X	1591593-1602514	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043247, HPA051020"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA043247: AB_10964776, HPA051020: "	"unprognostic (4.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.25e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.91e-3)"	"prognostic favourable (2.42e-4)"	"unprognostic (1.55e-3)"	"prognostic unfavourable (3.52e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.03e-2)"	"prognostic favourable (1.11e-5)"	7.4	10.3	28.1	14.5	42.3	18.0	24.5	27.5	25.2	32.8	7.2	2.5	2.5	14.2	40.9	9.7	9.2	9.1	7.4	12.5	27.1	3.4	20.3	16.4	12.2	15.4	37.6	27.1	38.0	15.6	5.2	31.0	42.7	33.7	12.6	4.3	2.5	17.0	7.8	6.9	12.3	11.6	3.2	27.8	21.4	14.2	7.0	37.2	2.5	16.1	2.5	8.9	6.8	47.6	1.8	1.8	7.0	1.0	1.3	1.6	0.4	9.5	12.3	9.8	11.1	4.8	6.2	24.1	10.4	4.2	8.4	7.1	13.6	8.8	14.4	6.7	5.1	8.4	6.0	5.2	5.0	11.8	20.5	17.9	11.8	12.6	10.4	6.9	30.1	5.5	9.6	6.2	6.9	5.7	11.2	9.1	4.9	6.3	15.3	30.0	14.7	10.7	11.6	11.7	12.0	5.6	6.6	11.0	16.1	8.1	13.2	12.5	8.6	12.7	11.0	13.1	6.0	11.3	8.9	39.6	6.6	20.0	5.3	11.3	3.4	7.0	1.0	1.9	0.8	0.5	0.9	1.8	1.0	1.6	0.6	1.2	0.8	0.8	4.1	1.3	0.8	1.8	0.5	0.4	28.1	42.3	27.5	25.2	27.1	3.4	37.6	27.1	33.7	37.2
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol			8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favourable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favourable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.5	15.4	19.6	45.7	17.1	34.5	9.9	12.7	40.7	15.7	22.3	21.1	22.9	28.5	16.1	16.4	20.6	23.5	20.2	43.4	39.6	30.3	26.4	38.0	25.8	21.6	40.2	39.5	12.0	32.6	20.0	11.9	32.4	13.2	23.7	16.4	37.4	26.2	47.1	48.6	22.5	26.0	15.0	16.9	67.6	24.7	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.5	29.9	19.1	15.5	39.6	6.8	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell line enhanced"	"Detected in many"		"A549: 121.0;BJ hTERT+: 222.0;RPTEC TERT1: 105.0;U-87 MG: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol			1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: "	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.3	121.0	13.6	19.3	58.9	16.0	36.3	13.0	222.0	19.1	24.8	5.6	12.3	0.0	6.0	21.7	5.7	14.8	12.9	15.2	4.8	13.6	6.8	18.2	16.4	84.4	0.0	0.0	14.9	9.7	27.3	7.3	26.9	0.0	4.5	21.1	0.2	20.0	9.2	22.7	0.1	20.9	8.7	10.1	105.0	65.4	10.2	22.7	90.9	0.1	9.5	0.0	10.2	21.2	18.9	8.8	1.7	14.1	12.5	13.7	33.8	99.9	0.0	11.3	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in some"	82	"A549: 252.0;Hep G2: 69.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"											"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: "	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	252.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	69.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.1;HDLM-2: 12.0;Hep G2: 10.5;SK-BR-3: 5.1;U-87 MG: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: "	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (8.36e-4)"	"prognostic unfavourable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.1	0.1	0.0	0.6	0.5	0.9	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	12.0	0.0	0.1	0.1	10.5	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.2	0.2	3.1	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.5	5.1	0.0	0.0	0.3	0.0	0.1	0.7	0.3	0.0	0.2	0.2	0.2	6.5	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Group enriched"	"Detected in many"	10	"ASC diff: 186.6;Hep G2: 316.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"											"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: "	"unprognostic (1.54e-2)"	"prognostic favourable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.6	0.1	25.8	186.6	22.5	0.0	0.8	5.7	0.3	0.2	0.5	0.0	0.0	0.3	5.8	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.2	316.4	1.8	0.1	0.0	11.4	1.6	2.7	1.6	0.6	5.5	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Group enriched"	"Detected in some"	4	"A549: 134.6;ASC diff: 167.1;Hep G2: 251.2;RT4: 76.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: "	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	134.6	0.1	14.2	167.1	5.7	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	3.8	0.0	0.7	0.0	0.0	0.0	0.0	38.0	251.2	0.3	0.0	0.0	14.9	8.4	0.7	0.7	0.0	5.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.2	76.9	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.9	0.0	0.0	0.0	0.0	1.7	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.1;intestine: 52.3"	"Cell line enhanced"	"Detected in many"		"A549: 149.2;AN3-CA: 43.6;ASC diff: 85.8;HeLa: 46.2;Hep G2: 62.6;RT4: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 50.1;gdT-cell: 26.7"	"Low lineage specificity"	"Detected in many"											"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			11000000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: "	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	16.6	6.6	3.2	3.2	3.9	3.5	12.8	3.2	3.9	3.2	17.3	3.2	3.2	52.3	3.2	3.2	6.0	4.5	32.2	4.8	4.4	1.0	20.1	34.4	5.5	3.2	3.2	3.2	3.2	4.2	1.8	3.2	3.2	4.2	3.2	11.4	3.2	4.4	3.2	13.0	2.6	31.1	4.2	3.2	3.2	28.6	3.2	3.2	3.2	3.2	3.2	3.2	12.3	3.2	0.1	9.6	50.1	0.7	4.6	26.7	9.7	0.0	149.2	0.1	43.6	85.8	30.9	0.0	0.0	2.1	0.0	0.1	4.4	2.5	0.0	8.1	2.0	1.2	0.1	2.9	0.0	0.3	0.0	0.2	46.2	62.6	0.4	0.0	0.0	17.1	6.1	2.0	0.0	2.8	0.9	0.0	3.9	0.3	1.0	0.2	0.0	0.4	0.3	0.9	4.4	14.7	58.9	0.0	0.3	21.4	0.0	0.0	0.0	0.0	20.8	0.5	0.4	9.0	0.3	0.0	0.0	0.0	5.0	5.9	0.4	50.1	0.7	1.1	26.7	0.2	1.7	0.0	5.0	4.8	0.5	0.1	3.2	2.4	1.9	4.6	0.3	9.6	4.9	9.7	3.2	3.9	3.2	3.9	4.4	1.0	3.2	3.2	4.2	3.2
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 11.8"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: , HPA068265: "	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138117986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 103.2"	"Cell line enriched"	"Detected in single"	20	"Hep G2: 16.5"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA057002: "	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favourable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	2.7	0.5	0.7	0.7	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.8	0.2	0.2	0.1	0.0	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.3	16.5	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.2	0.1	0.4	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.2	0.3	2.7	0.5	0.6	0.4	0.4	0.3	0.6	0.4	0.4	0.3	1.1	0.5	0.7	1.8	0.7	0.5	0.5	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312146	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	Cytosol			2700000	Cytosol		"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: "	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (8.59e-4)"	21.2	39.0	25.2	14.0	26.9	15.2	22.0	19.8	26.2	32.9	38.5	28.1	28.7	56.0	20.2	23.0	25.7	35.1	31.9	31.2	22.0	19.4	49.3	32.4	14.4	21.9	24.9	26.2	31.6	60.8	14.8	19.0	17.2	23.6	19.9	19.5	25.8	21.4	24.9	33.8	18.8	43.1	20.8	20.0	16.3	22.3	21.6	21.4	24.7	22.9	20.2	18.3	16.7	21.6	23.0	40.1	13.7	29.0	22.2	27.1	23.5	24.2	15.3	16.8	15.5	26.7	26.0	11.2	18.1	22.2	25.5	22.9	19.4	20.5	17.6	19.4	24.3	19.4	18.8	27.3	12.1	14.0	29.8	11.0	14.8	31.0	20.8	12.1	8.9	25.8	21.6	19.5	12.0	21.5	16.0	16.5	26.0	24.2	23.6	11.8	4.8	19.3	24.9	21.0	31.0	24.8	10.7	31.7	11.8	19.8	17.9	30.5	35.6	42.4	16.8	16.0	16.9	17.1	13.5	20.1	12.6	21.4	34.5	27.9	22.5	0.1	29.0	13.7	23.0	23.7	26.8	23.0	20.7	20.3	40.1	21.4	23.9	20.6	3.4	22.2	17.8	35.0	27.1	23.5	25.2	26.9	19.8	26.2	22.0	19.4	24.9	26.2	23.6	21.4
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282558-19289250	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 48.5;liver: 27.4;pancreas: 59.0;stomach 1: 35.5"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 19.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"									HPA064638			Approved	Cytosol			1000000	Cytosol		"HPA064638: "	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favourable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	0.7	0.4	0.7	0.7	0.7	0.0	0.7	0.7	0.9	0.7	5.1	0.7	0.7	48.5	0.7	1.3	0.7	0.0	6.9	0.7	0.7	0.2	13.4	27.4	0.7	0.7	0.7	0.7	1.0	59.0	0.0	0.7	0.7	0.7	0.7	3.0	0.7	0.7	0.7	0.7	0.2	27.0	0.7	0.7	0.7	35.5	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.3	1.9	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.4	0.4	0.2	1.9	0.1	0.1	0.2	0.1	0.5	1.5	0.2	0.4	0.3	0.7	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.9	0.2	0.1	0.3	0.3	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.6	0.4	1.5	0.3	0.7	0.7	0.1	1.5	0.0	0.3	0.9	1.4	0.3	19.3	0.4	3.5	0.4	0.3	0.3	0.2	1.0	0.3	1.4	0.3	0.3	0.5	0.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.2	0.7	0.7	0.7	0.7
AKT1S1	"Lobe, MGC2865, PRAS40"	ENSG00000204673	"AKT1 substrate 1"	Q96B36	19	49869033-49878459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021903, HPA043590, HPA064427"	Uncertain		Supported	Cytosol				Cytosol		"CAB021903: , HPA043590: , HPA064427: "	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-1)"	"prognostic favourable (6.60e-4)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (7.34e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.65e-1)"	22.2	22.9	16.2	11.9	18.1	10.7	13.8	12.9	19.9	16.9	15.3	21.3	20.1	18.8	17.1	13.5	21.1	14.7	14.6	20.1	15.1	12.6	15.0	43.0	11.7	7.2	17.4	11.3	15.5	17.3	19.1	14.7	25.7	18.3	15.1	13.0	14.8	17.2	19.2	72.7	21.2	16.3	15.8	13.7	10.5	16.2	13.5	21.4	7.4	17.8	20.5	10.5	15.4	29.5	1.9	3.5	5.0	4.3	2.0	3.0	1.3	23.3	28.3	8.3	19.1	17.7	19.0	14.7	21.0	23.8	19.9	17.3	15.2	15.7	4.7	10.8	23.7	16.1	14.3	23.9	11.7	10.5	39.8	5.6	16.3	14.4	15.8	4.8	9.2	23.3	22.1	21.6	24.5	18.4	18.5	6.2	17.9	16.4	4.6	12.1	21.7	41.3	5.6	11.6	14.2	19.8	16.6	19.4	22.6	18.0	32.1	12.8	16.8	9.6	17.6	41.3	21.5	11.8	20.6	9.1	22.2	4.9	23.8	9.0	19.6	0.4	3.1	2.4	2.1	4.0	1.4	1.2	1.6	2.3	2.3	1.9	1.4	2.3	5.0	2.0	4.3	3.5	3.0	1.3	16.2	18.1	12.9	19.9	15.1	12.6	17.4	11.3	18.3	21.4
AKT2		ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: "	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	31.1	20.3	15.4	17.6	15.2	21.3	18.2	46.3	18.2	23.3	18.2	23.4	21.2	12.3	22.8	28.0	22.1	22.7	14.0	23.1	15.4	10.0	23.0	62.5	14.6	17.8	17.9	13.3	27.8	24.5	21.1	24.0	17.5	14.7	19.7	12.3	26.8	18.5	24.3	48.5	18.3	17.1	20.0	16.8	18.7	15.5	21.3	15.7	26.6	52.6	29.5	23.6	19.6	19.9	6.3	8.8	7.7	4.4	3.2	4.9	2.4	22.4	55.4	21.1	21.7	26.3	32.2	11.7	15.0	22.2	31.1	27.8	24.3	20.9	22.9	13.4	33.1	9.8	23.4	31.3	20.1	21.9	26.7	15.0	35.1	15.3	16.5	17.2	18.1	29.7	18.8	21.1	20.1	6.7	19.3	24.0	17.3	18.7	27.3	8.4	11.4	14.9	18.2	11.5	16.5	24.2	36.8	29.1	17.8	15.4	26.4	12.5	20.8	22.2	6.7	19.0	18.8	17.0	23.5	22.4	19.2	18.8	18.6	20.4	15.5	7.6	4.4	3.6	4.5	2.0	4.5	3.9	3.6	3.0	3.0	6.3	3.5	4.9	7.7	3.2	2.6	8.8	2.7	2.4	15.4	15.2	46.3	18.2	15.4	10.0	17.9	13.3	14.7	15.7
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol				Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (9.27e-4)"	15.4	17.0	16.0	7.8	15.2	2.2	11.0	39.9	33.4	16.9	16.1	12.4	17.4	4.1	19.7	12.3	10.0	11.8	12.1	9.8	15.5	13.6	12.8	4.0	11.3	7.9	14.2	15.8	29.8	4.4	15.1	14.6	17.0	18.4	19.4	6.6	8.9	4.1	23.9	4.8	4.7	8.1	20.4	12.1	9.9	8.7	10.4	14.8	2.9	17.7	5.0	6.2	17.2	18.6	1.9	0.8	1.2	0.9	3.8	3.6	0.6	23.5	2.4	14.9	0.0	11.0	12.6	7.9	13.3	12.2	8.6	7.6	0.1	9.7	0.0	0.0	16.8	0.3	8.2	5.3	11.4	5.9	6.4	0.3	0.0	0.0	5.7	0.1	2.6	6.5	0.0	10.7	9.7	17.6	0.0	0.1	3.9	0.0	5.0	1.1	6.3	3.7	2.7	9.1	0.1	2.9	0.8	19.1	25.3	0.1	0.0	23.8	0.0	8.0	13.8	15.3	11.8	0.1	11.0	1.3	0.4	2.8	11.2	1.2	12.8	1.2	0.9	0.5	2.3	0.3	3.6	1.0	2.2	2.5	0.8	1.9	1.9	1.7	0.2	3.8	0.7	0.6	0.7	0.6	16.0	15.2	39.9	22.9	15.5	13.6	14.2	15.8	18.4	14.8
AL121900.2		ENSG00000284776			20	18567453-18744216	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 22.4"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA040981: AB_10673268"																		4.0	5.7	4.0	4.4	5.8	5.8	6.0	4.5	14.1	3.6	6.2	2.0	6.0	5.2	7.4	5.9	4.5	5.4	5.4	7.8	4.4		15.4	6.3	4.7	6.9	4.5	5.4	7.7	16.1	8.3	5.3	4.4	7.6	4.6	6.4	3.1	8.8	8.2	12.2	1.1	5.5	5.9	4.3	5.8	0.9	6.8	5.4	3.6	5.1	9.9	6.8	5.7	6.4	4.9	6.9	2.9	4.8	3.9	5.9	1.7	3.7	1.7	7.7	3.8	2.6	8.9	0.5	2.3	6.4	6.1	0.7	0.9	5.5	0.5	1.8	7.6	3.4	4.8	14.8	22.4	0.9	0.3	5.0	2.0	2.0	3.0	9.8	5.8	0.0	14.1	4.5	7.3	7.8	0.9	7.8	5.2	2.8	1.7	0.8	2.1	0.0	0.3	4.0	5.3	4.8	4.6	7.7	2.0	0.2	6.3	3.1	4.9	6.4	0.0	8.3	0.4	7.0	5.2	1.7	8.3	1.5	5.0	1.6	5.5	2.9	3.2	2.7	4.8	4.8	5.9	4.9	5.4	3.6	6.9	2.9	1.7	3.4	1.9	3.9	2.8	1.2	4.5	1.7										
AL136454.1		ENSG00000231767			1	192716132-192716653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 7.4;SK-MEL-30: 6.5;THP-1: 7.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA041344, HPA049132, HPA054087"	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA041344: , HPA049132: , HPA054087: "	"unprognostic (2.56e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.09e-2)"	"unprognostic (7.80e-3)"	"prognostic favourable (5.72e-4)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (6.48e-4)"	"unprognostic (3.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.62e-2)"	1.7	0.9	0.3	2.3	0.6	1.9	2.6	0.9	0.9	1.3	0.7	0.0	3.9	2.8	1.8	2.5	0.8	0.7	1.8	0.8	0.5		1.2	0.4	1.3	3.3	1.7	0.2	2.6	7.3	0.0	0.0	0.6	0.8	1.5	0.0	0.4	5.9	4.2	3.4	0.1	1.6	0.6	0.7	3.0	1.2	0.4	1.0	0.2	0.6	2.5	0.8	3.0	2.3	6.1	2.6	1.3	1.9	4.5	7.4	6.4	1.7	0.7	0.5	1.0	0.5	0.0	4.3	0.2	0.9	0.0	0.6	0.0	1.3	0.4	4.3	0.0	1.7	0.3	0.5	0.0	1.4	0.9	0.7	0.9	3.2	0.4	1.2	2.2	0.5	0.8	0.3	0.0	0.3	0.2	1.3	0.0	0.9	1.5	7.4	1.9	0.4	1.7	0.5	1.0	0.6	2.1	1.3	2.7	0.3	2.6	6.5	1.7	7.6	0.8	1.1	2.0	1.4	3.9	2.5	1.8	1.4	1.4	1.2	0.2	1.3	1.4	0.7	3.2	1.9	4.6	6.1	5.7	3.5	2.6	5.8	7.4	7.0	0.4	4.5	1.4	2.4	3.6	6.4										
AL139011.2		ENSG00000258465			1	160217464-160285130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0;THP-1: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA027218, HPA027381, HPA044837"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496"	"unprognostic (4.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.04e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-3)"	8.6	4.0	3.7	3.0	10.2	2.0	4.4	15.4	11.4	4.8	4.7	8.6	2.5	3.5	6.3	4.2	5.3	6.4	4.6	16.7	3.8	3.9	6.2	10.8	4.1	3.2	3.6	5.9	7.6	4.0	6.7	4.1	5.0	9.1	5.5	3.5	6.1	5.5	3.0	14.6	4.0	4.2	7.8	4.1	3.7	4.3	4.8	4.1	2.5	7.9	3.8	3.4	5.8	4.7	5.8	8.9	6.7	6.5	8.0	5.0	8.0	0.1	2.1	0.3	0.5	6.7	1.9	0.6	0.9	5.9	3.4	0.8	0.0	0.8	0.2	6.6	1.0	0.8	1.1	0.2	0.0	6.0	0.0	0.3	0.7	0.2	3.4	0.0	0.3	3.2	0.2	3.0	3.4	0.5	1.0	4.7	0.5	0.3	1.1	0.0	0.3	0.6	0.5	0.0	0.3	0.3	0.8	0.6	0.8	0.2	1.4	0.0	2.8	5.6	0.0	0.8	0.8	0.0	0.2	0.8	3.4	0.5	0.4	0.3	0.3	6.4	6.3	6.2	3.6	6.5	5.0	5.8	4.4	4.7	8.9	3.9	2.5	3.2	6.7	8.0	6.3	2.5	4.9	8.0	3.7	10.2	15.4	11.4	3.8	3.9	3.6	5.9	9.1	4.1
AL139300.1		ENSG00000256500			14	103562962-103685924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"skeletal muscle: 37.2"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA044617, HPA052450"	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044617: , HPA052450: "					"unprognostic (1.56e-1)"													10.2	7.5	16.6	7.8	20.3	2.8	15.5	21.9	25.1	5.9	4.8	3.2	5.1	2.0	5.5	4.6	5.8	3.9	4.2	20.0	17.2	17.2	5.3	5.6	4.2	7.7	17.3	6.2	5.0	15.8	9.9	5.8	4.2	5.2	5.0	2.9	2.7	7.7	6.3	37.2	2.0	4.2	8.5	22.6	2.9	2.8	18.5	4.0	2.2	7.8	9.2	5.4	6.6	6.9	4.2	4.9	4.2	5.1	2.3	4.4	1.3	6.3	11.9	13.1	1.1	7.2	8.9	5.7	18.3	14.1	20.7	13.1	7.2	9.6	16.0	11.9	13.2	6.2	8.7	10.5	13.1	5.4	1.0	6.1	6.2	6.7	9.6	8.4	3.7	6.9	2.8	9.8	11.3	11.8	8.2	4.1	14.9	11.9	13.1	3.1	9.0	14.9	5.8	10.3	8.6	10.6	7.3	17.1	10.5	10.9	4.6	10.2	10.1	4.8	8.3	9.1	7.2	14.6	8.6	5.3	6.2	18.3	15.3	3.5	8.3	0.7	3.2	4.2	2.8	4.3	2.9	1.9	3.4	4.1	1.9	4.2	4.4	1.9	2.8	2.3	5.1	4.9	4.2	1.3	16.6	20.3	21.9	25.1	17.2	17.2	17.3	6.2	5.2	4.0
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900662-73080442	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 207.2"	"Cell line enhanced"	"Detected in some"		"A549: 287.9;Hep G2: 88.6;RPTEC TERT1: 51.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"classical monocyte: 34.2"	"Lineage enriched"	"Detected in many"	30	"monocytes: 34.2"					"Region enriched"	"Detected in many"	6	"midbrain: 171.1"	"HPA002123, CAB020690"	Approved	Approved	Enhanced	Cytosol			62000000	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favourable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	20.0	26.9	8.8	12.3	21.4	3.9	10.8	44.8	11.7	33.6	53.6	14.5	65.3	77.1	25.5	87.1	14.5	27.8	38.3	8.9	12.5	5.9	86.7	207.2	31.4	9.4	56.4	3.6	35.8	69.7	0.7	57.5	7.9	14.0	20.0	13.1	30.2	31.8	40.3	12.1	2.7	76.5	17.1	29.1	16.3	75.5	43.0	14.9	2.0	45.8	21.0	16.8	14.1	16.0	0.3	0.5	1.1	34.2	0.0	0.1	10.5	0.0	287.9	0.0	0.0	1.6	0.0	0.1	10.0	0.0	0.0	0.0	9.6	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	0.0	88.6	1.0	0.0	0.0	0.5	0.0	0.0	0.0	10.3	1.1	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	3.2	0.1	51.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.2	0.5	0.0	5.8	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	1.1	0.0	0.4	0.3	0.0	10.5	8.8	21.4	44.8	11.7	12.5	5.9	56.4	3.6	14.0	14.9
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 42.0;HaCaT: 52.3;HBEC3-KT: 129.5;U-2197: 74.4;U-87 MG: 59.2;WM-115: 61.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: "	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.0	5.6	0.0	0.0	9.3	4.1	0.1	0.3	0.3	0.2	0.1	0.1	33.7	0.3	0.5	11.3	52.3	1.0	129.5	0.8	0.0	0.2	0.2	2.3	0.0	3.1	0.1	0.2	2.9	3.6	2.9	0.5	0.4	0.0	0.2	0.2	0.4	0.0	0.2	1.1	34.2	0.0	0.5	0.2	0.0	35.3	0.0	3.0	13.1	11.5	3.9	1.1	0.3	6.6	0.0	0.1	74.4	1.6	0.0	0.3	0.2	59.2	0.0	61.1	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7
ALDH1L1	"10-fTHF, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 48.1;liver: 148.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 23.4;Karpas-707: 24.1;RPMI-8226: 12.6;RT4: 64.5;U-266/70: 13.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol			640000	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favourable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	28.9	12.1	13.7	1.8	17.1	1.2	6.0	8.6	10.9	7.8	4.9	5.7	2.3	1.1	1.9	2.2	3.6	3.4	1.9	8.1	8.9	5.3	48.1	148.7	1.3	1.2	9.2	10.1	11.3	10.2	1.4	0.9	1.1	10.8	3.3	3.3	5.1	34.1	4.1	30.7	1.5	1.3	2.4	7.7	1.1	1.9	4.9	6.2	0.0	1.7	6.2	2.8	11.0	3.1	0.1	0.8	0.8	0.2	0.2	0.4	0.0	0.4	0.0	0.0	0.0	10.6	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.9	0.7	3.1	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	23.4	3.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	24.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.3	64.5	0.1	0.1	0.3	3.1	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	13.3	4.1	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	13.7	17.1	8.6	10.9	8.9	5.3	9.2	10.1	10.8	6.2
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell line enriched"	"Detected in some"	20	"A549: 321.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: , HPA063783: "	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favourable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	321.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	16.1	0.0	0.1	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023296	Enhanced		Supported	Mitochondria,Cytosol			140000	Mitochondria	Cytosol	"HPA023296: AB_1844738"	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	14.8	9.8	27.8	46.0	23.2	13.8	35.5	17.8	22.0	20.7	26.8	27.6	14.3	0.0	18.2	13.9	11.1	8.6	60.2	19.1	0.0	10.4	2.8	14.7	23.4	11.3	0.0	0.0	16.9	14.2	16.1	11.6	16.5	0.0	0.0	18.2	9.7	0.6	0.0	18.8	8.3	8.9	31.6	0.0	19.7	11.3	9.5	11.3	0.0	9.8	10.3	17.7	0.6	20.0	6.0	18.6	6.9	12.2	0.0	0.0	0.0	3.2	0.0	9.6	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favourable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.4	17.1	16.0	14.3	51.2	45.1	13.4	23.2	32.9	23.3	20.3	10.6	13.2	0.0	22.2	20.7	13.8	12.9	22.6	27.7	8.1	16.4	11.1	12.3	11.5	26.4	17.5	11.9	28.9	11.5	24.7	20.8	20.2	17.6	15.8	36.3	10.5	11.6	18.0	23.3	21.1	10.0	20.4	23.4	30.3	16.6	19.0	13.1	16.5	18.6	21.2	35.5	26.6	19.9	14.1	13.8	17.2	11.7	14.7	19.2	17.5	15.9	16.7	13.5	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Supported	Cytosol			1200000000	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavourable (5.79e-5)"	"prognostic unfavourable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.7	104.6	31.5	101.2	48.3	55.1	100.7	84.0	87.6	85.7	107.2	73.9	107.0	94.6	137.8	84.8	106.0	63.1	183.2	62.9	41.6	83.0	77.4	83.9	163.2	75.4	112.5	83.1	75.5	64.7	96.2	64.7	63.1	66.6	62.5	90.8	197.9	68.4	93.0	78.3	88.2	102.1	50.6	211.5	106.7	79.0	63.1	44.4	52.4	221.1	78.4	94.0	76.3	75.0	126.6	50.5	69.0	90.8	123.5	84.3	86.6	235.6	109.3	99.9	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9
ALDOA		ENSG00000285043	"Aldolase, fructose-bisphosphate A"	P04075	16	30053090-30070420	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA004177	Uncertain		Supported	Cytosol			1200000000	Cytosol		"HPA004177: AB_1078128"																		1.8	0.9	2.7	1.1	5.0	2.1	7.2	0.7	7.7	4.9	1.5	2.0	2.4	0.0	2.5	3.9	0.9	3.6	1.6	5.3	2.3		1.3	0.0	2.3	2.0	0.8	4.4	2.2	0.8	0.8	3.0	1.4	4.0	2.4	0.5	2.8	1.6	7.5	10.6	0.6	0.1	1.9	0.4	1.7	1.3	11.6	0.8	1.2	4.7	0.2	2.7	1.2	1.0	7.0	6.6	0.9	6.2	4.2	8.5	12.5	3.7	8.8	1.9	6.2	1.5	5.2	1.5	4.0	6.9	5.4	21.6	3.6	5.0	24.5	5.9	6.8	6.3	14.0	10.9	3.8	4.3	7.9	6.0	8.2	5.9	11.5	10.5	2.3	5.1	0.5	10.7	12.2	7.7	1.2	7.1	13.4	3.9	4.9	8.0	2.1	5.5	7.6	4.0	22.4	15.1	0.7	6.1	5.0	1.0	1.6	1.5	5.1	4.0	1.7	8.0	2.4	3.7	5.3	7.3	5.5	8.0	7.6	11.4	3.5	0.1	6.2	0.1	5.3	2.6	7.4	7.0	7.0	5.7	6.6	6.2	8.5	6.6	0.9	4.2	2.3	5.6	5.4	12.5										
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 62.2;U-266/70: 42.9"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"			280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavourable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavourable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.4	0.5	3.5	14.4	7.2	7.4	0.7	3.8	8.6	2.9	18.1	4.3	0.7	3.5	4.6	3.4	9.7	2.3	23.6	5.5	3.0	2.2	6.7	2.7	7.4	6.8	2.4	7.8	6.8	3.3	0.3	5.9	1.3	4.6	18.8	2.5	3.5	2.8	8.1	5.4	3.9	2.4	0.4	62.2	0.4	1.0	9.2	16.4	2.2	17.7	0.1	9.6	5.5	0.9	0.3	1.4	0.5	0.6	42.9	12.3	2.6	28.1	7.0	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4
ALG2	"CDG1I, CDGIi, FLJ14511, hALPG2, NET38"	ENSG00000119523	"ALG2, alpha-1,3/1,6-mannosyltransferase"	Q9H553	9	99216426-99221956	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041512, HPA041601"	Approved		Enhanced	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA041512: AB_10794380, HPA041601: AB_10794302"	"unprognostic (8.86e-3)"	"unprognostic (4.39e-1)"	"unprognostic (2.37e-1)"	"prognostic favourable (8.44e-5)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.06e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.28e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.81e-1)"	12.5	28.0	9.2	9.4	9.7	10.5	16.4	13.1	12.5	18.8	12.9	11.6	31.1	11.0	15.2	39.2	12.3	15.8	13.9	12.1	8.3	9.5	24.8	45.5	16.0	12.8	10.8	6.5	18.4	43.4	14.7	22.4	22.5	12.0	16.7	14.9	14.7	24.1	32.6	13.3	8.7	15.5	12.6	11.3	15.9	15.0	12.6	9.7	14.8	26.0	9.9	15.8	12.9	11.8	16.8	41.0	18.2	18.5	17.5	26.4	17.8	8.1	11.0	8.1	11.6	30.1	19.6	16.7	16.7	26.6	17.1	14.9	13.1	11.8	8.8	7.8	19.2	32.3	13.7	17.9	17.2	13.3	6.3	5.2	8.7	19.4	36.2	9.2	9.9	21.4	23.4	14.5	26.4	19.1	9.1	19.9	15.8	17.1	4.6	10.9	10.5	15.5	5.4	16.5	13.7	22.9	10.4	8.7	7.1	12.3	22.7	21.5	9.2	7.8	13.6	11.7	11.6	14.9	10.4	18.7	10.1	3.8	22.0	7.3	5.7	18.2	18.5	11.2	18.6	14.6	26.4	16.8	17.7	18.4	23.0	13.3	15.4	15.0	5.0	17.5	12.9	41.0	18.8	17.8	9.2	9.7	13.1	12.5	8.3	9.5	10.8	6.5	12.0	9.7
ALG5	bA421P11.2	ENSG00000120697	"ALG5, dolichyl-phosphate beta-glucosyltransferase"	Q9Y673	13	36949775-37000261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007989	Approved		Approved	Cytosol				Cytosol		"HPA007989: AB_1078132"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.30e-1)"	"prognostic favourable (1.40e-5)"	"unprognostic (7.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.86e-1)"	14.7	18.2	11.8	14.0	14.2	11.3	19.9	10.9	13.7	16.7	16.5	10.3	34.2	13.0	13.5	34.8	11.7	12.4	12.9	13.1	10.0	10.5	18.1	36.7	19.1	28.0	16.1	12.8	11.8	60.4	11.8	11.6	17.0	12.1	12.9	20.8	7.3	30.2	37.0	9.0	11.0	12.6	10.9	15.1	12.9	17.6	7.2	14.2	15.4	25.5	12.1	12.4	12.4	11.1	19.1	45.5	17.7	24.8	22.1	25.2	26.9	10.6	14.3	13.3	13.6	36.6	24.5	9.8	29.6	31.5	25.1	20.5	28.1	37.2	15.3	12.3	17.9	26.4	16.3	22.6	23.4	16.4	32.1	35.3	12.0	17.6	35.8	29.9	18.5	25.7	33.3	20.0	26.8	19.1	16.1	19.2	22.6	19.1	20.1	23.9	13.6	11.7	24.6	16.4	37.6	26.6	20.2	10.6	20.6	12.5	23.2	17.1	14.0	29.7	14.5	14.1	8.0	15.4	18.8	16.4	12.6	20.1	21.7	19.0	23.2	17.7	24.1	10.0	24.4	24.8	24.6	19.1	23.0	24.4	23.6	17.0	21.2	23.2	2.7	22.1	20.2	45.5	25.2	26.9	11.8	14.2	10.9	13.7	10.0	10.5	16.1	12.8	12.1	14.2
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 130.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavourable (5.69e-4)"	18.0	19.5	17.1	14.6	21.9	19.1	26.2	23.4	25.3	18.2	21.8	20.1	18.8	15.1	22.1	12.1	17.3	30.5	18.7	45.8	16.5	18.9	16.0	24.2	14.7	16.9	19.0	16.9	20.9	25.0	22.7	20.2	14.8	15.4	19.4	8.9	19.9	23.7	21.1	130.4	12.7	16.9	20.4	15.3	18.8	16.2	29.7	17.6	26.8	23.5	19.5	13.7	26.8	44.8	11.5	8.9	17.6	10.6	7.6	17.0	5.7	33.5	32.4	13.2	23.7	19.4	13.4	11.5	16.2	20.1	26.7	24.9	36.6	8.9	21.3	24.0	17.8	22.2	19.8	17.1	13.7	24.3	27.0	15.6	18.4	20.4	18.1	11.2	20.9	12.8	11.7	20.0	11.9	15.4	16.9	9.7	14.8	24.9	24.2	12.6	11.1	16.6	22.0	26.0	37.3	7.8	11.6	13.6	17.9	20.2	14.1	18.5	14.2	9.7	15.6	25.7	18.0	37.7	31.7	11.4	8.6	12.8	46.7	18.5	16.8	4.3	7.2	17.6	15.1	7.4	14.0	7.9	13.6	17.0	8.9	11.5	10.9	11.0	4.6	7.6	10.6	6.6	7.9	5.7	17.1	21.9	23.4	25.3	16.5	18.9	19.0	16.9	15.4	17.6
ALMS1	KIAA0328	ENSG00000116127	"ALMS1, centrosome and basal body associated protein"		2	73385758-73610793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 23.2"	"Cell line enhanced"	"Detected in all"		"RH-30: 23.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035276, HPA035277, HPA043200"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Centrosome, Cytosol"	Nucleoplasm	"HPA035276: , HPA035277: , HPA043200: AB_10796689"	"unprognostic (2.86e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.91e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.58e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	3.4	1.7	3.0	6.5	5.5	6.3	3.9	5.5	4.5	6.0	4.0	5.4	4.3	2.0	7.4	3.9	2.2	7.9	4.3	1.6	3.4		3.5	2.1	2.7	2.5	2.0	5.0	11.0	4.0	6.1	6.6	3.2	3.6	3.6	3.3	4.7	2.3	5.8	2.3	1.8	2.4	4.2	3.2	2.1	2.8	23.2	3.4	6.7	5.1	1.9	3.2	2.9	4.1	0.8	1.3	1.3	0.4	0.5	1.2	0.0	8.4	3.3	6.2	4.5	2.4	4.0	3.9	2.9	3.2	4.8	3.6	3.7	1.1	7.9	1.8	4.8	3.7	10.4	3.2	7.2	4.7	2.9	5.3	3.7	2.9	2.1	7.3	2.6	3.1	1.9	6.6	3.3	4.2	5.9	4.2	4.0	2.5	6.9	3.3	8.0	3.1	7.7	23.8	3.3	1.2	3.0	5.1	6.0	6.6	1.1	2.7	1.4	1.8	2.6	6.7	7.0	5.3	6.9	4.9	2.5	8.5	2.5	4.2	3.0	0.0	0.1	1.3	1.2	0.2	0.3	0.2	0.6	0.1	0.1	0.8	0.4	0.6	0.0	0.5	0.4	1.3	0.1	0.0										
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	5	"A-431: 17.1;HEL: 27.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Cytosol"			5800000	Cytosol	"Nuclear speckles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.1	2.9	1.3	1.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	2.5	0.6	0.8	0.6	0.0	2.2	0.0	0.1	0.0	1.8	2.2	27.4	3.8	1.8	0.1	0.2	4.5	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.2	0.3	0.6	0.9	0.6	0.9	0.5	0.4	0.0	2.2	0.1	0.6	0.5	0.5	0.2	1.0	0.7	3.2	1.5	0.8	1.4	0.7	0.5	0.2	0.5	0.8	2.0	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087703	"Disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 38.9;tongue: 55.3"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;HEK 293: 3.9;hTCEpi: 4.4;REH: 2.8;U-266/84: 2.8"	"Group enriched"	"Detected in many"	9	"cervical cancer: 2.6;head and neck cancer: 11.2;melanoma: 4.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024002	Supported		Approved	Cytosol				Cytosol		"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	1.1	0.1	0.3	7.7	0.1	0.1	0.1	0.1	0.5	0.1	3.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.6	38.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	55.3	11.4	0.1	6.2	0.9	0.2	7.0	0.0	0.2	1.1	0.2	1.5	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.7	0.3	0.2	0.0	0.0	3.9	0.0	1.1	0.3	0.0	0.6	0.0	0.0	4.4	0.2	0.7	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.7	0.4	2.8	0.0	1.1	0.5	0.0	1.2	1.7	0.3	0.2	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.5	2.8	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.5	0.0	0.7	0.9	0.3	0.5	0.0	0.3	1.1	1.0	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase, type B"	O15296	17	8039017-8049134	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.0;HSkMC: 12.7;hTCEpi: 26.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 6.1;myeloid DC: 6.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.8;monocytes: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA010562: "	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	8.9	0.6	0.4	0.7	0.6	0.3	57.4	0.1	0.4	7.6	4.6	0.1	0.0	0.2	0.3	0.7	30.6	0.8	0.5	0.2	1.3	0.0	2.9	0.7	44.0	7.1	1.8	0.3	0.8	0.8	0.2	0.9	0.7	1.3	35.9	0.3	0.1	3.6	0.2	0.3	15.4	1.9	0.2	4.1	3.1	1.6	1.0	2.0	0.5	0.8	6.6	4.1	1.1	12.9	0.0	6.8	0.2	6.1	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	12.7	26.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	1.7	0.4	0.6	0.1	0.4	1.3	0.0	1.8	0.3	1.3	2.0
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 30.2"	"Cell line enhanced"	"Detected in some"		"A-431: 6.5;HBEC3-KT: 10.6;hTCEpi: 7.8;hTERT-HME1: 14.8;T-47d: 4.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.9"	"Group enriched"	"Detected in many"	8	"basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1"	"Group enriched"	"Detected in some"	5	"gdT-cell: 1.0;naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: "	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.1	0.0	0.1	0.1	1.1	0.0	1.6	1.4	2.3	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	1.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.2	6.5	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.4	0.1	0.5	0.2	0.2	0.1	0.4	0.9	10.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.8	0.1	14.8	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	4.7	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	1.4	2.3	0.1	0.1	0.1	0.1	1.1	0.1
ALPK2	HAK	ENSG00000198796	"Alpha kinase 2"	Q86TB3	18	58481247-58628957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4"	"Cell line enhanced"	"Detected in many"		"BJ: 26.0;BJ hTERT+: 15.8;fHDF/TERT166: 23.5;U-138 MG: 13.3"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Low region specificity"	"Detected in many"			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol				Cytosol		"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	"unprognostic (7.35e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.20e-5)"	"unprognostic (5.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-2)"	0.8	0.0	0.1	2.8	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.8	0.0	0.4	35.3	0.1	0.0	5.2	2.8	0.1	3.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.2	0.4	0.1	35.3	0.3	0.6	0.1	0.1	0.2	1.2	0.6	0.1	5.5	0.3	12.4	7.9	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	6.9	0.5	0.0	0.2	1.8	0.1	26.0	15.8	11.0	9.5	1.6	0.0	0.0	2.7	23.5	0.0	0.0	0.0	11.3	5.6	0.0	0.0	2.1	0.9	1.4	0.0	0.0	1.6	0.0	3.3	0.1	0.0	0.0	0.2	7.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.3	5.8	1.8	4.4	10.7	9.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 52.2;hTEC/SVTERT24-B: 40.8;LHCN-M2: 29.7;SCLC-21H: 26.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		7300000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	1.9	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.6	2.2	0.0	0.0	8.9	0.0	0.1	0.0	0.6	0.0	1.1	1.0	0.5	0.0	0.2	52.2	0.0	40.8	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	11.9	0.0	0.0	1.1	0.0	0.0	0.0	26.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7
ALS2	ALS2CR6	ENSG00000003393	"ALS2, alsin Rho guanine nucleotide exchange factor"	Q96Q42	2	201700554-201781189	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 52.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 66.8"	"Group enriched"	"Detected in many"	6	"basophil: 19.0;eosinophil: 5.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 19.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 158.8"	HPA046588	Enhanced		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA046588: "	"unprognostic (3.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.84e-1)"	6.9	5.3	8.2	4.2	14.7	7.8	8.1	66.8	15.6	5.9	5.6	10.1	5.5	7.4	10.3	10.7	4.7	6.7	6.4	19.9	8.3	7.3	10.4	18.3	7.9	4.1	6.8	11.0	6.8	5.6	8.8	16.8	7.2	13.6	6.6	6.0	8.5	5.2	5.5	12.2	6.9	8.4	7.4	8.3	5.3	6.7	6.1	9.0	3.5	7.5	5.9	4.5	5.5	5.3	1.2	1.0	19.0	1.2	1.7	1.8	0.7	5.1	3.6	8.8	8.2	6.0	6.5	6.5	9.1	12.4	12.2	14.1	8.4	5.1	0.6	4.0	9.5	5.3	5.0	9.2	15.4	1.7	5.0	12.1	3.5	4.8	7.4	9.6	52.8	5.6	5.2	10.2	8.8	12.2	5.7	3.6	9.2	4.1	3.4	12.6	7.3	5.5	2.8	4.9	1.8	7.7	7.0	4.1	5.4	5.3	5.8	8.2	3.7	4.0	7.3	10.7	5.1	3.7	4.6	4.1	5.6	2.1	7.8	1.9	6.8	19.0	0.7	5.5	1.7	1.2	1.8	1.2	1.2	1.2	1.0	1.2	1.3	1.5	0.6	1.7	0.8	0.5	1.8	0.7	8.2	14.7	66.8	15.6	8.3	7.3	6.8	11.0	13.6	9.0
ALS2CR12		ENSG00000155749	"Amyotrophic lateral sclerosis 2 chromosome region 12"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.3;epididymis: 14.4;testis: 29.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 6.9;U-2197: 9.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 14.3"	"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA035793			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.8	0.9	1.5	0.7	3.6	4.3	0.5	0.7	1.1	0.9	0.6	7.6	0.4	0.3	0.7	14.4	1.1	9.9	0.9	4.7	2.1	2.6	1.3	0.7	3.7	1.4	1.0	1.3	5.3	0.7	1.2	1.3	0.9	14.3	0.4	0.9	0.5	0.7	0.7	1.4	1.1	0.9	0.9	0.9	0.8	0.5	29.9	1.3	0.4	1.7	0.4	0.5	0.6	0.4	1.8	0.5	7.3	1.1	2.8	1.5	0.4	0.3	0.4	2.0	1.4	5.6	2.2	0.1	1.5	0.5	1.2	0.8	0.0	0.4	0.7	1.2	2.1	2.0	0.7	0.2	0.6	1.2	0.2	0.3	2.5	0.7	1.1	2.1	1.8	1.0	0.5	1.3	0.3	0.2	1.0	2.9	1.2	0.0	1.1	1.8	0.6	1.2	0.5	1.0	1.3	0.7	0.5	0.5	1.3	1.6	0.0	6.9	1.5	2.4	1.5	2.8	1.7	9.4	1.0	1.6	3.0	1.0	2.7	1.0	1.3	5.4	1.1	1.0	1.5	0.5	0.7	0.6	1.0	0.9	0.5	1.8	1.2	1.4	7.3	2.8	0.6	0.4	0.6	0.4	1.5	3.6	0.7	1.0	2.1	2.6	1.0	1.3	14.3	1.3
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078472	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"liver: 592.2"	"Cell line enriched"	"Detected in some"	154	"Hep G2: 164.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"		71000000000	"Golgi apparatus"	Cytosol	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favourable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.1	0.0	0.0	1.7	592.2	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	164.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943293-95968716	"Enzymes, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 99.0"	"Cell line enhanced"	"Detected in many"		"A-431: 19.1;HMC-1: 21.1;Karpas-707: 26.1;SiHa: 17.5;SK-BR-3: 19.6;U-266/70: 21.1;U-266/84: 24.7"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			410000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.1	5.7	0.5	2.4	0.8	2.0	0.9	0.5	1.3	0.7	0.7	0.6	0.4	1.9	0.9	0.5	0.8	0.5	0.7	1.1	0.6	0.5	4.4	99.0	1.3	1.4	0.5	0.4	0.7	1.1	0.0	1.2	0.6	1.0	0.7	0.0	0.8	1.3	0.7	11.3	2.2	1.9	0.6	0.6	2.9	1.9	6.2	0.5	0.7	0.6	0.7	0.7	0.8	0.9	1.5	1.2	3.7	3.8	5.7	1.6	1.4	19.1	4.2	0.3	2.8	0.1	0.0	4.3	0.6	0.2	0.3	0.6	1.9	2.5	1.7	1.9	0.0	3.6	0.1	0.0	0.1	6.6	0.7	1.8	2.9	3.7	0.0	2.5	21.1	0.0	0.1	0.3	0.0	0.1	1.3	26.1	0.0	2.9	1.6	4.7	2.0	1.0	3.5	0.1	2.1	0.0	1.8	2.2	3.1	17.5	19.6	2.2	2.0	3.6	0.0	2.7	9.5	3.4	2.4	21.1	24.7	2.6	1.9	5.1	3.1	0.3	1.6	3.7	1.2	1.4	1.1	1.5	0.6	1.6	1.2	1.0	1.0	1.1	1.2	5.7	3.8	0.6	0.3	1.4	0.5	0.8	0.5	0.6	0.6	0.5	0.5	0.4	1.0	0.5
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol			69000	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favourable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	12.8	16.9	8.6	11.4	10.1	12.7	10.9	7.3	16.0	9.4	8.8	11.1	11.3	19.5	10.4	11.9	8.4	9.0	14.6	11.8	7.1	4.8	15.3	10.5	20.0	15.8	9.8	11.3	8.1	10.1	6.5	7.5	10.7	8.9	8.6	2.4	10.9	16.1	9.6	10.2	15.0	19.1	7.2	8.3	22.2	11.5	25.7	7.9	7.3	9.9	11.0	8.9	9.3	8.0	9.8	17.1	16.6	15.8	4.9	8.1	4.8	6.4	8.8	1.9	4.0	2.1	1.7	14.3	5.9	2.5	4.7	5.9	6.3	11.6	3.0	4.2	1.1	5.9	1.1	1.6	0.1	3.8	5.3	4.3	7.9	8.2	8.0	3.1	14.1	4.0	1.7	3.4	0.5	2.9	9.8	7.2	1.9	15.6	5.0	8.6	4.1	6.8	19.7	3.0	11.0	1.3	3.6	7.3	7.2	3.8	9.2	15.5	9.5	0.8	4.0	5.3	8.1	10.5	3.0	15.2	9.7	5.9	5.9	5.9	6.6	9.9	6.1	16.5	7.4	15.8	5.5	9.8	5.9	5.3	2.3	7.4	5.0	4.2	16.6	4.9	15.2	17.1	8.1	4.8	8.6	10.1	7.3	16.0	7.1	4.8	9.8	11.3	8.9	7.9
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755435-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 30.1"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 15.0"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebellum: 30.1"	"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: "	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.5	2.4	4.8	0.7	6.0	0.8	0.5	30.1	13.9	0.5	0.8	0.0	0.0	2.0	0.6	0.5	0.5	0.5	0.5	0.5	2.7	4.3	0.5	0.5	0.5	0.6	1.8	5.6	0.6	3.3	0.4	3.4	0.5	3.0	0.6	0.8	0.7	0.5	0.5	0.5	0.7	1.2	0.5	0.8	0.6	2.5	1.6	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.3	0.3	1.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	15.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.1	0.2	1.5	0.2	0.1	0.3	0.1	0.0	4.8	6.0	30.1	10.3	2.7	4.3	1.8	5.6	3.0	0.7
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.1;ovary: 38.2;testis: 15.2"	"Group enriched"	"Detected in some"	18	"HEL: 27.6;K-562: 15.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"hippocampal formation: 14.3"	"HPA060228, HPA069636"			Approved	"Nucleoplasm,Vesicles,Centriolar satellite,Cytosol"				Vesicles	"Nucleoplasm, Centriolar satellite, Cytosol"	"HPA060228: , HPA069636: "	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.3	27.1	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.6	0.4	0.2	0.4	0.8	0.2	0.0	0.2	1.1	0.3	0.2	0.2	0.2	38.2	8.8	0.1	0.2	0.2	0.3	0.4	0.0	0.2	0.2	0.2	2.5	0.0	0.4	0.5	0.2	3.7	0.3	15.2	0.2	0.2	0.2	0.5	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	27.6	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
AMIGO2	"ALI1, DEGA"	ENSG00000139211	"Adhesion molecule with Ig like domain 2"	Q86SJ2	12	47075707-47079951	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.9;fHDF/TERT166: 42.2;LHCN-M2: 42.2;RT4: 57.8;U-2 OS: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054004, HPA059601"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"			160000	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA054004: AB_2682339, HPA059601: "	"unprognostic (2.63e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (2.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.29e-3)"	5.6	11.9	5.4	4.0	8.8	1.4	14.5	1.6	6.5	18.3	20.3	3.5	1.9	1.6	19.7	12.4	3.1	21.2	12.4	3.4	2.7	7.5	4.3	2.9	11.9	6.7	2.9	5.1	43.4	2.3	2.0	9.5	7.6	16.2	12.8	5.6	6.7	3.1	7.1	1.5	2.3	7.1	21.0	3.0	9.8	3.5	13.1	3.6	1.6	2.5	4.1	4.5	16.6	15.1	2.8	7.4	0.1	0.2	6.6	14.2	4.3	9.7	24.1	1.5	0.0	0.6	0.0	3.9	3.3	9.1	1.1	0.9	0.0	43.9	0.0	11.0	42.2	14.6	0.0	27.0	1.3	1.9	0.1	0.0	2.4	0.0	0.9	0.2	0.4	0.2	4.8	28.9	14.3	3.5	1.8	0.0	42.2	0.4	0.7	0.0	1.0	6.1	0.0	10.9	0.0	12.5	57.8	4.4	0.0	17.4	2.1	0.1	2.6	0.2	0.9	0.6	35.0	0.4	26.9	0.4	0.0	0.0	2.3	0.7	0.6	0.0	0.1	0.0	4.0	0.2	5.4	2.8	6.2	6.2	0.6	1.3	14.2	11.1	0.1	6.6	0.0	7.4	3.6	4.3	5.4	8.8	1.6	6.5	2.7	7.5	2.9	5.1	16.2	3.6
AMMECR1L	MGC4268	ENSG00000144233	"AMMECR1 like"	Q6DCA0	2	127861630-127885922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 45.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000590, HPA057234"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA000590: , HPA057234: "	"unprognostic (1.34e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (1.92e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (8.91e-2)"	7.8	6.4	5.2	5.2	5.2	5.0	7.1	5.7	5.2	7.6	5.5	5.2	5.2	4.6	8.7	5.2	6.4	6.9	5.9	5.2	5.2	3.3	5.2	7.7	5.6	5.2	5.2	5.2	7.6	8.8	7.6	5.2	7.3	5.2	6.4	5.7	45.9	5.9	5.2	5.2	7.2	5.8	7.5	5.2	6.8	6.1	7.9	5.2	5.2	6.1	5.2	5.4	5.8	7.3	4.2	5.4	9.0	3.7	3.5	6.1	3.2	12.2	8.2	16.9	13.8	16.1	13.1	16.0	14.5	13.2	16.0	14.5	18.2	9.2	11.9	9.7	14.3	12.2	16.4	12.1	17.6	14.1	12.0	15.1	12.2	10.3	19.2	14.9	15.5	14.4	26.5	19.6	26.5	16.7	13.8	12.0	12.8	8.7	13.9	14.5	13.4	15.2	14.6	13.6	6.8	12.7	10.7	11.2	12.6	12.0	18.8	29.1	8.7	10.4	16.6	19.8	18.6	9.2	10.9	10.1	14.8	12.3	9.5	9.6	13.1	1.6	3.2	9.0	4.7	3.7	6.1	3.6	4.5	4.1	4.8	4.2	4.1	3.8	4.3	3.5	3.7	5.4	4.2	3.2	5.2	5.2	5.7	5.2	5.2	3.3	5.2	5.2	5.2	5.2
AMOTL1	JEAP	ENSG00000166025	"Angiomotin like 1"	Q8IY63	11	94706431-94876753	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 36.0;WM-115: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3;NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001196	Approved		Approved	"Cell Junctions,Cytosol"			11000	Cytosol	"Cell Junctions"	"HPA001196: AB_1078147"	"unprognostic (2.21e-1)"	"unprognostic (5.25e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (5.03e-6)"	"unprognostic (7.47e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.29e-2)"	14.4	5.7	3.3	6.9	4.0	0.6	9.2	3.7	4.8	12.8	15.4	2.7	9.1	2.2	16.4	11.4	19.3	7.5	10.9	10.1	3.1	3.9	4.4	4.8	10.0	2.5	3.2	2.5	7.3	10.8	13.5	13.9	25.4	3.5	18.7	4.0	11.3	8.9	13.6	78.2	11.7	4.8	32.8	2.6	6.2	8.1	7.1	1.8	12.9	8.6	21.9	10.1	24.4	9.5	2.3	1.0	0.0	0.7	2.3	0.1	0.5	18.0	5.1	13.8	0.0	14.9	12.9	6.6	10.0	17.5	4.6	5.4	9.4	0.5	0.8	4.9	13.5	23.5	6.5	36.0	4.8	1.4	5.0	9.7	5.4	0.0	3.4	2.1	0.0	7.6	22.3	15.7	26.3	9.5	24.5	0.9	10.8	5.2	6.6	1.3	2.0	3.4	0.0	25.1	1.5	6.5	7.6	10.5	12.7	0.6	13.9	3.6	0.7	3.0	8.7	12.6	9.3	0.2	6.8	0.5	0.0	5.1	3.5	0.0	34.4	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.6	2.3	0.0	0.0	0.0	2.3	0.2	1.0	0.0	0.5	3.3	4.0	3.7	3.0	3.1	3.9	3.2	2.5	3.5	1.8
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760, HPA050590"	Approved		Enhanced	Cytosol			380000	Cytosol		"HPA027137: , HPA045760: , HPA050590: "	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	8.1	22.7	20.2	21.7	41.3	64.4	4.9	16.3	26.8	9.5	10.1	9.5	6.3	17.1	9.0	6.0	5.9	11.8	13.2	5.2	21.7	19.4	7.8	13.0	8.2	10.7	14.2	14.2	16.3	9.4	13.0	37.1	10.8	18.3	9.7	5.7	15.7	9.1	12.2	2.1	10.0	11.6	9.1	8.5	15.9	8.3	5.3	12.2	10.3	6.4	3.0	7.5	8.2	8.1	2.8	8.8	29.7	24.5	3.0	4.3	5.4	10.9	12.8	18.8	15.8	16.4	16.4	7.1	15.6	32.0	16.0	15.8	9.7	4.7	5.4	12.0	29.3	8.6	9.8	14.5	9.9	8.8	13.3	28.6	16.8	10.8	15.4	12.1	30.8	18.3	7.7	21.2	16.5	13.8	8.8	14.8	11.4	17.0	17.9	29.0	12.1	13.6	12.8	7.2	8.4	14.7	6.7	14.6	15.3	10.7	13.0	12.7	7.3	11.3	13.2	19.8	23.0	24.2	16.1	29.6	14.3	7.8	29.5	18.9	20.6	0.5	9.2	11.2	3.4	19.6	4.3	2.8	3.3	3.4	8.8	1.7	3.8	2.8	29.7	3.0	24.5	1.4	2.6	5.4	20.2	41.3	16.3	26.8	21.7	19.4	14.2	14.2	18.3	12.2
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631567	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 57.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 31.8;ASC TERT1: 18.8;BJ hTERT+ SV40 Large T+: 12.3;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 11.3;HSkMC: 11.0;U-138 MG: 12.1;WM-115: 10.8"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.8	2.4	17.4	2.5	17.7	1.0	2.8	29.7	57.2	7.7	2.2	1.8	0.0	1.4	5.1	4.7	4.5	5.7	4.2	6.5	13.5	16.0	3.7	1.4	1.6	1.3	10.4	20.4	1.7	2.9	1.2	12.6	1.0	26.5	2.4	2.5	4.8	1.5	4.2	2.9	1.3	1.9	5.0	4.9	1.9	2.0	3.5	1.5	0.0	1.2	0.2	1.1	2.9	1.7	0.2	1.6	0.0	0.8	0.7	2.9	0.2	0.0	0.0	8.0	0.0	31.8	18.8	0.0	1.1	0.0	12.3	14.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	11.3	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	11.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	0.1	4.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.1	8.5	4.2	4.5	0.0	0.1	0.0	8.2	0.1	10.8	0.0	0.8	0.0	2.9	0.2	1.7	0.0	1.0	1.5	0.2	0.2	0.4	2.0	0.0	0.7	0.2	1.6	0.2	0.2	17.4	17.7	29.7	32.9	13.5	16.0	10.4	20.4	26.5	1.5
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68247574-68257164	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: "	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	22.3	21.3	29.3	13.7	43.3	14.2	20.8	29.2	35.8	19.8	19.8	20.3	19.6	11.9	19.0	25.3	22.3	24.6	17.7	33.6	26.8	23.7	26.8	16.6	14.1	22.4	26.0	27.0	23.4	20.4	29.4	25.4	18.9	28.3	21.1	15.0	19.0	17.9	25.1	39.9	15.5	13.5	19.3	27.8	16.6	15.7	77.2	20.5	15.5	28.4	20.6	22.4	20.2	14.9	20.9	17.2	31.4	21.1	34.8	31.2	19.7	23.3	25.9	22.0	18.6	16.9	29.5	34.6	16.9	22.9	29.5	24.8	10.6	15.0	35.0	19.1	26.2	11.5	17.9	49.9	38.7	12.3	16.9	12.8	11.5	20.7	32.0	11.7	22.2	25.1	56.0	27.4	51.0	29.8	13.1	22.4	37.2	17.4	26.3	10.9	10.3	24.3	10.0	59.9	26.2	17.7	12.4	22.2	17.4	15.7	32.5	31.6	25.6	8.0	15.5	39.7	18.9	14.2	18.3	31.4	28.8	60.3	28.0	16.6	20.0	31.4	14.4	19.6	22.1	16.6	28.6	17.4	27.3	29.0	17.2	20.9	24.4	26.3	25.2	34.8	21.1	15.7	31.2	19.7	29.3	43.3	29.2	35.8	26.8	23.7	26.0	27.0	28.3	20.5
ANAPC13	"APC13, DKFZP566D193, SWM1"	ENSG00000129055	"Anaphase promoting complex subunit 13"	Q9BS18	3	134477706-134486716	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046114	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA046114: AB_10961429"	"unprognostic (2.84e-2)"	"prognostic favourable (1.66e-4)"	"unprognostic (2.98e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (1.67e-4)"	"unprognostic (3.57e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.44e-2)"	"unprognostic (4.36e-1)"	"prognostic favourable (2.66e-7)"	"unprognostic (3.10e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.16e-1)"	35.5	29.5	29.0	10.8	24.0	9.7	26.2	14.6	26.7	21.3	20.0	14.8	19.6	13.2	18.7	46.5	24.5	19.2	19.3	37.5	25.3	36.3	47.1	54.4	22.1	17.3	33.3	13.3	30.1	36.0	29.6	34.3	34.8	29.2	29.1	18.3	23.4	30.5	22.6	36.8	14.4	25.4	20.7	23.2	19.2	20.1	20.4	12.4	14.1	44.3	22.2	13.4	27.3	16.9	25.5	26.9	69.4	30.5	18.7	30.0	22.8	20.8	13.1	20.7	17.6	35.2	46.9	16.0	27.2	25.1	19.9	18.8	16.3	12.4	14.2	59.0	39.8	12.3	19.3	19.4	28.8	7.1	9.0	14.4	10.6	27.2	25.4	23.6	10.3	31.1	21.2	20.0	37.5	30.8	19.2	12.1	62.7	26.8	12.0	23.2	14.1	12.8	9.7	16.3	25.7	38.8	12.9	8.4	13.9	24.1	8.9	23.6	22.1	23.3	21.4	27.7	11.3	38.9	11.9	13.4	14.5	29.3	17.1	13.1	23.6	28.9	28.3	24.2	16.4	30.5	21.3	25.5	24.6	21.4	26.9	18.6	30.0	25.2	69.4	18.7	29.6	20.5	20.5	22.8	29.0	24.0	14.6	26.7	25.3	36.3	33.3	13.3	29.2	12.4
ANAPC16	"APC16, bA570G20.3, C10orf104, CENP-27, FLJ33728"	ENSG00000166295	"Anaphase promoting complex subunit 16"	Q96DE5	10	72216000-72235860	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037815	Approved		Supported	Cytosol				Cytosol		"HPA037815: AB_10672288"	"unprognostic (2.87e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.75e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-3)"	16.9	26.7	13.9	15.6	15.9	10.8	18.7	21.6	15.8	18.3	21.2	9.4	25.8	13.1	19.1	19.9	22.7	19.9	17.0	35.6	14.8	9.5	24.9	22.7	15.8	21.6	18.7	9.8	23.4	49.0	17.9	27.3	12.4	13.6	23.9	15.3	17.5	41.4	26.2	46.3	14.2	19.6	26.4	14.4	23.2	23.6	11.9	18.0	25.5	32.3	20.5	20.9	22.4	32.2	32.1	23.5	18.4	11.9	16.5	26.2	15.5	11.1	5.6	5.7	6.8	15.5	7.4	4.4	4.0	7.7	5.4	5.1	6.8	14.8	11.3	6.6	5.4	9.0	4.9	9.6	5.4	13.1	8.4	5.7	5.2	6.7	18.7	9.7	7.1	9.6	43.4	4.8	16.3	6.5	8.3	13.7	6.2	7.0	8.0	9.6	4.4	3.2	4.7	5.2	11.0	13.8	4.9	8.4	7.7	6.8	18.3	13.5	5.8	10.0	8.7	2.9	6.8	4.6	6.0	13.8	11.6	11.7	8.0	18.5	3.3	16.2	11.3	18.4	16.7	11.4	18.2	27.7	18.7	16.4	9.0	32.1	26.2	20.9	10.5	16.5	11.9	23.5	16.3	15.5	13.9	15.9	21.6	15.8	14.8	9.5	18.7	9.8	13.6	18.0
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	15.6	20.3	17.8	14.7	25.1	12.2	19.9	24.8	25.1	20.6	16.2	16.8	12.2	11.9	21.4	19.8	34.2	20.9	15.6	18.8	19.1	18.5	21.4	16.8	16.6	20.8	16.2	22.1	18.1	16.7	26.6	14.9	9.6	17.6	21.8	18.9	16.4	19.7	21.3	29.7	16.0	13.3	24.0	17.1	16.8	14.9	36.3	16.3	25.8	23.2	24.5	22.2	19.2	22.5	14.9	17.7	17.6	15.1	20.1	22.4	12.5	18.3	25.3	18.6	15.8	19.5	9.9	10.6	12.9	11.8	23.9	16.6	25.8	11.8	29.4	13.2	17.3	18.7	27.6	17.7	24.4	15.6	22.3	26.0	18.8	21.3	14.2	23.2	12.3	10.7	12.8	20.7	13.8	23.1	40.7	6.0	18.7	19.7	35.1	17.3	16.1	22.1	27.2	18.4	35.0	16.2	23.6	24.2	13.9	20.2	15.9	21.2	33.7	21.1	14.5	14.3	13.4	12.7	15.2	10.6	21.7	39.6	15.9	19.9	16.5	14.3	10.5	17.6	17.2	15.1	20.2	13.3	18.5	16.5	17.7	14.9	15.5	16.5	8.3	20.1	13.1	9.7	22.4	12.5	17.8	25.1	24.8	25.1	19.1	18.5	16.2	22.1	17.6	16.3
ANKEF1	"ANKRD5, dJ839B4.6, FLJ21669"	ENSG00000132623	"Ankyrin repeat and EF-hand domain containing 1"	Q9NU02	20	9986126-10058303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.0;testis: 22.7"	"Cell line enhanced"	"Detected in many"		"U-266/84: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA041151	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"				"Nucleoli fibrillar center, Plasma membrane, Cytosol"		"HPA041151: AB_10796569"	"unprognostic (4.72e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.38e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.73e-2)"	"prognostic favourable (4.44e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (3.11e-1)"	5.6	2.9	1.4	2.3	2.4	0.5	3.7	5.7	2.0	2.7	3.1	0.8	11.3	2.9	1.9	4.2	4.7	4.9	4.0	3.2	2.3	2.5	5.7	6.7	2.3	1.3	1.5	1.1	3.6	25.0	5.3	13.6	1.7	4.1	3.4	3.0	3.0	4.2	13.0	1.7	2.9	3.6	1.0	1.2	1.8	5.1	22.7	1.0	3.2	8.6	2.5	3.9	2.1	2.6	2.5	1.6	0.7	0.1	1.5	5.4	1.3	10.1	10.3	1.4	2.5	2.1	1.2	5.9	1.9	0.1	1.8	0.9	6.0	9.2	0.0	3.2	0.4	8.8	1.8	12.1	2.2	0.0	1.6	1.3	2.0	5.5	1.4	1.1	0.2	3.7	8.6	1.6	1.7	1.5	3.8	9.0	0.4	3.2	1.6	0.0	4.3	2.4	0.0	0.0	6.9	4.4	6.5	7.8	3.9	4.7	10.3	0.0	9.0	0.9	1.1	1.3	1.5	0.1	2.0	9.3	17.9	1.6	2.6	0.3	1.7	0.0	0.0	0.0	2.8	0.1	5.4	2.5	3.3	2.6	0.2	2.3	4.1	3.0	0.7	1.5	0.0	1.6	3.8	1.3	1.4	2.4	5.7	2.0	2.3	2.5	1.5	1.1	4.1	1.0
ANKH	"ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1"	ENSG00000154122	"ANKH inorganic pyrophosphate transport regulator"	Q9HCJ1	5	14704800-14871785	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Phosphate transport, Transport"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068104			Approved	Cytosol				Cytosol		"HPA068104: "	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.76e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.46e-2)"	8.5	9.7	15.2	8.0	17.0	5.9	9.2	29.1	25.9	4.4	10.9	19.5	3.4	14.4	6.5	4.7	6.8	7.2	8.4	27.0	15.9	14.9	7.4	18.1	6.3	9.6	19.7	17.1	14.9	13.1	19.6	19.2	7.3	15.4	29.5	10.3	16.1	11.7	8.6	31.0	17.4	14.9	7.6	22.6	6.3	6.5	2.0	15.3	9.3	9.5	12.7	11.8	6.4	6.3	2.5	0.6	0.7	1.4	0.6	7.0	0.7	3.8	2.9	3.7	0.6	7.8	18.4	1.7	3.7	7.4	1.4	1.5	2.3	4.8	8.9	8.7	5.0	2.5	2.5	4.0	1.6	3.5	6.1	0.2	27.0	6.1	2.6	2.1	0.7	5.7	7.1	4.4	5.1	3.0	1.8	19.3	4.7	5.1	3.6	7.0	1.4	3.2	5.1	1.8	8.0	0.0	1.2	9.0	2.5	17.9	2.9	3.9	0.1	0.8	2.9	3.8	3.9	6.3	6.6	5.1	4.7	7.0	13.2	8.0	15.7	0.7	0.4	0.1	2.4	0.7	4.0	2.5	5.0	3.9	0.6	2.1	5.7	2.6	0.5	0.6	1.4	0.6	7.0	0.7	15.2	17.0	29.1	25.9	15.9	14.9	19.7	17.1	15.4	15.3
ANKIB1	"DKFZP434A0225, KIAA1386"	ENSG00000001629	"Ankyrin repeat and IBR domain containing 1"	Q9P2G1	7	92246234-92401384	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019358, HPA021780"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA019358: AB_1844831, HPA021780: "	"unprognostic (1.77e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.20e-1)"	11.9	11.8	21.4	9.2	29.2	5.8	12.3	15.0	25.5	13.6	12.1	34.9	16.0	10.7	12.6	16.4	11.8	10.0	14.7	9.7	22.7	20.0	25.3	10.1	10.6	11.5	31.1	18.4	13.1	12.7	28.5	10.9	12.2	23.4	10.2	12.6	8.4	12.7	18.4	8.6	14.0	11.3	13.4	23.8	11.4	10.9	19.4	35.0	11.5	17.1	4.5	11.1	13.1	13.3	4.8	4.5	3.1	2.0	3.2	4.9	1.1	17.3	10.6	9.4	14.2	17.4	18.6	10.0	13.6	15.6	13.2	17.4	7.7	26.8	10.0	12.0	20.1	8.4	8.6	14.3	20.2	16.9	7.1	6.3	12.2	6.2	11.9	9.0	14.0	12.6	12.1	15.6	20.6	14.9	8.0	21.6	15.6	14.0	19.1	8.4	10.2	12.0	7.2	11.5	10.7	14.0	15.0	13.0	15.4	19.4	21.9	11.5	9.1	5.1	13.3	25.6	20.7	28.8	13.8	13.6	24.2	12.6	14.8	10.9	29.2	2.8	1.3	3.1	2.7	2.0	2.2	3.9	2.6	3.8	1.1	4.8	2.2	2.8	0.8	3.2	1.6	4.5	4.9	1.1	21.4	29.2	15.0	25.5	22.7	20.0	31.1	18.4	23.4	35.0
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.2;HL-60: 13.3;NB-4: 17.0;U-937: 23.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3"					"Low region specificity"	"Detected in many"			"HPA026789, HPA073498"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA026789: AB_10611675, HPA073498: "	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavourable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.6	0.5	1.0	12.9	3.1	22.6	0.6	8.3	1.4	0.7	0.7	0.6	0.2	0.3	0.9	1.3	0.5	0.8	0.5	0.2	1.0	1.2	0.5	0.5	1.3	3.7	1.6	0.7	1.7	0.2	0.6	0.9	1.1	1.4	1.0	0.5	0.4	0.7	0.6	0.9	1.4	1.2	0.9	1.2	5.7	0.3	1.0	0.5	8.9	0.6	0.2	5.3	1.0	0.7	3.0	2.2	0.7	4.3	0.0	0.4	0.8	0.1	0.3	1.5	0.7	0.0	0.3	1.4	0.5	0.1	0.3	0.2	6.9	0.4	30.2	0.3	0.1	0.6	11.7	0.1	0.2	9.1	1.5	12.3	4.8	0.0	0.1	13.3	5.1	0.1	0.4	1.2	0.0	0.2	1.6	3.6	0.1	0.2	9.1	17.0	3.7	1.0	7.3	0.0	3.1	0.1	0.1	0.4	2.7	2.9	0.2	0.2	0.0	8.7	0.5	0.1	0.5	0.5	0.3	0.3	0.3	10.7	0.1	23.7	0.6	0.0	1.8	0.7	0.0	4.3	0.0	3.0	0.0	0.4	2.2	1.7	0.1	0.0	0.0	0.0	3.1	1.1	0.0	0.8	1.0	3.1	8.3	1.4	1.0	1.2	1.6	0.7	1.4	0.5
ANKMY1	"FLJ20499, ZMYND13"	ENSG00000144504	"Ankyrin repeat and MYND domain containing 1"	Q9P2S6	2	240479422-240569209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA026620, HPA048869"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026620: AB_1844834, HPA048869: "	"unprognostic (2.89e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.46e-1)"	"unprognostic (3.97e-5)"	"unprognostic (8.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.59e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.42e-2)"	"prognostic favourable (3.20e-4)"	4.5	4.3	5.2	9.0	7.9	9.8	5.8	6.4	7.3	7.2	5.7	10.3	10.8	5.8	6.6	9.0	5.3	21.8	9.2	3.6	6.1	4.3	5.1	5.1	6.3	7.2	8.7	4.8	7.3	8.0	6.6	5.4	6.4	6.4	5.8	5.1	5.1	6.9	13.6	5.0	7.2	6.2	5.8	6.3	7.3	8.4	45.0	6.7	6.0	6.0	3.4	10.7	5.8	6.0	7.4	4.2	6.9	3.4	2.0	7.5	3.4	5.2	11.5	2.5	4.6	2.3	3.3	10.4	2.5	3.8	2.1	2.8	3.7	10.8	5.2	0.4	2.8	5.8	4.8	5.9	2.5	9.6	3.9	10.3	5.6	9.6	1.9	5.7	10.0	5.2	14.5	1.9	13.8	2.1	9.6	6.7	3.5	5.0	5.3	9.4	2.1	6.9	14.9	7.6	8.2	3.2	11.3	5.9	4.4	2.0	5.5	7.6	4.8	8.9	2.7	7.8	2.7	3.1	4.4	15.6	3.9	5.0	4.4	8.8	6.0	0.1	3.3	6.9	7.5	2.6	4.3	4.7	4.8	4.7	4.2	7.4	7.1	5.1	1.3	2.0	3.4	2.8	1.5	3.4	5.2	7.9	6.4	7.3	6.1	4.3	8.7	4.8	6.4	6.7
ANKMY2	"DKFZP564O043, ZMYND20"	ENSG00000106524	"Ankyrin repeat and MYND domain containing 2"	Q8IV38	7	16599776-16645817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050447, HPA067100"			Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA050447: , HPA067100: "	"unprognostic (3.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.00e-2)"	"prognostic favourable (1.05e-7)"	"unprognostic (5.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.85e-2)"	9.6	10.3	14.5	6.6	30.1	10.0	11.8	14.6	28.7	12.4	13.6	9.0	13.3	12.2	10.8	10.4	9.4	13.1	11.1	30.2	18.5	12.7	13.3	8.9	9.4	6.7	12.7	21.2	21.5	9.6	13.2	14.9	7.3	20.4	11.3	14.1	11.8	11.4	16.3	17.3	8.5	13.5	14.4	11.9	8.8	19.1	8.0	7.8	8.9	17.7	7.5	7.1	14.6	11.6	6.7	4.9	18.5	8.9	10.6	10.2	5.2	11.5	9.9	13.5	13.4	12.8	13.5	7.3	14.2	17.4	10.9	17.0	16.4	17.8	2.3	16.6	14.8	12.1	9.1	5.4	16.4	5.2	6.3	21.0	11.9	7.4	8.4	15.6	8.2	11.7	2.9	11.0	11.1	9.8	21.5	3.9	15.5	3.1	6.6	10.9	9.0	11.8	10.9	12.2	5.6	17.1	10.1	8.5	5.1	9.6	7.1	5.7	8.3	14.1	6.1	8.5	7.6	18.9	9.6	14.2	10.3	3.6	13.1	12.9	13.5	18.5	3.2	14.3	10.0	4.3	9.6	6.7	8.2	10.2	4.9	6.7	6.9	8.2	2.7	10.6	8.9	4.7	8.3	5.2	14.5	30.1	14.6	28.7	18.5	12.7	12.7	21.2	20.4	7.8
ANKRD10	FLJ20093	ENSG00000088448	"Ankyrin repeat domain 10"	Q9NXR5	13	110878540-110915069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034211, HPA038878, HPA038879"	Uncertain		Approved	Microtubules,Cytosol				Microtubules	Cytosol	"CAB034211: AB_2058024, HPA038878: , HPA038879: "	"unprognostic (3.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.97e-3)"	"unprognostic (9.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (1.25e-6)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (6.41e-6)"	35.1	23.1	19.1	36.8	21.5	44.3	49.7	26.2	19.3	34.9	31.9	33.1	30.6	25.4	44.2	55.6	20.1	28.8	31.7	25.3	18.0	18.3	32.5	27.9	30.8	33.3	28.5	13.9	37.3	34.1	18.8	36.2	41.9	21.9	38.1	30.5	37.4	27.3	29.4	79.3	28.4	30.5	33.1	27.3	48.9	25.9	18.2	23.4	35.4	30.4	27.8	33.4	33.1	45.1	30.8	21.2	20.5	16.6	18.6	24.5	15.8	12.3	10.3	23.9	20.0	18.4	17.9	10.6	8.4	17.6	8.4	10.5	10.7	24.3	17.1	18.5	6.3	28.6	10.3	7.9	11.5	40.8	15.3	20.3	23.2	22.2	7.3	29.2	17.8	16.9	12.1	5.9	8.8	11.3	8.9	11.8	22.7	3.7	16.8	32.7	13.2	6.4	26.0	8.7	16.9	23.1	13.7	19.1	14.3	6.3	11.3	13.2	8.0	37.4	9.8	10.0	8.3	4.9	8.5	14.7	15.6	9.9	18.7	14.4	15.6	20.5	16.6	13.7	21.0	13.1	17.7	28.0	19.8	17.0	21.2	30.8	21.4	22.9	10.3	18.6	13.1	19.8	24.5	15.8	19.1	21.5	26.2	19.3	18.0	18.3	28.5	13.9	21.9	23.4
ANKRD11	"LZ16, T13"	ENSG00000167522	"Ankyrin repeat domain 11"	Q6UB99	16	89267619-89490561	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019288, HPA049470"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019288: , HPA049470: "	"unprognostic (7.31e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (6.39e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (7.67e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.16e-1)"	24.2	23.3	22.8	25.6	23.1	48.7	41.4	32.3	31.7	22.0	24.1	22.9	22.0	22.4	26.9	18.9	25.0	23.4	23.4	22.2	24.6	20.0	17.8	15.1	32.3	33.8	20.8	21.0	32.6	27.9	33.7	31.5	18.8	19.3	20.5	14.9	23.3	21.4	25.8	27.0	35.8	24.1	26.7	20.3	26.1	22.6	21.3	22.1	26.1	21.6	19.3	19.6	23.4	34.4	4.2	7.2	11.7	5.9	9.8	4.5	1.8	22.0	27.6	27.8	21.3	17.2	17.8	26.9	25.2	16.9	15.3	10.8	32.2	23.7	20.5	17.5	18.3	22.4	19.0	23.2	17.3	10.1	22.7	16.1	19.1	25.7	26.0	11.8	18.4	19.7	23.6	20.0	25.9	18.3	34.6	16.4	19.1	20.9	19.6	29.9	24.4	25.5	40.6	32.1	17.1	15.8	18.5	16.4	20.1	36.4	7.6	26.1	17.9	18.7	33.8	32.2	30.1	17.8	27.7	29.9	10.5	25.5	25.9	19.7	17.3	7.5	3.9	3.7	3.8	4.0	4.3	3.1	4.3	4.5	2.1	4.2	3.8	3.5	11.7	9.8	5.9	7.2	4.2	1.8	22.8	23.1	32.3	31.7	24.6	20.0	20.8	21.0	19.3	22.1
ANKRD12	"FLJ20053, GAC-1, KIAA0874"	ENSG00000101745	"Ankyrin repeat domain 12"	Q6UB98	18	9136228-9285985	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040705	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040705: AB_10673301"	"unprognostic (2.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.03e-2)"	17.0	10.9	22.2	23.1	26.1	19.6	15.4	48.1	25.4	17.8	18.8	10.1	18.2	13.7	14.6	15.4	16.1	12.1	16.1	12.3	19.9	13.5	14.7	16.5	14.6	22.1	20.2	18.3	16.3	16.7	15.5	16.4	19.2	17.4	15.9	13.6	9.5	15.7	20.6	25.8	21.8	18.1	17.2	21.3	20.3	15.3	29.3	23.8	11.4	18.2	13.0	19.5	24.2	22.6	18.7	19.2	51.2	10.7	8.8	19.0	5.2	4.1	2.8	3.9	2.6	6.3	6.5	3.2	6.5	6.1	2.3	3.2	2.5	3.2	5.8	3.8	4.5	3.9	2.9	2.5	6.3	6.1	3.5	2.6	2.0	3.7	4.6	6.1	8.5	3.4	5.7	3.3	5.4	3.9	6.0	45.8	5.7	2.3	4.1	4.2	1.4	2.9	3.7	5.5	21.1	3.0	6.6	9.1	3.3	6.4	3.2	4.6	3.9	5.2	8.4	17.3	8.0	13.8	6.0	13.4	20.6	10.8	8.5	3.3	6.5	27.4	8.7	25.5	14.5	7.7	16.1	18.7	18.7	13.9	5.9	17.3	19.0	14.8	51.2	8.8	10.7	19.2	13.0	5.2	22.2	26.1	48.1	25.4	19.9	13.5	20.2	18.3	17.4	23.8
ANKRD18A	"FLJ35740, KIAA2015"	ENSG00000180071	"Ankyrin repeat domain 18A"	Q8IVF6	9	38571358-38620660	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"bone marrow: 24.4;brain: 11.1;testis: 19.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 16.9;THP-1: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA046346: , HPA046695: , HPA049923: , HPA051288: "	"unprognostic (4.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.94e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.14e-1)"	0.5	0.7	1.4	0.8	9.1	24.4	1.1	0.4	4.1	1.0	2.1	8.5	2.4	0.9	0.7	1.1	1.4	1.2	2.7	1.1	3.0	2.2	1.5	1.2	1.5	0.8	4.8	2.3	0.4	4.1	2.5	3.2	0.7	8.7	1.6	1.5	0.4	0.9	3.9	0.4	2.4	1.5	0.7	11.1	0.5	2.0	19.1	6.9	0.0	3.8	0.0	0.5	0.7	0.8	0.4	0.0	1.1	0.0	0.1	1.7	0.1	4.6	3.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.0	0.0	0.9	3.5	3.3	0.0	0.0	4.8	0.0	4.8	2.8	0.0	16.9	0.4	0.0	2.3	0.0	3.1	0.0	1.6	0.4	0.3	4.3	0.1	0.8	3.7	2.1	0.0	6.4	6.4	2.1	1.9	1.5	3.0	2.3	0.5	0.1	2.5	8.0	4.4	0.0	1.3	0.1	0.0	0.3	0.5	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.5	0.0	0.7	0.0	1.3	0.8	0.0	0.4	0.7	1.7	0.5	0.1	0.0	0.0	1.0	0.1	1.4	9.1	0.4	4.1	3.0	2.2	4.8	2.3	8.7	6.9
ANKRD18B	bA255A11.3	ENSG00000230453	"Ankyrin repeat domain 18B"	A2A2Z9	9	33524394-33573009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.9;testis: 26.9"	"Cell line enhanced"	"Detected in many"		"NB-4: 20.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA046346: , HPA046695: , HPA049923: , HPA051288: "	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-2)"	"unprognostic (6.43e-5)"	"unprognostic (4.89e-2)"	"unprognostic (9.75e-4)"	"unprognostic (8.25e-2)"	"unprognostic (5.18e-2)"	1.5	0.9	4.3	0.1	0.4	0.2	1.3	12.9	3.9	0.3	0.2	0.2	0.1	0.0	0.5	1.0	2.1	1.0	0.9	0.3	2.1	1.3	0.1	0.4	0.7	0.1	1.0	1.4	0.1	0.1	0.1	1.6	1.3	2.6	2.0	0.3	0.2	0.2	0.1	1.4	5.5	0.2	0.1	1.0	0.9	0.0	26.9	0.1	0.1	0.9	1.6	0.7	1.2	1.1	0.5	0.8	0.1	0.2	0.0	0.8	0.1	7.4	8.4	0.7	0.2	0.3	1.4	0.7	1.6	1.7	2.1	2.3	1.5	0.2	0.2	0.4	0.2	1.7	4.5	1.6	2.8	0.1	4.5	8.1	9.8	3.1	0.0	2.7	0.6	1.1	4.5	2.9	7.5	3.8	4.4	2.1	2.6	1.2	0.2	20.5	7.2	3.7	0.0	10.3	1.5	1.2	1.8	0.2	7.2	3.4	0.3	0.5	5.9	10.0	3.8	1.7	7.5	3.4	2.9	1.2	0.8	0.1	0.8	0.1	1.2	0.0	0.1	0.1	0.3	0.1	0.7	0.4	0.2	0.6	0.0	0.5	0.4	0.8	0.1	0.0	0.2	0.8	0.1	0.1	4.3	0.4	12.9	3.9	2.1	1.3	1.0	1.4	2.6	0.1
ANKRD24	KIAA1981	ENSG00000089847	"Ankyrin repeat domain 24"	Q8TF21	19	4183354-4224814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.5;U-266/70: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	9	"B-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041534, HPA048498"	Uncertain		Uncertain	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA041534: , HPA048498: "	"unprognostic (3.70e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.23e-9)"	"unprognostic (7.03e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.31e-1)"	"prognostic favourable (9.13e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.73e-4)"	1.4	2.1	6.0	0.8	8.5	1.1	1.2	1.4	22.1	1.0	1.1	0.8	0.1	1.9	1.0	2.1	0.5	1.4	1.3	0.6	5.1	4.4	1.8	5.5	1.1	1.0	4.1	9.4	1.4	3.3	2.4	3.8	1.9	2.3	4.3	0.9	1.0	1.7	1.7	2.5	1.1	1.5	0.7	2.3	1.5	1.6	7.3	1.8	0.1	1.9	0.1	0.6	0.6	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	3.2	0.3	3.3	0.2	0.0	0.0	0.0	0.1	0.1	0.1	2.0	0.4	0.1	0.1	0.5	0.0	2.4	0.3	0.1	0.1	0.1	1.8	0.1	0.3	1.7	0.1	0.3	0.8	0.1	0.1	5.5	0.0	0.7	0.0	0.1	2.4	0.7	0.4	0.0	0.4	0.0	0.2	0.9	0.2	0.1	0.1	0.3	0.7	0.4	0.0	0.1	1.2	0.9	0.0	18.5	1.6	0.1	0.8	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	8.5	1.4	22.1	5.1	4.4	4.1	9.4	2.3	1.8
ANKRD27	"DKFZp434L0718, FLJ00040, VARP"	ENSG00000105186	"Ankyrin repeat domain 27"	Q96NW4	19	32597007-32676597	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042769	Approved		Approved	Cytosol				Cytosol		"HPA042769: AB_10796584"	"unprognostic (2.16e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (1.21e-5)"	"unprognostic (9.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-2)"	13.1	10.5	14.3	12.2	16.3	12.1	13.3	18.6	19.3	12.7	20.7	14.4	9.4	10.2	15.0	12.6	19.8	11.0	10.5	12.3	12.6	12.5	13.4	6.2	13.7	13.5	15.3	12.0	12.5	9.7	12.8	11.5	18.6	17.6	17.4	16.5	14.5	13.2	19.6	26.0	16.5	14.1	16.2	15.3	12.0	14.9	22.6	14.3	24.6	18.9	10.7	17.2	23.9	17.5	5.5	8.8	20.0	11.0	19.6	13.2	8.6	12.0	13.8	4.5	8.1	9.4	7.3	11.1	6.9	7.0	7.6	10.1	10.9	7.3	13.1	6.5	8.8	7.5	11.5	8.6	12.7	17.7	5.8	52.0	5.2	8.9	11.8	19.9	18.8	5.3	11.4	8.2	13.4	7.6	13.8	29.9	5.8	11.8	7.7	17.3	2.3	5.3	11.5	6.1	4.8	6.1	11.7	8.4	3.4	6.7	11.6	8.1	4.8	9.7	7.1	8.4	9.0	7.6	10.6	7.8	4.6	9.0	8.3	19.7	5.3	20.0	7.7	19.3	10.4	11.0	13.2	5.5	10.7	11.5	8.8	5.5	8.5	8.9	6.5	19.6	8.6	4.3	9.1	8.6	14.3	16.3	18.6	19.3	12.6	12.5	15.3	12.0	17.6	14.3
ANKRD34A	ANKRD34	ENSG00000272031	"Ankyrin repeat domain 34A"	Q69YU3	1	145959442-145964582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 18.1"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.4"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.5;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029642, HPA029643"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA029642: AB_10599277, HPA029643: AB_10601878"	"unprognostic (1.98e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.66e-8)"	"unprognostic (6.36e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.23e-2)"	0.8	1.3	6.4	2.0	10.5	0.3	0.6	7.8	18.1	0.9	0.7	1.2	0.0	1.6	1.5	1.2	0.9	0.7	1.1	1.7	4.2		0.5	0.2	0.7	1.4	0.4	6.7	1.6	0.5	2.0	1.2	0.5	5.7	1.7	0.4	1.3	0.8	2.2	2.3	0.8	1.6	1.6	0.0	1.4	1.1	0.5	1.0	0.0	0.6	0.0	1.5	0.9	0.0	1.5	0.4	0.6	0.3	0.3	3.5	1.0	1.4	0.7	0.7	2.4	3.5	2.7	0.3	2.7	5.1	0.6	1.7	0.2	0.8	2.7	0.3	3.4	0.6	1.1	0.8	0.4	5.8	1.7	0.2	2.1	0.0	0.5	0.3	2.3	2.4	0.3	2.2	2.5	0.9	1.3	6.3	4.0	2.5	1.1	0.8	0.3	3.0	0.3	0.6	12.4	1.1	0.1	3.4	2.5	0.5	0.1	1.6	3.6	0.4	0.8	6.2	4.2	5.3	1.3	4.4	8.4	0.4	6.1	2.2	0.4	0.0	0.1	0.6	3.5	0.3	2.6	1.5	1.7	1.9	0.4	1.4	2.3	3.4	0.3	0.3	0.0	0.1	1.7	1.0										
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 31.0"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 45.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enriched"	"Detected in many"	6	"basal ganglia: 31.0"	"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.1	0.3	0.9	1.5	31.0	5.7	0.3	0.0	0.9	0.5	0.1	0.4	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.0	4.1	2.8	0.1	0.2	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.4	1.0	0.1	1.0	5.1	0.0	0.1	0.0	4.6	0.1	0.0	0.0	0.0	7.2	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	45.8	0.0	0.1	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	0.9	31.0	0.0	0.9	1.0	4.1	1.2	0.2	0.7	5.1
ANKRD36	UNQ2430	ENSG00000135976	"Ankyrin repeat domain 36"	A6QL64	2	97113496-97264521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA051757: , HPA057661: "	"unprognostic (4.24e-3)"	"unprognostic (7.59e-2)"	"unprognostic (6.15e-3)"	"unprognostic (9.86e-2)"	"unprognostic (9.83e-3)"	"unprognostic (5.25e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.75e-1)"	5.1	3.3	8.8	6.0	14.5	22.0	6.8	20.5	10.2	5.6	4.6	4.8	2.2	3.0	8.5	7.7	2.4	6.0	3.8	3.9	7.6	3.3	3.2	1.8	5.0	5.0	4.0	11.3	8.9	5.1	5.3	9.2	2.3	6.8	4.8	5.2	4.7	4.3	3.1	2.2	5.9	4.3	4.7	3.7	5.9	5.1	13.3	8.2	5.6	5.4	2.1	3.7	4.0	4.9	9.9	11.7	9.3	3.3	4.9	9.2	1.7	6.3	1.6	5.3	3.3	1.2	2.7	2.4	2.5	1.7	1.9	2.0	1.6	3.3	8.2	1.7	2.3	3.2	1.9	2.2	1.6	3.9	2.9	6.2	7.0	3.0	0.5	4.5	2.7	1.8	1.4	1.4	2.5	3.5	4.2	14.3	0.9	1.1	5.7	5.9	1.2	2.9	5.5	2.2	2.3	1.5	3.1	3.7	2.7	2.6	1.5	0.8	1.6	2.6	5.3	5.5	5.4	6.3	2.9	8.4	3.6	6.7	3.2	6.5	1.8	9.3	2.6	3.5	9.2	1.2	9.1	9.9	8.4	7.3	1.2	9.9	8.6	9.2	3.9	4.9	3.3	11.7	7.0	1.7	8.8	14.5	20.5	10.2	7.6	3.3	4.0	11.3	6.8	8.2
ANKRD36B	"FLJ21281, KIAA1641"	ENSG00000196912	"Ankyrin repeat domain 36B"	Q8N2N9	2	97492663-97589965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA051757: , HPA057661: "	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.03e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.20e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.13e-6)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.71e-3)"	"unprognostic (6.98e-2)"	1.0	1.5	2.0	2.8	7.0	16.4	3.3	6.8	6.7	1.4	1.7	1.6	0.2	1.3	3.8	2.0	0.5	2.0	2.1	0.8	3.1		1.1	0.4	2.2	2.3	4.3	6.2	3.8	1.7	1.8	3.3	0.7	3.9	1.8	2.7	1.0	2.6	3.0	0.7	3.6	2.1	1.9	1.9	1.7	1.7	7.5	4.0	4.2	1.3	2.8	2.1	1.2	0.8	3.5	2.6	3.4	0.7	2.6	3.0	0.3	4.0	2.5	2.9	2.5	1.7	3.9	1.9	2.8	1.8	1.8	2.1	2.4	4.9	5.6	1.5	2.3	1.8	1.8	1.3	1.9	1.6	4.5	4.4	5.1	1.8	1.3	3.5	2.6	2.6	2.3	2.3	3.8	2.4	6.0	4.8	2.2	1.0	4.4	6.3	1.4	3.0	5.4	1.4	1.9	2.0	2.5	3.3	4.7	2.1	1.8	1.5	2.8	3.3	3.5	3.3	3.8	3.8	3.7	6.6	8.4	5.3	2.0	4.7	1.7	3.4	0.7	0.9	2.2	0.3	2.0	2.2	2.6	1.8	0.3	3.5	3.0	2.3	0.5	2.6	0.2	2.6	1.3	0.3										
ANKRD36C	DKFZp667P0924	ENSG00000174501	"Ankyrin repeat domain 36C"	Q5JPF3	2	95836919-95991831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.6"	"Cell line enhanced"	"Detected in many"		"PC-3: 25.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA051757: , HPA057661: "	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.35e-6)"	"unprognostic (9.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	2.2	1.0	4.2	1.8	4.1	13.2	5.3	8.0	5.8	3.1	3.1	0.5	2.8	0.7	3.2	1.9	1.8	2.6	4.0	1.5	3.3	1.8	1.2	0.8	2.0	2.7	1.6	1.7	5.6	3.1	1.2	3.9	0.9	3.1	1.6	2.1	2.1	9.2	1.5	0.9	2.9	2.6	1.5	1.9	2.4	4.5	10.1	1.1	2.8	1.6	2.4	4.0	2.5	2.2	11.1	19.6	18.1	2.0	7.2	12.5	0.7	6.6	1.3	2.7	1.9	1.8	4.9	1.0	1.6	1.1	2.1	2.7	1.5	1.5	6.6	2.1	1.1	1.5	2.4	1.2	2.6	3.7	3.3	2.7	3.2	1.9	0.4	7.8	2.0	1.4	0.9	1.6	0.8	3.5	2.5	8.4	2.3	0.9	5.9	2.9	0.6	25.4	3.2	2.0	2.6	1.0	1.3	2.5	2.2	1.0	1.7	1.1	0.8	1.9	3.8	2.6	2.8	2.0	1.9	3.2	2.6	7.1	0.7	5.4	1.0	18.1	2.0	1.5	12.5	0.3	8.1	9.2	10.0	8.1	1.4	11.1	8.7	8.5	0.1	7.2	0.5	19.6	8.3	0.7	4.2	4.1	8.0	5.8	3.3	1.8	1.6	1.7	3.1	1.1
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: "	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	7.7	8.9	11.0	3.9	15.2	3.3	10.9	9.9	20.9	17.2	7.5	6.0	5.4	4.8	4.9	4.1	35.8	8.0	4.8	13.6	12.0	9.6	6.4	14.2	12.4	3.0	12.3	5.8	14.8	13.5	1.7	11.7	10.7	16.8	24.1	7.0	8.4	35.4	21.9	22.1	7.3	4.9	5.0	16.1	4.6	5.2	8.7	14.2	1.5	14.2	18.6	12.2	14.3	22.8	7.7	4.2	10.2	3.9	3.2	8.1	3.0	6.6	1.0	0.7	3.8	5.2	3.3	3.6	3.1	2.3	2.3	5.0	1.6	1.9	3.2	1.3	5.6	2.5	3.6	4.0	2.9	9.0	1.0	2.2	3.4	4.8	2.2	2.0	4.9	0.6	4.3	2.1	3.0	2.8	3.3	5.4	6.2	1.7	1.7	8.0	1.1	5.3	0.5	1.0	8.7	2.8	0.5	5.3	9.5	2.1	2.1	9.2	1.9	1.3	3.7	4.9	3.9	2.8	3.5	10.2	2.9	1.4	14.0	1.5	5.7	0.4	3.8	10.2	5.5	3.5	4.7	7.6	4.3	8.1	2.6	7.7	3.3	4.7	2.0	3.2	3.9	4.2	5.1	3.0	11.0	15.2	9.9	20.9	12.0	9.6	12.3	5.8	16.8	14.2
ANKRD40	MGC15396	ENSG00000154945	"Ankyrin repeat domain 40"	Q6AI12	17	50693190-50707924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021668, HPA021759, HPA074884"	Uncertain		Approved	"Nucleoli fibrillar center,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoli fibrillar center, Cytosol"	"HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: "	"unprognostic (2.73e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (7.02e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	25.1	13.0	39.1	9.3	44.1	4.4	20.2	13.7	27.0	12.3	11.3	42.9	7.8	7.4	14.6	9.2	11.9	9.2	10.4	14.8	42.1	29.0	11.5	11.2	14.1	9.6	58.5	15.1	13.8	10.9	19.0	4.9	14.4	26.1	12.2	10.7	7.6	8.8	16.7	59.2	7.8	7.7	17.9	67.2	12.2	9.1	6.4	34.1	4.7	10.9	8.6	8.9	10.6	16.4	9.5	13.3	6.6	10.8	9.6	13.8	3.8	18.8	18.2	16.5	16.6	23.8	19.8	14.5	17.0	18.8	20.0	18.9	38.5	9.7	20.1	23.9	21.8	10.7	23.5	13.9	32.7	18.4	15.1	27.4	11.9	18.8	13.1	19.0	11.6	16.9	14.2	19.4	24.4	15.6	15.4	20.2	16.4	14.8	23.7	6.9	18.2	17.2	16.2	29.8	14.3	15.6	16.3	8.7	24.5	9.5	13.1	18.2	15.0	12.7	19.0	27.2	21.5	14.0	21.7	21.4	19.5	18.2	14.9	7.4	22.1	6.6	7.1	2.8	10.9	10.3	12.4	9.5	12.2	12.3	6.6	9.4	11.5	13.8	1.8	9.6	10.8	13.3	8.5	3.8	39.1	44.1	13.7	27.0	42.1	29.0	58.5	15.1	26.1	34.1
ANKRD42	"FLJ37874, PPP1R79, SARP"	ENSG00000137494	"Ankyrin repeat domain 42"	Q8N9B4	11	83193739-83260694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell line enhanced"	"Detected in all"		"U-2197: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039917	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039917: AB_10672894"	"unprognostic (6.59e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.90e-1)"	5.6	14.5	13.9	5.4	22.1	8.3	7.1	4.8	15.1	8.2	5.4	3.0	11.6	5.8	6.9	22.2	5.6	17.2	8.7	5.4	18.1	13.4	12.3	5.2	7.4	4.5	8.2	12.4	9.9	8.6	16.8	17.9	4.5	13.1	8.4	4.8	6.5	6.7	10.3	6.1	6.2	5.3	6.7	8.7	4.8	6.4	41.8	5.3	1.0	13.0	1.5	4.5	6.8	16.1	7.1	4.8	7.9	11.1	5.8	4.3	2.1	3.9	6.8	3.2	6.7	10.6	11.1	3.0	8.0	6.2	4.7	2.9	4.1	4.7	1.6	10.3	7.1	8.4	3.4	5.4	3.9	2.1	2.7	2.7	9.2	2.7	7.2	7.7	6.5	6.5	6.5	11.9	6.4	4.9	8.0	1.5	6.8	5.7	1.1	8.5	2.8	4.3	1.8	4.9	2.0	15.8	4.7	2.6	3.5	10.3	6.5	2.0	9.8	4.3	7.0	7.4	5.1	26.8	3.7	2.0	4.6	3.3	5.8	4.8	3.1	7.9	3.6	4.3	4.1	4.1	2.8	7.1	3.7	4.3	4.8	5.2	1.9	3.0	3.0	5.8	11.1	2.0	1.4	2.1	13.9	22.1	4.8	15.1	18.1	13.4	8.2	12.4	13.1	5.3
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.2;SH-SY5Y: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"				Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.0	0.9	2.0	0.1	4.2	3.8	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.7	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2
ANKRD46		ENSG00000186106	"Ankyrin repeat domain 46"	Q86W74	8	100509752-100559784	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013758	Approved		Approved	Cytosol				Cytosol		"HPA013758: AB_10962626"	"unprognostic (3.71e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.08e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-3)"	13.0	29.7	25.8	6.0	23.4	1.6	11.1	25.2	34.2	12.2	6.9	13.9	7.6	7.6	9.7	12.8	9.6	8.9	5.9	14.5	24.0	25.9	23.8	29.5	8.0	6.8	21.7	25.2	17.6	13.6	10.7	10.8	15.2	24.5	10.6	7.1	7.7	11.7	10.7	40.3	8.3	8.1	9.5	20.6	7.9	8.4	6.1	14.6	9.4	14.7	6.1	7.9	8.2	7.6	11.3	7.9	10.4	6.0	12.7	15.8	8.7	5.5	7.0	10.5	5.9	8.1	4.8	11.7	7.3	3.3	5.6	4.8	10.1	3.4	17.5	13.7	2.5	4.3	10.6	5.4	6.0	6.2	9.3	21.8	3.5	7.9	4.8	5.1	2.8	3.4	10.0	3.6	6.0	6.9	11.5	5.7	5.3	6.3	23.7	9.5	7.7	5.2	18.5	3.5	11.6	8.2	6.0	11.6	11.8	3.1	5.8	4.6	8.5	8.9	5.1	2.6	2.9	3.8	2.8	13.5	12.7	14.5	2.8	16.7	4.1	10.4	6.0	6.1	12.5	3.2	15.2	11.3	12.0	10.9	7.9	9.5	15.8	13.5	1.5	12.7	5.1	7.4	11.2	8.7	25.8	23.4	25.2	34.2	24.0	25.9	21.7	25.2	24.5	14.6
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664052-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 21.7;HUVEC TERT2: 21.6;TIME: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.4;monocytes: 3.8"					"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	10.1	4.8	6.6	8.2	6.8	4.7	7.6	4.0	8.3	17.1	10.0	4.3	8.7	3.7	17.5	7.4	11.4	5.9	10.2	7.3	6.2	6.5	9.8	6.9	13.4	5.4	5.5	6.5	9.0	5.2	12.5	3.9	17.1	6.2	19.1	6.9	6.7	7.7	7.9	3.2	12.9	7.9	14.2	4.8	7.1	8.2	16.8	4.8	15.4	9.2	5.8	4.4	16.5	10.9	0.1	2.4	0.5	3.8	0.4	0.1	0.4	2.2	4.2	12.0	5.5	9.6	6.1	1.2	5.8	5.0	3.0	1.9	1.8	3.0	0.0	1.8	8.3	2.1	7.9	4.5	5.4	0.0	1.7	1.9	5.5	1.8	6.9	3.1	2.5	6.2	6.2	4.8	21.7	21.6	3.4	4.1	5.7	5.1	3.9	1.1	2.5	6.3	3.2	3.7	0.5	3.8	9.4	3.5	4.3	4.0	2.6	4.7	2.7	2.7	54.4	6.5	5.0	3.2	5.0	3.0	0.0	0.8	2.9	1.3	7.4	0.0	1.5	0.5	0.0	3.8	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.4	2.3	0.9	0.0	0.4	6.6	6.8	4.0	8.3	6.2	6.5	5.5	6.5	6.2	4.8
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099678-56233359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7"	"Group enriched"	"Detected in some"	6	"HEL: 23.9;HMC-1: 12.4;NB-4: 15.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3"	"Group enriched"	"Detected in many"	67	"granulocytes: 13.1;T-cells: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA051049: , HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.9	0.5	3.3	1.3	20.0	1.4	0.5	0.5	6.7	0.3	0.5	1.5	0.0	0.5	0.3	0.2	0.6	0.6	0.8	0.4	4.3	7.8	1.1	5.7	0.6	6.1	2.3	3.5	0.5	0.3	0.2	0.5	1.4	9.9	0.3	0.7	0.7	2.1	0.3	0.3	0.9	2.4	0.5	4.1	3.0	0.7	16.7	1.8	0.0	0.4	0.0	3.8	1.0	0.3	0.0	0.0	13.1	0.2	0.0	14.3	2.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.1	0.9	0.0	1.1	12.4	0.0	0.0	0.0	0.0	3.0	1.9	0.8	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.3	12.6	0.2	13.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	14.3	0.5	1.2	0.0	0.0	0.0	0.6	2.1	3.3	20.0	0.5	6.7	4.3	7.8	2.3	3.5	9.9	1.8
ANKS1A	"ANKS1, KIAA0229"	ENSG00000064999	"Ankyrin repeat and sterile alpha motif domain containing 1A"	Q92625	6	34889265-35091413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036768, HPA036769"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036768: AB_10670923, HPA036769: AB_10672473"	"unprognostic (3.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.79e-3)"	"unprognostic (5.73e-2)"	"prognostic favourable (7.48e-4)"	"unprognostic (1.18e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"prognostic favourable (8.05e-5)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.80e-2)"	13.6	15.6	11.8	10.5	20.7	5.0	11.5	19.2	19.9	8.8	20.3	11.6	33.9	9.8	10.2	11.0	15.4	19.8	9.9	14.8	11.7	8.0	10.3	11.6	14.5	8.0	15.0	8.8	14.6	11.0	13.9	12.8	27.3	12.8	9.3	8.7	19.7	8.5	30.4	14.8	11.6	10.9	13.9	10.6	18.6	12.3	23.6	13.9	9.5	11.3	4.2	9.1	22.7	9.9	1.3	3.4	2.4	4.3	0.5	1.5	1.1	7.9	3.5	8.2	7.9	3.7	3.4	12.6	3.3	3.7	3.8	4.9	9.9	4.8	5.3	5.3	3.2	8.1	9.5	9.0	4.1	4.2	11.2	3.8	4.6	7.5	2.3	6.1	3.8	4.2	8.3	4.8	6.1	9.0	6.6	2.5	3.5	5.3	3.6	6.9	6.0	4.3	4.7	4.3	5.7	8.1	15.4	32.2	8.1	4.8	7.8	24.5	6.0	7.1	7.7	4.1	5.1	4.2	4.8	3.7	5.7	2.6	3.2	9.2	11.2	0.0	2.0	1.2	0.9	2.9	1.2	1.3	0.8	1.5	1.5	0.5	1.0	0.8	2.4	0.5	4.3	3.4	1.0	1.1	11.8	20.7	19.2	19.9	11.7	8.0	15.0	8.8	12.8	13.9
ANKS1B	"AIDA-1, ANKS2, cajalin-2, EB-1"	ENSG00000185046	"Ankyrin repeat and sterile alpha motif domain containing 1B"	Q7Z6G8	12	98726457-99984654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 66.2;skeletal muscle: 28.2"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;ASC TERT1: 7.0;SCLC-21H: 12.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA044628, HPA078230"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"HPA044628: , HPA078230: "	"unprognostic (5.50e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.97e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.75e-3)"	2.3	4.5	21.4	1.7	41.2	1.2	3.7	21.0	66.2	3.3	2.3	27.5	0.0	1.5	3.3	2.4	3.9	4.4	2.2	2.2	28.3	17.3	5.4	1.8	2.0	1.6	20.3	24.8	9.7	2.1	1.9	4.4	2.7	16.0	4.1	2.1	0.1	3.8	3.7	28.2	1.9	1.6	3.3	25.8	2.0	1.8	7.6	23.0	0.0	6.3	0.0	1.3	2.1	0.8	2.1	2.4	5.3	3.1	3.1	8.3	1.3	0.3	2.5	11.8	2.8	4.8	7.0	0.7	0.0	1.2	0.9	0.9	0.2	0.9	1.0	0.5	1.7	0.5	0.1	0.1	0.2	1.4	0.8	0.1	0.8	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.3	0.3	0.9	0.2	0.7	0.5	0.5	3.4	2.2	0.8	0.0	0.3	0.1	0.0	12.9	1.4	1.1	3.8	1.5	4.4	0.1	0.1	1.0	1.1	0.7	0.7	0.1	0.7	0.6	1.1	0.3	1.1	5.3	1.4	2.1	1.7	2.1	2.5	1.9	2.9	1.6	1.3	2.1	2.4	2.3	3.9	3.1	3.1	2.4	8.3	1.3	21.4	41.2	21.0	27.9	28.3	17.3	20.3	24.8	16.0	23.0
ANKS3	"FLJ32345, FLJ32767, KIAA1977"	ENSG00000168096	"Ankyrin repeat and sterile alpha motif domain containing 3"	Q6ZW76	16	4696510-4734378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041409, HPA041482"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041409: AB_10794375, HPA041482: AB_10795594"	"unprognostic (3.02e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-3)"	6.9	10.1	7.4	6.4	12.0	4.2	8.9	14.5	11.1	8.1	9.3	8.2	5.0	6.2	8.7	6.7	8.2	9.3	6.8	5.6	8.3	8.5	10.5	5.0	5.8	8.6	10.0	10.9	15.7	16.5	6.8	14.2	5.6	9.7	9.1	3.2	10.9	14.4	10.2	7.7	8.3	4.8	11.7	7.0	5.2	6.1	8.0	7.5	3.2	9.4	3.4	4.7	7.6	7.5	3.3	5.3	0.0	1.6	1.3	3.8	1.1	1.9	23.1	3.0	6.6	5.8	4.8	6.9	8.6	7.0	8.0	7.2	11.9	4.8	4.4	10.9	5.7	3.9	6.5	4.7	3.6	5.6	12.4	3.9	10.7	2.9	6.4	2.1	3.6	3.0	5.1	7.7	7.4	1.5	9.4	1.4	4.8	7.1	4.2	7.8	8.1	4.4	6.7	7.4	7.8	6.1	2.4	9.7	9.4	4.5	6.6	3.7	6.5	2.8	2.6	5.9	8.1	11.0	4.4	6.9	12.2	6.5	3.1	2.2	6.8	0.0	1.1	0.0	2.4	1.6	2.9	3.3	2.7	1.7	1.9	3.3	3.8	2.5	0.0	1.3	1.4	5.3	1.7	1.1	7.4	12.0	14.5	11.1	8.3	8.5	10.0	10.9	9.7	7.5
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233665-21253845	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 64.5;kidney: 16.2;liver: 15.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 5.3;Hep G2: 12.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 2.0"	HPA043523	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687"	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.1	0.1	0.1	4.3	0.2	0.0	0.1	0.9	0.1	0.1	26.9	0.0	0.0	9.3	0.1	1.5	0.1	0.1	9.2	0.1	0.1	0.1	16.2	15.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	7.6	0.0	0.1	0.0	0.5	0.1	64.5	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.6	2.0	0.4	1.1	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.1	0.0	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.5	0.4	0.4	0.3	0.3	0.2	0.5	0.3	0.2	0.1	0.8	0.4	0.4	2.0	1.1	0.2	0.6	0.3	0.1	0.1	0.2	0.9	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ANKS6	"ANKRD14, FLJ36928, NPHP16, SAMD6"	ENSG00000165138	"Ankyrin repeat and sterile alpha motif domain containing 6"	Q68DC2	9	98731329-98796965	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008355	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA008355: AB_2058277"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.31e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.94e-2)"	"prognostic favourable (3.44e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.68e-1)"	5.0	3.7	5.8	4.3	9.9	1.8	4.8	31.2	9.5	7.3	6.5	9.4	2.6	5.9	6.0	7.4	7.5	7.8	7.7	2.9	6.9	6.1	7.7	1.8	7.2	3.4	10.1	4.4	9.6	18.1	10.0	2.8	2.8	11.4	3.6	7.3	4.2	3.1	3.5	3.3	4.4	5.4	8.9	6.1	2.5	7.7	6.1	9.2	1.8	13.4	2.4	4.5	5.4	6.4	0.9	0.0	0.0	0.1	0.0	2.1	0.2	5.4	8.3	7.7	13.4	6.4	5.2	5.2	4.0	6.9	4.5	5.4	4.6	4.0	10.2	3.1	5.7	16.5	5.6	6.8	2.4	14.2	5.8	2.5	5.0	1.9	6.3	1.3	1.7	6.4	8.5	6.2	6.3	5.1	17.2	2.4	3.4	9.1	0.5	2.6	12.1	9.1	6.8	19.1	0.8	8.2	3.4	5.0	5.7	1.7	9.9	4.5	0.0	2.8	5.2	4.8	5.2	12.9	3.9	4.8	8.0	1.7	6.7	4.6	6.8	0.0	0.1	0.0	1.3	0.0	0.7	0.9	0.7	2.1	0.0	0.6	1.8	0.9	0.0	0.0	0.0	0.0	1.1	0.2	5.8	9.9	31.2	9.5	6.9	6.1	10.1	4.4	11.4	9.2
ANKZF1	"FLJ10415, ZNF744"	ENSG00000163516	"Ankyrin repeat and zinc finger domain containing 1"	Q9H8Y5	2	219229757-219236669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035208	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035208: AB_10602229"	"unprognostic (5.23e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.27e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.95e-3)"	"prognostic unfavourable (3.09e-5)"	"unprognostic (3.87e-2)"	"unprognostic (9.68e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavourable (2.01e-6)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-3)"	10.1	11.1	14.8	19.0	19.8	13.7	12.9	38.4	25.9	13.8	15.4	17.5	21.7	17.5	14.3	14.7	17.1	21.1	11.7	13.8	12.7	9.6	15.2	15.8	13.2	23.2	19.6	13.5	19.6	19.0	12.3	22.7	11.3	16.4	16.6	10.4	13.6	18.2	22.7	18.9	21.7	19.5	9.5	18.5	21.0	15.1	8.7	18.8	18.7	14.0	8.8	19.8	16.8	16.2	11.7	8.3	10.7	10.6	20.6	17.8	11.0	19.2	3.9	5.1	7.5	7.1	5.9	20.2	6.4	6.4	8.9	11.3	9.4	8.2	4.1	11.5	2.7	14.2	6.8	10.9	6.5	8.5	7.0	9.0	11.5	8.7	7.0	5.5	8.9	5.9	21.7	6.6	10.5	6.0	15.1	9.4	4.5	8.5	8.5	14.5	8.4	7.0	8.8	6.1	13.1	4.8	4.9	6.6	6.2	6.5	15.4	12.3	4.0	13.6	6.5	7.3	5.6	5.9	8.0	20.6	11.7	7.3	12.4	8.4	3.2	8.4	7.7	8.8	14.6	7.5	15.4	11.0	14.7	14.4	7.8	11.7	17.8	16.3	10.7	20.6	10.6	8.3	14.0	11.0	14.8	19.8	38.4	25.9	12.7	9.6	19.6	13.5	16.4	18.8
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45440404	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"			1500000	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavourable (7.56e-5)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	40.7	15.3	6.4	17.3	7.0	3.8	42.8	2.5	7.3	22.2	29.7	6.1	34.8	16.5	33.2	16.0	21.2	18.5	20.2	20.7	6.7	5.4	21.6	25.4	25.6	11.7	7.6	4.2	27.4	12.7	20.1	7.1	23.3	8.8	21.6	6.9	14.2	16.8	39.3	40.3	10.0	41.3	42.8	14.6	12.5	13.5	10.4	5.8	21.6	11.2	14.7	9.6	37.6	38.1	2.1	7.1	4.4	9.3	3.1	4.0	5.0	13.8	15.9	8.9	12.1	41.1	21.4	34.2	19.5	24.5	13.4	12.5	23.9	20.9	7.2	18.2	30.4	18.4	8.1	10.8	15.7	10.5	5.8	8.3	6.5	20.1	13.1	12.9	6.7	17.8	10.8	11.3	16.6	17.7	6.3	11.7	14.3	3.6	13.7	4.1	10.0	6.0	7.9	11.6	7.9	12.4	22.0	4.0	13.9	20.3	12.7	9.3	14.9	20.3	24.1	14.4	9.2	14.5	9.8	6.2	7.1	8.7	12.9	41.3	11.5	4.4	7.7	1.9	3.3	9.3	3.4	2.1	3.2	2.8	7.1	1.7	2.9	2.0	0.9	3.1	8.6	3.6	4.0	5.0	6.4	7.0	2.5	7.3	6.7	5.4	7.6	4.2	8.8	5.8
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			740000	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: , HPA067561: "	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	25.8	20.4	32.7	32.0	40.1	46.0	28.2	50.7	33.7	24.5	30.7	40.5	16.0	27.0	26.8	21.7	28.8	30.0	23.4	47.8	32.3	23.6	30.0	29.6	27.2	55.0	33.9	30.0	26.7	25.6	24.2	18.3	38.6	26.6	30.4	35.4	27.2	23.6	27.8	41.7	18.9	28.9	30.5	42.7	40.1	29.8	9.4	36.7	75.0	29.0	18.5	52.4	35.7	27.6	12.7	19.8	27.7	19.9	18.1	12.3	9.6	26.0	32.0	42.1	36.3	14.8	13.0	28.0	13.7	18.5	27.0	22.8	26.4	49.1	84.6	25.8	15.5	38.3	97.4	28.1	32.5	38.1	33.1	64.0	27.1	33.0	9.2	50.3	34.6	10.4	19.9	14.8	29.6	39.2	46.5	33.1	23.1	18.2	50.5	41.3	37.4	16.2	70.9	39.1	50.2	23.8	41.2	55.9	34.7	20.9	23.6	38.7	31.4	66.0	17.5	28.0	44.6	19.3	36.7	20.1	55.7	98.0	18.6	84.7	25.6	8.1	17.6	27.7	11.9	19.9	10.0	12.7	9.8	12.3	19.8	12.7	12.1	10.6	18.1	18.1	16.8	17.6	11.2	9.6	32.7	40.1	50.7	33.7	32.3	23.6	33.9	30.0	26.6	36.7
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983361-98015943	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			290000	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: , HPA067561: , HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	43.0	24.6	37.9	46.5	55.5	105.7	37.7	15.6	30.1	43.2	38.9	81.0	24.6	32.7	46.3	38.4	40.4	28.4	39.2	27.0	41.8	32.0	26.0	35.9	35.0	70.4	55.7	21.7	51.1	46.0	29.3	20.7	37.5	41.8	38.9	42.3	26.2	32.5	29.7	29.4	38.6	34.9	45.3	88.3	38.6	36.7	19.0	47.6	85.9	37.0	31.9	81.8	64.5	58.6	34.8	32.6	36.8	44.6	22.7	51.3	25.1	70.9	38.4	42.8	35.7	24.1	42.7	39.0	36.9	32.7	39.7	33.5	48.1	34.9	87.1	22.1	24.7	47.0	57.7	41.6	45.6	56.5	32.5	75.3	33.0	51.9	31.0	129.1	43.9	32.3	30.5	31.8	65.8	34.4	144.9	61.7	30.5	94.8	97.4	114.8	16.7	38.2	58.2	66.8	41.4	25.9	29.8	34.6	30.2	43.3	42.3	37.8	23.9	48.3	41.7	25.9	42.0	32.5	38.7	56.0	63.2	52.6	24.0	51.8	48.2	23.1	27.2	36.8	22.7	30.9	31.3	34.8	42.7	31.9	32.6	29.6	51.3	38.7	11.3	22.7	44.6	31.8	50.8	25.1	37.9	55.5	15.6	30.1	41.8	32.0	55.7	21.7	41.8	47.6
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472665-48473624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.3;REH: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: , HPA067561: "		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.1	0.9	0.3	0.0	0.2	0.1	0.2	0.2	0.6	0.0	0.5			0.0	0.6	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.7	0.0	0.2		1.1	0.1	0.0	0.2	0.5		0.3	0.2		0.4	0.3	0.2	0.0	0.1	0.2	0.2	0.5	0.2	0.9			0.8		0.0	0.4	0.1	0.1	0.1	0.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.4	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0										
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			18000	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: , HPA067561: "	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	11.5	18.3	31.2	21.0	30.9	38.4	10.6	50.3	20.6	14.3	11.3	18.3	13.5	12.9	16.5	21.0	12.8	12.8	11.9	19.8	22.9	25.9	18.6	16.8	13.3	38.4	26.5	19.5	19.1	6.9	20.1	14.7	12.3	21.2	14.2	10.9	20.1	9.2	20.9	25.5	12.5	14.5	25.2	32.7	20.3	9.9	6.0	17.8	52.2	18.1	13.6	34.7	20.6	12.1	24.5	8.2	20.7	10.5	14.6	27.0	15.7	33.7	21.9	45.7	22.7	3.6	5.3	17.4	18.2	10.3	17.6	16.9	16.1	24.0	61.6	16.2	10.4	11.8	25.7	11.3	25.3	70.5	15.6	42.7	27.2	23.2	3.4	85.6	21.7	4.3	1.8	16.4	15.2	13.0	40.8	36.5	16.1	35.1	34.9	22.3	46.1	10.0	37.2	25.4	32.4	12.5	13.6	15.0	25.8	38.0	6.1	10.7	16.5	43.8	13.4	9.0	25.5	9.3	36.4	47.2	47.3	60.4	10.3	61.9	16.4	20.7	10.5	16.3	18.0	7.3	27.0	24.5	24.2	19.7	8.2	17.0	17.4	21.6	7.2	14.6	8.8	5.7	25.7	15.7	31.2	30.9	50.3	20.6	22.9	25.9	26.5	19.5	21.2	17.8
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151757-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 432.6;tongue: 235.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		77000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: , HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favourable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favourable (4.57e-5)"	"prognostic unfavourable (6.19e-6)"	52.7	3.5	2.7	11.5	3.3	81.4	45.9	0.9	2.5	61.5	8.5	3.6	5.5	2.4	6.9	11.2	432.6	11.9	14.9	8.9	3.2	2.5	9.1	2.1	37.3	7.6	4.3	1.9	11.7	2.4	0.5	6.3	149.5	13.5	12.9	4.4	6.4	93.0	7.2	7.9	11.6	6.4	12.3	6.5	5.9	5.9	5.6	3.1	3.9	21.7	235.4	153.3	18.0	83.1	0.7	98.9	146.2	79.1	27.3	52.5	102.8	65.9	104.2	4.7	4.9	66.5	63.3	0.3	114.3	71.4	47.3	32.1	3.0	59.7	0.1	37.8	99.7	81.2	10.1	69.2	37.5	37.3	0.7	5.0	31.0	0.1	53.1	11.0	2.5	36.4	57.4	47.8	94.0	67.0	20.9	2.8	58.3	0.2	19.4	6.0	5.9	42.4	0.0	26.6	0.2	106.4	14.0	0.0	0.0	39.3	1.0	26.4	0.2	1.7	82.7	55.5	34.9	76.2	58.6	0.4	0.1	0.2	128.1	10.2	83.4	146.2	79.1	141.1	52.2	21.5	52.5	0.7	47.0	45.9	98.9	0.2	13.7	25.4	8.6	27.3	19.3	3.5	8.3	102.8	2.7	3.3	0.9	2.5	3.2	2.5	4.3	1.9	13.5	3.1
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol			530000	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favourable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	44.1	7.3	19.4	27.8	23.8	37.0	61.1	22.8	24.4	26.4	34.4	8.6	18.4	28.6	20.2	36.4	49.5	23.9	47.5	57.1	17.2	8.3	39.1	21.9	35.1	38.1	10.8	14.2	27.3	24.0	26.2	9.7	35.0	7.5	28.9	27.6	16.7	20.2	27.8	39.5	18.6	44.1	28.1	11.2	22.9	29.3	15.1	6.6	45.7	18.9	39.2	31.8	34.9	39.6	12.7	14.4	77.9	12.1	11.6	21.9	13.0	34.7	30.5	1.8	9.0	39.1	38.6	19.5	26.0	67.0	16.2	16.8	27.6	54.4	2.3	18.8	38.9	45.5	7.8	21.7	9.8	59.1	13.9	14.2	18.1	21.4	22.9	15.6	35.3	40.7	13.2	9.0	6.9	23.0	13.9	26.4	12.8	20.7	19.0	34.5	3.3	64.7	14.5	2.7	52.6	27.4	32.3	0.8	6.3	11.2	45.0	25.4	13.3	19.2	27.7	11.4	17.1	26.0	13.6	16.1	21.9	15.1	11.9	26.1	7.5	22.6	12.1	77.9	14.5	9.6	15.3	12.7	18.3	20.3	9.1	10.9	17.3	14.9	43.8	11.6	10.7	14.4	21.9	13.0	19.4	23.8	22.8	24.4	17.2	8.3	10.8	14.2	7.5	6.6
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"		16000000	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavourable (2.54e-5)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavourable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (6.59e-5)"	91.7	29.8	4.9	23.5	7.1	6.6	50.1	4.5	5.6	65.1	39.1	8.6	38.2	26.4	38.3	40.3	158.8	26.2	54.9	29.9	4.7	5.5	36.7	28.5	62.0	46.6	10.8	5.7	23.3	94.3	29.7	12.8	84.1	25.7	29.5	35.2	31.7	74.7	27.9	22.7	77.3	71.9	37.1	15.1	32.6	25.6	18.7	7.1	14.6	31.0	122.7	81.4	34.0	87.4	35.5	209.6	183.3	138.0	15.2	83.9	150.8	142.1	158.7	8.4	3.7	114.7	184.1	36.5	169.9	109.6	108.0	94.8	75.2	68.6	0.3	139.9	219.8	152.1	37.3	319.1	118.4	30.3	3.9	2.8	76.4	29.2	69.2	0.1	2.1	89.8	87.1	76.7	165.4	201.2	11.3	16.6	230.6	16.5	0.6	8.4	18.2	123.6	1.6	46.1	7.9	191.4	86.7	11.0	6.2	67.2	15.3	66.7	32.8	5.9	229.5	92.1	125.5	308.8	166.8	6.2	20.3	2.7	86.8	1.6	183.2	183.3	138.0	17.7	33.4	122.6	36.5	35.5	38.5	38.5	209.6	16.9	4.5	18.1	3.9	15.2	129.1	32.0	83.9	150.8	4.9	7.1	4.5	5.6	4.7	5.5	10.8	5.7	25.7	7.1
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039081-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 28.9;lymphoid tissue: 25.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 10.0;MOLT-4: 10.7;REH: 11.2;U-937: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: "	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavourable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	5.5	1.6	1.3	8.8	4.1	13.1	8.6	1.0	1.5	5.7	4.1	2.0	1.8	2.5	3.6	3.9	4.6	3.7	2.9	2.2	1.7	1.3	2.4	1.4	7.2	19.0	2.6	0.5	2.0	1.1	0.7	1.8	2.6	1.4	5.7	2.2	2.1	2.9	1.9	4.4	2.2	7.5	3.2	1.9	14.9	2.4	2.3	2.0	25.1	3.1	1.8	13.4	5.2	5.6	8.9	1.4	1.5	2.1	6.5	28.9	7.7	0.7	0.7	0.6	0.4	1.1	2.9	0.2	0.2	0.1	0.1	0.3	1.4	0.9	2.7	2.4	0.5	0.3	1.8	0.2	0.1	4.5	1.4	0.9	1.9	0.6	1.5	1.0	0.4	10.0	0.1	0.8	0.1	5.6	0.5	3.6	0.7	1.0	10.7	1.4	0.0	5.4	11.2	1.4	1.6	0.3	0.4	2.2	0.0	1.0	0.2	0.2	0.3	1.9	3.5	0.2	0.0	0.3	0.9	1.6	2.3	1.1	1.3	41.5	0.5	1.5	1.1	0.5	16.0	0.7	18.6	8.7	16.6	17.5	1.0	8.9	28.9	21.2	0.9	6.5	2.1	1.4	17.7	7.7	1.3	4.1	1.0	1.5	1.7	1.3	2.6	0.5	1.4	2.0
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551519-78610451	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 83.0"	"Cell line enhanced"	"Detected in many"		"A-431: 52.0;CACO-2: 53.3;CAPAN-2: 72.2;EFO-21: 44.2;hTERT-HME1: 73.6;RPTEC TERT1: 62.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	319	"neutrophil: 51.3"	"Lineage enriched"	"Detected in single"	319	"granulocytes: 51.3"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Enhanced	Cytosol			7400000	Cytosol		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favourable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	20.3	1.1	4.0	7.1	7.4	83.0	16.2	2.4	6.8	7.0	8.5	2.3	0.9	4.2	3.4	4.2	25.0	4.6	11.7	20.5	5.2	5.2	19.8	1.6	46.0	5.7	6.6	5.6	2.8	14.7	6.5	5.8	33.7	10.4	18.8	7.4	2.6	50.8	3.6	14.2	4.1	9.3	5.3	4.0	11.0	23.4	1.8	5.0	2.0	45.3	13.6	7.4	2.8	5.9	0.1	0.0	51.3	0.1	0.0	0.0	0.5	52.0	9.9	0.1	0.1	0.1	0.2	0.0	0.6	0.0	1.5	1.4	53.3	72.2	0.0	44.2	1.8	20.6	0.0	38.1	2.3	0.2	0.4	4.6	21.3	3.2	6.1	0.6	0.0	0.3	33.8	0.5	73.6	15.1	0.1	0.0	0.2	2.0	0.2	0.0	1.6	7.3	0.0	0.1	0.0	62.0	6.0	0.0	0.0	30.7	7.6	2.2	1.3	0.6	19.1	0.1	6.9	0.0	11.7	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	51.3	0.0	0.1	0.0	0.0	0.5	4.0	7.4	2.4	6.8	5.2	5.2	6.6	5.6	10.4	5.0
ANXA4	ANX4	ENSG00000196975	"Annexin A4"	P09525	2	69644425-69827100	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 212.1;pancreas: 160.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 67.4;Hep G2: 70.3;RPTEC TERT1: 98.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005076, HPA007393, CAB017560"	Enhanced		Approved	Cytosol			580000	Cytosol		"CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168"	"prognostic unfavourable (8.55e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (7.23e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (6.05e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.97e-2)"	18.7	5.9	4.2	12.2	4.3	4.1	9.7	1.3	3.0	16.9	32.7	5.3	12.9	43.2	22.8	11.5	16.1	11.9	212.1	6.8	4.3	3.1	36.2	30.9	19.2	5.9	5.1	2.4	12.3	160.1	5.8	3.3	50.9	11.8	18.1	14.9	10.3	11.7	11.4	6.9	12.9	85.7	12.3	6.5	7.2	16.9	5.6	3.6	4.0	24.7	12.9	8.3	11.0	13.2	17.6	21.3	27.6	23.7	3.6	10.3	8.9	10.7	39.0	0.5	4.8	30.0	25.9	1.8	10.4	15.7	4.2	6.1	5.8	19.4	3.5	67.4	16.9	16.6	3.7	16.7	4.5	9.9	3.1	5.3	3.5	70.3	21.3	1.8	6.9	15.4	16.6	5.8	14.1	11.0	0.3	3.2	11.7	9.7	2.7	3.4	0.9	5.4	2.9	1.0	4.3	98.6	15.6	0.8	3.6	11.5	16.0	15.7	5.3	24.3	15.9	7.9	3.8	10.5	5.8	1.3	1.4	0.1	12.3	9.2	5.3	27.6	14.8	11.9	10.3	17.4	7.8	17.6	5.3	7.7	21.3	15.9	0.9	5.8	2.0	3.6	23.7	6.4	5.9	8.9	4.2	4.3	1.3	3.0	4.3	3.1	5.1	2.4	11.8	3.6
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100712-151157882	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol			970000	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	78.3	38.2	22.2	44.7	38.3	28.6	109.1	22.0	70.0	37.4	50.2	13.3	34.1	12.5	52.2	34.2	27.0	39.5	39.0	53.0	28.7	37.8	22.1	54.7	33.7	66.7	38.6	30.0	54.9	27.6	8.2	41.4	47.4	62.5	39.3	24.0	36.7	19.7	60.7	85.4	16.6	30.7	82.8	16.8	41.4	31.3	16.8	7.2	44.6	25.5	34.7	50.1	53.0	51.4	36.4	22.4	15.0	15.3	47.0	58.1	50.1	0.3	3.8	24.3	35.9	104.9	47.9	6.6	48.9	58.1	36.8	51.2	12.9	1.9	3.3	17.2	62.3	0.0	18.8	23.0	37.4	13.2	6.7	1.9	7.7	24.1	35.3	11.9	11.9	59.4	0.1	31.3	5.1	46.8	2.6	45.6	86.7	11.7	21.8	18.3	6.8	10.9	14.3	75.1	3.6	5.4	0.0	1.4	6.3	5.1	34.7	21.0	59.4	22.5	41.0	34.6	10.5	2.5	12.7	25.5	34.7	0.5	18.8	55.6	5.5	13.8	15.3	15.0	58.1	10.3	38.6	35.0	43.4	52.6	22.4	36.4	30.4	36.9	3.3	47.0	4.6	5.5	34.8	50.1	22.2	38.3	22.0	70.0	28.7	37.8	38.6	30.0	62.5	7.2
ANXA7	ANX7	ENSG00000138279	"Annexin A7"	P20073	10	73375101-73414076	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004312, HPA064290"	Approved		Approved	Nucleoplasm,Cytosol			540000	Nucleoplasm	Cytosol	"CAB004312: AB_626681, HPA064290: "	"unprognostic (1.48e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.67e-1)"	"prognostic favourable (1.98e-4)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.06e-2)"	27.4	27.1	28.0	18.5	28.7	24.1	29.3	23.5	33.1	25.2	21.1	25.0	15.5	13.0	25.1	28.2	24.7	19.7	20.7	36.6	27.2	26.8	39.4	40.8	21.5	33.0	26.0	28.8	26.2	24.2	103.3	28.1	23.3	24.9	24.1	25.4	22.8	26.0	25.3	75.4	21.5	17.3	32.3	25.4	21.3	18.0	11.7	15.5	17.1	30.2	28.2	26.7	27.6	20.5	35.3	36.4	53.0	34.9	33.0	44.4	42.5	24.2	17.6	6.9	16.8	27.0	26.6	15.0	16.2	42.9	21.3	18.0	25.6	28.8	9.7	16.5	30.6	20.4	12.8	19.2	21.2	23.9	9.5	13.7	8.8	22.8	23.8	19.5	6.3	16.5	18.7	26.6	47.7	18.9	17.8	27.6	27.0	19.4	11.0	12.6	7.7	122.1	9.1	19.6	17.6	36.9	14.9	5.5	7.6	18.3	42.3	15.3	26.4	10.4	17.6	8.7	15.8	26.3	20.9	17.9	25.4	13.7	20.6	25.3	6.7	53.0	34.9	45.1	22.2	26.2	30.1	35.3	34.4	27.7	36.4	24.0	31.5	27.7	35.4	33.0	25.6	15.6	44.4	42.5	28.0	28.7	23.5	33.1	27.2	26.8	26.0	28.8	24.9	15.5
ANXA9	ANX31	ENSG00000143412	"Annexin A9"	O76027	1	150982017-150995634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 62.0;seminal vesicle: 78.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 12.0;CAPAN-2: 14.4;Hep G2: 14.5;MCF7: 19.3;T-47d: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028404, HPA028698"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA028404: AB_10599190, HPA028698: AB_10600227"	"unprognostic (4.06e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.93e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.97e-1)"	"prognostic favourable (8.74e-6)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.72e-2)"	2.4	1.1	1.2	0.9	1.2	0.3	2.6	1.3	2.5	2.3	0.9	0.6	62.0	1.4	6.0	11.6	10.7	2.3	12.5	1.9	1.4	1.0	12.1	15.8	1.2	0.5	1.8	0.8	1.8	32.0	9.9	1.2	0.7	1.3	4.1	0.0	1.2	2.5	78.1	0.9	18.9	1.2	0.9	3.2	1.0	1.3	3.6	0.6	1.3	10.4	9.1	21.1	4.5	4.4	0.5	3.8	2.5	3.1	0.1	0.8	0.8	3.9	0.9	1.4	1.4	0.0	0.0	4.1	0.3	0.2	0.0	0.0	12.0	14.4	0.1	0.8	0.0	2.4	0.0	0.2	0.0	1.2	1.4	2.0	1.4	14.5	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.9	4.4	0.0	19.3	0.1	1.0	0.3	0.2	0.9	0.2	4.7	0.0	5.6	2.1	1.2	0.8	9.9	0.5	48.0	1.2	1.5	0.3	0.4	0.2	0.2	1.3	4.0	6.2	2.1	1.3	1.1	0.0	3.1	1.8	0.1	1.8	0.8	0.5	0.3	0.5	3.8	0.1	0.8	0.2	2.5	0.1	0.4	0.0	0.0	0.8	1.2	1.2	1.3	0.9	1.4	1.0	1.8	0.8	1.3	0.6
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	18	"ASC diff: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	83.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.2	0.3	1.4	0.1	0.1	4.6	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3
AP000646.1		ENSG00000285509			11	121024125-121113108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"pancreas: 2.0;parathyroid gland: 2.5"	"Cell line enhanced"	"Detected in some"		"HEL: 4.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038593, HPA038594"	Uncertain		Uncertain	Cytosol				Cytosol		"HPA038593: AB_10669647, HPA038594: "																		0.0	0.0		0.2		0.0	0.0		0.8	0.6	0.1			0.0	0.5	0.0	0.2	0.0	0.5	0.6			0.8	0.2	0.5	0.0			0.8	2.0	2.5		0.4		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	1.7			0.0		0.0	0.5		0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.3	0.7	1.7	0.4	0.3	0.4	0.2	1.9	2.4	2.3	0.3	1.1	1.2	0.6	0.7	0.8	0.0	0.8	0.5	2.5	0.1	0.4	4.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	1.1	0.0	0.6	1.6	0.0	0.0	0.2	0.1	0.3	1.4	0.2	2.5	0.7	0.2	0.7	2.2	3.0	0.8	0.1	0.0	1.4	0.2	0.0	2.0	0.2	0.5	0.9	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
AP001273.2		ENSG00000284057			11	93741664-93812378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA040511, HPA046619"	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA040511: AB_10795369, HPA046619: "																		2.4	3.0	1.8	4.2	3.4	0.6	2.7	2.8	2.4	3.6	6.1	3.5	3.6	8.2	2.6	3.0	2.9	2.5	3.3	4.0	2.0		16.9	17.6	3.6	1.7	3.9	1.9	4.8	5.4	5.3	5.9	2.8	3.2	4.5	2.7	4.2	3.8	2.8	4.2	3.7	11.1	2.9	4.5	1.9	3.7	2.6	3.6	4.2	5.7	2.0	1.8	3.0	1.0	2.7	2.9	4.4	2.9	3.0	3.8	2.0	0.2	0.0	4.7	0.9	3.5	0.0	0.6	0.0	1.5	1.0	2.0	1.5	1.2	0.3	4.2	2.5	1.8	5.2	0.7	0.0	1.4	0.0	0.0	1.5	0.0	0.9	0.0	1.0	0.0	0.7	0.0	0.6	0.0	1.0	0.5	5.4	0.0	2.2	3.7	2.0	0.0	1.0	2.7	1.7	5.1	0.0	0.3	0.4	0.0	1.3	3.7	2.1	1.0	2.3	0.0	0.8	0.7	1.9	0.9	0.9	3.9	0.4	1.1	1.7	2.9	2.9	4.4	3.2	2.1	3.0	2.7	2.6	2.6	2.9	1.0	2.9	3.6	4.4	3.0	2.3	1.5	3.8	2.0										
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 beta 1 subunit"	Q10567	22	29327680-29423179	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Enhanced	"Golgi apparatus,Vesicles,Cytosol"			1000000	"Golgi apparatus, Vesicles"	Cytosol	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favourable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	22.2	25.8	28.0	32.3	35.2	29.9	17.2	37.3	43.1	17.2	23.9	26.5	23.9	32.1	14.8	18.4	46.4	17.7	22.0	16.6	24.4	30.4	24.2	25.8	21.2	37.2	29.4	24.1	12.7	28.4	48.2	31.1	32.3	31.9	27.3	21.8	24.1	29.5	31.2	31.3	34.0	28.7	19.3	22.4	33.0	24.9	23.4	16.7	25.2	21.6	25.5	37.4	25.6	21.0	12.2	16.9	3.1	17.3	4.0	5.8	11.6	26.9	15.4	16.0	17.0	12.3	9.0	20.0	19.0	21.2	23.4	22.4	23.5	11.1	14.9	12.6	21.6	24.3	22.9	32.0	14.9	19.1	33.4	24.7	20.0	13.3	13.7	35.2	34.2	12.9	11.9	22.3	18.0	32.4	16.9	18.2	15.4	29.5	14.8	11.7	12.4	17.5	28.4	17.6	39.6	16.5	61.4	25.4	18.0	23.5	27.6	11.8	22.4	16.1	27.9	27.0	16.7	15.4	19.8	19.8	10.3	27.3	19.2	15.3	15.7	0.0	15.5	3.1	5.8	17.3	5.8	10.1	3.9	4.9	16.9	12.2	3.2	3.2	1.7	4.0	17.3	5.2	5.2	11.6	28.0	35.2	37.3	43.1	24.4	30.4	29.4	24.1	31.9	16.7
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 gamma 1 subunit"	O43747	16	71729000-71809201	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol			150000	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: "	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favourable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	23.2	29.8	20.4	19.2	26.3	59.1	22.4	31.8	29.2	19.7	20.4	29.2	19.8	19.2	19.6	23.9	30.1	17.9	18.7	14.5	18.5	17.4	32.8	29.5	23.8	20.0	24.2	20.1	18.3	25.6	53.5	27.4	25.1	27.9	20.8	23.4	20.8	28.2	20.2	30.0	27.7	24.4	16.0	20.3	24.3	24.8	26.5	26.7	30.0	23.1	21.8	28.3	18.1	20.1	7.5	8.5	17.6	8.8	7.6	9.0	4.2	16.2	23.8	18.3	18.6	19.7	18.7	15.9	16.9	16.2	22.7	21.9	22.9	18.1	20.2	16.3	23.0	20.8	24.8	18.6	30.6	8.1	12.7	13.2	12.5	17.4	11.6	15.8	43.9	15.6	13.2	30.2	18.7	19.2	17.5	8.6	22.2	29.0	14.6	13.3	16.7	10.4	23.6	14.7	21.6	21.2	18.7	16.9	10.1	20.9	13.2	9.4	23.1	12.5	22.6	19.5	15.2	10.4	12.3	13.6	17.5	41.8	15.7	12.8	16.6	5.8	7.9	10.9	8.3	8.8	8.3	6.3	7.3	9.0	8.5	7.5	5.9	7.2	17.6	7.6	6.8	6.0	7.3	4.2	20.4	26.3	31.8	29.2	18.5	17.4	24.2	20.1	27.9	26.7
AP3B2	NAPTB	ENSG00000103723	"Adaptor related protein complex 3 beta 2 subunit"	Q13367	15	82659281-82709914	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8"	"Cell line enhanced"	"Detected in some"		"RT4: 11.5;SCLC-21H: 18.8;SH-SY5Y: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039467, HPA039818"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039467: AB_10795143, HPA039818: AB_10795299"	"unprognostic (3.17e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.48e-6)"	"unprognostic (8.44e-2)"	"unprognostic (7.62e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.43e-2)"	1.5	5.4	17.0	2.0	15.5	2.4	1.6	32.3	35.8	1.6	1.6	2.7	0.0	1.8	2.0	2.2	1.6	1.4	1.4	1.1	12.1	11.0	1.3	1.2	1.3	1.6	5.7	18.6	1.8	2.7	8.3	12.3	1.4	16.0	1.7	1.5	3.5	1.7	2.0	1.1	1.8	1.5	1.8	3.7	1.3	2.1	2.6	2.7	0.0	1.7	0.0	1.9	1.8	0.6	1.0	0.5	3.2	1.0	1.1	0.9	0.2	0.2	0.2	5.1	1.9	0.5	0.1	4.5	0.3	0.0	0.6	0.1	0.5	0.5	0.5	3.4	0.1	0.7	0.5	0.0	0.1	1.5	0.5	0.3	0.4	0.2	0.3	0.3	1.2	0.5	0.6	0.1	0.2	0.1	0.6	0.5	0.1	0.8	0.3	0.3	5.9	0.1	0.3	0.1	0.1	0.0	11.5	18.8	14.6	2.8	0.7	1.3	0.2	1.0	0.3	0.4	0.8	0.3	1.0	1.0	5.6	0.5	1.4	0.2	0.9	0.7	1.0	0.5	0.6	0.4	0.3	0.6	0.5	0.3	0.1	1.0	0.9	0.5	3.2	1.1	0.6	0.5	0.3	0.2	17.0	15.5	32.3	25.6	12.1	11.0	5.7	18.6	16.0	2.7
AP3D1	ADTD	ENSG00000065000	"Adaptor related protein complex 3 delta 1 subunit"	O14617	19	2100988-2164468	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA074408			Approved	Cytosol			10000	Cytosol		"HPA074408: "	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.35e-2)"	"prognostic unfavourable (9.23e-4)"	"unprognostic (4.24e-2)"	"unprognostic (8.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.37e-2)"	"prognostic favourable (2.61e-6)"	"unprognostic (8.11e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.73e-2)"	22.4	30.3	27.6	26.0	31.5	18.6	27.1	38.1	41.5	24.8	23.1	22.3	30.1	27.1	27.9	23.9	28.1	26.3	22.6	32.6	25.6	23.6	28.6	45.5	23.5	29.7	19.7	29.8	24.4	55.3	32.1	39.8	26.8	25.1	23.1	18.0	25.9	35.1	28.6	42.6	21.2	26.2	25.7	16.5	25.0	25.9	33.2	21.2	23.6	34.6	19.3	22.5	27.8	23.5	4.1	11.0	5.1	5.0	7.8	8.4	2.9	32.0	33.4	20.1	30.4	25.8	21.9	24.5	26.1	25.7	27.9	25.4	37.9	17.8	17.5	15.1	38.6	21.9	29.0	31.6	18.4	25.3	27.5	22.7	21.7	29.6	44.9	24.4	30.3	26.9	21.3	28.9	42.5	27.0	23.2	61.4	24.5	23.4	23.7	13.3	30.0	21.6	25.4	21.9	23.4	21.0	46.3	28.6	23.8	23.5	24.9	43.9	24.1	28.6	34.9	26.6	11.3	35.9	30.2	52.0	50.1	22.5	36.3	16.2	26.4	0.3	4.9	3.9	5.3	5.0	8.4	3.5	5.2	6.3	5.6	4.1	4.3	5.3	5.1	7.8	4.1	11.0	3.0	2.9	27.6	31.5	38.1	41.5	25.6	23.6	19.7	29.8	25.1	21.2
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 sigma 1 subunit"	Q9NUS5	20	3820524-3828837	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: , HPA048244: "	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favourable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	9.4	14.9	10.1	8.6	13.4	10.7	6.8	7.9	15.3	6.7	10.6	12.0	13.9	10.4	7.1	11.8	8.5	8.2	10.6	13.2	10.2	9.3	12.4	18.9	7.9	19.3	8.9	10.7	8.1	16.9	12.1	9.4	13.0	7.1	8.2	7.5	13.4	13.8	7.0	27.2	7.3	9.9	6.7	8.2	10.2	9.9	19.9	6.3	11.2	13.2	11.2	8.3	7.0	5.8	7.8	10.8	4.7	12.9	6.5	11.9	6.6	10.9	20.9	2.9	2.0	4.1	5.2	3.6	6.7	5.4	6.6	5.3	17.7	11.8	6.3	7.2	7.0	9.8	2.5	10.8	2.3	3.4	7.0	10.5	6.1	15.2	6.9	7.2	6.4	8.9	6.1	8.2	6.5	7.7	7.4	12.5	8.7	18.0	16.7	6.4	2.6	17.1	7.1	4.9	6.5	7.4	8.9	9.1	3.6	6.6	20.3	11.0	10.0	3.7	10.5	13.9	6.7	7.1	12.5	6.7	7.4	3.5	4.8	6.5	11.9	1.7	8.3	4.7	11.9	12.9	9.2	6.1	10.1	9.9	10.8	7.8	9.4	8.7	2.1	6.5	7.0	8.7	10.3	6.6	10.1	13.4	7.9	15.3	10.2	9.3	8.9	10.7	7.1	6.3
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645141-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favourable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	10.5	4.7	10.3	11.0	11.0	36.1	8.8	13.4	11.5	10.8	11.6	8.2	5.5	7.0	10.6	7.5	6.2	6.3	11.6	5.8	10.2	8.6	5.8	6.8	11.8	11.2	8.8	6.7	10.8	7.4	5.7	6.2	10.1	8.2	9.1	12.9	8.5	8.2	6.4	6.0	7.5	14.9	7.2	10.9	15.9	8.6	6.1	9.3	15.7	7.0	3.9	14.2	9.5	9.0	2.8	6.3	33.0	8.7	1.1	1.9	1.5	4.3	6.6	20.2	7.7	6.9	12.2	5.6	11.0	8.3	8.4	8.5	4.2	3.2	6.6	3.1	9.2	7.3	14.1	8.0	10.6	4.6	5.7	12.0	6.3	5.2	2.4	11.7	15.5	5.0	2.5	8.5	4.4	14.4	5.6	3.4	12.3	1.2	6.2	12.3	5.5	3.8	7.8	16.1	2.1	4.9	7.8	2.9	5.0	8.6	3.6	3.2	6.3	17.6	11.1	5.7	4.5	6.5	3.5	2.3	4.3	7.3	2.2	16.5	7.5	6.2	8.7	7.2	1.9	3.6	1.5	2.4	1.4	1.1	6.3	2.8	1.4	0.9	33.0	1.1	3.6	4.6	0.9	1.5	10.3	11.0	13.4	11.5	10.2	8.6	8.8	6.7	8.2	9.3
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438203-26567803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.2;lymphoid tissue: 100.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.2;MOLT-4: 21.6;REH: 48.6;U-698: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA017009: , HPA063903: "	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favourable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	18.3	3.9	7.9	27.7	14.2	25.8	10.1	1.2	7.3	2.6	3.9	16.6	0.0	4.5	2.0	1.5	2.9	4.9	7.5	4.8	7.3	4.9	4.8	25.4	11.1	28.2	14.5	3.2	1.5	3.0	1.3	2.7	5.5	11.1	2.5	4.5	1.6	4.0	1.6	1.5	2.8	12.0	4.7	21.9	41.5	5.4	1.3	12.1	100.5	3.0	0.7	26.2	8.0	3.9	11.0	14.8	54.2	10.3	5.3	9.5	3.5	0.0	0.4	0.0	0.0	3.4	5.6	2.9	9.4	1.8	5.4	5.2	0.0	0.0	25.2	0.1	6.2	0.0	0.0	0.0	7.5	0.0	0.0	18.2	0.0	0.0	0.0	3.4	0.0	8.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	21.6	4.8	0.0	0.0	48.6	0.0	17.8	1.5	0.0	0.0	0.0	0.8	0.1	0.0	0.0	11.9	0.0	0.0	0.1	1.7	0.0	4.4	0.0	51.7	4.4	17.8	0.0	19.0	7.1	16.1	9.5	6.9	7.7	9.5	8.1	7.9	4.4	11.0	9.3	9.0	54.2	5.3	10.3	14.8	7.6	3.5	7.9	14.2	1.2	7.3	7.3	4.9	14.5	3.2	11.1	12.1
APBB3	FE65L2	ENSG00000113108	"Amyloid beta precursor protein binding family B member 3"	O95704	5	140558268-140564781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005571, HPA076196"	Approved		Supported	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA005571: AB_1844912, HPA076196: "	"unprognostic (7.63e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.98e-1)"	"prognostic favourable (6.79e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.06e-6)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.67e-2)"	4.2	5.6	7.5	4.3	9.2	3.3	3.4	26.6	23.8	4.5	4.3	8.2	5.7	2.0	4.7	6.3	4.2	6.0	7.8	8.2	9.7	13.1	3.3	3.4	3.2	2.6	7.9	7.3	4.3	3.5	8.2	11.0	5.7	10.9	5.9	3.6	8.7	8.8	7.4	2.5	3.4	2.8	4.1	4.2	4.7	4.4	11.8	5.5	2.0	6.7	3.3	3.4	3.8	2.3	1.4	1.8	7.7	3.6	0.7	1.4	1.1	0.6	0.7	0.5	2.9	0.0	1.2	5.7	1.4	1.7	2.1	3.9	1.9	1.7	2.4	3.3	2.5	1.1	0.0	2.2	0.6	2.3	1.2	0.8	5.2	0.1	3.5	0.8	1.0	7.6	0.9	1.8	1.4	1.5	0.4	6.5	2.2	1.4	0.3	1.8	1.2	3.6	0.4	0.7	1.4	1.8	1.5	9.0	4.4	3.8	1.3	5.1	4.0	3.9	1.1	0.4	1.0	0.0	0.2	2.5	1.9	0.3	0.9	0.6	0.8	7.7	1.4	0.0	1.4	3.6	0.9	0.5	1.0	1.3	1.0	1.4	0.6	1.3	3.3	0.7	0.6	1.8	1.0	1.1	7.5	9.2	26.6	17.4	9.7	13.1	7.9	7.3	10.9	5.5
APC2	APCL	ENSG00000115266	"APC2, WNT signaling pathway regulator"	O95996	19	1446302-1473244	"Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 59.4"	"Cell line enhanced"	"Detected in some"		"AF22: 6.3;SCLC-21H: 7.6;SH-SY5Y: 25.9"	"Cancer enriched"	"Detected in some"	27	"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078002			Supported	"Cytokinetic bridge,Midbody,Cytosol"				"Cytokinetic bridge, Midbody"	Cytosol	"HPA078002: "	"unprognostic (1.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.88e-5)"	"unprognostic (3.64e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.49e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.98e-3)"	1.5	4.7	17.3	1.4	16.4	1.5	1.3	21.7	59.4	1.4	1.6	20.7	0.0	2.1	1.4	1.4	1.4	1.5	1.6	1.4	16.8	13.9	1.3	1.3	1.4	1.4	15.0	14.0	1.3	2.0	1.3	3.0	1.4	17.1	1.4	1.4	0.8	1.7	1.4	1.6	1.4	1.8	1.5	13.9	1.4	1.4	1.8	14.5	0.0	1.5	0.0	1.3	1.6	0.0	1.1	0.2	0.4	0.0	0.0	0.1	0.1	0.2	0.5	6.3	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0.0	0.7	0.0	0.0	7.6	25.9	0.9	0.0	0.4	0.1	0.0	0.0	0.5	0.5	0.2	0.2	1.9	0.4	0.3	0.7	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	17.3	16.4	21.7	21.3	16.8	13.9	15.0	14.0	17.1	14.5
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674002-49683963	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol			1600000	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favourable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	12.3	31.4	14.3	16.9	18.4	17.3	13.5	14.2	28.2	13.4	23.5	14.4	25.3	24.2	14.1	19.0	23.8	17.2	19.1	23.1	14.2	14.2	33.6	36.9	15.0	23.9	13.9	20.0	13.9	22.7	33.5	26.6	18.6	16.3	16.1	26.6	19.5	19.8	19.8	55.1	16.9	21.7	14.1	9.8	19.2	21.9	22.3	11.7	22.6	26.6	26.6	20.7	19.9	13.7	20.5	26.2	30.4	27.9	21.8	29.5	28.1	25.4	20.8	22.8	29.6	19.9	13.4	30.2	16.6	21.4	23.4	25.1	33.4	27.6	32.6	18.7	18.9	23.6	25.4	38.5	17.8	15.5	10.5	35.1	34.7	27.3	19.8	37.6	54.7	15.2	29.2	13.4	27.8	21.1	21.7	16.2	23.2	23.5	26.5	19.1	13.5	19.0	10.1	19.6	42.3	46.3	60.4	10.9	18.9	18.8	45.7	20.7	30.1	20.1	9.6	14.5	25.4	22.6	22.4	18.6	13.2	19.4	25.0	26.6	20.8	30.2	25.5	30.4	28.5	27.9	22.5	20.5	23.5	26.7	26.2	17.4	24.9	24.2	8.0	21.8	26.7	21.0	29.5	28.1	14.3	18.4	14.2	28.2	14.2	14.2	13.9	20.0	16.3	11.7
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916499	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol			77000	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	23.2	29.8	12.0	13.7	18.7	9.6	15.8	7.6	12.6	12.7	13.8	17.9	16.8	10.5	15.3	10.8	12.2	13.9	12.1	15.4	14.5	11.7	24.8	21.8	16.2	14.4	21.5	11.7	13.2	19.7	13.4	10.3	12.5	21.1	14.1	12.6	10.4	18.5	20.4	48.7	6.8	13.9	16.0	27.8	13.9	19.1	9.7	21.1	23.9	19.0	12.9	11.5	19.0	16.1	14.2	25.6	14.9	19.8	17.5	15.8	10.6	8.5	9.1	10.9	2.5	8.9	8.8	4.9	12.6	12.2	12.4	14.2	5.4	7.5	26.2	7.7	4.6	10.2	19.8	8.5	16.1	16.1	18.8	13.5	9.7	13.7	13.7	37.4	10.4	8.6	6.3	7.9	13.0	10.2	31.7	16.1	8.6	8.2	17.9	17.3	8.6	21.7	11.5	31.8	8.9	12.8	12.3	9.2	4.4	15.8	12.7	15.5	13.3	11.6	8.5	9.4	9.4	24.0	3.0	15.8	11.9	29.5	11.7	8.0	11.9	4.7	16.9	14.9	11.0	17.5	13.6	14.2	13.4	11.9	25.6	13.4	13.8	11.7	4.1	17.5	19.8	16.5	15.8	10.6	12.0	18.7	7.6	12.6	14.5	11.7	21.5	11.7	21.1	21.1
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837950	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 573.5"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 247.4"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;T-cells: 2.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	2185000000000	220000000000	Vesicles	Cytosol	"CAB016778: , HPA046715: "	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favourable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	24.6	0.2	0.2	55.6	0.2	0.3	0.2	0.1	0.3	1.3	0.2	0.0	0.2	573.5	0.2	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	127.9	0.2	0.2	0.4	0.3	11.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.5	3.6	0.0	0.7	0.7	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	13.8	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	247.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	1.2	1.5	0.0	0.2	0.4	1.7	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	2.4	0.7	0.3	0.0	0.2	1.8	0.8	0.5	0.8	1.7	0.0	0.7	0.0	3.6	2.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	145	"intestine: 224.8;liver: 442.2"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 151.8"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	1290000000000	89000000000	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: "	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	0.3	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.1	0.1	68.9	0.0	0.0	24.9	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.1	442.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	224.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.9	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
APOBEC3F	"ARP8, BK150C2.4.MRNA, KA6"	ENSG00000128394	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3F"	Q8IUX4	22	39040604-39053910	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA073637			Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA073637: "	"unprognostic (1.38e-3)"	"unprognostic (1.28e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (8.28e-4)"	6.9	9.0	1.9	7.9	2.3	2.5	3.1	0.7	2.0	9.6	5.4	3.9	14.5	3.1	8.2	5.6	5.6	8.1	3.1	6.7	2.4	1.7	5.9	4.5	5.4	13.1	1.8	1.2	14.1	5.5	3.9	4.9	1.7	2.6	6.4	2.4	6.6	6.4	16.3	3.2	1.6	5.0	3.9	3.6	14.3	4.3	11.9	1.9	7.3	4.2	2.5	15.9	5.4	4.5	23.2	4.3	5.9	9.1	9.3	6.9	4.7	4.4	3.5	1.4	5.4	4.0	6.0	1.9	3.3	6.2	8.0	12.7	3.0	7.9	10.5	3.5	7.0	5.6	1.3	5.3	3.1	9.8	4.4	14.1	0.0	1.5	8.0	1.5	5.9	7.9	2.3	4.1	1.4	7.3	1.0	17.4	3.9	3.1	3.1	1.9	0.6	0.5	5.3	0.5	2.3	6.6	5.8	0.7	1.1	4.1	1.0	2.2	4.2	1.2	1.9	1.7	4.6	0.2	1.5	3.0	1.5	0.5	4.8	1.4	2.6	1.4	3.3	5.9	6.1	6.6	6.9	16.4	4.0	6.2	4.3	23.2	2.5	3.9	1.5	9.3	9.1	3.7	5.4	4.7	1.9	2.3	0.7	2.0	2.4	1.7	1.8	1.2	2.6	1.9
APOBEC3G	"bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019"	ENSG00000239713	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3G"	Q9HC16	22	39077005-39087743	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 64.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 14.6;Daudi: 19.7;HDLM-2: 16.4;Karpas-707: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001812, HPA073637"	Enhanced		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA001812: AB_1078175, HPA073637: "	"prognostic favourable (4.78e-4)"	"prognostic favourable (4.70e-4)"	"unprognostic (8.18e-3)"	"prognostic favourable (6.03e-5)"	"unprognostic (2.37e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.13e-3)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (8.66e-13)"	"unprognostic (3.41e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.91e-2)"	"prognostic favourable (6.30e-4)"	6.0	6.1	1.9	8.0	2.2	4.8	3.8	1.4	1.8	6.4	4.2	2.8	8.0	1.7	6.1	4.3	3.7	8.8	7.2	4.6	2.4	1.7	4.1	4.1	5.1	16.0	2.5	1.3	12.4	0.9	2.0	3.4	3.4	2.5	5.0	3.3	4.8	3.8	28.0	3.3	1.2	5.6	3.6	3.1	18.9	3.5	15.6	1.4	6.5	3.8	2.6	15.2	7.4	6.0	16.1	8.6	5.9	17.5	35.5	64.4	39.1	1.9	0.0	0.0	0.0	2.4	4.8	0.1	0.4	8.1	9.4	14.6	0.7	11.7	19.7	0.2	3.3	0.0	0.1	0.6	2.8	16.4	0.0	10.1	0.0	0.1	10.9	3.3	4.8	7.3	0.2	5.1	1.1	1.3	0.9	22.6	1.4	0.0	3.7	3.4	0.3	0.7	7.6	0.0	12.5	0.0	8.7	0.0	0.0	0.2	0.0	1.0	0.0	6.4	0.0	1.4	0.1	0.0	0.0	0.0	1.8	0.2	1.7	3.0	2.5	4.0	6.8	4.5	64.4	15.1	37.7	16.1	20.2	49.8	8.6	11.6	6.9	30.3	5.9	35.5	17.5	5.5	15.8	39.1	1.9	2.2	1.4	1.8	2.4	1.7	2.5	1.3	2.5	1.4
APOL2	APOL-II	ENSG00000128335	"Apolipoprotein L2"	Q9BQE5	22	36226203-36239954	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA001078	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			10000000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA001078: AB_10602432"	"unprognostic (4.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.26e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.22e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.66e-2)"	"prognostic favourable (5.06e-6)"	21.5	14.2	17.4	25.3	12.0	6.9	20.3	26.5	30.1	16.7	15.6	11.1	11.1	25.0	20.3	17.9	10.2	15.3	25.6	17.3	15.1	19.3	18.2	39.7	23.6	22.0	20.2	11.9	12.6	10.1	11.2	57.1	14.6	28.7	19.0	16.1	15.9	15.2	18.8	16.5	9.6	21.7	22.2	16.2	26.2	22.7	7.2	12.0	14.9	23.0	12.7	17.0	25.8	19.4	6.2	6.0	43.0	17.0	9.9	15.5	4.6	7.4	5.5	5.4	4.1	21.2	16.5	10.3	10.1	23.7	27.6	37.5	2.2	6.1	9.0	17.2	18.2	3.5	5.9	8.1	13.7	30.4	6.7	4.2	11.7	10.4	35.8	9.0	8.2	20.8	5.5	19.3	5.1	17.9	7.5	25.6	17.2	2.7	9.1	4.0	2.0	5.1	9.4	7.0	5.3	27.8	19.7	9.8	2.8	6.9	13.2	5.4	4.1	1.3	17.3	16.7	8.3	3.4	5.6	15.5	7.7	2.8	14.4	4.7	6.3	8.9	8.6	5.8	15.5	17.0	14.1	6.2	11.2	12.7	6.0	4.1	6.5	10.9	43.0	9.9	11.4	3.7	10.5	4.6	17.4	12.0	26.5	30.1	15.1	19.3	20.2	11.9	28.7	12.0
APOL6	"APOL-VI, APOLVI"	ENSG00000221963	"Apolipoprotein L6"	Q9BWW8	22	35648395-35668409	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB028574, HPA029165, HPA029167"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832"	"unprognostic (7.25e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.76e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"prognostic favourable (6.61e-4)"	40.6	9.2	4.8	18.8	5.5	10.1	32.3	1.9	4.2	7.4	17.9	4.1	5.0	14.0	8.8	9.5	9.8	5.9	12.5	9.3	4.0	4.3	15.4	36.9	15.8	17.0	4.6	2.2	17.0	4.7	3.7	5.1	8.9	5.9	11.7	8.9	6.4	10.1	5.6	7.4	3.6	36.6	6.4	7.6	19.5	10.1	2.5	4.5	12.7	24.8	7.7	13.4	8.5	14.1	1.2	2.8	9.2	9.0	5.9	9.1	4.2	7.0	2.3	0.2	0.8	17.9	9.0	10.0	3.0	8.1	10.1	12.7	1.1	8.1	9.9	1.5	7.9	9.3	0.0	4.9	2.6	18.6	0.1	4.2	1.5	2.2	14.1	5.7	7.3	11.4	3.3	3.4	1.9	2.0	0.4	18.0	1.8	0.7	8.0	1.8	0.3	3.0	3.4	3.9	4.8	4.4	16.3	0.2	0.1	4.8	4.2	5.6	0.7	6.7	2.2	2.5	1.5	1.7	1.6	9.6	7.6	0.9	4.8	9.1	3.5	6.4	5.6	2.9	9.1	8.9	7.7	1.2	6.1	7.2	2.8	1.0	6.0	6.7	9.2	5.9	9.0	0.3	6.3	4.2	4.8	5.5	1.9	4.2	4.0	4.3	4.6	2.2	5.9	4.5
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 109.5"	"Cell line enhanced"	"Detected in many"		"AF22: 26.1;HDLM-2: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 5.8;olfactory region: 24.7"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA052462: , HPA058882: "	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	109.5	8.8	11.2	9.2	17.7	0.6	34.4	9.8	17.5	25.5	9.0	7.7	2.9	2.5	7.1	7.0	18.8	14.0	18.7	22.3	13.0	11.8	7.4	9.3	7.1	3.4	16.6	3.3	10.0	12.8	17.2	4.7	44.8	16.7	7.2	7.1	8.1	4.4	3.7	16.6	7.4	6.0	28.0	13.9	4.7	5.3	5.4	12.4	5.7	34.4	9.9	3.3	10.9	7.1	2.3	1.7	4.8	0.9	0.8	2.7	0.3	4.3	0.1	26.1	0.8	0.8	1.5	0.2	4.2	6.9	4.3	6.3	1.7	4.6	1.3	0.4	1.6	1.4	1.0	0.2	7.3	13.2	1.0	0.4	1.3	0.0	1.6	0.6	0.4	1.0	1.2	1.5	3.3	3.2	0.4	1.8	2.2	0.8	0.7	0.7	0.1	0.8	2.0	0.5	0.6	0.5	0.4	2.3	2.4	4.0	0.4	9.5	0.1	2.1	3.9	1.0	1.4	5.8	3.8	1.3	0.6	1.0	1.4	2.8	4.8	4.8	0.9	0.7	0.9	0.4	1.1	2.2	2.0	1.3	0.6	2.3	1.6	1.0	4.4	0.8	0.6	1.7	2.7	0.3	11.2	17.7	9.8	17.5	13.0	11.8	16.6	3.3	16.7	12.4
APOO	"FAM121B, MGC4825, Mic23, MIC26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907934	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"			Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favourable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favourable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	5.6	13.1	25.5	5.4	21.2	4.4	9.0	18.5	30.9	9.1	10.9	8.5	5.5	9.2	7.2	13.5	7.2	13.6	6.1	38.4	26.0	23.8	29.5	12.2	5.5	6.6	24.9	17.5	7.1	9.0	20.1	15.8	7.1	21.5	9.3	12.5	11.7	14.6	10.4	26.0	4.3	7.6	7.8	18.1	5.4	10.3	10.5	6.8	7.7	13.3	10.4	7.2	6.3	5.8	9.8	14.2	8.5	13.3	7.8	15.0	6.6	14.6	13.4	22.6	15.7	3.8	8.6	3.6	7.4	9.1	15.7	16.5	7.9	7.0	12.7	9.3	6.7	12.1	28.3	14.6	17.5	13.4	20.2	6.4	13.3	12.5	9.0	16.2	7.2	9.6	8.8	17.3	12.9	10.9	9.1	14.4	14.5	13.8	16.2	17.4	20.5	21.7	12.6	11.2	30.5	30.7	7.6	15.3	11.1	16.0	15.3	15.7	26.4	7.2	2.7	10.2	6.1	36.2	11.2	11.2	19.7	11.5	16.4	8.0	14.8	8.5	4.2	1.5	11.5	13.3	15.0	9.8	12.7	11.3	12.0	8.3	10.3	10.1	2.5	7.8	12.6	14.2	11.5	6.6	25.5	21.2	18.5	30.9	26.0	23.8	24.9	17.5	21.5	6.8
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811944	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Supported	Nucleoplasm,Cytosol			1200000	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	22.9	37.1	10.9	33.6	13.2	32.9	31.6	10.1	15.3	22.7	31.1	10.7	33.6	27.1	19.9	28.3	50.7	21.0	30.4	22.5	9.1	8.2	27.7	60.4	30.6	94.2	14.8	10.7	17.9	58.2	19.4	15.6	19.3	11.0	25.1	15.1	13.9	48.2	37.4	26.2	49.8	24.3	18.4	12.1	30.4	27.5	16.0	12.2	37.9	29.5	49.7	35.8	18.5	32.8	65.4	92.1	24.2	70.2	58.2	83.7	104.7	25.4	37.4	7.3	33.0	9.0	17.9	39.1	19.3	17.2	22.8	8.9	38.5	30.9	23.7	37.8	10.9	27.3	12.0	31.7	4.6	16.7	71.6	20.2	17.7	40.2	28.6	13.8	16.5	19.1	34.3	18.1	23.0	28.4	42.4	17.8	11.5	93.8	39.0	40.8	28.2	49.0	42.0	11.4	56.1	25.1	17.3	36.5	22.4	36.8	21.5	20.8	71.0	27.5	18.3	20.6	18.0	16.6	18.9	35.0	29.3	65.2	30.3	36.8	18.1	8.5	70.2	24.2	63.0	57.7	83.7	63.2	81.9	67.5	71.6	65.4	75.9	64.3	4.3	58.2	37.1	92.1	66.1	104.7	10.9	13.2	10.1	15.3	9.1	8.2	14.8	10.7	11.0	12.2
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"			39000	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: "	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favourable (6.41e-4)"	"unprognostic (7.56e-3)"	19.2	29.6	28.8	32.9	29.1	51.1	17.9	34.0	37.5	19.6	16.8	26.6	20.0	17.4	23.7	20.0	21.1	30.3	26.1	20.3	27.7	14.4	20.9	16.6	35.5	27.8	27.5	17.8	28.8	18.9	14.3	31.0	20.9	23.0	21.3	11.2	18.1	19.9	19.0	12.9	27.5	23.6	17.1	25.6	53.8	16.2	23.5	32.3	18.8	24.7	14.0	18.6	28.4	19.6	3.3	7.4	24.0	22.5	6.1	4.4	6.4	7.1	15.1	5.8	7.0	24.8	16.8	8.7	9.8	17.7	11.2	11.1	20.7	19.0	15.8	19.8	16.5	24.1	8.8	23.4	4.8	18.6	10.3	13.4	14.3	28.5	17.2	9.1	37.7	17.9	24.9	18.3	8.8	11.8	11.2	6.4	5.2	14.7	13.8	31.8	3.6	9.8	13.5	8.8	7.7	10.4	22.8	6.0	12.3	7.1	10.6	31.6	9.3	20.8	14.0	15.9	11.0	16.1	6.0	10.3	5.0	8.3	8.4	13.7	8.4	7.5	11.0	13.3	4.4	18.7	2.6	3.3	2.9	3.3	7.4	2.6	2.3	2.7	24.0	6.1	22.5	2.5	3.1	6.4	28.8	29.1	34.0	37.5	27.7	14.4	27.5	17.8	23.0	32.3
ARF1		ENSG00000143761	"ADP ribosylation factor 1"	P84077	1	228082660-228099212	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB007742	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB007742: AB_562043"	"unprognostic (9.54e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.73e-1)"	"unprognostic (8.95e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.94e-1)"	72.0	70.1	64.8	51.0	82.5	111.1	59.3	50.0	116.9	76.0	76.7	53.5	63.6	73.6	71.1	63.3	81.1	66.8	58.5	101.1	70.3	65.9	81.7	135.9	77.4	55.6	52.7	56.5	73.5	109.2	64.9	79.7	129.6	61.4	70.1	55.7	67.8	106.7	68.6	96.5	57.5	91.6	54.7	45.9	81.5	66.0	73.0	33.8	75.6	102.9	60.5	76.5	72.6	57.6	37.4	73.3	111.7	70.0	41.5	64.7	110.7	65.5	45.4	37.3	37.0	43.1	54.6	62.0	58.1	62.3	64.7	56.8	53.6	63.1	33.4	62.5	61.9	42.5	45.6	56.9	32.5	49.1	72.9	32.5	31.9	53.3	83.5	46.9	48.5	52.1	69.5	59.5	62.8	63.7	62.2	76.7	62.2	47.2	47.6	69.4	47.8	92.9	38.6	33.0	104.0	45.7	34.0	52.7	46.6	37.5	113.8	64.8	78.2	95.4	57.0	47.6	37.8	69.2	87.1	72.5	40.4	45.9	65.4	40.0	95.9	104.5	70.0	77.2	53.1	66.5	64.7	37.4	45.7	49.1	54.5	34.9	36.2	39.4	111.7	41.5	63.0	73.3	51.8	110.7	64.8	82.5	50.0	116.9	70.3	65.9	52.7	56.5	61.4	33.8
ARFGAP3	ARFGAP1	ENSG00000242247	"ADP ribosylation factor GTPase activating protein 3"	Q9NP61	22	42796502-42858106	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000638	Approved		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA000638: AB_1078188"	"unprognostic (3.29e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (8.97e-6)"	"unprognostic (5.83e-2)"	"unprognostic (8.85e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (2.65e-4)"	"unprognostic (1.73e-1)"	19.0	48.7	12.5	14.5	13.4	18.4	18.8	15.9	12.8	26.6	15.0	14.2	26.5	16.1	18.4	24.8	13.0	13.4	16.6	14.6	12.3	11.0	28.9	42.1	18.6	12.3	17.5	9.9	17.9	53.9	16.3	41.7	21.8	13.4	30.2	13.9	13.6	49.1	31.2	17.6	12.1	36.4	15.2	13.9	16.5	21.4	23.4	15.2	15.4	37.9	9.0	16.2	21.5	23.7	12.8	27.7	32.4	23.9	23.4	31.5	13.9	18.1	5.9	13.1	7.7	18.1	30.5	5.4	35.1	23.6	15.9	19.3	7.1	10.2	9.2	7.8	31.3	4.5	5.7	10.0	17.3	5.6	7.8	10.8	8.2	11.1	25.2	9.7	16.9	13.4	17.9	13.3	23.9	16.2	4.8	41.5	27.5	4.7	14.8	5.2	2.1	7.1	9.5	29.5	11.4	25.1	8.4	4.6	2.9	17.0	6.8	13.7	7.1	7.2	20.9	18.8	13.7	16.4	9.4	30.1	14.4	10.2	13.5	10.4	14.5	32.4	17.0	18.0	24.3	21.9	31.5	12.6	16.1	21.2	16.6	12.8	10.6	14.7	26.5	23.4	23.9	27.7	13.8	13.9	12.5	13.4	15.9	12.8	12.3	11.0	17.5	9.9	13.4	15.2
ARFGEF1	"ARFGEP1, BIG1, DKFZP434L057, p200"	ENSG00000066777	"ADP ribosylation factor guanine nucleotide exchange factor 1"	Q9Y6D6	8	67173511-67343677	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023399, HPA023822"	Supported	Supported	Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA023399: AB_1844981, HPA023822: AB_1844982"	"prognostic unfavourable (8.76e-4)"	"unprognostic (1.62e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.31e-1)"	"prognostic favourable (2.48e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.61e-2)"	17.0	17.1	14.5	24.3	15.6	24.9	14.0	20.4	16.3	17.7	24.7	9.5	24.7	16.8	15.4	20.3	23.8	13.1	16.0	12.0	11.3	11.7	23.9	15.3	18.6	22.7	11.4	9.5	15.1	21.4	38.6	21.8	17.4	16.7	15.8	17.7	13.2	20.7	29.4	20.9	18.4	26.9	13.8	12.0	20.1	19.5	27.1	12.6	36.7	22.9	15.7	16.8	22.9	17.7	2.1	3.7	8.4	3.7	3.7	6.1	1.3	15.5	10.1	9.9	3.7	11.4	15.8	11.7	10.9	12.3	11.2	11.4	6.2	15.2	11.8	4.8	13.8	11.2	11.8	15.4	13.8	15.1	8.3	19.8	6.2	6.6	9.9	10.1	19.8	9.6	11.1	10.1	17.2	15.9	12.1	12.8	12.9	3.5	23.8	4.8	21.7	9.3	11.6	7.1	2.4	18.6	29.0	3.9	7.7	7.1	17.2	9.7	29.7	9.1	19.3	7.7	10.3	10.1	8.2	11.3	12.3	8.9	12.2	10.4	7.2	8.0	2.6	6.6	4.8	3.7	6.1	2.1	3.2	3.9	2.6	2.1	5.3	4.5	8.4	3.7	1.5	3.7	5.9	1.3	14.5	15.6	20.4	16.3	11.3	11.7	11.4	9.5	16.7	12.6
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568164	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: "	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favourable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favourable (7.34e-5)"	43.5	31.8	59.1	46.5	63.6	67.5	46.1	82.1	72.8	37.9	41.7	44.9	33.5	35.2	62.2	50.9	38.1	50.2	55.0	40.4	55.7	20.6	30.5	24.4	65.3	75.7	62.5	44.5	65.2	34.1	24.0	61.1	48.3	44.0	38.9	48.6	35.5	46.8	48.2	34.1	53.0	54.3	43.3	51.8	50.4	42.8	25.9	67.2	40.2	45.5	22.0	61.0	44.0	44.9	23.7	23.2	34.7	18.0	16.5	18.6	10.9	26.1	14.4	66.0	14.8	10.5	18.2	14.7	29.0	8.8	9.8	14.9	29.6	38.0	31.7	10.0	11.3	29.5	13.9	12.0	18.4	41.2	14.8	36.5	89.5	15.2	9.3	58.7	24.2	16.2	15.8	8.9	12.0	12.4	13.1	24.7	12.6	9.2	23.2	31.2	17.4	5.5	40.0	16.5	15.1	11.0	30.4	17.3	24.7	13.7	22.0	6.5	17.3	30.4	22.5	13.1	13.1	14.5	16.3	27.7	22.8	38.0	27.1	37.6	15.0	34.7	18.0	16.7	18.6	14.6	17.2	20.7	13.8	11.6	14.4	23.7	15.8	13.8	30.3	16.5	13.4	23.2	15.5	10.9	59.1	63.6	82.1	72.8	55.7	20.6	62.5	44.5	44.0	67.2
ARHGAP10	"FLJ20896, FLJ41791, GRAF2"	ENSG00000071205	"Rho GTPase activating protein 10"	A1A4S6	4	147732063-148072780	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	9	"cerebellum: 154.3"	HPA039589			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039589: "	"unprognostic (8.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-2)"	"prognostic favourable (8.15e-5)"	"prognostic unfavourable (6.26e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.09e-2)"	31.2	7.9	2.3	11.3	3.2	2.0	27.8	1.8	3.7	20.1	23.9	1.9	13.2	3.4	15.4	17.6	25.2	17.6	20.3	20.0	2.8	1.6	9.6	4.8	11.8	8.3	3.8	1.9	19.9	7.8	20.8	4.7	7.5	9.9	19.8	6.0	16.0	6.7	17.0	37.5	12.3	8.9	58.0	5.2	9.7	15.9	11.2	2.5	8.7	9.9	12.4	7.9	28.7	24.9	0.0	2.6	14.0	1.5	4.1	9.7	2.1	9.6	3.9	2.1	4.4	16.4	22.4	22.3	13.4	11.2	8.6	6.7	10.1	5.6	0.0	2.3	11.4	4.8	7.8	11.0	10.5	5.3	5.2	3.3	3.1	0.3	25.3	3.2	3.9	11.5	8.6	10.7	9.2	10.4	0.4	18.3	15.4	11.8	2.0	0.0	1.9	1.9	3.7	6.1	11.3	5.9	8.9	5.2	2.4	3.5	14.1	3.7	1.7	0.3	10.4	8.2	6.3	4.9	6.4	6.8	0.8	0.0	12.4	0.4	7.2	0.0	1.5	14.0	5.2	0.0	9.7	0.0	3.9	5.7	2.6	0.0	1.1	5.7	0.2	4.1	0.0	0.0	4.6	2.1	2.3	3.2	1.8	3.7	2.8	1.6	3.8	1.9	9.9	2.5
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639949	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4;lymphoid tissue: 35.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040419, HPA040830"	Enhanced		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA040419: AB_10796121, HPA040830: AB_10805830"	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (2.05e-4)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.9	1.5	2.0	17.2	2.9	16.4	3.3	1.1	3.9	1.6	5.4	1.6	0.5	4.3	2.3	0.5	7.5	0.5	4.1	1.4	2.2	1.9	0.8	1.2	2.0	9.4	4.4	0.8	0.8	3.1	0.9	1.0	4.7	2.0	1.2	6.7	0.8	2.0	0.5	1.7	3.2	9.6	3.3	8.9	5.0	2.6	6.4	1.9	35.0	1.0	5.3	10.3	2.6	2.7	0.9	1.7	2.6	1.8	0.5	3.8	1.1	23.3	25.1	20.2	13.3	1.4	3.7	12.0	23.7	13.7	22.6	17.5	17.3	11.9	13.5	7.5	13.9	17.4	14.2	12.4	30.5	26.7	8.2	43.0	22.7	8.8	0.5	31.9	17.3	1.2	1.5	18.2	14.4	16.6	29.8	32.3	26.1	9.5	16.8	10.7	12.6	14.8	19.9	45.1	10.6	8.0	12.4	19.4	13.4	24.8	12.9	5.4	18.3	30.7	12.8	30.5	22.6	12.8	25.2	11.8	18.6	37.4	13.1	38.1	26.6	0.1	1.1	2.6	2.3	1.8	0.9	0.9	3.8	3.3	1.7	0.7	1.5	2.0	0.0	0.5	0.3	0.6	2.8	1.1	2.0	2.9	1.1	3.9	2.2	1.9	4.4	0.8	2.0	1.9
ARHGAP17	"FLJ10308, FLJ13219, NADRIN, RICH1, WBP15"	ENSG00000140750	"Rho GTPase activating protein 17"	Q68EM7	16	24919385-25015666	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041703	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041703: AB_10794304"	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.11e-2)"	"prognostic favourable (3.59e-4)"	"unprognostic (4.42e-2)"	"unprognostic (3.49e-2)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (3.02e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.81e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (3.76e-4)"	25.0	23.2	12.3	22.5	21.7	10.1	20.6	12.2	15.8	15.1	15.8	22.9	6.8	14.3	21.4	12.4	19.1	16.8	15.4	18.9	13.4	5.4	15.0	12.6	17.8	28.7	28.0	8.7	15.1	14.0	17.0	20.5	62.6	16.3	13.7	16.0	19.3	16.4	10.9	22.0	19.2	25.5	15.1	19.6	40.8	16.5	18.6	24.8	16.9	17.1	12.4	29.6	13.4	16.8	25.7	24.6	8.0	17.2	5.7	7.2	6.8	20.2	11.6	15.6	16.4	16.1	16.9	17.5	14.4	13.7	15.2	14.8	18.0	8.1	9.5	9.5	25.2	5.7	15.4	9.0	16.0	14.7	21.4	8.3	27.6	29.5	18.3	10.9	7.7	21.5	5.5	16.2	11.7	25.1	10.2	0.0	16.6	14.2	10.1	13.7	18.7	10.7	47.8	13.2	3.6	18.4	4.4	10.8	11.3	14.2	14.5	5.4	8.0	27.7	34.3	11.4	9.3	25.4	10.8	9.8	12.1	5.5	13.9	16.1	10.0	3.5	9.0	8.0	6.3	17.2	5.7	25.7	5.6	6.4	13.9	24.0	6.4	6.2	4.7	5.7	14.0	24.6	7.2	6.8	12.3	21.7	12.2	15.8	13.4	5.4	28.0	8.7	16.3	24.8
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710225	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 91.0;LHCN-M2: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"			840000	"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavourable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	23.8	32.2	4.1	14.1	4.0	1.7	19.7	2.5	2.4	9.6	19.5	2.9	12.0	13.3	7.8	25.8	5.8	15.7	11.8	16.9	4.4	6.8	33.2	4.5	38.8	15.5	4.1	1.4	8.0	38.2	10.6	22.0	16.7	12.2	9.6	8.2	10.4	16.7	24.2	12.1	5.4	40.6	6.5	9.0	15.8	15.1	10.9	3.8	5.1	12.7	12.1	6.4	10.3	5.8	2.9	11.8	13.0	5.9	2.5	5.8	6.0	1.8	4.2	0.4	0.5	4.1	5.9	3.4	14.3	11.0	6.3	4.3	2.2	3.1	1.5	7.0	9.6	2.4	3.0	4.7	11.9	1.5	1.3	10.2	3.3	12.5	5.9	1.5	91.0	3.7	0.7	11.5	10.3	18.0	5.4	3.9	25.6	0.5	0.0	1.4	0.4	1.0	0.0	1.9	2.9	19.3	1.0	0.0	0.0	1.1	2.0	7.0	2.2	1.8	13.7	6.6	0.9	0.5	11.4	1.8	1.3	1.0	2.2	2.8	9.2	8.9	5.2	13.0	5.3	5.9	3.3	2.9	2.8	5.8	4.8	1.7	0.5	2.9	4.0	2.5	3.1	11.8	2.7	6.0	4.1	4.0	2.5	2.4	4.4	6.8	4.1	1.4	12.2	3.8
ARHGAP22	RhoGAP2	ENSG00000128805	"Rho GTPase activating protein 22"	Q7Z5H3	10	48446034-48656265	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 32.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 15.4;LHCN-M2: 26.1;TIME: 27.7;U-87 MG: 34.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6"	"Group enriched"	"Detected in many"	29	"B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020696, HPA040391, HPA064439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB020696: , HPA040391: , HPA064439: "	"unprognostic (1.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (2.16e-8)"	"unprognostic (7.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.66e-2)"	2.6	3.1	10.2	6.7	12.5	3.0	2.0	7.3	12.2	1.8	2.7	32.3	1.0	1.7	2.1	1.9	1.6	2.2	4.4	3.3	12.5	9.6	1.2	0.8	2.9	6.0	18.3	6.6	7.7	1.5	2.7	1.8	2.2	24.6	3.2	2.8	1.6	3.4	3.2	3.9	3.4	2.5	3.4	27.3	6.2	2.3	4.6	18.4	2.0	6.0	0.4	5.4	3.1	1.9	2.6	2.9	0.0	3.2	0.0	0.0	0.9	2.5	0.5	0.1	0.0	2.2	8.8	1.7	13.5	6.2	1.2	1.7	2.7	0.3	0.0	0.5	5.2	4.9	0.1	4.5	2.2	0.2	4.6	7.1	0.0	0.0	1.1	0.8	0.8	2.1	4.6	15.4	1.2	8.4	6.7	1.3	26.1	0.1	0.1	0.0	2.9	0.2	0.0	0.0	3.2	2.6	0.2	0.4	2.7	0.6	0.0	0.2	0.1	0.1	27.7	12.7	0.2	1.6	9.4	0.0	0.0	0.0	34.4	0.1	2.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	10.2	12.5	7.3	9.2	12.5	9.6	18.3	6.6	24.6	18.4
ARHGAP23	KIAA1501	ENSG00000275832	"Rho GTPase activating protein 23"	Q9P227	17	38419280-38512392	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 75.4;RT4: 29.3"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019818, HPA047291"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"HPA019818: AB_1844993, HPA047291: "	"unprognostic (3.35e-1)"	"unprognostic (5.11e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.50e-3)"	"prognostic unfavourable (3.24e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavourable (5.38e-5)"	"unprognostic (8.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.25e-1)"	4.3	2.7	11.7	3.5	32.1	4.2	1.7	3.6	20.1	4.4	1.4	52.4	0.0	1.0	5.1	1.5	13.3	4.0	3.6	7.8	12.6		1.6	0.5	5.7	1.3	42.3	12.6	6.1	0.8	1.5	0.0	9.5	20.2	3.7	0.9	0.9	0.7	6.6	2.1	16.3	1.1	5.5	16.3	10.5	0.5	5.2	39.0	1.4	0.9	0.5	5.0	11.6	2.3	0.0	0.8	0.0	0.1	0.0	0.1	0.1	8.1	4.3	3.9	1.3	2.5	8.3	4.9	11.1	12.5	9.8	5.7	14.3	14.2	0.1	9.2	25.7	75.4	0.4	15.7	7.0	0.8	0.8	0.0	13.8	0.1	12.5	0.8	0.0	4.8	3.0	7.1	4.5	10.0	0.1	2.1	5.5	0.0	2.4	1.5	2.3	1.6	4.2	8.5	2.6	4.1	29.3	0.9	2.2	6.7	0.0	0.0	1.7	1.9	14.5	16.5	5.8	3.3	2.9	1.7	1.7	0.4	4.1	2.0	14.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1										
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475114-86002670	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 62.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.7;ASC TERT1: 21.6;HHSteC: 20.8;HUVEC TERT2: 38.4;RPTEC TERT1: 21.5;TIME: 27.1;U-138 MG: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5"	"Group enriched"	"Detected in many"	4	"B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favourable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	21.3	1.9	5.3	16.4	7.9	10.7	17.6	1.8	9.4	5.8	6.2	8.4	2.4	4.8	9.2	7.3	7.7	3.9	7.1	16.8	6.3	7.3	62.5	6.0	9.9	23.8	11.0	3.3	4.1	21.5	6.9	8.2	13.9	9.0	6.7	4.3	8.7	9.0	5.8	7.6	6.2	8.7	13.2	19.8	33.6	15.9	2.8	6.7	2.1	17.8	6.5	24.2	13.0	5.2	23.1	6.5	2.8	8.0	0.0	0.0	1.4	0.9	1.9	1.4	0.0	35.7	21.6	1.5	6.7	9.0	1.6	2.7	0.0	0.0	0.8	2.4	15.1	0.0	0.0	2.8	3.5	0.0	0.3	1.1	0.2	0.0	20.8	0.1	0.0	15.8	0.3	3.3	1.5	38.4	1.9	0.1	14.6	0.0	0.0	0.0	0.1	3.5	0.1	7.1	3.6	21.5	0.0	0.7	0.7	0.7	1.1	2.4	0.1	0.0	27.1	19.3	0.4	1.4	0.1	0.1	0.0	1.1	3.3	0.7	6.2	0.0	8.0	0.0	0.0	1.5	0.0	23.1	0.0	0.0	1.9	18.4	0.0	0.0	2.8	0.0	1.1	6.5	0.0	1.4	5.3	7.9	1.8	9.4	6.3	7.3	11.0	3.3	9.0	6.7
ARHGAP26	"GRAF, KIAA0621, OPHN1L, OPHN1L1"	ENSG00000145819	"Rho GTPase activating protein 26"	Q9UNA1	5	142770377-143229011	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"neutrophil: 19.6;NK-cell: 5.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 19.6;NK-cells: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035106, HPA035107"	Enhanced		Approved	Cytosol				Cytosol		"HPA035106: , HPA035107: AB_10669855"	"prognostic favourable (2.05e-4)"	"prognostic favourable (1.36e-4)"	"prognostic favourable (6.95e-4)"	"prognostic favourable (5.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (9.43e-3)"	"unprognostic (7.19e-3)"	"unprognostic (8.65e-2)"	"unprognostic (3.21e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-2)"	"prognostic favourable (2.88e-6)"	13.3	5.7	18.4	18.6	22.7	33.9	13.0	29.2	23.9	15.9	14.2	7.5	9.9	13.2	9.4	10.9	7.6	18.5	16.4	17.0	12.8	10.5	8.0	7.7	20.0	8.8	12.9	15.4	4.8	5.5	4.8	15.1	22.4	11.9	8.5	14.8	8.8	14.6	11.2	14.0	8.5	12.6	11.1	12.6	18.9	17.0	16.1	12.2	10.3	10.0	5.4	13.6	9.4	10.6	0.3	2.0	19.6	2.8	5.8	3.0	1.0	6.8	13.7	3.8	3.5	5.7	6.3	5.9	0.8	1.1	3.3	5.8	18.8	15.5	0.9	6.8	2.2	3.3	1.9	6.4	4.1	14.1	2.2	0.0	1.7	11.9	3.6	10.1	1.3	2.3	11.4	6.1	14.1	4.9	0.2	39.0	1.0	1.0	5.7	4.2	1.8	3.5	2.2	5.7	16.3	9.7	10.5	1.5	2.4	1.7	1.9	3.2	1.0	3.1	9.4	1.8	2.6	0.2	3.6	1.7	5.5	0.2	4.7	9.5	2.5	2.9	2.8	1.6	3.0	1.7	1.3	0.2	0.6	1.8	2.0	0.3	0.2	0.8	19.6	5.8	1.0	0.5	0.2	1.0	18.4	22.7	29.2	23.9	12.8	10.5	12.9	15.4	11.9	12.2
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 47.6;hTERT-HME1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	38	"monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	28.1	3.2	7.2	6.8	10.6	0.3	24.4	34.9	11.5	11.9	7.4	2.3	9.0	2.8	10.3	8.1	6.9	8.2	9.1	15.9	7.8	5.2	27.7	21.1	23.0	8.2	6.7	3.6	11.5	6.5	12.8	7.4	22.9	10.0	12.2	4.7	11.7	20.7	10.4	10.3	13.5	5.4	8.0	6.4	26.0	8.8	7.7	7.0	2.2	22.7	8.9	3.8	10.6	14.8	0.0	0.0	0.0	3.7	0.0	0.0	0.3	47.6	2.0	2.9	0.0	10.4	24.7	10.6	16.0	26.1	13.6	19.8	5.7	2.4	0.0	36.1	32.1	10.2	0.1	10.9	28.0	0.0	1.5	0.2	2.7	2.5	1.0	0.0	0.0	4.8	2.0	10.3	43.0	36.5	0.0	0.0	13.4	1.6	0.9	0.0	3.9	32.9	0.6	2.4	0.0	28.6	4.2	0.0	0.6	9.8	7.7	0.7	2.3	0.1	32.8	8.2	11.3	12.6	12.3	0.0	0.0	0.0	1.6	0.0	0.4	0.0	1.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	7.2	10.6	34.9	11.5	7.8	5.2	6.7	3.6	10.0	7.0
ARHGAP33	"FLJ39019, SNX26, TCGAP"	ENSG00000004777	"Rho GTPase activating protein 33"	O14559	19	35774532-35788822	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030117, HPA030118"	Supported		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"HPA030117: AB_10599306, HPA030118: AB_10601238"	"unprognostic (1.44e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.61e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (3.09e-8)"	"unprognostic (5.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-2)"	4.8	7.6	17.2	6.6	21.9	27.8	4.0	18.1	27.1	6.0	3.8	22.0	2.8	6.8	8.4	2.9	3.6	6.1	4.9	4.5	14.9	11.7	3.8	2.0	4.7	8.7	18.4	13.8	11.8	7.3	6.2	13.2	3.3	12.7	5.8	2.9	6.8	8.9	6.2	4.7	12.9	6.0	4.0	15.4	7.8	7.2	18.2	17.9	12.2	6.8	2.3	4.2	3.1	5.3	0.1	0.0	0.7	0.0	0.0	0.4	0.0	4.8	3.1	8.8	6.6	0.3	0.9	0.7	4.0	0.5	1.5	1.1	1.2	3.7	2.8	1.5	1.1	1.3	1.1	1.1	0.5	8.9	2.0	4.1	4.1	1.1	0.4	1.5	33.2	1.3	0.2	1.2	0.4	0.9	2.0	12.5	1.3	3.7	10.1	4.0	2.0	1.4	13.9	1.4	1.3	0.7	0.8	8.8	5.4	1.8	3.2	0.6	4.7	4.1	1.7	6.3	6.3	3.3	4.6	11.1	2.1	2.8	2.3	4.9	4.0	0.0	0.0	0.3	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	17.2	21.9	18.1	27.1	14.9	11.7	18.4	13.8	12.7	17.9
ARHGAP39	"CrGAP, KIAA1688, Vilse"	ENSG00000147799	"Rho GTPase activating protein 39"	Q9C0H5	8	144529179-144605816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044491			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"				Cytosol	"Nucleoplasm, Microtubules, Cytokinetic bridge"	"HPA044491: AB_10794775"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-7)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.97e-2)"	1.1	1.9	3.6	1.0	3.5	0.0	1.2	6.2	7.0	2.0	2.0			2.4	1.7	1.2	1.4	7.0	0.9	0.4	5.3	4.4	1.8	0.2	1.5	0.3	3.3		0.9	2.9	2.0	4.0	0.9		2.1	0.9		3.5	2.3	0.6	2.6	2.4	0.6	7.2	0.9	1.2	12.8			2.8		0.1	0.5	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	7.5	7.5	3.5	5.5	0.7	0.6	6.8	1.9	0.6	2.4	1.6	4.8	4.5	0.7	5.1	0.8	6.4	1.7	1.9	0.5	0.0	6.7	0.1	4.9	3.0	1.2	0.0	0.7	0.5	3.1	3.2	1.3	0.8	6.9	0.0	1.0	12.1	4.1	0.0	3.7	10.7	3.8	2.8	2.8	1.9	3.8	10.3	7.3	5.7	2.0	3.4	8.4	1.1	1.9	1.8	0.1	6.2	4.1	0.0	0.1	0.3	3.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 18.6;epididymis: 38.0;skin 1: 26.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HBEC3-KT: 12.0;RPTEC TERT1: 10.5;SK-BR-3: 11.3;T-47d: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.3	0.3	0.3	0.0	18.6	0.3	0.5	1.6	0.3	0.4	5.2	0.8	0.6	38.0	15.8	0.0	0.9	0.3	0.3	0.1	4.1	0.3	1.8	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	3.0	0.0	0.3	1.9	5.1	0.3	26.7	0.3	0.7	0.3	0.3	2.6	1.2	0.6	0.3	0.3	5.2	6.6	3.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.8	0.0	3.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	11.3	0.0	13.7	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.3	0.3	0.6
ARHGAP42	"AD031, FLJ32810, GRAF3, TMEM133"	ENSG00000165895	"Rho GTPase activating protein 42"	"A6NI28, Q9H2Q1"	11	100687653-100993941	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 38.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.8;RH-30: 15.8;RT4: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039924, HPA060528"	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA039924: AB_10674428, HPA060528: "	"unprognostic (1.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.03e-1)"	11.1	4.9	6.8	8.9	5.8	0.9	10.4	3.0	7.0	9.8	8.3	4.1	2.3	9.9	11.4	7.7	4.3	5.6	9.5	6.5	8.8	3.8	11.9	12.7	13.7	5.1	6.3	5.3	4.8	2.6	9.1	6.0	38.0	5.9	4.8	8.4	25.5	5.1	3.8	9.0	7.2	12.1	5.8	8.7	8.2	11.7	4.1	6.7	12.7	10.9	7.4	3.8	5.5	7.9	1.5	2.5	0.0	0.0	0.7	0.4	0.3	0.5	3.5	4.6	0.1	2.5	3.4	3.1	0.5	0.9	1.1	2.1	4.4	22.8	0.7	6.4	1.7	7.7	2.3	1.7	1.1	0.0	1.9	11.0	8.9	1.4	4.5	0.1	0.0	3.3	2.1	4.2	0.7	1.7	0.4	0.0	3.4	0.6	1.2	0.0	5.5	5.6	3.4	15.8	0.4	5.3	14.8	2.5	1.6	7.6	0.2	6.0	0.8	1.4	3.0	3.0	3.7	3.5	1.7	3.3	0.0	4.4	3.5	2.7	12.9	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.3	6.8	5.8	3.0	7.0	8.8	3.8	6.3	5.3	5.9	6.7
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA046993: , HPA056507: "	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favourable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	11.3	13.1	29.8	8.4	26.1	4.0	13.0	39.1	29.2	14.2	14.6	11.5	7.9	16.0	13.2	11.9	31.5	11.1	15.3	28.0	29.5	19.6	20.8	14.5	12.8	5.9	26.8	23.4	23.3	13.5	21.8	27.6	16.9	24.2	14.7	12.3	9.2	26.0	14.5	11.5	14.0	17.3	13.4	26.6	18.7	13.3	20.4	30.6	8.8	32.5	7.7	8.0	15.6	25.8	7.3	9.0	1.5	1.8	6.8	7.4	2.3	18.6	15.2	15.2	22.2	20.0	14.1	8.7	11.6	14.4	7.1	10.7	19.3	18.3	5.5	10.4	14.7	19.9	14.5	12.5	13.9	5.5	8.4	8.3	9.4	28.2	13.6	5.0	5.0	15.6	25.5	6.6	25.0	8.7	7.3	16.5	11.5	9.8	10.9	0.2	7.5	18.3	11.9	18.7	1.0	15.6	49.9	23.6	9.2	31.3	16.8	23.7	17.4	0.3	13.9	13.2	19.9	10.9	8.5	6.3	12.3	0.8	6.6	5.4	35.9	1.5	1.8	0.0	4.0	0.8	4.8	7.3	7.0	3.7	6.1	7.1	7.4	4.3	0.6	6.8	1.3	9.0	5.7	2.3	29.8	26.1	39.1	29.2	29.5	19.6	26.8	23.4	24.2	30.6
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11137543-11665701	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 57.3;seminal vesicle: 58.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.8;ASC TERT1: 19.2;HEL: 18.9;HMC-1: 13.3;HSkMC: 18.9;K-562: 13.7;RT4: 10.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		920000	Cytosol		"HPA001798: , HPA036779: AB_10672229, HPA064390: "	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	9.4	1.2	16.7	2.6	10.0	0.7	6.3	0.6	2.9	9.5	11.7	4.1	57.3	2.0	10.2	9.0	4.1	7.6	5.4	3.6	5.6	4.3	6.0	1.1	8.7	1.2	2.3	3.6	15.1	1.9	1.1	6.6	6.2	2.7	24.8	3.7	3.2	2.5	58.8	8.0	2.3	4.2	12.1	3.1	5.0	4.1	2.2	3.3	0.0	25.9	3.1	1.4	14.3	8.0	1.3	0.2	1.0	0.9	0.0	0.1	2.7	0.0	0.0	1.3	0.0	14.8	19.2	0.3	0.1	0.3	0.7	0.5	0.1	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.7	0.0	0.2	18.9	0.0	0.0	5.4	0.0	13.3	18.9	0.0	1.3	0.0	0.3	13.7	6.4	0.8	0.0	0.0	0.0	0.3	0.2	0.0	6.3	8.0	4.5	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	3.8	0.1	0.3	0.0	0.0	0.1	0.0	2.0	1.0	0.3	0.5	0.0	0.9	0.0	1.3	0.0	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.7	0.2	0.0	2.7	16.7	10.0	0.6	2.9	5.6	4.3	2.3	3.6	2.7	3.3
ARHGDIA	"GDIA1, RHOGDI"	ENSG00000141522	"Rho GDP dissociation inhibitor alpha"	P52565	17	81867721-81871406	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010005, HPA021407"	Approved		Supported	Cytosol			49000000	Cytosol		"CAB010005: AB_2227516, HPA021407: AB_1856267"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (5.32e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.88e-3)"	67.9	52.5	43.8	71.8	59.5	91.1	57.2	20.4	65.7	41.2	55.4	44.6	29.7	85.9	50.0	34.1	55.0	40.9	46.2	36.7	41.5	44.6	50.9	64.9	56.0	68.2	39.9	43.4	49.7	65.9	30.6	42.9	52.8	39.0	44.1	27.2	39.9	52.7	43.2	36.7	41.0	88.8	35.7	41.7	57.1	68.4	26.3	35.4	67.1	41.2	41.4	49.9	42.2	44.8	17.0	24.0	35.0	41.0	18.4	29.9	22.8	64.7	64.0	20.8	33.3	19.3	24.2	23.8	55.7	35.9	41.9	31.2	31.4	24.7	34.3	23.8	42.1	35.7	23.0	42.0	17.7	26.6	58.9	36.2	38.2	40.7	39.3	57.0	53.2	30.6	19.5	30.3	26.4	63.7	29.8	48.3	33.6	39.0	82.7	58.1	24.7	56.6	37.9	26.7	27.4	27.5	40.1	27.7	81.5	29.3	75.4	52.2	35.4	46.9	70.1	83.7	71.5	77.1	94.5	42.6	22.2	35.4	72.6	34.4	56.7	15.7	20.5	35.0	29.9	31.3	28.5	17.0	25.0	28.5	21.2	13.2	16.8	19.7	13.3	18.4	41.0	24.0	23.9	22.8	43.8	59.5	20.4	65.7	41.5	44.6	39.9	43.4	39.0	35.4
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942017-14961728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"blood: 333.1;bone marrow: 150.7;lymphoid tissue: 221.4"	"Cell line enhanced"	"Detected in many"		"HEL: 101.6;HL-60: 118.9;HMC-1: 134.6;MOLT-4: 140.7;REH: 118.4;U-698: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol			120000000	Cytosol		"CAB018584: AB_647972, HPA051235: "	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favourable (3.42e-4)"	40.3	13.4	9.0	66.1	18.4	150.7	27.9	1.8	8.9	14.6	14.5	13.9	3.6	8.5	14.7	13.2	16.9	18.2	18.3	20.5	8.3	7.8	24.5	20.0	41.3	93.9	17.0	3.9	11.7	7.1	3.9	8.1	35.6	11.4	18.0	16.1	20.4	22.4	7.6	13.3	14.7	38.3	15.7	17.9	157.8	11.1	11.2	15.8	221.4	22.7	12.4	108.1	31.2	13.5	114.0	95.5	267.1	151.9	96.3	231.1	333.1	9.3	0.3	0.3	20.8	1.4	1.1	0.1	0.3	0.1	0.1	0.1	1.2	10.3	75.4	4.8	1.7	10.3	0.0	16.7	1.1	0.1	0.0	101.6	0.2	0.0	0.3	118.9	134.6	0.1	2.1	0.0	1.5	58.5	0.5	28.9	1.8	0.0	140.7	85.6	0.4	0.1	118.4	1.3	33.7	3.3	52.2	0.1	0.0	0.1	13.5	0.1	0.7	86.6	74.1	0.3	0.7	0.1	2.2	4.8	0.7	108.9	0.3	83.4	0.1	206.0	109.9	267.1	125.6	130.8	123.3	114.0	144.4	140.7	95.5	103.2	141.1	146.5	237.7	96.3	151.9	41.4	231.1	333.1	9.0	18.4	1.8	8.9	8.3	7.8	17.0	3.9	11.4	15.8
ARHGDIG	RHOGDI-3	ENSG00000242173	"Rho GDP dissociation inhibitor gamma"	Q99819	16	268727-283010	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 60.4;intestine: 31.7;pancreas: 45.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;HEK 293: 18.4;MCF7: 23.6;SCLC-21H: 8.3;SH-SY5Y: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078260			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA078260: "	"unprognostic (1.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.86e-6)"	"unprognostic (2.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.32e-2)"	3.7	3.1	37.3	1.8	15.6	1.0	1.1	43.3	60.4	1.0	1.8	3.7	0.0	31.7	1.1	2.3	1.1	1.0	0.9	3.6	29.0	27.4	1.0	0.9	1.0	1.0	21.2	21.4	1.0	45.3	0.9	1.7	2.4	12.7	1.1	1.2	0.6	1.3	1.3	2.0	0.9	12.0	1.3	8.6	1.0	9.3	2.0	2.0	0.0	0.9	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.1	2.0	0.0	0.6	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.0	0.6	0.4	0.1	5.1	0.0	0.0	0.0	18.4	0.0	0.3	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.2	0.2	0.0	23.6	0.0	0.3	2.5	0.0	0.0	0.0	0.4	0.0	0.0	8.3	10.3	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.3	15.6	43.3	43.8	29.0	27.4	21.2	21.4	12.7	2.0
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883161-41930150	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 61.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favourable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavourable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	15.5	8.4	10.7	40.1	16.5	50.0	13.8	8.7	13.8	11.7	14.1	23.3	9.7	13.7	12.7	9.6	12.2	13.0	14.1	9.3	10.6	6.2	12.4	10.4	23.7	57.8	18.1	8.5	12.5	10.8	7.0	11.8	9.6	11.8	11.4	5.8	12.1	13.1	9.2	5.2	12.9	29.3	9.0	12.2	61.0	17.0	3.7	15.6	43.6	13.4	8.6	40.8	12.4	11.7	11.1	10.8	13.7	26.9	15.4	26.3	14.3	19.9	24.3	5.6	7.0	8.0	8.4	6.6	10.6	16.2	13.4	11.8	7.4	17.3	26.8	19.5	9.6	11.8	7.2	16.4	4.2	25.1	8.3	21.6	10.5	9.7	11.7	23.1	35.7	10.1	10.9	13.0	8.5	12.8	8.5	16.5	7.7	13.8	16.1	17.9	6.4	18.9	24.4	10.5	15.8	8.2	11.0	3.7	15.7	14.8	6.6	12.1	7.7	39.5	17.2	17.9	12.0	9.5	16.3	22.5	14.3	23.2	14.6	36.7	28.2	5.1	9.4	13.7	25.1	19.8	20.3	10.8	19.1	26.3	10.8	11.1	20.0	20.4	13.7	15.4	26.9	5.8	19.4	14.3	10.7	16.5	8.7	13.8	10.6	6.2	18.1	8.5	11.8	15.6
ARHGEF10L	"FLJ10521, KIAA1626"	ENSG00000074964	"Rho guanine nucleotide exchange factor 10 like"	Q9HCE6	1	17539835-17697874	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 50.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	40	"classical monocyte: 13.1;intermediate monocyte: 13.0;myeloid DC: 9.7;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	46	"dendritic cells: 9.7;monocytes: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026426, HPA026440, HPA028115"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles, Cytosol"		"HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285"	"unprognostic (4.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"prognostic favourable (8.13e-5)"	"unprognostic (3.61e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.83e-2)"	"prognostic favourable (5.65e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.21e-3)"	9.5	6.1	6.2	6.1	6.2	0.7	7.8	31.7	7.5	8.5	13.4	7.1	9.9	9.0	7.7	11.2	14.4	6.4	11.7	16.0	5.7	6.1	16.4	50.7	7.8	2.2	6.3	3.8	5.3	30.2	8.1	2.7	3.3	9.1	6.6	7.4	9.6	13.2	12.3	33.4	13.4	9.7	10.5	5.9	5.4	6.5	3.9	5.9	0.4	10.4	7.4	2.9	9.6	11.9	0.0	9.7	0.2	13.1	0.0	0.0	4.5	5.2	6.0	7.7	2.6	13.1	4.4	5.2	3.6	7.2	4.3	3.6	6.2	15.9	0.0	6.8	6.7	4.1	1.0	1.9	0.8	0.1	1.9	0.0	6.2	17.6	3.0	0.0	0.0	5.9	3.7	2.7	0.7	0.8	0.0	0.1	12.0	5.0	0.0	0.1	3.4	0.0	0.0	3.0	1.9	9.2	11.0	11.3	8.3	2.8	2.0	8.2	7.5	6.3	0.0	3.8	4.6	4.4	1.5	0.0	1.6	0.0	5.8	0.1	2.0	0.0	13.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	4.5	6.2	6.2	31.7	7.5	5.7	6.1	6.3	3.8	9.1	5.9
ARHGEF12	"KIAA0382, LARG"	ENSG00000196914	"Rho guanine nucleotide exchange factor 12"	Q9NZN5	11	120336914-120489936	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.2;NK-cells: 1.5;T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018911, CAB025581"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"CAB025581: , HPA018911: AB_1845003"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.91e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.78e-2)"	"prognostic favourable (5.43e-6)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	17.6	19.2	27.6	8.3	32.5	5.9	19.6	40.4	41.5	21.7	16.4	12.4	15.7	14.9	17.5	15.9	17.8	18.6	17.3	23.4	21.8	17.7	41.2	38.8	24.1	6.5	15.8	26.3	16.3	16.9	55.8	17.2	25.4	21.1	16.8	17.8	20.7	16.7	20.0	24.1	29.0	14.8	18.6	10.8	12.4	19.0	6.7	13.0	3.0	31.3	15.0	10.9	19.4	22.9	0.3	0.3	2.2	0.1	1.5	1.0	0.4	12.9	10.9	14.7	14.0	19.9	19.9	6.1	15.3	17.3	9.3	11.9	12.7	9.5	1.1	18.8	27.3	9.8	18.8	19.4	18.2	10.7	9.2	21.1	11.7	9.8	17.8	0.0	15.7	18.9	14.1	20.4	22.7	28.2	17.8	43.3	23.5	9.0	0.0	0.0	4.0	9.4	4.6	16.8	4.1	22.9	22.6	10.8	13.3	21.4	18.0	5.6	15.3	1.7	27.8	20.7	8.9	13.4	11.1	12.7	5.1	7.2	8.5	2.7	15.6	2.2	0.0	0.0	1.0	0.1	0.2	0.3	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.5	0.1	0.3	0.7	0.4	27.6	32.5	40.4	41.5	21.8	17.7	15.8	26.3	21.1	13.0
ARHGEF17	"KIAA0337, p164-RhoGEF, TEM4"	ENSG00000110237	"Rho guanine nucleotide exchange factor 17"	Q96PE2	11	73308289-73369388	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.0;plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007991	Uncertain		Approved	Cytosol				Cytosol		"HPA007991: AB_1845005"	"unprognostic (2.36e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (8.27e-5)"	"unprognostic (6.96e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-3)"	"unprognostic (7.12e-3)"	"unprognostic (6.85e-3)"	"unprognostic (3.42e-3)"	16.7	10.0	18.1	7.0	43.0	2.5	11.1	31.8	35.1	17.1	16.7	9.5	3.5	4.3	20.4	12.6	8.3	14.3	13.9	21.0	13.7	11.4	12.9	2.6	14.8	4.1	8.5	23.1	15.5	5.6	24.7	7.8	18.5	19.6	13.6	4.5	11.4	6.9	23.3	7.3	4.7	7.5	17.9	6.9	7.6	10.5	4.8	13.5	0.8	18.1	3.3	2.2	11.7	10.1	0.0	1.5	0.2	0.2	0.0	0.2	0.0	4.6	5.5	12.0	14.0	9.4	8.1	7.3	13.1	19.1	13.3	8.4	15.1	4.1	0.0	9.3	24.4	7.4	4.0	5.2	5.4	8.3	1.2	0.0	9.0	5.6	11.0	0.3	0.2	13.9	6.1	7.8	4.7	9.8	0.4	0.1	7.2	6.5	0.1	8.2	1.6	1.2	1.9	13.9	0.3	8.2	3.2	7.8	6.0	11.1	13.1	15.3	22.3	3.9	6.3	6.4	13.4	2.7	4.1	0.8	0.1	0.0	2.2	0.9	9.8	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	18.1	43.0	31.8	35.1	13.7	11.4	8.5	23.1	19.6	13.5
ARHGEF18	"KIAA0521, MGC15913, P114-RhoGEF"	ENSG00000104880	"Rho/Rac guanine nucleotide exchange factor 18"	Q6ZSZ5	19	7395113-7472477	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042689, HPA071867"	Approved		Enhanced	Cytosol				Cytosol		"HPA042689: AB_10794385, HPA071867: "	"unprognostic (2.55e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.65e-2)"	"prognostic favourable (4.21e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.26e-2)"	"prognostic favourable (3.11e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.79e-3)"	8.7	13.3	12.3	16.7	15.0	18.3	7.1	13.2	22.2	9.9	19.3	19.9	10.4	19.0	16.1	7.4	15.6	10.6	12.7	5.4	10.9	8.8	15.8	10.9	12.2	20.6	14.6	12.9	9.3	23.0	16.2	13.3	11.5	11.8	11.3	8.1	12.5	13.1	12.2	7.7	11.8	27.8	8.7	10.4	31.2	17.4	10.6	14.0	4.6	10.7	8.5	13.0	12.6	12.9	8.9	3.3	8.6	4.2	1.7	5.9	3.5	21.8	12.5	6.4	9.3	5.3	5.6	20.9	10.0	7.6	13.4	13.9	17.0	10.7	21.8	20.8	6.4	16.2	6.3	19.2	3.5	28.5	11.2	10.6	9.1	10.2	14.5	11.8	13.0	6.6	13.9	13.2	8.6	6.3	9.5	9.6	10.9	7.7	12.7	13.7	10.4	20.6	17.1	11.0	7.6	5.5	22.5	6.2	9.6	11.0	10.3	12.5	11.5	11.5	15.0	11.5	12.8	17.3	12.2	23.6	17.4	13.4	10.6	10.0	9.8	8.6	1.9	8.3	4.1	3.4	5.9	4.2	5.5	5.9	2.1	8.9	5.0	5.1	4.2	1.7	4.2	3.3	4.0	3.5	12.3	15.0	13.2	22.2	10.9	8.8	14.6	12.9	11.8	14.0
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 9.8;U-251 MG: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: "	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favourable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	11.2	4.0	9.1	5.8	8.7	1.0	9.8	5.6	17.8	9.2	20.0	6.5	3.3	10.3	5.9	3.1	12.0	8.3	17.6	4.1	8.7	4.6	3.1	22.0	18.6	1.0	5.4	6.3	5.3	27.1	13.9	2.9	4.7	12.2	5.3	3.7	4.4	4.1	5.5	1.5	7.0	11.5	12.7	9.7	1.6	12.3	7.4	5.5	0.0	4.1	2.5	2.0	7.4	11.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	5.2	3.0	6.0	4.1	2.7	0.4	0.1	0.3	0.0	1.5	1.7	2.4	0.4	2.4	0.4	0.1	6.2	3.0	1.5	2.8	0.0	7.9	0.0	2.2	0.8	2.5	0.8	0.1	0.9	0.1	1.9	0.3	0.1	0.0	0.0	1.0	6.0	1.0	0.1	3.8	2.6	0.0	9.8	0.0	0.5	3.5	2.2	0.7	0.7	8.6	1.3	5.2	0.4	0.0	0.9	3.9	0.0	17.7	2.5	0.4	0.0	1.6	0.0	6.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.1	8.7	5.6	10.1	8.7	4.6	5.4	6.3	12.2	5.5
ARHGEF28	"p190RhoGEF, RGNEF, RIP2"	ENSG00000214944	"Rho guanine nucleotide exchange factor 28"	Q8N1W1	5	73626158-73941993	"Predicted intracellular proteins"	Differentiation	"Guanine-nucleotide releasing factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 37.8;LHCN-M2: 34.8;TIME: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.2;memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA037602	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"				"Microtubules, Cytosol"	"Plasma membrane"	"HPA037602: AB_10672282"	"unprognostic (1.97e-1)"	"prognostic favourable (5.31e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.04e-1)"	"prognostic favourable (1.91e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-2)"	"prognostic favourable (8.98e-4)"	3.4	17.7	3.0	2.7	1.4	0.0	7.7	2.3	2.3	9.7	6.7	1.1	8.6	2.3	11.9	9.7	7.1	7.5	12.0	1.5	1.4	1.9	43.0	5.5	5.5	0.3	1.7	3.2	14.5	19.2	0.2	7.0	1.1	2.5	5.1	2.8	4.3	20.0	9.5	0.9	11.1	3.9	2.7	3.3	2.0	14.8	2.0	1.0	4.1	10.5	6.0	6.0	3.4	6.2	0.0	0.0	0.0	0.0	0.6	1.2	0.1	10.9	7.8	0.0	1.0	1.0	1.4	0.0	4.0	8.1	5.1	5.1	2.3	4.8	0.0	8.6	1.4	3.7	0.5	6.5	7.8	0.0	1.1	0.2	1.2	9.9	8.2	0.0	0.0	1.3	2.6	8.0	37.8	16.7	0.0	0.0	34.8	1.0	0.0	0.0	0.1	3.2	0.0	2.1	1.3	14.0	6.7	0.7	1.5	1.9	0.3	0.2	1.7	0.0	22.3	2.5	3.5	0.2	3.8	0.4	0.0	0.0	3.9	0.5	1.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.1	3.0	1.4	2.3	2.3	1.4	1.9	1.7	3.2	2.5	1.0
ARHGEF3	"DKFZP434F2429, GEF3, STA3, XPLN"	ENSG00000163947	"Rho guanine nucleotide exchange factor 3"	Q9NR81	3	56727418-57079329	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.9;RPMI-8226: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034715, HPA064945"	Uncertain		Approved	Cytosol				Cytosol		"HPA034715: AB_10600780, HPA064945: "	"unprognostic (1.84e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"prognostic favourable (2.17e-4)"	"unprognostic (8.25e-2)"	"prognostic favourable (2.61e-4)"	"unprognostic (9.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.99e-2)"	"prognostic favourable (1.96e-7)"	"unprognostic (8.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-2)"	14.5	33.0	8.3	14.2	22.8	6.4	13.5	24.0	31.1	12.8	12.9	8.8	8.2	4.8	29.6	14.4	16.2	17.8	16.6	9.3	19.0	12.0	19.5	3.9	18.1	19.5	9.3	18.4	20.6	36.9	29.8	30.4	15.5	18.3	11.6	10.5	19.9	18.6	12.3	7.7	10.8	9.1	26.1	9.7	14.9	11.3	10.2	5.8	33.4	10.9	10.2	20.4	13.9	11.2	8.4	4.4	4.9	9.3	11.9	32.7	20.8	9.4	3.3	0.5	3.1	1.1	0.9	6.8	1.0	0.9	1.0	1.4	1.6	9.0	5.0	1.0	1.9	4.9	2.9	12.4	1.2	7.2	1.4	4.1	2.2	34.9	2.8	0.0	4.5	4.1	8.2	0.9	1.4	10.3	1.1	11.1	2.4	1.4	13.4	0.5	0.9	5.2	0.0	3.8	36.3	8.1	5.2	0.6	1.5	6.0	4.5	2.7	1.1	4.2	4.7	0.5	2.5	2.2	1.6	14.2	5.4	18.0	9.0	4.9	4.3	4.9	7.1	1.1	32.7	8.0	24.5	8.4	25.2	28.5	4.4	5.6	20.7	25.2	2.7	11.9	9.3	1.9	20.7	20.8	8.3	22.8	24.0	31.1	19.0	12.0	9.3	18.4	18.3	5.8
ARHGEF37	FLJ41603	ENSG00000183111	"Rho guanine nucleotide exchange factor 37"	A1IGU5	5	149551947-149634968	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 66.1;seminal vesicle: 73.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 9.9;HaCaT: 18.2;hTCEpi: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 9.0;neutrophil: 4.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.0"	"Region enhanced"	"Detected in some"		"cerebellum: 9.5"	"Low region specificity"	"Detected in all"			"HPA043885, HPA053487"	Uncertain		Approved	Cytosol				Cytosol		"HPA043885: , HPA053487: "	"unprognostic (3.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.16e-2)"	"prognostic favourable (6.85e-4)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.10e-1)"	2.5	2.7	10.8	1.9	13.2	3.0	16.8	6.7	7.1	4.0	10.2	17.5	66.1	4.5	4.4	9.5	7.6	7.4	4.6	6.4	12.8	9.5	4.6	1.4	4.3	1.0	19.1	5.8	2.2	7.0	29.6	5.3	3.6	12.3	16.0	5.2	12.0	23.2	73.8	11.9	29.3	4.8	7.0	31.7	1.0	11.7	4.8	15.1	0.7	2.1	4.8	3.4	6.4	5.4	0.7	1.1	9.0	1.2	0.2	0.8	0.0	2.9	1.1	0.8	3.6	0.2	0.4	2.1	0.4	0.6	0.6	0.6	0.0	3.9	0.4	9.9	0.4	18.2	0.3	1.8	1.2	0.8	0.9	0.3	1.8	0.2	0.7	0.0	0.5	0.5	24.2	1.8	2.4	2.9	0.4	0.7	0.0	0.4	0.5	0.5	0.2	2.2	0.3	0.4	0.0	4.0	1.5	1.5	3.5	2.2	0.2	0.3	5.4	0.1	2.3	0.2	0.7	0.0	0.5	0.5	1.0	0.3	0.7	0.1	2.5	9.0	0.9	0.5	0.4	1.2	0.5	0.2	0.3	0.3	0.3	0.7	0.8	0.6	4.9	0.2	0.5	1.1	0.2	0.0	10.8	13.2	6.7	7.1	12.8	9.5	19.1	5.8	12.3	15.1
ARHGEF40	"FLJ10357, solo"	ENSG00000165801	"Rho guanine nucleotide exchange factor 40"	Q8TER5	14	21070270-21090240	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.4;ASC TERT1: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 2.8;neutrophil: 9.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030745, HPA030746, HPA030757"	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.95e-2)"	15.7	32.9	9.3	7.4	9.2	1.7	12.4	16.5	8.2	16.2	8.2	11.4	30.9	3.5	13.6	12.6	5.9	9.3	20.2	7.8	10.2	4.6	7.2	16.9	9.3	4.2	12.6	4.5	15.7	16.6	17.7	6.6	6.3	9.1	9.8	6.3	10.3	20.1	30.0	6.5	4.9	5.2	11.2	10.5	19.5	6.4	4.7	10.8	1.3	11.0	4.9	2.5	8.6	9.6	0.0	1.0	9.2	1.3	0.1	0.0	0.5	1.6	1.5	17.4	3.1	14.7	22.2	0.6	5.8	15.7	6.8	5.3	0.7	4.1	0.0	0.9	11.4	2.5	1.5	2.0	2.6	3.2	0.6	2.3	1.7	4.7	2.0	1.5	8.6	9.0	1.4	5.9	1.8	0.0	0.7	0.7	5.5	0.2	0.0	4.8	3.9	0.3	0.5	11.5	0.7	4.4	2.1	0.4	6.0	3.2	0.3	4.7	1.5	5.1	2.8	14.1	9.2	6.2	2.7	1.4	0.0	0.0	4.8	2.1	3.8	0.0	1.3	2.8	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.2	0.1	0.0	0.0	0.0	0.5	9.3	9.2	16.5	8.2	10.2	4.6	12.6	4.5	9.1	10.8
ARHGEF5	"GEF5, P60, TIM, TIM1"	ENSG00000050327	"Rho guanine nucleotide exchange factor 5"	Q12774	7	144355288-144380632	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 20.4;CAPAN-2: 13.9;hTCEpi: 15.3;WM-115: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"B-cells: 3.1;granulocytes: 1.1;T-cells: 4.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020980, HPA029504, HPA044188, HPA045619, HPA045699"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: , HPA045619: , HPA045699: "	"unprognostic (1.45e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.95e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (3.28e-7)"	"unprognostic (4.67e-2)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.76e-2)"	2.3	1.0	1.2	5.2	1.8	0.9	7.6	1.2	1.2	4.6	7.7	1.2	7.4	8.5	3.4	7.8	16.6	2.5	8.4	1.3	1.2	0.4	9.0	6.7	4.8	3.2	1.2	1.2	3.0	8.8	7.7	4.3	14.3	2.6	6.6	4.6	4.0	17.7	9.4	1.2	21.1	16.7	2.2	1.7	2.4	6.5	1.4	1.2	1.5	11.6	10.0	4.5	3.4	6.9	3.1	0.2	1.1	0.1	0.0	4.2	0.4	20.4	1.9	0.0	0.0	0.0	0.0	7.0	2.2	1.4	1.0	1.2	6.9	13.9	0.0	6.7	0.9	9.5	0.8	9.5	1.0	0.0	2.9	0.0	3.1	1.0	2.3	0.0	0.0	3.6	15.3	0.7	7.1	0.2	0.0	0.0	0.8	8.4	0.0	0.0	4.5	3.8	0.8	0.0	0.2	11.3	7.0	0.0	0.0	8.6	8.5	3.7	5.2	1.3	0.2	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	15.0	0.0	0.0	0.0	0.8	0.1	1.3	1.8	2.7	2.1	0.1	3.1	2.7	0.7	1.1	0.0	0.0	0.2	4.2	0.4	1.2	1.8	1.2	1.2	1.2	0.4	1.2	1.2	2.6	1.2
ARHGEF6	"alpha-PIX, alphaPIX, Cool-2, Cool2, KIAA0006, MRX46"	ENSG00000129675	"Rac/Cdc42 guanine nucleotide exchange factor 6"	Q15052	X	136665547-136782088	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 21.7;HL-60: 27.0;HMC-1: 103.2;U-937: 29.0"	"Cancer enhanced"	"Detected in all"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003578	Approved		Approved	Cytosol				Cytosol		"HPA003578: AB_1078203"	"unprognostic (9.64e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.08e-2)"	"unprognostic (7.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-3)"	22.0	10.4	16.9	15.3	15.4	14.8	13.9	6.4	14.6	6.4	8.3	12.8	3.7	4.0	8.4	6.1	4.4	4.5	9.5	27.0	21.7	13.6	5.0	4.5	13.8	20.6	20.7	10.2	9.5	2.7	8.8	4.8	24.4	15.1	6.4	6.3	8.4	6.2	5.1	37.5	4.3	9.6	9.3	14.6	20.2	6.4	3.2	14.6	2.6	4.1	8.6	20.5	8.8	7.9	3.1	8.8	31.5	8.8	5.5	9.9	6.2	0.2	0.0	1.0	0.0	2.2	5.8	0.0	0.3	1.8	0.3	1.6	0.0	0.0	1.0	0.4	1.5	0.1	1.2	0.0	0.3	5.0	0.3	21.7	0.0	0.0	0.8	27.0	103.2	6.2	0.0	1.0	0.0	0.5	0.1	4.3	3.9	0.0	12.7	16.6	0.9	0.4	4.8	7.3	0.0	0.3	5.4	0.0	1.3	0.0	0.2	0.7	0.6	11.3	0.1	1.5	0.2	1.8	1.3	0.7	0.0	10.4	6.9	29.0	2.0	20.2	7.2	31.5	6.8	8.8	8.0	3.1	7.6	5.5	8.8	2.6	7.0	6.1	4.2	5.5	6.8	2.8	9.9	6.2	16.9	15.4	6.4	14.0	21.7	13.6	20.7	10.2	15.1	14.6
ARHGEF9	"KIAA0424, PEM-2"	ENSG00000131089	"Cdc42 guanine nucleotide exchange factor 9"	O43307	X	63634967-63809274	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035419, HPA055291"	Approved		Supported	Cytosol				Cytosol		"HPA035419: AB_10669859, HPA055291: "	"unprognostic (3.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.02e-5)"	"unprognostic (4.56e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.98e-2)"	5.7	9.6	22.6	4.5	42.6	3.2	6.9	19.5	38.2	6.0	8.2	7.1	1.2	10.9	6.2	4.2	7.7	5.4	6.0	22.0	24.6	22.4	6.8	4.1	4.3	4.6	12.5	28.3	10.4	4.8	11.8	8.3	4.4	17.4	8.2	8.7	9.9	4.5	7.0	3.9	7.0	8.1	8.4	8.5	4.9	6.9	2.2	9.9	2.1	6.1	0.8	5.4	7.3	3.2	5.4	3.7	1.8	3.6	11.5	8.5	2.8	4.5	7.0	11.0	7.0	5.0	6.8	0.9	8.3	6.9	7.7	6.7	0.5	4.9	9.6	6.1	5.1	0.1	4.9	10.1	7.5	13.1	5.0	8.1	3.1	0.4	2.5	4.1	3.5	8.3	4.5	3.8	12.6	5.1	1.1	15.8	7.5	6.5	8.3	2.3	7.6	8.1	12.6	22.6	9.5	4.8	4.1	0.2	3.1	3.9	7.5	4.2	5.3	4.8	2.6	5.1	5.2	24.1	3.5	5.4	4.1	7.5	6.1	7.4	3.6	1.0	2.8	1.8	8.5	3.6	5.6	3.5	4.6	4.9	3.7	5.4	5.6	5.2	1.6	11.5	2.4	2.9	4.1	2.8	22.6	42.6	19.5	37.2	24.6	22.4	12.5	28.3	17.4	9.9
ARID3A	"BRIGHT, DRIL1"	ENSG00000116017	"AT-rich interaction domain 3A"	Q99856	19	925781-975934	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 38.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 62.8;CACO-2: 21.2;K-562: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004793, HPA076330"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA004793: AB_1847870, HPA076330: AB_2732309"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (1.95e-5)"	"unprognostic (4.00e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-2)"	4.0	2.3	1.7	6.2	2.3	11.5	4.4	4.8	3.8	3.6	5.0	1.6	3.3	4.2	2.9	2.9	4.1	2.7	3.2	2.1	2.2	1.5	4.4	2.6	6.1	7.8	2.8	2.0	1.6	5.5	3.4	4.1	38.3	2.1	2.3	1.8	2.6	2.8	5.6	2.0	3.3	5.0	2.6	2.4	8.3	3.4	17.8	2.5	6.6	2.1	2.1	4.6	4.0	6.9	1.5	9.2	6.4	2.9	1.9	0.5	0.8	1.1	1.4	5.2	1.3	2.2	1.6	62.8	4.9	3.2	2.6	1.8	21.2	0.1	0.4	1.1	1.6	0.4	2.1	1.1	1.1	6.5	1.5	2.1	1.8	19.0	0.9	7.2	5.4	2.4	1.6	1.6	0.4	0.9	27.3	6.1	0.7	1.6	2.8	8.3	5.0	0.3	6.3	1.6	4.0	0.3	1.0	2.5	4.8	1.5	1.3	0.9	2.2	19.5	1.4	1.7	2.4	2.5	0.5	14.3	12.7	3.7	1.1	4.3	1.2	0.8	2.4	1.6	0.5	2.1	0.5	1.5	0.3	0.4	1.5	0.9	0.5	0.2	6.4	1.9	2.9	9.2	0.3	0.8	1.7	2.3	4.8	3.8	2.2	1.5	2.8	2.0	2.1	2.5
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298385-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favourable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favourable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	15.1	8.5	17.3	15.1	22.2	34.5	13.4	45.9	27.0	12.8	12.0	7.9	12.7	10.2	11.6	9.7	10.1	10.7	10.7	10.0	13.3	11.5	11.3	21.7	12.0	15.8	9.6	18.7	15.3	11.4	17.2	22.9	11.3	17.3	10.8	10.6	6.4	10.8	13.5	10.6	13.2	12.3	12.5	11.0	15.3	10.2	7.9	15.0	15.0	12.6	4.5	12.8	13.8	11.9	15.1	7.5	42.7	14.1	10.7	11.1	3.6	6.6	5.6	15.7	7.7	7.8	9.5	7.9	7.9	6.8	5.4	8.6	6.5	10.5	16.0	8.5	6.6	7.7	6.9	3.8	8.0	11.2	4.4	7.2	6.3	6.3	4.7	15.2	10.5	7.1	4.2	5.2	5.4	8.5	8.2	13.2	5.7	8.9	11.0	13.7	3.1	6.8	11.3	13.5	4.7	5.8	11.8	13.5	11.7	13.4	6.8	9.4	11.6	14.0	12.1	9.2	7.2	7.4	3.6	4.3	3.2	14.7	5.5	9.7	4.6	19.3	7.6	21.7	8.5	7.8	9.5	11.6	10.3	8.8	5.6	15.1	11.1	10.8	42.7	10.7	14.1	7.5	7.2	3.6	17.3	22.2	45.9	27.0	13.3	11.5	9.6	18.7	17.3	15.0
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901300-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	43.3	5.6	7.8	13.8	9.9	4.2	22.6	3.3	11.5	27.5	14.0	9.5	4.4	6.8	29.4	10.4	14.0	15.6	27.2	16.0	5.9	5.1	14.6	5.7	14.6	14.4	11.8	6.5	18.6	4.3	14.7	11.4	22.4	9.4	16.6	8.2	6.9	14.5	7.3	88.6	15.0	12.1	29.4	10.4	12.7	9.4	7.7	10.5	8.6	7.5	11.7	18.0	22.5	17.1	21.2	1.0	4.3	3.6	5.7	14.7	2.6	0.8	0.3	2.3	5.7	5.1	13.7	0.4	16.6	44.8	11.8	9.3	20.1	0.9	1.4	4.0	15.9	5.5	8.0	2.5	14.3	5.2	2.4	0.7	4.1	5.0	9.5	0.2	9.9	17.3	1.3	7.0	8.0	1.4	0.7	2.2	3.8	2.8	5.4	0.4	0.4	5.2	6.6	3.8	0.4	7.8	9.0	1.3	1.7	7.4	4.1	4.8	3.4	0.2	1.2	6.6	8.9	9.9	4.2	0.1	0.0	4.3	5.7	0.3	2.1	4.3	0.6	0.4	7.3	1.4	0.9	19.0	10.5	6.3	1.0	21.2	6.9	4.5	1.2	5.7	3.6	0.5	14.7	2.6	7.8	9.9	3.3	11.5	5.9	5.1	11.8	6.5	9.4	10.5
ARL13B	"ARL2L1, DKFZp761H079, JBTS8"	ENSG00000169379	"ADP ribosylation factor like GTPase 13B"	Q3SXY8	3	93980139-94055668	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048926	Approved		Uncertain	Microtubules,Cytosol				Microtubules	Cytosol	"HPA048926: "	"unprognostic (2.29e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.50e-2)"	10.0	6.3	6.6	6.0	9.0	2.4	8.4	6.2	9.0	10.7	6.6	6.5	3.8	3.8	12.5	10.2	6.8	11.8	10.6	7.6	8.9	6.3	10.9	8.2	10.7	5.1	9.0	5.9	10.4	6.0	11.6	17.1	7.8	10.3	6.8	4.4	10.2	5.9	7.3	3.1	6.5	6.7	9.4	9.3	8.3	6.2	10.7	9.4	7.3	14.2	7.8	4.3	8.7	7.4	5.8	7.7	5.6	7.4	5.3	6.5	2.8	5.6	8.4	5.2	3.6	6.9	2.5	2.7	6.0	3.3	9.1	11.7	4.9	2.7	3.9	8.0	5.1	3.2	5.0	3.7	11.6	8.7	5.8	8.2	4.4	3.9	5.0	9.4	4.5	3.7	2.4	10.3	13.0	3.5	8.1	4.2	5.2	3.4	8.3	0.4	2.5	7.2	6.4	19.3	1.5	5.0	0.8	14.1	4.2	12.3	0.5	6.9	1.8	3.0	3.6	8.9	9.6	3.8	5.0	1.6	1.5	7.6	6.5	6.3	5.1	5.6	6.5	4.8	6.5	6.8	6.1	5.8	5.9	5.4	5.2	4.5	5.8	5.0	3.2	5.3	7.4	7.7	4.3	2.8	6.6	9.0	6.2	9.0	8.9	6.3	9.0	5.9	10.3	9.4
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323051-30338227	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"				"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: , HPA048127: AB_2680277"	"prognostic favourable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favourable (7.49e-4)"	13.9	21.5	24.5	12.9	29.1	6.3	18.7	22.7	23.4	17.0	14.5	8.0	22.4	8.7	18.1	22.7	11.1	15.8	12.4	20.5	17.7	15.5	16.5	17.6	10.3	23.5	15.5	20.5	20.1	15.0	33.4	28.6	10.6	15.1	19.0	10.3	9.0	17.0	19.9	28.0	11.6	12.5	18.3	16.0	18.2	14.4	14.5	15.0	11.6	23.3	13.9	19.1	16.1	15.1	17.6	12.7	5.5	9.6	24.4	28.7	11.2	5.7	8.3	9.3	8.2	15.3	16.6	4.7	11.2	14.2	10.2	11.3	4.6	2.2	23.4	7.7	8.1	9.7	13.5	9.5	14.5	18.5	16.8	7.0	6.6	8.0	24.1	12.6	8.1	17.2	19.2	4.8	18.3	11.2	11.1	12.8	17.8	5.4	11.3	10.4	10.8	11.6	10.0	22.8	9.5	13.7	8.0	10.6	11.3	8.8	11.7	13.8	12.5	7.1	9.8	11.7	6.2	23.0	10.6	20.0	11.3	15.2	11.2	7.9	11.1	5.5	9.6	3.0	12.1	9.4	28.7	17.6	14.8	13.4	12.7	14.0	13.7	13.1	1.7	24.4	7.0	9.1	9.5	11.2	24.5	29.1	22.7	23.4	17.7	15.5	15.5	20.5	15.1	15.0
ARL2	ARFL2	ENSG00000213465	"ADP ribosylation factor like GTPase 2"	P36404	11	65014113-65022184	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044610	Supported		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol"				Nucleoplasm	"Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol"	"HPA044610: AB_10964207"	"unprognostic (9.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-3)"	"unprognostic (6.43e-2)"	"unprognostic (6.87e-3)"	"prognostic favourable (7.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.24e-2)"	39.6	32.0	37.3	17.7	78.7	19.8	26.8	16.1	46.5	21.2	23.5	34.7	13.4	23.9	26.8	20.2	23.7	35.2	22.4	52.6	34.8	32.7	33.8	6.6	23.1	14.8	36.1	38.2	27.2	29.9	22.5	15.4	25.5	32.7	25.3	15.5	30.3	26.9	33.1	78.3	19.6	23.4	28.2	44.9	16.7	18.9	31.4	28.7	7.9	26.3	23.6	12.9	24.7	22.8	43.7	37.8	18.7	21.8	21.0	40.7	34.7	35.8	57.1	17.7	26.2	48.1	36.6	16.1	17.7	40.9	25.4	25.1	16.1	24.8	13.8	33.8	24.9	23.0	18.6	31.1	12.1	14.5	29.2	13.9	25.8	24.3	36.9	16.9	12.7	28.8	26.1	21.1	47.4	33.7	32.9	25.9	17.0	42.4	14.0	38.1	27.7	46.7	7.4	19.4	33.3	27.3	15.6	33.0	18.6	15.1	15.7	49.7	16.5	20.8	25.3	47.8	16.1	38.0	18.2	8.9	12.5	8.5	22.6	24.5	38.8	10.2	21.8	18.7	34.8	21.2	37.6	43.7	32.2	33.6	27.6	37.3	36.8	40.7	2.8	21.0	12.4	37.8	20.6	34.7	37.3	78.7	16.1	46.5	34.8	32.7	36.1	38.2	32.7	28.7
ARL4A	ARL4	ENSG00000122644	"ADP ribosylation factor like GTPase 4A"	P40617	7	12686856-12690934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.3;K-562: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA064513			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA064513: "	"unprognostic (8.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.94e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.42e-3)"	"unprognostic (9.49e-3)"	22.6	3.6	12.3	6.7	6.7	30.8	21.5	3.0	15.8	16.9	19.4	3.2	7.4	11.3	13.6	9.9	23.5	11.0	7.5	7.0	6.0	4.6	5.2	6.6	8.6	9.5	10.3	11.0	5.2	3.5	1.8	5.6	19.2	8.5	12.0	13.7	4.0	39.0	6.8	4.2	34.9	44.6	12.8	6.5	9.5	10.3	71.2	6.7	3.7	8.8	9.2	6.5	10.5	25.0	22.8	7.4	3.3	15.4	6.5	17.6	7.3	10.0	10.7	28.7	61.3	4.6	7.7	0.0	4.1	3.8	6.8	4.1	9.5	7.6	0.0	1.8	5.8	2.9	6.3	5.2	6.9	2.2	4.7	2.1	14.1	8.8	9.6	8.8	3.7	3.4	20.9	3.9	17.7	16.1	72.8	9.9	6.9	4.3	0.4	12.5	10.4	12.4	0.0	10.0	4.7	8.9	4.9	5.2	4.9	6.8	7.2	1.4	3.5	7.3	5.6	2.7	9.6	10.2	16.6	4.5	5.9	2.3	7.1	3.7	10.8	3.3	7.8	0.3	6.3	13.0	17.6	21.4	15.0	9.7	7.4	22.8	7.4	6.1	1.1	6.5	15.4	6.6	8.9	7.3	12.3	6.7	3.0	15.8	6.0	4.6	10.3	11.0	8.5	6.7
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497053	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 74.3;U-2197: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavourable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (6.99e-5)"	9.3	6.8	11.1	17.7	9.6	30.3	12.8	19.2	21.2	6.4	6.2	4.9	3.1	3.9	3.6	9.4	13.9	7.6	19.2	3.6	9.1	16.5	8.5	7.9	9.9	28.9	9.4	11.8	2.6	3.6	0.8	5.4	16.8	23.9	6.7	7.4	5.9	14.2	3.6	1.7	15.1	8.1	3.6	5.3	28.0	7.9	1.9	1.8	44.7	2.5	4.4	20.1	14.0	10.8	5.9	17.8	18.7	0.5	18.2	29.7	8.7	7.4	23.0	3.0	0.3	2.7	0.8	7.6	0.7	3.4	0.9	1.7	10.6	14.6	0.0	1.9	1.9	5.6	3.0	15.9	1.1	6.9	1.0	0.0	0.1	0.1	2.8	0.0	0.6	1.7	10.6	9.0	5.5	1.5	0.1	24.7	4.2	1.0	21.4	0.0	3.0	5.2	0.0	13.2	4.2	74.3	8.3	10.8	1.9	0.2	1.7	1.1	0.2	0.4	3.4	14.9	5.7	40.7	14.3	12.3	4.4	0.3	25.5	0.0	7.7	18.7	0.4	8.4	29.7	0.5	29.2	5.9	20.7	23.5	3.2	5.7	18.7	20.9	0.7	18.2	0.2	17.8	25.8	8.7	11.1	9.6	19.2	21.2	9.1	16.5	9.4	11.8	23.9	1.8
ARL6IP6	MGC33864	ENSG00000177917	"ADP ribosylation factor like GTPase 6 interacting protein 6"	Q8N6S5	2	152717893-152761253	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 50.7;eosinophil: 45.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014743	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane"	Cytosol	"HPA014743: AB_1845030"	"unprognostic (4.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.86e-3)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (5.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (2.14e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.57e-1)"	"unprognostic (7.39e-2)"	6.1	5.1	8.4	4.2	10.1	14.5	9.4	6.6	11.4	4.7	5.7	10.1	7.9	6.5	5.6	2.5	7.8	5.1	5.6	3.2	11.4	4.9	3.3	2.3	7.2	7.2	15.9	7.4	6.9	3.3	2.6	8.3	10.2	12.9	4.6	4.1	3.4	4.9	4.8	9.7	8.2	6.1	4.7	12.4	8.7	6.0	7.3	13.5	2.5	4.1	4.6	5.4	6.3	18.9	5.7	7.4	50.7	3.5	2.6	5.6	3.6	8.3	5.2	12.6	3.5	3.1	3.8	19.5	10.3	4.2	8.6	10.8	13.6	12.3	14.8	10.3	4.4	9.6	6.6	4.5	9.0	23.1	14.1	12.1	5.2	12.0	4.2	9.9	11.3	2.8	5.3	9.3	7.5	6.4	13.4	9.5	6.6	6.0	10.2	10.7	12.2	11.6	11.8	12.5	11.9	3.6	6.2	11.0	11.9	9.4	0.9	8.2	4.2	7.5	8.9	13.8	9.4	9.6	9.0	9.1	9.1	11.9	6.6	8.5	11.3	50.7	2.8	45.4	4.1	3.0	4.2	5.7	4.2	4.1	3.2	4.9	4.3	3.7	7.5	2.6	3.5	7.4	5.6	3.6	8.4	10.1	6.6	11.4	11.4	4.9	15.9	7.4	12.9	13.5
ARMC5	FLJ13063	ENSG00000140691	"Armadillo repeat containing 5"	Q96C12	16	31458080-31467166	"Disease related genes, Predicted intracellular proteins"			"Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041524, HPA063706"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA041524: AB_10796676, HPA063706: "	"unprognostic (1.37e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.14e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (1.97e-6)"	"unprognostic (4.70e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	8.3	8.1	6.6	8.1	11.6	35.3	8.4	13.1	13.6	5.3	5.7	7.8	5.5	9.7	9.1	6.0	8.4	7.1	4.9	6.6	8.4	7.5	6.7	16.1	8.4	7.3	8.9	5.4	8.6	9.3	9.2	9.4	7.3	9.1	7.2	2.9	6.5	10.4	5.8	14.2	13.2	8.3	4.5	5.9	8.6	8.0	6.0	8.9	6.8	9.9	6.8	5.3	5.1	16.8	4.0	10.0	2.8	3.1	9.8	4.9	3.2	2.9	4.6	2.0	2.9	1.3	1.0	5.2	3.8	1.7	2.3	1.9	4.3	3.0	2.8	8.1	2.1	4.4	2.3	3.5	0.4	4.0	5.9	1.2	7.0	9.9	2.5	8.6	8.8	2.3	4.0	2.2	0.6	3.4	6.3	7.0	1.5	7.3	3.3	34.7	3.3	2.9	5.8	2.9	10.6	1.7	3.4	6.6	5.8	3.5	4.8	2.6	3.1	10.3	6.4	4.9	3.6	2.0	3.1	6.4	5.5	1.8	3.2	7.3	3.4	2.8	3.1	0.9	4.9	1.6	4.1	4.0	3.8	3.8	4.1	3.5	3.4	3.8	1.8	9.8	1.7	10.0	4.6	3.2	6.6	11.6	13.1	13.6	8.4	7.5	8.9	5.4	9.1	8.9
ARMC6	MGC19595	ENSG00000105676	"Armadillo repeat containing 6"	Q6NXE6	19	19033575-19060311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041420, HPA041681"	Supported		Enhanced	Cytosol				Cytosol		"HPA041420: , HPA041681: AB_10793928"	"unprognostic (2.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.40e-1)"	9.8	10.1	10.3	9.6	11.3	12.9	10.6	13.0	20.1	8.5	10.2	10.2	5.7	8.9	9.5	10.0	10.9	9.2	9.5	11.4	10.7	12.0	10.4	54.4	8.0	12.6	10.1	11.4	10.1	6.7	9.2	11.2	10.3	12.6	10.9	8.2	11.0	12.2	8.1	14.8	9.4	7.9	8.4	8.7	11.1	8.3	17.1	7.2	21.4	16.1	12.3	10.7	8.4	7.5	10.3	19.8	6.3	13.9	20.7	16.4	11.8	21.5	14.7	10.8	13.3	5.2	9.0	14.0	14.0	8.2	23.0	17.1	20.6	19.5	32.8	22.8	11.7	11.0	25.8	16.5	12.7	6.9	36.2	16.5	13.9	16.5	11.6	29.5	19.3	11.3	15.9	15.6	11.0	14.5	28.7	12.7	12.5	26.4	31.0	23.8	25.1	30.4	25.8	9.8	23.4	11.2	14.6	25.0	10.8	11.2	14.4	11.4	12.3	18.5	9.4	11.8	10.3	16.7	28.5	9.8	17.3	31.5	9.8	40.0	15.3	6.3	13.3	3.5	16.4	13.9	12.3	10.2	9.2	14.2	19.8	10.3	12.0	13.5	2.8	20.7	10.8	12.7	15.9	11.8	10.3	11.3	13.0	20.1	10.7	12.0	10.1	11.4	12.6	7.2
ARMC7	FLJ22160	ENSG00000125449	"Armadillo repeat containing 7"	Q9H6L4	17	75109952-75130265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024229, HPA053076"	Uncertain		Supported	Cytosol				Cytosol		"HPA024229: AB_2059152, HPA053076: "	"unprognostic (1.35e-1)"	"prognostic favourable (2.98e-4)"	"unprognostic (7.73e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.86e-2)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.98e-2)"	7.5	7.5	11.1	14.1	9.8	6.1	12.0	26.6	13.8	7.8	13.5	7.6	8.8	15.3	7.9	8.1	11.2	8.4	10.1	9.8	10.5	7.9	31.6	13.3	15.8	19.5	7.8	7.4	6.3	8.9	11.2	7.9	9.2	9.5	11.9	11.3	8.9	11.4	12.3	7.2	12.6	13.7	8.5	6.9	15.0	15.5	9.8	8.4	14.8	14.9	5.9	13.4	9.6	11.1	11.9	10.5	22.1	11.3	11.6	16.6	9.1	10.0	20.1	6.1	5.6	5.1	2.9	6.6	5.7	6.1	10.8	9.8	16.4	9.7	5.9	7.4	5.1	8.2	9.8	4.0	5.2	5.8	15.9	11.3	8.9	10.1	10.8	8.5	10.9	3.9	7.6	6.8	4.1	9.8	10.3	11.8	3.6	14.0	16.3	9.5	3.0	15.3	9.5	12.3	10.9	24.0	17.8	5.6	8.4	10.4	10.6	11.9	12.3	8.4	7.7	11.0	10.4	4.6	8.6	10.1	3.6	8.5	4.9	6.3	7.9	20.5	11.3	22.1	15.8	8.0	13.7	11.9	11.4	13.2	10.5	9.5	8.8	13.2	15.4	11.6	6.1	9.0	16.6	9.1	11.1	9.8	26.6	13.8	10.5	7.9	7.8	7.4	9.5	8.4
ARMC8	"DKFZP434A043, GID5, HSPC056, VID28"	ENSG00000114098	"Armadillo repeat containing 8"	Q8IUR7	3	138187248-138298389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036996, HPA044869"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA036996: AB_10672786, HPA044869: "	"unprognostic (2.04e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (3.51e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavourable (8.90e-5)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (2.15e-4)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	19.4	13.5	16.9	14.3	21.9	43.5	14.5	52.6	26.4	17.1	14.4	16.8	9.4	9.9	15.2	10.8	18.0	13.7	13.0	14.4	16.9	20.9	16.6	13.8	13.9	16.3	17.6	16.1	14.3	11.9	20.5	26.1	16.3	26.3	14.5	15.9	12.5	11.9	15.8	34.6	11.8	13.1	20.6	18.7	16.7	14.2	14.7	19.1	21.3	18.2	12.1	18.4	16.9	12.9	25.6	25.4	40.1	23.8	25.3	26.5	19.3	20.2	9.9	13.1	10.6	16.5	14.6	17.6	15.7	15.2	21.5	21.1	15.5	10.7	19.1	16.2	13.5	10.6	16.8	15.3	26.7	12.8	11.8	34.0	6.6	10.5	20.9	26.3	38.2	21.7	9.8	13.8	19.9	16.7	12.7	10.9	26.6	17.7	18.4	12.4	18.1	8.7	14.5	21.0	15.2	14.1	18.9	15.2	11.1	22.5	7.8	13.0	15.5	14.0	18.1	11.5	9.4	15.2	11.5	20.9	15.9	29.3	10.4	12.6	11.4	32.3	22.1	40.1	22.8	23.8	26.0	25.6	21.0	24.0	25.4	22.0	24.6	24.4	15.6	25.3	23.5	11.2	26.5	19.3	16.9	21.9	52.6	26.4	16.9	20.9	17.6	16.1	26.3	19.1
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing, X-linked 1"	Q9P291	X	101550531-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;ASC TERT1: 23.8;BJ hTERT+ SV40 Large T+ RasG12V: 27.3;LHCN-M2: 24.0;RH-30: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005685, CAB020695"	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"CAB020695: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	17.5	29.8	13.6	7.4	16.5	2.7	18.9	13.4	21.5	24.4	18.7	9.6	15.9	6.2	27.3	19.0	12.3	16.3	14.8	26.6	13.3	18.4	12.1	3.8	11.6	4.4	13.7	14.6	42.6	10.2	20.1	18.0	12.5	16.4	25.8	7.0	13.0	12.0	21.1	22.7	8.1	7.6	26.3	9.1	11.4	10.0	8.1	10.5	3.5	14.0	11.6	3.3	26.8	29.7	0.2	9.9	0.5	4.3	2.1	3.7	2.1	0.7	0.2	5.5	0.0	26.4	23.8	0.0	8.6	16.9	10.8	27.3	0.0	0.1	0.0	7.4	13.2	0.7	0.0	1.2	6.1	0.0	0.0	4.9	1.6	0.0	14.0	0.0	0.0	19.9	1.6	8.2	0.0	6.5	0.1	0.1	24.0	0.3	0.0	0.0	7.9	0.0	0.0	30.3	0.0	7.4	0.0	5.4	4.5	0.0	0.1	14.8	0.8	3.6	8.6	6.6	3.5	19.1	0.1	0.0	0.1	0.0	6.4	0.0	4.1	0.0	4.3	0.5	0.0	3.9	0.7	0.0	0.6	0.3	9.9	0.2	1.5	3.7	0.1	2.1	1.1	5.1	0.9	2.1	13.6	16.5	13.4	19.9	13.3	18.4	13.7	14.6	16.4	10.5
ARMCX3	"ALEX3, GASP6"	ENSG00000102401	"Armadillo repeat containing, X-linked 3"	Q9UH62	X	101622797-101627843	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000325, HPA000967, HPA001530"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: "	"unprognostic (1.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.23e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.12e-2)"	"prognostic favourable (1.55e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-2)"	21.0	39.2	26.6	14.8	32.9	8.5	20.5	20.5	36.9	30.6	18.8	21.0	37.1	13.3	26.9	67.8	12.7	17.1	22.0	31.7	28.0	26.6	24.0	17.8	19.1	12.7	27.8	29.6	26.7	38.2	62.0	37.9	28.5	35.4	29.1	14.8	13.6	34.8	31.6	25.5	7.9	13.8	24.6	25.7	24.1	19.0	9.2	22.8	8.2	31.9	17.1	13.7	21.4	21.3	11.6	18.8	25.2	11.8	10.2	14.8	9.4	8.7	6.0	16.2	9.0	37.5	41.8	3.6	19.3	18.7	8.5	24.7	7.1	8.2	3.4	11.1	22.5	1.7	12.2	7.1	10.4	6.7	7.7	6.2	20.2	10.1	29.7	6.0	14.9	23.1	9.5	10.2	11.0	16.1	4.8	30.0	23.1	3.9	5.0	0.2	8.3	1.3	6.4	21.2	3.0	11.9	3.6	7.6	6.4	9.3	0.6	20.0	7.1	6.2	22.5	11.3	7.4	25.5	3.7	24.3	6.5	0.0	17.2	4.9	9.5	25.2	11.2	9.5	10.9	11.3	14.8	11.6	10.8	9.5	11.3	7.9	12.2	8.5	4.1	10.2	11.8	18.8	6.6	9.4	26.6	32.9	20.5	36.9	28.0	26.6	27.8	29.6	35.4	22.8
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing, X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favourable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.6	13.2	11.4	7.0	17.3	6.4	13.8	24.3	19.8	11.2	9.5	8.7	13.1	7.9	13.3	12.5	10.1	11.9	7.5	7.8	11.1	6.3	10.0	15.5	8.3	6.9	8.1	12.9	16.5	25.3	14.5	26.4	6.1	12.8	16.6	11.9	9.2	13.4	11.0	6.1	9.9	10.4	10.8	7.0	10.2	11.7	6.1	8.4	9.5	15.3	7.0	9.6	10.4	9.8	9.7	9.3	2.5	9.8	7.1	15.9	8.5	8.0	7.3	17.2	9.1	7.7	8.7	9.7	7.9	6.1	9.3	16.6	8.6	10.0	0.0	9.7	7.9	7.0	15.3	7.5	10.6	0.0	6.1	8.1	9.2	7.1	10.0	14.7	9.5	10.8	9.8	8.0	9.7	9.4	7.8	0.0	12.3	7.1	10.4	1.7	7.7	13.8	10.3	42.2	0.0	6.9	11.2	8.2	7.3	14.2	7.4	11.3	5.1	7.1	9.5	6.9	6.2	7.8	5.6	0.0	5.7	0.0	5.4	15.1	17.7	0.0	9.5	2.5	12.0	9.8	11.5	9.7	11.3	9.4	9.3	6.0	15.9	12.3	0.8	7.1	6.0	8.1	7.7	8.5	11.4	17.3	24.3	19.8	11.1	6.3	8.1	12.9	12.8	8.4
ARMCX6	"FLJ20811, GASP10"	ENSG00000198960	"Armadillo repeat containing, X-linked 6"	Q7L4S7	X	101615118-101618001	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043030, HPA048125"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane"	"HPA043030: , HPA048125: "	"unprognostic (1.20e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.38e-2)"	15.1	17.2	11.7	12.1	12.1	7.6	12.7	10.9	12.1	18.7	12.0	15.4	22.6	6.7	17.3	25.9	17.3	14.1	12.4	15.6	11.3	12.6	14.1	12.2	11.2	12.1	13.1	10.3	21.3	27.2	23.4	21.0	16.3	13.1	17.7	9.0	11.8	39.2	23.5	6.5	11.3	10.4	17.1	16.7	22.6	10.6	9.0	11.4	17.9	17.3	9.7	19.3	18.8	13.7	12.8	14.1	10.0	7.0	8.1	8.7	6.4	6.6	7.8	12.3	7.0	25.2	15.0	2.4	13.9	13.6	12.5	24.5	4.7	6.4	7.1	14.3	13.0	6.9	11.9	5.6	9.8	6.1	7.3	6.6	10.9	6.2	11.6	6.4	8.4	9.3	5.8	7.7	4.0	12.7	5.4	9.1	18.7	16.3	9.4	0.0	8.8	1.6	9.7	16.5	2.6	9.0	0.9	6.8	6.4	8.2	0.0	10.4	5.7	3.1	9.8	15.3	6.9	21.2	3.2	11.3	6.0	0.0	4.5	1.7	5.0	10.0	3.8	6.3	6.5	7.0	8.7	12.8	7.0	7.3	8.1	9.1	8.4	7.8	0.5	8.1	5.0	14.1	3.9	6.4	11.7	12.1	10.9	12.1	11.3	12.6	13.1	10.3	13.1	11.4
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			3200000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavourable (7.09e-4)"	"prognostic favourable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	15.5	15.8	10.7	11.5	16.2	3.9	20.5	17.5	18.2	13.7	12.8	7.5	9.9	14.7	13.0	13.4	11.5	10.6	9.0	13.4	11.4	13.0	34.7	33.2	15.4	15.0	10.9	8.6	15.3	7.7	7.7	13.8	26.7	18.6	11.6	14.2	9.2	8.8	10.6	14.9	7.0	16.2	11.8	10.6	16.2	10.9	10.8	9.4	13.2	26.5	11.9	14.0	14.1	10.6	9.6	12.3	26.9	18.6	10.8	13.2	10.8	8.1	6.3	13.2	11.8	10.8	17.0	21.2	15.3	13.4	12.9	17.1	16.2	6.7	12.2	10.3	10.8	8.3	38.8	11.4	21.8	13.4	12.2	8.8	7.5	18.8	13.4	16.5	11.1	13.7	8.1	17.2	10.2	18.2	12.6	15.7	16.0	33.9	10.3	15.8	22.4	5.3	13.6	11.4	9.6	39.4	10.4	5.5	3.5	12.8	12.1	7.8	34.2	13.0	15.0	6.3	8.8	23.3	12.1	7.3	9.2	14.5	11.2	20.4	7.4	22.8	14.7	26.9	7.8	18.6	10.3	9.6	10.2	8.3	12.3	7.1	9.5	8.7	12.2	10.8	16.6	4.6	13.2	10.8	10.7	16.2	17.5	18.2	11.4	13.0	10.9	8.6	18.6	9.4
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325910-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"			2400000	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	36.6	39.8	40.2	25.2	41.0	18.7	49.1	32.3	55.9	40.0	43.6	32.3	37.9	50.1	30.4	45.9	58.3	43.3	32.1	65.3	45.9	43.5	30.6	41.2	29.6	32.2	38.6	39.7	47.2	41.9	30.9	31.4	31.8	40.6	28.2	44.2	33.9	31.7	36.7	20.9	46.1	55.0	31.9	27.9	26.8	53.1	28.6	25.1	23.7	44.4	41.8	31.6	31.5	33.9	11.1	16.1	33.2	29.1	10.9	12.6	9.9	45.4	24.8	28.2	12.9	26.3	44.8	24.0	32.7	38.4	33.4	33.3	27.8	52.5	15.9	48.4	39.7	19.3	36.9	47.5	40.4	7.9	31.1	8.5	18.5	22.4	29.0	10.0	11.2	41.6	26.6	43.0	46.0	54.6	21.3	18.5	51.2	66.5	16.7	13.4	26.4	56.1	9.9	19.5	19.5	24.8	27.6	29.1	24.9	32.0	46.0	43.6	23.0	14.8	42.3	42.8	38.4	75.4	52.1	7.2	13.2	22.6	37.0	22.5	56.1	33.2	18.9	31.9	9.8	28.6	7.6	11.0	9.3	12.6	16.1	11.1	12.1	9.1	23.8	10.9	29.1	11.7	12.1	9.9	40.2	41.0	32.3	55.9	45.9	43.5	38.6	39.7	40.6	25.1
ARPC1B	"ARC41, p40-ARC, p41-ARC"	ENSG00000130429	"Actin related protein 2/3 complex subunit 1B"	O15143	7	99374249-99394814	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 213.6"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004832	Approved		Supported	Vesicles,Cytosol			53000000	"Vesicles, Cytosol"		"HPA004832: AB_1845044"	"unprognostic (5.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (2.57e-4)"	"unprognostic (4.37e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.27e-2)"	31.8	17.8	8.7	50.7	14.4	56.4	35.4	1.9	7.7	17.9	30.7	8.4	18.1	32.6	17.4	21.8	16.0	18.3	23.4	24.4	5.7	7.0	27.9	34.8	40.0	92.8	10.7	3.7	11.6	13.0	3.8	13.1	36.2	9.4	15.6	10.5	20.6	18.3	15.1	10.6	10.0	42.3	12.1	10.2	81.8	16.3	10.8	9.3	31.0	23.0	13.7	37.2	19.0	21.1	53.5	133.7	127.2	154.4	38.9	83.4	213.6	15.7	28.6	2.2	6.2	8.3	30.2	21.9	21.9	22.1	8.8	7.8	18.6	61.4	27.3	41.0	23.8	11.9	2.8	19.3	3.6	22.2	10.3	19.9	8.3	12.8	24.0	19.9	67.8	16.8	10.0	12.4	12.4	23.2	22.1	66.0	12.8	72.7	22.0	43.6	7.8	62.4	17.8	1.9	67.0	18.2	7.8	1.8	5.8	14.9	65.8	110.1	15.5	40.6	34.0	25.2	20.9	44.4	27.5	12.3	24.4	33.5	25.1	52.0	45.1	53.7	153.2	121.6	53.8	154.4	50.2	53.5	62.8	59.6	133.7	42.8	37.0	49.3	127.2	38.9	142.0	77.9	83.4	213.6	8.7	14.4	1.9	7.7	5.7	7.0	10.7	3.7	9.4	9.3
ARPC2	"ARC34, p34-Arc"	ENSG00000163466	"Actin related protein 2/3 complex subunit 2"	O15144	2	218217094-218254356	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001994, HPA008352"	Approved		Supported	"Golgi apparatus,Cytosol"			24000000	Cytosol	"Golgi apparatus"	"CAB001994: , HPA008352: AB_1854887"	"unprognostic (7.42e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavourable (1.07e-7)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.41e-2)"	46.9	28.8	32.6	78.6	37.9	79.5	67.1	19.3	31.4	34.1	42.5	19.9	26.3	34.0	37.2	35.8	103.4	30.2	51.2	52.3	40.7	25.0	38.2	35.1	71.8	118.3	26.4	27.8	30.7	31.2	18.9	23.0	67.1	26.8	35.6	48.6	23.7	39.0	32.7	60.1	56.2	59.2	69.1	23.9	73.7	43.8	36.5	22.3	59.0	27.2	72.7	102.5	58.5	49.7	60.6	101.2	167.7	145.0	50.0	76.2	149.4	46.7	20.5	29.5	21.9	39.6	53.3	54.9	73.1	70.6	61.8	62.2	63.5	49.8	38.2	39.9	83.1	54.5	39.9	108.1	72.9	31.8	28.4	38.8	31.0	34.8	44.4	80.9	109.7	35.4	87.5	61.8	51.3	80.6	18.3	75.6	94.7	32.4	43.9	94.9	35.1	20.0	33.5	26.1	52.0	62.2	85.3	17.4	31.7	26.6	29.6	62.8	21.4	74.5	70.1	80.5	30.8	36.1	54.7	41.2	43.6	66.7	58.3	50.9	60.5	106.1	97.2	143.7	75.0	131.3	50.2	60.6	58.9	72.7	101.2	47.6	42.1	62.0	167.7	50.0	145.0	56.1	76.2	149.4	32.6	37.9	19.3	31.4	40.7	25.0	26.4	27.8	26.8	22.3
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635757	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 154.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"			15000000	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	46.6	25.1	24.9	57.5	24.3	25.2	28.9	13.8	24.8	26.6	42.3	26.5	18.6	40.8	39.0	26.7	44.5	29.3	24.6	36.8	28.2	22.3	28.8	29.7	52.3	58.3	28.4	18.7	27.3	21.5	12.4	18.2	84.8	20.0	23.2	29.2	17.0	25.4	16.5	16.4	25.2	47.3	32.8	46.0	79.9	35.6	21.7	23.5	61.2	27.5	22.7	52.8	30.6	30.8	27.4	68.9	154.0	96.6	30.7	40.7	124.3	50.8	28.2	24.3	16.7	20.1	28.7	58.2	69.9	53.9	30.5	24.9	25.5	36.1	46.8	79.6	40.2	35.4	17.1	23.8	16.1	67.4	15.3	28.3	38.4	22.0	32.7	41.0	55.2	34.7	25.4	36.9	29.4	35.7	21.5	38.8	39.5	20.9	38.2	11.0	23.2	10.8	35.6	21.6	45.2	17.1	26.4	10.5	28.3	72.9	31.5	27.0	31.6	36.7	79.5	44.6	23.2	49.8	67.3	46.3	51.1	32.0	35.1	29.6	34.2	79.3	80.0	124.1	34.8	89.8	27.7	27.4	34.2	35.5	68.9	24.4	37.1	37.6	154.0	30.7	96.6	32.5	40.7	124.3	24.9	24.3	13.8	21.1	28.2	22.3	28.4	18.7	20.0	23.5
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6"	"Group enriched"	"Detected in some"	8	"MOLT-4: 34.9;REH: 19.4;RH-30: 11.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 146.9"	"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017303	Enhanced		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		1.2	1.3	12.3	1.5	146.9	4.6	1.1	27.8	67.9	1.1	1.4	0.3	0.0	1.3	1.1	1.1	3.2	1.1	1.1	1.1	6.8	2.8	2.0	2.9	1.2	1.2	3.9	11.5	1.1	1.1	1.1	1.9	1.1	6.7	2.0	1.5	0.0	1.1	1.3	43.6	1.1	1.4	1.1	0.8	1.2	1.1	1.1	14.8	41.2	1.5	3.5	1.5	1.1	0.1	0.1	12.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	34.9	0.0	0.0	1.4	19.4	11.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	12.3	146.9	27.8	14.7	6.8	2.8	3.9	11.5	6.7	14.8
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"		4500000	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favourable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	19.0	15.2	14.0	15.2	15.7	16.6	15.2	11.9	17.9	12.0	20.3	21.4	26.4	30.2	13.3	21.4	15.6	18.5	23.3	18.8	13.4	8.8	17.5	24.1	15.7	16.8	19.1	10.3	9.3	45.4	13.1	20.4	18.5	17.3	15.8	8.8	14.0	36.8	21.9	6.3	11.1	23.4	8.7	13.2	25.6	23.6	27.2	17.9	10.6	18.7	7.5	16.5	14.8	13.3	5.6	15.7	30.1	19.8	3.9	8.9	7.7	4.0	5.7	2.8	5.3	20.5	11.2	6.9	6.6	8.0	2.9	4.9	1.6	6.3	2.7	4.0	10.7	6.3	0.6	6.0	0.4	1.2	4.3	1.6	6.4	5.7	14.2	2.4	16.8	13.3	11.8	4.7	3.0	6.4	1.7	38.4	5.8	4.6	2.1	2.7	0.8	5.6	1.9	0.2	12.6	4.8	6.3	1.3	4.2	9.3	8.3	4.7	3.7	3.0	11.3	2.0	7.8	7.4	1.9	9.1	0.8	2.1	5.9	2.1	6.7	4.3	13.7	17.1	8.9	16.0	7.9	5.6	6.5	7.3	11.2	5.6	3.9	5.3	30.1	3.9	19.8	15.7	8.5	7.7	14.0	15.7	11.9	17.9	13.4	8.8	19.1	10.3	17.3	17.9
ARSF		ENSG00000062096	"Arylsulfatase F"	P54793	X	3041471-3112726	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;kidney: 11.5;skin 1: 8.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;U-266/70: 1.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"					"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"											HPA000549			Uncertain	Cytosol	"Secreted in other tissues"			Cytosol		"HPA000549: AB_1845055"	"unprognostic (2.19e-2)"	"unprognostic (8.88e-2)"		"unprognostic (2.87e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.70e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.48e-1)"	0.0	4.6	2.7	0.0	5.3	0.0	0.1	0.0	1.9	0.4	0.0			0.0	0.0	2.5	3.1	0.0	0.0	0.0	1.3	0.5	11.5	1.7	0.0	0.0	1.5		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	8.3	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.5	0.6	1.5	0.3	0.2	1.9	0.3	0.8	0.3	0.0	0.2	0.4	0.5	0.7	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.3	0.2	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.1	0.5	0.1	0.1	1.1	0.1	0.1	0.8	0.3	0.3	1.9	0.3	0.4	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.3	0.3	0.3	1.2	0.8	0.1	0.2	0.1	0.0										
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443660	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 13.0;monocytes: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"			25000	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: , HPA048565: "	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (5.63e-8)"	"prognostic unfavourable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	34.1	17.2	10.5	9.5	12.5	29.7	19.8	6.4	21.8	19.3	8.9	9.1	6.6	4.4	15.6	18.9	10.5	11.8	14.5	17.5	10.0	11.0	7.9	7.6	26.2	12.9	11.3	8.0	15.2	6.8	21.7	8.2	27.3	15.2	9.9	7.2	13.9	6.2	13.9	13.0	12.1	8.4	16.6	11.9	26.1	8.0	21.7	9.7	5.6	12.3	10.6	14.5	12.9	21.2	1.5	4.1	13.0	6.6	0.7	1.6	1.1	15.3	11.5	16.8	9.5	14.6	21.7	13.5	16.4	28.7	20.1	21.5	5.8	5.8	3.5	11.7	23.8	3.9	8.6	14.4	28.1	5.5	5.2	6.1	6.7	7.4	37.6	2.6	1.9	20.4	4.8	10.6	17.7	21.0	3.1	14.1	17.5	4.6	3.5	2.7	4.2	10.5	4.9	3.0	2.4	5.1	8.3	4.8	15.7	12.1	7.4	8.7	6.2	6.0	61.6	16.1	7.8	6.3	24.1	13.0	3.0	2.5	11.9	3.8	17.9	0.0	2.4	1.6	0.7	2.4	0.4	1.5	1.2	1.0	4.1	1.3	1.6	1.0	13.0	0.7	6.6	0.4	0.8	1.1	10.5	12.5	6.4	14.6	10.0	11.0	11.3	8.0	15.2	9.7
ASAP2	"CENTB3, DDEF2, KIAA0400, PAP, SHAG1"	ENSG00000151693	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 2"	O43150	2	9206765-9405683	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018615	Approved		Supported	Cytosol			66000	Cytosol		"CAB018615: AB_2242947"	"unprognostic (1.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (4.68e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.58e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.24e-2)"	13.7	3.4	7.3	8.2	14.5	0.9	11.7	16.3	13.9	13.8	15.3	8.1	6.8	12.1	19.3	10.5	8.1	10.1	16.5	10.5	8.1	5.6	21.7	3.7	9.0	2.6	10.7	7.3	7.9	7.0	12.4	44.1	9.2	10.8	6.6	14.4	10.7	7.1	8.9	3.3	12.3	13.5	12.6	8.7	1.6	21.6	38.5	7.8	0.1	17.5	6.1	3.3	8.5	11.4	0.0	0.9	6.2	0.0	0.0	0.0	0.3	11.8	6.9	12.6	7.5	9.3	13.1	2.1	11.9	9.6	8.8	8.9	4.7	17.8	0.0	10.6	13.4	11.4	6.9	21.0	10.9	8.5	2.9	2.7	5.3	9.0	22.8	0.0	0.8	4.9	8.6	10.6	34.6	18.1	1.2	1.2	34.2	7.4	3.4	0.7	6.0	8.1	6.6	19.0	2.2	17.3	9.2	5.6	21.6	10.0	6.6	11.1	4.6	1.9	28.2	14.9	0.7	11.5	10.9	0.0	0.0	0.0	10.8	0.0	18.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	7.3	14.5	16.3	11.6	8.1	5.6	10.7	7.3	10.8	7.8
ASB2	ASB-2	ENSG00000100628	"Ankyrin repeat and SOCS box containing 2"	Q96Q27	14	93934153-93976791	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.6;RPMI-8226: 7.8;U-266/70: 23.4;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	8	"eosinophil: 23.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001546			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA001546: AB_1078224"	"unprognostic (5.65e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.62e-6)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.49e-7)"	"unprognostic (2.51e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.27e-1)"	3.1	0.5	0.2	7.9	0.8	0.4	0.5	0.2	1.7	7.4	14.0	0.0	4.6	2.2	11.9	5.7	7.2	6.5	7.7	17.2	0.2	0.2	0.3	0.3	0.8	2.3	0.3	0.6	2.3	0.3	0.3	0.2	0.3	0.5	8.5	1.5	1.5	1.6	5.8	96.9	0.5	4.4	24.4	0.3	1.5	5.0	0.3	0.0	0.0	0.7	25.7	4.7	14.3	4.5	0.9	2.6	23.1	3.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	1.7	0.0	0.0	0.0	0.1	0.0	23.4	5.2	0.8	0.2	2.4	0.5	0.0	0.0	23.1	0.8	1.0	0.1	0.9	0.8	1.7	2.6	0.2	0.1	0.2	0.0	0.0	3.0	0.1	1.1	0.5	0.2	0.8	0.2	1.7	0.2	0.2	0.3	0.6	0.5	0.0
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavourable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	17.2	23.3	23.2	13.3	25.9	10.9	20.9	27.4	23.8	21.2	12.4	25.7	19.6	9.5	16.9	21.3	16.4	17.2	16.0	26.4	24.7	21.6	18.6	24.3	12.7	19.8	35.2	14.9	21.9	24.8	19.3	22.0	14.5	28.2	15.4	12.9	13.1	11.9	19.5	25.7	14.8	12.5	18.0	35.4	16.9	13.7	20.9	34.5	20.8	17.8	9.4	20.9	18.0	15.7	24.9	22.9	25.4	14.9	19.7	24.2	14.6	13.2	17.4	13.3	25.1	18.4	19.3	10.2	8.1	17.3	13.8	17.0	18.9	47.8	17.9	16.6	11.7	17.2	10.6	16.2	14.9	12.6	9.4	11.3	14.4	17.4	16.6	12.3	11.9	18.1	35.6	14.8	20.8	16.8	15.5	22.4	14.7	12.6	16.1	17.0	7.0	4.2	9.1	10.7	13.1	23.7	8.9	12.6	9.0	11.2	28.9	21.8	9.9	8.4	16.0	7.0	13.3	5.5	8.5	13.9	17.9	21.7	11.3	28.1	5.4	16.5	14.9	25.4	14.5	14.7	14.4	24.3	17.2	15.2	15.1	24.9	24.2	21.9	9.4	19.7	11.5	22.9	21.6	14.6	23.2	25.9	27.4	23.8	24.7	21.6	35.2	14.9	28.2	34.5
ASCC2	"ASC1p100, DKFZp586O0223, FLJ21588"	ENSG00000100325	"Activating signal cointegrator 1 complex subunit 2"	Q9H1I8	22	29788608-29838304	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001439, HPA052879"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA001439: AB_1078229, HPA052879: "	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.97e-3)"	"unprognostic (5.19e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.05e-3)"	19.5	24.2	13.1	22.1	15.1	32.3	23.1	13.4	14.0	16.8	16.9	17.9	22.5	16.5	17.1	17.7	31.1	14.6	19.0	17.7	10.8	8.2	15.8	35.3	19.2	20.2	15.4	9.1	16.2	18.4	17.5	20.6	23.2	12.5	20.1	17.8	17.6	22.2	30.9	50.0	21.7	22.3	14.2	12.9	22.7	25.8	41.0	13.0	28.9	21.9	25.0	26.6	19.1	21.2	11.3	21.1	28.5	27.6	17.3	18.8	10.9	19.6	11.5	12.5	16.9	18.7	16.7	17.9	20.5	15.8	21.4	21.4	13.3	10.7	19.7	14.8	19.8	24.0	16.0	23.3	18.1	25.1	27.9	16.9	14.6	15.9	23.6	30.2	51.3	17.9	21.2	24.3	22.3	18.7	17.3	19.1	19.3	24.3	18.5	15.9	9.1	15.7	22.3	15.3	20.6	13.1	32.6	19.4	17.0	19.1	21.1	15.3	14.9	15.9	18.4	29.9	5.0	18.1	20.3	22.9	17.5	23.3	17.4	17.0	21.5	18.2	16.7	28.5	18.8	27.6	16.8	11.3	14.2	15.8	21.1	8.9	14.7	14.8	5.1	17.3	22.5	12.0	16.4	10.9	13.1	15.1	13.4	14.0	10.8	8.2	15.4	9.1	12.5	13.0
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	15.9	15.4	10.9	15.5	14.5	13.6	13.4	16.1	11.7	16.7	13.2	7.7	10.1	11.4	16.4	12.9	18.4	11.3	11.1	14.9	9.7	8.4	10.4	28.3	12.6	13.1	13.1	7.6	13.8	15.1	25.0	38.6	26.1	10.4	16.4	17.1	6.4	15.4	14.0	13.6	15.3	16.1	12.2	15.5	17.7	11.5	11.7	12.4	25.0	10.6	11.6	15.2	16.0	17.9	8.5	9.4	5.9	6.4	6.0	7.8	1.8	7.0	8.8	13.3	8.2	14.9	19.0	20.7	31.0	20.0	10.7	12.4	18.0	5.7	21.7	6.1	20.8	15.9	11.4	27.5	17.4	13.7	9.8	16.4	16.5	11.7	13.7	17.4	12.7	17.2	14.1	15.6	19.9	19.6	19.4	9.9	29.5	6.8	8.6	5.3	7.0	6.7	10.5	10.1	8.0	10.6	20.0	8.7	6.6	12.9	11.7	5.3	6.5	9.9	26.9	12.0	9.1	10.3	13.0	4.3	3.9	19.4	8.6	13.2	12.5	5.9	3.9	2.4	6.7	6.4	7.8	5.8	5.6	6.0	4.1	8.5	6.5	6.2	0.3	6.0	5.2	9.4	4.3	1.8	10.9	14.5	16.1	11.7	9.7	8.4	13.1	7.6	10.4	12.4
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957686-102960516	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.3;liver: 23.0;pituitary gland: 29.4"	"Group enriched"	"Detected in some"	22	"SCLC-21H: 32.6;SH-SY5Y: 17.6"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA029217: AB_10669595, HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.9	2.8	11.1	0.7	6.9	0.7	0.7	3.3	19.3	1.3	0.9	6.6	0.0	0.9	1.0	0.8	0.7	2.2	0.8	0.7	8.5	5.8	0.8	23.0	1.7	1.4	7.6	4.7	1.6	0.9	0.7	29.4	0.8	13.9	1.1	1.0	0.0	0.7	0.8	0.8	0.7	0.8	0.9	18.7	0.7	3.2	0.9	7.3	6.0	1.0	0.0	0.8	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	6.9	3.3	10.7	8.5	5.8	7.6	4.7	13.9	7.3
ASIC3	"ACCN3, DRASIC, TNaC1"	ENSG00000213199	"Acid sensing ion channel subunit 3"	Q9UHC3	7	151048292-151052756	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 16.9;U-266/84: 8.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049155, HPA054805"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA049155: , HPA054805: "	"unprognostic (8.71e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.45e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-12)"	"unprognostic (1.49e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.31e-3)"	2.6	2.4	6.8	0.9	27.1	1.5	1.3	20.1	15.4	3.6	2.3	0.9	0.5	2.9	4.9	3.5	0.6	2.4	1.9	2.4	6.5	5.3	1.5	1.3	2.7	1.9	4.2	9.9	3.0	1.4	1.4	7.1	1.8	6.2	1.9	1.8	0.7	1.7	1.4	9.0	3.5	2.7	2.4	6.0	2.1	2.8	10.2	2.2	0.5	1.1	0.5	1.9	0.9	1.2	0.0	0.0	0.0	0.8	0.0	0.7	0.0	1.3	3.5	1.6	2.4	3.3	0.0	7.2	0.4	0.0	0.3	0.4	0.7	1.6	0.8	0.4	0.2	2.2	0.9	0.0	0.7	7.7	4.1	1.6	2.6	0.0	0.0	0.1	3.8	0.5	0.5	0.2	0.0	0.1	3.8	6.3	0.5	5.9	0.3	0.4	1.7	2.8	2.9	1.6	0.5	0.3	1.3	2.1	8.4	0.6	0.4	4.1	1.7	0.4	0.1	1.5	2.2	4.0	1.0	16.9	8.9	0.1	2.0	5.6	1.4	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.8	27.1	20.1	15.4	6.5	5.3	4.2	9.9	6.2	2.2
ASL		ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075798-66093558	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB003696, HPA016646"	Enhanced		Approved	Cytosol			10000000	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavourable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	5.6	4.8	4.0	8.0	4.3	7.3	5.9	7.2	7.4	5.5	17.2	3.7	7.8	20.8	5.0	7.1	7.7	4.9	19.5	4.3	3.7	4.3	16.0	99.5	8.1	4.5	4.4	6.2	5.9	10.4	3.3	5.8	3.3	7.2	5.4	12.4	5.8	7.1	5.7	2.4	4.1	16.6	3.4	3.2	8.6	12.6	2.1	3.5	1.2	7.1	7.9	5.9	5.2	5.9	8.6	19.3	20.7	18.4	30.4	9.2	10.7	18.2	7.5	4.1	14.8	9.4	7.3	9.0	12.8	11.2	18.3	16.7	16.8	22.6	5.6	20.5	16.8	5.0	2.6	21.7	5.3	4.6	3.4	7.4	7.3	26.1	17.7	8.4	21.7	13.7	7.9	12.8	20.5	18.0	13.1	10.7	10.1	13.0	1.7	11.6	6.2	9.7	4.5	4.3	19.2	13.3	11.0	7.1	9.7	11.7	40.8	4.4	17.8	7.6	20.4	23.2	12.0	9.2	16.5	11.7	6.1	7.3	21.9	16.0	18.7	12.1	18.1	20.7	7.7	18.4	6.5	8.6	5.2	6.1	19.3	5.6	3.7	4.0	4.0	30.4	13.8	1.2	9.2	10.7	4.0	4.3	7.2	7.4	3.7	4.3	4.4	6.2	7.2	3.5
ASMTL		ENSG00000169093	"Acetylserotonin O-methyltransferase like"	O95671	X	1403139-1453762	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA003630, HPA021865"	Supported		Enhanced	Cytosol				Cytosol		"HPA003630: AB_1078230, HPA021865: AB_1845099"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.17e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.70e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-1)"	10.4	11.7	28.5	8.9	42.3	9.1	33.6	24.5	38.9	46.4	10.6	3.3	3.3	6.9	52.0	9.2	8.6	11.4	8.2	50.0	29.4	11.4	35.2	15.3	7.0	11.8	25.5	55.3	47.6	13.2	9.9	31.4	27.5	36.7	12.5	4.6	3.3	16.2	16.0	10.0	11.0	8.9	7.5	31.9	11.5	9.0	4.6	25.0	3.3	12.8	3.3	7.2	9.1	31.5	19.8	23.3	34.5	16.4	27.8	16.9	12.3	5.2	9.1	10.9	8.3	6.6	10.3	15.3	6.2	8.2	7.1	9.2	8.4	6.3	9.2	3.5	8.2	1.9	2.8	3.0	4.5	13.7	9.2	8.0	6.1	9.9	15.0	3.7	51.6	13.6	5.2	5.4	5.3	8.4	4.0	7.5	5.6	19.6	16.0	14.7	13.2	5.7	13.1	10.4	22.5	5.0	2.9	0.4	5.1	8.4	10.8	7.7	2.5	5.0	10.9	6.0	6.6	11.3	2.3	9.7	2.9	23.5	7.6	5.4	1.7	20.1	14.2	34.5	16.9	16.4	14.8	13.8	15.3	15.6	12.1	19.8	13.5	10.6	20.4	27.8	11.5	23.3	16.5	12.3	28.5	42.3	24.5	38.9	29.4	11.4	25.5	55.3	36.7	25.0
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97852118-97872542	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;T-cells: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol				Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (8.79e-5)"	"prognostic unfavourable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavourable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	6.5	7.5	15.9	10.9	21.4	7.6	9.9	31.7	32.3	5.7	10.1	9.4	5.6	6.5	10.0	19.9	10.2	6.9	6.8	9.2	24.5	20.4	6.5	5.9	9.6	16.0	16.3	13.4	19.2	68.0	16.7	16.7	3.2	35.9	9.2	12.7	4.4	49.9	9.3	3.5	13.6	7.8	11.3	20.6	11.0	20.8	16.9	9.2	3.6	16.7	8.2	15.0	9.6	6.6	8.6	1.4	1.5	1.2	2.2	13.2	3.2	18.8	7.2	7.3	59.3	5.8	8.2	17.9	13.9	8.9	6.7	19.9	9.3	7.6	14.8	7.0	28.3	8.6	18.9	22.0	15.9	18.5	14.0	4.7	3.6	6.9	53.7	30.2	13.3	16.1	74.0	8.7	53.8	5.4	26.5	52.6	10.4	39.9	0.8	8.0	10.0	19.7	2.3	1.3	38.8	4.3	3.7	31.9	24.0	3.6	19.3	75.0	8.2	21.2	1.4	3.3	21.8	8.7	6.5	62.4	31.1	56.4	41.2	13.8	31.7	1.5	0.3	0.5	3.8	1.2	4.9	8.6	7.4	3.4	1.4	6.2	10.2	5.5	1.5	2.2	0.8	0.1	13.2	3.2	15.9	21.4	31.7	32.3	24.5	20.4	16.3	13.4	35.9	9.2
ASNSD1	"FLJ20752, NBLA00058, NS3TP1"	ENSG00000138381	"Asparagine synthetase domain containing 1"	"L0R819, Q9NWL6"	2	189661385-189670831	"Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036132, HPA036133, HPA075042"	Uncertain		Approved	Cytosol				Cytosol		"HPA036132: , HPA036133: AB_10696650, HPA075042: "	"unprognostic (1.32e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.15e-3)"	"prognostic favourable (4.54e-4)"	"unprognostic (8.42e-2)"	"prognostic unfavourable (8.66e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.98e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	23.1	22.4	25.5	15.9	24.7	25.5	29.1	41.0	29.4	22.7	19.5	14.1	18.1	18.0	23.6	17.3	18.2	20.6	18.2	23.9	22.9	26.0	25.0	31.9	16.9	22.3	24.2	22.6	33.2	22.4	20.8	36.8	26.8	29.1	19.6	16.5	13.2	18.2	18.6	52.4	14.0	15.4	23.9	27.8	22.0	18.1	14.0	21.8	20.1	25.0	19.8	20.8	22.4	23.6	15.9	11.0	41.9	11.2	21.5	24.5	15.2	13.2	10.4	21.9	18.4	23.9	23.3	19.3	29.0	27.3	31.4	31.2	25.9	9.5	26.5	17.6	24.8	11.0	23.6	20.1	36.8	27.8	26.4	24.6	19.8	26.0	26.6	24.2	13.8	23.8	14.9	27.4	24.2	28.0	22.8	20.0	29.1	17.5	28.7	25.9	32.8	40.8	16.3	19.7	25.2	17.6	18.8	25.1	15.9	20.9	15.5	24.6	22.3	22.5	21.8	25.4	19.7	21.5	28.5	29.3	39.5	46.5	21.6	14.5	22.5	24.6	11.2	41.9	17.7	9.4	21.5	15.8	19.5	19.0	11.0	15.9	23.3	20.8	20.4	21.5	10.3	10.1	24.5	15.2	25.5	24.7	41.0	29.4	22.9	26.0	24.2	22.6	29.1	21.8
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503419	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.3;kidney: 33.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.1;ASC TERT1: 6.3;CACO-2: 5.4;HSkMC: 11.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Uncertain	Cytosol				Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	10.9	4.1	14.5	1.8	37.6	1.7	3.3	3.0	19.4	6.2	3.6	35.2	3.1	9.7	4.1	5.5	4.5	5.0	3.3	2.2	21.9	11.0	33.2	12.6	3.2	1.3	50.2	11.3	2.9	1.0	0.9	0.9	3.1	18.9	4.0	4.6	2.6	1.9	4.8	9.3	4.6	13.3	2.9	22.4	4.6	3.9	5.6	51.3	0.0	1.8	1.1	0.8	4.5	3.5	1.7	1.2	3.6	0.7	1.6	1.3	0.2	0.4	0.2	0.9	0.7	8.1	6.3	0.5	0.4	0.3	0.3	0.3	5.4	0.3	1.1	0.3	1.0	0.5	0.5	0.3	0.4	2.8	0.3	0.5	0.9	0.4	0.9	0.7	0.8	11.4	0.6	0.7	0.2	0.1	0.6	1.9	0.4	0.4	0.3	0.9	0.8	0.5	0.4	0.5	0.9	0.4	1.6	0.7	0.5	1.6	0.6	1.2	0.6	0.3	0.6	1.0	0.7	0.7	0.4	1.2	0.6	0.7	0.4	0.6	0.8	3.4	0.7	0.8	1.2	0.6	1.0	1.1	1.0	0.9	0.5	1.7	1.2	1.3	3.6	1.6	0.7	1.2	0.5	0.2	14.5	37.6	3.0	19.4	21.9	11.0	50.2	11.3	18.9	51.3
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Abnormal spindle microtubule assembly"	Q8IZT6	1	197084128-197146694	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 62.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"plasmacytoid DC: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB017816			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (1.25e-4)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.7	0.7	0.2	12.4	0.4	13.8	1.5	0.2	0.4	1.2	2.8	0.2	0.2	2.8	0.3	1.5	8.7	0.2	0.4	0.6	0.2	0.2	0.5	1.3	1.9	7.0	0.3	0.2	0.5	0.3	0.0	0.2	1.8	0.5	0.4	2.8	0.3	1.5	0.2	0.5	4.6	3.1	0.8	0.5	4.3	1.7	6.3	0.2	62.8	0.3	5.0	6.9	1.2	2.3	0.0	1.5	0.0	0.0	0.3	2.4	0.0	19.8	11.1	18.1	11.0	1.0	2.5	6.8	15.9	11.2	15.8	12.5	7.7	15.5	20.3	5.7	12.4	20.1	15.5	6.3	19.7	18.2	11.8	14.2	26.2	7.4	0.2	21.2	10.1	0.2	0.6	12.7	8.9	16.6	17.8	24.1	16.2	7.8	17.0	9.9	8.2	3.0	13.0	24.8	14.9	5.7	5.5	9.5	13.5	22.6	11.7	5.1	13.0	8.8	12.6	9.8	9.5	16.8	28.9	6.9	9.4	11.7	7.7	5.8	19.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	2.4	0.0	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.5	0.2
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 86.6;HaCaT: 82.0;hTCEpi: 79.7;RPMI-8226: 132.8;THP-1: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol			4500000	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.6	1.1	1.3	2.2	8.8	22.5	4.2	13.9	86.6	2.7	8.4	4.9	3.2	0.0	9.4	28.6	82.0	5.7	0.5	1.9	2.0	2.6	0.0	1.8	12.7	30.7	1.7	0.1	14.8	79.7	4.4	8.0	0.1	0.4	51.7	2.7	57.6	0.6	24.3	1.8	2.5	0.1	1.5	132.8	7.6	5.8	33.4	0.5	49.5	52.2	3.9	35.8	99.5	0.0	1.1	6.9	0.2	1.2	8.6	8.2	2.9	21.8	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2
ASTN2	KIAA0634	ENSG00000148219	"Astrotactin 2"	O75129	9	116425225-117415070	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 24.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027035	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA027035: AB_1845122"	"unprognostic (3.25e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.93e-1)"	"prognostic favourable (6.66e-16)"	"unprognostic (3.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	4.1	11.9	13.0	3.3	14.9	4.4	5.3	17.2	25.5	5.6	4.6	20.0	5.5	4.6	3.8	5.3	3.2	9.6	3.4	18.6	13.5	16.3	5.5	5.2	3.0	3.0	15.4	19.4	4.0	7.4	5.6	10.7	2.6	16.1	29.2	4.2	6.7	6.1	13.6	7.7	3.5	5.2	3.6	11.3	3.1	4.1	16.7	16.9	1.9	2.4	0.9	2.4	3.6	3.0	2.3	1.3	2.5	0.7	7.8	10.3	1.3	2.5	7.7	3.1	4.7	5.1	4.7	10.2	3.8	1.5	1.7	1.8	5.3	3.0	5.7	4.4	2.5	0.9	7.5	0.4	2.0	3.1	1.9	2.1	3.6	10.9	2.0	1.4	4.1	6.4	0.7	5.1	0.4	1.2	2.6	4.3	5.1	2.6	2.6	1.1	8.9	4.6	3.3	18.1	1.7	5.3	8.2	4.2	24.5	4.5	1.5	3.2	10.2	0.9	2.3	3.9	6.4	3.8	3.2	6.2	3.5	5.4	7.0	1.4	16.7	2.5	0.6	0.6	3.9	0.4	4.8	2.0	4.2	3.2	0.3	2.3	4.0	3.3	2.4	7.8	0.7	1.3	10.3	1.3	13.0	14.9	17.2	23.2	13.5	16.3	15.4	19.4	16.1	16.9
ASZ1	"ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3"	ENSG00000154438	"Ankyrin repeat, SAM and basic leucine zipper domain containing 1"	Q8WWH4	7	117363222-117428123	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 15.7"	"Group enriched"	"Detected in some"	24	"Daudi: 3.9;U-266/70: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA020558	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA020558: AB_1845123"								"unprognostic (4.30e-1)"				"unprognostic (1.87e-1)"			"unprognostic (1.42e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family, AAA domain containing 5"	Q96QE3	17	30831970-30895869	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.0;lymphoid tissue: 29.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"			Nucleoplasm	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	2.0	1.2	1.1	8.1	3.8	19.0	2.4	9.6	3.2	2.7	3.3	1.2	0.7	2.8	2.1	2.5	4.0	2.0	1.7	1.4	1.8	1.3	1.9	1.4	2.3	6.4	1.9	2.7	3.0	1.7	1.3	3.1	5.3	2.3	1.8	3.1	0.6	2.1	1.2	1.3	4.5	3.4	1.5	1.5	6.3	2.2	4.0	2.6	29.9	1.8	2.7	5.3	1.8	2.7	2.3	2.1	3.1	1.3	3.0	1.6	0.3	4.8	4.0	9.5	9.0	0.2	1.0	3.8	4.2	2.1	4.7	6.8	4.4	3.4	12.9	4.1	1.9	8.8	6.1	3.2	8.6	2.9	5.3	7.8	5.2	3.0	0.1	15.1	6.3	0.4	0.4	6.9	2.4	2.4	12.1	10.8	3.1	2.8	16.8	7.5	5.6	1.9	11.6	18.1	6.1	1.2	5.1	5.6	5.0	4.7	2.7	2.5	5.1	6.7	1.9	5.9	7.9	8.2	7.5	3.6	3.7	16.2	2.5	7.2	5.7	1.2	1.0	1.4	1.6	1.3	0.9	1.2	0.9	1.2	0.7	2.3	1.1	1.2	3.1	3.0	0.6	2.1	1.4	0.3	1.1	3.8	9.6	3.2	1.8	1.3	1.9	2.7	2.3	2.6
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 10.9;AN3-CA: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Cytosol"		"HPA046816: , HPA050999: "	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavourable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.35e-4)"	4.8	3.8	16.8	5.4	16.8	4.4	4.1	12.5	20.7	5.5	4.9	16.3	3.0	4.6	10.2	21.0	3.2	8.3	5.4	3.9	15.7	15.9	4.4	3.8	3.9	4.8	14.0	12.2	10.1	4.4	4.4	10.6	4.3	13.0	9.8	5.3	4.1	5.4	4.0	4.5	6.9	6.1	4.9	13.5	4.3	7.9	7.0	12.8	3.3	4.3	1.7	5.6	4.0	3.8	1.7	2.6	2.6	1.7	0.7	2.1	0.8	2.0	1.1	10.9	8.1	1.5	1.1	0.4	0.3	0.1	0.4	0.8	2.9	2.1	0.3	1.7	1.7	2.4	4.0	1.4	0.1	1.5	4.7	0.1	0.4	2.7	0.7	0.2	1.3	2.2	0.9	0.7	0.0	0.9	1.6	0.2	2.0	1.8	1.6	0.7	0.7	0.2	0.9	0.3	0.6	2.0	3.0	0.6	4.3	0.7	1.0	0.7	4.4	0.5	0.8	3.1	2.2	0.1	0.8	1.6	2.1	1.0	2.5	4.8	3.2	2.6	1.7	1.3	0.8	1.5	1.0	1.7	1.0	0.8	1.6	1.2	2.1	1.6	0.3	0.7	1.1	2.6	0.9	0.8	16.8	16.8	12.5	20.7	15.7	15.9	14.0	12.2	13.0	12.8
ATF4	"CREB-2, TAXREB67, TXREB"	ENSG00000128272	"Activating transcription factor 4"	P18848	22	39519695-39522685	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011596	Approved		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"CAB011596: AB_725569"	"unprognostic (2.51e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavourable (9.77e-5)"	"unprognostic (7.06e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.95e-1)"	66.7	46.6	35.0	35.8	42.1	137.9	134.9	38.1	44.1	46.9	99.1	27.3	66.6	40.2	52.1	45.1	69.9	39.8	47.0	44.1	35.7	30.6	41.5	90.1	53.0	37.1	69.3	21.8	53.6	125.3	24.7	40.2	56.8	49.7	70.0	41.2	39.6	241.8	72.7	127.2	42.6	44.3	119.7	64.3	43.2	70.1	23.8	50.4	21.6	62.5	66.7	49.3	118.9	104.7	29.2	32.6	24.1	26.4	19.3	23.0	19.9	38.4	23.5	41.1	52.8	46.0	45.7	68.1	46.5	73.6	37.6	48.1	51.7	29.5	74.2	10.2	34.7	30.4	66.5	55.1	45.9	45.6	48.1	50.8	24.1	52.4	101.9	95.2	48.1	77.1	120.2	67.1	98.8	36.2	53.7	79.9	28.5	24.3	56.8	69.4	35.9	30.6	59.1	27.2	76.4	49.1	32.9	62.0	25.8	20.9	56.1	135.9	34.5	118.2	28.4	22.7	65.7	24.7	31.6	87.1	103.4	86.2	25.0	48.7	50.6	24.1	26.4	17.5	16.2	22.5	20.8	29.2	21.7	20.7	32.6	21.1	23.0	20.8	13.2	19.3	23.6	20.2	22.8	19.9	35.0	42.1	38.1	44.1	35.7	30.6	69.3	21.8	49.7	50.4
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	24	"liver: 470.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 78.3;THP-1: 65.2;U-266/84: 99.3;U-698: 46.7"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.9;intermediate monocyte: 11.7;myeloid DC: 7.5;plasmacytoid DC: 18.7"	"Group enriched"	"Detected in all"	7	"dendritic cells: 18.7;monocytes: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavourable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	4.6	6.6	2.1	5.0	2.7	2.9	7.0	1.3	2.2	2.4	2.9	2.4	3.9	4.6	2.3	4.0	3.4	2.6	3.1	4.2	2.1	2.1	3.0	470.7	2.8	5.0	2.2	1.4	2.6	3.8	1.4	1.9	4.4	2.1	2.8	1.6	2.6	3.1	2.5	4.3	2.1	4.2	2.5	2.6	3.3	2.8	5.3	1.9	3.8	20.0	3.3	5.5	5.6	7.1	1.1	18.7	2.2	11.9	1.5	1.3	2.5	9.8	6.9	2.6	1.8	2.8	2.4	2.7	7.2	6.0	7.4	4.6	5.2	5.4	8.8	3.7	4.1	3.6	3.3	2.9	3.5	45.0	3.3	6.0	2.1	3.9	1.9	23.3	17.2	16.6	4.7	5.4	1.3	3.2	5.4	78.3	3.6	9.2	3.3	5.1	1.3	9.3	27.9	2.9	3.6	8.4	13.4	4.3	3.0	16.7	7.2	5.0	5.8	65.2	5.4	14.5	9.2	1.7	7.3	2.1	99.3	46.7	11.3	9.3	5.4	0.3	11.9	0.7	0.7	11.7	1.3	1.1	0.9	0.9	7.5	0.7	0.7	0.9	2.2	1.5	3.0	18.7	0.9	2.5	2.1	2.7	1.3	2.2	2.1	2.1	2.2	1.4	2.1	1.9
ATF7	ATFA	ENSG00000170653	"Activating transcription factor 7"	P17544	12	53507856-53626410	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003384	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.59e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.28e-3)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.17e-1)"	22.6	12.2	18.3	14.6	25.3	11.4	21.5	56.1	22.9	17.8	17.7	31.6	12.1	10.5	21.5	13.0	19.7	14.6	15.6	18.8	20.1	9.5	15.1	12.3	18.0	10.3	28.2	12.9	23.5	15.6	15.3	17.3	15.4	22.2	17.1	18.6	15.6	21.9	13.4	23.1	20.9	12.2	24.5	22.3	11.4	16.1	12.4	27.5	11.4	15.2	10.8	13.1	18.1	18.4	11.5	11.4	14.2	19.5	15.5	11.5	9.3	10.2	19.8	10.5	11.6	20.3	26.0	7.0	12.3	12.8	13.7	9.1	14.2	16.0	16.0	16.4	15.1	12.8	8.2	13.7	12.6	15.5	10.4	13.8	22.8	15.2	13.6	17.7	10.4	20.2	17.9	17.0	19.4	26.8	15.7	14.9	20.4	18.9	10.6	12.4	10.5	10.7	14.1	12.7	15.4	20.6	13.2	8.9	9.5	18.8	13.9	19.5	18.6	11.0	19.7	16.4	11.6	13.0	11.1	7.3	8.7	10.3	13.4	16.8	14.9	12.9	14.8	14.2	8.6	19.5	8.7	10.8	11.5	8.4	11.4	11.5	8.5	9.9	9.3	15.5	14.3	7.8	10.8	9.3	18.3	25.3	56.1	22.9	20.1	9.5	28.2	12.9	22.2	27.5
ATG13	KIAA0652	ENSG00000175224	"Autophagy related 13"	O75143	11	46617527-46674818	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039350			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039350: AB_10673142"	"unprognostic (3.66e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (8.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.47e-1)"	13.8	15.8	20.2	11.9	27.3	25.8	12.5	32.8	37.0	13.2	12.6	39.5	9.2	14.3	12.9	16.8	14.9	16.6	14.5	17.8	19.5	16.3	14.3	21.1	11.5	13.6	31.8	18.2	15.6	19.7	24.4	23.1	13.5	27.2	12.8	12.0	21.3	17.0	13.5	20.9	16.3	12.4	12.3	15.7	16.2	16.5	60.6	34.9	14.8	18.6	8.8	15.8	12.5	13.0	15.8	20.0	38.9	24.0	17.0	24.7	20.3	13.7	25.2	19.4	11.4	27.1	31.8	19.6	16.0	28.4	19.8	25.4	17.2	13.7	12.9	11.4	24.1	16.8	18.6	21.7	20.1	24.4	35.5	13.8	17.6	30.0	30.4	18.4	24.1	38.2	25.9	13.6	30.2	19.5	24.1	29.5	17.7	20.6	18.3	27.3	24.2	21.9	17.5	25.1	22.5	13.3	15.1	18.5	18.6	22.1	17.8	23.6	25.4	38.1	19.1	24.4	15.0	22.5	17.5	26.9	29.8	16.3	30.3	16.7	17.9	21.2	20.7	26.9	21.3	24.0	17.2	15.8	19.2	16.8	20.0	12.7	16.6	18.3	38.9	17.0	18.7	14.9	24.7	20.3	20.2	27.3	32.8	37.0	19.5	16.3	31.8	18.2	27.2	34.9
ATG16L1	"APG16L, ATG16A, ATG16L, FLJ10035, WDR30"	ENSG00000085978	"Autophagy related 16 like 1"	Q676U5	2	233210051-233295674	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012577, HPA063900"	Supported		Approved	Cytosol				Cytosol		"HPA012577: AB_1845155, HPA063900: "	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.49e-1)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.93e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.08e-1)"	7.7	8.1	7.8	15.7	16.4	28.2	11.9	25.3	22.7	9.8	12.0	13.5	7.4	11.4	12.3	14.8	11.8	8.4	9.7	11.3	9.6	9.0	10.0	15.0	8.0	11.4	10.9	9.4	9.7	12.8	11.6	6.6	8.6	12.3	13.2	13.8	9.4	11.8	10.7	19.4	16.9	11.5	10.7	9.7	12.1	13.0	16.7	9.2	13.8	12.3	10.2	14.3	11.7	12.5	3.3	2.1	4.4	6.2	6.0	7.3	3.1	10.8	11.5	4.1	6.9	10.7	7.7	13.1	9.9	7.9	8.9	8.4	8.3	7.8	2.8	3.6	8.2	5.5	9.1	4.8	7.9	5.4	7.8	6.5	7.4	13.3	8.1	5.3	8.3	4.2	8.5	10.4	8.5	8.6	6.7	2.8	7.7	8.9	5.5	10.7	17.4	12.8	4.0	9.4	2.3	7.9	7.1	8.4	5.8	6.8	8.4	5.1	4.9	5.8	10.1	5.6	4.6	8.9	8.2	6.3	3.3	5.1	9.2	5.5	8.8	0.0	2.5	4.4	7.3	2.0	6.0	3.3	5.0	6.4	2.1	3.2	5.6	5.5	1.7	6.0	6.2	1.1	5.6	3.1	7.8	16.4	25.3	22.7	9.6	9.0	10.9	9.4	12.3	9.2
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917248	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 16.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"			Cytosol	"Nucleoplasm, Vesicles"	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	8.4	8.3	6.0	8.4	10.4	63.7	7.1	12.2	14.3	7.2	9.2	11.6	8.2	10.0	9.5	5.5	6.1	7.7	8.9	6.4	7.0	6.4	9.0	33.2	9.3	7.7	7.5	7.5	11.8	11.7	7.6	8.7	8.9	9.0	8.5	4.3	12.1	9.3	8.4	12.4	15.9	11.4	9.7	6.7	11.1	9.2	8.0	8.2	13.2	8.4	7.8	9.4	7.9	6.2	1.0	2.3	16.5	2.0	1.5	2.6	0.9	9.9	9.6	3.6	9.6	4.7	3.3	9.5	5.5	8.3	7.6	5.6	8.6	7.9	7.1	11.7	4.7	8.6	3.6	6.6	2.0	6.6	12.4	6.4	14.4	7.7	6.6	5.0	14.9	9.1	5.8	9.5	5.1	6.3	12.0	5.8	3.3	16.2	6.0	17.0	4.1	10.8	6.7	5.6	10.4	4.1	8.5	13.0	5.1	8.0	11.7	10.1	11.3	6.4	7.9	7.2	7.1	14.2	4.1	11.5	4.0	5.1	10.6	4.0	4.5	2.8	2.0	2.0	2.6	1.9	2.2	0.8	1.7	2.2	1.3	1.0	1.4	2.5	16.5	1.5	1.5	2.3	0.9	0.9	6.0	10.4	12.2	14.3	7.0	6.4	7.5	7.5	9.0	8.2
ATG3	"APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96"	ENSG00000144848	"Autophagy related 3"	Q9NT62	3	112532509-112562046	"Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037260, HPA040471"	Enhanced		Supported	"Plasma membrane,Cytosol"			26000	"Plasma membrane, Cytosol"		"CAB037260: AB_1078236, HPA040471: "	"unprognostic (2.77e-2)"	"prognostic favourable (6.82e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (9.35e-6)"	"unprognostic (6.79e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (7.52e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	24.2	27.7	30.8	30.3	34.2	51.6	23.1	19.5	26.8	20.0	24.3	29.9	16.6	24.5	18.0	17.0	23.6	15.7	17.4	20.9	31.4	27.1	32.2	36.2	23.2	31.0	38.9	17.9	21.1	29.0	24.5	27.7	24.5	33.3	18.5	26.9	13.1	20.3	22.3	18.7	19.6	27.9	19.6	53.3	40.1	23.5	51.7	34.8	33.8	28.2	23.4	28.6	21.6	19.7	12.3	34.5	35.6	61.9	9.7	15.0	24.0	31.2	17.1	16.1	16.3	21.2	17.6	18.1	27.6	20.2	27.3	25.0	23.9	18.7	39.4	21.0	23.8	22.7	26.2	23.9	38.5	6.7	12.7	24.7	17.0	15.3	33.1	43.2	21.1	16.2	18.3	26.8	41.3	25.4	21.1	33.9	28.8	27.4	25.5	20.4	17.6	34.0	22.3	14.4	33.2	22.7	17.1	27.7	10.9	22.9	22.0	32.2	24.7	32.5	20.4	29.3	23.9	12.3	24.1	22.1	21.1	60.9	26.7	40.3	21.4	10.8	34.3	23.9	8.6	51.6	10.7	12.3	10.6	10.6	34.5	11.5	10.4	10.2	35.6	9.7	61.9	7.4	15.0	24.0	30.8	34.2	19.5	26.8	31.4	27.1	38.9	17.9	33.3	34.8
ATG4B	"Apg4B, AUTL1, DKFZp586D1822, KIAA0943"	ENSG00000168397	"Autophagy related 4B cysteine peptidase"	Q9Y4P1	2	241637213-241673857	"Enzymes, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037195, HPA069803"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB037195: AB_1078237, HPA069803: "	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (2.60e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.66e-1)"	"prognostic favourable (9.64e-4)"	10.9	16.5	19.6	16.6	21.3	31.3	15.1	34.8	25.7	13.5	18.7	21.7	23.2	14.6	33.5	24.0	26.7	17.7	18.8	19.5	20.5	21.5	17.2	15.5	15.8	19.4	29.2	19.7	17.3	19.2	18.7	27.4	15.4	20.3	20.5	18.9	20.8	22.8	14.2	17.2	26.6	21.1	18.9	23.1	18.7	15.5	28.0	21.4	21.2	18.2	7.3	21.9	15.3	14.4	16.5	20.3	18.9	18.6	11.4	19.6	16.8	8.6	13.4	19.2	14.9	19.3	14.1	19.1	12.7	13.8	16.4	13.6	14.7	15.3	6.6	5.7	22.7	12.7	18.3	24.1	16.0	14.1	18.6	19.5	21.7	31.8	25.1	11.2	11.0	13.9	16.8	18.4	17.8	16.9	16.6	10.2	18.6	21.1	20.2	19.9	22.4	14.4	34.8	17.7	10.0	12.9	28.0	19.3	13.4	10.8	14.4	15.1	15.9	16.6	18.4	15.7	10.7	10.4	13.6	11.5	12.0	25.4	19.0	14.1	14.6	4.6	18.6	18.9	18.7	15.5	15.5	15.7	15.2	16.5	20.3	16.5	19.6	14.7	14.8	11.4	16.2	16.3	19.3	16.8	19.6	21.3	34.8	25.7	20.5	21.5	29.2	19.7	20.3	21.4
ATG4C	"APG4C, AUTL1, AUTL3, FLJ14867"	ENSG00000125703	"Autophagy related 4C cysteine peptidase"	Q96DT6	1	62784135-62865513	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007049	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007049: AB_1845159"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-1)"	"prognostic favourable (9.83e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	8.8	9.8	19.4	11.3	32.8	6.0	9.2	16.7	23.4	10.6	9.5	29.8	7.2	7.7	9.6	7.2	8.6	8.0	10.4	7.2	23.7	15.5	13.5	12.6	9.2	13.7	42.6	16.5	10.3	11.2	15.5	11.3	15.0	22.4	8.0	10.6	4.9	10.8	8.0	6.4	6.3	7.8	11.2	26.5	13.3	8.6	8.9	40.4	11.0	12.0	3.7	12.4	13.4	6.8	20.6	19.4	16.0	10.9	7.0	9.4	6.7	7.6	6.1	9.5	8.3	12.5	13.5	9.5	11.5	7.8	11.1	12.5	4.5	6.1	16.3	8.9	5.8	5.9	11.3	8.7	16.1	12.2	10.4	18.3	6.5	5.8	8.9	14.8	12.3	11.1	6.2	11.8	5.6	13.3	15.5	13.3	9.3	3.6	14.9	5.7	13.9	10.1	17.9	22.8	11.5	8.0	5.6	12.9	6.5	7.6	14.4	14.8	7.0	7.0	5.2	8.9	8.7	15.0	12.6	11.6	15.6	13.3	10.2	14.7	10.7	16.0	10.9	8.5	4.8	8.8	6.6	20.6	6.6	5.6	19.4	19.1	9.4	7.7	1.6	7.0	5.0	11.6	5.7	6.7	19.4	32.8	16.7	23.4	23.7	15.5	42.6	16.5	22.4	40.4
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			13000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favourable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favourable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	27.0	18.6	14.8	21.1	21.9	37.5	16.6	14.1	29.2	16.4	15.2	26.2	13.4	11.6	28.9	15.9	18.9	17.4	15.1	12.3	14.0	13.1	13.1	11.8	18.4	18.8	14.8	17.1	15.5	13.1	18.7	23.0	18.7	21.6	12.9	17.8	19.3	16.6	11.6	15.8	22.2	16.9	18.3	16.6	19.7	13.1	19.7	13.9	17.7	12.7	12.2	21.6	16.5	15.2	4.0	23.8	31.3	39.7	5.9	4.8	14.2	18.2	14.4	6.5	3.4	11.3	15.0	32.0	17.2	22.4	17.2	20.1	6.1	16.6	8.4	10.4	15.2	5.6	7.2	24.1	29.6	7.4	9.0	6.0	13.9	7.3	15.0	17.4	20.1	15.4	11.2	33.3	21.0	23.7	8.9	6.9	23.8	11.9	4.9	8.2	5.0	18.7	6.2	7.7	7.4	13.0	13.2	5.7	5.7	12.2	10.4	6.6	11.3	17.0	16.1	14.2	10.3	9.2	24.0	4.4	11.5	14.1	22.9	16.4	19.0	13.1	39.7	24.5	4.8	22.9	3.7	4.0	4.0	4.5	23.8	3.7	3.5	4.2	31.3	5.9	16.3	4.2	3.4	14.2	14.8	21.9	14.1	29.2	14.0	13.1	14.8	17.1	21.6	13.9
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311817-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Enhanced	"Plasma membrane,Cytosol"			3400000	"Plasma membrane, Cytosol"		"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavourable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	19.4	27.4	21.1	23.0	28.4	16.9	24.8	12.1	32.3	20.6	26.7	29.1	18.1	23.4	27.9	15.6	19.1	21.9	19.1	18.2	20.3	21.1	23.1	35.6	17.3	36.1	29.7	19.9	23.4	32.9	25.1	21.1	31.1	24.4	21.9	35.9	19.5	14.4	29.4	35.5	17.0	20.6	26.7	21.7	29.0	20.4	15.0	28.0	46.3	16.1	13.5	35.3	27.6	18.0	21.7	13.4	2.9	8.9	19.6	22.8	10.0	20.2	30.7	17.1	29.1	23.0	23.3	8.6	20.7	18.0	23.7	27.2	59.1	31.8	29.5	25.7	21.6	21.3	37.6	31.2	34.0	21.9	36.4	35.9	26.3	53.0	29.8	44.9	18.4	19.7	24.0	31.6	38.2	15.8	46.3	24.6	32.5	29.9	39.1	21.8	65.9	17.2	36.4	24.7	26.4	25.1	32.7	26.9	18.6	16.6	20.5	23.4	33.6	16.0	13.9	20.1	20.8	25.9	13.0	31.1	40.6	61.2	17.5	25.1	29.0	2.9	6.0	0.1	13.2	8.9	22.8	21.7	18.6	20.0	13.4	13.2	18.9	17.5	0.7	19.6	7.4	11.7	17.7	10.0	21.1	28.4	12.1	32.3	20.3	21.1	29.7	19.9	24.4	28.0
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793500-182921635	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	16.8	7.9	7.7	19.7	9.8	35.4	17.0	18.4	9.4	20.5	21.6	8.9	14.3	13.6	15.0	11.7	37.3	11.8	12.7	21.1	6.9	5.9	13.7	14.3	19.4	20.3	10.3	5.7	15.2	14.6	21.0	26.0	8.0	8.3	16.8	16.9	9.8	19.7	13.8	13.1	21.8	22.8	16.5	11.3	23.4	27.6	22.8	8.9	49.0	10.8	20.4	21.9	22.7	25.5	3.6	4.2	7.5	1.8	3.0	3.4	1.3	22.2	3.2	7.0	9.8	15.0	16.4	6.5	10.3	14.2	8.0	9.4	7.9	11.6	10.3	17.7	14.8	13.5	8.4	10.6	14.0	22.9	6.7	24.9	4.3	1.7	8.8	19.6	16.0	11.1	12.0	9.0	13.1	12.6	8.8	32.3	12.9	7.5	16.3	6.3	5.0	6.3	6.8	20.6	12.4	9.7	18.8	4.2	7.6	28.7	3.7	12.5	4.0	14.6	12.3	12.2	13.3	10.5	17.9	44.1	39.4	19.4	8.4	8.4	7.1	7.5	1.7	7.2	3.1	1.8	3.0	3.6	2.7	3.1	1.9	2.4	2.3	3.4	6.8	3.0	1.7	4.2	2.0	1.3	7.7	9.8	18.4	9.4	6.9	5.9	10.3	5.7	8.3	8.9
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"				Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	27.1	14.4	9.0	20.8	12.7	17.5	22.8	15.3	13.8	12.1	13.4	10.8	17.2	11.4	16.2	13.2	12.4	11.3	17.1	37.8	9.6	8.1	29.7	56.9	22.1	11.6	10.1	8.3	13.2	11.4	37.6	10.6	28.9	10.6	11.8	12.6	12.9	16.7	15.9	11.8	7.7	15.0	12.1	9.0	17.1	16.3	8.8	8.4	18.9	37.1	12.0	12.7	17.8	16.1	1.9	2.4	2.3	2.3	2.2	4.7	1.0	49.9	5.7	10.2	9.7	11.6	18.1	24.8	17.2	18.7	18.7	34.0	31.3	12.2	19.7	51.1	24.7	17.0	9.7	17.1	43.5	65.7	8.5	10.9	7.6	6.7	20.1	35.4	28.6	8.3	7.7	38.8	25.3	9.7	12.5	39.9	22.7	8.5	14.2	7.1	9.7	9.9	13.0	21.9	11.8	15.8	16.0	15.6	8.3	18.2	19.0	12.8	36.3	24.8	12.6	22.8	19.0	45.3	32.0	26.4	47.5	35.1	45.4	21.0	15.8	1.8	1.7	2.3	1.8	2.3	2.2	1.9	1.7	2.8	2.4	1.1	2.5	2.5	0.3	2.2	0.9	1.6	4.7	1.0	9.0	12.7	15.3	13.8	9.6	8.1	10.1	8.3	10.6	8.4
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57941541-57957269	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.8;RH-30: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: "	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	6.7	4.9	4.3	5.2	5.3	11.3	4.8	6.1	4.8	5.6	8.2	1.3	2.5	3.9	3.2	4.2	7.3	3.1	2.4	6.4	4.2	3.6	5.4	6.2	2.7	6.8	2.7	3.8	4.2	5.8	3.2	3.0	3.5	2.9	5.1	8.2	2.3	3.4	3.3	11.7	5.6	4.3	6.5	3.4	3.7	3.8	39.5	2.0	20.8	4.7	5.9	4.7	6.3	6.2	3.0	4.5	12.0	4.5	2.6	5.6	3.0	1.9	1.5	1.9	2.2	2.8	2.7	1.0	1.9	1.9	2.2	2.1	1.2	2.4	6.8	2.4	1.4	1.8	1.8	1.9	3.8	3.4	1.8	4.4	1.2	1.9	1.2	8.9	3.0	1.4	1.5	1.3	0.5	1.5	4.6	4.9	1.8	3.0	4.8	14.8	1.6	3.7	3.1	48.8	2.8	1.8	2.5	1.2	1.8	3.0	2.8	1.5	4.9	8.4	0.8	1.6	2.8	2.1	1.8	4.0	2.1	3.5	1.8	9.6	2.7	7.6	4.5	12.0	3.5	2.4	2.6	3.0	4.0	3.3	4.5	3.0	4.3	4.0	1.9	2.6	4.2	2.1	5.6	3.0	4.3	5.3	6.1	4.8	4.2	3.6	2.7	3.8	2.9	2.0
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428632-154436516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"			160000	"Plasma membrane, Microtubules, Cytosol"		"CAB015218: "	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favourable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favourable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	29.8	37.8	36.6	20.0	50.3	27.5	22.1	59.2	82.7	28.4	26.5	39.4	27.4	24.0	20.6	43.2	29.1	29.6	23.0	35.1	40.8	47.5	42.4	26.9	37.9	21.8	36.5	40.5	24.4	42.6	67.1	41.5	66.1	60.1	41.6	24.7	29.8	35.9	29.4	18.4	30.2	24.2	22.9	39.4	36.4	27.6	21.2	24.2	22.1	39.7	20.9	21.4	27.3	21.1	20.1	68.4	64.0	56.6	23.7	28.9	33.8	22.4	21.4	18.3	31.1	29.7	16.4	34.4	16.6	23.6	25.9	37.8	20.2	28.1	13.3	70.4	35.6	24.1	26.9	15.4	14.3	12.1	27.8	7.6	27.5	20.0	37.4	12.3	56.5	21.8	26.4	24.3	14.0	35.9	9.1	37.6	16.9	32.9	8.9	18.6	6.8	21.9	13.8	12.2	34.5	27.4	18.8	18.3	19.0	14.5	59.3	31.1	26.1	30.4	27.7	18.9	17.1	32.2	27.0	54.3	58.3	15.7	22.6	26.7	19.0	37.4	53.9	64.0	28.6	56.6	28.9	17.5	23.7	24.7	68.4	20.1	21.4	23.5	60.0	23.7	43.4	39.0	26.9	33.8	36.6	50.3	59.2	82.7	40.8	47.5	36.5	40.5	60.1	24.2
ATP6AP1L		ENSG00000205464	"ATPase H+ transporting accessory protein 1 like"	Q52LC2	5	82279462-82386977	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 15.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2"									HPA053771	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA053771: "	"unprognostic (1.64e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	1.6	1.0	2.6	0.2	2.4	0.6	0.7	2.5	2.1	1.8	1.2			0.1	1.5	0.1	1.4	2.4	1.7	2.0	2.7	1.8	0.8	1.4	1.5	0.7	2.5		4.4	2.4	0.1	2.0	0.7		1.4	0.6		2.6	2.5	3.3	5.1	0.2	0.6	2.7	0.8	1.8	3.8			1.5		0.4	0.9	0.5	0.1	1.3	0.0	0.1	1.5	1.2	0.0	0.1	0.0	0.1	1.0	0.6	0.3	0.0	0.1	0.3	0.4	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.3	2.8	0.0	1.2	0.6	0.5	0.2	0.3	2.2	0.2	0.0	2.0	1.1	0.0	2.6	0.5	0.7	1.2	0.0	0.2	15.3	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.7	1.2	0.0	1.5	0.0	1.3	0.0	0.0										
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"			21000	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favourable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.5	13.5	8.3	14.8	14.0	12.1	4.8	4.6	8.6	9.9	13.0	8.6	14.7	1.2	8.5	9.5	14.2	12.7	7.8	11.5	10.1	13.4	10.5	10.2	6.8	8.6	4.5	19.2	9.0	11.3	15.8	6.8	7.0	38.1	41.4	14.7	5.6	1.8	4.0	5.3	0.1	0.1	8.6	18.2	11.4	5.2	22.9	12.2	7.2	6.6	13.7	15.9	6.8	4.1	8.4	0.3	12.3	5.5	16.9	22.9	2.5	11.3	0.1	9.8	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712318-123761755	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	13.5	9.4	7.2	13.0	9.9	15.5	11.5	16.2	9.8	8.9	13.1	13.0	9.0	16.0	13.4	8.8	9.1	10.4	10.4	13.6	8.0	7.9	8.9	13.7	13.1	16.6	12.8	6.9	9.7	18.1	8.1	10.4	10.2	9.1	9.8	12.0	9.8	24.5	10.0	13.0	20.5	15.8	12.3	9.4	13.1	15.9	15.9	10.8	24.0	10.3	8.6	17.5	11.0	10.3	2.3	3.4	13.1	1.5	2.1	2.7	0.9	3.2	8.3	8.6	11.6	5.1	4.9	5.3	3.9	4.6	5.1	5.6	6.1	2.6	12.5	2.8	5.3	7.0	11.2	4.1	3.8	8.5	6.3	18.0	6.6	3.5	8.1	11.4	37.1	4.4	3.6	6.0	6.5	4.4	10.9	2.3	5.6	9.0	10.8	14.1	9.0	5.5	10.4	7.5	4.0	4.9	8.1	5.2	8.8	6.6	4.6	5.8	4.8	8.4	6.4	6.5	2.5	7.9	6.5	7.5	8.2	11.7	5.4	6.9	5.5	6.4	0.9	13.1	2.1	0.9	1.5	1.3	2.1	1.8	1.1	2.3	1.9	2.7	2.4	2.1	1.5	3.4	1.4	0.9	7.2	9.9	16.2	9.8	8.0	7.9	12.8	6.9	9.1	10.8
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 40.6;salivary gland: 55.4"	"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 35.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018029, HPA064555"	Enhanced		Approved	Cytosol				Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.1	0.0	0.5	0.0	0.3	0.0	2.2	0.1	0.4	1.7	0.0	0.3	3.1	0.0	0.3	0.5	2.7	0.0	0.0	0.0	0.4	0.3	40.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.2	1.0	0.2	0.5	0.0	0.3	55.4	1.2	0.0	6.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	1.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.4	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	3.0	1.1	0.0	0.1	0.0	0.0	0.4	0.0	2.9	0.1	0.0	0.0	0.0	35.0	1.2	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.1	0.4	0.4	0.3	0.3	0.0	0.2	0.1
ATP6V0B	"ATP6F, HATPL, VMA16"	ENSG00000117410	"ATPase H+ transporting V0 subunit b"	Q99437	1	43974487-43978295	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 173.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044281			Approved	Cytosol				Cytosol		"HPA044281: "	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavourable (4.79e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.23e-2)"	"prognostic favourable (3.24e-4)"	"unprognostic (6.13e-2)"	"prognostic favourable (3.62e-6)"	"unprognostic (5.55e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (8.87e-4)"	20.4	35.7	35.4	21.8	35.3	84.2	28.5	29.1	56.4	23.3	28.3	32.2	26.7	19.2	13.9	35.6	21.9	20.0	22.0	24.8	41.2	44.7	47.6	56.3	25.8	28.5	43.6	31.5	12.9	87.0	32.5	36.3	35.0	33.9	27.0	32.0	32.4	34.8	22.2	27.9	20.1	20.2	19.1	34.8	33.2	25.2	15.3	24.8	16.3	38.7	19.5	24.7	23.2	16.5	23.7	58.0	173.6	78.0	8.8	14.2	87.6	23.3	22.8	18.9	23.8	29.2	15.4	23.2	21.0	31.3	40.9	35.4	24.5	25.6	21.7	19.5	22.2	19.4	44.3	31.7	19.3	20.3	46.1	27.2	39.4	35.2	46.3	42.2	52.8	19.0	41.8	45.0	40.0	19.7	27.0	47.7	33.5	24.7	17.4	70.3	31.3	48.8	24.7	18.2	59.2	42.5	28.9	44.7	22.1	14.2	56.1	52.7	23.0	76.0	9.9	21.1	18.0	38.0	50.6	38.6	56.8	24.0	28.7	60.2	33.0	31.9	78.0	64.2	13.2	48.1	13.0	23.7	14.2	12.7	48.1	19.1	10.8	10.9	173.6	8.8	44.0	58.0	13.7	87.6	35.4	35.3	29.1	56.4	41.2	44.7	43.6	31.5	33.9	24.8
ATP6V0C	"ATP6C, ATP6L, ATPL, VATL, Vma3"	ENSG00000185883	"ATPase H+ transporting V0 subunit c"	P27449	16	2513870-2520218	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065100			Approved	Cytosol				Cytosol		"HPA065100: "	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"prognostic favourable (1.07e-6)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.04e-2)"	56.5	68.2	61.2	53.6	83.5	87.2	24.1	76.0	156.7	27.7	42.9	39.2	25.2	55.2	28.0	21.9	48.7	25.6	23.0	32.5	64.3	70.1	78.0	37.3	40.5	37.1	55.4	74.2	27.2	42.7	41.9	52.3	35.1	70.4	35.7	19.5	40.1	54.3	30.3	108.8	38.7	52.8	18.3	41.9	48.3	59.0	30.4	29.4	25.1	25.7	34.7	29.2	20.8	29.6	15.9	28.2	50.6	42.5	13.0	16.1	18.2	29.4	31.7	17.1	24.4	21.7	10.8	40.9	43.7	13.8	18.3	17.6	29.4	38.2	14.9	40.2	20.9	35.9	18.2	25.9	9.3	37.9	54.3	17.0	25.5	36.0	30.8	26.9	52.5	19.5	19.4	23.1	12.2	13.1	40.3	28.6	15.9	57.5	27.1	70.5	33.2	38.8	43.6	14.9	46.6	32.2	17.6	55.8	45.4	36.8	42.7	35.0	41.1	34.5	31.2	29.5	35.2	44.4	31.2	53.2	64.9	27.2	25.9	19.9	29.9	22.1	32.6	50.6	14.8	36.3	15.1	15.9	13.4	16.1	20.4	15.4	15.6	13.5	43.7	13.0	42.5	28.2	13.2	18.2	61.2	83.5	76.0	123.3	64.3	70.1	55.4	74.2	70.4	29.4
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747019-113812056	"Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.6"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035083, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol			2700000	"Nucleoplasm, Vesicles"	Cytosol	"CAB006910: , HPA035083: AB_2674453, HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favourable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	12.8	19.8	24.1	10.4	33.2	7.4	12.7	34.8	52.8	14.0	11.1	10.3	5.6	9.3	7.5	8.2	13.2	10.0	10.8	4.7	26.2	38.2	47.9	18.2	12.3	11.4	25.4	25.0	6.2	10.5	39.3	13.5	12.3	52.0	11.2	11.8	14.7	18.0	8.4	4.5	12.6	7.9	8.2	13.6	13.7	10.9	8.9	8.3	9.6	21.0	5.7	13.6	10.2	8.2	3.8	16.4	33.6	15.4	3.8	3.4	6.0	25.0	11.4	14.4	12.5	30.3	13.6	15.3	13.6	20.8	14.3	19.8	21.5	20.2	20.5	32.3	19.8	16.3	32.4	17.9	18.8	9.3	8.9	18.2	17.7	16.5	25.1	13.3	21.3	18.3	12.4	18.5	12.9	23.2	20.8	15.6	21.2	16.4	9.7	6.0	18.0	14.3	8.4	10.4	23.3	39.1	23.9	27.9	10.3	23.8	16.2	17.8	24.6	10.8	21.3	13.3	10.0	9.1	8.1	16.3	17.5	19.0	26.2	16.9	14.8	9.2	15.4	5.2	2.8	11.7	2.6	3.8	2.6	2.7	16.4	2.9	2.5	2.9	33.6	3.8	9.5	4.6	3.4	6.0	24.1	33.2	34.8	52.8	26.2	38.2	25.4	25.0	52.0	8.3
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: "	"unprognostic (5.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (3.29e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.83e-1)"	17.1	23.1	25.1	16.8	36.7	6.5	15.7	26.2	58.8	13.6	11.1	11.4	7.6	12.1	14.1	10.9	10.6	12.2	13.7	19.0	28.5	28.0	35.0	18.1	12.9	15.9	23.2	33.3	14.4	12.9	21.3	29.2	20.2	45.1	13.2	13.7	11.5	10.4	12.2	11.7	8.5	12.8	14.5	15.0	14.3	12.1	13.0	12.5	10.7	26.9	8.4	15.6	15.5	10.7	10.6	16.3	27.9	24.3	10.0	12.5	10.8	29.5	17.8	9.4	7.0	24.7	16.0	11.6	22.2	22.2	24.9	29.5	13.1	30.0	19.0	25.5	17.6	11.9	18.6	17.3	35.7	12.5	14.3	18.6	13.5	15.6	26.4	9.9	22.4	15.3	22.5	33.5	16.1	18.7	23.6	15.7	27.7	13.4	18.6	7.3	8.3	17.2	10.8	16.7	14.4	27.9	21.3	12.1	10.4	12.5	11.9	38.9	24.8	11.8	22.3	14.5	14.7	32.2	15.5	20.5	7.4	18.1	28.1	20.6	14.0	8.4	17.4	20.6	9.1	24.3	10.2	10.6	7.7	8.9	16.3	10.2	9.0	9.7	27.9	10.0	22.1	8.8	12.5	10.8	25.1	36.7	26.2	58.8	28.5	28.0	23.2	33.3	45.1	12.5
ATP6V1H	"CGI-11, SFD, SFDalpha, SFDbeta, VMA13"	ENSG00000047249	"ATPase H+ transporting V1 subunit H"	Q9UI12	8	53715557-53843558	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009532, HPA023421"	Approved		Approved	"Actin filaments,Cytosol"			48000	"Actin filaments"	Cytosol	"CAB009532: AB_667834, HPA023421: AB_1845202"	"unprognostic (1.67e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (7.81e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.30e-2)"	"prognostic favourable (1.46e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	14.1	25.1	42.2	9.7	41.5	14.0	15.8	22.5	46.2	14.6	12.1	12.0	10.5	8.3	13.7	19.3	18.1	13.1	11.6	17.2	39.0	25.5	36.6	11.3	13.8	11.1	21.4	30.0	15.0	11.7	27.0	20.0	14.0	30.0	19.6	12.0	12.7	16.4	18.2	17.3	14.4	8.3	14.6	14.7	10.2	13.3	10.8	11.3	15.3	30.0	11.5	12.3	15.3	11.0	12.0	16.3	30.6	17.0	18.8	17.7	9.3	19.1	13.4	12.3	13.3	21.9	14.0	10.5	21.3	19.2	24.5	24.8	12.4	22.2	12.2	20.0	17.2	30.1	20.3	26.4	21.7	19.0	16.4	13.4	14.1	15.2	31.8	8.5	15.0	20.9	32.8	16.8	26.2	16.3	16.9	6.0	31.1	13.4	13.5	13.5	12.1	8.0	11.7	4.9	7.7	34.7	25.7	9.9	16.4	12.3	22.1	33.2	28.1	7.3	19.0	10.9	10.0	26.0	11.5	12.8	12.8	14.2	26.2	11.6	11.8	19.0	11.5	30.6	11.5	13.0	13.1	12.0	14.2	13.7	16.3	10.8	13.8	14.3	13.8	18.8	17.0	13.4	17.7	9.3	42.2	41.5	22.5	46.2	39.0	25.5	21.4	30.0	30.0	11.3
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803101	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;HBF TERT88: 24.3;RT4: 57.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA018673, HPA018674"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favourable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	3.8	2.3	0.0	1.8	0.0	0.0	3.4	0.0	0.3	4.5	21.3			8.9	2.4	0.8	6.7	2.6	4.8	1.8	0.2	0.0	2.1	3.0	3.6	0.0	0.1		0.7	10.7	2.7	1.1	1.3		6.0	19.3		5.8	2.8	0.4	3.6	11.1	2.0	0.2	1.2	13.3	0.0			5.7		0.2	12.8	5.4	6.0	2.0	4.7	2.1	0.7	1.3	0.3	10.1	3.4	0.1	0.1	3.5	6.4	4.9	19.6	19.1	20.6	12.9	2.6	8.8	0.7	5.9	27.1	15.0	0.1	4.1	24.3	0.2	0.4	0.1	0.9	0.9	1.1	0.2	0.1	1.0	3.7	6.2	10.9	10.8	0.1	0.4	11.9	4.8	0.2	0.2	0.2	1.0	0.1	0.1	0.2	2.8	57.5	0.4	0.3	0.4	12.1	0.1	3.7	0.6	12.4	16.8	0.6	2.7	4.5	0.2	0.1	0.2	0.4	0.2	0.9	0.8	2.1	0.5	1.3	0.9	1.0	2.7	1.0	0.7	0.5	6.0	0.9	1.0	4.7	0.7	1.2	2.0	0.4	0.3										
ATPAF2	"ATP12, Atp12p, LP3663, MGC29736"	ENSG00000171953	"ATP synthase mitochondrial F1 complex assembly factor 2"	Q8N5M1	17	17977409-18039209	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023329, HPA059422"	Supported		Enhanced	Cytosol				Cytosol		"HPA023329: AB_1845209, HPA059422: "	"unprognostic (3.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (4.40e-2)"	"prognostic favourable (4.95e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.70e-3)"	"unprognostic (1.67e-2)"	"prognostic favourable (6.00e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.15e-1)"	"unprognostic (2.62e-2)"	9.8	23.1	14.2	11.0	12.5	18.0	11.4	18.1	20.9	10.3	14.3	17.1	12.7	11.5	9.9	12.1	16.1	11.1	8.9	25.3	12.4	12.6	19.1	21.6	9.8	12.5	12.7	11.6	9.8	14.5	20.0	14.2	11.5	13.0	11.3	14.1	15.4	19.5	10.7	28.3	16.4	13.8	11.2	10.9	13.6	12.9	17.3	12.5	12.9	14.2	13.5	19.1	13.0	10.4	13.0	24.2	6.9	20.6	3.9	6.0	9.7	8.1	15.2	10.1	9.6	10.1	11.0	10.2	7.2	10.6	15.6	13.3	20.2	12.5	16.5	16.3	12.5	12.8	9.6	15.5	13.7	13.1	7.5	3.6	9.9	11.6	17.1	5.2	11.4	13.1	11.1	14.0	7.9	17.8	5.7	5.8	8.5	16.7	12.0	7.9	6.8	8.7	12.5	17.7	18.8	12.5	7.3	6.5	8.9	9.6	5.0	8.9	16.0	10.4	7.4	3.9	8.3	14.5	6.9	4.0	5.0	6.0	7.2	7.6	20.3	3.5	20.6	6.9	4.8	14.0	5.3	13.0	3.7	4.6	24.2	9.4	5.7	4.4	1.4	3.9	10.1	20.5	6.0	9.7	14.2	12.5	18.1	20.9	12.4	12.6	12.7	11.6	13.0	12.5
ATRN	"DPPT-L, MGCA"	ENSG00000088812	Attractin	O75882	20	3471040-3651122	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008853	Approved		Approved	Cytosol	"Secreted to blood"		39000000000	Cytosol		"HPA008853: AB_1078248"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (2.19e-6)"	"unprognostic (3.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.91e-2)"	12.1	22.8	14.9	7.4	20.7	5.7	13.0	18.4	29.3	13.5	22.8	18.3	7.4	39.9	12.2	12.2	9.3	9.2	12.4	14.8	13.6	14.7	18.4	45.2	10.6	7.1	12.8	18.9	11.5	17.7	40.3	13.4	16.5	16.1	10.1	9.5	12.2	14.0	10.7	11.7	13.6	31.1	11.3	15.2	9.7	17.1	16.2	12.3	5.4	24.1	7.5	7.1	12.0	9.8	3.6	5.7	5.7	6.5	3.0	4.8	1.9	17.7	16.7	9.9	8.3	17.7	28.9	12.8	11.9	16.9	12.5	10.6	7.2	12.2	0.0	8.0	16.6	24.9	6.7	25.9	16.8	1.9	5.7	5.5	4.6	15.4	10.6	11.7	3.8	15.4	21.0	13.2	12.8	16.2	8.7	8.7	12.1	5.1	4.7	4.5	6.7	10.1	4.0	23.2	13.3	11.4	12.6	5.9	9.2	11.9	22.2	16.2	11.8	11.2	19.9	13.4	7.9	14.0	11.7	6.1	8.6	0.0	8.2	7.9	13.3	5.7	6.5	3.6	4.8	5.6	2.3	2.8	2.7	3.0	5.7	3.6	4.4	3.7	0.0	3.0	5.7	5.3	3.4	1.9	14.9	20.7	18.4	29.3	13.6	14.7	12.8	18.9	16.1	12.3
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: "	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	8.1	9.1	17.7	11.9	25.1	5.5	9.1	33.7	29.5	14.8	13.5	12.9	10.3	8.2	20.5	9.8	11.1	11.0	12.1	11.8	18.0	11.0	9.1	10.1	14.8	11.6	21.1	17.7	10.7	10.3	18.4	11.6	10.3	16.4	14.2	8.5	9.8	8.4	14.0	26.3	12.0	8.3	19.1	16.1	11.4	10.3	8.1	25.6	4.6	11.8	12.5	7.4	11.7	11.3	0.4	0.8	4.4	1.7	0.1	2.5	0.8	3.3	2.0	0.7	0.0	3.5	4.8	4.6	3.7	8.6	2.2	2.6	2.1	2.1	0.1	5.0	7.1	3.2	0.2	2.3	3.3	1.9	3.6	0.5	3.2	6.7	5.6	3.1	5.5	3.7	4.4	4.7	4.0	4.6	0.0	4.1	1.9	1.7	0.2	3.6	0.7	3.3	0.2	4.5	3.0	3.1	5.8	0.2	1.9	3.4	4.3	7.0	2.8	5.4	7.0	3.2	4.9	3.7	3.3	24.1	13.8	0.1	2.0	3.2	7.7	0.7	1.7	0.4	2.5	1.3	1.9	0.4	1.7	2.4	0.8	0.1	0.2	1.5	4.4	0.1	0.7	0.4	1.3	0.8	17.7	25.1	33.7	29.5	18.0	11.0	21.1	17.7	16.4	25.6
ATXN10	"E46L, FLJ37990, SCA10"	ENSG00000130638	"Ataxin 10"	Q9UBB4	22	45671798-45845307	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049531	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA049531: "	"unprognostic (5.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.48e-2)"	"unprognostic (6.98e-2)"	18.1	33.3	40.2	20.6	40.5	20.9	38.5	31.7	75.3	28.5	20.6	20.9	22.0	13.8	28.8	23.9	27.5	33.6	23.3	42.3	44.5	42.4	32.0	37.0	30.5	38.8	35.6	41.2	35.4	33.5	39.7	32.6	28.1	38.1	28.3	21.8	18.0	22.6	30.1	47.5	18.3	13.6	29.7	38.3	18.3	18.5	31.5	22.3	34.0	37.2	21.8	28.7	26.8	21.8	23.3	52.2	28.1	40.4	25.2	31.0	33.3	40.8	21.2	41.2	24.9	18.9	28.5	22.2	46.8	50.0	33.5	36.8	10.6	27.5	42.2	19.3	46.8	24.5	29.7	31.2	36.2	7.7	30.6	19.8	40.8	20.3	27.3	52.8	14.8	29.3	21.7	17.4	27.4	24.4	14.4	23.5	50.7	17.4	28.7	23.8	27.2	16.4	41.5	15.8	34.2	42.6	39.1	22.8	35.8	29.1	17.5	31.6	26.4	28.3	22.2	33.9	12.6	12.1	15.3	23.1	13.9	34.0	21.1	22.2	35.9	19.0	31.7	28.1	23.4	37.6	31.0	23.3	23.3	28.3	52.2	22.6	25.7	24.8	1.5	25.2	40.4	18.5	21.9	33.3	40.2	40.5	31.7	75.3	44.5	42.4	35.6	41.2	38.1	22.3
ATXN2	"ATX2, SCA2, TNRC13"	ENSG00000204842	"Ataxin 2"	Q99700	12	111443485-111599676	"Disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018295, HPA020339, HPA021146"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132"	"unprognostic (3.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (2.34e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.40e-2)"	21.3	23.4	25.1	24.3	26.5	15.5	34.5	32.4	32.8	21.2	20.7	32.6	20.5	17.6	24.0	20.3	17.6	26.5	20.8	25.9	24.6	26.7	19.0	20.8	30.2	15.2	29.5	25.9	30.2	16.8	33.4	23.3	25.2	26.4	22.0	17.6	21.0	16.2	24.0	28.0	15.1	15.4	26.7	28.8	16.5	16.8	30.8	30.2	18.4	23.8	14.2	13.1	22.7	24.5	9.9	8.0	11.1	10.8	10.7	10.6	4.8	19.0	22.8	20.5	22.0	21.1	18.1	17.4	25.1	14.8	18.0	15.3	13.6	14.3	15.2	8.9	26.0	15.5	28.0	10.9	22.3	13.8	24.2	23.3	12.6	22.9	28.5	15.5	12.8	17.9	12.1	22.3	24.6	16.3	29.0	9.2	21.3	14.8	12.7	13.8	20.3	15.0	12.2	12.5	12.1	17.0	24.0	18.9	16.6	25.9	29.0	13.2	17.6	9.2	25.6	21.8	13.7	19.8	14.1	15.7	21.4	15.9	12.3	12.9	14.7	10.3	6.8	11.1	8.2	6.8	10.6	9.9	9.2	9.3	8.0	6.1	8.5	7.1	7.8	10.7	10.8	4.8	4.1	4.8	25.1	26.5	32.4	32.8	24.6	26.7	29.5	25.9	26.4	30.2
ATXN2L	"A2D, A2lp"	ENSG00000168488	"Ataxin 2 like"	Q8WWM7	16	28823035-28837237	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041506, HPA043391, HPA071955"	Approved		Enhanced	Cytosol				Cytosol		"HPA041506: , HPA043391: , HPA071955: "	"unprognostic (1.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.63e-2)"	"prognostic unfavourable (9.85e-4)"	"unprognostic (5.59e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (7.99e-7)"	"unprognostic (1.79e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.98e-1)"	24.7	31.1	32.5	38.7	30.4	56.8	44.9	57.9	42.5	27.4	24.6	28.0	22.8	35.1	28.4	22.9	29.5	26.2	25.8	24.8	31.1	22.2	30.9	32.9	37.1	46.2	33.8	36.1	31.7	34.8	39.9	44.8	31.2	28.9	29.2	22.8	22.5	30.9	34.2	27.9	31.7	31.9	27.8	33.6	44.0	30.2	77.2	33.1	45.2	31.4	19.5	36.8	25.5	38.8	6.8	9.5	4.2	3.7	3.0	4.0	1.4	17.8	22.9	23.8	26.8	14.7	15.2	28.0	18.0	17.5	19.8	22.2	28.9	21.3	41.5	23.1	12.7	26.0	22.3	18.1	22.0	32.4	19.8	27.6	27.2	29.3	26.5	31.0	39.0	19.4	21.8	28.0	40.4	17.4	36.0	52.6	16.2	25.4	37.7	52.7	24.1	16.0	49.9	16.5	28.8	11.8	18.5	24.8	19.8	10.5	20.0	21.7	21.8	32.8	20.7	24.7	20.5	15.8	24.6	75.4	52.3	37.2	18.6	29.8	28.4	0.7	3.7	2.2	2.9	3.3	3.0	6.8	3.5	3.5	2.7	5.7	3.3	4.0	4.2	3.0	2.6	9.5	2.8	1.4	32.5	30.4	57.9	42.5	31.1	22.2	33.8	36.1	28.9	33.1
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000163635	"Ataxin 7"	O15265	3	63898399-64003453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.1"	"Low lineage specificity"	"Detected in many"											HPA034989			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA034989: AB_10602596"	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favourable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	8.8	6.4	4.9	14.5	7.4	19.7	8.9	10.2	6.5	9.5	10.7	4.9	6.7	8.0	10.9	9.2	9.2	7.5	11.4	7.5	5.0	4.3	6.3	8.2	10.2	19.9	6.1	3.1	12.4	21.7	15.3	10.9	15.1	6.0	8.2	8.1	15.1	12.2	7.8	9.6	10.6	12.5	9.2	5.7	11.1	7.2	14.6	6.7	55.4	8.8	8.5	24.2	8.4	10.2	0.9	0.5	11.1	0.5	2.6	5.9	1.1	5.9	4.8	5.0	4.0	5.7	6.5	6.5	3.5	6.4	7.4	6.0	6.8	5.8	5.7	2.1	6.7	3.9	6.3	6.5	7.9	15.0	2.6	10.0	5.7	2.0	2.9	4.2	12.1	6.2	3.5	11.0	12.2	5.5	3.7	17.5	4.6	14.2	8.8	3.4	3.4	2.2	3.8	4.5	6.9	3.6	7.1	2.0	3.7	7.7	5.2	7.0	3.6	6.0	7.6	6.4	8.7	9.3	8.0	7.9	7.9	6.4	7.6	7.0	6.1	11.1	0.3	0.9	3.2	0.5	2.6	0.0	5.9	3.4	0.1	0.9	5.7	3.7	1.2	2.6	0.1	0.5	4.7	1.1	4.9	7.4	10.2	6.5	5.0	4.3	6.1	3.1	6.0	6.7
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000285258	"Ataxin 7"	O15265	3	63864557-64003462	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.9"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA034989			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034989: AB_10602596"																		0.4	0.0		1.5		2.8	1.3		0.0	2.0	0.7			0.0	2.0	2.0	0.0	0.9	0.8	0.0			1.0	0.9	0.9	2.1			0.5	1.0	3.0		1.9		0.9	0.9		0.5	0.6	0.3	3.1	0.8	0.3		1.5	1.0	0.0			0.8		1.8	0.1		4.9	3.6	8.9	1.9	2.5	4.3	0.7	2.4	0.1	3.4	3.2	3.2	6.0	3.3	3.0	2.5	4.0	5.5	1.4	3.2	6.8	1.1	2.0	2.7	3.3	2.3	4.8	6.5	2.5	6.2	4.2	2.4	4.5	4.5	5.7	1.8	6.8	5.1	6.7	2.9	2.3	9.7	2.8	13.0	2.9	3.9	2.2	0.8	5.7	2.9	2.4	2.5	3.3	1.1	1.7	5.9	4.8	3.8	1.4	6.6	4.0	6.0	3.3	3.6	4.6	5.3	4.7	4.2	2.3	4.7	3.5	5.7	1.9	2.7	2.5	1.2	2.9	4.9	2.9	2.4	1.6	4.3	3.5	2.5	8.9	2.5	1.4	3.6	4.3	0.7										
ATXN7L1	"ATXN7L4, KIAA1218, MGC33190"	ENSG00000146776	"Ataxin 7 like 1"	Q9ULK2	7	105605067-105876604	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021448	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021448: AB_1845213"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.01e-1)"	10.8	10.7	10.3	12.1	16.6	7.7	10.6	24.7	13.4	13.3	11.7	9.7	12.3	7.9	9.2	9.1	9.6	11.7	8.4	6.4	8.5	6.2	14.1	12.3	7.8	15.6	7.1	7.3	13.3	7.2	11.2	17.8	10.8	6.9	10.1	11.6	8.3	11.4	12.1	5.2	12.2	10.9	9.7	6.9	10.4	9.8	20.8	9.9	12.4	11.8	4.6	17.9	11.3	11.7	3.9	3.1	4.3	4.8	4.2	14.5	3.4	2.8	3.8	8.3	3.9	5.1	6.0	2.6	5.1	5.1	4.6	4.3	3.7	5.5	1.1	4.0	5.4	2.7	4.6	5.3	3.4	15.9	3.1	3.8	2.8	3.6	3.0	6.2	12.8	4.1	4.3	3.1	3.1	4.1	4.5	2.6	3.8	6.8	3.4	3.5	15.3	3.9	3.4	2.8	0.8	3.5	2.9	5.2	3.4	3.6	7.3	7.2	3.8	6.4	10.4	7.3	3.3	5.9	2.0	0.5	0.0	0.1	4.5	9.7	7.2	2.3	4.2	4.3	2.9	4.8	2.1	3.9	7.5	6.4	3.1	3.6	8.2	4.7	1.4	4.2	2.8	2.1	14.5	3.4	10.3	16.6	24.7	13.4	8.5	6.2	7.1	7.3	6.9	9.9
ATXN7L2	"FLJ00381, MGC46534"	ENSG00000162650	"Ataxin 7 like 2"	Q5T6C5	1	109483479-109492804	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029827, HPA054952"	Uncertain		Approved	Nucleoli,Vesicles,Cytosol				Nucleoli	"Vesicles, Cytosol"	"HPA029827: AB_10602390, HPA054952: "	"unprognostic (4.53e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.77e-4)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (1.19e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.94e-3)"	4.2	5.2	7.5	4.0	9.2	10.2	2.6	15.2	10.9	2.8	2.8	5.1	1.2	2.7	4.4	1.8	2.8	3.3	3.8	2.0	6.5	3.3	3.4	3.0	3.4	3.8	5.7	7.0	7.3	2.4	1.6	9.9	2.5	4.7	2.2	1.4	5.7	1.8	3.2	13.3	3.5	3.1	2.0	3.1	5.4	2.9	8.8	4.8	2.7	4.2	1.0	2.6	3.2	2.4	2.4	1.3	2.4	2.4	2.7	5.6	2.2	2.2	1.7	1.2	4.5	1.6	2.9	3.2	1.6	2.1	3.4	2.2	3.6	1.5	5.8	2.6	2.0	2.5	2.4	2.2	0.4	5.3	3.4	3.2	3.6	1.6	1.0	4.8	7.6	3.1	1.2	3.5	0.0	0.8	5.3	3.3	0.6	7.0	8.4	6.3	7.0	2.5	5.9	2.9	4.1	1.2	2.3	10.6	4.3	1.7	5.7	2.6	1.0	5.0	0.3	2.4	7.0	2.2	6.4	2.1	1.4	5.5	2.8	4.0	6.0	0.0	1.9	2.4	5.4	2.4	5.0	2.3	4.3	5.6	1.3	2.4	4.0	3.8	1.9	2.7	1.6	1.0	3.8	2.2	7.5	9.2	15.2	10.9	6.5	3.3	5.7	7.0	4.7	4.8
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 32.3;testis: 41.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"CAB001454, HPA002636"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"		"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	3.7	2.3	1.5	12.7	1.3	8.3	3.0	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1.0	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6.0	8.7	2.0	6.6	2.6	32.5	24.0	16.1	11.3	0.9	2.1	20.4	26.7	12.5	64.7	27.3	67.2	22.8	10.7	18.4	10.9	26.3	28.5	17.9	69.0	9.6	10.9	19.0	24.6	41.8	0.5	25.4	26.8	1.0	1.9	22.4	20.1	15.1	21.5	8.5	27.5	33.2	15.2	19.7	14.7	24.8	11.6	31.1	11.8	10.3	8.6	13.9	7.5	37.3	43.0	17.9	25.5	15.9	8.6	28.1	27.9	15.5	37.6	11.9	13.8	18.5	15.2	14.8	23.2	0.2	5.3	6.0	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2.0	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"AUTS2, activator of transcription and developmental regulator"	Q8WXX7	7	69598296-70793495	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 27.5;REH: 26.9;SCLC-21H: 37.8;T-47d: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.6;naive B-cell: 11.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	10.3	7.3	29.3	11.6	30.3	9.3	20.3	14.3	19.1	10.5	14.0	17.3	4.1	8.9	10.5	12.4	13.7	8.0	16.6	5.6	22.2	12.9	14.6	19.7	14.7	6.1	14.8	12.3	17.2	6.0	9.9	17.4	5.7	18.9	14.6	13.1	9.9	52.1	8.3	14.9	23.3	18.8	13.6	10.2	8.2	11.3	10.0	20.6	10.5	6.7	7.9	8.9	13.0	10.8	11.6	3.2	0.8	0.2	1.5	2.2	0.7	0.1	2.4	27.5	1.4	1.8	1.1	0.3	1.7	0.0	0.1	0.1	9.3	0.1	4.0	0.6	1.6	8.9	3.3	3.7	0.7	18.3	7.4	2.0	2.6	0.1	0.8	0.0	0.1	2.9	5.1	4.1	1.0	0.0	0.1	2.2	2.3	1.5	0.4	0.7	19.6	0.0	26.9	13.4	11.4	0.0	4.1	37.8	20.6	1.7	3.0	0.0	25.9	0.0	0.0	0.1	9.3	2.9	16.9	0.0	0.0	13.9	0.0	0.0	0.0	0.8	0.2	0.2	1.6	0.1	2.2	8.6	1.1	1.5	0.7	11.6	0.2	0.9	0.5	1.5	0.1	3.2	0.2	0.7	29.3	30.3	14.3	19.1	22.2	12.9	14.8	12.3	18.9	20.6
AXIN2	"DKFZp781B0869, MGC126582"	ENSG00000168646	"Axin 2"	Q9Y2T1	17	65528563-65561647	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.3;CACO-2: 24.7;Hep G2: 36.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 33.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012283, CAB017783"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"CAB012283: AB_2290204, CAB017783: "	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.48e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.84e-3)"	"prognostic favourable (6.58e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.25e-1)"	7.4	10.1	9.0	7.0	8.9	0.9	5.2	8.2	13.1	16.5	12.2	8.7	10.5	7.2	29.0	7.7	6.5	18.6	6.9	7.3	7.9	5.7	3.5	2.5	15.2	3.4	5.3	10.3	14.7	3.9	3.2	5.8	18.2	10.6	14.8	15.2	7.8	4.6	9.8	12.4	14.9	7.5	18.0	4.8	6.9	14.6	6.8	9.0	27.6	11.3	3.6	3.8	11.8	8.7	4.1	0.0	4.4	0.0	1.9	5.1	0.8	0.0	6.6	13.3	0.2	4.8	2.0	5.9	0.2	0.6	0.4	0.8	24.7	2.4	0.4	0.8	3.8	0.2	2.7	0.0	0.9	1.1	1.5	0.0	1.1	36.9	0.5	0.0	0.0	1.2	1.0	1.0	0.3	1.1	0.1	0.6	0.6	0.1	6.4	0.0	2.6	0.3	4.6	0.7	0.0	1.2	0.1	4.1	2.7	0.2	0.1	2.3	0.4	0.1	3.0	2.6	4.8	3.7	0.8	0.0	1.3	1.7	1.2	0.3	1.2	4.4	0.0	0.0	0.3	0.0	0.8	1.0	2.3	0.4	0.0	4.1	5.1	0.8	0.0	1.9	0.0	0.0	0.0	0.8	9.0	8.9	8.2	13.1	7.9	5.7	5.3	10.3	10.6	9.0
AZIN2	"ADC, KIAA1945, ODC-p, ODC1L, ODCp"	ENSG00000142920	"Antizyme inhibitor 2"	Q96A70	1	33081104-33120530	"Predicted intracellular proteins"	"Polyamine biosynthesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 23.1;testis: 22.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 17.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028527			Approved	Cytosol				Cytosol		"HPA028527: AB_10602077"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.50e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.15e-4)"	"unprognostic (9.19e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.41e-1)"	1.5	5.3	7.8	3.1	11.9	0.2	3.6	5.8	14.6	5.1	4.4	23.1	0.5	1.4	3.8	3.4	1.7	7.0	4.1	5.7	10.1	7.8	3.5	0.9	2.5	1.9	10.2	12.2	9.9	3.0	4.4	2.9	1.4	13.6	3.9	3.0	3.4	3.5	3.6	0.9	1.8	1.3	3.4	18.1	1.9	1.8	22.9	10.1	0.7	4.3	0.0	3.0	2.3	1.9	0.2	17.9	3.5	0.0	0.0	1.6	0.7	0.5	0.7	2.2	1.3	1.1	4.8	0.6	0.8	3.3	3.4	2.7	0.3	2.7	0.0	1.0	0.6	1.5	1.4	0.6	1.0	0.0	0.0	0.1	0.1	0.5	5.2	0.0	0.2	4.7	3.0	2.8	1.1	0.5	0.1	0.2	2.5	0.0	0.2	0.9	1.0	0.4	1.5	2.0	0.1	2.4	0.2	0.4	2.2	0.5	0.0	19.7	0.8	0.3	0.1	0.8	1.5	2.3	0.5	1.2	0.0	0.0	5.3	0.0	0.9	3.5	0.0	0.0	1.3	0.0	1.4	0.2	1.4	1.4	0.0	0.0	1.6	1.6	0.0	0.0	0.0	17.9	0.0	0.7	7.8	11.9	5.8	12.8	10.1	7.8	10.2	12.2	13.6	10.1
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711477-44718877	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Immunity		"Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"		3200000000	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	127.2	50.9	24.2	109.2	29.8	131.1	85.2	11.8	23.1	70.5	111.4	29.1	43.3	79.1	72.7	74.7	80.5	36.8	112.8	73.6	26.0	23.1	109.7	140.3	191.2	172.1	42.2	18.8	54.8	42.7	7.8	40.5	91.9	33.1	78.7	128.9	53.5	121.5	40.9	45.7	94.1	178.5	55.1	56.7	272.8	52.5	30.0	29.5	108.0	97.7	71.5	131.6	135.9	73.5	138.9	74.9	341.3	132.8	128.8	215.8	323.7	33.1	14.7	1.4	8.3	54.6	73.6	52.1	22.0	44.9	35.8	60.9	19.1	77.4	15.8	31.1	21.4	29.3	5.5	9.8	17.2	110.7	13.0	60.2	89.2	22.1	41.6	33.7	36.1	37.2	9.1	11.0	11.8	24.4	15.3	2.2	39.6	17.7	13.8	89.0	2.4	31.4	16.8	36.0	100.3	31.2	137.5	5.8	2.1	23.0	18.7	25.9	6.2	175.3	48.5	70.3	7.8	92.6	42.9	41.0	93.8	29.5	68.5	111.3	33.6	221.2	90.4	210.9	126.8	132.8	125.9	138.9	171.7	141.1	58.9	109.4	137.0	167.5	341.3	128.8	106.5	74.9	215.8	323.7	24.2	29.8	11.8	23.1	26.0	23.1	42.2	18.8	33.1	29.5
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"			74000	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	20.7	18.7	16.5	17.2	22.1	17.3	33.4	20.1	23.2	15.0	19.0	12.4	22.2	18.4	13.6	21.0	20.4	17.2	17.5	17.2	13.4	14.7	22.5	21.7	20.8	21.6	16.4	13.4	25.4	37.5	15.8	29.1	41.0	16.6	18.5	19.3	14.8	33.0	27.8	19.5	20.2	15.1	11.7	14.1	26.6	21.5	28.4	16.4	14.8	28.2	10.7	21.4	20.6	22.9	16.7	22.6	7.1	12.6	15.1	25.5	11.9	9.7	6.5	9.6	12.7	14.3	7.3	15.3	5.6	10.0	11.6	10.7	12.7	19.9	9.0	16.0	6.2	9.9	10.1	6.2	6.9	9.4	12.3	5.1	4.3	10.2	10.3	10.1	14.4	10.2	9.2	10.7	11.6	13.1	16.6	20.3	9.4	10.1	6.6	9.7	12.0	13.8	8.0	5.4	22.2	9.8	6.0	13.7	16.2	5.6	14.8	11.7	14.8	18.5	5.5	5.8	10.5	6.5	16.2	73.3	39.5	12.0	8.6	8.7	9.2	5.1	8.9	7.1	17.6	10.1	15.7	16.7	16.7	16.8	10.8	13.5	16.4	15.4	5.9	15.1	12.6	22.6	25.5	11.9	16.5	22.1	20.1	23.2	13.4	14.7	16.4	13.4	16.6	16.4
BAALC		ENSG00000164929	"BAALC, MAP3K1 and KLF4 binding"	Q8WXS3	8	103140710-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 121.3"	"Cell line enhanced"	"Detected in some"		"AF22: 24.4;BJ hTERT+: 8.5;SCLC-21H: 13.3;SH-SY5Y: 9.8;U-87 MG: 36.2"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"NK-cell: 6.9"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: "	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	7.8	11.1	42.3	3.2	51.9	3.9	3.0	12.5	121.3	2.8	2.9	18.9	0.0	2.3	3.0	2.0	2.2	4.6	2.9	3.2	38.1	34.5	2.8	3.4	4.9	2.6	48.3	25.1	2.7	2.6	1.9	5.2	5.7	41.4	2.0	2.9	0.0	2.1	2.4	3.0	2.7	2.8	3.1	51.2	8.8	2.4	2.6	24.6	0.0	2.8	0.0	2.2	2.8	0.3	0.2	0.1	0.0	0.0	6.9	0.1	0.4	0.2	1.4	24.4	0.2	0.2	7.3	0.0	1.2	8.5	0.0	0.1	0.2	0.0	0.1	0.2	4.6	0.4	0.4	0.0	0.0	0.0	1.4	0.2	0.3	0.0	0.5	0.0	0.5	1.4	1.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.6	0.4	0.1	0.1	0.5	0.0	0.0	13.3	9.8	0.2	0.0	0.0	0.1	0.1	1.4	7.7	0.5	0.2	0.5	0.0	0.1	0.1	36.2	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.4	42.3	51.9	12.5	43.6	38.1	34.5	48.3	25.1	41.4	24.6
BABAM1	"C19orf62, FLJ20571, HSPC142, MERIT40, NBA1"	ENSG00000105393	"BRISC and BRCA1 A complex member 1"	Q9NWV8	19	17267350-17281249	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA054386, HPA068786, HPA077609"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA054386: , HPA068786: , HPA077609: "	"unprognostic (5.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.74e-2)"	23.2	26.7	39.8	24.2	33.6	37.3	23.7	32.5	50.0	25.6	25.6	24.5	18.7	25.5	24.9	20.5	26.3	22.0	26.8	36.8	35.2	33.3	24.0	31.2	21.6	30.7	34.4	33.8	23.6	29.2	22.2	15.7	31.9	25.8	22.7	23.8	20.8	30.5	25.5	72.7	25.0	23.4	23.9	23.3	29.1	24.5	24.6	22.2	34.5	19.2	33.5	31.3	21.4	19.8	44.7	51.6	51.6	50.1	33.2	55.2	59.7	34.9	19.6	19.9	18.8	22.2	15.8	45.3	21.0	28.0	42.5	42.4	22.5	41.9	24.8	50.2	29.1	17.4	23.2	29.1	27.3	35.6	37.1	21.8	26.1	27.2	18.0	39.1	27.9	23.9	20.3	28.1	16.8	35.7	36.3	29.2	30.7	28.6	39.4	37.2	51.8	42.3	26.5	26.3	32.7	31.2	17.3	19.3	34.9	25.5	26.7	22.9	23.4	31.7	25.7	25.9	16.4	31.5	34.9	39.2	46.8	32.7	36.6	51.9	24.3	50.0	50.1	51.6	45.4	46.0	43.4	44.7	42.0	43.8	51.6	43.3	39.2	38.6	12.6	33.2	43.4	42.8	55.2	59.7	39.8	33.6	32.5	50.0	35.2	33.3	34.4	33.8	25.8	22.2
BABAM2	"BRCC4, BRCC45, BRE"	ENSG00000158019	"BRISC and BRCA1 A complex member 2"	Q9NXR7	2	27889941-28338901	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"adrenal gland: 172.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017926	Approved		Supported	Cytosol				Cytosol		"HPA017926: AB_1845443"	"unprognostic (1.28e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavourable (6.33e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.22e-2)"	14.5	172.1	11.7	11.4	19.3	16.9	12.3	9.6	21.3	14.3	11.2	11.3	14.2	8.8	23.2	17.1	12.0	15.5	15.6	25.2	12.5	12.7	25.0	17.1	11.5	18.9	9.9	13.8	16.7	14.5	21.8	23.5	11.6	13.4	11.8	13.1	16.3	10.3	15.6	28.7	11.5	11.1	18.2	9.1	16.7	11.6	26.3	6.7	13.9	11.9	13.6	15.7	14.2	11.8	23.5	39.7	38.6	30.2	24.8	31.7	23.6	14.3	15.8	12.8	13.5	16.5	22.3	12.6	7.3	18.4	13.8	14.3	13.4	14.8	16.3	24.5	17.5	9.6	10.4	19.0	20.3	13.7	13.7	19.4	6.9	14.9	23.9	10.1	15.9	54.2	16.7	19.1	20.0	14.6	9.9	17.9	19.1	12.1	11.7	12.4	9.7	10.4	10.9	20.3	15.6	39.7	7.5	8.4	13.4	8.5	15.1	14.5	10.8	13.4	11.7	13.1	17.6	12.0	9.9	20.4	19.8	21.3	24.4	27.8	13.7	38.6	30.2	12.3	28.5	24.0	31.7	23.5	24.2	26.8	39.7	17.9	23.1	22.0	16.0	24.8	23.3	15.8	27.8	23.6	11.7	19.3	9.6	21.3	12.5	12.7	9.9	13.8	13.4	6.7
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 46.7;monocytes: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034949: "	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	23.3	7.8	7.9	15.5	13.1	44.7	10.3	4.7	8.8	13.5	12.8	9.6	6.7	9.9	16.0	10.0	18.6	8.9	15.6	10.7	8.0	5.8	11.7	17.6	25.2	21.9	10.8	5.5	9.5	12.5	5.3	9.2	28.8	11.1	14.9	7.8	9.2	12.2	5.3	30.7	22.9	17.9	15.9	16.0	22.9	9.5	20.6	11.1	14.3	11.3	12.6	14.0	19.4	15.8	4.0	7.6	46.7	15.2	2.1	4.4	4.0	7.4	3.0	9.5	2.4	7.5	21.8	5.9	8.2	19.7	8.0	9.0	6.3	10.4	8.9	6.6	7.5	3.9	5.7	11.0	14.2	7.4	4.7	27.5	6.4	6.5	10.0	7.9	10.3	11.2	16.9	15.6	23.3	4.2	13.9	47.2	10.9	2.6	6.7	4.6	14.7	3.1	6.9	22.6	11.5	4.2	5.9	3.9	4.6	4.5	8.5	10.4	6.2	9.6	10.5	7.8	10.9	8.5	4.1	27.4	17.5	9.6	6.4	9.8	23.4	17.9	15.2	11.3	1.6	12.4	1.3	3.2	2.7	1.4	7.6	4.0	3.9	1.9	46.7	2.1	13.3	1.8	4.4	4.0	7.9	13.1	4.7	8.8	8.0	5.8	10.8	5.5	11.1	11.1
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926529-90296908	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Group enriched"	"Detected in some"	6	"Daudi: 51.5;U-698: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 15.4"	"Lineage enriched"	"Detected in many"	4	"B-cells: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051384: , HPA058384: "	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	2.9	2.1	5.3	29.8	5.6	18.5	4.1	11.4	6.9	5.4	2.2	6.3	1.0	1.3	6.8	2.1	1.9	3.0	2.3	2.6	5.2	2.9	1.7	5.8	5.8	26.7	5.2	4.0	6.3	4.0	5.8	1.9	2.4	4.9	3.7	1.7	0.9	5.2	2.2	7.9	5.4	6.5	2.8	5.2	7.6	1.8	3.4	6.9	26.9	2.0	2.4	20.6	4.8	3.3	15.4	0.2	1.8	0.0	1.5	3.7	0.4	0.3	0.0	1.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	51.5	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	1.1	0.0	2.0	4.5	0.0	0.1	1.0	0.0	0.5	0.4	7.0	1.3	0.9	0.0	0.1	1.7	4.8	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.7	0.0	0.0	3.4	0.1	30.2	0.2	0.5	0.3	1.8	0.0	0.7	0.4	0.0	0.8	2.1	0.8	0.7	0.2	15.4	3.7	2.4	0.0	1.5	0.0	0.2	0.1	0.4	5.3	5.6	11.4	6.9	5.2	2.9	5.2	4.0	4.9	6.9
BAG3		ENSG00000151929	"BCL2 associated athanogene 3"	O95817	10	119651370-119677819	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 115.2;vagina: 160.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.6"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			890000	"Plasma membrane, Cytosol"		"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	17.8	14.1	18.8	7.7	25.7	2.7	38.3	18.4	20.7	11.7	14.1	7.3	6.5	6.3	10.1	10.6	23.3	8.7	17.0	38.2	20.6	14.3	16.8	10.1	14.3	5.9	20.9	4.5	7.3	9.3	27.6	8.8	16.5	27.4	14.4	6.7	5.5	14.6	12.9	115.2	18.5	5.6	20.4	35.8	4.4	15.1	8.1	20.6	1.3	11.1	32.7	12.8	14.0	160.1	0.3	0.8	0.4	1.1	0.2	7.6	1.0	26.1	29.8	8.3	10.8	21.6	15.2	15.6	23.9	20.3	18.3	15.8	12.6	12.8	1.0	11.4	20.5	39.1	8.5	42.2	12.7	12.8	14.0	1.4	8.0	15.7	18.3	0.0	6.1	15.3	24.4	13.3	21.1	20.4	11.2	6.5	18.2	37.4	1.4	5.8	3.2	34.1	0.0	11.8	4.5	13.8	5.9	1.5	1.4	9.5	16.9	12.4	10.5	3.5	25.4	9.7	8.4	13.1	34.1	6.0	3.5	0.6	18.1	0.4	7.3	0.0	1.0	0.0	1.2	1.1	2.0	0.3	4.4	1.5	0.8	0.0	7.6	2.7	0.4	0.2	0.5	0.2	3.0	1.0	18.8	25.7	18.4	20.7	20.6	14.3	20.9	4.5	27.4	20.6
BAG6	"BAT3, D6S52E, G3"	ENSG00000204463	"BCL2 associated athanogene 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"		2000000	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: , HPA053291: "	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	20.8	30.1	16.1	18.4	21.7	16.9	18.1	22.1	31.2	23.9	23.8	22.3	17.9	38.2	25.1	38.6	19.9	23.8	21.4	25.5	15.1	14.1	20.6	41.8	25.7	18.1	15.9	15.6	22.0	22.2	6.6	20.7	27.0	17.5	20.5	30.7	24.4	20.9	19.6	50.5	22.3	31.0	17.3	13.2	23.7	26.1	101.8	16.2	39.9	22.9	30.4	27.1	18.3	19.3	4.8	8.4	8.2	7.5	3.2	6.3	3.1	1.9	14.2	16.6	3.3	8.3	12.8	3.7	3.4	2.7	3.3	3.5	35.3	1.6	2.5	25.7	27.5	2.4	2.0	29.1	5.3	4.1	39.0	11.0	1.8	22.5	12.5	3.2	32.6	10.3	11.8	2.9	3.8	9.5	20.7	11.4	23.8	5.5	2.0	19.4	2.1	2.6	4.8	2.2	4.5	14.2	5.1	2.4	4.5	1.2	4.1	3.3	29.8	27.4	1.8	11.3	8.6	1.9	3.3	15.0	19.8	21.8	15.3	2.7	3.5	8.2	5.7	6.6	6.3	7.5	5.0	4.4	4.4	4.1	4.5	4.8	3.5	4.2	5.8	3.2	6.8	8.4	3.0	3.1	16.1	21.7	22.1	31.2	15.1	14.1	15.9	15.6	17.5	16.2
BAIAP2	"BAP2, IRSp53"	ENSG00000175866	"BAI1 associated protein 2"	Q9UQB8	17	81035122-81117432	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023310, HPA027421"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023310: AB_1845264, HPA027421: AB_10602392"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (7.58e-6)"	10.1	10.9	29.0	4.1	37.4	1.7	11.5	19.6	45.3	14.6	11.8	11.4	18.0	4.3	10.1	26.0	45.9	20.6	17.6	8.7	22.1	10.6	20.6	26.3	20.0	3.6	7.3	24.3	5.1	7.6	8.4	19.2	17.0	9.8	25.7	7.1	11.8	17.0	17.1	3.9	52.6	4.9	10.8	5.4	6.2	20.1	9.2	12.3	2.1	10.2	20.1	20.2	11.1	20.5	0.1	15.4	4.8	7.8	1.3	2.7	2.3	29.9	13.8	8.9	11.5	7.1	9.5	10.3	12.4	8.1	11.2	5.0	18.7	15.2	0.1	9.0	10.9	29.2	8.1	14.2	4.3	0.1	10.2	6.1	12.2	13.9	6.6	0.0	8.9	4.0	16.8	9.2	4.9	6.0	7.8	0.2	6.4	15.9	1.2	6.7	3.7	12.2	1.8	2.2	24.6	34.3	10.5	11.7	12.8	19.8	28.7	33.3	25.2	6.9	7.3	26.2	24.9	4.3	13.1	0.4	0.1	0.4	22.8	1.0	5.6	0.0	5.9	0.4	2.7	7.8	0.9	0.1	1.0	0.9	8.3	0.1	1.2	1.5	4.8	1.3	7.2	15.4	0.4	2.3	29.0	37.4	19.6	45.3	22.1	10.6	7.3	24.3	9.8	12.3
BAIAP2L1	IRTKS	ENSG00000006453	"BAI1 associated protein 2 like 1"	Q9UHR4	7	98291651-98401068	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA019484, HPA021257, HPA023874, HPA029503"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330"	"unprognostic (1.75e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.31e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	4.7	11.2	1.3	16.9	1.1	0.0	10.3	0.3	0.9	6.1	27.3	1.1	10.8	16.2	3.6	4.7	17.9	6.8	29.6	2.1	0.7	0.6	8.9	31.0	15.4	0.9	0.8	0.2	2.6	47.4	4.7	16.9	17.0	1.2	15.2	12.5	6.5	14.7	12.3	3.3	11.3	34.0	3.4	0.7	1.4	33.0	11.6	0.4	2.1	18.0	11.2	14.1	18.9	12.9	1.3	2.7	0.1	0.2	0.0	0.9	0.1	16.0	12.8	0.3	0.3	0.0	0.6	21.5	4.1	2.7	2.2	1.6	17.7	24.2	0.7	6.2	1.5	14.3	6.0	17.6	2.0	0.0	7.7	0.0	5.5	10.1	2.7	0.0	5.8	0.6	23.9	1.2	17.6	0.0	9.5	0.0	1.8	13.5	0.0	0.0	10.1	6.9	0.0	0.2	2.6	13.7	14.2	9.2	1.8	9.6	28.0	4.9	7.8	0.4	0.5	3.2	15.6	0.6	1.9	0.3	4.8	8.1	0.3	2.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	1.3	0.9	0.2	0.1	0.0	0.2	2.7	0.1	0.1	1.3	1.1	0.3	0.9	0.7	0.6	0.8	0.2	1.2	0.4
BANF1	BAF	ENSG00000175334	"Barrier to autointegration factor 1"	O75531	11	66002079-66004149	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB032896, HPA039242"	Enhanced		Supported	Nucleoplasm,Cytosol			77000	Nucleoplasm	Cytosol	"CAB032896: AB_2061090, HPA039242: "	"unprognostic (1.69e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.16e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.57e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	31.2	39.7	38.2	31.6	33.9	24.0	33.5	30.8	38.1	40.7	32.4	33.2	26.5	25.0	38.8	44.4	43.8	58.4	33.4	51.0	35.4	32.5	38.6	61.0	24.6	35.7	33.8	24.7	60.0	40.8	33.5	27.3	40.1	27.5	52.6	33.1	31.1	38.0	38.8	112.7	25.5	29.9	38.9	35.8	39.7	26.8	44.2	27.8	57.6	71.5	54.5	43.8	36.4	45.8	40.0	44.6	14.7	42.8	32.5	30.4	43.8	62.7	63.5	42.8	41.5	21.9	29.1	21.6	34.9	32.6	65.2	41.3	36.8	50.6	54.4	64.5	46.1	44.2	56.2	58.2	47.9	42.7	33.6	63.2	40.2	45.7	26.8	45.7	48.8	27.0	37.5	41.6	36.7	47.5	50.3	43.7	62.9	101.7	51.2	89.9	48.4	44.5	48.1	42.4	123.3	58.6	31.9	34.6	44.6	37.8	62.6	43.3	69.7	35.3	32.9	50.0	55.5	56.5	48.7	32.1	57.9	68.1	43.9	39.1	45.4	14.7	41.6	13.9	29.2	41.7	27.6	40.0	24.5	28.3	44.6	37.8	28.3	30.4	4.4	32.5	42.8	40.0	20.6	43.8	38.2	33.9	30.8	38.1	35.4	32.5	33.8	24.7	27.5	27.8
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.2;HEL: 8.0;HL-60: 7.1;U-266/70: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	15	"memory B-cell: 61.4;naive B-cell: 46.2"	"Lineage enriched"	"Detected in many"	17	"B-cells: 61.4"	"Low region specificity"	"Detected in many"							HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	3.3	2.9	0.7	45.4	0.9	2.0	1.9	2.1	0.7	0.7	1.3	0.7	1.4	0.7	0.4	1.2	6.0	1.0	1.6	0.9	0.8	0.7	2.0	0.5	4.9	30.3	0.7	0.2	0.9	0.6	0.0	3.7	0.5	0.6	2.2	1.1	0.5	7.7	1.8	0.4	0.6	18.0	0.3	0.8	67.0	2.5	1.3	0.7	4.8	5.5	0.4	42.3	6.5	1.1	61.4	2.0	3.6	0.3	0.2	0.0	2.1	0.0	2.2	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.3	0.5	0.0	3.5	10.2	1.0	0.0	0.1	0.1	1.1	0.3	0.0	0.0	8.0	2.1	0.0	0.1	7.1	0.0	0.5	0.3	0.0	0.0	0.1	0.0	3.1	0.4	0.4	0.0	0.4	0.0	4.3	0.1	0.4	0.0	0.3	4.7	2.0	0.0	0.2	0.1	0.0	0.4	1.8	1.0	0.0	0.4	0.0	0.0	24.5	0.0	1.6	0.1	4.1	0.0	1.5	0.3	3.6	0.0	0.1	0.0	61.4	0.0	0.0	2.0	46.2	0.0	0.0	0.1	0.2	0.0	1.0	0.0	2.1	0.7	0.9	2.1	0.7	0.8	0.7	0.7	0.2	0.6	0.7
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401013-52410350	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: , HPA055560: "	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favourable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	13.8	17.6	35.6	14.7	33.3	37.3	13.5	21.8	50.4	12.5	17.0	16.3	11.5	12.4	14.7	14.6	21.2	12.1	15.7	16.4	41.5	15.5	16.6	19.0	14.9	15.2	19.4	27.6	16.9	16.3	30.0	11.1	14.8	19.6	14.4	14.9	15.6	17.9	14.6	24.8	40.5	13.9	14.5	10.0	16.1	13.3	37.3	14.7	18.6	15.3	12.9	16.0	14.1	11.7	5.5	8.4	11.3	5.0	3.0	8.5	3.9	15.3	17.5	21.2	18.0	20.5	13.2	23.9	15.2	19.7	24.7	19.2	21.1	14.4	22.0	7.6	21.2	12.5	22.3	24.5	15.8	21.8	21.1	27.3	37.0	21.8	19.1	25.6	24.3	19.7	32.9	27.3	14.7	19.7	23.3	19.5	18.6	13.3	30.3	35.1	23.9	21.3	13.1	17.2	21.7	15.2	24.9	8.1	26.1	18.7	5.4	22.2	15.3	35.4	21.1	22.4	20.6	26.8	28.2	29.6	38.9	31.5	24.4	27.0	26.4	3.4	5.0	7.4	8.5	3.9	4.0	5.0	6.8	6.9	3.3	5.5	4.9	6.4	11.3	3.0	3.1	8.4	6.0	3.9	35.6	33.3	21.8	50.4	41.5	15.5	19.4	27.6	19.6	14.7
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 59.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033311, HPA068414"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB033311: AB_781574, HPA068414: "	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	7.7	0.0	1.9	0.0	59.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	7.3	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2
BAZ2B	WALp4	ENSG00000123636	"Bromodomain adjacent to zinc finger domain 2B"	Q9UIF8	2	159318979-159616692	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 24.1;neutrophil: 54.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 54.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019819, HPA059292"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA019819: AB_1845282, HPA059292: "	"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.14e-2)"	16.7	20.7	22.1	12.7	37.7	23.5	16.5	30.3	28.5	25.8	18.3	30.0	19.4	12.4	25.4	17.7	16.6	19.2	19.3	13.4	26.1	13.1	13.3	12.3	18.1	9.8	37.2	20.4	33.4	16.4	27.1	45.4	14.9	29.5	17.1	12.4	13.0	19.0	24.6	19.2	12.7	14.5	20.0	42.3	14.4	14.4	18.6	48.9	6.5	19.0	9.1	9.6	18.6	19.2	2.4	5.9	54.6	7.0	4.7	2.7	1.4	3.6	7.3	25.2	15.2	7.6	12.2	4.4	7.8	9.6	4.3	5.1	11.1	10.2	6.3	13.4	7.6	8.5	10.0	10.6	6.8	2.1	5.7	11.5	12.7	1.5	5.0	7.8	8.0	9.5	11.7	10.7	11.8	22.1	12.5	1.2	6.8	4.3	2.7	4.8	8.3	6.4	6.4	8.1	4.3	8.7	13.3	16.7	14.6	15.4	1.9	9.2	2.9	21.6	21.8	7.8	15.8	3.2	5.2	4.7	0.4	7.0	7.2	8.5	4.9	24.1	7.0	8.8	2.7	3.0	2.2	1.5	1.6	2.7	4.4	2.4	1.1	1.7	54.6	4.7	2.6	5.9	1.7	1.4	22.1	37.7	30.3	28.5	26.1	13.1	37.2	20.4	29.5	48.9
BBC3	"JFY1, PUMA"	ENSG00000105327	"BCL2 binding component 3"	"Q96PG8, Q9BXH1"	19	47220822-47232766	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.6;NB-4: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.4"									"CAB007752, HPA070403"	Approved		Approved	Cytosol				Cytosol		"CAB007752: AB_562336, HPA070403: "	"unprognostic (4.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (1.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.57e-1)"	"prognostic favourable (2.62e-5)"	6.8	5.4	4.0	4.7	2.9	9.4	6.5	14.0	7.2	6.3	8.9	1.4	2.3	5.9	5.4	3.7	8.2	5.0	8.0	5.8	4.9	3.9	4.6	5.9	19.0	11.8	3.6	4.3	5.2	11.8	1.6	2.5	5.6	3.4	9.8	4.9	4.5	9.2	4.2	28.6	9.4	6.6	5.7	2.8	7.4	7.9	3.2	3.0	13.3	6.2	1.7	3.2	8.2	3.0	0.2	0.4	6.4	1.0	1.0	1.1	0.3	2.3	5.2	5.7	1.2	1.4	2.7	14.1	3.7	5.1	0.9	2.3	1.5	3.9	9.1	1.6	0.9	0.7	0.8	3.3	0.1	5.8	10.1	2.6	1.8	10.0	18.6	0.4	8.6	6.4	5.4	1.9	1.8	6.5	6.6	5.7	0.6	5.2	0.9	21.3	3.6	0.7	2.5	0.8	10.5	0.2	0.8	0.9	8.7	1.7	3.6	11.2	1.2	7.2	4.3	1.1	7.2	0.1	1.2	9.4	2.0	5.7	1.7	1.3	3.9	6.1	0.9	0.5	0.9	1.0	0.8	0.2	0.2	0.6	0.4	0.0	1.1	0.7	6.4	1.0	0.8	0.1	0.5	0.3	4.0	2.9	14.0	5.7	4.9	3.9	3.6	4.3	3.4	3.0
BBS4		ENSG00000140463	"Bardet-Biedl syndrome 4"	Q96RK4	15	72686179-72738476	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039418	Approved		Supported	Cytosol				Cytosol		"HPA039418: AB_10672962"	"unprognostic (3.47e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	"prognostic favourable (2.57e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.76e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.05e-1)"	8.9	15.5	11.1	8.5	16.6	7.3	12.4	10.7	17.9	14.9	10.6	17.2	9.8	5.6	14.1	18.0	8.1	19.9	10.4	11.9	11.2	13.6	17.5	13.6	11.4	8.0	12.1	14.5	14.8	11.1	16.9	31.3	8.6	23.8	23.8	8.8	29.8	7.8	11.0	17.2	10.1	8.0	12.9	13.2	7.6	10.5	25.7	10.2	13.1	18.0	6.0	8.3	12.4	9.6	6.0	3.8	4.8	4.0	13.0	7.9	3.5	3.1	8.3	18.5	7.8	9.1	11.3	4.9	6.3	13.2	6.3	8.1	4.3	10.8	5.1	13.5	5.3	4.7	4.8	5.2	5.7	5.3	5.9	6.0	7.4	4.8	7.6	5.3	4.7	10.5	7.2	8.9	7.0	4.8	13.0	4.5	9.8	5.6	4.8	5.0	25.8	3.7	3.3	9.2	6.4	10.6	8.0	9.0	10.5	11.1	8.2	16.3	11.0	5.9	6.7	7.2	5.6	34.1	3.5	9.4	9.1	10.8	8.2	8.0	9.7	4.8	2.4	3.8	6.9	4.0	6.7	5.5	5.8	7.2	2.0	6.0	6.1	7.9	2.0	13.0	2.9	3.8	6.8	3.5	11.1	16.6	10.7	17.9	11.2	13.6	12.1	14.5	23.8	10.2
BBX	"HBP2, HSPC339, MDS001"	ENSG00000114439	"BBX, HMG-box containing"	Q8WY36	3	107522936-107811324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006049, HPA050646"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006049: , HPA050646: "	"unprognostic (7.57e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	10.6	22.6	13.1	11.0	20.6	11.2	10.8	12.8	15.1	14.3	13.2	15.4	27.8	6.7	15.1	28.3	10.2	13.2	12.7	11.5	14.8	11.6	14.9	7.3	10.8	10.4	24.5	9.0	21.0	9.0	35.7	39.6	17.8	17.5	17.4	7.3	9.1	11.8	25.1	8.5	7.5	9.4	14.0	26.7	14.1	9.6	43.9	25.5	13.5	19.3	8.0	10.1	15.9	15.6	33.7	16.3	25.2	17.5	25.2	26.1	11.4	18.7	17.4	15.0	22.5	13.4	19.5	12.2	17.8	18.4	16.2	18.0	1.9	15.3	9.7	22.3	11.3	13.0	16.8	21.7	24.5	12.6	7.8	14.6	14.1	4.1	15.9	20.0	9.0	16.3	15.9	16.3	32.8	13.6	6.7	14.7	13.7	6.2	11.3	2.0	7.3	14.8	16.0	14.2	11.0	10.3	14.2	10.8	11.0	31.5	3.1	15.5	12.5	4.5	17.8	19.9	14.8	7.3	12.7	6.3	4.2	11.0	18.0	10.4	11.5	25.2	9.1	21.6	22.6	9.2	26.1	32.8	20.3	22.8	12.7	33.7	25.7	21.1	14.9	25.2	17.5	16.3	13.4	11.4	13.1	20.6	12.8	15.1	14.8	11.6	24.5	9.0	17.5	25.5
BCAP29	"BAP29, DKFZp686M2086"	ENSG00000075790	"B cell receptor associated protein 29"	Q9UHQ4	7	107579977-107629170	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029215, HPA049694"	Enhanced		Approved	Cytosol				Cytosol		"HPA029215: AB_10602331, HPA049694: AB_2680854"	"unprognostic (3.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.42e-3)"	"unprognostic (4.71e-3)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (6.43e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.81e-1)"	25.6	16.0	17.6	13.7	21.3	11.0	24.0	15.9	33.8	30.5	18.9	10.3	13.6	10.4	27.4	12.3	23.3	13.5	14.7	34.0	18.9	17.0	16.7	24.4	17.3	10.6	20.3	28.7	14.6	12.3	20.8	14.8	23.6	25.7	18.5	19.3	10.0	12.1	17.0	22.9	13.6	13.6	24.0	28.1	12.8	14.6	40.0	13.7	6.3	51.4	13.8	9.8	20.5	20.8	6.6	6.3	20.0	12.4	5.1	6.5	4.3	18.8	5.0	7.9	4.1	16.9	20.1	6.4	21.3	18.5	10.4	11.6	5.4	20.2	3.7	15.1	15.9	9.5	4.8	10.0	14.5	12.4	5.1	9.0	7.8	5.3	16.7	10.4	12.5	12.9	7.4	13.3	11.0	28.3	15.2	10.6	20.6	12.8	6.6	8.8	4.7	7.8	6.0	10.7	11.6	15.7	9.8	3.3	11.0	20.6	17.8	15.7	6.8	10.2	30.1	30.9	14.2	27.0	29.4	8.2	21.0	8.8	23.1	9.5	22.5	20.0	6.4	13.0	5.4	7.4	5.5	6.6	4.5	5.7	6.3	5.2	2.7	5.1	2.2	5.1	12.4	6.1	6.5	4.3	17.6	21.3	15.9	33.8	18.9	17.0	20.3	28.7	25.7	13.7
BCAR1	"CAS, CASS1, Crkas, P130Cas"	ENSG00000050820	"BCAR1, Cas family scaffolding protein"	P56945	16	75228187-75268053	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000443, HPA042282"	Approved	Approved	Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB000443: , HPA042282: "	"unprognostic (5.44e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.43e-3)"	"prognostic unfavourable (9.11e-5)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.77e-2)"	"prognostic favourable (4.55e-8)"	"unprognostic (3.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.20e-1)"	16.6	12.3	14.3	8.4	19.5	1.8	11.5	29.1	26.7	16.7	22.7	31.5	9.1	28.6	17.5	11.0	9.6	10.8	20.4	17.8	14.2	9.4	21.3	17.3	15.9	4.9	18.9	13.5	11.3	31.0	9.2	13.2	28.1	13.9	10.9	7.9	14.6	25.7	12.5	37.4	7.2	25.7	8.6	10.4	28.9	28.7	17.3	20.1	0.2	11.8	9.7	6.3	13.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	16.2	7.9	2.6	3.0	2.8	15.2	12.8	7.4	9.4	7.4	20.7	13.9	0.8	17.0	14.2	7.9	2.6	14.6	2.7	0.0	9.1	0.0	9.8	17.2	7.7	0.0	6.6	8.6	7.3	11.1	5.5	25.4	8.2	0.4	5.5	22.0	0.0	0.5	10.4	10.8	0.3	3.5	3.3	8.6	12.0	9.7	13.9	12.2	2.8	4.9	6.6	2.2	22.8	15.8	13.7	3.9	18.8	3.5	1.9	0.2	9.9	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	19.5	29.1	26.7	14.2	9.4	18.9	13.5	13.9	20.1
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3, NSP family adaptor protein"	O75815	1	93561786-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 59.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4;memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavourable (8.41e-4)"	"prognostic unfavourable (5.42e-4)"	"prognostic unfavourable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	26.0	10.4	10.1	11.6	14.2	0.9	23.1	8.6	8.1	10.2	14.1	10.0	6.2	12.4	5.7	5.9	8.9	9.4	15.5	10.6	10.6	8.0	15.5	11.0	12.8	11.8	11.7	5.6	11.2	4.1	4.5	4.6	59.5	10.6	11.2	15.7	10.1	20.5	14.5	19.5	13.3	14.8	10.6	9.7	5.4	15.2	7.3	8.0	2.6	10.0	6.6	11.7	12.7	17.7	4.5	1.7	4.4	1.1	0.0	0.3	0.1	15.1	6.5	12.2	0.9	5.3	4.2	10.5	15.6	27.3	12.9	8.0	1.1	11.3	2.4	5.4	24.1	9.4	0.3	20.2	11.3	1.0	0.3	0.0	4.7	2.8	9.5	0.1	0.0	4.9	22.4	13.3	45.4	14.2	0.4	0.0	34.9	2.3	0.2	0.0	3.8	22.5	1.0	17.6	0.3	33.8	19.2	0.4	1.0	7.6	8.1	9.7	9.1	0.6	16.7	19.2	5.0	8.2	20.6	1.3	0.5	0.3	2.8	0.0	7.0	4.4	0.0	0.1	0.0	1.1	0.0	4.5	0.1	0.0	0.8	2.5	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.1	10.1	14.2	8.6	8.1	10.6	8.0	11.7	5.6	10.6	8.0
BCAS4	"CNOL, FLJ20495"	ENSG00000124243	"Breast carcinoma amplified sequence 4"	Q8TDM0	20	50794894-50882676	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.9;lymphoid tissue: 31.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;U-698: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.9;naive B-cell: 28.7"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA038812	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA038812: AB_10795141"	"unprognostic (3.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.30e-2)"	1.8	2.3	7.3	29.1	12.9	3.9	4.5	6.2	12.8	4.8	4.2	2.3	4.2	2.4	5.4	7.2	4.7	3.6	3.8	3.1	13.8	7.5	7.0	1.4	3.8	28.5	7.1	9.2	3.0	3.6	9.2	5.4	5.0	5.2	7.7	1.9	8.8	4.9	7.1	2.1	2.1	8.6	6.0	2.0	12.2	4.5	5.1	2.2	9.2	5.9	0.0	31.6	7.6	5.3	28.9	7.0	0.6	0.1	6.9	12.9	5.3	4.8	8.7	0.7	3.8	1.4	3.6	1.5	6.3	5.7	4.6	3.2	4.1	2.9	38.1	2.4	2.6	7.2	4.3	9.1	2.6	2.4	3.8	0.2	3.4	3.4	1.9	0.0	0.2	1.2	5.3	3.5	1.7	0.2	0.1	0.2	1.6	17.0	1.4	0.1	3.1	7.1	11.9	1.1	0.3	2.1	4.4	3.9	4.1	9.8	9.4	0.2	18.6	0.4	0.2	4.9	7.2	4.9	1.5	0.6	2.8	33.9	2.0	0.3	0.4	0.6	0.1	0.1	6.2	0.1	3.5	28.9	3.8	7.5	0.1	28.7	12.9	10.3	0.6	6.9	0.1	7.0	3.1	5.3	7.3	12.9	6.2	12.8	13.8	7.5	7.1	9.2	5.2	2.2
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038011: "	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	24.0	25.0	27.9	28.8	28.0	32.3	33.4	28.0	30.2	20.8	23.0	15.0	27.8	19.7	21.1	35.9	27.6	21.3	17.9	28.7	28.7	21.3	35.0	45.9	19.0	27.6	23.6	22.0	28.0	29.2	19.8	27.6	19.8	33.5	27.3	26.3	14.4	34.7	26.7	132.7	19.3	23.5	29.7	35.6	27.2	28.2	28.6	24.1	24.6	26.0	32.0	28.7	24.0	47.9	30.9	30.7	16.1	35.4	26.0	33.8	19.0	53.9	28.1	31.9	35.3	18.2	20.1	26.7	29.1	27.8	36.0	33.4	45.9	36.3	38.0	18.3	26.5	30.0	54.4	41.2	50.4	34.9	37.0	38.2	24.3	50.6	23.1	52.4	24.3	20.6	24.9	42.9	45.4	34.1	42.2	19.5	30.4	32.3	33.8	53.0	24.6	42.4	32.4	33.6	22.8	31.8	26.0	17.0	17.3	21.7	35.6	35.6	19.2	23.3	22.8	16.8	29.7	24.7	52.3	20.0	22.3	56.5	33.0	27.3	12.9	12.4	28.7	16.1	24.6	34.7	33.8	30.9	28.2	26.8	30.7	28.9	31.9	28.6	4.7	26.0	35.4	26.5	29.7	19.0	27.9	28.0	28.0	30.2	28.7	21.3	23.6	22.0	33.5	24.1
BCDIN3D		ENSG00000186666	"BCDIN3 domain containing RNA methyltransferase"	Q7Z5W3	12	49836039-49843129	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039911	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA039911: AB_10673021"	"unprognostic (2.21e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.96e-3)"	"prognostic favourable (3.24e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (1.03e-5)"	"unprognostic (2.31e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (1.06e-4)"	5.6	9.3	6.9	6.0	8.4	2.6	7.8	8.9	9.0	6.1	6.0	7.2	6.9	4.9	8.3	7.5	9.1	7.7	4.9	5.3	5.9	4.5	7.3	10.5	4.5	8.3	9.8	4.8	8.5	11.9	8.4	12.7	6.5	6.6	8.7	5.7	5.2	15.4	6.9	32.8	7.6	8.4	5.3	7.6	9.3	8.4	5.3	7.7	15.2	9.9	4.2	10.8	7.4	6.0	9.9	5.0	5.9	6.6	6.2	10.3	4.6	3.3	4.8	4.6	7.2	9.7	5.7	4.8	4.7	6.1	4.9	5.2	2.5	8.9	3.0	5.3	2.0	4.5	4.6	2.7	2.7	10.2	6.2	4.1	3.7	1.6	7.7	4.7	4.1	3.1	11.0	3.4	4.9	2.2	7.4	8.2	3.0	8.5	5.2	7.6	4.6	8.6	5.5	4.4	5.9	4.8	3.1	6.4	8.9	5.5	9.0	6.6	11.2	5.2	2.6	4.1	3.2	6.2	2.5	7.8	6.7	5.6	4.5	3.5	2.8	5.9	5.4	2.8	7.6	6.5	10.1	9.9	9.4	7.2	5.0	9.1	10.3	9.7	4.6	6.2	6.6	3.0	7.8	4.6	6.9	8.4	8.9	9.0	5.9	4.5	9.8	4.8	6.6	7.7
BCL2L14	"BCL-G, BCLG"	ENSG00000121380	"BCL2 like 14"	Q9BZR8	12	12049844-12211084	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 40.1;testis: 29.8"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 5.5;NTERA-2: 4.2;RT4: 5.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040665	Enhanced		Uncertain	Cytosol				Cytosol		"HPA040665: AB_10964282"	"unprognostic (3.65e-4)"	"unprognostic (4.95e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.70e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.59e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-6)"	"unprognostic (3.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-8)"	0.1	0.1	0.1	5.3	0.2	0.0	0.3	0.1	0.1	0.3	17.6	0.1	0.1	11.5	0.1	0.4	0.4	0.2	7.7	0.1	0.1	0.1	0.3	0.3	1.3	1.6	0.1	0.1	0.4	11.2	0.0	0.1	0.1	0.1	1.6	13.3	0.1	0.8	0.1	0.1	0.1	40.1	0.1	0.1	0.9	7.8	29.8	0.1	4.1	0.1	0.3	1.2	2.5	0.2	0.9	0.0	0.1	0.2	0.0	3.0	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.0	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.7	0.9	1.4	0.7	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	3.0	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR, RhoGEF and GTPase activating protein"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favourable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	14.5	8.4	24.0	9.1	41.2	26.7	10.5	14.2	26.5	13.6	9.7	10.3	10.6	8.7	9.2	13.9	19.3	10.8	8.3	7.8	20.9	13.0	16.3	8.3	11.3	10.9	16.0	15.6	8.8	12.9	14.5	14.9	15.7	14.2	7.0	6.8	8.3	15.5	9.7	3.4	12.8	8.7	9.0	9.5	9.1	14.0	9.6	15.4	11.8	16.6	5.5	9.2	9.2	8.8	1.5	0.8	1.2	1.0	2.8	6.6	2.5	18.6	8.1	12.4	12.7	7.4	5.1	18.8	6.8	6.3	6.3	5.1	14.1	7.5	13.0	12.6	5.7	19.2	1.3	18.8	1.8	24.9	12.9	11.4	11.1	11.2	9.7	10.5	6.0	4.3	12.7	9.4	8.2	21.8	43.5	6.1	2.8	12.3	9.8	8.2	10.5	7.9	12.9	5.0	8.6	9.7	11.8	11.4	10.8	12.4	10.7	5.1	6.7	8.6	24.6	3.8	0.4	6.1	5.5	1.4	5.6	4.6	9.7	8.0	5.8	0.0	1.0	0.0	6.6	0.4	2.3	1.4	3.3	3.3	0.8	1.5	2.6	3.6	1.2	2.8	1.0	0.8	1.6	2.5	24.0	41.2	14.2	24.9	20.9	13.0	16.0	15.6	14.2	15.4
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103079435-103099883	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 139.1"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol				Cytosol		"HPA036028: AB_10670674, HPA036029: "	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.75e-4)"	"unprognostic (9.69e-3)"	12.4	33.1	22.6	7.7	26.0	2.8	17.6	9.6	18.5	15.7	18.9	14.8	12.3	36.7	11.6	18.8	10.4	16.6	13.5	14.9	26.6	15.4	139.1	39.3	13.8	6.0	38.2	15.6	26.2	8.3	23.5	14.8	8.1	29.0	13.0	11.2	27.0	10.2	15.2	6.9	7.9	34.8	10.2	29.7	6.7	11.8	7.2	32.4	10.4	25.1	12.0	7.6	11.0	11.8	9.5	7.5	1.4	4.1	11.6	18.5	7.5	2.6	4.5	25.9	7.8	27.1	30.1	3.7	6.2	16.0	5.9	10.0	3.6	10.4	10.8	10.9	9.6	1.3	13.4	10.0	6.9	6.3	8.1	2.1	6.6	11.9	17.4	6.2	3.1	24.1	9.4	10.1	2.3	20.0	6.5	3.4	22.7	1.4	27.8	6.1	7.9	2.1	20.1	25.1	6.3	41.4	5.0	3.5	12.6	11.0	5.9	7.0	5.2	5.1	12.2	7.0	3.7	4.5	2.4	6.5	6.5	11.1	9.3	7.5	5.8	1.4	4.1	0.2	11.9	1.8	12.8	9.5	12.1	11.3	5.8	9.0	14.2	15.3	0.3	11.6	0.3	7.5	18.5	7.5	22.6	26.0	9.6	18.5	26.6	15.4	38.2	15.6	29.0	32.4
BEGAIN	KIAA1446	ENSG00000183092	"Brain enriched guanylate kinase associated"	Q9BUH8	14	100537147-100587413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9"	"Group enriched"	"Detected in some"	7	"HeLa: 21.3;SH-SY5Y: 51.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 6.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002899			Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA002899: AB_1078277"	"unprognostic (2.98e-4)"	"unprognostic (2.75e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.77e-3)"	"unprognostic (1.93e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-1)"	1.8	5.5	16.4	1.1	10.8	6.4	1.5	24.9	21.6	1.3	1.3	0.9	0.0	4.6	2.0	1.8	1.4	3.0	2.5	1.5	15.3	7.1	0.9	0.8	1.0	1.3	4.4	6.0	3.5	13.0	2.3	8.2	3.1	3.6	2.6	0.9	2.1	2.8	2.7	0.9	1.3	3.0	1.7	2.0	3.3	1.0	2.6	1.4	5.4	1.0	0.4	1.3	0.8	0.6	0.6	1.0	6.8	1.5	0.0	0.4	0.1	0.3	1.3	0.7	4.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.4	1.9	21.3	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.5	0.0	0.2	0.0	0.0	1.6	0.1	0.6	0.5	0.7	0.0	0.1	2.6	0.0	0.0	1.1	51.9	1.1	0.0	1.2	0.3	5.3	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.1	1.3	0.1	6.8	0.0	1.5	0.0	0.6	0.4	0.0	0.0	0.2	0.1	0.0	0.6	0.0	1.4	1.0	0.0	0.1	16.4	10.8	24.9	17.3	15.3	7.1	4.4	6.0	3.6	1.4
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110938-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 26.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 24.1;HEK 293: 5.8;HEL: 14.7;MOLT-4: 9.0;U-698: 9.6"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"memory B-cell: 1.1;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.4	0.3	3.9	5.0	1.0	1.6	0.3	0.2	2.6	0.2	0.6	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.4	0.3	2.8	1.9	0.3	0.5	1.0	3.7	2.8	1.1	0.6	0.3	0.1	3.8	0.8	1.8	6.4	0.7	0.2	0.8	0.2	0.2	0.2	2.8	0.4	0.4	4.8	0.5	26.7	0.3	4.8	0.3	0.0	3.0	0.7	2.3	3.3	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	24.1	0.0	0.0	0.0	5.8	14.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	4.4	1.3	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	3.9	1.0	0.2	2.6	2.8	1.9	2.8	1.1	1.8	0.3
BEND5	"C1orf165, FLJ11588"	ENSG00000162373	"BEN domain containing 5"	Q7L4P6	1	48727523-48776969	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 4.2;HDLM-2: 13.5;MOLT-4: 5.5;NTERA-2: 3.2;REH: 7.7;SH-SY5Y: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 7.1;naive B-cell: 10.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.1"	"Low region specificity"	"Detected in many"							"HPA054347, HPA058007"	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA054347: , HPA058007: "	"prognostic favourable (2.50e-5)"	"unprognostic (1.36e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.42e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.68e-2)"	"prognostic favourable (8.30e-6)"	2.7	5.4	6.5	5.6	7.7	3.0	3.1	2.1	15.5	4.8	5.0	2.8	3.5	1.6	5.0	4.9	2.3	4.3	6.0	4.0	6.0	5.1	6.5	0.8	3.0	5.9	5.4	9.7	12.8	2.8	1.9	5.9	1.4	14.7	3.9	1.6	3.3	2.5	4.3	6.6	1.9	2.6	2.6	3.2	6.4	2.9	2.6	1.9	11.3	4.3	0.5	4.1	4.4	2.9	10.1	1.9	0.2	0.0	1.1	2.0	0.6	0.0	0.0	4.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	0.2	3.2	0.0	7.7	1.4	0.0	0.1	1.5	1.4	3.8	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.2	1.9	10.1	2.0	1.2	0.2	1.1	0.0	1.9	0.0	0.6	6.5	7.7	2.1	15.5	6.0	5.1	5.4	9.7	14.7	1.9
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064240	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 150.2;pituitary gland: 64.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 42.0;BJ hTERT+ SV40 Large T+ RasG12V: 62.4;HBF TERT88: 69.6;HL-60: 152.4;SCLC-21H: 47.7;THP-1: 43.1;U-937: 47.8"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"											"HPA045384, HPA078630"	Approved		Approved	Cytosol				Cytosol		"HPA045384: , HPA078630: "	"prognostic favourable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favourable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (6.88e-4)"	"unprognostic (7.34e-2)"	1.8	37.4	66.4	2.8	65.1	16.3	1.9	44.7	150.2	1.8	3.0	6.2	0.0	3.3	7.7	25.2	1.6	10.1	1.8	3.6	77.4	81.0	4.5	3.0	2.1	1.7	38.9	67.8	9.5	30.9	48.1	64.3	1.5	35.8	3.8	3.1	4.7	2.2	2.9	1.3	1.5	3.9	3.3	24.3	2.3	5.0	27.5	12.0	0.0	12.1	0.0	1.5	1.5	0.4	2.4	0.2	6.4	0.5	1.7	3.1	1.5	0.0	0.0	3.8	0.0	0.0	0.0	0.1	2.1	0.0	42.0	62.4	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	69.6	0.0	0.1	12.7	0.0	8.2	0.7	152.4	0.2	0.9	0.0	9.1	0.0	0.0	0.0	0.0	8.4	0.0	28.6	0.0	34.7	6.2	0.0	0.0	0.7	0.0	0.0	47.7	27.5	0.0	0.0	0.1	0.0	43.1	0.0	0.0	14.4	0.1	1.6	7.4	0.2	0.0	5.6	47.8	2.7	0.6	0.5	6.4	0.7	0.1	0.7	1.2	2.0	1.2	0.1	2.4	3.1	1.4	1.2	1.7	0.4	0.2	0.9	1.5	66.4	65.1	44.7	89.0	77.4	81.0	38.9	67.8	35.8	12.0
BEX2	DJ79P11.1	ENSG00000133134	"Brain expressed X-linked 2"	Q9BXY8	X	103309346-103311046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 79.2;epididymis: 67.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.7;NTERA-2: 29.6;SCLC-21H: 43.6;SH-SY5Y: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 18.0;NK-cells: 21.3;T-cells: 26.8"									"HPA045384, HPA078630"	Uncertain		Uncertain	Cytosol				Cytosol		"HPA045384: , HPA078630: "	"unprognostic (7.56e-2)"	"unprognostic (7.08e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavourable (8.54e-7)"	"unprognostic (3.21e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.27e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (7.36e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.22e-3)"	"unprognostic (6.63e-2)"	"prognostic favourable (3.05e-13)"	"unprognostic (4.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	1.7	39.6	49.1	4.1	62.6	6.8	10.9	44.9	79.2	5.8	4.7	11.5	3.0	2.7	14.7	67.1	3.0	8.9	4.8	7.3	53.4	57.6	26.4	1.4	6.6	7.3	32.5	40.3	29.0	13.5	29.6	40.1	5.0	29.6	12.4	4.1	11.5	11.1	12.8	2.5	4.2	4.2	5.7	18.7	7.9	6.5	13.2	13.6	3.1	52.8	1.3	9.2	3.7	2.2	18.0	3.5	4.0	0.1	21.3	26.8	7.1	0.0	0.8	3.7	0.0	0.0	0.0	14.7	0.1	2.0	2.5	3.6	2.5	1.2	0.0	10.3	0.0	0.6	0.0	3.0	2.2	0.0	8.0	0.4	0.4	0.1	15.0	0.0	8.2	0.9	30.7	1.2	9.4	0.1	5.3	0.2	0.3	1.3	6.1	0.0	29.6	2.6	0.0	0.0	0.0	1.2	1.1	43.6	19.9	1.9	0.4	6.5	3.6	0.0	0.0	0.0	2.9	0.1	0.6	10.1	6.4	0.0	4.9	0.0	0.4	4.0	0.1	0.3	8.5	0.1	11.8	18.0	16.8	9.8	0.5	15.0	26.8	19.2	0.5	21.3	0.0	3.5	11.3	7.1	49.1	62.6	44.9	60.5	53.4	57.6	32.5	40.3	29.6	13.6
BEX3	"Bex, DXS6984E, HGR74, NADE, NGFRAP1"	ENSG00000166681	"Brain expressed X-linked 3"	Q00994	X	103376340-103378077	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 18.8;naive CD4 T-cell: 40.8;naive CD8 T-cell: 18.8;T-reg: 32.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018886	Approved		Supported	Cytosol				Cytosol		"HPA018886: AB_1854453"	"unprognostic (7.74e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.15e-3)"	"prognostic unfavourable (7.23e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.28e-4)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.68e-2)"	21.1	66.1	73.2	9.4	84.2	6.7	22.2	47.1	92.1	28.9	15.2	22.7	30.8	7.7	35.4	134.6	16.0	36.8	18.8	42.9	71.3	87.4	49.8	23.0	22.0	6.7	63.7	75.8	92.7	28.4	39.7	51.5	49.3	82.6	40.8	14.4	18.5	23.4	59.1	4.7	9.0	9.8	29.8	65.2	20.0	13.3	28.1	33.5	10.6	57.0	8.9	7.3	22.7	20.0	1.2	3.5	3.7	0.9	6.4	40.8	17.1	23.5	35.4	68.6	25.8	62.0	69.9	29.1	26.8	47.1	34.7	55.7	37.0	27.6	0.0	49.5	33.2	9.8	47.3	33.3	37.8	0.1	32.0	10.7	56.2	10.3	46.2	0.1	4.4	71.9	29.8	46.2	43.3	53.7	0.0	0.1	65.7	56.2	25.0	0.3	85.3	26.1	0.0	39.7	0.0	38.3	44.4	44.8	44.8	29.5	0.3	39.8	16.5	3.7	31.8	22.2	14.5	42.9	12.1	0.2	0.1	0.1	45.4	0.0	21.5	0.0	0.9	0.2	1.0	0.2	0.6	1.2	18.8	5.0	1.5	0.3	40.8	18.8	3.7	6.4	0.1	3.5	32.3	17.1	73.2	84.2	47.1	79.7	71.3	87.4	63.7	75.8	82.6	33.5
BEX4	"BEXL1, FLJ10097"	ENSG00000102409	"Brain expressed X-linked 4"	Q9NWD9	X	103215092-103217246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 37.4;HMC-1: 45.3;K-562: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA045105, HPA051935"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045105: AB_10966792, HPA051935: "	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.03e-1)"	"unprognostic (6.33e-2)"	"prognostic favourable (9.41e-4)"	"unprognostic (1.62e-2)"	"prognostic favourable (2.54e-14)"	"unprognostic (1.62e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.33e-2)"	9.8	36.8	63.8	8.6	71.4	21.5	20.8	53.6	68.8	20.7	14.3	29.5	11.5	6.4	25.5	99.8	17.7	24.5	14.8	35.1	61.6	77.6	34.9	5.1	15.8	10.7	54.3	54.7	38.8	12.6	40.7	34.1	29.4	50.5	30.1	10.1	18.0	27.1	32.1	2.5	7.5	8.7	20.9	51.2	23.1	9.6	16.2	24.4	8.6	47.8	3.5	12.3	14.1	11.5	12.9	28.3	36.7	10.4	34.0	25.7	15.0	0.0	0.0	23.2	0.0	5.9	4.1	20.7	5.4	4.7	10.2	18.9	0.0	0.3	0.0	9.1	3.8	0.1	9.3	1.2	11.4	0.0	8.7	37.4	0.0	0.0	18.1	28.0	45.3	15.3	3.1	5.3	0.0	11.9	52.4	0.1	3.1	0.1	19.5	0.2	28.0	1.6	0.0	6.7	0.1	9.4	0.5	17.3	26.4	1.9	0.3	1.1	0.9	0.3	0.3	1.3	8.3	0.1	0.0	3.0	1.3	0.0	3.9	0.0	1.1	36.7	8.6	14.8	12.1	10.4	10.1	12.9	14.7	12.2	18.2	12.6	25.7	20.2	1.9	34.0	8.5	28.3	13.5	15.0	63.8	71.4	53.6	68.8	61.6	77.6	54.3	54.7	50.5	24.4
BFSP1	"CP115, CP94, filensin, LIFL-H"	ENSG00000125864	"Beaded filament structural protein 1"	Q12934	20	17493905-17569220	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 18.3;SK-BR-3: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 6.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.5;T-cells: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040748, HPA042038"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA040748: AB_10963786, HPA042038: AB_10964054"	"unprognostic (2.24e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-1)"	"prognostic favourable (1.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-6)"	"unprognostic (5.11e-2)"	"unprognostic (5.53e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.35e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.50e-2)"	2.5	1.8	3.5	2.5	5.6	0.8	2.6	2.8	4.4	3.5	1.8	0.9	5.5	0.8	10.7	5.4	5.1	2.2	4.8	2.4	3.2	3.7	6.1	1.1	4.1	0.6	3.3	1.7	5.3	2.7	4.8	1.3	4.5	3.0	3.3	1.2	2.3	2.0	4.0	3.0	1.8	0.9	2.7	6.9	0.8	1.1	8.0	0.7	0.6	5.3	2.3	1.5	5.1	1.1	0.0	0.0	0.7	0.0	1.5	6.1	0.5	0.7	7.5	2.4	0.3	0.6	2.5	0.4	1.9	8.7	1.2	1.2	3.3	6.4	0.0	1.5	1.0	1.1	2.6	1.5	1.0	1.6	2.0	0.5	1.1	1.0	1.4	0.4	0.8	3.0	4.6	0.7	2.1	5.2	0.2	0.4	3.9	1.4	0.0	1.0	5.7	2.1	0.0	1.7	0.4	18.3	1.3	2.5	0.3	2.2	9.9	3.8	4.8	1.6	5.9	0.3	0.6	0.6	1.8	0.0	0.1	0.0	1.3	0.0	1.5	0.1	0.0	0.0	6.1	0.0	0.2	0.0	1.7	1.0	0.0	0.0	0.1	0.5	0.7	1.5	0.0	0.0	0.0	0.5	3.5	5.6	2.8	4.4	3.2	3.7	3.3	1.7	3.0	0.7
BFSP2	"CP47, CP49, LIFL-L, phakinin"	ENSG00000170819	"Beaded filament structural protein 2"	Q13515	3	133399995-133475222	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"blood: 12.7"	"Group enriched"	"Detected in some"	7	"Daudi: 5.5;U-698: 6.5"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"T-reg: 12.7"	"Lineage enriched"	"Detected in single"	48	"T-cells: 12.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA038464, HPA062959"	Enhanced		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038464: AB_10672746, HPA062959: AB_2684912"	"unprognostic (1.58e-3)"	"unprognostic (7.47e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.04e-5)"	"unprognostic (8.13e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.21e-2)"	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BHLHB9	"GASP3, KIAA1701, p60TRP"	ENSG00000198908	"Basic helix-loop-helix family member b9"	Q6PI77	X	102720688-102753540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 21.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000887			Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA000887: "	"unprognostic (4.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.42e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.40e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.74e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (8.88e-2)"	2.8	6.4	8.6	1.6	13.0	2.7	3.7	15.3	20.6	5.5	3.4	8.7	2.3	2.1	7.5	5.8	2.9	4.5	3.0	4.9	8.9	12.5	6.3	3.8	2.6	1.5	7.2	12.7	9.9	3.6	9.1	7.1	4.8	21.1	7.2	2.9	3.9	3.6	8.2	4.8	3.4	2.5	7.2	6.3	2.7	2.5	4.4	7.3	1.7	6.6	1.2	2.0	4.1	3.4	0.7	0.3	0.9	0.2	5.3	2.0	0.5	0.5	4.0	13.0	3.9	4.1	2.4	5.2	3.4	4.7	5.7	10.9	3.3	2.3	0.0	3.6	3.9	2.8	7.1	3.8	6.4	0.0	4.2	1.0	3.3	0.7	6.6	0.7	1.3	4.3	3.4	2.5	0.3	5.7	3.0	3.5	5.0	2.2	2.6	0.4	7.6	3.0	1.4	3.8	0.0	3.7	5.8	5.8	5.4	3.8	1.1	0.4	3.2	1.8	5.8	1.5	4.0	2.2	3.3	1.9	4.7	0.0	3.5	0.9	2.4	0.9	0.2	0.2	1.0	0.1	0.9	0.4	1.1	2.0	0.1	0.7	1.3	1.7	0.7	5.3	0.1	0.3	1.6	0.5	8.6	13.0	15.3	20.6	8.9	12.5	7.2	12.7	21.1	7.3
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111779-79132290	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 105.9;liver: 216.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.2;NTERA-2: 3.5;SCLC-21H: 2.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 90.6;renal cancer: 50.4"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol			9200000	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favourable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.1	1.5	0.0	105.9	216.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	4.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.2	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.6	0.1	0.0
BICD2	KIAA0699	ENSG00000185963	"BICD cargo adaptor 2"	Q8TD16	9	92711363-92764812	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023013, HPA024452"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA023013: AB_1845352, HPA024452: AB_1845353"	"unprognostic (9.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (1.39e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.39e-2)"	10.4	7.8	13.9	8.9	12.5	7.2	7.1	13.2	13.1	13.1	9.9	7.7	7.9	3.2	9.7	4.5	27.2	7.2	6.7	15.6	11.8	5.8	7.5	5.2	9.1	9.3	13.4	9.8	8.4	7.2	21.7	3.8	9.8	11.9	7.4	3.7	6.6	9.1	10.0	13.9	40.3	5.9	9.7	9.2	11.3	5.9	5.9	11.0	8.5	6.2	16.3	18.2	10.6	17.2	3.3	5.2	10.5	7.5	1.5	2.4	2.0	14.1	11.7	8.7	8.9	17.0	11.7	12.3	13.7	9.9	7.8	6.2	6.8	6.4	15.9	9.0	15.2	44.3	9.7	21.8	8.9	7.6	10.6	8.4	11.4	9.4	10.1	11.5	13.6	12.0	30.5	13.0	10.0	11.6	8.2	12.4	17.0	9.2	10.9	7.2	6.0	14.4	12.1	18.9	8.4	12.5	11.9	6.1	9.4	9.6	9.0	6.2	3.7	5.4	15.5	14.6	9.7	24.4	14.8	10.2	7.4	14.1	12.3	7.1	12.7	2.2	4.4	5.6	1.8	5.2	1.8	2.7	2.0	2.4	5.2	3.3	1.9	1.7	10.5	1.5	7.5	4.5	1.2	2.0	13.9	12.5	13.2	13.1	11.8	5.8	13.4	9.8	11.9	11.0
BICDL1	"BICDR-1, CCDC64, FLJ26450"	ENSG00000135127	"BICD family like cargo adaptor 1"	Q6ZP65	12	119989869-120094494	"Predicted intracellular proteins"	"Neurogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.9;skin 1: 20.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 27.3;MCF7: 14.7;SCLC-21H: 17.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061116	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA061116: "	"unprognostic (2.17e-1)"	"prognostic favourable (6.50e-4)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-2)"	"unprognostic (6.81e-4)"	"prognostic favourable (3.15e-4)"	"prognostic unfavourable (6.84e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.26e-2)"	"prognostic favourable (3.93e-5)"	"prognostic favourable (1.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-1)"	4.0	0.8	2.7	3.8	2.3	0.7	0.9	11.9	6.5	0.8	0.9			1.3	0.0	16.5	7.5	0.7	1.4	0.0	3.1	5.1	29.9	0.5	0.7	8.7	1.5		0.0	1.1	1.2	18.4	0.1		0.9	1.0		1.4	0.1	0.0	20.5	1.1	0.0	0.7	2.3	8.6	8.0			6.3		6.0	1.2	3.5	0.5	0.1	0.9	0.8	0.2	3.4	0.7	1.8	5.7	0.3	0.0	0.5	0.0	7.0	0.0	0.0	0.0	0.0	5.1	3.2	9.0	2.4	0.0	4.3	0.7	0.9	0.0	0.6	0.9	0.0	2.5	9.7	0.0	1.1	9.5	0.0	27.3	0.0	0.3	0.0	0.3	1.1	0.0	14.7	6.4	0.1	11.7	2.7	0.7	0.5	2.4	3.5	4.5	17.2	1.2	2.0	5.4	1.4	12.3	4.4	0.0	0.1	1.6	0.0	0.1	2.3	8.7	3.5	0.3	1.3	0.9	0.9	0.0	0.0	3.4	0.0	1.3	0.5	3.4	2.9	0.0	0.5	2.6	2.0	0.0	0.2	0.8	0.1	0.6	0.7										
BICDL2	CCDC64B	ENSG00000162069	"BICD family like cargo adaptor 2"	A1A5D9	16	3027682-3036926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.1;pancreas: 54.1"	"Cell line enhanced"	"Detected in some"		"A-431: 6.3;BEWO: 11.3;CAPAN-2: 10.4;HaCaT: 16.2;MCF7: 15.7;RT4: 7.4;SK-BR-3: 8.1;T-47d: 10.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.6;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043251	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"				"Intermediate filaments, Actin filaments, Cytosol"		"HPA043251: AB_10794925"	"unprognostic (2.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.06e-3)"	"unprognostic (9.65e-5)"	"unprognostic (5.79e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.32e-2)"	"prognostic favourable (9.04e-4)"	0.4	0.0	0.4	2.5	0.4	0.0	2.9	0.4	0.4	6.2	7.9	0.4	8.3	5.7	1.0	2.0	31.1	2.2	11.0	0.4	0.4	0.0	1.2	0.4	5.3	0.4	0.4	0.4	0.9	54.1	3.6	0.9	0.5	0.4	5.1	3.5	0.4	13.9	8.3	1.1	13.7	6.9	1.0	0.4	0.4	10.2	0.5	0.4	0.4	2.3	8.6	12.4	6.1	12.0	0.1	0.1	3.5	0.0	0.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	1.8	10.4	0.0	0.0	0.0	16.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	7.4	0.1	0.0	0.0	8.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.2	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
BID		ENSG00000015475	"BH3 interacting domain death agonist"	P55957	22	17734138-17774770	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 96.5;bone marrow: 55.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 44.3;eosinophil: 68.5;intermediate monocyte: 75.7;myeloid DC: 36.3;neutrophil: 96.5;non-classical monocyte: 92.8;plasmacytoid DC: 25.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 36.3;granulocytes: 96.5;monocytes: 92.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000722, CAB003771"	Enhanced		Supported	Cytosol			2400000	Cytosol		"CAB003771: AB_365478, HPA000722: AB_1078283"	"unprognostic (1.59e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.50e-13)"	"unprognostic (4.66e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.18e-2)"	13.0	5.2	16.8	21.7	18.7	55.0	8.5	17.1	23.0	3.9	12.2	9.3	1.0	11.2	4.3	7.1	6.7	4.9	11.3	9.6	17.8	12.8	6.1	31.9	13.7	22.5	16.5	6.3	3.7	8.9	4.3	3.5	6.9	8.1	7.1	8.3	4.5	8.0	3.8	11.3	4.7	13.0	5.3	10.9	29.1	9.5	2.4	9.2	21.0	5.5	5.9	12.8	16.2	9.4	5.5	36.3	96.5	92.8	11.6	10.1	37.0	28.5	22.7	3.9	11.6	3.9	7.7	5.1	14.1	11.5	11.4	9.8	13.2	17.1	4.8	11.1	6.1	24.4	3.4	3.4	6.3	9.2	16.9	22.9	9.0	23.9	4.7	23.5	26.7	7.1	8.3	11.2	2.7	11.4	17.2	6.8	5.7	56.4	40.1	33.4	11.9	12.6	18.5	8.4	7.3	3.1	37.1	23.2	17.1	2.8	10.1	9.7	20.1	32.9	19.6	6.5	9.4	10.9	11.0	10.1	15.7	17.9	20.0	26.8	8.7	13.8	44.3	68.5	8.8	75.7	8.2	5.5	8.1	9.6	36.3	3.2	6.4	7.5	96.5	11.6	92.8	25.3	10.1	37.0	16.8	18.7	17.1	23.0	17.8	12.8	16.5	6.3	8.1	9.2
BIN1	"AMPH2, AMPHL, SH3P9"	ENSG00000136717	"Bridging integrator 1"	O00499	2	127048027-127107355	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"skeletal muscle: 399.9"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 37.0;MAIT T-cell: 32.5;memory B-cell: 32.2;memory CD4 T-cell: 38.4;memory CD8 T-cell: 36.9;naive B-cell: 34.1;naive CD4 T-cell: 36.2;naive CD8 T-cell: 34.4;NK-cell: 31.2;T-reg: 45.0"	"Group enriched"	"Detected in many"	9	"B-cells: 34.1;NK-cells: 31.2;T-cells: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001945, HPA003894, HPA005437"	Enhanced		Supported	Cytosol			1200000	Cytosol		"CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284"	"unprognostic (2.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.22e-3)"	9.5	12.1	21.0	6.7	26.8	3.7	4.2	10.3	24.9	6.2	5.4	36.2	3.6	5.3	5.6	7.3	8.8	7.8	6.4	3.1	24.8	15.2	10.3	4.9	4.6	9.3	26.8	15.8	6.8	5.3	7.3	4.9	6.5	17.3	9.2	4.4	7.9	4.9	7.2	399.9	2.7	5.0	11.6	22.1	10.4	6.1	3.1	26.8	0.0	4.7	30.8	7.3	9.0	7.9	34.1	4.0	1.1	0.6	31.2	45.0	22.4	15.3	8.4	10.1	12.0	30.4	24.4	3.5	4.6	10.1	11.1	7.3	32.2	9.5	0.0	14.3	8.7	2.0	4.5	7.6	3.0	1.7	1.2	4.5	13.8	2.1	27.4	0.0	0.9	22.2	1.9	24.0	4.4	15.0	0.9	0.5	13.7	0.3	1.4	12.8	7.6	9.6	3.5	11.2	1.4	39.3	0.0	6.6	18.8	16.8	6.5	5.1	0.4	2.9	17.9	12.8	12.6	16.3	15.5	0.4	0.4	0.0	18.9	0.8	5.8	0.1	0.6	0.1	37.0	0.3	32.5	32.2	38.4	36.9	2.8	34.1	36.2	34.4	1.1	31.2	0.5	4.0	45.0	22.4	21.0	26.8	10.3	24.9	24.8	15.2	26.8	15.8	17.3	26.8
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	20.9	25.8	19.1	23.3	24.1	25.9	57.0	20.5	28.5	25.1	22.2	18.4	18.7	19.3	24.6	31.1	18.6	17.0	21.1	39.2	19.1	18.3	24.3	36.8	34.0	47.2	23.3	15.8	21.5	40.8	22.0	27.3	24.3	22.3	19.6	22.2	14.3	21.9	22.1	38.8	17.3	24.4	23.8	26.3	27.6	19.0	19.7	15.5	51.2	18.9	17.3	21.9	22.2	20.2	5.8	12.6	37.5	16.6	12.2	12.0	9.8	9.6	7.2	11.1	8.7	14.1	19.5	7.1	37.5	14.4	21.5	13.1	8.9	24.1	10.6	37.2	17.2	10.7	7.2	9.9	25.9	14.2	3.7	10.7	5.3	10.8	14.4	6.4	6.9	12.4	19.3	12.3	15.8	14.7	9.6	0.0	38.7	3.1	6.8	5.7	5.3	7.0	3.4	14.4	7.1	16.6	11.2	4.6	6.1	13.1	8.0	11.2	12.6	7.8	24.1	45.6	10.3	13.7	24.2	4.4	6.0	7.3	9.8	8.2	33.2	31.7	16.6	37.5	9.1	15.2	7.5	5.8	8.7	8.4	12.6	5.6	11.3	11.3	25.5	12.2	16.3	7.6	12.0	9.8	19.1	24.1	20.5	28.5	19.1	18.3	23.3	15.8	22.3	15.5
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.0;lymphoid tissue: 46.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;Daudi: 33.0;HDLM-2: 31.2;hTERT-HME1: 32.8;U-266/70: 22.0;U-266/84: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.9;naive B-cell: 32.9"	"Group enriched"	"Detected in many"	10	"B-cells: 32.9;T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favourable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	6.9	3.3	1.4	43.9	2.3	5.1	5.4	0.5	2.0	5.3	13.1	0.5	2.8	6.8	2.9	3.7	8.4	3.9	13.9	6.0	2.2	1.3	10.8	12.5	21.8	46.3	2.8	1.2	3.4	7.0	1.1	14.5	0.9	2.2	8.7	6.2	1.1	9.2	4.7	2.2	5.5	46.0	7.3	3.0	34.9	15.9	3.2	2.7	34.2	3.0	4.1	34.0	12.6	6.2	32.9	0.8	2.0	2.6	2.5	17.1	2.8	6.3	5.1	0.0	0.1	0.1	0.7	0.6	0.5	4.3	0.6	0.7	0.9	37.5	33.0	17.0	0.3	3.6	0.0	0.9	2.1	31.2	0.1	0.1	1.5	0.2	6.5	0.5	0.7	0.7	4.6	2.1	32.8	0.1	0.1	0.0	0.8	0.0	2.2	0.3	0.1	0.2	0.0	0.3	1.6	8.5	3.3	0.0	0.1	0.5	0.5	0.3	1.6	0.3	1.7	7.2	0.7	0.4	6.5	22.0	18.8	11.6	1.3	1.8	0.8	2.0	0.9	0.4	1.4	2.2	2.5	32.9	10.7	3.5	0.8	32.9	7.5	2.2	0.5	2.5	2.6	0.3	17.1	2.8	1.4	2.3	0.5	2.0	2.2	1.3	2.8	1.2	2.2	2.7
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 62.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: , HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.1	0.4	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"Bloom syndrome RecQ like helicase"	P54132	15	90717327-90816165	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	1.8	0.4	3.1	11.4	1.5	5.5	0.6	4.7	2.6	0.7	1.9	0.9	0.5	1.4	1.2	1.1	2.9	0.4	1.3	1.0	2.3	2.4	0.9	0.5	2.0	7.7	2.8	0.2	0.9	0.4	0.0	1.2	3.6	0.5	0.7	2.5	0.7	7.8	0.0	1.7	0.6	2.8	0.5	1.9	6.7	1.4	4.9	0.5	36.7	0.6	3.1	9.3	1.4	0.7	7.4	1.2	4.3	1.6	4.6	5.0	1.6	5.4	7.8	8.7	5.1	0.0	0.4	5.5	4.1	1.2	4.7	5.1	6.8	3.8	14.1	2.6	1.1	9.1	13.4	3.7	6.1	8.5	9.9	14.7	8.4	2.2	0.0	14.1	7.3	0.0	0.0	4.7	2.4	3.3	12.7	4.4	4.9	3.4	10.6	7.8	9.3	1.7	10.8	16.4	5.4	1.1	9.8	6.5	6.1	3.3	4.4	2.6	3.1	11.6	1.8	3.4	6.3	3.5	8.7	3.2	13.1	14.7	1.9	10.0	5.8	2.5	1.0	4.3	3.1	1.2	4.8	7.4	2.8	3.8	1.2	4.3	2.0	2.2	0.8	4.6	1.6	1.2	5.0	1.6	3.1	1.5	4.7	1.7	2.3	2.4	2.8	0.2	0.5	0.5
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248195-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 67.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			59000000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	11.2	8.3	9.0	17.1	10.2	8.5	14.2	12.1	14.5	10.5	9.8	8.5	9.6	6.7	13.1	12.2	15.7	8.4	10.1	9.7	7.5	7.2	13.6	7.5	13.6	20.3	9.5	8.5	8.8	15.3	15.0	8.3	14.6	9.2	8.4	8.5	7.3	12.8	9.5	15.0	67.5	10.0	15.7	11.1	13.2	9.2	12.4	8.6	24.7	9.3	15.5	13.6	10.8	11.7	4.6	6.6	0.9	5.7	9.8	17.3	6.3	10.1	16.1	15.6	10.8	10.7	11.5	7.5	9.5	5.9	15.0	13.0	23.6	3.0	30.3	17.0	7.6	7.1	33.7	13.0	12.7	8.0	26.5	18.6	14.5	20.0	15.6	33.8	11.5	13.5	0.9	11.7	6.8	22.0	39.6	12.4	6.2	7.7	41.8	24.7	14.9	7.5	36.3	40.5	20.0	12.0	9.1	36.0	12.9	8.4	16.4	10.3	11.2	17.5	14.0	9.3	18.7	4.1	16.8	15.0	30.8	40.9	7.1	0.0	12.4	0.0	5.7	0.9	10.5	3.9	17.3	4.6	12.6	13.7	6.5	4.2	11.6	12.3	0.7	9.8	1.9	6.6	12.4	6.3	9.0	10.2	12.1	14.5	7.5	7.2	9.5	8.5	9.2	8.6
BLOC1S4	"BCAS4L, CNO, FLJ11230"	ENSG00000186222	"Biogenesis of lysosomal organelles complex 1 subunit 4"	Q9NUP1	4	6716055-6717671	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043840	Approved		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA043840: AB_10965701"	"unprognostic (3.09e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (3.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.24e-3)"	"unprognostic (5.62e-3)"	14.6	15.5	9.2	11.8	11.5	13.6	11.4	10.7	14.4	15.4	15.2	9.5	10.1	14.6	13.8	14.3	14.1	12.3	15.7	9.6	9.3	7.7	13.6	13.8	8.7	16.9	8.6	9.4	19.1	18.4	8.4	9.8	23.2	9.8	13.7	9.4	13.3	10.8	11.2	16.6	10.7	15.8	8.2	7.4	17.7	13.3	14.0	8.9	20.9	16.8	10.1	15.5	12.3	10.9	6.1	3.8	13.7	4.8	2.5	9.6	1.8	9.9	6.8	10.4	10.6	8.1	10.5	21.0	8.1	8.9	7.6	6.7	6.1	10.8	9.5	8.8	7.2	6.8	5.8	9.3	5.9	7.6	9.5	14.5	6.5	15.0	10.0	7.0	13.6	9.9	9.3	6.0	5.2	6.9	19.0	8.7	7.8	9.9	11.4	24.4	13.6	13.7	11.9	11.5	8.5	10.4	8.9	9.0	12.1	6.8	4.9	14.4	15.4	13.7	7.7	7.1	6.2	8.1	10.2	13.0	12.6	12.6	7.8	12.9	11.1	2.5	3.1	13.7	5.1	4.8	5.2	6.1	6.2	5.5	3.8	4.9	9.6	5.3	1.8	2.5	3.1	3.7	5.1	1.8	9.2	11.5	10.7	14.4	9.3	7.7	8.6	9.4	9.8	8.9
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol			1600000	Cytosol		"HPA019709: , HPA042865: AB_10797024, HPA054322: "	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favourable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	31.7	13.1	14.5	16.2	14.7	23.8	22.5	13.3	21.9	22.7	25.9	9.1	12.6	5.2	19.3	58.7	35.8	18.7	17.5	21.7	11.9	16.2	26.8	6.0	27.7	25.1	15.8	15.4	26.4	14.8	19.3	13.1	12.2	20.5	21.8	8.8	17.2	17.9	21.1	23.0	15.1	12.2	26.4	10.6	40.9	17.7	9.3	6.7	12.1	19.0	21.3	21.5	28.5	18.9	4.9	23.2	27.5	61.6	3.4	14.0	30.7	11.4	22.3	6.5	27.1	13.9	18.6	0.3	7.8	24.3	13.4	16.4	5.3	6.9	0.0	15.1	12.4	15.1	19.9	19.8	11.5	53.8	13.9	24.7	20.5	32.6	35.5	2.7	9.3	12.6	33.6	14.1	9.4	22.7	16.4	13.7	10.1	12.4	8.6	1.5	8.8	25.7	19.0	11.3	62.2	29.7	6.4	8.4	25.9	16.0	16.0	13.0	36.0	18.5	13.8	12.3	13.7	5.4	13.3	18.5	14.6	0.0	20.1	11.2	19.1	7.8	50.5	27.5	7.0	61.6	6.6	4.9	14.0	11.7	23.2	2.4	7.5	5.8	4.5	3.4	57.7	3.4	13.6	30.7	14.5	14.7	13.3	21.9	11.9	16.2	15.8	15.4	20.5	6.7
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465840	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.6"	"Cell line enhanced"	"Detected in many"		"A549: 82.6;K-562: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 73.4"	"Group enriched"	"Detected in all"	7	"dendritic cells: 54.8;monocytes: 73.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			440000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	36.9	17.9	10.9	12.8	12.2	137.6	28.9	3.5	10.9	17.0	26.7	7.7	18.5	20.9	14.1	19.6	45.3	14.6	19.0	31.0	8.2	8.6	31.8	72.4	37.3	30.0	11.7	9.6	21.3	19.4	5.7	5.6	32.2	13.8	22.9	7.7	17.5	27.1	22.1	43.4	16.7	26.4	22.1	9.7	47.1	31.1	7.6	7.9	6.6	24.3	42.9	24.4	29.9	22.1	8.6	54.8	9.1	73.4	4.0	5.3	34.4	34.8	82.6	1.1	12.3	11.5	11.1	9.8	4.4	12.9	6.0	11.7	16.2	31.7	11.7	34.0	7.9	11.1	4.2	9.6	1.2	19.8	3.6	17.8	12.5	9.8	26.5	0.2	5.2	10.8	18.2	8.0	4.4	6.3	75.0	21.3	7.0	54.2	0.9	1.0	0.3	23.1	8.2	3.9	18.9	7.5	23.5	0.0	1.8	13.4	35.2	13.5	34.3	2.7	6.8	16.0	17.2	24.6	2.3	11.6	13.6	4.4	41.8	7.0	6.2	5.0	73.4	2.6	4.6	33.7	4.4	8.6	4.0	4.0	54.8	5.4	4.2	3.3	9.1	4.0	16.9	11.5	5.3	34.4	10.9	12.2	3.5	10.9	8.2	8.6	11.7	9.6	13.8	7.9
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321211-22331484	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 87.1;U-937: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: , HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	19.7	23.5	28.0	17.0	35.0	13.3	26.5	26.1	33.7	21.6	22.3	26.3	11.6	14.1	23.9	22.8	16.0	17.0	17.4	15.1	28.3	24.2	19.2	25.5	16.7	17.9	42.3	27.7	18.8	18.6	40.0	37.6	20.6	24.8	25.5	16.0	16.5	15.7	20.3	28.5	10.3	14.6	26.3	34.8	24.6	16.5	24.3	40.7	12.9	17.6	10.6	18.8	21.5	25.9	5.0	1.8	13.0	3.4	6.2	8.4	2.4	12.7	6.2	7.1	2.2	12.5	10.1	7.2	8.6	3.9	6.6	7.8	6.5	16.0	6.5	5.9	7.8	4.5	10.3	6.1	8.2	87.1	12.8	18.0	5.3	7.3	7.5	6.6	10.0	6.5	10.6	7.2	8.0	4.6	17.8	11.1	8.7	5.1	17.8	1.9	1.6	14.8	13.3	10.2	6.2	6.2	4.2	6.0	11.9	5.7	7.5	9.6	6.7	26.7	9.8	7.4	22.2	17.7	11.6	13.7	17.8	14.4	10.5	102.3	4.8	13.0	1.5	2.5	6.1	3.4	8.4	5.0	6.4	5.8	1.0	2.6	5.5	5.2	0.6	6.2	2.1	1.8	4.3	2.4	28.0	35.0	26.1	33.7	28.3	24.2	42.3	27.7	24.8	40.7
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932838	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol				Cytosol		"CAB019398: "	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.05e-3)"	"unprognostic (9.34e-2)"	"prognostic unfavourable (8.93e-4)"	"unprognostic (3.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.07e-1)"	8.9	7.0	9.4	7.9	12.4	0.9	10.7	14.1	9.2	19.4	20.6	10.9	7.7	6.2	16.3	12.3	8.4	10.9	10.8	11.0	7.7	6.1	8.2	4.6	7.4	2.9	7.3	7.6	16.1	10.6	10.0	14.0	7.4	8.5	12.8	9.3	10.9	12.6	14.2	8.4	11.3	9.8	16.5	12.2	3.4	12.1	7.8	9.2	0.3	19.4	7.8	5.7	16.0	11.4	1.8	1.1	3.6	0.8	0.9	1.4	0.3	7.5	3.8	14.7	12.5	7.7	5.0	2.6	7.6	8.0	4.5	5.2	6.5	6.7	2.3	3.5	9.7	8.1	6.5	8.3	6.6	2.5	3.7	2.9	3.6	10.7	4.1	4.0	20.4	4.4	3.5	6.0	4.4	0.0	4.5	1.6	5.2	3.2	2.6	3.2	8.0	1.8	0.0	5.8	0.0	9.2	7.2	1.5	4.8	8.5	4.3	5.1	7.3	2.0	3.8	3.2	5.2	6.6	7.0	0.4	7.0	2.9	2.8	2.7	2.6	2.0	0.8	0.6	1.4	0.5	0.9	1.8	1.4	1.2	0.3	1.5	1.0	1.1	3.6	0.9	0.6	1.1	0.7	0.3	9.4	12.4	14.1	9.2	7.7	6.1	7.3	7.6	8.5	9.2
BMT2	"C7orf60, DKFZp762M126, FLJ31818"	ENSG00000164603	"Base methyltransferase of 25S rRNA 2 homolog"	Q1RMZ1	7	112819147-112939916	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044405, HPA050733"	Uncertain		Approved	Cytosol				Cytosol		"HPA044405: AB_10959783, HPA050733: "	"unprognostic (5.26e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.61e-5)"	"unprognostic (1.50e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.22e-2)"	"unprognostic (9.10e-2)"	9.4	7.8	15.5	8.6	14.5	8.1	11.0	27.6	17.1	11.8	11.2	5.2	11.0	5.0	13.9	8.3	13.7	8.7	9.5	22.9	13.0	12.2	10.3	4.5	8.1	9.8	9.0	7.5	11.4	7.9	11.5	18.0	12.0	10.9	11.1	8.3	6.3	9.3	15.9	7.9	9.3	6.9	13.7	11.0	11.9	6.4	14.2	9.7	13.7	10.0	5.1	10.3	14.6	11.0	3.9	5.7	12.7	5.9	5.4	7.3	2.6	4.2	3.6	9.2	8.2	12.4	14.4	2.8	4.5	20.4	8.2	11.9	2.2	3.4	1.4	5.8	8.2	2.0	4.9	6.7	13.4	4.5	5.0	7.4	2.6	2.7	5.6	2.8	7.3	10.8	5.3	6.4	5.6	6.5	2.3	2.8	9.7	3.2	6.7	8.1	2.0	3.8	3.4	12.1	4.4	6.2	5.7	3.7	9.4	8.5	3.5	4.8	1.7	2.6	4.5	10.4	2.6	6.7	3.4	3.6	3.4	2.7	11.3	4.2	6.0	8.0	5.5	9.1	4.9	5.7	6.0	3.9	4.9	5.7	5.7	3.9	6.8	5.7	12.7	5.4	5.9	3.3	7.3	2.6	15.5	14.5	27.6	17.1	13.0	12.2	9.0	7.5	10.9	9.7
BNIP3	Nip3	ENSG00000176171	"BCL2 interacting protein 3"	Q12983	10	131966455-131982013	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 122.7"	"Cell line enhanced"	"Detected in many"		"A-431: 73.3;HBF TERT88: 51.0;U-87 MG: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003015, CAB011676"	Supported		Uncertain	Cytosol				Cytosol		"CAB011676: , HPA003015: AB_1078290"	"unprognostic (1.01e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-3)"	"unprognostic (6.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (4.55e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.98e-1)"	19.3	12.0	18.3	4.0	18.6	3.0	8.7	13.5	28.3	7.7	4.6	13.0	5.1	4.0	6.0	11.4	8.1	6.0	7.9	43.3	16.9	14.6	27.6	53.4	6.7	4.6	16.5	14.2	19.3	122.7	6.0	7.3	13.0	22.6	18.2	2.9	5.2	19.2	6.6	48.0	9.0	4.5	6.0	13.3	4.9	6.4	6.0	11.1	3.3	10.8	6.2	4.0	9.2	7.3	6.1	3.0	5.1	3.5	2.2	23.4	8.9	73.3	5.9	4.2	11.9	11.4	12.1	21.9	17.9	16.6	13.5	38.7	1.2	1.6	0.1	29.1	10.3	4.5	9.0	25.4	51.0	3.9	6.8	2.6	3.8	17.0	15.3	3.3	2.1	8.4	6.4	13.1	13.3	9.4	6.7	0.2	22.0	5.8	1.7	18.7	3.6	17.8	4.1	2.1	6.2	14.8	1.2	5.6	13.2	3.6	7.6	10.1	4.6	4.7	10.7	19.2	6.4	7.2	14.1	12.6	10.7	10.2	69.4	0.1	3.2	2.2	3.5	5.1	9.8	2.3	10.4	5.7	13.9	10.3	3.0	6.1	23.4	15.4	0.9	2.2	3.1	2.3	13.2	8.9	18.3	18.6	13.5	28.3	16.9	14.6	16.5	14.2	22.6	11.1
BNIPL	"BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753"	ENSG00000163141	"BCL2 interacting protein like"	Q7Z465	1	151036570-151047600	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.5;skin 1: 68.6"	"Cell line enriched"	"Detected in some"	10	"T-47d: 32.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basal ganglia: 1.4;cerebellum: 2.7"	"Low region specificity"	"Detected in many"			HPA019946			Uncertain	Cytosol				Cytosol		"HPA019946: AB_1845408"	"unprognostic (2.62e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (6.50e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.88e-4)"	"unprognostic (1.91e-1)"	"unprognostic (8.43e-11)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	"prognostic favourable (4.32e-4)"	"unprognostic (6.81e-2)"	0.1	0.1	0.2	0.1	0.2	0.3	6.4	0.2	0.2	9.7	0.1	0.1	9.4	0.1	0.6	0.6	42.5	1.0	0.1	0.2	0.2	0.0	0.5	0.2	6.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	3.2	0.1	3.4	0.1	0.3	7.1	21.0	0.7	68.6	0.2	0.8	0.1	0.1	0.6	1.0	0.1	0.2	2.7	25.8	23.2	5.0	18.2	1.8	0.8	3.2	0.6	0.5	1.7	0.4	0.3	0.2	0.5	0.6	0.3	0.3	0.6	0.3	0.0	0.2	0.1	1.1	0.4	0.6	0.5	0.0	1.2	0.7	0.2	0.4	0.8	0.8	0.9	0.5	0.2	0.1	0.5	0.6	0.0	2.3	0.1	0.2	0.0	0.5	0.5	0.2	1.4	0.5	0.9	0.5	0.4	0.3	0.2	0.3	0.5	0.3	1.1	0.5	0.4	0.7	0.2	32.4	0.2	0.7	0.6	0.4	0.2	0.1	1.4	1.1	3.1	0.0	0.2	0.6	2.7	0.6	0.7	1.7	0.6	1.4	0.5	1.0	1.2	0.3	1.8	1.0	0.6	3.2	0.5	0.6	0.8	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.1
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135398-74147994	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"				"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: "	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	18.5	16.1	23.2	11.7	26.0	18.0	20.4	15.6	29.8	11.0	24.0	7.5	12.1	18.4	10.0	13.8	12.6	11.2	12.5	56.8	18.9	21.0	22.0	15.7	14.1	14.7	24.1	18.1	6.9	27.8	12.8	12.3	7.7	17.6	11.5	19.7	11.9	21.5	14.2	57.2	5.9	15.3	14.4	15.8	8.8	16.8	8.2	10.6	7.7	12.1	27.9	11.1	8.9	9.1	14.3	20.7	3.4	9.7	15.2	32.0	13.9	23.5	30.7	11.2	11.0	20.7	19.6	27.6	22.0	13.0	24.5	16.8	39.9	11.0	15.6	20.2	19.0	12.5	25.6	31.4	22.0	30.5	42.2	19.8	21.3	60.8	18.5	38.8	9.7	15.6	24.1	23.8	29.6	18.2	41.4	18.5	26.5	36.3	32.4	29.0	16.4	47.1	21.3	29.1	32.0	32.4	23.9	16.9	10.1	15.6	25.7	27.1	14.7	24.7	10.0	20.3	34.7	22.7	43.6	17.0	29.9	21.4	21.4	31.2	18.2	3.4	4.8	1.1	23.2	9.1	25.3	14.3	32.0	24.5	12.1	12.4	28.0	24.1	0.9	15.2	9.7	20.7	27.8	13.9	23.2	26.0	15.6	29.8	18.9	21.0	24.1	18.1	17.6	10.6
BORA	"C13orf34, FLJ22624"	ENSG00000136122	"Bora, aurora kinase A activator"	Q6PGQ7	13	72727749-72756198	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040866	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA040866: AB_10794868"	"unprognostic (9.93e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.32e-12)"	"unprognostic (7.04e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.28e-2)"	3.7	3.0	2.3	10.9	3.2	10.9	6.8	5.8	4.2	3.3	9.0	1.8	6.3	6.9	3.1	5.9	7.1	3.2	3.2	2.3	2.6	2.2	4.3	4.3	7.7	11.8	4.3	1.5	3.1	5.6	0.8	6.3	6.8	4.4	4.0	9.1	2.2	4.6	6.7	2.1	6.1	10.6	3.5	5.3	8.9	5.5	7.0	4.6	26.5	5.0	5.8	12.4	5.6	4.5	5.0	5.7	7.2	5.4	4.6	8.3	3.7	22.6	3.9	12.9	8.7	1.6	1.6	9.1	7.6	6.8	12.0	13.1	10.4	13.1	14.8	4.3	4.3	9.7	11.6	7.5	15.9	13.7	6.4	18.2	6.3	8.5	1.5	34.4	11.8	1.3	1.9	5.3	11.7	9.9	8.3	6.4	8.6	5.3	15.4	10.0	5.7	4.7	11.3	7.6	6.5	4.0	5.9	3.4	4.1	7.6	7.4	5.5	5.0	12.6	3.6	3.3	7.6	5.8	9.7	5.5	5.0	10.6	9.4	16.3	8.3	7.2	3.1	1.6	6.6	5.4	5.8	4.6	5.7	6.4	5.7	5.0	4.7	8.3	0.7	4.6	3.3	3.2	5.9	3.7	2.3	3.2	5.8	4.2	2.6	2.2	4.3	1.5	4.4	4.6
BORCS5	"LOH12CR1, LOH1CR12"	ENSG00000165714	"BLOC-1 related complex subunit 5"	Q969J3	12	12357079-12469694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039509, HPA043627"	Approved		Supported	Cytosol				Cytosol		"HPA039509: , HPA043627: "	"unprognostic (1.82e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (6.78e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.51e-2)"	8.9	11.9	13.6	8.3	19.4	17.7	13.7	10.8	20.8	9.5	8.6	20.4	4.8	5.9	8.4	19.7	11.1	7.5	8.4	10.9	12.9	14.9	8.6	11.5	9.1	9.4	16.1	18.2	8.1	13.5	14.5	9.9	8.8	16.6	9.1	7.9	10.0	7.7	7.3	10.7	10.7	6.7	10.1	16.0	8.7	8.9	11.3	15.0	9.0	8.5	4.4	12.2	8.8	8.9	8.3	7.8	9.7	10.5	12.9	14.4	6.7	4.3	4.5	3.3	3.3	7.7	10.3	4.0	4.0	4.6	4.8	5.9	11.1	4.4	5.4	2.3	6.1	3.2	5.6	5.5	5.2	15.3	5.0	3.0	4.4	6.3	7.4	3.0	4.4	5.9	4.0	6.4	7.5	5.5	4.1	7.5	6.1	9.1	4.5	3.2	10.2	2.8	3.8	4.8	5.7	5.9	2.8	4.1	4.8	4.2	3.5	8.4	2.6	3.6	4.7	3.1	7.3	4.1	3.6	3.9	3.4	12.2	6.8	5.0	5.3	2.5	6.5	9.7	11.3	10.5	13.3	8.3	12.8	12.3	7.8	6.5	8.7	8.8	7.1	12.9	6.7	5.3	14.4	6.7	13.6	19.4	10.8	20.8	12.9	14.9	16.1	18.2	16.6	15.0
BORCS6	"C17orf59, FLJ20014"	ENSG00000196544	"BLOC-1 related complex subunit 6"	Q96GS4	17	8188333-8190907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045415, HPA060791"	Uncertain		Supported	Centrosome,Cytosol				Cytosol	Centrosome	"HPA045415: AB_10964575, HPA060791: "	"unprognostic (2.11e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.25e-2)"	"prognostic favourable (2.78e-4)"	"unprognostic (3.84e-2)"	"unprognostic (9.91e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (2.60e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.10e-2)"	3.1	4.5	3.5	3.8	3.4	2.8	2.6	3.2	3.9	2.3	4.4			6.3	3.7	2.9	5.5	2.3	1.6	4.4	3.4	2.6	3.9	3.7	3.7	4.8	3.7		2.3	8.4	4.7	2.1	3.0		2.9	1.9		4.3	4.3	11.5	6.2	5.5	2.1	2.8	6.8	3.9	2.1			2.7		3.7	3.3	2.9	13.4	11.3	27.0	12.0	14.5	17.4	10.5	4.7	5.4	1.9	3.9	4.0	3.0	7.6	3.5	3.8	3.3	3.6	3.0	3.3	4.2	7.7	2.7	6.8	2.9	3.9	1.1	12.7	11.9	3.3	5.3	4.7	4.6	1.9	7.2	3.1	4.2	3.0	3.4	5.2	3.5	9.0	2.0	5.2	6.4	5.5	1.3	6.3	7.8	2.4	6.4	4.5	2.7	2.3	5.2	3.6	2.7	2.9	4.0	3.0	4.3	2.1	1.8	3.4	3.6	13.8	6.1	2.0	3.0	6.9	2.5	21.4	10.1	27.0	16.2	10.3	13.1	12.8	13.7	17.4	11.3	13.4	13.2	14.6	9.5	14.5	12.0	9.9	12.4	10.5										
BORCS7	"C10orf32, FLJ40752"	ENSG00000166275	"BLOC-1 related complex subunit 7"	Q96B45	10	102854223-102864961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA037648	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA037648: AB_10673634"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.46e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (9.08e-8)"	"unprognostic (9.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-3)"	16.0	40.4	22.7	8.1	26.5	13.2	20.2	14.3	22.1	15.6	11.9	16.4	15.2	15.2	15.2	19.4	9.7	20.2	17.7	15.1	19.7	20.9	26.0	42.7	15.7	10.4	18.0	22.5	15.4	15.2	32.8	23.2	21.2	20.1	18.7	10.3	15.0	11.2	12.6	17.2	9.1	17.7	11.8	17.8	18.1	13.7	18.0	17.3	8.9	36.9	14.2	7.9	11.3	10.9	16.2	29.7	16.8	21.6	16.4	13.5	8.6	7.6	10.4	12.8	11.0	14.1	19.4	10.5	11.4	23.4	8.8	8.4	6.9	8.7	4.9	6.0	18.1	6.4	4.2	5.8	6.5	6.1	8.9	11.2	7.1	14.3	16.2	20.2	19.4	24.2	16.1	5.9	9.5	15.3	6.5	5.1	14.0	5.6	5.5	8.3	4.2	9.9	10.2	16.9	7.0	7.3	8.5	3.6	13.9	4.2	7.6	17.4	14.4	11.6	11.4	7.4	7.9	7.5	8.0	13.5	20.5	5.8	15.7	11.8	2.6	16.8	19.5	13.6	11.8	21.6	12.9	16.2	12.1	11.9	13.8	14.4	13.5	12.4	6.0	16.4	19.3	29.7	11.8	8.6	22.7	26.5	14.3	22.1	19.7	20.9	18.0	22.5	20.1	17.3
BORCS8-MEF2B	MEF2BNB-MEF2B	ENSG00000064489	"BORCS8-MEF2B readthrough"		19	19145567-19192158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 10.9;U-266/70: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA004734	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (2.74e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.29e-2)"	4.8	3.5	7.0	5.8	7.4	7.4	4.6	5.6	8.6	5.4	5.4	8.1	6.7	3.2	6.7	7.4	5.4	10.5	7.2	3.4	6.8	6.2	7.5	5.9	4.8	7.1	8.0	5.5	9.8	7.8	5.5	4.9	5.0	7.3	5.7	5.5	6.2	5.6	7.2	5.3	8.8	4.0	8.9	5.9	5.8	5.0	5.5	5.8	5.6	5.9	4.9	7.5	5.8	5.8	0.0	0.4	0.6	0.1	0.0	0.3	0.0	1.6	0.0	0.7	1.2	1.0	2.4	1.3	1.1	1.0	1.5	1.5	0.0	3.1	3.3	0.5	0.0	0.6	0.6	0.6	0.3	0.4	2.4	1.1	0.1	0.3	2.2	0.0	0.2	0.0	2.3	0.7	3.7	0.4	0.2	1.9	0.6	3.1	0.7	0.4	0.0	10.9	3.3	0.9	0.9	0.0	0.2	0.0	1.1	1.9	0.0	0.9	0.3	0.5	0.3	0.7	1.2	5.6	0.4	11.1	1.7	5.5	2.3	2.6	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	7.0	7.4	5.6	8.6	6.8	6.2	8.0	5.5	7.3	5.8
BRAF	BRAF1	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924928	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001328, CAB004552, HPA071048"	Approved		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: "	"unprognostic (2.98e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.46e-2)"	13.1	12.1	20.1	16.5	20.4	27.8	14.2	29.9	21.5	12.4	12.3	9.5	12.5	9.3	15.3	17.0	11.8	11.5	12.0	13.6	13.2	12.2	13.7	12.8	15.9	13.3	9.9	17.8	16.8	13.2	28.9	24.8	13.7	15.3	14.5	11.0	10.7	11.6	16.6	12.9	15.6	10.5	13.0	10.9	12.3	12.0	24.9	12.2	13.5	16.6	7.5	12.1	18.6	18.1	2.6	1.9	7.5	2.4	7.0	5.6	1.1	5.4	4.6	6.8	8.1	8.3	10.7	10.9	6.1	6.5	4.9	7.1	5.0	5.9	9.3	4.7	6.2	3.0	6.0	4.8	9.0	8.6	4.9	6.0	4.5	4.6	7.0	9.8	6.1	7.1	5.4	5.2	10.8	5.7	9.5	16.7	8.7	2.9	13.0	10.3	6.3	2.9	8.5	5.8	7.6	4.8	10.4	7.9	6.6	7.0	4.3	6.3	4.0	6.7	8.4	5.3	4.1	11.5	4.9	19.4	11.0	14.8	8.7	9.9	5.7	3.3	2.0	7.5	3.1	1.7	2.1	2.6	3.0	2.4	1.6	2.6	5.6	2.8	4.1	7.0	2.4	1.9	2.7	1.1	20.1	20.4	29.9	21.5	13.2	12.2	9.9	17.8	15.3	12.2
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685986	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"				Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: "	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.8	9.9	9.8	7.2	11.6	26.5	9.6	10.0	12.8	8.3	9.3	10.0	8.0	8.6	10.1	7.0	9.4	8.4	7.3	8.8	8.6	8.7	8.4	9.3	7.9	9.7	9.2	8.5	9.7	7.8	9.4	10.4	9.8	12.0	8.3	9.0	6.7	8.9	9.7	19.1	12.7	9.3	9.1	11.1	9.6	7.9	55.9	10.1	12.4	9.5	5.6	10.4	10.2	11.8	12.7	11.7	25.7	13.5	16.6	18.5	11.6	9.7	14.4	11.8	13.5	12.6	10.7	19.7	13.7	11.6	16.0	12.3	19.3	6.8	18.8	8.2	13.0	12.0	16.4	11.2	17.1	12.0	10.6	23.3	9.0	13.0	15.9	20.4	15.8	12.0	16.0	13.8	22.4	13.8	24.1	6.2	13.1	12.3	16.9	19.7	15.9	15.2	15.8	12.9	16.8	10.5	20.6	14.7	10.9	16.1	13.7	13.4	15.0	13.0	12.7	10.3	9.6	9.2	9.7	15.9	20.0	20.8	9.7	11.3	11.2	16.1	13.0	24.0	14.7	13.5	14.3	12.7	15.4	14.7	11.7	12.5	14.6	14.8	25.7	16.6	10.6	8.4	18.5	11.6	9.8	11.6	10.0	12.8	8.6	8.7	9.2	8.5	12.0	10.1
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2, DNA repair associated"	P51587	13	32315474-32400266	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.2;testis: 16.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026815	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	2.4	1.0	0.6	13.8	0.6	11.6	3.2	0.6	0.6	1.8	4.0	0.2	0.2	1.4	1.5	2.7	3.0	1.0	0.7	2.1	0.6	0.7	1.0	1.4	3.5	5.3	0.7	0.5	1.4	3.3	0.4	0.7	7.0	0.8	0.9	2.0	0.1	1.8	0.3	3.3	1.8	3.2	0.8	2.1	6.6	1.5	16.9	0.1	23.2	0.9	4.8	4.2	1.3	1.7	1.3	1.9	0.4	0.2	1.5	0.8	0.0	3.9	3.5	6.0	4.5	0.6	1.6	6.2	4.3	2.7	5.0	4.6	8.2	5.3	14.0	2.8	2.1	5.4	4.9	2.5	9.6	9.1	2.6	8.9	2.2	3.2	0.2	12.7	4.4	0.3	0.3	9.1	6.3	4.0	5.8	4.9	5.7	4.5	10.1	7.5	7.2	1.9	10.0	15.5	2.7	1.3	4.3	2.3	4.3	5.2	2.2	2.1	2.6	6.3	3.1	5.7	6.1	6.3	5.9	1.9	2.9	7.2	2.9	5.1	5.4	0.1	0.2	0.2	0.3	0.2	0.1	0.9	0.4	0.2	0.2	1.3	0.6	0.8	0.4	1.5	0.2	1.9	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.7	0.7	0.5	0.8	0.1
BRD7	"BP75, CELTIX1"	ENSG00000166164	"Bromodomain containing 7"	Q9NPI1	16	50313487-50368934	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042389, CAB046458, HPA060171"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB046458: AB_2066024, HPA042389: , HPA060171: "	"unprognostic (2.10e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.38e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.46e-2)"	"prognostic favourable (1.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.34e-2)"	23.5	26.9	38.8	33.7	39.0	42.2	39.1	34.5	35.9	24.5	30.7	32.4	26.4	23.4	29.0	38.1	37.3	27.1	24.4	41.2	35.3	31.9	29.9	22.9	27.9	32.1	38.4	26.9	26.8	36.5	53.3	35.1	37.9	42.6	29.5	30.3	22.2	26.9	30.7	37.9	31.2	31.1	27.2	48.1	32.1	29.0	41.5	36.4	46.1	31.2	26.5	36.4	24.5	40.0	8.8	11.2	9.6	6.8	12.3	12.1	3.7	21.9	19.4	34.2	20.3	14.5	14.3	22.5	18.1	17.9	28.6	13.0	32.6	22.4	32.9	19.0	16.0	20.4	31.2	18.2	33.1	14.9	25.9	22.3	15.6	45.0	17.1	30.7	24.6	10.5	27.5	14.7	25.4	19.0	32.1	10.6	17.4	14.3	34.7	41.4	26.8	18.5	42.8	32.1	23.9	25.1	15.6	26.6	21.6	22.0	21.4	14.8	12.8	27.9	19.1	18.2	22.2	14.9	17.5	5.0	1.9	56.3	14.3	22.4	18.0	8.2	6.8	9.6	8.8	5.7	6.8	8.0	8.9	8.1	5.4	8.8	10.1	12.1	4.0	12.3	5.1	11.2	8.5	3.7	38.8	39.0	34.5	35.9	35.3	31.9	38.4	26.9	42.6	36.4
BROX	"C1orf58, FLJ32421"	ENSG00000162819	"BRO1 domain and CAAX motif containing"	Q5VW32	1	222712553-222735196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"			190000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA031445: AB_10602697"	"unprognostic (1.27e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.50e-2)"	24.0	21.1	22.7	15.7	25.3	33.0	22.2	21.6	24.9	17.8	23.6	22.0	13.8	19.8	18.2	15.6	30.1	17.7	18.3	14.9	22.5	20.2	22.6	21.0	18.5	22.7	30.2	22.7	21.4	16.2	28.3	21.8	28.1	29.6	17.0	23.7	11.8	21.3	17.9	23.7	23.5	33.0	16.8	27.5	22.9	23.2	12.6	30.1	24.4	25.0	22.5	19.7	21.1	19.8	8.8	13.4	30.9	21.7	14.2	15.3	8.5	25.6	15.4	9.6	8.3	13.9	14.8	18.5	17.6	22.2	14.6	16.8	8.6	33.7	8.6	21.3	21.8	22.7	10.7	16.9	22.2	10.6	9.5	12.7	17.3	8.5	15.7	14.5	12.2	13.0	16.7	18.1	21.6	13.1	19.2	11.8	17.9	7.7	6.1	7.6	12.0	18.4	6.5	29.0	19.1	17.2	25.6	10.8	17.0	19.4	22.2	13.1	27.0	14.9	18.9	20.1	11.6	20.7	19.9	8.8	14.8	7.7	16.3	12.3	18.3	30.9	15.8	18.3	12.0	21.7	13.3	8.8	15.3	12.0	13.4	8.3	10.3	13.0	27.3	14.2	21.0	7.5	13.8	8.5	22.7	25.3	21.6	24.9	22.5	20.2	30.2	22.7	29.6	30.1
BRPF1	BR140	ENSG00000156983	"Bromodomain and PHD finger containing 1"	P55201	3	9731729-9748018	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003359	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003359: AB_1078217"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (3.20e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (5.28e-4)"	"unprognostic (1.51e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.67e-3)"	10.5	7.7	6.2	10.4	8.1	29.2	10.7	16.5	13.1	10.7	9.5	10.4	5.0	6.8	14.4	8.9	10.7	12.9	10.7	7.0	5.4	4.2	8.2	5.3	10.7	12.3	8.3	7.0	12.5	9.2	11.3	9.5	9.9	7.5	9.0	6.3	9.6	12.1	8.5	11.1	14.2	10.5	8.3	5.1	12.2	9.2	23.7	11.4	24.3	12.0	7.8	11.4	11.5	9.4	1.2	3.5	2.3	1.8	9.3	4.2	1.3	5.3	8.3	8.3	4.0	5.2	4.4	42.4	6.6	4.4	7.8	5.8	7.4	4.6	9.2	3.1	6.6	4.5	8.4	6.7	5.6	9.7	8.9	11.9	16.6	4.9	6.1	16.9	11.1	5.6	5.6	11.5	6.9	6.0	12.6	9.3	4.9	12.9	10.5	13.9	10.5	7.8	14.2	5.8	6.4	4.1	8.5	4.9	7.6	7.1	5.2	6.0	5.2	16.4	7.6	9.2	7.8	7.9	12.1	7.5	8.4	17.1	7.2	13.9	7.9	2.2	1.8	2.3	2.7	1.6	4.2	1.1	2.1	2.5	1.5	1.2	2.5	2.9	1.3	9.3	1.5	3.5	1.3	1.3	6.2	8.1	16.5	13.1	5.4	4.2	8.3	7.0	7.5	11.4
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"CAB034184: AB_2243666, HPA030943: , HPA030944: , HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	10.9	16.7	33.0	15.4	36.8	13.4	16.3	15.5	40.2	12.3	12.0	14.3	10.5	8.8	13.0	21.1	10.2	11.8	9.9	12.9	29.1	32.9	13.9	21.8	10.0	12.9	24.3	17.7	16.2	17.2	12.8	12.0	15.2	13.4	13.2	11.5	13.0	9.3	11.8	14.6	11.9	9.6	13.1	16.1	9.6	9.9	17.2	10.5	22.4	17.7	9.3	13.2	12.1	11.6	8.5	7.2	11.6	6.1	10.2	11.1	3.8	10.2	4.1	10.1	5.6	6.5	9.8	10.4	5.9	7.0	4.6	5.4	3.9	7.0	33.0	6.2	8.0	5.1	9.4	6.8	7.3	7.6	7.8	22.4	7.2	7.1	8.2	12.3	6.3	6.7	11.3	6.3	16.0	6.8	16.5	16.6	6.4	7.9	8.4	14.6	10.6	5.8	14.9	7.9	10.4	5.6	6.6	8.0	10.3	12.6	15.3	8.8	12.9	17.3	7.5	6.1	2.9	3.5	4.4	18.5	12.7	16.1	7.3	13.2	4.8	4.4	5.2	11.6	10.7	6.1	8.3	8.5	9.2	11.0	7.2	6.3	11.1	9.0	5.7	10.2	3.8	6.8	10.3	3.8	33.0	36.8	15.5	40.0	29.1	32.9	24.3	17.7	13.4	10.5
BRWD3	"FLJ38568, MRX93"	ENSG00000165288	"Bromodomain and WD repeat domain containing 3"	Q6RI45	X	80670854-80809688	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012802	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA012802: AB_2066662"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.17e-3)"	"unprognostic (7.04e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-1)"	7.7	5.7	7.5	9.1	7.7	10.5	13.0	20.9	8.5	9.3	8.2	5.6	8.6	8.5	8.0	6.2	10.8	8.1	6.3	5.0	7.4	4.6	5.6	7.5	12.7	9.3	5.3	5.5	11.9	7.8	7.3	12.5	8.6	6.5	6.7	8.1	7.7	8.2	11.3	3.7	14.0	10.3	5.8	12.7	8.9	7.3	9.3	7.1	10.1	9.0	6.0	9.1	10.7	12.7	1.1	0.7	2.8	1.1	0.5	1.2	0.5	4.7	5.2	7.9	5.2	3.2	4.0	5.8	2.8	2.4	3.6	4.9	2.3	6.6	5.1	6.5	2.6	8.5	12.0	4.7	4.8	4.4	4.9	10.4	8.4	3.6	2.3	6.0	7.1	2.7	3.2	4.1	5.7	5.4	7.6	13.0	4.1	0.8	3.4	5.5	12.1	2.2	3.1	13.8	3.0	4.1	4.1	1.8	4.5	6.8	3.7	3.0	1.7	5.9	4.9	4.2	5.3	3.9	3.0	5.8	6.0	6.1	3.4	12.1	2.8	0.5	1.1	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.6	1.1	0.6	1.2	2.8	0.5	0.8	0.7	0.6	0.5	7.5	7.7	20.9	8.5	7.4	4.6	5.3	5.5	6.5	7.1
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 67.7;salivary gland: 68.2"	"Cell line enhanced"	"Detected in some"		"A-431: 19.7;CAPAN-2: 12.7;MCF7: 29.4;RPMI-8226: 15.4;SK-BR-3: 14.8;T-47d: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 20.8"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042889, HPA077485"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favourable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.2	1.6	1.0	4.6	20.8	2.1	6.1	4.1	1.4	2.9	5.4	0.4	7.9	3.6	1.0	6.4	14.2	1.9	8.5	1.4	0.6	0.7	9.3	0.4	4.1	0.6	0.7	1.3	0.3	37.8	67.7	10.1	1.7	0.6	2.4	4.5	2.7	68.2	4.8	0.1	12.4	6.8	0.4	0.3	0.3	10.4	2.1	1.8	1.2	28.2	10.7	5.4	1.5	3.2	0.0	8.0	0.0	0.0	0.0	0.4	0.1	19.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	4.1	12.7	0.0	0.2	0.0	1.8	0.2	0.0	0.0	2.1	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	29.4	0.3	0.0	0.5	0.0	0.4	0.0	15.4	1.9	4.3	6.8	0.0	0.0	14.8	0.0	14.9	2.1	0.0	0.0	0.0	0.0	0.0	4.8	6.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.1	1.0	20.8	4.1	1.4	0.6	0.7	0.7	1.3	0.6	1.8
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405648	"CD markers, Plasma proteins, Predicted membrane proteins"	"Antiviral defense, B-cell activation, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 101.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA017060	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017060: AB_1845467"	"prognostic favourable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	29.6	72.2	8.4	31.1	9.8	13.6	27.9	2.5	7.6	14.4	12.0	5.6	24.8	6.9	13.4	36.7	8.6	26.8	30.1	13.9	7.9	4.9	24.7	30.8	44.9	16.6	10.0	5.2	101.0	6.9	0.3	8.6	31.5	8.8	15.6	4.8	8.4	11.4	17.5	6.0	3.2	14.0	11.3	9.0	32.9	12.3	8.5	9.4	10.3	10.3	5.9	12.3	14.0	42.4	26.2	74.1	35.8	66.4	57.9	32.6	54.5	39.2	0.0	0.1	18.1	0.0	0.1	6.2	0.1	3.0	58.0	78.1	18.4	35.4	30.4	42.9	24.2	0.1	26.4	2.9	1.8	33.5	0.2	0.4	63.6	17.9	33.2	14.3	38.6	0.1	0.0	19.1	0.0	14.7	17.3	75.8	0.0	10.7	6.8	25.1	19.9	50.8	12.8	0.1	63.5	13.8	0.1	0.0	0.1	40.1	1.5	48.2	30.4	20.3	0.1	0.2	1.4	0.0	0.4	39.1	51.0	20.1	0.1	56.7	0.2	35.8	61.6	21.0	32.6	66.4	30.8	21.0	27.5	30.2	50.7	26.2	22.5	25.6	20.3	57.9	59.3	74.1	24.8	54.5	8.4	9.8	2.5	7.6	7.9	4.9	10.0	5.2	8.8	9.4
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318413-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 61.8"	"Cell line enhanced"	"Detected in many"		"A549: 19.0;Hep G2: 10.0;MOLT-4: 12.7;PC-3: 9.0;RT4: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA055898: , HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.9	1.1	3.7	2.4	6.6	3.3	2.7	4.6	10.2	6.8	1.0	2.2	3.2	1.1	1.3	1.5	24.1	0.8	1.2	1.0	2.9	9.4	3.7	1.4	1.0	4.0	8.3	3.0	0.6	1.2	61.8	3.2	2.0	19.0	3.1	1.0	1.7	6.2	1.6	0.9	8.4	1.6	1.0	4.9	1.5	1.0	1.1	1.2	24.8	14.4	9.5	9.0	2.3	7.9	0.3	1.3	2.8	0.8	0.3	7.2	1.2	0.1	19.0	3.9	0.0	1.4	0.4	0.0	0.4	0.0	0.2	0.0	0.2	3.1	0.0	4.7	0.1	6.9	3.9	7.2	0.2	0.0	1.2	0.0	0.1	10.0	0.0	0.1	0.0	1.5	3.0	0.0	2.3	0.5	0.0	0.0	0.1	0.6	12.7	1.5	4.0	9.0	0.0	6.1	0.0	0.0	8.6	5.0	1.9	0.0	0.2	0.0	0.4	0.5	0.8	0.0	0.2	0.0	1.5	0.0	0.0	0.0	5.0	1.9	0.0	1.3	0.8	1.1	2.1	0.3	7.2	0.1	2.4	1.4	1.3	0.3	3.0	2.7	2.8	0.3	0.6	0.2	1.1	1.2	3.7	6.6	4.6	10.2	2.9	9.4	8.3	3.0	19.0	1.2
BTBD16	"C10orf87, Em:AC061711.1, FLJ25359"	ENSG00000138152	"BTB domain containing 16"	Q32M84	10	122271306-122338162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 9.1;testis: 27.6;urinary bladder: 17.9"	"Cell line enriched"	"Detected in some"	8	"RT4: 26.9"	"Cancer enriched"	"Detected in many"	14	"urothelial cancer: 18.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	29	"T-reg: 2.8"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA040529, HPA057638"	Uncertain		Uncertain	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA040529: , HPA057638: "	"unprognostic (1.41e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.12e-2)"	"unprognostic (9.44e-3)"	0.3	0.0	0.6	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.6	0.3	0.3	0.2	0.3	0.3	0.9	0.4	0.3	4.4	0.3	0.3	1.2	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	0.3	9.1	0.3	0.3	2.3	0.3	0.0	27.6	0.3	0.3	0.3	0.3	0.3	17.9	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	26.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	0.5	0.3	0.3	0.9	0.4	1.2	0.3	0.3	0.3
BTBD19		ENSG00000222009	"BTB domain containing 19"	C9JJ37	1	44808482-44815585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 6.4;TIME: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042633, HPA076404"	Uncertain		Uncertain	Cytosol				Cytosol		"HPA042633: , HPA076404: "	"unprognostic (4.69e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (4.18e-8)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.70e-1)"	6.7	8.7	3.5	3.6	1.9	2.7	4.9	0.6	2.8	13.5	2.0	2.4	6.2	1.6	13.9	21.4	2.1	6.4	4.2	3.8	1.3	1.4	4.2	2.2	4.1	1.8	1.4	4.0	8.4	1.5	3.2	11.9	7.9	6.3	5.6	1.8	7.6	1.7	8.3	1.8	1.2	2.2	5.6	1.9	2.3	2.2	3.5	0.6	0.1	6.0	2.0	1.4	2.1	4.3	0.0	0.2	2.3	0.1	0.0	0.2	0.0	0.1	1.1	1.0	1.1	2.3	2.6	0.7	2.2	1.3	1.0	2.1	0.0	0.9	0.1	1.0	3.7	0.3	0.0	1.1	0.4	0.9	0.2	2.0	0.3	1.1	2.4	0.0	1.6	3.9	0.1	3.7	0.7	6.4	0.2	0.0	2.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.3	0.1	1.2	0.0	0.0	14.9	3.8	3.0	1.8	1.6	0.5	0.1	0.0	2.3	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	3.5	1.9	0.6	2.8	1.3	1.4	1.4	4.0	6.3	0.6
BTF3	"BTF3a, BTF3b, NACB"	ENSG00000145741	"Basic transcription factor 3"	P20290	5	73498408-73505635	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013007, HPA056420"	Approved		Supported	Cytosol			100000	Cytosol		"CAB013007: , HPA056420: "	"unprognostic (3.48e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.16e-1)"	98.4	64.4	44.7	67.6	40.8	98.2	105.6	38.2	49.0	111.8	87.3	45.8	69.7	62.2	107.5	67.3	141.3	75.1	68.7	69.1	40.7	41.3	74.4	107.7	66.6	100.6	46.7	41.6	172.4	111.0	44.3	44.5	90.8	44.8	110.9	75.1	53.0	102.7	76.0	157.9	107.7	87.7	95.7	53.2	84.4	76.9	56.5	41.0	132.6	123.5	131.7	113.4	135.1	88.0	89.0	104.4	19.3	77.0	75.6	102.1	159.0	96.7	65.0	70.6	100.8	70.9	119.5	110.8	67.7	95.4	118.5	114.2	83.6	110.9	146.8	107.1	70.5	68.5	102.7	175.1	136.2	60.7	131.7	83.0	62.4	109.0	103.4	78.5	67.1	103.5	139.9	76.2	141.5	107.6	77.2	95.6	99.6	88.0	117.7	147.4	89.7	65.4	90.0	83.9	182.1	124.5	97.8	82.9	110.7	66.5	76.0	136.1	97.7	162.0	77.2	51.4	69.9	61.2	182.7	90.0	91.6	136.7	68.0	120.4	75.5	19.3	77.0	19.3	52.5	60.9	88.6	89.0	89.8	73.3	104.4	71.3	99.5	87.1	10.8	75.6	47.8	58.7	102.1	159.0	44.7	40.8	38.2	49.0	40.7	41.3	46.7	41.6	44.8	41.0
BTF3L4	MGC23908	ENSG00000134717	"Basic transcription factor 3 like 4"	Q96K17	1	52056125-52090716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA067026	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA067026: "	"unprognostic (6.12e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (6.73e-8)"	"unprognostic (8.85e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (4.43e-6)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.56e-2)"	22.3	29.1	20.6	14.8	22.1	26.7	26.2	25.5	52.3	17.5	12.8	17.2	8.4	7.1	19.5	16.7	20.3	19.6	12.5	28.4	23.7	22.4	18.5	20.8	19.6	38.8	20.4	23.8	29.2	47.6	21.0	24.3	19.1	16.7	15.7	12.6	16.5	26.4	13.5	36.9	19.3	9.8	22.4	23.1	14.1	14.2	19.2	14.6	20.7	22.9	13.6	20.4	19.0	16.2	23.2	34.1	32.2	36.0	21.3	28.2	27.9	27.7	6.8	33.1	17.3	17.9	23.1	34.3	27.5	27.7	31.6	34.0	12.3	14.6	25.9	27.6	19.3	16.2	31.9	21.4	40.5	17.9	22.4	29.7	12.4	18.3	49.1	32.8	20.5	23.7	29.7	29.2	41.2	25.0	22.4	16.6	28.3	11.9	22.7	19.5	59.0	14.8	15.0	38.6	30.4	30.5	22.3	26.1	29.6	32.2	29.8	39.5	26.9	35.2	18.2	17.8	19.3	22.9	32.3	29.0	47.8	25.3	15.4	25.6	22.4	24.1	35.4	32.2	15.0	36.0	20.1	23.2	21.7	15.4	34.1	22.1	25.4	19.4	15.1	21.3	31.0	16.1	28.2	27.9	20.6	22.1	25.5	52.3	23.7	22.4	20.4	23.8	16.7	14.6
BTG1	APRO2	ENSG00000133639	"BTG anti-proliferation factor 1"	P62324	12	92140278-92145897	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 190.7"	"Cell line enhanced"	"Detected in all"		"ASC TERT1: 49.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005972			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005972: AB_1078303"	"prognostic favourable (4.36e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (1.95e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (9.81e-2)"	52.0	22.1	11.5	58.3	13.4	126.9	114.4	66.8	10.4	41.7	40.1	5.5	21.9	15.5	30.1	22.0	28.7	27.9	39.9	49.2	11.9	8.1	22.2	58.1	85.6	190.7	10.4	8.2	29.1	64.2	17.6	17.1	23.4	13.3	28.7	18.1	21.0	19.0	25.9	31.6	70.6	34.3	26.0	24.6	77.1	26.4	19.0	8.9	148.9	15.7	14.3	58.2	54.2	35.2	58.3	6.6	94.3	14.0	47.1	95.2	26.1	6.8	8.6	9.5	1.1	35.7	49.6	4.1	7.7	17.1	5.2	5.2	5.1	2.4	7.4	1.6	8.2	4.7	3.1	8.7	9.7	8.9	6.7	1.4	6.0	2.6	36.2	5.4	2.5	42.3	26.2	11.9	36.9	10.4	5.1	9.8	5.9	7.1	3.8	17.4	2.3	9.9	13.1	5.3	2.3	16.0	14.3	5.3	10.6	9.7	7.5	25.0	31.4	12.6	3.3	5.9	1.8	4.5	4.7	13.6	7.2	12.3	4.6	4.3	6.6	22.3	13.6	94.3	17.0	10.6	20.1	44.5	34.3	29.8	6.6	58.3	95.2	39.1	52.3	47.1	14.0	6.2	39.2	26.1	11.5	13.4	66.8	10.4	11.9	8.1	10.4	8.2	13.3	8.9
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 77.5;lymphoid tissue: 37.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;HEL: 40.0;HMC-1: 144.1;U-937: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 77.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"			610000	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	7.3	2.4	3.3	23.5	5.6	14.0	2.6	0.8	3.6	2.3	3.0	4.7	0.3	2.2	1.9	2.6	2.4	2.0	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1.0	1.0	2.5	12.9	3.3	10.8	37.0	3.1	1.3	6.3	4.0	1.7	1.8	36.7	5.8	2.0	13.7	13.2	77.5	20.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	16.0	144.1	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	11.2	0.2	0.0	12.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	13.7	0.0	20.9	0.0	77.5	11.3	19.3	0.0	18.1	0.0	13.7	0.0	0.0	13.2	13.7	0.0	0.0	4.5	0.0	20.7	6.0	0.0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3
BTRC	"beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1"	ENSG00000166167	"Beta-transducin repeat containing E3 ubiquitin protein ligase"	Q9Y297	10	101354033-101557321	"Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031156, CAB032986"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB032986: AB_2243598, HPA031156: "	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.23e-1)"	6.6	11.2	16.0	7.3	23.1	3.6	11.8	16.2	28.0	10.2	6.6	10.7	13.7	5.4	8.8	14.5	11.5	10.8	8.1	18.6	15.7	18.3	11.6	7.1	6.8	5.3	14.3	15.3	15.5	8.6	21.5	17.3	10.4	13.5	12.2	7.0	11.9	9.0	8.7	14.1	9.0	5.4	9.7	10.2	7.5	6.4	17.9	9.0	6.3	11.4	7.1	7.5	7.3	9.8	5.2	4.8	3.9	3.7	5.1	8.1	3.4	6.5	10.1	14.2	16.3	13.9	12.1	5.1	9.5	15.3	9.9	8.3	7.0	5.2	10.7	9.6	8.0	10.2	11.6	10.3	10.8	7.0	9.2	7.8	6.3	9.1	7.4	11.3	4.2	7.4	12.0	8.5	15.2	12.2	8.4	3.6	9.5	5.6	7.6	5.7	6.6	7.9	9.6	19.9	2.2	9.1	4.3	10.5	9.0	6.2	2.8	8.8	7.7	4.0	10.3	5.2	8.3	6.8	6.6	6.0	13.0	6.8	5.2	5.7	3.5	3.8	3.7	3.9	6.1	3.1	6.1	5.2	6.5	5.5	4.8	4.4	8.1	6.5	2.4	5.1	3.1	2.4	5.6	3.4	16.0	23.1	16.2	23.3	15.7	18.3	14.3	15.3	13.5	9.0
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637698-110678114	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 56.5;testis: 30.9"	"Cell line enhanced"	"Detected in many"		"HEL: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA006123			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavourable (1.03e-5)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	1.1	0.9	0.5	15.8	1.0	8.9	0.6	0.3	1.0	1.2	2.8	0.4	0.0	2.4	0.7	2.3	5.8	0.5	1.0	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1.0	0.7	0.0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0.0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2.0	1.8	2.4	3.0	0.2	1.4	6.1	1.1	29.9	8.8	23.1	14.5	1.0	1.7	12.3	15.6	10.3	27.2	20.5	18.4	17.2	20.3	9.7	9.0	13.1	29.5	11.3	33.8	16.1	14.4	67.2	9.4	14.7	0.2	19.3	19.0	0.4	0.7	20.9	10.4	15.8	29.4	42.4	22.2	9.8	32.3	16.2	22.3	16.6	21.5	19.8	31.0	5.5	9.5	15.5	6.7	11.1	9.4	8.4	7.4	16.4	6.5	12.4	20.2	9.3	21.6	22.2	20.8	25.0	8.3	15.0	21.7	3.0	0.0	0.7	0.6	0.2	0.9	1.8	2.5	1.0	0.8	1.4	1.6	1.5	0.0	1.4	0.1	2.4	6.1	1.1	0.5	1.0	0.3	1.0	0.5	0.5	0.6	0.2	0.5	0.1
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221136	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.5;testis: 25.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.8;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008419			Supported	Cytosol				Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (7.43e-6)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	1.0	0.9	0.3	18.4	0.6	11.4	1.5	0.4	0.5	1.3	4.0	0.4	0.1	3.3	1.1	0.8	6.5	0.5	1.1	0.6	0.4	0.4	0.8	0.7	1.8	8.7	0.4	0.3	0.6	0.5	0.0	0.4	3.4	0.5	0.6	4.4	0.3	1.6	0.1	0.7	2.3	2.9	1.2	0.6	5.4	1.7	25.6	0.1	49.5	0.5	3.1	10.6	1.1	2.0	2.8	2.8	0.0	0.2	0.7	0.7	0.5	21.6	11.0	35.1	13.9	0.8	2.5	11.3	20.5	11.5	22.0	19.1	16.0	8.3	19.6	11.5	7.4	24.4	33.1	11.1	24.0	16.8	17.8	28.6	28.4	14.9	0.0	25.7	15.7	0.5	0.6	13.4	12.7	15.9	24.6	20.9	21.9	7.3	20.2	15.7	23.7	12.5	21.7	28.8	14.8	6.7	11.0	22.9	14.1	12.7	12.1	4.5	14.1	13.4	9.2	16.9	17.9	16.8	18.2	10.9	18.5	32.0	9.0	29.0	21.9	0.0	0.0	0.0	0.2	0.2	0.3	2.4	0.7	0.6	0.7	2.8	0.1	0.4	0.0	0.7	0.1	2.8	0.0	0.5	0.3	0.6	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.1
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 104.4;skeletal muscle: 89.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Actin filaments, Cytosol"		"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavourable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	10.6	7.2	4.2	7.8	8.5	10.1	13.5	3.4	8.9	7.9	13.6	3.4	22.0	7.7	7.6	7.6	17.9	7.1	6.1	70.8	4.4	2.8	8.4	10.2	8.1	11.4	3.5	5.8	6.4	12.3	1.8	5.7	104.4	2.5	9.8	16.2	13.2	10.1	25.3	89.7	16.8	8.0	16.6	2.8	8.4	15.6	3.5	3.4	14.5	13.6	41.1	11.1	16.8	10.3	17.2	37.3	1.7	20.3	20.1	23.6	16.3	16.8	16.4	27.9	40.2	13.6	24.2	25.0	24.1	31.7	23.9	25.4	39.7	25.7	39.4	28.7	18.7	35.2	32.8	27.5	31.6	5.2	18.9	24.5	18.5	22.3	14.2	33.5	15.4	18.5	14.9	20.8	38.5	34.0	46.9	8.5	19.3	19.8	17.0	38.9	28.4	33.9	20.4	18.2	41.4	22.5	30.8	35.7	21.0	9.5	85.1	12.6	37.5	29.1	19.3	18.9	23.9	27.7	26.5	16.4	17.1	55.5	9.2	42.2	67.6	0.9	17.4	1.7	11.0	20.3	17.9	17.2	16.1	14.9	37.3	15.8	23.6	19.5	0.7	20.1	14.5	14.4	11.9	16.3	4.2	8.5	3.4	8.9	4.4	2.8	3.5	5.8	2.5	3.4
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126670446	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 48.4;U-2197: 14.8;U-266/84: 10.4;U-87 MG: 15.4;WM-115: 12.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	1.9	0.8	7.5	1.0	21.5	0.8	9.2	1.4	18.7	0.9	0.9	30.9	0.0	0.7	0.8	0.8	0.9	0.7	1.1	0.8	10.8	5.9	0.9	0.8	0.8	0.7	26.0	5.9	0.9	1.1	0.7	0.5	1.3	14.4	0.9	1.0	1.7	18.6	0.7	0.9	1.9	0.8	0.8	17.2	0.8	0.7	12.3	28.0	0.0	1.3	0.0	2.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	48.4	0.0	0.1	0.0	1.9	0.0	14.8	0.2	0.0	10.4	0.0	15.4	0.0	12.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	21.5	1.4	11.3	10.8	5.9	26.0	5.9	14.4	28.0
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295645-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0"	"Cell line enhanced"	"Detected in some"		"HEL: 30.1;HL-60: 11.4;NB-4: 10.4;THP-1: 7.3;U-937: 12.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA037607	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.5	0.4	0.7	8.7	0.5	30.4	0.7	0.2	0.7	1.5	0.8	1.7	0.8	0.2	1.6	1.3	0.7	1.0	5.4	15.6	0.4	0.4	1.0	1.3	5.2	8.5	2.2	0.9	0.7	0.6	0.0	0.8	0.8	1.0	0.8	0.8	1.4	9.3	0.1	0.4	0.8	3.3	0.6	1.4	16.0	2.0	0.9	1.0	6.4	1.1	2.7	11.5	1.0	0.9	2.6	7.3	29.5	23.2	9.5	10.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	30.1	0.0	0.1	0.3	11.4	0.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	12.8	0.0	29.5	6.3	18.7	10.6	13.1	7.3	2.0	3.6	8.4	7.3	2.6	5.4	7.5	5.5	9.5	23.2	0.7	2.6	6.4	0.7	0.5	0.2	0.7	0.4	0.4	2.2	0.9	1.0	1.0
C11orf45	"FLJ43646, MGC35558"	ENSG00000174370	"Chromosome 11 open reading frame 45"	Q8TAV5	11	128899565-128906035	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.3;U-937: 9.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;monocytes: 1.8;T-cells: 1.1"									HPA039716	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA039716: AB_10672892"	"unprognostic (8.32e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.97e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.55e-9)"	"unprognostic (2.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.87e-2)"	"unprognostic (7.22e-2)"	0.7	4.9	1.1	0.3	5.3	0.4	0.7	0.0	1.0	0.9	0.4			1.2	0.3	0.4	3.3	0.9	2.1	5.0	0.7	0.9	1.6	0.2	2.8	0.3	1.1		0.7	4.1	4.7	3.7	2.1		1.2	0.6		1.7	3.6	0.0	8.0	0.6	0.1	1.5	1.6	2.0	1.0			1.8		0.6	1.7	1.8	0.4	3.5	0.0	1.8	0.0	1.1	0.6	2.4	4.7	0.0	0.0	0.1	0.4	1.8	0.8	5.1	1.9	4.8	6.8	6.1	0.0	3.4	0.4	2.5	2.5	12.3	0.9	0.0	1.2	0.3	3.0	0.0	0.2	0.0	0.0	0.3	1.7	1.3	0.8	1.1	0.0	0.3	2.1	1.3	2.7	2.5	1.9	3.4	1.2	4.9	0.5	4.3	1.2	0.0	0.2	2.0	5.6	0.4	0.7	4.1	0.6	0.0	7.0	0.0	0.8	0.1	0.0	0.0	0.9	9.5	0.2	0.0	1.8	0.0	0.3	0.8	0.7	0.4	0.5	0.5	3.5	0.4	1.1	0.7	0.0	0.0	0.0	0.7	0.0	0.6										
C11orf74	"FLJ38678, HEPIS, NWC"	ENSG00000166352	"Chromosome 11 open reading frame 74"	Q86VG3	11	36594493-36659290	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 66.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044880	Uncertain		Approved	Aggresome,Cytosol				"Aggresome, Cytosol"		"HPA044880: AB_10796908"	"unprognostic (9.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.65e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.24e-1)"	10.7	13.1	16.0	4.2	18.8	8.6	11.5	15.5	20.8	10.5	15.4	8.7	8.3	5.5	11.8	18.5	9.5	25.3	10.1	28.1	14.3	15.4	17.1	13.1	8.1	4.1	17.2	16.5	17.8	10.2	12.5	23.1	7.9	19.6	13.3	8.3	9.0	8.6	8.2	26.5	3.8	7.5	13.1	15.5	5.7	9.7	33.1	14.5	3.5	66.1	10.8	4.0	12.5	7.3	0.3	18.6	7.5	12.5	8.5	8.2	5.8	5.3	9.0	20.0	15.5	16.4	28.1	7.9	11.1	12.6	11.5	20.3	0.3	8.5	0.0	8.8	11.3	2.2	13.5	15.2	22.8	0.0	21.8	8.7	5.1	9.9	13.7	12.0	2.1	17.7	11.8	7.6	10.8	18.8	11.7	0.0	12.7	9.0	2.0	9.8	12.7	13.8	8.6	24.3	5.1	16.0	1.8	0.5	23.7	11.4	3.0	18.2	18.2	6.5	12.0	15.8	11.3	20.9	9.4	3.3	6.1	0.0	13.8	14.3	8.1	7.5	12.5	0.7	1.1	9.7	3.7	0.0	3.3	2.8	13.7	0.3	8.2	2.0	0.7	8.5	9.1	18.6	0.4	5.8	16.0	18.8	15.5	20.8	14.3	15.4	17.2	16.5	19.6	14.5
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"		11	43942505-43944338	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"ovary: 152.0"	"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavourable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"	68.2	81.2	4.9	23.4	17.4	3.4	42.6	2.6	10.5	39.7	32.2	3.3	6.6	12.4	35.1	41.5	16.3	69.3	70.0	34.3	8.8	7.9	17.9	67.7	61.9	4.9	7.6	4.7	152.0	18.1	3.8	14.2	14.6	32.8	28.6	6.2	7.6	2.3	12.8	38.2	10.1	17.2	22.9	15.3	12.7	31.3	41.7	4.2	0.0	16.7	14.0	2.3	62.9	32.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.9	1.9	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.4	0.7	0.0	0.0	0.0	0.7	0.8	0.5	0.3	3.2	0.2	1.4	0.0	0.0	0.7	63.8	0.0	0.0	5.9	0.0	0.6	0.8	3.1	1.2	0.7	0.0	7.4	0.0	0.9	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	17.4	2.6	7.1	8.8	7.9	7.6	4.7	32.8	4.2
C12orf40	FLJ40126	ENSG00000180116	"Chromosome 12 open reading frame 40"	Q86WS4	12	39626167-39908300	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	28	"testis: 26.4"	"Cell line enriched"	"Detected in some"	8	"K-562: 7.5"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							HPA039032			Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA039032: "					"unprognostic (1.75e-1)"								"unprognostic (2.76e-6)"	"unprognostic (3.45e-1)"	"unprognostic (1.96e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C12orf60	MGC47869	ENSG00000182993	"Chromosome 12 open reading frame 60"	Q5U649	12	14803572-14906586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA043911			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043911: AB_10963941"	"unprognostic (3.71e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.09e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-2)"	1.7	8.9	2.6	2.3	9.9	1.7	1.8	1.9	4.7	1.5	1.3	4.8	1.6	0.7	1.1	2.9	1.3	2.9	1.8	5.4	3.7	2.0	4.8	8.7	2.0	3.2	6.3	4.7	1.5	2.1	1.7	3.8	1.6	7.2	2.1	1.2	5.1	1.9	1.4	2.5	1.3	1.4	0.8	9.2	5.5	1.9	22.5	4.9	1.7	3.3	1.0	2.0	1.5	1.7	3.9	1.1	3.6	1.4	3.3	4.5	1.2	2.6	2.8	2.8	8.2	3.1	2.2	2.6	1.9	1.0	2.0	2.4	1.2	2.9	2.3	2.3	0.7	3.0	3.2	6.3	2.7	5.1	3.2	1.8	0.8	1.9	2.6	2.6	1.0	1.2	3.9	2.1	4.3	3.9	2.9	0.5	2.7	0.8	1.0	1.6	9.8	1.6	3.1	4.9	3.3	3.7	0.8	2.1	2.5	4.2	1.0	3.7	3.2	1.2	3.0	1.8	2.0	1.4	2.1	1.4	1.0	7.5	2.3	2.4	2.6	0.3	1.3	3.6	2.3	1.4	3.7	3.9	1.9	3.3	1.1	2.6	4.5	3.8	0.3	3.3	0.8	1.0	3.6	1.2	2.6	9.9	1.9	4.7	3.7	2.0	6.3	4.7	7.2	4.9
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123232916-123257959	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"		"Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favourable (7.82e-5)"	7.8	15.7	13.2	11.3	15.1	9.6	9.0	21.6	18.2	14.1	10.8	12.3	11.6	13.8	14.9	16.5	10.7	11.7	11.1	17.4	13.2	15.2	12.1	15.6	10.6	18.8	11.5	13.2	21.3	12.4	8.8	24.6	9.2	15.0	15.1	9.7	13.1	21.2	10.8	14.3	17.7	12.6	10.5	14.2	14.7	11.7	17.3	12.2	80.9	15.3	7.9	15.5	14.3	13.7	23.6	10.0	22.6	4.6	17.1	28.9	10.0	14.5	10.0	11.4	22.3	5.7	6.1	6.9	12.1	7.7	12.3	9.1	10.8	8.6	18.1	10.5	3.9	10.7	12.3	6.6	11.8	13.6	11.0	21.3	9.9	9.4	12.8	9.9	10.8	6.4	16.1	8.9	18.5	8.0	22.5	7.5	8.2	6.3	23.7	18.3	8.7	15.5	17.7	13.6	16.8	11.5	8.3	24.3	10.5	13.5	6.9	12.6	11.0	11.6	9.0	13.4	16.1	12.1	12.2	12.4	14.3	16.6	8.7	13.1	17.5	22.6	3.5	14.0	15.9	3.8	19.8	23.6	22.0	21.1	6.0	20.2	28.9	24.7	3.7	17.1	4.6	10.0	18.5	10.0	13.2	15.1	21.6	18.2	13.2	15.2	11.5	13.2	15.0	12.2
C14orf119	FLJ20671	ENSG00000179933	"Chromosome 14 open reading frame 119"	Q9NWQ9	14	23094765-23100462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003638	Uncertain		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA003638: AB_2243669"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.26e-3)"	"prognostic unfavourable (5.42e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.61e-2)"	"prognostic favourable (3.30e-5)"	"unprognostic (1.63e-1)"	28.2	35.0	16.3	22.0	18.5	9.2	38.9	11.6	17.3	30.4	28.4	17.0	23.9	22.6	29.9	30.3	32.0	23.5	22.4	29.6	16.3	19.9	36.3	24.6	30.4	37.3	22.4	15.1	25.2	39.4	16.7	28.1	32.2	23.1	27.9	35.8	27.1	28.0	28.1	21.2	20.7	27.4	33.5	20.1	33.8	28.2	33.0	16.7	27.2	40.0	26.3	33.1	25.8	24.0	34.6	37.4	72.7	40.2	30.2	45.0	43.7	13.6	13.6	20.5	12.4	45.3	39.5	16.5	23.0	34.1	30.4	36.2	10.7	21.3	10.4	12.0	37.3	23.5	19.5	30.6	42.3	16.6	9.5	15.7	11.3	45.8	35.7	23.5	24.6	48.0	27.6	25.6	18.9	33.2	10.4	11.7	33.3	19.7	11.0	18.2	12.8	20.8	9.8	15.3	12.0	34.5	22.1	9.9	9.0	19.2	18.1	19.9	12.2	13.7	26.7	14.5	12.7	21.7	10.3	11.0	12.9	12.8	13.3	14.9	12.9	63.7	40.2	72.7	32.6	25.7	37.1	34.6	37.2	36.2	37.4	28.5	39.1	38.3	23.8	30.2	17.3	25.2	45.0	43.7	16.3	18.5	11.6	17.3	16.3	19.9	22.4	15.1	23.1	16.7
C14orf28	DRIP-1	ENSG00000179476	"Chromosome 14 open reading frame 28"	Q4W4Y0	14	44897295-44907257	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059635			Approved	Cytosol				Cytosol		"HPA059635: "	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.06e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.33e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.01e-1)"	8.8	5.3	5.0	4.1	5.6	1.6	11.8	4.0	6.2	13.3	10.3	7.2	10.7	7.3	14.4	8.4	6.5	9.2	8.9	8.5	4.8	4.1	5.1	14.4	5.1	4.4	10.6	4.3	12.4	12.4	4.4	5.0	5.7	5.6	12.8	5.8	5.9	11.4	8.7	7.4	5.9	9.0	20.4	5.4	5.9	8.5	16.1	5.4	1.7	6.6	3.2	5.0	19.0	9.2	6.8	3.4	6.9	3.5	3.9	9.7	2.1	2.3	1.7	3.2	5.5	6.5	3.5	7.3	4.8	5.3	2.4	3.7	0.1	3.1	3.1	2.9	3.3	1.3	0.8	2.3	4.1	11.5	0.6	1.5	0.8	3.2	1.9	1.3	3.6	2.7	3.9	0.7	3.8	1.2	0.8	4.5	1.8	4.6	1.3	2.7	0.6	1.9	2.3	4.0	1.3	3.3	3.1	0.7	1.0	2.0	3.9	2.1	7.0	1.4	1.9	8.9	4.4	1.5	0.9	6.2	5.0	2.0	2.6	0.7	2.8	1.8	1.7	6.9	4.3	2.6	4.9	6.8	4.4	5.6	2.0	5.1	9.7	5.5	3.8	3.9	3.5	3.4	4.8	2.1	5.0	5.6	4.0	6.2	4.8	4.1	10.6	4.3	5.6	5.4
C15orf39	"DKFZP434H132, FLJ46337"	ENSG00000167173	"Chromosome 15 open reading frame 39"	Q6ZRI6	15	75195643-75212169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;granulocytes: 16.9;monocytes: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039961, HPA041907"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA039961: AB_10673024, HPA041907: "	"unprognostic (3.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.46e-2)"	"prognostic favourable (7.94e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.47e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.14e-1)"	14.7	10.2	3.5	9.6	5.3	36.1	9.0	2.5	4.1	11.8	8.5	3.1	3.8	7.9	16.5	5.8	13.1	11.5	13.9	7.7	3.5	3.3	5.6	5.3	11.7	11.6	3.3	2.2	23.3	11.4	5.2	7.5	24.4	3.9	10.0	3.9	7.7	12.5	5.3	4.4	9.9	7.6	10.0	3.3	21.1	6.6	71.7	3.2	11.1	7.8	9.0	17.0	10.5	13.7	0.8	5.7	16.9	10.4	2.2	1.3	2.2	7.6	15.6	3.4	4.0	4.6	3.0	10.3	2.2	4.5	2.6	2.8	19.3	10.6	17.2	7.5	3.2	10.3	14.5	6.6	0.7	16.8	16.4	34.1	7.6	13.2	5.3	9.8	35.3	4.0	5.3	5.5	2.6	6.6	14.6	25.8	0.8	4.5	9.4	11.9	10.6	6.3	8.6	2.6	18.3	1.6	6.0	9.9	3.2	5.1	11.9	8.0	4.0	12.5	5.6	4.5	6.8	8.1	6.4	18.7	11.7	10.0	4.5	19.0	4.4	4.8	4.2	12.2	1.3	8.2	1.0	0.8	0.7	0.9	2.7	0.5	0.6	0.8	16.9	2.2	10.4	5.7	0.9	2.2	3.5	5.3	2.5	4.1	3.5	3.3	3.3	2.2	3.9	3.2
C15orf40	MGC29937	ENSG00000169609	"Chromosome 15 open reading frame 40"	Q8WUR7	15	82988441-83011641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042980	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042980: AB_10964298"	"unprognostic (8.30e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.55e-3)"	"unprognostic (7.71e-2)"	"prognostic favourable (4.35e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.51e-2)"	13.5	16.3	14.3	11.1	15.4	15.1	13.5	15.9	15.8	10.9	13.9	15.0	16.3	16.3	9.6	24.2	10.8	10.6	10.1	9.0	13.1	9.1	17.2	16.3	9.2	16.0	13.2	13.8	13.9	16.7	12.3	14.1	9.0	12.7	10.3	10.0	11.9	13.8	12.1	13.4	18.2	16.8	10.6	10.5	13.8	11.3	14.3	10.3	14.3	16.0	11.9	12.5	9.9	10.4	27.9	18.8	27.0	14.1	26.5	24.7	12.2	9.3	11.9	7.8	10.7	9.9	9.2	7.5	6.2	10.0	6.1	6.9	8.6	16.7	10.2	8.5	4.8	18.2	17.2	12.8	6.9	19.4	12.0	9.7	15.9	9.8	9.8	15.9	10.2	8.1	18.0	10.2	11.6	10.6	13.1	17.0	5.8	9.6	13.6	8.7	13.7	8.1	18.3	11.0	13.6	10.4	14.7	19.1	11.7	16.4	11.8	23.1	14.8	9.5	6.7	13.2	18.5	9.9	11.0	15.8	23.9	19.3	16.6	16.4	14.4	27.0	14.1	18.8	19.3	13.6	21.1	27.9	20.5	19.9	13.2	24.4	24.1	20.7	15.1	26.5	12.6	18.8	24.7	12.2	14.3	15.4	15.9	15.8	13.1	9.1	13.2	13.8	12.7	10.3
C15orf59	"INSYN1, LOC388135, MGC131524"	ENSG00000205363	"Chromosome 15 open reading frame 59"	Q2T9L4	15	73735431-73752747	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 24.1;heart muscle: 16.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 11.3;fHDF/TERT166: 7.5;HEK 293: 7.8;NTERA-2: 4.8;SK-BR-3: 6.7;U-2 OS: 6.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favourable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	1.2	1.9	9.3	0.4	9.7	0.0	0.9	5.5	24.1	2.2	0.7			0.3	1.0	2.4	9.4	6.5	1.5	16.2	9.1	8.3	3.5	0.0	1.7	0.0	14.4		4.8	1.0	0.0	0.7	0.2		4.5	0.2		0.7	10.1	1.4	8.4	1.0	2.1	4.2	0.0	0.8	1.9			0.4		0.4	1.6	3.8	0.8	0.6	1.5	0.5	0.8	0.5	0.0	0.0	0.5	2.8	1.8	11.3	0.2	0.0	1.5	0.0	0.9	0.0	0.0	0.0	0.1	0.9	7.5	2.9	2.4	0.0	0.0	0.0	7.8	0.4	0.0	0.0	0.8	0.0	0.2	0.8	0.1	0.1	0.0	0.0	0.0	0.2	0.7	1.0	0.0	0.2	4.8	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.7	0.6	6.7	0.7	3.1	0.2	0.1	1.8	6.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.5	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.1	0.8	0.5	0.5	1.5	0.8	0.3	0.6	0.3	0.0										
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521068-67530143	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"			"Nucleoli, Vesicles"	Cytosol	"HPA062820: "	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favourable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	9.9	10.0	10.8	4.7	18.1	11.0	17.9	14.5	17.2	5.5	6.0	2.4	5.6	7.5	6.3	5.9	5.5	5.2	5.1	21.0	8.7	7.2	8.4	6.4	7.2	7.5	6.9	10.9	7.9	20.7	8.8	10.9	5.8	7.3	7.2	6.4	5.9	7.0	6.4	45.8	8.4	5.0	7.0	5.8	5.0	6.6	25.2	5.5	3.6	7.7	16.9	3.7	4.6	8.0	7.2	7.2	10.7	6.6	5.1	9.8	5.0	4.3	4.6	1.2	5.1	5.4	7.9	3.3	1.9	3.4	3.6	2.8	3.5	3.1	3.6	4.1	2.1	5.1	4.6	1.3	2.9	2.1	10.9	3.9	3.5	4.6	3.5	4.7	3.2	8.1	3.6	1.2	4.3	1.6	4.3	8.1	1.1	2.4	3.8	7.7	2.0	5.9	5.2	2.6	13.2	2.5	3.0	6.9	5.2	3.3	3.2	5.8	2.8	7.3	1.7	4.8	7.3	5.9	4.9	7.7	11.1	8.8	2.0	9.3	2.4	8.6	6.6	10.7	7.0	5.2	8.0	7.2	9.2	6.9	6.9	5.6	9.8	7.9	0.8	5.1	4.4	7.2	5.6	5.0	10.8	18.1	14.5	17.2	8.7	7.2	6.9	10.9	7.3	5.5
C15orf65	FLJ27352	ENSG00000261652	"Chromosome 15 open reading frame 65"	H3BRN8	15	55408548-55418764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 27.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA067189	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA067189: "	"unprognostic (2.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (3.18e-7)"	"unprognostic (1.59e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	3.4	3.1	6.5	0.9	7.4	0.8	5.4	2.4	6.7	7.7	5.2	3.7	5.4	2.9	3.7	11.2	3.4	13.7	5.3	7.0	6.0	7.6	11.2	1.9	3.8	2.2	5.2	6.8	4.6	11.0	6.2	17.2	1.2	12.0	5.8	6.2	2.8	27.6	5.3	8.7	2.4	2.5	3.7	3.4	1.9	7.8	11.3	4.6	1.7	7.1	0.6	1.8	3.6	1.5	2.3	0.6	6.5	1.6	0.0	0.7	0.4	0.8	1.7	2.9	1.8	4.5	6.6	0.5	1.6	2.2	1.4	2.8	0.0	1.5	1.3	4.4	5.1	1.3	0.0	2.7	0.5	2.4	2.0	1.2	10.0	0.4	8.7	2.8	1.6	2.8	14.7	4.1	1.2	2.6	2.3	4.3	6.1	2.2	0.1	9.2	0.9	3.3	0.5	0.0	11.1	7.6	0.0	7.8	4.7	2.0	3.3	12.7	6.8	2.7	1.9	2.4	0.9	2.5	0.9	1.9	4.9	1.2	6.1	7.2	1.1	6.5	1.1	3.9	0.5	1.6	0.0	1.9	0.1	0.7	0.6	2.3	0.1	0.0	2.1	0.0	0.8	0.2	0.0	0.4	6.5	7.4	2.4	6.7	6.0	7.6	5.2	6.8	12.0	4.6
C16orf45	FLJ32618	ENSG00000166780	"Chromosome 16 open reading frame 45"	Q96MC5	16	15434295-15625028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.5;U-2197: 23.6;U-87 MG: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 11.1"	"Lineage enriched"	"Detected in many"	4	"T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041114, HPA063757"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA041114: AB_10794542, HPA063757: "	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (1.53e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.28e-2)"	"prognostic favourable (1.75e-4)"	"unprognostic (3.79e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	11.5	10.2	38.8	6.8	27.6	1.3	8.4	30.6	72.3	28.4	10.4	10.1	3.8	5.9	21.3	12.7	14.2	12.3	14.6	28.7	39.2	30.4	9.4	12.9	6.0	4.1	21.8	33.8	26.1	5.6	2.2	11.3	1.4	61.3	15.0	6.2	8.5	6.5	17.8	25.5	4.9	4.4	21.5	12.5	5.3	7.6	13.8	12.0	0.0	5.7	4.4	3.0	14.2	10.7	2.7	0.5	0.6	0.1	0.2	11.1	1.5	0.4	10.5	4.4	0.4	19.8	16.9	0.0	5.7	19.7	5.1	2.8	0.0	0.2	0.0	1.3	32.5	0.0	1.2	1.6	2.7	0.2	0.2	2.5	4.1	0.3	6.5	0.0	4.3	8.2	1.7	11.4	0.1	7.8	0.1	0.1	7.6	6.3	1.4	0.1	5.6	4.0	0.3	6.0	0.0	2.8	1.8	8.7	8.6	0.3	2.9	1.7	0.1	0.1	4.5	11.5	5.9	23.6	2.8	1.9	4.5	0.0	40.5	0.0	2.8	0.1	0.1	0.2	11.1	0.0	2.0	2.7	2.1	6.2	0.5	1.6	2.0	3.3	0.6	0.2	0.1	0.3	2.7	1.5	38.8	27.6	30.6	52.4	39.2	30.4	21.8	33.8	61.3	12.0
C16orf46	FLJ32702	ENSG00000166455	"Chromosome 16 open reading frame 46"	Q6P387	16	81053497-81077267	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 25.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041136, HPA041379"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041136: AB_10795535, HPA041379: AB_10794666"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.53e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.72e-2)"	2.0	2.5	5.2	1.8	6.8	2.2	3.1	3.3	8.6	2.8	1.4	3.5	1.3	1.3	2.8	4.4	1.7	8.6	2.0	1.4	5.8	5.8	2.4	3.0	2.2	1.1	5.9	6.0	1.7	2.6	2.9	14.4	3.2	8.6	3.0	1.4	3.5	2.0	2.4	2.5	1.0	1.0	1.9	4.2	1.1	1.1	25.2	2.5	1.5	8.9	0.5	1.3	1.9	1.3	0.2	0.4	1.1	0.4	0.0	2.0	0.0	2.8	0.4	1.1	0.5	5.1	1.0	2.6	0.5	3.5	1.9	1.1	0.6	4.0	0.7	1.8	0.7	1.0	1.1	1.9	3.5	0.6	0.7	0.8	2.3	2.7	3.0	1.0	2.1	2.1	1.5	4.6	2.8	1.7	1.7	1.4	1.5	1.9	0.3	5.4	1.2	0.6	2.1	0.3	0.4	3.4	1.6	1.5	1.3	3.9	1.3	0.7	1.2	1.4	1.3	0.9	0.4	0.8	0.7	1.5	2.1	1.6	1.8	1.4	0.9	0.0	0.4	1.1	0.2	0.0	2.0	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	5.2	6.8	3.3	8.6	5.8	5.8	5.9	6.0	8.6	2.5
C16orf58	FLJ13868	ENSG00000140688	"Chromosome 16 open reading frame 58"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"				"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	13.5	17.7	15.9	15.3	22.3	11.0	15.7	17.9	30.8	22.6	17.5	16.6	34.2	18.6	24.2	21.4	16.8	21.0	20.0	16.7	12.9	15.3	19.1	51.0	13.9	15.7	13.8	16.4	29.5	49.1	30.7	27.6	23.1	13.1	22.0	11.6	22.9	36.9	26.7	4.8	14.1	22.2	15.6	9.1	12.9	19.7	11.9	14.3	15.1	26.4	14.2	19.3	15.9	17.4	8.9	12.0	8.8	9.8	10.8	11.3	8.4	11.4	15.2	9.5	16.5	22.1	14.8	17.6	13.7	23.5	10.7	12.8	4.6	20.2	9.8	29.2	20.2	16.0	9.5	12.7	5.0	14.3	9.4	10.0	8.6	11.4	32.1	11.7	12.0	17.8	13.8	14.1	29.0	10.3	14.7	17.0	10.4	21.6	5.4	7.8	7.4	10.0	12.4	14.3	29.7	12.2	7.1	10.4	16.0	10.3	27.2	21.4	23.5	17.3	8.9	18.7	10.5	12.0	8.9	24.8	14.4	7.4	23.9	18.0	25.7	3.8	6.9	8.8	10.3	9.8	9.6	8.9	10.7	10.2	12.0	8.5	10.8	9.3	1.2	10.8	9.6	11.0	11.3	8.4	15.9	22.3	17.9	30.8	12.9	15.3	13.8	16.4	13.1	14.3
C16orf70	"C16orf6, FLJ12076, lin-10, LIN10"	ENSG00000125149	"Chromosome 16 open reading frame 70"	Q9BSU1	16	67109958-67148539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041131, HPA041214"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA041131: AB_10795487, HPA041214: AB_10794267"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.15e-2)"	8.0	7.7	11.3	6.7	14.6	14.2	10.5	14.0	22.4	8.4	7.9	24.2	8.6	6.7	8.9	8.8	12.5	10.1	8.2	8.0	12.6	8.9	11.8	43.2	7.9	7.6	18.2	13.1	10.1	6.2	19.5	8.3	10.6	15.5	12.9	9.4	7.7	8.9	8.4	20.1	22.0	7.1	10.0	18.0	11.2	6.9	10.6	16.0	7.0	7.1	5.8	10.3	8.4	10.3	7.2	14.1	6.3	15.9	5.2	8.3	7.3	6.7	10.1	9.7	10.1	12.3	7.4	22.9	7.7	8.4	15.7	17.3	11.2	6.0	6.8	6.8	9.1	9.1	12.0	7.6	20.4	3.6	11.0	5.4	6.4	23.4	7.6	5.2	30.0	7.3	10.6	15.3	7.2	8.8	8.7	2.9	9.6	6.8	10.2	8.2	10.7	16.5	14.3	16.8	10.7	6.9	4.1	12.6	6.8	23.9	5.5	5.8	11.0	4.5	6.7	11.2	9.5	7.9	6.6	4.5	8.1	20.4	10.1	5.5	8.8	2.9	15.9	5.4	4.7	11.8	6.2	7.2	7.0	8.3	14.1	4.9	7.1	6.6	6.3	5.2	11.8	4.6	6.7	7.3	11.3	14.6	14.0	22.4	12.6	8.9	18.2	13.1	15.5	16.0
C17orf100	LOC388327	ENSG00000256806	"Chromosome 17 open reading frame 100"		17	6651718-6693202	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 18.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 11.7;SH-SY5Y: 11.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA046824			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA046824: "	"unprognostic (9.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.65e-2)"	0.8	1.5	1.4	1.6	3.3	0.1	1.4	3.8	5.6	2.3	2.4	4.0	1.2	3.6	1.5	2.8	2.1	1.7	1.5	0.3	1.5		2.2	18.4	1.2	3.5	1.3	2.5	1.1	8.5	2.5	9.1	0.6	3.0	2.2	1.6	0.8	5.2	1.1	0.3	9.3	4.3	0.7	1.6	2.2	2.8	3.6	2.3	1.6	3.3	0.2	1.1	1.7	0.5	5.7	3.1	7.5	2.4	2.5	5.5	1.9	1.3	2.6	5.7	1.8	0.8	1.6	2.7	0.7	4.1	1.7	3.4	3.8	1.8	1.5	2.9	1.3	4.9	1.1	2.6	2.5	6.6	7.6	1.4	2.6	11.7	2.0	0.2	3.9	2.3	2.5	0.8	1.8	1.0	1.8	1.5	2.2	2.8	1.6	2.4	0.8	1.7	3.1	0.9	2.3	3.4	1.1	5.9	11.6	3.4	0.4	3.9	3.0	0.4	1.5	1.6	3.3	0.9	1.3	2.1	1.4	1.0	1.4	0.5	3.7	5.7	1.9	7.5	2.5	2.4	3.4	4.3	4.6	2.9	3.1	5.7	5.5	3.0	1.8	2.5	2.3	1.0	3.0	1.9										
C17orf49	"BAP18, HEPIS, MGC49942"	ENSG00000258315	"Chromosome 17 open reading frame 49"	Q8IXM2	17	7014495-7017525	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022961, HPA024457"	Supported		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.09e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-9)"	"unprognostic (5.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.62e-2)"	28.3	21.9	32.7	30.7	29.1	55.4	25.8	24.9	32.1	21.4	20.7	20.9	13.9	18.5	19.1	29.9	29.7	27.2	25.6	25.6	28.4	24.5	23.3	34.3	30.4	45.2	25.9	21.1	19.0	25.1	20.8	20.9	29.7	19.7	20.4	23.2	22.5	22.7	16.8	32.7	30.2	19.2	18.4	23.1	44.6	18.4	21.8	17.9	60.4	31.4	30.7	53.7	25.7	18.8	52.3	78.9	48.8	49.8	82.3	48.3	40.4	18.1	24.1	38.2	29.5	27.3	38.8	13.2	9.9	16.2	19.8	16.3	11.9	15.0	17.4	27.3	23.6	15.1	9.5	19.1	15.2	60.9	25.2	15.7	7.7	22.7	20.5	10.0	21.0	24.4	25.8	14.8	29.9	30.9	5.7	49.9	24.2	20.7	16.4	33.4	12.8	14.1	10.2	11.2	25.2	22.4	12.1	10.4	29.6	17.4	8.9	17.5	11.3	12.9	16.8	11.5	14.2	19.4	25.0	17.9	10.2	5.8	18.0	14.9	16.5	48.8	37.6	34.4	47.0	49.8	29.8	52.3	48.3	47.0	57.6	50.6	32.3	35.7	34.3	82.3	37.1	78.9	47.9	40.4	32.7	29.1	24.9	32.1	28.4	24.5	25.9	21.1	19.7	17.9
C17orf53	MGC3130	ENSG00000125319	"Chromosome 17 open reading frame 53"	Q8N3J3	17	44141906-44162476	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA023004, HPA023393, HPA024430"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879"	"unprognostic (1.72e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (8.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavourable (3.46e-4)"	"prognostic unfavourable (9.39e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.86e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.40e-2)"	2.0	0.7	0.5	3.5	0.4	13.4	2.0	2.8	1.4	1.2	1.5	0.6	0.5	1.4	1.3	1.1	4.0	0.9	1.4	1.9	0.8	0.7	0.8	0.8	1.3	2.4	0.5	0.2	1.3	1.2	0.7	0.7	2.3	1.0	1.0	1.7	0.6	1.1	1.1	1.8	2.4	2.2	1.1	0.5	1.9	1.0	32.1	0.4	8.2	0.5	1.5	4.8	0.8	1.7	1.4	3.7	0.9	1.1	0.3	2.0	0.6	7.5	9.5	7.5	6.7	0.6	2.1	8.9	6.0	5.2	11.5	12.7	9.7	4.7	8.1	5.3	5.2	6.6	9.7	9.4	10.2	9.1	12.3	5.2	8.7	6.5	0.3	5.7	6.6	1.8	1.4	14.3	7.1	4.8	11.8	10.7	5.6	5.6	13.5	8.5	5.1	9.4	8.6	12.0	10.0	2.7	6.1	4.7	2.8	3.6	3.6	2.9	7.2	6.6	2.2	11.2	8.8	7.5	8.6	6.1	10.3	7.0	5.2	4.4	6.3	0.0	1.1	0.9	1.1	0.8	0.4	0.8	0.8	0.2	0.4	1.4	0.6	0.4	0.0	0.3	0.4	3.7	2.0	0.6	0.5	0.4	2.8	1.4	0.8	0.7	0.5	0.2	1.0	0.4
C17orf58		ENSG00000186665	"Chromosome 17 open reading frame 58"	Q2M2W7	17	67991101-67996431	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.1"	HPA023036	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023036: AB_10601144"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.65e-3)"	"prognostic unfavourable (8.99e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavourable (1.31e-10)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.01e-1)"	11.1	6.8	10.7	6.2	9.3	3.5	17.3	8.8	11.5	29.0	8.3	5.7	8.3	4.1	15.4	8.1	6.5	8.1	6.6	8.9	7.7	6.3	6.3	9.1	6.2	3.1	7.4	5.0	6.3	10.4	5.2	3.6	33.3	5.2	7.8	7.5	5.7	5.3	4.0	6.9	3.7	6.1	11.8	5.5	5.1	6.6	4.8	4.4	1.1	6.9	4.5	6.8	11.0	11.7	3.6	5.2	9.5	6.3	3.2	3.0	2.2	5.2	5.2	5.2	6.4	3.8	9.6	4.1	2.2	6.2	3.9	6.3	3.0	6.9	7.0	5.0	1.8	2.7	11.8	4.7	9.4	12.6	11.9	4.5	1.9	9.6	6.0	3.8	8.4	5.2	5.7	3.7	8.7	18.1	9.6	10.9	3.7	7.0	0.7	5.1	5.9	5.5	1.7	5.7	9.3	4.9	3.5	3.9	7.0	3.3	30.9	11.3	8.8	4.5	3.3	3.3	3.4	2.3	4.6	21.9	16.0	6.2	8.4	6.8	5.8	9.5	3.8	6.3	3.0	3.6	1.0	3.6	1.1	2.4	5.2	0.8	0.5	1.2	1.5	3.2	6.3	0.2	0.5	2.2	10.7	9.3	8.8	11.5	7.7	6.3	7.4	5.0	5.2	4.4
C17orf75	"NJMU-R1, SRI2"	ENSG00000108666	"Chromosome 17 open reading frame 75"	Q9HAS0	17	32324565-32350023	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004061, HPA075333"	Approved	Approved	Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA004061: AB_1078337, HPA075333: "	"unprognostic (4.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (3.13e-4)"	"unprognostic (1.92e-2)"	"unprognostic (7.80e-2)"	"prognostic favourable (1.33e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.60e-2)"	6.9	17.3	16.6	8.2	21.2	5.7	13.1	25.8	23.9	8.7	10.1	12.7	10.9	10.5	12.7	15.6	9.9	14.7	6.9	18.6	13.4	14.8	19.6	12.7	8.0	10.8	13.8	14.1	16.0	11.3	16.6	17.2	9.3	21.1	11.8	11.3	11.7	11.8	11.8	15.0	8.0	9.2	11.0	11.3	10.8	10.9	20.4	13.3	11.7	16.4	8.3	11.3	9.7	8.9	15.0	13.7	18.4	12.3	13.7	16.4	13.0	13.2	14.4	20.9	7.4	6.1	8.1	10.9	9.6	10.6	15.5	13.8	7.2	5.2	9.1	11.2	8.8	14.9	17.2	13.1	22.2	6.4	16.7	7.3	13.3	13.3	13.2	10.4	6.1	6.4	15.9	11.1	8.0	11.7	14.3	13.2	10.1	10.9	29.1	9.0	13.3	7.9	18.4	13.8	15.9	9.2	7.4	20.4	16.8	8.5	7.5	20.2	19.1	6.4	7.3	8.1	12.8	3.8	14.9	15.8	17.8	31.4	6.2	9.1	2.4	18.4	10.6	13.2	16.0	8.8	16.4	14.5	14.6	15.4	13.7	15.0	16.1	15.1	3.5	13.7	12.3	10.4	15.0	13.0	16.6	21.2	25.8	23.9	13.4	14.8	13.8	14.1	21.1	13.3
C17orf97	"LIAT1, LOC400566"	ENSG00000187624	"Chromosome 17 open reading frame 97"	Q6ZQX7	17	410327-431062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.0;U-2197: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in many"											HPA023583	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023583: AB_1853122"	"unprognostic (6.62e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (7.73e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.19e-2)"	2.1	4.9	6.0	2.4	10.6	1.9	2.7	5.2	8.7	3.9	3.6	4.2	4.4	2.2	3.5	4.5	2.4	13.6	6.6	3.8	5.2	6.1	7.6	1.9	3.8	2.8	4.0	7.6	3.8	3.8	3.4	8.2	1.4	6.2	3.3	2.9	4.2	3.5	5.8	4.3	2.5	4.7	1.9	2.8	2.1	2.4	53.2	2.9	5.0	6.9	1.8	1.9	3.1	1.8	0.4	0.9	2.7	0.4	0.8	1.4	0.2	2.6	3.9	1.8	2.2	1.0	0.8	0.9	2.0	1.4	1.5	1.0	0.1	4.0	0.7	1.5	4.3	9.0	4.9	1.0	1.5	0.3	0.6	1.9	3.4	0.3	3.4	0.4	0.8	1.0	2.5	3.4	0.4	1.5	0.3	0.1	1.0	2.3	6.5	3.5	2.8	1.2	0.7	0.4	2.4	6.3	2.3	0.6	2.1	2.4	3.4	0.5	2.0	2.9	1.5	1.9	0.9	12.0	0.8	0.2	0.2	0.0	2.3	0.9	1.1	0.4	0.4	2.7	0.3	0.2	0.0	0.2	0.2	0.8	0.5	0.4	1.4	1.3	0.2	0.8	0.4	0.9	0.0	0.2	6.0	10.6	5.2	8.7	5.2	6.1	4.0	7.6	6.2	2.9
C18orf25	"ARKL1, MGC12909, RNF111L1"	ENSG00000152242	"Chromosome 18 open reading frame 25"	Q96B23	18	46173553-46266991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 54.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051314, HPA051899"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051314: , HPA051899: "	"unprognostic (1.44e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.46e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (3.97e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	5.3	4.9	5.8	6.4	8.2	18.6	6.5	10.1	10.1	6.1	4.9	5.5	6.5	4.4	7.7	5.3	54.0	6.2	3.8	11.4	4.8	4.9	5.4	6.2	5.9	6.8	5.3	6.5	5.9	5.0	15.3	6.3	7.3	8.3	5.2	5.7	9.5	11.3	4.8	13.1	6.2	5.5	5.7	4.7	6.3	5.1	7.8	5.7	8.2	7.4	10.2	11.8	7.2	12.7	8.1	11.0	19.0	11.0	2.8	11.1	5.5	11.2	11.3	9.5	10.7	6.8	6.2	12.2	16.4	8.7	17.6	15.0	8.6	13.0	8.7	15.6	11.0	25.7	17.5	11.1	19.1	14.4	5.6	7.6	9.6	6.5	11.8	14.2	10.3	5.7	13.0	20.4	17.0	6.9	8.5	10.4	9.7	8.5	10.8	7.3	8.4	4.4	9.8	11.3	12.7	16.8	20.3	13.3	6.9	12.0	8.5	8.5	5.6	8.8	10.0	16.0	11.5	3.9	15.0	13.7	11.6	14.0	8.3	15.1	17.1	4.2	7.5	15.4	5.7	8.4	9.9	5.9	11.1	8.6	7.4	8.1	8.0	6.3	19.0	2.8	11.0	11.0	7.1	5.5	5.8	8.2	10.1	10.1	4.8	4.9	5.3	6.5	8.3	5.7
C19orf12	"DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43"	ENSG00000131943	"Chromosome 19 open reading frame 12"	Q9NSK7	19	29698886-29715789	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 57.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046930	Approved		Supported	Cytosol				Cytosol		"HPA046930: AB_10962836"	"unprognostic (1.76e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.94e-3)"	"unprognostic (7.93e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.22e-3)"	57.4	14.7	11.9	7.6	11.3	2.3	33.9	10.5	14.3	7.2	7.7	5.8	5.4	10.8	7.1	7.6	7.5	6.2	8.7	14.0	9.5	11.6	11.5	36.9	5.6	11.4	10.3	10.7	7.8	9.6	7.7	6.9	7.4	11.1	6.7	5.5	10.5	9.5	7.6	27.5	8.2	9.6	7.6	6.5	7.5	6.0	4.2	5.2	8.9	5.4	9.2	7.4	7.2	11.0	3.7	4.3	2.3	2.1	5.6	14.3	6.0	10.3	20.5	10.1	12.6	25.1	15.6	15.6	12.3	12.3	12.3	16.1	9.8	4.3	8.5	13.1	15.5	4.6	8.4	5.2	8.4	22.2	14.8	9.5	6.8	16.9	14.2	7.3	12.6	17.8	11.0	7.4	6.0	11.1	7.2	11.0	12.8	7.2	5.1	5.3	6.0	5.1	10.1	10.4	6.4	9.4	10.4	6.2	13.1	7.3	9.7	19.2	4.1	8.2	11.1	26.2	20.4	10.6	11.1	15.5	13.7	6.3	15.6	4.4	10.9	0.9	2.0	1.0	14.3	2.1	8.2	3.7	8.1	10.2	1.8	3.2	8.5	10.5	2.3	5.6	2.1	4.3	9.7	6.0	11.9	11.3	10.5	14.3	9.5	11.6	10.3	10.7	11.1	5.2
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304161-38305009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 105.8;tongue: 78.5"	"Cell line enhanced"	"Detected in some"		"A-431: 69.7;A549: 107.5;CAPAN-2: 66.4;HBEC3-KT: 64.5;hTCEpi: 67.5;PC-3: 61.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 15.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.1"									"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA054406: , HPA059696: "	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	6.9	0.6	0.5	16.4	0.7	0.3	5.0	0.5	0.8	14.5	58.8	0.6	3.5	34.6	3.9	4.3	88.4	18.2	45.2	9.9	0.8	0.3	5.8	1.0	34.8	0.6	0.7	1.4	4.9	0.8	0.0	2.0	10.0	1.7	10.3	18.2	1.2	21.5	6.8	2.8	53.3	105.8	2.9	3.1	1.9	28.7	1.5	0.5	1.5	4.4	78.5	39.2	16.2	35.1	0.1	15.1	1.4	0.6	0.3	0.4	14.6	69.7	107.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	66.4	0.0	39.9	0.0	26.2	0.0	64.5	0.0	0.0	0.0	0.0	22.6	1.8	0.5	0.0	0.0	0.0	67.5	0.0	43.3	1.1	0.0	0.0	0.0	18.0	0.0	0.1	0.1	61.5	0.0	0.0	0.0	40.8	20.7	0.1	0.0	40.7	29.5	0.0	9.2	0.2	14.6	0.0	20.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.6	1.4	0.3	0.0	0.3	0.1	0.2	0.1	15.1	0.1	0.4	0.3	0.9	0.3	0.0	0.9	0.0	14.6	0.5	0.7	0.5	0.8	0.8	0.3	0.7	1.4	1.7	0.5
C19orf38	HIDE1	ENSG00000214212	"Chromosome 19 open reading frame 38"	A8MVS5	19	10836575-10869790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;bone marrow: 54.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7"	"Group enriched"	"Detected in many"	19	"dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012150, HPA055027"			Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	"Golgi apparatus, Plasma membrane"	"HPA012150: AB_10603448, HPA055027: "	"unprognostic (6.65e-3)"	"prognostic favourable (2.43e-4)"	"unprognostic (6.44e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.56e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (1.75e-7)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.11e-2)"	2.7	1.2	2.1	6.9	4.0	54.4	1.8	0.7	3.1	2.0	1.3	4.8	0.0	1.3	0.9	4.0	0.9	2.6	2.1	5.6	2.4	2.1	1.4	2.3	12.8	19.6	4.2	0.6	1.6	1.3	0.3	1.0	1.9	3.8	1.6	1.0	1.5	1.0	0.8	2.3	0.6	1.7	2.3	6.3	22.3	1.2	15.0	3.7	4.1	0.7	0.5	2.0	2.8	3.5	2.1	26.2	37.3	58.7	1.2	0.8	20.7	1.5	0.0	0.1	0.3	1.4	0.8	0.1	0.2	0.0	0.2	0.6	0.1	0.2	3.7	0.3	0.0	0.1	0.2	0.2	0.2	1.7	0.4	0.2	0.0	0.0	1.1	2.4	0.4	4.0	0.4	0.7	0.2	0.1	0.2	7.9	0.1	1.3	0.1	5.7	0.3	0.2	2.8	0.0	1.9	0.0	0.1	0.2	0.1	0.7	0.0	0.5	0.1	5.5	0.0	0.0	0.0	0.7	0.0	4.8	2.2	1.1	0.0	32.0	0.0	1.2	44.3	26.1	0.1	48.7	0.2	2.1	0.1	0.1	26.2	1.2	0.8	0.2	37.3	1.2	58.7	0.5	0.3	20.7	2.1	4.0	0.7	3.1	2.4	2.1	4.2	0.6	3.8	3.7
C19orf66	"FLJ11286, IRAV, RyDEN"	ENSG00000130813	"Chromosome 19 open reading frame 66"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Antiviral defense"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 24.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042001: AB_10794167"	"prognostic favourable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favourable (1.35e-4)"	9.8	13.8	13.7	17.6	12.1	9.0	9.9	10.6	16.9	14.5	11.2	8.4	10.3	9.6	12.6	14.1	8.9	16.4	15.5	6.9	11.0	13.9	11.5	55.8	11.6	14.4	9.0	13.5	14.5	10.0	14.1	12.8	9.8	10.0	12.4	6.1	11.6	13.0	15.8	3.7	7.6	14.2	9.7	8.6	14.0	8.3	3.7	8.6	9.8	11.9	5.4	13.0	12.9	10.1	8.8	6.7	11.6	12.0	17.5	21.2	10.0	2.7	1.6	1.7	1.2	6.5	8.8	0.7	3.3	18.0	24.5	26.0	0.2	2.4	1.7	1.0	8.5	1.2	0.8	6.0	0.4	11.8	0.0	5.1	1.1	4.1	12.7	1.7	2.9	15.8	4.5	3.8	0.6	7.0	0.7	6.8	4.9	2.2	5.8	3.4	0.4	2.5	5.3	0.0	3.2	3.6	4.3	0.2	1.5	4.7	0.4	13.8	0.2	4.6	5.1	2.1	1.0	2.8	0.4	8.3	2.6	0.4	5.6	1.6	4.1	11.1	8.3	11.6	15.9	7.4	21.2	8.8	13.5	17.1	6.7	6.9	11.5	12.1	10.8	17.5	12.0	1.3	13.9	10.0	13.7	12.1	10.6	16.9	11.0	13.9	9.0	13.5	10.0	8.6
C19orf71	LOC100128569	ENSG00000183397	"Chromosome 19 open reading frame 71"	A6NCJ1	19	3539154-3544030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 88.8"	"Group enriched"	"Detected in many"	4	"HeLa: 26.7;SK-MEL-30: 16.3;WM-115: 58.2"	"Cancer enriched"	"Detected in all"	5	"melanoma: 23.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048654	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Endoplasmic reticulum"	"HPA048654: "	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.74e-2)"	"prognostic favourable (2.35e-4)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.13e-2)"	"prognostic favourable (2.03e-5)"	"unprognostic (6.19e-2)"	"prognostic favourable (2.02e-5)"	"unprognostic (5.52e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-3)"	1.6	2.3	1.6	4.1	2.2	5.1	1.6	9.8	2.2	1.7	1.6	2.0	1.6	4.7	2.5	1.9	1.6	2.6	1.6	1.6	1.6	1.3	3.5	1.6	2.1	4.9	1.8	1.9	2.8	4.2	0.0	4.5	1.6	1.7	2.2	0.0	1.6	7.6	1.6	1.6	7.4	3.9	1.6	1.6	5.2	3.2	88.8	1.8	1.6	6.3	1.6	1.6	1.7	1.6	0.3	0.5	0.0	0.2	0.0	0.7	0.1	5.2	4.3	1.4	1.9	0.0	0.0	2.9	3.3	0.0	0.0	0.0	2.7	1.6	0.9	2.5	0.0	4.7	0.0	0.2	0.0	5.3	2.5	0.7	26.7	0.8	0.0	0.7	3.3	0.0	0.0	0.1	0.0	0.0	3.6	4.8	0.0	3.7	1.1	1.7	1.2	1.3	1.7	2.1	4.9	0.0	2.1	3.4	3.1	5.8	2.9	16.3	3.3	1.7	4.4	2.6	3.5	8.0	3.0	3.8	1.0	1.3	7.9	3.1	58.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.2	0.5	0.0	0.1	1.6	2.2	9.8	2.2	1.6	1.3	1.8	1.9	1.7	1.8
C19orf73	FLJ10490	ENSG00000221916	"Chromosome 19 open reading frame 73"	Q9NVV2	19	49118397-49119140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA062719	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA062719: "	"unprognostic (3.02e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.97e-3)"	"prognostic favourable (1.58e-4)"	"unprognostic (3.05e-1)"	"unprognostic (9.00e-5)"	"unprognostic (1.19e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.13e-3)"	2.5	3.4	5.0	2.3	6.7	1.0	3.7	10.2	8.7	1.4	3.9	4.1	3.1	7.7	1.3	5.6	2.6	1.4	2.1	3.5	4.9	4.5	2.5	4.8	1.5	2.3	9.2	4.9	0.7	12.9	3.3	5.4	1.4	5.0	2.5	2.9	1.8	6.3	2.1	3.6	4.1	4.4	1.3	4.7	3.6	2.9	2.1	5.6	1.1	3.1	1.2	1.7	1.5	1.4	6.2	5.5	0.7	4.1	7.9	4.6	2.3	2.4	3.1	1.2	6.0	2.0	0.4	1.3	0.7	0.4	1.3	0.9	0.2	1.4	1.8	0.7	0.5	1.6	1.6	0.2	0.2	3.5	12.7	1.5	1.9	2.0	2.0	0.0	0.7	0.2	4.1	0.9	3.4	0.4	2.8	2.9	0.6	2.5	1.9	1.8	0.9	0.6	1.8	2.4	2.3	2.3	1.0	6.3	2.9	1.1	1.5	2.3	1.5	0.6	1.2	1.6	2.7	0.5	0.6	1.8	3.4	2.0	1.1	2.1	1.8	0.0	3.3	0.7	2.9	1.9	4.6	2.7	2.2	2.6	5.5	6.2	4.3	3.2	0.1	7.9	4.1	4.2	1.9	2.3	5.0	6.7	10.2	8.7	4.9	4.5	9.2	4.9	5.0	5.6
C1GALT1	"C1GALT, T-synthase"	ENSG00000106392	"Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1"	Q9NS00	7	7156934-7248651	"Enzymes, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"LHCN-M2: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA011294, HPA012819"	Enhanced		Approved	"Nuclear bodies,Cytosol"			10000	"Nuclear bodies, Cytosol"		"HPA011294: AB_1845623, HPA012819: AB_1845624"	"unprognostic (1.52e-1)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (7.38e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (1.42e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-1)"	11.4	7.7	10.1	12.4	14.1	23.1	11.0	10.6	14.9	13.9	10.7	21.5	4.0	19.3	5.4	7.1	24.7	12.7	16.1	11.6	12.8	10.8	21.5	14.7	10.9	11.7	23.7	8.9	6.2	6.2	42.3	11.0	30.2	19.2	5.7	12.2	8.1	17.6	5.7	8.1	8.6	15.8	5.3	31.0	13.8	15.3	5.4	21.4	12.9	10.6	6.2	11.6	10.3	8.4	15.9	13.5	33.2	26.0	16.6	17.4	12.2	18.7	8.1	2.5	4.3	7.4	15.5	8.7	21.5	16.1	10.0	14.9	5.5	19.4	8.7	5.5	8.5	6.0	3.6	8.0	15.8	5.2	3.0	8.2	4.8	15.3	8.1	8.6	3.6	12.7	5.7	24.6	19.0	8.1	17.7	5.5	80.7	3.2	2.3	4.2	15.6	8.7	7.9	14.7	5.3	11.4	8.3	3.0	8.1	13.6	15.3	14.6	4.8	4.5	8.6	16.1	24.9	22.9	8.7	10.5	8.9	9.9	10.6	11.7	17.8	33.2	11.1	31.2	16.1	16.5	16.9	15.9	15.0	17.4	12.2	13.7	15.7	17.0	24.3	16.6	26.0	13.5	13.0	12.2	10.1	14.1	10.6	14.9	12.8	10.8	23.7	8.9	19.2	21.4
C1GALT1C1	"C1GALT2, COSMC"	ENSG00000171155	"C1GALT1 specific chaperone 1"	Q96EU7	X	120625793-120630150	"Disease related genes, Predicted membrane proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 83.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015632	Approved		Approved	Cytosol				Cytosol		"HPA015632: AB_1845625"	"prognostic unfavourable (5.66e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.26e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (3.78e-2)"	16.5	28.0	8.4	11.1	9.2	3.0	21.1	9.0	9.9	19.2	16.7	10.8	16.5	12.7	13.0	23.1	15.0	15.1	11.6	17.7	9.0	10.9	25.9	35.2	12.4	12.9	11.0	7.5	13.2	18.8	18.7	83.5	13.3	11.5	14.1	19.4	10.9	19.4	15.5	7.4	5.8	20.6	12.4	12.0	16.5	14.6	9.6	10.6	16.3	19.8	12.3	12.4	13.9	12.3	17.2	23.0	31.3	22.3	15.1	23.8	16.2	8.5	8.3	4.6	7.9	72.7	13.9	7.3	15.6	22.1	8.3	15.7	5.4	27.5	5.5	7.8	31.4	12.0	9.0	7.6	13.2	9.4	10.9	3.5	7.7	7.9	11.3	6.2	5.6	12.0	6.8	10.3	3.4	26.0	2.2	6.5	9.7	11.6	2.1	5.9	5.1	8.3	0.9	3.6	15.2	16.7	5.7	5.1	4.8	14.8	10.2	7.7	8.8	6.1	23.8	3.8	4.7	15.2	14.6	2.8	4.2	4.4	13.9	12.3	8.3	13.3	17.7	27.0	17.6	22.3	19.4	17.2	22.9	19.0	20.1	10.6	23.8	18.9	31.3	15.1	17.5	23.0	21.0	16.2	8.4	9.2	9.0	9.9	9.0	10.9	11.0	7.5	11.5	10.6
C1orf100		ENSG00000173728	"Chromosome 1 open reading frame 100"	Q5SVJ3	1	244352635-244389663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 65.3"	"Cell line enriched"	"Detected in single"	51	"K-562: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA031179, HPA031180"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA031179: AB_10599995, HPA031180: AB_10599026"	"unprognostic (9.84e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.37e-2)"	"unprognostic (9.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-5)"	"unprognostic (1.85e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavourable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	13.8	15.1	12.0	9.3	15.0	9.3	14.5	17.9	20.5	12.9	11.1	11.4	16.2	11.0	15.9	14.3	13.7	13.9	10.5	11.1	13.1	12.9	12.8	12.0	8.8	14.1	13.6	15.0	19.7	19.6	20.5	10.9	14.6	15.9	15.0	7.8	12.9	20.3	14.8	15.2	14.9	8.5	11.6	9.9	10.1	11.1	11.2	12.2	13.1	15.7	9.1	12.6	13.7	12.8	11.4	27.5	3.3	5.0	12.2	16.2	7.5	8.2	9.5	8.2	13.4	7.2	5.2	18.7	9.9	7.1	15.0	11.1	14.4	10.0	11.7	12.0	4.3	12.0	15.1	10.1	15.4	18.7	17.0	13.4	9.6	9.0	13.9	14.5	8.8	7.0	12.5	14.8	19.3	7.5	26.2	14.3	8.5	5.7	14.1	6.4	25.6	18.3	14.0	17.2	32.2	7.9	7.1	24.8	11.9	8.7	13.5	20.1	7.6	6.6	5.0	15.1	9.5	12.1	20.1	11.7	13.0	24.0	7.5	14.3	15.8	1.7	5.0	3.3	10.3	3.9	16.1	11.4	12.4	9.9	5.9	10.3	16.2	13.8	0.9	12.2	4.2	27.5	6.2	7.5	12.0	15.0	17.9	20.5	13.1	12.9	13.6	15.0	15.9	12.2
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018521-207032756	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1"	"Cell line enhanced"	"Detected in some"		"A-431: 17.8;CAPAN-2: 31.8;HaCaT: 39.2;HBEC3-KT: 37.7;hTCEpi: 20.0;RPTEC TERT1: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			7900	"Plasma membrane, Cytosol"		"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favourable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.3	0.2	1.6	0.2	0.0	4.1	0.2	0.4	7.1	8.3	0.3	0.2	8.4	1.0	1.1	49.4	0.6	14.0	0.2	0.3	0.1	4.3	1.1	42.8	0.2	0.2	0.2	0.5	7.0	0.0	0.9	1.4	0.4	18.8	2.7	0.3	12.5	1.9	0.3	14.4	16.5	0.6	0.2	0.4	20.3	0.4	0.2	0.4	6.8	16.0	37.1	6.1	12.3	0.0	0.0	0.7	0.0	0.1	0.0	1.8	17.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	31.8	0.0	2.1	0.0	39.2	0.0	37.7	0.0	0.0	0.0	3.3	0.3	0.5	0.0	0.0	0.2	0.0	20.0	0.0	11.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	18.4	4.7	0.0	0.1	0.3	3.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.8	0.2	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.4	0.2
C1orf123	FLJ20580	ENSG00000162384	"Chromosome 1 open reading frame 123"	Q9NWV4	1	53214099-53220617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043835	Uncertain		Approved	"Vesicles,Mitotic spindle,Cytosol"			380000	Cytosol	"Vesicles, Mitotic spindle"	"HPA043835: AB_10796797"	"unprognostic (1.09e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.27e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (6.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-1)"	32.6	21.4	27.8	19.1	29.4	12.9	26.3	16.4	25.4	29.2	33.2	25.0	22.7	15.4	34.0	28.9	25.7	32.2	22.7	28.8	24.3	22.3	26.9	29.3	20.3	18.3	24.7	26.3	33.5	17.5	21.0	20.1	22.5	23.7	31.7	24.7	24.0	16.6	33.5	44.4	14.3	16.9	48.4	22.5	18.4	23.4	26.0	23.8	18.9	26.0	18.0	19.4	28.9	26.0	25.5	38.4	31.5	39.1	30.5	36.5	26.4	11.6	12.7	16.8	15.3	39.0	50.0	14.9	17.5	18.7	17.8	19.3	10.8	10.1	18.1	14.7	21.2	4.6	10.3	17.2	21.6	23.3	17.6	18.4	9.8	16.2	38.4	21.1	12.2	32.4	18.8	19.0	20.2	29.0	19.0	5.1	22.2	19.6	25.9	19.9	27.9	20.2	19.0	21.3	14.2	20.6	11.9	14.2	13.7	16.6	15.2	16.5	10.8	21.7	18.1	20.7	12.2	14.3	17.0	7.4	10.7	20.4	16.6	21.2	15.9	28.3	32.1	31.5	30.4	39.1	27.7	25.5	30.2	31.7	38.4	23.6	33.7	33.4	13.0	30.5	31.8	25.9	36.5	26.4	27.8	29.4	16.4	25.4	24.3	22.3	24.7	26.3	23.7	23.8
C1orf158	MGC35194	ENSG00000157330	"Chromosome 1 open reading frame 158"	Q8N1D5	1	12746215-12763699	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 23.5;testis: 74.6"	"Low cell line specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.5"	HPA028396			Uncertain	Cytosol				Cytosol		"HPA028396: AB_10603451"	"unprognostic (1.11e-2)"			"unprognostic (4.94e-3)"	"unprognostic (4.62e-1)"			"unprognostic (8.00e-2)"		"unprognostic (4.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.45e-1)"		"unprognostic (3.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"		0.0	0.0	0.7	0.0	2.4	0.3	0.0	0.0	0.2	0.9	0.0	6.2	0.0	0.0	0.4	4.2	0.1	23.5	0.1	0.0	1.0	1.4	0.0	0.0	2.8	0.1	0.2	0.1	4.8	0.1	0.0	0.4	0.1	9.3	0.0	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.2	0.1	0.1	74.6	0.9	0.0	0.5	0.0	0.1	0.0	0.0	0.9	0.6	2.3	0.6	1.1	0.8	0.1	0.5	1.3	1.1	0.7	0.6	0.0	1.0	0.1	0.3	0.2	0.2	1.3	0.7	1.1	0.3	0.3	0.4	0.1	0.1	0.2	0.2	0.7	1.1	1.9	0.5	0.0	0.9	1.0	0.1	0.7	0.2	0.1	0.0	0.9	1.4	0.3	0.5	0.2	0.7	1.5	0.5	0.6	0.3	0.9	0.1	0.5	1.8	0.8	0.5	0.6	0.3	0.7	0.2	0.5	0.5	0.8	0.4	0.8	0.6	0.5	1.2	1.0	1.1	0.5	1.6	0.6	0.5	0.7	0.5	0.6	0.5	0.5	0.5	0.1	0.9	0.8	0.7	2.3	1.1	0.6	0.6	0.4	0.1	0.7	2.4	0.0	0.2	1.0	1.4	0.2	0.1	9.3	0.9
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 36.5;fallopian tube: 60.2;testis: 77.6"	"Cell line enhanced"	"Detected in some"		"AF22: 4.4;RPTEC TERT1: 1.0;SCLC-21H: 6.1;U-87 MG: 1.7"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 36.5"	"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA031144: AB_10602109, HPA049684: "	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.3	0.4	1.5	0.3	6.8	0.3	0.4	0.3	2.6	1.8	0.3	12.3	0.0	0.4	1.0	11.1	0.4	60.2	0.3	0.3	3.0	1.6	0.3	0.3	7.5	0.4	0.5	1.8	10.3	0.7	0.4	2.7	0.3	36.5	0.4	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.7	0.3	0.5	77.6	2.3	0.0	0.5	0.0	0.3	0.5	0.2	0.2	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.1	0.3	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	6.8	0.3	2.6	3.0	1.6	0.5	1.8	36.5	2.3
C1orf198	"DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710"	ENSG00000119280	"Chromosome 1 open reading frame 198"	Q9H425	1	230837119-230869589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004798	Approved		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA004798: AB_1848722"	"unprognostic (7.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (4.50e-5)"	"unprognostic (3.53e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.77e-2)"	22.6	8.8	25.7	6.6	30.4	2.9	18.6	5.2	31.9	23.4	12.9	66.2	3.5	7.4	17.4	10.2	10.2	13.8	20.4	26.9	27.5	19.4	8.2	6.7	41.9	8.3	44.9	16.2	18.2	17.2	17.1	3.4	19.3	37.4	11.8	7.7	9.1	12.0	21.5	39.0	17.3	7.8	29.2	57.4	10.6	13.0	4.4	36.7	1.5	14.8	6.8	5.7	12.9	10.9	2.8	2.3	10.6	3.6	4.2	3.9	6.6	6.8	5.3	14.6	9.8	27.8	20.4	24.9	12.8	20.6	6.7	6.7	16.9	3.9	8.3	8.1	44.2	4.5	7.6	2.8	5.0	27.2	7.2	1.3	5.0	5.6	11.9	4.2	1.3	24.5	4.4	2.6	2.9	4.2	2.6	2.8	4.6	4.7	3.3	2.0	16.9	4.4	7.9	10.3	1.8	5.3	8.3	8.4	13.4	6.5	8.7	4.5	11.0	3.7	3.2	10.9	11.0	2.4	7.5	5.2	2.3	2.5	2.8	2.7	30.4	10.6	1.7	0.5	2.8	3.6	3.5	2.8	1.9	1.1	2.3	1.9	3.9	3.2	1.4	4.2	1.7	0.3	0.8	6.6	25.7	30.4	5.2	26.8	27.5	19.4	44.9	16.2	37.4	36.7
C1orf21	PIG13	ENSG00000116667	"Chromosome 1 open reading frame 21"	Q9H246	1	184387058-184629020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.9;Karpas-707: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 11.4;memory CD8 T-cell: 5.9;naive CD8 T-cell: 5.9;NK-cell: 7.5"	"Group enriched"	"Detected in many"	12	"NK-cells: 7.5;T-cells: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026831	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA026831: AB_1845636"	"unprognostic (8.27e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (3.35e-8)"	"unprognostic (1.81e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.60e-2)"	12.0	15.9	16.8	7.5	9.5	2.1	25.2	17.5	18.8	20.2	18.5	4.4	16.7	8.7	17.3	14.2	14.1	10.1	9.2	20.0	12.5	8.8	4.1	7.5	12.2	3.5	8.3	13.3	13.9	4.7	12.6	7.6	5.7	11.8	17.8	13.1	10.7	5.1	18.9	51.7	30.1	15.8	25.2	7.6	8.2	10.7	4.1	5.4	1.5	4.4	13.6	3.9	22.0	23.5	0.0	0.7	0.2	0.1	7.5	11.4	2.1	0.6	0.1	3.6	0.3	11.2	9.2	6.0	3.1	3.1	2.0	1.8	0.0	0.3	0.0	0.0	3.5	2.0	2.3	2.6	1.9	22.9	3.6	0.1	1.0	0.0	4.4	1.9	1.0	11.1	7.6	2.3	2.0	2.3	0.0	17.4	3.0	2.4	2.3	0.5	5.3	0.6	3.0	3.7	3.4	0.0	1.2	2.0	5.3	1.6	1.4	6.5	0.2	0.2	2.3	4.0	2.1	6.1	3.8	10.8	5.0	0.0	4.0	3.3	4.6	0.0	0.1	0.0	11.4	0.0	1.1	0.0	1.9	5.9	0.7	0.0	0.6	5.9	0.2	7.5	0.0	0.2	0.0	2.1	16.8	9.5	17.5	15.9	12.5	8.8	8.3	13.3	11.8	5.4
C1orf216	FLJ38984	ENSG00000142686	"Chromosome 1 open reading frame 216"	Q8TAB5	1	35713875-35719472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028299, HPA031343"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028299: AB_10601122, HPA031343: "	"unprognostic (1.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (2.15e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (7.68e-10)"	"unprognostic (3.31e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.93e-2)"	4.3	4.4	12.5	2.1	10.5	1.1	2.4	5.0	22.1	4.7	3.5			1.0	4.1	5.0	2.1	2.5	3.0	4.0	12.1	9.7	0.7	1.8	3.1	2.4	7.0		3.5	1.2	2.0	1.8	1.6		3.1	2.0		1.1	4.4	5.1	2.9	1.2	7.0	5.2	2.2	1.2	3.4			1.4		2.5	2.4	1.4	2.5	3.2	0.1	3.7	0.8	7.3	3.0	3.3	7.9	4.4	5.7	19.9	14.6	2.9	9.7	11.4	14.4	13.8	4.7	7.2	4.3	7.0	14.2	3.2	10.8	6.4	12.4	13.9	5.1	25.5	11.6	1.3	7.6	12.6	16.8	15.0	8.1	10.3	3.3	9.4	10.1	11.5	15.4	5.5	5.1	10.8	6.3	6.7	3.4	5.8	3.5	4.9	4.0	5.9	5.8	9.2	1.9	18.9	3.6	5.7	11.1	11.7	9.3	8.7	10.1	3.5	8.7	3.2	11.7	12.2	18.2	0.0	3.2	0.1	5.9	3.7	1.9	2.5	4.7	7.3	3.2	1.4	1.1	4.4	0.1	0.8	2.7	0.7	1.6	3.0										
C1orf228	"MGC33556, NCRNA00082, p40"	ENSG00000198520	"Chromosome 1 open reading frame 228"	Q6PIY5	1	44674692-44725591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.0;testis: 17.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.4;MOLT-4: 6.9;NB-4: 9.8;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034769	Uncertain		Uncertain	Cytosol				Cytosol		"HPA034769: AB_10670979"	"unprognostic (2.01e-5)"	"unprognostic (4.28e-3)"	"unprognostic (7.27e-2)"	"prognostic favourable (8.64e-4)"	"unprognostic (9.23e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.22e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-10)"	"unprognostic (1.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-3)"	0.9	2.2	6.3	0.7	11.2	4.3	1.5	3.2	6.8	1.7	1.0	5.6	3.9	0.7	3.1	6.8	1.3	14.0	1.5	0.6	6.5	2.4	1.4	7.0	2.0	1.5	1.4	7.5	4.5	1.4	3.0	5.4	0.8	7.7	1.8	0.9	3.3	1.6	1.4	0.5	1.7	0.8	0.9	2.4	0.8	1.4	17.9	5.4	0.2	1.3	0.0	1.0	0.8	0.8	1.4	6.2	10.4	2.7	0.5	2.3	1.8	0.2	0.3	2.0	0.1	0.7	2.5	0.5	0.0	0.3	0.5	0.3	0.4	4.2	0.3	0.3	0.9	0.5	0.0	0.0	0.0	1.1	0.2	1.0	2.5	0.6	0.2	8.4	5.0	2.0	0.3	0.8	0.0	0.2	0.1	0.7	0.2	0.1	6.9	9.8	0.1	0.1	3.6	0.1	2.4	0.8	0.0	1.4	0.9	0.0	1.4	1.1	0.4	4.4	0.0	0.3	0.3	0.3	0.0	0.3	0.3	0.2	0.3	13.4	0.4	10.4	2.7	7.5	0.3	0.8	0.1	0.7	1.5	1.0	1.3	1.4	2.2	2.3	1.2	0.5	0.1	6.2	0.1	1.8	6.3	11.2	3.2	6.8	6.5	2.4	1.4	7.5	7.7	5.4
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	10.1	12.7	14.3	15.6	17.0	12.7	12.0	23.9	15.7	12.5	11.2	11.6	16.1	12.5	13.7	10.6	17.3	14.9	8.1	8.0	13.8	10.0	10.6	10.2	11.0	12.5	17.7	13.6	19.0	21.0	12.5	10.0	12.4	15.0	13.2	6.4	10.4	19.1	16.1	14.0	24.1	11.3	13.3	9.2	12.6	13.2	8.8	13.2	14.6	12.4	6.9	12.0	12.8	13.9	20.2	26.7	21.9	18.4	17.6	21.5	10.3	9.5	10.7	6.8	4.1	3.7	3.8	16.0	7.4	3.4	6.6	4.8	9.6	9.1	9.3	16.0	2.5	10.7	6.4	7.1	2.4	10.6	34.1	5.8	7.4	9.4	6.2	12.9	7.3	3.3	8.5	6.3	6.1	7.2	14.7	5.2	4.9	11.3	17.2	16.5	13.4	24.8	12.2	10.8	15.4	5.7	7.2	12.0	11.3	6.9	11.1	9.5	13.2	12.1	6.3	5.2	7.7	13.7	15.6	9.6	4.9	8.7	6.3	7.6	8.1	6.3	16.3	21.9	16.2	18.4	20.9	20.2	18.1	17.7	20.4	16.7	21.5	18.1	2.2	17.6	17.5	26.7	18.0	10.3	14.3	17.0	23.9	15.7	13.8	10.0	17.7	13.6	15.0	13.2
C1orf74	"FLJ25078, URLC4"	ENSG00000162757	"Chromosome 1 open reading frame 74"	Q96LT6	1	209779208-209784559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028496	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028496: AB_10602698"	"unprognostic (3.25e-1)"	"prognostic unfavourable (8.52e-6)"	"unprognostic (8.41e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.40e-2)"	2.5	3.9	5.7	5.5	8.5	2.3	5.8	10.4	8.9	2.7	3.8	5.8	4.0	3.3	2.3	5.2	10.4	2.8	2.3	4.1	3.7	2.9	4.9	4.1	2.2	9.8	5.1	4.6	2.5	4.5	4.5	6.5	3.4	4.8	4.6	5.2	3.9	5.1	2.7	2.3	15.0	4.1	2.4	4.9	4.9	3.9	3.9	5.0	4.9	3.2	0.0	5.7	3.9	4.7	6.3	5.5	5.9	1.9	2.8	2.9	1.9	5.6	3.0	1.9	1.1	2.6	2.9	4.4	3.2	4.2	3.9	4.1	5.9	4.4	5.9	1.9	2.1	11.4	1.2	9.3	4.6	5.9	3.8	3.9	2.2	0.5	3.6	5.5	1.8	1.7	8.3	4.8	8.0	2.3	7.7	4.3	3.4	2.8	4.6	5.7	7.9	5.1	4.9	9.0	8.3	3.3	4.9	7.6	8.2	4.4	3.4	4.8	5.3	2.9	2.1	3.4	3.9	3.4	5.1	4.0	4.0	6.6	3.0	4.6	4.7	5.9	1.6	1.4	2.9	1.9	2.1	3.8	1.4	2.3	3.2	6.3	2.4	2.8	1.1	2.8	1.0	5.5	1.2	1.9	5.7	8.5	10.4	8.9	3.7	2.9	5.1	4.6	4.8	5.0
C1orf94	MGC15882	ENSG00000142698	"Chromosome 1 open reading frame 94"	Q6P1W5	1	34166883-34219131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 24.6"	"Group enriched"	"Detected in some"	7	"NTERA-2: 11.2;U-87 MG: 32.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA045805			Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA045805: AB_10969626"					"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"				"unprognostic (9.77e-2)"	"unprognostic (4.09e-2)"			"unprognostic (1.65e-2)"	"unprognostic (2.31e-1)"			0.0	0.1	0.6	0.0	0.8	0.0	0.0	1.2	1.8	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	24.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.2	1.8	0.5	0.7	0.5	0.0	3.2	0.0
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 82.7;BJ hTERT+: 19.4;HHSteC: 31.3;HSkMC: 16.6;U-87 MG: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	313900000	30000	Nucleoplasm	Cytosol	"CAB025429: , HPA051101: "	"unprognostic (2.58e-1)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.81e-3)"	"unprognostic (5.83e-2)"	"prognostic unfavourable (9.09e-9)"	"unprognostic (1.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.95e-2)"	62.4	18.3	1.7	7.4	4.3	0.4	60.5	1.3	5.1	14.3	10.3	5.2	30.8	2.5	11.0	14.2	10.2	14.4	19.1	77.5	2.0	4.1	9.5	19.4	9.7	16.6	4.8	2.5	25.2	7.5	10.1	4.2	34.0	7.6	13.3	3.3	19.6	13.8	51.8	11.9	8.6	6.1	6.9	2.5	14.3	6.1	8.8	2.8	1.3	26.9	13.3	5.0	14.8	27.5	0.5	0.3	1.9	0.3	1.2	0.4	0.0	0.0	8.0	0.0	0.0	82.7	7.4	0.0	4.1	19.4	1.7	3.4	0.6	3.9	0.0	0.4	1.2	0.2	0.2	0.1	1.3	0.0	0.9	0.0	3.0	0.3	31.3	0.0	0.0	16.6	0.0	3.7	0.2	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.8	8.4	0.0	5.4	0.0	0.0	0.1	0.3	1.5	2.6	0.4	7.7	0.0	0.0	0.3	8.8	0.2	0.9	1.2	0.0	0.0	0.0	19.5	0.0	0.7	1.9	0.3	0.5	0.3	0.2	0.2	0.2	0.4	0.2	0.1	0.5	0.2	0.4	0.4	1.2	0.2	0.3	0.0	0.0	1.7	4.3	1.3	4.2	2.0	4.1	4.8	2.5	7.6	2.8
C1R		ENSG00000159403	"Complement C1r"	P00736	12	7080209-7092607	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 370.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 177.7;ASC TERT1: 90.7;BJ hTERT+: 78.2;BJ hTERT+ SV40 Large T+ RasG12V: 48.2;HSkMC: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4"					"Low region specificity"	"Detected in all"			"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted to blood"		14000000000	"Nucleoplasm, Cytosol"		"HPA001251: , HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	45.8	17.4	2.6	18.1	3.8	0.0	82.0	1.4	2.8	36.7	24.5	2.4	11.2	5.0	27.2	66.8	38.1	33.3	46.7	49.5	1.9	1.8	27.5	370.2	25.3	46.8	3.5	2.0	103.5	11.4	1.4	6.3	10.3	4.6	47.8	15.3	17.7	12.8	13.2	16.0	10.7	14.4	53.2	6.2	35.1	19.8	39.3	1.9	2.3	30.6	20.7	15.1	46.8	83.8	0.4	0.0	2.5	0.4	3.2	3.4	0.8	0.1	1.5	0.1	1.3	177.7	90.7	0.1	19.9	78.2	23.7	48.2	0.2	0.3	0.0	0.6	15.6	0.2	1.7	0.8	3.3	1.8	0.1	0.0	0.6	0.6	34.2	0.1	0.2	105.0	0.5	10.8	0.8	0.4	0.0	2.5	3.1	0.0	0.8	0.1	0.8	0.1	1.1	0.5	0.1	0.1	0.9	0.0	0.3	14.4	0.4	0.4	0.0	0.0	0.0	5.6	0.9	26.1	0.1	0.1	0.4	0.0	8.1	0.1	0.8	0.0	0.4	2.0	1.6	0.1	2.0	0.0	1.4	3.4	0.0	0.4	2.8	2.9	2.5	3.2	0.0	0.0	1.4	0.8	2.6	3.8	1.4	2.8	1.9	1.8	3.5	2.0	4.6	1.9
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109273	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.6;HSkMC: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA011338, CAB026172"	Supported		Approved	Microtubules,Cytosol	"Secreted to blood"	5500000000	20000000000	Microtubules	Cytosol	"CAB026172: , HPA011338: AB_1847111"	"prognostic favourable (7.92e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.34e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (1.52e-7)"	"unprognostic (1.75e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.26e-3)"	16.5	31.2	3.8	10.0	5.5	6.1	14.2	1.2	4.9	12.1	13.5	3.2	10.5	6.0	12.4	14.9	13.3	14.5	14.7	10.0	2.5	1.6	21.4	96.1	14.2	13.1	4.5	2.7	21.3	23.8	5.2	15.7	4.2	6.4	16.5	7.2	11.3	16.9	11.5	11.1	7.8	9.5	15.4	9.3	12.7	11.1	7.2	4.7	2.8	14.4	8.1	7.0	15.5	16.4	2.2	1.7	11.7	2.5	0.6	1.4	0.9	2.2	5.9	0.6	5.9	18.4	31.6	4.2	3.7	17.2	3.6	11.3	3.8	10.3	0.9	3.2	2.9	5.0	1.6	6.4	1.5	9.3	0.3	3.5	5.9	8.8	14.9	0.7	17.2	35.0	12.0	2.3	7.4	3.9	2.8	2.2	2.3	0.1	0.5	0.7	1.1	0.1	2.0	0.0	0.7	10.5	10.0	0.4	1.3	12.6	1.5	2.2	1.5	3.1	3.3	3.4	6.3	3.9	0.6	1.7	0.7	0.1	6.4	2.5	1.5	7.2	1.5	8.0	1.4	2.3	0.6	2.2	1.4	1.0	1.7	1.1	0.9	0.8	11.7	0.6	2.5	0.9	0.8	0.9	3.8	5.5	1.2	4.9	2.5	1.6	4.5	2.7	6.4	4.7
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 351.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 97.0;ASC TERT1: 129.2;BJ hTERT+: 41.1;HSkMC: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 6.2"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 6.2"					"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	93000000000	13000000000	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favourable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	48.7	16.6	3.3	18.7	4.1	0.0	55.7	1.9	3.1	35.3	31.1	2.9	12.7	6.8	32.2	50.0	38.3	46.4	47.2	34.4	2.5	1.1	18.0	351.6	31.4	21.1	6.3	3.2	98.8	15.5	1.9	6.0	8.5	6.5	52.1	18.6	26.1	14.6	12.4	18.2	14.7	19.2	47.6	8.8	32.5	24.6	37.2	2.3	3.2	30.5	22.7	18.8	48.6	73.0	0.2	0.1	6.2	0.3	0.2	0.1	0.0	0.0	2.2	0.1	1.2	97.0	129.2	0.4	17.5	41.1	9.3	17.0	0.0	0.2	0.0	2.4	21.7	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.6	4.6	29.2	0.2	0.1	68.6	0.3	7.5	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	10.6	0.2	0.2	0.0	0.0	0.0	4.3	0.3	16.5	0.0	0.0	0.0	0.1	9.3	0.1	0.2	0.6	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	6.2	0.2	0.1	0.1	0.0	0.0	3.3	4.1	1.9	3.1	2.5	1.1	6.3	3.2	6.5	2.3
C20orf194	DKFZp434N061	ENSG00000088854	"Chromosome 20 open reading frame 194"	Q5TEA3	20	3249305-3407625	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052103, HPA067418"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"		"HPA052103: , HPA067418: "	"unprognostic (9.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-1)"	"prognostic favourable (1.68e-4)"	"unprognostic (2.97e-1)"	"prognostic favourable (7.68e-4)"	"unprognostic (9.58e-3)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.52e-2)"	15.2	13.4	18.5	6.9	20.1	4.6	11.9	20.3	21.9	12.6	11.8	25.3	7.3	5.8	12.5	9.7	11.7	12.8	11.3	19.4	16.3	17.2	14.2	3.7	13.3	5.7	16.5	20.3	17.2	7.5	8.5	10.4	12.2	17.4	12.2	6.4	10.9	6.0	16.5	36.8	7.5	6.0	17.2	23.0	9.5	9.1	13.5	16.9	4.6	13.2	4.0	4.3	12.2	11.0	1.6	3.5	1.0	3.0	0.0	1.7	0.7	2.8	2.6	7.3	3.5	15.2	16.9	0.8	6.8	7.7	4.6	5.8	0.0	3.2	0.0	1.9	9.0	3.4	2.7	6.7	6.3	0.6	1.4	0.8	1.0	7.2	7.1	0.9	0.4	13.7	5.3	6.0	5.2	9.1	1.4	0.0	6.6	1.3	1.8	4.7	2.2	1.7	2.1	6.6	0.0	5.9	5.9	1.5	4.3	3.0	5.4	8.8	5.1	8.3	10.1	5.7	2.5	3.5	3.3	0.0	0.0	0.0	1.8	0.8	4.3	1.0	3.0	0.0	1.7	1.5	1.0	1.0	1.3	1.7	3.1	1.6	0.5	1.3	0.0	0.0	1.4	3.5	1.4	0.7	18.5	20.1	20.3	21.9	16.3	17.2	16.5	20.3	17.4	16.9
C20orf24	"PNAS-11, RIP5"	ENSG00000101084	"Chromosome 20 open reading frame 24"	Q9BUV8	20	36605734-36612557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA057387	Uncertain		Approved	Cytosol				Cytosol		"HPA057387: "	"unprognostic (2.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.56e-6)"	"unprognostic (4.47e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.37e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.98e-2)"	17.0	19.7	15.1	18.5	16.3	25.1	29.1	11.9	21.1	15.8	31.1	10.9	15.2	21.9	11.8	18.1	55.5	10.8	25.1	24.2	14.3	14.0	35.6	71.1	21.4	24.4	15.0	11.7	9.5	27.6	15.4	8.5	19.3	12.6	13.3	26.5	9.8	21.5	17.9	70.0	13.6	26.1	14.6	12.7	26.2	20.0	19.0	11.3	20.4	21.6	42.3	28.3	14.3	20.4	10.0	15.8	41.3	24.2	6.1	11.9	7.7	35.7	26.9	8.9	11.8	21.3	12.3	23.9	22.4	12.3	21.4	19.5	73.6	45.1	15.6	55.6	19.2	26.6	19.1	35.0	20.5	11.7	19.8	37.0	38.2	80.5	25.0	38.9	18.2	15.3	37.1	31.0	17.6	19.6	25.2	36.6	20.2	24.2	22.7	50.2	16.3	57.5	18.2	22.9	38.9	18.5	26.7	16.5	12.5	32.3	83.9	28.1	17.7	32.0	22.1	32.1	22.1	33.1	33.9	23.4	37.8	26.2	34.6	45.4	17.0	7.2	24.2	29.9	6.2	12.4	6.2	10.0	7.4	9.6	15.8	8.1	9.0	6.7	41.3	6.1	14.7	10.8	11.9	7.7	15.1	16.3	11.9	21.1	14.3	14.0	15.0	11.7	12.6	11.3
C20orf27	FLJ20550	ENSG00000101220	"Chromosome 20 open reading frame 27"	Q9GZN8	20	3753508-3768387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 64.7"	"Group enriched"	"Detected in many"	5	"classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 38.5;monocytes: 46.6"	"Low region specificity"	"Detected in all"							HPA047483	Approved		Approved	Nucleoplasm,Cytosol			87000	"Nucleoplasm, Cytosol"		"HPA047483: "	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (1.69e-5)"	"unprognostic (8.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (6.18e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	23.1	9.7	10.2	11.8	64.7	51.9	17.2	4.9	15.8	12.0	22.6	7.7	3.7	10.3	16.9	10.9	14.4	18.7	26.6	7.3	9.2	14.4	5.0	5.4	8.4	13.5	14.5	6.1	20.9	8.5	3.9	5.3	6.7	13.7	18.3	4.9	5.0	9.0	7.1	11.2	9.6	9.4	22.3	5.7	13.4	21.2	6.0	13.2	6.0	5.4	7.9	6.1	27.4	10.3	7.8	38.5	1.1	46.6	5.8	8.5	13.8	34.0	36.1	5.7	24.0	11.7	6.5	8.9	8.8	5.8	16.3	12.0	24.7	13.0	21.4	8.6	10.3	29.4	15.1	22.1	6.2	4.9	27.1	12.1	7.3	44.0	8.4	17.3	5.3	9.1	9.3	20.8	10.4	11.0	21.4	13.5	8.4	48.2	22.9	41.3	24.4	48.9	17.7	13.9	25.3	10.2	12.4	25.4	11.6	8.0	35.8	17.6	7.9	21.8	6.7	22.9	15.8	36.2	26.9	10.4	17.3	15.9	6.8	32.9	11.1	0.2	28.1	0.4	5.9	46.6	8.5	7.8	7.0	7.8	38.5	7.3	8.0	7.8	1.1	5.8	42.2	7.3	6.4	13.8	10.2	64.7	4.9	15.8	9.2	14.4	14.5	6.1	13.7	13.2
C21orf2	"A2, LRRC76, YF5"	ENSG00000160226	"Chromosome 21 open reading frame 2"	O43822	21	44328944-44339402	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, DNA damage"		"Ciliopathy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030283, HPA030284, CAB034126, CAB034128"	Supported		Supported	Vesicles,Mitochondria,Cytosol				Mitochondria	"Vesicles, Cytosol"	"CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700"	"unprognostic (1.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (1.49e-1)"	"prognostic favourable (4.08e-4)"	"unprognostic (2.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.06e-1)"	18.8	13.4	19.8	11.3	21.6	19.7	9.2	10.3	23.4	13.8	14.7	18.2	14.3	13.4	12.6	19.1	6.9	14.7	13.2	11.3	19.5	16.6	18.0	11.6	12.8	12.4	16.4	19.1	15.2	14.5	7.4	17.6	12.4	13.2	12.3	3.9	14.3	16.1	17.2	21.0	22.3	15.4	5.8	12.6	16.1	21.1	16.7	11.2	10.9	16.4	8.1	13.0	8.1	7.0	10.8	21.7	1.2	8.5	12.1	9.7	4.9	7.8	3.3	3.2	4.1	2.1	1.4	12.6	4.1	2.4	1.6	0.9	6.0	2.4	5.7	8.2	1.4	3.8	0.6	0.7	0.4	8.6	8.2	5.9	2.6	7.0	2.8	6.3	6.4	1.9	1.4	0.7	1.4	1.0	7.2	9.8	1.0	9.8	6.9	15.6	8.0	5.1	17.8	4.1	12.7	1.9	11.6	8.4	7.8	5.7	1.3	6.8	6.1	14.0	4.6	3.6	4.6	3.8	3.0	16.1	8.4	3.9	8.8	12.8	6.4	1.2	7.1	1.0	7.1	8.5	8.5	10.8	7.3	9.7	7.3	8.6	8.5	8.2	0.9	12.1	6.2	21.7	4.0	4.9	19.8	21.6	10.3	22.4	19.5	16.6	16.4	19.1	13.2	11.2
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.1"	"Cell line enhanced"	"Detected in all"		"HMC-1: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011044	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"				"Nucleoplasm, Nucleoli"	"Nuclear membrane, Cytosol"	"HPA011044: "	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favourable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	5.2	7.0	15.9	7.3	33.1	14.7	4.8	18.2	31.2	5.8	10.3	7.5	8.3	18.7	4.1	6.1	9.4	10.9	6.3	7.9	15.8	13.6	6.3	7.3	8.3	8.5	9.1	12.6	3.9	7.5	7.8	14.2	4.8	11.7	4.8	8.8	5.6	8.7	7.0	8.3	12.5	19.4	6.1	7.3	9.2	5.5	2.6	9.1	7.0	5.5	6.7	6.6	6.6	5.3	0.4	1.1	5.7	4.2	1.7	1.6	1.1	3.3	2.5	3.5	7.1	4.5	1.9	2.2	5.1	4.5	5.1	4.3	4.0	3.5	5.1	13.4	3.5	7.6	4.3	2.2	2.0	8.0	3.6	20.0	3.2	2.9	6.0	5.7	29.2	2.2	4.5	9.5	3.5	3.2	8.3	9.1	4.7	8.9	6.4	13.8	1.3	6.8	4.1	3.1	5.8	5.0	2.1	10.7	6.1	2.1	11.5	3.2	20.2	7.7	3.8	4.7	1.6	5.6	8.9	4.0	2.4	2.0	2.9	9.9	5.2	1.1	3.0	5.7	0.6	3.2	1.0	0.4	1.4	1.4	1.1	0.1	1.6	0.8	1.0	1.7	4.2	0.7	1.6	1.1	15.9	33.1	18.2	31.2	15.8	13.6	9.1	12.6	11.7	9.1
C2CD5	"CDP138, KIAA0528"	ENSG00000111731	"C2 calcium dependent domain containing 5"	Q86YS7	12	22448583-22544546	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046194	Approved		Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA046194: AB_10965327"	"unprognostic (2.59e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-3)"	10.2	11.2	18.9	16.3	26.6	11.8	13.6	48.5	30.7	13.1	18.5	10.0	10.0	17.8	15.6	12.3	10.4	15.8	15.4	8.8	14.6	16.5	15.7	7.8	11.2	13.8	13.5	22.8	17.4	12.3	23.3	26.2	9.3	26.9	10.3	20.0	13.3	12.7	10.0	8.0	11.7	14.8	12.7	10.8	15.0	19.2	12.9	12.9	18.7	15.5	4.9	14.3	11.7	11.8	7.3	6.1	15.3	14.1	12.8	8.0	4.3	8.6	8.6	19.2	10.4	12.7	16.9	12.2	9.6	10.4	18.0	21.5	9.4	11.6	9.9	4.3	9.0	7.8	12.2	7.9	25.2	15.9	12.7	12.2	9.4	8.4	11.7	16.4	14.7	9.6	5.7	11.5	20.3	13.0	7.9	6.4	11.6	9.3	15.4	25.2	38.1	6.5	13.5	21.2	13.3	10.6	7.1	8.9	7.7	8.7	8.5	9.1	11.3	11.0	11.2	10.8	8.8	9.7	10.1	5.2	4.0	15.9	6.7	12.5	7.9	15.3	6.1	2.9	5.5	13.5	7.2	7.3	8.0	5.4	6.1	5.0	7.2	5.7	6.2	12.8	14.1	3.5	8.0	4.3	18.9	26.6	48.5	30.7	14.6	16.5	13.5	22.8	26.9	12.9
C3orf14	HT021	ENSG00000114405	"Chromosome 3 open reading frame 14"	Q9HBI5	3	62318973-62336213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA048286	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA048286: "	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.69e-3)"	"unprognostic (6.91e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.76e-5)"	"unprognostic (1.57e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (4.33e-5)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	3.8	14.7	28.2	5.6	23.6	1.0	35.0	16.4	31.2	5.0	3.9	7.7	2.5	3.3	5.5	6.8	11.0	4.1	6.8	4.6	20.9	22.0	9.6	2.9	6.4	5.0	19.9	20.5	8.2	6.3	2.3	19.0	4.8	25.9	17.8	4.1	4.1	5.0	5.6	1.0	12.0	2.7	6.8	15.2	3.0	6.1	20.9	8.1	1.2	9.2	3.8	8.2	13.5	3.4	3.7	6.7	5.2	21.0	0.7	6.1	2.1	0.0	5.7	6.9	0.0	5.0	7.3	5.3	9.3	5.6	11.8	11.7	0.0	8.4	0.0	0.0	6.3	1.5	0.0	5.9	9.1	0.0	3.9	5.1	0.0	0.0	3.4	0.0	11.0	3.3	8.0	13.3	10.9	5.7	0.6	0.0	11.6	105.2	0.0	0.0	8.7	11.8	0.0	0.0	2.8	9.6	16.0	12.1	10.2	6.2	22.3	8.6	9.0	5.7	0.1	5.8	0.0	26.9	9.3	5.7	0.0	0.0	5.6	0.0	20.2	5.2	4.3	0.4	0.2	14.3	0.1	3.7	3.6	2.8	4.6	1.1	1.0	0.7	0.3	0.7	21.0	6.7	6.1	2.1	28.2	23.6	16.4	31.2	20.9	22.0	19.9	20.5	25.9	8.1
C3orf18	G20	ENSG00000088543	"Chromosome 3 open reading frame 18"	Q9UK00	3	50558025-50571027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;NK-cells: 2.1;T-cells: 7.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 31.6;olfactory region: 33.8"	"Low region specificity"	"Detected in all"			HPA012105	Approved		Approved	Cytosol				Cytosol		"HPA012105: AB_1845717"	"unprognostic (9.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.29e-2)"	"prognostic favourable (2.80e-9)"	"unprognostic (7.65e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	5.1	6.7	10.0	3.4	12.3	1.2	6.2	34.5	20.1	6.0	6.1	8.0	2.2	2.2	8.0	5.1	5.0	8.4	6.0	25.3	8.1	9.7	6.0	3.0	4.1	3.9	11.4	9.3	14.0	6.1	19.2	7.4	2.6	10.3	8.5	3.2	11.9	7.3	11.0	32.4	2.8	2.9	10.4	6.9	4.1	5.2	9.8	6.1	1.8	6.9	7.2	4.0	6.8	4.9	2.9	0.9	0.8	0.5	2.1	7.7	3.0	1.1	1.6	1.9	0.4	6.4	5.8	0.6	6.8	10.6	6.2	4.5	0.1	1.7	1.3	1.6	9.2	0.1	0.0	2.6	3.3	29.2	0.2	2.8	3.8	0.5	3.2	0.0	3.7	5.7	0.3	6.0	0.3	1.2	0.6	1.3	3.6	0.2	0.2	0.8	2.4	7.6	0.6	0.2	1.6	0.3	0.2	2.1	10.1	1.8	0.4	0.1	2.0	0.8	0.3	6.2	4.9	11.3	0.8	1.8	1.4	0.2	8.9	3.1	0.1	0.0	0.5	0.8	6.3	0.2	7.7	2.9	5.5	6.0	0.5	1.8	6.4	7.7	0.0	2.1	0.1	0.9	2.5	3.0	10.0	12.3	34.5	20.1	8.1	9.7	11.4	9.3	10.3	6.1
C3orf20	DKFZP434N1817	ENSG00000131379	"Chromosome 3 open reading frame 20"	Q8ND61	3	14675099-14773034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 30.9"	"Group enriched"	"Detected in some"	4	"Daudi: 5.6;HEL: 11.9;U-698: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA039584	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039584: AB_10795152"	"unprognostic (1.23e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-4)"	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	30.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	11.9	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.9	0.0	0.5	0.8	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0
C3orf33	"AC3-33, FLJ31139"	ENSG00000174928	"Chromosome 3 open reading frame 33"	Q6P1S2	3	155762617-155806351	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037663	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"HPA037663: AB_10672610"	"unprognostic (1.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic favourable (6.48e-7)"	"unprognostic (3.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.56e-1)"	4.3	16.9	6.7	3.1	7.9	2.3	6.8	9.2	9.5	5.0	3.6	6.5	5.0	4.1	6.1	9.7	2.5	5.4	3.5	9.3	7.6	7.9	9.4	4.1	5.2	2.8	5.6	11.0	6.9	19.4	11.7	8.6	2.1	7.9	7.2	3.4	5.5	4.5	6.6	5.6	1.6	2.8	11.1	5.0	2.8	4.3	6.2	6.9	1.7	13.4	2.4	1.7	4.0	6.3	2.3	3.0	3.0	1.8	6.1	7.7	3.4	5.9	8.4	4.0	5.5	0.3	5.0	1.7	2.5	3.9	2.5	6.0	2.9	7.6	1.1	6.1	2.5	0.9	4.0	0.1	4.5	2.9	5.9	3.6	1.3	7.6	7.0	4.9	1.2	3.9	4.4	2.6	5.2	4.2	5.7	2.8	4.3	4.3	5.2	4.4	5.3	1.8	5.3	2.1	5.8	13.9	2.8	3.0	4.1	5.7	7.6	5.1	10.5	6.4	2.7	2.8	2.1	6.0	6.3	4.8	4.5	0.0	2.0	4.6	2.9	3.0	1.8	0.2	6.2	1.6	7.7	2.3	4.9	5.5	3.0	2.2	6.2	6.4	0.1	6.1	1.1	2.4	3.2	3.4	6.7	7.9	9.2	9.5	7.6	7.9	5.6	11.0	7.9	6.9
C3orf36	FLJ22173	ENSG00000221972	"Chromosome 3 open reading frame 36"	Q3SXR2	3	133928145-133929812	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"lung: 8.2;seminal vesicle: 14.7"	"Group enriched"	"Detected in some"	5	"EFO-21: 6.4;HeLa: 1.6;TIME: 5.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046432	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA046432: "	"unprognostic (3.56e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-3)"	"unprognostic (4.64e-4)"	"unprognostic (5.05e-3)"	"unprognostic (8.18e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	1.1	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.2	0.7			0.2	1.3	0.0	0.6	1.1	0.8	0.7	0.0	0.0	1.9	0.0	8.2	0.1	0.0		0.0	0.7	1.6	0.2	0.1		2.3	0.3		0.4	14.7	0.0	0.1	1.4	1.0	0.0	1.5	0.8	0.0			2.7		0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C3orf38	MGC26717	ENSG00000179021	"Chromosome 3 open reading frame 38"	Q5JPI3	3	88149743-88168729	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034736, HPA034737"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034736: , HPA034737: AB_10671505"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"prognostic favourable (3.55e-4)"	"unprognostic (9.28e-3)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.67e-2)"	12.2	11.7	13.7	12.8	16.1	35.2	12.3	12.9	12.8	11.6	11.9	13.6	8.4	9.5	11.5	10.7	14.6	10.7	9.4	9.7	11.3	11.1	10.2	13.5	10.6	19.2	15.1	9.4	12.1	9.3	7.1	15.8	12.5	11.4	11.2	11.2	9.0	10.6	10.2	9.7	11.6	11.4	10.9	11.3	17.0	10.1	33.2	13.5	29.5	11.6	9.0	17.1	12.4	11.6	20.0	17.7	25.8	24.2	17.1	17.4	15.3	6.3	6.6	12.9	6.9	8.6	7.8	5.9	10.3	12.3	15.3	20.8	7.5	8.7	8.5	9.2	9.4	4.6	9.3	7.5	13.2	15.2	4.4	10.4	5.1	6.4	12.3	14.2	9.0	11.2	7.6	10.3	8.8	8.8	6.6	9.7	16.6	7.3	14.3	6.0	15.6	7.4	9.0	4.5	8.0	10.1	8.6	3.9	5.7	9.4	5.1	15.4	9.9	10.8	8.0	9.6	10.4	58.0	11.3	9.0	13.3	12.6	7.4	11.3	8.9	25.8	16.8	17.5	13.5	24.2	17.4	20.0	12.6	13.8	17.7	15.9	12.6	12.8	7.5	17.1	19.7	12.3	15.1	15.3	13.7	16.1	12.9	12.8	11.3	11.1	15.1	9.4	11.4	13.5
C3orf70		ENSG00000187068	"Chromosome 3 open reading frame 70"	A6NLC5	3	185078050-185153014	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 26.6"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 19.0;SK-BR-3: 8.3;WM-115: 10.2"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041861	Uncertain		Approved	Cytosol				Cytosol		"HPA041861: AB_10804119"	"unprognostic (1.45e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.62e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (6.40e-6)"	"unprognostic (1.06e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	4.6	2.3	14.4	4.7	13.8	0.9	2.0	7.9	18.2	7.2	12.1	11.1	7.9	5.3	12.1	6.1	10.1	6.8	6.1	3.3	11.1	10.2	1.6	1.3	2.4	1.3	11.4	7.1	5.9	1.1	4.0	1.4	2.9	10.5	10.2	8.2	5.2	5.5	16.4	1.5	2.9	6.5	26.6	11.1	4.2	4.4	7.5	7.0	0.0	2.4	1.0	1.7	13.2	3.3	1.2	1.2	3.4	1.6	1.7	1.1	0.5	0.0	0.1	2.2	0.0	0.0	0.1	0.1	2.9	0.1	0.5	0.0	1.3	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.2	0.0	0.7	2.5	0.1	0.7	0.0	0.4	4.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.0	0.2	0.1	4.6	0.1	0.0	0.4	19.0	0.2	0.9	8.3	0.5	0.6	2.1	0.8	0.0	2.2	0.1	1.4	0.0	0.0	0.0	0.0	0.0	10.2	3.4	1.2	1.7	0.8	1.0	1.0	1.0	0.8	0.8	0.6	1.2	1.0	1.1	3.3	1.7	1.6	1.2	0.7	0.5	14.4	13.8	7.9	9.6	11.1	10.2	11.4	7.1	10.5	7.0
C4orf22		ENSG00000197826	"Chromosome 4 open reading frame 22"	Q6V702	4	80335720-80963756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;fallopian tube: 19.8;testis: 34.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;ASC TERT1: 2.1;BJ: 4.5;LHCN-M2: 2.7;SCLC-21H: 3.0;U-251 MG: 2.9;U-87 MG: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.4;pons and medulla: 22.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Low region specificity"	"Detected in many"							HPA043383	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.1	1.4	0.1	8.4	0.1	0.3	0.6	0.2	0.9	0.1	5.1	0.1	0.3	0.4	7.8	0.2	19.8	0.3	0.1	2.8	2.5	0.4	0.1	5.9	0.3	0.1	0.1	3.5	0.1	0.1	1.2	0.1	22.0	0.2	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.1	0.1	34.8	2.4	2.9	0.7	0.0	0.2	0.1	0.0	2.1	0.5	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.3	2.1	0.0	4.5	0.8	0.1	0.2	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.9	0.0	0.0	1.2	2.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.4	8.4	0.6	0.2	2.8	2.5	0.1	0.1	22.0	2.4
C4orf48		ENSG00000243449	"Chromosome 4 open reading frame 48"	Q5BLP8	4	2041993-2043970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.4;brain: 37.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 37.8;NB-4: 27.1;PC-3: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052447	Uncertain		Supported	Cytosol	"Secreted to blood"		32000	Cytosol		"HPA052447: "	"unprognostic (7.96e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.17e-3)"	11.4	7.8	25.5	9.7	22.2	5.6	4.8	7.7	37.2	3.4	19.7	18.2	3.2	6.5	4.1	3.0	1.2	3.2	3.1	3.8	26.4	26.2	5.2	2.5	4.7	8.7	24.8	15.6	2.9	16.8	5.6	19.8	5.3	14.9	3.9	3.1	4.3	5.1	4.3	3.3	3.7	16.6	2.4	30.7	9.6	9.8	13.9	15.7	1.2	2.2	0.7	2.4	2.6	2.6	29.8	49.4	67.5	78.4	4.5	31.0	28.4	7.6	6.4	1.2	5.9	0.5	0.9	8.5	7.4	1.4	1.3	1.3	4.4	4.6	1.0	7.1	0.2	2.1	0.1	0.8	0.4	4.6	37.8	2.4	3.5	2.4	1.3	4.9	16.9	0.7	1.4	0.3	0.0	1.4	8.0	0.0	0.9	4.7	5.6	27.1	3.8	82.0	13.0	2.0	2.5	1.1	2.9	10.3	14.5	3.6	0.1	9.9	2.0	2.4	6.2	3.6	7.7	2.6	8.2	5.7	4.9	0.0	3.5	3.1	4.9	11.5	78.4	67.5	21.5	50.6	22.0	29.8	27.8	23.9	44.2	22.6	16.0	16.7	59.0	4.5	44.0	49.4	31.0	28.4	25.5	22.2	7.7	37.2	26.4	26.2	24.8	15.6	14.9	15.7
C5orf42	"FLJ13231, Hug, JBTS17"	ENSG00000197603	"Chromosome 5 open reading frame 42"	Q9H799	5	37106228-37249428	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036775, HPA036776"	Approved		Approved	Cytosol				Cytosol		"HPA036775: AB_10669914, HPA036776: "	"unprognostic (3.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.09e-1)"	7.1	8.3	9.2	6.4	12.3	3.6	9.5	14.9	12.6	8.7	7.5	7.5	9.8	2.9	10.3	11.5	6.6	10.4	8.4	6.9	9.6	9.4	10.2	4.4	8.3	6.3	9.5	9.3	14.2	7.8	17.7	19.6	8.5	9.5	11.6	5.6	6.9	8.7	10.3	6.3	6.5	4.9	9.6	9.5	5.7	6.4	11.6	9.5	12.0	17.6	5.4	4.8	8.7	9.1	3.1	2.5	0.6	0.2	1.5	1.5	0.2	4.0	2.0	6.3	4.3	7.1	7.3	2.6	3.7	3.1	4.2	3.8	3.1	4.9	1.1	2.7	3.6	1.6	1.7	2.5	4.9	2.6	1.7	2.6	14.5	2.0	3.6	0.0	1.3	5.7	3.7	4.7	2.7	4.3	0.0	0.8	8.5	0.1	2.9	3.5	1.4	1.5	2.8	10.8	0.0	4.0	1.2	3.3	1.9	33.6	0.2	2.1	1.7	2.1	6.1	7.0	4.5	2.2	3.2	1.2	0.0	1.2	1.8	0.1	2.8	0.6	0.2	0.0	1.5	0.1	1.5	0.6	0.9	0.8	0.5	3.1	0.8	1.2	0.1	1.5	0.1	2.5	0.0	0.2	9.2	12.3	14.9	12.6	9.6	9.4	9.5	9.3	9.5	9.5
C5orf51	LOC285636	ENSG00000205765	"Chromosome 5 open reading frame 51"	A6NDU8	5	41904188-41921636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043779, HPA063816"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043779: , HPA063816: "	"unprognostic (6.64e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.93e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.67e-2)"	16.6	12.4	15.9	12.7	21.5	3.4	15.9	20.5	21.3	14.7	12.5	23.5	12.6	10.5	14.9	21.9	16.2	11.4	12.2	12.8	16.0	17.5	15.3	14.0	10.7	13.1	20.6	12.3	22.1	11.9	24.1	18.6	17.2	25.1	16.5	12.6	13.2	12.9	15.4	7.2	14.1	11.9	16.8	22.1	12.8	11.5	9.4	18.5	16.2	19.0	6.9	14.0	18.9	13.5	5.6	6.8	21.0	7.4	5.6	7.4	7.9	7.4	5.7	11.7	24.3	23.9	18.9	12.7	8.8	15.3	12.5	13.3	5.7	7.6	8.0	10.9	9.8	4.8	15.4	8.3	18.1	10.7	4.7	7.7	17.2	8.5	29.0	9.8	5.9	18.3	12.1	14.6	16.9	10.7	13.7	13.8	13.1	7.7	9.2	10.1	11.6	3.1	8.1	16.2	12.4	8.3	7.2	7.1	11.1	28.1	13.5	14.5	15.0	10.1	7.7	14.8	8.9	11.2	8.5	7.0	11.3	8.2	16.5	17.2	10.5	21.0	6.9	6.6	4.7	5.6	6.0	5.1	5.5	5.0	6.8	5.6	7.4	4.9	4.7	5.6	7.4	4.1	3.9	7.9	15.9	21.5	20.5	21.3	16.0	17.5	20.6	12.3	25.1	18.5
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101118-42142619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3"	"Cell line enhanced"	"Detected in many"		"A-431: 27.2;CACO-2: 24.8;CAPAN-2: 20.6;HaCaT: 18.4;SK-BR-3: 16.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	1.3	0.5	0.2	3.7	0.2	0.2	4.2	0.3	0.3	13.3	20.9	0.2	1.4	15.7	0.7	1.2	66.1	2.6	15.5	0.5	0.2	0.1	6.2	0.6	5.9	0.2	0.2	0.2	1.4	20.8	1.1	2.2	3.1	0.2	6.8	5.3	0.2	16.6	4.0	1.2	24.8	37.2	0.7	0.2	0.2	16.2	0.4	0.2	0.6	12.5	49.3	54.3	4.8	17.5	2.1	1.9	3.5	1.3	0.9	1.2	0.7	27.2	0.3	0.0	0.1	0.1	3.2	13.5	1.6	2.0	3.8	4.0	24.8	20.6	0.0	2.9	2.7	18.4	0.0	8.3	2.5	2.2	3.8	1.3	2.4	5.5	1.0	0.0	0.1	1.9	15.4	2.9	4.3	0.0	0.7	0.2	0.7	9.5	0.3	0.1	1.8	0.7	0.1	0.0	0.1	2.9	12.3	1.5	0.0	2.4	16.6	0.0	12.1	0.1	0.4	0.2	1.8	6.9	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.9	1.3	1.7	0.8	0.8	0.6	1.0	0.8	0.8	1.4	2.1	0.9	1.2	3.5	0.9	0.5	1.9	0.5	0.7	0.2	0.2	0.3	0.3	0.2	0.1	0.2	0.2	0.2	0.2
C6orf47	"D6S53E, G4"	ENSG00000204439	"Chromosome 6 open reading frame 47"	O95873	6	31658298-31660772	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.1;fHDF/TERT166: 6.2;HBEC3-KT: 8.8;HEK 293: 7.3;RT4: 8.5;U-2 OS: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045281	Uncertain		Approved	Cytosol				Cytosol		"HPA045281: AB_10961000"	"unprognostic (5.99e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.59e-3)"	7.3	9.1	5.4	7.7	7.1	3.4	14.0	7.7	10.2	8.1	11.7	8.3	9.8	2.6	10.8	18.4	14.2	8.9	13.9	13.6	5.1	4.9	10.3	9.2	14.3	16.0	6.1	4.8	11.7	18.7	2.7	8.0	8.7	6.0	9.0	10.0	9.7	9.2	10.5	11.8	23.3	14.8	15.4	6.3	13.0	10.2	4.0	5.3	11.5	11.3	10.9	11.8	11.5	8.3	3.5	1.5	1.7	2.1	0.0	3.0	1.1	0.0	5.7	0.0	4.3	7.1	1.0	0.0	0.5	0.4	1.8	0.5	0.0	0.8	1.9	4.5	6.2	0.0	0.0	8.8	0.1	0.1	7.3	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	4.9	8.5	0.0	3.0	0.0	0.0	0.0	0.0	0.0	3.7	3.7	6.3	0.0	0.0	4.1	0.2	0.7	1.9	0.0	2.4	0.0	0.8	1.6	3.0	2.1	0.1	3.5	1.1	0.5	0.5	0.0	2.1	1.9	1.7	0.0	0.0	1.5	2.1	1.1	5.4	7.1	7.7	10.2	5.1	4.9	6.1	4.8	6.0	5.3
C6orf62	"DKFZP564G182, FLJ12619, XTP12"	ENSG00000112308	"Chromosome 6 open reading frame 62"	Q9GZU0	6	24704861-24720836	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030564, HPA030566"	Supported		Approved	Cytosol				Cytosol		"HPA030564: AB_10600000, HPA030566: AB_10599425"	"unprognostic (2.07e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (4.04e-4)"	"unprognostic (4.16e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.01e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.93e-2)"	"prognostic favourable (3.62e-6)"	38.9	38.3	46.0	42.8	49.9	37.8	52.0	34.3	50.1	30.7	35.4	31.4	49.9	30.8	31.0	42.6	33.1	32.0	41.9	27.8	38.2	40.5	35.1	49.0	54.6	67.6	50.0	36.7	37.8	52.9	35.6	33.6	37.9	33.9	33.6	31.3	33.8	47.4	52.6	31.1	33.7	38.6	28.8	36.4	58.3	38.9	46.0	38.1	75.2	41.5	28.1	56.5	35.6	34.2	48.4	48.7	64.0	62.3	52.7	65.3	103.5	22.9	14.2	17.4	29.5	22.0	28.5	19.2	27.2	35.6	41.0	43.9	17.8	20.7	26.4	42.9	31.8	19.2	20.0	26.6	45.5	44.5	9.6	27.7	23.1	23.9	37.7	33.7	33.2	22.1	53.7	27.7	37.0	31.7	24.4	19.7	38.4	18.9	25.8	50.7	19.3	14.4	20.8	18.9	26.5	24.4	34.7	29.6	16.7	32.5	37.2	49.3	32.6	27.0	28.1	37.1	17.9	14.0	37.0	46.5	73.1	32.8	13.3	46.6	35.8	47.7	62.1	64.0	55.7	62.0	58.6	48.4	57.4	60.6	47.7	41.8	57.6	65.3	44.2	52.7	62.3	48.7	53.4	103.5	46.0	49.9	34.3	50.1	38.2	40.5	50.0	36.7	33.9	38.1
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 20.9;eosinophil: 12.3;neutrophil: 6.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: "	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	4.8	6.5	7.6	3.8	7.6	2.4	6.1	7.1	11.0	5.0	5.2	6.3	2.6	2.1	5.3	11.0	5.2	6.5	5.9	5.8	9.2	8.6	7.7	5.9	4.8	5.2	10.0	9.1	7.2	5.1	12.6	6.5	5.8	12.2	8.2	3.4	4.0	5.0	9.2	5.7	3.9	5.3	5.8	9.6	5.2	5.3	11.0	5.3	5.8	7.7	4.5	3.8	5.3	4.4	2.1	1.4	20.9	1.9	1.6	2.2	1.1	3.4	9.0	3.2	4.8	4.6	2.5	3.6	6.9	2.6	4.5	4.1	5.9	4.5	9.1	5.3	6.6	5.9	3.4	6.1	5.2	4.3	8.6	4.8	9.2	3.5	8.3	3.6	3.1	5.0	4.1	4.5	4.6	3.5	6.0	2.1	3.8	6.5	1.9	3.5	3.9	11.6	2.2	3.5	3.8	2.6	8.6	4.0	4.6	10.1	3.0	3.6	4.0	3.5	9.2	4.6	5.2	4.9	4.3	4.8	10.7	2.8	4.2	4.6	9.8	20.9	1.9	12.3	1.5	1.8	2.2	2.1	1.1	1.4	1.4	1.7	1.6	1.6	6.4	1.6	1.7	0.6	0.8	1.1	7.6	7.6	7.1	11.0	9.2	8.6	10.0	9.1	12.2	5.3
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590017-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"				Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: , HPA052175: "	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	19.8	17.1	13.4	21.7	17.7	29.2	20.0	20.6	26.9	19.0	17.9	21.1	21.5	19.4	23.0	15.4	14.7	19.9	15.6	12.8	14.4	14.1	15.4	18.4	19.3	24.1	18.8	20.2	20.6	23.9	17.2	16.6	14.0	15.4	21.1	11.5	16.4	21.2	16.6	18.7	21.9	16.4	19.6	13.1	27.3	18.6	16.8	16.1	31.7	18.3	18.5	20.6	17.6	19.6	4.2	6.4	4.6	3.4	3.3	6.1	1.9	11.1	9.3	6.5	15.4	10.7	6.0	8.6	6.7	5.9	9.7	6.0	8.7	4.7	13.2	8.8	4.9	12.4	8.7	6.1	4.4	5.1	12.5	4.9	5.8	9.1	12.6	11.7	15.9	6.9	9.3	5.8	6.1	10.5	12.9	10.1	5.7	18.7	10.2	24.3	13.0	12.5	20.9	5.2	11.2	6.3	9.8	8.6	15.9	6.5	21.6	9.0	9.8	17.7	7.5	8.1	26.5	8.8	14.6	12.3	12.0	12.2	5.4	13.1	23.8	1.1	3.4	4.6	4.7	3.3	6.1	4.1	5.7	6.0	2.6	4.2	5.9	4.9	3.4	3.3	3.3	6.4	5.4	1.9	13.4	17.7	20.6	26.9	14.4	14.1	18.8	20.2	15.4	16.1
C8orf37	"BBS21, CORD16, FLJ30600, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244919-95269201	"Disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease mutation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	4.8	5.6	7.9	5.8	9.9	2.4	6.4	9.8	8.0	6.7	3.1	10.5	2.9	2.6	6.5	8.6	3.3	10.5	4.0	7.0	8.7	7.1	6.6	4.9	4.3	5.6	7.4	6.9	13.0	3.8	10.1	9.9	4.9	7.9	5.6	2.8	4.6	4.3	7.1	2.9	4.2	3.3	6.2	9.2	4.4	3.2	4.5	9.5	3.8	6.7	1.6	5.1	4.0	4.4	3.9	1.9	2.3	1.4	2.7	2.3	0.8	4.1	6.7	5.6	2.9	2.0	5.2	1.6	1.8	4.1	2.4	3.1	1.0	9.1	8.3	4.4	3.0	3.4	2.3	4.6	5.2	2.6	2.1	6.5	4.1	3.0	2.2	1.4	3.6	5.2	2.2	2.8	7.8	3.5	3.3	4.9	3.0	3.2	6.9	1.6	1.8	4.6	3.6	3.0	2.1	5.2	1.8	5.4	5.3	3.7	0.8	3.1	6.5	1.3	3.0	2.9	3.8	2.5	1.8	4.5	4.3	5.6	5.6	3.1	3.6	1.3	1.4	0.6	1.2	0.9	2.1	1.9	1.4	1.3	1.9	3.9	1.4	2.3	2.3	2.7	0.7	0.9	0.5	0.8	7.9	9.9	9.8	8.0	8.7	7.1	7.4	6.9	7.9	9.5
C8orf48	FLJ25402	ENSG00000164743	"Chromosome 8 open reading frame 48"	Q96LL4	8	13566843-13568287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.7;testis: 17.3"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 11.7;WM-115: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA026107, HPA027440"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA026107: AB_10600765, HPA027440: AB_10601678"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.07e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.84e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-3)"	"unprognostic (7.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.70e-2)"	2.7	0.7	3.6	1.2	11.7	0.1	3.7	0.8	2.9	3.0	1.3	0.9	0.2	0.9	2.3	6.0	1.4	3.9	2.5	4.0	2.8	1.6	4.1	1.7	2.4	1.2	1.7	3.0	2.1	1.2	0.5	1.5	2.8	2.8	2.2	1.0	2.4	2.2	1.0	0.9	2.7	0.9	1.9	1.1	1.1	1.9	17.3	1.5	0.0	8.9	0.3	0.5	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	1.8	0.0	6.2	6.2	0.0	5.4	6.0	2.9	5.0	0.0	0.0	0.0	0.0	2.8	0.6	0.2	1.0	5.7	0.0	0.6	0.5	0.0	0.0	2.2	0.0	0.9	1.9	3.7	3.9	1.0	3.7	0.1	0.0	7.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.2	0.0	3.2	0.0	0.2	6.0	0.0	0.0	1.7	5.1	5.0	6.0	4.8	0.0	0.0	0.0	11.7	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	11.7	0.8	2.9	2.8	1.6	1.7	3.0	2.8	1.5
C8orf59		ENSG00000176731	"Chromosome 8 open reading frame 59"	Q8N0T1	8	85214076-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044805, HPA071903"			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: , HPA071903: "	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	28.1	28.2	25.3	25.3	21.9	33.0	46.1	18.9	26.5	33.0	38.4	12.6	36.3	28.1	32.0	45.5	44.8	28.7	25.8	41.5	20.6	24.1	32.3	47.1	20.8	30.7	26.3	27.2	45.1	35.1	19.5	36.0	27.7	24.4	35.5	27.7	14.7	37.8	36.2	43.9	24.8	37.1	33.7	27.0	32.2	36.9	16.7	25.7	39.1	43.5	53.6	32.0	39.1	35.2	33.3	42.7	21.3	25.3	36.5	38.0	23.9	43.6	22.3	33.1	21.5	20.6	39.9	25.9	29.0	27.9	34.0	33.6	25.9	37.8	10.9	24.1	19.2	30.4	23.0	31.9	38.4	30.7	25.1	64.4	21.1	38.3	24.4	24.2	29.2	33.8	37.9	21.9	27.8	28.8	28.9	26.8	28.2	34.4	53.3	45.5	9.5	38.9	22.8	27.7	49.5	33.0	28.0	11.2	24.0	22.0	36.2	40.0	41.8	36.1	22.0	21.7	45.5	24.0	27.5	31.3	36.6	51.2	43.3	31.0	24.1	21.3	20.5	13.4	24.7	25.3	29.5	33.3	32.7	30.1	34.8	29.9	38.0	36.3	5.1	36.5	21.5	42.7	32.1	23.9	25.3	21.9	18.9	26.5	20.6	24.1	26.3	27.2	24.4	25.7
C8orf76	FLJ14825	ENSG00000189376	"Chromosome 8 open reading frame 76"	Q96K31	8	123219957-123241398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"prognostic unfavourable (9.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.71e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (5.95e-11)"	"unprognostic (1.54e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.71e-2)"	11.9	15.4	13.5	11.4	21.8	13.8	14.5	18.5	15.2	12.0	13.5	11.5	27.0	11.8	9.2	16.1	16.4	9.5	11.2	11.1	11.5	11.8	10.1	19.3	10.2	15.9	11.8	10.6	9.8	12.3	8.5	24.0	15.5	10.9	11.5	15.8	12.5	13.9	23.7	16.9	10.0	12.5	10.8	9.4	15.9	10.4	7.4	14.4	18.8	13.9	9.9	18.3	10.3	10.7	12.7	17.2	24.4	18.9	13.4	18.6	11.0	8.4	7.8	7.3	5.1	7.2	6.6	5.0	8.0	7.8	9.4	9.5	7.1	6.2	5.8	8.8	7.6	6.5	8.3	4.3	10.7	9.2	11.8	6.8	3.6	10.0	12.9	3.5	5.6	4.8	8.5	8.4	7.1	8.3	9.7	4.5	7.8	24.7	10.3	8.1	5.9	13.6	5.5	3.7	6.6	8.0	7.0	9.6	9.0	8.0	59.1	8.4	7.2	8.7	4.5	5.4	10.2	5.8	6.5	6.0	6.6	6.3	5.8	8.1	5.7	15.9	16.7	24.4	13.3	18.9	13.9	11.2	14.5	16.8	17.2	12.7	13.9	13.7	9.8	13.4	15.3	14.9	18.6	11.0	13.5	21.8	18.5	15.2	11.5	11.8	11.8	10.6	10.9	14.4
C9orf116	"MGC29761, PIERCE1, RbEST47"	ENSG00000160345	"Chromosome 9 open reading frame 116"	Q5BN46	9	135495181-135501734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 63.3;testis: 47.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 22.2;T-47d: 23.0;U-2197: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021439, HPA065287"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021439: AB_1845799, HPA065287: "	"unprognostic (9.02e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.93e-1)"	"prognostic favourable (3.53e-5)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	1.5	7.2	8.0	1.0	9.2	1.0	2.2	1.5	6.2	4.1	1.1	6.2	8.2	1.1	3.3	22.1	1.0	63.3	2.7	1.5	9.6	9.3	7.8	1.5	9.8	0.9	4.9	4.9	9.3	4.5	3.3	7.6	1.5	19.9	2.0	1.3	1.7	2.0	5.0	1.4	1.2	1.0	1.3	2.6	1.0	1.8	47.8	2.6	0.1	6.7	0.2	1.2	2.2	0.3	1.7	0.9	0.1	2.6	1.8	4.2	1.1	5.8	10.1	4.5	6.9	1.9	4.2	0.9	4.0	2.8	4.8	3.3	3.8	5.9	1.0	5.3	2.6	4.0	4.9	2.2	4.1	0.3	4.5	0.0	11.2	11.6	5.4	0.8	2.8	2.9	1.7	2.4	0.7	2.3	5.4	0.8	2.3	22.2	3.0	1.0	9.4	11.9	4.6	2.2	3.6	11.4	4.2	4.3	4.6	5.5	2.4	0.6	23.0	0.9	1.1	2.7	3.7	23.7	1.5	2.6	6.4	0.9	8.2	0.3	0.8	0.1	2.6	0.0	1.9	1.6	4.2	0.7	1.3	1.4	0.9	1.7	2.4	1.8	0.0	1.8	0.4	0.4	1.6	1.1	8.0	9.2	1.5	6.2	9.6	9.3	4.9	4.9	19.9	2.6
C9orf40	FLJ10110	ENSG00000135045	"Chromosome 9 open reading frame 40"	Q8IXQ3	9	74946581-74952886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA042167	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol			290000	"Nucleoplasm, Cytosol"	Centrosome	"HPA042167: AB_10797382"	"unprognostic (2.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.15e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	6.2	4.0	8.3	9.7	8.0	9.0	18.8	8.1	12.4	5.1	9.9	5.6	2.8	14.3	5.2	3.0	5.2	3.6	5.0	3.6	7.4	8.4	4.1	5.1	2.8	8.4	8.4	5.6	4.2	3.5	6.6	4.4	6.5	6.7	3.9	9.2	2.2	3.0	4.8	4.7	3.5	18.7	4.9	11.2	5.4	3.6	31.1	5.1	10.5	3.0	3.4	8.0	5.0	16.0	1.8	0.9	5.3	0.5	0.0	2.1	0.3	16.7	3.7	9.6	3.9	3.9	5.0	17.9	13.4	4.2	9.3	10.1	1.0	5.2	15.1	4.0	3.3	5.0	7.5	0.7	15.0	20.4	11.6	8.0	6.7	6.4	3.1	9.6	12.8	2.4	5.1	5.2	3.7	2.8	11.3	10.3	12.1	4.7	16.9	11.3	11.3	11.3	15.9	7.6	3.6	3.9	4.1	10.5	4.6	5.8	5.0	4.0	6.0	7.4	3.7	8.5	9.5	11.5	11.6	19.8	14.8	9.6	6.4	10.8	9.0	1.8	0.2	5.3	1.0	0.4	0.4	1.8	1.1	1.0	0.2	1.3	2.1	1.3	0.5	0.0	0.5	0.9	1.2	0.3	8.3	8.0	8.1	12.4	7.4	8.4	8.4	5.6	6.7	5.1
C9orf43	MGC17358	ENSG00000157653	"Chromosome 9 open reading frame 43"	Q8TAL5	9	113410054-113429684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	10	"testis: 39.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA021310			Approved	Cytosol				Cytosol		"HPA021310: AB_1845825"	"unprognostic (2.91e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-1)"	0.5	1.6	1.5	0.4	2.4	1.8	1.3	2.1	2.3	0.5	0.4	1.6	0.2	0.4	0.4	1.6	0.5	0.9	0.6	0.4	1.4	0.8	1.0	1.7	0.5	0.6	0.8	1.9	1.0	3.5	1.3	3.8	0.5	1.6	0.7	0.5	1.0	0.9	0.7	0.4	0.8	0.5	0.3	1.8	0.6	0.6	39.4	1.0	0.6	1.0	0.0	0.6	0.5	0.5	1.5	1.3	2.3	1.5	1.0	2.1	0.8	1.2	1.2	0.6	1.9	1.5	0.8	0.9	0.6	1.1	1.8	1.3	1.3	1.1	3.3	1.1	0.3	2.5	0.7	1.7	0.7	2.7	0.5	2.9	2.1	0.6	1.3	0.5	0.4	1.9	2.6	2.2	2.6	1.5	1.8	3.1	0.9	2.4	1.4	0.8	0.9	4.0	0.8	0.7	1.9	1.8	0.6	3.1	0.7	3.1	1.4	1.7	4.1	0.3	0.2	2.6	0.6	1.7	2.6	2.0	3.6	5.0	1.4	1.1	0.9	0.0	0.7	0.0	1.5	1.5	0.0	1.5	0.8	2.1	0.8	0.8	1.4	2.1	2.3	1.0	0.3	1.3	0.1	0.8	1.5	2.4	2.1	2.3	1.4	0.8	0.8	1.9	1.6	1.0
C9orf84	FLJ32779	ENSG00000165181	"Chromosome 9 open reading frame 84"	Q5VXU9	9	111686173-111795008	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 33.0"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 21.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA032108			Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA032108: AB_10669884"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.33e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.31e-2)"	0.1	2.9	0.1	0.5	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.0	0.3	0.6	0.2	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	1.1	33.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.2	0.2	4.1	0.0	0.1	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	4.7	1.1	0.4	0.0	0.2	0.0	0.0	21.9	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.1	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell line enhanced"	"Detected in some"		"A-431: 39.6;HDLM-2: 20.7;U-87 MG: 83.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in all"			"CAB005100, CAB017107, HPA055207"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	Cytosol	"CAB005100: AB_2066539, CAB017107: , HPA055207: "	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favourable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.3	20.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0
CAB39	"CGI-66, MO25"	ENSG00000135932	"Calcium binding protein 39"	Q9Y376	2	230712845-230821075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037112	Supported		Approved	"Nucleoli fibrillar center,Cytosol"			130000	"Nucleoli fibrillar center"	Cytosol	"CAB037112: AB_1078367"	"unprognostic (4.36e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (8.33e-4)"	"unprognostic (1.04e-1)"	"prognostic favourable (9.05e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.36e-1)"	28.8	16.7	24.5	25.8	24.0	22.1	22.2	22.4	35.0	16.5	26.1	16.8	14.0	23.4	19.3	18.3	28.3	15.5	20.8	34.2	25.4	26.0	27.4	18.9	20.9	25.8	28.4	27.6	17.0	16.3	22.3	15.2	21.0	32.8	20.9	28.4	13.9	22.4	16.7	82.2	21.8	28.8	26.3	28.0	21.5	22.6	19.6	17.8	20.9	22.0	26.6	28.1	22.9	30.8	3.6	3.6	12.4	5.1	11.6	8.4	2.6	37.4	8.7	11.9	10.1	14.7	18.5	13.6	21.6	27.1	13.6	14.3	10.6	41.2	9.7	17.0	18.7	17.3	13.2	40.5	27.8	40.5	10.4	26.0	11.2	11.3	12.5	35.9	30.3	13.0	23.7	17.5	38.8	16.8	43.3	9.0	12.9	13.0	16.6	22.2	11.8	15.4	19.4	17.7	9.5	25.3	30.5	13.0	7.9	16.1	20.3	17.2	5.0	20.9	21.3	19.3	7.3	20.3	17.6	11.7	8.8	15.7	13.7	20.9	15.7	4.5	4.5	6.9	6.0	5.1	6.2	3.6	7.5	7.7	3.6	3.1	6.0	8.4	12.4	11.6	4.7	2.7	7.1	2.6	24.5	24.0	22.4	35.0	25.4	26.0	28.4	27.6	32.8	17.8
CABCOCO1	"bA63A2.1, C10orf107, Em:AC022398.2, MGC44593"	ENSG00000183346	"Ciliary associated calcium binding coiled-coil 1"	Q8IVU9	10	61662961-61766766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 33.1;testis: 18.6"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA041398: AB_10794374"	"unprognostic (1.89e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (1.79e-4)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.52e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.33e-2)"	1.5	1.2	6.3	0.7	5.7	0.5	2.1	0.4	6.8	6.1	1.6	9.5	3.0	1.0	5.2	7.6	0.9	33.1	3.8	0.7	8.1	7.3	2.6	0.9	10.3	0.9	8.1	5.8	4.1	1.6	10.0	5.2	1.4	13.7	5.9	1.3	1.5	1.7	3.7	0.6	0.8	0.9	3.0	14.8	1.9	0.9	18.6	5.6	0.0	1.9	0.0	0.6	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.4	0.0	0.4	1.6	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	5.7	0.4	6.8	8.1	7.3	8.1	5.8	13.7	5.6
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favourable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	14.4	14.6	15.9	18.5	22.9	34.2	13.4	47.2	29.2	17.5	17.3	23.3	22.6	17.6	24.9	17.2	12.4	23.7	16.9	15.4	14.7	13.2	18.2	13.7	19.7	22.4	12.7	17.4	16.6	18.2	24.4	24.9	12.0	17.8	17.6	11.4	19.0	18.6	24.2	10.2	20.7	16.7	18.0	10.9	21.2	18.6	24.4	10.8	22.5	27.0	10.6	19.3	14.1	14.2	4.1	2.7	15.9	3.7	4.8	7.0	2.0	12.3	9.0	12.3	10.8	11.2	13.0	17.3	10.4	9.1	8.4	9.6	11.1	6.1	14.4	5.8	10.4	11.8	14.6	9.5	7.5	24.0	14.3	12.4	10.2	23.2	5.3	28.4	13.4	11.0	6.2	10.3	7.8	14.0	25.6	7.9	4.8	15.9	13.4	30.9	7.6	6.5	13.1	9.1	18.0	7.6	12.6	15.9	13.6	12.9	9.1	13.2	8.1	12.9	11.4	19.6	15.3	7.5	7.5	13.9	8.3	8.7	9.1	13.7	8.1	5.9	3.7	12.9	5.5	2.5	6.2	2.5	4.2	7.0	2.3	4.1	5.0	4.6	15.9	4.8	1.7	2.7	3.2	2.0	15.9	22.9	47.2	29.2	14.7	13.2	12.7	17.4	17.8	10.8
CABYR	"CBP86, CT88, FSP-2"	ENSG00000154040	"Calcium binding tyrosine phosphorylation regulated"	O75952	18	24138956-24161603	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 91.1"	"Cell line enhanced"	"Detected in many"		"SiHa: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 6.3;memory B-cell: 6.6;naive B-cell: 7.1;neutrophil: 2.9"	"Group enriched"	"Detected in many"	5	"B-cells: 7.1;granulocytes: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040703, HPA047801"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA040703: , HPA047801: "	"unprognostic (1.18e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	0.8	1.2	3.9	0.7	3.2	0.7	2.3	0.7	4.8	3.0	0.7	3.5	0.0	0.7	1.5	1.2	1.0	1.8	1.0	0.5	3.6	2.1	0.6	0.5	0.6	0.8	3.1	3.0	0.9	0.7	0.4	9.5	0.7	5.4	1.0	0.8	0.6	0.9	1.0	0.6	1.1	0.7	1.7	2.3	0.7	0.8	91.1	2.9	0.0	0.7	0.0	0.7	1.5	0.6	7.1	0.7	6.3	0.5	1.3	1.0	0.4	3.3	9.0	2.5	1.3	2.8	7.0	10.7	6.0	3.9	7.4	8.1	1.7	6.7	0.1	4.9	8.9	3.3	2.5	5.2	7.9	0.4	4.0	0.2	4.9	2.0	4.0	0.2	0.4	8.4	8.4	9.6	2.5	2.2	0.0	0.2	2.0	1.0	0.1	0.3	8.0	5.2	0.5	0.3	0.1	3.2	4.2	5.3	6.5	18.4	3.8	0.3	8.4	0.9	1.2	0.6	1.8	2.5	0.1	0.2	0.2	0.0	3.6	0.6	0.3	6.3	0.5	1.0	0.4	0.3	0.2	6.6	0.5	0.5	0.2	7.1	0.4	1.0	2.9	1.3	0.5	0.7	0.2	0.4	3.9	3.2	0.7	4.8	3.6	2.1	3.1	3.0	5.4	2.9
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 30.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.6	3.0	17.9	2.1	19.7	3.1	0.5	3.9	22.5	0.6	0.8	1.3	0.0	0.6	0.6	4.4	1.1	2.3	0.6	0.6	30.8	5.8	3.8	0.6	0.6	1.4	2.4	10.6	0.5	0.6	0.5	0.2	0.8	4.2	0.5	0.8	0.5	0.5	0.5	0.6	0.5	1.1	1.0	5.2	0.9	0.8	2.8	2.4	0.0	0.6	0.0	1.0	0.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.9	0.0	0.0	0.0	1.0	1.3	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	7.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	17.9	19.7	3.9	22.5	30.8	5.8	2.4	10.6	4.2	2.4
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964910-67033398	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;prostate: 16.5"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 95.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 159.8"	"HPA005803, HPA065370"	Enhanced		Approved	Cytosol				Cytosol		"HPA005803: , HPA065370: "	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.7	1.8	16.0	0.8	32.3	0.7	8.1	3.5	37.8	1.2	0.9	11.4	0.2	1.0	1.2	0.8	0.8	6.2	1.2	0.7	9.6	12.9	0.8	0.7	8.0	0.7	7.5	7.1	0.7	1.2	4.9	0.1	1.6	6.8	16.5	0.8	0.1	0.9	2.4	0.8	0.9	0.9	2.0	4.2	0.7	1.7	0.9	10.3	0.0	0.7	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	3.8	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	3.8	0.0	0.0	0.1	2.0	0.0	2.6	3.8	95.2	0.8	2.5	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	32.3	3.5	13.0	9.6	12.9	7.5	7.1	6.8	10.3
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53992288-54012669	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 11.4;skeletal muscle: 45.4"	"Cell line enhanced"	"Detected in some"		"A549: 12.4;EFO-21: 21.8;HHSteC: 5.7"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	96	"basophil: 11.4;eosinophil: 7.8"	"Lineage enriched"	"Detected in single"	114	"granulocytes: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	Cytosol	"HPA056615: "	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"		"unprognostic (7.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.89e-2)"		"unprognostic (2.27e-1)"		"unprognostic (7.69e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.07e-8)"	"unprognostic (9.79e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.2	0.2	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	0.9	0.0		0.1	0.0		0.4	0.0	45.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	12.4	0.3	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	1.0	0.0	21.8	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	5.7	0.0	0.1	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	2.5	0.0	0.0	0.0	3.0	0.1	0.2	0.0	0.0	11.4	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CACTIN	"C19orf29, cactin, fSAPc, NY-REN-24"	ENSG00000105298	"Cactin, spliceosome C complex subunit"	Q8WUQ7	19	3610641-3626815	"Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042504, HPA042548"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA042504: AB_10797501, HPA042548: AB_10794760"	"unprognostic (1.18e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.09e-1)"	"prognostic favourable (3.69e-5)"	"unprognostic (5.93e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.55e-3)"	16.1	14.4	18.3	19.4	17.8	19.8	16.2	19.2	19.9	11.8	12.4	13.1	12.3	14.5	14.2	9.6	11.9	13.0	13.0	10.3	14.2	10.9	11.9	14.8	11.7	16.5	14.3	9.9	21.4	14.9	8.9	11.1	11.3	13.4	13.4	8.5	10.3	15.5	12.8	28.6	22.0	16.2	12.2	9.8	23.0	15.7	14.4	15.0	13.9	12.6	11.9	12.7	11.3	18.5	2.1	4.3	0.8	2.9	0.9	3.7	1.3	14.4	8.4	7.1	12.1	5.2	5.1	10.8	10.4	4.2	6.3	7.0	8.3	6.5	12.2	8.9	6.5	13.5	7.4	8.7	3.8	12.2	9.7	7.5	11.4	9.9	7.2	10.2	11.0	5.0	8.5	5.8	4.0	9.0	16.7	13.6	3.3	8.7	18.2	8.9	15.1	9.8	19.3	9.2	11.4	5.8	7.4	9.8	13.7	11.7	8.3	8.4	6.6	11.8	11.6	8.4	10.7	18.4	18.1	20.9	13.9	13.4	10.4	16.4	11.3	0.0	1.2	0.0	3.7	2.9	1.3	2.0	1.8	1.7	1.0	2.1	2.0	2.5	0.8	0.9	0.4	4.3	1.4	1.3	18.3	17.8	19.2	19.1	14.2	10.9	14.3	9.9	13.4	15.0
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175011715	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 117.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Approved		Enhanced	Nucleoplasm,Cytosol			360000	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: "	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favourable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	15.1	15.9	38.3	20.3	39.7	24.6	36.2	36.1	46.5	16.0	16.7	10.7	12.5	13.3	14.0	22.5	13.9	15.6	12.7	13.0	36.9	39.1	23.4	18.5	13.3	25.2	33.8	22.8	26.5	10.1	21.4	17.2	19.1	33.1	17.0	18.6	7.9	11.8	17.2	29.8	12.6	14.0	14.4	29.0	13.3	11.7	23.3	27.5	16.2	19.1	12.6	23.9	16.6	117.2	26.7	20.1	17.3	30.2	25.3	29.0	25.8	30.4	21.1	31.1	13.3	10.4	11.7	20.0	23.4	13.9	30.4	22.2	21.7	19.1	32.2	24.5	16.6	16.7	38.7	17.1	31.5	17.0	23.6	24.1	20.8	23.3	7.9	32.4	15.1	7.8	10.6	24.9	15.1	21.3	48.3	18.1	21.8	11.3	49.8	29.6	29.5	9.8	22.5	22.1	37.1	21.6	24.4	21.4	20.6	15.9	27.9	24.1	21.6	28.4	11.0	17.3	18.5	24.1	37.5	17.5	50.2	71.4	14.5	28.5	20.1	17.3	16.1	15.9	19.0	24.4	22.1	26.7	27.5	23.0	20.1	20.4	29.0	25.7	8.7	25.3	30.2	16.6	28.5	25.8	38.3	39.7	36.1	46.5	36.9	39.1	33.8	22.8	33.1	27.5
CADM3	"BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1"	ENSG00000162706	"Cell adhesion molecule 3"	Q8N126	1	159171609-159203313	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.5;placenta: 43.1"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.3;HSkMC: 64.8;hTERT-HME1: 34.7;WM-115: 17.2"	"Cancer enhanced"	"Detected in many"		"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002981, CAB025746"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		790000	Cytosol		"CAB025746: , HPA002981: AB_1078916"	"unprognostic (1.74e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.12e-3)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (5.52e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (5.75e-4)"	8.9	5.4	23.3	8.5	41.0	0.9	6.1	88.4	96.5	18.0	8.8	6.9	0.7	3.2	2.2	1.6	7.2	3.2	4.1	4.3	23.2	27.4	1.1	1.1	2.9	7.8	18.5	22.4	1.2	2.0	1.0	7.4	43.1	30.4	1.7	8.9	4.5	2.6	3.6	2.0	7.7	6.4	4.1	9.6	7.6	2.8	2.4	4.6	0.0	4.8	0.7	5.9	10.2	7.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.3	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	19.3	0.0	0.0	64.8	0.0	0.0	34.7	1.5	0.0	0.0	0.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	41.0	88.4	55.6	23.2	27.4	18.5	22.4	30.4	4.6
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390438	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 50.6;brain: 118.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.1;HEL: 23.4;HMC-1: 51.0;U-2 OS: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol			6400	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	50.6	11.6	10.1	5.1	7.5	0.9	18.2	31.2	9.9	1.7	8.9	1.7	0.0	1.7	1.4	3.0	3.0	2.4	2.0	2.2	5.9	74.2	0.9	0.9	2.1	0.9	17.7	7.5	5.6	1.4	0.9	3.0	0.9	118.9	1.1	6.0	4.9	2.1	1.3	1.0	1.0	2.7	2.7	7.5	0.9	1.2	14.6	1.5	0.0	0.8	0.2	1.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.7	6.5	0.0	0.2	0.0	1.2	0.2	0.1	0.2	0.0	0.0	8.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.2	0.0	0.0	51.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	14.6	0.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	7.5	31.2	9.9	5.9	74.2	17.7	7.5	118.9	1.5
CALCOCO1	"calphoglin, Cocoa, KIAA1536"	ENSG00000012822	"Calcium binding and coiled-coil domain 1"	Q9P1Z2	12	53708517-53727745	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.2;HSkMC: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038313, HPA038314"	Approved		Enhanced	Vesicles,Cytosol			11000	Cytosol	Vesicles	"HPA038313: AB_10675794, HPA038314: AB_10672587"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.63e-3)"	"unprognostic (9.88e-3)"	31.6	18.9	30.9	13.6	45.6	14.2	27.7	88.2	46.5	22.5	34.9	27.7	23.5	13.7	27.3	29.7	24.0	25.5	28.0	44.8	32.1	15.4	19.7	14.6	35.0	13.6	28.8	25.3	29.1	26.0	36.9	28.1	23.2	30.3	26.1	15.6	27.1	33.0	33.8	59.2	54.4	20.3	35.8	20.5	22.1	30.7	14.4	38.7	11.1	22.5	20.4	16.3	34.6	23.0	8.1	5.4	34.7	10.3	8.3	14.7	10.1	5.0	5.1	7.3	9.1	45.2	30.1	5.0	9.5	22.5	8.2	10.5	2.2	17.9	2.0	10.2	25.3	5.4	3.4	9.6	7.2	8.3	6.2	3.6	10.3	1.7	23.3	1.4	8.3	43.2	22.1	8.2	7.1	14.9	3.0	16.7	14.3	2.1	4.1	5.1	1.6	5.5	5.0	4.3	6.6	12.3	3.1	4.5	8.0	7.1	2.7	9.7	8.0	4.6	16.4	3.3	4.9	3.8	1.5	16.6	5.3	0.7	16.1	1.7	4.6	34.7	9.2	33.4	12.7	10.2	9.3	6.7	9.0	10.1	5.4	8.1	8.0	8.6	32.6	8.3	10.3	4.0	14.7	10.1	30.9	45.6	88.2	46.5	32.1	15.4	28.8	25.3	30.3	38.7
CALCOCO2	"MGC17318, NDP52"	ENSG00000136436	"Calcium binding and coiled-coil domain 2"	Q13137	17	48830988-48866522	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA022989, HPA023019, HPA023195"	Enhanced		Supported	Vesicles,Cytosol				Cytosol	Vesicles	"HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916"	"unprognostic (3.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.65e-2)"	70.5	30.8	20.6	21.0	29.5	22.2	50.8	22.1	28.1	38.5	40.2	26.8	32.7	27.0	39.4	35.6	41.3	36.1	28.4	55.5	24.8	16.6	36.6	48.7	42.6	28.2	36.8	24.8	37.7	22.7	24.6	46.3	26.5	32.3	37.3	42.1	46.9	30.0	31.8	70.1	31.3	35.2	47.8	42.8	29.5	35.5	51.8	37.3	25.0	48.4	32.3	26.0	46.4	74.2	18.0	22.0	44.4	40.7	33.2	34.2	24.7	26.3	17.1	7.2	13.9	53.9	39.1	20.9	25.6	34.5	29.7	33.4	31.9	17.3	8.9	25.8	31.1	14.7	17.5	21.7	35.8	40.8	14.5	8.4	10.7	12.4	62.0	28.5	43.2	57.5	32.4	31.4	22.9	21.7	15.4	27.1	25.7	7.7	24.5	15.2	2.2	21.1	16.3	35.4	16.8	11.4	8.4	2.9	6.2	8.0	5.2	22.8	33.5	16.0	21.0	32.5	9.9	19.8	18.1	24.1	33.4	6.3	19.7	14.5	13.3	30.2	36.2	36.3	19.8	39.5	18.9	18.0	17.7	20.3	22.0	16.6	18.1	19.6	44.4	33.2	40.7	11.1	34.2	24.7	20.6	29.5	22.1	28.1	24.8	16.6	36.8	24.8	32.3	37.3
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.4;BJ: 18.5;BJ hTERT+: 18.8;fHDF/TERT166: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	24.2	10.5	3.7	10.2	3.8	1.8	28.7	1.9	7.1	34.1	9.2	3.9	8.0	5.6	36.0	18.4	13.4	19.7	18.2	17.0	3.9	2.2	5.7	3.7	11.1	15.9	4.8	5.4	32.5	4.5	1.9	4.0	23.6	4.8	18.2	4.0	10.7	7.6	10.0	8.9	8.9	9.0	19.8	5.5	24.4	7.2	14.1	3.1	3.0	11.0	9.2	10.8	19.9	24.1	7.1	36.6	11.2	47.9	14.0	21.5	17.1	5.2	3.7	0.9	1.2	14.1	23.4	4.5	18.5	18.8	5.7	8.1	1.6	2.6	1.6	2.1	21.2	2.5	1.9	0.0	1.1	0.2	10.7	3.8	1.1	0.3	6.4	0.6	0.3	8.0	0.0	1.7	0.0	6.7	0.8	9.9	3.7	12.1	1.4	1.7	2.3	3.4	4.4	1.5	3.5	0.5	0.4	2.6	1.1	0.7	3.1	1.0	0.6	1.2	11.9	1.8	2.2	6.3	1.3	1.5	3.5	1.9	15.7	11.6	0.3	11.2	22.7	0.4	21.5	42.2	17.5	7.1	14.8	17.6	36.6	1.5	2.9	11.2	0.9	14.0	47.9	4.2	18.9	17.1	3.7	3.8	1.9	7.1	3.9	2.2	4.8	5.4	4.8	3.1
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206110	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 44.0;gallbladder: 28.4;intestine: 91.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 39.2;non-classical monocyte: 44.0"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA051109: "	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	2.4	2.5	1.8	12.0	1.1	0.8	2.2	2.6	1.0	3.2	40.3	2.2	7.7	34.0	1.5	7.8	5.1	7.3	28.4	1.4	2.6	0.7	12.6	12.3	3.1	2.6	0.9	1.3	2.3	5.3	0.0	3.1	2.1	8.4	4.3	21.8	3.1	1.9	6.7	1.4	1.7	91.6	2.7	1.0	5.3	5.4	2.4	0.6	1.1	1.5	1.3	1.3	1.9	2.0	0.0	4.5	1.8	44.0	0.0	0.0	2.8	2.5	7.7	5.7	3.4	0.6	1.0	4.0	1.6	1.5	2.6	2.6	14.9	16.0	2.5	2.0	1.1	10.8	12.8	2.3	1.0	2.1	12.4	4.1	13.2	5.2	2.3	3.5	5.5	1.1	3.4	1.5	2.2	2.9	3.8	2.9	0.6	7.2	5.6	7.7	4.9	2.3	8.4	5.6	5.1	0.9	4.3	2.9	3.3	2.5	2.3	6.7	1.7	3.4	2.4	3.8	3.5	6.6	6.3	10.6	6.2	7.0	2.4	6.9	1.3	0.0	6.5	0.0	0.0	39.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.0	44.0	0.2	0.0	2.8	1.8	1.1	2.6	1.0	2.6	0.7	0.9	1.3	8.4	0.6
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499555	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"salivary gland: 129.5;skin 1: 212.5"	"Cell line enriched"	"Detected in some"	21	"A-431: 92.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"			75000000	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favourable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	8.0	0.3	0.2	6.7	0.2	0.2	0.2	0.0	1.0	0.2	4.8	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	129.5	0.2	1.8	212.5	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.1	0.2	10.9	8.2	0.2	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CAMK1	CaMKI	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757342-9769992	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.5;blood: 59.4"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 59.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol			550000	Cytosol		"CAB031904: AB_630964, HPA051409: "	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	27.1	60.5	28.0	11.7	26.0	3.5	34.1	12.4	31.2	9.5	10.7	4.4	5.8	6.8	12.6	10.5	7.1	12.6	8.9	10.2	21.4	14.0	13.1	20.7	9.2	10.4	10.3	19.9	21.5	4.5	7.4	7.9	5.1	10.1	18.6	8.1	6.8	5.1	15.1	4.7	3.3	8.3	18.4	7.2	7.1	8.1	13.4	5.6	0.6	7.0	3.7	10.4	9.5	10.3	0.0	3.2	59.4	9.2	0.7	0.4	0.9	0.1	3.6	2.9	0.0	15.1	5.6	7.3	8.6	4.8	9.9	9.4	5.3	0.6	0.2	2.0	5.8	0.6	0.0	1.1	6.2	0.1	21.1	11.6	6.9	7.4	8.4	1.0	92.0	5.9	0.9	13.9	1.5	8.3	1.5	0.2	3.7	2.2	0.0	8.5	2.0	5.7	0.0	0.1	0.2	5.9	0.6	0.9	3.7	1.5	0.1	0.8	0.9	14.9	4.3	4.5	5.6	6.4	10.8	0.0	0.0	0.2	9.6	3.3	0.6	3.3	4.8	59.4	0.0	9.2	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.2	0.7	9.2	0.1	0.4	0.9	28.0	26.0	12.4	31.2	21.4	14.0	10.3	19.9	10.1	5.6
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349482-12835545	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.7;U-266/70: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favourable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	5.1	5.3	20.9	10.5	22.1	6.6	4.0	23.4	33.5	8.3	11.5	4.6	10.0	3.8	3.3	3.3	8.7	4.3	6.8	13.8	18.6	7.2	2.2	11.5	7.6	9.3	5.8	17.8	2.6	17.0	1.3	2.5	3.2	5.0	4.9	12.9	11.9	4.5	15.4	1.7	18.5	5.5	5.6	4.9	10.5	3.4	6.2	6.8	20.8	13.6	2.9	12.5	8.1	7.0	7.1	4.2	31.8	3.7	1.4	2.3	1.3	0.1	2.5	2.9	0.1	1.8	0.6	0.2	0.4	0.9	0.6	0.9	3.5	2.0	1.4	0.3	0.2	1.3	3.5	0.5	0.5	46.7	1.8	5.6	8.3	0.2	0.5	0.1	5.1	0.1	2.3	1.2	0.1	0.3	0.1	0.2	0.7	2.9	10.9	2.2	1.9	1.1	8.3	1.6	2.6	0.1	2.7	4.5	2.0	5.5	2.0	0.0	1.5	1.3	0.1	2.4	3.6	7.7	1.6	21.5	6.7	4.7	3.6	3.6	0.0	8.3	2.2	31.8	1.8	3.1	1.9	5.6	1.6	2.3	4.2	7.1	1.9	1.3	13.9	1.4	3.7	1.4	0.5	1.3	20.9	22.1	23.4	33.5	18.6	7.2	5.8	17.8	5.0	6.8
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"brain: 105.7;skeletal muscle: 50.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;SCLC-21H: 9.5;U-87 MG: 8.0"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Group enriched"	"Detected in all"	6	"amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1"	"Low region specificity"	"Detected in all"			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"			21000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: , HPA051785: , HPA053973: "	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0.0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0.0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0.0	1.2	0.0	1.1	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.5	1.3	0.8	0.7	0.0	0.1	0.0	0.2	0.6	2.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.2	1.7	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	9.5	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 41.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"			680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: , HPA051785: , HPA053973: "	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.7	0.0	1.0	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	5.2	0.0	0.2	0.1	2.3	0.1	0.9	0.1	0.0	0.0	41.0	2.2	0.2	0.0	0.0	1.9	0.1	0.2	0.2	0.3	0.2	0.0	0.5	0.4	0.1	0.1	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"			140000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: , HPA051785: , HPA053973: "	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	22.8	12.9	47.7	18.3	13.0	2.8	23.5	50.2	30.6	11.0	18.2	7.4	28.6	13.6	11.6	9.4	15.6	9.6	14.8	77.1	17.9	21.4	9.6	17.6	14.7	17.5	14.0	23.8	12.9	7.4	33.7	7.0	9.3	12.5	16.3	19.0	9.9	9.4	48.3	48.5	10.8	19.2	26.2	16.0	8.4	17.6	9.4	8.5	11.2	11.6	9.8	14.5	21.5	22.6	18.5	11.2	0.6	8.8	6.4	9.7	5.2	1.0	14.3	15.8	5.3	34.6	66.2	5.6	33.5	22.4	13.2	11.4	9.6	4.0	20.5	4.9	23.3	0.5	9.8	5.2	13.5	7.8	2.5	0.0	5.2	11.0	17.5	0.0	0.0	42.3	7.2	10.2	25.3	11.7	0.8	9.2	24.8	3.8	2.0	0.8	2.2	5.3	4.0	18.5	0.1	13.5	9.7	4.3	4.3	4.5	6.8	4.5	0.1	5.5	7.0	34.9	8.2	14.8	6.6	7.1	3.6	17.6	18.0	1.2	16.4	0.0	8.8	0.0	5.1	5.1	9.7	8.0	5.0	5.6	11.2	18.5	5.8	4.9	0.6	6.4	1.7	0.0	9.3	5.2	47.7	13.0	50.2	25.6	17.9	21.4	14.0	23.8	12.5	8.5
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Cell line enhanced"	"Detected in all"		"PC-3: 45.4;SK-BR-3: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"			170000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: , HPA051783: , HPA051785: , HPA053973: "	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	9.1	8.8	27.4	9.4	20.7	17.4	6.8	22.2	53.8	9.0	37.3	13.3	9.7	19.7	20.1	9.1	20.6	13.2	10.6	6.7	22.8	24.4	11.6	5.9	10.7	8.9	26.8	31.2	6.4	5.7	8.0	6.0	15.8	38.6	18.5	15.5	8.5	12.4	29.8	73.0	9.1	18.1	29.6	29.8	11.0	14.2	3.8	13.4	4.4	6.4	7.6	8.7	26.5	10.8	4.2	7.1	39.8	5.6	9.8	9.2	5.0	10.9	7.9	7.1	13.6	5.2	8.6	8.4	7.5	12.9	10.4	8.5	12.2	11.8	8.1	7.9	9.7	17.0	5.6	6.4	8.3	7.3	6.7	5.5	6.1	5.5	2.6	7.5	9.3	4.5	5.8	10.3	7.2	8.8	6.0	12.1	5.7	7.6	12.5	11.2	5.2	45.4	11.4	7.5	4.3	5.4	15.9	3.7	8.6	4.3	57.2	3.7	10.7	4.7	10.8	7.7	12.4	4.2	10.1	3.7	4.4	7.5	8.3	21.5	2.7	8.5	5.6	39.8	7.5	2.3	9.2	4.2	8.4	8.0	7.1	3.9	8.1	7.9	36.4	9.8	4.0	2.4	8.1	5.0	27.4	20.7	22.2	53.8	22.8	24.4	26.8	31.2	38.6	13.4
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	"Calcium/calmodulin dependent protein kinase kinase 1"	Q8N5S9	17	3860315-3894891	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.9;salivary gland: 27.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 17.8;U-87 MG: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009111, HPA028062"	Approved		Supported	Cytosol				Cytosol		"CAB009111: AB_2068406, HPA028062: AB_1845954"	"unprognostic (1.39e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.40e-3)"	"unprognostic (2.94e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.70e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.10e-1)"	4.3	10.2	15.3	5.1	21.4	3.7	4.7	23.2	38.9	4.1	3.2	2.2	4.0	3.1	7.5	5.2	4.2	3.7	3.8	5.7	13.8	6.8	1.5	1.0	4.0	2.5	5.5	16.0	6.0	7.5	5.0	10.1	2.3	11.2	3.3	3.1	2.5	27.1	11.2	2.2	7.8	3.7	6.2	2.2	4.3	2.9	6.1	5.0	1.7	7.2	2.3	2.5	5.6	4.9	0.1	1.6	5.6	4.1	0.0	1.0	1.1	4.8	8.4	0.9	4.2	3.0	5.4	0.3	3.4	3.7	3.2	1.5	3.0	1.5	2.9	3.6	6.4	14.5	2.3	4.1	2.0	0.1	7.7	3.3	17.8	1.1	3.1	0.5	2.6	4.1	3.5	6.1	2.1	1.4	2.6	0.1	1.6	1.3	4.0	1.9	0.9	7.9	2.1	3.7	3.4	3.5	3.1	4.9	2.7	1.3	10.0	2.2	3.8	1.1	2.0	5.6	7.6	7.1	2.7	0.4	0.2	0.1	20.5	2.8	0.7	0.0	1.8	3.6	0.6	3.9	1.0	0.0	0.6	0.5	1.6	0.1	0.6	0.3	5.6	0.0	4.1	0.8	0.0	1.1	15.3	21.4	23.2	38.9	13.8	6.8	5.5	16.0	11.2	5.0
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	"Calcium/calmodulin dependent protein kinase kinase 2"	Q96RR4	12	121237691-121298308	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 125.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 125.5"	"Group enriched"	"Detected in many"	5	"classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol				Cytosol		"HPA017389: AB_1845956, HPA063713: "	"unprognostic (5.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	11.7	6.5	19.7	7.8	30.2	13.8	8.8	125.5	45.5	9.0	9.5	7.1	2.6	12.8	8.6	5.3	8.3	11.8	6.3	6.9	11.2	5.1	7.1	8.9	9.6	6.9	6.2	17.3	10.5	5.8	6.4	4.1	7.5	9.1	12.2	9.7	6.2	7.5	13.2	5.1	9.1	13.2	10.3	6.2	14.1	7.6	3.6	5.8	5.2	6.1	4.5	7.2	7.2	7.4	2.2	7.2	26.1	19.4	3.6	2.2	6.3	12.3	9.3	6.9	13.4	20.8	19.4	10.6	10.2	10.9	8.4	7.7	9.7	5.3	19.1	8.6	20.7	10.2	8.5	11.0	6.6	13.1	16.7	9.5	6.2	9.5	14.1	21.6	9.1	12.5	16.4	7.9	18.0	19.6	11.0	10.4	8.1	12.0	23.9	17.8	5.0	10.5	15.6	8.0	16.9	8.1	13.8	26.6	10.6	13.4	7.2	8.5	17.9	26.4	14.3	6.9	5.6	5.8	5.6	39.7	23.6	14.5	12.9	15.1	6.8	0.7	14.2	26.1	2.1	19.4	2.2	2.2	1.7	1.9	7.2	1.2	1.5	1.7	17.2	3.6	16.5	1.6	1.3	6.3	19.7	30.2	125.5	45.5	11.2	5.1	6.2	17.3	9.1	5.8
CAMSAP1	"DKFZp434F195, FLJ31228"	ENSG00000130559	"Calmodulin regulated spectrin associated protein 1"	Q5T5Y3	9	135808487-135907228	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020527, HPA024161"	Approved		Supported	"Mitotic spindle,Cytosol"				"Mitotic spindle, Cytosol"		"HPA020527: , HPA024161: AB_1845967"	"unprognostic (3.18e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	"prognostic favourable (3.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-3)"	8.0	8.6	12.4	6.5	15.7	10.5	8.3	23.9	21.7	7.6	6.3	14.3	7.2	4.1	9.5	6.9	22.0	9.8	6.5	9.2	11.2	10.8	5.2	4.8	8.2	6.6	10.4	9.9	13.5	9.5	8.9	9.4	6.5	12.2	8.0	4.7	24.2	7.3	8.6	32.7	10.4	4.3	8.6	10.3	6.2	6.2	20.8	9.2	10.0	5.7	14.4	11.4	7.6	10.0	2.4	1.1	3.8	1.6	1.0	2.1	1.2	9.1	13.5	22.2	15.6	5.2	4.6	10.9	7.4	6.2	8.1	6.1	11.8	8.0	4.2	10.7	9.3	18.8	11.7	8.0	6.2	14.3	6.5	6.1	15.1	5.9	7.9	10.6	9.2	6.0	10.2	10.3	14.2	9.0	12.6	9.2	10.5	16.3	9.8	6.6	12.7	9.8	19.3	18.5	10.3	8.1	11.2	24.3	23.9	9.5	6.9	10.3	9.7	8.8	11.1	15.4	12.1	11.3	12.5	4.6	8.6	11.6	10.0	7.2	8.8	3.8	1.5	0.3	1.1	1.6	2.1	2.4	1.8	1.7	0.9	0.5	1.3	1.9	0.5	1.0	1.3	1.1	1.4	1.2	12.4	15.7	23.9	21.5	11.2	10.8	10.4	9.9	12.2	9.2
CAMSAP2	"CAMSAP1L1, KIAA1078"	ENSG00000118200	"Calmodulin regulated spectrin associated protein family member 2"	Q08AD1	1	200739558-200860704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026304, HPA026511, HPA027302"	Enhanced		Supported	"Microtubule ends,Cytosol"				"Microtubule ends"	Cytosol	"HPA026304: AB_1852376, HPA026511: AB_1852378, HPA027302: AB_1852380"	"unprognostic (1.19e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.82e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (8.23e-3)"	"unprognostic (9.56e-2)"	11.6	11.9	12.8	4.5	15.2	0.1	7.4	16.8	29.7	11.3	5.8	16.6	5.9	2.7	14.4	7.7	8.1	6.6	8.9	7.7	13.0	11.9	8.9	5.0	10.5	2.3	10.3	11.1	14.5	3.9	20.7	6.1	13.0	17.4	8.2	4.7	8.6	5.0	10.0	5.4	9.0	2.7	11.6	10.2	5.6	5.0	10.1	7.0	1.8	13.8	5.3	4.1	13.1	7.4	0.1	0.5	0.7	0.6	0.0	1.4	0.1	11.2	7.6	10.5	9.5	8.5	11.3	12.1	11.4	9.9	9.2	7.7	5.5	6.8	0.0	6.5	12.6	10.2	10.8	16.8	11.1	6.7	5.5	0.5	11.5	2.5	9.5	0.7	2.9	8.2	25.9	14.7	57.9	14.0	1.4	3.6	14.9	5.9	0.1	0.2	9.8	10.8	4.5	11.6	5.1	7.9	8.3	5.5	9.8	16.8	10.4	9.4	9.9	0.6	16.7	15.1	9.0	9.4	14.1	7.2	11.9	6.0	11.0	1.7	11.4	0.7	0.6	0.0	0.3	0.1	0.4	0.1	1.4	0.0	0.5	0.0	1.4	0.4	0.0	0.0	0.1	0.2	0.8	0.1	12.8	15.2	16.8	16.3	13.0	11.9	10.3	11.1	17.4	7.0
CAMTA1	KIAA0833	ENSG00000171735	"Calmodulin binding transcription activator 1"	Q9Y6Y1	1	6785324-7769706	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036342, HPA036343"	Approved		Supported	Cytosol				Cytosol		"HPA036342: , HPA036343: AB_10671839"	"unprognostic (1.11e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"prognostic favourable (4.10e-4)"	"unprognostic (3.90e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.17e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.03e-3)"	18.4	24.3	31.6	12.2	30.7	12.1	21.7	24.4	37.1	16.5	30.2	19.9	13.2	28.3	20.0	46.7	22.7	16.8	17.7	58.1	26.4	27.6	36.7	37.2	16.5	13.3	31.2	26.5	17.1	18.6	22.0	17.6	14.3	47.5	22.2	27.1	25.0	27.1	29.6	48.0	12.9	30.4	38.4	23.9	15.7	21.5	23.0	19.4	14.7	30.8	20.5	17.5	31.3	18.7	19.8	32.3	28.3	32.4	10.3	18.1	18.9	21.5	12.2	33.9	17.2	17.5	26.8	9.5	23.5	18.1	25.3	21.4	14.7	27.5	18.0	18.5	24.5	13.4	17.7	24.2	36.2	13.4	19.2	20.2	28.8	28.7	28.5	15.3	14.7	18.0	16.9	18.2	28.1	28.1	14.2	24.4	29.1	20.9	20.3	42.0	23.4	14.3	13.6	30.2	39.7	34.1	12.6	35.1	28.3	16.6	24.7	36.0	13.4	19.2	16.4	18.0	15.2	18.5	14.6	18.7	23.0	48.2	26.9	34.5	10.1	27.5	32.4	28.3	11.5	19.4	12.5	19.8	18.0	14.2	30.6	16.2	14.7	12.8	6.6	10.3	14.7	32.3	18.1	18.9	31.6	30.7	24.4	37.1	26.4	27.6	31.2	26.5	47.5	19.4
CAND1	"DKFZp434M1414, KIAA0829, TIP120, TIP120A"	ENSG00000111530	"Cullin associated and neddylation dissociated 1"	Q86VP6	12	67269281-67319951	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055748, HPA062833, HPA069053"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"			4200000	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074"	"unprognostic (1.50e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	21.3	26.7	28.7	19.1	38.3	19.6	27.0	34.6	32.6	23.9	20.0	17.5	17.0	19.7	22.8	29.9	26.6	20.6	19.0	15.2	24.8	27.0	25.4	27.7	18.7	25.4	23.3	29.0	29.0	22.1	33.2	27.1	23.3	33.2	24.1	21.7	15.8	19.6	22.0	11.1	29.5	19.5	22.4	21.5	20.2	19.3	26.9	23.8	39.4	27.0	17.0	30.2	21.1	22.1	11.9	7.8	6.1	10.1	14.7	15.2	4.3	22.2	23.0	35.1	24.9	26.9	21.1	23.5	22.2	19.2	23.4	20.7	21.3	12.8	48.2	19.4	22.2	21.4	37.6	25.2	26.9	18.3	22.5	27.2	18.5	20.1	17.7	31.9	15.5	19.8	19.2	21.4	19.8	21.8	21.4	27.1	25.2	21.9	28.9	21.7	37.1	16.1	28.3	30.0	20.4	21.6	38.1	36.0	17.9	27.6	25.5	17.9	27.3	14.7	18.5	18.7	12.1	12.8	16.7	8.9	10.9	41.1	22.2	19.0	19.1	6.1	5.0	5.5	11.6	5.9	14.1	8.6	14.2	12.7	7.8	11.9	15.2	12.7	2.2	14.7	10.1	6.6	14.7	4.3	28.7	38.3	34.6	31.8	24.8	27.0	23.3	29.0	33.2	23.8
CAND2	"KIAA0667, TIP120B, Tp120b"	ENSG00000144712	"Cullin associated and neddylation dissociated 2 (putative)"	O75155	3	12796472-12871916	"Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 76.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.2;REH: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005777	Approved		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"HPA005777: "	"unprognostic (6.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.78e-5)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-3)"	2.9	2.8	6.4	1.4	7.6	1.4	1.4	7.2	11.8	2.3	3.2	3.7	0.5	1.5	3.7	2.6	2.6	3.6	2.1	17.8	4.7	4.3	1.7	1.7	1.9	1.4	2.7	5.5	3.3	2.5	6.4	4.9	1.4	3.1	3.0	1.4	4.2	2.2	3.4	76.2	1.6	1.7	5.2	2.2	2.2	2.1	11.4	2.6	0.1	2.4	11.1	1.2	3.0	5.0	1.2	0.2	0.7	0.5	0.0	2.2	0.6	0.7	1.5	5.8	0.2	0.2	0.1	0.3	1.6	0.6	3.1	4.2	0.8	0.3	0.9	1.7	0.8	0.2	6.4	0.1	2.8	1.6	18.2	1.3	2.2	1.2	4.9	0.1	0.1	1.3	0.3	3.0	0.1	0.7	4.7	0.9	0.9	2.9	2.3	0.7	4.0	1.8	11.2	1.1	0.9	0.2	1.3	3.9	5.2	0.1	0.8	1.0	1.7	5.5	0.4	0.9	1.0	0.9	1.2	1.5	8.9	8.6	0.5	1.1	1.9	0.0	0.5	0.0	1.2	0.2	0.6	1.2	0.6	2.2	0.1	0.5	1.3	0.9	0.7	0.0	0.1	0.2	1.6	0.6	6.4	7.6	7.2	11.8	4.7	4.3	2.7	5.5	3.1	2.6
CAP1	CAP	ENSG00000131236	"Cyclase associated actin cytoskeleton regulatory protein 1"	Q01518	1	40040233-40072649	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 201.2"	"Cell line enhanced"	"Detected in all"		"THP-1: 199.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030124	Approved		Supported	Cytosol			270000000	Cytosol		"HPA030124: AB_10600799"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (1.44e-6)"	"unprognostic (5.37e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	70.0	31.8	33.3	68.7	41.0	74.6	42.4	16.6	37.4	40.1	58.2	42.7	25.2	37.9	69.4	28.9	60.9	44.6	36.9	27.2	28.6	26.6	56.6	52.0	58.2	63.7	37.2	26.9	44.5	22.6	29.7	22.5	74.4	39.5	42.0	57.7	31.3	39.8	39.7	20.6	37.1	58.9	62.9	42.7	79.9	44.6	39.0	30.0	62.4	40.2	32.6	83.1	53.3	40.8	27.4	70.6	201.2	106.1	37.2	57.6	115.5	44.0	19.1	24.2	14.3	34.4	32.3	36.1	78.1	47.2	44.1	44.5	27.5	46.8	34.2	31.9	64.3	27.7	28.9	57.2	60.8	45.7	17.1	53.7	21.1	21.6	31.7	33.1	153.1	32.9	29.5	67.3	38.1	37.2	20.0	23.0	65.9	13.0	26.3	18.2	39.2	21.5	19.9	32.1	21.0	46.7	46.6	11.5	24.1	33.2	38.5	53.0	17.8	199.4	66.1	37.7	34.3	19.7	66.1	18.8	36.9	31.4	49.6	37.0	49.4	95.4	60.2	201.2	57.6	88.9	45.3	27.4	41.7	55.1	70.6	26.3	35.4	47.9	128.3	37.2	106.1	27.7	55.1	115.5	33.3	41.0	16.6	37.4	28.6	26.6	37.2	26.9	39.5	30.0
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393216-17557792	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 165.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"MAIT T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	5.8	4.1	13.8	3.0	20.1	0.7	3.9	7.5	26.4	5.6	7.7	1.9	2.0	1.9	9.2	5.9	7.0	5.8	3.8	31.2	19.9	8.7	3.3	2.0	2.1	1.1	5.3	17.3	2.1	1.6	3.2	1.7	6.2	8.6	8.4	3.6	2.9	2.5	10.1	165.7	0.9	2.6	13.1	2.0	1.6	3.3	1.1	1.3	0.0	2.3	14.5	1.3	4.6	6.4	0.0	0.0	0.0	0.0	0.0	2.9	0.1	5.4	8.4	16.3	19.6	0.1	0.0	3.5	19.3	14.1	15.9	14.5	2.8	2.4	0.0	18.2	20.7	2.8	7.2	7.2	23.0	0.0	2.7	0.0	5.4	9.2	1.5	0.0	0.0	1.2	3.5	8.0	3.5	0.7	0.0	0.0	33.5	8.7	0.0	0.0	6.2	4.8	1.8	21.7	0.3	8.3	2.2	2.1	4.1	6.5	21.0	11.4	23.2	3.9	0.0	12.9	12.3	0.3	16.9	0.0	0.0	0.0	4.2	0.0	17.5	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	20.1	7.5	26.4	19.9	8.7	5.3	17.3	8.6	1.3
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 88.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol			28000000	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favourable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	22.0	15.6	9.6	23.8	11.6	18.2	18.8	17.7	20.1	25.8	33.3	8.4	23.0	25.4	19.3	30.2	86.9	28.1	39.1	21.4	8.8	11.2	27.8	21.3	19.4	19.5	10.8	9.7	21.4	24.9	13.3	14.1	38.1	16.8	27.3	17.0	15.8	39.7	24.3	24.2	38.9	49.9	16.5	7.7	21.3	20.7	8.3	6.7	32.1	37.5	50.2	53.7	33.7	35.2	16.7	22.8	34.5	24.8	15.7	19.6	28.5	47.4	25.3	7.2	16.1	13.2	16.7	22.0	14.1	22.5	16.6	12.7	16.1	42.7	11.9	23.6	26.8	70.2	9.4	59.6	5.3	12.6	7.5	28.3	14.6	15.7	13.1	6.6	39.8	18.4	32.1	14.1	6.9	28.5	16.8	9.6	13.6	30.5	13.1	21.0	20.9	22.9	13.0	7.4	7.2	22.6	88.3	13.0	9.6	14.9	57.7	13.6	24.8	13.1	24.7	13.0	8.9	27.6	6.3	5.9	4.3	14.1	22.6	8.1	14.0	34.3	24.8	34.5	19.6	23.7	15.7	15.6	15.5	17.7	22.8	16.7	9.1	12.5	15.8	15.7	14.0	17.9	16.6	28.5	9.6	11.6	17.7	20.1	8.8	11.2	10.8	9.7	16.8	6.7
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586716-240617705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: "	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favourable (8.47e-5)"	"prognostic unfavourable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favourable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	9.2	11.8	16.8	12.9	15.1	10.9	6.6	20.5	15.7	8.3	13.6	12.8	10.0	20.8	11.3	8.0	9.7	9.8	10.2	11.5	15.9	10.7	14.2	9.3	8.4	15.3	11.2	18.1	10.0	13.0	8.6	13.2	7.3	11.1	10.6	12.2	12.4	14.6	10.7	6.5	19.5	16.2	8.3	8.1	21.0	15.0	10.7	13.7	15.1	9.3	5.6	13.2	8.3	7.0	1.5	2.0	7.7	1.8	5.8	2.2	0.8	5.1	7.8	7.7	6.0	3.0	2.5	13.4	6.6	2.8	4.4	4.3	5.7	12.4	3.9	2.3	2.3	8.8	1.9	4.4	2.3	14.9	13.6	7.2	12.9	10.0	4.9	4.6	10.2	2.2	3.1	4.6	1.9	3.3	8.0	4.9	1.8	4.5	10.3	17.7	11.5	5.5	9.8	5.4	8.3	6.9	6.2	19.4	15.2	4.2	6.0	8.3	3.0	5.7	5.7	7.6	6.5	6.1	7.9	12.2	2.7	7.0	7.2	8.5	7.1	1.7	1.8	3.3	2.0	1.0	0.5	1.5	1.3	2.0	0.8	1.5	1.2	1.8	7.7	5.8	1.1	2.0	2.2	0.8	16.8	15.1	20.5	15.7	15.9	10.7	11.2	18.1	11.1	13.7
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol			1500000	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (6.21e-4)"	56.2	41.0	23.8	20.7	22.2	11.1	61.1	26.1	20.9	40.3	44.8	18.3	23.3	14.5	29.1	44.5	56.3	40.1	58.9	33.0	26.5	13.1	41.6	13.3	58.6	18.2	27.4	18.2	32.4	26.8	53.7	12.7	26.4	23.8	27.2	44.4	16.5	62.5	31.9	48.1	16.5	22.7	35.7	32.3	15.9	48.2	17.2	24.7	5.0	29.9	39.7	35.9	28.3	38.8	9.0	41.6	1.7	29.1	6.0	28.7	28.2	45.7	29.3	9.4	6.3	31.4	43.6	9.0	43.3	62.9	31.5	17.9	23.2	36.8	0.0	14.3	48.0	28.6	10.1	68.4	29.3	11.7	10.5	0.8	15.0	2.9	28.2	2.4	1.5	23.3	22.2	49.0	26.2	62.4	13.1	12.2	92.6	0.9	0.1	2.1	5.2	38.3	3.8	30.7	0.7	54.3	2.7	2.0	10.9	22.3	60.9	13.5	9.2	11.0	95.9	29.5	24.5	25.4	55.5	3.6	6.9	0.1	73.9	5.1	32.4	1.7	29.1	1.7	28.7	19.5	24.5	9.0	20.0	27.7	41.6	3.6	6.4	17.4	1.5	6.0	17.5	1.9	19.9	28.2	23.8	22.2	26.1	20.9	26.5	13.1	27.4	18.2	23.8	24.7
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066932-77126155	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.5;intestine: 47.8"	"Cell line enhanced"	"Detected in many"		"U-2197: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: "	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	3.9	7.1	5.6	19.5	5.4	1.5	3.9	6.3	10.8	7.4	34.1	6.0	4.8	32.7	6.3	8.3	18.3	6.6	49.5	4.4	5.4	4.6	8.7	26.8	2.8	1.2	3.7	7.0	15.4	3.2	0.7	3.3	2.6	10.2	9.3	27.9	7.4	4.7	7.5	1.8	1.9	47.8	9.3	4.1	2.2	29.3	22.0	2.3	0.6	3.1	4.6	7.3	9.8	6.3	0.2	0.7	0.0	0.9	0.0	4.8	2.1	0.4	6.7	4.5	4.4	17.0	16.4	0.4	6.8	11.8	7.0	5.1	3.9	2.0	0.2	4.9	11.7	0.3	1.8	0.5	3.0	0.4	0.4	1.3	0.2	0.4	4.2	0.1	0.4	8.1	0.7	11.2	2.7	8.1	0.1	0.1	12.9	9.4	1.1	0.2	3.8	5.3	1.0	15.2	0.2	2.3	8.5	0.3	8.1	1.6	1.3	3.0	1.0	0.0	16.7	13.6	8.0	18.7	0.8	0.4	0.9	0.0	7.0	0.2	3.1	0.0	0.7	0.0	4.8	0.9	0.4	0.0	0.5	1.6	0.7	0.2	2.4	2.5	0.0	0.0	0.2	0.3	0.0	2.1	5.6	5.4	6.3	10.8	5.4	4.6	3.7	7.0	10.2	2.3
CAPNS1	"30K, CANP, CANPS, CAPN4, CDPS"	ENSG00000126247	"Calpain small subunit 1"	P04632	19	36139575-36150353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006872	Approved		Approved	Nucleoplasm,Cytosol			50000000	"Nucleoplasm, Cytosol"		"HPA006872: AB_1078382"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-2)"	67.8	59.4	58.7	49.6	53.1	47.1	54.4	29.9	92.0	74.8	87.8	50.8	45.3	61.3	50.1	48.8	111.9	74.9	70.6	137.2	55.7	61.0	104.0	67.5	70.7	74.0	56.6	52.0	63.0	45.1	72.3	48.6	48.1	71.5	59.8	69.6	62.8	61.4	71.8	95.7	30.9	95.6	69.2	47.4	63.6	50.4	49.2	27.8	45.4	71.4	65.9	87.3	56.7	57.9	13.4	25.7	11.3	33.2	9.6	20.3	8.1	40.5	101.8	25.5	36.4	61.6	75.5	5.1	33.2	71.0	67.8	52.6	23.0	60.3	14.6	49.3	110.6	21.7	30.5	81.4	57.6	61.4	15.0	16.9	30.7	38.8	71.6	16.8	42.8	80.7	50.8	43.8	62.3	73.6	20.4	58.9	103.0	53.3	30.0	30.5	14.7	51.6	15.9	20.7	27.0	127.2	40.9	17.3	21.8	40.0	56.8	15.8	33.1	27.6	47.5	60.2	45.8	20.1	33.3	21.0	27.9	13.0	68.3	23.0	51.5	8.8	22.5	9.3	20.3	31.4	13.0	12.9	14.3	16.2	19.8	13.4	8.8	11.8	11.3	9.6	33.2	25.7	14.0	8.1	58.7	53.1	29.9	92.0	55.7	61.0	56.6	52.0	71.5	27.8
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566672-55567687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 56.0;skin 1: 44.1;tongue: 45.6"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 69.8"	"Group enriched"	"Detected in many"	15	"cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.9;intermediate monocyte: 2.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 2.1"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol				Cytosol		"HPA059749: , HPA076768: "	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.1	0.0	0.1	0.1	0.4	0.2	3.4	0.1	0.1	5.8	0.1	0.1	0.1	0.0	0.4	0.1	56.0	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.0	0.2	6.7	0.1	0.6	44.1	0.1	1.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1	45.6	14.6	12.3	10.8	0.0	0.5	6.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	69.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	6.9	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CAPRIN1	"caprin-1, GPIAP1, M11S1, RNG105"	ENSG00000135387	"Cell cycle associated protein 1"	Q14444	11	34051683-34101156	"Predicted intracellular proteins"	Differentiation	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018126, HPA063617"	Approved		Enhanced	Cytosol				Cytosol		"HPA018126: AB_1849929, HPA063617: "	"unprognostic (3.79e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (8.67e-8)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	36.7	34.5	32.7	32.0	37.5	38.4	41.5	45.8	48.7	40.4	32.0	34.0	31.2	30.2	42.6	31.6	36.1	40.8	28.7	34.4	32.1	30.5	35.8	27.8	30.8	36.0	27.5	35.7	41.0	30.6	61.2	33.4	36.8	29.7	32.4	40.4	26.2	35.3	37.7	43.8	29.8	31.3	42.6	38.3	35.5	28.3	80.0	30.3	64.3	35.1	32.9	38.8	41.5	32.9	14.3	26.0	15.8	28.2	21.6	20.7	17.7	32.6	39.3	58.9	34.0	45.4	46.5	30.5	42.1	42.4	49.3	46.2	35.9	20.0	52.5	25.3	51.3	44.0	74.9	49.1	60.0	31.5	40.3	41.0	39.6	31.3	27.8	65.1	31.3	40.9	27.4	31.2	58.2	49.1	52.4	24.9	52.3	26.2	56.4	12.7	30.1	37.2	44.1	80.3	23.3	31.4	62.1	39.1	38.2	47.4	26.0	23.3	45.8	28.0	46.9	41.6	29.7	42.3	47.5	27.2	39.3	56.8	29.8	28.8	47.3	15.8	21.2	8.8	14.1	27.4	20.7	14.3	16.6	17.3	26.0	12.8	17.5	16.5	9.4	21.6	28.2	14.2	19.4	17.7	32.7	37.5	45.8	48.7	32.1	30.5	27.5	35.7	29.7	30.3
CAPRIN2	"C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140"	ENSG00000110888	"Caprin family member 2"	Q6IMN6	12	30709552-30754951	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039746	Supported		Supported	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA039746: AB_10672902"	"unprognostic (7.45e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.50e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"prognostic favourable (8.36e-4)"	5.5	7.8	12.5	5.3	20.6	9.3	5.0	19.9	15.7	7.3	5.3	4.4	9.5	4.0	8.6	10.5	3.6	4.9	6.1	17.4	11.8	19.0	6.5	5.3	6.5	5.4	11.2	11.6	8.3	5.5	22.4	11.0	4.2	18.2	7.4	5.7	6.1	3.1	10.0	5.6	10.6	4.6	8.4	11.5	6.7	6.5	22.3	9.4	4.3	5.7	3.9	5.0	6.1	8.1	4.1	4.2	7.5	1.5	2.6	5.4	0.9	4.6	3.2	6.1	5.2	6.1	6.5	3.7	8.6	7.3	3.7	5.1	1.7	3.0	2.7	7.6	9.0	3.7	3.2	14.0	6.8	4.0	3.6	11.3	5.3	6.5	3.4	1.7	1.1	7.4	5.6	12.0	9.7	8.4	0.7	2.7	8.8	0.9	2.2	2.9	7.2	9.9	1.0	9.2	1.3	1.6	16.7	7.7	4.7	3.2	2.3	3.7	2.1	0.5	11.4	7.2	4.0	22.0	15.8	5.3	3.7	2.4	8.8	0.5	4.7	7.5	1.5	1.2	4.4	0.6	5.4	3.7	2.8	4.6	0.6	4.1	3.1	2.8	0.3	2.6	0.7	4.2	1.8	0.9	12.5	20.6	19.9	13.7	11.8	19.0	11.2	11.6	18.2	9.4
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine		19	5911707-5915877	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 71.4;fallopian tube: 116.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.0;U-266/70: 10.0"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 71.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favourable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favourable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	2.6	4.1	8.0	4.3	14.7	4.3	2.8	1.4	3.3	12.4	3.3	34.4	15.6	3.1	9.1	49.4	2.8	116.0	13.6	2.0	13.4	6.6	8.9	5.0	25.4	4.4	8.0	7.8	26.7	6.5	2.5	7.5	17.7	71.4	9.4	2.0	3.3	7.7	12.7	2.0	5.7	5.0	2.9	7.5	7.6	9.4	2.1	17.9	0.4	7.8	0.9	2.5	8.8	11.3	4.9	4.0	5.2	2.2	5.3	4.8	2.4	1.0	1.1	0.7	3.4	1.3	1.8	2.1	0.5	0.4	0.2	0.3	0.8	7.4	0.8	2.2	0.9	1.3	0.3	0.3	0.1	2.4	1.0	0.6	2.2	2.0	1.2	0.6	1.8	2.2	2.1	0.2	0.5	0.5	0.5	2.9	0.4	2.1	1.4	2.0	0.6	5.6	1.7	0.3	2.3	1.0	3.1	0.7	2.5	0.5	36.0	3.6	2.2	2.3	1.0	0.6	0.4	2.6	9.5	10.0	3.4	0.6	4.2	1.0	1.4	3.3	2.2	1.6	4.8	1.8	2.6	3.1	3.0	3.6	2.1	4.9	2.4	2.0	5.2	5.3	1.6	4.0	3.2	2.4	8.0	14.7	1.4	3.3	13.4	6.6	8.0	7.8	71.4	17.9
CAPZA2	"CAPPA2, CAPZ"	ENSG00000198898	"Capping actin protein of muscle Z-line alpha subunit 2"	P47755	7	116811070-116922049	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007470, HPA007643"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"			19000000	"Endoplasmic reticulum"	Cytosol	"HPA007470: AB_1845985, HPA007643: "	"unprognostic (1.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavourable (9.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.65e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.58e-2)"	32.4	17.7	23.6	15.8	22.6	33.6	18.5	17.6	30.2	17.7	26.3	10.7	13.5	16.9	20.6	16.4	25.9	14.9	17.6	36.4	26.7	20.6	40.9	29.2	23.2	16.6	22.1	15.9	17.3	13.8	12.9	16.4	26.1	27.1	21.8	20.6	11.8	14.4	18.3	47.1	11.6	30.6	30.3	19.6	26.0	17.8	12.4	13.7	17.7	24.5	21.0	14.0	31.5	15.0	6.6	14.8	32.0	22.8	7.1	7.8	17.7	12.9	8.8	8.5	11.1	16.3	17.3	4.7	12.8	18.1	12.9	14.8	6.4	16.6	8.8	21.0	18.1	8.1	8.8	10.5	20.0	9.6	7.0	13.2	8.7	10.7	10.1	8.8	17.9	13.9	11.8	10.5	9.9	27.1	8.8	15.3	25.3	6.3	11.4	14.8	12.6	7.6	8.1	11.5	17.4	30.0	11.1	9.1	10.4	11.9	44.9	12.2	6.3	10.2	10.0	20.7	6.6	16.3	12.0	12.1	8.8	16.8	12.3	12.5	14.7	19.9	16.4	19.2	5.5	20.1	6.1	6.6	6.5	5.7	14.8	6.0	6.4	6.5	32.0	7.1	22.8	8.2	7.8	17.7	23.6	22.6	17.6	30.2	26.7	20.6	22.1	15.9	27.1	13.7
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line beta subunit"	P47756	1	19338776-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol			35000000	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	29.6	24.8	57.1	38.4	47.3	27.9	28.1	23.0	39.7	34.8	84.1	34.3	19.3	29.2	40.3	28.2	41.8	29.2	29.3	80.3	53.8	40.7	29.3	37.5	29.7	50.4	53.5	33.6	38.6	24.9	23.7	18.1	36.9	29.5	42.2	43.5	30.4	23.7	35.9	160.5	27.0	43.7	49.5	72.0	42.1	32.6	70.5	22.3	51.2	34.2	35.3	54.3	56.9	32.3	39.8	55.6	155.9	96.3	27.1	57.2	78.0	47.7	28.4	51.2	36.8	70.3	90.5	36.0	81.3	84.9	72.1	74.2	35.4	67.4	33.0	35.5	101.6	40.6	43.9	56.1	81.2	51.9	31.1	64.6	38.1	55.2	72.1	42.8	106.8	83.4	46.7	61.7	58.4	65.6	22.9	47.2	72.0	33.9	47.4	49.8	38.4	30.8	42.9	36.0	43.3	90.9	27.5	31.1	24.1	47.8	40.0	53.8	43.9	37.5	67.6	48.6	39.9	79.5	38.7	29.2	35.1	41.6	63.7	56.4	52.3	53.8	54.4	155.9	49.1	79.4	41.8	39.8	51.1	52.3	55.6	29.1	43.1	46.1	87.8	27.1	96.3	30.2	57.2	78.0	57.1	47.3	23.0	39.7	53.8	40.7	53.5	33.6	29.5	22.3
CARD10	"BIMP1, CARMA3"	ENSG00000100065	"Caspase recruitment domain family member 10"	Q9BWT7	22	37490362-37519542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 23.6;U-2197: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029359, HPA055612"	Approved		Approved	"Vesicles,Intermediate filaments,Cytosol"				"Vesicles, Intermediate filaments"	Cytosol	"HPA029359: AB_10601354, HPA055612: "	"unprognostic (9.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.51e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (7.73e-6)"	"unprognostic (3.66e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.31e-2)"	"unprognostic (9.69e-2)"	8.1	6.8	3.5	4.5	2.3	0.0	10.2	1.5	2.7	5.7	16.4	2.4	4.1	23.7	9.8	6.4	6.8	5.9	14.1	7.6	1.7	1.1	14.0	10.5	7.0	2.4	1.6	1.3	6.8	8.9	1.6	1.7	4.9	3.8	5.6	6.2	5.6	12.6	3.2	8.0	7.3	33.6	4.1	1.3	3.3	7.0	11.1	1.3	0.7	5.6	13.5	3.9	4.9	9.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	12.8	9.4	1.7	1.3	0.0	3.8	8.5	1.2	2.8	5.5	4.3	5.8	9.2	0.0	4.6	2.2	18.2	2.1	23.6	1.7	0.0	5.1	0.3	5.9	9.0	2.3	0.2	0.8	1.3	4.9	10.5	13.5	11.0	1.3	0.0	4.1	4.4	0.0	0.8	3.1	5.7	0.0	16.9	1.3	8.2	2.2	0.6	1.0	9.0	4.0	0.9	4.3	0.7	14.6	4.1	12.1	35.4	6.7	0.0	0.0	0.0	13.1	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	3.5	2.3	1.5	2.7	1.7	1.1	1.6	1.3	3.8	1.3
CARF	"ALS2CR8, CaRF, FLJ21579, NYD-SP24"	ENSG00000138380	"Calcium responsive transcription factor"	Q8N187	2	202912214-202987063	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034557, HPA043191"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"				Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA034557: AB_10601663, HPA043191: "	"unprognostic (4.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.58e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	8.3	8.7	9.8	7.9	15.0	7.1	11.5	10.7	18.2	9.4	8.8	18.3	9.3	6.7	15.4	15.4	8.2	11.1	8.8	7.4	12.1	8.7	10.5	6.5	7.6	11.8	18.4	14.5	13.9	8.1	12.0	18.8	7.4	19.1	10.3	9.0	10.7	8.9	11.1	7.9	11.4	9.4	10.2	15.8	10.5	8.8	27.3	16.3	16.4	15.4	3.8	11.1	12.8	9.7	4.1	2.4	1.7	2.6	11.9	6.0	1.0	2.5	2.4	6.5	5.6	4.7	9.3	4.9	4.0	4.6	4.1	3.7	3.3	6.4	3.9	1.7	4.6	4.6	3.2	2.6	4.4	3.0	1.9	6.9	3.0	1.7	4.1	3.5	3.1	8.5	5.6	3.4	8.8	2.4	2.7	16.1	6.1	5.0	7.2	5.7	2.8	3.5	4.9	4.5	3.1	7.1	2.7	4.6	5.0	4.3	2.4	1.9	3.6	6.9	2.9	7.5	1.9	4.8	2.5	14.4	8.0	4.3	6.4	4.1	4.6	1.7	1.4	1.1	3.2	2.6	3.6	2.9	3.3	2.9	1.5	4.1	4.7	3.2	0.6	11.9	1.6	2.4	6.0	1.0	9.8	15.0	10.7	18.2	12.1	8.7	18.4	14.5	19.1	16.3
CARMIL1	"CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A"	ENSG00000079691	"Capping protein regulator and myosin 1 linker 1"	Q5VZK9	6	25279078-25620530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 20.8;RPTEC TERT1: 21.5;SK-BR-3: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029038, HPA029039"	Enhanced		Supported	Cytosol				Cytosol		"HPA029038: AB_10601668, HPA029039: AB_10611382"	"unprognostic (2.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.15e-3)"	"unprognostic (8.25e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-1)"	8.1	7.2	10.1	7.1	12.3	1.2	9.3	20.0	10.3	8.2	15.3	4.5	8.0	20.8	5.2	10.7	7.7	8.2	11.7	7.5	9.0	5.5	12.8	3.3	11.3	13.7	5.8	8.3	8.3	6.4	9.8	7.0	6.6	6.5	5.2	14.2	7.1	10.0	10.7	1.4	8.3	30.5	7.9	6.2	4.3	10.3	20.8	3.5	6.7	7.7	4.8	7.6	8.7	9.6	4.1	2.6	0.0	3.1	1.5	3.0	0.5	7.5	7.6	2.1	2.7	2.0	1.0	7.4	2.6	5.8	2.7	4.9	8.1	5.7	2.6	8.5	4.1	8.2	8.2	7.3	2.0	6.5	4.3	6.3	8.9	1.0	5.5	0.2	1.0	1.1	5.0	5.3	8.2	0.1	0.2	2.1	1.7	5.9	0.4	0.0	2.9	3.1	0.9	1.2	20.8	21.5	6.9	5.5	1.2	11.4	19.7	7.4	4.8	0.2	0.1	2.0	3.6	9.6	2.6	0.3	0.1	4.2	3.2	2.3	7.6	0.0	1.1	0.0	0.0	1.3	0.2	0.7	0.4	0.2	1.1	4.1	3.0	0.5	0.0	1.5	3.1	2.6	0.0	0.5	10.1	12.3	20.0	10.3	9.0	5.5	5.8	8.3	6.5	3.5
CARS	CARS1	ENSG00000110619	"Cysteinyl-tRNA synthetase"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol			110000	Cytosol		"CAB075734: , CAB075735: , CAB075736: , CAB075737: , HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	24.9	15.9	15.8	15.8	17.7	9.0	15.9	9.5	29.1	13.4	16.3	19.1	11.1	15.9	14.0	10.7	16.0	10.8	14.2	12.5	15.3	18.7	10.7	22.1	15.1	17.2	23.3	15.9	14.5	42.5	14.9	15.9	14.0	23.0	10.8	17.6	7.4	20.3	14.8	24.6	18.8	17.8	21.0	16.1	14.8	22.8	13.4	17.3	9.8	23.0	14.5	22.7	14.4	19.4	8.3	13.3	18.0	23.9	16.4	18.1	11.6	7.5	3.8	5.0	15.0	19.5	18.0	4.5	19.3	22.0	13.3	24.1	9.4	18.0	11.7	5.7	24.3	19.4	16.3	21.9	18.4	34.1	3.7	6.6	6.6	7.2	46.8	13.7	14.5	29.6	17.3	11.5	12.9	17.5	11.0	41.5	13.1	11.5	9.6	0.0	18.7	6.9	4.6	8.3	14.6	0.0	12.6	10.7	14.2	4.7	13.6	21.1	0.0	0.0	6.0	5.5	5.1	13.6	0.2	30.9	28.1	7.4	0.0	7.2	10.8	7.7	12.0	8.8	15.2	10.5	13.0	8.3	13.6	13.6	13.3	6.0	7.5	12.1	18.0	16.4	23.9	5.2	18.1	11.6	15.8	17.7	9.5	29.1	15.3	18.7	23.3	15.9	23.0	17.3
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923645	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavourable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	9.1	15.9	13.9	18.8	12.7	9.8	13.2	14.2	15.7	11.1	22.1	20.0	7.1	27.1	12.2	13.7	17.2	9.9	16.0	7.0	12.1	12.8	14.6	10.8	10.3	13.6	16.3	8.5	13.9	14.2	11.1	9.8	13.4	11.9	10.7	23.8	10.4	15.9	7.7	5.8	12.8	32.9	12.1	10.1	9.6	16.2	2.9	14.3	30.9	9.3	8.1	14.0	11.8	13.1	0.6	0.3	26.3	0.8	2.4	2.3	0.3	10.8	13.9	13.3	7.9	9.0	7.4	4.3	9.5	7.9	5.6	5.1	29.9	17.7	0.1	4.9	11.8	21.8	14.7	9.7	9.4	9.6	8.2	0.0	12.5	10.6	9.3	1.7	1.4	8.4	26.7	10.6	13.6	4.5	0.8	8.5	12.1	12.7	3.1	0.7	12.2	9.1	5.1	32.8	5.2	12.6	23.7	12.2	6.5	17.9	7.1	5.4	7.7	0.3	5.3	10.5	10.6	8.9	5.2	3.3	2.0	3.6	10.3	1.2	6.7	26.3	0.8	4.8	0.5	0.7	0.5	0.4	0.6	0.8	0.2	0.6	0.7	0.7	1.1	2.4	0.4	0.3	2.3	0.3	13.9	12.7	14.2	14.2	12.1	12.8	16.3	8.5	11.9	14.3
CASKIN1	"ANKS5A, KIAA1306"	ENSG00000167971	"CASK interacting protein 1"	Q8WXD9	16	2177180-2196525	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 30.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;HDLM-2: 16.6;HEK 293: 3.7;SCLC-21H: 7.7;SH-SY5Y: 3.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055990, CAB079050"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB079050: , HPA055990: "	"unprognostic (4.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.21e-4)"	"unprognostic (2.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.39e-1)"	1.1	1.8	17.7	1.2	18.1	1.1	1.4	15.0	30.4	1.5	1.2	2.3	0.0	1.2	1.5	1.3	1.2	1.4	1.2	2.5	16.4	12.8	1.3	1.1	1.1	1.1	12.4	11.7	1.2	1.5	1.9	1.4	1.2	11.1	1.8	1.2	1.8	2.5	1.4	1.3	2.2	1.3	1.2	2.8	1.1	1.3	1.8	4.0	0.0	1.6	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	4.5	0.0	0.0	2.2	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.9	0.0	0.0	1.2	0.3	0.0	16.6	3.7	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.3	0.0	0.9	0.7	0.0	0.9	0.0	0.4	0.2	0.0	7.7	3.7	0.1	0.2	0.2	1.0	0.5	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	18.1	15.0	21.7	16.4	12.8	12.4	11.7	11.1	4.0
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 64.2;lymphoid tissue: 40.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 37.8;HBEC3-KT: 17.9;HHSteC: 20.3;U-937: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"olfactory region: 22.8"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	7.4	3.9	6.6	15.1	17.0	8.2	6.9	3.5	7.0	4.1	12.8	2.2	2.9	34.0	3.0	4.2	10.6	4.3	7.3	4.9	9.3	3.0	6.4	5.8	20.5	16.2	16.7	2.6	4.4	3.4	0.2	3.7	8.7	13.3	6.1	13.9	3.7	7.0	3.2	1.6	9.9	37.2	5.2	17.4	40.7	5.6	1.5	11.0	4.1	3.7	5.6	9.0	9.7	13.2	7.3	39.6	40.5	64.2	11.1	34.3	31.2	0.4	0.1	0.0	1.8	2.0	4.2	0.3	1.9	37.8	4.8	13.2	0.0	0.2	6.1	0.7	2.1	2.7	0.0	17.9	1.1	4.0	0.0	0.3	0.2	0.4	20.3	7.1	0.0	7.2	12.7	3.9	10.4	2.0	0.0	0.0	1.1	0.0	0.2	9.9	0.0	0.1	5.9	0.1	4.8	0.1	2.9	0.1	0.1	5.6	0.3	8.3	0.4	16.4	2.4	4.4	0.2	0.4	0.5	0.0	1.7	0.0	2.7	44.7	0.9	12.3	42.8	23.2	25.4	64.2	34.3	7.3	18.1	22.0	39.6	6.0	9.9	16.4	40.5	11.1	64.0	1.4	22.2	31.2	6.6	17.0	3.5	7.0	9.3	3.0	16.7	2.6	13.3	11.0
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049384-15058293	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 109.4"	"Cell line enriched"	"Detected in some"	7	"hTCEpi: 32.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010059, HPA027062"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol			2200000	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: "	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavourable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.2	0.2	0.2	0.0	0.3	0.0	1.9	0.2	0.3	17.9	0.2	0.0	0.8	0.0	1.1	0.3	1.2	0.1	0.0	0.2	0.3	0.2	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.5	0.0	7.7	0.0	0.0	0.8	2.7	0.3	109.4	0.2	0.0	0.2	0.1	0.2	1.6	0.0	2.3	0.2	0.9	0.0	0.6	4.0	0.8	0.5	2.3	0.6	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.6	0.4	0.4	0.2	0.4	0.3	0.6	0.4	0.1	0.8	0.5	0.4	2.3	0.1	0.2	0.5	0.6	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0.0	0.0	0.0
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969436	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 82.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavourable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	10.6	6.3	0.5	9.7	0.5	6.1	9.4	0.0	0.0	4.7	3.5			8.9	3.5	5.9	14.1	5.8	7.3	4.9	0.5	0.5	6.7	16.5	14.0	10.5	1.0		7.5	16.8	0.0	3.0	10.7		5.8	4.0		11.2	1.9	1.6	10.4	8.8	4.3	2.0	19.0	8.2	0.2			4.2		11.3	8.2	8.0	20.5	29.3	82.8	43.2	29.6	35.7	46.8	6.3	2.1	0.0	2.8	13.7	31.2	5.3	11.0	21.5	17.7	24.8	5.3	29.0	3.3	23.7	14.2	10.6	0.0	19.0	16.9	3.7	0.1	8.6	1.6	13.8	33.6	8.6	4.2	28.3	28.5	21.1	29.5	30.7	0.2	0.0	13.5	0.6	5.0	10.2	0.0	6.3	3.8	4.1	2.9	14.8	10.1	0.1	0.0	10.1	7.2	10.0	2.9	12.6	15.9	18.7	6.5	16.4	7.7	0.0	0.0	0.0	9.5	19.7	13.0	14.9	39.1	7.0	31.5	43.2	34.6	20.5	24.2	30.1	29.3	20.0	14.8	22.0	82.8	29.6	33.5	4.9	35.7	46.8										
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.8"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favourable (9.93e-4)"	8.1	6.1	3.6	6.7	4.3	5.3	14.3	2.8	3.8	6.9	25.5	2.8	4.5	23.4	5.9	4.3	8.7	5.3	11.7	4.9	4.0	2.0	11.0	14.3	5.6	8.5	5.0	1.6	7.0	13.0	2.3	6.4	4.3	4.5	8.1	19.5	3.4	8.0	10.3	3.4	6.5	42.8	14.0	6.6	9.1	9.2	2.7	4.3	14.5	11.2	3.3	8.4	8.2	12.7	4.4	8.0	8.5	7.0	5.6	21.3	8.0	12.4	4.0	8.3	7.5	6.1	6.0	12.3	7.0	4.8	6.2	6.8	6.7	25.6	1.3	8.1	7.1	5.8	9.9	11.0	5.0	19.7	6.5	10.9	3.6	5.9	4.9	10.9	7.7	6.6	8.2	6.0	1.5	11.8	14.1	38.8	10.1	7.0	28.1	6.9	6.3	7.3	9.8	5.3	6.8	20.6	11.8	8.8	6.6	7.4	13.3	4.1	5.7	4.0	10.0	6.9	7.4	3.3	7.9	5.7	10.3	1.4	9.0	13.1	3.5	8.5	5.3	6.3	4.9	4.8	5.3	4.1	17.8	9.3	6.0	4.4	21.3	11.8	1.1	5.6	7.0	8.0	16.4	8.0	3.6	4.3	2.8	3.8	4.0	2.0	5.0	1.6	4.5	4.3
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: "	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	14.1	10.6	2.0	31.6	2.6	27.1	10.2	1.4	1.8	7.9	18.5	3.9	7.0	9.6	9.6	12.0	11.7	9.1	12.1	4.4	2.1	2.3	16.4	14.8	17.1	28.3	3.9	1.1	8.2	7.6	1.8	5.9	12.3	3.2	9.8	8.7	4.4	9.6	8.4	2.7	7.4	34.7	5.1	5.0	37.7	7.4	3.8	2.7	43.7	6.7	10.7	43.4	9.6	7.3	13.8	13.7	52.5	17.0	22.2	26.4	12.0	14.3	12.2	3.6	9.9	10.0	14.6	5.5	6.3	6.2	7.5	12.4	16.4	25.0	1.6	13.9	4.9	7.3	7.8	7.5	14.8	9.3	7.1	14.0	9.9	15.6	8.1	10.8	15.2	12.7	18.5	14.2	11.1	7.1	12.5	31.2	6.8	5.9	14.1	11.5	5.8	10.9	10.6	7.4	25.5	14.1	16.0	1.0	0.5	8.2	13.6	8.1	3.6	8.5	8.8	8.1	8.4	4.2	4.9	28.3	12.6	9.7	12.2	14.6	7.6	20.7	13.0	24.9	25.0	17.0	23.1	13.8	20.5	26.4	13.7	7.8	13.3	16.9	52.5	22.2	15.6	6.1	24.0	12.0	2.0	2.6	1.4	1.8	2.1	2.3	3.9	1.1	3.2	2.7
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 201.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			18000000	"Endoplasmic reticulum, Cytosol"		"CAB009491: AB_2259755, HPA036881: , HPA036882: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (4.98e-4)"	38.3	20.7	10.4	25.0	16.3	22.1	32.0	8.7	21.7	38.0	44.6	10.5	18.6	25.6	24.8	25.9	87.4	19.5	25.5	98.5	11.9	10.6	27.2	38.2	29.5	21.1	14.3	12.5	26.9	14.8	22.3	25.3	52.6	24.8	30.0	34.5	12.7	38.7	23.2	201.9	40.7	56.3	36.2	18.7	21.7	22.2	21.2	15.6	10.1	25.6	51.2	34.1	42.2	57.0	24.5	32.7	12.4	48.0	18.3	26.6	27.2	47.9	39.6	6.7	17.5	40.6	75.7	23.7	34.2	48.4	27.4	35.7	9.7	29.3	6.9	32.4	46.3	81.7	12.7	46.5	33.2	44.6	12.0	8.9	41.9	11.6	31.2	5.8	15.5	34.2	43.1	39.3	64.1	30.6	7.5	22.4	33.3	15.1	2.8	0.2	5.2	14.7	2.7	22.7	11.8	54.4	20.3	28.4	6.8	34.9	19.2	22.3	11.7	6.3	40.6	37.4	15.9	24.9	34.5	7.5	20.0	3.2	42.4	3.1	10.3	2.5	48.0	7.0	26.6	29.0	25.2	24.5	23.9	26.5	32.7	22.7	12.2	16.3	12.4	18.3	32.2	9.0	24.2	27.2	10.4	16.3	8.7	21.7	11.9	10.6	14.3	12.5	24.8	15.6
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 9.5;HDLM-2: 10.3;SCLC-21H: 16.0;SK-BR-3: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	3.4	0.9	0.3	2.5	1.5	2.8	6.0	0.3	0.7	6.1	20.7	0.5	14.7	8.8	11.0	2.4	9.9	3.4	13.8	9.9	0.2	0.2	4.5	1.4	7.4	0.8	0.8	0.3	1.7	4.4	0.0	4.0	1.2	0.9	12.1	2.4	19.8	17.0	17.4	29.9	25.3	27.1	8.0	0.2	1.2	9.2	1.0	0.8	0.2	1.9	14.4	6.2	7.2	7.2	0.5	3.5	1.9	2.2	1.6	1.6	0.4	9.5	0.8	1.8	1.7	0.0	0.0	0.4	0.3	0.1	0.3	0.3	2.0	2.2	0.4	2.0	0.4	8.3	1.8	1.9	0.1	10.3	3.3	0.6	1.6	2.2	0.3	1.1	3.1	0.1	7.1	0.1	0.6	0.3	0.0	0.0	0.0	5.1	0.5	6.8	0.2	0.5	0.8	1.2	0.1	1.6	3.9	16.0	1.4	2.5	15.2	0.2	8.1	1.0	0.1	0.0	1.3	0.8	0.2	0.0	0.0	1.0	0.0	2.9	0.1	1.9	0.2	1.2	1.6	0.4	0.7	0.4	0.6	1.1	0.6	0.5	0.0	0.5	0.4	1.6	2.2	3.5	0.3	0.4	0.3	1.5	0.3	0.7	0.2	0.2	0.8	0.3	0.9	0.8
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HMC-1: 5.2;MCF7: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;monocytes: 1.8"					"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"			Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.9	0.8	2.9	0.8	7.7	1.1	1.3	4.3	5.8	1.2	1.1	6.5	1.9	1.2	1.2	1.8	0.9	1.4	0.9	0.8	3.9	1.0	1.0	1.0	1.1	1.0	7.4	2.2	1.3	1.0	1.0	1.2	0.8	5.2	1.3	1.0	0.4	2.0	1.1	1.0	2.0	1.1	0.9	3.2	0.9	1.0	35.7	6.5	2.2	1.3	0.0	1.0	0.9	3.3	0.1	0.6	4.8	1.8	0.2	0.5	0.2	0.2	0.4	0.2	1.8	0.8	0.0	4.1	0.2	0.0	0.0	0.0	1.3	0.8	0.3	0.0	0.0	0.6	0.5	0.1	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.3	5.2	0.0	0.8	0.0	0.5	0.1	0.0	1.3	0.0	4.2	0.0	0.0	0.0	0.8	0.1	0.0	0.8	1.9	0.1	0.4	0.5	0.4	0.9	0.2	0.4	0.0	0.3	0.0	1.0	0.6	0.0	0.7	0.9	0.0	0.2	0.2	0.0	0.3	0.8	1.8	0.4	0.9	0.2	0.0	0.1	0.2	0.6	0.1	0.5	0.2	4.8	0.2	1.8	0.4	0.3	0.2	2.9	7.7	4.3	5.8	3.9	1.0	7.4	2.2	5.2	6.5
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834302-191847255	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 27.6;HEL: 20.1;HUVEC TERT2: 62.5;LHCN-M2: 96.9;TIME: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 9.9;neutrophil: 8.9"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			160000000	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: "	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (8.45e-5)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	60.3	8.9	4.9	10.1	8.3	1.8	37.8	2.8	6.1	26.1	32.6	2.8	14.5	3.9	23.9	17.4	18.2	19.5	45.3	46.5	7.1	5.3	15.9	10.4	57.9	20.1	8.9	5.6	20.4	7.6	3.2	4.3	11.6	5.8	19.3	8.9	9.8	6.9	11.2	35.7	3.8	10.6	39.3	7.1	52.9	8.8	7.2	4.4	0.3	34.5	20.1	2.8	33.2	34.5	0.1	1.0	9.9	0.8	0.4	0.1	39.0	0.0	3.4	1.2	0.0	0.1	0.6	0.0	0.7	0.6	0.1	0.2	0.0	0.0	0.0	4.4	27.6	0.6	0.0	5.4	0.4	0.0	0.0	20.1	0.2	7.6	7.8	0.0	0.0	1.5	3.6	0.5	1.7	62.5	7.2	0.0	96.9	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	2.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.8	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	8.9	0.4	0.4	1.0	0.1	39.0	4.9	8.3	2.8	6.1	7.1	5.3	8.9	5.6	5.8	4.4
CBFB	PEBP2B	ENSG00000067955	"Core-binding factor beta subunit"	Q13951	16	67029116-67101058	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038852	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA038852: AB_10795358"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.80e-3)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (2.89e-8)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	15.9	10.9	15.9	26.4	25.1	20.5	15.0	9.5	14.3	15.4	10.6	23.3	11.8	8.8	15.3	10.2	20.5	14.3	16.3	21.5	16.2	13.2	12.1	14.4	16.1	32.6	23.6	12.4	17.3	13.6	40.4	18.8	13.2	17.5	14.6	11.1	13.7	19.6	10.3	33.3	14.8	12.2	11.7	22.4	18.2	17.1	7.3	24.2	42.2	17.0	14.8	31.0	15.9	18.8	6.5	9.1	20.5	9.2	14.8	7.0	5.1	15.4	10.3	9.0	14.7	6.6	8.5	14.5	17.9	10.7	16.9	15.0	20.7	17.7	34.2	17.1	15.2	15.4	16.1	10.1	22.8	11.7	9.2	23.7	8.8	16.4	9.4	30.9	51.1	8.5	6.9	18.9	14.6	13.7	25.2	12.2	17.5	11.7	31.8	16.6	8.8	14.6	64.5	39.1	29.0	11.9	13.8	13.3	11.9	45.9	7.0	18.3	6.3	22.2	18.9	26.3	18.0	14.9	24.0	16.7	29.7	99.9	20.0	21.2	23.6	20.5	7.4	7.4	6.7	9.2	7.0	6.5	6.6	7.0	9.1	6.4	6.3	5.3	4.6	14.8	6.1	3.3	7.0	5.1	15.9	25.1	9.5	14.3	16.2	13.2	23.6	12.4	17.5	24.2
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206276-119313926	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Supported	Cytosol				Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	9.9	5.5	9.1	17.0	11.1	11.1	8.8	10.7	12.0	6.2	7.5	8.7	3.0	5.7	9.9	5.3	7.5	7.4	6.3	5.9	8.0	9.6	5.5	4.0	10.3	16.3	8.1	6.9	6.3	5.6	16.6	4.1	9.1	9.3	5.3	7.5	6.4	5.4	7.1	3.9	7.4	8.6	10.6	8.9	13.3	7.3	32.3	5.1	40.9	6.0	5.5	15.6	7.6	7.7	1.8	3.3	11.8	3.7	0.6	1.9	1.0	6.3	4.8	16.8	10.5	5.0	6.0	9.9	6.8	7.1	6.6	6.6	10.2	7.8	15.0	6.2	8.6	9.3	11.5	5.8	14.5	8.5	2.7	15.4	3.6	3.1	6.2	17.9	17.6	5.2	6.5	16.9	18.2	16.3	12.4	6.3	11.9	6.8	9.5	10.0	8.7	5.3	10.3	8.4	2.8	5.9	5.1	2.3	7.0	12.7	5.5	4.5	5.8	15.1	13.6	10.3	7.3	7.2	8.9	2.1	3.1	12.2	4.2	15.5	7.3	0.8	3.2	2.4	1.3	3.7	1.1	1.8	1.6	1.3	3.3	1.8	1.8	1.9	11.8	0.6	3.1	1.8	1.4	1.0	9.1	11.1	10.7	12.0	8.0	9.6	8.1	6.9	9.3	5.1
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	38.4	9.0	3.7	19.5	4.9	15.5	16.3	24.4	3.8	13.7	18.7	5.9	7.7	9.3	13.8	12.2	8.3	12.5	13.4	27.5	3.8	4.8	7.4	6.7	16.3	19.1	4.4	1.9	17.7	6.8	3.4	13.5	25.4	7.9	12.9	8.0	11.6	9.1	6.3	10.3	8.5	13.8	25.6	5.7	16.4	12.4	9.2	5.2	11.6	13.5	7.0	18.0	24.9	24.1	5.1	3.1	2.8	2.1	10.3	9.9	1.6	1.6	2.2	7.6	3.7	8.7	8.8	4.9	5.6	2.8	1.6	2.7	2.9	1.9	3.6	4.0	3.0	2.8	1.0	1.0	2.0	2.7	2.9	1.9	11.7	1.8	12.8	1.3	1.4	8.4	3.0	4.4	12.0	5.5	2.0	11.5	3.5	2.0	1.9	0.9	2.7	3.2	4.1	2.3	0.6	4.0	7.2	5.8	6.4	6.7	0.8	8.8	1.6	2.9	3.1	23.4	2.0	3.2	1.3	6.5	0.5	5.6	6.2	1.2	1.5	0.7	1.5	2.8	9.9	0.9	8.8	2.2	5.1	5.6	1.3	5.1	4.4	8.0	1.0	10.3	2.1	3.1	5.6	1.6	3.7	4.9	24.4	3.8	3.8	4.8	4.4	1.9	7.9	5.2
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 176.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018433	Enhanced		Approved	Nucleoplasm,Cytosol			12000000	Nucleoplasm	Cytosol	"HPA018433: AB_1846109"	"prognostic favourable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favourable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	9.6	22.9	31.7	8.4	41.6	3.7	8.5	12.0	35.8	14.6	63.4	75.9	6.5	176.1	9.3	17.1	40.2	9.6	15.1	7.8	37.7	24.7	35.2	77.2	11.7	8.5	57.3	25.2	10.4	8.0	8.9	7.9	11.7	51.6	16.7	16.8	10.4	23.1	15.0	8.7	34.4	118.1	11.6	48.1	10.0	41.4	5.7	41.9	3.6	11.3	29.8	14.3	12.4	17.1	17.0	29.9	17.1	51.4	19.1	29.2	37.0	25.4	39.2	4.8	12.4	25.2	25.5	0.2	28.5	20.5	15.6	18.7	14.4	15.0	6.4	18.8	26.6	18.7	9.8	28.0	12.0	31.6	23.2	19.2	22.8	9.8	14.4	10.6	17.7	12.4	35.3	15.1	6.6	16.6	0.0	4.7	14.3	25.2	5.3	11.1	0.0	28.6	0.0	0.1	17.7	41.5	12.7	14.0	12.6	27.6	40.1	32.4	19.0	14.8	16.7	17.5	7.4	44.5	20.6	32.1	58.1	0.1	32.2	10.6	25.4	1.8	36.6	17.1	18.1	51.4	15.3	17.0	22.7	16.9	29.9	15.6	29.2	21.4	2.5	19.1	38.6	10.4	22.7	37.0	31.7	41.6	12.0	35.8	37.7	24.7	57.3	25.2	51.6	41.9
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36134912-36146566	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 68.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 43.6"	"Low region specificity"	"Detected in all"			HPA018434	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	9.2	1.5	5.4	3.0	13.9	0.9	12.2	3.1	4.7	8.6	3.8	1.4	4.1	2.4	5.5	8.8	27.6	4.1	4.9	4.9	3.6	2.9	1.6	0.4	3.5	3.4	3.8	6.1	9.3	1.2	0.3	1.2	2.2	2.5	7.2	2.9	3.3	21.8	4.2	2.4	16.3	2.6	10.5	2.3	1.5	2.7	4.3	2.7	0.9	2.3	68.2	14.1	7.1	8.0	11.9	1.2	0.4	0.5	4.9	17.9	6.2	12.0	3.4	1.5	3.0	11.8	18.3	2.3	13.2	15.6	15.1	12.1	0.1	2.6	0.0	3.9	13.5	5.6	2.0	2.6	6.1	16.4	6.3	0.5	3.6	0.1	1.0	0.0	0.0	2.6	0.3	10.5	1.3	9.1	0.0	0.1	4.4	9.0	1.1	5.3	1.2	15.3	2.5	2.9	23.4	5.0	5.1	0.8	1.1	10.1	12.3	19.2	3.6	1.4	6.2	9.8	0.8	11.0	12.7	0.5	0.2	0.0	10.2	0.3	17.6	0.0	0.3	0.0	1.2	0.2	1.5	11.9	13.0	4.0	1.2	10.6	17.9	12.3	0.4	4.9	0.5	0.3	5.1	6.2	5.4	13.9	3.1	4.7	3.6	2.9	3.8	6.1	2.5	2.7
CBX7		ENSG00000100307	"Chromobox 7"	O95931	22	39120167-39152674	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.5;U-266/70: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011574, HPA048677, HPA056480"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB011574: AB_726005, HPA048677: , HPA056480: "	"prognostic favourable (6.18e-4)"	"prognostic favourable (3.63e-4)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.11e-3)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.03e-3)"	"prognostic favourable (2.45e-5)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.63e-2)"	17.6	23.1	26.1	14.2	34.3	4.0	14.0	45.0	44.7	20.1	29.3	17.2	24.1	12.3	27.8	21.9	18.0	24.7	19.1	36.5	23.9	19.5	17.6	6.4	19.1	17.2	18.7	29.5	36.9	15.0	33.4	17.1	6.2	19.7	27.1	10.6	21.1	24.0	44.0	38.6	15.4	15.8	35.9	12.9	22.0	18.8	6.5	19.9	4.5	16.9	10.8	15.1	26.2	21.1	3.7	0.7	5.5	0.9	1.7	5.1	1.6	4.4	1.9	0.9	7.2	8.9	3.4	2.4	4.2	5.2	2.3	2.8	0.9	3.0	0.7	5.0	3.1	1.6	0.6	1.9	1.7	23.5	2.3	0.1	3.0	0.4	3.1	1.0	9.3	1.7	2.9	1.1	0.4	0.6	1.1	11.9	1.8	4.2	1.5	0.5	0.5	3.2	1.7	1.5	6.3	1.1	1.8	2.4	0.5	2.1	3.1	4.8	3.8	1.7	1.7	3.9	7.4	3.9	1.8	20.4	11.4	2.7	7.9	1.7	1.6	0.6	0.5	4.8	3.7	0.1	3.8	2.9	4.0	4.0	0.1	3.7	5.1	4.8	5.5	1.7	0.9	0.7	3.8	1.6	26.1	34.3	45.0	44.7	23.9	19.5	18.7	29.5	19.7	19.9
CC2D1A	"FLJ20241, MRT3"	ENSG00000132024	"Coiled-coil and C2 domain containing 1A"	Q6P1N0	19	13906201-13930879	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005436, CAB015220"	Supported		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB015220: , HPA005436: AB_1078884"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (7.02e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.67e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.71e-2)"	11.2	9.5	19.1	14.5	18.7	9.1	12.0	30.5	22.2	11.4	28.7	13.6	15.3	43.2	10.1	10.0	18.2	16.9	16.6	10.4	17.8	21.3	12.6	16.2	11.9	9.5	15.8	20.1	11.5	30.0	17.3	18.7	12.2	16.1	14.2	14.7	13.3	32.7	16.9	18.7	28.6	35.3	11.1	12.6	11.3	21.0	10.1	13.7	10.6	12.0	13.6	13.7	13.1	14.1	2.4	3.0	4.1	5.2	1.6	4.8	2.0	22.0	9.3	3.1	12.8	6.3	5.2	9.9	7.7	9.5	12.5	12.0	12.8	6.7	11.6	12.6	7.7	16.2	5.8	11.7	4.3	16.9	32.0	5.7	11.4	8.0	10.5	4.7	16.9	6.3	14.3	7.7	5.1	8.4	5.9	9.5	4.0	23.4	11.1	12.9	7.0	16.7	11.5	6.9	9.2	8.5	16.8	11.5	6.7	10.2	15.5	11.6	11.4	9.0	7.9	9.6	4.8	21.2	9.3	16.2	7.2	6.0	12.2	15.9	8.7	3.9	3.2	4.1	4.8	5.2	1.9	2.4	2.3	2.1	3.0	1.3	1.2	2.7	2.8	1.6	4.8	2.5	1.9	2.0	19.1	18.7	30.5	22.2	17.8	21.3	15.8	20.1	16.1	13.7
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430940-59697380	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 28.0"	"Cell line enhanced"	"Detected in some"		"BJ: 26.2;BJ hTERT+: 26.9;BJ hTERT+ SV40 Large T+ RasG12V: 25.2;HBF TERT88: 30.2;hTERT-HME1: 40.9;LHCN-M2: 45.9;TIME: 24.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 10.0"	"Group enriched"	"Detected in some"	7	"basophil: 9.6;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	10.0	12.6	2.4	3.8	1.1	0.4	3.5	0.4	2.0	16.8	15.8	0.6	8.2	0.8	12.1	2.8	2.3	6.9	6.9	2.1	10.0	0.5	3.1	4.3	16.5	3.6	0.4	2.1	28.0	0.8	0.4	2.6	0.3	1.7	3.0	2.3	9.1	1.0	3.5	10.6	3.3	3.0	4.9	0.3	0.3	1.7	2.1	1.3	0.2	1.0	0.0	0.7	2.9	5.1	0.8	0.4	9.6	0.3	0.8	0.3	0.2	5.1	0.4	0.0	0.0	4.1	12.9	8.0	26.2	26.9	19.1	25.2	0.0	0.1	0.1	0.0	10.4	0.5	0.0	16.9	30.2	0.1	0.1	0.0	0.1	0.1	9.5	0.1	0.0	8.6	0.7	14.9	40.9	0.9	0.0	0.1	45.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.5	0.1	0.2	0.0	0.0	0.2	0.0	0.1	24.7	0.0	2.6	3.9	0.0	0.1	0.0	0.0	1.3	0.1	0.6	9.6	0.3	0.8	0.3	0.2	0.2	0.4	0.2	0.2	0.1	0.8	0.3	0.3	2.7	0.8	0.2	0.4	0.2	0.2	2.4	1.1	0.4	2.0	10.0	0.5	0.4	2.1	1.7	1.3
CCDC102B	"ACY1L, AN, C18orf14, FLJ23594, HsT1731"	ENSG00000150636	"Coiled-coil domain containing 102B"	Q68D86	18	68715209-69055189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 33.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.5;BJ hTERT+: 20.4;fHDF/TERT166: 18.3;HSkMC: 11.3;Karpas-707: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 11.5"					"Not detected"	"Not detected"			"HPA040623, HPA048194"	Approved		Approved	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA040623: AB_10805715, HPA048194: "	"unprognostic (3.92e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.50e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.50e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (2.90e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.13e-3)"	8.7	4.2	6.4	4.7	7.1	1.3	4.4	3.2	8.0	4.2	4.8	4.9	2.9	2.3	4.0	6.4	4.7	2.9	16.9	4.7	6.0	5.4	5.9	3.3	16.4	11.5	7.0	5.0	3.3	3.1	3.2	5.0	33.7	8.7	4.0	6.1	4.0	3.2	2.2	2.1	2.9	3.9	6.4	9.3	3.3	4.7	4.3	7.0	1.7	6.8	5.0	2.9	16.9	4.0	0.9	11.5	0.4	0.3	1.3	2.6	0.3	0.0	0.0	2.9	0.2	2.6	10.5	0.1	0.5	20.4	0.2	0.3	0.1	0.2	0.1	0.4	18.3	0.2	0.1	0.2	0.3	0.8	0.2	0.6	0.0	0.9	5.1	0.1	0.3	11.3	0.4	0.3	2.5	0.1	0.0	7.2	1.7	0.0	0.4	0.2	0.6	0.3	0.9	0.2	0.3	0.1	0.0	1.2	1.1	0.1	0.0	0.0	0.2	0.9	2.8	0.4	0.2	0.1	0.2	3.1	0.2	0.5	1.5	1.2	1.8	0.0	0.1	0.4	1.4	0.3	1.3	0.6	0.8	1.1	0.3	0.9	2.6	1.6	0.0	1.3	0.2	11.5	0.3	0.3	6.4	7.1	3.2	8.0	6.0	5.4	7.0	5.0	8.7	7.0
CCDC103	"CILD17, FLJ13094, FLJ34211, PR46b"	ENSG00000167131	"Coiled-coil domain containing 103"	Q8IW40	17	44899142-44905390	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 19.6;testis: 35.5"	"Cell line enhanced"	"Detected in many"		"A549: 12.6;RPTEC TERT1: 9.9;U-87 MG: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA043131			Approved	Cytosol				Cytosol		"HPA043131: AB_10796686"	"unprognostic (9.40e-3)"	"unprognostic (1.75e-1)"			"unprognostic (5.60e-2)"	"unprognostic (1.99e-2)"		"unprognostic (4.50e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-2)"		"unprognostic (4.69e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.60e-1)"	0.6	2.3	2.6	0.9	6.3	0.6	1.2	0.5	4.7	1.4	0.9	2.9	1.6	0.5	1.7	2.8	0.4	19.6	2.8	0.4	2.5	3.0	2.7	0.7	1.9	0.3	1.5	3.9	3.5	0.8	1.9	2.1	0.5	4.3	0.9	0.7	1.6	1.2	1.5	0.3	0.7	0.4	1.2	1.0	0.4	0.9	35.5	1.0	0.2	3.5	0.1	0.5	0.7	0.4	0.8	2.5	3.0	3.7	0.7	0.4	2.4	2.2	12.6	1.9	2.4	2.7	2.3	1.6	1.0	3.8	1.7	1.3	2.4	4.1	0.3	2.1	0.8	3.8	0.8	1.8	1.0	7.8	1.4	0.6	2.6	0.0	1.8	1.6	0.3	1.5	3.0	1.9	0.7	1.3	1.6	0.3	0.1	2.3	0.0	0.7	0.4	1.9	0.3	0.7	0.5	9.9	1.2	5.0	1.0	0.5	0.4	2.2	3.4	1.6	1.0	0.8	2.0	1.0	1.9	0.4	0.5	0.4	11.1	0.8	0.3	1.2	3.7	3.0	0.3	1.9	0.4	0.0	0.0	0.4	2.5	0.8	0.4	0.3	0.5	0.7	1.7	0.8	0.1	2.4	2.6	6.3	0.5	4.7	2.5	3.0	1.5	3.9	4.3	1.0
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 11.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041925: , HPA043219: "	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favourable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favourable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"	15.9	18.7	31.6	8.7	43.9	4.4	14.5	27.2	29.8	13.9	10.4	14.3	10.5	7.2	13.2	11.2	13.0	12.5	14.2	18.0	32.3	21.2	23.5	19.2	10.4	14.8	20.3	14.4	20.9	13.8	19.2	17.5	8.8	15.2	14.7	5.2	12.4	18.0	19.6	34.1	9.3	8.3	20.0	15.1	15.6	13.0	15.9	10.8	13.7	18.0	6.5	14.1	16.9	10.0	11.1	9.0	0.0	2.4	0.6	3.4	1.5	3.8	15.3	6.7	11.7	4.8	4.6	0.9	3.3	6.0	11.7	9.9	3.3	6.1	11.3	2.6	6.3	3.4	11.3	7.2	3.3	0.6	38.9	12.0	10.3	5.8	14.5	0.8	6.9	7.4	0.9	2.7	0.6	3.7	8.7	7.3	5.7	1.0	7.2	4.8	3.2	8.5	11.4	3.4	7.8	12.1	0.3	7.4	13.8	2.7	19.1	6.6	8.3	7.8	4.1	3.6	3.7	0.3	2.4	4.3	1.5	14.7	9.7	3.9	0.2	0.0	2.4	0.0	0.5	1.6	1.5	7.8	0.5	0.7	3.0	11.1	3.4	2.0	0.0	0.6	0.1	9.0	0.3	1.5	31.6	43.9	27.2	29.4	32.3	21.2	20.3	14.4	15.2	10.8
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267188-115296831	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.4"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045120, HPA050621"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in male reproductive system"			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: , HPA050621: "	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	5.5	4.3	9.7	5.7	13.2	7.0	7.7	12.6	12.8	6.5	9.8	7.0	4.3	8.1	6.6	7.3	6.3	4.9	3.9	6.4	11.0	9.0	3.5	1.7	6.1	4.8	9.7	7.6	2.9	13.2	6.5	12.1	3.0	12.6	7.7	10.6	1.9	6.8	8.6	4.5	5.5	6.8	7.7	14.0	5.3	7.0	40.4	11.8	3.7	4.7	3.2	4.7	7.1	4.8	5.3	11.0	11.6	5.5	3.1	3.8	2.1	5.3	2.6	5.4	8.5	3.5	6.7	1.3	4.8	2.5	3.6	4.2	1.1	3.1	6.6	4.0	3.3	3.4	5.6	2.7	7.6	5.2	4.3	4.3	4.0	1.7	4.6	5.6	2.2	3.0	3.3	4.7	6.2	5.5	1.8	5.4	4.8	4.1	8.5	4.9	5.8	4.7	9.1	6.7	49.2	3.5	1.9	8.1	10.6	5.2	3.3	14.3	5.6	8.3	5.5	4.8	3.2	9.1	6.6	5.9	5.7	1.3	3.2	4.5	2.8	0.2	5.5	11.6	3.4	4.4	3.8	3.2	2.6	2.9	5.9	5.3	3.4	2.3	3.6	3.1	5.0	11.0	0.1	2.1	9.7	13.2	12.6	12.8	11.0	9.0	9.7	7.6	12.6	11.8
CCDC117	FLJ33814	ENSG00000159873	"Coiled-coil domain containing 117"	Q8IWD4	22	28772674-28789301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000826	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA000826: AB_1078417"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.61e-3)"	"unprognostic (9.07e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-3)"	"unprognostic (8.25e-2)"	10.7	14.2	12.3	13.6	13.6	19.2	25.2	19.3	12.7	15.9	13.1	9.6	16.6	12.1	15.3	8.9	11.5	10.7	10.0	9.0	12.2	10.6	10.3	26.1	12.5	17.0	14.6	8.3	14.9	13.3	12.4	14.1	20.7	11.9	13.0	11.9	9.5	21.0	16.5	20.2	9.1	10.9	15.2	13.1	13.8	12.3	35.9	15.4	24.2	18.1	7.4	20.1	12.3	31.3	13.4	13.9	14.0	13.9	23.3	15.2	12.6	8.6	7.2	14.8	14.3	9.6	8.4	11.6	8.8	10.8	15.3	13.5	10.9	4.2	27.1	3.9	8.0	9.1	21.5	3.5	14.6	14.7	14.2	11.0	8.2	16.0	6.6	17.7	14.2	5.7	7.6	8.8	5.5	10.5	15.4	12.1	6.8	11.1	10.3	14.4	12.0	3.5	21.0	23.2	11.8	6.8	3.4	5.6	7.5	13.5	12.7	5.4	15.8	7.6	6.1	19.2	13.2	6.0	6.7	28.3	29.3	22.8	6.7	9.6	8.1	10.7	13.9	14.0	10.2	12.3	10.5	10.0	8.6	9.9	13.9	13.4	15.2	12.2	6.7	23.3	11.7	12.2	10.7	12.6	12.3	13.6	19.3	12.7	12.2	10.6	14.6	8.3	11.9	15.4
CCDC121	"FLJ13646, FLJ43364"	ENSG00000176714	"Coiled-coil domain containing 121"	Q6ZUS5	2	27625639-27629012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 27.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 12.5"	"Low lineage specificity"	"Detected in all"											HPA051791	Uncertain		Approved	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA051791: "	"unprognostic (1.52e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-3)"	"prognostic favourable (4.12e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.65e-4)"	"unprognostic (7.78e-2)"	"prognostic favourable (1.87e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.86e-2)"	"unprognostic (5.42e-2)"	4.4	3.6	7.4	2.0	12.2	1.4	5.9	7.0	10.3	5.8	3.6	5.5	6.7	2.6	5.5	5.3	5.9	8.3	3.0	6.3	9.0	5.2	6.2	3.2	4.5	2.3	13.3	6.0	11.7	3.9	8.3	7.3	3.8	9.3	7.3	3.5	3.4	5.7	8.5	3.6	3.3	3.0	4.6	10.8	4.3	3.8	27.5	11.2	1.0	8.1	1.7	2.5	4.4	3.0	3.1	1.7	12.5	4.0	2.6	3.0	1.3	3.6	4.2	5.8	6.4	10.5	4.7	7.2	1.9	0.9	1.9	0.9	3.2	3.3	1.8	3.0	1.2	3.4	4.2	1.5	2.1	2.6	4.6	1.1	2.5	4.0	2.0	1.7	3.4	1.6	5.1	1.0	2.7	3.9	4.9	2.6	2.7	3.0	1.2	1.7	6.0	2.1	6.2	14.1	3.2	4.0	2.9	7.5	8.6	1.5	7.1	2.3	5.8	3.9	2.0	1.7	6.3	1.4	5.1	1.6	1.6	2.8	4.1	2.3	2.0	2.0	2.4	12.5	0.6	3.4	1.7	3.1	1.9	0.7	1.7	2.7	3.0	2.2	5.1	2.6	4.0	0.5	0.3	1.3	7.4	12.2	7.0	10.3	9.0	5.2	13.3	6.0	9.3	11.2
CCDC124		ENSG00000007080	"Coiled-coil domain containing 124"	Q96CT7	19	17933016-17943991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041708, HPA046765"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041708: AB_2677628, HPA046765: "	"unprognostic (9.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.22e-1)"	32.2	21.8	28.8	23.1	25.7	28.1	16.3	16.8	34.4	15.0	22.3	16.8	16.5	20.0	29.0	17.8	22.0	13.6	20.0	34.8	26.5	22.3	18.1	24.4	15.5	16.2	26.4	23.8	15.5	29.4	14.0	12.3	16.3	18.5	17.6	7.6	16.1	34.7	19.9	96.8	20.6	21.2	20.5	20.2	20.7	26.7	14.0	13.3	13.6	19.1	29.0	14.1	17.0	33.2	30.2	39.1	31.9	42.4	32.4	42.2	28.7	48.3	34.5	11.8	23.3	7.9	6.1	38.8	24.3	8.0	13.0	11.0	25.9	20.3	37.1	35.3	10.1	18.6	13.0	23.2	3.8	38.8	71.2	30.7	27.0	29.9	15.3	34.4	21.2	9.7	15.5	13.1	12.6	13.6	39.2	15.7	6.6	47.7	33.6	43.7	26.7	59.1	33.2	21.5	40.4	10.6	17.5	23.5	33.9	16.9	19.7	24.2	18.0	12.9	28.7	22.0	27.4	42.2	37.5	22.1	23.4	35.6	27.4	41.7	27.7	27.4	39.0	31.9	42.2	42.4	33.5	28.2	32.8	38.8	39.1	30.2	26.1	31.6	9.5	32.4	30.2	34.5	36.9	28.7	28.8	25.7	16.8	30.4	26.5	22.3	26.4	23.8	18.5	13.3
CCDC138	FLJ32745	ENSG00000163006	"Coiled-coil domain containing 138"	Q96M89	2	108786757-108885477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049899, HPA054223"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA049899: , HPA054223: "	"unprognostic (2.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.24e-5)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.77e-2)"	"unprognostic (7.06e-4)"	"unprognostic (7.88e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.93e-2)"	2.6	2.5	5.7	5.0	7.0	6.1	4.8	13.5	8.2	3.1	3.9	4.9	1.6	2.1	6.0	2.8	5.5	8.6	3.8	2.3	6.8	5.0	3.6	5.5	2.8	8.1	4.3	5.1	3.7	3.5	2.3	7.4	2.8	8.0	3.1	4.8	1.9	3.3	2.1	2.1	4.8	3.4	3.3	6.4	3.2	3.7	19.4	6.5	19.5	2.3	2.9	7.2	4.3	6.1	5.4	8.1	3.1	2.1	3.2	4.8	2.4	8.1	3.8	13.0	6.7	1.0	1.2	8.3	3.6	1.1	8.5	6.3	12.3	4.8	19.7	5.4	1.1	7.0	9.4	4.9	7.7	4.5	12.1	9.1	7.1	10.1	1.3	12.4	1.3	0.8	1.4	10.0	3.0	4.4	17.2	9.1	4.3	4.6	17.7	8.4	19.3	3.9	11.7	12.3	12.1	4.7	6.5	9.2	9.0	7.8	4.2	6.2	4.5	6.0	2.8	5.4	9.5	3.4	7.5	2.9	6.6	20.6	2.2	9.7	5.3	3.1	0.9	1.3	2.1	2.1	3.9	5.1	2.8	4.0	0.9	5.4	4.1	4.8	0.5	3.2	0.8	8.1	4.1	2.4	5.7	7.0	13.5	8.2	6.8	5.0	4.3	5.1	8.0	6.5
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.2;testis: 19.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	1.9	1.3	2.2	2.5	3.9	3.2	5.2	1.2	2.4	1.6	2.2	2.2	0.3	1.3	2.2	2.9	2.4	2.1	1.5	0.9	1.9	1.2	1.2	2.4	2.6	2.0	1.6	0.8	1.7	2.3	1.7	3.8	1.6	1.6	3.0	1.6	1.5	7.7	2.2	0.8	3.7	1.8	1.2	3.3	2.5	1.5	19.4	2.3	16.2	1.3	2.6	2.9	2.6	2.2	1.5	1.1	6.7	1.7	2.3	3.9	1.3	4.7	0.9	6.4	0.0	0.5	1.8	0.0	5.2	6.4	4.9	6.1	0.1	4.0	5.6	4.6	1.8	3.8	2.7	3.5	8.9	4.7	1.1	6.9	0.8	1.5	0.2	2.0	4.0	0.4	2.5	10.2	5.1	3.7	4.6	5.8	10.3	1.0	4.2	2.3	1.5	5.9	5.3	11.7	1.8	0.7	2.0	3.6	3.2	3.0	0.3	1.3	7.3	1.8	2.6	10.1	2.3	4.4	6.4	1.4	1.5	4.9	1.4	11.3	6.7	6.7	1.3	1.7	2.4	1.7	2.5	0.8	2.2	3.9	0.4	1.5	3.1	3.4	0.8	2.3	1.7	1.1	3.7	1.3	2.2	3.9	1.2	2.4	1.9	1.2	1.6	0.8	1.6	2.3
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756801-42802360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.8;pituitary gland: 24.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 10.8;U-2 OS: 19.5;U-266/84: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	4.0	6.0	7.5	2.5	10.2	1.6	3.0	1.0	8.4	2.1	2.3	4.1	0.5	5.0	2.7	1.9	2.0	1.6	6.1	4.6	7.1	3.2	3.6	52.8	3.2	8.6	4.9	5.5	8.2	2.1	0.0	24.3	2.8	20.9	2.1	0.3	1.9	2.1	0.3	1.5	3.1	12.4	0.6	8.8	6.9	1.9	5.7	8.5	8.5	1.7	0.5	3.0	2.9	3.1	3.6	10.0	0.3	0.7	6.2	6.1	1.3	0.3	0.1	0.9	0.1	2.8	3.5	0.0	4.7	0.1	0.0	0.3	0.0	0.2	0.0	0.3	2.1	3.7	0.0	0.0	0.4	0.0	0.3	0.2	10.8	4.5	2.8	0.1	0.0	4.5	0.0	1.9	0.0	1.4	0.5	1.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.3	5.4	0.0	0.1	0.0	0.4	0.1	0.1	0.2	19.5	4.5	0.1	0.1	13.0	0.1	5.7	0.1	0.1	0.1	0.1	0.1	4.0	0.7	4.9	2.2	3.0	5.0	0.7	3.6	4.0	6.1	0.3	6.2	0.3	10.0	1.9	1.3	7.5	10.2	1.0	8.4	7.1	3.2	4.9	5.5	20.9	8.5
CCDC153	LOC283152	ENSG00000248712	"Coiled-coil domain containing 153"	Q494R4	11	119189638-119196769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0"	"Cell line enhanced"	"Detected in many"		"T-47d: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041497	Uncertain		Uncertain	Cytosol				Cytosol		"HPA041497: AB_10794378"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.98e-3)"	1.4	1.1	2.2	0.6	4.8	3.8	0.8	0.5	0.9	1.4	0.6	2.0	0.5	0.5	1.1	5.3	1.5	15.8	3.1	2.0	2.6	3.9	1.5	0.6	5.2	0.5	0.5	0.5	1.7	0.5	3.3	20.0	1.3	9.8	0.5	0.6	0.5	0.7	1.6	0.5	1.4	0.8	0.7	1.2	0.8	1.6	2.8	2.4	0.5	1.1	0.5	0.9	0.7	0.5	0.4	1.6	15.1	2.4	0.3	0.6	0.7	2.2	2.9	1.8	1.8	0.3	0.3	4.3	1.2	1.4	0.6	0.7	4.8	7.5	1.5	6.2	0.3	1.6	0.4	1.4	0.1	2.9	2.5	7.0	2.2	3.2	1.0	2.3	0.9	0.7	1.0	1.6	0.4	1.5	2.1	2.8	0.1	8.7	1.5	2.2	0.9	5.1	1.9	2.5	1.4	0.5	2.1	2.3	1.2	2.9	1.4	1.7	12.8	2.7	2.9	3.3	2.6	1.9	2.6	1.1	1.7	1.2	1.4	1.3	3.9	0.4	2.4	3.8	0.3	1.5	0.2	0.4	0.2	0.4	1.6	0.4	0.6	0.5	15.1	0.3	1.5	1.6	0.4	0.7	2.2	4.8	0.5	0.9	2.6	3.9	0.5	0.5	9.8	2.4
CCDC159		ENSG00000183401	"Coiled-coil domain containing 159"	P0C7I6	19	11344684-11354944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047126, HPA054655"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA047126: AB_10961722, HPA054655: "	"unprognostic (1.46e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.35e-3)"	"prognostic favourable (1.87e-7)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.40e-2)"	"unprognostic (6.68e-2)"	"prognostic favourable (9.46e-4)"	"prognostic favourable (1.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-2)"	"prognostic favourable (8.62e-4)"	7.9	24.6	21.0	13.4	35.1	22.2	10.9	15.5	28.6	14.8	12.9	30.6	28.3	17.8	13.9	21.1	11.8	14.2	19.0	13.6	22.8	11.9	13.4	18.9	12.8	14.7	38.5	22.9	19.2	15.1	34.3	20.8	7.3	28.0	24.7	9.5	17.7	14.5	17.4	6.3	14.6	14.3	12.5	24.2	24.1	16.1	28.2	43.5	7.5	17.8	8.5	11.2	13.7	12.6	9.9	16.5	21.2	28.0	15.7	15.2	11.8	2.2	1.9	1.6	5.1	6.7	9.7	1.7	3.6	3.8	4.3	5.8	0.6	2.4	1.8	9.4	6.8	1.8	1.0	5.8	2.7	9.0	1.4	4.4	1.6	2.3	11.7	1.7	6.6	11.6	15.4	3.1	4.2	12.1	3.9	21.4	2.1	2.7	2.6	3.5	0.9	7.3	3.0	0.0	12.0	3.9	3.2	0.7	2.7	3.7	4.2	6.7	6.2	7.4	8.0	3.4	1.0	5.9	3.3	19.7	4.7	3.8	4.6	9.0	4.9	21.2	28.0	19.1	12.1	23.6	11.7	8.1	8.2	11.0	16.5	9.9	7.5	5.9	13.2	15.7	16.4	4.3	15.2	11.8	21.0	35.1	15.5	28.6	22.8	11.9	38.5	22.9	28.0	43.5
CCDC167	"C6orf129, dJ153P14.2"	ENSG00000198937	"Coiled-coil domain containing 167"	Q9P0B6	6	37482920-37499922	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.0"	"Cell line enriched"	"Detected in many"	9	"U-698: 170.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045215	Uncertain		Approved	Cytosol				Cytosol		"HPA045215: AB_10962866"	"unprognostic (1.82e-1)"	"prognostic favourable (7.59e-4)"	"unprognostic (6.99e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (1.71e-7)"	"unprognostic (1.57e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.95e-1)"	6.4	10.3	16.1	11.6	18.9	12.7	10.2	11.3	15.5	12.6	10.5	12.8	11.4	6.3	8.7	25.2	13.6	11.5	6.2	17.3	13.8	12.1	10.2	29.5	7.0	23.0	18.1	9.1	4.6	14.9	6.9	8.4	9.6	15.8	12.2	13.0	5.0	16.2	7.7	10.5	6.5	8.2	16.7	22.8	15.1	7.5	18.8	16.9	32.1	11.5	11.2	35.5	8.7	8.7	24.8	9.9	23.6	6.0	8.6	70.0	26.4	3.0	7.1	16.3	11.2	4.4	7.8	5.9	3.7	2.9	5.7	6.4	7.4	4.6	16.7	8.3	6.2	2.4	10.4	8.5	5.8	13.9	19.3	7.9	3.1	18.7	4.7	7.7	3.1	3.6	17.6	6.1	5.6	17.6	4.9	14.5	9.7	10.1	14.4	6.4	0.9	4.5	9.0	5.7	12.3	7.7	6.0	11.0	13.0	5.5	5.4	8.5	5.9	8.1	4.4	3.8	7.4	2.1	3.7	10.7	10.4	170.9	3.7	16.6	10.6	4.8	6.0	23.6	26.1	5.9	31.1	24.8	43.5	32.8	9.9	17.0	20.1	19.4	1.8	8.6	4.9	6.3	70.0	26.4	16.1	18.9	11.3	15.5	13.8	12.1	18.1	9.1	15.8	16.9
CCDC175	C14orf38	ENSG00000151838	"Coiled-coil domain containing 175"	P0C221	14	59504539-59576831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 17.1;pituitary gland: 6.6;testis: 8.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;SCLC-21H: 1.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA004200	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA004200: AB_1078743"	"unprognostic (3.64e-3)"		"unprognostic (8.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"					"unprognostic (3.83e-1)"			"unprognostic (2.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.27e-1)"			0.2	0.1	0.9	0.2	2.9	0.5	0.2	17.1	3.3	0.2	0.9	1.2	0.0	0.3	0.2	1.0	0.2	1.3	0.5	0.2	0.8	0.5	0.4	0.2	0.5	0.2	0.8	0.9	0.2	0.1	0.3	6.6	0.1	3.0	0.2	1.8	0.6	0.2	0.2	0.2	0.3	0.9	0.2	0.4	0.4	0.2	8.2	1.5	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.4	0.9	2.9	17.1	3.3	0.8	0.5	0.8	0.9	3.0	1.5
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	3.8	2.3	2.7	20.0	4.3	13.4	4.6	3.7	2.7	2.2	3.2	0.4	2.9	2.5	1.8	4.0	3.2	1.8	1.7	2.6	3.4	1.9	2.0	3.0	3.8	11.9	1.7	1.8	2.8	1.5	0.7	4.8	1.9	2.6	1.9	4.1	1.3	2.0	3.1	6.2	3.1	3.4	2.3	3.8	6.0	2.3	12.6	2.5	15.8	2.1	2.8	8.2	2.9	3.3	12.2	11.9	6.0	3.9	1.1	2.7	0.5	15.5	5.2	12.2	3.8	3.0	3.1	6.4	9.7	5.1	10.0	10.1	2.7	5.4	20.2	5.4	5.2	7.4	5.3	7.6	14.5	9.9	7.0	13.8	11.1	4.7	1.1	14.3	6.4	2.1	0.6	7.5	7.4	6.4	14.7	15.6	13.2	2.2	6.8	5.8	11.2	6.5	8.8	14.6	5.9	4.9	7.0	5.4	3.4	13.7	7.0	4.0	3.3	8.4	4.9	11.7	8.3	7.5	11.0	6.7	8.7	12.1	2.4	12.8	3.1	3.4	3.8	5.3	2.4	3.9	2.7	8.8	2.2	2.1	1.6	12.2	1.7	2.0	6.0	1.1	3.5	11.9	2.2	0.5	2.7	4.3	3.7	2.7	3.4	1.9	1.7	1.8	2.6	2.5
CCDC184	"C12orf68, LOC387856"	ENSG00000177875	"Coiled-coil domain containing 184"	Q52MB2	12	48183584-48185926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Cell line enhanced"	"Detected in some"		"A549: 4.2;AF22: 9.8;NTERA-2: 3.3;SH-SY5Y: 6.7;U-2 OS: 3.9;U-87 MG: 4.9"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039947, HPA041715"	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA039947: , HPA041715: "	"unprognostic (2.02e-1)"	"unprognostic (1.16e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.36e-2)"	2.0	11.4	9.0	2.3	14.4	0.8	1.3	14.9	30.5	3.0	1.8	2.2	0.1	1.1	6.1	1.3	1.7	1.3	3.3	1.9	9.3	17.6	1.3	1.3	1.5	1.0	11.5	10.6	8.8	1.3	8.7	7.3	5.1	23.7	1.6	1.5	0.8	0.9	2.3	2.2	1.5	2.1	3.6	3.6	1.4	1.5	5.1	0.4	0.0	1.2	0.5	0.8	2.1	1.8	0.0	0.3	0.6	0.2	0.0	1.2	0.3	0.0	4.2	9.8	0.4	0.8	0.8	0.0	0.3	1.8	0.5	0.8	0.5	0.1	0.0	0.2	0.3	0.1	1.0	0.2	0.1	2.3	0.2	0.0	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	2.0	6.7	0.8	0.1	0.2	0.0	0.0	0.2	1.1	3.9	0.0	0.2	0.0	0.0	0.0	4.9	0.0	1.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	1.2	0.4	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.3	9.0	14.4	14.9	30.5	9.3	17.6	11.5	10.6	23.7	0.4
CCDC189	"C16orf93, MGC104706"	ENSG00000196118	"Coiled-coil domain containing 189"	A1A4V9	16	30757423-30762710	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041806, HPA046289"	Approved		Approved	Cytosol				Cytosol		"HPA041806: AB_2677684, HPA046289: "	"unprognostic (5.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.45e-4)"	"unprognostic (3.60e-2)"	"unprognostic (5.41e-3)"	"unprognostic (7.76e-5)"	"unprognostic (1.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.06e-7)"	"unprognostic (1.75e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.41e-2)"	1.0	4.2	4.7	3.1	5.3	11.0	4.8	0.9	6.4	3.2	2.8	2.9	5.5	2.0	2.2	15.0	1.2	15.6	4.2	0.8	5.5	6.8	4.5	0.9	5.5	1.9	7.5	3.3	3.1	3.0	4.4	10.3	1.2	7.6	3.0	3.1	2.3	3.4	5.1	0.4	1.8	1.4	1.3	1.3	1.9	2.0	23.7	2.2	2.3	6.3	1.6	3.4	1.7	0.8	1.2	13.0	6.2	3.1	1.8	1.1	0.8	7.1	4.9	1.4	5.8	1.6	1.8	0.4	2.7	1.0	2.9	2.2	0.4	5.3	0.2	4.8	2.0	8.9	0.8	4.4	1.2	0.8	11.6	1.9	10.1	3.1	0.3	2.9	2.1	0.4	0.4	5.4	4.4	2.2	2.7	1.3	2.1	3.7	3.1	5.8	2.3	2.7	3.0	1.9	5.5	6.5	0.1	5.0	1.8	2.9	8.2	1.8	8.0	3.7	1.9	1.5	1.2	2.5	2.7	3.9	2.2	2.6	8.7	7.5	0.7	1.2	1.3	6.2	0.2	1.4	1.1	1.2	0.0	0.2	1.8	0.1	0.0	0.4	0.6	1.8	3.1	13.0	0.1	0.8	4.7	5.3	0.9	6.4	5.5	6.8	7.5	3.3	7.6	2.2
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469301-57493867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 25.8;kidney: 75.8;pancreas: 21.8"	"Group enriched"	"Detected in some"	7	"A549: 9.1;RPTEC TERT1: 27.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA029202: AB_10600754"		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavourable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favourable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.6	0.1	0.6	0.1	0.0	1.6	0.7	0.4	25.8	0.1	15.3	17.7	0.1	0.1	0.2	75.8	17.7	0.1	0.0	0.1	0.0	6.1	21.8	0.0	0.1	0.1	1.5	0.1	0.0	0.0	0.1	0.8	0.1	0.4	0.1	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.1	2.7	1.9	4.5	0.9	3.4	5.0	3.6	0.0	9.1	0.0	0.3	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.9	0.9	0.4	2.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	0.1	0.2	0.1	0.0	0.2	27.1	0.4	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.5	0.1	0.1	0.3	0.4	0.3	1.4	0.3	0.2	3.1	0.9	0.6	2.1	0.4	2.6	2.1	4.2	3.0	0.2	2.7	3.5	5.0	4.5	3.4	0.6	1.9	5.0	3.6	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	1.5	0.0
CCDC22	"CXorf37, JM1"	ENSG00000101997	"Coiled-coil domain containing 22"	O60826	X	49235467-49250526	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000229, HPA000888"	Uncertain	Approved	Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA000229: , HPA000888: AB_1078420"	"unprognostic (1.24e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-3)"	11.5	15.4	12.1	18.2	14.9	26.0	16.3	20.7	16.5	12.5	11.8	13.7	17.2	16.3	14.8	12.3	15.8	13.7	11.9	12.9	12.2	9.8	13.9	14.2	19.8	24.7	12.2	15.9	13.7	20.3	12.1	13.5	11.0	11.8	15.2	8.6	12.8	19.2	21.3	23.0	15.1	15.3	14.6	12.4	23.9	14.2	4.5	14.1	25.0	13.0	15.5	17.9	12.6	12.3	12.4	23.5	13.9	22.1	6.1	13.9	15.1	10.5	9.2	5.6	19.5	5.2	5.4	12.0	6.3	4.6	7.0	8.1	9.2	9.2	3.9	9.3	5.5	8.6	6.1	10.3	2.9	10.1	13.6	4.1	8.7	8.7	8.8	11.6	7.3	5.0	8.9	9.3	5.1	6.9	8.1	6.9	5.0	32.7	8.4	13.6	6.5	13.5	12.3	9.1	16.9	5.5	5.4	6.7	5.1	9.6	11.3	8.4	17.6	11.4	7.6	9.1	9.9	11.2	6.5	12.5	6.8	7.0	9.9	21.7	7.1	5.1	22.1	13.9	12.0	19.2	13.1	12.4	12.5	13.9	23.5	11.6	11.4	12.9	1.8	6.1	15.7	9.3	12.9	15.1	12.1	14.9	20.7	16.5	12.2	9.8	12.2	15.9	11.8	14.1
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: "	"prognostic favourable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favourable (3.18e-4)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.8	5.5	9.3	2.6	9.8	1.1	5.1	3.0	9.8	7.2	5.0	3.2	18.9	3.7	4.9	6.6	2.6	20.3	13.1	1.5	6.4	8.0	8.9	3.0	3.2	2.6	5.5	9.6	3.4	6.0	9.6	14.5	2.4	5.2	7.2	4.1	6.5	8.4	14.7	1.5	0.9	3.3	3.4	3.3	3.0	4.9	15.4	1.7	0.6	8.8	1.0	2.5	4.7	2.1	6.8	0.8	1.4	4.0	0.5	0.6	0.5	5.1	3.0	1.4	1.5	1.4	0.9	3.1	0.2	2.1	1.6	2.8	2.0	14.8	4.1	5.8	0.6	5.2	0.8	7.3	1.5	4.3	1.8	2.1	1.8	0.6	1.6	0.7	3.6	0.3	0.7	5.2	0.5	1.3	0.9	1.5	2.2	4.4	0.2	1.5	3.1	2.6	1.3	0.0	0.8	6.1	2.0	3.4	3.0	4.5	2.6	2.8	7.6	0.1	0.4	2.4	6.9	1.7	0.7	0.6	1.9	0.9	6.2	0.6	1.9	0.0	0.7	1.4	0.6	4.0	0.3	6.8	0.2	0.2	0.8	3.0	0.0	0.0	0.6	0.5	3.1	0.6	0.0	0.5	9.3	9.8	3.0	9.8	6.4	8.0	5.5	9.6	5.2	1.7
CCDC25	FLJ10853	ENSG00000147419	"Coiled-coil domain containing 25"	Q86WR0	8	27733311-27772653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023256	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA023256: AB_2072067"	"unprognostic (1.43e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-2)"	"prognostic favourable (1.11e-7)"	"unprognostic (3.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-1)"	12.7	25.4	16.8	10.6	22.4	4.0	16.7	14.2	26.1	10.3	26.0	13.1	12.0	32.5	13.2	14.2	13.7	14.6	11.3	11.1	16.5	14.0	21.5	30.4	8.5	12.8	19.9	15.8	10.9	16.0	15.6	12.7	9.9	29.4	11.4	15.1	9.8	14.1	12.4	23.3	10.9	39.7	10.5	19.0	12.1	18.0	12.0	17.2	9.7	17.8	13.8	12.8	13.2	10.5	19.2	18.9	14.9	13.2	13.8	21.8	9.1	23.8	12.9	13.1	12.2	11.7	17.0	8.8	20.1	19.5	12.4	12.1	5.3	8.6	25.8	13.9	10.1	11.3	11.6	19.5	17.9	9.6	7.8	32.1	12.2	9.3	19.7	11.2	10.4	18.9	13.0	13.3	18.8	26.6	15.1	12.4	13.8	8.7	27.3	9.5	18.8	7.2	8.9	22.2	13.6	16.2	14.0	7.5	21.0	13.5	10.4	20.4	11.9	6.3	21.4	11.4	18.0	19.4	10.5	13.5	15.7	9.4	17.7	15.0	11.7	14.9	10.4	7.3	14.6	13.2	19.8	19.2	21.2	17.8	12.1	14.0	18.8	20.9	4.0	13.8	12.5	18.9	21.8	9.1	16.8	22.4	14.2	26.1	16.5	14.0	19.9	15.8	29.4	17.2
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 89.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.7;HAP1: 13.7;HDLM-2: 22.5;U-2 OS: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"			Nucleoplasm	Cytosol	"HPA062425: "	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	37.1	5.0	14.0	2.5	9.0	0.2	33.6	4.9	15.0	23.0	4.2	2.9	3.4	2.9	16.2	18.6	26.9	21.8	89.3	11.0	8.0	3.0	4.2	8.5	8.0	12.3	4.3	8.7	39.1	2.9	3.8	4.2	9.6	3.2	14.3	3.4	8.8	2.8	10.3	12.0	55.7	5.5	11.8	3.4	9.8	5.8	11.0	3.1	10.4	8.3	9.6	2.0	12.4	14.2	0.1	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.2	1.2	6.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.5	0.0	1.3	13.7	2.5	0.4	22.5	5.8	0.0	0.2	0.0	0.5	0.0	0.0	1.7	1.7	0.3	0.0	0.7	0.0	0.1	0.7	0.1	0.0	3.8	1.1	0.0	0.0	3.0	0.2	0.0	0.0	2.6	1.1	4.9	0.7	0.0	0.0	0.0	0.0	0.0	14.9	0.8	0.2	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	14.0	9.0	4.9	15.0	8.0	3.0	4.3	8.7	3.2	3.1
CCDC43	FLJ31795	ENSG00000180329	"Coiled-coil domain containing 43"	Q96MW1	17	44673069-44689779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 50.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA023391	Approved		Enhanced	Cytosol				Cytosol		"HPA023391: AB_1846146"	"unprognostic (6.05e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (3.42e-5)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.11e-1)"	10.4	10.4	14.3	8.5	15.6	13.8	10.0	14.9	14.7	7.9	9.3	9.8	7.2	9.1	8.2	9.0	10.7	7.6	6.1	16.3	13.8	10.4	11.2	7.5	7.5	9.6	11.9	9.2	7.3	9.4	12.3	5.8	14.2	14.4	9.8	12.0	6.9	8.9	7.6	50.6	8.8	8.8	8.6	14.4	9.8	8.5	7.3	9.6	10.9	10.8	17.1	10.9	9.1	7.8	11.5	17.5	10.7	17.9	15.8	14.7	10.0	12.2	14.7	14.0	12.3	9.6	14.2	25.7	18.7	11.1	18.4	18.2	19.8	13.2	21.4	14.6	15.1	9.7	22.9	21.6	26.9	26.1	26.7	19.2	24.2	29.1	17.1	26.7	14.4	12.7	22.0	19.1	26.1	17.8	20.2	14.9	18.6	15.2	26.0	19.1	14.4	18.9	17.0	35.1	18.5	18.8	8.0	14.1	13.9	13.7	11.0	18.9	28.2	18.2	15.3	22.9	16.9	13.6	24.8	15.2	19.2	24.8	16.7	15.6	16.3	10.5	16.0	10.7	12.9	17.9	11.9	9.3	12.2	14.3	17.5	11.5	12.0	13.0	3.3	15.8	11.7	12.4	14.7	10.0	14.3	15.6	14.9	14.7	13.8	10.4	11.9	9.2	14.4	9.6
CCDC50	"C3orf6, DFNA44, Ymer"	ENSG00000152492	"Coiled-coil domain containing 50"	Q8IVM0	3	191329077-191398670	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 95.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 95.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001336	Approved		Supported	Cytosol				Cytosol		"HPA001336: AB_1078421"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.73e-2)"	"unprognostic (8.29e-2)"	"prognostic unfavourable (2.48e-5)"	"unprognostic (3.03e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.19e-1)"	35.2	17.5	15.8	23.7	15.5	5.1	41.4	11.7	14.2	19.3	21.7	17.2	21.7	14.0	23.4	21.6	20.4	21.7	29.6	22.7	14.9	11.0	25.1	38.5	22.3	22.7	15.9	9.3	28.9	31.1	17.1	14.7	20.3	14.6	20.5	15.4	16.2	21.4	20.8	19.2	14.3	22.3	37.5	14.5	32.5	21.2	18.7	14.4	11.7	25.5	14.4	23.4	30.4	23.8	20.1	95.0	0.3	3.4	3.5	3.2	2.4	18.0	6.0	23.6	6.2	21.2	18.8	8.2	33.5	33.6	24.2	24.3	12.8	7.2	3.5	41.4	18.8	20.7	18.8	14.9	36.3	26.3	9.2	2.4	8.1	14.6	31.3	8.8	9.6	15.0	20.1	19.1	43.4	37.0	8.0	19.4	21.3	6.2	0.0	5.6	8.3	25.7	13.6	13.1	17.6	26.2	7.8	5.5	8.4	11.9	12.9	23.2	8.9	8.0	37.7	23.9	19.9	17.2	42.9	30.1	13.0	0.2	12.8	0.0	19.2	0.0	3.4	0.3	0.9	3.1	0.4	20.1	1.0	0.6	6.6	10.0	0.2	0.2	0.3	3.5	1.6	95.0	3.2	2.4	15.8	15.5	11.7	14.2	14.9	11.0	15.9	9.3	14.6	14.4
CCDC57	"FLJ00130, FLJ23754"	ENSG00000176155	"Coiled-coil domain containing 57"	Q2TAC2	17	82101460-82212830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.2;naive CD8 T-cell: 10.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.7"									"HPA023315, HPA023326, HPA023342, HPA023344"	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"				Microtubules	"Centriolar satellite, Cytosol"	"HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162"	"unprognostic (2.51e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.16e-1)"	"prognostic favourable (5.55e-5)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (2.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.80e-3)"	5.5	9.0	12.9	10.4	14.1	12.1	14.1	20.3	16.6	9.9	8.5	7.6	17.1	11.8	14.2	13.7	4.2	14.9	11.2	4.7	9.3	6.8	13.0	6.8	8.8	7.9	5.4	13.7	14.0	13.7	15.9	22.7	5.8	8.9	14.9	5.2	16.7	13.6	13.8	6.2	8.9	8.9	11.3	3.8	7.7	11.4	23.7	8.8	10.6	19.8	5.2	9.6	7.9	7.2	0.6	1.6	1.9	0.6	0.4	10.7	1.5	4.3	9.0	4.7	6.2	2.8	5.2	5.6	3.4	3.4	2.5	2.2	2.7	6.9	2.3	3.2	2.8	10.5	1.3	6.2	1.4	2.4	9.3	3.8	15.0	5.7	3.7	3.7	4.9	5.2	4.9	4.8	6.3	3.0	5.0	1.3	1.6	6.5	7.1	7.2	1.6	3.6	4.0	2.0	3.2	4.8	5.5	16.2	10.1	3.1	14.7	5.8	8.6	4.3	3.1	9.9	9.1	4.2	6.8	9.6	0.9	0.7	7.7	4.3	3.9	0.5	0.6	0.7	0.9	0.2	0.4	0.6	0.8	1.2	0.5	0.6	5.2	10.7	1.9	0.4	0.1	1.6	0.3	1.5	12.9	14.1	20.3	16.6	9.3	6.8	5.4	13.7	8.9	8.8
CCDC6	"D10S170, H4, PTC, TPC, TST1"	ENSG00000108091	"Coiled-coil domain containing 6"	Q16204	10	59788763-59906656	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019049, HPA019051"	Enhanced		Supported	Cytosol				Cytosol		"HPA019049: AB_1846163, HPA019051: AB_1846164"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.98e-3)"	"prognostic favourable (5.48e-4)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.95e-4)"	"unprognostic (4.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.19e-2)"	13.7	13.3	22.8	11.7	41.8	12.8	20.7	13.8	27.1	23.0	23.9	11.3	10.7	20.4	28.4	16.6	33.2	23.6	16.2	11.2	17.0	18.1	19.4	10.9	15.5	18.7	13.8	17.6	19.8	22.5	16.8	13.7	13.3	14.5	18.7	18.4	9.6	25.5	14.0	18.2	26.0	20.4	28.1	11.8	14.5	16.6	12.6	12.3	10.6	19.1	14.8	20.7	21.7	23.8	7.1	7.3	0.2	3.4	1.2	2.3	1.4	15.8	14.3	7.2	16.1	11.0	16.6	14.7	7.8	10.4	7.8	9.2	27.8	31.1	13.6	11.8	13.0	23.5	14.4	14.2	11.7	20.3	7.2	11.1	11.6	16.9	13.3	12.6	10.4	12.0	18.9	13.0	32.0	11.5	8.3	8.7	10.1	21.3	5.2	7.3	11.5	9.8	7.1	11.8	8.5	13.1	13.6	7.4	6.4	9.8	41.5	8.7	26.3	6.8	11.7	7.3	13.4	11.3	13.0	4.6	5.3	6.2	11.6	24.2	4.5	0.0	2.9	0.0	1.5	3.4	1.8	6.7	2.3	2.1	7.3	7.1	2.2	1.6	0.2	1.2	1.9	1.9	2.1	1.4	22.8	41.8	13.8	27.1	17.0	18.1	13.8	17.6	14.5	12.3
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621818	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"				"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	8.4	7.5	9.3	7.6	11.7	6.5	12.0	31.0	15.1	11.7	11.0	9.6	7.6	5.9	12.7	12.7	6.7	12.9	7.6	8.4	9.8	6.4	9.2	4.6	7.7	10.1	10.8	10.6	14.7	7.1	10.1	32.9	7.6	11.0	9.7	9.4	7.8	9.1	10.9	11.9	5.7	7.7	11.1	11.2	8.7	8.0	8.6	12.9	11.9	12.1	5.7	10.2	11.0	9.7	2.6	1.1	7.0	2.2	5.0	14.1	2.7	5.4	1.9	6.1	3.6	9.2	5.4	4.8	7.0	6.4	9.2	8.1	4.2	4.3	15.2	1.6	3.7	3.0	3.4	6.4	10.3	5.4	4.1	9.5	8.4	4.8	6.5	12.1	3.6	5.3	9.3	7.6	5.4	5.8	8.8	2.4	7.1	4.4	9.7	7.7	9.9	7.5	3.3	5.2	8.2	5.5	1.9	2.3	4.2	8.4	5.4	5.1	1.9	5.3	3.1	6.9	5.4	6.4	9.5	4.9	5.2	8.1	5.1	13.9	5.4	7.0	1.5	3.3	4.3	1.9	5.6	2.6	7.4	5.3	1.1	1.7	8.6	6.2	0.3	5.0	2.2	1.0	14.1	2.7	9.3	11.7	31.0	15.1	9.8	6.4	10.8	10.6	11.0	12.9
CCDC68	SE57-1	ENSG00000166510	"Coiled-coil domain containing 68"	Q9H2F9	18	54901509-54959508	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.1"	"Cell line enhanced"	"Detected in some"		"A-431: 7.9;HHSteC: 10.7;HSkMC: 11.7;RT4: 7.9;TIME: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040865, HPA048197"	Supported		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA040865: , HPA048197: AB_2680310"	"unprognostic (1.36e-2)"	"prognostic unfavourable (4.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.28e-4)"	"unprognostic (1.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.38e-1)"	5.6	3.0	1.2	7.7	2.4	0.3	5.8	0.6	4.7	5.5	20.7	0.8	3.1	14.8	4.5	2.5	2.1	2.6	9.1	5.7	1.7	1.7	5.6	9.9	15.2	2.3	2.0	4.7	15.4	2.8	0.5	15.7	23.9	4.4	5.2	13.9	9.3	2.2	13.0	7.7	1.0	40.1	2.1	1.6	5.8	10.5	7.4	0.1	0.0	3.5	2.1	1.0	3.0	4.2	0.8	0.6	1.1	2.2	0.5	1.0	0.5	7.9	2.5	0.0	0.0	2.3	6.6	0.0	0.2	3.2	0.5	0.5	4.4	4.7	0.0	5.9	0.0	0.1	0.5	5.1	0.4	0.0	1.2	0.6	2.9	0.9	10.7	0.0	0.0	11.7	0.0	2.4	0.1	3.7	0.0	0.1	0.3	0.6	0.0	0.1	0.0	2.7	0.2	0.0	0.2	0.9	7.9	0.0	1.9	2.5	0.8	0.1	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	0.7	0.7	0.4	0.8	0.6	0.6	0.6	0.5	0.4	0.8	0.9	1.0	0.7	0.5	2.2	0.6	0.5	0.5	1.2	2.4	0.6	4.7	1.7	1.7	2.0	4.7	4.4	0.1
CCDC7	"BIOT2, C10orf68, FLJ13031, FLJ32762"	ENSG00000216937	"Coiled-coil domain containing 7"	Q96M83	10	32446140-32882874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 65.5"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA075536			Approved	"Nucleoli,Mitotic spindle,Cytosol"				Nucleoli	"Mitotic spindle, Cytosol"	"HPA075536: "	"unprognostic (3.43e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.65e-5)"	"unprognostic (6.95e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.95e-5)"	"unprognostic (7.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	2.1	2.1	3.2	3.8	3.6	2.8	2.2	4.8	3.6	2.3	2.1	4.2	4.3	2.0	3.4	5.1	2.0	1.7	1.9	2.3	2.6	1.9	1.9	1.7	2.0	2.8	4.2	1.5	2.7	2.3	2.1	8.5	1.8	3.0	2.1	2.3	1.8	2.0	3.2	2.0	2.0	1.8	2.1	5.4	2.0	2.0	65.5	3.2	3.4	2.7	0.3	2.2	2.3	2.3	2.4	1.7	0.1	0.6	2.9	5.9	0.5	2.5	2.8	0.8	3.5	2.4	1.9	1.3	2.3	0.8	0.8	2.5	0.6	3.8	1.9	1.2	1.6	1.3	1.3	1.4	3.1	6.6	0.3	1.0	2.0	0.7	4.3	1.0	1.9	1.7	0.7	1.7	0.6	1.0	1.5	6.5	3.2	0.4	0.8	0.6	0.7	2.8	1.6	3.6	0.3	2.3	0.5	1.9	1.9	0.4	0.4	1.5	1.9	1.5	3.8	2.0	2.3	2.6	1.3	2.1	1.4	1.9	2.5	7.3	1.1	0.0	0.6	0.1	3.4	0.3	3.3	2.4	5.3	2.9	0.3	1.2	5.9	3.9	0.1	2.9	0.3	1.7	3.5	0.5	3.2	3.6	4.8	3.6	2.6	1.9	4.2	1.5	3.0	3.2
CCDC71L	"C7orf74, FLJ36031"	ENSG00000253276	"Coiled-coil domain containing 71 like"	Q8N9Z2	7	106656765-106660996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 42.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067925	Approved		Approved	"Golgi apparatus,Actin filaments,Cytosol"				"Golgi apparatus, Actin filaments"	Cytosol	"HPA067925: "	"unprognostic (1.51e-1)"	"prognostic unfavourable (9.08e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (2.53e-6)"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.35e-2)"	19.5	5.2	2.4	13.2	2.2	8.8	10.6	0.6	3.8	7.8	8.4	2.5	5.8	4.3	10.3	6.5	6.3	19.7	9.2	6.3	3.5	2.3	9.0	42.9	11.2	10.8	1.8	2.7	13.4	6.3	3.2	3.7	4.0	2.3	9.3	4.0	8.1	16.5	4.9	6.7	3.2	8.3	7.0	2.4	17.0	9.0	12.7	2.2	35.3	9.1	2.9	6.8	12.5	10.8	2.3	2.4	7.3	1.2	1.6	2.9	0.8	10.2	2.1	3.2	3.8	7.2	6.9	0.0	16.0	20.4	6.2	6.7	0.3	6.5	7.0	5.5	26.7	1.1	1.5	4.5	5.1	16.2	3.7	0.8	0.4	0.0	11.3	3.5	8.4	5.8	2.7	2.8	1.6	21.4	23.1	17.2	7.3	2.9	4.7	5.5	6.9	7.6	6.4	0.9	1.3	3.1	0.6	1.4	9.6	10.2	3.7	22.1	1.7	4.2	9.4	13.8	1.2	1.6	6.1	16.7	1.5	5.6	10.6	4.5	15.1	7.2	1.0	3.0	2.0	0.8	1.5	2.3	1.6	1.5	0.7	1.7	0.8	1.2	7.3	1.6	1.2	2.4	2.9	0.8	2.4	2.2	0.6	3.8	3.5	2.3	1.8	2.7	2.3	2.2
CCDC8	"3M3, DKFZp564K0322, PPP1R20"	ENSG00000169515	"Coiled-coil domain containing 8"	Q9H0W5	19	46410372-46413584	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.4"	"Cell line enhanced"	"Detected in many"		"AF22: 11.9;AN3-CA: 14.2;HSkMC: 13.0;K-562: 12.4;RH-30: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041993	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041993: AB_10795388"	"unprognostic (3.05e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.72e-2)"	"prognostic favourable (1.72e-5)"	"unprognostic (5.43e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.18e-3)"	2.7	13.3	3.0	2.1	3.8	0.6	7.6	0.9	2.3	18.9	2.4	5.1	6.2	0.8	15.5	17.3	2.9	19.0	9.7	18.9	3.1	2.3	7.9	0.7	7.1	0.9	2.4	2.9	39.4	19.2	8.5	9.9	5.6	4.6	12.1	1.1	10.0	8.7	7.5	3.0	2.2	1.6	6.7	2.0	1.8	1.7	9.0	2.6	4.2	11.8	2.6	1.4	4.8	5.8	0.4	0.3	3.6	0.4	0.2	0.2	0.1	1.1	0.1	11.9	14.2	3.2	4.0	5.8	6.1	0.0	1.4	0.6	0.0	0.1	0.1	8.1	4.8	0.1	0.1	9.5	0.6	0.0	6.0	0.0	0.1	0.6	10.6	0.0	0.1	13.0	0.0	3.3	9.9	0.0	12.4	0.0	4.3	0.0	0.0	0.8	8.6	0.0	0.4	16.1	0.0	10.4	0.0	1.9	0.1	0.0	0.0	0.0	0.1	2.9	1.1	0.8	3.2	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.2	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.2	3.6	0.2	0.3	0.3	0.1	0.1	3.0	3.8	0.9	2.3	3.1	2.3	2.4	2.9	4.6	2.6
CCDC82	FLJ23518	ENSG00000149231	"Coiled-coil domain containing 82"	Q8N4S0	11	96352769-96389956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038704, HPA070631"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA038704: AB_10674835, HPA070631: "	"unprognostic (3.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.94e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	19.4	12.5	22.8	14.6	32.7	12.1	15.3	34.5	29.6	13.6	12.7	18.3	6.7	9.8	18.4	12.2	9.0	14.9	13.9	10.4	23.7	9.0	13.7	17.8	15.7	17.4	31.9	20.3	16.5	13.5	11.7	22.3	14.3	25.6	12.2	11.6	8.1	11.9	13.7	10.8	10.5	15.5	14.1	26.0	16.5	13.6	19.4	35.5	7.5	15.9	6.2	15.8	15.4	16.9	14.3	12.2	28.6	10.8	22.7	19.2	11.0	5.3	8.1	25.1	9.7	16.7	14.3	9.3	21.0	12.9	13.8	20.2	13.3	18.9	11.2	19.8	10.9	12.7	8.9	7.6	20.5	19.1	5.4	22.9	17.4	11.3	12.0	17.9	15.3	8.8	4.1	27.8	10.4	16.4	13.7	12.2	18.5	0.2	15.1	17.5	5.0	5.9	10.4	21.4	9.9	10.5	14.1	4.0	10.7	11.6	1.2	10.3	1.9	8.9	19.0	24.5	13.5	20.4	11.1	4.1	12.5	16.3	7.3	14.1	17.4	28.6	8.3	15.5	16.5	10.2	17.2	14.3	17.6	16.1	8.9	12.1	19.2	18.2	11.6	22.7	10.8	12.2	18.4	11.0	22.8	32.7	34.5	29.6	23.7	9.0	31.9	20.3	25.6	35.5
CCDC83	"CT148, FLJ42119, MGC34732"	ENSG00000150676	"Coiled-coil domain containing 83"	Q8IWF9	11	85855101-85920021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.7"	"Cell line enriched"	"Detected in single"	10	"MCF7: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039707, HPA039882"			Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039707: AB_10795259, HPA039882: AB_10795410"	"unprognostic (1.14e-1)"				"unprognostic (4.09e-1)"					"unprognostic (1.49e-2)"		"unprognostic (4.43e-2)"	"unprognostic (7.05e-6)"	"unprognostic (3.52e-1)"			"unprognostic (2.17e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	1.8	0.8	0.3	0.6	0.0	0.1	0.0	0.5	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.7	0.3	0.3	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.1	0.3	7.7	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.6	0.3	0.1	0.1	0.1	0.5	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.2	0.1	0.3	0.8	0.6	0.3	0.6	0.4	0.4	0.3	0.3	0.3	0.3	0.4	0.3	0.5	1.8	0.3	0.8	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340223-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 39.8;Karpas-707: 10.4;THP-1: 15.8;U-937: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA026652	Approved		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"			Centrosome	"Nucleoplasm, Cytosol"	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavourable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	3.5	2.5	5.2	29.5	5.4	32.5	2.7	23.7	2.8	2.6	6.1	4.5	6.9	3.2	2.0	1.3	4.2	2.5	8.5	2.3	4.1	2.6	2.0	1.6	11.4	18.6	8.6	2.2	1.3	2.1	0.7	1.6	1.4	6.5	2.9	2.9	1.7	7.5	8.9	0.8	1.9	11.1	1.3	7.2	26.6	3.3	7.3	6.5	16.8	1.9	2.7	20.8	4.1	2.8	3.0	3.5	11.3	6.5	7.1	4.6	1.6	0.1	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	1.5	9.0	1.4	0.5	0.7	0.0	0.2	0.0	9.8	0.0	6.8	1.8	0.5	0.4	4.2	39.8	0.0	0.0	0.1	0.0	0.2	0.2	10.4	0.3	0.4	5.7	3.5	0.3	0.2	5.4	0.1	8.4	0.1	0.1	2.2	0.0	0.0	0.2	0.4	1.2	15.8	0.0	0.0	0.3	0.0	0.1	2.2	0.7	7.3	0.5	11.5	0.2	3.6	6.5	7.6	4.6	4.7	1.4	2.2	2.7	3.8	2.1	3.0	2.6	3.2	11.3	7.1	3.1	3.5	0.8	1.6	5.2	5.4	23.7	2.8	4.1	2.6	8.6	2.2	6.5	6.5
CCDC9	DKFZP586M1019	ENSG00000105321	"Coiled-coil domain containing 9"	Q9Y3X0	19	47255980-47273701	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045624, HPA072007"	Approved		Approved	Cytosol				Cytosol		"HPA045624: AB_10961402, HPA072007: "	"unprognostic (4.53e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.22e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (4.02e-1)"	17.4	16.9	10.1	18.4	13.5	38.3	16.0	14.9	15.0	18.0	16.1	13.0	20.6	14.8	31.2	19.6	15.0	16.2	17.4	15.6	10.6	7.1	14.3	16.0	18.0	14.3	14.7	10.4	23.4	35.1	16.2	14.9	21.8	13.2	19.3	9.8	17.9	14.7	19.8	23.2	23.5	14.0	28.2	9.3	16.8	17.3	23.3	15.6	11.1	19.0	13.1	13.3	21.8	23.2	2.3	2.9	7.8	2.7	2.0	3.6	0.8	11.4	11.7	9.3	10.3	2.9	8.1	10.5	16.0	7.1	9.8	10.9	12.4	9.1	5.3	4.4	10.6	10.8	8.5	6.8	5.4	13.9	5.2	13.5	10.7	9.4	9.5	5.4	14.1	8.6	10.1	9.3	8.8	6.5	18.3	26.9	6.5	13.8	6.3	47.9	10.2	4.6	11.2	8.8	5.9	4.4	8.4	3.6	9.2	21.7	15.8	8.5	13.1	11.2	8.9	11.4	10.3	6.8	13.5	9.0	15.5	7.9	10.7	7.4	8.7	0.8	2.5	3.8	2.9	2.7	1.5	1.4	2.3	2.4	1.9	2.3	2.4	1.7	7.8	2.0	1.7	2.9	3.6	0.8	10.1	13.5	14.9	15.0	10.6	7.1	14.7	10.4	13.2	15.6
CCDC97	"FLJ40267, MGC20255"	ENSG00000142039	"Coiled-coil domain containing 97"	Q96F63	19	41310189-41324883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043320, HPA043572"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043320: AB_10964344, HPA043572: AB_10962488"	"unprognostic (9.25e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"	20.4	15.3	15.5	20.7	18.8	21.5	16.8	16.1	24.7	21.3	16.7	26.7	17.8	15.1	21.3	26.6	22.9	24.5	15.8	16.4	14.6	14.1	16.5	13.3	15.4	23.2	16.0	16.2	27.4	20.6	20.8	21.9	22.9	18.6	19.0	12.6	20.9	21.1	17.2	28.8	21.5	18.4	15.6	21.0	24.2	17.3	39.9	16.8	27.7	17.9	20.4	27.2	17.7	19.7	13.6	7.6	14.6	13.3	11.5	16.8	8.3	12.9	28.4	15.1	17.5	19.9	15.9	10.9	8.7	7.1	13.9	11.9	16.8	12.5	12.3	9.4	7.2	8.8	20.6	17.4	10.6	22.6	20.0	11.3	12.8	11.0	15.2	18.7	24.5	15.4	22.4	16.1	13.5	9.5	14.4	23.7	13.2	9.4	17.0	4.5	7.0	10.3	19.3	12.0	9.0	12.7	24.7	13.5	12.0	19.5	21.5	8.5	14.7	14.3	11.3	12.0	12.1	6.2	14.4	24.4	20.8	11.9	11.4	13.8	15.9	9.0	8.3	9.7	15.3	9.2	16.8	11.3	10.3	10.9	6.8	13.6	11.4	10.0	14.6	11.5	13.3	7.6	8.5	8.3	15.5	18.8	16.1	24.7	14.6	14.1	16.0	16.2	18.6	16.8
CCDC9B	"C15orf52, FLJ43339"	ENSG00000188549	"Coiled-coil domain containing 9B"	Q6ZUT6	15	40331452-40340967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 39.2;WM-115: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040484, HPA041834"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA040484: AB_10794742, HPA041834: AB_10795643"	"unprognostic (5.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.68e-2)"	2.8	4.8	3.6	9.4	5.8	1.5	4.5	3.4	6.2	9.4	29.6	6.3	38.1	5.7	11.5	14.1	19.8	5.0	12.3	30.5	5.8	3.2	5.1	2.1	6.8	1.7	6.7	4.7	2.6	12.0	9.7	4.8	2.3	5.7	10.3	7.6	12.9	13.9	40.6	35.0	7.7	8.3	16.2	3.6	2.5	11.0	5.3	6.3	0.3	21.3	16.1	6.1	13.0	7.2	0.5	0.5	6.7	0.6	0.9	0.3	0.4	15.4	2.2	0.0	0.1	0.3	1.5	0.8	4.7	4.7	5.2	5.1	0.1	14.3	0.1	6.6	15.1	39.2	0.0	12.8	4.9	0.0	0.1	4.6	18.3	1.5	2.8	0.0	0.9	1.9	2.9	2.2	6.7	3.7	0.0	0.2	8.9	0.0	0.1	0.0	0.1	4.1	0.0	1.3	0.0	15.8	0.8	0.0	1.1	2.8	6.2	2.7	0.6	0.7	19.7	9.8	15.8	2.6	12.3	0.0	0.0	0.1	11.9	0.8	44.6	6.7	0.6	0.6	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.3	0.2	1.2	0.9	0.2	0.5	0.0	0.4	3.6	5.8	3.4	5.3	5.8	3.2	6.7	4.7	5.7	6.3
CCHCR1	"C6orf18, HCR"	ENSG00000204536	"Coiled-coil alpha-helical rod protein 1"	Q8TD31	6	31142439-31158238	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 50.1"	"Cell line enhanced"	"Detected in many"		"A-431: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054167			Supported	Cytosol				Cytosol		"HPA054167: "	"unprognostic (6.68e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-2)"	2.4	2.7	5.6	2.8	6.2	1.2	3.1	5.2	6.4	3.7	4.5	2.9	9.1	9.4	6.3	5.6	3.9	8.0	2.9	2.5	4.0	2.7	4.3	2.9	3.0	5.5	4.1	5.6	5.5	7.6	1.7	2.5	1.5	4.5	5.3	3.2	3.4	3.5	6.8	10.1	7.0	5.9	3.9	2.6	3.4	6.6	50.1	3.8	4.3	6.2	3.1	4.2	3.4	4.0	2.0	3.4	1.4	2.1	2.5	4.3	2.3	22.3	1.7	6.3	1.0	3.9	4.6	5.9	1.9	0.6	0.3	0.7	9.0	0.4	2.9	10.7	5.0	0.9	0.3	9.0	0.9	3.3	14.3	10.6	7.4	6.8	2.2	0.2	7.0	5.9	1.0	4.1	0.9	4.8	4.1	6.2	2.6	1.6	3.9	11.8	0.4	0.1	7.1	8.4	5.4	5.8	2.2	17.7	2.9	7.3	0.0	1.8	2.5	5.6	0.6	9.3	3.0	0.2	5.6	14.5	8.4	12.1	1.9	2.6	0.9	0.3	2.1	1.4	2.9	0.9	2.5	1.3	2.6	4.3	1.5	2.0	4.0	4.0	0.6	2.5	1.2	3.4	4.0	2.3	5.6	6.2	5.2	6.4	4.0	2.7	4.1	5.6	4.5	3.8
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823933	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 122.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 6.8"	"Low region specificity"	"Detected in single"							"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavourable (9.17e-5)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	3.2	1.5	1.3	18.6	1.7	21.6	1.8	5.1	1.2	2.5	6.3	1.0	0.8	6.6	2.2	2.1	11.7	1.7	2.4	3.2	1.8	1.8	1.7	1.6	3.4	15.6	1.6	0.8	4.5	0.9	0.5	3.2	12.0	1.3	2.2	7.8	1.0	2.1	0.8	1.1	4.2	7.4	2.4	1.8	8.9	2.9	8.4	0.8	122.3	1.4	18.8	18.4	2.5	5.1	0.3	0.9	0.6	0.3	1.7	6.8	1.9	38.1	9.9	27.3	11.6	1.4	3.8	22.3	26.6	11.7	35.5	26.4	21.6	23.7	35.1	7.2	14.0	12.9	34.3	15.7	29.2	16.8	15.8	28.2	13.2	21.0	0.3	42.4	20.0	0.9	1.2	14.6	8.8	21.2	40.0	35.3	28.1	13.7	54.0	24.6	21.5	11.1	24.8	52.8	17.1	10.0	7.6	11.6	12.3	14.0	17.1	7.4	14.3	18.0	12.4	16.6	25.2	17.5	25.4	22.4	23.7	40.2	9.5	43.2	18.4	0.0	0.3	0.6	0.2	0.1	0.1	0.3	2.0	1.4	0.9	0.1	0.0	0.5	0.3	1.7	0.3	0.1	6.8	1.9	1.3	1.7	5.1	1.2	1.8	1.8	1.6	0.8	1.3	0.8
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167010-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 71.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: , HPA061448: "	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.54e-7)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	3.2	4.6	2.7	23.9	4.8	20.5	4.6	6.5	5.6	4.4	9.9	1.6	1.6	9.3	3.5	2.8	28.8	3.3	3.5	1.9	3.5	4.2	4.6	2.9	3.4	23.6	4.0	4.2	3.7	4.0	1.6	2.6	12.1	11.5	2.6	14.2	1.7	5.3	1.7	2.0	6.4	8.7	6.4	2.5	9.1	7.1	21.7	1.3	71.4	6.3	23.3	30.1	5.3	7.5	13.2	5.1	2.4	4.1	6.5	14.7	5.5	58.7	40.7	55.8	49.6	2.9	5.0	131.9	26.0	19.5	68.7	58.1	60.1	55.4	36.1	31.7	24.0	37.1	56.1	56.9	77.1	35.4	27.8	22.9	33.9	41.4	0.9	19.9	26.2	2.2	3.6	39.4	27.5	36.6	27.7	28.7	55.9	55.9	27.3	23.8	31.1	25.8	28.7	40.3	37.0	25.1	21.7	28.4	17.9	44.8	21.1	19.3	40.3	20.9	15.4	15.3	49.8	27.6	65.0	14.4	26.6	50.4	21.2	35.0	47.0	2.4	1.8	1.2	2.8	4.1	4.0	13.2	7.6	6.7	5.1	8.6	2.5	2.4	1.0	6.5	1.9	4.2	14.7	5.5	2.7	4.8	6.5	5.6	3.5	4.2	4.0	4.2	11.5	1.3
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105078-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.2;testis: 73.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"T-reg: 17.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (2.83e-4)"	"prognostic unfavourable (4.63e-4)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	2.0	1.1	0.4	21.0	0.4	24.7	2.5	0.3	0.6	1.8	5.5	0.5	0.2	5.2	1.0	1.5	11.3	0.5	1.6	1.2	0.4	0.4	1.0	1.0	1.9	12.0	0.4	0.3	0.8	0.7	0.0	0.4	6.7	0.4	1.1	6.3	0.4	2.1	0.6	0.4	3.6	5.1	2.0	1.3	5.2	3.0	73.9	0.2	70.2	0.8	10.3	16.0	1.8	3.4	1.8	2.3	0.7	0.1	3.0	17.8	1.8	28.4	25.1	41.3	10.2	1.8	3.8	21.9	23.6	15.2	36.6	30.1	40.6	17.6	26.5	17.1	15.2	35.2	39.0	20.1	34.6	27.5	20.9	34.3	29.4	23.0	0.5	25.5	22.1	1.4	2.7	15.7	20.1	24.8	34.6	42.6	27.6	20.7	29.1	37.2	30.5	14.9	34.0	58.4	26.9	11.5	20.2	25.7	17.4	32.4	17.6	21.3	30.5	25.5	12.9	18.2	31.0	20.1	44.9	19.0	28.4	47.1	11.9	58.4	25.7	0.0	0.1	0.6	0.1	0.0	0.2	1.8	3.9	4.1	2.3	0.9	0.0	0.1	0.7	3.0	0.0	0.1	17.8	1.8	0.4	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.2
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542380-99568973	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: "	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favourable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	18.0	21.1	14.5	16.8	20.4	13.7	23.8	23.2	24.3	15.6	17.3	8.7	21.8	19.8	13.5	28.1	26.5	11.7	24.7	12.0	14.9	16.9	31.5	47.4	16.2	23.4	13.6	12.6	13.5	35.6	20.8	31.8	24.4	17.6	18.2	15.9	12.4	37.0	20.9	13.1	15.4	22.6	17.3	12.1	21.1	20.2	8.6	10.0	27.3	30.7	16.8	21.9	17.5	15.5	20.1	15.0	21.5	13.9	17.7	26.6	18.8	26.8	8.0	15.4	30.0	11.5	15.8	38.7	19.5	23.5	23.7	30.3	30.7	15.8	52.6	21.0	16.1	17.5	23.5	26.4	37.5	13.2	25.3	32.6	13.4	26.8	20.9	36.4	10.7	15.6	16.1	16.7	21.0	23.5	44.2	19.7	20.7	13.6	13.3	26.9	20.6	13.3	22.8	25.9	20.9	30.6	30.4	23.1	14.1	9.8	22.2	22.7	13.0	34.9	18.7	13.0	17.4	13.6	28.6	14.0	21.4	45.2	22.0	26.0	16.0	21.5	12.9	10.7	14.2	13.9	26.6	20.1	17.9	14.5	15.0	16.0	20.1	15.7	2.5	17.7	10.4	15.0	18.0	18.8	14.5	20.4	23.2	24.3	14.9	16.9	13.6	12.6	17.6	10.0
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934933-42050357	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 129.2;lymphoid tissue: 142.5"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 92.5;REH: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA071369"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB000116: , HPA071369: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (8.08e-6)"	"unprognostic (2.11e-1)"	20.2	39.8	16.1	28.9	17.5	74.7	36.0	13.3	19.8	13.3	17.3	11.3	14.1	16.0	10.8	10.4	13.5	13.4	19.0	16.3	15.4	14.5	13.7	8.0	32.1	83.8	14.1	15.5	11.1	10.9	5.0	10.1	21.9	9.3	14.2	11.4	10.2	18.1	14.4	6.5	14.6	22.0	11.7	11.5	51.2	18.0	7.4	10.0	142.5	26.8	9.3	32.8	13.0	16.6	24.1	42.4	129.2	45.8	39.0	52.8	66.2	9.0	33.1	3.5	7.7	6.3	12.9	40.2	10.6	6.1	11.0	8.1	6.2	4.1	39.0	18.0	7.1	5.6	9.2	13.0	5.7	6.6	6.0	61.8	14.8	5.0	13.9	10.1	54.6	12.3	8.5	10.6	4.0	13.5	31.1	3.8	15.7	12.2	92.5	48.5	1.5	7.1	87.9	13.5	4.3	25.4	6.1	11.8	3.1	9.0	11.6	5.2	7.1	39.5	22.5	12.2	6.7	10.6	11.9	2.5	1.9	60.9	7.1	21.3	7.4	129.2	30.5	87.7	52.8	35.1	37.0	16.4	36.4	42.5	42.4	24.1	42.8	45.0	42.8	39.0	45.8	27.8	23.2	66.2	16.1	17.5	13.3	19.8	15.4	14.5	14.1	15.5	9.3	10.0
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157151-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 99.1"	HPA034684	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favourable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	18.4	8.1	11.3	13.5	15.1	25.9	26.7	53.0	17.2	15.1	12.3	8.9	9.6	8.6	16.4	10.7	45.2	8.0	10.4	6.3	9.6	5.4	23.0	3.4	12.8	21.4	7.3	10.6	12.5	7.2	8.8	7.7	20.0	7.3	26.1	11.0	12.2	18.4	10.5	7.5	12.8	9.8	13.5	7.4	14.2	7.7	8.0	7.8	25.3	17.3	7.2	22.6	20.3	18.6	4.8	2.2	16.0	2.3	1.6	4.6	0.6	10.2	1.3	23.1	12.2	15.3	19.7	15.7	8.6	24.9	6.7	12.6	1.5	14.9	20.7	14.0	8.0	7.4	6.0	28.5	13.1	14.3	4.0	1.7	6.0	3.0	8.0	3.0	21.6	16.6	14.2	3.1	7.0	10.1	0.9	12.7	12.4	4.0	14.0	6.5	2.3	1.4	8.1	22.5	1.3	42.5	28.5	6.1	19.6	10.2	16.2	6.0	12.0	4.6	9.3	9.2	9.4	6.6	1.4	9.3	7.1	14.6	6.4	4.8	4.6	11.4	1.5	16.0	0.8	2.0	1.9	2.7	1.2	0.8	1.5	4.8	0.9	0.5	6.5	1.6	2.3	2.2	4.6	0.6	11.3	15.1	53.0	17.2	9.6	5.4	7.3	10.6	7.3	7.8
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747445-132754403	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 17.4;seminal vesicle: 15.7"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 23.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA056288: "	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favourable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.3	0.7	3.4	5.6	3.5	0.3	0.3	8.4	4.7	1.2	5.8	3.5	17.4	7.8	0.2	0.7	0.5	0.8	5.2	0.6	3.9	2.6	3.8	0.3	0.7	1.7	3.9	0.5	0.3	7.4	0.4	0.9	0.5	4.1	1.7	6.5	1.5	8.4	15.7	0.7	0.7	8.9	0.4	7.2	0.8	5.5	1.4	3.9	7.0	0.8	0.7	2.1	2.4	0.3	0.3	0.1	0.7	0.1	0.2	2.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	23.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.0	0.2	0.3	0.0	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.3	0.1	2.7	0.3	2.1	2.1	0.0	0.3	1.8	0.9	0.3	0.2	0.1	0.1	2.7	0.3	3.4	3.5	8.4	2.8	3.9	2.6	3.9	0.5	4.1	3.9
CCNQ	FAM58A	ENSG00000262919	"Cyclin Q"	Q8N1B3	X	153587919-153600045	"Disease related genes, Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050137, HPA059843"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA050137: , HPA059843: "	"unprognostic (3.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.25e-2)"	3.1	5.7	4.2	6.1	12.8	4.2	9.7	3.7	11.1	4.5	5.2	6.4	4.2	6.1	3.7	10.5	5.1	5.1	4.0	14.7	7.9		6.5	6.3	5.0	10.9	9.5	6.1	4.1	9.5	3.0	6.4	6.4	7.3	5.7	6.1	3.5	8.0	6.8	10.3	4.0	5.0	4.9	6.7	7.3	5.4	2.7	7.4	3.9	4.9	4.2	8.7	5.2	4.5	7.4	1.9	6.8	2.3	1.1	4.8	1.4	19.9	15.6	6.0	21.4	11.1	5.7	9.5	12.0	10.5	11.5	11.8	14.9	7.1	16.2	23.3	12.8	12.9	19.9	11.4	11.9	9.9	20.2	3.9	9.4	11.4	9.8	13.6	9.4	7.5	10.3	7.8	8.6	9.7	4.8	7.8	9.8	23.2	9.6	16.7	7.6	26.3	10.9	9.7	8.4	8.7	8.6	8.0	10.5	6.2	9.8	14.1	3.6	12.5	7.0	10.2	14.3	22.4	18.2	11.3	10.7	20.5	9.1	21.3	7.5	0.0	2.3	6.8	4.0	2.1	1.8	7.4	3.7	2.8	1.9	6.2	4.0	2.8	1.4	1.1	1.0	1.9	4.8	1.4										
CCNT2		ENSG00000082258	"Cyclin T2"	O60583	2	134918235-134959342	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005559	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA005559: AB_1078608"	"unprognostic (2.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (2.44e-4)"	"prognostic unfavourable (1.25e-5)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (3.28e-4)"	15.8	14.1	21.0	15.2	19.9	32.5	21.1	30.5	22.2	16.4	14.2	16.9	17.8	17.6	22.6	20.9	15.4	16.1	12.9	14.2	16.1	14.3	12.9	20.8	17.5	18.9	18.6	16.2	22.8	24.0	25.1	29.6	17.9	20.0	18.0	16.7	11.5	16.9	19.4	14.5	20.3	17.2	18.0	17.1	19.8	18.9	15.8	19.1	23.0	18.7	9.4	18.2	18.9	19.5	3.8	4.9	6.9	4.5	6.2	8.4	3.4	6.8	3.4	22.3	8.3	11.1	11.3	17.0	9.4	7.8	8.9	11.2	9.1	7.9	11.2	7.1	7.7	8.9	13.3	7.1	13.1	6.0	9.0	12.0	8.7	12.9	10.8	10.8	10.7	10.3	14.1	8.8	10.9	13.1	10.0	11.5	10.3	4.6	11.9	16.2	18.1	7.1	11.6	8.0	8.9	13.9	18.9	15.3	12.6	6.9	8.1	10.7	8.5	13.2	11.9	11.6	12.8	4.9	6.9	8.1	5.0	11.7	7.2	8.6	9.8	6.9	3.7	4.5	4.3	4.5	5.3	3.8	4.8	5.1	4.9	3.1	8.4	6.4	4.8	6.2	2.3	4.5	5.9	3.4	21.0	19.9	30.5	22.2	16.1	14.3	18.6	16.2	20.0	19.1
CCSER2	"FAM190B, KIAA1128"	ENSG00000107771	"Coiled-coil serine rich protein 2"	Q9H7U1	10	84328558-84518521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037481, HPA037482"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037481: AB_10672385, HPA037482: AB_10671501"	"unprognostic (4.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.74e-2)"	14.9	8.7	18.5	7.9	18.2	7.3	16.7	22.1	21.8	16.4	18.3	17.9	11.4	9.4	15.7	13.1	22.7	9.2	10.3	42.9	19.6	18.2	9.9	10.5	13.3	9.0	21.7	15.9	11.8	9.9	11.8	8.8	15.3	28.3	12.6	10.4	9.4	10.3	13.5	46.2	13.0	15.5	24.2	22.2	8.2	10.6	45.7	15.2	11.8	19.9	14.6	9.1	17.1	11.9	5.2	4.4	5.2	3.0	14.6	15.0	5.4	8.0	6.2	7.4	16.4	11.0	17.9	5.3	9.7	16.1	6.0	11.8	3.5	8.6	5.3	6.3	17.9	6.9	5.5	6.2	9.1	17.7	3.4	1.9	3.0	4.3	10.1	2.8	4.1	8.7	8.9	9.8	31.5	16.5	2.5	16.4	10.9	5.0	4.9	2.0	3.2	5.0	5.0	3.8	1.9	5.4	8.5	2.3	4.1	5.3	3.5	16.6	6.5	1.4	14.7	18.2	8.3	8.9	10.2	16.6	5.5	4.3	11.7	3.7	7.8	2.7	3.0	5.2	14.9	2.8	15.0	5.2	11.1	13.7	2.9	5.0	10.0	10.5	4.2	14.6	2.2	4.4	6.7	5.4	18.5	18.2	22.1	21.8	19.6	18.2	21.7	15.9	28.3	15.2
CCT2	Cctb	ENSG00000166226	"Chaperonin containing TCP1 subunit 2"	P78371	12	69585334-69601570	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003197, HPA003198"	Enhanced		Supported	Cytosol			9100000	Cytosol		"HPA003197: AB_1078425, HPA003198: AB_1078424"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-2)"	"prognostic unfavourable (8.38e-4)"	"prognostic unfavourable (3.61e-9)"	"unprognostic (5.28e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (6.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.21e-2)"	29.4	32.1	25.7	28.3	31.4	45.8	33.8	39.2	37.0	25.0	27.0	23.1	21.0	20.7	27.8	18.0	32.1	28.0	21.9	30.8	25.0	29.9	46.0	39.7	22.5	33.6	24.7	22.2	30.7	28.6	29.1	28.2	29.5	45.3	27.5	34.8	19.6	21.6	22.1	46.6	22.6	22.2	32.8	23.1	33.3	25.1	81.7	20.3	55.7	34.8	41.2	40.5	31.4	32.0	29.7	28.2	10.3	25.3	23.2	29.5	24.5	37.9	59.1	52.7	50.3	24.4	27.7	60.2	41.4	30.5	68.2	42.2	79.4	18.5	83.6	40.2	33.5	37.5	82.0	47.3	83.5	45.9	60.2	60.8	46.3	48.8	27.3	74.6	39.4	24.2	30.3	65.8	38.7	45.0	73.7	25.0	62.7	56.0	69.6	65.1	73.5	61.3	56.2	57.4	55.4	56.9	71.2	50.9	43.3	43.1	48.1	42.5	62.1	55.7	28.9	35.9	43.8	42.0	62.1	30.4	57.3	88.2	31.2	52.5	43.6	10.3	15.4	4.4	19.1	25.3	29.5	29.7	22.4	24.9	28.2	24.2	26.6	27.9	1.5	23.2	22.0	25.8	23.8	24.5	25.7	31.4	39.2	37.0	25.0	29.9	24.7	22.2	45.3	20.3
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Supported	"Plasma membrane,Cytosol"			4000000	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	38.8	68.8	37.6	41.8	43.2	26.9	51.2	54.5	51.4	35.1	42.1	46.2	33.8	37.9	50.4	34.8	56.1	52.2	29.2	41.5	36.7	41.6	60.8	61.9	30.9	48.1	43.5	32.8	53.0	59.0	56.7	55.9	39.2	43.0	38.1	50.0	35.3	34.4	41.4	66.4	38.2	39.5	59.7	41.2	41.6	41.9	49.8	47.6	62.1	60.0	49.9	60.7	44.8	82.4	34.8	39.3	14.2	30.5	30.8	45.1	43.9	50.2	57.4	39.2	37.5	43.5	32.4	51.1	47.1	37.4	74.5	45.8	56.8	46.7	83.1	54.8	39.4	47.4	124.0	61.2	63.7	44.5	78.0	52.7	46.7	44.8	32.1	65.1	44.4	41.1	36.7	66.8	62.3	63.0	90.4	30.0	44.2	46.8	85.7	40.0	79.3	83.2	69.0	39.7	89.9	54.6	31.8	53.1	54.8	43.3	76.4	41.9	67.6	79.8	43.5	30.3	45.2	31.7	83.8	55.9	99.2	123.6	35.3	41.6	49.1	14.2	25.3	11.2	31.2	30.5	41.6	34.1	34.7	34.2	39.3	34.8	45.1	37.8	3.6	30.8	30.2	25.5	35.5	43.9	37.6	43.2	54.5	51.4	36.7	41.6	43.5	32.8	43.0	47.6
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868089-61888804	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol			3400000	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavourable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	35.1	42.3	34.8	33.3	38.7	32.4	63.3	41.2	40.6	37.7	36.2	26.0	34.4	26.7	43.1	32.6	47.9	44.6	25.3	49.0	31.4	33.7	43.1	37.6	28.7	54.1	42.1	33.9	66.4	65.9	39.7	32.8	37.7	40.0	37.6	35.4	21.5	32.1	35.9	52.5	37.5	28.1	42.5	39.7	36.2	38.1	49.4	37.7	55.6	50.0	40.8	50.9	39.3	93.4	30.3	31.4	13.7	29.8	31.6	39.1	34.6	41.7	48.7	32.6	30.1	27.1	41.3	54.7	38.2	27.4	55.3	37.1	84.8	30.4	67.3	38.9	27.3	30.2	63.8	49.0	58.4	33.0	62.7	43.0	25.2	53.2	24.4	52.8	28.8	35.0	34.2	44.5	46.3	46.1	61.0	21.8	47.0	37.5	45.5	72.6	58.5	43.5	51.7	50.9	45.5	38.4	28.8	28.4	23.9	27.7	35.4	49.3	25.6	39.1	28.9	30.7	44.7	22.8	61.9	33.3	44.5	114.2	30.4	61.1	40.2	13.7	19.0	7.5	27.8	27.2	35.7	30.3	29.6	33.3	31.4	27.5	39.1	38.0	2.7	31.6	29.8	20.3	30.7	34.6	34.8	38.7	41.2	40.6	31.4	33.7	42.1	33.9	40.0	37.7
CCT6A	"CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20"	ENSG00000146731	"Chaperonin containing TCP1 subunit 6A"	P40227	7	56051630-56063989	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 176.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042996, HPA045576, HPA049949"	Supported		Approved	Cytosol			7400000	Cytosol		"HPA042996: , HPA045576: , HPA049949: "	"prognostic unfavourable (4.04e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (8.45e-4)"	"prognostic unfavourable (9.00e-10)"	"unprognostic (1.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.44e-3)"	32.9	36.5	35.3	35.8	36.1	32.0	62.4	43.7	40.4	26.2	29.1	19.6	28.4	29.8	31.7	23.7	39.5	29.7	22.9	49.3	34.7	39.8	43.2	45.7	22.6	42.0	36.8	26.8	33.4	42.9	48.3	33.7	33.9	34.9	30.2	35.4	16.4	27.3	32.2	72.3	32.6	28.6	35.3	35.8	36.7	32.3	27.0	26.5	41.1	38.2	41.4	44.0	37.1	83.7	24.0	35.3	11.8	34.2	26.6	29.9	25.8	176.1	40.4	24.3	36.6	17.1	21.5	28.0	33.3	18.9	32.8	26.5	45.4	22.2	54.6	25.9	21.4	37.5	49.7	38.2	45.5	30.7	37.7	34.1	39.1	39.9	18.5	48.9	27.7	18.4	21.9	33.1	33.0	32.2	74.6	13.8	37.0	21.8	37.6	42.7	51.4	53.8	34.6	24.8	31.4	36.9	33.8	32.5	32.6	29.5	50.3	29.4	37.0	37.7	27.0	22.5	43.3	74.8	68.5	16.9	34.8	67.4	22.5	43.4	74.6	6.9	25.0	11.8	22.4	31.6	29.9	24.0	23.5	24.4	35.3	17.8	24.0	25.4	3.1	26.6	34.2	19.6	24.2	25.8	35.3	36.1	43.7	40.4	34.7	39.8	36.8	26.8	34.9	26.5
CCT6B	"Cctz2, TSA303"	ENSG00000132141	"Chaperonin containing TCP1 subunit 6B"	Q92526	17	34927859-34981078	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"testis: 71.5"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Uncertain		Approved	Cytosol				Cytosol		"HPA042996: , HPA045576: , HPA049949: "	"unprognostic (1.56e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.99e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.56e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.82e-7)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-1)"	"unprognostic (4.23e-4)"	"unprognostic (1.49e-1)"	1.3	1.7	1.0	0.7	2.8	1.5	2.7	1.3	1.9	1.1	0.7	2.4	1.9	0.6	0.9	3.2	0.8	1.3	0.6	0.8	1.3	1.0	1.9	2.6	0.5	0.6	1.6	1.7	1.2	1.2	1.3	1.3	0.4	2.0	1.3	0.5	1.3	1.5	1.3	2.2	1.3	0.6	0.8	2.2	0.7	0.9	71.5	0.8	0.7	1.4	1.1	0.8	0.9	0.7	2.5	6.2	2.2	2.7	3.8	2.7	1.3	0.8	1.2	3.2	1.3	4.1	2.6	1.1	1.6	6.5	2.7	3.9	0.8	2.5	5.9	0.6	2.9	1.2	0.2	0.9	0.8	0.7	2.3	0.9	0.2	0.7	5.6	2.8	0.8	3.4	1.7	0.3	3.3	0.7	0.5	6.1	3.0	2.2	0.6	6.1	1.7	0.8	2.8	1.5	14.2	1.7	0.9	3.7	1.8	2.9	1.2	4.8	2.4	2.9	0.7	1.2	0.1	1.5	0.7	5.4	1.2	5.7	1.3	1.8	1.5	0.0	2.7	2.2	1.6	2.7	1.7	2.5	1.8	1.1	6.2	2.3	2.7	2.6	0.1	3.8	2.6	1.4	0.9	1.3	1.0	2.8	1.3	1.9	1.3	1.0	1.6	1.7	2.0	0.8
CCT7	"Ccth, Nip7-1"	ENSG00000135624	"Chaperonin containing TCP1 subunit 7"	Q99832	2	73233420-73253021	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008425	Approved		Approved	Cytosol			5900000	Cytosol		"HPA008425: AB_1078428"	"unprognostic (5.02e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (4.37e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.12e-2)"	35.1	55.7	33.5	34.6	46.3	27.0	54.2	52.2	46.9	34.9	36.3	32.4	29.5	28.7	46.5	42.3	43.6	47.4	32.7	56.5	36.4	36.1	38.9	48.0	29.4	47.0	35.8	37.1	51.3	56.1	45.3	34.9	34.3	36.1	41.2	43.7	27.6	33.2	41.2	82.1	32.7	28.9	51.0	33.5	36.1	36.9	80.6	28.6	49.0	44.0	52.5	51.5	37.5	61.6	53.1	49.4	29.1	45.6	42.7	54.8	62.6	46.0	77.0	44.2	48.0	32.5	27.0	56.7	40.0	38.0	70.8	44.6	125.6	32.8	88.2	26.7	43.3	39.5	98.7	64.0	78.4	48.9	87.7	58.1	49.1	89.7	36.5	67.6	45.4	41.6	36.5	69.0	85.0	63.4	74.8	32.1	59.5	73.7	78.8	94.4	62.7	55.5	72.0	108.2	63.2	51.0	44.7	63.0	38.3	34.7	50.3	47.9	28.6	39.3	39.0	48.3	57.7	29.7	79.1	36.9	38.0	81.5	39.4	80.1	52.8	29.1	31.5	17.9	48.5	42.3	53.8	53.1	50.1	48.5	48.4	49.5	54.8	51.0	9.6	42.7	45.6	49.4	43.3	62.6	33.5	46.3	52.2	46.9	36.4	36.1	35.8	37.1	36.1	28.6
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"			2700000	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	33.5	62.5	28.9	36.1	43.8	28.2	39.7	47.9	46.4	34.5	33.7	15.7	41.9	29.6	37.4	36.4	47.6	33.6	23.6	43.9	33.0	36.0	43.6	42.1	33.2	48.8	28.8	39.2	39.3	47.2	35.4	42.6	41.0	39.6	30.9	38.3	17.0	34.7	38.6	68.4	35.5	30.1	38.3	29.5	39.8	35.2	30.2	30.2	66.6	36.1	52.0	57.6	38.5	47.8	25.6	41.7	17.5	38.1	22.8	27.2	33.9	49.0	27.9	35.7	25.7	26.4	36.4	39.8	39.4	25.1	44.7	37.4	59.1	30.4	97.1	26.5	27.2	19.9	73.6	45.5	50.9	41.0	38.3	134.3	33.6	26.4	27.4	66.3	37.6	27.7	28.1	52.6	43.8	42.7	103.5	56.8	45.6	25.5	49.9	26.0	64.3	34.8	44.9	70.3	60.3	45.7	25.8	35.8	25.8	38.6	40.8	33.8	36.5	58.1	30.8	25.4	71.9	23.9	49.0	36.9	71.3	76.5	29.8	75.5	38.8	17.5	33.7	16.7	18.5	36.9	25.5	25.6	24.0	24.3	41.7	19.2	27.2	24.5	3.7	22.8	38.1	24.6	26.6	33.9	28.9	43.8	47.9	46.4	33.0	36.0	28.8	39.2	39.6	30.2
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.4;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;HUVEC TERT2: 8.8;TIME: 8.3;U-87 MG: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"		170000	"Centrosome, Cytosol"	Nucleoplasm	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	5.0	1.7	1.2	19.1	1.2	0.0	2.5	0.8	1.6	1.4	9.2	0.3	1.0	5.5	1.2	8.5	1.8	1.3	2.6	3.2	1.2	1.0	1.7	1.5	2.8	14.6	1.1	0.7	1.0	1.0	0.1	1.4	6.8	3.3	1.4	15.1	2.7	2.5	1.4	1.1	1.4	18.4	1.8	1.0	31.2	2.6	4.6	0.2	9.5	1.7	6.4	12.9	4.3	1.2	0.2	0.7	0.7	0.8	0.0	0.0	0.2	0.2	0.4	0.2	0.0	1.0	0.3	0.0	0.8	1.8	0.2	0.8	0.0	1.4	0.0	0.3	0.8	0.0	0.0	1.1	1.4	8.2	0.0	0.0	0.4	1.2	0.0	0.5	0.0	0.3	0.0	0.2	3.3	8.8	0.1	4.7	5.2	0.0	0.0	6.5	0.2	0.0	1.5	1.5	1.8	0.0	0.0	1.2	5.5	4.3	6.8	0.0	0.0	5.4	8.3	3.0	2.7	0.3	0.0	0.1	0.1	0.0	19.4	0.4	5.7	0.0	0.8	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.8	1.6	1.2	1.0	1.1	0.7	3.3	0.2
CD164L2		ENSG00000174950	"CD164 molecule like 2"	Q6UWJ8	1	27379176-27383380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.5;HaCaT: 3.5;HBEC3-KT: 3.9;hTCEpi: 5.3;SK-BR-3: 4.8;T-47d: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062915	Enhanced		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA062915: "	"unprognostic (8.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (1.64e-5)"		"unprognostic (7.81e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.91e-6)"	"unprognostic (1.33e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.71e-2)"	0.1	0.1	0.2	0.1	0.5	0.0	2.3	0.1	0.4	3.2	0.4	0.7	1.2	0.0	0.4	12.6	13.4	26.8	0.1	0.1	0.4	0.4	0.4	0.3	7.4	0.1	0.1	0.6	3.3	0.3	0.4	5.8	0.1	1.1	2.4	0.2	1.0	12.9	0.3	0.1	8.1	0.1	0.1	0.1	0.1	0.2	1.0	0.4	0.1	0.9	5.9	6.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	3.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.3	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.1	1.0	0.0	0.9	0.0	0.0	4.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.4	0.4	0.4	0.1	0.6	1.1	0.4
CD207	"CLEC4K, Langerin"	ENSG00000116031	"CD207 molecule"	Q9UJ71	2	70830214-70835822	"CD markers, Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.5;skin 1: 42.3"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"myeloid DC: 4.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002222, HPA011216"	Enhanced		Approved	Cytosol				Cytosol		"CAB002222: AB_563850, HPA011216: AB_1078453"	"unprognostic (1.45e-2)"	"unprognostic (8.28e-3)"	"unprognostic (9.34e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.92e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	0.5	0.1	0.1	1.8	0.1	0.0	1.4	0.1	0.1	2.4	1.7	0.1	0.1	1.6	1.1	0.4	9.7	0.3	2.9	0.3	0.1	0.1	0.2	0.9	3.7	0.2	0.1	0.1	0.2	0.2	0.0	1.1	0.1	0.1	1.0	1.1	0.4	1.2	0.2	0.1	42.3	2.6	0.1	0.1	1.5	0.4	0.4	0.1	3.3	0.2	11.3	16.5	0.3	1.9	0.0	4.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	13.7	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	1.9	0.0	0.0	0.0	2.4	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"			160000	"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (7.57e-5)"	15.2	9.9	5.3	18.0	7.6	6.6	11.9	13.6	6.1	13.2	23.5	6.2	19.0	31.0	13.2	12.9	20.1	8.0	14.7	7.3	4.9	5.3	31.3	19.2	17.3	8.0	5.8	4.0	9.9	19.3	24.0	14.4	17.2	7.3	15.0	20.9	6.6	17.5	19.4	8.7	13.0	31.9	9.5	7.7	17.0	22.3	8.7	6.4	55.1	13.3	13.3	13.8	16.9	15.5	1.3	12.2	3.7	0.7	3.8	2.4	0.7	20.4	8.1	2.5	5.2	3.5	5.2	20.3	5.0	6.2	6.8	8.7	13.3	14.5	26.5	21.2	6.5	7.7	8.4	12.6	11.2	10.5	13.6	14.7	6.8	11.9	4.7	8.2	5.7	3.6	11.9	6.5	9.5	11.0	25.7	8.5	6.2	6.4	15.5	3.0	7.5	2.9	8.3	6.5	12.1	43.1	36.6	7.7	3.0	10.1	13.6	9.8	12.8	5.2	13.1	13.8	11.6	4.4	14.2	6.5	10.8	19.0	14.7	4.4	7.0	1.9	0.7	3.7	1.5	0.5	2.4	1.2	1.4	1.5	1.5	1.3	1.3	2.0	0.1	3.8	0.4	12.2	1.1	0.7	5.3	7.6	13.6	6.1	4.9	5.3	5.8	4.0	7.3	6.4
CD2BP2	"LIN1, PPP1R59, Snu40, U5-52K"	ENSG00000169217	"CD2 cytoplasmic tail binding protein 2"	O95400	16	30350766-30355361	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041508, HPA061309"	Enhanced		Enhanced	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA041508: , HPA061309: "	"unprognostic (5.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	24.6	33.0	23.6	27.8	24.4	17.8	22.5	27.6	43.4	24.2	25.4	27.4	31.8	25.8	32.3	29.0	23.1	30.0	35.6	27.4	23.1	23.7	24.8	18.2	22.3	30.2	23.2	27.3	29.7	30.9	46.3	30.3	22.3	20.3	25.8	21.3	20.8	27.4	40.7	31.7	22.0	22.6	28.1	20.6	32.0	24.5	23.4	19.8	26.8	29.8	25.9	36.5	22.9	19.9	38.2	28.1	51.3	39.0	29.2	37.6	29.9	21.3	26.1	22.0	19.9	18.4	17.6	18.7	23.9	28.8	27.2	29.3	19.9	26.0	33.1	29.6	25.9	23.6	22.5	28.0	21.9	19.6	26.5	14.0	24.7	23.4	26.5	19.8	25.9	18.8	23.7	30.2	19.4	28.2	15.8	25.5	27.1	51.5	27.3	16.8	29.6	15.4	40.5	18.3	24.9	22.1	21.6	18.1	34.7	16.0	28.3	16.0	26.8	16.1	20.1	31.4	21.9	15.7	20.8	42.8	31.1	30.5	21.5	18.4	25.6	36.3	26.3	46.2	31.7	30.8	25.1	36.2	25.8	29.4	23.3	38.2	21.8	26.9	51.3	29.2	39.0	28.1	37.6	29.9	23.6	24.4	27.6	43.4	23.1	23.7	23.2	27.3	20.3	19.8
CD320	"8D6, 8D6A"	ENSG00000167775	"CD320 molecule"	Q9NPF0	19	8302127-8308356	"CD markers, Disease related genes, Predicted membrane proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 74.9;RPMI-8226: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014500, HPA073489"	Approved		Approved	Cytosol			400000	Cytosol		"HPA014500: AB_1846295, HPA073489: "	"unprognostic (9.97e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavourable (4.02e-4)"	"unprognostic (4.19e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.90e-2)"	23.1	20.1	13.1	13.4	14.9	6.3	39.0	12.6	19.1	12.0	23.2	9.7	10.5	16.6	15.8	58.1	11.4	14.9	28.9	20.7	13.2	18.7	15.2	16.3	15.1	18.0	18.0	8.5	14.0	27.6	7.6	11.9	38.0	19.9	19.7	14.2	18.6	16.5	12.8	14.0	6.4	17.4	11.9	11.9	32.8	21.3	23.7	9.3	14.3	22.4	9.3	8.6	12.1	19.6	10.3	25.0	0.8	0.6	18.0	51.3	15.0	12.7	13.0	2.9	37.3	9.4	4.9	6.8	6.6	9.0	13.4	10.3	13.9	7.7	11.5	21.0	4.9	8.2	0.0	10.6	2.6	16.1	39.9	5.5	11.2	19.8	6.3	10.5	13.9	4.7	2.5	7.8	6.5	13.1	16.8	39.6	5.2	12.0	11.1	74.9	20.4	54.5	13.7	3.9	68.0	10.0	0.3	27.0	11.7	13.8	5.9	16.8	0.4	4.7	7.3	15.4	11.4	23.0	21.0	37.7	23.6	12.5	11.0	38.6	16.7	0.0	0.6	0.0	51.3	0.6	29.2	10.3	34.0	27.4	1.1	9.9	23.1	26.0	0.8	18.0	0.4	25.0	21.7	15.0	13.1	14.9	12.6	19.1	13.2	18.7	18.0	8.5	19.9	9.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 187.6"	"Cell line enriched"	"Detected in single"	78	"MOLT-4: 64.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	30	"gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2"	"Lineage enriched"	"Detected in many"	37	"T-cells: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: "	"prognostic favourable (6.33e-4)"	"prognostic favourable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	1.1	0.6	0.4	7.1	0.4	0.5	0.8	0.3	0.3	0.7	2.3	0.4	0.4	2.0	0.9	0.6	1.5	1.1	1.9	0.6	0.4	0.4	1.2	0.9	2.4	17.2	0.5	0.2	0.7	0.7	0.0	0.5	0.4	0.3	1.0	1.6	0.9	2.9	0.3	5.9	0.6	8.1	0.2	0.8	11.5	2.4	0.5	0.2	187.6	1.4	1.7	19.2	2.5	1.1	0.1	0.2	1.2	0.2	0.2	46.7	14.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	64.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.2	0.2	43.5	0.1	25.6	0.1	36.1	37.1	0.1	0.1	37.6	46.7	1.2	0.2	0.1	0.2	34.2	14.1	0.4	0.4	0.3	0.3	0.4	0.4	0.5	0.2	0.3	0.2
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711851	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.3;lymphoid tissue: 86.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.0;HMC-1: 42.5;U-266/70: 90.0;U-266/84: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB002497, HPA055146"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"		2600000	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: "	"prognostic favourable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favourable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	5.5	1.4	1.0	44.6	0.9	23.1	2.8	0.6	0.7	3.2	5.0	0.5	1.1	3.2	1.9	2.5	7.3	2.1	4.8	1.8	1.0	1.0	3.6	3.1	15.4	86.3	1.6	0.3	2.3	1.5	0.0	1.3	2.2	0.8	2.8	5.7	2.4	13.9	1.5	1.3	1.2	21.2	1.7	3.8	66.6	5.0	1.3	0.2	50.8	2.9	3.6	58.0	8.6	2.6	34.6	53.6	35.8	74.1	24.9	57.9	81.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	4.5	42.5	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	13.2	6.5	0.0	0.0	0.8	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.0	60.1	15.4	0.0	11.4	0.0	28.2	52.2	35.8	42.4	74.1	57.9	34.6	48.3	48.8	53.6	27.9	49.7	52.5	13.4	24.9	73.5	9.4	36.4	81.3	1.0	0.9	0.6	0.7	1.0	1.0	1.6	0.3	0.8	0.2
CDAN1	"CDA-I, CDAI"	ENSG00000140326	"Codanin 1"	Q8IWY9	15	42723544-42737128	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039404, HPA040787"	Supported		Enhanced	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039404: AB_10673530, HPA040787: AB_2677137"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavourable (1.07e-4)"	"unprognostic (7.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.04e-1)"	6.5	9.0	8.4	9.8	8.1	14.4	9.8	16.2	9.7	11.8	6.8	8.7	9.4	6.0	11.0	9.6	7.1	9.1	7.2	5.2	6.4	4.4	6.3	6.7	6.6	8.0	8.3	7.4	21.7	9.6	9.1	9.5	6.7	5.8	11.4	5.5	9.3	10.6	10.1	6.6	10.1	6.9	9.3	5.1	8.1	8.0	14.7	8.6	14.7	9.0	3.3	8.2	10.2	12.2	0.3	0.8	3.7	0.3	0.0	0.6	0.1	6.8	4.7	6.4	9.2	5.7	4.9	7.7	9.1	3.8	8.9	6.5	11.7	3.6	3.3	10.1	5.0	13.6	6.8	4.1	2.6	8.4	6.3	12.4	8.4	4.5	4.2	9.1	11.7	6.7	4.6	5.6	4.1	6.7	15.8	5.0	7.2	3.8	7.0	12.1	3.2	7.5	10.1	8.0	2.9	2.8	6.8	5.2	6.1	7.1	10.0	1.5	7.6	13.7	4.8	9.3	8.4	7.6	10.3	10.0	10.4	7.5	4.9	13.6	7.6	3.7	0.3	1.7	0.5	0.1	0.6	0.1	0.4	0.5	0.0	0.3	0.4	0.3	0.4	0.0	0.0	0.8	0.1	0.1	8.4	8.1	16.2	9.7	6.4	4.4	8.3	7.4	5.8	8.6
CDC123	"C10orf7, D123"	ENSG00000151465	"Cell division cycle 123"	O75794	10	12195965-12250589	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037830, HPA057540"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA037830: AB_10671368, HPA057540: "	"unprognostic (5.35e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (3.16e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavourable (2.42e-6)"	"unprognostic (5.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.19e-2)"	26.1	28.0	30.8	28.8	50.8	35.7	25.5	24.6	35.0	25.8	32.0	24.2	16.3	21.5	26.1	27.2	34.1	25.3	18.4	36.5	28.5	25.1	33.2	45.1	21.5	34.7	25.9	27.6	19.5	26.0	18.4	26.9	28.8	36.6	20.7	31.8	16.1	22.4	22.9	29.2	29.8	24.7	30.2	24.9	36.2	21.8	22.5	24.6	39.0	24.4	20.5	41.9	29.2	23.4	43.7	40.7	66.4	34.0	32.3	38.8	40.6	32.0	43.0	30.7	37.2	29.5	29.2	25.2	27.9	19.4	40.3	43.4	59.4	41.1	55.4	29.4	35.2	36.2	55.8	51.1	33.7	38.8	43.9	43.2	34.7	54.4	36.4	33.7	37.5	31.1	26.6	50.9	30.2	44.0	44.5	26.7	35.1	29.7	43.0	28.3	54.0	16.1	44.7	25.7	49.2	36.9	18.7	15.8	31.2	29.8	38.8	34.6	40.5	38.0	47.2	24.8	30.5	37.8	35.2	26.2	48.1	67.9	31.1	32.2	16.1	28.6	28.7	66.4	31.4	32.4	32.4	43.7	35.3	34.6	40.7	42.1	29.0	30.9	64.6	32.3	34.0	33.2	38.8	40.6	30.8	50.8	24.6	35.0	28.5	25.1	25.9	27.6	36.6	24.6
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell line enhanced"	"Detected in many"		"K-562: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	6.2	2.4	5.8	6.5	5.5	13.7	12.2	1.8	6.2	7.7	11.8	4.8	2.2	7.2	15.1	4.8	3.4	13.7	3.6	4.1	8.8	3.5	6.6	2.4	12.3	15.4	3.8	5.4	5.8	6.7	9.8	8.1	7.6	4.6	10.0	6.3	8.3	7.7	3.9	4.3	5.6	22.6	5.0	3.2	9.6	6.0	38.2	4.7	12.0	6.1	3.4	11.3	5.8	8.4	4.8	6.1	11.6	3.7	3.9	13.0	4.1	2.2	1.8	5.8	6.5	2.1	1.6	4.0	2.8	1.9	2.8	2.3	6.1	1.9	1.1	2.1	1.7	1.7	3.9	1.6	2.9	2.2	9.7	3.9	1.7	1.9	0.8	5.2	7.0	1.3	0.4	3.0	1.0	4.9	30.0	3.4	4.1	0.9	4.2	5.9	3.5	2.3	4.6	7.5	1.1	1.9	5.0	1.0	1.8	3.0	2.9	3.9	1.3	6.8	2.1	1.6	3.5	2.6	1.6	1.7	0.6	1.7	1.9	4.9	0.9	11.6	3.7	8.4	7.3	3.3	13.0	4.8	11.3	8.4	3.5	3.1	11.0	5.8	5.5	3.9	2.3	6.1	5.6	4.1	5.8	5.5	1.8	6.2	8.8	3.5	3.8	5.4	4.6	4.7
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358955-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.0;testis: 73.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: , HPA055288: "	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.3	1.2	0.6	16.6	1.1	20.2	1.8	0.8	1.3	2.1	6.2	2.8	0.4	5.8	1.1	1.6	17.8	0.4	1.9	1.2	0.9	0.5	2.2	1.2	1.8	13.4	1.1	0.7	0.9	0.5	0.0	0.4	3.9	1.2	0.8	7.0	0.4	2.9	0.4	0.6	4.6	6.4	2.8	1.2	7.8	4.4	73.2	0.7	42.0	1.2	11.7	21.7	1.9	4.2	4.5	0.9	0.8	0.1	9.8	11.2	2.7	51.7	25.3	35.3	23.0	1.2	3.1	33.9	24.0	21.6	70.1	37.4	39.6	43.2	30.0	14.1	22.0	36.5	38.6	45.8	58.5	23.5	28.5	43.9	25.0	24.5	0.3	30.6	16.0	1.0	2.1	48.6	44.1	29.7	19.8	20.6	31.7	20.0	29.4	18.8	44.7	34.1	42.8	48.5	19.0	17.1	13.8	20.9	10.3	42.5	28.7	13.3	20.1	38.8	15.4	21.0	49.2	23.3	74.5	15.9	14.0	31.1	15.0	38.2	31.2	0.0	0.1	0.0	0.4	0.0	0.0	4.5	3.3	3.6	0.9	0.9	0.1	0.3	0.8	9.8	0.0	0.2	11.2	2.7	0.6	1.1	0.8	1.3	0.9	0.5	1.1	0.7	1.2	0.7
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34"	P49427	19	531712-542092	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370"	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	16.5	15.9	21.3	11.3	19.1	24.7	20.4	25.7	30.9	16.0	20.5	19.5	10.5	15.4	13.3	13.4	15.6	14.5	13.6	35.6	21.1	18.2	12.1	36.0	13.0	9.9	18.5	19.8	17.0	37.4	11.3	17.0	24.9	16.2	17.2	10.6	15.3	26.4	18.5	63.9	19.0	13.2	18.6	14.3	12.7	15.7	43.6	15.0	12.2	13.1	17.0	8.7	19.2	16.4	2.9	2.8	11.5	4.5	1.5	4.1	1.3	18.4	18.4	23.7	19.5	10.8	10.3	23.7	16.6	12.7	17.9	18.7	28.6	11.3	10.2	17.4	11.8	12.8	18.6	14.0	9.2	16.6	50.0	9.4	12.2	30.9	26.9	13.2	11.4	13.3	21.0	15.1	15.8	21.3	40.2	20.4	11.8	26.4	18.0	17.6	29.9	17.9	16.7	12.2	17.1	13.5	11.0	30.9	22.9	14.4	15.0	27.6	12.0	19.4	17.4	13.1	15.6	30.4	22.1	20.4	15.6	13.6	17.9	18.7	13.5	4.5	3.5	6.2	2.3	3.4	1.7	2.9	3.2	4.1	2.8	1.7	2.5	2.4	11.5	1.5	4.5	2.3	3.1	1.3	21.3	19.1	25.7	30.9	21.1	18.2	18.5	19.8	16.2	15.0
CDC37	P50CDC37	ENSG00000105401	"Cell division cycle 37"	Q16543	19	10391134-10420121	"Cancer-related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003928, CAB004214"	Supported		Supported	Cytosol			260000	Cytosol		"CAB004214: AB_627232, HPA003928: AB_1846373"	"unprognostic (2.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"prognostic favourable (2.33e-4)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.02e-2)"	47.3	29.7	33.0	41.6	33.0	41.8	42.0	35.8	46.8	31.9	35.5	17.8	32.7	31.8	36.3	34.8	37.9	30.1	42.8	49.5	28.1	31.3	33.6	35.6	38.2	33.4	26.6	36.4	34.4	34.2	26.8	24.2	34.3	32.9	31.5	27.7	21.6	37.0	34.4	148.6	29.3	31.3	28.7	23.0	43.5	34.0	23.4	29.8	32.6	33.5	50.7	34.6	33.0	48.0	33.2	45.2	40.0	46.0	40.2	52.3	53.0	52.9	35.2	19.0	27.1	26.2	22.9	24.5	62.9	28.6	39.7	34.1	40.2	20.9	31.6	51.1	38.4	33.1	25.7	40.8	27.5	25.4	75.8	60.0	28.5	56.9	41.4	34.7	27.5	27.9	22.4	46.3	20.9	50.8	46.5	38.3	30.6	50.4	34.6	85.5	46.5	62.5	34.5	25.5	36.2	36.3	34.6	22.2	32.4	29.5	31.2	26.9	21.4	37.5	56.4	46.5	26.7	63.7	50.2	52.2	51.3	39.1	36.5	56.5	37.5	29.2	46.0	40.0	52.3	45.8	47.3	33.2	42.3	46.9	45.2	29.1	33.0	38.1	26.6	40.2	44.1	38.4	44.0	53.0	33.0	33.0	35.8	46.8	28.1	31.3	26.6	36.4	32.9	29.8
CDC37L1	"CDC37B, FLJ20639, HARC"	ENSG00000106993	"Cell division cycle 37 like 1"	Q7L3B6	9	4679559-4708398	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.8"	"Cell line enriched"	"Detected in all"	4	"HDLM-2: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021175	Approved		Supported	Cytosol				Cytosol		"HPA021175: AB_10959752"	"unprognostic (1.18e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.71e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.78e-2)"	"unprognostic (7.97e-2)"	"prognostic favourable (2.66e-7)"	"unprognostic (8.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.28e-2)"	14.9	12.6	10.4	7.1	15.4	5.6	10.5	12.4	14.9	12.2	10.0	7.1	11.2	7.8	10.9	12.0	15.8	10.1	11.6	28.6	11.2	12.6	13.4	42.0	8.4	9.0	10.0	9.9	12.4	15.1	9.3	13.7	7.5	17.3	13.0	6.5	6.2	9.4	11.1	58.8	8.1	8.0	17.9	8.8	6.3	9.5	10.8	8.9	7.0	12.2	14.0	7.2	18.0	16.1	10.7	6.2	14.8	6.8	8.1	20.7	7.9	7.1	6.4	3.4	5.5	12.4	9.2	5.2	8.4	5.8	5.1	5.8	2.0	4.4	4.5	2.3	6.1	3.1	3.8	5.0	5.0	52.8	3.2	12.0	7.0	5.5	7.5	4.8	4.9	5.9	6.7	3.8	6.0	3.6	1.4	7.0	5.6	3.4	3.7	10.0	8.7	2.3	3.0	4.2	2.6	7.3	2.9	9.8	4.9	6.2	5.0	4.1	4.2	4.6	3.9	7.7	3.6	4.3	5.5	5.4	8.6	3.3	6.9	3.4	2.4	14.8	5.7	11.0	13.3	5.3	13.1	10.7	13.4	14.0	5.4	10.5	20.7	18.5	6.8	8.1	6.8	6.2	12.1	7.9	10.4	15.4	12.4	14.9	11.2	12.6	10.0	9.9	17.3	8.9
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	"CDC42 binding protein kinase gamma"	Q6DT37	11	64823387-64844569	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.1;HaCaT: 14.3;MCF7: 19.3;RT4: 11.7;SK-BR-3: 11.9;T-47d: 11.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"cerebellum: 19.4"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"cerebellum: 5.9"	"Low region specificity"	"Detected in single"			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol				Cytosol		"HPA027382: AB_1846378, HPA061836: "	"unprognostic (3.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"prognostic favourable (5.99e-13)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.99e-3)"	0.5	2.7	0.8	2.1	0.5	1.1	3.5	19.4	0.8	2.9	9.1	0.8	6.3	8.2	1.0	8.0	14.3	2.9	10.5	0.5	0.7	0.0	3.5	0.5	4.2	0.7	0.5	0.5	1.5	7.9	7.0	6.5	13.0	2.0	4.4	3.4	1.0	14.3	7.6	0.5	22.4	19.7	1.6	0.8	0.8	8.5	2.5	0.7	1.8	3.9	8.1	7.7	5.4	6.3	0.4	0.0	0.0	0.0	0.2	1.0	0.1	5.5	0.8	0.5	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	7.4	4.7	0.1	2.8	0.0	14.3	0.8	5.6	0.0	0.2	2.2	0.4	3.1	2.3	0.0	0.1	1.4	0.0	7.0	0.0	0.1	0.0	3.7	0.0	0.0	19.3	0.1	1.0	1.7	0.8	0.8	0.3	2.6	3.4	11.7	10.2	0.5	1.8	11.9	0.3	11.6	0.2	0.0	0.0	2.0	0.0	0.0	1.3	1.3	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.8	0.5	19.4	0.8	0.7	0.0	0.5	0.5	2.0	0.7
CDC42EP2	"BORG1, CEP2"	ENSG00000149798	"CDC42 effector protein 2"	O14613	11	65314818-65322429	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 28.3;U-2197: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 13.3;intermediate monocyte: 29.8;neutrophil: 46.1;non-classical monocyte: 21.7"	"Group enriched"	"Detected in many"	13	"granulocytes: 46.1;monocytes: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038562	Approved		Supported	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA038562: AB_10671745"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.73e-3)"	"prognostic unfavourable (2.89e-5)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-2)"	47.2	5.1	7.7	11.8	37.7	2.1	32.1	3.2	15.4	15.9	11.2	39.1	4.7	12.6	13.9	6.3	11.5	12.7	20.5	11.4	10.7	6.6	9.9	6.5	15.0	8.8	31.4	8.9	10.5	7.9	2.2	4.3	16.9	19.7	8.5	4.5	2.5	4.1	8.3	7.0	4.6	10.6	11.6	24.4	15.3	12.0	2.4	24.7	0.0	17.3	7.0	3.2	18.6	16.2	0.2	2.8	46.1	29.8	0.0	0.1	3.9	5.0	6.1	2.2	3.5	8.3	13.3	0.7	5.2	19.0	5.8	7.1	10.2	9.8	0.9	13.0	11.6	6.0	2.4	13.9	1.8	1.9	3.2	1.2	8.3	7.0	22.4	0.3	0.6	6.0	1.8	16.0	14.7	14.4	2.3	3.1	5.3	8.1	0.8	0.8	3.5	28.3	1.3	1.2	1.7	11.1	2.8	0.7	2.3	11.0	9.3	1.0	1.8	0.4	15.9	4.2	4.2	30.8	2.1	1.1	1.7	1.7	6.7	0.4	3.3	0.0	13.3	0.5	0.1	29.8	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	46.1	0.0	21.7	0.2	0.0	3.9	7.7	37.7	3.2	15.4	10.7	6.6	31.4	8.9	19.7	24.7
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell line enhanced"	"Detected in many"		"K-562: 86.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.1	11.0	13.7	10.7	0.6	1.3	5.8	16.2	7.6	18.7	18.6	8.4	7.3	14.6	5.7	4.8	12.6	14.6	10.7	16.8	17.8	24.7	19.5	12.4	9.2	0.7	28.3	10.7	0.4	0.5	14.3	6.4	9.4	86.6	18.4	10.9	17.5	22.9	13.4	4.1	8.3	19.1	22.8	6.4	4.3	12.6	17.7	9.3	8.8	9.7	2.8	6.3	12.6	3.6	14.6	23.4	11.0	14.7	6.3	11.6	17.0	7.7	14.2	19.5	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287633-40304657	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA050114, HPA065070"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"				"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: , HPA065070: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	1.8	2.9	3.1	10.8	2.6	16.8	1.5	2.3	6.0	2.7	5.8	0.8	2.7	5.3	1.9	1.6	9.0	1.3	5.4	1.6	1.9	1.4	1.8	5.1	2.8	10.6	1.0	1.5	1.5	3.6	1.1	1.2	9.4	0.8	1.4	5.6	0.2	3.2	4.1	0.9	2.3	7.9	2.4	1.6	7.7	2.7	14.8	1.2	30.0	1.3	5.0	10.1	4.1	3.0	0.7	6.2	0.2	0.3	2.2	3.4	1.2	25.0	17.3	21.0	14.9	1.1	2.3	19.1	27.3	8.2	23.9	29.0	19.6	11.2	20.2	17.1	5.8	36.4	18.1	12.4	23.8	10.7	14.2	16.4	20.7	17.6	0.7	22.4	10.1	0.5	0.9	27.7	16.7	7.2	29.9	19.0	11.6	13.1	32.5	5.4	17.2	6.4	24.0	51.0	19.1	4.0	28.2	14.4	12.9	24.8	85.2	8.4	17.3	19.4	6.0	17.3	24.7	28.3	32.3	7.9	17.2	39.0	15.0	14.8	18.9	0.1	0.3	0.0	1.3	0.0	0.9	0.7	1.2	2.1	1.4	0.7	0.9	2.1	0.2	2.2	0.0	6.2	3.4	1.2	3.1	2.6	2.3	6.0	1.9	1.4	1.0	1.5	0.8	1.2
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121997-193253901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016359, HPA030772"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA030772: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	23.4	20.0	18.1	16.8	22.9	21.0	20.1	25.6	22.6	20.4	20.1	14.5	16.3	12.0	26.8	15.2	20.6	14.9	16.4	21.4	18.4	15.0	18.8	17.1	17.2	16.6	19.7	15.9	23.3	14.5	27.1	24.8	17.3	19.4	26.9	16.2	13.6	17.3	19.0	44.5	15.0	14.5	25.6	23.9	16.0	15.7	16.3	22.1	20.6	27.1	14.1	15.8	26.8	35.0	6.6	6.7	10.2	7.0	9.0	12.5	5.2	13.3	12.0	15.9	10.2	14.9	14.5	12.2	14.4	14.0	17.4	15.3	8.2	15.9	17.4	10.2	17.7	13.1	14.4	13.6	21.3	11.0	6.8	12.6	10.9	8.0	14.0	17.1	12.6	11.8	13.2	16.3	15.6	14.8	19.1	14.1	23.3	12.3	13.9	8.5	15.3	4.5	12.5	9.6	16.6	20.4	9.3	4.8	13.1	18.0	22.2	20.5	19.1	12.4	16.5	17.0	3.9	14.4	14.7	13.2	9.8	14.3	10.2	10.5	29.6	6.6	7.0	10.2	9.3	6.8	12.5	6.6	9.2	9.2	6.7	5.4	8.4	8.7	7.4	9.0	5.7	4.9	9.3	5.2	18.1	22.9	25.6	22.6	18.4	15.0	19.7	15.9	19.4	22.1
CDCA3	"GRCC8, TOME-1"	ENSG00000111665	"Cell division cycle associated 3"	Q99618	12	6844793-6852066	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.6;lymphoid tissue: 51.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.8"	"Cell type enhanced"	"Detected in many"		"T-reg: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026587			Approved	Cytosol				Cytosol		"HPA026587: AB_1846386"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (6.51e-5)"	"prognostic unfavourable (9.77e-5)"	"unprognostic (3.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-3)"	"unprognostic (8.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.94e-2)"	1.6	1.9	1.0	19.2	1.8	9.9	1.9	8.8	2.2	2.0	17.3	1.2	1.2	15.5	2.3	2.0	6.9	1.0	2.9	2.2	1.1	1.6	1.3	0.9	1.9	10.8	1.3	0.7	3.7	0.6	0.3	6.9	4.7	1.2	2.2	5.3	0.7	2.4	0.4	0.7	4.3	34.6	2.0	1.4	5.2	2.4	18.2	1.1	51.0	1.3	8.5	15.1	1.6	2.8	1.6	2.3	0.5	0.6	0.8	7.7	0.9	29.8	21.6	22.1	13.4	1.3	2.0	25.6	19.7	12.1	32.4	22.6	32.0	25.7	16.5	2.5	14.8	20.5	14.1	13.6	32.2	24.8	15.7	14.8	14.4	20.8	0.2	11.0	14.2	0.9	1.1	17.4	9.5	13.7	12.3	10.8	30.8	23.3	16.0	12.7	25.7	16.7	16.2	19.2	9.3	10.7	8.4	3.4	6.6	17.8	16.6	6.1	6.5	10.7	6.0	15.8	20.5	10.3	33.0	5.5	5.6	25.8	7.4	13.7	27.8	0.0	0.6	0.0	0.5	0.3	0.8	1.6	1.3	1.9	0.7	0.8	0.6	1.2	0.5	0.8	0.5	2.3	7.7	0.9	1.0	1.8	8.8	2.2	1.1	1.6	1.3	0.7	1.2	1.1
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059416, HPA064971"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA059416: , HPA064971: "	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavourable (4.19e-4)"	"prognostic unfavourable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavourable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	4.5	2.6	1.7	11.5	2.6	38.3	4.1	8.3	3.2	8.7	3.7	2.6	4.5	4.1	5.6	4.0	16.6	4.1	4.2	2.4	1.5	1.3	2.8	3.0	5.1	9.1	2.7	1.4	5.0	6.2	1.6	1.9	12.4	3.3	4.6	2.7	3.3	5.3	2.2	1.3	21.8	4.4	3.1	2.3	6.7	3.6	12.8	2.3	24.9	5.1	11.2	15.0	3.7	8.8	7.4	4.2	8.3	4.3	10.6	14.7	5.5	15.0	15.7	18.2	13.7	3.1	5.2	23.8	22.5	6.9	17.7	15.5	19.2	19.3	19.8	12.3	7.9	24.2	12.7	25.9	10.4	21.6	10.0	12.5	13.4	16.0	3.8	22.1	10.5	3.7	8.1	13.6	12.8	11.9	13.7	20.5	12.2	36.9	20.6	14.9	13.5	36.0	20.0	26.5	7.3	6.0	17.5	10.6	13.1	21.5	8.6	17.3	17.0	14.9	18.5	15.7	19.9	21.5	29.9	7.6	9.4	20.2	13.1	11.2	25.9	0.9	3.6	8.3	10.9	3.9	13.3	7.4	11.4	14.7	3.9	5.2	6.8	8.0	1.3	10.6	4.3	4.2	8.9	5.5	1.7	2.6	8.3	3.2	1.5	1.3	2.7	1.4	3.3	2.3
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 8.3;olfactory region: 21.4"	"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA005565: AB_2078680"	"unprognostic (1.67e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (4.96e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.97e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.53e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.47e-2)"	1.1	0.6	1.2	28.0	1.5	9.7	1.8	0.5	1.4	8.3	12.3	2.8	2.6	14.9	7.9	1.7	12.9	2.3	6.6	0.9	2.0	1.4	0.8	0.4	1.3	17.2	1.3	2.2	1.1	2.9	0.0	0.4	7.3	3.4	3.2	14.8	1.1	3.3	0.6	4.3	8.3	16.4	1.5	2.0	2.9	7.6	8.1	2.0	71.4	0.9	10.5	24.0	2.3	8.0	2.6	4.2	0.3	0.7	3.6	9.4	2.7	9.8	7.6	17.9	19.4	0.8	3.3	18.7	5.9	2.1	14.2	16.0	11.7	12.5	27.6	7.6	3.6	10.3	28.3	10.7	20.7	13.2	15.6	6.2	5.5	14.8	0.9	40.3	5.9	2.7	0.9	7.7	6.4	6.4	14.9	6.3	4.1	7.9	61.8	40.7	21.1	5.3	43.7	13.6	17.5	6.8	8.7	5.2	9.2	9.3	3.1	5.0	0.0	15.9	2.9	9.3	4.0	3.0	10.9	1.7	3.7	38.7	5.8	22.5	7.8	0.0	0.7	0.0	1.4	0.0	0.5	2.6	3.9	7.6	4.2	0.3	0.3	1.4	0.3	3.6	0.0	0.6	9.4	2.7	1.2	1.5	0.5	1.4	2.0	1.4	1.3	2.2	3.4	2.0
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900900-21946084	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"olfactory region: 22.0"	HPA027169	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058"	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	6.2	1.2	3.7	19.9	9.6	24.2	8.0	6.5	4.2	8.4	9.0	7.8	3.9	5.2	11.1	3.6	6.0	7.0	5.4	12.5	3.9	2.5	2.7	4.5	7.3	18.7	6.2	4.0	13.9	17.4	1.0	1.6	2.2	3.7	7.6	10.2	5.8	10.5	8.0	2.7	13.6	8.7	6.6	3.0	9.3	12.7	12.6	5.3	47.9	20.0	5.1	16.5	6.0	9.4	38.5	21.8	11.8	1.3	0.8	9.7	3.3	19.6	6.7	6.3	0.1	3.5	4.4	0.0	16.1	13.9	12.5	17.8	2.5	17.9	41.0	5.3	13.8	12.1	10.0	16.5	25.4	0.0	6.6	9.8	20.0	1.6	4.5	25.8	0.1	8.3	3.0	9.7	28.4	24.7	13.5	0.0	9.7	7.3	32.5	9.3	36.3	8.4	32.7	22.8	27.4	3.5	3.7	23.3	19.0	7.3	4.5	7.3	10.9	11.7	10.4	13.7	16.9	23.8	19.4	21.1	14.5	53.0	13.1	34.8	13.4	0.3	0.6	11.8	0.6	0.9	0.1	28.6	1.9	0.9	4.3	38.5	9.7	3.9	1.1	0.8	1.3	21.8	2.7	3.3	3.7	9.6	6.5	4.2	3.9	2.5	6.2	4.0	3.7	5.3
CDH24	CDH11L	ENSG00000139880	"Cadherin 24"	Q86UP0	14	23047062-23057538	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065233			Approved	"Nucleoplasm,Cell Junctions,Centriolar satellite,Cytosol"				"Nucleoplasm, Centriolar satellite"	"Cell Junctions, Cytosol"	"HPA065233: "	"unprognostic (2.30e-1)"	"unprognostic (3.06e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.71e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.97e-2)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.85e-2)"	5.8	4.7	8.0	4.3	9.3	2.9	5.0	13.0	12.6	6.2	4.5	4.0	6.1	3.0	13.4	3.2	5.8	5.8	10.1	3.8	10.5	5.1	4.6	1.1	4.7	3.4	4.4	4.8	3.8	3.5	8.3	3.1	5.7	5.3	4.6	4.5	7.9	4.7	4.5	1.8	7.2	5.0	10.2	4.0	5.2	4.1	3.4	6.6	7.8	6.8	3.8	4.1	7.3	6.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.5	2.5	10.6	12.0	2.6	1.3	5.9	4.8	3.1	4.0	5.2	3.2	3.5	0.2	3.9	5.2	14.6	4.5	4.0	3.3	3.9	3.8	0.5	6.5	1.0	2.9	7.3	0.2	10.2	1.3	4.4	2.9	6.6	1.5	6.3	3.5	7.2	0.5	4.9	2.6	5.9	12.7	3.5	4.7	1.1	2.1	30.8	8.2	11.2	6.0	0.6	5.3	1.0	6.1	4.0	15.5	1.6	3.5	2.0	0.6	0.1	4.2	2.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	9.3	13.0	12.6	10.5	5.1	4.4	4.8	5.3	6.6
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavourable (1.10e-6)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.2	18.4	48.9	19.3	3.2	4.9	20.1	36.5	26.6	44.5	42.9	43.0	42.7	44.2	14.2	10.0	30.0	33.2	21.2	46.4	31.4	24.2	23.2	18.1	24.9	0.5	35.5	24.0	0.9	2.1	28.8	28.1	26.7	35.3	54.5	49.5	12.8	44.6	25.5	21.5	38.7	38.8	45.5	21.7	17.0	16.0	22.9	20.1	24.5	37.3	18.9	40.2	21.8	11.0	19.0	40.6	20.0	49.8	21.4	34.3	39.9	16.4	39.8	23.6	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	"Cyclin dependent kinase 11A"	Q9UQ88	1	1702730-1724324	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.5"	"Low lineage specificity"	"Detected in all"											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: "	"unprognostic (6.25e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.32e-3)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.97e-2)"	"prognostic unfavourable (5.06e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (1.15e-6)"	"unprognostic (1.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	14.3	14.9	17.2	23.7	26.9	39.7	13.0	35.2	32.7	12.5	16.4	14.3	6.1	29.2	16.5	8.5	12.1	12.6	10.2	10.2	19.4	8.4	11.7	12.5	19.0	20.3	22.6	9.0	16.2	12.9	12.2	27.5	12.9	17.1	14.4	14.6	11.6	12.7	10.3	21.5	15.1	34.9	13.1	26.0	24.2	15.7	16.4	25.1	14.9	14.6	7.6	22.4	13.5	15.2	7.4	11.8	33.5	6.3	4.4	5.5	1.4	16.1	9.7	7.0	6.4	9.2	7.4	6.9	15.9	7.1	7.9	9.2	12.2	14.8	17.2	9.7	4.6	12.0	6.5	8.2	6.3	13.1	10.4	15.3	18.3	10.9	6.1	17.1	22.1	8.5	5.6	6.9	4.5	13.6	17.9	14.4	6.6	9.1	7.9	13.4	9.7	8.3	14.5	10.7	8.3	6.4	7.3	7.8	11.3	13.9	16.4	19.1	11.0	7.1	13.8	12.5	12.1	5.6	8.8	20.1	14.6	21.6	4.2	13.9	3.9	16.7	6.3	7.7	5.5	3.4	4.2	6.2	4.7	4.2	2.0	7.4	4.7	4.0	33.5	4.4	3.7	11.8	4.5	1.4	17.2	26.9	35.2	32.7	19.4	8.4	22.6	9.0	17.1	25.1
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	"Cyclin dependent kinase 14"	O94921	7	90466424-91210590	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 9.8;granulocytes: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015267	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA015267: AB_1855249"	"prognostic favourable (5.86e-4)"	"unprognostic (3.96e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (7.79e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.39e-3)"	8.2	4.7	19.8	7.1	19.4	6.1	8.3	28.6	34.9	10.6	5.2	3.7	0.6	2.7	8.6	3.2	3.1	12.0	11.9	11.5	25.8	15.5	19.8	12.7	9.2	10.9	17.3	17.4	14.9	14.2	3.8	14.2	5.9	22.8	11.3	3.4	4.3	7.7	7.0	5.4	2.7	3.8	7.4	7.0	7.5	7.4	7.2	4.5	0.9	13.1	1.6	11.9	6.9	6.7	9.8	0.9	7.5	0.7	0.1	0.2	0.6	7.0	0.0	14.1	1.8	13.2	13.4	3.2	5.9	5.6	3.6	3.9	0.1	3.4	25.0	0.7	5.8	2.1	0.7	8.3	7.0	0.0	3.3	0.0	4.7	0.1	6.1	7.1	0.1	9.5	2.1	10.8	3.9	4.6	0.1	30.8	7.3	0.0	0.0	2.7	8.9	3.8	19.2	19.4	19.0	1.9	1.9	3.1	9.1	15.0	0.0	0.3	1.9	3.6	11.3	15.7	20.1	13.1	9.0	17.4	13.3	17.9	5.9	9.4	15.3	7.5	0.3	0.5	0.0	0.7	0.0	9.8	0.0	0.0	0.9	5.3	0.0	0.0	5.6	0.1	0.5	0.1	0.2	0.6	19.8	19.4	28.6	34.9	25.8	15.5	17.3	17.4	22.8	4.5
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	"Cyclin dependent kinase 16"	Q00536	X	47217860-47229997	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000974, HPA001366, CAB016535"	Approved		Uncertain	"Plasma membrane,Microtubules,Cytosol"				"Plasma membrane, Microtubules, Cytosol"		"CAB016535: AB_785112, HPA000974: , HPA001366: AB_1079584"	"unprognostic (2.37e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.16e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (2.02e-6)"	"unprognostic (2.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.55e-1)"	22.0	20.1	32.3	13.9	25.0	26.6	17.6	51.5	49.0	17.2	19.3	15.5	17.0	16.4	14.8	12.8	23.8	18.8	14.1	47.3	29.2	18.0	19.9	12.7	14.0	10.8	22.0	21.1	16.7	18.6	22.8	14.9	18.6	28.5	12.7	14.7	13.7	20.1	16.1	91.2	17.0	15.3	18.2	14.8	12.0	14.7	28.7	12.1	10.4	20.9	36.3	12.6	12.9	12.1	8.5	13.5	8.5	10.7	6.3	7.7	5.7	41.2	31.7	30.4	44.9	22.3	19.2	30.4	19.6	24.2	29.9	22.3	35.6	20.0	9.9	12.5	35.2	23.4	32.3	41.8	20.2	11.9	51.3	10.8	44.5	27.7	29.0	11.3	25.2	23.9	26.8	42.4	51.2	26.7	16.0	16.9	26.1	35.9	9.8	26.0	23.8	34.2	10.5	24.1	17.4	22.5	32.7	25.7	19.4	53.3	41.3	20.2	36.8	13.9	26.8	20.0	32.8	30.5	23.4	13.3	13.0	9.7	17.6	52.7	22.4	3.1	8.8	8.5	4.8	10.7	6.2	3.8	6.2	7.7	11.6	8.5	5.6	5.8	4.2	6.3	9.6	13.5	6.0	5.7	32.3	25.0	51.5	49.0	29.2	18.0	22.0	21.1	28.5	12.1
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400560	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 43.7;TIME: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavourable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	16.3	9.1	20.6	13.9	47.0	31.5	14.7	17.8	35.7	11.8	12.9	23.6	3.4	9.2	20.7	7.5	11.7	10.9	12.9	9.4	25.3	17.3	9.2	12.4	15.9	15.2	23.8	21.0	12.9	8.0	9.9	7.3	24.3	14.8	11.4	9.8	5.7	7.5	9.3	7.3	9.1	9.3	23.4	19.6	15.8	7.9	19.9	28.0	29.6	9.4	6.1	16.6	11.0	10.7	9.6	5.3	29.1	4.7	16.5	14.8	8.6	4.8	4.1	10.8	2.9	5.3	14.0	7.7	10.9	15.4	9.6	9.1	2.4	2.8	7.2	7.6	7.9	4.4	6.4	6.7	13.2	7.6	4.9	10.4	2.8	3.4	11.5	5.5	6.0	10.2	7.0	14.2	25.7	43.7	7.6	5.9	21.7	3.0	5.2	8.7	4.7	7.2	9.1	5.8	6.2	11.4	4.1	5.6	3.8	6.4	6.0	7.9	4.6	5.0	52.4	8.6	3.3	4.6	5.9	8.3	6.3	7.8	3.2	2.4	6.3	29.1	3.4	8.9	12.7	4.7	13.7	9.6	10.4	14.4	5.3	8.8	14.8	12.6	12.8	16.5	4.6	3.9	8.1	8.6	20.6	47.0	17.8	24.6	25.3	17.3	23.8	21.0	14.8	28.0
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966769-55972784	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 105.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: "	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.94e-4)"	"prognostic unfavourable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavourable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	10.7	7.6	4.5	20.8	6.5	18.7	11.5	4.2	4.3	12.6	11.6	3.5	6.0	6.1	10.7	6.4	13.6	10.8	12.6	10.1	5.4	2.2	8.3	16.7	19.5	12.2	6.0	2.0	14.2	8.3	5.2	4.2	49.0	7.3	10.8	9.1	51.2	9.3	9.9	10.8	14.6	9.3	11.8	5.0	12.5	10.1	7.8	5.1	39.3	9.5	10.7	14.7	16.7	10.1	9.3	10.8	5.2	3.9	4.5	7.6	4.3	16.5	8.9	19.6	10.9	4.0	5.2	36.2	20.6	10.8	25.6	24.0	18.7	15.9	15.7	15.5	7.6	10.6	14.9	9.0	26.1	18.5	14.6	18.1	14.8	7.1	1.3	14.3	13.1	2.7	2.3	17.3	6.0	12.9	17.2	14.3	17.8	12.7	29.6	12.1	7.8	13.3	29.0	18.9	11.8	7.4	16.2	8.1	10.5	23.5	8.6	105.5	18.6	10.5	7.2	17.7	17.2	13.6	15.0	8.2	9.4	19.6	10.0	10.5	15.2	5.2	3.6	3.1	7.0	3.9	7.0	9.3	3.2	5.0	2.7	6.1	3.0	5.3	1.7	4.5	1.6	10.8	7.6	4.3	4.5	6.5	4.2	4.3	5.4	2.2	6.0	2.0	7.3	5.1
CDK3		ENSG00000250506	"Cyclin dependent kinase 3"	Q00526	17	76000906-76005999	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA007420	Uncertain		Approved	Cytosol				Cytosol		"HPA007420: AB_1078490"	"unprognostic (6.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.80e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.75e-7)"	"unprognostic (4.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (4.47e-4)"	4.1	3.7	2.7	4.7	2.4	5.5	4.7	4.2	2.4	4.9	4.8			6.5	5.6	5.7	4.0	5.0	4.8	2.6	2.8	3.0	5.9	13.0	5.3	5.5	3.0		6.7	5.9	4.2	8.3	5.0		10.3	5.3		5.2	4.5	0.9	14.7	9.1	4.1	3.9	8.8	5.2	5.6			8.2		5.4	3.8	5.1	1.2	1.8	1.5	1.5	1.7	2.7	1.6	4.2	7.7	11.5	6.0	6.8	8.0	23.9	5.2	3.4	5.9	5.5	6.0	8.8	6.3	4.6	4.5	9.7	9.2	3.9	3.8	3.2	14.8	13.2	15.3	6.0	5.6	4.6	13.5	7.2	8.5	5.2	4.2	6.4	5.8	4.5	3.7	10.7	5.3	20.4	5.7	8.4	9.9	5.0	5.9	5.4	14.0	8.3	22.4	3.5	11.3	2.5	15.5	9.3	5.4	15.9	9.4	6.7	5.5	9.5	7.1	5.9	4.8	4.7	3.9	0.0	1.5	0.0	2.1	1.0	0.2	1.2	1.6	1.2	1.8	0.3	2.7	0.5	1.5	1.7	0.6	1.6	2.7	1.6										
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 125.1;LHCN-M2: 138.1;RH-30: 434.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: "	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	32.2	43.1	13.8	22.2	15.7	24.0	45.0	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31.0	32.3	27.4	14.5	12.1	24.0	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25.0	16.0	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.3	10.8	14.3	12.7	13.1	11.5	9.5	5.4	17.6	23.8	19.8	15.4	8.9	13.6	9.7	8.4	7.2	19.7	125.1	18.1	6.7	9.1	12.7	7.3	10.8	15.4	14.4	8.8	11.3	9.2	14.6	16.8	15.3	13.5	11.7	138.1	13.5	13.7	11.7	16.8	11.0	12.4	434.6	12.6	7.4	14.7	12.9	12.1	9.5	7.2	14.4	9.6	17.5	6.9	11.2	10.5	12.6	10.9	5.8	9.5	20.9	10.3	13.3	13.4	1.7	14.3	2.6	26.2	19.9	27.0	29.6	23.1	23.7	21.0	28.1	32.1	28.5	1.2	15.8	12.0	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16.0	17.5
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981774	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favourable (7.31e-5)"	15.5	19.7	20.8	30.0	38.3	21.2	22.5	35.7	31.9	21.1	21.2	27.1	39.4	24.1	26.2	45.4	20.8	26.1	22.0	14.4	23.2	16.7	23.2	31.0	18.8	22.0	31.3	25.8	28.9	51.9	29.4	41.3	15.4	27.3	24.2	25.5	25.1	44.0	26.4	10.7	16.8	25.8	18.4	18.2	32.3	28.6	40.1	29.5	32.3	29.7	16.5	24.6	20.0	18.5	22.8	26.9	27.2	33.5	22.4	22.3	21.0	22.3	36.0	19.9	35.6	16.7	16.8	35.7	16.3	19.8	16.5	15.2	28.2	21.7	26.9	33.8	17.0	21.9	12.9	18.3	18.5	39.7	17.0	12.8	42.9	38.2	18.7	15.1	14.3	19.1	15.5	14.8	29.1	15.9	15.1	25.0	16.7	42.8	41.1	24.5	12.0	15.6	22.0	33.5	30.5	16.4	28.1	13.6	32.6	12.6	11.3	16.4	25.7	19.8	12.7	13.7	12.2	16.5	20.8	32.9	31.0	16.6	17.1	21.0	16.6	9.1	33.5	27.2	20.9	32.7	22.3	22.1	20.0	18.5	26.9	22.8	18.1	19.9	15.7	22.4	32.5	24.4	19.0	21.0	20.8	38.3	35.7	31.9	23.2	16.7	31.3	25.8	27.3	29.5
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 91.7;REH: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavourable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (2.33e-5)"	6.6	11.3	6.0	9.1	7.5	22.5	5.9	2.4	6.0	7.8	10.0	9.6	5.7	7.5	6.0	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7.0	5.2	5.0	10.0	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2.0	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8.0	74.6	4.3	9.2	10.3	6.7	9.0	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6.0	2.8	7.8	5.0	2.3	2.6	1.6	6.3	3.9	3.1	3.0	7.7	4.7	4.7	3.6	4.2	3.8	4.3	9.0	7.4	10.3	3.0	11.8	5.4	7.4	1.4	7.3	0.5	2.5	4.9	4.2	20.0	1.2	11.2	13.0	5.6	1.2	91.7	0.7	2.4	2.6	44.8	27.6	7.9	4.3	0.1	4.1	26.8	0.7	2.1	3.7	0.1	12.0	4.6	10.3	16.1	4.0	12.6	7.0	0.1	6.3	1.5	25.0	13.6	4.9	1.9	6.5	5.2	3.9	5.9	2.0	5.5	5.6	4.0	3.6	7.1	4.0	1.1	3.9	4.8	5.6	2.8	2.3	6.0	7.5	2.4	6.0	6.9	4.2	7.0	5.2	7.5	8.0
CDKN1C	"BWCR, BWS, KIP2, P57"	ENSG00000129757	"Cyclin dependent kinase inhibitor 1C"	P49918	11	2883213-2885773	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.3;placenta: 105.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 8.3;HeLa: 8.5;RPMI-8226: 11.2;SH-SY5Y: 22.8;SiHa: 15.9;SK-MEL-30: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 26.1;non-classical monocyte: 60.3"	"Lineage enriched"	"Detected in many"	12	"monocytes: 60.3"									HPA002924	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA002924: AB_1079548"	"unprognostic (5.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.79e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	53.6	20.7	3.3	5.4	11.9	3.4	13.0	0.9	9.2	10.6	6.9	18.4	3.9	3.3	8.3	5.2	9.9	8.5	7.7	6.9	8.5	5.4	22.7	3.0	5.1	1.8	28.7	4.9	30.9	7.9	1.5	4.0	105.6	11.5	7.2	1.9	8.3	3.1	5.9	27.6	3.0	7.9	6.3	27.9	7.1	7.4	4.3	14.5	0.3	2.0	7.6	2.1	11.2	9.8	0.0	5.0	1.4	60.3	0.0	0.3	2.5	0.1	0.0	1.1	0.0	0.3	0.3	1.2	0.2	0.4	0.2	0.0	2.2	0.2	0.0	8.3	0.1	0.3	0.2	0.2	0.1	3.7	0.8	0.1	8.5	0.0	2.3	0.0	1.0	1.7	1.1	0.0	0.1	0.2	1.8	0.6	0.3	0.0	0.0	3.9	7.4	2.7	1.4	0.0	11.2	0.4	0.0	2.4	22.8	15.9	0.2	8.7	0.1	1.8	0.3	0.0	1.5	0.0	0.0	4.8	0.0	0.0	0.0	1.2	4.5	1.4	0.2	0.2	0.1	26.1	0.3	0.0	0.1	0.1	5.0	0.0	0.2	0.0	0.3	0.0	60.3	0.0	0.1	2.5	3.3	11.9	0.9	5.6	8.5	5.4	28.7	4.9	11.5	14.5
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974633	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavourable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	42.1	12.6	5.9	10.7	7.9	14.9	31.7	4.3	5.7	13.1	13.0	8.7	7.7	6.6	17.1	13.9	11.5	8.4	13.7	20.1	5.7	3.1	7.4	3.3	7.9	11.0	13.7	5.3	22.5	9.4	23.1	5.7	3.1	3.9	10.3	5.7	6.0	5.4	12.2	9.2	8.5	7.9	15.1	7.5	8.5	5.3	5.3	8.9	54.2	8.0	4.9	9.8	17.4	21.7	3.4	7.4	12.2	2.5	6.0	14.1	3.8	13.8	5.7	1.0	19.1	19.7	2.8	0.2	13.2	13.4	22.2	19.5	0.3	4.7	27.2	11.9	11.2	1.7	12.9	1.7	10.9	16.4	17.3	20.6	43.6	3.5	1.0	14.3	9.4	1.0	0.3	6.0	2.6	5.8	9.2	0.0	12.9	3.4	18.4	6.9	0.0	14.0	22.0	18.0	0.0	7.0	5.8	9.7	22.7	18.0	12.7	4.2	6.3	48.6	4.6	25.5	9.8	15.4	0.2	27.9	26.5	22.4	0.0	52.3	22.4	12.2	2.5	11.0	5.2	1.4	6.0	3.4	7.7	6.8	6.1	1.9	4.3	4.1	0.2	6.0	0.6	7.4	14.1	3.8	5.9	7.9	4.3	5.7	5.7	3.1	13.7	5.3	3.9	8.9
CDKN2D	"INK4D, p19"	ENSG00000129355	"Cyclin dependent kinase inhibitor 2D"	P55273	19	10566462-10569059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.1;bone marrow: 119.4"	"Cell line enhanced"	"Detected in many"		"HEL: 32.4;MOLT-4: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011201, HPA043546"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB011201: AB_261049, HPA043546: "	"unprognostic (3.08e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.55e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.90e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	5.5	4.7	27.9	6.8	24.2	119.4	4.1	14.3	28.7	2.6	3.9	4.2	0.5	3.9	2.4	2.5	3.8	3.0	4.0	8.4	22.9	17.9	2.7	2.1	6.6	11.1	14.3	14.3	2.8	2.8	2.6	3.4	4.8	11.8	2.5	3.6	2.4	3.2	3.0	6.3	6.0	3.5	4.6	5.7	9.7	2.8	10.9	3.6	18.6	1.8	2.8	8.4	4.2	2.4	17.3	16.0	44.1	10.7	11.9	11.3	9.5	10.9	1.7	5.6	3.7	3.0	4.7	1.4	7.2	8.5	8.0	7.0	2.2	2.6	3.0	2.4	7.6	2.3	1.9	1.8	2.9	12.2	4.6	32.4	2.0	3.6	3.5	3.2	26.3	1.9	6.0	4.1	3.0	2.2	1.3	26.7	7.9	1.5	39.9	17.1	1.1	8.4	6.5	5.5	1.8	3.6	0.9	7.9	4.2	5.1	3.8	5.5	3.4	8.6	1.7	9.5	4.9	15.6	10.7	16.8	5.7	5.6	10.0	5.5	6.7	35.9	5.6	23.5	10.0	6.8	8.0	17.3	8.3	11.3	5.4	15.9	7.9	9.4	44.1	11.9	10.7	16.0	6.7	9.5	27.9	24.2	14.3	28.7	22.9	17.9	14.3	14.3	11.8	3.6
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 80.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.1"	"Group enriched"	"Detected in all"	5	"NK-cells: 5.8;T-cells: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol				Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: "	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavourable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	2.4	1.0	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1.0	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3.0	1.4	1.9	1.0	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0.0	1.0	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4.0	2.2	1.0	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2.0	1.6	1.1	1.4	5.8	16.1	2.9	55.8	21.5	16.5	16.4	2.7	3.3	9.5	13.4	19.7	28.5	31.6	16.1	27.9	27.5	9.8	20.8	41.2	25.0	16.2	53.3	32.9	12.1	14.0	15.4	26.7	2.0	17.5	10.0	1.2	1.0	17.8	31.0	18.1	7.0	35.3	34.2	39.8	24.0	14.2	5.8	46.6	14.9	14.5	5.9	15.1	12.3	6.7	8.6	24.4	14.5	10.7	30.0	14.9	6.6	12.7	43.4	19.9	31.6	8.5	9.8	18.9	21.2	25.2	23.1	0.0	1.3	1.1	1.2	1.4	0.6	2.0	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816954	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 142.1;seminal vesicle: 53.7"	"Cell line enhanced"	"Detected in some"		"AF22: 22.6;ASC diff: 27.9;ASC TERT1: 10.8;HAP1: 8.0;NTERA-2: 8.4"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"memory CD4 T-cell: 4.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	31.9	6.2	9.3	1.7	11.2	0.8	9.9	7.6	9.4	3.4	1.5	3.7	36.4	1.0	3.1	42.6	1.8	4.9	3.7	7.6	7.3	9.0	1.7	142.1	3.9	2.3	6.5	5.5	8.7	4.7	1.0	6.5	17.7	14.5	4.0	1.3	19.2	2.8	53.7	3.5	1.1	1.1	2.6	5.3	1.8	1.2	5.0	4.3	0.0	2.8	2.5	1.6	2.4	2.1	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	22.6	0.0	27.9	10.8	0.1	0.6	0.2	2.2	2.1	0.0	0.0	0.0	0.0	0.2	0.0	8.0	0.0	3.1	0.0	3.9	0.7	0.0	0.6	0.1	0.0	0.0	4.1	0.0	0.3	0.0	2.9	0.0	0.0	2.5	0.0	0.5	0.1	8.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	9.3	11.2	7.6	9.4	7.3	9.0	6.5	5.5	14.5	4.3
CDPF1	"C22orf40, LOC150383"	ENSG00000205643	"Cysteine rich DPF motif domain containing 1"	Q6NVV7	22	46244011-46250679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018823	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018823: AB_1853018"	"unprognostic (1.98e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.42e-2)"	"prognostic favourable (3.13e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.83e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	7.3	12.7	10.4	9.4	10.9	5.3	7.8	10.6	12.4	10.1	11.4	11.4	5.3	7.0	12.4	11.8	6.0	11.9	8.3	14.1	10.4	6.8	9.4	8.5	9.4	9.0	10.7	9.5	11.2	8.5	8.0	11.1	7.9	10.9	11.0	6.0	10.3	15.5	11.8	12.3	7.7	9.4	8.2	8.7	11.6	9.9	4.0	10.9	12.9	11.2	5.2	9.6	8.1	12.2	8.9	11.6	11.0	8.5	8.3	11.6	7.3	5.5	4.1	6.6	9.6	4.2	7.4	5.5	3.0	4.4	6.1	5.7	0.7	5.7	5.7	3.2	2.2	6.5	3.0	1.0	3.7	5.3	10.5	3.0	6.2	6.2	7.7	8.1	4.6	7.9	5.9	4.5	5.6	4.5	5.8	7.1	4.3	4.0	10.0	5.8	5.1	4.0	6.4	2.7	12.1	4.6	1.8	3.3	8.0	3.7	6.6	6.3	7.1	3.4	3.5	11.5	7.3	6.4	3.7	7.0	3.3	4.4	5.3	5.9	11.3	1.5	6.5	11.0	10.1	8.0	9.5	7.3	9.9	8.9	5.5	8.9	11.6	8.4	1.7	8.3	8.5	11.6	7.4	7.3	10.4	10.9	10.6	12.4	10.4	6.8	10.7	9.5	10.9	10.9
CDR2L	HUMPPA	ENSG00000109089	"Cerebellar degeneration related protein 2 like"	Q86X02	17	74987632-75005800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 27.0;U-138 MG: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022015	Enhanced		Approved	Cytosol				Cytosol		"HPA022015: AB_1846462"	"unprognostic (4.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.36e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	9.5	6.1	7.0	4.2	18.7	0.8	20.1	40.0	14.3	6.8	9.9	19.1	4.2	31.0	14.3	2.1	4.3	6.8	12.9	8.3	11.7	8.3	6.9	2.3	8.9	1.8	22.0	6.9	2.4	6.3	4.3	4.1	10.2	21.9	5.4	2.7	2.7	10.2	8.3	3.2	3.1	15.8	8.3	25.1	2.2	17.7	5.6	14.0	0.0	3.2	1.0	1.7	7.0	10.1	0.3	0.1	0.0	0.4	0.0	0.1	1.5	6.2	18.0	4.0	8.4	7.1	6.3	1.8	9.1	4.1	5.4	6.9	10.6	5.8	0.0	9.7	15.9	16.8	4.8	2.2	3.5	0.1	8.1	0.0	11.2	6.8	4.1	0.7	0.3	3.6	3.5	12.7	1.3	11.5	2.7	0.9	5.6	5.6	0.8	0.6	5.2	8.9	2.9	6.1	2.7	14.1	3.9	7.0	23.5	11.5	27.0	0.8	7.4	1.2	8.1	27.7	5.9	17.4	5.7	0.8	0.5	0.0	7.7	2.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.4	0.1	0.0	1.5	7.0	18.7	40.0	14.3	11.7	8.3	22.0	6.9	21.9	14.0
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126786-5197887	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"U-266/84: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum,Cytosol"			200000	"Endoplasmic reticulum"	Cytosol	"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favourable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.8	16.1	22.2	9.9	25.5	12.1	12.1	36.0	34.5	12.7	11.8	21.4	6.7	5.9	12.9	9.8	10.5	12.5	10.0	26.6	22.0	34.0	16.9	14.2	14.5	10.9	26.7	24.0	10.9	7.2	20.6	15.6	11.1	28.3	15.9	12.3	19.8	8.0	19.7	9.4	6.2	9.9	20.2	16.2	9.8	10.6	13.0	12.5	8.1	14.2	4.6	13.6	11.6	8.2	7.6	7.9	28.3	9.7	6.5	11.1	11.7	9.4	10.6	10.6	5.5	6.3	5.8	4.9	5.2	10.7	8.6	12.5	6.5	9.3	7.2	2.6	9.7	13.6	8.6	10.9	9.2	7.6	3.0	8.3	3.0	10.0	5.9	5.4	3.1	5.0	6.1	11.3	4.4	11.5	4.0	9.3	8.0	1.6	10.6	2.0	5.1	3.2	9.2	8.6	3.3	5.5	9.2	4.4	6.2	5.8	9.9	13.4	6.1	2.5	8.4	6.2	4.9	5.5	5.2	8.1	59.6	6.0	2.8	4.2	3.7	24.1	9.7	11.5	10.0	8.0	10.6	7.6	10.2	11.1	7.9	7.4	8.0	7.8	28.3	6.5	7.3	6.3	11.1	11.7	22.2	25.5	36.0	31.6	22.0	34.0	26.7	24.0	28.3	12.5
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573730-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Enhanced	"Nucleoli,Plasma membrane,Cytosol"			220000	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	46.4	26.5	20.7	45.7	22.4	44.9	38.1	13.2	22.3	25.6	29.5	20.2	16.2	18.5	27.0	26.1	34.1	22.0	25.4	50.5	19.0	18.3	26.2	40.2	34.3	47.6	22.5	20.6	32.8	34.4	25.6	22.5	34.8	24.4	24.6	23.9	18.7	24.6	16.7	106.6	23.1	27.7	33.1	25.4	56.6	31.4	38.2	21.5	61.1	33.9	32.5	52.1	43.8	37.2	10.6	14.2	14.7	11.1	5.3	20.8	4.5	49.7	11.6	20.5	13.5	23.7	29.3	24.3	27.5	35.9	27.6	27.4	28.7	20.1	63.7	41.9	30.8	21.5	29.3	27.5	51.8	40.7	11.0	37.6	12.8	17.6	36.9	41.8	24.2	27.8	28.9	24.6	66.5	34.8	27.0	42.8	39.9	14.3	34.2	24.2	20.7	14.9	20.9	27.3	51.0	29.0	20.3	16.3	12.3	26.1	19.5	32.7	63.0	25.7	43.1	29.5	27.9	23.4	27.2	62.5	46.8	150.0	16.5	25.4	17.1	11.5	9.6	14.7	12.2	10.7	12.8	10.6	11.7	12.4	8.5	6.5	9.4	14.4	8.7	5.3	11.1	14.2	20.8	4.5	20.7	22.4	13.2	22.3	19.0	18.3	22.5	20.6	24.4	21.5
CEBPE	CRP1	ENSG00000092067	"CCAAT/enhancer binding protein epsilon"	Q15744	14	23117304-23119616	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 87.1;bone marrow: 29.4"	"Group enriched"	"Detected in some"	4	"HL-60: 58.0;NB-4: 30.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	201	"eosinophil: 87.1"	"Lineage enriched"	"Detected in single"	237	"granulocytes: 87.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.3	0.0	0.1	0.8	0.2	29.4	0.1	0.1	1.3	0.1	0.1	0.1	0.1	1.4	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.1	0.2	2.7	0.2	0.3	0.1	0.1	0.1	0.0	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.9	0.1	0.3	7.7	0.4	0.1	0.1	2.6	0.1	0.1	0.8	0.2	0.1	0.0	0.1	87.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	30.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.3	87.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	1.3	0.1	0.1	0.3	0.1	0.1	0.1
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase family member 3A"	P09093	1	22001656-22012539	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2051	"pancreas: 2541.2"	"Cell line enriched"	"Detected in single"	24	"MOLT-4: 21.1"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"			Cytosol		"HPA028086: , HPA045650: "			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	2541.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase family member 3B"	P08861	1	21977021-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	196	"pancreas: 1614.4"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"			Cytosol		"HPA028086: , HPA045650: "			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1614.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.9	5.3	8.2	3.0	2.3	3.2	0.9	0.6	4.9	1.7	1.3	2.5	1.5	2.2	1.1	1.8	1.7	1.7	5.3	2.7	5.4	2.6	1.4	1.6	1.0	0.5	0.0	2.4	4.1	2.4	4.9	3.9	1.3	1.9	3.2	2.3	2.4	1.4	0.0	2.4	2.5	5.5	0.4	2.5	2.1	1.5	1.3	3.5	3.6	0.9	4.2	0.0	3.6	3.1	1.7	3.4	0.8	0.3	2.5	2.8	3.6	2.9	1.6	2.3	1.0	4.8	4.7	2.4	1.8	4.7	0.6	5.1	2.5	1.8	3.1	3.0	2.0	3.7	2.2	2.8	1.4	5.9	3.2	3.0	8.2	2.3	1.7	5.3	2.9	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CELSR2	"ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3"	ENSG00000143126	"Cadherin EGF LAG seven-pass G-type receptor 2"	Q9HCU4	1	109250019-109275750	"G-protein coupled receptors, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.7;skin 1: 27.8"	"Cell line enhanced"	"Detected in many"		"AF22: 24.7;HaCaT: 24.4;MCF7: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013952	Uncertain		Approved	Cytosol				Cytosol		"HPA013952: AB_1846518"	"unprognostic (4.46e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.16e-2)"	1.5	2.3	12.6	1.1	16.0	0.9	5.4	9.2	31.7	6.9	1.8	13.7	3.4	1.4	3.1	4.3	10.9	18.8	1.8	5.3	17.1	8.1	5.6	1.2	1.8	1.3	10.0	15.4	1.2	4.8	7.8	2.3	1.6	8.3	3.5	1.4	5.4	6.4	10.4	9.3	27.8	1.5	2.4	14.1	1.0	2.0	11.0	8.6	0.5	10.9	2.7	3.2	2.3	6.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	6.8	6.4	24.7	4.5	0.0	0.0	6.7	0.8	0.6	1.5	0.4	1.0	0.2	1.2	5.6	0.5	24.4	6.4	3.9	0.8	0.1	2.6	0.5	5.9	1.4	0.5	0.3	3.2	0.1	9.6	0.6	0.4	0.3	4.0	0.3	0.0	28.1	0.7	0.3	8.0	1.2	6.2	2.2	0.3	5.4	2.3	10.0	4.7	3.8	8.3	5.3	7.8	1.5	0.0	0.0	4.5	0.4	6.1	1.6	0.4	0.3	1.3	0.5	2.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	16.0	9.2	31.7	17.1	8.1	10.0	15.4	8.3	8.6
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105806-103198409	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.3;lymphoid tissue: 25.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA042294	Enhanced		Approved	Nucleoplasm,Microtubules,Cytosol				"Microtubules, Cytosol"	Nucleoplasm	"HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	2.7	0.9	0.6	9.4	1.5	11.3	0.7	0.2	1.3	1.0	2.1	0.5	0.0	1.9	0.7	1.9	5.9	0.5	0.8	2.5	2.0	0.8	1.3	0.6	1.4	7.3	1.9	0.6	0.7	0.5	0.1	0.4	3.1	1.4	0.7	2.7	0.2	2.2	0.8	0.4	2.2	2.4	1.4	1.3	3.3	1.6	6.6	0.6	25.1	0.6	5.9	6.4	1.5	1.9	0.6	0.5	5.7	3.0	0.8	1.4	0.2	20.6	5.9	21.6	10.4	1.5	3.3	4.2	18.8	9.4	14.0	9.4	9.3	11.2	14.0	4.8	6.9	9.2	15.4	7.6	22.2	17.5	5.7	16.5	12.4	6.7	0.2	19.5	9.6	1.0	0.5	11.3	9.5	11.8	17.0	16.8	18.1	7.5	15.3	8.8	6.9	9.3	10.3	20.2	4.6	3.9	4.1	10.0	5.9	16.7	11.6	4.5	6.6	6.9	12.8	13.6	14.3	14.1	19.2	8.2	14.0	14.5	7.5	10.9	14.4	5.7	0.1	0.7	0.2	0.6	0.0	0.6	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.8	3.0	0.5	1.4	0.2	0.6	1.5	0.2	1.3	2.0	0.8	1.9	0.6	1.4	0.6
CENPI	"CENP-I, FSHPRH1, LRPR1, Mis6"	ENSG00000102384	"Centromere protein I"	Q92674	X	101098218-101163681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061297			Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"HPA061297: "	"unprognostic (3.10e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.78e-6)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.62e-3)"	"unprognostic (1.20e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-13)"	"unprognostic (1.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-1)"	2.6	1.8	1.5	10.8	4.7	9.1	4.0	1.7	2.9	3.7	3.9	3.6	0.0	4.0	4.1	2.2	7.1	2.7	2.8	1.7	1.8	1.4	1.5	1.6	2.9	7.7	3.3	1.8	4.5	1.2	0.3	1.3	3.6	2.6	1.8	5.3	1.2	2.0	0.8	1.5	4.5	3.8	4.3	4.3	4.0	3.3	4.6	2.7	18.3	1.3	4.1	11.0	3.1	3.7	2.6	2.9	4.8	2.8	3.2	3.3	1.2	16.9	11.7	14.5	11.1	1.8	3.3	6.4	18.3	9.8	18.6	37.8	15.6	10.8	12.4	6.6	7.2	9.9	21.1	9.7	26.1	7.7	5.4	7.6	16.7	5.9	0.2	10.0	8.4	1.3	0.8	24.7	3.1	15.8	5.4	22.9	18.0	11.9	9.9	3.6	11.1	14.4	9.3	20.9	8.0	4.6	10.1	9.2	4.9	22.5	6.4	3.8	6.3	3.3	6.4	17.5	14.7	16.3	14.6	3.7	8.5	14.0	6.9	13.4	13.5	2.2	2.1	2.3	2.0	2.8	1.3	2.6	2.0	2.6	1.0	2.1	1.6	1.7	4.8	3.2	2.6	2.9	3.3	1.2	1.5	4.7	1.7	2.9	1.8	1.4	3.3	1.8	2.6	2.7
CENPM	"C22orf18, CENP-M, MGC861, Pane1"	ENSG00000100162	"Centromere protein M"	Q9NSP4	22	41938721-41947164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.3;lymphoid tissue: 41.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 19.5;T-reg: 23.3"	"Group enriched"	"Detected in many"	7	"B-cells: 19.5;T-cells: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042404, HPA056500"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA042404: , HPA056500: "	"unprognostic (3.78e-2)"	"prognostic favourable (3.40e-5)"	"unprognostic (7.15e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (5.50e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (5.99e-7)"	"unprognostic (9.54e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.73e-2)"	"unprognostic (5.61e-2)"	1.6	1.4	1.1	31.9	0.9	18.2	3.8	1.9	1.2	1.7	6.9	1.1	0.4	6.0	1.4	2.2	8.9	9.6	4.3	3.2	1.0	0.8	2.1	1.4	4.2	17.0	1.0	0.4	1.4	0.6	0.0	0.4	3.4	0.8	1.2	3.7	1.1	3.3	0.9	0.5	6.3	7.2	1.1	0.9	9.7	4.5	13.5	0.4	41.5	0.9	5.5	18.8	3.2	3.3	19.5	0.3	0.8	0.1	2.9	23.3	4.0	22.1	22.8	12.7	8.4	1.0	0.9	5.4	10.9	5.7	19.3	19.7	26.4	11.9	28.8	8.2	5.7	8.5	9.6	11.2	4.8	8.2	40.0	13.5	24.4	18.3	1.0	25.5	15.3	0.8	0.8	12.3	5.8	7.2	10.2	27.9	11.2	34.2	25.4	26.7	6.9	16.9	24.5	12.7	30.0	7.8	13.3	14.6	2.8	16.9	10.1	5.7	9.6	16.6	3.6	18.7	28.0	12.3	18.1	14.9	10.3	26.6	6.5	21.3	20.4	0.8	0.1	0.0	3.2	0.0	4.3	13.1	9.4	4.1	0.3	19.5	1.8	2.4	0.5	2.9	0.0	0.2	23.3	4.0	1.1	0.9	1.9	1.2	1.0	0.8	1.0	0.4	0.8	0.4
CENPV	"CENP-V, p30, PRR6"	ENSG00000166582	"Centromere protein V"	Q7Z7K6	17	16342534-16353656	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 34.1;HEK 293: 28.0;NTERA-2: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.6;memory B-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042529, HPA042616"	Enhanced		Approved	Nucleoplasm,Midbody,Cytosol				Nucleoplasm	"Midbody, Cytosol"	"HPA042529: AB_10793882, HPA042616: AB_10794050"	"unprognostic (7.64e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.60e-3)"	4.6	5.6	13.7	4.0	14.7	6.2	6.6	12.0	17.3	4.2	19.5	6.7	2.8	13.6	8.0	5.5	1.3	9.1	3.5	5.7	10.2	10.1	5.2	14.6	2.5	2.3	7.8	11.8	9.1	5.9	3.7	7.3	2.2	5.8	4.6	11.5	2.4	1.6	6.4	25.4	0.9	29.1	6.1	7.3	1.5	18.0	10.6	6.1	22.5	4.0	2.9	2.1	3.2	2.3	3.3	1.0	3.6	0.0	0.0	1.0	0.3	3.2	6.4	34.1	17.2	0.9	0.9	5.9	2.7	2.7	8.6	6.6	6.4	1.4	13.1	5.5	2.0	0.9	22.0	0.2	5.4	0.0	28.0	3.0	1.7	12.6	9.6	3.1	0.0	2.4	0.9	10.3	6.1	4.8	5.3	0.0	2.5	0.5	24.4	10.4	33.5	0.0	17.6	1.3	1.5	1.9	4.8	18.3	13.9	6.9	0.1	1.5	0.1	7.7	0.3	0.0	2.7	0.3	0.0	0.0	0.0	7.6	0.0	4.3	0.2	0.0	0.0	3.6	0.3	0.0	0.1	3.3	0.1	0.1	0.7	0.3	1.0	0.9	0.0	0.0	0.0	1.0	0.2	0.3	13.7	14.7	12.0	17.3	10.2	10.1	7.8	11.8	5.8	6.1
CEP120	"CCDC100, FLJ36090"	ENSG00000168944	"Centrosomal protein 120"	Q8N960	5	123344885-123423592	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028823, HPA051556"	Uncertain		Approved	Microtubules,Cytosol				Microtubules	Cytosol	"HPA028823: AB_10601355, HPA051556: "	"unprognostic (3.65e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.58e-1)"	13.3	12.9	8.6	15.2	12.8	9.2	12.1	22.9	10.8	13.1	11.1	12.5	14.4	7.9	15.7	11.3	9.3	13.5	11.6	9.5	10.0	11.6	10.7	12.7	11.4	16.1	11.2	9.8	24.3	11.0	9.8	18.1	8.9	11.4	11.7	9.6	13.9	9.8	12.0	7.3	6.9	11.8	12.0	12.0	13.9	8.6	19.4	10.9	28.4	11.7	6.0	15.6	13.0	14.2	3.6	1.6	5.5	2.4	1.6	5.4	1.7	7.7	8.7	9.6	14.3	9.7	12.3	9.8	9.2	12.0	10.3	17.2	7.3	7.0	10.9	8.5	7.1	6.2	9.4	9.9	16.6	21.8	6.0	5.4	7.2	6.3	10.1	6.9	9.4	9.3	10.5	13.8	16.5	8.7	5.5	19.5	9.9	3.6	12.1	11.6	4.6	6.5	7.1	13.3	6.8	5.7	4.5	10.5	8.7	8.1	4.3	13.4	6.3	15.3	6.4	10.8	8.8	6.0	11.6	13.0	9.9	10.7	9.3	12.6	10.5	5.5	1.2	2.6	2.0	2.4	2.7	3.6	3.4	2.7	1.5	3.1	2.9	4.9	0.8	1.6	0.8	1.6	5.4	1.7	8.6	12.8	22.9	10.8	10.0	11.6	11.2	9.8	11.4	10.9
CEP126	KIAA1377	ENSG00000110318	"Centrosomal protein 126"	Q9P2H0	11	101915015-102001058	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 47.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.0;EFO-21: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038381, HPA038399"			Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA038381: AB_10669780, HPA038399: AB_10670157"	"unprognostic (7.61e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.55e-4)"	"unprognostic (1.52e-2)"	"unprognostic (5.77e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.72e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavourable (5.00e-4)"	"unprognostic (1.30e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.99e-3)"	7.6	11.1	9.0	2.4	20.2	2.4	8.3	16.8	14.8	7.9	4.2	5.0	4.2	2.0	9.1	6.7	5.3	17.5	4.9	4.5	9.6	8.3	3.8	1.4	6.1	3.3	7.5	10.2	11.4	5.0	6.4	47.3	2.6	12.4	6.6	4.8	3.2	3.2	7.6	2.3	8.5	2.7	7.3	9.2	3.1	4.0	19.2	8.9	0.5	7.4	1.5	2.5	3.9	9.7	2.5	4.8	1.4	0.5	3.3	2.0	0.5	0.9	2.2	1.0	1.3	10.0	5.5	0.4	2.1	1.8	1.0	0.9	0.6	3.0	1.3	9.5	1.9	0.9	1.2	2.3	0.9	3.0	1.4	0.3	3.7	1.1	1.1	0.2	0.3	1.9	4.7	1.3	2.8	2.9	0.3	0.4	2.5	1.1	1.0	0.3	0.8	1.6	0.2	1.1	0.2	1.9	1.2	2.7	4.2	1.3	1.9	0.3	3.7	0.4	1.7	3.3	1.9	1.0	2.2	2.2	1.2	0.2	3.2	0.3	1.3	0.7	0.5	1.0	2.0	0.1	0.9	1.8	1.2	1.6	0.4	2.5	1.7	1.7	1.4	3.3	0.2	4.8	0.3	0.5	9.0	20.2	16.8	14.8	9.6	8.3	7.5	10.2	12.4	8.9
CEP128	"C14orf145, C14orf61"	ENSG00000100629	"Centrosomal protein 128"	Q6ZU80	14	80476983-80959517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 61.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 25.2;MOLT-4: 21.6;U-266/70: 45.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.6;T-cells: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000602, HPA001116, HPA018498"	Uncertain		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite"	Cytosol	"HPA000602: , HPA001116: AB_1078323, HPA018498: AB_1845560"	"unprognostic (6.13e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.48e-1)"	3.8	2.0	5.2	6.5	7.6	10.5	7.5	13.6	5.4	3.4	3.6	4.2	2.7	3.2	4.0	2.2	4.4	4.8	2.0	3.1	3.8	2.5	2.4	2.0	3.8	8.1	6.9	3.1	4.4	2.1	4.2	8.6	2.3	4.5	2.9	3.3	2.3	4.5	3.2	3.1	5.1	3.0	4.0	5.5	6.3	3.1	9.0	6.8	61.2	5.7	3.1	9.1	6.0	4.4	2.2	8.6	1.7	0.8	1.1	9.6	0.8	5.9	3.1	2.8	2.3	0.6	1.1	1.5	6.7	2.0	3.9	3.9	2.1	3.4	13.7	1.2	1.9	3.2	3.0	1.9	7.5	7.7	1.9	2.6	3.9	1.1	0.3	2.7	3.5	0.2	0.5	5.6	3.0	2.9	3.3	25.2	3.7	3.7	21.6	1.4	2.1	3.9	3.9	6.9	10.7	0.8	3.1	3.6	1.7	5.4	2.2	1.1	2.5	2.0	2.7	8.6	4.7	2.3	6.5	45.6	1.8	6.1	2.4	3.6	2.9	0.0	0.8	1.7	2.9	0.3	2.3	2.2	3.2	2.2	2.5	0.9	2.8	1.3	0.1	1.1	0.5	8.6	9.6	0.8	5.2	7.6	13.6	5.4	3.8	2.5	6.9	3.1	4.5	6.8
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227635	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	5.9	4.3	4.2	5.3	6.0	3.8	5.4	9.4	7.8	6.4	6.3	4.8	6.6	2.1	9.1	4.4	4.1	7.2	5.2	4.0	4.5	2.6	7.7	2.6	5.3	4.6	4.8	3.2	7.9	4.1	9.6	19.1	4.5	5.8	4.7	4.9	2.7	5.5	4.6	4.1	4.1	4.2	6.4	7.6	5.8	4.9	14.4	6.4	11.6	7.7	2.1	4.2	7.3	5.4	2.5	1.8	2.2	1.3	0.1	2.6	0.8	2.9	1.3	8.7	9.5	5.2	7.8	5.5	3.3	3.2	4.7	5.8	3.8	4.0	3.2	3.2	2.6	4.6	5.1	3.1	7.5	8.0	3.5	5.8	5.9	2.8	2.9	6.2	5.6	3.6	2.3	4.8	1.8	5.2	11.7	3.7	3.4	1.5	1.6	4.0	5.7	2.0	8.9	11.2	1.7	3.5	2.7	6.0	7.5	2.3	1.4	2.5	3.1	4.6	4.2	4.7	4.2	4.1	3.7	2.9	3.9	1.9	2.9	3.4	5.8	0.0	1.3	1.5	1.9	1.2	2.6	2.5	1.5	1.7	0.7	1.6	1.2	2.0	2.2	0.1	1.0	1.8	0.3	0.8	4.2	6.0	9.4	7.8	4.5	2.6	4.8	3.2	5.8	6.4
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.7"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Enhanced	"Mitotic spindle,Centrosome,Cytosol"				Centrosome	"Mitotic spindle, Cytosol"	"HPA042151: , HPA045597: , HPA045787: "	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavourable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	9.5	6.1	13.7	10.8	13.2	36.5	6.8	27.7	23.2	7.4	5.4	11.4	3.1	3.1	9.1	5.2	5.5	6.4	11.1	8.6	12.8	11.2	3.8	6.7	8.4	7.3	19.3	13.7	13.3	2.8	2.8	10.8	9.8	20.2	5.0	4.2	3.3	4.2	5.5	9.3	4.2	4.7	7.4	25.8	7.8	4.2	53.7	18.0	11.6	14.4	3.3	8.9	8.6	6.6	9.4	8.4	12.3	10.1	2.8	4.7	2.1	6.0	5.1	13.1	11.1	8.2	15.9	2.8	16.1	9.5	12.1	11.4	3.1	5.9	4.5	9.8	13.6	3.0	11.3	6.9	17.2	10.0	6.5	4.6	4.8	2.2	7.1	8.2	8.8	10.0	1.9	38.5	16.9	28.1	11.3	4.7	15.3	1.3	5.0	4.3	16.5	14.5	9.0	9.4	1.5	2.5	1.0	19.0	25.7	8.2	0.7	7.7	2.8	11.1	31.1	22.6	6.7	12.1	18.4	4.6	5.9	9.0	12.0	7.5	51.8	3.5	8.3	7.6	1.9	10.0	2.7	3.6	3.8	1.6	8.4	9.4	4.7	2.7	12.3	2.8	10.1	5.5	2.9	2.1	13.7	13.2	27.7	15.8	12.8	11.2	19.3	13.7	20.2	18.0
CEP170B	"Cep170R, FAM68C, KIAA0284"	ENSG00000099814	"Centrosomal protein 170B"	Q9Y4F5	14	104865280-104896770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000871, HPA059017"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA000871: , HPA059017: "	"unprognostic (1.09e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (6.12e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (4.41e-4)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-2)"	10.3	8.8	19.9	7.3	26.3	1.3	10.9	25.9	39.7	6.6	18.0	5.3	9.1	24.7	7.4	5.0	14.7	8.5	15.1	4.9	18.5	12.4	9.9	9.4	8.0	2.1	8.9	19.7	4.6	25.4	9.0	10.5	4.8	13.5	10.3	8.9	5.3	17.5	12.5	4.6	35.0	24.6	6.7	6.5	3.8	23.2	10.9	6.0	0.2	10.1	6.2	5.6	8.8	11.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	10.8	9.0	0.7	8.6	3.6	2.7	20.1	8.6	3.4	4.3	2.9	9.5	6.7	0.0	10.5	6.5	24.1	2.0	10.0	1.1	4.0	4.2	0.0	9.6	6.2	7.4	0.0	8.9	2.6	12.8	4.5	6.6	4.3	2.7	0.1	3.6	22.9	0.0	0.1	2.8	7.8	3.6	0.0	2.6	4.3	18.5	2.3	2.4	12.7	7.5	11.4	13.1	1.6	9.5	6.9	7.6	18.9	5.7	0.4	0.0	0.0	5.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	19.9	26.3	25.9	39.7	18.5	12.4	8.9	19.7	13.5	6.0
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA039392, HPA040503"	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	7.6	6.5	7.9	14.9	11.8	16.3	8.3	14.5	11.8	8.8	7.7	11.1	7.1	6.7	13.6	9.3	7.6	8.8	9.9	7.1	8.1	4.7	6.9	6.1	8.7	11.0	8.7	11.8	17.4	9.5	10.4	11.1	7.8	11.8	8.0	9.4	7.9	10.4	6.6	6.2	8.2	9.6	9.5	7.6	8.4	8.2	16.4	9.8	18.3	11.1	6.0	12.2	12.1	8.6	3.9	1.8	2.1	4.9	0.9	3.5	1.0	9.9	5.4	14.8	7.7	6.5	10.1	4.8	7.0	9.3	11.1	11.8	7.4	4.4	11.3	4.7	7.1	4.9	12.8	6.6	13.2	4.4	4.6	10.3	8.3	3.9	3.4	16.3	7.9	6.9	2.5	9.3	8.5	9.1	14.1	7.6	8.6	5.0	14.0	7.1	4.7	3.4	12.1	11.6	5.8	3.8	10.2	10.8	6.1	11.2	5.6	3.5	4.4	8.4	9.1	8.8	20.8	10.0	9.6	5.1	7.3	12.9	5.6	7.4	8.4	1.5	2.1	1.5	3.2	1.5	2.4	1.8	2.1	2.0	0.9	3.9	2.3	3.5	2.1	0.9	4.9	1.8	1.8	1.0	7.9	11.8	14.5	11.8	8.1	4.7	8.7	11.8	11.8	9.8
CEP295	KIAA1731	ENSG00000166004	"Centrosomal protein 295"	Q9C0D2	11	93661639-93730358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038595, HPA038596, HPA038597"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038595: , HPA038596: AB_10672720, HPA038597: "	"unprognostic (1.35e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.18e-2)"	8.4	7.4	15.8	12.1	15.4	19.6	11.7	30.6	20.5	10.0	10.0	6.1	9.4	8.6	10.5	11.2	8.4	7.7	7.6	6.5	12.1	8.1	7.6	6.3	8.6	14.1	10.7	14.7	12.2	8.1	8.5	24.5	8.5	12.1	10.6	9.8	5.1	7.9	9.4	13.4	12.5	9.2	7.8	13.8	11.7	8.0	15.5	15.0	11.6	12.3	5.2	9.9	10.7	8.9	6.3	3.0	9.1	3.1	2.7	3.0	0.6	7.1	6.6	17.0	14.6	7.9	7.8	8.3	9.2	6.8	8.8	10.3	12.1	13.8	2.2	13.8	5.8	13.4	8.5	6.8	9.0	10.2	6.6	13.0	19.0	6.0	4.8	11.7	12.8	5.6	4.0	8.3	7.4	7.3	14.7	13.8	11.1	6.1	6.0	19.3	5.7	6.8	12.1	16.1	8.7	7.2	12.6	10.2	9.6	14.6	9.8	2.6	16.1	6.4	7.4	8.3	10.8	14.8	7.1	5.1	11.1	14.4	4.9	13.8	11.3	4.1	3.1	5.7	2.8	1.5	2.2	5.0	2.5	1.9	1.3	6.3	3.0	2.5	9.1	2.7	2.0	3.0	1.7	0.6	15.8	15.4	30.6	20.5	12.1	8.1	10.7	14.7	12.1	15.0
CEP57	"KIAA0092, Translokin, TSP57"	ENSG00000166037	"Centrosomal protein 57"	Q86XR8	11	95789965-95832693	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018315	Approved		Supported	Microtubules,Cytosol	"Intracellular and membrane"			Microtubules	Cytosol	"HPA018315: AB_1846537"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (7.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.25e-1)"	16.8	13.7	12.9	25.9	20.6	21.6	17.4	27.9	16.2	25.6	33.8	6.9	19.2	27.0	18.5	18.8	18.2	16.5	22.9	14.0	13.3	14.1	14.9	34.4	19.0	28.9	12.6	15.2	27.2	24.5	13.6	26.1	13.3	15.0	21.5	15.6	10.5	14.1	22.3	12.6	15.8	28.8	22.2	14.6	19.8	15.3	24.3	12.7	46.5	23.4	15.7	23.9	27.5	18.3	17.2	15.5	17.6	11.0	18.6	25.3	13.0	11.2	5.6	19.4	14.4	8.3	17.1	15.4	12.8	20.6	17.7	20.1	20.1	24.2	20.3	17.9	9.5	19.0	14.6	12.7	18.8	15.9	9.7	27.9	16.3	16.7	15.3	28.3	16.9	11.5	18.1	18.1	34.9	14.7	18.0	11.2	14.1	5.5	30.6	37.4	9.9	12.8	19.1	23.2	17.0	14.9	12.5	9.3	13.5	15.2	15.1	16.1	15.4	18.4	8.2	15.5	12.5	22.7	12.2	8.2	16.0	22.7	6.4	31.6	13.4	11.3	9.1	17.6	16.5	11.0	21.2	17.2	21.0	18.8	11.9	16.2	20.2	19.2	8.5	18.6	9.1	15.5	25.3	13.0	12.9	20.6	27.9	16.2	13.3	14.1	12.6	15.2	15.0	12.7
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109163932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	11.9	9.3	10.6	7.3	13.5	8.9	11.4	13.9	16.1	11.3	8.8	8.1	8.6	8.4	9.6	10.9	8.0	7.1	9.3	10.4	8.9	6.9	8.1	11.8	8.4	8.1	10.2	10.5	9.3	7.5	18.5	13.5	9.7	13.5	7.1	11.1	7.0	7.4	7.3	7.8	6.8	7.6	10.7	12.8	7.2	7.8	24.6	11.8	6.3	8.7	6.1	6.9	7.6	9.1	7.4	6.9	14.6	10.3	13.4	8.2	5.2	8.3	3.6	11.0	11.2	10.6	17.5	8.9	19.4	10.6	17.2	19.7	5.5	7.3	7.4	8.9	9.9	4.4	7.7	7.1	27.2	9.5	7.5	16.0	8.8	5.8	9.7	13.1	7.1	10.0	5.5	14.7	14.6	15.0	28.9	25.9	15.7	5.6	14.5	11.4	3.6	7.1	12.0	8.4	7.5	8.2	3.5	8.6	7.0	9.4	7.1	6.3	9.0	20.9	7.2	11.4	6.8	12.0	20.2	7.6	8.6	11.8	10.8	20.2	9.1	14.6	6.3	7.4	6.1	7.1	6.2	4.0	6.0	8.2	6.7	7.4	5.8	8.2	3.6	13.4	10.3	6.9	8.0	5.2	10.6	13.5	13.9	16.1	8.9	6.9	10.2	10.5	13.5	11.8
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0"	"Group enriched"	"Detected in many"	8	"B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4"	"Low region specificity"	"Detected in all"							"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favourable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavourable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	5.5	8.3	11.0	5.7	15.8	3.5	9.0	14.7	15.6	20.8	12.2	7.1	22.8	35.7	14.0	14.8	10.2	20.3	8.9	11.3	10.9	15.9	17.0	18.8	11.5	4.2	12.6	10.2	14.4	17.4	16.6	27.8	2.7	14.4	14.3	12.1	12.6	6.1	28.7	10.6	4.6	11.5	14.0	19.1	3.9	8.6	41.5	15.3	24.2	26.2	6.7	4.5	13.3	9.1	2.9	0.2	0.5	0.1	3.6	6.4	2.0	21.5	4.5	10.6	13.0	6.6	7.5	10.0	4.2	8.1	5.9	8.8	6.3	11.7	5.1	10.2	8.0	9.5	9.7	8.5	13.5	8.9	6.3	14.6	10.5	8.2	10.5	0.7	5.4	40.2	5.0	4.5	11.2	8.6	10.6	17.1	9.7	8.1	15.3	0.8	6.3	10.2	16.9	13.8	13.1	11.4	9.6	13.0	8.4	22.5	5.4	25.4	27.0	7.0	5.0	4.4	8.4	9.0	5.2	15.9	8.7	17.3	9.8	1.4	14.9	0.4	0.1	0.2	4.2	0.1	5.0	2.9	3.4	3.7	0.1	2.0	5.9	6.4	0.5	3.6	0.0	0.2	2.0	2.0	11.0	15.8	14.7	15.6	10.9	15.9	12.6	10.2	14.4	15.3
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Supported	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"				Nucleoli	"Golgi apparatus, Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.4	6.7	10.8	11.4	3.0	2.8	21.1	6.8	3.2	9.5	10.1	8.6	12.6	12.8	9.3	2.8	11.9	12.0	5.7	9.5	9.4	10.4	18.1	13.1	9.0	3.1	16.5	20.0	1.4	5.6	7.9	5.8	4.2	24.3	17.9	6.9	4.8	15.8	20.0	10.4	11.1	16.1	12.5	11.9	4.7	2.0	18.3	8.4	9.6	8.0	8.0	7.3	11.8	4.9	7.7	12.9	9.0	10.5	14.1	20.6	16.0	4.8	29.1	14.6	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5
CEP89	"CCDC123, FLJ14640"	ENSG00000121289	"Centrosomal protein 89"	Q96ST8	19	32875925-32971991	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039382, HPA040056"			Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane"	"HPA039382: , HPA040056: AB_10671048"	"unprognostic (4.23e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (8.78e-5)"	"unprognostic (1.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.47e-2)"	10.1	9.5	8.5	8.3	12.1	6.8	11.6	16.4	14.4	12.9	10.5	12.5	9.7	6.4	17.0	11.3	10.1	14.8	8.3	8.8	8.1	6.4	9.8	5.6	9.4	8.9	7.9	8.4	17.1	9.0	11.3	20.2	8.8	9.1	15.0	7.4	10.2	10.3	10.2	10.5	10.7	7.4	11.4	6.6	7.7	8.1	8.4	8.4	10.1	11.8	5.0	7.6	10.2	11.4	7.7	5.1	12.7	6.1	2.8	6.9	2.1	13.1	18.1	12.6	10.8	6.8	8.0	7.3	10.7	7.1	18.9	14.5	6.5	8.2	5.4	5.8	10.8	7.6	12.3	8.6	13.1	14.2	7.5	4.2	12.6	6.2	5.4	5.8	4.2	9.6	12.0	17.8	11.7	14.1	6.4	8.1	8.7	10.0	6.6	4.5	5.4	5.8	7.3	6.8	4.7	8.6	7.4	17.8	13.1	10.9	7.6	6.1	5.7	4.8	9.0	13.7	12.2	11.7	10.8	4.0	6.2	4.9	11.8	5.5	10.2	12.7	4.4	2.1	4.0	6.1	6.9	4.7	4.2	3.4	2.4	7.7	4.1	4.7	5.3	2.8	3.0	5.1	4.4	2.1	8.5	12.1	16.4	14.4	8.1	6.4	7.9	8.4	9.1	8.4
CEP97	"FLJ23047, LRRIQ2"	ENSG00000182504	"Centrosomal protein 97"	Q8IW35	3	101723925-101770562	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002980	Uncertain		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA002980: AB_1848820"	"unprognostic (7.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.05e-1)"	3.8	4.3	7.5	5.2	11.8	6.6	4.1	15.2	11.8	4.5	3.9	12.1	3.6	2.5	5.7	4.1	3.8	8.7	3.5	3.5	7.9	4.9	3.5	2.9	3.7	6.5	15.3	7.0	5.4	3.1	10.2	9.9	4.1	12.8	3.9	3.7	3.0	4.1	3.6	4.8	4.1	3.9	6.6	8.1	4.3	3.5	20.0	14.8	10.8	5.3	1.7	6.8	4.7	4.1	2.7	1.3	5.1	1.1	0.9	2.5	0.8	9.3	5.6	9.5	6.9	5.3	4.2	2.9	10.1	7.1	7.8	9.7	2.4	4.4	8.1	4.6	5.6	6.3	7.1	5.5	13.2	8.9	3.4	4.7	6.1	1.7	2.6	5.8	7.2	2.5	4.4	6.7	5.7	4.3	3.7	14.6	9.5	2.8	9.5	3.0	3.3	7.3	7.0	13.2	5.5	2.5	3.6	18.2	7.4	5.4	3.5	4.8	6.0	5.0	4.3	10.6	7.9	3.1	7.3	9.2	8.4	14.6	4.3	5.3	10.4	5.1	0.4	1.9	2.2	0.1	1.8	2.7	1.9	1.3	0.5	1.7	1.3	1.1	3.1	0.9	1.1	1.3	2.5	0.8	7.5	11.8	15.2	11.8	7.9	4.9	15.3	7.0	12.8	14.8
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536676-181680665	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5"	"Cell line enhanced"	"Detected in some"		"HEL: 26.2;HL-60: 14.5;MOLT-4: 35.2;NB-4: 30.9;SCLC-21H: 23.7;THP-1: 14.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"cerebellum: 49.5;pons and medulla: 13.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 31.8"	"HPA035443, HPA035444, HPA043203"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035443: , HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.6	1.2	9.2	2.0	14.4	1.1	49.5	2.5	3.7	1.7	4.2	0.4	3.1	1.0	5.3	0.6	5.8	4.1	0.5	2.9	1.3	8.1	1.3	5.0	13.8	0.6	1.4	2.9	0.8	0.1	2.1	2.0	13.7	1.0	0.0	6.8	1.0	0.4	0.5	0.5	6.4	0.4	1.0	17.9	2.8	1.1	1.1	0.4	0.9	0.4	1.1	4.3	1.3	4.0	5.2	12.6	12.7	4.7	6.9	4.2	0.0	0.5	0.6	0.0	0.0	0.1	0.0	4.1	0.1	0.1	0.1	0.0	0.1	4.4	0.0	0.1	2.6	0.1	0.1	0.1	0.0	0.4	26.2	0.3	0.0	0.1	14.5	0.7	0.1	0.3	0.1	0.2	0.0	0.0	4.6	0.0	0.0	35.2	30.9	0.6	0.2	7.5	2.2	0.6	0.3	0.0	23.7	0.7	0.0	0.0	0.1	0.0	14.6	2.4	1.2	0.6	0.1	1.0	11.3	6.3	2.0	0.9	9.8	10.7	2.0	4.7	12.6	4.5	12.7	3.7	4.0	6.4	6.9	5.2	3.4	3.5	4.5	0.7	4.7	10.9	2.9	1.4	4.2	1.2	2.0	49.5	2.5	2.9	1.3	0.6	1.4	13.7	1.1
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"esophagus: 46.7;intestine: 146.9;liver: 78.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018897	Enhanced		Approved	"Golgi apparatus,Cytosol"			7500000	"Golgi apparatus, Cytosol"		"HPA018897: AB_1846558"	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favourable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	5.8	15.3	8.5	8.8	11.7	2.4	5.1	13.0	15.9	9.5	42.3	12.1	11.2	146.9	7.0	11.9	46.7	6.1	14.5	15.2	7.4	6.6	22.5	78.6	6.7	4.6	8.2	10.7	8.4	12.0	10.0	6.8	7.3	10.3	9.7	42.6	13.0	12.7	7.9	11.6	8.9	117.3	10.4	5.6	7.8	10.9	8.5	8.2	9.0	11.7	14.1	12.1	7.6	11.6	6.9	8.9	5.0	10.6	7.9	10.7	5.2	6.8	9.0	9.5	12.7	9.4	8.8	7.2	7.8	12.6	9.2	11.7	9.7	11.4	8.0	7.8	10.2	17.8	6.9	19.7	7.2	7.1	9.6	7.9	5.1	18.2	13.3	10.3	13.8	12.7	37.3	13.0	21.9	6.8	11.0	5.9	15.5	4.3	9.1	8.6	5.1	9.1	10.8	9.6	9.4	26.1	12.0	6.2	8.1	25.5	6.4	6.6	11.1	12.8	8.4	12.1	6.5	7.5	5.9	11.9	14.2	9.5	18.7	8.1	9.1	4.7	10.4	4.7	10.1	7.8	9.2	6.1	7.7	10.7	8.9	6.9	9.5	8.6	5.0	7.9	10.6	7.7	6.8	5.2	8.5	11.7	13.0	15.9	7.4	6.6	8.2	10.7	10.3	8.2
CES4A	"CES8, FLJ37464"	ENSG00000172824	"Carboxylesterase 4A"	Q5XG92	16	66988589-67009758	"Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 32.3"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA035701	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA035701: AB_10696357"	"unprognostic (6.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (2.35e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-3)"	3.2	3.6	12.9	2.4	11.8	2.2	3.6	8.7	13.8	2.6	1.7	8.5	3.5	2.3	1.6	13.0	2.2	32.3	2.0	3.2	9.1	2.6	3.9	11.7	3.1	1.4	5.8	13.7	2.1	3.0	3.3	10.0	2.2	7.2	2.1	1.7	2.1	4.2	3.5	5.8	13.9	2.3	1.4	2.4	1.5	2.3	2.0	9.9	0.0	5.0	1.0	2.0	2.4	1.6	0.9	1.6	0.0	5.0	0.0	1.6	1.3	0.3	1.2	0.1	0.0	0.9	0.9	0.0	0.1	0.4	0.1	0.0	0.0	1.5	0.0	0.1	1.5	0.7	0.0	0.2	0.0	19.4	0.0	0.0	0.9	0.0	0.1	0.0	4.6	1.6	3.3	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.2	0.0	1.2	0.0	0.2	0.9	0.9	4.2	2.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.5	1.3	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.7	3.3	0.9	0.9	1.6	1.1	1.6	0.0	1.2	0.2	0.0	0.0	5.0	1.5	0.4	1.3	12.9	11.8	8.7	13.8	9.1	2.6	5.8	13.7	7.2	9.9
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706989-127716002	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5"	"Cell line enhanced"	"Detected in many"		"A549: 9.1;HeLa: 7.4;MCF7: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 19.8;pons and medulla: 30.2"	"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favourable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7.0	1.6	0.2	1.0	24.0	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0.0	0.0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0.0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0.0	0.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	9.1	0.9	1.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.9	1.3	1.4	1.4	0.0	4.5	0.0	0.0	0.0	3.4	1.0	0.9	7.4	2.2	0.0	0.7	2.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	6.5	1.3	0.5	0.8	4.9	2.0	0.9	1.5	0.0	0.4	6.3	1.1	1.9	3.6	0.7	3.2	0.3	1.7	1.9	1.5	4.9	0.8	1.0	2.5	1.1	0.7	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	19.8	0.1	0.3	4.6	5.8	0.0	0.0	30.2	3.5
CFAP36	"BARTL1, CCDC104, MGC15407"	ENSG00000163001	"Cilia and flagella associated protein 36"	Q96G28	2	55519604-55545879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008994, HPA017061"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA008994: AB_2275429, HPA017061: AB_1846129"	"unprognostic (8.11e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.66e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.96e-1)"	13.0	22.7	34.6	9.9	46.6	7.3	25.3	16.7	39.4	23.3	16.7	10.2	18.1	7.8	24.4	39.1	12.3	32.7	21.1	15.4	28.6	34.9	32.4	9.1	15.1	11.0	27.7	29.5	29.3	15.8	32.8	47.1	10.6	36.7	22.1	12.1	13.5	10.6	24.6	6.5	8.1	8.4	19.7	19.3	8.8	16.6	66.4	14.4	8.9	39.9	7.7	9.8	21.7	13.3	8.0	6.2	6.3	2.9	5.5	25.2	8.3	18.9	15.0	16.3	21.3	21.5	41.7	9.9	11.9	24.5	18.4	15.4	11.3	7.0	6.8	28.0	15.6	12.6	12.6	16.6	23.8	16.5	24.9	10.0	14.7	11.7	23.7	18.4	12.4	20.5	27.1	24.9	29.5	20.4	12.5	5.6	23.2	14.2	11.1	20.5	8.3	15.0	8.7	19.3	7.1	37.4	10.7	24.5	12.3	16.2	8.3	22.0	13.6	6.4	10.5	18.8	11.5	19.4	16.1	10.1	4.6	2.3	31.9	8.4	8.6	6.3	2.1	6.2	9.1	2.3	17.5	8.0	25.2	14.5	2.7	5.2	21.0	12.8	2.4	5.5	2.9	6.2	13.7	8.3	34.6	46.6	16.7	39.4	28.6	34.9	27.7	29.5	36.7	14.4
CFAP54	"C12orf55, C12orf63, FLJ31514, FLJ44112"	ENSG00000188596	"Cilia and flagella associated protein 54"	Q96N23	12	96489571-96875555	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;testis: 15.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 10.5;TIME: 12.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"basal ganglia: 16.5;pons and medulla: 30.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039897	Enhanced		Approved	Microtubules,Cytosol				Microtubules	Cytosol	"HPA039897: AB_10674427"	"unprognostic (1.87e-4)"	"unprognostic (3.63e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.55e-5)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.26e-2)"	"unprognostic (8.00e-2)"	1.0	0.9	3.4	1.9	16.5	4.5	1.4	1.0	3.4	2.0	1.4	9.5	1.8	2.3	3.3	8.6	1.2	8.9	1.5	0.9	5.3	3.6	1.4	1.5	8.1	1.9	1.3	3.1	3.8	0.7	1.3	11.7	0.9	30.7	1.7	1.5	0.3	1.8	1.9	1.8	2.9	1.5	1.9	1.7	1.9	1.6	15.1	5.2	0.0	2.4	0.5	1.6	1.0	1.1	2.7	1.6	3.7	1.4	1.5	1.7	0.1	1.6	0.8	1.3	1.8	0.8	1.1	1.1	1.4	0.3	0.4	0.6	0.8	2.4	1.4	2.1	0.5	1.3	0.7	0.4	0.5	2.2	1.0	1.4	3.0	0.8	0.2	2.6	1.7	0.4	0.5	1.9	0.7	10.5	0.7	4.9	1.3	0.7	1.2	2.4	2.4	1.4	1.5	1.5	1.7	3.0	1.8	2.3	1.7	1.3	0.7	1.5	2.3	0.7	12.7	2.4	2.9	2.2	2.4	5.4	2.3	1.1	1.7	1.2	1.7	3.7	1.4	1.4	1.7	0.9	1.4	1.4	1.3	1.3	0.4	2.7	1.6	1.5	3.7	1.5	1.1	1.6	1.0	0.1	3.4	16.5	1.0	3.4	5.3	3.6	1.3	3.1	30.7	5.2
CFAP57	"FLJ32000, WDR65"	ENSG00000243710	"Cilia and flagella associated protein 57"	Q96MR6	1	43172149-43254358	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.6;testis: 29.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 6.8;HDLM-2: 4.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002736, HPA028623"	Enhanced		Approved	Cytosol				Cytosol		"HPA002736: AB_2272982, HPA028623: AB_10603234"	"unprognostic (1.15e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.16e-1)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.50e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.78e-2)"	0.4	0.4	1.6	0.3	6.7	0.2	0.6	0.1	1.8	1.6	0.3	4.2	0.0	0.3	1.0	9.1	0.4	25.6	0.5	0.4	3.6	2.7	1.5	2.7	4.7	0.2	0.3	1.4	7.1	0.9	0.4	5.9	0.5	12.7	0.7	0.3	0.3	0.5	0.5	0.4	0.9	0.3	0.3	0.4	0.2	0.4	29.2	0.4	0.0	1.9	0.0	0.3	0.5	0.2	3.2	2.4	0.7	4.8	1.2	1.5	1.4	2.9	1.0	0.7	0.6	0.2	0.1	0.9	1.1	1.8	1.4	1.4	0.8	1.2	0.3	1.3	2.4	6.8	0.4	0.9	2.6	4.4	0.2	0.3	0.6	0.6	0.5	0.0	0.3	0.2	1.1	1.1	0.4	2.0	0.2	0.1	0.2	0.1	0.3	0.3	1.4	0.1	0.4	1.0	0.2	2.9	0.5	1.1	0.5	1.3	0.2	1.1	1.6	0.5	3.8	0.2	1.4	0.7	0.8	0.4	0.6	0.3	0.3	0.8	0.8	0.5	1.1	0.7	1.4	2.0	1.4	2.2	1.4	1.2	2.4	3.2	1.3	1.3	0.0	1.2	4.8	1.9	1.5	1.4	1.6	6.7	0.1	1.8	3.6	2.7	0.3	1.4	12.7	0.4
CFAP58	"bA554P13.1, C10orf80, CCDC147, FLJ35908"	ENSG00000120051	"Cilia and flagella associated protein 58"	Q5T655	10	104353764-104455090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 10.9;testis: 17.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 5.1;U-2 OS: 10.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	55	"granulocytes: 5.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036555, HPA071938"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA036555: AB_10673622, HPA071938: "	"unprognostic (5.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.57e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.62e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.59e-1)"	0.3	0.5	0.8	0.6	2.0	0.4	0.3	0.7	1.0	3.0	0.3	2.9	0.3	0.1	2.3	0.3	0.3	10.9	0.3	3.0	1.4	1.5	0.3	0.3	2.1	0.3	0.3	0.3	2.0	0.3	1.5	1.9	0.4	6.8	0.4	0.0	0.6	0.3	0.4	1.4	0.2	0.3	0.8	0.3	0.3	0.1	17.5	0.7	0.3	0.8	0.3	0.4	0.3	0.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.2	0.6	0.2	1.7	5.1	1.0	2.8	0.0	0.0	3.9	0.4	0.6	0.3	0.0	0.3	3.1	0.4	0.2	0.9	1.2	0.0	0.6	0.5	0.7	0.6	2.2	0.8	2.7	1.6	1.0	1.2	1.3	0.0	0.0	1.1	0.3	0.0	0.4	0.3	0.5	0.6	0.0	0.6	0.4	0.0	0.2	0.9	0.3	0.6	3.3	1.1	10.7	0.6	3.0	0.3	0.1	0.2	1.2	1.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	2.0	0.7	1.0	1.4	1.5	0.3	0.3	6.8	0.7
CFAP77	"C9orf171, FLJ46082"	ENSG00000188523	"Cilia and flagella associated protein 77"	Q6ZQR2	9	132410043-132573317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 30.9;testis: 22.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.7;SH-SY5Y: 6.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021329, HPA024647, HPA061069"	Enhanced		Approved	Cytosol				Cytosol		"HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: "	"unprognostic (7.28e-4)"	"unprognostic (5.68e-2)"	"unprognostic (5.25e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.74e-1)"		"unprognostic (3.01e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	0.2	0.2	1.6	0.2	4.5	0.2	0.2	1.6	0.3	1.6	0.2	8.4	0.0	0.2	0.7	8.8	0.2	30.9	0.2	4.2	2.5	2.5	0.2	0.2	5.5	0.2	0.1	0.0	9.7	0.3	0.2	1.7	0.2	8.9	0.2	0.2	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	22.0	1.6	0.0	0.3	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.3	0.4	0.4	0.1	0.0	0.0	0.2	1.7	6.5	0.0	0.0	0.0	0.3	0.0	0.6	0.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.5	1.6	0.1	2.5	2.5	0.1	0.0	8.9	1.6
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34706769-34714823	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 88.5;skeletal muscle: 185.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			90000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: "	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (2.16e-5)"	14.0	16.5	15.9	8.8	17.7	5.0	6.7	13.6	16.6	13.7	23.2	25.8	9.2	4.7	21.3	10.2	20.7	11.2	7.2	88.5	19.0	14.5	8.7	33.0	7.8	3.7	22.7	10.6	12.9	3.0	9.3	4.5	10.3	28.9	22.4	8.6	7.8	5.4	31.8	185.9	2.6	6.7	38.1	24.6	4.2	11.9	6.9	20.1	0.5	9.0	30.8	3.4	34.7	9.3	8.5	2.9	3.6	1.8	3.2	5.8	1.6	17.6	15.9	10.2	6.6	10.4	39.0	5.8	30.8	35.5	29.5	31.5	11.9	7.6	6.3	12.6	49.1	3.5	21.8	6.5	52.0	0.8	9.0	1.3	18.8	28.2	17.0	1.6	1.0	29.5	2.3	25.1	13.9	29.2	1.9	5.0	36.2	5.0	1.2	0.8	3.3	24.4	1.1	32.5	0.9	10.7	3.6	2.1	8.8	20.1	4.3	10.4	9.6	1.5	25.6	29.4	19.6	13.8	14.7	7.0	4.5	2.4	10.8	2.3	6.9	3.6	1.8	2.1	3.7	1.8	5.8	8.5	4.3	4.0	2.9	5.0	3.4	3.5	0.7	3.2	0.8	2.8	3.6	1.6	15.9	17.7	13.6	16.6	19.0	14.5	22.7	10.6	28.9	20.1
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116104-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 79.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favourable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	35.4	17.6	13.7	29.8	17.4	66.8	31.6	26.9	12.6	20.5	25.7	13.5	31.3	17.5	24.7	27.6	21.0	19.2	22.1	58.1	14.7	7.7	24.9	18.9	58.5	34.3	16.8	8.9	14.6	14.3	9.1	18.7	28.3	12.6	23.2	17.7	20.9	21.8	27.4	113.7	16.7	26.8	30.5	13.8	35.7	19.4	10.9	14.8	17.2	31.2	26.2	31.4	24.1	33.7	5.3	6.6	79.2	12.6	8.7	11.8	7.8	5.1	10.6	7.6	4.5	23.6	18.1	9.4	13.1	22.9	8.7	10.6	12.2	19.4	1.4	12.5	15.2	3.8	2.4	9.9	13.9	38.8	7.4	7.8	9.1	19.8	16.5	5.8	25.9	19.7	9.8	14.6	12.9	44.0	26.3	32.7	15.7	4.3	2.7	23.2	2.6	8.0	2.8	1.8	11.1	10.8	10.7	1.7	3.0	8.8	7.8	10.3	5.5	10.9	47.7	18.2	7.6	6.7	6.4	54.5	17.9	8.7	12.9	4.7	9.0	16.3	12.1	13.5	11.7	12.3	10.3	5.3	10.1	11.0	6.6	4.0	6.4	8.3	79.2	8.7	12.6	4.6	11.8	7.8	13.7	17.4	26.9	12.6	14.7	7.7	16.8	8.9	12.6	14.8
CGAS	"C6orf150, cGAS, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452276	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 32.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 21.2;RPMI-8226: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite"	Cytosol	"HPA031700: AB_10601693, HPA031702: "	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	6.5	2.0	2.9	10.5	4.5	18.5	8.1	1.2	3.9	4.7	3.7	3.4	2.1	4.1	5.5	2.8	5.3	3.9	4.3	3.2	2.8	2.9	2.5	1.9	9.6	11.8	7.2	0.6	3.4	3.8	2.3	1.8	4.8	4.4	6.6	3.1	2.2	4.2	2.9	1.9	1.8	5.2	3.6	4.7	12.8	3.5	1.7	4.3	6.2	3.9	4.2	15.5	6.6	32.0	6.3	12.5	13.3	12.9	3.0	6.0	3.9	8.8	3.0	0.0	0.1	0.6	1.3	0.0	4.4	1.9	5.8	6.4	9.8	6.7	0.1	9.7	2.1	4.6	4.9	0.0	6.2	14.7	0.0	7.7	3.8	0.0	2.1	5.9	5.4	0.8	1.6	5.7	0.0	1.7	0.0	18.4	4.2	3.6	0.0	13.4	2.9	5.4	11.5	21.2	22.3	0.0	3.7	0.1	0.0	7.8	0.2	4.6	0.0	16.0	2.0	0.0	4.3	3.9	0.1	4.0	8.7	0.1	0.0	8.5	5.8	13.3	9.2	13.2	4.6	12.9	3.6	6.3	6.0	4.6	5.4	4.8	1.4	2.6	5.8	3.0	7.8	12.5	5.8	3.9	2.9	4.5	1.2	3.9	2.8	2.9	7.2	0.6	4.4	4.3
CGB1		ENSG00000267631	"Chorionic gonadotropin beta subunit 1"	A6NKQ9	19	49035610-49036895	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 8.4"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 20.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Uncertain		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA038925: , HPA038934: "																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	8.4	0.0	1.4	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.9	0.1	0.1	0.0	0.0	0.5	0.3	4.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CGB2		ENSG00000104818	"Chorionic gonadotropin beta subunit 2"		19	49031912-49033238	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 2.1;testis: 4.1"	"Group enriched"	"Detected in some"	5	"HMC-1: 24.8;U-266/70: 9.9;U-266/84: 12.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"			Cytosol		"HPA038925: , HPA038934: "										"unprognostic (3.05e-2)"								0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0			0.0	0.0	0.7	0.3	0.0	0.0	1.1	1.0	0.9	0.2	0.0	0.0	0.4	0.1		0.0	0.0	0.0	1.1	1.4		0.4	0.0		0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.3	4.1			0.1		0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.3	0.0	0.4	0.0	0.0	0.1	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	2.9	9.9	12.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin beta subunit 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 6.7;placenta: 15.0"	"Cell line enriched"	"Detected in some"	20	"BEWO: 38.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9;testis cancer: 4.2"					"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol		"CAB000042: , CAB010884: AB_259037, HPA038925: , HPA038934: "									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	3.2	0.0	6.7	15.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	1.9	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0										
CGB5	HCG	ENSG00000189052	"Chorionic gonadotropin beta subunit 5"	P0DN86	19	49043884-49045311	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"placenta: 105.2"	"Group enriched"	"Detected in some"	24	"BEWO: 45.8;U-251 MG: 20.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA038925: , HPA038934: "		"unprognostic (1.38e-1)"				"unprognostic (1.68e-1)"					"unprognostic (1.51e-3)"			"prognostic unfavourable (1.18e-5)"	"unprognostic (1.07e-1)"		"prognostic unfavourable (9.47e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	12.7	105.2	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	20.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin beta subunit 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.9;HaCaT: 5.6;HBEC3-KT: 4.7;hTCEpi: 6.8;U-251 MG: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"			Cytosol		"HPA038925: , HPA038934: "	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.3	0.2	0.3	0.3	0.3	0.0	0.8	0.3	1.5	1.7	0.3	0.3	3.7	0.3	1.2	0.5	4.0	1.0	2.0	2.0	0.4	0.2	1.0	0.3	0.8	0.3	0.3	0.3	0.9	2.5	0.0	2.7	3.7	1.3	4.6	0.0	0.8	1.3	3.9	6.4	8.1	0.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.9	2.2	0.3	2.4	2.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.8	0.2	1.5	0.0	0.2	6.9	0.6	0.0	1.4	1.2	1.2	2.6	0.0	0.1	1.3	5.6	0.1	4.7	0.5	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.4	6.8	0.4	0.7	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.1	0.1	1.4	0.1	0.1	1.0	0.1	0.2	2.2	2.3	0.0	10.2	0.3	0.4	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.3	1.5	0.4	0.2	0.3	0.3	1.3	0.3
CGB8		ENSG00000213030	"Chorionic gonadotropin beta subunit 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	85	"pituitary gland: 7.0;placenta: 22.2"	"Group enriched"	"Detected in some"	7	"BEWO: 60.5;U-251 MG: 21.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA038925: , HPA038934: "		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	7.0	22.2		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.3	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	1.2	2.5	0.2	21.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CHAC2	GCG1	ENSG00000143942	"ChaC cation transport regulator homolog 2"	Q8WUX2	2	53767792-53775196	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049235	Approved		Approved	Cytosol				Cytosol		"HPA049235: "	"unprognostic (2.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavourable (3.80e-7)"	"unprognostic (5.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-6)"	"unprognostic (1.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	7.2	8.6	6.5	7.1	6.2	9.3	3.6	4.3	4.4	2.6	6.8	2.1	7.7	11.4	2.4	4.4	8.4	1.8	5.3	10.3	6.2	6.1	8.3	9.8	3.4	9.6	5.0	4.2	1.8	4.8	1.5	6.7	1.7	6.9	2.8	6.1	2.8	4.1	4.6	9.8	2.0	9.0	3.5	4.8	10.2	7.0	16.4	3.7	9.5	3.7	4.2	9.8	5.7	5.1	6.6	2.5	1.8	0.9	1.4	6.7	3.0	18.8	6.3	6.7	5.9	3.4	1.7	1.4	8.7	1.7	6.2	7.4	4.4	4.9	16.0	12.7	3.7	6.8	15.2	10.3	10.9	33.8	13.3	12.7	8.5	7.1	5.2	15.0	5.8	2.1	3.1	11.5	8.8	12.1	13.0	9.5	8.1	6.1	17.7	12.6	8.7	11.3	13.6	14.3	16.3	8.6	5.1	8.4	2.3	10.1	7.5	4.0	4.6	5.9	5.3	3.6	13.1	14.0	14.0	9.4	12.1	13.7	5.0	18.9	5.0	1.8	0.5	1.1	5.2	0.9	5.5	6.6	5.7	5.8	1.1	5.4	6.7	6.1	1.4	1.4	0.7	2.5	5.1	3.0	6.5	6.2	4.3	4.4	6.2	6.1	5.0	4.2	6.9	3.7
CHAF1A	"CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150"	ENSG00000167670	"Chromatin assembly factor 1 subunit A"	Q13111	19	4402662-4445018	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.2;granulocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015186	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB015186: AB_628065"	"unprognostic (1.91e-1)"	"prognostic favourable (8.22e-5)"	"unprognostic (2.49e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.89e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.54e-2)"	"prognostic favourable (4.15e-6)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.03e-2)"	5.3	5.3	6.3	14.6	7.3	28.2	5.3	12.6	8.8	4.7	7.2	4.9	8.6	6.9	4.7	5.1	11.5	4.7	5.2	4.0	6.1	3.9	3.0	4.5	4.6	13.3	5.5	5.6	4.6	4.4	3.3	4.3	7.5	5.4	6.5	7.2	4.1	7.8	8.1	12.2	11.3	7.0	6.8	4.8	8.2	5.6	20.4	4.9	27.8	3.3	9.8	11.5	6.7	5.9	1.7	15.2	4.3	2.4	1.0	0.8	0.9	21.2	14.5	24.2	15.2	2.4	3.0	12.5	20.2	8.3	17.1	19.4	17.6	7.6	32.7	8.4	6.4	16.7	20.6	13.8	20.3	18.8	22.7	20.3	21.7	13.8	1.2	23.5	16.6	1.6	2.9	14.0	6.0	8.0	24.5	29.7	10.4	12.2	38.0	13.2	27.0	12.1	28.3	19.1	18.7	4.4	25.3	17.2	13.3	13.8	9.8	8.0	8.6	17.6	5.8	14.1	12.4	24.0	24.4	14.9	22.0	31.4	11.9	30.4	16.7	2.9	2.3	4.3	0.5	2.4	0.4	1.7	0.6	0.1	2.0	0.8	0.6	0.4	1.2	1.0	0.4	15.2	0.8	0.9	6.3	7.3	12.6	8.8	6.1	3.9	5.5	5.6	5.4	4.9
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Group enriched"	"Detected in some"	4	"SCLC-21H: 16.6;U-2 OS: 7.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	16.6	0.2	0.1	0.0	0.0	2.8	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 42.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042053: , HPA049420: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	18.0	12.6	14.5	12.5	17.3	30.3	15.7	49.3	19.6	18.5	13.8	6.6	17.4	8.0	14.2	15.0	14.4	13.5	11.6	12.2	15.9	8.2	16.8	12.3	12.3	9.2	16.0	12.3	18.8	12.9	28.1	39.9	12.3	15.1	13.7	11.5	8.9	17.8	15.3	17.1	14.4	11.1	11.6	20.1	11.6	13.4	7.0	18.7	15.6	17.7	11.2	9.4	13.9	15.1	16.4	42.9	23.7	12.7	12.1	8.8	1.7	5.7	6.7	15.0	12.2	11.2	16.4	2.6	10.6	7.8	5.6	2.5	3.7	5.2	7.7	6.9	8.7	7.0	7.8	5.5	7.9	2.7	5.8	10.9	6.4	2.3	7.8	15.1	9.1	11.3	5.6	8.2	10.4	8.3	12.7	2.6	7.0	2.2	7.5	3.4	5.4	5.1	26.5	18.0	3.3	3.4	5.4	6.4	7.1	9.4	3.1	7.8	3.4	7.0	16.0	10.6	5.4	3.9	7.1	8.0	5.5	13.5	7.5	6.5	10.4	23.7	9.2	8.9	5.7	7.6	8.8	12.5	3.9	6.2	5.4	16.4	3.1	4.4	3.0	12.1	12.7	42.9	1.9	1.7	14.5	17.3	49.3	19.6	15.9	8.2	16.0	12.3	15.1	18.7
CHIC1	BRX	ENSG00000204116	"Cysteine rich hydrophobic domain 1"	Q5VXU3	X	73563200-73687102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA052062"	Uncertain		Approved	"Nuclear speckles,Vesicles,Cytosol"				"Nuclear speckles, Vesicles"	Cytosol	"HPA026782: AB_1846654, HPA052062: "	"unprognostic (9.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.10e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.65e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (1.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.76e-2)"	5.6	13.9	11.0	7.1	16.3	1.5	7.5	14.7	17.6	14.6	8.2	8.5	7.7	4.7	11.1	7.9	5.1	8.7	9.2	10.3	11.7	13.2	12.4	3.4	5.6	7.2	11.2	13.8	11.8	4.1	13.3	18.2	4.4	16.8	9.9	8.6	6.8	5.1	13.0	4.6	6.0	5.9	10.7	15.4	7.7	4.9	3.3	12.5	3.7	12.8	2.6	6.8	7.4	10.1	1.1	0.2	1.0	0.3	1.2	3.0	0.6	4.0	4.1	2.1	2.7	6.0	8.2	0.0	4.5	6.1	3.7	4.5	2.7	5.1	1.9	6.3	4.0	1.2	3.0	2.2	8.3	4.6	3.7	2.7	3.4	0.0	3.9	0.0	5.5	5.6	2.7	7.0	3.8	5.3	0.7	18.3	7.2	0.6	1.6	0.0	6.6	4.1	1.6	5.3	1.2	4.7	2.0	1.2	1.7	5.1	2.4	5.4	2.0	1.1	6.1	4.3	4.2	8.5	2.7	5.2	12.9	0.0	6.3	3.0	3.3	1.0	0.1	0.0	1.9	0.1	3.0	1.1	1.5	1.9	0.0	1.1	1.5	2.0	0.0	1.2	0.3	0.2	1.2	0.6	11.0	16.3	14.7	17.6	11.7	13.2	11.2	13.8	16.8	12.5
CHKB	"CHETK, CHKL"	ENSG00000100288	"Choline kinase beta"	Q9Y259	22	50578949-50601455	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018797	Approved		Approved	Cytosol				Cytosol		"HPA018797: AB_1846666"	"unprognostic (6.03e-4)"	"prognostic favourable (4.66e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-3)"	14.1	13.6	12.7	18.9	14.4	14.8	13.0	21.3	13.4	12.9	15.1	13.8	10.4	9.8	10.1	12.5	10.7	16.2	13.6	10.6	10.7	6.8	14.3	9.3	12.6	8.7	14.7	6.1	9.1	8.4	21.9	19.2	12.3	12.7	11.7	6.9	12.8	13.4	12.5	7.8	10.5	16.9	8.0	9.5	18.5	14.8	19.9	15.8	8.5	14.5	6.6	16.5	12.1	10.9	13.6	21.2	15.0	23.9	20.6	18.6	19.5	3.6	1.0	3.0	1.1	3.1	2.1	10.1	4.3	8.6	1.8	2.4	0.0	1.4	1.8	3.3	0.0	1.7	1.5	0.9	0.3	1.5	4.3	2.4	2.2	0.8	14.4	2.9	6.1	0.9	5.3	0.7	3.6	9.0	1.2	4.7	4.8	3.3	2.6	8.2	0.5	0.6	3.3	0.4	10.1	3.9	2.5	1.4	4.2	3.4	3.4	3.0	1.2	1.8	2.7	1.7	3.6	1.6	1.2	7.7	0.7	2.3	2.9	2.2	1.7	5.7	23.9	15.0	16.3	21.9	15.5	12.9	15.2	17.3	21.2	13.6	14.4	13.3	5.7	20.6	14.2	19.5	18.6	19.5	12.7	14.4	21.3	13.4	10.7	6.8	14.7	6.1	12.7	15.8
CHM	"DXS540, REP-1, TCD"	ENSG00000188419	"CHM, Rab escort protein 1"	P24386	X	85861180-86047562	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003231, CAB016171"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016171: AB_2229397, HPA003231: AB_1078518"	"unprognostic (6.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.40e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.60e-3)"	12.6	18.8	13.9	9.7	23.2	3.2	11.2	17.8	22.9	14.3	9.3	9.0	8.3	6.6	14.5	7.1	9.7	15.9	10.4	9.9	12.6	11.0	17.7	10.9	9.9	9.2	9.3	12.1	11.8	8.3	20.2	31.9	13.2	17.9	11.3	9.3	7.5	10.4	10.8	16.3	8.1	8.0	12.5	12.1	10.8	10.2	6.6	11.9	14.6	15.6	8.4	8.7	12.1	10.4	7.4	4.6	6.2	7.1	4.9	6.0	3.9	9.3	6.2	6.3	4.3	10.4	11.1	4.0	11.1	9.3	7.7	8.5	5.0	8.7	3.2	14.3	7.9	5.4	13.8	6.2	13.3	6.4	6.6	1.9	9.0	5.1	8.3	7.9	14.0	8.4	5.9	12.5	15.9	13.2	6.6	11.1	12.0	2.7	4.8	2.9	9.5	10.2	5.1	11.4	4.8	7.3	5.5	5.6	8.7	13.3	4.7	10.4	3.4	3.8	9.4	9.9	7.0	34.4	5.5	4.1	15.2	4.5	10.6	6.7	8.6	6.2	5.8	4.0	5.5	7.1	5.0	6.6	4.4	5.6	4.6	7.4	5.8	6.0	3.2	4.9	5.6	4.6	5.5	3.9	13.9	23.2	17.8	22.9	12.6	11.0	9.3	12.1	17.9	11.9
CHML	REP-2	ENSG00000203668	"CHM like, Rab escort protein 2"	P26374	1	241628853-241640254	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA029627, HPA029628, HPA062967"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: "	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.57e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (9.23e-5)"	"unprognostic (1.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.09e-1)"	6.5	3.8	6.0	5.7	10.5	10.8	7.7	3.6	18.0	6.0	6.4	3.1	1.4	3.8	7.6	5.0	6.1	7.2	5.6	5.1	5.3	5.1	6.5	21.1	12.5	10.0	4.9	13.1	13.3	5.6	8.5	8.2	30.7	4.2	3.7	6.1	2.0	5.8	3.0	7.1	6.5	6.5	5.6	3.7	9.3	5.6	9.9	2.2	14.8	11.0	2.2	5.1	5.2	6.6	1.6	2.9	3.0	1.3	0.5	1.4	0.2	17.4	5.4	8.5	6.7	2.6	7.7	16.6	6.9	3.5	6.0	4.2	9.9	3.2	4.8	10.6	4.6	3.6	11.9	7.5	11.3	9.2	10.9	6.3	22.1	6.9	5.2	15.0	8.2	6.4	3.4	8.0	8.3	4.7	17.0	6.0	7.1	6.8	9.9	10.1	11.3	17.6	15.1	10.5	16.1	6.1	10.9	10.9	18.0	8.7	6.7	7.5	7.8	9.8	9.5	12.4	24.0	6.2	13.1	6.9	16.9	5.2	12.0	9.1	19.1	3.0	0.9	0.6	0.5	1.3	0.8	1.3	0.3	0.4	0.8	1.6	1.4	1.1	0.1	0.5	0.8	2.9	0.1	0.2	6.0	10.5	3.6	18.0	5.3	5.1	4.9	13.1	4.2	2.2
CHMP2A	"BC-2, CHMP2, VPS2, VPS2A"	ENSG00000130724	"Charged multivesicular body protein 2A"	O43633	19	58551566-58555124	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041153, HPA042031"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			49000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041153: AB_10964358, HPA042031: AB_10961727"	"unprognostic (1.80e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.71e-2)"	40.7	59.6	52.5	37.3	56.7	55.1	41.2	36.3	44.8	39.0	53.2	37.8	50.4	43.5	36.9	61.7	57.4	41.9	60.4	80.6	45.0	40.1	64.8	66.5	36.4	55.8	48.2	38.7	36.9	59.8	46.9	39.1	79.2	38.5	35.2	49.2	33.0	62.4	64.8	75.7	54.9	72.0	42.4	48.5	43.4	45.2	29.4	35.1	34.0	49.8	53.9	44.4	42.5	34.0	17.5	30.5	117.2	34.7	17.0	29.4	24.9	17.7	48.1	15.5	14.2	24.0	30.1	19.1	16.5	34.2	8.8	9.6	14.1	26.6	4.7	24.4	27.6	14.6	12.8	31.5	7.5	15.9	104.7	11.6	35.2	21.7	46.5	19.3	18.3	34.9	44.7	13.8	44.2	25.5	13.8	22.8	26.5	30.1	24.4	17.9	6.5	36.9	10.6	13.4	35.7	38.4	40.5	18.3	31.0	26.9	35.9	19.7	27.6	19.8	28.7	45.1	6.5	13.1	19.1	58.2	63.6	15.5	31.7	22.9	29.5	33.5	34.7	46.6	20.2	31.7	17.0	17.5	22.3	22.7	30.5	15.8	15.7	17.7	117.2	17.0	31.6	27.8	29.4	24.9	52.5	56.7	36.3	44.8	45.0	40.1	48.2	38.7	38.5	35.1
CHMP2B	"CHMP2.5, DKFZP564O123, VPS2B"	ENSG00000083937	"Charged multivesicular body protein 2B"	Q9UQN3	3	87227271-87255548	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035069, HPA052754"	Uncertain		Supported	Cytosol				Cytosol		"HPA035069: AB_10602798, HPA052754: "	"unprognostic (7.83e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavourable (2.11e-5)"	"unprognostic (5.76e-2)"	"prognostic favourable (1.74e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.21e-1)"	21.8	21.5	20.1	17.6	23.5	36.5	22.1	12.5	35.9	23.6	32.4	21.4	19.2	30.1	28.2	20.5	30.9	20.1	23.4	26.2	20.8	22.0	30.9	36.1	21.5	17.7	29.5	21.0	22.9	23.5	14.7	41.7	45.1	30.7	29.2	30.5	14.7	22.7	25.4	30.1	22.9	45.8	24.8	52.6	22.3	24.3	13.3	25.6	14.5	35.5	26.3	16.4	30.7	25.3	21.2	22.4	53.4	24.8	11.4	20.0	14.3	16.4	18.0	6.1	3.9	11.1	9.0	7.8	13.0	16.5	10.8	13.9	14.0	27.0	5.9	9.2	14.0	8.4	7.9	9.0	13.1	10.4	8.3	7.2	6.5	5.7	9.8	9.7	10.1	6.9	15.2	10.6	14.4	8.2	4.4	8.9	11.5	11.8	9.4	4.0	7.9	16.1	5.0	7.6	5.6	8.1	16.9	2.3	2.4	12.7	10.4	19.8	9.3	3.0	7.4	10.0	9.2	106.3	8.8	9.0	13.3	10.1	10.9	5.5	7.2	42.8	20.8	53.4	11.9	24.8	16.0	20.0	14.9	14.6	22.4	21.2	14.1	13.7	40.3	11.4	24.7	12.8	20.0	14.3	20.1	23.5	12.5	35.9	20.8	22.0	29.5	21.0	30.7	25.6
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282069	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol				"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	29.7	37.5	48.0	24.3	48.6	18.8	36.2	39.9	49.4	28.3	39.0	28.1	28.4	38.1	28.2	36.3	39.2	31.4	30.6	35.1	45.1	45.2	55.6	39.2	35.6	26.1	44.1	47.5	26.5	19.9	36.4	34.8	55.7	47.4	40.8	40.9	19.8	26.0	30.2	27.1	25.6	51.9	27.5	49.2	33.0	37.3	21.2	37.0	24.9	42.0	26.1	26.0	33.7	33.5	12.4	27.8	51.2	24.6	18.1	16.6	18.1	30.8	23.0	23.4	15.1	35.9	32.7	21.9	30.9	35.0	49.3	54.8	17.5	19.6	16.7	34.2	29.0	13.4	24.5	25.2	40.1	34.5	17.3	14.0	46.5	19.0	31.2	17.7	27.6	34.7	46.7	33.1	30.9	25.6	15.0	22.1	38.8	14.1	18.4	54.9	21.5	28.4	11.3	20.8	11.0	40.5	16.9	11.5	29.6	31.4	18.5	28.3	18.9	28.0	25.5	24.7	25.8	21.1	27.3	14.7	29.1	19.2	35.6	12.3	15.8	31.5	20.1	40.2	10.7	21.6	11.5	12.4	14.3	14.0	18.3	10.6	13.2	12.5	51.2	18.1	24.6	27.8	16.6	18.1	48.0	48.6	39.9	49.4	45.1	45.2	44.1	47.5	47.4	37.0
CHMP7	MGC29816	ENSG00000147457	"Charged multivesicular body protein 7"	Q8WUX9	8	23243637-23262000	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.1"	"Cell line enhanced"	"Detected in all"		"Daudi: 24.5;U-698: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 31.7"	"Group enriched"	"Detected in all"	12	"B-cells: 15.2;T-cells: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036119	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036119: AB_10673000"	"unprognostic (2.94e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.59e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.83e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.06e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.30e-1)"	6.4	12.7	7.3	29.2	7.4	15.4	11.0	10.5	9.2	7.5	9.2	5.6	6.4	8.1	10.0	4.5	7.5	7.3	7.6	9.8	6.3	8.0	6.9	7.4	7.2	48.8	7.8	5.8	8.1	12.4	4.4	7.0	5.3	7.3	7.4	7.3	4.1	12.5	7.9	13.8	7.5	13.7	9.8	6.5	26.2	10.5	7.0	6.8	76.1	7.7	5.9	43.3	9.3	13.7	15.2	1.3	1.8	1.9	1.8	31.7	11.8	3.8	5.3	2.8	4.8	2.6	2.7	3.3	3.2	2.3	4.7	3.9	6.0	3.0	24.5	3.8	2.3	3.7	2.7	3.9	1.8	6.6	4.9	5.1	6.8	3.1	2.4	1.3	7.4	2.2	2.7	4.5	1.3	3.8	5.7	3.3	2.6	3.8	4.3	5.7	4.7	4.1	1.8	2.3	3.4	2.4	5.0	3.7	3.5	2.4	3.6	1.4	4.0	2.7	4.2	5.7	3.8	4.1	2.5	9.7	5.1	29.4	4.4	4.1	4.3	0.4	1.9	1.8	2.5	1.7	5.2	14.6	16.6	7.7	1.3	15.2	31.7	17.9	1.7	1.8	1.2	1.1	17.3	11.8	7.3	7.4	10.5	9.2	6.3	8.0	7.8	5.8	7.3	6.8
CHN1	"ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2"	ENSG00000128656	"Chimerin 1"	P15882	2	174799363-175005369	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 145.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 58.9;BJ hTERT+ SV40 Large T+ RasG12V: 29.7"	"Cancer enhanced"	"Detected in all"		"glioma: 18.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 9.0;memory CD8 T-cell: 2.9;T-reg: 10.0"	"Lineage enriched"	"Detected in single"	35	"T-cells: 10.0"	"Low region specificity"	"Detected in all"							HPA036111			Approved	Cytosol				Cytosol		"HPA036111: AB_10671241"	"unprognostic (3.18e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (7.31e-3)"	"unprognostic (4.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.46e-2)"	3.8	5.2	63.4	3.4	60.8	1.0	2.4	9.1	145.3	4.7	2.5	4.4	0.2	1.7	3.9	15.1	3.2	2.9	4.7	5.2	74.0	21.4	2.1	1.4	7.1	7.4	21.4	51.7	2.8	1.9	31.7	5.2	14.4	23.0	7.2	2.6	3.1	1.4	4.6	1.2	1.9	1.8	5.5	5.1	2.7	2.1	7.5	9.1	0.0	4.0	0.0	7.2	4.5	1.2	0.2	0.2	0.0	0.0	0.1	10.0	1.1	0.0	3.3	14.6	4.2	4.5	20.7	0.1	14.1	58.9	20.3	29.7	0.1	1.9	0.1	0.4	21.2	0.5	18.6	0.4	8.2	0.2	8.1	2.5	4.8	1.4	10.0	1.3	0.3	18.4	0.5	9.8	3.1	7.5	0.1	0.6	14.9	2.7	6.7	0.6	17.3	5.0	2.1	20.6	0.1	0.2	0.1	18.0	19.5	11.2	0.1	1.7	0.6	0.3	2.3	8.6	1.3	2.8	5.1	1.6	7.8	0.2	1.9	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.7	0.2	9.0	2.9	0.0	0.0	1.3	0.3	0.0	0.1	0.0	0.2	10.0	1.1	63.4	60.8	9.1	135.3	74.0	21.4	21.4	51.7	23.0	9.1
CHORDC1	"CHP-1, CHP1"	ENSG00000110172	"Cysteine and histidine rich domain containing 1"	Q9UHD1	11	90201160-90223364	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 100.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041040	Approved		Supported	Cytosol			51000	Cytosol		"HPA041040: AB_10794185"	"unprognostic (2.29e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (4.93e-7)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.27e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-1)"	13.9	17.8	24.9	18.1	31.9	17.8	22.2	29.9	30.7	12.5	10.9	9.0	10.6	10.6	13.8	17.3	13.1	13.2	12.4	17.1	23.6	24.6	11.0	16.2	12.4	21.3	37.8	12.9	19.8	9.5	14.1	47.6	21.3	33.7	14.8	13.2	6.1	9.6	13.0	12.9	12.4	9.0	12.8	39.8	15.3	12.1	13.1	40.2	14.2	16.8	8.7	23.3	14.9	100.9	12.6	11.9	7.9	12.5	14.5	15.5	9.3	9.6	27.8	9.3	6.1	8.9	5.0	14.0	12.0	4.0	11.5	10.2	39.7	7.6	17.0	20.2	5.1	13.2	27.1	6.3	14.3	15.1	13.8	16.8	16.2	18.8	7.1	11.9	11.2	1.8	7.4	10.9	12.8	9.1	24.5	7.5	13.6	4.9	11.1	16.3	10.9	23.1	16.7	5.8	9.4	9.6	4.4	8.9	3.8	13.3	10.8	4.8	17.7	5.6	8.7	8.6	19.0	12.9	14.2	3.5	27.2	13.6	2.7	17.7	7.7	6.8	7.7	7.9	12.0	12.5	12.9	12.6	13.1	12.5	11.9	10.8	14.0	13.3	2.3	14.5	8.0	9.2	15.5	9.3	24.9	31.9	29.9	30.7	23.6	24.6	37.8	12.9	33.7	40.2
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538947-219543787	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"			Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.96e-4)"	8.6	14.1	9.7	8.4	11.8	1.4	6.8	8.5	19.4	22.1	8.6	11.3	23.0	18.4	17.0	24.6	7.9	9.2	17.1	36.3	12.2	10.7	11.3	52.1	11.6	5.4	9.0	10.5	38.1	60.7	16.3	36.9	62.7	10.4	19.3	3.8	27.4	31.6	19.9	4.3	9.0	13.3	9.1	8.3	4.5	15.6	34.2	7.0	3.8	17.9	7.4	10.6	11.9	8.5	1.3	11.1	6.9	0.1	2.1	3.0	0.8	18.5	3.7	2.7	23.2	10.6	16.6	31.8	18.9	16.0	5.4	4.9	10.3	16.4	5.8	40.7	18.2	23.8	1.8	11.4	0.8	8.9	6.4	2.0	5.2	44.5	14.8	1.8	12.2	22.3	20.1	5.4	5.2	0.0	12.9	14.2	5.1	29.2	0.2	4.8	11.5	14.3	0.0	8.8	11.3	6.4	8.4	6.8	10.4	9.1	8.8	25.8	3.0	6.3	0.4	19.9	10.9	23.7	9.8	17.1	5.3	2.6	18.2	1.8	20.0	2.1	0.0	6.9	2.4	0.1	3.0	1.3	1.9	1.6	0.0	0.1	2.2	0.8	0.0	2.1	0.0	11.1	1.2	0.8	9.7	11.8	8.5	19.4	12.2	10.7	9.0	10.5	10.4	7.0
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.5	29.3	13.4	19.0	12.9	22.6	19.1	13.1	20.2	15.3	14.4	11.4	20.7	14.9	19.5	16.9	13.3	14.9	17.6	18.8	13.7	12.5	14.9	20.7	17.4	23.4	11.4	17.4	14.4	23.7	16.7	41.5	18.6	11.8	18.5	10.8	12.2	25.4	19.8	7.9	14.2	17.1	17.3	9.4	28.1	20.1	12.9	11.1	16.2	17.5	7.4	13.7	18.9	12.8	2.7	9.5	9.9	5.6	2.6	5.7	3.7	8.9	7.3	4.9	14.4	17.2	17.1	7.5	18.9	29.6	10.3	12.6	4.8	15.3	2.7	33.5	30.0	11.3	2.2	13.5	4.5	10.3	6.7	2.8	8.0	6.7	16.2	5.8	24.0	26.2	7.6	9.7	3.5	16.2	2.7	7.9	16.3	14.7	5.4	22.7	6.6	8.5	5.1	2.9	9.0	10.0	7.1	5.4	9.5	10.1	10.0	4.8	3.8	9.6	22.0	11.5	1.9	15.2	16.0	14.6	2.1	3.9	41.7	7.8	15.5	1.2	5.6	7.9	5.7	5.1	5.4	2.7	3.1	5.1	6.3	2.7	2.2	2.3	9.9	2.6	5.0	9.5	3.4	3.7	13.4	12.9	13.1	20.2	13.7	12.5	11.4	17.4	11.8	11.1
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.7;prostate: 28.2;salivary gland: 25.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 8.0;SK-BR-3: 4.0;T-47d: 2.6;WM-115: 1.4"	"Cancer enriched"	"Detected in some"	16	"prostate cancer: 27.9"	"Group enriched"	"Detected in many"	10	"amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8"					"HPA014101, CAB022366"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB022366: , HPA014101: AB_1854210"	"unprognostic (3.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.57e-4)"	"unprognostic (4.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"		0.5	3.7	13.2	0.8	22.0	0.5	3.2	0.2	34.7	0.6	1.3	0.5	0.0	1.0	0.7	0.6	0.8	0.8	0.7	0.6	14.2	1.7	0.7	0.6	2.9	0.6	1.4	14.0	0.5	1.2	1.0	0.1	0.8	0.1	28.2	1.3	1.3	25.3	0.6	0.6	2.6	1.3	0.6	0.3	0.6	1.9	0.6	1.8	0.0	0.8	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.7	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	22.0	0.2	34.7	14.2	1.7	1.4	14.0	0.1	1.8
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 49.1"	"Cell line enriched"	"Detected in single"	72	"RH-30: 42.8"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.4"	"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: , HPA065404: "				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	49.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHST10	HNK-1ST	ENSG00000115526	"Carbohydrate sulfotransferase 10"	O43529	2	100391860-100417656	"Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"B-cells: 2.3;dendritic cells: 3.1;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012884, HPA051545"	Approved		Approved	Cytosol	"Intracellular and membrane"		290000	Cytosol		"HPA012884: AB_1846710, HPA051545: "	"unprognostic (5.40e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-2)"	"prognostic favourable (4.05e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.27e-1)"	4.1	6.7	14.6	3.9	18.7	2.6	5.0	12.6	28.2	6.2	4.1	12.1	2.4	2.2	11.4	13.5	4.1	9.7	5.3	10.1	12.4	9.5	4.4	1.2	7.8	4.0	9.8	12.2	12.9	5.3	8.8	8.6	7.8	9.3	8.1	2.4	7.3	5.5	5.4	5.1	1.6	2.5	11.7	8.9	3.7	3.4	5.8	7.6	3.1	9.8	1.6	5.1	5.8	4.9	2.3	3.1	0.0	0.0	0.1	3.5	1.0	0.1	7.8	15.5	7.9	4.7	6.7	7.8	8.9	6.4	12.3	7.9	0.1	4.6	10.8	7.8	5.4	0.0	10.9	1.2	7.9	15.2	11.5	5.5	4.3	12.0	5.7	11.1	14.5	4.9	1.5	5.8	1.1	9.6	15.9	0.0	5.2	2.5	9.8	8.8	22.9	9.6	7.1	9.5	0.1	3.4	3.4	16.8	13.7	0.6	0.0	12.4	4.2	15.4	8.7	8.6	13.6	6.4	8.3	0.0	0.0	11.1	10.5	9.9	10.0	0.0	0.0	0.0	3.5	0.0	1.3	2.3	0.6	2.9	0.6	1.8	0.8	2.3	0.0	0.1	0.0	3.1	0.0	1.0	14.6	18.7	12.6	24.8	12.4	9.5	9.8	12.2	9.3	7.6
CHST15	"BRAG, GALNAC4S-6ST, KIAA0598"	ENSG00000182022	"Carbohydrate sulfotransferase 15"	Q7LFX5	10	124007666-124093607	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.1;REH: 35.6;U-266/70: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 29.4;monocytes: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017584	Approved		Approved	Centrosome,Cytosol			560000	Cytosol	Centrosome	"HPA017584: AB_1849437"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.62e-3)"	"unprognostic (7.90e-2)"	"unprognostic (8.16e-2)"	"prognostic unfavourable (2.22e-7)"	"unprognostic (6.47e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.63e-3)"	"unprognostic (5.26e-3)"	16.4	10.0	8.7	17.0	20.6	5.7	10.7	3.4	17.9	9.8	15.4	6.6	4.0	8.8	8.6	10.8	11.3	13.1	11.7	6.4	11.3	5.3	9.0	11.9	13.9	35.4	6.5	9.6	35.0	12.6	2.9	7.7	5.9	9.2	8.5	8.3	14.4	8.2	13.4	11.0	8.3	12.5	9.5	9.0	31.5	11.4	4.8	8.7	2.8	19.3	6.1	12.6	12.5	12.0	2.1	2.0	29.4	15.4	0.0	0.1	3.2	12.6	8.5	3.2	0.7	3.1	1.7	0.0	2.6	3.5	1.4	2.0	0.2	6.9	0.0	8.3	10.5	14.4	0.6	8.3	1.2	0.0	2.4	0.0	3.9	6.3	1.0	0.0	16.3	1.0	9.6	3.9	3.3	2.8	0.0	27.1	6.9	7.0	0.0	0.0	2.8	0.0	35.6	4.3	8.4	7.0	1.2	0.3	0.7	6.8	3.9	0.0	2.8	0.0	3.3	0.3	0.1	10.0	0.4	24.6	5.9	6.8	0.1	0.0	0.0	0.0	8.8	6.2	0.0	14.0	0.0	2.0	0.0	0.0	1.8	2.1	0.1	0.0	29.4	0.0	15.4	2.0	0.1	3.2	8.7	20.6	3.4	17.9	11.3	5.3	6.5	9.6	9.2	8.7
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119331-143124014	"Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 20.0;ASC TERT1: 20.6;HEL: 15.9;HHSteC: 41.3;HMC-1: 19.0;HSkMC: 21.7;U-266/70: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	4	"monocytes: 11.4;NK-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: "	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	6.5	2.6	8.2	11.6	16.6	20.0	4.1	9.8	15.1	4.6	3.1	6.5	2.6	3.6	6.4	2.7	2.0	1.6	3.1	2.6	7.3	10.4	4.8	1.6	5.1	10.2	10.6	5.8	3.6	2.0	1.5	5.5	15.3	14.0	7.6	2.3	5.9	4.0	15.9	2.7	3.0	4.9	6.0	32.9	17.0	5.4	2.3	4.8	24.7	5.4	0.1	8.1	7.4	5.4	1.4	1.8	0.8	11.4	4.8	0.8	0.9	0.0	0.1	1.0	0.9	20.0	20.6	0.0	1.1	3.2	0.8	0.7	0.0	0.0	0.2	0.7	0.7	0.0	0.7	2.7	0.4	0.2	0.5	15.9	0.0	0.0	41.3	0.4	19.0	21.7	3.3	1.0	3.4	1.2	1.8	1.0	5.2	0.0	2.9	4.0	5.6	2.7	0.1	0.3	0.0	0.5	0.7	1.3	0.0	0.2	0.0	1.8	0.0	0.6	4.1	2.4	1.4	3.2	4.6	18.2	0.2	1.1	4.7	3.0	12.6	0.7	0.6	0.8	0.4	4.5	0.0	1.4	0.1	0.2	1.8	1.0	0.8	0.6	0.3	4.8	11.4	0.1	0.5	0.9	8.2	16.6	9.8	15.1	7.3	10.4	10.6	5.8	14.0	4.8
CHST3	"C6ST, C6ST1"	ENSG00000122863	"Carbohydrate sulfotransferase 3"	Q7LGC8	10	71964365-72013564	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047523, HPA055704"	Enhanced		Approved	"Golgi apparatus,Cytosol"			510000	"Golgi apparatus, Cytosol"		"HPA047523: , HPA055704: "	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.54e-3)"	22.2	11.6	9.2	7.0	19.4	0.7	12.0	2.9	11.6	10.4	9.0	19.4	4.8	1.7	13.7	7.4	8.4	13.6	6.2	11.9	11.3	5.1	8.6	1.8	6.3	2.2	30.1	5.5	25.0	6.1	1.9	4.0	10.0	15.6	10.7	3.3	5.7	6.3	19.5	13.6	7.1	4.0	21.0	16.2	2.9	11.6	19.4	25.2	0.5	7.3	4.8	2.2	7.5	18.5	0.2	0.3	0.8	0.1	0.1	0.2	0.0	6.7	7.3	3.8	9.3	17.3	6.8	0.1	14.4	13.9	8.9	5.9	6.4	13.7	0.0	10.0	17.0	8.9	3.3	9.9	7.1	0.2	2.5	0.0	12.8	6.1	8.8	0.0	0.0	9.4	11.5	8.8	12.1	2.6	2.0	0.0	9.4	0.2	0.0	0.0	1.6	2.4	0.0	4.5	0.0	12.5	7.0	0.2	3.7	10.9	0.2	10.6	0.8	1.4	5.4	11.0	12.7	18.2	28.8	0.0	0.0	0.0	8.0	0.0	7.7	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.8	0.1	0.0	0.3	0.1	0.0	9.2	19.4	2.9	11.6	11.3	5.1	30.1	5.5	15.6	25.2
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Conserved helix-loop-helix ubiquitous kinase"	O15111	10	100188298-100229619	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	16.6	16.6	14.0	14.3	18.9	21.3	14.2	16.0	15.8	11.8	15.0	13.0	13.9	16.1	14.7	12.4	13.5	12.0	11.7	14.5	13.3	17.6	27.2	35.8	14.0	20.8	17.9	6.9	11.4	14.5	19.6	18.2	14.2	16.4	12.9	17.6	9.5	13.9	12.5	23.6	11.0	20.6	16.1	18.6	18.7	15.1	12.5	15.6	22.5	14.5	11.7	15.5	13.8	13.6	3.7	3.4	7.2	4.8	4.0	4.3	1.4	15.6	13.2	13.6	20.2	13.1	11.8	10.5	19.9	19.6	18.6	22.8	14.8	9.3	21.2	11.8	13.5	15.5	22.6	10.6	21.0	22.5	19.5	14.1	10.5	16.3	11.2	26.0	20.7	9.4	11.3	21.5	21.0	13.2	15.9	17.6	20.3	9.5	20.5	16.1	8.8	9.7	13.4	15.1	9.7	11.8	10.1	8.1	12.1	10.8	8.4	17.3	16.7	15.9	13.9	11.7	13.2	12.7	22.6	20.8	18.7	20.7	12.8	21.2	9.2	2.6	3.0	5.1	2.4	4.8	4.0	3.7	3.0	4.3	3.4	2.1	3.3	4.2	7.2	4.0	3.2	2.1	2.8	1.4	14.0	18.9	16.0	15.8	13.3	17.6	17.9	6.9	16.4	15.6
CHURC1	"C14orf52, FLJ33064, My015"	ENSG00000258289	"Churchill domain containing 1"	Q8WUH1	14	64914361-64944591	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040072	Approved		Approved	Cytosol				Cytosol		"HPA040072: AB_10963788"	"unprognostic (2.94e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (6.78e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	31.8	32.7	25.9	25.5	31.8	25.5	27.6	15.7	36.6	31.1	30.0	31.4	25.8	20.8	28.5	27.3	28.5	22.5	22.7	45.5	23.9	23.2	29.3	36.5	21.0	30.0	29.2	23.7	32.1	27.1	25.5	34.8	24.6	35.4	26.7	25.5	21.5	20.8	28.7	53.4	22.5	28.3	34.8	36.9	33.0	27.4	19.5	26.8	40.7	25.0	29.6	28.6	32.8	23.6	41.6	41.8	80.6	37.1	31.3	62.3	35.3	40.4	21.5	20.7	16.0	26.7	28.7	24.6	30.1	26.5	17.0	19.4	11.9	26.6	24.9	20.7	25.8	29.9	18.2	24.4	18.7	26.9	9.0	23.6	17.2	26.8	24.5	13.3	23.7	34.1	18.6	15.3	29.8	18.2	10.4	21.8	20.9	33.7	24.7	22.1	11.4	35.7	21.9	22.8	14.6	24.0	29.2	10.9	13.0	20.8	22.8	29.5	36.8	28.0	23.3	15.6	30.8	17.1	19.2	18.4	16.1	54.8	17.1	15.7	18.6	41.4	37.1	38.2	32.6	36.6	37.1	41.6	49.3	38.4	28.8	36.6	49.5	41.1	80.6	31.3	35.2	41.8	62.3	35.3	25.9	31.8	15.7	36.6	23.9	23.2	29.2	23.7	35.4	26.8
CIAO1	"CIA1, WDR39"	ENSG00000144021	"Cytosolic iron-sulfur assembly component 1"	O76071	2	96266132-96273349	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017882	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA017882: AB_1846738"	"unprognostic (2.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavourable (4.13e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.15e-2)"	19.8	39.7	23.6	22.2	27.6	11.1	21.4	17.9	31.9	22.1	18.4	19.9	22.3	20.4	19.4	16.5	24.0	22.3	18.3	26.1	18.3	18.2	25.4	32.5	17.7	17.7	19.2	22.7	20.4	22.2	30.6	17.8	22.2	24.5	16.4	21.1	19.2	22.0	23.5	26.1	16.3	18.5	21.5	19.7	21.8	19.3	19.1	19.0	21.6	19.4	12.2	26.0	19.9	16.9	29.6	39.8	33.1	39.7	25.9	35.2	38.5	20.5	20.6	15.7	14.6	20.2	16.4	25.6	15.8	16.8	25.6	25.3	35.1	15.2	21.7	33.6	19.5	15.7	24.2	23.4	18.4	11.5	39.9	16.7	15.3	37.9	13.1	19.4	15.2	16.4	18.8	21.3	26.7	28.5	21.3	14.9	17.2	32.6	19.3	18.2	22.0	41.8	19.4	13.9	25.2	16.8	19.3	16.9	19.4	9.9	26.9	18.9	13.5	14.2	14.7	16.0	22.8	19.0	20.9	20.3	21.4	19.3	20.8	18.9	15.7	30.6	35.3	33.1	32.7	29.3	35.2	25.3	28.7	34.9	39.8	29.6	28.5	34.2	32.4	25.9	39.7	24.0	27.6	38.5	23.6	27.6	17.9	31.9	18.3	18.2	19.2	22.7	24.5	19.0
CIP2A	KIAA1524	ENSG00000163507	"Cell proliferation regulating inhibitor of protein phosphatase 2A"	Q8TCG1	3	108549869-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavourable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	2.1	2.3	2.5	8.5	6.3	10.4	3.6	6.3	6.2	3.2	3.1	2.6	0.8	2.0	3.2	1.8	4.0	1.8	2.0	2.7	2.9	2.1	2.2	1.6	2.2	10.2	2.0	3.2	3.8	1.8	1.8	3.0	3.3	2.4	3.0	4.4	2.2	2.3	1.4	2.0	1.9	2.7	2.5	2.4	5.5	2.0	8.5	1.5	21.5	1.9	1.5	8.0	4.0	2.7	1.9	0.3	0.7	1.1	0.0	1.6	0.6	18.6	5.6	15.7	10.0	0.7	1.5	6.4	14.2	6.7	16.8	19.8	6.7	8.4	12.6	4.9	5.1	9.5	5.3	5.0	30.7	4.0	5.2	15.1	7.6	5.0	0.2	9.7	10.8	0.6	1.0	13.1	5.4	7.5	9.3	20.4	16.5	3.8	11.6	8.6	16.1	9.6	13.3	14.6	6.9	5.1	5.2	7.6	10.0	10.4	4.1	5.8	7.0	6.9	5.5	17.3	19.6	5.2	17.0	4.7	5.2	20.9	7.6	10.5	17.6	0.6	0.3	0.7	0.0	0.5	1.3	1.2	0.7	0.3	0.0	1.9	0.7	1.6	0.0	0.0	1.1	0.3	0.8	0.6	2.5	6.3	6.3	6.2	2.9	2.1	2.0	3.2	2.4	1.5
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685790-119877291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;brain: 35.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol				Cytosol		"HPA019082: AB_1846803, HPA048812: , HPA075506: "	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	1.4	4.4	14.7	3.3	14.0	15.3	1.6	12.7	35.0	1.6	4.6	2.9	0.0	4.0	1.3	1.5	3.2	0.9	1.6	1.0	9.8	5.7	5.7	1.4	3.0	3.4	3.2	21.9	0.7	0.7	1.2	2.9	2.6	7.4	1.0	5.3	0.6	1.3	1.0	1.3	5.1	3.5	2.6	5.0	5.6	3.5	8.3	9.5	5.9	1.5	0.1	4.9	1.7	1.7	0.4	0.0	0.0	0.1	0.0	1.2	0.8	15.0	13.5	11.9	11.2	1.1	3.3	7.0	11.5	9.6	12.1	9.1	8.6	6.2	10.8	6.2	8.9	9.4	8.1	6.7	16.7	7.7	5.9	13.7	8.7	5.3	0.1	7.2	12.6	0.7	0.7	14.4	8.9	9.2	8.7	9.2	11.3	7.5	13.0	11.0	6.4	9.1	11.9	21.6	3.6	2.4	6.6	8.5	4.7	19.1	3.7	9.1	13.5	5.2	7.0	15.1	13.9	10.3	12.5	6.3	7.0	7.4	10.0	7.9	23.3	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	14.7	14.0	12.7	35.0	9.8	5.7	3.2	21.9	7.4	9.5
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 247.1;pituitary gland: 62.8;testis: 89.9"	"Group enriched"	"Detected in some"	5	"AN3-CA: 17.5;SK-MEL-30: 69.6"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 18.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA049051: "	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favourable (6.10e-4)"	"prognostic favourable (3.95e-4)"	"unprognostic (2.99e-2)"	0.5	0.6	3.5	0.5	2.2	0.4	6.0	0.9	2.8	1.3	0.5	0.3	5.3	0.5	1.0	247.1	0.4	0.5	0.4	0.4	2.4	18.9	0.6	0.4	0.5	0.4	1.1	0.9	0.5	0.6	0.4	62.8	0.4	2.7	2.1	0.4	27.8	0.4	1.2	0.4	0.4	0.5	1.7	0.5	0.4	0.4	89.9	0.0	0.0	1.7	0.0	0.4	0.4	0.0	0.0	0.8	2.2	0.5	0.0	1.1	1.1	0.1	0.1	0.7	17.5	0.8	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	6.3	0.4	0.0	1.8	2.5	0.3	0.1	0.0	0.0	0.1	3.4	0.3	0.2	0.2	0.3	0.0	0.7	0.1	0.1	0.2	0.0	1.3	1.0	1.2	0.0	1.2	0.9	0.0	0.2	7.9	4.1	0.1	1.5	69.6	0.5	0.4	0.0	0.1	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	1.6	0.0	0.5	2.2	0.4	0.0	1.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	3.5	2.2	0.9	2.8	2.4	18.9	1.1	0.9	2.7	0.0
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3;lymphoid tissue: 49.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA008410, HPA027821"	Enhanced		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavourable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	4.6	9.2	7.1	12.1	12.2	42.3	4.4	16.4	9.9	4.3	6.7	1.9	2.3	9.0	4.2	5.2	14.7	3.0	4.1	5.3	5.8	7.8	5.0	3.2	5.0	13.5	5.9	5.8	3.5	2.4	3.4	10.9	10.2	16.1	4.6	7.4	1.4	6.7	3.6	5.8	10.4	7.0	6.5	5.5	12.4	4.2	22.1	5.2	49.2	5.0	10.3	14.8	8.1	6.6	15.2	16.1	30.4	12.8	2.5	15.7	4.2	19.2	10.4	41.8	20.6	5.4	5.4	10.5	31.7	18.7	37.0	23.9	15.0	24.4	36.9	5.1	23.6	22.6	28.8	16.1	51.7	25.0	23.7	33.3	11.7	10.6	2.3	33.1	13.6	3.9	6.7	17.3	22.8	22.4	14.0	15.3	40.8	9.0	22.7	16.3	24.7	11.0	21.9	23.9	16.1	11.3	10.5	12.8	16.7	17.9	13.2	9.8	14.5	15.9	14.7	10.7	16.6	16.7	31.7	9.0	13.3	45.6	7.5	17.3	28.2	30.4	7.2	10.4	5.4	10.4	4.8	12.2	8.2	6.4	7.5	15.2	6.5	5.5	2.2	2.5	12.8	16.1	15.7	4.2	7.1	12.2	16.4	9.9	5.8	7.8	5.9	5.8	16.1	5.2
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736607-112764677	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;lymphoid tissue: 38.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Mitotic spindle,Cytosol"				"Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: "	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	1.5	0.7	0.6	9.2	0.6	13.4	1.3	0.7	0.6	0.6	1.8	0.0	0.3	1.5	0.5	1.4	3.8	0.7	0.1	2.3	0.6	0.5	0.7	0.7	1.2	5.3	0.6	0.2	0.6	0.6	0.0	0.5	3.2	0.2	0.6	2.4	0.0	1.0	0.0	0.6	1.5	2.4	0.9	0.6	2.2	0.9	9.0	0.1	38.3	0.6	5.9	6.0	0.9	0.7	1.0	0.8	1.8	0.7	1.6	1.8	0.4	19.9	4.0	15.8	7.1	0.9	1.5	3.2	16.5	13.7	17.2	16.4	3.7	5.8	13.7	6.9	6.5	7.7	9.1	8.7	29.0	19.0	4.0	22.8	5.6	3.2	0.0	10.7	13.7	0.4	0.8	21.6	12.3	7.8	6.0	20.0	14.0	2.9	12.9	4.1	6.7	13.0	9.4	16.6	3.6	2.9	7.8	8.7	5.5	6.7	5.6	5.7	5.4	5.0	5.5	19.1	14.9	15.2	12.1	4.3	8.3	11.7	8.2	7.7	29.9	0.8	0.5	0.7	0.5	0.7	0.4	0.9	1.2	1.1	0.5	1.0	0.5	0.7	1.8	1.6	0.7	0.8	1.8	0.4	0.6	0.6	0.7	0.6	0.6	0.5	0.6	0.2	0.2	0.1
CKAP4	"CLIMP-63, ERGIC-63, P63"	ENSG00000136026	"Cytoskeleton associated protein 4"	Q07065	12	106237877-106304279	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 73.6;BJ hTERT+: 92.9;fHDF/TERT166: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 34.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000278, HPA000792, HPA001225"	Enhanced		Uncertain	"Nuclear speckles,Cytosol,Cytoplasmic bodies"			11000	"Nuclear speckles, Cytosol"	"Cytoplasmic bodies"	"HPA000278: AB_1078527, HPA000792: AB_1078526, HPA001225: AB_2666241"	"unprognostic (5.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (6.61e-5)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (5.02e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.20e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.66e-2)"	13.0	23.8	7.1	15.3	4.9	39.5	27.2	6.9	8.4	42.3	19.2	6.5	24.8	8.1	23.7	35.2	47.3	17.2	26.6	32.9	5.7	8.0	18.3	42.1	22.2	28.5	6.3	5.4	28.6	55.2	12.7	12.0	30.6	6.8	23.9	20.5	13.2	34.4	28.0	11.1	20.8	10.7	20.4	5.8	16.7	23.0	10.3	4.2	4.0	18.6	30.0	27.8	25.8	21.4	4.2	2.3	34.6	7.5	0.1	1.0	2.4	11.2	14.2	17.2	18.7	33.6	30.0	10.0	73.6	92.9	36.0	41.5	6.0	2.6	0.7	13.4	110.9	20.5	12.6	11.1	25.9	0.3	7.3	0.0	8.2	11.8	25.1	0.1	0.2	28.7	15.3	30.5	22.1	42.1	0.0	1.4	34.1	3.8	0.5	0.4	10.0	17.3	5.2	12.4	0.9	10.9	10.2	5.7	6.3	13.1	8.9	7.0	10.0	5.1	35.9	28.4	15.7	11.7	20.8	3.9	0.0	8.0	20.5	1.4	24.8	34.6	7.5	8.7	0.5	2.7	0.7	4.2	0.7	0.4	2.3	1.6	1.0	0.9	12.7	0.1	4.1	0.0	0.2	2.4	7.1	4.9	6.9	8.4	5.7	8.0	6.3	5.4	6.8	4.2
CKB	CKBB	ENSG00000166165	"Creatine kinase B"	P12277	14	103519659-103523111	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 158.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 53.1;HEK 293: 135.1;SCLC-21H: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"non-classical monocyte: 50.0"	"Lineage enriched"	"Detected in many"	17	"monocytes: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001254, CAB047313"	Enhanced		Supported	Cytosol			50000000	Cytosol		"CAB047313: , HPA001254: AB_1078528"	"unprognostic (9.97e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.89e-3)"	"prognostic favourable (4.02e-8)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.13e-1)"	32.4	27.3	75.4	10.4	114.6	3.1	5.3	94.3	158.5	29.1	121.5	51.4	23.8	17.6	37.3	8.9	28.6	35.7	17.8	36.4	60.7	43.2	26.7	3.4	12.8	3.6	63.4	93.3	15.8	10.2	20.3	9.7	3.7	63.3	107.5	55.0	43.9	18.3	92.1	19.1	14.4	17.5	53.2	31.9	3.6	66.7	22.1	50.9	0.0	19.8	7.8	3.9	43.0	13.0	0.0	2.9	1.4	50.0	0.0	0.1	0.9	0.3	6.7	26.9	1.4	0.2	0.2	0.5	2.9	0.0	0.3	0.1	53.1	0.8	0.0	3.2	2.0	5.9	7.8	0.1	0.0	1.2	135.1	10.0	29.7	18.2	1.1	0.0	8.2	1.0	0.0	0.2	0.1	0.0	17.4	0.4	0.4	2.2	0.2	0.3	10.5	21.0	1.7	0.5	27.6	4.9	0.2	76.9	31.6	5.7	0.9	2.1	2.5	4.1	0.1	0.1	5.2	0.5	12.6	1.3	0.3	0.9	0.7	0.2	0.9	0.3	0.1	1.4	0.0	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	50.0	0.0	0.1	0.9	75.4	114.6	94.3	152.7	60.7	43.2	63.4	93.3	63.3	50.9
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979249	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: , HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavourable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (4.87e-4)"	"unprognostic (1.37e-1)"	25.3	14.5	13.5	13.4	19.0	36.4	24.8	4.2	14.6	15.6	17.4	12.4	19.8	14.7	14.7	13.8	28.2	15.2	14.1	16.5	15.3	8.0	16.6	29.5	12.9	23.8	29.5	8.8	14.2	12.8	8.3	9.4	35.6	15.9	11.7	18.8	7.5	12.8	13.1	5.9	22.6	22.9	12.5	19.8	18.0	14.7	22.8	21.5	30.2	15.5	19.3	25.5	11.1	23.3	23.9	30.4	2.2	32.8	9.0	12.2	8.7	59.4	82.1	61.5	33.3	8.9	9.1	49.2	27.7	21.5	60.1	48.2	79.3	88.0	56.7	47.4	18.3	55.2	61.0	39.7	56.5	50.9	39.5	38.3	36.5	55.7	2.7	46.1	35.3	5.3	17.2	51.4	71.3	30.1	62.2	77.1	45.2	59.2	43.2	35.6	78.0	74.1	43.5	50.7	72.6	21.4	21.8	25.1	63.4	41.9	39.7	45.8	53.1	64.6	16.8	39.1	40.5	32.2	65.9	47.6	92.3	80.0	24.8	39.3	53.9	0.7	4.4	2.2	7.0	26.0	8.4	23.9	9.9	9.5	7.2	22.6	12.2	11.5	0.6	9.0	32.8	30.4	10.6	8.7	13.5	19.0	4.2	14.6	15.3	8.0	29.5	8.8	15.9	21.5
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311198-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.6;testis: 103.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 54.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: , HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	4.8	22.4	4.2	22.7	6.1	38.1	10.7	4.0	7.5	3.6	10.8	3.0	16.7	10.8	4.6	4.4	20.4	2.8	4.7	3.3	6.1	3.2	11.0	10.2	9.5	24.6	5.2	4.3	3.9	2.6	7.0	2.2	12.4	5.0	4.8	10.7	3.2	4.4	7.6	3.6	6.1	9.3	4.1	5.4	12.6	6.8	103.2	3.6	41.6	4.6	13.5	20.8	8.1	16.7	18.3	54.6	12.4	7.5	11.6	17.9	6.5	86.6	74.3	45.5	30.4	13.4	12.2	33.2	51.6	27.9	57.2	45.8	30.5	43.0	64.9	30.6	19.3	61.0	54.5	39.7	65.8	50.6	44.1	32.9	54.4	80.9	5.8	67.0	37.5	4.4	9.2	40.9	36.2	52.9	39.2	56.9	73.2	65.0	52.6	118.1	66.4	68.6	45.6	50.0	38.7	44.9	19.9	38.5	22.9	42.8	41.6	41.6	50.1	39.0	30.0	24.7	47.0	59.7	75.0	46.1	93.5	52.4	36.5	38.8	35.2	10.5	5.9	12.4	7.0	7.5	7.9	18.3	9.6	6.7	6.5	13.5	5.2	6.8	4.2	11.6	4.1	54.6	17.9	6.5	4.2	6.1	4.0	7.5	6.1	3.2	5.2	4.3	5.0	3.6
CLASP2	KIAA0627	ENSG00000163539	"Cytoplasmic linker associated protein 2"	O75122	3	33496245-33718356	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067071			Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA067071: "	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.48e-6)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.72e-2)"	7.9	14.5	20.6	6.5	31.6	6.0	9.0	45.4	67.1	13.0	8.9	50.7	3.4	5.6	11.7	6.7	10.2	9.4	10.0	22.0	19.1	16.8	10.4	6.1	8.6	7.9	33.4	22.1	16.1	6.5	11.6	16.1	8.7	44.7	9.8	7.7	13.4	6.5	12.4	31.7	7.3	6.7	11.2	29.7	7.7	6.8	6.5	37.3	4.1	8.1	4.9	8.6	8.0	7.5	8.4	8.7	4.7	8.4	12.3	7.2	5.6	7.2	16.0	18.4	15.4	12.0	11.8	13.2	13.6	12.8	16.0	17.3	9.3	7.6	23.9	7.9	10.6	6.3	23.7	10.8	19.5	19.2	16.9	23.5	14.1	8.2	5.7	23.1	20.1	7.2	10.8	17.3	16.5	15.4	22.8	13.7	17.2	4.0	17.1	9.9	13.6	10.2	18.5	17.3	12.9	10.2	8.3	15.4	26.1	15.7	12.3	13.5	11.6	20.6	14.7	12.6	11.0	9.4	14.9	9.7	18.1	19.8	11.4	16.0	15.9	4.7	5.9	3.3	4.8	6.3	7.2	8.4	4.2	4.5	8.7	5.6	5.7	5.2	1.2	12.3	8.4	8.3	4.5	5.6	20.6	31.6	45.4	38.7	19.1	16.8	33.4	22.1	44.7	37.3
CLBA1	C14orf79	ENSG00000140104	"Clathrin binding box of aftiphilin containing 1"	Q96F83	14	104985775-105010482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042052, HPA061117"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA042052: , HPA061117: "	"unprognostic (1.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	2.1	5.3	5.4	2.6	12.5	2.0	6.6	3.5	13.5	7.6	3.4	5.2	11.8	2.3	6.8	15.1	5.1	18.9	6.5	2.4	6.2	6.5	8.9	6.1	7.4	1.8	3.3	5.9	6.8	11.3	13.2	15.3	2.4	5.3	7.6	3.5	7.6	6.3	8.3	1.3	9.2	2.2	4.4	2.1	2.4	5.9	23.9	1.8	1.8	17.6	1.0	2.3	4.2	3.3	1.8	2.3	2.4	1.1	1.0	1.4	0.5	4.0	7.2	2.2	6.7	2.2	3.3	3.4	3.3	3.0	3.9	1.7	0.7	7.1	0.4	6.9	3.2	8.6	0.8	4.8	2.5	3.3	2.5	0.2	6.1	0.3	7.7	1.7	1.8	2.0	11.2	4.2	8.3	2.2	2.3	1.1	2.3	13.6	0.7	5.2	2.8	6.9	2.5	1.2	2.2	8.4	2.3	14.1	7.4	4.6	2.1	3.8	14.7	2.5	2.4	4.9	2.3	9.9	2.5	1.4	0.9	0.3	6.3	0.5	3.4	1.8	1.1	0.4	1.4	1.1	0.3	1.2	1.4	0.3	0.5	1.8	0.6	1.3	2.4	1.0	1.0	2.3	0.6	0.5	5.4	12.5	3.5	13.5	6.2	6.5	3.3	5.9	5.3	1.8
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361651	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 21.0;intestine: 20.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol				Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.6	5.4	4.9	2.6	8.3	1.3	1.6	8.8	6.3	2.8	20.2	16.9	5.1	11.6	4.5	5.0	1.7	2.8	21.0	1.5	6.3	3.1	3.7	1.8	1.3	1.0	15.3	4.1	6.1	5.9	4.4	4.0	1.5	8.9	2.6	14.0	15.6	3.7	9.0	1.2	2.2	11.8	2.4	10.8	1.6	2.7	11.9	9.8	0.1	3.2	1.3	1.3	2.2	2.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	7.9	2.8	2.3	6.1	2.1	1.8	5.3	2.8	1.6	2.8	1.8	14.9	2.7	2.8	7.9	1.4	13.8	3.3	3.1	0.8	2.5	4.0	2.5	5.8	6.3	1.3	1.0	2.5	3.4	2.5	2.4	2.8	2.7	0.9	1.4	0.9	4.4	0.8	1.3	3.4	4.3	4.9	2.2	9.5	3.5	6.0	3.8	2.3	2.9	10.4	4.7	8.4	1.1	1.3	1.4	4.3	7.0	6.9	3.7	4.8	1.7	2.5	4.8	6.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	8.3	8.8	6.3	6.3	3.1	15.3	4.1	8.9	9.8
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922615-50099235	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 24.9;RH-30: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 6.6;monocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: "	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favourable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	4.4	4.1	2.5	2.4	2.9	2.1	3.4	9.4	3.4	2.3	3.1	2.6	4.7	5.0	9.8	26.7	3.7	4.6	7.6	2.2	3.1	2.8	46.1	15.8	4.7	3.0	2.6	2.5	10.8	6.7	2.6	8.3	7.3	5.9	2.7	3.7	7.6	4.0	3.5	5.6	6.2	6.4	3.8	4.3	3.0	4.0	5.9	2.3	1.2	3.6	4.0	2.3	2.4	3.1	0.2	6.6	0.5	1.8	0.3	0.4	0.5	1.7	2.8	2.1	3.3	8.3	5.2	4.6	1.5	0.7	0.9	1.2	24.9	1.7	1.8	0.8	1.7	1.4	6.7	0.8	1.5	0.7	4.6	1.7	1.4	6.5	3.9	2.3	3.3	3.1	1.1	2.5	3.7	3.6	2.7	2.7	2.9	1.8	0.8	0.6	3.1	1.3	1.0	38.6	2.7	3.7	2.8	3.7	2.7	2.1	2.1	3.1	1.9	1.1	1.8	1.0	2.1	7.6	0.9	2.2	6.7	4.1	1.6	3.7	5.0	0.1	1.8	0.0	0.2	1.5	0.3	0.2	0.4	0.4	3.8	0.2	0.1	0.1	0.5	0.3	0.3	6.6	0.0	0.5	2.5	2.9	9.4	3.4	3.1	2.8	2.6	2.5	5.9	2.3
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11843144	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	11.2	14.6	18.9	11.5	18.7	12.2	8.6	18.0	27.9	9.2	8.7	22.4	8.6	9.6	12.8	14.2	6.3	10.7	8.1	15.7	15.0	20.6	10.0	9.1	10.6	11.1	16.4	17.8	21.4	6.6	8.4	14.8	9.6	32.4	11.3	7.8	13.1	6.7	8.7	11.2	10.0	9.1	10.8	15.9	10.6	8.5	16.1	14.5	4.3	10.7	5.0	9.5	7.7	8.2	10.1	3.2	4.2	4.6	2.0	3.2	1.1	5.7	5.3	12.1	10.1	13.0	13.5	3.8	4.8	9.2	6.6	10.4	8.2	13.9	8.1	4.0	4.4	8.5	7.9	8.9	5.9	3.6	4.3	8.4	10.6	10.8	16.8	4.7	7.9	9.2	5.3	12.5	7.0	5.9	10.7	11.8	6.7	3.1	4.9	12.8	8.1	4.2	6.1	6.6	7.4	8.8	4.7	5.3	8.4	3.2	5.1	11.1	4.5	8.5	7.2	6.2	7.0	10.6	3.3	7.1	4.3	21.0	7.7	9.5	4.5	4.2	4.6	1.5	2.6	3.7	1.5	8.0	2.1	3.2	2.7	10.1	2.3	2.1	3.9	2.0	4.6	3.2	1.4	1.1	18.9	18.7	18.0	27.9	15.0	20.6	16.4	17.8	32.4	14.5
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 75.9;brain: 227.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavourable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	14.7	12.4	61.6	10.7	76.1	11.7	14.1	11.9	77.1	14.1	10.4	100.5	3.3	10.0	16.9	12.6	22.6	10.9	14.3	15.9	85.4	52.3	11.0	14.0	12.2	13.6	133.4	28.9	19.1	5.8	7.0	6.7	20.5	72.7	14.6	13.6	4.9	6.8	15.7	9.7	17.6	9.4	18.5	227.4	11.5	7.5	28.5	95.4	4.3	11.5	4.7	14.8	14.7	11.1	19.9	19.7	28.1	18.6	49.5	75.9	28.6	17.9	7.3	23.0	14.1	27.8	21.7	12.5	14.3	19.6	20.1	27.8	14.8	18.4	9.0	19.3	13.7	24.4	17.6	10.8	35.2	21.2	7.5	18.8	5.2	13.3	22.2	16.9	18.7	25.3	58.5	15.7	16.8	21.8	9.3	27.8	28.2	9.4	12.4	11.2	20.0	15.6	8.4	30.9	11.5	18.7	8.2	8.3	22.9	19.7	6.6	28.2	6.6	14.3	20.1	26.2	24.2	17.8	18.5	36.8	15.7	14.5	43.8	16.3	33.4	28.1	18.6	19.8	21.7	10.7	40.8	19.9	40.9	39.8	19.7	16.4	16.6	16.9	13.8	49.5	10.5	12.7	75.9	28.6	61.6	76.1	11.9	38.8	85.4	52.3	133.4	28.9	72.7	95.4
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540963	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2"	"Group enriched"	"Detected in some"	4	"NB-4: 5.7;RPTEC TERT1: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 22.8;neutrophil: 81.7"	"Group enriched"	"Detected in many"	17	"granulocytes: 81.7;monocytes: 22.8"	"Not detected"	"Not detected"							HPA004935	Uncertain		Uncertain	Cytosol				Cytosol		"HPA004935: "	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	8.4	3.0	1.1	20.9	2.4	37.7	17.5	1.2	2.2	3.4	1.4	0.0	1.1	0.1	1.2	1.6	1.7	4.2	6.7	5.9	1.3	1.2	6.2	3.5	25.6	41.2	2.8	0.6	1.0	3.3	0.0	1.7	1.7	9.0	1.6	0.5	1.1	1.2	0.6	2.7	0.7	1.9	3.2	5.3	34.2	1.8	3.3	0.8	0.7	12.8	0.9	1.1	2.2	2.2	0.0	2.9	81.7	22.8	0.0	0.0	4.5	0.1	0.6	0.4	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.1	1.9	0.1	2.6	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.3	0.0	0.7	0.1	0.0	1.7	0.1	0.7	0.2	0.1	0.0	0.1	0.0	5.7	0.5	0.1	0.1	0.2	0.1	16.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.5	1.2	0.6	0.1	1.1	0.1	0.2	0.1	0.1	1.6	0.4	0.1	0.0	22.8	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	81.7	0.0	0.1	0.1	0.0	4.5	1.1	2.4	1.2	2.2	1.3	1.2	2.8	0.6	9.0	0.8
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8"	"Group enriched"	"Detected in some"	23	"HL-60: 14.8;U-937: 57.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"classical monocyte: 11.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA054137: "	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.4	3.2	1.8	7.3	2.4	35.8	0.8	0.8	2.5	1.7	0.4	1.9	0.6	0.4	0.8	0.5	1.4	1.2	2.0	3.8	7.6	3.1	2.9	2.1	13.9	0.3	2.4	0.5	2.7	2.6	1.4	1.1	2.7	8.2	0.9	0.5	0.8	2.7	0.8	0.3	2.7	0.3	1.5	4.8	2.1	0.4	0.9	4.8	1.1	1.4	4.9	1.4	1.9	1.1	0.0	0.5	1.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	1.9	1.8	2.4	0.8	2.5	7.6	3.1	2.4	0.5	8.2	4.8
CLIC1	"G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020825, CAB040557"	Enhanced		Supported	Cytosol			78000000	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	64.5	22.9	7.4	33.7	11.3	35.3	41.1	2.5	8.3	38.7	50.3	9.0	27.1	24.5	30.0	29.2	59.0	26.3	60.8	35.5	7.9	7.7	70.8	28.3	58.6	59.6	13.9	3.7	34.8	30.3	11.1	17.0	72.3	12.1	42.2	43.5	20.0	37.7	33.6	18.3	45.0	54.9	31.5	13.6	79.9	34.8	16.7	9.2	52.9	46.1	37.4	58.5	49.2	40.0	39.0	30.5	70.9	39.4	33.5	37.2	67.9	26.7	12.4	20.4	10.6	13.6	28.8	10.2	11.9	24.5	21.9	18.4	28.5	20.1	11.0	17.4	42.5	16.2	15.2	35.7	29.6	8.7	8.0	21.0	10.7	24.6	17.6	36.6	29.7	17.8	18.9	36.9	35.3	36.6	24.2	34.9	42.0	17.8	17.0	47.7	1.8	18.2	3.0	11.2	25.9	49.2	16.7	3.9	4.6	9.9	11.4	16.6	7.8	51.9	24.2	30.5	21.5	9.5	37.6	11.4	21.3	14.8	14.7	27.6	31.3	45.8	36.5	48.1	37.2	39.4	30.3	39.0	22.5	34.5	30.5	30.4	7.0	21.9	70.9	33.5	33.8	17.2	31.0	67.9	7.4	11.3	2.5	8.3	7.9	7.7	13.9	3.7	12.1	9.2
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745357-24844324	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 13.0;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	Cytosol			20000000	Cytosol		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavourable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favourable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	45.3	16.9	20.6	26.3	26.7	7.6	35.4	4.5	20.0	52.1	46.4	41.6	23.2	8.9	68.0	27.4	42.0	34.7	29.7	77.4	23.5	16.5	71.2	19.9	40.8	12.9	28.2	13.0	37.6	13.5	10.8	6.1	53.7	22.3	51.9	19.1	29.1	18.2	45.2	20.9	12.6	19.3	87.2	33.6	15.1	33.4	20.9	26.4	7.1	17.7	11.2	15.0	106.7	42.3	13.0	5.3	2.2	5.1	0.0	0.3	3.3	26.0	2.9	26.4	20.9	36.0	78.3	15.2	70.9	66.4	30.0	36.4	5.8	13.7	17.1	41.3	91.5	9.4	18.0	17.5	75.7	4.3	8.5	6.5	8.1	10.0	50.3	2.2	0.7	36.2	30.3	42.9	43.4	49.6	5.0	16.6	85.9	4.3	4.1	3.2	25.8	13.5	10.3	31.1	6.3	30.7	6.7	4.9	12.7	18.7	8.0	51.7	7.1	13.2	77.4	55.2	21.2	24.4	27.1	10.0	13.8	13.9	40.7	18.4	16.7	0.7	5.1	2.2	0.3	4.1	0.0	13.0	0.3	0.2	5.3	11.9	0.2	0.2	1.1	0.0	3.3	1.6	0.0	3.3	20.6	26.7	4.5	15.8	23.5	16.5	28.2	13.0	22.3	26.4
CLIP1	"CLIP, CLIP-170, CLIP170, CYLN1, RSN"	ENSG00000130779	"CAP-Gly domain containing linker protein 1"	P30622	12	122271432-122422632	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004399, HPA026678"	Approved		Supported	"Microtubule ends,Cytosol"			7700	"Microtubule ends, Cytosol"		"CAB004399: AB_671001, HPA026678: AB_1846954"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.52e-3)"	14.4	12.6	9.8	9.1	10.9	6.4	11.7	44.5	11.5	11.6	19.5	4.3	13.9	5.7	14.3	10.1	24.8	7.5	7.7	11.8	9.3	7.5	10.0	15.2	10.0	5.8	6.5	9.5	6.3	9.1	37.8	10.9	36.5	8.7	13.2	7.1	6.7	11.8	15.1	96.5	16.8	9.1	31.1	7.2	5.9	9.6	6.1	6.9	3.7	24.1	25.9	10.1	22.2	16.6	5.3	5.4	18.2	10.6	3.9	7.2	3.7	15.3	19.4	12.0	12.1	10.3	15.9	20.9	21.9	20.9	14.9	9.3	9.0	7.6	6.9	14.8	28.4	19.7	7.6	9.0	16.9	28.9	5.5	2.3	12.9	9.5	20.5	7.9	12.7	10.5	31.0	17.1	25.9	14.9	8.6	4.7	14.9	8.9	4.9	2.8	4.5	17.2	4.6	9.3	3.4	13.4	17.6	4.6	2.9	47.0	11.5	19.2	9.9	4.7	28.8	11.3	12.2	26.5	14.3	5.3	4.1	4.1	19.4	4.0	7.8	3.6	6.5	5.2	7.2	10.6	5.4	5.3	6.7	6.5	5.4	3.6	5.0	3.7	18.2	3.9	8.6	3.5	5.8	3.7	9.8	10.9	44.5	11.5	9.3	7.5	6.5	9.5	8.7	6.9
CLMN	"FLJ12383, KIAA0500, KIAA1188"	ENSG00000165959	Calmin	Q96JQ2	14	95181940-95319906	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.1"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 13.9;T-47d: 11.6;WM-115: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012634	Enhanced		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"HPA012634: AB_1846973"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.88e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.18e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.09e-2)"	"prognostic favourable (2.68e-7)"	"unprognostic (8.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.91e-3)"	14.1	2.3	11.0	5.9	36.3	2.0	13.0	3.1	20.1	7.8	15.3	31.6	5.6	4.6	5.6	11.0	4.3	8.2	8.3	3.7	13.0	5.6	18.9	18.8	5.2	2.3	38.1	8.0	3.5	18.1	4.7	3.4	9.2	17.2	8.0	17.6	7.1	9.4	7.9	4.6	3.5	6.9	4.5	14.5	3.6	10.0	33.4	34.0	0.0	6.6	1.8	2.9	7.3	7.1	3.8	3.0	7.2	8.4	0.0	0.1	2.1	5.2	7.1	1.1	0.2	4.4	2.0	0.4	0.1	0.0	0.3	0.2	0.6	9.0	0.0	0.8	0.0	4.7	0.5	3.2	0.0	3.6	1.3	0.1	0.2	4.2	0.4	0.0	0.1	2.1	3.2	1.4	5.1	3.6	0.0	1.0	2.6	4.6	0.2	0.4	0.4	1.7	4.0	3.8	2.3	3.4	8.7	1.4	1.4	1.8	13.9	7.1	11.6	0.3	1.0	0.1	3.2	0.0	0.2	1.4	0.1	4.9	2.5	2.1	13.2	6.0	8.4	0.7	0.0	3.0	0.0	3.8	0.0	0.0	1.8	2.2	0.0	0.1	7.2	0.0	1.8	3.0	0.0	2.1	11.0	36.3	3.1	20.1	13.0	5.6	38.1	8.0	17.2	34.0
CLNS1A	"CLCI, ICln"	ENSG00000074201	"Chloride nucleotide-sensitive channel 1A"	P54105	11	77514936-77637805	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017840, HPA031707, HPA031708, HPA032045"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Cytosol"	Microtubules	"CAB017840: , HPA031707: , HPA031708: , HPA032045: "	"unprognostic (1.30e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.12e-3)"	"unprognostic (5.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	22.6	44.7	43.0	31.3	37.3	27.8	36.4	24.5	45.6	30.0	31.9	41.8	26.2	22.1	29.3	47.4	41.5	34.5	29.9	33.2	37.2	39.5	26.8	90.9	20.8	41.2	45.3	31.2	49.2	44.9	26.5	28.9	29.0	38.5	28.7	35.7	29.6	28.2	27.4	43.1	24.4	26.3	26.1	48.5	32.5	28.5	21.7	31.7	47.0	40.5	36.8	45.1	31.9	28.8	33.4	45.9	12.8	34.1	31.8	32.7	30.6	24.4	24.1	40.3	29.9	30.2	43.4	16.3	21.6	33.4	35.3	31.9	58.9	35.1	55.3	36.0	26.3	29.8	48.7	44.9	43.3	30.9	29.7	54.3	30.4	33.9	25.4	80.2	25.2	34.8	52.5	31.1	59.1	40.0	71.2	17.1	34.6	36.4	52.7	65.4	38.0	45.3	28.5	78.4	59.3	25.5	34.4	41.1	46.8	29.1	33.1	20.0	44.9	35.1	26.3	26.4	32.3	51.4	20.8	34.4	47.9	59.3	10.4	30.2	21.1	12.8	33.1	12.2	21.0	34.1	24.0	32.1	26.8	23.1	45.9	33.4	32.7	27.5	2.3	31.8	28.7	28.2	23.0	30.6	43.0	37.3	24.5	45.6	37.2	39.5	45.3	31.2	38.5	31.7
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit"	O76031	15	65148219-65185342	"Predicted intracellular proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"			Mitochondria	"Nucleoplasm, Cytosol"	"HPA040262: AB_10793961, HPA048199: "	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favourable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	10.4	12.8	11.3	8.9	12.7	7.7	10.2	10.9	10.7	11.7	13.4	11.2	4.7	9.3	9.8	10.3	15.5	8.9	9.6	15.9	10.7	9.2	16.8	50.9	9.4	8.8	12.8	8.1	10.8	10.6	11.0	6.3	10.6	9.8	9.7	8.9	7.4	8.9	7.1	25.8	15.6	12.6	10.8	9.7	9.7	9.9	9.3	12.6	17.8	12.9	14.7	10.2	12.5	9.5	7.7	9.8	11.4	7.1	8.2	9.2	4.4	5.2	9.0	7.8	9.9	8.4	10.8	8.5	6.0	6.8	6.6	7.0	8.9	7.4	16.3	5.1	8.1	11.3	28.7	8.0	7.1	6.4	5.2	12.2	8.7	11.3	12.0	15.6	7.1	12.8	11.0	6.1	11.7	8.4	11.2	5.8	7.7	6.6	7.3	13.8	8.8	4.0	14.5	9.4	16.8	12.5	12.2	6.8	5.5	8.1	13.1	8.8	5.9	13.2	7.4	6.7	5.9	5.4	5.6	6.2	9.4	8.6	6.6	19.8	5.2	3.5	7.1	10.3	7.6	5.7	7.0	7.7	6.7	5.6	6.4	7.2	9.2	7.3	11.4	8.2	5.1	9.8	5.7	4.4	11.3	12.7	10.9	10.7	10.7	9.2	12.8	8.1	9.8	12.6
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392455-176416569	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 103.7;MCF7: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"			350000	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	20.4	24.1	29.7	18.7	26.7	13.5	16.0	27.5	47.9	27.7	34.7	14.2	11.4	35.4	15.0	15.7	94.2	12.7	28.4	65.7	26.4	26.9	20.3	15.0	15.6	12.2	25.9	22.7	24.3	19.7	17.9	19.8	61.2	28.7	16.8	18.1	19.4	22.2	19.3	93.7	81.8	41.1	27.1	15.4	14.2	39.6	9.9	10.1	14.3	17.2	55.4	31.2	26.1	45.3	4.3	9.9	28.0	9.9	7.4	11.6	3.6	32.8	15.8	4.5	19.1	10.1	7.6	36.8	42.4	16.5	26.9	19.3	20.3	15.4	7.2	25.0	19.0	31.4	7.6	103.7	10.5	49.2	14.1	4.8	23.4	12.5	15.9	7.6	12.9	8.0	36.1	14.7	17.4	12.6	9.2	18.5	14.8	92.2	12.0	11.6	3.6	23.5	13.1	7.9	23.6	14.2	13.4	19.3	6.6	20.1	22.2	14.4	9.0	14.8	27.2	9.7	14.5	17.6	23.9	14.7	10.1	9.7	7.8	16.3	11.0	2.8	9.9	28.0	7.2	7.5	3.7	3.1	6.4	7.0	9.9	4.3	5.2	5.5	18.7	7.4	9.7	8.0	11.6	3.6	29.7	26.7	27.5	47.9	26.4	26.9	25.9	22.7	28.7	10.1
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"			51000000	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: "	"unprognostic (1.56e-1)"	"prognostic unfavourable (7.35e-4)"	"prognostic favourable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavourable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.02e-4)"	39.5	45.7	47.4	35.1	57.6	30.7	57.9	59.1	83.6	38.1	45.0	25.1	47.7	27.9	38.7	52.3	32.1	30.9	34.1	39.9	47.1	53.7	48.6	46.0	46.5	60.7	53.9	59.3	29.8	23.3	96.1	30.0	51.5	57.0	38.9	48.9	22.7	28.6	54.4	44.2	30.5	27.7	45.8	47.8	28.0	34.2	29.4	28.8	28.0	43.7	26.6	31.2	37.1	40.6	10.0	24.6	13.9	24.6	12.3	15.6	13.1	46.9	71.1	35.1	34.7	59.3	48.3	40.1	50.5	53.3	45.3	47.3	43.5	28.9	32.7	58.0	71.7	31.0	52.2	42.0	60.5	35.1	28.1	53.6	45.0	67.5	45.2	36.6	31.0	45.7	25.7	68.8	44.4	50.0	53.3	46.3	70.5	83.7	21.7	10.9	30.2	41.5	19.3	58.8	39.6	50.7	66.7	31.5	37.5	31.3	20.5	29.9	48.7	23.1	63.9	83.1	49.6	39.6	51.7	36.5	51.2	30.2	60.9	24.8	50.7	10.5	20.9	13.9	12.7	24.6	15.6	10.0	11.7	13.7	24.6	9.1	10.0	11.0	13.4	12.3	20.7	16.1	14.5	13.1	47.4	57.6	59.1	83.6	47.1	53.7	53.9	59.3	57.0	28.8
CLYBL	CLB	ENSG00000125246	"Citrate lyase beta like"	Q8N0X4	13	99606669-99897134	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039959, HPA040691"	Enhanced		Approved	Cytosol				Cytosol		"HPA039959: AB_10793857, HPA040691: AB_10794746"	"unprognostic (1.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.30e-3)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (6.66e-16)"	"unprognostic (3.74e-2)"	"unprognostic (5.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (7.82e-2)"	4.2	11.6	6.2	10.4	9.4	2.6	6.0	6.7	6.4	4.6	11.2	3.8	4.8	13.6	5.2	7.6	6.4	4.7	8.3	12.3	5.1	6.3	35.0	57.7	4.7	9.6	7.9	8.6	3.5	15.0	6.1	5.7	2.2	12.5	4.2	12.3	8.9	8.7	5.5	22.2	5.7	12.5	8.6	4.5	5.5	4.8	10.7	4.3	4.6	7.0	13.3	8.2	4.9	4.4	11.0	7.5	1.2	6.7	9.2	16.7	5.5	0.2	1.3	9.8	4.4	4.6	4.3	2.1	0.4	0.9	0.8	1.5	0.2	7.2	1.7	2.8	0.5	2.2	0.8	1.6	1.1	8.6	1.4	10.9	2.6	6.7	3.2	5.8	0.8	2.3	4.9	0.1	3.8	1.2	1.5	5.7	0.9	2.4	2.6	8.1	6.3	2.0	3.4	0.4	4.0	9.7	0.6	31.7	4.8	1.9	2.2	1.9	4.7	7.6	0.1	0.4	1.1	0.8	1.5	13.3	2.6	0.3	6.8	8.6	1.3	1.2	3.3	0.3	7.5	6.7	9.0	10.9	13.3	10.6	6.7	11.0	10.3	12.1	0.5	9.2	3.2	7.5	16.7	5.5	6.2	9.4	6.7	6.4	5.1	6.3	7.9	8.6	12.5	4.3
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046174-22065674	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	8.1	28.2	28.1	9.6	31.6	17.6	14.9	16.3	39.3	12.1	34.3	14.5	17.1	29.4	12.8	32.0	33.2	10.0	11.0	18.1	28.8	33.4	12.8	31.9	7.9	9.8	33.9	27.3	11.9	18.6	14.6	14.3	20.2	34.3	17.0	33.1	10.2	14.8	12.9	18.2	12.9	32.9	13.3	18.0	8.5	12.9	30.2	14.8	6.4	10.9	11.9	12.4	11.8	17.2	12.2	19.5	19.4	18.9	22.8	19.9	15.0	19.5	15.8	19.5	9.2	15.3	19.2	28.4	13.7	15.0	14.9	15.7	35.4	22.7	17.4	13.4	11.7	16.0	11.5	19.0	20.1	22.9	14.4	52.4	12.9	17.8	14.3	13.8	27.8	12.9	18.1	18.9	28.3	19.7	32.9	8.9	26.3	25.8	15.8	32.1	47.1	22.1	11.3	20.4	16.5	17.7	21.5	7.8	13.7	10.8	19.1	15.3	26.3	18.9	14.3	16.8	13.9	14.7	25.1	6.1	7.8	23.1	27.3	10.8	16.9	10.3	17.9	19.4	13.7	18.9	17.8	12.2	18.6	18.1	19.5	12.1	16.8	17.4	1.8	22.8	16.5	12.3	19.9	15.0	28.1	31.6	16.3	39.3	28.8	33.4	33.9	27.3	34.3	14.8
CMIP		ENSG00000153815	"C-Maf inducing protein"	Q8IY22	16	81445170-81711762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054424, HPA066710"	Approved		Supported	Nucleoplasm,Cytosol			360000	"Nucleoplasm, Cytosol"		"HPA054424: AB_2682484, HPA066710: AB_2685708"	"unprognostic (6.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.02e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavourable (9.47e-7)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (1.59e-1)"	19.1	19.7	34.3	25.6	27.9	19.6	15.4	13.1	46.5	28.5	26.5	13.0	7.1	33.5	15.5	14.1	26.5	20.3	27.8	9.3	28.1	35.7	15.8	11.4	18.8	17.2	19.4	30.6	17.7	16.5	8.9	26.4	23.8	19.4	13.4	20.0	7.8	15.5	14.0	6.3	24.5	40.5	19.1	15.7	18.0	28.2	11.0	13.2	20.8	11.3	10.2	16.1	22.2	37.2	0.8	0.5	5.7	1.7	0.5	1.0	0.9	11.2	37.8	7.5	3.8	3.9	3.2	15.3	8.2	5.6	5.2	2.3	12.7	23.2	5.0	7.0	6.8	11.6	4.8	27.3	5.0	3.2	3.5	24.3	7.1	22.1	3.9	7.4	52.7	3.1	11.6	9.6	12.4	14.3	21.2	4.4	3.1	11.3	13.0	9.3	5.9	8.0	23.6	2.4	4.9	6.5	11.2	39.3	7.9	19.1	7.1	2.4	5.5	10.0	9.8	8.3	8.9	8.0	7.4	5.6	4.3	22.0	9.8	8.8	3.3	4.8	1.7	2.1	1.0	1.2	0.5	0.1	0.2	0.3	0.5	0.8	0.1	0.5	5.7	0.5	0.3	0.5	0.2	0.9	34.3	27.9	13.1	33.7	28.1	35.7	19.4	30.6	19.4	13.2
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavourable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	14.4	17.4	23.1	17.3	17.7	22.4	14.6	25.0	25.0	14.5	18.0	15.5	21.3	15.0	19.5	19.4	12.6	16.9	15.0	18.8	17.6	16.1	13.9	16.6	15.2	19.2	16.0	22.7	22.6	18.4	24.4	20.2	20.6	16.9	16.3	13.1	17.1	17.6	17.9	28.9	16.6	16.5	17.6	12.5	21.7	15.9	63.9	17.8	18.4	15.7	14.1	20.7	16.2	14.8	11.1	9.8	8.1	13.2	9.7	11.5	7.8	6.9	6.6	9.5	15.5	10.8	9.9	11.5	8.3	11.5	21.1	23.7	9.9	4.6	14.4	9.4	12.2	7.8	12.1	8.6	16.2	9.9	10.7	7.9	7.7	11.0	8.3	11.4	5.4	8.5	6.4	11.6	8.3	9.8	17.6	10.6	11.0	11.3	14.4	10.2	4.8	6.3	11.5	11.3	8.2	6.8	8.4	10.5	7.9	9.3	7.2	11.9	12.2	8.8	9.0	12.7	9.5	5.0	9.3	12.1	6.3	76.3	5.0	12.0	13.9	8.1	10.2	6.4	10.1	13.2	8.5	11.1	8.9	10.7	9.8	8.1	9.9	8.0	6.6	9.7	9.9	8.2	11.5	7.8	23.1	17.7	25.0	25.0	17.6	16.1	16.0	22.7	16.9	17.8
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129169484-129183922	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Supported	Nucleoplasm,Cytosol			43000	"Nucleoplasm, Cytosol"		"HPA063097: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	54.2	52.8	36.4	33.6	33.7	35.9	46.6	43.5	35.6	58.1	47.1	34.5	40.5	32.4	54.5	49.4	55.6	40.9	48.5	78.2	33.0	32.0	38.0	71.6	47.5	40.6	39.7	30.3	67.4	65.4	39.3	33.5	41.5	33.3	62.3	37.1	41.3	48.9	50.9	182.1	46.7	40.6	71.9	38.0	43.2	43.1	32.1	33.1	39.0	67.3	81.1	41.2	76.1	63.5	74.3	60.3	120.1	84.1	61.7	83.4	172.9	61.2	36.3	53.0	42.0	53.0	45.5	41.8	48.2	76.5	52.6	60.5	53.2	43.2	81.5	41.4	44.8	46.1	69.2	55.9	71.3	54.7	50.4	78.7	37.5	57.2	52.8	84.4	45.3	43.9	65.6	36.8	133.0	46.4	58.9	56.1	55.0	73.3	78.2	62.1	64.6	61.4	68.8	49.2	97.1	54.4	59.1	72.2	57.8	38.0	37.6	102.2	43.3	58.1	48.8	39.0	38.4	53.5	48.7	52.8	48.0	128.2	40.1	57.9	51.4	93.4	84.1	96.8	64.1	63.8	80.6	74.3	77.4	68.9	60.3	62.7	83.4	72.0	120.1	61.7	48.9	35.1	73.9	172.9	36.4	33.7	43.5	35.6	33.0	32.0	39.7	30.3	33.3	33.1
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 75.1;RPMI-8226: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol			2400000	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	19.0	11.5	31.0	19.1	36.0	6.1	16.9	10.4	33.0	39.4	37.6	45.2	27.0	51.3	12.5	35.3	20.4	38.9	25.9	11.6	31.1	26.4	89.0	66.4	22.1	23.0	36.1	24.1	11.4	27.6	15.7	13.7	28.8	27.2	34.7	22.2	14.1	16.9	32.7	7.5	11.8	71.1	10.4	39.4	39.2	27.2	6.5	32.5	10.9	43.9	11.6	21.4	28.4	12.0	29.6	49.0	12.5	44.4	31.4	23.9	30.3	10.0	13.6	9.9	9.3	12.1	7.2	41.6	10.6	10.0	14.5	14.5	7.9	10.8	12.7	13.5	11.5	15.3	15.0	20.1	10.4	19.0	5.9	12.6	6.9	12.5	17.6	24.7	19.7	10.8	15.5	12.5	22.7	12.7	13.3	75.1	9.6	11.3	13.1	11.8	14.9	8.1	14.3	11.4	96.6	57.1	42.2	10.7	5.6	8.3	59.0	14.1	24.7	10.2	13.2	15.6	13.3	3.4	7.1	14.1	57.6	17.0	10.5	18.1	13.0	7.8	30.0	12.5	21.8	44.4	23.8	28.9	17.6	20.3	49.0	29.6	19.1	20.7	4.4	31.4	43.1	43.0	23.9	30.3	31.0	36.0	10.4	33.0	31.1	26.4	36.1	24.1	27.2	32.5
CNEP1R1	"C16orf69, FLJ38101, NEP1-R1, TMEM188"	ENSG00000205423	"CTD nuclear envelope phosphatase 1 regulatory subunit 1"	Q8N9A8	16	50024410-50037088	"Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042815, HPA077906"	Uncertain		Supported	Cytosol				Cytosol		"HPA042815: AB_10794765, HPA077906: "	"unprognostic (4.11e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.37e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	15.4	12.7	14.5	16.3	15.0	25.1	17.0	19.1	17.2	10.6	11.3	12.2	4.0	10.9	13.0	17.1	17.2	10.9	13.5	14.3	12.8	12.6	12.5	12.9	14.1	19.7	17.7	11.9	12.9	13.6	11.7	17.3	18.5	14.0	10.6	16.7	14.9	12.2	10.7	10.5	13.9	12.9	13.9	12.9	21.4	11.9	22.4	14.1	12.4	8.4	10.3	18.6	12.8	12.6	5.5	9.6	28.7	18.7	6.3	9.6	7.2	7.5	7.3	8.6	9.1	17.3	16.6	12.8	15.4	11.8	14.9	9.0	7.6	10.9	8.7	11.6	12.6	12.1	7.0	7.6	19.0	6.2	8.3	4.0	4.4	11.9	11.7	5.4	12.7	12.4	12.8	9.7	7.7	10.2	5.0	5.0	18.9	2.2	10.4	13.8	6.4	9.8	13.2	11.4	8.7	10.0	5.1	6.8	8.0	14.4	5.9	5.5	5.2	6.7	13.2	14.5	11.6	13.6	5.4	8.2	7.4	10.2	8.1	5.6	11.8	7.4	12.2	8.6	9.6	15.7	8.9	5.5	7.6	7.0	9.6	4.9	7.6	8.9	28.7	6.3	18.7	3.8	7.4	7.2	14.5	15.0	19.1	17.2	12.8	12.6	17.7	11.9	14.0	14.1
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel beta 1"	Q14028	16	57882340-57971116	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 79.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;RPMI-8226: 3.3;SCLC-21H: 9.4;SiHa: 5.4"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA039159, HPA060355"			Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.2	7.2	13.1	3.0	3.0	0.7	0.2	0.2	6.3	0.2	1.7	0.0	0.0	0.5	0.2	0.5	0.2	0.4	0.8	0.2	7.1	11.0	0.2	0.2	0.4	0.7	1.3	4.0	0.1	1.5	0.0	0.5	1.2	4.2	0.2	1.2	79.8	0.3	0.4	0.1	0.5	1.8	0.2	0.7	0.2	0.2	1.3	0.0	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	2.6	0.3	0.3	0.4	0.0	0.6	1.2	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.6	1.7	0.9	0.0	0.0	0.2	0.0	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.0	3.3	0.0	1.2	9.4	0.1	5.4	2.7	0.0	0.1	0.1	0.7	0.3	0.4	0.4	0.1	0.2	0.5	0.1	0.1	0.3	0.1	0.6	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.4	0.2	2.6	0.3	0.3	0.3	0.0	0.0	13.1	3.0	0.2	6.3	7.1	11.0	1.3	4.0	4.2	0.0
CNKSR1	"CNK, CNK1, KSR"	ENSG00000142675	"Connector enhancer of kinase suppressor of Ras 1"	Q969H4	1	26177403-26189886	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 11.6;BEWO: 10.1;CAPAN-2: 17.9;HaCaT: 13.2;hTCEpi: 11.4;SK-BR-3: 11.6;T-47d: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.1;memory CD4 T-cell: 2.4;naive CD4 T-cell: 1.4;T-reg: 2.6"	"Group enriched"	"Detected in many"	8	"B-cells: 2.1;T-cells: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030847	Uncertain		Approved	Cytosol				Cytosol		"HPA030847: AB_10601100"	"unprognostic (2.73e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.91e-1)"	"prognostic favourable (5.91e-4)"	0.7	0.0	1.0	3.5	1.4	0.0	4.5	5.4	1.1	4.4	19.1	0.8	12.8	8.6	1.9	11.9	15.4	6.1	13.3	0.7	1.4	1.2	10.0	2.9	10.2	0.7	0.9	0.7	2.5	27.6	10.2	12.6	32.4	1.2	10.3	5.4	0.7	15.7	18.9	17.7	11.9	22.6	1.0	1.3	1.3	7.3	1.5	0.7	1.9	20.6	11.9	15.9	6.1	5.3	2.1	0.0	0.0	0.0	0.2	2.6	0.5	11.6	0.0	0.2	0.1	0.2	0.0	10.1	0.3	0.0	0.4	0.0	1.8	17.9	1.9	6.0	0.0	13.2	0.3	8.4	0.3	0.4	0.6	0.2	4.3	5.0	0.1	0.1	0.2	0.0	11.4	0.0	3.2	0.0	1.5	0.1	0.0	5.4	0.1	0.6	5.2	1.1	0.1	0.1	0.0	1.0	6.8	2.5	0.6	0.0	11.6	0.2	10.9	0.0	0.0	0.0	1.8	0.7	0.1	4.1	0.7	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.3	1.4	0.1	0.0	0.2	0.0	0.0	2.6	0.5	1.0	1.4	5.4	1.1	1.4	1.2	0.9	0.7	1.2	0.7
CNKSR3	"FLJ31349, MAGI1"	ENSG00000153721	"CNKSR family member 3"	Q6P9H4	6	154387504-154510659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in many"											"CAB037133, HPA049651"	Approved		Approved	Mitochondria,Cytosol				Mitochondria	Cytosol	"CAB037133: AB_477217, HPA049651: "	"unprognostic (3.07e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favourable (6.00e-4)"	"unprognostic (4.23e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.38e-1)"	9.4	2.2	4.2	5.5	5.8	1.6	5.8	1.8	5.0	7.6	12.5	11.6	6.0	8.7	15.8	8.3	19.4	6.5	9.2	8.9	5.3	3.4	17.0	20.0	6.3	3.5	8.0	2.5	10.0	26.6	1.5	4.5	8.2	8.3	8.3	5.5	12.6	7.5	7.7	2.2	6.7	13.5	15.3	8.2	7.6	6.7	8.6	7.7	0.6	4.1	8.7	6.6	9.8	10.2	0.9	1.4	3.6	0.6	0.9	0.5	0.2	0.3	3.9	2.7	5.5	4.9	3.7	0.3	4.8	3.0	8.4	7.0	17.1	0.4	0.1	5.3	5.2	1.7	8.1	0.5	4.4	0.0	5.0	13.0	0.8	9.4	2.2	0.0	2.9	5.0	2.6	3.2	3.4	2.6	1.7	0.1	2.3	1.0	0.1	0.3	2.0	5.1	3.8	4.8	6.3	9.8	2.7	1.7	10.5	2.2	1.2	1.0	0.0	1.1	3.0	0.8	2.5	6.3	3.1	0.1	0.0	0.1	0.1	0.3	3.7	2.1	0.6	1.2	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.9	0.5	0.5	3.6	0.9	0.4	1.4	0.3	0.2	4.2	5.8	1.8	5.0	5.3	3.4	8.0	2.5	8.3	7.7
CNN2		ENSG00000064666	"Calponin 2"	Q99439	19	1026581-1039068	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049095	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"			39000000	Cytosol	"Nucleoplasm, Actin filaments"	"HPA049095: "	"unprognostic (2.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (4.70e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.54e-1)"	36.6	6.5	1.3	46.2	2.5	44.2	29.2	2.0	3.0	38.2	16.9	5.4	22.2	5.5	35.5	24.5	39.4	25.0	40.1	18.7	1.5	1.5	24.6	15.8	54.7	61.5	3.5	1.5	81.1	26.8	1.9	6.9	21.5	4.8	35.6	7.8	26.3	40.9	34.4	6.1	21.3	17.7	28.2	2.9	59.4	21.1	15.9	2.1	37.0	68.1	27.3	78.6	37.9	51.2	33.6	29.3	115.7	26.3	27.1	57.0	43.1	37.2	12.6	35.1	43.7	18.1	34.5	27.3	33.7	37.4	42.6	33.1	43.3	32.2	24.5	34.6	60.9	36.7	20.8	53.9	28.4	17.0	1.7	17.0	20.2	33.8	72.6	15.9	39.2	58.7	25.7	26.9	20.4	23.9	10.1	38.2	34.6	7.1	1.4	14.6	43.3	5.5	8.4	12.4	27.7	41.8	44.8	0.0	2.5	42.7	5.8	4.8	42.4	26.8	58.7	23.3	24.2	35.6	34.3	17.8	13.5	48.9	13.7	19.1	37.2	61.3	18.6	81.0	34.8	24.2	57.0	33.6	43.7	46.4	29.3	30.8	37.3	36.3	115.7	27.1	26.3	13.0	45.6	43.1	1.3	2.5	2.0	3.0	1.5	1.5	3.5	1.5	4.8	2.1
CNN3		ENSG00000117519	"Calponin 3"	Q15417	1	94896949-94927278	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.7;naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	14	"B-cells: 9.7;T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009849, HPA051237"	Enhanced		Enhanced	"Actin filaments,Cytosol"			320000	"Actin filaments"	Cytosol	"CAB009849: AB_2276410, HPA051237: "	"unprognostic (8.47e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.22e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-2)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.33e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.99e-4)"	49.3	78.5	53.4	27.9	53.9	1.2	82.7	25.3	44.7	55.1	36.3	30.8	20.8	45.4	74.0	31.4	53.6	39.4	55.3	33.0	46.8	40.3	74.2	50.6	59.0	28.6	45.3	27.0	61.5	28.0	21.6	33.5	88.5	67.8	38.8	30.2	47.5	32.9	48.9	16.1	16.6	33.4	68.6	78.2	30.8	30.6	21.1	41.9	9.3	44.3	18.4	17.2	48.7	74.5	9.7	0.1	0.4	0.1	0.7	11.1	2.6	44.8	8.7	49.6	43.7	35.5	31.9	22.0	21.7	43.0	36.6	58.1	40.2	4.0	0.0	50.1	28.0	12.9	36.2	19.3	53.0	0.1	12.8	2.0	6.1	30.4	66.0	0.0	0.0	29.8	3.0	45.2	10.5	32.8	0.4	4.1	95.4	0.0	2.1	0.1	38.1	4.7	0.0	59.2	0.2	47.7	18.7	3.0	30.4	18.1	7.7	30.6	13.9	4.5	20.1	24.5	42.0	9.0	70.6	5.0	2.9	0.1	5.3	0.0	36.7	0.1	0.0	0.0	1.9	0.1	3.1	3.9	2.0	1.1	0.1	9.7	11.1	7.6	0.4	0.7	0.1	0.0	0.0	2.6	53.4	53.9	25.3	43.6	46.8	40.3	45.3	27.0	67.8	41.9
CNNM1	ACDP1	ENSG00000119946	"Cyclin and CBS domain divalent metal cation transport mediator 1"	Q9NRU3	10	99329099-99394330	"Predicted membrane proteins"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.5;testis: 16.8"	"Cell line enhanced"	"Detected in some"		"A549: 17.3;BJ hTERT+: 6.6;BJ hTERT+ SV40 Large T+: 6.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HAP1: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040408	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA040408: AB_10793963"	"unprognostic (9.04e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.60e-4)"	"unprognostic (4.08e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.03e-1)"	0.6	2.5	3.4	0.7	15.5	0.5	1.3	8.1	12.7	2.0	1.0	0.3	1.1	1.2	2.1	3.7	1.4	2.4	1.0	0.5	2.8	5.0	2.4	0.8	0.6	0.5	2.1	7.1	5.4	1.7	0.4	4.2	0.5	4.8	3.6	1.2	0.7	1.0	2.1	0.5	2.5	1.2	1.5	1.0	0.5	1.6	16.8	2.3	0.0	0.5	0.2	0.6	2.2	1.2	0.1	0.1	0.2	0.0	0.1	1.3	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	2.5	6.6	6.0	10.4	0.0	3.9	0.0	0.0	1.2	1.6	7.8	0.0	4.4	0.0	0.8	1.7	2.6	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.2	0.0	0.8	0.7	0.0	0.0	0.0	0.8	0.0	2.0	5.5	1.8	0.4	0.8	0.0	0.0	0.0	0.6	0.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.3	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.4	15.5	8.1	12.4	2.8	5.0	2.1	7.1	4.8	2.3
CNNM3	ACDP3	ENSG00000168763	"Cyclin and CBS domain divalent metal cation transport mediator 3"	Q8NE01	2	96816245-96833911	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016711	Supported		Approved	Cytosol				Cytosol		"HPA016711: AB_1847394"	"unprognostic (1.50e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.32e-3)"	"unprognostic (3.64e-1)"	"unprognostic (5.31e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.48e-2)"	8.1	10.7	8.6	6.4	11.5	5.2	8.6	25.0	11.2	8.9	13.3	16.9	7.4	17.4	10.7	5.3	7.5	12.0	15.0	5.9	10.0	5.2	8.6	20.7	8.8	7.2	14.5	9.7	11.6	27.9	28.9	15.7	10.3	11.4	8.9	8.3	13.1	11.4	9.9	9.9	7.7	15.1	10.7	7.0	9.5	12.3	11.4	15.9	13.8	10.0	2.4	10.2	9.9	8.2	3.0	1.8	5.5	3.3	2.1	5.4	1.3	6.8	7.1	5.9	9.6	7.3	3.5	17.9	4.8	4.1	4.6	4.6	18.5	11.5	7.7	16.7	3.7	8.0	8.9	6.3	3.0	7.5	21.5	10.4	9.0	18.6	6.5	8.9	7.7	3.5	7.7	6.1	5.5	5.6	9.4	12.2	1.8	9.0	8.3	8.8	8.1	8.4	10.3	8.2	9.5	7.5	9.3	18.9	11.5	6.2	9.4	5.2	9.5	6.5	2.7	4.1	11.7	5.9	6.7	12.3	11.8	5.6	2.3	8.6	4.1	2.7	1.4	5.5	5.4	0.6	2.9	3.0	2.8	4.4	0.4	2.8	2.5	2.7	3.0	2.1	3.3	1.8	4.6	1.3	8.6	11.5	25.0	11.2	10.0	5.2	14.5	9.7	11.4	15.9
CNOT1	"AD-005, CDC39, KIAA1007, NOT1, NOT1H"	ENSG00000125107	"CCR4-NOT transcription complex subunit 1"	A5YKK6	16	58519951-58629886	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046577, HPA049664"	Approved		Supported	Cytosol			210000	Cytosol		"HPA046577: , HPA049664: "	"unprognostic (1.30e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	20.4	26.5	14.9	31.5	16.5	18.2	18.8	24.2	16.8	21.3	26.6	16.7	26.6	24.3	22.2	19.1	45.6	19.0	15.4	15.5	14.2	9.0	18.8	20.9	19.6	24.1	19.0	12.3	22.6	21.8	39.6	25.4	23.2	16.1	15.9	26.6	17.3	28.3	27.2	32.6	27.4	31.4	20.0	13.6	25.8	22.7	53.9	18.1	45.1	20.2	22.6	32.6	26.9	26.0	15.4	14.6	18.8	20.9	14.6	19.2	10.6	25.9	30.6	23.3	18.7	11.3	14.5	26.8	20.6	18.0	23.7	17.6	34.6	15.7	39.6	9.9	15.7	25.6	37.4	21.0	32.1	14.7	20.4	30.8	25.2	39.5	15.4	47.4	34.5	13.9	14.4	27.5	32.4	18.4	36.0	11.6	16.0	10.6	36.6	12.4	24.1	26.6	46.7	40.3	25.1	13.4	36.6	19.3	12.5	69.9	23.7	11.7	14.2	24.8	20.6	17.4	17.3	13.1	18.0	26.5	26.7	80.4	18.4	20.2	16.1	18.3	11.6	13.0	14.6	15.9	19.2	15.4	14.1	14.6	14.6	14.2	12.6	13.5	18.8	14.6	20.9	7.4	14.8	10.6	14.9	16.5	24.2	16.8	14.2	9.0	19.0	12.3	16.1	18.1
CNOT10	"FLJ12890, FLJ13165"	ENSG00000182973	"CCR4-NOT transcription complex subunit 10"	Q9H9A5	3	32685145-32773875	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035614, HPA041450"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA035614: AB_10669975, HPA041450: "	"unprognostic (3.75e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.43e-1)"	12.3	12.6	11.3	15.2	12.4	16.6	14.0	14.2	13.4	13.4	14.0	12.5	12.8	10.8	19.8	13.5	14.8	16.1	9.8	13.0	10.5	9.4	13.1	13.5	11.4	14.7	9.7	11.9	14.7	14.0	16.0	23.0	11.3	13.3	13.1	15.7	12.2	12.0	10.9	13.5	14.9	14.7	12.8	10.5	15.1	12.2	40.5	10.9	30.2	13.8	11.9	17.4	13.0	12.6	15.0	14.1	16.0	21.0	9.0	18.5	11.2	8.2	9.3	9.7	9.1	4.7	5.4	64.7	7.0	7.0	10.0	11.3	7.0	7.2	13.6	4.7	4.9	7.3	11.4	9.2	10.0	11.7	11.7	17.4	8.4	6.8	13.7	14.3	6.7	4.0	8.3	11.0	14.6	8.1	18.1	10.6	5.8	6.8	12.7	6.9	14.6	8.9	12.9	6.6	13.6	6.4	9.7	5.5	10.7	10.3	14.5	8.4	14.1	16.2	5.0	6.2	8.8	8.1	11.5	11.0	22.5	13.6	6.3	10.9	7.5	12.8	11.2	16.0	11.4	15.7	12.3	14.8	18.5	13.6	14.1	15.0	18.5	16.2	8.8	9.0	21.0	7.8	14.4	11.2	11.3	12.4	14.2	13.4	10.5	9.4	9.7	11.9	13.3	10.9
CNOT2	"CDC36, NOT2, NOT2H"	ENSG00000111596	"CCR4-NOT transcription complex subunit 2"	Q9NZN8	12	70242994-70354993	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067711	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA067711: "	"unprognostic (5.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (7.36e-2)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (8.63e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.23e-2)"	27.8	19.9	18.9	24.6	23.8	44.5	24.9	53.3	24.7	24.0	21.7	21.9	21.6	20.1	37.5	25.8	22.5	20.6	18.8	20.1	18.7	16.2	21.8	24.1	25.9	24.8	23.8	21.2	26.8	20.5	25.0	41.2	30.1	19.8	24.3	24.9	20.5	21.6	21.9	27.6	36.7	24.4	25.5	23.4	26.8	18.8	16.3	24.8	46.1	22.7	20.9	28.8	24.8	24.5	28.8	33.1	37.1	36.5	32.2	41.3	27.2	19.9	19.0	32.3	20.4	17.8	20.2	26.9	22.2	26.8	24.6	21.2	24.4	19.5	42.9	20.5	25.3	19.8	22.4	21.8	27.7	20.5	20.3	28.2	17.6	22.8	19.0	36.4	25.2	22.0	24.5	23.2	28.2	26.1	25.6	24.9	21.4	21.6	41.5	26.0	27.5	20.3	32.3	26.7	26.0	22.8	40.3	21.6	25.5	26.1	21.1	18.7	27.0	30.2	19.0	23.0	15.9	21.0	17.9	22.7	26.0	34.0	23.6	17.9	18.0	37.1	26.0	28.3	29.4	36.5	32.8	28.8	31.9	32.9	33.1	27.6	38.0	41.3	15.1	32.2	29.3	23.0	29.7	27.2	18.9	23.8	53.3	24.7	18.7	16.2	23.8	21.2	19.8	24.8
CNOT3	"KIAA0691, LENG2, NOT3, NOT3H"	ENSG00000088038	"CCR4-NOT transcription complex subunit 3"	O75175	19	54137717-54155708	"Cancer-related genes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006408	Approved		Approved	Cytosol				Cytosol		"HPA006408: AB_1078543"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (2.22e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.08e-3)"	"prognostic unfavourable (2.77e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	18.1	25.2	25.5	23.6	26.4	21.4	20.2	46.8	27.9	22.1	20.7	24.5	27.7	21.3	25.0	26.5	22.1	23.6	19.7	16.2	21.9	15.6	21.3	20.2	17.9	23.9	25.5	20.8	28.0	22.7	27.6	30.2	24.2	20.3	23.3	17.5	20.7	22.4	31.4	20.2	25.2	21.4	22.0	16.7	26.3	21.9	34.4	26.9	33.6	26.3	14.3	23.3	23.8	29.9	3.2	6.7	8.4	3.1	1.6	3.6	2.9	13.6	22.0	22.8	13.1	8.5	8.6	16.0	12.8	22.2	17.2	15.4	14.1	11.8	16.8	8.2	14.8	14.4	25.3	12.5	17.8	17.4	71.4	26.1	14.3	12.5	14.8	14.9	18.3	10.9	12.0	15.3	25.9	13.6	19.2	15.8	12.6	16.9	18.4	8.8	13.9	17.7	18.4	17.5	10.9	11.5	27.7	14.7	12.5	24.7	17.8	8.1	10.2	16.0	12.1	14.6	16.9	7.7	17.3	14.8	16.2	23.2	12.7	11.4	15.4	1.4	3.1	5.2	3.6	2.2	2.5	2.9	2.4	3.2	2.8	3.2	2.7	2.6	8.4	1.6	2.6	6.7	2.5	2.9	25.5	26.4	46.8	27.9	21.9	15.6	25.5	20.8	20.3	26.9
CNOT6	"CCR4, Ccr4a, KIAA1194"	ENSG00000113300	"CCR4-NOT transcription complex subunit 6"	Q9ULM6	5	180494412-180578405	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044568	Approved		Approved	Cytosol				Cytosol		"HPA044568: AB_10797257"	"unprognostic (9.41e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (3.61e-7)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.57e-2)"	10.2	10.1	19.2	15.4	20.2	14.4	13.3	43.9	18.7	12.0	16.4	11.7	9.7	16.2	13.1	12.4	19.6	13.3	12.7	13.0	15.9	11.1	14.1	8.6	13.0	14.3	12.3	14.0	14.8	10.3	13.4	12.7	17.6	12.9	13.9	16.2	14.3	13.4	10.9	8.3	14.4	20.6	13.4	12.3	17.0	13.7	17.6	14.9	25.1	12.6	10.0	18.4	16.9	24.5	2.2	2.5	3.4	5.8	2.1	4.5	1.7	10.8	13.1	27.0	21.5	4.5	5.2	27.9	8.0	5.4	10.6	12.7	16.0	16.0	11.5	12.2	5.2	11.5	22.5	26.6	12.5	33.7	11.3	12.5	17.7	10.2	6.7	14.6	9.2	4.3	12.9	7.8	16.7	12.9	13.3	11.1	9.8	22.4	18.5	8.8	7.9	6.3	17.1	13.6	8.2	11.7	21.6	19.8	16.7	13.5	18.1	11.5	22.6	14.8	14.0	11.4	13.1	8.2	14.1	7.3	13.0	12.2	10.8	20.1	9.3	1.5	2.6	3.4	3.8	4.1	4.0	2.0	3.3	2.3	2.4	2.2	4.5	4.4	2.2	2.1	5.8	2.5	2.3	1.7	19.2	20.2	43.9	18.7	15.9	11.1	12.3	14.0	12.9	14.9
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 51.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol				Cytosol		"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	13.6	7.8	8.6	21.5	8.2	15.3	11.0	11.1	9.2	7.8	7.3	7.0	4.6	7.5	11.4	6.3	10.2	7.1	8.3	7.5	6.0	5.7	7.7	10.8	12.7	19.2	7.6	7.3	8.8	10.8	14.6	10.0	12.3	6.7	8.4	8.9	10.3	9.9	7.4	9.1	12.2	11.5	8.4	6.9	23.4	7.9	7.3	5.6	51.3	9.1	6.2	21.1	10.7	10.3	7.5	6.1	20.2	9.3	7.4	10.0	4.4	8.6	5.6	7.1	4.7	8.4	7.3	7.0	6.9	9.1	6.2	8.4	2.2	9.7	15.0	8.8	9.6	5.6	9.1	9.6	8.3	15.0	5.1	14.0	7.8	6.3	5.3	13.9	12.3	4.7	12.4	6.9	12.8	19.6	11.7	20.1	7.1	5.9	25.7	7.0	3.2	1.8	6.3	20.0	10.7	7.1	9.8	8.7	4.2	11.9	10.9	4.8	3.5	7.2	21.3	6.0	6.6	11.3	3.8	25.8	11.0	18.7	6.5	6.1	4.4	20.2	4.7	10.2	10.0	7.0	10.0	5.3	7.5	7.8	4.5	7.5	7.3	8.5	6.7	7.4	9.3	6.1	6.0	4.4	8.6	8.2	11.1	9.2	6.0	5.7	7.6	7.3	6.7	5.6
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966741-41977731	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 211.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 49.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol			730000	Nucleoplasm	Cytosol	"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	9.1	8.9	51.4	9.5	72.8	6.7	8.1	13.4	125.3	10.3	7.5	211.7	2.3	7.1	8.0	12.7	15.0	9.3	10.8	7.6	78.4	40.7	14.7	9.6	6.7	10.5	86.7	49.0	11.2	9.2	5.8	4.4	7.8	66.7	11.7	6.4	3.6	15.1	13.2	7.6	11.1	6.4	10.1	160.2	7.1	7.4	4.6	63.5	2.1	7.2	2.2	11.2	9.8	5.7	9.9	49.1	7.3	13.1	7.3	7.5	9.1	13.7	23.5	22.3	27.5	19.1	18.0	9.6	17.2	26.5	44.8	50.6	18.4	12.6	14.6	13.9	22.4	23.7	15.0	11.4	15.6	14.5	19.0	14.2	16.2	31.9	20.6	13.8	12.9	29.7	8.2	24.5	6.0	20.4	10.0	12.0	15.6	8.7	35.4	12.5	5.2	16.8	22.1	32.8	14.2	11.9	14.1	13.1	17.7	21.8	32.9	38.3	14.7	20.7	20.4	17.5	19.2	23.7	20.3	13.5	15.3	11.7	17.3	10.7	68.2	4.9	12.1	7.3	7.5	13.1	5.9	9.9	6.5	6.0	11.1	7.0	5.9	6.9	2.6	7.3	10.3	49.1	7.2	9.1	51.4	72.8	13.4	93.8	78.4	40.7	86.7	49.0	66.7	63.5
CNPY2	"Cnpy2, HP10390, TMEM4, ZSIG9"	ENSG00000257727	"Canopy FGF signaling regulator 2"	Q9Y2B0	12	56309842-56316336	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038465, HPA038466"	Supported		Supported	Cytosol	"Intracellular and membrane"		62000	Cytosol		"HPA038465: AB_10967609, HPA038466: AB_10672646"	"unprognostic (3.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (8.37e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (2.32e-8)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.06e-2)"	17.8	31.4	19.0	16.1	23.8	14.0	27.3	17.3	24.1	29.9	23.7	23.3	40.1	23.0	21.1	46.4	19.1	26.1	19.9	16.9	19.0	20.4	26.7	53.2	17.3	14.9	21.2	21.8	25.7	59.9	19.9	39.3	39.7	21.6	23.4	24.2	18.9	46.2	33.4	10.9	12.3	26.4	16.8	22.5	20.2	23.6	13.7	20.4	13.0	38.0	15.5	16.2	19.7	17.4	33.1	35.3	22.2	36.4	30.1	38.7	33.7	16.3	29.4	21.1	19.3	57.5	22.5	42.7	18.6	37.0	34.7	24.7	39.2	29.2	15.2	32.1	40.0	23.8	26.3	20.8	20.2	18.3	24.6	14.6	31.0	34.5	28.6	27.4	22.3	26.1	31.6	28.5	32.2	28.0	23.3	39.2	23.8	26.8	16.8	32.5	21.5	41.9	19.8	17.3	32.1	26.9	12.6	22.7	13.4	27.3	27.3	27.3	25.8	60.3	15.1	15.2	11.5	16.4	22.2	19.3	25.6	11.4	28.1	26.8	24.2	22.2	36.4	18.3	33.4	26.1	38.7	33.1	37.2	35.2	35.3	27.6	37.9	34.3	5.2	30.1	15.9	34.3	31.2	33.7	19.0	23.8	17.3	24.1	19.0	20.4	21.2	21.8	21.6	20.4
CNRIP1	"C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924"	ENSG00000119865	"Cannabinoid receptor interacting protein 1"	Q96F85	2	68284171-68320051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2"	"Cell line enhanced"	"Detected in many"		"HEL: 52.5"	"Cancer enhanced"	"Detected in all"		"glioma: 14.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	79	"basophil: 11.1"	"Lineage enriched"	"Detected in single"	79	"granulocytes: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035337			Approved	Cytosol			50000	Cytosol		"HPA035337: AB_10601359"	"unprognostic (1.23e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-3)"	26.6	8.6	26.9	7.1	21.9	6.4	11.8	28.3	42.2	15.3	7.3	7.5	2.0	4.9	15.7	8.0	6.3	9.3	10.3	8.8	26.9	22.4	5.0	3.8	10.0	5.7	16.0	22.9	24.5	2.6	2.7	7.2	14.7	12.7	10.1	6.3	10.9	3.3	11.6	7.8	3.6	7.0	11.8	10.8	10.8	5.7	4.0	6.5	0.1	4.1	3.0	4.1	9.3	13.6	0.1	0.0	11.1	0.1	0.0	0.1	0.1	0.0	0.3	3.0	0.0	11.2	8.3	0.0	11.3	8.7	10.2	7.4	0.0	0.0	0.0	0.4	10.8	0.0	0.2	0.1	10.8	0.0	2.7	52.5	0.7	0.0	11.8	0.0	7.4	7.7	0.0	6.7	3.9	15.7	0.0	0.0	7.3	0.0	0.0	0.1	5.1	5.2	0.0	4.6	0.0	0.0	0.0	15.5	15.7	0.8	0.0	8.7	0.0	0.5	16.7	7.2	4.6	6.3	16.4	0.0	0.0	0.0	5.7	0.0	5.2	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	26.9	21.9	28.3	31.9	26.9	22.4	16.0	22.9	12.7	6.5
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.9"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: , HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	13.2	5.6	4.3	5.2	5.1	12.5	7.4	15.5	4.5	16.6	8.6	4.2	6.7	2.2	22.6	6.0	6.0	8.0	7.4	4.9	4.2	3.8	5.0	20.0	5.4	4.8	4.9	2.6	15.2	3.6	10.0	13.2	6.1	6.3	9.8	4.0	7.0	3.8	6.3	5.9	3.5	4.4	11.9	8.1	8.6	4.4	8.2	6.8	4.4	5.5	5.8	2.8	11.7	13.5	0.3	1.5	0.8	6.9	1.2	0.2	0.5	5.8	4.0	8.9	5.0	4.4	10.3	0.3	6.9	4.6	5.1	7.0	0.3	2.0	4.3	1.1	4.7	0.3	10.2	2.8	8.1	0.2	3.6	25.0	8.6	1.4	4.8	3.4	5.5	6.5	1.5	4.3	4.2	7.3	0.9	1.0	8.2	0.5	2.8	5.5	6.9	7.5	4.1	8.2	2.1	3.0	1.4	5.6	5.8	8.4	0.2	2.1	1.7	8.7	5.3	7.1	2.8	7.7	5.9	3.5	4.2	0.1	3.3	4.3	3.2	0.6	2.7	0.1	0.1	3.3	0.0	0.3	0.2	0.1	1.5	0.3	0.1	0.1	0.8	1.2	6.9	1.5	0.2	0.5	4.3	5.1	15.5	4.5	4.2	3.8	4.9	2.6	6.3	6.8
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074863-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020468, HPA020480, HPA051583"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA020468: , HPA020480: , HPA051583: "	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	7.7	4.7	5.5	22.2	11.7	24.0	6.8	10.9	8.7	8.4	5.5	4.9	5.9	3.8	7.3	6.4	5.6	8.4	5.1	4.4	6.6	4.3	4.0	3.8	9.3	20.3	8.1	4.1	10.6	5.2	4.0	17.3	5.8	7.0	7.2	5.5	4.4	6.3	8.6	2.8	5.2	8.8	5.7	9.7	14.8	7.1	30.2	9.8	26.7	6.2	4.2	19.2	8.6	7.1	12.7	10.5	15.0	6.9	4.8	10.4	2.5	5.3	3.6	10.0	7.2	1.5	2.3	1.7	3.7	2.8	2.9	2.5	2.1	5.9	24.6	1.4	2.7	11.3	3.3	2.2	4.8	14.9	2.6	12.8	6.5	2.5	2.1	34.8	15.6	1.4	1.7	3.1	7.5	6.4	8.3	14.1	2.8	3.4	13.6	11.9	3.4	2.9	12.9	15.1	7.0	1.4	2.5	3.8	5.7	12.7	2.3	2.9	4.9	16.7	4.7	3.1	5.4	4.8	6.8	9.8	10.7	16.7	2.6	14.4	7.1	12.2	6.9	15.0	7.5	4.5	5.7	10.8	7.7	5.5	3.4	12.7	9.3	6.6	2.7	4.8	5.8	10.5	10.4	2.5	5.5	11.7	10.9	8.7	6.6	4.3	8.1	4.1	7.0	9.8
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949918	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	9.0	7.4	7.5	9.2	10.1	18.4	9.3	11.2	12.7	13.0	10.9	9.8	9.9	6.8	21.3	12.6	11.0	10.4	9.0	7.1	9.5	8.0	9.2	8.7	15.0	8.4	9.3	9.9	11.4	11.0	16.5	9.6	9.9	9.9	9.9	12.5	10.3	9.6	8.6	6.8	16.9	9.1	16.3	7.0	9.9	8.4	51.2	6.4	16.0	10.4	6.2	11.2	9.3	10.0	2.1	7.6	9.4	3.4	3.4	3.5	2.6	22.1	14.5	21.8	12.0	9.2	12.7	7.1	19.3	18.1	27.1	20.8	12.3	8.3	22.8	10.3	16.9	17.9	16.8	13.5	30.3	22.4	13.2	15.1	23.8	9.7	13.6	14.0	23.4	11.6	10.0	19.0	19.2	16.7	10.9	11.2	18.7	7.2	21.2	13.5	4.8	11.4	22.6	14.9	8.5	12.5	6.8	7.1	12.8	15.6	8.0	6.2	10.9	8.9	13.6	15.1	12.8	20.5	26.6	17.2	11.5	15.8	13.0	17.9	21.5	9.4	2.5	1.0	2.9	3.4	2.6	2.1	2.2	3.5	1.7	1.5	1.4	2.4	0.4	3.4	1.4	7.6	2.9	2.6	7.5	10.1	11.2	12.7	9.5	8.0	9.3	9.9	9.9	6.4
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536630	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: "	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	12.5	17.4	8.7	17.1	14.0	10.9	17.0	19.7	14.5	16.9	17.1	13.0	22.4	13.2	16.9	20.6	14.4	14.0	12.8	12.5	8.9	9.4	16.5	46.2	12.1	11.7	9.3	10.0	17.9	29.4	10.9	22.6	32.9	11.5	20.9	20.7	12.9	28.3	25.2	12.5	14.7	18.8	13.3	10.1	14.8	15.6	9.9	11.2	17.4	18.5	8.7	18.5	14.8	14.8	5.1	7.2	7.4	4.6	4.9	8.0	3.8	5.8	5.3	10.2	9.1	13.4	15.4	9.7	9.7	13.8	11.4	9.5	7.7	10.8	8.0	4.3	11.5	12.8	8.4	9.8	17.3	6.2	6.8	9.0	6.4	13.5	16.6	13.1	8.6	11.5	14.9	7.5	26.8	11.0	5.8	4.9	13.5	9.0	7.2	12.4	8.3	6.4	8.5	5.9	7.4	10.6	9.5	5.1	9.2	6.3	12.4	12.9	8.5	13.6	10.3	5.5	4.3	10.2	6.1	6.9	3.7	8.3	10.5	6.7	9.7	7.4	4.1	7.3	7.5	4.6	8.0	5.1	5.8	6.4	3.1	4.9	6.6	6.1	3.7	4.9	2.9	7.2	6.2	3.8	8.7	14.0	19.7	14.5	8.9	9.4	9.3	10.0	11.5	11.2
COL16A1		ENSG00000084636	"Collagen type XVI alpha 1 chain"	Q07092	1	31652247-31704319	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.1;ASC TERT1: 29.5;BJ hTERT+: 32.3;fHDF/TERT166: 29.4;HSkMC: 27.8;U-2197: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027235, HPA027237"			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		530000	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA027235: AB_1847101, HPA027237: AB_10600699"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavourable (8.08e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (4.00e-9)"	"unprognostic (9.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.15e-2)"	18.0	7.3	7.0	12.7	9.0	0.2	10.8	2.8	8.2	63.1	17.3	10.2	12.5	6.1	31.0	15.2	9.3	8.3	15.9	9.1	9.6	6.2	3.4	1.0	7.2	3.1	9.9	10.2	62.6	2.6	1.3	7.3	8.2	8.8	29.3	4.6	12.5	15.3	38.1	4.2	26.9	8.6	45.2	15.7	3.9	10.5	10.0	10.3	1.5	11.8	7.9	5.0	26.1	28.3	0.2	0.0	0.7	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	38.1	29.5	4.0	17.5	32.3	4.2	4.5	0.1	3.0	0.0	0.5	29.4	13.6	0.0	18.0	1.0	0.0	0.0	0.0	2.0	5.9	12.7	0.0	0.1	27.8	12.4	12.1	6.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.7	2.1	0.3	2.6	0.3	0.0	0.0	15.7	15.7	27.0	0.3	0.0	0.0	0.0	10.7	0.0	1.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.0	0.0	0.0	7.0	9.0	2.8	7.1	9.6	6.2	9.9	10.2	8.8	10.3
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50183289-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 415.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 89.7;BJ: 172.4;fHDF/TERT166: 260.2;HSkMC: 131.8;U-138 MG: 140.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA011795	Approved		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"		58000000	Cytosol	Vesicles	"HPA011795: AB_1847088"	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavourable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	30.2	5.7	0.7	28.2	4.0	0.1	31.7	0.6	0.9	415.7	25.7	1.6	23.9	3.0	121.8	70.9	17.4	33.0	110.3	43.9	0.7	0.1	7.5	4.6	18.8	38.5	0.7	1.2	73.6	10.5	1.0	10.7	89.1	2.2	31.5	4.0	9.2	9.1	21.0	11.0	35.5	10.6	88.0	1.3	13.7	15.0	44.6	0.7	7.7	6.7	15.5	8.7	67.3	49.7	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.2	0.9	0.1	36.9	89.7	1.5	172.4	46.8	43.0	27.0	3.4	0.8	0.0	0.4	260.2	0.5	0.4	0.1	7.7	0.2	0.3	0.0	4.3	0.2	70.3	0.0	0.0	131.8	2.5	52.5	0.2	0.0	0.1	0.0	21.6	0.4	0.0	0.0	0.9	0.5	0.3	0.1	0.1	0.2	0.0	0.1	0.4	0.3	0.2	0.0	2.2	0.0	0.0	140.1	30.6	20.9	0.8	0.1	0.3	0.0	10.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.0	0.6	0.9	0.7	0.1	0.7	1.2	2.2	0.7
COL21A1		ENSG00000124749	"Collagen type XXI alpha 1 chain"	Q96P44	6	56056590-56394094	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031212			Supported	Cytosol	"Secreted to extracellular matrix"		180000	Cytosol		"HPA031212: AB_10599941"	"unprognostic (1.69e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.32e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-3)"	3.9	1.6	6.6	2.1	2.3	0.3	3.0	5.1	3.6	25.8	11.3	5.2	7.9	0.8	20.0	7.0	3.3	7.6	3.9	4.5	8.5	2.5	1.4	1.5	7.4	0.7	3.6	4.6	3.9	2.1	0.8	3.6	26.4	6.9	5.4	2.2	5.9	4.4	10.9	2.3	6.3	2.6	24.2	5.3	0.7	5.7	3.8	5.8	0.0	2.1	4.1	0.8	10.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.1	0.0	1.0	18.9	6.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.1	0.0	19.2	0.7	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.6	2.3	5.1	3.6	8.5	2.5	3.6	4.6	6.9	5.8
COL25A1		ENSG00000188517	"Collagen type XXV alpha 1 chain"	Q9BXS0	4	108808725-109302752	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.4;retina: 22.1;testis: 23.6"	"Cell line enriched"	"Detected in some"	8	"HeLa: 30.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA029107			Approved	"Endoplasmic reticulum,Vesicles,Cytosol"				"Vesicles, Cytosol"	"Endoplasmic reticulum"	"HPA029107: AB_10600802"	"unprognostic (1.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.87e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.62e-3)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	9.0	0.8	6.7	0.2	4.4	0.0	5.1	0.8	3.4	1.6	0.9	0.4	0.9	4.0	2.1	3.5	0.8	1.4	3.1	2.0	4.7	2.1	2.9	3.2	0.9	0.1	0.8	0.0	1.6	0.9	3.9	17.4	0.4	2.5	0.9	0.4	22.1	6.7	1.4	1.4	1.1	3.1	1.5	0.9	1.0	0.9	23.6	1.5	0.0	3.7	0.1	0.0	1.6	3.4	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.9	0.0	0.1	0.0	2.3	4.1	30.8	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.8	0.2	3.9	0.0	0.5	0.0	1.1	0.1	0.0	2.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.4	0.8	3.4	4.7	2.1	0.8	0.0	2.5	1.5
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535853	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.2;U-266/70: 13.9;U-266/84: 3.7;WM-115: 6.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"olfactory region: 4.5"	"Not detected"	"Not detected"			"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"			"Nucleoplasm, Cytosol"		"HPA043844: , HPA060468: "	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	2.7	3.7	1.0	7.0	1.1	0.3	3.1	2.4	1.6	10.2	11.8	0.6	11.5	1.3	2.9	16.2	14.7	5.5	5.7	7.0	1.3	2.2	2.8	1.9	1.3	1.0	9.8	0.2	2.9	5.8	0.1	12.2	0.5	6.1	5.8	4.7	12.8	19.3	6.2	5.6	2.1	6.6	16.0	7.9	0.3	5.7	3.2	0.2	0.2	1.4	10.2	0.9	8.4	14.2	0.6	0.3	1.6	0.2	2.1	1.0	0.0	2.0	0.0	0.0	0.0	0.2	1.1	0.3	0.1	0.6	0.0	0.0	1.6	0.6	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.1	0.0	0.3	2.0	0.2	0.3	0.0	0.9	0.5	0.0	0.1	0.0	3.2	0.1	0.2	0.0	0.1	1.0	0.0	0.1	0.8	1.0	0.0	0.7	1.8	0.0	13.9	3.7	0.0	0.2	0.8	6.7	0.5	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.6	0.4	1.0	1.6	2.1	0.1	0.3	0.0	0.0	1.0	1.1	2.4	1.3	1.3	2.2	9.8	0.2	6.1	0.2
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981737-46005050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 92.0;ASC TERT1: 187.3;BJ: 70.3;HHSteC: 81.7;HSkMC: 136.9;U-138 MG: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in all"							"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"		250000000	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavourable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavourable (4.54e-4)"	73.4	10.8	6.8	45.5	7.1	0.1	85.4	31.9	9.1	100.7	111.6	5.1	34.7	17.1	98.8	75.0	54.5	64.7	89.7	39.7	6.0	5.6	10.2	9.9	21.6	24.7	4.8	5.4	83.0	13.5	6.2	19.8	65.7	9.2	59.6	9.9	18.6	23.1	36.4	20.0	28.2	33.8	147.8	4.7	15.9	40.9	20.2	5.5	9.4	15.9	23.4	12.8	86.9	49.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	1.5	2.4	7.7	92.0	187.3	0.3	70.3	45.4	18.1	6.3	1.2	4.8	0.0	5.8	39.5	0.3	1.0	0.1	1.5	0.0	1.0	0.0	0.2	0.3	81.7	0.0	0.1	136.9	0.0	45.0	0.6	0.4	0.0	0.0	4.6	0.1	0.0	0.2	1.7	19.7	0.0	1.4	0.3	0.1	0.8	0.0	3.0	6.5	0.0	1.3	0.3	0.3	0.0	102.6	6.8	28.1	26.8	0.0	0.0	0.0	36.6	0.5	8.9	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.3	1.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.1	31.9	9.1	6.0	5.6	4.8	5.4	9.2	5.5
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098097-46132849	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.7;ASC TERT1: 173.4;BJ: 83.4;BJ hTERT+: 77.6;HHSteC: 92.0;HSkMC: 123.8;U-138 MG: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 7.6;MAIT T-cell: 5.1;memory CD8 T-cell: 3.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		8900000	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	81.2	8.7	1.5	65.0	2.7	0.2	116.7	1.8	2.7	103.5	112.6	4.7	75.0	15.3	127.2	160.3	55.5	66.5	179.8	90.6	2.1	1.3	9.6	9.1	38.7	38.3	3.2	3.8	76.1	14.8	2.7	11.8	52.6	8.8	81.0	9.8	23.5	33.4	81.4	30.6	37.8	38.1	231.3	5.8	23.6	49.0	33.2	1.8	9.8	19.9	58.5	17.2	107.2	76.1	0.0	0.0	0.0	0.0	0.5	7.6	0.7	0.7	0.9	2.7	2.4	93.7	173.4	0.7	83.4	77.6	21.1	9.7	0.1	3.3	0.0	6.3	59.8	0.0	0.6	0.0	1.7	0.0	0.9	0.0	0.0	0.0	92.0	0.0	0.3	123.8	0.0	39.9	0.8	0.0	0.0	0.0	8.5	0.3	0.0	0.1	1.5	10.2	0.0	5.3	0.1	0.0	0.0	0.0	4.3	3.2	0.0	0.0	0.0	0.5	0.0	90.5	10.6	33.3	20.6	0.0	0.0	0.0	46.3	0.0	12.8	0.0	0.0	0.0	7.6	0.0	5.1	0.0	0.7	3.8	0.0	0.0	0.8	2.1	0.0	0.5	0.0	0.0	0.1	0.7	1.5	2.7	1.8	2.7	2.1	1.3	3.2	3.8	8.8	1.8
COMMD1	"C2orf5, MGC27155, MURR1"	ENSG00000173163	"Copper metabolism domain containing 1"	Q8N668	2	61888724-62147247	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034633, HPA049223"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034633: AB_10601800, HPA049223: "	"unprognostic (6.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.77e-1)"	19.6	26.2	18.6	23.2	22.3	14.2	22.8	26.7	21.4	20.1	16.6	16.7	21.2	18.2	21.0	26.2	25.3	18.0	16.8	41.7	16.1	15.2	25.4	28.8	15.6	17.3	17.8	22.4	19.9	32.8	15.0	30.0	21.2	16.8	19.0	19.0	17.9	26.6	24.3	32.1	21.0	14.4	24.7	19.9	16.1	19.5	26.8	19.0	16.3	23.6	20.3	19.7	17.6	19.5	33.0	42.7	17.1	36.5	31.2	31.8	35.7	10.0	13.0	14.9	11.5	19.2	22.3	12.7	12.1	20.5	24.6	18.0	22.1	9.2	17.8	10.4	22.6	7.9	8.1	14.8	26.6	19.1	9.9	13.8	7.6	24.4	16.5	21.4	10.9	16.2	17.2	11.9	14.2	24.7	8.4	29.1	26.0	18.9	16.5	38.1	12.6	17.8	11.8	19.4	20.3	22.3	11.1	8.9	10.1	13.7	23.1	12.3	14.6	9.4	11.6	22.2	19.1	13.8	18.5	12.8	10.0	22.1	13.0	19.1	19.2	16.5	36.5	17.1	25.1	30.8	24.6	33.0	28.4	27.7	42.7	30.7	27.2	29.0	3.0	31.2	26.2	39.6	31.8	35.7	18.6	22.3	26.7	21.4	16.1	15.2	17.8	22.4	16.8	19.0
COMMD3-BMI1		ENSG00000269897	"COMMD3-BMI1 readthrough"		10	22316388-22329542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA030471, HPA030472, HPA036584"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA030471: , HPA030472: AB_10601090, HPA036584: AB_10670803"	"unprognostic (8.63e-2)"				"unprognostic (2.36e-2)"									"unprognostic (1.83e-2)"				8.5	12.4	4.5	6.6	9.1	2.8	6.9	5.1	8.5	9.7	11.9	4.7	8.3	4.9	4.0	5.9	9.4	8.3	4.3	14.3	4.7	4.1	5.5	6.9	8.0	5.0	6.6	4.7	4.3	11.4	5.7	8.7	4.7	5.7	5.0	2.8	4.2	8.3	14.6	22.8	4.8	7.6	7.0	7.3	7.3	7.6	23.4	6.6	12.3	3.7	7.6	6.4	12.0	5.4	25.0	30.3	25.7	25.8	18.8	21.6	26.6	3.8	13.8	4.8	0.5	5.6	3.8	0.7	3.9	4.3	2.1	5.5	7.6	1.5	1.9	5.7	13.0	1.8	5.1	8.4	0.7	15.2	1.7	5.2	2.9	3.3	17.1	0.4	2.4	6.7	4.8	7.6	4.0	5.3	1.0	5.4	0.6	3.7	15.6	0.5	0.5	4.3	4.4	5.3	4.2	2.1	4.7	0.5	1.7	7.4	1.8	1.6	3.4	3.8	7.0	1.7	5.4	0.3	1.0	11.6	14.0	6.1	2.6	11.6	1.7	25.7	25.8	17.2	15.1	23.5	16.6	25.0	16.1	14.7	30.3	21.9	11.0	12.2	3.8	18.8	17.8	29.2	21.6	26.6	4.5	9.1	5.1	8.5	4.7	4.1	6.6	4.7	5.7	6.6
COMMD5	"FLJ13008, HCaRG, HT002"	ENSG00000170619	"COMM domain containing 5"	Q9GZQ3	8	144841042-144853736	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046905			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA046905: "	"unprognostic (2.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (5.05e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.24e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-3)"	24.7	22.3	18.2	16.7	18.1	27.6	14.6	26.0	22.9	15.2	19.1	18.1	17.7	17.8	16.6	15.3	18.9	15.9	17.0	20.9	18.4	17.1	18.0	21.8	20.0	21.0	23.8	12.2	13.4	20.3	11.0	18.3	16.3	15.9	15.8	10.5	16.4	22.4	17.4	16.0	17.5	15.5	17.9	18.5	22.2	16.9	11.7	16.8	17.7	23.6	14.3	19.0	20.2	15.1	29.3	36.6	36.3	42.6	32.0	33.8	31.8	16.0	18.9	9.2	12.3	11.4	9.1	8.2	9.4	10.0	16.0	12.6	11.5	12.7	11.1	20.8	11.3	10.9	11.4	15.4	6.9	14.5	16.1	23.3	18.1	19.2	15.3	7.9	20.3	12.0	14.1	10.9	8.2	12.2	16.6	20.6	12.8	29.3	7.0	8.2	14.0	38.4	9.2	10.6	17.0	15.4	14.4	21.6	18.8	15.6	9.5	13.4	18.4	14.8	11.2	12.1	23.8	16.9	18.2	8.6	9.1	10.2	16.7	14.7	15.5	28.5	42.6	36.3	29.3	34.6	26.1	29.3	22.8	28.7	36.6	26.1	22.8	25.3	25.7	32.0	21.8	13.4	33.8	31.8	18.2	18.1	26.0	22.9	18.4	17.1	23.8	12.2	15.9	16.8
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450796-47463719	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favourable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	11.4	14.0	14.7	13.9	21.3	13.1	10.9	9.5	18.8	9.7	12.5	5.7	7.7	13.1	9.7	17.3	21.1	8.3	10.0	19.1	14.1	14.0	32.5	16.1	15.1	21.4	13.9	15.0	8.4	10.4	15.5	20.5	20.0	11.3	9.2	13.4	6.5	9.8	9.2	7.7	12.5	17.1	12.8	11.6	14.5	10.0	16.9	10.9	15.2	15.7	19.7	17.5	15.5	12.7	21.1	32.7	39.8	36.4	23.9	22.9	27.9	12.4	6.9	6.1	3.1	13.0	18.6	8.5	18.8	12.5	12.4	16.9	11.6	14.8	20.0	15.8	17.7	6.7	19.5	15.3	22.4	11.8	8.8	11.5	7.7	8.9	17.7	28.0	14.8	15.9	20.7	11.7	13.1	15.6	8.5	8.2	30.1	6.9	16.6	22.7	4.2	9.0	8.4	13.9	4.3	35.5	10.2	12.0	6.1	7.8	6.4	14.9	11.7	18.6	12.8	17.7	17.0	15.7	22.3	8.7	10.4	16.1	19.2	36.8	12.7	39.8	26.2	29.5	21.3	34.9	22.9	21.1	19.6	21.1	32.7	18.8	18.5	21.0	12.9	23.9	36.4	15.3	22.0	27.9	14.7	21.3	9.5	18.8	14.1	14.0	13.9	15.0	11.3	10.9
COMMD9	"FLJ31106, HSPC166"	ENSG00000110442	"COMM domain containing 9"	Q9P000	11	36269284-36289449	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009142	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA009142: AB_1847105"	"unprognostic (1.56e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.15e-2)"	"prognostic favourable (8.54e-4)"	"unprognostic (4.94e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.08e-3)"	"unprognostic (7.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.88e-1)"	26.9	25.4	28.0	15.8	25.4	32.6	18.5	18.1	36.9	14.3	15.0	26.5	9.5	16.2	12.4	20.4	18.4	16.2	15.8	23.1	25.4	25.7	34.5	28.0	20.4	24.8	27.7	23.8	15.8	23.3	19.4	18.9	18.9	22.8	12.6	19.1	16.0	16.7	11.1	43.6	19.6	16.4	17.0	28.4	26.0	14.8	14.6	17.2	24.7	19.8	21.1	23.6	16.6	12.2	22.5	66.3	28.8	66.2	14.8	18.9	46.4	10.6	12.7	14.0	14.7	21.7	15.2	7.8	12.8	16.6	29.2	27.5	10.4	9.2	12.4	12.8	25.4	15.8	24.6	17.2	27.6	14.8	29.0	6.8	23.9	17.9	20.4	26.4	20.5	19.1	19.3	15.9	9.8	23.9	16.7	13.4	22.9	13.8	17.6	18.4	14.9	27.1	19.4	31.8	14.6	30.4	10.1	17.2	19.3	18.3	18.2	16.3	39.7	10.1	15.9	17.7	13.6	42.0	18.6	9.4	19.2	13.9	20.4	24.9	16.9	12.2	66.2	28.8	16.8	59.6	15.7	21.8	16.2	16.1	66.3	22.5	18.7	15.7	7.4	14.8	47.5	25.0	18.9	46.4	28.0	25.4	18.1	36.9	25.4	25.7	27.7	23.8	22.8	17.2
COMTD1	FLJ23841	ENSG00000165644	"Catechol-O-methyltransferase domain containing 1"	Q86VU5	10	75233969-75236030	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 57.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 22.5;PC-3: 31.2;RPMI-8226: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042165	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA042165: AB_10794042"	"unprognostic (2.53e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.08e-3)"	"unprognostic (9.35e-2)"	"unprognostic (6.74e-2)"	"prognostic favourable (1.88e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.35e-1)"	2.5	5.2	1.3	5.8	1.4	2.9	5.7	3.6	2.2	4.8	14.1	0.5	9.7	17.9	2.0	5.9	20.0	1.6	6.4	8.0	1.2	1.6	12.6	14.9	4.4	4.1	1.9	1.7	2.2	57.2	3.2	5.3	7.8	2.2	3.1	2.1	3.2	21.2	9.1	19.6	7.3	22.9	1.9	1.0	3.4	16.1	1.5	0.6	2.7	7.0	14.4	6.0	2.4	7.5	6.6	15.7	3.8	9.3	7.3	12.5	7.1	4.8	0.9	0.2	0.9	0.1	0.4	14.6	1.4	0.4	0.1	0.3	1.2	4.3	13.7	2.8	0.3	6.9	0.4	1.2	0.0	2.1	22.5	0.5	1.3	2.3	0.7	2.6	2.3	0.3	1.9	0.0	1.1	0.0	5.5	2.7	0.0	3.2	3.8	8.1	0.7	31.2	7.1	0.7	17.5	1.0	0.2	5.3	1.3	1.5	11.3	3.0	6.6	0.3	1.2	0.3	4.3	0.4	1.6	15.0	3.1	6.6	0.3	2.3	0.3	0.0	8.9	3.8	12.1	9.3	12.5	6.6	11.7	12.2	10.1	4.7	3.8	6.7	1.8	7.3	8.9	15.7	9.0	7.1	1.3	1.4	3.6	1.7	1.2	1.6	1.9	1.7	2.2	0.6
COPA	HEP-COP	ENSG00000122218	"Coatomer protein complex subunit alpha"	P53621	1	160289273-160343400	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"		260000	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	38.3	32.7	29.2	28.9	41.0	22.9	32.4	43.1	48.4	46.3	34.3	53.2	24.5	38.4	37.0	33.1	28.4	31.5	28.6	38.4	33.3	35.2	36.3	64.3	33.8	26.6	42.7	29.3	36.8	47.8	49.1	57.4	45.1	56.2	35.3	39.9	28.8	42.1	33.9	40.5	28.7	50.3	40.4	42.8	36.6	32.8	21.2	35.8	36.0	42.8	21.0	34.1	30.3	27.5	15.4	31.4	25.1	29.1	18.1	21.2	25.3	28.1	22.1	23.4	22.7	60.4	49.8	27.5	38.7	46.0	33.0	39.0	28.8	19.2	20.7	25.1	58.7	28.3	27.1	27.9	38.0	23.5	18.3	23.8	30.4	30.2	45.4	28.9	24.9	46.5	17.0	44.0	41.1	38.6	21.9	23.2	39.3	20.6	18.6	12.6	25.7	25.8	16.7	27.0	31.8	27.0	26.6	19.5	24.6	43.7	38.4	40.9	42.8	39.1	45.5	24.9	19.4	33.3	25.4	38.2	26.5	31.8	32.4	15.1	37.0	25.1	29.1	20.1	17.1	27.3	21.2	15.4	14.3	18.3	31.4	12.1	13.2	15.2	10.8	18.1	27.9	13.3	17.5	25.3	29.2	41.0	43.1	48.4	33.3	35.2	42.7	29.3	56.2	35.8
COPB1	COPB	ENSG00000129083	"Coatomer protein complex subunit beta 1"	P53618	11	14443440-14500027	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"			400000	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: , HPA064403: "	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (6.91e-4)"	"prognostic unfavourable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	30.9	33.0	18.4	23.5	20.8	31.2	55.4	23.7	23.6	32.5	26.6	15.5	42.0	25.9	32.2	33.0	32.2	28.3	25.1	34.8	18.9	16.8	37.6	56.6	38.4	53.9	22.6	15.5	31.3	52.2	40.1	43.5	52.3	22.2	31.9	31.3	17.2	43.4	41.7	21.9	24.7	33.1	39.7	26.1	29.8	30.2	21.7	20.6	46.0	37.7	26.7	28.0	28.2	27.3	26.7	33.9	27.9	30.4	28.0	39.6	24.8	31.2	26.8	28.7	21.5	48.0	55.7	23.2	47.4	49.8	42.3	49.7	20.7	48.7	30.4	21.3	59.8	34.5	32.3	31.8	52.3	28.4	26.8	32.3	19.2	31.5	42.6	29.6	32.8	38.8	42.0	28.2	53.6	44.2	23.9	25.0	53.2	23.5	26.9	18.2	14.9	29.2	22.1	39.6	20.7	38.1	28.9	18.4	19.8	36.7	29.7	24.3	27.0	25.9	44.8	40.7	21.1	43.8	25.7	13.4	22.6	33.5	30.7	18.5	37.9	27.3	24.9	27.9	32.2	30.4	39.6	26.7	27.5	32.9	33.9	22.6	27.6	28.6	20.5	28.0	30.3	20.4	29.3	24.8	18.4	20.8	23.7	23.6	18.9	16.8	22.6	15.5	22.2	20.6
COPB2	"beta'-COP, betaprime-COP"	ENSG00000184432	"Coatomer protein complex subunit beta 2"	P35606	3	139355600-139389732	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036867, HPA058180"	Approved		Approved	Cytosol			1000000	Cytosol		"HPA036867: AB_10672271, HPA058180: "	"unprognostic (3.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.41e-7)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.95e-2)"	28.7	40.8	21.9	22.3	26.2	12.1	28.7	31.7	29.0	39.5	32.4	22.6	40.3	26.1	33.0	44.7	35.9	28.9	26.2	31.4	21.6	18.9	42.1	67.5	29.1	20.1	26.0	16.6	36.0	65.5	41.2	72.2	51.7	28.7	35.5	33.8	20.5	46.5	28.6	20.6	23.5	37.1	30.0	21.1	31.3	29.9	21.1	25.7	33.1	40.4	27.4	31.2	30.0	26.5	22.6	36.4	35.9	34.4	27.4	23.5	22.6	53.1	21.4	31.4	28.3	63.1	58.1	27.5	63.7	60.6	41.2	50.9	40.0	20.3	21.5	59.0	67.5	28.3	35.6	34.1	51.7	37.2	24.4	32.3	33.8	38.2	37.8	28.8	37.1	40.7	31.0	32.4	33.6	39.7	21.1	26.2	48.8	32.2	14.4	17.7	28.5	23.5	19.5	25.5	37.0	37.8	38.5	22.3	20.4	62.6	56.8	35.1	45.3	31.1	46.3	23.2	18.7	34.1	22.4	40.8	24.3	38.0	38.8	16.4	35.8	35.9	28.4	30.1	22.9	34.4	23.2	22.6	20.4	23.5	36.4	16.3	15.9	20.0	26.9	27.4	32.3	17.0	21.9	22.6	21.9	26.2	31.7	29.0	21.6	18.9	26.0	16.6	28.7	25.7
COPG1	COPG	ENSG00000181789	"Coatomer protein complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"			110000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: "	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavourable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	25.2	39.4	21.1	22.2	28.0	20.1	37.3	23.6	50.3	43.3	42.1	24.3	50.6	34.2	27.6	66.5	29.5	24.4	34.5	33.4	24.2	26.7	32.4	72.1	36.5	39.4	23.0	21.6	28.6	75.6	47.6	49.7	49.3	34.9	45.1	45.1	22.4	59.9	45.5	24.1	24.3	32.4	29.1	20.7	29.0	36.3	23.6	16.2	26.9	33.0	22.0	27.7	19.9	24.1	15.7	31.9	34.9	33.0	31.1	31.8	26.0	32.4	16.5	24.1	20.9	56.6	45.9	25.8	52.9	50.6	36.5	46.2	30.3	20.2	17.8	30.8	75.2	19.6	19.9	31.2	39.8	21.7	8.2	29.6	21.8	48.9	51.6	22.4	31.8	47.9	27.5	29.2	48.2	32.8	10.3	43.1	43.9	49.3	13.1	22.8	14.4	20.2	14.2	22.7	34.5	45.5	27.0	15.1	17.6	40.6	30.4	48.5	33.6	32.8	44.4	19.9	18.9	42.0	20.4	33.7	16.1	31.2	48.6	17.1	38.1	34.9	26.8	20.2	26.2	33.0	31.8	15.0	23.7	25.7	31.9	15.7	18.5	21.6	21.3	31.1	29.7	29.4	23.6	26.0	21.1	28.0	23.6	50.3	24.2	26.7	23.0	21.6	34.9	16.2
COPRS	"C17orf79, COPR5, HSA272196, TTP1"	ENSG00000172301	"Coordinator of PRMT5 and differentiation stimulator"	Q9NQ92	17	31851864-31859337	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA052552	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA052552: "	"unprognostic (1.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.11e-2)"	20.9	19.0	32.6	9.7	31.0	6.3	30.3	23.0	37.6	15.3	24.2	11.8	15.6	8.0	15.2	57.3	10.5	24.9	14.9	24.7	28.2	35.5	22.7	31.0	12.3	9.2	29.7	31.3	24.3	20.7	12.2	18.9	9.4	23.9	27.5	13.6	16.0	14.6	23.5	19.9	7.8	7.9	21.2	16.0	8.1	14.1	75.0	14.4	2.6	28.1	11.2	12.7	16.1	18.5	5.8	4.5	3.5	3.5	0.0	3.0	0.4	21.5	28.4	14.3	14.6	23.4	22.5	10.0	24.2	30.3	27.7	28.4	17.7	5.8	12.2	13.5	28.8	12.9	25.1	14.5	31.5	4.1	37.6	3.3	16.3	20.8	23.8	11.4	9.8	14.4	19.1	37.3	20.5	14.8	16.6	10.2	30.1	18.6	16.9	36.3	10.8	14.3	13.5	26.5	22.1	16.2	13.3	12.9	10.0	14.3	6.9	22.1	22.8	12.3	8.3	73.0	19.8	26.0	33.5	17.5	16.2	12.4	38.2	10.6	9.8	3.5	3.5	0.0	1.1	3.3	3.0	3.8	1.1	0.2	4.5	5.8	0.6	0.7	1.2	0.0	1.6	1.8	1.5	0.4	32.6	31.0	23.0	37.6	28.2	35.5	29.7	31.3	23.9	14.4
COPS3	"CSN3, SGN3"	ENSG00000141030	"COP9 signalosome subunit 3"	Q9UNS2	17	17246820-17281293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021997, HPA050557"	Approved		Supported	Nucleoplasm,Cytosol			29000	Nucleoplasm	Cytosol	"HPA021997: AB_1847152, HPA050557: "	"unprognostic (3.35e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavourable (1.56e-4)"	"prognostic unfavourable (8.65e-5)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-3)"	15.2	15.2	16.3	15.7	21.9	51.9	16.3	20.8	24.7	15.4	15.4	15.7	14.9	13.9	14.3	14.1	21.0	12.1	10.0	22.7	17.5	18.8	16.1	21.0	11.7	18.7	17.4	15.2	16.0	26.2	17.6	21.8	21.7	26.7	16.5	17.1	11.9	17.1	15.7	69.4	15.7	13.3	16.9	15.9	14.3	15.8	39.5	11.8	31.4	15.2	24.4	21.9	16.1	14.0	28.1	45.2	37.7	35.8	32.3	33.0	38.2	37.8	35.6	27.9	24.2	13.4	18.4	17.1	29.6	18.1	42.8	34.5	58.3	14.2	52.5	24.0	23.5	27.8	37.9	29.3	48.6	20.9	53.9	36.6	27.6	25.0	22.9	31.3	41.7	16.6	22.3	29.6	29.7	24.7	29.8	19.5	27.0	38.0	57.7	39.8	25.0	22.9	43.5	49.9	27.3	17.1	16.7	21.9	19.1	25.9	12.1	23.4	18.1	21.1	17.7	26.1	29.2	47.0	50.4	15.6	20.2	28.1	22.6	31.2	26.2	20.8	30.5	29.4	27.6	35.8	31.9	27.2	32.2	31.6	45.2	28.1	32.2	30.5	37.7	32.3	34.6	21.8	33.0	38.2	16.3	21.9	20.8	24.7	17.5	18.8	17.4	15.2	26.7	11.8
COPS7A	CSN7A	ENSG00000111652	"COP9 signalosome subunit 7A"	Q9UBW8	12	6723741-6731875	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026915	Supported		Supported	Nucleoplasm,Cytosol			66000	Nucleoplasm	Cytosol	"HPA026915: AB_1847156"	"unprognostic (3.50e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	24.1	26.0	31.6	16.6	38.1	8.8	20.5	29.6	59.5	18.2	18.5	25.0	14.1	15.8	20.1	27.9	29.1	25.8	20.1	42.2	29.6	27.9	26.2	29.6	18.8	14.6	31.6	36.9	20.1	23.1	33.9	24.3	25.4	45.3	24.7	17.5	23.8	22.1	24.5	44.6	20.9	14.1	24.2	22.5	16.2	18.1	14.9	13.9	9.2	26.1	29.6	17.6	22.7	17.6	13.7	27.1	35.9	28.4	11.5	16.5	17.8	18.8	20.0	9.6	9.4	28.6	34.2	23.5	23.3	30.5	23.6	24.0	13.9	26.4	13.1	10.1	31.1	15.3	13.0	23.8	22.6	17.9	14.5	12.2	13.7	17.6	24.7	12.8	7.6	31.7	23.1	27.8	55.4	18.3	8.7	5.3	33.1	15.3	7.4	8.1	25.9	18.4	5.1	19.7	12.9	20.0	19.0	5.5	13.0	15.3	19.5	25.6	8.3	18.6	18.8	25.2	13.2	22.1	22.4	6.1	6.5	10.5	42.9	16.6	27.5	29.4	23.1	35.9	15.9	28.4	16.5	11.3	13.7	14.2	27.1	13.7	14.2	14.0	18.7	11.5	22.5	16.8	12.1	17.8	31.6	38.1	29.6	59.5	29.6	27.9	31.6	36.9	45.3	13.9
COPS8	"COP9, CSN8, MGC1297, SGN8"	ENSG00000198612	"COP9 signalosome subunit 8"	Q99627	2	237085312-237100466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 77.7;U-138 MG: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036485	Uncertain		Supported	Nucleoplasm,Cytosol			110000	Nucleoplasm	Cytosol	"HPA036485: AB_10670720"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavourable (4.70e-5)"	"unprognostic (1.34e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	20.1	23.1	25.2	15.6	37.0	15.7	17.9	15.2	33.8	20.6	14.0	16.7	8.6	7.7	20.9	18.3	12.5	18.0	19.9	37.8	31.7	27.9	24.2	15.6	12.3	13.5	23.6	25.8	23.7	10.8	18.2	15.0	19.8	28.1	16.6	11.7	18.6	12.7	18.1	64.5	12.3	9.7	25.4	21.3	10.4	13.5	20.8	15.4	14.8	17.5	20.3	14.5	18.0	13.2	32.4	26.9	26.1	25.9	32.2	36.2	31.7	9.4	8.0	17.6	8.7	50.5	40.0	11.7	16.7	16.6	17.2	19.1	5.2	9.6	6.5	6.4	18.1	7.2	17.2	22.7	24.0	15.3	11.1	9.5	10.3	18.5	34.9	12.3	5.6	65.8	26.3	17.2	77.7	20.0	13.1	6.3	54.2	9.0	15.1	12.6	15.5	11.8	11.6	20.9	13.0	21.2	7.7	8.6	14.9	10.0	8.6	24.8	9.9	10.1	21.0	92.0	15.5	18.0	18.0	12.1	10.0	20.9	28.7	7.5	23.2	21.9	22.8	26.1	29.7	25.0	36.2	32.4	31.7	33.8	26.9	26.9	30.8	32.1	7.0	32.2	25.9	19.4	33.1	31.7	25.2	37.0	15.2	32.3	31.7	27.9	23.6	25.8	28.1	15.4
COPS9	"CSNAP, MYEOV2"	ENSG00000172428	"COP9 signalosome subunit 9"	Q8WXC6	2	240126563-240136807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044845	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044845: AB_10962975"	"unprognostic (6.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-2)"	31.9	29.1	81.6	20.6	73.2	24.0	40.9	22.6	61.6	29.1	27.6	22.7	20.5	25.6	17.2	53.2	34.5	23.5	25.4	62.3	75.8	44.7	30.5	23.5	17.8	26.7	64.3	24.3	23.2	64.3	8.9	27.6	17.6	32.9	25.9	18.9	19.0	43.3	26.5	86.9	20.6	24.5	21.1	52.6	22.6	25.8	18.8	25.9	26.5	34.7	41.6	19.8	23.5	20.9	68.2	79.9	90.7	67.7	52.4	82.0	79.9	26.6	36.2	28.6	29.8	39.5	32.3	26.3	38.6	27.0	25.4	32.5	26.2	24.0	7.4	11.7	35.2	21.5	25.2	35.8	17.6	31.3	93.1	22.2	37.3	81.1	31.5	22.2	20.9	37.9	29.6	18.9	23.6	37.2	25.5	16.0	36.8	57.7	35.5	69.3	43.4	79.1	28.0	38.3	23.0	31.4	46.1	33.1	33.2	20.3	27.7	41.3	25.5	43.4	30.0	33.6	37.6	42.7	36.7	32.9	27.9	37.3	41.9	26.4	33.0	90.7	67.2	87.6	68.6	66.6	68.0	68.2	71.2	70.1	62.6	52.8	62.6	70.5	24.1	52.4	67.7	79.9	82.0	79.9	81.6	73.2	22.6	61.6	75.8	44.7	64.3	24.3	32.9	25.9
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266858-56270966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"HPA068931: "	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favourable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	2.9	12.4	5.0	2.3	6.8	2.2	3.1	7.6	7.3	3.7	2.9	4.8	5.9	1.9	3.6	7.7	4.3	5.2	3.2	43.5	4.5	5.4	7.2	12.8	3.5	3.4	5.6	3.9	4.5	5.5	6.0	9.9	1.7	4.8	4.1	2.7	14.0	6.5	5.6	103.7	2.2	2.9	3.7	3.6	3.8	2.6	2.4	3.0	4.9	5.4	46.1	6.2	2.7	3.3	11.7	6.8	8.0	1.1	5.0	8.6	3.6	2.4	10.2	9.9	6.4	5.7	5.7	4.2	3.5	8.5	12.6	12.6	7.9	3.8	14.6	8.1	8.9	2.3	11.4	2.0	7.5	2.2	12.7	6.8	9.3	8.2	7.8	5.3	4.1	5.9	3.3	9.3	3.7	6.6	4.5	6.0	11.6	3.3	7.6	19.1	8.4	5.9	16.4	10.8	9.6	6.9	1.5	14.3	15.5	12.2	2.5	3.8	3.9	5.9	4.6	2.4	7.0	6.7	3.6	12.6	13.5	7.1	7.0	5.0	1.8	8.0	1.0	0.9	7.7	1.1	7.9	11.7	7.1	8.2	1.7	6.7	8.6	8.4	0.4	5.0	0.8	6.8	4.6	3.6	5.0	6.8	7.6	7.3	4.5	5.4	5.6	3.9	4.8	3.0
COQ10B	FLJ13448	ENSG00000115520	"Coenzyme Q10B"	Q9H8M1	2	197453423-197475308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046057	Approved		Approved	Cytosol				Cytosol		"HPA046057: "	"unprognostic (9.17e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.28e-3)"	"unprognostic (5.76e-3)"	"unprognostic (4.55e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-3)"	24.5	34.0	19.3	14.5	18.2	34.0	21.8	13.3	23.2	15.1	16.8	16.6	13.0	13.9	19.2	14.6	16.7	14.9	23.2	28.7	18.7	18.8	30.1	34.3	17.3	15.3	18.3	14.1	15.2	25.0	20.4	23.0	33.1	20.6	16.1	18.2	17.6	17.4	16.3	16.0	13.3	22.3	25.5	17.3	17.7	17.8	9.1	12.6	11.5	18.7	16.2	16.4	21.1	14.1	14.8	11.7	40.6	17.8	13.9	24.1	16.0	6.9	6.6	4.8	8.6	23.4	16.8	11.4	18.1	26.2	19.5	21.8	13.4	8.4	6.5	15.6	14.6	6.3	6.9	9.6	22.4	12.7	6.0	9.3	9.6	15.6	19.6	7.5	21.6	18.6	15.1	18.6	13.3	10.5	7.8	17.4	18.6	9.1	8.1	11.6	7.4	13.7	6.1	7.2	8.5	21.0	18.8	3.1	6.1	8.3	10.9	22.5	7.8	10.6	11.1	19.3	6.7	21.5	13.0	16.6	23.5	7.3	24.1	7.3	14.8	27.3	13.6	24.4	20.7	15.6	23.3	14.8	20.0	20.5	11.7	11.5	21.1	21.4	40.6	13.9	17.8	7.4	24.1	16.0	19.3	18.2	13.3	23.2	18.7	18.8	18.3	14.1	20.6	12.6
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease mutation, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol				Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.6	25.5	4.9	8.4	7.0	8.9	9.9	1.9	6.0	7.4	12.1	5.8	8.4	7.8	8.0	10.2	13.1	5.4	7.4	17.5	4.3	4.1	8.0	14.9	9.8	9.0	6.5	3.4	8.0	5.9	6.7	12.3	7.2	5.0	6.6	12.5	5.2	12.7	8.5	21.8	13.8	8.2	5.8	6.7	14.1	4.8	6.6	6.7	2.9	10.1	23.9	9.2	6.2	7.4	3.6	11.8	6.0	17.4	3.7	2.0	6.8	11.6	6.8	6.8	12.8	5.3	5.4	4.8	7.6	12.5	14.4	16.8	4.7	16.8	7.9	5.5	13.4	9.0	11.4	12.3	18.1	8.0	7.2	7.0	8.9	6.7	5.7	14.2	33.9	8.0	7.8	6.9	12.0	14.3	4.5	9.4	13.3	12.0	3.7	9.6	5.0	9.7	6.5	5.3	10.2	20.9	5.6	4.7	3.1	8.7	11.0	3.8	7.1	7.8	9.9	6.7	7.0	5.1	10.5	2.8	2.2	4.6	13.2	16.8	9.2	1.1	16.3	2.3	1.6	14.4	1.2	3.6	1.8	1.5	11.8	3.5	1.3	2.0	6.0	3.7	17.4	6.2	2.0	6.8	4.9	7.0	1.9	6.0	4.3	4.1	6.5	3.4	5.0	6.7
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 204.4;bone marrow: 94.9;lymphoid tissue: 99.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;HL-60: 59.6;HMC-1: 103.1;MOLT-4: 57.6;NB-4: 68.1;RPMI-8226: 89.9;U-698: 55.7;U-937: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol			130000000	Cytosol		"CAB046473: AB_10602363, HPA051132: "	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favourable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favourable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	6.4	4.9	12.7	58.9	10.8	94.9	4.4	7.8	13.6	2.9	5.0	6.0	0.2	8.3	3.0	3.0	4.7	5.9	8.6	4.8	10.4	7.8	4.9	3.8	13.7	99.8	9.6	8.2	2.2	2.7	0.6	3.0	4.8	7.3	3.3	2.9	2.2	12.3	1.6	1.3	3.4	28.7	4.1	9.0	92.0	8.5	1.1	7.5	86.0	3.6	3.2	64.8	15.8	3.1	41.6	67.7	204.4	67.5	39.1	66.4	101.2	0.2	0.3	1.0	2.0	0.0	0.0	0.5	0.2	0.0	0.5	0.2	0.0	0.6	85.3	0.5	0.0	0.4	0.4	1.0	0.1	27.3	0.2	9.0	0.0	1.3	0.1	59.6	103.1	0.3	0.0	0.4	0.0	0.1	0.1	43.9	0.3	7.2	57.6	68.1	0.4	0.6	31.3	1.6	89.9	0.1	0.4	1.6	1.2	0.2	10.3	0.2	0.1	34.7	0.1	0.4	0.8	0.2	0.2	34.1	45.0	55.7	0.3	75.5	0.6	52.5	58.3	204.4	53.7	67.5	50.5	41.6	48.4	52.2	67.7	41.6	46.6	48.1	105.8	39.1	66.3	38.2	66.4	101.2	12.7	10.8	7.8	13.6	10.4	7.8	9.6	8.2	7.3	7.5
CORO1B	coronin-2	ENSG00000172725	"Coronin 1B"	Q9BR76	11	67435510-67443821	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017616, HPA040113, HPA070456"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			200000000	"Plasma membrane, Cytosol"		"CAB017616: AB_2087018, HPA040113: , HPA070456: "	"unprognostic (1.94e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.02e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.64e-3)"	26.0	24.0	12.6	20.6	16.1	9.7	21.6	9.7	19.0	25.8	37.0	20.3	23.1	35.0	28.7	34.0	31.2	25.6	35.3	15.2	12.6	11.0	27.5	36.4	21.6	23.3	15.9	10.7	21.2	24.2	15.4	16.1	29.2	14.3	31.4	19.1	20.5	42.5	27.4	9.2	16.7	44.7	20.5	14.8	34.7	29.8	13.9	16.5	16.1	31.6	23.3	20.0	25.8	20.8	4.2	17.5	10.9	47.1	2.4	12.3	11.7	18.9	18.6	9.0	18.4	23.4	20.4	13.5	13.4	28.5	23.1	17.5	31.1	28.1	0.6	28.1	19.0	16.4	10.1	17.9	4.1	4.3	8.8	13.3	12.2	13.3	37.3	0.2	28.7	27.6	16.0	19.5	9.0	29.1	9.8	2.0	13.1	54.0	2.9	1.5	11.6	17.6	2.6	9.4	3.3	15.5	23.7	10.2	12.7	12.7	34.6	41.7	43.3	15.2	23.0	15.8	11.4	21.3	8.3	0.3	0.6	3.0	25.4	1.8	15.9	10.9	22.9	1.7	1.9	47.1	1.4	4.2	9.3	3.0	17.5	1.4	5.3	2.3	10.9	2.4	45.8	13.5	12.3	11.7	12.6	16.1	9.7	19.0	12.6	11.0	15.9	10.7	14.3	16.5
CORO2A	"IR10, WDR2"	ENSG00000106789	"Coronin 2A"	Q92828	9	98120975-98192640	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 36.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.9;SK-BR-3: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041161, HPA041302"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041161: AB_10795537, HPA041302: AB_10794195"	"unprognostic (4.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.40e-3)"	1.6	0.8	1.2	6.9	1.8	8.1	2.9	9.3	2.4	3.9	22.0	0.7	1.3	20.8	2.0	2.2	13.6	2.7	27.7	1.5	1.3	3.0	1.4	2.9	7.5	1.6	2.6	1.3	1.5	1.4	2.8	5.2	3.5	3.3	9.0	7.9	1.2	5.4	1.9	0.9	6.3	36.1	1.9	0.6	3.8	6.6	11.4	0.6	5.6	1.1	3.6	6.6	7.7	6.2	0.6	0.7	10.9	7.0	1.5	11.1	1.4	4.1	1.4	0.3	1.0	0.6	0.7	33.9	0.3	0.3	1.0	1.6	9.4	0.7	0.0	4.8	0.6	11.5	3.8	6.3	0.7	3.3	0.9	0.1	5.8	8.3	1.4	3.8	0.3	0.2	7.8	0.5	9.5	0.3	3.2	1.9	0.1	3.1	0.7	3.8	4.3	1.1	2.9	0.0	0.1	0.7	11.6	0.8	1.2	2.1	22.8	0.8	2.7	6.3	0.3	0.1	5.0	0.1	1.2	0.3	1.9	0.3	0.2	1.2	1.4	7.7	1.5	10.9	2.4	3.0	5.5	0.6	4.1	3.8	0.5	0.6	2.7	3.5	1.1	1.5	7.0	0.7	11.1	1.4	1.2	1.8	9.3	2.4	1.3	3.0	2.6	1.3	3.3	0.6
COTL1	CLP	ENSG00000103187	"Coactosin like F-actin binding protein 1"	Q14019	16	84565594-84618077	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Chaperone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 206.6;lymphoid tissue: 103.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 110.8;eosinophil: 160.2;intermediate monocyte: 190.1;myeloid DC: 117.3;neutrophil: 86.8;non-classical monocyte: 206.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 117.3;granulocytes: 160.2;monocytes: 206.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008918, CAB062328"	Enhanced		Supported	Cytosol			28000000	Cytosol		"CAB062328: AB_2084785, HPA008918: "	"unprognostic (2.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.70e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.35e-3)"	28.6	9.9	20.4	68.1	19.5	57.7	13.7	12.4	18.1	7.6	16.5	25.3	2.4	22.0	13.2	8.4	8.2	13.2	18.7	7.2	19.6	24.9	34.3	12.4	26.6	103.0	28.9	8.1	10.8	7.5	5.1	13.1	29.4	23.2	11.8	16.7	30.8	7.7	7.6	5.1	5.1	26.1	16.2	27.8	92.3	29.6	8.0	13.4	33.0	10.1	5.2	62.0	29.3	7.6	28.5	117.3	160.2	206.6	30.8	32.5	108.3	52.7	44.1	101.0	106.6	11.6	32.0	30.5	46.0	29.7	36.3	14.0	59.8	82.0	14.6	14.1	34.5	26.6	6.1	36.2	36.6	0.1	7.8	27.5	9.3	15.8	32.7	30.8	109.2	25.5	5.8	35.0	31.3	17.3	2.5	6.1	21.6	8.5	9.4	18.6	12.4	45.2	1.0	3.4	0.9	53.3	22.5	16.0	0.8	42.9	10.3	22.9	7.7	25.1	44.3	52.3	29.8	16.8	33.4	1.1	5.5	12.0	40.9	15.0	127.4	29.6	110.8	160.2	3.6	190.1	4.8	28.5	23.0	21.7	117.3	13.2	10.3	12.1	86.8	30.8	206.6	6.0	32.5	108.3	20.4	19.5	12.4	18.1	19.6	24.9	28.9	8.1	23.2	13.4
COX10		ENSG00000006695	"COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor"	Q12887	17	14069496-14208677	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Heme biosynthesis"	Transferase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 34.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol				Mitochondria	"Nucleoli, Cytosol"	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favourable (4.32e-6)"	"prognostic favourable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	5.5	6.9	5.3	5.7	6.5	7.0	5.4	6.5	7.2	4.4	11.8	4.1	2.9	9.7	5.1	3.6	9.4	4.8	3.5	18.9	5.8	3.8	10.0	9.3	5.2	8.4	4.5	2.8	4.9	9.6	7.2	6.4	6.6	5.7	5.2	10.1	5.5	6.7	4.8	34.9	6.0	10.9	7.2	4.0	4.6	7.7	15.5	4.9	5.9	5.2	9.6	7.4	7.2	5.8	11.9	13.6	4.0	14.1	8.8	17.5	9.8	8.6	16.6	6.9	9.9	6.9	6.3	15.7	10.5	7.4	19.2	13.3	14.5	6.4	20.4	8.3	10.5	16.7	14.1	13.5	15.5	11.0	14.1	12.1	13.4	16.0	12.2	12.5	11.4	9.1	17.0	12.0	15.3	10.1	16.4	7.0	8.4	10.7	10.6	8.2	10.5	8.6	8.9	23.4	14.4	12.1	16.2	5.2	8.8	10.8	14.4	13.0	8.1	7.1	8.3	8.4	7.0	8.5	13.2	8.5	11.9	9.2	12.6	13.0	10.3	3.0	10.6	4.0	9.9	14.1	10.4	11.9	11.6	10.3	13.6	8.2	12.6	11.9	1.2	8.8	11.9	4.6	17.5	9.8	5.3	6.5	6.5	7.2	5.8	3.8	4.5	2.8	5.7	4.9
COX19	MGC104475	ENSG00000240230	"COX19, cytochrome c oxidase assembly factor"	Q49B96	7	898778-975599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021226	Approved		Supported	Cytosol				Cytosol		"HPA021226: AB_1847176"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-3)"	8.1	22.1	11.9	9.4	15.8	16.6	9.6	25.4	13.3	8.6	10.2	14.5	10.8	15.7	9.2	8.5	10.2	15.0	8.3	9.5	11.3	9.7	10.6	9.9	8.8	11.4	18.5	10.4	12.7	16.4	13.9	13.7	8.4	14.1	10.8	10.5	8.0	13.3	9.0	18.9	16.5	13.3	8.7	12.6	13.6	13.4	11.2	15.3	8.5	10.5	12.4	11.6	9.2	9.9	12.5	15.0	15.1	9.9	10.1	15.2	7.6	14.5	3.6	4.3	5.5	3.2	4.6	8.4	6.4	4.7	5.8	4.9	9.8	8.2	7.1	2.2	3.9	9.8	4.5	4.7	4.7	2.2	7.4	3.2	4.5	7.5	10.0	7.4	6.9	5.5	10.0	4.5	10.5	3.7	9.0	6.0	3.7	8.8	3.4	7.9	11.2	9.7	7.7	0.8	3.5	4.8	6.2	5.7	5.7	3.8	15.0	11.7	7.9	17.7	4.4	5.7	8.0	6.4	9.9	7.4	5.3	7.3	5.1	10.4	9.6	15.1	9.9	13.9	11.2	9.7	11.8	12.5	12.1	10.1	8.4	12.2	15.2	14.3	9.5	10.1	9.9	15.0	11.1	7.6	11.9	15.8	25.4	13.3	11.3	9.7	18.5	10.4	14.1	15.3
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354814	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 66.5"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 22.1;SCLC-21H: 9.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.3	0.0	0.4	0.6	0.6	0.7	0.5	0.3	0.6	0.2	3.3	0.2	0.2	0.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.5	0.5	0.2	0.2	0.6	0.4	0.2	0.4	0.2	0.0	0.4	0.2	0.6	0.2	3.5	0.7	0.6	0.2	0.2	1.8	0.2	0.2	0.7	0.2	0.0	66.5	0.3	0.2	0.2	0.2	1.2	0.2	0.4	1.3	1.4	5.7	1.0	1.6	0.9	0.8	2.7	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.1	22.1	0.1	0.2	0.2	1.7	0.7	0.2	0.2	0.8	0.6	0.0	1.7	0.1	0.3	0.1	1.7	0.2	2.4	0.4	0.5	0.0	0.4	0.2	0.0	0.4	0.1	0.2	0.6	0.5	0.1	0.0	0.2	0.0	0.4	9.5	0.3	0.3	0.1	0.0	0.4	0.0	0.3	0.3	0.5	0.1	0.2	1.5	1.2	0.1	0.1	0.3	0.2	1.9	1.0	1.0	0.8	0.5	0.5	0.7	0.7	0.6	0.3	1.3	0.7	0.9	5.7	1.6	0.7	1.4	0.6	0.8	0.4	0.6	0.3	0.6	0.2	0.5	0.4	0.2	0.6	0.3
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.8;LHCN-M2: 62.5;U-2 OS: 34.2;U-87 MG: 61.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	20.2	1.1	0.0	0.0	0.1	0.3	0.0	16.2	30.8	16.6	4.1	0.1	1.7	0.0	3.2	6.9	1.2	0.0	8.9	17.2	0.1	0.0	0.0	6.5	0.4	0.4	0.0	0.0	0.2	14.5	1.5	2.1	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	2.4	0.0	16.7	0.0	7.8	0.8	0.0	0.0	10.7	5.1	0.1	0.1	0.0	12.4	4.0	34.2	1.3	1.6	0.0	0.0	0.0	61.4	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1
CPEB1	"CPEB, FLJ13203"	ENSG00000214575	"Cytoplasmic polyadenylation element binding protein 1"	Q9BZB8	15	82543201-82648861	"Predicted intracellular proteins"	"mRNA processing, Translation regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.0"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 15.8;U-2197: 45.7;U-87 MG: 16.6"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.5"	"Group enriched"	"Detected in many"	27	"B-cells: 1.8;T-cells: 3.5"									HPA040396			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA040396: "	"unprognostic (3.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.50e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	2.1	5.6	7.5	1.6	10.8	0.5	2.1	11.9	15.7	5.2	5.3	9.4	0.2	1.6	4.2	8.7	4.0	9.2	4.3	2.9	6.2	6.2	1.6	0.8	1.9	0.8	12.4	9.0	15.4	1.6	1.4	8.3	0.6	13.0	2.7	2.9	3.9	1.4	4.4	2.2	1.5	2.2	3.9	7.7	0.9	2.6	32.0	8.1	0.0	2.7	0.0	0.8	5.5	3.8	1.8	0.0	0.0	0.0	0.0	3.5	0.6	0.0	1.5	0.1	0.1	1.1	0.0	0.0	1.2	0.1	0.7	0.6	0.0	0.0	0.0	2.7	0.4	0.0	2.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.8	0.0	1.0	0.6	0.0	1.5	0.0	0.0	3.6	0.0	0.5	0.0	0.2	0.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	4.5	1.0	3.9	0.2	15.8	0.0	0.5	0.0	8.3	3.3	45.7	2.5	2.3	5.8	0.6	16.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.7	1.8	0.3	1.8	0.0	0.5	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.6	7.5	10.8	11.9	15.7	6.2	6.2	12.4	9.0	13.0	8.1
CPEB2		ENSG00000137449	"Cytoplasmic polyadenylation element binding protein 2"	Q7Z5Q1	4	15002674-15070153	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072513			Approved	Cytosol				Cytosol		"HPA072513: "	"unprognostic (6.59e-2)"	"unprognostic (4.21e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	10.0	7.5	18.5	6.0	21.5	23.0	13.6	11.5	21.0	8.8	11.5	28.7	13.2	9.6	8.2	9.4	13.6	7.1	10.7	7.8	17.4	16.2	13.5	18.9	9.5	6.4	27.2	17.4	7.9	5.4	23.8	6.4	7.4	16.4	10.2	10.7	20.7	8.9	21.9	7.1	23.0	9.5	10.8	21.7	6.6	10.8	37.4	27.6	3.6	6.1	7.8	7.2	8.3	12.6	0.4	0.7	2.4	0.4	1.3	1.6	0.3	1.3	8.1	0.8	0.3	6.0	11.1	1.4	4.6	3.1	2.8	2.1	0.2	1.6	0.8	0.9	4.2	1.4	1.7	1.0	1.8	2.2	0.6	0.2	6.2	1.4	2.8	0.3	1.0	5.5	5.4	6.9	6.6	2.6	0.1	5.9	11.6	0.6	0.1	1.8	0.8	1.2	0.1	0.6	0.3	24.7	1.0	0.7	4.5	1.5	1.0	4.6	0.5	5.2	5.0	10.2	0.8	6.4	2.4	3.9	0.5	0.4	8.4	4.6	3.8	0.0	0.4	1.7	0.5	0.4	1.6	0.1	0.8	0.5	0.7	0.4	0.9	0.3	2.4	1.3	0.2	0.3	0.2	0.3	18.5	21.5	11.5	21.0	17.4	16.2	27.2	17.4	16.4	27.6
CPNE2	CPN2	ENSG00000140848	"Copine 2"	Q96FN4	16	57092537-57148367	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041132	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"HPA041132: "	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	14.1	3.9	8.4	4.6	15.1	22.8	11.4	7.9	15.4	16.4	12.0	40.6	1.1	2.0	8.8	3.1	6.4	12.0	5.6	5.9	10.6	11.6	4.8	4.3	15.5	8.2	20.8	9.8	5.1	3.3	3.7	4.9	11.5	12.9	5.1	11.9	4.6	3.7	7.4	4.9	4.0	6.6	10.5	13.5	6.0	3.7	15.3	20.1	0.2	5.8	2.2	3.2	6.4	8.3	0.0	2.1	4.0	4.2	0.5	1.2	0.9	8.2	16.0	24.8	13.7	4.5	4.3	4.1	9.1	14.3	20.8	14.6	4.5	9.7	5.0	8.3	13.7	13.1	9.7	5.4	11.3	6.1	5.7	2.0	6.4	3.7	8.1	1.6	0.2	4.1	6.1	8.1	4.0	30.5	5.5	0.1	5.2	3.8	2.4	24.3	5.6	3.4	31.0	7.8	4.1	13.8	3.2	0.5	10.1	11.5	2.5	6.9	2.7	33.2	21.5	19.0	10.4	4.7	11.7	1.2	1.0	11.1	12.3	7.2	13.3	0.0	4.2	1.9	0.7	1.2	0.7	0.0	0.4	1.2	2.1	0.0	0.3	0.6	4.0	0.5	0.4	0.1	0.5	0.9	8.4	15.1	7.9	15.4	10.6	11.6	20.8	9.8	12.9	20.1
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514427-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol			52000	"Nucleoplasm, Cytosol"	"Nucleoli, Mitochondria"	"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favourable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	26.5	16.6	21.3	9.8	18.0	35.1	20.6	18.8	13.5	26.0	16.4	20.9	13.2	15.1	28.6	12.6	40.5	15.9	14.6	24.4	17.6	19.7	29.8	25.5	16.9	22.6	19.7	10.5	26.7	24.1	25.4	28.9	16.1	17.0	22.4	16.5	21.0	20.6	15.3	10.4	18.7	19.5	20.9	18.7	18.3	16.9	9.7	14.1	30.5	33.6	21.8	29.7	25.4	20.0	14.6	31.4	28.2	24.3	15.0	18.3	14.4	34.3	12.1	8.4	10.9	32.4	25.3	6.9	16.5	24.6	13.8	15.7	7.8	11.8	9.4	11.0	20.1	26.6	18.0	17.6	24.9	10.0	14.1	1.5	8.9	9.3	11.2	0.8	0.8	17.1	19.0	15.3	20.4	16.9	8.4	18.2	17.1	13.3	16.5	0.5	3.2	17.6	7.9	7.7	44.0	17.9	24.7	17.8	14.0	14.4	66.0	10.4	25.1	2.6	18.0	12.4	12.1	16.4	12.8	13.0	15.6	2.6	17.8	3.5	11.4	10.8	16.7	26.4	18.3	19.1	14.2	14.6	14.8	12.8	30.8	14.1	13.3	14.3	28.2	15.0	24.3	31.4	10.5	14.4	21.3	18.0	18.8	13.5	17.6	19.7	19.7	10.5	17.0	14.1
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;prostate: 35.7"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;AF22: 9.1;Karpas-707: 2.7;RT4: 3.1"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 3.2"	"Low region specificity"	"Detected in many"							"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA032036: AB_10600898, HPA078300: "	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	1.4	1.4	7.0	0.8	11.6	0.8	0.7	0.4	27.2	1.0	1.1	2.5	0.7	1.6	0.9	1.6	1.1	1.2	0.7	1.9	17.5	5.3	2.1	0.8	1.2	0.7	1.3	11.8	0.7	0.8	3.8	9.5	0.7	3.1	35.7	1.0	0.1	1.1	6.0	0.6	1.0	1.4	1.2	4.6	1.8	1.4	2.3	3.6	0.0	1.1	0.0	0.7	0.7	1.1	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	9.7	9.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	2.7	1.3	0.6	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.6	3.1	1.3	0.6	0.0	1.2	0.0	0.0	0.0	0.0	1.1	2.3	0.3	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	7.0	11.6	0.4	27.2	17.5	5.3	1.3	11.8	3.1	3.6
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36840002	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;brain: 50.3;heart muscle: 28.6"	"Group enriched"	"Detected in some"	4	"Daudi: 32.3;HUVEC TERT2: 13.3;U-266/70: 11.1;U-266/84: 8.9;U-698: 15.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.3"	"Group enriched"	"Detected in some"	82	"memory B-cell: 27.1;naive B-cell: 12.9"	"Lineage enriched"	"Detected in single"	111	"B-cells: 27.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 100.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 166.9"	HPA031369	Enhanced		Approved	Cytosol				Cytosol		"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	1.8	1.1	8.1	12.5	50.3	1.1	1.7	1.9	49.4	1.8	4.2	1.3	0.0	3.9	3.7	1.0	1.8	11.3	1.7	28.6	3.7	4.9	1.3	0.5	1.5	14.3	3.6	12.8	2.3	1.0	0.8	3.6	1.3	3.3	2.9	3.6	4.1	2.0	2.2	0.5	1.0	2.9	3.6	3.0	7.1	3.4	11.8	6.2	0.1	1.4	0.0	20.3	5.5	1.9	27.1	0.1	0.2	0.1	0.0	0.1	2.2	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.1	32.3	0.3	0.4	0.3	0.1	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	13.3	0.1	0.9	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.5	0.0	0.5	3.0	0.2	0.4	0.0	1.3	11.1	8.9	15.2	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.1	0.1	0.0	0.0	12.9	0.0	0.0	0.2	0.0	0.1	0.1	0.0	2.2	8.1	50.3	1.9	20.4	3.7	4.9	3.6	12.8	3.3	6.2
CPPED1	"CSTP1, FLJ11151"	ENSG00000103381	"Calcineurin like phosphoesterase domain containing 1"	Q9BRF8	16	12659799-12804017	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 44.4;HMC-1: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 93.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040938, HPA041970"	Uncertain		Supported	"Plasma membrane,Cytosol"			380000	Cytosol	"Plasma membrane"	"HPA040938: AB_10673443, HPA041970: "	"prognostic unfavourable (9.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.64e-1)"	"prognostic favourable (1.62e-9)"	"unprognostic (5.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.40e-2)"	10.9	11.5	8.3	14.3	14.3	9.5	8.5	2.7	11.8	9.2	13.8	20.8	7.4	16.3	8.2	6.2	23.1	7.2	8.9	10.7	11.2	9.5	26.2	31.4	10.4	21.2	20.7	7.7	6.4	4.1	4.3	6.5	36.6	17.6	9.1	11.9	10.2	15.1	7.3	6.4	6.8	20.5	10.0	22.1	27.4	8.1	18.2	13.1	5.8	11.1	8.4	16.9	9.8	9.6	1.5	23.1	93.6	43.7	1.9	1.8	14.6	1.5	9.3	1.0	2.4	3.9	8.4	0.1	17.0	4.6	9.2	7.5	4.5	4.8	2.2	17.7	12.4	0.1	0.0	4.2	9.5	5.2	2.6	19.3	1.4	44.4	2.4	0.0	42.0	8.4	0.9	0.8	6.6	13.7	6.7	1.4	22.4	1.9	1.7	8.9	2.8	1.3	3.6	6.0	4.8	13.8	2.9	4.9	3.2	0.0	15.5	6.1	3.3	4.2	20.4	13.2	2.7	0.0	0.0	0.0	0.3	3.5	2.9	9.8	2.8	6.1	30.6	19.3	1.3	43.7	1.1	1.5	1.1	1.4	23.1	1.0	0.3	0.8	93.6	1.9	40.6	5.6	1.8	14.6	8.3	14.3	2.7	11.8	11.2	9.5	20.7	7.7	17.6	13.1
CPSF7	"CFIM59, FLJ12529"	ENSG00000149532	"Cleavage and polyadenylation specific factor 7"	Q8N684	11	61402641-61430031	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041094	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041094: AB_10794187"	"unprognostic (6.87e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavourable (9.83e-4)"	"unprognostic (5.35e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.18e-2)"	23.3	25.6	23.2	24.3	39.0	34.5	25.6	31.6	49.5	26.9	25.4	35.4	34.9	22.6	41.6	33.5	27.0	31.6	19.9	20.9	25.0	19.9	25.2	33.6	24.0	28.5	24.3	24.9	40.5	29.0	36.1	47.8	26.9	29.2	27.6	25.5	33.2	28.4	28.4	36.7	33.9	27.6	32.5	27.2	33.9	26.9	31.3	28.5	45.6	36.0	19.8	32.3	27.1	26.3	10.4	10.5	14.2	8.3	8.5	12.9	7.4	26.3	26.5	37.1	29.4	20.1	17.9	26.2	21.9	21.1	29.2	22.4	30.9	22.7	39.6	23.6	23.4	32.7	35.6	25.1	35.7	26.2	18.2	33.4	34.2	24.8	20.4	40.4	29.7	18.9	20.6	31.0	45.3	19.7	40.0	25.5	21.0	31.9	39.9	32.9	36.5	20.9	37.6	29.3	32.6	21.8	32.7	25.3	25.8	29.2	25.8	27.0	35.7	17.3	19.8	32.4	27.7	30.3	22.6	35.2	41.4	45.6	18.9	19.5	23.7	14.2	7.4	9.2	12.2	8.3	12.9	10.4	9.7	12.3	10.5	10.0	10.7	10.8	14.0	8.5	6.1	8.9	6.6	7.4	23.2	39.0	31.6	49.5	25.0	19.9	24.3	24.9	29.2	28.5
CPTP	"GLTPD1, MGC10334"	ENSG00000224051	"Ceramide-1-phosphate transfer protein"	Q5TA50	1	1324756-1328897	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056832	Approved		Approved	Cytosol				Cytosol		"HPA056832: "	"unprognostic (9.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.79e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.27e-2)"	9.8	8.7	8.0	9.2	7.6	3.7	8.1	7.2	13.8	10.7	14.9	6.0	12.0	21.4	7.0	21.9	20.5	6.1	9.6	43.1	9.3	5.8	19.1	38.9	6.8	9.0	8.1	7.2	6.4	14.5	9.0	3.7	10.4	9.2	8.4	6.2	5.3	46.4	15.0	51.7	13.9	21.1	4.3	5.7	13.4	15.7	28.2	4.8	12.0	8.8	18.4	13.7	6.6	10.2	4.9	1.8	8.6	1.9	1.8	7.6	1.9	18.5	6.7	3.2	5.9	3.2	2.7	5.3	9.9	5.3	9.3	6.1	9.1	10.4	7.4	11.4	4.5	13.9	2.6	5.8	3.4	8.7	8.9	5.5	7.2	9.1	8.0	5.3	5.6	5.1	4.5	9.7	2.8	4.9	8.1	4.5	3.0	6.8	5.8	6.2	2.9	29.9	7.3	5.4	21.3	7.5	5.0	7.7	8.1	7.9	25.0	16.8	8.9	3.7	8.3	10.0	7.0	10.8	7.9	9.8	7.5	7.7	9.6	7.9	3.0	2.9	1.9	8.6	2.6	1.0	1.5	4.9	3.2	2.5	1.3	1.9	1.9	1.5	2.7	1.8	1.8	1.8	7.6	1.9	8.0	7.6	7.2	13.8	9.3	5.8	8.1	7.2	9.2	4.8
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 154.2;tongue: 80.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 160.3;MCF7: 61.1;T-47d: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA004135	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	4.9	1.1	1.0	1.7	3.2	0.7	16.8	1.3	2.1	66.8	1.3	1.2	38.5	0.0	13.9	2.8	154.2	13.1	2.8	1.2	0.9	2.1	1.4	0.2	0.7	0.4	0.8	2.9	5.9	0.8	2.7	5.0	7.0	3.7	6.7	0.7	7.9	10.6	28.0	0.5	25.7	0.9	8.8	1.1	0.8	0.5	1.1	0.9	2.1	2.2	80.5	33.5	10.0	66.6	0.1	0.0	0.4	0.0	0.0	1.3	0.5	10.2	0.5	11.7	0.1	15.3	22.9	0.0	21.8	160.3	1.7	2.2	18.2	37.8	0.1	10.8	23.1	13.3	2.8	0.0	0.5	0.2	0.8	0.0	1.4	0.1	3.0	0.0	0.2	7.2	1.0	2.5	0.0	0.0	0.0	0.2	0.1	61.1	0.1	0.1	14.1	5.7	0.1	0.0	0.3	0.2	0.4	29.2	2.1	0.3	37.8	0.1	124.2	0.0	0.0	0.4	6.7	3.6	1.3	0.9	2.2	0.1	3.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	0.0	0.1	1.3	1.2	0.4	0.0	0.0	0.0	0.0	0.5	1.0	3.2	1.3	2.1	0.9	2.1	0.8	2.9	3.7	0.9
CRADD	RAIDD	ENSG00000169372	"CASP2 and RIPK1 domain containing adaptor with death domain"	P78560	12	93677375-93894840	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005337	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB005337: AB_2085481"	"unprognostic (1.07e-2)"	"prognostic favourable (9.06e-5)"	"unprognostic (9.65e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.10e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.18e-2)"	"prognostic favourable (4.04e-9)"	"unprognostic (2.57e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	7.8	15.9	11.0	4.4	14.2	7.1	10.4	12.5	10.4	8.8	9.3	11.5	16.7	14.8	10.6	11.9	9.9	8.3	9.6	35.7	12.3	8.9	14.8	31.4	7.5	7.1	9.8	9.7	8.5	9.7	18.7	21.2	6.5	13.3	9.4	7.5	11.3	10.3	8.8	22.1	8.0	15.4	12.2	11.5	8.3	9.5	15.0	13.2	9.7	8.6	15.5	5.5	10.2	8.4	8.6	7.6	25.3	12.2	10.8	15.0	6.8	6.1	13.9	6.9	7.8	10.0	18.1	8.7	7.0	8.7	6.2	7.3	13.0	2.5	10.9	4.4	8.1	6.3	7.4	9.3	8.1	11.5	10.0	5.8	5.9	9.5	10.3	5.3	5.6	16.4	14.2	10.0	7.9	7.5	16.4	5.2	7.3	9.8	7.7	9.5	8.8	10.7	13.1	3.5	15.1	6.0	4.5	10.6	10.2	9.5	9.4	16.8	16.6	10.4	7.9	14.5	7.2	6.9	7.1	12.3	6.7	10.1	6.8	7.9	6.8	24.9	6.9	25.3	14.7	8.3	13.0	8.6	10.3	15.0	5.6	7.2	11.1	8.2	19.4	10.8	12.2	7.6	11.5	6.8	11.0	14.2	12.5	10.4	12.3	8.9	9.8	9.7	13.3	13.2
CRAMP1	"CRAMP1L, KIAA1426"	ENSG00000007545	"Cramped chromatin regulator homolog 1"	Q96RY5	16	1612325-1677908	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041752	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA041752: AB_10796459"	"unprognostic (3.67e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.78e-4)"	"unprognostic (4.17e-2)"	"unprognostic (8.53e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.86e-3)"	"prognostic favourable (4.93e-4)"	"unprognostic (8.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	8.5	6.4	9.2	10.5	9.3	13.9	11.6	24.2	11.0	8.4	8.8	11.1	5.1	7.2	11.4	8.3	8.6	9.9	6.5	7.2	8.6	5.4	6.5	4.7	9.2	8.0	9.7	10.5	12.3	9.2	10.2	10.9	8.4	9.4	9.8	7.1	9.8	8.4	9.5	8.9	13.7	8.4	8.8	7.9	9.4	8.5	21.9	9.8	18.1	11.8	4.4	7.5	10.6	11.7	0.8	2.1	0.5	0.6	2.5	1.9	0.5	5.2	8.6	10.9	10.3	7.3	7.3	12.6	6.2	5.4	8.4	6.0	7.9	9.0	5.3	5.9	7.1	8.9	13.0	6.3	7.7	6.4	13.5	8.3	9.9	4.9	5.3	11.7	13.5	6.3	8.6	10.0	8.1	8.3	11.1	4.1	4.6	8.7	7.7	7.2	8.7	5.3	30.0	5.2	9.2	5.5	5.4	11.4	8.1	9.2	7.6	4.9	6.1	16.2	9.4	8.0	7.8	6.8	7.8	7.0	10.1	13.5	2.7	7.8	7.1	0.4	0.6	0.0	1.9	0.6	0.9	0.8	0.6	0.6	0.3	0.8	0.9	0.9	0.5	2.5	0.2	2.1	0.3	0.5	9.2	9.3	24.2	11.0	8.6	5.4	9.7	10.5	9.4	9.8
CREB3	"Luman, LZIP, sLZIP"	ENSG00000107175	"CAMP responsive element binding protein 3"	O43889	9	35732335-35737004	"Predicted membrane proteins, Transcription factors"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030978			Supported	Cytosol				Cytosol		"HPA030978: "	"unprognostic (1.73e-3)"	"unprognostic (9.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.62e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (4.63e-2)"	"prognostic favourable (5.40e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (3.77e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	15.7	25.1	23.7	12.0	27.6	5.6	19.4	18.5	30.2	25.4	20.3	17.6	28.2	12.8	20.9	22.5	15.0	23.9	25.2	16.3	19.4	21.3	21.3	42.3	15.9	15.3	23.1	17.1	20.2	26.3	22.1	23.1	19.5	17.3	32.9	16.7	17.4	31.7	37.6	12.6	9.9	14.6	26.0	19.6	13.0	20.5	23.0	14.0	9.1	24.4	9.4	14.9	22.0	17.6	17.7	19.4	14.8	16.9	15.9	21.8	15.7	12.2	11.4	12.1	9.0	25.4	16.6	7.9	22.4	35.8	23.9	24.8	12.7	6.0	4.4	9.9	32.7	4.7	7.7	18.5	15.8	16.4	6.4	3.4	10.1	5.8	32.4	5.6	6.8	14.5	15.2	23.2	22.7	14.6	4.9	7.4	24.5	6.0	5.8	2.0	7.5	15.0	6.4	5.3	5.6	19.3	5.9	5.6	7.8	8.9	7.9	5.3	12.1	2.4	15.6	15.8	8.9	11.5	13.7	4.3	5.2	5.3	16.6	2.0	17.2	14.8	16.9	6.3	19.2	16.0	20.7	17.7	16.8	21.8	17.9	12.3	13.7	13.4	7.7	15.9	12.8	19.4	18.5	15.7	23.7	27.6	18.5	30.2	19.4	21.3	23.1	17.1	17.3	14.0
CREBL2		ENSG00000111269	"CAMP responsive element binding protein like 2"	O60519	12	12611827-12645108	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043738	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Cytosol"	"HPA043738: AB_10795041"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-3)"	"unprognostic (6.73e-2)"	"prognostic favourable (2.26e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.53e-1)"	21.9	77.6	24.3	16.5	31.9	3.0	18.9	21.4	24.6	16.4	13.4	14.6	13.5	13.2	11.4	17.5	10.4	14.9	16.4	14.3	19.8	23.0	28.7	28.2	18.5	18.8	20.2	19.8	22.6	14.2	31.7	31.5	13.8	19.7	17.1	14.2	20.5	15.4	14.4	6.6	14.1	13.3	12.0	20.0	20.2	14.1	17.1	18.3	8.6	25.9	6.7	16.6	17.7	14.0	2.0	4.2	3.6	8.7	1.6	8.1	2.2	5.8	7.6	6.7	7.6	23.7	24.0	12.9	11.6	19.6	8.5	11.8	5.5	8.7	5.1	4.5	14.0	5.0	10.1	8.9	14.6	28.5	6.1	4.0	7.7	6.7	15.5	5.7	7.5	15.5	15.9	10.0	16.5	12.5	4.0	8.1	14.3	9.5	2.9	4.7	20.0	7.0	4.1	11.6	3.2	16.4	17.1	7.9	9.0	11.7	5.7	20.2	3.2	6.5	10.0	11.8	7.6	11.6	11.4	6.8	9.0	1.3	14.0	4.9	12.1	1.7	3.8	3.6	2.8	8.7	5.0	1.5	5.5	4.4	4.2	2.0	5.5	4.5	0.7	1.6	3.6	2.1	8.1	2.2	24.3	31.9	21.4	24.6	19.8	23.0	20.2	19.8	19.7	18.3
CRELD1	AVSD2	ENSG00000163703	"Cysteine rich with EGF like domains 1"	Q96HD1	3	9933822-9945413	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026964	Uncertain		Approved	Nucleoli,Cytosol	"Intracellular and membrane"		16000000	Cytosol	Nucleoli	"HPA026964: AB_10602210"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (8.07e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.78e-2)"	21.8	22.9	31.6	15.3	32.4	7.3	27.3	52.2	45.1	9.9	22.4	12.0	17.1	12.5	15.1	17.8	13.1	20.1	15.8	50.2	25.6	24.9	16.6	23.5	15.8	11.0	17.2	30.7	19.7	15.2	21.9	32.4	15.1	27.2	25.4	11.4	10.0	19.4	32.2	24.4	11.6	13.1	19.5	19.4	11.9	14.8	11.1	22.3	5.9	45.7	7.4	8.2	17.8	15.6	10.5	13.7	11.5	12.5	13.4	14.3	10.4	2.8	5.3	8.7	4.5	14.7	9.6	48.1	10.6	3.2	2.6	5.0	5.1	8.7	3.5	23.4	7.4	1.9	4.2	7.7	1.8	6.9	3.9	3.2	6.9	12.0	29.4	1.1	12.3	9.8	14.2	6.6	6.0	12.1	3.8	4.2	2.5	6.9	2.0	8.6	2.3	3.6	2.1	1.3	8.3	11.3	5.0	3.5	11.2	4.9	4.6	9.5	11.7	6.9	8.4	5.1	8.2	6.7	2.5	4.8	6.2	6.5	11.4	3.6	5.4	11.5	11.4	9.4	14.2	11.6	14.3	8.9	10.5	13.7	8.2	10.5	14.2	12.7	1.8	13.4	12.5	13.7	8.0	10.4	31.6	32.4	52.2	45.1	25.6	24.9	17.2	30.7	27.2	22.3
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 129.0;CAPAN-2: 71.9;HaCaT: 77.9;HDLM-2: 55.1;HeLa: 63.2;T-47d: 101.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	44.3	3.3	3.8	37.5	4.9	5.5	97.2	3.2	4.0	37.7	44.0	4.5	65.3	25.7	20.0	83.0	28.4	23.7	33.8	45.5	4.5	4.7	20.4	2.6	56.7	53.0	4.7	4.5	11.2	4.2	1.1	7.3	38.5	4.8	11.7	13.2	9.9	21.8	71.0	12.9	48.8	106.3	25.9	5.1	16.6	20.3	7.5	1.9	24.2	32.0	83.4	58.3	18.4	18.9	111.4	79.3	56.3	49.4	56.9	121.1	75.8	0.0	129.0	0.8	0.1	2.3	1.6	12.0	0.2	0.0	1.7	0.0	4.0	71.9	38.9	0.7	34.4	77.9	0.0	0.0	0.1	55.1	0.0	3.0	63.2	21.7	0.4	0.0	0.0	0.7	0.0	4.2	0.0	0.1	0.1	0.1	0.0	1.0	1.9	0.3	1.2	6.7	30.5	0.0	8.1	0.0	0.0	3.4	0.2	0.4	0.2	0.0	101.1	18.5	0.2	0.0	0.1	0.9	0.0	0.0	0.0	3.2	0.0	0.0	0.1	19.4	43.3	56.3	47.7	38.5	32.7	111.4	92.1	51.4	79.3	43.6	21.9	25.7	2.9	56.9	49.4	62.1	121.1	75.8	3.8	4.9	3.2	4.0	4.5	4.7	4.7	4.5	4.8	1.9
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917426-20953749	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol			1500000	Nucleoplasm	Cytosol	"HPA000532: , HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.4	15.2	25.0	18.1	24.1	41.9	18.4	34.0	31.7	17.8	19.9	26.4	12.3	20.2	18.9	12.8	25.2	19.9	13.6	22.6	22.6	23.8	16.4	24.9	19.0	21.3	24.6	26.1	26.9	21.7	22.2	17.9	25.1	20.7	18.8	18.7	16.7	14.5	19.1	48.1	22.7	19.1	18.6	23.6	19.6	14.3	12.6	19.8	35.7	16.6	17.8	24.7	17.7	24.6	11.7	14.8	19.2	21.5	11.0	19.7	16.8	11.2	6.7	15.2	11.9	10.3	6.6	16.4	7.6	9.4	11.8	13.4	11.1	5.1	14.5	6.2	8.0	14.5	17.8	12.2	14.1	12.3	17.4	20.1	7.4	12.2	10.3	21.3	10.3	6.7	16.3	10.2	17.6	10.4	87.6	12.0	9.5	10.6	12.4	10.0	12.0	7.4	16.2	24.2	3.5	7.9	9.9	9.9	12.7	12.8	11.3	9.3	9.7	11.9	8.4	18.8	21.4	7.0	9.6	11.5	11.1	16.9	13.9	9.1	11.5	13.4	13.0	19.2	17.5	12.5	18.9	11.6	15.8	17.5	14.8	11.7	19.7	18.4	14.1	11.0	21.5	7.4	12.8	16.8	25.0	24.1	34.0	31.7	22.6	23.8	24.6	26.1	20.7	19.8
CRLF3	"CREME9, CYTOR4"	ENSG00000176390	"Cytokine receptor like factor 3"	Q8IUI8	17	30769388-30824776	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 43.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007596	Enhanced		Supported	"Plasma membrane,Cytosol"			830000	"Plasma membrane, Cytosol"		"HPA007596: AB_1847241"	"unprognostic (1.02e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.52e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.31e-7)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.51e-2)"	8.7	4.8	8.8	22.7	8.3	16.7	7.3	12.4	9.4	6.9	7.0	5.9	3.9	5.5	6.3	3.6	15.4	6.1	7.0	5.8	7.5	6.6	5.3	5.4	9.7	28.6	6.6	9.3	5.8	5.5	5.1	6.9	12.3	7.3	6.6	7.4	4.4	7.5	3.9	3.8	10.7	11.3	6.1	8.7	22.0	5.9	9.6	6.7	26.7	5.7	4.5	27.8	10.3	9.3	15.9	13.9	43.6	21.8	12.9	35.7	25.2	6.2	6.9	4.3	9.0	7.9	6.2	6.5	5.9	5.8	11.5	12.1	9.1	4.3	20.9	8.9	7.3	11.0	7.3	4.9	13.9	9.7	13.4	8.7	6.1	6.0	4.4	11.5	6.5	3.6	6.9	9.3	7.9	11.2	22.1	22.2	7.2	3.8	25.4	12.7	8.6	4.6	11.3	14.0	12.2	7.6	5.3	3.1	7.3	6.3	9.4	6.5	7.2	5.8	5.9	6.7	8.3	10.7	14.4	9.3	7.7	14.0	6.4	9.4	7.4	15.5	18.8	43.6	13.0	19.2	13.7	15.9	18.3	14.6	13.9	14.9	35.7	26.4	38.3	12.9	21.8	7.2	20.1	25.2	8.8	8.3	12.4	9.4	7.5	6.6	6.6	9.3	7.3	6.7
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.1;pituitary gland: 23.0"	"Cell line enhanced"	"Detected in some"		"AF22: 20.4;HAP1: 29.2;NTERA-2: 21.2;REH: 55.5;RH-30: 32.7;SCLC-21H: 42.4;SH-SY5Y: 26.8"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favourable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	8.2	24.2	2.5	21.7	0.7	1.0	32.0	63.1	3.3	2.0	5.9	0.1	1.5	11.7	0.7	2.7	4.3	4.3	2.6	22.2	23.9	2.4	0.9	4.2	1.8	9.9	18.1	6.9	4.8	0.9	23.0	4.6	12.3	3.0	1.9	4.6	2.6	3.1	1.0	3.3	2.5	11.6	4.7	1.4	3.5	2.8	4.5	0.0	2.4	0.9	1.3	2.9	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	20.4	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	29.2	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	21.2	0.6	55.5	32.7	4.9	0.0	0.0	42.4	26.8	0.0	0.1	0.3	0.2	0.0	1.7	1.0	7.1	0.6	0.6	3.7	0.5	0.0	2.5	0.2	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	21.7	32.0	34.2	22.2	23.9	9.9	18.1	12.3	4.5
CRTAP	"CASP, LEPREL3, P3H5"	ENSG00000170275	"Cartilage associated protein"	O75718	3	33113979-33147773	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 121.2;ASC TERT1: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 67.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 55.8;monocytes: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043598, HPA044150"	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"	"Secreted to blood"			"Intermediate filaments, Actin filaments, Cytosol"		"HPA043598: AB_10960991, HPA044150: AB_10959594"	"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.85e-3)"	"unprognostic (7.36e-2)"	"unprognostic (4.73e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.28e-3)"	59.2	33.4	16.3	13.4	22.2	13.6	63.2	5.4	14.1	57.5	39.4	23.3	32.7	12.8	54.2	41.1	42.8	35.1	43.5	37.0	16.8	13.1	25.7	16.8	35.9	37.8	24.2	13.0	48.5	13.3	14.6	7.6	25.4	13.8	54.5	19.7	35.4	16.4	42.2	23.9	24.6	18.8	66.1	22.8	17.6	25.2	26.1	19.0	5.1	34.1	25.8	18.3	62.4	59.7	7.6	55.8	5.5	67.8	6.9	12.9	30.8	9.0	17.9	5.6	17.6	121.2	79.4	32.6	19.8	43.2	24.0	22.9	6.0	5.1	6.3	22.1	37.5	11.7	9.9	15.1	17.4	15.6	15.6	9.9	14.0	6.2	36.3	6.4	8.1	63.3	31.0	21.6	27.6	25.2	8.4	12.1	24.2	7.7	2.3	6.5	6.7	24.4	8.4	16.5	12.1	18.8	6.1	1.1	9.1	13.4	11.8	28.5	12.6	15.7	16.4	31.5	13.5	17.1	20.9	8.8	29.7	0.9	24.7	12.9	17.2	2.1	67.8	4.9	6.9	26.3	10.0	7.6	10.1	7.7	55.8	6.8	5.8	5.4	5.5	6.9	7.8	15.0	12.9	30.8	16.3	22.2	5.4	14.1	16.8	13.1	24.2	13.0	13.8	19.0
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683677-18782333	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022035	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255"	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favourable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favourable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.6	7.7	26.0	7.4	38.8	3.2	3.8	40.7	30.1	5.0	4.4	6.5	4.3	6.5	6.8	5.6	3.1	10.5	5.5	5.6	17.7	7.8	6.6	4.5	5.7	6.3	6.4	18.1	6.7	10.0	8.4	11.3	6.4	6.0	7.0	2.6	5.1	8.8	9.4	12.4	5.5	6.2	4.3	4.8	8.1	8.0	7.5	10.2	1.9	7.4	1.1	3.7	4.6	3.5	4.1	3.8	1.8	3.4	1.1	3.0	1.3	4.3	8.0	5.8	9.3	5.4	4.6	16.5	4.8	3.2	4.6	4.5	5.4	5.7	6.1	10.2	4.6	4.7	1.7	3.0	1.1	2.7	13.9	5.1	7.1	8.8	5.2	7.0	14.5	7.4	2.9	4.0	1.2	2.6	4.0	5.6	2.6	16.0	4.5	8.1	7.5	11.8	7.2	2.5	6.7	2.9	7.8	10.7	9.6	5.4	5.2	5.8	5.8	4.3	4.6	5.3	8.1	9.6	5.5	3.8	3.0	4.0	6.1	7.6	4.0	1.5	3.4	1.8	1.7	1.3	1.8	2.3	2.7	3.0	3.0	4.1	2.3	1.8	1.7	1.1	1.9	3.8	1.8	1.3	26.0	38.8	40.7	30.1	17.7	7.8	6.4	18.1	6.0	10.2
CRTC3	FLJ21868	ENSG00000140577	"CREB regulated transcription coactivator 3"	Q6UUV7	15	90529925-90645345	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043735, HPA063691"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043735: AB_10794286, HPA063691: "	"unprognostic (7.60e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.30e-1)"	22.3	14.0	13.7	17.0	20.9	11.4	26.6	15.0	16.2	21.2	22.2	27.5	15.3	8.9	23.9	14.5	15.1	19.4	21.5	17.2	14.0	9.7	10.7	11.7	19.2	21.7	24.1	10.9	45.9	13.9	17.1	9.6	20.2	15.7	18.2	11.7	17.4	19.9	22.0	16.1	15.8	13.7	31.8	20.3	13.1	14.2	15.3	23.6	12.8	22.7	9.2	18.1	24.0	29.6	5.3	2.1	16.0	2.5	3.3	6.6	3.0	4.7	7.9	5.4	8.8	11.7	8.7	24.7	6.1	8.9	9.6	9.1	6.5	4.8	0.1	4.4	12.6	8.0	8.6	5.3	7.6	8.2	10.0	12.1	39.3	3.0	13.3	3.1	20.7	9.7	8.5	7.9	10.7	6.9	6.4	2.8	7.1	5.5	1.3	4.5	1.9	3.7	4.1	8.6	0.2	3.4	10.1	9.9	8.8	17.8	5.9	9.9	5.9	5.9	8.5	10.7	7.9	9.9	7.0	3.7	5.0	3.6	4.4	6.3	5.1	16.0	2.5	1.4	3.7	0.8	4.2	3.1	4.5	4.0	1.6	5.3	6.6	4.1	0.5	3.3	0.3	2.1	4.2	3.0	13.7	20.9	15.0	16.2	14.0	9.7	24.1	10.9	15.7	23.6
CRY2		ENSG00000121671	"Cryptochrome circadian regulator 2"	Q49AN0	11	45847118-45883248	"Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037577	Supported		Supported	"Nuclear speckles,Cytosol"	"Intracellular and membrane"			"Nuclear speckles"	Cytosol	"HPA037577: AB_10672497"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"prognostic unfavourable (1.67e-4)"	"unprognostic (1.31e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.09e-2)"	"prognostic favourable (6.82e-5)"	"unprognostic (1.48e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.07e-2)"	"prognostic favourable (4.39e-4)"	"unprognostic (1.01e-1)"	"prognostic favourable (6.44e-15)"	"unprognostic (8.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.24e-1)"	17.4	13.3	18.2	8.8	27.4	17.2	16.7	29.8	36.5	17.7	12.1	15.4	10.5	7.6	16.2	12.4	11.2	20.8	18.7	39.5	15.6	13.1	15.7	27.8	15.7	6.7	12.7	15.0	26.3	23.4	20.6	16.4	9.3	11.5	15.0	7.3	35.5	14.4	17.1	58.2	24.3	8.5	18.7	10.4	9.2	12.2	17.4	9.6	5.9	23.6	22.4	10.3	17.4	10.6	7.8	5.2	7.6	10.6	10.4	10.4	7.1	1.2	3.6	5.6	6.6	15.3	7.7	12.3	4.3	7.8	5.5	4.1	5.9	2.9	8.4	3.4	9.1	7.4	5.3	4.5	3.8	8.9	4.8	5.5	6.3	8.0	5.8	6.7	7.6	9.0	6.7	4.3	6.8	3.8	10.7	14.4	5.0	4.5	5.7	8.0	15.2	4.4	9.8	8.1	3.9	4.0	6.8	9.0	3.4	7.3	6.6	3.7	8.8	4.8	4.8	7.9	4.8	12.0	3.0	13.4	9.2	6.9	4.8	3.0	4.7	5.7	5.0	7.6	8.7	7.1	7.2	7.8	8.4	9.3	5.2	7.7	10.3	10.4	2.6	10.4	10.6	3.8	6.9	7.1	18.2	27.4	29.8	36.5	15.6	13.1	12.7	15.0	11.5	9.6
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 45.5"	"Cell line enriched"	"Detected in single"	140	"Hep G2: 28.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA037737: , HPA038430: "							"unprognostic (3.68e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	8.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0										
CRYAA2		ENSG00000276076	"Crystallin alpha A2"		21	6560714-6564489	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	6	"kidney: 34.4"	"Cell line enriched"	"Detected in single"	200	"Hep G2: 28.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037737, HPA038430"	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA037737: , HPA038430: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			34.4	5.3	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.0	0.0										
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908565-111923722	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Eye lens protein"	"Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 743.1;skeletal muscle: 581.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 230.1;fHDF/TERT166: 75.0"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			12000	"Plasma membrane, Cytosol"		"CAB002053: AB_442024, CAB040560: , HPA057100: "	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.70e-5)"	107.4	11.5	47.8	16.7	82.3	2.1	69.5	24.8	153.7	22.4	23.6	132.9	7.2	5.5	14.8	25.9	41.9	13.5	14.0	743.1	65.9	44.0	151.8	3.8	8.4	3.9	139.2	29.7	8.8	6.6	3.3	8.6	16.1	80.7	30.3	12.9	23.3	30.6	75.1	581.1	18.1	6.2	45.2	168.0	5.5	11.6	3.9	101.8	0.0	40.7	94.1	9.2	16.2	53.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.3	230.1	10.1	1.6	6.4	0.2	0.1	0.2	0.1	0.0	0.0	3.8	75.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	1.2	0.6	1.9	0.0	0.0	8.1	1.0	0.0	0.5	0.0	0.5	0.2	18.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.8	3.4	0.5	0.0	0.1	29.8	10.7	0.8	0.3	0.1	0.0	0.0	0.6	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	82.3	24.8	48.5	65.9	44.0	139.2	29.7	80.7	101.8
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"	Q9Y4K1	6	106360808-106571978	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.7;placenta: 96.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.7;HBEC3-KT: 39.6;hTERT-HME1: 30.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"pons and medulla: 10.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.1"	"Not detected"	"Not detected"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: , HPA030949: "	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	4.6	0.8	0.6	6.8	0.7	6.5	11.3	0.6	0.9	7.4	7.4	1.6	2.5	7.6	1.5	10.8	61.7	2.0	2.0	0.9	1.1	0.6	9.8	3.6	4.0	5.6	0.7	0.7	2.0	5.5	5.0	0.9	96.6	10.3	12.6	5.9	16.0	10.2	4.3	0.8	16.6	7.6	4.4	0.8	6.5	2.5	1.8	0.5	2.3	1.8	24.6	35.8	11.5	13.1	6.8	8.7	3.1	4.4	5.7	10.9	3.9	10.4	0.0	0.0	0.0	8.8	31.7	3.2	1.5	11.6	3.4	3.2	0.7	3.7	16.4	0.7	7.2	16.9	0.1	39.6	1.6	22.3	0.7	0.0	0.4	5.1	4.2	10.0	0.0	15.8	23.1	6.4	30.7	14.4	0.5	2.3	9.1	1.2	2.8	4.0	0.1	6.9	4.9	0.1	0.1	5.3	24.9	0.7	0.0	6.4	11.0	0.1	5.4	7.6	4.2	3.8	0.5	0.0	10.5	1.8	1.4	17.9	18.1	12.6	8.2	0.3	3.8	0.4	8.1	4.4	10.9	6.8	10.5	8.9	8.7	3.8	6.7	6.3	3.1	5.7	4.4	1.0	9.9	3.9	0.6	0.7	0.6	0.9	1.1	0.6	0.7	0.7	10.3	0.5
CRYBG3	DKFZp667G2110	ENSG00000080200	"Crystallin beta-gamma domain containing 3"	Q68DQ2	3	97822040-97944963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 27.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 1.9;classical monocyte: 3.0;intermediate monocyte: 1.8;myeloid DC: 2.6;non-classical monocyte: 1.9;plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 7.1;granulocytes: 1.9;monocytes: 3.0"					"Low region specificity"	"Detected in all"			HPA044122			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044122: AB_10960490"	"unprognostic (1.88e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.10e-2)"	"unprognostic (3.41e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.86e-2)"	"prognostic favourable (7.07e-4)"	"unprognostic (1.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.38e-3)"	19.9	5.1	6.4	13.4	20.9	1.9	13.1	1.6	13.0	14.6	19.2	8.2	12.1	6.0	10.4	7.4	13.9	9.0	8.6	14.9	9.1	5.3	8.2	5.3	11.3	6.5	28.4	5.1	8.7	8.5	10.2	7.4	15.8	15.0	12.9	11.9	4.7	10.6	9.0	21.5	19.5	8.4	10.1	20.3	7.8	11.1	19.2	20.5	2.0	39.7	12.3	7.0	11.2	16.9	0.5	7.1	1.9	3.0	0.1	0.6	0.5	11.1	4.2	2.5	3.0	7.8	8.5	4.4	4.0	3.6	2.9	4.4	0.3	3.7	0.1	1.3	6.8	7.3	4.8	3.3	5.6	13.7	2.6	2.8	1.8	1.3	4.1	4.1	0.7	5.5	3.4	3.6	4.1	5.6	0.2	2.1	5.0	0.1	1.4	0.4	2.1	3.9	0.0	8.7	1.4	4.3	7.4	27.7	2.0	8.4	3.2	2.8	3.0	4.6	7.6	6.4	4.9	3.6	4.8	3.5	0.1	2.6	6.7	2.5	4.1	1.9	3.0	0.1	0.3	1.8	0.5	0.2	0.6	0.4	2.6	0.5	0.2	0.4	0.0	0.1	1.9	7.1	0.1	0.5	6.4	20.9	1.6	13.0	9.1	5.3	28.4	5.1	15.0	20.5
CRYGS	CRYG8	ENSG00000213139	"Crystallin gamma S"	P22914	3	186538441-186546702	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 15.1;cervix, uterine: 21.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035103, HPA063539"	Supported		Uncertain	Cytosol				Cytosol		"HPA035103: AB_10696367, HPA063539: "	"unprognostic (5.52e-4)"	"unprognostic (1.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.72e-9)"	"unprognostic (1.10e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.67e-1)"	"prognostic favourable (2.73e-4)"	1.6	1.9	3.6	1.8	2.7	4.0	3.4	15.1	3.3	21.8	1.8	3.5	1.6	1.7	2.7	3.8	1.6	1.3	1.6	1.6	4.1	4.1	2.2	1.8	2.6	4.2	4.2	1.6	2.2	1.8	1.9	1.6	1.6	3.0	1.6	3.7	5.8	1.8	2.9	1.6	3.0	1.8	2.3	3.2	3.6	2.4	1.8	1.6	6.0	1.6	3.2	3.3	1.6	1.6	0.3	0.6	0.2	0.2	0.0	2.1	0.1	1.0	2.0	3.7	3.1	3.6	5.6	0.5	0.5	1.2	1.3	2.5	0.4	1.5	3.8	4.1	2.7	3.2	1.7	2.8	5.5	3.2	4.9	5.0	1.4	1.9	1.4	2.9	3.4	5.9	3.8	1.2	2.1	4.2	1.0	2.2	3.0	1.2	2.6	1.5	0.2	1.6	4.3	0.8	1.8	1.5	2.3	1.7	1.6	2.6	2.5	1.0	2.0	1.7	4.5	1.4	1.1	1.6	2.7	4.6	2.3	5.3	1.9	1.9	2.7	0.0	0.2	0.0	1.4	0.0	2.1	0.3	1.9	0.8	0.4	0.1	0.2	0.4	0.2	0.0	0.0	0.6	0.2	0.1	3.6	2.7	15.1	3.3	4.1	4.1	4.2	1.6	3.0	1.6
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.7;brain: 61.3;heart muscle: 45.9"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 30.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Cell type enriched"	"Detected in single"	26	"plasmacytoid DC: 23.7"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.7"	"Group enriched"	"Detected in many"	12	"amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol			110000	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.4	0.5	7.6	0.5	61.3	0.5	1.0	15.6	21.2	1.8	2.2	0.0	0.0	0.7	0.8	0.3	2.3	0.5	2.3	45.9	6.5	2.1	17.8	4.2	2.7	0.5	1.0	15.5	0.5	0.8	0.6	3.3	0.3	0.1	10.5	2.6	1.0	4.8	0.3	4.0	1.4	1.0	2.0	0.9	0.5	0.6	1.6	1.2	0.0	0.5	0.0	1.5	8.3	0.8	0.9	23.7	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	1.6	0.0	0.0	0.0	0.4	7.0	0.0	0.7	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.3	3.2	0.0	0.0	0.0	0.2	30.5	0.0	1.2	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.3	7.6	61.3	15.6	20.7	6.5	2.1	1.0	15.5	0.1	1.2
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.0;liver: 79.8"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021921, HPA023290"	Approved		Supported	Cytosol			7200000	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	6.0	13.4	7.5	4.6	5.4	0.2	8.8	4.2	5.9	19.8	12.6	3.9	27.1	11.3	11.9	29.1	9.7	11.5	15.7	10.4	6.0	9.0	100.0	79.8	7.1	4.8	6.5	3.5	9.4	26.1	13.2	17.2	3.7	11.1	13.8	4.9	9.4	5.9	21.9	5.6	5.6	19.8	14.1	6.8	5.4	9.5	4.9	5.9	7.1	17.1	7.9	5.8	14.8	15.8	18.2	8.9	4.7	8.6	14.4	21.7	9.0	2.5	24.3	12.6	3.6	14.5	15.9	8.5	7.8	12.4	11.4	12.8	19.0	10.0	13.6	13.8	15.2	6.7	10.2	9.9	18.6	15.7	4.1	5.6	7.6	38.0	7.6	4.8	11.7	7.3	8.8	18.2	3.3	9.5	17.8	4.9	23.7	5.6	8.7	8.1	9.4	15.8	5.6	11.8	5.0	96.4	7.8	3.5	6.2	1.8	13.2	8.6	11.8	1.6	4.6	2.7	6.8	8.6	11.8	3.5	6.8	6.7	22.3	1.9	7.8	4.7	5.2	0.9	18.2	7.7	14.7	18.2	17.9	16.7	8.9	13.7	15.7	16.7	0.8	14.4	8.6	7.5	21.7	9.0	7.5	5.4	4.2	5.9	6.0	9.0	6.5	3.5	11.1	5.9
CRYZL1	"4P11, QOH-1"	ENSG00000205758	"Crystallin zeta like 1"	O95825	21	33589341-33643926	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019120, HPA029399, CAB034129"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.28e-3)"	18.9	17.6	32.6	14.1	27.6	18.4	19.4	36.6	32.4	20.5	21.5	24.8	13.2	13.4	26.9	18.0	17.6	17.2	15.1	17.9	26.4	23.0	21.6	16.0	14.5	14.7	30.8	19.4	20.4	13.6	18.5	27.7	19.3	25.2	17.3	18.8	17.2	15.2	21.7	15.5	20.9	13.3	19.8	29.9	13.2	15.6	28.9	27.0	18.2	22.6	9.7	13.4	20.8	15.6	27.5	30.7	24.8	26.1	31.5	33.8	18.2	21.0	9.4	26.7	19.6	14.4	20.9	13.5	15.0	21.6	19.3	17.3	13.6	16.7	14.9	13.6	18.4	11.7	14.0	15.5	17.6	13.7	14.8	27.3	19.9	12.4	22.7	17.1	17.5	19.6	13.6	20.3	16.0	24.2	20.2	15.4	17.9	10.7	16.5	17.7	18.6	12.7	15.9	21.4	20.4	27.1	18.9	11.6	18.4	19.7	10.0	21.4	19.7	12.7	25.4	15.6	14.9	12.8	11.6	25.4	34.9	16.1	20.3	12.8	17.4	21.7	25.2	24.8	24.2	26.1	25.9	26.5	25.9	22.5	30.7	27.5	33.8	27.4	14.4	31.5	23.7	24.2	20.3	18.2	32.6	27.6	36.6	32.4	26.4	23.0	30.8	19.4	25.2	27.0
CSDC2	PIPPin	ENSG00000172346	"Cold shock domain containing C2"	Q9Y534	22	41560763-41577741	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 84.8;ovary: 48.5"	"Group enriched"	"Detected in some"	6	"HeLa: 7.9;U-2 OS: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003073, HPA076549"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003073: AB_1078578, HPA076549: "	"unprognostic (9.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-1)"	"prognostic favourable (6.42e-4)"	"unprognostic (8.86e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.09e-3)"	2.5	39.0	4.7	2.1	9.6	1.1	1.2	30.5	15.3	16.8	2.6	2.7	5.5	1.6	18.4	2.0	2.2	4.1	2.6	84.8	6.0	8.5	9.9	1.2	2.8	1.1	9.0	6.0	48.5	25.5	1.1	4.1	1.3	17.7	5.3	1.4	5.6	1.4	11.7	1.5	1.1	1.5	9.1	10.5	1.2	1.6	11.1	3.4	0.0	1.1	0.3	1.0	5.8	6.2	1.0	1.0	1.7	1.1	0.4	1.6	0.7	0.0	0.1	1.0	0.1	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	3.1	0.1	0.0	0.0	0.0	0.0	2.0	0.0	7.9	0.9	2.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.7	0.1	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	29.0	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	1.0	1.0	1.7	1.3	1.1	0.5	1.0	0.8	0.7	1.0	1.0	1.5	0.7	1.0	0.4	0.9	0.2	1.6	0.7	4.7	9.6	30.5	14.7	6.0	8.5	9.0	6.0	17.7	3.4
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 266.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 222.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"			13000	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: "	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	71.2	31.4	33.5	25.8	33.2	37.9	42.1	29.6	35.4	39.0	64.7	29.6	35.9	29.5	46.4	38.9	58.8	30.3	29.4	64.2	33.2	31.7	37.4	39.5	34.2	31.4	41.6	31.4	43.9	37.2	50.3	38.4	38.8	44.4	52.6	32.9	32.0	43.2	42.0	266.5	33.8	46.5	88.3	42.4	32.2	39.9	41.5	35.1	39.6	55.7	73.9	31.9	75.4	45.5	43.9	59.0	57.9	65.2	48.1	62.3	80.5	60.6	21.4	38.1	38.0	43.5	56.6	53.3	53.6	40.1	36.1	29.4	31.3	18.4	47.8	45.3	51.1	25.8	42.2	41.6	52.7	58.4	28.8	46.9	39.0	27.7	38.5	34.8	28.0	41.0	45.3	43.2	57.1	41.3	47.5	31.4	44.1	222.4	46.7	22.2	72.6	28.9	35.0	118.0	22.5	28.7	47.8	47.1	31.3	52.5	43.8	40.6	22.5	55.7	49.7	42.7	58.9	56.0	58.8	48.0	52.2	53.6	55.2	39.6	130.2	46.4	57.7	57.9	40.9	60.8	55.5	43.9	52.2	49.7	59.0	34.7	62.3	52.3	40.9	48.1	65.2	23.0	56.7	80.5	33.5	33.2	29.6	35.4	33.2	31.7	41.6	31.4	44.4	35.1
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol			64000	"Nucleoplasm, Cytosol"		"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavourable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavourable (6.91e-4)"	15.7	18.9	19.5	18.7	23.7	13.7	21.2	24.9	31.3	17.5	14.2	13.4	14.0	12.0	19.5	15.5	25.5	17.3	11.8	17.8	20.0	17.7	18.8	18.7	12.8	24.0	27.3	19.4	18.7	17.3	23.2	16.8	23.1	24.2	16.7	18.4	8.4	15.5	17.0	34.3	20.9	12.4	21.7	31.3	12.6	17.1	50.9	21.0	27.0	14.7	28.1	25.3	18.3	17.5	12.8	14.8	9.4	15.9	16.8	18.0	12.8	35.5	24.8	30.3	23.3	11.8	15.2	32.9	28.1	14.9	88.5	37.5	81.0	28.8	36.5	37.7	17.8	41.3	44.5	52.8	84.5	5.9	21.6	25.3	29.1	39.2	7.2	27.8	13.9	8.5	19.8	43.2	25.1	29.2	35.7	14.4	33.1	12.2	33.5	14.4	25.5	37.0	21.4	49.9	28.4	19.4	24.9	26.7	15.5	44.9	48.7	16.0	40.6	18.2	18.8	47.1	39.6	27.7	39.8	8.4	20.4	34.2	28.1	22.5	25.0	9.4	11.8	2.7	11.0	15.2	16.5	12.8	16.8	13.4	14.8	10.4	18.0	15.3	3.3	16.8	15.9	6.6	14.4	12.8	19.5	23.7	24.9	31.3	20.0	17.7	27.3	19.4	24.2	21.0
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Approved	Vesicles,Cytosol			1500000	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favourable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favourable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (1.74e-4)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	9.3	8.0	9.5	39.3	11.0	19.9	12.6	18.7	13.4	12.1	13.5	11.8	7.3	16.1	13.9	6.4	33.3	10.6	11.2	14.0	9.8	8.5	8.0	20.9	15.6	67.2	11.1	7.4	10.5	6.7	6.6	10.4	8.8	12.2	9.8	8.9	9.8	13.2	7.0	8.7	14.9	26.2	8.5	10.9	62.7	13.1	8.1	10.6	62.7	8.1	9.5	47.4	17.4	13.2	35.6	22.8	49.6	46.8	16.3	30.7	19.9	12.7	18.0	8.8	14.5	8.4	6.5	7.6	8.6	8.2	16.3	11.6	16.4	11.8	57.1	11.4	7.7	13.3	18.5	17.3	4.6	27.6	22.8	48.3	6.6	16.5	11.7	25.2	61.6	9.2	8.5	11.6	10.4	12.3	13.9	19.9	9.7	21.5	18.1	14.9	10.9	12.9	20.1	7.6	41.6	7.5	28.4	14.7	10.2	11.1	23.4	14.8	16.1	37.2	10.6	19.8	10.4	15.5	14.8	10.7	21.5	58.3	10.2	48.2	13.3	20.7	19.7	49.6	23.4	42.4	20.0	29.4	20.3	23.1	22.8	35.6	15.7	18.4	39.1	16.3	46.8	13.2	30.7	19.9	9.5	11.0	18.7	13.4	9.8	8.5	11.1	7.4	12.2	10.6
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492197-149551552	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Supported	Cytosol				Cytosol		"CAB016680: AB_1614518, HPA051334: "	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favourable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	33.5	35.8	26.0	26.9	35.2	71.0	40.2	32.0	39.3	33.8	38.2	28.2	40.5	23.2	41.0	29.4	66.1	31.8	36.0	45.7	24.4	26.1	24.0	30.1	37.5	27.3	28.0	29.8	31.7	23.9	46.9	30.9	28.7	38.0	38.1	31.4	25.5	38.5	39.3	51.4	48.4	31.8	45.8	33.9	23.6	34.2	28.6	24.1	38.6	32.0	53.1	41.1	45.0	40.0	28.6	40.6	47.4	39.6	34.2	41.9	40.8	36.1	24.1	40.7	38.5	42.0	51.5	43.5	51.6	49.1	40.2	42.4	47.0	49.0	19.3	57.1	54.8	37.0	28.7	69.5	61.6	27.9	17.3	26.1	28.0	21.6	37.8	40.8	42.0	42.1	72.1	45.2	72.8	46.3	22.0	29.1	45.3	22.6	37.5	16.5	21.4	58.8	28.0	32.2	21.9	28.0	63.0	31.4	28.2	38.3	51.4	62.8	48.2	35.6	45.9	47.4	24.9	31.4	49.1	27.0	34.5	29.7	44.2	29.7	57.2	47.4	36.6	35.4	29.0	38.7	33.1	28.6	36.7	32.9	40.6	23.4	39.9	34.0	31.1	34.2	39.6	24.2	41.9	40.8	26.0	35.2	32.0	39.3	24.4	26.1	28.0	29.8	38.0	24.1
CSNK1A1L	MGC33182	ENSG00000180138	"Casein kinase 1 alpha 1 like"	Q8N752	13	37103259-37105664	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 10.5;testis: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	40	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.5"									HPA051334			Uncertain	Cytosol				Cytosol		"HPA051334: "	"unprognostic (1.23e-2)"		"unprognostic (1.59e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.40e-2)"		"unprognostic (5.40e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.38e-1)"		0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.0			0.0		0.0	0.0	0.0	0.1	0.2	10.5	0.2	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	10.5	0.1	0.2	0.1	0.2	0.2										
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Low lineage specificity"	"Detected in all"											"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (2.32e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.95e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavourable (8.20e-5)"	"unprognostic (2.08e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.16e-3)"	"prognostic unfavourable (4.67e-6)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.25e-3)"	28.5	22.9	30.7	18.3	32.5	21.4	28.6	40.1	42.6	26.4	21.5	32.3	15.7	19.0	37.3	27.3	23.4	28.0	22.1	28.8	31.7	22.3	17.3	11.8	28.4	17.3	28.6	30.1	38.1	25.4	56.2	29.2	33.1	28.7	26.2	17.4	30.5	23.9	23.1	26.3	35.3	17.1	24.0	23.2	20.9	21.8	13.0	33.9	13.3	21.4	14.2	17.4	25.5	28.8	3.7	15.7	4.8	1.8	5.9	4.0	1.2	23.3	11.4	31.0	29.7	15.5	23.8	23.3	30.5	39.1	27.8	27.0	14.6	18.3	17.6	13.3	28.8	20.0	23.5	42.2	20.2	28.1	51.1	5.6	37.7	11.2	32.0	12.3	15.0	22.7	35.8	42.3	57.3	29.5	12.4	36.4	26.8	15.6	17.1	15.1	22.7	16.5	32.0	22.2	27.6	25.5	19.6	45.9	18.0	26.0	27.0	30.5	13.8	17.9	33.5	25.2	27.5	14.5	24.3	16.3	23.3	24.8	37.4	13.9	42.2	3.8	1.8	3.4	3.4	0.8	4.0	2.5	3.8	3.4	1.8	3.7	2.1	3.1	4.8	5.9	0.6	15.7	1.7	1.2	30.7	32.5	40.1	38.8	31.7	22.3	28.6	30.1	28.7	33.9
CSNK1G1	CK1gamma1	ENSG00000169118	"Casein kinase 1 gamma 1"	Q9HCP0	15	64165517-64356259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018209			Supported	Cytosol				Cytosol		"HPA018209: AB_1847278"	"unprognostic (9.10e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	7.2	7.8	10.2	11.9	15.1	11.6	8.7	12.2	10.6	8.7	7.4	7.6	11.6	7.0	11.1	9.9	15.7	10.8	7.8	5.6	8.9	7.6	8.6	6.0	8.4	9.6	6.6	4.7	8.5	8.8	10.4	16.1	7.2	7.2	6.8	7.9	10.1	8.2	14.5	6.5	10.4	6.8	11.1	5.3	8.2	6.8	41.3	7.3	11.8	11.5	5.6	11.2	8.3	10.6	4.1	4.1	8.8	5.1	5.3	8.0	2.4	5.1	10.7	7.8	10.1	6.7	9.1	7.1	6.3	6.5	10.7	9.7	8.5	10.0	8.0	3.4	9.9	11.7	20.3	12.7	12.6	15.2	5.2	7.4	8.6	5.7	7.7	13.8	8.9	8.1	16.9	10.9	15.7	11.7	9.0	8.4	9.6	7.0	7.0	4.3	7.2	5.6	11.8	9.7	6.4	8.6	20.4	12.5	7.6	8.3	5.0	7.3	8.7	5.4	12.6	9.8	11.7	7.7	7.7	9.7	18.6	6.8	9.1	10.2	6.0	0.9	3.6	5.6	5.7	5.1	8.0	3.6	5.1	4.1	2.7	4.1	5.1	4.7	8.8	5.3	4.3	4.1	3.9	2.4	10.2	15.1	12.2	10.6	8.9	7.6	6.6	4.7	7.2	7.3
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66011841-66013505	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 124.5"	"Group enriched"	"Detected in some"	6	"A-431: 26.2;CAPAN-2: 73.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 171.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"		110000000	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: "	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	0.6	0.2	0.1	1.5	0.1	0.2	8.7	0.4	0.2	5.5	0.2	0.0	1.4	0.1	0.3	0.8	11.3	4.3	0.7	2.4	0.1	0.2	1.0	0.1	27.2	1.2	0.1	0.0	1.3	0.2	0.5	0.4	26.5	0.2	0.9	0.1	1.1	1.3	26.5	0.7	124.5	0.2	0.2	0.2	0.2	0.2	1.0	0.0	2.8	14.6	13.6	4.4	0.5	3.7	0.4	0.9	0.0	1.6	0.0	0.2	0.7	26.2	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.1	73.1	0.0	0.4	0.9	0.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	7.3	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.7	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.2	0.0
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325244-122341972	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 312.4;tongue: 421.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 33.1;hTCEpi: 146.6;THP-1: 91.6;U-698: 58.3;U-937: 29.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 405.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	20	"classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6"	"Group enriched"	"Detected in many"	193	"dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6"									"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol			39000000	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favourable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	2.0	0.2	0.3	4.4	0.8	19.8	4.5	0.2	0.5	55.4	0.4	0.2	1.1	0.0	4.7	1.7	312.4	0.2	0.7	1.0	0.3	0.0	0.4	3.4	6.8	4.8	1.1	0.2	1.8	0.2	0.0	0.3	1.3	0.5	1.3	0.1	0.3	57.4	0.7	0.7	28.2	0.3	0.4	0.7	2.0	2.2	0.3	0.6	2.2	0.3	421.9	99.0	1.5	93.5	0.1	54.6	36.0	74.6	0.2	0.2	32.0	1.6	0.1	0.0	0.3	3.8	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.6	10.2	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.7	0.8	13.3	0.2	3.7	146.6	0.3	14.4	0.0	0.0	3.5	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	1.6	0.8	1.1	0.1	91.6	0.0	0.2	2.4	0.0	0.1	0.0	0.1	58.3	3.2	29.1	0.0	0.7	74.6	2.2	0.0	37.5	0.2	0.1	0.1	0.1	54.6	0.0	0.0	0.1	36.0	0.2	21.6	1.0	0.1	32.0	0.3	0.8	0.2	0.5	0.3	0.0	1.1	0.2	0.5	0.6
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell line enhanced"	"Detected in all"		"RT4: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol			6100000	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: "	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	57.8	17.5	5.8	7.3	30.9	25.4	14.4	12.5	14.5	7.9	7.9	13.5	32.5	4.7	9.7	19.5	10.4	13.3	14.0	5.0	19.4	15.8	13.1	13.5	15.6	27.6	3.2	10.9	26.9	14.6	21.8	10.8	11.0	9.7	25.8	11.6	14.6	4.1	10.1	14.0	30.2	6.8	3.3	53.1	22.7	90.4	5.5	4.9	16.5	8.8	35.2	8.2	8.1	16.9	13.2	6.9	12.3	7.9	6.4	11.2	8.7	57.4	15.2	9.2	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1
CTBP2	ribeye	ENSG00000175029	"C-terminal binding protein 2"	P56545	10	124984317-125161170	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA023559, HPA023564, CAB031916, HPA044971, CAB079018"	Approved	Approved	Approved	Cytosol				Cytosol		"CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: "	"unprognostic (8.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.99e-3)"	"prognostic favourable (1.70e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.62e-1)"	13.9	13.1	14.5	9.6	16.3	9.0	29.8	23.5	11.8	31.1	20.9	22.5	17.8	19.8	29.0	21.2	16.3	23.3	17.4	10.9	16.1	12.3	15.4	3.1	17.3	6.5	19.2	11.8	24.1	24.5	12.9	13.6	14.9	15.6	22.9	17.9	28.6	19.9	18.5	11.4	8.6	19.4	23.7	15.1	12.1	19.9	14.5	16.8	3.1	43.3	11.6	6.1	16.7	23.8	0.3	6.5	15.4	11.6	19.7	5.3	2.6	25.1	28.6	25.3	21.0	13.6	13.4	14.0	19.7	23.0	18.6	21.2	17.7	29.7	0.0	10.2	19.7	19.9	25.1	31.6	14.0	0.1	19.0	18.5	18.8	0.4	28.5	7.8	14.8	11.5	25.1	19.2	38.4	23.6	0.7	0.1	11.6	27.9	0.8	8.0	19.0	18.4	22.4	10.6	0.2	21.9	11.4	7.7	22.2	19.1	16.8	25.3	11.9	12.9	19.0	11.2	14.3	16.0	16.8	0.4	1.4	0.0	14.1	0.1	11.0	15.4	5.1	9.2	5.3	5.0	0.6	0.3	0.2	1.4	6.5	0.2	0.3	2.3	8.5	19.7	11.6	5.5	0.1	2.6	14.5	16.3	23.5	11.8	16.1	12.3	19.2	11.8	15.6	16.8
CTBS	CTB	ENSG00000117151	Chitobiase	Q01459	1	84549606-84574480	"Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"basal ganglia: 7.6"	"CAB017043, HPA023594, HPA048810"	Approved		Uncertain	Cytosol	"Intracellular and membrane"		380000000	Cytosol		"CAB017043: , HPA023594: AB_1847311, HPA048810: "	"unprognostic (7.76e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-2)"	6.4	6.9	4.0	8.8	4.4	9.7	15.3	4.4	3.5	5.3	5.8	3.3	8.1	3.7	6.2	16.4	4.8	5.2	8.0	13.1	4.5	4.4	10.4	22.3	15.6	28.1	5.8	2.3	5.1	15.0	6.5	10.4	6.9	8.1	8.1	5.1	4.7	18.5	12.5	4.3	8.4	7.2	6.7	10.0	12.6	6.1	3.5	4.4	5.5	5.9	4.9	5.1	5.5	5.2	0.8	0.4	3.2	1.6	0.7	0.6	0.2	1.8	0.6	0.4	0.4	5.5	6.6	1.4	1.3	4.5	0.6	1.7	0.2	2.2	2.4	0.5	2.7	0.8	0.1	1.7	1.9	2.2	0.6	1.5	0.3	0.3	3.4	1.6	0.8	4.9	3.3	1.6	2.4	1.9	1.4	4.4	1.3	0.1	1.0	1.8	0.4	0.6	0.5	0.7	1.6	4.0	0.9	0.3	0.8	0.5	1.8	2.1	1.0	1.7	2.9	2.3	0.2	3.1	1.4	1.3	0.4	0.7	1.6	2.2	1.6	1.8	0.8	1.5	0.2	0.9	0.4	0.5	0.4	0.3	0.4	0.8	0.3	0.6	3.2	0.7	1.6	0.4	0.4	0.2	4.0	4.4	4.4	3.5	4.5	4.4	5.8	2.3	8.1	4.4
CTCFL	"BORIS, CT27, dJ579F20.2"	ENSG00000124092	"CCCTC-binding factor like"	Q8NI51	20	57495966-57525652	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 35.4"	"Group enriched"	"Detected in some"	33	"HMC-1: 32.5;K-562: 44.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001472	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001472: AB_1078583"	"unprognostic (2.50e-1)"	"unprognostic (4.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.85e-5)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.00e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.75e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.84e-2)"		0.2	0.1	0.1	0.1	0.4	1.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.3	0.1	0.1	0.1	0.4	0.0	0.5	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.1	35.4	0.1	0.1	0.4	0.1	0.1	0.1	0.1	2.1	1.0	4.3	0.8	0.8	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	32.5	0.0	0.0	0.0	0.0	0.0	44.5	0.3	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	1.1	0.1	0.1	0.1	1.8	0.7	1.2	0.6	0.7	0.5	1.3	0.4	0.5	0.3	2.1	0.7	0.8	4.3	0.8	0.8	1.0	0.5	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1
CTIF	KIAA0427	ENSG00000134030	"Cap binding complex dependent translation initiation factor"	O43310	18	48539046-48863217	"Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016865, HPA024801"	Uncertain		Supported	Cytosol				Cytosol		"HPA016865: AB_1852311, HPA024801: AB_1852312"	"unprognostic (5.84e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.35e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.33e-3)"	40.7	15.7	17.3	8.0	21.9	5.2	18.2	28.8	34.5	10.3	12.8	12.4	6.2	6.6	12.3	7.2	19.2	8.5	16.7	18.1	17.2	23.4	9.1	12.7	12.8	4.1	19.7	24.5	29.8	9.2	9.6	12.1	10.1	22.7	9.5	5.0	10.0	11.9	13.4	16.0	7.2	7.5	15.6	23.1	7.1	11.0	8.0	16.3	0.9	9.9	4.7	3.7	12.7	13.0	0.1	0.8	0.8	0.7	0.0	1.4	0.1	2.2	2.5	3.3	4.3	8.6	4.6	1.9	11.6	9.8	9.3	8.5	2.5	1.3	0.0	2.6	16.0	4.9	2.4	6.6	4.0	0.0	2.0	1.0	5.5	6.0	16.5	1.8	3.3	6.4	10.8	5.8	10.4	6.6	2.8	7.2	5.8	1.2	0.6	1.4	1.7	2.0	1.2	3.8	3.0	2.7	3.1	7.2	7.2	4.1	4.5	3.4	2.8	2.2	13.2	8.6	8.0	2.5	2.1	2.5	2.9	0.0	7.6	1.2	3.8	0.8	0.7	0.7	1.4	0.4	0.3	0.1	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	17.3	21.9	28.8	34.5	17.2	23.4	19.7	24.5	22.7	16.3
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	21.0	14.7	19.6	25.8	21.4	27.3	18.9	20.9	21.3	20.3	23.5	18.4	31.7	16.1	25.4	25.2	18.9	21.0	17.7	25.6	17.5	15.8	19.3	35.3	19.3	26.9	17.9	14.7	21.7	14.6	14.5	22.6	22.4	17.5	19.4	18.1	16.1	15.5	34.3	27.3	20.1	19.7	23.8	16.6	49.5	25.9	35.5	20.6	31.0	15.9	15.5	29.7	22.2	29.3	24.9	31.4	60.3	29.1	21.7	18.2	18.4	15.3	14.2	13.6	10.6	9.8	8.1	21.5	9.8	10.3	23.6	20.9	52.9	12.4	17.1	14.4	9.9	16.5	18.2	23.2	25.5	8.2	9.1	56.1	7.8	25.8	10.2	17.7	74.6	8.6	13.8	13.3	13.3	14.1	15.1	7.0	12.6	12.7	28.7	23.6	12.2	20.6	20.2	26.3	12.9	10.3	12.9	10.9	13.0	17.0	24.5	17.2	12.0	14.3	10.4	23.7	14.1	15.5	15.9	8.2	10.4	19.9	16.6	11.1	12.5	60.3	22.3	27.9	15.8	29.1	15.0	24.9	15.4	16.2	31.4	23.4	15.5	16.6	4.9	21.7	28.7	24.7	18.2	18.4	19.6	21.4	20.9	21.3	17.5	15.8	17.9	14.7	17.5	20.6
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979335-41012565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Supported	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"CAB017111: , HPA051322: "	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	7.1	10.0	4.5	10.8	7.8	9.7	5.1	5.9	9.8	14.4	23.6	5.8	16.3	4.3	25.9	8.4	11.3	21.9	13.4	6.7	4.7	5.1	8.6	26.4	7.0	9.4	7.9	4.7	10.1	6.3	16.8	5.4	7.7	6.2	14.4	9.8	9.1	56.5	19.6	13.2	5.8	13.5	35.8	5.1	7.5	9.0	11.8	6.7	14.6	4.5	11.3	13.2	21.3	9.5	6.0	12.8	0.0	7.3	6.6	7.0	3.8	21.1	19.4	27.5	22.1	7.6	9.5	43.2	37.2	16.0	40.9	27.6	38.1	18.8	39.7	16.9	17.0	15.0	29.4	27.8	40.9	16.6	22.3	24.3	25.9	12.0	24.9	32.4	19.1	10.4	15.1	42.3	30.4	18.6	24.4	17.5	28.6	11.9	35.0	12.1	37.5	23.1	27.0	33.4	25.7	20.7	19.3	36.9	18.0	23.2	25.0	9.2	8.7	44.8	15.2	27.1	35.4	18.2	46.2	11.3	13.2	35.3	17.7	25.8	28.1	0.0	4.0	0.0	4.6	7.3	6.6	6.0	5.3	4.8	12.0	3.9	4.4	7.0	0.0	6.6	6.1	12.8	6.6	3.8	4.5	7.8	5.9	9.8	4.7	5.1	7.9	4.7	6.2	6.7
CTPS2		ENSG00000047230	"CTP synthase 2"	Q9NRF8	X	16588003-16712936	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017437	Uncertain		Approved	Nucleoplasm,Cytosol			14000	"Nucleoplasm, Cytosol"		"HPA017437: AB_1847326"	"unprognostic (1.40e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (2.37e-5)"	"unprognostic (6.57e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.04e-2)"	"prognostic favourable (4.56e-4)"	10.0	12.0	7.8	11.5	11.9	7.8	13.5	14.3	9.9	17.5	13.3	14.8	10.8	15.6	22.0	10.2	9.6	12.1	11.9	7.2	8.6	7.1	8.1	13.4	8.3	7.9	9.1	6.1	17.9	14.9	22.9	8.5	8.3	9.3	12.8	12.6	14.1	11.8	9.7	5.5	9.2	12.8	14.0	12.3	7.1	11.3	4.4	10.8	11.5	11.8	8.4	10.6	11.8	11.2	1.6	3.3	1.1	6.1	3.8	2.4	1.4	7.5	6.9	11.3	9.4	5.8	4.4	0.1	4.2	3.5	6.8	6.2	7.0	7.9	0.2	13.3	4.3	6.1	15.9	7.6	8.1	0.0	10.5	4.3	9.7	10.1	3.0	3.0	0.1	4.8	2.6	6.3	5.4	9.0	6.1	0.3	6.1	10.0	0.1	2.4	19.4	8.1	0.1	6.5	2.3	7.2	8.5	7.1	13.0	13.2	1.0	7.6	18.3	8.8	5.8	3.5	1.9	9.3	3.6	0.2	0.1	25.1	2.8	2.7	3.9	0.4	1.5	1.1	1.3	0.8	2.4	1.6	2.2	1.4	3.3	1.4	1.7	1.7	0.1	3.8	6.1	2.2	2.0	1.4	7.8	11.9	14.3	9.9	8.6	7.1	9.1	6.1	9.3	10.8
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563463-66568841	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 28.2;SK-MEL-30: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 7.5;T-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431, HPA055610"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"		3600000	Cytosol	"Vesicles, Plasma membrane"	"CAB002141: AB_563471, HPA031431: , HPA055610: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favourable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	28.1	29.4	24.7	8.0	29.0	1.8	31.1	38.4	47.1	37.3	23.8	32.6	25.2	5.8	38.1	29.8	12.9	34.3	37.3	34.5	25.3	20.5	29.8	45.4	17.3	8.5	28.0	26.0	68.2	23.1	42.6	15.9	20.2	25.4	32.3	8.1	35.0	35.5	37.8	35.8	19.7	9.4	34.6	22.4	10.4	17.8	37.1	30.1	0.8	18.6	14.2	6.3	22.2	21.5	2.1	1.1	0.5	0.7	7.5	9.7	2.4	0.1	9.2	5.0	12.9	21.3	8.6	3.6	6.5	16.5	6.8	4.8	0.0	8.2	0.0	11.0	14.2	0.9	8.5	2.8	3.6	2.2	0.0	0.3	3.8	0.0	11.9	0.1	5.0	28.2	9.6	1.5	1.1	4.3	2.8	1.5	8.5	1.9	0.1	1.1	0.6	3.4	0.0	1.9	1.6	6.1	0.2	6.0	6.4	17.4	2.0	52.3	13.2	0.8	2.8	2.7	2.7	3.2	0.6	8.8	0.1	0.0	6.5	0.1	4.1	0.0	0.7	0.4	6.5	0.7	7.0	2.0	5.6	7.3	0.8	2.1	9.7	5.5	0.5	7.5	0.3	1.1	1.7	2.4	24.7	29.0	38.4	47.1	25.3	20.5	28.0	26.0	25.4	30.1
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 82.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5;HaCaT: 31.0;RT4: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 42.8"	"Group enriched"	"Detected in all"	5	"B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"		10000000	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	16.7	10.6	9.5	24.2	7.0	5.4	23.9	4.5	9.8	25.1	11.4	17.7	14.7	10.6	10.3	17.1	7.8	13.1	29.2	16.5	14.8	6.7	66.7	18.7	82.6	65.4	12.1	11.6	14.6	25.8	12.3	6.5	7.7	9.4	18.6	6.6	6.7	15.4	15.9	7.0	13.5	16.6	9.8	10.8	20.3	15.6	6.7	15.7	6.6	8.5	4.8	34.8	39.6	13.5	20.6	41.2	1.4	42.8	1.3	7.6	27.3	16.0	1.1	0.4	4.7	1.1	0.0	5.2	1.6	0.6	2.8	1.5	7.0	42.5	5.6	1.7	0.1	31.0	2.0	7.7	2.3	23.6	0.1	0.1	0.2	16.2	1.6	0.0	1.0	0.8	2.2	0.0	0.0	0.2	11.4	0.0	3.8	1.7	3.6	9.8	1.2	0.3	0.0	0.3	0.9	9.8	118.0	0.5	1.1	6.9	3.9	9.6	1.5	5.3	2.2	0.0	1.0	0.0	0.7	0.1	12.2	3.1	0.0	10.3	1.7	0.0	42.8	0.4	1.4	28.3	7.6	20.6	4.1	2.1	41.2	12.0	0.4	0.7	1.4	1.3	17.0	4.2	3.1	27.3	9.5	7.0	4.5	9.8	14.8	6.7	12.1	11.6	9.4	15.7
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell line enriched"	"Detected in many"	8	"BEWO: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"		260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavourable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	7.3	2.2	2.5	6.5	0.1	0.0	113.4	0.0	0.0	1.6	1.3	14.9	7.3	0.1	0.6	0.1	14.0	12.1	8.9	2.3	0.0	1.6	0.3	0.7	2.3	0.0	0.0	1.0	0.0	3.0	0.4	0.3	0.5	0.2	0.0	2.9	2.7	0.2	0.1	15.0	2.1	0.0	5.4	0.1	2.2	0.9	0.6	1.1	7.4	2.6	2.6	4.6	0.8	0.0	0.4	7.4	0.1	0.8	1.5	4.0	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 128.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"			34000000	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: "	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (2.19e-6)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	37.5	53.6	33.0	19.7	36.7	5.7	32.0	33.3	41.1	41.3	35.3	42.3	33.7	37.1	48.8	40.2	49.4	35.5	56.2	37.3	28.5	23.5	47.2	24.9	30.5	13.7	45.0	32.0	46.3	40.0	28.9	38.3	32.3	37.2	38.9	32.4	24.4	38.0	38.5	31.5	52.9	39.2	43.1	36.0	21.4	51.3	30.2	38.6	7.7	36.0	44.5	26.7	33.2	38.2	0.1	0.8	4.6	0.2	0.0	0.4	13.9	128.4	28.3	9.6	11.0	16.2	25.3	15.8	27.5	27.5	24.3	19.2	37.4	32.4	5.0	27.3	35.2	28.6	11.4	28.9	17.8	10.1	11.5	0.5	21.1	17.5	35.0	0.1	6.8	35.7	20.4	26.8	15.2	20.3	14.4	0.9	23.9	35.1	0.2	1.8	10.4	17.3	0.0	11.8	4.0	27.1	41.9	7.9	13.5	20.1	27.6	45.7	22.5	0.5	25.3	21.4	13.7	33.2	18.3	2.2	1.4	0.3	42.7	0.1	29.2	1.4	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	4.6	0.0	0.2	0.8	0.0	13.9	33.0	36.7	33.3	41.1	28.5	23.5	45.0	32.0	37.2	38.6
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HEL: 26.9;HMC-1: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"non-classical monocyte: 9.6"	"Lineage enriched"	"Detected in single"	22	"monocytes: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"				"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: "	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	11.2	3.9	10.7	1.8	17.6	0.7	4.7	8.3	15.5	10.7	3.9	22.1	2.0	3.3	11.4	9.4	14.0	7.2	6.6	2.4	13.5	9.1	11.5	3.8	3.2	1.0	16.2	9.9	5.4	13.1	21.9	5.8	3.4	15.5	6.6	5.0	5.0	5.2	4.0	1.1	2.5	3.3	9.5	14.3	4.2	1.8	2.2	16.8	0.0	9.8	1.7	2.1	4.8	4.9	0.0	0.4	0.0	9.6	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	3.8	0.0	0.0	0.0	1.0	26.9	0.2	0.0	0.1	0.0	35.8	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	5.0	0.1	0.0	0.0	0.1	5.1	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.5	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	10.7	17.6	8.3	15.3	13.5	9.1	16.2	9.9	15.5	16.8
CTTNBP2NL	DKFZp547A023	ENSG00000143079	"CTTNBP2 N-terminal like"	Q9P2B4	1	112396181-112463456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 10.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007301	Approved		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"		"HPA007301: AB_1847693"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (1.14e-4)"	"unprognostic (4.21e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (8.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (5.12e-2)"	18.8	5.3	10.0	9.8	13.0	0.5	15.0	10.6	12.4	12.9	15.3	14.4	5.0	7.5	18.3	7.6	20.0	8.8	17.0	8.9	10.1	7.9	10.3	5.5	16.5	5.7	10.8	7.8	10.1	4.7	9.6	9.3	20.1	10.2	9.5	15.2	9.7	10.8	10.0	4.4	20.0	12.3	13.9	18.7	10.1	8.5	5.8	11.0	2.6	8.9	7.2	9.5	13.6	15.6	0.5	10.6	0.1	3.3	0.0	2.3	0.5	9.4	3.5	11.7	5.5	7.9	10.4	3.9	15.0	14.1	9.7	9.7	2.6	4.8	1.5	6.1	11.2	7.8	7.6	10.3	11.4	3.1	3.6	2.0	6.1	2.1	9.2	0.7	3.5	12.3	6.3	12.0	10.6	23.6	1.8	1.4	13.4	2.8	1.2	0.2	7.5	5.5	2.3	10.9	0.0	14.8	7.0	5.7	6.0	11.6	2.4	6.0	1.9	0.8	30.5	9.8	11.5	10.0	7.0	0.1	1.3	0.0	10.2	0.8	25.6	0.0	3.3	0.0	0.0	2.6	0.0	0.1	0.0	0.0	10.6	0.5	0.0	0.0	0.1	0.0	0.5	4.6	2.3	0.5	10.0	13.0	10.6	12.4	10.1	7.9	10.8	7.8	10.2	11.0
CUEDC1		ENSG00000180891	"CUE domain containing 1"	Q9NWM3	17	57861243-57955323	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 17.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023050, HPA024836"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA023050: AB_1847332, HPA024836: AB_1847333"	"unprognostic (4.46e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.77e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.04e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (2.65e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"prognostic favourable (8.46e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-2)"	9.8	10.6	11.7	8.6	19.3	5.2	9.3	8.5	16.6	22.3	18.5	39.1	11.8	5.0	13.4	13.9	21.2	21.6	12.9	24.2	12.6	12.1	12.0	3.7	13.7	4.4	30.0	8.0	6.4	11.6	7.1	11.5	7.8	18.5	13.0	7.2	19.3	19.1	18.4	48.9	5.5	7.3	19.2	18.7	6.6	12.2	2.9	28.3	2.5	11.2	15.8	4.7	15.4	10.4	0.0	17.6	1.8	1.3	0.1	0.0	0.1	8.2	25.4	26.6	4.7	4.3	8.0	0.9	5.8	11.8	12.2	8.9	4.6	31.6	0.1	23.7	11.2	6.6	2.9	12.5	4.4	16.0	4.9	0.2	16.5	3.8	10.5	0.1	2.0	8.1	7.6	7.1	6.0	5.9	0.3	0.1	11.2	4.6	0.4	0.2	0.9	7.0	0.8	6.9	1.2	8.3	5.4	11.0	6.0	2.4	2.6	10.0	36.8	0.9	7.4	32.7	20.7	8.9	12.9	0.0	0.1	0.1	14.2	1.1	26.1	0.6	0.4	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	1.3	17.6	0.0	0.1	11.7	19.3	8.5	15.4	12.6	12.1	30.0	8.0	18.5	28.3
CUEDC2	"C10orf66, MGC2491"	ENSG00000107874	"CUE domain containing 2"	Q9H467	10	102423245-102432661	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036544, HPA041829"	Uncertain		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA036544: AB_10670111, HPA041829: "	"unprognostic (2.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.78e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.58e-2)"	18.8	26.2	29.9	14.9	28.5	13.0	16.2	22.0	49.7	19.8	20.3	19.0	18.5	10.8	19.6	20.8	17.1	25.1	22.7	38.7	25.5	22.3	20.1	18.2	14.9	15.3	27.5	29.5	27.9	23.3	24.4	16.7	14.6	25.4	20.7	12.6	17.5	21.5	22.4	61.6	13.2	11.2	23.6	23.6	15.1	16.3	13.5	18.2	16.5	20.0	25.5	15.8	17.1	14.9	37.4	50.1	35.5	50.5	38.2	36.1	36.0	15.7	18.0	28.2	33.2	23.5	30.3	10.6	13.3	42.9	28.5	21.8	5.6	15.9	26.2	28.3	22.2	15.5	18.3	28.7	14.1	23.4	18.6	16.1	15.3	5.6	39.9	12.4	11.0	35.6	26.7	27.8	27.7	29.4	12.5	26.2	31.9	16.9	28.8	27.6	9.7	11.3	33.4	34.6	13.5	29.0	7.3	14.0	33.5	8.9	8.8	27.1	26.9	19.7	16.8	14.2	13.5	18.1	17.7	32.5	26.3	17.4	25.7	43.3	11.3	34.1	50.5	35.5	32.3	39.7	36.1	34.8	32.1	33.7	50.1	37.4	32.0	30.7	19.2	38.2	24.6	43.3	35.7	36.0	29.9	28.5	22.0	49.7	25.5	22.3	27.5	29.5	25.4	18.2
CUL5	VACM-1	ENSG00000166266	"Cullin 5"	Q93034	11	108008733-108107776	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002185, CAB017787"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"CAB017787: , HPA002185: AB_1078587"	"unprognostic (5.66e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.77e-2)"	"prognostic favourable (1.06e-5)"	"unprognostic (3.83e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	11.6	13.2	10.8	9.0	14.8	25.0	13.4	17.1	19.3	13.1	10.8	12.7	11.0	9.0	13.6	10.7	11.2	10.9	8.7	14.8	11.3	10.6	16.7	15.3	9.7	10.2	12.5	12.3	13.2	11.2	17.8	14.6	12.6	19.5	12.9	9.5	11.2	11.4	10.9	41.6	11.5	11.2	11.8	13.1	12.5	10.3	6.5	12.7	23.1	14.6	15.1	10.0	10.8	13.6	6.4	5.9	4.1	6.7	4.0	6.2	3.6	9.7	4.6	13.8	10.6	9.1	14.6	6.9	10.3	11.4	9.5	10.7	14.6	11.5	13.7	19.3	12.9	12.5	12.8	8.6	13.9	8.8	7.8	12.9	4.4	10.8	15.6	14.5	10.5	11.5	11.8	9.9	13.2	13.0	16.5	5.1	14.9	5.4	13.9	12.6	7.2	8.1	10.1	10.3	14.9	12.0	14.8	10.0	14.2	14.0	14.9	8.4	21.7	12.0	13.5	17.6	8.2	12.4	11.0	5.2	4.0	17.9	6.9	16.6	11.1	1.9	6.7	4.1	5.4	5.2	4.9	4.4	5.6	5.3	5.9	6.4	6.1	6.2	1.2	4.0	6.0	5.9	4.0	3.6	10.8	14.8	17.1	19.3	11.3	10.6	12.5	12.3	19.5	12.7
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182175-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol				Cytosol		"HPA016434: AB_1848125, HPA052004: "	"prognostic favourable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favourable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favourable (4.87e-4)"	6.2	9.2	11.7	9.5	13.9	12.8	6.9	12.5	13.8	7.4	8.5	12.9	7.3	8.2	11.2	6.5	11.5	10.7	8.5	5.5	10.0	6.4	7.7	5.6	7.5	11.7	10.0	9.8	9.5	8.6	13.2	15.9	5.0	9.2	8.3	5.1	11.2	8.7	9.3	6.0	16.1	10.2	7.7	6.9	10.1	8.7	12.5	10.4	10.8	10.9	4.9	10.8	12.0	7.0	1.1	1.1	0.5	0.9	0.3	2.6	1.0	7.8	5.8	3.2	7.6	9.1	5.4	4.3	3.2	5.5	5.0	4.7	1.9	3.3	6.6	6.1	5.0	5.7	2.7	6.6	2.4	7.9	2.5	7.2	6.2	2.9	5.9	4.4	11.8	7.3	13.9	4.2	3.8	7.4	3.7	8.7	4.4	7.2	9.1	6.5	0.6	3.7	13.3	2.2	6.4	3.8	8.2	5.5	7.9	4.2	5.0	7.0	8.6	10.1	6.7	12.7	8.8	3.7	5.9	8.3	7.8	5.3	3.2	8.0	5.7	0.0	0.9	0.3	1.2	0.5	1.3	1.1	0.7	2.6	1.1	0.8	0.6	1.4	0.5	0.3	0.4	0.9	2.5	1.0	11.7	13.9	12.5	13.8	10.0	6.4	10.0	9.8	9.2	10.4
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038619	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649"	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	11.6	4.9	5.7	9.8	8.7	7.9	9.8	3.5	6.5	5.3	5.9	7.2	3.5	4.4	4.9	8.0	6.2	5.1	5.8	13.2	5.9	4.7	5.3	11.0	5.1	7.9	8.6	6.6	4.6	4.5	3.5	3.6	4.5	5.5	6.0	6.4	6.9	5.7	5.4	122.1	5.8	6.2	11.6	7.4	9.2	6.0	14.1	8.3	9.2	4.3	25.1	7.3	13.5	11.4	32.8	24.2	47.1	19.4	25.5	36.3	19.3	9.3	20.2	7.1	21.6	26.4	12.1	3.9	7.7	9.9	7.8	8.8	9.3	7.2	34.2	6.9	13.1	8.1	14.5	12.8	8.7	10.1	13.8	11.3	9.1	14.6	12.2	21.0	5.6	12.5	8.0	12.4	25.8	13.3	10.0	7.6	5.8	6.5	18.8	21.7	7.1	7.6	12.8	8.3	13.1	8.1	3.9	2.3	5.3	3.5	5.6	9.7	9.0	12.0	7.4	3.2	4.4	3.5	10.1	12.5	16.2	24.0	10.6	45.1	2.9	26.5	19.4	47.1	27.2	15.2	28.3	32.8	25.9	25.9	21.0	29.0	36.3	27.8	30.8	25.5	18.5	24.2	24.7	19.3	5.7	8.7	3.5	6.5	5.9	4.7	8.6	6.6	5.5	8.3
CWC22	"EIF4GL, fSAPb, KIAA1604, NCM"	ENSG00000163510	"CWC22 spliceosome associated protein homolog"	Q9HCG8	2	179944876-180007113	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036748	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA036748: AB_10669913"	"unprognostic (1.90e-1)"	"unprognostic (7.10e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (7.42e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.80e-2)"	"prognostic unfavourable (7.76e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-3)"	20.4	14.2	15.8	17.3	16.8	18.1	19.2	33.5	24.6	21.1	17.0	10.5	13.5	12.4	21.5	14.3	18.4	17.6	15.5	14.8	17.5	11.9	17.2	20.7	14.7	21.3	14.4	19.6	25.4	14.7	21.8	25.0	17.8	17.0	20.4	15.2	9.1	15.4	14.7	20.2	15.9	17.4	23.6	19.0	20.5	15.4	10.9	16.3	26.5	20.7	17.6	21.7	21.8	23.8	12.4	9.9	26.4	11.9	10.9	16.4	8.2	9.4	5.9	16.5	11.0	11.9	14.3	12.6	12.6	14.8	15.5	15.1	13.3	12.0	18.7	11.3	9.1	10.4	15.6	11.7	23.5	16.4	13.8	25.0	7.7	18.0	11.8	34.7	13.9	9.3	14.2	19.5	26.4	11.5	27.1	11.5	10.1	9.5	18.1	18.1	25.3	9.5	16.7	20.4	14.0	10.7	12.0	11.3	15.3	10.3	8.3	14.3	6.2	22.0	9.8	13.2	11.3	8.7	13.0	10.1	10.6	22.8	11.9	14.1	13.3	26.4	9.5	21.5	12.3	11.9	12.4	12.4	13.3	14.5	9.9	11.3	16.4	12.8	15.9	10.9	8.9	6.3	11.3	8.2	15.8	16.8	33.5	24.6	17.5	11.9	14.4	19.6	17.0	16.3
CWF19L2	FLJ32343	ENSG00000152404	"CWF19 like 2, cell cycle control (S. pombe)"	Q2TBE0	11	107326345-107457844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038166	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA038166: AB_10669518"	"unprognostic (1.38e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.76e-2)"	16.5	9.9	19.0	18.2	24.4	11.5	18.4	43.7	25.1	23.0	13.6	5.6	14.9	8.0	17.7	13.9	11.5	13.2	9.8	11.3	16.2	10.7	18.2	13.3	11.4	14.8	16.3	16.9	23.8	9.6	17.7	27.9	13.2	17.9	16.6	10.3	5.1	11.4	14.6	29.1	13.0	11.3	14.9	23.5	18.0	11.1	9.0	21.7	15.8	15.8	9.2	16.8	21.0	47.4	19.4	12.5	22.2	6.8	11.2	13.9	2.8	6.1	5.0	10.9	5.2	9.0	10.2	8.1	8.0	7.6	6.4	8.5	11.6	14.5	10.7	15.5	5.6	15.0	12.0	6.2	11.1	11.9	6.7	11.9	5.7	7.6	5.9	13.9	10.0	5.2	10.9	7.3	11.1	8.6	17.9	6.2	9.2	4.5	10.7	12.7	10.2	7.2	9.4	10.3	14.3	7.5	7.6	6.3	5.2	11.8	8.8	4.5	11.9	6.7	7.7	10.6	8.5	5.5	7.2	3.3	6.1	10.5	3.1	13.7	9.7	22.2	6.8	11.8	9.8	6.0	10.8	17.6	11.4	9.7	2.9	19.4	13.9	10.6	13.0	11.2	6.3	12.5	9.7	2.8	19.0	24.4	43.7	25.1	16.2	10.7	16.3	16.9	17.9	21.7
CXorf38	MGC39350	ENSG00000185753	"Chromosome X open reading frame 38"	Q8TB03	X	40626921-40647554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050120	Approved		Approved	Cytosol				Cytosol		"HPA050120: "	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.73e-2)"	"prognostic favourable (1.44e-8)"	12.5	12.5	6.5	14.2	9.6	11.7	11.7	8.2	7.2	11.6	14.3	9.7	13.9	10.1	12.5	13.9	9.4	13.0	8.8	11.2	7.7	6.1	11.1	11.2	14.4	25.3	8.5	7.2	12.4	9.6	16.5	9.4	12.5	8.8	8.5	9.7	7.8	11.0	19.3	7.1	9.1	14.6	8.9	10.9	18.3	8.2	4.8	9.0	17.3	16.5	7.5	16.4	12.2	9.9	9.0	13.7	21.3	21.9	6.7	9.8	9.4	9.4	5.0	5.1	3.9	5.6	9.7	3.0	6.5	9.0	8.1	8.5	6.6	13.4	16.5	6.2	9.7	6.4	6.2	10.9	7.6	23.0	10.1	10.5	5.6	3.5	9.7	18.7	16.8	8.2	7.2	11.5	10.7	9.8	4.6	11.8	14.8	9.3	12.3	11.9	4.7	11.5	10.3	11.0	11.7	9.4	15.0	6.1	8.1	12.9	6.1	7.1	10.4	7.8	11.3	10.1	6.3	7.7	5.3	13.5	5.0	7.1	13.1	8.8	6.8	9.5	16.1	21.3	9.6	15.0	9.6	6.8	8.8	7.0	13.7	9.0	7.9	7.4	20.4	6.7	21.9	5.9	9.8	9.4	6.5	9.6	8.2	7.2	7.7	6.1	8.5	7.2	8.8	9.0
CXXC5	"HSPC195, RINF, WID"	ENSG00000171604	"CXXC finger protein 5"	Q7LFL8	5	139647299-139683882	"Predicted intracellular proteins"	Transcription	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 68.2"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036508, HPA058148"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036508: AB_10673620, HPA058148: "	"unprognostic (3.08e-2)"	"unprognostic (9.03e-2)"	"prognostic favourable (2.40e-4)"	"prognostic unfavourable (4.10e-7)"	"unprognostic (2.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.57e-1)"	12.3	9.5	22.4	9.3	19.9	22.2	9.2	68.2	38.8	17.5	10.2	39.3	5.1	6.0	9.9	18.0	10.1	18.1	11.4	15.8	23.9	16.7	25.6	33.8	9.0	15.5	30.9	21.7	5.4	24.9	18.2	18.6	10.4	25.4	8.1	7.9	14.2	30.0	11.7	39.7	9.8	9.1	8.4	36.7	18.1	11.4	19.0	27.5	20.5	12.5	7.7	13.5	9.6	9.9	29.3	19.1	0.7	2.1	21.8	10.2	3.4	9.3	7.9	8.8	3.3	12.3	16.9	3.4	6.1	9.4	2.6	5.3	17.4	9.6	12.4	27.4	16.4	10.8	1.8	4.7	1.3	1.3	3.0	18.5	7.0	12.2	5.3	4.0	0.6	6.0	1.0	4.5	1.3	0.7	17.2	2.0	19.3	24.5	4.4	13.1	10.6	2.2	8.0	17.9	18.9	20.2	6.8	28.0	28.8	2.2	56.6	4.6	30.9	19.3	3.8	22.0	4.3	10.4	5.5	7.4	15.5	23.4	33.1	1.4	12.1	0.3	2.1	0.1	3.2	0.4	10.2	27.7	0.3	2.3	1.8	29.3	0.2	0.9	0.7	21.8	0.1	19.1	0.4	3.4	22.4	19.9	68.2	38.8	23.9	16.7	30.9	21.7	25.4	27.5
CYB561A3	CYBASC3	ENSG00000162144	"Cytochrome b561 family member A3"	Q8NBI2	11	61348745-61362299	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.7;blood: 98.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8"	"Group enriched"	"Detected in all"	10	"B-cells: 50.1;dendritic cells: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045674, HPA052548"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol				"Nucleoli, Vesicles"	"Nucleoplasm, Cytosol"	"HPA045674: , HPA052548: AB_2681866"	"unprognostic (2.61e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.41e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.80e-3)"	10.0	113.7	4.0	22.5	6.4	7.1	7.5	4.7	6.9	6.6	10.9	10.9	14.4	6.1	10.9	9.9	8.8	11.0	11.0	5.7	5.1	4.1	9.7	30.6	12.4	21.7	8.3	3.5	14.5	17.9	9.0	6.6	21.0	6.8	9.2	9.6	10.7	10.9	8.1	10.2	24.8	15.8	7.6	5.6	24.0	8.5	8.0	7.0	16.8	10.0	8.4	33.3	10.7	7.3	50.1	98.8	3.8	7.4	3.3	3.8	8.7	18.0	30.5	4.9	14.1	23.2	15.4	4.1	9.1	13.9	11.0	11.0	8.3	20.2	35.2	16.4	16.0	25.3	4.6	25.4	6.7	23.5	10.4	6.0	20.6	5.6	10.9	8.3	15.8	21.6	35.9	23.9	11.0	16.3	19.8	21.1	18.5	19.4	15.7	3.6	9.1	17.5	19.0	4.7	26.3	12.7	17.9	6.0	10.0	18.6	26.9	21.0	21.8	9.7	10.9	13.0	6.7	12.6	13.1	13.2	17.4	19.7	17.8	14.6	16.3	1.6	7.4	3.8	3.8	6.0	3.4	40.5	2.7	3.4	7.4	50.1	2.8	3.0	2.5	3.3	6.4	98.8	2.6	8.7	4.0	6.4	4.7	6.9	5.1	4.1	8.3	3.5	6.8	7.0
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250847-74292016	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 266.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.3;RT4: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol			780000	"Vesicles, Cytosol"		"CAB006333: , HPA047548: , HPA058547: "	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favourable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	25.0	13.2	4.3	11.0	5.8	1.5	39.4	6.9	5.9	7.5	68.2	4.3	38.5	37.7	4.9	16.0	8.3	7.0	34.8	14.5	4.1	3.7	76.2	266.8	67.0	9.2	6.5	3.4	25.1	75.3	10.1	6.5	7.2	5.2	13.5	9.0	6.2	7.6	54.9	4.3	11.4	70.7	21.2	11.5	10.3	18.0	12.2	5.5	4.6	4.6	7.9	4.3	21.6	18.8	34.9	16.9	2.1	12.9	10.2	38.0	13.5	9.8	16.8	8.8	0.0	151.3	26.9	11.7	6.8	14.7	14.5	21.8	19.8	10.7	12.0	4.8	12.4	22.0	0.0	9.3	11.6	22.4	11.7	4.4	9.2	52.5	23.5	8.4	5.8	45.0	7.4	8.2	4.2	7.9	7.1	4.5	12.1	17.7	4.7	10.0	3.9	10.9	11.7	2.8	0.2	14.4	66.0	25.1	10.4	6.6	18.0	8.0	35.6	8.0	7.4	0.0	11.4	3.5	8.6	3.2	13.0	3.7	8.9	2.3	8.4	1.1	9.6	2.1	16.7	10.8	38.0	28.5	18.7	19.6	16.9	34.9	18.4	23.1	1.1	10.2	12.9	14.8	14.4	13.5	4.3	5.8	6.9	5.9	4.1	3.7	6.5	3.4	5.2	5.5
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424525-69466266	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 130.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"			1600000	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favourable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	21.3	130.7	29.6	15.4	33.1	5.9	17.1	12.0	37.9	16.6	29.0	22.8	12.6	21.9	20.5	24.6	21.4	19.2	14.7	18.0	23.1	22.0	26.9	26.5	18.3	20.1	21.6	24.4	19.9	12.8	26.3	16.2	24.6	34.3	17.1	38.2	20.2	14.8	16.7	19.9	16.0	31.2	19.9	20.8	20.7	15.4	14.0	16.0	26.0	19.9	17.6	23.5	24.3	16.0	24.8	44.2	35.8	28.3	32.3	46.0	32.4	29.0	92.5	38.1	23.5	17.6	23.6	16.3	26.0	36.3	43.7	41.3	64.5	35.7	26.5	26.3	25.2	34.6	36.3	37.7	49.7	14.1	13.8	12.8	16.7	75.1	26.0	26.2	28.4	20.2	19.1	51.8	24.8	41.2	20.6	12.8	26.7	37.8	43.0	32.0	28.2	12.7	40.8	21.1	29.1	58.3	33.3	22.3	11.4	69.4	13.3	22.0	25.8	21.1	18.5	25.2	20.8	16.7	22.9	15.6	34.4	81.3	26.0	21.9	29.1	35.8	20.3	24.3	39.3	28.3	32.2	24.8	29.6	30.8	24.8	22.6	24.6	29.2	6.1	32.3	20.1	44.2	46.0	32.4	29.6	33.1	12.0	37.9	23.1	22.0	21.6	24.4	34.3	16.0
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961869-202967280	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 119.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Uncertain	Nucleoli,Mitochondria,Cytosol			860000	"Nucleoli, Mitochondria, Cytosol"		"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	9.6	14.5	7.8	5.0	8.4	3.9	16.9	6.2	11.0	11.6	7.5	8.7	10.6	4.4	10.1	32.3	13.7	16.4	9.2	33.9	7.3	9.2	15.5	18.4	10.1	11.7	10.0	9.1	10.8	11.1	16.3	11.1	63.8	11.9	10.5	5.0	15.7	14.4	10.1	119.2	28.5	6.9	10.6	7.4	10.8	18.6	20.1	6.7	11.7	13.5	26.4	10.0	13.6	10.1	20.2	21.9	25.7	33.3	17.2	26.5	28.8	8.3	5.2	4.6	9.4	42.9	9.9	45.1	16.8	15.8	10.9	9.8	4.3	9.9	5.2	14.3	16.7	46.3	3.7	14.4	7.2	7.5	9.5	2.9	6.3	4.9	15.5	2.5	7.4	15.8	47.6	12.0	6.6	7.2	8.8	9.4	39.4	9.8	3.2	2.2	3.0	10.0	5.3	22.2	11.1	10.3	10.0	3.9	4.8	9.4	31.4	13.6	14.5	5.7	7.0	12.5	5.3	4.7	9.3	8.8	10.4	2.4	13.8	3.9	9.3	11.6	33.3	25.6	16.7	24.2	22.2	13.6	19.3	17.8	21.9	20.2	26.5	18.8	25.7	17.2	15.7	15.1	19.1	28.8	7.8	8.4	6.2	11.0	7.3	9.2	10.0	9.1	11.9	6.7
CYBRD1	"CYB561A2, DCYTB, FLJ23462, FRRS3"	ENSG00000071967	"Cytochrome b reductase 1"	Q53TN4	2	171522247-171558133	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 141.9;ASC TERT1: 61.7;BJ hTERT+: 53.4;HSkMC: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.0;intermediate monocyte: 12.4;myeloid DC: 11.7;neutrophil: 6.7;non-classical monocyte: 9.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 11.7;granulocytes: 6.7;monocytes: 12.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014757, HPA056736"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA014757: AB_1847374, HPA056736: "	"unprognostic (1.35e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.44e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-2)"	75.2	26.0	10.1	9.3	13.2	4.0	78.9	6.1	8.0	44.5	56.3	14.7	16.3	49.5	44.3	28.5	29.6	26.1	38.8	43.1	12.1	5.5	8.6	6.2	35.6	10.6	11.0	11.2	49.5	5.4	2.0	9.5	9.5	11.4	41.7	10.2	32.0	21.5	21.1	17.5	26.7	111.3	41.1	12.8	7.3	18.1	20.1	11.7	2.1	103.8	23.9	10.0	43.8	56.0	0.0	11.7	6.7	12.4	2.5	1.2	4.4	3.1	2.3	1.3	2.5	141.9	61.7	0.1	11.6	53.4	6.1	7.7	0.1	4.4	0.0	2.0	27.2	1.6	1.1	0.9	7.2	2.4	0.3	2.6	3.6	0.0	29.8	2.8	0.2	43.7	9.0	9.4	1.8	3.8	0.8	0.0	16.6	0.0	0.9	2.5	0.6	0.6	0.3	16.8	0.1	0.9	0.1	0.1	0.6	13.5	0.0	7.2	4.7	1.7	7.6	13.7	1.9	12.7	4.9	0.0	0.0	0.0	6.5	2.3	7.3	0.0	12.0	0.5	1.2	12.4	0.2	0.0	0.2	0.1	11.7	0.0	0.0	0.0	6.7	2.5	9.4	0.5	0.0	4.4	10.1	13.2	6.1	8.0	12.1	5.5	11.0	11.2	11.4	11.7
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095027-144097525	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.2"	"Cell line enhanced"	"Detected in all"		"PC-3: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"			110000	Mitochondria	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	16.0	31.3	16.2	13.2	20.1	19.5	12.1	19.1	32.1	13.0	33.3	13.4	14.4	38.1	13.9	10.1	36.2	15.5	13.1	92.1	16.6	14.1	44.8	55.9	11.2	16.5	18.0	18.6	15.0	21.4	17.9	10.6	16.0	17.7	16.5	25.3	13.3	23.3	17.2	145.2	17.7	42.6	16.3	11.8	18.3	22.4	13.9	11.5	21.5	21.7	43.8	18.5	19.9	14.4	34.9	76.7	22.1	60.0	30.2	26.1	58.5	22.2	50.4	13.4	28.0	11.1	12.3	25.8	12.8	15.6	32.7	21.5	35.2	27.8	31.5	28.9	17.1	33.0	29.2	25.4	12.3	19.3	38.7	33.8	42.5	32.2	19.9	19.9	22.1	17.9	31.8	20.8	41.3	18.9	30.7	28.2	17.0	79.8	37.3	18.5	15.5	151.2	33.0	17.9	55.2	26.8	35.8	36.0	15.9	35.7	49.4	26.2	40.6	30.6	14.4	20.8	44.4	23.0	38.9	31.3	22.7	23.4	26.5	34.1	26.6	22.1	59.7	15.9	24.1	60.0	25.4	34.9	20.1	25.8	76.7	29.4	19.7	25.4	5.8	30.2	44.8	42.9	26.1	58.5	16.2	20.1	19.1	32.1	16.6	14.1	18.0	18.6	17.7	11.5
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.8;brain: 44.2;kidney: 69.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 52.2;MOLT-4: 49.5;U-266/70: 38.6;U-698: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"CAB055519: , HPA068106: , HPA071459: "	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavourable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favourable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favourable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	1.9	6.6	28.6	13.4	31.7	22.8	1.7	39.1	44.2	1.8	4.3	7.7	1.6	3.1	3.5	12.3	2.1	4.9	4.7	5.1	28.7	20.4	69.7	8.2	5.9	25.9	16.2	27.2	2.7	3.6	30.6	13.2	4.4	15.8	3.2	5.0	4.7	2.2	3.5	3.1	1.8	6.4	2.9	7.9	15.8	9.5	2.6	8.9	28.5	5.4	0.0	25.7	6.0	1.7	13.7	15.6	30.1	42.8	17.4	32.1	22.9	0.0	8.1	12.5	7.1	0.2	0.3	20.1	1.4	2.5	0.6	1.8	1.5	0.1	52.2	3.6	0.8	0.1	9.9	6.7	1.5	11.8	15.6	6.6	10.6	6.1	1.0	7.0	18.4	1.4	2.7	2.0	0.1	2.2	0.1	21.0	1.7	1.9	49.5	1.3	5.5	2.1	12.2	0.3	24.9	6.6	7.4	18.2	7.2	0.1	7.1	1.1	4.9	0.2	2.9	0.4	5.4	1.7	1.3	38.6	9.6	36.7	5.5	8.3	3.0	17.4	4.3	30.1	32.1	20.0	22.9	13.7	23.3	27.7	6.2	13.4	24.7	28.1	14.4	17.4	42.8	15.6	18.4	22.9	28.6	31.7	39.1	38.3	28.7	20.4	16.2	27.2	15.8	8.9
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 24.4;Hep G2: 18.6;HHSteC: 37.2;HSkMC: 30.3;SH-SY5Y: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: "	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favourable (2.55e-5)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	48.1	16.1	6.2	9.5	8.3	1.1	34.4	10.9	11.6	13.3	19.0	1.5	8.4	15.2	8.8	8.4	12.5	8.8	24.1	43.4	4.2	11.2	6.9	13.6	17.8	9.5	6.3	5.5	11.2	7.6	8.5	5.0	10.0	17.7	22.8	7.0	23.7	10.4	9.4	17.1	8.2	17.8	17.6	3.5	8.0	13.1	9.3	2.2	1.1	22.0	11.4	3.4	35.1	41.5	4.4	0.4	2.4	0.3	2.5	1.3	0.5	0.0	0.3	0.6	0.1	24.4	7.2	8.2	0.2	0.6	0.1	0.2	0.0	0.1	0.0	7.9	0.7	0.2	0.0	10.5	0.0	0.0	0.0	0.1	0.1	18.6	37.2	0.0	0.0	30.3	2.3	0.8	0.8	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.0	0.2	40.6	0.0	0.0	0.8	0.0	0.2	0.0	1.0	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.1	3.1	0.0	0.3	0.4	0.5	0.2	0.3	3.4	0.4	0.2	0.4	4.4	0.7	1.3	2.4	2.5	0.2	0.0	0.5	0.5	6.2	8.3	10.9	11.6	4.2	11.2	6.3	5.5	17.7	2.2
CYP26B1	P450RAI-2	ENSG00000003137	"Cytochrome P450 family 26 subfamily B member 1"	Q9NR63	2	72129238-72148038	"Disease related genes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.0;HaCaT: 11.8;RH-30: 15.2;U-2 OS: 16.9;U-2197: 7.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012567	Uncertain		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA012567: AB_1847429"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.19e-4)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.17e-4)"	"unprognostic (8.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.04e-2)"	16.6	2.6	8.3	2.1	7.8	0.1	7.7	25.0	23.9	5.8	2.4	1.2	1.6	3.6	1.5	1.6	3.4	2.7	1.2	6.0	2.5	1.5	4.2	0.7	2.7	4.4	3.4	10.0	4.9	0.2	0.9	5.2	3.2	35.4	1.3	1.2	1.2	5.1	7.5	7.6	20.5	2.4	1.5	0.6	1.9	0.5	13.8	1.1	4.9	9.2	2.2	2.8	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.8	0.0	0.1	8.0	3.0	4.8	0.7	0.1	0.2	0.2	1.4	0.4	0.0	0.4	0.6	11.8	6.8	0.0	0.1	0.0	2.1	0.0	4.8	0.6	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.8	0.4	0.1	0.7	2.2	0.0	0.1	0.0	0.7	0.0	15.2	0.0	0.0	1.1	0.5	0.1	2.6	0.0	2.8	0.2	0.7	0.0	1.2	16.9	7.5	2.6	0.0	0.9	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.8	25.0	23.9	2.5	1.5	3.4	10.0	35.4	1.1
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991250-41018398	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 137.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: , HPA062973: "	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	3.0	137.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	1.8	3.1	0.8	0.7	0.9	0.1	0.4	0.4	0.5	0.4	0.1	0.0	0.4	0.2	0.4	0.0	0.2	1.6	0.0	0.4	0.3	0.3	7.4	0.4	0.1	0.1	0.3	0.6	0.4	0.8	0.5	0.4	0.4	0.4	0.0	0.5	0.3	0.1	0.6	0.4	0.1	0.2	0.1	0.8	1.9	0.7	0.5	0.2	0.5	0.5	1.8	0.1	0.9	0.2	0.3	0.1	0.5	0.8	1.1	0.9	0.6	0.3	0.8	0.6	0.3	0.8	0.9	0.2	1.2	0.3	3.1	0.8	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.1	1.9	0.5	0.8	2.7	0.7	0.3	1.8	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;NB-4: 4.4;RPMI-8226: 6.6;SCLC-21H: 2.5;SH-SY5Y: 4.9"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033671, HPA072245"	Enhanced		Uncertain	Cytosol				Cytosol		"CAB033671: AB_782375, HPA072245: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.5	0.0	0.5	0.0	0.1	4.4	0.3	0.0	0.0	2.1	6.6	0.0	0.4	2.5	4.9	0.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.3	0.0	0.7	0.0	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"liver: 32.5"	"Low cell line specificity"	"Detected in some"			"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA066463, HPA072245"	Enhanced		Uncertain	Cytosol				Cytosol		"HPA066463: , HPA072245: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.2	32.5	0.1	0.1	0.1	0.1	0.1	8.0	0.0	2.2	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.5	1.6	0.6	0.3	0.6	0.2	0.1	0.0	0.9	0.3	1.1	0.2	0.2	0.0	0.1	0.2	0.2	1.2	0.7	1.5	0.2	0.3	1.3	0.2	0.0	0.7	0.2	0.5	0.9	1.4	1.3	0.3	0.9	1.3	0.0	0.7	0.0	0.0	0.5	1.0	1.0	0.0	0.0	0.0	0.6	0.4	0.0	0.9	0.0	0.2	0.7	1.6	0.5	0.4	0.6	1.7	0.0	0.5	0.0	1.6	0.5	0.2	1.1	0.7	1.1	1.2	0.1	0.8	0.4	0.2	1.5	0.6	0.4	0.6	0.2	0.3	0.3	0.3	0.2	0.1	0.6	0.5	0.5	1.6	0.3	0.2	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99680026	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 72.9;liver: 73.4;stomach 1: 21.3"	"Cell line enhanced"	"Detected in some"		"A549: 3.1;CACO-2: 12.1;CAPAN-2: 8.1;Hep G2: 8.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA072245			Uncertain	Cytosol				Cytosol		"HPA072245: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favourable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	1.0	3.3	0.4	2.0	0.5	0.0	1.3	0.6	0.6	1.9	32.6	0.6	1.0	30.3	0.7	0.5	5.2	0.5	8.2	0.4	0.4	0.0	6.8	73.4	2.4	0.8	0.4	0.4	0.6	12.1	0.0	1.8	0.6	0.8	4.9	5.1	0.4	0.6	1.3	0.4	4.3	72.9	0.6	0.5	0.4	21.3	0.7	0.4	0.5	0.4	2.2	4.0	3.0	2.7	0.0	0.2	0.1	0.6	0.0	0.7	0.2	0.0	3.1	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	12.1	8.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.4	0.1	0.1	0.2	0.0	2.6	0.0	0.1	0.0	2.6	0.2	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.0	0.8	0.7	0.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.5	0.6	0.6	0.4	0.0	0.4	0.4	0.8	0.4
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99684957-99735196	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 82.6"	"Group enriched"	"Detected in some"	5	"BEWO: 1.8;BJ hTERT+: 3.2;Hep G2: 6.2;HHSteC: 3.6;RT4: 1.9"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA072245			Uncertain	Cytosol				Cytosol		"HPA072245: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.1	0.4	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.7	0.0	0.0	0.1	0.3	0.1	0.2	0.0	3.9	0.0	0.1	0.0	2.8	82.6	0.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.2	3.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1
CYP3A7-CYP3A51P		ENSG00000282301	"CYP3A7-CYP3A51P readthrough"	P24462	7	99685226-99735093	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 73.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;U-87 MG: 2.6"									"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Low lineage specificity"	"Detected in single"											HPA072245			Uncertain	Cytosol				Cytosol		"HPA072245: "																		0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0		1.1	73.9	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.0	0.0	0.5	0.0	0.3	0.5	1.6	0.5	0.2	4.2	0.0	0.6	0.2	0.0	0.0	0.0	1.3	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.9	1.3	1.9	0.0	0.0	0.4	0.3	0.4	0.4	0.0	0.3	0.0	0.4	1.0	0.1	0.2	1.1	0.5	0.2	0.2	0.1	0.4	1.4	0.0	0.0	0.3	0.2	0.0	0.5	0.6	0.0	0.1	0.4	0.3	0.5	0.5	0.6	0.9	0.7	0.1	2.6	0.7	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0										
CYTH2	"ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like"	ENSG00000105443	"Cytohesin 2"	Q99418	19	48469032-48482314	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB014872, HPA060662"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"			11000	Cytosol	"Golgi apparatus, Plasma membrane"	"CAB014872: , HPA060662: "	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.33e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (3.21e-4)"	13.5	14.2	12.7	14.1	13.6	8.0	19.5	11.4	24.4	21.9	11.7	12.9	14.8	23.2	15.4	15.9	18.8	15.0	25.5	8.3	12.4	7.4	19.2	8.9	15.2	10.0	13.2	18.9	14.4	17.3	35.1	21.0	21.1	12.4	18.0	9.7	13.5	24.2	14.4	7.4	19.9	23.0	12.2	8.7	13.0	19.2	42.0	13.5	18.4	46.2	15.1	10.6	15.6	15.9	4.1	5.6	11.1	4.0	1.8	6.1	3.2	9.2	14.1	42.8	9.6	6.5	5.6	7.8	7.3	6.7	7.8	7.4	7.7	12.7	6.1	7.7	6.3	11.7	8.2	8.9	5.0	9.3	11.2	8.6	17.6	8.3	5.8	5.2	11.8	7.2	15.3	9.7	6.2	10.1	8.6	21.5	10.3	7.5	8.7	38.3	4.6	5.8	11.2	6.4	4.2	13.3	20.3	12.6	12.4	8.0	22.5	6.2	10.6	7.0	10.9	17.0	8.6	4.0	10.4	21.4	11.3	4.0	6.2	10.4	11.8	4.1	4.0	3.3	4.1	3.0	2.7	4.1	5.3	6.1	3.3	2.7	4.9	3.4	11.1	1.8	3.9	5.6	5.3	3.2	12.7	13.6	11.4	24.4	12.4	7.4	13.2	18.9	12.4	13.5
CYTH3	"ARNO3, cytohesin-3, GRP1, PSCD3"	ENSG00000008256	"Cytohesin 3"	O43739	7	6161776-6272644	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.6"	"Cell line enhanced"	"Detected in many"		"WM-115: 35.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 47.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013979	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA013979: AB_1855799"	"unprognostic (6.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (2.63e-5)"	24.0	9.1	10.9	6.6	14.4	6.1	22.0	14.2	17.6	10.4	16.4	7.0	5.7	15.1	13.0	8.1	13.4	12.6	13.9	21.1	11.4	7.2	8.8	3.0	14.0	5.4	9.4	10.7	11.0	6.6	9.4	7.1	66.6	9.4	6.8	6.7	17.8	8.6	8.7	12.3	15.6	18.5	15.2	8.5	7.5	9.2	26.0	6.5	2.9	20.4	10.8	5.0	7.7	16.5	0.6	1.8	0.7	0.4	3.3	5.9	0.4	21.2	5.4	5.1	3.5	24.1	28.5	7.3	12.6	11.0	12.5	11.9	8.3	10.6	2.9	7.7	25.4	20.1	3.5	9.1	8.3	0.2	5.1	0.8	6.4	1.0	11.5	0.8	1.3	20.1	4.2	6.6	9.6	2.1	3.3	0.4	9.1	3.5	0.7	3.8	3.6	7.3	3.8	13.8	1.6	9.6	2.6	3.3	6.4	7.8	27.4	22.1	1.6	6.0	7.8	8.6	22.8	9.2	7.7	1.0	0.3	3.0	2.7	2.3	35.0	0.7	0.4	0.0	2.2	0.2	5.9	0.3	1.0	2.4	0.4	0.6	0.1	1.5	0.3	3.3	0.4	1.8	0.8	0.4	10.9	14.4	14.2	17.6	11.4	7.2	9.4	10.7	9.4	6.5
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.4;lymphoid tissue: 92.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.3;Karpas-707: 39.0;RPMI-8226: 11.9;U-266/70: 66.4;U-266/84: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.4"	"Low region specificity"	"Detected in single"			HPA007191	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favourable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"	9.4	1.4	1.4	33.3	1.6	32.3	3.9	0.8	1.0	4.4	9.7	1.6	0.8	9.3	3.1	4.2	6.6	2.8	5.8	3.8	1.5	1.5	4.1	3.9	26.8	92.9	3.1	0.6	2.9	3.1	0.0	1.5	1.3	2.0	2.4	5.0	3.1	11.5	3.1	1.4	2.1	17.4	2.1	4.3	48.3	14.4	3.3	1.3	40.5	3.2	3.8	61.8	24.1	3.2	21.9	13.0	48.5	53.3	19.9	53.4	31.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.1	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	11.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	66.4	24.9	6.4	0.6	1.7	0.0	48.5	8.4	24.5	30.6	27.8	30.9	21.9	32.4	28.9	13.0	21.1	53.4	40.7	48.2	19.9	53.3	6.7	31.3	31.6	1.4	1.6	0.8	1.0	1.5	1.5	3.1	0.6	2.0	1.3
DAAM1	KIAA0666	ENSG00000100592	"Dishevelled associated activator of morphogenesis 1"	Q9Y4D1	14	59188646-59371405	"Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 18.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026605, HPA064789"	Uncertain		Approved	"Plasma membrane,Cytosol"			450000	"Plasma membrane, Cytosol"		"HPA026605: AB_1847464, HPA064789: "	"unprognostic (2.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-2)"	"prognostic favourable (3.77e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	13.8	8.0	13.8	9.4	9.3	3.7	9.3	17.3	13.3	14.6	11.4	6.3	7.4	4.5	16.9	7.0	19.2	8.4	6.0	17.3	10.2	6.7	6.0	10.7	9.7	8.8	5.6	13.6	8.6	8.2	25.6	9.6	12.4	8.7	10.9	7.8	16.9	12.0	10.5	6.0	25.6	7.7	19.5	10.0	10.2	9.1	5.8	7.2	4.1	7.1	14.1	13.8	15.3	13.1	10.7	18.3	4.9	3.1	6.9	3.8	1.9	12.8	1.3	8.8	2.3	5.8	4.1	11.6	1.6	1.6	3.4	3.6	6.6	10.7	13.3	3.4	4.0	26.5	8.3	6.4	2.8	5.8	2.9	5.0	3.3	7.9	3.6	5.6	2.6	2.7	6.5	2.9	2.9	7.5	8.1	6.6	2.1	11.0	4.7	2.7	4.8	3.8	4.4	7.5	1.3	4.4	10.1	13.8	3.1	11.2	16.4	10.0	21.8	1.2	7.5	2.6	5.1	5.9	1.5	1.4	1.6	15.6	3.6	1.0	6.3	4.9	2.1	2.5	2.6	2.4	3.1	10.7	3.3	2.4	2.4	4.7	2.7	2.7	2.6	6.9	3.1	18.3	3.8	1.9	13.8	9.3	17.3	13.3	10.2	6.7	5.6	13.6	8.7	7.2
DAAM2	KIAA0381	ENSG00000146122	"Dishevelled associated activator of morphogenesis 2"	Q86T65	6	39792298-39904877	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 83.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 25.6;LHCN-M2: 25.1;SK-MEL-30: 31.0;U-138 MG: 9.6;WM-115: 12.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	29	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051300, HPA054630"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA051300: , HPA054630: "	"unprognostic (7.53e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.93e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.24e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.54e-2)"	"unprognostic (7.94e-2)"	"unprognostic (8.54e-4)"	21.5	17.8	34.8	6.7	43.0	1.7	7.8	4.4	52.2	9.3	6.4	83.3	8.0	7.6	7.5	8.5	28.3	8.9	5.9	6.1	40.4	25.2	5.9	4.0	8.4	2.8	42.8	24.8	7.3	5.2	3.5	2.1	9.4	41.3	8.7	7.1	5.1	4.3	17.6	23.8	4.4	8.9	13.7	48.8	15.5	7.0	8.7	51.9	0.0	5.0	2.1	2.2	4.6	4.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.7	0.1	0.1	4.4	5.9	1.0	0.5	0.4	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	4.1	0.0	0.0	25.6	0.0	0.1	0.0	0.0	0.0	0.0	25.1	0.0	0.6	0.0	0.7	0.0	0.0	4.5	3.5	0.0	0.0	0.9	1.0	0.0	0.3	31.0	0.0	0.0	0.2	9.6	2.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	34.8	43.0	4.4	28.9	40.4	25.2	42.8	24.8	41.3	51.9
DAD1	OST2	ENSG00000129562	"Defender against cell death 1"	P61803	14	22564905-22589269	"Cancer-related genes, Predicted membrane proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028882	Uncertain		Approved	Cytosol			14000	Cytosol		"HPA028882: AB_10602214"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (9.43e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.37e-3)"	48.1	64.7	47.9	36.4	49.4	26.4	61.2	19.3	39.5	59.0	46.7	55.9	93.6	39.7	49.8	118.7	61.2	56.5	54.9	55.2	45.9	43.1	85.1	123.6	48.4	54.6	51.5	25.1	55.4	114.1	35.6	57.0	54.6	51.9	48.3	51.5	43.5	81.9	100.1	39.7	35.6	73.4	49.6	65.3	57.4	48.0	56.7	33.6	84.6	107.0	50.7	52.2	49.3	43.4	80.2	121.1	75.3	65.9	61.5	95.6	122.5	48.8	45.8	37.7	51.2	103.1	74.1	32.6	52.2	63.4	46.4	65.7	28.8	70.3	30.8	33.5	60.0	44.7	39.0	50.1	74.4	41.8	35.7	30.1	26.9	114.7	71.9	42.0	43.7	55.1	67.5	48.5	62.6	67.6	22.7	72.9	68.3	59.9	19.9	51.4	23.2	75.0	28.0	31.9	40.2	68.2	40.4	29.0	36.3	39.7	56.9	57.6	34.3	42.9	51.1	40.5	32.5	49.2	32.8	54.6	63.3	39.8	36.6	29.5	58.4	66.0	65.9	68.1	86.7	56.2	85.1	80.2	90.9	81.7	62.0	71.2	95.6	83.8	75.3	61.5	47.8	121.1	83.5	122.5	47.9	49.4	19.3	39.5	45.9	43.1	51.5	25.1	51.9	33.6
DALRD3	FLJ10496	ENSG00000178149	"DALR anticodon binding domain containing 3"	Q5D0E6	3	49015488-49022293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036862	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA036862: AB_10673507"	"unprognostic (2.76e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.56e-1)"	"prognostic favourable (9.03e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.33e-2)"	"unprognostic (9.52e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.79e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	9.4	14.1	9.3	13.9	9.0	4.4	21.6	10.2	11.9	11.3	9.5	7.7	14.9	7.2	7.7	14.7	13.1	34.3	14.2	8.6	8.6	7.3	16.0	9.3	10.8	9.1	7.2	9.4	13.5	29.3	12.6	11.1	8.7	6.3	8.4	7.5	8.4	13.2	18.5	7.5	13.0	10.2	6.5	5.1	8.5	9.9	32.0	6.8	21.1	21.1	13.5	12.7	9.5	14.1	17.7	8.2	7.3	9.3	14.5	19.2	9.3	6.2	8.6	5.4	10.6	15.4	20.6	6.6	5.3	14.3	8.8	8.5	6.0	7.8	2.5	7.6	14.0	4.2	7.0	13.5	6.2	3.8	4.7	2.7	7.9	11.2	10.1	7.6	5.4	13.9	14.1	11.1	24.6	13.6	2.1	6.2	8.6	10.6	3.4	5.1	8.9	8.1	1.7	0.7	18.0	23.4	9.8	3.4	11.4	5.8	15.9	11.9	11.2	8.4	8.4	3.4	5.5	12.2	4.7	20.0	10.9	1.3	13.0	3.5	6.8	7.1	7.7	3.7	10.2	9.3	18.8	17.7	17.0	12.7	8.2	15.5	14.4	9.3	7.3	14.5	8.6	5.6	19.2	9.3	9.3	9.0	10.2	11.9	8.6	7.3	7.2	9.4	6.3	6.8
DARS		ENSG00000115866	"Aspartyl-tRNA synthetase"	P14868	2	135906677-135986100	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol			160000	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavourable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	30.3	29.7	35.0	27.6	35.5	19.7	34.9	18.0	28.3	27.6	25.4	25.6	26.9	14.8	30.1	26.7	44.4	26.9	19.6	29.8	29.0	28.8	34.6	35.5	19.7	32.3	32.1	25.6	34.0	27.0	26.4	24.5	31.7	23.8	31.0	20.3	20.6	26.6	28.3	45.1	30.6	21.4	42.4	33.8	29.8	23.6	12.8	25.0	42.0	33.0	33.1	36.7	45.3	30.2	48.6	30.5	11.2	18.8	36.6	42.7	30.6	47.1	19.4	16.6	17.5	18.5	23.2	38.0	23.6	26.5	25.9	25.4	41.8	20.6	55.1	37.0	19.4	27.2	25.4	30.6	47.1	25.2	22.7	33.5	19.2	43.4	23.9	44.8	22.3	22.3	24.7	28.9	26.1	14.2	35.9	17.6	21.4	22.2	34.3	38.6	19.5	18.5	42.0	36.1	38.5	31.1	18.4	11.8	22.5	18.1	16.4	18.4	18.0	32.0	10.7	22.7	22.7	16.7	23.4	48.5	26.4	59.3	35.7	34.2	14.0	6.0	18.8	11.2	27.5	18.3	41.2	48.6	41.3	36.0	30.5	43.8	42.7	37.0	7.3	36.6	14.0	29.2	36.9	30.6	35.0	35.5	18.0	23.8	29.0	28.8	32.1	25.6	23.8	25.0
DAZAP1	MGC19907	ENSG00000071626	"DAZ associated protein 1"	Q96EP5	19	1407569-1435687	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004201, HPA004631"	Enhanced		Enhanced	Nucleoplasm,Cytosol			1700000	Nucleoplasm	Cytosol	"HPA004201: AB_1078627, HPA004631: AB_1078626"	"unprognostic (1.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-3)"	22.1	15.0	11.4	33.1	14.2	37.1	32.9	16.1	19.4	15.2	21.4	22.2	17.2	28.3	17.8	11.0	30.9	16.0	13.5	26.7	11.5	9.2	17.1	38.1	18.7	29.2	16.8	12.4	20.7	28.3	11.9	11.4	22.2	13.3	15.9	15.6	16.8	17.0	12.0	31.4	20.2	28.7	17.7	10.9	28.5	22.0	46.8	15.0	43.8	15.9	22.6	21.0	21.4	27.7	7.1	6.1	4.3	7.5	6.5	7.1	3.1	52.7	19.2	12.9	23.5	5.7	7.0	37.0	23.8	11.9	19.5	16.1	19.1	26.2	62.2	14.6	11.5	29.8	17.0	22.7	16.5	43.5	27.0	32.0	18.4	19.4	13.3	38.7	27.5	7.0	15.0	13.2	24.3	17.0	47.6	32.8	12.1	21.6	67.8	34.5	39.8	19.4	49.0	20.6	38.3	14.6	17.9	25.7	23.0	15.7	24.8	28.7	22.5	51.7	18.4	16.1	21.8	28.0	51.9	38.9	39.9	49.4	19.4	37.8	24.5	3.2	5.5	4.3	6.5	7.5	7.1	7.1	6.0	6.9	4.9	5.5	6.0	6.4	2.4	6.5	5.2	6.1	6.1	3.1	11.4	14.2	16.1	19.4	11.5	9.2	16.8	12.4	13.3	15.0
DBNDD1	"FLJ12582, MGC3101"	ENSG00000003249	"Dysbindin domain containing 1"	Q9H9R9	16	90004865-90020128	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6;skeletal muscle: 39.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 14.4"	"Lineage enriched"	"Detected in many"	6	"B-cells: 14.4"									HPA043018	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA043018: AB_10794921"	"unprognostic (1.07e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.86e-2)"	"prognostic favourable (2.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (5.67e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.00e-2)"	2.1	6.9	21.5	2.3	13.7	0.8	4.7	16.1	31.6	2.6	2.0	6.5	1.9	1.9	1.4	9.6	13.9	3.9	3.9	3.4	15.7	14.6	6.9	6.2	3.0	3.9	17.6	9.4	3.1	14.1	6.3	3.0	0.6	19.2	3.7	1.8	3.9	11.9	3.8	39.7	3.9	1.2	1.6	6.8	1.6	4.3	1.1	4.5	0.0	3.6	2.3	4.7	2.0	2.3	14.4	0.1	0.6	0.0	0.0	2.5	0.8	7.7	11.8	1.1	14.2	0.3	0.1	8.4	1.7	2.1	3.5	1.7	11.4	6.3	0.0	0.9	0.3	8.0	12.4	0.3	3.3	0.0	22.7	0.0	1.6	18.7	0.5	0.1	1.3	0.3	1.0	5.9	0.0	14.9	2.2	0.1	1.2	46.7	0.0	9.7	19.8	5.0	4.7	10.8	0.2	19.4	1.4	17.1	18.3	1.9	1.7	14.6	11.0	1.3	12.0	2.7	5.3	0.1	7.7	0.0	0.1	0.0	1.1	0.9	6.8	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.6	0.4	0.0	14.4	2.5	0.4	0.0	0.0	0.0	0.1	0.0	0.8	21.5	13.7	16.1	31.6	15.7	14.6	17.6	9.4	19.2	4.5
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 160.5;skeletal muscle: 84.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	12.2	7.8	56.5	9.9	64.9	2.1	15.3	21.3	88.8	11.0	26.4	132.3	5.0	16.6	14.9	13.6	18.3	17.7	10.2	68.4	85.1	47.3	5.9	2.5	13.9	5.8	98.2	31.5	6.5	6.7	18.4	5.0	13.2	51.8	14.2	28.4	3.1	9.0	29.1	84.2	10.4	19.4	31.0	160.5	5.0	13.3	3.0	70.7	2.7	4.8	10.5	8.2	16.8	8.2	0.3	15.0	0.3	9.3	0.6	7.9	3.5	21.4	3.8	3.1	21.7	2.0	0.9	4.3	12.6	13.8	10.6	7.2	10.4	29.4	0.3	2.2	12.4	31.8	21.2	1.1	6.5	0.1	12.5	17.9	16.6	9.4	12.7	0.9	27.3	0.3	3.6	4.0	3.7	7.2	1.2	0.4	0.8	27.2	1.5	1.3	4.0	22.9	0.0	0.3	0.2	30.2	0.4	7.1	3.6	4.4	2.4	27.2	29.8	5.5	11.6	0.4	21.1	14.0	13.8	0.3	0.4	0.1	1.5	0.1	3.1	0.0	8.4	0.0	7.9	9.3	2.9	0.1	6.9	5.8	6.0	0.3	6.4	6.0	0.3	0.6	5.0	15.0	5.8	3.5	56.5	64.9	21.3	62.5	85.1	47.3	98.2	31.5	51.8	70.7
DBNL	"ABP1, HIP-55, SH3P7"	ENSG00000136279	"Drebrin like"	Q9UJU6	7	44044640-44069456	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Endocytosis, Immunity, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020265, HPA027735"	Enhanced		Supported	Nucleoplasm,Cytosol			15000000	Cytosol	Nucleoplasm	"HPA020265: AB_1850723, HPA027735: AB_10603790"	"unprognostic (9.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (2.25e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.51e-2)"	23.9	19.6	21.2	45.4	17.4	34.1	20.5	11.4	24.0	23.9	21.0	19.6	23.5	17.9	22.0	21.8	65.6	19.1	32.7	18.0	18.3	18.8	18.9	18.4	23.6	49.8	19.1	23.8	15.2	19.2	16.7	18.5	25.8	16.1	21.0	15.2	17.2	23.4	22.3	15.9	26.2	23.2	25.2	19.8	46.8	24.7	13.0	15.8	31.0	18.2	32.0	52.3	23.6	31.6	46.7	66.0	64.1	73.7	31.6	35.4	80.5	19.4	28.4	17.8	19.3	22.2	14.3	16.5	32.1	26.8	32.0	26.9	28.4	27.2	43.7	23.3	34.9	34.6	10.3	37.5	12.0	23.3	12.0	14.8	21.3	16.2	22.5	22.1	27.6	13.5	15.0	30.4	10.6	21.9	18.6	15.2	30.3	28.3	39.6	24.9	14.5	24.0	22.0	14.5	21.7	20.7	27.2	21.6	28.7	21.9	43.0	6.8	31.7	30.9	35.1	26.3	23.8	15.2	37.1	35.6	15.3	24.5	24.7	25.1	62.2	39.2	66.3	50.2	35.4	73.7	28.0	46.7	26.7	28.8	63.9	45.8	27.0	28.2	64.1	31.6	71.0	66.0	31.3	80.5	21.2	17.4	11.4	24.0	18.3	18.8	19.1	23.8	16.1	15.8
DCAF12L1	"KIAA1892L, WDR40B"	ENSG00000198889	"DDB1 and CUL4 associated factor 12 like 1"	Q5VU92	X	126549383-126552851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 22.6;testis: 30.9"	"Group enriched"	"Detected in some"	15	"EFO-21: 17.2;U-2 OS: 9.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol				Cytosol		"HPA044737: , HPA048981: , HPA053138: "				"unprognostic (2.62e-5)"						"unprognostic (2.88e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.74e-1)"		0.2	0.1	0.2	0.0	0.1	0.0	0.7	0.1	0.1	0.5	0.1	0.0	6.2	0.0	0.6	22.6	0.1	4.3	4.3	0.1	0.1	0.4	3.3	0.1	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.6	0.0	0.3	1.0	0.0	0.5	0.1	3.9	0.1	0.1	0.1	2.5	0.1	1.5	1.6	30.9	0.0	0.3	0.9	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.3	0.0
DCAF12L2	WDR40C	ENSG00000198354	"DDB1 and CUL4 associated factor 12 like 2"	Q5VW00	X	126163499-126166097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 15.7;epididymis: 53.6;testis: 15.8"	"Group enriched"	"Detected in some"	6	"HAP1: 5.7;NTERA-2: 4.8;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol				Cytosol		"HPA044737: , HPA048981: , HPA053138: "	"unprognostic (1.16e-4)"			"unprognostic (8.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.52e-2)"		"unprognostic (2.72e-1)"		"unprognostic (3.02e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.47e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.51e-1)"	1.1	1.2	1.1	0.1	1.9	0.1	2.3	0.5	2.1	1.9	0.9	0.0	15.7	0.1	2.4	53.6	0.5	3.0	0.2	0.4	1.0	3.9	0.4	0.1	0.2	0.2	1.0	1.7	1.9	0.2	2.4	1.3	0.1	1.3	2.0	0.2	0.2	0.6	5.6	0.4	0.5	0.5	2.0	0.8	0.2	0.7	15.8	0.1	0.0	0.4	0.0	0.3	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.5	2.1	1.0	3.9	1.0	1.7	1.3	0.1
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: "	"prognostic unfavourable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavourable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	27.5	24.8	23.2	23.6	16.9	19.6	17.4	20.6	15.8	19.6	20.1	24.4	27.0	38.4	35.3	21.5	20.8	31.4	26.3	38.0	36.6	22.3	53.1	14.9	27.7	19.3	21.7	22.9	15.9	18.2	28.8	48.0	27.2	35.6	16.9	29.8	22.5	41.1	22.8	35.5	38.8	26.8	28.2	39.6	28.5	23.1	29.6	28.1	12.9	20.2	23.3	31.1	14.9	17.8	20.0	32.1	25.7	27.5	18.7	32.5	54.3	26.9	47.5	25.5	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0
DCAF16	"C4orf30, FLJ20280"	ENSG00000163257	"DDB1 and CUL4 associated factor 16"	Q9NXF7	4	17800655-17810758	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042487	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042487: AB_10795505"	"unprognostic (2.23e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (6.40e-4)"	"prognostic favourable (5.78e-4)"	"unprognostic (5.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-3)"	"prognostic favourable (7.67e-4)"	13.0	13.1	12.7	12.1	20.5	23.3	19.8	19.4	19.7	18.5	13.1	22.5	9.9	12.0	26.9	16.5	11.5	16.1	11.3	11.8	13.9	15.7	11.3	6.8	12.6	16.7	14.4	16.2	29.6	16.0	17.8	25.8	14.8	19.0	16.9	14.8	17.1	15.2	13.0	16.2	22.4	14.0	17.2	16.0	13.3	13.6	19.2	16.3	30.6	15.7	7.0	18.3	16.3	14.6	4.8	3.0	9.7	2.8	3.6	6.3	2.2	12.1	2.6	14.2	14.8	4.1	7.2	7.8	8.0	9.4	9.5	11.3	7.4	9.9	13.7	6.4	7.3	6.2	8.3	8.4	14.2	4.6	7.6	19.2	8.7	12.1	9.8	16.8	7.9	9.3	7.0	12.0	12.0	6.5	20.6	22.9	5.5	4.5	18.5	16.2	11.7	7.7	19.6	16.2	8.8	4.1	9.6	21.2	17.0	8.4	2.3	9.1	8.3	4.6	8.2	11.1	8.7	12.2	10.0	10.2	4.0	17.2	9.1	11.7	7.4	9.7	2.4	3.4	4.5	2.8	5.9	3.7	5.0	4.9	1.5	4.8	6.3	5.9	1.8	3.6	1.9	3.0	3.4	2.2	12.7	20.5	19.4	19.7	13.9	15.7	14.4	16.2	19.0	16.3
DCAF7	"HAN11, SWAN-1, WDR68"	ENSG00000136485	"DDB1 and CUL4 associated factor 7"	P61962	17	63550461-63594266	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022948, HPA022962"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA022948: AB_1858820, HPA022962: AB_1858821"	"unprognostic (7.75e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic favourable (3.49e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.18e-2)"	17.0	18.4	27.6	25.8	24.8	7.9	15.6	20.8	27.3	21.1	22.9	27.1	22.5	24.9	19.4	19.4	20.5	19.6	20.1	17.1	24.9	22.3	26.7	20.9	23.5	25.5	22.2	16.5	17.1	20.0	39.2	19.0	25.7	19.4	22.4	25.7	21.1	18.0	24.5	11.5	15.8	26.7	18.8	24.4	28.8	19.8	32.5	22.2	47.1	21.9	13.0	30.3	20.7	16.2	10.2	12.1	13.6	17.3	10.0	13.6	8.4	11.1	15.9	27.9	17.8	9.7	8.0	7.4	11.2	9.9	12.4	10.6	11.6	12.1	20.7	9.1	11.1	12.0	23.2	15.7	16.0	7.9	14.8	26.9	10.2	13.6	10.0	29.9	15.7	6.7	10.4	7.2	16.6	19.3	28.3	9.7	15.7	13.7	32.3	14.4	9.0	21.5	25.9	33.2	11.7	18.2	17.0	26.9	49.8	10.1	19.6	13.2	14.5	24.4	20.3	20.6	9.5	10.3	18.4	10.1	13.0	11.1	11.7	19.5	12.2	11.5	12.6	13.6	13.6	15.0	11.0	9.4	9.5	10.5	12.1	10.2	8.7	9.2	5.5	10.0	17.3	9.0	6.6	8.4	27.6	24.8	20.8	27.3	24.9	22.3	22.2	16.5	19.4	22.2
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262531	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favourable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	26.6	28.7	26.3	21.6	29.5	21.2	26.4	37.6	38.3	22.2	28.0	39.6	31.6	25.0	28.7	38.2	24.6	27.6	29.0	35.8	25.9	20.0	25.6	42.2	23.0	25.5	30.1	29.2	29.8	34.6	45.3	33.1	21.5	31.7	23.8	19.0	29.3	29.0	44.9	86.4	28.8	26.1	26.8	23.8	28.6	28.6	20.8	32.5	25.7	36.9	27.2	22.7	28.0	21.6	26.6	17.8	22.4	21.6	24.9	26.6	14.4	16.8	21.2	24.0	21.6	30.2	22.9	20.9	20.0	28.4	16.8	15.1	22.2	29.3	18.6	37.7	22.7	20.9	11.6	18.9	10.6	42.7	22.8	20.7	29.6	17.5	24.6	17.4	26.6	27.1	20.0	15.0	21.8	25.9	18.7	34.4	15.5	16.0	22.3	17.3	17.2	21.1	21.9	14.2	36.5	19.3	30.1	16.3	15.7	33.6	37.6	22.5	35.3	26.3	31.1	20.7	10.7	12.7	18.5	56.6	38.6	30.4	23.1	16.3	16.9	22.4	17.5	18.1	26.6	16.9	26.1	23.7	23.6	25.0	14.8	26.6	26.2	23.8	19.9	24.9	21.6	17.8	24.3	14.4	26.3	29.5	37.6	38.3	25.9	20.0	30.1	29.2	31.7	32.5
DCBLD1	"dJ94G16.1, MGC46341"	ENSG00000164465	"Discoidin, CUB and LCCL domain containing 1"	Q8N8Z6	6	117453817-117569858	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"			HPA059667	Approved		Approved	Cytosol			11000000	Cytosol		"HPA059667: "	"unprognostic (1.00e-1)"	"prognostic unfavourable (6.44e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.74e-2)"	"unprognostic (8.99e-2)"	"unprognostic (5.69e-3)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (8.57e-8)"	"unprognostic (6.99e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.36e-1)"	15.5	5.2	6.6	7.9	5.6	0.7	12.2	5.1	8.9	12.9	10.6	4.2	10.4	9.0	7.9	6.2	7.9	3.9	12.8	8.2	4.8	3.7	6.1	13.2	15.6	6.3	4.7	3.2	3.2	13.1	12.2	12.6	12.1	7.0	7.6	8.7	4.5	7.1	9.6	17.8	4.3	12.7	7.1	10.2	5.8	10.5	7.6	3.2	1.2	8.8	7.0	5.1	10.5	12.2	0.0	1.2	0.0	0.7	1.0	3.5	1.2	3.1	7.3	2.6	2.9	4.6	5.8	7.4	18.2	24.0	15.5	11.7	15.3	6.9	0.0	9.1	7.8	7.3	5.0	8.1	16.4	1.4	3.8	2.7	7.6	24.9	20.0	3.9	2.3	6.6	19.0	14.0	13.3	21.5	5.8	2.8	20.2	2.5	0.0	2.6	1.9	3.0	0.0	0.5	1.8	3.4	3.8	7.9	0.1	13.4	1.5	2.1	1.9	5.2	15.9	0.0	18.8	5.2	7.9	7.8	2.1	2.1	7.8	3.9	6.8	0.0	0.5	0.0	1.7	0.7	0.3	0.0	2.4	3.5	0.6	0.0	3.0	3.5	0.0	1.0	0.3	1.2	2.2	1.2	6.6	5.6	5.1	8.9	4.8	3.7	4.7	3.2	7.0	3.2
DCBLD2	"CLCP1, ESDN"	ENSG00000057019	"Discoidin, CUB and LCCL domain containing 2"	Q96PD2	3	98795941-98901689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 61.3;LHCN-M2: 102.3;RPTEC TERT1: 64.1;U-87 MG: 78.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016909	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"			1800000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA016909: AB_1847510"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-3)"	"unprognostic (9.29e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (3.32e-5)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.59e-3)"	13.1	14.6	4.5	6.4	7.2	1.1	19.3	9.7	9.6	12.0	13.1	5.1	8.1	2.7	16.8	9.2	8.8	13.9	11.7	24.2	4.5	6.2	11.3	9.2	13.1	3.2	6.7	3.5	19.0	6.4	17.6	12.7	9.9	6.5	11.2	6.8	19.3	11.1	14.7	6.6	7.7	5.2	16.7	7.1	2.1	8.6	33.8	7.3	8.1	18.7	6.3	3.6	15.1	6.8	0.6	1.2	1.7	0.5	0.1	1.1	0.2	7.0	51.5	6.9	5.4	9.2	22.0	3.0	15.9	7.6	10.8	12.4	4.3	22.5	0.0	50.1	27.3	6.5	3.1	25.9	25.1	0.1	1.1	2.4	1.6	6.5	5.6	1.1	1.1	8.7	4.0	31.2	61.3	7.1	0.5	0.6	102.3	1.8	0.9	0.7	4.8	17.8	1.0	13.0	0.6	64.1	1.8	1.8	3.2	4.3	0.9	18.6	3.4	0.9	11.7	28.0	22.5	7.1	55.7	0.8	1.2	0.9	78.2	0.4	12.2	1.2	0.5	1.7	0.0	0.1	0.0	0.6	0.1	0.1	0.5	0.2	1.1	0.1	0.9	0.1	0.3	1.2	0.0	0.2	4.5	7.2	9.7	9.6	4.5	6.2	6.7	3.5	6.5	7.3
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171756-24358052	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 37.0;kidney: 46.4;pancreas: 22.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 19.7;EFO-21: 13.8;Hep G2: 22.3;RPTEC TERT1: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Cytosol"	"Microtubules, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: , HPA031584: "	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.1	0.9	1.1	0.2	1.5	0.0	3.5	0.3	0.9	1.6	0.3	0.2	1.0	0.3	3.4	37.0	0.2	5.8	7.7	0.2	1.3	1.7	46.4	1.8	3.9	0.0	0.6	0.5	2.1	22.7	7.6	4.3	1.7	1.8	1.5	0.3	2.8	0.9	3.7	0.5	0.2	0.2	0.4	0.5	0.1	1.1	3.7	0.2	0.2	8.4	0.0	0.2	1.0	0.1	1.2	0.5	1.3	0.4	1.0	0.5	0.2	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	1.5	0.1	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.3	0.5	0.2	0.2	0.5	0.5	0.3	0.3	1.2	0.4	0.4	1.3	1.0	0.2	0.5	0.2	0.2	1.1	1.5	0.3	0.9	1.3	1.7	0.6	0.5	1.8	0.2
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131306	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 76.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 17.3;ASC TERT1: 16.4;fHDF/TERT166: 13.3;HAP1: 10.3;HSkMC: 15.1;NTERA-2: 21.4"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol			11000	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: , HPA015655: "	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	13.9	3.3	14.3	4.2	25.0	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2.0	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3.0	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17.0	10.4	4.6	2.5	2.2	8.5	0.0	2.1	1.4	2.9	5.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	17.3	16.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	13.3	0.0	10.3	0.2	0.0	0.0	0.6	0.0	0.4	0.0	0.6	0.0	0.0	15.1	7.5	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	21.4	0.2	0.0	1.2	0.0	0.6	0.0	4.3	2.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.5	4.4	0.7	0.1	0.0	0.0	1.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	25.0	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5
DCP1B	FLJ31638	ENSG00000151065	"Decapping mRNA 1B"	Q8IZD4	12	1946054-2004535	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 19.1"	"Low region specificity"	"Detected in all"							HPA039709	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA039709: AB_10672901"	"unprognostic (9.60e-2)"	"unprognostic (7.19e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.84e-2)"	"unprognostic (7.42e-2)"	7.3	14.3	8.6	7.1	9.9	2.4	7.4	10.7	8.4	11.0	17.9	6.7	5.6	4.8	18.1	9.8	6.1	11.5	9.2	3.2	10.3	4.9	6.5	7.2	6.4	7.0	7.6	8.2	12.9	8.5	8.5	19.8	6.0	6.1	11.7	8.4	7.5	7.2	11.6	8.7	6.2	7.7	29.1	8.5	7.5	9.9	15.8	7.5	10.0	8.0	1.7	7.1	14.4	8.2	3.8	3.9	2.6	3.4	4.0	19.1	3.8	0.1	3.4	6.2	4.8	7.9	10.0	10.4	4.2	8.3	5.3	6.6	0.2	5.3	8.2	1.5	6.1	0.0	4.2	4.4	4.6	13.9	4.6	3.5	2.6	4.9	10.6	4.8	4.0	7.6	7.3	4.8	4.1	8.6	2.1	3.4	6.4	4.2	6.7	4.1	13.6	1.5	3.9	2.9	1.5	6.2	0.0	0.9	4.5	3.6	3.0	3.0	3.0	4.5	5.0	2.5	9.3	5.8	4.2	2.9	2.1	5.6	6.1	3.2	6.4	2.6	2.1	0.2	7.9	3.1	9.7	3.8	8.0	7.6	3.9	3.8	6.3	8.0	0.4	4.0	3.4	2.0	19.1	3.8	8.6	9.9	10.7	8.4	10.3	4.9	7.6	8.2	6.1	7.5
DCPS	"HINT-5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126303752-126345749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol			1400000	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: "	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	11.1	13.1	6.8	14.4	8.2	13.5	9.2	8.5	14.5	12.1	10.6	6.8	8.0	7.8	12.4	9.6	14.4	9.9	13.9	10.9	5.5	6.1	13.3	39.6	9.9	18.5	6.3	5.8	11.8	17.2	7.0	9.5	14.1	6.8	12.7	11.7	13.3	17.4	9.4	21.8	11.3	9.7	11.3	7.1	21.9	9.6	13.4	6.5	22.0	12.7	18.5	22.1	15.1	9.8	13.2	39.5	3.2	14.3	7.8	14.6	7.1	10.5	6.6	8.3	13.7	6.4	8.6	6.9	5.6	8.3	8.6	8.7	12.5	21.7	14.4	21.2	8.9	12.4	11.7	17.6	5.7	27.2	6.3	21.1	7.6	10.8	14.0	22.6	19.1	8.7	11.1	10.9	14.9	11.5	8.5	24.7	9.4	15.2	14.4	25.9	5.8	22.7	10.0	12.1	27.4	8.3	11.8	10.7	8.2	17.0	13.9	10.3	23.6	14.2	7.3	13.5	6.3	6.4	10.5	9.9	9.2	14.9	3.9	39.2	33.8	1.7	9.2	3.2	8.8	14.3	8.2	13.2	8.5	9.0	15.4	9.0	6.0	6.8	0.5	7.8	12.6	39.5	14.6	7.1	6.8	8.2	8.5	14.5	5.5	6.1	6.3	5.8	6.8	6.5
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol			13000	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	24.8	46.2	24.7	19.9	23.8	12.9	27.3	11.6	28.3	27.1	20.4	17.3	22.6	16.4	26.0	20.1	30.9	25.9	40.9	25.8	22.5	22.2	25.7	47.6	25.8	29.4	21.1	20.3	35.9	51.7	28.3	25.3	18.9	21.3	23.7	21.5	30.0	26.4	22.8	24.8	19.4	19.1	27.4	25.6	24.9	27.2	11.8	16.7	15.0	52.9	21.3	26.0	24.5	25.1	31.9	24.8	23.7	25.7	30.8	36.8	22.7	22.4	20.7	21.2	19.5	32.0	43.7	27.7	43.3	38.7	31.1	19.3	21.0	43.7	7.8	10.7	42.2	11.2	15.4	27.0	28.6	37.8	11.7	36.1	12.0	25.0	34.3	35.1	22.6	36.3	28.9	27.3	28.5	26.6	35.8	78.2	41.3	16.3	22.7	21.5	16.8	18.1	24.8	15.1	15.1	25.0	27.0	20.9	13.0	20.5	17.7	20.2	13.6	18.4	30.9	25.9	19.9	12.5	33.0	30.1	16.2	10.0	28.6	23.0	30.4	23.7	22.0	19.7	29.2	25.7	36.8	31.9	25.6	29.7	24.8	21.7	25.5	26.7	1.6	30.8	24.9	19.1	21.9	22.7	24.7	23.8	11.6	28.3	22.5	22.2	21.1	20.3	21.3	16.7
DCTN3	DCTN-22	ENSG00000137100	"Dynactin subunit 3"	O75935	9	34613545-34620523	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044905	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA044905: AB_10960996"	"unprognostic (3.38e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.47e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.88e-2)"	"unprognostic (4.41e-2)"	"prognostic favourable (2.10e-5)"	"unprognostic (1.26e-3)"	"unprognostic (4.24e-3)"	"prognostic favourable (5.76e-11)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.43e-2)"	26.4	32.5	42.4	16.2	49.1	46.5	30.4	33.7	58.3	25.7	23.3	20.7	22.2	21.4	24.6	25.5	33.7	31.7	23.1	42.8	36.3	37.4	32.8	32.4	21.1	21.9	35.8	48.4	32.6	33.7	29.8	36.3	23.0	37.4	27.4	20.6	27.5	32.4	28.6	69.1	37.9	18.3	28.0	26.2	19.4	23.7	16.2	22.0	42.6	32.4	37.1	29.2	22.5	24.9	28.5	44.6	62.3	45.9	29.9	56.0	46.8	34.0	28.6	26.6	27.8	23.7	33.1	11.0	29.1	27.2	40.6	32.0	18.3	12.8	15.7	18.3	38.3	13.6	24.1	30.5	26.0	49.2	30.3	10.4	50.6	15.7	25.6	27.4	31.9	29.1	26.4	28.0	18.4	26.7	12.4	32.6	35.3	28.0	34.5	74.0	8.0	46.2	17.4	14.4	21.5	19.5	12.1	8.8	22.7	21.6	19.9	11.1	26.6	31.5	24.2	25.6	20.7	29.0	28.2	22.0	28.5	10.4	40.3	16.0	52.0	62.3	44.0	59.3	35.2	44.2	32.0	28.5	37.8	37.2	44.0	28.3	29.9	35.7	38.4	29.9	45.9	44.6	56.0	46.8	42.4	49.1	33.7	58.3	36.3	37.4	35.8	48.4	37.4	22.0
DCTN6	WS-3	ENSG00000104671	"Dynactin subunit 6"	O00399	8	30156297-30183640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024049, HPA024558"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Nucleoli, Cytosol"	"Plasma membrane"	"HPA024049: AB_1847524, HPA024558: AB_1847525"	"unprognostic (1.28e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-2)"	"unprognostic (9.26e-2)"	"prognostic favourable (5.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.43e-1)"	29.5	34.6	41.4	15.6	39.4	23.3	32.6	23.6	43.6	21.0	20.6	27.4	15.4	14.2	24.1	27.2	24.1	18.0	20.0	44.5	37.7	35.2	32.8	27.5	20.3	15.3	42.3	36.3	26.3	19.5	31.0	27.7	32.7	41.4	21.9	22.5	16.5	20.3	23.7	20.4	17.5	15.6	26.0	46.2	16.8	19.3	13.9	30.3	15.4	33.7	18.2	17.9	25.7	18.8	7.4	19.8	9.5	15.9	10.2	11.2	6.9	18.9	18.2	23.0	12.1	21.0	28.9	14.8	25.8	29.9	25.2	26.4	11.8	12.6	14.1	27.7	27.0	14.1	15.9	21.8	29.7	11.3	12.4	20.2	15.6	18.5	16.2	11.4	17.2	24.4	31.2	18.0	19.3	22.5	22.6	15.6	26.7	14.4	21.1	16.4	18.8	11.6	11.3	17.3	12.3	35.8	18.6	37.8	21.4	15.0	18.5	25.6	17.8	16.2	21.6	13.7	47.8	11.2	18.3	6.6	7.4	18.2	25.2	13.1	23.8	9.5	14.1	4.9	8.6	15.9	9.8	7.4	7.8	10.1	16.8	5.5	9.0	11.2	4.5	10.2	15.1	19.8	8.7	6.9	41.4	39.4	23.6	43.6	37.7	35.2	42.3	36.3	41.4	30.3
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423619-30430075	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002832	Uncertain		Approved	Nucleoplasm,Cytosol			270000	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavourable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	15.3	15.8	14.8	25.0	13.2	12.5	20.7	15.5	19.2	12.1	37.4	10.3	11.3	20.7	14.1	14.4	19.7	18.9	28.1	23.3	12.1	12.6	27.0	25.3	11.2	27.6	13.3	16.6	16.6	25.2	16.4	7.7	16.3	11.4	15.4	40.3	10.6	20.5	21.1	28.3	16.1	22.9	13.9	11.3	22.5	16.4	9.9	7.8	21.3	22.6	26.0	25.0	13.2	13.0	47.3	30.9	19.0	24.5	23.1	26.2	25.3	26.3	32.4	14.8	19.0	4.2	5.7	13.7	12.7	7.6	19.2	19.6	24.3	22.5	35.7	26.7	7.9	20.7	30.6	24.9	24.0	18.8	48.3	20.8	14.9	31.6	5.4	37.1	32.4	6.5	14.2	21.4	12.3	19.7	26.1	12.6	13.6	46.0	44.1	41.6	19.5	26.2	62.6	16.4	46.5	22.2	17.2	31.5	17.8	8.4	30.2	11.9	26.1	16.0	9.9	14.9	13.3	19.1	22.8	8.3	24.7	45.5	9.8	30.8	17.3	19.0	12.4	11.7	18.8	22.1	26.2	47.3	24.2	21.3	28.7	40.2	21.8	21.0	1.5	23.1	24.5	30.9	24.1	25.3	14.8	13.2	15.5	19.2	12.1	12.6	13.3	16.6	11.4	7.8
DCUN1D1	"DCUN1L1, RP42, SCCRO, SCRO, Tes3"	ENSG00000043093	"Defective in cullin neddylation 1 domain containing 1"	Q96GG9	3	182938074-182985953	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 95.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol			70000	Nucleoplasm	Cytosol	"HPA035911: AB_10673489"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.98e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.52e-1)"	5.0	5.2	7.9	5.0	7.1	6.9	4.8	9.3	8.3	4.5	4.9	4.1	2.7	4.9	5.4	4.9	6.7	4.3	4.6	5.5	7.4	5.0	7.2	11.2	4.3	5.0	9.3	6.8	4.7	3.6	4.6	14.6	4.5	8.0	6.1	4.8	2.8	4.9	5.4	14.7	5.2	6.5	8.1	9.2	5.2	4.2	95.0	7.6	7.2	6.7	5.2	6.0	8.4	4.9	7.4	10.7	17.3	9.8	11.2	8.0	5.7	23.0	10.2	13.7	5.9	14.6	14.3	11.6	14.8	16.7	16.7	16.4	15.1	17.2	27.0	32.6	13.8	13.0	11.5	11.9	22.2	22.1	6.2	26.0	8.0	6.3	9.2	15.3	19.7	10.2	14.5	9.3	8.8	11.4	8.7	14.2	12.2	12.4	15.0	8.2	11.2	9.4	11.8	14.5	17.9	12.0	16.3	10.0	9.9	25.9	18.7	13.9	38.2	12.4	11.1	10.4	10.0	14.1	17.4	11.7	21.8	27.5	13.0	14.5	14.9	9.4	9.1	17.3	7.8	9.8	7.5	7.4	6.4	7.7	10.7	4.7	7.5	7.9	15.0	11.2	6.3	8.2	8.0	5.7	7.9	7.1	9.3	8.3	7.4	5.0	9.3	6.8	8.0	7.6
DCUN1D2	"C13orf17, FLJ10704, FLJ20092"	ENSG00000150401	"Defective in cullin neddylation 1 domain containing 2"	Q6PH85	13	113455819-113490952	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039349	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039349: AB_10673240"	"unprognostic (3.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.43e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.02e-2)"	"prognostic favourable (5.65e-5)"	"unprognostic (1.21e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.25e-2)"	4.9	4.5	6.2	6.0	7.0	7.8	4.6	24.0	13.3	4.1	4.3	6.5	3.4	3.1	6.2	6.6	4.7	4.0	4.9	59.1	5.9	7.2	4.3	4.0	3.8	4.6	7.2	5.9	5.5	4.5	3.5	7.1	5.2	9.7	3.9	4.5	6.2	4.5	4.5	65.6	9.1	5.4	5.2	8.5	4.9	4.3	5.6	6.1	5.3	3.3	7.5	4.9	3.8	3.7	3.5	2.7	10.9	2.2	2.8	4.1	1.8	6.7	4.2	7.1	5.4	5.2	4.6	5.5	5.3	6.5	5.0	5.7	15.0	4.1	4.9	1.7	6.1	9.8	7.6	4.0	7.2	3.2	12.8	8.3	19.2	4.1	2.7	12.6	6.2	6.8	6.7	5.6	4.5	4.2	4.6	4.7	4.8	4.8	8.6	20.8	4.5	6.6	9.0	11.7	6.5	3.7	4.5	31.6	7.0	4.1	14.2	3.9	8.1	5.9	7.0	6.6	9.0	5.0	7.6	14.0	5.9	9.8	15.0	5.6	4.4	10.9	1.9	3.6	3.1	1.7	4.1	3.5	2.8	1.9	2.7	1.9	3.0	1.6	1.5	2.8	2.2	0.3	2.9	1.8	6.2	7.0	24.0	13.3	5.9	7.2	7.2	5.9	9.7	6.1
DCUN1D3	"DKFZp686O0290, FLJ41725, MGC48972, SCCRO3"	ENSG00000188215	"Defective in cullin neddylation 1 domain containing 3"	Q8IWE4	16	20854925-20900384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 38.4"	"Cell line enhanced"	"Detected in all"		"ASC diff: 30.1;ASC TERT1: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041983, HPA043511"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041983: , HPA043511: "	"unprognostic (9.34e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (5.41e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.42e-1)"	19.2	9.9	4.3	6.0	4.6	2.7	17.2	7.9	5.6	7.5	6.0	5.5	3.2	3.4	7.7	5.9	8.5	6.6	9.6	8.9	2.5	2.8	10.0	17.4	9.7	3.1	5.2	3.0	5.3	6.6	6.4	9.5	9.4	6.7	6.6	4.1	6.3	3.9	4.5	38.4	7.1	4.9	11.9	3.9	4.5	6.4	7.9	3.8	1.5	4.8	11.5	4.5	6.7	15.8	1.4	1.6	4.8	2.5	2.6	2.7	1.0	2.6	4.7	2.4	5.1	30.1	22.7	3.2	8.9	7.7	4.5	6.1	5.9	5.1	1.7	7.3	8.7	3.7	2.7	3.7	6.0	2.3	1.9	1.4	3.7	8.5	7.9	2.2	13.7	14.9	5.1	8.6	4.9	12.3	1.6	4.6	9.2	3.6	2.0	3.1	5.6	1.6	3.4	2.7	1.6	4.0	2.8	2.2	2.9	3.5	3.9	2.0	2.6	1.0	6.0	9.6	3.4	4.0	2.4	3.9	2.3	1.2	10.2	2.3	4.9	4.8	1.4	1.2	1.7	2.5	1.7	1.0	1.2	2.7	1.6	1.4	1.5	2.7	1.9	2.6	2.2	1.2	1.0	1.0	4.3	4.6	7.9	5.6	2.5	2.8	5.2	3.0	6.7	3.8
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.1;testis: 6.4"	"Group enriched"	"Detected in some"	8	"SCLC-21H: 33.8;SH-SY5Y: 13.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"olfactory region: 90.9"	"Region enriched"	"Detected in all"	4	"olfactory region: 130.1"	HPA036121	Enhanced	Supported	Approved	Cytosol				Cytosol		"HPA036121: "	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"	0.8	1.1	7.0	0.7	9.2	0.7	3.2	0.7	17.1	0.7	0.6	0.9	0.0	0.7	4.1	3.6	0.6	0.6	0.8	0.7	4.2	5.4	0.5	0.5	0.6	0.7	2.5	6.7	0.6	0.8	0.5	1.0	0.6	3.7	0.5	0.8	0.0	2.2	0.6	0.5	0.7	0.7	0.6	3.0	0.6	1.2	6.4	2.3	0.0	0.6	0.0	0.5	0.6	0.3	0.3	0.4	0.6	0.2	0.7	0.4	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	33.8	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.1	0.4	0.3	0.3	0.2	0.1	0.3	0.3	0.3	0.6	0.7	0.0	0.4	0.1	0.0	7.0	9.2	0.7	10.8	4.2	5.4	2.5	6.7	3.7	2.3
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.6"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006308	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"			140000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	4.3	14.3	43.9	5.8	44.9	0.7	6.6	14.4	37.2	7.7	22.1	20.7	4.3	21.1	6.0	33.8	4.9	18.4	12.2	6.4	29.5	24.1	61.6	39.9	11.8	1.1	24.9	37.0	3.4	13.8	13.0	7.2	3.1	13.8	13.1	21.4	4.1	8.5	6.2	13.8	2.8	19.9	7.4	8.1	4.1	15.6	9.3	11.0	0.0	14.1	1.0	1.2	6.0	3.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	18.7	2.3	6.6	1.2	11.1	9.4	0.8	22.1	13.4	7.9	8.4	26.6	5.0	0.0	9.2	25.0	5.4	23.9	4.6	10.1	0.0	9.2	0.0	6.3	9.2	4.0	17.0	1.0	7.8	0.4	6.6	4.2	12.5	0.0	1.9	20.2	1.5	0.9	0.0	7.9	6.9	0.0	15.5	0.2	33.7	14.0	18.7	36.3	2.9	16.8	2.7	9.1	1.3	24.4	6.9	5.6	1.7	15.4	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	43.9	44.9	14.4	37.2	29.5	24.1	24.9	37.0	13.8	11.0
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.6;ASC TERT1: 13.2;EFO-21: 16.9;fHDF/TERT166: 10.5;SK-MEL-30: 10.6;U-2 OS: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012509	Uncertain		Supported	"Centriolar satellite,Cytosol"			1800000	Cytosol	"Centriolar satellite"	"HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	24.3	7.8	12.5	11.1	10.3	5.5	22.7	3.1	7.8	32.1	17.0	7.9	12.9	2.6	34.6	22.0	18.4	18.1	26.7	20.7	11.8	10.8	16.9	12.9	37.4	16.5	10.6	6.6	22.5	4.3	3.0	6.2	13.7	13.1	19.8	5.4	13.0	18.1	13.2	6.8	15.1	22.3	27.1	18.9	21.4	11.4	7.3	9.9	14.1	35.4	17.1	8.9	16.3	23.4	2.9	5.5	8.0	2.7	2.3	0.5	0.3	0.4	6.6	0.2	1.4	10.6	13.2	0.7	0.6	0.3	0.4	0.1	4.3	0.7	0.2	16.9	10.5	0.8	0.0	6.2	0.0	0.1	8.9	0.5	0.5	0.1	0.3	0.9	0.0	8.5	0.1	0.8	0.1	0.1	0.2	2.2	0.0	3.6	0.5	2.5	0.1	0.2	0.3	0.5	0.0	7.5	0.7	0.4	0.9	0.3	0.0	10.6	0.7	0.9	1.1	0.8	12.6	0.2	0.1	2.7	9.2	2.5	7.3	1.5	0.2	8.0	0.8	7.7	0.5	2.6	0.3	2.9	0.2	0.3	1.5	2.5	0.1	0.1	1.3	2.3	2.7	5.5	0.4	0.3	12.5	10.3	3.1	7.8	11.8	10.8	10.6	6.6	13.1	9.9
DDHD2	"KIAA0725, SAMWD1, SPG54"	ENSG00000085788	"DDHD domain containing 2"	O94830	8	38225218-38275558	"Disease related genes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015202, HPA023143, HPA023147"	Supported		Supported	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535"	"unprognostic (1.49e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.49e-1)"	20.1	14.3	24.5	13.5	27.1	9.4	14.9	34.4	48.1	18.9	13.5	23.2	10.6	15.3	16.6	18.7	16.9	15.5	13.9	21.3	26.6	25.1	17.4	9.1	13.0	13.8	28.6	24.9	24.3	16.4	17.3	15.4	11.8	27.5	18.6	13.4	20.0	13.6	23.8	21.4	12.5	17.1	16.7	37.3	12.5	11.0	16.8	17.9	8.8	15.0	9.3	16.4	14.9	13.3	13.3	5.5	3.7	4.0	13.2	12.3	5.9	25.0	11.4	25.9	12.7	10.4	14.0	8.4	7.9	14.2	18.9	17.0	13.7	9.9	10.0	11.1	13.7	9.7	14.6	14.6	28.9	8.5	10.0	35.6	15.7	13.0	9.0	4.2	5.6	7.2	11.7	11.7	12.2	22.3	25.2	10.9	11.9	5.3	28.1	6.3	5.8	6.8	15.0	22.4	6.8	10.3	15.0	9.4	14.6	19.2	10.2	9.7	11.7	11.2	20.3	10.8	14.4	10.7	12.5	11.6	10.4	22.7	17.7	8.1	15.3	2.1	3.1	3.7	9.6	4.0	10.7	8.3	8.6	10.6	5.5	13.3	9.5	6.7	0.3	13.2	2.8	3.0	12.3	5.9	24.5	27.1	34.4	48.1	26.6	25.1	28.6	24.9	27.5	17.9
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617500-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol			170000	"Nucleoplasm, Cytosol"		"HPA043119: , HPA043225: "	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	14.8	8.1	5.1	10.5	7.1	10.5	15.0	8.7	8.4	8.7	10.8	8.2	9.8	9.0	12.3	9.6	19.4	7.7	8.3	12.5	5.8	4.7	10.4	24.9	10.2	9.1	6.7	5.2	8.3	9.4	14.8	8.0	11.5	7.5	12.1	7.9	11.5	13.5	13.8	54.8	13.3	9.2	8.0	6.5	9.9	6.9	4.3	6.0	11.1	7.6	11.7	16.4	12.1	12.3	3.8	5.4	0.8	2.3	2.0	3.5	1.4	7.4	4.3	7.9	8.2	10.9	8.6	7.7	4.7	3.6	4.1	3.6	10.6	6.8	18.8	5.5	5.1	8.0	17.2	7.6	7.0	8.6	11.5	14.7	7.3	10.4	4.7	19.4	7.4	8.5	9.0	7.7	8.3	8.4	23.5	7.0	5.0	5.0	11.2	6.4	7.6	3.6	10.6	11.2	11.1	5.8	6.2	9.7	5.4	8.8	14.2	13.0	7.4	5.1	7.3	6.0	5.1	6.7	5.7	6.6	7.9	15.2	4.7	14.2	4.6	0.7	2.3	0.4	3.3	2.1	2.9	2.6	2.5	2.6	2.3	3.8	2.8	3.5	0.8	2.0	1.6	5.4	2.3	1.4	5.1	7.1	8.7	8.4	5.8	4.7	6.7	5.2	7.5	6.0
DDIAS	"C11orf82, FLJ25416, FLJ38838, noxin"	ENSG00000165490	"DNA damage induced apoptosis suppressor"	Q8IXT1	11	82899975-82958277	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.6;testis: 16.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA038540, HPA038541"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"		"HPA038540: AB_10672648, HPA038541: "	"unprognostic (2.53e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.86e-6)"	"unprognostic (4.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.04e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.11e-16)"	"unprognostic (7.17e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.13e-2)"	1.3	1.0	0.8	6.1	0.8	7.0	1.7	0.8	1.2	1.9	2.3	1.2	0.2	1.3	1.5	2.6	5.5	1.0	0.4	2.6	0.9	0.7	1.0	2.3	3.1	5.0	0.8	0.6	1.3	0.9	0.0	0.5	2.5	1.0	0.9	2.0	0.2	2.1	0.2	10.1	2.3	1.9	1.5	0.9	5.5	1.1	16.3	0.9	17.6	0.8	9.5	5.9	1.8	1.8	2.0	4.5	5.8	10.7	1.9	0.7	3.2	6.0	9.5	9.8	7.1	1.0	1.5	7.2	11.4	4.8	12.6	14.7	9.3	7.5	7.3	17.1	2.6	11.5	16.6	7.2	17.5	13.2	8.9	10.4	4.9	4.1	0.1	12.7	9.2	0.3	0.7	15.9	7.3	5.9	10.4	12.7	11.1	8.7	12.0	10.4	11.7	10.9	8.9	19.0	9.4	2.7	10.0	7.4	9.9	7.0	7.1	2.7	7.7	5.3	2.8	12.7	17.2	33.3	13.8	7.2	18.9	25.5	4.0	9.2	12.0	0.6	10.7	3.9	0.5	8.3	0.3	1.1	0.3	0.7	4.5	2.0	0.7	0.4	5.8	1.9	7.8	1.4	0.5	3.2	0.8	0.8	0.8	1.2	0.9	0.7	0.8	0.6	1.0	0.9
DDIT4	"Dig2, FLJ20500, REDD-1, REDD1, RTP801"	ENSG00000168209	"DNA damage inducible transcript 4"	Q9NX09	10	72273920-72276036	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 159.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 65.0;hTCEpi: 220.7;hTERT-HME1: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034507, HPA034508"	Approved		Supported	Cytosol				Cytosol		"HPA034507: AB_2674199, HPA034508: AB_10601206"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (7.65e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.96e-3)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (9.72e-2)"	"prognostic unfavourable (2.54e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.66e-1)"	29.0	43.9	27.3	28.0	28.0	35.5	88.2	23.1	27.1	38.7	18.7	6.4	14.4	7.5	16.3	13.5	37.0	14.5	21.7	23.0	28.2	8.4	13.6	27.5	33.7	26.5	45.5	11.6	73.4	159.3	5.4	16.4	16.2	34.4	15.8	5.1	10.2	41.2	29.2	29.5	21.0	13.0	11.7	22.8	17.5	19.6	8.1	34.9	30.8	13.4	11.1	34.5	37.8	47.7	25.9	40.5	9.7	2.5	70.6	57.1	40.9	12.5	9.1	1.8	16.9	12.2	7.0	5.5	3.8	4.2	1.4	5.7	1.0	27.2	1.4	11.6	0.6	14.7	2.6	65.0	3.1	20.4	3.4	1.5	20.6	6.7	48.5	4.2	6.1	29.7	220.7	5.8	81.1	5.4	12.1	33.9	4.9	5.2	2.5	5.8	0.4	2.1	1.4	2.1	24.0	11.6	3.0	3.3	4.7	9.0	14.2	51.0	2.0	9.5	11.2	0.4	3.6	0.8	2.0	24.1	13.3	3.7	24.2	9.6	2.8	9.2	1.6	9.7	50.4	2.5	48.6	17.9	32.8	27.8	7.2	25.9	57.1	42.9	5.3	70.6	2.0	40.5	24.0	40.9	27.3	28.0	23.1	27.1	28.2	8.4	45.5	11.6	34.4	34.9
DDN	KIAA0749	ENSG00000181418	Dendrin	O94850	12	48995149-48999309	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 40.8;skeletal muscle: 73.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.3;RPMI-8226: 19.7;SCLC-21H: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"amygdala: 228.1;basal ganglia: 257.7;cerebral cortex: 232.0;hippocampal formation: 236.4;olfactory region: 128.1"	HPA060952	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA060952: "	"unprognostic (2.80e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.56e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.20e-5)"	"unprognostic (8.61e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-6)"	"unprognostic (1.72e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.53e-2)"	0.7	0.7	40.5	0.8	40.8	1.3	0.7	0.0	38.5	0.7	0.7	0.2	0.0	0.7	0.7	3.8	1.0	0.7	0.7	0.9	30.5	2.0	4.8	0.7	0.7	0.9	2.9	9.3	0.7	0.8	0.8	0.0	0.7	0.0	1.6	0.7	0.0	0.7	0.7	73.8	0.8	0.8	0.7	0.0	0.8	0.8	0.8	1.2	0.0	0.7	0.0	0.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.3	0.3	0.2	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	4.4	0.4	0.0	0.2	0.0	1.5	10.3	0.0	0.1	0.5	4.7	2.3	0.5	1.0	0.0	5.3	0.2	0.0	0.1	0.1	0.0	0.1	0.0	3.5	0.2	0.1	5.2	5.8	0.1	1.4	4.8	0.3	19.7	0.0	0.1	10.3	1.0	0.2	0.5	0.2	0.2	0.7	0.1	0.2	0.5	0.2	0.0	1.2	2.3	4.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	40.5	40.8	0.0	31.9	30.5	2.0	2.9	9.3	0.0	1.2
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415562	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 14.5;U-937: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.9;myeloid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	3.7	11.0	5.2	1.1	12.1	1.6	3.3	1.9	5.5	2.7	3.6	10.8	4.9	8.6	2.7	5.4	1.2	6.1	3.9	21.0	6.9	3.4	12.3	12.8	3.9	1.3	8.0	6.1	1.2	5.5	18.6	1.9	2.1	8.0	2.9	3.9	2.3	4.9	3.2	11.3	0.8	7.9	5.6	7.7	2.6	1.9	0.4	8.2	0.0	3.3	5.7	0.5	3.6	1.6	0.0	7.3	0.1	4.9	1.7	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.2	1.0	0.2	5.1	1.2	0.9	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	2.3	4.6	0.0	4.7	0.0	4.0	1.6	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.0	1.8	4.2	0.0	0.0	0.2	0.0	0.1	0.1	2.9	14.5	0.0	4.6	0.1	0.1	0.0	0.4	0.6	0.7	1.0	0.9	1.0	0.1	0.0	2.4	0.1	0.3	0.0	1.9	16.1	0.0	0.1	4.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	1.7	1.6	0.0	0.0	1.5	5.2	12.1	1.9	5.5	6.9	3.4	8.0	6.1	8.0	8.2
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15631111	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Enhanced	Nucleoplasm,Cytosol			46000	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favourable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	23.8	28.2	29.3	17.6	35.0	17.1	30.1	35.3	37.2	25.1	24.5	15.0	20.5	21.0	24.3	25.6	27.7	21.0	15.8	47.6	34.7	25.3	35.8	35.2	17.8	16.0	24.5	36.9	23.6	27.6	42.1	41.2	28.1	35.1	22.2	28.1	14.8	23.9	24.5	67.5	24.5	25.9	31.0	21.0	17.1	24.1	19.2	23.0	23.0	29.6	24.8	21.5	26.1	19.8	18.7	22.8	19.2	25.1	23.0	26.6	19.9	19.1	29.4	41.8	31.2	36.3	31.9	48.2	40.3	33.8	39.7	33.4	46.9	19.8	49.7	19.6	46.4	29.2	57.1	38.6	42.0	21.1	37.1	54.5	39.3	59.1	27.3	44.5	25.7	24.7	26.7	33.0	31.8	35.7	55.5	16.4	39.1	26.8	24.3	33.6	53.8	24.8	29.4	63.3	36.0	45.4	38.6	33.7	42.2	27.5	29.0	36.6	20.2	18.9	28.8	33.3	34.5	20.9	45.4	21.5	37.3	67.1	30.0	35.7	31.0	19.2	20.0	11.5	20.2	25.1	21.3	18.7	23.4	23.4	22.8	18.0	26.6	23.6	3.1	23.0	23.2	19.5	21.6	19.9	29.3	35.0	35.3	37.2	34.7	25.3	24.5	36.9	35.1	23.0
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111755245-111768016	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 81.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favourable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavourable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	3.1	2.8	2.9	2.7	4.3	5.9	9.8	5.8	5.1	2.7	2.6	1.8	2.6	2.0	4.0	2.9	2.6	3.7	1.7	2.0	4.3	1.6	2.7	2.4	4.1	3.8	2.4	1.9	3.9	2.9	4.0	3.9	2.7	3.4	2.9	2.6	1.2	2.6	2.7	5.1	2.5	3.5	2.9	5.6	4.5	2.8	81.7	3.3	5.1	3.2	1.7	4.1	2.9	5.0	11.9	7.4	12.7	7.4	10.5	14.1	7.8	11.4	4.7	12.2	11.0	8.8	7.0	11.4	11.2	8.7	16.1	15.7	7.0	4.0	26.8	8.8	7.6	9.2	14.4	11.3	18.0	12.2	13.0	13.0	9.2	7.2	8.8	12.8	9.6	7.0	9.9	13.7	13.9	11.1	12.4	9.8	12.2	10.8	15.7	13.0	15.3	9.6	15.4	20.1	6.7	10.5	9.0	12.7	11.5	10.8	13.5	18.0	8.4	13.6	9.8	9.8	14.5	17.5	13.0	4.9	6.9	20.5	10.2	13.2	22.1	12.7	7.0	6.9	10.0	7.3	13.3	11.9	11.7	11.8	7.4	10.1	14.1	12.3	5.0	10.5	7.4	5.2	11.7	7.8	2.9	4.3	5.8	5.1	4.3	1.6	2.4	1.9	3.4	3.3
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048291-94081245	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 103.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favourable (3.06e-9)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	18.0	45.5	19.7	13.7	41.3	53.3	18.5	31.4	40.8	17.4	20.9	21.9	14.3	13.6	23.2	103.0	20.1	18.9	21.3	28.6	25.0	31.3	36.3	30.1	16.4	27.4	22.0	29.0	21.4	12.5	8.3	32.0	11.2	38.7	16.0	14.6	17.4	15.9	17.7	28.5	23.4	12.6	17.9	21.8	18.1	15.0	38.5	17.4	14.3	25.3	11.8	25.8	21.7	14.9	4.1	3.1	10.6	3.3	6.2	5.3	5.0	3.8	1.0	7.1	4.6	4.3	5.6	1.7	10.7	8.9	13.9	12.5	1.3	2.4	17.7	4.0	2.3	2.5	7.3	0.6	15.2	7.7	0.4	9.4	2.0	5.7	3.5	13.5	4.2	0.9	4.0	2.5	2.4	2.3	4.9	5.2	5.9	10.6	4.0	11.5	4.7	0.1	5.4	16.5	2.0	10.1	1.4	5.6	5.2	10.5	2.6	4.9	4.1	4.8	6.8	4.0	2.6	5.1	3.2	2.1	13.6	19.0	5.7	7.4	3.1	10.6	3.3	2.5	5.0	2.6	1.4	2.9	2.9	3.0	2.0	4.1	5.3	5.3	2.6	6.2	2.5	3.1	3.3	5.0	19.7	41.3	31.4	40.8	25.0	31.3	22.0	29.0	38.7	17.4
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68021274-68023442	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: "	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favourable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	9.8	12.7	6.2	6.7	8.3	19.7	7.1	6.0	12.9	8.3	7.2	6.4	6.8	5.2	7.5	7.3	9.7	7.1	7.0	9.2	5.2	5.9	8.9	12.4	5.8	18.4	6.4	5.1	8.6	13.3	6.8	4.6	17.1	6.6	6.1	6.0	7.8	6.3	5.2	16.2	9.9	7.9	5.3	3.0	11.1	7.0	11.5	2.7	14.6	10.2	7.3	10.6	8.0	4.8	17.8	18.0	22.9	19.1	17.0	22.9	16.6	6.1	9.1	4.5	5.4	6.3	3.5	10.5	4.2	6.2	10.6	7.6	8.8	9.8	23.0	6.5	5.2	11.1	6.4	10.2	6.3	3.1	10.5	8.3	4.8	9.1	8.5	13.0	9.0	6.8	11.1	8.7	8.0	5.9	14.8	3.6	4.7	13.7	13.6	18.3	11.0	6.8	13.4	4.2	24.6	7.4	7.1	9.4	6.3	17.1	4.9	9.3	9.4	14.3	4.2	4.7	4.0	6.7	6.9	8.1	9.8	22.1	5.8	10.1	6.3	17.7	19.1	22.9	15.7	18.8	17.3	12.6	14.6	16.9	18.0	17.8	22.9	16.9	6.3	17.0	18.5	9.0	13.8	16.6	6.2	8.3	6.0	12.9	5.2	5.9	6.4	5.1	6.6	2.7
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3, X-linked"	O00571	X	41333284-41364472	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol			110000	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: "	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	80.9	49.3	26.1	40.0	34.5	49.3	46.5	31.1	36.2	52.4	43.3	35.1	21.3	29.5	56.4	25.9	53.5	56.3	42.6	47.6	30.8	24.5	55.6	77.9	45.3	40.4	41.4	29.0	60.1	30.9	68.7	60.2	79.9	37.9	30.0	29.2	30.8	37.4	26.5	63.4	42.2	54.0	57.2	53.9	46.1	43.0	27.0	39.0	49.2	45.6	44.0	42.6	55.8	50.2	13.1	20.5	32.0	21.6	17.3	21.5	17.9	45.4	50.5	47.2	25.9	55.6	47.2	28.8	33.1	46.6	34.0	27.4	51.9	30.6	0.5	23.7	37.1	30.7	57.7	46.6	56.7	26.9	45.0	28.9	50.3	31.2	28.9	54.1	52.0	34.1	33.1	57.3	55.4	53.3	53.0	28.6	31.6	34.4	34.1	16.9	45.4	20.4	40.0	50.3	37.0	32.0	61.2	32.3	48.9	75.0	38.5	39.7	34.6	36.8	48.1	35.1	37.6	37.5	39.3	33.4	39.6	44.9	35.4	32.8	33.2	22.5	20.2	17.5	14.8	21.1	21.5	13.1	14.5	16.3	20.5	9.0	16.3	15.1	32.0	17.3	21.6	6.9	14.3	17.9	26.1	34.5	31.1	36.2	30.8	24.5	41.4	29.0	37.9	39.0
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3, Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 40.6;HEL: 41.4;U-266/84: 34.4;U-698: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favourable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	12.0	10.5	4.9	29.5	14.1	46.1	8.7	17.0	16.3	0.4	24.4	12.6	31.5	7.6	0.4	29.7	12.2	0.4	14.2	10.8	5.6	7.1	8.9	26.5	20.0	17.7	5.7	0.0	0.4	14.5	0.4	12.2	14.0	20.2	26.7	15.8	15.1	20.4	32.6	17.7	8.4	16.0	40.7	6.2	34.3	8.9	41.9	0.0	26.9	10.8	21.4	19.3	14.4	0.0	6.1	8.8	6.5	7.1	6.5	8.4	3.8	0.1	7.5	0.0	0.0	0.0	0.0	5.5	18.6	13.3	9.8	12.1	0.0	0.0	40.6	0.0	18.3	0.0	0.0	0.0	17.3	10.2	0.0	41.4	0.0	12.2	9.7	0.0	0.0	10.3	11.6	0.0	0.0	0.0	0.0	0.0	11.6	0.0	16.0	0.0	7.4	0.0	0.0	4.9	7.4	10.5	11.2	12.2	0.0	0.0	0.0	13.6	0.0	9.7	13.3	15.3	0.0	0.0	12.2	21.9	34.4	30.2	1.8	0.0	0.0	1.6	6.2	5.7	8.4	7.1	7.7	6.1	6.4	7.1	8.8	5.9	7.8	6.5	6.5	6.5	4.6	2.5	5.7	3.8	4.9	14.1	17.0	16.3	5.6	7.1	5.7	0.0	20.2	0.0
DDX51		ENSG00000185163	"DEAD-box helicase 51"	Q8N8A6	12	132136594-132144335	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039503	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA039503: AB_10796328"	"unprognostic (2.84e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavourable (4.73e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.65e-3)"	10.5	8.5	12.7	12.7	17.1	17.2	10.3	23.5	18.9	8.8	8.4	11.8	10.6	7.8	11.5	12.2	8.5	12.4	10.0	8.1	11.6	9.9	9.5	7.2	8.9	11.1	10.5	16.9	19.6	14.8	10.1	9.8	7.2	11.8	9.3	7.3	8.9	10.7	12.4	13.8	18.0	8.2	10.4	10.5	10.6	9.3	6.7	12.0	9.5	9.9	7.1	10.4	9.3	8.6	2.5	2.3	2.6	2.1	1.6	2.0	1.0	6.2	10.1	4.2	5.3	4.0	3.9	8.0	4.8	2.9	7.1	3.0	6.2	3.1	10.9	4.2	2.9	6.6	10.4	7.7	3.5	2.6	10.1	12.9	5.4	2.0	4.8	9.0	7.5	3.4	5.7	4.0	3.6	3.8	9.5	3.6	2.1	6.1	10.9	18.4	7.4	17.3	13.0	5.7	12.1	4.8	4.9	10.3	5.4	5.2	7.5	5.3	6.6	8.3	6.6	2.7	8.2	6.6	11.0	10.1	5.9	12.7	5.6	6.8	6.3	1.1	2.1	1.2	2.0	1.0	0.7	1.5	1.3	0.9	0.6	2.5	1.2	1.6	2.6	1.6	1.0	2.3	0.6	1.0	12.7	17.1	23.5	18.9	11.6	9.9	10.5	16.9	11.8	12.0
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999961-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 11.5"	"Cell line enhanced"	"Detected in some"		"K-562: 6.2;RPMI-8226: 3.2;U-2197: 2.1;U-266/84: 14.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX58	"DKFZp434J1111, FLJ13599, RIG-I"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455705-32526324	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 44.8;BJ hTERT+ SV40 Large T+ RasG12V: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012643, HPA047193"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB012643: , HPA047193: "	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	27.7	8.2	5.7	14.5	7.9	5.6	11.3	4.2	5.7	9.9	9.5	5.2	9.1	7.2	12.7	11.7	10.8	7.6	10.3	7.1	6.0	5.1	14.7	8.5	13.7	14.3	6.3	4.5	9.2	7.7	6.6	10.2	14.8	7.5	12.1	8.1	5.5	12.4	5.8	8.3	10.7	16.1	10.8	7.7	13.8	8.0	4.5	6.4	35.4	13.0	7.4	9.7	9.9	9.4	4.9	2.0	24.8	5.7	6.1	6.5	3.0	2.9	1.1	1.6	0.9	3.8	4.0	2.5	1.8	8.8	44.8	46.8	1.2	2.6	0.8	3.2	1.6	2.4	1.7	1.9	6.3	7.2	0.6	2.8	2.5	2.0	3.1	1.8	2.2	2.8	0.7	5.2	1.5	8.1	0.6	0.6	5.9	0.4	2.5	4.6	1.3	1.2	2.4	1.2	0.3	6.8	1.6	1.2	0.7	2.6	1.1	4.9	1.9	1.5	9.3	1.3	1.3	1.1	0.9	0.1	0.5	0.5	2.0	0.8	0.9	8.5	3.8	10.3	6.2	5.7	5.5	4.8	5.6	5.6	2.0	4.9	5.1	5.6	24.8	6.1	3.9	0.1	6.5	3.0	5.7	7.9	4.2	5.7	6.0	5.1	6.3	4.5	7.5	6.4
DDX6	"HLR2, RCK"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747766-118791149	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"				"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	29.8	23.0	25.0	24.1	41.0	43.3	25.1	41.9	39.2	26.9	23.2	29.4	14.5	17.1	30.1	22.9	31.8	23.4	17.5	26.8	25.5	25.1	22.8	24.6	23.4	32.2	21.9	27.1	38.2	27.9	30.9	43.2	26.1	29.6	24.9	20.8	25.4	26.8	22.9	43.8	23.9	24.1	27.8	30.4	30.6	21.2	19.9	24.0	46.0	27.9	19.4	42.8	33.0	25.7	12.2	6.5	17.8	10.3	7.2	12.6	5.7	11.7	16.0	25.8	25.4	22.6	23.3	16.9	15.9	20.9	14.8	14.1	23.3	18.1	26.9	16.7	26.0	18.8	30.1	23.2	23.9	20.2	6.0	51.8	10.3	18.9	15.0	37.1	20.0	24.6	17.1	21.9	35.7	23.6	23.8	39.1	20.9	32.0	27.0	17.2	18.3	11.8	29.8	20.8	21.5	17.3	30.4	17.1	23.6	30.0	24.1	9.5	28.2	14.6	26.9	24.6	13.5	14.0	16.0	12.2	15.8	32.1	9.8	17.9	21.0	10.5	4.1	11.6	10.1	5.7	12.6	11.4	9.9	10.4	4.7	12.2	12.4	10.8	17.8	7.2	10.3	6.5	8.9	5.7	25.0	41.0	41.9	39.2	25.5	25.1	21.9	27.1	29.6	24.0
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216293-168318807	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 22.5;BJ hTERT+ SV40 Large T+ RasG12V: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"				Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavourable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	18.0	8.3	4.1	18.5	5.0	4.4	9.0	1.3	3.8	11.4	14.8	4.3	5.1	8.8	10.8	15.2	10.7	8.1	11.5	8.5	3.7	3.5	10.0	8.8	21.6	18.7	4.2	3.2	20.3	5.5	8.8	6.7	25.5	5.6	11.6	14.3	9.0	15.6	6.2	5.6	7.9	16.7	11.2	6.1	18.9	29.2	5.7	3.9	23.2	14.5	6.0	9.3	8.2	7.2	4.1	2.5	3.2	6.3	7.6	10.0	3.5	5.5	1.2	2.8	1.1	2.1	7.7	3.1	1.8	13.5	22.5	21.8	0.0	12.2	0.0	1.1	3.0	4.6	0.3	4.5	6.5	4.3	0.5	8.7	4.8	0.0	10.1	3.2	2.2	6.9	1.9	5.7	1.3	8.4	0.0	1.6	2.8	0.3	4.9	2.4	0.5	1.6	3.3	1.4	0.1	6.6	3.4	0.6	0.6	3.5	0.9	13.6	0.9	4.1	5.6	1.4	1.4	0.5	1.4	1.0	0.2	0.0	4.3	3.8	3.9	3.2	2.8	2.6	8.5	5.1	10.0	4.1	6.7	8.0	2.5	3.3	6.8	8.5	2.8	7.6	6.3	0.2	5.5	3.5	4.1	5.0	1.3	3.8	3.7	3.5	4.2	3.2	5.6	3.9
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 22.5;monocytes: 7.8"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: "	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	12.7	5.0	2.8	13.1	3.1	33.0	9.9	1.4	3.2	7.2	8.4	3.2	2.7	6.0	9.2	7.9	3.8	6.9	6.7	6.0	2.4	2.4	4.5	6.0	25.8	17.7	3.8	1.4	7.3	5.1	4.4	5.2	32.6	3.4	5.0	6.5	6.8	7.0	5.7	3.3	4.3	14.0	5.3	4.2	11.9	9.5	2.7	3.1	25.3	5.8	3.5	8.1	4.9	6.8	1.6	2.4	22.5	7.8	1.7	3.7	1.6	6.0	3.6	1.4	0.6	3.7	10.7	7.0	6.1	13.0	23.1	16.1	0.0	14.4	0.1	0.3	6.2	2.4	0.6	3.7	6.7	3.5	0.5	13.4	4.0	0.3	4.5	5.5	3.4	3.0	1.1	8.3	0.7	16.2	0.2	0.1	14.8	0.1	4.9	3.5	0.3	3.0	2.7	3.1	0.0	2.2	3.6	0.2	1.9	10.9	1.3	6.1	1.0	7.7	17.3	1.2	8.2	2.9	2.1	5.9	0.9	0.0	4.1	16.3	1.7	1.6	4.0	3.5	2.7	6.3	3.7	0.9	2.7	2.7	2.4	1.6	2.2	2.3	22.5	1.7	7.8	0.0	3.6	1.6	2.8	3.1	1.4	3.2	2.4	2.4	3.8	1.4	3.4	3.1
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 129.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol			740000	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavourable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.3	5.9	17.4	19.7	12.2	19.9	3.7	9.1	15.7	5.9	9.3	2.3	10.3	7.9	7.2	10.9	7.8	6.4	9.2	9.9	11.9	0.7	19.0	5.3	9.4	15.3	4.1	3.9	15.7	7.1	4.7	8.0	17.7	19.7	15.7	28.5	11.9	11.8	6.1	1.1	17.8	10.0	4.6	14.1	29.2	26.0	0.7	6.6	13.8	129.9	10.9	16.6	10.7	15.9	10.1	4.8	13.3	5.4	7.9	6.0	9.3	9.6	9.4	12.8	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5
DEF8	FLJ20186	ENSG00000140995	"Differentially expressed in FDCP 8 homolog"	Q6ZN54	16	89947925-89968060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041745, HPA049434"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041745: , HPA049434: "	"unprognostic (4.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-2)"	"prognostic favourable (1.35e-7)"	"unprognostic (1.39e-2)"	"prognostic favourable (1.95e-8)"	"unprognostic (9.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.09e-1)"	18.0	15.9	25.4	22.4	23.0	25.3	15.6	42.4	30.6	12.6	16.4	15.4	19.4	12.0	17.1	14.1	22.5	14.3	16.3	23.7	23.7	24.8	14.9	12.2	15.4	42.8	28.0	29.0	18.2	22.5	19.0	18.0	11.5	20.5	14.5	9.2	13.9	21.4	18.9	19.5	27.4	13.6	17.6	23.6	16.6	15.2	8.8	15.0	4.8	14.5	13.6	32.4	15.5	23.8	23.0	27.4	32.0	16.7	5.3	11.5	11.1	15.0	30.9	14.0	19.0	14.5	15.4	16.0	23.5	20.0	34.8	16.2	32.7	18.3	18.3	17.7	16.0	10.0	16.6	27.9	15.5	4.4	47.2	8.2	16.5	46.8	15.7	5.9	13.1	17.3	23.1	24.9	14.7	25.9	26.9	6.2	20.6	55.2	11.6	18.0	17.8	31.6	24.2	10.3	15.7	18.6	14.6	20.8	21.4	37.8	14.1	13.2	13.1	19.3	26.0	20.1	22.0	10.7	24.9	12.2	8.6	23.0	21.5	15.4	23.5	2.3	16.7	32.0	11.5	13.4	10.5	19.6	9.6	8.4	10.7	23.0	6.6	6.4	22.5	5.3	7.6	27.4	11.4	11.1	25.4	23.0	42.4	30.6	23.7	24.8	28.0	29.0	20.5	15.0
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favourable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	11.4	12.2	17.4	13.9	19.8	32.5	10.0	18.6	21.2	10.9	14.8	12.8	10.3	15.8	13.3	9.0	11.3	13.0	10.5	10.3	15.9	12.8	16.4	14.5	9.4	11.6	11.8	14.9	12.0	8.9	20.1	19.0	23.9	13.9	11.0	14.1	14.5	8.5	11.8	11.0	9.3	17.2	14.4	10.1	20.2	9.9	12.1	13.2	10.6	15.5	5.6	9.5	10.6	17.4	1.5	8.4	11.2	15.2	0.5	1.3	3.2	14.7	8.7	7.9	14.9	5.4	8.5	36.6	14.4	21.7	12.3	10.6	11.9	6.6	11.9	3.0	11.6	8.4	6.7	10.4	12.0	5.0	5.1	5.6	21.2	8.7	7.2	6.7	3.8	7.8	9.4	10.1	17.4	10.9	15.3	9.1	9.9	8.4	8.0	9.7	15.7	13.3	12.4	7.7	10.1	6.1	5.2	16.8	13.6	11.6	7.7	8.9	10.5	17.0	5.0	13.3	5.1	15.4	7.5	14.0	10.8	8.2	11.1	13.4	8.7	11.2	15.2	2.8	1.3	10.1	0.7	1.1	0.9	0.6	8.4	1.5	0.6	0.7	9.3	0.5	8.2	1.3	0.4	3.2	17.4	19.8	18.6	21.2	15.9	12.8	11.8	14.9	13.9	13.2
DENND1B	"C1orf218, FAM31B, FLJ20054, MGC27044"	ENSG00000213047	"DENN domain containing 1B"	Q6P3S1	1	197504748-197775696	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042586	Uncertain		Supported	"Nuclear speckles,Cytosol"				Cytosol	"Nuclear speckles"	"HPA042586: "	"unprognostic (8.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.54e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-2)"	5.9	3.9	6.2	12.7	8.3	6.4	8.7	3.9	5.6	5.7	13.0	1.4	8.8	7.5	3.6	6.4	9.0	3.1	5.4	7.3	4.9	4.9	7.9	6.6	7.3	7.8	4.0	2.7	5.6	8.7	9.9	15.9	3.6	3.7	7.5	7.8	6.4	9.9	15.8	6.5	3.8	21.6	4.1	3.5	7.7	6.1	4.4	2.6	17.9	8.2	6.5	11.7	6.9	6.8	2.3	2.0	5.0	0.6	5.8	3.6	0.7	5.9	1.5	1.7	2.9	0.8	4.4	2.7	4.6	3.2	2.8	1.7	1.6	3.8	10.9	2.4	7.0	3.1	2.7	3.3	2.5	8.2	2.9	3.9	3.0	0.7	2.4	12.8	4.9	1.5	4.5	1.1	3.2	1.2	3.0	16.9	2.8	1.1	6.8	6.6	0.6	1.5	4.2	1.5	8.5	7.0	5.6	2.9	4.6	7.1	4.8	1.2	2.0	11.2	3.4	0.3	2.8	0.1	2.7	8.6	0.0	5.5	3.0	5.2	5.3	5.0	0.3	2.3	2.1	0.6	1.1	2.3	1.4	3.3	1.5	0.7	0.8	1.5	1.0	5.8	0.6	2.0	3.6	0.7	6.2	8.3	3.9	5.6	4.9	4.9	4.0	2.7	3.7	2.6
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.7;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.9;HEL: 8.6;HMC-1: 26.9;MOLT-4: 8.3;THP-1: 7.9;U-937: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favourable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (8.95e-4)"	"prognostic favourable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favourable (5.62e-4)"	2.1	1.3	1.5	22.0	2.5	14.1	2.0	0.5	1.6	1.0	2.8	2.5	0.0	3.4	1.0	1.5	1.7	1.7	3.4	1.0	1.3	1.3	2.2	2.0	5.2	30.1	3.1	0.6	0.8	1.0	0.0	1.1	1.3	2.2	1.7	0.8	1.4	5.4	0.8	0.6	1.0	12.1	0.8	2.7	31.3	3.5	0.5	2.7	32.9	1.8	1.2	25.2	3.0	1.5	16.3	12.2	19.0	20.6	14.1	26.7	20.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	12.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	8.6	0.0	0.8	0.0	4.2	26.9	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	8.3	6.5	0.0	0.0	0.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.0	0.0	17.9	0.0	10.4	11.6	19.0	26.7	20.6	23.4	16.3	19.1	22.9	12.2	13.7	24.8	21.6	17.6	14.1	20.0	7.1	21.9	20.2	1.5	2.5	0.5	1.6	1.3	1.3	3.1	0.6	2.2	2.7
DENND2D	"FLJ22457, RP5-1180E21.2"	ENSG00000162777	"DENN domain containing 2D"	Q9H6A0	1	111187174-111204535	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 51.0;lymphoid tissue: 67.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.7;MOLT-4: 51.9;SK-BR-3: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7"	"Group enriched"	"Detected in all"	6	"NK-cells: 45.1;T-cells: 51.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043630, HPA048642"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043630: , HPA048642: "	"unprognostic (1.72e-3)"	"prognostic favourable (1.67e-4)"	"unprognostic (2.60e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (2.70e-4)"	"unprognostic (5.09e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (8.66e-5)"	8.9	11.1	0.9	42.9	2.6	3.5	6.5	0.8	1.6	4.9	10.4	1.4	4.9	6.4	2.4	5.9	19.5	6.4	9.9	2.5	1.0	1.0	11.4	9.3	11.5	42.0	2.6	0.8	3.0	7.5	8.8	8.0	20.2	1.9	9.2	6.9	3.7	21.1	4.7	1.3	7.9	13.8	1.3	3.2	33.8	9.0	5.1	1.8	39.2	8.0	7.0	67.6	15.7	8.2	8.2	3.2	3.5	3.5	45.1	51.0	29.6	10.2	0.4	0.0	0.0	2.5	1.0	0.1	0.6	0.0	1.1	0.2	3.1	5.0	10.9	3.7	1.5	3.2	0.0	0.5	1.1	20.7	0.0	3.2	0.7	0.0	3.8	0.0	3.4	3.0	2.3	0.3	0.0	0.1	0.0	3.4	0.3	8.7	51.9	0.3	0.0	1.4	1.2	0.0	15.8	3.6	11.1	3.7	0.0	3.7	33.7	1.2	9.9	10.3	0.0	0.0	0.0	0.0	0.0	3.1	1.2	8.2	0.0	9.2	0.0	0.8	3.5	2.3	44.8	2.5	38.2	7.2	32.5	45.6	3.2	8.2	51.0	48.4	3.5	45.1	1.8	2.4	13.7	29.6	0.9	2.6	0.8	1.6	1.0	1.0	2.6	0.8	1.9	1.8
DENND3	KIAA0870	ENSG00000105339	"DENN domain containing 3"	A2RUS2	8	141117278-141195808	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.8;HeLa: 33.1;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.0;neutrophil: 22.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024491, HPA041668"		Approved	Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA024491: , HPA041668: "	"unprognostic (2.27e-1)"	"unprognostic (9.62e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.42e-2)"	21.8	6.2	12.2	21.7	15.2	75.9	17.6	1.7	12.3	10.4	17.0	11.5	2.3	5.5	10.3	6.1	6.8	8.3	12.0	8.8	12.1	8.5	12.2	3.9	30.1	27.8	15.9	7.7	8.9	4.7	4.5	5.8	13.0	13.7	9.0	7.4	7.1	10.2	8.3	12.9	8.3	12.7	7.8	21.9	24.7	9.1	4.6	11.8	3.4	11.4	3.5	20.6	9.5	9.8	2.4	2.2	22.2	5.4	1.4	0.4	1.6	6.8	6.2	0.4	1.3	1.9	2.8	1.0	3.9	11.5	1.6	1.3	1.9	6.4	1.8	10.2	7.3	3.5	1.7	4.2	1.1	26.8	1.6	7.1	33.1	0.6	1.7	7.0	1.1	0.2	2.1	1.8	2.3	9.0	0.0	17.3	1.2	2.1	1.0	9.8	0.4	8.1	1.2	0.3	6.7	6.4	2.3	2.0	1.2	0.7	0.5	0.4	2.8	11.3	7.1	0.3	3.1	4.5	0.1	3.5	15.4	0.5	1.1	24.3	0.4	9.3	2.9	18.0	0.4	4.5	0.4	2.4	0.3	0.1	2.2	2.3	0.0	0.1	22.2	1.4	5.4	0.0	0.1	1.6	12.2	15.2	1.7	12.3	12.1	8.5	15.9	7.7	13.7	11.8
DENND4C	"bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF"	ENSG00000137145	"DENN domain containing 4C"	Q5VZ89	9	19230435-19373545	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014917, HPA015096"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles, Cytosol"		"HPA014917: AB_2261659, HPA015096: AB_1845831"	"unprognostic (4.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"prognostic favourable (3.51e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	31.5	14.0	7.4	11.2	9.4	5.8	17.8	17.7	10.4	18.8	17.9	7.3	17.5	17.4	15.0	12.7	15.8	12.5	9.9	13.7	8.0	5.7	10.2	10.1	16.3	7.2	9.1	6.7	16.3	16.0	16.9	18.2	14.6	8.4	14.9	14.5	10.4	16.9	12.2	11.5	20.5	18.4	19.1	8.9	9.8	13.8	9.0	9.6	14.3	12.9	8.3	11.0	22.3	17.7	3.0	4.0	8.5	2.1	8.1	10.2	3.4	11.6	10.9	7.9	10.2	17.3	21.0	14.4	6.7	10.1	7.1	9.5	5.4	7.7	4.9	5.6	8.8	6.3	9.2	5.6	8.7	32.5	5.2	22.6	12.6	6.3	8.6	5.2	12.9	8.2	12.8	6.2	10.6	13.2	6.1	5.7	9.0	4.4	9.2	11.6	5.9	5.5	8.3	4.6	7.1	18.7	22.4	8.0	5.9	6.0	13.5	4.7	8.3	7.1	12.3	6.3	3.5	6.9	6.9	3.9	9.4	2.6	5.2	5.1	3.5	8.5	2.1	2.5	7.8	1.1	10.2	2.5	6.7	7.8	4.0	3.0	6.1	7.3	1.1	8.1	1.1	4.0	4.8	3.4	7.4	9.4	17.7	10.4	8.0	5.7	9.1	6.7	8.4	9.6
DENR	"DRP, DRP1, SMAP-3"	ENSG00000139726	"Density regulated re-initiation and release factor"	O43583	12	122752774-122771064	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021783	Approved		Approved	Cytosol			120000	Cytosol		"HPA021783: "	"unprognostic (3.65e-2)"	"unprognostic (7.00e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (1.58e-7)"	"unprognostic (2.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavourable (8.57e-6)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-1)"	19.5	23.2	23.3	28.3	23.8	19.3	27.1	21.7	36.8	19.1	20.8	12.0	24.8	20.9	20.8	23.6	33.6	17.8	23.1	20.1	22.5	26.1	22.4	26.2	16.8	28.6	24.9	30.3	19.2	21.6	56.5	23.7	27.9	23.2	23.6	21.2	13.2	24.5	24.9	42.5	23.1	21.8	30.4	16.4	24.5	19.0	11.7	14.8	35.5	24.0	28.4	26.9	22.6	22.2	15.5	15.5	57.7	20.8	14.8	17.7	13.7	34.0	19.3	24.6	24.9	15.4	23.0	21.3	31.1	17.2	27.3	19.0	26.7	12.7	30.5	33.0	21.9	26.1	28.7	27.2	36.9	27.5	20.6	37.3	11.4	19.0	20.2	41.8	31.0	19.9	27.0	25.0	33.7	26.4	38.7	11.3	29.1	22.4	41.1	39.8	49.7	39.5	36.6	28.8	19.4	26.5	30.2	28.1	20.2	43.1	12.7	31.6	40.6	23.4	25.6	25.7	30.8	29.0	30.9	18.6	42.9	49.3	24.4	30.4	28.4	57.7	11.7	18.5	13.8	17.2	16.0	15.5	15.0	13.8	15.5	14.0	17.7	15.5	13.9	14.8	20.8	13.8	15.7	13.7	23.3	23.8	21.7	36.8	22.5	26.1	24.9	30.3	23.2	14.8
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6;placenta: 71.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA038255: AB_10669521, HPA072558: "	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favourable (2.42e-4)"	"prognostic unfavourable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (3.08e-4)"	"prognostic unfavourable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.6	0.6	0.6	3.7	1.5	7.9	0.6	0.8	1.4	1.2	3.3	0.6	0.1	4.8	0.9	0.5	5.2	0.4	19.0	0.4	0.8	0.8	3.3	0.9	1.0	6.9	2.3	0.7	0.6	0.5	0.0	0.3	71.5	1.4	0.5	4.6	0.4	1.3	0.1	0.2	2.1	5.1	0.5	3.2	3.3	2.0	17.0	1.2	21.6	1.5	2.3	7.6	0.9	2.2	1.0	0.6	3.3	0.3	1.4	6.4	0.9	23.7	8.1	24.7	15.1	0.5	0.8	27.1	6.4	4.4	11.4	14.8	13.4	15.1	13.6	15.9	1.9	8.0	19.8	14.5	15.3	19.3	14.3	16.9	9.3	16.7	0.4	14.2	16.6	0.5	1.5	3.7	5.3	10.5	12.1	18.6	10.0	14.9	23.0	12.4	18.2	13.2	25.6	20.1	11.6	9.2	11.9	13.8	6.3	15.1	5.4	7.1	10.1	11.3	4.8	4.8	14.3	3.9	16.3	9.4	16.5	26.8	6.0	21.0	13.4	3.3	0.3	1.7	0.5	0.0	0.4	1.0	2.2	1.5	0.6	0.1	0.3	0.3	0.0	1.4	0.0	0.1	6.4	0.9	0.6	1.5	0.8	1.4	0.8	0.8	2.3	0.7	1.4	1.2
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015864-33033582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 51.8;liver: 42.2"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 26.7;RH-30: 20.2;SiHa: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favourable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.5	2.0	1.4	4.1	0.9	2.0	0.5	2.6	1.7	15.3	4.3	1.2	14.1	1.2	1.4	3.1	0.8	3.1	0.9	2.6	1.4	10.9	42.2	0.7	0.4	4.0	1.5	1.3	2.7	3.5	0.8	1.2	2.8	1.4	3.1	1.2	1.7	1.0	3.3	3.4	51.8	1.0	3.2	0.5	2.2	15.6	3.3	1.8	0.6	2.0	0.9	0.9	2.4	0.0	4.4	9.0	0.7	3.0	3.1	0.6	4.5	2.5	3.7	1.6	1.9	1.9	2.4	8.0	2.7	4.9	6.6	6.5	0.4	0.0	1.8	7.9	4.6	5.3	1.9	5.8	0.0	7.4	1.2	7.8	9.2	1.6	4.3	5.5	2.3	2.9	2.8	2.1	0.0	2.9	0.0	26.7	0.5	0.0	7.0	2.4	0.0	0.0	20.2	0.0	1.6	0.6	0.8	2.1	18.4	3.3	15.9	0.8	2.3	0.0	3.2	5.3	17.1	5.1	0.0	0.0	0.0	1.1	0.0	15.6	4.0	0.7	9.0	0.3	0.2	0.0	0.0	0.6	0.3	4.4	0.0	2.9	3.1	0.0	3.0	0.0	1.8	0.0	0.6	2.0	4.1	0.5	2.6	2.6	1.4	4.0	1.5	2.8	3.3
DESI1	"D15Wsu75e, FAM152B, PPPDE2"	ENSG00000100418	"Desumoylating isopeptidase 1"	Q6ICB0	22	41598028-41621096	"Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053415	Approved		Approved	"Cytokinetic bridge,Cytosol"				Cytosol	"Cytokinetic bridge"	"HPA053415: "	"unprognostic (1.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-2)"	"prognostic favourable (7.70e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.16e-3)"	"unprognostic (8.75e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	12.9	14.5	24.6	12.6	25.4	8.4	13.4	17.0	33.3	11.7	11.9	22.8	9.5	14.5	10.4	15.1	19.7	11.3	11.5	30.3	24.3	19.7	19.5	69.2	14.0	13.2	23.5	16.3	12.7	13.2	15.7	10.0	11.8	18.3	13.4	14.0	9.7	13.2	14.4	14.6	15.9	16.1	14.5	22.4	11.3	12.6	29.2	19.0	9.7	9.7	14.6	16.8	10.8	9.2	6.2	7.4	10.6	12.5	2.8	7.3	5.5	7.1	7.6	7.6	10.4	10.8	12.9	4.3	14.4	9.3	13.4	9.9	10.0	4.6	27.2	10.0	16.6	10.4	20.1	16.1	14.1	12.2	15.4	6.1	14.1	8.4	13.2	24.0	8.3	11.0	18.9	16.5	15.4	20.2	17.7	31.0	10.6	9.0	5.4	7.3	7.5	11.5	7.4	3.2	27.8	16.9	4.6	5.4	2.8	13.9	15.3	9.8	5.0	7.9	20.4	10.0	7.2	10.5	7.0	11.4	8.8	13.0	24.6	10.6	13.1	9.5	9.3	10.6	5.0	12.5	6.4	6.2	6.2	5.9	7.4	5.4	5.6	6.5	5.5	2.8	8.2	4.4	7.3	5.5	24.6	25.4	17.0	33.3	24.3	19.7	23.5	16.3	18.3	19.0
DET1	FLJ10103	ENSG00000140543	"DET1, COP1 ubiquitin ligase partner"	Q7L5Y6	15	88494440-88546675	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Microtubules"	"Cytokinetic bridge, Cytosol"	"HPA048873: "	"unprognostic (9.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.67e-2)"	6.0	9.3	5.5	4.3	7.0	1.9	6.4	5.5	6.8	9.5	6.3	8.2	7.0	5.5	15.9	9.1	3.8	9.6	7.8	8.8	4.3	4.2	5.4	4.5	4.3	4.2	5.0	6.1	17.9	10.1	7.1	6.4	5.6	5.9	8.5	5.6	12.6	6.7	7.4	13.8	4.4	5.9	11.4	5.1	4.4	5.5	3.6	4.6	10.7	6.8	4.1	6.4	7.7	6.0	5.3	7.6	2.9	7.4	3.4	6.6	3.8	2.0	6.7	9.5	6.9	4.7	7.1	1.8	6.5	7.0	5.7	6.0	1.4	6.3	3.9	5.0	8.3	3.1	10.7	2.0	4.9	0.3	6.9	7.4	3.7	2.3	7.4	2.8	1.5	6.1	7.2	2.7	7.8	4.4	9.4	4.7	7.1	3.2	4.0	3.1	4.3	2.1	4.7	7.8	4.8	3.0	5.9	3.7	5.8	7.3	2.5	16.2	3.6	5.9	3.6	5.8	4.5	5.9	6.0	2.7	1.9	2.6	6.5	4.8	5.1	0.0	4.8	2.9	5.3	7.4	3.9	4.8	4.6	4.7	7.6	5.3	6.6	5.4	0.7	3.4	4.6	4.1	5.1	3.8	5.5	7.0	5.5	6.8	4.3	4.2	5.0	6.1	5.9	4.6
DEXI	MYLE	ENSG00000182108	"Dexi homolog"	O95424	16	10928891-10942460	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041511	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA041511: AB_10796675"	"unprognostic (4.14e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.47e-2)"	"prognostic favourable (4.23e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.83e-2)"	15.0	25.2	15.7	8.0	20.8	4.1	10.7	14.0	27.5	12.2	13.9	9.8	12.7	11.1	11.7	18.5	12.9	14.5	11.6	32.2	13.1	13.6	13.3	26.3	9.5	9.9	18.8	12.3	15.9	18.0	22.1	12.9	13.3	21.3	13.6	6.6	13.7	15.4	16.6	81.6	10.3	11.1	12.1	9.4	12.7	10.6	8.9	11.9	13.7	18.4	10.6	8.1	10.9	10.5	4.0	2.4	8.2	0.7	3.9	7.0	1.2	9.3	13.7	7.4	13.0	30.2	16.6	6.8	14.5	15.1	9.5	9.1	6.4	9.9	11.2	21.9	16.4	12.2	8.7	15.6	8.2	26.2	19.5	5.5	9.0	27.1	17.3	9.5	10.5	16.9	18.0	9.3	10.8	13.7	12.6	11.2	10.5	16.5	11.8	10.3	10.3	14.3	11.0	9.8	17.1	11.8	7.0	15.3	13.5	13.8	15.3	11.5	12.1	16.5	14.9	9.6	10.4	22.7	9.4	14.9	11.4	3.2	8.4	20.4	10.8	1.7	0.6	8.2	6.0	0.7	5.6	0.6	5.2	7.0	0.4	4.0	6.4	6.0	0.7	3.9	0.3	2.4	3.9	1.2	15.7	20.8	14.0	27.5	13.1	13.6	18.8	12.3	21.3	11.9
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472526	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	17.8	19.9	22.9	15.6	23.0	7.9	20.9	20.4	20.7	16.6	15.1	22.5	19.1	16.5	18.4	14.4	24.2	18.6	15.3	17.2	20.7	19.9	23.7	18.9	15.5	15.6	26.4	18.9	22.5	19.8	25.7	17.2	27.2	26.1	17.0	17.3	15.0	16.3	18.4	16.8	14.8	14.7	22.4	24.1	14.8	16.8	13.4	21.9	16.7	18.0	13.0	21.4	18.7	26.1	14.1	10.7	7.2	9.9	14.1	14.4	8.9	14.3	14.4	12.4	14.1	10.5	10.0	6.0	20.6	13.3	21.5	16.0	34.3	19.1	30.8	13.3	17.3	11.9	23.9	24.4	21.8	12.2	16.5	15.3	14.9	13.7	17.2	18.7	10.2	12.5	12.3	33.8	27.3	16.3	27.4	7.0	15.2	18.3	18.4	8.5	10.9	16.8	15.9	14.8	15.5	19.3	11.1	14.7	14.3	19.1	16.8	22.6	10.7	6.5	17.0	10.1	13.8	18.5	13.5	8.7	12.1	44.9	10.7	17.8	15.2	1.3	9.9	7.2	14.4	8.0	10.9	14.1	9.7	12.4	9.2	13.7	10.2	12.3	1.5	14.1	9.7	10.7	13.5	8.9	22.9	23.0	20.4	20.7	20.7	19.9	26.4	18.9	26.1	21.9
DGKD	"DGKdelta, KIAA0145"	ENSG00000077044	"Diacylglycerol kinase delta"	Q16760	2	233354507-233472104	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 22.1;U-698: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027530, HPA049101"	Approved		Supported	Cytosol				Cytosol		"HPA027530: , HPA049101: "	"unprognostic (1.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavourable (1.69e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (4.07e-8)"	"unprognostic (1.78e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.94e-3)"	5.9	3.6	10.0	10.9	12.4	26.3	5.3	34.3	7.9	3.7	7.8	8.9	12.4	8.1	5.8	12.6	2.7	5.5	8.0	6.4	9.6	4.3	3.1	3.3	9.3	14.0	11.7	4.3	8.6	3.0	2.3	3.7	8.9	7.2	6.0	8.4	6.2	4.9	8.0	25.4	2.9	10.9	7.3	11.1	10.3	19.4	17.4	8.3	4.5	7.6	1.3	13.5	5.6	10.1	6.6	1.0	5.9	2.0	1.8	3.4	2.5	3.2	8.0	4.7	3.0	2.2	2.2	7.2	1.9	1.7	1.8	1.9	13.8	3.2	5.8	1.0	3.0	3.2	5.1	2.3	3.0	8.7	4.8	8.1	22.1	4.7	2.8	7.0	8.8	3.1	4.9	2.3	4.4	2.0	5.7	1.3	1.9	3.1	5.7	7.3	2.5	4.5	11.4	8.7	4.7	1.4	3.8	7.2	5.2	6.5	3.5	3.4	1.5	12.5	1.9	3.9	7.2	2.3	5.8	4.7	2.9	22.4	3.4	10.9	3.0	1.7	2.0	5.9	3.3	0.8	1.6	6.3	1.0	2.9	1.0	6.6	2.3	3.4	2.0	1.8	1.4	0.6	0.5	2.5	10.0	12.4	34.3	7.9	9.6	4.3	11.7	4.3	7.2	8.3
DGKE	"DAGK6, DGK"	ENSG00000153933	"Diacylglycerol kinase epsilon"	P52429	17	56834099-56869567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 42.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017167	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017167: AB_1847638"	"unprognostic (1.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.92e-5)"	"unprognostic (4.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-3)"	7.8	4.9	7.8	8.3	17.7	5.5	5.2	21.3	18.6	9.5	7.4	4.4	5.6	5.4	13.3	8.9	5.0	8.2	9.4	4.9	7.4	9.2	4.2	4.9	8.1	9.3	5.6	10.0	7.3	6.5	9.5	14.5	5.5	9.9	8.9	7.0	17.4	4.3	7.3	2.4	3.4	7.1	9.3	6.8	12.7	6.4	12.5	5.4	14.5	8.3	2.5	8.6	6.5	15.3	2.4	2.4	1.2	0.8	1.9	4.5	0.8	1.6	1.6	1.5	0.1	0.2	0.5	0.7	2.8	2.3	1.9	2.3	3.7	2.0	2.4	3.5	1.5	2.0	3.6	1.5	4.0	7.8	4.6	3.1	3.9	2.4	1.7	6.0	4.5	0.9	2.0	2.0	4.1	2.6	2.5	42.7	2.4	2.4	14.2	3.4	1.1	4.8	4.4	6.2	5.8	1.9	3.7	2.3	1.6	2.3	1.2	0.1	2.6	2.9	2.4	0.5	2.7	0.8	0.4	5.6	11.5	1.6	1.7	3.5	0.1	0.3	0.5	0.0	2.7	0.4	2.0	2.4	1.9	2.3	0.6	0.9	1.9	2.5	1.2	1.9	0.8	2.4	4.5	0.8	7.8	17.7	21.3	18.6	7.4	9.2	5.6	10.0	9.9	5.4
DGLUCY	"C14orf159, FLJ39975"	ENSG00000133943	"D-glutamate cyclase"	Q7Z3D6	14	91060333-91225632	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 57.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041423, HPA052932"	Approved		Supported	Cytosol				Cytosol		"HPA041423: AB_10795540, HPA052932: "	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (4.28e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favourable (9.48e-5)"	"unprognostic (3.56e-1)"	"prognostic favourable (7.28e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.77e-15)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.57e-3)"	12.5	18.7	23.4	15.9	23.1	10.7	9.3	27.3	22.6	14.6	16.7	18.1	16.0	13.8	16.8	13.1	16.0	21.9	12.5	63.9	18.8	16.6	20.1	13.1	13.7	11.2	20.1	19.2	13.4	9.3	29.3	14.2	9.2	19.0	13.3	17.0	11.3	17.4	22.3	82.9	13.9	12.3	20.0	18.5	17.3	18.9	12.2	21.6	11.2	16.8	29.1	14.1	19.4	11.4	9.4	19.8	57.9	19.3	5.6	12.0	7.0	2.7	7.4	3.8	9.1	15.5	14.7	9.9	2.8	8.0	8.9	9.2	4.8	21.4	18.5	21.5	8.5	8.2	10.4	11.3	3.7	10.2	4.3	12.4	3.7	6.1	22.8	12.6	18.1	22.6	4.9	4.9	1.9	15.8	6.2	25.3	8.4	0.7	9.9	12.0	7.6	0.7	17.1	7.4	13.4	15.1	11.7	10.5	5.3	4.8	8.3	3.4	14.7	10.7	11.3	2.7	2.3	8.0	2.6	14.5	10.3	6.2	13.9	16.6	1.7	13.7	13.6	8.1	8.8	19.3	9.0	9.4	5.9	7.2	19.8	7.0	4.9	6.0	57.9	5.6	15.5	6.2	12.0	7.0	23.4	23.1	27.3	22.6	18.8	16.6	20.1	19.2	19.0	21.6
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	Cytosol	"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favourable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (5.67e-4)"	8.0	40.1	12.1	5.6	14.5	19.0	16.8	5.3	22.8	5.5	9.3	27.9	8.8	20.8	4.0	27.3	14.6	5.2	5.8	10.7	13.7	13.2	7.1	64.8	12.0	2.7	20.6	12.3	21.5	7.3	14.0	7.0	3.7	23.4	10.0	6.6	16.6	10.0	3.9	5.4	22.9	15.8	4.5	20.5	5.9	8.5	17.7	15.5	2.8	5.4	12.1	7.7	4.3	7.4	6.3	6.2	3.5	1.9	4.6	12.1	5.7	21.6	19.6	19.2	21.2	9.0	14.0	6.0	8.9	23.8	7.6	20.8	73.0	71.1	15.1	14.3	8.5	41.6	22.8	48.3	8.1	5.7	17.1	5.7	16.6	31.2	23.1	10.8	2.8	16.2	21.4	28.6	19.7	11.2	27.0	32.3	7.6	58.1	8.9	12.2	27.5	11.7	8.1	27.0	65.0	28.6	32.7	26.1	9.7	8.5	28.2	20.3	27.3	5.9	10.6	2.1	11.6	0.6	10.7	10.7	12.9	16.1	6.1	19.2	8.6	3.5	1.9	1.7	9.7	1.2	11.8	6.3	8.2	9.0	2.5	5.4	10.5	12.1	1.0	4.6	1.2	6.2	5.1	5.7	12.1	14.5	5.3	22.8	13.7	13.2	20.6	12.3	23.4	15.5
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 72.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	5.9	4.2	4.7	8.8	5.1	2.9	5.0	2.7	5.0	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3.0	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4.0	2.6	5.2	3.9	4.8	5.9	6.0	4.4	11.7	4.0	3.0	7.5	4.0	3.5	3.4	4.3	5.4	4.0	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.3	15.4	4.5	7.4	2.4	3.2	8.5	6.3	2.5	9.6	7.4	12.1	6.8	16.6	8.6	3.4	7.8	8.8	6.8	11.3	3.7	8.3	9.1	7.5	11.8	6.8	12.6	6.7	3.1	7.0	11.6	12.2	6.9	13.9	3.0	5.8	19.6	11.9	12.1	10.1	6.0	15.1	5.9	17.5	5.8	4.9	5.3	6.3	8.5	9.1	4.1	8.1	6.4	3.0	8.8	5.5	8.3	9.2	5.8	10.8	28.1	4.6	13.8	8.0	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9.0	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5.0	4.3	3.0	4.8	2.7	5.2	5.4
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681902	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	16.4	30.3	26.9	18.6	31.2	17.0	24.8	43.3	38.8	20.7	25.7	27.5	25.3	23.1	20.9	16.9	21.3	32.3	18.2	26.0	26.3	28.0	23.4	30.3	18.9	24.2	27.5	28.0	34.8	32.0	28.8	32.6	23.2	22.4	24.1	24.5	20.2	24.8	24.6	65.1	25.6	21.5	24.5	29.1	19.5	24.2	13.3	26.3	31.9	24.9	22.9	26.9	23.5	19.2	39.6	29.5	35.8	30.5	27.8	38.1	29.7	20.7	15.3	24.9	13.2	11.2	18.5	5.8	13.3	19.6	25.5	25.7	10.9	10.1	21.5	15.1	14.5	12.6	17.0	18.9	17.6	18.8	12.0	14.3	16.7	14.3	13.8	17.1	22.9	14.9	23.3	15.4	26.6	17.8	13.0	15.3	18.6	41.2	30.5	24.8	19.5	26.1	20.3	9.3	31.0	19.6	11.2	32.4	44.0	13.4	19.5	22.6	18.1	28.7	8.9	30.0	12.2	29.3	20.2	48.9	52.7	14.6	18.4	21.1	28.3	14.5	27.0	35.8	24.7	24.2	25.9	39.6	28.9	25.6	29.0	36.9	38.1	28.1	9.7	27.8	30.5	29.5	34.3	29.7	26.9	31.2	43.3	38.8	26.3	28.0	27.5	28.0	22.4	26.3
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299833	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000599	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655"	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favourable (1.18e-5)"	"prognostic favourable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	6.5	8.9	3.0	6.1	5.0	3.3	7.4	6.3	6.0	8.6	12.0	9.8	8.4	16.1	6.7	8.9	35.7	5.4	10.2	3.7	2.7	3.1	8.5	47.1	6.7	4.8	3.6	5.3	4.2	10.7	11.5	5.2	4.1	6.0	5.5	5.4	7.1	14.0	15.6	1.8	20.8	25.7	4.8	4.4	6.3	6.1	2.8	3.7	5.6	6.6	25.6	16.5	6.0	13.0	10.4	10.7	17.3	9.5	4.2	11.7	4.7	11.0	2.6	2.9	1.1	6.7	7.1	0.7	3.9	8.7	9.4	10.2	1.0	10.7	5.2	1.7	6.1	9.0	2.1	18.3	4.5	3.5	2.3	1.5	6.4	17.4	3.1	3.1	1.2	6.4	10.7	2.3	1.7	7.0	3.2	4.9	7.6	4.4	1.1	1.1	0.5	4.0	3.9	2.0	7.1	7.2	4.1	2.5	1.8	5.6	7.6	1.9	3.9	0.9	2.7	0.7	1.8	1.1	1.3	2.8	2.2	2.5	3.3	2.7	0.9	10.0	8.7	17.3	6.9	9.5	7.5	10.4	7.5	6.3	10.7	7.0	7.6	4.2	5.7	4.2	5.9	6.4	11.7	4.7	3.0	5.0	6.3	6.0	2.7	3.1	3.6	5.3	6.0	3.7
DHRS11	"MGC4172, SDR24C1"	ENSG00000278535	"Dehydrogenase/reductase 11"	Q6UWP2	17	36591798-36600806	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"intestine: 88.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041226, HPA048236, HPA053623"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"		11000	Cytosol	"Golgi apparatus"	"HPA041226: , HPA048236: , HPA053623: "	"unprognostic (2.00e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.11e-2)"	"prognostic favourable (3.24e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	1.3	0.6	1.2	4.1	2.4	0.4	0.7	0.5	5.7	0.4	38.7	0.4	0.4	42.7	0.4	0.1	1.2	1.1	1.4	2.0	0.5		2.5	1.7	0.1	0.0	0.0	2.4	0.1	2.8	1.5	0.2	0.0	1.6	0.5	12.4	2.8	2.1	0.8	2.0	0.8	88.0	0.9	0.1	0.0	1.1	2.2	0.3	0.0	1.3	1.3	1.0	0.4	0.0	0.9	0.2	0.9	0.7	0.1	2.7	0.1	6.5	5.9	2.8	7.4	0.6	1.7	5.5	2.0	1.4	6.4	5.8	9.6	5.3	0.7	1.4	2.0	6.9	6.0	4.1	6.5	3.4	11.4	1.7	5.7	18.6	3.1	1.9	0.6	0.9	3.9	4.4	3.3	4.9	15.6	5.8	3.5	5.8	6.4	3.5	2.2	2.3	8.0	7.0	11.0	6.5	5.6	6.0	2.6	7.0	7.3	16.4	10.0	1.8	1.8	0.9	9.1	4.8	5.0	9.5	8.0	2.3	3.3	4.7	2.8	0.4	0.5	0.9	1.0	0.7	0.1	0.4	1.0	0.6	0.1	0.9	1.3	0.9	0.5	0.1	0.1	0.2	2.7	0.1										
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	15.9	17.8	14.0	10.3	14.5	2.5	16.2	11.1	15.2	17.6	14.2	11.9	16.7	14.4	13.5	25.3	12.8	15.4	16.3	17.9	11.8	13.2	23.1	18.4	13.9	14.0	14.5	14.8	11.8	18.9	31.2	11.4	14.2	12.9	14.8	15.2	16.5	17.5	10.5	23.7	15.7	18.3	12.7	11.1	11.5	14.7	30.5	9.1	8.0	19.7	15.8	10.9	10.7	12.8	4.2	11.7	15.0	20.4	4.1	5.7	7.5	10.0	11.9	4.4	9.5	11.6	8.0	7.6	9.6	5.4	7.0	12.9	15.0	10.6	4.2	14.7	8.2	14.3	6.4	15.7	10.0	8.1	20.6	5.8	8.8	12.8	6.4	3.2	4.3	6.2	10.5	9.0	13.7	6.8	3.5	5.3	8.2	20.7	3.5	12.7	6.0	5.1	5.9	11.5	7.4	23.4	12.2	2.4	5.1	11.9	10.6	10.3	7.1	6.7	3.4	5.9	4.1	17.6	10.8	2.9	4.5	7.9	9.2	12.0	8.7	9.7	18.9	15.0	3.8	17.9	3.4	4.2	3.8	2.5	11.7	3.6	4.1	3.6	13.5	4.1	20.4	5.0	5.7	7.5	14.0	14.5	11.1	15.2	11.8	13.2	14.5	14.8	12.9	9.1
DHRSX	"DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6"	ENSG00000169084	"Dehydrogenase/reductase X-linked"	Q8N5I4	X	2219516-2502805	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003035	Approved		Approved	"Actin filaments,Cytosol"	"Secreted to blood"			"Actin filaments, Cytosol"		"HPA003035: AB_1080631"	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.69e-2)"	7.3	9.5	21.5	3.1	26.7	2.9	55.7	21.5	25.3	32.1	7.3	1.2	1.2	4.6	25.1	6.4	3.2	7.5	6.7	37.8	23.7	3.4	34.6	18.9	5.8	3.2	21.8	16.9	25.0	15.2	5.5	24.2	32.7	28.3	7.7	6.5	1.2	10.8	5.7	6.3	4.9	6.5	5.3	26.5	5.9	8.6	3.4	23.6	1.2	8.1	1.2	2.7	6.1	27.4	12.2	18.3	30.0	21.1	8.7	9.1	10.0	4.5	20.8	14.0	6.5	17.6	11.0	10.6	10.4	17.6	8.0	10.8	15.5	9.9	7.2	13.4	12.3	2.2	9.7	8.4	5.6	13.3	15.0	7.0	10.9	11.6	20.2	3.8	5.6	13.6	10.4	6.9	6.9	6.3	7.6	3.6	12.8	5.2	13.9	5.3	3.4	5.8	5.4	7.4	2.0	8.6	11.1	13.4	13.4	9.9	11.8	7.7	5.1	6.0	8.5	8.7	2.1	4.9	6.1	4.2	0.0	18.8	5.8	5.0	3.9	6.5	21.1	17.1	8.4	15.7	8.9	12.2	7.6	7.0	18.3	10.6	7.2	6.0	30.0	8.7	9.5	14.8	9.1	10.0	21.5	26.7	21.5	25.3	23.7	3.4	21.8	16.9	28.3	23.6
DHX29	DDX29	ENSG00000067248	"DExH-box helicase 29"	Q7Z478	5	55256245-55307722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038317, HPA038318"	Approved		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA038317: AB_10673169, HPA038318: AB_10672589"	"unprognostic (3.43e-2)"	"unprognostic (5.09e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.01e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.78e-3)"	"unprognostic (9.40e-2)"	14.6	16.2	15.1	12.2	16.6	9.8	16.3	22.0	16.9	17.3	18.4	9.2	20.2	11.3	17.4	12.8	18.5	13.6	11.7	22.1	12.8	9.6	22.4	20.6	15.2	11.8	13.7	11.9	13.8	15.3	30.3	30.7	17.7	16.3	18.9	13.3	7.8	15.2	24.3	31.8	15.9	14.7	18.5	13.1	14.3	14.8	10.2	16.6	15.6	20.9	12.0	11.9	19.9	14.4	18.5	25.9	32.4	19.6	16.0	18.8	6.3	22.2	15.7	13.1	17.3	21.6	18.2	16.1	23.8	18.8	17.5	18.2	12.8	14.6	13.0	21.7	26.7	16.5	20.6	23.1	25.2	5.3	11.6	12.0	14.6	8.9	12.4	8.0	12.8	15.9	14.3	18.7	11.3	23.0	14.6	10.0	20.9	15.4	14.0	8.0	11.1	17.6	6.8	20.6	21.5	15.2	15.4	12.2	8.3	23.6	13.0	11.8	18.4	14.8	20.1	16.1	13.6	14.4	17.3	9.6	14.4	17.7	19.8	13.9	18.1	32.4	16.3	15.9	13.5	16.4	15.1	18.5	16.9	15.0	12.1	17.6	18.8	15.8	15.2	16.0	19.6	25.9	13.9	6.3	15.1	16.6	22.0	16.9	12.8	9.6	13.7	11.9	16.3	16.6
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favourable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	18.4	18.7	22.1	18.5	31.1	23.6	18.3	31.2	43.5	22.3	17.8	26.9	15.5	17.3	23.3	14.8	21.0	24.8	17.9	21.3	19.1	19.8	18.6	19.3	16.7	22.0	20.4	28.0	27.1	21.2	37.3	24.8	20.6	23.6	20.4	13.0	22.0	20.4	23.6	27.1	26.2	16.1	18.8	15.3	21.2	18.7	54.4	18.4	23.8	20.1	15.2	16.9	18.6	17.6	9.9	13.0	9.8	10.5	8.2	16.1	11.6	8.1	20.7	20.5	21.1	9.5	7.9	14.0	15.4	13.2	26.6	19.2	23.8	17.4	26.5	12.1	15.0	12.5	30.3	21.5	9.5	18.0	36.3	23.1	30.5	23.2	16.5	21.5	24.0	13.8	13.7	28.1	19.8	17.3	32.5	17.1	12.4	22.0	27.3	23.6	22.8	35.4	18.2	11.0	23.5	13.3	20.7	16.9	22.5	15.0	21.4	11.1	15.0	22.6	12.0	16.1	20.9	18.1	28.2	20.7	25.8	24.1	16.7	18.8	19.9	9.8	10.1	7.2	15.0	10.3	13.0	9.9	12.7	16.1	13.0	9.3	12.1	13.0	1.5	8.2	10.5	7.8	14.3	11.6	22.1	31.1	31.2	43.5	19.1	19.8	20.4	28.0	23.6	18.4
DHX36	"DDX36, KIAA1488, MLEL1"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324497	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035399	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	16.3	14.0	11.5	14.1	27.5	12.6	15.7	19.0	21.3	17.9	14.7	10.3	12.4	10.7	20.4	10.6	14.5	14.3	13.7	23.9	13.4	12.7	16.7	17.1	14.6	17.0	12.2	15.0	20.0	13.7	34.0	36.2	16.4	20.1	15.7	12.2	9.3	15.5	20.5	53.4	14.7	14.3	15.1	13.7	18.9	13.4	28.3	11.3	24.3	20.4	13.4	17.1	20.7	15.6	6.3	5.9	3.1	5.7	4.8	6.9	1.1	26.7	18.3	24.9	14.3	11.7	16.5	12.4	17.5	17.6	20.0	23.9	18.6	21.5	26.0	28.4	15.3	17.3	23.4	14.8	31.5	24.9	15.5	18.8	15.7	10.5	19.9	26.1	16.5	18.6	12.6	21.4	26.3	17.1	17.7	15.0	18.4	13.0	21.6	5.7	33.0	17.6	22.5	20.9	37.4	14.3	19.0	23.3	24.8	18.2	19.4	25.4	19.9	13.3	19.3	21.0	13.2	19.6	34.9	28.1	18.1	37.5	17.0	13.7	22.2	1.9	2.7	3.1	6.9	2.8	4.4	4.7	6.1	4.7	2.3	6.3	5.8	6.0	1.1	4.8	5.7	5.9	5.4	1.1	11.5	27.5	19.0	21.3	13.4	12.7	12.2	15.0	20.1	11.3
DHX57	DDX57	ENSG00000163214	"DExH-box helicase 57"	Q6P158	2	38797729-38875934	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036160	Uncertain		Approved	"Nucleoli,Intermediate filaments,Microtubules,Cytosol"				"Intermediate filaments, Microtubules"	"Nucleoli, Cytosol"	"HPA036160: AB_10670711"	"unprognostic (6.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (3.32e-6)"	"unprognostic (1.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.77e-1)"	9.6	11.2	9.7	8.5	16.7	7.0	10.4	11.9	16.4	14.1	9.4	9.9	9.8	4.2	13.9	17.1	8.4	11.2	9.5	9.3	9.6	11.0	11.2	7.2	7.9	9.2	8.9	9.5	13.2	9.5	18.9	17.9	11.2	13.1	10.5	9.2	11.6	7.8	14.2	11.5	11.1	6.9	11.8	7.7	9.9	7.9	27.7	8.3	13.9	11.8	8.1	11.1	10.5	8.3	7.1	5.2	1.7	10.1	3.3	6.0	4.2	16.9	13.6	15.2	11.4	10.0	12.4	12.5	11.8	11.6	11.2	11.0	10.9	5.2	4.9	11.9	12.0	8.8	17.2	13.0	18.4	20.4	12.7	9.6	9.1	14.8	9.1	10.1	5.6	11.8	7.9	14.5	9.1	14.9	12.3	7.0	12.1	12.3	10.1	9.3	19.0	8.1	5.0	20.2	9.7	10.3	6.5	12.6	18.5	11.8	12.2	13.8	8.5	5.6	11.4	11.1	12.9	8.5	12.6	7.4	8.2	2.1	8.7	7.1	7.4	1.7	10.1	1.7	4.5	6.9	6.0	5.7	4.0	3.5	5.2	7.1	4.8	3.0	0.5	3.3	8.0	1.7	3.3	4.2	9.7	16.7	11.9	16.4	9.6	11.0	8.9	9.5	13.1	8.3
DHX58	"D11LGP2, LGP2"	ENSG00000108771	"DExH-box helicase 58"	Q96C10	17	42101404-42112733	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 24.4;BJ hTERT+ SV40 Large T+ RasG12V: 28.5;SK-MEL-30: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018670, HPA019570"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA018670: AB_1847665, HPA019570: AB_1847666"	"prognostic favourable (3.45e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-3)"	12.7	16.3	6.7	15.3	7.8	11.1	9.8	2.8	8.4	7.9	9.8	9.6	15.0	8.2	9.6	16.2	8.7	12.0	12.6	5.3	6.5	5.3	11.0	20.9	21.7	14.4	5.9	9.0	12.9	7.4	4.3	9.6	7.0	8.2	10.6	5.0	13.4	18.0	17.1	6.9	7.8	10.5	9.2	7.9	17.1	9.1	10.7	5.1	17.2	7.5	5.6	12.9	10.9	7.6	6.4	7.6	8.6	12.0	7.6	7.1	5.9	1.2	0.0	0.0	0.7	6.2	5.3	0.2	1.7	11.8	24.4	28.5	0.1	7.6	0.1	1.8	2.8	1.0	0.1	1.9	0.9	4.7	0.1	2.0	1.1	0.4	6.9	1.8	4.6	8.6	3.2	2.1	2.1	2.9	0.0	6.7	1.3	0.0	10.9	2.2	0.2	0.0	3.9	0.0	0.5	2.7	4.4	0.2	0.0	0.7	3.1	13.9	4.2	1.9	1.2	1.2	0.0	0.4	0.6	2.3	1.9	0.1	2.4	1.7	1.3	3.1	9.9	8.6	4.5	12.0	6.5	6.4	6.4	4.0	7.6	4.9	7.1	5.3	4.0	7.6	10.5	2.5	5.5	5.9	6.7	7.8	2.8	8.4	6.5	5.3	5.9	9.0	8.2	5.1
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol				Cytosol		"CAB068185: , HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	23.2	12.5	18.4	22.4	33.3	20.5	23.2	28.5	29.9	19.0	18.1	31.4	22.4	13.0	20.8	20.6	23.4	18.5	16.2	15.3	22.0	14.1	19.5	23.6	22.4	20.3	29.7	19.6	23.8	19.8	26.9	30.9	29.9	23.2	20.3	19.7	14.5	19.5	18.9	28.0	20.7	17.3	19.0	26.8	20.7	17.1	20.6	32.0	17.0	23.8	14.7	20.3	20.7	24.1	2.5	1.8	10.7	7.2	1.2	3.3	1.0	12.8	13.4	25.1	9.3	6.5	9.8	19.9	10.6	6.4	6.8	8.2	17.0	9.9	14.5	11.5	9.8	15.2	19.9	10.0	14.2	22.5	8.9	21.9	7.4	12.2	6.6	13.4	13.5	9.1	8.3	9.1	13.9	10.1	9.2	12.9	11.4	18.0	15.0	8.9	7.1	6.6	12.0	20.5	8.0	9.0	20.5	20.8	11.8	10.7	11.0	12.0	12.4	9.9	10.0	5.2	10.3	10.1	11.9	14.8	21.1	20.6	5.4	10.9	9.3	3.1	3.0	1.2	1.6	3.1	3.3	1.9	1.5	1.2	1.8	2.5	1.5	1.3	10.7	1.2	7.2	1.6	1.6	1.0	18.4	33.3	28.5	29.9	22.0	14.1	29.7	19.6	23.2	32.0
DIDO1	"BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333"	ENSG00000101191	"Death inducer-obliterator 1"	Q9BTC0	20	62877738-62937952	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004374, HPA049904"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB004374: AB_2093108, HPA049904: "	"unprognostic (9.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.68e-1)"	"prognostic favourable (5.13e-4)"	"unprognostic (9.92e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (3.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.82e-2)"	25.1	15.9	19.7	21.5	21.3	22.8	26.9	38.1	23.2	29.7	24.0	27.0	26.7	18.4	33.2	26.9	20.7	29.2	27.0	23.2	17.9	14.7	18.2	18.3	22.9	27.5	22.9	18.8	37.4	21.4	28.0	25.1	30.6	17.6	24.3	19.2	27.0	26.3	25.5	27.6	34.0	25.2	27.5	17.5	25.8	21.2	24.1	23.1	35.1	25.1	20.5	29.6	26.1	35.6	9.7	8.6	20.9	7.6	10.1	15.3	7.1	11.6	9.0	15.2	8.6	7.8	9.6	8.1	8.8	7.5	32.9	9.5	38.6	12.1	11.5	12.2	10.8	18.3	13.8	17.1	21.4	6.3	9.3	16.6	14.9	27.5	9.9	14.8	17.2	9.8	23.6	11.4	6.4	9.0	16.2	10.6	8.3	11.3	30.0	13.1	12.1	13.2	21.3	19.4	7.3	5.4	10.4	18.7	11.1	17.7	17.2	11.6	17.1	17.0	11.2	26.9	18.8	8.9	12.5	7.1	4.6	15.4	12.2	7.5	9.7	20.9	5.6	15.1	12.9	7.6	13.3	9.7	11.3	12.3	4.1	8.2	15.3	14.1	8.6	10.1	5.8	8.6	9.0	7.1	19.7	21.3	38.1	23.2	17.9	14.7	22.9	18.8	17.6	23.1
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIM1 dimethyladenosine transferase 1 homolog"	Q9UNQ2	5	62387254-62403939	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA042944: "	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavourable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.7	14.0	18.9	16.7	17.0	10.6	18.9	11.5	23.5	18.6	11.8	12.4	11.8	11.0	16.2	11.9	20.1	14.2	15.3	19.7	19.1	17.0	11.9	16.3	11.7	22.5	18.8	8.5	17.8	28.4	8.9	13.4	16.7	12.3	18.8	9.5	10.0	16.1	18.3	17.9	12.2	11.9	24.6	20.2	22.1	10.2	10.7	9.8	16.3	19.0	19.0	19.2	21.7	13.2	7.9	7.7	5.0	5.6	7.0	13.2	6.1	14.4	8.7	15.9	20.8	11.8	15.7	15.9	18.6	7.0	14.4	15.3	14.1	15.5	29.8	17.0	13.8	11.3	10.7	11.0	18.3	21.2	18.7	20.5	11.4	11.7	14.2	16.8	15.8	13.6	8.9	14.0	13.7	12.5	20.7	13.8	14.6	14.5	24.7	25.9	15.4	18.4	16.0	16.1	41.1	13.0	13.4	17.9	15.6	15.9	14.9	15.9	12.0	15.8	13.8	9.9	10.4	14.0	25.4	18.2	18.9	26.9	15.1	30.2	14.6	5.0	3.1	2.3	7.7	5.6	11.7	7.9	10.4	9.3	5.0	6.6	13.2	11.0	0.8	7.0	4.3	7.7	9.3	6.1	18.9	17.0	11.5	14.7	19.1	17.0	18.8	8.5	12.3	9.8
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197527-80387757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 67.7;thyroid gland: 128.7"	"Cell line enhanced"	"Detected in some"		"BJ: 26.1;fHDF/TERT166: 14.3;HeLa: 29.9;HHSteC: 14.9;SiHa: 54.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029544, HPA048002"			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029544: AB_10600804, HPA048002: "	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favourable (1.67e-4)"	"prognostic favourable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.3	1.8	13.0	0.9	12.3	0.7	6.1	1.0	19.7	67.7	1.2	1.6	1.9	1.2	15.6	1.1	36.1	0.9	2.5	4.7	14.2	2.7	2.4	0.7	1.2	1.0	4.1	7.6	0.7	1.3	0.9	35.9	5.9	13.2	5.0	1.3	13.1	17.7	12.4	3.0	3.3	1.2	2.4	1.2	0.9	2.5	2.5	1.4	0.0	128.7	15.8	12.0	2.6	13.7	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.4	0.0	26.1	5.5	2.3	0.3	0.0	0.1	0.0	0.1	14.3	0.5	0.9	0.0	1.9	0.0	0.0	0.0	29.9	0.0	14.9	0.0	0.0	1.6	0.0	0.5	0.0	0.5	0.0	0.2	0.1	0.6	0.0	0.0	0.5	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.0	54.7	11.4	0.1	0.0	0.0	0.3	0.1	2.4	5.5	6.6	0.8	0.0	0.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	13.0	12.3	1.0	19.7	14.2	2.7	4.1	7.6	13.2	1.4
DIP2C	KIAA0934	ENSG00000151240	"Disco interacting protein 2 homolog C"	Q9Y2E4	10	274190-689668	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.8;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030264, HPA059325"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA030264: AB_10600903, HPA059325: "	"unprognostic (1.72e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (2.46e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.10e-3)"	15.4	8.1	19.9	5.0	25.0	0.9	9.9	23.0	24.7	12.6	20.8	21.2	6.4	6.2	14.1	7.8	12.2	9.1	11.3	17.3	16.3	10.1	19.2	11.5	6.7	3.4	21.7	14.4	18.1	10.4	10.4	7.4	6.3	16.5	11.5	6.3	13.0	5.6	12.7	38.2	5.5	7.3	16.1	14.9	4.5	8.3	9.4	23.1	0.0	7.3	2.9	2.5	11.6	13.0	3.8	0.5	0.1	0.3	0.3	1.3	0.4	0.4	4.0	7.4	3.9	12.6	13.7	6.1	8.8	5.5	6.8	5.6	1.1	1.2	0.3	2.4	14.1	0.1	4.5	0.7	4.2	0.2	4.0	0.1	2.7	1.2	6.1	0.0	5.5	11.1	3.6	4.3	0.0	1.5	0.0	0.7	5.1	10.8	0.4	0.0	1.9	1.6	6.1	3.1	1.2	4.8	4.5	3.7	5.3	1.5	3.2	12.7	4.2	0.0	0.1	7.2	1.9	21.5	2.9	0.5	8.5	4.6	9.1	0.2	4.1	0.0	0.3	0.0	0.4	0.0	0.4	2.6	0.8	1.0	0.0	3.8	1.2	1.3	0.1	0.3	0.0	0.5	0.5	0.4	19.9	25.0	23.0	24.7	16.3	10.1	21.7	14.4	16.5	23.1
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045896-68051631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 49.9;ovary: 33.2;pituitary gland: 35.2"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.3;HSkMC: 15.3;TIME: 9.5;U-251 MG: 7.7;U-87 MG: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 49.9"	"Group enriched"	"Detected in some"	18	"plasmacytoid DC: 2.1;T-reg: 1.8"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.1;T-cells: 1.8"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favourable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favourable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.0	10.2	2.0	0.2	49.9	0.0	2.4	0.9	2.9	2.3	1.6	1.0	0.0	3.4	1.2	5.4	1.3	1.3	5.9	5.7	1.3	8.7	3.2	4.5	2.3	0.0	1.3	1.1	33.2	9.9	8.8	35.2	0.0	17.3	2.3	0.1	2.4	1.3	1.1	1.0	1.1	1.2	0.3	1.7	1.2	1.9	2.4	0.5	0.0	1.6	0.3	0.1	1.2	1.9	0.0	2.1	0.0	0.0	0.0	1.8	0.0	0.0	1.3	1.4	0.0	4.7	3.5	0.5	4.0	1.4	0.3	1.1	0.0	0.7	0.0	0.2	4.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.6	0.0	7.3	0.0	0.0	15.3	0.1	0.6	0.0	0.9	0.2	0.0	4.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.1	0.1	0.0	9.5	0.0	0.4	0.2	7.7	2.4	0.0	0.0	14.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	0.0	2.0	49.9	0.9	2.9	1.3	8.7	1.3	1.1	17.3	0.5
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039281: AB_10795583, HPA058762: "	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	25.5	14.7	11.7	17.6	24.8	23.8	22.4	23.4	19.4	20.3	18.8	11.6	17.0	11.8	18.0	19.3	23.1	17.8	16.0	21.6	12.4	13.6	20.2	25.6	19.3	22.2	13.9	17.0	23.4	15.3	15.8	22.8	26.3	18.7	18.0	15.6	9.8	17.4	19.3	19.9	17.3	17.9	17.5	12.9	22.8	16.2	27.7	14.6	23.7	21.3	19.1	23.0	26.7	19.3	6.9	6.8	11.1	9.7	10.3	10.0	5.0	15.6	7.3	14.4	12.1	15.4	18.4	9.5	14.0	17.1	14.3	17.6	11.2	13.1	19.1	12.2	14.3	13.1	19.7	16.1	23.2	15.6	14.5	22.4	15.7	10.1	19.2	37.8	13.0	19.1	11.3	16.2	21.4	15.3	14.9	8.0	17.4	5.5	16.0	18.6	13.5	8.6	13.0	11.0	8.6	14.4	12.6	13.1	17.2	11.5	9.6	13.5	9.3	17.3	14.3	8.7	7.0	9.7	14.8	15.5	17.4	15.3	24.2	18.0	12.5	11.1	5.5	7.8	6.5	9.7	9.4	6.9	8.5	7.3	6.8	6.0	8.1	7.6	3.4	10.3	7.6	4.3	10.0	5.0	11.7	24.8	23.4	19.4	12.4	13.6	13.9	17.0	18.7	14.6
DIS3L	"DIS3L1, FLJ38088, KIAA1955, MGC4562"	ENSG00000166938	"DIS3 like exosome 3'-5' exoribonuclease"	Q8TF46	15	66293217-66333898	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041805	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA041805: AB_10796783"	"unprognostic (2.57e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.40e-1)"	13.7	15.4	18.7	14.7	16.6	11.8	14.5	15.7	16.4	13.7	11.8	20.7	19.1	9.0	14.7	15.5	10.6	15.5	10.0	20.1	17.3	17.0	14.2	15.2	10.8	14.0	19.4	10.8	16.2	24.4	24.9	18.9	9.0	17.7	14.7	10.3	15.4	14.4	16.3	29.4	9.4	9.0	15.2	19.6	11.1	10.5	15.4	14.0	19.3	18.0	9.4	12.8	12.5	9.7	9.1	10.5	7.8	13.1	14.1	13.2	8.0	8.4	19.2	5.8	7.7	7.3	9.9	8.2	6.3	6.9	9.3	7.8	9.4	5.7	30.0	6.9	7.5	14.4	14.3	5.0	6.9	7.9	13.2	17.6	12.5	10.7	5.5	17.1	6.2	4.0	5.7	2.5	8.3	7.2	10.2	7.3	8.3	6.2	7.6	10.0	9.2	10.6	11.5	25.0	17.5	3.1	9.6	9.9	9.7	12.8	4.2	7.0	6.3	11.4	9.3	10.8	10.2	4.5	10.8	6.4	19.9	14.5	3.7	22.6	4.3	7.8	5.9	5.1	9.9	7.1	12.8	8.5	9.5	13.2	10.5	9.1	11.6	9.6	0.7	14.1	13.1	7.5	8.8	8.0	18.7	16.6	15.7	16.4	17.3	17.0	19.4	10.8	17.7	14.0
DISP3	"KIAA1337, PTCHD2"	ENSG00000204624	"Dispatched RND transporter family member 3"	Q9P2K9	1	11479166-11537584	"Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;testis: 7.5"	"Cell line enhanced"	"Detected in some"		"AF22: 7.8;NTERA-2: 3.3;SCLC-21H: 3.2;SH-SY5Y: 10.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054579	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054579: "	"unprognostic (4.93e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.34e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.34e-1)"	0.9	1.9	7.3	1.1	10.0	0.9	0.9	4.1	17.4	0.9	1.0	9.0	0.0	1.3	1.1	0.9	0.8	1.0	0.8	0.8	7.3	5.7	0.9	0.8	0.9	1.2	4.0	6.5	0.9	1.6	0.8	4.2	0.8	5.1	1.6	0.9	5.4	0.9	0.8	0.8	0.8	1.3	1.0	2.1	1.1	1.2	7.5	6.8	0.0	0.9	0.0	1.0	0.9	0.1	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	7.8	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.3	0.0	0.8	0.0	2.0	0.0	0.2	3.2	10.8	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	10.0	4.1	12.9	7.3	5.7	4.0	6.5	5.1	6.8
DIXDC1	"Dixin, KIAA1735"	ENSG00000150764	"DIX domain containing 1"	Q155Q3	11	111927144-112022584	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 23.1;TIME: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 8.6"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039658			Supported	Cytosol				Cytosol		"HPA039658: AB_2676611"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.11e-2)"	"prognostic favourable (6.89e-5)"	"unprognostic (4.10e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (4.19e-5)"	9.7	10.4	8.8	4.5	16.1	0.0	8.6	52.2	15.7	11.5	7.4	20.2	4.9	2.9	14.3	11.0	8.4	12.3	7.0	12.7	8.7	9.9	6.4	4.7	5.1	1.0	16.1	10.2	9.5	3.9	10.2	8.9	5.9	10.8	14.1	5.7	6.8	4.7	22.0	6.6	4.2	3.9	24.9	9.2	3.1	4.8	10.1	16.2	0.0	6.5	1.7	1.0	17.4	18.0	0.1	0.1	8.6	0.2	0.1	0.9	0.2	0.4	1.9	5.2	9.8	16.5	9.6	1.1	4.0	2.8	1.6	2.8	0.3	1.0	0.8	1.0	11.2	0.4	2.2	1.2	1.5	3.2	2.0	0.4	3.0	5.2	2.5	2.7	0.3	7.8	10.4	3.3	23.1	16.1	2.6	0.3	6.3	0.4	1.7	2.3	3.2	3.6	0.8	1.5	3.1	6.5	0.1	4.3	9.0	3.0	2.4	1.3	3.6	1.0	26.2	7.1	3.0	1.3	6.6	0.6	2.7	0.4	3.9	6.9	2.4	0.0	0.2	8.6	0.6	0.0	0.1	0.1	0.5	0.6	0.0	0.1	0.9	0.8	0.7	0.1	0.1	0.1	0.0	0.2	8.8	16.1	52.2	12.4	8.7	9.9	16.1	10.2	10.8	16.2
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11963106-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 94.7;heart muscle: 297.4"	"Cell line enhanced"	"Detected in many"		"BJ: 60.0;BJ hTERT+: 92.8;fHDF/TERT166: 86.9;TIME: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	90	"T-cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"		15000000	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	4.8	21.7	44.9	3.5	94.7	1.3	6.8	32.5	60.3	25.8	7.3	12.1	4.1	4.9	7.8	5.6	8.8	4.9	17.9	297.4	49.6	23.5	5.1	2.7	17.8	3.1	19.1	45.8	10.8	5.7	10.9	6.6	7.5	24.7	16.8	4.6	10.7	9.1	22.3	2.7	8.3	7.3	12.0	32.9	9.0	7.0	8.9	25.5	0.0	4.7	2.5	2.6	10.5	7.8	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.2	1.8	2.6	0.0	2.2	4.4	0.0	60.0	92.8	26.6	30.2	1.3	0.4	0.0	6.6	86.9	9.2	0.2	25.9	10.2	0.0	0.0	0.0	0.2	0.0	16.9	0.0	0.0	6.7	8.7	9.0	22.2	28.1	0.0	0.0	36.7	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	9.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	49.8	15.8	12.4	1.6	15.5	0.0	0.0	0.0	2.6	0.0	14.8	0.0	0.0	0.0	0.8	0.0	8.9	0.0	0.8	5.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	44.9	94.7	32.5	46.5	49.6	23.5	19.1	45.8	24.7	25.5
DLEC1	"CFAP81, DLC1"	ENSG00000008226	"Deleted in lung and esophageal cancer 1"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 23.2;testis: 28.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA019077	Enhanced		Supported	Cytosol				Cytosol		"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	0.8	0.3	1.3	0.7	8.3	1.1	0.5	0.0	0.6	3.3	0.6	6.1	3.5	0.7	1.1	21.1	0.3	23.2	1.3	0.3	1.7	2.5	0.3	0.3	10.0	1.7	0.5	0.2	6.3	0.2	0.6	14.2	0.3	9.8	0.8	0.6	0.8	0.6	1.8	0.2	0.7	0.7	0.3	0.6	0.7	0.6	28.9	1.7	0.0	0.8	0.0	0.6	0.4	0.1	0.2	0.1	0.9	0.4	0.1	1.1	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.1	3.4	0.0	0.0	0.0	0.2	0.1	2.8	0.5	0.2	0.3	1.7	0.5	0.1	0.3	0.0	0.0	0.4	0.3	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.8	0.2	0.4	0.2	1.1	0.0	0.1	0.1	0.2	0.0	0.9	0.1	0.1	0.1	0.2	0.1	1.3	8.3	0.0	0.6	1.7	2.5	0.5	0.2	9.8	1.7
DLGAP4	"DAP4, KIAA0964, SAPAP4"	ENSG00000080845	"DLG associated protein 4"	Q9Y2H0	20	36306336-36528637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054105, HPA056378"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA054105: , HPA056378: "	"unprognostic (1.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-2)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (3.73e-6)"	"unprognostic (1.23e-1)"	"prognostic favourable (9.88e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	18.8	16.6	25.7	14.3	32.9	4.5	18.0	16.2	31.9	19.0	20.1	9.0	14.9	13.5	23.1	13.1	16.8	18.5	17.0	25.9	23.7	12.7	10.2	11.0	21.6	9.8	9.5	20.7	18.9	30.2	7.7	10.2	16.9	8.8	15.7	10.1	15.4	19.3	21.2	58.0	27.1	13.6	27.2	6.8	14.5	12.2	12.6	10.9	8.3	13.8	16.8	10.8	29.0	15.0	16.1	13.5	19.5	13.1	6.9	12.5	9.1	13.9	12.6	15.5	12.8	14.7	24.1	15.6	21.0	19.3	20.6	14.3	19.1	8.9	3.9	11.3	29.4	13.4	4.1	21.5	15.4	6.3	1.5	8.9	6.5	12.9	21.3	3.6	7.8	15.8	16.7	24.3	17.0	20.2	6.2	10.8	15.5	10.4	7.2	13.7	6.7	27.1	7.3	4.1	5.4	9.6	6.9	10.2	14.1	13.7	28.0	17.3	16.0	6.3	20.3	62.8	19.2	27.0	11.5	3.7	2.7	4.2	25.1	4.5	24.6	2.1	12.8	19.5	12.5	13.1	9.8	16.1	11.3	8.7	11.3	14.9	8.8	7.0	18.5	6.9	12.6	13.5	8.7	9.1	25.7	32.9	16.2	31.9	23.7	12.7	9.5	20.7	8.8	10.9
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191678	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 8.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.52e-6)"	"prognostic unfavourable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavourable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	1.4	0.9	0.3	11.4	0.4	16.2	0.5	0.3	0.5	1.3	3.3	0.2	0.2	2.9	0.9	1.0	8.7	0.3	1.3	0.7	0.2	0.3	1.1	0.8	2.1	10.6	0.3	0.2	0.7	0.4	0.0	0.3	3.3	0.3	0.5	4.1	0.3	1.5	0.2	0.5	1.9	4.1	1.3	0.3	6.6	2.2	13.0	0.2	65.1	0.4	6.4	11.4	1.7	2.4	1.1	0.4	0.4	0.0	1.3	8.3	1.2	37.0	14.7	38.8	17.4	0.9	3.9	12.0	21.5	14.2	31.9	30.4	12.0	20.5	21.6	11.9	12.5	23.1	24.8	17.3	41.9	25.9	12.2	22.1	13.8	10.3	0.1	21.6	13.6	0.7	0.6	14.9	7.2	35.1	17.9	21.6	29.6	17.8	27.3	11.1	20.0	15.4	21.3	37.5	9.9	10.4	12.1	19.8	11.1	22.9	8.6	8.5	19.3	8.1	13.6	14.3	37.4	13.8	24.7	5.3	11.5	28.6	10.0	15.4	22.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.1	2.3	0.4	0.1	0.5	0.2	0.4	1.3	0.0	0.0	8.3	1.2	0.3	0.4	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.2
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: "	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	12.7	31.7	21.5	17.6	22.4	12.5	12.6	21.3	31.5	12.8	13.8	20.4	15.6	13.5	14.0	14.9	12.9	19.8	11.7	20.3	20.7	18.3	14.9	16.1	12.9	17.2	18.0	19.4	23.3	19.9	25.3	15.7	14.3	17.9	13.9	11.9	19.2	21.1	15.2	30.5	18.0	12.7	17.0	15.8	16.7	13.8	13.8	17.0	15.2	18.1	14.3	13.6	12.7	11.4	18.6	15.4	23.2	14.8	26.5	23.1	15.0	12.4	13.3	18.8	9.9	9.8	9.3	21.7	11.1	14.9	26.8	23.2	21.7	15.7	18.7	15.1	17.8	10.3	16.7	14.3	14.3	15.0	27.0	17.2	23.7	21.4	17.7	16.8	13.1	14.5	15.9	22.1	12.8	17.2	11.9	17.2	15.6	14.5	23.5	21.2	26.7	17.0	23.9	19.0	20.4	14.1	15.8	17.5	14.4	20.8	14.9	21.1	12.3	19.5	16.5	7.6	23.0	17.4	22.3	21.0	12.5	15.0	14.4	16.8	12.5	23.2	14.8	14.1	21.2	13.1	21.6	18.6	21.4	21.8	15.4	18.6	19.6	19.3	6.4	26.5	10.5	12.4	23.1	15.0	21.5	22.4	21.3	31.5	20.7	18.3	18.0	19.4	17.9	17.0
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 365.3"	"Cell line enhanced"	"Detected in many"		"A-431: 31.5;CACO-2: 39.0;CAPAN-2: 33.5;HBEC3-KT: 51.1;RPTEC TERT1: 50.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Cell type enhanced"	"Detected in many"		"NK-cell: 11.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.1;T-cells: 7.0"									HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"		29000000	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	0.6	0.5	4.7	0.6	23.9	0.7	2.0	54.8	1.2	1.1	2.5	1.0	5.6	9.2	25.3	8.7	0.6	1.4	0.7	1.1	11.3	0.8	8.8	0.5	0.9	0.6	11.7	29.5	4.7	13.3	1.7	9.5	5.0	1.0	9.5	8.2	9.1	2.4	365.3	1.2	0.9	0.9	0.6	1.8	0.8	2.3	3.1	25.9	62.9	16.9	3.5	27.5	1.7	0.2	0.0	0.0	11.1	7.0	1.2	31.5	5.1	0.0	0.0	1.2	1.9	8.9	0.1	4.2	0.2	0.3	39.0	33.5	0.0	12.8	0.3	17.7	9.6	51.1	0.4	0.1	9.3	0.0	0.0	8.7	1.5	0.0	0.1	17.5	13.8	0.9	29.7	0.0	0.1	0.0	0.1	27.6	0.0	0.0	28.3	2.1	0.0	0.0	1.2	50.5	20.9	0.1	0.0	7.7	0.0	3.1	12.8	0.0	0.0	4.9	15.0	0.1	0.1	0.2	0.0	0.2	4.2	0.0	0.3	0.0	0.0	0.0	7.0	0.0	6.1	1.7	0.6	3.4	0.0	0.2	0.1	2.4	0.0	11.1	0.0	0.2	0.0	1.2	0.6	4.7	0.7	2.0	0.7	1.1	0.9	0.6	9.5	2.3
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769717-45782552	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	9.0	18.7	5.1	9.7	6.3	1.7	4.9	8.8	6.2	16.5	23.4	4.4	15.6	8.7	21.2	15.0	31.2	13.7	20.3	56.7	5.0	5.3	4.9	2.2	6.5	4.1	4.8	6.5	8.4	33.3	3.1	10.7	6.8	5.6	16.3	3.8	22.0	6.1	19.7	79.6	5.1	11.3	65.1	4.2	5.3	12.0	5.9	4.0	1.1	6.1	36.6	5.0	44.9	8.2	1.5	0.0	0.0	0.8	0.3	2.2	0.0	7.2	10.1	12.0	7.4	8.1	11.3	7.2	16.2	12.0	6.5	6.3	1.2	3.9	2.3	2.4	18.5	10.6	3.4	1.6	2.4	11.3	10.6	0.9	12.6	1.7	7.9	0.1	4.1	16.5	5.7	5.6	2.7	3.0	7.1	5.8	9.4	8.0	1.1	2.7	7.1	2.2	3.7	44.2	3.7	3.5	8.3	6.5	10.3	8.8	18.5	5.2	15.2	3.5	9.1	7.6	7.5	7.2	11.8	11.2	9.6	2.3	6.9	1.0	10.6	0.0	0.0	0.0	2.2	0.8	0.5	0.3	0.7	0.2	0.0	1.5	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.1	6.3	8.8	6.2	5.0	5.3	4.8	6.5	5.6	4.0
DMXL1		ENSG00000172869	"Dmx like 1"	Q9Y485	5	119037772-119249138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036431, HPA036432"	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA036431: AB_10669791, HPA036432: "	"unprognostic (2.47e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.26e-1)"	"prognostic favourable (5.16e-5)"	"unprognostic (4.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.18e-2)"	17.8	10.4	9.3	14.0	14.1	29.3	16.1	14.2	15.4	12.0	11.6	15.4	9.6	8.3	15.7	8.5	13.0	12.0	10.3	10.2	8.9	5.6	18.8	9.6	13.9	12.5	11.5	11.4	17.4	20.1	21.3	14.1	9.5	18.9	35.9	9.8	13.3	13.6	10.9	10.9	21.4	13.1	13.0	10.9	11.5	12.4	9.2	13.1	18.1	17.9	6.8	13.8	14.3	12.4	11.2	9.5	4.6	9.0	1.5	3.8	2.6	9.5	7.4	8.4	8.6	9.1	12.1	9.0	7.9	7.9	7.9	9.4	8.9	5.9	18.6	8.2	10.1	5.8	9.3	9.4	10.4	14.3	9.3	13.1	12.9	3.1	7.6	8.5	11.4	9.6	5.3	9.2	7.7	10.4	11.0	12.6	6.4	6.0	11.4	4.9	4.6	4.5	9.0	15.6	7.2	6.2	11.1	7.9	8.0	13.6	4.9	12.2	8.2	9.9	10.0	9.5	8.0	9.5	8.3	11.9	8.4	16.2	11.8	8.4	7.6	4.6	5.5	3.9	2.9	4.9	3.6	9.7	2.3	2.4	3.8	11.2	3.8	2.1	4.5	1.5	9.0	9.5	2.8	2.6	9.3	14.1	14.2	15.4	8.9	5.6	11.5	11.4	18.9	13.1
DNAAF1	"CILD13, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.3;testis: 49.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.4;Karpas-707: 8.6;PC-3: 2.6;SK-BR-3: 2.4;U-266/70: 7.2;U-266/84: 4.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.1"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA041166: AB_10794190, HPA074239: "	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favourable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.8	1.2	3.5	0.6	9.4	1.5	0.5	0.1	1.5	2.1	0.6	5.3	1.5	0.4	1.0	13.3	0.9	21.3	0.5	0.4	4.6	6.5	0.7	2.0	3.7	0.9	0.5	1.5	4.2	0.4	0.7	6.1	1.5	11.1	0.4	0.4	0.9	0.5	0.6	0.6	0.5	0.6	0.4	1.0	7.2	0.5	49.6	1.2	0.0	1.2	0.0	0.4	0.8	0.0	0.5	1.0	5.5	0.8	0.9	2.1	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.1	1.3	0.2	0.0	0.0	2.4	0.1	0.9	0.0	0.0	0.4	0.0	0.0	0.0	7.2	4.7	0.7	0.2	0.4	0.0	3.6	0.8	0.4	0.4	0.6	0.1	0.0	0.2	0.1	0.4	0.5	0.8	0.8	5.5	0.9	0.4	1.0	2.1	0.9	3.5	9.4	0.1	1.5	4.6	6.5	0.5	1.5	11.1	1.2
DNAAF2	"C14orf104, CILD10, FLJ10563, KTU, PF13"	ENSG00000165506	"Dynein axonemal assembly factor 2"	Q9NVR5	14	49625174-49635230	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002894, HPA004113"	Enhanced		Supported	Cytosol				Cytosol		"HPA002894: AB_1078316, HPA004113: AB_1078315"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.25e-2)"	"prognostic favourable (6.74e-7)"	"unprognostic (6.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.44e-2)"	3.4	5.7	4.3	3.9	9.1	2.5	5.8	5.9	4.9	4.6	7.1	4.8	2.3	7.6	4.2	13.8	5.3	9.2	6.1	4.1	5.5	5.2	7.0	9.5	9.7	4.9	4.0	3.8	14.6	7.0	3.6	7.3	3.7	10.7	4.0	4.7	2.9	5.3	3.0	5.4	2.9	6.8	3.0	3.8	3.9	4.8	48.1	3.2	4.8	5.4	8.5	4.3	4.3	3.5	12.6	6.2	7.2	5.8	13.7	11.5	5.3	10.1	6.1	13.4	10.4	6.6	7.6	12.8	5.5	6.1	6.1	6.8	5.9	9.9	14.9	8.8	3.6	11.2	11.0	7.7	7.7	10.4	6.6	7.6	4.6	10.1	5.1	12.2	6.4	5.0	8.4	5.2	7.2	6.3	11.3	10.2	6.0	12.6	8.0	12.7	14.6	11.2	10.0	10.4	5.0	8.6	8.6	20.5	15.3	8.2	8.9	9.7	10.1	4.9	5.1	5.8	16.3	5.9	6.8	20.6	12.8	12.3	2.2	7.5	6.2	6.7	5.5	7.2	8.7	4.7	10.4	12.6	9.8	11.5	6.2	9.7	9.5	9.3	2.1	13.7	5.8	5.6	9.1	5.3	4.3	9.1	5.9	4.9	5.5	5.2	4.0	3.8	10.7	3.2
DNAAF4	"CILD25, DYX1C1, EKN1, FLJ37882"	ENSG00000256061	"Dynein axonemal assembly factor 4"	Q8WXU2	15	55410525-55508234	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 26.6"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA051048	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA051048: "	"unprognostic (5.97e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.30e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	1.8	3.0	11.4	1.8	14.7	1.6	4.9	1.8	8.0	4.3	2.1	3.2	5.9	1.1	7.0	15.3	1.8	15.7	3.4	1.6	9.2	7.8	7.2	1.0	6.2	1.5	4.2	8.9	4.8	3.5	13.6	26.6	1.2	9.1	3.2	1.5	6.9	2.4	3.2	1.3	2.4	1.3	3.1	3.7	2.0	1.7	14.6	4.5	0.1	14.3	0.9	1.3	2.8	2.0	2.9	4.2	4.3	1.8	0.7	1.1	0.4	6.5	4.3	4.7	10.0	1.9	3.3	1.5	0.8	2.4	3.1	3.6	0.9	2.6	0.5	4.2	2.0	1.8	1.8	2.6	3.7	2.0	2.1	2.3	2.8	1.5	1.8	5.0	4.1	2.0	5.5	7.5	2.8	7.0	0.7	0.3	4.6	2.3	0.9	4.3	2.6	3.6	0.8	2.3	0.8	17.1	2.3	4.8	10.5	4.3	1.1	5.8	6.0	1.2	2.3	5.0	2.5	4.1	4.8	1.8	4.8	1.4	8.2	1.0	1.1	0.0	1.8	1.3	0.6	1.2	0.4	2.9	0.9	0.7	1.2	2.6	1.1	0.8	4.3	0.7	1.2	4.2	0.9	0.4	11.4	14.7	1.8	8.0	9.2	7.8	4.2	8.9	9.1	4.5
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726701-786475	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavourable (8.42e-4)"	"prognostic unfavourable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	11.5	13.0	9.3	13.5	11.4	10.7	12.3	17.4	14.2	15.5	16.3	14.7	10.3	12.0	18.4	13.9	16.7	23.4	15.4	18.8	11.6	8.6	15.0	18.2	9.9	11.8	9.5	7.6	20.6	22.5	14.4	21.1	12.1	10.4	16.1	9.9	14.0	17.6	14.3	33.9	12.0	13.6	13.9	9.2	12.5	13.0	14.8	9.4	20.7	15.9	11.2	14.2	15.6	12.4	3.3	4.6	1.4	2.8	3.0	4.7	1.9	30.3	24.0	7.2	16.7	4.7	5.2	18.1	6.3	6.1	7.9	7.5	23.9	16.1	18.6	9.2	6.6	18.5	13.3	15.8	6.1	3.1	22.5	4.6	14.3	17.3	6.5	13.8	8.3	6.3	6.8	9.9	7.3	10.7	28.9	3.9	5.7	29.8	8.2	12.4	26.4	19.1	15.2	2.3	12.8	9.2	12.9	15.1	25.1	10.3	25.5	7.3	22.5	11.6	8.8	4.4	15.7	15.0	14.1	7.6	9.1	10.8	9.7	14.6	23.0	0.0	1.9	1.4	2.2	2.8	3.3	1.6	3.5	4.7	2.7	3.3	3.3	2.5	0.0	3.0	2.0	4.6	0.8	1.9	9.3	11.4	17.4	14.2	11.6	8.6	9.5	7.6	10.4	9.4
DNAH17	"DNAHL1, DNEL2, FLJ40457"	ENSG00000187775	"Dynein axonemal heavy chain 17"	Q9UFH2	17	78423697-78577394	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 39.4"	"Group enriched"	"Detected in some"	5	"HeLa: 9.8;MOLT-4: 4.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA024354, HPA076261"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"HPA024354: AB_1847911, HPA076261: "	"unprognostic (4.98e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.70e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.35e-3)"	"unprognostic (1.58e-10)"	"unprognostic (5.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.12e-1)"	"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.1	0.0	39.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	9.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0
DNAH7	KIAA0944	ENSG00000118997	"Dynein axonemal heavy chain 7"	Q8WXX0	2	195737703-196068812	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7;fallopian tube: 19.4;pituitary gland: 25.2"	"Cell line enhanced"	"Detected in some"		"PC-3: 10.5;RPTEC TERT1: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"neutrophil: 2.0;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;granulocytes: 2.0"					"Low region specificity"	"Detected in many"			"HPA034724, HPA044070"	Approved		Supported	Cytosol				Cytosol		"HPA034724: AB_10670977, HPA044070: "	"unprognostic (1.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.98e-2)"	1.0	2.6	6.8	1.4	9.9	0.7	1.9	0.6	6.4	3.3	1.9	4.6	4.3	0.9	2.2	12.9	1.1	19.4	1.9	1.4	7.1	5.8	4.5	1.2	9.5	0.9	3.4	3.5	3.9	4.2	3.6	25.2	0.9	21.7	1.9	1.6	1.8	1.8	2.5	0.6	0.9	1.9	1.2	2.1	0.8	1.5	18.3	2.3	0.0	5.9	0.0	1.0	1.3	0.5	0.3	2.0	2.0	0.0	0.1	0.2	0.2	0.6	2.4	0.5	0.2	1.3	0.9	0.1	0.2	1.4	0.5	0.5	0.5	1.7	0.0	0.7	0.5	0.1	0.0	0.3	0.4	0.0	1.4	0.0	2.9	0.7	0.2	0.1	0.2	0.3	0.4	2.1	0.4	0.0	0.6	3.3	0.9	2.4	0.0	0.1	0.5	10.5	0.1	0.6	0.8	4.9	0.3	1.1	1.9	0.6	0.4	0.2	0.9	0.2	0.0	1.3	0.4	2.0	0.6	2.6	2.3	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.1	2.0	0.1	0.0	2.0	0.0	0.2	6.8	9.9	0.6	6.4	7.1	5.8	3.4	3.5	21.7	2.3
DNAJA1	"dj-2, hdj-2, HSJ2, HSPF4, NEDD7"	ENSG00000086061	"DnaJ heat shock protein family (Hsp40) member A1"	P31689	9	33025211-33039907	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 189.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001306	Approved		Supported	Microtubules,Cytosol				Cytosol	Microtubules	"HPA001306: AB_1079043"	"unprognostic (3.11e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.58e-2)"	"prognostic favourable (5.39e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (3.27e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.70e-2)"	29.0	46.7	46.5	26.1	47.2	42.7	57.2	31.6	53.3	30.4	18.7	20.7	25.5	14.4	27.6	27.9	17.1	34.8	28.2	22.2	42.5	51.7	36.0	71.9	30.7	23.8	56.5	30.8	30.7	19.5	47.3	40.2	35.0	49.6	29.8	21.7	9.0	18.9	23.0	14.5	13.1	15.9	29.0	42.4	22.3	20.8	42.2	51.5	24.1	47.0	15.3	28.1	27.9	189.5	36.6	60.0	50.0	69.0	31.6	37.2	49.5	38.0	68.3	55.3	19.2	38.5	25.0	31.7	39.4	31.8	70.9	55.2	45.3	17.7	39.1	30.2	26.7	17.4	79.6	23.7	61.2	55.0	23.2	31.3	84.1	57.3	18.5	36.0	36.8	15.4	24.4	26.7	8.5	42.2	48.7	17.1	40.5	31.1	60.0	79.2	53.8	47.7	44.2	19.8	20.0	39.7	22.6	35.2	38.4	53.0	34.3	17.5	16.0	35.0	36.1	25.3	43.3	28.8	52.2	11.0	34.0	41.3	33.2	31.4	21.7	33.3	40.1	43.3	28.5	56.0	33.3	36.6	35.6	31.4	35.7	32.7	37.2	34.7	50.0	31.6	69.0	60.0	30.1	49.5	46.5	47.2	31.6	53.3	42.5	51.7	56.5	30.8	49.6	51.5
DNAJA2	"CPR3, DNAJ, DNJ3, HIRIP4"	ENSG00000069345	"DnaJ heat shock protein family (Hsp40) member A2"	O60884	16	46955362-46973788	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049789, HPA060538"	Approved		Approved	"Nucleoli,Intermediate filaments,Cytosol"			31000	"Nucleoli, Cytosol"	"Intermediate filaments"	"HPA049789: , HPA060538: "	"unprognostic (7.68e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.67e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (2.81e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.19e-9)"	"unprognostic (9.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.69e-2)"	25.0	29.2	32.3	18.0	36.5	23.6	22.8	29.8	44.2	21.7	21.1	17.1	20.3	22.3	25.6	33.6	23.4	20.3	18.9	37.9	30.5	27.1	31.2	39.0	17.7	21.4	25.5	27.6	26.1	18.9	29.0	18.9	22.1	31.5	25.6	21.9	18.4	19.1	24.9	43.7	22.3	23.8	26.9	21.2	24.1	20.3	33.0	18.7	20.8	25.4	31.8	23.2	24.5	23.5	13.6	10.5	14.5	14.0	14.3	18.9	10.2	10.9	13.1	13.2	11.2	18.1	17.5	20.1	14.3	17.3	21.6	10.3	11.4	11.5	17.7	11.6	15.4	17.1	21.0	14.8	25.1	4.2	17.6	13.0	6.4	24.0	21.7	19.7	18.2	18.6	17.2	12.5	11.9	14.9	14.9	6.0	18.2	12.0	14.1	27.5	20.1	19.5	16.4	24.2	21.0	26.0	11.7	18.1	11.6	17.0	25.8	15.6	10.0	15.4	15.3	12.8	8.1	9.2	12.0	14.8	10.1	23.7	13.5	17.0	10.7	13.0	11.5	14.5	11.9	14.0	15.4	13.6	16.1	13.3	10.5	10.4	16.0	15.7	12.1	14.3	12.0	7.4	18.9	10.2	32.3	36.5	29.8	44.2	30.5	27.1	25.5	27.6	31.5	18.7
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 63.2;skeletal muscle: 69.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.4;HeLa: 18.2;RT4: 33.9;SCLC-21H: 21.8;SiHa: 17.0;THP-1: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB004646: AB_426011, HPA041790: "	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	7.3	10.1	29.6	7.6	33.7	28.6	7.6	20.1	25.8	8.6	8.7	10.5	10.4	7.8	5.1	25.3	9.1	21.7	6.6	63.2	22.3	33.8	7.7	1.9	7.0	6.0	26.0	28.1	3.6	3.2	9.5	11.9	5.5	29.2	15.4	10.6	7.2	6.8	9.6	69.0	15.5	9.0	10.7	16.0	5.1	10.8	26.8	14.9	2.0	6.3	15.2	6.9	12.6	62.3	1.9	1.1	2.7	1.0	0.4	4.7	1.6	13.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.2	0.0	17.4	0.0	0.1	1.2	12.5	0.0	0.0	0.0	0.0	0.0	7.8	18.2	0.0	3.9	0.0	8.4	1.5	1.7	1.0	0.0	2.6	0.0	0.0	0.1	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	33.9	21.8	0.0	17.0	3.4	1.5	13.1	15.7	0.2	0.0	3.6	1.6	0.1	0.2	0.9	0.0	0.0	1.6	0.0	0.0	0.8	2.7	1.8	0.9	2.6	1.9	2.5	2.5	1.1	0.4	4.7	3.9	0.0	0.4	1.0	0.6	1.4	1.6	29.6	33.7	20.1	25.8	22.3	33.8	26.0	28.1	29.2	14.9
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 89.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 42.5;LHCN-M2: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	23.3	39.0	19.2	8.4	20.7	4.9	16.6	22.7	24.1	21.3	12.7	7.2	9.3	5.4	20.8	10.1	25.0	11.7	25.2	42.0	18.0	16.8	16.0	15.5	21.7	7.0	25.7	9.1	15.3	18.5	16.4	19.1	19.5	23.8	19.4	9.4	5.1	7.0	12.2	33.3	7.6	8.8	23.0	29.5	30.3	11.9	7.8	22.5	2.8	35.1	29.4	5.1	22.1	89.8	3.6	5.0	4.5	1.9	3.1	7.2	2.6	1.4	2.7	3.5	2.0	15.0	28.0	1.6	27.2	6.9	12.1	13.7	0.9	1.8	2.0	4.6	12.9	2.1	4.4	2.4	20.7	2.3	1.2	1.0	8.2	6.6	20.3	0.5	0.5	11.6	6.6	15.7	4.5	42.5	4.4	1.4	72.3	0.1	0.6	1.5	2.1	1.3	1.1	6.0	1.3	2.9	0.7	2.5	0.8	3.1	2.3	2.6	0.9	0.8	20.3	17.1	4.2	12.1	3.5	1.2	0.4	1.8	2.3	1.2	2.9	4.5	1.7	2.7	2.6	1.7	4.4	3.6	3.2	3.1	1.7	3.0	7.2	5.1	0.4	3.1	1.9	5.0	4.2	2.6	19.2	20.7	22.7	24.1	18.0	16.8	25.7	9.1	23.8	22.5
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 99.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"myeloid DC: 7.7;neutrophil: 7.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023818: AB_1847793, HPA050794: "	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	7.2	6.3	5.9	5.1	7.2	0.9	2.6	8.6	13.0	6.5	19.1	6.2	9.2	3.8	18.5	9.7	15.7	9.6	8.7	29.3	6.6	6.3	3.7	2.0	3.7	2.2	4.7	3.4	6.5	3.1	2.2	8.6	1.4	6.0	13.8	6.2	5.7	3.7	26.2	99.4	1.5	6.1	29.9	4.5	5.6	11.3	8.1	3.5	1.6	4.4	38.0	2.9	23.0	3.6	0.7	7.7	7.6	1.5	0.5	1.3	0.7	2.6	2.1	13.6	7.2	8.0	6.2	1.5	11.3	8.3	17.5	15.6	1.6	0.6	2.5	2.8	12.4	0.3	5.2	8.9	14.9	3.5	1.6	0.9	3.1	0.7	9.2	0.3	8.2	9.0	0.6	10.3	5.2	11.1	0.2	5.3	14.1	1.8	4.2	3.6	6.4	4.6	3.3	14.1	1.4	2.5	0.2	5.8	9.5	6.1	0.3	1.3	2.2	0.8	4.9	8.4	18.5	4.3	3.5	2.0	1.3	1.8	9.6	1.0	9.0	0.1	1.5	0.0	0.4	0.4	1.3	0.7	0.3	0.1	7.7	0.3	0.5	1.1	7.6	0.5	0.1	0.2	1.3	0.7	5.9	7.2	8.6	8.5	6.6	6.3	4.7	3.4	6.0	3.5
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: "	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	24.0	23.1	38.0	17.9	35.0	51.3	40.5	42.2	41.3	17.1	25.5	21.7	19.1	14.5	23.3	38.8	33.2	20.9	17.3	37.0	31.7	32.2	24.5	16.7	19.4	16.4	37.6	32.2	22.8	18.8	17.2	20.2	24.4	37.7	19.5	17.2	15.3	20.1	25.6	96.9	34.2	15.6	31.7	33.9	17.2	16.8	38.3	35.2	12.2	17.9	23.5	21.9	23.4	51.9	32.7	30.4	74.3	48.1	35.5	42.1	55.0	38.0	23.1	28.2	28.5	28.6	26.0	26.1	42.8	35.1	39.9	43.8	31.4	38.5	14.6	80.7	31.6	24.4	19.1	29.9	62.0	29.4	26.1	26.2	13.9	22.2	26.3	19.4	22.1	22.7	29.1	30.2	14.4	29.6	42.5	14.7	51.0	25.8	48.4	38.2	56.3	30.9	26.1	20.3	20.4	32.9	23.4	17.0	44.9	33.4	26.2	31.3	19.1	27.6	36.9	25.2	19.2	60.0	36.8	28.2	40.1	17.2	35.8	44.7	31.8	70.6	41.5	48.8	36.2	41.6	36.1	32.7	33.2	37.2	30.4	28.1	42.1	39.3	74.3	35.5	48.1	27.6	38.9	55.0	38.0	35.0	42.2	41.3	31.7	32.2	37.6	32.2	37.7	35.2
DNAJB9	MDG1	ENSG00000128590	"DnaJ heat shock protein family (Hsp40) member B9"	Q9UBS3	7	108569568-108574850	"Predicted intracellular proteins"	"Unfolded protein response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 33.6;Karpas-707: 30.6;U-266/70: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040967, HPA041553"	Supported		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"			"Endoplasmic reticulum, Cytosol"		"HPA040967: AB_10794430, HPA041553: AB_10794300"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.75e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.76e-2)"	13.7	28.9	11.6	9.7	14.1	16.7	14.6	8.6	15.4	18.2	11.1	10.0	33.7	11.1	12.6	31.4	8.7	12.8	10.8	24.2	11.6	18.7	29.2	54.3	16.1	13.3	14.0	11.4	14.6	47.9	6.9	31.0	51.2	15.7	14.2	9.6	10.1	32.2	29.5	29.4	7.6	10.8	10.7	14.7	10.8	11.9	18.5	10.6	5.4	37.4	7.2	14.2	18.1	13.5	10.0	30.1	25.8	7.7	9.9	24.0	11.4	2.5	2.9	4.0	4.5	11.1	8.0	8.8	9.3	11.3	5.1	6.2	2.9	4.9	3.3	10.4	2.9	3.0	4.4	2.2	5.3	3.6	2.4	1.7	2.0	8.9	33.6	2.6	3.5	5.6	17.8	3.0	16.7	5.3	2.5	30.6	8.0	3.7	2.4	3.1	4.0	1.6	1.6	4.0	17.4	4.2	1.6	2.7	5.8	3.4	15.6	17.0	2.9	3.7	6.1	5.4	2.5	6.7	3.2	54.0	17.2	3.8	4.8	3.4	4.9	25.8	7.7	3.5	14.1	5.8	24.0	10.0	15.4	14.1	5.7	8.1	8.9	10.2	2.1	9.9	6.2	30.1	8.9	11.4	11.6	14.1	8.6	15.4	11.6	18.7	14.0	11.4	15.7	10.6
DNAJC11	FLJ10737	ENSG00000007923	"DnaJ heat shock protein family (Hsp40) member C11"	Q9NVH1	1	6634168-6701924	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028705	Uncertain		Approved	Cytosol				Cytosol		"HPA028705: AB_10603662"	"unprognostic (3.74e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (9.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.38e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (2.63e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.04e-1)"	13.8	24.0	20.5	16.1	25.2	10.2	12.7	19.1	31.3	13.0	23.4	17.3	10.5	22.4	14.6	11.2	19.5	12.7	11.9	26.9	15.7	13.0	33.5	25.8	11.2	14.4	13.9	19.6	16.5	15.3	21.4	13.4	15.5	25.0	12.6	27.4	15.4	13.8	12.4	44.2	16.6	19.5	15.1	14.6	19.6	16.2	12.4	14.2	12.6	12.3	17.2	18.4	14.0	12.6	8.1	12.2	7.2	13.4	10.0	10.1	8.6	16.4	16.1	19.0	17.2	16.7	11.7	17.6	16.5	14.2	32.9	23.3	19.3	23.8	26.4	16.1	18.9	22.3	32.6	26.6	29.1	14.9	22.4	26.9	30.6	19.4	16.2	32.3	14.8	16.9	7.4	29.6	19.5	15.4	33.9	11.8	16.5	13.3	20.1	16.6	19.3	27.8	22.3	16.5	19.2	21.0	14.4	25.4	18.0	18.8	38.7	20.6	15.2	16.8	15.1	19.5	10.4	16.1	19.2	13.7	14.9	35.1	19.0	35.2	9.6	7.2	9.6	3.4	9.4	12.5	9.4	8.1	6.9	10.1	12.2	8.1	7.4	5.9	0.3	10.0	13.4	5.3	7.2	8.6	20.5	25.2	19.1	31.3	15.7	13.0	13.9	19.6	25.0	14.2
DNAJC13	"KIAA0678, RME8"	ENSG00000138246	"DnaJ heat shock protein family (Hsp40) member C13"	O75165	3	132417526-132539032	"Predicted membrane proteins"	"Protein transport, Transport"	Chaperone	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036923, HPA036924"	Approved		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA036923: AB_10672480, HPA036924: "	"unprognostic (3.35e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavourable (7.49e-4)"	"unprognostic (3.68e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (8.36e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.81e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	23.3	17.8	20.4	15.1	14.4	20.5	16.2	18.0	19.9	20.8	23.1	8.1	23.3	14.5	25.0	18.7	22.3	16.8	13.1	20.5	19.9	11.0	23.6	12.1	17.7	14.9	11.5	17.8	20.1	12.2	21.1	12.3	22.9	17.3	17.8	18.8	10.2	16.1	24.6	20.0	13.7	20.1	26.3	12.5	19.4	16.0	10.3	16.4	13.0	20.6	13.8	13.6	24.5	32.4	2.2	5.7	3.4	7.0	1.7	2.1	1.6	14.6	8.4	11.5	5.8	26.8	23.9	7.0	15.9	29.9	15.5	17.2	9.4	9.3	7.7	10.2	21.6	12.0	10.7	11.6	21.6	8.7	3.0	9.5	8.4	6.2	14.1	9.5	9.3	17.4	8.5	14.0	17.4	21.6	5.3	12.8	21.9	11.2	7.8	4.5	6.7	7.6	7.6	8.2	6.1	14.0	15.5	4.1	6.8	15.2	8.0	17.2	12.5	9.0	20.1	17.5	9.0	17.0	6.8	7.3	7.1	10.4	18.3	6.7	12.8	3.4	5.2	0.7	1.9	4.3	1.8	2.2	2.0	1.7	5.7	1.4	1.5	2.1	1.2	1.7	7.0	2.7	1.1	1.6	20.4	14.4	18.0	19.9	19.9	11.0	11.5	17.8	17.3	16.4
DNAJC2	"MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin"	ENSG00000105821	"DnaJ heat shock protein family (Hsp40) member C2"	Q99543	7	103312474-103344873	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chaperone, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020454	Approved		Supported	Cytosol				Cytosol		"HPA020454: AB_1859492"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.28e-1)"	12.8	12.5	12.8	21.5	14.2	37.0	13.6	12.9	16.8	13.3	15.0	5.1	10.7	14.3	13.4	12.5	13.6	11.8	11.5	13.6	11.4	11.0	16.2	25.2	10.7	15.5	13.3	12.7	16.4	13.2	12.2	28.5	13.8	16.1	12.0	13.0	5.6	12.6	9.1	29.4	12.7	18.6	13.1	12.2	19.7	12.8	30.6	15.7	17.6	13.0	12.0	13.6	16.6	16.5	9.1	7.1	28.6	9.1	10.0	8.8	3.7	17.3	12.6	7.2	13.8	5.8	8.1	14.8	12.0	8.7	13.4	10.0	18.7	12.8	24.6	19.3	8.2	11.8	19.5	8.7	20.5	13.1	16.1	18.2	11.9	15.8	10.5	32.0	14.5	7.0	7.6	15.6	14.0	8.7	42.1	16.1	10.9	29.1	30.5	33.1	25.8	19.5	19.6	14.9	22.9	7.9	8.3	14.2	13.2	16.2	22.6	12.5	9.6	16.3	10.3	13.3	21.3	28.7	23.4	17.1	22.5	49.3	9.5	33.4	16.6	28.6	6.0	5.5	7.6	6.5	8.4	7.8	7.6	7.9	5.9	9.1	8.8	8.8	2.4	10.0	9.1	7.1	8.1	3.7	12.8	14.2	12.9	16.8	11.4	11.0	13.3	12.7	16.1	15.7
DNAJC24	"DPH4, JJJ3, ZCSL3"	ENSG00000170946	"DnaJ heat shock protein family (Hsp40) member C24"		11	31369840-31431849	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020025, HPA025237"	Approved		Approved	Cytosol				Cytosol		"HPA020025: AB_1847801, HPA025237: AB_1847802"	"unprognostic (2.07e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.67e-1)"	10.4	10.7	13.0	8.8	21.6	3.7	10.2	16.4	17.4	9.1	8.9	9.4	7.4	7.2	10.7	9.9	10.7	6.8	9.2	20.2	12.7	13.4	10.5	9.8	7.6	10.6	12.3	11.1	8.4	13.3	9.7	21.8	8.4	14.7	9.9	7.7	8.9	9.0	10.1	25.6	14.1	8.1	11.9	13.5	9.0	8.7	8.2	12.8	7.1	11.8	9.5	9.5	11.2	7.0	5.1	4.3	7.5	4.5	3.5	8.1	3.2	4.1	5.4	9.6	6.9	7.2	9.6	4.7	10.8	6.8	6.1	5.9	4.3	4.4	5.2	5.8	7.2	5.2	6.0	7.1	10.1	13.3	10.5	6.1	9.4	4.3	8.8	11.6	9.3	8.7	8.3	3.9	11.8	8.3	11.8	9.6	11.7	4.6	8.7	5.6	4.5	6.3	5.7	17.8	5.4	7.3	4.3	4.5	6.4	10.4	6.9	7.8	9.6	7.1	9.7	11.9	8.1	13.7	13.1	11.2	9.6	7.2	17.5	5.9	12.6	7.5	2.9	2.1	6.1	4.5	8.1	4.2	5.6	5.2	2.1	5.1	7.3	7.4	2.3	3.5	2.6	4.3	3.9	3.2	13.0	21.6	16.4	17.4	12.7	13.4	12.3	11.1	14.7	12.8
DNAJC25	bA16L21.2.1	ENSG00000059769	"DnaJ heat shock protein family (Hsp40) member C25"	Q9H1X3	9	111631352-111654351	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 41.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019122	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA019122: AB_1853155"	"unprognostic (3.07e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.94e-3)"	"prognostic favourable (3.73e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (9.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.19e-2)"	5.1	10.2	3.3	3.9	4.6	1.9	5.8	4.5	4.2	3.4	5.1	2.5	5.7	4.6	4.1	7.7	3.4	3.8	3.6	6.7	4.3	3.8	7.8	41.9	3.5	4.1	2.7	2.3	5.7	7.0	7.4	9.0	4.4	3.3	5.9	3.0	3.6	9.7	4.0	3.6	2.4	6.9	5.0	2.9	2.9	3.7	4.2	1.9	1.4	4.3	2.4	2.2	6.4	4.5	0.6	1.1	1.2	1.9	0.4	0.8	0.3	2.6	2.0	1.4	2.3	14.5	6.5	5.3	10.1	4.8	4.0	3.9	3.8	1.6	2.2	4.0	6.9	8.4	1.5	2.9	3.8	1.9	2.0	2.2	0.0	7.8	4.7	4.2	3.3	5.6	8.2	3.0	5.8	3.3	4.6	2.0	5.0	2.8	1.3	0.2	2.5	4.7	2.2	7.4	2.1	8.2	2.9	2.3	1.2	5.6	7.9	3.5	4.1	1.1	6.3	4.9	2.2	12.8	5.7	3.6	5.5	1.3	8.2	2.1	4.2	0.0	0.1	1.2	0.6	1.9	0.2	0.3	0.5	0.0	0.5	0.6	0.5	0.2	0.8	0.4	1.0	1.1	0.8	0.3	3.3	4.6	4.5	4.2	4.3	3.8	2.7	2.3	3.3	1.9
DNAJC27	"RabJS, RBJ"	ENSG00000115137	"DnaJ heat shock protein family (Hsp40) member C27"	Q9NZQ0	2	24943636-24972094	"Predicted intracellular proteins"			Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 30.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036815, HPA036816"	Uncertain		Supported	Cytosol				Cytosol		"HPA036815: , HPA036816: AB_10673506"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.44e-4)"	"unprognostic (8.84e-2)"	"prognostic favourable (8.48e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.78e-3)"	6.0	5.6	6.7	3.4	13.8	5.3	5.9	9.4	15.7	5.6	4.1	6.8	1.9	3.2	6.6	8.1	3.7	5.7	4.8	7.3	6.7	8.0	6.1	3.1	4.4	4.1	9.5	6.5	10.9	3.6	7.6	10.2	4.6	19.0	5.5	4.6	4.9	3.2	5.2	6.5	4.5	3.3	5.0	8.3	4.1	3.7	30.4	8.2	3.6	5.3	2.4	3.9	4.1	6.1	1.4	0.8	2.9	1.2	4.5	1.9	0.9	4.5	2.0	4.3	4.3	6.1	5.2	3.3	3.5	5.2	3.8	3.3	2.1	2.1	4.3	0.8	2.5	3.6	3.2	2.2	3.8	1.9	2.6	2.7	2.3	1.9	3.9	2.4	3.7	3.9	3.7	3.0	5.9	1.5	1.8	4.0	4.0	1.6	4.3	4.1	2.8	1.8	2.7	8.6	2.3	3.6	2.5	1.6	5.5	3.3	2.6	4.9	2.2	1.8	1.4	5.0	3.6	2.5	3.2	10.3	3.6	5.1	2.5	4.0	2.1	0.0	0.8	2.9	1.0	0.5	1.9	1.4	1.2	0.8	0.8	1.1	1.6	1.8	0.2	4.5	1.2	0.4	1.1	0.9	6.7	13.8	9.4	15.7	6.7	8.0	9.5	6.5	19.0	8.2
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.9;HEL: 55.8;K-562: 21.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: "	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	2.1	12.1	18.6	2.2	28.5	5.0	2.0	24.2	91.4	2.2	2.8	26.9	0.0	2.3	1.9	1.8	1.7	2.4	2.3	9.0	25.0	26.7	8.5	1.6	2.7	1.6	28.8	23.8	1.9	3.4	2.1	7.5	8.0	40.5	2.5	3.0	2.2	1.7	2.1	1.6	2.1	2.3	2.2	28.7	3.2	2.9	3.2	21.1	0.0	3.0	0.0	1.7	1.8	0.6	0.5	0.5	0.0	0.0	0.6	1.5	0.3	3.5	0.9	0.0	1.6	0.7	0.2	8.3	7.0	11.4	11.5	11.3	0.9	0.1	3.3	0.6	2.9	0.8	5.0	1.1	9.1	20.9	2.4	55.8	1.9	0.2	0.0	1.8	1.4	1.0	0.8	1.1	4.9	0.2	21.7	0.4	2.3	0.6	0.7	0.0	2.3	0.7	0.0	1.7	0.1	8.7	0.0	13.9	9.6	4.1	5.5	1.9	2.6	0.1	2.1	1.7	1.2	0.2	2.0	2.1	1.3	1.0	4.7	1.4	2.8	0.0	0.0	0.0	1.5	0.0	0.1	0.5	0.5	0.9	0.0	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.3	18.6	28.5	24.2	37.4	25.0	26.7	28.8	23.8	40.5	21.1
DNAJC7	"TPR2, TTC2"	ENSG00000168259	"DnaJ heat shock protein family (Hsp40) member C7"	Q99615	17	41976433-42021376	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023015, HPA052395"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023015: AB_1847804, HPA052395: "	"unprognostic (3.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavourable (3.35e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.93e-3)"	22.9	24.2	42.0	27.6	49.3	24.7	28.3	36.6	44.1	22.2	30.5	25.0	21.0	21.5	18.6	32.3	31.4	19.3	19.9	30.6	36.5	38.6	36.9	30.8	21.8	30.1	38.1	30.5	26.4	29.0	37.7	38.2	24.4	48.2	20.4	29.0	21.0	21.0	22.1	44.3	28.0	22.4	18.9	28.9	23.7	22.0	25.2	32.9	31.8	26.5	29.0	40.9	24.3	33.5	15.8	48.1	14.0	21.2	17.8	16.2	13.2	19.4	33.3	31.2	23.3	19.1	32.2	26.6	20.0	28.5	38.0	30.5	38.4	19.8	30.1	23.9	29.1	29.3	49.1	36.0	45.4	26.8	68.8	24.2	28.4	53.3	27.4	35.1	22.0	26.8	21.2	35.0	32.8	29.9	37.1	21.3	32.1	16.3	37.9	29.1	30.5	24.3	26.5	35.6	26.5	28.5	25.5	30.4	23.9	16.9	49.9	24.5	28.0	29.3	23.5	20.9	19.7	21.8	33.2	15.6	35.2	27.8	22.6	25.7	22.1	14.0	20.6	13.6	13.2	21.2	14.6	15.8	14.6	15.1	21.6	15.0	14.4	13.8	8.9	17.8	20.4	48.1	16.2	13.2	42.0	49.3	36.6	44.1	36.5	38.6	38.1	30.5	48.2	32.9
DNAL4	"dJ327J16, PIG27"	ENSG00000100246	"Dynein axonemal light chain 4"	O96015	22	38778508-38794198	"Disease related genes, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003647	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Nucleoli, Cytosol"	"HPA003647: AB_1078712"	"unprognostic (8.45e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.07e-1)"	"prognostic favourable (1.20e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.83e-2)"	8.2	11.4	24.1	9.6	21.9	3.9	13.7	8.6	19.8	17.8	10.1	8.5	19.7	7.3	9.8	15.0	12.3	33.5	12.7	9.9	17.7	15.2	16.0	7.1	12.8	7.5	9.5	15.7	15.8	14.9	19.2	19.3	11.9	7.9	13.2	9.2	13.1	16.4	16.3	4.4	11.4	8.0	7.7	6.4	7.5	11.1	36.5	9.7	13.2	26.1	6.6	8.6	8.4	9.1	12.6	14.8	17.5	11.2	15.7	16.6	8.1	8.8	4.5	9.1	8.1	11.6	11.7	0.0	3.7	7.3	5.8	6.4	2.8	10.5	2.2	8.2	5.5	4.3	5.7	10.1	4.1	5.5	7.4	1.2	1.3	3.1	18.5	7.1	1.9	9.4	33.0	7.8	14.1	8.4	2.6	4.5	7.2	11.0	6.6	7.0	3.5	3.6	6.4	3.9	2.9	12.3	5.3	12.8	6.9	7.8	6.0	15.3	10.9	6.8	5.1	5.3	5.4	8.1	3.8	2.8	0.8	1.0	16.0	2.4	5.1	15.6	9.6	12.8	13.5	9.5	16.6	8.7	11.2	12.1	9.8	12.6	13.3	11.0	17.5	15.7	11.2	14.8	10.2	8.1	24.1	21.9	8.6	19.8	17.7	15.2	9.5	15.7	7.9	9.7
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009952, HPA039324"	Supported		Enhanced	Vesicles,Cytosol			10000000	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: "	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	15.4	16.2	24.9	14.8	34.4	22.3	14.3	40.5	37.8	13.0	14.5	12.4	14.9	12.3	16.5	16.5	19.8	13.3	11.9	25.4	26.1	28.1	19.4	12.8	11.2	13.8	23.4	23.2	14.1	9.8	28.7	18.8	16.0	27.9	19.3	16.0	12.1	11.1	21.1	25.6	11.8	11.0	21.7	21.7	11.6	12.2	23.1	14.9	13.4	15.2	17.4	15.8	16.9	12.2	5.9	17.0	5.0	14.6	7.2	7.9	7.1	22.1	22.1	23.2	23.8	18.8	19.3	44.9	24.9	19.2	23.5	21.8	31.0	17.0	29.8	17.5	22.5	19.9	24.4	28.6	28.3	15.7	19.9	33.9	21.3	17.0	15.5	24.0	17.9	17.4	14.5	24.9	25.7	28.4	24.5	12.9	26.9	8.6	9.6	20.2	48.9	10.8	16.2	43.7	20.3	19.8	30.5	20.3	20.8	26.5	18.2	19.4	20.9	16.4	25.6	20.1	20.2	47.1	23.1	9.1	24.6	31.1	19.5	16.1	15.2	5.0	9.7	3.1	5.6	14.6	6.8	5.9	6.0	5.9	17.0	5.2	7.3	7.9	1.7	7.2	13.6	5.4	6.1	7.1	24.9	34.4	40.5	37.8	26.1	28.1	23.4	23.2	27.9	14.9
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"			500000	"Golgi apparatus, Cytosol"		"HPA054246: "	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (8.91e-4)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	23.8	32.6	18.5	29.3	31.2	53.4	20.4	25.7	29.7	20.1	51.4	57.5	46.0	32.1	20.4	16.8	29.9	19.7	27.0	35.0	20.8	18.0	38.5	25.1	39.2	28.2	48.3	18.0	17.9	32.2	19.5	20.0	32.3	32.2	24.0	42.5	24.5	24.7	37.7	46.6	40.6	50.8	18.6	43.1	37.6	48.2	23.3	36.4	39.1	23.5	21.1	41.5	35.7	31.5	3.4	11.1	8.6	9.8	10.1	5.8	4.6	34.9	28.9	21.2	16.9	21.9	21.5	27.2	23.4	22.2	34.7	29.5	28.8	23.1	25.4	42.2	25.2	30.7	28.9	25.4	29.1	31.1	23.0	48.7	25.8	32.2	27.0	26.7	46.3	22.0	19.6	26.5	25.0	33.7	39.1	43.7	21.3	42.3	37.2	25.5	24.1	35.0	37.8	23.0	28.6	22.8	52.7	30.6	20.0	26.7	22.9	16.7	18.4	31.8	30.5	38.1	12.9	53.5	30.9	36.2	36.9	23.4	28.5	40.9	18.8	3.0	4.5	8.6	5.6	8.2	5.1	3.4	4.2	5.8	5.3	3.1	2.4	4.1	8.5	10.1	9.8	11.1	4.8	4.6	18.5	31.2	25.7	29.7	20.8	18.0	48.3	18.0	32.2	36.4
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009919	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"				"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: "	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favourable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (6.15e-4)"	11.0	4.8	3.7	8.3	3.6	5.8	8.4	9.2	4.4	13.0	24.9	3.2	23.0	14.5	15.6	11.1	8.2	9.2	10.2	6.0	3.1	2.6	11.1	8.6	6.6	4.5	2.3	3.0	13.8	22.3	24.6	5.0	8.5	3.5	11.6	13.8	8.5	7.2	23.3	10.2	20.0	38.3	15.9	3.1	6.2	15.3	8.6	2.3	30.4	7.1	8.8	7.7	17.4	16.8	4.3	0.8	1.6	2.7	5.3	1.7	1.2	10.8	8.9	8.1	12.8	14.9	12.5	1.9	19.6	19.0	9.5	9.2	6.0	16.5	11.3	8.4	15.0	8.6	9.4	11.3	13.4	0.6	2.9	1.6	10.1	4.2	7.7	1.1	0.8	5.9	2.5	11.7	10.4	22.7	1.5	0.0	19.2	1.3	1.9	2.1	7.8	5.4	2.3	8.3	0.5	16.2	9.4	1.4	1.8	3.2	0.8	2.4	0.7	1.0	27.4	7.1	6.8	5.7	12.8	0.9	0.7	15.9	6.8	3.6	5.3	0.0	1.8	0.4	1.7	2.7	1.6	3.0	0.4	1.2	0.8	4.3	0.4	0.8	1.6	5.3	2.7	0.6	0.0	1.2	3.7	3.6	9.2	4.4	3.1	2.6	2.3	3.0	3.5	2.3
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219373527-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol			6200000	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	20.1	12.3	8.8	15.5	10.4	7.2	20.0	7.2	9.3	16.5	30.4	8.6	13.8	27.9	15.1	13.3	16.9	15.3	16.6	22.9	10.4	6.8	21.2	33.5	15.5	11.7	10.5	7.2	19.4	19.0	9.7	11.0	28.5	9.4	21.0	15.8	15.9	18.7	14.7	36.6	14.6	50.3	12.9	6.8	17.5	15.2	33.7	9.3	11.3	15.0	20.0	17.4	20.7	13.1	11.6	16.1	5.8	15.0	15.7	15.7	10.9	16.0	8.8	5.4	16.1	14.4	11.9	43.0	8.0	16.2	20.9	22.1	24.3	21.2	9.8	17.3	16.6	15.8	6.5	18.3	7.6	19.2	4.6	15.9	9.0	26.4	38.2	13.1	11.4	19.3	19.5	21.5	18.0	14.3	17.9	15.8	10.7	34.9	20.0	14.6	8.9	5.5	26.0	12.4	12.9	11.6	25.0	6.8	9.2	9.3	30.8	11.3	9.0	14.5	7.9	20.1	16.6	10.5	11.5	17.7	10.3	7.0	28.6	12.6	8.5	5.8	13.2	5.4	13.6	15.0	15.4	10.2	11.0	15.0	16.1	11.6	12.0	15.7	1.0	15.7	12.2	5.8	12.6	10.9	8.8	10.4	7.2	9.3	10.4	6.8	10.5	7.2	9.4	9.3
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229484	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol			370000	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	17.4	25.5	24.1	16.2	27.5	10.1	8.4	7.0	18.7	11.9	39.3	15.0	10.2	53.1	12.3	13.2	19.3	19.5	18.5	12.0	17.3	16.7	48.7	34.7	10.0	14.8	17.2	14.0	13.7	38.8	17.2	9.3	7.3	13.4	13.1	9.7	16.9	22.4	11.8	40.8	10.7	51.0	10.4	10.4	18.8	22.2	5.4	10.8	14.6	14.2	19.2	19.3	12.2	8.9	44.1	36.2	0.9	46.7	7.5	52.6	19.5	35.6	26.2	4.1	16.9	2.9	9.0	12.7	8.7	3.1	5.9	7.7	10.7	13.0	25.7	13.8	2.9	18.3	3.1	6.9	1.7	13.6	62.2	12.1	24.0	30.3	6.9	10.2	7.9	5.6	8.8	1.7	5.3	7.7	27.3	45.6	4.7	59.0	9.7	25.5	8.1	15.9	16.5	5.4	65.0	10.1	12.2	15.8	19.0	8.0	21.3	17.5	29.2	33.9	9.6	4.5	7.8	10.2	17.1	31.9	14.6	20.0	2.8	13.6	7.0	0.1	23.3	0.9	9.2	46.7	16.7	44.1	30.4	16.2	36.2	38.2	27.2	18.3	0.8	7.5	33.2	27.4	52.6	19.5	24.1	27.5	7.0	18.7	17.3	16.7	17.2	14.0	13.4	10.8
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304396-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Terminal addition"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 171.0"	"Group enriched"	"Detected in some"	420	"MOLT-4: 48.7;REH: 168.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"naive B-cell: 1.2;naive CD4 T-cell: 4.5"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036532: , HPA044194: AB_10960525"								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.1	0.1	0.3	24.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.7	0.0	171.0	0.6	0.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	168.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042445	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;lymphoid tissue: 27.6"	"Cell line enhanced"	"Detected in many"		"BJ: 20.0;HDLM-2: 22.7;TIME: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA058106: "	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.2	7.6	17.1	16.7	28.8	8.8	4.0	3.0	18.4	9.5	5.9	27.6	0.0	4.1	3.4	1.4	3.4	2.5	6.4	1.8	24.3	14.7	2.9	5.4	7.3	23.9	33.3	9.6	15.9	1.8	1.9	1.4	2.5	23.2	2.0	6.7	1.1	4.1	2.0	1.3	5.0	8.5	4.4	37.7	26.5	6.1	2.3	35.5	27.6	2.7	1.3	18.4	6.6	3.7	6.8	6.2	2.6	9.6	12.8	10.5	4.0	0.0	9.4	3.0	0.0	3.9	8.3	0.0	20.0	16.4	9.6	7.2	0.0	0.0	0.2	0.0	12.6	0.2	0.0	0.0	7.7	22.7	0.0	0.2	2.0	0.0	0.1	1.9	0.9	1.9	0.2	13.9	5.4	9.5	0.0	18.8	16.2	0.9	3.4	2.6	1.1	2.2	4.5	4.4	2.7	0.5	0.0	0.1	2.5	0.0	0.0	2.0	0.6	8.7	21.2	10.4	2.5	4.9	6.8	0.0	0.0	0.0	14.7	12.9	4.5	2.6	2.8	0.2	6.2	8.2	6.4	6.8	10.5	8.8	6.2	3.8	10.4	9.0	0.1	12.8	9.6	2.6	7.5	4.0	17.1	28.8	3.0	18.4	24.3	14.7	33.3	9.6	23.2	35.5
DOCK3	"KIAA0299, MOCA, PBP"	ENSG00000088538	"Dedicator of cytokinesis 3"	Q8IZD9	3	50675241-51384198	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.0;HAP1: 5.4;HEK 293: 5.5;HMC-1: 6.4;U-87 MG: 10.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037543, HPA037544"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA037543: AB_10672495, HPA037544: AB_10670383"	"unprognostic (1.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-3)"	"unprognostic (6.35e-8)"	"unprognostic (2.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.83e-5)"	"unprognostic (7.96e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.24e-1)"	1.6	5.5	15.3	1.7	19.8	1.6	1.7	24.2	38.9	1.7	2.3	11.6	1.9	1.7	2.1	2.7	4.2	2.2	1.9	4.6	11.5	9.8	1.9	1.3	1.8	1.8	9.1	17.6	1.7	2.0	15.8	9.2	1.5	13.1	3.8	1.9	1.8	3.2	5.0	4.3	4.0	1.7	3.1	8.5	1.8	1.7	9.0	10.7	0.0	17.4	0.0	1.9	2.0	0.7	0.7	0.7	0.2	2.0	0.6	1.3	0.0	0.1	0.2	0.2	8.0	0.0	0.0	3.5	0.1	0.2	0.4	0.3	0.2	0.5	0.0	0.7	2.5	0.5	5.4	0.0	0.1	4.6	5.5	0.1	1.3	0.1	0.1	0.2	6.4	0.1	0.2	0.3	0.0	0.1	0.0	0.1	0.6	0.3	0.0	0.0	2.6	2.5	0.0	0.8	0.0	0.4	0.7	4.9	0.0	0.4	4.5	0.1	0.1	0.0	0.5	0.3	2.2	0.3	2.8	0.3	0.0	0.0	10.6	1.0	0.1	0.0	0.1	0.2	0.5	0.4	0.5	0.4	0.4	0.2	0.1	0.7	1.3	0.5	0.2	0.6	2.0	0.7	0.1	0.0	15.3	19.8	24.2	25.3	11.5	9.8	9.1	17.6	13.1	10.7
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206411	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.7;HUVEC TERT2: 35.6;TIME: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: "	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	10.7	6.5	16.5	10.0	28.2	2.3	6.8	11.7	28.2	9.1	4.4	21.0	2.0	2.8	7.9	4.4	4.4	8.7	7.9	6.9	22.2	10.1	7.3	13.9	25.5	3.7	18.2	12.4	14.2	5.0	4.7	4.0	10.8	12.2	6.5	4.9	1.7	4.4	3.9	6.7	3.5	3.2	10.7	20.3	3.2	3.1	3.5	21.8	0.0	5.8	2.7	3.6	5.7	5.2	0.2	0.3	6.4	1.2	0.1	0.1	0.2	0.0	1.6	4.0	3.2	3.3	4.9	2.3	0.4	4.4	0.8	1.3	0.0	0.0	0.3	3.3	1.0	0.1	0.6	3.8	3.4	1.2	6.6	0.1	2.7	5.6	2.4	0.5	0.2	2.6	0.4	18.7	9.7	35.6	0.0	10.1	1.7	0.4	0.8	0.2	2.1	6.9	0.2	2.9	1.6	2.7	0.1	0.9	3.1	2.5	2.0	2.4	0.3	0.1	30.7	3.1	1.5	6.0	1.3	0.4	0.1	0.3	0.3	0.7	6.9	0.2	0.7	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	6.4	0.1	0.2	0.3	0.0	0.2	16.5	28.2	11.7	18.2	22.2	10.1	18.2	12.4	12.2	21.8
DOCK5	FLJ21034	ENSG00000147459	"Dedicator of cytokinesis 5"	Q9H7D0	8	25184723-25418082	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017719, HPA056837"	Approved		Enhanced	Cytosol				Cytosol		"HPA017719: AB_1847820, HPA056837: "	"unprognostic (2.16e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.25e-2)"	"prognostic favourable (1.91e-4)"	"unprognostic (8.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.18e-3)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (1.18e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	5.5	4.3	12.1	10.4	30.3	26.2	7.2	3.3	18.2	6.3	11.5	38.8	12.1	14.9	6.3	7.8	4.3	7.6	9.6	8.0	15.1	7.6	4.8	16.2	10.7	4.7	35.0	9.4	10.4	5.7	6.3	10.8	15.6	18.8	9.4	13.4	10.8	7.9	14.3	3.3	7.1	17.0	5.3	17.0	21.9	9.2	7.8	33.8	0.6	18.5	2.3	2.7	5.6	5.8	0.0	1.6	22.0	4.6	0.3	0.3	0.2	10.2	21.5	2.1	0.2	5.0	5.4	7.8	25.0	12.7	6.1	4.8	3.1	7.4	0.3	2.3	19.3	17.9	2.4	15.8	9.8	3.3	3.1	10.3	18.5	7.5	5.8	2.4	11.4	3.7	6.4	6.8	10.0	5.2	0.1	0.5	5.9	5.9	0.3	4.7	2.2	6.8	0.1	4.8	0.2	4.4	6.1	1.5	0.7	13.1	7.2	2.3	2.3	2.2	15.7	10.5	7.4	13.0	8.9	0.5	0.1	0.2	13.6	5.5	13.2	7.6	1.9	2.6	0.3	3.8	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	22.0	0.3	4.6	0.2	0.0	0.2	12.1	30.3	3.3	18.2	15.1	7.6	35.0	9.4	18.8	33.8
DOCK6	"KIAA1395, ZIR1"	ENSG00000130158	"Dedicator of cytokinesis 6"	Q96HP0	19	11199295-11262481	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 32.5;TIME: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049423, HPA049424"	Approved		Supported	Cytosol				Cytosol		"HPA049423: , HPA049424: "	"unprognostic (2.69e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.72e-3)"	"prognostic favourable (9.09e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.95e-1)"	17.8	4.9	6.4	5.1	7.9	0.0	12.8	3.3	8.5	7.1	12.6	6.7	6.5	10.3	11.0	8.6	9.3	4.9	8.8	10.5	6.1	2.3	12.2	7.3	19.7	3.6	8.1	2.0	5.8	8.1	3.7	6.2	11.1	6.7	7.1	4.5	10.2	7.4	5.8	9.8	18.2	11.7	13.4	5.5	7.1	10.3	5.4	5.3	1.3	14.5	8.6	7.6	7.3	22.9	1.5	0.0	0.0	0.5	0.0	0.3	0.2	6.6	4.2	4.8	3.9	3.6	5.2	7.7	2.0	3.3	2.0	3.1	7.8	5.2	0.4	12.3	3.3	3.9	2.0	10.5	1.2	5.7	3.3	1.3	0.9	5.8	5.8	1.9	6.6	4.0	6.2	3.6	8.2	32.5	7.1	0.0	4.3	15.1	0.0	6.7	6.0	7.9	0.4	3.2	6.3	3.2	9.3	0.2	8.5	1.9	2.0	3.6	2.3	3.5	32.3	3.7	3.8	8.2	3.5	0.6	0.1	6.5	3.1	1.4	3.2	0.0	0.3	0.0	0.3	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	6.4	7.9	3.3	8.5	6.1	2.3	8.1	2.0	6.7	5.3
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 40.5;lymphoid tissue: 61.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.0;HL-60: 16.8;MOLT-4: 15.7;NB-4: 26.6;REH: 19.8;RT4: 17.5;THP-1: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003218	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol				Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695"	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favourable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favourable (6.89e-6)"	6.7	12.9	5.6	27.4	8.4	20.8	6.1	1.2	4.1	3.1	3.9	9.2	0.9	3.9	3.0	4.3	6.0	4.1	8.2	2.9	6.3	3.3	7.5	3.9	16.8	35.3	10.2	2.3	2.5	6.4	7.6	3.5	10.4	8.1	4.9	4.1	4.4	10.5	2.4	1.7	3.3	15.0	3.4	13.6	43.5	4.9	7.2	8.9	61.0	5.1	3.0	27.1	10.5	4.0	7.3	15.4	40.5	21.5	6.6	5.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.5	0.4	17.0	1.2	0.0	0.7	0.2	0.1	0.0	5.8	0.6	0.0	0.0	0.0	0.0	16.8	2.3	0.0	3.1	0.0	0.0	0.0	3.7	8.6	0.0	1.0	15.7	26.6	0.0	0.2	19.8	0.0	6.5	0.0	17.5	0.0	0.0	0.0	0.2	1.1	0.4	50.6	3.3	0.0	0.1	0.2	0.0	3.4	0.0	0.0	0.0	10.6	0.3	14.2	14.7	16.7	4.6	15.1	3.8	7.3	5.5	4.8	15.4	6.8	4.4	4.2	40.5	6.6	21.5	4.4	5.3	6.4	5.6	8.4	1.2	4.1	6.3	3.3	10.2	2.3	8.1	8.9
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490822-3500940	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favourable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	8.1	6.5	10.5	6.6	13.0	9.3	3.4	5.5	13.0	3.9	5.5	6.9	2.6	18.9	3.7	4.1	4.1	3.1	4.9	5.1	14.9	9.1	6.0	6.4	4.0	4.5	18.2	6.2	3.8	7.6	3.8	3.9	3.8	8.4	5.1	2.0	3.2	6.0	4.0	23.1	7.0	12.3	2.4	25.5	5.9	7.3	4.2	6.1	4.7	2.9	7.8	4.5	3.1	4.7	11.6	11.0	1.8	6.6	6.9	12.3	4.4	9.1	11.0	1.7	3.6	0.9	1.0	7.3	8.7	1.8	4.3	3.4	15.2	3.8	7.2	6.8	1.3	9.5	2.7	3.0	0.9	10.5	12.3	7.5	6.2	18.1	3.5	9.9	10.4	1.2	3.0	4.1	1.8	2.2	16.2	8.5	1.7	10.4	10.8	11.3	9.7	14.8	12.2	4.0	10.3	2.6	5.1	10.4	7.7	6.1	5.4	8.7	7.5	5.5	5.0	5.4	7.4	14.2	15.9	11.3	8.1	9.5	6.4	22.6	6.4	1.1	5.3	1.8	6.2	6.2	8.1	8.1	8.5	12.3	8.7	11.6	12.3	10.4	0.3	6.9	6.6	11.0	9.6	4.4	10.5	13.0	5.5	13.0	14.9	9.1	18.2	6.2	8.4	6.1
DOK1	p62dok	ENSG00000115325	"Docking protein 1"	Q99704	2	74549026-74557554	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004224, HPA048561"	Approved		Supported	Cytosol			74000	Cytosol		"CAB004224: AB_627447, HPA048561: "	"unprognostic (2.40e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.60e-1)"	"prognostic favourable (8.42e-4)"	"unprognostic (9.86e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.10e-2)"	"prognostic favourable (4.64e-4)"	"unprognostic (7.57e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (3.16e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-2)"	13.2	4.9	4.7	11.2	6.0	15.7	13.3	1.3	3.3	6.2	5.9	5.3	2.6	4.3	7.0	3.6	3.4	5.5	8.0	5.0	4.9	4.2	4.7	2.3	8.0	9.5	6.9	2.8	6.7	10.9	5.5	3.1	5.0	5.4	5.6	5.1	3.1	4.1	5.0	2.0	2.2	7.2	4.7	6.7	15.5	6.6	4.5	5.2	14.5	8.8	1.3	10.8	5.0	7.7	6.9	13.9	17.9	16.1	7.4	5.6	9.9	2.1	0.6	2.0	1.5	4.3	4.7	1.9	4.3	2.7	1.3	2.1	0.7	2.2	1.0	6.8	4.1	0.3	2.9	1.2	0.7	31.2	2.9	13.3	1.9	0.1	3.6	7.6	14.3	4.5	0.0	10.7	4.9	1.7	4.1	2.8	3.1	2.2	6.1	16.6	4.1	0.9	4.9	3.9	1.6	1.0	1.9	0.9	3.7	1.4	0.2	3.4	1.5	11.1	3.4	10.5	6.1	5.7	1.0	4.4	3.2	0.0	10.1	10.8	1.8	10.8	15.1	11.3	4.9	14.3	4.1	6.7	3.9	4.2	13.9	6.9	3.6	3.6	17.9	7.4	16.1	2.9	5.6	9.9	4.7	6.0	1.3	2.8	4.9	4.2	6.9	2.8	5.4	5.2
DOK6	"DOK5L, HsT3226, MGC20785"	ENSG00000206052	"Docking protein 6"	Q6PKX4	18	69401055-69849087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.4;Hep G2: 10.9;RPMI-8226: 10.6;SCLC-21H: 4.8;SH-SY5Y: 10.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041099, HPA063534"	Approved		Approved	"Focal adhesion sites,Cytosol"				"Focal adhesion sites, Cytosol"		"HPA041099: , HPA063534: "	"unprognostic (5.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.62e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.13e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.09e-3)"	2.1	1.6	21.3	1.6	11.3	0.6	1.3	6.8	22.1	3.8	1.5	0.9	0.3	1.0	3.0	1.4	1.7	1.7	5.8	10.2	19.2	9.2	8.7	4.4	4.2	1.2	13.7	13.1	4.2	0.7	3.4	1.1	9.9	14.0	3.5	1.3	5.5	1.7	4.2	0.6	1.2	1.3	6.6	2.7	1.8	1.3	2.8	2.7	0.0	4.1	0.0	1.2	5.2	6.6	0.0	0.0	0.0	0.0	0.9	0.9	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	10.4	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	10.9	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	10.6	0.0	0.0	4.8	10.9	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.6	0.0	1.5	0.3	0.0	0.0	3.1	0.0	3.2	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.0	0.9	0.0	0.0	0.3	0.4	21.3	11.3	6.8	17.1	19.2	9.2	13.7	13.1	14.0	2.7
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947619	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Enhanced	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: , HPA068706: "	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favourable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (6.88e-5)"	"unprognostic (6.13e-3)"	11.0	20.2	7.9	7.8	13.8	1.4	9.5	7.0	18.6	9.8	8.6	14.9	7.1	8.8	12.4	16.8	10.9	10.8	10.8	12.0	7.6	9.9	17.5	22.0	10.6	10.6	8.1	6.7	13.2	16.9	19.2	8.0	19.5	16.3	12.3	8.0	14.2	15.5	12.8	7.9	11.4	10.9	11.1	5.9	11.6	12.4	22.4	6.0	12.5	11.0	11.9	12.1	10.4	7.3	9.4	14.2	5.6	16.4	9.8	13.7	9.0	5.1	19.1	6.8	10.0	20.1	10.6	9.2	10.7	17.4	13.2	9.8	15.0	8.1	2.8	5.7	15.5	36.4	9.2	13.4	6.8	4.7	8.1	3.5	13.1	10.8	20.3	3.8	6.3	14.6	12.4	14.2	7.8	12.8	8.5	4.5	14.2	25.2	3.1	3.2	8.7	11.9	3.1	9.0	11.1	11.8	7.7	6.2	7.0	14.2	11.7	6.3	20.5	5.0	10.6	11.9	4.3	14.9	8.8	4.3	10.7	2.8	11.2	3.5	9.0	2.3	13.5	5.6	10.2	13.3	9.1	9.4	9.2	11.2	14.2	9.2	12.1	12.3	2.1	9.8	16.4	8.1	13.7	9.0	7.9	13.8	7.0	18.6	7.6	9.9	8.1	6.7	16.3	6.0
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"Downstream neighbor of SON"	Q9NYP3	21	33559542-33588708	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: , HPA049033: "	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	6.4	3.5	4.1	9.2	8.0	9.4	10.2	7.8	5.6	6.8	7.1	3.3	3.5	6.1	6.7	5.8	8.3	6.3	5.9	7.5	5.5	4.4	5.6	16.2	5.2	11.1	4.7	4.0	13.5	5.7	11.7	6.9	12.2	8.1	5.7	7.4	4.4	4.8	4.3	5.9	9.1	9.3	5.4	5.2	8.2	5.8	24.0	3.0	26.4	5.0	8.1	10.7	4.5	9.7	0.7	0.5	0.1	0.9	0.4	1.4	0.3	27.0	6.3	13.3	11.6	4.2	7.7	10.4	21.6	9.3	16.6	18.8	17.8	7.4	14.7	5.6	10.7	8.1	17.9	7.7	18.2	14.7	15.5	27.6	13.9	16.1	3.0	14.6	6.7	5.5	2.5	18.7	4.6	10.6	26.3	25.7	14.2	5.5	13.3	5.2	13.8	7.8	12.0	27.6	15.7	7.4	7.3	14.5	6.0	32.4	10.4	9.5	13.6	7.4	6.1	15.8	11.0	11.5	15.2	23.3	22.9	24.2	8.8	19.5	17.8	0.0	0.3	0.1	1.4	0.9	0.7	0.2	1.4	0.6	0.2	0.7	0.8	0.1	0.0	0.4	0.0	0.5	0.6	0.3	4.1	8.0	7.8	5.6	5.5	4.4	4.7	4.0	8.1	3.0
DPF1	"BAF45b, NEUD4, neuro-d4"	ENSG00000011332	"Double PHD fingers 1"	Q92782	19	38211006-38229714	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 31.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.4;SCLC-21H: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049148	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA049148: "	"unprognostic (7.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-16)"	"unprognostic (2.56e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.96e-2)"	"unprognostic (8.20e-4)"	1.1	1.5	11.8	1.5	15.7	1.0	0.9	6.4	31.6	0.8	1.0	0.9	0.0	0.9	1.0	0.8	0.8	1.0	1.0	1.0	12.4	7.7	0.8	0.8	1.0	1.1	4.5	11.3	0.9	0.9	0.9	1.3	1.1	2.0	0.9	0.9	0.0	1.2	0.8	1.1	1.2	1.0	1.3	2.1	1.1	0.8	2.5	1.2	0.0	0.8	0.0	1.1	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.4	2.9	12.5	9.1	0.9	0.6	1.2	3.7	2.1	6.3	5.4	2.1	0.3	5.7	2.5	2.8	2.2	15.4	2.1	2.8	5.4	3.0	1.9	1.4	0.8	0.3	1.4	1.6	0.7	0.0	3.8	1.2	1.1	4.2	0.3	6.0	4.8	3.0	0.3	2.2	3.5	5.7	6.3	1.2	0.6	1.0	18.2	6.3	4.2	0.4	0.8	1.9	0.3	1.4	9.2	2.9	2.2	3.3	2.3	7.5	7.6	4.8	2.0	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	11.8	15.7	6.4	19.6	12.4	7.7	4.5	11.3	2.0	1.2
DPH3	"DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2"	ENSG00000154813	"Diphthamide biosynthesis 3"	Q96FX2	3	16257978-16264972	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035287	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA035287: AB_10604113"	"unprognostic (2.49e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.44e-2)"	17.6	13.9	15.7	10.6	14.8	8.0	21.3	10.7	15.0	12.6	15.3	8.9	8.2	12.4	13.2	13.0	12.6	11.5	12.1	15.4	14.2	17.3	17.9	27.4	12.5	10.0	19.3	6.9	15.8	9.1	7.6	19.3	17.3	18.6	11.0	10.4	5.6	7.2	13.6	33.2	5.4	32.8	17.3	17.4	15.3	12.0	13.2	12.6	12.8	14.4	10.1	9.0	15.3	12.8	7.3	11.3	25.6	15.6	7.2	10.6	8.7	5.2	7.7	16.6	10.2	30.7	22.4	13.3	15.2	12.2	14.4	16.9	9.5	3.3	5.0	5.1	18.8	3.3	15.2	9.7	17.3	25.2	10.4	8.4	6.2	10.6	19.3	12.3	8.3	15.5	12.9	19.6	8.5	13.1	14.3	8.7	20.4	6.9	9.2	8.1	13.4	8.1	6.5	10.9	7.7	12.8	4.2	3.6	10.6	7.1	3.5	17.4	6.8	12.2	15.3	12.4	7.7	21.8	12.6	6.7	22.4	6.6	17.8	13.9	10.7	15.3	12.0	17.8	8.6	15.6	10.6	7.3	9.2	10.4	11.3	6.6	7.8	9.1	25.6	7.2	14.4	4.5	8.1	8.7	15.7	14.8	10.7	15.0	14.2	17.3	19.3	6.9	18.6	12.6
DPP3		ENSG00000254986	"Dipeptidyl peptidase 3"	Q9NY33	11	66480013-66509657	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035780, HPA035781"	Approved		Supported	Cytosol			2600000	Cytosol		"HPA035780: AB_2674778, HPA035781: AB_10669529"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.85e-2)"	"prognostic favourable (1.34e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.66e-2)"	10.4	13.0	5.2	16.8	12.1	10.9	16.9	13.7	11.5	7.3	18.5	9.1	10.3	15.3	10.5	6.8	15.6	7.1	15.7	8.4	9.3	5.9	18.4	31.1	9.8	20.0	9.5	10.6	5.1	11.6	11.2	6.9	10.9	7.4	10.3	16.9	5.7	17.6	8.5	15.8	9.4	15.5	10.0	10.6	12.5	11.8	15.5	6.7	16.1	10.5	10.8	14.0	11.4	8.6	7.5	19.7	12.2	24.4	18.2	17.9	9.9	28.5	24.8	11.5	12.8	9.6	10.4	17.9	16.2	21.8	21.9	14.6	31.2	24.0	16.6	55.2	18.3	25.7	18.3	19.8	14.1	31.5	8.3	21.6	11.6	18.3	14.8	26.1	36.1	14.7	19.4	16.4	8.2	16.7	15.1	9.9	19.9	32.4	30.4	26.6	19.6	15.2	21.5	11.6	27.2	18.8	24.6	21.8	18.7	13.8	16.1	21.6	25.0	15.3	17.4	13.1	14.3	14.4	15.8	8.3	15.1	18.9	17.4	12.5	16.1	9.6	11.3	12.2	13.7	24.4	8.4	7.5	10.3	11.4	19.7	7.2	6.3	9.2	2.0	18.2	16.0	13.7	17.9	9.9	5.2	12.1	13.7	11.5	9.3	5.9	9.5	10.6	7.4	6.7
DPP8	"DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141"	ENSG00000074603	"Dipeptidyl peptidase 8"	Q6V1X1	15	65442463-65517704	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008706	Approved		Supported	Cytosol				Cytosol		"HPA008706: AB_1078665"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.59e-1)"	15.6	16.1	16.4	14.9	18.8	16.2	13.9	22.9	24.9	15.5	14.5	15.0	12.7	18.0	15.9	13.9	13.1	11.1	12.4	18.8	15.1	14.6	16.0	9.9	13.3	16.0	15.4	11.8	16.2	11.7	22.2	14.5	15.9	21.7	13.5	15.8	13.9	15.6	20.8	30.5	14.2	16.5	16.2	17.5	17.2	13.2	29.9	15.8	22.5	17.4	12.5	16.0	16.2	13.2	10.7	8.1	20.0	10.8	6.1	10.3	5.3	9.4	15.3	10.1	10.1	11.4	16.4	8.6	15.3	18.1	13.7	13.2	6.6	8.2	16.7	12.1	19.1	17.7	19.5	11.0	16.8	14.1	12.1	16.1	11.8	6.3	11.9	20.7	15.9	12.2	10.5	11.1	10.5	15.0	10.9	15.6	16.8	7.6	11.0	7.6	6.9	7.9	14.7	18.7	16.2	11.3	20.6	7.2	12.7	9.9	10.1	15.4	9.3	12.4	18.9	18.4	12.9	8.7	16.3	20.2	26.4	17.0	13.9	20.9	13.2	20.0	9.1	11.1	9.9	9.2	10.3	9.2	8.6	9.5	8.1	10.7	8.6	9.2	18.3	6.1	10.8	7.5	8.9	5.3	16.4	18.8	22.9	24.4	15.1	14.6	15.4	11.8	21.7	15.8
DPP9		ENSG00000142002	"Dipeptidyl peptidase 9"	Q86TI2	19	4675224-4724673	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036059	Approved		Supported	Cytosol				Cytosol		"HPA036059: AB_10671240"	"prognostic favourable (4.96e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.03e-1)"	"prognostic favourable (6.21e-5)"	"unprognostic (5.67e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (3.38e-8)"	"prognostic favourable (7.72e-5)"	"unprognostic (1.55e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.80e-1)"	18.1	11.9	11.7	24.3	14.0	25.8	13.7	13.0	12.5	12.6	16.3	14.2	15.8	18.3	15.3	10.5	17.4	11.6	13.5	19.7	11.0	7.2	13.5	38.6	19.3	20.7	14.7	7.1	13.5	15.5	9.5	9.8	15.2	11.7	14.0	13.1	14.2	13.1	12.9	46.4	21.5	18.9	14.2	9.3	21.0	14.7	7.1	13.9	24.3	14.6	16.3	17.0	16.0	21.7	10.3	9.0	10.0	10.5	13.4	13.8	8.0	23.5	18.8	5.5	8.7	8.5	11.9	10.1	13.8	18.4	23.3	15.2	16.9	18.3	11.2	10.5	17.8	16.1	11.3	63.6	14.3	14.3	10.9	8.1	10.3	14.4	13.0	14.2	17.8	9.1	14.8	36.4	21.6	21.0	11.2	24.9	20.1	6.4	16.5	9.2	11.4	28.0	10.3	11.9	13.0	12.1	16.2	7.9	7.1	11.9	21.6	9.1	5.9	11.9	16.9	20.9	9.1	32.3	27.5	17.4	18.1	11.2	20.4	16.5	17.5	10.0	8.8	9.4	13.8	10.5	10.5	10.3	6.4	11.2	9.0	6.8	6.3	9.9	4.7	13.4	7.8	4.3	11.3	8.0	11.7	14.0	13.0	12.5	11.0	7.2	14.7	7.1	11.7	13.9
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.3;lymphoid tissue: 35.8"	"Group enriched"	"Detected in some"	5	"HAP1: 22.7;NTERA-2: 83.5"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 10.3"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 10.3"									"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB020678: , HPA035249: , HPA035250: "	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.1	0.1	0.2	0.3	1.0	8.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.1	0.2	1.3	0.6	0.8	0.3	0.0	0.0	0.0	0.0	2.2	4.2	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	8.1	0.0	35.8	0.1	0.0	1.0	0.4	0.1	0.9	10.3	0.0	0.0	0.7	0.2	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.7	0.0	10.3	0.0	0.1	0.2	1.0	0.1	0.3	0.6	0.1	0.3	0.0	0.4	0.0
DPYSL2	"CRMP2, DHPRP2, DRP-2, DRP2"	ENSG00000092964	"Dihydropyrimidinase like 2"	Q16555	8	26514022-26658178	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.4;Karpas-707: 62.2"	"Cancer enhanced"	"Detected in all"		"glioma: 89.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 25.5;monocytes: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002381, CAB018719"	Supported		Supported	"Plasma membrane,Cytosol"			3900000	Cytosol	"Plasma membrane"	"CAB018719: AB_2085366, HPA002381: AB_1847244"	"unprognostic (2.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (5.41e-5)"	31.6	21.7	53.5	13.4	48.1	3.0	21.3	51.8	137.0	14.6	12.2	54.7	3.9	7.1	14.2	8.1	12.0	14.7	18.0	27.2	52.9	48.6	12.1	11.2	45.3	9.9	56.5	45.4	25.8	7.5	5.1	7.2	25.6	46.9	9.8	12.4	8.2	6.5	10.3	10.9	10.2	9.7	19.9	70.1	19.0	8.5	7.5	44.9	5.8	7.7	5.2	12.3	14.0	13.1	3.2	25.5	0.6	26.7	4.0	4.6	8.8	4.7	22.7	22.4	11.9	60.4	27.9	2.2	9.2	21.4	8.8	11.5	8.8	6.8	7.0	6.7	28.7	4.6	23.5	9.2	8.4	15.8	2.0	7.9	8.6	12.4	38.7	1.7	3.2	34.5	13.3	24.0	14.0	17.6	0.2	62.2	8.8	3.0	13.5	1.7	17.5	4.4	18.0	9.0	4.6	14.7	5.4	10.2	21.5	11.2	0.1	6.0	1.7	3.2	31.7	20.0	8.1	16.5	4.0	8.8	9.0	5.5	28.9	10.4	10.1	0.4	24.0	0.2	3.5	26.7	1.2	3.2	3.1	2.3	25.5	1.7	1.6	2.1	0.6	4.0	16.2	15.1	4.6	8.8	53.5	48.1	51.8	68.4	52.9	48.6	56.5	45.4	46.9	44.9
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390811-147510056	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 91.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 34.8;SH-SY5Y: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Supported	Cytosol			170000	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (8.23e-4)"	21.7	7.2	22.9	18.9	20.4	0.5	14.1	6.7	31.0	26.8	39.7	20.9	31.4	6.8	38.8	28.0	28.8	20.1	33.9	18.5	23.7	24.7	2.5	1.8	16.2	6.1	16.7	15.2	33.0	2.2	1.0	4.2	7.1	27.0	40.0	14.3	32.3	7.1	61.4	22.1	7.3	12.9	91.4	24.7	9.1	15.0	12.1	15.9	0.3	7.2	15.5	9.6	45.6	18.9	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	6.0	10.9	0.0	0.4	11.1	0.2	5.7	27.4	12.2	16.3	18.8	0.5	0.0	1.6	16.6	0.6	2.2	0.2	13.7	2.6	4.9	0.0	5.2	0.0	11.0	0.0	0.0	2.1	0.1	26.3	10.4	34.8	0.0	0.2	6.9	0.0	0.0	0.1	23.1	9.0	0.0	23.1	0.0	10.7	2.3	8.0	117.8	0.0	0.0	1.8	0.0	0.1	15.2	8.9	6.7	21.6	21.0	19.5	3.4	0.0	8.2	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	22.9	20.4	6.7	12.5	23.7	24.7	16.7	15.2	27.0	15.9
DPYSL5	"CRAM, CRMP-5, CRMP5, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 47.1"	"Group enriched"	"Detected in some"	4	"AF22: 41.0;HAP1: 34.1;SCLC-21H: 48.9;SH-SY5Y: 28.9"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: "	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	1.2	4.7	6.1	1.6	18.4	1.1	1.1	7.8	36.6	1.4	1.6	43.5	0.0	1.7	1.2	1.1	1.3	1.2	1.1	1.1	10.3	11.3	1.2	1.1	1.1	1.1	24.3	8.8	1.1	1.1	1.1	2.8	1.2	21.9	1.3	1.5	1.6	1.1	1.1	1.2	1.2	1.7	1.6	47.1	1.1	1.1	10.3	19.7	0.0	1.1	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	41.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.0	0.0	34.1	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	48.9	28.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	18.4	7.8	11.8	10.3	11.3	24.3	8.8	21.9	19.7
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526336	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 41.0"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 6.4;Hep G2: 18.0;hTCEpi: 6.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039158	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039158: AB_10960125"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.1	0.0	0.1	2.1	0.2	0.0	0.1	0.1	0.1	0.8	13.3	0.2	0.1	14.7	0.1	0.1	3.7	0.2	3.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.0	0.1	0.2	5.1	0.1	0.6	0.1	0.1	1.5	41.0	0.3	0.1	0.2	2.9	0.1	0.1	0.2	0.1	0.7	1.5	1.1	1.4	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.5	0.1	0.3	0.0	0.0	0.7	0.1	6.4	0.1	0.0	0.3	0.4	0.1	18.0	0.0	0.2	0.3	0.0	6.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.1	0.0	2.5	0.0	0.6	0.0	0.0	0.8	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
DRAP1	NC2-alpha	ENSG00000175550	"DR1 associated protein 1"	Q14919	11	65919257-65921561	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006790	Uncertain		Approved	Cytosol				Cytosol		"HPA006790: AB_1078702"	"unprognostic (1.69e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.58e-2)"	"unprognostic (8.47e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (3.73e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.96e-5)"	"unprognostic (1.62e-1)"	39.1	41.0	45.9	39.7	43.2	41.8	22.4	43.1	53.5	22.0	27.2	28.4	17.1	30.2	27.2	19.4	32.3	20.2	27.2	41.0	40.5	36.6	23.9	27.7	24.7	34.0	37.1	40.6	24.3	39.1	21.6	25.2	24.6	33.3	25.9	12.7	18.9	27.7	28.4	84.4	31.2	26.6	28.4	32.7	38.5	25.1	46.9	30.8	40.2	40.3	42.0	25.8	25.2	23.8	21.6	30.9	45.7	84.6	31.2	24.6	16.7	58.7	22.9	13.0	25.3	12.8	25.1	7.7	68.4	34.3	43.0	28.3	8.4	34.2	15.2	31.1	52.6	25.3	5.0	34.0	18.7	22.0	7.5	18.4	9.3	8.1	22.9	15.2	24.9	15.6	14.1	46.2	31.3	16.0	7.8	28.9	47.1	29.4	27.5	26.5	18.9	62.6	24.9	11.1	32.6	13.9	7.5	14.1	15.3	16.2	17.6	35.0	22.0	12.8	46.5	55.8	51.4	107.3	63.1	23.8	19.9	15.8	54.9	9.8	76.8	21.5	20.6	45.7	23.5	50.3	21.5	21.6	21.5	24.6	30.9	19.8	21.3	22.9	27.3	31.2	84.6	22.6	24.4	16.7	45.9	43.2	43.1	51.1	40.5	36.6	37.1	40.6	33.3	30.8
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399523-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 86.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001218	Enhanced		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	14.5	18.1	12.3	10.6	18.1	11.9	15.3	14.1	20.9	12.7	10.5	13.3	11.7	9.3	13.6	17.6	13.4	14.7	8.4	18.5	11.2	12.7	15.3	15.7	9.4	11.1	12.6	14.9	15.7	16.4	14.2	11.9	19.6	17.2	13.5	13.3	14.3	17.0	13.3	47.0	11.9	10.1	14.9	10.9	11.7	12.4	86.8	9.9	23.6	17.8	12.1	15.7	15.0	10.5	29.4	25.2	25.1	27.1	25.0	27.6	24.8	22.0	18.2	22.6	18.6	20.3	24.0	18.1	20.7	25.2	38.9	32.7	29.7	11.3	32.5	11.2	25.9	18.9	38.9	25.1	42.5	15.1	47.2	20.9	20.9	29.9	29.2	50.3	19.7	20.4	18.8	31.5	47.8	26.9	26.9	14.0	29.8	25.9	20.1	25.8	18.0	20.3	27.7	36.0	28.4	25.5	20.3	24.1	15.1	23.2	23.2	29.5	17.4	22.2	15.0	17.5	23.3	17.6	23.2	19.0	21.4	31.3	17.1	22.2	22.5	13.7	23.9	25.1	20.5	27.1	23.8	29.4	22.1	25.2	25.2	21.7	24.7	23.9	5.4	25.0	19.9	22.1	27.6	24.8	12.3	18.1	14.1	20.9	11.2	12.7	12.6	14.9	17.2	9.9
DRG2		ENSG00000108591	"Developmentally regulated GTP binding protein 2"	P55039	17	18087886-18107971	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007716	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA007716: AB_1078705"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"prognostic favourable (1.56e-4)"	"unprognostic (1.26e-3)"	"unprognostic (7.86e-2)"	"unprognostic (8.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.88e-3)"	"prognostic unfavourable (7.34e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	19.9	19.9	16.1	17.5	21.8	17.4	19.3	14.7	30.8	19.3	19.3	22.9	16.6	19.2	23.5	22.8	21.6	25.2	18.2	22.4	15.7	17.0	19.1	31.9	15.7	21.2	17.6	16.1	27.6	23.9	20.6	18.8	22.4	17.9	21.1	13.4	18.4	21.7	21.7	33.3	19.4	17.9	18.3	17.1	20.7	17.6	14.6	17.2	21.6	23.6	21.2	25.6	20.5	18.0	12.6	18.4	17.0	20.9	20.0	19.8	14.0	16.8	24.1	8.2	8.1	15.3	16.3	15.7	11.9	11.8	19.3	18.0	25.5	10.1	16.3	15.5	13.7	17.8	13.5	16.5	13.1	14.4	36.9	7.1	12.8	14.2	16.6	6.5	11.4	18.1	14.7	19.3	16.3	18.4	12.5	6.4	11.2	19.0	17.3	11.0	6.1	17.7	18.6	19.9	30.2	11.5	9.9	4.7	13.3	11.8	7.0	14.6	13.9	9.9	13.8	9.3	8.9	10.9	19.5	7.3	8.9	9.2	13.4	11.9	17.1	11.6	15.9	17.0	19.8	17.2	16.4	12.2	14.7	15.8	18.4	12.6	14.0	15.3	2.1	20.0	20.9	10.3	18.3	14.0	16.1	21.8	14.7	30.8	15.7	17.0	17.6	16.1	17.9	17.2
DRGX	"DRG11, PRRXL1"	ENSG00000165606	"Dorsal root ganglia homeobox"	A6NNA5	10	49364181-49396016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"adrenal gland: 13.9;brain: 8.0"	"Cell line enhanced"	"Detected in some"		"RH-30: 8.1;SH-SY5Y: 36.6;U-2197: 13.2"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low region specificity"	"Detected in all"			HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA043978: AB_10961154"		"unprognostic (1.42e-2)"	"unprognostic (5.68e-2)"		"unprognostic (3.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.58e-1)"		"unprognostic (4.54e-2)"	"unprognostic (3.74e-2)"			"unprognostic (8.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"		0.2	13.9	0.0	0.4	0.2	0.3	0.1	0.4	3.3	0.0	0.4	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.1	2.0	0.6	0.0	0.0	0.0	0.9	0.0	4.8	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.3	0.0	8.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.3	0.2	0.3	2.0	0.6	4.8	0.0
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847139	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 22.2;pituitary gland: 9.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.4;MCF7: 12.0;NTERA-2: 3.3;SCLC-21H: 5.0;T-47d: 3.3"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019324	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA019324: "	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.9	1.1	12.7	0.9	10.3	0.9	1.2	3.0	22.2	0.9	1.0	8.2	0.0	1.0	0.9	2.8	0.9	1.1	1.0	0.9	10.1	8.6	0.9	1.4	1.0	0.9	6.8	10.1	0.9	1.2	0.9	9.1	2.9	9.5	1.0	1.0	0.7	0.9	1.0	0.9	0.9	1.0	0.9	3.7	2.9	0.9	2.0	6.9	0.0	0.9	0.0	0.9	1.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.7	10.3	3.0	14.7	10.1	8.6	6.8	10.1	9.5	6.9
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: "	"unprognostic (1.28e-1)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.4	2.2	7.8	7.3	21.1	14.0	8.8	12.3	29.0	15.5	22.7	0.0	2.9	0.2	1.1	21.4	19.9	1.1	28.9	20.3	10.7	4.8	0.7	3.3	0.1	23.6	0.4	0.5	29.6	12.5	17.1	16.8	9.1	0.2	4.8	7.3	0.3	1.3	0.6	4.2	0.6	1.8	7.2	4.9	10.2	0.7	2.6	2.0	11.9	0.0	0.2	0.1	1.2	3.4	15.6	4.6	3.9	9.8	1.0	0.3	0.5	8.3	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 homolog, MIS12 kinetochore complex component"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Cytosol"	"HPA002813: AB_1078343, HPA030627: "	"unprognostic (3.60e-2)"	"prognostic favourable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavourable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	6.7	10.4	5.6	15.6	7.4	11.6	8.2	5.4	7.2	5.1	8.6	4.1	9.5	6.3	9.5	12.0	9.1	5.0	8.1	6.2	5.1	4.7	5.8	8.6	6.1	11.0	4.8	3.9	5.3	5.4	3.6	7.6	12.9	5.1	6.5	10.3	10.1	9.7	8.1	4.6	7.3	8.8	5.9	4.1	11.6	7.0	27.2	4.1	21.2	6.3	11.4	13.8	5.8	5.5	10.9	25.4	21.7	5.9	5.6	6.5	3.7	13.1	11.9	14.0	11.1	5.5	7.2	9.2	16.1	13.6	24.7	27.9	20.6	17.0	15.1	10.7	8.7	17.3	13.0	12.6	23.6	6.7	8.3	29.5	11.4	13.8	1.2	16.9	13.0	2.8	3.6	17.1	5.4	12.0	11.5	12.6	16.2	9.4	21.6	13.0	6.5	21.0	17.0	42.6	10.1	6.2	7.8	14.3	6.5	20.0	20.6	9.7	21.0	11.4	6.3	22.6	13.8	22.1	17.3	10.6	14.2	17.2	19.0	15.3	16.1	21.7	3.6	7.5	4.4	5.9	4.9	8.8	4.8	5.8	3.9	10.9	5.9	5.5	6.5	5.6	5.0	25.4	6.5	3.7	5.6	7.4	5.4	7.2	5.1	4.7	4.8	3.9	5.1	4.1
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954628	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 92.5;hTERT-HME1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	26.5	29.2	43.4	11.7	57.1	2.5	59.2	43.6	52.4	53.8	31.5	32.1	11.5	15.1	53.6	21.7	37.1	19.4	16.8	28.1	41.2	36.2	18.0	26.6	29.4	5.4	56.5	28.9	30.3	14.0	32.1	28.2	15.1	53.9	22.6	17.4	8.4	23.6	25.3	57.5	81.8	16.9	53.6	54.9	12.8	14.8	11.7	66.5	6.1	7.6	33.6	7.7	19.7	23.7	0.6	5.3	0.3	1.7	2.1	0.4	0.3	11.9	5.7	7.7	4.4	12.8	20.2	4.4	16.1	15.4	6.7	7.5	3.3	3.2	1.8	6.7	36.4	8.4	6.5	28.4	13.2	11.4	9.7	3.4	10.4	6.1	11.5	3.2	0.0	8.9	92.5	16.2	68.5	12.6	2.7	7.9	17.3	3.3	0.9	1.3	5.9	4.2	0.0	6.0	2.7	20.2	15.4	10.3	7.7	6.9	2.4	11.0	3.7	5.2	33.8	14.8	12.4	7.0	13.3	8.9	6.3	0.9	10.5	1.7	7.0	0.3	1.7	0.0	0.3	1.3	0.1	0.2	0.4	0.0	3.2	0.6	0.1	0.2	0.1	2.1	1.0	5.3	0.0	0.3	43.4	57.1	43.6	52.4	41.2	36.2	56.5	28.9	53.9	66.5
DTD1	"bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68"	ENSG00000125821	"D-tyrosyl-tRNA deacylase 1"	Q8TEA8	20	18587893-18766644	"Enzymes, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol			180000	"Nucleoli, Cytosol"		"HPA040981: AB_10673268"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.53e-2)"	14.9	17.7	25.2	13.6	26.5	13.6	19.7	22.4	35.4	13.5	13.7	22.2	10.5	10.6	14.4	17.2	18.8	14.5	11.1	16.7	24.7	29.5	20.1	9.4	13.7	15.5	25.2	30.4	19.1	19.7	20.3	23.7	12.7	27.3	13.6	16.0	17.1	17.6	12.4	22.5	17.6	9.8	15.0	30.9	12.7	16.3	20.6	14.4	4.8	29.5	24.9	17.4	13.4	12.6	20.9	27.5	29.9	20.6	16.4	22.5	12.6	18.5	20.9	20.6	20.2	8.8	16.4	11.5	16.4	15.2	13.1	14.4	13.6	14.5	0.0	11.2	15.3	10.5	16.4	34.8	13.8	9.0	11.8	20.7	4.8	22.7	27.9	16.0	11.2	13.0	28.0	14.7	54.4	22.2	12.9	24.1	19.0	27.2	3.4	29.2	19.1	46.0	0.0	30.7	15.6	19.9	10.0	28.2	21.3	8.8	24.4	42.4	13.9	10.0	21.8	17.3	9.4	22.1	22.2	19.4	19.2	10.3	11.9	18.8	14.3	29.9	14.5	10.4	22.2	20.6	22.2	20.9	21.7	22.5	27.5	17.8	16.0	16.7	17.1	16.4	20.5	6.4	16.1	12.6	25.2	26.5	22.4	35.4	24.7	29.5	25.2	30.4	27.3	14.4
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: , HPA032031: "	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.5	10.7	18.4	9.2	1.1	2.3	9.0	15.8	9.8	14.9	22.3	6.6	11.1	9.5	5.9	6.0	9.8	24.2	13.3	21.6	11.5	11.6	15.2	14.1	8.1	0.0	19.9	9.5	1.0	0.4	24.2	12.9	6.8	18.1	19.4	17.2	5.0	26.6	9.1	21.2	12.4	21.1	32.4	18.4	4.2	8.7	11.5	18.0	15.0	14.4	6.5	12.2	9.1	3.7	15.0	11.2	15.4	17.7	7.1	11.1	22.0	7.6	13.2	14.5	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.7;lymphoid tissue: 13.3"	"Group enriched"	"Detected in some"	12	"Daudi: 40.0;REH: 16.4;U-698: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA051249: , HPA055275: "	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.7	2.3	6.1	8.9	7.0	3.2	3.9	7.3	8.3	0.8	0.7	1.1	0.5	1.6	2.0	0.5	1.2	1.7	1.0	2.7	5.4	5.9	1.7	6.4	0.5	13.3	3.7	4.2	0.5	2.0	0.0	2.2	0.9	4.6	0.8	0.2	1.4	3.2	0.5	0.5	0.5	2.2	0.5	1.1	9.8	1.0	4.9	0.5	0.5	1.3	0.5	8.1	0.5	0.5	2.3	0.0	0.0	0.0	1.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.7	0.0	16.4	0.0	0.9	0.0	0.0	1.0	2.7	0.1	0.1	0.9	0.0	0.1	0.4	0.0	1.5	0.0	0.0	0.2	0.0	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.2	6.1	7.0	7.3	7.1	5.4	5.9	3.7	4.2	4.6	0.5
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564238-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.3;BJ hTERT+ SV40 Large T+ RasG12V: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	32.3	13.0	5.9	22.7	8.4	8.1	11.2	2.0	6.8	14.2	18.5	5.9	6.0	14.8	14.0	12.8	17.9	12.0	15.1	21.5	5.0	5.1	17.3	39.2	21.3	18.3	6.4	3.3	21.7	18.5	10.3	13.9	22.2	6.5	20.9	12.1	7.6	13.9	9.8	14.6	6.2	31.8	10.8	9.7	35.2	12.4	4.9	6.9	24.8	23.9	8.0	18.3	17.0	22.1	6.4	6.5	21.9	13.6	7.8	10.2	6.7	11.4	3.5	1.0	3.0	4.7	10.9	3.9	3.0	11.1	35.3	43.7	3.4	11.8	1.3	5.9	4.9	11.6	3.5	4.8	7.8	9.7	1.3	10.0	2.6	3.6	9.3	5.1	7.9	9.4	5.7	5.3	3.0	6.6	1.2	7.2	2.6	3.5	12.4	3.6	0.6	6.5	13.8	8.1	2.2	9.0	7.4	1.5	1.6	6.2	2.8	22.3	3.2	6.5	8.1	4.0	5.7	0.4	3.8	2.6	1.4	6.1	7.0	6.7	4.1	12.5	8.5	8.7	9.3	13.6	10.2	5.9	7.8	10.0	6.5	6.4	7.1	7.6	21.9	7.8	13.5	0.7	7.4	6.7	5.9	8.4	2.0	6.8	5.0	5.1	6.4	3.3	6.5	6.9
DUS2	"DUS2L, FLJ20399, SMM1"	ENSG00000167264	"Dihydrouridine synthase 2"	Q9NX74	16	67987746-68079320	"Predicted intracellular proteins"	"tRNA processing"	"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042560, HPA043528"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA042560: AB_10965170, HPA043528: AB_10959753"	"unprognostic (2.21e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-1)"	"prognostic favourable (3.50e-5)"	"unprognostic (1.44e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.81e-1)"	6.9	8.2	7.0	12.5	11.3	8.6	6.7	7.6	15.0	6.4	9.2	12.8	5.1	6.1	10.1	5.4	13.6	6.1	5.8	5.9	7.0	6.2	7.0	10.3	7.6	18.3	9.2	10.5	6.0	5.1	11.1	6.6	10.3	9.5	6.2	9.1	9.9	7.2	5.7	10.3	11.6	11.2	8.5	7.9	18.4	7.1	32.2	10.8	6.9	6.3	8.8	21.0	8.5	8.1	23.9	8.7	34.2	13.7	7.9	5.1	6.1	9.5	15.2	6.3	10.1	5.2	10.2	11.7	9.3	9.0	19.9	13.6	15.9	17.4	23.1	8.8	9.9	13.9	16.1	16.5	16.1	3.5	9.7	8.1	9.2	12.4	8.9	8.4	10.3	9.2	12.1	16.9	16.3	13.1	9.0	4.1	9.7	15.0	9.3	12.0	7.0	8.5	15.6	8.0	15.7	10.3	6.8	7.8	7.2	18.7	6.4	4.1	14.9	4.1	8.1	9.2	8.5	7.8	7.8	10.8	14.3	21.4	6.3	11.9	5.1	4.9	11.8	34.2	4.0	10.3	3.9	23.9	2.7	4.3	8.7	17.3	4.0	3.6	11.1	7.9	13.7	3.3	5.1	6.1	7.0	11.3	7.6	15.0	7.0	6.2	9.2	10.5	9.5	10.8
DUS3L	"DUS3, FLJ13896"	ENSG00000141994	"Dihydrouridine synthase 3 like"	Q96G46	19	5784832-5791238	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041854, HPA041944, HPA062846"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: "	"unprognostic (1.25e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.64e-3)"	"unprognostic (6.08e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (7.35e-3)"	"unprognostic (4.25e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	9.1	9.4	7.4	11.4	9.4	25.4	9.5	7.1	13.2	8.9	12.4	13.7	8.7	16.6	13.1	7.7	12.3	11.1	11.1	7.8	6.0	5.0	9.9	17.5	7.9	12.6	8.3	6.7	11.8	17.6	4.7	8.6	11.1	7.8	11.8	4.6	12.4	12.4	10.1	14.3	17.5	14.4	7.6	7.5	12.5	12.3	42.5	8.1	15.6	11.7	10.3	11.1	8.8	9.7	13.5	19.2	4.3	18.6	15.8	16.6	9.9	10.8	10.7	3.1	10.9	0.8	1.4	10.2	3.6	2.1	3.8	2.9	16.7	5.1	11.1	13.9	1.4	7.1	2.6	3.5	0.6	8.1	24.6	7.3	5.6	6.3	5.5	16.2	21.3	3.3	3.8	4.3	3.0	2.5	19.4	0.0	2.0	14.2	13.6	16.5	11.1	29.2	7.1	6.4	13.6	1.6	7.8	10.8	10.9	3.8	6.4	7.1	4.4	13.3	3.3	5.4	9.6	16.1	15.6	31.9	23.4	10.6	5.3	16.8	6.1	4.3	13.2	3.4	14.8	18.6	16.6	10.2	11.0	13.5	18.7	13.5	15.1	14.4	1.5	15.8	14.4	19.2	12.5	9.9	7.4	9.4	7.1	13.2	6.0	5.0	8.3	6.7	7.8	8.1
DUS4L	"DUS4, PP35"	ENSG00000105865	"Dihydrouridine synthase 4 like"	O95620	7	107563484-107578464	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044301	Approved		Approved	Cytosol				Cytosol		"HPA044301: AB_10967460"	"unprognostic (7.95e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-3)"	"unprognostic (7.74e-3)"	"unprognostic (6.72e-3)"	4.5	6.2	9.4	7.0	10.4	2.9	7.8	5.0	8.2	5.5	5.7	7.5	6.2	4.8	5.7	10.4	5.5	6.0	4.7	10.1	8.0	7.7	9.9	9.0	3.9	5.0	10.3	6.2	7.8	5.4	8.0	5.1	4.8	7.6	7.8	5.7	5.7	5.1	4.8	7.1	7.1	5.2	5.3	11.0	4.3	5.4	7.7	6.6	6.6	8.5	5.9	5.7	6.2	4.5	1.5	1.3	0.5	1.3	1.2	2.4	0.7	6.5	3.0	3.0	1.8	1.2	2.0	3.9	1.9	2.6	2.8	2.7	3.4	5.4	7.0	3.5	1.5	1.9	3.1	4.0	4.3	2.1	2.6	2.4	1.6	3.7	3.0	4.8	0.4	2.0	5.4	2.7	9.1	4.0	8.6	2.6	4.2	4.8	6.6	8.3	4.2	5.4	3.5	2.7	7.8	5.3	3.3	2.7	6.8	3.0	6.4	5.4	3.0	3.8	2.9	4.0	3.2	3.0	4.4	4.9	6.0	7.8	4.3	6.8	4.8	0.0	1.2	0.1	1.4	1.3	1.6	1.5	2.3	1.2	1.3	0.7	1.9	2.4	0.5	1.2	0.7	1.1	1.7	0.7	9.4	10.4	5.0	8.2	8.0	7.7	10.3	6.2	7.6	6.6
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768090-172771195	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 43.1;hTCEpi: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 326.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA069577: "	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	158.4	78.0	12.4	68.5	14.0	89.7	91.8	17.4	14.9	81.4	37.1	32.4	48.5	9.4	55.4	71.6	82.7	94.8	138.8	49.2	12.5	11.4	29.8	115.4	135.0	43.5	30.6	9.7	69.4	34.4	26.6	40.8	93.7	29.3	67.1	34.2	61.0	38.1	192.8	54.8	116.1	27.6	65.0	29.5	36.1	53.6	45.9	18.7	10.8	90.4	104.1	46.9	69.0	109.7	2.4	11.5	326.0	31.8	4.5	9.8	14.0	2.1	5.4	1.7	2.3	37.5	22.0	2.9	34.9	10.2	23.5	9.5	5.9	2.5	0.7	10.2	24.5	0.9	1.6	8.6	11.0	19.1	4.6	0.4	11.9	2.5	43.1	0.2	0.8	21.0	75.3	10.6	17.3	7.3	1.7	13.7	15.1	2.5	1.1	1.0	1.5	1.6	40.5	3.2	6.3	16.7	1.1	7.4	3.1	9.4	16.1	1.2	1.3	0.4	19.2	16.7	8.3	16.2	2.6	2.8	1.6	0.6	14.8	0.3	0.6	33.3	24.6	69.8	3.9	25.0	9.8	2.4	3.5	4.0	11.5	2.1	1.7	1.9	326.0	4.5	31.8	0.6	2.8	14.0	12.4	14.0	17.4	14.9	12.5	11.4	30.6	9.7	29.3	18.7
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favourable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	7.4	4.7	6.0	7.1	11.2	23.2	8.2	5.9	11.1	5.7	10.8	21.1	0.3	2.1	4.9	2.7	7.0	8.5	7.6	3.8	7.2	4.0	2.8	35.4	8.0	9.0	14.0	5.6	2.8	18.3	1.8	2.5	4.5	8.4	3.6	4.9	8.5	9.5	1.7	21.0	8.0	6.2	9.7	10.1	6.4	4.5	3.9	14.1	5.6	5.3	10.6	8.6	8.5	4.1	0.8	5.4	4.6	4.2	15.1	12.7	1.6	6.0	2.6	0.2	0.1	18.8	9.7	0.2	4.0	10.6	6.7	5.2	0.1	1.6	4.7	1.4	10.4	41.5	0.9	3.9	5.8	12.0	0.5	8.1	1.1	0.7	4.4	3.6	5.5	13.5	2.9	7.2	7.3	0.2	0.8	1.6	6.4	0.1	0.7	2.7	0.6	0.2	0.4	11.5	0.3	2.3	3.7	15.5	1.2	0.5	0.5	17.2	0.9	2.1	1.4	3.4	0.9	5.1	4.9	2.8	2.0	2.5	5.3	1.6	3.6	4.6	4.2	0.2	3.6	3.7	3.3	0.7	2.5	2.5	5.4	0.8	0.8	1.5	0.3	15.1	1.4	0.2	12.7	1.6	6.0	11.2	5.9	11.1	7.2	4.0	14.0	5.6	8.4	14.1
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489831-37513501	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 12.5;HBF TERT88: 17.9;WM-115: 10.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol			44000	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavourable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	4.7	3.7	3.3	2.1	6.6	1.1	3.9	1.8	8.0	3.3	1.0	1.5	0.1	0.7	2.7	1.2	7.2	11.7	5.1	2.6	2.3		2.1	6.5	2.4	1.0	1.9	2.5	3.0	2.9	1.7	3.3	11.6	2.6	1.4	1.4	1.6	2.8	1.1	1.7	8.4	0.9	3.5	2.7	1.7	1.0	3.5	0.8	2.3	8.3	6.1	4.3	1.9	1.0	0.5	0.0	3.2	0.0	0.4	0.4	0.5	1.7	0.1	0.4	0.8	0.0	0.5	1.5	8.0	6.1	10.7	12.5	0.9	1.8	0.1	0.7	5.8	1.3	0.1	4.7	17.9	0.1	0.5	0.0	1.0	2.0	0.8	0.4	1.2	4.7	2.9	3.8	2.0	0.2	0.4	0.0	7.9	0.3	0.8	0.2	0.2	0.0	0.7	0.5	0.2	2.6	0.7	1.3	0.1	0.4	0.7	1.1	0.6	1.0	0.7	8.6	2.0	0.1	4.0	0.0	0.2	0.1	0.0	0.0	10.3	0.0	0.0	0.9	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.3	0.2	3.2	0.4	0.0	0.0	0.0	0.5										
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 75.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.3;REH: 17.4;SH-SY5Y: 5.0;SK-MEL-30: 4.3;U-2 OS: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.6"					"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA076649: "	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favourable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.1	2.1	2.8	0.6	4.0	0.5	1.3	1.2	3.7	1.6	0.8	4.2	6.9	0.9	1.4	10.4	0.6	0.7	1.1	2.7	2.8	3.1	15.4	0.6	0.8	1.0	4.9	2.3	2.1	1.8	10.6	2.7	1.1	5.9	1.9	0.5	5.3	2.1	9.3	2.4	0.7	1.0	2.3	5.2	1.0	1.1	75.1	1.4	0.0	3.5	0.1	0.6	0.7	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	5.3	0.1	1.0	2.2	0.3	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.7	0.7	0.0	17.4	2.0	0.1	0.0	0.0	2.4	5.0	2.8	0.0	4.3	1.3	1.0	0.0	0.0	4.2	0.0	0.0	1.8	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.0	1.2	3.7	2.8	3.1	4.9	2.3	5.9	1.4
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240564014	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.8	2.8	2.7	3.0	3.4	7.9	3.5	6.3	3.7	3.1	2.6	3.3	6.5	2.9	2.6	5.0	3.5	3.1	4.4	16.3	2.8	2.7	3.2	3.4	2.5	6.1	3.5	2.4	2.6	10.2	2.6	5.0	3.2	2.8	4.3	2.8	2.7	3.7	2.4	21.2	4.9	4.2	4.3	2.2	5.9	4.2	8.2	2.3	2.6	4.4	13.4	4.2	2.8	4.5	3.8	3.3	10.7	2.1	2.7	3.3	2.0	1.7	1.6	2.2	2.5	1.4	0.7	2.3	1.9	1.1	1.5	1.1	0.9	4.4	2.7	1.0	1.2	4.9	1.7	0.6	1.6	3.3	6.2	3.8	3.3	2.4	1.0	2.5	6.6	1.6	1.7	1.0	1.3	0.7	2.7	3.2	1.3	1.8	3.1	4.0	1.4	1.4	3.8	4.7	3.6	1.1	2.9	4.8	2.7	1.8	1.9	2.1	2.3	4.3	1.7	3.5	2.8	2.2	1.7	12.9	3.7	4.3	2.1	1.9	2.7	10.7	2.1	0.7	2.7	1.4	3.0	2.1	2.8	2.8	1.2	3.8	3.3	3.0	3.6	2.7	1.5	3.3	2.2	2.0	2.7	3.4	6.3	3.6	2.8	2.7	3.5	2.4	2.8	2.3
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766121-43778988	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol			1300000	Nucleoplasm	Cytosol	"HPA063616: "	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favourable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	17.1	17.8	23.1	10.2	20.8	4.6	22.0	14.3	28.6	12.8	28.4	11.1	16.7	13.4	17.5	18.7	23.6	10.6	19.3	64.0	21.5	18.1	27.1	39.9	17.2	9.0	17.6	19.1	9.1	19.2	27.5	11.4	15.0	17.1	22.6	13.1	14.3	11.1	36.6	106.9	8.9	15.2	31.1	12.7	14.5	19.6	8.0	10.8	1.2	13.9	22.8	6.5	20.7	24.1	1.7	19.5	5.2	17.0	0.9	1.7	5.8	10.9	19.8	7.6	8.1	22.3	12.0	6.5	8.3	19.9	19.4	23.5	19.0	7.4	1.7	13.2	15.5	9.5	11.8	10.2	20.5	3.7	9.0	5.5	9.1	15.5	27.3	0.6	5.7	11.1	18.4	14.9	13.1	13.5	4.9	1.9	22.6	7.8	2.8	2.8	3.5	14.5	3.6	23.0	4.1	26.9	11.5	4.3	7.7	9.7	6.5	24.4	29.1	15.4	14.0	22.0	14.9	31.2	13.7	10.2	13.4	0.4	26.1	7.7	7.3	5.2	17.0	3.5	1.0	8.9	1.7	1.7	1.5	1.2	19.5	1.6	1.2	1.1	4.1	0.9	10.8	8.2	0.9	5.8	23.1	20.8	14.3	28.6	21.5	18.1	17.6	19.1	17.1	10.8
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 80.6;NB-4: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favourable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.0	80.6	20.8	17.7	0.0	8.7	11.1	1.7	1.3	7.0	1.2	0.0	2.0	3.7	9.3	0.1	21.6	2.5	0.1	0.1	3.6	0.2	11.2	14.7	15.5	39.5	3.4	7.6	15.3	14.3	40.1	0.0	3.8	5.5	0.5	0.5	57.8	14.6	19.7	39.3	3.0	1.5	24.8	23.3	0.4	17.1	0.2	0.1	45.9	1.2	8.6	10.7	5.9	0.1	1.1	4.1	0.6	3.1	0.0	24.5	10.9	37.4	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4
DUSP8	"C11orf81, FLJ42958, HB5, HVH-5"	ENSG00000184545	"Dual specificity phosphatase 8"	Q13202	11	1554044-1571920	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 6.1;SH-SY5Y: 5.4;U-251 MG: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020071	Approved		Approved	Cytosol				Cytosol		"HPA020071: AB_1847903"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.82e-1)"	"prognostic favourable (2.75e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.30e-2)"	6.3	2.2	18.8	3.2	18.8	7.5	3.5	20.0	30.2	1.9	4.3	4.2	1.4	1.7	5.9	4.8	3.5	4.0	5.4	5.7	16.6	9.3	2.6	3.7	3.6	3.5	5.5	11.2	2.2	12.7	1.7	10.8	2.8	5.1	3.0	4.1	2.7	5.1	2.7	6.1	3.2	6.3	9.3	3.6	6.3	4.3	2.4	5.1	0.0	2.6	2.2	2.3	2.7	1.6	0.1	0.1	0.0	0.0	0.0	0.7	0.0	1.8	0.8	1.0	0.1	0.0	0.1	2.2	0.1	1.1	0.4	1.2	0.0	0.0	0.1	0.0	0.3	1.2	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.4	0.1	0.0	1.8	0.0	6.1	0.0	0.4	0.0	1.9	0.1	0.1	0.7	0.0	0.2	0.0	5.4	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	1.0	2.3	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	18.8	18.8	20.0	30.2	16.6	9.3	5.5	11.2	5.1	5.1
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Cell line enhanced"	"Detected in some"		"A549: 2.4;U-2 OS: 3.6;U-266/70: 7.8;U-266/84: 10.1;U-698: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: "																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.4	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.6	0.0	0.0	0.0	3.6	0.7	0.0	7.8	10.1	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972292	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: "	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favourable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavourable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	4.3	18.4	8.3	8.0	11.0	4.2	7.0	15.5	12.4	7.1	5.0	6.5	8.6	7.8	6.4	6.4	4.0	7.9	6.0	8.4	7.7	6.5	8.5	8.7	5.1	4.3	9.0	6.5	10.5	12.3	9.4	12.4	4.7	7.4	7.6	4.2	5.8	5.5	6.8	5.6	3.4	4.1	6.3	4.9	7.2	7.6	32.8	7.3	3.4	8.8	4.7	4.3	6.4	5.5	2.2	3.2	1.5	1.9	3.0	3.3	1.5	3.0	1.3	0.4	14.1	1.7	1.0	1.5	1.6	2.6	4.4	3.6	2.2	2.9	1.0	3.1	5.8	4.1	1.5	3.2	1.6	1.9	4.4	1.9	2.9	2.8	3.9	0.0	2.7	2.2	2.9	1.8	3.0	6.6	2.4	3.2	1.8	4.4	0.1	2.3	0.7	0.1	0.1	2.0	1.8	5.2	0.7	7.3	5.5	3.3	1.4	3.7	0.0	4.4	0.9	0.8	4.8	2.8	3.6	1.9	3.4	2.4	2.6	4.6	2.1	0.0	1.0	1.5	1.1	1.9	3.3	1.4	1.4	1.8	3.2	2.2	1.3	1.6	0.6	3.0	1.2	1.2	0.6	1.5	8.3	11.0	15.5	9.4	7.7	6.5	9.0	6.5	7.4	7.3
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964510-102056443	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol			120000	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavourable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	23.3	17.2	24.3	13.9	42.9	21.1	12.7	43.9	53.4	16.9	18.4	35.0	10.2	13.9	18.6	12.5	18.3	15.5	16.1	26.6	26.1	26.6	11.2	9.4	14.6	14.0	29.1	23.4	24.7	15.4	28.1	16.4	14.8	51.5	16.7	11.9	15.5	18.0	18.6	44.5	42.0	13.8	17.7	30.3	15.4	15.5	17.2	12.6	15.1	18.1	11.1	12.9	19.1	12.8	2.7	6.3	4.5	6.0	7.8	4.7	3.3	23.8	35.7	19.7	15.1	44.1	28.8	12.0	20.7	19.3	24.4	21.5	15.2	12.1	13.7	17.0	28.2	21.8	19.2	23.1	8.9	11.8	11.6	9.8	23.3	24.6	20.1	14.4	10.2	18.7	12.2	57.6	43.0	26.7	8.4	15.7	27.7	23.4	9.4	3.6	11.9	44.2	8.9	20.7	7.8	19.7	38.0	22.4	18.1	27.3	13.9	18.0	11.5	6.1	58.6	29.0	12.4	40.0	28.2	10.8	10.9	9.2	39.9	8.6	17.8	3.6	3.4	2.5	4.6	6.0	4.7	2.2	3.0	4.0	6.3	2.7	3.6	4.2	4.5	7.8	3.9	3.3	3.0	3.3	24.3	42.9	43.9	53.4	26.1	26.6	29.1	23.4	51.5	12.6
DYNC1I2	"DIC74, DNCI2"	ENSG00000077380	"Dynein cytoplasmic 1 intermediate chain 2"	Q13409	2	171687409-171748420	"Predicted intracellular proteins"	"Host-virus interaction, Transport"	"Motor protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033836, HPA040619, HPA053987"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol"			33000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Microtubules"	"CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.19e-1)"	"prognostic favourable (8.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.42e-2)"	33.4	32.9	39.6	22.5	53.2	10.8	35.5	30.1	50.0	36.1	33.0	50.0	20.1	28.8	43.1	29.3	37.5	26.5	32.0	34.3	45.2	38.3	43.5	21.8	27.3	18.5	59.3	37.9	40.6	23.3	35.8	29.9	40.2	58.7	33.7	35.8	15.1	28.3	34.7	41.3	27.9	27.7	43.7	92.7	25.8	26.5	28.6	49.2	27.9	31.2	23.5	24.3	36.7	31.8	23.5	35.3	51.7	30.8	18.9	19.9	11.5	19.9	12.8	39.9	14.6	36.9	35.6	22.6	35.0	27.3	29.5	32.2	22.3	19.9	18.3	30.8	41.6	20.2	31.3	33.6	38.7	6.9	14.1	16.0	16.5	25.1	18.5	18.2	17.2	27.6	32.0	36.4	23.5	51.6	25.2	5.0	58.2	12.5	15.5	14.8	18.3	13.1	15.7	35.9	13.2	39.2	32.1	25.0	28.1	19.4	15.6	20.7	15.2	17.8	55.9	45.0	22.3	17.9	20.9	6.3	12.0	14.8	30.6	14.8	32.9	51.7	30.8	14.7	16.9	30.1	18.0	23.1	19.5	19.6	21.4	23.5	17.6	16.7	1.8	18.9	29.4	35.3	19.9	11.5	39.6	53.2	30.1	45.7	45.2	38.3	59.3	37.9	58.7	49.2
DYNC1LI1	DNCLI1	ENSG00000144635	"Dynein cytoplasmic 1 light intermediate chain 1"	Q9Y6G9	3	32525971-32570874	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035013	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA035013: AB_10600807"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.38e-2)"	"prognostic unfavourable (9.19e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-2)"	16.1	11.6	15.8	14.8	18.6	27.5	18.9	24.5	28.0	13.4	13.8	12.7	9.2	11.6	17.0	11.6	13.9	14.7	14.1	40.1	16.3	23.4	18.4	15.9	16.3	15.8	18.3	16.4	15.2	18.6	16.8	18.9	14.9	26.5	18.6	14.2	14.1	12.0	12.9	41.1	32.1	13.0	19.7	16.6	18.1	13.8	34.0	11.7	19.3	12.8	16.6	17.2	15.5	13.5	6.2	15.3	29.8	25.1	7.5	6.1	10.7	13.1	14.2	22.1	13.8	12.7	15.0	61.0	20.3	28.0	36.7	30.2	15.0	11.3	16.4	13.8	20.5	6.8	22.1	15.9	35.1	15.5	15.3	21.7	10.4	13.4	15.6	24.6	12.8	12.1	12.7	25.8	20.3	23.6	25.1	15.2	19.6	10.5	18.8	10.9	22.8	19.1	16.6	11.8	17.1	14.9	12.0	9.5	14.0	14.3	17.7	15.3	14.7	14.4	17.5	20.2	17.0	17.5	20.3	11.0	27.7	26.6	11.3	21.3	15.7	11.3	13.3	11.7	5.2	16.8	5.4	6.1	5.6	5.7	15.3	6.2	3.9	5.0	29.8	7.5	25.1	8.4	6.1	10.7	15.8	18.6	24.5	28.0	16.3	23.4	18.3	16.4	26.5	11.7
DYNC1LI2	DNCLI2	ENSG00000135720	"Dynein cytoplasmic 1 light intermediate chain 2"	O43237	16	66720893-66751798	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057201			Approved	Centrosome,Cytosol				Centrosome	Cytosol	"HPA057201: "	"unprognostic (6.03e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.34e-1)"	26.5	21.4	63.8	16.8	63.5	16.7	19.0	28.8	43.3	23.0	24.4	61.2	17.6	19.5	23.9	19.5	23.7	17.9	22.5	26.6	68.3	48.3	20.3	13.0	20.8	11.0	75.0	28.9	22.1	20.2	44.7	19.3	21.1	51.1	25.3	28.7	13.6	20.8	24.5	17.2	23.1	19.8	30.1	89.5	15.5	22.6	14.9	55.0	6.7	28.8	7.9	12.6	20.4	20.0	9.0	12.1	16.3	17.1	8.2	14.9	7.9	15.0	15.8	23.5	21.0	30.4	30.2	21.4	24.6	19.7	20.2	26.3	21.4	14.8	6.3	19.6	24.1	21.8	18.0	17.6	29.6	4.2	13.0	7.7	18.3	20.2	16.9	8.1	11.5	19.7	24.2	23.2	16.1	28.3	12.5	8.3	26.1	10.7	5.1	10.7	14.1	27.5	11.2	49.7	7.5	20.1	21.2	23.6	16.5	44.4	9.6	28.5	11.7	8.2	35.9	26.2	13.1	12.8	16.7	10.6	7.7	12.5	22.5	7.9	16.4	10.1	17.1	16.1	13.4	9.8	14.9	5.2	11.3	10.7	12.1	9.0	9.6	9.1	16.3	8.2	13.1	7.6	10.9	7.9	63.8	63.5	28.8	43.3	68.3	48.3	75.0	28.9	51.1	55.0
DYNC2LI1	"CGI-60, D2LIC, DKFZP564A033, LIC3"	ENSG00000138036	"Dynein cytoplasmic 2 light intermediate chain 1"	Q8TCX1	2	43774039-43810010	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062905	Approved		Approved	Cytosol				Cytosol		"HPA062905: "	"unprognostic (3.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (2.73e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.60e-2)"	11.2	18.2	16.9	8.9	32.2	4.4	23.3	8.1	25.3	24.2	10.7	9.8	22.7	13.1	25.1	34.0	8.5	38.1	14.7	11.5	17.2	18.0	35.2	9.3	16.4	6.5	13.9	24.8	29.2	11.8	25.5	39.8	9.6	28.7	15.3	13.0	13.2	11.5	22.4	12.0	11.0	11.2	14.3	19.0	7.5	11.9	29.0	13.0	5.9	24.3	9.0	6.8	11.4	10.4	5.1	4.0	13.3	5.1	3.2	3.9	2.2	8.6	4.8	8.7	5.5	14.2	28.5	7.5	4.8	10.5	5.7	5.3	1.6	6.0	4.9	10.7	6.3	5.8	4.2	6.9	6.6	6.3	8.9	3.8	2.4	6.2	13.7	7.3	6.3	16.7	10.0	11.3	5.2	7.8	11.6	2.4	7.9	4.4	3.7	8.4	4.0	5.1	5.0	8.1	1.5	47.1	7.4	6.0	10.8	5.4	3.0	6.1	8.3	6.9	5.4	5.0	4.5	6.1	4.0	9.0	4.9	1.2	11.1	1.9	5.3	13.3	3.0	2.8	2.5	5.1	2.6	5.1	3.1	3.4	4.0	3.2	3.9	3.4	1.3	3.2	3.8	2.5	1.9	2.2	16.9	32.2	8.1	25.3	17.2	18.0	13.9	24.8	28.7	13.0
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			650000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: "	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavourable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	45.5	48.5	128.5	34.4	97.8	21.9	54.3	48.4	120.5	50.6	61.8	61.9	31.1	31.6	47.2	64.9	113.7	107.1	46.7	44.2	124.1	105.2	49.7	40.7	40.3	41.2	92.9	90.7	49.0	45.7	30.4	46.4	49.8	67.4	39.9	64.5	24.8	34.0	54.9	15.0	117.3	38.9	75.2	93.6	30.4	45.1	59.4	56.8	35.4	37.1	84.3	65.6	59.0	63.0	55.0	80.6	73.6	55.0	46.7	63.4	50.8	78.4	89.7	89.0	68.2	78.2	83.0	28.6	108.6	50.2	88.7	53.2	84.5	52.9	44.0	58.7	103.7	70.8	105.7	90.8	88.7	58.3	69.2	43.0	64.3	114.3	79.0	44.8	71.5	50.4	97.2	66.5	54.6	92.1	53.9	50.7	117.0	103.9	58.5	97.6	73.0	104.7	59.8	46.1	54.6	126.7	72.7	61.2	45.2	88.5	76.9	98.6	76.2	65.6	70.8	68.3	58.3	60.2	93.5	30.6	58.7	43.7	75.7	70.1	87.4	73.6	49.5	63.6	37.7	51.4	28.7	55.0	39.0	39.0	49.1	36.5	25.2	31.5	9.1	46.7	55.0	80.6	63.4	50.8	128.5	97.8	48.4	120.5	124.1	105.2	92.9	90.7	67.4	56.8
DYNLL2	"Dlc2, DNCL1B, MGC17810, RSPH22"	ENSG00000264364	"Dynein light chain LC8-type 2"	Q96FJ2	17	58083415-58095536	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039954			Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: "	"unprognostic (7.22e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"prognostic favourable (5.26e-4)"	"unprognostic (1.24e-1)"	"prognostic favourable (1.12e-12)"	"unprognostic (2.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.02e-2)"	15.4	28.3	38.6	11.1	55.2	9.9	11.6	41.1	41.1	12.9	14.5	22.6	16.3	16.2	12.0	15.6	11.9	13.5	13.3	43.8	32.2	40.2	28.1	23.1	11.8	9.4	48.3	28.7	14.4	11.8	36.2	15.0	19.7	40.6	20.6	13.7	15.5	19.2	18.8	64.8	12.6	15.6	14.3	32.5	11.2	12.7	19.0	27.2	7.6	22.0	15.1	11.8	9.9	16.4	1.5	0.8	3.5	3.0	1.5	3.1	0.8	20.3	13.9	28.5	12.9	17.8	9.8	45.3	20.6	8.2	10.0	7.9	30.7	9.9	18.2	23.4	12.7	11.0	13.1	16.3	17.3	18.0	9.5	19.7	8.1	18.0	14.1	21.0	12.3	9.8	11.2	11.6	9.2	6.6	19.6	11.1	9.6	30.8	23.8	8.7	19.6	14.2	22.0	16.8	7.5	8.6	22.2	19.5	15.6	18.4	7.4	15.6	22.0	9.9	11.9	19.7	24.8	13.1	15.1	20.8	25.2	22.2	10.1	17.0	13.7	3.5	1.1	2.0	2.6	0.6	2.9	1.3	2.1	2.3	0.5	1.5	2.2	3.1	1.7	1.5	3.0	0.8	1.4	0.8	38.6	55.2	41.1	41.1	32.2	40.2	48.3	28.7	40.6	27.2
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	20.0	18.5	19.2	23.4	20.0	49.7	19.9	31.6	24.6	23.7	23.0	16.3	17.6	15.4	24.4	18.7	16.8	19.4	19.0	23.2	18.8	17.9	16.9	16.1	24.8	27.3	15.5	17.8	25.7	17.8	31.0	25.1	25.0	14.0	17.6	18.1	18.5	18.7	22.7	39.8	20.1	18.7	22.7	13.8	24.1	18.5	23.5	16.3	60.9	22.7	17.4	22.1	22.7	29.3	3.0	3.3	6.0	2.5	1.3	3.8	0.8	10.2	8.0	16.3	11.5	7.8	8.5	14.5	9.1	11.7	9.3	9.8	11.4	9.0	13.8	6.2	16.0	7.0	11.9	8.9	10.9	21.1	5.1	40.8	13.3	6.9	11.7	16.1	15.0	8.6	10.6	12.0	18.5	9.6	15.4	32.0	9.6	10.3	21.1	11.0	17.3	4.8	27.4	9.0	12.7	9.7	13.4	16.9	9.4	20.8	14.3	14.3	13.4	15.0	12.3	12.7	3.8	7.9	7.6	21.8	16.9	19.8	10.1	18.2	13.8	5.5	1.5	2.0	3.4	2.1	2.1	2.8	3.6	2.6	1.8	3.0	3.8	3.7	6.0	1.3	2.5	3.3	3.1	0.8	19.2	20.0	31.6	24.6	18.8	17.9	15.5	17.8	14.0	16.3
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: "	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	12.2	5.3	4.5	20.1	4.8	8.6	8.1	4.4	6.6	10.1	21.3	4.1	8.3	13.7	14.6	9.6	9.6	9.1	16.9	26.1	4.7	3.2	6.3	4.6	10.1	17.9	4.0	3.3	7.6	8.5	3.6	4.4	13.0	5.0	7.1	15.3	6.6	7.2	6.6	23.7	9.4	26.0	11.2	5.3	10.3	14.0	4.4	3.9	34.3	7.6	12.5	17.2	11.1	12.2	2.7	1.9	5.9	1.3	6.9	6.8	1.6	13.5	7.7	11.5	8.3	5.8	7.9	9.2	13.8	9.0	6.8	3.9	10.1	7.5	25.4	17.1	20.0	15.9	9.2	5.4	7.3	10.9	12.0	4.1	5.1	3.8	2.2	9.2	8.9	6.5	7.8	18.2	14.6	3.8	5.0	13.3	8.6	7.8	7.9	4.5	10.0	12.4	21.1	11.4	11.2	7.9	17.1	15.2	18.0	5.8	7.8	8.0	5.3	7.8	5.6	10.8	10.2	7.4	10.9	6.3	1.0	14.1	10.4	6.3	11.1	3.2	0.5	5.9	5.2	1.3	4.0	2.7	3.9	6.8	1.9	2.7	3.3	6.1	0.7	6.9	1.3	0.8	3.1	1.6	4.5	4.8	4.4	6.6	4.7	3.2	4.0	3.3	5.0	3.9
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA075041			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA075041: "	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6.0	3.4	3.4	7.4	5.0	1.6	2.6	2.0	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3.0	2.1	2.0	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3.0	1.7	5.4	7.6	0.0	6.1	0.0	0.1	0.0	0.3	0.0	2.5	3.4	0.8	4.8	8.6	7.7	0.1	8.1	17.9	7.4	9.6	0.2	1.2	3.7	1.2	9.5	0.7	4.2	6.5	7.9	0.0	2.8	5.4	4.4	0.8	13.7	3.7	3.5	5.4	4.2	12.8	35.2	5.7	10.3	0.7	11.4	0.9	8.1	2.1	6.8	6.4	20.2	2.6	0.0	2.3	0.1	4.9	3.6	7.3	0.3	9.9	0.9	0.9	4.3	15.5	5.9	7.5	6.7	2.9	1.0	4.4	9.2	4.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	4.2	3.5	1.3	2.7	6.0	3.4	2.6	2.0	4.6	3.1
DZIP1	"DZIP, KIAA0996"	ENSG00000134874	"DAZ interacting zinc finger protein 1"	Q86YF9	13	95578202-95644703	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054891, HPA057272, HPA070194"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				"Nucleoplasm, Cytosol"	"Centriolar satellite"	"HPA054891: , HPA057272: , HPA070194: "	"unprognostic (6.74e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.89e-3)"	5.0	6.3	17.2	4.4	17.4	0.4	3.7	13.9	16.1	11.5	6.7	4.1	3.8	2.2	16.2	10.7	6.2	10.7	8.5	3.8	13.1	18.1	16.2	1.7	4.0	3.6	8.7	13.5	24.2	9.6	0.9	8.9	4.6	8.8	7.7	3.7	5.8	3.2	13.3	1.7	1.1	2.6	12.3	5.6	2.8	3.6	27.3	4.5	0.6	1.7	1.8	3.5	5.0	5.2	0.4	0.2	1.2	0.2	0.3	0.3	0.0	1.4	5.2	17.5	17.8	13.6	16.9	3.5	12.6	14.6	14.1	17.0	0.1	0.0	0.0	2.9	10.1	0.0	11.6	4.6	16.0	0.9	10.3	16.1	4.0	10.9	9.4	0.0	0.1	11.9	0.4	4.3	5.8	9.5	0.0	0.0	10.3	0.0	0.0	0.0	7.9	0.4	0.0	12.0	0.0	13.6	1.8	4.3	11.4	9.6	0.0	0.5	0.0	6.0	0.7	14.1	6.8	1.9	10.3	0.0	0.0	0.0	3.7	0.0	2.5	1.2	0.2	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.0	0.4	0.1	0.3	1.1	0.3	0.1	0.2	0.1	0.0	17.2	17.4	13.9	16.1	13.1	18.1	8.7	13.5	8.8	4.5
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401906-20493715	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: , HPA065012: "	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	9.5	8.4	7.6	12.2	13.4	22.1	10.8	1.7	10.1	4.8	7.1	2.9	3.2	6.8	6.3	6.9	8.0	4.9	9.9	11.1	8.3	6.8	14.6	6.1	7.8	19.7	5.8	7.3	4.0	3.6	2.9	3.2	7.4	7.9	5.0	8.6	5.1	4.7	4.5	15.1	4.3	8.0	7.9	5.0	16.9	5.0	8.9	3.1	17.7	11.4	10.2	12.0	9.2	4.8	0.7	3.7	10.3	3.1	4.8	3.6	1.5	6.7	5.5	15.9	17.0	5.3	5.9	11.0	9.1	7.9	8.8	9.7	6.8	4.2	15.1	17.7	8.5	7.1	18.1	8.2	14.8	5.9	12.8	27.5	9.1	7.5	5.7	18.0	16.5	4.7	6.1	8.6	10.5	6.0	30.4	9.4	9.9	6.9	20.4	20.1	11.9	5.7	22.2	14.0	17.4	10.5	11.8	11.5	21.0	8.5	11.7	12.0	6.0	10.9	8.0	14.2	8.9	7.0	14.5	5.9	18.7	19.0	3.5	11.2	20.1	6.9	3.1	1.4	2.3	2.3	3.1	0.7	1.5	3.6	3.7	0.7	1.3	2.8	10.3	4.8	1.5	1.6	2.2	1.5	7.6	13.4	1.7	10.1	8.3	6.8	5.8	7.3	7.9	3.1
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: , HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	1.0	0.4	0.4	7.2	0.2	11.5	0.3	0.2	0.4	1.6	3.6	0.2	0.2	3.3	1.2	1.4	8.2	0.9	2.0	3.4	0.2	0.2	0.4	0.5	0.8	6.1	0.2	0.2	0.7	0.3	0.0	0.2	4.0	0.2	0.6	4.8	1.2	1.8	0.9	11.5	2.6	4.6	0.7	0.2	2.4	5.1	4.7	0.2	30.3	0.3	8.0	12.5	3.4	2.1	0.0	0.1	0.0	0.0	0.0	2.9	0.4	14.2	4.3	4.4	6.1	0.2	0.6	18.9	7.9	2.2	9.3	10.1	14.7	4.7	14.1	3.3	2.5	12.6	10.8	1.0	8.5	9.5	8.7	4.9	2.4	4.0	0.0	7.5	11.9	0.2	0.0	1.9	0.6	13.1	10.3	13.7	3.7	6.9	14.6	9.3	4.1	6.0	15.9	8.3	9.6	4.0	9.7	3.8	4.3	3.5	7.0	0.8	4.8	8.0	2.5	4.5	5.6	11.0	7.1	4.7	9.5	17.9	5.7	14.7	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.4	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2
EAPP	"BM036, C14orf11, FLJ20578"	ENSG00000129518	"E2F associated phosphoprotein"	Q56P03	14	34515929-34539711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002916	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA002916: AB_1078715"	"unprognostic (8.76e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.80e-1)"	"prognostic favourable (9.34e-4)"	"unprognostic (1.81e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.80e-2)"	"prognostic favourable (2.23e-6)"	"unprognostic (2.64e-1)"	"unprognostic (2.68e-1)"	"prognostic favourable (2.96e-4)"	"unprognostic (3.24e-2)"	30.1	32.8	24.4	23.1	23.5	53.4	36.5	32.4	30.1	30.0	35.0	20.6	25.3	24.7	27.9	33.0	26.3	28.5	19.9	19.9	22.8	26.4	30.1	34.4	20.5	23.2	21.8	25.3	37.3	22.5	31.1	28.1	33.8	27.8	29.4	36.8	21.6	27.3	27.8	41.3	39.1	43.2	23.8	20.9	26.5	23.5	21.6	24.2	34.8	34.1	22.6	24.8	27.7	31.2	36.8	19.3	50.2	26.2	33.6	42.3	24.8	15.0	18.5	17.3	10.2	20.5	21.1	27.0	13.9	21.4	17.4	18.3	8.7	20.1	15.8	19.7	16.9	14.2	12.7	18.5	20.6	19.7	11.3	11.6	14.5	36.9	28.1	20.5	12.8	24.1	23.9	10.0	25.8	17.3	11.4	17.6	16.2	35.3	28.3	16.6	10.1	20.7	18.0	20.8	15.8	21.0	20.5	14.0	15.4	19.7	19.1	29.7	33.2	13.1	18.7	9.1	7.7	11.8	8.9	22.2	24.9	16.8	8.5	11.4	11.4	40.7	22.0	45.2	24.8	20.1	29.7	36.8	31.1	28.0	19.3	33.7	31.8	28.8	50.2	33.6	26.2	16.9	42.3	24.8	24.4	23.5	32.4	30.1	22.8	26.4	21.8	25.3	27.8	24.2
ECD	"GCR2, hSGT1"	ENSG00000122882	"Ecdysoneless cell cycle regulator"	O95905	10	73130155-73169055	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006465	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA006465: "	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.71e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.55e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.84e-2)"	23.2	22.3	22.2	22.4	23.8	34.8	23.2	34.7	27.0	20.4	18.6	21.8	20.0	15.6	23.7	20.9	21.2	17.0	20.6	18.8	17.9	16.9	22.4	23.6	17.7	21.4	23.4	16.7	24.1	21.1	32.5	32.1	23.4	25.5	21.8	18.1	16.7	21.4	21.3	19.9	23.3	16.8	19.9	19.4	20.5	18.5	25.4	23.1	32.7	24.2	18.7	22.4	22.1	20.7	20.4	16.8	23.3	26.3	25.4	27.2	15.7	18.5	13.4	15.2	23.1	14.0	13.9	12.5	14.5	22.8	23.7	27.8	24.3	19.5	14.6	14.3	14.1	15.6	16.2	17.2	24.4	11.8	15.8	18.4	11.0	17.3	21.2	21.9	12.3	15.5	14.4	19.9	25.0	25.2	19.0	10.2	22.3	15.7	19.6	12.2	15.6	38.8	14.6	16.9	7.9	19.0	13.8	6.7	12.6	13.1	29.9	18.6	17.1	10.6	15.5	10.3	20.9	11.1	16.6	11.9	8.1	24.9	19.3	18.4	8.8	15.0	19.3	20.9	21.8	20.5	23.2	20.4	20.6	21.4	16.8	18.6	27.2	19.4	23.3	25.4	26.3	11.5	19.7	15.7	22.2	23.8	34.7	27.0	17.9	16.9	23.4	16.7	25.5	23.1
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 76.4;BJ hTERT+: 53.2;fHDF/TERT166: 50.1;hTEC/SVTERT24-B: 36.0;LHCN-M2: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA027241	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"		12000000000	Cytosol	Nucleoplasm	"HPA027241: AB_1847976"	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.1	0.6	2.3	0.0	13.8	76.4	2.1	22.4	53.2	14.0	18.3	0.3	3.4	0.1	0.2	50.1	12.9	0.0	2.6	14.7	0.1	0.1	0.9	0.7	0.1	3.8	0.0	23.2	6.7	0.1	36.0	1.3	3.9	4.8	0.1	39.0	0.0	0.0	0.7	0.2	0.7	0.3	16.8	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.1	0.0	5.9	1.0	29.7	4.4	3.3	4.8	0.1	0.1	0.2	15.6	2.0	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0
ECSIT	SITPEC	ENSG00000130159	"ECSIT signalling integrator"	Q9BQ95	19	11505916-11529174	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042979	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042979: AB_10964063"	"unprognostic (9.88e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.08e-2)"	"prognostic favourable (1.48e-9)"	"unprognostic (2.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.95e-2)"	15.3	16.8	13.8	10.7	15.5	12.9	12.8	20.0	24.5	13.5	21.0	9.5	11.1	24.2	13.1	6.8	19.7	16.2	13.8	49.5	12.9	11.6	15.6	27.7	8.4	9.9	13.5	10.8	27.2	28.5	14.7	10.5	6.4	12.5	16.3	12.0	13.2	26.8	11.0	64.2	11.8	17.9	12.9	9.1	10.1	18.4	8.2	11.9	13.8	21.4	29.5	12.7	14.1	14.2	21.4	22.3	6.2	20.9	13.1	18.6	15.2	14.9	13.6	8.2	12.0	12.7	14.6	9.2	8.0	10.9	17.5	14.2	20.2	10.5	22.4	17.2	10.4	20.3	20.8	17.1	6.2	12.8	17.0	20.9	8.8	18.3	12.4	11.9	17.5	15.2	18.7	14.3	15.9	12.9	22.6	23.4	6.5	20.7	20.8	17.8	22.3	36.5	20.9	8.8	29.9	9.5	9.7	31.6	19.9	9.6	16.1	16.1	18.3	18.2	6.6	18.3	12.7	25.9	14.9	20.9	40.3	11.2	15.3	17.9	13.0	2.1	17.2	6.2	15.2	20.9	17.3	21.4	16.5	14.1	22.3	20.3	18.6	16.9	3.5	13.1	18.6	12.6	18.1	15.2	13.8	15.5	20.0	24.5	12.9	11.6	13.5	10.8	12.5	11.9
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036363: , HPA053261: "	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (6.82e-6)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	6.4	6.0	5.4	9.9	7.2	16.3	7.4	11.1	7.6	9.0	11.0	2.6	2.1	9.1	4.6	2.8	14.9	3.2	6.6	4.2	5.4	5.0	10.1	4.3	8.9	9.6	6.7	5.8	3.2	4.1	4.0	6.1	11.1	10.2	4.1	16.1	2.4	9.0	2.7	2.9	7.0	7.6	7.2	8.4	8.7	9.2	14.7	6.8	50.8	5.7	9.3	10.8	8.0	6.5	2.8	2.6	10.4	3.2	1.3	3.6	1.0	46.0	32.9	25.9	13.4	2.7	5.6	13.0	20.4	16.8	30.7	29.8	18.2	48.9	11.4	31.1	11.9	20.3	20.9	13.1	42.0	16.3	11.5	7.1	18.0	9.3	1.1	11.0	8.3	1.8	2.2	18.2	18.7	13.2	7.4	16.8	24.2	16.3	11.2	8.3	21.2	17.9	8.1	25.5	14.7	23.3	10.8	17.4	11.1	25.8	29.4	10.4	48.9	8.2	11.4	14.9	14.3	20.0	42.4	8.3	11.1	21.6	13.2	9.7	19.4	6.8	3.2	1.3	1.8	2.8	1.9	2.2	2.4	1.6	2.4	2.8	1.2	1.8	10.4	1.3	1.2	2.6	3.6	1.0	5.4	7.2	11.1	7.6	5.4	5.0	6.7	5.8	10.2	6.8
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 36.7;RT4: 29.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	6	"basophil: 24.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 24.6"	"Group enriched"	"Detected in some"	5	"olfactory region: 0.7;thalamus: 0.8"	"Low region specificity"	"Detected in many"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.9	0.4	0.5	2.4	0.5	0.2	5.8	0.3	0.4	1.1	1.1	0.1	13.7	0.2	0.9	13.0	7.2	1.0	1.3	2.2	0.4	0.4	2.5	0.6	1.7	1.2	0.5	0.0	0.7	5.5	0.0	0.4	6.4	0.1	11.3	0.2	1.7	3.6	16.6	0.3	5.7	0.7	3.6	0.4	2.9	6.4	4.0	0.2	4.5	6.4	5.3	6.8	15.6	9.9	0.1	0.3	24.6	0.2	2.9	4.0	1.1	0.0	1.7	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.7	0.4	0.4	0.0	0.0	0.0	0.1	4.1	3.0	4.4	0.7	5.9	3.5	0.0	0.0	0.6	0.0	0.1	36.7	0.0	1.3	0.5	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.8	0.0	1.5	0.0	0.0	0.0	29.7	0.2	0.1	0.0	0.6	0.1	7.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.6	0.2	0.0	2.1	0.2	2.7	0.1	3.2	4.0	0.3	0.1	0.3	2.1	0.2	2.9	0.1	0.0	2.9	1.1	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.0	0.1	0.2
EDF1	"CFAP280, EDF-1"	ENSG00000107223	"Endothelial differentiation related factor 1"	O60869	9	136862119-136866286	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035642	Approved		Supported	Nucleoplasm,Cytosol			140000	"Nucleoplasm, Cytosol"		"HPA035642: AB_10611959"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	49.5	68.5	77.7	58.3	67.3	55.6	71.0	68.2	75.2	51.6	68.7	35.1	75.3	106.6	55.0	60.9	68.4	57.3	66.7	83.2	66.5	61.8	65.4	107.5	47.2	75.3	64.9	64.2	72.1	273.4	44.5	64.4	47.7	62.3	64.1	46.5	38.2	123.3	96.5	175.4	69.4	102.3	64.3	71.9	48.8	61.9	49.5	44.8	43.6	64.5	75.1	51.5	51.9	57.7	78.2	116.5	58.0	70.5	68.6	83.6	85.4	63.5	85.6	47.7	48.4	47.6	50.2	93.9	73.5	49.8	59.6	46.6	69.2	44.6	55.9	68.5	63.9	77.0	37.1	56.3	22.0	60.4	45.2	38.9	107.7	94.0	94.7	66.3	53.3	49.6	72.5	46.7	54.4	57.3	56.3	72.6	51.0	139.4	59.0	105.5	50.3	73.5	52.0	69.7	113.0	79.1	68.0	61.2	58.8	76.7	108.1	74.4	104.4	93.2	69.4	65.2	49.3	70.5	68.3	41.9	69.9	47.1	85.2	39.9	59.6	45.7	70.5	58.0	69.9	59.9	77.2	78.2	74.8	72.1	70.8	71.9	66.9	68.8	28.2	68.6	48.9	116.5	83.6	85.4	77.7	67.3	68.2	75.2	66.5	61.8	64.9	64.2	62.3	44.8
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484673	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.4;EFO-21: 21.2;HeLa: 7.2;SCLC-21H: 10.2;SK-BR-3: 25.2;U-2 OS: 9.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Region enriched"	"Detected in single"	12	"pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 1.0"	HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.5	0.2	0.0	0.9	0.2	0.3	2.2	0.0	0.1	15.1	13.6	0.4	1.4	4.5	1.8	6.3	17.4	2.3	0.4	1.9	0.0	0.0	4.0	0.8	18.4	0.1	0.0	0.0	0.8	3.2	0.1	1.1	0.4	2.6	9.7	1.3	1.4	4.3	1.0	0.9	8.9	27.8	0.2	0.0	0.1	0.9	0.7	0.1	0.0	1.3	4.0	13.7	1.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	8.4	0.0	21.2	0.0	1.0	0.0	0.0	0.0	2.4	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.4	0.0	0.0	0.8	4.9	5.7	0.4	10.2	0.0	0.2	25.2	0.0	0.5	0.0	0.0	0.0	9.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.1
EDNRA		ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 62.6;seminal vesicle: 52.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.2;ASC TERT1: 14.2;HHSteC: 7.3;LHCN-M2: 16.8;SH-SY5Y: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Uncertain	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (1.50e-7)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	7.6	2.6	1.3	1.4	1.8	0.0	7.2	0.6	2.4	62.6	2.6	1.0	21.7	1.5	37.3	14.2	4.7	13.3	7.3	15.1	1.3	1.3	3.1	1.4	12.7	2.0	1.8	1.0	23.5	0.9	1.9	2.2	5.9	2.7	21.5	1.5	10.3	4.1	52.3	4.8	3.2	1.8	19.4	1.6	11.5	4.4	9.1	1.4	2.9	5.0	6.0	2.6	14.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.1	0.0	7.2	14.2	0.0	2.1	2.8	0.3	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.5	0.2	0.0	1.5	0.0	2.4	0.0	7.3	0.0	0.0	5.5	0.4	0.4	0.0	0.0	0.0	1.1	16.8	0.2	0.0	0.1	1.2	0.8	0.0	0.7	0.1	1.1	0.8	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.0	0.0	1.1	0.3	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.6	2.4	1.3	1.3	1.8	1.0	2.7	1.4
EDNRB	"ETB, HSCR, HSCR2"	ENSG00000136160	"Endothelin receptor type B"	P24530	13	77895481-77975529	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.5"	"Cell line enhanced"	"Detected in some"		"AF22: 24.6;ASC diff: 18.7;SK-MEL-30: 22.6;U-266/70: 14.8;WM-115: 47.1"	"Group enriched"	"Detected in all"	7	"glioma: 41.1;melanoma: 127.7;renal cancer: 28.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 2.0;intermediate monocyte: 2.1"	"Lineage enriched"	"Detected in single"	21	"monocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017842, HPA027546"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB017842: , HPA027546: "	"unprognostic (7.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.59e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (4.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.01e-2)"	"prognostic favourable (7.20e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.77e-3)"	25.4	23.2	22.2	10.3	29.8	0.8	23.1	10.3	30.7	8.1	7.2	13.6	2.3	10.9	7.7	3.6	4.9	6.0	8.5	23.7	16.7	16.4	22.3	26.5	28.4	15.6	24.2	8.1	4.9	6.4	7.7	6.3	67.5	33.2	14.9	7.7	51.0	13.4	4.4	6.7	5.1	11.9	7.4	33.4	16.0	5.8	3.1	12.4	0.0	17.6	2.0	2.9	10.9	8.2	0.0	0.0	0.0	2.1	0.0	0.0	0.4	1.9	0.0	24.6	0.0	18.7	0.7	0.3	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	22.6	0.0	0.1	0.1	0.2	0.0	0.0	0.1	14.8	8.3	0.0	0.4	0.0	47.1	0.0	2.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.2	29.8	10.3	11.9	16.7	16.4	24.2	8.1	33.2	12.4
EDRF1	"C10orf137, DKFZp586F1019, FLJ21617"	ENSG00000107938	"Erythroid differentiation regulatory factor 1"	Q3B7T1	10	125719515-125764143	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031820			Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA031820: AB_10600753"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.84e-4)"	"unprognostic (4.76e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.63e-3)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (3.16e-5)"	"unprognostic (3.44e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.68e-3)"	9.2	6.7	6.3	16.6	9.7	27.9	9.0	20.3	10.0	10.5	8.1	7.7	6.8	7.1	12.2	8.3	7.5	9.8	6.4	7.5	7.4	5.4	5.9	5.0	7.2	12.5	8.8	7.3	13.4	14.0	6.3	18.1	8.2	8.0	10.0	7.3	5.2	19.7	12.7	12.7	8.3	9.0	9.5	7.8	9.3	8.4	21.2	9.0	20.2	7.7	4.5	10.7	10.1	8.7	9.6	9.9	9.1	7.0	6.9	9.7	3.5	8.9	8.7	10.9	11.9	5.1	8.5	5.7	11.2	11.0	13.0	14.8	11.0	7.6	12.0	5.6	7.1	11.3	17.2	2.7	14.8	7.9	13.7	8.4	7.4	6.4	8.6	12.6	8.7	5.2	4.3	12.4	5.6	6.1	7.9	9.2	7.3	3.6	12.5	8.7	16.1	7.9	10.0	10.5	7.8	4.5	4.1	5.9	11.6	8.3	4.2	7.6	7.7	4.8	3.9	6.9	7.1	9.0	12.7	12.0	8.0	18.9	7.4	6.2	3.8	9.1	7.0	6.5	7.8	5.8	9.7	9.6	6.9	7.1	6.8	8.1	7.3	7.5	8.4	6.9	4.2	9.9	7.4	3.5	6.3	9.7	20.3	10.0	7.4	5.4	8.8	7.3	8.0	9.0
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73515750-73523797	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol				Cytosol		"HPA051759: , HPA053862: , HPA056990: "	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	134.1	124.1	80.2	136.0	75.6	140.9	182.0	103.3	106.2	149.6	133.3	94.9	93.7	81.7	152.0	127.3	136.4	143.1	102.4	88.2	71.5	58.0	130.9	123.1	169.6	135.6	74.3	93.2	240.8	227.6	106.3	111.2	89.1	79.7	115.0	114.7	105.0	133.3	123.6	51.3	139.8	101.6	121.6	108.6	111.3	121.5	129.9	71.6	125.1	132.4	143.1	169.7	151.1	134.8	258.9	209.7	54.6	187.6	184.6	366.8	517.5	111.1	141.0	200.2	273.4	410.7	679.5	159.4	166.6	430.1	213.7	205.1	218.7	153.9	454.1	222.8	281.5	118.0	244.5	318.4	206.0	79.2	153.0	169.5	115.0	243.6	356.6	315.0	185.1	587.0	541.5	157.3	530.9	289.4	313.2	143.7	258.2	148.2	134.8	330.2	214.2	98.0	268.8	337.3	509.0	274.5	235.6	164.3	182.4	83.5	196.4	329.6	133.5	509.2	240.4	91.3	130.0	67.6	189.1	161.4	143.4	106.6	94.8	261.3	143.4	54.6	187.6	20.8	198.7	165.4	366.8	258.9	288.8	250.9	209.7	199.5	323.8	277.8	17.0	184.6	169.0	161.7	202.9	517.5	80.2	75.6	103.3	106.2	71.5	58.0	74.3	93.2	79.7	71.6
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488012-63499322	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 298.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 55.3;HBF TERT88: 27.8;MCF7: 45.7;SCLC-21H: 29.1;T-47d: 23.7;U-2 OS: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Supported	Cytosol			55000000	Cytosol		"CAB034019: AB_1562672, HPA051759: , HPA053862: , HPA056990: "	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	2.2	8.0	21.3	2.3	23.5	1.9	2.2	41.1	51.3	1.9	2.3	2.3	0.1	2.2	2.0	2.3	4.1	2.1	2.6	51.9	23.0	21.0	2.0	2.0	2.0	2.1	13.9	31.0	2.0	3.5	6.1	16.6	2.0	23.1	3.7	2.1	1.8	3.4	2.2	298.6	2.2	2.3	2.1	4.8	2.0	3.6	2.3	3.6	0.0	2.0	23.9	2.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.3	0.1	10.6	0.2	2.5	0.0	0.1	1.3	2.1	0.3	10.5	3.5	1.4	7.0	0.0	18.6	0.1	5.0	55.3	0.1	27.8	0.1	2.5	0.0	4.0	0.4	0.6	0.0	2.5	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.1	45.7	0.1	0.1	1.9	17.8	1.3	0.0	1.7	0.4	0.5	29.1	17.7	16.8	1.9	0.1	23.7	0.6	0.0	0.0	32.4	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	21.3	23.5	41.1	51.3	23.0	21.0	13.9	31.0	23.1	3.6
EEF1AKMT1	N6AMT2	ENSG00000150456	"EEF1A lysine methyltransferase 1"	Q8WVE0	13	20728731-20773958	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040417, HPA042543"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA040417: , HPA042543: "	"unprognostic (4.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-2)"	"prognostic favourable (1.82e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.31e-2)"	12.1	14.1	15.2	8.9	13.8	3.9	13.4	20.9	14.1	12.2	9.4	9.5	8.6	5.9	14.8	19.9	8.0	15.2	8.4	12.4	12.2	14.7	11.5	17.3	7.8	8.1	14.3	14.7	14.5	10.3	9.1	19.1	8.5	11.7	14.1	8.1	10.6	12.8	12.7	15.5	7.2	5.9	12.5	16.2	8.1	8.1	8.2	14.0	11.3	12.9	8.2	8.6	8.9	8.6	10.7	8.8	0.7	4.4	13.1	11.2	5.7	5.7	4.5	3.7	6.1	15.7	16.3	9.2	7.6	5.8	6.7	3.5	6.2	6.5	9.4	5.7	8.3	4.7	5.0	6.5	7.0	6.0	4.4	12.0	2.1	11.8	8.7	23.7	2.4	11.1	5.8	5.0	11.2	12.0	6.9	1.3	19.0	15.9	7.9	21.1	6.4	3.3	9.9	4.0	1.8	9.5	6.7	8.6	5.1	6.5	3.3	8.5	3.4	21.9	7.0	4.6	0.0	10.3	3.3	1.8	3.3	10.1	4.0	16.4	3.3	0.0	4.4	0.7	7.7	3.3	8.1	10.7	9.0	7.6	7.2	4.9	11.2	9.8	0.6	13.1	3.4	8.8	9.5	5.7	15.2	13.8	20.9	14.1	12.2	14.7	14.3	14.7	11.7	14.0
EEF1AKMT4		ENSG00000284753	"EEF1A lysine methyltransferase 4"	O60344	3	184249650-184259585	"Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 29.5"	"Low cell line specificity"	"Detected in all"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA062215			Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA062215: "																		2.1	1.7	0.2	3.3	0.8	1.8	1.9	0.3	0.5	1.3	4.2	0.0	2.5	2.5	0.6	0.5	4.1	0.4	1.4	2.4	0.4		4.2	29.5	2.3	2.5	0.2	0.0	1.7	8.3	1.0	3.1	8.4	0.8	1.6	2.3	0.8	5.7	2.7	5.4	2.4	4.3	1.1	0.1	3.7	1.6	13.0	0.6	4.8	6.9	4.5	3.7	1.3	1.6	4.9	10.1	1.2	12.0	3.4	7.6	5.6	13.1	6.9	1.6	4.4	2.4	1.6	10.1	1.5	2.9	2.3	2.2	12.9	2.0	15.6	10.3	1.7	4.9	7.4	7.5	1.3	6.1	8.7	4.1	4.4	8.2	2.9	10.8	3.5	2.0	9.1	2.6	4.5	1.9	7.4	14.5	1.1	20.6	4.4	13.1	3.3	13.0	9.2	2.2	12.6	2.7	3.2	8.0	2.7	3.0	23.6	5.8	19.9	5.0	1.4	2.6	3.5	6.1	7.6	8.7	17.5	15.4	2.1	17.8	2.7	0.0	12.0	1.2	4.3	9.7	4.8	4.9	4.6	4.2	10.1	3.2	3.3	5.2	0.2	3.4	6.2	9.0	7.6	5.6										
EEF1AKMT4-ECE2		ENSG00000284917	"EEF1AKMT4-ECE2 readthrough"	O60344	3	184249695-184293031	"Predicted membrane proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 22.6"	"Cell line enriched"	"Detected in single"	10	"REH: 5.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043346, HPA062215"	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043346: AB_10794181, HPA062215: "																		1.2	6.6	0.0	2.1	0.1	0.3	0.3	0.0	1.5	0.6	2.9	0.0	1.5	0.9	0.3	0.3	2.8	0.5	0.6	2.1	0.0		2.8	22.6	1.3	1.5	0.0	0.0	0.9	6.0	1.5	2.0	6.1	0.2	1.4	0.6	0.2	4.0	1.6	3.8	0.3	2.9	0.4	0.0	2.4	0.3	9.7	0.0	3.3	4.9	3.1	2.5	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EEF1B2		ENSG00000114942	"Eukaryotic translation elongation factor 1 beta 2"	P24534	2	206159585-206162928	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012477, HPA035029"	Supported		Approved	"Nucleoli fibrillar center,Cytosol"			640000	"Nucleoli fibrillar center, Cytosol"		"CAB012477: AB_732078, HPA035029: "	"prognostic favourable (2.60e-4)"	"unprognostic (3.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (9.95e-4)"	"unprognostic (2.70e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.62e-6)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-2)"	42.9	33.9	37.6	72.1	32.6	93.8	78.8	18.8	37.1	46.7	80.3	23.3	37.8	55.8	41.4	43.9	71.7	42.1	54.1	40.7	30.2	26.4	36.9	72.4	41.9	171.3	35.9	20.7	73.2	252.4	9.1	19.4	34.6	35.3	41.6	49.1	19.3	93.2	60.0	122.3	59.4	58.3	59.7	36.1	58.7	40.4	27.3	22.4	58.3	44.2	101.5	69.2	63.1	79.0	88.9	55.0	6.2	29.4	46.5	95.3	121.3	27.3	34.0	40.0	37.3	57.1	96.7	85.1	55.0	56.5	58.2	38.7	74.9	46.8	78.3	37.0	64.9	35.5	53.0	65.5	53.0	24.2	48.7	55.6	48.1	101.0	76.2	110.1	49.7	97.6	77.8	43.2	98.2	61.1	76.5	65.3	64.4	56.9	97.7	91.5	55.5	57.9	73.1	78.0	99.2	63.0	53.8	40.3	41.2	22.0	47.9	53.5	29.3	136.3	43.1	30.7	41.0	40.0	52.1	70.5	57.8	89.2	35.7	74.9	23.3	6.2	28.2	3.5	37.2	29.4	68.4	88.9	66.4	49.4	55.0	69.7	95.3	76.8	4.1	46.5	23.1	53.5	35.1	121.3	37.6	32.6	18.8	37.1	30.2	26.4	35.9	20.7	35.3	22.4
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102578	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: "	"unprognostic (9.39e-3)"	"prognostic favourable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favourable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	10.5	21.8	20.1	14.2	26.9	34.0	18.5	20.0	24.6	10.8	12.2	13.5	12.3	8.2	13.6	19.2	15.9	10.3	9.5	12.5	19.4	27.0	34.9	19.2	9.9	19.7	26.9	16.2	10.8	26.6	19.8	28.6	11.7	41.2	12.5	15.2	9.6	13.5	13.4	14.4	8.4	8.4	13.3	21.3	11.8	14.8	36.3	19.4	9.9	13.9	15.8	20.3	11.6	9.3	20.9	29.6	6.8	15.0	14.0	21.3	13.5	27.7	14.7	23.7	16.3	7.8	13.1	14.4	23.4	14.8	21.1	21.8	24.0	11.6	30.5	51.6	15.2	11.6	26.7	26.9	35.6	17.0	34.8	24.6	19.4	41.6	14.5	48.6	18.1	10.9	25.4	25.1	26.1	29.8	58.7	8.5	20.2	11.6	20.8	39.5	21.3	23.6	25.6	13.9	47.8	34.5	21.5	35.2	10.9	9.9	22.5	27.8	17.9	16.7	15.3	17.7	17.5	16.0	33.9	13.3	60.2	43.3	9.9	20.6	28.0	6.2	11.0	6.8	13.5	15.0	19.1	20.9	18.1	17.8	29.6	20.5	20.3	20.6	1.1	14.0	11.2	13.0	21.3	13.5	20.1	26.9	20.0	24.6	19.4	27.0	26.9	16.2	41.2	19.4
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985469	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			9700000	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (5.47e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.75e-1)"	"prognostic favourable (1.81e-6)"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (4.46e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.86e-2)"	104.2	84.9	64.0	66.7	57.1	92.7	77.5	55.7	96.2	93.4	91.3	55.8	80.8	95.4	100.1	75.1	115.1	83.4	88.6	104.1	51.6	44.4	65.5	161.0	67.7	108.9	51.4	38.3	167.1	395.7	45.1	72.3	63.7	47.5	105.6	41.3	67.7	191.3	64.4	260.8	87.2	100.9	112.3	46.8	85.4	98.5	70.9	32.4	123.4	127.1	112.5	108.3	111.8	94.7	84.9	60.0	10.0	58.4	48.3	76.3	83.7	95.2	68.4	39.8	105.1	106.7	192.3	57.3	74.9	101.4	71.7	70.6	107.8	44.2	199.0	44.6	69.1	72.3	62.8	116.0	38.0	49.6	104.2	50.8	65.7	110.7	156.0	109.1	88.4	248.2	122.7	63.1	97.7	74.2	99.1	146.7	43.6	138.2	97.9	83.7	105.3	69.2	109.1	59.2	126.5	59.0	85.2	109.0	101.3	47.1	94.3	135.0	91.9	132.7	88.9	51.4	53.7	104.4	115.2	157.4	105.6	99.0	76.6	137.2	67.0	10.0	58.4	8.3	38.6	45.8	68.7	84.9	67.7	50.8	60.0	70.7	76.3	59.4	6.1	48.3	43.8	50.5	58.4	83.7	64.0	57.1	55.7	96.2	51.6	44.4	51.4	38.3	47.5	32.4
EEFSEC	"eEFSec, EFSEC, SELB"	ENSG00000132394	"Eukaryotic elongation factor, selenocysteine-tRNA specific"	P57772	3	128153454-128408646	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.5;SH-SY5Y: 8.8;SK-BR-3: 14.8;SK-MEL-30: 12.7;T-47d: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035795	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA035795: AB_10696512"	"unprognostic (1.01e-1)"	"prognostic favourable (2.98e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-3)"	"unprognostic (6.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	8.2	6.8	5.6	7.9	7.9	3.1	7.9	8.4	9.8	11.6	8.6	9.3	7.3	2.5	10.8	5.4	8.0	9.4	7.1	18.7	7.6	6.4	9.4	18.1	7.1	15.5	5.4	4.2	11.5	8.4	23.9	9.2	9.7	6.9	9.0	4.9	7.2	10.7	11.2	20.3	15.9	15.7	10.0	5.0	9.2	6.9	11.5	6.2	17.2	8.4	6.7	10.5	7.7	7.9	7.1	10.9	7.3	7.8	9.7	7.0	3.8	0.4	0.1	3.4	1.4	0.1	0.2	0.4	0.0	0.2	0.2	0.2	0.3	5.7	12.5	0.1	3.1	0.9	0.3	0.1	0.1	0.3	0.3	0.0	0.1	0.1	4.9	0.2	0.3	0.1	0.1	3.4	0.1	0.2	0.0	0.2	2.9	0.1	6.2	0.3	0.4	0.1	0.2	0.2	0.8	0.0	0.0	0.3	8.8	0.0	14.8	12.7	8.0	0.5	0.0	0.1	0.0	0.1	0.2	0.4	0.6	0.3	0.1	0.4	0.2	0.5	7.5	7.3	6.7	7.8	5.6	7.1	5.9	5.8	10.9	5.8	5.6	6.5	0.0	9.7	6.2	4.6	7.0	3.8	5.6	7.9	8.4	9.8	7.6	6.4	5.4	4.2	6.9	6.2
EFCAB11	C14orf143	ENSG00000140025	"EF-hand calcium binding domain 11"	Q9BUY7	14	89794669-89954777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051209			Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA051209: "	"unprognostic (1.03e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.84e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.45e-2)"	4.7	5.8	10.2	6.2	8.1	5.3	9.3	5.7	7.6	5.6	5.2	10.4	6.7	5.1	4.9	6.9	6.2	11.0	4.9	3.7	7.8	6.6	7.6	5.8	3.2	3.3	8.6	5.7	5.2	4.8	8.3	8.2	8.4	7.7	5.4	5.6	6.1	5.6	5.4	2.4	3.7	3.6	6.3	8.4	6.7	4.4	36.9	6.2	2.5	7.9	3.3	6.3	5.2	4.1	2.6	2.1	12.8	5.3	3.3	1.6	0.8	4.9	7.6	6.6	8.2	4.1	4.4	18.7	7.2	6.6	9.9	6.9	8.9	17.5	7.7	13.8	4.8	10.8	5.7	14.4	14.3	8.6	3.6	5.5	6.5	14.5	0.9	7.0	13.4	3.0	3.6	6.4	7.4	8.2	5.8	7.6	11.7	25.5	5.2	9.5	2.8	13.7	6.0	10.5	5.5	9.1	13.7	2.8	4.7	9.1	17.0	8.5	13.8	5.1	6.9	5.4	7.4	5.6	7.0	4.6	13.1	13.3	7.8	3.3	9.7	12.8	1.3	3.4	0.6	3.0	0.3	2.6	1.0	1.0	2.1	2.6	1.6	1.4	4.0	3.3	5.3	1.8	1.3	0.8	10.2	8.1	5.7	7.6	7.8	6.6	8.6	5.7	7.7	6.2
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 29.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	4.1	2.8	2.9	12.2	3.4	3.4	6.5	2.8	3.8	6.5	4.7	2.3	3.5	4.8	8.9	4.4	2.4	4.2	4.1	3.5	2.3	1.5	7.5	4.0	3.1	4.3	3.6	0.4	5.5	2.8	8.4	7.6	5.4	3.2	9.3	3.4	2.6	5.4	2.0	1.3	2.2	6.3	9.9	3.5	4.6	3.5	20.0	2.7	2.4	14.9	0.7	4.3	5.5	29.9	5.6	1.0	5.3	2.1	0.8	2.6	0.8	0.9	3.9	1.7	0.2	2.1	7.2	3.0	2.2	0.5	0.6	1.1	1.7	5.6	0.3	6.5	0.8	1.0	0.0	0.4	3.9	0.2	0.6	5.1	3.2	0.5	2.0	3.9	0.6	1.3	1.9	2.7	0.0	4.4	1.5	9.7	2.4	0.1	1.7	2.2	0.9	3.1	4.6	1.2	1.8	9.1	3.2	1.2	0.6	1.2	0.1	2.6	6.5	4.7	1.6	0.2	1.3	0.4	1.0	10.0	6.9	0.9	6.2	7.7	4.2	5.3	2.1	0.6	1.1	1.2	0.9	4.3	0.9	0.6	1.0	5.6	2.6	1.2	0.0	0.8	0.7	0.4	0.1	0.8	2.9	3.4	2.8	3.8	2.3	1.5	3.6	0.4	3.2	2.7
EFCAB14	KIAA0494	ENSG00000159658	"EF-hand calcium binding domain 14"	O75071	1	46675159-46719064	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011224, HPA011938"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"			58000	Cytosol	"Nucleoli, Golgi apparatus"	"HPA011224: AB_1852314, HPA011938: AB_1852317"	"unprognostic (2.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-1)"	29.4	17.4	29.4	14.3	29.5	6.7	22.5	16.2	24.8	25.3	26.0	40.6	15.6	17.2	23.7	27.3	30.0	22.0	19.7	20.2	27.2	20.5	27.8	24.9	24.0	16.4	31.0	15.2	25.2	16.0	107.1	17.2	25.2	27.3	24.4	24.0	23.0	19.9	24.9	24.7	20.4	26.9	22.5	36.1	24.0	36.4	21.9	30.6	28.7	30.1	13.2	20.2	25.7	20.0	16.6	16.0	30.3	21.1	17.1	28.5	18.3	14.3	8.2	7.0	11.1	33.5	21.1	16.1	15.5	23.0	17.2	17.8	9.8	9.7	11.5	16.3	21.1	17.4	12.0	17.2	23.5	21.9	7.7	14.4	9.1	4.0	11.5	18.6	28.4	18.6	28.7	13.7	11.4	21.0	8.9	16.5	17.8	5.6	12.2	8.4	10.0	9.3	9.3	19.6	10.1	18.2	29.1	3.6	5.0	19.2	27.2	14.6	12.2	16.2	19.3	14.8	7.2	17.1	15.7	16.9	23.5	9.3	18.9	16.0	10.9	15.6	18.6	30.3	23.6	21.1	28.5	16.6	20.6	20.2	16.0	16.2	18.0	19.5	12.5	17.1	18.3	12.9	17.8	18.3	29.4	29.5	16.2	24.8	27.2	20.5	31.0	15.2	27.3	30.6
EFCAB2	"CFAP200, DRC8, MGC12458"	ENSG00000203666	"EF-hand calcium binding domain 2"	Q5VUJ9	1	244969705-245127164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 34.2;THP-1: 30.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031206, HPA031207"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA031206: AB_10599710, HPA031207: AB_10599946"	"unprognostic (1.36e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (6.51e-4)"	"unprognostic (4.88e-2)"	11.0	12.5	16.7	5.6	18.6	10.8	14.7	20.1	15.5	11.6	7.3	23.6	13.9	3.0	18.7	19.5	9.6	32.1	13.1	13.7	18.0	14.3	12.5	6.5	11.2	7.8	22.3	12.3	10.6	12.1	14.6	20.6	14.7	16.3	9.2	11.3	11.8	7.4	16.0	15.5	6.1	6.5	13.2	20.9	6.4	10.5	24.4	21.9	5.4	23.7	13.5	9.1	11.5	16.0	3.6	10.8	4.9	1.8	2.9	0.8	1.2	3.1	3.9	8.9	2.3	3.2	7.6	10.9	3.9	4.2	5.1	4.7	10.0	8.5	10.8	8.5	4.9	2.5	3.6	2.3	3.2	1.1	2.1	5.2	15.6	4.4	6.9	5.3	34.2	6.6	4.8	6.8	6.4	7.8	19.9	8.8	4.4	3.2	1.1	14.6	11.4	3.0	20.5	1.3	2.8	13.0	5.3	7.0	9.5	6.9	2.6	5.7	2.6	30.1	1.2	6.3	2.3	3.4	14.2	3.0	5.0	7.2	5.0	15.3	5.1	1.2	1.7	2.8	0.5	1.8	0.8	3.6	0.7	0.4	5.5	3.3	0.6	0.6	4.9	2.9	1.3	10.8	0.8	1.2	16.7	18.6	20.1	15.5	18.0	14.3	22.3	12.3	16.3	21.9
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	4.3	8.4	12.7	3.5	16.7	3.1	9.3	24.5	19.5	9.4	5.1	3.7	6.4	3.2	9.6	9.8	5.7	12.6	7.2	9.7	11.4	11.8	8.8	2.8	6.2	5.2	8.1	10.8	12.8	4.9	16.3	31.6	5.1	13.7	8.7	5.0	3.5	5.3	8.2	10.8	4.9	3.4	7.5	9.4	4.2	5.0	20.0	10.2	11.5	9.1	2.4	5.2	7.3	12.9	3.3	1.7	9.8	3.3	1.8	2.9	1.1	6.2	5.2	6.9	4.4	7.3	10.9	3.5	4.1	4.4	7.0	8.7	1.7	4.9	4.4	9.7	2.3	5.8	5.9	3.9	8.4	8.1	4.1	3.5	9.8	3.6	4.7	4.9	3.2	5.9	9.5	8.2	5.6	5.9	4.4	7.2	4.6	1.3	9.3	3.3	3.0	5.3	6.0	10.4	4.3	10.8	3.4	14.8	5.7	7.7	4.4	9.9	4.5	3.5	1.6	3.9	3.5	11.7	3.8	4.8	8.3	5.1	7.3	3.5	5.8	9.8	0.7	0.2	2.1	0.4	2.9	3.3	2.4	2.5	1.3	2.8	2.5	2.4	0.1	1.8	3.3	1.7	2.7	1.1	12.7	16.7	24.5	19.5	11.4	11.8	8.1	10.8	13.7	10.2
EFHD2	MGC4342	ENSG00000142634	"EF-hand domain family member D2"	Q96C19	1	15409895-15430343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 45.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048961	Enhanced		Approved	Cytosol			35000	Cytosol		"HPA048961: "	"unprognostic (1.37e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (9.11e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (6.31e-9)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"prognostic favourable (2.70e-4)"	"prognostic favourable (3.60e-5)"	12.9	21.8	16.1	35.4	15.4	69.3	8.7	13.3	41.2	9.3	24.8	7.0	7.5	39.5	11.8	6.2	18.4	10.3	21.2	7.2	19.6	15.3	7.4	10.4	19.2	31.8	14.2	22.0	9.2	26.8	4.0	10.1	16.4	56.5	14.6	14.8	6.8	11.1	10.3	3.3	10.8	45.0	8.7	8.2	48.9	42.8	28.5	7.1	17.1	14.7	7.5	27.2	20.6	12.9	1.4	9.7	45.0	11.9	9.4	15.6	4.9	78.0	19.9	1.9	5.2	3.2	6.8	10.4	10.0	9.5	9.5	9.1	7.6	21.6	17.0	31.6	6.9	19.1	5.4	17.6	6.1	21.1	10.5	4.0	4.6	12.1	5.1	20.7	35.6	5.4	6.0	19.3	4.9	12.2	9.7	8.3	5.8	7.8	10.6	39.9	2.5	24.8	14.2	18.2	13.5	5.5	16.4	4.4	3.4	8.8	7.6	16.2	3.3	22.4	22.8	14.0	15.0	43.5	16.0	5.6	13.1	7.2	19.6	41.2	19.0	4.7	11.9	16.3	15.6	11.1	4.5	1.3	3.6	7.2	9.7	1.4	1.7	6.7	45.0	9.4	9.3	3.4	2.3	4.9	16.1	15.4	13.3	41.2	19.6	15.3	14.2	22.0	56.5	7.1
EFL1	"EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1"	ENSG00000140598	"Elongation factor like GTPase 1"	Q7Z2Z2	15	82130230-82262763	"Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Elongation factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039654, HPA047110, HPA052345"	Uncertain		Approved	Cytosol				Cytosol		"HPA039654: , HPA047110: , HPA052345: "	"unprognostic (2.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.92e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.56e-2)"	"unprognostic (3.14e-1)"	"prognostic favourable (1.50e-6)"	"unprognostic (8.58e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.05e-2)"	16.3	14.0	7.0	17.3	9.9	8.9	11.8	10.2	9.4	9.5	17.2	11.0	6.8	13.2	9.2	12.2	14.1	9.1	8.0	10.7	8.8	7.9	11.9	15.4	9.0	10.0	9.5	4.5	9.8	12.5	17.9	15.0	12.8	13.3	12.7	19.6	7.4	12.1	8.5	18.5	14.6	25.7	10.8	10.1	10.1	9.7	13.9	9.9	26.9	9.8	11.3	14.9	10.8	11.7	10.7	6.8	15.8	9.0	5.8	9.0	4.5	4.8	12.1	9.1	7.8	6.1	8.4	5.8	14.1	16.7	10.3	13.8	6.0	8.6	11.9	5.8	10.5	12.6	24.0	9.4	16.3	10.5	11.7	13.0	11.6	4.5	9.7	8.4	9.3	4.1	14.6	10.3	23.8	13.5	9.7	5.4	11.8	6.8	10.9	7.6	8.2	6.3	11.7	13.5	6.4	7.2	14.6	8.2	8.8	8.9	10.5	10.8	7.8	7.5	11.3	14.5	9.8	36.3	14.0	6.9	25.9	10.1	13.2	15.8	5.4	15.8	5.6	13.7	9.0	8.1	7.2	8.9	8.4	7.6	6.8	10.7	7.3	6.3	1.0	5.8	9.0	3.3	7.6	4.5	7.0	9.9	10.2	9.4	8.8	7.9	9.5	4.5	13.3	9.9
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1286154-1300237	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"gallbladder: 10.0;intestine: 30.3;liver: 14.2"	"Cell line enhanced"	"Detected in some"		"AF22: 4.8;BEWO: 4.9;Hep G2: 9.3;NTERA-2: 5.4;REH: 7.1;SH-SY5Y: 16.8;U-2 OS: 5.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"			"Mitochondria, Cytosol"		"HPA067567: "	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.2	0.1	1.5	3.4	2.2	0.2	0.1	1.5	2.0	0.1	10.7	2.0	0.0	12.0	0.2	0.1	0.4	0.1	10.0	0.1	1.0	1.6	0.3	14.2	0.1	0.1	1.2	0.5	0.1	0.1	0.1	0.3	0.2	1.1	0.1	2.3	1.9	0.1	0.2	0.2	0.1	30.3	0.2	0.9	0.2	0.6	0.6	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.8	1.7	0.0	0.0	4.9	0.2	0.0	0.0	0.0	3.5	0.0	0.0	2.3	0.0	0.0	2.2	0.0	0.0	0.1	2.1	0.0	0.0	9.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.4	0.0	7.1	0.6	0.0	0.0	0.1	0.0	16.8	0.2	0.0	0.1	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.2	1.5	2.0	1.0	1.6	1.2	0.5	1.1	0.7
EFNA5	"AF1, EPLG7, LERK7"	ENSG00000184349	"Ephrin A5"	P52803	5	107376889-107670895	"Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 19.3;RPTEC TERT1: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5;memory CD8 T-cell: 3.0"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.5;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013282, HPA054047"	Approved		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB013282: AB_2533353, HPA054047: "	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.98e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (9.46e-3)"	"unprognostic (4.92e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (1.92e-7)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.27e-1)"	5.3	1.9	1.9	2.3	6.0	0.0	7.3	10.1	22.2	15.0	4.2	0.9	2.5	1.2	1.6	2.8	9.1	3.9	3.6	8.3	2.5	5.3	5.3	0.6	7.0	3.2	2.1	8.9	5.5	0.7	6.9	18.5	3.1	4.8	6.2	3.6	3.3	11.2	6.8	1.1	13.3	2.3	2.8	3.5	6.3	3.1	1.8	1.1	0.1	2.5	6.0	3.3	4.0	8.1	0.0	0.0	0.4	0.1	2.5	3.5	0.4	6.2	11.1	19.3	0.0	9.3	8.1	1.8	0.2	3.3	2.4	6.0	0.1	7.0	0.0	10.6	1.2	6.5	10.7	9.2	2.3	0.0	6.5	0.0	6.1	0.0	1.8	0.3	0.0	8.6	8.8	0.0	7.8	7.6	0.0	0.0	4.6	6.0	0.0	0.0	2.3	0.9	0.0	8.7	0.2	29.4	8.1	2.9	7.7	3.0	4.5	1.9	1.9	1.2	0.1	14.6	2.6	8.9	3.5	0.5	0.0	4.0	6.4	0.4	15.7	0.2	0.0	0.1	3.5	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.3	1.4	0.4	2.5	0.1	0.0	0.1	0.4	1.9	6.0	10.1	22.2	2.5	5.3	2.1	8.9	4.8	1.1
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489731-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 49.4;SH-SY5Y: 24.8;U-87 MG: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol			760000	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavourable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavourable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	15.7	4.9	11.2	8.2	11.0	0.8	21.8	8.3	14.0	13.2	23.1	5.8	13.1	13.9	10.8	5.2	11.4	13.6	11.2	11.8	10.4	6.5	9.3	11.8	50.1	7.8	6.2	11.5	8.4	3.7	5.7	6.1	27.7	5.2	11.8	18.4	15.2	12.7	20.6	6.6	14.3	20.6	10.5	5.0	9.3	21.3	7.2	5.9	7.3	11.2	8.8	5.9	7.7	12.4	0.2	0.0	0.4	0.0	1.5	0.0	0.0	11.8	1.1	49.4	0.0	0.1	0.4	0.2	5.4	3.4	5.3	3.1	11.9	18.1	0.0	5.2	1.6	14.1	1.8	6.9	5.8	0.0	10.6	0.0	4.1	0.0	1.0	3.9	0.3	2.3	12.4	0.2	10.6	6.7	0.0	0.0	5.8	2.0	0.1	0.0	2.6	2.4	9.9	2.0	0.0	7.6	1.5	3.5	24.8	2.0	1.0	0.0	0.6	0.1	5.2	10.6	0.0	0.3	12.1	0.1	0.0	0.0	22.2	0.2	2.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	11.2	11.0	8.3	14.0	10.4	6.5	6.2	11.5	5.2	5.9
EFR3A	KIAA0143	ENSG00000132294	"EFR3 homolog A"	Q14156	8	131904088-132013642	"Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022859, HPA023092, HPA023402"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA022859: AB_1848029, HPA023092: AB_2293240, HPA023402: AB_1848031"	"unprognostic (4.79e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-3)"	14.7	16.0	21.6	13.6	21.4	8.0	46.8	48.6	52.2	20.4	19.2	7.1	15.0	15.0	18.0	26.5	18.6	16.5	14.6	22.7	28.2	18.5	20.2	28.9	18.8	22.4	20.7	24.4	13.6	13.8	29.2	12.9	13.3	63.3	18.7	12.5	13.9	14.6	20.8	37.1	13.8	15.2	28.1	11.9	14.5	14.8	13.8	7.6	18.7	25.4	9.8	17.7	18.1	14.1	9.5	12.0	11.8	25.8	10.0	12.1	9.5	20.9	18.9	5.9	4.9	24.3	28.1	11.9	15.0	21.1	12.5	16.6	4.1	15.7	12.9	14.2	33.7	6.9	9.3	20.5	15.4	29.6	5.1	12.8	9.4	8.3	23.3	4.9	13.6	23.7	11.7	12.3	19.6	15.7	7.0	17.4	22.1	13.7	13.6	4.5	3.3	11.9	5.5	11.6	6.1	15.1	13.1	4.0	13.8	29.8	4.2	11.6	13.5	8.4	21.8	22.3	20.5	10.8	15.6	12.4	10.6	8.1	16.5	11.9	11.3	5.4	11.7	11.8	12.1	16.4	10.8	9.5	9.8	9.8	12.0	8.3	9.0	9.1	7.2	10.0	25.8	2.8	7.7	9.5	21.6	21.4	48.6	52.2	28.2	18.5	20.7	24.4	63.3	7.6
EFR3B	"FLJ37871, KIAA0953"	ENSG00000084710	"EFR3 homolog B"	Q9Y2G0	2	25042130-25159137	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;retina: 21.1;skeletal muscle: 25.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.9;BEWO: 10.4;SH-SY5Y: 9.3;SK-BR-3: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038089, HPA071831"	Uncertain		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"HPA038089: AB_10672618, HPA071831: "	"unprognostic (9.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.49e-6)"	"unprognostic (4.83e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	1.9	3.2	13.1	1.7	22.9	1.3	1.3	15.5	30.5	1.4	1.7	9.4	0.0	1.4	1.8	8.4	1.3	1.8	1.5	6.9	11.4	8.7	1.4	1.1	4.4	1.3	8.7	13.5	1.4	1.3	2.4	4.1	3.2	29.9	1.5	1.8	21.1	1.1	2.0	25.1	1.7	1.3	2.6	7.8	4.3	2.2	3.5	9.0	0.0	4.5	0.2	1.1	1.4	0.7	1.0	0.6	4.4	0.5	1.0	0.7	0.1	0.1	7.0	8.2	8.9	0.5	0.1	10.4	0.8	0.2	0.4	0.1	5.6	0.3	0.1	0.5	1.2	0.5	6.5	0.0	0.1	1.3	1.6	1.3	0.3	0.5	0.0	0.1	0.7	0.1	0.0	2.0	0.1	0.2	0.1	0.4	0.2	0.8	0.2	0.4	1.6	5.6	0.6	7.9	0.2	0.1	0.2	3.5	9.3	1.0	15.6	5.0	0.8	0.1	0.5	0.5	2.4	3.6	1.7	0.6	0.7	0.1	6.4	0.1	1.7	4.4	0.4	1.1	0.7	0.3	0.5	0.6	0.4	0.6	0.3	1.0	0.4	0.7	1.7	1.0	0.5	0.6	0.2	0.1	13.1	22.9	15.5	22.7	11.4	8.7	8.7	13.5	29.9	9.0
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356402-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 27.7;AN3-CA: 15.1;BEWO: 23.2;SH-SY5Y: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA001581: , HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	12.0	10.2	11.7	4.4	15.7	0.6	13.1	9.4	21.2	17.9	8.5	29.4	8.0	2.8	17.0	9.8	18.3	10.0	6.7	5.5	14.3	8.3	3.2	1.2	5.7	2.8	14.9	8.2	23.7	1.5	25.0	3.2	33.1	15.6	17.9	3.1	8.3	15.6	18.6	3.8	42.3	3.9	13.0	25.7	4.5	4.7	4.4	16.0	0.4	6.8	15.5	10.0	11.8	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	27.7	15.1	6.9	8.0	23.2	2.0	4.2	0.7	0.3	0.0	0.0	0.0	0.0	11.4	10.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	4.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	8.8	0.0	0.0	8.8	3.0	26.5	5.9	0.9	0.0	6.6	0.0	0.0	2.9	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	15.7	9.4	11.8	14.3	8.3	14.9	8.2	15.6	16.0
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849943-44899662	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	22.5	26.5	16.0	23.1	27.0	25.0	17.7	13.4	34.9	14.8	20.3	22.0	10.4	16.6	22.1	15.4	27.0	20.2	12.7	22.6	16.6	16.7	21.5	27.7	17.3	25.2	15.8	19.8	15.3	20.0	21.2	15.3	27.5	22.6	14.9	23.2	19.1	27.2	15.7	49.6	22.0	20.3	18.5	15.7	25.9	18.5	30.2	13.1	36.9	18.6	17.9	34.9	18.6	16.0	12.8	31.8	31.6	31.5	15.6	16.9	23.3	22.8	45.8	22.3	36.2	17.1	17.0	26.3	18.2	24.4	46.0	40.0	35.2	19.6	39.6	21.5	22.9	26.2	48.5	31.8	53.8	39.7	40.2	39.2	28.6	37.4	18.9	46.2	29.2	18.4	18.2	42.5	23.2	39.8	48.3	15.4	26.1	22.8	46.2	30.5	23.0	38.3	32.6	45.4	34.3	26.2	25.7	36.8	22.0	17.9	13.3	18.8	35.2	29.2	24.1	34.6	26.7	20.9	45.8	16.3	20.5	39.8	27.8	25.7	35.2	12.3	31.5	31.6	15.2	31.0	16.9	12.8	13.5	14.6	31.8	12.5	12.0	13.3	5.1	15.6	29.7	13.7	13.2	23.3	16.0	27.0	13.4	34.9	16.6	16.7	15.8	19.8	22.6	13.1
EGLN3	"HIFPH3, PHD3"	ENSG00000129521	"Egl-9 family hypoxia inducible factor 3"	Q9H6Z9	14	33924231-34462774	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 49.6;skin 1: 44.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;RPTEC TERT1: 15.2;RT4: 47.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 50.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 19.0"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064895			Supported	Cytosol				Cytosol		"HPA064895: "	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.75e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.38e-2)"	"prognostic unfavourable (2.14e-5)"	"unprognostic (1.39e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.30e-2)"	6.3	0.8	12.9	4.8	10.6	0.4	6.0	3.0	11.9	7.3	14.3	13.4	4.9	19.3	5.9	2.8	10.4	5.4	7.8	49.6	10.9	7.3	6.1	2.4	3.0	3.0	10.7	8.1	2.5	6.5	0.4	1.5	19.6	9.9	9.9	11.3	3.5	4.2	11.3	9.7	44.1	21.7	11.7	9.7	2.8	19.9	1.0	12.5	3.4	1.2	1.3	5.3	25.6	16.1	0.0	19.0	1.2	0.0	0.8	1.0	0.6	11.8	3.1	0.3	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.2	0.0	4.0	0.0	0.3	5.9	11.5	0.0	1.2	3.1	3.2	8.7	0.4	0.0	0.0	0.1	1.6	5.8	0.0	0.0	0.0	6.3	0.0	0.1	1.0	0.2	0.0	9.6	1.1	0.0	17.8	4.2	15.2	47.8	2.5	2.8	0.8	4.6	1.2	4.7	0.0	0.0	0.1	1.3	0.0	0.6	0.1	2.5	0.0	2.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.8	1.9	0.0	0.1	0.0	0.1	0.8	0.0	19.0	0.0	0.6	12.9	10.6	3.0	9.8	10.9	7.3	10.7	8.1	9.9	12.5
EHBP1	"KIAA0903, NACSIN"	ENSG00000115504	"EH domain binding protein 1"	Q8NDI1	2	62673851-63046487	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035468, HPA035469"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA035468: AB_10671513, HPA035469: AB_10601365"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (8.78e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (1.95e-8)"	19.6	12.6	19.8	10.2	15.4	4.0	12.0	27.5	22.5	22.5	22.3	8.0	7.5	6.8	22.3	6.0	20.9	12.7	18.2	7.8	16.0	15.9	12.3	36.9	8.1	5.7	17.1	13.0	35.1	10.9	9.7	14.5	8.2	12.8	12.6	10.4	8.6	10.2	14.0	5.4	7.4	8.5	21.4	9.3	5.4	11.1	24.1	9.8	5.4	10.4	7.5	7.0	12.3	12.7	8.4	5.4	3.5	3.6	4.7	6.8	2.8	18.3	25.4	10.4	6.2	18.2	35.2	10.5	16.4	16.1	12.1	10.0	30.2	13.8	12.7	6.0	30.0	11.2	13.4	11.6	20.1	13.5	6.3	10.9	9.0	35.6	12.5	6.3	8.4	16.2	21.0	12.3	24.1	7.7	7.5	7.3	19.4	7.1	7.3	4.0	10.1	9.9	6.6	13.0	5.4	8.1	6.0	11.3	9.2	13.5	10.0	16.3	4.8	6.3	5.6	13.1	13.6	21.5	8.6	8.4	5.7	12.1	13.0	9.9	26.1	0.2	3.4	3.5	6.3	3.6	6.3	8.4	6.8	6.0	5.4	7.3	6.7	5.7	1.3	4.7	1.9	3.5	3.7	2.8	19.8	15.4	27.5	22.5	16.0	15.9	17.1	13.0	12.8	9.8
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24, autophagy associated transmembrane protein"	O14681	11	125569216-125584687	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 164.6"	"Cell line enhanced"	"Detected in all"		"HEL: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	13.4	10.2	13.3	8.9	16.2	4.6	16.7	11.2	22.1	12.7	17.0	14.4	13.8	11.3	13.6	12.9	22.7	12.1	15.8	16.4	10.6	10.7	14.6	55.5	12.1	11.2	12.0	11.1	13.1	34.2	164.6	9.2	11.9	11.0	13.7	18.9	13.2	20.9	14.3	26.5	17.2	16.1	15.9	9.2	10.5	17.7	10.4	10.5	9.9	12.0	14.2	13.0	16.2	12.9	8.5	15.5	5.4	7.3	6.5	10.0	4.9	24.5	18.7	21.4	25.8	35.2	26.8	26.8	25.2	19.1	17.4	15.7	28.4	49.6	24.7	42.9	23.7	28.4	32.5	53.0	22.6	6.5	20.6	117.8	13.4	26.6	26.2	26.5	12.8	25.0	48.6	26.1	38.6	36.7	53.4	10.1	24.4	17.3	12.1	13.6	28.2	20.5	17.8	25.3	21.0	29.0	44.0	20.0	19.2	29.5	35.2	9.5	71.9	26.5	30.5	22.4	15.2	15.6	20.3	6.3	12.7	32.2	9.8	40.8	29.8	4.1	7.3	5.4	8.2	7.0	8.1	8.5	6.5	10.0	11.6	7.3	9.4	7.6	0.9	6.5	5.1	15.5	9.0	4.9	13.3	16.2	11.2	22.1	10.6	10.7	12.0	11.1	11.0	10.5
EIF1AX	"eIF-1A, eIF-4C, EIF1A, EIF4C"	ENSG00000173674	"Eukaryotic translation initiation factor 1A, X-linked"	P47813	X	20124518-20141844	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA002561	Uncertain	Supported	Approved	Cytosol				Cytosol		"HPA002561: AB_1078724"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.26e-3)"	"unprognostic (7.13e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.23e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	30.9	23.2	22.0	23.7	28.8	28.3	53.4	35.4	57.3	26.1	23.6	14.5	23.9	22.7	33.8	18.7	32.6	24.7	18.4	29.2	21.4	19.5	31.0	32.0	22.1	20.9	23.5	23.5	37.0	33.0	28.7	19.8	24.7	29.0	19.5	16.9	12.0	25.2	25.0	61.5	22.5	18.9	32.5	34.1	16.5	22.7	18.0	23.7	14.8	25.7	24.6	17.2	29.3	33.9	31.1	30.2	12.6	19.9	27.2	30.9	23.8	45.8	25.9	20.0	26.6	19.5	26.6	16.3	41.0	15.1	22.4	17.7	37.2	22.0	42.9	27.5	27.1	19.7	35.2	35.6	35.1	17.5	58.1	19.0	32.6	31.7	13.6	50.5	26.8	12.4	21.8	34.6	54.4	31.2	49.1	24.1	22.0	22.4	31.1	31.7	51.9	43.1	25.6	45.9	45.9	17.6	25.6	23.2	26.0	43.5	34.0	26.9	27.6	21.5	17.8	27.3	17.0	88.9	30.6	16.5	31.2	50.9	18.6	23.2	20.6	12.6	19.1	11.5	23.1	19.9	30.2	31.1	26.5	27.1	18.3	27.7	30.9	25.8	4.7	27.2	19.2	30.2	20.3	23.8	22.0	28.8	35.4	57.3	21.4	19.5	23.5	23.5	29.0	23.7
EIF1AY		ENSG00000198692	"Eukaryotic translation initiation factor 1A, Y-linked"	O14602	Y	20575725-20593154	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 78.3;skeletal muscle: 124.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.3;HEL: 45.7;U-266/84: 32.3;U-698: 73.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA002561	Uncertain	Supported	Approved	Cytosol				Cytosol		"HPA002561: AB_1078724"			"unprognostic (4.31e-2)"		"unprognostic (3.74e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.89e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.89e-1)"		"unprognostic (6.03e-2)"	5.9	8.3	7.0	18.6	8.3	29.2	5.0	4.5	10.9	0.0	12.6	10.0	22.2	9.0	0.1	20.2	9.9	0.0	10.5	78.3	6.5	10.4	9.1	23.0	13.3	22.8	8.2	0.0	0.1	15.0	0.2	11.4	10.3	13.4	17.4	16.1	8.8	13.1	22.9	124.6	4.2	17.9	28.2	9.2	45.8	6.5	13.1	0.0	28.7	6.2	48.9	15.9	8.9	0.0	22.1	23.0	44.5	8.0	7.8	11.9	5.0	0.1	5.4	0.0	0.0	0.0	0.0	11.3	12.1	8.1	8.4	8.3	0.0	0.0	37.3	0.0	6.4	0.0	0.0	0.0	11.6	20.1	0.0	45.7	0.0	13.6	8.4	0.0	0.0	4.5	9.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	29.4	0.0	8.1	0.0	0.0	15.3	14.8	11.8	14.1	10.8	0.0	0.0	0.0	8.3	0.0	6.4	12.0	6.5	0.1	0.0	13.1	22.5	32.3	73.3	2.5	0.0	0.0	10.0	6.7	9.3	5.2	7.7	7.3	19.2	9.5	6.1	5.7	22.1	11.9	9.0	44.5	7.8	8.0	23.0	10.9	5.0	7.0	8.3	4.5	10.9	6.5	10.4	8.2	0.0	13.4	0.0
EIF2A	EIF-2A	ENSG00000144895	"Eukaryotic translation initiation factor 2A"	Q9BY44	3	150546678-150584242	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036256	Approved		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA036256: AB_10611961"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.05e-3)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.57e-6)"	"unprognostic (6.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-1)"	33.5	23.7	12.6	21.4	22.8	27.2	34.3	38.3	23.8	35.1	29.4	12.6	17.3	23.1	31.5	19.9	37.2	20.6	19.0	24.9	11.3	11.9	27.0	44.5	24.7	32.8	16.5	11.7	35.6	39.4	22.6	36.4	26.2	22.7	32.9	23.8	15.4	29.8	23.9	53.3	26.8	33.1	25.0	16.9	28.9	26.5	16.3	17.9	38.5	41.8	33.8	25.8	44.0	26.1	17.0	27.7	7.9	24.6	20.5	26.9	19.0	38.1	13.9	19.5	20.6	25.1	50.0	27.0	23.6	32.7	30.3	32.8	38.5	42.2	50.4	36.2	28.1	31.1	32.4	32.7	43.1	19.0	21.7	29.6	16.7	29.7	24.1	36.8	28.3	33.3	37.2	22.2	49.6	37.5	24.3	30.0	24.4	26.9	26.8	19.5	27.7	22.0	23.6	25.6	58.5	31.7	23.7	24.8	26.5	14.2	22.7	36.9	33.3	34.3	21.9	19.2	18.3	27.1	45.3	52.1	27.4	46.4	24.3	32.3	9.5	7.9	22.6	4.7	14.9	23.5	23.3	17.0	21.2	18.2	27.7	14.9	26.9	21.0	1.8	20.5	24.6	13.1	17.3	19.0	12.6	22.8	38.3	23.8	11.3	11.9	16.5	11.7	22.7	17.9
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022244-6059230	"Enzymes, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: "	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	21.0	38.2	31.7	25.4	32.7	62.8	26.9	23.9	41.1	22.8	34.5	31.0	20.8	26.5	22.6	28.6	28.4	23.4	21.5	40.0	29.9	30.0	32.0	46.3	22.1	23.3	33.3	30.3	23.0	32.4	61.9	25.4	43.9	33.4	26.4	34.9	23.4	46.4	26.3	31.6	28.9	29.9	17.8	35.6	25.4	34.7	16.3	22.6	37.1	29.0	17.4	29.6	22.4	20.1	11.7	7.5	17.4	7.4	10.4	10.6	4.8	41.1	25.9	20.8	31.6	20.0	18.0	27.4	21.2	19.4	19.0	24.1	23.7	27.8	32.2	23.3	23.3	29.1	27.0	19.3	24.5	19.9	41.5	33.2	28.2	35.7	16.4	28.2	30.3	14.5	24.4	17.9	19.3	20.1	53.1	31.2	17.8	41.1	15.4	36.0	26.1	29.3	34.0	21.9	37.8	24.1	20.1	25.9	46.6	40.8	54.5	18.1	41.0	34.6	19.2	10.9	40.7	19.2	22.4	31.7	31.6	32.8	22.0	37.2	31.6	10.6	7.4	17.4	9.5	5.9	6.4	11.7	7.4	10.6	7.5	7.7	8.6	7.7	4.1	10.4	6.5	6.6	8.8	4.8	31.7	32.7	23.9	41.1	29.9	30.0	33.3	30.3	33.4	22.6
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157065	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol				Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: "	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	25.5	14.2	15.9	16.3	15.5	36.4	13.9	16.4	19.0	14.7	13.7	9.9	9.3	14.5	17.2	21.5	12.1	12.8	15.4	10.7	13.7	19.2	12.2	11.5	13.7	10.7	14.3	15.0	18.7	11.7	19.2	21.1	18.2	17.3	15.0	12.8	10.2	23.0	17.8	7.1	6.7	15.2	16.2	14.0	15.5	14.3	5.1	12.8	14.1	13.6	8.1	10.6	14.8	15.5	8.8	6.9	27.6	10.8	8.6	9.9	3.3	24.9	12.8	7.9	10.0	8.7	11.9	15.6	13.2	19.0	41.8	40.3	14.6	14.9	13.3	17.2	14.4	14.8	13.6	13.4	18.8	29.3	7.2	14.6	9.8	9.5	8.6	14.0	0.1	9.7	5.3	16.7	12.2	10.3	10.1	13.4	9.4	11.1	17.9	7.2	8.2	9.2	18.1	19.4	6.6	7.8	9.6	8.9	9.4	16.1	11.7	25.4	6.0	4.0	13.4	17.0	18.0	7.2	21.2	9.9	16.3	0.2	8.1	9.5	14.8	17.1	8.2	11.1	8.9	10.6	9.0	8.8	7.5	8.1	6.9	7.0	6.1	7.5	27.6	8.6	10.8	4.7	9.9	3.3	15.9	15.5	16.4	19.0	13.7	19.2	14.3	15.0	17.3	12.8
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	"Eukaryotic translation initiation factor 2 alpha kinase 4"	Q9P2K8	15	39934146-40035591	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.9;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011811	Approved		Approved	Cytosol				Cytosol		"HPA011811: "	"unprognostic (3.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.97e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.11e-3)"	20.7	16.5	20.2	19.4	27.3	20.2	36.0	22.4	27.3	16.8	16.3	13.6	17.1	12.2	35.7	17.9	17.8	18.1	19.4	18.2	19.5	20.5	15.4	22.7	22.5	16.6	18.6	14.2	20.1	21.5	20.3	34.7	20.5	17.6	22.0	14.6	17.9	16.7	20.3	20.4	20.7	12.2	24.3	14.6	16.1	16.4	11.5	15.1	17.7	24.1	10.6	15.9	27.0	14.4	5.0	32.9	4.2	9.3	3.8	4.5	2.4	13.8	6.6	11.9	17.9	19.6	33.0	11.3	19.5	22.4	16.0	15.8	9.5	6.0	7.3	10.2	26.5	14.8	15.9	23.6	22.4	34.8	7.9	15.7	12.3	11.4	16.8	9.4	10.9	26.0	16.2	15.2	27.5	22.3	11.6	7.0	31.5	4.6	7.8	13.0	7.3	14.9	9.5	16.5	12.1	19.9	9.4	6.2	9.6	13.9	8.5	12.1	11.9	16.3	23.6	21.4	16.2	10.7	12.6	9.7	17.4	2.3	15.0	13.0	29.8	4.2	5.8	4.0	3.6	6.7	3.1	3.5	4.0	4.1	8.4	5.0	4.5	4.2	1.7	3.8	9.3	32.9	2.7	2.4	20.2	27.3	22.4	27.3	19.5	20.5	18.6	14.2	17.6	15.1
EIF2B1	"EIF-2B, EIF-2Balpha, EIF2B, EIF2BA"	ENSG00000111361	"Eukaryotic translation initiation factor 2B subunit alpha"	Q14232	12	123620406-123633766	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034258, HPA049509"	Approved		Supported	Cytosol			8500	Cytosol		"CAB034258: AB_2095995, HPA049509: "	"unprognostic (2.14e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (6.75e-7)"	"unprognostic (5.65e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (1.78e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.40e-2)"	27.9	29.5	24.0	27.8	29.0	27.5	27.6	35.6	33.4	24.1	26.4	25.7	24.6	24.3	32.3	27.3	30.2	27.3	27.2	21.1	22.6	20.3	22.8	30.2	21.3	32.7	29.9	28.0	32.7	29.2	22.0	29.0	29.8	26.8	25.8	28.0	21.7	25.6	28.0	34.9	44.3	27.6	33.8	24.3	30.1	24.9	29.1	26.9	33.3	25.2	30.5	36.6	28.0	27.3	23.2	35.6	42.3	38.2	22.6	26.6	32.6	18.8	16.6	17.7	18.6	16.3	16.4	18.5	23.2	13.1	22.5	16.3	21.0	11.9	35.7	27.8	17.2	19.0	27.2	17.7	23.7	29.0	29.7	25.6	23.6	18.6	15.3	36.0	32.2	14.8	21.9	19.3	13.7	20.6	45.6	12.0	20.5	16.7	28.9	37.2	29.1	21.8	30.4	21.6	27.0	14.9	15.8	22.0	25.0	17.1	17.2	21.4	31.2	21.7	19.7	15.6	19.0	22.3	21.5	32.5	34.1	52.7	22.8	24.5	22.4	32.5	32.7	42.3	22.5	38.2	20.4	23.2	22.9	23.1	35.6	20.3	23.7	21.8	3.6	22.6	34.5	22.4	26.6	32.6	24.0	29.0	35.6	33.4	22.6	20.3	29.9	28.0	26.8	26.9
EIF2B3	"EIF-2B, EIF2Bgamma"	ENSG00000070785	"Eukaryotic translation initiation factor 2B subunit gamma"	Q9NR50	1	44850522-44986722	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024213, HPA024218, HPA024219"	Supported		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069"	"unprognostic (2.12e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavourable (1.73e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.80e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.73e-2)"	16.5	18.3	12.9	9.2	14.6	7.1	16.1	22.2	16.5	11.6	10.1	13.1	11.2	6.6	13.1	10.1	11.8	9.6	7.5	22.5	10.7	11.1	11.9	20.7	8.8	9.9	13.7	11.1	12.3	18.5	23.3	26.7	7.3	16.0	10.6	10.6	12.3	17.9	11.9	52.1	10.5	6.6	14.8	12.1	9.8	9.1	13.7	12.3	11.1	9.8	13.7	12.4	12.2	10.9	11.3	21.9	2.3	21.4	14.1	15.4	12.5	13.8	11.3	12.5	10.6	15.3	18.4	15.0	22.4	17.1	23.0	21.8	16.3	8.3	36.2	16.5	16.9	8.2	26.3	19.0	28.2	12.5	24.1	17.9	12.5	15.6	19.5	27.5	10.2	12.7	10.4	25.1	28.7	21.1	41.1	12.6	24.9	9.5	26.4	12.0	17.4	22.5	21.4	20.9	25.8	11.8	6.5	22.6	8.2	22.6	26.0	14.3	10.1	12.8	11.3	15.0	17.9	21.9	29.0	13.1	14.7	27.0	11.6	23.1	17.8	1.0	14.3	2.3	12.2	21.4	14.4	9.5	12.0	13.5	21.9	11.3	15.2	15.4	1.2	14.1	18.5	15.4	9.9	12.5	12.9	14.6	22.2	16.5	10.7	11.1	13.7	11.1	16.0	12.3
EIF2B5	"EIF-2B, EIF2Bepsilon"	ENSG00000145191	"Eukaryotic translation initiation factor 2B subunit epsilon"	Q13144	3	184135038-184145311	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015412, HPA064370, HPA069303"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB015412: AB_831253, HPA064370: , HPA069303: "	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.33e-2)"	"prognostic unfavourable (3.38e-8)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	15.2	20.1	15.3	15.4	20.2	10.6	21.5	24.5	25.8	15.1	18.8	17.8	24.3	17.3	16.3	14.9	24.3	15.4	14.0	21.5	13.0	16.1	17.5	27.5	15.6	20.1	20.8	15.1	16.0	19.1	27.0	21.2	20.6	17.7	20.4	23.7	15.3	23.2	21.0	47.2	22.8	18.2	17.5	14.7	21.1	19.6	11.9	17.3	20.9	17.4	16.9	26.9	19.1	18.3	12.7	10.3	10.9	8.4	11.2	17.2	6.5	24.5	11.3	13.9	15.1	14.0	11.5	15.0	14.7	15.7	21.5	18.3	18.5	12.4	22.4	17.0	14.4	19.0	24.9	17.2	22.1	20.1	20.4	36.6	11.5	16.2	10.9	27.6	19.4	9.6	15.5	13.0	13.5	15.4	19.7	19.6	15.2	20.6	20.2	19.3	18.7	20.9	21.9	16.7	25.2	19.6	21.7	15.0	16.6	12.6	39.9	16.3	37.0	27.3	14.3	13.1	15.3	12.4	28.2	16.9	23.3	28.5	15.6	29.6	16.3	7.2	8.4	10.9	7.6	7.4	10.5	12.0	11.9	12.7	10.3	12.7	17.2	10.7	1.6	11.2	7.7	5.0	9.5	6.5	15.3	20.2	24.5	25.8	13.0	16.1	20.8	15.1	17.7	17.3
EIF2D	LGTN	ENSG00000143486	"Eukaryotic translation initiation factor 2D"	P41214	1	206571292-206612463	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028220	Approved		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA028220: AB_10602022"	"unprognostic (1.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.09e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.13e-2)"	19.4	22.3	12.3	14.6	17.0	15.7	25.0	16.7	14.5	23.6	22.2	19.4	23.7	12.1	24.5	21.1	22.3	25.2	19.0	15.2	13.5	9.0	19.6	20.0	15.4	19.9	19.7	10.0	36.2	38.1	19.7	17.3	15.2	14.9	22.8	18.9	18.1	26.9	18.3	27.7	19.2	15.2	22.6	14.5	16.0	21.9	13.1	18.5	29.3	29.3	20.0	21.7	21.0	21.1	19.2	16.6	5.6	13.1	16.4	21.3	10.5	20.1	12.5	10.2	8.8	30.2	39.8	12.4	11.4	23.7	20.7	20.4	10.1	17.7	34.3	8.9	23.2	14.3	16.6	25.8	18.4	11.2	21.3	12.0	14.9	19.1	33.3	21.7	12.4	36.2	34.5	16.4	32.8	26.2	27.9	16.1	18.0	15.8	19.4	10.1	8.3	19.1	15.8	21.9	37.8	21.0	7.5	9.6	8.8	10.0	26.9	24.3	20.6	17.1	18.3	11.5	11.5	5.3	15.2	14.8	8.2	23.9	15.4	14.8	8.5	5.6	10.3	1.6	11.8	9.2	15.9	19.2	16.4	14.5	16.6	15.5	21.3	15.3	0.2	16.4	13.1	8.8	14.5	10.5	12.3	17.0	16.7	14.5	13.5	9.0	19.7	10.0	14.9	18.5
EIF2S1	"EIF-2alpha, EIF2, EIF2A"	ENSG00000134001	"Eukaryotic translation initiation factor 2 subunit alpha"	P05198	14	67359997-67386516	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011663, HPA064885"	Supported		Enhanced	Cytosol			52000	Cytosol		"CAB011663: AB_2096478, HPA064885: "	"unprognostic (1.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavourable (4.73e-7)"	"unprognostic (4.14e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.68e-2)"	"prognostic unfavourable (4.97e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (7.11e-4)"	35.5	26.2	18.7	24.8	26.3	18.9	22.5	18.9	30.6	17.8	25.7	16.3	16.1	18.5	22.9	18.0	34.8	18.4	19.1	27.9	21.9	17.0	23.8	45.0	21.1	24.1	19.9	20.8	22.9	27.8	21.3	16.3	28.0	24.1	24.4	24.2	12.6	19.9	21.0	52.0	23.8	18.4	30.9	18.9	22.8	22.9	29.1	15.1	27.3	29.0	29.9	28.0	31.1	23.1	26.6	32.9	17.3	32.7	25.7	29.2	30.2	67.2	22.5	15.8	24.3	15.3	17.4	34.0	30.1	18.0	34.0	29.8	26.2	24.1	30.4	15.3	22.6	26.1	36.5	28.7	51.9	22.1	13.6	19.6	21.9	17.9	16.1	20.8	19.2	14.0	16.7	30.3	46.4	27.6	33.2	23.6	33.5	33.4	28.4	16.4	16.1	37.6	21.8	26.3	21.6	20.9	31.0	22.9	16.2	21.6	25.5	23.2	43.4	18.1	21.0	45.1	48.6	21.7	31.8	20.5	22.3	45.9	26.1	37.3	28.9	17.3	24.2	14.8	23.9	32.7	29.1	26.6	27.9	25.7	32.9	21.3	26.0	26.5	3.3	25.7	27.4	22.5	29.2	30.2	18.7	26.3	18.9	30.6	21.9	17.0	19.9	20.8	24.1	15.1
EIF3A	"EIF3, eIF3-p170, eIF3-theta, eIF3a, EIF3S10, KIAA0139, TIF32"	ENSG00000107581	"Eukaryotic translation initiation factor 3 subunit A"	Q14152	10	119033670-119080823	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038315, HPA038316"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA038315: AB_10672588, HPA038316: AB_10673168"	"unprognostic (8.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.07e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.89e-2)"	36.7	27.4	19.6	29.4	20.2	41.4	42.4	22.4	22.3	27.8	29.2	21.7	32.3	26.0	33.4	26.0	35.7	22.7	25.0	36.7	19.9	18.6	28.2	41.5	24.6	39.0	24.2	20.1	29.2	61.9	35.8	33.2	33.7	25.5	26.9	26.4	14.4	31.4	31.6	92.3	36.0	29.2	49.3	29.8	29.8	34.1	18.6	22.6	45.8	28.6	33.6	28.7	40.5	38.9	15.0	20.2	21.6	29.7	14.2	27.6	13.9	50.8	38.5	31.8	43.4	34.6	50.2	24.7	46.4	48.2	29.9	30.1	36.2	33.7	59.7	17.3	38.2	51.2	41.3	35.6	42.6	32.8	34.0	51.3	29.8	40.2	39.5	75.0	38.2	43.3	40.1	44.0	75.9	33.8	52.5	39.4	38.6	30.1	31.0	35.5	30.4	19.7	32.1	68.7	28.5	28.6	43.0	14.8	31.5	36.5	34.3	48.0	22.0	48.0	49.6	29.0	26.8	30.3	67.0	34.2	37.5	58.8	30.8	74.0	19.9	21.6	21.2	12.6	16.5	23.9	19.1	15.0	19.9	14.9	20.2	13.3	13.9	15.0	5.7	14.2	29.7	11.6	27.6	13.9	19.6	20.2	22.4	22.3	19.9	18.6	24.2	20.1	25.5	22.6
EIF3B	"eIF3b, EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol			22000	Nucleoplasm	Cytosol	"CAB017562: AB_2246341, HPA048983: "	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavourable (2.20e-4)"	"prognostic unfavourable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	27.5	27.3	16.5	28.9	21.8	38.7	28.8	20.0	26.2	23.5	33.3	22.4	25.7	20.3	29.6	24.1	38.8	28.6	26.2	32.1	15.8	16.5	24.3	51.4	21.7	29.6	22.2	19.4	31.2	66.6	24.2	20.3	34.6	21.1	26.0	24.0	18.0	34.1	24.2	72.3	39.8	23.9	33.0	16.5	31.6	29.7	45.2	19.0	44.9	23.1	34.3	35.9	32.9	29.7	6.5	8.0	3.7	7.3	16.5	9.5	4.4	85.0	43.5	18.0	48.8	20.4	18.5	44.7	29.9	22.5	34.1	32.0	56.8	33.3	49.7	24.7	31.7	46.4	49.6	39.4	37.7	14.8	58.2	37.8	42.2	38.3	28.8	46.0	28.1	23.0	26.0	36.9	38.9	27.4	96.1	23.2	31.1	60.4	22.2	51.8	56.3	39.2	27.4	36.5	51.2	21.8	39.0	41.2	30.8	31.6	70.5	17.1	46.9	51.1	28.9	26.4	58.3	40.4	54.0	25.6	34.4	50.4	29.9	51.7	64.4	1.8	7.3	3.7	7.6	6.8	9.5	6.3	7.4	8.4	7.8	6.5	8.8	8.9	0.6	16.5	5.8	8.0	8.7	4.4	16.5	21.8	20.0	26.2	15.8	16.5	22.2	19.4	21.1	19.0
EIF3C	"eIF3-p110, eIF3c, EIF3S8"	ENSG00000184110	"Eukaryotic translation initiation factor 3 subunit C"	Q99613	16	28688558-28735730	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB034045, HPA047097, HPA049495, HPA050112"	Supported		Supported	Cytosol				Cytosol		"CAB034045: AB_1122487, HPA047097: , HPA049495: , HPA050112: "	"unprognostic (2.42e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-3)"	30.0	24.4	22.2	20.9	33.5	21.2	30.2	24.3	34.8	24.4	31.8	18.1	14.5	23.6	41.5	26.5	30.1	31.0	32.0	32.3	35.9	20.8	30.1	51.7	22.8	21.8	20.9	33.4	42.3	38.1	63.8	21.4	20.0	26.9	20.3	29.3	18.8	54.7	27.9	114.0	32.3	25.0	33.3	19.8	20.7	25.4	47.2	17.5	25.6	32.8	46.4	29.3	24.9	23.6	28.5	50.5	20.6	49.1	37.9	36.1	52.5	25.7	40.8	56.7	68.5	50.7	62.1	87.5	65.4	48.9	77.5	55.6	81.5	48.8	60.7	85.9	41.8	31.8	47.8	80.6	87.5	26.4	48.3	69.6	66.4	105.5	62.9	107.6	53.7	71.3	48.8	49.3	79.4	88.6	75.4	57.6	41.6	94.9	85.8	31.3	94.6	63.9	87.5	87.0	59.8	41.0	56.7	53.5	82.1	55.3	76.7	63.4	76.5	44.3	78.4	55.1	54.7	25.9	42.6	50.0	38.1	122.3	58.3	42.6	56.2	10.7	44.9	20.6	31.1	47.8	36.1	28.5	32.9	33.0	50.5	27.4	33.3	30.3	3.8	37.9	49.1	23.7	34.0	52.5	22.2	33.5	24.3	34.8	35.9	20.8	20.9	33.4	26.9	17.5
EIF3CL		ENSG00000205609	"Eukaryotic translation initiation factor 3 subunit C like"	B5ME19	16	28379579-28403879	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 32.4;REH: 25.6"	"Group enriched"	"Detected in some"	5	"glioma: 0.8;ovarian cancer: 0.5;stomach cancer: 0.7"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA047097, HPA049495, HPA050112"	Supported		Approved	Cytosol				Cytosol		"HPA047097: , HPA049495: , HPA050112: "	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.75e-5)"	"unprognostic (6.56e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.58e-2)"	6.9	4.6	5.2	2.5	5.5	5.5	6.0	3.0	4.9	4.7	8.9			8.9	4.1	10.2	5.8	7.9	2.5	5.5	5.0	4.6	5.9	5.5	3.6	3.7	4.6		7.3	10.4	4.3	4.2	3.6		4.1	1.2		9.3	13.7	13.2	18.0	9.1	4.0	3.3	4.0	7.3	3.4			5.5		10.6	4.2	4.1	7.7	10.5	4.6	15.9	10.8	11.5	5.1	2.5	4.3	5.4	3.3	2.3	3.3	3.0	3.1	7.3	9.1	11.4	4.8	1.8	1.5	10.3	2.8	3.1	3.8	7.4	5.9	1.1	2.0	2.1	5.6	7.0	2.5	3.9	7.2	2.7	6.0	2.7	2.2	5.9	2.9	2.7	2.0	5.4	9.2	32.4	6.0	2.2	25.6	5.5	5.8	7.2	2.9	8.1	10.2	1.6	8.0	12.4	4.1	6.9	2.7	2.6	8.5	2.9	3.1	7.8	2.0	4.8	2.9	6.3	1.7	4.6	6.9	4.3	6.5	15.9	5.5	6.2	11.3	8.1	10.5	7.7	10.2	11.5	0.6	10.8	9.6	6.2	7.7	5.1										
EIF3D	"eIF3-p66, eIF3-zeta, eIF3d, EIF3S7"	ENSG00000100353	"Eukaryotic translation initiation factor 3 subunit D"	O15371	22	36510850-36529436	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045882, HPA063330, HPA066216"	Approved		Supported	Cytosol				Cytosol		"HPA045882: , HPA063330: , HPA066216: "	"unprognostic (4.98e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (8.10e-5)"	"unprognostic (1.47e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.98e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.78e-2)"	49.5	28.2	15.7	30.2	21.3	38.1	47.9	22.6	23.6	51.6	43.1	25.7	27.6	27.0	46.1	32.7	57.8	42.1	30.1	27.2	15.0	13.4	35.3	36.6	29.8	55.0	19.6	17.6	60.7	87.2	32.7	20.9	42.3	18.0	50.3	35.7	27.7	40.7	28.8	55.5	49.1	41.1	46.7	19.8	51.3	39.7	28.9	20.7	65.9	55.4	41.2	61.9	52.7	38.6	70.5	72.2	19.2	51.5	51.6	82.8	93.2	51.1	29.4	31.5	34.5	42.1	82.8	49.3	39.6	53.8	55.6	54.1	45.7	29.1	67.2	29.5	45.6	39.7	54.8	64.1	58.4	36.2	52.6	37.3	27.5	34.8	75.0	86.7	38.0	74.0	74.7	61.6	88.6	60.0	40.5	33.8	63.4	31.6	29.9	44.6	33.6	23.3	54.3	51.1	51.0	55.9	37.4	25.3	33.9	26.9	54.6	54.6	35.0	78.1	41.4	44.6	39.1	33.6	55.4	42.2	28.5	55.5	44.5	54.1	42.0	19.2	51.5	18.7	46.8	47.2	74.9	70.5	67.3	55.4	72.2	68.4	82.8	66.9	13.5	51.6	44.5	41.6	79.7	93.2	15.7	21.3	22.6	23.6	15.0	13.4	19.6	17.6	18.0	20.7
EIF3E	"eIF3-p48, eIF3e, EIF3S6, INT6"	ENSG00000104408	"Eukaryotic translation initiation factor 3 subunit E"	P60228	8	108201216-108435333	"Cancer-related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023973	Approved		Supported	Cytosol				Cytosol		"HPA023973: AB_1848083"	"unprognostic (8.18e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.52e-3)"	"unprognostic (6.93e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (3.06e-7)"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-2)"	88.2	44.0	27.6	49.2	38.2	57.8	75.1	41.5	25.2	101.6	73.6	14.6	47.2	34.4	55.5	47.6	111.2	45.4	41.0	39.5	23.9	22.4	51.8	63.6	60.3	75.3	33.0	19.5	127.6	90.2	29.2	72.5	54.6	28.9	100.1	40.3	22.8	56.9	45.5	100.4	46.7	56.3	73.7	38.4	63.9	49.7	52.7	31.5	100.5	93.8	70.8	50.7	121.7	69.2	49.0	51.7	14.0	39.5	38.7	78.1	59.4	62.0	30.6	41.0	50.7	69.9	147.9	28.0	32.4	50.6	48.2	50.4	38.3	62.5	106.9	42.6	36.4	38.6	54.0	63.6	64.2	42.0	55.0	85.3	32.4	54.6	56.0	50.8	40.0	111.7	94.1	36.4	101.0	73.3	71.8	44.4	54.2	61.3	65.8	96.3	40.9	48.9	61.2	50.8	83.2	63.0	37.4	46.4	42.3	18.2	15.4	72.2	65.5	73.7	46.5	28.2	48.7	29.2	40.7	33.5	25.0	61.2	34.9	88.8	31.4	14.0	39.5	7.4	26.6	36.2	52.0	49.0	52.6	37.7	51.7	40.4	78.1	56.1	3.7	38.7	33.6	27.3	45.2	59.4	27.6	38.2	41.5	25.2	23.9	22.4	33.0	19.5	28.9	31.5
EIF3G	"eIF3-delta, eIF3-p44, eIF3g, EIF3S4"	ENSG00000130811	"Eukaryotic translation initiation factor 3 subunit G"	O75821	19	10115017-10119918	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 175.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041997	Approved		Enhanced	Cytosol			12000	Cytosol		"HPA041997: AB_10804123"	"unprognostic (1.80e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (3.94e-4)"	"unprognostic (4.90e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.43e-1)"	41.6	29.0	20.2	34.2	21.5	34.1	36.1	18.1	28.4	41.1	41.2	27.0	30.3	29.8	40.2	34.6	37.7	34.1	47.0	52.3	19.0	18.4	30.5	45.0	28.2	40.1	22.6	18.5	63.6	88.6	30.9	24.8	34.9	19.3	41.9	17.6	25.6	57.1	35.5	141.1	40.2	30.1	39.1	24.3	36.7	38.9	51.0	23.4	46.4	42.3	49.7	40.3	46.2	48.7	47.1	58.4	31.4	60.6	80.3	70.8	74.7	25.1	21.4	16.4	21.6	21.8	28.0	21.1	21.5	30.2	34.0	31.6	35.0	13.6	25.9	30.9	25.7	19.3	19.9	32.4	14.1	23.3	60.6	45.9	21.6	34.9	36.4	36.0	24.2	33.6	24.0	23.9	23.0	24.2	41.1	30.8	20.3	33.7	39.2	175.1	40.1	46.1	31.7	16.1	34.1	21.6	22.1	21.3	41.3	14.3	18.8	33.7	16.5	31.9	23.8	29.4	16.7	31.9	40.8	91.1	66.2	28.9	22.1	39.5	28.0	31.4	60.6	25.3	54.6	44.4	70.8	46.7	59.0	59.1	58.4	47.1	60.3	54.1	11.7	80.3	35.6	45.9	64.9	74.7	20.2	21.5	18.1	28.4	19.0	18.4	22.6	18.5	19.3	23.4
EIF3H	"eIF3-gamma, eIF3-p40, eIF3h, EIF3S3"	ENSG00000147677	"Eukaryotic translation initiation factor 3 subunit H"	O15372	8	116642130-116766925	"Cancer-related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 201.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023117, HPA023553"	Approved		Approved	Cytosol			3300000	Cytosol		"HPA023117: AB_1848076, HPA023553: AB_1848077"	"prognostic unfavourable (5.26e-4)"	"prognostic unfavourable (8.07e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (8.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.11e-1)"	63.1	41.3	39.4	41.3	47.6	65.8	56.8	39.5	39.9	69.2	52.8	35.1	30.8	38.8	53.1	43.6	80.9	49.7	36.4	52.9	33.2	33.0	53.4	55.6	44.2	58.0	38.6	26.7	96.0	65.4	37.6	52.6	52.0	40.1	77.1	47.0	34.9	51.5	38.5	94.6	44.8	56.2	68.3	45.4	56.0	46.3	44.9	31.6	90.0	72.3	59.3	74.7	83.7	57.6	69.1	73.6	21.6	55.3	47.1	88.5	76.7	48.4	28.0	33.8	29.4	44.7	78.5	33.7	32.1	41.5	35.6	34.7	28.9	57.5	77.6	32.6	33.4	31.3	37.1	48.8	44.9	50.2	30.1	68.5	25.1	43.0	56.0	29.5	36.6	72.2	68.0	32.1	74.7	38.5	57.8	41.1	39.9	36.0	82.1	41.5	34.4	44.8	47.6	22.6	55.0	53.4	35.7	38.4	46.5	16.8	201.6	53.5	59.8	59.6	35.3	22.8	42.6	33.7	41.9	66.5	59.9	64.1	31.7	52.3	31.1	21.6	55.3	19.8	36.7	54.8	60.3	69.1	66.5	53.1	73.6	59.1	88.5	71.9	12.0	47.1	53.3	41.1	73.2	76.7	39.4	47.6	39.5	39.9	33.2	33.0	38.6	26.7	40.1	31.6
EIF3I	"eIF3-beta, eIF3-p36, eIF3i, EIF3S2, TRIP-1"	ENSG00000084623	"Eukaryotic translation initiation factor 3 subunit I"	Q13347	1	32221928-32231604	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029939, HPA029940"	Enhanced		Approved	Cytosol			16000	Cytosol		"HPA029939: AB_10611109, HPA029940: AB_10600878"	"unprognostic (4.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.82e-2)"	"prognostic favourable (2.14e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-2)"	"prognostic unfavourable (4.21e-4)"	"unprognostic (9.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (4.81e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.47e-2)"	46.3	45.9	26.1	28.9	27.6	32.2	44.8	21.2	28.7	36.6	39.1	25.3	41.0	24.5	33.5	50.4	61.0	37.9	42.7	44.4	25.2	25.0	47.6	89.7	33.9	42.7	27.1	21.9	50.5	72.0	27.0	25.0	45.4	22.8	38.7	45.5	26.5	59.6	40.6	79.1	35.0	39.5	38.5	25.9	36.1	34.8	31.3	17.0	55.8	67.9	75.4	46.6	43.3	34.5	44.4	56.6	23.8	50.3	42.4	52.9	61.6	48.6	38.4	31.2	57.8	47.2	59.5	29.9	38.7	72.3	74.6	59.2	44.8	53.9	74.0	39.2	68.5	34.3	66.8	76.1	91.6	27.3	63.2	45.0	34.4	49.7	53.7	74.3	38.2	57.2	68.3	72.1	81.5	64.8	86.4	29.7	67.5	38.2	55.5	58.1	81.6	60.3	40.4	51.9	62.7	73.7	34.2	42.0	46.7	42.2	45.6	75.5	35.0	37.5	39.8	43.1	45.5	66.0	81.1	50.0	54.0	62.5	48.6	60.6	56.2	23.8	47.3	21.7	42.1	50.3	47.7	44.4	45.1	41.9	56.6	39.7	40.2	38.3	6.1	42.4	36.8	43.5	52.9	61.6	26.1	27.6	21.2	28.7	25.2	25.0	27.1	21.9	22.8	17.0
EIF3J	"eIF3-alpha, eIF3-p35, eIF3j, EIF3S1"	ENSG00000104131	"Eukaryotic translation initiation factor 3 subunit J"	O75822	15	44537057-44563029	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050977	Approved		Enhanced	Cytosol			8600	Cytosol		"HPA050977: "	"unprognostic (4.47e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.76e-1)"	"prognostic unfavourable (4.96e-5)"	23.7	17.8	24.7	21.0	21.9	16.4	22.8	16.6	23.1	15.6	18.4	13.2	20.5	17.7	15.8	17.2	28.0	11.9	14.8	36.8	22.8	23.7	23.3	46.3	14.7	18.3	26.3	19.2	15.0	35.1	17.3	22.9	22.9	31.6	17.1	20.0	6.9	27.0	25.4	134.3	18.9	16.6	18.6	29.0	20.9	18.4	14.7	20.9	17.0	19.2	27.3	24.9	23.0	20.6	26.7	33.2	22.6	19.2	28.2	23.9	6.4	22.3	11.9	19.5	12.2	13.9	14.1	23.9	35.4	10.5	24.7	16.8	37.7	13.7	20.7	41.7	14.8	42.4	31.3	22.6	30.3	23.1	15.9	47.1	29.4	23.9	26.2	50.4	21.0	12.5	30.3	17.0	33.4	26.5	61.2	27.3	22.1	15.7	25.3	34.4	11.9	19.5	29.6	33.5	30.7	28.1	26.8	26.4	16.2	32.7	31.1	19.6	26.1	41.9	31.2	26.9	31.9	28.8	47.6	32.5	61.1	52.2	18.7	55.1	25.3	22.6	19.2	16.8	17.4	18.3	21.0	26.7	23.2	22.3	22.2	24.7	22.8	23.9	7.7	28.2	16.3	33.2	23.6	6.4	24.7	21.9	16.6	23.1	22.8	23.7	26.3	19.2	31.6	20.9
EIF3K	"ARG134, eIF3k, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001"	ENSG00000178982	"Eukaryotic translation initiation factor 3 subunit K"	Q9UBQ5	19	38619082-38636955	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045446, HPA054590"	Uncertain		Supported	Cytosol				Cytosol		"HPA045446: AB_10962716, HPA054590: AB_2682534"	"unprognostic (7.07e-3)"	"prognostic favourable (1.31e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.26e-2)"	"prognostic favourable (5.43e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.69e-2)"	37.7	30.1	33.1	39.0	32.8	47.1	43.3	23.9	48.6	34.0	53.7	29.5	36.8	46.1	34.0	37.2	48.2	39.9	39.0	84.0	29.4	28.0	58.2	45.6	28.1	47.5	34.1	25.0	43.2	57.2	36.3	31.0	27.4	32.5	37.8	54.0	43.7	50.8	38.6	111.4	45.2	57.1	43.4	26.6	39.5	42.8	17.5	19.4	50.6	42.1	92.9	55.7	42.9	36.6	52.1	72.7	26.3	57.7	37.7	58.7	74.9	25.7	80.1	21.6	34.7	36.0	37.1	26.2	19.0	32.5	41.7	38.7	52.0	22.7	52.8	22.3	32.1	23.3	42.0	49.4	32.6	25.5	36.1	35.9	27.6	36.3	39.1	57.9	33.1	40.0	43.3	28.7	49.6	40.6	38.7	48.0	35.3	39.6	31.6	29.9	20.4	40.8	41.7	35.3	42.1	40.7	57.9	27.4	27.4	20.9	72.8	31.6	27.9	48.9	22.7	26.4	26.6	16.3	35.3	47.6	48.2	46.3	22.3	58.1	29.6	25.6	52.5	26.3	39.4	57.7	49.7	52.1	48.4	45.8	72.7	44.1	50.5	44.7	14.5	37.7	56.6	42.4	58.7	74.9	33.1	32.8	23.9	48.6	29.4	28.0	34.1	25.0	32.5	19.4
EIF3M	"eIF3m, FLJ29030, GA17, hfl-B5, PCID1, TANGO7"	ENSG00000149100	"Eukaryotic translation initiation factor 3 subunit M"	Q7L2H7	11	32583798-32606262	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031063	Approved		Supported	Cytosol			48000	Cytosol		"HPA031063: AB_10602128"	"unprognostic (4.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (1.28e-9)"	"unprognostic (5.79e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.42e-2)"	44.3	46.1	25.4	36.8	30.9	41.0	47.1	19.3	32.2	49.0	35.1	17.3	26.5	26.2	40.2	38.9	48.7	52.0	29.1	34.3	23.3	23.0	50.0	54.5	30.8	47.7	23.4	21.9	80.9	60.6	34.0	33.1	44.7	28.3	44.3	35.0	18.8	32.5	30.3	48.8	35.1	37.8	39.2	26.4	45.0	37.1	43.5	19.6	84.1	55.1	54.7	48.1	59.8	34.6	36.5	64.0	15.4	53.2	33.3	38.5	39.4	28.4	36.8	29.4	37.3	39.2	56.6	43.4	29.7	41.2	45.7	44.6	47.4	21.0	73.9	20.5	33.7	36.3	51.1	53.9	57.3	24.9	63.3	33.3	29.9	50.0	56.9	77.3	47.9	50.6	61.2	30.8	75.7	51.2	65.5	25.8	50.0	33.5	38.5	81.3	32.2	57.0	31.6	74.2	34.5	49.8	53.8	22.7	35.1	21.1	39.9	45.5	44.3	46.3	23.9	28.7	32.7	60.6	89.2	31.7	39.8	54.0	25.8	47.1	28.1	14.3	53.2	15.4	26.5	45.8	36.3	36.5	36.6	33.4	64.0	29.2	38.5	34.8	6.3	33.3	33.3	38.4	37.9	39.4	25.4	30.9	19.3	32.2	23.3	23.0	23.4	21.9	28.3	19.6
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572706-7579005	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol			2300000	Cytosol		"CAB011689: AB_732122, HPA068286: "	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavourable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	56.5	49.0	19.3	41.4	19.8	51.4	80.2	13.6	26.6	40.4	45.6	28.5	26.4	28.7	45.9	30.2	76.4	43.4	39.2	33.5	18.5	17.1	34.2	58.0	46.3	135.7	27.7	12.9	55.2	77.0	19.8	28.8	45.2	21.8	36.2	44.0	33.0	65.8	30.7	36.5	48.4	30.9	46.5	33.4	46.8	42.2	31.6	21.8	91.5	34.7	73.8	67.7	42.5	40.8	35.1	143.6	29.1	115.7	47.1	60.3	170.1	84.2	115.6	77.5	70.2	69.7	81.7	72.4	81.4	92.6	150.9	116.7	116.6	38.2	115.4	62.7	85.3	75.7	164.4	125.3	162.7	37.3	121.9	65.0	75.2	129.6	106.9	66.4	65.8	108.2	64.8	126.8	129.7	113.2	66.3	23.9	108.6	88.6	68.9	57.0	66.4	80.1	65.1	58.5	55.4	105.5	77.5	41.0	79.6	73.3	49.4	102.0	54.8	51.1	80.9	79.8	55.7	51.0	163.6	23.5	32.8	75.6	85.8	81.8	87.4	19.6	115.7	29.1	37.0	102.6	60.3	35.1	40.0	39.5	143.6	28.9	39.4	39.6	12.1	47.1	75.7	54.8	49.2	170.1	19.3	19.8	13.6	26.6	18.5	17.1	27.7	12.9	21.8	21.8
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789900	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 106.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB011690, HPA068286"	Uncertain		Approved	Cytosol			1000000	Cytosol		"CAB011690: AB_732123, HPA068286: "	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	34.6	66.1	61.2	27.7	79.9	1.9	53.5	121.1	111.5	65.1	52.1	26.5	30.1	30.3	73.1	45.5	44.5	73.9	45.1	83.7	58.4	71.9	63.9	43.5	33.7	36.1	48.9	61.7	142.0	59.0	30.9	84.1	47.3	69.6	57.9	40.1	31.8	43.7	62.8	126.7	19.8	35.6	57.1	41.9	32.5	39.0	32.9	39.5	23.9	67.8	36.4	35.4	61.1	51.7	55.1	19.3	39.4	24.8	33.0	63.4	51.3	10.5	5.3	22.3	3.6	85.9	81.0	6.8	19.0	17.2	20.2	26.6	19.6	3.8	23.6	106.5	27.3	17.8	32.7	8.0	35.6	22.0	17.2	38.0	7.1	26.3	33.7	8.0	26.7	54.2	38.5	5.8	48.6	35.8	12.8	39.8	65.6	1.8	12.7	3.9	22.1	25.5	16.3	15.8	14.3	40.0	12.9	43.9	8.8	30.9	21.3	40.4	33.2	29.3	26.1	16.0	8.0	15.4	11.6	31.7	44.8	10.8	11.0	8.4	7.5	39.4	16.0	18.5	28.5	18.2	45.3	55.1	41.9	34.8	19.3	46.1	63.4	50.2	11.0	33.0	24.8	17.4	38.6	51.3	61.2	79.9	121.1	111.5	58.4	71.9	48.9	61.7	69.6	39.5
EIF4B		ENSG00000063046	"Eukaryotic translation initiation factor 4B"	P23588	12	53006158-53042209	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039072, HPA046164"	Approved		Enhanced	Cytosol			50000	Cytosol		"HPA039072: , HPA046164: "	"unprognostic (1.91e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.44e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.69e-1)"	"unprognostic (8.20e-3)"	35.6	36.9	20.1	21.5	25.4	26.4	34.5	29.5	30.2	41.0	27.9	35.4	26.8	26.7	35.8	18.8	30.9	40.1	33.6	25.0	21.6	15.2	27.8	29.4	22.5	28.7	23.1	27.9	94.9	55.8	31.0	37.2	22.2	24.3	25.9	24.5	27.0	39.1	21.0	76.9	31.9	24.4	37.9	25.7	27.5	31.1	31.9	29.5	27.2	32.9	33.6	39.0	35.7	33.5	27.2	26.0	10.5	24.0	25.4	46.3	33.9	25.3	41.3	28.1	36.6	51.3	95.5	37.3	24.7	58.4	22.7	20.8	42.3	41.2	154.5	37.1	36.3	28.4	50.1	55.5	28.5	30.4	29.9	59.8	56.7	45.6	38.4	85.4	35.0	96.4	56.2	26.9	82.8	44.4	65.2	63.6	37.0	55.6	51.5	53.2	51.9	21.6	53.0	40.0	64.3	31.0	41.9	29.9	40.1	25.9	56.3	49.1	64.4	55.1	40.8	15.8	34.6	17.3	21.7	55.8	61.8	39.4	26.6	36.9	22.0	9.1	20.0	10.5	30.0	20.8	43.1	27.2	36.3	33.1	26.0	19.6	46.3	42.6	5.4	25.4	24.0	16.3	29.3	33.9	20.1	25.4	29.5	30.2	21.6	15.2	23.1	27.9	24.3	29.5
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98871684-98930637	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004077, CAB016316, HPA051311"	Supported		Enhanced	"Cytosol,Cytoplasmic bodies"			580000	"Cytosol, Cytoplasmic bodies"		"CAB004077: AB_823488, CAB016316: AB_627502, HPA051311: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	22.3	26.8	25.7	20.1	35.3	25.2	23.1	40.8	38.4	21.4	27.2	23.3	19.1	19.8	21.7	21.4	39.6	19.9	18.8	23.0	26.0	29.9	29.3	26.2	18.8	24.4	27.7	28.4	18.8	16.1	24.7	25.6	21.8	35.3	19.9	33.2	15.4	23.2	21.0	29.8	19.1	19.5	24.8	31.0	19.4	20.6	39.1	23.4	22.4	33.4	27.1	34.2	22.1	24.2	31.3	25.4	36.6	32.0	32.6	32.2	30.0	25.6	22.5	38.4	25.5	21.9	23.0	23.0	48.9	30.7	40.5	30.5	30.2	32.5	52.0	15.8	30.0	13.0	52.8	36.8	49.5	34.3	15.3	35.4	15.7	27.5	18.8	50.8	26.8	16.4	23.5	31.2	24.7	31.1	58.8	24.3	35.8	22.0	47.0	19.7	30.2	21.0	29.7	26.0	23.1	35.7	22.9	32.5	21.4	22.8	48.4	15.8	23.6	20.1	22.8	29.3	31.5	26.3	39.4	18.2	46.1	47.0	26.1	26.1	33.1	23.3	22.3	36.6	26.3	25.9	30.5	31.3	29.2	27.0	25.4	26.9	32.2	31.9	16.2	32.6	32.0	21.4	28.7	30.0	25.7	35.3	40.8	38.4	26.0	29.9	27.7	28.4	35.3	23.4
EIF4E2	"4EHP, EIF4EL3, IF4e"	ENSG00000135930	"Eukaryotic translation initiation factor 4E family member 2"	O60573	2	232550052-232583644	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019253, HPA077074"			Enhanced	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA019253: AB_1848092, HPA077074: "	"unprognostic (3.44e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (1.42e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.38e-2)"	19.0	22.9	27.9	24.0	24.4	25.4	19.4	27.1	38.1	17.6	30.7	18.4	17.0	24.4	26.2	18.2	32.1	18.5	20.0	21.3	25.8	14.8	29.8	43.2	20.4	21.0	18.6	27.2	22.0	26.2	16.3	25.0	26.8	26.3	19.9	35.7	16.1	27.3	15.9	77.6	23.8	25.2	25.3	27.0	25.4	26.7	25.2	21.5	18.1	19.1	24.8	27.1	20.0	21.2	13.5	38.9	49.6	46.8	14.1	24.1	29.7	27.6	22.9	28.1	20.7	20.6	28.2	43.3	37.2	20.2	25.6	26.3	25.2	26.1	27.1	10.6	36.2	23.5	31.6	32.3	32.3	24.2	26.0	37.0	24.7	33.5	25.1	51.6	35.0	24.2	24.3	26.9	19.5	41.6	34.7	9.2	28.9	44.5	21.0	43.9	44.7	19.1	18.2	62.4	17.7	51.4	32.9	27.3	37.4	19.8	23.0	23.7	21.9	36.3	38.0	24.0	31.7	25.1	27.4	17.3	16.3	35.6	26.9	28.5	20.8	49.6	45.1	40.7	14.8	46.8	11.8	13.5	15.1	15.4	38.9	12.2	12.9	13.1	29.5	14.1	41.7	15.2	24.1	29.7	27.9	24.4	27.1	38.1	25.8	14.8	18.6	27.2	26.3	21.5
EIF4EBP1	"4E-BP1, PHAS-I"	ENSG00000187840	"Eukaryotic translation initiation factor 4E binding protein 1"	Q13541	8	38030341-38060365	"Cancer-related genes, Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 94.7;salivary gland: 109.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005032, CAB005039, HPA023501"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095"	"unprognostic (1.55e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (8.86e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.18e-3)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.72e-3)"	17.7	3.4	2.5	4.9	3.6	9.2	21.7	1.8	3.2	5.5	15.4	2.0	7.7	6.2	5.3	2.1	22.2	5.0	7.0	9.4	2.2	1.8	6.0	39.6	6.9	7.4	4.3	1.4	9.3	94.7	1.7	2.2	8.7	2.8	7.4	4.6	2.8	109.8	8.0	38.4	4.9	9.0	7.1	4.2	9.3	10.6	3.0	2.7	2.7	3.7	12.6	9.2	11.3	11.1	16.3	41.3	31.3	53.5	4.0	7.6	28.0	20.4	10.6	3.1	18.4	4.0	3.5	13.6	22.7	10.6	12.3	19.7	7.0	5.3	8.0	15.9	11.3	10.9	10.3	18.5	7.3	6.1	33.5	46.8	4.7	9.6	41.8	15.1	7.5	9.8	30.2	13.6	25.5	19.7	25.5	21.4	5.1	12.8	13.2	36.8	22.9	42.7	11.6	13.0	28.2	4.6	2.0	43.2	32.8	4.6	7.5	53.4	10.0	17.8	18.5	7.4	24.3	21.9	17.2	30.8	16.7	9.2	17.3	26.8	16.0	5.1	53.5	31.3	3.9	41.2	3.5	16.3	4.5	4.0	41.3	13.5	3.6	3.6	4.7	4.0	31.4	31.3	7.6	28.0	2.5	3.6	1.8	3.2	2.2	1.8	4.3	1.4	2.8	2.7
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol			17000	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: "	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	30.2	33.1	18.3	26.4	18.9	26.3	30.3	18.0	23.2	24.1	25.2	19.6	33.6	21.9	24.5	30.5	45.2	20.9	31.1	33.0	16.9	16.9	40.6	108.0	26.0	21.0	19.4	15.9	29.3	46.4	47.5	21.9	34.6	18.3	24.0	21.8	19.9	31.4	34.1	103.7	39.0	31.6	26.8	15.7	33.1	27.1	30.8	18.0	25.8	30.0	46.2	34.3	28.6	27.6	8.8	15.9	5.5	17.0	8.1	11.4	9.1	90.2	37.9	31.8	36.1	35.5	35.1	55.1	49.8	35.2	55.4	42.2	80.3	29.5	57.8	66.4	61.8	48.9	54.9	61.1	43.2	61.0	57.7	52.2	38.8	35.5	30.8	52.2	36.6	35.4	35.6	50.4	48.2	48.3	37.9	45.8	36.6	67.1	35.4	18.8	62.6	30.7	36.4	31.3	46.3	29.3	55.1	33.4	29.7	42.5	70.4	33.8	75.0	37.4	60.4	39.4	39.8	51.5	93.3	35.7	43.1	106.8	44.3	45.9	43.0	4.8	13.6	5.5	11.4	13.9	11.0	7.6	7.7	9.2	12.2	8.8	7.1	7.0	5.1	8.1	17.0	15.9	5.4	9.1	18.3	18.9	18.0	23.2	16.9	16.9	19.4	15.9	18.3	18.0
EIF4G2	"DAP5, NAT1, p97"	ENSG00000110321	"Eukaryotic translation initiation factor 4 gamma 2"	P78344	11	10797050-10809110	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005163, HPA006773, HPA016965"	Approved		Enhanced	Cytosol			25000	Cytosol		"CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100"	"unprognostic (1.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (6.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.74e-1)"	86.2	86.5	81.0	73.8	78.4	124.4	122.8	76.8	84.8	94.3	102.2	64.5	70.2	57.5	108.8	85.3	125.4	83.5	82.4	199.1	83.8	85.7	121.2	115.8	84.6	71.3	92.0	66.4	81.3	76.1	117.7	118.9	187.1	96.8	90.8	90.2	69.5	84.4	97.1	162.7	84.2	102.0	113.1	104.8	120.0	83.9	60.5	65.5	110.6	110.0	81.9	96.5	107.8	98.9	48.4	57.5	87.4	72.2	44.5	52.7	114.7	104.7	85.7	116.0	63.1	79.0	87.9	78.5	97.3	104.8	91.4	61.1	90.3	124.9	60.2	58.5	120.8	62.8	126.6	90.9	119.0	97.7	53.2	76.6	54.3	66.0	67.5	117.1	65.9	70.8	68.4	54.0	69.0	98.0	59.2	67.8	109.0	52.0	87.3	40.1	81.0	83.7	80.6	67.8	38.5	71.8	158.5	43.3	69.8	113.8	76.0	58.7	66.8	51.1	94.6	110.8	72.7	93.7	81.4	32.7	99.7	92.3	64.2	67.3	117.3	50.2	60.0	87.4	42.3	70.9	52.7	48.4	45.7	47.8	57.5	40.6	40.4	41.6	42.9	44.5	72.2	28.5	50.3	114.7	81.0	78.4	76.8	84.8	83.8	85.7	92.0	66.4	96.8	65.5
EIF4G3	eIF4GII	ENSG00000075151	"Eukaryotic translation initiation factor 4 gamma 3"	O43432	1	20806292-21176888	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025031, HPA025039, HPA025041"	Enhanced		Approved	Cytosol				Cytosol		"HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104"	"unprognostic (1.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (9.60e-7)"	"unprognostic (1.02e-1)"	"unprognostic (6.95e-3)"	"unprognostic (8.36e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	17.8	19.2	24.8	19.0	28.6	24.1	14.3	24.8	33.8	17.2	17.9	24.5	18.6	12.2	19.7	17.5	16.8	17.1	17.0	16.6	25.9	24.8	14.8	13.6	12.9	14.8	23.1	24.8	15.7	10.6	44.5	30.3	13.8	36.3	16.1	21.0	17.4	11.3	18.5	29.1	17.7	14.0	23.8	25.0	16.1	14.2	67.1	23.1	13.9	30.5	9.7	16.1	18.0	15.7	3.6	5.6	4.2	2.6	1.4	3.7	1.5	11.1	9.0	30.1	11.9	31.5	31.3	6.2	24.3	26.2	17.0	17.6	9.8	12.3	22.4	15.7	26.3	12.5	18.5	19.7	24.1	19.5	17.5	11.1	18.0	6.9	15.9	18.4	20.7	32.8	16.0	17.9	23.2	21.9	8.4	15.7	25.2	9.8	5.7	9.6	8.5	8.2	11.1	11.1	7.4	18.8	6.1	17.1	13.3	25.2	10.9	14.8	7.9	21.4	22.4	19.3	7.2	27.4	11.0	7.2	7.7	0.1	24.7	29.4	17.9	2.0	2.6	3.0	3.7	0.5	1.6	2.6	1.5	1.8	3.4	3.6	1.0	2.8	4.2	1.4	1.0	5.6	1.7	1.5	24.8	28.6	24.8	33.8	25.9	24.8	23.1	24.8	36.3	23.1
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174245-74197101	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			520000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (3.89e-4)"	"prognostic unfavourable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	46.8	42.7	47.6	37.6	52.8	82.3	42.8	56.0	89.5	39.8	44.5	46.6	36.2	43.1	48.1	37.9	58.6	44.4	40.7	47.4	45.6	41.4	34.5	50.7	37.4	42.8	45.4	54.6	54.2	74.3	54.3	30.1	72.2	47.6	44.8	35.1	35.6	60.3	45.4	89.6	53.0	41.5	43.4	59.9	34.6	45.4	52.5	32.1	46.8	43.5	57.9	44.2	43.4	41.4	38.4	57.6	60.2	64.2	46.7	52.0	80.6	86.2	57.5	43.9	53.2	39.1	41.7	49.9	61.7	46.9	51.1	50.3	70.4	66.5	74.1	16.9	56.9	45.8	48.3	82.0	48.4	49.8	56.6	41.3	54.0	56.5	44.8	69.6	41.7	48.7	52.1	56.7	80.8	55.9	72.5	32.2	52.3	73.6	54.9	82.6	58.5	56.9	64.4	58.8	66.9	42.5	55.2	44.6	56.4	57.5	72.7	48.9	82.2	45.1	58.2	73.3	49.8	61.2	77.5	38.3	45.7	126.5	57.3	73.1	75.2	45.7	58.4	60.2	43.5	64.2	44.9	38.4	44.7	43.0	57.6	35.3	52.0	42.4	39.0	46.7	63.6	24.4	47.6	80.6	47.6	52.8	56.0	89.5	45.6	41.4	45.4	54.6	47.6	32.1
EIF5		ENSG00000100664	"Eukaryotic translation initiation factor 5"	P55010	14	103333544-103345025	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 123.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000867, CAB004226"	Supported		Enhanced	"Plasma membrane,Cytosol"			21000	Cytosol	"Plasma membrane"	"CAB004226: AB_627507, HPA000867: AB_1078731"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.47e-3)"	"unprognostic (6.33e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.70e-2)"	"prognostic favourable (5.67e-7)"	"unprognostic (2.76e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.14e-2)"	35.7	31.9	36.5	20.8	41.1	67.7	34.4	31.5	47.2	21.3	32.5	25.5	18.8	31.7	27.6	23.5	34.0	27.6	26.2	34.1	37.9	34.2	37.9	78.4	27.3	37.2	37.1	33.3	24.7	32.1	30.1	26.7	31.9	39.3	23.4	32.5	19.2	28.5	32.8	59.4	22.7	31.5	39.5	36.9	31.1	28.2	39.1	27.0	29.6	40.1	30.5	31.1	29.1	37.9	96.7	96.6	90.1	74.3	86.8	90.5	102.2	21.4	25.2	29.3	13.3	25.5	22.6	31.0	31.7	34.4	32.7	24.9	37.1	22.9	22.3	20.1	28.4	28.9	36.9	32.1	55.9	18.2	14.7	19.9	13.3	19.5	26.6	35.8	17.1	24.2	21.6	28.9	39.6	32.8	41.1	21.4	27.0	30.8	24.4	11.9	15.3	48.1	20.7	38.2	13.9	19.3	70.0	26.2	18.4	31.7	23.8	25.7	22.8	16.5	24.9	26.2	17.9	33.4	33.0	64.1	123.4	46.8	25.8	25.2	30.5	83.4	74.3	90.1	74.1	73.2	82.6	95.9	76.0	69.3	70.7	96.7	90.5	76.1	80.3	86.8	73.8	96.6	62.3	102.2	36.5	41.1	31.5	47.2	37.9	34.2	37.1	33.3	39.3	27.0
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005042, HPA061298"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB005042: AB_562281, HPA061298: "	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavourable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	69.0	55.6	37.9	57.0	40.4	83.1	44.5	35.0	59.8	44.6	54.8	37.5	39.8	47.4	47.2	45.5	107.0	38.1	52.9	55.8	35.6	33.6	58.5	192.9	46.6	67.2	34.3	35.9	50.3	126.0	26.0	34.1	73.9	34.0	38.0	57.2	40.7	87.7	40.7	100.6	71.1	49.0	45.4	29.5	65.5	42.9	56.8	24.2	77.9	57.9	105.4	79.0	48.6	50.7	64.7	87.7	44.4	75.7	75.2	79.3	64.3	133.0	166.1	51.2	102.5	39.6	51.0	72.0	100.5	66.3	135.9	95.1	99.3	56.8	129.0	65.1	77.2	91.0	111.3	129.5	123.7	71.7	161.6	77.6	137.6	127.2	70.2	58.9	80.3	54.1	68.0	100.3	136.3	87.2	106.7	36.1	91.9	82.5	69.2	85.2	97.2	82.0	68.5	62.3	118.9	82.0	74.0	59.6	77.5	64.4	78.5	62.2	62.1	45.4	81.7	95.8	69.0	63.6	158.7	30.4	41.5	83.4	90.6	88.7	109.1	44.4	56.0	38.9	65.1	75.7	79.3	64.7	67.1	57.7	85.8	62.6	62.3	62.6	25.1	75.2	68.6	87.7	58.9	64.3	37.9	40.4	35.0	59.8	35.6	33.6	34.3	35.9	34.0	24.2
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337353-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"			11000	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: "	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavourable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favourable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	24.5	16.0	25.2	22.4	32.6	11.5	22.6	27.7	26.0	23.7	25.1	10.5	19.9	14.8	19.4	28.7	30.8	14.5	15.0	61.7	26.0	22.3	28.8	32.1	17.9	19.2	26.9	23.0	22.3	24.6	26.8	27.5	26.4	28.5	26.0	20.3	7.1	22.3	29.1	105.8	25.3	19.3	31.5	37.6	27.0	20.7	22.6	33.8	17.8	18.2	29.2	22.8	40.1	31.9	15.9	20.2	11.6	12.1	14.1	14.9	4.5	33.7	16.9	19.3	25.1	23.4	27.8	32.0	29.8	18.8	19.9	19.8	38.9	24.2	38.7	25.9	22.2	19.4	33.7	28.9	35.2	23.4	20.2	46.5	17.3	51.1	18.6	45.5	28.8	18.7	20.4	27.6	28.3	28.9	51.3	19.4	28.5	27.4	28.8	42.2	30.1	24.9	25.2	28.7	31.6	40.7	28.4	16.4	15.5	16.2	37.4	24.0	15.2	30.1	31.7	30.9	30.3	16.1	26.5	14.4	20.4	31.6	22.5	50.5	22.7	11.6	8.8	9.8	12.7	9.5	14.9	15.3	13.4	12.5	6.4	15.9	13.2	14.0	2.3	14.1	12.1	20.2	9.0	4.5	25.2	32.6	27.7	26.0	26.0	22.3	26.9	23.0	28.5	33.8
ELAC1	D29	ENSG00000141642	"ElaC ribonuclease Z 1"	Q9H777	18	50967991-50988121	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040867, HPA066483"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040867: AB_10697716, HPA066483: "	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.75e-2)"	"unprognostic (8.61e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.67e-3)"	"unprognostic (6.36e-2)"	"prognostic favourable (8.43e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	8.7	15.0	7.7	7.7	9.7	3.3	9.4	7.1	11.9	8.0	9.1	12.8	12.1	7.6	11.3	20.1	7.5	10.0	9.6	7.2	7.3	8.3	12.4	15.2	7.6	11.2	7.6	7.2	8.8	19.5	17.1	15.7	12.3	8.7	9.9	10.8	13.7	20.1	12.2	6.8	7.7	11.7	8.3	7.1	10.8	10.1	16.7	3.9	10.1	15.6	7.0	9.9	8.7	6.6	14.2	12.4	7.8	9.1	16.1	15.7	8.1	6.9	4.8	12.7	10.8	14.3	6.1	5.4	7.6	10.1	7.2	5.1	1.8	6.6	5.4	5.3	7.0	7.0	3.9	8.0	4.9	11.7	1.0	6.6	1.8	1.2	8.4	16.7	4.8	7.6	6.4	3.8	8.9	7.4	6.7	13.5	12.6	3.1	5.7	5.0	6.3	2.1	6.6	4.5	10.0	8.3	3.0	7.5	8.6	6.3	1.1	12.1	5.9	12.8	6.5	9.4	4.9	2.7	5.1	12.7	10.6	7.2	8.7	5.6	11.8	4.1	7.8	7.8	13.2	9.1	14.6	14.2	12.7	12.9	12.4	13.6	12.4	15.7	0.9	16.1	8.7	10.4	10.0	8.1	7.7	9.7	7.1	11.9	7.3	8.3	7.6	7.2	8.7	3.9
ELAVL1	"Hua, HuR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958579-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			210000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: "	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favourable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	19.7	23.8	28.0	22.4	34.1	17.2	22.4	35.4	28.0	23.1	21.4	21.2	19.6	17.9	27.5	19.7	24.4	25.7	16.9	25.2	23.6	17.6	20.8	21.4	19.4	26.5	27.5	22.2	25.7	20.4	29.4	25.4	23.3	26.5	20.4	20.2	19.7	21.2	23.0	27.6	19.2	18.4	30.4	17.7	21.9	19.7	46.7	26.5	40.4	20.6	18.7	30.7	23.4	32.2	17.1	17.6	24.3	14.7	23.2	19.6	9.4	35.6	23.7	39.8	29.9	15.6	15.7	22.4	26.6	22.4	39.7	31.1	34.2	20.8	43.0	37.5	29.2	24.9	44.3	30.5	33.6	38.4	41.2	37.7	17.4	31.8	22.9	35.7	30.2	19.4	18.3	27.6	16.8	30.3	38.7	32.3	27.3	26.5	59.6	28.8	35.5	30.2	67.1	26.0	28.3	25.2	26.4	28.6	20.9	25.2	25.5	20.1	29.1	28.2	22.7	37.2	26.1	34.4	45.8	33.0	31.8	45.2	20.8	43.0	32.0	16.4	13.0	24.3	12.2	11.7	12.9	14.0	17.8	19.6	17.6	17.1	16.1	12.4	3.8	23.2	14.7	8.8	13.5	9.4	28.0	34.1	35.4	28.0	23.6	17.6	27.5	22.2	26.5	26.5
ELAVL2	"HEL-N1, HuB"	ENSG00000107105	"ELAV like RNA binding protein 2"	Q12926	9	23690104-23826337	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 30.7;testis: 45.3"	"Cell line enhanced"	"Detected in some"		"A-431: 9.9;AF22: 15.2;SCLC-21H: 51.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022222, HPA063001"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB022222: , HPA063001: "	"unprognostic (3.51e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.74e-4)"	"unprognostic (3.98e-1)"	"unprognostic (9.08e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.65e-1)"	1.0	2.4	8.7	1.0	13.4	1.4	1.1	18.3	27.5	1.0	1.3	0.7	0.0	1.0	1.5	1.4	1.1	1.0	1.1	1.0	8.1	19.2	1.4	0.8	1.1	1.0	16.3	18.9	2.1	0.8	1.2	2.5	0.9	30.7	1.2	1.5	0.5	1.0	1.0	1.0	1.5	1.1	1.1	5.0	1.0	1.0	45.3	1.1	0.0	1.2	0.0	1.0	1.6	0.3	1.8	1.1	5.1	0.9	1.4	1.3	0.1	9.9	0.1	15.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	4.1	6.4	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	3.9	0.0	4.6	0.1	0.3	0.5	2.1	0.0	0.0	0.0	4.0	4.8	0.0	5.5	0.0	0.0	0.0	51.0	4.8	0.1	0.1	0.1	0.2	0.7	0.0	0.1	3.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.5	2.7	0.9	1.6	0.5	0.6	0.6	1.0	0.5	0.4	0.4	1.8	1.1	1.3	5.1	1.4	0.5	1.1	0.6	0.1	8.7	13.4	18.3	27.5	8.1	19.2	16.3	18.9	30.7	1.1
ELMO2	"CED-12, CED12, ELMO-2, FLJ11656, KIAA1834"	ENSG00000062598	"Engulfment and cell motility 2"	Q96JJ3	20	46366049-46432985	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018811	Approved		Supported	Cytosol				Cytosol		"HPA018811: AB_1848126"	"unprognostic (1.19e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (8.81e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.92e-1)"	"prognostic favourable (6.10e-4)"	"unprognostic (4.53e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.20e-2)"	12.6	14.9	23.8	11.9	30.0	28.1	10.6	39.8	32.6	14.8	9.9	34.8	5.2	7.8	12.7	17.5	18.0	13.5	9.4	13.1	25.4	17.1	12.6	8.5	13.7	15.5	21.5	16.8	11.6	17.5	30.1	13.9	13.2	20.6	18.1	9.3	13.8	11.6	22.8	16.8	18.6	9.3	19.5	20.4	17.5	9.1	18.5	22.6	12.3	13.0	7.0	16.3	11.4	13.8	5.3	13.4	38.3	27.6	21.9	22.3	15.6	4.8	14.3	17.1	14.0	29.9	19.3	8.8	11.3	15.5	15.9	15.5	19.3	5.5	6.0	18.1	18.8	11.5	14.4	16.8	12.4	9.9	6.5	9.8	9.3	14.1	22.7	5.4	20.9	18.9	15.0	16.8	12.0	12.7	9.7	20.1	14.7	12.8	10.7	14.1	6.5	14.1	9.1	16.6	12.1	15.5	11.2	10.3	9.3	16.3	14.5	21.8	11.2	21.8	14.7	32.8	18.6	13.4	7.3	8.1	12.2	6.2	13.6	8.8	9.9	38.3	10.1	16.3	18.4	19.3	22.3	4.3	16.5	17.4	9.6	5.3	10.7	12.0	11.1	21.9	27.6	13.4	10.8	15.6	23.8	30.0	39.8	32.6	25.4	17.1	21.5	16.8	20.6	22.6
ELMOD1	DKFZp547C176	ENSG00000110675	"ELMO domain containing 1"	Q8N336	11	107591091-107666779	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 51.1;pituitary gland: 20.8;skin 1: 34.7"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 11.6;RH-30: 26.5"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038435, HPA066479"			Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038435: AB_10795575, HPA066479: "	"unprognostic (2.74e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.13e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	1.5	4.2	10.7	1.5	41.1	1.3	4.1	12.8	51.1	1.5	1.4	1.7	0.0	1.4	1.6	1.3	1.2	3.6	1.2	4.8	13.8	14.3	4.7	1.3	1.6	1.3	8.7	15.2	1.2	1.2	1.2	20.8	1.2	14.8	2.1	1.3	1.4	1.3	1.2	2.8	34.7	1.3	1.4	6.6	1.2	1.2	2.9	3.9	0.0	1.3	0.0	1.2	1.1	0.1	0.9	0.7	2.4	0.9	1.8	0.5	0.2	0.0	0.0	4.4	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.2	0.4	2.1	0.3	0.4	0.0	1.8	0.1	0.0	0.0	1.2	0.1	0.0	0.4	0.1	0.0	0.0	11.6	0.0	0.1	0.8	0.0	0.0	0.1	0.5	1.7	0.0	26.5	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.6	0.1	0.0	0.0	3.5	0.0	2.0	1.6	0.9	0.6	0.4	0.6	0.4	0.5	0.5	0.2	0.2	0.9	0.4	0.5	2.4	1.8	0.6	0.7	0.4	0.2	10.7	41.1	12.8	26.9	13.8	14.3	8.7	15.2	14.8	3.9
ELMOD2	MGC10084	ENSG00000179387	"ELMO domain containing 2"	Q8IZ81	4	140524158-140553770	"Predicted intracellular proteins"	"Antiviral defense"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047600	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA047600: "	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.65e-1)"	"prognostic favourable (1.17e-8)"	"unprognostic (3.17e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (1.82e-2)"	11.6	20.8	9.2	11.9	14.0	8.5	16.7	14.0	10.6	13.8	17.9	10.4	24.7	14.4	15.4	15.8	13.9	13.9	10.9	18.0	10.4	11.2	20.6	19.3	14.5	13.9	13.6	9.2	13.0	17.2	20.2	24.1	17.3	13.6	15.5	15.2	12.1	13.5	21.2	8.4	10.5	31.0	12.4	14.4	11.6	12.1	9.1	12.3	18.2	19.6	10.5	11.2	12.1	11.6	6.0	10.6	17.0	7.8	7.8	8.6	4.8	6.5	7.3	14.9	11.4	15.7	18.1	9.6	15.5	14.8	8.6	10.4	7.1	14.0	10.7	6.9	9.7	6.0	14.1	9.8	10.7	10.4	8.4	8.8	5.8	9.3	14.2	13.4	7.8	12.4	16.4	7.3	7.6	9.4	11.3	17.7	14.8	4.8	14.5	4.6	7.9	6.0	17.1	11.5	6.9	12.5	10.5	7.1	26.4	10.2	10.4	11.1	10.2	5.6	9.4	19.9	7.2	9.3	16.0	18.6	26.4	13.6	14.5	10.6	15.0	2.6	7.2	8.7	7.5	7.8	8.6	3.8	6.9	8.3	6.1	6.0	7.1	7.0	17.0	7.8	5.9	10.6	8.0	4.8	9.2	14.0	14.0	10.6	10.4	11.2	13.6	9.2	13.6	12.3
ELOA	"SIII, TCEB3, TCEB3A"	ENSG00000011007	"Elongin A"	Q14241	1	23743155-23762059	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005910	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA005910: AB_1080227"	"unprognostic (6.90e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	25.6	13.7	10.0	14.2	16.1	22.9	16.3	16.0	17.2	13.7	12.2	15.2	15.1	9.8	15.0	9.0	23.6	13.3	15.7	12.9	9.9	9.8	18.1	41.7	20.3	24.1	10.3	12.5	16.0	41.5	19.1	17.1	19.6	12.7	13.6	13.5	13.0	18.6	13.4	26.0	18.3	14.1	14.0	10.9	20.5	24.6	14.4	10.0	19.3	18.4	22.4	21.8	15.6	14.5	20.7	18.8	18.3	20.9	11.0	14.8	13.2	20.0	11.2	16.2	13.9	19.2	12.0	10.3	20.8	18.8	31.0	27.1	13.7	17.6	10.5	25.6	21.0	19.3	33.2	21.9	34.7	30.1	16.4	23.7	17.6	15.9	17.0	24.8	14.4	12.7	17.7	33.8	25.9	18.5	35.1	18.3	24.7	15.2	12.8	10.1	18.8	17.0	19.3	20.6	20.0	14.6	13.7	31.0	17.5	18.9	19.1	23.1	13.8	9.2	19.6	24.4	21.6	43.2	24.4	19.0	21.2	23.2	21.4	24.8	24.3	18.3	19.8	15.4	14.8	20.9	14.6	20.7	12.4	13.3	18.8	16.6	10.2	13.4	5.5	11.0	18.4	15.5	14.0	13.2	10.0	16.1	16.0	17.2	9.9	9.8	10.3	12.5	12.7	10.0
ELOF1	"ELF1, MGC4549"	ENSG00000130165	"Elongation factor 1 homolog"	P60002	19	11551147-11559236	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045606	Uncertain		Approved	Cytosol				Cytosol		"HPA045606: AB_10965133"	"unprognostic (4.32e-2)"	"prognostic favourable (1.83e-4)"	"unprognostic (4.38e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.12e-2)"	19.0	23.4	25.5	20.4	23.9	33.0	20.9	32.8	29.0	24.5	19.8	19.8	19.5	19.2	27.4	28.6	21.2	29.2	20.6	21.2	25.1	27.6	24.8	45.2	18.9	24.9	25.0	22.4	28.1	39.3	19.7	29.6	19.4	21.2	25.4	15.9	21.0	34.2	30.6	24.9	22.7	20.8	22.1	20.5	22.5	23.2	69.0	20.8	33.1	29.3	24.3	23.2	22.5	22.6	63.1	60.4	44.2	43.2	32.4	47.1	41.4	38.9	27.3	18.8	25.8	23.6	24.0	9.7	25.3	21.4	34.8	35.2	27.1	10.8	25.2	24.9	22.8	18.5	22.9	35.1	24.3	19.8	23.3	31.4	17.9	25.5	26.6	20.4	21.7	23.2	26.2	30.7	22.4	16.9	43.6	33.0	20.7	50.4	30.1	23.8	48.9	50.5	22.5	16.1	26.4	28.6	18.3	23.8	30.2	20.4	24.6	23.7	20.6	16.4	11.7	36.1	13.6	37.7	37.9	38.4	51.5	21.3	33.6	28.7	18.0	25.0	42.4	44.2	34.3	40.1	31.7	63.1	36.0	31.8	36.8	46.9	32.6	29.1	28.8	32.4	43.2	60.4	47.1	41.4	25.5	23.9	32.8	29.0	25.1	27.6	25.0	22.4	21.2	20.8
ELOVL3	CIG-30	ENSG00000119915	"ELOVL fatty acid elongase 3"	Q9HB03	10	102226328-102229589	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 24.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 8.1;HSkMC: 11.9;NB-4: 9.2;SiHa: 18.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	11	"classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.6;monocytes: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036236	Enhanced		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA036236: AB_10601550"	"unprognostic (1.52e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (6.25e-5)"	"unprognostic (8.23e-3)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-4)"	"unprognostic (4.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.66e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.79e-1)"	6.3	1.1	1.2	2.1	2.4	3.6	7.3	0.4	0.9	0.2	0.2	0.0	0.0	0.0	0.9	0.3	0.3	0.3	2.5	2.5	0.6	0.2	0.5	0.2	1.8	0.1	0.7	0.0	0.2	0.2	0.0	1.8	2.4	1.1	0.3	0.2	1.6	3.4	1.7	1.7	24.6	0.3	0.0	0.2	0.8	0.2	6.8	0.0	0.0	0.2	2.8	0.0	0.6	2.6	0.0	2.6	0.5	9.4	0.0	0.0	1.9	2.6	0.2	0.1	6.5	8.2	8.1	2.3	0.1	0.2	0.3	0.4	0.4	2.5	0.0	0.3	0.0	0.0	4.9	0.0	0.4	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.1	11.9	1.4	3.0	0.0	0.0	0.1	2.9	0.7	0.0	0.0	9.2	0.1	0.9	0.0	4.3	0.0	1.6	0.0	0.0	0.3	18.5	0.8	0.6	6.7	2.2	0.0	1.3	0.0	0.3	0.2	0.4	5.7	0.0	2.9	5.3	0.0	0.0	9.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.0	6.6	0.0	0.0	1.9	1.2	2.4	0.4	0.9	0.6	0.2	0.7	0.0	1.1	0.0
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108867517-108934116	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Low region specificity"	"Detected in all"							"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB021340: , HPA049677: , HPA050686: "	"prognostic unfavourable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	10.4	33.0	18.7	10.6	22.9	10.8	13.1	37.6	19.9	13.0	11.5	17.2	11.4	8.2	15.7	17.3	9.8	15.1	10.3	15.3	14.8	15.2	13.0	14.7	11.2	12.8	20.9	17.3	26.4	12.9	41.3	42.3	11.2	20.5	13.1	12.6	15.0	12.0	12.8	11.6	15.7	11.2	14.4	16.7	13.3	11.3	11.7	19.3	12.1	15.4	8.3	13.2	10.4	13.4	2.1	2.7	26.9	2.6	4.0	4.2	1.9	9.1	17.6	15.2	9.8	16.7	16.1	12.5	15.0	10.4	15.3	12.2	16.6	6.7	16.8	6.8	13.4	23.6	23.3	18.7	16.9	15.8	14.6	9.8	27.4	44.9	12.5	19.1	8.8	12.3	13.2	21.3	20.1	13.1	23.1	11.8	14.0	15.6	16.3	11.8	19.4	17.7	14.2	20.5	10.5	11.6	11.8	18.4	14.8	16.5	16.5	10.2	21.4	8.6	12.5	8.8	10.1	19.6	14.9	11.2	25.2	8.5	14.7	12.7	11.9	26.9	1.7	2.5	3.1	2.0	4.2	2.1	3.0	4.0	2.7	1.4	2.9	3.6	0.3	4.0	2.6	1.3	2.4	1.9	18.7	22.9	37.6	19.9	14.8	15.2	20.9	17.3	20.5	19.3
ELP2	"FLJ10879, STATIP1, StIP"	ENSG00000134759	"Elongator acetyltransferase complex subunit 2"	Q6IA86	18	36129444-36180556	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002996, CAB020835"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB020835: , HPA002996: AB_1857552"	"unprognostic (5.51e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (6.66e-3)"	"unprognostic (4.33e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.74e-3)"	"unprognostic (7.31e-3)"	"unprognostic (7.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.97e-2)"	21.3	19.8	16.5	21.0	22.4	10.5	32.9	23.2	23.6	23.2	19.8	21.6	29.6	14.0	32.3	29.7	15.0	27.2	18.7	21.0	15.8	16.2	17.8	41.0	16.1	17.1	18.6	18.0	46.3	26.7	22.0	43.6	18.7	21.3	28.0	15.4	22.5	19.7	27.4	34.7	23.7	15.6	22.5	18.0	18.1	18.3	19.4	21.7	23.5	20.2	14.1	20.5	25.2	19.5	17.1	14.2	13.4	18.2	17.3	18.8	11.1	10.1	7.3	13.8	12.4	19.6	29.6	15.3	21.1	30.7	17.8	23.9	7.7	9.5	21.4	14.8	17.6	14.5	17.6	15.7	25.4	9.7	9.5	8.3	12.7	13.3	21.5	26.8	8.9	24.0	18.1	17.7	28.9	19.9	13.9	11.4	18.9	12.3	12.9	11.6	16.4	5.6	21.1	16.6	14.9	16.2	23.8	11.0	21.0	19.8	7.8	30.9	10.0	13.6	11.7	16.2	9.4	5.9	10.8	13.7	10.8	19.9	13.6	14.4	13.9	13.4	9.7	7.7	10.9	14.3	15.3	17.1	14.7	12.8	14.1	14.3	18.8	16.4	1.6	17.3	18.2	14.2	14.4	11.1	16.5	22.4	23.2	23.6	15.8	16.2	18.6	18.0	21.3	21.7
ELP3	"FLJ10422, KAT9"	ENSG00000134014	"Elongator acetyltransferase complex subunit 3"	Q9H9T3	8	28089673-28191156	"Enzymes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation, tRNA processing"	"Acyltransferase, RNA-binding, Transferase, tRNA-binding"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025297, HPA025812"	Uncertain		Supported	Cytosol				Cytosol		"HPA025297: , HPA025812: AB_10601369"	"unprognostic (1.29e-2)"	"unprognostic (1.26e-2)"	"prognostic favourable (9.25e-4)"	"unprognostic (3.49e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.46e-2)"	"prognostic favourable (1.31e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	14.8	15.3	18.7	11.5	23.4	6.7	19.4	20.0	27.4	33.4	14.8	21.8	35.2	10.8	27.3	14.4	12.8	18.6	17.5	16.0	17.7	19.0	19.1	22.8	13.6	15.4	17.6	13.6	18.9	12.6	14.3	17.4	12.7	23.3	15.9	18.0	13.9	11.1	36.1	28.8	13.4	12.3	16.0	15.8	16.1	12.1	15.0	15.5	16.0	19.9	13.8	20.3	14.7	12.0	16.2	12.2	11.6	18.2	15.8	20.8	11.0	14.3	15.1	11.5	11.0	17.0	14.9	8.2	7.4	13.4	17.4	15.6	12.5	6.1	27.1	11.7	14.2	9.8	12.6	17.6	20.6	4.9	5.2	18.2	10.0	20.6	15.2	9.8	13.6	15.7	27.2	12.0	18.5	16.3	20.4	16.8	17.8	8.8	20.8	16.7	12.9	5.3	15.8	11.2	10.4	17.4	11.8	6.9	12.0	8.4	7.2	14.1	13.7	11.3	11.4	12.0	15.7	12.4	10.7	7.1	11.4	20.8	11.9	11.0	12.2	11.6	10.1	8.2	19.4	14.4	20.8	12.5	16.6	18.3	11.8	16.2	15.0	17.0	2.8	15.8	18.2	12.2	15.6	11.0	18.7	23.4	20.0	27.4	17.7	19.0	17.6	13.6	23.3	15.5
ELP5	"C17orf81, DERP6"	ENSG00000170291	"Elongator acetyltransferase complex subunit 5"	Q8TE02	17	7251416-7259940	"Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023279, HPA052411"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023279: AB_1847613, HPA052411: "	"unprognostic (3.73e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.60e-2)"	"prognostic favourable (2.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.30e-2)"	12.4	18.2	14.0	13.6	14.0	11.8	10.4	14.1	17.8	11.1	15.5	12.2	13.3	11.4	13.1	13.5	10.9	12.6	11.9	23.0	13.2	12.0	16.5	21.3	9.1	15.0	13.6	12.8	15.2	10.6	9.6	15.9	12.6	12.5	14.0	11.0	16.4	20.9	12.7	28.3	7.8	14.6	18.0	11.2	14.1	10.7	103.3	12.4	23.6	15.7	17.2	16.1	11.6	11.0	31.1	36.7	16.3	29.3	27.6	34.7	21.5	12.3	35.1	15.8	14.3	27.8	22.0	6.9	11.1	13.2	17.9	16.6	35.0	8.2	24.6	12.3	17.6	9.3	39.9	26.2	12.9	15.2	56.3	22.7	11.8	31.8	13.8	16.0	9.0	15.5	19.7	12.2	24.1	15.2	15.6	6.6	27.7	20.9	40.7	30.7	13.0	24.4	35.0	17.8	13.3	19.8	11.7	7.7	15.4	21.6	6.6	17.1	9.4	11.7	17.2	10.3	12.1	19.7	17.6	7.7	10.3	28.6	18.8	15.7	13.3	16.3	25.3	12.4	27.9	29.3	34.7	31.1	24.9	25.5	30.0	31.0	26.4	31.2	4.4	27.6	19.3	36.7	33.8	21.5	14.0	14.0	14.1	17.8	13.2	12.0	13.6	12.8	12.5	12.4
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513761	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: "	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favourable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	10.8	25.9	15.6	16.3	18.5	8.8	15.3	23.2	24.6	12.8	13.3	22.7	19.0	13.3	17.5	22.1	14.2	16.0	13.3	17.0	16.3	15.7	16.4	18.7	11.6	17.5	16.7	21.8	20.8	18.8	16.6	18.8	12.9	19.9	18.1	13.0	18.5	14.8	17.5	23.6	14.7	11.7	16.4	18.6	14.9	13.9	24.9	13.6	23.7	17.8	13.7	17.8	15.5	11.9	20.4	19.5	10.4	12.0	18.4	21.3	14.2	16.7	15.9	21.3	21.5	17.1	15.8	12.1	20.3	14.1	26.0	23.6	15.5	17.8	31.6	12.7	17.5	10.4	20.6	29.6	15.9	17.6	16.0	28.6	24.6	17.2	18.8	21.6	17.8	17.1	16.0	29.6	18.9	22.3	29.9	9.9	25.8	18.5	25.8	24.5	25.5	27.3	12.9	10.3	19.3	18.2	14.9	19.0	18.5	17.3	14.0	10.5	19.1	17.5	14.5	26.6	19.0	13.8	25.3	20.9	27.4	29.0	13.8	26.4	27.1	10.4	12.0	8.4	19.5	11.0	15.1	18.7	18.3	19.5	15.0	20.4	17.3	17.4	1.7	18.4	7.6	19.5	21.3	14.2	15.6	18.5	23.2	24.6	16.3	15.7	16.7	21.8	19.9	13.6
EMC3	TMEM111	ENSG00000125037	"ER membrane protein complex subunit 3"	Q9P0I2	3	9962537-10011116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042372	Approved		Approved	Microtubules,Cytosol				Cytosol	Microtubules	"HPA042372: AB_10795609"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (2.81e-6)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.58e-2)"	41.8	31.5	19.8	17.2	27.1	35.4	24.7	17.2	28.0	17.6	25.0	18.6	23.5	23.2	19.4	19.6	31.3	18.8	17.7	28.3	18.6	21.5	33.0	47.2	22.3	12.7	23.6	20.6	16.3	27.2	25.5	15.9	19.6	27.9	20.8	23.2	16.3	26.0	21.9	54.7	25.4	24.8	20.2	21.9	17.1	23.1	52.6	19.2	15.0	37.7	22.4	20.3	27.3	25.4	25.0	35.1	41.6	46.1	28.1	40.2	51.4	13.4	28.6	10.7	6.4	68.6	27.0	36.0	27.7	24.0	17.3	18.8	19.5	21.5	10.7	20.2	31.4	18.9	18.2	16.4	17.9	29.1	18.3	17.5	21.7	12.7	29.6	19.7	19.8	31.6	29.6	30.3	17.5	21.5	22.3	31.5	25.6	33.1	10.4	9.8	11.9	19.6	13.5	15.1	31.9	21.1	24.4	7.6	15.4	19.7	29.7	17.7	25.1	16.2	24.6	17.4	14.6	18.8	28.0	16.9	44.0	21.7	36.7	14.5	21.8	38.4	46.1	41.3	27.4	36.2	28.3	24.9	27.2	31.2	35.1	25.0	19.9	26.8	41.6	28.1	34.7	31.5	40.2	51.4	19.8	27.1	17.2	27.9	18.6	21.5	23.6	20.6	27.9	19.2
EMC8	"C16orf2, C16orf4, COX4NB, FAM158B, NOC4"	ENSG00000131148	"ER membrane protein complex subunit 8"	O43402	16	85771758-85799608	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049476	Approved		Supported	Cytosol				Cytosol		"HPA049476: "	"unprognostic (2.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (8.49e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-3)"	"prognostic favourable (6.39e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	16.8	17.4	18.8	17.1	19.8	26.9	39.3	12.4	21.0	14.5	16.6	16.3	14.1	18.9	18.2	14.4	17.3	14.0	16.8	23.0	17.7	15.5	19.1	22.5	14.2	16.2	18.0	12.4	16.2	16.2	20.5	14.6	20.9	14.0	14.5	16.2	13.4	16.6	17.0	25.6	13.3	16.3	17.0	17.3	17.9	15.5	15.5	13.3	24.3	19.5	18.2	16.5	14.8	12.3	12.8	20.9	21.2	15.8	16.3	13.9	9.5	12.7	15.0	9.6	8.7	10.4	10.0	18.7	12.7	12.6	21.2	9.5	23.9	14.8	11.1	14.7	12.7	14.7	14.2	13.3	19.0	4.7	20.3	9.1	8.3	21.7	15.8	9.2	6.2	10.9	9.1	16.1	18.9	12.1	20.6	4.3	13.0	21.7	14.6	26.4	19.1	19.3	21.5	7.8	9.4	13.3	9.1	16.3	9.7	23.3	7.6	14.0	15.1	16.5	10.5	12.8	13.0	11.2	16.1	12.0	11.5	44.4	11.0	17.9	13.4	12.5	15.2	21.2	9.9	15.8	11.7	9.6	11.0	13.5	20.9	12.8	13.9	13.2	6.6	16.3	15.7	15.5	10.2	9.5	18.8	19.8	12.4	21.0	17.7	15.5	18.0	12.4	14.0	13.3
EME1	"FLJ31364, MMS4L, SLX2A"	ENSG00000154920	"Essential meiotic structure-specific endonuclease 1"	Q96AY2	17	50373220-50381483	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 15.3;epididymis: 10.6;testis: 21.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	29	"basophil: 15.3"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016127, HPA052188"	Supported		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"CAB016127: AB_2278026, HPA052188: "	"unprognostic (3.81e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.94e-5)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.83e-3)"	"unprognostic (0.00e+0)"	"unprognostic (9.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-1)"	1.0	0.9	1.6	2.5	2.0	6.0	0.8	0.8	1.8	1.3	1.9	3.0	0.0	1.1	0.9	10.6	2.6	0.7	1.6	0.7	0.9	0.6	0.7	0.8	1.1	3.3	1.4	0.9	1.3	0.6	0.2	0.5	2.4	1.5	0.7	2.0	1.0	1.6	0.1	1.4	1.5	2.1	0.8	1.9	2.2	1.1	21.9	2.8	5.7	0.5	0.9	3.9	1.0	1.2	0.1	0.5	15.3	0.0	0.0	0.1	0.2	7.4	11.0	14.7	7.6	0.7	1.5	10.6	7.8	3.0	10.9	10.1	17.3	6.1	5.9	10.4	3.1	5.9	13.6	6.2	15.6	11.6	10.7	14.3	12.7	8.0	0.0	5.8	4.7	0.3	0.4	12.5	5.2	2.5	8.6	14.4	6.4	8.1	13.3	7.5	8.5	7.6	13.8	28.5	8.3	2.4	3.0	5.7	11.4	4.8	2.6	4.5	9.4	6.7	1.7	14.2	8.5	9.3	10.7	9.0	9.1	5.8	4.5	6.6	8.7	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.6	2.0	0.8	1.8	0.9	0.6	1.4	0.9	1.5	2.8
EML4	"C2orf2, ELP120, ROPP120"	ENSG00000143924	"Echinoderm microtubule associated protein like 4"	Q9HC35	2	42169350-42332548	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036687, HPA036688, HPA065337"	Enhanced		Supported	"Intermediate filaments,Microtubules,Cytosol"			41000	Microtubules	"Intermediate filaments, Cytosol"	"HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	11.3	17.3	5.8	29.3	6.8	19.2	10.5	4.6	5.2	9.4	21.6	6.7	6.8	20.3	13.6	11.6	10.7	8.7	20.3	6.5	5.1	3.9	11.7	26.4	19.3	27.7	4.6	4.0	12.5	37.8	10.8	11.6	26.9	6.5	8.5	12.8	12.1	17.7	8.9	4.3	17.9	33.5	9.2	5.0	30.9	11.7	14.2	5.3	17.4	13.2	6.9	30.0	14.0	9.0	11.5	4.2	10.0	11.0	9.4	17.5	5.9	14.4	25.1	14.6	11.6	5.3	8.8	16.0	9.0	7.1	10.0	9.7	26.2	18.2	13.2	6.2	8.8	7.5	12.6	8.6	17.5	25.8	10.5	12.1	7.8	60.0	6.8	9.1	12.5	9.6	3.3	13.2	9.0	6.9	12.0	13.4	10.7	8.5	8.6	2.4	14.9	7.2	8.9	23.2	7.8	8.2	21.0	14.5	29.2	8.8	9.2	6.8	4.8	3.7	8.0	10.2	13.7	8.1	8.1	15.1	10.5	11.4	8.9	8.8	7.1	4.4	3.9	7.7	7.8	10.9	16.3	11.5	13.0	12.7	3.3	7.9	11.4	8.3	10.0	9.4	11.0	4.2	17.5	5.9	5.8	6.8	4.6	5.2	5.1	3.9	4.6	4.0	6.5	5.3
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580698	"Disease related genes, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 118.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 58.3;RT4: 40.1;SK-BR-3: 57.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014711	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA014711: AB_1848147"	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	16.5	2.0	5.0	7.9	5.1	0.0	26.2	3.4	4.7	14.8	10.4	3.4	6.1	4.2	7.3	13.8	35.7	7.4	7.3	14.0	5.5	3.0	3.1	47.5	118.7	5.7	5.4	2.5	14.0	3.2	19.9	3.2	23.5	5.3	11.1	10.0	10.8	9.9	5.8	7.7	40.2	6.6	12.8	3.4	5.3	9.3	5.6	4.1	2.2	7.5	26.4	18.4	10.6	16.3	1.3	1.1	4.1	1.1	1.4	1.0	0.4	6.2	8.6	3.6	4.2	8.1	7.0	7.1	8.9	8.2	5.4	8.2	28.2	21.9	0.0	2.8	10.6	27.8	9.2	11.0	7.1	0.0	5.8	0.0	18.1	15.4	1.4	0.0	0.0	4.2	2.9	7.2	0.7	2.2	2.0	0.5	14.9	58.3	0.1	0.1	4.1	2.1	1.6	4.1	13.6	1.2	40.1	5.0	5.7	11.0	57.6	3.3	35.2	1.3	1.2	17.3	7.5	5.7	4.9	0.1	0.2	0.0	7.6	0.1	16.9	3.4	1.0	1.0	0.8	0.8	1.0	1.0	0.8	0.7	0.5	1.3	0.9	0.9	4.1	1.4	1.1	1.1	0.8	0.4	5.0	5.1	3.4	4.7	5.5	3.0	5.4	2.5	5.3	4.1
ENAH	"FLJ10773, MENA, NDPP1"	ENSG00000154380	"ENAH, actin regulator"	Q8N8S7	1	225486835-225653142	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA028448, HPA028696"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites,Cytosol"			18000	"Plasma membrane, Focal adhesion sites, Cytosol"		"HPA028448: AB_10600766, HPA028696: AB_10611249"	"unprognostic (2.56e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.71e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.93e-2)"	19.2	17.4	15.8	11.9	17.0	0.6	11.1	7.6	17.6	17.8	24.4	15.3	39.9	9.3	21.9	19.9	16.7	11.8	29.0	18.2	16.7	15.3	5.8	5.9	13.8	3.5	13.7	11.3	24.3	16.7	22.5	10.3	13.5	12.7	26.4	8.0	3.3	14.5	44.9	20.2	8.2	8.0	61.4	13.4	17.3	21.0	18.5	17.2	5.3	6.8	11.4	3.5	35.3	21.9	2.1	0.4	1.0	0.3	0.5	0.4	0.0	20.2	16.2	20.1	18.2	7.9	10.4	26.0	22.5	10.8	13.6	10.3	10.4	7.5	8.6	60.0	34.7	17.9	23.5	8.5	12.9	0.1	14.5	8.9	14.4	14.0	23.6	1.0	0.3	16.1	10.3	17.6	22.6	10.7	0.6	0.4	13.4	3.9	4.0	1.0	33.9	14.7	6.1	28.5	0.2	6.2	15.7	19.8	16.0	44.2	16.9	14.9	20.1	1.3	20.8	35.3	26.0	29.3	44.6	0.9	2.5	5.8	19.4	1.1	18.0	1.0	0.3	0.2	0.4	0.1	0.3	0.6	0.4	0.3	0.0	2.1	0.4	0.4	1.0	0.5	0.2	0.4	0.2	0.0	15.8	17.0	7.6	13.7	16.7	15.3	13.7	11.3	12.7	17.2
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074939-79088599	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 51.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favourable (8.73e-5)"	10.0	10.1	9.5	20.7	18.4	8.9	11.4	7.0	13.9	10.9	15.1	12.4	8.8	20.3	11.4	6.8	6.5	10.6	8.6	10.3	9.3	5.8	9.2	10.2	10.1	10.7	16.8	8.5	16.3	9.3	11.3	9.8	8.1	13.6	12.3	12.5	10.7	12.1	9.6	35.4	11.9	17.3	7.3	11.9	24.9	11.4	3.9	14.0	8.1	13.6	7.0	9.1	17.5	51.4	0.2	0.7	0.0	1.1	0.0	2.1	0.6	4.5	9.6	3.4	6.2	3.6	1.5	6.5	3.4	1.7	2.8	2.0	5.1	4.9	0.0	4.2	3.5	6.7	5.4	3.7	1.6	2.7	7.2	4.0	9.8	3.0	2.7	4.6	7.7	4.0	5.2	2.4	2.7	2.9	5.8	2.8	1.8	3.8	0.4	4.4	1.5	8.7	8.5	11.6	2.9	1.5	12.7	2.8	5.7	5.5	25.5	2.5	9.0	4.4	3.8	5.5	4.1	4.8	3.4	6.8	1.2	1.9	2.3	8.5	4.0	0.0	0.7	0.0	0.0	1.1	0.9	0.0	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.6	2.1	0.6	9.5	18.4	7.0	13.9	9.3	5.8	16.8	8.5	13.6	14.0
ENKD1	"C16orf48, DKFZP434A1319"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Centrosome, Cytosol"	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favourable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	8.5	7.7	4.9	5.9	7.0	3.8	6.6	5.0	6.9	10.4	11.7	6.1	18.6	4.7	11.2	14.2	8.2	14.5	11.0	6.1	5.4	5.2	10.9	4.7	8.9	2.9	4.5	4.4	10.9	38.8	23.7	12.0	4.8	8.3	12.7	3.6	7.9	11.7	12.6	6.0	7.2	5.1	12.9	4.3	6.1	7.3	19.6	6.4	7.1	20.4	5.2	4.9	12.9	6.4	0.6	4.2	3.0	1.3	0.7	1.5	0.5	6.9	4.8	11.3	5.2	3.8	3.9	5.6	5.5	3.3	4.3	5.4	3.4	10.7	2.6	9.4	3.4	8.1	2.9	6.5	5.4	4.0	6.6	2.5	14.4	8.1	6.0	4.6	3.6	3.4	4.7	6.0	5.4	3.5	4.2	1.6	2.2	3.5	5.0	19.2	5.3	1.9	17.8	1.2	19.1	4.6	0.7	11.4	12.4	11.6	1.1	5.9	10.2	6.5	9.2	5.4	7.5	10.0	0.0	12.5	5.6	2.7	8.1	6.8	1.6	0.0	1.3	0.0	0.3	0.5	1.5	0.6	1.2	0.7	0.5	0.0	0.8	1.1	3.0	0.7	0.7	4.2	0.0	0.5	4.9	7.0	5.0	6.9	5.4	5.2	4.5	4.4	8.3	6.4
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879250	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394"	Supported		Enhanced	"Plasma membrane,Cytosol"			490000000	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: "	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	68.6	57.7	92.7	94.9	109.6	121.8	73.4	46.6	119.4	47.3	63.8	74.6	21.7	71.3	44.9	24.2	138.2	52.2	55.0	45.2	79.1	70.7	180.4	165.4	64.8	80.3	74.9	62.7	58.2	31.6	52.7	35.5	70.5	88.6	38.6	66.4	62.6	106.1	69.1	45.0	74.6	70.3	84.0	56.4	80.0	44.3	31.7	48.8	98.8	55.4	91.0	119.3	73.5	62.9	38.7	114.1	22.1	105.4	55.5	63.7	159.3	180.7	158.0	76.2	65.2	63.8	71.3	69.1	98.3	109.0	211.8	199.1	101.1	105.0	130.3	131.2	118.2	89.2	129.4	262.3	216.0	88.9	136.7	110.0	160.5	125.6	95.9	219.2	67.8	73.6	79.6	167.7	255.0	135.6	120.5	51.0	137.3	89.5	82.6	117.4	83.1	158.6	85.6	113.6	212.8	250.7	43.1	103.1	63.7	115.3	167.9	121.2	84.1	65.7	123.9	146.7	129.9	125.1	167.1	145.5	103.2	197.7	227.8	179.8	123.1	13.9	105.4	20.8	52.3	75.8	59.1	38.7	55.8	53.8	114.1	32.7	45.6	47.8	22.1	55.5	72.4	31.2	63.7	159.3	92.7	109.6	46.6	119.4	79.1	70.7	74.9	62.7	88.6	48.8
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 119.2"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5"	"Group enriched"	"Detected in many"	7	"B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"			89000000	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: "	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	4.2	20.7	31.2	8.3	48.0	4.0	4.9	115.2	119.2	7.6	7.9	10.9	2.6	4.9	11.7	6.3	5.9	9.4	8.0	10.3	30.2	39.2	3.5	2.0	10.1	10.5	29.6	47.4	3.7	4.1	19.1	15.5	4.8	47.7	8.0	7.4	28.6	3.1	15.3	2.1	5.8	6.0	15.2	15.7	5.8	6.4	3.2	13.3	1.7	14.2	0.3	10.3	7.1	5.0	5.6	1.0	6.2	0.2	0.4	10.8	4.5	14.0	8.9	3.2	0.1	4.8	5.2	0.2	10.9	7.0	16.2	25.0	1.7	1.1	19.8	1.8	4.7	2.1	33.7	3.0	24.6	39.6	3.1	27.3	9.1	11.8	3.5	1.6	32.9	2.6	0.1	11.9	2.4	3.4	1.8	0.2	10.8	1.9	12.8	1.7	17.1	5.0	14.2	2.7	4.3	7.9	1.9	25.9	18.2	2.8	0.2	18.6	0.9	0.8	4.3	14.2	15.0	19.1	14.1	14.5	14.5	2.9	81.3	0.0	2.9	1.3	0.0	0.1	8.2	0.0	9.7	5.6	10.8	9.6	0.0	3.3	7.1	7.4	6.2	0.4	0.2	1.0	5.5	4.5	31.2	48.0	115.2	91.3	30.2	39.2	29.6	47.4	47.7	13.3
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 638.2;tongue: 320.3"	"Group enriched"	"Detected in many"	4	"HDLM-2: 70.1;HeLa: 30.0;HMC-1: 29.6;RH-30: 48.2;RPMI-8226: 25.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"			100000000	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: "	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.6	0.3	0.2	0.6	0.2	0.7	0.5	0.6	0.2	0.2	0.4	0.0	0.1	0.8	0.4	8.5	8.6	0.4	0.1	38.3	0.2	0.1	0.5	5.0	0.4	0.5	0.2	0.0	0.4	0.3	0.3	0.5	0.2	0.1	2.1	0.1	1.2	11.8	0.1	638.2	0.3	0.7	0.4	0.2	0.8	0.4	0.5	0.0	0.6	4.8	320.3	10.5	0.3	0.3	13.3	21.0	27.1	24.8	18.5	23.3	36.0	2.8	6.2	2.8	2.6	2.4	0.6	6.8	5.0	0.6	0.3	0.3	3.0	1.9	5.2	6.8	0.4	3.6	1.0	0.4	0.2	70.1	5.7	5.1	30.0	4.4	0.9	1.5	29.6	4.1	1.0	0.5	1.0	0.3	2.3	9.7	1.5	1.5	1.8	6.2	3.6	2.6	8.3	48.2	25.2	0.7	1.9	1.8	6.8	3.2	2.8	3.6	2.5	1.6	1.5	3.0	5.5	1.3	3.7	6.9	3.8	4.3	1.7	5.0	2.9	13.5	15.6	27.1	21.8	22.5	14.7	13.3	18.7	20.3	21.0	11.1	12.3	19.7	19.7	18.5	24.8	16.6	23.3	36.0	0.2	0.2	0.6	0.2	0.2	0.1	0.2	0.0	0.1	0.0
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)"	Q9UJA9	6	46159187-46170971	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 116.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.8;HSkMC: 7.9;T-47d: 9.3;U-266/70: 5.8;U-266/84: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 13.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"		300000	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favourable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favourable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favourable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.5	4.8	6.5	1.3	10.3	0.8	7.1	9.2	16.1	6.9	2.0	3.3	28.7	1.5	1.6	116.5	1.6	7.9	3.9	3.9	6.6	9.4	12.1	1.0	4.7	1.2	14.2	10.5	5.4	6.2	21.8	23.3	1.5	14.4	14.6	2.3	11.8	6.9	27.5	6.9	1.3	1.6	5.1	5.5	3.2	3.5	16.2	3.5	1.0	24.3	0.9	1.4	5.7	1.7	0.4	0.0	1.0	0.1	2.2	13.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.6	0.1	0.3	11.8	1.9	3.9	0.3	0.0	0.6	1.6	0.1	0.0	2.6	0.8	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.5	2.5	0.0	0.0	0.3	0.2	4.9	0.6	5.1	0.2	0.0	4.9	0.0	9.3	0.0	0.0	0.0	1.4	0.0	0.1	5.8	8.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	13.4	0.1	7.2	0.4	2.7	8.6	0.0	0.4	0.8	8.2	1.0	2.2	0.0	0.0	0.0	2.6	6.5	10.3	9.2	16.1	6.6	9.4	14.2	10.5	14.4	3.5
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	13	"U-698: 419.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol			22000	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: "	"unprognostic (6.27e-2)"	"prognostic favourable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	30.3	26.4	48.9	26.9	48.9	46.8	33.0	33.8	69.3	31.7	31.8	28.0	26.8	34.4	29.7	45.4	66.3	26.3	28.5	30.0	42.4	37.9	31.7	32.3	28.6	30.0	42.0	39.0	27.7	30.5	33.0	25.2	37.5	34.6	23.9	30.4	28.5	29.4	22.8	67.7	49.8	34.0	27.3	38.3	23.8	28.7	12.8	27.3	25.8	35.2	42.9	35.5	31.7	36.3	34.4	39.5	49.5	33.6	33.0	33.2	38.4	14.3	7.6	10.5	10.1	6.7	5.6	11.4	6.5	6.6	9.7	8.2	8.5	10.9	12.9	10.8	5.2	11.6	8.5	14.4	7.2	22.3	11.9	18.5	10.7	6.4	4.5	14.9	23.9	4.4	8.9	10.0	12.8	9.1	14.1	27.2	6.5	31.1	14.6	12.1	21.1	9.3	14.3	8.7	16.1	12.7	12.6	15.8	10.0	9.2	19.4	10.0	26.5	21.9	9.6	7.2	13.4	8.6	16.7	15.3	22.2	419.6	10.0	17.3	9.5	28.7	30.7	49.5	32.2	33.6	28.9	34.4	27.0	33.2	39.5	31.8	22.3	32.9	29.0	33.0	31.9	30.2	29.8	38.4	48.9	48.9	33.8	69.3	42.4	37.9	42.0	39.0	34.6	27.3
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5"	O75356	14	73958010-74019399	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.0;kidney: 43.1;liver: 71.4"	"Cell line enhanced"	"Detected in all"		"RT4: 33.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 15.0;eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced		Approved	Cytosol	"Secreted to blood"		5000000	Cytosol		"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	3.0	3.6	2.8	9.4	3.8	1.7	3.5	3.0	4.0	2.4	25.8	5.8	3.1	19.3	3.0	2.7	4.5	2.4	6.6	2.6	2.8	2.3	43.1	71.4	2.3	1.3	3.5	2.3	3.3	5.9	1.8	2.7	2.2	5.5	10.2	29.6	3.2	4.7	1.5	3.8	2.7	52.0	3.9	5.5	3.2	11.8	4.5	2.5	2.1	2.7	3.0	3.3	9.5	3.0	1.6	1.6	15.0	2.1	0.6	2.5	1.2	5.3	4.3	4.9	9.1	9.8	9.3	5.7	5.6	4.6	3.7	4.3	3.3	6.4	6.0	2.8	7.6	6.3	4.9	8.1	4.2	5.1	2.3	4.5	3.2	17.8	9.5	2.7	5.3	7.6	8.2	5.3	11.0	7.5	5.0	9.3	5.5	7.6	3.0	3.3	1.5	9.4	3.5	4.7	2.9	6.6	33.8	3.5	3.7	9.5	7.5	5.4	10.9	2.4	6.2	7.6	7.9	4.5	4.1	6.0	9.4	4.9	4.8	5.0	6.8	15.0	1.2	8.3	2.5	2.1	1.3	1.3	1.3	1.7	1.6	1.6	2.1	2.1	0.2	0.6	1.3	0.8	1.4	1.2	2.8	3.8	3.0	4.0	2.8	2.3	3.5	2.3	5.5	2.5
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 48.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.0;RPMI-8226: 8.7;T-47d: 4.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favourable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.4	0.0	0.4	2.6	0.4	0.0	0.4	0.4	0.4	0.4	19.2	0.4	0.4	18.5	0.4	0.4	0.4	0.3	2.2	0.4	0.5	0.0	2.1	9.8	0.8	0.4	0.4	0.4	0.4	1.8	0.0	4.2	0.5	0.4	0.4	7.5	0.8	4.1	0.4	0.4	0.0	48.1	0.4	0.4	0.4	6.1	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.0	9.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.5	0.2	0.0	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.6	0.0	0.2	0.1	0.4	0.0	0.0	8.7	1.4	0.0	0.3	0.9	0.2	0.0	0.1	4.7	0.2	0.1	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.5	0.0	0.4	0.4	0.4	0.4
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975214-69013961	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavourable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	14.9	5.8	3.4	10.1	4.4	3.0	11.9	2.5	4.8	16.8	12.1	4.4	10.2	4.8	23.3	10.4	15.1	11.4	18.1	18.2	3.9	3.6	6.6	5.5	15.8	9.6	4.2	5.0	12.7	7.8	3.9	5.5	15.2	5.1	18.9	5.8	8.7	14.0	24.0	28.0	6.1	7.7	29.4	4.9	10.2	10.1	7.4	2.4	8.3	5.4	14.2	7.3	27.0	9.8	1.7	3.4	5.5	2.2	3.3	9.2	1.8	8.1	2.7	5.4	6.5	7.6	14.9	3.9	11.0	13.5	7.0	9.3	3.7	4.6	0.4	1.7	11.9	2.7	3.7	14.3	8.8	26.3	2.6	8.4	6.2	5.2	8.4	4.7	3.5	12.4	12.2	9.0	11.5	38.4	2.3	5.0	23.4	2.1	0.7	1.5	6.2	1.3	0.3	5.6	3.5	6.0	18.7	0.5	3.0	12.6	1.0	10.0	2.8	6.5	20.3	19.7	6.0	2.2	10.6	2.5	8.3	4.0	7.8	7.3	11.0	5.5	2.2	0.0	3.0	1.9	3.5	1.7	4.8	6.4	3.4	1.2	4.1	4.1	0.3	3.3	0.7	0.6	9.2	1.8	3.4	4.4	2.5	4.8	3.9	3.6	4.2	5.0	5.1	2.4
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386703	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 200.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.9;HHSteC: 57.5;RT4: 56.9;TIME: 56.7;U-138 MG: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 14.9;eosinophil: 7.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA031200: , HPA069697: "	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favourable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	71.2	14.2	12.5	17.1	15.7	0.8	101.7	5.3	13.9	24.9	20.9	8.9	11.3	12.0	28.8	13.0	21.6	24.8	35.2	40.0	12.8	11.0	35.2	31.2	200.8	27.2	14.3	11.1	20.2	15.5	18.1	9.4	119.6	18.4	20.7	11.5	41.2	13.3	18.7	25.2	13.0	15.6	19.2	12.5	20.5	12.8	13.8	8.0	1.1	43.8	15.2	10.3	32.2	39.3	0.0	0.0	14.9	0.1	0.7	0.1	0.1	5.2	5.6	0.3	0.4	27.0	17.4	45.9	16.6	45.2	9.5	10.4	0.9	0.9	0.0	4.1	31.5	2.5	0.1	13.3	7.1	0.1	0.2	0.0	1.8	11.7	57.5	0.0	3.4	25.5	18.3	18.6	13.1	32.7	0.5	0.0	5.8	4.5	0.1	0.1	0.2	3.1	0.1	0.6	1.7	5.9	56.9	0.2	11.8	13.0	29.9	3.6	2.0	2.3	56.7	49.3	1.4	6.5	1.3	0.0	0.0	0.0	36.0	0.9	1.2	14.9	0.1	7.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	12.5	15.7	5.3	12.6	12.8	11.0	14.3	11.1	18.4	8.0
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell line enhanced"	"Detected in many"		"HEL: 39.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"			3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: , HPA028096: , HPA028412: , HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavourable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.3	1.7	18.3	8.6	1.5	0.2	6.1	1.8	2.8	2.3	2.9	4.9	8.8	13.6	4.9	2.5	3.3	22.8	1.7	2.5	24.5	7.0	39.0	5.5	7.9	2.8	13.2	26.0	0.5	5.4	2.2	3.9	4.0	36.7	10.8	0.0	2.5	21.4	8.6	19.2	2.8	32.9	8.0	19.5	2.2	9.3	24.7	18.3	5.7	5.4	12.4	4.1	5.1	0.3	0.1	3.8	3.6	3.8	16.3	21.1	24.3	3.5	13.6	2.0	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9
EPB41L4B	EHM2	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171975-109320964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.1;pancreas: 59.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.4;hTCEpi: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavourable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	6.5	4.2	7.3	1.2	14.6	0.0	4.8	4.9	11.4	1.1	18.4	1.5	7.1	15.1	0.7	5.9	0.7	3.2	1.8	3.5	2.9	3.5	1.9	28.1	1.7	0.2	1.6	6.8	4.7	59.8	3.3	0.9	1.1	2.7	2.2	18.7	2.4	8.0	3.5	2.2	5.6	16.1	0.3	2.2	0.2	9.4	2.7	1.3	0.4	14.6	1.3	1.2	1.2	1.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	4.5	5.7	0.4	0.4	0.4	0.0	17.4	0.6	0.2	2.0	1.0	9.8	4.5	0.0	1.2	0.5	7.5	11.6	6.1	2.1	4.8	2.7	0.0	1.8	13.9	1.2	0.2	0.0	0.1	27.3	0.8	9.4	0.1	0.1	0.0	2.8	11.6	0.2	0.1	7.5	8.5	0.0	0.0	0.3	7.0	6.9	7.2	0.7	1.8	12.1	0.0	2.8	0.0	0.2	4.1	4.2	1.3	1.6	0.0	0.0	0.0	3.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.6	4.9	11.4	2.9	3.5	1.6	6.8	2.7	1.3
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 54.8;placenta: 16.1"	"Cell line enriched"	"Detected in single"	92	"HEL: 42.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol			7500000	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	7.5	0.4	0.4	0.4	0.9	54.8	1.3	4.3	1.0	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.6	1.9	0.4	0.9	0.5	0.9	5.5	0.3	0.5	0.3	0.8	0.3	0.3	0.3	16.1	0.7	0.5	0.3	0.3	0.3	0.3	1.3	1.1	1.0	0.3	0.3	5.3	0.5	2.4	0.3	0.5	1.2	0.3	0.5	1.6	4.5	0.0	0.3	0.2	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	4.2	0.4	0.9	4.3	1.0	0.4	0.9	0.5	0.3	0.7	0.3
EPGN	"ALGV3072, EPG, epigen, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308473-74315307	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 14.3;esophagus: 39.6;tongue: 25.7"	"Group enriched"	"Detected in some"	6	"hTCEpi: 61.2;U-2197: 27.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"			"Nucleoplasm, Cytosol"	Vesicles	"HPA014420: AB_10601551"	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavourable (2.40e-4)"	1.1	0.0	0.0	1.3	0.0	0.1	1.0	0.0	0.0	7.9	0.3	0.0	1.0	0.0	0.0	14.3	39.6	1.2	0.3	0.6	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.0	1.0	0.0	1.7	0.0	0.3	0.0	0.0	2.5	2.8	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	25.7	5.4	0.6	6.5	0.4	0.1	0.0	0.6	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	1.1	0.0	1.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.1	0.0	61.2	1.0	4.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.2	1.1	0.0	0.1	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Cell line enriched"	"Detected in some"	6	"AF22: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.8	0.0	0.0	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 74.7"	"Group enriched"	"Detected in some"	4	"HDLM-2: 33.9;HMC-1: 20.1;RPTEC TERT1: 9.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 74.7"	"Group enriched"	"Detected in some"	33	"neutrophil: 15.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 15.4;granulocytes: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: "	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	2.0	1.5	9.0	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2.0	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1.0	3.3	2.8	7.0	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6.0	1.7	1.7	6.0	3.4	1.3	16.7	6.0	0.0	11.6	2.9	3.3	4.5	2.6	0.0	15.4	15.9	0.0	0.0	0.4	0.1	0.0	0.0	4.7	0.0	0.1	0.0	0.1	3.5	0.0	0.2	0.0	0.0	0.0	0.6	1.0	1.8	0.0	3.1	0.0	0.6	33.9	0.4	2.5	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	0.1	0.1	0.1	1.3	0.0	0.0	0.5	0.1	9.2	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.6	2.0	0.3	4.2	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	15.4	0.0	0.1	9.0	16.6	74.7	19.0	9.4	5.3	2.8	7.0	7.1	6.0
EPHX2		ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490779-27545564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.9;liver: 87.6"	"Cell line enhanced"	"Detected in many"		"K-562: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 39.2"	"Lineage enriched"	"Detected in many"	24	"T-cells: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Approved		Enhanced	Cytosol			720000	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favourable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favourable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	4.8	25.1	4.8	14.3	6.0	0.4	8.3	5.6	3.3	7.6	56.2	6.1	21.8	29.8	10.3	15.1	15.2	11.3	9.4	7.8	4.1	4.8	44.2	87.6	4.6	5.0	5.8	3.2	11.4	25.3	11.6	14.6	2.9	10.5	17.9	15.6	13.3	18.0	22.7	8.5	11.5	83.9	13.1	4.5	3.5	6.7	5.4	3.9	45.7	7.5	13.2	11.7	7.0	7.4	1.6	0.0	0.0	0.0	1.4	39.2	7.6	8.4	5.7	3.6	4.7	0.2	0.0	2.7	0.7	0.5	0.4	0.1	4.5	5.8	0.0	3.4	2.1	6.1	0.6	1.4	0.3	0.0	2.7	12.5	0.6	13.7	2.0	0.0	2.6	5.1	6.2	0.0	0.7	0.3	28.2	0.1	0.0	2.6	8.1	0.3	5.8	9.9	0.0	0.0	0.2	5.1	1.2	3.0	9.4	6.9	8.2	8.2	12.5	2.3	0.1	0.0	2.3	1.0	0.1	7.3	5.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.9	0.0	4.0	1.6	12.5	4.5	0.0	0.9	39.2	18.0	0.0	1.4	0.0	0.0	9.4	7.6	4.8	6.0	5.6	3.3	4.1	4.8	5.8	3.2	10.5	3.9
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB009729, HPA061136"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB009729: AB_2277865, HPA061136: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	26.7	23.4	34.2	20.6	31.4	15.7	31.4	26.3	47.1	13.5	32.7	17.2	18.1	67.7	13.7	19.8	21.3	15.4	28.2	56.0	28.0	18.6	23.1	36.0	16.5	25.5	17.5	25.9	23.2	54.5	12.1	14.3	15.0	15.8	19.3	13.8	13.5	24.8	22.7	84.7	22.2	59.7	12.2	14.3	26.9	55.1	20.2	13.1	11.2	15.3	26.3	14.6	13.1	16.2	2.2	3.6	4.6	6.9	0.7	2.0	2.4	24.6	34.1	8.5	17.4	9.8	9.4	17.5	18.4	10.5	13.1	13.1	14.2	15.6	15.2	12.5	14.7	18.9	7.4	14.0	4.7	5.2	70.5	11.1	18.2	16.8	13.6	7.1	10.7	12.2	12.4	11.3	8.2	12.5	16.5	12.9	8.6	13.9	11.3	11.7	19.5	48.2	7.6	11.6	26.6	9.9	14.6	12.3	29.9	17.0	18.5	12.1	13.9	25.0	20.8	36.5	17.6	13.1	26.5	14.2	12.9	10.9	26.8	14.4	18.0	2.4	3.5	4.4	1.4	4.5	1.0	2.2	1.4	1.3	2.4	2.0	1.4	1.3	4.6	0.7	6.9	3.6	2.0	2.4	34.2	31.4	26.3	47.1	28.0	18.6	17.5	25.9	15.8	13.1
EPOP	"C17orf96, LOC100170841, PRR28"	ENSG00000273604	"Elongin BC and polycomb repressive complex 2 associated protein"	A6NHQ4	17	38671703-38675421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.7;Hep G2: 18.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055190, HPA056555"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA055190: , HPA056555: "	"unprognostic (9.08e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.78e-10)"	"unprognostic (8.97e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	1.2	2.0	2.5	1.5	5.1	0.4	1.1	0.0	13.5	0.3	0.2	0.0	2.5	0.2	0.7	0.7	0.7	0.4	0.8	0.4	1.1		0.3	3.4	0.4	2.4	0.3	3.2	0.1	3.6	3.0	0.0	1.2	0.4	0.7	0.3	0.2	0.5	1.2	0.1	1.0	0.2	0.5	0.8	0.6	0.5	5.8	0.8	1.7	0.1	1.1	3.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	2.9	3.4	2.2	15.7	0.5	0.1	3.8	0.6	0.2	0.6	1.1	3.4	1.1	5.5	3.8	0.4	2.3	7.3	1.5	1.2	5.7	5.6	1.2	0.6	18.0	1.0	0.6	3.0	0.3	2.6	0.7	1.5	0.5	3.7	8.5	0.4	4.6	4.9	1.6	0.5	3.1	11.8	1.3	12.0	0.4	0.7	3.4	5.3	1.9	2.6	0.6	3.7	2.3	0.8	0.6	0.7	0.7	0.6	4.5	4.9	7.0	1.3	8.1	2.3	0.0	0.0	0.0	0.4	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
EPRS	"EARS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase"	P07814	1	219968601-220046658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol			29000	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavourable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (2.62e-4)"	25.0	20.4	16.8	18.6	22.2	13.2	20.6	24.2	26.3	19.3	20.4	15.4	13.6	15.8	17.8	15.3	25.2	15.9	11.9	20.1	15.9	18.0	23.3	31.6	17.4	20.8	21.7	16.1	21.3	32.7	47.1	38.6	15.7	34.9	14.3	23.2	9.4	64.0	16.3	42.9	19.6	23.3	18.9	24.7	22.3	20.1	13.2	20.8	28.0	25.1	25.7	23.4	18.3	16.3	14.7	15.4	6.4	16.6	14.2	19.8	10.7	30.1	19.2	13.9	37.9	29.6	32.8	34.8	39.4	27.6	25.7	28.8	22.7	24.3	57.8	22.0	41.5	32.2	34.8	31.8	34.6	28.3	22.1	31.4	25.9	19.3	32.3	52.1	26.9	23.6	40.8	32.7	41.0	28.0	54.0	45.6	25.0	14.8	22.3	12.7	26.8	39.7	23.7	24.5	56.5	23.5	13.2	33.1	26.0	23.0	38.2	40.2	35.3	56.9	24.9	12.2	22.6	37.5	36.7	30.9	35.1	48.9	28.3	37.5	38.7	4.2	11.9	6.4	14.0	16.6	19.8	14.7	14.1	15.6	15.4	11.5	15.9	16.3	0.4	14.2	13.7	5.0	13.5	10.7	16.8	22.2	24.2	26.3	15.9	18.0	21.7	16.1	34.9	20.8
EPS15	"AF-1P, MLLT5"	ENSG00000085832	"Epidermal growth factor receptor pathway substrate 15"	P42566	1	51354263-51519328	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008451, CAB010164, HPA061431"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"		67000	"Vesicles, Cytosol"		"CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: "	"unprognostic (1.45e-2)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (1.05e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	39.0	26.9	35.5	25.3	27.8	13.2	19.3	22.2	41.0	25.7	16.7	35.7	16.2	11.4	21.8	21.3	19.6	14.1	19.3	18.9	40.7	26.0	21.0	19.1	24.4	30.7	36.2	11.2	22.4	10.9	17.0	14.6	22.8	20.3	22.5	15.5	25.7	24.3	16.4	30.9	18.1	19.3	18.2	36.8	33.8	15.2	32.4	33.1	25.0	20.3	23.4	32.1	25.3	17.0	16.1	10.8	14.9	12.2	10.7	18.7	8.0	14.7	4.4	9.6	9.0	22.2	22.2	23.9	10.3	16.4	8.5	12.6	6.0	8.2	30.2	10.7	16.2	14.1	12.4	9.9	12.9	34.1	7.8	26.9	7.6	7.2	20.9	15.2	24.8	18.0	9.2	14.8	20.2	15.8	16.6	13.8	12.9	7.2	12.2	8.3	13.1	7.2	10.0	14.5	6.6	11.2	18.4	6.6	9.2	12.3	21.9	17.9	8.9	10.8	21.8	7.9	8.5	15.8	8.6	16.5	16.7	20.4	11.7	17.3	6.9	14.9	10.1	11.6	10.1	10.7	15.3	16.1	12.2	15.6	10.8	10.0	7.3	10.5	7.8	10.7	12.2	7.1	18.7	8.0	35.5	27.8	22.2	41.0	40.7	26.0	36.2	11.2	20.3	33.1
EPS8L1	"DRC3, FLJ20258, MGC23164, MGC4642"	ENSG00000131037	"EPS8 like 1"	Q8TE68	19	55072020-55087923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.9;placenta: 45.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.1;BEWO: 31.9;SK-BR-3: 9.8;T-47d: 15.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041851, HPA043545"	Uncertain		Supported	Cytosol				Cytosol		"HPA041851: , HPA043545: "	"unprognostic (1.91e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (7.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.63e-1)"	1.2	0.0	0.2	2.1	0.3	0.0	1.7	0.3	0.4	7.6	2.1	0.2	1.5	2.0	1.3	1.8	40.9	6.2	6.9	0.2	0.2	0.0	4.1	0.2	1.8	0.2	0.2	0.2	1.6	4.0	1.1	1.1	45.0	0.3	2.9	0.5	0.3	6.6	2.5	0.4	18.7	1.5	0.7	0.2	0.4	23.2	0.9	0.2	1.0	6.2	12.1	16.9	1.9	12.1	0.1	3.5	5.1	0.4	1.7	0.8	0.5	9.1	0.4	0.3	0.2	0.0	0.0	31.9	0.8	0.0	0.0	0.0	2.9	7.6	0.1	1.9	0.0	4.6	0.2	0.5	0.0	0.2	0.9	0.7	0.3	0.2	0.1	1.4	6.4	0.0	1.4	0.0	0.0	0.0	3.4	0.0	0.0	4.2	0.5	1.4	0.5	0.0	0.1	0.0	3.0	0.7	0.7	0.1	2.3	0.6	9.8	0.4	15.5	1.8	0.7	0.0	0.4	0.0	0.0	1.4	1.7	0.9	2.0	0.5	1.2	2.6	0.4	5.1	0.8	0.1	0.7	0.0	0.4	0.8	0.0	0.1	0.1	0.0	0.0	1.7	0.0	3.5	0.7	0.5	0.2	0.3	0.3	0.4	0.2	0.0	0.2	0.2	0.3	0.2
EPS8L2	"FLJ21935, FLJ22171, MGC3088"	ENSG00000177106	"EPS8 like 2"	Q9H6S3	11	694438-727727	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 73.3"	"Cell line enhanced"	"Detected in many"		"A-431: 45.8;BEWO: 45.3;CAPAN-2: 43.2;SK-BR-3: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 6.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 13.6"	HPA041143	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041143: AB_10794985"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.03e-2)"	1.7	3.0	2.0	6.4	3.3	0.0	12.4	6.9	2.5	11.6	31.5	1.2	23.9	38.7	4.6	10.1	53.3	5.3	21.7	1.0	1.3	1.6	30.4	38.3	18.0	0.4	1.7	0.5	3.9	11.6	1.8	4.3	39.6	3.6	8.4	6.0	2.7	26.2	17.6	0.7	22.8	73.3	2.4	2.4	0.5	18.0	7.2	1.5	0.9	29.5	29.4	33.7	6.9	19.2	0.2	6.4	0.7	0.1	0.1	0.1	0.1	45.8	14.0	0.0	0.3	0.5	3.1	45.3	4.0	4.2	6.0	2.6	10.5	43.2	0.1	16.8	4.3	24.3	0.1	24.3	1.4	0.1	0.9	0.0	5.2	18.8	3.4	0.0	0.0	1.6	16.3	1.7	4.2	0.0	0.3	0.2	0.6	14.7	0.1	0.2	0.5	4.5	0.1	0.1	0.3	21.2	11.4	0.1	0.1	14.3	53.0	0.1	20.0	0.0	0.3	2.4	5.7	1.5	0.3	0.1	0.2	0.1	1.3	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	6.4	0.0	0.1	2.0	3.3	6.9	2.5	1.3	1.6	1.7	0.5	3.6	1.5
ERAL1	HERA-B	ENSG00000132591	"Era like 12S mitochondrial rRNA chaperone 1"	O75616	17	28854938-28861067	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021425, HPA024423"	Supported		Enhanced	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA021425: AB_1848228, HPA024423: AB_1848229"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.37e-3)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (8.20e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.79e-2)"	16.2	24.8	24.1	13.3	31.6	12.7	19.4	25.1	47.9	18.4	20.9	27.1	15.8	18.0	21.5	19.2	20.6	22.2	17.2	24.5	23.0	22.0	24.9	33.7	14.8	16.0	21.3	20.2	22.0	18.1	29.3	15.4	24.7	27.6	18.0	23.4	17.3	28.2	21.2	34.1	18.3	19.7	21.8	18.4	17.0	18.2	17.3	15.5	20.4	20.3	21.5	23.8	16.1	14.8	20.1	29.0	11.1	23.1	20.8	18.2	14.9	15.9	31.1	18.2	20.6	20.1	13.8	17.8	12.8	18.3	38.9	32.0	30.3	10.3	20.6	15.6	22.0	17.8	33.3	29.2	32.5	20.3	39.0	16.5	20.7	30.6	25.8	19.6	15.1	18.0	26.0	31.5	29.9	31.7	32.8	13.0	21.6	25.1	20.4	30.4	16.8	14.9	18.9	28.9	26.6	23.5	18.2	19.4	15.6	20.9	51.5	16.5	36.2	23.1	12.7	15.9	17.9	17.5	26.9	10.5	19.0	22.0	17.2	17.2	16.1	11.1	17.9	7.1	17.8	23.1	13.4	20.1	15.2	13.0	29.0	18.6	17.6	18.2	1.4	20.8	15.6	15.0	16.3	14.9	24.1	31.6	25.1	47.9	23.0	22.0	21.3	20.2	27.6	15.5
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		27000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: "	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	23.8	13.6	9.3	22.7	11.9	11.6	23.3	14.2	14.6	14.5	23.8	10.1	11.2	30.8	14.7	13.4	12.3	14.3	19.9	16.1	9.7	6.8	13.3	23.7	17.8	16.4	13.5	7.6	15.5	16.5	11.1	39.4	28.2	11.4	13.4	21.9	8.5	13.9	15.2	23.1	17.7	39.7	10.6	17.1	19.5	16.5	5.4	13.8	55.5	13.5	9.8	17.8	15.9	14.1	14.9	15.2	19.8	17.5	19.8	21.8	10.7	7.3	4.7	6.3	5.9	35.0	34.3	18.4	5.4	17.5	13.1	23.0	5.9	26.7	22.0	11.3	10.4	7.6	5.2	11.1	8.2	39.8	2.2	7.1	3.1	4.0	40.1	3.4	13.2	14.2	4.8	15.0	4.6	18.0	3.7	21.4	7.8	3.4	31.6	3.5	3.1	3.0	23.5	8.6	10.9	9.8	11.4	2.3	1.6	8.6	5.8	8.4	5.1	16.4	14.3	11.3	3.8	1.9	8.9	8.0	15.0	17.1	12.1	11.6	6.6	19.8	13.2	15.6	21.2	11.4	19.7	13.0	18.5	18.2	9.5	14.9	21.8	17.4	14.4	19.8	17.5	15.2	12.3	10.7	9.3	11.9	14.2	14.6	9.7	6.8	13.5	7.6	11.4	13.8
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	27	"SK-BR-3: 263.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.8"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Supported	"Plasma membrane,Cytosol"			430000	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: , HPA001060: , HPA001338: , HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavourable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favourable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	5.8	2.4	5.2	10.4	7.0	0.1	20.1	4.2	7.0	19.1	46.5	9.1	55.2	21.6	14.9	18.7	40.9	22.7	26.6	24.8	6.3	3.1	37.5	21.5	17.6	3.7	5.1	5.6	19.3	16.2	27.7	8.1	60.8	7.5	23.6	16.6	15.9	28.7	58.1	8.9	35.3	47.2	10.9	4.5	4.0	17.1	6.5	3.7	2.8	35.7	20.8	22.9	19.7	20.3	1.3	0.3	2.1	0.4	0.9	8.8	2.2	3.1	3.8	4.2	2.7	5.1	3.6	5.7	2.2	3.7	4.9	4.2	2.8	8.6	0.2	4.6	5.1	9.8	0.2	5.1	2.3	0.4	3.2	0.1	3.0	4.5	3.0	0.0	0.0	3.5	4.8	3.0	1.8	2.0	0.4	0.1	3.6	4.8	0.5	0.2	7.6	0.9	0.3	1.7	0.4	5.0	9.8	0.8	0.2	4.2	263.9	1.3	7.4	0.1	0.2	2.5	3.3	3.2	1.4	0.4	0.2	0.2	0.2	0.0	8.2	1.6	0.4	0.8	8.8	0.3	0.7	0.9	0.5	2.5	0.3	1.3	1.0	2.5	2.1	0.9	0.2	0.2	0.4	2.2	5.2	7.0	4.2	7.0	6.3	3.1	5.1	5.6	7.5	3.7
ERC1	"CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2"	ENSG00000082805	"ELKS/RAB6-interacting/CAST family member 1"	Q8IUD2	12	990509-1495933	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019513, HPA019523, HPA024130"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavourable (7.01e-4)"	12.6	11.4	10.3	12.5	14.7	7.4	15.1	41.7	10.4	11.2	11.9	8.5	9.2	4.3	17.1	11.0	13.7	9.8	9.9	14.7	10.0	11.2	11.2	8.0	8.8	5.4	9.0	6.4	12.5	8.6	24.3	19.4	13.2	10.7	11.4	7.5	10.1	9.3	14.4	9.2	9.9	6.4	22.1	8.5	7.3	8.6	11.0	9.9	9.8	15.3	7.2	8.6	15.7	15.3	8.6	2.9	2.1	3.8	1.1	3.5	0.5	2.9	7.3	3.9	2.6	10.4	8.8	5.4	9.2	7.4	6.3	5.8	6.4	3.6	4.5	1.3	11.9	5.0	8.3	7.1	8.8	9.5	4.2	11.1	7.3	3.2	7.9	5.7	2.6	7.1	6.2	11.1	20.8	8.1	3.3	9.0	4.7	3.2	1.8	1.2	6.2	3.5	3.6	14.8	1.4	6.2	5.3	2.3	4.6	14.4	3.3	5.2	3.4	2.4	15.0	10.9	11.1	8.0	8.6	2.4	4.5	6.7	7.1	3.4	4.8	1.4	2.8	2.1	1.6	1.0	2.2	8.6	2.4	2.4	2.4	5.6	3.5	2.6	2.1	1.1	3.8	2.9	2.2	0.5	10.3	14.7	41.7	10.4	10.0	11.2	9.0	6.4	10.7	9.9
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: , HPA069266: "	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	7.4	15.6	11.4	10.6	17.7	6.7	7.1	9.5	23.8	9.4	8.1	11.7	7.8	7.9	11.7	6.0	6.7	10.0	10.1	7.9	9.4	9.1	8.7	13.2	6.5	9.9	8.2	10.5	9.5	13.1	12.9	10.9	7.2	14.0	8.2	6.4	12.5	9.5	11.8	15.9	10.7	7.1	11.2	5.3	9.7	8.3	17.2	7.8	10.8	10.2	5.1	8.3	9.3	6.6	7.8	17.2	5.0	13.9	11.3	9.8	8.7	12.3	6.0	12.6	17.7	7.5	8.9	6.7	17.6	12.1	22.8	17.5	14.0	8.5	4.4	10.1	17.1	6.4	8.8	14.8	8.7	10.6	14.5	7.5	11.5	14.7	15.9	11.9	13.3	10.2	2.3	26.0	14.8	13.2	18.2	5.0	15.7	6.0	7.0	7.9	5.8	10.6	13.5	8.9	3.7	6.5	10.9	7.4	8.0	15.6	11.1	6.2	10.5	15.8	17.1	21.8	11.9	9.2	39.1	11.6	6.7	6.4	6.4	7.3	9.6	0.0	13.3	5.0	7.7	13.9	9.8	7.8	7.4	7.4	17.2	5.8	7.1	7.4	0.4	11.3	10.9	8.3	7.4	8.7	11.4	17.7	9.5	23.8	9.4	9.1	8.2	10.5	14.0	7.8
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239047	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 5.3"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: "	"prognostic unfavourable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.4	0.5	0.2	3.1	0.2	6.0	3.0	0.9	0.8	1.5	2.2	0.2	0.2	1.5	0.9	0.8	4.6	0.6	1.0	0.2	0.2	0.3	0.5	0.5	0.8	4.7	0.7	0.2	1.2	0.5	0.0	0.6	0.9	0.9	0.7	2.5	0.2	1.1	0.2	2.6	1.3	2.1	0.5	1.3	4.0	1.5	2.0	0.2	13.1	0.5	2.8	5.6	0.7	1.6	0.5	0.3	0.5	0.2	5.3	1.1	0.4	10.9	9.6	8.9	5.6	0.6	1.1	4.9	11.8	5.4	10.4	10.9	7.8	6.9	17.8	4.5	4.2	9.1	16.6	8.8	18.5	10.1	12.1	6.1	3.3	4.6	0.0	11.9	8.6	0.1	0.5	14.4	2.7	5.7	8.0	4.4	10.5	8.6	11.3	7.0	16.1	14.9	9.5	15.9	3.1	2.6	6.8	7.3	5.2	8.7	5.9	2.2	4.5	2.6	3.5	7.0	11.3	13.2	7.7	3.4	5.3	15.3	4.9	8.3	7.0	0.0	0.2	0.5	0.1	0.1	0.6	0.2	0.5	0.1	0.1	0.5	0.4	1.1	0.3	5.3	0.2	0.3	1.1	0.4	0.2	0.2	0.9	0.8	0.2	0.3	0.7	0.2	0.9	0.2
ERCC6L2	"C9orf102, FLJ37706, RAD26L"	ENSG00000182150	"ERCC excision repair 6 like 2"	Q5T890	9	95875701-96014571	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021260, HPA022422"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021260: AB_1859544, HPA022422: "	"unprognostic (6.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (8.70e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.39e-2)"	13.5	13.9	14.6	12.7	17.4	7.6	13.6	21.8	19.3	17.7	12.9	13.2	13.9	10.4	18.7	11.8	11.6	11.4	11.8	13.3	14.0	9.7	12.4	11.7	12.7	15.0	15.3	12.2	21.7	10.6	26.2	22.0	11.7	16.1	15.5	11.5	11.0	11.2	12.7	13.9	10.1	13.5	16.1	12.1	15.8	13.4	12.5	15.4	29.7	20.3	7.1	12.4	17.4	13.8	7.3	12.7	4.3	5.3	5.1	12.9	4.0	11.3	14.3	17.0	12.2	6.7	11.4	8.2	10.1	10.3	10.2	11.7	11.0	5.0	12.8	5.6	14.3	14.0	16.4	7.0	15.2	9.1	7.9	11.5	10.9	7.1	6.5	14.6	11.5	10.1	7.2	12.6	10.0	9.5	14.9	7.2	10.6	9.1	12.2	5.5	12.7	8.7	11.4	22.2	4.5	8.7	10.3	15.9	12.2	7.1	7.4	7.2	7.0	7.6	10.1	11.5	14.7	14.2	11.9	4.8	7.3	6.2	11.1	7.0	16.6	3.2	4.4	4.3	8.7	5.3	8.4	5.7	8.3	9.3	4.8	7.3	12.9	9.4	2.7	5.1	4.2	12.7	9.9	4.0	14.6	17.4	21.8	19.3	14.0	9.7	15.3	12.2	16.1	15.4
ERG	"erg-3, p55"	ENSG00000157554	"ERG, ETS transcription factor"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 42.7;MOLT-4: 14.0;REH: 45.3;TIME: 34.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.7;NK-cell: 1.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018377, HPA046598"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: "	"unprognostic (2.14e-1)"	"prognostic unfavourable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"	39.1	4.2	5.7	6.5	8.5	6.6	20.5	3.6	7.0	17.9	5.2	2.3	5.6	3.3	16.9	9.0	6.2	9.2	11.6	10.1	6.2	3.6	10.8	6.0	19.9	7.4	8.0	1.8	7.7	4.8	2.3	3.9	23.2	8.0	8.1	3.6	7.8	4.2	5.6	13.5	5.3	6.2	11.8	4.7	32.5	5.0	4.8	5.0	2.4	10.8	9.1	3.6	9.6	15.8	0.0	1.7	0.0	0.2	1.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	7.0	0.0	0.0	0.3	0.0	42.7	0.0	0.0	0.0	0.3	14.0	0.0	0.1	0.0	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	34.6	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	5.7	8.5	3.6	7.0	6.2	3.6	8.0	1.8	8.0	5.0
ERG28	"C14orf1, NET51"	ENSG00000133935	"Ergosterol biosynthesis 28 homolog"	Q9UKR5	14	75649791-75661189	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043172, HPA063568"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043172: AB_10793942, HPA063568: "	"unprognostic (2.68e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.66e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.01e-2)"	"prognostic favourable (4.30e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.20e-1)"	6.4	20.0	14.2	6.3	16.3	8.1	12.6	9.2	25.5	11.8	11.7	16.3	10.5	14.9	11.3	29.6	23.7	12.4	11.8	9.4	13.6	15.5	17.6	48.3	19.3	9.4	11.9	10.4	15.0	12.4	16.5	13.2	15.6	17.9	15.5	11.2	26.2	15.4	10.6	6.6	15.6	16.9	10.5	18.2	7.1	9.5	52.2	9.6	7.5	24.3	21.3	15.6	9.2	13.5	18.1	18.2	11.8	6.0	14.2	22.0	13.9	14.1	8.0	16.2	12.6	11.0	20.5	10.0	5.8	17.9	11.3	19.4	12.3	33.9	6.0	8.5	7.2	15.7	14.3	24.6	12.9	11.2	9.5	6.5	8.1	17.3	16.0	7.1	9.7	25.6	21.3	16.1	9.0	13.1	5.7	14.8	7.7	27.8	10.8	7.9	15.7	12.9	8.7	11.0	11.9	36.9	18.4	13.9	7.7	14.6	12.5	8.6	20.9	10.5	9.4	6.2	12.4	5.9	5.7	9.6	11.3	13.0	9.9	10.4	10.4	11.8	6.0	8.9	20.1	5.9	19.8	18.1	22.0	20.9	14.2	15.3	20.2	20.1	3.2	14.2	5.9	18.2	19.4	13.9	14.2	16.3	9.2	25.5	13.6	15.5	11.9	10.4	17.9	9.6
ERH	DROER	ENSG00000100632	"ERH, mRNA splicing and mitosis factor"	P84090	14	69380123-69398627	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002567	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA002567: AB_1078749"	"unprognostic (2.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (8.61e-3)"	"prognostic unfavourable (7.89e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.39e-1)"	42.6	45.4	54.9	43.9	46.7	47.0	51.3	45.1	48.4	46.6	43.5	31.1	39.4	42.1	53.3	63.3	44.8	46.4	35.9	40.6	47.6	51.1	56.1	62.2	34.5	52.5	43.5	48.5	47.8	38.7	23.9	45.5	55.2	45.4	40.4	50.3	41.3	58.5	40.3	43.3	31.0	47.3	46.9	43.6	55.2	35.6	54.6	28.4	72.2	55.2	37.5	64.4	47.7	36.8	38.7	37.3	24.2	32.4	34.1	35.3	38.8	89.6	58.2	58.3	38.8	29.3	21.6	35.3	47.0	27.1	42.5	39.8	59.3	37.3	85.1	20.7	31.4	26.3	58.9	39.1	50.6	44.4	36.0	42.7	38.6	66.1	45.2	37.1	31.0	24.6	21.0	38.0	34.2	34.7	41.1	28.6	34.7	102.5	56.1	52.9	45.4	55.2	45.4	57.8	29.1	42.8	61.4	44.8	41.8	44.9	41.2	25.7	50.6	52.0	37.0	41.6	61.7	27.6	46.8	32.2	30.5	95.1	30.9	39.5	40.1	15.3	32.4	24.2	26.1	30.1	25.7	38.7	32.5	28.6	34.0	30.6	30.7	27.2	15.4	34.1	27.1	37.3	35.3	38.8	54.9	46.7	45.1	48.4	47.6	51.1	43.5	48.5	45.4	28.4
ERI3	"FLJ22943, PINT1, PRNPIP"	ENSG00000117419	"ERI1 exoribonuclease family member 3"	O43414	1	44221070-44355260	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027147, HPA029895"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA027147: AB_1855725, HPA029895: "	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (5.94e-2)"	"unprognostic (6.21e-2)"	"prognostic unfavourable (2.04e-6)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.70e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-3)"	12.6	15.4	30.7	8.3	32.0	12.4	15.2	19.7	43.7	15.1	13.4	23.2	10.8	12.3	14.7	22.2	13.4	23.4	12.7	21.1	28.9	25.1	25.3	15.5	11.7	10.0	23.9	26.8	18.6	15.7	24.0	17.2	13.5	22.9	16.7	14.1	14.8	14.7	16.9	35.7	13.3	8.6	17.7	17.9	9.5	10.6	24.4	21.9	9.7	17.6	11.9	11.0	12.5	12.1	18.8	25.3	9.6	22.2	14.8	18.2	15.2	28.1	21.8	27.7	30.6	18.2	22.9	17.4	18.4	24.6	32.8	30.6	14.1	30.1	20.1	31.2	22.6	16.3	24.8	31.4	23.2	22.5	47.7	22.5	36.8	19.8	26.6	22.6	12.9	23.3	29.5	24.8	34.2	22.5	21.9	16.4	21.5	18.9	25.1	21.2	32.7	34.6	24.3	25.4	29.4	25.4	14.9	47.2	22.3	20.1	27.6	32.6	18.1	18.8	13.6	21.7	22.7	23.5	27.8	15.6	18.1	21.6	26.9	19.7	27.3	9.4	16.3	9.6	16.7	22.2	18.2	18.8	14.0	16.2	25.3	18.3	16.7	17.2	1.5	14.8	21.3	18.9	18.1	15.2	30.7	32.0	19.7	43.7	28.9	25.1	23.9	26.8	22.9	21.9
ERICH1		ENSG00000104714	"Glutamate rich 1"	Q86X53	8	614746-738106	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003725	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA003725: AB_1853023"	"unprognostic (7.19e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.42e-1)"	20.2	11.7	12.3	35.7	16.9	30.5	18.1	9.0	15.6	13.6	16.0	13.9	13.7	13.1	21.7	25.6	15.3	13.7	17.1	14.7	15.1	11.4	17.6	15.3	19.4	29.3	14.5	14.0	16.9	12.2	13.8	16.1	16.9	16.9	15.4	11.7	14.0	13.5	19.4	17.2	17.0	15.8	16.2	17.0	22.2	14.9	11.8	14.0	21.8	18.2	13.3	25.0	17.1	15.3	11.7	10.2	18.5	20.9	7.2	6.2	6.0	9.1	13.2	7.1	8.4	7.6	9.3	14.7	8.8	4.7	8.0	8.9	8.4	5.9	20.9	4.2	7.4	15.4	12.9	13.5	5.7	9.0	16.8	14.6	8.5	12.0	8.6	8.9	13.7	10.7	8.8	6.1	7.9	8.7	14.9	12.1	8.0	7.6	17.1	15.8	11.2	5.9	15.5	4.6	14.3	8.9	16.9	3.2	9.1	6.4	8.3	11.7	3.4	10.7	13.9	5.9	2.8	0.3	9.3	7.9	20.6	22.6	12.1	14.3	6.2	11.4	20.9	7.2	5.4	19.0	4.8	9.7	6.2	5.3	10.2	11.7	5.3	4.7	18.5	7.2	16.8	7.8	4.4	6.0	12.3	16.9	9.0	15.6	15.1	11.4	14.5	14.0	16.9	14.0
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443158-41444765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 78.1"	"Group enriched"	"Detected in some"	12	"CACO-2: 4.7;Hep G2: 10.8;THP-1: 3.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042632: , HPA048484: "	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.2	0.2	0.3	0.0	0.6	0.2	0.3	0.4	21.0	0.2	0.2	27.1	0.4	0.4	0.2	0.4	0.5	1.3	0.2	0.0	10.0	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.9	0.0	78.1	0.2	0.3	0.2	0.1	0.8	0.2	0.2	0.3	0.2	0.2	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.2
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064311-98093610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 27.9;retina: 26.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.8;EFO-21: 5.2;HAP1: 6.3;HEK 293: 9.1;RPTEC TERT1: 6.1;RT4: 15.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 5.3"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favourable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favourable (9.38e-4)"	0.5	0.2	2.3	0.2	6.7	0.0	0.8	0.4	2.2	2.0	3.3	0.1	3.6	4.3	1.1	0.6	0.7	8.8	13.1	5.4	0.7	2.6	8.7	8.1	1.7	0.7	1.0	2.2	1.6	27.9	0.6	1.7	4.1	1.9	2.2	3.0	26.7	1.3	1.9	0.1	0.6	1.3	0.4	1.0	0.2	9.5	3.4	0.5	0.3	0.6	0.0	0.5	3.1	0.5	0.0	5.3	0.0	0.0	0.0	0.5	0.0	0.0	6.8	0.0	0.0	0.1	0.0	4.0	3.6	1.3	1.9	1.4	0.1	2.0	0.0	5.2	0.9	0.3	6.3	0.1	2.3	0.0	9.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	1.4	2.7	0.0	0.0	0.1	6.1	15.9	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	6.7	0.4	2.2	0.7	2.6	1.0	2.2	1.9	0.5
ERMAP	"BTN5, RD, SC"	ENSG00000164010	"Erythroblast membrane associated protein (Scianna blood group)"	Q96PL5	1	42817088-42844993	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA042573, HPA054672"	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA042573: AB_10794282, HPA054672: "	"unprognostic (9.46e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.48e-2)"	10.0	14.1	9.3	6.7	10.4	25.7	8.4	2.5	9.3	9.3	7.9	12.4	12.2	6.4	9.4	16.7	8.3	10.2	7.4	4.7	9.3	6.3	7.8	13.1	9.8	4.4	10.4	8.3	6.2	11.7	9.8	12.3	12.0	10.8	9.4	8.3	11.8	10.2	8.0	4.0	9.2	9.4	6.5	14.6	8.6	7.8	4.2	11.9	4.8	13.1	3.2	8.1	9.7	8.0	2.4	8.1	3.0	7.1	3.5	5.0	2.9	3.4	4.6	1.5	4.6	5.2	15.3	1.3	6.9	11.6	6.1	6.2	1.8	6.3	3.1	2.5	7.2	4.4	1.6	2.1	5.6	5.1	5.6	24.7	3.4	1.5	6.5	3.5	12.7	9.3	7.9	2.8	6.7	4.0	16.7	3.1	5.6	2.3	1.7	1.2	3.5	2.5	1.7	2.1	2.9	5.3	5.3	3.2	2.4	5.9	2.2	2.6	4.3	13.1	6.3	4.7	2.8	3.9	3.2	1.4	2.7	1.3	3.8	3.8	2.9	0.5	6.8	3.0	2.1	7.1	1.2	2.4	2.3	2.2	8.1	1.3	2.0	2.3	2.1	3.5	4.5	2.3	5.0	2.9	9.3	10.4	2.5	9.3	9.3	6.3	10.4	8.3	10.8	11.9
ERMARD	"C6orf70, dJ266L20.3, FLJ11152"	ENSG00000130023	"ER membrane associated RNA degradation"	Q5T6L9	6	169751622-169781584	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041741	Approved		Approved	Cytosol				Cytosol		"HPA041741: AB_10804116"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.31e-2)"	12.6	14.4	11.9	16.6	15.6	10.6	13.2	12.4	16.0	10.9	10.1	17.5	18.6	8.6	21.8	25.0	10.1	13.3	11.0	7.2	10.0	9.3	12.1	16.4	9.9	16.6	10.9	14.6	18.7	13.3	14.1	17.7	13.6	12.1	12.0	11.1	16.1	15.4	15.6	13.0	21.8	12.4	12.8	11.7	16.7	10.1	27.4	11.8	15.5	14.8	12.1	15.8	11.2	9.9	7.1	7.0	2.2	13.4	7.3	9.8	6.3	4.0	4.9	9.1	14.0	10.6	12.1	3.6	5.2	10.4	6.3	6.7	3.3	9.2	7.6	5.3	7.6	11.5	4.2	11.6	6.6	7.9	4.6	10.1	7.3	3.2	14.8	12.4	6.7	12.8	12.9	6.4	17.8	7.1	9.5	10.1	10.4	7.3	5.9	11.2	3.0	3.9	7.3	6.2	11.8	9.8	4.5	3.2	6.1	8.2	10.0	4.0	6.3	13.9	5.4	5.1	2.9	7.9	5.6	10.8	12.3	6.7	7.7	10.3	7.9	2.2	5.7	1.9	6.9	11.1	6.9	6.2	7.2	7.5	7.0	7.1	8.1	7.5	0.9	7.3	13.4	5.3	9.8	6.3	11.9	15.6	12.4	16.0	10.0	9.3	10.9	14.6	12.1	11.8
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318625-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 106.7"	"Cell line enriched"	"Detected in some"	6	"HAP1: 20.8"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 2.2;glioma: 9.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favourable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	1.6	1.4	29.1	2.9	50.5	9.7	1.6	2.7	106.7	1.4	1.8	52.4	0.0	1.8	1.6	1.5	1.7	1.4	1.9	1.6	40.9	21.4	1.5	1.5	2.0	3.1	75.1	18.4	1.5	1.6	1.4	0.1	1.4	54.5	1.5	1.9	4.3	2.4	1.5	1.7	1.9	1.9	1.6	100.9	2.5	2.2	1.7	69.5	0.0	1.6	0.0	2.7	1.7	0.1	1.7	1.3	3.9	1.6	2.4	2.1	0.7	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.2	0.0	1.9	0.3	20.8	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.2	2.8	0.4	0.2	0.7	2.3	0.3	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.6	0.0	0.1	0.0	0.7	1.2	0.0	0.2	0.1	0.2	0.6	3.4	1.9	0.5	1.8	0.9	1.0	2.6	1.6	1.1	2.1	1.2	1.0	0.7	0.8	0.6	0.6	1.7	1.5	1.6	3.9	2.4	1.0	1.3	0.9	0.7	29.1	50.5	2.7	27.9	40.9	21.4	75.1	18.4	54.5	69.5
ERRFI1	"GENE-33, MIG-6, RALT"	ENSG00000116285	"ERBB receptor feedback inhibitor 1"	Q9UJM3	1	8004404-8026308	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 141.1;pancreas: 133.6"	"Cell line enhanced"	"Detected in many"		"HHSteC: 93.0;LHCN-M2: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027206, HPA076543"			Enhanced	Cytosol				Cytosol		"HPA027206: AB_10600908, HPA076543: "	"unprognostic (2.13e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.03e-3)"	38.6	8.8	4.4	6.3	6.3	0.6	27.8	9.6	7.0	17.5	13.6	5.4	8.4	6.8	15.9	9.6	13.6	12.2	27.3	8.8	4.7	2.5	32.6	141.1	15.5	7.7	7.5	3.7	29.7	133.6	7.7	41.9	33.7	8.1	9.3	5.1	12.0	14.5	5.9	68.3	20.2	26.5	22.9	12.5	2.1	22.3	7.4	5.2	0.6	19.4	4.7	3.8	20.0	19.5	0.4	0.3	0.2	4.9	0.0	1.3	0.2	13.2	7.8	3.3	4.5	32.0	23.9	35.1	13.0	3.8	2.4	2.8	3.4	35.0	0.2	7.8	4.3	2.8	0.9	23.0	11.2	0.4	2.5	0.2	2.3	40.4	93.0	0.1	0.5	32.5	23.2	8.0	19.5	6.1	0.9	0.1	71.0	5.7	0.0	0.8	8.0	19.5	1.1	37.9	0.2	11.2	4.2	2.3	1.3	2.5	5.9	4.0	4.0	0.3	8.6	9.4	5.5	7.9	18.3	0.2	0.1	0.2	36.4	0.6	8.7	0.0	0.4	0.0	1.3	0.1	0.2	0.3	1.2	1.3	0.2	0.4	0.9	1.2	0.2	0.0	4.9	0.3	0.6	0.2	4.4	6.3	9.6	7.0	4.7	2.5	7.5	3.7	8.1	5.2
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751640	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 32.0;placenta: 26.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 27.6;hTCEpi: 19.9;RPTEC TERT1: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"		5000000	Nucleoplasm	Cytosol	"HPA011423: , HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.3	1.3	1.2	0.4	0.7	0.2	2.8	0.5	3.0	1.3	0.5	0.0	1.4	0.5	0.9	1.3	3.7	0.7	0.4	6.2	0.8	1.0	4.4	0.3	1.8	1.9	0.6	0.2	3.9	1.7	32.0	0.2	26.9	0.8	0.7	0.7	0.8	1.3	3.0	0.2	1.0	0.5	0.4	1.5	1.9	1.1	1.7	0.3	0.0	2.5	3.7	1.2	1.0	1.8	0.6	0.4	1.2	0.1	0.4	0.3	0.0	4.4	0.2	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	27.6	5.9	0.0	0.6	0.1	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	1.3	19.9	0.0	2.9	0.0	1.5	0.0	0.1	0.3	0.0	0.0	1.8	0.8	0.0	0.0	0.0	14.7	0.4	1.2	0.2	1.8	0.8	0.0	2.4	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.1	0.5	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.3	0.2	1.1	0.4	0.1	0.4	0.2	0.0	1.2	0.7	0.5	3.0	0.8	1.0	0.6	0.2	0.8	0.3
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797232	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Golgi apparatus,Cytosol"			16000000	"Golgi apparatus"	Cytosol	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	58.5	30.9	32.0	28.6	29.8	24.2	44.5	23.7	32.0	54.4	37.3	29.0	34.2	31.8	53.2	50.4	54.1	40.6	30.3	45.6	30.7	29.3	58.8	82.2	28.2	31.4	31.7	32.1	61.3	24.9	27.5	47.5	26.4	28.6	55.2	41.7	32.5	31.5	45.2	47.4	29.7	38.4	50.8	37.4	31.1	32.1	32.4	26.7	65.5	78.9	50.9	31.7	62.5	36.9	30.1	48.7	15.1	37.1	29.8	35.7	26.4	21.8	12.7	38.6	26.5	45.3	74.8	10.3	31.5	45.7	43.9	34.2	21.5	26.8	24.9	9.5	37.7	22.4	42.4	37.2	56.2	28.4	44.0	32.1	12.8	33.1	37.1	62.8	13.8	51.1	34.6	28.3	38.1	41.1	31.4	6.7	72.6	21.4	55.6	41.7	10.0	24.2	44.3	22.7	16.8	62.3	8.9	19.1	21.7	14.0	11.9	25.2	22.9	36.0	27.4	16.2	19.1	31.0	29.0	4.6	9.7	21.5	35.0	36.0	21.6	7.7	37.1	15.1	15.0	31.5	24.6	30.1	30.0	23.0	40.8	25.3	35.7	27.9	4.3	29.8	28.0	48.7	24.9	26.4	32.0	29.8	23.7	32.0	30.7	29.3	31.7	32.1	28.6	26.7
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002132	Approved		Uncertain	Cytosol			130000	Cytosol		"HPA002132: AB_1078807"	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (2.81e-5)"	33.3	25.6	15.3	16.2	23.5	19.6	27.3	21.7	26.3	26.7	27.9	17.8	21.6	15.8	31.2	31.0	32.5	28.3	31.1	28.4	16.1	17.5	20.6	16.7	26.1	18.0	15.6	16.7	41.6	23.2	29.7	22.0	35.2	20.6	21.1	22.6	23.4	26.7	31.4	34.5	24.5	22.5	37.8	14.9	13.2	19.4	13.3	12.1	29.0	30.5	24.3	23.2	30.5	27.6	1.4	3.6	2.0	2.3	6.6	8.5	2.9	29.0	17.4	5.6	5.9	18.8	21.9	18.6	13.7	14.1	10.9	12.4	9.7	38.2	8.9	15.9	24.6	14.5	8.0	14.4	10.6	9.2	8.2	7.4	13.9	10.3	19.2	26.4	16.9	15.8	18.0	12.4	16.6	13.0	15.8	30.2	17.9	24.4	27.3	19.1	8.9	16.8	23.3	10.8	10.9	18.7	12.4	16.4	9.0	43.7	35.3	19.9	12.9	28.9	20.0	12.1	6.4	53.6	17.4	20.6	5.3	8.7	30.1	27.4	35.7	2.0	1.9	1.5	8.5	2.3	4.7	1.4	7.1	6.0	3.6	1.0	6.7	7.9	1.2	6.6	1.5	2.4	5.8	2.9	15.3	23.5	21.7	26.3	16.1	17.5	15.6	16.7	20.6	12.1
ETAA1	ETAA16	ENSG00000143971	"ETAA1, ATR kinase activator"	Q9NY74	2	67397319-67412089	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035048, HPA035049"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA035048: AB_10670300, HPA035049: AB_2674430"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.14e-2)"	9.3	23.4	6.4	11.0	11.3	6.6	14.7	14.0	10.6	15.4	11.7	6.3	9.4	7.2	14.6	13.9	12.0	13.9	15.7	9.4	8.7	5.5	17.5	11.1	11.3	14.8	9.7	10.4	15.6	16.2	14.2	13.9	8.8	10.7	11.6	9.2	6.1	12.4	13.7	11.4	12.4	11.1	10.6	8.5	11.8	10.5	11.3	10.3	19.2	15.9	9.7	9.8	11.6	12.7	7.5	4.4	3.4	5.2	4.2	7.4	3.1	9.1	7.1	12.0	10.8	9.4	13.0	9.9	9.8	13.0	10.5	10.1	5.7	11.1	17.1	5.4	8.0	11.2	10.2	11.9	15.0	10.0	8.1	9.5	17.1	8.3	9.0	9.5	9.0	10.2	17.0	7.7	12.1	16.6	7.7	7.4	14.3	4.1	14.0	10.5	12.2	7.7	10.1	19.1	7.9	12.7	6.0	10.1	20.1	9.9	9.1	9.3	7.9	4.6	11.4	14.3	11.0	6.7	11.5	8.3	7.4	13.8	13.3	10.1	10.8	3.4	2.5	2.0	5.5	4.1	6.0	7.5	5.1	3.2	3.1	7.0	7.0	6.2	0.2	4.2	5.2	4.4	7.4	3.1	6.4	11.3	14.0	10.6	8.7	5.5	9.7	10.4	10.7	10.3
ETNK1	"EKI, EKI1"	ENSG00000139163	"Ethanolamine kinase 1"	Q9HBU6	12	22625075-22690665	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010712, HPA029407"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA010712: , HPA029407: "	"unprognostic (2.06e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (3.98e-3)"	"unprognostic (8.30e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.53e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-1)"	"prognostic favourable (1.75e-4)"	15.7	17.7	15.2	41.1	19.4	13.7	16.9	19.7	22.2	12.9	33.2	16.4	14.6	27.2	16.6	24.1	14.7	13.1	27.3	10.4	15.6	23.9	22.0	30.2	19.6	18.5	17.2	15.8	17.2	14.9	15.8	30.6	13.4	18.9	13.8	19.5	15.9	16.7	14.7	8.2	17.8	24.5	10.0	17.1	18.3	53.7	22.3	17.5	33.4	17.6	8.2	16.5	14.2	18.6	16.2	10.7	28.1	17.6	14.0	15.7	13.4	6.7	14.0	15.5	14.3	11.2	11.4	11.6	8.0	6.0	8.3	8.5	10.8	17.0	20.0	7.2	5.2	5.1	13.6	3.8	14.9	16.6	11.0	16.5	6.1	9.2	10.7	15.8	15.2	7.4	3.7	11.1	9.5	10.2	19.8	8.5	10.9	4.6	17.2	32.2	30.0	9.1	15.6	13.8	16.1	13.7	9.1	5.0	8.8	8.7	7.5	12.5	11.8	15.3	8.8	6.6	10.6	8.9	12.0	6.2	7.7	21.5	8.4	10.3	11.0	28.1	11.7	12.1	12.9	17.5	12.7	16.2	14.1	11.9	10.7	13.0	15.7	15.5	11.5	14.0	17.6	9.7	15.3	13.4	15.2	19.4	19.7	22.2	15.6	23.9	17.2	15.8	18.9	17.5
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805307-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 59.3;hTCEpi: 54.3;hTERT-HME1: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: "	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	33.6	10.4	25.8	29.6	12.8	44.7	28.5	5.5	36.5	28.4	38.1	7.3	13.7	39.7	27.0	20.3	30.1	21.8	42.6	42.9	16.2	10.8	21.2	75.5	58.3	56.9	13.8	18.2	23.6	11.7	20.0	19.7	23.2	14.2	31.4	50.6	12.9	17.6	17.4	64.2	72.4	59.0	43.3	13.6	68.7	25.8	8.3	11.0	7.2	21.5	28.4	13.7	40.8	35.5	0.2	16.5	18.5	14.9	0.1	2.5	3.6	22.9	4.9	3.4	1.1	3.9	13.3	9.2	5.4	31.4	7.2	9.5	4.4	6.5	5.0	2.6	4.8	6.8	5.8	14.5	13.7	4.6	2.3	59.3	29.8	10.8	40.4	3.6	5.8	7.9	54.3	10.1	44.3	5.7	6.0	0.0	3.1	3.4	11.0	3.9	11.1	3.3	36.1	2.2	4.6	10.1	14.9	2.7	3.6	15.3	6.3	1.2	0.3	6.7	6.1	17.2	2.5	11.0	11.8	0.1	0.0	5.0	4.1	12.3	14.3	10.1	9.2	3.3	1.7	12.3	2.0	0.2	1.6	2.5	16.5	0.2	1.6	1.6	18.5	0.1	14.9	4.0	0.1	3.6	25.8	12.8	5.5	36.5	16.2	10.8	13.8	18.2	14.2	11.0
ETV6	TEL	ENSG00000139083	"ETS variant 6"	P41212	12	11649854-11895402	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.9;NB-4: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000264	Enhanced		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA000264: AB_1078763"	"unprognostic (4.03e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavourable (9.38e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (4.66e-8)"	"unprognostic (1.33e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.92e-2)"	"prognostic favourable (1.54e-5)"	17.2	8.9	5.1	20.0	7.6	32.8	20.4	1.6	9.1	10.5	14.5	6.0	9.8	7.2	10.8	14.2	11.3	8.9	15.3	6.7	5.6	3.8	9.2	9.6	16.0	13.4	6.0	3.1	10.5	10.4	8.4	8.7	7.7	7.4	14.9	11.0	8.0	41.9	12.4	6.9	23.9	14.6	25.0	9.4	17.8	9.7	4.7	5.7	30.6	10.0	10.0	19.9	19.0	15.8	2.9	6.2	11.4	7.1	2.4	2.2	1.3	2.5	3.5	3.2	5.5	2.4	2.3	3.8	1.9	3.2	2.5	3.0	0.2	12.2	2.1	1.9	3.2	3.3	1.4	5.8	3.0	38.9	0.7	13.7	1.9	1.3	3.0	14.4	15.0	4.5	3.6	2.4	5.1	7.5	1.0	7.3	2.2	1.6	8.1	20.7	5.1	0.9	2.3	3.0	5.6	5.7	16.2	0.6	3.2	3.8	3.7	3.5	1.2	9.1	8.5	5.6	4.8	1.8	4.0	3.2	2.4	1.2	3.6	0.1	6.4	5.6	5.7	6.6	1.5	6.6	2.0	2.9	2.2	1.4	4.1	2.3	1.3	0.8	11.4	2.4	7.1	6.2	1.4	1.3	5.1	7.6	1.6	9.1	5.6	3.8	6.0	3.1	7.4	5.7
EVA1B	"C1orf78, FAM176B, FLJ10647"	ENSG00000142694	"Eva-1 homolog B"	Q9NVM1	1	36322031-36324154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 19.6;NB-4: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041928, HPA043537"	Approved		Approved	Cytosol				Cytosol		"HPA041928: , HPA043537: "	"prognostic favourable (4.58e-4)"	"unprognostic (5.66e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (4.79e-5)"	"unprognostic (1.87e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	7.2	5.9	3.3	5.0	2.6	3.1	10.6	1.7	3.7	9.4	4.4	2.5	4.1	8.9	9.8	3.8	4.1	5.1	4.2	7.7	2.4	1.1	10.5	2.8	6.3	8.1	3.4	1.7	8.9	1.9	1.3	2.0	23.3	3.2	7.4	0.5	2.9	7.8	4.3	3.6	6.9	8.1	6.4	3.4	10.4	3.9	5.1	2.9	2.6	9.2	1.7	2.5	5.4	8.3	0.0	1.1	5.8	2.1	3.5	2.2	0.3	2.7	1.7	1.4	2.6	5.1	14.5	7.4	19.6	13.4	3.3	3.7	2.8	2.0	0.4	6.5	5.7	4.3	0.1	0.6	0.7	2.3	4.8	2.6	1.7	2.3	10.9	0.1	1.5	12.9	0.0	4.1	0.4	5.1	0.9	1.0	2.1	3.2	0.1	24.2	1.6	7.6	1.6	0.3	4.2	2.6	0.6	1.0	3.3	2.0	2.2	7.8	0.3	1.8	8.7	5.3	0.5	7.8	2.1	1.1	0.3	0.5	3.2	1.5	4.4	5.8	2.1	0.0	0.4	0.8	1.4	0.0	0.8	1.2	1.1	0.0	0.0	0.1	3.7	3.5	0.3	0.0	2.2	0.3	3.3	2.6	1.7	3.7	2.4	1.1	3.4	1.7	3.2	2.9
EVC	DWF-1	ENSG00000072840	"EvC ciliary complex subunit 1"	P57679	4	5711197-5814305	"Disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.1;BJ hTERT+: 26.9;hTERT-HME1: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008703, HPA016046"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA008703: AB_1078765, HPA016046: AB_1848299"	"unprognostic (1.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.82e-1)"	"prognostic favourable (5.60e-9)"	"unprognostic (3.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (9.47e-5)"	5.0	2.9	2.5	4.6	2.7	0.0	4.1	1.9	2.3	13.2	4.3	1.8	8.4	0.6	17.2	10.1	6.0	8.1	16.0	3.8	2.2	2.2	26.5	3.7	6.4	1.0	2.3	1.4	20.2	9.2	14.9	2.3	1.8	2.9	10.2	1.6	12.0	9.1	5.7	2.4	4.2	2.8	15.8	2.4	2.1	3.6	5.3	1.0	1.0	6.9	3.9	3.8	7.5	9.0	0.1	0.3	1.2	0.1	0.1	0.5	0.0	3.1	4.0	2.2	5.8	14.6	21.1	0.8	7.0	26.9	8.1	10.6	0.0	0.0	0.0	2.2	11.1	3.7	2.3	5.8	6.7	5.1	1.6	0.0	2.3	1.0	10.8	0.0	0.6	10.4	8.5	10.8	26.8	5.6	0.0	0.0	18.8	0.0	0.0	0.0	2.4	3.7	4.7	6.2	0.0	2.8	0.5	1.2	3.8	0.0	0.0	2.8	1.4	0.2	9.8	7.0	1.3	4.9	6.1	4.3	3.5	0.3	20.0	0.0	6.5	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.3	0.5	0.0	2.5	2.7	1.9	2.3	2.2	2.2	2.3	1.4	2.9	1.0
EVL	RNB6	ENSG00000196405	Enah/Vasp-like	Q9UI08	14	99971449-100144236	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 98.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018849, HPA019536, CAB033987"	Enhanced		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180"	"unprognostic (1.12e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.35e-3)"	"prognostic favourable (4.07e-6)"	"unprognostic (3.50e-3)"	"prognostic unfavourable (4.14e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.43e-1)"	14.5	15.0	50.9	37.0	57.8	19.9	28.5	57.4	66.2	11.8	12.4	20.7	10.7	12.7	23.6	25.1	11.2	18.0	20.1	19.7	42.4	43.3	12.4	24.4	28.4	63.5	34.8	31.4	23.3	17.1	9.8	28.6	13.5	26.2	16.4	12.0	24.2	20.0	16.5	12.8	15.6	18.7	29.4	23.1	44.2	15.2	13.2	20.3	98.2	11.0	7.5	55.8	18.3	9.3	7.8	2.5	14.2	8.7	9.3	20.6	5.4	4.0	3.6	27.4	8.2	5.5	15.9	15.8	5.4	6.8	3.5	4.8	0.2	2.8	7.7	7.1	4.9	0.1	12.9	9.3	4.4	8.3	8.2	12.7	2.9	2.1	4.6	3.8	30.2	8.4	4.8	2.4	9.3	9.5	6.3	0.5	3.8	5.6	70.9	20.3	5.7	5.4	17.1	14.2	1.3	4.5	0.1	33.3	19.5	3.8	5.9	1.6	4.5	11.2	5.8	2.9	4.6	17.9	2.9	14.5	10.9	21.8	3.8	6.4	4.7	1.5	1.5	14.2	11.6	7.6	8.9	6.2	13.6	11.0	2.5	7.8	16.5	14.6	0.3	9.3	8.7	0.4	20.6	5.4	50.9	57.8	57.4	66.2	42.4	43.3	34.8	31.4	26.2	20.3
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027452	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 24.1;MCF7: 15.8;RT4: 34.9;SK-BR-3: 17.4;T-47d: 22.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"CAB002220: AB_563701, HPA053969: "	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	0.2	0.0	0.0	2.3	0.1	1.1	1.2	0.0	0.3	11.6	5.7	0.1	2.8	4.8	1.9	1.3	69.9	0.9	4.1	0.0	0.0	0.0	4.8	0.0	5.7	0.2	0.0	0.0	0.4	2.4	1.8	1.1	2.3	0.1	3.2	0.7	0.7	10.9	4.5	0.5	43.7	7.8	2.1	0.2	0.1	1.9	0.3	0.1	0.4	6.3	43.1	46.1	5.0	21.6	0.4	1.7	1.9	0.3	1.6	1.4	0.0	11.0	9.3	0.0	0.1	0.1	0.0	3.9	0.1	0.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	24.1	0.0	3.1	0.0	0.0	0.0	0.2	6.9	7.0	0.0	0.0	1.7	0.0	5.0	0.1	0.0	0.0	0.0	0.4	0.0	15.8	0.4	1.5	0.0	4.2	4.5	0.0	0.1	7.3	34.9	0.4	0.0	4.6	17.4	0.0	22.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.0	1.0	0.3	0.7	0.6	0.3	0.7	0.2	0.2	0.5	0.1	0.4	1.4	0.6	1.9	1.6	0.2	1.7	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1
EXO5	"C1orf176, DEM1, FLJ21144"	ENSG00000164002	"Exonuclease 5"	Q9H790	1	40508741-40516556	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028429			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA028429: AB_2092105"	"unprognostic (9.44e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (9.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.91e-3)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (9.95e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.53e-1)"	8.6	9.1	9.9	8.6	12.4	6.5	16.9	13.9	10.4	8.6	8.4	5.5	11.1	6.9	11.7	8.9	8.5	8.4	7.5	10.3	8.5	5.9	9.9	10.7	8.3	12.3	6.4	10.2	7.5	8.1	8.4	6.9	8.1	6.5	8.9	8.4	7.3	9.0	11.8	6.2	8.2	10.0	12.5	6.1	13.8	7.2	10.1	7.5	15.7	7.3	5.8	16.9	8.6	10.8	11.8	7.9	16.4	9.8	8.6	14.9	7.0	5.4	1.9	4.9	8.1	3.3	3.0	3.4	7.4	1.9	6.7	8.1	3.5	6.6	7.3	4.6	4.7	6.8	4.7	4.9	8.0	2.4	3.0	6.4	9.3	4.8	4.0	0.0	6.4	3.1	3.1	9.2	3.4	4.2	7.3	0.0	9.5	2.3	10.0	5.0	7.3	0.7	7.7	16.6	2.9	3.3	8.4	5.9	5.2	9.5	3.4	6.0	4.8	56.5	4.6	4.6	13.8	10.3	7.1	2.2	6.8	0.0	0.6	2.0	9.1	7.5	6.6	16.4	14.9	9.8	12.3	11.8	10.4	10.7	7.9	9.8	12.8	12.4	11.3	8.6	7.2	6.4	13.4	7.0	9.9	12.4	13.9	10.4	8.5	5.9	6.4	10.2	6.5	7.5
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853616-55905034	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"				"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: "	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavourable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favourable (5.50e-5)"	21.2	19.7	20.7	21.0	24.0	12.9	25.3	22.8	40.7	18.4	20.2	18.2	14.6	18.9	20.8	24.6	32.7	18.3	17.9	19.8	26.9	23.6	18.7	11.4	26.2	29.2	24.7	22.8	18.2	14.9	29.7	20.0	23.4	30.7	16.8	22.4	12.9	20.3	19.2	14.6	31.6	20.5	18.4	29.1	23.7	17.5	18.5	21.5	19.1	19.0	15.8	21.9	18.8	21.4	7.3	11.7	16.4	18.1	10.1	9.2	6.3	11.3	6.6	11.9	13.7	20.5	25.8	8.0	16.1	16.2	13.2	13.9	4.6	19.9	11.0	11.3	17.3	13.6	9.7	12.8	19.0	5.8	6.7	10.2	8.2	5.3	19.4	11.0	14.5	20.8	17.5	13.7	15.2	21.4	14.6	10.9	28.6	7.2	8.0	11.2	7.5	12.6	9.4	8.9	8.9	14.7	12.5	8.9	15.8	9.6	15.9	13.3	10.1	11.9	25.8	16.4	13.4	14.0	13.8	13.1	6.5	9.8	21.3	12.4	15.4	15.2	12.1	10.4	5.8	15.7	7.5	7.3	8.2	8.2	11.7	6.7	7.4	5.4	16.4	10.1	18.1	5.3	9.2	6.3	20.7	24.0	22.8	40.7	26.9	23.6	24.7	22.8	30.7	21.5
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"	Q2M3D2	19	45212621-45245431	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HEL: 17.8;K-562: 16.4"									"Group enriched"	"Detected in some"	4	"basophil: 1.6;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.5"									"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"				Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: "																		3.2	4.3	0.0	2.0	0.0	0.9	3.0	0.0	0.3	3.6	2.1	0.1	2.4	2.3	14.5	1.2	2.3	0.6	6.9	1.9	0.0		12.7	9.4	3.4	6.3	0.0	0.0	3.4	2.8	2.4	3.5	0.4	0.0	3.7	0.2	13.7	3.3	3.6	1.0	2.4	3.9	1.6	0.0	12.6	2.4	2.1	0.0	0.0	4.6	1.5	3.2	1.6	3.3	0.5	0.3	2.5	0.4	0.2	0.4	0.2	0.1	0.3	2.3	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	2.1	0.0	1.1	0.0	0.1	0.0	0.1	0.0	17.8	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.4	0.3	0.0	0.2	0.0	0.0	0.2	0.5	1.2	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.4	0.8	1.6	0.3	0.1	0.2	0.1	0.0	0.1	0.2	0.1	1.6	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	2.5	0.2	0.3	0.3	0.1	0.2										
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: "	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favourable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	21.2	23.7	18.5	17.7	22.3	10.5	19.4	25.7	24.4	20.8	17.0	19.7	22.2	11.2	25.8	20.6	21.5	24.2	16.8	16.5	14.7	15.4	15.6	15.2	16.5	12.6	14.2	19.3	27.7	26.5	28.5	31.2	16.4	22.0	16.9	18.8	19.3	20.5	18.8	50.7	24.4	13.7	20.8	18.7	17.9	16.3	17.2	17.3	34.7	22.9	18.3	22.1	26.3	20.6	8.3	16.3	8.1	12.7	18.4	12.4	10.4	17.7	14.6	20.2	19.9	23.7	24.7	7.0	13.0	21.7	11.8	15.6	8.4	25.0	13.3	9.4	24.4	11.3	10.8	17.7	19.7	20.2	12.9	10.7	15.4	8.9	26.1	14.0	11.7	24.0	22.2	16.8	31.2	20.1	15.4	13.3	21.9	11.6	25.5	15.5	15.1	13.7	11.4	17.9	23.9	19.1	15.9	15.8	24.9	19.5	18.0	20.8	11.9	13.2	21.8	13.2	6.9	13.9	14.1	21.1	12.8	12.8	38.9	16.5	20.1	8.1	12.0	6.9	11.8	12.7	10.5	8.3	12.3	12.4	16.3	8.0	10.1	10.4	4.0	18.4	10.5	7.3	12.4	10.4	18.5	22.3	25.7	24.4	14.7	15.4	14.2	19.3	22.0	17.3
EXOC6B	"KIAA0919, SEC15B, SEC15L2"	ENSG00000144036	"Exocyst complex component 6B"	Q9Y2D4	2	72175984-72826041	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 51.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034546, HPA063991"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034546: , HPA063991: "	"unprognostic (5.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.29e-2)"	12.1	14.2	17.9	5.7	23.0	1.9	9.5	19.8	23.3	10.2	7.2	18.0	6.0	8.4	11.8	7.5	16.5	8.7	7.8	51.7	18.3	14.4	8.8	4.8	7.9	3.8	18.5	17.0	17.4	6.0	18.6	11.2	34.7	19.8	9.7	7.0	7.3	7.6	10.9	11.2	27.5	10.7	11.6	15.0	6.0	8.0	7.7	20.4	3.1	11.7	7.8	7.3	9.5	12.6	3.0	1.7	3.2	2.0	1.6	3.4	1.2	10.8	8.3	7.6	9.2	22.0	9.1	13.2	8.0	11.3	6.9	4.5	11.2	1.7	2.8	5.0	13.3	18.2	6.4	13.1	10.0	2.1	5.2	8.4	5.8	6.4	11.8	1.2	2.9	7.7	19.1	7.7	12.1	11.2	0.9	0.0	9.0	3.7	3.1	1.4	7.9	4.6	1.7	13.7	1.1	6.6	25.5	3.8	3.3	13.6	4.2	5.5	2.9	1.1	12.3	8.0	6.8	6.8	4.8	2.9	2.8	0.0	9.3	0.6	6.3	3.2	1.9	0.2	2.7	1.7	2.1	2.4	2.1	1.7	1.7	3.0	2.4	3.4	0.0	1.6	2.0	0.6	2.6	1.2	17.9	23.0	19.8	22.8	18.3	14.4	18.5	17.0	19.8	20.4
EXOC7	"BLOM4, EXO70, Exo70p, KIAA1067, YJL085W"	ENSG00000182473	"Exocyst complex component 7"	Q9UPT5	17	76081017-76121576	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022840, HPA022842"	Supported		Approved	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA022840: AB_1848316, HPA022842: AB_1848317"	"unprognostic (5.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-1)"	23.2	22.2	30.5	18.2	37.1	27.5	20.4	27.8	46.2	23.8	24.4	33.0	20.8	19.1	28.7	20.8	31.8	32.6	21.3	27.5	29.2	23.5	21.0	22.6	21.2	17.6	20.9	28.2	31.5	24.1	40.5	29.3	24.0	34.6	30.0	17.0	27.0	29.2	27.9	24.0	21.8	21.6	31.1	21.7	21.4	19.6	14.5	23.0	23.7	29.5	14.1	26.4	30.2	20.5	12.8	13.7	29.6	34.4	15.5	17.9	19.0	21.2	26.4	24.4	19.7	23.2	16.5	25.4	19.5	26.1	35.4	25.7	22.2	14.4	11.0	14.3	34.1	17.5	14.7	19.0	23.8	9.5	19.9	18.3	20.7	23.4	16.2	20.3	19.0	23.0	15.0	27.4	13.4	39.2	12.2	11.3	22.0	19.5	32.6	9.0	12.8	28.2	17.6	41.8	11.2	20.4	44.1	13.3	31.1	22.1	16.4	15.1	26.9	16.8	25.6	38.0	22.9	25.0	21.4	15.6	5.7	10.2	22.7	9.2	19.6	21.1	19.2	29.6	17.9	26.6	12.3	12.4	13.7	15.3	13.7	12.8	14.5	12.2	22.2	15.5	34.4	5.9	14.8	19.0	30.5	37.1	27.8	46.2	29.2	23.5	20.9	28.2	34.6	23.0
EXOC8	"EXO84, Exo84p, SEC84"	ENSG00000116903	"Exocyst complex component 8"	Q8IYI6	1	231332753-231337852	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027438	Approved		Supported	Cytosol				Cytosol		"HPA027438: AB_1848318"	"unprognostic (3.85e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	12.1	9.3	10.4	11.2	9.6	22.1	10.3	14.8	12.8	8.6	8.6	9.9	9.5	8.8	9.3	7.6	11.1	8.5	7.7	9.0	9.2	10.3	9.2	11.2	9.5	12.6	9.1	9.9	11.2	11.2	17.1	11.9	14.4	11.9	8.7	7.3	6.7	9.5	9.9	26.7	12.2	11.4	6.8	9.0	13.0	10.1	6.7	9.3	16.9	12.9	9.2	13.3	7.7	9.9	1.8	2.1	6.0	3.8	2.0	3.5	1.2	7.3	8.1	5.0	5.0	13.0	10.6	12.1	9.0	7.6	6.8	6.5	7.7	7.4	8.4	8.1	9.0	12.1	7.1	9.7	7.5	10.8	17.4	5.0	10.3	4.8	7.3	8.8	14.1	10.6	10.7	10.1	9.7	8.3	9.3	20.0	10.8	3.8	8.2	5.5	7.6	7.0	5.5	7.7	10.7	8.6	8.5	6.6	7.1	9.1	12.0	8.8	11.5	12.9	11.3	9.2	6.6	12.3	15.8	15.0	8.6	9.1	10.6	8.0	11.6	4.5	1.8	3.3	1.3	2.3	1.6	1.2	1.7	1.5	1.3	1.8	2.0	3.5	6.0	2.0	3.8	2.1	1.5	1.2	10.4	9.6	14.8	12.8	9.2	10.3	9.1	9.9	11.9	9.3
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099881	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favourable (5.27e-4)"	"unprognostic (1.33e-1)"	28.2	21.8	30.4	22.1	31.9	30.8	27.9	58.8	34.7	24.8	22.0	31.9	22.4	18.5	27.0	22.9	27.6	22.7	18.3	18.3	27.8	16.2	22.4	18.2	20.8	26.0	31.5	26.3	31.2	24.2	23.1	32.1	23.5	24.3	22.1	25.9	20.4	24.6	20.5	27.3	33.2	22.7	25.6	23.2	26.0	25.2	20.3	32.7	28.2	20.8	12.5	29.9	23.6	24.6	21.0	21.6	24.8	26.4	27.5	25.9	22.3	23.1	14.8	31.1	12.0	16.6	18.4	17.8	22.9	16.9	40.4	36.8	21.8	33.9	23.4	14.9	21.7	23.1	34.3	25.5	37.2	26.2	34.4	34.0	29.1	22.2	16.3	27.6	27.1	14.4	22.1	39.6	23.4	25.1	35.6	21.6	22.2	13.1	27.1	25.5	20.6	17.8	28.0	26.5	20.4	23.7	11.9	20.1	19.6	24.7	21.4	27.4	18.7	25.5	22.7	21.6	22.5	19.3	26.8	13.1	20.5	46.3	22.0	41.2	25.8	24.8	18.2	14.6	22.2	23.4	25.9	21.0	23.1	22.1	21.6	19.9	19.8	22.0	3.6	27.5	26.4	11.0	21.8	22.3	30.4	31.9	58.8	34.7	27.8	16.2	31.5	26.3	24.3	32.7
EXOSC4	"FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p"	ENSG00000178896	"Exosome component 4"	Q9NPD3	8	144078626-144080647	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024792	Approved		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA024792: AB_1848325"	"unprognostic (2.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.36e-2)"	"prognostic favourable (2.23e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.11e-2)"	12.3	16.7	12.8	11.4	17.6	13.8	8.9	13.9	20.6	8.1	12.0	10.5	13.6	15.8	9.8	10.4	14.5	10.0	9.3	16.5	11.4	11.2	14.9	21.5	8.7	11.4	11.5	13.0	10.3	15.0	8.0	10.2	11.5	12.0	12.1	6.5	11.6	28.0	14.7	12.1	12.7	11.1	6.7	9.3	13.4	13.9	45.0	9.7	14.8	10.8	10.4	11.1	8.7	7.8	24.7	38.2	19.0	31.8	17.1	16.1	18.8	10.2	22.5	4.0	9.6	3.5	2.6	11.0	8.0	3.3	6.3	6.4	15.7	7.2	6.2	11.7	3.3	8.4	7.4	8.8	1.8	8.1	25.0	8.9	16.8	17.4	5.8	6.6	10.6	3.8	9.0	7.3	5.8	3.2	13.9	4.2	5.1	37.2	10.2	13.1	10.4	90.3	4.5	6.6	16.0	6.0	10.4	12.6	16.7	10.0	13.0	18.5	14.7	10.0	3.2	6.5	14.2	15.5	13.6	11.2	13.4	7.7	9.4	10.6	10.1	19.0	31.8	12.5	15.9	29.4	16.1	22.0	12.4	15.4	29.8	24.7	15.9	15.4	9.2	17.1	16.1	38.2	13.7	18.8	12.8	17.6	13.9	20.6	11.4	11.2	11.5	13.0	12.0	9.7
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895998	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"		83000000	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: "	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	7.5	23.0	9.8	4.1	19.9	1.7	10.4	14.7	22.8	13.4	8.7	8.1	9.9	4.5	16.7	13.1	6.0	10.1	10.3	8.2	9.5	13.3	11.2	10.0	7.6	3.4	14.0	12.0	18.8	7.7	17.5	18.7	21.8	20.1	12.3	7.1	8.6	6.0	11.4	5.3	5.9	4.6	15.4	11.4	5.4	6.2	9.7	16.3	6.4	9.3	5.0	3.4	9.0	6.2	2.1	7.4	3.3	1.1	5.3	5.6	1.9	5.1	2.7	19.8	20.7	22.0	16.2	12.6	8.9	14.6	7.0	15.7	2.5	3.9	5.7	8.6	8.1	5.0	7.2	7.6	14.2	11.6	5.0	7.0	9.6	7.1	7.2	10.9	3.7	19.2	2.7	14.0	2.7	25.5	8.8	0.7	17.6	2.6	5.7	6.0	24.9	6.0	4.2	20.4	4.7	7.5	3.9	8.2	23.3	6.8	1.7	15.9	4.3	4.9	10.7	17.5	10.3	11.2	9.3	6.1	5.4	3.5	27.9	11.3	5.7	3.3	0.8	0.0	5.6	1.1	2.8	1.9	1.9	3.7	2.5	2.1	2.1	4.8	0.2	5.3	0.9	7.4	0.0	1.9	9.8	19.9	14.7	22.8	9.5	13.3	14.0	12.0	20.1	16.3
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 47.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 13.4;SCLC-21H: 20.4;U-266/70: 38.0;U-266/84: 46.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"memory B-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"B-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol				Cytosol		"HPA027024: AB_1848334, HPA059291: "	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favourable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	10.5	2.0	6.5	2.6	7.4	0.8	13.4	2.4	6.5	47.4	6.4	3.8	21.0	1.0	15.7	10.7	25.9	28.2	2.2	4.3	7.0	4.1	5.2	1.8	2.3	1.3	6.3	4.9	5.2	2.4	11.5	4.7	5.9	9.1	18.5	3.2	15.4	28.6	27.3	2.1	4.2	1.1	2.3	7.2	1.1	8.2	4.9	5.1	14.3	21.4	3.6	14.0	5.5	17.3	2.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.1	13.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.3	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	20.4	0.0	0.0	9.1	0.0	1.8	0.0	0.0	0.0	1.6	0.1	3.0	38.0	46.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	7.4	2.4	6.5	7.0	4.1	6.3	4.9	9.1	5.1
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888860-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.4;breast: 30.7;lung: 33.0"	"Group enriched"	"Detected in some"	7	"HEL: 24.3;HMC-1: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favourable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	69.4	3.3	0.2	2.6	0.4	1.3	30.7	0.2	0.6	1.3	16.9	0.4	0.5	1.9	1.3	1.9	4.3	1.0	4.5	9.7	0.5	0.2	5.0	0.8	33.0	2.6	0.2	0.3	3.9	12.3	0.5	2.3	1.1	1.4	1.4	1.5	1.3	1.0	0.8	6.5	2.2	4.4	1.1	0.2	3.0	5.4	2.5	0.2	0.3	27.1	2.3	1.5	3.4	1.9	5.3	4.3	5.8	2.5	3.9	3.3	3.2	0.2	0.2	0.7	0.3	0.1	0.2	0.7	0.4	0.0	0.2	0.1	0.4	0.7	0.5	0.5	0.2	0.6	0.1	0.2	0.2	0.3	0.3	24.3	0.9	0.4	0.2	0.3	9.8	0.0	0.1	0.3	0.2	0.8	1.9	1.0	0.1	0.3	0.3	2.4	0.3	0.2	0.2	0.2	0.7	0.2	0.5	0.4	0.2	0.2	0.1	0.1	0.5	1.6	0.9	0.5	0.5	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.4	5.8	2.5	1.6	2.2	1.4	2.1	3.9	2.4	1.9	0.8	5.3	3.3	3.1	5.3	3.9	1.8	4.3	1.7	3.2	0.2	0.4	0.2	0.6	0.5	0.2	0.2	0.3	1.4	0.2
FAAH	FAAH-1	ENSG00000117480	"Fatty acid amide hydrolase"	O00519	1	46394265-46413848	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.0;RT4: 23.7;SK-BR-3: 12.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 19.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007425	Approved		Approved	Cytosol				Cytosol		"HPA007425: AB_1078820"	"unprognostic (6.12e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.51e-2)"	"prognostic favourable (1.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.39e-3)"	"unprognostic (9.86e-2)"	"prognostic favourable (4.25e-5)"	"prognostic favourable (3.63e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.00e-3)"	6.1	7.7	11.2	2.5	22.0	7.9	7.9	20.4	21.9	6.9	15.0	40.7	10.1	18.0	3.1	8.2	4.9	10.6	4.6	2.9	14.7	11.7	12.0	18.3	6.7	2.1	19.1	19.3	2.7	18.2	15.1	10.6	3.5	17.6	33.3	12.8	7.4	12.8	8.6	7.1	10.1	17.8	2.3	23.6	2.0	14.3	30.9	18.8	5.6	24.9	3.5	3.5	5.7	4.2	0.1	6.0	19.1	4.7	0.3	0.4	0.9	2.7	0.7	0.4	0.5	0.7	0.5	22.0	0.6	0.3	0.3	0.5	4.0	6.6	0.1	2.3	0.4	9.3	0.4	1.3	0.1	1.2	3.1	0.0	0.1	1.9	0.4	0.8	1.6	0.4	6.3	0.2	0.8	0.0	0.1	0.5	0.0	5.9	0.4	1.2	1.8	0.2	0.5	0.2	0.1	5.2	23.7	2.8	2.1	3.2	12.3	0.1	8.5	8.2	0.0	0.0	0.3	0.6	0.4	1.2	0.5	0.3	0.1	7.5	0.2	0.0	4.7	19.1	0.3	1.2	0.1	0.0	0.3	0.1	5.7	0.1	0.4	0.4	0.2	0.3	0.6	6.0	0.1	0.9	11.2	22.0	20.4	21.9	14.7	11.7	19.1	19.3	17.6	18.8
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128116	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 453.2;liver: 370.7"	"Group enriched"	"Detected in some"	7	"CACO-2: 25.6;Hep G2: 81.3"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	23	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol			32000000	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		0.4	0.1	0.4	33.9	0.4	0.0	0.4	0.4	0.5	0.4	153.5	0.4	0.4	137.9	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.2	57.6	370.7	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	97.7	0.4	0.5	0.4	0.4	0.1	453.2	6.7	0.4	0.4	0.2	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	25.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	81.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.1	0.0	0.0	1.4	7.5	0.0	0.1	0.8	5.6	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.4	0.4
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322390	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"intestine: 358.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Hep G2: 2.4;NB-4: 3.8;RPMI-8226: 3.2;SH-SY5Y: 2.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"			46000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.1	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	47.0	0.0	0.0	50.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.9	0.1	0.1	0.0	0.1	0.1	358.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.5	7.6	0.7	0.9	0.5	0.0	0.2	0.3	0.2	0.4	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.4	0.3	0.4	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.3	0.1	0.4	2.4	0.0	0.5	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.5	0.0	0.1	0.4	3.8	0.2	0.5	0.3	0.2	3.2	0.0	0.5	1.0	2.6	0.1	0.4	0.0	0.3	0.1	0.9	0.4	0.4	1.4	0.1	0.7	0.2	0.6	0.3	0.2	0.1	2.1	0.7	0.7	0.4	0.3	0.4	0.2	0.4	0.3	0.2	0.5	0.5	0.5	7.6	0.9	0.2	0.5	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 92.9;MOLT-4: 90.8"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"		28000000	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: "	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.7	16.5	10.1	0.0	48.4	4.5	0.0	11.8	0.6	9.2	11.7	0.1	7.9	92.9	6.8	2.9	5.4	24.6	18.9	7.9	47.2	53.4	33.5	11.8	25.0	4.3	32.0	8.7	3.5	38.9	11.4	23.5	53.0	9.6	10.1	5.5	5.6	90.8	16.4	13.4	64.3	40.5	0.0	9.8	14.8	71.8	42.0	15.9	5.7	1.9	4.4	0.0	16.5	7.5	0.0	26.3	0.1	0.1	12.5	4.9	66.2	4.2	30.7	14.8	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779475-122784074	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 62.7;breast: 26.8"	"Group enriched"	"Detected in some"	8	"AF22: 37.8;U-251 MG: 10.2;WM-115: 22.7"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1"	"Region enriched"	"Detected in all"	6	"olfactory region: 1471.1"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: , HPA028825: AB_10602130"	"prognostic favourable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavourable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	2.1	1.3	34.8	1.1	15.5	1.3	26.8	51.6	62.7	1.1	1.5	13.0	0.0	1.2	1.2	1.3	1.6	1.2	1.2	1.2	32.0	16.4	1.6	1.4	1.1	1.1	11.4	30.3	1.1	1.1	1.0	2.1	1.3	11.2	1.3	1.2	5.7	7.0	3.7	6.7	10.5	1.1	1.1	8.1	1.1	1.3	1.2	6.9	0.0	1.1	0.0	1.1	1.4	0.0	0.4	0.2	3.1	0.3	1.1	0.4	0.0	0.0	0.0	37.8	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	10.2	0.0	0.0	0.0	0.4	0.0	22.7	3.1	0.3	0.1	0.3	0.1	0.3	0.2	0.3	0.4	0.1	0.4	0.3	0.3	0.5	1.1	0.2	0.2	0.1	0.0	34.8	15.5	51.6	27.3	32.0	16.4	11.4	30.3	11.2	6.9
FADD	"GIG3, MORT1"	ENSG00000168040	"Fas associated via death domain"	Q13158	11	70203163-70207390	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001464, CAB010209"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB010209: AB_2100622, HPA001464: AB_1848348"	"unprognostic (2.08e-1)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (6.91e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.89e-1)"	"prognostic unfavourable (8.22e-5)"	"unprognostic (7.25e-3)"	"prognostic unfavourable (2.21e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"prognostic favourable (3.45e-4)"	"unprognostic (7.29e-2)"	16.1	20.2	7.9	13.3	8.9	7.1	13.5	10.9	11.8	13.7	16.2	10.9	20.8	13.5	18.0	18.7	18.8	13.3	19.7	11.4	7.8	8.0	17.9	17.4	11.0	19.2	10.5	6.6	12.9	24.9	9.1	9.3	26.3	7.9	12.5	12.7	10.1	14.4	14.5	10.3	13.7	16.9	10.1	8.3	18.8	14.0	8.7	7.4	33.5	16.9	12.4	19.8	14.6	15.1	18.6	17.6	42.7	19.5	16.6	24.6	16.0	81.8	13.8	6.9	6.2	8.4	6.8	6.2	14.1	11.1	12.3	8.3	11.8	13.4	12.2	13.6	9.3	12.1	6.7	12.5	9.6	11.3	7.4	5.5	7.9	6.0	7.5	6.9	7.4	6.7	8.9	13.3	16.9	11.6	9.0	6.3	10.8	12.0	8.4	12.2	10.9	22.9	6.5	16.7	11.6	12.1	6.0	6.1	5.8	10.4	9.8	28.9	10.6	7.7	12.9	9.6	9.4	14.7	13.4	8.8	6.7	7.1	14.0	7.0	13.5	15.0	17.1	12.7	21.0	17.7	24.1	18.6	22.3	24.6	17.6	16.4	23.2	20.9	42.7	16.6	19.5	16.0	20.7	16.0	7.9	8.9	10.9	11.8	7.8	8.0	10.5	6.6	7.9	7.4
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041370, HPA044093"	Enhanced		Approved	Cytosol			230000000	Cytosol		"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavourable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	32.1	17.8	4.6	6.1	3.6	4.7	22.8	2.3	3.3	4.7	8.6	3.1	8.3	4.1	5.1	14.8	4.4	6.8	7.1	6.8	4.1	2.8	18.9	109.4	7.9	6.2	4.0	2.1	7.2	6.5	4.8	4.4	2.3	3.5	4.9	3.4	2.4	5.3	5.4	7.7	2.4	7.6	4.4	5.9	6.0	3.3	9.7	3.0	2.3	4.2	4.9	3.9	4.1	6.1	0.1	16.0	16.9	11.7	3.6	5.8	6.1	4.4	7.5	3.1	3.8	14.5	14.8	7.6	5.7	13.1	6.0	5.2	4.5	8.2	0.0	9.4	12.0	6.6	11.0	13.6	5.9	2.8	6.2	38.1	4.4	23.3	75.2	18.0	21.1	25.6	8.5	5.2	9.4	8.4	15.9	8.1	11.3	6.7	4.9	9.0	2.2	8.6	2.7	4.4	28.5	17.5	5.4	0.1	1.9	6.4	17.7	17.8	13.5	12.3	29.3	11.1	7.0	5.9	9.6	7.4	15.2	3.0	23.1	42.2	6.2	16.9	11.7	1.9	5.8	4.9	1.5	0.1	1.6	3.9	16.0	0.0	2.0	1.8	0.7	3.6	4.8	1.2	1.5	6.1	4.6	3.6	2.3	3.3	4.1	2.8	4.0	2.1	3.5	3.0
FAIM	"FAIM1, FLJ10582"	ENSG00000158234	"Fas apoptotic inhibitory molecule"	Q9NVQ4	3	138608606-138633376	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 61.9"	"Cell line enhanced"	"Detected in many"		"U-698: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042440, HPA052209"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042440: , HPA052209: "	"unprognostic (6.45e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (3.96e-5)"	"unprognostic (4.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.63e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.98e-2)"	13.7	6.6	12.3	6.7	11.6	2.6	19.0	7.8	9.9	24.5	6.8	10.2	38.5	4.7	9.6	15.1	8.8	28.5	9.0	4.7	12.2	12.5	15.4	6.0	7.6	7.2	13.9	7.1	8.4	27.5	7.2	15.4	6.1	10.7	11.4	6.0	9.1	7.2	61.9	6.1	6.2	4.2	7.2	19.6	3.7	6.7	5.4	9.1	13.2	15.2	9.3	9.6	10.3	13.2	13.9	5.0	11.1	2.6	13.9	9.1	3.4	26.5	5.2	0.5	4.7	5.1	9.6	19.1	8.2	5.0	8.7	7.5	8.9	7.8	0.0	7.3	10.7	7.0	22.7	4.7	9.8	21.8	23.7	5.0	14.4	12.9	5.7	0.0	1.6	13.5	9.1	3.2	5.0	9.4	3.2	6.8	5.4	10.1	0.1	22.5	10.3	5.2	26.8	6.2	0.7	13.8	13.2	9.0	7.6	14.6	8.1	20.5	13.7	6.6	5.7	1.8	4.1	8.9	3.9	0.0	0.1	44.7	7.2	0.0	7.1	11.1	2.4	1.7	9.1	2.6	8.5	13.9	5.0	7.2	5.0	7.9	3.4	8.5	0.3	13.9	1.7	3.5	5.4	3.4	12.3	11.6	7.8	8.2	12.2	12.5	13.9	7.1	10.7	9.1
FAM102A	"bA203J24.7, C9orf132, Eeig1, SYM-3A"	ENSG00000167106	"Family with sequence similarity 102 member A"	Q5T9C2	9	127940579-127980513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036030			Approved	Cytosol				Cytosol		"HPA036030: AB_10670675"	"unprognostic (3.27e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.98e-2)"	5.3	18.3	28.2	19.9	39.1	7.6	12.1	10.5	31.8	22.4	35.8	65.9	8.7	33.3	15.7	12.6	27.4	29.8	28.5	6.7	29.4	17.3	15.1	23.9	8.5	34.4	41.5	22.9	19.7	21.6	12.9	22.9	5.7	28.0	10.6	11.2	12.5	19.1	13.5	1.9	18.7	39.3	16.7	39.0	12.9	61.8	15.4	53.0	32.0	12.1	13.7	26.3	17.8	18.6	4.7	0.1	2.2	0.1	0.5	11.8	3.0	9.9	22.2	4.7	3.8	10.1	12.2	18.1	3.9	10.8	2.6	1.6	12.7	17.9	11.5	2.6	7.5	11.1	2.5	2.0	1.0	5.4	2.5	3.4	5.6	11.4	6.3	1.6	26.5	4.9	10.2	7.4	3.1	3.6	2.8	14.4	3.0	25.9	6.6	3.6	5.8	10.7	3.5	3.5	4.1	7.5	17.3	7.4	3.6	6.4	14.5	9.2	27.3	2.1	3.8	4.2	4.5	21.8	5.8	19.5	26.6	7.9	17.9	2.2	9.7	0.6	0.1	2.2	1.9	0.0	6.1	4.7	9.4	5.6	0.1	1.2	9.1	6.0	0.1	0.5	0.0	0.0	11.8	3.0	28.2	39.1	10.5	31.8	29.4	17.3	41.5	22.9	28.0	53.0
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavourable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	11.6	5.2	11.8	10.4	11.4	19.0	11.3	23.3	20.0	8.5	13.8	3.8	6.6	11.4	7.5	8.2	6.5	6.7	15.7	9.2	15.6	14.3	4.6	5.1	8.1	8.8	12.6	19.0	10.5	5.8	12.1	7.3	6.0	11.4	8.5	15.7	5.5	13.5	9.6	2.3	4.2	11.5	11.4	10.2	8.6	7.9	8.8	5.0	9.4	6.7	4.3	8.4	16.4	18.0	0.9	2.7	5.7	2.3	0.7	1.4	0.5	3.6	2.6	5.2	2.8	9.5	5.7	3.4	2.1	2.9	3.3	5.7	0.9	3.6	4.0	2.0	5.5	7.1	17.8	0.7	4.3	2.6	2.6	5.6	20.1	0.4	2.4	7.2	10.7	3.0	0.8	4.9	0.3	2.1	13.5	22.3	7.8	14.7	4.6	5.2	4.1	13.1	10.6	13.3	0.8	0.9	4.2	17.1	5.0	8.5	14.8	4.4	3.1	11.8	0.4	5.4	10.2	4.6	8.1	4.0	0.9	3.7	7.9	5.7	2.8	5.7	1.1	1.0	1.0	2.3	0.6	0.9	1.0	1.4	2.7	0.9	0.7	0.5	1.0	0.7	0.9	0.5	0.8	0.5	11.8	11.4	23.3	20.0	15.6	14.3	12.6	19.0	11.4	5.0
FAM104A	FLJ14775	ENSG00000133193	"Family with sequence similarity 104 member A"	Q969W3	17	73207353-73236753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021459			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021459: AB_1848361"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavourable (2.12e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (1.26e-10)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	9.3	7.2	8.7	9.1	9.0	23.2	12.4	10.8	7.9	9.9	9.1	6.9	7.4	7.8	8.4	8.4	10.4	6.6	8.5	11.6	8.1	7.0	6.4	10.0	8.2	10.1	6.9	8.3	8.2	11.4	8.4	11.2	14.2	6.4	9.3	8.1	8.4	8.3	8.0	11.9	11.7	10.1	7.3	7.1	11.8	13.3	74.8	6.5	14.6	9.2	7.1	11.2	9.9	11.6	21.3	19.7	34.3	20.3	26.7	49.5	29.9	22.6	18.6	9.4	17.4	14.4	13.6	30.8	18.5	19.5	20.5	21.2	15.6	14.7	13.3	15.3	17.8	14.5	12.0	13.5	22.3	15.5	16.2	19.3	16.0	23.6	19.2	16.8	33.2	14.3	18.0	18.1	13.3	23.9	14.9	22.2	24.5	15.4	29.8	11.6	12.9	23.9	16.4	26.2	12.8	15.6	18.6	15.5	20.6	10.8	15.8	19.9	22.2	17.4	16.6	24.3	28.1	16.5	21.6	22.0	21.7	16.1	21.7	18.4	17.9	24.5	20.3	34.3	24.7	17.6	23.7	21.3	30.3	28.1	19.7	20.2	22.2	26.7	33.3	26.7	18.6	12.8	49.5	29.9	8.7	9.0	10.8	7.9	8.1	7.0	6.9	8.3	6.4	6.5
FAM105A	"FLJ11127, NET20"	ENSG00000145569	"Family with sequence similarity 105 member A"	Q9NUU6	5	14581775-14615007	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 13.8;HMC-1: 43.3;THP-1: 12.0;U-937: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA046638: "	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	5.1	3.5	4.0	7.9	4.9	35.4	5.2	3.1	5.1	6.3	15.4	9.0	4.5	8.3	3.0	5.6	2.9	3.1	4.1	3.0	3.9	4.3	5.2	1.9	28.8	16.7	6.1	3.8	4.0	13.3	1.9	8.7	6.7	7.9	12.6	17.3	10.3	3.1	13.5	1.3	2.6	13.7	3.3	10.8	13.2	5.4	4.4	4.1	3.5	27.2	3.0	6.2	7.1	5.8	0.1	26.7	6.9	26.2	14.1	9.6	16.2	0.0	0.6	1.2	0.0	0.2	0.0	5.2	1.5	1.4	0.4	0.7	1.9	1.3	0.0	0.8	0.7	0.1	2.6	1.2	0.6	0.8	3.6	3.4	13.8	0.3	1.3	0.0	43.3	0.1	0.3	0.2	0.0	0.0	0.0	5.4	0.1	1.0	0.0	1.2	1.9	9.2	0.3	0.5	1.5	0.0	10.4	4.5	5.0	0.7	0.4	0.0	0.4	12.0	0.0	0.6	3.4	0.2	1.1	0.0	0.0	0.0	0.7	20.5	0.2	0.0	26.2	0.1	4.5	12.4	6.0	0.1	5.7	6.1	26.7	0.1	7.8	7.5	6.9	14.1	9.4	19.7	9.6	16.2	4.0	4.9	3.1	5.1	3.9	4.3	6.1	3.8	7.9	4.1
FAM110A	"bA371L19.3, C20orf55"	ENSG00000125898	"Family with sequence similarity 110 member A"	Q9BQ89	20	833715-857463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 83.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7"	"Group enriched"	"Detected in all"	9	"granulocytes: 83.4;monocytes: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034110, HPA069240"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles, Cytosol"		"CAB034110: AB_1562838, HPA069240: "	"unprognostic (6.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (4.42e-4)"	"unprognostic (9.64e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.42e-3)"	"unprognostic (4.21e-3)"	5.2	3.6	1.7	17.7	4.2	7.4	7.7	1.9	3.9	6.5	8.8	2.0	7.7	10.0	4.0	6.1	22.1	1.9	6.9	4.8	1.7	2.5	4.8	3.9	15.2	18.7	2.1	1.9	2.6	3.5	9.3	5.1	11.1	3.6	11.1	3.4	3.1	12.7	10.5	3.7	39.9	9.2	1.3	1.6	15.1	5.5	2.8	1.3	22.9	7.7	8.0	18.9	7.8	9.7	1.9	5.8	83.4	37.7	1.0	6.4	3.2	12.4	3.4	1.9	3.5	2.1	0.9	13.2	3.9	2.2	2.5	2.2	7.3	7.9	4.1	1.7	2.4	20.3	1.5	10.3	2.1	3.3	1.1	8.4	2.1	1.9	0.9	2.3	3.0	0.5	12.8	3.4	3.4	1.7	4.5	10.1	2.3	7.5	6.4	6.2	2.5	5.8	6.4	3.3	5.3	1.9	9.1	3.6	4.3	3.3	39.7	1.7	16.4	3.4	2.2	6.0	4.4	5.4	4.3	3.7	3.2	1.7	0.9	6.0	4.3	83.4	4.4	24.8	2.2	25.1	2.0	1.1	4.0	4.6	5.8	1.9	4.9	4.7	2.5	1.0	37.7	0.6	6.4	3.2	1.7	4.2	1.9	3.9	1.7	2.5	2.1	1.9	3.6	1.3
FAM110B	"C8orf72, MGC39325"	ENSG00000169122	"Family with sequence similarity 110 member B"	Q8TC76	8	57994509-58204279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.0;RPTEC TERT1: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 13.1;intermediate monocyte: 3.6;non-classical monocyte: 6.4"	"Group enriched"	"Detected in many"	11	"granulocytes: 13.1;monocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008318, HPA011781"	Uncertain		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA008318: AB_1853892, HPA011781: AB_1853891"	"unprognostic (2.07e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (3.88e-8)"	"unprognostic (4.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.72e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (1.06e-2)"	"prognostic favourable (4.31e-8)"	"unprognostic (2.23e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.15e-4)"	6.5	3.1	15.7	4.1	12.2	4.1	9.9	23.7	18.4	8.8	6.1	5.0	24.3	2.3	8.9	6.8	3.0	9.1	7.9	21.7	10.3	14.4	6.6	6.0	4.1	2.0	8.0	5.9	8.2	3.0	16.7	4.1	5.0	7.9	10.0	3.2	9.5	8.5	19.8	17.1	3.0	3.3	10.4	11.5	30.8	5.5	14.7	4.9	0.0	8.6	3.4	2.1	7.9	9.4	0.3	0.9	13.1	6.4	0.0	0.2	0.5	0.0	1.1	4.1	0.1	1.8	0.7	1.6	7.7	9.0	5.4	2.5	0.0	0.1	0.0	1.5	5.5	0.0	3.6	0.0	4.2	0.0	3.8	0.7	1.2	4.5	6.2	1.0	0.2	6.6	1.5	0.2	3.4	0.0	0.0	0.1	4.1	0.1	0.0	2.7	3.9	1.7	0.0	4.6	0.0	13.4	0.8	3.9	4.3	0.0	0.5	0.2	3.6	0.4	0.0	3.8	2.5	0.0	2.6	1.7	0.0	0.0	1.8	0.0	4.4	0.0	1.4	13.1	0.0	3.6	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.2	0.5	0.0	6.4	0.0	0.1	0.5	15.7	12.2	23.7	11.8	10.3	14.4	8.0	5.9	7.9	4.9
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127410	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 43.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.7;naive B-cell: 5.7"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	1.3	1.3	0.4	8.9	0.8	3.5	1.9	0.3	1.1	1.8	4.7	0.4	0.3	2.5	0.8	2.0	9.3	0.7	1.8	1.0	0.4	0.4	1.8	2.6	2.1	9.9	0.5	0.3	1.0	0.8	1.4	0.9	2.8	0.8	1.2	5.0	0.3	2.6	0.3	0.5	3.5	4.1	1.3	0.6	5.4	2.8	1.0	0.6	43.9	0.7	9.2	11.1	1.5	2.6	5.7	0.3	3.1	0.2	0.1	1.4	0.3	24.0	6.2	9.3	0.1	1.0	1.8	0.1	18.3	9.2	10.9	16.2	13.1	9.6	30.0	12.4	5.3	18.7	13.5	12.3	19.5	15.6	3.3	3.2	11.8	5.7	0.0	0.1	3.9	0.4	0.4	10.5	0.8	5.8	0.9	28.3	12.8	9.1	18.9	0.2	0.1	7.3	20.0	13.8	11.7	5.8	20.8	1.8	5.9	15.1	17.5	3.0	19.4	1.7	3.2	8.5	18.5	25.5	16.6	21.8	15.7	0.2	12.3	0.1	12.1	0.5	0.2	0.2	0.3	0.1	0.2	5.7	0.4	0.7	0.3	5.7	0.2	0.2	3.1	0.1	0.2	0.3	1.4	0.3	0.4	0.8	0.3	1.1	0.4	0.4	0.5	0.3	0.8	0.6
FAM114A1	Noxp20	ENSG00000197712	"Family with sequence similarity 114 member A1"	Q8IWE2	4	38867677-38945739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.2;ASC TERT1: 44.2;BJ hTERT+: 50.5;fHDF/TERT166: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.1;intermediate monocyte: 6.3;myeloid DC: 4.3;neutrophil: 3.8;non-classical monocyte: 2.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.3;granulocytes: 3.8;monocytes: 6.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA067948, HPA069104, HPA069701"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA067948: , HPA069104: , HPA069701: "	"unprognostic (2.13e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.40e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (3.63e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-3)"	15.8	27.3	4.4	11.8	7.3	0.3	17.9	2.5	5.1	23.3	18.9	8.0	17.1	9.0	34.1	23.5	19.9	11.4	24.1	14.1	7.0	4.2	9.6	31.8	14.5	6.1	5.8	5.0	21.7	33.4	8.8	18.7	19.1	6.5	22.0	14.0	13.0	59.9	12.6	9.3	10.1	15.8	36.7	6.2	6.3	13.9	10.8	5.8	1.5	11.5	16.7	15.1	29.1	17.8	0.7	4.3	3.8	6.3	0.1	0.2	1.3	8.6	6.2	3.8	4.5	42.2	44.2	1.2	34.4	50.5	14.6	22.4	1.6	6.8	0.0	4.8	55.7	2.4	0.0	11.0	17.0	0.0	0.9	0.6	6.6	8.1	15.1	0.0	1.2	26.1	3.5	21.2	4.9	20.9	0.6	0.0	21.3	2.2	0.0	0.4	0.8	3.2	0.1	19.0	0.6	4.9	1.7	0.1	1.9	6.9	0.1	7.0	4.3	0.7	31.9	15.9	7.4	19.9	8.0	0.1	0.0	0.0	26.1	0.6	13.0	0.8	5.1	0.1	0.2	6.3	0.1	0.7	0.2	0.1	4.3	0.3	0.2	0.2	3.8	0.1	2.2	0.5	0.1	1.3	4.4	7.3	2.5	5.1	7.0	4.2	5.8	5.0	6.5	5.8
FAM118A	"bK268H5.C22.4, C22orf8, FLJ20635"	ENSG00000100376	"Family with sequence similarity 118 member A"	Q9NWS6	22	45308968-45341955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003902	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"HPA003902: AB_1848368"	"unprognostic (6.22e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (1.87e-6)"	"unprognostic (9.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.16e-3)"	8.4	7.9	9.8	14.3	17.3	11.7	14.7	14.6	12.0	10.5	13.9	9.6	10.3	12.2	15.5	41.7	10.8	6.5	15.3	13.9	12.1	7.7	8.4	8.8	10.0	29.0	10.2	5.0	13.8	8.2	32.9	22.7	11.4	11.7	23.7	7.6	12.1	14.6	18.6	20.0	23.9	16.0	14.5	8.1	14.5	12.5	22.1	10.7	14.0	14.4	6.6	17.9	17.3	13.3	8.3	15.7	6.5	8.6	5.9	13.9	4.7	5.5	4.0	4.6	5.9	4.0	4.2	12.9	4.1	6.1	5.9	5.2	11.6	5.2	24.8	3.2	3.7	19.5	6.2	5.4	5.6	5.5	16.3	13.3	5.9	7.8	6.0	12.1	3.5	4.8	5.5	7.9	5.2	3.5	19.9	26.3	2.5	12.3	7.6	23.1	3.9	5.9	9.2	3.4	8.6	2.9	13.9	10.5	13.2	4.7	8.8	11.0	4.3	6.1	4.0	4.4	15.0	5.4	5.2	14.5	2.8	12.8	5.4	8.0	8.1	4.5	8.6	2.5	7.0	7.1	5.6	5.3	8.6	8.6	10.9	8.3	13.9	10.0	6.5	5.9	5.6	15.7	11.4	4.7	9.8	17.3	14.6	12.0	12.1	7.7	10.2	5.0	11.7	10.7
FAM120A	"C9orf10, KIAA0183, OSSA"	ENSG00000048828	"Family with sequence similarity 120A"	Q9NZB2	9	93451722-93566107	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019734, HPA055800"	Approved		Enhanced	Cytosol				Cytosol		"HPA019734: AB_1848369, HPA055800: "	"unprognostic (5.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (5.03e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.71e-3)"	"prognostic favourable (1.08e-7)"	"unprognostic (8.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	25.7	35.1	23.3	28.6	19.1	15.7	23.0	22.1	21.8	26.1	27.0	14.9	32.2	21.3	33.2	17.2	26.0	24.2	24.1	22.1	20.5	11.0	21.2	33.2	25.7	26.4	18.4	12.6	25.5	34.4	40.6	16.8	24.6	20.0	17.4	26.0	15.9	27.7	22.4	71.5	17.6	23.6	23.3	17.7	21.7	25.3	7.5	17.7	19.5	19.8	23.8	17.6	46.5	33.1	4.7	6.6	15.2	9.2	4.2	7.5	3.5	48.3	39.7	9.0	25.9	27.1	34.0	28.3	34.0	30.1	26.2	19.3	12.8	30.1	31.6	19.5	42.9	52.3	24.0	39.8	20.4	31.4	17.5	17.2	35.5	20.3	30.4	29.2	23.6	33.0	24.8	29.7	47.6	37.3	19.7	26.5	28.3	54.2	28.6	16.6	11.5	37.2	16.7	24.1	26.4	31.8	29.2	24.2	14.9	38.4	46.8	23.2	25.4	19.2	38.5	28.5	20.5	34.8	37.1	21.0	20.5	12.2	30.8	26.4	25.2	3.0	7.1	5.0	5.4	8.1	5.1	4.7	5.2	5.6	6.6	4.1	3.6	5.1	15.2	4.2	9.2	4.6	7.5	3.5	23.3	19.1	22.1	21.8	20.5	11.0	18.4	12.6	20.0	17.7
FAM120B	"CCPG, KIAA1838, PGCC1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407065	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavourable (1.60e-4)"	"prognostic favourable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	18.4	20.6	18.5	21.1	28.7	10.7	20.5	28.4	27.7	20.5	16.6	28.5	16.3	15.8	28.3	24.1	16.5	26.8	18.1	18.4	18.1	22.8	17.3	15.6	18.3	16.7	20.6	19.5	23.4	17.0	24.7	32.0	19.5	26.1	22.4	18.6	19.1	21.4	21.2	25.7	18.4	16.2	20.1	21.1	16.9	16.9	20.7	20.4	24.7	22.3	15.3	22.0	19.8	16.3	7.4	9.2	14.7	13.6	15.9	10.2	8.5	5.9	6.1	9.3	11.1	13.4	13.0	5.5	10.0	11.7	8.9	8.9	5.4	4.6	8.4	6.0	14.3	7.2	9.6	11.5	11.7	12.1	5.9	9.0	5.7	7.1	12.0	8.8	7.2	15.7	12.3	8.2	10.9	13.7	9.8	6.9	14.9	12.2	6.4	7.9	4.6	4.2	5.5	8.7	8.7	9.3	5.3	6.6	10.1	8.6	7.7	3.0	7.6	17.6	11.6	3.8	6.3	10.0	7.0	8.6	7.1	8.9	10.4	7.3	13.9	14.7	8.1	10.0	8.3	9.0	9.5	6.6	7.9	8.9	9.2	7.4	10.2	8.1	13.9	15.9	13.6	5.3	8.4	8.5	18.5	28.7	28.4	27.7	18.1	22.8	20.6	19.5	26.1	20.4
FAM124A	FLJ30707	ENSG00000150510	"Family with sequence similarity 124 member A"	Q86V42	13	51222334-51284241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.3"	"Group enriched"	"Detected in some"	4	"HAP1: 13.0;HUVEC TERT2: 7.7;NTERA-2: 25.5;SH-SY5Y: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048182	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA048182: "	"unprognostic (3.94e-3)"	"unprognostic (8.76e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.38e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.05e-2)"	5.3	3.5	7.7	4.7	19.6	0.7	2.6	2.6	15.0	3.3	7.2	40.3	0.3	1.4	3.8	8.4	2.4	3.6	4.3	7.1	13.5	7.4	6.7	1.5	3.3	1.5	29.1	7.7	1.3	2.7	1.2	1.5	6.2	18.8	6.5	2.6	3.8	12.4	8.1	1.8	1.9	2.1	8.9	25.3	13.2	4.1	2.3	26.7	0.3	2.8	0.6	1.1	4.1	1.8	0.8	1.0	2.7	0.9	1.2	0.8	0.3	0.0	1.2	0.9	0.8	0.2	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.4	0.0	0.0	0.1	13.0	0.1	0.1	0.0	1.9	0.0	0.3	0.0	1.0	0.6	0.8	0.3	0.1	0.4	0.0	7.7	0.1	0.0	0.0	0.2	3.1	0.2	25.5	2.0	0.7	0.0	1.8	0.0	0.1	1.8	9.8	0.4	1.6	1.5	0.2	0.7	0.1	0.0	0.9	0.6	0.9	0.2	0.0	0.0	1.2	2.2	1.0	2.7	0.8	0.8	0.8	0.6	0.8	0.6	0.5	0.6	0.4	0.8	0.7	0.7	2.4	1.2	0.9	1.0	0.6	0.3	7.7	19.6	2.6	11.8	13.5	7.4	29.1	7.7	18.8	26.7
FAM126A	"DRCTNNB1A, HCC, HYCC1, hyccin"	ENSG00000122591	"Family with sequence similarity 126 member A"	Q9BYI3	7	22889371-23014130	"Disease related genes, Predicted intracellular proteins"			"Cataract, Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042873	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042873: AB_2678207"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-4)"	"unprognostic (1.35e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavourable (6.04e-7)"	"prognostic unfavourable (5.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (9.03e-4)"	15.6	6.1	12.4	13.6	16.9	4.6	14.3	1.7	10.2	10.5	10.5	9.3	1.5	9.6	10.9	4.7	16.1	7.3	12.3	12.2	11.9	6.4	6.1	8.6	15.0	16.8	12.0	5.2	8.6	7.9	1.5	13.2	16.6	10.0	9.7	5.2	11.3	8.4	6.0	28.4	6.0	10.7	13.1	8.6	14.7	6.0	22.3	11.4	12.8	8.1	10.3	14.3	10.6	15.0	9.5	5.9	16.3	12.1	3.6	5.3	3.3	9.5	4.0	19.6	7.9	18.6	29.6	3.0	28.9	29.4	12.8	19.2	6.3	3.6	8.7	5.2	23.5	3.7	19.8	6.5	21.1	4.2	7.0	7.5	6.7	4.4	16.1	12.9	8.8	12.9	4.8	26.3	25.8	14.9	16.1	26.3	23.1	2.7	7.9	10.2	19.2	8.5	8.6	19.4	4.5	3.7	3.3	6.5	0.0	11.7	0.2	12.0	5.7	9.3	14.6	44.0	5.9	22.7	15.5	36.1	14.0	30.4	28.4	6.9	38.4	3.9	4.6	16.3	2.3	9.5	1.8	7.6	3.3	2.1	5.9	9.5	1.8	2.4	0.9	3.6	12.1	2.2	5.3	3.3	12.4	16.9	1.7	9.4	11.9	6.4	12.0	5.2	10.0	11.4
FAM129A	"C1orf24, GIG39, NIBAN"	ENSG00000135842	"Family with sequence similarity 129 member A"	Q9BZQ8	1	184790724-184974550	"Cancer-related genes, Predicted intracellular proteins"	"Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 129.1;urinary bladder: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 32.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"			40000	"Plasma membrane, Cytosol"		"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (4.52e-4)"	10.1	3.5	1.1	16.9	1.8	2.3	7.8	0.8	1.3	13.0	39.3	1.0	14.9	2.5	14.6	11.0	32.3	10.7	30.4	52.2	1.1	1.1	1.8	1.2	6.1	10.7	3.0	0.5	8.0	27.3	0.8	1.9	2.9	1.7	34.6	5.1	13.8	59.3	14.7	21.4	4.1	8.3	129.1	2.1	6.5	30.0	4.1	1.3	4.9	4.7	14.7	8.7	90.3	20.3	0.5	2.3	32.7	1.5	2.6	5.3	0.8	13.6	0.1	0.0	0.0	9.8	14.9	0.5	7.0	14.4	6.1	7.7	0.0	5.8	0.0	4.6	18.0	15.4	0.8	0.5	9.8	27.2	1.1	5.7	2.9	0.0	22.8	18.5	6.5	13.6	22.3	17.7	21.5	0.0	1.3	28.9	0.1	0.0	0.6	3.2	3.7	1.4	4.3	3.3	0.2	8.4	0.2	0.7	0.7	0.1	0.0	10.0	3.0	5.9	1.1	12.1	0.0	2.1	14.4	24.3	9.6	2.9	23.7	7.7	11.8	7.1	1.5	4.7	2.5	0.9	2.1	0.5	2.2	2.3	2.3	0.1	0.2	0.9	32.7	2.6	0.3	0.2	5.3	0.8	1.1	1.8	0.8	1.3	1.1	1.1	3.0	0.5	1.7	1.3
FAM129B	"bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Family with sequence similarity 129 member B"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 95.6;placenta: 103.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			1200000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	7.8	17.9	4.5	8.4	5.6	5.1	6.7	6.5	4.2	19.1	13.9	4.2	12.3	11.9	9.6	7.3	95.6	8.9	22.9	8.2	4.8	4.1	9.9	5.5	24.0	5.1	6.9	3.1	9.3	24.8	6.8	5.7	103.7	9.1	12.8	7.2	9.4	23.6	11.7	4.1	17.3	17.1	10.5	7.0	6.8	13.8	5.4	4.2	1.3	39.8	44.6	48.8	11.8	28.3	0.0	2.4	0.5	3.7	0.0	0.5	1.7	22.1	25.3	5.1	6.7	15.5	30.3	24.0	44.0	40.9	24.3	15.1	8.0	24.5	0.0	17.5	49.7	36.9	4.4	32.6	8.0	4.2	4.7	3.7	37.5	8.3	30.7	0.1	10.8	33.2	20.5	40.0	14.1	36.6	7.1	0.2	46.1	26.1	0.2	6.2	5.3	33.3	2.6	17.3	11.6	20.9	17.8	8.2	3.8	35.9	25.6	15.6	16.8	1.2	47.3	25.0	10.9	31.4	36.3	0.4	0.8	0.0	70.5	3.6	46.3	0.5	3.7	0.0	0.2	1.3	0.0	0.0	0.5	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.7	4.5	5.6	6.5	4.2	4.8	4.1	6.9	3.1	9.1	4.2
FAM129C	"BCNP1, FLJ39802"	ENSG00000167483	"Family with sequence similarity 129 member C"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9"	"Group enriched"	"Detected in some"	22	"Daudi: 29.1;REH: 14.6;U-698: 18.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	226	"memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2"	"Group enriched"	"Detected in many"	284	"B-cells: 19.5;dendritic cells: 37.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043277	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.5	0.2	0.2	37.9	0.2	12.1	0.2	0.3	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.6	0.2	0.2	0.5	0.3	0.9	17.4	0.2	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.4	9.9	0.2	0.1	0.2	12.3	0.0	0.3	28.5	0.4	0.5	0.0	2.5	0.5	0.4	35.4	3.0	0.4	19.5	37.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.7	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0
FAM131B	KIAA0773	ENSG00000159784	"Family with sequence similarity 131 member B"	Q86XD5	7	143353400-143362770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.1;NTERA-2: 16.5;PC-3: 15.9;SCLC-21H: 16.2"	"Cancer enriched"	"Detected in many"	11	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021371, HPA029992"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021371: AB_1852341, HPA029992: "	"unprognostic (1.70e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-2)"	1.5	2.1	10.0	2.0	12.4	0.9	1.2	37.2	47.1	2.7	2.0	15.1	0.0	1.7	4.4	1.0	1.7	1.6	1.4	1.1	9.1	6.8	1.1	0.9	1.5	1.3	14.6	12.3	1.0	0.9	6.4	0.4	0.9	13.8	1.0	2.2	0.0	0.9	1.0	7.7	0.8	2.1	5.6	18.6	1.1	1.4	1.2	11.3	0.0	0.9	0.0	1.1	1.2	0.5	0.0	0.2	0.0	0.5	0.1	2.1	0.2	0.0	0.1	4.9	0.0	4.0	5.1	0.0	0.2	1.2	0.8	0.2	10.1	0.0	0.0	0.0	0.3	0.2	2.0	0.4	0.7	2.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.3	16.5	15.9	0.0	0.0	0.0	0.0	0.0	16.2	0.5	0.2	1.1	0.0	0.0	0.0	0.7	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.1	3.2	0.1	0.0	0.3	0.0	2.1	0.5	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.2	10.0	12.4	37.2	25.0	9.1	6.8	14.6	12.3	13.8	11.3
FAM131C	"C1orf117, FLJ36766"	ENSG00000185519	"Family with sequence similarity 131 member C"	Q96AQ9	1	16057769-16073632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 41.1"	"Cell line enhanced"	"Detected in some"		"A549: 10.7;HEK 293: 6.9;PC-3: 7.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031046	Uncertain		Approved	"Nucleoli,Intermediate filaments,Cytosol"				"Nucleoli, Intermediate filaments, Cytosol"		"HPA031046: "	"unprognostic (4.69e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-1)"	"prognostic favourable (9.33e-6)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.44e-1)"	0.7	7.8	5.6	0.6	4.0	0.5	1.1	41.1	9.1	1.1	1.0	7.7	0.0	0.7	1.0	1.4	1.2	1.1	1.4	5.2	5.0	6.5	10.4	2.2	0.6	0.5	10.7	3.8	1.2	7.1	2.0	5.6	0.7	8.7	0.8	0.6	0.8	6.3	1.6	0.6	3.2	0.8	0.9	17.7	0.6	1.6	1.3	4.9	0.0	1.7	0.0	1.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.2	10.7	0.4	0.6	0.0	0.0	0.0	1.0	0.9	1.2	2.7	0.2	2.3	0.0	0.4	0.5	1.2	1.4	0.3	0.3	0.0	6.9	0.0	2.4	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.9	0.7	0.0	0.0	0.1	2.2	0.0	0.0	0.4	7.9	0.0	0.0	4.5	0.8	0.0	1.5	3.1	0.4	1.3	0.3	0.3	0.0	1.7	0.2	3.8	0.0	0.0	1.7	0.1	0.0	3.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	4.0	41.1	7.1	5.0	6.5	10.7	3.8	8.7	4.9
FAM135A	"FLJ20176, KIAA1411"	ENSG00000082269	"Family with sequence similarity 135 member A"	Q9P2D6	6	70412941-70561174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031743, HPA031744"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA031743: AB_10600767, HPA031744: AB_10601101"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (8.00e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.69e-4)"	"unprognostic (4.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (3.46e-4)"	"unprognostic (3.99e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.65e-2)"	5.8	4.3	6.4	9.2	6.8	1.7	5.3	14.0	10.7	9.6	13.3	4.0	5.3	14.9	7.7	4.9	33.8	5.4	8.8	5.2	5.4	5.2	9.6	5.5	5.5	4.1	6.1	7.1	8.0	6.9	16.4	13.8	22.7	8.5	18.9	13.0	4.2	10.4	6.7	5.7	14.2	27.9	4.8	8.9	4.5	12.3	11.0	6.0	4.1	4.8	13.1	10.6	7.6	14.4	3.9	6.3	3.3	5.3	5.4	2.2	1.5	5.8	3.4	7.6	4.7	3.5	2.6	6.8	1.9	3.8	2.1	3.5	6.6	4.8	10.5	13.7	1.4	5.7	7.5	4.7	3.6	5.0	6.2	4.8	3.7	5.8	4.3	8.8	5.0	2.2	11.0	4.0	10.9	5.4	7.5	5.5	2.3	0.6	1.6	4.1	4.9	2.8	5.1	23.9	5.0	7.8	3.2	8.0	2.4	2.3	2.0	2.3	1.4	4.0	2.6	1.8	4.6	1.7	4.3	6.5	7.4	4.2	1.2	8.0	3.2	3.3	4.3	0.2	1.5	3.5	1.9	3.0	1.4	0.6	6.3	3.9	2.2	1.3	1.2	5.4	5.3	1.0	1.7	1.5	6.4	6.8	14.0	10.7	5.4	5.2	6.1	7.1	8.5	6.0
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2"	"Low region specificity"	"Detected in all"							"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: , HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favourable (4.28e-4)"	58.6	10.8	9.1	11.0	9.3	6.5	19.0	17.9	18.5	15.5	41.0	3.7	7.4	30.5	10.9	12.0	9.3	14.8	10.7	8.8	9.6	5.7	14.0	22.9	13.3	5.3	10.0	6.8	17.8	23.5	45.5	11.2	20.7	11.4	15.9	9.3	11.5	13.3	8.0	8.4	17.5	30.5	15.6	19.4	4.9	13.4	11.1	12.9	3.2	20.4	16.1	4.0	30.4	23.8	0.1	5.7	1.4	6.5	0.7	5.2	2.6	2.4	3.7	5.5	7.2	32.2	13.3	9.1	5.7	6.9	2.2	2.1	3.1	5.7	0.1	2.3	4.0	1.5	8.1	4.1	5.1	0.3	5.6	4.0	5.1	0.4	9.4	3.3	0.5	12.7	3.3	5.7	2.1	3.8	10.5	0.4	4.9	0.1	0.3	1.5	6.8	3.8	5.5	9.4	2.1	4.2	12.0	14.0	3.7	1.4	4.4	5.4	3.1	0.1	1.4	6.4	3.5	3.1	3.2	1.9	1.1	0.0	9.5	0.3	3.3	0.1	6.5	0.1	1.8	3.2	1.3	0.1	4.7	0.6	5.7	0.1	5.2	1.3	1.4	0.7	1.0	1.9	2.5	2.6	9.1	9.3	17.9	18.5	9.6	5.7	10.0	6.8	11.4	12.9
FAM13C	FAM13C1	ENSG00000148541	"Family with sequence similarity 13 member C"	Q8NE31	10	59246129-59363181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.2;HSkMC: 6.8;NTERA-2: 5.7;SCLC-21H: 11.3;SH-SY5Y: 6.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037888	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037888: AB_10962981"	"unprognostic (3.68e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.69e-5)"	"unprognostic (8.54e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-6)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.66e-3)"	11.8	17.0	16.1	3.8	22.3	0.3	7.7	12.4	24.9	9.4	6.4	36.6	3.2	4.5	9.0	8.7	14.4	15.3	11.6	7.8	18.9	15.9	3.8	2.3	10.0	4.5	23.8	18.8	22.2	2.5	4.0	8.3	2.9	21.2	17.9	6.7	16.5	4.9	8.7	15.3	7.3	5.0	12.5	33.2	5.0	3.9	5.2	28.9	0.0	6.0	7.6	2.5	7.4	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	1.7	0.3	0.1	0.0	1.6	0.0	5.2	2.4	0.2	0.0	0.0	6.8	0.8	0.3	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	5.7	0.5	0.0	1.1	0.0	0.0	1.7	11.3	6.6	0.0	0.3	0.0	0.9	0.0	0.0	3.3	3.0	0.1	2.6	0.0	0.0	0.1	4.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	22.3	12.4	23.4	18.9	15.9	23.8	18.8	21.2	28.9
FAM151B	UNQ9217	ENSG00000152380	"Family with sequence similarity 151 member B"	Q6UXP7	5	80487969-80542563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.0;eosinophil: 2.2;intermediate monocyte: 1.1;myeloid DC: 3.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.5;granulocytes: 2.2;monocytes: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043805	Uncertain		Approved	Cytosol				Cytosol		"HPA043805: AB_10794287"	"unprognostic (1.29e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.28e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.46e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.44e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.63e-1)"	2.8	4.6	5.2	2.4	7.7	13.1	2.5	4.5	7.2	3.1	1.8	2.2	0.2	1.7	3.3	4.8	2.5	4.4	3.2	3.0	8.5	3.6	5.5	3.7	2.9	2.9	3.1	4.8	2.5	6.8	3.0	6.9	5.6	3.2	3.0	2.3	2.5	3.4	2.1	2.6	1.7	1.4	3.1	2.9	3.0	2.0	3.2	2.0	0.0	2.8	0.3	1.6	2.7	2.4	0.0	3.5	2.2	2.0	0.1	0.2	0.5	0.2	2.8	1.2	5.2	4.4	6.5	2.0	2.2	3.3	1.8	4.1	0.2	2.2	0.0	0.5	5.8	1.4	1.8	0.5	1.5	0.5	1.0	0.7	1.0	0.8	1.9	0.7	2.9	3.0	2.0	2.3	0.1	2.9	0.1	0.9	3.1	2.3	0.4	0.5	0.1	1.0	0.6	4.3	0.7	2.0	1.0	0.5	1.4	0.8	2.1	2.2	3.2	2.3	1.3	0.3	0.3	0.0	0.8	0.2	1.3	0.0	3.0	2.4	1.9	0.0	2.0	2.2	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.5	5.2	7.7	4.5	7.2	8.5	3.6	3.1	4.8	3.2	2.0
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409216-151663632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.6"	"Cell line enhanced"	"Detected in many"		"A-431: 8.1;HaCaT: 7.4;HeLa: 9.9;hTERT-HME1: 9.3;SiHa: 8.8;SK-BR-3: 7.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046348	Enhanced		Approved	Cytosol				Cytosol		"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	1.4	1.2	3.0	3.4	0.8	1.5	3.8	7.5	0.9	6.3	5.2	0.6	10.4	1.7	6.1	5.9	13.1	2.8	4.9	6.5	0.7	0.7	7.0	1.6	5.4	0.1	0.6	0.0	3.7	23.7	11.1	9.4	1.8	4.8	4.5	3.3	10.0	11.1	12.5	33.6	12.6	9.0	1.8	0.7	0.7	2.3	3.5	0.0	0.9	11.4	22.0	10.0	6.2	5.0	0.0	5.8	0.4	0.0	0.1	0.1	0.0	8.1	0.7	0.0	0.2	0.0	0.0	3.0	0.4	1.9	0.8	0.2	3.5	3.0	0.0	0.9	0.1	7.4	2.1	6.2	1.2	0.0	3.6	0.0	9.9	0.8	0.0	0.0	0.1	0.1	6.2	0.0	9.3	0.1	0.0	0.0	0.5	1.2	0.0	0.0	2.9	0.8	0.0	2.0	0.3	4.3	5.6	1.4	0.4	8.8	7.8	0.0	3.3	0.0	0.0	0.5	3.6	0.2	1.4	0.0	0.0	0.0	2.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	3.0	0.8	7.5	0.9	0.7	0.7	0.6	0.0	4.8	0.0
FAM160B1	"bA106M7.3, KIAA1600"	ENSG00000151553	"Family with sequence similarity 160 member B1"	Q5W0V3	10	114821744-114899832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043624	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA043624: AB_10797145"	"unprognostic (2.61e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.45e-3)"	"unprognostic (6.43e-2)"	"unprognostic (9.87e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (4.02e-6)"	"unprognostic (3.41e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.25e-2)"	15.9	13.3	9.9	12.1	13.1	40.9	31.0	10.2	15.7	11.7	10.8	6.1	11.8	11.2	18.4	10.6	9.8	13.4	11.0	18.1	7.7	5.9	7.4	16.8	13.4	18.7	5.9	8.5	15.1	10.8	13.6	11.4	14.4	7.0	10.0	7.6	8.5	9.6	11.0	42.6	9.4	13.4	18.7	6.7	12.1	10.9	16.0	5.2	17.7	12.9	7.2	8.8	13.6	19.7	3.4	3.2	15.0	2.7	3.9	8.7	2.0	9.2	5.2	5.7	8.5	14.0	16.0	6.6	16.8	17.0	10.1	8.1	1.8	3.7	5.6	5.0	15.8	6.3	2.7	7.0	12.0	18.9	5.3	2.2	9.1	4.1	10.2	5.9	7.7	12.4	6.8	7.5	12.2	13.5	3.0	14.5	18.7	4.4	10.2	5.9	3.7	3.6	8.9	9.4	3.8	6.8	5.7	1.2	5.1	7.4	8.1	8.7	3.2	3.5	13.4	6.2	4.0	18.1	5.9	5.5	1.6	6.5	8.1	15.1	5.8	15.0	2.7	3.9	5.0	2.1	3.7	3.4	6.8	8.5	3.1	3.2	3.8	5.0	13.6	3.9	2.3	3.2	8.7	2.0	9.9	13.1	10.2	15.7	7.7	5.9	5.9	8.5	7.0	5.2
FAM160B2	"FLJ21801, RAI16"	ENSG00000158863	"Family with sequence similarity 160 member B2"	Q86V87	8	22089159-22104898	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025040	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA025040: AB_1856049"	"unprognostic (3.45e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.28e-2)"	"prognostic favourable (4.56e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.67e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.75e-3)"	15.8	11.8	9.6	13.1	10.0	6.6	14.3	14.3	14.8	12.9	13.2	12.9	20.8	12.0	13.2	16.9	13.7	14.1	14.5	26.0	8.5	6.9	12.3	9.8	11.0	11.2	12.5	10.5	11.4	22.1	15.3	14.1	22.4	10.9	14.4	6.0	13.4	18.8	25.1	15.1	24.4	13.4	25.3	10.4	12.3	16.1	6.4	10.3	6.5	16.0	11.6	13.2	19.9	11.2	2.7	0.9	0.5	1.4	1.7	3.2	2.1	3.7	9.2	4.4	6.8	8.9	8.3	6.8	5.7	12.5	8.5	5.9	3.8	4.5	3.8	6.3	17.9	5.2	3.2	10.3	1.8	3.3	3.5	5.7	2.4	2.6	12.1	1.5	5.3	13.9	7.0	6.2	4.2	8.7	3.8	3.3	8.0	7.7	4.1	2.2	1.8	3.2	4.3	3.2	2.2	7.1	9.1	1.5	4.8	3.5	7.4	4.8	4.4	3.4	8.3	8.6	6.6	7.7	3.9	2.6	0.8	0.7	9.1	2.8	9.2	0.0	1.2	0.5	3.2	0.7	1.9	2.7	2.1	2.6	0.8	2.3	1.9	2.7	0.3	1.7	1.4	0.9	0.3	2.1	9.6	10.0	14.3	14.8	8.5	6.9	12.5	10.5	10.9	10.3
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA058113"	Approved		Enhanced	Mitochondria,Cytosol			29000	"Mitochondria, Cytosol"		"HPA035856: AB_10611965, HPA058113: AB_2683609"	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favourable (3.93e-4)"	13.6	32.8	24.9	18.6	49.9	14.1	18.7	10.7	44.8	21.8	57.8	11.5	19.6	22.7	17.0	25.5	58.7	13.8	25.4	54.2	40.2	21.7	35.9	78.1	12.2	16.5	23.6	27.7	30.2	71.5	24.6	16.1	7.3	31.0	27.3	61.3	16.2	17.7	23.1	56.6	29.2	21.2	27.2	24.4	10.9	25.7	16.9	18.8	8.6	17.9	48.6	16.7	34.6	36.0	26.8	29.4	25.3	24.4	16.4	33.1	12.9	30.4	6.5	9.7	18.1	17.9	16.6	5.0	12.5	11.2	11.9	30.5	16.3	14.0	33.2	21.8	4.3	21.4	17.6	30.4	31.9	17.1	13.2	26.9	11.3	29.1	11.8	26.2	9.6	19.2	16.0	11.3	24.0	15.8	18.1	13.3	17.0	11.9	26.7	31.9	14.3	34.7	16.1	13.9	43.2	34.5	74.4	14.6	11.7	9.3	22.2	25.5	13.9	13.0	11.1	11.8	8.5	6.9	12.9	26.5	9.0	33.7	35.1	25.7	5.4	2.6	9.3	25.3	21.7	23.0	32.1	26.8	29.8	27.1	29.4	23.9	32.6	33.1	3.0	16.4	24.4	24.6	27.1	12.9	24.9	49.9	10.7	44.8	40.2	21.7	23.6	27.7	31.0	18.8
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133578415-133586197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 41.7"	"Cell line enriched"	"Detected in some"	21	"SH-SY5Y: 39.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067336	Supported		Approved	"Nuclear bodies,Plasma membrane,Cytosol"				"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: "	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	8.2	10.0	0.0	2.7	0.0	0.0	3.2	41.7	0.0	0.4			0.0	0.0	0.3	0.0	0.0	0.4	1.2	6.1	3.9	0.1	2.7	0.0	1.3	3.3		0.0	0.1	0.0	0.0	0.6		0.0	0.4		0.4	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.5	0.1	0.0	0.0	0.0	1.8	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM169A	"KIAA0888, SLAP75"	ENSG00000198780	"Family with sequence similarity 169 member A"	Q9Y6X4	5	74777574-74866951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;epididymis: 23.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.1;Hep G2: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041574	Enhanced		Supported	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA041574: AB_10794382"	"unprognostic (3.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.75e-4)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	0.7	4.2	9.9	1.4	13.5	1.5	1.1	11.0	21.8	1.7	1.9	5.2	2.9	0.7	3.8	23.6	0.9	3.8	3.0	2.2	9.4	14.2	6.7	3.1	0.8	2.5	9.6	10.3	3.4	2.0	10.7	8.3	1.2	10.4	6.4	3.0	11.3	1.9	7.0	0.8	0.7	1.0	1.0	11.1	2.5	2.1	15.5	4.6	3.7	9.6	0.0	2.5	4.1	1.1	1.4	0.5	0.0	0.0	0.8	4.0	1.2	5.2	4.7	3.3	4.5	0.0	0.0	23.1	0.7	1.7	3.5	3.6	2.1	3.5	0.0	2.4	0.0	3.7	6.9	10.4	3.7	3.9	7.9	1.4	0.8	15.7	0.1	0.0	0.0	0.1	11.0	0.8	5.2	0.0	0.0	0.0	2.1	1.5	4.9	0.0	8.4	2.6	7.2	2.1	0.3	3.3	8.3	2.0	2.7	8.7	3.9	0.6	3.7	1.0	0.0	0.2	3.4	0.0	3.8	12.8	11.9	0.0	0.4	0.0	0.4	0.0	0.0	0.0	2.7	0.0	4.0	0.8	1.6	2.5	0.0	1.4	3.5	3.4	0.0	0.8	0.0	0.5	0.9	1.2	9.9	13.5	11.0	17.1	9.4	14.2	9.6	10.3	10.4	4.6
FAM172A	"C5orf21, DKFZP564D172"	ENSG00000113391	"Family with sequence similarity 172 member A"	Q8WUF8	5	93618069-94111699	"Predicted intracellular proteins, Predicted secreted proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012299, HPA045505"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"HPA012299: AB_1845724, HPA045505: "	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.03e-2)"	18.4	15.4	24.2	17.8	21.8	9.8	19.3	28.8	20.8	19.9	14.4	15.5	13.9	11.2	19.1	16.1	17.7	18.8	14.3	14.0	21.0	19.9	18.5	8.0	14.9	22.4	18.9	13.0	23.0	18.2	20.7	28.4	15.1	15.6	19.4	12.3	12.6	14.3	22.6	6.2	11.8	12.9	26.2	20.8	13.6	13.7	8.3	16.6	16.1	22.8	9.5	16.1	19.0	15.7	9.8	7.1	13.1	7.3	12.3	11.9	6.4	4.5	5.3	13.1	14.7	15.8	19.1	6.8	9.8	7.6	4.2	4.2	3.6	6.4	6.6	7.4	11.5	4.0	3.9	13.8	10.0	4.5	4.7	8.7	11.2	2.4	6.7	6.7	10.2	16.7	7.9	3.9	7.5	9.7	1.7	2.0	17.4	5.0	5.6	5.1	2.0	4.4	6.3	13.8	6.2	6.7	8.9	11.7	20.9	7.9	3.3	7.2	8.1	8.2	9.5	10.2	9.2	6.6	11.5	8.5	12.3	7.5	16.0	7.5	18.6	13.1	5.4	7.0	11.9	7.3	11.9	9.4	8.9	8.7	7.1	9.8	10.1	10.2	13.0	12.3	5.1	6.8	9.2	6.4	24.2	21.8	28.8	20.8	21.0	19.9	18.9	13.0	15.6	16.6
FAM173A	"C16orf24, MGC2494"	ENSG00000103254	"Family with sequence similarity 173 member A"	Q9BQD7	16	720581-722601	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046262	Approved		Approved	Cytosol				Cytosol		"HPA046262: AB_10963070"	"unprognostic (3.94e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.54e-2)"	"prognostic favourable (8.88e-4)"	"unprognostic (2.11e-1)"	"unprognostic (4.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.70e-2)"	"prognostic favourable (4.24e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.28e-2)"	"unprognostic (3.60e-3)"	16.0	10.4	15.6	10.3	9.1	7.3	9.6	8.9	21.5	4.8	15.5	8.2	9.3	19.1	6.5	8.3	6.1	5.2	10.6	11.1	13.6	11.5	18.6	15.8	7.5	7.5	11.3	12.2	4.3	10.2	8.5	13.4	5.8	9.2	8.4	3.5	6.5	15.1	8.6	37.3	6.2	14.5	5.6	9.5	15.0	19.3	21.8	7.9	8.6	7.8	11.1	7.1	5.9	8.9	9.0	6.0	5.3	6.8	6.3	18.0	4.2	6.3	4.2	0.8	2.3	0.1	0.3	10.1	5.5	1.4	1.3	1.5	4.2	5.3	8.1	9.9	0.6	9.9	0.8	2.7	0.3	18.0	11.2	3.4	4.4	4.4	1.9	5.7	4.7	0.7	2.0	0.6	1.6	0.5	7.2	3.7	1.1	10.3	0.9	13.7	3.2	13.8	3.4	2.0	15.3	3.5	2.3	3.6	9.5	2.9	4.7	9.1	5.2	5.1	4.6	1.2	9.9	3.5	3.8	32.9	14.7	8.8	2.5	4.2	3.1	0.0	6.8	5.3	7.3	3.9	16.5	9.0	5.8	12.9	4.4	9.0	5.9	18.0	0.8	6.3	4.8	6.0	12.5	4.2	15.6	9.1	8.9	21.5	13.6	11.5	11.3	12.2	9.2	7.9
FAM174A	"NS5ATP6, TMEM157, UNQ1912"	ENSG00000174132	"Family with sequence similarity 174 member A"	Q8TBP5	5	100535305-100586741	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	8	"neutrophil: 28.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019539	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA019539: AB_2293743"	"unprognostic (2.34e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-3)"	"prognostic unfavourable (2.57e-6)"	"unprognostic (5.55e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.69e-2)"	"prognostic favourable (5.48e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	15.6	24.6	18.8	8.3	21.0	3.0	15.3	14.2	26.8	11.1	12.0	16.5	14.0	11.8	11.3	15.2	18.0	35.9	9.5	17.3	22.0	25.0	18.3	15.2	17.6	5.5	19.3	18.2	9.1	26.8	23.6	21.9	15.6	24.1	19.5	9.1	16.6	16.5	13.7	38.8	20.4	10.7	9.6	19.4	10.1	15.5	37.3	12.2	4.4	14.3	17.0	9.6	9.9	11.7	1.5	2.2	28.0	2.7	2.5	2.7	1.6	4.9	5.3	2.1	6.8	5.3	4.2	7.6	11.5	6.4	4.7	6.4	1.0	6.5	0.9	23.4	4.9	4.3	1.8	7.4	3.4	6.0	5.4	0.6	9.1	3.0	7.2	2.5	6.3	5.5	17.7	3.6	2.7	7.0	1.8	6.9	7.8	10.0	0.7	5.4	1.1	14.3	1.7	8.2	8.6	8.2	6.0	4.3	11.6	8.0	7.2	6.3	7.0	5.6	8.0	6.0	3.7	9.5	9.0	21.7	28.4	1.1	7.4	3.4	5.2	3.6	2.5	3.4	1.8	2.7	2.7	1.4	1.8	2.2	2.2	1.5	1.6	2.1	28.0	2.5	2.7	2.2	2.2	1.6	18.8	21.0	14.2	26.8	22.0	25.0	19.3	18.2	24.1	12.2
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.4"	"Cell line enhanced"	"Detected in many"		"AF22: 16.4;HEK 293: 9.6;K-562: 13.4;SCLC-21H: 10.7;SH-SY5Y: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: , HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	4.0	2.8	14.2	3.7	13.7	0.6	6.1	13.9	16.0	2.8	3.0	4.6	0.4	3.8	3.9	3.6	2.6	3.9	2.3	2.4	11.3	10.5	6.7	6.4	15.3	4.9	9.1	10.0	7.1	5.1	14.2	15.4	31.4	11.9	4.0	1.9	2.7	2.9	4.1	1.2	2.3	2.6	3.1	4.6	1.0	1.7	23.2	7.1	0.1	8.5	1.1	5.8	2.1	2.0	0.5	0.0	0.0	0.2	0.3	1.9	0.0	0.1	0.3	16.4	1.6	0.2	0.2	0.0	0.5	0.3	0.5	0.8	2.1	1.3	1.1	0.0	0.2	0.0	5.0	0.0	0.2	1.3	9.6	0.5	1.5	7.2	0.1	0.0	1.5	0.3	0.2	0.1	0.0	0.0	13.4	0.6	0.2	0.3	0.3	0.0	5.5	1.2	0.0	0.0	0.0	0.1	0.1	10.7	7.9	0.5	0.5	1.6	2.2	1.9	0.2	0.8	0.5	0.2	4.1	4.1	4.4	0.3	1.3	0.0	2.1	0.0	0.0	0.0	0.2	0.2	0.6	0.5	0.2	0.0	0.0	0.1	1.5	1.2	0.0	0.3	0.0	0.0	1.9	0.0	14.2	13.7	13.9	12.9	11.3	10.5	9.1	10.0	11.9	7.1
FAM185A	MGC35361	ENSG00000222011	"Family with sequence similarity 185 member A"	Q8N0U4	7	102748971-102809225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020470, HPA029883"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA020470: AB_1853890, HPA029883: AB_10601903"	"unprognostic (8.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.03e-1)"	"prognostic favourable (9.36e-5)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.25e-2)"	3.7	4.6	6.6	3.0	4.9	3.6	3.8	9.3	6.3	5.6	4.3	4.4	4.1	2.3	3.8	3.1	4.4	3.1	3.4	4.2	4.2	2.3	4.0	9.4	4.8	2.3	5.1	6.0	4.7	3.7	8.7	4.8	2.8	4.0	5.2	4.3	6.1	5.1	8.4	9.5	4.6	3.1	3.7	4.5	3.0	5.9	2.2	5.1	3.0	3.8	2.4	2.7	4.4	4.0	3.3	2.6	7.5	3.0	1.2	2.2	0.9	1.3	3.5	1.6	4.1	0.6	1.7	4.2	0.9	1.7	1.6	0.5	3.4	2.9	0.0	2.2	1.2	3.6	2.3	2.4	1.6	1.7	2.0	0.2	0.4	4.1	1.0	2.9	0.4	0.0	2.7	0.9	1.2	2.0	2.1	1.5	1.6	2.7	1.4	0.3	1.7	0.0	0.3	0.1	10.1	0.8	2.5	1.4	2.9	3.4	5.3	0.4	3.2	0.0	3.5	0.4	1.7	2.5	0.5	4.8	1.5	0.6	0.7	0.9	0.0	0.0	3.0	3.3	2.1	2.2	0.9	3.3	1.4	2.2	2.6	1.9	1.3	1.5	7.5	1.2	1.0	2.4	1.6	0.9	6.6	4.9	9.3	6.3	4.2	2.3	5.1	6.0	4.0	5.1
FAM187A		ENSG00000214447	"Family with sequence similarity 187 member A"	A6NFU0	17	44899712-44905390	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.2;testis: 37.0"	"Cell line enhanced"	"Detected in many"		"A549: 8.7;RPTEC TERT1: 12.3;U-87 MG: 13.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.9"	"Low lineage specificity"	"Detected in many"											"HPA022794, HPA043131"	Approved		Approved	Cytosol				Cytosol		"HPA022794: AB_1848384, HPA043131: AB_10796686"																		0.7	1.3	5.8	0.6	8.9	0.7	1.4	1.0	5.0	2.5	0.9	3.1	1.7	0.3	1.9	2.7	0.5	21.2	3.0	0.6	5.4	6.7	3.7	0.5	2.0	0.7	5.3	4.1	3.7	1.6	2.2	2.2	0.3	4.5	1.1	1.0	1.7	1.3	1.9	0.4	0.6	0.6	1.1	4.2	0.4	0.6	37.0	1.1	0.3	4.5	0.2	0.6	0.9	0.3	0.8	1.8	1.9	2.9	0.2	0.8	2.0	1.7	8.7	2.2	1.7	2.7	3.0	1.4	0.5	4.2	2.4	3.0	2.6	4.6	0.2	1.4	1.6	5.2	0.5	2.2	1.1	5.2	2.1	0.7	3.6	0.7	1.1	1.0	0.7	0.4	3.0	4.7	1.0	1.1	1.6	0.1	0.9	1.1	0.1	1.3	0.7	1.2	0.8	0.2	0.4	12.3	0.8	5.8	1.3	0.5	0.1	0.7	6.2	1.0	0.6	1.0	2.2	1.2	1.0	0.1	0.2	0.4	13.9	0.8	1.1	0.0	2.9	1.9	0.2	0.8	0.0	0.0	0.0	0.8	1.8	0.8	0.0	0.1	0.0	0.2	0.3	0.0	0.6	2.0	5.8	8.9	1.0	5.0	5.4	6.7	5.3	4.1	4.5	1.1
FAM193A	"C4orf8, RES4-22"	ENSG00000125386	"Family with sequence similarity 193 member A"	P78312	4	2536631-2732565	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043116	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043116: AB_10795767"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.84e-1)"	"prognostic favourable (4.80e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.96e-3)"	17.1	14.1	17.8	25.5	17.7	22.4	19.7	33.0	23.2	17.4	14.5	18.2	21.3	15.3	23.5	16.0	12.1	16.4	17.2	11.9	16.7	14.3	12.4	13.7	20.2	17.3	18.0	11.8	23.7	17.4	20.4	21.5	15.3	16.1	16.4	11.9	18.8	16.4	19.3	18.1	16.6	15.8	16.0	13.9	17.0	14.7	29.1	17.2	26.3	15.4	13.7	16.0	14.6	30.7	2.5	3.9	5.7	6.3	3.2	2.9	1.0	7.0	8.8	16.5	9.4	10.0	10.3	9.0	10.8	9.2	10.6	9.0	9.0	11.5	13.9	6.7	11.8	6.1	11.4	7.7	8.7	8.6	7.5	20.7	10.9	9.3	12.2	12.4	14.6	11.3	8.2	10.4	10.7	10.5	14.5	15.3	8.7	7.4	20.3	20.2	13.5	10.0	20.0	8.7	6.8	7.1	9.2	14.5	12.5	9.2	6.4	9.3	11.8	12.8	14.1	16.3	9.7	8.8	14.0	15.5	11.4	13.4	9.2	10.4	11.5	5.7	2.2	1.8	2.2	1.5	1.5	1.5	1.9	2.9	1.4	2.5	1.9	2.7	4.2	3.2	6.3	3.9	1.4	1.0	17.8	17.7	33.0	23.2	16.7	14.3	18.0	11.8	16.1	17.2
FAM199X	CXorf39	ENSG00000123575	"Family with sequence similarity 199, X-linked"	Q6PEV8	X	104166620-104195902	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003093	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA003093: AB_1078597"	"unprognostic (2.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.08e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-2)"	19.5	13.4	19.6	7.5	24.4	13.0	13.1	17.1	25.9	11.1	9.3	14.2	21.0	8.7	13.0	39.2	9.0	10.5	7.8	8.0	17.4	19.2	17.1	8.6	9.0	8.7	19.3	17.9	13.9	13.1	24.9	11.8	9.9	22.6	11.8	9.7	8.7	10.8	16.6	10.7	10.4	8.2	9.9	16.9	9.2	8.9	10.9	12.9	6.5	19.4	5.6	8.5	9.5	12.8	3.8	2.3	2.6	2.0	1.5	3.9	1.3	16.9	10.8	9.8	10.7	7.3	8.8	9.9	9.0	8.5	11.8	11.1	8.3	14.2	9.4	11.2	8.3	12.9	17.6	13.3	19.4	4.5	9.8	7.4	13.8	9.4	10.4	14.0	10.5	6.8	17.0	11.6	11.7	11.9	8.0	21.2	13.1	12.1	7.5	10.0	9.7	12.6	8.0	6.4	11.7	20.1	11.4	5.3	6.5	21.8	14.6	15.6	7.3	7.0	14.6	13.2	4.8	10.2	9.6	10.0	8.3	10.5	14.9	15.2	9.6	2.2	2.0	1.1	2.8	1.5	3.2	1.6	2.6	3.4	2.3	3.8	3.9	2.3	2.6	1.5	2.0	1.2	2.9	1.3	19.6	24.4	17.1	23.3	17.4	19.2	19.3	17.9	22.6	12.9
FAM206A	"C9orf6, CG-8, FLJ20457, Simiate"	ENSG00000119328	"Family with sequence similarity 206 member A"	Q9NX38	9	108934181-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035917, HPA035918"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Cytosol"	"Cytokinetic bridge"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	12.0	11.4	16.8	9.0	28.8	12.9	17.8	12.3	19.2	11.6	13.3	12.8	10.3	13.8	12.6	22.9	16.0	18.9	9.9	13.3	16.2	16.0	14.1	12.6	12.0	9.9	16.7	20.0	13.7	13.7	23.3	28.5	10.6	16.0	11.9	15.1	7.6	16.9	13.5	12.2	22.9	15.1	14.4	16.6	7.5	13.0	16.7	14.8	8.4	20.9	10.2	10.6	10.5	11.7	10.6	23.6	24.4	20.7	12.4	16.1	11.9	8.7	9.5	10.4	11.4	18.5	25.7	13.9	9.0	9.7	8.4	6.9	14.1	4.8	8.6	5.0	8.0	21.4	8.3	8.7	8.4	5.2	8.6	5.2	12.9	13.2	15.5	18.8	7.4	13.5	16.6	10.2	23.6	11.4	18.4	8.9	9.9	24.8	13.4	7.6	11.7	13.9	6.7	16.8	9.0	10.9	9.8	13.4	7.3	12.9	11.3	14.1	15.4	10.2	7.4	4.7	8.6	20.8	10.6	7.3	18.9	6.3	15.0	7.5	6.8	19.9	20.6	19.0	9.9	20.6	15.2	10.6	15.8	13.1	22.6	6.9	16.1	12.1	24.4	12.4	20.7	23.6	13.0	11.9	16.8	28.8	12.3	19.2	16.2	16.0	16.7	20.0	16.0	14.8
FAM208B	"bA318E3.2, C10orf18, FLJ20360, KIAA2006"	ENSG00000108021	"Family with sequence similarity 208 member B"	Q5VWN6	10	5684838-5763740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038042, HPA038043, HPA061547"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: "	"unprognostic (3.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.25e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.12e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (2.39e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.23e-2)"	15.4	15.5	10.1	22.9	13.6	16.1	16.4	18.9	13.4	18.7	15.0	11.8	13.6	8.6	21.2	20.7	14.6	19.6	13.4	16.9	12.0	9.3	13.6	15.9	15.1	20.5	15.0	10.6	23.8	19.4	26.2	24.3	16.0	12.6	15.9	15.8	12.9	15.6	17.0	26.9	12.7	16.4	17.4	12.8	16.7	15.7	29.7	14.0	19.5	22.6	14.1	21.1	17.4	22.0	4.3	2.2	1.8	2.4	8.6	3.2	0.8	17.2	14.7	9.5	16.0	12.2	14.6	13.3	14.8	9.4	12.7	16.2	15.5	10.3	35.4	9.5	14.5	13.7	27.0	15.1	20.7	6.9	18.2	16.5	11.4	10.4	12.2	12.1	9.9	11.1	17.0	20.7	17.7	14.7	26.5	8.3	14.2	11.7	15.7	4.3	11.5	9.5	11.7	13.2	12.4	7.7	15.8	11.7	13.2	14.7	13.4	10.5	17.5	9.6	14.7	16.2	17.5	31.1	20.1	10.2	9.6	31.6	8.0	12.0	8.5	1.4	2.4	0.5	2.4	2.3	2.2	2.1	1.8	2.3	1.4	4.3	1.8	3.2	1.8	8.6	0.9	2.2	2.4	0.8	10.1	13.6	18.9	13.4	12.0	9.3	15.0	10.6	12.6	14.0
FAM210B	"C20orf108, dJ1167H4.1, DKFZP434A1114"	ENSG00000124098	"Family with sequence similarity 210 member B"	Q96KR6	20	56358915-56368663	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042652	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042652: "	"unprognostic (3.29e-1)"	"prognostic favourable (5.44e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.34e-2)"	"unprognostic (9.45e-2)"	"prognostic favourable (4.26e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (1.44e-10)"	"unprognostic (1.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.00e-1)"	19.8	47.7	13.2	9.3	22.8	30.5	29.0	13.4	12.3	23.4	18.1	10.9	24.0	10.7	22.3	24.7	24.4	18.5	29.5	48.1	13.0	12.9	15.2	43.2	16.3	11.8	15.2	9.3	50.5	21.8	13.1	15.1	17.6	13.7	30.9	13.8	21.4	29.0	33.5	54.2	17.5	15.0	19.9	11.1	12.2	16.3	11.1	9.7	5.9	19.8	25.7	12.3	22.8	30.9	1.9	2.8	10.3	5.6	2.2	4.0	1.5	4.7	1.8	7.3	17.8	21.3	24.1	14.3	5.8	13.2	10.7	12.4	3.3	2.3	0.4	3.0	10.0	13.8	3.9	16.9	18.0	0.7	6.1	2.9	4.4	31.8	14.0	0.3	1.8	20.6	18.9	6.0	8.6	17.1	22.1	3.1	13.1	4.9	2.4	1.3	6.2	11.6	0.0	15.2	3.8	5.5	5.6	10.2	18.4	14.2	31.0	71.6	13.7	2.7	11.8	9.6	6.4	15.2	3.5	2.5	2.5	0.1	7.6	1.8	6.2	3.3	3.8	10.3	2.9	5.6	2.2	1.9	3.4	4.0	2.8	1.8	3.6	3.4	1.7	2.2	2.4	2.4	3.7	1.5	13.2	22.8	13.4	12.3	13.0	12.9	15.2	9.3	13.7	9.7
FAM221A	"C7orf46, DKFZp686F0810, FLJ45875, MGC72075"	ENSG00000188732	"Family with sequence similarity 221 member A"	A4D161	7	23680130-23703249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.8;HMC-1: 10.1;MOLT-4: 15.3;SCLC-21H: 14.3;SH-SY5Y: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA019719, HPA026748, HPA026752"	Enhanced		Approved	Cytosol				Cytosol		"HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.42e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.81e-2)"	3.9	4.8	12.8	3.8	19.7	2.1	5.7	12.9	12.3	5.0	8.2	25.1	2.9	12.0	3.5	5.1	8.7	12.1	6.8	4.0	15.9	13.4	8.4	10.0	5.5	4.3	30.0	10.3	4.5	25.2	3.8	4.5	2.3	17.2	4.7	11.0	27.8	8.7	9.2	2.1	4.7	8.9	3.2	24.6	2.3	14.6	22.9	24.3	2.1	7.7	1.4	6.2	4.2	3.1	6.9	5.3	3.8	5.2	6.8	11.4	3.7	0.0	0.3	6.8	5.5	0.2	0.0	3.2	0.2	0.5	0.8	1.0	6.9	3.0	0.8	11.8	0.1	1.3	0.0	0.0	1.3	0.0	9.2	1.9	0.6	0.0	1.8	0.0	10.1	0.5	0.4	0.1	0.0	2.1	0.0	0.0	0.2	3.1	15.3	0.0	0.0	3.4	6.2	0.6	0.0	3.7	3.1	14.3	24.4	1.0	0.0	0.0	3.0	4.4	0.3	0.0	2.5	1.3	0.6	0.0	0.0	0.0	0.6	0.0	1.2	0.0	3.0	3.8	5.4	1.9	11.0	6.9	9.0	6.5	5.3	6.0	10.6	5.7	0.1	6.8	5.2	4.3	11.4	3.7	12.8	19.7	12.9	12.3	15.9	13.4	30.0	10.3	17.2	24.3
FAM241B	C10orf35	ENSG00000171224	"Family with sequence similarity 241 member B"	Q96D05	10	69630251-69633599	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 20.5;PC-3: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.2"	"Lineage enriched"	"Detected in single"	25	"T-cells: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034591	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA034591: AB_10670572"	"unprognostic (1.12e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.17e-3)"	"prognostic unfavourable (8.64e-4)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (9.72e-4)"	1.4	3.3	13.1	2.0	13.5	1.1	5.3	34.5	23.9	1.3	3.0	3.2	0.6	3.0	2.7	13.0	4.0	4.8	2.1	6.9	15.0	17.8	4.7	2.3	4.1	2.7	10.8	14.4	2.0	7.9	5.6	5.3	1.3	8.3	7.8	2.6	5.1	5.6	5.6	1.6	2.4	2.2	4.5	4.6	0.8	4.2	11.4	2.4	0.7	6.0	0.1	2.4	2.6	1.6	0.3	0.0	0.5	0.0	0.2	14.2	2.8	13.3	14.6	1.8	15.0	0.0	0.0	6.5	1.3	0.3	2.4	2.6	10.5	11.1	0.0	20.5	0.3	5.5	7.8	4.5	3.4	13.3	10.7	0.0	3.2	4.0	4.0	0.0	4.8	0.0	4.4	0.1	2.3	0.0	4.9	0.0	0.2	17.9	0.1	0.0	9.0	26.9	0.0	0.0	0.1	5.1	7.6	7.6	10.4	5.5	14.0	8.5	9.6	2.4	0.6	0.4	9.3	0.0	3.9	2.4	6.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	3.4	0.0	8.9	0.1	8.5	5.6	0.0	0.3	14.2	4.9	0.5	0.2	0.0	0.0	5.3	2.8	13.1	13.5	34.5	23.9	15.0	17.8	10.8	14.4	8.3	2.4
FAM43B	FLJ44952	ENSG00000183114	"Family with sequence similarity 43 member B"	Q6ZT52	1	20552439-20555010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"adrenal gland: 21.9;brain: 14.9;epididymis: 8.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;BJ hTERT+: 3.3;fHDF/TERT166: 6.5;Hep G2: 4.8;SCLC-21H: 5.9;SiHa: 11.0"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050813	Approved		Approved	Cytosol				Cytosol		"HPA050813: "	"unprognostic (1.51e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.78e-4)"	"unprognostic (1.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.12e-2)"	3.2	21.9	5.6	1.5	14.9	0.9	1.5	8.8	14.4	1.6	1.3	2.4	0.0	1.1	1.4	8.7	1.3	1.6	1.5	3.3	5.3	12.1	2.6	1.4	1.2	1.0	10.1	6.0	1.0	1.2	0.9	0.7	2.5	11.2	1.4	1.1	0.5	1.2	1.3	2.8	1.0	1.2	2.9	4.0	1.4	0.9	1.3	2.8	0.0	1.3	1.7	0.9	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	4.5	0.2	0.1	0.0	0.5	3.3	0.6	0.0	0.1	0.0	0.0	0.2	6.5	0.0	0.7	0.0	0.1	0.0	0.9	0.1	0.3	4.8	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	5.9	0.7	11.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	14.9	8.8	14.4	5.3	12.1	10.1	6.0	11.2	2.8
FAM45A		ENSG00000119979	"Family with sequence similarity 45 member A"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	12.2	13.2	16.2	8.5	20.0	17.0	9.5	10.2	17.6	11.6	12.5	10.2	6.5	7.6	9.4	10.7	16.0	9.0	8.5	10.8	13.5	10.4	16.6	18.9	8.6	6.8	10.6	17.6	17.3	8.8	11.6	5.4	10.8	18.4	8.9	11.0	7.7	10.7	8.3	14.0	12.0	9.7	9.8	13.5	8.4	9.7	7.1	11.5	10.1	14.8	10.8	9.9	13.1	14.7	2.3	9.9	30.2	19.2	3.8	10.0	6.0	8.3	9.8	12.5	14.4	21.4	21.4	5.5	11.9	29.8	10.7	10.3	9.5	11.2	5.9	4.5	14.6	12.6	10.6	10.4	9.3	10.0	6.0	1.3	3.4	8.3	24.4	3.5	2.8	22.2	8.9	7.8	11.0	14.4	2.8	6.7	13.4	6.7	4.4	6.0	7.5	4.0	4.8	15.7	4.3	10.3	8.9	2.1	8.3	8.5	8.9	17.4	8.6	12.3	14.6	7.6	3.9	7.8	6.0	7.3	2.7	6.5	12.3	15.3	3.4	23.0	15.1	30.2	4.2	18.3	3.4	2.3	6.3	5.5	9.9	1.9	3.1	4.1	20.1	3.8	19.2	2.5	10.0	6.0	16.2	20.0	10.2	17.6	13.5	10.4	10.6	17.6	18.4	11.5
FAM46A	"C6orf37, FLJ20037"	ENSG00000112773	"Family with sequence similarity 46 member A"	Q96IP4	6	81491439-81752774	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 106.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.8;fHDF/TERT166: 25.0;HeLa: 24.7;HL-60: 28.3;THP-1: 48.8;U-937: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051067: , HPA067140: "	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	10.0	7.1	1.4	4.9	1.4	64.7	5.6	2.8	0.9	14.4	17.7	1.3	24.2	5.1	12.8	20.0	4.2	8.8	17.1	19.4	1.2	4.4	3.2	11.8	5.8	2.3	1.4	0.9	20.1	3.5	6.5	20.4	106.4	3.5	16.2	5.6	4.9	49.8	45.6	4.5	7.0	32.6	15.3	2.5	5.8	13.2	6.8	1.4	1.2	7.7	6.7	3.7	13.4	31.1	12.0	12.4	22.4	22.2	8.3	6.2	6.1	1.0	1.5	1.0	0.0	21.8	9.6	1.9	8.2	5.9	4.9	7.5	15.4	0.8	0.1	0.3	25.0	0.9	0.7	1.3	3.6	0.0	1.9	0.0	24.7	2.4	6.8	28.3	2.2	4.2	0.7	3.8	0.6	0.6	0.4	0.0	3.2	4.4	0.0	20.1	0.2	1.1	0.0	9.0	0.0	0.6	1.9	1.0	1.4	3.7	1.6	2.4	0.3	48.8	1.3	5.6	1.2	2.4	2.2	0.1	0.1	0.1	8.0	21.9	2.4	16.1	14.9	22.4	6.2	15.1	3.7	8.0	2.4	3.0	12.4	12.0	4.7	4.4	7.3	8.3	22.2	4.3	2.7	6.1	1.4	1.4	2.8	0.9	1.2	4.4	1.4	0.9	3.5	1.4
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283780	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 3.1;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	5	"B-cells: 3.1;dendritic cells: 2.3"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA053331: "	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	5.5	6.8	12.5	0.8	8.5	1.2	8.9	2.4	14.8	3.7	3.2	9.2	4.4	4.3	2.4	15.5	1.6	23.5	5.1	3.2	10.1	13.7	9.1	11.2	4.8	0.9	10.7	15.5	1.2	9.7	9.9	10.3	10.0	12.1	5.2	3.8	2.7	5.4	4.0	9.5	2.0	4.2	3.0	13.3	1.8	6.0	9.2	6.2	0.0	13.2	1.5	0.9	2.6	1.1	3.1	2.3	0.1	0.4	0.1	0.5	0.1	0.8	3.6	3.3	0.9	2.5	0.4	0.7	0.4	2.3	0.7	0.8	4.2	3.2	0.2	1.0	1.2	1.1	1.5	0.8	1.3	3.4	0.2	0.2	2.0	5.9	1.5	0.8	0.6	1.5	0.9	1.0	0.9	0.5	0.3	2.1	1.1	5.2	0.3	0.4	0.7	1.8	0.5	0.9	0.5	4.5	3.0	5.6	4.1	1.5	1.9	0.6	1.9	0.4	0.9	0.7	0.7	2.1	0.6	8.0	1.9	0.3	2.4	0.3	1.1	0.0	0.4	0.1	0.2	0.0	0.5	0.2	0.2	0.1	0.2	3.1	0.4	0.1	0.1	0.1	0.4	2.3	0.0	0.1	12.5	8.5	2.4	14.8	10.1	13.7	10.7	15.5	12.1	6.2
FAM47E-STBD1		ENSG00000272414	"FAM47E-STBD1 readthrough"		4	76251721-76311129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 38.2;skeletal muscle: 41.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 17.5;Karpas-707: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA053331	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA053331: "	"unprognostic (3.52e-3)"		"unprognostic (3.44e-1)"		"unprognostic (1.53e-1)"		"unprognostic (8.98e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.92e-6)"	"unprognostic (5.59e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.77e-1)"	17.4	2.3	7.8	1.6	8.0	4.0	7.6	1.9	13.9	2.5	8.2	8.6	4.1	2.1	3.0	7.3	3.5	5.0	4.2	16.5	9.4	3.9	4.2	38.2	7.5	0.6	5.4	14.6	2.6	4.6	2.8	9.2	9.4	11.4	6.3	9.0	2.5	5.0	5.0	41.3	1.6	10.7	6.5	9.6	1.6	3.7	6.1	5.8	0.0	8.1	1.3	0.9	4.9	2.5	0.2	1.0	2.2	1.5	3.4	1.6	0.4	2.0	2.4	1.0	2.2	17.5	5.9	2.3	3.4	7.2	3.0	3.1	4.1	2.3	0.0	2.1	8.3	1.2	3.6	1.5	2.7	2.7	0.5	0.8	4.9	5.8	1.9	1.8	2.5	2.5	9.2	2.8	3.7	0.3	0.2	24.4	7.2	3.8	0.0	1.8	1.0	1.7	0.0	0.5	1.5	3.4	6.1	1.0	4.3	1.5	4.8	0.1	1.0	1.0	0.9	1.5	0.7	3.9	3.0	5.8	2.7	0.0	4.3	1.9	1.3	0.0	0.5	2.2	1.1	1.5	0.6	0.2	1.1	1.2	0.9	0.1	0.9	1.3	1.3	3.4	0.1	1.0	1.6	0.4	7.8	8.0	1.9	13.9	9.4	3.9	5.4	14.6	11.4	5.8
FAM49B	BM-009	ENSG00000153310	"Family with sequence similarity 49 member B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.5;bone marrow: 80.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA009076	Approved		Approved	Nucleoplasm,Cytosol			990000	Nucleoplasm	Cytosol	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavourable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavourable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	19.2	14.5	23.2	42.8	33.1	80.1	20.6	28.0	36.9	7.2	14.3	18.2	5.5	14.2	8.0	10.6	17.9	7.9	14.9	9.8	25.5	25.2	11.8	12.3	19.1	49.6	28.5	19.6	6.4	10.0	7.5	16.1	19.4	21.2	7.6	17.4	7.3	12.0	7.9	16.8	9.0	19.3	13.5	38.8	41.3	12.9	13.6	21.2	28.2	13.8	9.7	46.4	20.6	8.4	21.0	47.3	93.5	42.2	30.8	29.3	43.4	31.6	17.0	18.5	10.4	1.6	2.4	24.7	9.6	9.3	13.4	14.3	9.7	21.8	31.6	21.2	6.3	15.8	15.3	25.4	20.1	66.2	10.7	31.7	9.5	10.9	6.5	20.5	27.3	3.9	11.9	9.0	18.8	11.8	22.7	36.7	14.6	14.1	69.6	15.2	15.7	23.5	30.4	12.5	53.1	27.4	13.0	12.4	16.2	19.3	12.2	28.5	14.2	26.6	7.2	4.9	31.8	10.4	20.4	12.2	36.0	52.5	7.8	44.7	12.7	45.5	35.3	65.6	29.3	42.2	22.4	21.0	16.7	23.9	47.3	15.1	15.0	24.6	93.5	30.8	36.5	30.4	22.5	43.4	23.2	33.1	28.0	36.9	25.5	25.2	28.5	19.6	21.2	21.2
FAM53B	"bA12J10.2, KIAA0140, smp"	ENSG00000189319	"Family with sequence similarity 53 member B"	Q14153	10	124619292-124744269	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037751, HPA037752"	Approved		Approved	Cytosol				Cytosol		"HPA037751: , HPA037752: AB_10672285"	"unprognostic (7.88e-2)"	"prognostic favourable (4.96e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.91e-1)"	"prognostic favourable (1.97e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.02e-2)"	"prognostic favourable (7.00e-6)"	"unprognostic (1.93e-1)"	"prognostic favourable (4.81e-7)"	"prognostic favourable (3.26e-4)"	"unprognostic (3.41e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.45e-2)"	12.1	14.2	13.8	20.0	20.1	20.9	8.2	15.4	20.2	9.9	10.9	32.4	11.5	14.9	17.8	5.1	11.3	11.5	8.5	11.9	17.6	10.9	8.0	3.1	11.8	28.6	21.5	12.0	17.6	5.7	14.6	9.6	7.3	12.8	6.4	7.0	12.2	14.3	8.2	36.9	11.9	14.1	12.5	19.7	16.5	8.2	10.4	30.2	37.7	14.4	7.9	23.7	8.1	5.8	9.5	2.8	4.5	3.6	1.0	10.7	4.0	5.7	6.6	5.0	14.4	6.0	3.1	14.7	2.7	3.4	2.9	2.6	3.3	3.4	21.4	5.9	3.2	11.4	6.7	8.1	1.2	25.5	7.3	9.8	3.2	8.3	4.1	8.6	6.6	3.0	8.4	2.7	4.3	4.7	7.6	8.8	2.8	10.3	10.1	11.4	3.4	6.0	18.3	1.9	9.4	2.4	10.1	6.9	6.6	2.4	9.4	31.1	3.8	11.0	2.5	3.6	3.2	3.6	5.6	1.4	2.8	13.0	2.7	6.9	1.9	1.2	3.1	2.9	10.7	3.0	5.1	4.8	4.6	5.5	2.0	9.5	1.8	3.2	4.5	1.0	3.6	2.8	5.0	4.0	13.8	20.1	15.4	20.2	17.6	10.9	21.5	12.0	12.8	30.2
FAM69A	FLJ23493	ENSG00000154511	"Family with sequence similarity 69 member A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favourable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	13.3	3.4	20.7	10.4	22.5	7.0	7.8	19.4	22.2	7.3	13.2	15.9	4.2	8.8	15.7	3.8	9.3	8.3	11.1	5.3	22.6	18.0	6.1	24.7	4.5	10.1	25.0	12.2	6.0	3.5	20.5	4.1	12.8	17.7	9.5	12.4	5.4	5.5	11.3	7.5	5.6	8.2	19.4	24.7	7.6	8.8	6.4	24.4	9.6	6.2	3.6	8.8	12.2	6.0	22.5	7.1	0.2	0.9	11.8	14.2	6.7	4.2	4.7	1.9	4.7	7.4	13.9	2.4	13.4	27.7	7.6	15.5	2.7	0.9	14.5	2.4	24.7	5.5	0.3	10.1	12.7	5.8	4.8	0.5	3.7	6.8	2.6	1.3	0.9	8.2	8.1	16.7	3.8	0.1	5.1	15.5	9.6	1.6	4.8	1.2	3.5	1.9	4.3	14.3	4.5	1.1	4.5	4.9	3.8	3.7	3.7	4.9	1.8	0.4	0.5	9.0	6.9	17.5	4.7	23.4	22.3	17.0	4.3	0.9	0.8	0.0	0.9	0.0	10.5	0.4	8.1	22.5	12.1	8.2	4.3	13.6	14.2	12.1	0.2	11.8	0.2	7.1	10.7	6.7	20.7	22.5	19.4	22.0	22.6	18.0	25.0	12.2	17.7	24.4
FAM71F1	"FAM137A, NYD-SP18"	ENSG00000135248	"Family with sequence similarity 71 member F1"	Q96KD3	7	128709061-128731743	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	146	"testis: 64.8"	"Cell line enriched"	"Detected in some"	12	"NTERA-2: 19.0"	"Cancer enriched"	"Detected in single"	23	"testis cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020636			Uncertain	Cytosol				Cytosol		"HPA020636: AB_1854739"	"unprognostic (3.09e-2)"	"unprognostic (3.39e-3)"		"unprognostic (6.03e-2)"	"unprognostic (5.25e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-6)"	"unprognostic (6.97e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.99e-1)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	1.5	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0
FAM72A	"LMPIP, MGC57827, RP11-312O7.1, UGENE"	ENSG00000196550	"Family with sequence similarity 72 member A"	Q5TYM5	1	206186179-206204414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (3.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.20e-5)"	"unprognostic (3.61e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.01e-5)"	"unprognostic (7.70e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-16)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.89e-1)"	3.4	2.5	1.9	4.7	1.6	6.3	3.2	8.0	1.3	0.8	1.5			2.4	0.6	0.0	2.5	1.8	2.2	0.9	2.4	1.8	1.0	1.3	2.4	8.9	2.6		0.8	0.7	2.3	0.4	2.8		0.5	1.7		0.7	0.2	0.2	5.0	2.2	1.3	3.1	6.3	0.8	6.3			0.5		6.2	1.1	1.2	2.1	5.6	1.2	9.2	0.6	3.6	2.4	9.7	8.0	8.4	3.6	1.2	1.5	10.1	7.0	3.0	8.1	6.1	4.7	14.6	25.1	6.0	1.8	11.7	9.7	3.8	9.7	13.8	8.0	11.3	7.3	6.3	0.8	19.5	12.8	2.1	0.7	7.2	12.8	5.0	22.5	17.3	5.0	5.7	12.1	17.5	15.2	10.7	13.4	14.6	18.9	4.5	1.5	8.4	4.9	5.0	4.6	4.1	9.7	10.6	2.6	6.5	7.5	8.4	11.5	14.0	20.5	22.5	5.3	16.0	8.9	0.0	7.5	0.0	0.9	9.2	0.2	2.1	1.8	1.8	5.6	0.8	0.2	0.4	1.2	0.6	5.4	2.3	3.6	2.4										
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 6.5;lymphoid tissue: 9.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.3"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	1.0	0.8	1.3	4.1	1.0	6.5	0.6	5.1	1.0	0.5	1.0			1.3	0.4	0.2	3.0	0.5	1.0	0.2	1.6	0.9	0.3	0.4	0.8	9.3	1.4		0.4	0.1	1.5	0.1	1.4		0.2	1.3		0.5	0.0	0.0	2.1	1.3	0.7	1.4	3.2	0.9	3.6			0.2		7.9	0.9	0.9	0.8	3.3	0.1	2.4	0.8	1.4	1.1	11.9	4.4	7.4	3.6	0.7	1.1	5.8	6.4	2.7	7.5	6.3	0.1	6.3	26.6	8.9	1.2	7.5	10.1	3.6	11.6	17.6	7.5	11.5	4.9	5.3	0.4	19.9	10.3	0.6	0.4	5.9	12.0	4.5	15.0	16.4	5.4	5.0	10.0	16.4	13.9	9.1	15.0	15.8	12.1	2.9	1.4	8.0	4.6	4.8	3.7	3.7	5.0	15.6	1.5	6.2	10.5	12.0	11.2	14.6	18.1	26.3	5.5	21.7	14.3	0.0	2.4	0.0	0.0	0.9	0.0	0.8	0.4	0.5	3.3	0.3	0.0	0.1	0.1	0.8	1.1	0.4	1.4	1.1										
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6;lymphoid tissue: 6.4"	"Cell line enhanced"	"Detected in many"		"U-266/84: 29.0"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.1	0.0		1.6		3.6	0.0		0.0	0.0	0.2			0.5	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.0	6.1			0.0	0.0	0.0		0.3		0.0	0.6		0.0	0.0	0.0	1.5	0.0	0.1		0.5	0.1	1.9			0.0		6.4	0.4		1.1	0.4	0.0	1.0	1.7	2.2	0.6	8.5	5.0	6.1	2.7	0.3	0.8	5.8	4.3	1.4	5.7	4.4	0.7	10.3	20.4	5.6	0.5	8.3	8.1	2.6	6.3	7.0	4.8	8.8	4.4	1.5	0.3	17.9	8.0	0.1	0.0	4.5	11.8	2.5	15.4	9.6	0.3	0.6	10.6	13.9	4.8	3.2	13.5	4.3	14.5	1.0	1.1	3.0	5.5	4.1	2.4	2.3	5.9	15.4	1.7	4.6	7.6	6.0	9.3	20.1	29.0	12.1	2.4	11.2	2.9	0.0	1.0	0.0	0.1	0.3	0.0	1.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	1.7	0.6	0.1	2.2	0.6										
FAM72D		ENSG00000215784	"Family with sequence similarity 72 member D"	Q6L9T8	1	145096000-145112696	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (2.70e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-3)"	"unprognostic (5.88e-5)"	"unprognostic (7.65e-4)"	"unprognostic (6.72e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (6.63e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.74e-2)"	"unprognostic (6.50e-2)"	1.1	0.7	0.8	7.2	0.8	5.5	0.7	4.0	0.9	0.6	1.1	0.6	0.4	1.4	0.8	0.4	4.4	0.2	0.5	0.4	1.0	0.7	0.5	0.4	1.3	7.6	1.0	0.4	0.4	0.4	0.3	0.4	1.5	0.8	0.4	1.6	0.4	0.6	0.4	0.4	2.9	2.0	0.5	1.1	3.3	0.8	6.7	0.4	17.7	0.4	2.7	7.4	1.1	2.5	0.1	0.7	0.1	1.7	0.0	1.0	0.5	8.3	5.1	6.0	2.4	0.2	0.5	6.6	4.8	1.4	6.1	3.8	3.4	7.6	13.7	4.9	0.7	8.9	7.3	1.4	7.2	11.0	7.3	6.8	2.5	5.0	0.1	12.2	7.7	0.3	0.5	4.8	9.3	2.7	13.6	19.2	4.0	6.3	8.2	11.9	11.4	7.1	7.3	7.6	16.2	2.1	1.1	5.9	5.0	3.6	3.3	2.2	9.3	7.9	1.2	4.5	5.0	3.8	8.6	14.5	22.8	21.3	0.0	9.7	5.1	0.0	1.2	0.0	0.0	1.7	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.0	0.5	0.8	0.8	4.0	0.9	1.0	0.7	1.0	0.4	0.8	0.4
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725979-27763122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: "	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favourable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	22.1	8.6	10.6	12.2	17.2	14.3	14.1	17.9	18.3	14.7	12.8	17.4	8.4	10.2	15.9	16.6	13.9	13.8	15.3	13.8	11.3	11.4	13.7	13.8	13.1	11.3	9.5	16.1	14.6	14.4	11.7	19.5	12.8	14.3	12.9	16.2	15.7	12.4	16.8	39.7	15.4	12.1	17.8	11.9	12.1	13.8	28.5	10.9	13.6	18.7	17.8	13.8	14.0	14.1	13.6	14.6	13.7	12.2	12.0	16.0	6.4	8.6	7.0	8.0	8.2	10.1	8.8	14.4	8.1	8.6	12.1	11.9	8.0	11.7	15.9	5.3	9.0	11.5	10.0	9.0	9.4	8.2	7.6	4.9	9.9	9.4	8.1	7.8	7.7	9.0	9.8	13.2	13.3	6.0	9.3	15.0	8.6	8.4	18.4	7.2	12.6	7.0	11.2	9.5	9.0	9.6	12.5	11.6	5.2	9.3	10.1	9.7	7.3	3.1	6.4	14.3	6.2	16.5	5.6	13.7	14.9	13.0	8.9	10.2	6.1	10.0	12.2	13.7	14.7	12.1	15.6	12.2	15.3	14.0	10.4	13.6	14.5	16.0	8.3	12.0	12.1	14.6	11.3	6.4	10.6	17.2	17.9	18.3	11.3	11.4	9.5	16.1	14.3	10.9
FAM81A	MGC26690	ENSG00000157470	"Family with sequence similarity 81 member A"	Q8TBF8	15	59372693-59523549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.2"	"Cell line enriched"	"Detected in many"	4	"Daudi: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.5;plasmacytoid DC: 12.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001847, HPA065797"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA001847: , HPA065797: "	"unprognostic (3.43e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.80e-2)"	1.0	0.8	13.7	3.1	14.0	0.4	1.8	1.2	32.2	8.4	5.2	3.2	0.7	3.0	3.3	5.7	1.0	7.8	2.1	1.9	16.1	8.7	8.7	0.8	1.1	5.7	5.6	17.7	1.1	2.5	0.6	3.3	1.1	3.7	3.1	6.6	1.2	3.3	2.2	0.9	1.5	1.8	1.7	4.3	1.8	3.1	2.2	1.9	0.0	2.7	0.0	6.6	0.9	1.1	2.6	12.5	0.4	0.6	0.1	0.0	0.3	5.7	8.4	0.6	0.1	0.2	0.1	3.4	0.3	0.0	0.5	1.6	1.0	1.0	36.7	0.2	0.1	4.4	4.7	1.4	1.1	0.4	2.4	0.0	5.6	0.3	0.0	3.1	0.7	0.0	0.9	0.2	0.4	0.0	0.0	0.0	0.5	1.9	0.0	0.1	0.5	3.0	0.8	8.5	0.9	1.9	2.1	1.7	0.5	3.3	0.1	5.4	1.4	1.9	0.2	1.4	4.3	1.6	6.2	0.0	0.0	0.4	1.4	1.2	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.5	2.6	0.0	0.0	0.4	0.1	0.0	12.5	0.0	0.3	13.7	14.0	1.2	32.2	16.1	8.7	5.6	17.7	3.7	1.9
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;smooth muscle: 69.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"				"Mitotic spindle"	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA049333: , HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (5.44e-6)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	0.5	0.5	0.5	4.9	0.8	7.9	0.7	0.4	1.2	1.7	29.6	0.4	0.7	3.4	0.8	1.5	39.0	0.2	5.6	1.5	0.5	0.1	2.2	1.4	2.6	1.5	0.3	0.5	0.7	0.2	0.0	0.3	2.2	0.7	7.6	3.6	1.2	3.1	1.0	0.4	4.1	16.2	69.8	0.4	1.0	22.8	3.8	0.2	9.2	0.5	8.6	17.9	24.5	6.4	1.6	0.1	0.0	0.4	2.4	4.6	1.2	31.2	19.3	15.3	12.8	1.7	1.9	27.4	14.1	8.8	27.9	17.1	29.4	14.4	7.9	14.0	9.2	26.9	20.8	24.1	26.2	2.6	8.2	9.2	14.8	21.2	1.4	4.0	4.8	1.0	1.2	16.0	9.3	15.3	8.1	11.5	15.8	16.8	6.2	5.9	12.6	24.6	6.0	28.1	4.4	8.0	8.0	7.1	11.8	41.1	34.3	6.1	21.4	4.2	7.3	18.5	22.7	21.0	30.9	3.5	5.3	8.2	8.3	6.0	13.5	0.0	0.0	0.0	0.7	0.4	2.3	1.6	2.4	2.7	0.1	1.6	2.7	3.4	0.0	2.4	0.1	0.0	4.6	1.2	0.5	0.8	0.4	1.2	0.5	0.1	0.3	0.5	0.7	0.2
FAM83G	"FLJ41564, PAWS1"	ENSG00000188522	"Family with sequence similarity 83 member G"	A6ND36	17	18968789-19004804	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.0;skin 1: 33.8;tongue: 28.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023369, HPA023940"	Enhanced		Approved	Cytosol				Cytosol		"HPA023369: AB_1848415, HPA023940: AB_1848416"	"unprognostic (2.12e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (8.29e-4)"	"unprognostic (1.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.65e-2)"	"prognostic favourable (7.58e-6)"	"unprognostic (9.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.74e-2)"	1.8	1.0	0.5	5.1	0.8	0.6	2.2	1.0	0.8	6.2	5.5	0.4	1.3	6.6	1.4	0.9	36.0	0.8	13.4	8.7	0.9	0.6	2.6	26.5	2.3	1.5	0.4	0.4	1.1	7.0	4.7	2.2	2.6	1.6	1.7	3.2	1.5	5.7	3.0	3.4	33.8	10.1	1.6	0.4	1.0	5.9	0.8	0.3	3.2	3.3	28.9	19.1	2.4	6.9	1.5	0.2	3.4	0.7	0.0	2.6	0.7	12.7	11.8	0.1	0.0	0.4	1.1	19.6	13.5	5.9	11.4	8.6	15.1	4.7	8.4	8.3	8.8	15.2	1.9	11.3	5.3	6.9	4.3	0.2	5.8	8.2	8.5	1.5	4.3	1.5	21.2	7.4	12.3	4.1	4.0	0.3	3.2	7.8	0.3	3.1	6.0	0.0	0.0	0.0	4.1	5.6	3.3	6.1	0.0	4.6	2.9	0.8	5.0	1.9	7.6	7.1	11.9	3.3	15.5	1.2	2.0	2.1	5.5	0.0	4.6	3.4	0.0	0.0	2.6	0.1	1.4	1.1	1.5	0.8	0.2	1.5	1.4	0.2	0.0	0.0	0.7	0.2	1.8	0.7	0.5	0.8	1.0	0.8	0.9	0.6	0.4	0.4	1.6	0.3
FAM83H	FLJ46072	ENSG00000180921	"Family with sequence similarity 83 member H"	Q6ZRV2	8	143723933-143733801	"Disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.2;lymphoid tissue: 30.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 19.5;MCF7: 26.8;RT4: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024505, HPA024604"	Enhanced		Approved	Cytosol				Cytosol		"HPA024505: AB_1848417, HPA024604: AB_1848418"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (9.69e-3)"	"prognostic favourable (4.42e-4)"	"unprognostic (5.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	0.8	1.9	1.2	4.1	1.0	0.2	2.9	0.2	1.6	8.8	12.5	0.9	6.1	6.3	1.1	3.0	42.2	3.0	17.7	0.3	1.1	0.4	5.0	10.4	3.9	0.5	0.3	0.6	1.3	6.7	5.9	2.8	8.9	0.9	5.6	2.7	2.6	8.3	2.9	0.1	17.7	17.9	1.8	0.7	0.7	9.1	1.3	0.2	1.1	6.9	27.9	30.7	5.1	9.5	0.3	0.2	0.5	0.3	0.1	0.2	0.0	13.7	6.5	0.0	0.0	0.0	0.0	12.1	0.9	0.0	0.4	0.1	5.9	12.4	0.0	10.0	0.2	19.5	0.8	12.0	0.2	1.0	2.1	0.3	12.9	4.1	1.0	0.3	0.9	0.7	14.2	0.0	3.6	0.0	7.2	0.0	0.0	26.8	0.2	0.0	2.5	5.9	0.0	0.0	1.3	3.8	16.1	3.7	0.0	10.8	12.6	2.1	13.6	1.8	0.0	0.0	3.9	0.9	0.0	1.9	2.0	0.0	0.0	0.0	0.6	0.3	0.3	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	1.2	1.0	0.2	1.6	1.1	0.4	0.3	0.6	0.9	0.2
FAM96A	"CIA2A, FLJ22875"	ENSG00000166797	"Family with sequence similarity 96 member A"	Q9H5X1	15	64072559-64094018	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: "	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	13.6	32.3	11.2	19.1	12.8	17.0	13.9	9.0	10.3	8.5	24.3	13.6	17.7	31.3	8.1	14.9	13.6	8.3	14.0	20.6	11.2	10.8	39.4	89.7	18.1	22.7	15.2	8.0	7.8	27.0	10.6	15.4	25.2	11.2	17.2	20.2	10.7	16.5	15.7	28.2	7.6	45.5	6.4	14.9	25.2	17.9	8.9	13.8	20.5	30.1	18.3	19.3	14.6	9.0	51.8	63.7	23.7	48.6	11.8	21.3	38.2	19.5	28.7	17.6	10.9	14.9	18.3	11.6	15.4	17.2	20.6	21.8	28.3	31.7	32.5	27.1	9.7	21.6	34.3	15.1	17.5	26.5	18.5	26.5	26.0	26.6	11.8	42.9	22.9	14.4	15.2	13.4	12.0	20.8	36.2	25.2	14.5	33.1	16.3	37.1	25.4	15.2	26.2	23.2	72.0	26.5	23.0	18.8	14.2	12.3	28.1	29.8	20.6	44.8	12.5	16.3	23.2	18.6	33.1	24.4	57.5	29.2	19.8	77.6	15.5	16.2	48.6	16.9	10.1	44.1	12.4	51.8	15.3	13.5	42.6	48.8	12.3	11.6	23.7	11.8	36.7	63.7	21.3	38.2	11.2	12.8	9.0	10.3	11.2	10.8	15.2	8.0	11.2	13.8
FAM96B	"CGI-128, CIA2B, MIP18"	ENSG00000166595	"Family with sequence similarity 96 member B"	Q9Y3D0	16	66932055-66934423	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041501, HPA041736"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041501: AB_10795123, HPA041736: AB_10793932"	"unprognostic (2.49e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.12e-2)"	22.5	34.2	38.7	26.5	38.2	17.7	31.9	26.8	34.5	19.6	28.8	30.3	19.8	26.3	20.4	27.5	43.5	28.6	25.0	58.0	36.7	33.6	41.6	57.8	27.4	30.6	39.4	27.4	29.5	38.3	23.2	30.0	27.3	30.7	22.0	25.6	16.6	21.9	22.2	89.6	14.2	29.4	22.3	41.4	25.3	24.3	32.2	28.5	24.1	41.2	40.8	25.3	25.7	37.0	51.8	92.7	46.3	52.7	40.7	61.2	44.8	25.3	57.5	19.5	24.4	24.7	23.5	23.8	23.2	26.1	35.6	44.8	60.6	29.5	23.0	30.2	27.4	33.6	27.9	28.0	25.5	28.5	39.3	14.0	17.1	70.6	47.0	20.7	55.9	23.1	27.2	42.0	36.9	24.0	23.5	15.4	28.8	48.7	35.2	49.9	26.0	70.0	30.1	20.9	44.2	52.6	22.9	34.4	38.5	49.8	13.5	35.2	14.8	34.6	20.4	26.8	31.8	15.0	32.1	33.8	27.1	58.4	47.4	21.5	34.7	41.5	47.0	46.3	43.2	51.2	42.3	51.8	46.3	46.9	51.7	44.4	37.3	41.5	23.0	40.7	52.7	92.7	61.2	44.8	38.7	38.2	26.8	34.5	36.7	33.6	39.4	27.4	30.7	28.5
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favourable (5.53e-4)"	10.8	8.9	18.3	9.3	16.9	11.0	9.8	17.0	19.9	8.7	14.2	12.8	9.0	19.6	9.9	7.2	14.3	13.8	9.1	11.6	16.0	13.1	9.1	13.4	8.7	9.5	12.3	16.9	10.2	22.4	10.6	8.1	7.6	13.0	12.5	7.0	8.2	17.7	9.5	2.5	17.0	22.2	6.8	12.7	10.1	19.2	5.4	9.7	5.3	11.8	7.7	11.2	9.4	9.5	6.0	3.2	12.6	3.4	3.3	5.6	1.6	11.7	12.8	1.5	7.4	1.6	5.6	6.5	6.8	5.8	6.8	7.2	2.1	8.6	10.7	7.7	4.0	5.7	2.9	4.9	1.1	17.2	6.0	3.5	2.1	4.9	7.3	3.0	6.4	5.3	10.3	3.4	6.3	4.0	9.6	11.8	4.0	13.0	4.3	2.3	1.1	13.8	8.9	3.1	6.3	8.2	6.2	2.6	7.6	6.9	12.2	4.0	9.3	9.4	5.1	3.1	8.3	9.4	8.2	12.7	6.4	4.5	7.9	7.0	4.9	0.0	2.3	12.6	3.1	3.3	4.2	2.6	5.6	4.6	3.2	6.0	4.3	3.4	2.0	3.3	3.4	1.2	4.4	1.6	18.3	16.9	17.0	19.9	16.0	13.1	12.3	16.9	13.0	9.7
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30903852-30943108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: "	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favourable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	5.9	8.9	11.6	6.9	17.4	6.3	12.7	19.6	18.4	15.0	11.4	17.7	11.9	4.6	11.6	22.9	6.5	8.5	8.5	13.0	12.6	11.0	14.7	14.4	6.9	5.5	18.5	11.8	12.5	18.2	7.2	17.0	10.6	15.4	16.4	9.7	8.6	17.3	8.3	16.8	9.3	6.7	11.5	13.0	7.3	8.5	9.4	15.0	5.1	14.3	6.3	5.8	9.0	9.1	4.0	3.6	0.6	1.7	4.5	5.4	1.6	6.4	11.0	3.6	2.0	13.0	11.6	2.4	4.5	1.9	4.8	5.1	7.5	3.3	1.5	8.1	4.9	13.0	6.1	9.5	4.7	5.1	2.9	1.1	11.2	1.3	5.6	0.9	6.1	3.5	7.0	2.9	7.7	2.3	5.5	10.1	7.8	1.4	10.0	4.4	2.8	2.5	8.5	11.9	2.8	7.1	5.1	8.3	5.8	9.9	6.8	3.5	6.1	7.6	8.3	15.1	3.6	4.2	5.8	13.9	9.7	1.7	6.6	4.8	1.3	0.1	0.8	0.6	3.7	1.3	4.7	2.8	3.5	1.7	2.7	4.0	5.4	2.8	0.3	4.5	1.7	3.6	3.2	1.6	11.6	17.4	19.6	18.4	12.6	11.0	18.5	11.8	15.4	15.0
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: "	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavourable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.5	9.1	17.5	4.9	0.9	1.3	45.3	7.9	3.5	11.4	9.3	6.8	8.5	16.8	3.7	2.6	7.5	18.0	6.1	11.4	8.0	12.2	23.0	14.0	6.5	0.1	17.0	14.4	0.4	1.0	12.8	7.1	6.8	14.0	19.3	8.5	9.9	14.2	6.5	21.1	6.4	15.5	14.2	11.9	3.9	9.7	4.9	9.6	9.7	7.6	3.1	11.6	10.8	3.9	9.4	10.8	5.7	11.4	8.2	16.0	28.5	5.4	17.5	16.1	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6
FANCG	"FAG, XRCC9"	ENSG00000221829	"Fanconi anemia complementation group G"	O15287	9	35073835-35080016	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008105, HPA045335"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"CAB008105: AB_2231542, HPA045335: "	"unprognostic (9.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (2.38e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	5.8	5.0	4.4	7.1	6.5	14.9	7.5	13.9	8.5	6.2	5.9	5.3	8.4	6.7	6.8	3.2	9.2	8.6	4.7	5.9	7.6	4.0	5.2	4.5	5.1	9.9	8.7	4.4	9.2	17.0	6.7	4.8	7.6	6.6	7.0	5.5	3.5	8.7	9.7	2.9	8.9	6.5	6.4	4.2	8.6	5.8	8.9	7.6	25.6	9.3	4.8	9.2	6.8	6.9	6.8	4.8	8.9	2.5	8.8	9.2	3.4	15.7	19.5	14.3	13.2	3.2	5.1	12.0	11.1	8.0	21.8	20.9	9.3	9.9	15.6	7.7	3.5	9.7	11.9	10.2	8.3	18.2	7.2	11.1	20.9	5.7	0.9	11.3	12.9	4.2	2.0	19.0	8.6	11.1	7.3	21.0	10.9	14.0	19.1	15.5	14.9	15.1	19.8	16.9	11.0	5.1	6.7	6.9	12.6	7.3	10.4	4.1	13.5	8.1	6.7	10.3	20.7	13.2	14.9	5.7	10.8	9.4	9.2	8.4	14.1	8.9	0.8	7.7	7.4	2.5	6.5	6.8	6.1	5.7	2.2	6.5	4.8	5.0	1.3	8.8	2.3	4.8	9.2	3.4	4.4	6.5	13.9	8.5	7.6	4.0	8.7	4.4	6.6	7.6
FARP1	"CDEP, MGC87400, PLEKHC2, PPP1R75"	ENSG00000152767	"FERM, ARH/RhoGEF and pleckstrin domain protein 1"	Q9Y4F1	13	98142562-98455176	"Predicted intracellular proteins"		"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.7;Hep G2: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000760			Supported	Cytosol				Cytosol		"HPA000760: AB_1078816"	"unprognostic (4.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (1.39e-5)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.18e-2)"	10.4	16.5	21.3	9.1	14.6	1.4	28.3	4.6	19.0	18.3	22.9	11.2	16.0	6.5	16.5	26.2	5.9	15.4	15.1	10.7	16.0	13.1	43.4	38.4	29.3	9.2	11.7	20.0	11.0	32.7	14.1	17.5	22.2	17.2	23.9	10.6	16.8	27.2	21.9	14.0	8.0	8.0	18.8	19.7	9.5	17.2	8.1	10.6	1.5	28.7	3.9	3.6	17.7	18.7	2.2	0.1	0.3	0.2	0.0	0.8	0.2	0.2	3.3	14.9	21.0	4.3	8.5	7.2	22.4	14.7	12.7	11.2	25.8	10.0	0.0	8.6	38.7	0.4	6.3	6.2	21.4	0.4	6.4	0.1	11.7	39.7	11.5	0.0	0.2	9.9	2.8	3.7	0.8	8.3	0.0	0.2	8.7	5.6	0.8	0.1	7.1	3.9	7.7	5.8	0.4	28.0	14.4	6.4	13.9	2.7	5.9	15.9	8.5	0.0	7.9	13.7	5.3	9.2	11.3	0.2	0.2	0.1	6.4	0.4	9.5	0.3	0.1	0.0	0.3	0.2	0.0	2.2	0.8	0.6	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	21.3	14.6	4.6	19.0	16.0	13.1	11.7	20.0	17.2	10.6
FARP2	"FIR, FRG, KIAA0793, PLEKHC3"	ENSG00000006607	"FERM, ARH/RhoGEF and pleckstrin domain protein 2"	O94887	2	241356243-241494841	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031226, HPA055592"	Approved		Approved	Cytosol				Cytosol		"HPA031226: AB_10602808, HPA055592: "	"unprognostic (3.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-1)"	10.2	11.2	11.2	17.6	15.3	5.5	10.1	28.4	16.5	9.9	24.5	24.0	17.3	22.2	16.4	9.3	16.0	10.8	14.4	8.4	12.3	11.5	11.4	16.1	11.1	12.2	18.3	9.7	12.8	12.9	16.0	10.2	10.1	19.5	10.9	24.4	19.7	10.1	20.1	10.5	22.6	26.1	13.3	15.7	12.1	22.6	27.0	15.2	6.1	7.8	8.2	18.2	13.9	10.6	7.1	8.2	9.2	6.7	2.0	2.5	1.9	10.1	7.3	13.6	9.2	11.7	15.7	12.2	10.1	8.4	10.5	11.0	7.8	12.1	4.3	2.8	19.8	11.6	18.1	10.6	16.1	6.8	9.4	9.5	13.2	10.3	8.6	8.5	7.4	15.8	8.0	15.3	12.6	9.5	10.7	4.0	8.4	8.5	9.1	6.3	6.7	5.8	10.2	30.6	12.9	13.7	21.0	16.1	10.8	11.4	8.1	31.0	4.2	8.6	14.3	10.1	7.8	12.5	8.2	6.8	4.9	9.6	9.1	5.9	20.3	5.4	2.6	9.2	1.8	6.7	1.6	6.1	1.9	2.1	3.9	7.1	1.3	1.4	1.6	2.0	3.5	8.2	2.5	1.9	11.2	15.3	28.4	16.5	12.3	11.5	18.3	9.7	19.5	15.2
FARSA	"CML33, FARSL, FARSLA"	ENSG00000179115	"Phenylalanyl-tRNA synthetase alpha subunit"	Q9Y285	19	12922479-12934037	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001911	Approved		Supported	Cytosol			11000	Cytosol		"HPA001911: AB_1848427"	"unprognostic (1.52e-1)"	"prognostic favourable (8.23e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (9.22e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.45e-3)"	"prognostic favourable (8.32e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.84e-2)"	18.0	20.7	24.8	23.6	29.5	23.5	15.4	24.6	49.2	17.7	24.0	18.3	14.9	22.1	16.1	13.1	26.6	21.2	16.3	24.9	23.9	30.1	23.0	39.6	13.4	27.6	25.6	28.1	19.1	26.7	17.8	21.0	22.9	29.1	18.5	15.0	14.8	25.1	20.4	33.3	27.8	18.8	15.3	17.2	21.2	18.9	17.1	18.6	32.7	24.4	15.2	22.0	19.5	15.2	34.7	42.2	28.9	41.2	38.3	40.2	39.7	29.1	27.6	11.1	23.8	7.7	7.3	20.0	21.0	13.6	30.1	23.7	33.7	12.4	32.2	33.8	11.8	22.4	27.0	24.0	11.0	18.9	40.7	25.3	24.3	26.7	25.0	48.7	33.4	10.0	17.7	23.2	18.7	16.3	38.1	6.8	12.6	39.1	57.8	60.7	34.6	46.9	30.0	11.5	41.4	15.8	17.2	34.8	31.9	14.1	24.4	14.9	19.2	29.7	15.6	24.5	10.8	37.2	39.0	45.2	38.5	33.5	22.2	44.1	25.2	17.3	39.2	28.9	32.5	41.2	40.2	31.9	32.0	30.2	42.2	34.7	32.9	31.2	2.5	38.3	30.4	34.1	29.4	39.7	24.8	29.5	24.6	49.2	23.9	30.1	25.6	28.1	29.1	18.6
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase beta subunit"	Q9NSD9	2	222570536-222656337	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036677: , HPA036678: AB_10673504, HPA061398: "	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (1.25e-4)"	15.7	10.8	11.9	12.6	23.5	11.5	16.0	15.1	28.5	11.6	17.3	13.7	5.9	15.9	14.2	11.7	19.1	10.8	7.2	13.4	13.7	15.1	11.7	18.3	9.0	12.0	11.6	18.0	16.7	18.6	15.0	15.7	8.8	29.4	11.2	20.7	9.6	12.3	11.5	33.2	14.1	11.5	14.9	9.7	10.3	13.9	15.6	11.2	15.6	11.9	17.1	14.2	11.8	12.0	16.3	16.0	1.2	11.4	18.5	20.0	14.6	22.0	13.0	15.1	19.7	13.8	19.9	23.3	22.5	14.2	22.2	18.2	32.8	12.2	10.8	17.1	16.4	18.6	29.1	25.2	32.8	16.2	15.1	24.8	14.7	20.9	21.6	36.1	10.3	13.3	19.8	25.4	39.0	21.0	37.3	22.3	27.0	20.6	21.6	20.4	19.3	16.2	21.3	36.4	35.0	18.2	14.4	24.6	8.0	9.4	16.5	19.4	15.3	15.2	11.4	19.1	15.7	27.3	27.1	10.7	10.7	39.5	14.9	24.3	19.9	0.2	8.5	1.2	11.4	10.3	16.8	16.3	15.4	14.0	16.0	14.0	20.0	17.2	0.9	18.5	11.4	8.0	13.3	14.6	11.9	23.5	15.1	28.5	13.7	15.1	11.6	18.0	29.4	11.2
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990582-89015785	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 40.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 40.1;T-cells: 30.9"					"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"		450000	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	13.5	26.3	6.1	17.3	7.7	12.4	10.6	2.1	7.2	15.6	14.2	6.1	7.0	5.9	15.7	16.6	14.1	14.2	14.5	8.9	8.2	2.7	11.7	21.9	28.6	15.6	6.0	3.9	24.7	4.1	4.5	4.6	9.0	7.5	22.3	21.3	4.4	7.1	8.5	4.3	9.6	16.3	12.5	10.2	15.3	5.0	7.3	5.1	12.5	10.0	15.8	14.4	14.8	21.4	3.0	4.0	40.1	6.8	1.2	30.9	3.9	8.5	3.3	1.7	5.5	14.2	21.0	0.0	18.9	19.1	0.7	3.7	0.0	9.3	1.7	7.3	17.7	1.3	0.3	15.8	1.3	27.5	2.7	0.1	1.8	5.6	13.6	0.9	0.4	26.0	14.2	11.8	25.5	1.6	0.0	43.8	19.2	0.7	2.7	1.4	0.2	0.9	0.1	0.1	1.7	26.5	2.7	0.1	0.1	2.7	0.0	0.3	6.0	0.3	4.1	6.0	3.4	5.6	4.3	17.2	1.7	0.1	5.0	3.4	1.8	11.3	3.2	9.4	3.3	3.9	4.8	3.0	10.4	7.2	4.0	0.7	1.2	3.4	40.1	1.2	6.8	0.0	30.9	3.9	6.1	7.7	2.1	7.2	8.2	2.7	6.0	3.9	7.5	5.1
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078333-82098332	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 147.6"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 152.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			1600000	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavourable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	147.6	7.8	8.2	14.2	11.5	11.1	57.5	19.1	23.0	6.6	27.7	17.0	14.1	8.2	4.7	14.2	17.1	4.3	19.4	6.3	7.9	6.7	3.7	30.8	26.8	9.8	7.3	11.5	6.4	10.4	6.7	15.3	8.4	21.7	28.8	3.4	7.6	16.9	10.8	7.5	17.2	6.5	4.6	8.4	5.1	11.9	6.6	8.8	1.9	5.1	10.7	5.4	8.0	6.6	0.5	1.4	0.0	0.8	0.2	1.9	0.8	23.1	24.3	11.3	7.8	18.3	12.4	24.2	4.6	6.0	4.9	9.0	25.4	15.8	7.7	3.8	3.5	19.4	10.9	21.3	0.9	3.6	47.4	16.0	18.2	33.9	5.2	8.6	2.4	11.9	5.6	12.5	2.9	5.5	24.1	6.9	1.7	40.1	9.4	13.7	21.9	14.2	8.3	6.4	15.3	5.5	29.7	28.1	15.6	6.8	152.8	12.4	27.2	16.5	9.6	7.2	14.8	5.9	11.0	9.3	2.0	8.0	4.3	9.4	10.6	0.0	0.8	0.0	1.2	0.5	0.7	0.5	1.9	1.4	1.4	0.2	0.7	0.6	0.0	0.2	0.4	1.1	0.6	0.8	8.2	11.5	19.1	23.0	7.9	6.7	7.3	11.5	21.7	8.8
FAT4	"CDHF14, CDHR11, FAT-J"	ENSG00000196159	"FAT atypical cadherin 4"	Q6V0I7	4	125316399-125492932	"Cancer-related genes, Disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.1;ASC TERT1: 9.0;fHDF/TERT166: 8.8;HSkMC: 10.4;HUVEC TERT2: 10.9;TIME: 17.1"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052819	Approved		Approved	Cytosol			7900000	Cytosol		"HPA052819: "	"unprognostic (1.18e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.81e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (1.89e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-3)"	3.8	0.5	0.9	0.8	0.7	0.0	3.2	0.0	0.5	4.4	7.1			0.3	2.7	0.6	1.9	2.1	4.1	5.0	1.0	0.4	2.6	2.0	5.3	0.1	0.9		5.3	0.5	6.7	0.4	2.5		3.6	1.9		1.0	2.3	1.1	1.4	2.4	3.3	0.6	2.1	2.4	0.1			3.9		0.2	3.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	5.9	0.6	12.1	9.0	0.0	2.0	2.3	0.9	1.0	0.0	0.3	0.0	2.4	8.8	0.0	2.2	2.5	0.6	0.0	1.0	1.3	2.5	0.0	3.9	0.8	0.0	10.4	1.3	0.5	5.5	10.9	0.0	1.6	5.0	0.1	0.4	0.0	0.4	0.2	0.7	1.2	0.0	0.1	0.0	0.1	1.2	0.3	0.0	0.0	0.0	0.0	17.1	6.0	1.7	2.1	0.9	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0										
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU, ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120628-65122473	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059015	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: "	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	79.7	95.0	90.6	84.9	76.2	186.7	95.4	50.9	80.9	103.6	134.8	77.6	63.4	77.8	84.0	80.5	115.2	100.0	87.2	133.9	70.0	58.9	88.0	162.9	77.5	182.6	78.9	40.8	176.0	202.8	27.5	56.1	73.2	46.6	123.5	53.0	67.8	97.3	76.7	190.8	86.8	93.8	97.5	72.4	130.9	79.2	53.6	53.2	126.8	121.5	83.6	149.5	122.0	136.6	291.3	169.7	90.9	119.0	116.3	253.8	346.5	78.1	51.5	45.5	72.1	44.6	66.6	62.4	44.6	43.5	62.6	39.7	58.2	78.5	93.1	121.2	38.4	69.1	42.2	59.5	26.1	68.3	64.6	75.1	54.1	79.9	82.0	89.0	82.8	82.1	99.1	53.7	73.2	48.2	70.0	110.4	33.1	97.7	102.7	179.6	125.2	85.8	100.0	36.4	182.7	57.6	44.2	63.4	63.6	34.7	100.3	139.4	89.7	123.4	45.6	56.6	65.3	87.3	71.3	120.1	114.1	158.5	68.6	69.3	64.0	90.9	119.0	70.6	128.9	107.0	176.1	291.3	212.1	165.5	132.1	281.7	253.8	198.1	78.9	116.3	92.8	169.7	153.8	346.5	90.6	76.2	50.9	80.9	70.0	58.9	78.9	40.8	46.6	53.2
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408306-48645849	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.6;ASC TERT1: 79.0;fHDF/TERT166: 67.8;HSkMC: 42.7;U-138 MG: 34.8;U-2197: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"		540000000	Cytosol		"CAB002670: , CAB058696: , CAB068188: , HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (7.44e-5)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavourable (5.11e-4)"	34.2	5.4	2.1	7.8	2.7	1.8	10.9	1.0	2.8	24.6	11.1	3.5	10.7	2.2	18.4	25.6	22.1	12.1	15.5	24.3	2.5	2.3	2.9	1.9	10.7	5.8	2.8	2.6	20.4	2.5	2.6	3.3	69.8	3.1	11.8	6.9	13.4	5.7	7.8	15.4	6.6	6.9	21.5	3.8	11.3	7.2	13.6	1.6	1.9	17.9	16.3	4.9	22.8	11.2	0.8	0.8	1.8	0.6	1.1	0.6	0.2	0.0	0.8	3.3	3.7	36.6	79.0	0.0	28.5	10.3	8.5	5.4	0.0	0.0	0.0	1.3	67.8	0.1	0.6	0.1	7.7	3.2	0.2	0.3	14.5	0.0	20.6	0.1	0.0	42.7	0.0	22.5	2.6	9.1	0.0	0.0	9.1	0.0	0.2	0.0	0.6	1.1	0.0	2.8	0.0	1.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.2	17.2	34.8	1.0	50.5	6.0	0.2	0.1	0.0	23.3	0.0	2.2	1.1	0.5	0.7	0.5	0.3	0.4	0.5	0.4	0.4	0.2	0.8	0.5	0.6	1.8	1.1	0.6	0.8	0.3	0.2	2.1	2.7	1.0	2.8	2.5	2.3	2.8	2.6	3.1	1.6
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"placenta: 175.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 37.3;HSkMC: 26.6;hTERT-HME1: 58.9;HUVEC TERT2: 33.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;non-classical monocyte: 5.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.0"	"Region enhanced"	"Detected in single"		"olfactory region: 2.6"	"Low region specificity"	"Detected in some"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"		4600000	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (7.41e-5)"	0.3	7.9	0.3	1.0	0.3	1.6	0.1	0.2	0.3	1.5	0.7	0.4	1.0	0.2	2.9	0.6	1.1	0.6	0.2	6.7	0.2	0.5	0.2	0.2	0.2	1.3	0.2	0.4	0.9	0.1	0.0	1.3	175.9	0.4	1.0	0.8	6.2	0.4	0.9	0.2	0.3	0.5	0.8	0.4	0.6	0.5	4.6	0.2	0.3	0.9	0.4	0.7	0.4	1.2	0.0	1.1	0.6	5.0	0.0	0.0	0.4	0.0	4.4	16.1	0.0	2.6	4.6	3.3	17.6	0.0	15.6	11.7	0.0	0.0	0.0	0.0	23.5	2.6	10.4	2.6	14.7	0.0	4.2	0.0	7.4	0.0	37.3	2.3	0.0	26.6	1.4	6.6	58.9	33.1	0.0	0.0	9.6	0.0	0.0	0.8	6.9	5.3	5.1	5.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	4.9	0.0	6.3	12.0	17.9	0.0	0.0	0.0	0.0	1.8	0.0	6.6	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	5.0	0.0	0.0	0.4	0.3	0.3	0.2	0.3	0.2	0.5	0.2	0.4	0.4	0.2
FBRSL1	KIAA1545	ENSG00000112787	"Fibrosin like 1"	Q9HCM7	12	132489551-132585188	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA049880	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA049880: "	"unprognostic (2.02e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-3)"	"prognostic unfavourable (9.82e-4)"	"prognostic favourable (1.17e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.09e-2)"	"prognostic favourable (7.21e-4)"	7.6	4.7	4.3	4.9	6.6	5.2	3.2	13.0	9.9	3.4	4.9	2.9	2.9	7.0	4.8	4.6	4.5	4.7	9.6	4.4	4.8	3.1	4.3	5.2	4.2	4.5	9.8	5.5	5.1	12.7	3.9	7.9	4.5	4.5	5.4	1.8	5.0	9.7	4.4	17.9	4.7	7.3	2.9	2.9	10.9	6.1	6.1	4.5	8.0	4.0	2.9	8.6	4.5	3.2	2.8	3.6	4.1	2.0	0.7	1.9	0.9	4.5	7.3	3.4	5.9	1.4	1.7	25.7	4.3	1.1	2.8	1.7	13.4	2.6	6.9	7.6	1.3	8.6	3.6	2.2	0.9	6.0	18.2	8.8	4.2	10.1	2.9	9.2	9.7	1.6	4.1	2.8	1.8	2.6	19.2	1.5	1.1	11.7	12.0	34.2	9.2	13.0	19.0	3.8	4.8	2.2	4.3	13.7	10.6	4.1	6.5	5.2	7.1	9.6	4.2	3.1	7.8	5.8	5.4	9.3	4.8	4.5	3.4	9.3	3.9	2.3	1.5	4.1	1.2	1.3	1.3	2.8	1.2	1.2	1.2	2.6	1.1	1.6	1.7	0.7	2.0	3.6	1.9	0.9	4.3	6.6	13.0	9.9	4.8	3.1	9.8	5.5	4.5	4.5
FBXL14	"Fbl14, MGC40195"	ENSG00000171823	"F-box and leucine rich repeat protein 14"	Q8N1E6	12	1565993-1594165	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053889	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA053889: "	"unprognostic (8.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.90e-2)"	"unprognostic (8.98e-2)"	"prognostic favourable (9.04e-6)"	"unprognostic (5.60e-3)"	"unprognostic (1.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.12e-3)"	6.0	6.0	12.5	8.1	13.0	7.4	4.9	10.2	15.8	5.9	11.7	9.3	4.2	7.3	5.1	3.4	7.2	9.2	7.5	5.7	11.4	9.3	5.4	4.8	6.2	10.4	9.7	7.2	6.8	17.4	9.9	11.3	6.2	7.9	5.2	5.3	6.2	8.2	6.8	3.4	3.6	8.0	3.7	10.5	8.9	14.1	20.1	9.9	21.2	9.4	1.8	6.2	6.3	19.4	3.8	0.6	2.2	0.5	2.4	4.6	0.5	7.6	11.4	3.4	5.9	2.9	3.0	9.9	1.7	3.3	1.7	1.9	11.9	10.2	10.6	2.1	2.0	5.5	2.7	4.2	0.3	17.5	12.8	13.1	3.2	3.8	3.8	9.9	9.6	4.7	2.0	3.1	2.6	3.0	5.3	30.3	2.0	8.5	9.9	4.9	14.1	4.7	8.7	5.4	6.7	2.7	7.2	6.4	6.3	4.2	6.7	6.6	5.2	8.2	4.2	3.8	11.8	4.7	6.2	3.6	3.8	13.1	8.0	5.9	5.7	2.2	0.5	0.0	0.4	0.4	0.4	0.9	1.4	1.5	0.6	3.8	1.5	0.7	1.1	2.4	0.5	0.6	4.6	0.5	12.5	13.0	10.2	15.8	11.4	9.3	9.7	7.2	7.9	9.9
FBXL18	"Fbl18, FLJ11467"	ENSG00000155034	"F-box and leucine rich repeat protein 18"	Q96ME1	7	5431335-5513798	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036049			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA036049: "	"unprognostic (2.86e-3)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.98e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.28e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.30e-4)"	"unprognostic (1.73e-3)"	6.4	6.2	11.0	7.2	15.0	8.5	3.7	10.8	17.7	3.0	4.6	8.1	4.3	5.6	5.1	3.4	6.1	4.4	3.3	5.0	10.2	8.0	4.3	3.6	4.4	5.7	6.6	12.3	4.3	8.0	6.2	4.8	4.2	7.6	5.0	3.2	5.6	5.3	3.8	10.8	10.2	5.0	4.3	5.4	5.4	4.6	5.7	7.7	4.3	4.8	2.8	5.6	4.8	3.2	3.4	2.5	8.9	4.0	3.9	2.7	1.8	9.2	12.2	3.5	7.4	3.2	3.4	6.0	5.5	2.9	3.4	3.7	9.2	5.9	4.2	6.7	2.7	14.6	4.0	9.7	2.6	3.2	5.1	2.2	9.2	3.0	2.3	4.7	3.6	2.8	5.2	5.3	2.5	4.1	6.7	3.8	2.3	9.7	2.5	3.0	11.2	10.1	6.2	6.7	2.3	2.2	4.8	7.5	10.5	8.6	14.6	2.9	14.3	2.9	9.3	11.3	16.2	8.3	8.4	5.0	6.2	3.2	5.8	5.8	13.4	7.9	3.5	1.3	2.7	3.2	2.7	2.1	1.7	2.5	2.5	3.4	1.9	2.4	8.9	3.9	4.0	2.5	2.0	1.8	11.0	15.0	10.8	17.7	10.2	8.0	6.6	12.3	7.6	7.7
FBXL22	"Fbl22, FLJ39626"	ENSG00000197361	"F-box and leucine rich repeat protein 22"	Q6P050	15	63597353-63602428	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 65.9;smooth muscle: 68.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 7.9;SCLC-21H: 9.0;U-937: 5.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA047624, HPA054627"	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA047624: , HPA054627: "	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	1.9	0.4	0.4	5.5	0.4	0.0	1.1	0.6	0.7	31.4	26.0	0.0	20.8	1.4	65.9	7.6	11.9	10.5	31.1	10.3	0.4	0.4	0.6	0.4	0.7	0.2	0.4	0.3	7.1	0.4	0.0	0.4	1.0	0.2	20.1	2.9	1.9	3.3	24.0	2.2	0.7	4.1	68.0	0.4	0.4	6.3	4.2	0.0	0.0	0.6	1.0	0.4	38.2	4.8	1.5	4.3	0.5	0.2	2.0	2.9	0.5	1.2	2.1	0.3	1.3	0.7	0.9	0.1	0.4	0.1	0.5	0.0	1.4	1.6	0.5	1.1	0.2	1.3	0.7	0.4	0.0	1.3	0.9	0.4	1.5	3.5	0.2	0.5	0.2	0.5	0.3	0.1	0.7	0.2	0.0	1.9	0.0	7.9	1.2	1.0	2.5	0.8	1.1	0.0	3.8	0.3	0.4	9.0	0.3	1.0	1.8	0.3	3.2	0.9	1.3	0.6	1.7	0.8	0.4	1.2	2.0	1.3	0.9	5.6	1.3	0.4	0.1	0.0	1.2	0.1	1.6	1.5	1.3	1.4	0.0	1.2	2.9	1.0	0.5	2.0	0.2	4.3	0.1	0.5	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.3	0.2	0.0
FBXO10	FBX10	ENSG00000147912	"F-box protein 10"	Q9UK96	9	37510892-37576349	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.7;HHSteC: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002863, HPA072721"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA002863: AB_10965996, HPA072721: "	"unprognostic (2.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.93e-5)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-1)"	3.8	7.5	4.8	7.5	8.3	1.2	3.4	4.4	12.1	3.6	6.7	4.9	6.3	2.8	5.0	16.9	4.7	2.8	4.5	4.3	6.3	5.9	3.9	4.0	3.5	7.7	4.0	6.7	3.1	7.4	6.4	20.8	3.1	3.9	4.0	2.9	5.3	15.0	5.2	27.0	2.9	4.8	5.0	3.1	10.1	3.6	12.2	3.3	2.9	11.7	6.0	7.7	4.5	2.9	5.9	0.8	0.0	0.2	0.2	1.1	0.5	1.6	4.0	17.7	4.5	8.3	3.0	1.4	3.1	5.5	3.8	5.8	2.3	1.1	10.3	1.0	3.3	0.1	6.4	1.5	2.8	5.7	5.1	2.0	3.8	1.9	25.4	5.4	0.7	6.7	1.2	3.5	2.3	5.4	7.1	2.9	6.8	1.4	2.1	1.8	8.1	1.5	4.0	7.7	1.3	2.2	1.1	3.7	9.4	2.0	2.4	2.2	1.0	5.6	4.3	2.8	4.8	2.4	2.1	3.5	2.8	1.7	2.3	2.1	2.6	0.0	0.1	0.0	0.7	0.2	0.7	5.9	1.1	0.7	0.0	3.2	0.1	0.1	0.0	0.2	0.2	0.8	0.2	0.5	4.8	8.3	4.4	12.1	6.3	5.9	4.0	6.7	3.9	3.3
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;Karpas-707: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: , HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favourable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.0	2.5	15.4	6.0	0.4	0.0	0.4	0.1	0.6	2.4	4.5	2.4	3.6	4.6	5.6	0.1	4.1	1.7	2.5	2.3	1.8	2.9	2.2	0.2	1.3	0.3	2.6	1.6	0.2	8.3	0.6	2.5	0.0	0.8	17.8	1.0	4.1	0.3	3.6	3.3	3.5	0.1	3.6	7.1	3.2	2.1	10.0	4.2	0.3	2.5	6.7	10.7	4.5	0.5	1.3	4.7	2.7	2.2	3.9	3.4	3.9	5.2	0.6	2.7	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.7;pancreas: 52.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 20.6;HBEC3-KT: 18.1;Hep G2: 43.2;SiHa: 81.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 1.4;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA005472: "	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favourable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	1.7	21.8	49.7	2.6	39.2	1.2	7.9	21.1	48.3	2.1	1.8	13.2	2.1	13.7	1.5	6.4	3.6	3.6	2.9	2.6	33.1	32.6	6.9	11.0	3.0	2.5	40.0	23.0	2.2	52.5	17.7	20.2	1.3	25.7	5.1	1.3	2.7	21.7	7.6	1.3	6.6	4.9	1.7	31.4	2.2	3.8	4.4	24.3	1.1	3.7	0.0	3.8	2.6	2.9	1.4	0.1	0.0	0.0	0.0	3.1	0.6	6.7	2.0	0.0	6.6	0.1	0.0	1.0	0.3	0.6	0.1	0.0	20.6	2.0	0.0	8.5	0.0	0.0	0.7	18.1	0.0	0.1	0.2	0.0	0.2	43.2	0.9	0.0	0.0	0.6	3.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.5	0.5	0.7	0.9	81.5	0.0	0.8	4.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	3.1	1.4	1.2	2.9	0.1	1.1	1.8	2.6	0.0	0.0	0.0	0.0	0.8	0.6	49.7	39.2	21.1	30.3	33.1	32.6	40.0	23.0	25.7	24.3
FBXO3	"FBA, FBX3"	ENSG00000110429	"F-box protein 3"	Q9UK99	11	33740939-33774543	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002467			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA002467: "	"unprognostic (1.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.36e-2)"	"prognostic favourable (2.46e-9)"	"unprognostic (6.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-2)"	18.2	16.0	18.4	8.7	33.9	14.1	17.4	27.7	30.3	16.1	13.3	17.1	11.5	11.2	16.4	15.8	21.1	15.0	13.5	28.1	17.3	19.3	29.3	25.3	12.2	10.3	15.2	15.4	18.8	16.5	35.9	21.8	15.3	27.8	16.6	15.0	16.7	17.0	16.9	67.6	18.4	16.3	19.0	12.4	12.6	14.6	15.1	15.2	18.6	21.6	24.2	16.6	15.9	16.6	11.1	8.4	13.0	9.2	15.7	22.8	10.4	11.6	10.5	14.3	15.2	17.3	13.6	8.6	14.0	14.1	11.4	14.3	11.9	11.8	7.8	9.9	15.2	20.3	19.1	18.5	19.2	7.8	26.4	4.0	16.4	9.7	11.0	9.2	9.4	13.8	18.8	7.8	12.5	15.0	13.6	15.7	12.8	7.9	6.8	5.4	7.2	16.1	5.2	32.0	11.0	16.5	14.8	20.3	11.2	19.8	13.7	10.3	19.7	7.1	13.7	14.1	12.4	19.9	11.7	8.8	11.4	13.3	12.6	7.2	13.9	13.0	7.8	11.1	15.1	7.5	16.6	10.9	17.9	17.0	8.4	11.1	22.8	15.9	8.4	15.7	9.2	4.3	21.4	10.4	18.4	33.9	27.7	30.3	17.3	19.3	15.2	15.4	27.8	15.2
FBXO31	"FBX14, Fbx31, FBXO14, MGC15419"	ENSG00000103264	"F-box protein 31"	Q5XUX0	16	87326987-87392142	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA030150	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA030150: AB_10670559"	"unprognostic (4.85e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (9.16e-5)"	"unprognostic (3.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.26e-3)"	25.7	11.5	10.5	6.1	12.1	5.4	22.3	39.7	18.7	10.4	14.1	5.9	9.3	9.0	13.3	7.4	10.8	11.1	6.7	17.2	8.3	8.2	5.3	11.3	5.6	6.3	6.9	10.4	13.9	13.5	8.8	16.6	5.4	8.5	9.4	6.4	7.9	10.3	12.0	50.4	8.9	11.4	14.8	4.6	5.3	8.3	9.1	5.6	4.5	6.0	7.0	5.4	12.2	22.6	2.4	0.9	1.4	0.7	0.2	3.7	1.4	4.8	9.3	3.1	8.4	16.1	9.7	9.1	8.5	8.6	8.5	4.5	8.4	4.1	11.4	9.4	9.0	7.5	6.0	7.1	5.7	5.2	11.0	3.8	5.7	23.6	9.0	3.7	3.2	11.5	6.0	11.0	10.5	5.2	10.9	4.5	4.5	7.0	8.6	5.0	6.0	8.3	11.1	3.7	4.8	3.8	3.5	14.5	7.1	19.0	3.9	5.8	6.1	3.2	7.1	8.2	6.2	7.8	6.7	10.4	8.0	14.1	6.5	6.8	5.0	1.4	0.6	0.2	1.0	0.6	1.8	2.4	1.7	2.4	0.4	1.6	1.8	1.9	0.9	0.2	0.7	0.9	3.7	1.4	10.5	12.1	39.7	18.7	8.3	8.2	6.9	10.4	8.5	5.6
FBXO32	"ATROGIN1, Fbx32, MAFbx"	ENSG00000156804	"F-box protein 32"	Q969P5	8	123497889-123541206	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 200.5"	"Group enriched"	"Detected in some"	5	"HDLM-2: 59.7;U-251 MG: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058955, HPA065209"			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA058955: , HPA065209: "	"unprognostic (2.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (8.58e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-3)"	3.5	1.5	2.4	4.9	5.1	0.8	13.2	1.0	3.8	5.6	31.1	8.9	14.4	2.6	25.3	5.8	8.1	15.8	16.6	26.1	2.9	2.1	1.5	1.0	1.7	4.1	10.2	2.5	9.5	2.0	0.9	5.6	4.9	7.3	19.7	8.0	4.2	8.0	23.1	200.5	3.7	6.5	36.9	8.8	1.7	10.8	3.5	7.6	0.2	9.0	15.1	3.1	24.8	16.1	0.6	0.2	2.9	0.3	4.4	7.6	1.4	1.8	0.3	0.0	0.0	3.8	0.9	0.6	0.3	4.0	0.2	0.4	0.0	1.0	0.0	1.1	2.9	0.1	0.0	0.3	0.3	59.7	1.4	0.0	2.1	0.0	5.2	0.0	0.2	7.7	2.6	0.9	1.1	0.2	0.1	0.5	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.6	0.6	0.1	0.4	0.4	6.8	6.9	6.6	0.1	0.2	1.1	0.3	0.4	17.9	6.2	0.8	0.1	4.5	0.0	0.8	2.9	0.3	0.0	3.7	0.2	3.6	0.6	5.1	5.4	0.2	0.6	6.0	7.6	0.2	4.4	0.2	0.1	4.5	1.4	2.4	5.1	1.0	3.8	2.9	2.1	10.2	2.5	7.3	7.6
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: "	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	23.2	19.3	13.8	17.7	21.2	12.6	20.6	20.8	21.1	22.3	18.4	20.0	20.4	13.8	25.2	18.2	17.6	16.7	16.9	24.1	18.8	13.8	19.2	25.7	20.7	19.0	16.3	18.8	19.2	16.9	29.2	34.1	19.7	24.6	22.2	19.3	16.4	19.4	18.7	28.5	19.3	18.4	18.2	17.8	24.8	18.8	20.0	18.9	26.9	18.1	17.1	21.7	21.7	18.0	5.5	8.1	13.7	14.8	8.0	7.9	4.9	8.4	9.0	14.1	10.3	15.9	17.9	7.4	11.1	21.3	15.9	21.8	13.3	10.5	12.4	11.0	18.0	12.0	14.7	14.0	19.2	13.5	9.4	7.3	13.3	9.0	15.9	19.8	12.1	17.3	12.0	15.2	15.0	21.3	8.1	13.4	15.5	3.4	12.4	9.3	6.6	13.8	11.2	20.6	12.3	15.4	9.9	12.6	12.3	14.8	9.9	14.3	10.5	14.4	13.9	14.5	5.3	7.6	12.3	16.5	16.6	10.6	14.5	11.3	11.0	13.7	6.3	9.0	5.9	8.6	6.3	5.5	5.5	5.7	8.1	4.8	5.7	7.2	12.0	8.0	14.8	3.9	7.9	4.9	13.8	21.2	20.8	21.1	18.8	13.8	16.3	18.8	24.6	18.9
FBXO41	"Fbx41, KIAA1940"	ENSG00000163013	"F-box protein 41"	Q8TF61	2	73254682-73284431	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055246, HPA058386"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA055246: , HPA058386: "	"unprognostic (1.15e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (1.74e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (7.97e-3)"	"unprognostic (7.55e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-2)"	1.5	3.6	21.9	5.9	19.3	4.2	2.1	21.7	33.3	1.2	2.1	1.7	0.9	2.2	1.9	3.6	1.6	2.0	2.7	1.1	18.8	10.6	0.8	1.1	2.2	9.4	5.9	17.8	2.5	4.1	9.8	7.3	1.1	6.8	3.0	2.4	0.8	3.7	3.3	0.6	3.4	2.7	2.1	2.1	7.5	2.5	2.4	3.5	2.1	1.5	0.0	9.0	2.8	0.8	0.5	0.9	0.0	2.6	1.1	0.7	0.4	3.5	1.7	0.6	0.0	0.1	0.1	0.8	0.7	0.6	1.2	1.5	4.0	2.1	26.5	0.1	0.1	2.9	3.7	2.3	1.2	11.0	0.3	8.1	4.0	1.6	0.9	12.2	6.2	1.5	0.9	0.0	0.9	0.2	1.6	4.4	1.2	0.9	4.2	11.4	2.7	1.6	14.9	6.8	12.9	0.7	1.2	9.2	3.4	4.5	1.9	2.8	2.6	5.1	0.2	4.1	3.6	3.7	0.7	5.2	2.2	12.6	1.0	13.4	1.7	0.0	0.5	0.0	0.6	2.6	0.7	0.5	0.4	0.0	0.9	0.2	0.4	0.4	0.0	1.1	0.1	0.7	0.2	0.4	21.9	19.3	21.7	33.3	18.8	10.6	5.9	17.8	6.8	3.5
FBXO45	Fbx45	ENSG00000174013	"F-box protein 45"	P0C2W1	3	196568611-196589059	"Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040730	Uncertain		Approved	Cytosol				Cytosol		"HPA040730: AB_10959311"	"unprognostic (7.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (7.61e-5)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (1.16e-5)"	"prognostic unfavourable (4.93e-5)"	"unprognostic (5.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.65e-1)"	6.3	5.6	15.6	7.2	15.0	14.6	9.4	19.0	19.4	6.2	8.4	12.5	4.0	6.6	6.2	4.0	11.5	4.8	5.7	4.5	15.5	12.0	4.9	8.4	5.6	7.7	13.5	11.1	6.7	6.7	13.7	7.8	6.7	11.8	6.6	9.1	3.5	5.9	5.8	15.3	15.8	6.2	6.3	14.9	6.0	6.8	14.4	13.3	6.7	4.7	7.7	12.0	7.3	11.4	2.0	4.4	3.8	3.3	1.6	4.8	1.2	19.7	3.7	8.0	10.1	5.4	5.3	9.5	8.8	4.0	7.0	7.2	10.5	6.7	8.3	15.2	5.7	8.5	15.2	10.0	12.9	12.0	6.9	15.2	6.9	6.6	5.2	20.2	7.8	2.7	11.4	7.9	14.6	7.6	18.2	17.8	7.7	19.8	11.8	9.5	12.4	14.6	10.0	10.5	20.2	5.9	8.1	16.3	11.1	9.5	16.7	10.1	28.6	13.6	7.5	8.1	8.8	11.7	23.6	17.5	29.2	23.4	7.1	26.3	7.7	3.8	3.1	3.1	2.8	2.9	4.6	1.8	2.8	1.6	3.7	2.0	2.6	3.0	1.2	1.6	3.3	4.4	4.8	1.2	15.6	15.0	19.0	19.4	15.5	12.0	13.5	11.1	11.8	13.3
FBXO46	"20D7-FC4, Fbx46, FBXO34L"	ENSG00000177051	"F-box protein 46"	Q6PJ61	19	45710629-45730904	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049390	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA049390: "	"unprognostic (9.02e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (2.13e-5)"	"unprognostic (9.33e-2)"	"prognostic favourable (5.44e-4)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.13e-2)"	"prognostic favourable (8.11e-4)"	"unprognostic (9.77e-2)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favourable (5.09e-6)"	7.4	7.4	13.8	12.9	13.1	10.4	9.8	10.4	15.7	11.2	10.3	8.6	10.6	9.6	15.7	10.0	20.7	10.7	7.3	8.7	13.3	4.8	7.6	10.5	7.7	17.2	13.9	10.1	17.1	12.6	8.4	10.4	12.3	10.2	10.1	9.7	8.6	11.0	9.0	12.8	12.8	11.4	10.9	9.7	15.8	13.3	11.5	13.0	13.6	12.8	9.2	17.1	10.0	12.4	5.9	2.6	7.1	2.3	1.1	3.7	1.2	6.9	10.8	8.4	9.8	2.2	3.9	9.6	3.7	2.0	2.9	3.4	9.0	9.2	12.1	5.0	2.0	10.1	6.2	4.6	2.2	14.9	13.1	9.8	36.6	4.8	3.3	4.4	12.7	3.3	4.2	4.9	3.1	4.3	7.7	14.8	2.4	6.6	10.0	5.1	5.3	3.8	13.6	4.7	11.2	3.4	8.4	8.4	7.4	5.8	12.3	4.8	10.4	5.4	4.9	6.2	5.6	3.4	6.0	14.2	19.6	8.1	6.9	6.2	5.0	7.1	2.3	2.3	3.7	1.8	2.5	4.0	2.8	2.5	1.5	5.9	2.6	3.0	6.7	1.1	2.1	2.6	2.6	1.2	13.8	13.1	10.4	15.7	13.3	4.8	13.9	10.1	10.2	13.0
FBXO7	"Fbx, FBX7, PARK15"	ENSG00000100225	"F-box protein 7"	Q9Y3I1	22	32474676-32498829	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032113, HPA032114, CAB034296"	Uncertain		Supported	Nucleoplasm,Cytosol			430000	"Nucleoplasm, Cytosol"		"CAB034296: AB_2102563, HPA032113: , HPA032114: AB_10696202"	"unprognostic (3.99e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (1.08e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.53e-1)"	"prognostic favourable (2.66e-10)"	"unprognostic (3.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.79e-3)"	22.9	27.8	25.5	16.2	28.6	92.9	27.7	14.5	30.6	23.7	22.5	55.9	17.0	20.1	22.5	29.6	18.5	28.3	18.8	16.3	29.3	26.2	43.3	51.2	24.9	26.0	39.9	18.2	27.7	26.9	27.6	23.2	31.8	33.4	23.0	22.7	35.9	18.6	23.6	12.4	20.7	28.4	24.0	52.7	29.5	20.6	42.1	24.4	33.3	77.6	16.4	24.4	19.7	26.3	22.0	25.4	60.4	21.7	28.6	33.0	24.9	21.3	15.0	19.6	22.1	30.3	28.9	14.2	18.3	33.1	29.0	34.6	14.8	14.6	19.6	15.3	31.3	14.3	28.5	23.4	29.8	33.7	25.8	27.0	16.4	22.9	36.9	35.3	24.1	24.1	37.9	25.5	19.6	31.2	21.4	25.5	31.4	15.7	17.5	22.1	7.7	11.2	17.3	20.8	23.6	33.2	22.3	28.7	18.8	22.8	18.4	64.7	10.2	18.7	21.8	15.2	21.7	14.7	14.3	18.0	19.1	18.8	28.5	18.0	60.6	60.4	18.9	39.8	27.6	21.7	33.0	22.0	25.3	27.0	25.4	19.6	22.4	24.3	7.2	28.6	20.7	16.7	30.7	24.9	25.5	28.6	14.5	30.6	29.3	26.2	39.9	18.2	33.4	24.4
FBXO8	"FBS, FBX8"	ENSG00000164117	"F-box protein 8"	Q9NRD0	4	174236658-174284264	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002885	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA002885: AB_1078835"	"unprognostic (8.17e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-1)"	"prognostic favourable (1.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-1)"	16.8	18.5	13.5	9.2	14.1	7.3	16.4	19.4	14.0	15.6	17.3	14.0	10.7	13.4	13.1	19.5	16.4	15.1	13.1	19.1	13.3	12.0	20.2	43.5	11.8	9.5	14.6	10.1	15.7	22.6	16.5	26.9	27.1	14.3	16.8	15.3	14.7	13.3	13.1	7.4	16.0	18.9	18.8	14.7	13.9	14.7	10.0	14.0	18.2	19.9	6.5	12.4	20.6	18.2	12.6	8.6	19.2	8.9	9.8	15.5	7.8	4.7	3.2	6.5	2.2	14.6	16.0	5.1	9.7	8.9	6.4	6.5	2.5	8.4	3.6	9.2	6.3	3.0	4.3	5.6	6.8	10.8	9.8	3.2	5.3	3.9	11.1	4.3	3.5	9.2	13.9	5.9	7.8	6.4	6.7	18.8	8.4	4.7	4.5	4.5	1.8	3.4	2.6	4.3	5.7	10.0	2.0	6.0	39.3	4.3	7.6	10.7	4.3	4.7	7.3	3.8	3.6	10.7	5.4	9.7	4.6	3.1	12.7	3.1	5.2	19.2	6.2	12.7	12.3	7.8	15.5	12.6	14.2	12.1	8.5	10.7	13.5	11.8	6.2	9.8	8.9	8.6	15.0	7.8	13.5	14.1	19.4	14.0	13.3	12.0	14.6	10.1	14.3	14.0
FBXW8	"FBW6, FBW8, FBX29, FBXO29"	ENSG00000174989	"F-box and WD repeat domain containing 8"	Q8N3Y1	12	116910956-117031148	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038850, HPA038851"	Supported		Supported	Cytosol				Cytosol		"HPA038850: , HPA038851: AB_10673479"	"unprognostic (2.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.55e-1)"	10.5	10.6	8.5	16.2	9.5	5.6	10.4	8.2	9.5	13.1	9.0	12.3	14.7	6.2	16.4	14.1	9.5	11.5	15.5	8.9	6.8	6.6	8.1	8.8	9.2	9.3	6.8	6.2	15.5	18.4	17.3	21.5	16.7	8.2	10.4	8.9	11.7	18.4	11.8	8.6	11.3	8.7	11.0	7.5	9.0	11.1	12.4	7.3	11.3	17.4	7.9	13.8	10.6	10.3	5.3	2.2	3.9	1.9	6.8	3.0	1.5	5.8	10.7	9.3	6.7	8.8	12.7	6.1	12.5	11.3	7.8	7.9	3.4	3.9	9.3	4.5	13.7	6.3	6.4	3.8	6.6	14.6	5.6	4.5	4.4	3.3	14.1	5.6	3.6	11.8	3.6	7.3	16.1	8.8	5.8	4.0	7.4	14.0	4.2	3.9	10.8	6.9	7.0	4.4	7.9	6.0	9.6	8.6	24.6	8.2	2.6	5.0	10.4	4.9	11.5	7.0	3.4	7.8	3.5	15.2	8.8	8.4	10.8	3.6	11.3	0.3	1.6	3.9	3.0	1.6	2.7	5.3	1.6	1.9	2.2	4.4	1.1	1.9	0.2	6.8	1.9	2.2	2.4	1.5	8.5	9.5	8.2	9.5	6.8	6.6	6.8	6.2	8.2	7.3
FBXW9	"Fbw9, MGC10870"	ENSG00000132004	"F-box and WD repeat domain containing 9"	Q5XUX1	19	12688053-12696643	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042087	Approved		Approved	Cytosol				Cytosol		"HPA042087: AB_10794168"	"unprognostic (4.46e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (4.69e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.42e-3)"	4.0	8.3	5.6	5.1	7.7	6.2	6.8	6.3	10.8	7.1	5.7	4.2	6.5	7.6	5.4	11.0	10.3	22.6	8.6	3.4	6.0	6.6	8.3	5.4	9.4	4.8	3.7	7.2	6.3	7.4	4.6	7.0	4.5	7.0	6.8	3.3	5.4	12.0	6.7	2.5	10.2	5.3	3.2	2.5	3.8	6.1	30.4	4.9	7.3	9.0	10.6	5.9	4.8	5.6	3.3	12.0	0.4	8.2	4.6	6.1	5.3	11.1	7.6	5.1	7.3	2.2	3.8	6.1	3.6	3.8	7.8	6.5	4.2	6.9	2.7	9.5	3.3	10.1	4.8	6.9	1.4	1.9	12.8	3.3	8.6	6.9	5.1	8.3	2.0	5.0	11.1	5.4	2.7	6.1	7.9	1.9	1.7	23.2	8.9	10.7	8.5	7.2	4.7	3.5	15.6	6.9	3.4	11.7	13.8	5.4	11.5	5.0	11.5	6.2	2.9	4.6	4.3	5.7	5.7	11.6	4.8	3.0	5.7	3.0	3.0	0.0	8.2	0.0	3.2	7.8	5.3	3.3	3.5	2.4	12.0	3.2	3.3	2.3	0.4	4.6	5.1	3.4	6.1	5.3	5.6	7.7	6.3	10.8	6.0	6.6	3.7	7.2	7.0	4.9
FCHO1	KIAA0290	ENSG00000130475	"FCH domain only 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 27.9;RPMI-8226: 19.2;U-937: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: "	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	2.3	13.6	13.7	18.9	18.9	1.9	11.4	15.2	1.1	2.7	30.2	0.0	3.7	1.8	1.8	1.5	1.9	4.5	1.1	17.8	11.7	1.0	2.7	3.4	22.6	23.0	10.0	2.2	0.9	0.8	2.6	1.4	10.8	1.4	2.6	0.6	2.7	1.2	0.9	13.4	4.0	2.1	15.9	13.7	3.5	4.3	23.3	16.4	1.2	0.0	17.3	5.1	1.0	9.9	10.4	25.7	9.5	4.1	5.7	4.4	0.4	5.4	3.5	2.5	0.1	0.1	3.5	0.5	0.1	0.1	0.2	0.7	0.6	27.9	8.0	0.2	1.1	1.7	1.0	0.1	12.3	0.9	2.2	0.7	2.8	0.3	6.9	4.7	0.0	0.1	0.1	0.2	0.7	10.9	13.4	0.0	7.7	15.8	12.4	1.7	13.3	13.5	0.1	19.2	0.1	0.5	0.6	1.3	0.1	2.8	0.4	2.7	6.9	0.5	0.1	2.0	0.5	0.2	8.5	3.8	15.1	0.4	17.2	0.3	6.9	6.6	6.5	5.2	9.5	4.5	8.8	5.7	4.5	9.7	9.9	5.5	4.4	25.7	4.1	7.2	10.4	5.2	4.4	13.6	18.9	11.4	15.2	17.8	11.7	23.0	10.0	10.8	23.3
FCHO2		ENSG00000157107	"FCH domain only 2"	Q0JRZ9	5	72955981-73090522	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 15.9;monocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037685, HPA037686, HPA077850"	Enhanced		Approved	Vesicles,Centrosome,Cytosol				Centrosome	"Vesicles, Cytosol"	"HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: "	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.21e-1)"	"prognostic favourable (7.00e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-1)"	32.2	9.6	10.7	10.0	12.2	8.3	18.0	23.1	18.3	16.2	18.3	8.9	15.3	15.5	23.7	13.0	30.2	14.6	15.7	12.5	11.2	7.0	18.6	16.0	22.8	18.5	10.8	9.5	16.1	11.1	17.5	11.4	19.2	10.9	12.6	16.1	9.9	17.1	12.6	17.7	15.2	20.8	16.6	11.9	18.9	12.2	10.5	12.4	3.2	22.4	11.7	11.8	14.6	22.5	0.7	1.1	15.9	4.5	0.7	1.3	0.5	9.0	7.4	7.1	6.2	10.0	13.3	20.9	8.0	11.9	6.1	9.6	3.7	15.9	2.2	11.3	11.1	6.9	6.0	14.1	8.3	2.3	7.0	4.4	6.1	4.6	5.0	0.9	4.6	8.9	7.3	8.2	13.1	13.8	5.0	3.9	12.5	4.2	0.0	4.4	2.2	3.7	2.0	6.9	2.6	14.8	12.9	2.8	4.5	11.0	7.8	5.0	9.5	6.3	14.3	8.0	3.8	8.8	5.6	1.4	2.5	0.4	5.2	0.6	9.8	11.5	2.6	6.4	1.3	3.5	0.8	0.3	0.4	0.5	1.1	0.7	0.2	0.4	15.9	0.7	4.5	0.4	0.3	0.5	10.7	12.2	23.1	18.3	11.2	7.0	10.8	9.5	10.9	12.4
FCHSD1	FLJ00007	ENSG00000197948	"FCH and double SH3 domains 1"	Q86WN1	5	141639302-141651419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043795	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043795: AB_10963435"	"prognostic favourable (8.62e-4)"	"unprognostic (4.08e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.50e-3)"	"unprognostic (8.56e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (6.19e-6)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (4.77e-4)"	"unprognostic (4.12e-3)"	"prognostic favourable (1.21e-4)"	7.5	6.6	9.2	16.1	14.1	15.2	8.6	3.0	12.5	11.7	9.9	11.1	4.9	9.7	12.5	8.6	8.6	8.5	13.7	5.4	8.8	6.6	6.8	2.9	9.6	18.6	18.8	4.3	17.7	7.5	23.8	12.6	7.9	14.5	10.0	4.8	5.6	10.3	6.1	2.6	18.5	15.3	8.8	14.5	18.4	10.5	7.4	15.4	7.4	10.6	8.8	23.2	12.1	13.8	5.3	1.9	9.8	3.0	2.3	7.2	2.9	7.3	4.6	6.2	13.0	5.3	6.7	11.0	15.9	8.2	14.3	22.6	8.6	15.7	3.0	8.0	12.2	4.2	2.0	8.8	6.4	12.9	3.3	6.4	6.1	3.1	4.1	2.0	21.7	8.2	7.0	11.2	3.7	8.2	3.9	5.8	1.6	6.5	1.6	3.9	1.8	4.3	0.0	0.0	2.9	4.9	11.0	0.7	7.0	0.3	6.0	9.1	7.3	6.1	16.5	0.2	4.0	5.8	6.6	7.0	2.3	1.6	12.5	7.2	6.8	6.3	1.7	5.6	7.0	2.0	5.2	5.3	3.8	7.2	1.9	3.0	3.6	4.9	9.8	2.3	3.0	1.7	5.0	2.9	9.2	14.1	3.0	12.5	8.8	6.6	18.8	4.3	14.5	15.4
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206904386-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 51.7;U-266/70: 26.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 99.6;T-cells: 60.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"		2400000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA003910: AB_1078798"	"prognostic favourable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	15.5	0.6	0.5	42.9	0.5	2.9	1.5	0.4	0.4	0.8	2.5	0.4	0.3	1.2	1.2	0.8	3.4	1.3	2.6	1.0	0.5	0.5	2.4	1.5	3.9	77.2	0.5	0.0	1.3	0.7	0.0	0.9	0.8	0.2	1.4	2.3	1.3	10.1	0.3	1.9	0.6	30.1	0.4	0.6	78.8	2.8	0.5	0.0	51.8	1.8	1.2	84.9	8.5	1.2	99.6	1.4	5.3	0.4	18.4	60.0	28.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.1	0.0	0.0	3.3	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	7.2	0.0	0.1	1.0	0.1	0.0	0.0	1.6	0.2	51.7	0.0	0.1	0.0	0.0	1.0	0.2	4.8	0.1	0.0	0.2	0.0	0.2	0.0	0.0	26.1	1.9	7.2	0.3	0.0	0.2	0.5	0.2	0.2	20.3	0.4	26.4	80.3	28.1	26.2	0.2	99.6	49.5	33.3	5.3	18.4	0.3	1.4	60.0	28.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.2	0.0
FCRLB	"FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2"	ENSG00000162746	"Fc receptor like B"	Q6BAA4	1	161721563-161728143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.9;lymphoid tissue: 5.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.0;Daudi: 7.3;fHDF/TERT166: 10.7;HMC-1: 9.3;PC-3: 5.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 7.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"basophil: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB026139	Uncertain		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"CAB026139: "	"unprognostic (1.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (5.77e-3)"	"unprognostic (7.49e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.14e-2)"	0.5	0.2	0.2	3.4	0.3	0.0	0.3	1.0	0.8	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	1.4	0.6	0.3	2.4	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	1.2	0.0	0.2	0.7	2.7	0.2	0.3	0.8	0.2	0.4	1.5	0.2	0.2	0.2	0.2	0.3	0.2	5.0	0.8	0.2	4.9	0.6	8.9	0.2	5.3	2.7	0.6	0.7	0.1	0.0	0.3	0.5	0.7	0.0	4.5	6.0	1.5	1.5	0.1	0.2	7.3	0.2	10.7	0.1	0.2	0.4	3.9	0.1	0.3	0.2	0.1	0.2	0.2	0.0	9.3	1.4	0.0	2.7	0.2	1.3	0.3	0.3	0.2	0.4	0.0	2.5	0.2	5.4	0.0	0.5	0.3	0.2	0.2	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.8	1.6	0.7	1.7	0.8	0.0	0.0	2.9	3.2	0.4	0.8	8.9	0.1	2.4	2.7	0.1	1.0	4.6	1.6	1.5	0.6	4.9	0.8	1.2	1.5	5.3	0.2	0.0	0.0	0.6	0.2	0.3	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol			2000000	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavourable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	21.0	57.8	19.3	17.6	26.5	16.5	19.8	12.8	32.2	19.0	25.0	22.6	14.5	45.9	18.0	21.7	41.4	16.7	18.8	19.6	18.6	23.4	23.7	100.8	25.7	19.2	19.5	24.3	15.2	27.5	15.6	12.3	20.2	47.3	16.5	29.7	20.5	29.2	12.9	15.7	29.3	32.3	18.9	23.0	17.7	23.4	15.1	16.5	25.1	19.5	41.7	27.3	13.7	20.8	41.1	39.7	49.4	37.1	45.3	45.5	48.3	35.6	19.4	71.3	25.7	16.7	61.3	25.4	17.0	33.7	27.2	44.3	31.4	84.9	27.2	41.4	14.9	39.8	42.4	147.8	25.5	14.8	30.4	15.8	34.6	37.8	27.5	25.5	18.1	43.6	23.4	43.2	21.7	47.3	28.1	73.3	28.3	38.3	32.6	24.8	42.8	28.4	28.2	30.9	75.4	71.6	23.8	27.7	23.7	17.5	31.9	29.4	23.0	69.4	34.4	15.2	18.7	9.4	31.1	31.1	23.9	48.5	14.8	27.2	23.9	30.5	36.0	49.4	39.4	37.1	35.0	41.1	34.8	39.8	39.7	34.2	31.5	39.3	16.5	45.3	27.2	31.4	45.5	48.3	19.3	26.5	12.8	32.2	18.6	23.4	19.5	24.3	47.3	16.5
FDXACB1	"hCG_2033039, LOC91893"	ENSG00000255561	"Ferredoxin-fold anticodon binding domain containing 1"	Q9BRP7	11	111874056-111881243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039012, HPA061375"	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039012: AB_10670916, HPA061375: "	"unprognostic (2.91e-2)"	"unprognostic (3.32e-3)"	"unprognostic (1.32e-2)"	"unprognostic (6.81e-7)"	"unprognostic (1.32e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.95e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.79e-2)"	3.7	6.7	4.4	6.2	5.2	4.0	5.8	2.2	6.1	4.4	3.2	4.7	3.1	4.0	3.9	6.0	3.9	3.7	5.0	2.8	6.6	4.7	3.4	4.3	5.2	8.5	3.6	3.4	4.3	5.1	5.3	3.6	3.0	5.2	3.4	4.2	4.1	6.2	2.2	1.6	6.6	4.3	3.0	5.3	7.6	3.2	11.1	4.0	11.2	3.4	2.6	7.9	4.2	2.7	6.5	4.8	1.8	4.6	5.6	10.4	4.5	1.6	2.1	3.0	6.0	2.2	2.0	1.4	1.2	1.3	1.3	1.6	2.6	3.6	5.8	3.3	1.1	4.8	2.7	2.7	2.9	7.4	1.3	6.7	1.1	2.1	1.3	6.7	5.9	1.7	1.6	1.9	2.4	2.3	4.6	7.8	2.5	2.2	6.4	6.5	1.6	3.1	4.0	1.9	7.2	3.0	2.9	1.4	2.0	1.8	3.5	1.8	5.1	4.1	1.8	3.2	3.2	3.6	2.8	3.9	5.7	16.0	1.8	9.9	4.1	0.2	3.2	1.8	6.8	4.6	9.0	6.5	6.1	6.2	4.8	5.2	9.4	10.4	0.9	5.6	3.8	4.6	3.2	4.5	4.4	5.2	2.2	6.1	6.6	4.7	3.6	3.4	5.2	4.0
FEM1A		ENSG00000141965	"Fem-1 homolog A"	Q9BSK4	19	4791681-4801273	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 103.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016565, HPA063622"			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA016565: AB_1848489, HPA063622: "	"unprognostic (4.62e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (6.18e-5)"	"unprognostic (3.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.70e-2)"	3.0	2.4	3.3	2.2	4.4	3.3	4.0	4.1	5.0	2.0	2.7	3.0	0.9	2.2	2.7	4.0	4.2	2.1	1.9	8.6	3.3	2.6	2.2	4.4	2.3	3.8	3.2	2.5	2.1	4.2	4.4	2.3	4.5	3.1	2.8	2.0	2.7	3.1	2.1	103.9	6.9	2.3	2.3	2.2	2.7	2.2	2.2	3.2	4.2	2.1	18.6	3.0	2.5	2.3	7.2	6.8	9.1	8.2	6.8	6.9	4.2	7.2	5.0	4.7	10.2	5.3	3.1	6.8	4.3	3.6	7.0	4.9	7.8	3.4	8.2	4.5	5.4	7.5	8.2	7.2	4.6	9.7	9.4	8.0	4.0	5.8	7.9	13.2	10.3	4.5	11.1	5.4	7.8	5.0	11.7	15.8	4.8	7.3	11.0	4.9	14.5	12.2	10.3	6.1	8.7	6.3	9.3	15.3	10.9	5.7	10.8	8.1	8.3	11.5	7.0	6.5	4.6	10.0	11.4	18.4	15.2	7.1	6.6	9.6	9.0	9.1	7.3	7.1	6.9	8.2	6.0	5.3	5.5	6.3	6.8	7.2	5.0	5.7	6.6	6.8	7.3	6.6	3.9	4.2	3.3	4.4	4.1	5.0	3.3	2.6	3.2	2.5	3.1	3.2
FEM1B		ENSG00000169018	"Fem-1 homolog B"	Q9UK73	15	68277803-68295865	"Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041920, HPA042192"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041920: AB_10796788, HPA042192: AB_10796574"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.67e-2)"	13.4	10.5	13.1	11.2	17.0	38.1	17.7	23.0	22.9	14.8	14.6	14.1	13.6	11.1	23.2	12.6	18.5	14.1	11.1	16.9	13.7	13.7	10.4	14.6	11.9	14.2	17.8	16.1	17.4	8.5	14.0	12.9	13.7	17.2	15.0	12.4	12.4	12.3	16.6	42.9	18.7	14.2	22.3	14.3	11.9	10.4	55.4	15.4	12.9	12.9	11.4	13.1	18.7	17.8	4.4	4.4	4.0	7.9	6.5	6.9	3.0	7.2	13.4	13.8	13.0	12.6	11.7	9.3	10.4	10.9	10.7	9.9	9.0	9.8	16.8	7.6	14.1	26.5	28.7	13.1	9.0	8.0	11.4	18.4	15.9	5.7	10.9	14.9	11.5	10.7	28.8	13.0	31.6	8.4	15.4	20.6	9.1	8.5	10.7	7.7	14.1	4.3	15.5	15.6	21.6	6.9	26.5	18.6	11.7	10.7	11.2	28.8	10.0	14.0	10.9	18.8	16.5	6.5	9.5	13.5	28.9	17.9	10.7	16.4	11.1	0.0	5.1	3.6	5.7	7.9	5.8	3.7	5.7	6.2	4.4	4.4	6.9	5.0	4.0	6.5	6.3	3.2	3.0	3.0	13.1	17.0	23.0	22.9	13.7	13.7	17.8	16.1	17.2	15.4
FER	"PPP1R74, TYK3"	ENSG00000151422	"FER tyrosine kinase"	P16591	5	108747822-109196841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007641, CAB022464"	Approved		Supported	Cytosol				Cytosol		"CAB022464: , HPA007641: AB_1078845"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.05e-2)"	"prognostic favourable (5.55e-4)"	"unprognostic (3.83e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-3)"	13.4	5.7	5.5	6.1	13.4	1.8	5.2	6.0	5.0	9.7	6.7	1.4	16.8	2.5	6.5	19.3	8.2	4.6	5.3	4.6	4.8	4.8	7.2	3.6	12.2	1.9	4.9	2.2	7.2	3.0	18.5	15.9	5.7	3.1	6.8	3.6	5.0	4.5	21.9	5.0	6.6	3.5	7.2	6.2	8.1	4.1	15.9	2.6	3.9	10.2	12.8	2.8	7.7	9.0	10.5	5.4	8.0	5.1	1.2	2.8	1.1	4.6	1.6	5.7	9.0	3.4	5.2	3.6	5.6	5.5	3.3	3.9	9.5	2.9	7.5	3.5	6.7	3.3	3.1	7.0	7.5	3.1	4.2	4.9	7.2	3.4	2.3	2.7	4.2	3.1	3.9	7.9	9.0	4.9	6.1	5.6	4.2	1.3	2.1	0.8	0.8	3.3	1.7	5.5	44.2	3.2	1.6	1.9	2.8	9.2	0.5	6.0	2.2	1.2	7.2	6.4	4.9	3.2	4.4	4.8	7.1	2.9	4.0	0.8	3.0	8.0	5.1	5.4	1.7	3.1	2.8	10.5	1.0	1.8	2.8	3.8	1.6	2.0	0.4	1.2	2.4	5.4	2.1	1.1	5.5	13.4	6.0	4.2	4.8	4.8	4.9	2.2	3.1	2.6
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.8;lymphoid tissue: 49.7"	"Cell line enhanced"	"Detected in many"		"HEL: 20.9;HL-60: 18.6;HMC-1: 39.8;NB-4: 24.4;THP-1: 36.6;U-937: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	14.9	3.4	4.8	9.7	4.1	38.3	12.7	2.4	5.7	6.8	5.4	3.2	4.7	3.0	7.4	5.6	4.9	7.6	7.3	7.9	4.2	2.2	5.2	11.8	12.7	23.3	3.7	0.9	6.4	3.7	1.8	2.7	8.1	7.2	7.7	2.4	5.3	33.8	6.3	3.4	3.5	5.2	5.4	6.9	49.7	4.3	3.2	4.7	3.1	7.2	4.1	4.5	7.2	9.4	1.1	32.6	60.8	30.5	9.3	0.1	13.8	0.1	0.2	0.3	3.5	1.0	3.1	6.0	0.9	0.0	1.7	1.0	0.8	0.0	2.2	0.1	2.0	0.5	0.6	0.1	0.5	1.1	0.3	20.9	0.0	3.7	2.0	18.6	39.8	3.0	0.0	2.6	0.0	10.5	0.6	0.0	0.0	6.8	0.5	24.4	1.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	0.0	36.6	8.3	0.0	3.6	0.1	0.0	0.0	2.6	0.8	0.1	15.8	0.8	10.4	30.5	60.8	0.1	17.6	0.0	1.1	0.0	0.0	32.6	0.9	0.0	0.0	20.0	9.3	7.3	12.9	0.0	13.8	4.8	4.1	2.4	5.7	4.2	2.2	3.7	0.9	7.2	4.7
FEZ1	UNC-76	ENSG00000149557	"Fasciculation and elongation protein zeta 1"	Q99689	11	125445745-125496317	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 123.4"	"Cell line enhanced"	"Detected in many"		"AF22: 39.9;HBEC3-KT: 38.6;NTERA-2: 36.5;SCLC-21H: 39.0"	"Cancer enriched"	"Detected in all"	10	"glioma: 68.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 30.8;MAIT T-cell: 18.0;memory CD8 T-cell: 8.9;naive CD8 T-cell: 7.7"	"Lineage enriched"	"Detected in many"	14	"T-cells: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038490, HPA076844"	Approved		Supported	Microtubules,Cytosol				Microtubules	Cytosol	"HPA038490: AB_10672647, HPA076844: "	"unprognostic (5.68e-2)"	"prognostic unfavourable (9.06e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	6.6	5.6	48.3	4.4	50.1	1.3	4.3	28.2	121.4	6.4	5.1	58.8	0.2	2.9	6.9	4.0	5.9	4.1	9.4	12.4	54.2	38.2	2.7	7.4	10.0	3.5	68.2	29.8	6.0	1.4	5.0	2.3	6.0	43.4	6.6	5.3	1.4	2.4	12.9	1.7	3.5	3.5	13.0	123.4	3.9	2.5	7.2	51.4	0.0	2.2	0.0	2.9	16.8	2.1	0.0	0.4	2.1	0.5	1.0	30.8	5.0	0.0	0.0	39.9	0.0	26.3	24.0	0.0	6.2	8.0	1.5	0.3	0.0	0.0	0.0	7.3	11.7	0.1	18.1	38.6	0.8	3.2	0.2	18.3	0.0	0.0	22.2	0.0	0.1	19.6	8.9	7.2	19.1	17.6	2.4	0.2	1.9	0.9	0.1	0.0	36.5	0.4	0.0	0.0	0.0	0.0	14.0	39.0	4.1	0.1	0.0	0.6	2.9	17.9	15.8	0.1	1.0	0.0	5.2	0.4	0.1	0.0	4.3	0.0	16.8	2.1	0.5	0.0	30.8	0.1	18.0	0.0	1.1	8.9	0.4	0.0	0.4	7.7	0.6	1.0	0.0	0.0	0.0	5.0	48.3	50.1	28.2	97.4	54.2	38.2	68.2	29.8	43.4	51.4
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	31.7	23.4	28.7	12.0	25.3	8.1	18.6	20.1	31.2	18.3	17.2	28.0	6.0	13.1	20.4	13.1	20.4	13.1	14.6	28.5	26.1	22.6	21.4	18.4	16.5	13.1	27.6	21.6	18.3	6.8	14.2	8.5	29.6	29.3	15.6	18.4	19.0	9.7	22.1	51.0	9.1	18.7	26.9	33.8	17.8	12.2	12.6	25.4	9.4	14.8	12.2	12.1	15.5	13.5	1.7	13.6	4.7	3.5	3.1	1.5	0.7	15.3	9.2	12.6	5.3	24.9	33.0	9.9	39.1	20.0	24.0	15.2	6.4	5.0	9.5	24.0	50.6	6.1	10.6	13.5	26.2	2.2	5.8	7.7	3.3	10.6	11.9	7.7	1.9	31.6	11.6	14.8	17.8	34.2	8.3	3.0	44.2	5.4	4.7	6.7	6.6	14.5	3.1	11.4	3.2	19.0	15.0	0.3	11.4	9.6	7.9	9.3	2.8	9.7	39.7	15.0	8.0	8.2	22.7	2.2	2.6	6.5	14.9	5.4	21.1	2.4	3.5	4.7	1.5	3.3	1.0	1.7	1.1	0.8	3.6	1.0	1.3	0.5	4.0	3.1	1.9	13.6	1.3	0.7	28.7	25.3	20.1	28.8	26.1	22.6	27.6	21.6	29.3	25.4
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301394-122310691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.7;testis: 11.0"	"Group enriched"	"Detected in some"	10	"NTERA-2: 57.4;SCLC-21H: 25.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 13.7"	"Region enriched"	"Detected in single"	9	"hypothalamus: 6.9"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA064639: , HPA073693: "		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.6	0.2	6.4	0.2	4.9	0.2	0.2	0.0	2.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	1.0	16.7	0.2	0.2	0.2	0.2	2.0	0.0	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	1.4	0.6	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	11.0	3.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	57.4	1.0	0.0	0.0	0.0	0.0	0.1	25.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.9	0.0	2.0	1.0	16.7	2.0	0.0	0.0	3.5
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496166	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000911	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA000911: AB_1078853"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	5.9	7.7	15.6	5.9	10.9	1.6	7.1	16.3	15.6	12.3	7.2	3.7	3.4	4.5	12.4	4.4	9.3	7.6	7.8	9.2	9.6	7.1	5.1	1.9	4.6	4.0	4.8	11.2	13.7	6.9	6.9	5.4	9.4	5.7	6.5	3.8	6.8	7.7	7.9	3.3	11.8	5.5	11.9	3.7	5.8	5.2	4.6	4.8	0.0	5.6	7.3	4.3	7.6	7.8	1.6	0.6	0.5	2.6	1.2	3.2	1.1	13.8	5.9	11.4	14.9	5.3	9.5	5.5	8.3	8.4	7.0	5.7	1.8	1.2	0.8	6.8	12.8	5.4	9.6	5.9	3.9	1.4	8.4	0.5	4.5	2.1	5.7	0.7	0.5	7.7	3.7	10.7	5.1	6.3	2.2	0.5	5.5	2.9	1.6	1.5	11.2	9.3	8.0	6.5	0.5	6.0	0.8	10.6	10.0	9.1	0.8	13.7	10.0	1.2	6.1	8.8	7.8	19.3	7.6	1.0	2.0	1.5	9.7	1.6	4.8	0.0	0.6	0.5	2.0	1.3	2.0	1.5	1.6	2.2	0.6	1.6	3.2	1.8	0.0	1.2	2.6	0.2	1.4	1.1	15.6	10.9	16.3	15.6	9.6	7.1	4.8	11.2	5.7	4.8
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947451-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.2;lymphoid tissue: 48.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 20.7;Karpas-707: 28.7;RT4: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA020963: , HPA021018: "	"unprognostic (5.66e-3)"	"prognostic favourable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	3.1	1.5	2.3	20.5	2.5	23.4	3.5	0.5	1.6	1.8	3.1	3.1	1.6	1.9	2.8	2.5	2.8	2.5	3.1	1.5	2.2	2.0	4.6	2.1	7.5	30.5	3.3	1.0	1.1	5.7	0.1	1.0	2.6	2.6	3.2	1.4	2.2	6.6	1.0	0.7	3.1	10.1	1.5	6.3	28.1	2.6	3.9	2.5	48.1	3.5	2.1	25.8	7.7	3.2	11.3	10.3	49.2	24.7	10.5	15.7	17.1	6.3	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.9	4.4	5.1	0.2	0.0	4.1	0.3	0.0	0.0	8.8	0.0	8.1	0.0	0.3	0.0	2.1	20.7	0.0	0.1	0.0	0.0	0.0	0.3	28.7	0.0	10.6	9.4	9.0	0.2	0.5	9.4	0.0	7.2	0.0	16.3	0.6	0.2	0.0	7.0	0.2	2.7	9.5	0.0	0.0	0.3	0.0	0.0	2.9	2.9	2.4	1.5	4.5	0.0	34.0	13.4	36.7	15.1	17.3	15.5	8.5	15.6	14.1	10.3	11.3	15.7	13.3	49.2	10.5	24.7	4.7	13.5	17.1	2.3	2.5	0.5	1.6	2.2	2.0	3.3	1.0	2.6	2.5
FGF12	"FGF12B, FHF1"	ENSG00000114279	"Fibroblast growth factor 12"	P61328	3	192139395-192767764	"Disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7"	"Cell line enhanced"	"Detected in some"		"AF22: 11.6;NTERA-2: 7.9;SCLC-21H: 18.6;U-251 MG: 11.1;WM-115: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071557			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA071557: "	"unprognostic (1.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.75e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.87e-7)"	"unprognostic (2.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.99e-2)"	1.2	21.5	8.8	0.7	15.8	0.6	1.0	17.7	31.9	0.9	0.9	1.9	0.0	1.0	1.2	0.7	1.5	1.5	0.9	75.7	6.8	4.1	2.0	0.9	1.2	0.7	5.1	15.8	1.1	4.9	0.7	2.9	0.8	22.3	1.3	0.8	1.1	3.6	4.2	1.1	0.7	0.7	1.0	2.7	6.8	0.9	1.7	2.8	0.0	1.4	0.0	0.7	0.8	0.8	1.1	0.3	1.2	0.4	0.5	0.4	0.1	0.0	0.8	11.6	0.0	0.0	0.0	0.0	0.0	0.1	1.1	1.4	0.0	0.1	0.6	5.6	0.2	0.1	0.0	0.0	1.3	0.1	0.1	2.4	4.9	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	3.2	0.0	0.0	7.9	0.2	0.0	0.1	0.0	3.6	1.3	18.6	0.0	0.0	0.4	0.0	0.8	0.1	0.3	4.8	2.5	0.0	11.1	0.1	1.8	0.0	1.0	0.0	13.4	1.2	0.2	0.5	0.2	0.3	0.4	1.1	0.2	0.2	0.1	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.3	0.1	8.8	15.8	17.7	31.9	6.8	4.1	5.1	15.8	22.3	2.8
FGF13	"FGF2, FHF2"	ENSG00000129682	"Fibroblast growth factor 13"	Q92913	X	138614731-139222777	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;parathyroid gland: 44.3;skeletal muscle: 37.0"	"Cell line enhanced"	"Detected in some"		"AF22: 19.5;fHDF/TERT166: 16.8;HAP1: 17.8;RPMI-8226: 15.1;U-2197: 31.4;WM-115: 16.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002809			Supported	Cytosol				Cytosol		"HPA002809: AB_1078855"	"unprognostic (3.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (9.92e-3)"	"unprognostic (2.97e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (5.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.96e-4)"	"unprognostic (4.36e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.48e-2)"	11.1	1.9	30.0	1.9	29.5	2.7	4.2	0.9	22.9	7.9	3.1	1.5	2.4	2.7	7.0	2.8	4.4	2.6	4.1	1.3	36.7	22.3	4.9	1.4	1.7	3.1	19.7	12.9	6.0	0.9	44.3	2.4	8.4	7.8	11.6	3.3	4.8	6.5	3.5	37.0	1.1	3.1	4.5	3.3	3.8	2.9	2.7	4.1	0.0	3.6	7.9	1.6	3.5	5.7	0.5	0.9	7.4	0.5	0.2	0.3	0.1	0.0	0.2	19.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	16.8	1.2	17.8	0.0	0.0	0.2	5.0	0.1	0.1	0.7	0.7	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.7	5.6	2.0	0.1	0.0	0.1	2.0	6.4	2.9	1.2	15.1	2.8	0.1	0.1	0.0	0.0	0.1	11.9	0.0	0.1	0.4	0.6	0.8	31.4	8.3	7.4	4.1	0.0	7.0	5.6	16.8	2.7	0.5	1.6	0.2	0.3	0.1	0.5	0.2	0.1	0.1	0.4	0.3	0.2	7.4	0.2	0.5	0.9	0.2	0.1	30.0	29.5	0.9	22.9	36.7	22.3	19.7	12.9	7.8	4.1
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell line enhanced"	"Detected in some"		"BJ: 19.7;BJ hTERT+: 37.4;fHDF/TERT166: 26.9;HBF TERT88: 28.1;LHCN-M2: 25.2;U-138 MG: 34.9;U-251 MG: 16.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: "	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.1	0.1	0.1	1.7	0.1	0.5	0.1	38.2	1.3	0.1	3.1	0.0	0.0	0.4	0.4	0.1	1.3	0.1	9.2	0.3	1.6	0.2	2.3	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.3	0.1	4.1	0.2	0.1	0.0	0.1	0.0	0.5	0.4	2.8	2.4	0.3	0.1	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.7	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	1.9	7.1	0.0	19.7	37.4	5.2	3.8	0.0	0.0	0.0	0.0	26.9	0.0	0.0	6.9	28.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	2.0	0.0	15.3	7.3	1.7	0.0	0.1	25.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	6.4	34.9	1.4	1.7	16.7	0.0	0.0	0.0	2.0	0.0	0.7	1.7	0.3	0.3	0.4	0.2	0.5	0.2	0.3	0.4	0.2	0.7	0.5	0.5	0.9	0.2	0.2	0.7	0.2	0.0	0.1	0.1	38.2	1.3	1.6	0.2	0.2	0.2	4.1	0.1
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 557.6;tongue: 239.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.7;fHDF/TERT166: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 20.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4"	"Low region specificity"	"Detected in all"							"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"			18000000	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavourable (2.11e-4)"	61.9	4.1	7.6	11.0	9.5	0.7	30.6	6.3	7.2	31.5	30.6	3.9	10.0	5.0	25.5	27.7	43.2	14.2	11.7	79.0	6.1	8.1	3.3	2.5	13.7	2.5	5.5	8.1	6.7	2.4	13.4	5.0	13.5	4.4	23.4	10.0	13.5	16.5	30.1	557.6	4.9	11.4	77.7	4.3	2.5	22.1	5.7	3.0	0.6	18.2	239.4	22.1	47.0	14.3	3.4	12.5	0.7	0.4	20.6	11.4	6.2	0.0	9.4	13.1	12.3	28.5	11.5	0.2	36.7	57.7	7.3	17.8	0.0	2.7	0.1	12.8	52.2	0.1	25.3	31.3	6.2	0.1	29.2	0.1	7.8	0.0	26.7	0.0	6.1	21.4	5.1	8.9	28.1	7.7	0.0	5.5	17.2	0.4	5.1	0.3	4.0	11.1	14.4	0.5	7.8	0.2	0.0	9.2	13.8	1.3	0.0	2.6	0.0	0.5	21.6	34.1	15.8	1.3	9.2	1.4	3.2	0.2	2.5	0.2	3.8	0.0	0.4	0.0	3.2	0.0	8.6	3.4	11.4	4.5	1.8	2.3	7.6	2.3	0.7	20.6	0.0	12.5	1.2	6.2	7.6	9.5	6.3	7.2	6.1	8.1	5.5	8.1	4.4	3.0
FHOD1	FHOS	ENSG00000135723	"Formin homology 2 domain containing 1"	Q9Y613	16	67229387-67247658	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.0;skeletal muscle: 61.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024468	Approved		Supported	Cytosol			2500000	Cytosol		"HPA024468: AB_1848568"	"unprognostic (6.53e-3)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (1.90e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-3)"	"unprognostic (4.70e-2)"	8.3	7.5	2.5	5.1	4.4	2.9	7.9	4.7	2.8	4.2	5.3	2.5	3.8	3.3	3.9	4.7	2.5	3.4	5.6	3.7	2.3	1.3	4.8	2.3	12.5	4.4	4.0	0.7	12.9	3.4	2.5	2.5	5.8	4.2	4.2	2.6	4.0	5.7	4.0	61.1	2.5	3.9	3.5	5.6	38.0	2.9	2.2	3.0	2.7	8.2	11.1	5.8	2.6	3.5	0.5	2.0	2.2	3.0	1.3	1.4	2.1	4.3	11.9	4.4	3.6	18.1	10.9	15.0	9.2	7.6	10.6	10.3	8.2	5.7	5.2	6.7	6.7	5.3	5.2	7.5	5.3	4.1	8.3	23.2	4.6	8.9	4.8	9.5	42.6	13.5	0.9	16.2	1.5	16.4	12.0	3.2	6.6	14.9	6.4	17.1	6.7	3.8	7.4	10.0	12.3	3.3	1.7	1.4	7.4	14.5	8.3	8.4	8.9	7.6	19.0	14.4	8.4	8.8	7.4	11.1	11.3	7.6	29.6	9.0	13.1	1.5	3.0	0.5	1.1	1.2	1.4	0.1	1.3	1.0	2.0	0.5	0.8	0.6	2.2	1.3	1.0	1.2	1.2	2.1	2.5	4.4	4.7	2.8	2.3	1.3	4.0	0.7	4.2	3.0
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	54	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	8.5	7.6	9.6	2.9	13.7	2.8	5.2	5.1	11.9	6.8	5.9	5.5	3.7	2.1	3.3	5.0	2.9	4.5	4.4	10.1	8.8	4.3	7.2	7.9	4.3	2.5	8.7	4.7	14.3	7.2	1.8	12.1	4.4	7.7	4.8	3.4	4.3	8.4	9.9	3.6	3.2	3.6	5.6	9.1	8.7	4.5	4.4	10.5	0.0	3.1	3.0	1.6	4.1	6.3	0.0	0.0	5.4	0.0	0.0	0.0	0.0	5.7	2.1	17.3	0.0	0.0	0.0	6.4	2.2	1.5	1.6	3.0	0.0	2.1	0.0	6.2	2.4	0.8	5.7	2.4	1.3	0.0	4.3	0.0	4.0	4.1	1.4	0.0	0.0	0.8	2.1	3.1	8.5	3.7	0.0	0.0	4.7	1.4	0.0	0.0	7.3	2.7	0.0	5.8	0.0	4.0	1.9	2.7	2.3	0.0	1.6	1.5	1.8	0.0	0.3	7.2	6.5	0.0	4.6	1.0	0.0	0.0	2.1	0.0	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	13.7	5.1	11.9	8.8	4.3	8.7	4.7	7.7	10.5
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FK506 binding protein 14"	Q9NWM8	7	30010587-30026684	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"			Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavourable (4.25e-4)"	8.8	7.4	8.7	9.2	7.3	5.1	8.8	17.6	7.7	14.9	7.8	4.1	6.9	4.2	12.1	14.2	8.0	8.1	8.5	9.8	7.1	5.2	5.4	9.2	7.6	8.1	9.2	5.2	13.0	9.8	8.6	27.8	10.7	7.1	9.8	6.9	8.4	7.6	10.9	3.3	6.4	5.3	18.8	8.1	6.7	7.2	4.2	7.1	2.6	5.6	5.9	7.7	13.4	8.7	1.6	3.3	2.7	1.2	1.0	1.6	0.6	3.4	2.6	7.3	17.0	19.1	24.5	3.4	17.5	16.4	6.1	12.0	2.2	2.2	1.2	8.3	15.3	7.5	4.1	6.4	12.3	0.6	5.8	2.7	4.9	6.4	9.7	1.9	4.8	15.3	6.7	10.6	12.6	13.5	4.4	2.5	11.0	1.4	1.0	2.4	3.8	4.7	0.0	4.9	4.0	6.1	3.0	1.9	6.4	6.2	14.0	4.3	3.2	2.6	10.9	6.6	7.7	11.2	6.9	3.9	4.0	2.1	9.3	1.9	20.3	1.9	1.2	1.2	1.3	0.8	1.0	1.1	1.6	1.1	2.2	1.6	1.5	1.3	2.7	1.0	0.5	3.3	1.4	0.6	8.7	7.3	17.6	7.7	7.1	5.2	9.2	5.2	7.1	7.1
FKBP15	"FKBP133, KIAA0674, PPP1R76, WAFL"	ENSG00000119321	"FK506 binding protein 15"	Q5T1M5	9	113161006-113221361	"Predicted intracellular proteins"	"Endocytosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007979	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA007979: AB_1848615"	"unprognostic (2.81e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (3.44e-2)"	"unprognostic (5.62e-3)"	19.8	17.8	16.7	25.3	21.9	19.2	19.4	18.6	21.6	16.9	15.3	25.4	14.2	15.1	18.1	17.0	18.8	16.7	14.4	16.4	16.2	13.1	15.7	17.2	26.7	30.9	22.6	15.4	18.6	17.5	34.7	22.1	24.4	19.2	17.2	18.7	17.6	20.0	22.3	19.2	22.3	18.2	20.5	23.5	36.5	15.9	6.8	20.9	25.1	18.7	13.4	23.3	18.6	18.3	2.8	8.5	5.7	20.5	3.7	3.4	4.5	12.3	12.7	8.5	8.3	18.5	16.4	11.6	15.4	23.4	17.3	15.5	8.0	12.9	20.6	7.5	19.5	27.0	10.3	15.1	16.0	15.7	6.9	7.9	13.8	7.6	15.0	16.8	20.8	16.4	15.3	19.1	19.9	16.9	9.7	12.6	17.7	18.9	12.6	8.9	8.9	10.1	11.4	18.0	7.4	12.6	11.4	7.6	7.5	18.7	14.3	9.0	17.2	6.3	19.6	18.7	7.0	18.5	15.9	10.9	11.9	9.5	19.5	9.7	15.2	1.8	11.6	1.6	3.4	14.6	2.8	2.0	2.1	2.1	8.5	2.8	2.5	1.9	5.7	3.7	20.5	3.5	2.2	4.5	16.7	21.9	18.6	21.6	16.2	13.1	22.6	15.4	19.2	20.9
FKBP3	"FKBP-25, PPIase"	ENSG00000100442	"FK506 binding protein 3"	Q00688	14	45115600-45135319	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol			980000	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	11.7	13.2	28.1	10.2	40.7	9.8	15.5	25.1	32.1	12.0	14.6	11.4	8.3	13.2	9.9	20.4	14.6	8.8	9.1	31.3	26.0	24.4	16.5	20.5	8.0	14.6	23.2	23.8	9.9	10.9	15.0	17.1	14.0	22.9	17.9	15.2	6.6	10.7	12.2	113.3	11.3	13.9	12.8	19.6	9.9	10.6	13.5	22.4	12.7	12.4	24.2	16.5	12.7	9.3	19.5	27.5	13.5	17.4	15.4	19.4	13.0	36.9	41.2	60.0	31.5	26.7	29.2	23.7	22.7	26.1	36.0	39.7	36.0	31.8	19.7	24.0	25.6	30.8	44.5	29.3	51.3	28.5	26.6	16.2	32.0	46.5	26.4	28.0	17.6	27.5	30.6	20.9	19.5	46.8	23.4	14.9	42.6	45.2	44.8	37.5	30.4	39.1	43.2	44.2	23.9	57.5	42.8	36.6	14.3	36.4	22.7	34.8	53.1	21.0	30.1	27.5	47.6	14.4	17.4	25.1	44.6	30.7	16.6	19.3	25.6	11.6	14.6	13.5	13.0	17.2	15.7	19.5	17.5	17.6	21.8	13.6	16.8	18.8	2.3	15.4	17.4	27.5	19.4	13.0	28.1	40.7	25.1	32.1	26.0	24.4	23.2	23.8	22.9	22.4
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FK506 binding protein 4"	Q02790	12	2794953-2805423	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"vagina: 209.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Approved		Enhanced	Nucleoplasm,Cytosol			110000	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: "	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.12e-5)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	16.2	21.6	26.0	13.7	30.7	13.3	40.7	50.4	31.9	19.9	22.6	22.8	36.2	13.1	20.1	30.7	34.2	25.7	16.4	20.4	25.0	32.5	31.6	31.3	15.8	11.7	44.7	23.4	23.9	30.3	30.1	19.5	32.0	39.4	30.2	25.3	11.5	30.1	31.6	33.5	25.3	16.1	26.4	25.2	11.5	25.3	36.0	42.1	15.6	47.1	16.5	18.5	17.4	209.6	13.8	6.0	10.9	13.7	8.4	14.0	9.9	15.5	34.6	10.0	16.8	12.5	7.4	48.1	15.3	5.5	25.3	17.2	34.4	19.0	20.8	4.4	9.8	21.3	62.3	20.7	30.5	38.0	39.9	22.9	25.5	12.2	9.6	17.9	6.2	6.7	19.0	29.9	30.0	14.7	21.0	29.7	10.1	44.7	31.3	16.2	85.5	25.0	18.8	17.6	12.4	21.3	19.9	14.5	20.8	17.7	48.4	7.7	65.3	12.1	7.8	12.5	39.3	14.0	38.5	7.4	11.3	30.7	11.1	26.7	12.7	10.9	10.8	5.9	12.5	9.8	14.0	13.3	11.1	11.8	6.0	13.8	11.8	13.7	1.5	8.4	13.7	5.3	10.1	9.9	26.0	30.7	50.4	31.9	25.0	32.5	44.7	23.4	39.4	42.1
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FK506 binding protein 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 32.5;neutrophil: 31.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"				Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: "	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	44.3	38.1	75.9	27.5	82.1	82.5	26.5	43.4	113.7	35.2	31.9	41.2	34.6	31.1	31.4	27.2	48.7	39.3	34.5	43.4	69.6	62.1	28.9	42.7	34.3	31.1	55.3	54.3	56.1	60.4	28.8	42.2	36.6	51.2	36.5	12.9	31.9	73.1	46.1	56.7	35.1	31.6	34.6	46.3	36.7	31.9	49.5	26.9	32.1	38.8	24.2	30.7	36.3	45.8	4.3	4.3	32.5	6.9	3.1	6.6	9.1	36.6	26.3	20.6	39.1	21.3	33.5	51.7	29.7	31.6	22.7	31.5	24.9	50.0	21.0	48.3	36.4	19.9	12.7	41.3	6.4	25.6	60.3	19.6	34.3	29.9	36.7	19.4	43.2	43.7	39.9	20.4	13.0	23.3	41.1	50.0	19.7	61.0	35.2	58.1	42.1	38.2	37.0	17.1	71.8	30.5	24.0	22.9	41.7	20.8	17.2	37.0	20.2	56.7	27.1	28.4	26.0	55.4	22.5	38.3	21.9	24.4	64.3	31.2	25.2	6.3	5.6	32.5	6.0	5.8	5.5	4.1	6.1	6.6	4.3	4.3	4.7	5.3	31.0	3.1	6.9	4.3	6.0	9.1	75.9	82.1	43.4	113.7	69.6	62.1	55.3	54.3	51.2	26.9
FKRP	"LGMD2I, MDC1C"	ENSG00000181027	"Fukutin related protein"	Q9H9S5	19	46746046-46776988	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043115, HPA060454"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA043115: , HPA060454: "	"unprognostic (4.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.59e-3)"	"prognostic favourable (8.98e-4)"	"unprognostic (3.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-2)"	13.7	10.7	12.4	12.5	17.5	12.6	9.6	7.4	25.2	10.5	11.5	12.8	13.7	7.8	15.7	8.7	8.3	12.7	10.1	13.1	9.8	12.2	10.7	10.8	11.6	11.0	11.5	11.1	13.3	13.2	12.9	16.9	16.5	14.1	13.6	7.3	13.0	17.8	13.2	23.6	9.6	9.7	13.4	9.1	14.7	10.3	13.0	11.1	8.8	13.5	7.8	7.9	12.3	10.2	6.9	5.0	5.4	4.2	5.6	4.5	2.4	8.4	18.0	12.4	8.6	10.9	12.2	11.0	21.5	14.5	8.8	14.0	11.4	14.7	7.5	12.1	12.3	8.9	4.6	10.0	8.1	14.9	15.3	8.0	8.7	7.2	9.7	6.2	13.7	13.5	8.7	10.9	10.7	11.5	7.9	7.7	8.9	3.8	4.5	15.1	12.1	4.5	12.2	7.6	2.8	5.6	18.1	8.5	16.1	10.8	5.2	7.0	6.4	4.9	11.9	13.2	13.9	4.8	17.2	8.2	9.8	7.2	10.7	5.0	17.5	3.4	4.2	2.5	4.1	2.5	2.8	4.6	3.0	4.5	2.6	6.9	3.7	4.5	5.4	5.6	2.6	5.0	1.6	2.4	12.4	17.5	7.4	25.2	9.8	12.2	11.5	11.1	14.1	11.1
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavourable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	16.5	16.5	20.3	15.5	18.9	12.1	17.4	15.9	20.8	14.1	16.4	19.3	14.7	19.6	15.9	21.2	19.8	16.7	11.8	16.1	18.2	10.4	19.0	36.5	13.5	20.0	20.8	15.6	14.5	19.0	13.6	12.0	18.5	15.9	18.7	19.0	16.1	16.2	16.3	26.3	23.3	23.9	17.6	12.4	22.9	16.1	19.1	18.9	15.7	20.8	18.4	22.0	15.5	15.4	25.1	24.5	15.2	24.1	14.9	26.4	22.7	13.1	21.2	13.5	23.0	11.8	8.7	25.7	10.0	8.3	14.6	12.5	18.8	16.3	15.4	20.2	9.2	17.3	25.8	20.7	9.5	16.0	19.4	12.5	16.8	13.2	16.1	18.0	16.3	12.4	27.2	16.6	17.8	16.9	20.0	12.5	12.3	28.4	12.4	12.6	29.4	22.0	20.9	6.7	35.3	13.9	18.4	22.8	31.3	15.6	35.4	19.7	30.3	27.4	10.7	9.2	12.7	11.8	15.7	19.6	24.3	26.5	11.1	14.7	14.7	15.2	23.0	14.8	24.0	20.9	26.4	25.1	22.1	22.7	24.1	20.5	20.5	20.2	5.2	14.9	24.1	24.5	23.3	22.7	20.3	18.9	15.9	20.8	18.2	10.4	20.8	15.6	15.9	18.9
FLCN	"BHD, MGC17998, MGC23445"	ENSG00000154803	Folliculin	Q8NFG4	17	17212212-17237188	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB015158, HPA028760"	Supported		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB015158: AB_2231645, HPA028760: AB_10601323"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.90e-1)"	"prognostic favourable (4.49e-4)"	"unprognostic (6.45e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.65e-1)"	11.9	15.3	23.6	10.8	41.6	15.6	13.9	49.4	26.9	18.0	21.3	18.5	10.4	25.0	22.1	15.8	11.0	14.5	17.6	17.2	17.2	8.6	9.6	15.5	15.6	11.6	24.2	13.5	25.2	13.7	6.1	20.3	13.3	18.1	15.4	10.7	14.8	10.5	14.8	22.7	12.6	20.2	15.4	14.8	16.5	15.3	12.5	29.1	6.6	15.8	3.9	8.0	15.0	14.8	6.0	2.4	10.5	6.8	4.5	5.0	3.1	6.4	15.7	5.8	7.5	18.9	10.8	8.5	5.8	9.7	9.2	12.8	11.9	5.4	3.2	8.1	7.0	7.5	7.0	3.6	4.8	6.1	5.9	6.5	4.6	6.8	17.5	2.4	18.3	15.8	12.4	14.4	10.7	7.5	8.9	8.3	8.8	8.3	4.3	4.1	5.9	3.9	8.6	26.8	3.7	5.5	7.1	7.0	4.5	6.1	3.7	10.1	5.6	4.5	8.8	21.7	9.4	29.9	7.6	4.1	3.9	3.0	13.7	5.5	8.5	3.6	4.7	2.8	2.9	6.8	4.1	5.3	3.5	2.5	2.4	6.0	3.9	3.4	10.5	4.5	2.2	2.4	5.0	3.1	23.6	41.6	49.4	26.9	17.2	8.6	24.2	13.5	18.1	29.1
FLII	"FLI, Fli1, FLIL, MGC39265"	ENSG00000177731	"FLII, actin remodeling protein"	Q13045	17	18244836-18258916	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007084, HPA008903, CAB016132"	Approved		Enhanced	"Nucleoplasm,Centriolar satellite,Cytosol"			1800000	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	21.2	16.8	8.6	16.9	12.4	16.6	21.7	11.7	11.4	17.5	18.5	12.8	14.3	14.6	17.3	16.3	25.9	13.7	15.6	28.3	9.3	7.4	19.0	18.8	17.3	13.4	15.0	6.1	15.3	20.0	15.4	13.5	15.8	13.6	17.2	10.7	11.0	21.3	17.0	78.4	14.4	18.9	19.1	11.1	20.0	15.4	15.6	11.9	21.2	15.1	25.4	17.5	21.5	16.3	5.3	16.0	12.9	24.9	5.2	7.2	10.3	58.9	21.3	6.0	9.3	14.0	12.7	9.1	16.4	19.9	18.5	11.5	27.1	13.5	11.5	17.2	18.8	26.3	8.1	27.3	10.9	9.6	12.6	6.3	15.7	10.7	15.8	7.0	13.4	11.4	16.7	15.1	22.8	17.9	5.1	4.7	10.8	17.6	10.3	5.8	6.3	11.2	10.1	27.2	14.3	13.8	16.7	2.1	3.2	19.1	16.3	8.8	27.7	5.5	21.9	16.5	17.0	31.7	19.3	4.9	3.6	3.5	15.6	6.8	8.9	4.8	13.6	12.9	7.0	21.4	7.2	5.3	5.8	7.2	16.0	3.6	4.3	4.6	12.0	5.2	24.9	4.7	6.6	10.3	8.6	12.4	11.7	11.4	9.3	7.4	15.0	6.1	13.6	11.9
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374638	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 396.7;urinary bladder: 276.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"			2900000000	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: , HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.88e-4)"	42.8	8.8	2.9	46.4	3.9	22.9	30.7	2.0	5.2	106.5	204.2	6.3	86.0	13.1	158.9	54.4	140.2	79.9	121.0	18.8	3.2	2.2	17.2	5.5	29.1	21.1	3.4	5.9	77.4	7.3	1.6	4.8	20.0	9.4	129.3	13.4	19.0	12.6	98.8	13.7	15.0	50.2	396.7	3.6	25.5	82.7	29.9	2.9	12.1	11.7	16.3	15.1	276.1	64.5	6.3	13.1	7.1	19.7	5.9	22.6	24.1	87.2	67.8	23.9	30.8	20.9	27.7	39.4	58.4	65.1	53.6	47.7	43.9	16.2	7.5	151.6	90.7	50.1	21.5	51.2	15.1	30.8	7.5	24.2	88.7	15.2	38.5	28.6	31.8	26.5	12.4	79.8	31.9	39.8	6.8	52.3	38.3	20.0	13.6	9.9	25.2	45.1	13.7	21.7	6.7	20.8	18.2	5.3	12.1	48.8	7.9	39.3	7.6	9.0	95.2	61.2	59.0	62.0	107.6	32.8	19.2	15.2	56.9	19.2	61.2	4.1	11.5	7.1	22.6	15.2	14.3	6.3	10.5	18.7	13.1	3.0	4.0	9.1	2.6	5.9	19.7	1.7	12.8	24.1	2.9	3.9	2.0	5.2	3.2	2.2	3.4	5.9	9.4	2.9
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 70.2;TIME: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"			37000000	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favourable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	24.7	17.8	7.8	25.3	10.6	2.2	30.0	12.6	7.4	21.3	33.5	17.2	49.6	19.4	36.1	47.4	18.6	17.3	16.0	7.7	10.6	8.5	20.6	29.2	14.1	9.4	16.1	5.3	22.9	22.4	25.6	7.8	36.0	13.2	35.8	28.5	20.1	25.5	44.0	7.7	28.9	50.2	39.7	24.3	12.1	21.2	11.7	13.5	49.3	28.2	12.0	13.0	32.8	34.7	3.8	15.9	7.4	1.2	5.9	4.9	1.2	19.8	34.0	3.4	5.0	2.3	4.0	59.9	7.4	6.0	16.5	16.9	34.0	34.0	3.2	2.8	26.0	32.7	6.4	47.2	16.1	17.9	3.1	2.7	28.9	16.5	17.1	2.3	9.8	6.3	20.5	22.9	70.2	55.8	4.5	1.0	10.2	4.3	7.2	5.7	5.3	29.4	3.2	0.9	2.8	22.1	33.9	3.8	3.6	37.5	20.6	4.1	17.0	6.6	79.1	4.3	13.5	51.5	26.3	0.7	0.2	2.6	16.0	4.3	4.5	7.4	0.3	4.2	0.5	0.8	2.6	3.8	1.6	0.7	1.2	1.6	4.9	3.5	0.1	5.9	1.2	15.9	1.7	1.2	7.8	10.6	12.6	7.4	10.6	8.5	16.1	5.3	13.2	13.5
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830377-128859274	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 546.8"	"Cell line enhanced"	"Detected in many"		"BJ: 78.6;fHDF/TERT166: 35.8;hTEC/SVTERT24-B: 38.9;U-2 OS: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006135	Enhanced		Supported	"Plasma membrane,Cytosol"			54000000	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (3.73e-5)"	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1.0	5.2	24.4	1.4	18.4	1.9	14.0	10.1	16.0	4.8	13.3	70.0	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1.0	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1.0	5.2	69.0	4.7	0.3	10.0	1.3	0.6	0.0	4.7	40.0	2.2	39.6	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	7.1	8.6	0.8	78.6	14.9	22.4	10.8	24.4	0.2	0.0	13.3	35.8	0.0	4.8	0.1	13.3	0.0	2.6	0.0	4.0	0.0	9.0	0.0	0.0	16.3	0.0	38.9	0.0	13.9	9.4	0.0	15.2	0.0	0.0	0.3	13.1	4.5	0.0	26.0	0.2	0.0	0.0	0.4	1.4	0.1	0.0	0.0	0.1	0.3	28.8	7.8	33.6	2.0	0.0	0.0	0.0	0.0	26.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322988-14337616	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.1"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;hTCEpi: 28.9;RPTEC TERT1: 9.7;WM-115: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"		240000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: "	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favourable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	7.3	4.3	3.4	2.2	7.4	0.1	2.7	27.5	18.9	3.8	5.0	0.7	3.2	12.4	2.6	5.5	2.5	2.7	5.6	1.6	9.3	4.1	43.1	28.9	26.2	0.2	2.3	5.3	11.9	2.3	4.6	2.1	2.0	2.9	12.7	1.0	1.9	1.5	16.4	2.1	6.9	6.0	3.9	2.3	0.8	9.7	1.7	0.7	4.8	8.5	1.8	0.4	12.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	15.3	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	8.4	3.1	0.0	0.5	0.3	4.3	0.0	4.5	0.1	0.0	0.9	0.0	0.2	0.1	1.3	0.0	0.0	2.7	28.9	0.0	5.4	0.0	0.0	0.1	2.9	0.2	1.9	0.0	5.0	0.0	0.0	0.1	0.0	9.7	1.8	0.3	3.1	0.0	0.0	4.8	0.2	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	7.4	27.5	18.9	9.3	4.1	2.3	5.3	2.9	0.7
FLYWCH1	DKFZp761A132	ENSG00000059122	"FLYWCH-type zinc finger 1"	Q4VC44	16	2911937-2951208	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040753, HPA041001"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA040753: AB_10794880, HPA041001: AB_10794259"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-2)"	15.6	16.6	13.1	12.6	17.2	12.5	10.2	24.4	27.4	13.6	12.2	17.7	9.5	14.7	14.3	13.4	11.8	11.9	15.0	16.7	12.1	15.9	10.1	5.9	10.7	11.6	15.8	18.5	21.4	12.2	22.6	12.2	9.5	18.8	13.9	4.7	25.3	14.4	15.6	28.1	22.8	14.4	14.1	16.2	19.9	11.0	5.1	10.9	8.5	11.5	8.4	10.3	17.1	15.7	4.6	1.6	2.3	1.6	0.9	5.5	2.1	5.0	17.9	4.1	12.1	6.7	6.8	12.5	9.4	7.4	4.8	4.9	2.9	16.5	12.4	25.1	7.2	10.6	3.4	6.3	0.9	20.6	10.2	4.1	15.1	9.9	15.0	5.5	14.5	6.1	20.1	10.0	7.4	6.7	9.2	13.2	3.6	12.1	12.5	6.6	6.7	12.3	22.0	6.1	22.2	5.6	3.4	8.9	8.2	9.9	10.8	12.6	8.4	10.0	12.6	8.0	7.3	15.5	6.3	19.6	16.7	11.1	8.8	9.0	9.3	2.3	1.6	0.6	3.0	0.7	4.9	2.0	4.5	5.5	1.6	4.6	3.9	3.4	0.2	0.9	0.8	1.0	2.2	2.1	13.1	17.2	24.4	27.4	12.1	15.9	15.8	18.5	18.8	10.9
FMN1	"DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289"	ENSG00000248905	"Formin 1"	Q68DA7	15	32765545-33194733	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 21.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 9.3;RH-30: 12.5;SK-MEL-30: 13.0;T-47d: 11.4;U-138 MG: 7.3"	"Cancer enriched"	"Detected in many"	9	"melanoma: 14.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005465, HPA046786"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005465: AB_1859515, HPA046786: AB_10963545"	"unprognostic (1.57e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (7.61e-2)"	7.0	2.1	3.7	3.9	5.3	2.2	4.9	0.6	12.1	8.9	8.5	1.8	2.6	2.6	2.2	4.8	3.9	5.1	4.0	2.4	3.3	2.0	4.7	1.4	7.7	3.3	5.9	7.3	1.1	2.5	2.6	8.0	5.1	4.6	3.8	6.9	21.9	6.4	2.5	2.2	9.2	4.3	3.7	6.4	3.0	11.7	12.4	4.6	1.8	4.7	1.5	2.0	2.7	6.8	0.6	1.8	2.8	0.7	0.1	0.7	0.1	1.6	1.8	0.3	0.2	0.0	0.2	2.0	2.3	1.8	0.6	1.7	0.2	2.2	0.2	0.8	2.7	1.4	0.0	1.5	1.7	0.0	0.1	1.2	0.3	0.1	0.1	0.0	0.1	0.7	0.0	2.7	0.0	0.0	0.0	9.3	4.1	1.7	0.0	0.0	0.5	0.1	0.2	12.5	2.2	0.8	0.6	0.1	0.3	0.0	1.5	13.0	11.4	0.0	1.6	7.3	1.2	6.6	0.6	0.0	0.0	0.4	3.5	0.0	4.5	2.8	0.7	0.0	0.3	0.0	0.5	0.0	0.7	0.6	1.4	0.6	0.4	0.0	0.1	0.1	0.0	1.8	0.1	0.1	3.7	5.3	0.6	12.1	3.3	2.0	5.9	7.3	4.6	4.6
FMNL1	"C17orf1, C17orf1B, FMNL"	ENSG00000184922	"Formin like 1"	O95466	17	45221444-45247320	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.4;lymphoid tissue: 56.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 49.5;MOLT-4: 33.9;U-266/70: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008129, HPA028288"	Enhanced		Approved	Cytosol				Cytosol		"HPA008129: AB_1848963, HPA028288: AB_10612110"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"prognostic unfavourable (4.23e-8)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.16e-1)"	8.6	3.8	10.7	29.7	9.6	107.4	7.5	8.1	16.1	4.6	5.2	4.2	0.8	5.8	2.6	5.8	4.5	6.1	9.1	5.8	13.4	6.0	4.2	3.6	22.2	38.1	6.1	6.4	3.1	3.6	3.6	7.4	7.4	7.2	4.3	4.1	3.3	8.4	2.3	2.5	4.2	14.9	4.3	6.2	45.9	6.6	2.7	3.3	56.6	3.9	4.1	22.8	11.3	4.6	3.5	4.3	22.3	5.6	5.4	7.6	3.5	4.1	8.1	0.0	0.4	0.0	1.8	0.4	0.5	1.1	3.1	2.3	0.3	1.8	12.8	4.2	0.1	0.7	0.0	0.1	1.0	22.5	1.1	7.4	12.1	0.6	8.7	19.3	26.3	1.4	0.3	4.0	1.7	0.0	0.6	49.5	2.2	2.7	33.9	20.0	0.4	0.2	21.5	2.9	22.9	0.8	0.5	2.6	1.2	2.5	0.4	0.9	2.3	15.8	1.0	0.1	2.9	0.4	18.2	41.3	18.2	13.1	0.3	15.8	0.6	6.8	5.1	8.2	7.0	5.6	4.7	3.5	5.5	7.6	4.3	3.3	3.6	4.8	22.3	5.4	4.2	2.5	6.0	3.5	10.7	9.6	8.1	16.1	13.4	6.0	6.1	6.4	7.2	3.3
FMNL2	"FHOD2, KIAA1902"	ENSG00000157827	"Formin like 2"	Q96PY5	2	152335237-152649834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 56.7;hTERT-HME1: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7;non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005464	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	"Golgi apparatus, Plasma membrane"	"HPA005464: AB_1848965"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavourable (9.04e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.58e-1)"	15.1	13.6	26.2	7.0	44.6	0.8	9.4	18.3	55.0	8.5	6.6	55.0	1.4	5.8	13.6	10.2	4.6	6.7	11.1	4.8	32.0	20.6	9.7	5.3	17.9	8.2	63.4	27.9	35.9	7.4	17.8	10.2	35.9	39.2	8.9	8.4	5.4	20.1	8.2	31.0	4.0	5.5	10.7	74.1	12.0	8.2	5.8	56.7	1.3	14.5	3.2	5.4	9.1	11.6	0.0	0.9	0.0	4.2	0.0	0.1	0.0	4.0	4.3	13.6	7.5	16.5	17.8	56.7	4.1	8.5	7.4	10.4	4.6	0.2	0.0	8.9	3.6	4.7	6.5	13.2	11.8	0.0	6.8	0.0	2.8	19.9	4.7	1.1	0.2	11.6	8.2	14.3	36.9	13.0	0.1	0.1	4.0	1.1	0.2	1.2	8.7	8.8	7.3	2.9	5.9	21.6	2.8	13.9	11.3	3.5	1.3	14.4	0.3	0.4	14.4	11.2	0.3	3.7	7.1	0.3	0.1	0.0	10.4	0.9	22.7	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.9	0.1	0.0	26.2	44.6	18.3	36.7	32.0	20.6	63.4	27.9	39.2	56.7
FMNL3	"DKFZp762B245, MGC45819, WBP3"	ENSG00000161791	"Formin like 3"	Q8IVF7	12	49636499-49708165	"Predicted intracellular proteins"	Angiogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002552, HPA023201"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"				"Golgi apparatus, Vesicles, Plasma membrane"	Cytosol	"HPA002552: AB_1078862, HPA023201: AB_1848575"	"unprognostic (2.97e-1)"	"unprognostic (2.77e-3)"	"unprognostic (4.97e-3)"	"unprognostic (7.19e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.37e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	18.3	6.4	10.1	19.9	10.7	5.0	13.8	8.5	11.2	9.3	8.0	23.2	6.3	6.0	13.5	20.8	5.1	7.5	13.0	12.6	10.6	9.0	10.1	3.1	18.0	22.5	14.0	7.7	18.9	3.8	3.7	5.0	14.4	12.9	7.5	6.2	9.8	5.0	5.1	6.3	4.8	10.7	12.3	14.2	13.0	6.7	10.5	11.3	16.2	15.0	5.1	27.9	9.6	7.7	1.7	8.6	3.6	0.7	1.1	1.5	0.7	4.4	1.3	10.0	3.3	2.8	11.3	0.1	5.5	11.3	7.6	6.7	5.1	1.2	9.6	10.7	6.6	0.2	5.1	2.3	7.0	8.4	1.9	10.5	1.5	0.2	4.9	2.1	13.8	7.1	0.3	11.8	5.0	20.0	2.3	7.1	11.1	3.3	8.5	3.1	3.3	2.9	4.1	12.5	1.4	7.1	0.6	1.7	4.7	3.2	0.4	6.5	0.8	3.1	25.2	18.9	6.6	0.3	9.5	3.7	0.2	5.2	11.7	6.5	7.9	3.6	0.3	1.2	1.5	0.7	0.7	0.4	0.5	0.9	0.4	1.7	0.8	0.9	0.0	1.1	0.6	8.6	0.3	0.7	10.1	10.7	8.5	11.2	10.6	9.0	14.0	7.7	12.9	11.3
FMO4	FMO2	ENSG00000076258	"Flavin containing monooxygenase 4"	P31512	1	171314208-171342084	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 33.8;liver: 42.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.2;EFO-21: 7.9;HSkMC: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA049100: , HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favourable (1.09e-4)"	"prognostic favourable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	5.3	3.6	1.4	5.1	4.8	0.9	4.5	0.6	2.7	4.5	6.0	4.8	3.1	4.2	3.0	10.0	4.6	3.8	4.6	6.3	2.3	1.5	33.8	42.2	3.4	2.8	7.5	2.8	4.1	3.2	5.5	5.0	2.3	3.7	3.9	3.7	6.7	2.7	2.0	1.6	2.9	16.1	2.0	7.0	3.8	3.9	2.0	6.2	2.7	4.5	3.3	3.4	2.9	3.7	5.3	2.9	0.9	4.0	3.9	4.9	2.0	0.1	0.0	0.4	0.6	5.4	4.9	0.2	1.1	5.0	1.6	1.7	0.8	7.2	4.4	7.9	0.0	0.3	0.8	1.3	2.2	2.1	1.1	0.0	0.0	0.1	0.8	0.9	1.0	9.3	3.1	0.6	1.3	0.3	0.2	3.3	0.7	1.0	2.1	1.9	0.5	1.6	0.4	0.4	2.5	3.5	0.0	0.2	0.0	1.4	1.5	3.0	3.1	1.3	0.1	1.3	0.4	1.4	1.0	4.0	1.3	2.7	2.4	1.4	1.1	0.6	2.6	0.9	2.5	4.0	1.8	3.1	2.4	3.3	2.2	5.3	3.3	2.5	0.5	3.9	2.7	2.9	4.9	2.0	1.4	4.8	0.6	2.7	2.3	1.5	7.5	2.8	3.7	6.2
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 28.4;HMC-1: 6.4;THP-1: 7.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favourable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.0	1.9	0.5	0.6	0.4	0.3	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.3	0.0	0.0	0.0	1.0	0.1	1.1	0.0	28.4	0.6	0.9	6.4	0.9	0.1	0.3	0.0	0.4	0.1	0.1	1.1	0.9	0.2	0.5	2.0	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	1.9	0.9	1.4	7.2	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0
FMR1	"FMRP, FRAXA, MGC87458, POF, POF1"	ENSG00000102081	"Fragile X mental retardation 1"	Q06787	X	147911951-147951125	"Disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation, Mental retardation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012444, HPA050118, HPA056084"	Approved		Enhanced	Cytosol				Cytosol		"CAB012444: AB_732400, HPA050118: , HPA056084: "	"unprognostic (4.11e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.89e-3)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.98e-2)"	14.9	13.3	24.8	14.9	21.1	28.3	14.3	32.6	25.7	16.0	14.5	17.7	14.4	13.3	21.2	33.2	13.9	18.3	12.3	15.0	22.2	19.0	26.5	30.3	15.3	15.7	23.3	22.8	23.4	11.5	27.8	20.5	49.9	18.9	15.4	15.0	14.0	12.7	19.6	7.8	17.7	15.9	18.3	23.1	20.1	13.2	14.5	19.2	21.7	29.0	9.8	16.1	17.1	27.3	5.3	3.4	7.3	3.5	4.9	7.4	2.4	14.8	13.3	13.9	9.3	8.6	6.9	11.1	8.0	8.5	12.9	23.4	14.6	14.1	29.6	33.3	9.9	25.7	22.1	9.9	14.5	11.6	15.4	8.3	24.8	13.7	8.8	9.2	5.2	7.5	5.7	10.9	10.2	10.7	5.2	19.6	11.5	19.3	10.3	6.7	6.2	7.5	11.6	39.8	12.5	15.1	39.8	12.2	8.0	9.2	8.4	11.9	7.5	8.3	10.2	10.5	9.1	12.9	20.1	21.2	21.0	31.8	9.5	15.8	5.5	2.8	2.7	6.6	6.0	3.5	7.4	4.7	3.9	6.6	3.4	5.3	5.0	5.8	7.3	4.9	3.2	2.8	4.7	2.4	24.8	21.1	32.6	25.7	22.2	19.0	23.3	22.8	18.9	19.2
FNBP1L	"C1orf39, FLJ20275, TOCA1"	ENSG00000137942	"Formin binding protein 1 like"	Q5T0N5	1	93448131-93554661	"Predicted intracellular proteins"	"Autophagy, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065273	Approved		Supported	Cytosol				Cytosol		"HPA065273: "	"unprognostic (1.83e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic favourable (4.72e-7)"	"unprognostic (3.59e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.78e-1)"	22.8	6.8	17.8	8.3	36.0	1.7	27.0	20.3	11.3	15.7	24.3	5.4	27.3	16.5	14.2	15.9	7.6	11.4	11.9	16.3	13.0	13.7	29.9	10.9	18.0	3.3	10.5	10.3	12.2	15.0	16.0	15.6	13.7	14.0	14.5	14.5	5.6	32.2	23.2	23.4	10.3	27.5	10.3	13.9	2.6	19.0	12.0	16.1	2.5	26.3	7.1	3.3	15.2	24.2	0.9	2.2	11.1	0.1	0.1	0.4	0.2	10.2	5.7	30.0	16.7	6.5	4.7	33.5	5.1	3.5	3.9	5.4	7.1	3.2	0.0	10.8	5.0	5.2	7.2	5.9	5.6	6.6	5.4	5.5	8.3	10.3	3.2	0.9	0.1	8.4	9.8	3.6	5.4	18.5	2.1	0.0	9.2	4.7	3.9	0.4	22.8	5.8	8.7	22.9	2.6	17.1	16.5	12.0	17.0	16.1	31.6	8.9	12.0	1.4	18.3	9.2	11.7	0.2	3.5	3.2	2.6	0.1	0.9	0.1	6.2	11.1	0.1	1.1	0.0	0.0	0.1	0.6	0.4	0.0	0.5	0.9	0.0	0.4	0.1	0.1	0.0	2.2	0.4	0.2	17.8	36.0	20.3	11.3	13.0	13.7	10.5	10.3	14.0	16.1
FNDC4	"FLJ22362, FRCP1"	ENSG00000115226	"Fibronectin type III domain containing 4"	Q9H6D8	2	27491883-27495245	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.9;liver: 57.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.9;ASC diff: 17.3;HUVEC TERT2: 20.7;SH-SY5Y: 16.2;TIME: 18.9;U-87 MG: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051804, HPA063581"	Uncertain		Approved	Nucleoplasm,Aggresome,Cytosol	"Intracellular and membrane"			Nucleoplasm	"Aggresome, Cytosol"	"HPA051804: , HPA063581: "	"unprognostic (2.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.40e-3)"	"prognostic unfavourable (6.11e-4)"	18.5	45.9	13.4	2.7	13.7	0.7	9.1	10.8	29.5	3.8	2.0	4.0	0.5	1.5	2.8	2.8	11.8	1.5	10.0	3.1	15.6	8.5	2.3	57.6	2.0	1.4	12.0	8.6	16.5	4.6	18.6	2.8	2.5	22.2	6.3	2.1	1.9	2.1	3.3	1.3	2.4	1.4	4.7	5.4	3.5	3.2	10.2	3.8	0.0	1.8	0.7	2.7	4.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	16.9	17.3	10.6	0.1	3.8	7.7	2.8	2.4	0.7	0.2	0.0	0.4	12.2	0.0	6.4	2.3	2.4	0.0	1.0	0.8	0.0	8.7	6.4	0.0	0.1	9.0	1.1	4.8	0.9	20.7	0.9	0.0	10.2	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	1.6	0.0	0.1	16.2	0.1	0.0	0.1	0.0	0.0	18.9	2.6	1.2	1.0	2.9	0.0	0.0	0.0	14.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.7	10.8	29.5	15.6	8.5	12.0	8.6	22.2	3.8
FNIP2	"FNIPL, KIAA1450, MAPO1"	ENSG00000052795	"Folliculin interacting protein 2"	Q9P278	4	158769138-158908049	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 60.9;U-266/70: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.8;myeloid DC: 3.1;non-classical monocyte: 9.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.1;monocytes: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042779, HPA052758, HPA072420"	Approved		Supported	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA042779: AB_10794386, HPA052758: , HPA072420: "	"unprognostic (3.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (3.96e-11)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.10e-2)"	23.6	8.6	12.5	7.4	15.5	5.8	11.3	10.9	16.0	10.4	15.7	17.5	11.4	5.6	9.3	9.8	11.0	7.6	15.3	20.9	15.1	9.1	35.5	44.0	21.8	12.0	14.1	14.4	8.5	14.2	13.0	5.2	21.7	11.1	8.5	16.8	8.0	10.0	14.7	15.3	11.4	8.1	13.3	12.9	9.6	16.3	7.2	15.0	5.5	13.9	8.3	4.1	9.3	9.5	0.0	3.1	0.6	9.4	0.9	1.0	0.5	1.3	1.5	6.8	3.5	5.1	3.2	7.5	3.0	3.2	3.1	3.4	1.8	1.4	0.0	0.7	10.8	1.3	6.4	3.1	3.8	60.9	2.3	6.4	0.8	2.5	3.2	2.6	12.8	2.3	2.6	2.1	2.7	3.4	3.8	0.2	5.1	0.4	6.2	0.3	2.1	1.6	3.6	3.3	1.7	2.5	3.5	4.4	3.9	1.6	1.1	6.8	1.4	1.5	4.3	5.0	3.1	3.4	2.2	20.6	8.6	1.3	5.0	3.3	3.5	0.6	1.1	0.3	0.7	4.8	0.4	0.0	0.4	0.3	3.1	0.0	0.4	1.0	0.2	0.9	9.4	0.6	0.1	0.5	12.5	15.5	10.9	16.0	15.1	9.1	14.1	14.4	11.1	15.0
FNTA	"FPTA, PGGT1A, PTAR2"	ENSG00000168522	"Farnesyltransferase, CAAX box, alpha"	P49354	8	43034194-43085788	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010149, HPA018830"	Approved		Approved	Cytosol			220000	Cytosol		"CAB010149: AB_2106299, HPA018830: AB_1848992"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavourable (2.94e-12)"	"unprognostic (3.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-3)"	32.5	21.5	25.3	20.9	31.9	15.3	29.8	21.2	28.8	26.7	25.7	36.9	25.0	23.7	23.7	29.4	28.0	22.9	18.1	32.6	25.6	23.1	24.0	30.5	22.7	27.4	43.3	23.8	21.5	26.0	17.9	24.7	32.6	33.4	25.1	22.5	14.1	23.6	25.9	45.2	29.7	20.4	23.9	75.9	22.9	20.9	18.3	36.8	26.0	25.4	26.8	28.1	27.1	29.8	11.7	11.7	11.1	8.9	13.9	11.9	5.3	23.5	11.7	16.1	5.2	28.4	37.0	13.4	13.7	16.1	16.1	14.8	18.9	18.2	27.7	10.6	17.2	12.9	19.8	22.8	18.9	7.2	13.1	21.7	8.0	16.3	37.0	8.8	11.6	28.6	37.3	11.5	33.1	27.6	26.2	16.3	17.6	2.8	21.1	13.5	28.0	8.5	18.5	25.6	14.9	22.0	17.5	9.6	14.9	17.8	14.8	23.5	18.8	16.8	22.1	5.4	7.1	21.8	14.5	15.2	12.9	27.1	14.2	17.2	12.6	3.0	6.6	11.1	8.7	8.9	10.3	11.7	9.1	11.7	11.7	11.6	11.9	11.9	1.6	13.9	6.7	11.0	11.5	5.3	25.3	31.9	21.2	28.8	25.6	23.1	43.3	23.8	33.4	36.8
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609972-1613897	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"retina: 32.7;salivary gland: 86.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.9;HEK 293: 37.9;RPTEC TERT1: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040670	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	7.7	4.4	2.6	1.3	3.4	1.0	9.4	2.3	3.4	6.6	1.4	2.8	3.2	1.2	2.4	3.8	3.8	3.4	9.8	9.5	3.2	2.1	12.9	1.4	3.8	1.6	4.5	2.3	4.8	2.8	2.2	6.5	3.1	6.5	6.0	1.3	32.7	86.6	4.9	3.6	7.1	1.2	2.1	3.9	0.9	1.1	4.6	2.6	2.8	3.7	4.2	2.9	5.7	4.6	0.0	0.0	0.2	0.1	1.4	0.0	0.0	7.2	0.8	0.2	38.9	1.8	2.0	1.2	3.6	4.3	2.3	1.8	2.7	1.5	0.0	4.2	2.1	8.2	3.7	2.7	1.9	2.2	37.9	1.5	2.2	1.3	1.2	0.5	2.5	6.8	3.7	3.1	3.6	3.3	1.0	0.0	0.9	1.5	0.0	0.8	0.1	3.1	0.0	1.6	0.2	15.2	5.5	1.4	3.4	4.5	0.0	2.6	1.1	0.6	0.8	4.9	3.0	2.5	3.8	0.1	0.3	0.0	1.4	1.8	4.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	2.6	3.4	2.3	3.4	3.2	2.1	4.5	2.3	6.5	2.6
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857681-2877155	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.5;testis: 40.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB017832	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavourable (1.95e-6)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.7	1.7	1.0	9.3	0.9	13.8	2.4	0.4	1.2	2.0	6.5	0.4	1.1	6.0	1.2	2.1	13.5	0.4	4.1	1.2	0.8	0.6	1.3	1.6	2.8	6.6	0.8	0.3	0.8	0.6	0.0	0.5	3.9	0.9	0.9	8.2	0.6	2.6	1.1	0.7	3.7	7.1	4.4	1.2	5.0	3.2	40.1	0.4	47.5	0.6	11.4	11.6	2.0	3.7	0.7	0.6	1.0	0.6	0.4	1.9	0.1	28.6	29.1	22.6	20.7	3.4	4.5	28.8	18.7	18.5	38.1	34.5	36.7	25.7	18.5	4.0	26.8	22.3	33.8	17.2	37.3	34.6	18.1	20.9	27.9	15.7	0.5	16.8	17.1	2.3	1.9	35.3	24.9	26.8	11.7	41.7	29.9	26.9	22.8	8.0	49.8	21.7	16.6	34.3	9.7	9.0	18.4	12.7	20.2	24.0	20.1	11.0	19.7	18.8	10.7	30.9	47.0	36.1	65.0	5.5	9.1	26.8	14.3	16.1	32.7	0.4	0.6	0.1	0.4	0.2	0.4	0.7	0.5	0.4	0.2	0.7	0.9	0.3	1.0	0.4	0.1	0.6	1.9	0.1	1.0	0.9	0.4	1.2	0.8	0.6	0.8	0.3	0.9	0.4
FOXN4		ENSG00000139445	"Forkhead box N4"	Q96NZ1	12	109277979-109309220	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 13.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 2.4;SCLC-21H: 6.3;SH-SY5Y: 6.5;U-266/70: 8.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Region enriched"	"Detected in single"	11	"basal ganglia: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA050018	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA050018: "	"unprognostic (1.09e-3)"	"unprognostic (9.63e-2)"		"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"		"unprognostic (1.08e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"		"unprognostic (6.00e-2)"	0.2	0.0	0.1	0.1	2.7	0.0	0.1	0.2	0.1	1.4	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.9	2.3	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.4	0.1	0.4	0.1	0.1	0.0	13.1	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3	6.5	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.0	8.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1
FOXO1	"FKH1, FKHR, FOXO1A"	ENSG00000150907	"Forkhead box O1"	Q12778	13	40469953-40666597	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.9;Daudi: 20.0;HSkMC: 25.2;U-698: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001252, CAB022326"	Approved	Approved	Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB022326: , HPA001252: AB_1078906"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.33e-5)"	"unprognostic (1.93e-1)"	"unprognostic (5.44e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.63e-2)"	41.6	6.9	7.0	18.4	11.2	8.0	35.5	2.3	5.0	21.4	13.4	8.4	7.7	3.5	27.4	9.8	9.5	17.2	13.3	9.9	7.8	3.9	8.3	25.6	15.3	22.4	8.3	3.9	46.0	12.2	3.8	6.2	9.5	6.5	7.9	6.8	5.7	7.5	9.3	85.9	12.3	7.6	18.6	9.7	10.8	7.4	12.3	9.0	9.4	13.1	9.0	15.6	14.4	16.2	6.1	0.5	2.8	1.6	1.1	7.1	1.0	0.3	0.6	5.6	0.1	18.9	3.7	5.4	0.8	1.1	0.2	0.1	1.4	1.3	20.0	3.7	0.5	4.8	4.4	2.4	0.3	9.1	4.6	0.0	0.6	4.4	9.0	0.1	0.5	25.2	16.4	0.1	3.1	14.2	0.3	6.4	1.4	0.7	0.0	0.2	8.2	1.4	14.2	6.5	1.5	10.5	2.5	1.2	0.3	0.7	3.8	0.8	0.6	0.5	8.3	0.1	1.1	0.0	0.5	3.6	1.3	25.9	0.5	0.9	2.6	0.9	0.8	0.5	1.5	1.0	2.3	3.2	3.9	2.2	0.5	6.1	7.1	5.3	2.8	1.1	1.6	0.0	5.5	1.0	7.0	11.2	2.3	5.0	7.8	3.9	8.3	3.9	6.5	9.0
FOXO4	"AFX1, MLLT7"	ENSG00000184481	"Forkhead box O4"	P98177	X	71096197-71103535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 98.6"	"Cell line enriched"	"Detected in many"	5	"BEWO: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039560, HPA040232"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA039560: , HPA040232: "	"unprognostic (4.64e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.79e-2)"	"prognostic favourable (4.61e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.16e-2)"	"prognostic favourable (3.46e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-3)"	8.5	13.2	21.7	3.8	21.5	9.9	5.1	9.1	15.6	4.8	8.4	9.1	11.9	6.3	6.8	10.2	7.3	7.7	5.8	9.7	21.4	14.5	5.2	3.6	5.5	3.6	22.8	8.4	13.4	6.8	8.7	3.0	98.6	9.2	7.0	4.7	4.9	8.5	11.3	33.8	5.5	6.6	9.4	17.3	6.0	5.2	13.9	13.1	4.4	5.9	7.5	4.2	7.5	11.0	0.9	0.2	3.4	0.6	1.0	1.8	0.9	1.7	0.5	1.4	1.8	3.3	2.3	60.0	1.4	1.6	0.7	1.7	1.2	2.4	2.3	1.8	1.8	0.8	3.6	1.6	0.8	2.3	5.5	3.4	11.2	1.9	1.9	1.9	2.7	1.9	3.8	0.6	0.4	1.8	6.9	4.6	0.3	0.3	3.0	3.1	6.5	2.1	2.1	3.5	3.6	1.2	1.0	1.0	2.9	2.9	0.4	3.1	0.7	1.2	1.7	0.4	0.9	3.1	0.3	3.0	1.6	0.4	1.6	5.2	0.5	0.2	0.6	3.2	0.9	0.6	0.3	0.8	0.5	0.9	0.2	0.9	0.4	1.8	3.4	1.0	0.3	0.0	1.3	0.9	21.7	21.5	9.1	15.6	21.4	14.5	22.8	8.4	9.2	13.1
FOXP4	FLJ40908	ENSG00000137166	"Forkhead box P4"	Q8IVH2	6	41546426-41602384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007176	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007176: AB_1078911"	"unprognostic (8.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (1.17e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavourable (9.72e-4)"	"unprognostic (2.13e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-2)"	12.1	7.8	6.3	13.7	12.6	4.4	15.5	12.3	10.0	28.2	15.8	14.0	16.4	18.7	20.7	8.4	10.5	10.1	29.5	12.9	6.6	7.3	16.4	18.9	14.4	9.1	12.9	4.9	17.1	24.8	5.9	12.6	5.5	9.4	21.7	7.2	21.2	30.1	13.0	7.9	7.1	19.3	11.7	7.9	5.8	37.0	15.4	10.9	12.0	23.9	6.3	14.0	11.7	27.6	2.0	1.0	0.3	0.9	0.6	1.5	0.4	10.1	13.9	17.6	18.8	3.4	1.1	18.0	5.6	3.0	5.0	3.4	43.4	3.2	11.7	10.5	3.4	7.8	5.1	5.3	2.1	9.2	8.1	9.3	7.7	29.1	6.4	5.9	7.7	2.8	6.6	4.4	2.7	4.8	11.5	4.8	2.3	27.4	6.9	10.1	4.4	4.9	7.5	5.6	7.9	4.3	8.4	4.9	7.1	6.0	14.3	9.9	8.1	14.4	6.8	6.3	15.7	9.8	9.4	3.8	2.4	16.3	5.2	9.9	5.9	0.3	0.7	0.3	0.7	0.9	1.2	1.0	0.6	1.5	0.6	2.0	0.1	0.3	0.3	0.6	0.3	1.0	1.1	0.4	6.3	12.6	12.3	9.2	6.6	7.3	12.9	4.9	9.4	10.9
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844301-31845619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;RH-30: 11.9;U-2 OS: 15.9;U-251 MG: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavourable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	5.9	3.1	2.7	3.0	4.7	0.3	11.7	2.7	4.9	9.7	2.6	4.8	1.8	0.9	15.5	6.2	2.8	3.6	11.7	14.0	3.2	2.6	5.5	0.9	6.5	4.6	4.1	4.8	4.0	1.1	0.8	3.2	14.4	5.2	5.0	1.6	7.0	2.0	7.0	4.5	1.8	1.8	3.7	2.6	5.5	1.6	9.7	0.6	3.0	4.9	7.0	3.1	4.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.9	0.1	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.0	15.9	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.7	2.7	4.9	3.2	2.6	4.1	4.8	5.2	0.6
FP565260.1		ENSG00000275464			21	5130871-5154734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 17.2"	"Cell line enhanced"	"Detected in many"		"HEL: 37.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA024573	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	3.0	3.0	1.1	3.0	2.2	3.3	1.4	1.1	6.8	1.7	1.9	7.2	1.1	2.8	1.6	2.6	1.9	2.4	4.8	2.9	3.2		1.8	1.1	1.8	4.2	2.4	1.1	1.9	2.0	2.5	1.1	2.3	2.9	1.8	2.7	1.1	1.7	1.1	6.8	1.8	2.2	3.4	1.1	2.8	1.4	1.4	1.1	1.1	1.7	1.1	2.3	2.4	1.1	8.9	6.6	5.0	12.9	7.4	17.2	7.5	11.6	8.7	5.9	9.1	2.6	1.9	3.5	0.0	0.0	0.0	0.0	0.0	7.5	0.0	5.4	3.9	7.7	16.4	7.2	0.0	2.5	5.3	37.5	4.6	4.5	4.1	17.2	11.2	7.1	8.8	10.1	7.9	7.7	20.9	4.1	2.5	10.3	12.6	11.8	23.3	11.0	19.8	5.5	10.3	5.3	9.3	5.7	10.3	9.6	14.6	5.5	12.2	9.3	3.7	4.5	11.4	0.1	12.1	4.9	5.3	23.6	8.0	22.7	6.2	2.6	5.5	5.0	15.0	9.7	17.2	8.7	9.1	11.0	6.6	8.9	9.2	12.6	3.3	7.4	12.9	4.4	6.0	7.5										
FRAT1		ENSG00000165879	"FRAT1, WNT signaling pathway regulator"	Q92837	10	97319267-97321915	"Predicted intracellular proteins"	"Wnt signaling pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 9.0;neutrophil: 11.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.2"					"Low region specificity"	"Detected in all"			"CAB046472, HPA055258"	Approved		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB046472: AB_1849131, HPA055258: "	"unprognostic (1.48e-2)"	"prognostic favourable (5.92e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.89e-1)"	"prognostic favourable (6.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (5.27e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.43e-2)"	5.2	3.7	3.0	8.0	4.0	14.9	3.9	5.8	5.8	3.9	6.9	3.4	5.0	7.4	3.6	2.0	3.8	4.0	6.8	3.5	3.3	4.5	2.9	12.6	6.6	18.7	4.4	3.1	3.4	6.7	4.1	2.8	6.5	4.9	4.9	3.3	2.8	6.1	5.9	5.7	4.9	9.9	2.6	2.7	16.2	8.2	21.6	3.3	9.7	2.7	3.3	4.3	3.5	4.7	0.6	1.1	11.2	2.2	0.2	0.8	0.5	0.9	1.5	1.8	8.1	2.3	1.1	1.8	0.9	3.5	0.7	0.7	0.2	1.0	5.3	1.8	0.6	2.4	1.3	1.7	0.1	4.6	2.5	4.5	0.8	2.1	0.8	1.7	4.9	1.0	2.5	0.3	1.1	1.4	1.9	3.8	0.5	4.9	4.6	9.2	2.3	6.6	3.9	0.4	3.4	0.6	1.1	0.9	2.7	1.2	2.5	1.7	9.4	6.4	1.3	0.4	0.5	1.3	0.4	3.5	2.0	1.8	0.6	8.3	0.0	1.0	2.2	9.0	0.6	1.4	0.4	0.5	0.5	0.8	1.1	0.6	0.8	0.6	11.2	0.2	1.6	0.7	0.3	0.5	3.0	4.0	5.8	5.8	3.3	4.5	4.4	3.1	4.9	3.3
FREM2	DKFZp686J0811	ENSG00000150893	"FRAS1 related extracellular matrix protein 2"	Q5SZK8	13	38687129-38887131	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 13.9;lung: 11.2;thyroid gland: 12.2"	"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 10.4;MCF7: 7.5;RT4: 7.0;SK-BR-3: 6.3;WM-115: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA028831	Uncertain		Approved	Cytosol			170000	Cytosol		"HPA028831: AB_10603668"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (2.23e-7)"	"unprognostic (7.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.14e-1)"	0.6	0.4	1.3	0.1	1.7	0.1	0.5	1.5	6.4	0.7	1.3	1.2	1.1	0.4	1.1	0.5	0.2	0.9	1.5	0.2	2.8	0.4	13.9	3.4	11.2	0.1	0.4	0.8	1.8	5.2	0.1	1.1	2.6	0.8	3.5	0.4	2.9	0.4	1.5	6.3	0.6	0.7	0.7	0.4	0.3	2.2	1.8	1.5	0.1	12.2	4.1	0.1	1.5	0.3	0.3	0.3	0.9	0.2	0.2	0.2	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	10.4	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.3	0.2	0.0	1.5	0.1	2.4	7.0	0.2	0.1	0.0	6.3	0.3	1.1	0.0	0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.8	0.9	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.2	0.7	0.2	0.2	0.3	0.1	0.0	1.3	1.7	1.5	6.4	2.8	0.4	0.4	0.8	0.8	1.5
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell line enhanced"	"Detected in many"		"RT4: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025217, HPA030479"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB025217: , HPA030479: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favourable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	1.5	2.2	0.8	3.0	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9.0	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2.0	41.4	2.5	2.4	1.0	5.5	1.8	0.5	1.2	1.0	5.2	7.4	5.0	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	3.2	5.3	0.8	1.3	0.4	0.4	1.0	0.8	0.2	0.1	0.1	4.1	5.1	1.3	4.9	0.8	7.7	0.4	1.5	0.2	4.4	0.5	1.8	4.6	3.5	0.3	1.2	1.1	0.3	2.2	0.5	0.6	0.3	0.9	3.3	1.3	1.8	1.0	0.8	1.4	0.9	1.5	4.6	1.6	6.5	10.1	1.1	1.2	1.1	6.8	0.7	2.1	1.0	1.3	1.5	1.6	1.2	0.8	5.0	3.5	2.3	1.5	0.8	1.0	3.2	1.0	1.0	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1.0	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5
FRMD8	"FKSG44, FLJ90369"	ENSG00000126391	"FERM domain containing 8"	Q9BZ67	11	65386599-65413525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002861, HPA005506"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA002861: AB_1078878, HPA005506: "	"unprognostic (1.54e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (9.94e-5)"	"unprognostic (9.12e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.36e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.91e-2)"	14.6	11.9	7.8	18.5	12.1	13.1	15.2	8.9	10.3	12.5	15.1	11.4	6.9	13.6	10.5	12.2	23.9	14.6	17.4	10.0	8.0	5.4	10.5	12.0	15.1	17.3	17.0	8.5	8.9	20.9	5.7	8.2	12.2	11.7	10.7	8.2	7.8	18.6	10.9	12.0	24.3	16.5	8.1	8.9	29.0	11.7	11.3	14.6	16.6	12.4	16.6	21.8	11.0	18.1	10.9	11.4	19.7	14.9	6.5	14.3	9.0	6.8	8.8	3.6	8.3	9.6	5.1	6.3	7.7	7.3	6.7	5.3	8.4	11.5	8.5	16.8	11.0	12.1	4.5	6.8	2.9	14.1	4.1	11.7	8.0	4.6	5.2	6.5	18.3	6.3	5.4	6.4	3.4	10.8	9.7	9.5	7.4	9.3	9.9	9.6	3.9	11.5	13.2	6.6	9.6	5.5	8.6	7.6	5.3	6.0	24.4	18.6	8.9	5.4	9.4	7.6	7.9	10.2	4.8	16.4	8.4	8.0	6.6	4.1	52.2	0.8	9.7	13.4	11.5	11.0	12.7	10.9	8.4	14.3	9.1	9.2	7.8	8.4	19.7	6.5	14.9	11.4	8.9	9.0	7.8	12.1	8.9	10.3	8.0	5.4	17.0	8.5	11.7	14.6
FRYL	"AF4p12, DKFZp686E205, KIAA0826, MOR2"	ENSG00000075539	"FRY like transcription coactivator"	O94915	4	48497361-48780322	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 12.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031106, HPA031107"	Supported		Approved	"Microtubules,Cytokinetic bridge,Cytosol"				Cytosol	"Microtubules, Cytokinetic bridge"	"HPA031106: AB_10600660, HPA031107: AB_10600536"	"unprognostic (7.50e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.22e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	9.6	7.5	13.4	13.1	27.4	12.4	8.3	10.1	20.2	7.3	30.5	23.4	7.1	8.6	8.5	3.7	6.3	6.5	7.1	7.7	13.8	8.6	7.6	4.8	9.0	10.6	30.2	7.9	7.1	5.8	28.4	12.5	9.0	17.6	5.9	30.8	5.5	6.1	6.2	9.1	8.8	13.4	8.1	25.8	8.8	9.1	5.2	30.1	11.8	6.9	3.9	10.9	8.8	6.0	2.1	2.2	12.6	2.0	3.3	2.8	0.9	10.2	6.3	14.8	9.4	6.2	8.7	8.0	9.4	9.6	10.0	11.9	4.9	8.3	12.9	8.0	10.1	6.6	9.6	16.0	21.3	7.3	3.3	24.1	6.4	2.3	4.1	16.5	9.6	6.7	6.1	13.7	14.3	14.4	7.4	5.2	12.5	5.2	16.9	5.8	2.5	5.8	13.5	18.8	2.6	9.1	11.2	13.1	5.8	9.8	2.5	5.3	3.9	10.8	21.4	10.8	14.5	5.7	18.8	7.0	9.1	11.7	9.1	11.0	10.8	12.6	1.2	2.3	2.8	2.0	2.2	2.1	2.5	2.2	1.1	1.8	2.8	2.7	3.7	3.3	1.2	2.2	1.8	0.9	13.4	27.4	10.1	20.2	13.8	8.6	30.2	7.9	17.6	30.1
FSCN1	"FLJ38511, p55, SNL"	ENSG00000075618	"Fascin actin-bundling protein 1"	Q16658	7	5592823-5606655	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 80.6;K-562: 67.5;NB-4: 76.7;PC-3: 67.5;SH-SY5Y: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000121, HPA005723, CAB035991, HPA050654"	Enhanced		Supported	"Plasma membrane,Cytosol"			4500000	Cytosol	"Plasma membrane"	"CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: "	"unprognostic (1.91e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (8.15e-7)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.93e-3)"	26.3	13.3	23.7	29.6	30.1	6.3	8.1	5.5	56.9	9.9	5.5	35.1	0.0	5.4	11.7	2.3	22.3	5.9	8.9	10.6	27.7	16.8	5.5	7.1	11.3	15.2	26.9	23.6	21.8	5.1	2.3	7.0	29.4	20.1	4.1	3.0	8.1	11.0	3.9	7.8	17.3	6.6	7.0	29.6	39.3	7.6	15.9	28.3	9.3	8.5	15.9	11.4	14.7	12.3	0.2	5.4	1.0	1.9	0.0	0.1	1.4	7.8	18.3	12.2	43.7	4.7	9.1	80.6	18.9	8.4	3.2	3.5	12.7	2.0	0.1	23.2	8.3	30.0	7.0	30.4	0.2	9.0	3.8	0.5	19.4	59.7	2.5	0.0	1.5	5.6	9.0	6.1	5.0	15.9	67.5	0.1	4.2	0.8	0.2	76.7	31.9	67.5	17.8	2.9	0.3	4.7	0.7	9.8	64.8	15.9	0.2	0.6	0.4	4.8	32.3	22.5	39.6	13.0	19.4	0.1	0.1	0.0	14.5	0.0	42.2	0.0	1.9	0.1	0.0	0.5	0.0	0.2	0.1	0.0	5.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	1.4	23.7	30.1	5.5	41.3	27.7	16.8	26.9	23.6	20.1	28.3
FSD2	"RP11-127F21, SPRYD1"	ENSG00000186628	"Fibronectin type III and SPRY domain containing 2"	A1L4K1	15	82755362-82806070	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046263			Approved	Cytosol				Cytosol		"HPA046263: "	"unprognostic (2.80e-1)"	"unprognostic (3.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.59e-2)"	1.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.6	0.7	0.1	0.0	20.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.4	1.0	0.0	54.0	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	18.1	1.4	0.0	0.1	1.4	0.8	2.3	0.9	0.8	2.2	0.5	1.3	1.3	2.0	2.3	0.0	0.0	1.1	1.3	0.0	0.0	0.0	1.1	2.1	4.0	0.9	0.0	4.8	0.0	0.0	0.4	0.7	5.3	2.2	5.6	1.8	0.0	1.3	0.9	0.1	0.2	0.0	0.6	0.0	2.0	3.6	0.0	1.2	0.7	2.3	1.8	1.0	1.3	1.5	1.0	0.2	2.2	1.9	1.6	1.0	1.0	1.5	1.6	1.7	0.8	2.9	1.5	1.0	1.8	8.3	3.5	1.4	1.8	4.8	0.7	2.3	0.8	0.8	1.0	0.7	0.8	1.4	1.1	0.9	0.8	1.1	2.2	1.1	1.1	0.8	0.9	0.8	1.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
FSTL1	"FRP, FSL1, OCC-1, OCC1, tsc36"	ENSG00000163430	"Follistatin like 1"	Q12841	3	120392293-120451253	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 127.1;BJ: 147.5;fHDF/TERT166: 182.0;HBF TERT88: 121.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 10.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035251, HPA040815"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"		32000000	"Vesicles, Cytosol"		"HPA035251: AB_10601906, HPA040815: "	"unprognostic (2.60e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.84e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.47e-3)"	72.3	28.6	4.8	23.1	5.8	0.0	104.0	2.5	6.7	52.1	39.1	7.3	28.7	5.8	41.6	58.1	39.2	42.6	45.6	69.4	5.9	3.2	15.1	5.5	33.6	44.4	4.3	4.3	26.9	8.7	5.5	7.9	110.0	13.2	36.3	15.4	26.2	17.5	32.5	23.6	18.4	18.6	90.2	9.4	16.7	22.1	19.8	4.9	4.7	23.8	29.1	11.1	67.1	65.8	0.1	1.2	10.2	0.1	0.0	0.0	3.6	5.3	1.4	15.3	6.3	92.4	127.1	0.0	147.5	82.8	95.5	84.8	0.0	12.3	0.0	12.5	182.0	1.4	4.7	18.3	121.8	0.0	2.2	0.0	11.6	0.0	20.3	0.0	0.0	96.6	0.5	61.7	13.5	55.3	0.0	0.0	15.5	0.0	1.4	0.1	12.6	12.3	0.0	6.4	0.0	10.2	0.1	2.7	6.5	52.4	0.9	5.3	1.6	0.4	67.5	35.9	34.5	18.7	21.8	0.0	0.0	0.1	12.5	0.0	4.6	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	3.6	4.8	5.8	2.5	6.7	5.9	3.2	4.3	4.3	13.2	4.9
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 126.8"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 44.4"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.5"									"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"			580000	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favourable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.2	0.0	0.6	0.2	1.6	0.0	0.2	0.2	0.7	0.2	0.3	0.2	0.2	0.3	0.2	2.0	0.2	0.0	0.2	0.2	0.5	0.4	25.9	126.8	0.2	0.2	0.4	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.1	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	44.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	2.5	0.1	0.6	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.2	0.2
FTL	"MGC71996, NBIA3"	ENSG00000087086	"Ferritin light chain"	P02792	19	48965301-48966878	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Iron storage"		"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 1149.4"	"Cell line enhanced"	"Detected in all"		"HHSteC: 570.4;HSkMC: 477.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"granulocytes: 1149.4;monocytes: 890.5"									"CAB020769, HPA041602"	Enhanced		Approved	Cytosol			240000000	Cytosol		"CAB020769: , HPA041602: "	"unprognostic (2.95e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (4.40e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	326.0	111.3	147.1	113.6	130.9	179.8	321.8	25.8	101.3	105.7	107.5	134.7	58.2	120.5	54.9	85.4	85.0	71.3	214.6	140.8	111.7	88.2	295.2	526.9	391.6	444.6	139.4	49.6	126.8	108.0	27.0	63.6	166.3	89.0	108.0	92.3	114.4	59.4	75.4	75.6	48.3	159.4	149.2	194.5	317.9	105.2	53.9	74.5	45.1	130.0	57.5	67.5	159.8	172.1	147.8	231.2	1149.4	890.5	41.5	86.1	674.1	18.5	282.8	21.2	32.4	367.1	381.0	38.0	48.2	283.8	69.5	156.5	61.9	75.4	14.1	92.8	287.8	11.1	17.4	28.5	62.8	190.6	11.2	37.5	73.8	404.9	570.4	88.0	126.2	477.2	38.7	118.2	52.1	100.6	69.3	29.6	137.1	4.5	24.3	51.4	38.5	28.9	20.3	14.4	145.7	44.1	11.8	27.2	15.8	126.6	6.9	26.3	4.0	184.1	75.2	76.1	40.0	97.6	65.9	128.1	282.4	13.2	80.7	92.8	133.0	488.0	642.5	675.8	63.9	890.5	72.6	147.8	71.3	68.3	231.2	132.2	86.1	74.8	1149.4	41.5	768.3	97.2	83.8	674.1	147.1	130.9	25.8	101.3	111.7	88.2	139.4	49.6	89.0	74.5
FTO	"ALKBH9, KIAA1752, MGC5149"	ENSG00000140718	"FTO, alpha-ketoglutarate dependent dioxygenase"	Q9C0B1	16	53701692-54158512	"Disease related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017123, HPA041086, HPA068695"	Enhanced		Approved	Vesicles,Cytosol			130000	"Vesicles, Cytosol"		"CAB017123: , HPA041086: , HPA068695: "	"unprognostic (9.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.11e-3)"	17.5	25.4	19.7	8.7	37.4	5.6	27.1	29.7	37.5	20.2	13.5	30.1	11.4	5.8	22.7	16.8	13.2	19.5	16.2	19.5	19.9	25.9	19.0	13.0	27.3	10.1	21.8	19.6	21.2	15.2	42.0	31.6	14.7	28.9	15.8	10.9	18.9	13.4	19.1	19.9	13.6	8.1	22.6	23.8	11.5	10.1	6.2	22.2	10.0	20.7	7.8	10.6	16.1	12.5	12.3	15.3	8.1	14.8	16.3	22.1	14.0	6.6	12.0	16.0	16.4	31.6	23.9	5.3	16.0	14.6	13.5	3.9	7.5	8.8	15.1	17.7	20.6	9.8	14.8	15.7	19.8	7.0	11.6	6.8	16.3	13.9	21.8	5.4	7.8	26.2	16.7	12.2	15.1	19.9	6.6	3.8	21.7	5.2	12.0	8.3	8.3	7.9	18.5	24.3	14.2	20.4	5.6	19.8	13.7	18.2	10.8	4.9	14.2	13.0	18.9	16.9	11.3	9.0	9.8	7.3	5.9	15.6	15.7	10.1	12.9	8.1	11.6	6.0	17.7	14.8	22.1	12.3	17.0	17.7	15.3	11.7	16.0	17.2	2.0	16.3	10.0	6.1	16.5	14.0	19.7	37.4	29.7	37.5	19.9	25.9	21.8	19.6	28.9	22.2
FTSJ1	"CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7"	ENSG00000068438	"FtsJ RNA methyltransferase homolog 1"	Q9UET6	X	48476021-48486364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002718	Approved		Approved	Cytosol				Cytosol		"HPA002718: AB_1078914"	"unprognostic (2.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.77e-2)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.96e-3)"	"unprognostic (2.06e-3)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (5.24e-10)"	"unprognostic (2.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	17.6	19.4	12.3	18.2	21.6	18.4	17.1	18.7	21.2	23.3	11.7	13.6	20.8	10.7	18.5	12.6	19.0	15.9	12.8	15.0	9.9	10.3	15.9	21.3	16.9	22.9	13.6	9.2	17.4	36.6	13.9	16.2	11.3	14.9	13.3	10.6	12.4	20.8	18.6	17.3	18.0	12.0	16.6	11.0	19.6	17.8	14.6	15.2	17.2	20.0	24.8	18.6	17.3	17.2	17.1	16.8	10.7	16.1	15.9	26.9	15.1	25.5	17.7	6.8	26.9	9.7	10.2	11.1	12.6	12.1	18.4	14.6	10.5	35.9	14.9	9.4	19.2	17.3	13.5	44.3	8.3	11.3	12.7	9.5	22.4	11.8	27.7	13.0	24.0	9.5	22.4	23.1	22.8	12.8	8.0	12.5	23.8	14.5	16.8	9.3	15.3	30.4	13.7	22.2	30.9	17.3	8.6	9.2	9.1	20.0	11.0	9.2	12.6	7.5	12.5	14.6	19.8	30.3	15.3	16.9	13.1	10.7	32.2	24.5	15.2	9.2	14.1	10.7	21.9	16.1	26.9	17.1	18.9	22.1	16.8	16.9	17.3	21.9	2.0	15.9	15.1	11.6	17.5	15.1	12.3	21.6	18.7	21.2	9.9	10.3	13.6	9.2	14.9	15.2
FUBP3	FBP3	ENSG00000107164	"Far upstream element binding protein 3"	Q96I24	9	130578965-130638352	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047658, HPA058392"	Uncertain		Approved	Nucleoplasm,Cytosol			6200	Nucleoplasm	Cytosol	"HPA047658: , HPA058392: "	"unprognostic (1.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (3.12e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.23e-2)"	"prognostic favourable (4.39e-5)"	"unprognostic (2.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.23e-2)"	26.6	24.1	24.3	18.5	24.3	10.5	21.8	23.9	30.3	22.8	24.0	37.7	22.9	19.9	32.7	20.7	24.2	22.1	25.4	24.3	24.6	20.0	22.4	37.6	19.9	18.7	27.4	22.8	25.2	27.7	36.6	23.8	33.8	23.9	26.1	20.4	21.9	26.1	25.3	15.2	22.0	20.5	26.9	30.0	20.2	22.0	30.0	27.5	26.4	39.9	18.1	20.1	23.2	22.9	4.5	5.6	2.1	4.5	7.3	6.9	3.0	20.6	19.1	27.9	22.9	20.1	23.0	35.4	29.7	26.6	24.0	18.7	27.5	19.2	20.1	15.7	28.1	36.2	23.4	25.2	28.6	22.1	20.1	22.2	30.4	20.1	27.6	33.3	25.2	22.1	20.3	25.2	23.9	19.6	35.3	12.5	24.8	27.8	25.7	17.0	35.8	24.4	23.0	34.8	26.9	21.0	21.9	18.5	30.7	31.5	23.5	19.4	32.2	25.4	24.8	43.5	20.7	29.3	34.3	11.5	18.9	26.1	24.3	14.5	31.0	0.0	3.7	2.1	4.7	4.5	6.9	4.5	5.1	5.6	5.6	3.3	5.9	5.1	1.0	7.3	3.5	4.9	4.0	3.0	24.3	24.3	23.9	23.7	24.6	20.0	27.4	22.8	23.9	27.5
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705950	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.3;salivary gland: 58.1"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 40.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favourable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.4	0.6	0.7	5.3	0.8	0.0	0.8	8.7	1.6	9.3	25.0	0.3	13.9	24.1	1.3	0.1	16.0	1.2	23.3	0.5	0.7	0.7	0.8	0.4	1.1	0.1	0.7	0.1	1.0	7.5	0.0	1.5	0.2	0.7	1.2	10.9	0.1	58.1	14.5	0.5	2.6	41.3	0.4	0.7	0.6	15.8	0.7	0.2	0.5	0.6	16.1	19.3	3.1	5.4	1.7	1.8	3.5	1.0	1.4	2.5	0.6	1.1	1.0	0.2	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.8	40.9	0.3	0.3	0.0	7.2	0.0	0.0	0.0	0.4	0.3	0.4	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.5	0.9	0.3	0.3	0.3	0.1	1.8	0.0	0.3	2.2	0.3	0.1	0.3	0.0	6.1	0.0	0.1	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.2	0.2	0.1	3.5	0.8	0.4	2.0	0.7	1.1	1.5	2.3	1.0	0.5	1.7	2.1	0.7	3.4	1.4	1.0	1.8	2.5	0.6	0.7	0.8	8.7	1.6	0.7	0.7	0.7	0.1	0.7	0.2
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA040863, HPA043410"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA040863: , HPA043410: "	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	7.2	7.6	16.2	12.0	21.1	3.3	9.4	24.1	18.1	6.7	9.8	29.1	16.1	15.4	8.7	5.0	6.5	14.0	10.1	5.2	19.8	12.9	6.2	2.9	7.0	11.2	20.5	11.2	7.2	10.5	6.2	5.2	18.8	17.3	5.4	10.4	7.1	33.7	13.7	3.5	4.9	15.1	9.5	39.8	8.5	27.6	13.1	23.6	8.4	7.5	2.4	15.2	14.4	5.6	13.5	2.2	0.5	1.7	12.0	8.2	2.5	34.9	6.9	3.3	30.7	14.8	11.2	20.8	11.2	17.2	7.8	8.7	5.4	12.9	9.3	9.6	11.1	2.6	7.9	3.1	12.0	34.5	3.4	9.4	2.5	7.0	7.6	2.1	7.7	28.1	2.0	10.8	5.1	19.8	3.4	7.9	5.6	18.0	9.9	5.1	4.5	24.2	6.8	2.9	5.3	14.0	9.8	7.1	5.3	6.0	2.8	2.4	2.8	3.4	43.1	10.3	11.0	4.5	9.1	15.9	6.0	22.2	20.8	3.7	3.2	0.5	1.7	0.5	3.5	0.6	3.5	13.5	5.6	5.1	2.2	6.8	6.1	6.0	0.2	12.0	1.1	2.2	8.2	2.5	16.2	21.1	24.1	17.3	19.8	12.9	20.5	11.2	17.3	23.6
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015984-96215612	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 37.7;stomach 1: 35.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.1;RT4: 9.4;SCLC-21H: 9.6;SK-BR-3: 5.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: "	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	1.1	1.7	18.5	1.1	22.5	1.1	1.9	37.7	28.6	1.1	1.1	10.7	0.0	4.1	1.4	1.2	1.1	1.4	1.1	1.1	20.0	6.2	1.2	1.1	1.1	1.1	10.2	24.0	1.1	8.0	1.1	0.9	1.7	13.8	1.5	1.2	0.0	1.1	1.5	1.2	1.1	1.1	1.1	10.2	1.1	35.4	1.1	16.5	0.0	1.2	0.0	1.1	2.2	0.4	0.3	0.2	1.5	0.1	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	9.4	9.6	0.2	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.8	0.2	0.0	0.2	0.0	0.0	18.5	22.5	37.7	28.6	20.0	6.2	10.2	24.0	13.8	16.5
FUZ	"FLJ22688, Fy"	ENSG00000010361	"Fuzzy planar cell polarity protein"	Q9BT04	19	49806869-49817376	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 116.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041779, HPA042196"	Approved		Approved	Cytosol				Cytosol		"HPA041779: AB_10793974, HPA042196: AB_10797383"	"unprognostic (2.40e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (1.50e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.70e-1)"	5.6	7.8	7.4	2.1	8.4	4.7	4.1	5.4	9.0	6.5	3.8	11.3	3.5	3.7	6.1	6.6	3.4	17.8	4.7	4.5	7.7	5.8	9.0	3.0	4.4	4.1	7.8	5.6	9.8	7.0	5.6	5.2	3.6	6.8	4.5	1.7	4.8	6.2	7.1	15.1	2.0	3.2	3.8	7.9	3.6	4.6	116.2	8.1	5.4	6.8	3.4	3.2	3.5	3.0	5.7	12.3	14.9	4.0	3.0	4.6	2.4	0.0	6.5	6.1	7.9	5.4	6.2	1.6	3.0	3.3	5.2	7.1	0.5	10.7	1.8	6.4	2.9	2.8	1.5	5.7	2.3	6.1	12.4	7.4	4.4	0.0	6.5	4.5	4.3	6.5	3.8	10.1	2.4	4.4	1.8	5.3	2.5	0.4	8.8	9.5	10.2	3.4	15.2	4.4	4.2	5.8	1.4	17.2	19.9	0.6	6.6	10.6	3.7	2.8	2.3	4.4	3.9	1.1	1.1	15.3	15.2	4.9	4.9	0.1	5.3	5.4	4.0	14.9	4.6	1.9	3.6	4.6	2.8	3.7	3.2	5.7	3.5	4.0	8.9	3.0	1.3	12.3	3.2	2.4	7.4	8.4	5.4	9.0	7.7	5.8	7.8	5.6	6.8	8.1
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035259-69120427	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"CAB022164: , HPA068304: "	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	8.7	19.9	10.8	9.1	9.8	21.9	11.8	13.9	11.0	8.3	9.3	12.3	11.6	6.6	12.4	11.7	9.2	9.6	7.2	20.2	8.7	10.1	10.2	40.2	9.5	12.8	11.7	8.5	16.8	25.9	18.8	8.6	8.4	10.5	9.9	11.6	12.1	11.9	13.6	25.1	5.2	7.2	16.6	8.9	12.9	9.2	13.3	9.7	3.7	11.1	9.5	9.6	10.5	7.9	15.8	17.7	2.0	18.5	24.2	28.3	19.1	11.2	9.6	15.7	7.5	7.2	10.7	15.2	8.2	7.2	12.5	9.7	5.1	7.3	20.2	6.3	8.5	12.4	18.5	18.7	15.8	23.6	21.1	28.5	6.3	37.5	12.3	20.8	12.4	11.8	15.1	12.5	13.6	16.7	21.3	19.8	11.6	11.0	5.9	9.1	21.2	19.1	14.0	10.8	13.8	14.4	9.4	12.1	5.4	8.4	5.5	8.5	6.2	6.4	9.9	8.2	14.3	10.7	11.8	5.6	4.8	12.0	3.8	17.2	8.2	2.0	16.7	0.1	21.5	18.5	16.3	15.8	22.0	21.2	17.7	10.3	28.3	27.1	0.8	24.2	14.1	15.0	17.0	19.1	10.8	9.8	13.9	11.0	8.7	10.1	11.7	8.5	10.5	9.7
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 215.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol				Cytosol		"HPA018246: AB_1849204, HPA055475: "	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	12.4	13.8	13.0	7.6	16.1	13.7	11.7	14.8	15.0	11.5	14.3	10.5	11.4	7.5	14.7	10.1	13.4	11.7	8.9	36.1	13.7	14.3	10.1	11.3	8.5	9.4	19.4	9.6	16.9	11.4	11.4	17.3	12.7	18.1	13.1	7.4	6.5	10.2	11.8	215.4	7.7	7.9	12.3	23.4	9.1	10.5	39.1	19.4	17.2	16.2	22.7	10.0	15.6	28.8	13.8	14.9	11.4	14.0	11.0	21.8	9.4	37.8	17.6	38.1	29.6	29.3	33.5	17.2	30.1	30.8	33.9	33.6	25.9	19.1	19.3	49.9	20.7	18.3	30.7	18.5	47.5	25.5	20.7	19.7	23.3	29.5	31.3	12.2	16.3	35.3	21.2	17.1	41.0	34.1	15.7	23.5	42.6	13.7	23.2	20.5	43.0	19.4	16.1	48.7	20.6	26.1	11.9	16.1	20.6	26.1	30.4	38.9	42.2	23.5	27.2	25.6	28.6	16.0	59.2	22.0	27.5	23.0	26.7	17.6	32.5	8.9	12.9	10.0	12.9	14.0	13.6	13.8	13.8	11.7	14.9	9.5	17.6	14.4	11.4	11.0	10.2	10.5	21.8	9.4	13.0	16.1	14.8	15.0	13.7	14.3	19.4	9.6	18.1	19.4
FXR2	FMR1L2	ENSG00000129245	"FMR1 autosomal homolog 2"	P51116	17	7591230-7614871	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 55.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011205, HPA022997"	Supported		Supported	Cytosol				Cytosol		"CAB011205: AB_476964, HPA022997: AB_1849208"	"unprognostic (9.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.49e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.67e-2)"	10.4	13.6	15.9	7.4	22.5	5.8	7.5	21.2	25.2	9.6	9.5	14.5	11.2	9.2	9.7	8.3	11.1	9.0	7.4	31.9	16.1	18.1	11.1	9.6	10.5	8.5	18.8	18.5	10.2	11.2	19.2	13.9	10.6	22.4	11.8	8.0	13.5	10.9	13.2	55.0	9.1	8.5	11.7	15.1	8.4	7.8	13.5	18.2	8.3	9.4	9.5	9.8	8.9	8.3	2.4	3.1	6.0	2.2	2.1	4.6	1.9	15.3	20.4	18.9	19.7	16.2	11.1	14.6	23.1	19.3	33.5	23.3	11.3	5.0	14.4	15.4	15.6	16.9	24.8	10.5	22.5	16.1	26.7	8.1	17.8	6.5	15.8	0.1	17.4	10.4	15.5	25.4	24.7	11.6	14.4	4.9	16.5	7.7	11.1	7.9	11.3	11.0	16.1	11.4	8.7	12.3	5.4	11.3	21.0	15.7	10.5	15.7	10.8	6.0	10.7	15.7	10.0	10.3	27.3	8.3	7.4	6.4	18.0	6.6	20.6	6.0	2.0	5.8	2.4	2.2	3.2	1.1	3.8	4.6	3.1	2.4	3.1	3.3	5.1	2.1	1.4	2.1	3.8	1.9	15.9	22.5	21.2	25.2	16.1	18.1	18.8	18.5	22.4	18.2
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138808-35143109	"Predicted membrane proteins"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 30.3;ASC TERT1: 8.8;HSkMC: 12.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.7"	"Group enriched"	"Detected in many"	5	"B-cells: 11.7;T-cells: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	28.2	8.1	35.7	5.2	40.7	2.0	21.8	16.8	34.7	46.5	16.9	25.5	7.1	5.0	26.3	17.9	18.8	31.1	14.8	134.1	23.8	19.9	4.5	137.1	14.1	3.0	36.1	23.7	34.0	6.2	2.1	4.3	8.6	21.5	21.6	7.9	14.1	6.4	20.7	299.8	5.8	7.5	27.7	19.0	6.2	8.4	7.5	14.8	0.0	3.9	29.0	3.5	12.7	23.7	11.7	0.7	1.2	0.7	2.0	7.1	0.7	0.7	0.0	0.0	0.1	30.3	8.8	0.8	3.6	0.1	0.0	0.0	0.0	0.2	2.4	0.9	0.0	0.6	0.7	0.4	0.0	2.1	0.8	0.4	0.0	1.1	3.5	0.2	0.2	12.5	0.0	0.1	0.3	0.1	0.6	2.5	0.1	0.0	0.0	0.5	0.1	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.1	0.4	0.1	1.0	0.1	3.9	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.6	0.4	5.0	1.2	0.3	0.0	1.4	0.7	0.9	11.7	4.1	1.7	0.3	6.6	0.8	1.0	0.6	2.0	0.7	0.7	7.1	0.7	35.7	40.7	16.8	34.7	23.8	19.9	36.1	23.7	21.5	14.8
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 142.8"	"Cell line enhanced"	"Detected in some"		"AF22: 37.1;HAP1: 24.5;RH-30: 15.4;SCLC-21H: 56.2;SH-SY5Y: 32.1"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"classical monocyte: 21.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: "	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favourable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favourable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.60e-4)"	12.9	38.7	41.2	9.5	46.2	3.1	8.1	49.1	142.8	24.3	52.0	30.2	9.2	7.6	54.8	19.0	9.8	26.7	29.0	25.6	35.4	51.6	12.3	10.4	21.5	8.5	18.4	59.5	82.8	9.5	3.5	28.5	5.6	20.2	35.6	11.7	11.9	9.8	22.9	11.0	3.9	16.3	58.5	12.8	42.8	17.6	23.2	18.5	2.9	15.9	6.4	5.9	38.1	13.9	0.0	3.6	0.5	21.9	0.0	0.3	5.1	0.0	0.2	37.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	24.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	1.6	0.1	7.4	0.0	0.0	15.4	0.2	0.9	0.0	56.2	32.1	0.0	0.1	1.2	0.6	0.6	0.0	0.0	9.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	21.9	0.0	0.0	5.3	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	5.1	41.2	46.2	49.1	78.8	35.4	51.6	18.4	59.5	20.2	18.5
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"NK-cells: 15.3;T-cells: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"			2000000	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: "	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favourable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	29.1	7.2	49.2	29.0	38.4	16.3	18.1	33.9	62.1	25.7	12.1	33.7	4.1	10.1	21.8	21.4	10.2	32.0	19.4	21.2	39.4	34.0	9.5	12.2	25.2	57.2	35.7	23.1	18.6	4.4	15.0	12.5	17.7	25.6	9.6	10.0	11.0	6.4	8.4	7.0	16.5	19.0	24.2	30.9	39.8	15.4	10.1	31.3	34.8	27.5	5.6	38.5	22.6	19.3	1.6	1.7	0.7	1.5	15.3	43.2	10.7	1.9	0.2	34.2	5.7	26.2	16.1	0.6	5.4	17.1	4.6	8.3	0.2	0.3	3.8	3.5	10.4	0.2	4.8	7.5	9.1	0.1	12.6	10.5	2.5	0.5	15.5	3.5	3.6	15.4	11.3	17.4	14.9	18.8	0.8	26.8	16.4	0.2	16.7	3.2	4.9	3.4	5.3	4.6	0.2	0.0	1.7	24.0	9.7	1.0	0.4	22.8	0.2	10.6	11.9	14.0	2.6	103.1	3.4	3.8	3.5	5.9	26.4	8.2	24.3	0.2	1.5	0.0	34.1	1.2	43.2	1.1	21.2	37.5	1.7	1.6	7.0	18.7	0.7	15.3	0.9	1.0	17.6	10.7	49.2	38.4	33.9	35.3	39.4	34.0	35.7	23.1	25.6	31.3
G2E3	"FLJ20333, KIAA1333, PHF7B"	ENSG00000092140	"G2/M-phase specific E3 ubiquitin protein ligase"	Q7L622	14	30559123-30620063	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001601	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"				Cytosol	"Golgi apparatus, Vesicles"	"HPA001601: AB_1079198"	"unprognostic (4.75e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.44e-6)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	7.6	5.1	5.6	7.6	14.2	8.5	6.6	10.8	10.4	8.1	5.8	5.8	4.2	5.9	8.5	4.8	7.0	5.4	4.5	4.9	6.7	5.2	5.4	5.5	5.4	8.6	7.3	4.9	7.1	5.7	6.0	10.9	6.9	7.6	6.0	6.1	5.3	5.9	7.1	5.2	6.1	5.8	6.7	7.1	7.9	5.4	39.6	8.8	20.9	7.3	4.8	9.5	6.0	8.3	11.5	8.1	16.5	12.5	7.9	12.4	5.0	20.8	9.5	21.3	9.8	6.9	8.5	18.0	19.6	7.1	11.9	13.4	9.2	12.7	17.5	6.3	10.7	17.6	20.4	11.2	24.2	14.4	8.3	9.6	10.4	16.9	6.2	18.5	12.2	5.3	4.5	9.5	21.7	14.0	11.8	14.6	16.6	12.1	12.4	4.6	17.8	16.7	11.4	0.0	4.8	7.0	13.0	18.1	12.2	15.8	10.7	4.5	12.2	6.3	10.4	12.7	13.6	9.3	12.8	8.4	24.6	21.0	3.8	9.3	18.8	16.5	7.5	14.1	9.6	9.7	12.4	10.8	9.4	7.7	6.4	11.5	12.0	10.1	6.8	7.9	12.5	8.1	7.3	5.0	5.6	14.2	10.8	10.4	6.7	5.2	7.3	4.9	7.6	8.8
G3BP1	"G3BP, HDH-VIII"	ENSG00000145907	"G3BP stress granule assembly factor 1"	Q13283	5	151771045-151812785	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, Transport"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004052, CAB037068"	Supported		Supported	Cytosol			150000	Cytosol		"CAB037068: AB_1840864, HPA004052: AB_1849348"	"unprognostic (1.31e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (3.33e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.88e-2)"	36.7	27.5	21.1	29.1	23.7	12.2	29.7	24.3	21.4	28.5	23.4	27.7	19.6	18.1	29.9	19.3	40.7	26.5	20.7	24.8	21.7	21.2	30.7	44.1	25.9	36.8	31.8	16.7	38.2	30.6	29.9	29.9	27.9	24.9	24.5	27.2	22.6	24.1	19.7	66.4	25.3	22.8	27.0	27.4	28.9	20.6	27.4	25.8	57.1	28.9	37.0	42.3	27.7	34.8	25.6	19.9	19.5	19.1	29.4	40.0	32.1	37.4	29.3	36.1	15.8	46.0	24.9	41.7	37.2	33.8	48.0	57.0	53.8	48.6	69.9	54.7	34.5	35.6	54.5	72.2	63.0	19.3	26.2	43.2	27.1	36.0	26.2	54.1	28.6	24.9	39.4	41.7	41.4	39.5	33.8	34.5	47.0	20.1	45.6	24.0	40.3	30.0	41.8	45.6	33.3	31.5	37.2	34.1	24.7	35.2	51.3	53.8	41.0	30.1	43.1	34.7	40.4	32.8	67.5	21.5	29.6	55.0	26.1	41.6	62.6	19.5	13.9	13.0	25.7	19.1	40.0	25.6	34.4	28.7	18.0	21.9	33.0	32.9	6.1	29.4	16.8	19.9	34.0	32.1	21.1	23.7	24.3	21.4	21.7	21.2	31.8	16.7	24.9	25.8
G3BP2	KIAA0660	ENSG00000138757	"G3BP stress granule assembly factor 2"	Q9UN86	4	75642782-75724525	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018304, HPA018425"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA018304: AB_1849350, HPA018425: AB_1849352"	"unprognostic (2.42e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.88e-2)"	"prognostic favourable (6.65e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.99e-2)"	22.7	24.7	28.2	21.9	48.4	31.6	23.9	52.2	55.6	24.3	28.6	21.5	18.7	24.5	25.1	18.7	24.5	26.9	23.3	23.0	29.3	46.3	32.3	33.7	21.3	24.8	31.3	30.0	20.4	18.8	31.0	27.6	17.7	57.9	37.7	27.3	16.3	22.0	24.2	69.7	15.3	27.8	25.9	35.2	22.9	22.0	27.4	19.6	29.9	35.4	28.1	26.6	26.9	17.9	18.8	20.4	32.5	28.2	31.9	41.4	24.7	27.3	28.4	46.4	38.2	40.0	40.9	15.4	42.1	40.3	27.0	28.7	36.7	38.3	52.5	37.7	33.5	18.5	47.8	49.0	39.5	31.1	19.7	54.5	28.4	41.3	35.3	49.9	40.6	32.3	42.1	32.7	33.9	48.6	39.9	40.0	42.9	17.6	58.0	18.0	48.6	13.2	44.0	57.2	27.4	31.9	33.6	38.1	40.9	30.9	44.5	54.5	21.4	25.2	49.2	27.5	22.3	30.7	23.4	39.0	37.2	53.9	39.3	34.3	35.5	32.5	17.0	30.7	26.8	23.1	41.4	18.8	26.1	28.8	20.4	14.6	26.3	28.4	16.6	31.9	28.2	9.9	22.1	24.7	28.2	48.4	52.2	55.6	29.3	46.3	31.3	30.0	57.9	19.6
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.1"	"Cell line enhanced"	"Detected in all"		"A549: 225.5;MCF7: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 77.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 77.3"					"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"			12000000	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	21.9	29.4	10.4	15.6	10.7	51.4	18.2	8.4	14.7	12.2	7.5	13.6	4.8	7.2	14.0	13.2	29.0	11.0	24.7	10.1	8.8	10.1	15.4	3.7	20.8	31.0	10.3	8.0	19.8	7.9	5.9	20.7	9.2	10.9	11.3	7.3	17.8	13.9	8.6	4.4	11.3	7.3	17.5	11.1	20.3	9.9	83.1	9.5	22.5	24.6	44.8	25.7	24.1	19.0	3.6	7.6	77.3	16.2	12.7	10.3	11.8	15.4	225.5	4.6	17.8	19.5	26.7	4.1	10.8	31.0	11.0	19.1	10.3	5.8	10.0	16.8	24.7	13.8	7.2	18.3	5.7	10.2	5.0	10.6	51.0	23.2	38.2	10.6	36.4	12.9	5.4	21.6	4.6	22.9	6.3	4.4	19.9	85.5	6.8	7.6	3.3	16.7	6.7	2.6	10.9	33.2	19.3	4.7	5.9	10.8	42.1	9.0	6.3	8.9	27.2	7.0	24.7	9.7	16.6	5.3	6.9	17.1	19.4	7.0	14.3	29.3	16.2	77.3	10.3	13.6	6.6	3.4	2.7	7.4	7.6	3.6	3.5	5.9	27.1	12.7	11.1	3.5	3.5	11.8	10.4	10.7	8.4	14.7	8.8	10.1	10.3	8.0	10.9	9.5
GAB1		ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.0"	"Cell line enhanced"	"Detected in many"		"REH: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favourable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	9.2	8.4	15.0	7.3	33.3	8.8	9.7	5.8	22.0	10.1	17.0	64.0	10.2	10.4	17.7	13.1	18.2	8.6	11.1	26.2	19.5	11.4	12.9	7.9	15.6	5.0	35.7	19.0	18.1	7.0	17.2	6.3	18.0	30.5	7.8	20.3	15.4	11.7	13.9	11.2	11.1	10.4	15.9	32.3	6.2	11.0	7.9	41.7	1.0	7.8	6.0	7.3	9.9	11.9	3.1	3.4	5.9	2.3	7.4	0.4	0.4	3.3	0.7	8.7	6.3	4.4	4.3	11.4	2.3	7.8	2.8	5.0	6.5	5.7	0.1	0.7	3.3	1.9	8.3	2.7	3.2	0.4	2.0	6.1	1.9	3.0	3.0	0.8	1.2	5.2	4.9	3.4	2.3	3.7	2.0	11.2	1.9	4.9	0.5	0.0	2.5	2.7	37.3	4.3	4.3	4.4	4.1	2.0	6.2	1.6	6.8	2.9	4.4	0.8	2.8	3.6	2.9	1.7	1.7	18.1	8.8	13.4	2.4	2.4	2.9	5.9	0.6	0.7	0.0	0.8	0.4	1.3	0.1	0.0	0.8	3.1	0.0	0.0	4.0	7.4	2.3	3.4	0.0	0.4	15.0	33.3	5.8	22.0	19.5	11.4	35.7	19.0	30.5	41.7
GABARAPL2	"ATG8, ATG8C, GATE-16, GATE16, GEF2"	ENSG00000034713	"GABA type A receptor associated protein like 2"	P60520	16	75566351-75577881	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036726	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA036726: AB_10672476"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.58e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.33e-2)"	"prognostic favourable (5.95e-8)"	"unprognostic (3.11e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.85e-1)"	29.6	47.4	69.0	18.0	70.5	24.7	33.8	52.3	61.4	29.4	23.9	54.2	26.0	18.7	25.7	47.1	21.7	30.9	23.7	76.6	59.6	69.5	42.0	31.4	25.4	23.4	73.4	52.5	28.9	25.8	46.2	33.6	31.8	52.4	33.4	23.6	30.8	27.3	31.0	52.7	24.3	19.4	28.2	72.0	25.7	21.8	20.2	45.4	17.5	35.7	22.4	26.8	22.6	19.3	38.2	47.0	87.8	25.4	18.9	35.1	35.9	23.4	19.9	34.1	16.1	53.1	46.8	17.3	27.6	40.0	37.8	42.6	18.3	30.4	33.9	34.1	31.4	20.2	25.3	25.9	46.9	14.6	48.3	20.0	18.4	27.1	28.9	19.1	36.1	32.3	36.7	31.9	23.8	30.7	29.2	13.9	37.8	33.2	28.2	36.6	20.4	22.4	31.8	16.5	40.8	39.6	15.4	40.2	42.1	43.1	10.4	39.7	33.3	30.2	28.0	16.5	25.1	23.9	14.8	39.6	37.5	70.9	39.6	18.6	24.2	47.8	25.3	61.1	23.9	23.4	30.6	38.2	25.6	27.3	30.4	32.1	23.3	21.8	87.8	18.9	25.4	47.0	35.1	35.9	69.0	70.5	52.3	61.4	59.6	69.5	73.4	52.5	52.4	45.4
GABPB2	MGC29891	ENSG00000143458	"GA binding protein transcription factor beta subunit 2"	Q8TAK5	1	151070578-151125542	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028471, HPA058483"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA028471: AB_10602319, HPA058483: "	"unprognostic (1.21e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.76e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.65e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.98e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-3)"	9.9	8.3	9.5	9.3	13.3	12.2	10.9	12.3	12.2	10.0	8.5	14.8	10.7	7.0	10.1	8.0	8.7	10.2	10.7	11.0	11.6	5.8	7.9	6.4	7.7	9.9	14.4	9.7	17.6	7.8	15.1	12.8	6.5	11.4	9.4	9.8	11.0	7.6	12.6	10.0	13.9	8.1	12.0	10.2	10.1	9.8	20.2	15.2	15.7	10.0	11.6	9.8	9.9	16.6	4.7	5.0	4.7	5.1	2.6	4.8	2.6	6.8	2.4	1.7	2.1	6.0	8.9	2.2	6.3	3.9	3.7	2.6	0.7	5.1	7.1	2.4	6.0	6.0	3.6	3.2	5.4	2.6	1.4	1.9	3.7	0.1	4.0	7.7	4.0	4.8	3.8	5.1	7.5	1.3	4.7	5.0	4.4	9.7	10.6	1.4	0.8	2.7	3.2	2.8	3.3	3.1	1.9	3.0	1.2	8.0	2.8	2.4	7.1	8.5	4.0	0.9	3.2	6.5	5.1	2.7	1.3	26.0	3.0	5.9	4.3	3.6	2.8	1.6	4.4	3.3	2.7	3.1	4.8	3.9	2.5	4.7	4.3	4.7	4.7	2.6	5.1	5.0	1.7	2.6	9.5	13.3	12.3	12.2	11.6	5.8	14.4	9.7	11.4	15.2
GADD45B	"DKFZP566B133, GADD45BETA, MYD118"	ENSG00000099860	"Growth arrest and DNA damage inducible beta"	O75293	19	2476122-2478259	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029816	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029816: AB_10601325"	"unprognostic (1.32e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.90e-2)"	"unprognostic (8.27e-3)"	"unprognostic (6.00e-2)"	50.5	37.3	10.3	24.6	33.8	142.2	34.2	6.7	26.4	20.0	29.2	17.9	4.1	9.7	14.2	10.7	17.6	34.3	44.6	59.0	22.5	15.6	26.2	143.6	49.8	14.7	17.1	3.9	36.3	45.5	16.7	27.5	22.6	32.4	27.2	6.6	26.6	28.1	36.9	38.4	22.1	12.3	14.5	32.8	14.7	27.1	12.4	13.1	6.7	53.9	29.5	13.7	35.0	15.0	12.2	13.5	45.1	14.9	14.9	22.6	10.1	21.2	4.2	0.5	2.8	16.2	12.5	1.3	21.7	6.3	17.1	8.9	5.9	8.2	10.1	14.7	10.7	11.8	1.1	7.2	4.2	7.7	3.9	1.1	4.7	2.2	27.4	2.3	7.1	20.2	4.7	5.1	25.5	6.8	0.5	27.6	17.6	6.8	2.6	11.3	2.6	9.2	9.8	7.9	15.9	7.7	3.8	0.2	0.2	24.2	18.2	7.0	9.6	17.0	27.6	17.1	15.8	12.2	27.0	12.4	9.2	4.1	4.1	6.9	5.5	11.7	11.8	45.1	22.6	14.9	20.4	7.4	15.8	17.3	11.9	12.2	14.1	18.5	34.5	14.9	11.6	13.5	19.1	10.1	10.3	33.8	6.7	26.4	22.5	15.6	17.1	3.9	32.4	13.1
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 21.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.5	0.3	0.2	0.2	0.3	1.0	0.4	0.5	0.7	0.4	0.2	0.0	0.0	0.1	0.2	1.6	1.4	0.2	2.0	2.3	0.2	0.3	0.7	0.2	1.6	0.3	0.3	0.8	0.5	0.3	0.1	0.6	0.5	2.1	0.5	0.1	0.3	0.3	0.0	21.6	0.8	0.2	2.5	0.7	0.5	0.2	1.1	0.0	0.0	1.2	3.3	0.7	0.5	0.3	1.7	0.5	1.9	0.8	0.5	1.3	0.3	1.3	0.3	0.8	1.1	0.9	0.5	1.5	0.6	0.3	0.3	0.2	1.3	1.2	1.1	0.5	0.2	0.9	9.7	0.3	0.4	1.7	0.5	1.6	1.5	0.5	0.4	0.9	3.3	0.4	0.5	0.7	0.3	0.6	1.2	4.0	0.9	1.1	0.6	1.3	1.8	0.5	1.9	2.1	1.0	1.0	1.5	1.1	0.9	1.1	0.7	2.9	1.1	0.8	5.0	1.5	1.4	1.9	0.7	1.6	0.8	0.7	0.6	0.9	1.9	1.9	0.7	0.8	1.0	0.6	0.8	1.2	0.9	0.6	0.4	1.7	1.1	1.0	1.7	0.5	0.8	0.5	1.3	0.3	0.2	0.3	0.5	0.7	0.2	0.3	0.3	0.8	2.1	0.0
GAGE1	CT4.1	ENSG00000205777	"G antigen 1"	Q13068	X	49589496-49608536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	37	"testis: 36.8"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 243.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8			0.0		0.0	0.0	0.0	0.6	1.0	0.7	0.8	0.1	0.7	0.0	0.0	0.0	0.0	243.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	56.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.1	0.3	0.3	0.7	0.0	0.2	0.3	0.3	0.0	0.0	0.6	0.1	0.3	0.7	0.1	0.8	1.0	0.1	0.0										
GAGE10		ENSG00000215274	"G antigen 10"	A6NGK3	X	49303669-49319844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ovary: 3.9;pituitary gland: 3.1;testis: 2.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.0;BJ hTERT+: 1.4;T-47d: 1.3;WM-115: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "					"unprognostic (2.81e-2)"					"unprognostic (2.26e-1)"						"unprognostic (3.97e-1)"		0.0	0.0	0.6	0.0	1.8	0.1	0.8	0.5	0.3	0.0	0.2			0.0	0.5	2.0	0.0	1.7	0.1	0.5	0.5	0.5	0.0	0.0	0.0	0.6	0.4		3.9	0.0	0.0	3.1	0.0		0.4	0.3		0.2	1.1	0.2	0.0	0.0	1.4	0.2	0.3	0.0	2.9			0.8		0.2	0.0	0.1	0.0	0.7	0.0	0.5	0.1	0.5	0.3	0.0	0.0	0.6	7.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.0	0.1	0.5	0.7	0.3	0.3										
GAGE12C		ENSG00000237671	"G antigen 12C"	A1L429	X	49532211-49539538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 23.7"	"Group enriched"	"Detected in some"	11	"U-2 OS: 7.6;U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	7.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
GAGE12D		ENSG00000227488	"G antigen 12D"	A1L429	X	49541767-49549094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	57	"testis: 23.7"	"Group enriched"	"Detected in some"	11	"U-2 OS: 7.6;U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	7.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
GAGE12E		ENSG00000216649	"G antigen 12E"	A1L429	X	49551333-49558649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	18	"testis: 9.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.3;HeLa: 4.0;Karpas-707: 1.9;T-47d: 1.7;U-266/84: 4.3;WM-115: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.5	0.8	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.5	0.3	0.0	0.0	0.7	4.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0										
GAGE12F		ENSG00000236362	"G antigen 12F"	"P0CL80, P0CL82, O76087"	X	49551278-49568218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"blood: 16.2;testis: 58.6"	"Group enriched"	"Detected in some"	4	"AN3-CA: 133.5;K-562: 130.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	58.6			0.0		0.0	0.0	0.0	7.0	8.5	3.1	9.1	9.6	14.7	16.2	1.1	0.0	0.0	133.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	130.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.5	6.7	0.8	0.0	0.1	0.0	7.7	0.0	0.0	0.0	16.7	0.9	9.1	3.1	3.9	7.5	2.5	7.0	10.3	7.2	0.0	6.2	8.5	7.5	0.9	9.6	6.3	8.5	14.7	16.2										
GAGE12G		ENSG00000215269	"G antigen 12G"	"P0CL81, O76087, P0CL82"	X	49570434-49577754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	33	"blood: 7.4;stomach 1: 14.0"	"Cell line enriched"	"Detected in some"	7	"AN3-CA: 145.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 7.4"	"Low lineage specificity"	"Detected in many"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0			0.0		0.0	0.0	0.0	2.6	1.4	1.3	2.5	0.4	7.4	6.2	0.0	0.0	0.0	145.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.4	2.5	1.3	0.8	2.2	1.3	1.5	3.6	0.5	0.0	2.6	0.6	3.2	0.0	0.4	1.8	1.4	7.4	6.2										
GAGE12H		ENSG00000224902	"G antigen 12H"	A6NDE8	X	49579983-49587301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	223	"testis: 22.3"	"Group enriched"	"Detected in some"	52	"A-431: 19.2;U-266/84: 56.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GAGE12J	GAGE11	ENSG00000224659	"G antigen 12J"	A6NER3	X	49322057-49329384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 20.2"	"Group enriched"	"Detected in some"	5	"AN3-CA: 47.2;K-562: 47.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.2			0.0		0.0	0.0	0.0	0.8	0.6	0.4	0.7	0.8	1.6	0.0	0.0	0.0	0.0	47.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	9.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.2	0.4	0.8	0.7	0.9	0.0	0.7	1.6	0.4	0.4	0.8	0.5	0.6	1.4	0.0										
GAGE13	GAGE12A	ENSG00000274274	"G antigen 13"		X	49331616-49338952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	17	"testis: 26.8"	"Cell line enriched"	"Detected in some"	6	"AN3-CA: 126.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	26.8			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	126.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	4.6	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6										
GAGE2A	"CT4.2, GAGE2"	ENSG00000189064	"G antigen 2A"	Q6NT46	X	49589529-49596827	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	34	"testis: 46.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 19.2;T-47d: 66.1;WM-115: 72.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "															"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7			0.0		0.0	0.0	0.0	1.0	0.7	0.4	0.7	0.5	0.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	66.1	0.0	0.0	10.7	2.3	0.0	0.0	0.2	2.8	0.0	0.6	0.0	72.7	0.4	0.6	0.1	0.1	0.7	0.0	1.0	0.5	0.6	0.0	0.4	0.5	0.2	0.0	0.5	0.6	0.7	0.6	1.3										
GAGE2E	GAGE8	ENSG00000275113	"G antigen 2E"		X	49341192-49345922	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	52	"blood: 5.8;stomach 1: 18.4;testis: 4.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 141.3;K-562: 67.6;T-47d: 34.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"											HPA043232	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0		0.0	18.4	4.9			0.0		0.0	0.0		2.5	2.6	0.7	1.2	0.7	5.8	0.2	0.0	0.0	0.0	141.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	67.6	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	34.2	0.0	0.4	8.7	0.3	0.0	0.0	0.1	2.6	0.0	0.1	0.0	14.8	0.7	1.2	0.3	1.0	0.0	0.0	1.5	0.4	2.2	0.0	2.5	4.9	0.0	0.7	0.7	0.0	2.6	5.8	0.2										
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168750	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.5;HSkMC: 8.6;WM-115: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 4.3;T-cells: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: "	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	3.9	5.4	8.4	4.2	9.4	1.0	4.1	1.5	10.9	7.8	6.5	18.6	0.4	4.1	9.0	3.7	8.4	6.3	5.9	4.9	8.0	3.8	1.8	1.0	5.3	2.9	11.9	4.7	7.6	1.5	1.6	4.6	9.8	8.1	6.5	7.0	4.2	24.9	4.3	1.9	27.8	8.9	10.6	14.9	2.7	2.8	4.4	10.2	37.8	2.0	2.4	3.9	7.3	10.6	0.1	4.3	0.3	0.1	0.2	15.0	2.2	0.0	0.6	4.0	1.8	3.6	7.0	7.5	2.1	2.2	1.3	1.7	0.4	0.2	0.7	0.5	7.3	8.5	0.2	1.2	0.4	0.0	0.4	0.2	0.1	0.2	2.4	0.4	2.4	8.6	3.3	3.9	0.4	2.5	1.1	0.1	2.3	0.2	2.7	0.1	1.3	0.9	2.1	1.8	0.1	0.0	0.3	0.2	1.7	0.6	0.0	4.5	0.0	0.2	2.2	0.2	1.2	0.3	0.1	0.1	0.1	1.6	1.4	0.4	29.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	4.4	0.3	0.0	0.1	15.0	4.5	0.3	0.2	0.1	4.3	1.1	2.2	8.4	9.4	1.5	10.9	8.0	3.8	11.9	4.7	8.1	10.2
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.2	19.5	7.8	12.4	2.9	4.1	7.6	11.1	15.0	19.7	14.7	17.8	54.5	3.8	15.6	6.5	18.0	6.9	28.4	15.0	8.2	4.5	10.9	9.9	19.3	29.8	4.7	3.2	8.8	15.0	18.1	45.5	16.9	12.1	1.0	14.0	17.3	7.7	5.0	2.2	19.0	9.2	7.6	4.9	31.9	10.9	3.0	6.9	20.1	18.3	19.7	13.4	3.9	9.2	14.4	21.4	14.8	13.6	5.0	12.1	5.0	15.2	20.0	7.7	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765711	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"			8600	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (1.62e-5)"	6.4	3.3	3.8	6.2	4.4	3.6	14.2	4.6	5.1	4.7	9.3	3.7	3.5	15.9	4.7	5.0	9.0	4.8	3.8	7.2	3.6	3.6	12.3	31.6	4.7	11.7	4.3	3.8	5.2	16.0	1.9	2.6	4.6	3.2	4.7	1.3	3.6	14.9	4.7	5.4	6.2	17.3	3.7	4.0	7.2	5.3	5.7	3.3	7.6	3.3	5.1	4.8	3.6	5.0	10.6	36.7	20.7	30.2	5.7	9.4	14.6	8.0	30.3	1.8	8.5	2.7	6.8	7.1	6.5	5.4	6.7	6.3	16.8	1.6	12.5	8.2	3.4	4.7	2.0	1.9	0.7	5.4	19.0	7.8	11.5	28.1	9.2	5.2	17.3	6.0	2.6	3.3	1.4	15.6	6.2	7.7	4.1	34.4	14.4	19.7	2.1	15.7	17.3	21.1	20.8	3.7	3.3	4.1	11.4	5.6	14.4	14.2	11.7	8.6	13.7	10.0	9.6	9.5	5.7	19.5	4.8	3.2	11.2	12.2	7.7	2.6	30.2	8.3	9.4	25.5	8.5	10.6	7.8	8.6	27.2	6.8	4.2	6.2	20.7	5.7	20.2	36.7	8.7	14.6	3.8	4.4	4.6	5.1	3.6	3.6	4.3	3.8	3.2	3.3
GALK2	GK2	ENSG00000156958	"Galactokinase 2"	Q01415	15	49155656-49367869	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043564, HPA048267"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043564: AB_2678557, HPA048267: "	"unprognostic (2.27e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"prognostic favourable (7.31e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (1.88e-5)"	"unprognostic (2.33e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.93e-1)"	12.7	24.9	10.2	9.2	15.3	6.5	12.4	15.7	15.3	14.7	16.3	15.3	25.6	21.5	16.0	9.9	11.5	13.5	9.9	14.2	11.3	10.3	32.3	28.4	12.7	8.0	16.2	9.4	11.5	18.5	19.4	34.2	10.8	15.3	11.1	17.9	13.2	12.2	16.3	12.5	11.6	17.9	11.8	13.9	12.8	13.9	9.2	14.8	14.6	16.7	10.9	11.5	10.3	11.6	9.6	10.4	24.2	11.3	12.8	23.1	8.7	6.2	7.3	3.4	4.5	8.7	13.6	9.9	6.5	8.7	6.5	7.7	9.3	6.6	2.0	5.2	6.8	9.1	13.4	9.3	9.2	11.2	3.9	11.7	7.0	7.8	9.5	8.0	3.7	7.0	17.1	6.9	17.3	13.1	11.6	11.4	7.0	6.7	5.8	6.4	1.4	7.0	7.1	4.1	30.3	12.0	5.9	4.1	2.7	7.2	15.0	12.3	7.4	7.8	7.2	6.4	4.4	25.9	6.1	9.4	32.3	3.8	9.9	30.7	8.7	24.2	10.6	18.6	12.8	11.3	13.6	9.6	13.1	12.6	10.4	6.7	10.5	10.7	5.4	12.8	10.8	9.2	23.1	8.7	10.2	15.3	15.7	15.3	11.3	10.3	16.2	9.4	15.3	14.8
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433"	Supported		Approved	Cytosol	"Intracellular and membrane"		2400000	Cytosol		"CAB026404: , HPA042433: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	11.9	14.9	9.3	11.2	11.1	25.0	14.8	12.9	15.4	11.1	15.5	11.5	8.8	13.3	9.0	19.9	10.2	14.8	12.7	12.5	11.2	13.9	13.7	17.8	14.7	10.6	11.8	5.2	11.9	7.3	9.9	13.2	15.6	11.6	10.5	8.3	7.1	10.6	9.0	7.1	10.0	17.2	9.4	9.4	10.4	9.5	27.4	8.8	7.9	14.5	6.1	9.0	11.1	13.0	2.1	7.1	19.3	11.2	2.4	3.1	4.7	2.5	19.3	2.8	19.8	22.3	10.7	19.4	8.1	12.6	8.9	6.9	10.1	16.7	3.2	17.2	13.2	14.9	4.1	6.4	5.4	2.1	6.4	2.0	7.9	5.7	15.0	1.5	13.1	14.9	12.5	9.9	2.8	7.6	4.3	1.9	5.2	14.8	4.0	6.4	6.5	9.0	8.6	2.5	5.3	5.5	5.9	7.3	5.6	19.2	1.8	9.6	12.5	14.2	14.1	19.5	14.9	19.9	4.4	2.0	1.9	5.4	21.1	13.1	11.5	0.9	11.2	19.3	3.1	8.0	2.6	2.1	1.8	2.7	7.1	0.9	1.7	2.1	14.2	2.4	5.6	3.0	3.0	4.7	9.3	11.1	12.9	15.4	11.2	13.9	11.8	5.2	11.6	8.8
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174649-16231992	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 66.7;brain: 52.3"	"Group enriched"	"Detected in some"	5	"ASC diff: 43.8;ASC TERT1: 43.2;HSkMC: 32.9"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.7;pons and medulla: 6.7"	"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"		25000	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	66.7	5.3	7.6	2.6	17.4	1.1	22.8	2.3	31.5	3.9	8.6	28.1	1.1	2.8	3.5	3.3	11.4	5.3	5.2	7.3	14.8	6.6	8.3	2.8	3.1	3.4	38.9	8.4	8.4	3.2	1.6	1.0	35.5	24.8	4.9	3.8	1.3	8.0	4.1	17.3	11.6	5.3	10.5	52.3	12.8	4.6	8.1	19.9	0.0	6.3	1.6	1.5	16.6	23.5	0.6	0.9	0.9	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.0	43.8	43.2	0.0	0.9	0.7	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	32.9	0.0	0.4	0.5	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	7.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.0	0.6	0.4	0.2	0.9	0.3	0.3	0.9	0.3	0.3	7.6	17.4	2.3	13.6	14.8	6.6	38.9	8.4	24.8	19.9
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257598-157314211	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell line enhanced"	"Detected in some"		"A-431: 23.1;BJ: 15.2;BJ hTERT+: 27.2;fHDF/TERT166: 31.7;HaCaT: 27.1;K-562: 15.7;LHCN-M2: 27.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 28.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"			630000	"Nucleoli, Golgi apparatus, Cytosol"	Vesicles	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.4	0.2	0.2	1.5	0.2	0.5	1.1	28.2	0.2	7.5	12.0	0.7	0.0	2.3	0.5	0.5	9.0	0.2	17.1	0.9	0.4	0.2	0.3	0.2	15.5	0.0	0.2	0.0	0.3	1.5	0.0	6.8	0.1	4.4	1.6	16.1	0.3	18.9	0.2	0.2	0.5	8.4	0.8	0.3	0.3	15.2	0.5	0.0	0.1	0.3	12.2	11.7	2.3	6.6	0.2	0.1	0.2	0.1	0.1	0.5	0.0	23.1	2.5	0.0	0.0	1.0	8.1	0.0	15.2	27.2	0.2	0.6	1.0	13.4	0.0	0.0	31.7	27.1	0.4	5.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.5	0.0	15.7	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.1	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.2	28.2	0.2	0.4	0.2	0.2	0.0	4.4	0.0
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol			120000	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favourable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.3	16.1	8.0	13.8	12.5	7.4	6.6	9.3	7.3	8.5	19.4	5.8	12.4	18.1	7.2	8.4	7.7	6.5	10.5	10.9	6.7	8.6	11.8	47.0	6.8	10.8	9.0	6.0	8.7	7.6	12.1	10.3	21.7	7.5	7.2	6.8	11.0	12.5	13.4	9.5	14.4	26.1	5.9	5.0	9.4	8.1	2.6	7.1	11.3	8.5	7.2	10.6	7.0	6.5	16.3	15.9	10.9	17.5	20.5	21.1	13.1	4.9	6.6	6.0	2.4	8.3	8.3	7.0	3.7	10.6	3.9	4.4	8.2	4.6	5.6	3.8	4.4	2.7	1.1	10.3	0.7	8.3	4.5	2.3	13.2	8.3	8.1	1.3	2.9	12.1	6.6	2.5	3.1	9.3	1.9	6.1	6.2	4.3	4.7	9.4	2.1	1.2	7.3	5.5	2.9	10.7	6.9	1.4	5.3	4.7	9.3	5.0	8.3	7.2	1.4	1.7	3.2	3.3	0.0	3.5	2.0	1.1	4.0	3.9	9.8	10.9	17.5	8.3	12.1	15.0	16.7	16.3	19.8	16.3	15.9	9.3	12.2	12.0	3.3	20.5	14.1	13.3	21.1	13.1	8.0	12.5	9.3	7.3	6.7	8.6	9.0	6.0	7.5	7.1
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"			2200000000	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavourable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	196.0	345.9	99.8	155.5	97.4	160.6	217.5	149.0	212.2	218.1	227.7	244.1	134.6	229.2	29.5	175.6	111.7	92.7	345.6	151.4	201.0	100.7	126.8	217.1	207.3	131.3	204.9	102.1	134.3	112.9	214.3	242.1	240.0	68.1	48.3	247.7	391.1	233.5	107.9	368.8	115.3	189.9	177.7	109.1	248.1	239.9	70.7	113.5	131.5	343.1	197.9	53.6	144.8	149.7	170.2	205.7	87.8	257.4	109.8	79.8	295.4	360.8	129.9	266.3	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9
GAPVD1	"DKFZP434C212, KIAA1521"	ENSG00000165219	"GTPase activating protein and VPS9 domains 1"	Q14C86	9	125261794-125367207	"Predicted intracellular proteins"	Endocytosis	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029386, HPA029387"	Uncertain		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA029386: AB_10599604, HPA029387: AB_10600311"	"unprognostic (8.43e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.82e-2)"	17.6	16.2	16.0	14.9	18.6	26.6	16.9	25.7	21.3	17.5	16.1	20.9	18.0	10.8	19.1	14.0	24.3	16.0	13.7	15.4	15.5	14.1	17.6	14.5	20.5	15.1	21.1	15.6	18.9	14.1	30.3	20.2	23.3	20.1	14.7	13.2	16.4	15.9	17.2	31.6	23.5	14.6	17.4	15.3	17.3	14.6	32.1	20.2	18.6	24.8	12.2	19.9	16.2	17.7	10.4	14.8	19.2	17.8	13.6	14.8	10.0	11.5	12.0	11.4	10.6	13.8	15.1	16.6	12.9	14.8	15.0	12.6	19.1	8.3	15.4	7.0	16.2	23.5	23.6	13.5	16.0	14.1	14.1	17.5	29.5	9.4	16.3	20.8	29.6	10.8	13.2	17.8	14.4	17.8	33.9	8.5	12.5	16.9	15.5	9.1	11.5	13.7	13.6	24.9	14.9	8.6	11.9	15.2	10.2	18.8	17.4	10.3	21.4	10.8	18.6	10.6	7.8	18.9	13.8	11.0	20.7	15.8	13.0	11.8	13.6	18.6	15.0	18.0	13.7	15.6	13.4	10.2	14.2	14.8	14.8	10.4	14.2	14.7	19.2	13.6	17.8	5.6	10.9	10.0	16.0	18.6	25.7	21.3	15.5	14.1	21.1	15.6	20.1	20.2
GAREM1	"C18orf11, FAM59A, FLJ21610, GAREM"	ENSG00000141441	"GRB2 associated regulator of MAPK1 subtype 1"	Q9H706	18	32124877-32470484	"Predicted intracellular proteins"		Mitogen		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 12.0;hTERT-HME1: 20.8;RT4: 17.7;SH-SY5Y: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040709, HPA042046"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA040709: , HPA042046: "	"unprognostic (9.52e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (6.73e-5)"	"unprognostic (1.45e-1)"	"prognostic favourable (5.49e-6)"	"unprognostic (2.36e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	11.1	8.7	9.7	2.9	10.9	8.0	6.0	17.6	11.1	6.0	7.2	19.5	0.3	6.5	4.2	3.4	11.0	4.8	4.9	8.9	11.8	5.8	15.3	12.5	5.2	1.3	16.3	10.1	4.4	43.5	1.9	5.1	4.8	13.2	4.3	6.3	3.0	11.2	5.1	7.7	13.9	7.8	4.6	12.9	3.1	12.7	6.7	16.4	0.0	3.5	3.1	2.9	9.3	9.1	1.9	5.0	2.6	1.0	3.1	1.4	0.0	1.0	1.5	1.7	0.3	4.6	3.2	4.7	0.3	0.0	0.0	0.0	0.3	2.6	3.0	2.5	0.2	3.3	2.6	4.9	0.0	0.9	1.6	0.0	3.0	1.0	2.3	0.3	0.2	3.8	12.0	0.2	20.8	0.1	0.1	0.6	1.8	2.4	0.8	0.1	1.8	0.8	1.2	6.8	5.2	6.0	17.7	5.6	14.7	3.9	5.0	0.2	1.0	2.5	0.2	1.2	1.4	0.0	0.4	2.1	0.2	0.7	1.9	0.0	1.4	0.0	1.0	0.2	0.5	0.1	0.2	0.3	0.8	0.5	0.1	1.9	1.0	1.4	2.6	3.1	0.1	5.0	0.1	0.0	9.7	10.9	17.6	11.1	11.8	5.8	16.3	10.1	13.2	16.4
GAREM2	"FAM59B, FLJ00375, GAREML, KIAA2038"	ENSG00000157833	"GRB2 associated regulator of MAPK1 subtype 2"	Q75VX8	2	26173091-26189663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 21.2;parathyroid gland: 17.0"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.1;SH-SY5Y: 9.4;U-2 OS: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071575			Approved	Cytosol				Cytosol		"HPA071575: "	"unprognostic (1.70e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.04e-1)"	3.2	1.6	19.9	1.8	13.9	0.9	1.5	8.2	21.2	2.5	3.0	11.7	0.7	1.2	3.0	1.7	2.6	2.4	2.8	2.0	17.9	11.0	1.8	0.5	1.1	2.2	13.1	8.9	4.1	4.4	17.0	1.4	1.5	16.5	1.7	2.9	0.9	1.8	3.5	3.7	2.4	1.1	3.6	15.9	1.6	1.5	2.6	13.9	0.0	2.6	0.0	2.0	2.1	1.2	0.8	2.5	1.6	0.6	0.4	1.9	0.3	2.6	4.0	4.8	0.4	0.8	1.7	0.4	1.4	0.0	0.4	0.4	7.5	0.9	0.0	1.9	3.0	0.1	15.1	0.0	0.6	1.6	5.6	1.3	1.3	0.5	5.9	0.1	0.3	2.3	0.7	2.3	0.2	1.8	6.9	0.1	2.8	0.0	0.4	0.5	5.1	1.1	1.5	0.0	0.0	2.4	0.8	1.0	9.4	3.3	0.3	2.8	0.2	7.9	0.8	2.1	12.9	3.8	0.1	0.3	0.0	1.6	0.1	0.0	2.7	0.4	0.6	0.2	1.2	0.2	0.5	0.5	1.9	1.4	0.5	0.8	1.5	0.5	1.6	0.4	0.5	2.5	0.4	0.3	19.9	13.9	8.2	14.1	17.9	11.0	13.1	8.9	16.5	13.9
GARS	"CMT2D, DSMAV, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase"	P41250	7	30594681-30634033	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		660000	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavourable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavourable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavourable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavourable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavourable (3.04e-5)"	25.8	27.3	24.5	26.2	28.5	24.6	32.4	31.1	44.7	21.5	23.7	17.0	11.5	17.2	24.1	23.3	43.7	18.6	18.4	25.7	21.1	26.8	27.6	57.2	27.9	28.0	22.9	28.4	35.4	49.4	44.4	33.3	24.3	37.6	17.2	30.2	14.1	28.7	21.6	35.6	33.2	18.1	30.1	17.6	23.5	30.5	29.7	14.9	28.6	31.4	33.9	38.4	22.8	25.7	22.5	26.4	21.2	27.2	15.3	27.6	21.2	33.0	16.4	14.5	51.5	27.2	40.9	27.6	49.5	44.8	25.5	51.7	21.8	16.5	55.7	14.9	60.2	26.2	36.2	31.4	44.9	13.3	16.9	25.7	13.4	18.3	86.4	37.8	22.8	38.9	55.2	36.6	43.5	32.7	50.9	64.9	40.4	20.3	32.9	26.2	39.2	31.4	16.7	12.8	43.2	29.2	14.9	17.6	29.4	13.2	37.0	70.3	33.0	58.0	30.0	12.1	40.7	24.3	31.2	64.2	53.8	65.5	42.3	57.3	56.9	21.2	19.0	17.7	23.2	25.8	23.7	22.5	23.7	25.1	26.4	19.3	25.5	27.6	5.6	15.3	27.2	18.0	25.9	21.2	24.5	28.5	31.1	44.7	21.1	26.8	22.9	28.4	37.6	14.9
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Uncertain	Nucleoplasm,Mitochondria,Cytosol			1300000	"Nucleoplasm, Mitochondria, Cytosol"		"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (5.05e-5)"	"prognostic unfavourable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavourable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.9	24.7	16.0	20.0	22.3	14.2	22.2	14.5	20.3	16.2	20.1	20.5	13.3	18.9	21.7	15.9	28.1	19.9	14.3	19.3	16.4	14.9	19.2	33.6	18.3	24.4	21.9	14.6	21.0	30.6	21.6	22.9	23.1	21.0	16.4	26.9	19.5	18.6	16.1	33.2	17.6	19.1	23.5	17.9	21.4	21.9	47.0	21.7	40.8	20.0	19.4	32.8	21.6	17.6	18.7	19.5	9.7	20.9	27.1	21.1	13.3	30.0	14.3	21.2	23.5	15.6	16.1	23.8	19.5	16.5	22.8	24.2	27.1	25.6	40.0	11.6	13.0	15.9	44.4	30.6	33.3	21.0	26.4	60.3	17.1	17.7	21.3	33.5	15.9	14.2	21.4	26.9	39.6	21.5	70.1	25.7	20.6	14.4	35.3	22.5	46.2	16.9	29.5	39.5	56.6	18.3	16.1	22.6	20.3	27.0	21.3	25.2	27.0	21.5	15.8	15.5	18.6	13.4	20.8	25.6	35.4	43.7	16.3	39.5	22.9	5.3	15.2	9.7	17.3	20.9	21.1	18.7	16.9	17.9	19.5	14.4	17.7	17.4	7.0	27.1	17.7	14.7	20.6	13.3	16.0	22.3	14.5	20.3	16.4	14.9	21.9	14.6	21.0	21.7
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625642-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7"	"Group enriched"	"Detected in some"	10	"Hep G2: 19.6;Karpas-707: 40.2;SCLC-21H: 11.7;U-266/84: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: "	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favourable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.7	1.1	2.1	1.1	3.6	0.4	0.9	0.9	2.2	1.2	0.7	1.4	1.2	2.0	1.1	1.3	1.0	1.5	2.7	3.6	2.1	2.5	5.3	37.2	1.3	1.1	4.3	1.2	2.3	22.7	0.5	4.8	0.7	4.5	1.3	0.7	0.5	2.2	0.9	4.8	1.0	1.8	0.6	8.6	1.5	2.6	1.1	3.2	19.6	1.1	3.0	1.0	1.8	0.7	1.0	0.6	0.3	0.0	0.1	1.7	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.0	19.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	40.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	2.0	0.0	0.5	11.7	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.5	0.0	0.5	13.4	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	1.7	1.0	0.4	0.0	0.0	0.9	1.6	0.4	0.0	0.1	0.0	0.6	0.3	0.1	2.1	3.6	0.9	2.2	2.1	2.5	4.3	1.2	4.5	3.2
GAS6	"AXLLG, AXSF, DKFZp666G247, FLJ34709"	ENSG00000183087	"Growth arrest specific 6"	Q14393	13	113820549-113864067	"Predicted secreted proteins"	"Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 55.7;BJ hTERT+: 80.6;HSkMC: 47.2;RPMI-8226: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in single"	51	"dendritic cells: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008275, HPA056080"	Approved		Approved	"Centriolar satellite,Cytosol"	"Secreted to blood"	8904000	920000	Cytosol	"Centriolar satellite"	"HPA008275: AB_1849497, HPA056080: "	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"prognostic unfavourable (8.93e-6)"	25.6	12.6	10.6	6.8	10.7	1.0	35.3	8.0	13.2	52.9	17.1	7.9	35.7	17.9	48.6	20.1	27.0	45.8	24.3	45.9	10.6	8.3	14.7	13.9	27.9	14.4	9.2	9.5	33.0	18.4	7.3	15.8	19.1	13.9	34.2	9.5	20.3	26.8	35.9	27.1	27.9	17.0	53.4	8.8	7.7	16.5	25.2	9.5	10.0	29.2	13.1	6.5	31.8	44.7	0.0	31.7	0.0	0.6	0.0	0.1	0.5	23.6	1.0	0.7	0.6	28.4	15.9	3.0	55.7	80.6	23.3	27.9	1.5	11.4	0.2	1.8	25.1	22.3	0.3	12.4	5.9	0.0	3.2	0.1	1.7	0.1	20.3	0.1	0.2	47.2	7.3	6.4	6.4	0.8	0.4	13.0	37.5	1.1	0.1	0.2	1.5	1.6	0.7	0.0	76.5	8.4	0.3	3.8	3.5	6.1	0.2	0.0	7.4	18.9	13.1	6.1	7.6	0.7	15.7	0.0	1.2	0.2	6.9	0.5	0.9	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	31.7	0.0	0.5	10.6	10.7	8.0	13.2	10.6	8.3	9.2	9.5	13.9	9.5
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041311: , HPA048238: "	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favourable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favourable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	7.1	11.1	8.5	6.5	13.2	2.3	7.6	13.5	12.2	11.7	6.8	10.0	10.8	4.1	12.7	16.2	7.8	26.5	11.6	21.0	8.7	9.8	12.4	6.3	9.9	4.0	8.9	8.9	12.8	12.9	23.2	22.0	3.5	10.1	8.9	4.6	11.0	16.2	12.6	18.8	4.2	4.2	8.4	7.5	4.2	7.6	16.1	6.4	1.7	15.5	5.5	5.2	6.6	5.1	2.5	4.8	4.3	5.0	0.0	3.7	2.3	10.6	8.6	1.1	5.4	5.1	3.9	9.2	2.1	5.4	8.8	2.6	8.6	8.1	0.6	5.9	4.4	10.6	3.6	6.3	1.9	0.0	6.4	2.2	5.5	9.8	5.7	1.2	1.8	5.2	3.6	6.6	3.0	5.2	8.5	1.2	3.7	25.6	1.5	5.4	7.2	4.5	0.4	10.1	0.6	11.0	5.2	9.1	6.6	11.3	6.1	12.9	11.5	5.0	3.6	5.4	6.3	2.9	5.1	2.0	3.2	0.0	13.8	1.7	9.4	4.3	3.1	3.7	1.8	5.0	1.8	1.2	2.8	3.7	4.4	2.5	2.3	2.0	4.0	0.0	3.1	4.8	3.5	2.3	8.5	13.2	13.5	12.2	8.7	9.8	8.9	8.9	10.1	6.4
GATA5	"bB379O24.1, GATAS"	ENSG00000130700	"GATA binding protein 5"	Q9BWX5	20	62463497-62475970	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 22.1;intestine: 23.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.5;HEL: 4.9;K-562: 7.7;SiHa: 3.4;T-47d: 8.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067583			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA067583: "	"unprognostic (2.21e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.34e-2)"		"unprognostic (1.69e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	1.9	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	4.4	15.9	0.0	5.2	14.8	3.8	1.7	0.3	9.1	22.1	6.8	0.0	0.0	3.3	0.7	1.6	0.0	0.0	0.0	3.1	0.0	0.3	0.6	0.6	0.0	11.3	0.0	1.0	0.4	0.8	0.1	0.3	23.6	18.3	0.2	0.1	10.3	16.8	0.0	0.0	1.2	0.0	0.0	14.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.0	0.3	4.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.6	3.4	0.0	0.0	8.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favourable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favourable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favourable (6.60e-4)"	15.6	19.3	28.9	17.0	23.3	11.0	24.3	42.3	41.6	14.8	35.1	17.0	28.4	41.5	19.0	22.3	16.6	16.8	21.4	34.6	22.4	21.0	34.8	25.0	20.9	17.3	23.7	19.5	16.4	20.9	27.9	27.1	19.3	36.6	23.9	32.8	28.4	27.7	25.5	46.1	23.5	51.1	23.3	21.0	23.4	26.9	11.6	19.5	10.9	25.4	15.5	16.4	18.2	16.9	5.6	6.8	12.2	6.1	3.1	7.3	3.1	8.1	13.5	18.7	18.1	9.1	5.6	19.0	11.1	8.8	11.4	12.0	15.0	6.5	8.8	8.1	6.7	8.6	17.9	7.5	5.7	12.4	12.2	9.4	35.4	16.1	10.1	14.0	23.5	9.6	14.1	9.6	10.1	29.7	9.2	16.9	10.5	8.1	3.8	14.5	19.4	21.5	7.0	7.5	7.4	15.8	19.3	15.3	20.5	6.2	15.7	11.0	10.7	12.7	20.6	12.3	14.9	10.5	13.5	11.5	7.3	7.3	15.5	5.1	9.5	12.2	4.4	2.9	6.0	6.1	4.1	5.0	5.8	7.3	4.2	5.6	3.7	3.2	4.9	3.1	3.7	6.8	4.0	3.1	28.9	23.3	42.3	41.6	22.4	21.0	23.7	19.5	36.6	19.5
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489699-81762161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Nucleoplasm,Cytosol			5900000	"Nucleoplasm, Cytosol"		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	23.1	22.4	2.2	7.8	4.2	5.6	19.2	4.2	4.6	6.4	7.7	5.2	5.2	4.1	8.4	4.9	7.5	4.9	11.5	19.7	3.6	4.3	14.0	36.3	11.3	7.5	7.9	3.4	8.2	5.7	8.2	11.6	11.4	8.4	5.7	4.5	9.9	8.0	10.1	56.9	5.9	6.3	7.2	6.1	8.0	4.5	4.6	4.1	5.4	6.5	11.2	4.5	9.6	10.0	11.6	13.6	14.5	11.4	13.0	7.2	6.1	12.0	7.3	2.4	34.6	60.9	46.3	4.4	20.0	28.6	12.0	20.4	1.4	3.1	13.5	8.8	24.6	1.4	2.0	9.2	28.3	6.3	1.1	4.2	15.1	4.5	41.9	14.1	3.7	34.1	6.9	19.3	19.9	26.6	3.2	7.8	39.0	3.5	2.3	16.8	2.4	11.1	4.4	11.0	15.8	8.5	4.1	1.2	1.6	13.0	3.8	4.1	2.7	11.7	37.0	24.9	5.8	17.4	18.5	35.7	4.1	4.9	40.5	9.5	10.1	6.3	11.4	14.5	5.6	10.4	5.4	11.0	6.0	5.9	13.6	11.6	7.0	7.2	11.0	13.0	10.8	4.5	5.0	6.1	2.2	4.2	4.2	4.6	3.6	4.3	7.9	3.4	8.4	4.1
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.5;HDLM-2: 25.9;RT4: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042682, CAB045975"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"				Nucleoplasm	"Actin filaments, Cytosol"	"CAB045975: AB_10584474, HPA042682: "	"prognostic favourable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavourable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favourable (1.10e-5)"	40.1	39.4	4.7	24.4	14.3	8.9	31.9	2.3	11.0	38.2	35.7	3.3	9.5	11.0	29.0	20.6	39.0	17.5	18.5	12.6	4.6	4.1	21.6	17.9	42.8	21.3	14.3	2.9	35.5	4.9	39.8	5.9	17.3	12.2	48.7	13.8	12.4	14.2	15.4	20.1	19.5	39.6	48.1	26.7	27.5	20.2	13.0	6.0	7.7	22.0	18.2	15.3	63.1	40.3	3.1	8.5	78.9	44.2	20.1	61.2	22.2	6.0	0.5	0.0	0.0	17.4	15.2	4.5	1.5	15.7	2.6	6.0	0.1	9.6	0.0	23.5	10.4	1.1	0.0	0.2	1.4	25.9	0.0	0.1	4.4	1.3	4.6	0.7	1.1	15.8	0.1	3.9	0.0	17.7	0.3	0.9	7.2	0.0	0.0	5.7	0.0	0.4	0.1	6.6	0.0	4.9	32.4	0.0	0.2	7.6	2.2	0.2	0.2	1.0	12.0	1.9	0.4	2.8	1.6	18.8	0.0	0.0	6.0	0.1	0.3	12.2	20.5	6.6	24.6	31.2	32.6	3.1	26.3	27.1	8.5	2.7	18.0	18.9	78.9	20.1	44.2	0.5	61.2	22.2	4.7	14.3	2.3	11.0	4.6	4.1	14.3	2.9	12.2	6.0
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 41.1;neutrophil: 112.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 112.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"			890000	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	13.1	6.8	13.4	24.8	21.3	116.0	7.8	6.9	15.8	6.0	7.7	15.3	3.2	8.2	4.6	11.0	5.0	7.2	9.7	11.2	15.9	13.0	8.5	7.6	15.6	51.8	26.0	9.7	4.4	11.5	4.8	8.1	10.6	24.6	5.7	8.6	3.7	6.9	4.9	2.2	3.7	7.8	7.7	30.2	50.0	10.3	10.7	20.8	5.8	7.4	2.5	10.3	10.0	6.3	3.1	8.9	112.7	18.2	0.3	1.3	8.4	1.3	2.1	5.8	0.0	1.4	1.2	0.2	2.1	6.1	3.4	6.2	4.8	16.3	1.9	15.0	0.1	0.8	2.2	6.9	4.2	9.1	9.2	17.1	1.5	9.1	1.7	21.4	5.0	1.5	2.4	3.1	0.7	0.4	0.3	6.6	0.2	16.8	0.4	12.4	3.7	8.3	7.4	1.4	9.6	17.9	9.6	3.8	6.5	2.8	12.6	10.6	8.6	9.6	0.4	0.8	6.2	9.7	3.2	6.3	11.7	0.3	5.3	8.4	4.0	4.4	18.2	41.1	0.4	10.7	0.5	3.0	0.6	0.6	8.9	3.1	1.1	0.7	112.7	0.3	8.0	2.2	1.3	8.4	13.4	21.3	6.9	15.8	15.9	13.0	26.0	9.7	24.6	20.8
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580618-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	11.5	14.1	13.4	11.0	13.7	17.7	14.2	13.9	12.8	11.6	10.2	12.8	8.6	9.6	13.2	10.3	14.1	10.7	12.2	9.0	10.2	7.9	9.8	17.8	10.4	12.3	19.8	7.6	13.6	12.7	14.8	14.5	13.6	13.0	11.5	9.6	8.4	13.8	11.0	12.5	14.5	12.9	8.4	12.1	15.5	12.7	20.7	17.9	15.7	11.8	9.5	14.4	10.3	29.2	8.4	7.9	15.6	9.1	10.2	11.6	8.8	8.2	11.2	5.0	10.7	11.1	7.7	6.9	7.3	8.5	7.3	9.2	9.3	5.7	7.6	4.4	6.7	9.2	7.1	8.0	7.9	10.7	6.5	5.6	6.1	4.9	16.5	9.7	9.4	7.2	21.9	7.8	15.5	6.9	9.1	8.8	8.2	8.3	9.3	8.4	10.3	8.8	6.7	5.4	8.7	6.3	6.4	7.9	11.4	7.8	37.2	14.5	6.3	7.0	8.8	10.9	3.5	9.4	8.3	24.2	10.5	4.9	10.7	9.9	11.0	5.8	8.1	15.0	9.1	8.2	11.6	8.4	8.2	8.9	7.9	8.0	6.8	6.7	15.6	10.2	9.1	4.6	7.6	8.8	13.4	13.7	13.9	12.8	10.2	7.9	19.8	7.6	13.0	17.9
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902852	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.8;liver: 58.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;Daudi: 13.2;SH-SY5Y: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 15.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favourable (8.69e-4)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (6.67e-4)"	4.8	5.2	1.3	5.7	4.5	26.8	2.1	0.6	1.1	2.2	5.5	1.2	1.5	7.5	1.8	1.9	3.8	1.3	1.6	1.5	1.6	4.3	7.9	58.2	11.6	6.7	2.9	0.7	1.4	3.2	0.3	2.5	2.5	2.8	2.9	4.0	5.2	2.5	4.7	1.4	2.5	9.1	2.0	1.7	10.0	4.2	3.6	1.1	13.0	2.3	2.0	8.5	2.9	2.5	1.6	3.0	0.4	11.5	2.3	3.2	1.3	1.9	0.6	0.7	3.5	0.0	0.0	11.6	0.0	1.2	0.8	2.2	0.9	0.6	13.2	3.3	0.1	2.0	5.7	0.9	0.0	5.1	4.9	0.3	0.2	1.9	5.6	0.0	1.2	1.4	1.6	1.9	0.0	0.4	0.8	0.0	0.0	6.8	7.1	0.2	1.1	4.5	5.8	1.4	0.0	1.6	2.7	5.8	29.3	2.4	1.5	0.7	5.6	1.6	0.2	0.1	1.9	3.7	2.3	5.6	4.2	3.2	2.4	4.5	0.0	0.0	3.0	0.2	3.0	6.3	2.5	0.8	1.6	2.1	3.0	1.6	3.2	1.8	0.4	2.3	11.5	0.1	2.3	1.3	1.3	4.5	0.6	1.1	1.6	4.3	2.9	0.7	2.8	1.1
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44144271-44198170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 46.8"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 12.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	17	"B-cells: 4.4;T-cells: 4.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	1.1	0.5	3.2	0.7	2.8	0.0	0.7	9.5	3.7	1.4	1.4	1.3	0.7	0.3	1.5	1.5	0.7	2.3	0.9	7.1	2.1	7.5	0.7	8.7	0.7	0.7	2.9	1.2	2.2	2.9	0.0	46.8	3.3	1.6	0.8	0.5	0.8	0.7	1.6	0.7	1.2	0.7	0.7	1.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.9	4.4	0.2	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.6	0.9	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	2.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.6	4.4	1.6	0.4	0.2	0.7	4.8	0.9	0.0	0.0	0.0	0.0	0.0	0.7	3.2	2.8	9.5	2.4	2.1	7.5	2.9	1.2	1.6	0.7
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell line enhanced"	"Detected in all"		"A549: 54.7;Hep G2: 46.7;RT4: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol			3600000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favourable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavourable (8.24e-4)"	"unprognostic (2.30e-2)"	15.8	11.1	12.9	9.0	16.0	14.4	13.0	5.4	15.1	6.8	16.2	21.6	8.2	18.9	9.2	5.3	20.0	29.1	14.9	7.4	13.1	10.6	15.4	69.2	12.9	10.1	21.6	12.2	6.2	12.4	6.6	5.4	6.2	13.0	13.0	12.2	5.2	11.2	10.1	7.0	8.6	14.8	11.9	13.6	16.8	14.8	5.2	17.5	3.1	14.1	32.4	10.6	34.4	12.3	1.6	4.2	2.2	1.9	8.0	2.3	0.6	8.1	54.7	4.5	10.6	5.4	2.4	6.0	4.1	6.7	3.1	3.7	8.0	19.0	15.5	7.9	3.7	11.6	13.7	30.1	4.2	12.2	8.4	10.4	10.6	46.7	6.2	13.6	6.4	3.8	12.8	3.5	15.7	4.7	5.7	4.9	1.5	8.6	11.7	5.4	8.3	5.1	3.9	2.7	13.7	10.1	50.4	13.0	6.4	6.9	11.1	7.2	7.6	6.5	6.5	2.8	9.8	7.1	6.1	6.6	10.1	9.0	7.0	9.8	4.7	2.2	1.1	0.6	1.2	1.9	0.8	1.6	1.0	2.3	4.2	1.0	0.6	1.3	0.5	8.0	1.8	3.0	1.6	0.6	12.9	16.0	5.4	11.9	13.1	10.6	21.6	12.2	13.0	17.5
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885205-93909456	"Cancer-related genes, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			1000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavourable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	10.3	17.5	7.0	6.0	7.7	11.3	23.9	5.7	8.9	4.5	22.8	4.2	11.5	16.6	3.5	6.5	8.8	12.8	12.5	7.7	6.8	8.9	17.8	41.7	8.4	10.4	9.2	5.7	4.6	6.9	6.3	5.1	10.3	8.7	5.3	5.2	6.4	6.7	6.4	19.2	3.4	20.0	3.4	7.7	6.9	6.1	3.2	2.8	5.6	15.0	23.0	8.6	8.9	8.0	3.2	1.9	3.3	0.7	4.6	6.7	1.2	14.0	22.2	2.4	4.8	8.3	5.2	9.5	16.8	10.5	12.8	9.6	3.7	8.3	5.3	33.7	10.8	14.2	3.6	6.8	10.3	14.4	4.9	37.1	15.2	16.0	15.6	13.6	5.9	6.4	2.6	26.0	4.2	13.9	14.7	7.9	9.2	2.7	9.8	3.1	8.4	10.6	4.6	7.4	7.8	9.1	16.4	5.8	2.4	15.8	12.5	5.8	2.8	8.5	14.6	13.4	7.9	25.2	25.1	7.1	9.1	5.5	11.1	7.7	4.7	3.3	0.7	1.3	5.3	0.4	3.1	2.6	5.0	6.7	0.6	3.2	3.2	3.2	2.9	4.6	0.5	1.9	1.3	1.2	7.0	7.7	5.7	8.9	6.8	8.9	9.2	5.7	8.7	2.8
GCN1	"GCN1L, GCN1L1, KIAA0219"	ENSG00000089154	"GCN1, eIF2 alpha kinase activator homolog"	Q92616	12	120127203-120194710	"Plasma proteins, Predicted intracellular proteins"	"Stress response, Translation regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018799, HPA019648, HPA024367"	Enhanced		Enhanced	Cytosol			40000	Cytosol		"HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569"	"unprognostic (7.36e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (1.87e-8)"	"unprognostic (5.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.43e-1)"	23.1	14.6	7.9	14.3	14.4	15.7	14.4	18.3	20.6	15.3	15.2	22.3	9.7	11.5	31.2	10.2	20.2	14.8	11.3	12.6	7.7	7.8	14.7	19.1	14.0	16.0	11.5	6.8	18.9	19.9	23.8	21.4	24.4	14.9	15.1	12.2	16.8	33.3	13.2	36.0	20.9	15.5	14.4	9.7	18.3	17.2	16.0	10.3	22.2	20.6	14.3	27.4	15.9	15.1	4.3	4.9	2.2	6.5	3.1	7.8	3.1	16.7	33.1	12.0	13.4	19.0	11.5	42.0	15.0	13.2	15.7	12.9	28.3	11.6	22.3	17.1	21.5	16.6	27.7	21.3	9.8	14.8	22.6	27.6	21.6	19.6	12.4	25.4	17.7	14.1	12.4	18.5	17.6	14.3	32.3	5.7	13.1	16.9	16.0	19.3	21.2	20.3	19.5	12.3	22.1	10.8	57.5	19.7	19.7	24.7	10.8	8.9	22.9	14.4	19.5	12.9	14.3	8.4	15.5	22.7	20.8	22.6	12.3	13.4	12.9	1.2	3.1	2.2	6.4	3.2	7.8	3.9	5.0	5.3	4.1	4.3	3.8	4.0	0.1	3.1	6.5	4.9	4.6	3.1	7.9	14.4	18.3	20.6	7.7	7.8	11.5	6.8	14.9	10.3
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 48.3;brain: 17.6"	"Group enriched"	"Detected in some"	73	"HEL: 27.8;HMC-1: 110.6"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	10	"cerebellum: 17.6"	"Cell type enriched"	"Detected in single"	439	"basophil: 48.3"	"Lineage enriched"	"Detected in single"	439	"granulocytes: 48.3"					"Not detected"	"Not detected"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol				Cytosol		"HPA027507: AB_10600756, HPA027510: "	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	3.7	0.3	0.4	1.1	0.4	2.4	1.6	17.6	0.4	3.8	2.1	0.2	0.0	2.2	2.4	2.2	1.9	0.6	2.7	1.3	0.4	0.5	0.5	0.4	5.6	1.1	0.5	0.0	0.3	0.5	0.1	0.4	0.3	1.7	9.5	2.4	0.4	1.0	0.9	0.5	1.2	2.5	6.6	0.9	0.5	1.4	5.3	0.0	1.4	0.4	2.4	1.5	3.4	9.4	0.1	0.0	48.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	110.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	48.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	17.6	0.4	0.4	0.5	0.5	0.0	1.7	0.0
GDAP1	"CMT2K, CMT4, CMT4A"	ENSG00000104381	"Ganglioside induced differentiation associated protein 1"	Q8TB36	8	74321130-74488872	"Disease related genes, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.3"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014266, HPA024334"	Enhanced		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA014266: AB_1849581, HPA024334: AB_1849583"	"unprognostic (3.19e-2)"	"unprognostic (1.52e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.72e-2)"	"prognostic favourable (2.68e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.17e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.99e-2)"	"prognostic unfavourable (4.54e-4)"	"unprognostic (2.73e-1)"	2.8	11.2	19.2	3.8	25.9	2.1	5.6	24.9	48.3	3.2	2.9	7.6	1.1	3.2	5.4	5.7	5.3	3.7	3.4	2.8	17.6	21.4	5.3	2.0	3.2	3.7	16.5	19.2	8.2	10.8	12.3	16.4	2.3	23.3	5.6	3.6	3.7	2.9	5.4	2.6	2.1	3.0	3.9	14.6	2.9	3.2	5.4	9.6	0.7	7.5	0.5	3.4	3.8	1.8	2.7	1.7	2.8	7.2	1.9	4.6	1.4	2.3	7.7	11.9	2.7	1.0	0.9	1.1	1.0	5.6	6.0	6.9	4.0	2.7	9.1	1.4	1.3	3.9	6.4	3.9	11.8	7.9	2.0	4.8	4.3	7.8	1.3	3.9	9.8	2.8	1.3	2.9	6.1	0.7	2.3	0.1	3.6	2.9	7.9	0.6	13.7	10.5	4.0	5.6	1.7	2.0	7.2	11.7	28.7	7.0	2.6	5.9	11.8	1.3	0.1	8.8	4.1	2.0	2.8	6.0	5.6	4.4	4.0	0.2	9.2	0.0	1.7	2.8	1.5	4.3	1.8	2.7	1.6	1.9	1.7	1.9	1.3	1.6	0.0	1.9	7.2	0.0	4.6	1.4	19.2	25.9	24.9	25.8	17.6	21.4	16.5	19.2	23.3	9.6
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113856	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6"	"Group enriched"	"Detected in many"	6	"MCF7: 13.7;SK-BR-3: 48.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"eosinophil: 1.6;neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.1"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	"Not detected"	"Not detected"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	3.0	0.9	1.2	10.5	1.2	0.5	2.5	5.7	1.3	9.4	11.3	1.2	1.2	4.0	2.8	3.4	30.8	2.1	3.6	1.7	1.2	0.7	5.9	1.2	3.7	2.3	1.2	1.2	3.3	1.2	0.4	2.3	12.9	2.5	2.4	7.4	1.2	4.9	1.2	1.3	5.3	8.6	2.4	1.2	4.1	8.3	1.2	1.2	1.9	2.3	36.6	40.8	2.7	9.2	0.1	0.0	5.1	0.2	0.0	0.2	0.0	5.3	0.0	1.8	0.5	0.5	2.8	1.6	0.5	0.4	0.5	0.6	0.6	3.7	0.6	0.7	0.3	0.5	0.5	0.2	0.5	1.0	1.5	0.1	0.8	2.5	0.5	0.2	0.4	0.1	0.7	1.5	0.1	2.1	0.4	0.9	0.7	13.7	0.4	0.9	1.1	0.2	2.5	0.6	2.9	1.1	2.4	0.5	0.9	0.0	48.5	0.3	0.9	1.0	1.5	0.5	0.5	1.1	0.5	1.6	0.3	0.6	1.4	0.8	0.3	0.1	0.0	1.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	5.1	0.0	0.1	0.0	0.1	0.0	1.2	1.2	5.7	1.3	1.2	0.7	1.2	1.2	2.5	1.2
GDPGP1	C15orf58	ENSG00000183208	"GDP-D-glucose phosphorylase 1"	Q6ZNW5	15	90233808-90245811	"Enzymes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA048189, HPA059841"	Approved		Approved	Cytosol				Cytosol		"HPA048189: , HPA059841: "	"prognostic favourable (6.32e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-3)"	3.9	9.2	9.8	5.7	9.8	5.1	4.8	9.9	12.4	4.4	10.7	8.0	7.2	10.1	5.0	7.5	6.2	9.4	6.0	10.8	12.9	7.1	7.7	12.2	5.8	6.1	5.9	11.6	6.1	9.1	11.9	10.2	2.1	8.8	7.5	14.8	7.2	9.9	10.0	12.5	4.5	9.4	5.8	5.1	8.2	6.9	9.5	8.4	8.5	7.6	3.1	7.8	7.2	3.9	8.3	4.6	7.4	5.2	6.7	7.8	2.9	3.2	13.0	1.6	4.8	4.9	1.0	4.4	3.0	1.9	4.0	3.8	3.8	12.9	8.0	5.9	2.3	5.4	5.1	3.4	1.6	7.2	8.6	7.2	7.5	5.5	5.3	3.9	4.8	1.3	2.4	2.8	1.4	4.6	2.6	3.2	2.3	7.3	2.9	1.9	2.0	5.4	5.1	1.2	4.0	4.6	6.4	5.1	2.2	4.7	7.4	5.0	8.5	4.0	4.6	2.1	2.2	3.0	2.9	6.6	7.5	3.6	4.6	3.3	3.8	6.8	4.6	2.2	6.6	5.2	5.6	4.8	6.2	7.8	4.1	8.3	6.7	6.2	7.4	6.7	4.1	4.6	7.5	2.9	9.8	9.8	9.9	12.4	12.9	7.1	5.9	11.6	8.8	8.4
GEMIN4	"DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97"	ENSG00000179409	"Gem nuclear organelle associated protein 4"	P57678	17	744414-753999	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065699, HPA067891"	Uncertain		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA065699: , HPA067891: "	"unprognostic (1.85e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.56e-3)"	10.8	6.5	6.4	5.9	5.1	10.5	10.1	15.0	7.2	11.1	6.9	5.4	11.3	6.1	10.5	5.9	12.0	9.5	9.9	9.1	5.5	3.3	5.4	9.9	8.0	12.8	5.8	4.0	13.5	8.5	4.1	5.2	7.6	5.4	11.2	5.0	6.8	9.1	8.8	10.5	29.5	7.6	8.7	4.2	11.4	10.7	36.7	6.5	20.5	20.1	8.7	11.4	10.4	9.9	11.7	8.3	1.5	9.6	6.9	13.4	8.4	18.6	33.1	11.1	16.6	7.1	8.9	13.8	10.7	7.5	19.4	17.3	18.8	10.1	32.8	14.3	9.2	23.7	20.9	20.1	15.6	12.3	31.1	11.8	17.6	10.5	5.0	12.4	16.2	8.6	10.2	15.9	11.3	10.9	16.3	13.8	10.3	13.2	20.4	7.0	10.7	14.3	22.2	5.3	15.4	8.3	13.8	11.5	9.3	11.0	11.3	5.0	12.0	9.1	8.6	12.0	10.9	15.5	25.8	2.3	5.0	18.8	10.3	17.6	13.7	1.5	6.1	0.3	7.6	8.5	13.4	11.6	8.2	8.0	8.3	11.7	10.0	9.8	0.8	6.9	9.6	4.8	5.5	8.4	6.4	5.1	15.0	7.2	5.5	3.3	5.8	4.0	5.4	6.5
GEMIN5		ENSG00000082516	"Gem nuclear organelle associated protein 5"	Q8TEQ6	5	154887416-154938209	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037392, HPA037393"	Uncertain		Enhanced	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA037392: , HPA037393: AB_10672489"	"unprognostic (1.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.41e-3)"	"prognostic unfavourable (6.23e-5)"	"unprognostic (5.44e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.40e-3)"	"unprognostic (5.01e-2)"	17.7	10.5	9.4	13.8	13.2	6.4	17.0	11.2	11.7	12.9	10.8	16.5	12.1	7.0	14.4	10.2	11.3	13.2	8.6	14.8	9.5	10.4	10.3	12.3	9.5	14.9	14.0	10.5	18.3	15.4	17.1	15.1	9.9	10.4	12.8	10.1	9.1	10.4	13.3	23.0	15.3	8.6	14.6	11.4	11.0	9.6	13.8	12.5	19.7	11.9	11.0	14.5	12.4	10.9	6.1	4.6	2.9	4.0	4.5	7.3	3.4	8.6	12.9	8.4	19.3	9.0	7.7	10.8	8.4	5.1	14.8	11.0	21.2	7.8	22.8	10.7	8.0	9.2	24.8	15.4	20.3	4.5	11.6	13.8	8.4	12.7	5.0	24.0	8.1	5.8	7.2	20.5	12.3	12.0	21.8	5.6	11.0	11.8	12.9	9.6	11.7	10.1	16.8	16.4	19.0	6.2	5.9	11.0	7.6	9.7	10.9	6.8	12.8	5.5	7.3	13.4	9.6	10.0	18.9	5.6	8.6	17.9	5.7	19.8	11.7	0.0	3.1	2.9	4.5	4.0	7.3	6.1	4.2	4.3	4.6	5.0	6.3	6.6	0.3	4.5	3.9	3.4	3.9	3.4	9.4	13.2	11.2	11.7	9.5	10.4	14.0	10.5	10.4	12.5
GEMIN7	FLJ13956	ENSG00000142252	"Gem nuclear organelle associated protein 7"	Q9H840	19	45079195-45091524	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052075			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA052075: "	"unprognostic (3.32e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.00e-2)"	"prognostic unfavourable (5.86e-5)"	"unprognostic (7.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (9.64e-11)"	"unprognostic (7.01e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.83e-1)"	"prognostic favourable (8.00e-4)"	9.7	10.6	8.9	13.0	12.2	18.3	12.3	22.1	19.0	8.1	13.6	10.0	8.2	18.9	10.0	8.7	18.5	9.0	9.6	13.3	9.8	9.7	12.4	20.2	10.3	21.6	10.0	9.0	8.5	24.1	6.1	20.4	12.9	12.8	11.9	13.2	12.7	16.8	9.5	20.7	14.7	16.5	9.7	6.9	24.3	17.4	5.3	10.5	12.8	12.5	14.7	17.1	13.1	11.7	28.4	22.9	15.2	14.3	29.6	32.0	18.9	20.7	27.7	16.2	19.9	12.4	13.0	12.6	16.0	11.8	24.6	27.4	16.8	13.4	20.9	11.1	13.8	13.0	23.5	19.0	14.9	16.6	30.6	23.0	12.7	21.8	17.4	18.3	13.8	19.4	15.7	13.7	9.9	23.9	24.0	21.9	9.6	30.7	17.5	19.0	15.2	14.4	21.1	7.5	27.0	18.6	15.4	16.2	11.3	12.5	27.2	14.1	18.3	19.7	12.8	9.1	17.4	5.9	21.0	22.8	33.6	33.3	14.6	18.5	14.6	10.7	14.3	15.2	32.0	11.5	30.2	28.4	23.6	29.4	20.1	23.7	18.3	23.8	7.9	29.6	8.3	22.9	19.8	18.9	8.9	12.2	22.1	19.0	9.8	9.7	10.0	9.0	12.8	10.5
GEMIN8	"FAM51A1, FLJ20514"	ENSG00000046647	"Gem nuclear organelle associated protein 8"	Q9NWZ8	X	14008279-14029893	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028613	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028613: AB_10602905"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (7.78e-5)"	"unprognostic (3.87e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.75e-2)"	"prognostic favourable (7.73e-5)"	13.4	13.5	14.5	12.9	17.0	12.0	19.9	12.3	20.0	16.5	13.9	24.0	27.3	9.0	21.5	16.9	13.2	22.8	16.4	15.5	14.8	14.0	16.7	12.9	14.5	16.0	16.6	14.7	28.9	22.2	18.7	27.4	10.3	21.0	13.1	11.9	16.8	24.7	30.2	7.6	15.7	10.0	17.1	23.3	12.5	13.6	8.2	12.7	14.6	21.3	7.9	13.2	12.7	13.0	11.3	15.4	0.8	6.9	9.9	15.2	7.5	6.3	6.3	7.5	1.8	12.2	18.7	3.7	5.9	6.6	5.2	3.6	3.3	11.0	14.8	14.2	4.8	8.5	4.6	10.4	5.0	7.9	9.5	3.8	4.7	7.4	7.1	9.0	8.0	15.0	17.2	9.0	15.7	11.2	6.6	13.1	7.8	8.5	9.0	14.1	8.1	3.7	13.8	5.2	26.3	8.7	6.2	7.4	20.5	6.3	11.9	7.0	16.3	9.0	8.5	3.8	2.2	11.1	2.4	8.9	4.4	9.3	8.8	5.5	2.2	0.6	6.7	0.2	9.4	6.4	11.6	11.3	15.2	8.9	12.2	9.8	13.1	9.8	0.8	9.9	6.9	15.4	8.4	7.5	14.5	17.0	12.3	20.0	14.8	14.0	16.6	14.7	21.0	12.7
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Golgi to ER traffic protein 4"	Q7L5D6	7	876552-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	13.7	39.8	22.4	14.8	21.4	28.5	15.3	22.1	23.5	10.3	15.5	20.9	19.0	21.8	12.3	23.8	18.8	14.6	12.8	18.7	16.4	15.4	27.8	37.5	12.2	15.1	22.9	21.5	16.5	32.6	11.3	32.9	21.7	18.9	16.8	9.9	15.2	25.0	21.9	53.7	29.7	20.9	12.6	18.9	16.9	22.2	32.0	22.7	12.5	16.0	21.8	12.5	14.3	17.3	23.3	31.5	28.9	30.7	24.9	27.3	21.9	26.0	12.8	9.0	13.3	4.6	3.2	28.5	7.3	5.1	9.3	9.3	34.9	32.6	9.6	7.6	4.1	16.6	10.1	7.9	4.0	3.9	17.3	5.3	10.1	19.7	10.3	9.0	9.8	4.9	9.5	8.1	5.3	7.3	34.1	8.9	5.2	19.8	6.8	21.7	32.3	19.3	14.4	1.5	10.3	8.2	15.4	16.3	17.6	6.7	24.6	10.5	18.7	16.0	7.3	6.9	15.4	15.8	9.9	13.5	8.4	12.4	7.1	15.5	17.3	16.8	27.4	28.9	24.2	24.7	23.7	23.3	26.5	24.0	27.7	23.2	26.0	27.3	21.1	24.9	30.7	31.5	24.5	21.9	22.4	21.4	22.1	23.5	16.4	15.4	22.9	21.5	18.9	22.7
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984207-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Intracellular and membrane"			"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: "	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	9.7	12.2	9.7	15.2	9.9	10.7	14.8	15.2	12.5	8.1	24.8	10.8	15.2	29.6	10.1	10.2	11.0	10.2	16.1	17.8	9.8	9.7	13.7	33.5	17.1	18.1	10.7	9.7	9.4	43.8	19.2	10.9	18.0	8.0	11.9	18.0	10.5	22.5	12.5	27.5	8.3	33.2	9.2	9.6	15.2	12.8	20.0	7.8	7.7	15.1	15.0	11.4	12.4	17.1	16.1	9.1	9.8	12.7	7.8	17.7	7.7	11.3	18.1	14.9	12.1	6.3	12.6	19.3	13.2	12.9	18.6	15.2	26.0	19.0	6.4	18.0	9.8	17.1	11.3	17.4	11.8	19.7	23.1	8.8	17.8	29.5	11.4	12.7	16.6	8.1	13.5	16.2	14.6	8.7	13.7	21.4	13.5	26.7	14.5	13.8	23.8	18.1	31.8	11.4	20.7	18.9	8.9	13.1	12.5	17.8	38.0	14.1	18.1	13.6	8.1	18.1	20.2	10.1	22.6	36.3	19.6	18.3	6.0	8.7	15.2	3.1	12.6	9.8	9.2	10.5	9.9	16.1	12.6	15.6	9.1	13.4	11.5	7.9	1.1	7.8	12.7	4.0	17.7	7.7	9.7	9.9	15.2	12.5	9.8	9.7	10.7	9.7	8.0	7.8
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.4;HMC-1: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 12.8;NK-cell: 11.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;NK-cells: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	15.7	3.8	9.4	4.6	11.5	17.5	8.7	28.5	22.3	5.4	5.0	4.0	0.5	3.5	4.0	2.6	12.1	4.3	11.8	18.5	11.9	7.1	2.1	6.6	8.2	6.6	6.3	14.2	1.7	2.3	3.9	3.3	6.8	6.6	4.4	5.2	1.5	3.4	3.0	15.5	4.7	5.6	8.3	4.2	12.0	8.2	1.5	4.1	1.9	3.9	4.5	6.9	4.7	7.6	2.3	0.2	12.8	0.8	11.4	1.4	0.8	7.2	0.7	0.6	1.3	1.1	1.1	0.8	0.6	0.3	0.4	0.2	0.2	0.5	9.9	10.4	0.7	6.5	2.0	3.1	0.4	0.7	3.7	18.4	3.8	3.8	1.5	5.2	28.5	0.6	2.5	0.9	2.7	5.6	0.5	0.9	0.8	2.3	1.2	3.2	1.0	2.1	4.0	1.3	5.1	0.3	1.4	3.4	0.6	2.4	0.4	2.3	0.6	0.5	7.5	0.9	2.0	2.1	3.3	8.3	4.7	11.9	0.8	3.1	0.2	0.1	0.4	12.8	1.4	0.7	0.2	2.3	0.2	0.6	0.2	1.9	0.1	0.5	0.3	11.4	0.8	0.0	0.1	0.8	9.4	11.5	28.5	18.7	11.9	7.1	6.3	14.2	6.6	4.1
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719421	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favourable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favourable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	9.0	9.4	9.6	7.7	13.8	13.4	8.6	42.9	18.9	10.7	10.6	5.0	9.4	10.7	8.1	5.9	21.8	12.2	8.4	6.8	10.1	12.4	9.8	24.4	7.9	6.9	8.2	11.1	5.6	9.0	14.1	11.7	19.4	10.8	7.4	8.7	6.4	8.7	7.2	6.5	14.1	8.1	8.6	5.7	12.8	7.5	8.3	5.1	6.1	9.7	13.2	12.8	9.0	16.4	9.1	6.5	10.6	5.5	6.4	10.2	4.1	9.3	15.1	9.3	19.1	9.4	7.1	10.9	7.8	10.0	14.6	14.9	12.8	8.5	15.7	7.3	9.0	11.8	9.5	8.9	12.4	9.4	11.7	4.0	8.0	18.3	7.2	6.5	7.8	5.9	10.4	19.2	5.8	20.9	8.2	3.1	8.1	19.8	10.5	7.7	12.6	8.2	17.0	5.4	12.2	8.9	13.2	19.0	11.1	19.2	6.5	5.9	9.8	4.3	16.1	11.3	11.3	10.0	7.6	8.0	11.2	17.1	7.0	9.5	8.1	0.7	5.5	5.7	5.6	3.5	9.0	8.0	9.5	9.6	5.6	9.1	8.4	6.6	10.6	6.4	3.4	6.5	10.2	4.1	9.6	13.8	42.9	18.9	10.1	12.4	8.2	11.1	10.8	5.1
GFRA3	GFRa-3	ENSG00000146013	"GDNF family receptor alpha 3"	O60609	5	138252379-138274671	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	17	"SH-SY5Y: 26.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020731	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA020731: AB_1849635"	"unprognostic (1.22e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.90e-5)"	"unprognostic (2.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	2.4	2.4	0.3	7.1	1.0	0.0	1.8	7.0	0.6	7.9	13.0	0.1	11.0	3.8	3.0	6.1	9.3	1.2	9.4	6.2	0.3	0.3	0.9	0.4	2.9	0.1	0.6	0.1	4.7	7.0	0.0	2.3	0.1	1.3	4.4	5.8	10.0	7.5	10.9	1.3	3.6	4.7	8.6	1.4	0.1	6.9	8.4	0.5	0.4	1.0	2.8	0.8	4.4	8.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	26.4	0.4	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	7.0	0.6	0.3	0.3	0.6	0.1	1.3	0.5
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Group enriched"	"Detected in some"	5	"HSkMC: 13.3;T-47d: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	2200000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: , HPA057705: "	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.0	2.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.3	4.3	0.0	0.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.1	33.9	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.5	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2
GID4	"C17orf39, VID24"	ENSG00000141034	"GID complex subunit 4 homolog"	Q8IVV7	17	18039292-18068404	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044348	Uncertain		Approved	Cytosol				Cytosol		"HPA044348: AB_10959602"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.65e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	10.9	5.7	9.6	4.7	9.4	5.6	7.5	13.4	9.3	9.0	9.4	6.9	7.3	4.5	7.9	7.2	13.0	6.7	5.5	10.1	8.8	5.3	6.2	6.2	5.6	5.3	9.5	5.8	8.6	7.8	10.8	3.9	6.7	7.0	9.5	5.1	4.6	7.7	9.3	24.7	11.6	5.1	9.5	7.0	6.3	6.4	55.2	10.2	8.0	7.1	5.8	6.2	13.3	10.8	4.4	3.2	6.8	2.4	3.8	3.6	1.0	8.9	9.3	5.3	8.5	13.8	13.5	9.1	7.4	12.0	8.2	9.3	8.0	3.6	11.2	6.4	8.7	10.1	7.5	8.3	10.8	6.0	15.2	4.9	7.8	5.8	12.0	3.0	8.8	10.0	14.5	8.3	12.9	9.2	4.4	3.3	6.6	2.4	9.5	6.4	4.6	6.9	8.1	18.6	11.1	5.6	3.6	4.0	6.0	5.0	4.4	5.2	2.8	3.8	7.6	5.3	3.1	12.2	3.7	5.7	4.9	2.4	7.5	5.1	6.8	6.8	2.4	6.6	2.6	1.3	2.9	4.4	2.4	2.5	1.9	4.4	2.9	2.9	6.3	3.8	1.5	3.2	3.6	1.0	9.6	9.4	13.4	9.3	8.8	5.3	9.5	5.8	7.0	10.2
GIGYF2	"GYF2, KIAA0642, PARK11, PERQ2, PERQ3, TNRC15"	ENSG00000204120	"GRB10 interacting GYF protein 2"	Q6Y7W6	2	232697299-232860575	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050899, HPA054612, HPA059918, HPA065064"	Approved		Enhanced	Cytosol				Cytosol		"HPA050899: , HPA054612: , HPA059918: , HPA065064: "	"unprognostic (7.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.61e-2)"	"unprognostic (8.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.40e-3)"	"unprognostic (8.01e-2)"	"prognostic favourable (6.97e-5)"	"unprognostic (7.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.66e-1)"	22.8	22.1	20.7	16.5	19.4	15.2	19.7	33.0	21.7	17.9	17.5	25.0	21.2	15.9	23.7	15.0	18.6	17.8	13.7	21.3	19.2	15.7	23.1	13.7	15.7	15.4	21.4	15.6	24.6	26.5	47.5	38.1	18.1	21.5	19.4	16.9	18.1	21.4	21.7	41.5	23.4	17.2	22.3	27.5	18.9	18.2	53.4	22.0	19.2	22.4	17.7	17.3	20.8	20.5	10.1	9.8	21.5	14.6	9.8	9.9	5.2	15.9	15.4	18.0	18.6	24.5	23.6	20.1	20.1	17.3	14.8	15.9	14.4	13.3	9.6	5.4	15.0	16.9	21.5	16.2	18.2	22.3	16.0	35.3	15.9	21.7	15.4	28.6	22.6	14.8	16.7	17.8	25.4	16.5	32.9	10.6	16.9	16.9	18.7	10.2	18.3	11.4	19.0	35.6	13.1	13.8	24.5	16.0	13.3	20.3	14.8	15.6	14.3	19.9	23.9	15.7	13.3	17.6	15.5	21.7	14.5	18.9	14.2	16.8	15.2	21.5	8.6	10.8	7.9	6.7	9.9	5.6	6.5	7.2	9.8	10.1	7.8	5.9	11.2	9.8	14.6	7.6	9.6	5.2	20.7	19.4	33.0	21.7	19.2	15.7	21.4	15.6	21.5	22.0
GIMAP7	"IAN7, MGC27027"	ENSG00000179144	"GTPase, IMAP family member 7"	Q8NHV1	7	150514830-150521073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 155.1"	"Group enriched"	"Detected in some"	12	"HUVEC TERT2: 39.0;MOLT-4: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"monocytes: 41.1;NK-cells: 65.0;T-cells: 155.1"					"Low region specificity"	"Detected in many"			"HPA020266, HPA020268"	Enhanced		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA020266: AB_1849680, HPA020268: AB_1849682"	"unprognostic (4.85e-3)"	"unprognostic (1.65e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.71e-1)"	"prognostic favourable (7.43e-4)"	"prognostic favourable (8.98e-5)"	"unprognostic (6.49e-3)"	"unprognostic (5.24e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	32.2	7.3	6.2	30.1	9.8	1.9	19.7	4.3	8.0	19.9	9.5	2.1	5.3	7.6	13.4	11.9	12.2	10.2	9.4	14.6	9.3	6.4	20.1	10.5	22.8	54.7	10.0	3.3	7.0	4.7	3.3	4.9	12.5	7.2	13.5	8.8	6.2	10.7	4.6	17.0	4.6	20.5	12.4	8.1	51.5	7.7	6.7	8.2	18.7	16.7	11.3	34.9	13.4	11.0	0.4	18.0	3.4	41.1	65.0	155.1	131.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	41.1	0.5	79.6	36.9	77.6	0.4	118.6	95.4	18.0	0.3	155.1	108.0	3.4	65.0	38.6	1.0	64.7	131.0	6.2	9.8	4.3	8.0	9.3	6.4	10.0	3.3	7.2	8.2
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.1;HaCaT: 4.8;Hep G2: 17.9;HUVEC TERT2: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.9;naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051212: , HPA062684: "	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favourable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	6.4	17.0	0.8	3.2	0.9	0.0	4.0	0.4	1.0	2.6	27.0	0.3	0.2	19.6	5.4	4.5	5.7	1.4	8.1	3.1	0.5	0.5	21.3	10.4	3.2	2.2	0.5	0.3	3.7	24.7	3.3	2.5	1.6	1.3	2.1	7.8	1.5	6.9	1.0	1.8	2.7	64.0	1.4	0.6	22.7	3.0	2.2	0.4	0.1	1.5	4.9	1.4	2.5	5.1	0.1	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	5.1	0.0	0.8	0.0	0.4	0.9	4.0	2.6	1.2	0.0	0.4	4.8	0.0	0.0	2.6	0.1	0.0	0.6	0.0	17.9	1.0	0.0	0.0	0.8	0.0	2.8	0.1	18.9	0.0	0.1	2.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.0	1.0	0.6	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	0.5	0.5	0.5	0.3	1.3	0.4
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573469-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"			53000	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	13.0	8.5	34.0	11.1	38.1	8.0	9.4	18.9	43.4	7.8	9.8	15.6	2.2	11.6	10.0	5.3	13.2	14.0	10.2	12.2	41.5	16.4	7.0	3.7	12.0	12.6	19.2	21.8	13.6	14.3	10.2	8.1	13.8	15.0	8.4	6.9	7.8	11.9	10.3	10.0	20.2	10.9	8.7	11.9	11.1	9.5	42.9	19.8	10.8	11.0	4.5	9.7	9.8	7.5	1.8	4.7	3.0	6.0	5.6	4.9	3.6	17.1	28.8	14.2	25.2	11.3	7.2	16.5	8.5	8.4	10.3	9.2	11.6	6.4	13.0	13.7	11.1	28.4	14.9	21.9	5.3	16.8	17.8	9.4	14.1	10.4	13.8	11.8	7.7	8.7	25.2	11.8	18.5	19.0	7.6	11.3	7.3	17.7	37.3	16.0	10.5	6.9	28.4	19.0	19.5	9.3	9.5	29.9	25.6	12.0	28.0	42.0	13.7	15.8	23.5	9.8	14.2	21.5	17.1	9.4	12.9	14.2	16.1	10.2	16.5	0.3	3.6	3.0	4.7	6.0	2.2	1.8	4.5	4.9	4.7	1.7	3.7	2.7	1.2	5.6	3.7	4.0	2.9	3.6	34.0	38.1	18.9	43.4	41.5	16.4	19.2	21.8	15.0	19.8
GJC1	"CX45, GJA7"	ENSG00000182963	"Gap junction protein gamma 1"	P36383	17	44798448-44830816	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071788			Uncertain	"Nucleoli,Cell Junctions,Cytosol"				"Nucleoli, Cytosol"	"Cell Junctions"	"HPA071788: "	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (3.55e-8)"	"unprognostic (5.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.52e-2)"	"prognostic unfavourable (7.83e-4)"	7.3	0.8	2.2	4.1	3.4	1.0	4.7	8.2	4.2	14.8	23.0	2.8	7.0	1.6	24.2	3.1	3.2	5.0	5.4	10.0	3.3	1.8	1.5	0.9	6.5	2.3	2.5	4.0	2.2	1.3	2.6	0.7	28.5	3.4	8.2	2.8	3.7	1.7	17.0	5.4	1.9	4.8	27.5	2.2	0.9	7.8	8.0	2.9	1.4	5.3	2.9	1.7	12.6	10.4	1.2	1.0	4.7	1.0	1.9	1.0	0.4	17.6	9.1	23.0	7.9	3.0	4.7	9.0	19.6	15.5	21.1	22.7	5.3	9.8	0.1	1.0	18.3	4.6	11.9	6.1	29.8	0.1	8.9	0.1	4.9	0.6	1.9	0.1	0.8	3.3	0.6	16.1	5.3	7.2	0.8	0.2	12.2	0.1	2.8	1.8	10.3	7.8	16.7	29.2	0.1	5.1	7.4	4.4	10.0	2.2	0.1	6.6	4.8	2.8	6.0	18.7	18.1	8.5	16.6	0.1	4.6	13.1	6.5	0.1	17.5	4.7	1.0	1.1	0.9	0.6	0.8	0.9	0.7	0.6	0.3	1.2	0.9	1.0	3.9	1.9	0.7	1.0	0.6	0.4	2.2	3.4	8.2	4.2	3.3	1.8	2.5	4.0	3.4	2.9
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149852-228159826	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 34.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;SCLC-21H: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.4	1.9	4.6	1.2	10.0	0.5	2.0	2.2	14.8	2.8	2.6	34.3	0.0	0.6	4.5	2.0	1.7	4.8	1.4	1.6	9.3	5.3	0.6	0.5	3.1	1.2	27.2	5.6	3.4	0.9	2.9	0.6	1.2	18.3	2.1	0.8	0.0	1.5	4.0	1.5	2.4	1.2	3.8	32.6	1.9	1.2	1.0	15.7	0.0	0.9	0.0	0.7	1.3	1.8	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.2	0.5	1.3	0.7	1.8	1.4	0.4	0.6	0.7	0.9	1.2	0.2	9.7	2.6	0.9	0.3	0.3	0.3	0.3	1.5	0.3	2.4	2.1	2.5	0.0	0.0	0.4	0.2	0.8	0.5	0.2	1.0	0.3	0.4	0.5	1.8	0.6	0.6	1.9	0.4	0.3	0.1	0.8	0.0	5.1	3.0	0.4	0.1	0.3	0.1	0.3	4.5	1.3	3.7	4.4	1.5	0.3	0.6	0.2	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	4.6	10.0	2.2	10.4	9.3	5.3	27.2	5.6	18.3	15.7
GK5	MGC40579	ENSG00000175066	"Glycerol kinase 5 (putative)"	Q6ZS86	3	142157527-142225607	"Enzymes, Predicted intracellular proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042606, HPA057998"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042606: AB_10795509, HPA057998: "	"unprognostic (7.79e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.59e-3)"	6.1	12.2	5.6	5.7	7.2	10.8	10.9	9.0	9.4	11.5	10.9	8.4	11.5	14.4	10.9	14.8	7.9	7.2	8.3	5.4	5.5	4.1	5.7	3.1	6.2	3.5	9.3	6.0	11.5	4.8	5.4	20.3	3.7	12.6	13.5	11.8	6.7	14.8	14.7	5.0	8.8	14.0	9.4	11.6	3.5	8.1	6.2	5.3	4.6	7.4	4.2	6.1	8.5	6.7	1.3	1.1	3.6	5.3	3.8	3.8	0.5	10.9	2.7	4.0	2.7	8.3	15.8	6.9	3.6	2.5	4.0	2.5	4.2	6.1	7.9	3.3	3.5	4.7	4.5	3.5	5.3	2.8	4.4	5.1	6.6	3.1	4.5	5.8	6.9	6.5	3.1	2.6	3.5	2.3	4.5	4.8	7.3	7.0	5.1	4.9	2.6	3.2	4.9	4.2	2.9	4.2	6.9	3.9	2.9	10.1	10.7	3.2	14.9	3.9	2.5	3.2	2.7	7.0	4.0	5.1	4.8	8.1	5.8	3.7	5.4	3.6	1.1	0.7	3.8	0.9	1.9	0.5	1.3	1.4	0.8	1.3	1.0	1.7	3.2	3.8	5.3	1.1	0.6	0.5	5.6	7.2	9.0	9.4	5.5	4.1	9.3	6.0	12.6	5.3
GKAP1	"FKSG21, GKAP42"	ENSG00000165113	"G kinase anchoring protein 1"	Q5VSY0	9	83739421-83829516	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 98.8"	"Cell line enhanced"	"Detected in many"		"U-266/84: 22.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035117, HPA035118, HPA066173"	Enhanced	Supported	Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA035117: , HPA035118: AB_10671100, HPA066173: AB_2732740"	"unprognostic (1.91e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.66e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.86e-2)"	"prognostic favourable (6.96e-5)"	"unprognostic (4.18e-1)"	"prognostic favourable (1.05e-6)"	"unprognostic (9.73e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.24e-3)"	4.4	4.2	6.0	2.8	6.1	2.5	9.2	15.6	6.1	4.7	5.0	4.1	6.6	3.0	5.5	4.5	3.2	3.9	3.4	9.0	6.1	6.8	4.2	5.1	2.9	2.6	6.5	3.1	7.0	5.2	6.2	7.9	2.0	6.1	6.6	2.7	3.2	4.2	5.9	25.0	1.7	3.0	8.1	8.0	2.4	3.5	98.8	7.2	8.4	8.1	5.2	2.7	6.0	14.7	1.9	0.6	3.0	0.8	5.3	1.9	0.1	4.8	6.0	4.4	5.8	0.6	0.0	6.2	1.9	1.5	3.0	3.1	0.8	2.7	7.5	1.9	0.8	1.0	4.3	0.5	5.1	8.9	3.9	4.3	3.0	4.3	6.5	2.0	0.4	0.2	3.5	1.5	1.6	2.7	3.5	6.3	0.9	4.5	10.5	6.9	3.6	3.0	7.4	9.9	2.6	3.1	0.8	14.7	8.7	4.3	2.0	3.4	0.8	4.1	0.9	1.0	7.1	0.7	3.3	10.3	22.6	2.9	2.2	1.4	1.2	3.0	0.8	0.6	1.4	0.0	1.3	1.7	1.3	1.5	0.6	1.9	1.0	1.9	2.5	5.3	0.3	0.3	1.5	0.1	6.0	6.1	15.6	6.1	6.1	6.8	6.5	3.1	6.1	7.2
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57460135-57472262	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.9;BJ hTERT+: 7.6;NTERA-2: 7.7;RH-30: 35.1;U-266/70: 9.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: , HPA068903: "	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	3.2	1.7	4.0	2.1	2.5	0.6	2.1	8.2	4.4	14.4	3.5	0.0	3.0	3.7	12.8	8.3	0.7	4.7	8.3	2.7	2.9	1.9	3.2	1.8	2.0	1.3	1.5	2.0	4.7	1.0	0.1	1.2	0.6	3.3	5.6	4.9	9.6	2.9	4.3	3.1	2.4	3.7	3.8	2.8	1.2	2.4	6.2	2.5	0.6	3.3	3.4	1.4	4.8	4.6	0.9	0.4	5.2	0.2	0.1	0.5	0.1	0.0	5.5	1.6	11.9	0.2	0.0	0.2	0.7	7.6	1.3	1.3	0.2	0.4	1.9	0.0	0.3	1.0	0.9	0.7	0.2	2.1	0.1	0.0	0.6	0.1	1.2	0.3	0.6	0.5	0.2	1.3	0.4	0.2	0.4	4.0	0.6	0.0	0.3	0.2	7.7	0.5	0.6	35.1	0.8	1.5	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	1.3	4.4	0.4	0.2	9.7	0.4	3.2	1.2	0.8	2.1	2.2	0.2	0.9	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.4	0.4	0.3	5.2	0.1	0.1	0.4	0.5	0.1	4.0	2.5	8.2	4.4	2.9	1.9	1.5	2.0	3.3	2.5
GLIPR1L2	MGC39497	ENSG00000180481	"GLIPR1 like 2"	Q4G1C9	12	75391070-75432688	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 44.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.7;SK-BR-3: 8.4;U-2 OS: 11.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039795, HPA039866"	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"				Vesicles	"Golgi apparatus, Cytosol"	"HPA039795: AB_10805595, HPA039866: AB_10795235"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.57e-2)"	1.3	3.1	5.5	1.2	10.4	0.8	3.0	2.9	5.8	2.2	1.2	4.2	2.9	1.0	2.7	4.2	1.4	3.5	1.5	2.5	5.5	4.6	2.5	1.9	2.7	1.1	6.6	3.9	7.7	3.0	7.3	5.2	1.3	6.2	2.3	0.8	2.0	1.4	3.6	2.4	2.2	1.2	1.5	8.1	1.9	1.0	44.0	5.0	1.4	2.8	0.5	0.8	1.7	1.4	1.4	2.6	2.0	0.7	1.0	3.4	0.6	0.3	0.5	0.3	0.5	4.3	2.5	0.7	0.6	0.5	0.2	0.3	0.1	0.4	0.3	1.5	0.4	0.2	0.1	0.1	0.4	0.8	0.3	0.1	0.6	5.7	3.2	0.5	0.1	0.8	1.3	0.6	2.3	0.2	0.3	0.7	1.1	0.1	0.6	0.4	0.3	0.2	0.1	0.1	0.3	0.1	0.4	1.1	0.6	0.7	8.4	2.4	2.5	0.2	1.2	1.0	11.1	1.2	0.4	1.0	1.0	0.3	0.4	0.3	0.8	1.8	0.3	0.5	1.1	0.2	0.7	1.1	1.2	2.0	0.4	1.4	2.2	3.3	2.0	1.0	0.7	2.6	3.4	0.6	5.5	10.4	2.9	5.8	5.5	4.6	6.6	3.9	6.2	5.0
GLIS2	NPHP7	ENSG00000126603	"GLIS family zinc finger 2"	Q9BZE0	16	4314761-4339597	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 27.5"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056976			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA056976: "	"unprognostic (2.86e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavourable (1.59e-5)"	"unprognostic (3.76e-1)"	"unprognostic (5.15e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.48e-1)"	"prognostic favourable (8.06e-6)"	"unprognostic (1.59e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.40e-3)"	3.6	6.0	1.5	2.3	1.6	0.0	2.4	4.3	2.4	5.0	4.4			1.2	5.8	1.0	1.2	4.3	7.4	8.4	0.9	1.2	11.5	0.3	7.8	1.4	1.4		8.0	3.2	2.2	5.3	5.7		5.6	0.2		3.0	5.8	1.1	1.5	1.2	4.3	0.2	0.8	2.7	1.9			5.3		0.5	5.6	2.7	0.3	0.0	0.2	0.0	0.0	0.1	0.0	4.0	10.4	1.7	3.8	1.4	5.6	3.5	4.4	4.2	1.6	1.2	2.8	2.9	0.0	7.7	4.8	2.5	1.0	4.5	0.1	4.6	0.0	0.0	7.9	1.4	6.1	0.0	0.8	3.3	1.1	1.4	0.7	1.5	0.3	1.8	1.1	2.6	0.1	0.8	3.7	1.8	6.7	2.3	4.7	0.0	0.1	0.7	3.6	5.1	2.2	1.0	6.1	0.7	3.4	2.3	3.9	27.5	1.3	0.8	0.5	1.2	0.9	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA031446: , HPA031448: "	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favourable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavourable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	4.9	6.6	12.5	8.1	14.8	9.0	10.3	21.3	19.5	7.4	6.8	6.6	5.1	5.1	11.5	8.6	10.1	6.3	5.7	7.2	9.4	6.9	6.4	5.2	5.3	10.6	6.8	13.2	8.3	4.7	8.5	13.6	7.9	8.6	7.6	7.3	13.9	4.9	6.9	7.5	13.5	6.6	6.9	8.0	7.6	5.8	11.2	5.7	13.3	9.0	4.8	12.1	7.9	6.9	2.5	2.0	1.4	1.4	9.0	5.5	1.9	12.1	4.7	15.7	8.6	5.6	8.8	14.5	8.5	7.0	10.6	9.5	9.6	4.8	12.3	13.7	5.0	9.3	8.2	7.7	15.3	8.7	11.6	16.4	9.3	9.5	5.5	20.7	8.6	6.8	4.5	12.4	5.6	11.4	13.6	7.6	13.9	2.8	12.7	15.8	23.9	8.5	11.0	21.6	8.5	12.0	11.8	14.5	7.5	14.7	14.0	8.8	6.7	20.0	7.1	7.7	7.5	13.2	12.7	6.7	9.1	15.5	2.9	21.0	4.5	0.0	0.7	1.4	3.2	1.4	5.5	2.5	3.5	3.9	2.0	1.5	3.1	3.6	0.2	9.0	0.8	1.4	2.7	1.9	12.5	14.8	21.3	19.5	9.4	6.9	6.8	13.2	8.6	5.7
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703141	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 244.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			1600000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: "	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	22.2	30.5	42.1	19.5	42.3	11.4	32.0	25.4	42.3	27.1	42.1	19.7	22.9	48.1	25.3	49.2	28.2	31.5	17.8	39.2	37.8	37.7	37.1	65.3	30.7	31.6	38.9	29.7	37.6	25.9	33.2	12.6	26.7	40.6	74.0	22.7	21.7	21.7	28.2	57.5	31.3	64.3	28.9	37.6	25.6	21.3	12.9	21.4	19.8	32.6	42.5	24.3	28.6	24.7	25.9	28.6	8.5	15.6	10.8	24.4	14.7	18.1	8.4	24.2	24.0	11.5	20.8	21.4	15.8	15.0	22.3	23.2	20.5	7.0	20.2	12.5	12.6	12.0	20.7	20.4	28.3	18.3	32.0	29.9	10.9	19.1	17.3	11.3	244.2	17.7	12.6	21.1	15.1	24.0	23.5	13.4	20.8	15.3	17.7	14.4	17.4	16.5	15.4	29.3	13.2	20.3	13.7	18.9	19.1	11.1	15.5	29.8	18.0	57.1	9.9	17.4	16.0	15.0	25.0	10.6	20.0	55.5	6.3	29.4	27.9	8.5	9.8	6.9	18.0	15.6	24.4	24.7	18.1	18.3	18.3	25.9	17.1	17.9	1.2	10.8	12.1	28.6	15.7	14.7	42.1	42.3	25.4	42.3	37.8	37.7	38.9	29.7	40.6	21.4
GLOD4	"C17orf25, CGI-150, HC71"	ENSG00000167699	"Glyoxalase domain containing 4"	Q9HC38	17	757097-783390	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021623, HPA023246, HPA023248"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol			3800000	Cytosol	"Nucleoplasm, Nucleoli"	"HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (2.18e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"	21.7	29.5	31.3	16.7	35.6	10.2	19.1	26.0	36.2	17.8	37.1	21.5	16.5	43.0	22.3	23.3	23.6	24.9	20.9	19.7	26.1	38.5	41.6	40.4	16.8	22.8	23.0	34.8	22.9	32.3	13.9	19.4	28.1	28.6	21.1	26.6	21.9	29.2	20.9	21.4	27.5	42.5	24.7	18.2	23.8	43.4	17.9	18.2	22.7	26.0	19.2	24.0	25.2	17.5	27.5	17.9	17.8	24.6	22.8	36.7	26.0	40.3	36.6	42.2	23.3	18.6	18.5	25.8	32.4	19.9	26.3	20.0	29.6	29.0	48.2	35.3	14.5	29.3	36.8	20.5	27.5	35.3	31.4	23.2	20.3	38.7	18.5	23.9	30.7	12.9	28.6	26.4	23.2	24.2	37.9	31.4	27.7	24.9	41.0	18.4	30.9	12.5	41.1	17.1	22.1	25.9	27.6	19.3	32.4	25.7	18.6	41.5	23.1	25.4	31.5	25.1	20.1	35.1	40.5	17.7	32.2	29.6	29.8	26.9	26.2	9.2	19.8	17.8	27.7	24.2	30.2	27.0	33.6	33.3	17.5	27.5	28.7	31.3	2.7	22.8	24.6	17.9	36.7	26.0	31.3	35.6	26.0	36.2	26.1	38.5	23.0	34.8	28.6	18.2
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95823005	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 94.4;skeletal muscle: 141.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 83.5;U-87 MG: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008634, HPA046431, CAB069419"	Approved		Approved	"Plasma membrane,Cytosol"			13000000	"Plasma membrane, Cytosol"		"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: "	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	17.7	20.7	6.2	15.0	6.6	30.6	10.5	15.5	15.5	5.4	22.6	3.1	4.0	40.2	2.9	4.6	3.1	3.7	9.5	25.2	12.1	7.8	45.9	46.9	23.1	21.5	7.8	5.9	3.5	2.6	9.5	6.4	63.9	7.6	5.7	8.8	2.4	17.9	5.5	141.6	7.3	42.5	4.5	7.3	15.2	8.2	2.2	4.0	14.4	6.3	6.4	14.3	11.6	5.8	16.0	52.2	94.4	81.6	11.2	48.9	71.1	3.2	14.7	1.1	2.4	31.8	45.8	0.2	49.2	83.5	5.3	8.9	3.6	1.5	12.8	7.0	14.8	1.2	1.8	23.4	14.8	11.1	3.7	9.3	9.7	33.8	60.6	9.8	27.5	28.5	2.8	33.7	3.3	10.1	1.2	7.7	33.4	1.1	16.9	17.4	3.2	16.8	27.4	10.1	15.8	63.9	2.4	3.3	1.8	12.9	6.4	5.6	1.7	9.7	11.7	14.0	15.8	11.1	2.0	5.5	28.2	10.2	68.6	24.7	2.9	3.8	81.6	94.4	26.2	51.0	35.7	16.0	24.1	19.5	52.2	10.7	24.1	22.1	85.7	11.2	40.5	18.0	48.9	71.1	6.2	6.6	15.5	15.5	12.1	7.8	7.8	5.9	7.6	4.0
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.1;bone marrow: 25.4;liver: 24.7"	"Group enriched"	"Detected in some"	7	"MOLT-4: 12.2;NTERA-2: 17.6;SCLC-21H: 8.3"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 23.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	3.0	0.6	7.0	7.0	12.4	25.4	0.6	7.1	15.5	1.8	0.6	1.2	0.2	0.5	4.1	1.4	0.9	2.1	2.1	1.2	6.3	10.5	1.2	24.7	2.2	4.5	5.8	6.4	0.6	1.2	0.4	1.0	1.0	7.6	1.3	0.7	2.6	0.4	1.9	8.2	1.3	0.6	3.6	1.6	9.2	0.6	14.7	1.3	0.1	2.0	0.0	0.8	1.7	0.6	0.0	1.4	23.1	3.8	0.0	0.3	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.1	0.0	1.1	1.4	0.0	0.8	7.0	12.4	7.1	15.5	6.3	10.5	5.8	6.4	7.6	1.3
GLTP		ENSG00000139433	"Glycolipid transfer protein"	Q9NZD2	12	109850943-109880488	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 82.0;lymphoid tissue: 78.0;skin 1: 84.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056461	Approved		Supported	Cytosol			280000	Cytosol		"HPA056461: "	"unprognostic (1.18e-1)"	"prognostic favourable (2.01e-5)"	"unprognostic (7.46e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (7.68e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (4.17e-6)"	"unprognostic (3.28e-2)"	7.0	5.8	11.4	6.1	16.4	6.6	10.5	4.7	19.3	21.8	13.2	31.3	6.6	5.4	5.4	13.4	82.0	4.9	5.4	6.4	15.9	9.7	13.7	4.5	9.2	7.0	22.4	8.9	5.9	7.7	5.7	3.4	7.9	14.8	8.0	11.8	4.0	21.2	8.0	6.1	84.3	8.2	7.1	48.7	7.4	7.6	4.0	24.7	6.2	8.9	60.6	78.0	10.8	38.5	11.8	23.2	16.7	32.3	21.2	26.7	17.2	14.0	10.0	5.8	6.2	13.9	16.0	4.3	17.4	21.7	13.6	11.4	4.0	5.4	12.4	9.4	21.4	17.3	9.0	20.6	19.3	12.6	8.0	8.1	6.1	6.0	12.2	8.6	9.6	11.8	25.9	24.2	17.2	22.7	3.7	8.6	19.8	19.5	11.7	7.1	10.5	13.6	10.5	13.8	13.0	7.6	42.3	7.4	7.4	11.0	28.6	9.3	13.3	3.1	31.0	15.5	8.3	22.8	13.1	11.4	9.4	8.5	31.3	9.1	9.6	16.7	32.3	16.5	26.7	30.8	16.2	11.8	16.1	23.3	23.2	11.4	10.5	18.8	15.8	21.2	24.8	3.7	17.6	17.2	11.4	16.4	4.7	19.3	15.9	9.7	22.4	8.9	14.8	24.7
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182381704-182392206	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 138.5;ASC TERT1: 97.9;HSkMC: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 92.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 92.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	Mitochondria,Cytosol			28000	"Mitochondria, Cytosol"		"CAB008636: AB_1616669, HPA007316: AB_1078981, HPA007571: AB_1078980"	"prognostic favourable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	173.3	19.2	83.7	37.2	91.0	47.6	63.1	48.5	80.7	41.9	20.4	49.9	9.4	6.2	20.5	29.7	54.0	31.6	26.2	23.5	74.0	48.7	15.6	64.9	39.5	36.9	71.0	48.8	66.2	49.0	7.4	8.9	41.8	70.6	17.4	23.3	39.3	30.4	25.5	159.8	27.9	16.4	30.5	51.3	36.1	71.4	24.0	55.2	8.6	63.9	15.5	24.2	34.7	32.2	2.5	11.0	92.2	21.1	3.4	6.3	18.6	2.9	1.2	13.7	0.0	138.5	97.9	10.1	5.0	16.2	3.0	2.7	7.2	3.0	2.5	5.4	9.7	6.8	5.9	35.6	2.5	6.8	16.6	33.5	5.7	14.0	7.3	14.7	26.8	84.6	42.8	3.8	45.4	6.1	28.2	1.5	10.7	1.6	22.9	14.1	10.1	6.4	8.3	3.6	4.3	5.3	13.0	9.4	6.2	1.4	18.3	1.9	17.8	18.7	4.5	0.1	0.2	0.0	1.1	0.5	0.3	0.0	2.6	8.4	0.5	43.6	21.1	54.9	6.3	20.5	2.6	1.6	4.5	5.2	11.0	2.5	2.3	3.9	92.2	3.4	17.1	6.1	1.7	18.6	83.7	91.0	48.5	80.7	74.0	48.7	71.0	48.8	70.6	55.2
GLYATL1	"FLJ34646, MGC15397"	ENSG00000166840	"Glycine-N-acyltransferase like 1"	Q969I3	11	58905398-59043527	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 113.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.9;Daudi: 9.6;RPTEC TERT1: 3.2;U-2197: 2.5"	"Group enriched"	"Detected in some"	8	"liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"									HPA039501	Supported		Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA039501: "	"unprognostic (9.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-5)"	"unprognostic (3.93e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-1)"	"prognostic favourable (3.69e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.92e-1)"	"prognostic favourable (3.03e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.1	27.7	113.8	0.1	0.0	0.2	0.0	0.2	0.2	0.9	0.1	0.0	0.5	2.1	0.0	0.5	1.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.1	1.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	1.3	0.0	0.5	0.2	1.1	0.8	3.9	0.0	9.6	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.4	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.4	3.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.2	0.1	2.5	1.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1
GLYATL1B	GLYATL1P3	ENSG00000255151	"Glycine-N-acyltransferase like 1B"		11	59086307-59094786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	7	"blood: 4.9;breast: 12.5;lymphoid tissue: 4.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.8;Karpas-707: 2.2;T-47d: 3.2;U-2197: 2.5;U-266/70: 4.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"					"Group enriched"	"Detected in some"	17	"memory B-cell: 1.9;naive B-cell: 4.9"	"Lineage enriched"	"Detected in single"	24	"B-cells: 4.9"									HPA039501	Uncertain		Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA039501: "	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"						"unprognostic (1.44e-1)"			"unprognostic (1.25e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.21e-4)"	"unprognostic (3.45e-1)"		0.0	0.0		1.0		0.0	12.5		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	4.1			0.0	0.0	0.0		0.0		0.9	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.6	0.0	0.0			0.0		0.0	0.0		4.9	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	0.0	0.3	0.4	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.5	2.5	0.2	4.9	1.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52293476	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 108.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 18.9;Hep G2: 25.1"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"				Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	6.4	4.9	1.9	8.4	5.0	5.2	4.8	2.7	6.2	2.3	7.9	7.1	4.2	23.8	4.3	4.8	2.8	2.5	7.2	2.7	1.9	2.2	10.7	108.4	3.1	6.5	2.5	4.9	2.3	3.6	1.9	2.5	3.1	3.9	2.8	3.5	4.7	3.2	3.0	7.0	1.9	17.8	1.9	1.8	5.5	6.0	2.7	1.8	3.3	3.1	2.4	5.9	2.7	2.2	8.3	9.1	10.9	9.5	5.7	11.8	6.3	2.2	5.5	3.0	1.1	16.0	2.2	1.8	2.5	2.6	4.7	3.5	18.9	1.9	5.9	1.5	2.2	1.5	1.7	6.2	0.9	1.6	1.9	8.3	6.7	25.1	1.5	2.7	5.0	2.1	3.1	6.9	2.7	9.0	2.2	4.3	3.6	1.7	4.6	2.2	1.6	4.6	1.5	2.7	8.9	4.8	3.1	2.2	2.2	2.4	1.3	2.5	3.1	1.3	3.8	3.7	4.4	2.4	4.8	4.5	3.1	3.8	2.5	4.5	2.8	3.0	9.5	10.9	11.8	5.1	6.1	8.3	9.0	10.3	9.1	5.7	6.8	10.1	7.8	5.7	6.1	5.6	11.7	6.3	1.9	5.0	2.7	6.2	1.9	2.2	2.5	4.9	3.9	1.8
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847342	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favourable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	24.1	33.2	39.1	29.4	37.4	27.5	22.5	26.3	44.8	24.8	32.6	31.0	32.8	30.7	30.0	20.6	32.1	33.9	26.1	28.3	29.8	24.8	39.0	30.5	24.5	27.6	27.0	33.1	22.2	27.4	53.4	34.7	24.1	37.1	30.4	32.3	28.5	29.9	29.4	41.6	24.3	29.9	30.1	27.3	30.7	33.9	17.4	26.0	27.6	29.6	17.2	30.0	35.3	22.7	7.6	8.3	22.2	14.5	5.2	7.5	5.5	12.9	14.4	23.8	14.8	21.0	16.9	22.9	24.4	18.3	18.8	16.1	20.3	23.1	21.1	23.3	22.5	14.3	29.8	20.5	16.9	34.2	17.9	21.7	17.4	14.2	11.9	35.0	40.4	16.0	16.3	17.6	13.1	23.8	36.2	18.2	20.3	21.0	28.4	19.4	28.3	10.9	36.8	18.7	25.9	23.0	19.4	29.2	14.8	26.5	24.8	11.3	27.8	37.1	26.3	12.9	14.5	57.9	15.2	15.2	21.1	44.1	9.2	17.4	26.2	6.3	10.9	5.7	7.5	9.8	6.5	5.1	4.9	7.1	7.3	7.6	5.2	4.6	22.2	5.2	14.5	8.3	4.9	5.5	39.1	37.4	26.3	44.8	29.8	24.8	27.0	33.1	37.1	26.0
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627041	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: "	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	9.3	8.2	7.4	9.0	9.8	29.8	8.4	13.5	11.5	8.7	10.5	7.7	6.9	9.6	10.6	6.1	10.0	11.0	9.5	7.4	8.1	6.2	7.7	9.3	8.7	11.5	6.0	6.5	11.5	17.6	9.6	9.5	14.5	7.2	9.9	5.1	9.8	16.0	7.5	10.1	10.0	11.0	10.3	7.1	12.1	8.8	18.8	5.7	24.7	18.0	9.5	10.4	9.2	13.8	3.0	2.6	4.4	5.6	1.9	4.5	2.2	10.7	6.6	8.1	7.0	3.9	3.6	10.8	7.5	4.8	12.1	6.4	20.4	8.0	8.6	7.9	6.5	15.4	6.3	11.0	5.4	4.6	7.1	6.6	9.6	9.8	5.3	6.3	11.0	5.2	10.5	7.8	9.8	5.3	9.7	6.2	4.2	11.6	15.3	13.8	5.8	10.7	16.7	8.3	7.9	4.9	9.6	12.2	10.0	13.5	12.0	7.8	14.6	10.4	6.5	13.3	7.3	7.9	8.2	11.9	9.8	13.6	8.0	5.9	8.6	0.0	1.9	3.2	4.5	2.6	4.3	2.1	4.0	3.9	2.1	3.0	4.5	3.9	4.4	1.9	5.6	2.6	2.7	2.2	7.4	9.8	13.5	11.5	8.1	6.2	6.0	6.5	7.2	5.7
GMFB	GMF	ENSG00000197045	"Glia maturation factor beta"	P60983	14	54474484-54489196	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Approved	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			1000000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (7.93e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"prognostic favourable (9.48e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.09e-2)"	14.2	13.2	37.9	12.9	26.7	14.2	15.3	25.1	41.6	11.8	19.8	23.9	6.1	19.1	11.6	8.5	9.3	8.4	9.7	9.6	36.7	30.1	19.9	14.7	13.8	13.3	36.9	28.3	9.8	7.3	10.1	13.6	17.9	25.6	9.0	20.7	6.6	7.0	8.0	4.1	7.8	17.5	10.5	54.4	10.1	10.7	6.2	21.7	6.4	12.8	6.1	13.5	10.0	7.4	9.1	12.8	16.4	14.5	9.0	8.8	6.8	30.4	12.3	24.7	18.0	26.7	33.4	18.5	31.2	23.0	22.7	28.4	14.2	27.0	28.0	14.8	30.7	11.3	24.9	21.6	36.0	10.1	8.6	14.0	13.9	13.1	22.8	19.5	12.3	25.3	20.3	19.7	19.5	20.4	10.2	9.9	35.9	15.1	11.9	7.6	15.9	13.1	12.1	29.0	8.1	29.0	29.0	14.7	22.8	21.7	18.5	23.6	20.4	15.5	16.1	33.0	25.1	16.7	19.3	3.5	6.2	17.5	27.8	12.1	20.8	8.7	11.0	9.2	6.1	13.5	8.5	7.6	7.2	6.0	12.8	9.1	7.8	8.2	16.4	9.0	14.5	5.2	8.8	6.8	37.9	26.7	25.1	33.5	36.7	30.1	36.9	28.3	25.6	21.7
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 77.0;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			1500000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favourable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	22.6	6.1	7.3	29.6	7.4	80.9	16.8	2.2	4.8	6.0	8.8	4.0	1.7	5.3	4.4	9.4	6.4	7.3	8.7	7.5	6.0	4.9	9.4	9.7	28.5	42.2	8.6	2.3	4.7	3.6	1.1	3.1	18.0	5.8	6.1	7.9	4.9	8.1	2.3	5.4	4.2	17.8	6.8	8.2	86.0	5.9	2.9	5.6	109.5	9.8	7.0	37.1	11.1	7.5	39.1	57.2	276.5	79.4	41.6	88.0	106.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.8	33.5	0.3	0.0	0.2	0.0	0.1	0.1	11.3	0.0	36.5	0.0	0.5	0.6	39.0	77.0	0.1	0.0	0.0	0.1	2.0	1.3	59.8	0.3	0.0	35.5	43.6	0.0	0.0	49.0	0.4	21.9	0.0	5.2	0.1	0.0	0.1	0.2	0.2	0.1	76.8	20.0	0.0	0.4	0.1	0.1	3.4	11.6	38.3	0.2	52.7	0.3	185.2	79.4	178.1	37.7	72.3	40.0	39.1	56.7	46.6	57.2	35.0	55.9	46.4	276.5	41.6	78.9	22.2	88.0	106.7	7.3	7.4	2.2	4.8	6.0	4.9	8.6	2.3	5.8	5.6
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643667	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: , HPA045481: "	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavourable (3.97e-5)"	"prognostic favourable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (5.15e-4)"	6.1	2.8	3.5	20.3	4.9	31.0	4.0	0.9	4.1	2.9	6.9	4.3	2.7	7.0	2.7	3.2	6.2	4.4	7.9	3.3	4.3	3.4	4.2	3.9	11.7	28.0	4.2	2.5	2.4	4.6	10.6	3.0	3.9	3.4	4.1	4.6	2.7	6.0	4.5	1.5	4.9	15.3	2.9	4.9	40.0	11.1	2.2	3.1	26.8	6.2	2.7	23.2	6.1	4.5	6.6	6.7	32.7	13.9	4.2	6.4	4.6	4.4	2.0	2.7	3.0	3.0	1.6	11.0	2.8	2.4	1.7	1.6	1.6	5.9	10.8	5.7	1.9	5.3	1.7	3.0	1.1	3.7	2.8	3.4	3.2	1.7	0.9	9.6	43.0	2.0	2.1	1.8	0.9	3.8	2.3	3.9	1.8	6.5	6.0	15.9	1.6	3.7	10.4	1.2	6.2	3.2	10.5	2.3	7.1	3.8	4.0	1.6	3.7	13.8	6.8	3.1	1.8	3.5	2.0	2.0	0.8	8.9	2.0	12.6	2.1	2.9	8.3	21.5	6.4	10.6	5.9	5.9	4.0	5.7	6.7	6.6	4.5	4.6	32.7	4.2	13.9	6.1	4.5	4.6	3.5	4.9	0.9	4.1	4.3	3.4	4.2	2.5	3.4	3.1
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870536-155944026	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol				Cytosol		"HPA046630: "	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	15.9	18.3	10.4	19.7	14.0	24.6	22.4	22.1	24.9	16.1	13.9	9.8	15.3	10.3	17.5	15.4	19.5	14.0	10.8	15.3	9.2	7.7	11.0	14.7	15.8	19.5	9.3	12.1	15.7	23.5	19.1	14.1	13.5	14.8	13.0	15.3	9.0	21.6	18.6	16.6	21.0	12.6	16.1	8.9	14.6	15.4	60.9	10.5	28.3	13.6	12.5	18.4	15.9	18.5	11.1	17.2	10.9	18.1	19.0	20.7	10.8	55.8	22.1	30.1	24.5	12.2	19.4	29.0	23.8	22.1	31.5	31.9	40.3	37.7	40.4	28.5	18.3	27.5	25.5	25.0	43.4	23.4	19.6	43.0	16.2	21.8	14.0	43.7	16.8	14.3	15.4	24.3	37.3	19.3	30.2	15.5	23.4	37.5	35.4	23.1	28.8	16.4	34.9	35.6	48.7	16.2	24.6	18.0	16.7	26.5	38.0	23.8	39.7	28.8	13.5	20.9	16.9	29.5	48.0	21.7	13.3	69.1	21.0	32.6	18.6	10.9	10.4	7.2	17.3	13.1	20.7	11.1	16.8	15.7	17.2	8.8	16.8	15.8	1.4	19.0	18.1	9.5	17.6	10.8	10.4	14.0	22.1	24.9	9.2	7.7	9.3	12.1	14.8	10.5
GNA12	gep	ENSG00000146535	"G protein subunit alpha 12"	Q03113	7	2728112-2844324	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010046	Approved		Supported	Cytosol				Cytosol		"CAB010046: AB_2263416"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavourable (1.20e-6)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.45e-3)"	"unprognostic (7.90e-2)"	"prognostic unfavourable (4.71e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.27e-4)"	19.4	15.0	26.5	12.3	22.8	10.5	11.9	12.9	22.5	13.7	11.9	19.4	5.2	5.9	13.8	5.9	9.2	12.1	11.0	17.6	22.9	19.3	7.6	7.3	10.4	14.2	25.2	11.4	21.9	13.4	9.5	13.8	27.2	22.1	11.4	7.4	7.4	8.8	14.2	5.4	4.4	8.5	16.8	24.4	11.7	9.1	11.5	18.2	4.6	7.7	3.9	11.4	13.3	12.8	4.7	4.3	2.5	3.1	0.2	1.8	0.9	15.5	8.6	8.9	13.3	14.3	11.5	24.7	13.1	15.3	14.3	16.5	8.2	11.1	3.3	9.0	15.5	7.0	6.1	13.6	9.7	39.6	6.1	6.7	4.7	8.6	16.7	1.1	6.0	11.1	7.4	16.7	11.3	15.1	7.5	10.5	12.8	7.3	1.8	6.2	12.4	15.0	11.8	10.3	6.7	5.2	10.6	7.1	10.2	7.4	11.1	5.5	6.2	9.3	17.8	15.6	18.8	15.2	21.5	7.4	8.7	3.0	16.8	10.0	15.3	2.5	1.3	0.2	0.6	3.1	0.9	2.7	1.5	0.8	1.1	4.7	1.4	0.2	0.3	0.2	0.8	4.3	1.8	0.9	26.5	22.8	12.9	19.7	22.9	19.3	25.2	11.4	22.1	18.2
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65010715-65056839	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol			4000000	Cytosol		"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	28.2	17.4	16.4	25.3	17.5	75.6	15.1	15.1	15.0	14.2	19.1	23.0	13.0	14.0	12.9	12.1	13.2	12.1	17.7	15.4	16.8	13.3	12.4	17.4	27.6	27.5	18.5	9.4	16.3	10.0	12.1	10.0	25.0	14.8	16.8	17.3	10.7	10.5	13.9	35.0	11.4	17.5	15.9	32.1	22.5	13.6	11.3	20.4	34.9	11.9	9.0	27.5	28.3	26.0	5.7	5.5	15.8	13.4	7.8	11.2	4.4	11.6	13.2	12.1	8.2	12.6	11.4	12.5	9.1	10.6	12.5	14.3	7.4	7.8	47.6	6.0	9.8	8.1	12.9	11.1	19.3	12.3	7.5	24.8	8.0	14.5	18.2	18.5	16.5	9.6	17.0	12.0	16.6	18.8	10.0	29.7	14.4	11.0	28.4	6.7	7.5	9.8	16.5	24.3	17.3	12.6	19.1	8.9	18.8	6.6	13.8	15.6	14.2	18.1	13.4	20.8	18.3	8.9	11.9	22.0	26.1	54.0	7.6	12.0	11.0	7.1	6.4	8.5	7.2	13.4	7.3	5.7	8.9	8.5	5.5	4.8	5.2	5.7	15.8	7.8	8.3	2.5	11.2	4.4	16.4	17.5	15.1	15.0	16.8	13.3	18.5	9.4	14.8	20.4
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259355	"Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			53000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favourable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	81.9	37.8	50.8	69.5	47.2	102.5	53.4	17.7	45.3	56.2	47.9	67.2	34.5	22.6	51.4	41.1	44.4	47.1	55.5	57.0	44.6	48.0	34.1	50.9	72.8	78.7	53.3	34.3	54.0	21.4	24.9	42.1	81.3	46.8	44.3	22.5	38.5	25.8	60.0	29.6	29.0	35.7	53.6	81.8	96.7	30.1	28.5	45.9	70.0	37.7	32.4	55.5	60.7	49.8	5.3	14.2	35.8	19.4	6.1	8.4	5.6	15.1	8.2	24.8	24.8	30.5	38.3	4.5	33.0	53.3	47.6	49.1	9.2	21.4	18.1	14.5	74.4	12.1	17.7	46.1	30.5	38.5	6.2	45.5	22.3	14.3	30.1	41.5	60.6	37.1	20.6	43.1	17.7	111.5	3.0	39.3	47.5	19.6	35.1	44.9	13.3	32.1	22.0	11.9	26.4	30.6	17.1	6.1	10.4	24.1	7.3	15.2	11.5	43.1	97.0	41.1	24.1	38.7	33.0	24.9	31.7	15.9	46.3	56.7	49.2	2.6	16.5	23.4	8.4	19.4	4.9	5.0	6.3	7.6	14.2	5.3	5.0	5.7	35.8	6.1	15.0	11.7	6.6	5.6	50.8	47.2	17.7	45.3	44.6	48.0	53.3	34.3	46.8	45.9
GNAL		ENSG00000141404	"G protein subunit alpha L"	P38405	18	11688956-11885685	"Disease related genes, Predicted intracellular proteins"		Transducer	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 18.0;HeLa: 18.5;U-2 OS: 9.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"basal ganglia: 82.7"	"Group enriched"	"Detected in some"	4	"basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.7;T-cells: 4.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	13	"basal ganglia: 183.9"	"CAB015464, HPA051160"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB015464: AB_831819, HPA051160: "	"unprognostic (2.29e-3)"	"unprognostic (7.43e-2)"	"unprognostic (8.14e-3)"	"unprognostic (3.41e-5)"	"unprognostic (4.71e-2)"	"unprognostic (9.58e-3)"	"unprognostic (9.93e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.03e-2)"	7.2	1.5	17.8	3.0	82.7	0.7	4.2	2.7	18.1	8.0	3.7	3.2	3.3	1.6	6.7	2.4	8.2	4.1	4.6	2.2	7.1	7.6	4.2	1.3	2.5	5.1	6.6	5.3	3.2	1.3	1.0	20.7	2.9	8.8	9.9	3.7	2.1	4.6	18.1	18.3	7.0	2.0	9.9	3.3	1.8	2.1	6.2	11.3	0.9	8.0	1.4	5.7	9.5	7.7	0.4	0.2	1.7	0.2	0.5	4.2	1.4	0.5	5.9	7.3	0.5	0.6	0.1	0.8	0.1	0.2	0.5	0.0	6.4	1.1	18.0	1.2	0.1	0.3	6.8	5.7	0.0	3.8	6.2	0.1	18.5	3.6	0.0	0.2	0.4	0.8	8.6	0.0	0.1	0.0	1.6	0.2	0.2	0.2	0.2	0.5	6.0	0.1	0.1	1.0	0.2	0.4	0.2	6.7	0.1	8.5	0.4	2.1	0.2	0.2	1.0	0.7	9.5	0.3	1.8	0.3	0.1	0.1	0.3	0.2	0.2	1.1	0.2	0.4	4.2	0.1	0.1	0.4	0.5	2.9	0.0	0.3	0.2	2.2	1.7	0.5	0.1	0.2	0.1	1.4	17.8	82.7	2.7	12.7	7.1	7.6	6.6	5.3	8.8	11.3
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716087-78031458	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 18.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"			28000000	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: "	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	12.7	12.6	24.3	9.9	20.8	21.8	11.6	12.5	29.6	13.1	16.6	17.1	9.1	7.9	13.7	11.2	13.1	10.0	11.6	5.6	24.2	18.3	12.1	12.3	23.1	11.8	19.1	14.6	13.5	8.5	12.7	7.6	12.1	14.3	13.0	16.0	10.4	9.8	15.9	5.9	5.1	9.0	18.2	23.9	5.8	15.5	6.0	14.8	18.6	13.3	4.0	4.8	14.5	13.1	0.8	2.8	18.4	3.5	3.3	2.0	1.2	12.1	13.9	12.3	13.5	15.6	16.0	17.8	16.5	12.5	7.3	8.8	4.2	10.0	0.0	13.4	15.1	20.0	9.1	10.0	9.1	0.4	5.3	33.3	12.1	8.5	14.1	20.3	12.5	10.9	12.3	14.1	14.4	17.8	5.8	0.1	12.8	15.4	23.4	12.9	10.0	2.0	8.7	15.1	0.1	16.5	26.1	13.8	21.1	11.9	10.1	12.4	9.1	7.6	22.3	12.8	0.8	17.4	9.6	0.1	0.0	0.1	8.8	12.0	13.2	18.4	2.2	4.6	0.8	1.9	1.6	0.8	1.8	1.0	2.4	0.8	2.0	1.6	7.7	3.3	3.5	2.8	1.9	1.2	24.3	20.8	12.5	24.0	24.2	18.3	19.1	14.6	14.3	14.8
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.6	32.5	54.8	25.5	93.1	42.6	49.2	55.8	51.0	63.9	45.8	94.7	50.1	31.7	86.9	72.5	41.8	50.2	74.3	43.3	20.9	30.2	35.2	49.4	62.0	43.1	20.4	22.2	50.7	37.8	31.0	41.7	48.3	30.9	43.3	42.0	132.2	104.3	50.1	17.4	34.4	64.2	48.0	55.9	51.2	38.2	68.0	155.7	77.6	77.0	62.2	58.9	56.1	53.1	84.8	76.2	30.5	52.5	75.9	49.0	66.9	37.2	10.0	43.2	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4
GNB1L	"GY2, WDR14"	ENSG00000185838	"G protein subunit beta 1 like"	Q9BYB4	22	19783224-19854939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034627, HPA034628"	Approved		Approved	Cytosol				Cytosol		"HPA034627: AB_10600662, HPA034628: AB_10600440"	"unprognostic (2.14e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.68e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.26e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.64e-5)"	"unprognostic (9.80e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.86e-2)"	6.1	6.4	6.9	12.4	10.3	7.7	8.7	11.6	16.1	7.4	7.2	5.7	8.2	18.6	8.9	7.1	9.8	8.0	5.7	5.8	6.9	5.7	5.2	5.4	6.2	9.9	6.1	9.9	7.6	12.8	3.1	6.0	11.3	5.4	7.7	2.8	4.6	9.4	7.5	13.9	12.6	10.0	4.3	5.5	13.2	8.9	6.1	4.9	30.3	8.3	4.6	8.6	7.9	8.2	11.6	12.8	14.5	7.3	10.9	16.1	7.6	6.9	5.4	1.6	4.7	0.5	0.9	4.3	4.8	1.3	2.4	2.2	9.5	2.7	9.4	3.1	1.1	13.4	1.1	2.3	0.3	6.0	18.0	5.6	6.6	4.6	1.5	6.4	1.5	0.8	1.0	2.1	0.8	0.9	33.8	3.6	0.4	9.9	14.2	9.3	2.7	9.1	7.5	4.3	2.1	0.2	2.8	3.2	3.4	1.8	4.7	8.1	1.2	1.6	2.2	5.3	6.5	8.6	4.8	4.7	3.9	4.9	5.8	5.8	1.8	5.5	5.9	14.5	13.7	7.3	13.2	9.6	13.3	10.4	9.5	11.6	13.0	11.7	5.9	10.9	5.5	12.8	16.1	7.6	6.9	10.3	11.6	16.1	6.9	5.7	6.1	9.9	5.4	4.9
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.0;salivary gland: 45.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol				Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favourable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	7.7	6.7	6.0	6.5	8.3	8.3	16.6	11.1	12.1	7.9	20.7	7.0	4.6	2.9	8.0	3.9	7.6	6.7	5.2	7.6	7.8	6.8	6.8	55.0	5.5	6.0	6.0	7.8	9.8	8.4	4.1	7.0	20.2	10.2	10.1	30.1	4.8	45.3	5.0	10.5	3.7	7.2	11.7	10.9	4.5	4.9	3.4	5.3	3.2	4.6	4.2	7.9	8.6	7.9	3.9	2.2	1.2	2.7	2.4	4.2	1.8	4.4	19.9	8.9	7.6	10.1	10.1	12.9	6.2	7.9	8.6	11.1	4.8	14.2	5.8	6.6	10.3	1.7	6.7	2.0	9.6	10.9	0.6	5.0	11.7	6.6	6.9	0.1	14.3	6.6	2.0	14.3	13.5	3.6	6.3	12.1	8.3	0.7	8.1	2.6	5.1	11.2	6.7	7.5	1.6	47.6	8.2	7.6	6.9	6.6	2.3	5.7	2.1	5.1	5.2	5.7	5.9	6.8	5.4	5.3	11.3	3.2	7.8	4.3	8.1	0.7	1.7	0.9	2.7	2.2	1.8	2.4	3.4	2.9	1.4	3.9	4.0	4.2	1.2	2.4	2.7	2.2	1.5	1.8	6.0	8.3	11.1	12.1	7.8	6.8	6.0	7.8	10.2	5.3
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530211-54561071	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	12.7	12.9	10.3	16.1	12.3	19.2	12.5	8.6	13.1	10.8	10.2	14.8	10.5	8.5	15.2	10.2	16.3	11.0	10.1	15.3	8.1	8.0	12.0	12.5	13.0	15.5	13.0	10.8	13.2	17.5	15.9	16.9	12.0	10.2	10.6	13.3	12.3	13.3	12.4	24.0	13.2	13.5	15.0	11.5	17.6	11.7	5.9	13.9	20.5	18.0	12.0	18.6	13.7	13.1	17.2	11.4	20.2	15.2	21.8	17.7	11.5	11.1	27.7	5.7	11.8	5.9	4.0	10.6	6.7	4.9	7.5	6.0	23.4	9.2	15.7	12.9	9.6	10.9	19.2	8.4	10.4	10.8	9.9	15.7	22.2	11.0	4.5	24.4	15.5	5.8	4.0	17.6	10.6	8.1	10.3	15.8	7.5	21.7	13.8	5.1	16.6	15.6	14.9	13.1	15.2	5.7	17.7	9.4	5.6	21.8	13.5	6.3	17.8	6.2	11.5	13.7	13.7	13.2	11.3	11.9	15.2	20.2	7.1	20.2	15.2	18.9	14.2	15.1	17.7	12.6	16.1	15.0	16.2	15.4	11.4	17.2	12.4	13.0	20.2	21.8	15.2	9.6	8.6	11.5	10.3	12.3	8.6	13.1	8.1	8.0	13.0	10.8	10.2	13.9
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960758-42963880	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 83.9;pancreas: 100.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 10.3;SCLC-21H: 12.2;T-47d: 7.8"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 17.7"	"Low region specificity"	"Detected in all"			HPA027501	Enhanced		Approved	Cytosol			150000	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favourable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0.0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0.0	2.5	0.1	0.4	5.2	0.0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2.0	0.9	0.0	1.2	0.3	0.5	0.4	1.8	5.0	0.6	0.2	0.3	0.4	2.0	0.8	1.2	0.1	0.1	1.6	0.2	0.4	0.5	0.3	0.3	0.2	2.0	1.6	1.3	1.0	10.3	0.0	1.1	2.4	0.4	0.0	0.4	0.2	0.0	1.4	1.9	0.3	2.2	2.0	3.7	0.2	0.5	1.7	1.6	1.0	0.8	0.2	12.2	1.7	0.1	1.7	0.6	7.8	3.5	0.4	0.9	0.9	0.5	1.0	1.3	1.1	1.4	0.2	2.0	1.0	0.0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2.0	0.0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1
GNPTG	"C16orf27, c316G12.3, CAB56184, GNPTAG"	ENSG00000090581	"N-acetylglucosamine-1-phosphate transferase gamma subunit"	Q9UJJ9	16	1351923-1364113	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004055	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		420000000	"Endoplasmic reticulum"	Cytosol	"HPA004055: AB_1079006"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.07e-2)"	23.1	67.3	38.0	16.9	35.7	19.9	20.2	22.0	38.8	19.6	23.5	41.7	22.2	16.5	18.9	28.4	17.3	19.1	22.2	17.8	38.5	31.7	29.9	41.1	21.7	22.6	39.3	28.6	22.3	34.6	33.7	25.1	27.2	28.9	21.1	15.6	20.5	37.8	22.2	28.1	33.4	19.5	15.1	43.3	26.3	21.2	18.0	31.0	11.1	24.0	13.2	13.2	20.0	17.8	15.5	29.3	25.8	37.1	14.6	21.7	20.9	4.7	7.6	5.6	9.8	51.7	19.2	7.2	13.9	18.2	5.5	10.6	6.8	13.4	3.0	16.1	18.7	8.7	3.4	8.1	2.8	9.5	7.4	3.9	23.7	11.6	21.9	6.4	16.0	25.6	14.2	5.3	7.6	10.1	4.7	17.9	9.1	10.8	3.0	6.4	5.2	4.3	10.8	4.8	13.6	13.7	6.2	4.4	5.8	14.0	14.5	10.0	13.4	9.7	9.8	11.1	9.5	9.1	6.7	18.9	13.7	6.2	9.1	5.6	7.3	25.8	37.1	22.2	21.7	34.0	19.9	15.5	18.7	20.5	29.3	14.6	17.3	15.8	15.0	14.6	31.9	24.7	21.3	20.9	38.0	35.7	22.0	38.8	38.5	31.7	39.3	28.6	28.9	31.0
GOLGA8A	"GM88, GOLGIN-67"	ENSG00000175265	"Golgin A8 family member A"	A7E2F4	15	34379068-34437466	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 30.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"NK-cell: 2.7"	"Low lineage specificity"	"Detected in single"											HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA051808: "	"unprognostic (4.80e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-3)"	"prognostic favourable (7.58e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"prognostic favourable (5.68e-6)"	2.6	4.7	3.6	5.1	4.4	3.1	5.8	20.1	3.5	6.3	3.5			5.8	5.3	18.0	4.1	3.7	3.6	2.9	3.9	3.7	2.6	0.4	2.3	6.5	3.3		7.4	3.3	8.0	2.4	0.7		4.6	0.8		6.7	5.3	2.6	18.4	4.0	1.2	3.8	8.3	3.3	8.3			5.7		0.6	2.6	5.3	0.7	0.0	0.8	0.0	2.7	0.2	0.0	1.0	5.9	1.7	5.9	0.0	0.0	1.2	9.2	0.0	1.5	0.7	10.3	0.0	0.0	1.7	1.1	9.7	4.3	3.1	2.4	8.9	3.6	21.7	30.0	6.5	0.6	8.3	5.8	0.0	8.9	1.0	0.2	0.1	19.7	18.4	4.1	1.8	2.2	15.1	3.1	3.2	8.8	5.2	7.3	3.4	6.1	8.0	3.7	6.1	4.2	1.0	1.6	5.0	4.8	7.4	1.7	0.0	1.6	17.7	5.8	2.5	2.3	17.7	1.6	0.0	0.0	0.8	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0										
GOLGA8B		ENSG00000215252	"Golgin A8 family member B"	A8MQT2	15	34525207-34588503	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 25.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 14.3;Hep G2: 12.7;NB-4: 19.7"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	16	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 2.2"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA051808: "	"unprognostic (2.12e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.90e-3)"	"unprognostic (9.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (9.38e-6)"	"unprognostic (2.14e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.31e-1)"	"prognostic favourable (5.79e-4)"	2.6	3.4	0.0	2.8	0.6	6.8	4.3	2.5	2.7	2.5	2.0			0.0	4.1	6.1	0.8	3.8	2.8	1.6	0.0	0.7	3.0	2.3	4.5	8.0	0.0		9.0	25.2	0.1	4.9	0.9		5.4	0.1		4.6	5.2	1.8	3.3	5.4	0.5	0.0	5.2	4.0	5.3			16.4		3.1	3.0	1.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	2.0	2.2	0.2	4.2	2.3	4.6	6.0	1.8	0.5	2.1	3.5	2.2	2.8	0.0	4.0	1.9	1.7	0.8	1.9	1.7	2.9	7.0	0.3	14.3	12.7	3.4	1.7	2.3	6.6	2.6	1.2	3.8	2.1	0.7	0.2	1.9	1.0	0.8	19.7	2.6	3.8	0.1	0.0	0.3	1.7	4.0	3.2	4.8	1.0	0.3	2.2	1.9	3.9	0.0	3.1	7.3	0.9	3.2	1.4	1.3	2.9	1.0	0.9	0.8	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GOLPH3L	GPP34R	ENSG00000143457	"Golgi phosphoprotein 3 like"	Q9H4A5	1	150646225-150697144	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028558			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA028558: AB_10601656"	"unprognostic (1.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.24e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-2)"	16.5	19.4	16.0	10.2	14.6	4.9	18.6	20.7	16.7	21.6	26.5	10.5	26.2	15.7	19.3	30.0	36.6	24.6	14.8	11.7	10.6	15.5	21.3	13.0	14.5	10.5	12.2	11.0	22.7	30.4	16.8	30.8	14.1	15.9	19.2	32.6	16.5	25.4	22.4	16.1	17.3	20.2	14.9	11.0	15.0	19.5	14.9	12.1	21.1	30.7	11.7	20.8	21.6	22.2	10.6	11.7	7.1	3.1	16.2	13.1	4.9	6.9	6.8	3.8	2.2	9.7	7.0	6.3	6.4	9.9	7.1	10.2	3.0	12.5	8.8	9.3	4.6	6.1	6.3	5.5	8.6	5.9	6.9	9.8	3.7	4.0	8.5	8.0	7.8	4.7	9.4	7.4	16.0	10.4	7.9	5.7	4.1	7.1	6.7	3.4	7.2	6.7	4.7	4.4	10.0	8.2	4.7	5.9	5.5	3.3	9.4	4.6	7.1	8.9	8.2	2.4	3.9	3.1	5.4	7.2	6.2	98.2	6.8	8.3	3.1	7.1	1.5	2.7	9.7	1.3	13.1	10.6	9.8	9.5	8.1	8.8	12.9	9.6	1.3	16.2	3.1	11.7	10.3	4.9	16.0	14.6	20.7	16.7	10.6	15.5	12.2	11.0	15.9	12.1
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532129-170553446	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027208, HPA027250, HPA027746"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favourable (1.39e-4)"	"prognostic unfavourable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	7.7	14.7	8.4	9.4	9.2	0.5	10.6	8.7	9.5	10.7	9.4	4.8	7.0	4.8	8.8	10.5	6.3	6.8	6.7	8.2	7.4	7.8	7.2	11.1	6.8	9.6	6.3	8.1	12.6	9.7	6.5	20.6	9.4	8.7	11.1	10.4	6.3	8.8	13.1	3.3	6.5	7.0	6.4	11.1	10.4	5.6	8.6	7.3	8.7	10.5	4.2	9.7	10.4	10.0	6.2	7.3	1.2	7.4	7.9	9.4	5.5	5.1	5.0	9.6	3.6	12.8	9.5	6.3	7.8	12.0	6.9	7.1	3.2	8.7	7.5	8.9	7.8	6.5	9.5	4.6	9.2	8.0	2.9	5.0	6.5	4.0	8.6	6.6	5.1	8.3	4.5	7.3	6.9	5.4	6.8	3.7	7.3	1.2	9.4	6.0	8.5	6.3	5.7	6.4	9.9	6.2	3.8	2.4	5.3	6.4	7.8	18.1	5.0	11.6	6.8	10.9	5.8	4.3	10.7	6.7	7.2	6.6	9.1	6.0	9.8	1.0	7.4	0.0	4.7	7.4	7.4	6.1	8.3	7.2	7.3	6.2	7.3	6.2	1.2	7.9	5.7	4.6	9.4	5.5	8.4	9.2	8.7	9.5	7.4	7.8	6.3	8.1	8.7	7.3
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol			130000000	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favourable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	16.9	9.4	11.1	28.0	8.6	7.4	31.4	13.9	25.6	24.3	26.5	21.3	13.8	16.6	4.8	11.7	21.3	25.3	18.3	26.8	5.7	10.8	6.3	12.1	27.7	45.6	18.0	10.8	11.6	19.8	20.6	55.9	11.7	16.2	26.0	15.5	15.3	9.6	13.5	7.1	13.1	10.5	10.6	17.3	42.4	9.3	4.8	7.1	10.5	14.9	51.9	28.5	6.2	5.4	6.2	13.8	6.7	15.9	18.6	21.9	16.9	16.3	9.4	8.2	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.7"	"Cell line enriched"	"Detected in some"	9	"HEL: 18.6"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA072646			Uncertain	Cytosol			400000000	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.3	0.0	0.4	2.1	0.5	1.6	0.3	0.3	0.3	0.6	0.3	0.3	0.3	0.0	0.3	0.3	0.3	2.5	0.3	0.3	0.4	0.6	0.3	0.6	0.9	3.7	0.3	0.3	0.8	0.3	0.0	0.4	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.3	1.7	0.2	0.3	0.3	0.3	1.0	0.3	1.9	0.3	0.5	0.1	1.1	0.2	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.4	0.1	0.1	2.0	2.2	0.1	0.0	0.0	1.1	0.0	0.4	0.4	0.5	0.3	0.3	0.4	0.6	0.3	0.3	0.3	0.3
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.2;kidney: 43.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 54.5;HMC-1: 20.0;U-87 MG: 23.8;WM-115: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 42.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029414, CAB033749"	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB033749: AB_2224941, HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favourable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavourable (8.21e-4)"	7.9	0.7	0.7	5.2	1.4	5.2	17.5	4.2	2.9	3.7	18.0	1.2	1.3	20.2	3.0	2.1	5.1	2.1	6.0	24.8	1.2	2.2	43.7	9.0	3.2	4.5	1.9	0.8	12.9	1.7	11.8	5.8	1.2	9.5	2.6	5.7	1.3	3.6	1.9	35.9	1.9	47.2	3.7	3.0	4.3	7.4	4.6	1.4	0.9	26.6	14.6	3.4	4.5	7.2	0.0	23.2	42.0	9.7	0.5	1.8	2.9	10.4	10.3	0.0	0.1	0.5	1.3	0.2	0.8	1.5	0.2	0.2	0.7	54.5	0.0	1.1	2.0	2.3	4.9	0.9	0.1	0.7	2.3	0.0	3.2	10.0	1.4	2.9	20.0	0.7	0.0	0.4	1.2	5.1	8.3	8.2	0.2	1.0	0.7	0.7	0.2	4.4	0.1	2.3	3.9	10.3	0.7	0.2	0.0	2.0	2.1	5.7	0.4	0.5	0.2	2.5	4.4	2.4	9.8	0.4	0.7	0.0	23.8	5.9	18.2	42.0	9.7	1.0	0.2	7.7	1.8	0.0	1.0	0.6	23.2	0.0	0.7	0.3	26.4	0.5	6.1	0.1	0.6	2.9	0.7	1.4	4.2	2.9	1.2	2.2	1.9	0.8	9.5	1.4
GPATCH2L	"C14orf118, FLJ10033, FLJ20689"	ENSG00000089916	"G-patch domain containing 2 like"	Q9NWQ4	14	76151916-76254342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018856	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018856: AB_1845553"	"unprognostic (5.98e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.81e-1)"	15.3	12.4	15.5	14.6	20.6	40.1	14.3	17.9	22.4	12.8	14.1	18.1	9.0	10.5	17.0	12.9	14.8	12.3	16.0	20.6	11.2	9.3	12.2	11.2	16.2	14.5	14.3	12.7	16.2	12.4	14.0	20.2	14.1	16.7	14.4	13.9	17.9	13.4	13.8	18.2	13.9	14.0	19.1	12.2	13.0	12.8	19.7	14.4	18.1	14.4	8.7	16.2	15.5	15.0	8.7	10.6	11.5	10.9	7.6	8.1	5.1	12.2	16.2	12.8	10.5	7.7	13.5	10.8	14.5	10.3	14.4	14.1	10.8	20.6	14.8	8.7	11.1	14.8	15.6	9.7	25.1	16.4	8.9	13.4	16.3	6.9	9.9	8.8	19.1	12.3	9.2	12.1	15.7	14.4	13.4	20.7	12.6	20.3	11.8	11.8	16.4	11.8	13.4	16.0	7.6	9.9	24.9	10.6	13.6	16.5	14.6	8.3	17.0	14.1	16.0	18.5	10.8	10.3	11.0	20.7	19.6	19.2	14.8	12.3	18.9	6.9	10.9	11.5	5.7	9.3	4.8	8.7	3.1	8.1	10.6	6.8	6.7	4.8	8.3	7.6	6.7	8.2	6.4	5.1	15.5	20.6	17.9	22.4	11.2	9.3	14.3	12.7	16.7	14.4
GPATCH3	"FLJ12455, GPATC3"	ENSG00000198746	"G-patch domain containing 3"	Q96I76	1	26890488-26900466	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032078, HPA054973"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA032078: AB_10603671, HPA054973: "	"unprognostic (2.93e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavourable (1.23e-7)"	"unprognostic (4.37e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.46e-2)"	"prognostic favourable (6.42e-4)"	"unprognostic (3.77e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.82e-2)"	11.7	14.5	13.1	10.2	13.6	31.8	13.0	19.5	20.9	9.4	11.7	15.8	11.8	13.0	11.8	14.5	11.6	10.3	12.0	9.6	11.6	10.9	10.9	14.8	10.5	12.4	12.6	10.8	11.8	11.8	12.0	10.1	13.3	13.6	10.3	10.1	10.1	10.4	10.5	21.5	16.0	11.7	10.4	12.1	15.4	12.0	17.2	16.2	16.9	10.1	10.5	11.7	10.5	12.2	12.4	17.4	22.4	16.8	8.1	16.0	12.8	8.8	7.3	6.9	11.0	6.7	6.4	9.4	7.0	7.9	13.9	12.2	9.7	10.6	8.2	7.7	6.8	9.3	11.4	12.7	7.3	9.2	17.2	15.8	16.0	20.6	9.3	10.9	11.1	9.9	11.8	14.0	7.4	9.0	18.6	10.8	5.7	8.1	9.3	21.3	16.1	11.0	11.8	9.8	13.1	7.0	4.8	9.1	11.2	13.4	11.9	20.7	10.5	11.5	9.2	9.0	10.4	12.1	7.8	14.0	19.2	10.9	8.1	15.8	7.8	22.4	16.8	19.7	16.0	13.7	12.9	12.4	13.3	14.0	17.4	12.1	14.0	13.2	7.1	8.1	15.8	13.3	11.4	12.8	13.1	13.6	19.5	20.9	11.6	10.9	12.6	10.8	13.6	16.2
GPBP1	"DKFZp761C169, vasculin"	ENSG00000062194	"GC-rich promoter binding protein 1"	Q86WP2	5	57173948-57264679	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA037773	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Cytosol"	"Plasma membrane"	"HPA037773: AB_10671721"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (3.70e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.57e-1)"	"prognostic favourable (4.15e-5)"	25.6	33.1	33.8	27.0	37.8	38.0	37.2	53.9	34.0	30.6	23.5	29.7	20.3	20.8	29.0	33.1	25.5	32.4	24.5	25.4	32.5	28.4	27.1	28.4	29.9	34.0	41.5	34.0	46.7	23.5	37.6	43.9	35.6	33.2	27.6	24.9	19.7	27.2	26.9	37.3	24.6	25.8	22.0	42.4	31.5	24.0	46.9	37.2	49.9	35.1	20.3	33.7	29.4	50.2	31.7	18.9	35.5	18.9	33.5	37.7	27.1	21.7	17.4	33.4	28.1	21.9	21.8	30.8	16.6	28.3	27.6	35.6	28.2	25.3	28.9	19.5	17.0	15.0	28.5	19.2	34.9	16.4	19.6	23.7	19.9	23.4	25.5	17.1	24.6	17.7	29.8	22.4	31.5	22.2	24.1	47.6	22.0	27.3	27.0	30.0	20.8	12.2	29.2	27.4	28.4	21.2	22.7	30.1	23.3	24.3	21.8	26.5	42.6	29.3	14.7	10.1	20.6	14.6	24.0	36.3	30.3	32.2	16.9	25.9	18.8	35.5	17.1	32.3	28.1	17.7	35.2	31.7	34.0	33.1	18.9	26.8	37.7	34.9	33.2	33.5	18.9	13.4	35.3	27.1	33.8	37.8	53.9	34.0	32.5	28.4	41.5	34.0	33.2	37.2
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435671-240468078	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 142.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030571	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"		6500000	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (5.78e-5)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	13.6	22.8	32.4	7.2	21.0	1.9	8.1	42.7	33.6	11.5	8.1	10.1	9.5	5.4	9.6	9.8	26.3	7.8	7.1	40.7	26.5	11.9	8.5	11.0	7.4	4.0	8.8	22.5	14.1	18.1	5.8	14.4	20.2	13.6	29.5	4.0	6.3	16.3	17.6	62.9	142.6	4.9	12.0	8.3	5.2	6.5	20.0	10.5	1.7	4.5	24.3	10.7	10.5	15.2	0.9	0.1	0.0	0.0	0.1	0.8	0.3	16.0	22.1	5.2	13.7	16.0	15.4	21.3	38.6	19.2	4.5	5.2	7.9	18.0	0.4	5.3	40.8	44.4	2.8	27.4	0.9	7.7	2.3	0.0	20.3	9.7	23.0	0.3	1.5	13.5	17.9	10.0	5.2	2.3	0.1	0.8	11.4	8.4	0.2	0.1	8.2	4.9	2.8	23.9	3.7	3.6	26.0	5.2	3.5	25.2	22.3	2.3	7.0	1.6	10.8	24.0	40.7	11.4	15.9	0.1	0.1	0.1	17.1	0.4	26.8	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.3	32.4	21.0	42.7	33.6	26.5	11.9	8.8	22.5	13.6	10.5
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398607-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;kidney: 14.8;testis: 11.3"	"Group enriched"	"Detected in some"	11	"CACO-2: 30.6;HeLa: 17.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA040152: , HPA044081: "	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavourable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.8	3.8	11.8	1.1	18.3	0.8	0.7	3.1	18.9	0.6	1.5	2.9	0.1	0.7	0.6	0.9	0.6	0.8	1.6	2.3	11.8	6.0	14.8	2.9	6.5	1.0	7.3	5.6	1.5	0.8	0.6	7.7	1.4	19.4	0.9	1.5	0.0	0.8	1.5	0.6	0.7	0.8	0.8	4.4	0.7	0.9	11.3	6.6	0.0	2.7	0.0	0.7	0.6	0.3	0.5	0.4	0.3	1.8	2.0	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	17.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.5	0.1	1.2	0.4	0.2	0.0	0.5	0.3	2.0	1.8	0.0	0.0	0.2	11.8	18.3	3.1	8.6	11.8	6.0	7.3	5.6	19.4	6.6
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.1	107.4	9.4	73.5	30.9	23.0	22.5	29.4	23.2	37.1	44.8	60.5	27.0	50.2	43.7	28.8	53.1	56.8	63.9	42.2	55.8	22.9	64.5	51.8	63.6	20.0	83.5	42.0	31.5	26.4	43.9	22.8	34.6	32.8	39.8	26.1	64.6	36.3	29.2	25.4	38.0	34.0	24.9	94.8	46.5	51.3	51.4	29.9	59.3	104.6	21.4	23.7	26.6	29.8	14.0	30.9	39.8	45.3	73.5	41.7	45.5	46.8	63.5	28.4	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0
GPN1	"ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1"	ENSG00000198522	"GPN-loop GTPase 1"	Q9HCN4	2	27628247-27651508	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036793, HPA036794, CAB037303"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230"	"unprognostic (9.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (2.88e-5)"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavourable (1.71e-5)"	"unprognostic (3.50e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	24.3	24.3	18.8	18.7	23.2	28.1	26.3	22.9	27.2	18.3	21.6	20.7	13.7	19.3	21.3	21.2	26.7	21.0	18.2	21.5	17.2	22.1	29.7	29.2	18.2	29.2	20.0	16.1	24.6	35.4	19.8	18.5	31.1	23.3	18.8	25.6	14.3	23.0	17.6	30.9	25.0	25.3	22.1	16.4	26.6	20.8	30.2	15.9	29.0	26.9	22.5	28.3	21.5	24.3	29.1	35.8	28.5	28.2	39.6	38.6	29.7	32.1	18.3	17.2	12.5	16.3	16.7	17.5	18.0	17.9	25.5	18.9	19.9	16.9	20.1	17.5	19.6	14.0	23.9	22.3	25.9	18.7	16.7	23.0	14.7	24.2	21.2	33.6	12.1	17.1	19.7	26.2	24.6	26.6	28.5	18.9	30.1	18.7	20.3	25.2	29.8	18.0	20.5	51.1	21.0	20.6	18.6	15.4	24.4	19.7	22.2	20.0	13.3	19.5	21.6	22.3	32.9	11.0	42.1	21.9	23.5	54.1	32.0	29.2	18.3	28.5	24.7	21.1	33.4	28.2	36.0	29.1	31.1	38.6	35.8	25.2	27.7	34.1	3.7	39.6	26.3	18.5	30.3	29.7	18.8	23.2	22.9	27.2	17.2	22.1	20.0	16.1	23.3	15.9
GPN3	"ATPBD1C, MGC14560"	ENSG00000111231	"GPN-loop GTPase 3"	Q9UHW5	12	110452484-110469268	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039764, HPA047793"	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA039764: , HPA047793: "	"unprognostic (1.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.82e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.27e-3)"	"prognostic unfavourable (3.98e-5)"	"unprognostic (5.50e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	"prognostic favourable (2.65e-6)"	"unprognostic (5.81e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.27e-1)"	17.8	15.1	14.1	11.2	17.3	9.6	26.7	18.4	14.2	13.0	12.5	11.9	10.1	5.9	14.9	11.8	15.6	15.1	10.2	24.8	11.4	10.9	23.3	23.2	13.6	14.8	26.6	11.4	19.4	14.5	19.6	12.2	15.4	18.6	17.0	10.0	11.0	16.6	14.3	35.1	9.6	8.7	17.5	20.0	16.0	13.6	28.3	19.4	11.8	20.1	22.0	12.6	16.5	13.1	20.2	28.0	34.4	31.4	11.8	18.9	16.8	15.2	23.5	16.4	16.0	18.4	11.7	21.7	20.9	12.7	23.6	19.2	21.9	9.1	29.3	14.6	11.4	14.0	20.2	18.8	32.2	16.7	18.8	17.3	12.7	18.0	12.8	27.0	16.0	12.4	11.9	23.1	15.0	17.0	29.1	6.7	16.5	10.3	24.7	51.5	20.0	24.1	8.5	22.6	22.4	14.8	13.7	12.6	13.0	21.4	14.6	17.7	24.9	31.9	9.3	19.7	14.5	19.1	24.1	9.2	23.8	30.5	14.5	25.0	22.4	15.3	24.5	34.4	14.0	31.4	15.5	20.2	15.0	15.8	22.6	19.9	18.9	12.6	12.6	11.8	31.1	28.0	12.3	16.8	14.1	17.3	18.4	14.2	11.4	10.9	26.6	11.4	18.6	19.4
GPR142	PGR2	ENSG00000257008	"G protein-coupled receptor 142"	Q7Z601	17	74367407-74372622	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.3;lymphoid tissue: 1.3"	"Cell line enhanced"	"Detected in single"		"U-937: 1.1"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031392	Uncertain		Uncertain	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA031392: AB_10601935"	"unprognostic (6.81e-2)"		"unprognostic (1.75e-1)"			"unprognostic (1.98e-1)"		"unprognostic (1.34e-1)"		"unprognostic (1.36e-1)"	"unprognostic (6.54e-5)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-7)"	"unprognostic (3.95e-2)"	"unprognostic (7.72e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-3)"	0.2	0.0	0.0	1.3	0.1	0.0	0.1	1.3	0.2	0.3	0.1			0.8	0.6	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.2	0.0		0.1	0.8	0.0	0.0	0.1		0.2	0.1		0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPR155	"DEP.7, DEPDC3, FLJ31819, PGR22"	ENSG00000163328	"G protein-coupled receptor 155"	Q7Z3F1	2	174431571-174487094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5;stomach 1: 43.2"	"Cell line enhanced"	"Detected in many"		"U-266/70: 16.0;WM-115: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036159, HPA057384"	Approved		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA036159: AB_10671835, HPA057384: "	"unprognostic (3.91e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.11e-4)"	"unprognostic (5.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.54e-2)"	4.5	10.1	9.3	6.6	34.5	2.6	3.0	15.1	17.3	3.2	11.4	6.1	2.2	4.0	2.6	13.1	6.7	2.5	5.9	6.8	15.5	9.4	19.8	7.3	3.3	5.9	7.7	11.5	3.0	16.9	8.0	3.2	4.7	27.4	8.0	4.2	4.9	3.7	8.8	5.1	13.4	5.1	7.8	6.9	5.3	43.2	2.6	9.9	1.6	8.3	0.8	3.8	6.6	3.6	1.5	0.8	9.6	6.8	4.7	7.0	1.9	0.7	0.4	1.0	2.4	5.6	3.1	0.6	4.2	1.4	0.7	2.4	0.3	0.3	2.4	1.3	2.9	0.4	1.4	1.3	2.3	0.9	1.6	2.5	1.4	0.2	1.0	0.9	1.3	4.5	3.6	2.1	0.7	1.1	0.4	6.0	4.7	0.7	1.7	1.1	0.5	1.7	2.0	6.1	1.1	2.4	1.5	6.5	5.5	1.3	1.0	2.1	0.4	0.4	3.0	3.1	1.2	4.4	0.6	16.0	2.3	0.4	3.5	0.8	10.5	1.5	2.9	0.1	2.4	5.4	2.2	1.3	4.4	4.0	0.8	1.5	3.5	5.4	9.6	4.7	6.8	0.5	7.0	1.9	9.3	34.5	15.1	16.2	15.5	9.4	7.7	11.5	27.4	9.9
GPR158	KIAA1136	ENSG00000151025	"G protein-coupled receptor 158"	Q5T848	10	25175062-25602226	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;seminal vesicle: 11.2"	"Group enriched"	"Detected in some"	5	"HEL: 20.7;T-47d: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013185	Uncertain		Approved	Cytosol				Cytosol		"HPA013185: AB_2113957"	"unprognostic (4.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.66e-5)"	"unprognostic (5.67e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.60e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (3.90e-1)"	0.9	2.4	3.6	1.0	16.2	0.8	0.8	28.4	25.2	0.8	1.1	1.6	6.1	0.9	0.8	1.0	0.8	0.8	0.8	0.8	1.9	2.8	0.8	0.9	0.9	0.8	2.4	4.8	0.8	0.9	1.5	8.9	1.5	14.9	1.2	1.1	1.4	0.8	11.2	0.8	0.8	1.2	0.8	4.0	0.9	1.1	1.9	2.9	0.0	1.0	0.0	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	20.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.5	1.1	1.9	5.7	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	16.2	28.4	11.6	1.9	2.8	2.4	4.8	14.9	2.9
GPR173	SREB3	ENSG00000184194	"G protein-coupled receptor 173"	Q9NS66	X	53049091-53080615	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2"	"Cell line enhanced"	"Detected in many"		"HAP1: 10.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.7;NK-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003905			Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA003905: AB_1078922"	"unprognostic (2.68e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.95e-3)"	"prognostic unfavourable (2.88e-6)"	"unprognostic (3.87e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (2.33e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.47e-4)"	"unprognostic (1.08e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.95e-2)"	2.5	5.2	8.2	3.0	9.4	2.2	3.1	15.4	23.2	4.2	2.8	11.6	0.8	1.8	6.4	5.0	2.4	7.7	3.3	4.2	7.9	10.0	2.4	1.1	2.8	2.1	7.3	11.2	15.0	1.3	1.3	14.6	4.5	9.7	3.2	2.6	6.4	2.0	5.4	4.6	3.9	2.1	4.5	6.5	4.0	2.1	2.4	9.6	0.7	3.1	0.1	1.5	3.3	2.8	0.9	0.7	5.7	0.4	1.8	0.7	0.0	0.0	0.0	8.2	0.5	4.7	2.8	0.0	1.3	3.0	2.2	2.6	0.8	0.1	0.2	2.0	2.8	0.7	10.3	0.0	1.9	0.6	1.0	0.5	8.4	0.3	6.8	0.5	0.1	6.6	0.0	3.3	4.7	3.5	0.0	5.7	3.2	4.2	0.0	0.0	6.3	3.6	0.1	2.5	0.3	0.5	0.4	5.9	8.3	0.0	0.4	0.0	1.1	0.1	6.5	3.6	5.2	2.3	1.1	0.2	0.3	0.7	2.5	0.0	2.0	5.7	0.2	0.3	0.7	0.1	0.5	0.3	0.2	0.1	0.1	0.9	0.5	0.4	1.2	1.8	0.4	0.7	0.0	0.0	8.2	9.4	15.4	15.1	7.9	10.0	7.3	11.2	9.7	9.6
GPR20		ENSG00000204882	"G protein-coupled receptor 20"	Q99678	8	141356500-141367267	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 6.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 3.7;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 5.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.3"	HPA071337			Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA071337: "	"unprognostic (4.47e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.23e-2)"	"unprognostic (4.07e-1)"	2.8	0.5	0.7	2.7	1.4	0.1	2.5	0.2	2.0	10.6	9.1	1.0	4.3	2.2	6.7	1.9	3.4	3.9	6.1	2.1	0.8	0.4	1.1	0.4	3.5	0.3	1.4	0.9	3.7	0.5	0.5	0.5	3.2	2.1	2.2	1.0	1.1	0.5	3.0	2.1	1.0	10.5	4.5	0.5	0.8	4.3	1.6	0.7	0.0	1.4	1.5	0.5	1.7	3.4	0.0	0.3	0.3	5.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	6.9	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.1	0.7	1.4	0.2	2.0	0.8	0.4	1.4	0.9	2.1	0.7
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71754050-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;parathyroid gland: 29.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.8;HL-60: 12.2;MCF7: 10.5;NTERA-2: 21.1;RPTEC TERT1: 10.1;SH-SY5Y: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.7;neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favourable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.7	4.5	14.9	1.7	23.2	14.5	4.3	4.4	15.4	3.4	1.0	5.8	1.7	0.6	5.5	3.3	2.7	7.7	1.2	3.5	12.8	12.4	3.2	0.9	2.4	5.5	10.6	8.8	5.0	2.6	29.6	5.1	2.0	5.9	5.7	0.7	3.3	1.7	5.1	1.8	1.9	0.7	3.3	16.8	3.7	2.4	4.2	3.6	0.0	6.8	1.2	0.5	2.1	2.8	0.0	0.2	10.5	0.8	0.0	0.4	0.1	0.0	0.8	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	12.8	0.0	0.0	3.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	12.2	0.7	0.0	2.2	0.0	0.9	0.0	0.0	0.0	0.0	10.5	0.8	0.2	21.1	0.0	0.0	0.0	0.0	10.1	5.7	2.2	8.0	2.8	0.0	0.0	7.4	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	3.7	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	10.5	0.0	0.1	0.0	0.0	0.1	14.9	23.2	4.4	9.9	12.8	12.4	10.6	8.8	5.9	3.6
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697277	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.1;U-937: 1.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 60.8;eosinophil: 25.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	25.1	12.4	15.1	9.7	16.6	0.4	15.0	2.1	11.7	10.5	9.1	13.5	1.0	4.4	4.9	6.6	5.8	5.5	12.2	5.9	16.0	9.5	11.7	5.3	11.4	26.8	22.4	7.5	5.4	4.4	2.8	3.3	29.3	15.4	5.7	9.3	4.9	7.1	6.4	2.1	2.4	11.4	11.5	34.0	22.3	5.1	5.0	21.4	1.9	3.4	1.5	11.1	12.5	3.7	0.3	0.4	60.8	2.8	3.0	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.1	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.3	0.5	0.1	1.1	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.8	0.1	0.0	0.0	0.1	0.6	1.4	0.0	60.8	2.2	25.3	0.0	2.8	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.2	3.0	1.5	0.0	0.1	0.5	15.1	16.6	2.1	11.7	16.0	9.5	22.4	7.5	15.4	21.4
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124745997-124765627	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 62.4"	"Cell line enhanced"	"Detected in many"		"AF22: 9.4;fHDF/TERT166: 21.9;hTCEpi: 9.7;SK-BR-3: 8.5;TIME: 15.3"	"Cancer enhanced"	"Detected in many"		"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"			48000	"Nuclear membrane, Cytosol"		"HPA042903: , HPA068009: "	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favourable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	1.6	1.0	14.5	1.1	19.6	0.9	1.7	2.3	52.6	1.5	1.4	62.4	0.0	1.0	2.1	1.4	7.8	2.1	1.4	0.9	23.9	11.3	1.2	8.8	1.3	1.1	33.5	12.3	1.0	3.0	0.8	0.3	10.0	23.3	1.8	1.5	3.5	1.6	1.8	1.1	4.1	1.3	3.0	49.4	4.3	1.2	15.5	26.5	0.0	0.9	0.0	0.9	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	9.4	0.0	0.0	0.0	2.7	0.5	2.5	2.4	0.6	0.4	0.8	0.0	0.0	21.9	0.2	2.7	0.0	0.5	0.4	1.2	0.1	5.9	0.0	2.8	0.0	0.4	0.0	9.7	0.0	0.1	4.5	0.0	4.3	0.0	0.5	0.0	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.1	2.2	3.3	0.0	8.5	3.2	2.2	0.0	15.3	2.0	0.7	0.0	0.0	1.3	0.0	0.0	1.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	19.6	2.3	19.6	23.9	11.3	33.5	12.3	23.3	26.5
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794126-96837463	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 7.8;HHSteC: 12.7;Karpas-707: 19.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	1.8	3.4	3.8	3.1	11.0	0.8	1.6	7.5	10.7	3.3	3.9	1.6	1.0	5.1	1.9	1.5	2.0	2.8	2.7	1.9	3.2	2.2	1.4	0.5	1.4	0.9	2.2	6.4	4.0	5.0	3.9	4.3	2.5	10.1	3.3	6.2	2.5	1.7	2.2	1.0	1.7	3.6	3.6	1.4	1.3	4.1	8.0	5.2	2.5	2.3	0.0	0.9	2.2	4.8	0.8	0.9	2.6	0.6	1.4	1.1	0.1	0.0	0.1	1.5	0.3	2.1	0.8	0.4	0.9	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.1	1.1	4.9	2.2	0.0	7.8	3.7	4.6	0.4	0.0	12.7	2.9	0.5	2.4	0.4	0.0	3.4	0.0	3.3	19.0	0.4	0.4	2.2	0.0	4.9	0.7	0.0	1.7	3.8	0.3	0.2	2.2	1.4	0.3	3.0	0.5	1.2	0.6	0.0	1.3	1.9	0.2	1.7	1.5	0.8	0.1	0.8	1.8	1.0	0.8	0.6	0.2	0.6	0.2	0.3	0.7	1.1	0.6	0.1	0.8	1.0	0.9	2.6	1.4	0.2	0.9	0.3	0.1	3.8	11.0	7.5	10.7	3.2	2.2	2.2	6.4	10.1	5.2
GPR65	"hTDAG8, TDAG8"	ENSG00000140030	"G protein-coupled receptor 65"	Q8IYL9	14	88005124-88014811	"G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.4;lymphoid tissue: 40.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.1;HEL: 6.6;HL-60: 7.9;HMC-1: 10.2;RH-30: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA072624, HPA077397"	Enhanced		Approved	Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoli, Cytosol"	"HPA072624: , HPA077397: "	"unprognostic (8.56e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.80e-1)"	9.8	3.1	1.8	12.1	6.4	15.2	2.3	0.7	3.0	1.9	2.4	0.9	0.9	2.3	2.2	2.2	2.3	2.2	4.1	2.3	6.0	2.1	4.0	6.9	10.6	13.1	8.2	0.0	1.7	1.8	0.8	6.2	3.6	6.3	2.9	2.3	1.2	2.6	0.9	0.9	1.2	7.7	3.3	15.7	40.8	2.5	1.5	6.2	12.5	1.8	2.3	8.9	4.8	2.3	4.3	5.9	19.1	13.7	21.3	30.4	9.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.6	0.0	0.0	0.3	7.9	10.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.2	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	14.6	9.1	19.1	16.5	12.8	30.4	4.3	8.4	12.6	5.9	4.0	4.4	9.7	6.9	21.3	13.7	2.7	4.0	9.4	1.8	6.4	0.7	3.0	6.0	2.1	8.2	0.0	6.3	6.2
GPRASP1	"GASP, GASP1"	ENSG00000198932	"G protein-coupled receptor associated sorting protein 1"	Q5JY77	X	102651366-102659083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 6.7;REH: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.2"	"Group enriched"	"Detected in many"	5	"B-cells: 1.4;T-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000161, HPA031061"	Uncertain		Supported	Cytosol				Cytosol		"HPA000161: AB_2247872, HPA031061: "	"unprognostic (3.92e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.42e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.82e-1)"	"prognostic favourable (1.77e-5)"	"unprognostic (3.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (1.23e-2)"	3.5	16.6	19.0	3.7	34.3	2.5	4.0	28.2	37.0	8.9	7.2	4.3	1.6	1.9	18.2	8.1	3.3	8.7	5.5	10.6	19.9	18.3	5.2	1.4	3.8	6.2	7.9	30.3	29.9	3.0	22.4	16.1	2.2	20.6	12.0	3.5	4.0	5.1	13.4	4.0	2.2	4.1	11.7	6.6	6.8	3.5	2.9	5.6	0.9	11.9	0.8	5.4	6.3	6.3	1.4	0.6	0.0	0.0	0.3	5.2	1.0	0.4	0.8	2.6	1.6	2.6	2.6	1.5	2.7	0.2	4.0	6.7	0.3	0.5	0.0	0.6	5.5	0.7	0.8	0.1	5.8	0.0	0.3	0.2	0.7	0.7	2.1	0.3	0.3	3.4	1.0	4.9	0.4	0.4	0.5	0.2	6.3	0.6	5.2	0.2	1.8	0.8	8.0	2.5	0.0	0.4	0.6	2.5	4.1	0.9	0.4	0.7	0.3	1.3	0.7	1.3	1.6	0.8	0.4	0.4	0.6	0.0	0.6	0.4	1.7	0.0	0.0	0.0	1.3	0.0	2.9	0.6	2.4	1.0	0.0	1.4	5.2	4.8	0.0	0.3	0.0	0.6	1.8	1.0	19.0	34.3	28.2	37.0	19.9	18.3	7.9	30.3	20.6	5.6
GPRASP2	"FLJ37327, GASP2"	ENSG00000158301	"G protein-coupled receptor associated sorting protein 2"	Q96D09	X	102712176-102717733	"Predicted intracellular proteins"			"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017438	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA017438: AB_1849504"	"unprognostic (8.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.14e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.71e-4)"	"unprognostic (1.42e-1)"	"prognostic favourable (4.60e-6)"	"unprognostic (1.19e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavourable (6.63e-5)"	3.7	12.2	13.8	1.5	22.6	0.2	6.1	16.9	30.0	7.7	3.7	3.4	1.7	1.3	13.8	7.4	3.3	8.8	4.0	10.9	15.8	22.3	8.1	5.2	3.9	1.2	8.7	22.5	24.8	7.1	13.3	11.5	2.8	18.7	10.2	2.5	3.6	6.6	9.8	5.2	4.4	1.8	8.3	7.2	3.0	2.2	3.6	4.1	0.8	12.0	1.3	1.3	3.6	3.8	0.4	1.6	0.0	0.6	2.1	4.7	1.2	0.4	5.0	13.5	10.4	4.3	5.1	1.0	7.7	6.9	6.6	12.9	1.7	2.3	0.0	2.6	7.9	1.8	16.1	4.1	8.4	0.0	6.2	0.7	1.5	0.4	3.1	1.2	1.0	5.3	4.4	7.3	0.3	4.7	1.9	0.5	7.9	2.3	3.5	0.5	6.7	7.0	4.7	2.2	0.0	4.1	1.8	3.0	9.3	7.7	1.5	1.0	4.3	2.6	4.1	4.7	9.9	9.5	7.3	0.2	0.3	0.0	6.3	0.8	2.6	0.0	0.4	0.0	0.9	0.6	0.8	0.4	1.1	1.3	0.8	0.4	4.7	1.9	0.0	2.1	0.2	1.6	1.6	1.2	13.8	22.6	16.9	30.0	15.8	22.3	8.7	22.5	18.7	4.1
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 76.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 23.9;HMC-1: 42.1;RPTEC TERT1: 56.7;RT4: 26.2;T-47d: 31.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.1"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.2;monocytes: 4.7"	"Region enriched"	"Detected in many"	9	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"				"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	4.3	4.1	5.2	2.2	5.3	0.0	7.7	31.1	5.7	19.7	15.4	4.4	17.0	10.0	5.8	9.9	5.3	12.5	17.6	7.7	5.3	2.6	43.8	46.1	11.5	2.8	4.8	4.9	12.3	76.2	12.0	3.4	4.5	6.1	15.1	6.2	18.0	16.8	11.7	25.4	9.2	15.2	3.9	4.6	5.1	44.7	4.4	4.1	1.9	42.2	10.2	3.5	12.6	8.0	0.7	10.2	0.1	4.7	0.0	0.1	0.3	4.6	16.6	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	21.4	0.0	13.2	0.1	14.7	2.2	0.3	0.0	0.0	2.7	0.0	1.2	23.9	4.9	0.0	42.1	0.4	7.6	0.0	0.0	0.0	1.2	0.3	0.0	5.2	0.1	4.5	2.7	19.4	0.0	0.0	1.0	56.7	26.2	8.0	0.7	0.8	1.8	0.0	31.9	1.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.0	0.6	0.1	0.0	1.7	0.1	0.0	3.4	0.0	0.7	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	4.7	10.2	0.0	0.3	5.2	5.3	31.1	5.7	5.3	2.6	4.8	4.9	6.1	4.1
GPS1	"COPS1, CSN1"	ENSG00000169727	"G protein pathway suppressor 1"	Q13098	17	82050691-82057470	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047448, HPA052848"			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA047448: , HPA052848: "	"unprognostic (1.96e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favourable (3.06e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.07e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.15e-1)"	23.5	23.9	27.2	19.3	28.2	23.6	18.8	27.7	47.2	20.5	18.7	33.3	19.8	22.4	21.5	21.1	22.2	24.5	19.2	33.4	28.7	26.7	29.6	39.9	17.2	21.6	28.7	25.9	25.3	34.4	23.2	22.3	20.8	28.0	23.2	12.0	25.1	37.1	28.9	67.1	26.5	19.7	16.8	23.7	20.7	21.9	36.0	18.2	32.3	25.3	29.8	20.6	19.5	17.0	26.1	37.3	25.2	34.5	29.7	44.0	36.0	26.7	50.1	18.7	24.3	13.2	12.8	26.4	18.0	14.5	28.7	23.8	43.8	16.7	13.3	16.2	18.0	20.4	17.7	23.1	9.8	8.8	63.3	22.4	28.1	48.5	21.9	24.4	21.8	18.2	16.9	25.3	15.1	29.8	21.0	15.4	15.8	52.9	41.6	27.7	23.7	37.5	25.6	25.6	21.5	17.6	27.9	32.0	50.2	18.3	34.0	26.6	38.5	22.1	16.9	28.7	34.0	22.1	28.9	28.3	11.8	14.0	22.4	15.8	25.7	19.6	34.5	25.2	33.0	31.7	34.5	26.1	34.8	33.0	37.3	24.5	25.0	31.2	5.4	29.7	28.6	25.7	44.0	36.0	27.2	28.2	27.7	47.2	28.7	26.7	28.7	25.9	28.0	18.2
GPSM2	"DFNB82, LGN, Pins"	ENSG00000121957	"G protein signaling modulator 2"	P81274	1	108875350-108934545	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 35.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007327, HPA008408, CAB018962"	Uncertain		Supported	Cytosol				Cytosol		"CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939"	"unprognostic (1.97e-1)"	"unprognostic (6.80e-2)"	"prognostic favourable (7.86e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.57e-6)"	"unprognostic (7.12e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (7.55e-3)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (6.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.00e-2)"	3.8	4.0	16.6	4.4	17.9	13.9	8.5	10.1	20.6	7.5	13.6	17.9	2.5	8.0	6.9	4.3	30.4	2.9	3.1	3.0	15.2	14.1	2.6	1.9	6.6	5.8	19.7	9.0	2.4	2.4	4.0	2.1	7.6	19.6	6.3	15.4	1.3	7.0	5.7	8.0	35.6	10.1	10.6	25.1	2.0	5.3	11.4	18.8	14.1	2.3	23.5	12.1	6.5	10.6	1.8	1.6	8.6	1.2	0.7	4.4	0.4	40.7	5.9	13.4	10.6	13.5	8.1	10.1	8.2	20.8	10.2	15.7	6.3	10.5	9.3	2.2	11.4	8.9	8.6	21.5	13.1	9.6	5.8	6.9	11.4	6.9	1.8	9.2	6.3	1.5	44.0	11.0	43.9	10.8	5.2	14.1	21.8	12.7	7.3	4.7	3.4	9.9	6.5	21.7	2.5	8.8	6.4	10.2	8.9	11.2	22.9	8.6	9.0	8.9	6.7	7.8	12.3	20.8	15.4	6.3	5.8	9.2	12.5	15.3	36.2	0.1	1.2	8.6	0.8	0.9	0.5	0.7	0.6	1.1	1.6	1.8	1.1	0.8	1.6	0.7	0.4	0.7	4.4	0.4	16.6	17.9	10.1	13.6	15.2	14.1	19.7	9.0	19.6	18.8
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 126.9;liver: 195.2"	"Group enriched"	"Detected in some"	20	"A549: 120.7;HaCaT: 33.4;Hep G2: 112.0;RT4: 79.8;SCLC-21H: 36.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Low region specificity"	"Detected in single"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	0.1	0.0	0.1	23.8	0.2	0.0	0.8	0.2	0.1	5.5	50.4	0.5	2.0	14.4	0.3	1.0	53.0	0.6	126.9	0.2	0.1	0.2	29.4	195.2	2.0	0.1	0.1	0.1	0.9	7.0	0.0	0.2	0.1	0.2	16.8	71.6	0.1	59.7	4.1	0.3	3.9	35.4	5.6	0.2	0.1	57.8	0.4	0.1	0.5	0.2	44.0	7.4	56.3	15.0	0.2	0.0	0.5	0.8	2.4	0.1	0.0	0.0	120.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.0	0.0	0.7	0.0	33.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	112.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	79.8	36.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160118-55167071	"Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 51.7;fHDF/TERT166: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA036720	Enhanced		Supported	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA036720: "	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavourable (5.13e-9)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	12.6	7.1	0.8	5.8	1.0	0.0	12.2	0.5	0.7	31.4	6.8	1.7	17.3	1.3	23.6	34.5	13.3	13.2	11.2	12.1	1.0	0.9	13.7	2.6	7.3	5.6	1.1	0.9	31.5	5.0	4.5	3.2	40.9	4.0	24.2	4.7	17.8	7.3	16.7	5.0	5.1	4.4	14.1	3.3	7.5	4.9	10.2	0.5	0.7	28.4	11.0	5.4	15.8	19.7	1.0	0.7	2.4	0.5	0.6	0.9	0.2	6.9	5.9	12.7	12.4	33.7	38.4	7.0	35.6	51.7	20.0	40.1	0.6	15.9	0.0	38.0	48.4	6.0	7.6	10.3	27.5	0.0	3.2	0.3	10.4	1.2	10.7	0.0	0.0	27.1	10.3	12.2	6.4	23.3	0.2	0.0	22.7	2.2	0.0	0.0	5.8	8.2	0.0	7.3	0.0	12.3	0.2	0.0	0.3	12.0	0.8	12.6	11.4	0.7	20.9	10.7	11.8	15.9	19.1	0.0	0.0	0.0	17.0	0.0	23.2	1.4	0.5	0.3	0.5	0.3	0.5	0.6	0.5	0.5	0.2	1.0	0.9	0.9	2.4	0.6	0.3	0.7	0.2	0.2	0.8	1.0	0.5	0.7	1.0	0.9	1.1	0.9	4.0	0.5
GRAMD1A	"FLJ90346, KIAA1533"	ENSG00000089351	"GRAM domain containing 1A"	Q96CP6	19	34994784-35026471	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008852, HPA012570"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA008852: AB_1079203, HPA012570: AB_2112577"	"unprognostic (3.09e-2)"	"unprognostic (4.62e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (7.95e-12)"	"unprognostic (2.04e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.36e-2)"	15.6	19.1	14.6	21.4	14.0	17.1	19.4	13.8	18.1	16.8	13.2	10.4	17.4	13.0	16.9	12.9	7.8	17.2	13.8	17.2	15.9	12.0	13.3	11.0	27.5	42.0	13.7	12.2	21.8	44.1	11.5	14.9	14.1	16.6	15.6	7.5	11.5	45.3	17.2	35.7	6.8	10.9	21.3	12.8	21.1	16.1	11.7	12.1	17.9	12.7	11.5	12.1	17.3	21.4	1.1	4.1	13.1	14.9	3.8	5.5	2.5	5.4	42.3	8.3	16.4	9.7	11.1	6.9	6.6	10.9	8.9	8.8	16.0	4.7	3.1	13.2	9.9	3.6	8.6	13.0	3.4	13.1	15.0	9.1	10.5	14.7	19.5	6.4	14.5	19.6	8.1	6.3	10.8	28.8	9.9	2.1	6.1	5.2	14.6	7.9	13.0	4.7	13.9	2.6	3.8	9.5	1.0	12.5	25.2	6.7	5.1	10.9	7.7	7.1	15.6	14.3	7.4	2.9	9.4	2.3	7.8	7.5	9.4	7.1	10.5	13.1	4.5	3.6	2.9	7.3	5.5	0.5	3.9	2.1	4.1	1.1	2.9	4.2	9.8	3.8	14.9	1.4	3.1	2.5	14.6	14.0	13.8	18.1	15.9	12.0	13.7	12.2	16.6	12.1
GRAMD1C	DKFZp434C0328	ENSG00000178075	"GRAM domain containing 1C"	Q8IYS0	3	113828182-113947174	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.4;HUVEC TERT2: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 5.1;naive B-cell: 4.1;neutrophil: 4.0"	"Group enriched"	"Detected in many"	11	"B-cells: 5.1;granulocytes: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012316	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA012316: AB_1849949"	"unprognostic (2.73e-3)"	"unprognostic (6.16e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.49e-2)"	"prognostic favourable (4.22e-15)"	"unprognostic (8.48e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.09e-2)"	1.7	2.6	12.6	2.5	13.0	0.5	9.1	5.0	13.4	3.4	8.0	2.6	0.5	7.6	5.2	5.1	6.0	10.3	2.9	1.5	13.6	7.6	23.3	26.5	5.0	2.0	9.4	8.1	1.1	12.5	11.8	24.1	6.2	9.2	2.9	4.2	4.5	10.8	2.8	1.1	12.0	24.5	1.0	8.2	1.7	8.6	14.5	9.3	0.0	6.9	1.6	3.7	3.8	3.8	5.1	0.1	4.0	0.0	0.3	0.4	0.1	1.5	0.0	4.1	3.2	0.8	2.1	5.9	3.7	3.3	0.7	2.2	0.0	14.4	0.4	1.1	1.9	1.6	0.7	1.6	1.7	1.9	0.6	0.3	0.1	0.0	1.6	0.2	0.1	3.3	1.1	0.6	0.1	11.2	0.0	0.2	1.1	0.4	1.6	0.2	0.3	0.5	0.0	0.8	2.5	4.5	2.0	0.8	1.0	1.0	5.9	3.0	4.1	0.0	2.3	1.5	2.9	0.0	0.3	2.2	1.3	1.8	2.4	0.1	1.7	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.3	0.4	0.1	4.1	0.3	0.4	4.0	0.3	0.0	0.1	0.0	0.1	12.6	13.0	5.0	13.4	13.6	7.6	9.4	8.1	9.2	9.3
GRAMD2A	GRAMD2	ENSG00000175318	"GRAM domain containing 2A"	Q8IUY3	15	72159807-72197785	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 24.6;placenta: 49.2"	"Group enriched"	"Detected in some"	12	"BEWO: 58.1;SK-BR-3: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 2.3"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.3"	"Low region specificity"	"Detected in many"							HPA029435	Uncertain		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nucleoli, Nuclear speckles"	Cytosol	"HPA029435: AB_10601811"	"unprognostic (5.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (7.01e-4)"	"unprognostic (7.29e-2)"	0.1	0.0	2.0	0.2	4.5	0.0	6.8	1.1	1.0	3.1	0.7	1.2	9.8	0.6	0.4	24.6	1.0	8.2	0.8	0.1	2.9	6.5	1.9	0.1	9.7	0.2	1.1	0.1	1.1	1.0	0.2	0.9	49.2	3.9	1.2	0.5	1.0	1.8	4.0	0.3	1.5	3.6	0.1	1.0	0.1	0.4	0.7	0.9	0.2	7.7	1.3	1.1	0.3	0.6	0.0	2.3	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	26.5	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.5	1.1	1.0	2.9	6.5	1.1	0.1	3.9	0.9
GRAMD2B	"FLJ21313, GRAMD3, NS3TP2"	ENSG00000155324	"GRAM domain containing 2B"	Q96HH9	5	126360132-126496494	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 38.8;CAPAN-2: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009678, HPA010095"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA009678: AB_2112580, HPA010095: AB_1849952"	"unprognostic (2.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.90e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.12e-2)"	8.3	12.0	30.8	5.2	31.6	1.3	29.5	10.2	25.3	27.5	21.8	38.7	9.7	22.5	24.0	11.9	7.7	26.8	8.7	9.2	38.8	15.9	25.9	18.0	7.8	5.1	21.8	28.3	21.1	6.8	9.0	7.2	44.3	26.4	14.2	23.4	14.9	15.5	20.9	2.8	17.5	26.1	17.6	29.7	4.3	12.9	3.3	31.8	3.6	35.6	3.7	8.6	11.6	11.1	0.8	6.5	0.5	0.7	1.7	5.1	2.1	21.1	1.2	1.0	4.7	21.3	7.4	6.4	22.1	38.8	10.5	14.3	1.0	26.0	0.0	9.5	24.8	5.4	0.3	8.9	11.2	1.8	1.5	1.0	2.4	1.3	5.0	0.0	0.7	12.4	4.0	9.6	3.2	0.0	0.0	0.0	18.2	2.1	0.0	0.3	1.1	1.5	0.4	6.3	5.0	14.1	23.4	0.4	0.0	4.0	2.3	6.9	8.0	1.3	1.8	2.1	0.7	3.8	4.1	1.4	1.1	0.0	0.4	0.0	6.3	0.5	0.5	0.0	4.6	0.7	4.8	0.8	2.6	3.9	2.5	0.4	5.1	3.1	0.5	1.7	0.5	6.5	3.8	2.1	30.8	31.6	10.2	25.3	38.8	15.9	21.8	28.3	26.4	31.8
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2-related adaptor protein 2"	O75791	22	39901082-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 138.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.4;HEL: 18.1;K-562: 17.3;MOLT-4: 47.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 22.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			260000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.6	0.4	0.3	7.7	0.7	7.6	1.5	0.3	0.4	1.1	2.3	0.6	0.4	2.9	2.3	1.6	1.6	1.2	3.5	2.8	0.6	0.4	1.2	1.8	6.4	12.6	0.9	0.4	1.0	0.8	0.0	0.6	1.1	0.6	2.4	1.9	1.2	2.4	1.2	0.5	1.4	6.2	2.0	2.2	13.2	2.9	2.4	0.3	138.0	1.3	1.5	11.3	3.0	1.9	2.1	0.4	2.5	0.2	1.7	22.5	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	18.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.2	0.0	19.5	0.1	14.4	1.0	14.4	21.1	0.4	2.1	12.2	22.5	2.5	1.7	0.1	0.3	12.0	25.9	0.3	0.7	0.3	0.4	0.6	0.4	0.9	0.4	0.6	0.3
GRB14		ENSG00000115290	"Growth factor receptor bound protein 14"	Q14449	2	164492812-164621848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 17.7"	"Cell line enhanced"	"Detected in some"		"A549: 5.5;HUVEC TERT2: 10.5;RPTEC TERT1: 8.7;TIME: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022294, HPA035052, HPA035053"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB022294: , HPA035052: , HPA035053: "	"unprognostic (2.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.47e-2)"	"unprognostic (8.33e-5)"	"unprognostic (5.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (9.27e-2)"	1.6	2.9	1.0	1.2	1.5	0.0	6.0	0.7	3.6	0.8	1.2	0.0	1.1	1.2	0.6	7.5	1.7	0.5	0.3	10.8	5.7	1.1	8.3	17.7	0.7	0.1	0.9	2.0	2.4	6.0	0.0	1.8	2.2	1.4	0.8	0.4	1.2	1.0	0.5	3.2	0.5	0.8	0.6	0.6	0.6	1.1	3.1	0.4	0.0	5.5	3.0	0.1	0.6	1.1	0.0	0.0	0.4	0.1	0.0	0.0	3.0	0.9	5.5	0.4	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	2.4	0.6	0.0	3.4	0.0	0.4	0.9	1.6	0.3	0.0	4.8	0.0	0.3	1.3	0.1	0.0	0.0	0.4	1.0	2.0	0.0	10.5	0.0	0.1	1.7	2.2	0.0	0.0	2.1	1.4	0.0	0.0	0.1	8.7	0.4	3.3	0.4	0.0	0.3	0.0	0.6	0.0	13.2	0.2	1.4	0.0	0.1	0.5	0.1	0.0	3.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.0	1.0	1.5	0.7	3.6	5.7	1.1	0.9	2.0	1.4	0.4
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9"	"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 89.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 7.4"	"Cell type enriched"	"Detected in single"	20	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Region enhanced"	"Detected in some"		"cerebellum: 9.3"	"Low region specificity"	"Detected in all"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: "	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (3.10e-4)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favourable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	2.9	0.1	0.1	2.8	0.6	0.0	16.1	7.4	1.2	6.7	12.7	0.3	25.0	6.7	2.6	8.1	53.9	14.5	16.3	0.8	0.2	0.1	23.4	5.2	12.3	0.1	0.1	0.4	3.1	20.5	5.8	3.7	42.6	1.6	10.2	6.4	0.7	14.0	25.5	0.5	19.1	12.4	2.0	0.1	0.3	7.2	2.3	0.3	0.5	8.5	6.5	17.2	7.2	11.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.0	0.0	0.0	4.4	0.0	0.2	0.0	0.1	10.4	5.9	0.0	0.9	0.1	5.6	0.0	3.9	0.0	0.0	0.5	0.0	1.3	9.0	0.0	0.0	0.0	0.0	3.4	0.0	0.9	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.2	0.8	0.0	0.0	4.1	4.6	3.3	2.3	0.0	4.5	89.5	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	7.4	1.2	0.2	0.1	0.1	0.4	1.6	0.3
GREB1	KIAA0575	ENSG00000196208	"Growth regulation by estrogen in breast cancer 1"	Q4ZG55	2	11482341-11642788	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 74.9"	"Cell line enhanced"	"Detected in some"		"AF22: 14.8;Hep G2: 14.0;MCF7: 21.9;SH-SY5Y: 14.9;T-47d: 50.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA024616, HPA027843, HPA028416"	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344"	"unprognostic (1.52e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.05e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.80e-2)"	1.2	2.0	3.0	0.6	5.0	0.5	11.1	1.3	5.4	13.7	0.5	2.8	3.0	0.7	21.3	15.6	0.6	11.2	1.8	2.3	3.9	3.0	1.3	1.5	0.6	0.6	3.9	3.5	74.9	2.9	0.6	5.0	9.4	3.8	19.2	0.5	2.8	0.7	2.4	2.1	1.2	0.6	7.3	3.2	0.4	0.8	10.9	3.2	0.0	0.5	0.5	0.5	0.8	5.7	0.8	1.0	2.8	0.6	1.0	1.3	0.4	0.0	0.3	14.8	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.1	0.0	0.1	1.1	0.0	0.0	1.7	1.3	0.0	0.1	14.0	0.1	0.1	0.7	0.2	0.8	0.2	0.1	0.0	0.1	0.3	0.1	21.9	0.4	0.7	4.8	0.0	10.2	0.0	0.6	0.0	0.0	4.3	14.9	0.3	0.4	10.9	50.6	0.2	0.0	1.5	0.7	0.1	0.0	2.2	1.5	8.6	2.5	4.2	0.4	2.6	0.6	0.8	0.7	0.3	0.3	0.5	0.5	0.4	0.4	0.8	0.5	1.3	2.8	1.0	0.5	1.0	0.5	0.4	3.0	5.0	1.3	5.4	3.9	3.0	3.9	3.5	3.8	3.2
GREB1L	"C18orf6, FLJ13687, KIAA1772"	ENSG00000141449	"Growth regulation by estrogen in breast cancer 1 like"	Q9C091	18	21242242-21525417	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 25.0"	"Cell line enhanced"	"Detected in many"		"AF22: 21.6;BEWO: 43.9;CACO-2: 19.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041647, HPA044218"	Uncertain		Approved	Cytosol				Cytosol		"HPA041647: , HPA044218: "	"unprognostic (1.88e-3)"	"unprognostic (9.01e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.30e-8)"	"unprognostic (4.72e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-1)"	5.0	3.2	12.5	0.8	5.9	0.8	5.5	2.3	4.5	2.5	1.1	4.0	25.0	0.8	4.9	12.4	0.9	6.7	0.8	9.2	5.5	3.9	1.3	3.9	0.7	0.7	5.6	2.6	7.2	0.5	0.9	3.1	5.4	5.8	3.8	0.7	1.0	1.3	14.2	15.9	2.5	1.5	2.1	2.8	0.6	1.7	12.0	3.0	0.0	7.4	0.0	0.5	0.5	1.7	0.2	0.2	2.8	0.1	0.0	0.6	0.0	0.0	0.3	21.6	0.0	5.0	0.0	43.9	1.1	1.0	1.8	1.6	19.7	1.5	0.0	2.2	3.2	4.1	8.4	1.0	3.2	0.3	4.1	0.0	5.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	4.0	0.0	0.0	0.1	4.3	1.4	0.1	0.1	2.0	2.7	0.0	0.0	0.8	2.0	3.6	1.4	0.0	0.0	0.6	0.1	1.1	0.0	9.0	0.2	1.2	2.1	0.0	0.0	0.2	0.0	0.9	0.0	0.1	2.8	0.1	0.1	0.6	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	12.5	5.9	2.3	4.5	5.5	3.9	5.6	2.6	5.8	3.0
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 172.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022971	Uncertain		Approved	Nucleoplasm,Cytosol			1400000	Cytosol	Nucleoplasm	"HPA022971: AB_1849975"	"prognostic favourable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	12.8	33.7	16.3	13.8	17.4	9.9	12.3	9.5	22.3	12.1	17.6	27.5	11.6	17.2	14.3	18.1	17.6	12.9	18.1	29.2	15.8	14.7	41.9	172.0	9.7	13.8	20.0	16.5	17.0	15.5	9.5	8.8	13.2	15.5	14.2	10.2	13.5	21.6	14.0	40.0	14.8	14.6	14.2	19.4	10.0	13.3	13.0	18.7	9.5	15.1	25.2	13.6	13.4	11.7	30.6	33.2	17.8	30.3	28.9	25.9	22.4	31.3	45.2	25.6	23.4	23.6	26.2	26.0	25.1	33.3	34.2	37.2	17.1	13.6	30.1	14.8	29.4	14.2	14.7	32.7	20.5	40.2	18.4	17.6	42.1	30.3	37.3	16.7	18.3	31.3	28.7	19.8	25.5	29.6	32.2	12.4	30.0	24.0	16.3	17.2	15.6	19.7	16.1	18.8	16.7	45.6	17.8	10.7	19.2	21.6	41.2	23.4	23.2	21.6	32.2	18.8	30.2	13.0	21.6	9.8	7.6	20.1	26.7	9.6	27.5	17.8	30.2	15.0	19.4	30.3	16.2	28.6	20.7	22.0	33.2	30.6	20.4	17.3	7.0	28.9	24.7	29.8	25.9	22.4	16.3	17.4	9.5	22.3	15.8	14.7	20.0	16.5	15.5	18.7
GRINA	"HNRGW, LFG1, NMDARA1, TMBIM3"	ENSG00000178719	"Glutamate ionotropic receptor NMDA type subunit associated protein 1"	Q7Z429	8	143990058-143993415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036980, HPA036981"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	Cytosol	"HPA036980: AB_10696791, HPA036981: AB_10962980"	"unprognostic (2.73e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.01e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.70e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.72e-2)"	76.4	48.8	46.6	52.3	61.0	89.0	70.2	73.8	85.8	37.1	28.4	34.5	37.1	35.6	33.1	42.1	30.5	41.4	37.5	35.2	54.2	45.1	61.7	143.7	49.7	67.4	47.4	51.5	46.1	32.0	66.8	29.3	42.4	46.5	42.6	17.7	49.3	44.4	99.4	32.8	37.4	33.5	38.0	43.3	82.0	23.2	52.2	24.3	24.3	54.7	19.2	26.8	43.2	31.3	4.5	12.4	10.2	19.3	1.6	2.6	6.4	12.6	24.8	12.7	21.5	67.7	34.2	18.8	18.1	42.9	30.9	28.6	15.0	10.6	9.1	20.0	40.8	11.4	22.6	26.8	12.7	12.9	15.5	9.4	14.4	17.8	71.7	1.9	15.2	44.0	74.2	22.4	32.7	14.9	8.8	12.8	26.5	76.4	5.3	5.1	8.9	37.5	7.2	6.4	17.5	15.8	35.9	8.6	14.0	26.4	29.7	35.2	57.1	12.5	15.0	19.6	21.5	26.1	13.1	20.8	11.9	6.8	24.8	12.5	11.1	0.9	16.6	4.6	1.4	19.3	2.0	4.5	1.4	1.6	7.1	4.3	2.6	2.3	10.2	1.6	18.0	12.4	1.2	6.4	46.6	61.0	73.8	85.8	54.2	45.1	47.4	51.5	46.5	24.3
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"		3	14489111-14556075	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 10.3;skeletal muscle: 25.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.1;BJ hTERT+ SV40 Large T+ RasG12V: 3.3;NTERA-2: 3.5;PC-3: 10.0;SCLC-21H: 5.6;U-2 OS: 3.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol				Cytosol		"HPA035673: AB_10669776"	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	0.5	0.8	3.2	0.4	2.6	0.0	0.5	0.7	6.0	0.4	0.4	1.2	1.9	0.1	1.3	0.5	1.7	0.3	1.0	10.3	3.2		1.5	0.1	0.2	0.1	0.0	3.3	2.0	0.2	0.1	0.1	3.0	1.1	0.4	0.7	0.6	0.4	0.2	25.7	1.4	0.4	0.6	0.0	1.0	2.7	0.4	1.0	0.0	0.0	4.6	0.4	0.5	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.5	0.3	0.0	0.5	5.1	0.6	3.3	2.0	0.0	0.0	1.2	0.3	0.3	1.2	0.0	0.0	0.0	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	10.0	0.0	0.1	0.0	0.0	0.0	5.6	1.1	0.5	0.0	1.7	0.0	0.0	0.0	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0										
GRIPAP1	"DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3"	ENSG00000068400	"GRIP1 associated protein 1"	Q4V328	X	48973720-49002264	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000282, HPA000615"	Approved		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA000282: AB_1079022, HPA000615: AB_1079023"	"unprognostic (3.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.93e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (3.92e-7)"	"unprognostic (4.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (4.63e-7)"	7.3	10.1	12.4	10.0	19.5	14.0	7.1	24.8	20.6	7.3	7.3	7.4	6.8	8.3	7.5	12.0	7.0	9.9	6.4	7.8	9.4	8.6	6.6	8.5	9.0	10.5	9.7	20.8	8.8	7.7	11.7	12.9	7.0	12.9	7.5	6.9	8.7	7.7	7.4	7.0	10.9	11.1	7.0	10.7	13.1	8.5	8.0	9.0	7.4	8.6	3.2	10.6	7.5	8.6	11.5	10.0	21.2	12.2	12.9	9.1	7.0	12.7	20.3	14.6	30.5	8.8	6.8	13.1	10.4	13.0	13.5	12.9	11.0	11.2	19.3	6.0	10.3	18.3	18.1	11.4	10.9	22.5	9.2	15.5	25.8	11.5	15.2	16.6	27.9	7.0	16.5	18.0	13.4	12.3	11.3	25.5	12.4	23.5	14.4	22.4	17.2	11.1	16.1	22.0	15.4	13.5	15.8	12.9	14.4	22.1	8.9	13.0	20.2	33.4	14.5	7.1	11.3	14.6	8.5	15.5	12.1	13.5	12.5	25.3	12.2	18.8	12.2	16.9	8.9	10.9	7.5	9.4	9.1	8.4	9.8	11.5	8.0	8.3	21.2	12.9	9.9	10.0	7.2	7.0	12.4	19.5	24.8	16.8	9.4	8.6	9.7	20.8	12.9	9.0
GRM7	"GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87"	ENSG00000196277	"Glutamate metabotropic receptor 7"	Q14831	3	6770001-7741533	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.8;parathyroid gland: 11.3"	"Cell line enriched"	"Detected in single"	11	"SH-SY5Y: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015964			Uncertain	Cytosol				Cytosol		"HPA015964: "	"unprognostic (2.04e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.37e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.84e-6)"	"unprognostic (1.45e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.59e-2)"	0.9	5.3	8.1	0.6	10.5	0.6	0.9	1.6	15.8	2.9	0.8	2.1	0.0	0.9	3.1	0.5	0.6	1.0	0.7	0.6	11.1	9.3	0.5	0.7	0.8	0.5	2.3	10.1	0.8	0.7	11.3	0.6	0.9	4.3	1.2	0.8	0.8	2.1	1.4	0.5	0.6	0.6	5.9	2.8	0.8	0.6	2.8	4.1	0.0	0.7	0.0	0.7	1.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	10.5	1.6	15.8	11.1	9.3	2.3	10.1	4.3	4.1
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977766	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 35.7;tongue: 19.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.1;hTCEpi: 4.9;hTERT-HME1: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 5.6"					"Not detected"	"Not detected"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"			7100	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	2.1	0.4	0.2	0.4	0.1	0.0	2.2	0.1	0.1	1.1	0.6	0.0	0.0	0.1	0.4	8.6	1.9	0.3	0.3	2.0	0.2	0.2	0.4	0.2	0.7	8.5	0.2	0.7	0.2	0.2	1.0	0.9	0.9	0.1	0.2	0.6	0.0	0.6	0.0	0.9	35.7	0.3	0.5	0.2	0.3	0.2	0.9	0.0	0.8	0.2	19.4	7.8	0.8	1.1	0.6	0.5	1.9	0.4	0.6	5.6	1.0	0.4	0.1	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.0	7.1	0.0	0.1	0.5	0.9	0.6	0.4	0.0	0.3	1.6	0.0	4.9	0.8	9.6	0.0	0.2	2.3	0.0	1.0	0.0	0.2	0.1	0.1	0.6	0.0	0.8	0.2	0.6	0.0	0.2	0.2	0.3	0.0	0.5	0.1	0.1	0.3	0.7	0.1	0.1	0.3	0.1	0.6	0.4	0.1	0.0	1.7	0.4	0.4	4.8	0.2	5.6	0.3	3.1	1.8	0.2	0.6	1.6	2.5	1.9	0.6	0.3	0.5	1.1	1.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.7	0.1	0.0
GSDMB	"GSDML, PRO2521"	ENSG00000073605	"Gasdermin B"	Q8TAX9	17	39904595-39919854	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 71.3"	"Cell line enriched"	"Detected in some"	8	"SK-BR-3: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.8"	"Low lineage specificity"	"Detected in many"											"CAB013681, HPA023925, HPA052407"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB013681: , HPA023925: AB_1850383, HPA052407: "	"unprognostic (5.78e-2)"	"prognostic favourable (3.41e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavourable (5.13e-11)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.91e-2)"	"prognostic favourable (5.91e-9)"	4.0	0.0	1.3	13.3	2.0	1.3	2.8	4.8	1.7	2.1	33.1	1.4	2.0	25.2	1.3	1.7	1.3	1.3	14.4	1.3	1.3	0.6	2.2	17.1	2.4	3.5	1.3	1.3	2.0	2.8	0.0	1.3	1.8	1.3	3.5	22.4	1.3	1.3	2.7	1.3	2.8	71.3	3.9	1.3	4.7	18.1	1.4	1.5	1.6	2.9	1.3	2.8	4.1	4.5	0.8	0.0	1.8	0.0	0.1	2.8	0.4	0.4	0.3	0.6	0.1	1.5	0.9	0.5	0.3	0.2	0.1	0.4	0.3	12.0	0.6	0.5	0.3	1.6	0.3	0.3	0.8	2.4	0.3	0.2	0.1	0.1	0.4	0.0	0.1	0.6	2.0	0.5	0.7	0.2	0.2	0.7	0.1	0.1	0.6	1.3	0.1	0.4	0.6	0.1	0.9	0.0	0.3	0.2	0.3	0.1	100.5	0.3	0.5	0.3	0.3	0.4	0.6	1.1	0.2	2.2	1.8	0.5	0.1	0.4	0.0	0.0	0.0	1.8	1.1	0.0	0.0	0.8	2.8	1.4	0.0	0.0	2.6	0.6	0.7	0.1	0.0	0.0	0.4	0.4	1.3	2.0	4.8	1.7	1.3	0.6	1.3	1.3	1.3	1.5
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698351-24758113	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 8.7;myeloid DC: 6.9;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Enhanced	Cytosol				Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	8.1	6.5	7.7	2.2	10.3	0.5	6.1	5.9	12.1	12.0	14.5	7.8	0.5	6.1	18.4	12.8	4.2	9.9	6.7	7.4	7.5	8.8	10.7	3.6	4.0	4.0	9.3	4.5	14.1	2.3	2.2	4.5	27.1	10.1	5.9	2.1	9.0	2.0	17.7	5.1	1.8	31.3	12.2	25.4	1.5	2.7	9.9	5.0	0.8	11.7	4.0	2.9	9.5	7.0	8.7	6.9	0.0	2.1	0.0	0.1	0.7	9.8	7.2	3.1	13.4	17.2	9.7	5.4	7.7	20.6	8.0	11.4	7.5	0.3	0.1	6.9	21.2	6.7	1.8	33.8	14.2	0.0	0.7	0.2	12.7	15.1	14.4	0.0	0.5	10.6	24.8	14.2	34.2	13.7	0.9	1.7	17.9	0.1	0.6	0.2	3.3	5.2	0.0	11.0	0.0	24.4	6.9	0.1	19.8	12.1	0.2	13.4	0.7	0.9	9.2	7.6	13.4	10.3	9.2	0.8	0.2	4.7	23.1	0.0	1.9	0.0	2.1	0.0	0.0	0.2	0.0	8.7	0.1	0.0	6.9	8.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	7.7	10.3	5.9	9.5	7.5	8.8	9.3	4.5	10.1	5.0
GSK3A		ENSG00000105723	"Glycogen synthase kinase 3 alpha"	P49840	19	42230186-42242625	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004422, HPA028423"	Approved		Approved	Cytosol				Cytosol		"CAB004422: AB_627680, HPA028423: AB_10612116"	"unprognostic (5.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (4.02e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.22e-3)"	15.3	19.8	31.0	16.8	38.0	14.4	12.0	31.4	62.2	15.9	16.8	24.3	11.4	28.6	16.9	18.0	17.3	16.7	11.8	21.3	31.3	23.6	17.5	13.1	14.2	15.0	21.8	26.3	20.0	19.3	16.1	14.2	14.7	31.7	15.8	16.1	15.5	18.1	20.3	41.0	25.1	27.0	18.5	18.0	14.5	14.7	19.1	17.7	16.6	15.8	11.9	15.8	15.8	15.5	1.6	2.2	4.0	1.9	1.7	2.0	1.0	23.6	42.0	24.1	22.3	14.4	12.9	10.2	16.7	15.9	22.1	20.0	15.7	15.1	17.1	17.2	13.1	10.9	19.8	19.4	15.5	13.8	31.8	17.8	13.5	15.5	19.0	20.2	21.8	12.6	20.6	18.1	20.7	20.0	29.9	25.6	18.9	28.7	26.2	17.9	17.8	17.4	23.9	14.0	13.2	20.4	24.8	28.1	28.4	22.9	30.0	15.2	17.3	26.8	17.7	22.8	17.1	13.2	29.5	26.2	30.0	13.4	26.5	20.4	25.0	2.5	1.5	1.6	2.0	1.9	1.4	1.2	1.2	1.3	1.4	1.6	0.7	1.5	4.0	1.7	1.1	2.2	1.0	1.0	31.0	38.0	31.4	62.2	31.3	23.6	21.8	26.3	31.7	17.7
GSPT1	"eRF3a, ETF3A, GST1"	ENSG00000103342	"G1 to S phase transition 1"	P15170	16	11868128-11916082	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052488, HPA074588"	Approved		Approved	Vesicles,Cytosol			150000	Cytosol	Vesicles	"HPA052488: , HPA074588: "	"unprognostic (4.13e-2)"	"unprognostic (1.66e-1)"	"prognostic favourable (2.10e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavourable (7.94e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.65e-1)"	"prognostic favourable (3.06e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-3)"	"unprognostic (3.13e-2)"	28.5	36.5	27.0	31.2	25.0	30.1	52.5	18.1	33.9	21.7	25.8	18.5	23.3	15.6	20.8	23.1	42.8	18.7	20.1	35.6	22.4	15.3	26.2	46.0	31.3	38.1	26.4	21.6	20.8	48.2	40.9	18.5	23.1	24.1	24.3	29.1	12.6	26.4	30.8	74.1	25.3	20.5	25.6	27.4	26.3	28.1	30.6	23.2	34.8	27.7	24.8	37.0	23.9	30.1	8.8	7.8	7.9	12.0	7.3	11.4	4.6	45.1	44.8	25.0	34.4	36.2	37.7	36.2	50.3	52.3	40.5	40.5	31.9	42.0	61.3	66.1	43.5	34.8	63.3	46.5	68.3	29.3	32.8	41.8	36.4	67.3	30.5	52.9	22.4	29.4	36.7	45.7	62.9	44.7	67.4	31.8	46.9	43.5	44.6	27.5	49.9	25.6	52.9	43.2	71.6	40.0	39.7	40.4	21.6	72.2	54.9	29.4	47.6	25.5	34.4	45.1	28.4	32.6	39.5	31.7	46.8	53.5	31.7	54.0	27.3	1.5	6.5	7.9	7.6	12.0	10.6	8.8	9.8	9.0	7.8	6.4	9.9	9.5	2.2	7.3	10.1	4.3	11.4	4.6	27.0	25.0	18.1	33.9	22.4	15.3	26.4	21.6	24.1	23.2
GSPT2	"eRF3b, FLJ10441"	ENSG00000189369	"G1 to S phase transition 2"	Q8IYD1	X	51743431-51746232	"Predicted intracellular proteins"	"Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.0;PC-3: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044769, HPA074588"	Approved		Enhanced	Cytosol				Cytosol		"HPA044769: AB_10963577, HPA074588: "	"unprognostic (8.55e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.39e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.07e-1)"	8.6	11.1	11.6	8.6	17.6	3.6	9.3	14.1	18.3	8.2	7.3	6.5	3.4	4.8	8.3	11.5	4.2	8.8	7.6	9.8	11.5	19.5	9.6	16.0	7.9	12.0	9.2	13.0	15.3	7.3	7.1	14.9	3.6	8.8	10.5	5.5	6.7	8.9	9.7	7.8	4.0	7.6	8.0	6.7	9.0	6.5	18.4	8.8	18.4	9.1	3.8	12.1	7.7	4.1	9.5	9.7	2.7	4.1	7.2	8.3	4.2	0.0	5.1	10.4	0.0	7.3	6.4	0.0	5.9	1.0	4.2	5.3	3.2	5.2	14.9	0.0	5.0	1.6	0.0	2.7	4.9	0.0	6.6	0.2	0.0	0.0	5.4	0.0	6.5	8.4	1.3	3.7	3.7	6.1	3.9	1.1	7.4	0.0	1.3	0.9	25.0	28.1	7.1	9.8	0.0	7.6	5.4	0.0	8.8	0.0	0.0	5.0	0.0	4.8	3.8	4.2	8.6	3.9	3.8	0.0	8.5	0.0	5.6	1.0	4.6	2.7	2.9	1.8	5.7	4.1	5.7	9.5	5.1	5.3	9.7	9.5	8.3	7.1	0.3	7.2	3.1	8.2	6.4	4.2	11.6	17.6	14.1	18.3	11.5	19.5	9.2	13.0	8.8	8.8
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678061-30727999	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632"	Approved		Supported	"Plasma membrane,Cytosol"			110000000	Cytosol	"Plasma membrane"	"CAB008632: AB_1616690, HPA001538: AB_1078986"	"unprognostic (1.23e-1)"	"prognostic favourable (3.37e-4)"	"prognostic favourable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favourable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	8.9	14.4	6.8	10.7	9.1	7.9	6.2	9.1	11.8	18.6	18.7	7.1	18.4	20.4	13.2	12.0	19.4	8.8	17.3	11.9	5.0	5.7	27.9	17.8	10.8	9.7	4.9	6.0	11.8	17.6	22.9	7.2	8.9	6.8	16.4	17.2	10.9	12.0	17.4	14.7	6.5	31.8	9.3	4.5	13.6	17.7	7.9	4.2	17.0	9.2	11.8	12.0	23.9	14.5	2.5	4.7	19.0	5.7	2.6	7.3	2.1	12.0	51.0	8.3	6.4	8.9	10.0	8.0	5.4	11.8	7.7	10.3	15.0	6.4	23.6	26.7	6.9	13.6	12.5	11.7	8.4	6.1	11.6	23.7	17.6	50.1	24.0	7.2	38.3	16.6	7.4	11.5	4.6	10.9	19.6	10.5	17.3	11.0	25.5	8.5	14.7	9.1	9.8	9.5	11.4	15.2	30.6	6.3	8.1	7.4	17.3	12.9	7.5	8.2	14.7	3.2	8.9	7.6	8.0	5.8	6.4	15.1	10.2	10.2	10.5	19.0	4.6	11.5	4.2	4.2	7.3	2.5	3.8	4.6	4.7	2.0	2.4	3.1	6.5	2.6	5.7	2.9	3.2	2.1	6.8	9.1	9.1	11.8	5.0	5.7	4.9	6.0	6.8	4.2
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 87.7"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol		"HPA004342: AB_1078987, HPA048934: , HPA053817: "	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	87.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750089-52763569	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 63.4;liver: 192.2;pancreas: 54.1"	"Group enriched"	"Detected in some"	20	"CACO-2: 20.3;Hep G2: 15.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol		"HPA004342: AB_1078987, HPA048934: , HPA053817: "	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.2	1.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	6.4	0.2	0.2	13.4	0.2	0.3	0.2	0.0	9.9	0.2	0.2	0.0	63.4	192.2	5.3	0.2	0.2	0.2	0.3	54.1	0.0	0.2	0.3	0.2	0.7	0.0	0.2	0.3	0.2	0.2	0.0	27.6	0.2	0.2	0.2	1.5	14.1	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	20.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	15.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909685	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;BJ hTERT+: 1.1;CACO-2: 1.5;HAP1: 2.8;HEK 293: 1.5;SK-BR-3: 2.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol				Cytosol		"HPA004342: AB_1078987, HPA048934: , HPA053817: "	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.2	36.5	0.2	0.2	0.6	0.0	0.7	0.3	0.2	0.9	0.2	1.0	0.2	0.0	0.3	6.6	0.2	32.4	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	0.2	0.2	3.8	0.2	1.1	0.2	51.9	2.1	0.2	0.0	0.5	0.6	0.2	0.2	12.5	0.2	0.2	0.2	0.2	1.0	6.4	0.3	0.2	0.2	0.9	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.2	0.2	0.2	0.2	0.2	2.1	0.3
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52846095	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol				Cytosol		"HPA004342: AB_1078987, HPA048934: , HPA053817: "							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 163.2;seminal vesicle: 101.4"	"Cell line enhanced"	"Detected in some"		"HEL: 26.6;HeLa: 31.8;HHSteC: 25.4;hTEC/SVTERT24-B: 23.0;HUVEC TERT2: 19.5;MOLT-4: 34.3"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	Cytosol				Cytosol		"CAB022669: , CAB047357: , HPA048652: , HPA055972: , HPA055973: "	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	14.5	25.4	15.2	6.9	15.6	2.9	8.2	5.6	19.2	22.0	7.8	16.9	0.0	7.7	9.8	20.2	22.5	13.8	8.2	6.4	14.4	6.8	14.1	163.2	7.7	1.0	7.8	32.1	29.0	18.2	41.4	5.3	2.9	8.2	38.1	6.6	25.7	11.8	101.4	25.1	18.8	17.7	18.2	6.8	21.7	7.5	15.1	11.2	10.9	7.6	1.6	14.5	30.8	19.5	14.6	34.9	14.1	18.9	13.3	17.3	10.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	8.2	0.0	12.7	0.4	0.0	0.1	0.2	0.0	0.1	26.6	31.8	0.5	25.4	0.0	0.2	0.0	0.0	23.0	0.1	19.5	0.0	17.8	0.7	0.0	34.3	0.2	17.1	0.0	0.1	0.1	3.3	2.8	0.0	1.6	0.2	0.0	0.1	0.1	0.3	14.0	0.0	11.4	0.6	0.2	0.0	14.3	18.8	1.1	9.8	0.3	0.6	0.7	12.2	14.1	14.8	18.9	15.7	14.6	15.8	13.7	34.9	14.6	16.5	15.6	1.0	13.3	7.4	19.2	17.3	10.0	15.2	15.6	5.6	19.2	14.4	6.8	7.8	32.1	8.2	11.2
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 41.0;HSkMC: 40.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB040547, HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"			930000	Cytosol	"Cytokinetic bridge"	"CAB040547: , HPA055972: , HPA055973: "	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favourable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	23.8	27.3	30.7	14.7	48.3	5.7	31.7	13.7	25.0	36.4	20.9	19.9	54.3	14.5	24.0	37.1	15.4	31.4	15.7	35.2	32.5	21.7	15.9	6.0	11.1	7.5	17.0	21.1	90.1	17.8	20.4	40.2	5.8	22.4	30.7	10.7	36.0	26.6	87.5	88.5	39.2	13.6	22.0	24.9	10.7	16.4	9.2	28.9	6.7	20.4	25.6	8.7	20.2	31.0	5.2	16.5	16.0	3.5	8.9	20.9	5.8	0.0	1.2	12.9	13.1	15.4	41.0	2.4	8.1	14.3	7.5	9.6	2.3	0.0	0.2	8.7	20.3	0.0	1.0	0.0	9.8	0.4	0.2	4.6	0.1	3.0	10.4	0.4	8.6	40.5	0.3	11.2	0.0	5.3	1.3	0.2	16.3	0.1	6.3	8.0	2.3	10.9	7.8	0.0	0.0	2.3	0.2	2.8	6.4	0.0	0.3	4.2	13.1	2.3	0.1	8.4	0.4	12.0	0.6	4.0	5.9	0.4	12.6	0.1	0.1	1.0	2.2	16.0	1.9	3.5	1.8	5.2	5.3	2.0	12.7	3.7	20.9	8.9	1.3	8.9	2.1	16.5	4.5	5.8	30.7	48.3	13.7	25.0	32.5	21.7	17.0	21.1	22.4	28.9
GSTM3	GST5	ENSG00000134202	"Glutathione S-transferase mu 3"	P21266	1	109733932-109741038	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 115.3;testis: 96.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 44.8;T-47d: 94.8;WM-115: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.1;T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017130, HPA035190, CAB040583, HPA055972"	Enhanced		Supported	Cytosol			560000	Cytosol		"CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: "	"unprognostic (2.13e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.48e-2)"	7.5	11.3	21.4	2.9	27.8	0.9	23.1	8.5	18.4	15.4	11.7	9.9	51.0	12.6	9.0	67.2	11.1	8.8	12.3	27.6	14.0	14.4	54.0	5.3	5.2	2.4	9.6	22.0	32.3	26.5	7.3	9.4	5.8	30.7	13.6	5.6	13.4	4.5	115.3	15.5	15.0	7.5	15.9	13.3	3.3	14.2	96.0	6.4	0.1	15.8	15.6	3.3	17.4	12.0	0.6	0.8	4.1	0.3	1.0	11.1	1.4	0.0	1.3	9.7	0.0	13.2	8.1	1.6	10.5	1.8	11.5	11.2	4.2	0.3	0.0	6.1	5.3	0.5	1.9	4.3	16.0	0.0	2.9	9.8	31.8	6.3	14.1	0.0	22.8	8.1	5.3	17.3	0.0	14.2	0.8	0.1	5.1	5.7	2.6	0.2	1.0	18.2	0.0	6.2	0.4	3.2	22.5	17.1	9.2	21.9	44.8	2.0	94.8	14.3	11.1	0.1	4.2	11.8	6.9	1.5	2.4	0.0	0.1	0.0	36.8	0.8	0.3	4.1	4.2	0.1	1.2	0.6	5.3	3.1	0.1	0.6	11.1	5.5	2.0	1.0	0.2	0.8	2.3	1.4	21.4	27.8	8.5	18.4	14.0	14.4	9.6	22.0	30.7	6.4
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656081-109674836	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 69.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 69.8"	"Low region specificity"	"Detected in all"							"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"			660000	Cytosol	"Cytokinetic bridge"	"HPA048652: , HPA055972: , HPA055973: "	"prognostic favourable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	12.5	17.6	14.0	12.3	20.2	3.6	10.9	12.9	24.7	12.6	33.2	18.0	9.4	85.3	12.1	15.3	15.9	11.0	14.5	14.7	13.7	12.3	27.2	22.0	7.4	10.1	14.8	16.9	31.4	12.2	23.1	9.9	5.1	15.8	14.7	23.2	20.5	15.4	26.3	47.4	10.6	77.2	19.0	16.1	16.2	14.7	11.8	14.0	4.0	14.9	14.5	12.8	22.2	14.2	3.6	7.8	69.8	3.0	2.5	3.1	2.3	5.3	2.4	4.3	32.5	9.7	15.0	5.5	1.7	14.0	4.1	5.4	17.1	0.6	5.0	6.7	7.7	5.5	11.1	5.8	2.6	7.4	0.0	10.8	10.0	15.3	15.8	3.7	13.2	9.4	5.8	5.2	0.0	3.3	5.0	7.5	2.8	4.9	3.1	16.4	3.3	12.9	6.6	2.4	7.3	16.0	3.8	3.0	7.2	0.0	28.1	21.7	7.6	8.0	1.4	4.7	18.7	5.2	2.5	11.2	19.6	0.4	15.5	5.5	13.3	2.0	2.9	69.8	2.7	3.0	1.6	3.6	2.0	3.1	7.8	2.8	2.0	2.3	0.4	2.5	0.7	2.7	2.8	2.3	14.0	20.2	12.9	24.7	13.7	12.3	14.8	16.9	15.8	14.0
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109712255-109775428	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"breast: 237.6;ovary: 66.1"	"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 17.6;HHSteC: 7.6;HSkMC: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;T-cells: 1.9"									"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"				Cytosol	"Cytokinetic bridge"	"HPA048652: , HPA055972: , HPA055973: "	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	5.8	3.5	25.7	2.6	23.4	1.6	237.6	15.8	24.6	27.2	4.2	14.0	4.7	2.1	14.0	12.0	4.8	19.8	9.0	4.8	24.9	6.2	2.9	2.1	5.7	2.6	4.9	17.9	66.1	2.7	1.6	2.7	1.6	8.9	12.8	4.0	23.0	3.9	11.9	2.4	3.7	3.5	9.8	11.0	3.5	3.9	5.1	11.9	0.0	2.6	2.1	3.2	10.5	16.1	0.0	5.7	0.6	0.2	0.7	1.9	0.9	0.0	0.0	0.0	0.0	1.5	1.5	0.2	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.2	0.0	0.7	0.0	5.7	1.9	0.9	25.7	23.4	15.8	24.6	24.9	6.2	4.9	17.9	8.9	11.9
GSTO1	"GSTTLp28, P28"	ENSG00000148834	"Glutathione S-transferase omega 1"	P78417	10	104235356-104267459	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037603, HPA037604"	Enhanced		Approved	Nucleoplasm,Cytosol			200000000	Cytosol	Nucleoplasm	"HPA037603: AB_2675574, HPA037604: AB_10672283"	"prognostic favourable (6.95e-4)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-3)"	"unprognostic (4.57e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.82e-2)"	29.6	31.9	19.9	21.8	24.4	35.8	20.0	15.0	24.3	17.8	29.7	16.8	17.8	36.3	16.5	21.4	22.6	15.2	24.7	67.9	19.7	21.5	32.7	137.3	32.0	35.7	23.2	23.1	19.7	21.2	18.6	23.2	26.3	17.0	18.2	20.8	18.0	25.3	21.2	42.7	13.3	41.0	21.4	18.9	26.8	19.8	7.0	14.2	30.8	32.9	24.0	16.8	28.0	18.8	18.7	55.4	85.5	68.3	21.8	25.5	68.0	31.0	21.3	16.5	28.2	23.2	44.3	7.2	40.6	72.1	26.9	29.4	26.7	33.2	27.7	17.6	26.9	17.9	10.8	36.0	28.4	13.8	25.9	20.4	15.2	58.3	41.5	26.1	34.3	33.6	15.4	39.1	47.3	51.5	41.9	17.3	56.4	16.9	20.3	36.8	15.2	14.9	14.9	10.8	11.7	40.0	20.0	8.2	10.3	13.1	9.4	121.1	10.3	21.1	47.5	32.0	16.8	49.7	36.1	0.3	0.4	0.2	59.9	45.5	12.6	85.5	68.3	19.2	18.3	57.2	22.0	18.7	22.6	23.4	55.4	15.0	19.7	19.8	19.5	21.8	43.9	25.7	25.5	68.0	19.9	24.4	15.0	24.3	19.7	21.5	23.2	23.1	17.0	14.2
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583595-67586656	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol			120000000	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	24.2	25.3	20.2	23.8	21.7	46.2	39.5	15.5	19.8	51.8	51.9	23.5	125.4	35.2	43.5	41.9	181.6	60.8	51.1	45.3	18.3	23.5	44.2	5.9	61.0	39.4	25.5	19.9	33.4	60.7	44.1	33.8	57.9	46.0	37.0	17.9	59.9	50.2	110.8	33.7	58.5	34.0	30.1	22.8	25.1	48.5	15.4	15.4	29.8	91.6	131.5	75.6	40.8	79.5	25.3	191.4	12.4	168.2	70.1	40.7	167.2	68.1	93.0	45.3	70.5	35.1	39.6	41.9	29.8	40.0	45.6	35.5	170.8	71.7	0.1	68.4	47.1	99.7	122.4	131.2	12.9	47.5	44.5	3.3	67.7	0.0	52.1	22.4	39.9	49.1	298.4	36.3	35.1	68.3	73.9	19.0	35.6	0.2	51.3	62.5	86.7	39.9	47.9	7.6	0.2	72.5	0.2	15.4	44.0	41.8	13.6	135.0	0.2	37.7	36.8	21.0	53.4	44.0	21.6	11.8	73.8	25.0	23.9	37.1	43.6	2.3	168.2	12.4	40.7	125.7	15.0	25.3	18.4	33.3	191.4	24.3	15.3	27.3	7.0	70.1	79.4	76.2	18.3	167.2	20.2	21.7	15.5	19.8	18.3	23.5	25.5	19.9	46.0	15.4
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B (gene/pseudogene)"	P0CG30	22	23957414-23961186	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"breast: 83.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.4;HHSteC: 33.0;SK-MEL-30: 22.8;T-47d: 25.2"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favourable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	1.6	11.7	2.7	0.7	1.9	0.0	83.4	0.0	4.2	2.6	1.5			0.1	1.7	2.9	2.6	1.4	1.1	2.4	1.7	2.9	1.3	6.1	2.0	0.1	2.5		3.1	3.2	0.9	3.6	0.8		6.1	0.2		1.2	2.5	1.3	11.4	0.7	2.7	1.4	0.9	2.6	0.5			2.5		0.1	0.7	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.4	0.3	0.0	22.4	0.4	0.5	0.9	3.1	1.8	4.6	4.8	9.6	0.0	0.0	5.1	7.8	9.4	0.0	9.9	2.1	0.0	0.8	0.3	12.6	1.5	33.0	0.0	3.6	13.6	1.6	13.1	2.7	3.6	0.0	0.0	2.7	0.1	0.0	0.0	0.1	4.7	0.0	16.7	0.0	10.1	0.0	0.4	9.4	3.1	0.0	22.8	25.2	0.3	12.2	3.8	2.5	0.5	2.4	0.0	0.0	0.0	2.4	0.0	9.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol			62000	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favourable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.4	12.4	9.8	6.9	6.2	8.6	16.6	4.1	4.1	7.6	10.8	4.2	16.4	14.4	5.8	4.8	8.3	6.7	7.8	7.3	7.6	6.6	7.0	4.7	8.8	9.8	2.6	5.8	8.1	8.5	4.4	7.5	6.5	5.8	13.3	5.1	60.2	4.0	5.5	2.9	9.9	6.9	10.3	11.2	11.6	8.0	10.8	9.8	9.0	18.0	12.7	29.4	3.8	4.4	5.9	20.2	6.7	3.0	10.0	10.7	12.7	15.5	3.9	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2
GTDC1	"FLJ11753, Hmat-Xa"	ENSG00000121964	"Glycosyltransferase like domain containing 1"	Q4AE62	2	143938068-144332568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036694	Uncertain		Approved	Cytosol				Cytosol		"HPA036694: AB_10671709"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-7)"	"unprognostic (8.01e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-3)"	"unprognostic (6.96e-2)"	"prognostic unfavourable (6.60e-4)"	"unprognostic (2.44e-1)"	"unprognostic (8.23e-2)"	"unprognostic (6.31e-3)"	"unprognostic (1.89e-1)"	14.5	12.9	22.1	7.1	17.3	12.3	8.9	7.3	26.7	12.9	6.9	15.3	1.6	4.0	6.8	9.8	7.5	6.0	10.1	15.2	21.4	14.1	9.4	6.4	8.0	9.8	18.2	14.9	12.6	7.0	10.9	10.7	9.3	14.1	6.4	6.7	7.0	5.9	6.0	8.8	5.3	4.8	7.1	24.0	12.6	4.8	11.7	11.6	6.1	10.6	3.1	11.2	8.9	6.3	4.3	2.0	10.8	2.5	8.0	12.3	3.4	4.6	1.9	14.0	2.6	14.4	13.3	4.2	3.2	8.2	7.2	9.9	2.1	4.3	10.0	2.3	5.8	1.3	2.8	4.8	15.5	12.8	3.2	15.5	1.7	2.2	5.9	6.2	8.4	9.2	12.0	7.8	11.4	10.3	2.8	11.7	16.4	2.1	1.6	6.8	3.9	3.1	4.7	7.2	2.6	8.0	9.5	7.0	5.6	6.3	5.4	6.3	3.5	7.1	6.3	8.0	5.9	3.5	4.0	7.4	0.0	5.6	4.7	4.2	10.7	2.1	2.5	7.3	5.7	2.2	12.3	4.3	3.8	9.5	2.0	3.4	0.8	6.3	10.8	8.0	2.4	0.7	4.7	3.4	22.1	17.3	7.3	26.7	21.4	14.1	18.2	14.9	14.1	11.6
GTF2A1	TFIIA	ENSG00000165417	"General transcription factor IIA subunit 1"	P52655	14	81175452-81221377	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000869	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000869: AB_1080253"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.88e-2)"	16.9	14.9	18.2	15.7	23.3	8.7	17.1	32.6	23.4	15.7	12.9	17.7	12.7	12.2	16.0	20.1	17.9	12.5	13.1	12.7	17.0	17.8	15.3	18.4	11.6	18.9	16.2	17.0	17.6	14.7	21.0	20.6	24.5	19.9	14.8	14.7	14.0	14.5	13.1	20.3	14.7	12.4	16.2	18.5	17.2	13.4	23.9	16.7	36.3	30.4	11.3	18.5	15.9	15.0	1.3	3.2	9.3	3.9	1.5	2.3	0.8	10.5	10.6	22.3	14.9	12.7	10.7	8.1	12.8	13.3	11.8	10.7	15.7	10.7	17.3	10.4	10.6	8.0	15.3	9.7	21.0	14.6	4.6	15.7	12.2	9.3	12.5	11.0	16.3	9.9	7.5	16.2	21.2	12.0	9.6	23.9	15.1	17.7	28.0	6.5	12.1	10.2	15.1	19.5	10.7	7.9	21.7	21.1	12.5	30.2	12.4	13.5	18.5	9.4	15.0	12.0	9.2	16.6	13.3	19.2	20.5	18.0	9.6	12.9	19.0	9.3	1.2	2.1	2.3	0.9	2.0	1.3	2.1	1.3	0.7	1.2	1.9	2.1	2.0	1.5	3.9	3.2	1.1	0.8	18.2	23.3	32.6	23.4	17.0	17.8	16.2	17.0	19.9	16.7
GTF2E2	"FE, TF2E2, TFIIE-B"	ENSG00000197265	"General transcription factor IIE subunit 2"	P29084	8	30578318-30658251	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004816, CAB009603, HPA025065"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009603: AB_2114537, HPA004816: , HPA025065: AB_10601658"	"unprognostic (4.84e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.38e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (5.82e-7)"	"unprognostic (8.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.24e-1)"	19.0	21.9	11.4	16.2	17.0	7.5	26.7	21.2	13.1	16.4	19.1	10.7	15.1	16.8	17.7	15.8	20.0	12.3	11.7	12.7	11.1	10.9	14.7	21.1	13.4	20.3	11.6	12.2	24.2	44.6	14.1	22.5	14.5	11.9	14.2	14.4	12.1	12.6	13.8	9.9	14.8	26.2	16.3	11.6	17.2	20.9	31.0	11.7	21.4	17.2	10.6	22.0	16.9	27.5	16.4	8.0	5.6	4.2	8.7	7.9	2.6	21.4	17.4	12.0	12.7	32.5	29.1	9.1	23.4	21.2	19.2	24.5	10.4	15.4	27.8	19.9	20.8	15.2	19.8	21.8	25.6	12.4	11.7	13.8	12.2	24.6	31.6	6.6	12.2	21.2	28.9	20.6	21.0	26.4	26.6	17.1	30.1	14.5	32.5	16.7	13.6	21.0	17.1	13.0	13.8	20.7	14.7	9.3	12.0	12.9	8.7	18.2	8.4	8.2	20.1	12.7	13.2	10.7	15.9	17.5	23.8	30.1	20.0	11.4	16.7	3.0	4.2	5.6	3.9	3.3	4.2	16.4	6.0	7.9	7.2	9.3	5.9	5.9	2.2	8.7	3.3	8.0	6.7	2.6	11.4	17.0	21.2	13.1	11.1	10.9	11.6	12.2	11.9	11.7
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602604	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 62.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	4.6	7.6	4.3	5.1	6.8	0.6	6.3	4.4	7.8	9.4	8.2	8.2	9.2	7.0	7.4	8.7	16.4	7.0	8.6	7.7	3.9	5.5	9.3	3.6	7.2	2.6	8.5	5.3	8.6	10.0	21.1	25.3	5.3	6.6	8.2	5.5	21.6	11.3	8.3	62.8	15.6	5.2	12.1	5.6	1.6	8.8	4.5	5.7	1.3	16.4	12.9	7.3	10.5	13.2	0.6	1.8	2.7	0.5	0.6	0.7	0.1	9.3	5.9	12.9	14.1	10.4	5.1	0.1	4.0	10.6	7.8	8.2	10.2	13.5	2.4	3.0	8.0	5.4	10.2	4.7	5.8	0.1	6.1	0.4	19.9	11.5	33.4	0.1	0.3	7.1	19.2	5.5	22.7	4.0	6.9	0.0	8.7	11.8	1.2	8.2	10.3	6.1	12.6	7.5	8.8	14.9	6.5	10.7	14.5	9.8	17.9	8.7	10.6	9.4	2.2	8.1	8.3	5.2	9.0	0.5	1.4	3.9	3.3	0.1	6.5	1.2	0.5	0.5	0.3	0.2	0.3	0.4	0.7	0.2	1.8	0.6	0.3	0.4	2.7	0.6	0.1	0.6	0.2	0.1	4.3	6.8	4.4	7.8	3.9	5.5	8.5	5.3	6.6	5.7
GTPBP1	"GP-1, HSPC018"	ENSG00000100226	"GTP binding protein 1"	O00178	22	38705723-38738299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003166, HPA064702"	Approved		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA003166: AB_10601476, HPA064702: "	"unprognostic (1.42e-3)"	"unprognostic (5.82e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (3.17e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.98e-3)"	18.0	17.1	16.0	22.1	20.6	86.0	16.5	24.9	24.9	16.2	17.4	26.8	20.8	20.6	19.6	15.6	19.3	22.7	20.6	19.5	17.2	14.1	15.9	14.7	24.8	20.9	20.6	21.7	25.9	21.0	23.1	23.1	15.6	17.2	20.8	17.9	28.8	18.7	19.9	28.5	23.0	21.2	20.3	16.1	25.5	18.8	17.2	22.7	18.3	23.1	12.6	23.6	23.6	16.5	7.2	5.0	12.1	7.3	3.4	7.7	4.3	13.5	4.9	18.0	14.5	6.3	9.4	8.9	12.3	13.9	19.2	16.4	10.3	7.1	12.7	4.8	12.8	12.2	21.2	13.7	10.6	21.6	15.4	22.4	16.0	7.3	11.8	26.4	11.3	10.0	10.4	15.4	24.0	10.3	13.4	26.8	10.5	5.5	14.8	11.5	13.0	9.5	28.8	18.3	15.7	6.6	10.7	24.6	8.6	15.3	10.1	9.3	9.2	11.2	12.4	10.3	10.5	7.6	9.8	24.8	8.5	17.7	9.9	13.4	8.2	3.6	4.3	5.5	7.5	7.0	6.6	7.2	5.5	7.7	5.0	6.6	4.1	5.7	12.1	3.4	7.3	2.6	4.9	4.3	16.0	20.6	24.9	24.9	17.2	14.1	20.6	21.7	17.2	22.7
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807591	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.6"	"Cell line enhanced"	"Detected in many"		"HEL: 24.8;Karpas-707: 13.1;MOLT-4: 15.6;RPTEC TERT1: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 5.6;non-classical monocyte: 17.8"	"Lineage enriched"	"Detected in many"	12	"monocytes: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol			5200	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	8.8	5.4	18.7	9.8	42.0	1.8	5.5	12.2	36.8	8.1	14.9	5.7	0.4	4.2	11.3	4.7	5.9	9.5	9.2	12.2	16.1	25.0	9.2	5.4	9.4	6.6	14.5	23.2	3.7	7.4	71.6	3.8	28.0	20.6	9.8	6.2	5.8	3.2	8.7	3.8	2.2	5.9	16.3	6.7	7.2	8.9	2.1	5.5	2.6	4.6	2.4	5.1	8.0	6.8	0.2	1.4	1.1	17.8	0.9	0.0	4.8	0.0	0.2	3.5	0.0	1.2	6.6	0.0	1.1	1.9	0.1	0.0	0.0	0.0	0.0	1.7	0.6	0.0	7.3	0.1	0.4	0.0	2.6	24.8	0.0	0.0	0.7	0.0	0.0	2.9	0.2	0.0	0.1	0.0	0.0	13.1	1.7	1.1	15.6	0.0	0.2	1.8	1.8	0.5	0.4	25.2	2.3	0.4	4.4	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	7.1	5.2	0.1	0.0	0.0	9.0	0.0	0.0	1.1	0.4	0.3	0.0	5.6	0.0	0.1	0.0	0.0	1.4	0.2	0.0	0.0	0.4	0.9	17.8	1.2	0.0	4.8	18.7	42.0	12.2	36.8	16.1	25.0	14.5	23.2	20.6	5.5
GUK1		ENSG00000143774	"Guanylate kinase 1"	Q16774	1	228139962-228148984	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028118, HPA048587"	Approved		Uncertain	Nucleoplasm,Cytosol			240000	"Nucleoplasm, Cytosol"		"HPA028118: AB_2756308, HPA048587: AB_2680453"	"unprognostic (9.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavourable (8.85e-5)"	"unprognostic (2.91e-1)"	"unprognostic (5.41e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-2)"	44.6	38.2	106.4	32.5	76.0	76.7	43.0	25.2	74.4	31.5	33.3	30.1	27.3	41.5	26.3	34.1	77.0	28.0	42.5	61.6	93.1	43.9	31.9	43.5	34.6	39.0	60.0	52.9	24.7	62.2	12.8	26.0	29.2	40.1	25.5	12.1	37.4	66.5	29.4	35.8	59.6	42.1	34.8	49.6	36.1	44.3	22.2	34.9	27.5	31.6	29.3	24.1	45.9	44.5	43.9	97.7	110.1	62.9	55.8	83.7	84.5	57.4	20.3	8.9	27.7	27.0	32.6	45.0	38.3	19.7	22.4	17.6	11.6	40.0	21.7	45.5	25.0	38.2	7.7	42.1	2.4	33.0	59.7	12.9	50.1	25.2	49.2	14.5	22.7	45.2	25.6	15.6	12.6	30.2	34.7	34.6	18.3	48.0	65.7	31.5	28.1	88.0	25.2	16.9	57.5	21.0	27.1	29.6	53.1	24.7	42.3	49.6	31.2	31.5	52.6	40.9	27.0	59.8	63.0	32.0	34.6	23.9	51.5	23.8	41.2	55.5	57.1	110.1	77.3	59.8	75.2	43.9	64.8	83.7	48.9	36.6	48.7	61.1	74.9	55.8	62.9	97.7	64.6	84.5	106.4	76.0	25.2	74.4	93.1	43.9	60.0	52.9	40.1	34.9
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828788-2882820	"Enzymes, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 76.7;brain: 21.2;breast: 30.4"	"Cell line enhanced"	"Detected in many"		"AF22: 17.7;BEWO: 12.8;CACO-2: 13.1;Hep G2: 14.2;NTERA-2: 17.4;SK-MEL-30: 37.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: "	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favourable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	76.7	1.4	4.6	1.3	4.6	0.5	30.4	2.1	3.7	2.1	3.5	8.2	0.7	1.2	4.2	0.9	1.0	3.6	1.7	1.7	3.9	2.9	1.4	9.9	0.7	0.7	5.5	2.9	1.9	3.2	0.4	0.5	1.6	12.9	2.7	2.0	4.2	2.8	4.4	0.5	1.2	1.3	2.8	21.2	0.5	2.2	0.8	5.1	0.0	1.3	0.5	0.6	2.9	1.4	1.0	0.6	0.6	0.4	1.2	0.7	0.0	0.0	5.4	17.7	0.0	10.6	0.0	12.8	0.5	3.1	3.1	3.9	13.1	0.3	0.0	1.4	2.2	0.0	10.0	0.2	3.0	0.1	2.8	0.0	0.2	14.2	3.1	0.0	4.3	3.8	0.1	0.3	0.0	0.0	0.1	0.0	3.2	0.8	0.0	0.4	17.4	0.1	2.9	5.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	37.7	1.7	10.7	0.0	0.0	3.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.3	0.1	1.0	0.3	0.2	0.6	1.2	0.4	0.6	0.4	0.0	4.6	4.6	2.1	3.7	3.9	2.9	5.5	2.9	12.9	5.1
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140786	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 56.9"	"Cell line enriched"	"Detected in some"	4	"HEL: 55.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"											"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.0	0.2	0.1	0.4	56.9	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.3	1.7	1.3	3.2	0.1	0.3	0.1	0.1	0.1	0.0	0.3	4.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.3	0.4	0.2	0.2	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.2	0.9	0.1	0.2	0.2	1.5	0.2	0.6	0.2	0.2	0.2	0.3	0.0	0.8	0.2	0.4	0.1	0.5	0.2	0.3	0.3	0.1	0.1	0.1
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968125-48993310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol			10000	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: "	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	9.7	7.3	5.1	6.1	6.5	16.0	10.6	11.3	6.2	5.3	7.3	6.2	5.8	6.1	6.2	6.9	11.5	5.9	6.1	37.3	6.8	4.0	7.2	4.3	5.0	6.3	5.3	5.5	6.8	4.4	6.4	5.1	5.0	5.9	8.7	6.1	12.4	7.2	7.6	106.1	8.1	6.1	6.8	6.0	5.8	7.3	2.2	5.5	6.4	5.2	42.6	9.0	7.9	6.9	6.7	15.9	8.2	10.5	12.8	10.9	7.3	28.3	11.3	8.4	11.5	19.6	7.7	16.7	19.7	13.9	20.8	24.4	11.0	9.3	11.8	12.0	19.2	20.3	14.0	25.0	18.2	7.3	20.3	9.8	14.5	9.7	11.0	10.7	7.3	19.0	12.0	13.4	11.4	17.4	6.8	15.9	26.0	10.8	13.2	9.3	4.5	13.1	11.2	14.7	11.6	20.6	30.4	5.2	7.3	17.5	22.9	4.6	12.1	11.1	13.4	25.6	9.9	11.5	21.3	13.2	13.6	5.8	26.1	9.4	5.7	8.2	10.5	7.5	8.8	6.3	10.9	6.7	7.6	8.2	15.9	5.5	6.3	5.6	4.4	12.8	8.5	8.6	10.1	7.3	5.1	6.5	11.3	6.2	6.8	4.0	5.3	5.5	5.9	5.5
H2BFS		ENSG00000234289	"H2B histone family member S"	P57053	21	43565189-43565648	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.0"	"Cell line enhanced"	"Detected in many"		"K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "					"unprognostic (1.29e-1)"					"unprognostic (4.33e-3)"				"unprognostic (2.06e-2)"				1.1	0.9	0.2	7.4	0.3	1.8	2.6	0.3	0.8	1.8	1.7	0.4	1.1	2.3	2.4	4.3	4.9	4.2	4.2	4.9	0.5		0.5	4.0	3.3	12.2	0.1	0.5	2.2	4.2	0.0	0.0	4.5	0.4	5.3	1.8	0.8	3.0	2.1	1.0	0.4	3.0	1.8	0.7	5.7	2.0	7.9	0.0	65.0	2.6	7.1	6.1	2.1	1.3	7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.0	3.2	0.6	0.9	2.2	0.8	2.3	2.5	1.3	3.2	1.9	4.5	1.0	0.5	8.6	0.8	2.4	0.2	0.7	0.9	2.1	3.5	0.5	4.9	0.2	0.3	0.9	4.4	2.4	0.4	0.6	0.0	0.3	23.2	2.7	0.8	6.0	1.0	2.2	0.3	2.6	0.8	0.5	8.5	0.6	0.7	3.4	2.4	10.2	3.1	2.0	10.9	1.4	0.9	1.7	22.9	1.1	0.6	7.4	23.3	4.9	1.1	11.6	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2										
H2BFS		ENSG00000274559	"H2B histone family member S"		21	5972924-5973383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"blood: 16.0"	"Cell line enhanced"	"Detected in many"		"K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "										"unprognostic (3.37e-2)"				"unprognostic (2.63e-1)"				0.4	0.3		0.5		1.0	0.0		0.0	1.0	0.9			1.4	1.3	2.9	3.3	2.8	2.8	0.0			0.0	2.2	0.3	2.3			0.2	1.2	0.0		0.8		3.7	0.9		1.9	0.0	0.0	0.0	1.8	0.7		0.6	1.1	0.9			1.6		1.0	1.2		7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.0	3.2	0.6	0.9	2.2	0.8	2.3	2.5	1.3	3.2	1.9	4.5	1.0	0.5	8.6	0.8	2.4	0.2	0.7	0.9	2.1	3.5	0.5	4.9	0.2	0.3	0.9	4.4	2.4	0.4	0.6	0.0	0.3	23.2	2.7	0.8	6.0	1.0	2.2	0.3	2.6	0.8	0.5	8.5	0.6	0.7	3.4	2.4	10.2	3.1	2.0	10.9	1.4	0.9	1.7	22.9	1.1	0.6	7.4	23.3	4.9	1.1	11.6	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2										
H6PD	GDH	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234775-9271337	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 116.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.6;ASC TERT1: 32.8;HSkMC: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"		91000000	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	18.3	16.1	4.1	10.7	5.5	4.8	12.2	4.1	6.3	16.6	11.9	10.5	8.2	6.3	22.0	18.0	11.1	15.6	11.9	11.9	3.7	3.0	7.0	116.9	12.2	11.1	6.8	2.6	38.3	10.6	8.0	8.7	14.9	6.0	11.6	5.3	11.8	29.8	8.1	24.7	20.7	10.4	10.2	6.6	10.7	9.9	12.4	5.5	16.2	12.6	12.9	14.1	12.2	10.1	4.5	3.7	4.1	6.3	3.1	4.7	3.0	3.8	3.1	2.7	10.2	28.6	32.8	2.6	3.9	9.6	2.9	4.5	0.6	7.9	4.2	4.5	6.0	4.0	0.7	1.9	4.2	12.6	0.9	0.0	1.0	2.6	16.0	1.3	1.6	32.2	3.7	6.9	4.5	13.1	1.1	7.3	5.6	2.2	1.5	3.2	1.5	1.8	0.4	0.3	3.5	3.7	1.6	0.9	4.9	5.1	4.0	4.8	3.0	6.8	13.0	9.9	1.6	2.5	1.0	9.8	2.9	1.0	16.6	6.1	6.2	3.5	6.2	0.9	4.7	6.3	3.7	3.5	3.5	4.1	2.8	4.5	3.4	3.2	4.1	3.1	5.8	3.7	2.8	3.0	4.1	5.5	4.1	6.3	3.7	3.0	6.8	2.6	6.0	5.5
HABP4	"IHABP4, SERBP1L"	ENSG00000130956	"Hyaluronan binding protein 4"	Q5JVS0	9	96450201-96491336	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055969	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA055969: "	"unprognostic (1.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"prognostic favourable (1.10e-7)"	"unprognostic (2.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.62e-2)"	13.2	11.9	31.2	6.1	44.8	1.7	6.5	14.1	40.6	7.9	5.5	12.4	1.5	3.0	8.2	6.8	7.2	5.3	8.1	19.1	26.1	24.9	23.5	5.7	6.1	6.8	27.1	20.5	11.7	4.8	13.8	7.4	3.4	31.6	8.3	4.2	8.4	4.1	10.6	9.4	6.1	3.3	10.6	19.4	5.0	5.0	21.8	13.0	0.4	11.2	2.2	4.9	7.6	6.5	4.1	0.1	0.3	0.8	1.0	4.0	0.7	7.4	8.5	10.8	11.6	24.1	20.6	7.7	10.1	11.3	7.6	8.4	12.7	12.5	3.8	5.0	15.1	5.5	9.0	1.9	6.2	4.6	5.4	1.5	4.0	21.1	12.2	0.3	1.6	8.3	3.5	8.7	6.9	5.4	1.7	11.3	13.7	7.6	0.1	2.3	5.0	8.3	3.9	9.5	0.1	13.0	3.3	6.9	4.7	5.4	3.3	16.1	2.3	1.6	9.2	10.6	2.4	19.3	8.5	7.1	7.0	1.6	8.4	3.0	15.5	0.0	0.1	0.0	1.4	0.3	1.4	4.1	4.0	3.2	0.0	1.7	2.8	2.8	0.3	1.0	0.8	0.1	3.0	0.7	31.2	44.8	14.1	33.8	26.1	24.9	27.1	20.5	31.6	13.0
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 29.5;liver: 96.8;skin 1: 26.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;NB-4: 3.9;THP-1: 15.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 20.1;neutrophil: 29.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol			67000	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	0.5	0.0	0.1	1.1	0.3	4.4	0.9	0.1	0.3	0.3	0.2	0.1	0.1	0.1	1.1	0.3	0.5	0.2	0.3	0.2	0.1	0.0	0.2	96.8	1.7	2.3	0.5	0.1	0.3	0.5	0.0	7.4	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.2	26.9	0.2	0.2	0.3	2.7	0.1	0.2	0.2	0.1	0.2	0.9	1.3	0.2	0.5	0.0	1.4	29.5	6.3	0.3	0.1	1.6	0.5	0.0	0.2	0.1	0.0	0.0	3.1	0.0	0.2	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.5	0.4	0.2	0.0	0.0	0.6	0.6	0.0	0.9	0.4	0.4	0.3	0.0	0.2	0.1	0.0	0.2	3.9	1.3	0.6	0.2	0.1	0.1	0.1	0.8	0.2	0.4	0.4	0.1	0.0	0.0	15.1	0.2	0.1	0.2	0.2	0.2	0.6	0.7	0.2	0.0	2.4	0.0	20.1	6.3	0.9	0.0	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	29.5	0.3	5.1	0.1	0.1	1.6	0.1	0.3	0.1	0.3	0.1	0.0	0.5	0.1	0.2	0.2
HAP1	"HAP2, hHLP1, HIP5, HLP"	ENSG00000173805	"Huntingtin associated protein 1"	P54257	17	41717742-41734644	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.5;stomach 1: 23.3"	"Cell line enriched"	"Detected in some"	7	"REH: 45.1"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076992	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA076992: "	"unprognostic (2.84e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	"unprognostic (8.76e-2)"	"prognostic favourable (4.26e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.29e-2)"	0.7	3.2	11.7	1.1	16.2	0.8	2.0	5.6	13.1	4.8	1.3	3.8	2.2	5.2	4.6	3.5	0.9	2.8	3.1	0.6	10.1	30.5	1.1	1.2	1.4	0.9	6.6	6.6	1.0	2.2	0.5	6.8	3.1	15.5	1.6	1.4	0.4	3.4	3.0	1.0	1.6	2.5	1.7	8.3	3.3	23.3	3.4	2.2	0.0	7.2	0.0	1.0	0.9	1.2	1.2	0.8	2.6	0.6	1.5	1.0	0.1	0.1	1.5	0.7	1.5	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.9	0.1	0.1	0.5	0.1	6.2	3.2	0.2	0.0	0.0	1.6	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.8	0.4	45.1	0.0	1.7	0.3	0.5	0.2	0.0	0.3	0.2	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.6	0.6	0.5	0.6	0.3	0.4	0.5	0.5	0.6	0.2	1.2	0.8	1.0	2.6	1.5	0.6	0.8	0.8	0.1	11.7	16.2	5.6	9.3	10.1	30.5	6.6	6.6	15.5	2.2
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877288-88895626	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.4;lymphoid tissue: 23.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.6;U-2 OS: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavourable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1.0	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6.0	4.7	9.8	3.2	1.0	3.0	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6.0	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6.0	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.3	0.9	9.6	2.7	3.0	3.0	2.6	0.6	1.0	1.3	2.7	4.0	0.0	7.6	3.3	1.0	9.1	1.2	0.0	20.6	8.0	3.0	0.2	0.0	0.4	0.0	0.1	1.1	0.5	1.9	0.1	4.5	0.0	5.9	0.4	0.1	0.0	0.0	7.1	0.1	0.0	0.4	7.2	1.8	0.1	0.1	2.6	0.5	0.5	3.6	0.0	0.3	0.8	6.9	20.6	5.2	0.4	0.9	0.0	0.0	2.5	0.0	5.9	0.7	0.6	0.0	0.6	0.3	3.0	0.1	10.0	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1.0	2.3	3.2	1.0	3.1	0.9	3.6	1.8
HARBI1	"C11orf77, FLJ32675"	ENSG00000180423	"Harbinger transposase derived 1"	Q96MB7	11	46602861-46617909	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038671, HPA045457"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038671: AB_10675947, HPA045457: "	"unprognostic (1.29e-1)"	"unprognostic (6.82e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.23e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.13e-1)"	3.3	5.9	6.3	3.3	13.9	7.5	3.7	2.6	8.5	3.8	4.4	11.8	5.4	4.0	3.6	5.4	4.4	3.3	3.7	3.7	6.0	4.4	4.6	4.9	3.2	4.6	16.6	4.2	2.6	4.8	5.4	8.3	5.9	9.2	3.6	5.3	3.4	4.5	3.0	4.9	5.0	4.1	4.5	7.7	4.3	6.2	19.2	13.0	4.8	4.1	0.6	5.0	4.4	3.1	6.7	8.2	20.3	10.2	6.0	10.1	4.5	3.7	6.1	5.1	4.8	10.1	6.2	6.0	5.4	5.2	7.5	9.4	4.2	4.3	6.5	3.5	4.4	7.3	5.4	4.7	7.0	7.6	6.4	6.6	4.7	4.7	11.7	6.1	9.0	7.7	12.7	4.9	9.7	4.6	10.3	8.2	6.1	7.9	7.5	2.6	13.7	7.4	5.1	7.1	11.5	5.8	4.4	4.8	4.0	6.4	6.9	7.7	11.5	5.4	4.4	7.5	5.8	9.8	4.8	7.8	8.3	7.0	5.7	3.7	7.6	20.3	7.5	10.2	10.1	10.2	7.1	5.0	8.3	7.5	6.2	6.7	8.1	8.9	11.1	6.0	9.2	8.2	9.8	4.5	6.3	13.9	2.6	8.5	6.0	4.4	16.6	4.2	9.2	13.0
HARS	USH3B	ENSG00000170445	"Histidyl-tRNA synthetase"	P12081	5	140673904-140691862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol			52000	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	22.4	24.5	28.5	21.1	35.5	18.1	21.0	41.1	46.3	20.6	22.7	20.0	23.6	17.4	21.6	23.5	26.9	23.7	17.5	25.1	29.5	35.9	20.6	34.2	16.7	22.4	36.9	33.0	24.7	25.2	29.5	38.7	15.0	38.2	21.7	24.8	13.6	22.1	27.9	27.1	33.9	16.4	28.0	21.0	18.3	18.8	16.6	23.5	17.6	19.4	20.3	28.5	19.9	20.9	16.8	22.1	10.7	22.9	25.2	29.4	23.4	20.5	30.0	18.1	39.5	23.1	25.1	19.1	33.1	23.9	38.3	35.9	54.7	17.4	27.4	29.2	37.1	21.6	27.5	53.3	36.1	23.2	34.0	19.7	39.0	34.6	28.7	30.9	16.9	26.6	16.7	41.7	23.8	38.4	17.2	22.7	39.8	35.3	22.0	28.8	14.2	19.8	20.3	26.3	22.3	30.8	26.2	28.5	27.5	27.4	40.0	26.1	29.5	17.4	32.0	36.0	13.8	20.2	44.6	22.9	27.2	27.7	27.3	26.0	24.5	6.7	14.1	10.7	29.4	20.8	26.3	16.8	25.8	27.3	22.1	14.8	28.2	26.9	4.3	25.2	22.9	15.6	22.1	23.4	28.5	35.5	41.1	46.3	29.5	35.9	36.9	33.0	38.2	23.5
HARS2	"HARSL, HARSR, HO3"	ENSG00000112855	"Histidyl-tRNA synthetase 2, mitochondrial"	P49590	5	140691426-140699318	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035941	Approved		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA035941: AB_10671237"	"prognostic unfavourable (6.49e-4)"	"unprognostic (3.15e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-2)"	17.1	23.8	14.2	22.9	19.4	13.4	25.0	24.7	19.0	15.0	21.6	16.6	19.7	17.7	20.2	16.9	16.7	14.9	16.7	25.2	15.7	12.6	19.6	14.5	21.4	25.2	15.5	11.2	17.4	13.6	22.9	21.1	15.8	14.4	14.3	24.4	16.4	16.4	15.4	32.7	18.3	17.2	15.6	12.9	18.5	17.9	15.1	15.6	16.5	15.8	13.9	18.8	20.6	18.4	13.7	12.0	22.9	15.0	22.8	17.6	9.7	10.7	24.4	10.6	27.2	12.1	16.0	17.5	14.0	16.0	19.6	17.2	22.4	13.6	13.7	22.6	15.4	13.7	14.6	26.2	18.2	13.8	12.0	10.0	23.4	14.7	11.6	13.4	14.7	15.0	17.8	19.1	21.7	14.1	9.2	13.0	19.0	13.8	13.1	16.6	12.2	15.5	13.4	10.8	13.8	18.4	25.3	14.7	21.2	20.2	32.9	27.6	29.0	13.3	17.2	17.7	9.8	9.8	18.3	12.8	18.7	13.2	13.9	15.4	17.6	22.9	10.5	21.3	16.2	15.0	17.5	13.7	15.6	16.2	12.0	12.5	16.4	17.6	12.1	22.8	11.4	9.5	15.3	9.7	14.2	19.4	24.7	19.0	15.7	12.6	15.5	11.2	14.4	15.6
HAUS1	"CCDC5, FLJ40084, HEI-C, HsT1461"	ENSG00000152240	"HAUS augmin like complex subunit 1"	Q96CS2	18	46104332-46128333	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040601, HPA040652"	Supported		Supported	Centrosome,Cytosol				Cytosol	Centrosome	"HPA040601: AB_10794743, HPA040652: AB_10793966"	"unprognostic (1.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (1.39e-1)"	"unprognostic (4.76e-3)"	"prognostic favourable (1.55e-4)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (6.76e-4)"	"unprognostic (5.97e-3)"	"unprognostic (5.40e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.96e-2)"	15.2	11.8	10.3	14.6	13.1	23.1	14.5	15.8	12.2	14.3	13.4	6.2	13.1	9.9	15.5	28.4	15.9	13.8	11.6	9.3	10.3	8.0	14.4	12.1	10.9	22.9	13.6	6.8	20.4	12.0	6.5	18.1	13.0	12.0	14.8	16.3	7.3	11.4	14.4	7.1	8.6	13.4	12.2	14.4	17.9	12.2	11.8	15.4	38.4	14.3	14.4	26.1	13.9	12.3	28.1	23.4	13.0	18.2	19.3	34.9	19.3	18.4	11.2	42.5	22.9	10.9	16.9	11.4	18.1	18.1	28.9	28.8	10.9	10.5	35.3	10.9	12.9	19.7	25.4	15.3	31.9	19.8	17.0	25.9	12.0	20.6	9.2	47.2	15.9	8.2	6.1	17.8	9.2	31.5	18.4	10.1	25.8	10.8	37.4	22.6	27.1	6.6	37.5	30.5	25.2	22.8	13.0	20.0	20.8	16.8	5.8	13.6	8.5	23.0	17.8	17.0	11.5	7.3	18.8	11.8	17.9	32.7	10.8	40.1	19.4	4.4	18.2	13.0	16.0	16.4	17.7	28.1	21.6	18.9	21.6	23.7	15.4	18.1	2.0	19.3	12.7	23.4	34.9	19.3	10.3	13.1	15.8	12.2	10.3	8.0	13.6	6.8	12.0	15.4
HAUS2	"C15orf25, CEP27, FLJ10460, HsT17025"	ENSG00000137814	"HAUS augmin like complex subunit 2"	Q9NVX0	15	42548810-42569994	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039965	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA039965: AB_10673025"	"unprognostic (5.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.81e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-3)"	18.7	11.3	13.1	12.1	11.5	49.9	18.6	13.3	15.4	9.9	11.9	11.1	5.6	8.9	14.0	10.4	12.8	9.7	9.3	10.8	14.1	13.6	10.3	11.0	16.8	16.6	14.6	13.9	12.1	12.1	8.4	9.9	11.6	13.1	8.8	10.8	8.5	10.5	8.5	13.5	11.8	9.5	12.3	18.7	11.2	9.7	13.7	11.7	18.4	10.1	11.8	13.0	10.8	14.0	10.3	7.2	7.5	13.5	4.4	8.7	4.3	11.3	6.0	11.0	7.0	5.6	6.3	10.7	11.5	6.9	10.9	9.1	12.2	7.2	7.3	5.7	6.3	19.0	11.7	7.4	10.9	9.4	6.8	10.0	10.6	9.5	8.0	17.5	9.1	5.5	5.6	8.6	8.9	10.9	17.3	9.0	10.5	7.1	12.8	14.1	9.6	7.9	14.4	13.4	9.4	6.9	8.1	9.0	7.4	11.5	11.1	6.8	11.1	13.0	8.6	16.7	12.2	25.8	21.3	13.7	38.3	21.9	10.4	19.2	12.7	7.3	7.7	7.5	8.4	9.0	8.3	10.3	8.3	6.0	6.5	8.9	6.1	8.3	3.8	4.4	13.5	7.2	8.7	4.3	13.1	11.5	13.3	15.4	14.1	13.6	14.6	13.9	13.1	11.7
HAUS6	"dgt6, FAM29A, FLJ20060, KIAA1574"	ENSG00000147874	"HAUS augmin like complex subunit 6"	Q7Z4H7	9	19053143-19103119	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020960, HPA020965"	Approved		Supported	"Nuclear speckles,Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"	"Nuclear speckles"	"HPA020960: AB_1848393, HPA020965: AB_1848394"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (6.04e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (3.13e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.03e-1)"	8.7	9.6	10.9	9.2	13.1	17.5	11.1	10.8	10.3	7.7	7.0	9.9	5.6	4.9	8.9	8.0	7.0	7.4	6.4	7.1	10.5	7.3	5.2	11.0	7.1	12.8	15.0	8.9	11.1	6.3	5.8	8.5	8.4	12.4	7.6	7.9	5.6	7.1	7.4	7.2	9.8	7.2	8.9	13.5	10.0	5.8	27.1	13.6	27.3	6.6	3.8	12.7	7.0	7.1	3.6	2.6	10.9	2.2	7.2	6.1	2.5	10.8	7.4	15.3	11.9	5.9	7.1	8.3	11.7	8.3	10.8	16.7	3.8	5.0	12.7	4.3	6.7	4.5	14.0	6.8	16.8	11.6	6.7	67.7	13.5	8.7	3.9	8.9	15.5	4.4	7.1	10.2	22.3	7.8	9.2	8.4	12.4	3.5	17.4	15.2	16.3	7.5	13.6	10.4	5.2	5.8	6.3	8.9	12.3	5.2	4.8	7.4	3.8	11.3	7.7	9.7	5.9	8.3	13.4	3.3	7.3	12.6	9.1	7.6	4.2	10.9	2.2	2.2	4.5	2.2	6.1	3.5	4.3	5.6	2.2	3.6	5.2	4.6	3.5	7.2	2.0	2.6	5.4	2.5	10.9	13.1	10.8	10.3	10.5	7.3	15.0	8.9	12.4	13.6
HAUS7	"UCHL5IP, UIP1"	ENSG00000213397	"HAUS augmin like complex subunit 7"	Q99871	X	153447666-153495516	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003614			Approved	"Nucleoli,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"	Nucleoli	"HPA003614: AB_1080368"	"unprognostic (2.06e-1)"	"prognostic favourable (6.12e-4)"	"unprognostic (3.81e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-3)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.09e-2)"	13.1	9.4	16.1	10.3	16.4	9.4	7.9	9.1	19.3	12.7	9.3	8.9	20.3	7.9	10.8	17.1	7.0	9.9	15.1	11.9	20.3	9.1	13.3	11.9	9.4	12.1	12.0	16.5	9.3	4.3	3.1	6.4	12.6	11.1	11.8	6.2	7.8	8.5	17.4	7.2	46.9	7.4	12.1	8.9	16.4	8.8	6.1	18.4	14.2	10.8	8.8	9.8	7.5	11.8	20.2	22.3	10.1	31.1	16.7	18.5	15.8	13.7	22.2	9.8	19.1	3.5	4.8	13.7	9.5	5.4	11.0	19.7	16.1	7.7	13.2	30.7	6.5	11.7	14.1	9.6	8.6	15.8	23.2	9.6	20.6	12.0	3.1	15.8	13.9	7.3	2.5	9.8	6.2	7.8	12.0	6.8	6.5	26.5	14.8	19.1	6.1	22.2	13.9	16.2	19.9	3.5	8.7	10.9	8.3	5.2	11.3	3.9	4.5	7.6	5.0	9.5	19.0	22.2	17.4	9.9	26.2	51.5	5.1	28.4	13.1	4.7	26.2	10.1	17.0	31.1	17.8	20.2	18.5	17.1	22.3	16.6	18.4	16.7	3.4	16.7	27.1	12.6	15.5	15.8	16.1	16.4	9.1	19.3	20.3	9.1	12.0	16.5	11.1	18.4
HBS1L	"DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038"	ENSG00000112339	"HBS1 like translational GTPase"	Q9Y450	6	134960378-135103056	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029728, HPA029729"	Approved		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA029728: AB_10611112, HPA029729: AB_10601228"	"unprognostic (3.68e-3)"	"unprognostic (6.39e-2)"	"prognostic favourable (6.77e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-2)"	16.9	18.6	17.5	13.0	27.3	31.8	18.0	23.2	34.7	16.7	14.9	18.2	9.2	10.1	15.6	10.8	20.0	13.8	12.0	22.3	18.4	18.8	17.4	28.4	11.7	16.3	21.1	16.0	15.6	20.4	19.5	25.4	18.7	33.6	14.2	13.5	11.0	17.1	14.1	66.4	14.7	15.3	18.6	25.0	14.4	14.2	14.0	17.1	42.5	17.5	19.9	18.5	16.3	13.6	25.2	28.4	38.4	24.6	32.9	38.4	28.3	14.8	10.0	20.9	30.3	19.2	17.1	16.0	30.1	26.0	28.7	35.6	16.7	11.2	25.8	13.6	26.6	11.2	29.2	22.1	44.9	26.2	20.0	78.9	28.4	22.4	23.1	48.7	21.6	16.9	16.9	27.2	33.4	23.7	42.1	21.8	30.3	14.1	29.9	12.3	13.5	10.9	28.1	23.3	17.6	17.7	14.2	20.7	14.1	20.6	21.6	21.4	18.0	29.4	22.4	20.4	21.3	25.2	31.8	49.7	35.8	43.8	31.1	25.4	25.3	38.4	24.6	25.4	23.4	22.1	26.3	25.2	28.1	23.8	28.4	22.6	38.4	31.6	11.2	32.9	21.1	22.6	32.9	28.3	17.5	27.3	23.2	34.7	18.4	18.8	21.1	16.0	33.6	17.1
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	152687-154503	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.9;placenta: 5.0;testis: 9.9"	"Cell line enriched"	"Detected in some"	79	"K-562: 222.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol			160000000	Cytosol	Nucleoplasm	"HPA063268: , HPA064073: , HPA071726: "					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.8	0.0	0.8	0.1	0.5	8.9	0.6	0.6	0.6	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.6	3.3	0.7	0.3	0.1	1.1	0.6	0.1	1.1	0.1	0.7	0.1	0.0	0.1	5.0	0.1	1.2	0.0	0.1	0.1	0.1	0.9	0.5	0.1	0.1	0.1	0.8	0.1	9.9	0.1	0.1	0.1	0.1	0.1	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.5	0.6	0.6	0.7	0.3	1.1	0.1	0.1	0.1
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064457-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	11.5	10.0	11.9	4.7	13.2	3.2	12.9	3.8	11.1	11.5	14.4	9.1	8.7	7.2	12.6	7.5	9.1	8.5	8.1	7.7	9.3	5.8	8.5	10.2	9.1	5.9	12.5	8.1	11.8	9.1	10.4	14.3	10.6	10.0	10.8	6.3	6.8	8.0	14.6	17.5	7.4	7.5	19.0	10.2	6.8	9.9	19.2	11.0	9.1	10.1	5.1	5.0	12.8	10.3	1.8	2.2	2.8	5.0	2.5	3.2	1.7	1.9	2.1	2.2	1.9	12.4	12.4	1.6	8.5	3.9	6.5	3.8	1.0	0.9	1.9	3.0	6.6	2.1	2.7	1.5	7.1	3.2	2.6	1.9	2.0	0.9	8.4	1.6	3.1	7.7	4.2	4.1	3.4	5.0	2.2	4.0	11.6	1.7	2.8	3.7	0.4	4.4	2.3	7.3	1.2	2.9	1.3	3.2	2.4	4.2	3.0	3.2	4.8	1.7	7.5	10.4	1.4	5.3	2.8	5.1	1.5	1.7	4.9	2.1	4.1	1.3	2.0	2.8	2.6	3.7	3.1	1.6	2.5	3.2	2.2	1.8	3.0	3.2	0.5	2.5	5.0	1.2	2.8	1.7	11.9	13.2	3.8	11.1	9.3	5.8	12.5	8.1	10.0	11.0
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 149.7;lymphoid tissue: 110.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 42.3;HMC-1: 60.1;THP-1: 41.9;U-266/70: 59.5;U-698: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"			200000	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	24.7	10.7	7.8	44.9	14.7	35.5	9.1	1.3	7.4	6.3	10.4	8.5	2.2	5.5	5.6	8.2	4.8	9.1	10.1	7.5	6.7	5.0	10.5	10.1	18.7	59.4	12.9	3.2	4.6	5.1	1.4	6.1	15.4	10.9	6.1	8.6	4.9	7.4	3.1	7.0	4.6	23.0	8.9	15.1	110.1	7.1	3.6	11.6	41.0	6.1	4.4	61.5	12.5	5.6	33.4	59.6	149.7	84.9	24.3	44.1	103.5	0.1	0.0	0.0	0.0	3.5	1.9	0.9	0.6	0.6	0.1	0.2	0.0	0.0	42.3	20.6	0.0	0.0	1.1	1.6	0.1	18.8	0.0	27.4	0.0	0.0	1.9	30.1	60.1	0.3	0.0	0.0	0.3	24.9	5.4	39.1	0.0	0.0	21.3	25.4	0.0	0.7	21.6	0.0	40.2	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.0	41.9	32.5	0.0	0.3	0.0	0.1	59.5	18.1	59.5	0.3	29.0	0.0	26.6	64.1	104.2	40.2	80.6	32.9	33.4	33.3	36.8	59.6	29.4	28.5	33.0	149.7	24.3	84.9	18.5	44.1	103.5	7.8	14.7	1.3	7.4	6.7	5.0	12.9	3.2	10.9	11.6
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 28.3;monocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004431, HPA048723"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoplasm, Cytosol"	"CAB004431: AB_627706, HPA048723: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.33e-4)"	"prognostic favourable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	7.9	6.8	6.1	6.8	5.2	17.1	4.6	6.4	12.3	11.3	21.4	4.6	4.3	2.5	10.2	6.4	8.8	9.0	24.6	5.2	5.0	6.0	3.2	3.1	4.2	4.3	6.1	5.4	8.5	5.8	4.9	8.3	2.5	5.2	7.5	4.8	8.3	3.7	7.3	54.6	6.9	6.5	15.8	4.2	5.4	7.0	8.1	4.3	6.5	4.8	13.2	5.6	10.2	4.6	0.5	1.7	28.3	7.4	2.1	1.2	0.4	4.3	4.3	5.5	6.6	3.1	5.3	6.5	4.5	3.1	3.6	3.4	2.0	7.8	2.0	1.8	3.9	4.3	3.8	1.8	1.8	12.0	2.0	3.2	5.3	6.3	4.2	4.9	2.9	3.6	4.6	6.6	5.3	3.8	4.5	4.6	1.7	5.3	31.6	6.7	4.3	2.2	8.2	10.4	3.2	4.1	5.5	4.4	7.8	6.3	2.8	11.1	1.5	13.4	6.1	4.2	0.3	7.2	6.1	3.3	3.1	3.9	6.1	6.8	8.3	10.5	7.4	1.1	0.9	2.4	1.1	0.5	0.9	0.8	0.8	0.5	0.5	1.0	28.3	2.1	1.0	1.7	1.2	0.4	6.1	5.2	6.4	7.5	5.0	6.0	6.1	5.4	5.2	4.3
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"				"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favourable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favourable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	15.6	17.6	24.9	7.9	15.8	13.2	18.1	35.9	25.8	16.5	8.8	19.6	9.5	8.4	15.0	11.9	20.1	16.9	11.3	24.4	22.1	24.2	8.6	6.3	13.6	8.8	24.7	22.1	24.5	16.1	28.2	17.5	23.0	19.3	13.6	5.5	11.7	14.2	11.9	42.6	34.0	9.7	12.4	20.5	13.8	9.3	10.3	18.1	7.6	15.0	9.8	8.2	14.9	20.4	7.6	9.4	17.9	13.6	3.5	4.9	5.0	3.5	2.3	6.4	1.5	12.4	9.7	23.1	9.6	24.0	4.8	7.9	5.1	3.8	5.6	3.9	22.8	2.9	7.5	4.1	2.0	8.7	12.2	10.9	7.7	11.7	5.3	3.5	15.4	13.7	7.1	5.5	6.9	3.9	8.1	11.4	27.8	2.7	5.8	10.7	7.0	5.5	22.5	17.9	14.4	0.5	1.6	16.7	8.8	2.8	11.8	13.0	16.8	20.7	2.1	12.1	7.8	2.8	4.8	18.8	15.7	6.7	7.0	4.4	5.7	7.1	7.3	7.7	4.9	11.6	3.5	6.6	3.9	4.9	9.4	7.6	4.1	3.5	17.9	3.5	13.6	8.3	3.5	5.0	24.9	15.8	35.9	25.8	22.1	24.2	24.7	22.1	19.3	18.1
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 85.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol				Cytosol		"HPA004775: AB_1850548"	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (4.65e-4)"	26.0	21.6	8.2	22.7	10.8	17.3	24.4	8.4	10.7	28.2	20.7	8.7	15.4	8.0	27.9	21.5	19.2	25.2	22.1	16.5	10.3	4.3	17.7	5.1	27.6	21.1	8.2	8.0	25.4	8.9	23.7	11.5	17.5	10.0	20.1	4.1	17.6	16.3	18.9	12.5	19.7	13.9	24.9	10.3	23.1	14.9	9.5	11.5	85.8	20.9	12.9	21.0	24.8	25.0	1.4	0.6	10.5	1.9	1.7	1.5	1.8	14.0	9.6	10.0	16.3	7.8	21.9	9.0	13.9	10.8	10.1	6.6	12.8	13.4	28.3	46.2	12.6	13.1	2.3	10.8	3.7	13.2	4.8	9.6	9.4	2.9	8.5	3.0	0.4	14.3	3.8	10.0	5.4	20.8	10.2	11.6	6.4	6.1	27.8	7.5	14.0	10.7	21.4	5.3	10.2	4.3	9.2	2.8	6.8	10.6	4.9	5.0	4.6	4.1	23.5	20.7	22.5	16.8	9.8	26.2	19.0	22.5	8.5	14.3	6.7	0.0	1.9	0.0	1.5	0.8	1.5	1.4	1.3	1.1	0.6	1.1	1.5	1.0	10.5	1.7	0.7	0.5	0.6	1.8	8.2	10.8	8.4	10.7	10.3	4.3	8.2	8.0	10.0	11.5
HDDC3	MGC45386	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929964-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	14.3	18.8	16.3	8.9	17.1	10.7	11.3	10.3	17.6	8.2	13.1	9.3	12.6	12.4	5.4	12.8	7.7	12.7	7.1	15.2	12.9	12.3	14.7	18.3	7.8	9.0	14.6	12.5	10.3	30.3	15.1	10.4	10.4	11.0	8.7	11.1	9.7	24.8	14.0	14.2	9.3	17.1	6.1	11.4	13.1	11.2	4.5	8.2	11.8	12.0	10.1	10.7	7.5	7.5	19.9	25.3	5.6	15.6	16.4	21.5	14.3	6.9	8.5	3.0	3.6	6.9	7.0	5.0	4.6	6.4	4.4	6.5	4.3	14.4	13.0	4.9	3.9	10.8	6.3	10.9	3.7	16.5	13.2	16.5	3.3	9.6	14.1	6.2	8.1	6.1	17.2	8.0	14.4	9.6	13.1	11.8	3.9	10.1	8.5	5.4	2.4	8.8	7.2	1.1	20.8	9.0	7.3	7.6	4.9	3.9	11.0	11.7	16.6	17.0	5.5	2.7	6.1	4.6	6.0	19.4	21.7	9.0	10.1	12.3	8.1	5.6	11.8	4.7	14.0	15.6	18.4	19.9	18.4	16.2	15.9	17.5	21.5	15.7	2.8	16.4	14.2	25.3	17.4	14.3	16.3	17.1	10.3	17.6	12.9	12.3	14.6	12.5	11.0	8.2
HDLBP	"HBP, VGL"	ENSG00000115677	"High density lipoprotein binding protein"	Q00341	2	241227264-241317061	"Plasma proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 210.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004189, CAB026457"	Enhanced		Supported	Cytosol				Cytosol		"CAB026457: , HPA004189: AB_1079044"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.58e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (6.39e-5)"	"prognostic unfavourable (4.12e-4)"	38.2	38.7	18.1	18.1	27.7	15.9	37.4	18.1	27.0	39.6	30.4	24.7	38.2	22.5	34.8	43.2	35.3	38.7	30.9	37.5	17.9	15.9	33.9	92.0	29.9	20.9	19.8	16.6	40.1	210.4	40.5	40.0	44.4	22.5	35.9	29.4	26.1	105.2	34.3	80.2	27.6	36.1	29.9	18.5	23.0	39.2	39.6	19.3	20.8	39.0	45.7	34.7	31.9	31.0	10.9	22.4	11.6	28.8	10.1	12.3	12.4	33.8	27.3	28.6	45.5	73.0	89.6	40.6	84.6	86.8	38.5	55.0	24.4	34.7	10.3	10.3	122.4	27.2	42.5	55.4	63.1	16.4	26.3	32.9	34.4	59.5	71.5	23.5	28.8	66.2	45.0	55.9	63.0	52.4	31.3	13.9	60.0	35.3	13.5	12.3	27.6	18.1	12.6	55.5	20.5	31.4	40.4	23.8	27.3	36.9	38.9	33.0	30.7	23.0	65.8	47.1	30.0	65.0	35.4	16.4	13.5	18.3	59.7	17.6	43.1	11.6	20.0	9.1	9.3	21.9	12.3	10.9	10.6	11.1	22.4	7.4	9.6	8.9	11.5	10.1	28.8	14.7	9.8	12.4	18.1	27.7	18.1	27.0	17.9	15.9	19.8	16.6	22.5	19.3
HDX	"CXorf43, FLJ30678"	ENSG00000165259	"Highly divergent homeobox"	Q7Z353	X	84317874-84502479	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Cell line enhanced"	"Detected in many"		"AF22: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047189	Uncertain		Approved	Cytosol				Cytosol		"HPA047189: AB_10965463"	"unprognostic (7.26e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-5)"	"unprognostic (3.23e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.40e-6)"	"unprognostic (1.14e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.66e-2)"	5.1	7.4	8.3	3.3	7.9	0.6	6.4	23.1	10.2	8.2	4.6	2.6	3.5	1.8	7.4	5.3	4.2	6.3	5.5	4.8	5.5	4.6	4.3	4.5	4.4	2.3	6.5	7.0	8.0	2.2	5.5	16.4	1.4	6.6	6.0	4.5	2.0	4.5	6.2	1.7	1.9	2.9	6.6	5.7	4.2	3.2	4.0	7.1	0.4	5.7	2.7	2.7	5.2	8.3	2.7	6.1	0.0	6.9	1.4	1.4	1.1	0.0	2.2	9.0	0.0	5.4	4.7	0.0	3.0	4.0	6.9	7.9	0.4	1.2	0.0	0.6	3.0	0.5	0.1	1.1	5.4	0.0	0.6	0.0	1.7	0.0	5.0	0.0	0.0	3.3	0.1	4.5	3.0	7.0	0.0	0.0	6.9	0.1	0.0	0.0	6.7	3.0	0.0	7.7	0.1	3.3	1.5	0.3	5.2	0.0	0.2	0.0	0.4	0.0	7.4	3.8	2.7	1.3	2.7	0.2	0.0	0.0	1.8	0.0	1.6	0.0	4.3	0.0	1.4	6.9	0.2	2.7	0.4	0.3	6.1	1.0	1.2	0.7	0.0	1.4	5.9	0.6	0.2	1.1	8.3	7.9	23.1	10.2	5.5	4.6	6.5	7.0	6.6	7.1
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065941-50106387	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: "	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavourable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	14.7	13.6	8.8	17.8	16.1	10.1	9.3	19.5	14.0	10.2	11.5	12.4	11.1	10.1	9.2	10.3	13.0	8.5	9.4	9.9	9.4	9.6	10.7	20.7	10.5	14.6	10.9	8.1	7.1	19.2	14.8	13.3	12.1	8.7	8.4	13.8	7.8	12.4	7.8	19.6	13.3	10.9	11.3	10.5	21.6	11.4	15.6	11.1	14.5	6.4	10.7	12.9	9.2	8.0	2.4	4.2	2.2	7.0	2.0	2.9	2.2	10.7	11.1	10.2	16.2	6.4	8.6	11.0	13.2	8.7	13.2	5.3	13.5	8.2	20.4	9.6	12.5	13.0	12.3	9.8	15.4	5.2	13.3	10.1	7.7	17.1	9.1	17.4	20.5	6.7	6.8	9.3	5.7	10.6	12.8	3.5	12.9	6.6	13.3	21.8	12.1	11.5	14.8	13.9	16.5	7.3	8.9	13.3	7.0	12.7	16.6	8.3	7.5	12.8	13.8	10.6	7.2	8.1	10.0	8.7	6.8	18.3	10.5	17.6	10.4	1.3	6.2	1.4	2.6	7.0	2.8	1.6	1.6	2.9	4.2	2.4	2.3	2.4	2.2	2.0	6.1	3.7	2.6	2.2	8.8	16.1	19.5	14.0	9.4	9.6	10.9	8.1	8.7	11.1
HEATR5B	"DKFZp686P15184, KIAA1414"	ENSG00000008869	"HEAT repeat containing 5B"	Q9P2D3	2	36968383-37084342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042025, HPA055639"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA042025: AB_10959880, HPA055639: "	"unprognostic (3.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.80e-3)"	"unprognostic (8.69e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.95e-1)"	14.7	13.6	13.5	14.1	23.8	21.8	15.0	23.3	22.8	11.1	10.2	15.4	10.1	10.9	16.5	18.0	14.9	9.7	10.9	10.7	11.4	12.1	9.9	12.9	12.5	29.6	13.0	16.6	12.3	23.8	17.9	16.6	10.3	21.6	12.2	14.0	12.4	18.0	9.6	7.1	18.0	14.9	9.4	16.1	18.0	12.8	9.6	14.5	16.0	13.6	8.4	30.0	11.3	12.9	15.2	10.7	15.8	4.9	7.0	9.1	5.0	10.2	5.2	7.7	11.7	8.0	8.0	9.8	6.5	4.8	5.9	6.1	5.9	7.1	22.0	4.7	5.5	8.7	7.6	5.3	7.8	10.7	8.2	14.3	6.9	8.3	5.0	15.3	18.9	7.3	7.4	8.6	8.2	9.9	13.5	19.5	7.1	6.1	13.3	11.0	5.0	3.7	12.9	7.9	16.4	7.0	8.9	9.5	8.4	6.7	10.9	5.1	7.8	5.0	11.1	9.1	5.2	6.5	5.0	12.2	10.0	24.2	7.4	9.2	5.9	15.8	4.9	11.3	7.9	2.6	7.2	9.9	8.8	8.8	8.6	15.2	9.1	7.9	5.1	7.0	3.8	10.7	8.9	5.0	13.5	23.8	23.3	22.8	11.4	12.1	13.0	16.6	21.6	14.5
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112599-43566001	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;kidney: 15.4"	"Cell line enhanced"	"Detected in some"		"A549: 5.5;U-266/70: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Approved		Supported	Cytosol				Cytosol		"HPA007203: , HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.7	0.5	10.3	0.8	12.1	1.4	0.8	13.6	24.0	0.6	0.8	1.1	0.0	0.4	0.8	1.7	2.6	0.5	4.0	0.4	3.9	4.1	15.4	0.6	0.6	1.3	3.8	15.5	1.0	0.4	1.7	0.4	0.6	10.2	3.2	0.5	0.6	1.0	0.8	1.8	2.1	0.6	0.7	1.4	0.6	1.0	3.7	1.6	0.0	1.5	0.0	0.8	1.2	0.6	2.4	1.6	7.0	1.7	1.6	0.7	0.1	0.1	5.5	0.6	0.8	0.0	0.0	0.0	1.6	2.8	0.1	0.6	0.0	0.0	0.2	3.0	2.7	0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.4	0.2	0.2	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	2.3	0.9	0.5	0.0	0.0	0.0	0.1	0.2	0.7	0.5	0.1	0.0	0.4	0.0	0.0	0.8	1.1	1.3	0.4	15.6	0.5	0.0	3.5	0.4	0.0	6.4	1.7	1.1	0.7	1.0	0.5	1.0	0.7	0.3	0.2	2.4	0.6	0.7	7.0	1.6	0.9	1.6	0.2	0.1	10.3	12.1	13.6	24.0	3.9	4.1	3.8	15.5	10.2	1.6
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 32.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: , HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favourable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	2.5	3.3	3.2	2.2	4.5	3.9	3.1	7.0	5.7	3.2	4.6			2.7	4.4	1.7	2.8	4.1	2.1	4.6	3.5	3.6	3.3	1.6	2.5	2.1	3.8		8.5	3.6	9.2	3.5	2.7		3.0	3.0		2.3	3.3	8.2	3.1	3.1	4.1	4.1	2.3	3.4	3.2			5.6		2.4	3.3	2.3	1.0	1.1	0.5	0.4	0.2	1.1	0.4	5.1	10.1	7.0	2.9	5.9	4.4	2.0	3.7	4.4	4.8	4.6	5.2	0.6	5.1	4.5	6.3	5.2	7.4	3.6	3.5	3.1	4.8	32.6	11.7	1.7	2.2	7.6	2.6	3.7	2.9	5.7	7.1	6.3	12.5	2.1	4.5	2.3	1.7	2.5	2.1	4.4	6.1	10.0	0.4	1.6	11.1	7.8	4.5	8.9	2.5	2.9	3.0	9.0	9.4	8.9	5.8	3.4	5.5	1.4	1.9	4.8	4.1	3.6	4.7	0.0	0.4	0.5	1.1	0.1	0.6	0.5	0.2	0.5	1.1	1.0	0.9	0.5	0.0	0.2	0.3	0.9	0.4	0.4										
HERC3	KIAA0032	ENSG00000138641	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"	Q15034	4	88592423-88708542	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039170	Approved		Approved	Cytosol				Cytosol		"HPA039170: AB_10673414"	"unprognostic (2.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.58e-2)"	"prognostic favourable (5.65e-7)"	"unprognostic (1.83e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	12.7	13.3	16.9	13.0	27.1	21.0	15.3	37.8	20.1	14.4	12.0	17.9	11.6	11.2	12.0	10.5	16.8	10.7	12.1	22.0	15.2	13.7	15.8	13.0	15.0	15.3	21.9	15.0	12.7	9.7	33.8	16.1	10.0	21.1	22.0	13.4	22.0	14.0	14.0	17.3	19.1	12.8	13.8	16.3	15.7	12.9	3.6	21.5	16.6	15.7	12.6	16.4	13.3	16.7	5.2	7.0	18.2	9.7	3.1	9.0	3.9	7.2	1.1	1.3	2.3	7.7	16.4	4.6	8.2	15.0	8.6	5.7	1.8	8.4	7.7	3.9	27.0	2.5	1.9	7.4	8.2	3.4	2.2	5.3	3.3	1.2	4.4	13.1	9.6	7.8	9.2	8.1	36.8	9.4	3.8	3.4	17.3	2.1	9.0	3.1	0.4	2.0	10.2	9.5	3.1	5.5	1.3	1.9	1.8	9.4	6.0	3.2	1.0	5.9	14.7	9.7	5.3	9.1	6.1	6.4	1.6	4.4	6.1	6.0	4.0	5.7	5.7	7.7	4.7	6.2	5.5	5.2	5.5	4.7	7.0	4.9	8.2	5.8	18.2	3.1	9.7	2.4	9.0	3.9	16.9	27.1	37.8	20.1	15.2	13.7	21.9	15.0	21.1	21.5
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075348	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 55.1;fHDF/TERT166: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: "	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	25.3	29.4	21.9	28.0	28.4	14.6	22.7	30.5	24.9	24.2	20.5	22.2	26.7	20.0	28.1	24.3	22.2	19.2	20.2	20.5	21.9	22.7	20.6	24.5	20.6	30.2	30.9	14.8	24.5	17.1	25.2	35.6	23.8	26.8	19.4	23.9	17.8	17.7	24.1	19.6	20.9	25.8	23.0	28.7	27.0	17.3	22.2	33.6	23.6	19.5	13.8	28.3	24.7	47.9	7.7	10.4	13.5	9.3	9.9	11.5	6.5	22.4	8.0	5.1	8.5	13.2	18.1	4.6	55.1	34.1	20.7	13.4	4.5	10.6	7.9	4.3	61.8	11.9	5.6	8.1	28.0	5.2	2.7	3.6	13.3	3.5	7.0	4.4	6.5	8.9	9.5	11.0	9.8	12.8	3.8	4.0	31.9	9.6	3.1	5.2	3.0	14.0	4.2	2.1	2.8	9.4	6.4	2.4	2.8	17.9	7.7	7.8	4.8	5.6	17.4	10.9	6.1	26.8	9.4	2.8	3.3	5.0	20.0	8.6	3.7	13.5	9.3	11.1	8.2	7.9	11.5	7.7	9.1	9.8	10.4	7.5	8.8	9.0	11.7	9.9	7.6	2.7	10.6	6.5	21.9	28.4	30.5	24.9	21.9	22.7	30.9	14.8	26.8	33.6
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443111	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 46.0;BJ hTERT+ SV40 Large T+ RasG12V: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favourable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	8.0	7.5	7.8	7.2	10.2	7.3	6.3	2.1	14.6	13.6	6.3	5.9	3.4	5.4	13.2	9.6	23.9	10.4	11.2	9.8	7.7	8.4	10.4	5.0	8.3	4.6	7.3	15.8	9.8	6.3	5.2	8.4	7.1	8.5	9.1	6.5	7.2	28.4	5.7	2.9	4.3	7.1	8.5	5.6	8.0	7.3	3.9	5.3	9.0	5.9	7.6	7.8	7.2	13.8	3.6	2.7	4.5	6.4	5.6	13.4	4.2	2.5	1.7	0.1	0.3	0.1	1.5	0.5	0.3	8.6	46.0	34.3	0.1	3.2	0.0	0.6	0.8	0.9	4.2	2.2	3.0	5.2	0.8	2.4	1.4	0.2	1.5	4.2	1.6	2.1	0.5	3.5	0.1	1.3	0.0	0.5	1.0	1.5	1.9	1.3	0.6	0.8	1.3	0.0	0.1	3.1	3.1	0.1	1.1	3.2	1.0	5.1	1.9	0.7	0.4	0.6	0.8	0.1	0.8	0.1	0.0	0.0	2.1	0.9	2.1	4.4	3.1	4.5	6.7	3.1	13.4	3.6	9.4	6.5	2.7	2.7	7.5	5.1	1.9	5.6	6.4	0.3	11.8	4.2	7.8	10.2	2.1	14.6	7.7	8.4	7.3	15.8	8.5	5.3
HERPUD1	"HERP, KIAA0025, Mif1, SUP"	ENSG00000051108	"Homocysteine inducible ER protein with ubiquitin like domain 1"	Q15011	16	56932048-56944863	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 61.2;RPMI-8226: 76.8;U-266/70: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037041, CAB037104, HPA040754, HPA041219"	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.39e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.69e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.50e-1)"	"prognostic favourable (1.41e-9)"	"unprognostic (1.06e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.27e-3)"	22.7	38.8	16.2	35.6	20.7	21.6	39.4	17.7	20.0	30.1	32.1	20.0	48.8	21.4	21.6	51.6	15.0	20.2	32.5	28.8	15.8	15.5	42.9	57.7	30.4	40.0	25.6	12.5	44.8	148.6	37.6	26.7	26.2	25.6	49.5	32.3	35.3	108.6	76.1	34.6	18.3	24.7	17.6	24.2	38.3	37.2	10.6	20.8	9.6	64.2	20.4	53.8	24.4	25.9	50.8	121.9	29.0	39.5	22.4	33.4	46.5	4.4	4.9	4.8	10.0	11.2	14.6	17.2	10.6	16.9	13.7	10.7	6.8	10.2	18.1	13.6	10.2	7.7	8.2	3.7	13.6	10.4	4.9	1.5	8.2	24.5	61.2	3.2	8.1	17.7	35.8	6.2	19.7	10.4	2.4	25.9	38.2	3.7	6.1	6.7	3.1	11.1	4.2	12.2	76.8	29.4	5.0	5.3	6.1	9.2	45.4	46.9	5.0	12.2	6.3	5.7	5.7	5.0	4.2	87.6	28.5	28.3	8.1	4.5	7.4	23.9	39.5	18.0	16.1	31.0	17.4	50.8	17.5	21.1	30.6	37.8	11.4	17.4	29.0	22.4	21.5	121.9	33.4	46.5	16.2	20.7	17.7	20.0	15.8	15.5	25.6	12.5	25.6	20.8
HES4	bHLHb42	ENSG00000188290	"Hes family bHLH transcription factor 4"	Q9HCC6	1	998962-1000172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"HEK 293: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 12.4"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.4"					"Low region specificity"	"Detected in all"			HPA062465			Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA062465: "	"unprognostic (6.23e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.07e-2)"	"prognostic favourable (3.85e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.99e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.76e-2)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.08e-3)"	14.8	4.0	8.3	3.9	15.6	2.8	8.7	2.5	16.9	7.6	10.8	2.9	4.8	5.4	7.8	9.0	7.5	6.8	9.6	13.6	5.9	9.4	5.3	3.2	9.1	2.2	7.3	4.0	4.2	14.8	3.1	5.7	6.1	7.2	10.4	2.6	12.8	5.6	9.4	8.0	7.8	4.2	12.1	3.4	8.6	6.1	3.4	3.1	9.0	3.6	8.4	3.3	10.6	5.6	0.0	0.3	12.4	1.4	0.0	0.0	0.0	4.5	0.5	0.5	0.0	0.0	0.0	5.8	2.7	0.3	1.7	1.8	0.7	1.4	0.0	6.6	0.2	8.0	0.7	0.1	0.0	0.0	65.3	0.0	0.7	0.9	0.5	0.0	0.5	0.0	0.6	0.1	0.1	0.2	1.2	0.1	0.0	2.4	3.6	0.2	0.0	6.3	0.0	0.6	1.3	0.6	0.0	0.3	1.5	1.9	4.6	8.2	3.4	0.0	0.3	0.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	12.4	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.3	15.6	2.5	7.0	5.9	9.4	7.3	4.0	7.2	3.1
HES5	bHLHb38	ENSG00000197921	"Hes family bHLH transcription factor 5"	Q5TA89	1	2528745-2530245	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.6;HaCaT: 5.0;HAP1: 1.1;SCLC-21H: 1.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA065458, HPA076164"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA065458: , HPA076164: "	"unprognostic (2.04e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.60e-4)"	"unprognostic (1.76e-4)"	"unprognostic (1.60e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (9.95e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-1)"	1.1	0.9	11.1	1.1	12.7	1.4	2.8	3.5	16.7	1.0	1.9	1.2	0.4	1.2	1.9	2.7	1.6	1.1	1.2	2.3	9.7	11.2	1.0	1.0	1.4	1.1	4.1	15.8	1.0	0.9	1.0	2.4	2.2	1.6	1.3	1.4	6.3	1.2	1.1	1.6	6.2	1.2	0.9	0.9	1.0	1.2	2.0	1.9	0.0	1.1	1.9	1.4	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	12.7	3.5	16.7	9.7	11.2	4.1	15.8	1.6	1.9
HES6	bHLHb41	ENSG00000144485	"Hes family bHLH transcription factor 6"	Q96HZ4	2	238238267-238240662	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell line enhanced"	"Detected in many"		"NB-4: 50.4;SCLC-21H: 33.4;SK-MEL-30: 48.2;U-937: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 8.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061763			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nucleoli, Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA061763: "	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.79e-4)"	"prognostic favourable (9.18e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.35e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.49e-2)"	2.1	5.2	15.4	3.4	10.6	10.5	3.0	7.3	47.4	3.7	12.2	17.1	0.8	18.1	6.3	1.5	1.6	14.3	5.7	1.7	17.5	9.1	1.9	2.5	2.2	3.3	11.4	12.3	1.3	13.9	5.3	23.6	1.7	14.3	2.0	9.6	1.5	3.8	1.7	8.2	1.7	12.9	3.3	18.8	4.6	5.2	9.4	11.7	0.4	5.5	1.7	2.8	1.3	1.0	0.3	1.4	8.0	0.3	0.1	1.0	0.2	1.2	1.4	6.4	7.2	0.4	0.2	4.1	0.4	0.4	0.6	0.9	1.1	0.8	0.0	1.0	0.1	0.8	6.5	0.4	0.2	2.8	7.8	1.4	1.0	13.1	1.0	10.5	8.8	0.6	4.0	0.9	1.3	0.4	13.3	0.1	0.4	3.2	1.6	50.4	10.2	1.1	7.1	16.2	3.0	0.8	0.6	33.4	14.6	1.9	2.9	48.2	2.5	22.4	0.6	0.6	1.3	3.5	3.7	3.0	0.5	2.2	2.2	25.7	1.1	0.1	0.3	8.0	1.0	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.3	1.4	0.7	0.2	15.4	10.6	7.3	39.3	17.5	9.1	11.4	12.3	14.3	11.7
HEY1	"bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1"	ENSG00000164683	"Hes related family bHLH transcription factor with YRPW motif 1"	Q9Y5J3	8	79764010-79767863	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 48.4;PC-3: 11.0;SK-MEL-30: 33.1;WM-115: 11.3"	"Cancer enhanced"	"Detected in all"		"glioma: 43.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055599, HPA063472"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA055599: AB_2682858, HPA063472: "	"unprognostic (1.15e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.71e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.77e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.00e-1)"	13.3	3.8	13.7	3.6	22.9	1.8	8.8	11.2	60.6	8.9	4.4	10.7	0.0	3.3	3.8	2.4	4.6	3.9	5.7	13.4	11.3	11.6	3.8	2.9	16.4	3.3	11.9	9.3	2.6	4.3	3.0	9.9	20.3	12.5	4.5	3.9	10.3	4.5	3.0	10.3	3.5	3.2	4.4	9.1	2.8	3.6	3.9	10.5	1.3	5.0	3.7	3.7	5.2	2.5	0.0	0.0	9.9	1.7	0.0	0.3	0.1	0.6	0.0	0.4	3.4	0.3	0.2	8.8	0.8	0.8	0.1	0.1	0.1	0.0	1.6	0.8	0.3	2.2	1.8	0.1	0.2	0.1	48.4	0.0	1.5	0.8	0.5	0.0	0.3	0.4	1.4	0.0	6.1	1.6	3.1	1.4	0.5	0.1	0.0	0.2	0.1	11.0	0.0	1.8	1.4	0.1	1.5	2.0	5.6	0.0	1.0	33.1	0.0	0.0	1.1	0.2	0.9	0.0	0.6	1.2	0.2	0.0	1.2	0.0	11.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.9	0.0	1.7	0.0	0.0	0.1	13.7	22.9	11.2	12.3	11.3	11.6	11.9	9.3	12.5	10.5
HEYL	"bHLHb33, HESR3, HEY3"	ENSG00000163909	"Hes related family bHLH transcription factor with YRPW motif-like"	Q9NQ87	1	39624153-39639945	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 66.3"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 17.3;RH-30: 21.4;THP-1: 4.9;U-266/84: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001438, HPA076960"	Approved		Approved	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA001438: AB_1079052, HPA076960: "	"unprognostic (1.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (2.26e-6)"	"prognostic unfavourable (3.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (2.63e-5)"	10.0	8.3	2.9	4.7	6.2	0.5	6.5	1.8	4.0	14.7	4.4	2.9	5.1	1.9	21.7	13.2	4.0	11.2	13.9	28.2	3.2	4.8	12.3	3.3	12.5	2.0	6.8	2.9	14.4	66.3	1.7	8.2	22.1	7.1	8.1	2.9	10.9	2.3	11.4	8.9	1.9	2.7	18.9	2.4	4.5	3.4	25.4	4.4	0.0	11.0	6.8	1.9	6.0	8.8	1.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	2.4	3.9	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	1.6	0.2	0.0	1.4	0.4	0.0	2.2	0.0	0.2	0.0	2.6	4.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.5	17.3	1.4	0.0	0.0	0.0	0.1	1.1	21.4	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.2	0.0	0.0	0.6	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.2	1.8	4.0	3.2	4.8	6.8	2.9	7.1	4.4
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 44.8;HHSteC: 35.1;HL-60: 19.6;hTEC/SVTERT24-B: 22.0;Karpas-707: 60.7;U-87 MG: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved		Approved	Centrosome,Cytosol	"Secreted to blood"			Cytosol	Centrosome	"CAB010333: AB_647965, HPA040360: , HPA044088: "	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	44.8	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.1	19.6	0.1	10.6	0.0	22.0	0.0	0.5	0.0	60.7	0.1	0.0	0.0	13.6	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.1	4.1	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9
HGH1	"Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236"	ENSG00000235173	"HGH1 homolog"	Q9BTY7	8	144137769-144140843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042470	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA042470: "	"unprognostic (2.13e-2)"	"prognostic unfavourable (3.12e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (3.72e-5)"	"unprognostic (4.62e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.48e-1)"	13.4	12.3	6.3	7.7	5.5	4.6	7.6	7.3	8.6	5.5	11.8	5.2	4.9	5.0	6.5	3.8	8.7	5.1	5.5	5.1	5.2	3.6	8.2	15.1	5.1	9.5	5.7	7.3	9.7	12.8	6.8	4.4	3.8	6.1	8.6	4.5	5.9	10.5	6.4	13.2	8.9	5.9	5.8	3.8	8.8	15.7	7.9	4.7	11.3	11.0	4.7	8.6	4.9	7.7	2.1	0.9	0.0	0.9	2.2	2.9	0.6	4.7	1.6	1.2	2.1	1.6	1.1	2.9	8.2	0.6	1.7	1.2	2.1	1.2	14.0	11.3	1.5	5.0	2.3	1.1	0.5	6.7	8.7	5.3	1.3	1.0	1.6	2.9	3.5	0.7	3.5	1.9	1.2	0.8	15.1	0.5	1.1	4.0	10.1	2.7	3.3	27.9	12.6	1.0	2.1	1.0	1.1	2.5	2.6	3.8	2.0	2.7	1.7	1.1	2.9	1.0	8.6	3.0	9.7	8.4	5.4	3.4	1.0	5.0	1.7	0.0	0.6	0.0	1.5	0.9	0.9	0.5	1.9	2.9	0.9	2.1	1.8	1.3	0.0	2.2	0.7	0.7	0.6	0.6	6.3	5.5	7.3	8.6	5.2	3.6	5.7	7.3	6.1	4.7
HGS	"Hrs, Vps27, ZFYVE8"	ENSG00000185359	"Hepatocyte growth factor-regulated tyrosine kinase substrate"	O14964	17	81683326-81703138	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA004872, HPA007728"	Uncertain		Enhanced	Endosomes,Lysosomes,Cytosol			250000	"Endosomes, Lysosomes"	Cytosol	"HPA004872: AB_1079053, HPA007728: AB_1850681"	"unprognostic (6.52e-2)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (5.61e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (4.31e-7)"	"unprognostic (3.69e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	26.8	33.5	34.7	31.9	44.7	66.5	28.9	35.7	45.6	25.4	31.1	35.2	24.5	33.2	27.3	37.2	42.1	32.8	29.1	25.4	32.7	30.4	34.2	31.3	29.4	34.3	39.8	44.2	33.2	39.7	21.8	31.7	32.4	40.7	31.9	31.1	23.6	38.2	27.9	36.3	57.5	32.5	32.6	28.5	38.5	35.6	53.1	38.1	22.2	26.2	25.9	32.5	24.9	34.6	12.2	14.6	28.9	20.2	17.2	18.7	18.8	33.2	27.1	20.5	25.4	18.5	20.9	22.5	25.0	24.3	29.3	22.6	22.8	23.8	9.3	17.1	33.8	28.3	17.3	27.4	20.7	7.9	28.9	20.0	34.1	28.7	27.9	17.2	26.4	23.3	30.0	32.7	46.6	36.7	21.8	17.1	30.8	20.1	18.9	39.8	14.8	28.8	20.6	16.4	14.7	28.7	25.2	29.3	34.9	19.0	48.4	22.2	29.7	33.4	30.5	57.1	33.6	28.2	46.4	21.9	7.7	11.8	35.1	22.5	30.0	25.2	17.4	22.3	18.7	20.2	12.4	11.4	13.5	13.0	14.6	12.2	10.1	11.7	28.9	17.2	19.1	12.4	14.9	18.8	34.7	44.7	35.7	45.6	32.7	30.4	39.8	44.2	40.7	38.1
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548103	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 9.4;testis: 10.4;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;Hep G2: 5.4;RH-30: 20.3;U-87 MG: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"			Mitochondria	Cytosol	"HPA059673: "	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.3	0.7	0.0	0.1	0.6	0.1	0.2	0.1	1.4	0.7	0.0	0.6	0.0	0.0	0.1	0.5	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.9	9.4	0.2	0.3	1.9	3.9	0.0	0.1	0.1	0.0	0.0	0.1	0.1	10.4	0.0	0.0	4.6	0.0	0.3	0.2	0.7	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.1	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.3	0.0	20.3	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.1	0.0	10.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.1	0.0	0.0	0.9	0.0
HID1	"C17orf28, DMC1, HID-1"	ENSG00000167861	"HID1 domain containing"	Q8IV36	17	74950743-74973166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 34.7;SH-SY5Y: 18.0;SK-BR-3: 53.2;T-47d: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.8"	"Group enriched"	"Detected in many"	34	"B-cells: 1.5;dendritic cells: 5.8;T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031406	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA031406: "	"unprognostic (7.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.47e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.37e-1)"	"prognostic favourable (3.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (1.34e-4)"	5.4	3.8	10.1	3.9	21.2	1.3	8.9	62.3	22.2	12.2	9.2	19.9	21.3	21.9	7.1	17.3	2.4	11.3	16.7	5.4	12.8	13.3	4.7	2.0	7.5	3.0	21.3	12.2	1.3	49.4	9.0	16.9	11.4	15.8	19.7	10.4	4.1	46.7	20.0	2.6	2.9	15.3	4.0	10.5	6.4	31.2	2.6	17.1	0.7	8.5	1.4	3.7	7.4	3.8	1.5	5.8	0.0	0.0	0.0	2.8	1.3	1.5	3.4	0.4	4.8	0.0	0.0	0.8	0.0	0.2	0.3	0.3	3.1	1.8	0.0	0.3	0.0	1.6	4.4	0.3	0.2	0.0	3.5	0.0	0.1	3.0	0.8	0.0	0.3	0.0	1.8	0.0	0.7	7.9	0.2	1.2	0.0	34.7	0.2	0.0	0.1	2.1	0.0	0.0	6.5	4.5	13.5	6.5	18.0	0.0	53.2	0.0	31.4	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	1.5	2.3	1.8	0.0	0.4	2.5	2.8	0.0	0.0	0.0	5.8	0.0	1.3	10.1	21.2	62.3	22.2	12.8	13.3	21.3	12.2	15.8	17.1
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 alpha subunit inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: , HPA065302: "	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	8.8	12.7	11.6	11.9	10.8	7.6	12.9	9.5	14.1	9.2	10.7	11.5	8.8	9.7	11.6	10.4	11.1	9.6	12.5	16.0	10.2	9.4	10.3	8.8	9.3	12.3	13.0	9.5	14.5	14.3	17.1	10.6	10.2	10.8	10.7	9.3	9.2	10.6	12.1	46.8	13.3	10.6	14.9	9.7	11.1	10.0	17.9	10.3	13.5	8.1	14.8	12.3	10.8	10.8	9.7	8.5	16.9	14.0	10.1	11.3	9.3	9.2	9.8	13.2	13.2	20.5	8.5	11.5	9.8	23.8	14.6	17.3	15.1	7.9	9.9	9.0	14.7	10.8	11.6	8.8	16.0	10.9	7.0	9.5	8.6	11.5	10.6	11.3	12.6	8.3	9.0	14.2	15.6	8.2	4.1	5.6	16.4	9.7	12.1	7.4	4.3	4.7	8.8	16.3	4.8	10.2	12.3	5.1	8.3	8.5	5.2	9.2	17.8	6.2	6.9	7.5	9.8	7.3	9.8	7.7	7.7	7.7	12.4	9.3	5.6	13.1	8.8	16.9	9.8	12.4	9.6	9.7	10.1	9.0	8.5	7.5	9.8	9.9	9.3	10.1	14.0	3.1	11.3	9.3	11.6	10.8	9.5	14.1	10.2	9.4	13.0	9.5	10.8	10.3
HIF3A	"bHLHe17, IPAS, MOP7, PASD7"	ENSG00000124440	"Hypoxia inducible factor 3 alpha subunit"	Q9Y2N7	19	46297046-46343433	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.1;HHSteC: 16.5;HSkMC: 14.5;TIME: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041141	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041141: AB_10803997"	"unprognostic (9.20e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (6.90e-9)"	"unprognostic (4.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.41e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-4)"	"unprognostic (5.98e-2)"	15.8	7.7	17.9	4.9	9.8	2.5	8.7	10.6	11.1	15.8	16.1	4.7	6.7	3.1	8.1	10.3	11.6	9.8	9.2	31.2	21.4	6.8	4.5	2.1	13.5	5.2	10.8	8.3	17.7	5.1	2.1	12.1	42.4	9.8	9.7	4.5	10.0	4.3	13.1	12.3	3.6	7.0	26.9	11.2	21.7	14.1	3.3	11.4	0.0	3.2	5.6	2.0	18.8	14.6	1.0	1.3	3.3	1.1	0.5	0.7	0.1	0.0	0.0	1.3	0.3	3.8	8.1	0.4	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	16.5	0.1	0.6	14.5	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.1	13.3	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.1	0.0	3.3	0.4	0.8	0.4	0.4	0.4	0.5	0.4	0.4	0.2	1.0	0.6	0.7	3.1	0.5	1.1	1.3	0.2	0.1	17.9	9.8	10.6	11.1	21.4	6.8	10.8	8.3	9.8	11.4
HIGD2A	"MGC2198, RCF1B"	ENSG00000146066	"HIG1 hypoxia inducible domain family member 2A"	Q9BW72	5	176388747-176389771	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042715	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA042715: "	"unprognostic (9.24e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-2)"	37.2	38.5	31.4	33.5	36.0	34.9	37.5	21.4	33.2	26.8	43.8	22.5	29.7	36.7	25.7	31.1	47.0	31.5	39.4	80.0	28.5	26.6	46.3	56.1	30.1	54.1	30.3	20.0	33.2	42.6	36.6	28.8	26.4	21.0	41.2	30.9	31.2	64.0	32.6	115.9	27.8	38.1	43.3	25.9	37.3	31.6	28.8	15.0	63.1	42.3	53.8	34.3	42.1	28.7	70.4	104.6	25.5	107.7	31.1	67.6	88.9	17.6	31.2	18.6	31.6	19.6	37.4	48.9	11.1	21.2	32.4	40.8	32.5	37.3	32.1	27.1	20.2	22.7	28.2	49.8	13.0	75.2	44.3	15.8	32.1	44.5	27.5	24.6	43.1	47.4	41.4	18.2	22.2	27.2	17.5	64.7	23.7	58.2	28.0	31.4	22.0	34.2	27.2	13.9	58.1	50.6	29.4	19.6	26.2	12.7	53.6	54.5	32.0	41.6	17.0	22.1	22.9	20.3	23.1	30.1	35.9	26.1	28.6	44.2	13.8	25.5	84.5	23.8	46.3	106.5	45.8	70.4	64.9	53.5	104.6	52.2	59.6	55.6	14.4	31.1	107.7	68.6	67.6	88.9	31.4	36.0	21.4	33.2	28.5	26.6	30.3	20.0	21.0	15.0
HIGD2B	HIGD2BP	ENSG00000175202	"HIG1 hypoxia inducible domain family member 2B"	Q4VC39	15	72675783-72686149	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	12	"testis: 11.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019016, HPA042715"	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA019016: AB_1850711, HPA042715: "	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"		"unprognostic (2.24e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.80e-2)"	"unprognostic (6.11e-4)"	"unprognostic (6.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.6	0.2	0.0	0.7	0.0	1.3	0.7	1.1	0.0	0.0	0.4	0.0	0.6	0.6	0.8	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	1.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.8	0.7	0.0	0.0	0.0	0.3	0.3	0.2	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
HINT1	"HINT, PKCI-1, PRKCNH1"	ENSG00000169567	"Histidine triad nucleotide binding protein 1"	P49773	5	131159027-131171735	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044577	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			3600000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA044577: AB_10795618"	"unprognostic (2.00e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.49e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.68e-1)"	28.5	46.5	56.6	46.2	51.6	50.5	64.7	42.9	78.4	29.8	53.3	20.4	49.1	36.5	30.6	43.8	44.3	42.3	36.7	61.4	47.3	43.9	65.4	124.4	38.9	54.7	48.7	50.6	32.2	62.9	43.9	39.6	24.6	40.8	41.3	50.0	22.6	44.4	41.8	84.0	38.3	41.3	37.9	37.5	32.5	32.5	30.5	25.1	29.4	47.5	56.6	39.4	29.1	45.1	26.6	46.5	19.2	25.3	20.9	40.3	52.9	37.5	55.0	43.2	88.5	30.8	33.4	39.9	28.6	26.8	28.9	33.6	53.7	52.7	51.7	57.1	36.7	23.2	34.4	75.4	26.8	45.2	63.3	19.9	77.9	68.7	64.5	31.0	6.4	44.6	66.6	34.7	58.3	36.2	30.2	113.2	37.1	41.4	52.4	78.1	41.9	43.9	37.9	43.2	93.5	54.3	48.5	53.0	33.2	37.9	25.9	45.1	31.4	45.4	39.7	38.2	21.7	30.3	58.1	32.6	41.6	44.9	53.6	50.2	35.2	19.2	25.3	9.6	21.7	12.8	29.7	26.6	40.3	28.6	39.2	25.7	32.0	25.3	5.0	20.9	12.9	46.5	27.0	52.9	56.6	51.6	42.9	78.4	47.3	43.9	48.7	50.6	40.8	25.1
HINT3	FLJ33126	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956781-125980244	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol				"Nucleoli, Mitochondria"	Cytosol	"HPA027914: AB_10602424"	"prognostic unfavourable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	11.4	16.3	27.4	8.0	23.3	7.2	15.6	19.4	24.3	13.1	13.1	24.8	10.6	10.4	11.5	12.6	15.2	11.4	10.9	19.0	28.1	23.0	15.1	18.5	13.9	7.0	28.7	17.0	10.4	12.8	16.3	13.4	12.1	20.7	20.5	12.1	10.3	16.0	16.2	65.8	11.6	10.5	15.2	40.8	6.8	16.0	21.9	17.0	7.7	15.9	16.8	7.4	16.1	8.8	11.0	11.1	15.0	13.2	7.9	9.9	7.0	6.9	5.5	7.7	15.9	3.0	8.3	9.5	7.5	10.9	5.8	6.0	13.5	3.8	15.1	14.0	5.0	10.4	9.8	6.3	6.8	14.2	12.6	6.3	8.3	11.3	14.2	9.9	10.7	6.5	14.1	5.8	14.8	8.7	19.6	10.2	5.7	10.5	7.9	7.2	2.6	5.3	6.7	5.3	5.0	12.0	12.7	15.4	9.5	6.8	9.8	35.1	9.9	15.3	6.1	4.0	5.6	18.9	10.6	14.8	16.9	9.6	11.2	9.5	5.1	14.4	13.2	11.4	7.2	8.4	7.8	11.0	9.2	7.5	11.1	10.4	9.9	8.7	15.0	7.9	10.8	6.9	9.1	7.0	27.4	23.3	19.4	24.3	28.1	23.0	28.7	17.0	20.7	17.0
HIP1R	"FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655"	ENSG00000130787	"Huntingtin interacting protein 1 related"	O75146	12	122834453-122862960	"Cancer-related genes, Predicted intracellular proteins"	Endocytosis	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.5;naive B-cell: 12.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017187, HPA038135, HPA038136"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852"	"unprognostic (4.52e-1)"	"unprognostic (6.39e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.72e-2)"	"prognostic favourable (6.50e-7)"	"unprognostic (2.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.54e-3)"	"prognostic favourable (7.26e-4)"	9.8	14.5	24.6	13.2	26.5	11.6	8.0	11.5	31.6	4.6	11.6	40.5	19.7	29.2	4.0	9.1	7.0	4.0	7.8	10.8	29.5	21.7	16.2	9.0	6.3	15.3	31.4	20.6	3.2	27.7	7.4	15.6	5.2	18.0	8.6	5.4	2.9	52.0	24.1	5.7	26.5	21.3	3.0	27.4	11.1	30.4	4.0	30.6	8.1	8.1	5.9	12.6	7.4	6.5	12.3	0.0	2.7	0.0	0.6	3.2	1.6	17.3	5.0	3.8	15.6	1.1	3.0	18.7	2.7	4.5	2.8	2.2	7.7	5.2	16.5	9.2	2.0	15.0	4.6	10.0	0.2	2.6	6.6	0.3	5.7	8.1	3.5	1.3	11.8	1.8	7.1	3.8	6.4	19.3	4.3	0.9	1.6	24.9	7.8	4.0	3.5	6.0	4.1	4.8	5.7	9.4	21.0	3.8	8.5	3.2	8.5	4.5	17.4	0.7	15.2	1.8	13.4	5.5	2.6	11.9	6.3	9.8	2.9	2.8	1.5	0.0	0.0	2.7	2.9	0.0	1.7	9.5	1.8	2.2	0.0	12.3	3.2	2.0	0.2	0.6	0.0	0.0	0.4	1.6	24.6	26.5	11.5	19.8	29.5	21.7	31.4	20.6	18.0	30.6
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929192-113977869	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 90.1"	"Cell line enhanced"	"Detected in all"		"MCF7: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"		"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	15.1	16.8	21.2	14.7	23.0	90.1	13.6	38.1	20.4	20.4	14.4	20.7	14.5	10.2	15.5	14.2	18.7	27.3	17.5	27.9	22.9	17.2	14.8	13.8	19.3	14.7	15.0	16.4	18.7	16.8	20.7	23.8	13.8	21.3	14.4	15.2	20.7	13.0	14.9	19.7	18.5	13.4	15.1	18.3	15.9	14.8	33.5	21.3	47.2	23.3	13.1	15.5	17.3	26.7	2.3	6.2	9.8	4.2	4.3	6.0	2.3	8.1	6.6	9.2	7.0	10.8	5.7	6.2	5.6	6.8	8.0	7.7	7.6	3.1	10.9	7.7	8.9	5.5	11.8	6.6	11.6	7.9	6.0	15.9	8.3	8.0	9.0	12.7	19.7	6.1	9.6	10.2	10.5	11.8	10.8	11.8	11.5	61.5	16.6	7.2	9.4	5.9	10.1	27.0	3.8	7.2	7.0	4.1	5.4	10.2	11.0	7.2	6.4	18.3	11.5	7.9	10.7	12.8	8.5	7.4	5.8	9.5	8.8	10.3	17.9	3.4	4.2	8.2	5.5	3.7	5.2	1.7	4.9	4.9	3.1	2.3	5.0	6.0	9.8	4.3	2.6	6.2	3.6	2.3	21.2	23.0	38.1	20.4	22.9	17.2	15.0	16.4	21.3	21.3
HIPK3	"DYRK6, FIST3, PKY, YAK1"	ENSG00000110422	"Homeodomain interacting protein kinase 3"	Q9H422	11	33256672-33357023	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028069	Approved		Supported	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA028069: AB_10601815"	"unprognostic (2.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-3)"	"unprognostic (7.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	46.3	13.4	12.7	15.9	15.9	12.7	49.2	11.7	13.7	23.6	24.8	11.9	15.9	9.9	28.3	22.8	22.9	24.1	18.8	69.0	13.4	11.8	23.4	21.1	20.2	20.9	15.5	8.2	23.6	15.4	49.7	21.2	20.5	15.2	23.2	12.8	15.6	18.8	18.1	45.9	18.7	25.0	32.9	15.9	20.1	20.5	14.7	14.2	15.2	37.9	26.0	14.4	33.6	34.6	3.1	11.3	17.6	10.1	3.3	4.4	3.7	9.4	9.0	6.8	7.7	31.6	20.0	6.8	10.0	11.6	8.1	6.9	9.9	6.9	10.2	8.5	12.2	12.1	5.1	11.2	11.5	14.8	8.0	10.3	10.2	7.5	13.1	11.0	6.5	18.7	22.0	3.1	9.2	9.9	3.2	20.5	13.1	4.9	9.1	7.7	1.7	5.5	12.3	24.2	10.2	13.4	14.8	1.0	5.7	13.6	15.6	9.3	17.5	20.4	12.7	12.8	8.8	14.7	7.1	11.3	17.7	10.8	6.2	11.7	11.9	6.6	10.1	4.8	3.5	7.6	4.4	2.4	3.2	3.7	11.3	3.1	2.9	3.5	17.6	3.3	8.6	1.4	3.2	3.7	12.7	15.9	11.7	13.7	13.4	11.8	15.5	8.2	15.2	14.2
HIST1H2BB	"H2B/f, H2BFF"	ENSG00000276410	"Histone cluster 1 H2B family member b"	P33778	6	26043277-26043657	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 104.9"	"Cell line enhanced"	"Detected in some"		"K-562: 3.6;Karpas-707: 3.5;MOLT-4: 4.4;NB-4: 4.8;THP-1: 5.4;U-266/84: 5.9"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.4	0.3	1.0	6.4	0.3	6.6	0.6	0.5	1.0	0.5	1.0	0.0	0.0	1.1	0.4	0.5	4.1	0.6	0.3	1.0	0.2		0.8	0.3	1.7	3.0	0.1	0.4	0.3	0.5	0.3	0.0	0.9	1.0	0.3	0.3	0.2	0.3	0.3	1.3	1.0	0.8	0.3	0.8	5.8	0.5	15.8	0.1	104.9	0.3	4.8	7.4	0.3	0.0	2.1	10.5	4.2	1.1	0.2	3.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	1.1	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	1.3	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.6	0.0	1.4	3.6	3.5	0.0	0.0	4.4	4.8	2.1	2.0	2.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.3	5.4	0.0	0.3	0.3	0.3	0.9	0.8	5.9	0.0	0.7	1.7	1.3	4.2	1.1	0.8	1.5	0.1	3.9	2.1	3.9	1.6	3.3	1.6	2.0	0.8	3.6	0.2	0.4	10.5	2.9	0.6										
HIST1H2BC	"H2B.1, H2B/l, H2BFL"	ENSG00000180596	"Histone cluster 1 H2B family member c"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 115.7;lymphoid tissue: 143.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.9;U-2 OS: 23.0;U-266/70: 19.0;U-266/84: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	20	"neutrophil: 115.7"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 115.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	7.8	5.8	5.5	21.3	7.1	31.3	10.7	2.1	5.9	12.9	11.5	5.9	12.8	5.2	4.1	13.1	20.9	10.8	8.1	5.8	6.5	4.6	8.4	20.2	15.3	11.4	5.4	4.1	5.6	9.6	1.7	9.9	17.5	3.8	31.7	4.1	5.9	12.4	18.6	20.0	10.0	6.0	4.3	10.4	11.7	10.6	9.4	4.5	143.2	6.4	8.7	23.4	12.9	14.3	4.3	2.8	115.7	1.3	1.2	1.8	2.7	2.9	1.7	0.9	0.9	0.9	0.5	1.1	2.9	1.1	2.0	1.6	2.4	1.8	1.1	5.6	1.0	2.2	1.2	1.2	1.0	2.6	1.0	0.9	2.7	4.1	1.1	1.4	3.7	12.3	0.7	0.8	0.5	0.7	16.6	9.3	3.8	3.3	3.1	3.0	0.9	5.4	1.4	1.3	6.9	3.4	0.7	4.2	1.3	32.9	2.5	1.1	14.0	1.3	2.4	2.4	23.0	1.5	1.2	19.0	23.3	5.5	1.0	3.6	1.6	4.5	1.1	5.8	1.2	1.3	1.6	2.3	1.8	1.7	0.8	4.3	1.4	1.0	115.7	1.2	1.2	2.8	1.1	2.7	5.5	7.1	2.1	5.9	6.5	4.6	5.4	4.1	3.8	4.5
HIST1H2BD	"H2B/b, H2BFB"	ENSG00000158373	"Histone cluster 1 H2B family member d"	P58876	6	26158146-26171349	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 174.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 36.8;U-266/84: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Not detected"	"Not detected"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB062336: AB_10622324, HPA042205: , HPA043013: , HPA048671: "	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	7.9	6.6	6.0	33.2	9.0	36.4	17.3	14.0	8.9	33.6	17.0	2.9	13.2	8.2	9.5	21.4	18.2	17.4	11.1	17.4	7.5	4.2	19.9	25.3	13.8	32.3	7.7	7.1	33.1	21.7	2.2	11.5	10.1	7.4	43.4	12.9	8.3	13.0	14.7	12.0	14.7	9.5	13.0	18.7	11.0	18.8	7.1	5.6	174.9	9.5	23.9	18.9	13.2	32.7	15.6	12.9	19.3	4.5	6.8	9.6	2.0	5.3	12.1	3.7	2.1	29.0	2.6	1.1	4.7	2.7	6.1	3.8	4.0	4.4	2.4	29.8	5.6	8.5	2.0	2.0	2.9	10.9	5.2	1.6	9.7	4.2	3.1	2.1	4.6	19.0	3.2	1.7	2.4	1.5	16.7	13.4	1.1	19.1	4.8	5.4	3.9	5.6	1.9	2.3	15.8	5.8	3.8	11.9	5.0	29.6	7.8	4.6	19.6	0.7	0.9	7.7	19.9	3.1	1.0	36.8	38.8	6.1	0.9	9.9	1.5	19.3	1.5	10.5	5.8	3.4	7.4	8.4	8.9	9.6	3.7	15.6	8.4	5.7	16.6	6.8	4.5	12.9	5.8	2.0	6.0	9.0	14.0	8.9	7.5	4.2	7.7	7.1	7.4	5.6
HIST1H2BE	"H2B.h, H2B/h, H2BFH"	ENSG00000274290	"Histone cluster 1 H2B family member e"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	26	"lymphoid tissue: 165.1"	"Cell line enhanced"	"Detected in many"		"NB-4: 8.0;REH: 7.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.7	1.1	0.4	12.2	0.8	5.9	1.8	0.6	1.7	2.5	2.9	0.1	1.8	1.1	1.5	2.9	5.5	1.6	1.6	1.9	0.5		1.7	0.3	1.5	6.7	0.0	1.2	2.1	1.2	0.7	0.0	2.4	0.2	5.2	1.5	0.7	4.0	2.2	2.1	1.9	2.0	1.8	1.6	4.5	2.5	5.4	0.0	165.1	1.2	6.4	7.1	1.8	0.0	3.6	3.1	5.5	1.7	1.6	2.9	0.8	0.5	3.6	2.9	0.9	2.9	0.4	0.4	3.0	1.0	0.5	0.3	0.8	2.1	0.6	1.4	0.5	4.2	0.5	1.1	0.6	1.5	0.9	0.5	1.4	0.1	0.2	0.3	2.4	0.6	0.2	0.6	0.2	0.3	2.3	1.8	0.1	1.6	4.5	8.0	2.4	0.9	7.8	0.2	2.5	1.4	1.8	2.7	3.6	3.9	1.4	0.9	2.7	1.6	0.8	1.5	2.6	1.0	1.9	2.3	4.4	0.6	0.6	1.4	0.5	5.2	1.7	2.4	2.0	1.3	1.6	2.1	2.0	2.5	0.7	3.6	1.8	1.7	5.5	1.6	1.5	3.1	2.9	0.8										
HIST1H2BF	"H2B/g, H2BFG"	ENSG00000277224	"Histone cluster 1 H2B family member f"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"lymphoid tissue: 252.2"	"Group enriched"	"Detected in some"	4	"U-266/70: 21.3;U-266/84: 15.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.4	1.2	0.0	17.3	0.1	3.8	5.7	0.3	0.7	2.7	3.3	0.4	1.0	0.5	1.6	1.3	9.9	1.3	1.2	0.6	0.0		0.5	0.4	2.5	7.0	0.0	0.2	0.8	0.6	0.4	0.0	3.2	0.2	5.4	1.1	0.5	1.4	1.3	0.2	0.4	3.0	0.3	0.9	8.3	1.3	2.2	0.1	252.2	0.4	3.3	14.6	2.4	0.0	3.0	0.7	6.2	0.7	0.4	1.5	1.2	0.4	0.2	0.2	0.4	0.2	0.0	0.2	0.1	0.1	0.6	0.1	0.5	0.0	0.5	0.9	0.0	0.8	0.4	0.1	0.3	0.6	0.2	0.3	1.4	0.1	0.1	0.1	0.7	0.2	0.0	0.1	0.1	0.1	1.6	3.8	0.0	0.1	3.2	1.3	0.5	0.5	1.2	0.6	2.4	0.1	0.1	2.1	0.3	4.1	0.8	0.0	3.7	0.2	0.1	0.3	1.9	0.0	0.5	21.3	15.0	1.2	0.1	0.9	0.4	0.0	0.2	1.4	0.7	0.3	1.5	0.7	0.7	0.8	0.4	3.0	0.6	1.2	6.2	0.4	0.7	0.7	0.6	1.2										
HIST1H2BG	"H2B.1A, H2B/a, H2BFA"	ENSG00000273802	"Histone cluster 1 H2B family member g"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 8.8;T-47d: 17.8;U-266/70: 16.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	0.4	1.5	0.7	16.5	1.2	8.9	20.2	5.1	3.4	4.3	2.9	0.5	5.1	1.8	2.8	4.0	6.6	2.1	1.8	1.7	0.2		1.2	0.6	2.0	7.2	0.1	2.0	1.3	1.9	0.4	0.5	1.6	0.7	10.3	3.0	1.2	5.0	5.8	0.3	1.6	2.2	2.8	4.7	3.1	2.9	6.7	0.3	75.2	1.0	6.9	8.3	4.3	0.0	5.8	14.6	12.0	1.6	1.3	6.2	2.0	2.4	0.1	1.2	0.0	3.8	0.2	0.3	3.1	0.2	2.0	0.8	0.3	2.1	0.0	3.1	0.3	2.6	1.1	1.0	1.1	2.1	1.3	0.7	1.2	1.1	0.6	0.2	2.0	1.4	0.5	0.6	0.0	0.4	7.6	0.1	0.0	1.8	2.2	1.7	1.2	1.6	1.4	0.7	4.3	1.1	0.6	7.2	1.1	8.8	3.2	1.0	17.8	0.8	0.2	0.0	1.0	0.3	0.4	16.7	0.1	0.0	0.3	1.0	0.5	12.0	1.2	2.5	2.0	0.9	6.2	3.7	3.1	3.8	4.4	5.8	1.5	1.3	5.6	1.3	1.6	14.6	2.7	2.0										
HIST1H2BH	"H2B/j, H2BFJ"	ENSG00000275713	"Histone cluster 1 H2B family member h"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 220.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 17.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.9	0.6	0.0	25.6	0.0	3.1	2.1	0.0	0.0	0.9	5.5	0.0	0.9	7.8	1.0	2.4	8.4	1.5	4.0	1.8	0.0		0.7	0.0	2.2	11.3	0.0	0.0	0.4	0.1	0.0	0.0	4.9	0.0	1.2	2.2	0.0	1.8	0.1	0.0	0.6	8.1	0.1	0.0	9.6	1.6	3.3	0.0	220.5	0.4	9.5	23.3	1.4	0.0	1.0	0.9	4.7	0.4	1.0	0.7	9.3	1.8	0.1	7.3	0.0	0.0	0.1	1.2	0.9	0.4	1.3	0.6	2.4	1.1	0.0	1.8	0.1	3.6	0.0	0.6	1.8	0.9	0.1	1.3	5.5	0.4	0.0	0.0	4.2	0.3	0.3	0.5	0.5	0.3	2.6	6.5	0.1	2.0	3.8	2.7	1.7	1.9	4.0	0.0	0.9	0.0	2.8	3.4	3.0	4.3	1.4	0.6	2.1	3.3	0.0	0.6	0.0	0.8	3.2	17.7	4.4	0.0	0.5	1.5	3.9	3.5	0.4	0.7	0.5	0.0	0.2	1.0	0.3	0.7	0.9	0.6	0.1	0.2	4.7	1.0	0.2	0.4	0.7	9.3										
HIST1H2BI	"H2B/k, H2BFK"	ENSG00000278588	"Histone cluster 1 H2B family member i"	P62807	6	26272976-26273356	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 150.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 5.3;MOLT-4: 14.8;THP-1: 6.2"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.5	0.1	0.0	19.0	0.0	8.9	1.2	0.4	0.1	1.3	3.1	0.0	0.5	0.1	0.7	2.1	6.6	0.4	2.0	1.3	0.0		0.3	0.1	2.0	6.3	0.0	0.0	0.7	0.1	0.1	0.0	2.8	0.0	0.1	0.3	0.0	1.3	0.3	0.1	1.2	1.9	0.1	0.1	11.1	0.4	1.9	0.0	150.8	0.4	8.2	14.5	2.2	0.0	4.7	0.7	0.9	1.3	0.4	4.6	0.2	1.8	0.8	1.2	0.0	0.0	0.0	0.2	0.7	0.7	2.0	5.3	0.8	0.0	0.9	0.4	0.4	0.9	1.8	0.5	0.8	2.6	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.8	0.0	3.8	0.0	0.7	14.8	2.5	2.8	0.0	4.0	0.0	4.9	0.0	0.4	0.3	0.9	1.1	1.0	0.0	0.0	6.2	0.9	0.8	0.0	0.6	3.0	3.1	0.4	0.0	1.1	0.5	2.2	0.2	0.5	0.0	3.4	1.3	2.2	2.2	3.2	4.6	0.7	4.7	1.4	0.8	0.9	0.4	0.1	0.3	1.5	0.2										
HIST1H2BJ	"H2B/r, H2BFR"	ENSG00000124635	"Histone cluster 1 H2B family member j"	P06899	6	27125897-27132750	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 124.3"	"Cell line enhanced"	"Detected in many"		"K-562: 41.2;Karpas-707: 24.3;SiHa: 37.1;U-2 OS: 41.1;U-266/70: 35.0;U-266/84: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (4.02e-2)"	"prognostic favourable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.1	2.2	1.5	30.0	2.4	10.7	11.3	0.9	1.9	12.8	6.2	1.6	3.9	2.1	3.1	5.9	12.8	5.1	2.8	6.0	2.5	1.7	1.9	3.9	7.3	12.0	3.2	0.9	1.3	5.1	0.6	1.2	5.1	2.9	8.0	3.0	0.5	4.0	4.8	5.9	2.9	2.8	2.8	5.9	12.0	5.1	30.5	2.2	124.3	2.7	10.1	22.3	5.2	9.4	2.2	1.0	13.6	0.6	0.7	2.4	14.7	3.7	4.7	1.4	1.3	7.1	0.5	1.8	2.1	1.2	8.3	3.6	4.0	2.2	0.6	6.7	2.2	2.7	2.0	1.8	4.6	4.4	3.5	1.1	5.3	0.2	0.6	0.4	3.0	3.4	0.2	1.7	0.8	0.4	41.2	24.3	2.2	2.0	1.7	2.4	1.7	4.4	0.9	1.2	3.7	1.0	1.4	9.2	1.0	37.1	2.5	1.0	0.1	1.5	1.0	2.1	41.1	1.6	0.9	35.0	43.1	9.9	0.5	11.6	1.0	1.8	0.6	0.7	0.5	0.5	0.8	1.6	0.7	0.3	0.4	2.2	0.4	0.5	13.6	0.7	0.2	1.0	2.4	14.7	1.5	2.4	0.9	1.9	2.5	1.7	3.2	0.9	2.9	2.2
HIST1H2BK	"H2BFAiii, H2BFT"	ENSG00000197903	"Histone cluster 1 H2B family member k"	O60814	6	27146418-27146798	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 243.8"	"Cell line enhanced"	"Detected in many"		"K-562: 115.0;U-2 OS: 104.9;U-266/84: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	9.4	6.0	3.0	39.8	4.1	7.8	8.6	2.4	3.6	14.9	11.0	2.5	10.5	8.4	8.0	14.6	19.1	13.5	10.5	9.8	4.3	3.7	4.0	19.3	12.7	25.9	3.6	2.3	8.5	17.4	0.6	5.9	18.7	2.0	16.0	5.3	3.5	11.3	10.7	3.7	6.3	10.3	6.9	7.6	28.0	13.7	30.6	1.9	243.8	8.9	32.3	26.4	11.5	16.7	26.5	22.1	60.7	16.2	5.0	11.5	12.5	6.1	15.9	2.5	4.4	11.5	4.3	8.8	10.1	7.3	14.7	9.5	14.4	8.1	2.0	34.4	5.8	8.1	3.1	3.1	2.2	9.1	15.4	3.4	10.0	0.4	5.0	2.7	20.9	20.6	2.7	2.5	2.8	3.0	115.0	23.3	6.6	16.8	4.9	4.9	2.3	6.9	3.2	1.7	25.9	5.5	2.7	12.9	7.4	60.5	20.8	5.5	53.7	3.1	3.3	6.6	104.9	6.1	1.7	32.0	137.9	18.3	3.8	27.4	3.7	33.8	9.4	60.7	4.1	8.3	3.9	20.3	4.2	4.1	9.6	26.5	5.0	3.9	60.1	5.0	16.2	22.1	11.5	12.5	3.0	4.1	2.4	3.6	4.3	3.7	3.6	2.3	2.0	1.9
HIST1H2BL	"dJ97D16.4, H2B/c, H2BFC"	ENSG00000185130	"Histone cluster 1 H2B family member l"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 217.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.9;U-266/84: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	1.2	1.0	0.2	13.9	1.0	13.7	1.6	1.4	0.6	1.8	5.1	0.0	0.3	0.6	0.8	0.6	7.4	0.9	0.9	1.3	0.9	0.7	0.3	0.6	1.5	3.5	0.5	0.0	1.3	1.2	1.2	0.2	1.9	0.0	1.2	1.1	0.0	0.7	0.2	0.2	0.9	3.9	0.7	2.8	4.8	0.8	1.5	0.0	217.6	1.2	5.9	15.6	1.1	1.2	1.9	1.2	7.7	0.6	0.4	2.0	0.9	2.4	2.2	0.7	2.3	0.0	0.0	0.1	1.4	0.4	1.2	3.2	1.0	1.7	0.9	0.5	0.3	1.5	0.0	0.2	0.4	1.1	3.2	1.7	3.1	3.8	0.0	2.8	2.3	1.0	0.0	0.0	0.0	0.7	2.2	5.7	0.0	6.0	12.9	4.8	2.1	3.3	3.0	0.0	1.4	0.0	2.2	3.0	1.1	3.9	1.6	0.2	1.4	0.9	0.5	0.1	1.6	1.3	1.0	3.3	12.7	4.2	0.4	5.0	0.5	0.6	0.5	4.0	1.1	0.2	1.3	1.9	0.6	1.1	1.2	1.3	0.4	0.6	7.7	0.4	0.6	0.7	2.0	0.9	0.2	1.0	1.4	0.5	0.9	0.7	0.5	0.0	0.0	0.0
HIST1H2BM	"dJ160A22.3, H2B/e, H2BFE"	ENSG00000273703	"Histone cluster 1 H2B family member m"	Q99879	6	27815044-27815424	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"lymphoid tissue: 232.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.3;NB-4: 11.1;REH: 7.2;U-266/70: 13.4;U-698: 6.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.1	0.1	0.0	19.9	0.0	11.6	0.1	0.0	0.2	1.6	3.4	0.0	0.0	0.1	0.7	0.9	8.4	0.1	1.4	0.3	0.0		0.1	0.3	1.8	7.3	0.0	0.0	0.3	0.1	0.1	0.0	1.5	0.0	0.5	1.1	0.0	0.3	0.1	0.1	0.8	3.8	0.1	0.5	13.9	0.5	3.5	0.0	232.2	0.1	9.4	27.6	0.1	0.0	2.6	0.4	0.3	0.3	1.5	1.7	0.0	1.5	0.0	0.3	0.0	0.0	0.0	1.2	0.4	0.2	0.5	2.1	0.4	0.3	2.2	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.8	0.2	0.8	0.0	0.0	2.0	0.0	0.0	0.8	0.0	0.0	0.2	17.3	0.0	0.5	4.5	11.1	3.3	0.8	7.2	0.0	0.4	0.0	0.0	0.1	1.9	0.7	1.1	0.0	1.0	3.3	0.0	0.0	2.0	1.2	0.1	13.4	0.5	6.8	1.1	1.2	0.9	0.0	0.1	0.1	1.5	0.3	1.7	1.9	1.7	1.5	0.4	2.6	0.1	1.2	0.3	1.5	0.0	0.2	0.6	0.0										
HIST1H2BN	"H2B/d, H2BFD"	ENSG00000233822	"Histone cluster 1 H2B family member n"	Q99877	6	27837760-27865798	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	13	"lymphoid tissue: 193.3"	"Cell line enhanced"	"Detected in many"		"K-562: 8.7;SCLC-21H: 9.6;U-266/84: 9.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 14.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	2.4	7.2	2.3	14.0	3.3	9.3	3.1	4.9	6.2	3.4	4.5	1.0	4.4	1.8	3.4	3.7	7.6	3.2	3.7	6.4	3.7	2.4	2.3	5.3	5.4	8.0	4.1	4.2	5.0	8.3	4.2	3.8	4.5	1.4	4.0	2.5	1.7	3.3	4.7	4.6	2.3	4.3	2.5	9.4	7.0	2.4	6.8	0.5	193.3	6.1	6.2	10.9	3.6	2.2	6.0	6.2	14.6	2.6	1.0	2.8	1.4	1.4	0.2	1.5	1.5	1.2	1.9	0.9	0.7	1.1	0.7	0.8	0.5	0.8	0.7	3.0	0.7	2.1	1.3	0.4	0.3	1.5	4.4	0.7	3.6	1.3	1.4	0.9	3.6	1.2	0.3	0.1	1.3	0.2	8.7	6.8	0.8	1.8	2.9	4.4	1.3	1.0	2.0	0.9	5.1	0.4	0.9	9.6	1.9	3.5	1.3	2.9	2.4	0.8	1.5	2.1	2.1	1.1	0.6	6.0	9.0	3.5	0.7	1.7	0.7	2.3	2.6	1.7	2.6	2.4	1.8	5.8	2.0	1.9	5.0	6.0	1.3	1.2	14.6	1.0	1.8	6.2	2.8	1.4	2.3	3.3	4.9	6.2	3.7	2.4	4.1	4.2	1.4	0.5
HIST1H2BO	"H2B.2, H2B/n, H2BFN"	ENSG00000274641	"Histone cluster 1 H2B family member o"	P23527	6	27893463-27893843	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 164.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 28.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favourable (4.89e-4)"	1.9	0.4	0.0	14.9	0.0	8.1	1.5	0.0	0.0	0.9	3.9	0.0	0.0	0.9	0.6	1.6	9.9	0.0	0.7	1.5	0.0		0.3	0.5	2.6	7.4	0.0	0.0	0.0	0.0	0.7	0.0	4.4	0.1	0.3	1.5	0.0	1.2	0.0	0.3	1.5	2.1	0.1	0.5	8.1	0.7	1.4	0.0	164.5	0.0	7.1	15.4	1.1	0.0	2.6	2.2	6.5	0.8	1.3	1.7	5.5	2.2	2.9	1.4	4.3	0.7	0.0	2.6	0.8	0.1	5.3	5.3	1.1	1.3	2.5	1.9	0.2	2.2	2.4	0.5	0.7	1.7	1.9	1.6	4.4	1.7	0.0	0.2	1.0	0.3	0.0	0.4	0.5	1.4	6.4	7.2	0.2	0.5	10.9	9.3	1.6	2.1	6.4	1.5	4.8	0.9	0.3	6.1	1.3	4.6	1.2	0.7	2.0	0.2	0.0	1.5	0.3	1.7	2.0	8.0	28.8	7.4	0.9	9.3	0.7	1.3	0.3	3.8	0.8	0.6	1.1	1.4	0.8	1.7	2.2	2.6	0.5	0.5	6.5	1.3	0.8	1.7	1.4	5.5										
HIST2H2BE	"H2B, H2B.1, H2B/q, H2BFQ"	ENSG00000184678	"Histone cluster 2 H2B family member e"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.8;U-266/70: 39.7;U-266/84: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	14.3	16.2	9.8	22.2	10.0	19.4	16.9	17.2	14.0	31.3	9.0	11.2	10.5	6.4	18.5	24.9	25.5	13.3	9.6	51.1	13.1	10.1	12.5	10.2	27.5	24.5	12.4	8.7	28.0	13.4	5.8	15.4	17.2	8.5	72.8	7.6	19.4	24.1	15.3	43.1	33.5	8.6	18.8	18.2	22.0	17.5	9.3	11.6	198.1	12.1	12.4	25.3	27.2	33.8	2.3	4.5	29.9	5.5	0.7	1.2	5.1	1.1	1.1	1.9	0.4	10.1	2.7	0.9	4.0	2.7	1.7	0.5	0.4	1.8	0.2	1.1	3.5	4.5	1.5	0.7	0.9	1.4	1.2	0.3	4.5	0.8	3.2	0.3	5.3	9.2	3.3	0.7	2.8	0.5	4.8	23.8	2.1	6.8	1.2	2.0	1.2	2.4	1.4	0.7	5.4	1.6	0.9	12.8	2.0	13.8	1.9	1.0	9.8	0.9	0.7	1.3	14.4	0.9	0.3	39.7	21.2	1.0	1.7	1.4	0.7	8.4	2.1	3.8	0.7	3.2	1.2	0.8	0.9	1.1	1.6	2.3	1.2	1.1	29.9	0.7	5.5	4.5	1.0	5.1	9.8	10.0	17.2	8.5	13.1	10.1	12.4	8.7	8.5	11.6
HIST2H2BF		ENSG00000203814	"Histone cluster 2 H2B family member f"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 117.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 21.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 21.7"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB007814: AB_598159, HPA042205: , HPA043013: , HPA048671: "	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	5.6	17.7	3.9	14.9	3.5	3.7	7.1	8.5	5.6	17.4	3.8	3.7	3.2	1.5	5.6	6.2	7.1	7.9	3.6	12.1	3.4	2.4	5.0	4.2	14.6	27.5	3.2	3.8	24.2	6.2	2.6	4.4	5.1	3.2	16.7	2.5	3.5	3.7	5.5	1.2	10.9	3.4	6.0	7.7	12.7	7.9	5.9	3.1	117.6	4.4	6.3	16.7	6.1	21.5	2.0	0.8	21.7	1.1	0.6	0.8	0.2	0.4	0.6	0.5	0.6	4.5	3.0	0.3	7.7	4.0	5.9	5.2	0.3	2.2	0.4	0.6	4.4	1.3	0.1	0.5	4.6	1.2	0.9	0.4	1.5	0.0	6.6	0.2	1.7	5.4	0.0	7.6	1.9	3.3	1.2	2.3	0.8	0.9	3.1	3.7	0.4	1.0	0.3	1.1	0.7	2.8	0.4	2.6	7.2	4.1	3.5	0.3	1.3	9.6	1.4	1.5	0.0	11.2	2.0	31.4	1.0	1.3	5.2	0.3	3.3	0.0	1.0	0.2	0.6	0.8	0.7	0.6	0.8	0.3	0.8	2.0	0.4	0.3	21.7	0.6	1.1	0.8	0.2	0.2	3.9	3.5	8.5	5.6	3.4	2.4	3.2	3.8	3.2	3.1
HIST3H2BB		ENSG00000196890	"Histone cluster 3 H2B family member b"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 56.0"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 18.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 12.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	2.0	4.7	1.2	12.1	3.1	2.8	1.3	12.8	3.2	8.9	1.3	1.1	0.6	2.1	1.4	2.0	4.1	6.2	1.7	2.2	1.5	2.2	1.3	0.9	2.1	5.4	1.2	1.5	1.6	1.7	1.7	2.0	1.5	4.1	2.2	1.5	3.4	2.0	2.0	1.8	4.8	1.7	1.2	6.2	4.5	2.4	2.1	0.7	56.0	1.7	5.9	11.8	2.0	7.9	1.5	1.1	3.4	1.5	1.1	0.9	0.5	0.2	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.5	1.0	0.1	0.1	0.0	2.5	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.3	0.4	0.1	0.4	0.2	0.0	0.0	0.8	0.0	0.2	1.4	0.5	0.9	0.4	0.3	3.7	0.1	0.1	0.0	0.0	0.5	0.1	18.1	4.3	0.0	0.2	0.1	0.1	1.7	1.0	0.5	0.5	0.5	0.7	1.3	0.8	0.9	0.2	1.5	0.9	0.7	3.4	1.1	1.5	1.1	0.7	0.5	1.2	3.1	12.8	3.1	1.5	2.2	1.2	1.5	4.1	0.7
HLCS	HCS	ENSG00000159267	"Holocarboxylase synthetase"	P50747	21	36750888-36990236	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017379	Approved		Supported	Cytosol				Cytosol		"HPA017379: AB_1850768"	"prognostic unfavourable (7.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.02e-1)"	6.3	9.6	7.1	9.8	10.3	2.9	10.6	12.2	8.5	7.7	7.2	10.3	12.1	5.7	6.4	9.4	7.1	8.1	9.9	5.3	8.4	8.0	9.1	16.4	6.7	5.8	10.2	6.0	5.5	15.6	23.3	23.9	9.9	9.4	12.8	6.4	11.7	9.9	11.6	13.5	4.3	8.1	7.3	10.6	4.5	7.6	7.7	5.1	4.9	14.3	6.1	8.0	9.2	4.9	3.9	5.3	3.2	10.0	8.5	7.8	2.9	17.6	6.5	9.9	7.2	11.8	10.8	9.7	10.8	10.4	4.9	5.5	7.1	8.4	9.6	5.2	15.5	6.0	5.0	8.2	4.4	19.0	10.3	14.1	6.4	4.5	14.1	7.6	7.4	8.5	12.7	7.4	19.9	6.2	15.3	24.5	12.4	10.7	3.4	3.5	15.5	9.2	6.0	5.6	7.8	7.6	17.8	7.0	7.2	14.2	6.6	10.8	11.5	7.8	8.3	7.1	2.2	6.5	5.8	23.8	14.5	5.9	10.2	9.6	8.2	3.2	2.1	1.6	7.8	4.0	6.1	2.6	4.5	5.2	2.0	3.9	5.4	5.5	2.7	8.5	10.0	5.3	2.7	2.9	7.1	10.3	12.2	8.5	8.4	8.0	10.2	6.0	9.4	5.1
HLX	"HB24, HLX1"	ENSG00000136630	"H2.0 like homeobox"	Q14774	1	220879400-220885059	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 13.2;THP-1: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 25.8;neutrophil: 28.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 28.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA005968	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA005968: AB_1079066"	"unprognostic (6.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (7.28e-6)"	"unprognostic (8.44e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	27.7	3.0	2.7	8.8	3.0	54.0	18.4	0.9	2.3	5.7	24.3	2.0	3.8	4.5	7.4	3.6	8.7	5.0	7.5	15.2	3.3	0.9	4.0	11.5	14.3	10.5	6.2	0.3	4.9	4.9	1.8	2.0	14.0	2.5	6.9	2.4	4.2	2.3	3.8	10.4	5.7	11.1	4.2	6.4	10.9	3.1	3.9	3.1	1.4	6.3	3.0	3.2	10.4	12.9	2.2	5.5	28.5	6.3	0.2	0.1	1.8	0.0	1.8	0.0	1.4	4.2	6.8	3.5	5.1	8.5	5.8	4.9	0.4	0.1	0.0	0.1	3.2	0.0	1.1	0.0	2.4	1.3	3.7	0.0	2.1	0.2	7.4	1.7	0.3	7.8	0.2	6.6	0.3	2.5	2.2	0.0	0.8	0.0	0.0	6.1	0.2	3.5	0.1	4.0	0.0	0.6	0.0	0.0	2.0	0.7	0.1	13.2	0.0	46.4	0.7	4.0	0.0	0.6	4.0	0.0	0.0	0.0	6.4	5.3	1.6	25.8	6.3	10.7	0.0	1.8	0.0	2.2	0.0	0.0	5.5	1.1	0.0	0.0	28.5	0.2	0.3	3.5	0.1	1.8	2.7	3.0	0.9	2.3	3.3	0.9	6.2	0.3	2.5	3.1
HMBOX1	"FLJ21616, HNF1LA, HOT1, PBHNF"	ENSG00000147421	"Homeobox containing 1"	Q6NT76	8	28890394-29064764	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055855, HPA058586, CAB070418"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB070418: AB_11154826, HPA055855: , HPA058586: "	"unprognostic (2.68e-3)"	"unprognostic (2.30e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-1)"	10.8	23.1	16.4	10.5	15.5	21.2	10.4	18.6	15.8	9.2	8.4	13.9	8.5	6.7	14.9	8.6	9.6	8.7	9.4	12.7	14.6	8.2	10.1	10.0	15.9	11.0	16.6	10.1	13.9	10.9	13.5	13.6	14.6	15.9	7.6	8.8	9.9	11.7	12.5	9.7	12.1	10.2	11.6	20.0	11.8	9.3	16.8	18.2	13.0	13.7	5.6	12.6	10.4	14.3	6.6	4.8	5.0	9.0	2.2	5.5	2.6	5.0	5.5	6.1	7.0	5.7	6.0	5.1	2.2	2.9	3.4	3.9	2.5	3.2	12.3	5.4	3.8	4.3	11.8	4.4	4.8	4.5	2.1	12.8	10.3	3.4	4.5	4.3	8.6	2.9	6.3	4.5	8.5	7.6	18.1	12.3	4.8	2.9	7.9	2.2	4.2	1.3	6.5	6.0	2.9	2.4	9.3	2.6	7.8	4.2	3.2	4.6	3.2	3.9	10.9	3.1	14.6	3.3	3.0	3.7	3.8	4.8	4.2	5.3	4.5	5.0	4.8	2.0	4.0	4.9	5.5	6.6	3.9	3.5	4.8	5.7	5.0	4.8	2.7	2.2	9.0	3.8	1.7	2.6	16.4	15.5	18.6	15.8	14.6	8.2	16.6	10.1	15.9	18.2
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43289395-43313512	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 117.0"	"Cell line enhanced"	"Detected in all"		"AF22: 123.5;HBEC3-KT: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			310000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: , HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favourable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	6.0	16.5	13.3	8.1	24.4	4.3	12.8	8.4	38.2	16.9	15.5	16.9	9.5	27.8	6.8	11.5	53.0	4.1	7.5	5.1	19.4	18.8	10.5	117.0	26.9	6.2	10.4	20.7	15.4	8.4	10.8	5.0	6.9	59.3	12.9	14.2	13.0	18.5	7.7	5.0	25.2	17.1	6.3	25.8	4.4	13.4	9.8	8.1	3.3	7.5	58.1	23.3	6.1	21.4	9.3	7.8	6.9	7.7	6.7	7.9	3.3	15.3	7.4	123.5	14.2	7.2	28.7	8.4	2.4	9.7	3.5	7.0	12.8	22.2	16.3	5.5	3.5	12.1	30.7	71.2	3.7	3.4	36.9	6.0	6.8	17.3	11.3	13.1	4.3	15.6	8.6	18.5	7.4	3.6	10.7	44.6	2.9	7.1	11.8	16.0	22.1	3.9	8.5	17.3	18.0	54.7	23.8	10.6	5.1	12.6	6.3	3.7	9.9	17.5	4.3	2.6	13.3	2.8	2.3	6.0	9.1	22.2	2.3	15.8	2.3	5.5	4.0	3.7	5.6	7.4	5.6	9.3	6.2	7.9	7.8	7.5	5.3	7.3	6.9	6.7	7.7	6.5	5.7	3.3	13.3	24.4	8.4	32.1	19.4	18.8	10.4	20.7	59.3	8.1
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: "	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favourable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	26.6	57.2	53.6	22.9	52.7	18.8	37.2	73.1	84.6	26.1	28.3	22.6	28.4	27.7	29.9	55.4	29.0	66.8	26.4	68.6	53.3	33.4	52.5	44.6	34.4	35.5	70.8	36.1	34.9	27.8	38.7	66.8	35.4	53.0	27.4	23.5	28.0	47.4	30.6	41.8	24.8	22.3	33.0	53.2	27.7	31.0	24.8	63.5	21.9	36.1	37.9	32.8	26.1	25.6	28.0	52.3	7.7	38.3	32.8	29.4	36.4	14.1	12.9	45.2	19.5	18.2	15.0	10.2	9.8	10.6	11.1	16.3	72.1	12.0	0.1	18.3	8.0	9.1	29.3	11.2	10.9	41.7	24.6	49.9	40.4	37.5	11.7	40.8	7.6	18.1	12.5	7.3	4.0	24.6	29.2	40.0	17.9	12.9	18.7	78.8	33.1	32.4	32.1	69.1	14.5	75.9	20.6	18.5	24.8	18.8	21.7	13.8	12.3	68.9	10.7	3.0	13.5	10.7	21.7	34.5	50.8	0.2	1.7	0.1	14.8	7.7	38.3	3.2	29.4	36.2	25.5	28.0	20.6	24.6	44.8	23.2	24.3	29.2	1.8	32.8	33.3	52.3	21.9	36.4	53.6	52.7	73.1	84.6	53.3	33.4	70.8	36.1	53.0	63.5
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491945	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.5;testis: 16.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol				Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: , HPA043926: , HPA061524: "	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (5.52e-4)"	"prognostic unfavourable (1.93e-7)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	1.6	1.4	0.6	13.4	0.6	11.4	2.4	0.4	0.9	1.7	5.0	0.6	0.6	4.5	0.6	2.3	6.4	0.5	0.9	1.6	0.8	0.7	1.4	1.8	2.5	10.9	1.0	0.4	0.6	1.1	0.6	0.5	6.9	1.1	0.7	5.6	0.4	1.6	0.2	1.4	2.3	4.8	1.4	1.9	8.6	2.6	16.7	0.3	54.5	0.7	5.6	10.8	1.8	2.1	1.2	1.8	0.6	0.7	1.5	4.8	0.8	21.1	13.3	27.1	14.5	1.4	2.6	20.2	20.1	9.8	25.2	22.9	27.0	40.8	35.1	19.2	6.2	24.4	31.3	19.0	43.0	31.8	9.7	21.0	9.5	13.1	0.4	18.6	19.4	0.7	1.1	23.6	18.5	14.3	19.8	28.8	26.2	7.7	19.6	10.6	23.4	14.5	21.4	36.3	17.6	9.8	5.7	22.7	12.6	29.9	9.4	11.4	27.6	14.9	9.3	18.1	15.3	14.4	26.9	15.5	25.9	28.3	11.9	28.8	17.3	0.5	0.7	0.0	0.5	0.3	0.9	1.2	1.0	0.6	0.9	0.9	0.4	0.7	0.6	1.5	0.0	1.8	4.8	0.8	0.6	0.6	0.4	0.9	0.8	0.7	1.0	0.4	1.1	0.3
HMOX2	HO-2	ENSG00000103415	"Heme oxygenase 2"	P30519	16	4474690-4510347	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025464, HPA040611"	Supported		Approved	Vesicles,Cytosol			1200000	"Vesicles, Cytosol"		"CAB025464: , HPA040611: AB_10961034"	"unprognostic (3.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.91e-4)"	"unprognostic (2.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (9.87e-2)"	"prognostic favourable (8.98e-6)"	"unprognostic (3.51e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.64e-1)"	19.4	19.2	32.1	15.7	50.7	13.6	16.6	19.7	38.6	13.3	17.9	22.9	12.2	23.5	11.9	18.7	36.6	15.6	19.7	57.2	29.3	22.0	32.2	39.7	15.8	20.8	27.3	35.1	12.5	22.4	20.6	14.7	12.5	36.5	12.1	19.9	8.6	16.0	10.0	20.1	16.6	19.3	16.6	27.2	23.3	29.7	48.1	28.2	8.7	13.8	16.7	25.3	16.5	15.0	14.5	14.5	48.7	8.9	18.7	35.8	25.8	24.6	10.5	6.3	13.6	18.8	9.7	10.5	17.0	8.4	14.5	12.6	13.3	16.8	11.4	19.2	15.6	14.9	19.7	36.5	16.5	14.6	13.4	8.3	10.1	18.0	12.7	18.0	14.2	15.1	12.3	16.8	12.3	26.6	13.4	5.8	13.3	30.5	14.8	14.1	9.6	10.0	15.7	11.0	24.0	20.1	16.2	10.6	6.2	13.6	28.9	18.3	18.0	10.1	25.9	8.2	12.2	35.1	8.7	7.2	8.9	25.2	5.2	14.9	10.4	13.7	7.4	48.7	35.2	8.9	29.9	14.5	32.7	35.8	14.5	13.0	31.7	32.7	26.1	18.7	6.5	8.2	30.0	25.8	32.1	50.7	19.7	38.6	29.3	22.0	27.3	35.1	36.5	28.2
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566843	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 139.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;CAPAN-2: 17.3;Karpas-707: 4.9;PC-3: 5.3;THP-1: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005438: AB_1850822, HPA010610: "	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.2	0.5	5.0	0.5	0.0	0.3	0.3	0.3	0.6	56.2	0.1	0.3	35.9	0.4	1.1	0.4	0.3	12.6	0.2	0.3	0.3	6.1	12.1	0.4	0.0	0.4	0.2	0.2	10.9	0.0	0.2	0.0	0.3	0.6	6.9	0.2	0.4	0.6	0.2	0.2	139.6	0.2	0.3	0.2	2.6	0.9	0.1	0.1	0.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	4.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.3	17.3	0.0	2.5	0.0	0.0	2.2	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.3	0.3	5.3	0.0	0.0	0.3	3.0	0.1	0.3	1.7	0.4	0.1	0.0	0.3	5.8	0.0	0.4	0.2	0.1	0.0	1.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.3	0.3	0.4	0.2	0.3	0.1
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 61.3;HSkMC: 25.1;RT4: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6"	"Group enriched"	"Detected in many"	22	"dendritic cells: 20.9;monocytes: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol			64000	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: , HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (4.68e-4)"	41.4	5.8	12.2	12.3	11.1	3.3	28.8	10.7	11.3	27.6	16.3	8.6	13.9	8.7	22.2	21.4	11.6	14.6	21.6	14.7	12.7	7.8	33.4	74.2	21.9	17.0	13.7	9.2	33.1	14.1	24.5	5.5	14.3	11.2	22.3	17.7	8.7	14.1	20.1	4.9	8.1	11.1	13.2	14.8	18.5	11.5	11.7	14.6	1.0	7.3	8.5	6.5	21.3	12.0	0.5	20.9	1.2	34.6	0.1	0.2	9.2	0.2	0.3	1.5	4.1	17.6	18.9	0.1	1.1	1.7	0.1	0.7	7.8	4.4	0.2	13.9	4.6	0.4	3.2	0.0	0.0	0.2	1.6	0.1	13.1	61.3	7.9	0.0	0.2	25.1	0.0	6.2	0.0	4.4	0.2	0.3	13.2	1.0	0.0	0.2	7.8	1.6	0.1	0.5	0.0	18.9	31.8	0.1	0.4	6.0	7.7	0.0	0.2	14.4	1.3	1.3	3.4	1.8	4.4	0.1	0.0	0.2	6.0	7.5	0.9	0.8	34.6	0.2	0.2	26.7	0.1	0.5	0.1	0.1	20.9	0.3	0.1	0.2	1.2	0.1	14.6	0.6	0.2	9.2	12.2	11.1	10.7	11.3	12.7	7.8	13.7	9.2	11.2	14.6
HNRNPLL	HNRPLL	ENSG00000143889	"Heterogeneous nuclear ribonucleoprotein L like"	Q8WVV9	2	38561978-38603586	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046084	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA046084: AB_10960895"	"unprognostic (2.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-2)"	16.6	19.5	14.9	13.3	16.2	47.3	20.0	22.1	17.5	18.2	16.4	10.8	17.0	16.2	21.9	19.4	14.4	17.6	16.5	14.3	17.8	11.8	12.5	11.6	17.6	12.1	13.2	19.2	19.9	16.8	18.8	16.4	13.8	10.9	16.8	13.0	13.5	14.0	22.8	13.1	12.0	13.6	14.2	12.8	12.0	16.3	24.8	12.4	40.0	19.2	11.5	11.5	20.8	26.4	1.0	6.9	5.3	3.6	3.6	21.7	3.5	16.4	7.7	22.7	13.3	11.0	10.4	14.1	15.6	12.8	13.6	11.5	8.7	9.6	0.2	14.0	13.9	10.5	14.2	11.7	14.1	24.5	12.4	12.0	14.5	21.9	10.4	22.4	12.4	8.2	9.3	11.3	12.6	14.2	20.4	37.3	16.0	7.7	24.4	12.2	22.8	14.2	4.8	15.9	8.1	11.7	21.7	15.5	17.4	13.7	12.1	11.4	10.1	9.7	14.7	10.2	15.4	11.2	12.7	20.5	20.4	0.1	8.8	5.5	12.4	5.3	3.6	5.1	6.2	1.8	11.0	0.2	15.1	11.6	6.9	1.0	4.6	2.9	2.5	3.6	0.7	0.1	21.7	3.5	14.9	16.2	22.1	17.5	17.8	11.8	13.2	19.2	10.9	12.4
HOMER1	"HOMER-1B, SYN47, Ves-1"	ENSG00000152413	"Homer scaffolding protein 1"	Q86YM7	5	79372636-79514217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9;skeletal muscle: 28.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004437, HPA036521, HPA036522"	Enhanced	Supported	Approved	Cytosol				Cytosol		"CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171"	"unprognostic (2.80e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.83e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.86e-3)"	3.0	1.6	11.3	2.4	19.7	0.6	2.7	8.4	28.9	4.4	1.6	1.2	0.0	1.0	6.8	4.5	4.7	2.5	6.9	19.1	8.5	4.2	5.9	2.0	5.1	1.3	2.9	13.3	4.7	2.4	4.5	3.6	5.3	5.3	2.0	1.3	2.1	1.9	2.1	28.0	2.6	1.2	4.7	2.2	1.1	2.1	5.1	3.5	1.7	14.4	4.8	1.7	5.0	2.2	2.0	0.6	0.2	0.0	0.4	2.3	0.5	8.4	5.9	8.8	14.0	3.4	2.2	20.4	5.4	4.3	5.5	5.9	9.2	6.0	0.1	16.5	4.6	4.6	10.9	14.6	9.5	1.2	8.6	10.2	2.5	9.1	5.5	4.7	3.3	3.6	9.5	4.9	13.8	2.5	12.4	5.6	7.1	11.9	20.0	3.3	14.9	5.0	13.1	14.5	12.9	5.8	13.2	9.0	5.4	10.2	7.3	5.4	10.0	4.2	0.4	4.1	10.3	4.9	9.5	2.7	6.1	5.0	11.6	1.9	7.8	0.0	0.0	0.1	2.3	0.0	1.3	2.0	0.9	0.7	0.0	1.6	0.5	1.7	0.2	0.4	0.0	0.6	0.0	0.5	11.3	19.7	8.4	18.8	8.5	4.2	2.9	13.3	5.3	3.5
HOMER2	"CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2"	ENSG00000103942	"Homer scaffolding protein 2"	Q9NSB8	15	82836946-82986153	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 80.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 21.1;Karpas-707: 37.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040134, CAB079014"	Uncertain	Supported	Supported	Cytosol				Cytosol		"CAB079014: , HPA040134: AB_10795272"	"unprognostic (7.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.75e-4)"	"unprognostic (3.31e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.16e-4)"	"unprognostic (2.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.45e-3)"	0.7	2.9	3.9	0.5	3.8	1.6	9.9	5.1	6.5	8.9	1.4	4.6	2.7	3.2	3.4	13.0	8.0	9.6	12.9	12.5	5.0	3.1	2.8	19.4	2.5	1.0	2.5	4.2	1.7	80.9	2.7	4.5	0.4	13.2	21.8	0.6	12.7	34.5	2.0	36.0	15.9	0.6	0.7	5.4	2.3	17.8	2.3	2.0	0.2	13.4	14.2	5.0	0.8	4.3	1.4	4.1	1.6	0.6	0.4	1.1	1.0	6.4	2.7	2.9	7.6	0.0	0.0	0.4	0.4	0.0	0.7	0.2	0.5	4.6	0.0	3.6	3.3	3.6	21.1	9.9	0.5	17.5	13.4	4.1	0.1	3.2	0.2	0.1	13.3	0.7	15.2	0.2	0.8	0.0	0.1	37.4	2.8	18.8	1.2	0.4	4.6	2.0	0.8	4.6	2.2	10.2	7.9	20.7	5.3	7.4	5.7	6.9	6.9	1.4	0.1	7.0	13.0	0.5	5.9	4.8	2.2	0.7	11.9	0.1	2.5	0.3	0.6	1.5	0.4	0.5	0.3	0.7	0.8	0.2	4.1	1.4	0.6	0.4	1.6	0.4	0.3	1.8	1.1	1.0	3.9	3.8	5.1	6.5	5.0	3.1	2.5	4.2	13.2	2.0
HOMER3	HOMER-3	ENSG00000051128	"Homer scaffolding protein 3"	Q9NSC5	19	18929201-18941261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 61.2;THP-1: 73.6;U-266/84: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 14.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.1;monocytes: 14.7"	"Region enriched"	"Detected in many"	6	"cerebellum: 212.2"	"Low region specificity"	"Detected in all"			"CAB032656, HPA040999, CAB079015"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"				Cytosol	"Plasma membrane, Cytoplasmic bodies"	"CAB032656: AB_2120801, CAB079015: , HPA040999: "	"unprognostic (3.41e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (4.24e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (4.93e-5)"	"unprognostic (1.07e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	11.4	8.3	11.1	6.5	16.0	12.4	31.0	42.3	12.2	8.7	6.7	17.6	2.1	4.9	8.2	5.2	7.6	4.8	10.9	11.9	15.8	9.0	21.2	4.1	7.0	5.5	19.4	7.2	8.2	5.3	13.6	2.4	9.7	15.5	8.1	4.5	15.4	8.4	7.0	49.2	10.9	5.5	7.6	24.2	64.8	6.5	3.4	14.6	2.2	19.6	7.8	3.3	12.3	16.8	2.4	1.2	5.1	14.7	0.0	0.7	3.6	19.3	5.0	9.6	7.9	8.9	9.0	4.7	19.2	17.0	19.3	9.8	2.5	7.4	0.1	9.1	21.5	12.1	3.3	24.9	10.8	0.6	2.0	0.0	1.6	4.7	8.3	3.7	0.3	7.3	16.1	10.7	14.5	23.4	0.5	5.1	14.0	5.2	0.3	61.2	4.9	20.7	9.5	2.9	9.0	6.9	5.0	0.0	8.1	4.7	5.6	13.5	2.5	73.6	18.6	17.2	7.7	20.7	23.0	49.9	63.2	16.1	27.1	47.3	12.4	0.1	14.7	2.6	0.1	5.1	0.0	2.4	0.7	0.3	1.2	1.7	0.1	0.0	5.1	0.0	1.4	0.2	0.7	3.6	11.1	16.0	42.3	12.2	15.8	9.0	19.4	7.2	15.5	14.6
HOOK2	HK2	ENSG00000095066	"Hook microtubule tethering protein 2"	Q96ED9	19	12763003-12872740	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4;RT4: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043519, HPA050351"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA043519: , HPA050351: "	"unprognostic (4.26e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (7.59e-5)"	"prognostic favourable (3.28e-4)"	"unprognostic (3.27e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-2)"	18.6	6.6	14.9	5.7	13.5	1.9	15.5	21.9	17.5	8.5	14.5	4.2	32.7	25.5	8.0	24.9	18.5	8.9	16.8	15.5	12.2	6.9	16.0	15.0	8.1	4.1	10.2	8.4	8.7	31.9	28.4	49.1	11.3	12.9	17.3	12.2	6.6	22.9	35.9	29.8	26.4	27.1	5.3	10.8	6.0	18.1	7.4	12.1	3.5	33.5	15.8	11.4	10.1	12.0	3.9	3.7	2.2	2.7	2.6	6.8	2.4	15.3	3.8	4.7	3.2	5.0	4.8	16.6	4.6	2.2	2.6	3.4	12.8	18.3	2.8	8.7	4.6	20.4	4.8	14.0	2.7	8.8	3.4	3.0	7.1	4.3	2.9	1.5	4.8	5.8	13.4	3.7	5.4	1.5	5.0	2.5	5.3	34.4	1.6	2.9	2.2	4.0	5.1	2.8	7.0	5.5	39.8	12.5	6.0	3.3	10.4	3.1	15.1	4.0	3.1	6.0	3.5	8.8	1.7	9.7	9.5	1.8	5.6	5.8	3.9	0.8	1.6	0.0	3.4	2.7	2.1	3.9	4.0	1.5	3.7	3.1	6.8	4.4	2.2	2.6	1.6	1.3	1.0	2.4	14.9	13.5	21.9	17.5	12.2	6.9	10.2	8.4	12.9	12.1
HOOK3	HK3	ENSG00000168172	"Hook microtubule tethering protein 3"	Q86VS8	8	42896932-43030539	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024756	Approved		Supported	"Golgi apparatus,Centriolar satellite,Cytosol"				"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA024756: AB_1850913"	"unprognostic (1.84e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.73e-1)"	"unprognostic (8.61e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.13e-1)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.12e-2)"	15.5	9.3	11.3	10.1	15.1	13.1	16.3	16.0	19.2	13.5	11.3	10.3	14.1	10.2	13.7	12.0	14.8	11.7	20.0	9.5	11.2	11.3	9.9	10.7	14.6	10.3	14.7	11.7	13.4	13.9	13.4	14.4	12.0	13.1	17.7	10.9	6.8	17.1	15.2	24.1	11.0	11.9	19.3	17.5	11.6	12.8	14.5	14.3	7.4	37.5	8.9	10.1	19.2	17.6	1.8	3.8	10.2	3.2	2.0	2.0	1.8	7.3	7.3	17.8	9.6	13.2	11.7	6.8	9.3	7.8	7.8	7.3	9.6	8.6	9.1	9.6	12.4	4.1	14.7	6.3	12.7	6.2	4.2	17.2	6.0	6.6	7.4	1.8	10.2	9.5	4.6	10.5	9.1	11.2	9.4	10.7	9.4	1.8	13.9	3.4	6.4	2.2	8.2	18.6	2.3	5.8	10.9	4.5	7.2	10.6	4.5	4.9	8.2	6.2	20.0	11.7	9.2	14.1	5.9	10.6	11.5	12.0	9.9	6.6	17.3	10.2	3.2	3.1	2.0	3.2	0.8	1.6	1.9	1.5	3.8	1.8	1.1	1.5	3.8	2.0	3.1	2.4	1.4	1.8	11.3	15.1	16.0	13.1	11.2	11.3	14.7	11.7	13.1	14.3
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.8;skin 1: 154.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.1;HUVEC TERT2: 29.0;RT4: 21.6;TIME: 32.8;U-266/70: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 68.6;NK-cell: 90.9"	"Group enriched"	"Detected in many"	14	"NK-cells: 90.9;T-cells: 68.6"									"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	1.7	5.0	24.1	5.2	13.0	2.0	23.1	4.0	28.2	26.4	3.1	3.6	3.0	3.4	2.5	106.2	90.3	2.3	6.7	5.7	20.0	8.2	2.3	0.7	112.4	3.4	12.1	12.9	1.4	1.1	2.3	1.2	128.8	15.0	4.5	1.6	1.0	19.0	12.9	3.4	154.6	3.4	20.9	11.2	2.3	3.2	9.6	1.9	1.8	65.9	93.2	66.3	6.8	37.8	5.6	0.4	1.5	0.5	90.9	68.6	38.2	0.0	0.0	0.0	0.0	2.2	7.1	2.6	0.0	0.0	0.6	0.4	0.0	0.0	5.3	0.3	0.1	0.9	0.6	0.0	0.8	13.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.3	1.6	0.0	29.0	0.0	0.2	1.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	21.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.1	0.2	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.6	0.1	0.2	68.6	0.4	37.4	5.6	17.1	30.1	0.3	4.3	3.1	21.0	1.5	90.9	0.5	0.4	1.0	38.2	24.1	13.0	4.0	28.2	20.0	8.2	12.1	12.9	15.0	1.9
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593961	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 21.1;RPTEC TERT1: 15.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enriched"	"Detected in single"	33	"pons and medulla: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	90	"pons and medulla: 24.0"	"Region enriched"	"Detected in single"	100	"pons and medulla: 14.7"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA043851: , HPA074454: "	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favourable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favourable (8.59e-5)"	3.4	3.1	0.2	2.1	0.2	0.0	5.0	0.2	0.7	5.4	10.5	0.2	25.9	1.5	2.2	18.5	0.6	7.2	0.2	0.7	0.2	0.0	16.0	0.4	5.2	0.8	0.2	0.2	1.9	0.5	0.9	0.2	1.2	25.4	1.3	4.7	0.2	0.6	27.6	0.2	0.5	9.5	1.6	22.5	2.0	4.3	0.7	0.2	0.2	0.7	0.2	0.2	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.7	0.0	2.4	2.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.1	2.6	0.0	0.2	0.0	0.0	0.0	21.1	0.9	5.4	0.0	4.1	0.0	1.2	1.3	0.0	2.8	0.0	1.4	1.6	0.0	3.2	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	15.7	1.6	0.0	0.0	0.1	0.0	2.3	0.4	0.0	5.2	0.7	2.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	25.4	0.2
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607227-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 62.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 30.8;RPTEC TERT1: 24.5;SK-MEL-30: 29.2;WM-115: 21.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	45	"pons and medulla: 6.0"	"Region enriched"	"Detected in single"	13	"pons and medulla: 1.5"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favourable (2.39e-4)"	8.3	8.3	0.0	7.3	0.3	0.1	17.2	0.1	0.6	10.0	8.1	0.1	24.1	0.5	4.1	62.3	0.8	4.2	0.3	1.1	0.0	0.0	23.7	0.8	1.7	2.4	0.1	0.3	2.3	0.6	0.4	0.5	4.1	4.1	5.2	7.0	0.1	0.1	22.1	2.4	2.2	12.4	3.5	20.1	2.2	4.6	3.0	0.2	0.1	0.5	0.1	0.6	5.8	15.1	2.2	1.8	0.0	0.0	2.0	4.7	0.5	17.1	7.5	0.0	0.2	5.4	8.1	0.0	0.0	0.0	0.1	0.3	11.4	0.3	0.3	30.8	7.2	2.5	0.0	0.0	0.0	7.9	5.5	2.6	5.9	0.0	4.5	0.0	5.5	5.3	2.3	5.3	0.0	16.2	2.8	0.1	17.0	4.4	0.3	0.1	0.0	0.0	0.0	14.6	2.0	24.5	5.7	0.0	0.0	5.8	0.0	29.2	1.4	1.7	13.9	0.0	9.4	7.6	13.2	0.9	2.2	0.0	0.1	0.0	21.5	0.0	0.0	0.0	3.8	0.0	1.9	1.9	0.7	2.1	0.0	2.2	0.0	1.4	0.0	2.0	0.0	1.8	4.7	0.5	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.3	4.1	0.2
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 7.0;skin 1: 9.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 23.0;BJ hTERT+: 11.6;HaCaT: 10.1;T-47d: 18.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	4.8	0.0	0.1	0.1	0.1	0.0	1.2	0.1	0.1	2.5	0.1	0.1	0.1	0.8	2.0	1.0	0.1	0.7	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.7	0.1	0.1	0.5	0.1	0.0	0.1	0.6	0.3	0.5	0.0	0.1	0.1	2.0	7.0	9.2	2.7	0.4	0.1	0.1	0.0	1.6	0.1	0.5	0.1	0.1	0.1	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.7	0.0	23.0	2.2	3.3	0.0	3.3	11.6	4.9	3.6	0.2	0.9	0.0	0.2	3.1	10.1	4.4	0.0	2.2	0.6	0.1	0.1	7.5	0.0	0.0	0.1	0.1	0.6	0.9	0.0	0.3	0.0	0.9	0.0	3.1	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.8	0.0	0.1	2.1	5.2	2.0	18.1	0.0	0.0	0.0	4.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 31.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.3;fHDF/TERT166: 18.6;HDLM-2: 31.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	17	"pons and medulla: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	23	"pons and medulla: 1.5"	"Not detected"	"Not detected"			HPA054981			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054981: "	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	10.9	11.2	0.4	1.2	0.4	0.0	16.3	0.4	0.4	0.7	1.9	0.6	0.4	0.0	3.9	14.8	3.1	13.5	0.4	2.0	0.4	0.0	11.3	0.4	0.9	3.0	0.4	0.4	31.2	0.4	0.0	0.4	4.0	7.0	0.8	0.0	0.4	0.4	0.4	11.0	7.6	8.8	6.1	8.1	1.0	0.3	3.3	0.4	0.4	0.6	0.8	0.4	0.7	2.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.4	1.7	0.0	37.3	13.7	13.0	0.3	1.9	1.9	3.1	2.8	1.5	2.8	1.1	2.5	18.6	4.2	1.4	0.2	2.8	31.2	10.8	1.9	4.8	0.0	1.5	0.2	4.7	12.3	2.0	6.1	2.2	0.1	1.3	0.0	10.8	0.5	0.0	1.2	0.0	1.6	0.0	1.4	0.0	9.4	0.1	0.0	4.6	2.8	2.7	7.6	6.6	0.5	0.0	3.9	8.4	4.2	2.6	0.3	0.3	0.0	1.4	0.3	7.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	7.0	0.4
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119942	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 21.7;endometrium 1: 38.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.1;HEK 293: 25.4;RPTEC TERT1: 18.2;SCLC-21H: 7.1;SiHa: 10.6;U-251 MG: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA065871: "	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	0.9	0.0	0.1	1.2	0.1	0.0	21.7	0.1	0.1	10.3	9.5	0.1	1.4	0.0	38.2	2.8	1.2	1.6	0.6	0.6	0.1	0.0	16.3	0.1	0.8	0.2	0.1	0.1	2.7	0.1	0.0	0.1	3.0	0.1	9.5	4.3	0.1	0.5	5.1	0.2	1.0	0.1	14.2	0.1	0.1	0.0	3.9	0.1	0.2	0.3	0.4	1.4	2.1	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	18.2	0.0	7.1	1.9	10.6	0.0	0.0	0.0	0.0	1.6	0.0	1.3	0.5	8.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HPCAL4	"DKFZp761G122, HLP4"	ENSG00000116983	"Hippocalcin like 4"	Q9UM19	1	39678648-39691689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 80.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.9;SH-SY5Y: 13.1;SK-MEL-30: 4.1;U-2 OS: 2.8;U-266/70: 3.4;U-266/84: 4.2"	"Group enriched"	"Detected in some"	11	"glioma: 5.4;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6;naive CD4 T-cell: 5.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 5.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 336.7;basal ganglia: 201.9;cerebral cortex: 348.1;hippocampal formation: 324.0;olfactory region: 266.4"	HPA053808			Approved	Cytosol				Cytosol		"HPA053808: "	"unprognostic (2.62e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.56e-4)"	"unprognostic (4.73e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.63e-1)"	1.2	10.2	35.8	1.8	46.0	1.5	1.2	31.1	80.4	1.2	1.2	3.7	0.0	1.3	1.2	1.5	5.5	1.2	1.3	1.4	28.3	17.0	3.5	1.2	1.7	1.9	7.5	32.7	3.7	4.7	1.2	0.4	1.2	6.8	1.4	1.3	0.0	1.2	1.3	2.1	1.2	1.3	1.2	4.4	1.4	1.3	4.1	3.0	0.0	1.2	0.0	1.8	1.3	0.0	0.0	0.1	0.0	0.0	0.0	5.6	1.8	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.0	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	0.0	1.2	13.1	0.4	0.0	4.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	3.4	4.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.0	5.6	1.0	0.1	0.0	5.0	1.8	0.0	0.0	0.0	0.0	3.8	1.8	35.8	46.0	31.1	40.4	28.3	17.0	7.5	32.7	6.8	3.0
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729465-169757953	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"				Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (5.63e-4)"	"prognostic favourable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	16.5	18.6	27.3	14.9	26.3	13.7	20.9	22.9	31.7	17.6	17.5	17.6	10.0	11.5	23.2	25.2	17.2	16.9	12.7	20.9	27.3	24.0	17.5	20.8	13.5	18.0	24.9	22.6	23.1	13.1	13.9	22.9	16.0	33.4	17.4	17.6	15.1	12.2	16.0	17.4	18.6	11.3	24.2	23.8	16.4	14.0	12.9	19.8	20.8	18.5	14.9	19.3	19.0	14.8	13.6	15.6	12.8	14.1	14.9	22.2	13.3	12.4	7.9	27.6	14.4	16.9	20.9	11.7	22.7	22.5	28.3	30.1	5.3	13.5	6.5	6.1	14.7	5.6	18.9	16.5	30.0	20.4	12.9	21.2	11.6	7.5	11.9	17.9	7.8	13.5	16.8	18.2	5.6	24.5	15.9	25.5	24.6	10.1	37.5	15.6	11.2	10.3	16.6	13.1	7.8	16.1	8.2	6.6	24.6	15.0	6.6	20.5	13.0	16.1	11.8	9.7	15.4	22.6	20.2	12.2	18.1	19.4	26.8	17.5	15.4	8.9	12.3	12.8	18.5	14.1	21.9	13.6	21.5	22.2	15.6	11.1	21.2	21.7	3.3	14.9	13.1	10.7	22.0	13.3	27.3	26.3	22.9	31.7	27.3	24.0	24.9	22.6	33.4	19.8
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell line enhanced"	"Detected in some"		"A549: 27.3;ASC diff: 16.9;HEL: 59.7;RT4: 92.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favourable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.3	0.0	0.0	16.9	1.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	59.7	2.0	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.4	2.8	0.0	0.2	5.6	92.8	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.8"	"Group enriched"	"Detected in some"	8	"HEL: 31.6;HMC-1: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol			170000	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	14.3	2.9	8.0	1.6	12.1	1.6	5.8	2.0	7.7	5.4	6.9	4.4	0.2	7.5	4.7	3.3	4.1	2.5	9.3	3.0	8.4	3.6	2.5	1.3	12.7	0.9	9.6	2.4	1.5	1.8	1.7	1.5	24.8	9.0	6.4	7.5	2.9	3.8	2.2	1.4	5.8	8.6	5.8	14.6	1.4	4.4	1.8	12.1	1.5	1.2	2.8	1.5	4.5	3.5	0.0	0.1	15.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	2.4	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	8.0	12.1	2.0	7.7	8.4	3.6	9.6	2.4	9.0	12.1
HPRT1	"HGPRT, HPRT"	ENSG00000165704	"Hypoxanthine phosphoribosyltransferase 1"	P00492	X	134460153-134520513	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets, Gout"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006360, CAB012200"	Enhanced		Supported	Cytosol			15000000	Cytosol		"CAB012200: AB_297217, HPA006360: AB_1079082"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (1.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	7.9	14.9	31.0	12.6	30.2	25.3	11.3	24.2	49.8	7.5	13.7	5.8	9.8	11.0	7.9	36.2	10.3	9.4	8.1	12.8	27.6	37.3	18.4	24.7	7.3	15.9	23.5	28.9	9.8	20.2	9.9	18.6	8.8	34.4	8.8	13.2	9.7	7.1	9.5	10.7	8.0	14.2	9.5	9.8	8.7	17.1	39.7	4.9	13.7	12.3	8.6	15.9	10.8	7.5	13.5	19.7	10.1	18.5	19.9	29.3	12.6	31.0	15.0	4.2	8.7	9.5	13.7	12.8	16.6	16.0	21.3	28.0	13.4	19.9	35.2	37.9	10.8	19.1	27.4	22.8	36.8	29.2	51.3	19.1	21.3	13.6	9.4	41.0	17.6	10.1	8.6	18.9	30.3	24.5	14.6	0.9	16.6	31.7	31.6	35.6	8.7	40.3	19.0	21.6	36.1	25.6	15.1	26.9	14.7	12.0	9.7	11.3	8.3	17.2	12.1	14.5	10.9	41.4	41.2	13.4	23.2	0.2	17.8	45.6	7.9	2.2	11.6	10.1	11.6	18.5	16.7	12.3	17.3	15.3	19.7	13.5	14.3	15.1	2.9	19.9	17.2	8.2	29.3	12.6	31.0	30.2	24.2	49.8	27.6	37.3	23.5	28.9	34.4	4.9
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: , HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	12.3	11.4	25.2	9.1	34.5	5.0	16.2	16.1	25.3	7.9	9.5	8.1	10.8	8.9	6.2	9.2	22.3	8.3	10.9	28.7	22.2	22.4	8.2	6.5	8.9	8.0	23.2	12.9	7.7	9.7	11.7	10.3	10.1	15.0	10.0	6.2	8.2	10.1	12.7	51.8	32.0	8.2	8.4	17.0	6.5	7.2	6.1	11.0	5.9	8.1	24.5	9.3	9.9	19.8	2.1	1.1	0.7	4.6	0.1	2.0	0.3	21.8	19.4	9.3	8.3	5.8	4.1	12.0	10.9	5.8	17.1	14.6	9.8	8.7	8.4	3.4	14.8	17.4	9.9	26.5	4.8	6.9	22.1	4.3	7.8	8.5	8.8	3.4	3.3	6.2	29.6	9.2	10.0	8.5	8.8	12.3	9.6	17.9	12.7	12.1	9.4	19.3	10.2	11.8	7.5	9.6	5.4	36.3	14.4	10.1	18.1	7.8	14.8	6.7	13.5	15.3	12.1	5.6	14.0	4.6	6.1	6.5	14.4	6.3	14.3	0.0	0.6	0.7	1.4	1.2	1.6	0.8	1.4	1.3	0.7	2.1	2.0	0.6	0.0	0.1	4.6	1.1	2.0	0.3	25.2	34.5	16.1	21.1	22.2	22.4	23.2	12.9	15.0	11.0
HRASLS	"H-REV107, HRASLS1"	ENSG00000127252	"HRAS like suppressor"		3	193241125-193277738	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"skeletal muscle: 40.9;testis: 42.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.5;NTERA-2: 7.4;PC-3: 16.5;RH-30: 7.2;SCLC-21H: 15.0;U-2 OS: 9.1;U-251 MG: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"				"Focal adhesion sites"	Cytosol	"HPA051179: "	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favourable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.6	1.1	1.8	0.2	3.1	0.1	1.0	0.6	3.3	0.5	0.6	1.7	0.0	0.1	0.6	3.1	2.4	0.5	0.2	4.3	2.0	1.1	0.6	0.6	0.5	0.1	1.5	2.1	0.6	0.8	0.5	0.7	0.1	2.4	0.5	0.1	3.1	6.1	0.5	40.9	1.7	0.6	0.7	0.6	0.6	0.6	42.1	1.7	0.2	3.7	6.2	0.2	0.5	0.6	0.0	0.2	1.7	0.1	0.0	0.0	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.3	0.0	0.1	0.0	0.1	0.0	0.0	8.5	0.2	0.4	0.0	3.8	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.4	16.5	0.0	7.2	0.0	2.4	0.0	15.0	2.8	1.0	2.2	0.0	4.3	0.0	0.1	0.0	9.1	0.0	11.5	0.0	0.0	0.0	4.7	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.2	1.8	3.1	0.6	3.3	2.0	1.1	1.5	2.1	2.4	1.7
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.4;hTEC/SVTERT24-B: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	9.1	4.4	7.3	4.6	4.4	0.2	9.6	0.5	10.6	8.0	13.5	1.3	2.4	3.8	6.2	7.2	5.7	10.6	9.9	7.0	5.1	4.0	3.3	1.1	8.2	1.8	2.2	2.1	8.7	2.1	1.7	1.2	5.5	3.2	7.2	7.2	2.0	3.4	6.1	3.0	8.0	10.5	9.2	8.6	1.4	3.3	2.4	2.0	0.1	2.5	7.2	3.1	11.2	16.2	0.1	0.3	1.2	0.2	0.1	3.5	0.1	1.5	3.4	0.0	0.0	1.6	17.4	2.4	2.6	8.7	7.8	5.3	0.6	12.5	0.0	7.8	6.0	9.8	0.0	3.5	10.6	5.5	0.0	0.8	5.6	0.0	5.2	2.4	1.4	6.0	2.2	17.5	6.2	10.8	0.0	0.0	3.4	0.0	0.0	1.1	0.0	3.2	0.2	0.9	0.3	13.9	2.0	0.1	0.0	3.7	2.7	0.0	0.0	1.9	16.1	8.8	5.5	8.9	13.0	0.0	0.9	0.0	13.4	2.2	7.5	0.4	0.2	0.0	0.1	0.2	0.0	0.0	1.3	0.5	0.3	0.1	0.1	0.1	1.2	0.1	0.0	0.1	3.5	0.1	7.3	4.4	0.5	8.4	5.1	4.0	2.2	2.1	3.2	2.0
HS1BP3	"FLJ14249, HS1-BP3"	ENSG00000118960	"HCLS1 binding protein 3"	Q53T59	2	20560448-20651089	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035050	Approved		Approved	Nucleoli,Cytosol			32000	Nucleoli	Cytosol	"HPA035050: AB_10601816"	"unprognostic (4.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.45e-3)"	"prognostic unfavourable (2.97e-5)"	"unprognostic (2.06e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.00e-2)"	"prognostic favourable (2.30e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-1)"	17.9	23.1	10.4	8.8	15.7	10.7	11.8	6.7	17.6	17.6	22.6	21.3	14.3	11.7	17.6	18.6	22.6	13.9	28.4	17.5	11.0	9.1	18.5	47.8	14.2	11.7	16.7	9.4	14.8	13.9	10.6	14.3	22.3	13.5	20.3	11.7	17.0	12.9	17.3	9.6	17.0	16.0	27.3	13.8	14.5	16.4	9.7	14.1	6.6	18.5	8.0	9.9	20.8	17.1	6.0	8.0	14.6	13.3	2.9	5.3	6.1	8.8	10.3	5.2	6.3	27.7	18.6	10.4	3.4	15.7	8.0	10.6	8.0	10.7	5.9	2.7	4.9	5.6	10.3	10.6	3.9	7.6	8.5	3.2	5.2	26.7	26.1	2.3	13.9	19.7	24.9	9.1	16.9	15.2	2.0	12.8	9.1	7.6	1.0	4.0	4.3	7.5	5.7	10.6	5.8	17.8	10.7	4.9	7.6	2.4	10.5	20.1	6.6	4.9	9.8	8.0	8.6	12.2	5.1	9.2	10.2	5.4	17.2	11.3	8.4	11.4	11.3	11.0	5.3	11.2	3.7	6.0	3.2	4.0	8.0	4.0	2.7	2.8	14.6	2.9	13.3	3.0	2.9	6.1	10.4	15.7	6.7	17.6	11.0	9.1	16.7	9.4	13.5	14.1
HSCB	"DNAJC20, HSC20, Jac1"	ENSG00000100209	"HscB mitochondrial iron-sulfur cluster cochaperone"	Q8IWL3	22	28742031-28757515	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018447, HPA031518"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"HPA018447: AB_1853867, HPA031518: "	"unprognostic (8.19e-3)"	"unprognostic (6.48e-2)"	"unprognostic (9.62e-3)"	"prognostic favourable (3.78e-4)"	"unprognostic (3.30e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.38e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (8.38e-4)"	9.6	18.8	13.1	9.2	13.9	4.9	12.4	13.7	12.9	14.1	11.6	9.1	20.3	13.7	11.5	8.8	11.8	10.4	11.4	9.6	12.3	8.3	12.9	29.5	7.3	15.5	15.8	9.0	16.5	15.2	6.2	16.1	8.7	10.6	15.9	7.7	8.2	28.2	17.5	14.6	9.2	10.0	8.9	12.2	10.9	12.8	6.0	13.2	6.9	14.4	8.1	10.3	15.0	10.5	12.9	11.3	7.7	14.4	9.7	8.5	5.8	9.3	6.0	2.5	3.8	4.6	11.8	4.8	6.9	9.7	10.2	6.3	2.6	3.4	10.5	3.3	3.8	6.6	4.8	4.5	4.9	10.0	19.4	3.6	4.7	7.4	9.8	6.6	5.4	7.9	9.9	5.7	9.0	7.8	5.6	9.3	4.0	13.5	3.0	6.1	6.0	14.8	5.9	7.7	11.9	11.1	2.7	8.5	7.7	3.8	14.6	18.4	6.0	4.0	4.1	14.1	7.3	13.3	6.2	13.1	10.6	9.1	9.8	4.9	9.3	7.7	7.9	3.6	6.3	14.4	7.6	12.9	6.4	7.4	11.3	9.9	7.0	8.5	0.4	9.7	11.0	5.9	4.8	5.8	13.1	13.9	13.7	12.9	12.3	8.3	15.8	9.0	10.6	13.2
HSD17B1	"EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1"	ENSG00000108786	"Hydroxysteroid 17-beta dehydrogenase 1"	P14061	17	42549214-42555213	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 217.6"	"Cell line enriched"	"Detected in many"	8	"BEWO: 87.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA021032, HPA065296"	Enhanced		Supported	Cytosol				Cytosol		"HPA021032: AB_1844345, HPA065296: AB_2685457"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.88e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-2)"	"unprognostic (5.09e-1)"	"unprognostic (4.98e-1)"	"unprognostic (1.32e-2)"	2.8	1.5	2.0	1.7	2.1	1.1	1.8	2.7	3.1	1.3	1.3	1.3	1.3	1.9	1.5	1.3	4.3	1.4	1.3	1.4	2.4	1.4	1.4	1.3	1.3	1.6	2.4	1.3	5.8	2.6	0.2	1.4	217.6	1.3	1.5	0.2	1.3	2.9	1.3	3.5	4.1	1.9	1.3	1.9	2.1	2.0	2.3	1.3	1.3	1.8	1.3	1.3	1.3	1.8	6.0	5.5	7.5	8.6	6.1	5.4	5.5	1.6	1.7	0.9	4.5	0.6	0.1	87.6	1.2	0.0	0.0	0.0	1.0	0.9	0.0	1.1	0.0	2.6	0.1	0.7	0.0	2.4	2.8	1.2	1.1	1.5	0.2	1.0	1.4	0.2	2.5	0.1	0.5	0.0	1.6	0.3	0.0	1.5	1.3	1.1	0.4	0.8	1.3	1.1	0.7	0.1	1.3	1.2	1.8	0.7	8.9	1.4	10.7	0.8	1.4	1.4	1.7	0.9	0.8	2.5	1.4	0.6	0.5	0.9	1.0	3.6	7.6	7.5	4.9	8.6	5.3	5.6	5.4	5.1	5.5	6.0	5.1	4.4	7.2	6.1	5.3	4.3	3.7	5.5	2.0	2.1	2.7	1.5	2.4	1.4	2.4	1.3	1.3	1.3
HSF1	HSTF1	ENSG00000185122	"Heat shock transcription factor 1"	Q00613	8	144291591-144314722	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004239, HPA008888"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004239: AB_627753, HPA008888: AB_1079088"	"unprognostic (7.08e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.07e-2)"	"prognostic unfavourable (8.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (5.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	24.7	22.9	17.4	21.0	20.9	20.8	30.8	24.4	23.6	21.3	26.9	18.3	17.7	18.9	23.3	16.7	25.5	28.5	22.9	42.8	17.0	17.5	21.2	19.5	20.3	23.6	17.4	15.9	32.4	36.8	25.8	21.8	22.8	17.8	26.7	15.2	20.7	26.4	24.6	55.2	20.3	17.8	35.1	14.4	20.3	23.6	42.6	17.8	23.2	29.9	24.2	19.8	30.3	33.9	16.9	20.3	20.3	24.2	12.9	18.4	14.2	14.6	19.9	8.6	7.3	14.5	13.6	14.3	11.0	10.0	10.9	9.5	13.3	12.9	16.9	16.2	15.2	10.7	13.1	15.8	7.0	10.7	15.1	21.2	20.4	18.1	22.9	6.1	16.4	13.2	14.9	15.3	28.3	14.7	14.0	10.2	10.9	29.7	20.6	9.4	11.0	57.4	13.4	7.5	21.4	7.8	14.9	13.0	10.5	16.8	13.5	19.4	15.2	12.6	14.8	11.2	25.4	17.6	18.0	7.1	5.4	14.5	16.0	11.5	10.7	10.6	18.9	20.3	14.5	19.9	15.2	16.9	15.7	18.4	20.3	15.5	15.6	13.9	8.1	12.9	24.2	10.3	18.1	14.2	17.4	20.9	24.4	23.6	17.0	17.5	17.4	15.9	17.8	17.8
HSF2BP		ENSG00000160207	"Heat shock transcription factor 2 binding protein"	O75031	21	43529192-43659493	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 28.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 14.9;hTCEpi: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.5;NK-cells: 1.5;T-cells: 2.8"	"Low region specificity"	"Detected in some"							"HPA031724, HPA075775"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA031724: AB_10601022, HPA075775: "	"unprognostic (1.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.36e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.77e-4)"	"unprognostic (6.00e-2)"	0.7	0.8	1.3	0.6	3.1	0.5	1.1	1.4	4.1	0.9	0.6	3.5	1.8	0.6	1.1	1.1	0.8	1.2	0.7	0.7	1.3	1.5	0.8	0.6	0.6	0.7	2.3	3.0	1.4	0.6	1.2	2.3	1.6	2.7	0.8	0.6	2.6	1.2	1.4	0.5	0.8	0.7	0.7	2.0	0.5	0.7	28.5	1.6	1.0	1.0	0.0	0.6	0.8	0.8	1.5	0.2	0.0	0.1	1.5	2.8	0.8	5.2	1.1	1.4	0.6	0.3	1.4	1.3	1.8	1.1	1.9	1.7	7.1	5.2	4.0	2.9	1.1	2.1	0.7	14.9	0.6	1.0	1.3	0.7	2.2	0.4	1.8	1.7	0.5	0.9	9.8	0.8	4.6	0.5	1.5	1.3	4.6	0.9	2.3	1.6	4.6	2.2	3.4	1.4	0.5	2.3	1.0	1.5	1.1	3.9	1.9	2.1	2.1	1.9	3.0	1.0	3.6	0.2	2.7	1.4	1.0	3.2	1.0	3.5	2.6	0.0	0.1	0.0	0.2	0.0	1.6	1.2	0.5	1.4	0.2	1.5	2.7	2.8	0.0	1.5	0.1	0.2	0.0	0.8	1.3	3.1	1.4	3.6	1.3	1.5	2.3	3.0	2.7	1.6
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.4;lymphoid tissue: 33.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 13.4;HMC-1: 18.5;NB-4: 43.6;RPMI-8226: 19.6;U-937: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"basophil: 47.4"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"				"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (3.47e-5)"	1.2	1.1	1.2	31.5	1.1	19.2	1.2	1.1	1.1	1.4	8.9	0.0	5.2	5.5	1.1	6.2	2.0	1.5	10.3	1.2	1.1	1.1	1.3	1.5	6.0	16.7	1.0	0.0	1.1	4.8	0.9	3.7	2.3	0.3	2.2	4.0	1.0	8.8	5.2	1.1	1.1	12.1	0.7	1.1	21.8	5.4	1.1	0.0	8.5	1.7	2.4	33.8	4.7	1.1	14.5	6.0	47.4	8.4	19.0	4.3	3.6	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	6.8	12.9	0.2	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.2	0.1	0.8	0.0	13.4	18.5	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	2.8	0.0	43.6	0.0	0.0	0.9	0.0	19.6	0.1	1.8	0.0	0.0	0.0	0.4	0.1	0.1	5.0	0.0	0.0	0.0	0.0	0.0	1.9	12.6	7.1	0.0	42.8	0.0	47.4	3.7	23.0	4.3	5.0	3.9	14.5	1.9	2.8	6.0	8.6	1.8	2.3	43.7	19.0	8.4	1.8	2.9	3.6	1.2	1.1	1.1	1.1	1.1	1.1	1.0	0.0	0.3	0.0
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080738-102139699	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 519.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol			94000000	Cytosol		"CAB002058: "	"prognostic unfavourable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavourable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favourable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	50.8	75.3	96.1	46.7	106.8	64.1	118.6	81.3	113.4	51.0	47.3	50.7	43.0	31.0	40.7	55.5	40.9	94.7	61.0	70.9	99.6	113.3	75.6	62.5	51.7	48.1	134.4	58.6	53.4	40.1	94.9	121.6	67.2	143.6	63.2	53.3	23.4	57.0	57.0	65.2	35.6	38.9	51.0	139.7	35.7	41.3	84.6	132.7	53.5	91.5	34.3	59.5	54.2	519.3	30.7	46.9	31.8	29.9	57.7	63.1	21.9	86.3	118.1	75.4	52.0	45.8	38.8	100.2	96.1	46.2	117.9	66.5	71.7	81.2	106.2	90.5	61.8	95.9	216.5	94.0	215.1	80.3	71.3	82.0	67.5	91.5	22.7	122.0	63.3	36.4	40.0	75.3	27.8	65.0	113.2	54.6	106.6	116.8	130.4	56.1	78.4	111.7	125.8	102.5	45.8	68.4	111.7	99.4	71.7	121.5	91.5	53.6	117.6	48.7	46.0	82.5	53.4	122.6	182.5	51.7	161.1	157.1	78.1	75.4	99.4	31.8	19.9	24.0	47.8	29.9	63.1	29.6	40.5	49.0	23.9	30.7	30.1	43.5	13.5	57.7	27.5	46.9	39.2	21.9	96.1	106.8	81.3	102.7	99.6	113.3	134.4	58.6	143.6	132.7
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		62000000	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favourable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	79.9	116.1	88.0	65.9	105.0	74.6	107.8	92.1	118.2	92.3	60.4	61.7	80.9	40.6	113.3	107.6	71.6	138.4	63.8	115.0	89.0	110.5	72.0	70.7	76.2	73.8	109.7	94.4	238.4	113.9	151.6	95.3	83.6	133.7	93.5	76.4	52.7	64.8	100.3	197.1	67.9	49.0	102.1	93.9	57.5	77.3	45.9	100.2	58.3	133.8	89.8	102.5	86.2	223.4	75.9	50.5	7.2	45.7	55.7	82.5	74.9	138.6	89.0	79.1	97.1	54.3	56.9	82.8	62.7	61.5	116.1	81.8	133.0	42.5	177.7	68.0	65.2	80.9	192.3	93.3	143.7	58.8	77.8	138.3	50.4	173.8	39.3	138.0	95.8	52.5	63.2	91.2	78.8	111.1	184.5	66.3	78.9	140.0	114.9	83.3	92.2	68.2	110.9	80.8	97.5	78.5	84.4	115.8	70.8	48.7	70.6	87.9	91.8	69.1	69.6	69.3	116.0	56.6	143.1	76.8	120.4	321.0	75.3	101.5	78.9	7.2	30.2	6.8	49.3	45.7	82.5	75.9	55.2	56.4	50.5	63.2	75.2	71.3	3.7	55.7	43.3	31.4	42.6	74.9	88.0	105.0	92.1	118.2	89.0	110.5	109.7	94.4	133.7	100.2
HSPA12A	"FLJ13874, KIAA0417"	ENSG00000165868	"Heat shock protein family A (Hsp70) member 12A"	O43301	10	116671192-116850236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011273, HPA073244"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA011273: AB_1851190, HPA073244: "	"unprognostic (7.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.31e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.62e-1)"	"prognostic unfavourable (3.61e-7)"	"unprognostic (2.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.55e-4)"	21.2	24.9	15.4	4.0	21.8	1.1	7.5	10.2	47.7	7.6	6.3	6.8	3.3	2.1	9.4	8.0	5.3	9.1	5.9	6.4	17.1	15.5	23.5	1.9	2.8	2.0	17.1	17.8	23.5	3.0	4.0	17.2	4.2	23.3	4.1	4.9	7.4	3.6	9.1	4.9	9.5	2.9	8.6	8.2	3.6	2.8	8.2	8.6	0.0	6.8	1.2	1.6	4.1	6.6	0.0	0.0	3.1	0.0	0.0	0.4	0.0	2.3	8.9	0.9	7.8	9.0	6.5	0.4	4.5	9.0	2.2	1.2	8.3	0.1	0.0	2.4	5.5	5.9	5.8	0.7	7.4	0.0	3.1	0.0	3.1	8.7	1.2	0.0	0.7	2.7	3.6	6.7	0.6	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.7	0.0	0.0	2.7	0.1	33.9	0.1	2.0	11.7	2.6	2.2	3.1	1.7	0.0	0.0	2.1	3.6	11.9	4.4	0.1	0.0	0.0	3.6	0.0	1.5	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	21.8	10.2	32.4	17.1	15.5	17.1	17.8	23.3	8.6
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815464-31817946	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"breast: 216.1;vagina: 741.6"	"Cell line enriched"	"Detected in some"	10	"HEK 293: 302.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol			77000000	"Nucleoplasm, Vesicles"	Cytosol	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: "	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	29.1	74.5	35.3	18.4	48.0	3.5	216.1	40.4	36.0	8.8	22.6	27.4	41.1	3.6	33.1	32.3	36.7	14.5	14.6	40.3	37.5	28.8	35.3	49.5	54.7	14.1	89.2	10.8	15.1	31.2	3.5	23.8	22.1	67.4	47.8	11.4	6.1	28.3	52.7	66.7	57.9	17.3	36.4	47.0	35.6	19.3	10.9	85.9	1.3	26.8	16.3	11.8	41.3	741.6	1.0	0.5	8.8	4.7	1.2	4.5	0.5	0.0	30.5	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.7	0.0	0.0	2.3	0.0	0.2	302.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.4	4.5	1.8	4.7	1.0	1.0	2.5	2.3	0.5	0.4	1.2	1.1	8.8	1.2	2.5	0.5	4.5	0.5	35.3	48.0	40.4	36.0	37.5	28.8	89.2	10.8	67.4	85.9
HSPA1B	HSP70-2	ENSG00000204388	"Heat shock protein family A (Hsp70) member 1B"	P0DMV9	6	31827735-31830255	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"vagina: 508.1"	"Group enriched"	"Detected in some"	4	"A549: 23.9;Karpas-707: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"CAB008640, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"CAB008640: AB_1617331, HPA052504: "	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.69e-2)"	"unprognostic (5.99e-2)"	21.9	89.9	25.0	20.3	31.1	5.7	129.4	30.8	23.6	8.4	14.6	17.0	36.6	6.2	19.9	40.5	24.4	13.2	12.6	29.2	25.5	22.5	18.6	28.7	30.8	6.3	61.9	8.5	29.3	36.7	35.1	21.6	6.4	53.8	31.1	8.4	5.6	39.7	48.5	102.8	11.3	11.0	27.9	33.4	10.0	20.5	11.8	55.1	0.9	32.1	14.3	9.7	43.4	508.1	1.1	0.6	1.4	1.3	0.4	0.4	0.3	0.2	23.9	0.1	0.0	0.9	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	7.5	1.3	1.0	0.0	0.0	0.0	0.5	7.4	0.0	0.2	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	71.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.1	0.0	1.8	0.4	0.0	0.0	0.1	5.0	0.0	0.1	11.6	0.1	0.1	0.0	0.0	0.0	0.5	1.3	1.4	0.1	0.2	0.1	0.2	0.4	0.0	0.6	1.1	0.0	0.0	0.8	0.4	0.7	0.5	0.3	0.3	25.0	31.1	30.8	23.6	25.5	22.5	61.9	8.5	53.8	55.1
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133051962-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Supported	Nucleoplasm,Cytosol			10000000	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavourable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	20.6	35.0	26.6	25.6	27.6	20.5	39.0	25.9	35.6	19.4	20.5	18.7	19.9	17.4	23.3	20.2	42.0	19.2	18.9	32.9	26.4	31.9	30.3	31.1	17.2	28.9	30.9	24.5	23.2	19.5	37.1	32.8	24.5	34.3	18.9	23.9	16.0	20.3	19.2	48.3	19.6	18.5	23.6	25.9	20.0	20.9	39.8	29.5	27.3	26.8	24.8	38.6	24.5	77.1	27.7	17.9	15.5	23.0	14.1	14.9	11.5	34.2	47.2	33.0	53.7	31.4	26.5	59.9	37.6	28.3	36.5	45.3	88.6	36.0	57.0	39.6	36.1	30.6	57.2	62.2	52.9	26.3	32.8	42.0	31.7	48.5	25.1	26.0	36.9	26.3	26.3	47.0	30.9	34.8	43.9	17.7	39.8	30.2	36.6	19.4	45.2	21.9	33.6	40.4	30.3	33.0	45.2	26.3	21.6	35.8	18.8	50.0	27.6	25.6	30.4	33.3	47.9	28.4	44.5	20.3	45.0	43.8	28.5	43.3	33.0	14.8	14.4	15.5	12.6	23.0	14.9	22.6	11.6	13.0	17.9	27.7	12.1	11.2	9.6	14.1	16.4	6.8	11.3	11.5	26.6	27.6	25.9	35.6	26.4	31.9	30.9	24.5	34.3	29.5
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.0;vagina: 32.0"	"Cell line enhanced"	"Detected in many"		"HAP1: 37.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: , HPA061446: "	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favourable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (6.78e-4)"	1.6	9.3	7.4	1.4	9.0	2.8	5.5	16.6	11.4	2.9	2.5	1.7	1.6	2.5	1.5	1.7	10.9	5.9	3.5	5.3	6.1	10.1	10.6	5.9	1.9	1.0	6.6	6.6	3.5	3.6	12.2	23.2	2.8	20.1	3.9	3.5	3.5	4.6	4.7	1.5	6.5	1.6	3.8	5.0	1.4	2.1	73.0	5.2	1.0	3.7	4.1	4.0	2.8	32.0	0.7	0.5	3.9	0.4	0.5	0.4	0.1	8.9	11.8	6.4	10.1	4.4	4.5	7.4	4.1	1.7	4.0	4.4	8.6	4.1	0.0	7.5	1.1	2.1	37.3	14.7	5.5	16.7	11.1	4.8	16.2	10.4	1.6	18.5	8.2	4.1	13.7	2.6	9.4	5.1	8.5	5.5	4.9	6.5	5.8	1.6	1.5	9.8	0.0	0.7	0.9	13.5	4.1	11.8	4.3	7.4	12.9	0.6	9.8	3.1	1.4	1.4	0.0	1.7	9.8	10.8	12.4	2.8	5.4	12.6	4.2	1.6	0.4	3.9	0.4	0.2	0.2	0.4	0.3	0.3	0.5	0.7	0.4	0.4	1.3	0.5	0.3	0.4	0.3	0.1	7.4	9.0	16.6	11.4	6.1	10.1	6.6	6.6	20.1	5.2
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241330	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		1000000000	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	44.2	40.3	26.3	40.8	38.4	125.0	58.8	19.5	26.9	37.7	29.3	19.8	47.0	25.5	31.6	75.3	34.1	31.1	25.5	72.7	23.3	28.6	60.4	147.6	43.6	32.7	34.3	14.3	36.2	110.3	41.1	47.6	62.6	43.5	34.3	33.0	16.5	84.9	40.7	23.9	32.3	38.3	33.8	28.2	33.8	35.1	33.0	41.5	23.2	219.3	21.7	29.8	50.4	75.1	33.3	53.8	57.4	55.3	51.9	63.0	90.0	35.5	24.1	31.7	41.9	38.0	43.9	74.7	64.1	50.9	47.7	56.0	37.2	71.2	41.1	40.1	46.8	45.5	28.3	57.3	51.3	23.8	14.3	24.6	30.1	67.2	200.7	33.5	46.6	27.0	112.5	38.3	167.9	74.1	18.2	57.5	34.7	26.3	14.8	23.7	35.8	24.2	14.0	32.3	66.7	46.2	23.6	16.4	29.2	40.8	43.7	65.4	45.0	24.5	49.7	29.1	28.4	29.7	29.8	60.2	57.5	34.8	70.7	28.3	43.8	57.4	55.3	44.3	61.9	54.8	63.0	33.3	45.7	57.7	48.6	24.9	37.6	46.6	44.3	51.9	35.5	53.8	31.2	90.0	26.3	38.4	19.5	26.9	23.3	28.6	34.3	14.3	43.5	41.5
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302544-76304295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 565.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 162.0;MCF7: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			57000000	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavourable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	67.6	41.7	23.0	42.9	22.8	7.3	186.2	10.1	21.3	127.6	84.9	10.8	89.2	27.1	126.5	65.9	410.5	57.7	52.2	164.8	21.4	22.5	85.4	26.3	43.3	25.1	25.7	14.3	63.4	34.7	16.6	15.5	106.9	32.8	99.6	12.0	31.1	50.5	101.3	439.2	164.4	24.6	139.7	27.3	17.8	37.6	22.0	23.4	31.9	72.9	207.3	126.8	146.2	565.5	27.8	17.8	4.1	27.9	23.2	36.8	14.4	72.6	54.0	5.8	43.1	35.1	31.1	0.3	30.9	16.3	16.8	21.1	4.8	42.6	0.6	23.9	40.0	66.7	25.3	18.1	5.4	40.5	8.5	3.3	41.7	22.8	18.8	4.9	30.5	38.6	162.0	25.3	3.7	55.4	26.4	74.3	19.2	227.6	8.3	33.6	29.6	47.3	25.7	11.9	59.0	24.9	27.7	0.4	33.1	21.7	88.6	27.6	104.4	34.8	29.9	50.5	75.3	15.7	77.9	5.2	8.6	0.7	36.9	15.2	36.7	4.1	4.5	2.8	18.6	21.1	9.6	27.5	30.6	20.2	11.1	27.8	36.8	31.5	1.7	23.2	27.9	17.8	19.7	14.4	23.0	22.8	10.1	21.3	21.4	22.5	25.7	14.3	32.8	23.4
HSPB11	"C1orf41, HSPCO34, IFT25, PP25"	ENSG00000081870	"Heat shock protein family B (small) member 11"	Q9Y547	1	53916574-53945929	"Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Stress response, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030140	Uncertain		Approved	Nucleoplasm,Cytosol			18000	Nucleoplasm	Cytosol	"HPA030140: AB_10600713"	"unprognostic (5.73e-2)"	"unprognostic (6.37e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (9.58e-7)"	"unprognostic (5.12e-1)"	"unprognostic (6.70e-3)"	"unprognostic (8.31e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (1.84e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-2)"	12.2	19.7	21.5	20.1	19.5	22.6	19.5	13.1	18.6	17.4	15.6	9.5	19.4	11.0	19.1	30.6	19.0	31.9	11.0	12.9	15.4	16.0	16.0	20.0	19.9	24.0	15.0	18.7	20.8	13.4	9.5	31.3	18.2	16.8	15.1	14.6	22.4	13.3	25.1	5.6	16.0	13.1	17.8	17.3	16.0	15.6	19.6	10.0	27.1	40.4	15.0	24.2	23.5	14.3	28.6	35.9	37.5	20.0	31.1	35.0	16.8	20.8	8.9	27.7	6.5	9.6	12.7	11.2	18.7	16.0	26.0	30.7	20.6	11.7	25.3	14.6	12.6	17.0	11.4	17.8	31.1	20.5	16.4	31.0	19.4	27.6	10.4	15.5	21.7	13.2	13.6	24.6	6.9	13.6	18.1	6.0	32.3	4.3	34.5	23.9	11.1	19.4	23.5	35.1	13.0	21.0	23.2	14.1	11.6	26.5	12.2	16.8	76.0	22.6	10.1	18.2	22.3	20.3	19.7	10.9	16.3	25.0	28.8	14.6	15.6	35.4	14.8	37.5	28.0	19.0	25.1	28.6	27.8	33.0	16.8	22.9	21.9	28.0	10.3	31.1	20.0	35.9	35.0	16.8	21.5	19.5	13.1	18.6	15.4	16.0	15.0	18.7	16.8	10.0
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754569-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 356.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 184.7;ASC TERT1: 77.9;HHSteC: 62.6;HSkMC: 72.9"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"		86000	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: , HPA054811: "	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (1.43e-6)"	95.3	39.5	3.9	18.3	8.1	1.1	40.5	1.1	6.1	49.7	48.4	3.8	18.6	5.7	42.6	57.4	24.6	33.3	80.6	132.0	4.4	2.4	6.2	3.5	8.7	7.2	5.4	2.8	53.4	5.8	1.7	1.2	12.7	8.1	42.1	8.7	18.2	8.6	35.8	356.8	2.5	14.3	128.2	10.2	1.9	32.4	22.6	4.9	0.0	11.0	153.5	16.4	121.6	23.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	184.7	77.9	0.1	8.2	0.1	0.5	0.9	0.1	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	62.6	0.0	0.0	72.9	0.0	1.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	1.7	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	8.1	1.1	6.1	4.4	2.4	5.4	2.8	8.1	4.9
HSPB8	"CMT2L, E2IG1, H11, HSP22, HspB8"	ENSG00000152137	"Heat shock protein family B (small) member 8"	Q9UJY1	12	119178642-119221131	"Disease related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 152.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 29.1;HeLa: 21.7;MCF7: 38.2;U-87 MG: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015876	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA015876: AB_1850458"	"unprognostic (1.52e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (2.98e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.17e-2)"	12.2	4.4	19.3	8.2	22.7	0.7	6.8	2.0	18.1	15.3	52.7	34.1	13.1	2.8	18.6	7.2	42.9	9.6	12.0	107.9	17.4	17.6	16.3	1.7	13.4	3.3	27.4	14.7	5.7	7.7	73.3	3.0	64.3	24.5	40.1	11.9	21.7	11.4	79.4	152.6	10.0	7.9	65.5	35.0	13.6	20.6	3.6	19.3	5.4	8.0	42.1	26.7	55.6	18.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.4	4.9	0.2	0.0	5.7	4.5	19.1	10.7	9.5	2.2	0.1	12.0	0.2	0.0	29.1	14.8	0.8	0.1	0.0	0.3	0.0	0.4	0.0	21.7	1.0	3.9	0.0	0.0	5.0	1.7	7.2	0.7	4.4	0.0	0.0	5.3	38.2	0.0	0.1	2.2	7.0	0.0	7.9	1.0	15.7	2.0	0.1	0.3	4.1	0.5	2.2	9.9	0.0	6.1	5.3	13.4	6.9	0.5	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.7	2.0	16.0	17.4	17.6	27.4	14.7	24.5	19.3
HSPBP1	"FES1, HspBP1"	ENSG00000133265	"HSPA (Hsp70) binding protein 1"	Q9NZL4	19	55262231-55280381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005865, HPA070398, HPA071444"	Supported		Approved	Vesicles,Centrosome,Cytosol				Cytosol	"Vesicles, Centrosome"	"CAB005865: AB_304116, HPA070398: , HPA071444: "	"unprognostic (3.07e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.20e-3)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.14e-2)"	14.1	13.9	24.5	15.8	42.9	16.4	13.8	13.3	32.5	11.3	17.3	9.1	13.0	18.8	14.8	12.4	14.5	30.3	13.3	19.1	25.3	20.1	15.4	18.0	18.2	17.6	16.2	20.0	17.4	21.1	13.0	10.2	9.8	15.2	12.0	8.3	7.6	19.3	13.6	35.4	15.4	17.2	16.8	15.0	11.6	15.3	21.1	9.3	11.7	12.0	24.4	8.9	10.5	10.5	24.0	23.0	3.0	19.0	18.4	20.5	11.5	22.0	39.7	7.0	10.3	4.2	3.5	21.6	11.6	4.7	11.6	9.9	22.4	15.4	14.6	11.3	6.2	15.4	8.3	11.2	3.1	12.4	68.3	19.5	12.6	20.6	9.1	18.2	10.3	4.9	10.1	11.6	5.5	5.8	15.5	8.3	4.0	20.9	16.4	16.9	25.2	33.4	16.0	11.1	31.5	7.8	14.5	19.4	29.0	14.3	14.8	11.1	11.3	14.2	8.0	14.0	15.2	7.9	21.1	13.3	30.6	15.2	15.6	15.8	14.8	0.8	11.5	3.0	18.0	19.0	18.7	21.0	19.8	20.5	23.0	24.0	19.9	19.3	0.8	18.4	16.0	13.1	17.8	11.5	24.5	42.9	13.3	32.5	25.3	20.1	16.2	20.0	15.2	9.3
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822245-21937297	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 104.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 45.8;HUVEC TERT2: 101.1;TIME: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009820, HPA018892, CAB020718"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		1700000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597"	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (2.82e-4)"	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60.0	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32.0	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3.0	0.0	0.0	0.0	0.2	0.0	6.8	6.4	2.1	7.5	22.1	16.8	8.5	10.4	2.7	3.0	2.8	7.7	14.1	0.5	45.8	16.1	4.3	0.5	5.1	0.7	0.1	0.7	2.3	6.8	5.6	4.6	0.0	0.6	10.1	1.5	3.1	0.9	101.1	3.1	0.9	4.1	1.9	0.0	3.1	1.9	2.9	1.0	9.0	0.9	5.8	0.9	0.2	0.6	7.9	3.3	4.6	1.3	1.1	80.7	6.0	7.8	4.6	0.3	0.0	1.0	0.3	1.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134974-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"vagina: 286.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol			820000	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.90e-4)"	"prognostic unfavourable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	13.7	19.8	36.6	12.2	57.1	9.8	33.7	11.7	44.0	14.7	10.6	9.8	13.0	6.1	13.3	21.7	13.9	31.0	18.1	14.2	34.8	40.3	16.6	14.8	15.9	17.4	36.5	16.3	13.4	10.1	15.1	24.1	19.8	32.7	14.5	14.5	3.6	7.0	17.3	10.5	11.0	6.4	15.7	34.8	9.0	12.2	35.0	34.6	12.1	22.5	7.8	23.8	17.0	286.1	9.0	6.8	2.1	14.6	13.7	12.8	5.5	14.5	27.8	23.0	2.2	22.1	12.6	15.3	25.2	22.4	39.2	18.3	32.7	22.6	37.7	15.8	17.5	28.2	88.5	22.4	50.6	29.5	11.1	32.7	15.4	28.8	7.3	22.6	26.1	7.9	51.8	26.1	15.0	22.6	27.3	6.0	27.4	19.8	32.4	25.9	32.7	20.8	25.6	18.8	12.5	29.5	17.7	23.8	19.8	22.9	22.6	11.6	7.5	22.0	13.7	13.5	17.2	19.4	27.8	4.7	15.4	32.3	11.2	27.5	22.5	1.0	3.9	2.1	6.6	9.6	8.1	9.0	8.4	10.0	6.8	7.8	12.8	11.9	0.4	13.7	14.6	5.3	5.3	5.5	36.6	57.1	11.7	44.0	34.8	40.3	36.5	16.3	32.7	34.6
HTATIP2	"CC3, FLJ26963, SDR44U1, TIP30"	ENSG00000109854	"HIV-1 Tat interactive protein 2"	Q9BUP3	11	20363685-20383783	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Differentiation, Host-virus interaction"	"Developmental protein, Oxidoreductase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006417, HPA024321"	Approved		Supported	Cytosol				Cytosol		"HPA006417: AB_1079091, HPA024321: AB_1851288"	"unprognostic (8.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.79e-3)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavourable (6.18e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (8.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	16.3	28.1	8.5	11.9	16.3	6.3	26.3	3.2	10.6	9.4	50.4	16.2	10.8	52.2	6.8	13.0	23.1	5.7	17.6	9.5	10.8	9.9	21.5	41.8	19.5	16.2	24.3	8.0	6.8	11.9	17.9	27.4	22.9	12.4	13.9	32.2	3.3	16.5	9.2	19.4	14.8	74.6	12.1	15.0	19.6	29.4	10.6	14.6	6.6	23.9	17.2	12.1	17.8	26.7	16.4	17.4	69.4	30.6	13.5	30.6	23.8	23.4	38.9	0.8	0.0	12.0	9.1	8.7	10.3	10.1	7.9	9.5	22.5	20.7	5.3	21.0	12.7	33.0	0.0	6.2	7.6	61.1	4.8	6.6	38.5	0.0	28.8	2.4	31.5	13.1	44.1	6.4	10.1	22.6	16.2	7.0	14.7	22.0	0.0	1.5	12.6	19.4	5.0	0.0	19.3	10.8	13.1	10.6	0.1	33.2	13.2	15.6	27.6	12.4	27.4	5.7	12.5	11.4	0.2	7.5	9.3	0.1	0.1	16.7	24.4	43.7	30.6	37.3	15.5	27.5	17.5	14.9	18.0	16.5	17.4	16.4	15.8	15.5	69.4	13.5	28.3	5.1	30.6	23.8	8.5	16.3	3.2	10.6	10.8	9.9	24.3	8.0	12.4	14.6
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90857698	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.8;testis: 14.3"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.1;hTCEpi: 7.3;hTERT-HME1: 24.5;LHCN-M2: 9.8;U-87 MG: 7.5;WM-115: 9.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"myeloid DC: 4.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: "	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	1.0	0.5	2.4	1.1	2.5	0.5	0.7	0.3	4.3	0.6	0.8	1.7	1.2	0.8	0.4	0.3	1.0	0.4	1.3	0.6	9.9	5.1	0.3	0.6	0.5	0.7	1.7	1.8	0.4	1.4	30.8	0.2	0.5	3.1	1.0	1.2	0.4	0.6	0.3	1.7	0.9	2.2	3.6	1.5	1.3	1.5	14.3	1.0	0.0	0.3	0.1	0.6	3.5	2.1	0.0	4.6	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.2	0.5	0.7	0.0	0.9	0.0	0.0	0.1	3.3	0.9	8.1	2.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.4	5.8	7.3	2.4	24.5	0.0	0.0	0.0	9.8	0.0	0.0	0.1	0.9	1.2	0.7	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	3.8	0.0	0.2	0.2	4.5	0.0	0.0	6.8	0.0	0.0	0.0	7.5	0.0	9.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.1	0.1	2.4	2.5	0.3	4.3	9.9	5.1	1.7	1.8	3.1	1.0
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3074681-3243960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favourable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	12.9	13.8	19.4	16.6	18.3	14.1	12.3	24.7	32.3	10.0	13.6	11.6	11.0	10.5	11.5	15.9	16.3	11.6	9.4	8.9	19.7	12.1	11.3	13.1	21.5	18.1	11.8	19.5	13.0	27.0	29.5	13.0	12.0	12.8	10.5	11.4	13.3	10.2	11.4	19.1	25.4	12.8	12.0	10.4	17.4	12.0	14.9	10.4	17.4	13.3	7.3	15.6	11.7	9.6	2.9	3.5	2.8	4.5	2.9	4.3	1.9	12.3	8.6	12.1	7.1	22.3	12.7	12.3	5.8	7.1	8.7	8.3	11.4	8.1	19.0	6.2	13.9	7.1	14.3	10.5	8.8	5.0	10.5	18.1	12.3	12.2	5.2	12.1	26.5	8.8	6.5	17.1	8.0	10.1	11.8	6.8	7.7	11.9	12.9	11.5	14.8	14.0	11.6	11.6	3.7	9.3	12.8	13.3	9.4	10.3	3.9	10.1	10.7	7.6	14.0	12.2	7.7	8.4	12.9	5.3	6.2	15.1	9.1	11.2	8.7	0.0	2.6	2.8	3.5	3.4	2.4	2.9	2.7	4.3	3.5	2.4	2.0	2.4	0.4	2.9	4.5	2.6	3.5	1.9	19.4	18.3	24.7	32.3	19.7	12.1	11.8	19.5	12.8	10.4
HUS1B		ENSG00000188996	"HUS1 checkpoint clamp component B"	Q8NHY5	6	655939-656963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;U-266/84: 5.0;WM-115: 5.4"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA034511, HPA063449"			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034511: , HPA063449: "	"unprognostic (3.56e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-10)"	"unprognostic (7.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	0.5	0.1	0.1	0.5	0.1	3.3	0.6	0.0	0.0	1.4	0.4			1.3	0.9	0.7	0.9	0.2	0.6	0.5	0.2	0.1	0.6	0.8	1.0	0.2	0.3		0.8	0.0	0.0	0.8	1.1		1.4	0.2		0.5	0.1	0.0	0.9	0.3	1.0	0.6	1.0	0.1	4.3			0.7		0.2	0.3	1.2	1.6	1.6	0.0	0.7	0.0	1.9	0.6	0.6	0.0	0.0	1.8	0.0	0.0	1.7	0.2	0.1	0.0	0.1	0.8	0.1	0.3	0.5	0.1	0.0	0.5	0.0	0.4	1.3	4.3	0.9	0.0	0.0	0.3	0.0	1.5	0.0	0.3	0.4	0.4	0.1	1.7	1.0	0.5	0.0	0.4	2.4	2.8	1.4	0.9	0.8	2.5	0.2	0.6	1.0	0.1	0.3	0.0	0.7	0.1	0.1	0.4	0.7	0.8	1.5	0.4	2.2	5.0	1.0	0.1	0.5	5.4	0.0	0.7	0.0	0.7	0.3	0.5	1.6	1.1	0.9	0.0	0.8	1.0	1.9	0.0	0.0	0.0	1.6	0.7	0.6										
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase"	Q7Z6Z7	X	53532096-53686729	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol			3400	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	24.6	28.2	27.7	23.8	43.3	22.4	28.0	37.0	41.1	31.8	25.9	34.3	26.6	17.1	31.9	52.4	27.4	26.5	23.1	27.1	28.0	31.8	30.3	26.2	20.3	23.1	30.0	30.2	43.3	27.8	59.8	34.2	27.2	34.6	27.3	22.7	25.6	26.4	29.6	59.1	50.1	22.1	33.9	23.9	26.6	25.7	28.4	27.7	32.4	27.6	20.7	28.6	27.0	22.9	5.1	7.2	8.2	7.0	6.9	8.9	3.5	50.1	30.9	20.1	14.2	35.3	21.1	24.8	15.1	19.5	15.9	16.7	23.5	16.2	26.3	10.3	27.4	24.1	45.4	25.3	21.8	37.9	20.1	20.9	27.7	18.3	32.5	31.3	12.9	20.1	19.0	38.2	43.9	27.5	20.8	17.1	20.6	30.9	16.9	17.5	27.5	22.3	15.7	27.8	15.9	26.4	34.8	16.8	12.1	42.6	19.0	13.6	27.2	15.2	35.0	14.7	21.1	20.9	19.2	15.0	14.7	23.0	15.7	30.7	21.1	4.0	4.7	8.2	7.2	3.8	8.9	5.1	6.9	7.6	6.7	5.1	4.9	4.9	4.2	6.9	7.0	7.2	5.7	3.5	27.7	43.3	37.0	41.1	28.0	31.8	30.0	30.2	34.6	27.7
HYDIN	"CILD5, DKFZp434D0513, KIAA1864, PPP1R31"	ENSG00000157423	"HYDIN, axonemal central pair apparatus protein"	Q4G0P3	16	70807378-71230722	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5;pituitary gland: 23.6;testis: 19.1"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 5.2;SiHa: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA067155, HPA074129"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA067155: , HPA074129: "	"unprognostic (8.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.88e-4)"	"unprognostic (4.25e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.52e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.97e-2)"	0.8	0.9	6.3	1.2	13.9	1.7	1.5	2.9	4.2	2.1	1.2	13.3	4.4	1.0	2.4	18.4	0.9	14.5	1.9	1.0	6.9	4.3	3.5	1.8	7.1	1.1	2.3	4.1	7.2	1.6	9.0	23.6	0.7	21.5	1.4	0.8	3.9	0.9	1.5	0.8	1.7	1.1	1.0	3.1	1.5	1.1	19.1	3.8	0.0	3.2	0.0	0.6	1.2	0.8	0.9	1.1	3.7	1.3	0.7	1.2	0.2	0.1	0.1	2.1	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.3	0.2	0.3	0.3	0.7	0.3	0.2	1.6	0.4	0.5	0.1	0.1	0.2	0.4	0.5	0.2	0.4	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.8	1.3	0.7	0.2	0.2	0.8	5.2	0.7	2.4	0.5	10.9	0.3	0.4	0.7	0.0	0.3	0.3	0.8	0.1	0.3	1.8	0.1	1.0	0.9	0.2	0.6	1.5	1.0	0.8	1.2	0.9	1.2	0.6	1.0	1.1	0.3	0.9	0.9	0.8	3.7	0.7	1.3	1.1	0.6	0.2	6.3	13.9	2.9	4.2	6.9	4.3	2.3	4.1	21.5	3.8
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43451003-43453989	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 130.4;seminal vesicle: 80.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 38.7;WM-115: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA040092	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favourable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favourable (2.72e-5)"	16.5	12.5	11.6	12.1	10.1	5.3	12.8	11.3	9.7	14.6	16.5	13.0	130.4	23.4	15.8	14.8	8.4	15.3	16.7	10.9	9.2	10.0	15.9	25.8	17.8	6.7	10.9	9.3	25.1	34.0	13.8	11.2	10.8	9.0	15.6	7.5	15.0	20.8	80.0	8.8	8.4	22.1	13.4	14.3	7.6	14.1	4.5	11.1	4.9	12.8	9.6	6.4	10.7	11.3	3.2	21.6	6.2	1.2	4.8	5.4	3.0	17.2	2.2	0.7	1.2	3.4	6.3	0.0	15.1	13.5	19.0	12.7	8.8	30.1	0.0	1.1	9.7	3.2	0.0	15.9	7.8	4.2	6.2	2.8	7.9	0.0	22.4	0.0	0.0	3.7	4.6	21.5	0.0	38.7	0.2	0.0	12.7	0.3	2.5	2.9	3.2	4.4	13.3	0.0	0.1	13.2	0.6	8.2	6.1	16.8	9.5	3.7	2.4	21.6	17.8	1.2	0.0	3.4	29.3	0.0	0.0	0.0	1.0	4.0	32.8	6.2	1.1	2.4	3.3	0.9	4.1	3.2	5.4	2.6	4.1	2.7	5.1	1.5	0.1	4.8	1.2	21.6	0.5	3.0	11.6	10.1	11.3	9.7	9.2	10.0	10.9	9.3	9.0	11.1
HYLS1	FLJ32915	ENSG00000198331	"HYLS1, centriolar and ciliogenesis associated"	Q96M11	11	125883614-125900648	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041210	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041210: AB_10794987"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (3.28e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.56e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	4.3	4.3	6.5	3.6	8.8	2.8	5.2	12.3	11.6	5.9	5.5	2.7	6.0	7.0	5.3	8.3	5.7	5.0	3.2	5.7	6.7	7.2	8.7	7.2	3.1	6.7	5.0	8.6	5.0	3.4	3.4	5.5	5.1	7.6	6.2	6.0	2.2	3.9	7.6	3.7	5.7	6.7	7.1	3.5	5.6	6.2	28.6	4.3	7.6	5.1	4.6	9.6	5.0	3.8	11.8	14.3	3.2	6.0	4.6	10.3	4.7	4.6	10.4	3.8	2.8	7.5	5.1	6.6	12.0	4.8	11.2	7.6	0.1	7.8	2.0	5.0	10.5	7.1	5.4	4.2	13.1	11.5	3.8	1.5	1.1	2.1	5.6	5.3	8.0	3.3	4.9	11.1	12.7	8.1	2.6	12.8	14.6	7.9	3.8	15.9	8.4	17.5	8.1	0.0	6.9	12.0	7.9	5.4	3.3	12.7	9.8	4.7	24.2	11.7	7.3	0.8	9.8	8.9	2.0	4.7	4.7	4.9	2.4	11.6	9.8	3.2	5.5	1.1	8.1	6.0	7.6	11.5	10.2	9.4	6.7	11.8	10.3	7.4	0.9	4.6	4.2	14.3	10.3	4.7	6.5	8.8	12.3	11.6	6.7	7.2	5.0	8.6	7.6	4.3
IARS	"IARS1, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Supported	Cytosol				Cytosol		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	20.6	31.0	19.1	21.1	28.5	13.8	24.8	24.5	32.1	22.8	23.7	17.5	25.8	13.6	31.9	24.8	29.7	23.8	15.1	26.0	21.4	18.5	24.5	29.9	24.4	24.1	21.6	20.6	28.4	42.8	57.4	29.0	21.1	31.6	23.6	26.7	17.1	25.2	27.7	47.4	25.4	18.8	32.6	20.0	23.1	29.0	18.7	16.9	25.1	52.3	26.7	28.8	22.1	20.5	14.5	15.3	1.9	7.3	18.6	18.6	9.7	35.9	37.3	20.9	32.8	34.4	38.8	33.0	38.2	36.5	30.3	37.1	13.1	23.2	48.9	15.0	58.9	45.0	64.3	49.7	38.3	30.7	23.9	29.8	32.1	23.2	72.7	40.6	22.0	37.8	55.9	52.8	87.4	31.8	52.5	44.5	42.5	26.2	37.5	15.8	33.8	34.5	26.3	31.7	23.5	25.0	18.1	26.7	22.1	25.9	28.5	36.0	22.8	25.4	23.4	22.4	28.0	36.9	31.0	32.6	41.6	25.9	52.4	31.3	41.3	1.9	6.7	0.5	14.7	7.3	18.6	14.5	14.5	14.9	15.3	10.7	14.7	15.3	0.8	18.6	6.2	6.2	12.9	9.7	19.1	28.5	24.5	32.1	21.4	18.5	21.6	20.6	31.6	16.9
ICA1	"ICA69, ICAp69"	ENSG00000003147	"Islet cell autoantigen 1"	Q05084	7	8113184-8262687	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 58.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.2;MCF7: 15.2;RT4: 17.8;SCLC-21H: 24.9;SH-SY5Y: 41.0;SK-BR-3: 19.5;T-47d: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"T-reg: 20.8"	"Lineage enriched"	"Detected in many"	8	"T-cells: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017646, HPA061452"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA017646: AB_1851382, HPA061452: "	"unprognostic (1.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.83e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.62e-1)"	"prognostic favourable (4.23e-8)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.08e-2)"	8.9	6.1	12.6	4.2	15.3	11.7	13.0	19.4	24.2	10.7	13.2	2.5	8.7	7.7	5.5	8.5	5.8	8.1	10.4	25.7	7.7	7.8	9.1	5.3	9.2	6.9	4.8	12.4	1.6	58.6	13.2	13.5	4.6	10.5	13.7	14.3	2.5	21.2	8.3	2.8	7.0	10.4	3.7	2.8	7.6	17.9	16.0	3.2	0.8	8.1	4.1	5.5	9.6	4.1	0.3	1.7	2.4	1.6	0.7	20.8	1.1	0.0	0.3	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.3	16.2	0.1	1.6	0.0	0.0	0.3	0.7	0.0	0.0	2.4	3.4	0.3	0.0	0.1	2.8	0.5	0.0	1.1	0.0	0.0	11.8	9.5	0.0	0.0	15.2	0.1	0.0	3.7	0.1	0.0	0.0	7.0	6.9	17.8	24.9	41.0	0.0	19.5	0.2	15.8	5.1	6.9	0.0	0.3	0.0	0.3	5.1	2.4	0.0	0.0	2.2	3.4	0.5	1.6	0.1	0.2	0.5	0.4	0.2	3.9	0.3	1.7	0.3	0.2	0.1	2.4	0.7	0.2	0.4	20.8	1.1	12.6	15.3	19.4	24.2	7.7	7.8	4.8	12.4	10.5	3.2
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10270835-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 68.3;lung: 91.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 31.1;Karpas-707: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002126, CAB002142, HPA004877"	Enhanced		Uncertain	"Plasma membrane,Cytosol"			3100000000	"Plasma membrane, Cytosol"		"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favourable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	26.1	8.6	4.0	41.0	4.1	36.5	15.0	1.0	4.5	5.6	10.0	2.7	1.6	6.1	8.5	7.7	7.9	10.7	19.8	16.3	2.6	2.1	10.9	68.3	91.3	32.8	5.4	1.7	12.4	7.2	2.5	4.0	9.3	6.8	10.4	6.6	10.6	7.2	3.6	13.9	6.9	7.9	8.0	7.8	42.2	7.3	6.5	3.6	8.3	11.6	13.7	13.4	14.8	17.1	2.2	13.3	22.2	14.2	7.9	5.6	8.9	8.2	0.1	1.5	0.0	0.4	0.9	2.1	1.7	18.5	4.1	12.5	2.7	9.3	7.6	25.8	0.7	1.7	0.3	0.0	8.7	22.7	0.0	0.7	0.2	11.3	31.1	0.2	4.5	10.9	0.7	2.6	4.0	2.1	2.8	88.5	0.3	0.6	0.1	6.4	0.5	4.7	0.2	0.0	28.1	7.0	0.0	0.0	0.2	11.4	0.6	18.1	1.4	0.5	6.4	4.2	0.4	2.3	0.1	27.0	27.8	4.7	6.8	4.9	6.2	2.2	13.9	2.6	3.0	14.2	5.6	2.2	2.4	3.6	13.3	0.9	1.0	2.2	22.2	7.9	7.9	7.5	3.4	8.9	4.0	4.1	1.0	4.5	2.6	2.1	5.4	1.7	6.8	3.6
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 74.5;lymphoid tissue: 63.9"	"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 163.3;TIME: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071155			Approved	"Plasma membrane,Cytosol"			1200000000	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	36.0	3.6	8.4	13.0	11.5	8.3	34.1	3.5	7.7	9.4	9.7	5.6	2.8	6.4	9.8	5.2	9.5	7.4	8.8	22.8	9.5	8.9	10.5	8.7	27.9	24.0	12.3	3.1	6.3	7.4	3.1	4.5	36.8	9.1	7.9	8.5	8.1	8.8	4.3	17.1	5.5	10.8	13.9	10.5	63.9	8.0	4.0	7.4	14.3	11.6	9.0	18.0	12.8	23.6	49.0	30.9	56.5	74.5	26.0	65.3	67.5	0.0	0.0	0.0	0.0	1.3	1.5	0.4	0.1	0.1	0.0	0.1	0.3	6.8	11.5	2.1	0.0	0.0	0.1	0.0	0.2	2.5	0.0	10.3	0.6	1.2	0.2	1.7	0.0	0.0	0.0	0.1	0.0	163.3	8.4	6.7	0.0	0.0	12.8	1.5	0.0	0.0	7.8	0.0	15.9	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	41.2	0.0	0.1	0.8	0.0	6.4	2.2	10.2	0.0	2.1	0.0	56.5	30.0	8.9	45.8	66.5	52.8	36.5	60.1	42.8	30.9	49.0	65.3	40.7	3.6	26.0	74.5	10.0	64.5	67.5	8.4	11.5	3.5	7.7	9.5	8.9	12.3	3.1	9.1	7.4
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1, cytosolic"	O75874	2	208236227-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 108.5;RT4: 75.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"			16000000	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: , HPA035248: AB_10600714, HPA057936: "	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavourable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	41.3	82.3	6.2	8.8	7.0	1.3	20.9	6.5	8.3	12.6	35.2	8.7	38.0	30.6	8.0	29.9	30.3	8.8	18.7	10.8	6.3	6.2	20.5	91.0	19.8	14.3	8.1	4.7	19.4	21.5	4.8	6.2	24.1	8.7	38.5	23.1	15.4	18.7	39.0	4.7	7.4	54.1	10.1	9.3	21.3	20.4	15.6	8.4	3.5	7.9	11.0	11.9	43.4	12.1	4.9	22.8	6.4	31.6	7.4	6.6	12.0	9.6	16.2	23.2	9.4	42.2	30.1	13.2	4.0	18.4	6.8	16.6	25.6	23.6	1.9	25.6	12.5	14.9	16.7	19.4	6.6	1.3	6.3	8.3	13.4	108.5	56.2	5.4	8.3	25.9	41.3	15.5	11.3	18.7	8.3	6.7	10.4	6.1	3.8	9.3	42.4	6.7	3.7	8.4	5.4	30.6	75.8	4.0	6.9	15.3	14.8	50.1	5.7	15.8	12.3	6.9	7.0	9.8	4.3	3.2	5.0	2.5	22.4	32.8	5.5	5.7	31.6	4.8	4.5	14.5	5.1	4.9	4.0	5.3	22.8	4.9	3.3	3.9	6.4	7.4	6.5	8.4	6.6	12.0	6.2	7.0	6.5	8.3	6.3	6.2	8.1	4.7	8.7	8.4
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK, gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 35.9;liver: 39.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA020378: AB_1845794, HPA058429: "	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favourable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	4.3	6.1	9.4	2.9	20.3	2.2	4.5	12.3	8.3	2.3	11.3	7.0	3.1	14.2	2.5	7.4	4.1	6.8	4.5	2.8	7.6	8.6	27.2	39.1	3.7	4.7	7.3	6.3	3.2	6.6	3.6	5.2	1.8	6.2	4.2	4.7	5.2	4.6	5.0	1.2	3.3	20.2	3.5	7.0	4.2	4.3	2.0	6.8	14.5	7.0	1.2	4.3	2.8	2.1	17.5	9.6	35.9	20.5	15.0	23.0	11.4	3.4	8.4	1.1	1.3	3.8	5.5	6.1	2.4	7.0	2.6	2.1	2.2	3.1	4.4	4.1	3.7	5.9	0.9	1.6	2.8	9.6	1.0	1.6	3.3	9.6	16.7	1.0	2.0	3.7	2.2	5.8	5.5	6.0	1.3	4.6	3.9	19.3	2.7	1.1	1.0	3.8	3.3	3.2	2.5	7.0	4.0	5.4	6.9	5.6	4.4	5.9	4.4	5.9	6.1	1.2	0.8	10.9	4.5	6.8	7.8	0.6	6.0	1.8	2.1	35.9	6.1	8.6	14.7	10.6	12.3	17.5	12.7	12.1	8.5	11.4	10.2	13.8	1.1	15.0	20.5	9.6	23.0	11.4	9.4	20.3	12.3	8.3	7.6	8.6	7.3	6.3	6.2	6.8
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 35.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol				Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favourable (5.27e-4)"	"prognostic favourable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.4	2.5	0.1	0.3	0.0	35.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA002134, CAB016293"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099"	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	64.2	21.0	10.9	42.5	18.0	10.2	34.8	6.7	11.4	28.5	18.6	9.6	7.8	7.5	32.5	21.8	32.8	25.0	33.4	24.8	16.5	7.5	13.3	10.2	32.1	51.0	19.5	6.3	32.6	5.5	3.2	7.0	21.4	18.0	23.0	15.2	10.9	33.6	11.2	14.6	23.7	21.6	29.1	32.2	63.2	11.8	14.2	16.0	81.8	19.1	24.2	41.8	30.9	27.6	28.9	20.8	51.2	21.0	27.9	24.6	16.9	6.9	0.5	2.4	0.1	16.8	55.6	0.0	14.8	39.7	41.7	55.5	0.0	8.9	40.9	12.8	9.0	20.3	0.3	15.0	16.7	12.6	0.1	10.5	3.1	0.0	31.4	3.6	0.7	52.3	26.9	21.3	30.4	43.8	0.2	30.0	23.1	0.0	48.0	3.3	6.4	5.4	22.7	15.4	47.2	5.8	2.6	1.1	0.0	19.4	0.1	42.1	0.0	4.2	24.7	10.7	5.1	30.2	6.2	28.0	13.1	38.4	30.8	11.8	25.8	2.5	21.0	0.1	18.9	20.5	16.9	27.6	18.1	19.3	20.8	28.9	11.5	14.6	51.2	27.9	18.5	15.6	24.6	16.9	10.9	18.0	6.7	11.4	16.5	7.5	19.5	6.3	18.0	16.0
IFI27L2	"FAM14A, TLH29"	ENSG00000119632	"Interferon alpha inducible protein 27 like 2"	Q9H2X8	14	94127779-94130253	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049588			Approved	Nucleoli,Cytosol	"Intracellular and membrane"			Cytosol	Nucleoli	"HPA049588: "	"unprognostic (9.70e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.76e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.52e-2)"	11.4	39.9	38.6	18.3	23.8	17.0	18.8	15.2	24.7	19.9	16.0	23.5	8.7	11.6	15.8	9.6	24.5	21.9	20.8	38.9	29.7	32.4	13.2	3.7	16.5	21.5	37.1	22.8	25.9	13.2	11.7	20.6	5.4	27.4	10.6	9.7	20.4	7.2	12.5	4.0	16.0	13.5	15.5	35.7	17.0	15.7	9.1	22.9	13.8	8.5	16.0	22.5	12.0	17.2	31.5	29.6	19.8	38.7	6.0	30.5	31.9	8.3	5.9	1.7	11.9	8.6	22.1	1.0	15.6	16.1	11.8	13.9	1.6	3.8	3.7	17.1	16.8	10.3	1.2	20.8	4.8	24.9	0.9	5.7	5.8	0.5	14.5	6.7	15.7	20.0	7.7	7.0	4.3	7.8	0.5	56.9	12.2	15.7	3.9	4.1	2.1	6.7	0.1	5.5	4.9	18.0	3.2	3.1	4.7	0.4	0.1	10.0	19.3	11.2	7.6	7.9	4.8	10.6	4.3	23.2	19.2	1.2	25.2	14.9	5.1	19.8	38.7	7.1	25.6	25.9	16.4	31.5	24.4	28.1	29.6	27.4	17.6	23.0	5.7	6.0	18.8	24.6	30.5	31.9	38.6	23.8	15.2	22.8	29.7	32.4	37.1	22.8	27.4	22.9
IFI30	"GILT, IFI-30, IP-30, IP30, MGC32056"	ENSG00000216490	"IFI30, lysosomal thiol reductase"	P13284	19	18173162-18178117	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 348.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 75.3;RPMI-8226: 81.6;SK-BR-3: 55.1;U-266/84: 90.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 348.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5"					"Low region specificity"	"Detected in many"			HPA026650	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"		89000	"Vesicles, Cytosol"		"HPA026650: AB_10602237"	"unprognostic (4.66e-2)"	"unprognostic (1.25e-4)"	"unprognostic (2.35e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (9.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.29e-11)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.59e-3)"	104.2	31.0	5.8	85.5	10.8	28.3	13.9	1.2	5.2	5.3	17.4	6.5	3.2	23.3	5.0	13.7	9.3	15.9	13.1	16.2	5.0	4.0	37.5	60.4	109.7	139.5	12.0	0.8	15.0	14.6	2.0	7.6	123.2	11.0	8.6	18.2	9.2	18.7	4.3	7.2	10.1	28.5	18.9	13.3	140.6	19.4	5.7	7.9	20.6	15.6	9.6	41.2	24.5	8.2	24.3	145.5	95.4	348.5	1.7	1.0	213.4	12.7	6.7	0.0	4.4	1.3	1.8	12.1	1.4	1.8	3.9	10.1	15.2	22.8	75.3	11.6	4.3	10.0	8.0	2.9	0.4	20.0	5.7	0.8	12.5	21.5	12.8	2.2	5.8	7.8	6.8	6.4	2.2	0.2	10.6	47.3	1.9	24.9	1.0	0.2	2.5	6.7	7.3	0.5	81.6	11.6	0.4	0.6	0.8	23.4	55.1	1.3	3.7	0.9	0.3	6.7	4.0	13.8	1.4	1.6	90.3	42.9	18.7	14.9	1.0	2.0	228.9	95.4	1.0	348.5	1.0	24.3	0.7	0.8	145.5	16.8	0.5	0.6	52.5	1.7	230.0	4.3	1.0	213.4	5.8	10.8	1.2	5.2	5.0	4.0	12.0	0.8	11.0	7.9
IFI35	IFP35	ENSG00000068079	"Interferon induced protein 35"	P80217	17	43006725-43014456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 50.4;BJ hTERT+ SV40 Large T+ RasG12V: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045946, HPA075580"	Approved		Approved	Nucleoplasm,Cytosol			93000	"Nucleoplasm, Cytosol"		"HPA045946: , HPA075580: "	"prognostic favourable (1.41e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (4.03e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.49e-1)"	24.9	27.9	9.3	18.1	12.4	14.6	15.1	5.0	9.3	10.7	20.5	9.4	12.8	15.9	13.6	17.4	11.3	14.0	15.5	13.2	7.7	7.0	21.8	26.2	17.7	20.2	9.4	8.1	19.2	11.0	8.3	10.1	15.8	9.5	24.2	13.6	19.5	18.7	10.8	6.4	7.3	33.6	14.1	9.2	31.5	14.9	5.7	9.7	19.5	30.3	8.3	17.8	13.2	10.1	13.2	23.3	22.2	43.2	18.6	17.6	24.9	2.9	6.9	0.0	0.3	6.0	7.3	1.4	1.9	20.5	50.4	74.4	2.5	11.1	0.9	3.9	5.9	1.6	0.3	3.1	4.0	7.8	1.4	2.1	2.5	9.2	15.0	2.4	4.7	10.1	1.2	7.1	0.8	4.5	1.2	14.8	2.0	2.9	5.1	1.9	0.0	3.1	4.2	0.0	5.4	6.2	2.5	1.3	0.0	3.9	1.4	20.2	6.4	4.7	2.2	3.7	0.0	1.1	3.1	13.2	4.9	0.2	6.6	1.9	3.5	19.1	35.9	20.5	16.6	43.2	15.2	12.9	12.9	15.4	21.7	13.2	10.4	12.8	22.2	18.6	39.3	23.3	17.6	24.9	9.3	12.4	5.0	9.3	7.7	7.0	9.4	8.1	9.5	9.7
IFIT1	"G10P1, GARG-16, IFI56, IFNAI1"	ENSG00000185745	"Interferon induced protein with tetratricopeptide repeats 1"	P09914	10	89392546-89406486	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 113.0;BJ hTERT+ SV40 Large T+ RasG12V: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 47.8;monocytes: 13.5"									"CAB045980, HPA055380"	Approved		Supported	Cytosol				Cytosol		"CAB045980: AB_11125836, HPA055380: "	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.35e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.82e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.75e-3)"	"unprognostic (6.40e-3)"	17.4	25.1	21.8	4.6	18.4	10.5	8.7	38.8	29.8	9.2	8.1	9.9	3.5	4.1	8.0	13.7	7.6	10.3	17.5	15.6	16.5	24.0	23.7	28.7	16.8	3.4	20.1	22.6	10.3	6.8	19.5	13.5	12.4	28.8	9.6	6.4	10.6	46.4	8.2	18.3	3.3	4.7	10.1	24.9	20.8	4.5	5.2	18.3	5.0	7.9	7.7	2.9	9.6	6.2	2.2	2.7	47.8	13.5	1.3	4.5	5.2	3.1	0.3	0.7	5.5	2.8	5.8	0.0	3.7	23.6	113.0	111.5	0.3	3.3	0.2	1.2	4.8	2.4	0.3	0.3	5.5	0.1	0.3	0.4	2.7	0.2	3.2	0.4	0.3	4.7	0.0	2.1	0.0	0.1	0.0	2.5	1.2	0.0	0.7	2.1	0.0	2.0	0.9	0.2	0.6	2.7	0.3	0.0	0.1	0.9	0.4	22.0	0.2	0.3	0.1	0.5	0.5	0.7	0.4	0.2	0.3	0.1	0.7	0.7	0.1	6.8	8.9	10.6	1.2	11.0	2.1	2.2	3.2	2.2	2.7	2.2	4.5	2.7	47.8	1.3	13.5	0.1	3.4	5.2	21.8	18.4	38.8	29.8	16.5	24.0	20.1	22.6	28.8	18.3
IFIT3	"CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G"	ENSG00000119917	"Interferon induced protein with tetratricopeptide repeats 3"	O14879	10	89327894-89340971	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 80.0"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 34.4;BJ hTERT+ SV40 Large T+: 80.5;BJ hTERT+ SV40 Large T+ RasG12V: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 80.0"					"Low region specificity"	"Detected in all"			HPA059914	Approved		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA059914: "	"unprognostic (2.81e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.09e-2)"	50.5	15.7	14.9	11.3	17.3	22.1	10.6	6.9	17.0	6.8	9.7	7.6	4.1	14.5	8.8	16.8	6.2	10.9	15.1	8.9	14.2	12.9	19.3	17.0	25.9	10.0	13.5	12.4	11.3	4.3	3.8	5.5	22.9	23.0	9.7	5.4	9.2	19.6	8.1	8.1	5.0	11.3	11.1	18.4	26.0	7.2	5.1	12.1	14.3	14.9	5.5	2.9	11.0	5.9	1.6	2.5	80.0	18.4	0.3	2.6	3.2	6.2	0.4	0.1	1.7	7.3	7.9	0.0	4.0	34.4	80.5	93.5	0.3	9.1	0.5	1.7	6.4	5.6	0.1	0.8	5.9	0.9	0.0	2.4	1.8	0.2	4.2	0.7	2.0	4.9	0.1	7.0	0.5	0.4	0.1	1.4	2.0	0.0	1.5	1.9	0.1	2.0	1.5	0.5	0.4	2.3	3.0	0.0	0.0	0.7	0.1	15.8	0.2	0.8	0.6	1.3	0.2	2.2	1.0	2.2	1.8	0.1	1.8	3.0	1.3	15.2	7.5	26.6	0.7	16.0	0.1	1.6	1.1	0.5	2.5	1.4	0.7	0.8	80.0	0.3	18.4	0.5	2.6	3.2	14.9	17.3	6.9	17.0	14.2	12.9	13.5	12.4	23.0	12.1
IFITM1	"9-27, CD225, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	313506-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 120.0;BJ hTERT+ SV40 Large T+ RasG12V: 215.2;HMC-1: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1"									"HPA004810, CAB017615"	Enhanced		Supported	Cytosol				Cytosol		"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	81.1	14.2	17.4	36.7	24.5	41.2	57.0	11.9	23.1	71.0	28.2	12.9	20.6	17.2	48.3	152.4	44.4	67.2	31.2	62.6	19.8	13.9	59.8	34.5	44.1	159.7	34.8	14.7	100.2	16.3	22.3	23.3	36.3	27.3	38.7	22.1	49.5	27.4	41.6	38.7	23.6	33.0	46.0	37.9	112.9	20.5	29.4	20.1	42.7	48.3	28.0	50.3	39.3	52.8	13.0	4.3	106.8	18.6	164.4	128.1	147.7	6.2	0.1	52.2	4.2	3.8	13.4	0.3	11.1	51.9	120.0	215.2	0.1	43.5	0.1	8.3	11.6	14.8	1.6	1.1	2.4	13.2	2.7	6.4	4.0	0.4	34.6	9.3	66.4	25.1	0.0	1.3	0.1	0.2	22.7	52.7	0.0	0.9	4.6	17.9	14.8	1.6	1.2	0.1	1.2	32.1	0.0	0.0	0.0	5.8	0.6	10.6	2.1	0.8	0.3	0.1	0.1	0.0	0.0	3.7	2.0	0.3	0.1	14.0	0.1	15.6	2.3	56.6	120.0	10.9	80.7	13.0	128.1	121.4	4.3	11.3	123.5	123.4	106.8	164.4	18.6	1.2	70.4	147.7	17.4	24.5	11.9	23.1	19.8	13.9	34.8	14.7	27.3	20.1
IFNLR1	"CRF2/12, IFNLR, IL-28R1, IL28RA"	ENSG00000185436	"Interferon lambda receptor 1"	Q8IU57	1	24154157-24187959	"Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 29.5;U-266/84: 10.2;U-698: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;dendritic cells: 11.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA017319	Uncertain		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA017319: AB_1851708"	"prognostic favourable (5.12e-4)"	"unprognostic (7.16e-2)"	"unprognostic (8.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.66e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-1)"	3.0	3.0	1.1	9.5	1.9	0.4	2.9	10.2	2.1	2.1	9.9	3.8	3.6	6.5	0.8	6.7	4.7	2.0	2.9	6.4	0.9	2.1	4.3	10.1	9.2	8.2	2.0	1.9	1.5	7.8	5.7	8.2	2.5	2.9	4.1	4.6	1.6	9.3	5.7	3.5	8.3	19.2	0.2	5.3	4.4	3.1	1.2	1.1	1.2	5.3	3.1	10.7	2.0	2.7	6.8	11.9	0.0	0.0	0.0	2.0	0.5	3.6	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.7	0.5	6.2	1.0	7.9	8.6	0.0	2.8	3.7	6.4	0.5	1.6	2.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	2.1	0.2	2.0	0.0	0.1	0.0	0.0	0.8	0.1	0.2	7.9	2.3	0.0	0.0	0.6	1.5	1.5	1.1	0.7	1.9	1.1	0.7	1.5	0.0	0.0	0.0	1.6	0.0	0.0	29.5	10.2	22.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	5.1	0.3	1.5	0.0	6.8	0.6	1.6	0.0	0.0	0.0	11.9	0.3	0.5	1.1	1.9	10.2	2.1	0.9	2.1	2.0	1.9	2.9	1.1
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422968-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 93.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 25.6;neutrophil: 44.2"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024122	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA024122: AB_1851452"	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favourable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	19.5	18.0	16.7	12.9	19.6	83.1	24.0	14.3	15.7	10.7	18.3	15.6	11.7	18.7	15.7	12.5	12.7	11.4	12.7	16.0	15.2	13.3	11.9	14.1	19.2	7.9	30.9	13.2	16.9	93.0	12.5	23.1	18.7	16.9	14.7	11.7	11.2	14.3	11.0	37.6	12.3	19.0	23.9	28.2	11.7	17.7	17.9	22.0	7.5	16.5	13.5	7.4	14.7	37.5	3.8	2.9	44.2	3.2	3.4	3.7	2.6	15.0	10.2	15.8	14.8	27.0	17.5	14.6	14.9	14.3	19.4	17.4	16.8	12.8	7.3	28.6	7.8	9.0	10.9	12.6	26.5	12.4	15.6	8.2	18.8	16.0	30.9	11.1	6.5	13.4	27.1	20.4	23.4	8.0	25.1	16.5	7.8	13.6	14.1	18.8	35.9	17.8	12.3	6.3	13.6	5.9	4.2	25.4	13.1	17.0	14.5	48.3	5.6	12.0	6.9	32.9	7.0	25.7	45.0	14.8	17.5	20.0	9.0	31.0	37.7	5.7	3.2	25.6	3.6	2.8	2.8	3.8	3.5	3.4	2.9	3.0	3.4	3.3	44.2	3.4	2.8	2.1	3.7	2.6	16.7	19.6	14.3	15.7	15.2	13.3	30.9	13.2	16.9	22.0
IFT122	"SPG, WDR10, WDR10p, WDR140"	ENSG00000163913	"Intraflagellar transport 122"	Q9HBG6	3	129440036-129520507	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 84.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041815	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA041815: AB_10804118"	"unprognostic (7.16e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.67e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.33e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.20e-3)"	7.4	5.7	11.1	4.9	14.0	6.4	9.1	13.3	13.1	10.2	5.6	7.6	6.4	3.5	10.2	9.6	5.4	18.5	5.0	10.0	7.8	6.4	8.8	6.7	6.7	4.5	4.4	9.2	19.0	9.6	13.1	18.9	7.7	7.2	5.7	5.2	10.5	6.3	6.7	3.7	9.9	4.1	7.6	4.2	3.7	6.7	84.7	5.7	7.6	9.6	2.0	4.2	5.3	6.9	4.7	6.0	8.3	5.7	2.8	5.5	3.8	10.8	16.5	14.3	9.4	20.8	14.8	7.6	5.8	8.8	10.2	9.9	7.9	7.2	7.0	6.9	7.5	7.0	5.5	5.1	9.3	3.8	5.9	5.3	13.5	6.7	5.7	14.7	5.0	17.3	3.9	7.8	6.1	13.7	5.4	15.1	8.2	12.0	12.0	7.6	9.5	4.7	10.7	5.5	5.0	10.9	2.0	18.2	7.4	16.7	5.6	5.0	15.3	11.8	6.0	7.2	6.2	9.3	6.9	10.3	7.2	6.1	6.5	7.5	5.5	8.3	5.7	6.6	1.9	3.9	3.3	3.8	3.3	4.5	6.0	4.7	3.7	4.5	2.7	2.8	1.7	1.4	5.5	3.8	11.1	14.0	13.3	13.1	7.8	6.4	4.4	9.2	7.2	5.7
IFT22	"DKFZp761N0823, FLJ13225, FLJ14117, RABL5"	ENSG00000128581	"Intraflagellar transport 22"	Q9H7X7	7	101313367-101321823	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042930	Approved		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA042930: AB_10794537"	"unprognostic (1.55e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-1)"	6.6	12.3	18.1	4.4	19.9	2.9	9.3	4.8	17.1	11.2	9.9	10.1	9.5	3.1	13.0	28.8	7.6	39.9	12.0	15.9	14.6	15.8	25.5	6.1	7.9	5.7	12.9	13.9	15.3	13.2	15.6	16.2	3.9	13.5	11.2	4.6	15.5	10.6	12.7	14.7	6.5	3.5	13.8	8.6	2.9	7.7	59.5	6.4	9.2	26.2	6.7	4.6	9.3	5.8	9.9	6.7	1.5	5.1	8.3	7.9	3.0	15.0	18.9	15.3	29.4	9.7	12.4	3.8	8.0	7.0	10.7	8.3	7.2	13.6	2.2	14.7	12.4	8.0	7.7	9.2	7.4	3.5	7.6	0.7	9.6	6.3	9.1	5.3	3.1	9.9	8.2	16.1	4.3	8.6	6.2	1.4	8.8	46.9	11.5	6.2	11.3	9.9	9.4	8.9	2.3	17.7	8.1	12.8	22.7	18.1	11.3	7.4	12.0	2.9	7.5	18.4	15.7	42.0	11.0	1.3	7.1	4.7	14.6	1.2	10.6	1.0	1.2	1.5	6.5	2.0	6.7	9.9	7.9	5.9	2.3	9.3	7.0	6.8	1.1	8.3	5.1	6.7	3.1	3.0	18.1	19.9	4.8	17.1	14.6	15.8	12.9	13.9	13.5	6.4
IFT52	"C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5"	ENSG00000101052	"Intraflagellar transport 52"	Q9Y366	20	43590931-43647296	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063367, HPA067423"	Enhanced		Approved	Cytosol				Cytosol		"HPA063367: , HPA067423: "	"unprognostic (2.88e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.18e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (3.30e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.51e-2)"	"prognostic favourable (3.33e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	20.1	13.6	14.2	12.7	13.9	18.6	20.3	14.2	24.9	24.1	12.8	13.4	14.5	7.0	22.2	25.9	11.6	29.8	16.8	16.5	13.1	14.2	16.0	7.1	16.3	20.2	12.1	13.9	31.6	16.2	10.8	15.8	13.1	13.8	14.1	13.9	15.0	11.6	19.4	5.1	13.7	9.5	21.7	13.2	11.3	11.2	36.8	10.8	16.3	24.3	12.1	13.8	14.7	16.8	14.6	23.1	12.8	19.2	13.0	15.9	13.2	14.9	11.4	23.2	16.3	19.7	22.1	11.0	9.4	21.0	24.8	24.1	31.5	15.3	8.3	15.3	19.1	12.6	9.7	16.9	27.4	6.9	9.1	11.0	7.8	29.2	24.3	14.6	7.6	17.8	18.6	16.1	12.6	19.4	9.2	12.0	18.2	14.9	20.1	22.6	13.0	11.4	21.4	26.5	12.2	19.1	14.7	18.0	21.0	28.7	21.4	22.4	9.9	20.1	12.1	22.1	16.4	12.1	13.8	11.7	11.6	14.7	26.5	10.7	15.8	6.6	18.0	12.8	15.9	16.4	12.9	14.6	12.9	15.0	23.1	12.2	13.8	14.3	5.2	13.0	19.2	17.5	14.2	13.2	14.2	13.9	14.2	24.9	13.1	14.2	12.1	13.9	13.8	10.8
IFT57	"ESRRBL1, FLJ10147, HIPPI, MHS4R2"	ENSG00000114446	"Intraflagellar transport 57"	Q9NWB7	3	108160812-108222570	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding	Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035514, HPA035515"	Supported		Approved	"Nuclear speckles,Mitochondria,Cytosol"				"Nuclear speckles"	"Mitochondria, Cytosol"	"HPA035514: AB_10601757, HPA035515: AB_10696505"	"unprognostic (1.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (6.96e-5)"	"unprognostic (2.98e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.59e-2)"	"prognostic favourable (7.63e-4)"	"unprognostic (5.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.12e-2)"	8.5	13.1	9.4	12.1	11.0	8.8	10.4	5.5	16.4	13.3	10.9	6.3	15.7	5.0	11.8	36.3	11.6	24.8	11.6	12.1	9.2	11.2	19.7	3.7	34.3	12.2	9.1	9.9	21.6	13.4	16.4	30.6	6.2	13.5	21.9	11.6	9.4	8.2	16.0	5.7	7.1	9.4	13.1	6.2	14.3	10.0	38.6	5.6	8.3	31.3	7.4	12.2	14.1	9.1	22.4	5.8	1.8	6.7	3.6	4.7	2.9	18.6	9.7	7.0	12.5	14.7	15.2	3.9	5.7	14.0	8.5	7.6	6.6	3.3	21.1	7.4	9.5	7.5	6.2	9.5	14.5	3.3	6.7	7.2	4.3	1.7	11.0	14.9	16.7	9.2	8.9	10.9	19.0	9.5	3.3	3.8	9.6	10.4	4.9	13.7	7.5	11.5	3.2	6.3	3.6	17.4	6.8	11.6	8.1	8.6	2.8	5.2	6.1	4.6	4.0	10.9	5.6	5.7	6.7	4.5	3.2	11.1	15.8	1.5	4.0	0.1	2.1	1.8	2.2	3.6	3.6	22.4	4.7	2.8	5.8	18.6	4.1	2.3	1.1	3.6	6.7	1.2	2.9	2.9	9.4	11.0	5.5	16.4	9.2	11.2	9.1	9.9	13.5	5.6
IFT81	"CDV-1R, CDV1, MGC4027"	ENSG00000122970	"Intraflagellar transport 81"	Q8WYA0	12	110124335-110218797	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019087, HPA020051"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA019087: AB_1851462, HPA020051: AB_1851465"	"unprognostic (2.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.45e-1)"	5.3	9.6	8.9	4.6	13.2	1.7	9.2	14.4	11.9	12.6	11.5	6.6	18.8	3.0	14.9	19.6	6.4	18.8	8.9	7.3	8.9	8.5	10.0	4.4	8.5	3.0	5.9	8.4	14.7	5.1	21.8	30.4	5.2	10.7	13.7	6.2	11.8	8.9	15.5	6.4	5.9	4.6	17.7	8.5	4.0	7.4	29.8	8.4	6.2	14.3	5.4	3.1	13.5	10.4	1.8	3.5	3.0	1.3	2.1	1.9	1.3	7.3	13.9	28.7	12.1	5.3	10.9	2.1	4.7	7.2	10.1	8.7	2.6	4.1	2.4	2.6	8.9	6.5	10.5	5.5	13.2	3.0	5.7	5.0	8.2	4.3	4.5	3.1	2.4	7.8	6.2	9.5	2.4	6.3	6.1	1.3	9.3	1.5	6.3	5.2	14.1	4.6	7.4	7.5	3.2	12.6	4.9	17.8	19.8	12.7	2.7	19.0	14.4	4.7	4.2	5.7	3.0	4.7	4.3	4.2	4.1	3.3	13.8	3.9	6.4	0.3	1.3	0.6	0.7	0.8	1.9	1.6	1.7	0.8	3.5	1.8	1.5	0.7	3.0	2.1	1.0	3.5	0.7	1.3	8.9	13.2	14.4	11.9	8.9	8.5	5.9	8.4	10.7	8.4
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381464-65423072	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 5.0;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.6"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol			34000000	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	1.7	6.2	8.3	3.7	5.0	0.2	1.3	2.0	4.9	6.1	1.4	8.0	0.0	1.0	2.3	7.2	2.6	2.9	6.7	2.2	6.2	4.1	0.6	0.3	0.7	1.1	5.6	3.1	13.3	0.7	0.2	2.4	8.2	6.1	0.9	1.2	1.6	1.5	1.3	14.1	1.5	1.7	3.1	5.0	0.5	1.9	2.5	6.5	0.0	4.6	4.0	1.5	4.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	10.2	0.0	0.0	1.1	0.1	0.4	0.0	0.0	0.4	0.6	8.9	0.0	5.1	0.4	0.0	2.5	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.4	0.0	0.0	5.7	0.0	0.5	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.8	7.6	0.0	0.0	2.5	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.1	2.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	5.0	2.0	3.9	6.2	4.1	5.6	3.1	6.1	6.5
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2149603	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 330.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 112.8;Hep G2: 77.4;LHCN-M2: 44.5;RH-30: 55.3;SH-SY5Y: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	609000000	1700000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: , HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favourable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	16.6	8.0	1.3	4.5	2.0	0.5	23.3	2.3	1.9	23.4	5.0	3.4	4.7	1.0	9.9	32.0	5.2	17.2	4.5	20.5	1.5	1.6	8.1	39.7	1.9	1.1	3.5	1.6	20.4	5.5	0.7	5.0	330.5	7.6	10.4	1.0	33.2	2.6	6.7	21.9	1.7	2.3	7.5	17.0	2.0	3.2	12.4	0.2	1.8	2.6	14.5	1.8	15.2	14.1	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	14.9	0.1	0.4	0.0	112.8	0.0	0.0	1.1	0.0	0.0	0.1	0.9	1.0	0.0	0.0	0.0	0.0	77.4	19.8	0.0	0.0	24.1	0.0	0.1	0.0	0.1	0.0	0.0	44.5	0.2	0.0	0.1	0.1	0.2	0.0	55.3	0.1	0.0	0.1	4.4	67.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	1.3	2.0	2.3	1.4	1.5	1.6	3.5	1.6	7.6	0.2
IGF2BP1	IMP-1	ENSG00000159217	"Insulin like growth factor 2 mRNA binding protein 1"	Q9NZI8	17	48997412-49055650	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"placenta: 17.6;testis: 17.8"	"Cell line enhanced"	"Detected in many"		"AF22: 35.9;CACO-2: 56.5;Hep G2: 26.5;K-562: 28.6;NTERA-2: 28.7;REH: 32.7"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 28.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA021367, HPA062273"	Enhanced		Supported	Cytosol				Cytosol		"HPA021367: AB_1851480, HPA062273: AB_2684733"	"unprognostic (6.79e-4)"	"unprognostic (2.76e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.30e-6)"	"unprognostic (1.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.80e-6)"	"unprognostic (2.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.47e-1)"	0.1	0.1	0.0	0.9	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.1	0.3	0.5	0.1	0.3	0.1	0.1	0.0	0.1	17.6	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	17.8	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	35.9	0.0	1.3	1.9	25.7	2.0	0.0	2.9	4.9	56.5	0.9	2.9	0.2	0.2	0.0	22.1	0.0	5.2	0.0	13.0	21.4	7.7	26.5	1.7	11.3	5.7	2.6	0.0	0.7	0.0	6.0	28.6	0.0	4.0	0.2	0.0	9.5	28.7	0.0	32.7	11.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	3.1	0.1	0.0	0.3	3.0	0.0	0.0	0.0	19.3	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643739-185825056	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 43.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB017126: , HPA035145: "	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavourable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	7.9	8.9	1.0	6.4	1.9	7.6	4.9	8.6	1.6	6.5	16.4	1.6	1.5	11.3	7.6	4.8	3.7	8.3	8.1	9.9	1.7	1.4	8.0	2.6	14.0	4.0	2.8	0.7	6.7	11.3	7.6	2.9	43.0	4.5	4.9	11.6	16.9	9.0	1.6	3.2	4.3	21.4	3.3	3.7	5.8	9.9	5.1	1.5	2.4	8.6	3.2	3.3	6.2	12.5	0.0	5.5	0.9	3.3	1.3	0.0	1.2	28.2	2.4	27.6	5.2	15.1	23.9	16.9	14.9	21.1	23.2	27.9	20.3	8.0	0.0	22.2	12.6	12.9	12.9	21.7	37.7	0.0	13.4	8.0	0.1	14.0	32.3	0.2	0.0	17.5	11.5	15.4	60.0	21.3	7.8	0.0	17.0	0.2	0.0	6.8	20.2	10.2	2.9	11.0	8.4	15.0	0.1	1.7	0.2	1.1	0.0	26.6	2.2	18.9	32.3	8.1	17.6	10.1	17.1	0.1	0.0	0.0	8.0	0.0	11.3	0.9	3.0	0.5	0.0	2.8	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.2	1.3	3.3	1.0	0.0	1.2	1.0	1.9	8.6	1.6	1.7	1.4	2.8	0.7	4.5	1.5
IGF2BP3	"CT98, IMP-3, IMP3"	ENSG00000136231	"Insulin like growth factor 2 mRNA binding protein 3"	O00425	7	23310209-23470467	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 74.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 52.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002037, HPA076951"	Enhanced		Supported	Cytosol				Cytosol		"HPA002037: AB_1851483, HPA076951: "	"unprognostic (5.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.02e-5)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.43e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.87e-4)"	"unprognostic (7.51e-3)"	0.4	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.3	0.4	0.3	0.4	0.1	0.0	0.2	1.3	4.8	0.7	0.1	0.5	0.3	0.2	0.2	0.3	1.2	3.4	0.2	0.0	0.2	1.5	0.0	0.2	74.0	0.7	0.2	0.0	0.3	0.7	0.1	0.2	0.2	0.3	0.0	1.2	1.0	0.2	6.5	0.0	11.4	0.6	0.2	6.0	0.2	0.6	1.2	0.4	1.5	1.5	0.0	0.2	3.0	14.5	4.3	32.7	9.7	5.2	13.8	20.0	2.4	11.0	6.1	7.6	13.8	11.6	11.0	13.2	6.5	9.6	14.1	10.8	10.8	1.7	5.6	5.8	11.7	11.5	16.1	10.5	4.1	14.1	7.6	4.7	2.0	52.3	26.4	0.0	14.8	0.0	6.4	7.1	26.1	13.4	9.9	10.9	14.1	12.1	1.3	8.6	18.8	1.4	0.1	12.2	0.0	2.0	21.0	5.9	0.3	12.8	6.3	0.0	4.6	17.3	23.5	11.8	22.6	0.0	1.5	0.0	0.1	0.8	0.0	1.2	0.0	0.0	0.4	0.9	0.2	0.0	1.5	0.0	0.0	0.0	0.0	3.0	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.0	0.7	0.0
IGFBP3	"BP-53, IBP3"	ENSG00000146674	"Insulin like growth factor binding protein 3"	P17936	7	45912245-45921874	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 320.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 412.2;U-2197: 171.0;U-87 MG: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB010360			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	3247666667	5600000000	Vesicles	"Nucleoplasm, Cytosol"	"CAB010360: AB_2233528"	"unprognostic (4.46e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (8.14e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (5.07e-7)"	"unprognostic (2.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.63e-1)"	47.4	1.6	4.4	10.6	2.7	0.0	52.1	2.7	4.1	44.3	21.3	1.7	3.2	6.9	58.4	8.1	11.7	14.9	5.4	41.6	4.4	2.6	11.1	80.4	11.7	12.7	3.7	1.9	49.2	2.2	0.6	19.2	320.7	4.1	22.5	6.1	9.1	6.4	9.3	13.9	23.9	10.2	22.9	3.8	18.7	8.3	12.1	3.1	2.2	5.6	8.6	8.3	32.0	26.3	0.0	28.9	0.0	0.0	0.0	6.0	1.7	9.3	2.8	5.5	0.0	4.2	1.7	0.0	41.2	7.5	3.5	1.9	0.0	7.6	0.0	13.1	412.2	22.6	0.0	0.1	1.4	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	14.4	0.6	0.7	2.6	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.3	0.5	0.0	0.0	3.8	2.6	20.4	0.6	1.6	14.2	0.5	0.7	0.0	0.0	0.0	40.7	0.0	171.0	2.3	0.5	0.0	0.0	88.5	0.0	13.7	0.0	0.0	0.0	5.2	0.0	4.3	0.0	6.0	5.6	0.0	0.0	2.8	4.7	0.0	0.0	0.0	28.9	0.3	1.7	4.4	2.7	2.7	4.1	4.4	2.6	3.7	1.9	4.1	3.1
IGFL4		ENSG00000204869	"IGF like family member 4"	Q6B9Z1	19	46039748-46077118	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 8.5;skin 1: 13.9"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;HaCaT: 6.9;RH-30: 3.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA047655	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA047655: "	"unprognostic (1.22e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.96e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.59e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	0.1	0.8	4.4	0.3	4.4	0.2	0.3	3.9	8.5	0.2	0.3	0.0	0.0	0.9	1.0	2.9	1.9	0.4	1.1	1.9	2.8	2.8	0.3	0.4	0.7	0.9	1.2	6.0	2.0	0.2	3.3	4.5	0.2	2.1	0.9	0.5	4.6	1.1	0.0	0.5	13.9	0.7	0.1	1.6	0.5	0.7	0.8	0.5	0.0	1.5	0.6	0.2	1.2	0.2	0.3	1.6	1.3	0.7	0.2	0.5	0.1	0.1	7.7	0.2	0.6	0.0	1.3	0.5	0.0	0.0	0.0	0.0	1.7	0.3	1.1	0.1	0.1	6.9	0.0	0.0	0.0	0.8	1.2	0.0	0.9	1.9	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.9	0.1	0.6	0.3	0.4	0.1	3.3	1.6	0.0	0.4	0.5	0.5	0.0	0.2	2.0	0.5	1.4	0.7	0.9	1.6	0.5	0.5	1.0	0.5	0.2	0.2	1.0	2.1	1.3	0.7	0.7	0.5	0.3	0.3	0.3	0.2	0.1	0.1	0.3	0.1	0.4	0.9	0.2	0.1	1.6	0.4	0.1	4.4	4.4	3.9	8.5	2.8	2.8	1.2	6.0	2.1	0.5
IGSF1	"IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2"	ENSG00000147255	"Immunoglobulin superfamily member 1"	Q8N6C5	X	131273506-131578899	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pituitary gland: 138.7"	"Group enriched"	"Detected in some"	5	"Hep G2: 23.0;SH-SY5Y: 20.7"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 65.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012732, HPA035582"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		430000	Cytosol		"HPA012732: AB_2732404, HPA035582: AB_2674687"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavourable (4.25e-8)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.52e-3)"	"unprognostic (8.03e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.13e-2)"	0.8	11.9	1.4	0.4	5.3	0.0	2.7	0.6	6.2	2.7	0.5	3.3	1.2	0.2	1.1	1.5	1.3	1.6	0.8	5.6	3.3	15.4	0.5	1.5	0.2	0.0	3.8	1.9	1.0	1.7	0.0	138.7	0.6	4.7	3.9	0.2	2.2	2.0	6.4	0.3	0.6	0.4	3.2	2.7	0.2	0.5	11.8	1.9	0.2	5.3	0.8	0.5	0.6	0.5	0.6	0.4	1.5	0.3	0.3	0.3	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.1	0.0	0.0	1.2	0.0	0.0	4.0	0.3	0.0	1.7	23.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	1.9	20.7	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.6	0.0	2.3	0.7	0.3	0.0	0.0	0.0	0.0	1.5	0.3	0.2	0.2	0.1	0.2	0.3	0.3	0.3	0.1	0.6	0.3	0.2	1.2	0.3	0.1	0.4	0.3	0.2	1.4	5.3	0.6	2.3	3.3	15.4	3.8	1.9	4.7	1.9
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;ovary: 21.1;testis: 39.9"	"Cell line enhanced"	"Detected in some"		"A549: 5.9;HEL: 4.3;SK-MEL-30: 25.6;U-266/70: 8.9;U-266/84: 10.4"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	1.1	10.5	12.5	1.4	14.6	0.9	1.2	3.4	23.9	1.3	2.6	27.8	0.0	1.1	1.6	2.3	2.0	1.6	1.9	2.2	12.3	6.0	10.6	0.9	1.0	1.0	25.2	8.9	21.1	5.1	3.8	1.4	1.1	15.3	1.3	1.8	7.0	1.4	2.0	2.9	2.6	1.6	1.5	20.5	1.0	1.4	39.9	20.7	0.0	5.0	0.0	1.1	1.1	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	5.9	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	25.6	0.5	0.1	0.0	0.0	1.0	0.0	0.0	8.9	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.5	14.6	3.4	13.6	12.3	6.0	25.2	8.9	15.3	20.7
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;WM-115: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036305: , HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favourable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.4	1.5	1.9	1.2	5.1	0.1	7.7	2.5	8.3	5.8	5.7	1.5	3.0	6.7	2.5	6.5	22.0	1.7	3.5	7.9	1.8	2.8	10.7	0.8	7.4	0.3	1.8	2.8	0.7	4.5	1.4	2.7	42.9	4.1	5.1	5.1	7.8	9.3	5.5	1.1	16.1	12.9	2.4	1.7	0.5	7.3	3.6	0.9	6.2	8.1	9.0	9.3	8.2	9.8	0.0	0.2	0.3	0.6	0.0	0.7	0.2	5.3	9.1	7.0	1.7	1.6	3.4	18.9	0.0	0.2	0.7	0.2	5.2	3.0	0.0	2.8	0.0	14.9	3.1	7.3	0.3	61.2	2.3	2.9	3.5	0.1	0.0	0.2	5.5	0.4	5.8	0.0	1.3	0.0	0.8	0.0	0.1	18.7	0.2	0.1	4.4	0.2	2.1	8.6	0.0	5.4	6.7	4.1	12.5	2.2	21.0	13.5	7.0	0.3	0.0	1.2	4.2	0.0	5.5	0.0	0.3	0.0	0.5	0.1	59.0	0.0	0.6	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	1.9	5.1	2.5	8.3	1.8	2.8	1.8	2.8	4.1	0.9
IGSF9B	KIAA1030	ENSG00000080854	"Immunoglobulin superfamily member 9B"	Q9UPX0	11	133908564-133956985	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.7"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 17.9;SH-SY5Y: 9.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 39.7"	"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010744, HPA010802"	Uncertain		Approved	Cytosol				Cytosol		"HPA010744: , HPA010802: AB_1079194"	"unprognostic (9.04e-4)"	"unprognostic (1.74e-2)"	"unprognostic (7.52e-3)"	"unprognostic (4.38e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.99e-4)"	"unprognostic (3.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-4)"	"unprognostic (3.12e-3)"	2.2	2.1	4.9	3.7	6.8	0.7	1.2	39.7	12.4	7.4	6.8	2.4	4.6	1.1	7.7	4.3	5.9	7.6	4.9	13.4	2.9	3.1	1.1	0.5	1.8	1.6	2.1	4.0	2.4	2.1	1.5	6.2	1.3	3.8	4.2	2.4	6.1	2.1	6.4	5.0	2.4	2.4	12.8	1.6	1.8	3.7	5.0	2.3	0.0	4.9	2.6	1.2	5.2	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.3	1.2	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	2.6	1.6	0.8	0.5	3.2	2.6	0.0	0.1	2.9	2.5	0.0	0.0	0.0	0.2	0.7	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.4	0.3	2.0	0.1	0.0	0.0	0.0	0.3	0.0	17.9	9.1	0.1	0.2	0.0	1.8	0.0	0.0	1.3	1.4	1.1	0.8	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	4.9	6.8	39.7	9.7	2.9	3.1	2.1	4.0	3.8	2.3
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	"Inhibitor of nuclear factor kappa B kinase subunit beta"	O14920	8	42271302-42332653	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001249, CAB004447"	Enhanced		Approved	Cytosol				Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.02e-1)"	"prognostic favourable (1.46e-6)"	9.1	10.8	10.9	17.0	16.7	9.3	10.0	26.1	16.9	10.3	10.3	12.4	11.4	4.7	15.3	13.2	17.9	16.4	14.9	7.9	13.1	6.9	12.4	9.9	14.9	12.2	20.3	7.9	9.6	13.3	18.0	13.6	11.2	11.9	14.0	10.9	10.5	11.4	9.7	17.6	22.2	9.8	16.4	10.5	18.7	10.8	8.3	18.6	12.9	14.3	8.4	17.1	18.1	12.8	12.6	14.8	14.1	9.6	11.9	11.2	5.8	3.6	13.1	3.7	6.4	14.5	12.6	4.8	3.2	11.5	9.7	8.5	3.0	6.8	7.2	5.6	8.9	4.2	5.1	13.0	12.5	7.0	5.8	10.1	6.1	2.3	11.1	1.9	10.6	8.4	9.9	9.3	14.4	14.3	8.5	3.5	21.2	4.2	7.0	3.2	3.6	4.1	7.2	6.4	4.2	10.9	3.3	1.1	2.1	2.1	3.6	5.3	4.8	8.5	7.4	6.8	3.6	5.3	2.3	2.1	2.2	5.1	8.1	4.8	7.7	14.1	9.6	10.4	10.1	7.6	10.3	9.4	10.5	11.2	8.9	12.6	10.2	10.4	11.4	11.9	9.0	14.8	9.9	5.8	10.9	16.7	26.1	16.9	13.1	6.9	20.3	7.9	11.9	18.6
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	"Inhibitor of nuclear factor kappa B kinase subunit epsilon"	Q14164	1	206470476-206496889	"Enzymes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.8;lymphoid tissue: 19.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 25.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015788, CAB025983"	Approved		Supported	Cytosol				Cytosol		"CAB025983: , HPA015788: AB_1851566"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.78e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (5.34e-7)"	"unprognostic (1.48e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.84e-2)"	2.1	0.9	1.0	17.3	3.4	4.3	1.4	1.1	1.7	2.2	4.8	1.5	1.7	3.9	2.0	3.9	6.1	1.2	3.6	1.1	2.9		1.5	0.6	3.7	13.6	2.1	0.7	1.0	1.5	0.0	0.8	2.5	1.9	1.8	4.3	1.5	8.3	2.9	0.1	8.9	4.2	1.0	2.9	12.8	4.0	0.0	2.4	18.8	2.6	4.4	19.5	4.4	0.4	12.9	4.6	4.2	15.9	10.8	24.8	12.3	8.8	7.0	1.9	0.2	3.5	5.0	2.0	3.6	11.3	4.9	5.5	5.5	14.4	17.5	9.7	7.2	12.0	0.0	9.1	1.0	2.8	1.7	2.4	4.2	3.8	4.6	14.9	8.0	6.5	1.6	4.0	0.8	7.1	1.1	5.4	5.1	1.8	9.5	25.1	2.8	5.4	5.1	2.1	14.0	5.8	15.1	0.0	0.0	1.5	12.0	2.2	7.2	10.6	13.7	4.9	3.0	3.5	4.0	1.8	0.8	11.4	9.2	12.5	2.0	4.2	15.9	0.3	10.5	11.2	7.5	12.9	16.7	15.2	4.6	7.4	13.3	13.6	1.1	10.8	6.4	1.5	24.8	12.3										
IKBKG	"FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9"	ENSG00000269335	"Inhibitor of nuclear factor kappa B kinase subunit gamma"	Q9Y6K9	X	154541199-154565046	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"		"Disease mutation, Ectodermal dysplasia, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000426, CAB010373"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB010373: AB_2124846, HPA000426: AB_1851572"	"unprognostic (7.53e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.37e-3)"	"unprognostic (9.77e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.36e-2)"	6.5	5.8	5.2	10.2	6.1	15.1	5.0	5.4	9.2	5.2	4.5	9.1	5.9	7.5	5.2	6.2	6.3	4.5	7.7	5.1	4.9		3.9	16.3	6.5	10.4	6.9	5.1	5.1	6.1	3.5	2.0	6.8	6.7	5.0	3.9	5.6	5.7	3.9	4.6	11.4	6.6	8.1	3.7	10.8	7.4	4.2	6.2	6.9	5.0	6.9	9.9	4.9	6.2	11.3	13.7	28.8	21.8	13.8	17.9	13.5	15.9	16.4	4.0	13.0	9.1	7.7	11.0	10.7	13.9	11.4	16.5	11.6	9.6	12.8	27.1	12.0	15.0	5.8	9.8	4.9	15.3	8.2	10.5	23.7	21.7	14.0	10.3	36.8	9.1	8.3	16.0	6.5	13.6	5.8	12.8	9.1	15.5	10.6	17.3	3.7	27.3	11.7	6.3	13.6	11.3	10.2	7.1	7.1	13.3	12.5	7.7	7.2	11.5	13.8	10.6	12.4	28.3	25.6	25.2	17.8	24.0	15.8	18.7	15.4	10.5	15.4	28.8	17.9	20.5	12.3	11.3	11.4	13.0	13.7	10.1	9.5	11.3	25.4	13.8	21.8	12.2	13.0	13.5										
IKZF2	"Helios, ZNFN1A2"	ENSG00000030419	"IKAROS family zinc finger 2"	Q9UKS7	2	212999691-213152427	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.8"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 19.2;RT4: 18.3;U-698: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 5.7;NK-cells: 7.2;T-cells: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059142	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA059142: AB_2683923"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.93e-3)"	"unprognostic (7.09e-2)"	3.4	2.4	6.1	4.1	12.4	5.9	4.0	8.0	8.6	4.9	2.6	5.3	7.6	1.0	2.3	3.9	24.8	3.4	3.6	2.8	6.3	2.6	2.1	2.1	3.7	7.4	11.8	3.4	2.5	3.0	9.7	6.9	3.2	8.6	5.4	2.0	2.3	13.5	9.2	4.3	10.4	2.5	1.2	9.1	5.9	5.2	2.8	13.4	55.8	9.2	5.5	7.5	11.9	11.6	1.5	0.7	5.7	0.0	7.2	7.1	0.3	1.8	0.6	3.5	0.2	11.5	11.6	2.2	2.2	2.5	0.5	1.1	0.9	3.0	2.3	2.9	1.3	4.2	0.0	1.1	1.8	0.0	0.6	1.2	2.3	0.3	0.1	5.5	0.4	11.3	1.0	0.0	0.3	0.0	0.7	2.0	1.0	3.3	19.2	5.6	0.7	0.5	11.4	2.3	0.0	1.0	18.3	1.1	0.6	0.0	2.3	0.0	3.1	0.6	5.9	3.3	2.5	1.5	0.4	3.9	1.2	13.2	1.6	0.0	0.7	4.1	0.0	5.7	2.5	0.0	6.5	0.2	0.8	1.9	0.0	1.5	0.4	1.9	0.0	7.2	0.0	0.7	7.1	0.3	6.1	12.4	8.0	8.6	6.3	2.6	11.8	3.4	8.6	13.4
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757715-39864188	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.7;lymphoid tissue: 55.1"	"Group enriched"	"Detected in some"	4	"Daudi: 26.5;Karpas-707: 14.0;U-266/70: 16.9;U-266/84: 18.8;U-698: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 8.3;T-cells: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024377, HPA073266"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favourable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favourable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favourable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.7	0.7	0.5	41.7	0.5	3.1	1.0	0.5	0.5	1.1	4.5	0.0	0.6	1.8	1.2	0.6	3.6	1.2	2.4	0.9	0.6	0.6	1.5	1.4	5.3	30.5	0.6	0.0	0.9	0.9	0.0	0.7	0.4	0.1	1.5	1.7	1.2	5.5	1.3	0.6	0.8	11.3	1.2	0.9	41.0	3.3	2.6	0.1	55.1	1.6	1.8	54.1	4.0	1.3	8.3	0.3	0.7	0.1	2.6	17.7	4.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	26.5	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.1	1.6	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	14.0	0.0	0.1	2.3	0.9	0.1	0.0	0.1	0.1	4.8	0.0	1.6	0.1	0.1	0.5	0.2	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.0	16.9	18.8	43.1	0.0	0.1	0.0	0.5	0.1	0.4	16.3	0.1	17.7	8.3	6.7	12.1	0.0	7.7	2.8	7.5	0.7	2.6	0.1	0.3	10.6	4.1	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.0	0.1	0.1
IKZF5	"FLJ22973, Pegasus, ZNFN1A5"	ENSG00000095574	"IKAROS family zinc finger 5"	Q9H5V7	10	122990806-123008817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015297, HPA051574"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA015297: AB_1855183, HPA051574: "	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.15e-2)"	11.7	11.7	20.3	9.2	23.5	38.0	16.6	24.9	20.5	12.0	9.2	22.1	7.5	8.8	12.5	13.6	9.4	9.9	8.4	9.4	18.0	14.5	11.8	14.7	10.6	13.4	28.9	13.5	19.3	14.8	14.2	22.9	10.7	21.2	11.6	9.8	11.2	10.6	8.8	12.3	13.7	10.8	9.8	21.8	11.6	9.9	13.4	26.8	14.7	13.6	7.0	12.4	9.4	11.1	7.6	6.7	8.2	8.0	9.7	13.4	6.7	5.9	3.0	6.0	10.2	9.7	8.9	6.6	5.0	10.8	6.7	8.2	4.8	7.0	15.0	3.7	6.1	8.2	10.6	7.5	9.9	8.4	9.4	9.6	4.9	7.1	6.5	11.6	8.8	7.0	10.4	8.0	17.4	7.3	13.1	10.1	7.2	4.3	10.5	12.7	5.5	4.2	8.6	7.5	8.6	5.5	4.1	6.6	5.9	4.2	5.1	9.7	4.2	7.5	7.5	4.9	4.1	7.1	8.0	9.4	5.1	14.2	6.2	20.4	2.9	7.5	6.3	8.2	9.4	8.0	10.9	6.2	8.6	9.0	6.7	7.6	11.9	13.4	6.1	9.7	7.7	4.7	10.9	6.7	20.3	23.5	24.9	20.5	18.0	14.5	28.9	13.5	21.2	26.8
IL10RB	"CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2"	ENSG00000243646	"Interleukin 10 receptor subunit beta"	Q08334	21	33266358-33310187	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB020670, HPA047550"	Approved		Approved	Cytosol			1300000	Cytosol		"CAB020670: , HPA047550: "	"unprognostic (8.43e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (5.62e-9)"	"unprognostic (3.09e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	17.6	11.0	5.4	19.6	7.3	8.9	21.5	3.6	4.4	15.2	29.2	10.3	10.6	19.6	17.5	9.6	22.7	13.2	14.8	12.3	5.6	5.4	11.6	27.5	19.3	36.1	6.6	3.1	18.2	23.2	5.5	9.7	47.4	9.3	17.7	20.8	11.7	26.0	9.7	12.4	13.8	53.6	12.2	8.0	31.7	17.6	8.4	7.3	34.0	14.3	15.3	26.2	15.1	22.6	13.8	19.4	57.9	34.7	14.0	19.5	20.4	10.2	7.9	1.5	6.4	32.2	23.6	11.3	7.9	22.3	8.7	12.5	7.5	12.7	2.9	9.1	13.7	12.8	4.2	5.4	5.7	9.5	5.9	8.0	6.0	5.6	22.4	10.2	19.3	23.7	10.2	15.1	8.9	11.5	7.1	24.0	12.0	10.7	6.8	9.8	1.1	4.2	6.3	3.6	12.1	7.8	6.1	2.0	2.9	16.2	12.0	13.7	8.0	38.4	10.4	8.7	8.5	14.8	4.3	12.7	14.2	1.7	15.4	14.6	5.6	22.3	30.1	24.8	8.8	34.4	9.6	13.6	11.1	10.6	17.8	13.8	10.5	10.4	57.9	14.0	34.7	19.4	19.5	20.4	5.4	7.3	3.6	4.4	5.6	5.4	6.6	3.1	9.3	7.3
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 20.7"	"Cell line enriched"	"Detected in single"	177	"HDLM-2: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042421			Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	33773		"Plasma membrane, Cytosol"		"HPA042421: AB_10795504"	"unprognostic (2.17e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-1)"	0.3	0.0	0.1	0.8	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	3.0	0.0	0.0	0.1	0.0	0.0	1.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	20.7	0.0	2.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.7;lymphoid tissue: 97.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.2;HEL: 12.9;HMC-1: 23.3;RPMI-8226: 22.1;U-266/70: 27.7;U-698: 11.4;U-937: 15.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 40.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"cerebellum: 61.1;hippocampal formation: 29.7"	"Region enriched"	"Detected in single"	38	"cerebellum: 96.7"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Midbody ring,Cytosol"	"Secreted to blood"	125370	14000	"Nuclear speckles"	"Plasma membrane, Midbody ring, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	8.8	2.4	4.1	48.0	5.8	19.5	7.8	40.1	4.3	4.7	4.8	4.6	0.9	3.8	5.4	2.9	3.4	9.7	5.6	5.1	4.9	2.1	2.5	3.9	14.7	58.0	5.8	2.3	3.7	1.7	0.7	1.4	3.0	6.7	3.5	5.9	3.4	13.5	1.5	1.8	6.1	19.2	3.3	7.8	38.2	5.0	2.2	5.5	97.9	3.7	2.4	54.8	8.7	5.4	43.3	37.1	75.7	35.0	49.3	60.5	66.5	0.0	0.0	0.0	0.0	8.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.0	0.4	9.1	23.3	0.4	0.0	0.0	0.2	0.1	1.3	4.9	0.0	0.0	0.7	9.7	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	2.0	0.1	0.1	0.1	0.4	0.0	27.7	2.3	11.4	0.8	15.5	0.7	52.7	27.4	75.7	43.1	35.0	48.6	43.3	45.1	47.1	37.1	39.9	60.5	48.6	69.1	49.3	33.7	28.0	47.0	66.5	4.1	5.8	40.1	4.3	4.9	2.1	5.8	2.3	6.7	5.5
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 27.0;NB-4: 23.7;THP-1: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"		20000	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favourable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	17.7	7.6	6.5	13.6	13.8	40.5	24.7	4.0	6.7	8.6	8.1	7.7	4.6	6.2	7.4	9.4	6.8	7.8	7.4	8.8	6.1	4.9	8.3	11.6	16.8	39.2	10.3	2.0	7.7	7.7	6.9	5.4	6.2	8.3	6.9	5.7	5.3	7.0	5.3	5.3	8.6	9.1	8.3	11.2	23.4	7.3	5.3	9.7	50.0	7.9	3.2	11.0	6.3	12.8	0.5	3.6	15.6	6.9	1.4	2.4	2.0	3.6	2.1	1.9	2.4	3.8	2.2	2.4	5.3	3.5	2.5	3.2	2.0	2.4	3.3	2.2	5.3	5.8	2.6	2.5	1.8	5.3	3.1	0.0	1.2	1.2	4.4	27.0	8.4	3.3	3.7	2.2	1.7	2.7	1.4	3.4	2.5	3.0	3.2	23.7	1.0	2.0	0.7	0.4	0.6	2.4	2.7	1.3	0.0	3.7	3.2	2.6	2.5	34.1	7.4	2.0	2.8	2.9	1.9	2.8	1.5	1.6	2.8	13.1	2.1	6.7	6.9	6.1	1.1	3.2	0.9	0.4	1.5	1.1	3.6	0.5	2.4	1.8	15.6	1.4	2.9	1.7	0.9	2.0	6.5	13.8	4.0	6.7	6.1	4.9	10.3	2.0	8.3	9.7
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143251-112164117	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9;skin 1: 57.2"	"Cell line enhanced"	"Detected in many"		"A-431: 26.0;CAPAN-2: 41.2;HaCaT: 37.8;HBEC3-KT: 28.4;hTCEpi: 43.5;PC-3: 25.2;U-2 OS: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 17.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	136427		"Nucleoplasm, Golgi apparatus"	Cytosol	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favourable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	9.4	2.6	5.3	12.5	7.9	10.8	5.2	1.3	5.3	18.5	13.1	6.4	2.5	8.6	2.1	3.7	53.9	3.3	11.9	2.1	5.7	3.1	17.5	3.6	15.2	22.6	7.4	1.4	1.4	7.0	0.3	3.3	2.6	8.2	5.5	11.6	2.2	8.3	1.4	3.8	57.2	9.1	4.0	24.7	26.6	5.1	1.7	7.5	3.9	1.8	21.2	26.5	9.1	35.4	0.5	17.1	10.4	6.9	13.8	0.3	1.6	26.0	9.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	5.0	41.2	0.0	6.0	0.0	37.8	0.0	28.4	0.0	0.0	0.2	3.9	9.3	2.1	0.9	2.0	7.6	0.0	43.5	0.0	10.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	25.2	0.0	0.0	0.0	18.6	5.6	0.0	0.0	17.9	11.9	0.1	7.1	5.7	0.0	0.1	49.0	0.3	8.0	0.1	0.0	0.1	0.0	15.1	0.0	3.5	6.0	10.4	0.1	6.9	0.0	0.4	0.0	0.0	17.1	0.5	0.0	0.3	6.7	13.8	3.7	3.8	0.0	1.6	5.3	7.9	1.3	5.3	5.7	3.1	7.4	1.4	8.2	7.5
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.4;ASC TERT1: 41.7;HHSteC: 29.3;HSkMC: 115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"		1000000	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: , HPA029560: "	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	48.6	25.2	2.6	18.2	5.2	4.0	92.4	2.4	3.9	47.8	21.0	2.5	34.3	5.2	15.2	30.2	18.2	17.1	25.8	27.0	4.2	2.5	23.7	74.8	40.5	28.0	5.6	1.1	25.1	17.1	16.9	7.3	66.2	10.9	26.0	8.4	8.6	12.7	36.4	15.5	13.5	13.0	15.1	10.0	19.2	15.6	13.4	2.8	3.5	33.6	9.0	9.6	32.0	36.4	0.1	0.1	4.0	0.5	0.8	1.8	0.2	0.2	1.8	0.0	1.5	93.4	41.7	0.6	3.9	17.7	2.8	4.2	0.8	0.4	0.0	2.9	7.8	0.7	0.0	0.3	2.3	7.7	0.0	0.1	0.4	4.3	29.3	0.0	0.0	115.0	0.3	3.1	0.7	1.2	0.4	0.1	4.0	0.7	0.0	0.1	0.1	0.1	0.0	0.2	0.0	2.6	1.9	0.0	0.0	1.7	1.1	0.0	1.6	0.1	0.0	8.0	0.5	13.4	0.3	0.0	0.0	0.0	3.1	0.0	0.5	0.6	0.5	0.1	0.0	0.0	0.7	0.1	1.1	0.0	0.1	0.1	0.0	0.1	4.0	0.8	0.0	0.1	1.8	0.2	2.6	5.2	2.4	3.9	4.2	2.5	5.6	1.1	10.9	2.8
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.5;liver: 91.8;placenta: 35.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 36.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"		260000000	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (6.29e-4)"	3.4	1.7	3.7	5.2	4.5	7.8	2.8	0.8	6.0	2.9	1.8	3.4	0.7	1.1	2.6	1.7	9.1	3.2	5.7	3.3	7.4	2.9	1.9	91.8	6.3	12.6	3.5	2.5	2.2	2.0	1.0	1.4	35.9	5.5	2.1	1.4	1.6	4.7	2.0	1.2	5.8	1.5	3.1	6.3	7.1	2.3	1.0	2.9	2.3	2.2	3.8	3.4	3.3	4.4	0.9	1.4	36.5	2.2	0.1	1.3	0.5	3.8	1.0	1.6	0.2	2.8	2.3	3.0	1.7	3.5	4.0	3.9	1.6	8.6	0.6	17.9	4.7	10.0	0.8	16.7	5.6	0.7	1.0	0.8	1.7	4.1	6.0	5.7	2.8	3.1	6.9	5.8	18.5	1.7	0.1	0.0	1.8	1.8	0.4	2.6	2.5	1.8	2.7	2.5	1.3	1.5	4.1	0.3	0.0	7.8	4.4	71.2	2.8	4.1	2.3	3.1	3.2	9.5	7.8	1.4	0.0	0.1	5.2	5.1	18.2	3.5	1.5	8.5	0.7	1.7	1.3	0.9	0.8	0.9	1.4	0.9	0.8	0.5	36.5	0.1	2.2	0.2	0.8	0.5	3.7	4.5	0.8	6.0	7.4	2.9	3.5	2.5	5.5	2.9
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Group enriched"	"Detected in some"	6	"HHSteC: 54.1;HMC-1: 80.5;HUVEC TERT2: 39.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	19074133	1700000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	3.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.5	0.1	0.1	54.1	0.4	80.5	1.1	0.3	1.3	8.7	39.3	0.1	0.1	0.1	0.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell line enhanced"	"Detected in some"		"A-431: 20.6;HaCaT: 40.8;RT4: 39.8;THP-1: 11.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	421933		Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavourable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	40.8	0.0	1.1	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.1	7.7	0.0	5.3	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	0.3	0.0	0.0	11.5	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.0	3.9	4.6	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2
IL20RA	"IL-20R1, ZCYTOR7"	ENSG00000016402	"Interleukin 20 receptor subunit alpha"	Q9UHF4	6	136999971-137045180	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 28.9"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 9.6;HaCaT: 6.9;RT4: 11.4;SH-SY5Y: 11.1;T-47d: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB024990, HPA042281"	Approved		Approved	Cytosol				Cytosol		"CAB024990: , HPA042281: AB_10806235"	"unprognostic (3.75e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (1.43e-6)"	"unprognostic (1.57e-2)"	"prognostic favourable (2.29e-5)"	"unprognostic (9.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (8.03e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.85e-6)"	"unprognostic (9.38e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.64e-3)"	0.6	7.0	2.0	1.6	5.9	0.1	21.2	4.4	2.8	13.9	3.5	4.3	0.6	2.4	5.5	3.7	6.4	13.6	7.9	5.9	3.6	3.0	0.4	0.8	4.7	0.1	3.7	2.3	5.4	16.3	0.2	1.8	0.4	4.6	7.3	3.7	3.5	11.8	7.8	0.5	28.9	1.3	2.9	5.5	0.0	4.9	2.9	3.3	1.0	2.2	3.7	5.6	5.6	9.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	9.6	0.0	0.1	1.4	6.9	1.2	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.4	1.4	0.0	0.4	0.0	0.0	11.4	0.7	11.1	0.5	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.9	4.4	2.8	3.6	3.0	3.7	2.3	4.6	3.3
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 64.5;skin 1: 61.2"	"Cell line enriched"	"Detected in some"	4	"hTCEpi: 104.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 0.6"	"Not detected"	"Not detected"			HPA063914			Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA063914: "	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	1.6	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	13.2	0.2	0.0	0.0	0.0	1.3	0.3	64.5	0.1	0.1	0.3	0.0	0.0	0.1	2.1	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.2	2.8	0.0	1.6	0.3	0.4	4.1	0.2	0.4	61.2	0.1	0.1	0.3	0.0	0.1	0.9	0.0	0.5	0.2	22.6	17.1	0.9	19.2	0.1	0.4	0.0	0.3	0.0	0.6	0.0	4.8	0.0	0.0	0.0	2.9	12.6	0.4	0.1	0.3	0.0	0.1	0.4	0.5	0.0	2.7	1.7	15.7	0.0	25.8	0.1	0.0	0.0	0.0	3.2	0.0	17.4	0.0	0.0	2.1	104.1	0.8	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IL21R	CD360	ENSG00000103522	"Interleukin 21 receptor"	Q9HBE5	16	27402162-27452042	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 17.9;lymphoid tissue: 47.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.1;HDLM-2: 42.9;Karpas-707: 19.9;RH-30: 15.1;RPMI-8226: 24.0;U-266/70: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042296	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042296: AB_10806236"	"unprognostic (2.91e-2)"	"unprognostic (2.65e-3)"	"unprognostic (6.64e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.14e-1)"	"prognostic favourable (7.29e-4)"	"unprognostic (8.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.50e-6)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-10)"	"unprognostic (8.79e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.58e-2)"	0.8	0.6	0.6	33.6	3.7	5.7	0.6	0.5	1.6	0.5	0.9	0.3	0.0	0.5	0.5	1.3	1.0	0.8	1.1	1.8	0.6	2.3	1.6	1.3	5.6	20.9	1.3	0.0	0.5	0.5	0.0	0.9	0.9	1.9	0.9	0.9	1.8	3.7	0.3	0.7	0.7	4.0	0.6	1.7	11.2	1.3	1.0	1.4	47.8	1.3	0.8	31.7	2.7	0.8	11.5	1.6	0.7	17.9	6.3	10.3	4.2	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.3	0.0	0.0	0.9	0.0	0.0	10.1	0.1	0.8	0.0	0.0	0.0	0.0	42.9	0.0	2.1	0.0	0.2	1.4	0.0	0.6	1.5	0.0	2.7	0.0	0.0	0.1	19.9	1.5	0.0	0.0	0.2	0.3	0.0	0.1	15.1	24.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	1.1	0.8	0.2	0.2	0.0	10.0	3.5	2.3	2.1	0.5	0.0	0.2	0.3	0.0	9.8	5.8	3.6	1.0	6.3	10.3	1.6	11.5	6.9	6.7	0.7	6.3	17.9	0.7	7.6	4.2	0.6	3.7	0.5	1.6	0.6	2.3	1.3	0.0	1.9	1.4
IL23A	"IL-23, IL-23A, IL23P19, P19, SGRF"	ENSG00000110944	"Interleukin 23 subunit alpha"	Q9NPF7	12	56334174-56340410	"FDA approved drug targets, Predicted secreted proteins"	"Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling"	Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.0;lymphoid tissue: 15.2;testis: 12.1"	"Cell line enhanced"	"Detected in some"		"A-431: 9.2;CAPAN-2: 16.1;U-266/70: 27.0;U-266/84: 12.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"MAIT T-cell: 8.4;memory B-cell: 10.6;memory CD4 T-cell: 15.5;memory CD8 T-cell: 7.4;naive B-cell: 10.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 10.6;T-reg: 8.4"	"Group enriched"	"Detected in many"	14	"B-cells: 10.6;T-cells: 17.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA001554	Approved		Approved	Cytosol	"Secreted to blood"	11000		Cytosol		"HPA001554: AB_1079135"	"unprognostic (2.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.50e-3)"	0.7	0.5	0.4	3.9	0.5	3.6	0.4	0.3	0.3	0.5	0.6	0.3	0.3	0.0	1.3	0.8	6.0	0.5	2.0	0.3	0.4	0.5	1.3	1.4	1.2	7.5	0.4	0.3	0.3	1.1	0.0	1.1	0.6	0.3	1.0	0.2	0.3	1.8	0.3	0.3	0.8	2.5	1.0	0.4	2.8	0.7	12.1	0.3	12.9	0.6	10.4	15.2	7.4	0.6	10.6	0.5	0.1	0.2	1.0	17.0	5.9	9.2	0.2	0.3	0.3	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.4	16.1	0.5	4.8	0.0	0.8	0.0	1.6	0.0	0.6	0.3	0.2	0.1	0.7	0.0	0.2	0.5	0.1	0.0	0.0	0.4	0.0	0.4	4.0	0.0	0.4	0.3	0.5	1.4	0.2	0.2	0.1	0.4	5.5	4.6	0.3	0.4	0.2	0.2	0.8	0.1	4.3	0.3	0.3	0.3	0.3	1.1	27.0	12.1	1.2	0.3	2.3	0.2	0.0	0.2	0.0	1.7	0.0	8.4	10.6	15.5	7.4	0.5	10.6	17.0	10.6	0.1	1.0	0.0	0.0	8.4	5.9	0.4	0.5	0.3	0.3	0.4	0.5	0.4	0.3	0.3	0.3
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.6;testis: 48.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 17.6;HDLM-2: 30.5;Karpas-707: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 38.6"	"Group enriched"	"Detected in many"	6	"monocytes: 13.0;T-cells: 38.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"			"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	5.4	3.3	4.0	30.9	4.6	7.1	4.1	5.8	5.6	4.6	4.1	5.5	2.9	8.2	5.9	3.4	4.5	8.2	5.4	4.2	3.9	3.5	11.0	3.5	6.7	15.5	4.0	3.2	6.2	3.7	1.5	5.1	6.8	4.3	5.3	3.8	3.9	4.1	5.0	6.2	3.4	7.4	3.8	7.2	7.6	6.2	48.8	4.4	14.6	4.1	4.4	12.3	6.5	4.9	0.2	4.1	0.1	13.0	0.4	38.6	3.0	0.5	0.6	0.4	0.4	0.0	0.4	0.1	0.3	1.0	0.7	1.0	0.3	1.0	1.7	17.6	0.2	0.3	0.2	0.0	0.1	30.5	0.1	0.8	0.0	0.2	0.1	0.6	6.3	0.5	0.2	0.3	0.0	1.3	0.1	24.7	0.0	0.2	0.3	1.0	0.2	0.1	0.5	0.5	1.7	1.2	1.5	0.3	0.4	0.2	0.4	0.3	0.2	1.4	1.5	3.7	0.5	0.0	0.5	2.1	4.6	1.0	0.5	0.2	0.4	0.1	8.0	0.1	2.3	13.0	38.6	0.2	5.0	4.3	4.1	0.1	0.1	0.0	0.1	0.4	1.6	0.4	0.2	3.0	4.0	4.6	5.8	5.6	3.9	3.5	4.0	3.2	4.3	4.4
IMPAD1	"FLJ20421, gPAPP, IMPA3"	ENSG00000104331	"Inositol monophosphatase domain containing 1"	Q9NX62	8	56957933-56993844	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"			560000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	30.6	33.9	17.8	13.9	23.7	9.6	17.6	23.6	33.1	24.7	17.7	30.9	17.8	11.7	23.2	15.2	17.7	15.6	18.0	25.2	19.9	21.6	21.3	32.6	16.5	10.3	23.6	21.1	16.0	25.2	30.4	20.4	23.3	27.2	28.8	16.2	25.2	28.7	22.5	41.4	13.4	12.3	23.0	21.7	13.0	14.7	19.0	19.5	12.0	24.4	18.1	13.0	17.2	14.9	1.9	2.0	6.1	4.6	6.8	2.4	0.6	17.1	14.3	11.0	11.3	33.9	23.3	15.2	26.1	25.4	18.7	16.4	7.1	12.2	10.7	20.0	27.7	14.1	13.3	17.6	27.9	14.7	9.5	20.9	10.1	12.7	21.1	13.2	14.9	18.7	17.7	16.8	27.4	24.8	9.0	19.5	20.5	9.1	16.1	8.0	8.2	5.3	11.3	9.9	12.1	19.5	10.2	4.3	12.0	14.6	18.1	14.8	16.1	9.7	20.7	25.4	14.7	25.0	18.7	20.2	16.8	11.5	34.8	11.1	15.6	2.9	1.9	1.1	2.0	1.2	1.6	1.3	1.3	1.2	1.4	1.9	1.5	2.4	6.1	6.8	4.6	2.0	0.9	0.6	17.8	23.7	23.6	33.1	19.9	21.6	23.6	21.1	27.2	19.5
IMPDH1	"LCA11, RP10, sWSS2608"	ENSG00000106348	"Inosine monophosphate dehydrogenase 1"	P20839	7	128392277-128410252	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 21.6;eosinophil: 20.2;intermediate monocyte: 26.2;myeloid DC: 15.1;neutrophil: 49.9;non-classical monocyte: 31.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 15.1;granulocytes: 49.9;monocytes: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001400	Approved		Supported	"Cytosol,Rods & Rings"				Cytosol	"Rods & Rings"	"HPA001400: AB_1079139"	"unprognostic (2.84e-1)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (2.23e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (7.31e-5)"	"unprognostic (6.03e-2)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (1.24e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (1.78e-12)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (3.72e-5)"	26.0	7.4	7.5	20.7	8.5	24.5	37.1	7.7	10.2	11.3	10.9	3.6	12.4	5.2	8.5	6.5	14.6	9.1	7.6	12.6	7.6	5.0	7.5	3.5	14.8	31.2	5.1	5.8	10.7	20.3	5.2	12.0	7.2	9.9	12.1	6.3	19.5	20.6	11.4	3.5	11.9	8.8	12.3	6.4	25.1	20.6	7.1	5.6	3.9	5.5	11.2	9.7	14.2	9.9	4.1	15.1	49.9	31.0	2.8	6.4	11.7	25.1	21.6	3.2	24.2	13.7	10.0	9.2	17.2	10.9	14.8	9.6	15.7	8.1	16.0	5.9	25.6	19.3	18.3	24.3	7.4	5.8	20.4	10.6	16.0	11.1	12.5	13.9	5.0	11.8	11.6	15.0	14.9	17.4	10.5	12.1	4.9	17.3	9.7	37.4	18.3	25.4	11.7	6.0	33.2	6.5	8.1	13.0	13.1	11.1	88.5	15.6	10.0	27.0	15.9	24.9	9.1	13.0	12.2	9.1	8.4	20.6	12.7	30.9	15.1	2.3	21.6	20.2	5.9	26.2	6.4	4.1	4.7	5.1	15.1	2.4	2.8	3.4	49.9	2.8	31.0	1.5	5.2	11.7	7.5	8.5	7.7	10.2	7.6	5.0	5.1	5.8	9.9	5.6
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029408	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001400, CAB020717"	Approved		Enhanced	"Cytosol,Rods & Rings"			19000	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.47e-2)"	25.0	21.5	16.1	25.7	15.4	23.9	47.0	9.7	21.1	34.7	24.9	15.1	19.1	18.9	29.5	19.8	40.1	51.9	33.3	29.3	13.0	11.2	21.4	29.4	19.9	52.5	18.1	13.0	89.0	88.8	19.1	16.6	23.2	15.6	33.2	31.7	10.8	22.1	22.2	61.4	40.7	17.8	34.1	15.2	23.7	22.2	15.3	15.4	31.2	29.8	51.3	33.4	30.3	32.1	31.6	18.8	6.2	16.8	21.6	34.8	16.0	39.6	22.9	31.8	32.8	47.6	86.9	30.9	27.5	44.6	66.4	56.6	39.8	35.8	72.4	19.7	33.1	27.7	65.6	55.9	58.2	19.0	21.9	53.6	33.8	36.4	40.8	56.8	22.1	77.2	61.6	63.4	115.3	46.6	32.0	41.0	53.4	32.2	48.0	39.5	41.2	46.3	21.0	33.5	71.0	37.8	25.7	20.6	20.3	29.9	33.8	49.7	41.9	25.3	23.4	29.1	54.0	70.7	70.5	39.8	28.7	34.7	33.6	63.4	28.4	6.2	10.1	4.0	17.0	16.8	31.7	31.6	23.3	19.6	18.8	31.1	34.8	28.6	4.4	21.6	13.9	14.5	15.5	16.0	16.1	15.4	9.7	21.1	13.0	11.2	18.1	13.0	15.6	15.4
ING1	"p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a"	ENSG00000153487	"Inhibitor of growth family member 1"	Q9UK53	13	110712736-110723339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016136, CAB017773, HPA052591"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016136: AB_628077, CAB017773: , HPA052591: "	"unprognostic (1.14e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.51e-2)"	"prognostic favourable (5.81e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.40e-3)"	11.8	11.1	8.9	11.7	10.2	24.9	19.8	12.8	12.1	15.7	14.9	6.9	9.5	13.9	16.3	8.3	10.7	13.7	20.0	9.5	9.4	9.0	9.3	16.7	14.1	20.5	11.6	8.0	25.8	11.8	3.8	9.5	13.3	11.7	13.3	6.6	9.5	13.6	10.9	12.2	8.5	13.6	11.1	10.2	17.6	10.0	26.0	12.0	22.0	11.5	8.3	10.6	18.3	14.8	15.5	3.0	21.4	3.7	12.3	11.6	6.1	17.4	6.9	12.5	12.0	5.9	4.1	12.5	9.0	7.6	5.9	7.1	13.2	12.4	11.2	14.7	3.5	11.0	5.0	4.4	4.9	21.1	9.6	9.9	9.5	9.8	3.3	13.0	9.6	3.7	4.7	5.1	3.1	4.1	9.1	9.5	3.8	10.0	22.5	15.1	12.3	5.8	16.4	6.4	6.3	5.1	9.0	12.3	13.3	8.9	17.9	12.3	6.0	15.5	6.1	7.2	8.9	7.5	10.0	11.5	11.5	14.3	12.1	10.8	11.8	21.4	2.9	11.1	10.8	3.6	11.1	14.8	9.1	9.7	2.8	15.5	9.4	7.8	4.0	12.3	3.7	3.0	11.6	6.1	8.9	10.2	12.8	12.1	9.4	9.0	11.6	8.0	11.7	12.0
ING2	"ING1L, p33ING2"	ENSG00000168556	"Inhibitor of growth family member 2"	Q9H160	4	183504994-183511096	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019486, HPA021517"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA019486: AB_1851780, HPA021517: AB_10601914"	"prognostic favourable (5.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (8.87e-4)"	"unprognostic (7.47e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.30e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.82e-2)"	6.1	28.5	7.8	4.4	12.2	20.0	7.6	8.3	10.3	6.2	13.0	6.0	5.9	10.1	4.2	11.6	15.7	8.0	8.1	5.0	8.0	8.9	10.4	9.4	6.1	6.0	9.9	6.0	34.4	17.3	6.3	18.8	11.5	9.5	6.0	6.3	6.5	6.8	6.7	16.2	7.4	23.1	6.8	11.0	7.2	7.5	16.9	7.2	11.5	9.1	10.9	6.8	10.3	9.4	11.4	7.4	21.8	7.9	3.5	10.7	3.9	14.5	7.7	12.6	10.2	20.0	13.1	10.9	16.3	13.8	12.8	11.7	7.5	14.7	11.3	3.6	11.9	6.2	7.5	13.9	18.4	7.9	6.8	16.7	8.9	8.9	5.8	12.9	19.0	9.9	11.1	13.4	5.2	6.5	10.2	40.2	10.3	14.2	18.1	15.5	9.1	10.3	8.5	6.3	17.5	14.7	7.2	11.9	8.1	9.5	13.3	3.9	6.3	9.7	4.5	8.6	14.6	6.7	9.5	8.5	5.6	7.1	16.6	11.8	6.0	13.1	6.2	21.8	3.6	6.3	5.5	11.4	7.6	6.5	7.4	8.1	10.7	9.0	7.4	3.5	7.9	7.0	5.6	3.9	7.8	12.2	8.3	10.3	8.0	8.9	9.9	6.0	9.5	7.2
INPP1		ENSG00000151689	"Inositol polyphosphate-1-phosphatase"	P49441	2	190343470-190371665	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036698, HPA036699"	Supported		Approved	"Centriolar satellite,Cytosol"			15000	"Centriolar satellite"	Cytosol	"HPA036698: AB_10672226, HPA036699: "	"unprognostic (1.08e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"prognostic favourable (1.12e-5)"	"prognostic favourable (5.70e-4)"	14.9	25.8	18.3	9.1	26.5	10.3	32.5	17.4	25.1	15.0	19.8	20.4	11.5	27.4	12.0	10.8	42.7	9.8	20.6	17.7	21.2	17.9	11.0	24.8	19.9	8.8	21.0	16.5	10.0	25.6	32.3	17.0	10.4	18.6	10.0	16.8	12.0	9.9	16.0	13.1	28.3	28.0	15.5	23.6	15.7	13.9	31.4	17.1	4.6	12.9	14.0	15.4	19.2	18.8	1.8	3.5	36.6	3.4	6.2	8.0	1.9	10.8	3.0	5.9	0.0	6.5	14.0	0.1	13.1	17.5	12.3	16.2	11.8	6.9	0.0	15.6	12.5	15.0	2.4	8.4	15.1	13.3	4.6	8.2	9.6	7.0	13.7	6.0	2.6	9.5	13.0	14.0	8.1	22.9	19.4	6.9	21.6	0.0	0.4	5.8	1.7	16.8	0.2	4.8	0.1	9.5	25.9	8.8	3.3	9.0	0.5	12.7	0.0	8.8	21.2	7.9	5.6	14.1	7.6	1.3	1.4	0.1	2.5	2.4	6.2	8.1	3.4	36.6	3.0	3.1	2.7	1.4	1.9	2.0	3.5	1.8	1.0	1.5	1.6	6.2	1.8	0.1	8.0	1.9	18.3	26.5	17.4	25.1	21.2	17.9	21.0	16.5	18.6	17.1
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Approved	Cytosol				Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favourable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	14.5	10.2	11.7	15.9	18.2	22.3	12.8	25.4	16.1	15.3	18.3	21.0	9.4	9.3	19.5	13.7	9.9	15.0	13.7	14.3	12.2	9.0	11.7	16.2	18.7	21.1	23.2	11.4	28.7	11.4	13.1	14.4	14.3	15.9	12.0	13.7	18.9	9.4	16.0	9.7	12.0	13.9	17.5	18.5	19.0	14.7	8.6	21.8	17.4	13.8	4.7	22.3	17.4	13.2	6.7	5.3	19.1	4.7	5.3	9.1	3.8	3.7	2.8	6.6	10.5	8.2	10.6	11.6	4.6	8.1	5.8	8.4	4.3	5.6	13.8	2.2	8.4	5.1	8.6	3.3	7.7	8.9	3.8	21.0	9.0	2.8	12.0	11.1	30.5	12.4	2.1	6.1	3.9	7.0	7.1	18.0	8.0	3.2	8.9	11.8	9.2	2.2	10.9	13.0	6.5	3.4	3.4	2.6	4.5	4.9	2.3	12.0	2.9	9.8	6.9	5.9	5.5	5.5	4.2	14.7	7.1	11.1	7.0	10.4	5.0	19.1	2.5	13.2	6.3	2.0	9.1	6.5	4.5	6.1	5.3	6.7	5.8	5.3	3.4	5.3	4.7	4.8	5.6	3.8	11.7	18.2	25.4	16.1	12.2	9.0	23.2	11.4	15.9	21.8
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in many"		"HEL: 31.2;HMC-1: 32.8;hTCEpi: 30.0;NB-4: 29.3;THP-1: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016300, HPA070455"	Enhanced		Approved	Cytosol				Cytosol		"CAB016300: AB_628250, HPA070455: "	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	7.1	3.1	7.2	33.0	10.7	24.6	4.7	1.7	6.9	3.6	3.7	12.5	0.7	3.5	4.1	2.9	3.3	3.3	6.7	3.2	6.6	9.1	5.1	3.3	8.0	26.1	8.8	2.6	1.9	2.1	1.6	3.4	7.4	7.6	4.5	4.5	3.3	18.8	3.0	1.9	3.4	15.8	3.4	17.6	40.9	4.1	2.4	9.5	16.7	3.1	3.4	32.3	6.2	3.5	14.5	12.0	10.5	18.2	11.9	16.7	14.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.4	5.9	0.0	0.0	0.0	0.0	15.1	0.0	5.0	0.0	31.2	0.0	2.9	0.2	9.4	32.8	0.6	30.0	0.1	3.3	4.3	0.1	2.7	0.1	0.0	4.3	29.3	1.0	0.0	9.1	0.0	2.1	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	20.9	3.6	0.0	0.5	0.0	0.0	0.0	1.6	9.0	0.0	12.1	0.0	9.8	9.8	10.5	16.7	15.8	11.4	14.5	7.5	12.3	12.0	13.9	6.3	8.8	9.9	11.9	18.2	6.0	10.2	14.0	7.2	10.7	1.7	6.9	6.6	9.1	8.8	2.6	7.6	9.5
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.2;thyroid gland: 71.2"	"Cell line enhanced"	"Detected in many"		"HL-60: 12.1;SK-BR-3: 26.2;T-47d: 16.5;U-698: 11.4"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034539			Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favourable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	0.9	4.6	0.8	6.3	0.5	3.7	27.4	13.4	1.5	6.4	0.8	16.7	7.9	1.3	0.8	1.0	1.0	1.0	9.5	7.4	2.0	9.5	0.5	1.5	0.7	2.3	4.6	0.8	5.3	65.2	3.7	0.5	5.5	3.5	2.2	5.6	15.5	19.2	1.6	1.7	21.7	1.2	0.9	0.6	3.8	1.6	1.1	0.0	71.2	0.0	0.7	1.1	0.9	0.3	2.4	0.0	0.4	0.0	0.0	0.2	1.3	1.3	0.8	1.4	0.2	0.1	0.7	0.5	0.5	2.6	2.6	0.7	0.8	0.0	0.6	0.2	1.5	1.6	0.7	1.1	0.0	4.2	0.0	5.5	0.2	0.5	12.1	0.1	0.1	0.8	2.2	0.2	0.1	1.1	1.8	0.0	4.0	0.1	0.0	1.4	0.2	0.0	0.3	2.8	1.1	1.6	6.4	4.8	1.0	26.2	0.3	16.5	1.0	0.0	0.1	4.8	0.5	0.3	0.0	2.0	11.4	0.4	0.0	2.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	4.6	6.3	27.4	13.4	7.4	2.0	2.3	4.6	5.5	1.1
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239105	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	20.9	23.7	22.2	20.4	19.5	25.1	18.6	11.1	18.9	25.2	32.0	22.7	28.8	19.8	24.7	18.4	17.4	24.3	29.6	29.5	24.1	10.3	23.9	17.1	24.9	19.0	27.6	10.4	30.1	22.7	21.6	26.9	31.9	20.4	28.7	13.5	30.7	27.5	24.2	60.0	17.7	23.0	34.7	27.5	28.3	24.5	11.8	24.3	16.0	29.1	19.3	18.3	25.0	18.1	2.6	5.2	7.0	7.6	4.2	4.5	3.3	6.4	13.8	16.6	11.3	8.2	9.8	29.6	29.8	13.9	18.7	11.9	18.9	16.3	18.4	30.5	22.8	24.6	13.6	8.4	6.4	23.8	14.2	19.1	70.0	6.9	16.1	12.6	42.8	13.9	8.9	18.1	7.2	10.0	13.4	7.9	10.2	17.4	9.3	51.0	16.9	21.6	43.9	37.7	4.1	21.7	10.8	8.1	11.8	32.0	19.3	41.6	20.4	23.9	16.9	20.1	23.5	30.7	9.7	22.9	3.8	17.9	5.7	12.0	10.8	5.2	7.6	7.0	4.5	4.4	3.7	2.2	3.7	3.0	5.2	2.6	2.7	3.7	5.2	4.2	7.0	3.9	3.3	3.3	22.2	19.5	11.1	18.9	24.1	10.3	27.6	10.4	20.4	24.3
INTS10	"C8orf35, FLJ10569, INT10"	ENSG00000104613	"Integrator complex subunit 10"	Q9NVR2	8	19817140-19852083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039129, HPA050570"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA039129: AB_10794424, HPA050570: "	"unprognostic (9.11e-2)"	"unprognostic (8.41e-3)"	"prognostic favourable (4.00e-4)"	"prognostic favourable (1.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.33e-1)"	21.9	20.9	31.4	18.9	30.2	22.8	23.5	38.5	28.4	23.7	23.2	23.2	19.9	21.3	18.8	17.4	21.8	31.4	17.0	20.9	31.1	27.1	25.0	42.7	19.2	21.9	28.3	18.4	21.6	39.1	18.1	25.5	18.0	21.2	24.5	22.2	17.3	23.2	26.0	20.7	25.7	19.5	22.0	28.7	21.4	19.4	12.0	24.3	26.9	34.9	21.1	25.0	20.8	23.7	17.8	20.0	8.8	15.0	16.9	21.2	12.6	15.2	22.3	12.3	16.0	18.4	20.6	16.8	11.1	18.9	15.6	14.8	12.4	7.7	42.9	19.6	12.1	16.4	14.5	14.3	17.6	8.5	16.3	19.9	24.9	24.0	13.7	17.1	13.7	16.4	22.5	11.6	18.1	14.9	23.9	34.5	10.6	13.3	30.9	20.4	17.4	12.2	16.7	14.8	27.8	19.3	23.7	12.5	9.9	15.7	19.7	13.8	10.2	17.6	12.1	9.9	14.2	23.3	15.5	9.7	12.4	32.5	20.2	24.2	16.3	6.6	15.0	8.8	13.9	13.8	21.2	17.8	17.8	17.5	20.0	15.1	19.9	17.6	5.4	16.9	11.5	17.0	19.9	12.6	31.4	30.2	38.5	28.4	31.1	27.1	28.3	18.4	21.2	24.3
INTS11	"CPSF3L, CPSF73L, FLJ20542, INT11, RC-68"	ENSG00000127054	"Integrator complex subunit 11"	Q5TA45	1	1311585-1324691	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028379, HPA029025"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA028379: AB_10599598, HPA029025: AB_10600425"	"unprognostic (7.54e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavourable (7.44e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-3)"	"unprognostic (5.14e-2)"	"unprognostic (5.62e-3)"	21.4	22.5	22.8	25.4	24.9	23.2	26.9	50.8	30.4	26.5	31.2	32.1	24.1	29.1	33.1	39.8	25.3	39.1	24.8	29.8	23.7	19.8	23.5	26.7	19.7	25.7	25.9	25.8	34.1	33.5	24.1	26.9	25.8	21.0	29.5	19.9	20.4	33.8	28.0	52.8	28.6	25.4	34.0	20.0	27.3	27.9	57.8	25.9	28.5	23.3	23.5	22.5	27.5	25.7	24.6	37.7	22.0	42.2	28.4	35.2	32.4	21.1	21.9	12.4	23.7	21.3	17.3	13.4	11.7	19.7	27.2	20.2	19.7	26.9	23.7	17.0	23.8	15.6	18.4	26.2	12.1	22.2	24.0	18.2	29.8	26.5	32.8	14.4	20.1	29.2	14.3	24.7	37.2	28.4	21.6	21.6	13.4	19.1	28.4	19.6	15.0	23.6	22.4	11.7	34.1	19.1	10.8	17.5	16.2	11.8	31.9	33.2	17.2	21.1	20.4	16.9	15.4	19.2	14.9	33.9	36.3	30.8	23.7	25.6	8.3	22.0	32.3	20.8	31.7	37.2	33.8	24.6	28.1	29.3	37.7	20.3	26.5	24.9	15.3	28.4	42.2	24.5	35.2	32.4	22.8	24.9	50.8	30.4	23.7	19.8	25.9	25.8	21.0	25.9
INTS12	"INT12, PHF22, SBBI22"	ENSG00000138785	"Integrator complex subunit 12"	Q96CB8	4	105682627-105895986	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035772, HPA041814"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies, Plasma membrane"	"HPA035772: AB_10671109, HPA041814: "	"unprognostic (5.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-1)"	16.7	13.5	18.7	12.5	20.7	25.3	20.0	17.3	18.1	14.5	17.0	13.4	11.6	17.0	16.1	17.9	13.6	14.4	12.3	19.3	18.3	15.3	18.2	21.4	15.4	12.1	16.5	11.5	15.0	16.0	17.3	20.7	11.2	17.4	18.1	15.4	10.4	14.8	13.7	28.2	14.1	21.0	16.6	19.3	15.9	14.9	12.6	13.8	22.1	31.1	15.9	15.4	13.8	12.6	20.6	27.6	33.3	17.0	27.1	21.9	14.0	12.5	6.7	15.4	15.9	15.2	18.2	11.2	14.9	15.5	18.8	19.6	9.4	14.3	18.1	8.3	16.7	7.3	16.8	21.5	23.4	18.9	10.2	13.6	10.9	13.2	24.5	23.9	12.4	17.1	28.0	18.6	28.1	17.2	20.2	14.3	20.2	13.2	28.0	14.9	6.6	10.3	14.4	16.7	13.8	17.5	8.5	16.6	13.3	10.5	17.4	16.3	14.1	14.1	11.2	12.4	12.7	13.3	15.9	22.1	20.4	27.0	13.7	16.4	24.4	33.3	15.9	24.1	17.9	16.8	20.0	20.6	20.6	20.2	18.0	19.3	21.6	20.2	12.1	27.1	17.0	27.6	21.9	14.0	18.7	20.7	17.3	18.1	18.3	15.3	16.5	11.5	17.4	13.8
INTS5	"INT5, KIAA1698"	ENSG00000185085	"Integrator complex subunit 5"	Q6P9B9	11	62646848-62653302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046181, HPA056915"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046181: , HPA056915: "	"unprognostic (2.87e-1)"	"unprognostic (9.51e-2)"	"unprognostic (9.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-2)"	"prognostic favourable (8.44e-5)"	"unprognostic (7.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.35e-2)"	13.8	13.2	9.1	14.0	8.9	6.5	17.2	9.7	16.5	12.8	11.0	7.0	14.3	10.9	16.0	10.6	16.0	19.1	14.0	14.3	7.4	6.7	12.0	19.9	11.6	22.3	7.8	7.6	15.4	21.3	17.4	9.5	12.1	6.9	12.4	8.5	11.0	16.0	17.4	17.3	15.7	11.2	11.9	5.5	14.8	12.4	9.4	6.6	26.0	16.4	10.8	12.8	12.6	15.7	7.6	7.2	5.1	6.2	10.1	14.3	7.0	11.2	13.9	8.2	7.6	16.2	11.9	7.7	9.3	9.6	12.7	9.1	9.8	12.6	21.5	17.0	11.8	17.7	16.4	21.7	6.1	13.4	11.4	11.1	11.1	6.6	14.7	12.2	10.7	13.7	17.1	13.5	11.7	12.5	16.9	12.7	10.8	23.1	13.9	14.3	12.5	17.7	14.4	11.1	25.8	9.7	7.4	11.1	9.4	10.5	14.7	14.5	21.0	8.4	10.3	12.2	9.4	18.6	8.4	17.9	13.7	15.4	14.0	9.3	11.4	5.1	6.2	4.8	8.7	4.6	14.3	5.8	8.2	7.7	7.1	7.6	9.6	8.7	2.6	10.1	5.1	7.2	6.1	7.0	9.1	8.9	9.7	16.5	7.4	6.7	7.8	7.6	6.9	6.6
INVS	NPHP2	ENSG00000119509	Inversin	Q9Y283	9	100099256-100301000	"Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Calmodulin-binding, Developmental protein"	"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049994			Approved	Cytosol				Cytosol		"HPA049994: "	"unprognostic (3.84e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (3.53e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.83e-1)"	11.9	13.4	9.5	10.7	15.8	7.9	10.1	18.6	15.7	13.4	11.3	14.6	12.4	7.6	16.5	12.3	9.2	10.3	10.4	9.7	10.4	7.1	16.4	17.1	10.2	10.2	15.8	8.5	19.2	9.7	20.9	26.0	11.1	12.1	12.0	9.1	12.8	8.2	10.4	7.2	7.0	9.4	11.9	15.3	10.1	9.1	12.0	15.5	16.9	12.5	4.6	10.7	10.4	15.4	6.0	3.5	3.9	3.8	4.7	5.3	2.6	6.6	12.2	10.2	10.9	13.2	10.9	8.5	7.8	8.5	7.1	5.7	6.5	4.2	15.5	4.7	9.3	10.4	8.2	10.3	5.9	12.0	5.5	11.7	10.7	6.7	9.7	11.7	9.7	11.0	12.9	7.7	15.2	12.8	10.1	9.5	7.5	5.9	9.2	4.6	6.0	7.4	8.4	18.1	3.7	6.6	6.3	9.5	7.5	8.9	5.5	8.9	3.9	6.5	9.5	8.4	6.0	8.4	5.9	9.8	11.6	3.2	8.6	5.0	4.4	0.0	2.5	3.9	4.9	1.7	4.3	5.3	4.1	2.6	3.5	6.0	5.3	5.1	0.2	4.7	3.8	3.5	2.6	2.6	9.5	15.8	18.6	15.7	10.4	7.1	15.8	8.5	12.1	15.5
IP6K1	"IHPK1, KIAA0263"	ENSG00000176095	"Inositol hexakisphosphate kinase 1"	Q92551	3	49724294-49786542	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040825	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040825: AB_10960426"	"unprognostic (6.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (2.08e-4)"	"unprognostic (9.97e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic favourable (6.85e-4)"	"unprognostic (1.29e-2)"	"prognostic favourable (5.77e-5)"	"unprognostic (8.75e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.64e-2)"	14.2	17.5	23.5	12.9	26.9	12.1	15.8	38.6	40.4	17.7	16.1	20.7	16.1	13.6	21.4	14.5	19.6	20.0	14.7	13.7	23.8	23.5	16.3	15.9	16.9	16.3	17.9	18.3	30.2	21.9	30.3	16.7	18.3	21.2	14.3	13.2	18.6	18.3	21.1	9.0	18.2	12.7	19.5	16.9	16.9	13.7	27.3	14.8	22.3	17.1	8.4	14.4	16.3	15.6	6.8	4.1	24.0	4.8	6.9	9.7	6.0	12.3	15.0	17.6	20.6	18.4	14.2	14.2	16.5	17.4	27.1	23.8	19.4	12.9	10.8	10.7	18.2	9.2	24.8	14.9	15.4	21.6	19.7	24.4	23.0	13.1	20.3	14.9	17.1	16.5	18.6	29.2	17.7	22.6	15.9	12.7	13.3	11.0	18.1	15.6	18.9	25.0	11.5	12.5	21.6	17.5	18.9	9.5	19.0	21.0	13.7	18.9	11.0	22.0	20.2	15.2	15.3	20.8	19.1	15.5	20.8	11.5	13.9	17.3	15.5	2.5	4.8	8.2	8.7	3.9	8.8	4.6	8.0	9.6	4.1	6.8	9.7	9.5	24.0	6.9	4.8	2.9	8.2	6.0	23.5	26.9	38.6	40.4	23.8	23.5	17.9	18.3	21.2	14.8
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721670-33746905	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 22.5;skeletal muscle: 87.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 15.8;HSkMC: 5.7;LHCN-M2: 25.1;RH-30: 11.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA053644	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053644: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	2.2	1.0	2.1	0.8	13.0	0.5	0.9	0.6	6.2	1.2	2.2	11.8	1.4	0.8	1.6	1.4	5.2	1.3	0.6	10.0	3.2	1.3	4.7	7.7	2.0	0.6	22.5	1.1	0.6	0.7	0.5	0.5	3.8	7.7	2.8	1.0	1.2	1.4	1.8	87.9	0.5	1.1	1.8	9.2	1.4	0.9	0.6	15.2	0.0	9.9	8.1	0.5	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.1	0.2	0.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	5.7	0.8	0.1	0.4	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	13.0	0.6	6.2	3.2	1.3	22.5	1.1	7.7	15.2
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	25.5	15.3	13.6	14.2	17.1	8.8	22.2	18.4	18.3	19.5	13.7	14.2	17.4	10.4	19.9	13.9	18.6	16.1	16.4	20.0	15.2	13.4	18.5	16.9	12.8	14.2	14.9	13.7	18.6	14.4	23.9	20.9	24.4	17.1	15.9	13.7	13.2	14.8	16.6	19.0	14.0	12.3	17.0	14.4	26.3	13.7	30.9	13.3	18.8	21.7	15.7	15.0	19.8	24.4	4.2	3.6	12.2	5.6	18.0	5.3	3.2	11.7	11.1	10.3	15.9	8.4	11.4	14.0	12.7	9.7	13.3	15.0	12.4	9.3	20.2	10.2	12.9	9.7	21.3	14.8	21.1	7.6	11.2	9.4	11.4	11.1	6.1	10.6	5.4	8.1	8.6	16.0	17.2	50.4	17.7	6.6	13.3	11.1	11.2	13.8	13.2	6.8	13.7	15.2	18.3	8.3	11.6	11.0	6.4	11.1	8.8	9.0	11.3	7.4	22.7	8.0	8.9	8.9	11.6	5.2	8.5	14.0	10.0	14.8	9.6	12.2	2.1	1.8	3.5	3.4	4.2	3.1	3.7	3.6	3.6	4.2	5.3	3.8	2.1	18.0	5.6	2.3	2.3	3.2	13.6	17.1	18.4	18.3	15.2	13.4	14.9	13.7	17.1	13.3
IPO4	"FLJ23338, Imp4"	ENSG00000196497	"Importin 4"	Q8TEX9	14	24180219-24188964	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039043, HPA064572"	Uncertain		Approved	Cytosol				Cytosol		"HPA039043: AB_10673233, HPA064572: AB_2685291"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavourable (8.08e-6)"	"unprognostic (9.45e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.28e-2)"	"prognostic unfavourable (3.20e-4)"	"unprognostic (8.59e-4)"	"unprognostic (5.45e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.15e-2)"	5.3	8.1	1.2	5.2	2.2	6.9	6.1	1.7	3.3	6.5	5.8	2.8	5.5	7.5	5.4	6.5	8.8	6.3	4.4	3.6	2.2	1.6	18.0	29.0	4.4	10.8	1.8	1.2	9.8	27.0	2.2	6.4	4.4	4.1	5.0	2.3	3.0	8.7	7.9	17.2	8.5	4.7	5.3	2.4	8.8	6.9	49.5	1.4	8.8	6.5	11.0	7.4	5.7	4.0	3.5	5.3	0.3	3.0	3.6	5.4	2.2	7.7	10.3	0.9	6.1	0.8	1.2	10.5	4.8	0.2	2.3	0.7	8.8	3.8	11.2	7.7	1.7	8.7	3.6	6.8	0.3	5.4	15.4	6.9	3.2	19.8	0.7	8.4	5.0	1.6	2.2	2.1	0.7	2.2	13.0	0.9	2.4	17.2	5.4	7.5	9.3	22.6	7.4	4.4	6.0	2.1	5.4	8.0	8.6	7.9	3.7	4.1	6.8	2.0	4.0	4.7	11.5	5.1	6.9	7.9	11.8	9.9	3.2	4.5	7.8	0.0	1.9	0.3	4.8	2.6	5.4	2.8	4.6	4.4	3.1	3.5	3.6	5.0	0.0	3.6	3.0	5.3	2.2	2.2	1.2	2.2	1.7	2.8	2.2	1.6	1.8	1.2	4.1	1.4
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024297	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol			92000	"Nucleoplasm, Cytosol"		"CAB009110: AB_2264985, HPA040983: , HPA056548: "	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	26.3	13.8	16.5	14.5	18.3	13.0	23.5	16.3	20.2	20.2	19.7	15.9	13.5	9.6	21.1	13.4	19.4	18.9	12.4	23.9	15.7	12.7	18.9	23.2	14.1	16.0	20.8	15.9	33.5	60.7	12.5	13.0	14.3	15.3	19.1	16.6	11.0	13.9	20.2	65.0	13.5	11.3	25.5	24.3	14.9	18.9	79.5	19.4	23.3	23.0	24.1	21.1	21.8	23.9	8.0	11.0	1.1	7.3	10.3	12.3	6.1	28.2	19.1	35.8	32.8	24.4	62.1	22.0	41.6	32.8	58.7	41.8	39.1	21.8	81.8	14.6	50.0	24.6	74.4	28.5	81.2	20.6	23.4	44.5	36.2	30.6	17.4	48.0	15.9	34.8	18.8	47.6	40.1	33.4	30.7	11.0	50.1	7.7	36.2	13.0	36.0	22.9	46.6	40.7	24.2	14.1	18.6	26.6	21.7	21.4	25.0	15.6	18.9	26.5	23.4	39.7	20.0	19.8	37.8	14.8	18.2	25.5	41.0	30.5	27.1	0.5	4.4	1.1	7.1	7.3	12.3	8.0	8.3	8.8	11.0	7.6	11.6	9.6	0.6	10.3	5.1	5.4	8.5	6.1	16.5	18.3	16.3	20.2	15.7	12.7	20.8	15.9	15.3	19.4
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384622-9448126	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol			26000	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: "	"unprognostic (1.92e-1)"	"prognostic unfavourable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	23.9	20.6	21.8	18.6	24.4	12.3	36.0	24.1	30.6	24.3	27.4	14.4	19.3	17.0	25.7	19.3	29.0	20.3	20.3	37.7	22.8	23.4	26.5	24.7	22.0	23.2	23.3	17.4	23.4	25.9	33.1	19.1	26.5	24.8	24.4	22.1	12.0	21.4	22.4	88.2	17.1	16.1	53.4	25.7	16.6	21.5	9.7	16.8	20.8	34.3	28.5	20.9	43.7	33.9	3.8	5.8	1.3	6.3	6.9	5.4	1.6	37.3	29.2	34.4	27.3	34.9	45.1	27.6	45.5	29.3	33.7	36.5	25.3	34.4	35.1	16.6	35.0	29.4	48.8	35.3	56.3	16.7	40.3	29.0	33.2	25.3	21.8	44.3	22.1	28.8	38.3	22.1	52.2	39.7	43.4	21.1	43.8	15.2	26.7	21.7	33.9	34.0	28.1	54.2	15.8	27.8	35.3	13.7	26.9	20.3	40.3	32.8	18.5	22.3	31.1	41.5	28.6	42.7	48.6	6.1	23.4	24.2	27.2	23.9	22.5	0.1	2.5	0.6	2.7	4.8	5.4	3.8	3.1	3.9	5.8	3.1	3.9	3.2	1.3	6.9	6.3	2.7	2.8	1.6	21.8	24.4	24.1	30.6	22.8	23.4	23.3	17.4	24.8	16.8
IPO9	"FLJ10402, Imp9"	ENSG00000198700	"Importin 9"	Q96P70	1	201829141-201884294	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059540			Approved	Vesicles,Cytosol	"Intracellular and membrane"		30000	Cytosol	Vesicles	"HPA059540: "	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (4.11e-5)"	"unprognostic (8.92e-3)"	"unprognostic (2.23e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (5.78e-4)"	16.8	18.0	27.1	14.2	26.5	11.0	15.2	29.1	27.8	14.2	14.3	18.7	11.0	11.5	19.7	24.2	15.2	17.4	12.2	12.0	22.3	17.9	14.9	23.1	16.5	15.7	17.7	22.8	20.9	16.5	24.9	26.0	18.1	21.2	16.3	18.1	24.7	11.2	14.7	15.4	21.9	13.3	21.5	15.0	18.3	13.4	12.8	17.2	21.1	18.4	8.4	20.3	14.4	13.7	10.9	14.6	10.7	15.3	11.0	13.3	8.3	18.4	19.6	26.9	21.8	15.6	10.6	20.2	14.3	14.5	23.9	23.3	31.4	16.2	11.0	8.1	13.7	17.2	18.2	19.8	20.7	10.0	16.1	8.2	31.9	23.4	11.9	10.7	13.5	11.7	9.1	25.7	21.0	23.9	16.3	10.5	17.0	18.5	12.3	14.0	27.0	6.4	13.2	28.0	10.9	13.0	29.6	22.9	26.0	15.7	25.0	12.6	18.3	13.5	13.0	22.5	20.1	12.6	26.1	7.7	4.7	12.7	11.2	12.6	16.8	10.7	11.7	9.7	12.2	15.3	10.6	10.9	11.9	13.3	14.6	10.3	9.7	10.4	2.9	11.0	14.9	7.7	10.7	8.3	27.1	26.5	29.1	27.8	22.3	17.9	17.7	22.8	21.2	17.2
IPPK	"C9orf12, FLJ13163, INSP5K2, IP5K, IPK1"	ENSG00000127080	"Inositol-pentakisphosphate 2-kinase"	Q9H8X2	9	92613184-92670265	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020603	Uncertain		Approved	Cytosol				Cytosol		"HPA020603: AB_1851853"	"unprognostic (3.51e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.26e-9)"	"unprognostic (1.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (1.28e-4)"	5.0	7.5	7.6	5.2	12.3	8.3	7.5	13.4	14.1	7.9	4.7	9.7	6.8	3.7	6.0	5.9	29.7	6.4	5.3	8.1	7.9	5.9	5.2	5.8	4.9	6.0	7.1	5.7	6.5	4.2	11.3	11.0	7.1	10.0	5.1	5.3	6.0	10.8	4.3	6.9	31.5	4.6	6.3	6.4	5.8	4.8	12.0	7.7	5.7	5.5	17.8	16.1	4.9	13.7	4.2	3.9	5.8	3.2	1.4	7.5	3.1	11.7	6.3	5.8	5.0	7.2	5.4	19.3	8.4	5.2	8.6	5.0	3.9	4.7	7.3	4.2	11.7	16.9	10.2	11.7	7.2	9.1	6.6	6.0	13.4	6.0	5.1	10.1	7.1	5.3	11.6	10.3	8.1	6.4	8.1	8.9	8.5	16.0	5.8	4.7	9.9	9.4	5.1	6.3	2.9	5.1	7.2	12.2	7.2	6.8	28.2	4.9	6.7	2.5	12.4	6.4	7.3	17.9	8.8	8.2	9.6	4.1	8.4	4.6	6.2	0.0	2.3	5.8	6.4	3.1	7.3	4.1	5.6	5.7	3.6	4.2	4.4	4.8	3.6	1.4	3.2	3.9	7.5	3.1	7.6	12.3	13.4	14.1	7.9	5.9	7.1	5.7	10.0	7.7
IQCE	KIAA1023	ENSG00000106012	"IQ motif containing E"	Q6IPM2	7	2558972-2614734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019515	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA019515: AB_1851855"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.78e-2)"	"prognostic favourable (5.91e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.56e-3)"	"unprognostic (3.13e-2)"	5.5	7.6	15.1	6.8	17.0	7.0	7.4	11.1	18.7	6.9	10.2	12.8	6.7	13.1	9.6	12.3	6.6	17.1	11.2	7.1	14.3	15.6	7.1	3.6	9.1	4.7	12.0	12.1	9.7	8.4	12.9	15.4	4.1	11.3	8.1	9.9	7.3	9.8	11.2	4.5	8.1	10.9	7.9	11.1	5.1	10.6	35.3	9.6	2.8	11.9	3.0	3.9	6.0	7.4	0.7	4.3	8.3	2.1	0.3	1.3	0.3	19.7	10.3	4.5	13.6	5.5	8.4	7.7	4.2	7.0	5.5	6.0	5.3	11.4	1.4	4.8	9.7	10.3	3.0	4.8	5.8	3.4	6.4	2.7	12.5	1.7	4.1	7.0	4.0	3.5	8.0	5.3	5.6	5.9	8.5	2.6	7.3	20.1	3.1	5.4	3.8	7.6	3.0	5.1	5.1	5.9	9.2	9.4	11.0	4.7	19.7	4.3	24.1	9.6	5.8	4.6	9.3	17.5	7.0	2.9	4.8	0.3	9.1	5.1	12.9	1.1	1.4	3.6	1.3	2.1	0.5	0.5	0.7	0.6	0.6	0.7	0.5	1.1	8.3	0.3	0.7	4.3	0.3	0.3	15.1	17.0	11.1	18.7	14.3	15.6	12.0	12.1	11.3	9.6
IQCG	"CFAP122, DKFZp434B227, DRC9"	ENSG00000114473	"IQ motif containing G"	Q9H095	3	197889075-197960142	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 44.9;testis: 34.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042787, HPA051981"	Enhanced		Approved	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA042787: AB_10797021, HPA051981: "	"unprognostic (1.50e-2)"	"unprognostic (6.20e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.75e-2)"	6.2	5.0	10.9	3.0	14.6	3.0	5.4	3.6	7.6	5.7	3.0	12.3	4.1	2.5	4.5	11.6	3.9	44.9	4.4	4.2	12.6	12.9	5.9	3.6	8.0	3.9	9.0	5.7	5.0	2.1	4.5	12.0	3.4	20.8	3.9	3.7	5.3	2.5	4.6	2.0	2.8	2.6	4.1	9.2	3.1	3.4	34.2	11.2	1.4	7.4	1.0	3.9	4.5	2.2	8.9	7.3	8.9	8.4	6.6	9.1	5.0	3.8	4.2	5.5	5.3	11.9	12.2	2.2	4.7	5.2	5.5	5.8	0.8	3.7	1.3	5.3	3.8	3.6	3.9	3.6	9.1	2.9	2.7	2.3	2.2	2.0	2.7	3.1	3.7	6.2	4.6	6.0	2.0	2.6	2.4	5.2	4.2	8.8	1.7	1.5	3.3	5.6	4.9	3.6	1.9	5.4	1.6	4.8	5.8	7.9	3.2	3.2	23.9	2.1	2.7	3.6	2.4	10.8	4.3	4.6	12.9	2.3	13.3	4.4	5.8	4.6	8.4	8.9	8.2	6.4	5.3	8.9	6.9	5.4	7.3	4.2	6.2	9.1	5.8	6.6	5.7	6.5	6.8	5.0	10.9	14.6	3.6	7.6	12.6	12.9	9.0	5.7	20.8	11.2
IQCH	FLJ12476	ENSG00000103599	"IQ motif containing H"	Q86VS3	15	67254800-67502260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.5;testis: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.0;dendritic cells: 1.2;T-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040845	Uncertain		Approved	Cytosol				Cytosol		"HPA040845: AB_10672898"	"unprognostic (2.69e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.89e-5)"	"unprognostic (2.48e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.16e-3)"	"unprognostic (6.42e-2)"	0.9	1.8	1.3	0.4	2.9	0.2	2.5	0.9	2.8	1.4	0.8	2.9	4.1	0.3	1.3	6.4	0.9	10.0	2.1	1.3	1.6	2.1	3.3	1.5	2.4	0.5	1.2	1.8	2.7	1.4	6.5	14.5	0.5	2.6	1.2	1.1	3.5	1.0	1.4	0.9	1.0	0.8	0.6	1.4	0.8	1.6	20.9	1.4	0.6	6.1	0.7	0.4	1.3	1.0	1.0	1.2	0.1	0.3	0.2	2.1	0.3	2.8	3.0	1.3	2.2	2.0	4.6	1.0	1.5	1.2	2.4	1.6	0.3	3.1	1.8	1.4	2.5	4.7	4.3	1.7	3.9	0.3	2.0	0.6	3.0	0.4	3.4	0.9	0.6	3.1	1.8	5.0	4.8	0.9	4.2	1.9	1.6	3.0	0.7	0.7	1.6	1.9	0.6	2.1	2.1	2.7	1.2	4.5	1.2	2.0	2.8	7.8	7.2	0.4	2.0	2.6	1.3	4.1	1.7	4.0	5.3	0.5	5.3	2.1	2.6	0.0	0.3	0.1	1.2	0.0	2.1	0.4	1.0	1.1	1.1	1.0	0.9	0.8	0.0	0.2	0.1	1.2	0.8	0.3	1.3	2.9	0.9	2.8	1.6	2.1	1.2	1.8	2.6	1.4
IQCJ-SCHIP1		ENSG00000283154	"IQCJ-SCHIP1 readthrough"	B3KU38	3	158962235-159897366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Low cell line specificity"	"Detected in many"											"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"											"HPA003243, HPA003445"	Approved		Approved	Cytosol				Cytosol		"HPA003243: AB_1079877, HPA003445: AB_1079875"																		5.3	2.1	11.1	4.1	12.4	0.5	2.4	1.5	30.0	1.9	3.8	17.8	0.3	1.7	5.6	2.8	7.3	1.4	5.8	16.4	7.7		7.6	6.3	6.8	0.6	18.8	10.6	0.8	0.9	0.2	1.3	10.9	13.1	6.3	3.0	0.4	0.6	10.0	1.8	0.8	1.7	11.8	7.3	1.2	1.0	1.7	15.1	0.0	0.6	0.1	0.4	5.9	0.9	0.0	1.0	0.1	0.0	0.9	0.2	0.2	28.4	5.0	9.8	11.6	2.3	2.2	8.5	24.5	5.8	20.3	13.9	18.3	7.0	1.4	15.9	8.1	11.6	3.8	8.3	16.7	23.6	9.3	0.0	10.9	0.9	2.6	1.3	0.1	2.2	7.1	9.0	10.7	15.0	0.0	0.1	9.3	1.2	0.1	0.0	8.2	10.7	3.3	19.8	0.0	19.5	1.5	1.9	9.2	13.2	5.6	7.0	3.3	0.2	12.5	11.7	16.3	7.8	33.3	0.1	0.1	0.1	6.5	4.0	30.9	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.9	0.0	1.0	0.0	0.2										
IQCK	"FLJ36575, MGC35048"	ENSG00000174628	"IQ motif containing K"	Q8N0W5	16	19716456-19858467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026792, HPA048786"	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA026792: AB_1853889, HPA048786: "	"unprognostic (4.21e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	5.5	4.8	9.3	2.8	11.4	1.1	7.8	3.7	7.1	10.1	3.7	13.9	19.4	5.1	6.3	19.9	2.5	25.2	7.5	4.8	10.4	11.2	11.2	3.0	5.3	2.3	8.3	8.9	8.9	5.7	20.7	14.6	4.4	12.1	5.4	4.2	9.3	8.2	22.4	4.0	3.3	2.7	5.3	8.5	2.6	5.1	27.2	7.9	1.1	21.0	3.2	1.9	5.7	3.5	1.5	1.0	0.0	3.8	0.1	3.0	1.0	2.5	7.1	9.0	6.0	2.7	8.9	0.5	0.0	4.5	4.3	3.3	0.4	4.9	0.3	5.0	2.5	3.0	2.0	3.4	2.9	1.1	1.9	0.1	1.8	3.4	8.9	1.6	0.1	5.0	3.0	5.4	1.3	4.5	2.7	0.8	2.6	8.6	1.6	1.0	2.7	6.6	5.3	0.7	0.4	10.6	1.8	8.3	3.6	3.6	1.2	5.5	3.6	0.9	3.1	0.9	0.9	4.8	0.9	0.2	0.5	0.0	5.5	0.2	1.8	0.0	0.7	0.0	1.4	3.8	2.5	1.5	1.6	2.3	0.4	0.6	3.0	1.5	0.0	0.1	3.5	1.0	1.2	1.0	9.3	11.4	3.7	7.1	10.4	11.2	8.3	8.9	12.1	7.9
IQSEC3	"KIAA1110, MGC30156"	ENSG00000120645	"IQ motif and Sec7 domain 3"	Q9UPP2	12	66765-178460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8"	"Cell line enhanced"	"Detected in some"		"HEL: 9.4;U-266/70: 12.7;U-266/84: 3.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039025			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039025: AB_10672768"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.83e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-2)"	5.6	1.3	5.6	0.7	4.2	0.8	0.4	19.8	15.5	1.6	0.4	0.5	0.0	0.5	2.0	0.5	0.4	5.2	2.2	1.9	6.5	5.1	2.4	0.2	2.9	0.5	3.7	4.7	2.1	1.2	0.0	2.2	1.3	5.0	1.5	0.2	0.4	0.2	4.5	1.3	0.2	0.7	1.9	1.4	0.3	0.6	1.2	0.8	0.0	0.3	0.0	0.2	1.3	0.6	0.0	2.1	0.0	0.0	0.5	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.7	3.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	1.2	0.0	0.5	0.0	2.1	0.0	0.4	5.6	4.2	19.8	12.4	6.5	5.1	3.7	4.7	5.0	0.8
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452400-123535077	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.8;testis: 35.5"	"Cell line enhanced"	"Detected in some"		"K-562: 1.8;RPTEC TERT1: 7.1;T-47d: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nuclear speckles,Intermediate filaments,Cytosol"				"Nuclear speckles, Intermediate filaments"	Cytosol	"HPA049626: "	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.6	1.0	1.3	0.3	2.9	0.3	0.9	3.0	3.5	1.2	0.5	1.8	3.2	0.4	1.4	6.9	1.8	5.7	1.6	0.6	2.6	1.2	8.5	0.4	3.2	0.3	0.7	1.2	2.7	0.7	2.7	20.8	0.5	6.4	0.9	0.4	0.3	0.7	4.3	0.6	0.5	0.5	0.6	1.0	0.4	0.6	35.5	2.8	0.0	5.6	0.0	0.3	0.7	0.6	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.3	0.0	1.3	0.6	0.6	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.8	0.8	0.0	0.4	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.7	0.3	0.2	0.3	0.0	1.8	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.1	1.6	1.1	0.4	0.0	0.0	0.1	2.5	0.0	0.0	0.5	0.3	0.4	0.2	0.4	0.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.3	0.4	0.2	0.2	0.2	0.0	0.8	0.7	0.2	0.0	0.5	0.1	0.0	0.3	0.0	1.3	2.9	3.0	3.5	2.6	1.2	0.7	1.2	6.4	2.8
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010500-154019980	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: "	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	22.3	23.7	12.1	25.0	11.4	48.3	38.5	7.7	14.8	11.1	24.8	10.8	13.4	29.9	13.2	12.4	25.5	12.2	23.1	14.1	9.9	12.3	23.7	46.9	18.5	37.5	12.6	7.9	15.1	34.6	8.1	15.2	14.3	11.9	18.0	11.0	10.1	31.9	15.9	32.6	15.9	34.6	11.5	12.7	34.0	19.3	14.3	9.8	17.0	12.6	20.4	26.7	17.2	15.3	10.0	13.0	6.7	10.6	6.3	6.7	3.4	76.3	29.7	4.2	34.3	8.4	6.7	18.3	11.4	10.8	17.6	16.4	23.5	34.0	32.6	64.3	12.2	20.9	9.7	18.6	6.9	25.6	29.0	11.9	26.7	14.0	19.4	28.1	20.5	9.3	16.4	16.8	18.6	10.5	20.9	37.8	12.3	28.1	11.5	25.1	10.4	59.3	30.0	21.3	54.8	11.7	14.5	23.6	17.0	13.6	15.2	22.5	5.9	29.9	14.3	21.4	33.9	48.9	70.7	47.6	30.4	59.8	31.3	33.8	22.2	1.3	8.7	6.7	6.7	10.6	5.9	7.5	5.3	5.3	5.4	10.0	3.1	6.1	5.9	6.3	8.1	13.0	2.5	3.4	12.1	11.4	7.7	14.8	9.9	12.3	12.6	7.9	11.9	9.8
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol				Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favourable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (4.42e-5)"	18.0	9.4	5.1	15.0	10.4	10.3	11.3	3.7	6.0	10.3	12.2	9.1	12.5	10.2	13.0	14.1	15.0	9.4	10.8	7.6	6.7	5.2	13.3	11.8	12.0	24.0	13.2	3.9	9.3	20.1	9.1	16.1	14.0	9.8	10.5	10.0	11.9	11.9	15.1	4.1	15.2	15.0	11.8	13.0	25.0	12.3	7.1	11.7	30.3	17.0	7.7	18.9	11.1	10.7	5.1	5.8	16.9	6.0	8.8	7.7	4.7	5.3	3.9	2.8	3.7	10.1	17.0	4.0	7.5	5.3	6.0	5.5	3.3	5.1	9.1	7.4	6.2	4.4	3.1	4.8	8.6	13.0	2.9	8.7	3.0	2.1	5.8	12.0	10.7	9.0	7.8	7.6	4.4	8.8	8.0	6.8	16.4	2.9	10.4	6.8	1.0	4.6	6.9	3.4	4.8	4.6	5.1	2.0	1.9	3.6	4.7	3.6	5.9	10.7	7.8	7.4	1.4	9.0	5.1	8.4	10.8	7.9	7.6	32.4	4.0	16.9	4.6	9.4	7.4	5.4	7.7	4.0	6.1	6.3	4.5	5.1	5.5	5.9	9.3	8.8	6.0	5.8	7.5	4.7	5.1	10.4	3.7	6.0	6.7	5.2	13.2	3.9	9.8	11.7
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501456	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"				"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: , HPA068982: "	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	18.9	42.4	12.0	16.2	22.0	22.6	18.3	22.3	24.9	19.0	16.2	14.8	14.3	16.6	20.4	17.9	19.7	17.6	14.4	13.6	10.7	11.8	18.2	21.1	22.4	31.1	10.3	16.7	23.1	17.0	20.3	23.6	23.2	21.7	16.5	19.7	19.2	17.1	15.8	27.3	18.6	25.3	15.5	13.7	25.5	15.7	18.0	12.3	39.6	27.8	14.0	20.3	17.8	18.4	7.1	9.5	7.1	7.8	7.2	8.8	3.4	7.4	13.2	20.6	12.9	18.2	12.0	13.9	12.7	9.9	11.6	10.6	13.0	13.0	27.6	8.7	10.6	14.5	47.9	12.9	10.3	8.7	16.6	23.9	13.9	9.1	9.5	25.7	25.8	12.6	8.8	8.9	10.9	13.6	25.0	9.9	9.9	11.2	15.7	13.1	26.9	4.8	18.5	20.6	7.8	12.7	20.6	12.4	18.6	17.3	12.2	13.3	11.4	22.6	11.0	12.0	8.2	6.5	11.0	12.3	27.0	15.8	8.6	23.9	8.5	7.1	5.8	4.4	6.0	7.8	7.7	6.5	6.6	5.9	8.0	7.1	6.5	8.8	6.8	7.2	6.0	9.5	5.3	3.4	12.0	22.0	22.3	24.9	10.7	11.8	10.3	16.7	21.7	12.3
IRF1	MAR	ENSG00000125347	"Interferon regulatory factor 1"	P10914	5	132481609-132490798	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 103.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011662, HPA063131"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB011662: AB_775784, HPA063131: "	"unprognostic (1.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.09e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.53e-3)"	19.7	8.5	4.1	64.2	9.9	43.8	21.0	3.9	4.6	10.6	27.3	4.0	4.4	31.1	11.4	9.9	12.4	11.8	18.1	11.8	4.2	3.5	14.2	20.9	49.3	41.0	6.8	1.4	11.5	14.5	2.8	8.8	24.7	10.3	18.9	13.6	10.3	13.2	10.3	14.0	8.4	52.1	11.3	8.0	51.7	17.5	5.7	4.9	36.6	26.5	14.7	33.0	14.7	26.7	12.1	16.2	103.0	42.1	21.3	28.5	21.3	8.9	7.2	0.6	2.5	7.1	6.2	14.7	4.3	18.3	13.7	17.2	3.7	26.7	8.9	5.8	6.4	12.5	2.2	10.4	4.6	18.8	2.4	11.9	3.4	2.7	46.9	5.8	10.2	11.6	2.6	10.1	9.7	6.4	2.1	34.3	3.8	4.9	31.6	9.7	0.8	5.1	36.7	7.7	10.8	7.0	10.1	1.3	1.1	4.5	10.2	4.4	1.7	8.0	4.0	7.8	2.8	4.5	6.3	27.2	6.8	6.3	9.0	9.3	5.6	23.1	26.2	40.2	28.5	40.0	19.4	12.1	18.7	22.9	16.2	11.5	11.5	16.0	103.0	21.3	42.1	8.2	20.2	21.3	4.1	9.9	3.9	4.6	4.2	3.5	6.8	1.4	10.3	4.9
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387713-184474580	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 49.8;Karpas-707: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"				Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: "	"prognostic favourable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favourable (8.34e-5)"	"unprognostic (1.31e-3)"	27.5	30.6	15.2	31.0	19.3	11.3	21.0	21.5	16.4	21.5	23.7	28.8	16.6	21.2	19.8	16.5	20.5	18.1	17.3	16.1	15.3	12.1	15.3	26.1	24.0	38.7	22.8	9.7	28.0	14.9	12.4	24.5	19.7	17.8	20.5	20.4	16.8	22.1	16.1	21.9	18.1	27.7	21.2	22.4	39.4	21.3	8.4	22.0	36.1	24.0	12.6	34.5	28.8	26.4	22.2	16.2	83.9	27.5	18.1	21.9	17.2	6.0	4.4	5.5	3.6	12.1	12.4	3.3	4.4	13.9	10.9	11.5	1.3	11.6	3.7	2.3	6.6	5.6	3.7	8.4	7.1	49.8	2.0	10.3	2.5	8.0	12.0	6.2	8.7	13.3	7.8	6.2	16.1	8.3	2.0	52.0	4.5	4.2	12.0	7.7	1.2	3.3	15.9	2.1	16.5	8.3	9.3	2.3	3.6	6.2	5.2	9.1	4.0	5.7	6.8	3.1	3.4	3.5	3.9	14.9	11.9	3.2	6.6	6.1	5.5	17.7	19.4	34.5	16.4	25.3	16.9	21.2	16.3	17.6	16.2	22.2	17.5	17.3	83.9	18.1	27.5	4.1	21.9	17.2	15.2	19.3	21.5	16.4	15.3	12.1	22.8	9.7	17.8	22.0
IRF3		ENSG00000126456	"Interferon regulatory factor 3"	Q14653	19	49659569-49665875	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004895, CAB013018"	Approved		Supported	Cytosol				Cytosol		"CAB013018: AB_2533904, HPA004895: AB_1851887"	"unprognostic (5.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.17e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.91e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.52e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavourable (1.56e-7)"	"unprognostic (1.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (3.47e-2)"	"prognostic favourable (3.61e-4)"	14.8	17.0	13.4	33.2	22.1	21.8	17.1	16.9	20.1	23.4	18.9	14.1	30.1	18.3	20.0	16.3	18.7	18.9	22.0	15.9	17.7	11.2	20.5	21.3	19.4	36.3	22.2	10.9	23.5	18.5	13.4	22.3	21.2	18.7	23.1	11.7	18.1	26.3	37.7	8.6	19.9	25.4	20.0	17.4	37.3	21.4	7.6	20.0	23.7	22.6	11.8	31.0	19.0	20.6	17.8	13.4	21.8	14.7	20.3	35.4	17.4	29.1	32.1	11.2	16.6	8.5	13.6	25.4	12.9	19.5	22.3	29.4	22.6	34.4	17.2	14.7	11.9	23.9	11.9	33.1	10.0	23.3	21.2	16.1	12.4	20.6	9.8	11.8	16.4	12.9	23.7	29.5	8.9	17.6	17.7	18.8	11.8	28.4	18.5	33.7	13.2	29.8	21.4	11.2	29.8	16.3	25.0	6.3	7.9	23.5	25.7	12.7	11.1	23.3	12.2	13.3	12.5	10.0	16.5	25.8	26.4	16.5	15.1	27.6	13.1	8.8	12.6	21.8	28.5	12.7	25.4	17.8	27.9	26.6	9.8	16.2	24.9	22.5	16.1	20.3	14.7	13.4	35.4	17.4	13.4	22.1	16.9	20.1	17.7	11.2	22.2	10.9	18.7	20.0
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391739-411447	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 49.1;Karpas-707: 45.6;RPMI-8226: 44.1;U-266/70: 41.3;U-266/84: 30.7;WM-115: 25.0"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8"	"Group enriched"	"Detected in many"	5	"B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favourable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	7.1	0.5	0.4	36.6	0.4	18.4	4.0	0.4	0.4	17.4	13.9	0.1	0.4	5.0	2.2	0.7	6.4	1.2	4.1	1.6	0.4	0.5	1.4	5.6	4.2	31.5	0.5	0.0	1.9	0.7	0.0	0.7	0.5	0.1	1.5	4.8	15.8	21.3	1.9	0.7	4.5	11.1	0.3	0.6	33.8	4.6	1.7	0.1	15.2	1.3	2.4	48.7	8.4	4.2	9.7	10.4	0.0	1.6	0.2	4.8	1.3	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	45.6	0.0	0.0	0.0	0.0	0.2	0.0	5.8	0.0	44.1	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	30.7	13.4	0.0	0.0	25.0	0.0	1.6	0.0	0.6	1.2	0.0	9.5	0.9	0.9	9.0	9.7	1.6	0.7	0.0	0.2	1.2	10.4	4.8	1.3	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.0	0.1	0.1
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785623-209806175	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 16.0;HaCaT: 58.3;HBEC3-KT: 21.3;hTCEpi: 47.0;hTERT-HME1: 23.5;RT4: 20.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 8.6;pons and medulla: 4.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.0	6.3	1.1	4.1	1.0	0.3	13.3	8.6	0.9	11.7	12.9	1.0	38.6	9.2	3.9	31.4	63.7	7.6	17.5	10.3	1.1	0.8	12.9	18.4	8.8	0.3	0.9	0.7	3.9	13.9	10.3	6.8	26.7	4.4	21.8	11.3	1.5	24.8	34.6	0.6	45.6	20.3	3.1	1.1	1.2	9.5	4.3	0.3	13.0	22.1	32.3	33.8	15.0	19.1	0.9	0.5	2.0	1.0	0.6	2.8	0.7	16.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.1	0.0	0.0	3.4	5.7	0.0	0.0	0.0	58.3	0.0	21.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	0.0	23.5	0.9	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	20.8	5.2	1.7	0.4	9.3	0.5	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.2	0.1	2.0	2.8	1.0	1.9	0.6	0.6	0.9	0.5	0.9	2.1	1.1	0.1	0.6	0.1	0.2	0.0	0.7	1.1	1.0	8.6	0.9	1.1	0.8	0.9	0.7	4.4	0.3
IRF7		ENSG00000185507	"Interferon regulatory factor 7"	Q92985	11	612553-615999	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 81.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.0;Karpas-707: 10.6;SCLC-21H: 5.2;SK-BR-3: 3.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	12	"plasmacytoid DC: 81.1"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017694, HPA052757"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017694: AB_2280489, HPA052757: "	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (1.71e-10)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.71e-2)"	9.6	4.7	4.5	9.9	6.1	17.2	12.1	2.9	4.9	4.8	4.6	2.5	2.2	2.2	4.2	5.1	6.9	4.9	9.0	5.2	3.7	2.0	8.2	23.3	11.6	12.8	4.6	1.4	4.8	3.6	2.2	3.8	4.8	5.5	5.3	2.9	5.2	5.4	7.4	6.1	4.1	8.4	5.7	4.5	19.0	4.5	4.0	5.2	8.5	9.0	2.4	12.8	7.5	3.9	2.5	81.1	3.7	6.6	2.1	1.5	1.8	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.1	0.0	10.6	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	5.2	0.0	0.0	3.1	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	3.7	1.1	6.6	1.1	2.5	1.0	1.2	3.3	2.4	1.1	1.2	1.7	2.1	6.1	81.1	1.5	1.8	4.5	6.1	2.9	4.9	3.7	2.0	4.6	1.4	5.5	5.2
IRF9	ISGF3G	ENSG00000213928	"Interferon regulatory factor 9"	Q00978	14	24161053-24166565	"Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.4;BJ hTERT+ SV40 Large T+ RasG12V: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001862	Approved		Supported	Cytosol				Cytosol		"HPA001862: AB_1079153"	"unprognostic (4.96e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.84e-3)"	"unprognostic (8.17e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (7.58e-8)"	"unprognostic (1.56e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.40e-2)"	"prognostic favourable (9.92e-4)"	34.4	20.9	23.4	35.0	25.3	21.5	15.8	10.1	19.5	19.1	19.1	22.5	15.1	19.2	23.5	31.3	18.6	22.6	27.4	13.5	17.7	24.6	27.4	26.8	23.8	22.7	22.1	18.4	26.5	13.6	13.9	17.5	25.4	22.1	21.7	11.8	17.8	36.0	16.2	8.1	14.7	20.3	20.4	23.8	37.0	22.4	9.3	20.1	26.4	29.2	12.0	28.3	30.1	21.9	28.4	21.4	57.8	30.9	19.5	29.0	25.4	1.6	1.5	1.5	0.6	7.7	8.1	0.9	3.0	16.5	34.4	26.7	2.9	9.5	2.2	3.4	8.3	2.9	1.0	0.7	8.7	10.1	0.3	4.7	1.6	2.8	11.7	0.5	6.4	7.7	2.5	4.3	1.0	3.7	0.8	12.5	4.5	2.3	1.0	1.9	0.5	3.0	0.7	1.1	1.2	7.8	1.7	0.4	1.4	3.0	1.9	16.3	0.7	4.3	7.0	3.5	2.6	2.3	0.9	13.3	10.4	2.1	4.1	0.8	3.2	45.6	24.3	30.8	21.5	30.9	18.4	28.4	22.7	19.3	19.4	25.5	20.1	18.1	57.8	19.5	29.2	21.4	29.0	25.4	23.4	25.3	10.1	18.5	17.7	24.6	22.1	18.4	22.1	20.1
IRS1	HIRS-1	ENSG00000169047	"Insulin receptor substrate 1"	P35568	2	226731317-226799759	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.0;naive B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005261, HPA046433"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005261: AB_649615, HPA046433: "	"unprognostic (2.20e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.55e-3)"	7.0	9.9	3.1	5.0	2.7	0.6	11.7	9.6	5.4	13.3	14.2	1.4	3.9	4.0	17.2	5.0	3.8	13.9	11.5	6.3	3.9	2.2	5.2	12.0	5.0	2.5	2.3	2.6	21.9	7.1	3.4	2.5	9.1	4.2	9.8	2.9	5.5	3.3	7.5	23.3	5.1	6.5	11.7	2.6	3.3	5.8	2.4	1.7	17.1	23.4	5.6	2.5	14.6	15.8	1.2	0.4	0.0	0.2	0.0	0.3	0.2	3.2	14.7	10.8	0.4	14.9	8.9	0.0	8.8	7.0	11.9	7.7	8.4	8.2	1.3	1.5	6.0	5.6	0.7	8.5	6.8	3.2	0.6	0.0	0.9	3.9	7.4	0.3	0.0	12.3	4.7	9.3	8.5	0.0	1.6	13.1	8.0	12.6	2.7	3.7	4.3	8.2	0.6	14.0	0.1	5.4	10.7	1.9	0.3	2.8	2.0	4.7	7.9	0.1	0.7	15.7	14.4	12.1	8.5	6.1	2.5	1.9	15.5	0.3	4.6	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.1	1.2	0.2	0.1	0.0	0.0	0.0	0.4	0.3	0.2	3.1	2.7	9.6	5.4	3.9	2.2	2.3	2.6	4.2	1.7
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752698-109786568	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 18.0;SH-SY5Y: 18.9;THP-1: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol				Cytosol	Aggresome	"CAB016944: , HPA054664: "	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	38.9	24.3	27.6	10.9	25.2	70.1	33.5	19.6	30.6	13.5	10.9	13.0	6.7	8.7	14.4	12.2	7.1	7.7	8.4	13.5	23.6	14.6	7.7	24.6	11.6	5.3	24.2	22.1	27.1	7.9	6.1	23.0	13.6	19.5	20.0	7.5	9.3	11.5	12.2	20.9	15.3	9.7	9.7	25.1	9.0	8.3	6.3	21.3	2.0	10.7	4.7	5.3	8.4	17.8	0.5	0.1	6.9	1.4	0.2	0.5	0.2	2.6	3.0	1.9	0.0	16.5	3.3	1.0	2.9	3.4	1.7	1.5	0.2	3.2	0.0	1.8	2.0	1.2	1.0	2.6	2.2	1.0	13.6	1.2	4.3	0.0	16.7	4.7	1.5	6.9	13.9	0.5	18.0	0.6	0.8	0.0	17.0	1.3	0.0	13.9	2.1	0.6	5.9	1.8	1.2	4.9	0.7	2.9	18.9	1.5	0.0	11.6	0.3	28.3	0.0	3.7	0.0	0.2	3.8	0.0	1.3	0.9	2.7	4.6	6.3	2.7	1.4	1.9	0.2	0.3	0.3	0.1	0.4	0.1	0.1	0.5	0.5	0.4	6.9	0.2	0.4	0.1	0.5	0.2	27.6	25.2	19.6	30.6	23.6	14.6	24.2	22.1	19.5	21.3
IRX5	IRX-2a	ENSG00000176842	"Iroquois homeobox 5"	P78411	16	54930862-54934485	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Vision"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 19.0;heart muscle: 26.5"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.8;T-47d: 24.3;THP-1: 13.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"cerebellum: 4.1;hypothalamus: 3.2;midbrain: 7.6;pons and medulla: 5.7;thalamus: 4.7"	HPA047130			Approved	"Nuclear speckles,Microtubules,Cytosol"				"Nuclear speckles"	"Microtubules, Cytosol"	"HPA047130: AB_10962983"	"unprognostic (2.63e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.38e-3)"	"prognostic favourable (4.59e-4)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.28e-2)"	3.3	0.7	0.2	0.2	1.4	0.2	19.0	5.8	0.3	3.6	0.5	1.7	0.2	0.2	0.4	1.9	7.6	0.3	0.4	26.5	0.9	1.3	4.7	0.2	10.3	0.3	2.6	0.0	0.5	0.3	0.5	0.3	0.2	5.3	4.2	0.2	6.5	13.6	0.5	6.7	13.9	0.2	0.3	4.5	0.2	3.3	0.9	2.2	0.4	0.2	1.0	2.4	0.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	5.7	2.1	2.1	0.4	0.2	2.2	5.4	0.7	0.5	1.2	0.5	0.0	0.5	2.9	5.5	2.0	2.3	0.4	3.8	2.7	0.6	2.3	0.0	0.0	1.3	2.2	0.6	10.1	3.6	1.5	0.0	0.3	0.0	4.1	2.0	6.0	7.8	0.1	1.6	3.2	2.9	0.3	17.8	0.1	2.0	2.0	0.9	4.9	2.4	24.3	13.0	0.3	4.0	0.1	2.8	0.8	2.4	1.4	1.8	6.4	2.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	5.8	0.2	0.9	1.3	2.6	0.0	5.3	2.2
ISCU	"hnifU, IscU, ISU2, NIFUN"	ENSG00000136003	"Iron-sulfur cluster assembly enzyme"	Q9H1K1	12	108562582-108569384	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006329, HPA038602, HPA057592"	Approved		Supported	Cytosol				Cytosol		"CAB006329: AB_425907, HPA038602: , HPA057592: "	"unprognostic (1.72e-1)"	"prognostic favourable (4.90e-7)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.49e-2)"	"prognostic favourable (2.73e-7)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-3)"	"prognostic favourable (6.12e-4)"	37.3	91.2	44.7	25.2	62.2	23.6	44.5	27.4	61.6	37.4	39.7	20.1	32.7	25.2	36.5	44.7	25.2	32.5	34.6	121.6	37.5	56.1	86.7	33.1	29.6	34.1	54.9	58.9	48.5	28.3	41.7	48.5	31.4	65.8	36.6	33.1	34.7	33.9	59.6	87.3	21.4	27.2	50.5	27.4	33.6	32.9	29.9	21.9	30.3	53.2	39.1	37.6	36.3	42.1	86.6	34.7	85.9	34.3	29.6	61.9	53.8	9.9	24.4	17.3	10.3	62.4	48.0	42.2	20.0	33.0	15.3	14.6	18.1	14.3	10.0	17.3	27.4	14.6	16.5	23.0	13.9	30.9	17.7	10.9	13.3	40.0	36.4	25.9	13.0	46.4	51.6	16.6	33.2	23.3	20.3	32.6	32.1	21.6	20.3	47.3	16.7	36.0	13.5	11.5	43.1	44.6	28.7	14.9	13.8	14.5	8.6	21.9	22.3	21.1	19.8	15.6	13.1	12.4	10.1	38.9	42.3	31.0	24.3	19.4	15.7	62.3	29.4	84.0	37.2	30.2	44.0	86.6	49.1	48.0	19.9	73.7	61.9	51.7	85.9	29.6	34.3	34.7	49.7	53.8	44.7	62.2	27.4	61.6	37.5	56.1	54.9	58.9	65.8	21.9
ISOC2	FLJ23469	ENSG00000063241	"Isochorismatase domain containing 2"	Q96AB3	19	55452985-55462343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA043142	Enhanced		Approved	Mitochondria,Cytosol			230000	Mitochondria	Cytosol	"HPA043142: AB_10794653"	"unprognostic (2.74e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.90e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.09e-2)"	12.7	16.4	13.4	12.8	15.0	10.5	28.1	9.0	15.6	10.9	15.9	9.9	17.1	20.6	8.9	13.5	14.7	10.7	19.2	20.9	13.4	12.9	33.2	93.9	11.2	10.2	15.4	11.2	9.1	23.8	12.8	14.2	5.5	14.6	12.0	10.0	7.2	23.3	21.2	47.2	10.0	20.5	12.0	13.9	15.8	12.9	23.3	13.4	5.9	14.9	22.9	11.8	12.8	8.8	11.5	18.1	0.5	20.0	14.1	10.4	9.1	12.6	19.3	5.3	14.3	3.7	7.7	17.0	9.0	9.6	11.9	12.2	9.5	22.6	24.2	16.8	10.9	12.7	10.3	11.9	4.0	9.2	68.2	13.7	4.6	31.2	14.7	15.3	42.0	11.4	11.4	7.6	5.9	10.8	22.3	16.2	7.6	25.0	0.0	18.0	8.2	54.9	17.4	11.0	31.6	19.8	12.0	6.3	18.0	8.8	19.8	10.2	16.5	27.3	7.7	8.7	12.5	9.8	10.8	19.6	16.9	18.8	13.7	19.5	15.0	0.4	9.9	0.5	8.3	20.0	8.2	11.5	7.7	10.4	18.1	8.8	7.8	7.8	0.4	14.1	16.1	14.8	9.1	9.1	13.4	15.0	9.0	15.6	13.4	12.9	15.4	11.2	14.6	13.4
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438301	"Enzymes, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.6"	"Cell line enriched"	"Detected in many"	4	"BEWO: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	7.9	8.4	7.1	3.0	5.7	4.5	7.1	2.7	6.7	9.9	3.5	10.0	44.2	3.4	13.9	12.3	4.5	20.0	6.5	8.0	5.7	7.4	12.7	4.1	4.7	3.8	4.1	4.1	31.6	25.5	7.7	12.6	44.2	16.2	9.5	1.3	19.3	8.8	34.4	8.2	3.4	3.9	3.0	2.3	10.5	3.7	83.6	3.5	3.0	5.6	3.8	3.3	5.9	7.8	4.0	1.9	0.9	0.2	11.9	8.5	4.9	2.7	8.4	20.1	5.9	0.1	0.0	101.5	1.3	0.2	0.1	0.0	4.8	5.1	0.0	6.9	0.6	7.2	0.6	0.0	0.0	7.5	23.1	10.1	0.5	15.5	2.1	0.1	0.2	1.6	0.1	0.5	0.1	1.2	20.6	0.4	0.0	16.2	0.7	0.7	10.5	6.8	13.9	0.0	4.7	1.7	0.0	6.2	15.5	0.3	1.9	10.2	13.7	1.1	3.9	0.1	0.2	0.1	0.3	3.2	1.4	0.6	0.6	0.4	3.5	0.9	0.1	0.0	7.6	0.2	5.9	4.0	7.4	6.7	0.7	2.3	6.1	8.5	0.8	11.9	0.1	1.9	5.2	4.9	7.1	5.7	2.7	6.7	5.7	7.4	4.1	4.1	16.2	3.5
ITGA2	CD49b	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989326-53094779	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.1;HaCaT: 30.4;HUVEC TERT2: 28.0;TIME: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol			46000000	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.9	14.0	2.9	4.7	13.4	0.4	7.9	1.8	6.8	7.1	6.5	22.5	12.1	7.6	5.1	10.4	16.7	2.8	9.3	2.5	5.4	3.6	15.1	1.8	17.2	1.4	18.3	4.5	1.8	2.7	16.1	2.5	4.8	10.7	8.5	6.0	0.8	15.8	16.8	1.2	16.9	17.0	2.5	8.4	9.1	7.4	1.3	13.0	1.5	2.5	7.4	10.0	7.5	11.1	0.5	1.5	1.7	0.6	0.2	0.6	0.3	19.5	5.0	0.4	0.2	1.3	2.4	1.5	19.8	30.1	0.7	1.2	9.4	13.8	0.0	3.4	8.4	30.4	1.6	22.2	2.9	0.0	1.5	1.4	1.3	5.6	4.6	0.2	0.4	1.0	3.9	19.9	3.5	28.0	0.0	0.0	0.5	3.6	0.2	0.0	1.2	10.1	0.0	0.1	0.0	6.3	10.4	0.2	1.1	1.0	1.3	2.0	3.2	0.0	23.9	3.6	2.1	0.5	3.9	0.0	0.0	0.0	21.8	0.0	15.9	1.7	0.6	0.2	0.6	0.2	0.4	0.4	0.5	0.5	0.1	0.5	0.5	0.6	0.8	0.2	0.1	1.5	0.4	0.3	2.9	13.4	1.8	6.8	5.4	3.6	18.3	4.5	10.7	13.0
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590065-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.7;monocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"			750000	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavourable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	23.2	22.1	17.9	18.3	21.8	3.1	25.8	16.7	23.1	22.9	13.6	23.4	11.6	8.4	26.0	11.4	14.2	14.5	25.2	40.7	16.8	12.3	51.5	9.5	20.6	7.6	24.2	11.6	35.4	18.7	65.0	11.0	29.6	22.1	16.5	11.9	83.4	17.9	15.9	13.1	21.5	10.1	29.6	33.0	12.1	17.3	11.2	17.0	7.8	33.1	10.9	11.1	17.6	17.9	0.3	0.9	7.7	2.3	0.4	1.1	0.5	9.7	11.7	7.8	24.9	28.7	19.4	29.7	19.2	15.5	6.8	6.8	10.2	33.8	0.0	37.9	21.6	12.3	3.9	18.1	9.8	1.9	3.5	2.3	15.4	14.0	11.3	1.6	1.4	14.1	8.6	15.2	12.9	16.2	2.2	4.9	18.1	3.8	0.9	1.3	5.9	5.9	0.0	15.9	1.3	17.6	75.3	1.6	4.8	22.2	6.9	8.1	5.4	4.5	49.1	42.2	13.2	8.6	16.2	1.2	2.0	1.1	17.0	0.6	20.8	7.7	1.1	1.6	1.0	2.3	0.7	0.3	0.5	0.8	0.9	0.1	0.5	0.5	0.5	0.4	1.2	0.4	1.1	0.5	17.9	21.8	16.7	17.3	16.8	12.3	24.2	11.6	22.1	17.0
ITGB1BP1	"ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B"	ENSG00000119185	"Integrin subunit beta 1 binding protein 1"	O14713	2	9403475-9423547	"Predicted intracellular proteins"	"Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067348, HPA071538"			Supported	"Nucleoplasm,Nuclear bodies,Centriolar satellite,Cytosol"				Nucleoplasm	"Nuclear bodies, Centriolar satellite, Cytosol"	"HPA067348: , HPA071538: "	"unprognostic (2.21e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (4.39e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavourable (4.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (7.10e-5)"	"unprognostic (3.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.08e-3)"	61.1	15.0	19.0	11.6	29.2	16.1	73.0	17.6	24.0	24.5	16.3	9.9	10.2	7.7	18.0	16.6	13.3	15.0	14.4	23.9	17.1	15.6	23.6	7.7	13.4	12.1	19.7	18.7	14.3	7.6	14.8	9.7	14.1	19.4	11.1	14.8	11.4	7.7	15.1	16.0	16.6	8.6	22.1	19.2	8.6	11.2	5.6	17.0	10.2	11.2	12.1	14.8	12.8	33.6	20.7	29.5	35.2	27.3	24.1	31.3	24.9	16.0	11.5	13.6	15.5	48.5	41.2	7.4	29.4	20.2	26.6	20.7	15.3	10.0	17.7	13.3	40.3	15.2	20.7	19.2	29.4	47.7	10.5	16.1	13.6	19.0	16.9	12.4	17.6	23.2	15.9	24.3	17.4	23.2	9.0	14.7	32.9	14.3	21.9	8.1	11.0	19.3	12.6	18.6	16.4	26.9	13.2	14.8	14.3	16.4	12.6	19.8	9.3	9.4	14.7	23.9	17.6	31.8	32.6	14.7	31.6	25.9	32.7	17.1	16.5	35.2	23.0	27.9	30.4	27.3	28.9	20.7	26.5	29.4	29.5	17.5	20.6	26.5	5.0	24.1	20.0	26.6	31.3	24.9	19.0	29.2	17.6	24.0	17.1	15.6	19.7	18.7	19.4	17.0
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301734-71305371	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040721			Approved	Cytosol				Cytosol		"HPA040721: AB_10805827"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.3	0.2	1.0	0.3	0.6	0.3	0.6	0.2	2.7	2.8	0.0	2.3	0.4	12.8	3.4	4.0	1.8	4.8	43.0	0.2	0.2	0.4	0.6	0.5	0.5	0.3	0.0	2.4	0.3	0.0	0.3	0.2	0.2	3.2	0.9	3.5	0.7	5.8	21.3	0.3	1.0	18.6	0.3	0.6	1.1	1.6	0.1	0.0	0.4	19.6	0.7	5.6	0.8	0.2	0.2	1.5	0.2	0.0	0.5	0.0	0.7	2.1	3.1	2.8	0.1	0.1	0.7	1.0	1.4	0.7	0.8	1.6	1.6	3.1	0.3	1.6	1.5	2.8	0.8	1.7	1.0	1.3	1.9	1.9	0.6	0.4	0.6	13.7	1.7	1.2	0.5	0.4	1.2	1.4	0.8	1.6	0.9	1.2	3.4	4.6	1.3	2.0	2.5	1.1	1.5	2.0	1.5	0.5	0.7	0.1	0.8	0.9	0.4	0.0	1.4	2.7	0.3	0.5	2.9	3.7	4.7	0.4	2.4	0.6	0.0	0.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.3	0.0	0.2	0.1
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191318-53207307	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.3;lymphoid tissue: 37.6"	"Group enriched"	"Detected in some"	99	"Karpas-707: 288.3;RPMI-8226: 225.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA042277			Uncertain	"Plasma membrane,Cytosol"			42000	"Plasma membrane, Cytosol"		"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"	1.8	1.4	1.4	29.1	1.8	7.5	1.5	0.6	1.2	1.8	8.7	2.9	0.8	6.7	2.3	2.8	6.6	2.0	5.6	1.4	1.5	1.0	5.4	5.1	4.9	26.4	1.9	1.0	1.1	1.3	0.7	1.7	1.8	2.4	2.7	5.6	2.1	10.7	2.2	1.0	6.4	15.1	1.5	2.0	26.7	4.3	0.9	2.0	7.8	3.6	4.4	37.6	4.6	3.0	10.1	15.4	31.3	1.9	7.5	23.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	288.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	225.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.2	0.2	0.1	0.0	22.6	1.9	31.3	19.3	0.5	14.3	10.1	19.4	23.0	15.4	8.3	16.3	17.1	0.5	7.5	0.1	4.2	22.7	5.2	1.4	1.8	0.6	1.2	1.5	1.0	1.9	1.0	2.4	2.0
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 16.3;EFO-21: 21.0;RPTEC TERT1: 32.6;WM-115: 46.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	105	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	4.7	4.1	18.0	5.8	20.0	1.2	12.7	7.8	24.3	22.1	4.6	19.4	9.0	4.6	10.5	19.0	8.8	10.4	11.7	3.9	19.4	12.5	28.1	1.7	3.7	1.3	29.3	14.5	7.1	17.5	8.1	7.7	10.7	22.8	9.6	4.4	37.5	16.6	13.1	0.9	8.5	6.0	7.0	23.1	0.8	6.2	8.7	24.0	0.0	3.4	1.3	9.0	6.8	9.9	0.0	0.0	13.8	0.1	0.0	0.1	0.0	10.0	0.4	16.3	2.0	1.4	5.7	0.0	0.0	0.1	0.1	0.5	0.1	2.5	0.0	21.0	0.7	11.2	0.7	1.6	0.2	0.0	0.2	0.0	7.8	0.0	0.7	0.0	0.0	0.6	4.6	0.2	0.8	0.8	0.0	3.0	0.3	0.0	0.0	0.0	1.2	1.8	0.0	1.4	0.0	32.6	0.8	0.2	0.7	3.1	0.0	8.1	0.2	0.0	1.1	4.3	2.8	1.2	2.1	3.8	0.0	0.0	1.0	0.0	46.6	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	18.0	20.0	7.8	14.2	19.4	12.5	29.3	14.5	22.8	24.0
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			69000	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	17.7	27.5	18.6	24.7	21.2	20.4	17.7	10.2	22.7	21.3	21.4	18.3	20.6	22.9	18.1	17.3	31.0	26.6	19.6	25.9	18.1	13.5	22.9	20.3	22.7	30.6	20.5	24.1	16.5	43.8	17.6	10.2	17.0	16.2	14.6	16.8	13.2	19.9	21.5	19.5	23.4	19.0	16.3	16.3	20.6	19.3	16.7	19.5	15.2	24.9	29.0	24.1	14.6	17.7	19.3	30.7	11.3	31.0	24.7	24.1	18.2	33.1	26.2	13.0	13.4	8.6	12.7	8.6	15.0	21.0	19.8	17.4	21.0	30.9	14.3	13.8	13.8	28.9	17.8	22.6	13.9	9.3	26.6	35.8	10.9	31.8	16.3	15.3	12.2	12.1	17.3	18.7	11.6	15.1	24.5	9.9	17.8	15.2	18.0	44.4	21.7	26.5	17.3	18.1	37.5	27.1	10.5	19.7	23.2	11.9	41.7	27.6	17.3	25.6	10.6	22.3	12.4	14.6	31.8	14.7	18.4	27.0	10.4	28.4	24.2	11.3	25.7	8.8	20.7	31.0	18.0	19.3	18.9	21.8	30.7	17.8	14.2	17.2	1.4	24.7	21.9	28.3	24.1	18.2	18.6	21.2	10.2	22.7	18.1	13.5	20.5	24.1	16.2	19.5
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 97.1;tongue: 152.1"	"Group enriched"	"Detected in some"	25	"HaCaT: 77.0;RT4: 20.2;SK-BR-3: 23.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"			8000000	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: "	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	39.0	0.1	0.0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	1.8	0.1	0.0	18.7	0.1	0.2	34.2	0.1	1.0	0.0	0.1	0.1	0.1	0.0	1.9	0.1	152.1	49.1	4.9	43.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	77.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IVNS1ABP	"HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP"	ENSG00000116679	"Influenza virus NS1A binding protein"	Q9Y6Y0	1	185296388-185317329	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 171.2"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003405	Approved		Supported	Cytosol				Cytosol		"HPA003405: AB_1079141"	"unprognostic (4.11e-3)"	"unprognostic (9.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.18e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.28e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	23.7	8.7	9.9	19.8	35.8	171.2	29.0	9.9	13.8	12.5	17.0	19.2	28.5	16.2	10.2	12.9	17.1	9.0	15.9	19.3	10.9	8.6	38.7	10.2	26.5	29.9	23.0	7.8	12.7	17.1	11.6	11.9	15.8	16.8	12.6	21.5	9.2	36.2	38.8	13.5	19.5	14.3	7.9	19.3	12.8	18.3	9.0	20.8	13.1	17.3	16.0	16.3	11.5	22.5	4.6	9.1	24.5	8.1	7.4	7.9	8.1	6.8	7.6	22.3	8.9	8.0	2.6	21.0	13.6	4.2	8.6	7.8	8.1	11.0	11.0	11.3	6.6	9.6	8.1	8.9	9.2	8.1	7.8	10.4	11.4	6.5	3.1	7.2	4.1	1.9	10.1	6.5	21.1	11.0	6.9	6.2	15.4	5.2	11.9	5.1	14.0	1.7	7.1	5.9	5.9	73.0	9.2	15.6	13.3	12.0	10.0	8.1	4.5	3.5	7.5	12.0	7.3	3.0	9.6	8.9	7.1	6.5	8.9	7.4	5.3	5.1	8.1	7.7	7.9	5.9	7.0	4.6	6.0	5.7	9.1	3.3	6.7	6.3	24.5	7.4	7.2	2.5	6.1	8.1	9.9	35.8	9.9	13.8	10.9	8.6	23.0	7.8	16.8	20.8
JAG2		ENSG00000184916	"Jagged 2"	Q9Y219	14	105140981-105168824	"Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.0"	"Cell line enhanced"	"Detected in many"		"HaCaT: 32.3;SCLC-21H: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025481, HPA030636, HPA050567"	Approved		Supported	Vesicles,Cytosol			120000	Vesicles	Cytosol	"CAB025481: , HPA030636: AB_10602607, HPA050567: "	"unprognostic (6.74e-2)"	"unprognostic (4.49e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.17e-1)"	11.5	2.5	5.4	3.5	6.3	1.3	11.4	6.4	8.4	4.2	3.0	3.5	5.2	3.2	7.5	8.4	8.1	5.0	4.4	9.5	5.6	6.4	3.0	1.5	6.6	2.4	4.5	5.3	2.7	5.8	4.3	15.9	6.8	8.7	7.1	1.7	5.9	12.2	6.9	16.8	36.0	4.3	3.2	2.9	3.7	3.8	4.2	3.0	2.7	4.2	11.0	4.1	5.2	5.6	0.0	0.0	0.0	0.0	0.5	0.3	0.0	8.4	3.4	0.2	0.8	0.0	0.0	10.5	0.1	0.1	0.0	0.0	2.8	10.5	0.0	7.3	0.0	32.3	2.1	10.8	0.0	1.1	5.0	0.0	9.3	0.0	0.1	0.0	2.0	0.1	5.3	0.0	1.2	2.6	2.0	0.0	0.0	3.8	0.0	0.0	1.0	1.2	2.6	2.0	3.6	0.1	2.2	16.6	0.5	2.9	0.7	0.1	8.2	1.2	8.9	0.0	0.9	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	5.4	6.3	6.4	8.4	5.6	6.4	4.5	5.3	8.7	3.0
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 68.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.1;HEL: 9.0;HMC-1: 9.2;Karpas-707: 23.5;U-266/70: 9.1;U-266/84: 13.5;U-937: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA070314: "	"unprognostic (5.59e-3)"	"prognostic favourable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.8	1.7	4.0	24.5	8.5	12.0	2.7	2.4	3.1	1.9	2.3	1.0	0.0	2.2	1.7	2.0	2.5	3.5	3.6	4.3	2.7	2.8	3.8	2.0	8.4	68.3	7.5	0.0	11.0	2.0	0.4	2.3	4.1	5.3	3.0	2.4	1.6	6.1	1.5	0.7	1.3	9.5	2.5	8.4	36.1	3.2	1.8	5.8	20.9	3.4	1.7	28.8	5.3	2.4	7.4	4.5	16.9	9.6	8.4	15.0	6.8	0.1	0.3	0.3	1.0	0.4	1.4	0.2	0.5	0.0	0.0	0.1	0.0	0.9	0.4	1.9	0.4	0.1	0.0	0.2	0.0	20.1	0.0	9.0	0.0	0.8	0.7	0.0	9.2	5.0	0.2	0.0	0.0	0.2	0.0	23.5	0.0	0.4	3.6	0.0	0.1	0.7	4.6	0.0	0.4	0.5	0.0	0.0	0.3	0.1	0.2	0.0	2.0	1.3	0.4	0.0	0.4	0.0	0.0	9.1	13.5	2.5	0.1	13.7	0.2	1.2	4.9	0.2	12.6	9.6	14.5	6.5	15.0	13.1	4.5	7.4	14.9	13.0	16.9	8.4	8.8	3.7	11.8	6.8	4.0	8.5	2.4	3.1	2.7	2.8	7.5	0.0	5.3	5.8
JMJD1C	"DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8"	ENSG00000171988	"Jumonji domain containing 1C"	Q15652	10	63167221-63521850	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056175, HPA066195"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA056175: , HPA066195: "	"unprognostic (7.72e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.13e-1)"	31.7	10.9	8.7	26.0	10.9	25.9	16.2	43.0	11.1	21.8	16.6	5.4	11.8	12.2	18.1	17.4	16.4	13.1	18.5	11.7	10.8	8.1	14.1	16.7	29.9	20.9	9.6	6.5	19.2	12.6	27.1	18.6	10.3	14.1	14.1	9.2	13.8	15.3	15.6	13.4	11.0	22.2	11.7	17.6	29.1	12.9	10.9	13.3	27.2	15.6	20.1	15.3	21.9	11.8	4.8	4.2	15.2	2.8	1.7	3.1	1.1	10.9	5.5	13.1	10.0	7.0	12.8	4.6	7.6	15.8	6.9	9.5	9.4	11.7	14.9	4.7	7.1	9.0	3.7	7.3	12.3	4.0	4.7	5.6	5.7	6.8	8.5	12.0	2.1	12.7	7.6	12.2	35.7	12.3	9.9	11.2	16.2	2.9	9.2	6.5	13.9	19.5	16.0	28.4	7.0	7.0	7.9	7.1	11.6	11.5	7.2	11.0	7.1	22.0	14.8	6.4	9.1	5.6	9.5	10.1	8.0	14.1	7.8	7.2	5.7	0.6	2.8	3.1	2.0	1.9	3.1	4.7	2.2	2.1	2.4	4.8	3.1	2.6	15.2	1.7	1.6	4.2	1.9	1.1	8.7	10.9	43.0	11.1	10.8	8.1	9.6	6.5	14.1	13.3
JMJD7		ENSG00000243789	"Jumonji domain containing 7"	P0C870	15	41828085-41837581	"Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 28.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005726	Approved		Approved	Cytosol				Cytosol		"HPA005726: AB_1852017"	"unprognostic (2.92e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	5.8	7.3	9.8	10.7	10.2	9.3	8.1	39.2	10.8	8.9	6.3	12.3	11.2	6.4	5.5	7.4	26.1	8.8	8.6	14.1	10.2	9.6	6.1	7.1	11.2	8.5	10.8	7.8	11.9	19.1	8.0	9.1	4.3	11.2	11.5	4.4	10.9	26.7	15.1	7.1	29.2	6.1	7.6	13.9	6.4	8.5	5.9	10.7	4.9	13.1	11.9	13.9	11.0	13.6	7.9	8.7	8.3	12.6	9.8	17.7	10.0	4.9	4.8	6.2	1.7	1.7	1.2	3.8	2.0	4.3	3.3	2.7	6.7	3.9	0.6	4.2	1.2	12.7	2.8	10.0	1.0	4.9	3.0	6.7	6.4	4.0	2.8	3.2	7.2	0.8	9.0	2.3	4.8	3.8	4.4	4.1	2.4	6.8	4.0	3.1	2.6	3.2	1.8	4.1	4.9	7.5	28.2	6.5	2.3	1.7	8.9	2.8	17.2	3.4	3.5	2.5	5.6	5.2	3.9	6.8	2.3	2.0	3.3	7.9	3.7	5.1	12.4	8.3	12.3	12.6	12.9	5.8	13.9	16.2	8.7	7.9	17.7	14.0	3.3	9.8	11.9	5.4	13.3	10.0	9.8	10.2	39.2	10.8	10.2	9.6	10.8	7.8	11.2	10.7
JMJD7-PLA2G4B		ENSG00000168970	"JMJD7-PLA2G4B readthrough"		15	41828095-41848155	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.0"	"Low lineage specificity"	"Detected in many"											HPA005726	Approved		Approved	Cytosol				Cytosol		"HPA005726: AB_1852017"	"unprognostic (9.87e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.75e-3)"	6.6	2.8	4.7	5.2	4.9	6.8	4.5	21.4	5.3	6.0	4.3	6.1	5.5	2.7	4.9	3.5	8.7	6.5	3.8	3.9	4.9	2.2	2.9	3.0	6.7	3.8	5.3	3.6	5.5	5.8	2.7	4.3	1.9	5.5	4.3	2.5	5.3	9.0	7.7	4.9	12.0	4.4	4.2	3.7	3.6	4.0	2.6	5.2	1.9	4.6	5.9	7.0	6.4	6.3	0.7	1.3	0.0	1.5	0.7	4.0	1.0	0.8	0.5	1.2	4.1	1.1	3.0	1.9	0.9	2.2	1.4	2.0	2.0	0.1	0.4	1.7	1.1	4.2	0.4	3.3	0.2	0.0	0.4	0.6	0.9	0.6	4.6	0.0	2.5	1.6	2.2	0.5	1.1	0.5	0.0	0.6	0.3	0.7	0.8	0.1	0.0	0.2	0.6	0.0	1.4	1.1	5.5	1.5	1.8	3.7	0.0	0.4	0.9	4.4	0.7	0.7	0.5	4.7	1.6	1.1	0.4	0.0	2.1	0.6	0.4	0.0	1.1	0.0	4.0	1.5	1.9	0.7	0.4	0.6	1.3	0.1	0.7	0.0	0.0	0.7	1.0	0.0	0.1	1.0	4.7	4.9	21.4	5.3	4.9	2.2	5.3	3.6	5.5	5.2
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 44.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 6.4;NTERA-2: 5.7;SH-SY5Y: 7.3;SiHa: 4.7;U-2 OS: 23.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076304			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA076304: "	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	1.3	3.6	27.2	1.6	24.1	1.1	1.2	18.9	44.2	1.5	1.4	1.2	0.0	1.4	1.3	1.2	2.4	1.4	1.2	1.2	30.9	14.6	1.2	1.2	1.2	1.2	8.3	12.2	1.1	1.5	1.2	4.4	1.2	6.4	1.3	1.3	0.8	1.2	1.7	1.1	1.2	1.7	1.3	3.3	1.2	1.5	1.8	3.5	0.0	1.2	0.0	1.2	1.1	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.4	0.0	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.5	7.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	27.2	24.1	18.9	30.3	30.9	14.6	8.3	12.2	6.4	3.5
JPH4	"JPHL1, KIAA1831"	ENSG00000092051	"Junctophilin 4"	Q96JJ6	14	23568035-23578800	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.7;seminal vesicle: 37.8"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 9.9;SH-SY5Y: 24.6;U-2 OS: 18.6"	"Cancer enhanced"	"Detected in some"		"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.4;myeloid DC: 5.9"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.9;monocytes: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013492			Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB013492: "	"unprognostic (3.30e-2)"	"unprognostic (1.91e-3)"	"unprognostic (5.05e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-3)"	"unprognostic (5.98e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.96e-3)"	1.9	12.3	33.6	2.0	43.8	1.3	1.6	45.3	63.7	3.4	1.9	2.1	8.0	1.8	17.1	6.2	1.5	5.1	1.6	1.3	32.3	16.8	2.7	1.3	3.4	2.0	8.3	27.6	6.2	1.5	3.1	23.2	1.6	9.8	11.6	1.7	0.8	1.2	37.8	1.2	1.6	2.2	13.9	4.2	2.9	1.7	2.2	10.9	0.0	1.3	0.0	1.7	1.7	1.8	0.0	5.9	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.5	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	9.9	24.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	33.6	43.8	45.3	42.6	32.3	16.8	8.3	27.6	9.8	10.9
JPT2	"C16orf34, FLJ13092, HN1L, KIAA1426, L11"	ENSG00000206053	"Jupiter microtubule associated homolog 2"	Q9H910	16	1678256-1702280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA041888, HPA041908"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041888: AB_10793937, HPA041908: AB_10794160"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-3)"	"prognostic favourable (7.85e-4)"	"unprognostic (3.60e-1)"	"unprognostic (2.37e-2)"	"prognostic unfavourable (9.14e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.78e-2)"	10.6	11.3	6.7	10.4	24.3	4.9	19.9	11.1	12.3	22.5	16.7	24.1	12.6	11.3	11.5	11.1	28.6	34.4	12.4	10.1	10.5	8.7	18.5	37.3	12.0	11.7	33.8	6.2	12.3	31.0	13.2	10.1	33.6	37.7	26.3	16.5	6.8	15.7	12.7	12.8	16.2	12.8	12.4	72.4	8.7	14.8	14.1	17.3	20.3	16.1	15.7	16.8	16.9	16.8	9.7	8.2	4.7	4.6	7.5	10.0	5.4	31.2	32.1	37.3	20.7	5.4	9.0	33.8	31.1	9.9	26.3	22.5	41.8	41.1	20.3	24.0	15.4	30.8	49.0	42.3	30.3	16.3	29.5	16.7	18.4	23.7	8.3	19.6	10.0	6.3	26.8	25.8	33.6	16.6	39.2	8.2	15.1	36.2	24.4	9.7	40.9	24.4	45.1	35.3	29.2	41.0	17.7	34.8	19.2	46.8	45.4	14.2	55.0	12.7	19.1	25.6	45.1	12.1	30.3	7.0	27.9	42.3	8.0	15.2	37.3	2.6	4.6	4.7	7.1	4.1	10.0	6.3	7.8	5.6	3.6	9.7	8.5	7.1	0.4	7.5	2.0	8.2	7.0	5.4	6.7	24.3	11.1	12.3	10.5	8.7	33.8	6.2	37.7	17.3
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;retina: 31.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.1;HEL: 19.6;SH-SY5Y: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.3"	"Low region specificity"	"Detected in many"							"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol			110000	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	5.5	4.3	12.7	2.4	14.1	0.6	4.2	1.8	35.2	4.0	3.8	3.7	0.5	2.7	5.6	2.3	9.6	4.2	3.1	12.1	17.6	3.9	2.6	7.3	2.9	1.1	4.1	15.8	2.3	11.9	2.5	14.4	6.8	9.4	3.1	2.1	31.2	2.2	5.4	23.5	1.5	7.2	6.4	3.6	8.0	11.5	2.2	2.4	0.0	5.3	6.7	3.1	2.9	4.1	0.1	0.0	0.9	0.0	0.1	4.3	1.2	0.3	0.6	3.6	0.7	0.5	0.1	4.6	1.4	0.8	1.4	0.6	32.1	2.5	0.1	0.4	3.6	0.2	0.8	0.0	1.1	0.0	0.3	19.6	0.3	4.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.6	4.5	0.1	0.4	2.3	0.0	0.0	2.0	3.1	1.0	1.6	0.0	0.1	0.3	1.2	9.2	0.4	0.3	0.3	0.7	0.1	8.1	4.1	1.6	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.0	2.4	0.7	0.9	0.1	0.0	0.0	4.3	1.2	12.7	14.1	1.8	35.2	17.6	3.9	4.1	15.8	9.4	2.4
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236979-62319414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.0;CACO-2: 3.7;Hep G2: 10.9;SCLC-21H: 5.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol				Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.6	0.7	0.9	1.0	3.1	0.1	3.1	0.5	2.2	0.6	1.2	8.9	1.0	0.4	0.3	1.0	0.4	0.7	0.6	0.6	1.9	2.7	1.7	3.6	2.9	0.1	11.1	0.1	0.4	18.4	20.4	0.4	14.4	23.2	1.8	1.2	2.6	10.4	0.8	0.5	0.8	0.6	0.2	13.4	0.8	2.4	1.0	4.9	0.1	0.7	0.8	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	26.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	10.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.8	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.1	0.5	2.2	1.9	2.7	11.1	0.1	23.2	4.9
KANSL1L	"C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2"	ENSG00000144445	"KAT8 regulatory NSL complex subunit 1 like"	A0AUZ9	2	210021423-210171383	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 178.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043102, HPA046790"	Uncertain		Approved	Cytosol				Cytosol		"HPA043102: , HPA046790: "	"unprognostic (3.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.55e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.99e-3)"	"unprognostic (4.65e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.95e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-3)"	8.4	5.6	8.3	6.0	12.9	3.8	8.8	12.7	10.9	10.4	6.9	7.5	11.1	4.4	11.3	9.9	5.9	8.9	8.9	7.9	8.8	5.7	12.3	5.8	9.8	4.3	12.1	5.5	16.2	10.0	178.9	14.4	5.3	9.5	14.3	4.7	6.2	7.6	9.9	8.8	7.7	4.9	9.8	13.0	4.5	7.2	12.4	13.6	21.6	14.2	4.4	3.8	11.1	33.0	2.1	2.1	2.7	2.2	3.1	1.7	0.5	2.4	1.3	12.9	5.4	10.4	7.8	3.8	3.7	4.7	2.4	6.6	2.5	9.6	6.8	4.9	2.3	3.5	2.9	1.2	3.8	2.9	2.4	5.6	5.0	4.4	6.5	6.5	4.0	4.9	5.7	2.3	1.7	5.2	4.1	6.3	3.5	2.4	7.2	16.7	7.7	1.8	5.2	3.7	5.3	14.1	3.7	8.1	7.7	3.3	2.3	2.6	2.3	13.8	4.5	5.1	4.1	1.8	2.8	4.5	1.9	6.7	6.3	3.2	6.2	1.1	1.4	2.7	1.2	2.2	1.1	0.9	1.0	1.4	2.1	2.1	1.7	1.7	2.4	3.1	0.9	1.4	0.8	0.5	8.3	12.9	12.7	10.9	8.8	5.7	12.1	5.5	9.5	13.6
KANSL2	"C12orf41, FLJ20436, NSL2"	ENSG00000139620	"KAT8 regulatory NSL complex subunit 2"	Q9H9L4	12	48653401-48682238	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038497, HPA038498"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038497: AB_10674685, HPA038498: "	"unprognostic (3.87e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (4.98e-4)"	"unprognostic (5.46e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-3)"	"unprognostic (4.19e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"prognostic favourable (4.32e-4)"	11.4	12.3	9.8	9.0	14.0	41.3	14.5	19.7	14.7	12.0	10.7	15.6	8.9	8.9	14.9	14.3	13.7	12.0	9.0	12.8	8.6	8.6	13.8	10.2	11.0	16.8	13.0	11.2	17.4	14.3	10.6	21.0	18.2	11.3	12.5	11.3	14.1	13.2	10.4	36.3	13.1	11.6	13.5	11.2	14.0	10.8	16.5	12.7	20.1	16.4	12.6	16.5	11.8	12.8	23.6	21.3	28.2	18.4	19.8	26.8	18.7	9.4	12.7	11.5	5.5	12.8	11.4	24.1	10.7	8.6	17.5	10.0	22.4	12.2	15.3	19.1	12.7	9.5	18.6	12.5	14.6	13.7	11.1	17.9	11.4	6.2	14.4	19.8	7.0	11.8	15.9	13.3	23.3	8.5	20.7	10.3	12.7	8.8	19.4	15.1	14.8	12.8	16.7	11.3	17.5	9.5	13.1	13.1	9.1	20.8	15.4	12.7	20.3	19.4	7.2	13.3	9.8	5.7	9.7	15.5	22.9	22.4	6.6	45.1	6.8	28.2	16.8	19.3	23.0	17.4	22.0	23.6	22.9	23.8	21.3	21.1	26.8	25.5	7.7	19.8	18.4	17.3	25.1	18.7	9.8	14.0	19.7	14.7	8.6	8.6	13.0	11.2	11.3	12.7
KARS	"DFNB89, KARS1, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	25.4	21.1	19.2	29.2	22.0	24.6	28.0	17.5	19.5	26.3	28.3	15.2	28.1	20.6	23.4	26.7	35.8	24.1	27.5	49.6	16.3	18.6	31.7	47.1	25.8	26.6	18.8	16.2	34.9	62.6	28.5	22.4	30.4	19.6	30.7	29.7	20.1	31.7	23.2	80.0	26.6	32.3	28.4	17.1	37.3	26.3	33.6	14.5	41.3	34.4	43.6	34.7	38.6	33.4	32.8	39.0	35.5	44.2	35.0	62.4	39.5	26.7	31.3	22.9	31.5	24.6	24.9	45.1	22.7	27.9	50.0	37.8	55.3	35.3	48.4	25.1	30.2	38.6	46.1	41.5	54.7	14.1	23.7	26.5	27.4	57.2	45.0	39.9	29.9	29.2	29.8	44.2	72.0	40.7	44.2	11.6	37.7	61.9	41.0	42.7	48.4	23.1	54.0	20.5	59.0	40.0	22.8	34.5	28.0	57.0	20.9	25.3	28.2	37.8	22.4	27.7	28.6	21.1	32.4	24.9	28.5	115.3	24.2	34.1	33.7	20.9	31.5	35.5	34.1	44.2	62.4	32.8	42.3	40.2	39.0	27.6	40.1	36.1	7.2	35.0	43.2	24.6	43.5	39.5	19.2	22.0	17.5	19.5	16.3	18.6	18.8	16.2	19.6	14.5
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051990	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: , HPA065052: "	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	20.8	10.9	15.3	19.8	20.3	36.8	22.6	29.9	18.7	19.7	14.6	19.4	14.4	10.7	20.6	12.1	16.9	16.5	14.3	13.0	15.5	11.5	12.3	13.6	26.9	28.2	23.2	10.3	27.2	13.1	26.8	22.3	20.9	15.7	14.1	12.0	12.8	15.1	17.0	21.0	25.5	18.0	25.0	22.9	20.4	14.0	14.1	21.7	30.4	17.9	14.3	20.1	16.9	24.2	4.7	1.8	10.9	1.6	3.1	3.9	1.4	12.9	10.6	17.5	11.1	9.8	11.2	5.9	8.7	11.3	10.8	8.4	6.7	6.2	19.2	8.7	8.5	8.3	13.6	8.2	12.7	9.9	7.9	27.6	6.6	5.0	7.4	14.5	12.7	9.3	9.4	10.0	12.4	10.3	23.1	12.2	9.8	5.7	29.5	4.6	6.7	4.2	23.6	19.6	6.1	5.3	14.9	10.9	9.4	10.1	6.8	7.0	15.6	6.4	12.0	13.3	9.4	11.8	9.3	10.0	16.1	20.8	7.1	6.6	11.5	3.5	1.6	2.8	3.5	1.2	3.9	2.4	2.6	3.3	1.0	4.7	3.6	2.9	10.9	3.1	1.2	1.8	3.5	1.4	15.3	20.3	29.9	18.7	15.5	11.5	23.2	10.3	15.7	21.7
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788555-49835030	"Enzymes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	15.8	14.3	16.9	16.2	25.9	44.4	17.5	37.0	35.0	19.5	17.3	23.8	17.9	13.1	27.3	18.6	18.8	19.5	14.6	25.3	16.8	21.8	18.7	11.3	13.9	15.3	17.0	23.6	21.9	13.6	44.4	19.8	19.8	21.9	20.4	14.9	20.8	18.9	23.3	31.7	22.7	14.7	21.8	17.9	15.8	15.5	63.7	19.1	25.9	28.6	14.5	20.6	22.7	17.4	13.0	12.7	15.2	11.4	20.6	20.7	14.2	13.0	18.4	17.8	12.5	8.4	11.2	21.6	11.4	13.3	20.5	14.7	28.4	9.3	15.0	18.5	12.1	11.5	17.0	11.9	24.2	16.3	16.8	17.8	13.4	11.8	12.6	18.2	14.8	10.6	11.9	18.4	23.0	15.1	19.7	14.9	19.1	19.9	25.8	13.1	44.3	16.1	16.3	28.5	12.9	9.6	14.8	19.4	16.5	11.6	7.0	10.7	25.6	16.1	9.0	26.0	14.1	11.3	14.7	21.9	23.9	17.6	11.8	10.9	16.2	15.2	11.0	15.1	16.9	8.9	20.7	13.0	16.3	17.1	12.7	12.2	20.6	16.2	13.1	20.6	11.4	6.6	14.3	14.2	16.9	25.9	37.0	35.0	16.8	21.8	17.0	23.6	21.9	19.1
KATNAL1	MGC2599	ENSG00000102781	"Katanin catalytic subunit A1 like 1"	Q9BW62	13	30202630-30307484	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046205			Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA046205: AB_10965325"	"unprognostic (3.34e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.83e-3)"	11.0	5.7	12.2	6.4	12.5	7.6	12.0	11.0	14.4	14.1	11.4	10.4	4.6	2.2	12.7	4.2	8.1	6.6	5.4	22.6	8.5	9.8	5.9	5.4	6.7	8.2	10.3	14.9	6.3	2.9	3.2	11.9	4.2	11.9	6.7	5.9	4.1	3.5	8.5	7.1	3.8	4.2	19.7	10.8	4.5	4.7	25.1	7.8	12.0	4.4	3.3	9.1	7.7	7.9	5.2	6.9	3.4	1.0	9.5	7.1	1.4	5.4	4.6	8.1	4.3	6.1	13.1	0.2	22.8	7.3	12.2	9.6	0.9	5.6	8.9	2.7	30.4	1.5	5.7	5.9	18.6	7.6	2.1	6.3	5.7	2.0	3.2	3.1	4.3	5.0	2.9	13.7	3.4	12.8	3.3	3.9	14.9	1.1	7.0	2.9	3.5	2.9	7.9	9.5	0.9	4.4	0.4	3.3	7.0	6.0	1.2	4.3	2.0	1.9	11.6	10.8	16.4	5.9	9.1	2.1	3.7	12.2	4.3	3.1	15.5	1.9	0.9	3.4	5.8	0.5	2.9	2.6	4.6	5.8	2.3	5.2	1.1	2.6	0.3	9.5	1.0	6.9	7.1	1.4	12.2	12.5	11.0	14.4	8.5	9.8	10.3	14.9	11.9	7.8
KATNB1		ENSG00000140854	"Katanin regulatory subunit B1"	Q9BVA0	16	57735730-57757250	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041165, HPA041839"	Enhanced		Supported	"Plasma membrane,Microtubules,Cytosol"				"Plasma membrane, Cytosol"	Microtubules	"HPA041165: AB_10795584, HPA041839: AB_10795598"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (9.24e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (2.89e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.54e-1)"	6.9	9.1	15.3	9.3	21.4	18.7	6.3	13.2	29.0	7.0	7.4	8.8	6.7	9.4	6.6	5.8	11.0	18.7	5.9	8.5	16.0	14.5	5.8	10.3	8.0	8.8	9.3	14.1	7.0	9.4	9.5	8.0	7.9	10.6	6.3	5.2	6.2	11.9	8.0	7.1	21.4	8.5	6.0	6.9	8.0	9.1	32.7	8.1	10.8	7.2	10.3	8.6	7.4	6.4	5.8	9.8	24.6	11.6	8.4	12.4	10.5	7.4	13.6	7.5	9.6	4.1	3.7	13.3	5.3	7.0	13.9	7.7	11.3	6.7	6.1	10.6	3.3	10.1	10.0	10.5	6.3	4.1	28.6	7.9	7.6	15.5	4.4	17.2	29.8	3.8	6.5	10.9	6.4	8.2	15.5	3.0	5.4	8.0	24.9	22.4	13.2	23.7	20.0	9.3	22.0	4.1	3.6	38.0	11.4	8.5	10.4	6.2	3.9	8.9	5.8	9.7	8.5	8.5	11.4	6.9	5.5	7.4	13.5	13.4	5.9	24.1	10.1	24.6	12.4	11.2	12.4	5.6	10.5	9.9	9.8	5.8	10.1	10.0	15.5	8.4	11.6	7.4	10.9	10.5	15.3	21.4	13.2	29.0	16.0	14.5	9.3	14.1	10.6	8.1
KAZN	"FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.7;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 6.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 6.9"									"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: , HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favourable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	8.0	11.0	13.4	3.0	17.4	1.2	7.6	41.1	21.9	8.0	3.8	27.5	5.7	4.6	3.1	11.1	18.8	11.0	7.0	4.1	12.4	12.4	13.2	5.2	8.5	1.5	25.1	12.1	10.4	8.0	22.9	2.7	11.0	15.0	4.1	4.0	10.5	16.8	7.2	1.7	14.2	4.9	3.7	25.0	64.9	4.9	4.1	18.9	0.0	6.6	7.0	6.3	7.9	9.4	0.3	0.0	6.9	0.0	0.0	0.0	0.0	7.8	1.4	8.6	39.7	3.8	3.9	2.9	3.8	3.2	7.1	5.1	1.8	4.2	0.0	9.9	8.1	2.8	1.9	6.2	3.5	0.2	3.9	4.5	4.7	11.8	2.8	0.0	2.3	5.5	8.3	1.6	1.1	0.0	1.8	9.2	5.6	5.7	0.0	0.4	2.4	1.2	2.7	0.2	4.8	11.9	2.4	4.6	3.3	0.6	21.6	14.8	1.2	3.0	0.0	5.8	5.5	9.2	4.5	1.5	1.3	0.0	5.4	7.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	13.4	17.4	41.1	21.4	12.4	12.4	25.1	12.1	15.0	18.9
KBTBD4	"BKLHD4, FLJ10450, HSPC252"	ENSG00000123444	"Kelch repeat and BTB domain containing 4"	Q9NVX7	11	47572197-47579015	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037792, HPA037793"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA037792: AB_10671633, HPA037793: "	"unprognostic (5.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.22e-2)"	"prognostic favourable (2.70e-7)"	"unprognostic (4.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.25e-2)"	8.4	13.4	7.9	6.7	15.9	11.7	9.0	16.2	25.8	9.0	9.7	13.6	13.3	6.5	12.3	13.7	8.0	15.5	7.6	9.5	7.5	8.7	12.0	9.4	8.6	10.7	7.0	7.1	13.2	8.4	23.0	11.9	10.0	11.7	12.1	9.2	13.6	8.6	10.5	19.1	10.8	10.3	10.0	6.2	9.9	9.0	11.6	4.6	13.5	12.4	9.4	14.2	10.9	8.1	12.4	6.6	11.8	5.3	12.3	14.7	10.4	5.0	10.5	11.3	9.5	6.9	9.4	4.0	8.5	10.1	11.1	9.6	4.4	9.4	9.3	4.9	9.7	8.4	6.3	11.2	9.5	11.9	10.1	6.7	14.6	4.9	5.1	13.9	13.6	8.5	7.8	4.4	6.0	11.2	5.3	7.2	8.6	12.6	10.2	4.4	6.2	7.5	10.2	15.3	5.9	11.8	10.6	15.7	10.4	7.3	9.8	6.4	16.5	4.5	10.2	8.0	8.9	11.0	8.4	11.2	17.2	12.8	11.1	4.0	8.2	10.7	5.3	11.8	13.7	4.3	14.7	12.4	11.0	12.6	6.6	11.0	11.7	12.5	8.0	12.3	4.1	3.1	12.8	10.4	7.9	15.9	16.2	25.8	7.5	8.7	7.0	7.1	11.7	4.6
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavourable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavourable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	19.2	13.3	17.9	20.2	16.0	23.6	26.1	13.4	18.6	15.0	20.2	10.7	20.3	15.4	16.3	18.8	28.5	12.8	17.9	30.4	16.5	12.0	14.8	20.7	16.4	18.8	13.7	11.1	17.2	48.6	14.7	18.7	20.5	14.4	17.5	21.4	14.0	19.4	15.7	67.2	17.6	20.6	25.7	10.3	16.7	16.8	29.0	11.5	19.7	18.7	21.8	22.5	23.9	34.0	4.0	4.2	8.1	3.4	2.8	8.8	1.5	27.1	21.4	19.1	14.7	20.2	19.5	32.5	29.1	27.1	28.0	18.7	26.1	29.4	29.6	29.3	39.4	18.1	14.8	28.2	36.9	22.1	10.4	18.9	16.1	26.6	39.5	20.7	18.1	20.1	44.6	27.4	76.0	21.0	18.7	23.6	27.9	25.1	20.0	11.5	20.8	18.0	14.4	26.8	18.5	25.3	23.9	18.4	13.8	16.9	21.6	28.2	10.0	13.2	17.9	28.6	27.9	26.6	30.2	26.9	33.2	30.0	21.5	15.3	21.4	5.0	2.6	8.1	4.5	2.2	3.6	3.5	3.2	3.4	2.2	4.0	2.8	3.1	7.5	2.8	3.4	4.2	8.8	1.5	17.9	16.0	13.4	18.6	16.5	12.0	13.7	11.1	14.4	11.5
KCNA10	Kv1.8	ENSG00000143105	"Potassium voltage-gated channel subfamily A member 10"	Q16322	1	110517217-110519175	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 3.2"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.4;U-87 MG: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.2"	"HPA015061, CAB022564"			Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB022564: , HPA015061: AB_1855573"														"unprognostic (2.96e-2)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 67.5"	"Cell line enhanced"	"Detected in some"		"RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 67.5"	"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: , HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.7	2.3	8.2	1.0	10.0	2.9	0.9	67.5	33.3	3.0	1.0	1.0	0.0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1.0	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1.0	1.3	2.9	2.0	0.0	1.5	0.0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.0	1.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.2	0.0	1.1	1.8	0.0	0.3	0.3	2.1	0.6	2.9	0.2	0.3	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.5	1.4	0.0	0.5	0.5	1.1	1.5	0.0	0.7	7.4	0.9	0.0	0.4	7.0	4.3	0.4	0.4	0.0	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1.0	0.5	0.3	0.9	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10.0	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2.0
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209868	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 39.3"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.5;prostate cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB022571: , HPA019664: AB_1855578"	"unprognostic (2.01e-1)"				"unprognostic (1.14e-1)"		"unprognostic (2.68e-1)"				"unprognostic (5.58e-3)"	"unprognostic (4.46e-2)"		"unprognostic (3.39e-2)"				0.7	0.7	8.7	0.7	12.9	0.7	3.3	0.4	39.3	0.7	0.8	1.9	0.0	0.7	0.9	0.9	0.7	0.7	0.7	0.7	7.4	10.4	0.7	0.9	0.7	0.7	4.7	13.5	0.7	0.7	0.7	6.0	0.7	19.1	4.4	0.8	1.3	1.1	0.7	0.7	0.7	0.8	0.7	1.0	0.7	0.7	1.0	0.6	0.0	0.7	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	12.9	0.4	27.3	7.4	10.4	4.7	13.5	19.1	0.6
KCNC4	"C1orf30, HKSHIIIC, Kv3.4"	ENSG00000116396	"Potassium voltage-gated channel subfamily C member 4"	Q03721	1	110211343-110283100	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.1;U-87 MG: 14.4;WM-115: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014740			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA014740: AB_1855580"	"unprognostic (9.16e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.25e-2)"	2.3	4.7	12.1	1.6	3.2	0.7	3.3	9.2	12.7	1.9	1.4	1.9	1.1	0.8	4.5	3.1	2.1	3.7	4.8	4.5	9.1	14.2	5.1	1.1	3.0	1.9	6.8	2.0	3.4	4.3	11.2	3.8	2.8	14.3	2.4	1.3	4.7	7.1	3.7	4.5	4.0	2.0	2.6	3.6	3.3	2.8	2.2	1.1	7.2	2.3	7.8	2.3	1.2	1.5	0.8	0.7	0.9	0.4	0.3	1.5	0.1	1.9	1.5	0.4	2.8	1.1	0.3	3.4	8.4	1.4	0.6	0.8	4.7	0.9	3.2	3.3	3.1	3.1	1.4	0.7	0.4	16.1	1.6	0.1	3.2	0.7	0.5	2.7	0.8	0.3	0.3	1.9	0.2	4.3	0.6	1.4	0.0	0.4	1.8	0.6	1.6	3.8	2.6	0.1	0.5	4.0	0.1	0.6	0.8	0.4	8.1	0.8	1.1	1.4	1.6	1.0	3.9	0.6	0.3	2.1	1.9	0.6	14.4	2.3	9.3	0.8	0.4	0.2	0.5	0.2	1.5	0.6	0.9	0.4	0.0	0.8	1.3	0.5	0.9	0.3	0.3	0.7	0.4	0.1	12.1	3.2	9.2	12.7	9.1	14.2	6.8	2.0	14.3	1.1
KCNE5	KCNE1L	ENSG00000176076	"Potassium voltage-gated channel subfamily E regulatory subunit 5"	Q9UJ90	X	109623700-109625172	"Disease related genes, Predicted membrane proteins"			"Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;hTEC/SVTERT24-B: 5.4"	"Group enriched"	"Detected in some"	8	"glioma: 7.9;testis cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.6;monocytes: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042316			Uncertain	Cytosol				Cytosol		"HPA042316: AB_10795397"	"unprognostic (5.33e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.83e-2)"	"unprognostic (5.64e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.37e-3)"	4.8	1.1	6.4	1.3	11.3	6.8	1.2	6.0	6.6	1.0	0.6	8.2	0.0	0.7	0.8	1.3	1.2	0.5	2.4	2.2	8.9	8.1	0.7	0.7	0.8	0.8	14.3	1.6	1.7	0.4	0.4	0.2	2.5	29.5	1.9	0.5	0.1	0.6	2.3	3.2	1.1	0.8	0.9	7.3	1.4	0.6	1.2	0.3	8.5	0.6	2.6	0.8	0.8	0.2	0.0	5.6	0.0	1.7	0.1	0.8	0.3	0.9	0.0	0.2	0.4	0.1	0.1	0.1	1.9	0.4	0.7	0.7	0.1	0.4	0.4	0.0	0.4	0.8	0.0	2.2	0.9	0.2	0.4	2.6	2.6	1.8	0.1	0.0	4.1	0.6	1.4	5.4	1.3	0.4	0.0	0.1	0.5	0.0	0.8	3.3	0.0	0.1	0.2	0.1	0.1	0.7	0.1	0.2	0.4	1.2	0.0	1.1	0.0	2.5	1.2	1.8	0.9	1.0	2.4	0.5	0.6	0.3	1.2	1.2	0.5	0.0	0.7	0.0	0.8	1.7	0.0	0.0	0.1	0.1	5.6	0.0	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.3	6.4	11.3	6.0	6.5	8.9	8.1	14.3	1.6	29.5	0.3
KCNH5	"eag2, H-EAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699454-63102037	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 9.2;retina: 5.7"	"Group enriched"	"Detected in some"	5	"HeLa: 9.9;RT4: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.9	4.6	1.7	0.5	3.6	0.3	0.4	0.2	9.2	0.3	0.4	0.4	0.0	0.3	0.4	0.5	0.3	0.3	0.3	0.3	1.3	3.0	0.4	0.3	0.3	0.3	1.2	4.2	0.3	0.3	0.3	1.5	1.2	6.5	0.7	0.3	5.7	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	1.7	0.0	0.0	0.3	0.0	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.6	0.2	9.2	1.3	3.0	1.2	4.2	6.5	0.0
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium voltage-gated channel subfamily J member 12"	Q14500	17	21376197-21419872	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 39.4;skeletal muscle: 47.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.7;HeLa: 6.2;PC-3: 6.5;SCLC-21H: 7.6;SiHa: 3.8;U-2197: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 39.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.2	1.3	1.9	0.9	2.9	0.7	0.9	39.4	5.8	1.2	0.8	1.1	0.5	0.5	0.8	1.4	1.5	2.1	0.7	5.1	0.9	1.4	1.2	0.5	1.3	0.4	1.3	3.4	0.7	0.5	10.6	0.7	0.7	4.0	0.9	0.6	1.7	0.6	0.9	47.8	6.0	0.6	1.0	0.9	1.3	0.9	1.3	0.9	0.0	1.0	7.5	1.1	0.8	1.5	0.0	0.9	0.0	0.5	0.0	0.1	0.0	0.0	1.1	0.4	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	3.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	1.5	6.5	0.0	1.0	1.7	0.0	0.0	7.6	0.4	3.8	0.0	1.6	0.0	0.0	2.9	0.0	0.5	6.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.9	2.9	39.4	5.8	0.9	1.4	1.3	3.4	4.0	0.9
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium voltage-gated channel subfamily J member 15"	Q99712	21	38155549-38307357	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 74.8;kidney: 99.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 28.0;HBEC3-KT: 26.9;LHCN-M2: 12.3;RPTEC TERT1: 26.8;RT4: 31.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	21	"neutrophil: 74.8"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 74.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favourable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favourable (1.95e-4)"	6.0	0.3	0.4	5.3	0.3	3.2	1.4	0.2	0.3	3.5	0.4	0.2	27.1	0.2	0.5	12.8	6.0	0.8	17.7	1.0	0.2	0.1	99.7	1.5	34.1	0.8	0.5	0.2	0.6	16.7	0.0	0.3	1.0	0.6	4.0	0.0	0.2	14.4	26.8	1.0	1.7	0.2	0.9	0.4	6.8	10.7	1.1	0.2	0.4	36.8	3.2	1.9	11.3	4.3	0.0	0.2	74.8	3.5	0.0	0.0	0.7	0.6	0.0	0.1	0.2	5.5	28.0	0.2	0.4	1.9	0.0	0.0	0.0	0.2	0.1	0.0	2.9	9.4	0.0	26.9	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	8.2	2.7	7.0	1.5	1.3	0.1	0.2	12.3	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	26.8	31.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.1	1.4	0.0	0.7	0.1	0.0	2.2	1.6	0.1	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	0.7	0.4	0.3	0.2	0.3	0.2	0.1	0.5	0.2	0.6	0.2
KCNJ18	"KIR2.6, TTPP2"	ENSG00000260458	"Potassium voltage-gated channel subfamily J member 18"	B7U540	17	21692523-21704612	"Disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"lymphoid tissue: 3.5;skin 1: 8.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enhanced"	"Detected in many"		"cerebellum: 75.1"	HPA027021	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"		"unprognostic (2.41e-1)"				"unprognostic (3.90e-5)"			"unprognostic (2.56e-1)"						"unprognostic (1.95e-1)"			0.0	0.0		0.0		0.0	0.4		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	8.1	0.0	0.0		0.0	0.0	0.3			0.0		3.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314553	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.1;retina: 20.0"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 41.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	34	"plasmacytoid DC: 29.1"	"Lineage enriched"	"Detected in single"	34	"dendritic cells: 29.1"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.7	0.4	0.3	0.6	1.1	1.4	3.3	0.3	0.8	0.7	1.3	0.8	1.9	3.0	1.9	0.5	1.0	1.3	6.5	7.9	0.6	0.6	0.3	4.6	10.4	0.9	2.6	0.8	0.4	6.1	0.4	2.7	6.3	1.9	1.1	0.6	20.0	2.9	1.0	0.2	0.1	1.7	1.5	0.6	1.1	5.4	0.6	0.1	3.4	9.3	2.6	2.4	0.9	0.5	0.0	29.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	29.1	0.0	0.1	0.3	1.1	0.3	0.8	0.6	0.6	2.6	0.8	1.9	0.1
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319844-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 21.7;HMC-1: 24.3;T-47d: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 16.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.9;granulocytes: 16.2;monocytes: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: "	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.0	2.0	2.1	7.4	2.5	2.8	4.9	0.8	2.0	25.3	9.2	1.7	10.6	3.8	20.1	5.2	21.7	8.6	13.1	4.3	2.1	1.0	2.8	2.7	7.1	8.9	2.0	1.3	8.0	21.3	0.2	1.7	11.6	2.3	7.3	8.3	2.3	29.0	13.5	0.9	15.1	10.1	13.4	3.7	12.7	7.0	2.0	2.2	4.2	1.7	17.5	18.8	14.3	12.5	1.2	8.9	16.2	5.4	0.6	1.9	1.5	5.3	1.9	0.3	0.3	3.1	2.0	0.4	4.6	2.2	1.2	1.6	1.5	5.8	0.4	2.2	6.5	6.9	2.5	10.4	0.8	0.2	0.2	21.7	1.0	0.2	2.8	1.6	24.3	0.5	9.4	1.5	2.9	3.1	0.3	1.7	3.4	11.6	1.5	1.4	0.3	1.3	2.3	0.4	1.6	4.2	0.5	0.3	0.5	0.5	0.5	0.2	13.7	6.1	3.5	0.4	2.7	2.5	0.2	0.6	0.1	0.6	0.4	7.8	0.2	16.2	5.4	11.7	1.3	4.8	1.1	1.2	1.7	1.6	8.9	1.1	1.5	1.1	4.2	0.6	5.1	2.5	1.9	1.5	2.1	2.5	0.8	2.0	2.1	1.0	2.0	1.3	2.3	2.2
KCNMB4		ENSG00000135643	"Potassium calcium-activated channel subfamily M regulatory beta subunit 4"	Q86W47	12	70366276-70434292	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 24.4;brain: 37.7"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 9.0;RH-30: 9.7;RT4: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA072287	Enhanced	Approved	Approved	Cytosol				Cytosol		"HPA072287: "	"unprognostic (3.90e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.05e-2)"	4.4	24.4	19.8	2.6	24.6	1.3	2.6	13.8	37.7	3.5	5.0	28.4	1.0	2.5	3.2	2.8	2.6	3.3	3.2	5.9	25.9	10.4	5.8	1.8	4.6	2.8	28.6	19.3	5.4	1.5	1.3	1.4	4.9	11.6	2.9	2.9	2.0	3.8	4.5	4.2	4.9	3.0	2.8	15.2	2.8	1.8	3.8	26.0	0.8	3.3	0.0	2.6	2.4	2.1	1.7	0.6	0.3	0.3	0.2	2.8	0.5	0.0	0.4	5.7	3.2	0.3	0.3	0.6	0.7	1.0	0.3	0.9	0.2	2.1	2.8	0.3	0.0	0.1	6.2	0.9	0.2	1.3	3.5	1.4	1.3	3.2	0.0	0.1	0.1	1.7	0.1	0.0	0.0	0.2	0.0	0.0	1.1	0.8	2.0	0.5	9.0	6.5	2.9	9.7	0.2	0.3	10.6	2.8	3.5	0.9	1.1	0.1	3.2	0.1	0.1	0.4	1.5	0.1	0.4	2.0	0.0	2.8	0.5	0.0	0.9	0.3	0.3	0.0	0.3	0.3	0.3	0.6	0.6	0.6	0.6	1.7	2.2	2.8	0.3	0.2	0.1	0.2	0.6	0.5	19.8	24.6	13.8	19.1	25.9	10.4	28.6	19.3	11.6	26.0
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	12	"brain: 32.5"	"Cell line enriched"	"Detected in some"	12	"REH: 57.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA065938: "	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.8	0.9	25.8	1.5	11.3	0.9	0.8	3.3	27.0	1.6	1.0	0.5	0.1	1.0	1.7	1.0	1.0	0.9	1.0	1.3	32.5	3.3	0.9	0.8	0.8	1.0	5.0	8.7	2.6	0.9	0.7	0.2	0.8	4.1	1.2	0.8	0.0	1.5	1.3	1.0	0.9	1.2	0.9	1.2	0.9	0.9	2.8	1.6	0.0	0.9	0.0	1.0	0.9	0.0	0.2	0.2	2.3	0.1	0.1	0.2	0.0	0.0	0.2	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.1	0.1	0.9	1.8	0.1	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	57.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.0	0.2	0.0	0.0	25.8	11.3	3.3	22.4	32.5	3.3	5.0	8.7	4.1	1.6
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114360945-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 25.3;brain: 23.1;liver: 33.2"	"Group enriched"	"Detected in some"	5	"BJ: 14.7;NTERA-2: 5.6;SK-MEL-30: 10.4;THP-1: 18.3;U-937: 6.5"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.8	25.3	12.6	0.8	7.3	0.6	1.1	21.7	15.0	1.7	1.2	9.5	0.0	0.9	3.9	0.9	0.8	1.0	1.0	7.7	23.1	3.6	4.8	33.2	2.5	0.9	4.5	16.9	1.4	3.8	1.0	16.0	0.6	9.1	11.7	1.3	4.2	1.1	5.4	9.9	2.1	0.9	2.8	8.4	1.1	1.1	3.8	6.5	0.0	0.9	0.0	0.8	2.4	1.1	0.3	0.3	0.8	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	14.7	2.2	0.3	0.1	0.0	0.2	0.0	0.5	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.2	5.6	0.0	0.1	0.0	0.7	0.2	0.1	1.8	0.0	0.0	0.1	10.4	0.2	18.3	0.2	0.0	0.4	1.6	0.0	0.1	0.0	0.1	1.8	6.5	0.5	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.3	0.1	0.3	0.8	0.1	0.3	0.3	0.1	0.0	12.6	7.3	21.7	15.0	23.1	3.6	4.5	16.9	9.1	6.5
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.1;RPMI-8226: 13.3;RT4: 22.5;U-266/84: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.2	1.1	2.7	5.6	3.2	0.4	14.8	0.5	5.1	6.8	7.9	4.8	1.3	3.1	4.5	2.4	7.2	3.3	5.3	4.6	3.9	3.4	4.2	2.6	17.6	1.2	6.8	1.4	1.1	7.7	1.9	0.8	8.3	15.2	4.4	4.1	9.9	7.6	2.8	54.4	3.7	4.3	9.7	4.7	1.1	7.0	3.9	1.4	0.2	2.4	19.0	3.6	5.0	4.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.3	0.0	0.8	0.4	1.8	1.3	4.0	0.8	1.0	0.0	8.1	0.0	0.4	1.4	1.2	9.8	0.0	0.9	0.0	2.5	0.0	0.1	0.0	4.0	0.1	0.3	0.3	6.2	0.0	0.6	0.2	0.2	0.0	0.5	1.0	0.0	0.0	4.8	0.1	1.1	33.1	13.3	0.8	22.5	9.8	0.3	0.0	2.5	2.7	1.3	0.0	0.0	1.3	0.0	0.1	9.9	0.0	15.4	0.0	7.4	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.2	0.5	5.1	3.9	3.4	6.8	1.4	15.2	1.4
KCTD10	"BTBD28, MSTP028"	ENSG00000110906	"Potassium channel tetramerization domain containing 10"	Q9H3F6	12	109448656-109477544	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014273	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA014273: AB_1852159"	"unprognostic (7.21e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (5.32e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	29.1	16.2	10.4	16.3	17.1	8.4	21.3	10.6	20.0	25.3	26.9	14.1	15.1	8.5	30.5	15.6	24.4	18.1	23.2	16.1	11.0	16.4	23.2	9.3	20.5	13.9	11.7	8.4	16.7	7.9	14.6	12.7	19.2	16.9	19.8	22.2	29.4	14.4	29.8	9.9	19.3	14.1	36.4	9.6	17.5	19.4	13.5	12.6	12.8	30.8	15.4	17.5	27.8	19.0	6.2	10.4	7.9	14.0	20.8	12.7	11.8	9.1	9.7	28.4	9.4	23.0	32.9	6.3	20.0	26.3	13.3	13.2	9.1	7.5	8.9	11.7	45.6	7.3	10.0	16.5	12.8	8.6	6.8	10.3	6.2	5.7	14.7	7.5	9.0	31.3	10.2	17.5	9.6	31.0	6.9	3.9	23.1	4.8	9.7	10.2	16.8	12.0	9.6	12.4	6.9	13.3	15.8	10.1	15.1	12.0	12.5	12.5	15.4	6.2	22.9	14.1	5.4	8.0	11.0	8.7	16.4	12.4	16.0	6.6	20.7	7.9	8.1	5.4	12.7	12.4	9.3	6.2	7.6	9.2	10.4	6.2	8.4	10.5	5.9	20.8	14.0	7.9	8.4	11.8	10.4	17.1	10.6	20.0	11.0	16.4	11.7	8.4	16.9	12.6
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.1;Hep G2: 16.5;RPTEC TERT1: 26.8;U-2 OS: 12.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 5.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (3.96e-5)"	"prognostic favourable (8.01e-4)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favourable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.63e-1)"	2.6	18.9	1.2	1.5	0.8	0.0	11.6	5.5	0.8	6.5	4.8	1.2	40.8	2.5	2.3	10.8	2.1	6.8	10.3	0.7	1.0	1.3	10.7	14.4	9.6	0.3	0.9	0.5	2.4	42.8	6.2	2.5	5.1	1.3	5.3	6.9	5.8	43.9	47.8	0.7	1.5	6.1	0.9	0.8	0.7	12.1	1.9	0.8	0.7	12.4	2.9	3.6	1.4	1.1	0.4	1.4	0.6	1.1	1.1	1.8	0.4	0.0	2.0	0.3	0.3	0.8	0.4	2.1	1.1	0.9	2.0	5.0	7.8	5.1	0.0	5.6	0.6	0.6	0.3	15.1	5.3	0.2	7.7	0.0	1.8	16.5	3.0	0.1	0.0	2.4	0.4	8.2	6.5	0.5	0.1	0.0	0.8	0.1	0.2	0.4	3.8	0.3	0.2	0.0	0.0	26.8	2.0	1.3	0.1	0.0	0.1	2.5	0.8	0.6	0.4	0.1	12.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.7	0.6	0.7	0.9	0.5	0.0	0.7	1.8	1.4	0.4	0.8	1.8	0.2	1.1	1.1	1.3	0.0	0.4	1.2	0.8	5.5	0.8	1.0	1.3	0.9	0.5	1.3	0.8
KCTD21	KCASH2	ENSG00000188997	"Potassium channel tetramerization domain containing 21"	Q4G0X4	11	78171249-78188822	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041964	Uncertain		Approved	Cytosol				Cytosol		"HPA041964: AB_10795647"	"unprognostic (1.17e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.40e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.70e-1)"	"prognostic favourable (9.57e-5)"	"unprognostic (3.43e-2)"	8.6	18.1	13.2	7.3	12.5	4.0	15.8	8.4	14.0	7.7	7.7	9.7	7.5	6.2	6.5	11.8	12.1	8.2	9.8	12.4	10.3	12.2	6.8	18.9	8.2	6.1	15.2	9.7	17.9	9.0	11.3	8.4	9.5	10.0	5.9	6.1	6.2	6.7	6.8	9.3	6.0	5.5	11.9	12.3	5.4	5.5	5.6	8.4	7.2	13.8	5.3	7.4	10.1	7.4	2.0	4.3	9.5	7.1	1.9	2.1	2.3	3.7	8.8	4.9	3.7	17.5	12.7	3.1	7.4	7.1	5.2	5.2	8.1	5.7	3.6	7.4	8.0	7.6	4.6	6.1	5.3	4.9	2.9	2.6	10.1	7.2	9.8	1.7	3.5	12.1	11.1	11.6	6.6	7.9	5.6	3.3	7.0	5.1	2.7	5.2	2.3	6.5	3.7	3.7	2.2	6.1	6.8	3.5	5.2	4.7	3.3	3.4	8.0	1.9	9.7	8.3	8.3	22.5	2.8	6.4	6.3	3.5	4.4	2.8	4.7	2.1	6.5	8.3	1.2	7.1	1.7	0.8	1.8	2.1	4.3	2.0	1.8	1.3	9.5	1.9	5.6	1.0	1.4	2.3	13.2	12.5	8.4	13.3	10.3	12.2	15.2	9.7	10.0	8.4
KCTD3	NY-REN-45	ENSG00000136636	"Potassium channel tetramerization domain containing 3"	Q9Y597	1	215567392-215621807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015142	Approved		Approved	Cytosol				Cytosol		"HPA015142: AB_1852174"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.60e-3)"	"unprognostic (9.27e-2)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (8.94e-6)"	"unprognostic (2.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.27e-1)"	"unprognostic (3.31e-3)"	18.4	47.6	17.3	7.3	16.6	7.7	37.5	23.6	16.9	19.8	35.1	24.1	20.3	25.1	22.6	18.4	25.8	12.1	15.7	10.3	17.4	14.4	16.3	39.6	10.9	4.4	18.7	13.1	13.8	18.2	24.5	12.4	18.1	19.5	22.7	16.4	13.9	24.5	17.9	10.0	10.6	35.1	17.1	26.6	7.5	16.6	13.3	15.0	5.3	15.8	11.0	9.2	18.1	21.9	2.6	2.6	3.3	2.1	2.5	1.3	0.6	15.5	11.2	12.8	7.4	10.9	18.4	17.7	12.9	12.0	11.5	12.0	9.8	26.0	4.3	7.2	13.4	15.3	13.3	13.1	13.2	2.4	13.9	7.8	21.8	13.8	9.0	7.9	1.5	16.8	9.2	14.6	11.1	10.4	15.1	4.2	12.5	13.5	3.4	4.1	21.5	14.4	5.2	18.1	16.9	13.4	10.5	15.1	16.9	19.9	29.3	10.8	69.9	10.3	9.3	11.5	11.4	14.1	14.7	3.9	5.2	1.5	9.0	4.2	8.7	1.8	2.1	1.0	1.0	1.1	0.8	1.6	1.1	1.0	2.0	2.6	1.2	1.3	3.3	2.5	1.0	2.6	0.6	0.6	17.3	16.6	23.6	16.2	17.4	14.4	18.7	13.1	19.5	15.0
KCTD9	"BTBD27, FLJ20038"	ENSG00000104756	"Potassium channel tetramerization domain containing 9"	Q7L273	8	25427847-25458476	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042468, HPA047902"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"				Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA042468: , HPA047902: "	"unprognostic (4.18e-2)"	"unprognostic (3.90e-2)"	"prognostic favourable (7.88e-4)"	"unprognostic (7.04e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.97e-3)"	14.4	5.8	7.4	17.3	7.7	11.5	14.6	17.7	10.1	15.7	14.1	5.4	16.8	12.4	15.6	12.2	18.2	11.3	12.8	48.4	5.9	5.2	9.6	6.6	10.3	6.9	7.4	5.3	12.4	8.3	7.3	11.2	7.4	14.6	11.8	14.8	9.4	14.6	18.4	19.0	15.0	10.9	16.7	10.8	8.6	10.6	11.2	6.6	11.8	8.7	11.7	8.7	19.1	14.8	2.2	3.2	3.7	2.9	0.9	3.8	1.5	17.9	12.8	14.0	4.8	18.2	24.2	11.5	27.3	24.6	18.0	18.3	9.1	13.2	11.8	11.7	27.2	12.1	12.2	12.8	21.7	6.0	7.3	13.7	12.5	8.4	22.1	4.8	10.2	18.6	15.6	16.3	13.6	15.1	14.4	9.3	20.3	4.8	18.4	8.3	6.8	6.8	7.2	16.2	4.3	18.3	10.3	3.5	4.6	20.9	9.3	14.1	7.1	5.5	16.7	19.9	11.6	38.1	14.7	2.7	4.9	15.6	13.9	8.5	14.3	2.6	1.7	3.7	3.4	2.5	3.8	2.2	3.6	3.6	1.1	1.2	2.2	3.6	1.8	0.9	2.9	3.2	3.5	1.5	7.4	7.7	17.7	10.1	5.9	5.2	7.4	5.3	14.6	6.6
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382570-48391553	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (3.49e-4)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	46.9	49.3	22.6	23.4	21.5	14.5	60.6	16.1	28.8	51.8	43.3	24.4	64.8	47.7	44.0	45.2	41.3	40.3	56.5	42.8	20.9	20.4	57.3	81.3	38.0	44.6	18.6	20.4	68.9	61.0	63.5	45.7	81.4	20.9	44.8	47.7	39.7	65.8	69.9	31.8	37.4	59.9	39.6	26.0	33.7	42.5	33.2	18.6	26.2	75.5	32.9	42.3	53.2	54.4	10.6	26.5	6.8	23.3	11.6	12.8	9.3	30.1	43.7	25.4	26.9	57.1	66.8	18.6	29.8	52.8	36.4	41.8	28.8	34.5	12.6	19.6	65.2	27.1	30.5	31.9	34.8	10.1	32.6	10.5	15.5	53.6	49.7	11.7	19.7	63.1	39.4	24.7	26.5	33.8	18.2	23.5	48.3	24.3	11.0	120.2	18.4	17.8	15.7	15.1	19.7	46.2	25.2	25.5	19.8	26.1	23.5	15.6	18.4	14.4	26.1	25.8	21.3	21.3	25.3	66.5	52.0	8.5	16.3	15.8	26.2	5.9	23.3	6.8	11.2	19.8	12.8	10.6	11.0	12.1	17.7	9.6	9.2	9.9	5.9	11.6	16.5	26.5	11.7	9.3	22.6	21.5	16.1	28.8	20.9	20.4	18.6	20.4	20.9	18.6
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: "	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	15.1	19.0	19.7	16.8	23.2	24.9	19.3	28.0	26.6	20.0	20.6	15.1	21.0	16.2	28.9	30.6	20.9	22.0	15.7	18.6	16.4	18.9	15.9	14.8	15.1	19.5	13.8	25.4	27.4	21.4	24.6	28.7	19.3	20.3	20.9	21.6	16.4	21.3	19.9	24.8	23.3	16.9	19.1	10.7	16.2	17.1	78.4	12.1	48.1	20.9	19.1	22.1	18.7	21.9	9.1	9.7	5.7	6.9	3.8	7.4	1.9	30.0	15.6	44.5	39.3	11.8	15.1	31.7	12.8	16.2	26.2	23.4	14.6	29.3	22.4	18.4	21.0	33.8	41.2	24.4	33.3	20.3	25.0	31.5	26.0	35.5	15.1	24.2	13.9	14.0	17.6	27.8	19.7	32.6	34.4	10.6	18.6	17.9	52.8	18.6	29.0	22.7	50.7	29.4	15.1	22.0	19.4	55.7	42.1	57.8	15.3	19.0	15.3	18.1	26.4	11.7	19.8	21.6	17.4	13.8	10.8	26.1	12.2	28.8	16.6	2.8	3.7	5.7	5.9	5.9	5.2	9.1	5.4	5.7	4.4	3.3	7.1	7.4	0.3	3.8	6.9	9.7	5.8	1.9	19.7	23.2	28.0	26.6	16.4	18.9	13.8	25.4	20.3	12.1
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153595	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.1;dendritic cells: 2.5;granulocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062872			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA062872: "	"prognostic favourable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (2.74e-4)"	"prognostic favourable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"	13.3	16.0	14.8	15.1	13.4	22.0	20.0	26.1	18.7	19.4	12.6	18.3	24.3	12.1	24.2	18.1	15.9	18.4	12.0	12.6	13.3	9.2	10.4	18.2	11.8	19.2	13.8	12.9	18.5	19.0	12.1	17.9	29.4	11.2	24.8	6.0	18.8	16.5	22.6	38.0	21.1	12.9	16.2	13.3	21.2	12.0	19.9	13.8	14.6	28.9	8.8	13.7	13.3	21.9	7.1	2.5	6.9	0.9	1.3	0.8	0.5	8.8	3.1	7.3	8.7	4.2	4.2	14.7	4.4	3.3	3.9	4.9	5.2	2.5	12.3	4.7	5.0	5.0	4.4	5.2	2.4	5.5	11.2	4.1	5.3	4.3	7.9	4.1	9.6	6.5	5.6	3.2	2.7	5.2	10.1	7.6	3.5	4.5	4.7	6.3	6.4	7.7	8.0	5.5	10.2	3.9	5.8	13.6	10.4	5.7	6.4	7.0	34.9	10.9	7.5	5.8	3.3	7.1	4.4	20.9	8.6	9.5	11.5	8.3	3.3	1.6	0.9	2.6	0.5	0.3	0.3	6.1	0.4	0.4	0.4	7.1	0.6	0.8	6.9	1.3	0.4	2.5	0.5	0.5	14.8	13.4	26.1	18.7	13.3	9.2	13.8	12.9	11.2	13.8
KDM5A	"JARID1A, RBBP2"	ENSG00000073614	"Lysine demethylase 5A"	P29375	12	280129-389454	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006201			Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"HPA006201: AB_1079160"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.81e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.69e-2)"	13.6	14.4	10.6	13.7	13.0	41.6	13.1	21.8	13.2	11.8	10.3	14.8	11.3	7.8	14.2	8.1	13.6	11.2	10.0	10.1	11.5	5.7	9.0	10.7	13.1	14.9	15.1	9.1	15.2	11.5	16.8	13.8	12.4	11.3	10.6	10.9	10.6	12.9	8.6	9.7	20.3	13.0	10.4	10.1	15.5	10.6	21.2	14.8	28.8	11.4	7.1	16.1	13.1	18.8	17.2	16.8	33.7	14.1	18.6	18.1	10.1	7.6	13.7	10.1	7.8	9.1	8.7	11.2	6.8	9.0	10.2	11.1	8.1	9.3	12.8	2.1	11.3	7.2	10.5	7.7	12.3	20.1	8.7	15.6	14.4	4.8	7.4	20.3	12.3	9.4	7.3	12.5	16.8	10.3	9.3	18.0	8.6	5.1	14.5	5.8	15.7	4.3	13.6	26.4	6.0	4.9	17.6	3.9	11.4	13.3	6.0	7.2	6.5	12.8	14.1	6.7	9.7	7.5	11.3	6.4	7.0	29.4	8.7	8.9	9.9	30.2	11.3	22.2	17.7	13.1	18.1	14.1	13.8	14.2	11.8	17.2	15.1	12.9	33.7	18.6	14.1	16.8	10.5	10.1	10.6	13.0	21.8	13.2	11.5	5.7	15.1	9.1	11.3	14.8
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724491-202809470	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB068193: , HPA027179: AB_1851987, HPA053723: "	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	7.7	7.1	5.9	8.2	7.8	14.8	12.3	12.7	9.0	12.9	9.6	5.1	9.7	5.0	13.6	9.4	17.6	8.6	8.4	5.7	6.1	4.5	6.0	4.6	9.0	5.4	3.7	7.3	13.3	9.0	9.8	8.6	23.1	5.0	11.3	9.0	16.0	11.1	8.8	4.3	19.5	7.3	10.1	4.9	6.9	8.2	74.0	5.2	25.8	9.1	6.2	10.4	12.2	12.6	4.1	3.0	16.0	5.2	7.3	4.4	2.6	11.1	4.6	30.4	14.6	14.4	13.1	25.7	7.7	11.9	8.1	8.6	3.8	11.9	0.0	5.3	12.1	17.3	14.4	12.6	10.5	0.1	5.5	6.1	4.3	6.1	12.4	19.0	8.1	13.5	21.0	11.6	15.3	18.0	19.0	0.0	8.2	11.4	5.3	22.7	20.6	8.0	22.4	0.0	0.0	11.7	19.4	9.3	20.5	16.3	10.1	13.6	20.6	13.6	13.3	7.2	5.4	0.9	4.5	1.2	0.8	4.7	6.3	7.0	2.9	16.0	2.9	6.4	3.7	3.4	3.1	2.8	3.3	2.7	3.0	4.1	4.2	1.8	9.5	7.3	5.2	2.1	4.4	2.6	5.9	7.8	12.7	9.0	6.1	4.5	3.7	7.3	5.0	5.2
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038244: , HPA046147: "	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	19.5	22.9	22.4	22.6	24.7	26.3	17.9	43.0	31.7	25.9	19.5	23.4	16.7	22.2	29.2	13.3	26.9	24.8	15.2	17.6	21.6	15.3	17.0	18.8	20.6	25.8	24.6	21.8	33.1	22.5	37.7	31.8	34.0	22.8	18.7	13.5	17.0	25.6	17.1	36.6	28.4	22.2	23.6	16.0	25.0	19.4	10.6	26.2	29.0	22.2	11.3	24.5	21.5	26.4	4.5	4.3	4.8	4.0	2.8	6.1	3.8	17.3	23.8	25.5	19.5	17.7	16.2	18.1	10.9	12.8	14.8	13.8	16.0	11.4	16.2	14.2	14.3	15.6	28.8	23.3	11.3	12.1	42.6	15.7	25.3	11.3	21.8	18.6	31.4	12.7	17.2	28.9	35.6	21.8	30.6	10.8	10.8	22.3	13.6	20.9	21.6	22.3	15.4	15.2	17.6	9.4	16.7	19.2	24.8	33.1	30.7	12.4	21.5	16.4	14.9	16.5	14.3	14.8	10.5	15.7	12.8	12.4	21.4	22.1	12.2	3.0	3.8	2.7	6.1	3.6	5.1	4.5	3.7	5.7	3.1	3.2	4.5	2.9	4.8	2.8	4.0	4.3	4.3	3.8	22.4	24.7	43.0	31.7	21.6	15.3	24.6	21.8	22.8	26.2
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203495-27221768	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA026545: AB_1852015"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	1.9	3.2	2.7	3.6	3.5	1.4	2.1	5.9	5.9	2.2	4.2	3.7	3.2	12.0	3.1	2.2	2.1	2.5	2.5	2.0	2.7	3.2	2.3	44.9	2.0	3.3	2.3	5.1	3.0	4.5	2.8	3.3	1.7	3.7	2.9	1.9	2.1	2.6	2.5	4.0	1.9	16.8	1.9	2.2	3.7	2.3	2.2	2.2	5.9	2.9	2.0	3.7	2.8	2.2	5.6	6.5	1.3	3.4	2.2	8.2	3.5	1.6	3.7	6.3	3.2	1.6	1.8	3.4	2.1	2.3	4.7	4.2	3.1	2.9	9.5	3.6	3.5	1.9	3.6	3.2	2.8	10.9	5.4	6.0	4.1	7.2	3.4	4.2	7.2	2.5	2.5	3.1	2.0	3.6	7.6	5.8	2.9	2.8	4.2	7.6	11.0	2.2	6.2	3.9	8.4	1.8	1.9	5.9	3.8	0.9	3.0	2.2	3.2	5.6	4.1	5.7	2.9	2.0	2.2	3.6	3.8	7.6	2.3	3.9	0.5	0.4	3.2	1.3	4.2	3.4	3.6	3.2	6.2	6.0	3.0	5.6	6.0	8.2	0.1	2.2	2.9	6.5	3.6	3.5	2.7	3.5	5.9	5.9	2.7	3.2	2.3	5.1	3.7	2.2
KEAP1	"INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454"	ENSG00000079999	"Kelch like ECH associated protein 1"	Q14145	19	10486120-10503741	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005558, CAB025337"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				"Nucleoplasm, Centriolar satellite"	Cytosol	"CAB025337: , HPA005558: AB_1079175"	"unprognostic (1.98e-1)"	"prognostic favourable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.06e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	16.0	13.7	13.5	10.4	14.3	9.1	12.4	13.2	15.1	13.1	15.7	15.4	13.8	13.6	11.0	12.7	26.3	15.1	12.7	19.7	13.9	13.7	13.2	22.0	10.8	15.5	16.7	7.4	11.8	14.3	11.1	10.2	11.5	14.3	13.9	8.8	11.8	11.3	13.9	63.9	16.8	13.8	11.6	16.5	11.3	10.6	12.2	13.8	13.1	14.5	29.1	16.1	14.5	11.2	14.6	23.7	21.3	19.8	21.0	30.8	19.6	17.2	31.7	8.8	11.7	18.1	15.5	9.4	14.7	11.0	15.1	13.6	22.5	17.4	24.6	38.8	16.3	15.5	17.4	11.5	7.5	23.8	19.1	37.2	9.4	26.6	17.5	19.4	20.2	16.0	15.6	17.0	7.9	14.3	22.7	45.6	13.1	23.9	14.1	53.4	25.6	26.7	25.6	11.0	28.7	9.8	20.7	24.2	12.6	20.5	13.8	12.7	11.9	26.0	17.6	24.4	13.1	27.3	17.8	26.6	33.3	24.1	18.8	23.2	17.9	16.1	19.8	21.3	30.8	17.0	29.3	14.6	21.5	28.3	23.7	5.7	13.5	19.1	10.9	21.0	16.6	16.3	25.4	19.6	13.5	14.3	13.2	12.8	13.9	13.7	16.7	7.4	14.3	13.8
KEL	"CD238, ECE3"	ENSG00000197993	"Kell blood group, metallo-endopeptidase"	P23276	7	142941114-142962681	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 21.1;testis: 36.4"	"Group enriched"	"Detected in some"	12	"HEL: 14.9;K-562: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA064442			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5.0	2.0	0.2	0.2	0.2	0.0	0.2	1.1	0.3	0.2	0.0	0.3	2.5	0.2	0.2	0.0	0.5	0.2	4.4	3.8	0.0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2.0	0.2	0.3	0.3
KHDC1	"bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1"	ENSG00000135314	"KH domain containing 1"	Q4VXA5	6	73241314-73310365	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA029032			Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA029032: AB_10602914"	"unprognostic (3.46e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.83e-4)"	"unprognostic (8.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.17e-3)"	2.9	2.9	10.3	2.0	12.9	0.9	2.2	8.8	14.6	4.7	1.3	2.6	1.2	0.6	3.9	3.3	2.7	6.2	2.6	3.4	8.5	8.4	1.3	0.4	1.8	3.1	8.6	5.7	7.4	4.4	5.0	9.6	1.5	4.7	4.4	1.4	2.9	1.3	3.6	2.7	1.0	1.1	2.4	6.2	0.9	2.9	8.2	4.1	5.4	5.9	1.7	3.4	2.2	2.1	2.7	2.6	3.8	0.2	2.5	5.2	2.0	2.8	4.2	0.8	2.2	4.0	4.5	2.0	5.6	5.4	8.7	12.8	4.0	2.2	6.1	2.2	2.4	2.8	5.8	1.1	6.6	5.8	4.2	4.1	3.4	0.0	5.1	1.9	0.1	5.8	2.4	8.6	2.4	1.9	3.0	7.3	3.4	6.8	0.4	1.8	3.8	8.3	0.9	0.0	4.9	1.3	0.1	10.3	2.1	3.2	0.1	0.2	0.1	6.1	0.1	1.8	4.0	1.1	5.9	12.5	7.5	4.4	0.1	1.7	0.6	3.8	0.2	0.0	4.4	0.0	2.6	2.7	2.8	4.9	0.7	1.9	2.2	3.4	0.0	2.5	0.0	2.6	5.2	2.0	10.3	12.9	8.8	12.4	8.5	8.4	8.6	5.7	4.7	4.1
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Cell line enhanced"	"Detected in many"		"HEL: 18.5;Hep G2: 26.9"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol			320000	Cytosol		"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	13.9	10.6	1.6	6.4	1.2	0.3	1.4	0.9	0.6	1.3	0.8	5.1	3.0	2.1	3.4	0.0	6.2	5.5	1.8	0.4	4.9	10.0	18.5	2.8	26.9	0.6	2.5	2.2	0.1	0.8	1.6	0.1	1.2	3.3	3.5	0.1	9.1	3.0	2.0	2.3	4.2	10.6	0.8	11.8	1.6	1.7	6.0	9.3	2.0	3.6	3.9	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.8	3.6	1.8	6.0	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6
KHNYN	KIAA0323	ENSG00000100441	"KH and NYN domain containing"	O15037	14	24429286-24441834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003402	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003402: AB_1079190"	"unprognostic (2.95e-1)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (1.03e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.73e-1)"	18.3	16.7	8.3	24.2	12.8	21.1	18.1	18.9	9.4	21.6	22.4	14.3	25.2	16.9	18.7	19.5	24.3	18.3	28.8	11.2	8.6	5.9	11.8	12.5	16.8	19.2	12.9	7.2	30.7	23.2	17.6	12.8	31.5	11.3	21.5	16.1	10.8	17.0	20.0	15.1	16.9	21.2	24.5	13.6	22.7	24.6	9.3	12.5	20.1	16.1	16.6	26.0	19.7	30.7	6.6	4.5	7.0	5.8	4.5	5.8	3.7	12.4	15.1	12.6	10.0	13.9	13.7	13.4	12.3	14.2	14.2	11.1	9.4	21.5	17.6	7.1	10.9	11.8	11.0	19.3	10.1	26.8	5.5	7.9	13.5	17.0	14.9	11.5	16.8	13.9	43.6	15.2	19.0	15.9	10.1	15.7	8.2	16.7	4.0	6.9	3.3	13.1	6.3	0.1	8.7	8.6	17.9	9.2	9.8	10.4	6.5	16.0	7.6	12.9	16.0	12.4	11.2	14.7	7.0	30.3	16.3	11.7	6.8	6.2	11.6	4.7	4.1	7.0	5.8	5.8	3.4	4.6	4.5	4.9	3.1	6.6	3.5	3.3	5.7	4.5	4.8	4.5	4.4	3.7	8.3	12.8	18.9	9.4	8.6	5.9	12.9	7.2	11.3	12.5
KIAA0100	"BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488"	ENSG00000007202	KIAA0100	Q14667	17	28614440-28645454	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042781	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"			"Nuclear speckles, Cytosol"		"HPA042781: AB_10797020"	"unprognostic (1.91e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.89e-2)"	"prognostic unfavourable (3.47e-5)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.24e-3)"	"unprognostic (7.58e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	27.7	31.2	22.3	21.3	34.7	21.9	26.3	28.1	40.1	20.0	24.0	28.2	20.9	15.5	24.7	21.6	25.4	24.0	20.1	21.4	22.0	22.4	38.1	30.7	24.1	26.3	23.1	19.6	25.6	24.6	48.0	27.0	32.7	35.6	22.7	28.5	22.1	27.0	23.3	40.7	25.0	27.9	28.4	21.4	26.4	22.8	24.8	18.6	26.3	28.6	20.2	26.6	22.7	18.8	2.9	7.2	3.5	3.0	2.0	3.3	1.3	19.3	37.0	18.8	17.8	34.3	20.5	13.7	18.2	24.2	22.2	21.0	25.4	8.8	27.0	21.8	33.1	25.9	27.6	26.9	27.0	29.9	25.8	21.5	29.4	13.9	14.8	37.5	37.3	20.8	20.9	30.0	23.0	31.7	20.2	8.8	20.2	27.7	27.3	17.9	8.2	13.7	21.0	21.0	17.6	13.4	34.9	18.5	14.2	22.9	62.6	15.2	37.4	26.2	29.3	17.0	18.8	22.7	34.2	8.3	9.6	17.4	19.4	24.3	19.8	0.8	3.0	3.5	3.0	2.5	3.3	2.9	1.5	2.7	3.3	1.7	1.8	1.8	1.8	2.0	2.7	7.2	1.7	1.3	22.3	34.7	28.1	40.1	22.0	22.4	23.1	19.6	35.6	18.6
KIAA0232		ENSG00000170871	KIAA0232	Q92628	4	6781375-6884170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 13.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036891, HPA036892, HPA061498"	Approved		Approved	Cytosol				Cytosol		"HPA036891: AB_10672272, HPA036892: , HPA061498: "	"unprognostic (6.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"prognostic favourable (3.91e-10)"	"unprognostic (1.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.18e-2)"	12.5	12.7	18.7	8.1	22.2	14.0	13.8	22.8	25.5	13.3	13.8	20.5	12.4	8.5	15.8	13.4	21.1	15.9	12.7	32.2	19.8	18.8	19.5	15.0	12.0	7.0	20.7	17.5	13.9	10.6	25.4	22.2	25.8	25.4	15.5	12.7	11.5	10.6	15.7	32.4	7.7	18.8	13.5	19.8	12.3	11.0	13.5	17.9	10.0	15.5	13.3	8.5	12.1	13.2	1.6	2.4	13.1	2.5	2.1	3.8	0.9	8.8	8.6	18.1	11.2	13.1	14.2	9.5	11.7	12.2	8.2	6.9	5.4	7.5	5.9	4.0	13.0	4.7	9.1	5.1	10.7	3.3	3.7	17.4	7.4	7.1	6.9	7.5	23.0	9.5	12.1	9.1	5.0	8.4	13.1	5.1	10.3	4.3	14.3	7.6	9.5	9.6	10.2	18.5	2.7	13.9	8.4	13.8	8.9	8.5	7.7	8.0	9.8	13.8	10.6	7.5	9.0	6.7	9.9	8.9	8.9	4.7	9.2	8.1	20.3	1.9	2.4	6.3	2.8	1.6	3.8	1.6	2.1	3.1	1.6	1.6	2.0	2.0	13.1	2.1	2.5	2.4	1.9	0.9	18.7	22.2	22.8	25.5	19.8	18.8	20.7	17.5	25.4	17.9
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127440343-127459391	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6;smooth muscle: 37.2"	"Cell line enhanced"	"Detected in many"		"AF22: 12.4;SCLC-21H: 31.2;SH-SY5Y: 15.4;U-138 MG: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: "	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	22.9	3.1	9.1	3.4	6.9	0.0	2.8	12.4	21.0	7.4	12.0	0.6	1.9	1.1	2.6	4.7	16.7	1.1	2.9	2.6	10.2	9.7	0.6	0.7	15.3	0.5	11.5	0.7	3.3	0.5	0.0	6.8	1.1	0.9	20.4	5.0	0.7	1.9	1.7	38.6	0.4	6.7	37.2	13.1	2.0	3.7	3.4	1.2	0.7	1.5	15.4	0.8	25.2	11.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	2.8	12.4	0.0	1.1	2.9	0.0	0.3	2.2	1.9	4.4	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	0.0	8.1	0.0	0.0	0.0	0.3	2.3	0.0	4.3	0.0	4.2	0.0	0.0	2.1	0.0	0.7	0.0	31.2	15.4	0.0	0.0	0.3	0.0	0.8	0.0	8.5	1.4	0.0	2.0	0.0	0.0	0.0	4.9	0.2	6.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.1	6.9	12.4	11.8	10.2	9.7	11.5	0.7	0.9	1.2
KIAA0513		ENSG00000135709	KIAA0513	O60268	16	85027751-85094230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 15.9;monocytes: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012866, HPA014431"	Enhanced		Uncertain	Nucleoplasm,Cytosol			8400	"Nucleoplasm, Cytosol"		"HPA012866: AB_1852321, HPA014431: AB_1852322"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic favourable (1.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.88e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.34e-1)"	5.2	11.0	20.8	8.8	30.8	14.3	2.8	57.6	57.6	6.9	8.1	4.6	1.8	4.7	3.3	3.1	7.6	2.3	4.9	4.5	19.7	14.9	3.0	1.9	6.7	5.2	11.3	27.6	2.9	13.0	4.1	14.8	4.0	17.6	6.2	6.1	2.9	8.3	5.2	5.6	9.9	6.0	5.6	6.9	7.4	10.1	5.7	4.6	0.5	2.8	1.0	6.2	8.3	3.5	0.0	3.6	15.9	13.6	0.7	0.9	3.1	5.6	6.1	4.1	5.9	7.8	5.8	1.0	5.7	9.1	8.2	4.8	2.7	2.7	2.0	2.5	6.8	5.0	3.8	9.0	5.1	4.2	3.1	3.6	1.9	1.5	3.7	0.4	5.2	10.7	4.8	9.4	1.2	4.3	15.8	4.7	7.2	8.8	0.7	1.5	4.0	4.9	0.6	5.3	1.2	7.6	4.1	12.2	1.9	6.7	11.1	2.7	9.0	1.1	8.7	5.1	3.8	7.7	2.0	7.4	1.3	4.0	6.7	2.8	5.4	11.0	7.2	10.6	0.9	8.3	0.3	0.0	0.6	0.6	2.6	0.0	0.6	0.6	15.9	0.7	13.6	3.6	0.2	3.1	20.8	30.8	57.6	45.9	19.7	14.9	11.3	27.6	17.6	4.6
KIAA0586	"JBTS23, Talpid3"	ENSG00000100578	KIAA0586	Q9BVV6	14	58427385-58551289	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000846, HPA050249"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000846: AB_2234167, HPA050249: "	"unprognostic (1.90e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"prognostic favourable (7.20e-4)"	"unprognostic (8.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-1)"	9.5	9.9	10.2	9.2	14.7	9.8	9.9	23.9	13.0	9.9	8.3	7.5	8.0	6.1	9.4	10.7	9.4	7.5	8.3	8.0	12.4	9.6	7.4	11.1	7.9	11.2	15.3	10.7	13.5	8.2	14.6	33.2	6.7	14.5	9.7	11.0	7.0	8.1	8.6	10.4	9.1	8.3	15.8	19.8	9.5	7.6	25.0	14.8	24.5	9.0	7.4	12.7	10.0	8.6	9.1	5.0	13.5	3.6	13.1	10.9	3.1	14.3	10.7	17.8	7.3	12.2	10.9	6.6	13.4	9.5	11.4	10.4	4.3	8.0	17.9	8.5	8.8	9.2	16.5	8.0	19.5	15.7	6.0	14.6	9.1	12.4	7.2	19.8	10.8	7.0	3.4	9.4	12.4	13.4	14.8	9.5	18.3	9.0	10.7	8.4	7.1	17.4	15.3	20.1	10.8	8.2	6.7	11.1	6.9	13.8	8.3	6.5	10.6	10.5	12.7	16.8	14.6	9.5	10.6	4.8	8.6	14.3	11.2	14.6	10.5	13.5	2.8	6.1	9.3	2.4	8.6	7.3	9.0	7.1	3.2	9.1	10.9	8.7	3.2	13.1	3.6	5.0	8.5	3.1	10.2	14.7	23.9	13.0	12.4	9.6	15.3	10.7	14.5	14.8
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578148-6640927	"Disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023057, HPA023494"	Enhanced		Enhanced	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	6.5	7.0	7.5	11.7	12.8	4.5	9.9	7.4	9.4	10.1	7.7	7.3	20.1	4.4	17.8	15.6	8.5	13.4	10.7	5.0	8.3	7.7	8.7	4.3	8.3	6.6	4.9	7.9	15.4	10.5	26.4	26.0	7.4	8.0	9.6	9.2	9.6	7.0	13.6	5.4	7.4	6.4	11.5	7.2	9.0	7.9	20.1	5.1	13.7	12.1	4.1	6.8	8.4	7.7	2.3	1.8	5.5	2.2	1.1	2.0	0.7	15.6	12.1	15.8	11.0	6.0	10.4	6.0	8.5	8.0	12.1	10.6	8.9	3.6	5.6	5.7	7.8	14.6	14.9	7.7	19.4	5.6	11.9	3.2	10.5	6.3	8.9	5.5	7.2	6.8	10.9	12.1	10.0	8.8	7.9	0.8	9.4	5.5	6.0	4.8	9.6	6.4	8.8	5.3	1.8	10.8	10.2	5.9	10.6	11.2	2.9	6.5	5.0	3.6	8.1	11.4	5.2	5.9	12.5	1.3	1.9	2.4	8.0	3.2	7.6	0.0	2.0	1.7	1.8	2.2	2.0	2.3	1.5	1.6	1.3	1.4	1.2	1.1	5.5	1.1	1.1	1.8	1.1	0.7	7.5	12.8	7.4	9.4	8.3	7.7	4.9	7.9	8.0	5.1
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324221-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"				Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: , HPA061066: "	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.5	9.9	8.1	1.3	11.0	2.8	5.2	28.9	13.5	3.7	3.0	5.8	6.0	3.0	4.6	9.1	3.6	8.6	4.6	2.6	6.2	8.1	13.1	10.4	4.2	0.7	4.2	8.2	12.7	12.4	18.6	14.7	2.0	8.0	4.6	2.1	6.6	4.1	4.7	2.1	7.8	1.7	4.4	4.7	1.2	14.3	27.1	4.9	2.1	5.5	1.5	0.9	2.3	2.7	0.6	0.5	1.3	0.1	0.5	1.5	0.4	7.2	4.4	9.1	8.9	0.2	0.2	2.0	1.9	2.2	4.3	5.3	1.9	3.7	0.0	2.0	0.4	4.2	11.8	3.8	3.8	0.6	7.5	0.1	6.9	1.7	1.6	1.1	0.2	1.0	7.0	3.9	4.9	0.1	2.9	0.1	0.4	2.3	3.6	2.5	0.4	1.0	1.4	0.3	0.0	9.9	0.8	27.9	9.7	3.6	8.5	2.5	8.5	1.2	0.0	0.6	2.2	1.3	2.8	4.1	9.2	0.0	1.7	0.3	2.1	0.8	0.1	0.3	0.1	0.1	1.3	0.3	0.9	0.2	0.1	0.6	1.4	0.6	1.3	0.5	0.1	0.5	1.5	0.4	8.1	11.0	28.9	13.5	6.2	8.1	4.2	8.2	8.0	4.9
KIAA1217	"DKFZP761L0424, ETL4, SKT"	ENSG00000120549	KIAA1217	Q5T5P2	10	23694746-24547848	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 91.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.6;Karpas-707: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004941	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA004941: AB_2130659"	"unprognostic (3.60e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-1)"	24.9	12.7	3.3	6.6	8.7	0.0	21.6	5.5	16.2	10.2	15.1	2.7	18.0	7.5	7.2	16.5	22.6	10.4	11.9	8.6	5.1	3.7	13.5	10.4	8.6	1.4	4.3	8.1	8.4	10.1	34.1	5.5	12.2	8.8	15.1	8.9	16.9	28.8	26.6	91.1	12.0	13.7	4.1	3.8	5.7	10.1	16.8	1.8	3.3	20.5	20.4	8.8	10.1	13.0	0.0	0.0	0.0	0.0	0.9	2.8	0.0	7.5	3.8	1.5	0.0	1.0	2.8	33.6	1.5	2.4	3.5	7.5	6.5	12.1	0.4	7.6	3.0	12.6	1.9	14.4	3.9	2.8	1.4	0.1	8.8	7.6	1.7	0.0	0.1	10.5	9.3	7.7	2.1	0.0	0.0	30.6	1.7	2.6	4.1	0.2	3.4	3.5	0.3	9.0	6.2	8.2	10.0	1.0	0.5	3.7	12.7	0.0	6.1	0.0	8.0	5.4	5.8	21.5	1.9	13.6	11.5	0.0	17.9	0.2	0.2	0.0	0.0	0.0	0.5	0.0	2.8	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.3	8.7	5.5	16.2	5.1	3.7	4.3	8.1	8.8	1.8
KIAA1468	"FLJ33841, HsT3308, HsT885"	ENSG00000134444	KIAA1468	Q9P260	18	62187255-62310217	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039708, HPA040038"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"				"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA039708: AB_10794753, HPA040038: AB_10793860"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.71e-2)"	11.7	13.3	14.8	15.7	31.6	18.3	17.8	25.7	25.9	14.3	16.5	14.3	16.6	13.8	13.9	18.3	36.5	11.8	13.9	10.3	12.5	14.4	14.8	11.5	11.8	15.8	13.7	16.0	12.8	12.6	20.2	20.0	11.9	22.8	18.5	21.7	13.5	18.8	14.1	11.8	29.6	15.5	11.1	11.4	17.1	18.0	8.0	16.8	18.3	14.4	16.6	22.0	15.5	21.7	3.7	3.5	6.0	3.5	4.0	4.7	1.9	7.7	7.0	8.6	8.2	9.2	10.8	9.2	13.9	11.6	12.4	13.8	3.6	7.2	5.3	7.2	12.2	16.1	12.2	8.3	15.4	4.8	7.6	4.4	7.9	8.2	8.2	8.5	6.3	8.0	10.2	10.6	6.5	8.5	3.3	5.4	13.1	4.5	5.2	7.3	5.0	6.0	6.5	10.8	6.2	14.2	15.5	12.3	6.5	8.3	12.3	7.1	6.3	9.3	10.8	13.4	4.2	5.8	6.9	16.0	2.9	5.2	9.4	9.2	10.6	5.0	3.5	4.1	4.1	3.0	3.3	3.0	3.8	3.9	3.5	3.7	4.1	4.7	6.0	4.0	2.5	2.4	4.4	1.9	14.8	31.6	25.7	25.9	12.5	14.4	13.7	16.0	22.8	16.8
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Intermediate filaments,Cytosol"				Nucleoli	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.9	5.3	9.2	3.5	4.2	5.0	13.7	3.6	3.6	2.6	2.8	20.0	19.6	14.3	9.0	3.0	4.0	12.6	2.4	3.7	10.5	1.7	20.0	2.6	2.6	8.2	14.4	32.4	2.7	3.7	2.9	4.8	20.2	11.4	22.8	2.7	1.4	20.2	6.0	19.6	2.2	9.4	8.8	6.2	2.6	5.5	3.7	3.3	4.7	2.4	2.5	8.4	16.0	12.7	2.7	4.4	4.7	3.8	13.9	14.7	17.6	1.5	8.1	3.0	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9
KIAA1958	FLJ39294	ENSG00000165185	KIAA1958	Q8N8K9	9	112486847-112669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020625	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA020625: AB_1852451"	"unprognostic (3.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.58e-1)"	2.6	14.7	8.6	2.8	14.4	8.7	6.3	21.2	11.7	10.4	3.0	10.8	5.6	3.7	7.0	3.1	3.6	6.3	3.1	2.8	7.8	5.2	11.7	6.9	7.8	2.9	14.0	6.2	19.9	10.8	4.1	8.0	1.9	11.3	3.5	3.4	5.5	5.5	8.0	2.7	4.0	3.9	6.5	10.6	3.2	8.8	11.0	16.5	4.7	5.0	0.4	2.9	3.8	4.8	2.1	2.4	2.6	2.8	2.4	2.7	1.5	2.9	4.2	17.3	5.0	1.2	0.3	8.3	2.2	0.7	2.7	3.0	7.7	2.0	9.5	2.6	7.2	2.6	12.6	1.2	3.8	2.9	5.1	3.7	5.7	5.4	0.7	5.6	4.7	0.5	1.0	3.5	1.7	2.1	8.6	2.4	0.8	3.4	8.7	3.2	9.5	2.0	7.1	9.9	2.7	3.6	4.1	8.9	9.4	3.7	3.9	2.2	3.5	5.7	0.4	0.9	5.2	0.6	2.7	4.5	8.1	5.7	1.2	3.9	0.7	1.4	2.8	0.2	2.1	0.9	0.9	0.3	0.8	1.6	0.9	2.1	2.0	2.7	2.6	2.4	0.8	2.4	0.4	1.5	8.6	14.4	21.2	11.7	7.8	5.2	14.0	6.2	11.3	16.5
KIAA2013	"MGC33867, RP5-1077B9.1"	ENSG00000116685	KIAA2013	Q8IYS2	1	11919591-11926428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052677, HPA060536"	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA052677: , HPA060536: "	"unprognostic (3.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.51e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.74e-3)"	13.8	13.9	12.0	10.6	16.7	10.9	12.9	11.9	18.7	13.7	32.0	25.2	16.7	42.6	19.1	24.9	15.4	14.7	19.7	18.9	12.5	10.8	17.1	34.4	12.4	12.6	22.8	10.6	12.2	34.0	9.6	17.7	24.6	16.1	15.1	13.5	14.8	26.2	18.6	24.4	18.6	55.1	14.4	16.0	19.2	16.0	21.7	19.0	15.0	19.8	11.2	14.1	17.4	13.1	7.0	10.8	13.8	6.3	4.6	6.3	3.0	23.5	17.6	8.3	16.3	14.1	9.7	13.7	15.1	16.0	18.3	19.0	21.6	24.6	15.5	23.2	14.2	27.6	11.2	14.9	9.8	17.9	28.6	10.6	16.3	36.9	16.0	22.0	22.1	12.3	16.7	17.9	7.9	17.5	16.3	20.8	10.9	17.9	14.0	31.0	10.9	24.3	18.0	15.2	37.5	11.6	6.5	31.0	17.5	12.2	13.7	28.8	11.5	20.6	16.6	15.5	20.3	22.7	20.5	25.1	17.7	17.7	18.4	35.9	16.4	4.2	6.3	6.1	6.2	5.3	4.9	6.1	3.4	4.7	4.3	7.0	3.4	4.5	13.8	4.6	4.2	10.8	6.3	3.0	12.0	16.7	11.9	18.7	12.5	10.8	22.8	10.6	16.1	19.0
KIAA2026	FLJ20375	ENSG00000183354	KIAA2026	Q5HYC2	9	5881596-6007901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002109	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA002109: AB_1078071"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.41e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.52e-1)"	"prognostic favourable (8.34e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	7.0	6.3	10.3	13.7	11.1	6.6	6.7	21.4	12.4	10.2	7.5	8.6	5.7	5.5	9.7	7.0	7.2	6.7	7.4	6.2	11.7	9.0	7.5	5.4	6.4	7.0	16.7	7.1	13.0	6.0	13.9	14.5	8.1	9.9	8.0	5.9	5.9	12.8	15.6	15.3	9.4	6.7	7.7	11.2	9.1	7.8	13.3	12.9	11.0	10.3	3.7	7.5	8.0	17.8	7.0	4.1	9.4	5.9	7.0	7.5	1.2	5.8	2.9	5.9	3.8	4.5	7.2	2.9	4.0	5.6	3.6	3.4	1.8	3.2	7.3	1.5	4.8	3.0	3.4	3.0	5.5	16.8	2.8	21.9	6.4	2.9	3.5	7.7	10.1	4.4	4.1	3.1	5.3	5.6	2.3	13.1	4.6	1.6	4.1	13.3	3.4	2.5	4.6	3.8	3.7	3.9	3.8	8.1	4.8	3.7	3.3	3.0	3.3	9.9	6.7	6.9	4.2	3.5	4.3	10.2	8.0	7.3	3.5	3.6	2.0	5.2	3.4	9.4	6.4	2.6	7.3	7.0	6.2	5.7	1.3	6.1	6.8	7.5	8.8	7.0	5.9	4.1	3.6	1.2	10.3	11.1	21.4	12.4	11.7	9.0	16.7	7.1	9.9	12.9
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92593286-92655395	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 74.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"				Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: , HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (8.19e-7)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	2.3	1.6	1.0	20.2	2.6	14.3	1.6	0.7	1.5	2.4	4.6	0.7	0.5	3.7	1.4	1.9	11.5	0.8	2.6	2.0	1.1	1.2	1.1	1.1	2.8	12.1	1.0	1.0	1.1	1.1	0.5	0.7	3.1	1.4	1.0	5.4	0.5	2.7	0.2	0.6	4.2	4.4	1.6	1.8	5.2	2.7	10.5	1.1	74.2	1.2	7.5	13.4	2.2	3.8	2.4	0.9	2.5	1.2	3.5	3.9	1.0	30.6	13.7	31.0	28.8	2.2	3.4	7.7	22.1	19.3	24.6	24.4	12.0	20.4	33.9	11.4	10.3	22.2	22.1	11.3	28.9	20.2	12.7	21.2	13.1	12.5	0.4	34.1	19.8	1.1	1.0	19.0	17.7	15.2	15.0	39.7	18.5	12.3	29.0	19.2	12.3	9.5	31.3	30.7	12.0	6.4	9.0	9.5	13.6	17.3	7.8	9.0	21.2	10.9	8.6	11.2	16.2	11.4	29.0	11.1	17.0	34.9	9.1	24.7	15.2	2.5	0.5	0.5	0.4	1.2	1.1	2.4	1.4	1.9	0.9	1.0	0.5	0.7	1.4	3.5	0.4	0.4	3.9	1.0	1.0	2.6	0.7	1.5	1.1	1.2	1.0	1.0	1.4	1.1
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620734	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 9.0;lymphoid tissue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"				Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: "	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.4	0.6	0.2	2.7	0.4	9.0	2.6	0.3	0.3	0.7	2.0	0.4	0.2	1.8	0.4	0.5	3.8	0.2	0.2	0.5	0.3	0.3	0.4	0.8	1.2	4.7	0.2	0.2	0.3	0.3	0.0	0.2	2.8	0.6	0.6	1.8	0.4	0.9	0.2	0.2	1.4	2.4	0.8	0.6	2.0	1.1	4.5	0.2	34.4	0.3	0.6	4.9	0.8	1.3	0.5	0.1	2.4	0.2	0.7	1.9	0.2	15.5	9.2	14.6	8.1	0.4	1.7	8.1	10.7	6.3	10.3	9.3	5.5	8.1	9.4	3.8	5.1	12.4	11.6	7.1	14.8	11.5	6.1	15.1	13.1	5.4	0.0	23.6	8.6	0.3	0.3	11.4	9.8	7.2	22.6	12.3	12.7	6.3	13.8	7.4	12.3	8.1	12.7	19.3	12.0	3.4	4.4	6.9	7.7	15.1	5.2	6.2	7.0	6.1	5.9	8.1	9.7	8.8	18.6	4.5	4.5	13.8	4.7	12.7	16.5	2.4	0.1	0.1	0.1	0.2	0.1	0.5	0.5	0.4	0.0	0.4	0.2	0.1	0.5	0.7	0.1	0.1	1.9	0.2	0.2	0.4	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947711	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 12.3;lymphoid tissue: 34.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"				"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.7	0.6	0.5	8.2	0.4	12.3	0.4	0.4	0.5	0.9	1.6	0.3	0.7	2.9	0.5	0.6	3.2	0.3	1.3	1.5	0.5	0.5	0.5	0.7	0.8	5.9	0.6	0.1	0.6	0.4	0.0	0.4	1.9	0.2	0.5	1.5	0.1	0.7	0.1	0.4	2.9	2.5	0.8	0.4	1.7	1.5	3.8	0.1	34.7	0.4	2.7	7.6	0.7	1.1	1.1	0.8	2.0	0.6	1.0	1.4	0.4	14.2	18.6	15.9	14.9	0.3	1.3	13.4	12.2	4.6	15.4	12.1	15.4	12.3	12.6	5.3	4.6	15.7	11.0	4.9	7.8	26.0	16.4	16.3	20.9	9.5	0.0	13.4	14.3	0.3	0.2	13.3	5.3	7.8	12.2	21.5	7.9	11.1	24.9	13.3	11.7	12.8	19.1	24.3	8.4	2.5	7.7	12.0	11.7	8.2	7.4	4.5	13.9	9.6	5.1	23.0	22.8	13.6	25.6	6.9	6.8	15.5	7.4	10.2	14.8	1.8	0.6	0.4	0.5	0.3	0.4	0.8	0.7	0.5	0.3	1.1	0.4	0.5	2.0	1.0	0.3	0.8	1.4	0.4	0.5	0.4	0.4	0.4	0.5	0.5	0.6	0.1	0.2	0.1
KIF1A	"ATSV, C2orf20, SPG30, UNC104"	ENSG00000130294	"Kinesin family member 1A"	Q12756	2	240713764-240820308	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 144.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.8;HAP1: 33.3;K-562: 29.1;SCLC-21H: 89.7;SH-SY5Y: 14.4"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low region specificity"	"Detected in all"							HPA005442			Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA005442: AB_1079210"	"unprognostic (1.19e-1)"	"unprognostic (2.17e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavourable (4.97e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.90e-2)"	2.1	15.2	47.0	2.9	37.0	2.0	2.0	28.4	144.1	1.9	2.7	35.8	0.0	2.9	2.3	3.1	2.0	2.3	2.1	8.2	40.9	28.4	2.1	2.3	2.1	2.0	35.1	46.8	3.5	31.3	2.0	15.7	2.0	38.7	6.4	2.6	8.6	2.0	2.2	1.9	2.8	2.9	2.3	35.0	2.2	5.0	10.0	30.9	0.0	2.9	0.0	1.9	2.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.5	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	1.0	0.0	0.0	33.3	0.0	0.0	2.6	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	29.1	0.1	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	89.7	14.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	47.0	37.0	28.4	62.2	40.9	28.4	35.1	46.8	38.7	30.9
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701610-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031263, HPA050214"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"				"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA031263: AB_10602610, HPA050214: "	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	3.9	2.3	1.3	5.9	6.6	11.1	3.2	12.8	3.0	4.1	3.8	0.7	1.1	4.3	3.4	2.2	7.0	3.3	1.5	2.2	2.1	1.3	2.4	3.2	2.8	9.5	1.6	2.6	4.3	2.0	2.1	3.2	4.0	3.6	2.3	5.1	1.5	3.4	2.0	2.1	4.9	5.5	3.0	3.0	8.0	3.0	10.2	2.6	26.2	2.8	3.9	9.1	2.8	3.8	13.3	4.8	8.3	3.9	2.4	8.6	1.9	35.5	7.3	10.7	9.4	2.1	3.6	8.9	14.6	13.4	15.3	16.2	9.6	16.5	13.8	4.6	7.4	18.1	11.8	8.2	20.7	16.6	8.1	14.0	12.7	8.2	0.6	23.8	11.6	1.5	1.2	14.8	15.2	9.8	13.3	15.9	13.6	6.1	13.9	4.6	10.9	7.0	9.7	21.0	6.0	4.8	4.8	3.4	6.1	10.5	4.8	5.5	12.4	6.9	7.7	9.9	9.9	12.8	23.4	4.4	12.0	18.6	9.3	21.2	7.3	8.3	2.3	3.7	5.5	3.9	6.7	11.5	7.4	5.9	1.2	13.3	8.6	8.0	0.1	2.4	3.8	4.8	8.6	1.9	1.3	6.6	12.8	3.0	2.1	1.3	1.6	2.6	3.6	2.6
KIF21A	"FEOM1, FLJ20052"	ENSG00000139116	"Kinesin family member 21A"	Q7Z4S6	12	39293228-39443390	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.5"	"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	8	"NK-cells: 3.1;T-cells: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022079, HPA058432"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB022079: , HPA058432: "	"unprognostic (1.08e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-2)"	"prognostic favourable (8.07e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.34e-2)"	3.4	10.1	17.7	3.1	18.5	0.8	5.1	22.1	36.7	8.4	9.2	7.7	2.9	7.1	7.7	4.7	16.0	26.8	5.1	13.4	18.0	28.7	20.9	15.6	4.8	2.2	26.4	18.0	3.2	10.1	17.4	12.3	6.4	41.5	9.3	10.6	5.9	16.4	3.5	8.0	8.5	7.9	7.2	29.2	5.0	9.6	9.5	9.6	0.0	7.1	2.5	4.1	3.6	6.0	0.7	0.0	0.1	0.0	3.1	8.5	1.1	5.8	7.5	10.5	4.5	2.0	1.0	8.4	1.4	0.7	1.9	1.3	13.5	7.3	0.0	4.7	0.6	5.1	6.0	3.6	1.8	11.4	4.8	0.0	13.1	12.3	1.5	9.7	0.0	0.6	8.1	2.4	11.8	2.5	11.0	12.1	1.5	3.5	1.2	0.0	14.1	6.5	0.0	0.0	6.7	7.4	9.7	14.4	62.6	5.7	9.1	3.4	10.5	1.2	1.7	1.1	4.6	0.3	4.1	5.5	1.8	0.0	2.7	1.4	0.9	0.0	0.0	0.0	8.4	0.0	4.1	0.7	5.2	8.5	0.0	0.0	1.3	5.9	0.1	3.1	0.0	0.0	2.3	1.1	17.7	18.5	22.1	31.6	18.0	28.7	26.4	18.0	41.5	9.6
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023700	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;brain: 20.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.4;HMC-1: 17.5;Karpas-707: 20.7;RPMI-8226: 17.6;U-266/70: 37.8;U-266/84: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"				"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	2.2	1.6	19.8	10.0	12.9	34.3	1.5	3.7	20.4	1.5	2.8	6.0	1.0	2.7	1.4	1.0	1.5	1.4	2.9	1.5	15.1	12.5	1.4	1.7	4.3	15.7	8.3	12.7	1.4	1.5	11.3	0.9	1.6	7.1	1.2	2.6	8.6	2.1	1.7	0.9	1.3	6.1	1.5	4.3	11.5	3.2	11.1	4.9	10.8	1.2	0.0	9.1	3.7	1.1	0.9	0.2	8.0	0.5	2.4	1.7	0.6	0.5	0.6	4.9	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.1	16.4	0.2	0.0	0.1	0.5	0.1	0.1	0.8	0.1	3.9	0.1	0.1	0.4	12.0	17.5	0.4	1.7	0.1	0.3	0.6	1.8	20.7	0.0	0.0	9.5	4.3	2.1	0.0	3.3	0.0	17.6	0.1	0.0	3.4	0.4	0.2	0.2	0.2	0.0	3.6	1.1	0.0	1.5	0.0	0.1	37.8	17.5	8.2	1.7	5.2	0.1	8.0	0.1	1.0	1.6	0.4	1.7	0.9	1.2	1.7	0.1	0.7	1.0	1.1	2.0	2.4	0.5	0.2	1.0	0.6	19.8	12.9	3.7	20.0	15.1	12.5	8.3	12.7	7.1	4.9
KIF26A	"DKFZP434N178, KIAA1236"	ENSG00000066735	"Kinesin family member 26A"	Q9ULI4	14	104138723-104180894	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 16.8;MCF7: 14.3;NTERA-2: 12.6;REH: 10.9;SCLC-21H: 11.7;SH-SY5Y: 23.8"	"Group enriched"	"Detected in many"	5	"stomach cancer: 3.8;testis cancer: 14.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046882, HPA060346"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046882: , HPA060346: "	"unprognostic (3.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.24e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (7.78e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.68e-3)"	12.0	6.8	1.8	4.9	2.1	5.0	15.9	1.3	3.9	8.9	3.3	1.5	4.9	1.7	5.9	3.9	2.1	3.7	4.9	10.1	1.6	2.6	3.4	2.5	8.5	2.5	1.9	2.8	23.5	9.4	1.6	4.4	6.8	2.0	2.5	1.6	6.9	2.5	4.0	9.1	3.9	2.5	2.3	1.0	9.3	2.5	4.1	0.9	1.9	2.3	5.6	0.9	2.6	8.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	2.3	0.0	0.0	4.1	0.2	0.0	0.0	0.0	1.8	0.0	0.0	3.2	0.0	1.5	1.8	0.0	0.0	0.0	2.9	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	14.3	0.0	0.0	12.6	1.2	10.9	4.8	1.1	0.0	0.0	11.7	23.8	2.6	0.4	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.3	3.5	1.6	2.6	1.9	2.8	2.0	0.9
KIF3A	"FLA10, KLP-20"	ENSG00000131437	"Kinesin family member 3A"	Q9Y496	5	132692628-132737638	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 27.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037085	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				"Nucleoplasm, Intermediate filaments, Cytosol"		"CAB037085: AB_477147"	"unprognostic (8.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.21e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.23e-1)"	3.4	9.9	19.6	5.0	21.0	2.5	6.6	23.8	54.5	6.2	3.6	8.1	3.2	3.5	6.5	7.1	4.5	8.7	5.3	7.0	28.0	22.9	7.6	2.5	5.7	4.8	18.7	25.5	6.9	4.0	15.8	18.5	4.3	37.7	6.6	3.8	3.8	3.8	6.6	3.5	5.1	3.0	5.7	15.0	3.8	4.9	23.9	11.1	3.5	6.9	0.1	4.7	5.3	3.5	3.4	0.7	27.1	1.1	2.4	4.3	1.1	7.1	8.8	7.9	14.2	5.3	5.3	6.3	6.0	4.7	5.7	8.0	8.6	5.8	19.5	8.3	6.9	4.6	6.1	11.8	11.8	5.8	7.2	2.8	4.4	3.2	5.2	3.6	7.7	4.0	6.1	8.2	9.1	7.0	2.9	11.3	6.9	5.1	22.9	2.7	3.9	3.3	6.4	6.3	2.3	5.6	6.1	24.5	7.7	8.9	2.9	9.0	9.0	1.1	7.4	7.1	12.4	5.2	7.2	8.2	11.9	11.2	8.7	2.9	7.8	27.1	0.4	1.1	3.9	0.8	4.1	3.4	4.0	3.6	0.7	2.1	3.9	4.3	0.3	2.4	1.1	0.7	3.0	1.1	19.6	21.0	23.8	32.3	28.0	22.9	18.7	25.5	37.7	11.1
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57549998-57586632	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 138.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.0;K-562: 8.4;NTERA-2: 10.3;SCLC-21H: 21.3;U-87 MG: 7.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.4;naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"				"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: "	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favourable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	1.8	7.6	85.4	3.0	47.6	1.9	1.9	15.2	138.6	2.1	2.8	4.0	0.0	2.4	3.4	2.1	1.9	2.0	1.9	1.7	52.4	18.3	2.0	1.7	1.8	1.8	12.9	43.6	1.8	2.3	6.0	2.5	1.7	21.6	1.9	2.8	0.6	2.0	2.0	1.7	1.7	3.0	2.8	9.0	1.8	2.1	4.4	12.9	0.0	2.8	0.0	1.8	1.8	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.7	3.2	0.0	0.0	0.1	0.2	0.7	1.3	1.7	0.0	0.0	1.6	0.0	0.6	0.1	2.0	0.0	1.0	20.0	1.4	0.1	0.1	1.6	0.6	0.0	0.1	0.2	0.1	1.0	0.0	0.2	8.4	4.4	0.0	0.0	0.3	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	21.3	4.8	0.0	0.2	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.9	2.8	3.4	0.3	7.9	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.4	0.8	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.3	0.0	85.4	47.6	15.2	112.0	52.4	18.3	12.9	43.6	21.6	12.9
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009010-32056431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"			260000	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	26.3	19.9	55.7	20.2	55.5	34.1	23.0	22.2	42.4	23.8	34.2	21.7	20.9	23.5	25.7	17.8	28.0	20.3	28.0	48.4	51.5	39.3	21.1	15.3	23.8	16.5	62.9	26.1	18.2	18.9	56.8	22.4	27.7	38.3	31.8	30.0	8.9	20.1	25.6	34.3	17.6	28.6	37.2	80.4	21.1	23.1	27.7	43.7	25.0	23.5	21.5	16.1	33.8	28.1	13.8	27.6	30.0	18.9	13.4	16.5	9.2	29.4	25.1	34.0	23.8	24.4	26.9	14.5	40.7	19.3	31.5	26.9	27.5	32.6	20.2	17.7	48.3	24.5	31.0	26.0	42.3	17.4	16.9	25.7	23.5	26.8	28.1	17.8	28.3	21.8	37.0	36.3	25.4	40.2	30.9	21.3	43.5	17.7	18.6	10.1	5.5	11.5	24.4	63.4	8.3	24.3	20.7	33.1	24.2	31.5	12.6	30.3	15.2	25.6	33.5	32.1	30.1	37.1	30.1	6.4	7.4	23.9	30.6	36.9	30.1	20.8	15.2	24.2	11.8	18.9	11.4	13.6	14.9	12.5	14.2	13.8	13.3	13.0	30.0	13.4	18.9	27.6	16.5	9.2	55.7	55.5	22.2	42.4	51.5	39.3	62.9	26.1	38.3	43.7
KIFC2		ENSG00000167702	"Kinesin family member C2"	Q96AC6	8	144466043-144474202	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 36.2;skin 1: 48.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029264	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA029264: AB_10609999"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-3)"	"unprognostic (4.12e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.71e-2)"	4.2	5.1	18.7	4.2	28.4	4.5	3.4	36.2	35.0	3.1	6.3	2.3	6.6	8.8	2.7	5.2	7.0	2.9	4.4	2.2	13.5	7.2	4.7	2.8	3.8	4.8	4.4	16.8	2.1	7.9	9.8	7.9	2.5	8.3	7.2	4.8	2.2	7.5	6.5	2.3	48.2	7.9	2.1	2.6	8.1	8.7	5.2	6.6	1.6	4.1	1.3	3.5	5.0	4.9	0.8	0.1	0.1	0.1	0.0	0.8	0.1	7.9	6.8	3.3	7.2	4.8	2.9	7.8	4.8	3.4	2.6	2.6	2.7	9.9	8.3	2.7	2.7	16.3	3.3	4.3	1.1	8.4	2.9	5.0	16.7	3.5	6.2	1.3	14.8	3.7	15.5	2.6	3.4	1.7	5.4	8.7	1.9	13.6	6.0	4.2	0.5	10.1	15.1	0.2	4.9	10.8	12.5	10.4	9.5	3.4	10.6	3.8	27.9	2.7	4.6	5.1	15.4	5.4	4.8	4.3	2.0	2.3	9.9	7.0	2.8	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.3	0.6	0.1	0.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	18.7	28.4	36.2	35.0	13.5	7.2	4.4	16.8	8.3	6.6
KLC1	"hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A"	ENSG00000126214	"Kinesin light chain 1"	Q07866	14	103561896-103714249	"Predicted intracellular proteins"	"Host-virus interaction"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 117.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009798, HPA044617, HPA052450"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009798: AB_2280879, HPA044617: , HPA052450: "	"unprognostic (6.93e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.62e-2)"	"prognostic favourable (6.75e-4)"	"unprognostic (6.84e-3)"	"prognostic unfavourable (7.17e-4)"	"unprognostic (6.58e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.49e-1)"	19.5	20.4	61.3	15.7	45.6	17.6	16.6	103.0	117.9	15.2	14.8	22.4	11.5	10.5	21.1	18.7	19.7	16.0	15.7	27.1	61.0	65.1	8.6	8.9	20.0	15.9	66.2	47.9	19.8	14.8	25.2	17.0	17.9	50.7	16.3	14.1	14.1	16.9	19.7	28.2	22.4	12.8	23.1	56.0	18.3	13.8	14.3	23.2	7.9	13.8	13.0	18.1	15.7	14.9	7.3	10.4	12.4	8.6	4.1	10.9	3.1	16.3	22.0	42.5	23.1	28.7	31.4	19.5	38.5	31.6	36.2	24.8	18.8	17.9	21.7	20.1	41.5	27.3	25.9	20.3	34.4	26.1	13.0	12.1	26.0	19.0	32.7	23.7	24.1	22.8	33.1	27.3	33.3	31.1	18.0	24.9	31.5	27.5	15.9	20.9	13.6	40.6	15.3	17.8	10.7	22.5	36.3	50.1	28.0	31.3	15.9	25.4	14.0	11.7	45.2	26.9	13.3	36.8	21.3	20.0	13.9	24.1	30.8	13.7	28.8	7.6	5.8	12.4	10.3	6.0	9.5	6.4	9.3	10.9	6.8	7.3	7.9	7.2	7.0	4.1	8.6	10.4	8.4	3.1	61.3	45.6	103.0	90.3	61.0	65.1	66.2	47.9	50.7	23.2
KLC2	FLJ12387	ENSG00000174996	"Kinesin light chain 2"	Q9H0B6	11	66257294-66267860	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040416, HPA040434"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Mitochondria"	"HPA040416: AB_10795524, HPA040434: AB_10795367"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (3.16e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.57e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.08e-2)"	7.5	12.5	15.9	7.9	20.7	2.9	6.6	51.7	49.4	7.4	7.8	7.5	6.5	8.5	11.3	6.0	8.8	9.0	8.0	15.3	20.0	17.4	6.7	2.4	6.6	7.5	13.8	26.0	11.3	11.2	15.4	15.4	6.4	29.0	13.6	4.4	8.2	8.4	15.5	23.8	9.3	7.7	10.1	8.6	6.6	9.8	17.4	10.0	13.5	6.3	4.5	5.6	8.8	8.5	4.7	4.1	0.8	0.4	2.3	6.2	1.5	20.2	24.8	12.1	7.2	7.3	5.9	9.4	14.3	10.3	14.7	11.4	13.5	6.1	9.1	13.8	10.6	17.1	12.4	13.9	4.9	14.6	15.6	1.8	19.6	9.1	14.2	4.0	9.7	5.9	18.4	17.2	14.1	6.8	9.8	12.4	11.7	28.5	22.9	6.1	11.9	20.6	8.8	6.3	12.4	11.5	11.4	33.0	16.0	10.4	9.4	17.1	15.5	2.8	11.2	24.2	21.7	29.2	18.8	12.9	10.8	4.9	17.1	2.8	9.7	0.0	0.4	0.8	4.6	0.1	6.2	3.6	2.2	3.1	0.6	4.7	2.2	2.7	0.7	2.3	0.3	4.1	0.6	1.5	15.9	20.7	51.7	49.4	20.0	17.4	13.8	26.0	29.0	10.0
KLC3	"KLC2L, KLCt, KNS2B"	ENSG00000104892	"Kinesin light chain 3"	Q6P597	19	45333434-45351520	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 39.5;tongue: 25.3"	"Cell line enhanced"	"Detected in some"		"A-431: 25.2;HaCaT: 11.7;HBEC3-KT: 7.6;hTCEpi: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052797, HPA056508"	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Actin filaments"	"Nucleoplasm, Cytosol"	"HPA052797: , HPA056508: "	"unprognostic (4.11e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.07e-4)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (3.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.14e-1)"	"unprognostic (2.37e-1)"	0.1	0.2	0.0	0.2	1.2	1.9	1.9	0.0	0.5	4.0	0.1	0.0	0.0	0.1	0.6	2.9	10.6	0.1	0.2	0.1	0.2	0.0	1.9	0.1	0.7	0.2	0.0	0.0	0.3	4.5	1.5	1.1	0.9	0.5	1.7	0.2	4.0	7.8	2.2	0.6	39.5	0.3	0.0	0.0	0.2	0.2	2.8	0.2	0.3	1.1	25.3	9.2	0.2	7.9	1.5	1.0	3.3	0.9	1.0	1.3	0.6	25.2	0.2	0.1	0.3	0.1	0.1	2.1	0.2	0.0	0.0	0.1	2.5	4.7	0.2	2.1	0.0	11.7	1.6	7.6	0.1	0.6	3.8	0.1	0.7	0.5	0.0	0.2	1.6	0.0	9.5	0.1	1.8	0.0	0.4	0.3	0.1	3.3	0.1	0.3	0.6	0.8	4.0	0.0	0.2	0.2	0.9	3.4	0.5	0.2	5.4	0.7	4.7	0.1	0.0	0.3	2.7	0.2	0.3	0.6	0.5	0.2	0.1	0.1	0.3	3.3	0.7	0.6	0.8	0.5	0.7	0.9	1.0	0.9	0.3	1.5	1.0	1.3	2.6	1.0	0.9	1.0	0.8	0.6	0.0	1.2	0.0	0.5	0.2	0.0	0.0	0.0	0.5	0.2
KLC4	"bA387M24.3, KNSL8"	ENSG00000137171	"Kinesin light chain 4"	Q9NSK0	6	43040777-43075099	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 55.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030168, HPA030169"	Enhanced		Approved	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA030168: AB_10599285, HPA030169: AB_10601105"	"unprognostic (2.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.36e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.22e-2)"	"prognostic favourable (6.99e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	6.1	9.7	13.1	8.5	11.5	5.3	6.9	25.0	15.2	7.6	35.0	10.2	8.1	35.1	8.5	12.3	5.6	9.3	15.2	12.2	13.8	10.8	13.6	47.2	8.2	5.8	12.2	13.7	11.2	9.1	17.6	13.3	5.9	12.1	8.6	17.4	9.0	11.4	8.4	9.9	8.7	55.7	7.4	9.2	6.6	16.0	22.6	13.2	6.7	10.9	4.5	5.4	10.2	9.9	5.6	12.2	9.0	3.7	6.1	7.0	3.3	4.2	3.9	10.3	12.4	10.2	10.1	9.2	3.4	5.7	6.3	9.7	6.3	7.5	6.3	12.7	8.3	7.5	10.3	9.7	5.1	6.3	12.6	7.4	10.9	27.8	9.8	3.5	5.8	13.1	12.2	7.6	7.5	8.0	4.9	8.4	5.2	8.6	9.4	7.7	4.1	5.2	7.5	5.8	12.1	9.6	4.3	16.9	8.3	6.7	5.9	13.2	10.9	9.0	5.7	7.2	8.5	3.6	3.5	16.7	5.9	15.4	3.9	5.3	2.5	2.6	3.7	4.4	4.0	3.6	5.1	5.6	5.5	3.9	4.2	4.3	7.0	4.8	9.0	6.1	3.6	12.2	6.4	3.3	13.1	11.5	25.0	15.2	13.8	10.8	12.2	13.7	12.1	13.2
KLF11	"MODY7, TIEG2, Tieg3"	ENSG00000172059	"Kruppel like factor 11"	O14901	2	10042849-10054836	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058276			Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol"				Nucleoplasm	"Nuclear bodies, Focal adhesion sites, Cytosol"	"HPA058276: "	"unprognostic (9.66e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.63e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.24e-2)"	28.7	9.1	2.5	7.0	3.5	11.8	33.1	8.2	4.4	12.9	13.0	5.1	10.8	3.5	12.8	11.7	8.3	11.2	11.6	19.4	2.9	2.3	12.7	27.9	14.6	15.9	5.5	2.4	13.7	38.3	7.3	2.4	9.9	3.4	13.9	4.7	9.2	11.3	10.9	14.0	19.1	7.7	30.4	3.5	16.1	10.2	16.7	2.7	1.5	9.1	8.5	5.6	11.1	42.7	2.9	6.6	1.7	12.7	5.4	2.7	3.8	3.7	1.8	4.4	0.3	3.0	5.4	10.6	4.3	4.4	2.5	2.6	4.2	8.7	0.0	7.8	5.2	0.8	3.7	3.3	1.6	25.5	2.9	1.9	5.3	0.8	3.0	7.7	12.4	8.4	12.5	4.7	1.3	2.1	5.1	17.2	2.5	4.4	0.0	1.4	7.0	3.7	4.1	0.1	7.2	6.0	4.6	5.6	3.5	6.6	13.7	12.7	3.2	10.6	6.1	10.9	9.2	8.2	1.4	15.7	18.6	10.1	2.8	2.1	5.8	0.0	6.9	1.7	2.6	11.0	0.8	2.8	1.7	1.8	6.6	2.9	0.5	1.0	0.2	5.4	12.7	0.3	2.7	3.8	2.5	3.5	8.2	4.4	2.9	2.3	5.5	2.4	3.4	2.7
KLF12	"AP-2rep, AP2REP, HSPC122"	ENSG00000118922	"Kruppel like factor 12"	Q9Y4X4	13	73686089-73995056	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064146, HPA075652"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA064146: , HPA075652: "	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (5.03e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.67e-3)"	2.1	0.9	0.4	2.9	0.4	0.9	1.9	0.6	3.4	2.1	1.5			0.1	1.7	7.1	0.7	1.1	1.1	3.2	0.4	0.5	2.9	5.8	2.0	6.1	0.5		2.8	0.6	0.0	3.5	0.0		1.2	1.1		0.9	1.4	1.9	1.4	1.2	1.4	1.3	3.9	1.4	1.5			2.1		5.5	1.7	2.1	1.7	0.9	0.9	0.6	2.6	5.1	1.4	0.0	1.0	10.1	0.0	5.7	12.5	0.1	3.9	1.9	4.4	4.7	0.8	2.5	7.5	1.9	5.9	2.7	2.6	3.1	11.9	4.9	3.6	0.2	4.5	0.0	1.9	4.9	1.8	10.8	0.8	6.2	5.1	8.7	0.0	1.9	13.2	0.8	9.5	0.0	1.4	2.0	5.3	3.7	0.0	2.5	0.2	2.4	10.3	2.7	1.3	4.5	0.3	0.8	0.0	8.6	2.6	3.8	1.8	5.2	6.6	2.4	15.2	0.0	4.3	0.9	0.1	0.1	4.2	0.4	5.1	1.7	3.7	4.7	0.5	1.4	2.6	4.0	0.0	2.6	0.6	0.9	1.9	1.4										
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: "	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favourable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	69.8	10.0	8.4	26.3	10.6	80.6	101.1	7.4	10.1	28.6	31.7	10.3	9.7	11.0	24.9	28.8	38.6	28.0	38.6	18.6	7.8	5.1	32.2	32.5	46.0	35.8	13.8	4.2	20.2	23.8	7.5	4.7	26.1	11.2	20.1	21.0	13.2	26.9	16.5	57.8	60.2	44.8	42.8	17.0	20.3	26.7	14.3	10.0	12.5	41.0	28.8	21.5	44.7	30.7	15.6	29.8	77.8	18.7	13.0	30.8	23.2	13.0	3.5	6.8	2.2	39.6	39.8	4.3	22.5	11.5	24.1	16.4	9.1	17.6	3.7	5.2	24.3	7.9	4.2	20.7	20.1	18.3	2.5	0.5	4.1	8.6	17.0	2.4	12.9	13.1	39.6	17.1	32.7	24.5	4.1	29.2	30.5	0.9	4.5	3.8	2.5	6.4	3.0	7.0	13.1	23.6	13.0	3.0	2.9	5.5	16.0	33.7	7.9	2.0	31.9	32.5	4.5	19.2	10.3	5.6	18.2	6.9	8.7	3.3	10.0	50.9	17.0	43.7	27.1	14.2	23.9	15.6	30.8	26.8	13.1	12.5	9.6	14.8	77.8	13.0	18.7	29.8	22.2	23.2	8.4	10.6	7.4	10.1	7.8	5.1	13.8	4.2	11.2	10.0
KLF9	BTEB1	ENSG00000119138	"Kruppel like factor 9"	Q13886	9	70384597-70414624	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 22.4;ASC TERT1: 31.1;HHSteC: 40.0;HSkMC: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029308			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA029308: AB_10601923"	"unprognostic (2.12e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (4.34e-1)"	"unprognostic (5.55e-1)"	"unprognostic (9.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.44e-1)"	"prognostic favourable (6.59e-6)"	"unprognostic (1.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	35.9	15.3	6.8	8.8	25.8	6.1	25.7	42.6	21.4	10.2	20.0	9.7	16.1	6.0	19.6	13.2	17.0	22.2	17.8	18.2	8.4	4.0	26.2	36.7	22.6	5.1	26.3	8.0	22.1	21.3	13.0	8.6	3.9	14.7	12.4	11.0	20.4	31.4	10.7	38.9	12.6	17.6	25.0	12.0	8.6	16.7	5.5	25.2	1.9	24.0	20.3	5.4	15.4	11.9	2.8	1.7	2.8	0.7	0.7	2.8	0.6	0.1	0.2	0.0	2.8	22.4	31.1	0.3	1.4	9.7	0.5	1.1	0.0	1.3	0.0	1.1	2.6	0.0	4.2	6.5	1.0	0.0	3.3	1.4	4.8	0.8	40.0	0.7	4.0	26.6	6.7	0.4	9.5	8.5	2.8	5.9	3.6	0.4	0.1	2.1	0.2	1.4	0.0	1.3	3.7	1.8	0.0	0.3	1.9	13.2	7.7	15.1	2.5	2.3	11.6	2.6	1.9	2.9	0.7	4.3	4.5	0.2	2.3	2.3	12.8	2.8	0.5	0.3	1.6	0.3	2.3	2.8	2.1	1.6	1.2	2.5	2.8	1.6	0.0	0.7	0.7	1.7	2.2	0.6	6.8	25.8	42.6	21.4	8.4	4.0	26.3	8.0	14.7	25.2
KLHDC1	MST025	ENSG00000197776	"Kelch domain containing 1"	Q8N7A1	14	49693105-49753152	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 8.8;ASC TERT1: 8.4;HSkMC: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020461	Approved		Supported	Cytosol				Cytosol		"HPA020461: AB_1852556"	"unprognostic (2.97e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-1)"	"prognostic favourable (1.94e-4)"	"unprognostic (3.42e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	8.6	9.7	8.5	8.0	14.5	3.3	11.0	13.4	15.2	10.9	8.7	15.4	8.6	4.5	13.3	13.3	5.3	8.9	7.2	9.9	9.2	10.0	7.2	5.9	6.6	7.5	12.0	12.2	18.2	6.7	11.0	13.2	6.0	10.7	10.2	5.6	12.4	7.1	14.2	14.1	11.3	6.5	11.0	12.9	7.9	6.5	11.7	11.7	2.9	12.5	4.4	6.0	7.1	8.5	3.0	3.7	2.5	2.2	1.6	4.8	1.7	1.0	0.5	0.9	0.7	8.8	8.4	0.0	2.3	3.1	0.7	0.6	0.0	2.8	0.5	0.5	0.9	0.7	0.3	0.0	0.7	2.3	0.8	0.4	0.2	0.0	4.6	0.2	1.0	7.0	0.4	0.3	0.3	1.8	0.4	0.0	3.4	0.3	0.6	1.1	0.0	0.4	0.6	0.7	0.0	1.7	0.2	0.3	2.3	0.4	0.0	0.9	1.0	1.8	2.6	1.9	2.2	0.7	0.2	0.8	0.1	0.6	1.9	0.3	1.1	1.4	1.0	2.5	2.1	2.2	4.2	3.0	2.8	2.4	1.1	2.1	4.8	4.0	0.1	1.6	1.1	3.7	0.9	1.7	8.5	14.5	13.4	15.2	9.2	10.0	12.0	12.2	10.7	11.7
KLHDC8B	MGC35097	ENSG00000185909	"Kelch domain containing 8B"	Q8IXV7	3	49171611-49176486	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.4"	"Group enriched"	"Detected in many"	9	"granulocytes: 19.4;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008463, HPA014467"	Approved		Enhanced	Cytosol				Cytosol		"HPA008463: AB_1852563, HPA014467: AB_1852565"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.66e-1)"	"unprognostic (5.03e-3)"	"unprognostic (1.71e-3)"	"prognostic favourable (1.47e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	15.0	44.0	5.6	4.7	5.8	3.2	12.6	4.5	8.8	12.8	19.3	6.2	10.5	4.6	15.9	12.2	22.6	11.6	13.6	30.5	3.7	8.5	5.6	8.8	6.6	6.3	4.9	5.4	29.6	6.2	5.2	4.2	7.9	5.2	15.2	2.5	21.8	8.4	9.5	15.8	9.8	5.4	18.0	2.4	6.7	6.7	10.0	3.0	2.0	17.1	10.7	6.6	20.0	8.8	0.1	0.6	19.4	5.7	0.0	1.4	1.6	1.5	3.4	14.2	7.2	8.7	5.2	4.4	5.2	3.0	5.2	4.2	2.2	4.6	0.0	2.9	8.6	0.0	3.5	3.1	1.3	2.8	0.9	9.1	9.2	5.7	16.6	0.0	5.4	8.6	15.2	6.7	0.5	13.3	14.1	0.1	3.9	0.4	0.9	10.1	4.6	8.1	1.4	1.3	0.4	3.9	0.8	0.6	16.0	4.2	0.1	10.4	4.3	4.4	5.7	4.0	11.2	7.1	1.6	1.3	0.4	0.1	2.9	0.0	1.9	0.0	3.8	19.4	0.8	5.7	0.3	0.0	0.4	0.6	0.3	0.1	1.4	0.8	6.7	0.0	5.0	0.6	0.1	1.6	5.6	5.8	4.5	8.8	3.7	8.5	4.9	5.4	5.2	3.0
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 35.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 22.2;RH-30: 13.9;RPTEC TERT1: 39.9;SH-SY5Y: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;eosinophil: 9.3;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;granulocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol				Cytosol		"HPA046039: , HPA059901: "	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.4	5.5	3.4	3.9	11.9	0.2	19.0	2.5	3.7	24.9	5.3	3.1	6.6	2.2	35.6	5.6	5.4	8.1	10.1	9.0	2.3	4.0	15.4	3.3	1.4	0.4	4.7	2.1	7.7	3.3	3.5	5.0	1.7	6.6	7.3	3.0	5.6	2.6	9.7	2.3	1.5	4.9	22.2	3.5	1.1	3.5	2.8	4.9	3.6	1.4	3.1	1.2	8.2	5.0	0.0	5.6	9.3	0.1	1.4	0.9	0.4	0.4	0.1	2.6	5.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.3	0.0	0.0	6.2	0.0	6.2	12.5	2.0	0.0	0.0	4.8	0.1	22.2	0.0	0.3	0.4	0.8	0.6	0.9	0.0	0.2	9.5	0.0	0.0	0.0	0.5	2.1	0.5	5.0	3.5	0.0	13.9	0.0	39.9	1.4	0.0	35.6	0.1	0.4	0.3	7.7	0.0	0.2	0.9	1.1	0.7	3.1	0.1	0.0	0.0	3.8	0.0	1.5	3.2	0.1	9.3	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.9	0.8	0.0	1.4	0.0	5.6	0.4	0.4	3.4	11.9	2.5	3.5	2.3	4.0	4.7	2.1	6.6	4.9
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672671-32773062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 14.6;seminal vesicle: 19.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;Hep G2: 16.4;REH: 4.4;RPTEC TERT1: 9.1;SCLC-21H: 3.5;U-698: 4.8"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	97	"memory B-cell: 10.7;naive B-cell: 8.5"	"Lineage enriched"	"Detected in single"	108	"B-cells: 10.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"hippocampal formation: 22.7;olfactory region: 20.4"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"				Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.6	0.1	0.4	1.0	0.4	1.5	0.6	0.4	1.0	2.4	0.4	0.4	14.6	0.0	1.5	1.4	0.4	6.3	0.4	0.4	0.4	0.3	4.3	0.4	0.4	5.1	0.4	0.4	1.1	0.4	10.3	1.1	0.4	1.5	1.6	0.0	1.0	0.4	19.3	0.4	0.1	2.3	0.4	0.4	9.5	0.1	2.8	0.4	0.4	11.7	0.4	3.8	0.4	0.7	10.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	16.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	4.4	1.4	0.0	9.1	0.0	3.5	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.4	1.0	0.4	0.3	0.4	0.4	1.5	0.4
KLHL15	KIAA1677	ENSG00000174010	"Kelch like family member 15"	Q96M94	X	23983720-24027186	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 25.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065730	Uncertain		Approved	Aggresome,Cytosol				Cytosol	Aggresome	"HPA065730: "	"unprognostic (5.89e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-3)"	"unprognostic (7.42e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.40e-2)"	2.9	6.1	1.7	1.3	2.3	25.1	1.3	2.8	1.8	1.9	2.0			1.0	2.3	4.0	4.3	3.8	1.9	2.1	1.6	1.9	2.2	6.4	1.6	1.4	1.3		4.6	2.9	4.3	2.6	1.2		2.8	1.2		1.3	1.8	2.6	1.0	1.5	2.2	1.6	1.5	3.4	9.0			2.3		1.2	1.3	1.1	1.4	2.1	2.8	2.6	1.6	2.8	1.3	4.2	4.1	4.6	6.8	6.9	4.9	4.8	6.9	6.0	3.2	3.9	3.7	3.8	11.2	2.5	4.4	3.2	7.3	3.7	7.8	4.3	15.0	7.1	11.1	2.0	4.3	9.2	5.0	5.1	1.9	5.4	5.4	2.3	4.5	15.8	5.9	1.5	8.3	9.0	8.7	5.1	6.6	8.4	6.9	2.9	3.8	12.2	5.7	9.6	2.3	7.9	3.2	8.3	2.9	4.9	3.0	9.7	4.4	8.8	8.8	12.9	3.9	6.0	3.8	1.5	1.1	2.8	2.0	2.6	2.8	1.0	1.8	2.3	2.1	1.4	2.4	2.4	1.5	1.6	2.6	1.7	1.8	1.3										
KLHL20	"KHLHX, KLEIP"	ENSG00000076321	"Kelch like family member 20"	Q9Y2M5	1	173714941-173786702	"Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025034, HPA053704"	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA025034: AB_1852578, HPA053704: "	"unprognostic (2.97e-3)"	"unprognostic (3.11e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.62e-2)"	18.2	14.5	10.4	12.5	15.1	6.9	15.4	18.8	18.0	17.9	16.1	14.3	17.3	9.1	21.9	13.0	14.4	14.2	13.9	15.2	11.6	10.3	15.1	21.7	13.6	12.0	13.3	10.5	18.0	9.7	12.3	20.6	15.4	16.2	18.8	12.7	11.5	11.3	15.4	17.1	12.9	16.0	18.8	14.8	16.4	11.0	20.7	15.2	20.7	13.3	14.7	13.6	14.3	14.8	6.2	7.1	9.7	5.0	4.7	9.5	3.3	8.2	5.2	8.4	8.7	19.7	18.3	6.9	13.0	12.7	10.0	10.6	3.8	5.8	5.8	11.1	13.9	8.2	7.4	9.3	11.9	7.1	4.0	5.3	7.2	4.5	12.7	9.9	6.3	15.5	10.9	9.3	12.5	14.7	11.7	6.7	18.3	3.0	5.7	5.1	8.9	24.0	6.2	10.3	6.2	7.7	5.3	3.6	10.0	11.8	8.1	7.7	7.2	11.7	14.5	9.7	5.8	11.8	10.1	9.0	4.6	8.9	6.4	7.2	10.8	9.7	4.5	6.3	7.3	5.0	6.5	5.9	7.2	8.7	4.3	6.2	9.5	9.1	2.5	4.7	3.5	7.1	8.1	3.3	10.4	15.1	18.8	18.0	11.6	10.3	13.3	10.5	16.2	15.2
KLHL25	"ENC-2, ENC2, FLJ12587"	ENSG00000183655	"Kelch like family member 25"	Q9H0H3	15	85759323-85795030	"Predicted intracellular proteins"	"Translation regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 31.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 6.1;NK-cells: 5.1;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 36.7;hippocampal formation: 25.8"	HPA023450	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023450: AB_1852583"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.66e-2)"	10.6	4.2	5.2	6.8	12.1	1.5	12.7	3.9	21.5	4.7	4.8	7.5	7.7	9.9	7.9	7.2	8.2	6.2	5.2	4.2	5.7	5.9	4.3	18.3	4.8	4.0	5.3	5.8	4.4	3.6	4.4	4.6	2.8	5.4	5.7	2.9	3.8	6.2	7.6	7.8	9.7	7.0	6.2	3.0	2.6	7.5	16.3	4.3	3.7	4.7	2.5	3.9	4.1	31.5	0.6	1.2	0.5	6.1	5.1	3.5	1.0	2.3	7.0	10.3	5.0	2.1	1.1	5.3	2.9	1.4	4.2	3.2	9.4	3.9	1.4	1.5	2.4	5.8	11.1	5.6	0.9	1.4	5.1	0.4	3.0	7.1	2.4	0.4	1.8	2.1	1.9	4.0	1.4	2.2	0.6	1.3	1.7	4.3	3.6	2.2	9.3	3.7	7.4	6.2	2.4	1.5	4.9	14.4	10.0	4.3	5.0	1.8	9.1	0.6	1.9	4.4	8.1	2.8	5.3	1.5	3.0	1.5	1.9	2.6	2.4	0.0	0.2	0.5	2.0	2.3	1.1	0.1	2.1	1.5	0.5	0.6	3.5	2.2	0.0	5.1	6.1	1.2	1.8	1.0	5.2	12.1	3.9	11.1	5.7	5.9	5.3	5.8	5.4	4.3
KLHL28	"BTBD5, FLJ20081"	ENSG00000179454	"Kelch like family member 28"	Q9NXS3	14	44924319-45042322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000988			Approved	Cytosol				Cytosol		"HPA000988: AB_1845480"	"unprognostic (8.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.84e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.36e-3)"	"unprognostic (4.92e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.53e-2)"	10.9	9.0	8.8	11.6	12.7	39.2	10.4	22.9	15.5	12.1	9.9	11.1	10.5	9.1	12.6	9.4	12.8	11.2	9.9	8.9	10.3	10.4	8.6	11.2	10.1	13.5	11.2	9.4	14.4	10.6	9.8	18.1	9.9	16.7	10.2	10.8	12.2	12.6	9.0	13.8	11.5	11.0	10.5	12.8	11.5	8.8	14.2	10.9	27.9	13.6	8.6	12.7	11.3	10.8	10.2	6.0	17.7	7.0	13.0	23.1	4.5	4.5	6.9	9.2	6.0	8.4	7.6	7.0	6.1	6.8	9.1	7.7	3.0	7.2	6.8	6.7	10.6	8.0	8.2	6.5	10.0	12.6	4.4	5.9	7.1	3.5	7.6	9.4	12.9	5.8	9.1	5.8	9.3	7.2	5.2	17.0	5.2	6.6	7.4	4.8	5.7	6.7	6.5	10.3	3.7	5.2	8.3	10.6	6.5	7.9	5.3	8.4	10.0	4.0	9.1	8.1	9.5	5.7	3.4	10.1	11.0	9.4	2.8	4.2	4.9	17.7	5.0	11.9	12.4	6.9	23.1	10.2	12.4	13.0	4.4	9.6	14.9	12.6	11.6	13.0	7.0	6.0	9.3	4.5	8.8	12.7	22.9	15.5	10.3	10.4	11.2	9.4	16.7	10.9
KLHL29	"KBTBD9, KIAA1921"	ENSG00000119771	"Kelch like family member 29"	Q96CT2	2	23385217-23708611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049057, HPA057379"	Approved		Approved	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA049057: , HPA057379: "	"unprognostic (8.08e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (1.12e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.25e-4)"	9.5	20.8	8.9	6.4	14.5	0.8	7.4	9.0	11.7	6.7	9.4	2.6	5.2	2.6	10.9	3.5	5.4	4.8	10.7	3.3	6.7	7.5	4.7	5.4	6.2	5.7	3.6	9.0	4.0	4.7	5.8	17.7	7.6	6.3	10.8	3.4	11.7	4.2	11.7	12.0	6.9	4.2	7.2	2.7	10.6	5.5	2.5	3.7	0.5	1.9	1.8	4.0	7.5	6.4	0.1	0.4	0.0	0.0	0.9	0.7	0.0	1.0	0.9	6.1	3.1	5.8	3.9	10.5	6.2	4.8	2.5	1.8	0.0	0.3	4.0	2.1	2.4	0.2	1.4	5.3	1.7	0.0	6.4	0.0	5.2	0.0	2.0	0.0	8.0	2.8	7.2	3.3	9.5	4.3	0.0	0.0	1.4	0.5	1.3	0.0	3.0	1.8	0.3	15.6	0.0	4.7	1.8	9.2	1.9	0.8	0.7	3.5	0.0	0.0	4.2	2.5	11.9	5.4	2.1	0.1	0.0	0.0	9.7	0.4	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.9	0.0	0.4	0.0	0.0	8.9	14.5	9.0	11.7	6.7	7.5	3.6	9.0	6.3	3.7
KLHL36	"C16orf44, FLJ12543"	ENSG00000135686	"Kelch like family member 36"	Q8N4N3	16	84648525-84667686	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023423	Approved		Approved	Cytosol				Cytosol		"HPA023423: AB_10962985"	"unprognostic (6.50e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.59e-2)"	"prognostic favourable (9.81e-5)"	"unprognostic (3.79e-3)"	"prognostic favourable (5.52e-10)"	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.67e-3)"	14.6	10.3	13.7	10.8	14.8	26.3	12.2	12.1	11.7	8.9	9.7	7.5	13.0	13.7	11.1	11.1	13.8	10.4	10.1	12.6	10.8	6.0	11.6	16.2	12.7	12.3	10.2	8.6	14.7	21.9	12.7	10.1	9.2	8.7	12.1	5.6	8.8	13.5	12.4	7.8	11.9	14.9	12.0	6.7	16.8	13.1	21.3	10.5	8.4	13.9	7.2	14.0	15.1	22.6	5.9	5.4	8.8	3.7	3.1	10.4	3.2	12.3	13.3	2.5	6.6	2.6	4.8	13.1	8.6	4.7	3.9	2.1	11.7	8.8	8.5	12.7	5.2	13.1	2.7	7.1	1.8	5.5	5.3	3.0	4.3	6.5	3.4	3.6	8.5	4.6	5.3	5.0	3.9	4.6	9.5	1.5	2.7	19.3	0.4	5.2	4.9	5.8	11.7	3.3	4.1	5.4	11.5	3.7	2.7	10.9	2.8	5.4	11.9	8.5	10.4	5.0	9.2	5.5	5.7	5.0	6.3	14.7	6.7	4.4	14.7	5.3	3.7	8.8	4.9	2.5	4.1	5.9	8.7	7.1	5.4	5.7	10.4	7.2	4.8	3.1	2.6	4.9	4.0	3.2	13.7	14.8	12.1	11.7	10.8	6.0	10.2	8.6	8.7	10.5
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 72.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.4;SK-MEL-30: 1.7;U-2197: 9.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.5	0.7	0.6	0.1	0.1	16.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.1	72.0	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.7	1.0	0.0	0.0	0.0	0.2	9.5	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526262	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"skeletal muscle: 564.4;tongue: 157.3"	"Group enriched"	"Detected in some"	9	"HSkMC: 12.5;LHCN-M2: 19.8;RH-30: 31.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	12.0	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.1	0.1	17.8	9.8	0.2	0.6	10.2	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.5	0.1	0.0	3.9	0.1	0.0	6.6	0.1	564.4	0.2	0.1	2.3	0.2	0.1	0.2	0.5	0.0	0.0	2.0	157.3	5.0	2.1	0.1	0.2	0.5	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.1	0.0	12.5	0.2	0.1	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.1	0.0	31.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.0	0.0
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favourable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	7.5	14.6	9.2	5.6	13.0	8.2	10.3	12.6	15.1	8.8	5.7	7.9	4.7	5.9	9.1	9.9	7.7	7.4	7.6	37.1	8.1	8.7	9.2	7.7	6.4	5.8	8.3	9.7	9.6	5.9	7.1	6.1	6.5	15.9	8.1	6.3	8.6	7.2	6.8	7.4	8.6	5.8	8.1	10.6	5.8	5.2	40.7	6.2	9.6	7.2	5.1	6.7	6.9	7.1	5.5	5.5	32.0	8.7	4.2	8.0	6.0	10.8	9.3	25.7	30.3	12.6	11.0	9.4	9.6	14.3	14.2	16.6	11.3	7.9	10.7	7.8	11.7	11.8	9.8	6.8	12.0	2.8	7.1	7.0	8.1	14.5	9.4	14.2	5.5	9.7	8.8	16.2	13.4	18.0	12.3	11.7	23.1	12.5	11.8	22.6	35.4	11.2	10.5	14.4	9.8	13.3	9.4	15.5	15.1	20.9	10.4	9.8	8.6	7.5	7.7	12.0	12.5	26.3	11.4	18.5	15.0	25.5	7.9	15.1	14.3	18.7	7.8	32.0	6.8	8.7	7.1	4.5	7.3	6.4	5.5	5.5	5.5	5.4	7.4	4.2	7.5	4.0	8.0	6.0	9.2	13.0	12.6	15.1	8.1	8.7	8.3	9.7	15.9	6.2
KLHL9	"FLJ13568, KIAA1354"	ENSG00000198642	"Kelch like family member 9"	Q9P2J3	9	21329671-21335380	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol				Cytosol		"HPA046039: , HPA059901: "	"unprognostic (7.82e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.06e-2)"	"prognostic favourable (9.43e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.33e-3)"	17.8	15.1	16.4	12.4	15.6	9.3	20.8	18.0	19.5	19.7	14.4	19.4	12.7	8.7	19.5	18.7	14.8	16.8	12.6	13.6	15.8	19.9	17.8	15.1	13.6	13.2	16.9	11.9	25.3	20.4	18.1	16.9	22.6	15.7	20.0	15.1	15.3	16.2	14.8	9.3	10.1	15.6	17.6	16.9	17.3	16.1	9.9	13.2	23.0	19.9	11.6	13.5	15.7	16.5	3.4	5.0	16.7	7.2	6.0	8.3	4.5	5.9	7.3	16.6	9.0	21.6	21.5	3.6	11.3	11.5	8.6	9.7	2.7	4.8	2.7	7.3	16.4	3.3	9.7	11.0	10.7	14.9	7.0	0.0	13.8	7.1	15.0	4.7	3.3	21.0	11.9	6.7	10.9	13.0	0.0	3.6	19.5	3.8	9.8	16.5	6.8	6.3	0.0	7.3	3.2	10.6	7.5	5.3	10.1	6.5	5.9	6.9	10.6	0.0	15.5	0.0	6.1	4.8	6.5	3.9	5.3	2.8	0.0	5.0	5.8	7.5	6.2	16.7	5.5	6.9	6.2	3.4	6.7	5.0	5.0	2.6	8.3	5.6	2.0	6.0	7.2	3.7	4.6	4.5	16.4	15.6	18.0	19.5	15.8	19.9	16.9	11.9	15.7	13.2
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607886	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 178.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.0;Karpas-707: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 178.9"	"Group enriched"	"Detected in many"	133	"NK-cells: 53.0;T-cells: 178.9"					"Low region specificity"	"Detected in all"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favourable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favourable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favourable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (5.61e-4)"	"unprognostic (1.17e-2)"	3.8	0.8	0.8	22.8	0.8	18.6	2.1	0.5	0.6	2.9	9.1	0.0	1.3	5.0	1.8	3.7	2.6	1.8	7.3	1.3	0.7	0.8	3.8	4.9	11.8	23.7	1.1	0.2	2.0	1.0	0.0	0.9	2.1	0.8	1.8	3.9	0.9	4.8	1.4	0.9	0.8	20.4	0.6	1.8	25.2	4.4	1.3	0.2	6.2	1.9	2.9	17.7	5.5	2.0	0.1	0.3	0.8	0.2	53.0	178.9	18.5	0.0	0.0	1.5	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.0	0.2	1.9	0.0	0.0	0.2	0.0	3.0	0.0	0.4	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.8	0.8	0.6	0.5	0.0	1.1	0.2	0.9	0.0	0.5	0.4	0.6	0.6	0.7	0.1	0.3	0.2	0.0	1.6	0.0	0.4	0.7	0.6	0.4	1.5	0.0	1.8	0.9	0.5	0.1	0.0	43.1	0.1	178.9	0.1	25.6	28.1	0.1	0.1	1.5	8.7	0.8	53.0	0.2	0.3	5.7	18.5	0.8	0.8	0.5	0.6	0.7	0.8	1.1	0.2	0.8	0.2
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: "	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	11.9	5.5	14.9	11.2	9.1	10.9	4.4	5.4	7.8	5.7	6.6	11.1	8.7	14.7	11.1	7.9	10.4	15.8	5.9	11.3	16.2	6.1	28.8	5.1	6.0	5.1	17.2	5.6	5.2	6.1	12.4	16.7	8.8	18.7	12.6	7.1	9.3	11.4	10.1	9.0	8.2	8.7	14.3	4.9	8.4	9.0	12.3	8.0	13.5	4.4	2.8	7.6	5.8	13.0	9.8	8.8	7.1	9.6	3.7	2.8	9.9	3.7	12.7	5.8	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35718019-35738878	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA006487			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	10.2	9.3	11.4	14.2	13.1	18.4	10.4	23.9	11.4	10.0	12.0	14.2	12.9	13.8	13.0	7.1	11.4	11.6	12.6	7.5	11.0	5.3	9.9	8.9	10.6	14.7	14.7	6.8	15.3	19.6	10.8	13.3	9.3	11.2	12.1	5.6	13.8	14.7	10.0	13.3	19.9	12.3	12.2	12.4	15.8	12.1	21.5	14.9	14.1	14.9	7.0	14.2	12.4	14.2	0.4	0.7	3.2	0.7	2.1	0.7	0.2	11.3	19.2	8.9	9.7	4.6	4.5	9.3	5.5	4.0	5.6	4.3	12.8	5.8	10.1	8.7	4.6	7.5	8.0	4.7	2.5	15.0	8.9	18.2	9.0	6.4	4.5	11.1	20.9	6.1	6.4	5.7	6.3	5.5	15.2	12.7	3.6	11.6	9.4	9.6	8.2	6.8	14.8	5.8	5.5	3.1	10.1	10.1	8.1	8.4	13.6	5.8	8.3	11.8	7.6	11.3	12.2	7.5	11.7	17.5	10.7	8.1	6.1	10.3	7.8	1.0	0.7	0.6	0.7	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.4	3.2	2.1	0.3	0.7	0.2	0.2	11.4	13.1	23.9	11.4	11.0	5.3	14.7	6.8	11.2	14.9
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018975-49059774	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	12.1	7.6	4.9	6.7	10.8	26.1	6.8	11.7	10.5	9.5	6.5	5.8	13.0	5.5	15.7	7.4	8.8	8.9	5.8	9.1	6.1	3.5	6.2	6.5	22.9	9.6	6.7	3.3	9.7	11.6	13.3	9.2	12.9	13.7	6.7	6.6	9.8	7.6	8.0	16.1	13.6	9.4	7.1	9.1	13.6	8.3	7.3	5.7	6.2	11.0	6.1	7.6	7.0	6.3	2.0	2.2	5.9	0.5	1.5	0.8	0.6	17.0	16.2	16.4	13.2	17.0	11.4	17.6	9.0	9.4	11.7	6.3	28.4	7.2	17.7	11.7	12.6	11.6	21.6	10.0	9.8	10.3	17.3	22.5	16.9	15.2	11.7	26.7	22.6	9.7	14.3	16.4	17.0	17.4	28.2	9.8	13.2	18.7	13.2	24.9	15.5	14.0	19.9	10.1	6.4	9.8	18.9	13.7	11.6	13.9	13.7	9.5	13.6	23.4	23.1	9.2	16.5	8.1	15.1	14.0	9.0	17.2	10.6	13.8	6.9	0.6	0.5	3.0	0.8	0.2	0.4	0.3	0.3	0.5	0.3	2.0	0.3	0.8	5.9	1.5	0.1	2.2	0.0	0.6	4.9	10.8	11.7	10.5	6.1	3.5	6.7	3.3	13.7	5.7
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409358	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA064495: "	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	7.6	5.4	8.9	14.0	7.5	20.2	7.9	9.8	14.1	13.9	9.1	9.9	21.4	7.3	15.7	9.5	22.3	12.3	8.3	10.9	8.1	5.5	6.7	7.4	8.7	8.4	7.8	10.6	7.2	13.1	6.8	7.4	9.9	12.8	18.6	9.1	7.9	19.3	12.5	13.6	15.6	9.1	11.0	10.3	13.3	9.0	5.2	8.6	42.2	17.2	8.9	19.7	12.3	14.2	3.5	3.8	7.8	3.8	4.1	5.4	0.6	12.2	7.8	9.3	14.3	6.0	10.7	12.8	18.2	8.8	10.6	9.4	8.9	7.2	28.3	10.6	12.1	11.4	13.3	6.7	11.4	11.9	13.8	23.7	8.2	4.4	9.0	18.4	6.0	4.6	8.4	11.5	10.7	8.7	42.9	13.1	8.7	8.9	18.6	27.5	4.3	8.9	22.2	8.0	7.6	7.4	14.9	12.8	10.1	18.2	9.3	8.4	12.9	23.5	11.0	12.0	8.7	14.2	13.1	7.3	7.6	25.9	8.2	9.7	10.0	4.1	2.5	7.8	2.8	3.8	5.4	3.5	3.3	4.3	2.0	2.3	1.8	2.3	3.4	4.1	3.6	3.8	2.7	0.6	8.9	7.5	9.8	14.1	8.1	5.5	7.8	10.6	12.8	8.6
KNOP1	"101F10.1, C16orf88, FAM191A, TSG118"	ENSG00000103550	"Lysine rich nucleolar protein 1"	Q1ED39	16	19701934-19718235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041079, HPA066169"	Uncertain		Enhanced	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041079: AB_10962350, HPA066169: "	"unprognostic (6.55e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (3.75e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	6.9	7.1	13.9	7.6	34.7	3.9	13.8	11.1	23.7	7.1	9.5	20.9	8.5	8.2	8.5	10.9	10.1	8.1	7.3	6.9	17.0	10.5	6.2	7.6	5.5	9.4	33.1	9.1	12.8	19.6	17.2	6.4	10.3	18.1	8.1	11.1	4.9	13.9	9.8	15.2	15.0	8.2	5.8	21.2	6.4	9.3	10.0	33.2	4.9	7.3	5.8	7.5	8.4	7.7	7.0	5.2	1.6	8.0	4.5	12.8	4.4	12.2	18.9	21.1	15.9	5.2	4.9	10.8	7.6	4.2	7.3	7.4	13.3	10.7	14.6	31.1	4.6	11.4	16.3	10.4	7.1	9.8	11.4	8.6	10.7	17.4	9.5	13.4	6.8	3.1	14.9	9.5	7.9	7.7	26.4	6.6	6.8	16.0	11.9	11.2	40.9	7.5	25.6	11.3	17.0	7.7	11.7	18.9	16.0	9.5	12.2	12.4	14.2	9.2	8.8	11.4	11.8	7.0	10.0	9.8	20.1	18.4	6.2	10.4	11.1	0.4	3.5	1.6	4.8	8.0	7.2	6.6	6.9	4.8	4.2	7.0	12.8	7.2	1.0	4.5	7.0	5.2	4.4	4.4	13.9	34.7	11.1	23.7	17.0	10.5	33.1	9.1	18.1	33.2
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favourable (8.69e-4)"	"prognostic unfavourable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	5.6	5.6	4.5	15.3	5.4	28.9	5.8	7.5	5.6	5.2	6.4	2.7	3.9	7.0	5.4	5.5	9.6	4.9	2.9	2.9	4.6	1.8	4.9	4.5	5.8	11.8	4.0	3.8	6.7	4.9	3.5	5.9	8.1	3.6	5.3	9.7	3.9	6.1	2.8	1.6	11.7	10.9	7.7	3.1	14.1	5.5	23.2	2.8	39.6	4.0	7.0	15.6	4.4	6.6	4.8	2.1	5.0	2.6	2.2	3.6	0.8	13.0	10.9	31.5	7.2	2.5	4.5	14.2	12.1	7.9	12.0	11.4	10.3	11.0	15.6	6.3	5.8	18.0	13.6	7.6	16.0	11.1	9.4	19.2	20.4	10.5	0.8	18.9	13.3	2.4	1.7	12.4	8.3	8.1	19.2	11.8	9.0	9.7	15.6	43.8	15.9	13.8	21.4	15.3	17.3	7.2	14.0	9.8	12.6	22.0	4.7	6.5	17.8	10.9	5.9	13.8	13.2	13.4	14.1	15.9	16.0	24.1	8.2	12.3	15.7	5.0	1.4	4.6	2.0	1.9	1.8	4.8	3.3	3.6	1.3	3.0	2.5	2.9	4.4	2.2	2.6	2.1	1.4	0.8	4.5	5.4	7.5	5.6	4.6	1.8	4.0	3.8	3.6	2.8
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421949-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053627: , HPA063426: "	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	15.4	16.9	15.1	14.4	15.5	7.6	17.8	14.6	19.3	11.8	13.6	12.0	9.0	9.9	14.4	12.3	17.2	10.8	9.6	18.7	13.9	11.6	13.1	24.6	12.5	11.2	14.4	16.8	10.8	14.5	19.6	13.8	13.6	16.5	12.3	12.3	8.6	13.2	15.1	89.4	13.1	11.3	17.7	15.8	10.9	12.3	15.2	13.5	12.4	14.1	10.9	15.3	14.5	13.6	11.4	17.3	29.3	18.2	13.5	13.9	10.9	29.5	17.6	30.3	15.3	19.7	21.9	9.6	22.9	19.4	25.1	22.8	21.2	14.5	21.6	21.2	25.1	15.6	23.7	19.5	37.2	5.8	9.0	26.5	15.8	11.7	11.6	23.4	12.3	15.1	25.5	18.1	25.5	27.5	18.5	12.5	22.8	13.9	17.0	5.6	13.1	18.9	17.5	25.2	13.8	11.0	20.9	20.9	12.6	24.6	13.4	20.0	17.8	13.9	23.4	15.8	17.4	7.7	17.6	12.1	12.1	40.2	22.1	16.5	16.0	15.7	13.1	12.5	12.6	13.4	13.5	11.4	11.2	13.9	17.3	8.8	11.6	11.8	29.3	13.5	18.2	5.5	11.8	10.9	15.1	15.5	14.6	16.7	13.9	11.6	14.4	16.8	16.5	13.5
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035519-68046842	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol			38000	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: "	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavourable (2.12e-10)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (2.19e-4)"	10.6	8.3	10.2	19.5	12.0	38.6	11.9	6.1	13.2	7.4	11.5	6.6	4.3	10.1	8.3	10.4	21.1	6.3	7.9	8.9	11.6	13.2	10.9	11.8	9.1	25.5	10.3	10.3	5.3	4.7	4.5	8.4	16.4	11.4	4.6	14.5	4.0	8.2	4.7	7.2	8.7	10.2	13.2	8.5	14.8	9.7	103.9	9.0	56.6	5.9	20.3	36.8	10.0	8.3	24.6	28.1	16.4	22.6	20.3	17.7	15.0	61.9	81.5	77.8	31.2	11.5	11.2	49.4	54.7	42.5	88.4	69.0	56.0	29.0	58.2	17.3	31.5	34.4	86.0	42.7	101.8	23.4	50.7	51.5	39.3	53.4	12.2	44.3	35.5	6.9	8.1	50.8	31.4	85.0	40.9	42.1	78.4	57.8	55.2	28.5	52.5	42.3	30.5	71.0	31.9	34.9	29.1	30.9	34.4	30.7	99.2	32.1	57.8	22.3	33.1	49.1	60.6	34.5	73.5	35.0	49.9	58.1	23.9	38.1	52.6	16.4	16.1	6.6	14.1	22.6	10.9	24.6	10.3	14.4	28.1	19.7	7.9	12.3	1.2	20.3	18.9	21.4	17.7	15.0	10.2	12.0	6.1	13.2	11.6	13.2	10.3	10.3	11.4	9.0
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699307-49792921	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 71.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046852	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA046852: "	"unprognostic (4.20e-2)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	12.4	8.0	15.2	9.1	11.8	14.1	12.4	10.9	14.4	8.5	11.4	7.5	8.1	7.0	9.5	6.8	14.5	7.3	8.4	17.2	12.3	11.4	8.0	13.6	9.6	9.4	11.1	11.4	8.1	6.3	9.1	8.1	8.3	13.0	9.4	9.7	5.9	8.3	11.4	71.8	9.0	8.5	14.3	13.2	8.1	8.3	15.1	11.8	11.4	10.9	14.6	10.8	15.0	16.3	6.0	5.0	7.6	6.8	8.1	12.1	4.1	13.8	9.6	18.5	15.4	18.9	20.9	9.3	25.3	20.9	22.2	16.2	29.1	13.0	29.9	5.2	29.3	16.4	22.0	20.3	37.1	17.9	15.4	21.9	9.5	33.9	18.5	32.7	14.2	15.3	14.7	18.6	24.6	27.4	12.1	8.1	30.6	6.3	17.5	17.8	21.3	6.8	23.0	18.2	9.1	13.6	11.5	7.8	12.4	9.2	11.6	10.0	6.8	13.2	24.8	16.5	13.4	15.0	16.8	6.6	9.2	26.4	10.0	15.1	16.3	7.6	4.6	4.3	8.6	5.5	12.1	6.0	8.8	8.4	5.0	4.0	8.8	7.9	2.8	8.1	6.8	2.9	10.1	4.1	15.2	11.8	10.9	14.4	12.3	11.4	11.1	11.4	13.0	11.8
KPNA5	"IPOA6, SRP6"	ENSG00000196911	"Karyopherin subunit alpha 5"	O15131	6	116681187-116741866	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026464, HPA054037"	Enhanced		Supported	Cytosol				Cytosol		"CAB026464: , HPA054037: "	"unprognostic (9.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.56e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.98e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.43e-1)"	5.7	6.5	11.9	5.9	12.8	7.5	7.6	24.1	21.2	8.6	6.0	4.3	3.4	4.0	11.2	5.3	6.1	9.8	6.5	5.8	11.0	8.1	6.6	3.6	7.2	10.7	9.0	13.5	22.3	4.4	9.5	19.7	5.6	14.1	8.4	4.5	5.7	4.7	7.1	14.0	4.7	5.6	8.5	12.0	7.4	4.8	46.6	8.2	10.9	12.2	3.9	7.3	6.4	7.4	18.0	10.5	11.9	4.0	6.3	16.6	2.9	2.5	1.5	10.9	6.7	4.1	7.8	4.5	3.8	10.5	6.7	9.4	7.0	2.6	9.1	4.9	4.0	4.2	5.8	3.4	8.6	5.7	15.6	8.8	4.6	4.0	5.2	6.7	5.5	6.9	2.1	8.1	4.8	7.5	12.8	4.0	7.3	3.4	10.4	4.6	4.8	4.0	8.6	3.6	2.5	5.1	5.0	11.4	10.9	2.9	2.3	3.6	4.6	6.7	5.9	2.8	5.6	2.9	6.5	10.3	11.2	10.6	3.1	4.8	5.8	11.9	3.1	3.7	8.8	3.2	10.9	14.9	10.0	10.3	1.6	18.0	16.6	12.1	0.8	6.3	4.0	10.5	7.3	2.9	11.9	12.8	24.1	21.2	11.0	8.1	9.0	13.5	14.1	8.2
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108038-32176568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol			11000	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	16.1	18.7	24.6	14.6	19.0	22.9	18.1	23.9	25.2	16.3	18.8	15.7	23.0	11.5	21.3	17.5	21.4	15.9	12.1	23.4	22.7	18.2	18.3	18.0	17.3	13.2	15.4	19.8	16.9	17.1	40.9	18.0	23.5	29.7	17.6	17.3	14.1	16.2	19.8	54.0	20.5	14.2	23.1	29.2	14.8	17.4	22.2	17.6	12.6	17.8	14.5	18.3	17.9	17.8	9.1	9.3	9.5	12.5	5.0	11.2	6.4	17.4	13.8	12.3	15.9	19.0	16.8	14.5	14.1	16.7	20.6	20.0	15.3	19.1	14.6	16.8	25.3	15.1	18.9	21.6	26.4	14.7	10.4	15.1	21.3	12.4	16.9	16.4	12.4	16.9	20.6	25.6	24.5	21.5	14.5	13.5	19.5	9.6	13.2	9.4	28.7	10.4	13.4	17.8	12.0	18.0	16.1	11.9	10.0	25.6	15.4	13.7	10.9	8.8	24.9	19.2	13.3	24.9	20.2	9.7	11.0	11.6	21.0	15.4	18.3	4.0	10.2	9.5	11.2	12.5	11.0	7.8	9.7	8.7	8.3	9.1	11.2	10.8	6.0	5.0	12.5	9.3	9.6	6.4	24.6	19.0	23.9	25.2	22.7	18.2	15.4	19.8	29.7	17.6
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 28.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"			5500000	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: "	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavourable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	38.0	42.1	31.9	46.1	30.7	22.1	33.3	32.9	33.5	37.6	37.9	29.7	39.9	24.5	39.3	35.4	51.2	33.1	35.0	43.5	28.1	30.5	33.8	48.8	35.8	50.5	31.6	35.3	47.2	32.3	42.3	29.4	34.6	34.9	36.1	39.3	23.7	35.2	45.9	74.6	31.7	32.1	40.7	36.6	50.3	35.7	62.4	34.8	47.6	37.0	34.3	62.8	50.8	47.5	5.4	4.0	28.2	3.9	3.7	6.3	2.8	43.2	73.6	46.9	42.6	22.7	39.5	47.1	51.5	46.2	67.6	53.1	128.4	25.7	55.7	35.2	48.0	30.6	84.6	47.5	102.7	34.2	51.6	61.6	59.4	40.2	23.4	69.6	40.6	32.0	21.0	77.6	76.0	44.5	69.6	38.2	52.2	47.0	64.6	20.9	44.6	46.6	40.0	82.9	32.4	27.7	61.9	41.2	38.3	35.2	18.9	29.8	41.0	26.9	37.0	73.9	45.9	38.4	62.4	46.7	54.0	79.9	31.5	33.7	54.1	4.3	3.5	7.1	4.9	3.6	6.3	5.4	5.5	5.5	2.1	5.1	5.2	4.9	28.2	3.7	3.9	4.0	4.0	2.8	31.9	30.7	32.9	33.3	28.1	30.5	31.6	35.3	34.9	34.8
KPTN	2E4	ENSG00000118162	"Kaptin, actin binding protein"	Q9Y664	19	47475144-47484268	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 18.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041710, HPA041796"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041710: AB_10961904, HPA041796: AB_10962832"	"unprognostic (4.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.54e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (9.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (1.40e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-1)"	6.0	5.8	7.1	5.3	15.6	8.9	6.2	17.2	11.0	4.6	5.4	5.7	3.4	6.0	4.5	3.0	7.3	3.6	4.4	6.5	9.5	7.1	5.8	6.8	4.5	5.5	13.0	6.3	2.7	5.5	9.2	8.9	6.3	8.9	6.5	4.2	3.7	17.6	3.9	8.7	5.4	5.1	4.8	8.5	5.0	3.9	3.9	9.6	12.5	4.8	6.2	3.9	5.1	4.7	1.4	18.5	2.6	3.8	0.9	1.3	1.7	6.2	10.9	8.6	5.3	8.8	6.9	6.0	3.5	6.6	19.1	11.9	7.8	7.4	7.5	2.7	6.2	7.2	7.3	12.5	5.3	7.0	11.3	3.2	7.4	7.0	7.9	6.3	9.1	7.9	8.2	6.3	5.9	7.2	6.3	7.3	5.5	4.8	11.2	27.0	7.7	6.6	8.1	4.3	3.2	5.9	9.3	18.4	14.1	5.8	6.6	4.3	5.5	9.2	4.1	4.5	5.2	2.4	7.8	1.8	2.9	3.3	4.1	4.1	6.8	0.0	3.0	1.2	1.2	2.5	0.4	1.3	0.8	1.0	3.6	1.4	1.1	0.9	2.6	0.9	3.8	18.5	1.3	1.7	7.1	15.6	17.2	11.0	9.5	7.1	13.0	6.3	8.9	9.6
KRBA1	KIAA1862	ENSG00000133619	"KRAB-A domain containing 1"	A5PL33	7	149714781-149734575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 30.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021237, HPA050448"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021237: AB_2134145, HPA050448: "	"unprognostic (2.19e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (7.48e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.01e-5)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (2.77e-4)"	"unprognostic (2.55e-1)"	"unprognostic (6.33e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.31e-2)"	3.8	4.6	5.6	6.2	8.1	4.7	5.6	8.7	12.8	5.2	5.2	7.6	11.0	2.2	7.8	4.9	5.5	5.2	5.8	30.6	6.7	5.2	5.3	2.2	4.5	5.7	6.3	9.0	7.9	7.0	9.7	16.9	3.1	7.1	6.0	1.9	9.4	17.2	9.5	7.4	6.4	3.6	8.5	5.1	6.4	5.0	5.7	6.5	2.5	4.3	5.5	4.8	5.0	5.3	4.1	3.7	1.3	3.7	0.3	4.2	1.7	6.2	3.9	7.7	16.1	3.5	3.5	6.7	3.3	4.1	5.4	6.2	0.4	1.7	1.9	7.0	4.2	6.2	5.8	11.2	2.7	8.7	11.0	3.5	5.0	3.6	4.4	0.0	9.8	7.7	5.2	3.7	2.0	4.9	14.1	2.0	2.7	2.4	8.9	5.3	9.3	3.8	9.5	3.1	1.0	4.1	5.0	6.1	10.4	5.1	14.8	3.5	2.6	5.4	5.0	6.6	2.8	0.0	4.6	9.6	3.1	8.3	3.9	6.0	6.8	0.0	1.8	0.4	3.8	1.7	2.6	1.8	1.9	2.2	2.6	4.1	3.4	2.9	1.3	0.3	3.7	3.7	4.2	1.7	5.6	8.1	8.7	12.8	6.7	5.2	6.3	9.0	7.1	6.5
KRCC1	FLJ22333	ENSG00000172086	"Lysine rich coiled-coil 1"	Q9NPI7	2	88027205-88055729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045618, HPA052666"	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA045618: AB_10960406, HPA052666: "	"unprognostic (7.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-3)"	22.5	15.0	23.1	30.6	27.3	5.7	25.9	23.5	20.4	23.3	29.9	15.8	19.9	20.7	17.8	29.1	26.4	18.4	16.5	21.4	27.0	15.7	21.5	28.1	23.4	22.3	30.3	15.2	20.3	19.4	24.8	23.8	17.3	23.8	24.0	29.7	12.1	20.8	37.9	23.0	16.7	28.9	24.7	28.2	22.0	17.5	10.0	29.9	20.2	26.9	14.5	20.5	22.1	20.2	18.3	12.7	37.2	11.6	14.8	16.5	8.0	11.5	7.1	11.2	8.1	27.0	32.0	8.3	18.3	20.4	9.8	9.6	0.6	15.5	16.4	6.6	11.5	6.0	2.5	3.8	11.1	17.1	3.5	3.1	1.8	1.1	19.7	4.7	2.2	16.0	19.1	6.5	14.0	11.0	4.4	8.2	21.1	9.8	5.4	6.6	8.5	4.7	11.1	2.0	1.7	14.7	6.3	8.7	8.8	6.9	9.7	21.3	6.8	19.5	15.3	11.6	0.8	19.0	5.7	18.6	12.9	13.1	12.5	12.7	27.3	24.7	11.0	37.2	10.1	11.6	11.7	18.3	12.4	12.3	12.7	16.9	14.2	11.2	17.9	14.8	10.0	11.2	16.5	8.0	23.1	27.3	23.5	20.4	27.0	15.7	30.3	15.2	23.8	29.9
KREMEN1	"KREMEN, KRM1"	ENSG00000183762	"Kringle containing transmembrane protein 1"	Q96MU8	22	29073078-29168333	"Disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 18.3;U-2197: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058513			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			400000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA058513: "																		5.2	11.8	7.1	6.8	17.8	2.7	5.8	5.0	6.9	9.6	9.6	7.6	25.7	4.9	6.0	13.2	27.8	8.6	5.0	16.8	8.3	3.6	10.5	3.2	8.3	9.1	5.2	4.3	17.4	3.4	16.3	8.0	7.2	4.2	7.1	8.5	21.2	35.4	20.6	18.9	26.5	8.1	4.7	3.0	13.9	6.4	14.5	6.8	19.0	17.1	33.4	20.0	5.9	10.0	0.7	1.2	9.0	0.6	0.8	0.4	0.2	2.6	1.8	6.3	3.2	2.1	6.5	5.3	0.7	6.3	2.0	3.0	8.4	1.2	0.1	2.4	2.9	12.9	12.8	5.1	2.2	3.1	8.1	0.7	0.9	7.9	2.2	0.1	0.7	6.2	10.4	2.2	1.2	0.3	2.7	0.2	2.5	2.2	0.0	0.8	0.3	1.4	0.4	18.3	0.2	2.2	5.0	12.5	7.0	7.3	2.6	9.6	9.7	0.4	0.2	8.4	2.6	31.3	0.9	0.6	0.2	0.2	5.3	1.1	9.7	2.1	0.6	0.3	0.3	0.5	0.3	0.3	0.3	0.2	0.1	0.7	0.4	0.4	9.0	0.8	0.4	1.2	0.2	0.2	7.1	17.8	5.0	6.9	8.3	3.6	5.2	4.3	4.2	6.8
KRT18		ENSG00000111057	"Keratin 18"	P05783	12	52948871-52952901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 268.7"	"Cell line enhanced"	"Detected in many"		"A549: 225.8;BEWO: 142.5;CACO-2: 248.3;CAPAN-2: 180.4;MCF7: 330.6;SK-BR-3: 182.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 10.0"	"Cell type enriched"	"Detected in many"	5	"basophil: 28.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000008, CAB000030, HPA001605"	Enhanced		Supported	Cytosol			140000000	Cytosol		"CAB000008: , CAB000030: , HPA001605: "	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.26e-3)"	"unprognostic (4.09e-3)"	"prognostic unfavourable (5.06e-4)"	"unprognostic (8.81e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	23.3	4.8	1.0	31.0	1.1	0.0	24.1	2.9	1.2	28.6	45.4	1.3	66.3	35.0	6.6	55.3	22.4	21.7	147.4	6.8	1.1	2.5	61.9	181.0	39.6	2.8	1.2	1.0	13.7	162.9	8.2	39.8	268.7	10.0	29.3	57.0	14.1	121.1	49.9	1.3	6.5	83.6	3.9	1.4	4.4	36.0	9.5	0.8	4.2	83.4	10.8	20.9	21.5	10.8	4.1	1.0	28.6	0.1	1.0	5.9	1.6	75.7	225.8	0.0	0.3	0.0	0.0	142.5	11.5	14.0	14.9	4.2	248.3	180.4	0.0	32.1	12.5	18.5	3.1	87.6	9.0	0.0	5.3	0.7	36.9	68.3	38.6	0.0	0.0	0.5	8.2	13.0	18.0	15.9	18.2	0.0	0.0	330.6	0.1	1.3	18.4	17.1	0.1	0.0	8.6	72.7	45.7	2.6	0.1	18.7	182.8	0.7	96.5	0.2	5.0	0.2	17.4	0.2	2.5	0.0	0.2	0.1	0.0	0.0	1.4	28.6	0.1	1.1	0.2	0.1	1.1	2.1	2.3	0.6	1.0	4.1	5.9	2.1	1.5	1.0	0.0	0.0	0.2	1.6	1.0	1.1	2.9	1.2	1.1	2.5	1.2	1.0	10.0	0.8
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652164	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 289.9"	"Group enriched"	"Detected in some"	6	"HEL: 6.5;HMC-1: 2.8"	"Group enriched"	"Detected in some"	35	"head and neck cancer: 4.7;melanoma: 23.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Group enriched"	"Detected in some"	6	"amygdala: 1.8;hippocampal formation: 2.9"	"Low region specificity"	"Detected in single"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"			14000000000	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	9.5	0.1	0.1	18.3	0.1	0.1	0.1	0.0	2.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.4	289.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	6.8	0.1	19.2	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	4.4	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875941-40885227	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 232.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.3;BEWO: 2.6;NB-4: 2.3;RPMI-8226: 2.8;RT4: 7.2;SH-SY5Y: 2.2"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.7"	"Low region specificity"	"Detected in all"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol			34000000	Cytosol		"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	0.2	0.1	0.2	38.0	0.2	0.0	0.2	0.2	0.2	0.2	75.5	0.2	0.2	40.4	0.2	0.2	0.3	0.3	3.9	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.3	45.0	0.2	0.3	0.2	0.2	0.2	232.0	2.7	0.2	0.2	13.6	0.2	0.2	0.2	0.2	0.3	0.2	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	2.8	0.0	7.2	0.4	2.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
KRT23	"CK23, DKFZP434G032, HAIK1, K23, MGC26158"	ENSG00000108244	"Keratin 23"	Q9C075	17	40922696-40937634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.3;salivary gland: 99.8;skin 1: 48.2"	"Group enriched"	"Detected in some"	9	"HBEC3-KT: 20.7;Hep G2: 12.8;T-47d: 35.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	12	"neutrophil: 30.1"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012050, HPA016959, CAB017091"	Approved		Approved	"Intermediate filaments,Cytosol"			170000	"Intermediate filaments"	Cytosol	"CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228"	"unprognostic (1.62e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.18e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (8.26e-4)"	0.3	0.0	0.2	0.5	0.2	0.5	10.0	0.3	0.3	9.8	0.2	0.2	2.1	0.0	1.1	1.2	2.5	1.5	4.5	0.2	0.2	0.0	0.3	0.6	1.1	0.6	0.2	0.2	0.6	1.2	0.0	0.9	128.3	0.2	6.9	0.0	0.3	99.8	2.8	0.3	48.2	0.2	0.3	0.2	1.0	0.0	9.1	0.2	2.0	0.3	11.7	9.5	2.3	3.2	0.0	0.0	30.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.3	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2	0.2
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703750	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6"	"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 12.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Region enriched"	"Detected in single"	18	"cerebellum: 1.1"	"Low region specificity"	"Detected in all"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	9.2	4.1	0.0	0.0	0.0	0.7	9.3	62.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	48.6	0.0	0.1	3.1	0.0	1.2	0.8	0.1	0.1	0.2	3.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	1.4	68.9	0.6	3.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434525	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skin 1: 22.9;tongue: 18.8"	"Group enriched"	"Detected in some"	6	"PC-3: 21.7;U-2 OS: 29.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 0.1"	"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"			2200000000	Cytosol	"Plasma membrane"	"HPA019367: AB_1852239, HPA076201: "	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	3.5	0.0	18.8	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821410-52834295	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 11.3;skin 1: 34.3"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 97.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 0.2;hippocampal formation: 0.3;olfactory region: 0.5"	HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"			950000000	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA059347: "	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	4.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	34.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	11.3	0.1	0.1	0.2	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	97.6	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT86	"Hb6, KRTHB6, MNX"	ENSG00000170442	"Keratin 86"	O43790	12	52249300-52309163	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.5;skin 1: 60.4;testis: 23.0"	"Cell line enhanced"	"Detected in some"		"A-431: 13.6;A549: 14.4;MCF7: 28.4;RPMI-8226: 17.9;U-251 MG: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 31.5"									"HPA039798, HPA049778"	Supported		Approved	Cytosol			240000000	Cytosol		"HPA039798: AB_10674986, HPA049778: "	"unprognostic (4.52e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.22e-2)"	0.8	0.3	0.2	0.1	0.2	3.5	0.9	0.5	1.1	0.4	0.3	0.1	1.0	0.6	0.6	2.4	0.3	1.1	1.0	0.1	0.2	0.3	3.8	0.2	1.0	0.1	0.3	0.1	0.6	7.9	0.0	0.2	0.6	0.3	0.5	0.0	0.3	6.3	0.4	1.5	60.4	0.2	0.1	0.7	0.1	0.2	23.0	0.1	0.1	7.6	0.1	0.3	1.2	0.2	0.0	0.0	31.5	0.0	3.8	0.0	0.2	13.6	14.4	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.2	0.0	0.1	0.7	0.0	0.6	0.0	0.8	0.0	2.5	0.0	6.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.0	0.0	28.4	0.0	1.6	0.0	3.4	0.0	0.0	17.9	0.2	1.8	1.7	0.0	2.6	1.1	1.1	0.8	0.0	0.4	0.0	0.7	0.0	8.0	0.0	0.0	0.0	0.0	2.9	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.5	0.2	0.3	0.3	0.1	0.3	0.1
KRTAP25-1	KAP25.1	ENSG00000232263	"Keratin associated protein 25-1"	Q3LHN0	21	30289145-30289514	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031438	Uncertain		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				"Nuclear membrane"	"Plasma membrane, Cytosol"	"HPA031438: AB_10610000"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTCAP3	KCP3	ENSG00000157992	"Keratinocyte associated protein 3"	Q53RY4	2	27442366-27446481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.8"	"Cell line enhanced"	"Detected in some"		"A-431: 27.9;CAPAN-2: 32.0;HaCaT: 10.2;SCLC-21H: 15.0;SK-BR-3: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8"	"Group enriched"	"Detected in many"	19	"B-cells: 5.4;T-cells: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047136, HPA060203"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA047136: AB_2679949, HPA060203: "	"prognostic favourable (2.67e-5)"	"unprognostic (5.93e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.42e-3)"	0.9	1.0	0.5	10.0	0.8	0.5	6.3	1.3	1.7	4.6	24.4	0.7	13.3	16.2	1.5	3.2	8.5	9.8	16.5	1.7	0.7	0.3	4.8	6.5	11.8	1.9	0.7	1.4	2.7	28.8	3.3	6.9	1.5	1.5	9.7	6.2	1.9	17.4	22.6	1.0	4.9	34.8	0.9	0.9	1.0	16.7	1.8	0.8	2.3	12.3	6.9	5.4	7.6	4.5	5.4	0.0	0.1	0.0	0.3	7.0	1.8	27.9	0.2	0.7	0.5	0.0	0.0	5.8	0.0	0.0	0.0	0.1	9.0	32.0	0.2	0.2	0.0	10.2	0.2	7.2	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.0	0.3	0.1	0.0	7.5	0.3	1.9	6.0	0.1	0.1	0.2	0.7	0.0	0.0	15.0	0.5	0.4	9.3	0.6	0.2	0.2	0.0	0.3	0.7	0.2	0.2	1.6	1.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.6	0.0	6.9	5.4	6.2	3.2	0.0	4.6	7.0	3.3	0.0	0.3	0.0	0.0	4.8	1.8	0.5	0.8	1.3	1.7	0.7	0.3	0.7	1.4	1.5	0.8
KXD1	"BORCS4, C19orf50, FLJ25480, KXDL, MGC2749"	ENSG00000105700	"KxDL motif containing 1"	Q9BQD3	19	18557762-18569387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041507, HPA041599"	Approved		Approved	"Nucleoli fibrillar center,Centrosome,Cytosol"				"Nucleoli fibrillar center, Centrosome, Cytosol"		"HPA041507: AB_10795698, HPA041599: AB_10795502"	"unprognostic (8.48e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (8.46e-4)"	"unprognostic (7.36e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (7.71e-10)"	"unprognostic (7.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-1)"	52.9	42.2	47.2	48.7	44.9	49.1	42.8	28.4	60.9	37.2	44.5	56.7	34.3	43.7	48.9	43.2	45.9	45.6	44.1	43.2	43.3	41.8	39.6	73.3	42.2	56.1	46.7	34.2	52.3	58.9	33.6	48.2	53.7	43.7	46.6	43.2	40.0	60.4	45.4	58.3	46.8	39.9	49.3	56.2	48.3	44.5	75.4	38.9	42.1	47.0	45.5	53.2	57.2	54.0	26.9	37.1	41.3	46.4	29.7	37.6	30.6	32.8	33.2	27.3	31.0	28.3	32.8	44.7	36.5	29.3	27.3	31.7	27.2	39.4	22.7	42.9	32.4	25.1	41.9	44.6	24.6	27.5	59.2	24.9	26.0	24.5	32.7	38.8	27.4	34.8	31.8	40.9	49.0	38.6	38.6	35.9	28.4	38.2	34.9	28.6	34.4	50.9	33.6	21.4	33.0	27.8	30.1	25.4	32.7	23.8	21.4	30.6	18.2	26.8	31.3	24.6	21.7	78.6	47.2	42.8	31.9	33.9	42.5	45.6	35.5	15.0	41.0	35.0	29.8	46.4	27.7	26.9	27.6	29.5	37.1	26.4	22.2	24.2	41.3	29.7	43.4	22.1	37.6	30.6	47.2	44.9	28.4	60.9	43.3	41.8	46.7	34.2	43.7	38.9
KYAT1	"CCBL1, GTK, KATI"	ENSG00000171097	"Kynurenine aminotransferase 1"	Q16773	9	128832942-128882494	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021176, HPA021177, HPA027736"	Approved		Supported	Cytosol			21000	Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"	"unprognostic (6.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	4.4	5.2	12.2	5.1	18.9	3.9	7.0	17.8	17.6	4.7	3.8	14.2	5.5	4.1	5.5	5.4	4.6	8.5	4.8	13.5	12.1	9.3	8.1	12.0	4.1	7.3	18.4	12.1	7.1	5.0	8.9	8.1	4.5	12.2	8.9	2.7	5.8	7.0	8.4	17.0	12.2	4.8	5.8	10.2	5.8	4.0	6.9	17.2	3.7	7.5	2.8	7.4	8.1	8.1	12.1	7.6	3.5	5.1	4.6	9.6	4.9	4.0	9.3	8.5	8.4	7.7	9.7	4.4	5.6	6.4	5.5	8.3	5.1	7.6	7.8	2.8	4.2	13.2	12.6	10.9	7.1	8.7	8.8	5.1	22.5	9.2	6.9	4.9	2.2	4.2	6.9	7.2	6.9	9.7	7.8	6.9	7.2	2.6	11.3	3.3	14.9	7.2	13.5	7.3	14.5	7.6	1.7	9.0	7.7	8.9	2.2	5.1	5.4	1.9	6.4	4.2	7.2	6.2	4.9	12.7	10.7	9.6	8.0	7.6	3.4	0.1	3.1	3.3	7.8	2.2	6.2	12.1	8.1	8.1	7.6	5.8	8.6	9.6	3.5	4.6	5.1	4.8	8.7	4.9	12.2	18.9	17.8	17.6	12.1	9.3	18.4	12.1	12.2	17.2
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favourable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favourable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	22.2	26.8	16.6	13.2	19.3	10.6	27.5	14.9	23.5	23.7	17.5	20.0	13.0	19.4	24.1	21.2	27.2	18.9	17.8	13.2	18.6	14.2	27.3	23.8	17.1	17.6	16.9	22.2	27.4	28.6	27.0	19.5	21.9	23.4	19.0	19.6	19.5	21.0	20.7	10.4	22.0	17.2	22.1	14.8	20.7	23.5	15.6	17.2	15.5	24.5	13.4	20.2	25.2	17.7	9.6	17.0	9.2	12.7	11.5	16.7	8.2	20.4	4.3	20.9	7.0	7.5	21.0	18.2	12.6	23.7	16.1	21.0	6.2	7.2	13.5	9.6	9.3	5.8	5.9	9.7	24.7	7.9	8.4	12.1	4.1	10.3	24.6	16.9	3.3	17.7	9.8	11.0	20.0	15.6	15.5	7.1	15.1	6.7	18.0	8.2	12.5	3.8	18.4	14.7	7.2	33.9	20.9	15.3	18.6	16.7	22.3	10.9	12.3	4.1	10.4	6.8	4.5	21.6	9.1	9.6	4.8	9.0	3.3	7.5	5.7	5.6	12.7	7.1	9.1	7.9	12.6	9.6	11.8	10.5	17.0	9.3	12.4	10.4	9.2	11.5	10.2	6.3	16.7	8.2	16.6	19.3	14.9	23.5	18.6	14.2	16.9	22.2	23.4	17.2
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;HeLa: 44.8;Hep G2: 27.2;hTEC/SVTERT24-B: 23.5;SiHa: 22.2;U-87 MG: 70.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol			360000	Cytosol	Nucleoplasm	"HPA031686: "	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	40.1	0.1	0.1	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.7	0.5	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	44.8	27.2	0.5	0.1	0.2	3.9	3.2	23.5	0.1	0.0	0.1	0.2	0.3	20.5	0.0	2.4	0.1	0.1	0.0	0.2	0.1	0.6	20.7	0.1	0.0	22.2	3.3	0.2	11.1	5.7	0.3	1.3	0.1	19.6	0.0	0.1	0.0	0.0	70.2	4.6	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6
LACTB2	CGI-83	ENSG00000147592	"Lactamase beta 2"	Q53H82	8	70635318-70669174	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.1;liver: 58.8"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044391, HPA053040"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"			24000	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA044391: AB_10965168, HPA053040: "	"unprognostic (6.33e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.60e-4)"	"unprognostic (3.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.93e-2)"	9.3	31.4	6.8	6.7	10.0	1.2	8.9	2.0	7.1	5.5	13.5	9.0	5.3	17.8	5.7	8.3	7.6	5.2	14.6	19.3	7.2	7.2	70.1	58.8	9.7	8.9	11.5	7.5	5.5	10.6	6.2	12.6	6.3	10.1	7.5	10.0	6.2	7.8	8.6	12.0	6.1	19.1	7.2	11.6	8.0	7.7	45.7	11.7	6.0	9.8	10.9	5.9	8.2	7.4	14.0	18.2	13.4	17.3	11.0	13.8	6.4	14.0	14.7	4.6	1.9	8.1	12.5	2.8	7.9	4.6	8.6	6.4	7.0	15.9	0.0	3.2	3.8	10.1	5.6	8.3	6.8	8.5	6.2	6.6	1.9	3.8	17.1	6.4	5.7	15.0	10.2	4.2	6.4	2.2	11.3	13.4	11.2	4.2	3.6	1.2	5.0	13.9	3.2	2.7	2.9	32.6	7.5	6.7	2.3	17.6	97.4	8.8	16.3	8.6	3.5	0.6	4.7	15.1	6.4	10.9	8.2	0.0	4.8	11.0	6.3	11.1	15.2	13.4	9.9	17.3	12.5	14.0	10.4	9.7	18.2	13.2	10.1	10.6	6.4	11.0	16.4	12.8	13.8	6.4	6.8	10.0	2.0	7.1	7.2	7.2	11.5	7.5	10.1	11.7
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112108760-112254939	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.3;ASC TERT1: 78.1;HSkMC: 60.8;HUVEC TERT2: 64.1;TIME: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		350000	"Plasma membrane, Cytosol"		"CAB078156: , HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	42.3	3.6	5.8	20.7	5.4	0.0	21.7	3.7	4.6	28.7	28.6	4.7	12.9	6.3	41.0	24.8	29.7	29.6	23.3	13.8	5.1	4.1	4.6	1.8	27.9	8.8	5.5	2.1	19.9	1.6	3.6	5.6	25.4	5.0	21.3	13.2	18.4	22.9	15.7	5.7	6.8	13.1	53.6	3.6	0.4	15.6	9.4	2.5	1.1	9.1	15.2	6.6	35.6	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	51.3	78.1	0.0	12.8	7.7	1.3	0.2	0.0	4.8	0.0	8.5	22.2	0.0	0.5	0.0	0.2	0.0	6.6	0.0	6.4	0.0	10.5	0.0	0.0	60.8	0.0	9.3	0.0	64.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	21.0	0.3	0.0	0.3	1.9	0.0	9.9	0.0	0.0	58.6	21.1	1.1	23.6	4.3	0.0	0.0	0.0	5.3	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.4	3.7	4.6	5.1	4.1	5.5	2.1	5.0	2.5
LAMB2	"LAMS, NPHS5"	ENSG00000172037	"Laminin subunit beta 2"	P55268	3	49121114-49133118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 45.0;fHDF/TERT166: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;myeloid DC: 2.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.0;monocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000053, HPA001895, HPA050033, CAB078160"	Supported		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"		18000000	Vesicles	Cytosol	"CAB000053: AB_2313665, CAB078160: , HPA001895: AB_1079227, HPA050033: "	"unprognostic (1.12e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.24e-2)"	46.1	35.3	7.4	13.0	7.7	0.9	29.0	5.1	8.3	55.0	25.9	10.5	41.3	9.3	43.4	38.6	34.3	27.1	37.7	62.5	9.7	4.1	30.6	29.6	28.2	5.7	8.2	6.1	56.0	12.9	51.7	8.0	41.3	9.9	37.7	7.3	45.1	17.4	39.2	22.7	17.0	23.0	31.5	6.9	16.7	22.7	24.1	8.1	2.1	36.5	21.8	11.4	45.3	38.4	0.0	2.0	0.2	2.4	0.0	0.0	0.4	3.2	8.0	7.4	26.4	43.4	45.0	6.7	28.0	34.7	16.7	16.8	3.8	11.1	0.0	9.7	63.2	10.5	6.4	10.0	11.5	0.0	2.0	1.4	12.6	6.6	29.3	0.0	0.0	39.1	15.0	13.3	13.6	16.3	0.8	0.0	13.5	6.2	0.0	0.0	3.2	6.7	0.0	3.6	0.1	11.7	4.1	0.0	4.4	16.0	9.3	14.6	20.2	0.2	27.0	18.1	7.9	6.4	7.3	0.0	0.0	0.0	8.6	0.0	12.2	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	7.4	7.7	5.1	8.3	9.7	4.1	8.2	6.1	9.9	8.1
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183244900	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 48.3;CAPAN-2: 43.7;HBEC3-KT: 216.9;hTERT-HME1: 133.9;RPTEC TERT1: 52.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, CAB078165"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"			Cytosol		"CAB004257: AB_627873, CAB078165: , HPA024638: AB_1852689"	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavourable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	2.6	0.0	1.0	20.6	4.1	0.0	11.4	3.6	1.2	8.7	8.4	0.9	2.4	0.9	6.6	2.9	6.5	19.0	12.8	1.8	0.7	0.1	10.5	0.8	18.3	3.3	1.6	1.1	1.9	2.9	0.0	7.0	21.2	1.5	3.7	6.8	0.9	11.2	3.2	1.3	12.8	14.3	1.8	0.7	0.7	7.6	1.9	0.9	3.5	9.8	10.0	15.6	3.4	4.8	0.9	0.8	1.7	0.5	0.4	0.6	0.1	48.3	2.2	0.0	0.0	0.4	1.0	3.5	0.3	0.4	0.1	0.0	3.5	43.7	0.0	18.6	0.1	21.8	0.0	216.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	16.8	0.5	133.9	2.8	0.0	0.0	0.2	0.1	0.0	0.0	0.3	3.1	0.0	0.1	0.0	52.0	12.6	2.7	0.0	1.2	0.0	0.0	0.1	0.2	0.3	0.2	2.6	1.3	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.4	0.6	0.4	0.3	0.4	0.5	0.4	0.4	0.1	0.9	0.5	0.6	1.7	0.4	0.5	0.8	0.3	0.1	1.0	4.1	3.6	1.2	0.7	0.1	1.6	1.1	1.5	0.9
LAMP5	"BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46"	ENSG00000125869	"Lysosomal associated membrane protein family member 5"	Q9UJQ1	20	9514358-9530524	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.1;brain: 105.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 92.7;SH-SY5Y: 17.0;THP-1: 32.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"basal ganglia: 105.2"	"Cell type enriched"	"Detected in some"	15	"plasmacytoid DC: 42.1"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 42.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004802, HPA070765"	Enhanced		Uncertain	"Mitotic spindle,Centriolar satellite,Cytosol"				Cytosol	"Mitotic spindle, Centriolar satellite"	"HPA004802: AB_10603682, HPA070765: "	"unprognostic (2.78e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.73e-4)"	"unprognostic (5.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (6.46e-6)"	"unprognostic (5.12e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.49e-3)"	0.5	4.1	21.6	1.5	105.2	2.0	1.0	2.3	28.6	9.1	1.3	0.6	1.8	1.3	4.6	6.0	0.6	9.7	2.9	0.6	18.7	4.1	0.9	0.5	1.1	4.8	4.5	7.7	21.2	1.3	0.3	2.0	0.4	23.2	2.3	1.4	2.6	1.4	3.6	0.3	0.5	1.4	3.8	6.7	1.4	1.6	1.1	4.8	0.0	1.1	0.0	4.7	1.2	0.6	1.4	42.1	0.9	0.5	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	92.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.9	0.5	0.0	0.0	0.1	0.0	1.4	0.0	0.0	2.8	0.1	0.0	0.0	0.1	0.0	0.0	42.1	0.0	0.7	21.6	105.2	2.3	19.1	18.7	4.1	4.5	7.7	23.2	4.8
LAMTOR5	"HBXIP, MGC71071, XIP"	ENSG00000134248	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5"	O43504	1	110401249-110407942	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006812	Approved		Supported	Cytosol			270000	Cytosol		"HPA006812: AB_1079040"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (9.97e-2)"	"unprognostic (7.58e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.80e-3)"	"prognostic favourable (5.52e-4)"	"unprognostic (6.66e-2)"	29.0	32.1	38.9	21.0	35.2	60.9	30.1	25.2	35.8	23.6	29.8	24.4	28.9	23.7	21.6	47.3	30.4	26.7	31.0	63.8	33.2	34.8	118.7	54.3	26.7	28.1	41.5	28.5	29.7	34.8	28.9	35.2	46.3	35.8	28.0	31.6	31.0	32.9	29.6	64.0	21.5	34.2	22.9	36.4	30.7	28.6	24.0	29.5	22.6	37.8	56.7	32.3	27.8	24.7	62.0	59.0	86.1	42.6	25.4	32.4	42.1	46.4	38.9	35.3	21.1	59.2	45.2	35.3	39.5	31.2	33.5	31.9	33.9	23.0	37.0	42.2	38.2	18.9	35.8	33.0	41.3	39.6	40.2	27.1	46.9	68.5	45.3	38.8	33.8	39.4	51.2	34.6	22.1	40.0	31.9	34.9	48.5	75.6	35.2	47.0	25.0	64.8	24.4	63.8	28.0	77.2	52.3	26.1	34.1	35.1	51.3	85.5	19.8	55.1	38.0	25.4	33.0	63.8	37.0	36.8	41.1	47.1	83.2	38.9	58.2	47.1	42.6	86.1	25.2	41.2	22.1	62.0	29.5	27.0	34.7	54.6	25.9	27.3	65.6	25.4	39.0	59.0	32.4	42.1	38.9	35.2	25.2	35.8	33.2	34.8	41.5	28.5	35.8	29.5
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365448-55433742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell line enriched"	"Detected in all"	7	"A-431: 57.1"	"Cancer enhanced"	"Detected in all"		"glioma: 52.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favourable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favourable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.1	4.9	20.4	2.3	17.0	3.1	5.9	9.9	28.5	6.1	4.6	19.8	1.8	5.0	9.6	5.3	3.5	5.6	3.8	3.9	17.2	11.3	6.0	4.8	3.0	4.0	12.9	21.1	9.6	3.4	10.4	4.2	3.9	10.1	5.9	4.7	2.4	3.3	6.9	5.7	5.3	4.2	7.0	10.8	2.8	3.5	5.7	13.1	3.3	6.6	0.3	2.7	2.8	2.7	2.7	4.7	0.7	4.5	3.6	6.0	2.6	57.1	2.0	4.0	2.7	1.2	2.1	2.2	2.6	3.1	4.0	3.4	2.0	1.6	4.0	2.4	3.7	2.6	2.1	1.4	2.5	1.7	4.2	1.4	1.6	2.0	2.2	4.4	2.7	3.8	1.5	3.0	1.0	2.0	2.5	2.6	3.7	1.7	1.1	2.0	7.7	2.5	1.7	1.8	2.0	2.6	4.5	7.0	6.7	3.7	5.6	1.5	2.3	4.7	3.3	2.5	3.5	4.8	5.0	2.5	3.0	4.3	2.0	1.0	4.8	0.4	3.6	0.7	2.6	4.5	4.5	2.7	3.4	3.9	4.7	2.6	3.1	2.7	0.5	3.6	3.0	3.7	6.0	2.6	20.4	17.0	9.9	28.5	17.2	11.3	12.9	21.1	10.1	13.1
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol			4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.8	9.5	9.1	8.6	18.1	22.1	0.1	17.1	19.3	62.3	75.7	17.3	20.7	42.7	11.4	13.1	6.7	34.2	12.1	23.7	16.3	9.8	23.7	10.5	22.6	21.1	21.3	15.2	22.4	7.7	20.4	10.7	21.6	22.9	30.5	14.6	11.7	18.9	29.2	19.0	18.2	29.4	8.7	21.6	16.2	12.7	13.5	11.1	15.7	9.7	33.5	8.2	8.2	14.0	15.8	10.7	16.6	29.7	28.1	42.9	36.9	21.4	35.5	15.3	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757820	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 46.0;HEL: 87.3;HL-60: 55.3;HMC-1: 206.8;REH: 64.8;U-698: 75.1;U-937: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol				Cytosol		"HPA051293: "	"unprognostic (3.12e-2)"	"prognostic favourable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	56.0	15.5	11.5	59.1	17.8	157.5	15.0	2.2	10.4	8.2	11.2	20.7	1.8	9.5	7.5	6.8	8.3	13.7	19.9	9.2	11.2	12.7	14.0	18.2	60.8	144.5	19.0	3.3	7.7	6.3	2.0	6.8	20.1	14.6	8.2	13.2	7.4	11.7	4.7	4.0	5.5	37.1	12.9	33.8	130.9	9.5	6.7	15.8	75.2	10.1	5.2	91.2	21.4	6.4	98.2	69.1	145.1	109.3	26.0	55.4	166.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	46.0	4.8	0.1	0.1	0.0	0.0	0.0	5.1	0.0	87.3	0.0	0.1	0.0	55.3	206.8	0.0	0.1	0.0	0.3	10.5	1.1	2.9	0.7	0.0	9.5	11.6	0.0	0.0	64.8	8.6	32.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	35.2	12.2	0.0	0.2	0.0	0.2	0.2	0.0	75.1	0.2	45.2	0.1	73.5	109.3	115.3	47.7	87.9	55.4	70.2	43.7	44.6	69.1	98.2	44.2	43.1	145.1	26.0	83.9	33.2	53.7	166.6	11.5	17.8	2.2	10.1	11.2	12.7	19.0	3.3	14.6	15.8
LARP1	"KIAA0731, LARP, MGC19556"	ENSG00000155506	"La ribonucleoprotein domain family member 1"	Q6PKG0	5	154712902-154817607	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: , HPA054819: "	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	24.9	30.1	30.5	21.9	31.9	18.9	20.3	25.7	46.5	21.3	20.4	27.3	23.2	21.0	26.5	23.0	29.2	25.4	18.5	28.5	27.8	29.1	25.6	22.6	19.9	23.1	26.8	29.7	28.4	81.2	55.9	23.6	25.1	29.2	18.2	21.3	18.9	38.8	21.4	41.7	24.7	22.3	23.8	22.2	21.5	24.4	27.8	27.4	26.1	33.5	16.4	25.8	22.1	28.7	5.2	6.4	2.8	7.9	10.1	5.8	2.5	26.0	36.5	28.5	32.7	24.8	20.2	31.6	26.5	27.1	31.1	30.4	57.3	31.4	68.9	37.7	33.1	26.3	51.9	48.8	36.0	22.8	29.3	49.8	38.0	26.4	31.6	66.5	23.1	24.9	28.3	38.6	49.4	27.3	40.9	47.8	28.8	25.7	39.4	26.0	30.3	18.4	44.1	27.1	32.8	19.1	32.5	51.7	27.8	36.0	57.8	31.9	34.4	31.4	36.1	39.1	24.5	29.5	47.5	42.8	30.7	58.7	26.0	36.9	27.3	2.8	4.0	1.1	4.5	4.9	5.8	4.3	5.4	5.3	4.0	5.2	4.3	4.7	2.4	10.1	7.9	6.4	3.4	2.5	30.5	31.9	25.7	46.5	27.8	29.1	26.8	29.7	29.2	27.4
LARP1B	"DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2"	ENSG00000138709	"La ribonucleoprotein domain family member 1B"	Q659C4	4	128061268-128222931	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036280	Approved		Approved	Cytosol				Cytosol		"HPA036280: AB_10673126"	"unprognostic (1.84e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.39e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-1)"	"prognostic favourable (5.13e-5)"	"unprognostic (8.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.50e-2)"	9.3	7.1	8.1	6.5	9.8	10.1	9.8	11.7	11.4	11.2	12.6	6.2	21.4	11.7	8.9	20.3	10.3	8.1	8.2	8.7	7.8	9.0	14.8	39.9	9.1	5.1	8.5	10.3	10.1	37.9	12.3	21.4	17.2	9.4	9.3	13.5	4.8	17.0	17.2	26.2	9.7	13.9	9.6	8.4	6.4	12.1	41.9	7.1	5.3	11.3	8.8	7.4	13.2	9.2	3.1	8.5	2.3	3.9	4.6	6.2	1.5	10.6	3.7	6.8	8.8	7.2	8.2	14.1	9.1	10.2	8.9	5.6	8.5	8.4	13.2	12.8	8.9	4.2	17.0	10.3	10.5	12.4	10.7	10.4	6.4	20.7	15.8	19.9	4.2	4.3	14.9	7.1	25.9	10.1	18.3	22.0	5.0	12.4	17.3	11.5	7.8	6.2	9.5	10.6	14.8	9.9	8.3	20.6	8.1	7.9	18.6	8.3	5.4	8.8	8.1	5.6	6.2	9.1	9.1	29.1	11.0	15.2	7.2	15.7	5.9	0.3	3.9	2.3	3.4	2.8	6.2	3.1	3.8	4.3	4.4	3.0	3.1	3.3	1.0	4.6	3.0	8.5	3.0	1.5	8.1	9.8	11.7	11.4	7.8	9.0	8.5	10.3	9.4	7.1
LARP4	PP13296	ENSG00000161813	"La ribonucleoprotein domain family member 4"	Q71RC2	12	50392383-50480004	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039306, HPA039673"	Approved		Enhanced	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA039306: AB_10805362, HPA039673: AB_10795110"	"unprognostic (4.41e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.93e-3)"	"unprognostic (9.08e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.99e-3)"	15.1	22.5	12.3	13.5	14.4	9.4	15.0	12.2	13.1	12.1	13.8	8.1	17.7	13.0	12.4	11.6	15.1	10.7	10.4	14.7	11.3	10.4	28.5	47.8	13.6	11.3	15.6	9.0	11.5	17.1	18.3	23.1	17.7	14.8	13.1	11.7	13.4	17.3	14.7	31.3	10.2	14.8	15.7	17.9	10.9	13.2	11.2	13.5	14.0	15.9	11.2	11.8	14.0	21.4	11.8	15.6	8.9	14.6	10.9	12.1	8.9	14.8	21.1	14.0	10.2	13.1	11.0	23.9	18.3	10.9	18.1	14.5	41.2	17.3	34.9	22.6	11.4	14.2	30.5	12.4	23.9	21.6	12.5	28.3	19.9	14.7	12.3	31.4	16.8	9.9	11.9	21.4	23.1	15.9	40.7	16.7	16.8	13.2	25.7	10.6	20.3	18.5	19.0	22.4	20.7	9.8	22.3	16.7	9.8	32.4	16.9	18.8	14.7	12.7	22.9	12.0	17.9	13.9	17.2	16.4	43.7	31.0	16.7	12.9	10.0	8.9	11.6	7.7	11.4	13.0	10.8	11.7	10.1	6.4	15.6	11.8	12.1	9.6	6.5	10.9	14.6	13.5	9.8	8.9	12.3	14.4	12.2	13.1	11.3	10.4	15.6	9.0	14.8	13.5
LARP4B	"KIAA0217, LARP5"	ENSG00000107929	"La ribonucleoprotein domain family member 4B"	Q92615	10	806914-931705	"Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036566, HPA042738"	Approved		Enhanced	Cytosol				Cytosol		"HPA036566: AB_10673624, HPA042738: AB_2678137"	"unprognostic (3.02e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.13e-3)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (8.95e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.54e-2)"	17.5	23.1	16.5	27.7	20.7	17.9	17.3	23.8	23.8	15.0	19.7	21.2	20.9	21.7	19.1	23.6	30.9	17.0	19.4	22.0	15.8	13.0	17.6	17.0	25.4	23.0	16.0	16.7	18.2	21.0	22.3	18.6	27.1	18.3	20.0	18.4	18.9	22.1	28.1	37.1	25.1	21.7	16.0	14.4	25.2	25.3	22.9	15.9	29.5	25.8	16.8	21.8	18.3	20.0	8.3	12.2	13.5	13.6	7.7	9.8	5.2	21.4	18.3	9.4	10.6	8.7	8.9	13.8	14.6	6.8	15.8	15.5	24.6	24.4	26.3	5.7	14.3	22.9	16.9	12.1	13.9	17.7	12.2	21.6	12.5	14.4	14.2	16.1	19.5	9.6	14.2	16.0	9.3	10.8	28.7	17.1	12.8	21.3	23.0	14.3	10.2	8.5	16.7	8.3	17.7	12.7	16.5	9.4	13.3	14.1	27.4	10.8	25.7	15.3	15.1	12.1	3.3	38.6	14.4	19.6	23.4	26.0	13.6	13.1	7.7	12.9	12.6	13.5	8.7	13.6	9.0	6.7	9.5	9.8	10.8	8.3	9.2	9.8	12.0	7.7	11.1	12.2	8.6	5.2	16.5	20.7	23.8	23.8	15.8	13.0	16.0	16.7	18.3	15.9
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein domain family member 7"	Q4G0J3	4	112636964-112657592	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (4.33e-4)"	22.9	20.2	26.5	24.2	37.0	23.9	23.9	32.5	33.2	26.8	24.7	15.0	24.5	20.7	26.8	23.3	26.4	21.9	20.0	38.3	34.3	21.3	38.8	26.9	18.1	25.6	33.3	26.5	26.3	14.4	21.4	42.6	23.1	34.7	27.3	23.9	11.5	19.2	19.9	35.5	19.1	35.2	31.1	46.9	32.4	20.0	16.0	41.2	27.5	26.4	21.2	25.2	30.1	20.9	23.8	34.6	30.7	27.8	17.8	19.2	10.4	11.4	11.3	23.9	12.0	16.4	19.1	12.1	14.5	12.1	13.5	12.9	7.8	18.1	27.9	12.9	13.9	7.7	22.5	13.1	18.2	23.4	15.9	16.0	9.5	12.3	12.2	37.9	23.9	15.3	15.5	12.1	7.1	12.6	19.5	14.3	17.5	9.8	30.4	14.1	61.7	8.5	17.1	19.2	12.2	20.9	12.5	13.2	18.2	9.3	23.1	14.3	10.1	14.9	12.1	12.7	12.9	12.9	15.4	9.7	16.1	28.4	16.4	14.2	13.5	30.7	15.0	25.3	18.5	20.7	16.5	23.8	18.8	19.2	12.3	22.8	18.4	17.8	18.3	17.8	27.8	34.6	18.1	10.4	26.5	37.0	32.5	33.2	34.3	21.3	33.3	26.5	34.7	41.2
LARS	"FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase"	Q9P2J5	5	146113038-146182660	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Enhanced	"Nuclear bodies,Cytosol"			14000	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: "	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavourable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (2.98e-4)"	"unprognostic (2.96e-2)"	32.2	30.1	27.0	25.8	31.2	17.8	38.6	31.8	33.7	25.5	25.3	30.1	23.9	16.8	35.8	31.3	28.5	26.8	16.4	29.0	24.2	22.2	26.5	18.4	20.0	24.8	27.3	26.1	32.0	40.8	35.0	43.0	20.6	31.6	26.3	29.9	19.5	39.9	24.8	55.5	24.1	21.5	32.5	30.9	25.2	24.9	20.5	30.5	25.6	30.8	22.8	28.9	30.9	29.2	21.3	28.0	5.8	18.3	19.0	21.8	11.2	20.4	24.2	28.0	45.9	23.2	30.3	43.6	23.9	17.7	24.2	35.1	25.2	22.4	31.1	14.8	31.4	17.5	47.3	39.3	42.4	26.7	27.8	35.5	30.6	14.6	32.2	50.4	23.5	23.8	39.6	39.6	68.8	33.0	39.4	58.3	26.0	16.9	38.9	30.9	43.4	26.8	30.1	35.3	31.0	18.5	18.5	27.6	34.8	26.0	28.7	60.4	32.6	43.5	32.2	28.3	18.8	25.6	35.7	30.3	44.7	50.9	30.8	53.2	33.0	2.5	13.5	5.8	14.8	18.3	19.8	21.1	16.4	13.6	18.6	21.3	21.8	18.0	1.2	19.0	13.6	28.0	14.8	11.2	27.0	31.2	31.8	33.7	24.2	22.2	27.3	26.1	31.6	30.5
LAS1L	FLJ12525	ENSG00000001497	"LAS1 like, ribosome biogenesis factor"	Q9Y4W2	X	65512582-65534775	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044431, HPA061463"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"				Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA044431: AB_10965695, HPA061463: "	"unprognostic (9.71e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.53e-1)"	16.4	14.7	22.6	17.8	26.4	27.9	21.4	38.3	26.1	18.0	17.9	30.1	14.1	11.1	21.9	17.4	17.1	23.8	14.2	14.0	24.2	22.0	15.7	24.4	15.5	23.2	26.4	23.4	26.2	19.8	29.0	13.8	16.3	26.0	17.8	17.2	19.7	19.5	22.5	20.4	23.9	13.4	20.4	29.7	17.8	14.6	23.7	25.7	26.7	16.4	15.4	26.7	15.3	16.2	20.7	22.0	12.4	20.8	17.8	22.5	17.3	20.0	33.3	15.9	13.2	6.9	8.8	15.5	12.1	7.8	18.9	16.7	16.3	15.0	31.3	17.4	9.1	14.2	31.9	21.3	21.4	11.9	26.1	14.1	29.1	16.0	8.4	36.1	12.8	9.1	12.6	18.9	13.5	12.5	33.0	32.7	11.2	23.8	27.4	27.6	23.5	30.8	23.6	22.1	34.7	13.0	9.1	12.6	14.5	19.3	14.2	8.8	10.6	19.2	9.0	11.7	23.2	35.7	18.2	11.9	14.0	34.4	11.4	38.2	6.2	12.4	15.7	7.8	18.8	20.8	20.8	20.2	17.6	22.3	22.0	20.7	22.5	18.5	1.7	17.8	15.0	16.4	17.6	17.3	22.6	26.4	38.3	26.1	24.2	22.0	26.4	23.4	26.0	25.7
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 124.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"			26000000	"Plasma membrane, Cytosol"	"Focal adhesion sites"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"	51.2	20.0	23.8	40.3	22.4	45.4	35.5	15.5	25.7	23.6	57.4	16.3	18.7	54.4	23.4	24.1	22.4	20.8	48.3	15.2	18.4	23.3	33.1	47.5	33.3	44.2	20.0	14.3	28.4	30.1	10.1	17.6	40.0	16.1	18.9	38.6	24.2	22.4	24.1	10.7	18.3	124.5	21.3	12.2	43.1	39.5	13.9	12.9	40.5	18.3	18.7	33.7	22.0	28.3	6.4	13.9	34.0	19.9	17.3	16.5	13.1	34.8	72.7	21.3	18.8	31.3	34.0	36.7	43.9	42.9	46.3	34.0	21.7	38.0	15.9	36.7	67.8	55.6	9.6	33.4	40.5	11.6	5.2	7.6	21.0	37.7	29.7	17.5	23.1	30.1	11.7	39.2	11.1	31.0	12.9	5.3	64.3	11.5	20.8	27.0	10.6	18.2	11.8	11.3	20.1	56.8	30.7	3.2	7.8	26.1	27.4	22.7	43.3	21.4	54.1	27.8	40.5	32.4	26.6	13.7	18.1	12.3	29.3	15.8	33.4	9.9	14.8	16.8	16.5	17.1	11.3	6.4	8.4	11.0	13.9	6.3	7.2	10.9	34.0	17.3	19.9	10.7	10.7	13.1	23.8	22.4	15.5	25.7	18.4	23.3	20.0	14.3	16.1	12.9
LATS2		ENSG00000150457	"Large tumor suppressor kinase 2"	Q9NRM7	13	20973032-21061547	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA039191: , HPA049037: "	"unprognostic (2.77e-1)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-1)"	"unprognostic (6.57e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-2)"	22.9	13.0	3.0	8.6	5.7	12.8	33.0	7.9	3.7	16.6	14.0	6.8	9.3	2.9	21.2	12.7	15.1	11.0	20.6	14.1	5.4	2.6	12.4	11.0	19.8	10.9	5.2	2.4	17.4	10.2	5.0	3.5	18.3	6.3	13.7	4.5	16.7	8.0	11.1	23.0	9.3	7.4	34.6	7.5	15.2	10.4	27.8	5.2	1.4	17.2	13.8	7.0	20.3	28.0	0.1	1.5	3.3	1.9	1.3	3.1	0.5	3.3	3.7	8.3	5.0	9.8	12.9	7.6	11.2	11.7	11.8	10.1	10.6	5.1	0.0	5.5	17.1	4.9	4.9	5.1	17.5	1.9	1.2	6.2	4.7	7.9	15.3	1.6	2.2	19.1	9.4	7.7	5.2	16.4	1.1	0.2	14.8	5.8	0.1	5.8	2.0	1.8	1.4	14.8	0.0	8.4	1.6	0.1	0.0	8.8	5.8	11.6	5.0	3.2	20.6	12.5	8.4	9.1	7.1	1.5	0.8	0.0	3.0	1.9	9.5	0.4	1.9	1.8	1.6	1.5	3.1	0.1	0.2	0.5	1.5	0.0	0.1	0.3	3.3	1.3	0.6	0.1	0.0	0.5	3.0	5.7	7.9	3.7	5.4	2.6	5.2	2.4	6.3	5.2
LAX1	"FLJ20340, LAX"	ENSG00000122188	"Lymphocyte transmembrane adaptor 1"	Q8IWV1	1	203765176-203776233	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 11.4;U-266/70: 14.1;U-266/84: 31.7;U-698: 12.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0"	"Group enriched"	"Detected in many"	19	"B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9"					"Low region specificity"	"Detected in all"			"HPA002461, HPA003887, CAB025358"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240"	"unprognostic (2.85e-3)"	"unprognostic (3.83e-3)"	"unprognostic (3.90e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.23e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	1.6	0.6	0.4	19.9	0.4	1.3	1.3	0.4	0.4	1.8	3.4	0.0	0.2	2.1	1.2	1.1	4.5	1.1	3.8	0.6	0.4	0.4	1.0	0.8	6.3	17.4	0.4	0.0	0.7	0.6	0.0	0.5	0.1	0.0	2.2	2.6	1.1	5.7	1.5	0.5	1.0	5.5	1.1	0.5	11.7	3.4	1.0	0.0	22.7	1.1	0.7	26.7	6.3	2.8	6.5	0.0	0.3	0.0	4.6	9.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	11.4	0.0	0.0	3.7	0.0	0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	31.7	12.1	0.0	0.9	0.0	0.0	0.0	0.3	9.9	0.0	7.4	6.5	5.7	7.3	0.0	1.5	4.5	5.9	0.0	4.6	0.0	0.0	6.0	2.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0
LAYN	"FLJ30977, FLJ31092"	ENSG00000204381	Layilin	Q6UX15	11	111540280-111561745	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 39.4;BJ hTERT+: 43.0;BJ hTERT+ SV40 Large T+ RasG12V: 27.4;fHDF/TERT166: 25.5;HSkMC: 25.3;U-138 MG: 29.6;U-2 OS: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"myeloid DC: 10.3;T-reg: 11.8"	"Group enriched"	"Detected in many"	111	"dendritic cells: 10.3;T-cells: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040087	Approved		Approved	Cytosol				Cytosol		"HPA040087: AB_10793927"	"unprognostic (2.27e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-2)"	7.7	2.3	9.3	5.9	12.8	1.3	8.0	1.7	12.5	11.3	21.2	28.9	3.0	4.0	15.1	10.5	5.3	12.8	17.0	5.6	12.6	7.5	4.1	1.4	9.6	12.4	20.6	5.9	39.5	2.3	1.6	5.4	13.1	12.3	13.2	3.8	10.9	4.4	17.9	4.8	2.1	8.2	21.7	10.1	7.5	12.1	4.6	13.1	4.6	26.9	4.8	5.0	11.3	10.1	0.0	10.3	0.0	0.0	0.0	11.8	0.4	0.1	1.0	0.2	0.0	7.0	13.6	1.9	39.4	43.0	20.0	27.4	0.0	0.0	0.0	0.3	25.5	0.8	2.5	0.2	20.7	0.0	0.1	0.2	0.0	0.0	12.0	0.0	0.0	25.3	0.0	8.2	0.0	0.2	0.0	0.0	8.1	0.0	0.0	0.0	1.2	0.0	0.0	3.0	0.0	0.1	0.0	1.3	4.8	0.1	0.0	0.1	0.0	0.1	0.1	29.6	21.8	0.2	19.2	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	10.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	11.8	0.4	9.3	12.8	1.7	12.5	12.6	7.5	20.6	5.9	12.3	13.1
LCA5L	"C21orf13, MGC33295"	ENSG00000157578	"LCA5L, lebercilin like"	O95447	21	39405844-39445805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 57.2"	"Cell line enhanced"	"Detected in many"		"MCF7: 6.7;T-47d: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019790, HPA032010"	Enhanced		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA019790: AB_1845690, HPA032010: "	"unprognostic (1.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.53e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.95e-1)"	0.4	1.3	1.4	0.3	3.7	0.3	1.2	1.1	1.6	1.2	0.6	2.3	2.7	0.4	0.9	4.6	0.4	4.4	1.0	0.5	1.9	1.2	1.6	1.3	1.0	0.3	0.7	1.2	0.8	1.1	1.7	9.1	0.3	3.1	0.7	0.4	2.2	0.8	1.8	1.7	0.7	0.4	0.5	0.7	0.4	0.6	57.2	1.1	0.3	2.9	0.4	0.3	0.5	0.5	0.3	0.7	0.2	0.5	0.0	1.1	0.0	1.7	1.8	1.0	3.1	1.5	1.3	0.2	0.4	0.8	0.9	0.1	1.0	1.9	1.2	1.5	1.6	0.4	0.1	1.0	0.6	0.6	1.5	0.9	1.8	0.2	1.3	2.0	0.0	1.2	4.2	3.0	3.3	0.6	3.1	1.2	1.1	6.7	0.6	0.7	6.0	1.8	0.4	0.3	1.2	3.2	0.6	2.1	0.9	3.8	1.6	2.4	7.2	0.3	0.1	0.5	0.4	1.8	0.5	3.6	1.9	0.4	2.7	0.7	1.2	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.5	0.6	0.2	0.3	0.0	1.1	0.2	0.0	0.5	0.7	0.0	0.0	1.4	3.7	1.1	1.6	1.9	1.2	0.7	1.2	3.1	1.1
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: "	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavourable (9.67e-4)"	"prognostic unfavourable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	7.7	9.7	7.0	13.7	8.7	12.3	7.1	10.2	10.1	11.6	10.7	5.2	12.6	15.7	18.7	15.0	13.0	9.9	12.6	21.7	7.5	9.2	15.2	13.8	10.0	12.5	6.1	6.0	15.4	16.7	10.8	21.8	5.7	7.0	10.7	10.6	9.7	9.5	16.3	10.9	9.4	25.0	11.3	5.5	8.0	8.4	12.1	4.2	20.7	17.9	11.9	11.7	9.1	10.4	9.6	2.8	10.5	3.9	4.1	12.6	2.8	10.9	14.6	7.9	13.3	1.8	4.2	11.2	8.0	7.9	8.5	7.2	14.6	13.0	7.1	7.4	12.3	12.5	26.0	10.7	8.4	8.9	8.9	13.0	9.1	14.1	8.4	18.4	10.0	3.2	8.5	9.0	12.5	5.9	11.9	6.8	6.5	8.5	10.5	10.9	8.6	8.4	10.3	15.8	14.5	6.7	16.2	9.2	14.2	17.8	11.9	10.3	8.6	6.3	6.7	15.5	12.8	8.2	12.5	4.9	10.2	16.0	15.8	13.5	11.8	10.5	2.5	4.8	5.6	3.9	6.6	7.5	8.7	7.1	2.8	9.6	12.6	12.1	7.4	4.1	3.5	2.2	4.0	2.8	7.0	8.7	10.2	10.1	7.5	9.2	6.1	6.0	7.0	4.2
LCMT1	"CGI-68, PPMT1"	ENSG00000205629	"Leucine carboxyl methyltransferase 1"	Q9UIC8	16	25111729-25178231	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041559, HPA043530"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041559: , HPA043530: "	"unprognostic (9.08e-2)"	"prognostic favourable (2.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (1.41e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (7.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-3)"	"unprognostic (6.71e-2)"	9.8	18.0	27.9	11.6	30.6	13.9	18.1	27.5	36.4	15.4	17.1	15.5	17.5	13.1	16.2	26.7	13.4	16.8	14.1	25.3	22.8	27.5	17.8	7.5	10.8	11.9	21.7	26.7	23.8	31.4	25.3	20.5	18.9	24.8	15.7	17.2	15.0	14.4	18.3	31.6	16.5	12.7	15.1	18.9	10.1	12.6	29.8	14.4	16.9	15.5	14.3	15.3	11.7	12.1	19.7	17.6	21.6	18.9	15.8	38.9	19.5	16.8	15.9	14.9	20.5	13.4	19.6	15.3	10.6	17.5	15.5	20.4	20.1	15.5	10.3	15.2	16.0	8.7	15.4	14.5	21.0	10.5	23.4	5.5	16.2	32.5	30.5	13.3	9.2	22.1	16.1	17.6	18.4	14.1	8.8	13.6	17.0	43.1	15.8	25.5	22.7	16.5	18.8	13.6	20.0	17.5	11.9	24.3	15.1	12.6	19.6	24.1	19.9	6.1	8.3	15.4	10.8	10.0	10.4	17.7	17.9	10.9	18.9	11.6	11.3	12.7	18.9	21.6	20.6	16.7	22.6	19.7	25.6	22.3	17.6	14.3	23.1	21.1	7.4	15.8	17.5	9.1	38.9	19.5	27.9	30.6	27.5	36.4	22.8	27.5	21.7	26.7	24.8	14.4
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 188.6;lymphoid tissue: 118.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 82.6;HDLM-2: 75.5;HL-60: 80.2;HMC-1: 85.1;THP-1: 74.8;U-698: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"			2200000000	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	57.1	10.0	5.6	44.3	9.4	71.2	8.7	3.9	4.6	3.6	6.2	4.5	5.0	4.5	5.3	43.1	6.2	8.3	8.9	5.5	4.3	3.8	7.2	12.2	33.7	59.1	12.0	1.0	5.7	3.9	0.1	2.8	24.7	7.7	21.5	8.1	5.5	9.5	2.5	3.5	6.8	21.7	6.5	11.9	112.9	6.1	8.2	9.2	118.2	4.5	4.1	68.7	14.0	7.1	25.4	79.3	133.5	127.6	43.2	67.2	188.6	3.3	0.0	0.1	0.0	0.0	0.0	40.1	0.0	0.1	0.3	0.2	22.1	0.1	82.6	17.6	0.0	0.1	0.0	0.0	0.3	75.5	19.6	17.8	0.0	0.0	0.0	80.2	85.1	0.2	0.0	0.1	0.1	0.0	9.3	55.0	0.0	0.1	56.8	55.5	0.0	0.8	42.3	0.1	59.0	0.0	22.8	0.1	0.7	0.1	8.8	0.6	0.4	74.8	0.2	2.1	1.3	0.1	2.4	13.1	27.3	106.3	1.6	48.9	0.3	57.1	96.6	54.3	67.2	127.6	60.8	25.4	40.4	55.5	79.3	18.3	25.2	42.3	133.5	43.2	118.1	20.8	40.5	188.6	5.6	9.4	3.9	4.6	4.3	3.8	12.0	1.0	7.7	9.2
LDAH	"C2orf43, FLJ21820"	ENSG00000118961	"Lipid droplet associated hydrolase"	Q9H6V9	2	20684014-20823130	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034729, HPA034730"	Approved		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA034729: AB_10603684, HPA034730: "	"unprognostic (1.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.34e-2)"	"prognostic unfavourable (6.09e-6)"	"unprognostic (3.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.44e-1)"	"prognostic favourable (1.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.97e-2)"	10.4	23.6	8.7	13.3	18.7	4.9	10.6	3.1	11.7	10.5	12.5	8.2	8.8	9.9	12.7	13.2	10.4	7.6	8.4	6.9	7.7	8.6	20.3	14.8	8.1	12.3	7.9	8.3	10.8	10.0	15.1	22.4	15.4	9.6	9.6	14.5	10.4	10.8	9.9	2.0	8.8	9.9	11.4	9.7	17.2	10.3	10.0	8.5	22.9	9.4	4.6	15.4	13.6	10.0	9.8	6.5	1.1	5.8	6.0	8.5	4.2	10.0	10.6	23.8	0.0	10.2	14.2	14.9	8.7	6.2	8.1	6.0	10.0	6.4	13.1	0.0	6.7	8.5	18.5	7.4	8.6	15.1	8.7	18.5	8.5	16.8	9.9	14.1	4.8	11.7	11.3	7.2	1.9	15.5	25.2	9.6	14.2	6.5	20.6	10.8	14.9	0.0	16.3	19.1	14.8	16.6	14.4	13.2	20.7	5.9	10.8	10.0	8.4	10.5	13.3	7.1	3.6	8.6	5.6	11.8	20.9	5.8	13.1	14.6	12.5	1.1	3.5	0.3	8.5	5.8	5.2	9.8	8.3	6.9	6.5	6.6	7.5	7.3	0.3	6.0	4.5	6.3	6.4	4.2	8.7	18.7	3.1	11.7	7.7	8.6	7.9	8.3	9.6	8.5
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668449-86736068	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 6.0;SCLC-21H: 9.7;SK-MEL-30: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"			450000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: "	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0.0	4.9	0.4	4.2	9.9	9.9	1.3	1.0	213.9	1.7	1.0	0.3	0.2	0.4	0.2	2.6	0.0	1.5	0.3	0.3	0.1	0.5	0.0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0.0	0.0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0.0	0.3	0.3	0.4	3.2	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.3	0.6	0.0	0.4	0.2	0.0	0.1	0.9	0.8	0.7	0.9	0.1	0.1	0.1	1.7	6.0	0.5	0.1	0.0	0.0	0.3	1.9	0.3	1.6	0.4	0.2	0.4	0.3	0.0	2.0	0.1	0.0	1.1	9.7	1.8	0.3	0.2	4.7	0.3	0.2	0.0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.8	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0.0	0.9	1.6	0.1	0.6	1.7	1.0	2.6	0.0	0.0	0.0
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol			300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavourable (3.26e-8)"	"prognostic unfavourable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	66.1	48.6	48.0	131.1	34.9	70.0	53.9	19.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol			780000000	Cytosol		"CAB004641: AB_425525, HPA019007: "	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.7	88.0	77.4	50.9	55.5	61.8	90.0	45.8	45.8	64.1	63.5	139.3	0.1	116.1	30.1	30.8	16.5	106.4	84.9	81.7	29.7	74.1	119.5	84.1	0.1	53.1	111.5	51.7	70.6	30.4	56.1	76.4	73.1	65.3	17.5	70.5	0.1	94.7	135.0	223.2	38.2	85.6	108.0	93.6	318.2	146.3	24.9	57.7	21.0	32.6	79.0	0.2	87.5	28.4	43.2	56.7	30.7	86.3	15.5	20.9	152.5	47.9	53.4	51.2	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116771	"Enzymes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3;skeletal muscle: 39.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;HMC-1: 11.8;T-47d: 22.9;U-266/70: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 8.9;classical monocyte: 2.7;intermediate monocyte: 4.6;non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 8.9;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol				Cytosol		"HPA041766: , HPA048639: , HPA066148: "	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favourable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	15.3	5.5	6.8	1.6	6.7	0.8	3.7	4.9	11.7	4.1	12.5	7.6	4.5	6.1	1.5	3.0	3.8	2.1	3.6	25.3	6.6	5.8	21.5	44.3	2.8	0.9	8.1	9.7	7.9	7.7	8.5	4.4	2.1	9.9	4.4	6.8	5.1	14.2	4.5	39.7	1.8	2.5	1.2	4.5	0.7	11.2	1.0	4.0	0.0	4.3	14.4	2.7	1.1	1.2	0.0	0.2	8.9	5.7	0.1	0.1	0.9	0.5	1.6	0.0	0.3	1.3	1.1	5.0	0.1	0.1	0.1	0.2	2.1	2.1	0.0	1.7	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.5	2.1	0.0	11.8	1.6	0.2	0.0	0.0	0.1	0.6	1.9	0.0	3.9	0.0	0.6	1.1	1.0	0.0	0.0	5.9	1.1	0.1	0.0	0.0	0.0	4.0	0.2	22.9	2.5	0.0	0.0	0.2	0.0	0.0	9.1	0.5	0.0	1.5	0.0	0.0	8.9	2.7	0.8	0.0	4.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.9	6.8	6.7	4.9	11.7	6.6	5.8	8.1	9.7	9.9	4.0
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.26e-4)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.2	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.8;testis: 28.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 16.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 16.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 50.6"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	2.3	1.3	3.3	1.7	7.9	6.8	1.5	9.9	6.6	2.6	1.3	2.9	0.5	1.5	2.1	2.1	2.1	2.1	2.0	1.4	4.3	4.1	3.5	1.4	3.2	1.7	3.1	4.2	2.6	1.4	3.6	5.5	6.7	3.3	1.9	1.5	3.0	1.4	1.4	0.8	1.8	1.1	1.2	3.2	2.3	4.1	28.6	1.6	3.8	1.6	1.0	2.2	3.1	1.7	1.4	1.3	16.8	3.8	1.2	4.0	1.2	13.6	2.5	1.9	1.7	1.5	4.2	1.4	4.6	5.5	6.6	4.0	1.0	5.4	1.7	10.8	1.0	1.5	3.8	16.5	6.9	0.8	1.5	2.0	1.9	2.4	1.8	0.3	1.9	1.2	4.6	7.0	15.0	6.9	1.7	2.7	5.8	2.8	4.9	1.2	0.4	11.6	1.7	3.1	1.0	10.8	0.6	1.6	1.5	1.5	0.3	0.5	1.6	0.8	11.8	2.0	14.6	3.7	1.1	1.7	1.0	1.3	3.2	2.1	1.5	0.9	3.4	0.5	0.9	1.3	1.5	1.4	0.8	1.3	1.3	1.4	1.6	1.5	16.8	1.2	3.8	0.6	4.0	1.2	3.3	7.9	9.9	6.6	4.3	4.1	3.1	4.2	3.3	1.6
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675608-37679806	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"		19000000	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favourable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavourable (5.10e-4)"	167.5	49.3	23.0	56.0	22.9	29.8	213.7	7.6	30.9	158.6	94.5	20.1	44.2	22.0	150.9	80.3	74.0	66.8	78.8	108.6	18.9	29.3	24.0	20.8	55.8	45.4	41.4	28.9	105.1	18.2	5.1	17.5	80.1	53.6	85.9	23.4	35.7	34.9	89.6	117.1	29.2	29.2	145.8	88.3	40.3	40.0	42.4	20.5	16.7	19.6	59.1	20.4	99.8	81.7	29.0	185.2	44.0	149.1	19.6	73.1	180.2	93.4	55.1	1.2	49.0	114.7	225.4	1.1	217.4	255.3	161.1	160.6	6.1	12.4	0.1	22.4	219.6	10.0	1.9	143.0	56.3	96.0	1.0	8.2	57.9	25.3	74.9	4.7	109.7	139.5	9.7	128.5	55.0	176.9	5.9	39.6	124.6	41.7	0.1	66.6	0.4	131.0	0.1	82.1	25.7	66.3	0.2	0.1	29.0	43.4	7.6	54.3	40.4	56.3	239.1	215.3	107.7	95.5	111.0	24.3	16.2	0.3	252.9	24.9	85.7	44.0	149.1	5.3	40.8	114.2	6.1	29.0	38.0	39.8	185.2	10.8	6.6	26.8	6.3	19.6	120.0	45.7	73.1	180.2	23.0	22.9	7.6	30.9	18.9	29.3	41.4	28.9	53.6	20.5
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145413	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.8;CAPAN-2: 74.5;SK-MEL-30: 175.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA003162, CAB005191"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		2300000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937"	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	95.7	11.0	10.4	50.9	13.6	29.8	53.2	6.5	11.7	54.1	127.1	6.1	42.4	75.7	50.3	30.7	76.1	26.1	83.9	42.3	8.4	5.7	19.9	3.9	65.5	16.6	8.5	9.4	58.9	24.2	0.5	11.0	78.7	5.5	51.7	93.7	25.7	78.3	51.7	31.3	76.1	182.4	48.2	8.7	11.1	36.9	20.4	5.7	5.5	18.0	65.7	41.7	41.1	44.4	1.3	41.7	3.6	67.4	2.5	25.9	37.2	22.4	7.2	0.2	0.1	46.8	93.8	27.4	18.0	37.9	5.0	8.9	15.5	74.5	0.0	9.5	20.9	22.5	0.4	18.8	2.8	26.6	0.3	0.0	8.0	7.1	35.5	0.0	0.0	29.3	28.7	5.7	12.1	7.8	0.1	21.7	11.3	15.1	0.0	5.4	0.4	20.2	0.0	0.9	1.6	46.8	30.0	0.6	1.7	42.1	0.0	175.1	18.5	2.4	14.2	23.7	3.3	8.8	0.3	12.1	38.3	0.1	34.1	1.4	2.5	1.7	67.4	3.4	1.8	55.4	11.4	1.3	6.8	5.1	41.7	0.4	0.3	1.0	3.6	2.5	44.2	1.1	25.9	37.2	10.4	13.6	6.5	11.7	8.4	5.7	8.5	9.4	5.5	5.7
LGALS9	LGALS9A	ENSG00000168961	"Galectin 9"	O00182	17	27629798-27649560	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 11.1;HMC-1: 29.1;MOLT-4: 14.4;REH: 10.2;THP-1: 26.0;U-937: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA046876, HPA047218"	Approved		Approved	Cytosol	"Secreted to blood"	448287		Cytosol		"HPA046876: , HPA047218: "	"unprognostic (2.62e-2)"	"prognostic favourable (2.35e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (1.52e-5)"	"unprognostic (4.76e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	25.7	3.9	6.4	15.6	11.2	22.2	6.1	2.0	5.3	5.7	26.9	12.6	0.2	8.6	4.3	6.1	6.0	8.5	13.9	4.6	5.6	3.4	5.0	9.0	14.7	29.6	9.7	2.7	5.9	6.0	0.5	2.9	8.5	8.7	4.2	26.0	10.9	5.7	2.1	2.5	3.7	15.0	5.1	13.2	48.9	20.2	2.2	7.9	22.1	3.8	2.0	17.1	14.8	3.6	6.6	28.7	12.0	35.2	4.2	7.0	10.9	0.4	0.3	0.2	0.1	0.0	0.1	0.5	0.2	0.4	3.3	11.1	0.0	2.2	0.4	2.5	0.5	1.1	0.1	0.0	0.2	3.4	0.4	3.6	0.4	0.0	0.1	7.3	29.1	0.1	0.0	0.2	0.0	3.9	0.2	0.2	0.0	0.0	14.4	3.5	0.1	0.0	10.2	0.0	0.2	1.6	0.3	0.1	0.3	0.0	1.0	0.0	0.1	26.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	22.3	0.1	5.6	16.4	12.0	1.0	35.2	0.6	4.5	2.6	1.3	28.7	6.6	1.5	0.7	7.2	4.2	31.2	4.5	7.0	10.9	6.4	11.2	2.0	5.3	5.6	3.4	9.7	2.7	8.7	7.9
LGALS9B		ENSG00000170298	"Galectin 9B"	Q3B8N2	17	20449395-20467539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 13.4;esophagus: 13.6;stomach 1: 23.2"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 13.3;U-937: 4.4"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	15	"NK-cell: 13.4"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 13.4"									"HPA046876, HPA047218"	Approved		Uncertain	Cytosol				Cytosol		"HPA046876: , HPA047218: "	"unprognostic (4.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.05e-1)"	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	1.2	5.7			2.3	0.0	0.0	13.6	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0		0.0	0.0	0.0	0.0	0.0		0.4	8.4		1.8	0.0	0.0	0.3	2.6	0.0	0.0	0.4	23.2	0.0			0.0		1.0	0.0	3.4	0.3	0.4	0.2	0.3	13.4	0.9	1.7	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.2	0.2	0.0	0.4	0.3	0.2	0.4	0.2	13.4	0.3	0.2	0.0	1.7										
LGALS9C		ENSG00000171916	"Galectin 9C"	Q6DKI2	17	18476737-18494945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 8.9;esophagus: 15.8;intestine: 8.3;lymphoid tissue: 8.5;stomach 1: 15.4"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;CAPAN-2: 2.9;Daudi: 1.0;Karpas-707: 2.8;RPMI-8226: 1.5;U-937: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 3.2;NK-cell: 8.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 8.9"									"HPA046876, HPA047218"	Approved		Approved	Cytosol				Cytosol		"HPA046876: , HPA047218: "	"unprognostic (4.47e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.17e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.84e-2)"	0.1	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	2.1	8.3	0.2	0.0	1.6	0.0	0.0	15.8	0.0	4.7	1.0	0.0	0.0	0.0	0.8	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.9	0.0	1.6	1.0	0.0	0.2	5.1	0.1	0.0	1.5	15.4	0.0	0.0	0.4	0.0	3.0	7.5	0.0	2.1	0.0	0.4	3.2	1.2	8.9	0.6	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.9	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.5	0.5	0.6	1.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.2	3.2	8.9	1.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146825-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;SCLC-21H: 4.5;SK-MEL-30: 4.5;U-2 OS: 2.5;WM-115: 2.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"			Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	1.2	4.8	13.1	1.1	26.4	1.1	1.2	7.7	52.2	2.6	1.2	35.5	0.0	1.4	1.5	1.3	6.1	2.0	1.1	1.5	20.7	15.7	1.1	1.0	17.7	1.0	24.2	10.4	1.1	1.5	0.9	0.7	1.0	24.9	2.3	1.1	4.6	1.2	4.2	1.0	16.3	1.4	1.7	29.8	1.1	1.3	1.4	14.8	0.0	14.9	0.0	1.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.0	1.0	0.8	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	4.5	0.6	0.0	0.0	4.5	0.5	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	1.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	26.4	7.7	32.1	20.7	15.7	24.2	10.4	24.9	14.8
LHB	"CGB4, hLHB, LSH-B"	ENSG00000104826	"Luteinizing hormone beta polypeptide"	P01229	19	49015980-49017081	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pituitary gland: 301.4"	"Cell line enhanced"	"Detected in many"		"A549: 6.5;U-266/84: 7.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.8;T-reg: 1.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.8"									"CAB022241, CAB022707, HPA038925"	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol		"CAB022241: , CAB022707: , HPA038925: "	"unprognostic (8.12e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.69e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (9.52e-2)"	"unprognostic (4.86e-2)"	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	23.1	0.0	301.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.5	0.1	0.1	0.1	0.5	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.1	1.3	6.5	0.2	1.3	0.0	0.0	1.8	0.5	0.0	1.0	0.5	5.3	1.9	1.7	0.1	0.0	0.5	0.0	0.4	0.0	1.7	5.1	0.3	1.7	2.5	0.3	0.4	1.7	0.0	0.0	0.3	0.0	0.3	4.7	2.8	0.3	0.3	0.1	0.6	0.7	0.5	2.8	1.1	1.3	0.0	1.3	3.0	1.2	1.9	0.4	2.2	2.0	0.0	0.0	2.6	2.7	0.3	3.3	2.4	7.0	1.8	1.3	3.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461834-124617888	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 106.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"			880000	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	9.6	14.2	37.3	6.0	34.0	6.9	7.9	11.9	34.2	12.3	13.6	29.7	8.2	17.9	7.5	11.0	12.7	8.1	8.3	9.8	43.0	31.5	18.6	33.8	6.6	8.2	62.7	19.3	5.5	12.2	6.6	5.6	7.2	20.5	6.9	6.7	6.7	13.3	10.6	6.5	8.9	15.7	8.1	106.0	8.2	12.4	14.2	19.5	7.1	20.5	3.6	11.2	8.7	5.7	24.7	20.0	13.3	16.1	3.9	17.2	12.9	14.7	7.3	3.0	7.5	11.6	9.5	7.9	5.4	11.1	3.4	6.3	1.3	13.7	14.6	12.6	8.1	16.0	0.9	2.8	3.6	3.2	10.5	10.6	2.3	6.7	11.8	2.1	17.3	7.0	12.5	3.4	8.2	5.4	5.2	5.8	4.2	14.6	7.0	6.8	5.3	4.1	7.5	3.3	18.6	7.4	1.9	1.6	9.0	3.8	13.9	4.9	10.5	0.3	2.5	5.3	7.9	4.4	1.4	4.9	1.5	4.7	4.9	4.1	1.2	4.6	16.1	13.3	9.5	13.5	12.4	23.7	11.1	10.1	20.0	24.7	13.7	9.6	2.7	3.9	14.9	7.5	17.2	12.9	37.3	34.0	11.9	25.0	43.0	31.5	62.7	19.3	20.5	19.5
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 23.3;U-266/70: 7.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 9.5;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 9.9"	"Group enriched"	"Detected in some"	32	"basal ganglia: 15.3;hypothalamus: 4.4"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: "	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	2.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.0	3.9	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.3	0.0	0.5	4.9	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.2	0.0	0.0	7.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.5	0.0	1.1	0.0	0.6	0.0	3.3
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39458587-39485109	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Cytosol"	"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favourable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	9.8	12.9	9.9	7.0	12.7	10.2	11.3	10.2	13.3	7.0	10.7	12.9	8.1	10.4	9.1	10.7	11.6	11.9	7.4	14.0	10.6	10.6	15.7	15.5	5.7	9.0	12.3	10.5	19.2	12.4	10.0	11.5	6.8	15.7	8.2	12.4	9.0	7.8	7.0	42.7	8.8	9.9	13.6	12.4	8.9	9.9	20.1	13.2	8.7	8.8	13.5	8.3	10.0	7.9	9.6	5.8	3.7	7.1	6.9	16.7	4.3	3.9	3.0	4.0	3.7	8.3	8.1	3.4	4.6	2.5	4.3	2.9	5.0	5.5	14.4	5.3	1.7	3.5	11.1	6.3	5.7	1.6	2.8	6.0	1.6	5.0	7.6	13.1	3.9	7.8	10.4	5.0	16.0	4.9	14.3	3.6	5.2	2.5	7.3	16.8	5.2	10.0	6.4	10.7	8.7	5.1	2.1	4.3	3.7	2.6	3.5	14.8	3.9	6.0	1.8	3.4	7.6	4.5	10.6	7.0	10.6	10.1	5.3	15.3	2.9	2.0	6.2	3.7	6.1	7.1	12.6	9.6	8.3	8.0	5.8	8.5	16.7	11.5	3.3	6.9	5.1	5.4	5.2	4.3	9.9	12.7	10.2	13.3	10.6	10.6	12.3	10.5	15.7	13.2
LIF	"CDF, DIA, HILDA"	ENSG00000128342	"LIF, interleukin 6 family cytokine"	P15018	22	30240447-30246851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 35.5;U-138 MG: 39.6;U-251 MG: 28.6;U-87 MG: 31.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.7"	"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA018844, CAB025985"	Uncertain		Supported	Cytosol	"Secreted in other tissues"			Cytosol		"CAB025985: , HPA018844: AB_1852814"	"unprognostic (1.28e-2)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (6.78e-8)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.71e-3)"	20.3	1.7	1.4	21.6	3.3	0.6	5.2	0.9	4.3	4.4	3.9	1.8	1.6	3.7	6.9	2.6	2.0	7.3	28.7	14.2	1.2	0.6	5.7	3.4	17.4	3.8	2.2	0.5	7.9	7.5	0.2	7.3	1.3	11.7	8.6	4.7	3.5	3.2	1.2	1.9	6.0	5.2	4.6	4.3	1.6	4.1	2.0	1.8	0.9	3.4	2.2	5.4	20.8	1.7	0.0	0.0	0.0	0.0	1.2	0.2	0.1	8.7	14.7	0.4	3.3	0.0	1.2	5.4	1.2	5.3	1.6	3.8	2.3	14.3	0.0	3.2	0.0	2.2	0.3	4.0	2.1	2.0	0.6	1.1	5.0	3.2	1.4	0.0	11.5	1.4	0.7	35.5	1.0	0.0	0.2	0.0	6.9	6.5	0.1	0.0	0.5	9.1	0.2	5.0	0.0	12.7	3.4	0.0	0.1	1.4	0.1	2.6	0.3	0.1	0.1	39.6	14.6	14.9	28.6	0.0	0.0	0.0	31.3	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.4	3.3	0.9	4.3	1.2	0.6	2.2	0.5	11.7	1.8
LIMA1	EPLIN	ENSG00000050405	"LIM domain and actin binding 1"	Q9UHB6	12	50175788-50283546	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 83.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023871, HPA052645"	Enhanced		Enhanced	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"			160000	"Plasma membrane, Actin filaments"	"Focal adhesion sites, Cytosol"	"HPA023871: AB_1852875, HPA052645: AB_2681898"	"unprognostic (6.22e-2)"	"unprognostic (9.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavourable (1.76e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.28e-3)"	"unprognostic (6.27e-2)"	"prognostic favourable (2.79e-4)"	"unprognostic (7.12e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-1)"	50.3	19.8	6.6	22.3	6.8	0.9	34.1	73.6	6.6	30.9	49.2	10.4	21.3	35.2	31.1	22.1	25.0	18.0	31.1	12.6	6.6	5.1	29.3	11.1	23.3	11.8	7.2	4.1	21.1	12.4	12.4	18.6	42.0	15.4	28.2	42.8	20.7	27.0	22.1	10.5	16.3	90.5	33.8	10.4	23.6	30.3	11.8	6.0	12.1	17.0	20.7	18.0	41.8	21.4	0.6	4.4	1.3	2.1	5.8	13.6	2.7	24.0	0.7	7.7	11.3	35.4	35.6	29.1	60.5	42.6	48.7	39.0	9.1	35.4	1.0	5.6	83.2	27.4	6.9	55.8	42.7	15.3	7.3	10.0	2.7	3.2	22.7	3.6	14.3	23.8	16.5	17.1	49.3	17.1	7.0	4.9	15.6	4.1	4.4	1.1	3.9	3.3	4.4	18.8	0.3	11.3	28.7	5.7	12.4	8.2	16.7	25.9	7.9	2.2	26.6	20.9	16.1	19.3	9.8	2.7	0.3	4.4	22.7	4.0	8.9	0.1	0.2	1.3	6.4	1.0	2.5	0.1	8.1	7.8	4.4	0.6	3.3	5.9	0.1	5.8	2.1	1.1	13.6	2.7	6.6	6.8	73.6	5.6	6.6	5.1	7.2	4.1	15.4	6.0
LIMD2	MGC10986	ENSG00000136490	"LIM domain containing 2"	Q9BT23	17	63695902-63701172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 175.1;lymphoid tissue: 98.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 53.5;NB-4: 37.3;SH-SY5Y: 37.3;U-698: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062432, HPA075172"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA062432: , HPA075172: "	"unprognostic (2.90e-3)"	"unprognostic (2.89e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (5.36e-11)"	"unprognostic (1.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.08e-2)"	3.6	2.0	6.5	54.8	14.8	28.7	2.3	1.2	8.5	2.7	2.9	3.0	1.3	3.9	2.6	3.2	3.0	2.6	5.1	2.7	9.6	3.3	3.7	5.1	8.1	63.5	3.6	3.7	2.8	1.7	0.8	3.5	6.4	2.8	4.1	2.8	5.0	11.3	1.7	1.1	1.8	12.9	2.6	3.0	51.1	5.5	6.1	1.7	98.4	2.5	2.2	79.7	7.4	2.6	81.9	55.1	175.1	65.1	46.6	67.5	73.0	0.1	1.7	21.1	5.1	0.2	0.5	0.5	0.5	0.3	2.1	1.4	0.9	0.4	53.5	4.7	2.5	0.8	4.6	0.2	0.6	18.4	1.9	15.9	0.3	4.5	4.1	20.6	1.7	5.3	0.2	2.1	0.0	5.7	1.4	3.1	2.4	0.2	18.2	37.3	11.4	1.0	7.5	8.5	9.4	2.9	0.2	25.5	37.3	2.6	0.0	4.9	0.1	28.0	7.1	2.9	6.5	0.1	0.7	0.6	0.2	55.8	0.3	2.9	5.1	175.1	54.6	122.9	35.7	63.3	35.1	64.6	49.4	41.5	55.1	81.9	67.5	48.1	112.7	46.6	65.1	20.8	58.1	73.0	6.5	14.8	1.2	8.5	9.6	3.3	3.6	3.7	2.8	1.7
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.2"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028064, HPA028516"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA028064: AB_10600111, HPA028516: AB_10601751"	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	8.8	8.6	31.6	18.2	18.6	6.3	7.4	14.3	44.1	11.5	6.6	7.1	6.6	6.9	7.3	5.3	6.4	6.0	10.8	6.3	26.8	32.9	5.2	2.6	12.5	22.0	33.4	22.2	12.1	8.1	4.0	7.2	8.0	45.2	6.1	4.7	4.8	18.1	9.6	10.9	6.8	7.2	7.6	10.8	18.4	7.8	10.4	6.5	4.3	7.5	3.7	18.1	14.1	7.2	4.6	8.6	3.8	7.7	6.9	2.4	3.1	17.2	13.5	10.3	17.1	13.6	18.5	7.5	10.7	10.3	8.7	9.7	7.8	17.0	10.7	4.8	13.1	10.4	3.8	6.6	3.3	18.5	6.7	7.9	4.6	8.9	15.6	6.0	29.0	18.2	5.9	7.0	3.7	12.9	5.3	3.4	10.8	15.1	5.1	10.8	19.5	8.4	7.5	16.0	6.7	9.6	3.7	4.1	9.4	6.9	16.5	8.6	5.2	5.4	15.3	13.9	12.9	35.7	17.1	3.9	4.3	19.5	51.4	4.4	9.4	0.1	6.5	3.8	2.4	7.7	1.8	4.6	0.6	1.5	8.6	2.4	0.2	0.7	0.7	6.9	4.7	0.8	0.4	3.1	31.6	18.6	14.3	44.1	26.8	32.9	33.4	22.2	45.2	6.5
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 37.8;hTCEpi: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 14.7;neutrophil: 37.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB019313: , HPA008183: AB_1079252, HPA053882: "	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	9.4	6.6	23.5	23.6	26.2	29.4	17.0	9.9	16.8	11.0	20.9	15.6	10.7	13.1	12.9	8.7	33.7	22.1	28.7	6.0	15.4	10.7	15.4	19.9	21.6	18.1	20.8	7.2	11.4	19.9	20.0	12.8	64.3	23.3	17.1	22.1	10.1	25.7	16.2	9.7	36.7	13.3	10.1	28.3	17.4	18.5	16.8	17.9	12.4	25.8	15.6	15.3	13.1	20.0	1.0	1.6	37.2	1.9	2.4	5.6	1.6	7.0	1.1	4.9	2.7	2.1	2.5	37.8	4.7	2.2	4.7	4.0	6.1	3.3	6.9	8.4	7.0	14.4	5.7	24.6	3.0	5.0	6.2	5.0	5.6	6.5	3.2	9.2	9.2	4.0	70.1	3.8	11.5	12.0	2.8	5.0	6.4	5.5	5.6	3.2	4.6	1.8	7.5	8.3	3.8	5.5	16.8	6.3	5.7	3.5	22.7	9.4	18.9	3.7	7.2	4.2	6.6	2.3	4.3	2.8	4.1	6.0	2.7	4.4	1.8	2.1	1.9	14.7	1.3	1.3	2.4	0.8	2.3	1.7	0.7	1.0	2.3	1.8	37.2	2.4	0.5	1.6	5.6	1.6	23.5	26.2	9.9	16.8	15.4	10.7	20.8	7.2	23.3	17.9
LIMS1	"PINCH, PINCH1"	ENSG00000169756	"LIM zinc finger domain containing 1"	P48059	2	108534355-108687246	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA058455, HPA061230"	Approved		Supported	"Focal adhesion sites,Cytosol"			130000000	Cytosol	"Focal adhesion sites"	"HPA058455: , HPA061230: "	"unprognostic (1.79e-1)"	"unprognostic (8.82e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (7.51e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.11e-1)"	39.3	26.3	7.8	18.3	13.3	14.9	21.5	3.9	9.6	18.1	16.9	14.4	38.2	8.3	21.9	21.7	18.4	16.9	16.5	20.2	8.0	7.5	20.8	18.0	26.3	21.2	13.3	4.6	18.3	10.6	6.6	13.6	19.0	10.8	15.8	9.5	11.0	13.8	43.6	54.0	11.2	17.9	18.8	16.7	24.3	13.0	9.3	10.7	20.2	13.1	15.0	25.5	21.1	16.1	4.4	14.2	45.6	34.0	8.8	20.9	29.6	9.2	10.4	4.1	4.9	6.8	10.0	19.9	10.4	12.0	8.1	8.3	18.0	20.1	9.0	31.9	13.3	6.0	6.2	10.7	10.8	22.2	11.1	47.2	7.4	9.5	15.7	8.8	88.1	9.7	9.9	21.4	17.7	29.2	16.6	12.6	24.9	7.6	8.4	6.5	8.1	10.7	10.8	14.3	7.3	15.4	16.8	7.5	10.1	16.4	7.0	7.3	3.6	8.3	39.2	36.8	16.8	8.1	21.3	12.3	16.3	12.8	30.7	10.0	9.3	38.3	16.9	45.6	4.3	28.7	7.8	4.4	18.5	5.7	14.2	3.5	5.0	1.8	8.0	8.8	34.0	1.8	20.9	29.6	7.8	13.3	3.9	9.6	8.0	7.5	13.3	4.6	10.8	10.7
LIMS3		ENSG00000256977	"LIM zinc finger domain containing 3"	P0CW19	2	109898428-109924868	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 11.9;endometrium 1: 9.7"	"Cell line enhanced"	"Detected in many"		"HEL: 9.6;HMC-1: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.9"	"Low lineage specificity"	"Detected in many"											HPA058455	Uncertain		Approved	"Focal adhesion sites,Cytosol"				Cytosol	"Focal adhesion sites"	"HPA058455: "										"unprognostic (2.23e-2)"								1.2	2.8	0.5	2.2	0.5	0.0	1.0	0.8	0.5	1.0	0.7	0.3	4.2	0.2	9.7	2.8	1.2	7.1	0.9	2.6	0.5	0.5	2.6	0.6	0.8	2.8	0.6	0.3	2.2	0.7	0.3	2.4	5.6	0.3	1.0	0.8	0.6	2.2	0.6	3.0	0.8	0.5	1.2	0.6	0.6	0.7	3.7	0.3	0.3	1.0	0.3	0.3	2.6	0.7	0.7	2.5	11.9	5.5	1.1	6.2	8.0	0.0	0.1	1.2	1.5	0.5	0.4	0.0	1.5	0.0	0.2	0.6	1.5	0.0	0.0	4.6	0.3	0.8	0.0	1.8	1.3	2.3	0.0	9.6	0.4	0.9	1.4	1.7	29.2	2.1	1.1	1.1	1.3	2.4	2.0	1.6	3.2	0.1	0.0	0.2	1.5	0.5	1.7	3.1	1.0	0.8	1.5	0.4	3.5	3.9	0.0	0.7	0.0	0.5	7.1	6.3	5.8	3.2	0.3	0.0	0.0	1.8	0.8	0.0	1.9	4.7	3.3	11.9	0.9	5.5	1.5	0.7	5.0	1.7	2.5	0.2	0.9	0.3	0.7	1.1	5.2	0.2	6.2	8.0	0.5	0.5	0.8	0.5	0.5	0.5	0.6	0.3	0.3	0.3
LIMS4	LIMS3L	ENSG00000256671	"LIM zinc finger domain containing 4"	P0CW20	2	110446640-110473075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.6;HHSteC: 2.5;hTEC/SVTERT24-B: 4.8;HUVEC TERT2: 2.8;U-138 MG: 5.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058455	Uncertain		Uncertain	"Focal adhesion sites,Cytosol"				Cytosol	"Focal adhesion sites"	"HPA058455: "										"unprognostic (2.12e-1)"								4.0	4.1	0.0	0.3	0.0	0.6	1.5	0.0	0.3	0.3	0.6			0.3	4.1	0.3	0.3	3.7	0.3	3.5	0.0	0.0	5.5	2.7	0.8	0.3	0.0		1.9	2.2	0.3	0.8	0.6		0.3	0.3		0.3	0.3	5.6	0.4	0.3	0.3	0.0	0.3	0.3	1.3			1.1		0.3	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	2.6	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	4.8	0.0	2.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410778-26429722	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 9.8"	"Cell line enriched"	"Detected in some"	10	"NTERA-2: 137.5"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"				Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.5	0.1	0.1	0.1	0.2	0.3	9.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.6	2.3	0.5	1.0	0.8	0.1	0.0	0.0	13.5	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.7	0.7	0.3	0.4	1.0	0.5	0.6	0.2	1.3	0.8	0.7	2.2	1.0	0.3	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 51.9"	"Cell line enhanced"	"Detected in some"		"AF22: 13.9;BEWO: 71.7;K-562: 23.2;NTERA-2: 12.6"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	1.2	0.0	0.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.0	0.1	0.1	0.1	0.5	0.8	0.0	0.0	0.0	1.0	51.9	1.2	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	5.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.7	2.1	0.4	0.2	0.5	0.3	0.0	0.9	13.9	2.8	0.0	0.0	71.7	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	6.7	9.9	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.3	0.0	0.0	1.4	1.6	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.3	0.0	0.0	1.1	0.0	2.9	0.3	0.0	1.5	0.0	0.0	4.2	5.9	0.0	0.0	0.0	0.0	1.6	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.7	0.1	0.2	2.1	0.2	0.4	0.7	0.2	0.3	1.2	0.8	0.1	1.3	0.9	1.3	0.5	0.8	1.2	0.4
LIN54	"CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1"	ENSG00000189308	"Lin-54 DREAM MuvB core complex component"	Q6MZP7	4	82909973-83012926	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056606	Approved		Approved	Cytosol				Cytosol		"HPA056606: "	"unprognostic (2.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.56e-3)"	"unprognostic (6.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.60e-2)"	"prognostic favourable (1.06e-4)"	"unprognostic (3.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-2)"	6.9	6.2	9.0	6.7	13.7	16.5	7.1	13.3	12.4	8.4	8.4	12.2	2.0	7.6	6.5	6.1	15.4	5.5	5.6	6.0	10.2	8.6	10.9	11.6	6.1	8.5	15.7	7.5	7.6	4.6	9.8	8.5	8.8	10.5	5.9	10.2	6.7	8.1	6.7	10.6	7.7	6.0	6.5	15.2	7.8	6.4	9.5	12.7	27.2	14.9	8.5	11.9	7.5	8.2	3.4	2.2	8.1	8.8	6.9	7.6	3.6	6.9	4.1	6.5	7.4	3.4	3.3	4.9	11.4	7.9	8.6	8.3	4.9	8.1	7.6	6.3	11.7	5.5	8.9	3.7	10.6	8.2	3.9	7.0	6.5	5.5	3.0	8.5	51.6	2.8	2.2	9.5	4.6	5.2	7.6	15.4	8.3	4.9	18.1	3.6	2.7	2.8	9.9	7.3	5.3	4.1	6.0	6.8	3.6	6.9	11.1	4.5	4.8	5.6	4.0	10.4	7.8	9.6	5.1	7.7	5.6	13.0	5.7	5.4	8.1	5.3	3.8	7.7	6.1	3.0	6.9	2.7	6.1	6.6	2.2	3.4	7.6	6.4	8.1	6.9	8.8	1.7	6.8	3.6	9.0	13.7	13.3	12.4	10.2	8.6	15.7	7.5	10.5	12.7
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401507-42427426	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 207.4;breast: 65.1"	"Cell line enriched"	"Detected in many"	7	"ASC diff: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol				Cytosol		"CAB017700: AB_2135504, HPA006567: "	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	207.4	6.0	3.2	2.9	9.4	2.1	65.1	2.0	6.8	1.2	6.7	19.6	0.8	2.4	1.7	1.3	2.2	1.6	3.6	4.8	6.2	4.2	1.5	1.1	1.4	2.7	18.0	2.3	1.5	2.2	2.2	0.8	1.7	9.9	1.7	1.3	3.7	5.4	1.7	3.7	2.9	3.4	1.7	19.2	3.1	1.6	9.0	10.8	1.7	1.5	1.8	1.9	2.0	3.7	6.1	4.8	10.8	12.1	4.1	5.2	4.0	4.8	3.7	2.4	0.9	56.0	0.5	0.0	2.3	1.2	3.7	3.4	0.9	1.8	8.0	2.5	0.7	2.1	1.4	4.5	0.4	1.5	2.4	2.2	1.8	0.1	1.1	0.0	5.5	0.4	4.3	0.6	0.8	1.0	1.0	5.1	0.4	0.0	5.6	0.2	0.3	1.1	4.6	0.4	2.6	1.0	5.1	3.4	3.5	2.0	2.3	2.1	0.6	2.9	1.8	1.0	3.2	0.4	2.0	3.8	3.1	5.9	2.5	0.2	3.4	10.8	12.1	4.7	3.6	6.0	3.3	4.8	4.6	5.2	4.8	6.1	4.1	3.7	2.0	4.1	3.3	3.9	3.9	4.0	3.2	9.4	2.0	6.8	6.2	4.2	18.0	2.3	9.9	10.8
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 202.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 202.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 202.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	55.0	14.1	18.0	49.2	42.4	53.3	65.7	5.0	18.5	50.4	36.4	45.2	20.2	13.9	42.7	28.8	19.6	34.0	35.3	31.5	20.7	15.7	48.9	66.3	73.0	80.6	28.6	13.2	43.1	26.3	15.9	17.1	46.2	42.8	36.2	36.7	26.0	57.3	32.2	18.6	28.5	24.1	41.6	52.1	57.9	26.3	11.0	19.0	18.7	53.3	18.8	36.4	47.4	41.6	14.1	16.9	202.5	10.3	20.2	37.6	35.6	13.7	25.6	16.2	7.8	2.5	1.9	16.4	17.9	55.1	17.0	25.4	10.6	37.1	6.9	22.9	15.1	17.0	6.8	30.0	16.3	52.7	7.1	0.5	22.3	53.7	38.0	2.1	2.3	5.7	58.3	13.9	38.2	0.0	4.2	26.8	0.2	13.1	0.3	31.8	26.4	0.1	2.1	3.5	39.6	14.3	19.4	4.0	12.2	30.9	39.5	31.8	22.1	11.7	0.1	7.1	12.0	4.1	4.1	10.5	23.1	17.7	8.1	16.8	40.5	32.2	10.3	20.8	37.6	9.8	22.8	14.1	23.5	33.5	13.6	13.9	26.8	31.7	202.5	20.2	5.7	16.9	26.2	35.6	18.0	42.4	5.0	18.5	20.7	15.7	28.6	13.2	42.8	19.0
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142872	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 35.9"	"Cell line enriched"	"Detected in some"	12	"RPTEC TERT1: 26.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"naive B-cell: 5.9"	"Lineage enriched"	"Detected in single"	9	"B-cells: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"				Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: "	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	1.0	1.2	14.9	1.3	16.9	1.4	1.1	6.1	35.9	1.0	1.3	19.2	1.0	1.2	1.2	1.2	1.0	1.2	1.1	1.1	24.6	10.7	4.9	1.0	1.1	1.6	11.7	13.2	1.0	1.0	1.0	1.2	1.4	12.4	3.0	1.4	3.3	1.1	8.3	1.1	1.1	1.2	1.2	10.1	1.2	1.2	1.1	13.0	0.0	6.5	0.0	1.0	1.0	0.2	5.9	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.2	1.2	0.1	0.0	0.0	5.9	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	14.9	16.9	6.1	11.9	24.6	10.7	11.7	13.2	12.4	13.0
LIX1L	MGC46719	ENSG00000271601	"Limb and CNS expressed 1 like"	Q8IVB5	1	145933423-145958001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063598			Approved	Cytosol				Cytosol		"HPA063598: "	"unprognostic (5.21e-2)"	"unprognostic (4.09e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.51e-2)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.95e-1)"	"unprognostic (1.25e-2)"	"prognostic unfavourable (5.27e-4)"	13.8	8.9	4.6	6.5	4.4	2.1	6.0	4.1	5.9	14.4	8.0	7.1	3.2	2.7	15.9	7.6	5.8	6.3	10.6	10.0	4.3		4.2	5.4	6.4	9.2	5.7	4.0	19.6	1.7	4.4	9.4	7.5	4.0	11.6	4.2	11.4	3.3	10.7	10.5	2.4	4.0	12.7	4.2	9.4	2.6	7.4	5.8	11.1	4.6	4.5	9.5	11.8	8.4	4.3	4.2	5.1	4.4	4.8	11.1	3.1	3.2	4.6	14.1	15.6	29.6	25.2	0.2	7.2	13.3	11.3	8.3	0.3	3.0	8.6	8.0	14.6	0.1	6.5	6.1	10.8	7.9	2.1	4.8	5.1	4.5	9.7	11.3	11.4	15.3	2.8	9.3	13.5	21.9	7.0	13.9	17.9	0.1	14.8	9.5	4.1	6.0	10.1	7.1	14.1	11.7	0.0	5.1	14.5	14.9	0.0	10.8	0.5	8.9	16.9	19.4	5.3	12.6	12.2	11.2	7.9	8.8	13.6	9.4	9.3	4.8	2.9	4.6	8.0	2.7	9.7	4.0	9.2	8.0	2.7	4.3	8.6	11.1	5.1	4.8	4.4	4.2	6.7	3.1										
LLGL2	"HGL, Hugl-2"	ENSG00000073350	"LLGL2, scribble cell polarity complex component"	Q6P1M3	17	75525080-75575208	"Predicted intracellular proteins"	"Cell cycle, Cell division, Exocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;CAPAN-2: 38.2;MCF7: 36.7;RT4: 26.1;SK-BR-3: 36.6;T-47d: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 6.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.2;NK-cells: 4.1;T-cells: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022913	Uncertain		Supported	Vesicles,Cytosol				Cytosol	Vesicles	"HPA022913: AB_1852930"	"unprognostic (1.18e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"prognostic favourable (9.25e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.49e-1)"	"prognostic favourable (6.00e-5)"	"unprognostic (6.22e-3)"	"prognostic favourable (6.14e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.56e-2)"	1.7	3.9	1.5	17.3	4.2	1.4	4.2	5.1	3.7	7.1	27.5	5.2	23.0	22.9	2.8	17.1	24.3	6.4	45.7	1.7	1.7	1.0	35.6	17.1	16.0	2.1	11.2	1.8	4.6	37.5	5.0	8.3	5.1	3.6	6.6	11.9	6.3	21.4	20.0	0.7	13.9	36.0	1.2	2.5	9.6	27.7	4.3	4.9	1.5	13.4	13.0	13.6	7.0	10.6	0.6	2.2	0.3	0.6	4.1	6.2	0.9	16.5	15.4	0.0	2.9	0.0	0.0	6.5	0.1	0.1	0.3	0.2	25.9	38.2	1.1	3.9	0.0	20.9	2.9	2.8	0.0	1.4	5.2	1.1	4.3	9.8	0.1	0.1	2.5	0.0	3.9	0.0	0.6	0.6	2.1	1.5	0.0	36.7	0.9	1.9	2.1	6.1	1.9	0.0	4.1	8.2	26.1	6.4	1.2	3.3	36.6	1.1	27.7	2.6	0.1	0.0	0.1	0.0	0.2	1.8	2.4	0.4	0.1	0.1	0.7	0.0	0.3	0.1	6.2	0.6	1.4	0.6	1.5	4.2	0.3	0.6	0.2	2.5	0.3	4.1	0.2	2.2	1.0	0.9	1.5	4.2	5.1	3.7	1.7	1.0	11.2	1.8	3.6	4.9
LMAN1	"ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60"	ENSG00000074695	"Lectin, mannose binding 1"	P49257	18	59327823-59359962	"Disease related genes, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002320, CAB037163"	Supported		Uncertain	Cytosol			13000000	Cytosol		"CAB037163: AB_532237, HPA002320: AB_1079256"	"unprognostic (5.64e-2)"	"unprognostic (8.96e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.71e-3)"	6.2	7.7	2.6	4.5	3.0	1.6	5.7	4.6	1.8	9.8	3.9			5.7	6.7	7.4	6.6	6.5	3.8	8.0	2.7	3.0	9.1	26.2	7.0	2.7	2.8		8.1	15.3	12.7	9.7	7.1		8.2	5.0		8.4	6.1	6.9	3.4	6.1	4.6	3.5	4.8	7.5	2.1			12.3		3.9	4.7	5.6	6.9	8.2	4.0	3.4	9.0	9.8	3.8	18.7	11.1	11.9	9.9	27.8	48.2	24.0	33.9	48.7	23.0	30.8	11.0	18.2	3.3	24.2	40.2	23.1	16.9	19.2	41.9	12.7	10.8	10.9	14.9	22.8	33.1	37.8	16.8	32.1	23.2	22.2	45.6	23.1	18.3	37.3	22.3	5.0	10.9	7.8	8.2	13.8	12.4	21.7	36.2	12.8	14.2	8.1	8.9	17.1	16.8	19.2	12.4	14.8	19.0	37.4	13.1	11.9	19.6	28.5	14.2	16.2	39.3	20.1	30.5	4.0	2.3	0.6	7.2	3.4	9.8	6.9	7.9	7.5	3.1	4.7	7.6	7.5	0.3	9.0	1.9	8.2	8.7	3.8										
LMBR1	"ACHP, C7orf2, FLJ11665, ZRS"	ENSG00000105983	"Limb development membrane protein 1"	Q8WVP7	7	156668946-156893230	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016592	Approved		Approved	Cytosol				Cytosol		"HPA016592: AB_1852943"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.44e-6)"	"unprognostic (3.35e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.10e-2)"	15.8	30.5	15.2	12.4	23.7	7.1	12.9	20.4	25.5	16.3	10.1	13.4	12.8	9.1	19.0	19.4	12.1	16.9	12.8	12.9	15.9	17.4	17.5	15.9	11.5	11.3	17.8	11.5	18.9	12.0	38.2	22.7	11.6	24.4	14.1	12.2	11.3	10.6	13.1	14.8	11.2	10.9	15.1	14.4	9.4	12.7	20.3	13.2	14.7	20.9	8.7	12.8	13.9	12.3	2.3	3.6	4.2	2.0	0.9	4.1	1.5	12.3	10.7	12.2	15.1	9.8	11.9	8.3	7.1	9.0	6.4	7.2	7.7	20.1	12.0	13.7	9.2	9.8	12.8	13.3	13.7	8.6	13.0	8.9	5.9	9.3	6.9	11.0	6.2	9.0	12.0	9.4	12.3	13.9	17.0	11.0	13.1	11.6	11.0	8.8	14.2	9.7	6.0	8.7	14.7	10.2	12.2	13.0	24.3	9.4	12.8	6.9	9.0	6.0	19.4	11.6	4.5	40.0	9.0	13.4	10.5	12.0	19.8	13.9	7.2	4.2	2.0	2.7	1.7	1.0	4.1	1.3	3.6	2.6	3.6	2.3	4.0	2.5	1.5	0.9	1.7	2.2	2.2	1.5	15.2	23.7	20.4	25.5	15.9	17.4	17.8	11.5	24.4	13.2
LMBRD2	DKFZp434H2226	ENSG00000164187	"LMBR1 domain containing 2"	Q68DH5	5	36098412-36151961	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 11.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012165	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA012165: AB_2136131"	"unprognostic (9.43e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.45e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.35e-2)"	6.2	9.7	12.1	6.6	21.4	2.2	8.8	12.8	25.5	7.3	8.7	9.5	7.6	9.6	5.3	7.2	6.8	4.8	5.8	8.2	14.2	11.4	10.5	14.2	5.7	7.6	9.9	15.6	5.0	7.7	16.9	16.9	8.4	14.1	9.7	9.1	4.8	7.6	6.8	11.1	7.7	9.6	5.5	10.5	6.7	10.1	5.2	8.6	8.4	12.8	2.9	7.4	7.6	6.1	1.5	1.2	11.0	1.2	1.0	2.3	0.8	4.8	3.6	4.4	7.3	9.2	8.1	15.6	10.1	5.3	7.4	7.5	4.5	10.6	8.7	5.1	5.3	6.7	5.8	3.5	12.3	12.4	3.5	6.8	12.4	0.8	5.9	8.2	9.0	4.8	6.3	6.4	6.4	4.0	7.9	9.2	9.0	3.2	7.0	5.4	2.4	4.6	5.3	10.3	5.3	6.4	4.3	8.3	6.4	14.5	8.6	3.5	9.8	9.9	5.3	8.9	2.3	11.3	5.3	7.6	11.1	7.7	8.4	9.3	6.1	11.0	1.2	2.0	1.6	1.2	1.1	1.5	1.4	1.4	1.0	1.3	1.9	1.9	0.8	1.0	1.2	1.2	2.3	0.8	12.1	21.4	12.8	25.5	14.2	11.4	9.9	15.6	14.1	8.6
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501707-8574673	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 189.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 29.8;HSkMC: 41.7;hTEC/SVTERT24-B: 30.6;U-2197: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	38.6	3.3	1.6	10.1	1.8	0.0	36.4	3.9	1.9	11.7	4.4	3.8	5.2	1.9	22.3	20.8	8.3	11.9	15.4	15.9	2.3	1.7	5.5	2.2	25.9	3.8	2.4	1.7	17.9	8.5	5.8	2.0	14.1	4.5	16.1	1.6	4.6	19.2	7.0	189.9	5.7	3.3	72.9	3.7	14.3	10.6	9.3	1.3	0.8	4.6	34.3	7.1	29.4	15.7	1.8	2.7	0.0	0.3	0.0	17.0	0.2	2.9	16.6	2.8	2.1	20.7	11.7	2.9	12.1	6.2	6.7	16.5	12.2	3.7	0.0	1.4	14.0	0.2	1.6	3.1	2.7	5.0	1.1	3.6	1.1	2.4	29.8	0.0	0.3	41.7	0.0	30.6	0.2	3.2	0.0	0.0	8.6	2.1	0.0	0.0	5.4	0.7	0.0	9.2	0.0	6.1	1.1	0.1	6.9	2.0	10.1	6.3	13.2	0.0	1.5	6.7	13.5	27.0	8.1	1.6	1.9	0.8	1.3	0.9	8.7	0.0	0.0	0.0	0.0	0.3	0.1	1.8	2.6	0.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.9	17.0	0.2	1.6	1.8	3.9	1.9	2.3	1.7	2.4	1.7	4.5	1.3
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"				Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favourable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	3.9	4.9	5.2	2.5	11.0	2.3	4.5	6.1	9.1	6.2	3.5	5.8	14.3	2.2	4.8	20.3	3.5	9.3	5.1	5.9	5.7	7.4	6.6	3.7	8.1	3.5	5.6	8.9	6.5	6.1	8.8	15.0	3.9	11.6	4.6	4.1	5.4	4.2	11.7	3.7	6.5	2.3	4.0	5.5	3.0	3.9	27.0	4.4	1.2	7.6	3.0	2.6	3.5	3.7	1.9	1.9	0.8	2.4	1.8	2.4	1.2	6.5	2.5	3.0	3.5	5.9	8.3	2.5	3.4	3.1	6.2	5.1	2.4	2.4	2.1	16.0	2.4	2.5	2.8	2.7	9.0	0.3	2.0	1.2	2.1	1.8	3.7	3.7	1.8	3.9	6.1	7.7	5.0	2.7	6.3	4.0	5.9	4.9	2.2	3.2	3.3	6.0	2.5	0.7	2.2	6.4	1.7	4.8	1.4	4.8	4.3	3.4	11.1	2.8	5.7	7.6	1.1	9.2	5.7	7.1	13.8	0.6	10.9	6.4	6.9	0.2	0.6	0.5	1.2	2.4	1.7	1.9	0.8	1.6	1.9	1.1	2.2	2.4	0.8	1.8	0.9	0.5	0.0	1.2	5.2	11.0	6.1	9.1	5.7	7.4	5.6	8.9	11.6	4.4
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140089	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease mutation, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.4;memory CD4 T-cell: 8.9;myeloid DC: 34.8;T-reg: 35.4"	"Group enriched"	"Detected in all"	8	"dendritic cells: 34.8;granulocytes: 10.4;T-cells: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006660, HPA012078"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"			3200000	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB004022: AB_2136278, HPA006660: AB_1079231, HPA012078: "	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	64.0	37.3	7.4	51.4	11.8	21.3	88.6	9.0	10.8	62.8	32.6	21.9	27.2	28.6	69.1	52.3	62.2	40.1	77.7	62.5	8.8	7.5	25.9	26.6	51.8	39.6	15.7	11.2	60.3	30.9	15.2	17.4	73.3	18.1	34.0	15.2	32.7	37.5	26.4	36.3	68.7	29.9	63.0	10.3	22.4	36.7	30.2	12.9	9.4	31.5	140.0	35.6	46.4	51.2	1.1	34.8	10.4	3.5	1.7	35.4	6.4	58.6	58.2	6.4	17.3	32.6	56.6	19.9	63.4	80.9	47.9	33.2	14.7	58.1	0.5	37.7	97.5	68.7	9.4	49.2	12.4	19.9	5.5	18.5	46.9	34.0	29.5	3.2	54.7	33.9	21.4	38.9	26.8	42.7	9.9	4.5	52.4	46.3	0.1	10.2	4.8	74.2	0.2	22.6	17.2	47.4	28.2	6.6	13.2	42.8	46.5	58.9	39.3	15.3	76.1	45.7	29.1	56.4	51.2	4.4	1.1	1.2	74.7	3.0	136.2	10.4	3.5	0.1	1.2	0.8	1.0	1.1	8.9	3.4	34.8	0.0	0.1	0.3	0.8	1.7	0.1	0.3	35.4	6.4	7.4	11.8	9.0	10.8	8.8	7.5	15.7	11.2	18.1	12.9
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6"	"Cell line enhanced"	"Detected in many"		"BJ: 54.7;fHDF/TERT166: 90.2;LHCN-M2: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2"	"HPA020923, HPA050184"	Approved		Supported	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA020923: AB_1852963, HPA050184: "	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favourable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	2.2	2.2	10.1	6.3	32.6	0.9	2.5	2.7	13.2	6.7	24.3	0.5	2.4	17.5	2.3	7.8	42.5	4.0	16.3	65.6	9.8	2.5	21.7	19.9	57.0	2.6	2.3	8.8	5.5	6.8	6.2	3.1	10.9	1.1	7.6	8.9	2.7	14.3	7.0	44.4	8.6	55.0	2.1	2.0	1.5	16.7	4.7	4.1	16.2	25.7	36.3	23.7	4.6	15.4	2.4	1.1	3.0	0.5	0.5	14.1	2.6	12.1	6.9	0.2	0.2	14.4	10.2	2.4	54.7	27.0	13.9	15.1	16.9	15.7	1.0	4.2	90.2	11.8	3.0	2.6	16.1	16.3	0.7	7.4	36.7	15.8	4.1	2.3	3.9	7.0	5.1	6.0	6.9	5.8	0.2	0.0	84.9	4.7	1.8	1.0	0.3	10.4	1.1	25.5	0.2	5.9	2.8	0.8	1.9	9.9	1.7	2.2	2.2	1.7	8.8	34.4	6.4	4.1	13.3	3.7	2.7	4.3	10.1	2.6	15.6	3.0	0.2	2.4	0.7	0.5	0.9	1.1	3.2	1.0	0.4	2.4	14.1	8.5	0.1	0.5	0.3	1.1	1.2	2.6	10.1	32.6	2.7	13.2	9.8	2.5	2.3	8.8	1.1	4.1
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896452-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 199.7;urinary bladder: 165.5"	"Group enriched"	"Detected in some"	10	"ASC diff: 11.1;BJ: 14.3;BJ hTERT+: 23.3;fHDF/TERT166: 11.5;HSkMC: 10.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol				Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	27.4	12.7	1.9	26.7	6.2	0.0	20.5	2.2	1.9	65.6	83.5	1.8	42.7	6.0	84.9	29.0	94.6	33.2	80.7	8.3	1.6	1.6	5.3	1.0	11.0	5.5	2.3	3.2	38.1	1.6	7.4	1.3	10.2	4.1	77.1	12.0	28.9	6.8	63.8	29.5	7.4	20.9	199.7	1.8	6.3	47.0	23.3	0.7	0.0	7.9	12.3	2.7	165.5	39.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	11.1	1.4	0.9	14.3	23.3	0.9	1.1	0.0	0.1	0.0	0.5	11.5	0.2	0.3	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	10.2	0.0	0.6	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.1	0.5	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	6.2	2.2	1.9	1.6	1.6	2.3	3.2	4.1	0.7
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106885-98209633	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"				"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: "	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavourable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	5.1	10.3	13.7	5.6	21.3	17.3	5.6	16.6	34.3	7.3	13.8	6.1	5.6	12.6	6.1	6.3	12.7	6.4	7.9	16.9	11.0	10.1	10.1	8.5	10.0	5.1	7.5	18.9	8.0	21.0	22.2	10.0	4.8	13.2	7.9	11.8	5.4	10.5	6.5	17.5	11.5	13.8	5.7	5.5	6.8	9.4	8.0	6.9	7.2	8.7	5.7	7.4	8.3	8.1	0.6	0.7	4.8	0.9	0.3	1.6	0.5	9.9	11.7	9.1	9.3	4.9	3.9	8.5	4.1	4.5	4.1	4.9	9.2	9.1	5.2	11.9	5.3	10.9	10.5	6.3	6.4	7.4	7.4	3.5	10.5	9.2	6.0	6.3	6.4	2.7	8.8	8.4	11.4	6.1	9.2	11.1	3.7	13.5	6.6	3.8	11.1	5.7	7.3	6.2	10.3	6.8	17.5	6.5	13.1	8.3	15.2	6.0	4.2	2.6	7.4	8.5	14.0	16.9	9.4	4.9	8.6	10.5	5.7	5.0	10.1	1.2	0.6	0.5	0.8	0.3	0.5	0.6	0.9	0.9	0.3	0.6	1.1	1.6	4.8	0.3	0.9	0.7	0.8	0.5	13.7	21.3	16.6	34.3	11.0	10.1	7.5	18.9	13.2	6.9
LNP1	NP3	ENSG00000206535	"Leukemia NUP98 fusion partner 1"	A1A4G5	3	100401193-100456319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4"	HPA047926			Approved	"Nuclear speckles,Vesicles,Cytosol"				Vesicles	"Nuclear speckles, Cytosol"	"HPA047926: "	"unprognostic (1.78e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.40e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.08e-2)"	3.1	2.8	6.5	1.7	11.4	0.6	2.7	7.9	9.7	3.4	2.3	1.5	3.4	1.2	4.6	8.4	1.9	4.0	2.7	9.5	5.3	7.2	4.8	7.4	3.8	1.4	5.7	5.6	6.3	4.5	3.0	17.0	3.7	7.4	2.8	2.2	9.0	2.4	3.3	4.3	1.0	1.5	4.5	4.2	1.8	1.9	31.9	3.5	1.6	5.3	0.8	1.7	3.1	1.8	0.9	0.2	0.0	0.4	0.2	2.7	0.8	2.8	1.6	8.3	1.2	5.4	2.3	0.7	2.2	5.5	1.8	2.2	0.6	0.7	2.5	1.0	1.6	1.8	2.2	1.9	2.2	2.6	2.3	6.1	0.8	2.8	1.6	3.5	0.7	2.5	0.7	1.0	4.7	0.4	2.3	9.5	1.6	2.1	4.9	3.5	5.7	12.5	3.8	4.6	5.0	1.7	0.3	8.6	4.3	1.6	2.4	3.4	0.6	0.4	0.6	0.9	8.9	0.8	2.0	11.2	11.9	7.3	2.5	3.0	1.5	0.0	0.4	0.0	1.1	0.2	2.5	0.9	1.1	0.6	0.2	0.9	1.0	1.1	0.0	0.2	0.0	0.0	2.7	0.8	6.5	11.4	7.9	9.7	5.3	7.2	5.7	5.6	7.4	3.5
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"			"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: "	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	16.9	2.5	11.8	1.7	24.6	0.8	13.2	4.4	33.3	5.9	7.2	1.5	11.2	8.3	4.5	3.2	21.7	5.6	4.8	6.9	6.1	5.5	10.0	3.7	2.5	1.8	3.8	11.6	2.1	12.9	10.8	5.0	21.6	4.8	5.1	5.6	2.0	22.1	10.0	5.1	10.0	8.2	2.8	1.3	0.9	8.0	4.1	2.0	0.7	15.0	5.7	7.8	5.8	7.7	1.4	1.1	1.5	1.9	3.8	1.6	0.6	1.6	0.6	1.9	1.0	3.5	7.3	9.2	1.5	0.7	0.0	0.0	2.7	8.4	2.1	1.2	4.2	1.6	0.0	0.3	0.0	0.5	4.6	2.9	1.7	1.6	1.4	2.7	0.8	5.4	0.3	0.5	0.0	2.8	1.7	1.0	6.6	4.7	2.4	1.8	4.8	1.0	1.5	0.7	0.9	6.3	8.8	2.3	2.6	0.7	9.7	1.0	5.2	1.4	8.0	10.5	3.1	3.4	1.8	3.9	0.6	1.4	9.6	2.4	1.9	1.5	0.5	0.3	1.0	0.5	1.5	1.4	1.5	1.5	0.8	0.9	1.6	1.2	0.4	3.8	1.9	1.1	1.3	0.6	11.8	24.6	4.4	33.3	6.1	5.5	3.8	11.6	4.8	2.0
LNX2	"MGC46315, PDZRN1"	ENSG00000139517	"Ligand of numb-protein X 2"	Q8N448	13	27545911-27620404	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040698	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA040698: AB_10673138"	"unprognostic (4.97e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.79e-2)"	"prognostic favourable (7.09e-13)"	"unprognostic (4.18e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-2)"	4.6	10.3	2.5	6.7	4.2	2.7	9.8	7.6	4.1	6.0	13.2	2.3	8.3	12.2	4.4	4.3	12.4	4.1	9.7	8.8	2.8	2.9	9.2	24.5	22.1	4.9	3.4	3.1	6.3	24.7	7.6	9.6	10.8	3.7	7.0	9.3	10.2	12.1	9.9	8.0	7.6	19.6	6.5	3.3	4.6	9.0	10.3	2.6	13.4	9.9	4.2	10.0	6.2	8.5	1.6	0.8	5.3	0.9	3.3	2.8	0.6	5.1	2.8	5.4	5.9	5.7	2.6	5.7	4.6	4.0	4.5	4.1	10.2	10.3	7.8	4.0	4.0	9.8	9.6	12.2	5.9	4.7	4.0	9.9	6.0	7.4	9.0	5.3	6.3	2.2	19.0	3.1	12.5	8.1	3.0	3.0	6.5	6.3	7.8	3.5	6.0	3.2	7.2	10.6	4.0	9.9	9.0	13.9	2.9	6.3	12.7	8.0	8.9	4.1	10.3	2.6	3.6	2.6	3.7	2.9	4.9	8.1	1.7	5.1	3.6	5.3	0.9	2.4	1.7	0.3	2.3	1.6	1.8	2.1	0.8	1.3	1.9	1.8	1.1	3.3	0.7	0.4	2.8	0.6	2.5	4.2	7.6	4.1	2.8	2.9	3.4	3.1	3.7	2.6
LONRF1	"FLJ23749, RNF191"	ENSG00000154359	"LON peptidase N-terminal domain and ring finger 1"	Q17RB8	8	12721894-12756073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023584, HPA024814"	Uncertain		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA023584: AB_1853233, HPA024814: AB_1853235"	"unprognostic (2.59e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.15e-1)"	16.5	7.6	7.6	4.9	9.9	4.9	10.4	9.9	8.4	14.0	8.1	6.3	8.8	2.2	11.1	13.0	12.9	11.2	9.4	6.5	8.9	5.3	6.3	9.3	8.1	8.7	6.9	6.9	20.4	10.3	12.6	4.9	9.6	5.5	12.8	4.2	13.9	7.9	10.9	18.4	29.7	5.3	10.0	6.1	9.2	6.9	16.1	4.5	6.2	8.6	7.3	7.3	10.6	19.0	1.1	0.9	2.4	2.1	0.1	1.6	0.2	0.6	1.6	8.4	2.6	8.9	4.3	5.6	2.1	3.5	2.3	3.2	0.5	2.1	12.9	0.5	3.6	1.0	6.6	2.5	2.6	2.0	3.7	4.2	0.3	3.4	8.3	1.1	1.6	4.0	4.6	1.4	5.1	3.6	0.6	31.8	1.5	2.3	5.5	3.7	8.6	0.5	3.1	5.7	2.3	2.0	5.6	17.7	2.1	1.2	2.8	16.4	0.6	5.7	1.6	1.2	2.1	5.0	1.6	2.4	10.7	6.8	6.8	3.9	3.8	0.0	0.5	2.4	0.5	1.8	1.6	1.0	1.0	0.6	0.4	1.1	0.0	0.0	1.9	0.1	2.1	0.9	0.0	0.2	7.6	9.9	9.9	8.4	8.9	5.3	6.9	6.9	5.5	4.5
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	18.1	10.1	13.0	10.7	18.3	6.0	22.1	20.0	16.4	10.5	8.6	10.9	7.3	8.9	11.0	15.0	20.0	7.0	10.4	12.8	11.6	11.9	7.6	13.2	8.0	15.4	13.2	11.2	19.3	7.5	17.2	32.0	9.0	17.9	9.6	7.1	9.0	14.4	11.6	88.4	6.5	9.2	11.0	10.3	8.4	7.6	39.0	13.2	8.3	8.1	14.0	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8.0	11.1	3.2	5.4	6.5	5.4	12.1	25.1	27.9	2.8	7.6	13.2	5.0	8.6	2.3	5.4	2.7	1.0	6.5	5.9	6.1	16.8	4.6	11.2	3.4	6.7	3.6	3.5	8.8	4.6	31.6	25.1	7.5	20.5	7.8	9.5	9.2	24.3	3.6	2.1	4.3	4.0	5.6	6.6	6.0	10.0	17.0	12.5	3.5	15.1	11.9	2.7	6.6	17.3	1.6	2.6	6.7	7.9	7.1	5.0	6.6	38.2	29.5	5.1	11.1	8.3	5.8	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5.0	8.4	7.1	1.1	8.0	2.1	9.6	10.5	3.2	13.0	18.3	20.0	14.4	11.6	11.9	13.2	11.2	17.9	13.2
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013315	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"				Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: "	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	6.8	5.6	13.0	10.5	18.4	9.2	7.7	11.9	16.5	6.6	25.2	10.4	2.4	31.6	6.7	3.9	5.9	6.3	14.3	5.1	11.0	14.5	20.7	83.9	11.8	11.8	11.2	9.8	8.8	9.0	9.7	8.2	16.3	15.3	5.8	7.4	6.8	4.4	5.3	2.2	2.7	43.3	6.1	9.6	10.7	15.6	13.5	9.6	6.3	7.5	1.5	10.0	6.8	6.7	1.2	1.1	20.8	2.0	10.1	9.5	2.1	4.9	6.7	10.6	3.7	18.4	17.1	6.3	11.9	14.6	11.9	11.6	8.7	4.2	3.6	7.3	18.3	0.2	8.7	3.7	9.4	7.0	1.8	9.2	5.2	9.9	17.2	7.3	10.1	17.2	2.5	11.8	10.3	14.8	8.3	1.9	16.6	3.7	9.1	6.3	3.4	9.6	16.0	9.2	13.4	9.5	11.1	8.9	6.2	11.2	5.3	3.8	0.0	10.0	20.8	15.4	18.7	19.7	8.8	3.5	5.3	7.8	13.6	7.5	5.4	6.5	2.0	6.1	9.3	1.3	9.5	0.9	7.1	5.3	0.8	1.2	7.3	4.7	20.8	10.1	0.6	1.1	6.3	2.1	13.0	18.4	11.9	16.5	11.0	14.5	11.2	9.8	15.3	9.6
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340920-41360582	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 6.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.8;NK-cells: 6.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol				Cytosol		"HPA051466: , HPA052667: , HPA070640: "	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	11.6	3.7	3.0	8.1	5.2	0.1	23.4	1.5	3.0	10.9	29.2	2.8	13.5	26.8	12.8	21.6	16.3	7.5	11.2	8.8	3.6	0.7	28.2	14.4	4.5	1.6	2.8	3.7	7.9	7.4	8.1	6.7	4.4	4.2	10.1	8.8	8.7	11.0	15.1	1.8	26.1	49.1	5.5	2.4	2.7	7.4	2.5	1.5	1.2	14.2	10.6	9.0	8.0	12.5	0.9	0.7	1.8	0.9	6.3	0.8	0.2	6.8	6.7	0.4	4.0	11.0	17.1	5.2	4.2	5.9	5.1	7.0	12.5	6.1	0.3	5.3	9.3	17.4	2.0	11.0	3.2	0.1	3.9	0.3	9.4	6.3	1.8	0.0	4.7	12.3	14.0	8.7	3.4	1.3	1.7	0.2	6.4	14.6	0.0	0.1	0.6	6.9	0.0	0.1	0.4	18.1	8.6	0.5	0.1	5.6	7.2	3.6	8.5	3.4	0.4	0.3	1.7	5.8	0.0	3.4	1.8	0.0	0.1	0.1	0.3	1.8	0.5	0.7	0.5	0.5	0.8	0.6	0.7	0.4	0.3	0.9	0.7	0.6	1.8	6.3	0.9	0.7	0.5	0.2	3.0	5.2	1.5	3.0	3.6	0.7	2.8	3.7	4.2	1.5
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 127.8;urinary bladder: 105.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 28.8;EFO-21: 35.8;U-698: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Enhanced	"Focal adhesion sites,Cytosol"			520000	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	19.6	4.2	2.7	29.5	2.8	3.1	12.5	3.0	2.7	42.2	29.9	2.1	19.6	5.0	68.6	14.9	59.7	10.0	37.9	9.3	2.6	2.8	10.9	5.3	11.4	6.0	2.8	1.6	26.1	4.4	4.7	3.2	5.2	3.0	37.7	12.8	8.5	7.0	28.4	11.6	5.9	17.2	127.8	3.2	9.5	12.1	30.7	1.5	5.1	5.4	4.2	7.8	105.1	38.3	5.9	4.9	18.0	4.5	4.3	5.0	1.4	7.5	7.0	5.1	3.4	11.1	11.4	5.5	4.9	6.3	3.6	2.4	12.6	3.6	28.8	35.8	11.2	3.2	1.5	3.3	9.1	3.1	1.7	1.4	5.4	3.3	4.7	0.6	1.7	8.1	4.7	8.1	7.0	6.1	0.0	0.6	6.3	2.4	1.4	0.6	2.0	2.3	1.8	3.8	0.1	4.0	8.0	0.3	0.0	10.6	3.5	6.0	2.7	2.4	13.1	8.4	6.5	6.0	12.2	0.0	1.1	59.7	4.2	1.3	7.6	0.8	4.5	1.9	5.0	4.2	3.2	2.9	4.3	3.6	2.4	5.9	2.3	2.9	18.0	4.3	4.0	4.9	1.6	1.4	2.7	2.8	3.0	2.7	2.6	2.8	2.8	1.6	3.0	1.5
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.0;lymphoid tissue: 75.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 39.3;HMC-1: 65.8;Karpas-707: 56.4;U-2197: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"				"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	16.3	5.6	5.1	34.2	4.7	4.2	5.1	3.5	4.9	4.4	6.7	9.0	4.1	5.1	6.5	5.9	3.8	4.7	7.2	3.9	5.2	5.1	6.3	7.1	19.7	37.2	6.3	2.5	6.6	5.6	3.9	4.8	2.6	5.0	5.7	9.6	6.2	7.6	5.1	2.1	3.7	16.0	4.7	11.4	32.2	5.7	5.9	4.9	75.1	6.8	4.4	52.9	11.2	3.9	19.9	36.5	3.8	19.1	20.1	42.0	20.9	0.3	0.4	0.4	0.7	1.5	1.9	0.2	9.8	39.3	2.4	4.4	0.0	1.0	28.7	0.4	11.9	0.3	0.3	26.7	10.3	12.4	0.1	1.3	0.2	0.1	2.6	7.7	65.8	1.4	0.6	33.9	4.4	15.8	0.3	56.4	19.9	0.2	27.1	9.7	0.3	8.9	0.4	0.5	24.7	1.6	13.7	0.2	0.3	0.4	0.6	3.9	0.5	2.2	15.4	6.2	1.8	39.6	8.8	3.6	3.5	28.2	14.3	7.0	14.0	1.7	19.1	3.1	28.2	11.0	42.0	19.9	29.0	32.4	36.5	11.5	22.6	26.8	3.8	20.1	5.6	33.1	38.7	20.9	5.1	4.7	3.5	4.9	5.2	5.1	6.3	2.5	5.0	4.9
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264531-151015727	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"			190000	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favourable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.6	15.8	7.1	14.7	10.9	7.2	16.5	14.4	8.3	11.3	12.2	7.3	17.9	9.8	12.9	11.8	21.4	11.9	12.7	10.5	6.4	4.3	18.4	10.2	10.1	14.2	7.4	5.6	10.1	13.8	33.0	32.1	8.8	7.7	14.3	13.0	8.3	18.2	15.1	10.5	20.5	14.7	7.9	8.3	11.3	12.8	10.1	7.8	26.5	15.2	11.0	17.9	14.0	12.4	5.7	2.6	5.9	0.8	3.8	7.9	2.3	15.3	7.9	7.2	6.2	7.7	10.6	9.0	3.3	8.8	6.2	6.1	17.0	19.5	17.8	4.1	4.9	7.9	12.0	19.2	9.4	13.3	8.6	12.5	12.2	9.1	4.5	16.8	10.0	8.3	11.5	9.2	14.2	18.7	13.0	12.7	7.3	10.2	12.3	2.1	6.1	5.9	10.0	7.5	6.5	20.1	20.3	18.6	7.5	8.7	17.8	4.3	17.6	3.2	9.9	9.0	6.6	4.9	6.3	11.8	11.5	12.1	14.0	6.9	4.6	5.9	0.7	1.6	7.9	0.3	4.7	5.7	5.3	6.9	1.5	3.5	3.7	5.6	0.2	3.8	0.8	2.6	5.9	2.3	7.1	10.9	14.4	8.3	6.4	4.3	7.4	5.6	7.7	7.8
LRCH1	"CHDC1, KIAA1016"	ENSG00000136141	"Leucine rich repeats and calponin homology domain containing 1"	Q9Y2L9	13	46553168-46753040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 46.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021536	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"				"Actin filaments, Cytosol"	Nucleoli	"HPA021536: AB_1853258"	"unprognostic (7.13e-3)"	"prognostic unfavourable (6.24e-4)"	"unprognostic (3.59e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (6.67e-4)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (5.75e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.04e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.98e-2)"	17.9	5.0	6.5	20.3	5.9	7.2	15.2	46.4	7.2	17.5	14.6	4.6	11.5	7.0	24.6	9.8	10.6	11.9	14.1	8.0	6.3	5.9	13.8	10.9	14.3	13.5	6.6	4.9	9.5	5.1	5.2	13.1	24.1	8.0	12.8	9.3	8.4	11.3	14.5	5.3	18.1	12.0	20.9	8.5	13.7	14.6	5.0	6.0	31.7	7.8	6.4	13.7	16.6	18.3	6.2	2.3	1.8	2.0	5.1	3.6	1.8	4.6	6.7	6.1	6.3	4.5	8.6	15.7	8.0	10.5	10.0	9.5	15.1	8.0	15.0	2.2	7.5	6.8	4.6	8.1	14.5	15.4	4.3	13.4	2.7	7.0	5.6	8.7	23.0	5.4	6.4	9.2	11.3	8.6	2.6	4.5	7.3	9.0	9.3	10.9	3.4	3.6	5.1	6.6	4.0	18.6	4.9	9.7	9.7	4.5	4.5	12.0	3.4	11.7	8.1	5.9	4.0	7.3	7.6	0.8	2.3	6.7	6.9	7.6	7.1	1.5	2.0	1.8	3.6	1.6	2.1	5.3	2.7	2.6	1.9	6.2	2.1	2.1	0.7	5.1	1.2	2.3	1.9	1.8	6.5	5.9	46.4	7.2	6.3	5.9	6.6	4.9	8.0	6.0
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA012380: AB_1853260, HPA017299: "	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	16.4	14.0	19.3	23.4	19.1	11.0	18.0	37.5	19.1	21.9	19.0	28.2	15.6	11.0	24.7	14.8	15.6	18.3	16.7	18.2	15.9	14.5	12.6	14.2	14.8	23.4	19.7	13.1	27.5	12.9	23.7	26.0	15.2	15.4	20.4	16.7	23.6	15.6	22.4	23.0	15.7	15.9	28.3	15.9	18.7	15.0	20.2	20.4	27.0	13.5	9.5	26.0	20.3	18.0	6.9	2.8	22.6	4.8	4.9	6.0	3.3	18.2	6.5	17.6	10.9	21.3	24.3	6.8	13.3	16.1	16.2	19.0	15.4	9.6	10.0	20.9	16.3	12.0	14.7	12.9	21.8	8.0	9.1	16.6	9.7	13.1	14.5	12.7	13.1	16.6	7.8	15.4	19.7	19.1	10.4	16.6	15.2	15.5	9.5	5.5	12.1	13.7	10.0	11.0	7.2	8.6	10.8	8.7	9.5	16.1	12.2	12.8	21.4	11.2	18.6	13.5	7.8	16.3	13.3	15.4	13.8	9.1	12.8	18.1	12.7	22.6	3.4	7.0	5.9	4.8	4.5	6.9	4.6	5.0	2.8	5.7	4.3	6.0	2.3	4.9	4.6	2.6	4.4	3.3	19.3	19.1	37.5	19.1	15.9	14.5	19.7	13.1	15.4	20.4
LRCH4	"LRN, LRRN1"	ENSG00000077454	"Leucine rich repeats and calponin homology domain containing 4"	O75427	7	100574011-100586153	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 44.8;NB-4: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037667, HPA037668"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA037667: AB_10671882, HPA037668: AB_10672910"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (1.61e-7)"	"unprognostic (8.32e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.98e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.63e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.26e-2)"	11.4	15.2	14.5	32.0	25.7	52.7	13.8	19.7	22.2	12.0	14.0	16.4	11.8	22.0	12.3	9.6	14.4	14.0	15.9	10.2	16.2	9.1	16.1	12.2	20.8	39.1	25.8	13.1	23.7	17.3	8.9	22.8	26.4	19.2	14.6	7.2	18.3	23.5	13.0	15.8	15.0	27.8	8.1	25.7	54.5	14.9	43.3	23.1	31.1	20.0	6.8	25.2	9.9	12.0	5.9	6.2	24.2	8.4	1.4	7.3	2.9	7.8	4.4	4.4	4.0	2.6	2.0	8.4	7.6	3.4	4.5	3.6	7.3	11.4	5.6	8.5	2.2	6.7	2.1	3.2	1.2	5.6	5.9	6.5	5.2	3.5	8.4	11.2	44.8	3.4	3.4	3.7	2.1	4.5	8.0	11.7	3.1	14.7	12.8	69.2	4.6	5.2	14.3	3.6	6.9	3.4	2.7	5.7	8.6	3.6	11.6	8.8	7.8	24.4	7.0	6.1	11.0	8.4	4.5	11.9	5.6	5.1	4.7	27.7	10.4	12.6	8.4	11.9	5.2	6.8	4.7	4.7	5.1	5.9	6.2	5.9	7.3	5.9	24.2	1.4	4.7	5.9	5.2	2.9	14.5	25.7	19.7	22.2	16.2	9.1	25.8	13.1	19.2	23.1
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 64.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.4;hTEC/SVTERT24-B: 18.3;U-698: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.7"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol			21000	Cytosol		"HPA011846: "	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (1.50e-4)"	12.6	1.7	22.3	8.1	21.1	2.4	13.4	9.6	31.8	15.5	24.6	20.3	0.7	8.2	12.7	2.6	6.9	13.3	13.8	16.8	24.6	7.1	2.5	15.8	8.6	4.1	19.8	12.4	8.8	64.0	4.2	6.7	2.8	18.9	12.2	7.6	4.8	9.4	4.3	16.6	6.6	7.5	14.5	10.9	2.4	21.2	6.4	19.8	0.2	8.1	5.0	5.0	5.1	5.4	0.3	0.0	0.7	0.0	0.0	2.7	0.4	0.4	0.4	9.3	0.1	2.6	1.6	0.8	1.5	8.7	1.5	4.7	7.3	0.0	23.4	4.0	0.7	0.0	1.8	3.2	3.4	0.0	4.8	0.0	1.4	0.6	0.6	0.2	5.3	2.0	1.8	18.3	3.0	8.0	0.0	0.0	0.3	1.1	0.0	0.0	6.9	0.0	4.2	2.7	1.2	1.7	0.0	1.2	0.3	1.4	1.4	0.0	8.4	2.1	2.4	4.6	2.0	9.1	3.9	1.8	0.8	17.9	8.1	0.0	1.6	0.0	0.0	0.7	0.4	0.0	1.4	0.3	1.1	1.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	2.7	0.4	22.3	21.1	9.6	20.2	24.6	7.1	19.8	12.4	18.9	19.8
LRIG3	"FLJ90440, KIAA3016"	ENSG00000139263	"Leucine rich repeats and immunoglobulin like domains 3"	Q6UXM1	12	58872149-58920522	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010773	Approved		Approved	Cytosol				Cytosol		"HPA010773: AB_1853275"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.46e-2)"	15.8	1.7	3.6	11.8	4.1	0.0	16.4	1.0	3.7	18.7	14.8	7.8	12.1	8.4	14.2	13.8	17.1	9.9	17.8	4.7	4.6	1.8	6.5	6.1	9.6	5.0	3.6	2.6	14.7	15.3	4.8	10.3	6.8	5.8	15.5	16.0	13.5	24.9	11.6	5.0	25.9	10.0	21.6	3.0	7.2	13.5	6.4	6.6	5.4	37.6	15.0	12.8	15.7	20.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	1.9	7.3	0.5	13.4	15.6	1.7	4.9	14.1	4.7	5.0	5.7	2.6	1.9	9.9	5.4	9.4	2.7	12.4	3.4	14.4	9.5	0.5	3.3	2.8	2.6	0.7	0.2	15.5	27.0	5.0	10.8	12.9	0.1	2.4	3.1	0.9	2.3	0.0	7.8	2.9	0.0	6.2	4.7	3.6	10.4	7.4	0.0	4.3	2.7	4.4	5.0	0.1	5.5	6.5	4.4	3.8	6.3	1.0	0.0	0.0	1.3	0.0	3.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	4.1	1.0	3.7	4.6	1.8	3.6	2.6	5.8	6.6
LRIT3	"CSNB1F, FIGLER4, FLJ44691"	ENSG00000183423	"Leucine rich repeat, Ig-like and transmembrane domains 3"	Q3SXY7	4	109848202-109872315	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 17.1"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013454	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"HPA013454: AB_1853277"	"unprognostic (5.41e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.14e-2)"	0.6	0.6	0.7	0.6	1.2	0.4	1.7	2.0	1.3	1.2	0.6	0.6	0.6	0.3	0.7	1.8	0.6	1.0	0.6	0.6	0.8	0.7	4.4	0.7	0.6	0.6	0.6	0.6	0.6	0.7	0.7	0.6	0.6	0.6	0.9	0.5	17.1	0.8	0.6	1.6	3.2	0.6	0.6	0.6	0.8	0.2	1.3	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.1	0.3	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.0	0.6	0.6	0.0	0.1	1.3	0.1	0.2	0.3	1.6	0.3	0.4	0.2	0.1	1.3	0.0	0.0	2.0	0.1	0.3	0.1	0.3	0.6	0.0	0.0	0.9	1.0	0.2	0.2	0.6	0.0	0.2	1.0	0.3	0.5	0.0	0.0	0.4	0.0	0.1	1.2	0.0	0.3	0.3	0.6	0.3	0.6	1.0	0.0	0.3	0.9	0.3	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.7	1.2	2.0	1.3	0.8	0.7	0.6	0.6	0.6	0.6
LRMDA	"C10orf11, CDA017, OCA7"	ENSG00000148655	"Leucine rich melanocyte differentiation associated"	Q9H2I8	10	75431453-76560167	"Disease related genes, Predicted intracellular proteins"	Differentiation		Albinism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 18.0;HMC-1: 14.0;NB-4: 25.9;SK-MEL-30: 36.5;THP-1: 19.4;U-937: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 23.6;myeloid DC: 27.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 27.3;granulocytes: 8.7;monocytes: 23.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047446, HPA050419"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047446: AB_2680050, HPA050419: AB_2756316"	"unprognostic (1.04e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (6.80e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.26e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.64e-2)"	12.7	35.3	4.6	4.7	6.4	13.2	6.1	2.6	3.6	7.1	4.6	8.2	12.5	3.1	12.5	34.9	5.3	5.7	8.9	13.2	3.7	5.1	11.5	19.1	13.1	5.6	7.4	3.1	8.6	21.0	6.8	9.7	6.9	6.7	8.3	4.0	19.8	10.7	8.8	2.2	2.3	4.5	5.3	8.1	7.8	8.6	5.8	5.0	0.1	13.2	6.9	3.9	5.5	5.3	0.0	27.3	8.7	23.6	2.6	0.1	6.7	0.1	2.5	0.1	0.0	1.2	1.5	0.0	0.2	0.0	0.1	0.2	3.0	5.4	0.0	10.6	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.6	1.3	18.0	0.5	3.6	14.0	0.7	0.5	0.2	0.0	0.5	0.0	0.6	0.0	0.3	0.0	25.9	0.1	1.1	0.0	0.1	0.0	0.2	3.3	0.1	0.2	3.2	0.0	36.5	0.2	19.4	0.3	0.1	1.3	0.9	2.0	0.2	0.0	0.0	9.4	17.4	4.6	2.6	23.6	8.7	0.0	11.2	0.1	0.0	0.0	0.0	27.3	0.0	0.0	0.0	1.3	2.6	6.4	0.2	0.0	6.7	4.6	6.4	2.6	3.6	3.7	5.1	7.4	3.1	6.7	5.0
LRMP	JAW1	ENSG00000118308	"Lymphoid restricted membrane protein"	Q12912	12	25004342-25108334	"Predicted intracellular proteins, Predicted membrane proteins"	"Fertilization, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;lymphoid tissue: 69.5"	"Group enriched"	"Detected in some"	6	"Daudi: 94.1;REH: 32.7;U-698: 107.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA002967, HPA018505"	Enhanced		Uncertain	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA002967: AB_1079161, HPA018505: AB_1851988"	"unprognostic (3.78e-2)"	"unprognostic (2.59e-3)"	"unprognostic (7.54e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.97e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.59e-2)"	5.5	1.4	15.1	51.7	2.9	19.2	4.6	0.4	5.6	1.9	3.6	2.1	0.9	3.2	1.4	1.8	3.9	2.3	3.0	1.7	8.1	1.8	5.5	2.3	5.6	57.8	3.5	4.7	2.3	15.1	0.4	2.1	1.7	7.4	2.8	3.5	1.3	4.1	2.1	0.8	2.7	13.2	1.8	5.3	27.6	3.6	0.7	2.8	67.0	3.6	1.7	69.5	10.4	5.7	17.4	5.7	51.8	12.2	12.0	7.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.1	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	5.6	0.0	0.0	0.0	7.2	8.3	0.0	0.0	0.1	0.0	0.0	1.1	6.3	0.0	0.0	7.9	13.4	0.0	0.0	32.7	0.0	9.3	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	0.0	0.0	6.2	1.1	107.6	0.0	3.2	0.0	17.0	5.4	51.8	6.5	10.5	5.4	17.4	4.1	6.6	5.7	13.3	7.1	6.9	39.3	12.0	12.2	5.4	0.7	4.7	15.1	2.9	0.4	5.6	8.1	1.8	3.5	4.7	7.4	2.8
LRRC1	"dJ523E19.1, FLJ10775, FLJ11834, LANO"	ENSG00000137269	"Leucine rich repeat containing 1"	Q9BTT6	6	53794497-53924121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 22.1;HAP1: 21.8;RT4: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031603, HPA031604"	Enhanced		Supported	Cytosol				Cytosol		"HPA031603: AB_10601753, HPA031604: AB_10601224"	"unprognostic (2.90e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.02e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (3.97e-1)"	"prognostic favourable (2.21e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-3)"	13.1	2.3	8.6	7.6	17.0	2.5	12.4	4.0	13.4	12.1	22.6	17.5	7.3	15.3	5.3	8.9	17.2	7.9	12.0	3.8	9.4	6.1	7.3	1.1	7.0	2.4	21.8	6.1	5.7	8.3	24.8	8.0	26.1	11.2	8.3	23.2	7.8	14.9	7.0	1.9	20.2	20.7	6.1	11.9	1.8	13.2	12.3	20.6	8.3	16.3	8.4	9.3	12.3	16.1	1.8	1.4	0.4	0.2	3.3	1.1	0.1	19.9	2.5	2.8	5.0	0.7	0.4	19.8	2.7	5.6	2.4	3.3	22.1	9.9	2.8	2.3	1.7	9.9	21.8	8.8	3.1	3.5	6.3	1.7	2.0	14.8	7.2	2.1	1.3	0.7	7.3	0.2	5.4	4.3	0.4	2.7	1.3	8.7	14.6	0.3	2.2	1.9	3.0	4.7	1.4	6.5	25.8	7.3	0.7	3.3	14.6	4.3	9.5	2.2	1.9	1.8	5.9	0.1	2.5	2.7	2.1	2.0	2.1	3.0	2.2	0.0	0.2	0.4	1.0	0.0	0.4	0.3	0.9	1.1	1.4	1.8	0.8	0.6	0.0	3.3	0.0	1.2	0.1	0.1	8.6	17.0	4.0	13.4	9.4	6.1	21.8	6.1	11.2	20.6
LRRC14	"KIAA0014, LRRC14A"	ENSG00000160959	"Leucine rich repeat containing 14"	Q15048	8	144517992-144525178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021047	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021047: AB_1853298"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"prognostic favourable (1.78e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.04e-3)"	9.4	10.3	11.9	15.0	11.9	9.5	26.5	14.3	22.3	10.4	10.5	15.1	5.0	11.0	13.7	8.9	11.5	10.6	11.3	9.7	12.4	8.2	9.4	8.9	10.0	12.2	15.3	16.0	11.2	17.5	16.9	13.5	8.4	12.7	15.6	7.9	9.4	16.8	12.9	9.8	17.6	10.6	12.7	9.2	11.9	11.0	9.6	12.1	9.7	13.8	6.2	9.8	11.9	9.4	10.6	9.8	4.7	8.6	13.1	10.3	8.7	9.5	19.6	5.3	8.6	5.7	4.7	7.6	8.5	3.7	6.9	6.0	8.7	11.7	7.8	9.1	6.3	10.5	8.3	8.5	3.2	10.4	19.2	11.6	20.9	3.6	5.4	4.9	9.6	5.7	7.3	6.9	3.4	5.9	15.2	9.3	6.7	11.7	18.1	6.4	4.3	28.5	15.5	4.4	10.9	4.2	8.4	14.5	8.1	13.1	10.5	6.1	16.2	5.5	6.3	11.9	21.1	10.4	12.5	5.3	3.1	9.6	11.1	11.4	7.3	1.9	8.6	1.8	10.3	8.1	10.2	9.0	7.7	9.6	8.4	10.6	8.6	7.0	4.7	13.1	6.7	9.8	7.2	8.7	11.9	11.9	14.3	22.3	12.4	8.2	15.3	16.0	12.7	12.1
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191511-195353	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 28.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA038046: AB_10672504, HPA038047: "	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	30.6	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.9	0.4	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	14.3	0.7	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	3.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	7.0	28.5	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.3	0.2	0.0	0.5	0.0
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 111.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039630: AB_10795467"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	1.3	2.5	5.6	1.4	7.2	1.6	1.4	5.2	11.2	3.3	3.2	2.5	0.0	1.4	2.7	3.1	7.1	2.4	2.1	15.8	5.0	3.9	1.2	8.3	2.2	1.7	3.7	6.3	2.2	1.3	2.1	3.6	1.1	4.9	2.6	2.0	1.8	1.8	2.4	111.8	1.6	1.4	3.5	2.0	1.4	1.6	3.5	1.9	1.6	2.6	14.3	3.1	2.2	4.8	0.9	2.6	0.0	1.0	1.1	4.1	1.1	14.6	11.3	7.3	15.6	4.1	3.3	0.0	1.9	6.6	5.0	4.7	9.6	15.3	2.9	7.8	1.4	5.3	7.1	10.6	3.5	8.2	2.3	1.7	2.5	22.0	4.5	4.2	1.4	1.3	3.2	6.9	2.3	9.7	2.1	4.7	4.6	2.3	16.0	3.5	2.4	25.7	13.4	4.2	8.3	6.5	1.5	18.5	8.0	1.2	1.3	5.1	1.9	4.3	5.9	4.0	34.6	5.3	4.5	7.6	13.4	4.8	6.5	17.4	0.8	0.0	0.9	0.0	1.7	1.0	1.4	0.9	1.3	1.9	2.6	0.0	4.1	1.5	0.0	1.1	0.7	0.4	0.2	1.1	5.6	7.2	5.2	11.2	5.0	3.9	3.7	6.3	4.9	1.9
LRRC37B		ENSG00000185158	"Leucine rich repeat containing 37B"	Q96QE4	17	32007872-32053504	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9"									HPA015135	Approved		Approved	Cytosol				Cytosol		"HPA015135: AB_1853309"	"unprognostic (5.46e-3)"	"unprognostic (2.56e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.60e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.72e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.72e-3)"	"unprognostic (6.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-3)"	4.7	5.0	13.7	4.8	15.0	28.5	6.4	35.5	14.4	5.9	5.2	7.2	5.0	4.5	8.3	6.5	4.6	8.2	4.8	2.7	10.7	8.5	3.7	3.0	6.7	5.5	8.6	10.2	12.1	4.3	7.4	13.8	4.6	8.9	5.3	6.4	6.1	6.5	4.2	3.5	11.7	6.3	7.2	8.5	7.6	6.6	24.5	10.3	8.3	4.4	1.8	5.8	5.3	10.2	0.8	1.1	2.8	0.5	6.4	4.9	0.5	2.0	3.9	12.4	7.0	3.1	3.9	3.8	1.8	7.0	5.4	7.0	5.4	2.0	5.6	4.0	4.2	2.8	7.3	1.5	4.3	1.6	6.2	2.6	5.7	2.0	4.6	9.9	4.7	4.1	4.6	5.0	12.6	4.6	6.0	5.4	2.0	1.9	17.3	15.4	3.7	2.6	12.3	2.9	4.5	3.1	5.2	2.3	3.9	4.7	3.1	6.4	8.1	16.1	3.8	3.8	2.6	8.5	4.6	5.4	7.6	5.5	2.7	10.1	2.7	0.0	0.4	2.8	1.1	0.5	2.1	0.2	2.2	3.0	0.8	0.8	3.0	0.8	1.1	6.4	0.2	1.1	4.9	0.5	13.7	15.0	35.5	14.4	10.7	8.5	8.6	10.2	8.9	10.3
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023302-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.1	4.9	7.1	7.0	9.3	12.0	4.5	20.3	10.8	4.6	7.0	5.7	9.5	11.1	4.4	5.0	8.0	10.5	5.8	3.1	7.7	3.9	5.9	12.9	5.6	6.5	8.3	4.7	3.7	15.5	4.5	4.8	4.9	6.5	6.6	3.6	4.9	13.6	5.0	4.3	10.2	9.4	5.2	3.3	7.6	10.4	3.1	9.9	7.1	9.8	6.8	6.5	5.0	5.1	2.3	3.3	5.0	3.2	2.8	4.6	3.1	9.7	11.1	3.4	6.9	1.4	1.9	13.2	6.8	2.8	4.1	3.5	9.9	6.7	7.3	6.2	1.3	11.4	3.2	4.1	0.9	4.4	20.9	4.6	20.2	13.3	1.1	5.4	11.6	1.8	1.7	2.4	0.6	6.0	3.2	3.2	1.0	16.5	12.1	18.1	3.5	14.9	10.0	6.6	4.0	2.6	9.0	10.5	10.2	3.1	16.3	5.7	13.3	6.3	3.5	7.2	9.1	11.4	11.5	6.3	1.6	1.1	3.9	4.7	7.5	5.0	3.2	3.6	3.9	2.4	4.0	1.5	4.5	4.6	2.2	2.3	2.4	3.1	0.2	2.8	1.0	3.3	3.8	3.1	7.1	9.3	20.3	10.8	7.7	3.9	8.3	4.7	6.5	9.9
LRRC46	MGC16309	ENSG00000141294	"Leucine rich repeat containing 46"	Q96FV0	17	47831627-47837713	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 51.2;testis: 94.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 7.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.4"	"Region enriched"	"Detected in many"	4	"pons and medulla: 14.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021882, HPA074893"	Enhanced		Approved	Cytosol				Cytosol		"HPA021882: AB_1853320, HPA074893: "	"unprognostic (1.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (9.24e-2)"	"prognostic favourable (2.11e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-1)"	0.3	0.4	1.8	0.3	3.3	0.6	0.5	0.4	0.5	2.3	0.3	5.2	1.6	0.4	1.5	13.8	0.4	51.2	0.5	0.5	2.0	2.4	0.7	0.4	11.8	0.5	0.3	0.1	8.8	0.5	0.3	4.2	0.4	14.0	0.5	0.3	1.8	0.4	1.3	0.3	0.3	0.3	0.3	0.6	0.5	0.3	94.4	1.1	1.2	1.4	0.0	0.4	0.3	0.1	0.6	2.5	4.4	1.6	2.4	1.0	0.5	1.4	6.3	0.8	3.2	0.5	1.4	1.8	0.2	1.7	1.7	3.3	3.0	1.4	0.6	4.0	0.8	1.4	0.8	1.1	2.6	2.8	2.7	1.2	1.7	1.0	0.3	0.1	1.5	0.0	1.0	3.5	1.3	0.3	1.2	0.8	2.2	2.3	2.1	0.3	0.2	1.3	2.0	0.2	1.3	2.7	1.1	2.6	1.9	0.7	0.0	0.9	7.5	0.2	0.5	3.4	1.3	0.6	0.4	1.4	1.2	1.3	2.3	0.5	0.3	4.4	1.3	2.0	0.2	1.6	0.0	0.6	0.1	1.0	2.5	0.4	0.7	0.0	1.6	2.4	1.5	1.3	0.2	0.5	1.8	3.3	0.4	0.5	2.0	2.4	0.3	0.1	14.0	1.1
LRRC4C	"KIAA1580, NGL-1"	ENSG00000148948	"Leucine rich repeat containing 4C"	Q9HCJ2	11	40114203-41459773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 31.5"	"Group enriched"	"Detected in some"	6	"AF22: 16.9;U-2 OS: 18.6"	"Cancer enhanced"	"Detected in some"		"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054800, HPA075816"	Approved		Approved	Cytosol				Cytosol		"HPA054800: , HPA075816: "	"unprognostic (4.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (7.62e-3)"	"unprognostic (4.87e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-13)"	"unprognostic (5.05e-4)"	"unprognostic (5.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-3)"	1.6	5.7	20.2	1.6	23.7	0.5	2.6	3.6	31.5	5.3	1.9	3.3	0.0	1.1	2.3	1.0	1.2	1.3	1.8	2.6	16.7	8.7	0.9	2.1	1.6	1.4	7.5	10.3	1.6	1.0	4.3	3.2	0.5	8.7	1.5	1.6	1.3	1.4	3.0	0.7	0.7	1.3	2.4	6.0	1.3	0.9	0.9	7.9	0.0	4.0	0.0	1.6	1.1	1.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	18.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	23.7	3.6	16.4	16.7	8.7	7.5	10.3	8.7	7.9
LRRC57	FLJ36812	ENSG00000180979	"Leucine rich repeat containing 57"	Q8N9N7	15	42537820-42548802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040894	Approved		Approved	Mitochondria,Cytosol			230000	"Mitochondria, Cytosol"		"HPA040894: AB_10794996"	"unprognostic (8.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.73e-2)"	"prognostic favourable (2.15e-4)"	"unprognostic (7.45e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	13.9	14.7	15.8	11.6	13.6	32.7	19.2	12.4	19.1	11.8	16.0	10.6	9.7	12.3	15.7	12.2	18.0	15.3	10.2	15.6	18.0	8.4	14.2	11.1	15.9	11.2	11.8	16.5	17.6	14.5	13.2	12.2	14.4	9.9	12.3	18.9	16.4	15.7	11.6	11.0	16.5	14.5	12.8	10.3	13.0	14.1	12.4	11.3	14.9	15.1	10.0	12.8	13.1	15.6	4.8	6.9	22.1	12.0	11.1	6.7	4.3	10.3	7.8	14.3	10.7	11.8	9.4	7.7	14.8	7.9	10.5	11.1	16.1	8.3	4.9	10.4	11.5	17.0	9.5	11.6	10.6	10.2	8.9	19.3	17.3	7.2	11.5	11.9	12.4	10.3	15.5	9.5	11.8	16.7	14.8	11.7	9.5	4.8	6.9	5.3	3.8	7.1	10.9	13.7	7.6	7.2	16.9	7.4	8.8	17.1	12.4	8.6	11.5	14.2	17.0	12.6	8.9	13.0	11.0	9.9	24.6	20.1	7.2	12.0	15.5	22.1	6.5	20.5	5.4	9.4	6.7	4.2	5.2	4.9	6.9	4.8	4.3	5.3	8.5	11.1	12.0	4.0	5.2	4.3	15.8	13.6	12.4	19.1	18.0	8.4	11.8	16.5	9.9	11.3
LRRC58		ENSG00000163428	"Leucine rich repeat containing 58"	Q96CX6	3	120324509-120349339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057574	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA057574: "	"unprognostic (7.87e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.98e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (6.18e-4)"	"unprognostic (1.06e-1)"	15.8	30.1	12.7	10.7	14.3	10.0	15.4	13.9	14.8	15.4	13.3	16.3	11.3	9.6	14.5	11.3	14.6	11.0	9.7	9.6	12.9	9.6	19.2	14.1	10.9	12.7	15.9	10.5	19.7	13.1	21.0	9.8	12.1	14.4	15.1	9.9	13.2	11.6	12.1	9.2	13.8	12.2	15.5	22.9	14.6	10.0	7.9	15.5	27.9	18.3	9.0	11.0	17.2	16.1	5.7	6.4	3.5	5.8	3.7	8.4	3.4	24.5	8.7	6.0	7.6	13.8	13.2	9.5	8.8	7.7	9.4	11.9	8.1	7.6	16.1	11.1	9.4	10.8	10.9	8.7	18.1	6.2	6.8	17.2	11.9	9.4	9.3	27.8	8.9	9.7	11.2	11.5	14.8	5.5	9.7	20.8	10.2	11.2	21.8	8.9	6.0	15.9	4.8	16.0	10.4	7.2	9.1	7.7	10.2	15.6	10.7	22.0	11.7	12.6	8.2	15.9	17.7	10.6	11.1	17.9	20.5	34.2	16.0	21.1	13.2	2.4	5.8	2.3	4.4	5.1	6.4	5.4	5.5	5.6	5.5	5.7	8.4	6.2	3.5	3.7	3.9	6.4	5.4	3.4	12.7	14.3	13.9	13.5	12.9	9.6	15.9	10.5	14.4	15.5
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"	Q96NW7	1	69568398-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 29.1"	"Group enriched"	"Detected in some"	6	"HaCaT: 10.3;HEL: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 1.4;T-cells: 1.7"	"Low region specificity"	"Detected in many"							HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	1.0	1.3	20.2	1.0	29.1	1.0	0.8	0.5	21.9	1.2	1.9	5.0	0.0	1.0	1.2	1.0	1.3	0.8	3.2	2.8	15.4	5.8	2.8	1.2	0.8	0.9	4.4	17.6	1.0	2.7	0.7	0.4	1.2	2.4	1.5	2.4	0.2	0.9	1.1	2.8	1.1	1.3	1.2	2.5	0.8	0.8	5.8	7.6	0.0	6.7	0.0	0.8	0.9	0.5	0.0	0.1	1.4	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.3	0.0	10.3	0.2	0.0	0.0	0.0	0.5	30.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	20.2	29.1	0.5	19.2	15.4	5.8	4.4	17.6	2.4	7.6
LRRC73	"C6orf154, dJ337H4.2"	ENSG00000204052	"Leucine rich repeat containing 73"	Q5JTD7	6	43506969-43510686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5;testis: 31.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.2;MCF7: 6.2;T-47d: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046698	Enhanced		Approved	Cytosol				Cytosol		"HPA046698: AB_10959526"	"unprognostic (3.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.89e-2)"	1.2	6.1	10.4	0.9	19.4	0.8	1.1	2.3	23.5	1.4	1.3	2.3	0.9	2.1	1.4	1.5	1.0	11.3	1.8	1.8	8.9	5.2	3.0	1.2	1.6	0.9	3.1	12.1	2.0	2.8	7.5	4.1	1.2	6.2	1.9	1.1	0.6	1.4	2.1	1.0	1.1	1.2	1.5	1.1	1.2	1.8	31.6	1.8	0.0	1.6	0.0	0.9	1.4	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.9	6.2	1.0	3.2	0.2	0.2	1.8	0.5	0.3	0.0	0.3	0.2	0.1	1.1	2.4	0.7	0.7	0.0	0.1	1.0	0.0	0.4	0.2	1.0	0.0	0.1	0.5	1.2	2.0	0.3	0.2	0.4	0.6	1.1	6.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	1.6	0.0	2.3	2.7	0.6	0.4	0.2	6.3	0.0	0.3	0.5	0.6	2.3	0.2	0.6	0.4	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	19.4	2.3	23.5	8.9	5.2	3.1	12.1	6.2	1.8
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 42.3"	"Cell line enhanced"	"Detected in some"		"HEL: 11.8;HUVEC TERT2: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	1.0	8.9	5.2	2.8	3.7	1.7	0.6	0.7	6.3	2.2	26.3	1.5	1.4	15.0	1.9	0.5	0.4	0.9	0.5	0.4	4.1	2.4	0.8	0.2	1.6	1.9	1.6	3.2	1.8	1.6	3.7	4.1	1.5	2.1	1.1	10.4	1.9	0.3	1.7	0.4	0.4	42.3	3.0	0.8	6.4	1.3	8.5	0.4	0.5	1.2	0.0	1.9	1.3	0.7	0.8	0.0	0.3	0.6	0.3	0.6	0.2	1.1	1.0	1.2	0.8	0.3	0.5	0.1	0.3	0.8	2.7	2.2	1.1	0.3	0.0	0.8	0.1	0.4	0.3	0.2	0.1	0.4	0.9	11.8	0.6	0.0	0.4	0.2	0.9	0.0	0.0	0.6	0.0	3.8	0.5	0.2	0.0	1.9	1.9	0.8	0.2	0.1	0.6	0.7	0.1	0.5	0.2	2.3	0.6	0.0	0.2	2.8	0.2	0.1	0.0	0.3	1.4	0.9	1.5	1.5	0.3	0.2	0.1	0.7	1.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.6	0.3	0.3	0.6	0.0	0.0	0.2	5.2	3.7	0.7	6.3	4.1	2.4	1.6	3.2	2.1	0.4
LRRC75B	"C22orf36, FAM211B, MGC131773"	ENSG00000178026	"Leucine rich repeat containing 75B"	Q2VPJ9	22	24585620-24593208	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.3;MCF7: 7.4;SH-SY5Y: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.7;NK-cell: 2.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.7;NK-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002540	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA002540: AB_1079263"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.69e-2)"	4.2	1.9	7.5	1.4	6.0	3.0	2.6	3.8	6.6	3.5	3.8	2.6	11.5	1.4	2.4	5.8	3.4	3.3	9.8	4.3	5.5	9.1	6.0	3.4	1.7	1.7	7.8	4.0	7.3	7.2	1.4	1.5	2.3	4.1	6.9	2.0	4.9	7.5	15.0	10.7	4.3	8.2	6.7	7.0	2.7	2.6	8.3	0.5	0.0	8.6	3.0	2.1	5.5	2.7	0.0	0.3	2.7	0.4	2.0	0.2	0.0	0.1	4.2	0.0	2.3	0.6	1.7	0.4	0.6	0.7	1.5	1.6	3.0	0.0	0.0	1.0	1.2	4.7	0.4	2.3	0.0	1.3	2.8	0.3	0.6	8.3	4.2	0.0	0.0	0.0	1.7	1.5	0.2	1.1	0.4	0.0	0.1	7.4	0.0	1.5	2.1	1.7	0.0	0.2	0.0	1.9	0.4	2.2	6.6	2.2	0.7	0.6	0.0	0.7	2.3	2.5	1.6	0.9	0.8	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.3	2.7	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	7.5	6.0	3.8	5.6	5.5	9.1	7.8	4.0	4.1	0.5
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627576-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA006979	Approved		Supported	Cytosol			120000	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	27.2	9.9	11.2	28.6	9.4	28.5	31.3	8.8	14.5	28.0	30.9	5.4	16.4	13.7	36.3	24.1	30.1	18.5	23.3	30.7	11.1	12.0	32.1	27.6	29.9	25.5	7.7	10.0	18.0	10.4	31.3	14.2	16.8	12.2	27.5	16.3	8.2	20.2	14.4	52.7	12.6	19.8	56.8	7.4	27.9	21.5	7.3	5.8	27.6	19.0	23.1	19.4	49.3	39.5	12.8	17.6	71.6	33.1	9.3	19.9	10.6	22.2	11.5	5.5	11.1	7.9	15.7	18.5	16.8	16.1	9.1	9.1	4.4	15.0	1.9	6.7	25.8	18.7	12.6	23.2	19.5	72.9	8.2	17.7	13.1	12.4	15.9	23.3	16.9	7.0	48.8	21.1	51.9	18.4	13.0	18.3	19.5	10.8	13.5	17.8	7.2	10.6	20.1	32.3	18.1	29.1	32.6	11.3	7.5	7.8	17.9	21.2	10.1	29.4	32.2	11.0	10.7	11.8	17.6	3.7	3.1	12.5	16.0	23.6	12.0	14.3	22.8	49.4	16.5	19.7	12.4	11.0	19.9	17.1	17.6	12.8	10.6	11.8	71.6	9.3	33.1	15.5	15.3	10.6	11.2	9.4	8.8	14.5	11.1	12.0	7.7	10.0	12.2	5.8
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	"Leucine rich repeat kinase 1"	Q38SD2	15	100919215-101078254	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.1;Karpas-707: 17.0;U-266/84: 15.4;U-698: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010537	Uncertain		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA010537: AB_1079283"	"unprognostic (3.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (5.71e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.25e-2)"	6.1	1.9	4.5	26.3	3.9	6.5	5.0	2.1	8.1	6.4	8.0	5.9	2.2	2.9	7.9	6.0	5.4	7.1	4.2	3.4	4.0	1.5	2.7	1.0	4.7	15.0	4.5	4.0	6.3	5.3	2.8	2.3	4.4	2.5	7.1	6.5	2.8	7.7	6.8	1.6	7.3	8.5	5.7	3.7	11.1	3.9	5.1	3.4	1.2	3.5	2.1	17.4	7.5	6.7	2.3	3.3	3.2	1.1	0.0	0.0	0.1	0.8	4.7	0.0	0.0	7.3	7.5	0.0	2.8	2.1	2.6	1.8	0.8	2.1	23.1	1.0	7.7	4.7	0.6	0.5	1.3	0.4	1.1	7.0	1.0	0.0	0.5	3.7	5.4	5.9	1.0	1.7	1.5	4.7	1.1	17.0	0.5	0.0	0.0	2.3	0.2	2.0	1.6	0.4	6.3	0.0	0.0	0.0	1.6	1.8	2.7	5.3	0.3	4.5	5.4	0.0	0.8	1.0	0.0	8.7	15.4	15.0	0.3	0.5	4.3	0.0	0.7	3.2	0.0	0.3	0.0	2.3	0.0	0.0	0.9	1.5	0.0	0.0	0.8	0.0	1.1	3.3	0.0	0.1	4.5	3.9	2.1	8.1	4.0	1.5	4.5	4.0	2.5	3.4
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.5;brain: 23.8"	"Cell line enhanced"	"Detected in some"		"AF22: 14.6;BJ: 8.2;BJ hTERT+: 18.0;SH-SY5Y: 26.2;T-47d: 14.3"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043820: , HPA046792: "	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.8	26.5	12.7	1.6	21.2	1.1	2.1	20.0	23.8	3.6	1.4	1.9	0.8	1.0	1.0	3.1	1.9	1.3	1.6	9.0	10.4	10.7	0.9	2.7	8.7	3.6	7.7	13.0	7.9	1.5	0.7	4.9	6.7	9.0	4.7	1.6	0.8	1.9	6.4	4.0	0.8	2.1	1.0	2.9	2.0	0.9	16.4	6.3	8.8	22.3	0.0	4.4	1.6	1.3	0.2	0.0	0.1	0.0	0.0	20.3	4.0	0.0	0.0	14.6	1.7	6.8	2.9	0.0	8.2	18.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	7.1	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	26.2	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	1.2	0.0	0.0	20.3	18.4	0.1	0.0	0.0	0.0	0.2	4.0	12.7	21.2	20.0	23.8	10.4	10.7	7.7	13.0	9.0	6.3
LRSAM1	"CMT2P, FLJ31641"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451486-127503501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol				Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favourable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favourable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	9.5	13.6	15.6	10.1	17.2	15.3	9.2	24.2	22.6	10.7	18.0	15.3	10.9	10.8	12.6	17.6	12.3	11.0	11.9	18.7	13.3	17.3	11.2	15.6	11.7	11.5	13.5	22.7	16.0	9.6	17.6	11.8	9.2	17.9	13.6	8.6	10.2	11.9	13.7	20.4	28.3	11.1	16.0	18.7	12.6	12.2	6.1	13.9	5.5	11.6	9.6	11.5	17.2	12.9	4.1	5.4	17.4	6.6	1.3	4.8	3.2	5.7	8.7	5.3	10.1	8.9	8.8	8.3	5.4	6.7	8.3	6.2	10.0	5.6	9.8	5.5	7.5	18.9	6.4	11.3	3.3	10.4	4.9	5.3	11.3	8.7	7.1	5.8	11.2	5.1	9.3	5.7	10.9	8.9	4.7	10.2	3.6	14.4	4.1	5.1	5.0	8.8	6.7	4.7	15.3	9.0	5.0	9.7	8.0	3.5	12.0	7.0	24.6	3.1	10.4	5.6	5.7	7.0	3.6	11.3	8.4	1.6	9.2	5.4	2.9	14.6	4.9	17.4	4.4	6.6	4.8	4.1	3.0	3.7	5.4	3.1	1.5	2.0	5.7	1.3	5.5	4.6	2.4	3.2	15.6	17.2	24.2	22.6	13.3	17.3	13.5	22.7	17.9	13.9
LRTM2		ENSG00000166159	"Leucine rich repeats and transmembrane domains 2"	Q8N967	12	1820267-1836752	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"brain: 18.7"	"Group enriched"	"Detected in some"	8	"HEL: 9.0;SCLC-21H: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055094, HPA062745"	Uncertain		Approved	Cytosol				Cytosol		"HPA055094: , HPA062745: "	"unprognostic (1.84e-3)"			"unprognostic (4.83e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.24e-1)"		"unprognostic (6.20e-4)"	"unprognostic (2.21e-1)"	"unprognostic (8.02e-2)"		0.7	0.7	5.1	0.7	12.3	0.7	0.7	0.8	18.7	0.7	0.7	1.7	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.7	3.3	5.0	0.7	0.7	0.7	0.7	1.7	10.5	0.7	0.7	0.7	0.1	0.7	4.7	0.7	0.7	0.1	0.7	0.8	0.7	0.7	0.7	0.7	1.7	0.7	0.8	0.9	4.3	0.0	0.7	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.3	0.8	18.7	3.3	5.0	1.7	10.5	4.7	4.3
LSAMP	"IGLON3, LAMP"	ENSG00000185565	"Limbic system-associated membrane protein"	Q13449	3	115802363-117139389	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell line enhanced"	"Detected in some"		"AF22: 6.8;SH-SY5Y: 13.9;WM-115: 33.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054051, HPA076122"			Enhanced	Cytosol			200000000	Cytosol		"HPA054051: , HPA076122: "	"unprognostic (4.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.97e-3)"	"unprognostic (6.03e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.31e-2)"	2.3	12.7	21.9	4.3	23.7	1.1	1.6	43.4	48.4	17.8	5.5	16.6	0.0	1.9	4.4	2.8	3.4	2.9	11.3	2.1	23.7	18.8	2.5	1.0	8.5	4.0	17.6	21.5	4.8	11.1	0.6	3.1	1.2	18.3	21.1	3.5	1.2	1.7	6.2	0.7	4.6	1.9	3.3	13.1	1.7	3.2	3.9	21.3	0.0	4.2	0.0	5.2	7.3	3.4	1.6	0.4	3.0	0.8	0.3	1.0	0.3	0.2	2.2	6.8	0.2	0.7	2.1	0.7	0.6	0.3	0.2	0.7	0.2	0.4	0.5	0.2	3.5	0.1	0.1	0.1	0.3	0.5	0.1	0.2	0.7	0.3	0.1	0.5	0.3	1.7	0.0	0.8	0.1	0.0	0.3	2.3	0.0	0.2	0.7	0.6	2.6	0.8	0.2	0.1	0.1	1.7	1.6	1.6	13.9	0.0	0.1	2.1	0.2	0.8	0.1	1.5	1.3	1.7	0.4	1.4	1.8	0.2	0.4	0.2	33.8	3.0	0.8	1.4	0.9	0.5	1.0	0.7	0.6	0.5	0.2	1.6	1.0	0.7	2.8	0.3	0.6	0.4	0.5	0.3	21.9	23.7	43.4	23.7	23.7	18.8	17.6	21.5	18.3	21.3
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640788-194672477	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	20.4	17.8	14.2	17.9	20.7	28.8	21.8	14.5	18.9	17.7	18.5	19.2	16.6	20.4	21.6	24.8	22.5	18.3	15.3	17.8	13.3	15.1	20.4	30.6	18.2	20.2	19.9	13.3	21.9	25.6	20.6	24.4	24.2	23.8	21.0	22.3	15.9	19.8	22.2	30.1	26.0	20.0	18.0	16.3	22.2	18.5	18.6	15.9	25.0	23.5	15.8	28.1	18.7	20.3	13.2	14.0	10.7	10.6	17.0	14.9	8.2	20.5	13.7	8.3	13.9	13.0	7.1	16.9	12.4	12.0	17.0	15.1	18.0	9.5	16.3	37.3	11.3	15.0	26.2	14.1	20.7	21.0	12.6	17.4	14.2	10.2	9.3	19.1	16.9	6.9	12.2	17.6	16.4	18.4	14.5	18.1	14.0	28.7	17.2	11.4	22.6	25.2	20.9	13.7	18.4	9.1	17.9	15.8	10.9	16.1	14.7	15.0	34.7	12.5	14.0	13.0	14.8	18.2	25.3	20.0	26.2	38.7	10.4	24.7	20.0	2.8	8.1	10.7	13.5	10.6	14.9	13.2	11.0	11.9	14.0	11.0	12.9	11.5	1.1	17.0	7.1	7.4	12.2	8.2	14.2	20.7	14.5	18.9	13.3	15.1	19.9	13.3	23.8	15.9
LSM1	"CASM, YJL124C"	ENSG00000175324	"LSM1 homolog, mRNA degradation associated"	O15116	8	38163321-38176730	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024601			Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA024601: AB_1853379"	"unprognostic (1.19e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.97e-1)"	21.8	27.6	25.5	20.0	23.5	21.6	34.1	20.8	23.2	19.5	23.4	15.3	21.2	20.6	24.9	27.2	24.9	17.8	21.6	44.2	21.2	23.2	35.3	30.7	16.2	22.5	25.1	18.4	18.0	24.7	14.5	23.2	29.8	22.5	21.3	21.5	18.7	27.7	29.0	26.6	17.7	26.3	31.3	17.1	20.5	22.6	17.6	19.9	18.8	25.7	25.6	22.2	23.5	22.7	21.1	38.2	42.8	26.0	19.9	27.3	26.5	21.5	25.3	14.9	18.2	27.4	23.0	13.8	26.4	26.9	24.5	26.2	17.3	14.9	10.7	23.7	31.3	11.5	20.1	21.8	25.8	16.2	25.3	33.7	18.1	21.3	24.3	11.4	21.5	24.0	20.1	21.2	16.8	20.8	26.7	25.5	30.2	22.9	35.5	22.3	23.4	25.8	17.3	16.3	12.6	33.8	24.0	28.0	23.3	11.7	17.5	31.1	13.9	24.5	21.9	21.9	26.9	32.2	20.8	28.2	36.6	21.1	25.3	23.8	22.3	42.8	24.0	32.7	21.8	24.7	23.2	21.1	24.5	23.8	23.2	16.4	22.2	25.5	18.3	19.9	26.0	38.2	27.3	26.5	25.5	23.5	20.8	23.2	21.2	23.2	25.1	18.4	22.5	19.9
LSM12	FLJ30656	ENSG00000161654	"LSM12 homolog"	Q3MHD2	17	44034635-44067619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051934	Approved		Approved	Cytosol				Cytosol		"HPA051934: "	"unprognostic (3.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.98e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (7.49e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavourable (1.18e-7)"	"unprognostic (8.91e-3)"	"unprognostic (2.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.18e-2)"	26.7	26.6	26.9	19.8	22.1	30.1	35.1	22.5	30.0	19.5	23.8	23.0	20.7	20.8	22.6	31.5	32.8	18.8	23.8	42.7	24.6	28.9	24.8	44.8	20.4	26.8	25.5	21.2	24.5	36.8	27.4	23.7	30.5	20.4	20.7	30.0	21.7	21.8	26.6	40.8	19.6	19.6	29.2	23.6	23.4	23.4	37.5	18.6	27.7	24.2	17.4	29.1	30.5	19.8	25.4	36.3	16.8	40.1	22.8	29.4	27.0	20.2	22.7	16.0	25.1	21.2	23.1	28.8	23.2	22.8	29.4	29.8	26.1	22.4	33.9	16.8	26.0	16.7	33.6	29.9	44.8	25.2	35.1	23.6	17.6	31.4	19.5	40.7	25.3	20.5	24.2	27.7	40.2	25.4	34.1	25.2	20.0	20.0	38.6	22.3	23.5	32.1	24.7	31.5	32.8	27.4	30.2	22.4	14.8	18.6	20.3	24.1	42.2	27.1	22.5	37.7	22.3	20.3	37.5	20.0	20.5	37.2	32.1	29.2	28.3	16.7	32.6	13.6	26.3	40.1	29.4	25.4	29.3	27.9	36.0	23.0	26.3	25.8	16.8	22.8	36.8	36.3	28.7	27.0	26.9	22.1	22.5	30.0	24.6	28.9	25.5	21.2	20.4	18.6
LSM14A	"C19orf13, DKFZP434D1335, FAM61A, RAP55, RAP55A"	ENSG00000257103	"LSM14A, mRNA processing body assembly factor"	Q8ND56	19	34172504-34229515	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Repressor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017961	Approved		Supported	"Cytosol,Cytoplasmic bodies"				"Cytoplasmic bodies"	Cytosol	"HPA017961: AB_1845610"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.62e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.56e-1)"	22.7	22.9	20.8	28.4	23.7	78.7	36.1	33.4	24.9	26.4	26.2	20.3	21.2	13.4	31.5	51.6	22.2	21.0	20.8	22.5	21.3	18.9	33.9	30.7	25.6	32.7	24.6	19.3	30.3	18.2	32.1	18.5	38.1	23.1	27.8	21.8	21.0	20.2	30.2	38.8	38.3	25.9	29.0	25.6	23.2	17.9	20.1	25.7	42.1	37.9	21.5	23.2	26.6	25.3	8.2	10.7	16.4	10.1	10.9	12.0	7.6	1.0	0.4	1.6	1.9	0.7	2.1	0.8	0.7	4.6	0.6	0.9	1.6	1.1	2.0	0.6	1.3	0.2	7.0	10.1	12.9	0.9	1.2	0.4	2.9	1.8	11.5	1.2	0.8	8.3	6.4	1.2	2.0	1.5	0.8	0.0	9.8	3.1	5.8	8.3	9.9	0.1	1.6	0.4	4.8	8.0	0.1	1.0	2.9	0.6	13.0	7.9	1.4	27.6	0.5	1.7	1.4	0.0	0.6	0.4	4.1	4.4	10.0	4.4	0.6	11.2	8.2	16.4	10.5	10.0	12.0	7.8	9.1	8.5	10.7	8.2	10.4	9.6	6.1	10.9	10.1	2.8	8.9	7.6	20.8	23.7	33.4	24.9	21.3	18.9	24.6	19.3	23.1	25.7
LSMEM1	"C7orf53, FLJ39575"	ENSG00000181016	"Leucine rich single-pass membrane protein 1"	Q8N8F7	7	112480853-112491062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 51.3;tongue: 19.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.6"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013753, HPA047988"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA013753: AB_1848926, HPA047988: "	"unprognostic (6.87e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.47e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.42e-2)"	1.1	0.7	0.6	0.6	0.6	0.8	0.9	3.6	0.7	0.6	0.6	0.6	0.6	1.3	0.6	1.7	0.7	0.4	0.6	2.1	0.7	0.8	1.4	3.5	1.8	0.6	0.7	0.6	0.6	2.8	0.3	0.9	0.6	0.6	0.9	0.8	0.6	1.9	0.6	51.3	0.8	0.8	0.6	0.6	1.9	0.8	1.1	0.6	0.6	0.9	19.2	1.5	0.6	0.6	0.0	0.1	2.7	0.1	0.0	0.2	2.2	0.8	1.3	0.7	2.8	2.8	3.1	0.1	1.3	0.9	0.6	0.5	2.2	1.8	1.2	1.9	0.3	0.7	0.8	0.9	1.2	0.6	0.8	0.8	12.3	2.2	1.3	1.2	0.6	2.2	3.7	0.8	0.8	0.7	0.9	2.8	0.4	1.0	1.0	3.6	0.6	0.9	0.4	0.2	0.6	2.4	1.4	2.6	1.4	2.2	1.1	1.5	0.4	0.5	0.5	2.8	1.0	0.8	1.0	0.8	1.7	1.1	0.8	0.8	0.8	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	2.2	0.6	0.6	3.6	0.7	0.7	0.8	0.7	0.6	0.6	0.6
LSR	"ILDR3, LISCH7"	ENSG00000105699	"Lipolysis stimulated lipoprotein receptor"	Q86X29	19	35248330-35267964	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.3;pancreas: 98.6"	"Cell line enhanced"	"Detected in many"		"A-431: 89.3;CACO-2: 39.1;CAPAN-2: 41.6;HaCaT: 37.5;RT4: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007270	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			2100000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA007270: AB_1079253"	"unprognostic (3.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.42e-2)"	"prognostic favourable (8.09e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.54e-2)"	5.0	11.2	2.9	20.9	4.0	0.9	12.4	2.0	4.5	8.7	32.8	4.0	24.4	29.5	6.5	21.4	20.3	10.6	58.2	2.6	3.4	3.1	15.7	106.3	21.1	17.0	4.1	2.6	4.8	98.6	6.2	13.4	36.6	7.1	11.2	15.4	40.9	26.2	33.8	1.9	16.8	39.5	1.8	3.8	9.1	46.7	21.0	1.9	3.4	24.0	20.1	20.9	9.9	9.5	5.3	0.3	5.9	0.2	6.1	7.1	3.2	89.3	1.5	0.1	0.2	0.2	0.1	16.2	0.2	0.3	0.4	0.3	39.1	41.6	3.5	13.8	0.2	37.5	8.3	13.7	0.0	5.4	15.1	0.0	1.2	17.3	0.3	0.0	0.1	0.2	15.3	0.3	4.5	0.1	14.1	3.2	0.2	31.7	0.1	0.1	12.8	0.5	0.7	0.1	9.7	8.6	36.2	7.1	0.2	7.5	24.4	6.7	20.9	0.5	0.0	0.7	8.6	0.5	0.4	5.1	9.0	8.1	0.6	0.1	2.2	5.9	0.2	0.2	3.3	0.0	3.3	5.3	7.1	6.7	0.1	4.1	5.5	6.0	0.1	6.1	0.0	0.3	4.8	3.2	2.9	4.0	2.0	4.5	3.4	3.1	4.1	2.6	7.1	1.9
LSS	OSC	ENSG00000160285	"Lanosterol synthase"	P48449	21	46188141-46228824	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Isomerase	"Cataract, Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032060, HPA032062, CAB034116"	Supported		Approved	Cytosol				Cytosol		"CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: "	"unprognostic (2.78e-3)"	"unprognostic (8.53e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"prognostic unfavourable (6.80e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (3.07e-4)"	21.1	22.9	17.9	9.9	38.8	5.0	14.7	22.5	33.9	11.2	16.9	37.7	5.8	26.4	16.6	12.5	23.4	11.0	12.1	17.8	19.0	17.3	8.4	33.8	19.7	8.3	49.5	14.9	25.7	15.8	10.4	22.7	10.3	42.7	24.0	10.7	13.2	11.0	13.2	24.5	26.2	10.3	12.2	33.3	7.1	14.1	13.8	46.9	6.0	7.5	9.8	8.3	12.3	11.8	4.8	8.0	5.2	3.3	2.7	8.3	5.0	20.0	6.5	21.2	9.0	28.8	27.7	5.9	7.8	55.1	9.6	18.9	21.4	16.0	4.3	6.6	15.0	9.6	18.7	32.5	3.9	4.2	10.0	10.7	10.7	13.8	26.3	3.9	7.5	27.3	12.4	17.9	7.7	7.9	10.4	26.0	8.2	6.8	8.4	5.6	34.5	5.9	10.0	6.5	26.2	24.9	11.1	12.4	11.0	9.1	7.1	8.0	11.3	9.7	11.8	11.4	9.3	10.0	6.0	9.5	8.1	8.7	11.9	17.2	4.9	5.2	3.3	3.5	6.9	3.0	4.7	4.8	5.0	8.3	3.8	3.0	4.2	6.2	0.0	2.7	2.5	8.0	2.3	5.0	17.9	38.8	22.5	33.9	19.0	17.3	49.5	14.9	42.7	46.9
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000828-96043520	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol			85000000	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favourable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favourable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	27.9	33.2	11.2	21.5	16.7	55.7	19.0	24.1	15.6	27.2	29.1	13.1	16.7	27.6	27.6	14.1	53.4	22.7	14.5	19.2	10.6	12.2	27.2	19.4	68.0	33.4	12.3	11.3	49.9	28.2	21.2	31.8	11.3	13.3	29.6	17.8	20.7	21.1	16.1	20.6	23.6	41.2	21.5	13.3	44.3	22.1	13.7	11.5	29.2	38.8	22.3	43.1	30.1	25.2	20.6	35.3	6.1	84.2	14.2	9.0	54.6	23.5	25.4	35.7	21.3	31.0	34.7	15.6	9.9	29.3	19.6	22.8	18.6	20.5	52.9	12.4	14.7	31.1	29.2	40.3	26.8	18.1	28.3	19.4	16.3	22.5	18.3	10.2	11.8	33.0	34.0	27.0	33.1	38.7	11.8	9.3	28.2	16.2	26.8	31.5	41.6	34.5	25.2	26.6	30.5	35.9	30.1	18.5	21.9	20.0	23.4	21.4	29.0	12.5	13.8	8.3	14.0	11.8	10.7	12.6	21.8	24.5	5.9	18.6	6.5	0.4	76.0	2.2	4.5	84.2	8.4	15.1	6.3	5.8	35.3	20.6	9.0	6.7	6.1	14.2	73.2	8.7	6.3	54.6	11.2	16.7	24.1	15.6	10.6	12.2	12.3	11.3	13.3	11.5
LTBP1		ENSG00000049323	"Latent transforming growth factor beta binding protein 1"	Q14766	2	32946972-33399509	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 104.0;HSkMC: 33.5;HUVEC TERT2: 34.0;U-87 MG: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005707, CAB025428"	Approved		Approved	Cytosol	"Secreted to extracellular matrix"		200000000	Cytosol		"CAB025428: , HPA005707: AB_1853394"	"unprognostic (1.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (4.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (1.62e-4)"	10.4	4.9	4.5	16.3	5.4	3.4	9.2	1.3	3.9	66.7	15.6	9.5	10.2	3.6	28.5	22.9	22.9	21.7	64.9	45.6	5.7	2.9	10.6	6.5	15.5	3.4	3.5	4.9	23.4	3.1	0.6	7.0	28.7	11.7	29.6	6.1	10.0	10.6	27.6	8.0	6.6	8.6	38.9	10.9	3.7	22.7	16.2	4.7	2.1	4.4	16.4	10.0	37.4	18.1	0.1	0.3	4.3	0.1	0.0	0.1	8.1	0.0	2.2	5.6	0.0	4.7	104.0	2.4	8.0	16.7	1.1	1.6	4.3	0.8	7.0	0.1	1.0	0.4	0.1	0.2	3.9	0.1	2.7	23.2	2.7	0.6	21.5	0.0	2.8	33.5	0.7	24.9	1.2	34.0	1.4	0.0	8.9	3.3	0.9	0.0	3.9	6.8	0.8	11.6	0.1	0.0	3.8	1.1	0.6	1.6	12.7	0.1	4.9	0.0	21.8	1.1	4.7	31.9	6.4	13.3	13.3	10.2	45.7	0.8	1.8	4.3	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	8.1	4.5	5.4	1.3	3.9	5.7	2.9	3.5	4.9	11.7	4.7
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.3"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 50.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 8.5;eosinophil: 31.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 31.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	9.0	6.7	3.5	2.8	3.5	8.6	4.6	1.7	5.0	6.9	5.0	9.4	5.4	3.6	8.7	10.4	4.2	13.0	15.7	11.3	3.9	3.1	6.2	2.3	28.3	8.0	6.8	4.2	5.8	2.4	2.0	3.2	2.9	4.3	5.6	1.9	3.3	7.4	11.6	2.7	3.5	5.7	4.5	6.3	6.7	5.0	3.3	3.9	0.8	5.3	5.6	3.2	3.6	3.9	0.1	4.5	31.3	0.3	2.2	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	5.1	0.0	0.2	0.2	0.3	50.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	8.5	0.2	31.3	0.5	0.3	1.7	0.1	1.2	0.8	4.5	0.1	0.2	0.5	0.1	2.2	0.0	0.2	0.1	0.3	3.5	3.5	1.7	5.0	3.9	3.1	6.8	4.2	4.3	3.9
LTN1	"C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294"	ENSG00000198862	"Listerin E3 ubiquitin protein ligase 1"	O94822	21	28928144-28992956	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029143, CAB034164, HPA055604"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: "	"unprognostic (3.67e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.38e-2)"	"unprognostic (5.40e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.52e-1)"	17.9	15.1	10.3	12.4	19.8	21.2	17.9	19.9	23.2	16.6	14.7	17.8	12.1	12.4	16.5	15.4	15.2	14.5	10.8	13.1	12.0	10.6	14.1	19.3	12.0	15.7	19.6	14.2	16.4	23.7	18.4	22.6	29.0	28.7	19.0	15.6	9.7	16.1	12.6	22.5	14.8	17.1	13.4	17.4	16.7	15.4	20.7	15.8	23.0	17.6	14.6	14.9	16.6	14.7	7.8	6.2	12.2	11.9	8.6	8.4	3.3	12.6	5.5	11.3	5.1	9.7	13.3	11.5	10.7	8.7	9.2	12.8	7.6	10.6	8.3	5.2	9.5	6.5	12.0	8.8	16.8	9.7	8.3	24.8	7.5	6.0	7.3	8.2	9.7	9.2	7.9	13.1	10.9	9.7	20.2	20.0	10.5	3.9	5.3	8.0	16.2	6.5	7.1	22.7	17.4	10.4	10.9	6.2	12.9	12.3	9.4	10.7	9.6	11.6	12.8	8.1	15.2	10.9	9.0	16.4	15.3	11.8	12.7	17.9	9.6	12.2	6.4	9.5	8.4	9.8	7.0	7.8	5.8	5.6	6.2	7.1	6.2	4.7	11.3	8.6	11.9	3.9	6.1	3.3	10.3	19.8	19.9	23.2	12.0	10.6	19.6	14.2	28.7	15.8
LTV1	"C6orf93, dJ468K18.4, FLJ14909"	ENSG00000135521	"LTV1 ribosome biogenesis factor"	Q96GA3	6	143843344-143863812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA030159, HPA030160, HPA030161"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001"	"unprognostic (2.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"prognostic unfavourable (4.95e-5)"	"unprognostic (7.09e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.70e-2)"	"prognostic unfavourable (6.01e-13)"	"unprognostic (2.94e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.41e-1)"	20.0	20.6	15.6	19.5	26.2	39.3	26.7	19.4	26.0	14.6	16.5	11.1	17.9	13.8	21.2	14.7	21.2	18.0	11.3	15.7	25.1	10.9	14.4	29.0	18.9	21.2	21.0	17.1	20.6	20.9	13.3	19.7	17.3	17.4	16.3	18.9	8.0	16.6	18.5	52.0	23.5	17.2	20.7	18.5	20.8	18.3	17.5	18.1	15.0	16.1	26.4	21.8	16.6	25.5	17.3	18.4	4.1	12.9	21.2	16.1	8.3	11.5	10.8	12.9	28.7	9.6	11.7	15.0	18.0	13.3	20.0	16.0	17.6	6.0	24.4	14.6	16.3	13.1	21.5	17.7	28.0	14.0	21.0	48.3	12.5	26.9	17.0	59.3	28.1	13.2	13.0	22.2	24.4	13.8	45.9	16.2	15.4	19.5	20.2	25.3	15.2	12.0	17.5	24.5	10.9	14.8	16.2	11.5	13.8	18.4	15.3	16.8	8.5	38.0	12.5	12.8	14.8	28.5	33.0	20.3	25.0	33.3	12.9	31.1	18.0	1.2	10.1	4.1	12.1	12.9	13.1	17.3	12.7	13.0	15.2	14.3	14.1	16.1	0.3	21.2	11.0	18.4	10.9	8.3	15.6	26.2	19.4	26.0	25.1	10.9	21.0	17.1	17.4	18.1
LURAP1	"C1orf190, FLJ25163, LRAP35a"	ENSG00000171357	"Leucine rich adaptor protein 1"	Q96LR2	1	46203334-46221261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 110.5"	"HPA030060, HPA030061"	Uncertain		Supported	Vesicles,Cytosol				Cytosol	Vesicles	"HPA030060: AB_10599997, HPA030061: AB_10601990"	"unprognostic (3.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.33e-1)"	"prognostic favourable (8.81e-8)"	"unprognostic (1.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.39e-2)"	3.0	7.3	7.1	2.2	13.2	3.4	3.9	12.7	12.7	5.8	3.8	15.2	2.2	2.0	5.5	4.9	4.0	4.0	3.7	8.7	6.7	5.8	7.4	1.1	3.2	1.6	18.8	6.0	7.2	1.1	21.5	3.2	2.3	11.2	7.5	2.5	4.7	5.2	9.8	2.5	4.2	1.9	5.6	17.5	3.5	3.7	10.8	13.6	0.0	19.6	0.0	2.1	5.6	5.3	1.0	0.7	6.2	1.1	1.9	0.8	0.3	0.2	0.2	3.0	0.2	4.1	5.6	3.1	2.1	5.4	2.9	3.5	0.1	0.2	0.2	0.1	5.1	0.3	3.2	6.8	2.4	0.6	1.5	0.2	0.7	0.3	1.2	0.2	0.1	2.9	4.6	5.7	2.7	4.2	2.6	0.6	1.7	0.3	0.3	0.3	1.1	0.5	1.1	1.5	0.0	7.6	0.1	0.4	1.2	0.1	0.2	4.9	1.5	0.3	0.2	1.8	2.3	1.5	0.4	0.3	0.1	0.3	1.7	0.3	0.4	1.3	1.1	0.4	0.3	0.5	0.8	0.5	0.4	0.3	0.4	1.0	0.8	0.6	6.2	1.9	0.5	0.7	0.1	0.3	7.1	13.2	12.7	12.7	6.7	5.8	18.8	6.0	11.2	13.6
LUZP1	LUZP	ENSG00000169641	"Leucine zipper protein 1"	Q86V48	1	23084023-23177808	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028506, HPA028542"	Enhanced		Uncertain	"Vesicles,Actin filaments,Cytosol"				"Actin filaments"	"Vesicles, Cytosol"	"HPA028506: AB_10600083, HPA028542: AB_10601986"	"unprognostic (3.04e-2)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.46e-3)"	"unprognostic (9.77e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.50e-1)"	"prognostic favourable (1.46e-7)"	"unprognostic (4.49e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.33e-1)"	9.7	10.3	5.2	6.5	10.7	8.3	7.3	7.8	18.2	7.5	11.7	2.5	4.4	15.7	9.6	4.5	7.5	6.6	9.1	9.2	6.3	6.1	8.1	4.0	9.1	4.0	5.4	9.5	6.6	4.4	21.8	4.9	8.6	21.8	7.0	9.4	4.6	7.1	7.1	4.2	6.8	27.1	8.9	5.0	9.4	5.9	20.4	3.4	5.2	7.9	4.7	5.5	7.9	9.9	4.5	11.9	21.5	7.4	4.8	10.5	2.1	9.5	6.6	9.3	10.8	9.6	12.3	6.8	9.4	15.1	11.8	12.5	3.7	4.5	0.2	8.7	15.9	13.0	9.2	25.6	14.5	3.5	6.1	13.5	8.2	3.5	6.3	6.6	8.7	10.8	10.1	17.3	13.7	26.5	4.9	0.8	9.5	2.5	4.5	2.8	7.9	7.2	6.9	14.0	1.1	5.4	6.3	1.7	4.4	22.5	6.4	7.7	3.6	3.5	47.3	13.9	10.6	10.4	9.3	1.2	2.8	3.7	6.2	11.0	11.9	21.5	5.8	6.1	9.3	4.0	10.5	2.4	7.0	5.8	5.6	4.5	5.6	5.5	3.2	4.8	7.4	11.9	3.7	2.1	5.2	10.7	7.8	18.2	6.3	6.1	5.4	9.5	21.8	3.4
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082631	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 11.1;brain: 32.7"	"Group enriched"	"Detected in some"	4	"HaCaT: 14.3;HAP1: 7.1"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: , HPA046161: "	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	1.2	11.1	14.5	0.9	10.8	0.9	1.6	2.6	32.7	0.9	2.1	5.9	0.0	0.9	1.0	0.8	0.9	0.8	1.0	1.0	10.3	13.8	1.0	2.3	1.1	0.8	13.7	5.6	0.8	0.8	0.7	1.9	0.8	26.7	4.5	1.7	0.0	1.0	0.9	0.8	0.9	1.1	1.2	30.0	0.9	0.9	1.6	14.5	0.0	0.8	0.9	0.8	1.6	0.3	0.5	0.4	1.9	0.3	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	14.3	7.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.2	0.2	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.5	0.3	0.4	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.5	0.3	0.2	1.9	0.3	0.2	0.4	0.1	0.0	14.5	10.8	2.6	9.3	10.3	13.8	13.7	5.6	26.7	14.5
LXN		ENSG00000079257	Latexin	Q9BS40	3	158645822-158672693	"Predicted intracellular proteins"	"Inflammatory response"	"Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 31.8;HUVEC TERT2: 69.1;MCF7: 37.6;RT4: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014179, CAB025128"	Approved		Approved	Nucleoplasm,Cytosol			4200000	"Nucleoplasm, Cytosol"		"CAB025128: , HPA014179: AB_1853404"	"unprognostic (4.46e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.86e-5)"	"unprognostic (8.45e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.84e-2)"	32.3	31.5	2.8	13.6	3.3	9.4	35.8	11.7	3.5	11.8	20.9	1.2	12.7	12.4	9.8	17.7	14.0	15.2	17.2	24.4	5.7	3.6	13.6	4.0	16.9	17.8	3.0	2.1	37.1	15.0	7.9	20.6	15.5	4.4	34.0	18.6	11.1	29.3	11.3	7.8	4.8	24.1	22.8	2.6	10.0	7.0	8.5	1.3	12.4	15.8	6.6	7.3	29.3	31.5	5.9	4.5	22.2	3.6	5.2	17.0	4.2	0.0	9.4	0.7	0.1	4.1	14.2	0.8	7.2	18.7	1.8	3.6	0.0	21.3	0.0	6.7	2.0	3.3	1.9	2.9	2.7	0.0	9.3	4.4	8.2	0.1	4.7	1.1	0.1	31.8	0.5	3.4	0.5	69.1	0.0	0.2	0.0	37.6	0.4	0.0	0.8	2.4	1.2	0.0	9.0	6.4	26.1	1.2	0.0	0.0	10.0	2.4	0.0	0.0	9.9	0.1	0.0	10.0	0.0	0.1	0.0	0.0	3.5	0.3	0.1	13.8	3.6	5.0	3.7	3.4	3.6	5.9	7.6	5.9	4.3	4.1	8.5	4.7	22.2	5.2	2.1	4.5	17.0	4.2	2.8	3.3	11.7	3.5	5.7	3.6	3.0	2.1	4.4	1.3
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favourable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.4	0.0	0.5	2.1	2.5	1.1	0.3	4.6	3.8	0.0	0.0			0.2	0.3	0.4	0.0	0.5	2.0	0.8	0.4	0.7	0.0	0.9	0.5	1.2	0.3		0.4	2.5	0.0	1.0	0.4		0.1	0.0		0.2	0.0	1.3	0.3	0.3	0.0	0.4	0.8	1.2	2.1			0.2		0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.4	2.1	3.1	0.1	0.1	0.1	0.3	0.3	0.8	0.0	2.4	1.5	0.1	0.1	0.6	0.0	0.0	0.9	2.7	1.4	1.1	0.0	0.5	0.0	0.3	1.2	0.0	0.0	0.7	1.7	0.0	0.0	1.5	0.1	0.0	2.3	0.4	0.1	0.0	1.0	0.4	0.8	0.1	0.5	0.3	0.2	0.9	0.0	0.5	0.1	1.8	0.0	0.2	1.0	1.8	0.1	0.4	0.5	0.5	2.3	1.5	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0										
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43795929-43827206	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 39.6;skin 1: 39.8;tongue: 34.7"	"Cell line enhanced"	"Detected in some"		"A-431: 5.8;BEWO: 9.0;HaCaT: 9.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	4	"monocytes: 3.8;T-cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042511: AB_10794279, HPA054670: "	"unprognostic (4.27e-3)"	"prognostic favourable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.5	1.2	3.4	2.1	7.9	0.7	4.2	2.4	8.8	5.7	1.4	3.5	0.5	1.2	1.3	2.4	7.8	1.6	1.9	1.3	3.9	4.8	0.9	1.0	3.4	1.4	4.5	4.0	0.8	0.9	1.1	1.4	39.6	9.3	1.3	1.5	0.7	2.1	1.5	0.7	39.8	1.1	1.9	3.3	5.9	1.3	7.4	2.7	0.6	1.4	34.7	3.4	2.4	5.4	0.4	0.0	0.5	3.8	0.0	1.2	0.5	5.8	0.0	0.3	0.0	0.1	0.0	9.0	0.4	0.0	0.8	1.0	0.6	2.0	0.3	1.1	0.7	9.3	0.0	1.0	0.5	1.0	0.0	0.2	0.6	0.0	2.5	0.1	0.1	2.8	2.6	0.4	1.1	0.3	0.1	0.3	0.0	0.3	0.2	0.1	0.6	1.9	0.0	0.1	0.1	0.6	0.9	0.7	0.2	1.2	1.4	0.0	0.6	0.2	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	1.2	0.0	0.0	3.8	0.3	0.0	0.8	0.1	0.0	0.4	0.4	1.2	0.5	0.0	1.4	0.0	0.0	0.5	3.4	7.9	2.4	8.8	3.9	4.8	4.5	4.0	9.3	2.7
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474148	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 17.7;placenta: 22.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.3;fHDF/TERT166: 23.4;HBF TERT88: 12.9;LHCN-M2: 23.2;RT4: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"			Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favourable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.72e-4)"	2.6	1.0	8.7	1.8	7.9	0.4	14.6	3.3	8.2	2.0	4.4	4.3	1.1	2.8	4.0	1.0	1.2	2.9	17.7	1.4	6.2	11.5	3.4	0.8	1.3	0.8	6.2	5.3	1.4	3.2	2.6	0.9	22.7	7.2	2.5	4.1	2.8	0.8	2.6	0.7	1.4	5.6	4.7	5.1	1.3	6.2	4.5	2.6	0.0	0.6	0.0	2.3	4.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.4	18.3	0.0	0.0	0.2	7.4	3.2	9.5	6.0	0.1	1.5	0.0	0.4	23.4	1.9	2.6	0.0	12.9	0.0	0.8	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.7	0.1	0.0	0.0	23.2	2.9	0.0	1.7	2.6	2.1	0.0	10.1	0.0	1.1	19.1	0.7	3.3	5.0	5.7	0.6	0.7	0.3	0.0	0.2	2.9	0.2	4.0	0.0	0.0	0.0	1.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	8.7	7.9	3.3	8.2	6.2	11.5	6.2	5.3	7.2	2.6
LYPLA1	LPL1	ENSG00000120992	"Lysophospholipase I"	O75608	8	54046367-54102017	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol			1700000	"Nucleoplasm, Cytosol"		"HPA050941: , HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	14.1	17.7	7.2	12.2	8.9	13.4	16.4	10.8	15.2	10.7	14.6	6.9	4.7	15.4	8.0	11.1	30.4	8.0	11.9	27.1	6.8	6.8	31.1	37.3	13.6	23.4	7.3	4.9	12.3	24.3	9.0	7.4	51.1	12.0	15.3	15.2	17.0	23.3	7.1	26.4	22.1	17.6	10.4	6.3	14.0	14.9	64.8	4.1	21.3	13.3	19.3	19.7	24.6	17.3	29.1	37.1	42.7	40.4	27.1	29.2	35.1	30.3	17.2	22.4	20.1	8.1	13.3	28.3	18.2	10.5	16.8	15.9	12.4	29.5	53.3	21.3	11.8	20.4	31.5	30.3	23.6	19.3	17.2	37.1	11.0	19.9	13.4	22.7	50.3	11.6	26.7	13.1	29.5	43.6	37.6	16.2	23.4	8.0	34.5	17.3	33.3	7.9	20.9	11.8	24.4	26.0	41.2	11.8	20.1	12.8	23.9	27.9	34.9	20.3	20.9	10.2	14.9	17.6	16.8	22.6	34.0	48.1	13.8	24.1	19.9	31.4	33.1	42.7	19.1	31.1	19.0	29.1	18.2	18.4	37.1	23.9	18.4	17.8	19.5	27.1	40.4	23.8	29.2	35.1	7.2	8.9	10.8	15.2	6.8	6.8	7.3	4.9	12.0	4.1
LYPLA2	APT-2	ENSG00000011009	"Lysophospholipase II"	O95372	1	23790970-23795539	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063151			Uncertain	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA063151: "	"unprognostic (8.84e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (5.84e-5)"	"unprognostic (3.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.40e-1)"	"prognostic favourable (4.99e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.24e-1)"	12.4	13.6	14.8	13.3	34.8	20.6	13.5	10.7	17.7	9.9	21.2	12.3	5.6	21.3	10.9	17.2	25.4	19.2	21.6	14.4	9.9	9.5	33.2	34.5	14.3	19.0	7.6	12.8	10.3	18.3	32.0	12.0	31.6	35.4	14.8	12.7	11.3	21.1	11.2	14.2	17.7	24.0	9.5	5.4	22.1	19.1	9.9	6.9	27.7	16.5	9.5	16.5	15.3	13.5	29.5	32.3	50.0	40.6	32.0	48.0	42.4	25.1	15.6	19.0	22.1	9.6	11.7	26.2	15.6	14.9	14.8	12.7	21.6	41.1	13.8	22.0	14.7	24.0	13.7	40.5	6.3	25.7	19.4	17.2	25.7	35.4	15.0	16.2	22.8	14.6	25.0	22.3	8.5	34.9	24.1	13.8	16.2	25.0	21.7	26.4	38.8	22.0	24.1	11.0	25.3	34.9	19.4	27.7	48.0	17.7	28.4	26.5	23.0	17.1	29.9	14.9	19.8	18.0	13.0	37.5	31.7	19.2	24.6	37.5	18.8	28.9	40.6	50.0	48.0	39.6	38.7	27.6	40.1	41.6	32.3	29.5	35.2	36.0	48.4	32.0	31.2	24.6	35.6	42.4	14.8	34.8	10.7	17.7	9.9	9.5	7.6	12.8	35.4	6.9
LYPLAL1	Q96AV0	ENSG00000143353	"Lysophospholipase like 1"	Q5VWZ2	1	219173844-219212865	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045806	Approved		Supported	Cytosol				Cytosol		"HPA045806: AB_10966647"	"unprognostic (1.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"prognostic favourable (1.31e-4)"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	10.7	22.3	19.0	9.4	17.4	2.1	12.4	15.2	13.2	10.6	7.2	14.4	4.4	10.7	19.4	5.9	10.0	7.1	10.5	39.7	17.9	15.4	46.6	29.9	8.9	9.5	19.5	12.3	12.5	12.9	14.6	25.0	9.9	14.9	16.3	7.7	16.1	9.9	8.6	12.0	11.5	9.2	15.6	28.2	6.5	7.7	10.6	17.0	7.3	19.3	9.9	10.3	9.0	12.9	12.8	6.8	8.9	9.6	4.0	7.3	5.3	6.6	6.6	3.0	0.0	6.0	12.0	7.7	3.7	4.4	3.5	3.9	3.1	8.9	7.1	11.2	3.3	3.5	6.0	8.6	5.1	10.0	6.9	4.1	3.5	6.8	24.2	8.6	3.0	13.9	7.8	3.7	8.8	10.2	12.1	7.0	7.9	4.3	4.0	7.4	5.8	10.8	2.3	7.7	12.0	13.8	4.9	7.2	4.7	4.4	11.8	13.2	11.1	11.1	6.2	2.9	2.0	5.8	4.6	6.5	3.7	5.2	9.4	7.1	6.3	2.4	8.6	4.7	3.6	6.3	5.7	12.8	4.9	4.2	6.8	7.6	7.3	5.7	8.9	4.0	9.6	6.0	4.8	5.3	19.0	17.4	15.2	12.9	17.9	15.4	19.5	12.3	14.9	17.0
LYRM2	DJ122O8.2	ENSG00000083099	"LYR motif containing 2"	Q9NU23	6	89568144-89638753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063932	Uncertain		Approved	Cytosol				Cytosol		"HPA063932: "	"unprognostic (3.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.52e-3)"	"unprognostic (8.49e-2)"	"unprognostic (4.27e-2)"	"unprognostic (6.26e-2)"	"prognostic unfavourable (2.58e-8)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (8.07e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.64e-2)"	11.2	17.5	21.6	9.8	22.0	12.5	14.5	11.9	22.5	10.3	13.6	15.2	15.1	8.6	13.4	15.4	12.8	14.1	10.7	17.3	19.2	19.6	18.2	13.8	10.2	11.8	22.2	23.0	11.3	10.3	24.9	34.0	16.1	19.0	14.1	16.8	9.0	10.9	10.2	20.9	7.0	10.0	12.5	19.8	9.4	12.9	11.0	22.2	9.8	26.2	13.2	10.8	12.0	8.9	21.9	17.5	9.2	21.0	16.6	20.2	9.6	9.4	5.0	17.3	10.3	8.8	13.4	7.2	16.5	11.8	12.9	13.0	4.5	5.0	13.0	16.0	15.5	8.7	11.0	15.6	16.8	16.4	19.1	20.5	5.5	3.8	13.2	21.7	16.1	16.3	15.3	14.6	19.8	10.0	21.0	16.9	14.9	8.5	5.0	7.7	3.9	6.3	10.4	21.5	9.7	14.6	9.4	19.3	13.1	9.5	6.0	16.5	8.4	22.4	15.8	8.2	7.2	14.7	22.8	12.1	17.5	6.7	17.1	15.7	15.4	8.7	14.4	9.2	15.3	16.2	16.3	21.9	17.4	20.2	13.1	20.3	19.8	18.2	4.1	16.6	21.0	17.5	15.7	9.6	21.6	22.0	11.9	22.5	19.2	19.6	22.2	23.0	19.0	22.2
LYSMD3	FLJ13542	ENSG00000176018	"LysM domain containing 3"	Q7Z3D4	5	90515611-90529584	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018024	Approved		Approved	Cytosol				Cytosol		"HPA018024: AB_2138525"	"unprognostic (4.50e-2)"	"unprognostic (1.85e-2)"	"prognostic favourable (3.83e-4)"	"unprognostic (5.59e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.02e-1)"	"prognostic favourable (9.25e-4)"	"unprognostic (1.81e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.97e-3)"	"unprognostic (9.46e-2)"	12.7	14.0	8.9	11.1	10.5	9.3	11.1	16.0	11.2	15.8	14.1	4.7	16.2	11.8	13.1	9.3	12.0	11.2	12.8	15.7	10.2	8.9	21.1	33.6	15.6	12.9	11.9	6.1	19.1	13.1	24.5	31.1	19.0	12.2	12.9	10.8	7.3	13.3	21.2	16.6	6.4	17.4	10.5	12.1	14.6	9.5	6.6	12.7	18.5	18.8	9.0	11.4	15.4	12.5	6.4	7.3	27.7	9.4	11.9	10.4	7.4	10.3	7.0	9.0	9.5	14.0	14.4	8.9	16.6	18.2	11.6	19.1	5.9	10.7	12.9	7.2	14.6	5.3	13.8	16.3	22.8	9.4	8.7	9.8	8.7	9.6	14.6	8.1	16.6	10.5	11.5	10.6	17.8	16.6	9.3	19.7	12.9	9.2	9.4	4.7	4.5	11.9	8.8	15.2	18.5	12.7	7.1	2.7	5.5	9.8	7.5	13.5	8.6	7.7	20.6	7.0	10.0	15.4	12.0	22.5	14.2	11.0	11.9	14.0	10.9	27.7	7.7	11.6	6.5	9.4	10.4	6.4	7.5	7.9	7.3	5.4	10.3	8.8	11.5	11.9	9.3	3.5	8.1	7.4	8.9	10.5	16.0	11.2	10.2	8.9	11.9	6.1	12.2	12.7
LYSMD4	FLJ33008	ENSG00000183060	"LysM domain containing 4"	Q5XG99	15	99715697-99733561	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029152, HPA059824"	Approved		Approved	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA029152: AB_10602033, HPA059824: "	"unprognostic (2.43e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.30e-1)"	8.8	4.7	5.8	11.6	8.7	4.7	11.1	8.6	14.1	9.5	6.4	7.8	3.6	8.1	9.3	11.4	11.4	5.5	8.3	9.2	7.1	5.6	4.7	6.6	7.0	3.9	4.7	5.7	7.8	6.5	14.9	5.4	5.0	6.7	6.3	5.9	8.3	15.9	7.7	12.3	25.2	6.5	6.9	7.9	4.5	5.6	6.8	6.3	5.4	4.1	11.1	6.3	4.6	8.4	3.1	4.8	8.0	4.0	1.0	6.2	3.4	3.8	3.7	7.6	4.4	8.5	7.7	4.5	4.5	3.1	3.9	5.7	9.2	3.5	4.3	2.7	4.1	11.5	5.9	7.2	4.5	0.9	10.6	2.8	7.5	6.3	4.9	2.0	5.4	4.4	10.7	3.5	4.2	5.2	6.8	5.5	2.5	4.6	5.3	5.6	5.0	4.2	3.7	5.4	2.1	6.9	10.2	4.4	3.9	8.2	2.5	4.3	1.7	3.9	6.6	3.2	8.7	4.3	1.8	7.4	9.8	3.5	4.1	5.0	3.4	0.0	2.0	8.0	3.8	3.3	2.9	1.8	5.2	4.5	1.1	3.1	6.2	2.8	0.7	1.0	4.0	4.8	5.0	3.4	5.8	8.7	8.6	14.1	7.1	5.6	4.7	5.7	6.7	6.3
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol			110000	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: "	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavourable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favourable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	13.6	14.2	21.4	12.8	18.0	11.4	17.7	13.6	21.6	18.2	19.2	24.5	15.1	19.5	18.3	13.5	17.6	16.9	14.1	21.0	19.8	16.5	20.0	20.4	11.5	13.6	24.3	10.3	25.5	15.3	26.1	15.9	14.9	20.5	15.8	19.4	13.0	16.6	14.6	21.7	13.9	23.7	21.3	28.2	11.0	12.2	44.3	20.1	20.2	17.2	13.2	15.6	14.9	23.1	13.9	28.1	28.3	22.7	16.8	21.0	12.9	15.8	10.5	20.3	14.3	12.6	21.0	9.0	14.4	12.3	20.4	19.8	13.1	27.9	19.3	16.5	18.2	12.1	19.1	21.0	30.8	17.8	13.0	28.1	13.7	21.5	12.2	25.6	14.5	13.7	30.1	28.6	27.1	16.0	34.7	11.0	18.8	11.2	21.0	12.5	10.2	17.2	22.5	26.9	15.4	11.0	7.2	10.1	16.0	17.7	7.8	34.0	12.9	13.2	14.6	14.2	19.5	20.2	15.1	9.0	20.6	33.1	14.6	38.3	18.9	22.0	18.8	28.3	16.0	20.7	14.0	13.9	16.3	15.5	18.1	13.8	16.3	16.9	18.9	16.8	22.7	28.1	21.0	12.9	21.4	18.0	13.6	21.6	19.8	16.5	24.3	10.3	20.5	20.1
LZTFL1	BBS17	ENSG00000163818	"Leucine zipper transcription factor like 1"	Q9NQ48	3	45823316-45916042	"Disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043466, HPA048447"	Enhanced		Supported	Cytosol				Cytosol		"HPA043466: AB_2678491, HPA048447: AB_2680398"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.27e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.19e-1)"	5.8	7.2	12.3	5.0	14.9	4.8	13.6	9.3	21.6	14.5	6.9	4.4	10.4	6.0	14.4	16.6	6.1	20.8	7.3	5.3	10.2	11.6	12.9	10.1	9.7	4.4	6.9	13.4	12.8	8.6	14.6	30.7	6.2	10.1	9.0	6.8	5.6	7.5	10.4	3.6	6.4	6.8	8.7	6.1	5.8	6.3	27.7	5.6	55.7	20.4	4.3	5.7	7.3	6.4	7.2	4.6	1.9	2.5	2.3	4.0	2.7	6.7	3.5	5.5	3.5	5.2	12.5	2.6	3.6	6.0	7.5	9.8	1.0	5.1	2.0	2.2	4.5	3.2	5.9	6.0	10.5	0.0	4.2	1.3	4.9	2.9	6.8	6.6	1.9	6.7	20.9	9.3	6.1	4.2	6.2	4.3	4.1	1.0	18.1	6.3	5.7	2.9	2.5	0.5	7.1	10.3	2.6	3.7	7.7	4.4	4.1	8.8	4.9	11.6	6.8	3.2	2.2	8.5	4.7	12.3	6.4	0.0	10.1	7.8	2.6	0.0	1.9	0.7	2.8	2.5	3.9	7.2	2.5	2.4	4.6	3.7	4.0	3.3	1.9	2.3	1.6	4.5	3.5	2.7	12.3	14.9	9.3	21.6	10.2	11.6	6.9	13.4	10.1	5.6
LZTR1	"BTBD29, LZTR-1"	ENSG00000099949	"Leucine zipper like transcription regulator 1"	Q8N653	22	20982013-20999038	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067852, HPA068772, HPA071248"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA067852: , HPA068772: , HPA071248: "	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.25e-2)"	21.2	16.9	17.3	15.6	17.4	10.3	17.9	20.7	24.7	18.5	18.3	25.3	20.6	18.9	24.9	14.0	16.5	18.3	21.2	15.8	15.4	10.9	17.2	13.1	16.2	12.8	19.6	16.5	21.7	16.2	24.9	26.0	18.8	19.0	16.9	12.9	18.9	17.5	18.0	17.2	15.0	15.7	21.9	14.0	19.3	14.5	10.8	19.2	10.8	19.6	12.6	12.5	18.5	16.4	1.6	2.2	0.2	3.4	1.8	3.0	1.5	6.2	5.1	7.6	9.2	17.6	12.2	6.2	12.8	9.0	7.3	10.0	3.0	2.6	6.6	4.8	14.2	8.4	5.7	10.5	2.9	12.3	13.3	7.1	6.7	4.4	9.4	3.8	9.4	11.2	5.3	9.2	6.7	14.1	29.4	11.5	8.2	3.8	6.8	3.6	2.4	5.6	8.0	11.1	2.6	5.7	8.4	7.5	11.2	6.9	12.1	7.5	5.6	7.1	12.6	17.0	8.7	7.7	6.9	5.0	4.4	2.0	7.7	3.7	8.2	0.0	2.5	0.2	3.0	3.1	1.6	1.6	1.5	2.8	2.2	1.0	2.1	1.5	0.1	1.8	3.4	1.2	0.5	1.5	17.3	17.4	20.7	24.7	15.4	10.9	19.6	16.5	19.0	19.2
LZTS2	"KIAA1813, LAPSER1"	ENSG00000107816	"Leucine zipper tumor suppressor 2"	Q9BRK4	10	100996618-101007836	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044956	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA044956: AB_10795989"	"unprognostic (1.42e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (3.39e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.76e-3)"	34.2	25.8	14.6	12.4	21.4	10.9	24.7	15.4	25.0	29.3	30.2	41.0	16.4	15.2	33.7	18.6	28.0	22.6	21.0	20.0	19.0	13.6	18.2	7.4	18.6	9.5	32.8	14.4	30.1	13.9	22.7	16.1	24.5	20.6	32.9	8.2	22.3	34.6	38.4	28.5	24.7	14.9	32.0	29.9	20.1	19.6	18.7	25.6	9.5	29.7	11.8	13.7	38.8	22.7	5.0	2.8	0.5	1.2	4.4	6.1	2.3	11.1	14.9	12.2	20.9	16.3	13.3	25.1	13.4	25.7	11.3	12.9	17.3	9.3	4.5	12.5	18.1	18.9	7.6	9.8	2.8	4.3	11.2	4.1	14.7	22.4	23.2	2.1	5.4	24.0	7.1	8.9	10.7	11.5	12.9	2.6	10.0	10.7	1.9	5.3	13.6	12.3	25.4	35.9	4.5	8.6	13.6	3.0	22.3	9.1	4.2	34.4	21.5	17.7	14.6	13.6	15.5	14.3	7.0	4.9	3.3	1.1	23.0	6.1	6.8	0.0	1.2	0.5	4.5	0.5	6.1	3.7	5.4	4.9	1.8	5.0	5.8	4.9	0.5	4.4	0.1	2.8	4.5	2.3	14.6	21.4	15.4	25.0	19.0	13.6	32.8	14.4	20.6	25.6
MACO1	"FLJ10747, TMEM57"	ENSG00000204178	"Macoilin 1"	Q8N5G2	1	25430858-25500209	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019680			Approved	Cytosol				Cytosol		"HPA019680: AB_1858125"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.02e-2)"	"prognostic favourable (7.13e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.35e-3)"	9.8	16.5	12.1	6.9	11.3	26.5	8.9	27.8	13.2	9.2	8.9	11.3	12.7	9.5	9.7	11.9	17.2	7.9	8.8	8.8	8.7	9.4	11.9	33.0	9.4	7.8	12.9	11.5	17.2	28.1	11.4	12.8	8.1	11.3	12.9	9.2	10.4	20.7	13.5	31.2	10.7	9.7	8.5	10.1	9.6	11.5	15.6	13.8	17.9	13.2	12.5	11.1	10.5	10.2	2.6	4.0	6.8	2.5	1.5	3.0	0.7	10.0	3.4	10.3	18.6	12.5	9.6	5.5	10.8	11.3	9.7	10.8	3.1	13.5	20.3	12.6	11.9	10.4	8.8	10.3	10.3	10.5	8.6	25.3	5.7	8.3	8.9	9.0	18.6	9.4	12.6	14.3	9.5	11.1	16.7	7.4	9.5	6.1	21.7	11.6	12.2	5.5	13.2	10.9	16.0	10.8	5.1	17.5	19.0	8.2	20.8	13.0	7.6	11.0	12.9	11.7	7.5	14.5	7.0	13.2	8.5	11.8	12.7	12.4	9.0	6.8	1.1	6.2	2.1	0.9	3.0	1.6	2.4	2.7	1.4	2.6	2.5	3.0	0.5	1.5	2.5	4.0	1.4	0.7	12.1	11.3	27.8	13.2	8.7	9.4	12.9	11.5	11.3	13.8
MAD2L2	"FANCV, MAD2B, POLZ2, REV7"	ENSG00000116670	"Mitotic arrest deficient 2 like 2"	Q9UI95	1	11674480-11691650	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008110, HPA024176, HPA024612"	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB008110: AB_217976, HPA024176: , HPA024612: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.27e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.36e-1)"	12.4	10.1	15.4	15.7	15.6	37.9	13.7	15.5	13.5	10.0	10.5	14.5	11.9	8.6	10.4	11.8	9.8	9.9	10.3	17.3	13.2	11.2	13.2	34.4	12.9	18.3	19.6	9.7	14.6	23.0	5.8	11.1	8.2	12.4	11.8	6.1	8.4	21.0	9.2	23.0	12.0	7.4	11.5	15.0	11.9	12.4	37.0	15.8	42.1	12.0	10.4	19.0	11.9	13.4	19.5	46.9	13.8	31.7	13.2	29.8	27.7	11.5	10.6	17.9	20.1	5.5	10.8	7.2	10.8	12.1	21.2	18.9	13.7	11.2	16.3	13.2	11.3	5.1	22.2	11.1	12.3	24.6	24.6	7.3	16.4	16.9	9.7	14.7	12.1	7.0	11.4	15.5	13.4	9.6	30.0	26.2	10.4	17.1	67.9	69.8	46.0	17.3	46.2	19.7	20.0	7.6	2.5	33.2	23.3	17.9	6.9	31.1	10.1	32.0	5.0	17.6	22.3	16.3	15.2	21.0	14.7	42.4	13.0	51.9	13.4	11.9	29.4	13.8	29.8	31.7	23.9	19.5	20.1	23.1	34.0	15.9	13.7	20.3	12.5	13.2	27.2	46.9	22.9	27.7	15.4	15.6	15.5	13.4	13.2	11.2	19.6	9.7	12.4	15.8
MADD	"DENN, KIAA0358, RAB3GEP"	ENSG00000110514	"MAP kinase activating death domain"	Q8WXG6	11	47269161-47330031	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038568	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038568: AB_10795030"	"unprognostic (3.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.51e-3)"	"prognostic favourable (6.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.36e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.78e-2)"	"prognostic favourable (5.69e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	"prognostic favourable (8.25e-4)"	7.7	18.2	18.3	11.5	27.6	16.9	8.7	66.3	46.5	9.2	10.8	15.5	13.1	8.6	9.4	8.9	6.9	9.4	8.6	13.8	20.2	18.4	9.8	7.7	11.0	13.2	15.5	19.8	14.0	12.2	18.8	26.7	11.2	20.7	12.5	12.0	16.0	10.2	14.0	16.1	14.0	9.8	10.5	11.3	12.3	13.2	19.4	11.0	14.6	8.4	6.0	12.2	11.0	7.8	3.5	4.1	20.8	5.8	4.5	5.7	4.4	6.3	13.3	14.6	13.0	10.0	7.0	3.3	9.0	12.1	11.5	12.5	9.7	6.0	13.6	2.9	9.9	12.7	11.8	6.3	10.0	15.0	12.0	24.1	24.7	8.3	7.2	16.3	33.2	6.7	6.8	6.0	7.6	10.5	15.4	10.0	10.1	9.0	7.7	17.6	8.7	9.2	10.6	23.5	8.9	5.9	30.6	23.1	15.1	11.6	13.7	7.9	10.8	12.4	8.9	10.8	6.8	15.3	6.0	11.9	12.3	7.7	10.0	11.6	10.1	20.8	2.6	4.8	4.8	4.6	4.2	3.5	3.4	4.0	4.1	3.3	4.0	3.1	0.7	4.5	5.8	2.2	5.7	4.4	18.3	27.6	66.3	44.6	20.2	18.4	15.5	19.8	20.7	11.0
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.6;parathyroid gland: 154.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 15.8;hTCEpi: 33.3;SCLC-21H: 9.1;SiHa: 8.2;U-138 MG: 9.0;U-2197: 13.1;U-87 MG: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 27.4;non-classical monocyte: 36.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	38.3	7.9	3.2	13.0	4.0	17.0	19.5	1.0	9.7	10.6	6.9	3.0	1.2	3.3	5.6	8.9	16.8	7.0	9.2	12.4	3.6	2.3	10.9	14.0	21.9	28.9	4.7	3.4	7.0	6.1	154.1	2.3	9.4	5.0	7.6	3.3	5.6	10.4	2.7	11.0	41.6	7.6	5.5	7.7	87.6	4.7	7.5	3.8	6.9	18.2	20.5	11.4	8.2	10.9	0.0	2.5	0.7	36.7	0.0	0.0	2.5	0.0	0.0	0.0	1.4	0.8	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	1.0	0.2	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.5	0.0	0.1	15.8	33.3	0.1	1.1	0.2	0.0	0.0	0.0	0.5	0.1	3.8	1.4	0.0	0.0	0.0	0.0	0.3	0.2	9.1	0.7	8.2	0.8	2.0	0.8	0.1	0.2	9.0	0.1	13.1	0.0	0.0	0.0	0.0	8.7	0.3	0.0	0.1	7.3	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.7	0.0	36.7	0.0	0.0	2.5	3.2	4.0	1.0	9.7	3.6	2.3	4.7	3.4	5.0	3.8
MAGEA1	"CT1.1, MAGE1, MGC9326"	ENSG00000198681	"MAGE family member A1"	P43355	X	153179285-153183880	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"HEL: 17.4;HMC-1: 30.3;RPMI-8226: 15.0;U-2 OS: 29.0;U-266/70: 43.3;U-266/84: 69.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB002620	Enhanced		Supported	Cytosol				Cytosol		"CAB002620: "						"unprognostic (8.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"				"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"		"unprognostic (2.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	3.2	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.1	0.0	0.0	29.0	0.1	0.1	43.3	69.0	0.0	2.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 48.7"	"Group enriched"	"Detected in some"	7	"PC-3: 9.3;SH-SY5Y: 5.9;U-266/84: 6.3;WM-115: 14.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: "		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	48.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.9	0.8	2.6	0.8	1.2	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.1	0.0	9.3	0.0	0.1	0.0	0.0	0.0	0.2	5.9	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.0	1.2	6.3	0.0	0.5	0.0	14.9	2.6	0.8	0.7	0.4	0.7	0.4	0.7	0.5	0.4	0.3	0.9	0.6	0.7	2.6	1.2	0.5	0.8	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
MAGEA11	"CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511"	ENSG00000185247	"MAGE family member A11"	P43364	X	149688228-149717266	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 36.5;testis: 9.3"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 22.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052687			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA052687: "	"unprognostic (4.06e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-2)"		"unprognostic (9.64e-2)"		"unprognostic (1.32e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.16e-1)"				"unprognostic (6.67e-4)"	"unprognostic (1.14e-1)"		"unprognostic (1.33e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	36.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	22.9	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MAGEA4	"CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336"	ENSG00000147381	"MAGE family member A4"	P43358	X	151912509-151925170	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"placenta: 12.1;testis: 23.5"	"Cell line enhanced"	"Detected in some"		"A-431: 61.4;AN3-CA: 38.3;HMC-1: 73.1;U-266/84: 113.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA021942, CAB040535"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB040535: , HPA021942: AB_1853490"						"unprognostic (7.90e-3)"		"unprognostic (6.66e-3)"	"unprognostic (5.39e-1)"	"unprognostic (1.36e-1)"				"unprognostic (5.81e-2)"	"unprognostic (2.94e-2)"		"unprognostic (4.10e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	19.6	0.0	0.3	15.6	113.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB2	"CT3.2, DAM6, MAGE-XP-2, MGC26438"	ENSG00000099399	"MAGE family member B2"	O15479	X	30215560-30220089	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 35.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 25.5;K-562: 18.3;Karpas-707: 22.3;U-2 OS: 26.5;U-266/70: 43.8;U-266/84: 45.7"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 33.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"											"HPA065224, HPA074544, HPA075519"	Enhanced		Approved	Cytosol				Cytosol		"HPA065224: , HPA074544: AB_2732258, HPA075519: AB_2732294"					"unprognostic (4.52e-1)"	"unprognostic (2.55e-2)"		"unprognostic (6.39e-2)"	"unprognostic (5.02e-1)"					"unprognostic (6.57e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	18.3	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	26.5	0.0	0.0	43.8	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909388	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 23.5"	"Cell line enhanced"	"Detected in some"		"K-562: 22.3;Karpas-707: 22.4;U-2 OS: 15.1;U-2197: 28.5;U-266/70: 20.4;U-266/84: 18.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	15.1	28.5	0.0	20.4	18.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEC2	"CT10, HCA587, MAGE-C2, MAGEE1"	ENSG00000046774	"MAGE family member C2"	Q9UBF1	X	142202345-142205290	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	319	"testis: 31.8"	"Group enriched"	"Detected in some"	8	"K-562: 34.9;U-266/84: 39.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 19.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062230	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA062230: "					"unprognostic (1.25e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.82e-1)"						"unprognostic (1.04e-1)"		"unprognostic (4.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	1.5	0.0	0.0	0.1	2.4	0.4	4.8	0.0	0.0	39.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED1	"DLXIN-1, NRAGE"	ENSG00000179222	"MAGE family member D1"	Q9Y5V3	X	51803007-51902357	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 82.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043645			Approved	Cytosol				Cytosol		"HPA043645: "	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.14e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.71e-3)"	15.4	57.6	35.3	16.8	52.9	6.9	18.6	34.6	61.8	50.9	18.8	25.9	38.9	15.2	27.6	67.4	13.1	31.6	28.1	32.4	42.2	58.4	22.5	48.6	17.5	13.6	32.2	38.0	30.7	37.2	42.9	69.6	53.5	39.4	35.1	19.3	34.7	38.1	45.5	19.6	12.7	13.4	36.3	25.7	15.9	25.8	33.8	16.1	24.6	35.4	12.5	17.9	23.9	15.8	10.1	28.8	1.5	3.2	7.7	11.6	6.9	3.2	11.8	37.9	32.6	30.0	54.2	20.4	43.8	56.3	24.3	38.6	24.2	11.1	4.6	8.6	82.7	2.4	33.8	15.6	18.3	4.8	13.1	3.1	0.0	31.3	23.0	11.5	5.7	50.9	5.6	20.5	4.7	29.1	4.7	9.1	48.8	29.6	13.1	3.8	29.8	24.4	13.4	24.6	0.6	25.0	5.8	9.8	54.5	0.0	12.8	6.4	23.0	2.8	28.9	10.6	27.3	37.3	4.8	6.0	8.8	9.4	41.5	1.0	27.5	0.7	2.2	1.5	11.6	3.2	10.3	9.3	7.6	10.0	6.8	10.1	9.6	11.3	0.7	7.7	2.8	28.8	10.5	6.9	35.3	52.9	34.6	61.8	42.2	58.4	32.2	38.0	39.4	16.1
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Supported		Enhanced	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favourable (2.88e-4)"	"prognostic favourable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavourable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	22.1	38.4	26.9	14.8	26.5	8.2	50.2	24.4	43.0	55.7	27.3	27.8	21.4	16.2	41.1	31.8	21.9	45.9	28.5	40.7	23.8	38.2	42.7	17.3	24.0	13.5	30.3	36.0	79.7	23.5	34.5	57.6	58.6	57.1	63.9	16.4	43.1	32.0	53.7	25.6	16.5	17.6	41.6	24.7	17.5	22.5	21.8	18.3	23.4	45.1	17.3	22.0	31.9	29.2	17.1	11.7	43.1	37.0	28.5	35.5	32.5	5.5	10.3	61.7	18.8	29.4	40.0	11.4	23.1	41.2	18.3	32.6	10.2	14.2	7.7	60.6	46.4	7.6	17.5	17.4	13.2	13.8	14.5	16.1	12.2	20.0	25.2	4.1	12.4	52.4	7.3	18.6	9.4	34.8	3.9	9.5	35.0	15.4	9.1	6.9	22.8	12.3	6.1	22.1	11.0	25.1	4.2	9.7	25.1	9.2	10.7	53.4	44.0	7.0	29.9	15.6	24.4	23.3	6.5	6.1	5.1	5.6	22.8	10.8	79.7	43.1	9.1	35.5	35.5	22.4	27.3	16.3	29.4	33.1	11.7	17.1	29.7	34.1	3.4	28.5	37.0	7.2	29.2	32.5	26.9	26.5	24.4	43.0	23.8	38.2	30.3	36.0	57.1	18.3
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427724-76431353	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"				Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favourable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	2.6	5.8	13.8	3.0	23.5	1.1	3.3	18.7	33.9	4.7	1.9	3.2	0.5	1.5	5.4	3.5	2.3	4.8	2.3	3.9	18.9	20.3	4.1	1.1	2.6	4.1	10.2	22.0	8.4	4.1	15.1	5.1	0.8	19.8	5.9	2.1	2.3	3.4	7.4	2.2	3.3	2.0	4.8	5.4	4.5	2.6	1.3	4.9	1.1	4.0	0.1	3.6	2.4	1.8	1.0	0.0	0.0	0.0	1.5	2.4	0.4	0.2	4.7	4.8	9.2	3.4	2.0	4.3	3.5	3.5	3.0	1.7	1.0	0.7	1.0	1.8	3.1	3.6	7.1	6.6	2.5	2.3	0.1	0.0	0.0	3.0	0.7	1.8	0.6	1.5	3.0	0.8	0.8	1.1	0.3	0.0	4.5	0.6	5.1	0.2	5.8	7.1	4.0	3.6	0.0	3.9	0.0	0.0	2.5	0.0	0.5	0.7	2.2	0.1	0.6	4.5	5.8	4.8	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.8	0.8	1.1	2.3	0.0	1.0	1.4	1.3	0.0	1.5	0.0	0.0	0.0	0.4	13.8	23.5	18.7	33.9	18.9	20.3	10.2	22.0	19.8	4.9
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671386-58754477	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: "	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	11.2	3.9	4.1	21.7	5.6	10.2	10.6	9.1	6.8	11.0	10.7	3.9	10.9	5.5	8.1	10.5	16.4	6.6	8.1	8.7	4.0	4.3	14.9	10.5	14.3	29.0	4.1	1.8	8.1	6.2	10.0	9.3	8.8	4.9	18.1	7.9	7.5	10.7	8.4	10.7	12.6	12.2	6.6	6.2	19.9	6.2	11.8	4.8	22.4	7.9	12.4	24.0	9.6	12.3	6.3	3.6	1.2	1.7	1.6	4.8	1.1	7.4	10.6	13.0	3.2	2.6	5.8	5.8	13.3	9.4	11.6	9.9	8.6	9.6	11.8	6.0	16.5	7.3	5.6	5.5	14.3	7.9	3.1	4.2	7.6	13.8	4.2	8.5	5.7	3.6	11.7	9.1	9.2	2.5	6.8	20.6	6.3	2.4	1.8	3.6	3.2	3.6	6.4	7.7	8.3	50.8	3.1	1.4	3.0	7.3	3.8	5.0	3.7	4.9	3.4	15.0	6.6	4.4	12.2	18.4	21.8	10.3	6.0	6.4	5.9	0.8	1.5	1.0	2.7	1.7	2.1	3.6	4.8	2.9	2.2	6.3	4.3	2.8	1.2	1.6	1.6	3.6	2.9	1.1	4.1	5.6	9.1	6.8	4.0	4.3	4.1	1.8	4.9	4.8
MAMDC4	"AEGP, DKFZp434M1411"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;liver: 48.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	10	"cerebellum: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB026377: , HPA059977: "	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favourable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.0	1.6	1.2	1.9	1.5	1.4	1.2	14.9	1.2	1.2	2.3	1.2	1.2	5.0	1.2	1.2	1.2	1.7	1.2	1.6	1.2	0.4	2.6	48.9	1.2	2.5	1.2	1.2	1.2	3.4	0.5	7.2	1.2	1.2	3.2	0.9	1.2	3.5	1.4	1.7	1.5	6.1	1.2	1.2	5.1	2.3	6.5	1.2	1.2	5.1	1.2	1.2	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	1.5	2.5	1.4	2.8	0.6	0.1	18.5	2.7	0.3	0.3	0.6	2.0	1.6	1.3	0.6	0.7	2.2	0.3	1.3	0.0	2.0	0.9	0.8	5.2	2.2	1.2	0.1	4.8	0.8	1.7	1.4	0.6	0.6	2.6	1.2	0.2	4.1	0.9	3.6	1.4	0.7	1.6	0.4	2.4	0.9	1.3	1.6	2.0	0.5	1.2	1.1	4.3	0.8	0.8	7.5	4.7	1.5	0.4	3.1	1.6	0.4	1.7	1.9	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	14.9	1.2	1.2	0.4	1.2	1.2	1.2	1.2
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343180	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavourable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	26.3	5.5	10.2	16.1	8.1	4.2	19.7	27.8	13.4	15.8	9.2	10.4	8.4	4.3	11.2	8.5	9.3	11.7	10.8	8.9	10.5	6.9	13.8	3.5	15.0	10.9	6.9	3.4	11.7	8.2	13.3	15.2	18.8	9.3	12.3	8.9	10.8	16.6	12.3	4.4	14.2	8.9	10.2	14.4	16.8	6.5	4.3	10.6	21.2	11.8	4.8	13.6	16.0	15.3	2.1	1.2	4.7	1.1	4.2	6.4	2.0	5.5	1.1	9.6	2.5	10.0	11.6	2.1	6.4	9.6	4.2	4.4	0.6	11.8	1.2	15.2	14.8	5.1	1.9	6.2	5.9	27.4	0.7	0.7	2.0	2.1	5.8	0.0	0.0	16.9	0.6	7.5	4.5	2.4	3.1	1.7	7.5	0.4	0.1	1.5	1.0	1.8	1.9	1.8	6.4	6.3	7.8	0.1	0.8	2.4	1.0	2.7	0.9	0.2	10.4	7.5	1.8	2.5	4.0	1.2	0.2	1.8	3.6	1.1	13.7	0.1	1.1	0.0	1.5	0.6	2.6	1.9	3.2	4.1	1.2	2.1	6.4	4.3	4.7	4.2	0.7	0.9	1.2	2.0	10.2	8.1	27.8	7.0	10.5	6.9	6.9	3.4	9.3	10.6
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 39.5;HHSteC: 74.2;HSkMC: 18.6;hTCEpi: 20.9;RT4: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol				Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: , HPA059299: "	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.3	39.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	1.4	5.3	0.0	0.0	0.5	1.6	0.1	4.2	74.2	0.0	4.0	18.6	20.9	0.0	10.9	4.7	0.0	0.1	1.3	0.6	0.0	0.1	0.3	1.2	0.0	0.0	0.1	5.3	30.6	0.7	1.8	0.0	0.0	0.0	0.1	0.0	2.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 103.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.4;BJ hTERT+: 21.1;fHDF/TERT166: 31.5;hTEC/SVTERT24-B: 20.0;U-87 MG: 42.4"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	74	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in single"	74	"dendritic cells: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol				Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: "	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavourable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (1.09e-5)"	"prognostic unfavourable (1.66e-5)"	5.2	7.9	43.6	5.4	42.8	2.5	4.3	24.5	103.6	10.5	5.4	18.3	1.0	3.0	5.6	4.3	4.8	9.1	5.9	14.8	40.9	30.2	2.8	1.9	3.4	2.7	34.7	31.3	7.1	2.7	4.1	4.4	4.4	56.2	6.7	5.3	3.1	2.5	9.6	4.5	3.1	3.2	14.5	21.4	2.6	2.7	5.4	12.6	6.5	3.7	0.1	2.7	6.3	2.8	0.0	12.3	0.0	0.0	0.0	0.1	0.2	0.1	0.8	3.8	2.2	21.4	14.7	0.0	12.2	21.1	3.6	3.5	1.4	0.0	0.0	5.3	31.5	0.1	5.1	0.0	2.1	1.8	0.5	4.7	1.2	0.1	2.0	0.1	2.0	11.0	0.0	20.0	0.1	2.7	7.8	0.1	14.6	0.1	8.6	0.2	2.8	0.3	2.3	11.1	0.0	0.0	0.0	12.0	3.6	0.4	0.0	0.1	0.7	0.2	0.5	11.7	3.9	3.9	0.1	0.0	0.5	1.7	42.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.2	43.6	42.8	24.5	63.1	40.9	30.2	34.7	31.3	56.2	12.6
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209570	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 102.5"	"Cell line enhanced"	"Detected in many"		"TIME: 64.1"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol			140000	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (8.22e-5)"	20.3	18.1	27.5	10.2	39.6	1.6	9.3	52.3	101.9	15.3	6.1	21.6	3.5	3.2	9.2	9.8	12.8	7.7	10.7	17.1	37.6	40.7	4.4	3.3	3.7	3.2	42.4	42.5	7.8	4.5	3.0	7.0	9.5	102.5	19.0	6.2	9.4	7.6	24.0	3.6	10.2	3.9	22.9	45.7	2.4	7.2	11.0	11.3	0.0	5.7	0.1	2.6	13.4	5.9	0.2	0.4	0.6	0.0	0.0	0.3	2.1	0.3	12.1	30.5	11.0	19.0	33.3	0.0	6.5	5.0	6.6	7.9	0.1	0.4	0.0	15.7	24.1	0.1	16.6	0.6	10.0	0.0	2.4	1.3	4.3	3.9	10.1	0.0	1.0	33.4	2.1	26.6	9.9	20.6	1.9	0.0	11.2	0.1	0.0	0.0	8.2	3.9	0.1	3.6	0.0	0.5	0.0	19.7	13.6	6.4	0.0	3.3	0.0	1.2	64.1	21.0	9.9	15.3	29.4	1.4	0.0	0.0	22.7	0.0	16.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.6	0.0	0.0	0.4	0.2	2.1	27.5	39.6	52.3	59.1	37.6	40.7	42.4	42.5	102.5	11.3
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734516	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Enhanced	Cytosol				Cytosol		"HPA050934: , HPA054637: "	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavourable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	14.7	7.1	18.9	14.0	27.0	14.9	13.4	15.4	42.1	12.3	11.5	15.5	4.9	12.5	13.4	9.8	11.6	11.1	13.1	9.3	17.2	12.9	8.3	6.9	17.6	13.2	11.4	18.1	16.8	13.8	8.9	11.9	16.1	14.3	10.0	4.7	8.4	12.6	12.1	21.2	6.0	10.5	8.8	10.3	14.2	16.0	34.1	13.1	13.2	8.5	4.3	8.6	12.6	7.6	13.1	20.7	24.9	17.7	9.4	13.3	12.5	12.8	20.3	6.2	8.0	5.2	7.7	15.5	8.5	4.3	5.4	6.1	27.5	7.4	7.6	15.8	5.4	7.1	5.0	7.0	2.2	9.5	28.4	6.9	18.0	18.0	11.0	7.5	9.9	8.4	4.0	8.2	5.1	10.8	10.6	4.4	2.9	18.1	9.2	19.1	13.5	23.8	15.0	4.7	7.7	7.0	19.8	10.8	12.0	4.7	7.3	8.5	4.6	8.3	16.7	10.0	8.6	19.3	12.7	8.3	9.9	7.7	11.5	12.0	11.7	13.3	17.0	19.2	13.3	17.7	12.8	13.1	10.4	13.1	20.7	13.1	8.8	11.7	24.9	9.4	13.1	16.7	9.5	12.5	18.9	27.0	15.4	42.1	17.2	12.9	11.4	18.1	14.3	13.1
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386817-66492312	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"			62000	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.92e-2)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.81e-3)"	"unprognostic (5.78e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.40e-3)"	28.6	16.9	33.9	19.1	54.1	29.0	23.6	32.5	48.4	12.5	12.1	8.4	10.2	10.0	11.8	16.5	22.0	10.6	14.4	19.1	49.2	26.4	15.3	53.1	16.4	23.3	17.6	31.2	13.5	11.7	23.4	12.0	15.4	17.2	14.4	12.9	9.1	13.2	12.4	39.5	12.3	10.9	16.9	17.4	14.5	10.8	7.8	12.6	12.6	12.3	9.7	27.9	13.6	18.7	4.6	16.2	5.5	8.2	8.4	7.9	2.7	33.1	15.6	31.5	13.1	19.0	14.3	18.2	24.1	20.6	26.2	23.4	23.5	27.3	30.5	29.9	19.8	29.6	29.4	35.2	30.8	24.5	17.5	9.8	16.4	12.7	15.4	12.9	14.6	11.0	21.8	18.9	28.1	20.4	17.3	39.0	38.1	12.8	10.3	16.8	16.1	13.7	11.7	19.5	27.1	25.4	14.3	19.4	10.8	19.5	15.3	20.2	13.8	11.0	28.1	34.1	20.9	24.0	35.7	24.2	43.0	19.4	36.0	22.8	15.9	3.2	8.2	5.5	7.4	8.2	6.7	3.0	6.6	6.9	8.3	4.6	7.9	4.9	3.9	8.4	7.3	16.2	4.9	2.7	33.9	54.1	32.5	46.9	49.2	26.4	17.6	31.2	17.2	12.6
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	"Mitogen-activated protein kinase kinase 2"	P36507	19	4090321-4124129	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB003835, HPA051993"	Supported		Supported	Cytosol				Cytosol		"CAB003835: AB_562312, HPA051993: "	"unprognostic (4.39e-1)"	"prognostic favourable (3.72e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.58e-1)"	"prognostic favourable (7.98e-4)"	"unprognostic (2.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (5.43e-5)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.90e-2)"	23.9	33.0	35.6	27.6	36.1	46.7	30.2	31.2	43.4	22.6	38.8	24.6	27.0	70.9	21.8	23.2	32.8	21.7	27.9	41.4	33.1	31.0	22.7	42.0	24.1	44.5	34.4	29.2	30.8	46.0	18.9	29.7	21.3	26.1	25.7	24.3	21.7	41.5	24.0	134.9	27.4	56.7	19.0	25.2	25.9	28.3	42.0	20.9	44.1	26.2	42.2	29.1	20.0	26.9	11.4	10.7	28.3	10.6	11.3	12.1	4.5	36.2	40.0	21.9	30.7	30.3	36.6	21.9	23.9	32.0	32.7	29.7	34.6	19.7	31.0	22.6	27.2	26.2	17.1	25.5	25.4	26.3	20.8	11.3	21.8	38.2	46.5	20.8	23.9	40.4	24.9	22.9	30.6	28.9	21.6	61.3	27.5	45.4	41.1	29.2	25.1	29.1	31.5	14.4	35.4	28.5	23.3	29.7	29.6	21.9	30.4	74.5	23.4	35.7	25.5	26.9	23.3	68.6	36.8	61.7	37.3	21.7	41.7	37.5	45.9	15.2	9.1	28.3	11.9	10.6	9.7	8.9	9.7	12.1	10.7	11.4	8.9	11.6	14.4	11.3	8.7	6.0	9.2	4.5	35.6	36.1	31.2	43.4	33.1	31.0	34.4	29.2	26.1	20.9
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315240	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	16.1	12.1	5.5	14.8	7.3	66.9	29.0	12.4	8.9	10.2	12.4	6.3	10.3	18.1	7.6	11.1	24.2	11.6	25.1	26.8	5.6	5.3	15.8	37.1	25.5	34.0	7.4	3.9	10.1	26.3	9.6	15.8	26.7	9.5	12.2	9.3	12.7	18.5	9.2	46.4	20.9	23.8	18.1	7.6	26.7	16.3	5.3	4.1	16.4	11.5	45.0	21.4	16.0	17.3	13.2	17.3	49.2	33.3	5.4	16.2	10.0	21.6	22.0	2.9	13.3	17.8	11.4	11.1	33.6	36.5	26.8	24.7	24.3	14.0	19.6	13.7	52.5	21.5	9.3	29.8	19.1	20.3	17.0	11.4	12.6	22.0	5.5	14.9	23.4	8.8	8.5	36.5	11.0	12.0	2.2	9.8	22.3	21.5	7.4	14.2	8.4	12.6	15.5	18.9	14.5	15.1	22.9	8.0	2.8	12.4	13.4	23.3	6.7	5.1	10.9	25.5	20.8	27.2	21.6	12.3	6.2	25.2	24.6	12.9	13.1	14.5	16.0	25.2	14.6	24.0	12.6	13.2	12.1	13.6	17.3	10.6	7.8	10.1	49.2	5.4	33.3	12.7	16.2	10.0	5.5	7.3	12.4	8.9	5.6	5.3	7.4	3.9	9.5	4.1
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414698-69553861	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.9;skeletal muscle: 55.6"	"Cell line enhanced"	"Detected in many"		"A549: 23.9;HUVEC TERT2: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favourable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favourable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	4.5	2.0	3.2	8.6	5.9	10.1	14.0	13.7	7.5	19.8	21.5	6.2	4.7	7.2	4.7	3.1	3.4	3.3	5.1	2.5	3.9	3.5	4.1	8.6	2.6	10.3	5.4	4.1	2.7	8.5	0.0	3.2	1.1	5.3	2.8	22.8	5.3	4.0	4.6	55.6	2.3	7.3	2.3	6.2	5.9	5.4	2.1	5.4	13.7	2.8	4.8	5.1	3.0	2.5	2.3	31.9	19.3	9.3	1.8	2.1	2.6	0.1	23.9	10.8	13.0	4.7	2.5	1.6	0.1	3.5	1.0	1.5	0.7	1.1	0.6	8.8	0.5	1.2	3.7	0.5	0.3	0.8	1.9	0.1	6.7	6.7	4.6	1.0	0.9	11.9	0.3	0.3	0.0	17.2	0.0	1.7	0.0	0.1	12.5	0.4	7.6	4.4	4.5	1.1	0.3	4.8	3.3	4.8	7.3	1.0	0.9	2.2	3.3	1.3	3.0	1.3	1.5	1.1	0.4	1.2	1.3	0.3	1.0	1.5	1.0	0.8	9.3	1.6	1.2	1.1	2.1	1.6	1.4	1.5	2.9	2.3	1.6	1.5	19.3	1.8	0.4	31.9	1.9	2.6	3.2	5.9	13.7	7.5	3.9	3.5	5.4	4.1	5.3	5.4
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: "	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favourable (1.56e-4)"	16.3	14.9	13.5	16.4	16.4	23.8	13.6	28.7	21.5	14.3	15.6	23.2	15.1	19.3	19.1	9.9	13.6	13.1	14.3	15.8	14.6	11.9	12.8	15.9	12.5	15.9	17.2	13.9	18.4	22.3	13.9	17.0	16.4	16.2	14.4	7.9	14.2	23.0	13.4	61.6	21.3	18.7	14.1	12.5	19.4	14.8	21.5	16.5	9.8	13.7	17.3	12.8	15.4	15.2	3.0	2.6	4.8	2.7	3.3	2.5	1.0	12.7	7.3	6.4	10.4	5.1	5.0	11.9	8.4	4.1	5.7	6.0	10.5	7.8	15.2	13.6	4.4	11.7	5.5	6.4	2.2	12.1	27.4	10.7	9.7	7.8	6.6	9.9	13.6	5.7	8.4	4.5	5.2	5.2	15.6	20.0	3.3	6.7	14.2	24.2	11.2	16.5	14.1	6.9	15.4	5.1	10.7	11.7	11.8	5.7	10.1	11.7	10.8	11.4	7.7	17.5	10.0	12.3	11.3	29.0	13.4	14.3	8.7	14.7	7.0	0.0	2.7	1.9	2.3	2.5	1.5	2.1	1.9	2.0	1.3	3.0	1.7	2.5	4.8	3.3	1.5	2.6	0.7	1.0	13.5	16.4	28.7	21.5	14.6	11.9	17.2	13.9	16.2	16.5
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815574-56896152	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 27.0;THP-1: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"olfactory region: 22.5"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol				Cytosol		"CAB004500: AB_627926, HPA046509: "	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	6.7	4.9	5.4	14.6	4.8	15.2	14.9	8.0	4.5	7.6	6.7	5.4	7.3	4.3	7.1	9.4	12.7	7.2	5.9	4.3	3.7	3.2	9.5	4.4	8.8	21.4	6.4	3.1	8.4	9.2	6.3	7.9	8.1	4.5	8.3	4.5	12.6	15.4	9.7	3.5	21.8	11.2	4.0	3.8	21.3	5.5	8.5	5.1	11.7	19.2	6.6	18.2	6.0	11.7	6.6	2.8	6.7	7.2	2.7	5.8	2.3	6.4	3.9	6.2	4.1	1.0	0.8	10.4	1.2	1.7	3.9	5.5	18.4	4.9	5.8	0.4	1.5	3.4	5.1	2.3	5.4	2.0	2.2	3.2	1.7	8.6	2.5	5.1	9.0	1.0	2.5	1.2	1.9	1.7	2.8	10.5	1.0	2.8	3.5	6.9	2.8	0.5	5.6	4.4	19.9	6.8	6.8	2.6	27.0	3.8	4.8	11.0	13.2	25.2	4.9	0.3	3.3	1.4	2.3	7.7	3.9	11.1	0.6	3.0	6.6	6.7	4.5	1.0	1.2	6.8	1.2	6.6	3.8	1.8	2.8	5.1	2.5	0.9	2.6	2.7	7.2	1.5	5.8	2.3	5.4	4.8	8.0	4.5	3.7	3.2	6.4	3.1	4.5	5.1
MAP3K10	"MEKK10, MLK2, MST"	ENSG00000130758	"Mitogen-activated protein kinase kinase kinase 10"	Q02779	19	40191744-40215575	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007039	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Actin filaments, Cytosol"		"HPA007039: AB_1079357"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (8.69e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.62e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.77e-3)"	"prognostic favourable (2.13e-4)"	7.7	7.0	29.6	4.7	22.8	3.7	2.2	14.3	32.0	3.3	3.4	5.3	1.8	4.4	4.5	1.8	3.7	3.1	4.0	8.2	28.2	11.2	4.7	2.1	4.2	4.6	11.5	9.4	4.3	8.1	4.7	5.2	3.7	9.0	4.6	2.0	2.4	6.9	4.8	22.9	5.6	5.0	4.0	5.3	6.7	6.2	6.6	7.1	2.3	3.3	2.6	2.4	3.8	5.4	0.8	0.0	0.0	0.2	0.0	0.9	0.0	6.2	7.5	2.3	5.5	2.2	1.3	6.5	4.4	2.2	2.0	2.1	1.7	1.8	5.7	4.6	1.5	2.0	0.9	2.2	0.3	10.9	7.1	1.5	3.2	1.7	4.2	1.2	3.7	1.2	5.4	2.2	1.5	1.9	5.4	9.8	0.6	3.7	4.7	2.3	2.8	4.9	5.9	2.5	3.4	1.8	4.0	7.8	11.3	5.1	1.8	10.3	2.5	2.3	3.1	5.3	5.1	7.8	8.4	13.0	7.5	2.5	6.2	2.4	7.7	0.0	0.1	0.0	0.4	0.2	0.0	0.8	0.2	0.9	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	29.6	22.8	14.3	28.7	28.2	11.2	11.5	9.4	9.0	7.1
MAP3K11	"MEKK11, MLK3, PTK1, SPRK"	ENSG00000173327	"Mitogen-activated protein kinase kinase kinase 11"	Q16584	11	65597755-65615382	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 75.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010165	Approved		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"CAB010165: AB_631936"	"unprognostic (8.36e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.27e-3)"	23.2	10.8	11.4	23.7	21.2	14.2	27.4	7.9	13.8	8.6	15.8	29.8	6.1	31.9	11.0	8.1	14.7	11.6	12.0	11.6	13.3	8.1	16.1	31.2	21.1	14.4	30.9	8.2	8.4	12.5	8.3	10.3	14.7	16.7	13.4	8.2	15.4	13.5	9.5	11.9	13.7	31.9	8.6	17.7	28.8	16.9	8.6	19.0	8.9	13.6	7.6	12.7	8.9	75.8	2.3	7.6	13.8	12.0	1.8	3.5	5.6	16.5	14.6	7.9	8.4	2.5	3.2	8.1	6.4	4.5	7.7	5.3	14.6	16.0	6.2	23.7	5.0	14.4	4.7	6.9	2.8	13.6	6.0	17.5	10.0	17.4	7.0	10.0	26.5	5.0	6.7	5.7	5.2	21.5	7.5	12.5	4.0	20.4	11.7	18.9	8.6	18.7	19.5	5.1	12.6	7.2	14.3	7.1	8.0	7.5	21.8	37.5	17.4	16.3	23.9	11.8	12.8	17.2	11.3	8.0	9.0	5.5	13.8	11.6	27.3	4.3	7.7	9.2	2.4	12.0	2.4	2.0	2.6	3.5	7.6	2.3	2.0	1.5	13.8	1.8	11.7	2.3	1.4	5.6	11.4	21.2	7.9	13.8	13.3	8.1	30.9	8.2	16.7	19.0
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489097	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"				"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavourable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favourable (1.11e-4)"	"prognostic unfavourable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	9.8	24.8	21.7	8.7	22.2	9.5	15.1	16.4	26.1	12.9	16.9	18.4	10.5	16.8	12.9	42.1	15.2	14.6	13.1	8.1	19.2	18.6	21.9	20.7	15.2	7.4	23.2	17.1	16.5	24.9	20.9	24.5	9.1	21.8	14.5	18.9	18.6	26.2	11.4	3.3	9.8	23.4	12.1	26.4	8.7	16.4	12.9	15.8	4.4	18.6	8.3	10.3	12.5	11.5	23.7	21.5	21.1	13.2	11.5	17.4	7.8	29.1	5.8	11.3	0.3	10.3	12.7	6.6	6.7	4.6	10.9	13.2	11.2	11.0	0.2	23.0	12.2	16.7	0.3	15.5	19.4	32.4	15.0	0.1	7.9	9.2	11.2	15.3	8.4	11.5	13.6	9.3	11.7	12.1	0.3	23.7	9.7	9.1	1.8	7.2	13.0	13.7	0.2	13.5	16.0	19.2	7.6	18.6	12.4	11.3	17.1	23.2	25.8	8.6	8.0	9.0	11.7	16.2	14.5	12.1	15.6	9.6	13.2	7.8	14.7	6.4	13.2	5.1	10.3	12.2	15.8	23.7	12.4	12.8	21.5	19.0	17.4	16.8	21.1	11.5	8.6	9.4	4.8	7.8	21.7	22.2	16.4	26.1	19.2	18.6	23.2	17.1	21.8	15.8
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263121-45317040	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;HDLM-2: 22.6;U-251 MG: 22.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_10600302, HPA027270: AB_10600884"	"unprognostic (1.05e-2)"	"prognostic favourable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	3.7	3.4	3.0	14.7	4.0	3.4	2.7	4.9	3.6	5.0	7.3	4.5	3.5	6.0	5.5	3.3	6.8	4.2	6.2	4.5	3.0		4.4	5.1	4.9	12.0	3.0	0.6	3.5	5.7	3.5	7.7	1.5	4.6	5.2	3.5	4.3	7.5	4.8	14.5	6.1	9.6	5.2	4.1	8.4	4.0	4.5	4.5	7.1	2.2	6.9	18.0	4.9	2.8	9.5	4.8	7.7	3.6	5.6	5.2	2.3	9.4	22.0	2.2	3.9	1.5	3.7	5.6	2.6	1.8	8.3	5.1	3.4	11.6	4.2	13.3	2.7	6.6	1.0	3.5	4.3	22.6	1.7	0.9	6.0	1.5	4.0	0.7	4.4	5.8	2.2	4.1	2.2	1.6	1.8	18.0	4.2	3.4	3.9	1.5	1.2	3.1	5.2	6.7	9.5	6.0	1.9	2.3	1.9	4.0	2.7	2.8	1.7	0.4	3.5	3.8	5.9	3.2	22.1	17.2	6.4	2.2	2.1	2.4	5.1	1.5	3.4	1.6	3.5	3.6	2.0	7.6	2.4	2.5	2.3	9.5	2.6	2.5	7.7	5.6	2.2	4.8	5.2	2.3										
MAP3K19	"FLJ23074, RCK, YSK4"	ENSG00000176601	"Mitogen-activated protein kinase kinase kinase 19"	Q56UN5	2	134964491-135047468	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 18.3;fallopian tube: 23.9"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 4.0;U-266/70: 2.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.3"	"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 20.2"	HPA011388			Uncertain	Cytosol				Cytosol		"HPA011388: AB_1848822"	"unprognostic (7.12e-3)"	"unprognostic (6.55e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.83e-4)"	0.1	0.2	1.7	0.2	6.2	0.1	0.1	0.0	0.5	1.1	0.2	7.3	0.0	0.2	1.0	6.7	0.2	23.9	0.1	0.1	2.9	3.8	0.2	0.2	5.6	0.2	0.5	1.5	7.3	0.1	0.1	1.0	0.1	18.3	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	7.6	3.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	4.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.7	6.2	0.0	0.5	2.9	3.8	0.5	1.5	18.3	3.1
MAP3K2	"MEKK2, MEKK2B"	ENSG00000169967	"Mitogen-activated protein kinase kinase kinase 2"	Q9Y2U5	2	127298730-127388465	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 13.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021540	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021540: "	"unprognostic (5.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.97e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.11e-1)"	18.5	14.5	13.7	20.1	14.5	41.0	22.6	20.1	16.3	16.6	19.6	12.7	18.9	18.8	19.8	18.0	13.4	15.9	18.6	13.3	12.5	10.2	15.5	27.6	20.0	28.5	17.9	13.0	20.3	15.4	23.8	21.2	13.9	12.3	13.6	13.1	12.2	18.1	25.5	24.5	19.4	22.5	18.1	14.9	17.0	18.0	14.9	14.3	25.8	22.5	13.7	16.8	17.1	20.3	3.1	5.1	13.6	2.9	2.3	2.1	1.1	16.3	7.0	5.6	5.6	7.8	10.4	9.3	10.2	11.1	10.1	8.2	8.3	7.3	10.8	17.6	14.5	13.9	8.9	6.8	11.3	27.0	6.9	10.0	12.6	7.3	9.1	10.0	21.7	9.3	7.6	12.2	15.0	4.6	4.7	21.6	9.9	5.9	11.7	7.1	5.7	9.1	7.7	10.5	8.0	4.1	15.3	11.1	5.9	14.8	9.1	9.2	5.9	7.7	10.6	19.8	18.6	9.1	13.8	22.4	16.1	11.1	9.5	6.6	8.5	4.0	2.9	2.0	1.7	1.8	2.1	3.1	1.6	1.7	2.4	2.6	1.9	2.0	13.6	2.3	2.2	5.1	1.4	1.1	13.7	14.5	20.1	16.3	12.5	10.2	17.9	13.0	12.3	14.3
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268010	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.1"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 13.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 13.7;monocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol				Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	21.7	5.0	2.9	7.4	3.3	0.8	9.2	2.8	3.1	25.7	24.8	2.1	10.7	3.1	30.2	15.4	26.2	13.1	14.9	52.5	3.5	3.0	2.4	8.5	7.5	2.5	4.5	3.0	21.7	4.4	22.6	3.1	6.9	4.2	25.6	5.4	11.5	6.7	15.8	96.1	5.8	8.0	68.4	4.7	3.7	15.8	6.6	3.5	2.8	6.7	38.0	4.9	46.7	24.0	2.1	13.7	2.3	8.0	0.4	1.6	2.7	8.7	7.3	5.8	7.6	16.9	25.2	3.6	31.6	24.7	14.8	15.9	5.0	5.8	6.7	8.3	31.6	5.9	8.6	16.7	33.3	13.1	5.8	11.0	8.3	1.0	6.7	9.8	11.6	20.2	7.2	27.8	43.9	9.7	4.9	1.3	9.7	3.7	6.1	4.9	3.2	4.2	9.1	11.9	0.0	3.6	5.0	3.4	3.3	12.2	3.0	5.1	3.4	5.3	9.7	47.2	19.4	14.0	7.1	0.0	0.0	1.4	33.9	2.7	4.9	0.1	8.0	0.0	0.9	7.5	0.9	1.5	0.8	1.6	13.7	2.1	0.0	0.8	2.3	0.4	6.6	0.3	0.7	2.7	2.9	3.3	2.8	3.1	3.5	3.0	4.5	3.0	4.2	3.5
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327768-233385148	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 28.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.6	3.2	2.0	3.4	2.2	1.3	2.2	10.0	3.3	1.5	11.4	0.6	9.1	9.9	0.8	5.2	2.4	3.9	3.9	0.7	1.3	2.1	12.5	13.3	5.6	0.5	0.9	1.7	0.8	28.9	4.4	2.6	1.0	1.2	1.3	6.0	1.0	3.7	2.5	0.4	2.7	17.2	0.3	0.9	0.7	10.1	12.4	0.6	0.5	2.4	0.8	1.3	1.1	1.6	0.5	0.8	0.1	0.3	5.0	0.2	0.1	7.3	12.5	0.2	0.0	0.0	0.0	6.3	0.2	0.0	0.3	0.5	6.9	6.4	0.7	5.2	0.1	3.9	9.4	3.8	0.8	13.6	18.0	0.1	7.0	0.0	0.4	11.9	2.9	0.1	5.1	0.2	7.3	0.4	0.1	2.4	0.0	1.6	3.8	4.3	8.9	5.5	0.0	0.0	13.1	8.6	3.1	9.2	2.5	4.3	0.2	0.0	3.7	3.8	0.0	0.0	1.2	0.0	7.3	2.2	2.8	0.0	1.2	3.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.8	0.5	0.0	0.0	0.1	5.0	0.0	0.2	0.2	0.1	2.0	2.2	10.0	3.3	1.3	2.1	0.9	1.7	1.2	0.6
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	"Mitogen-activated protein kinase kinase kinase 4"	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007625	Uncertain		Approved	Cytosol				Cytosol		"HPA007625: AB_1853770"	"unprognostic (3.05e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.84e-2)"	12.0	8.0	13.1	17.7	12.6	9.1	14.6	23.1	14.0	16.4	13.9	9.3	12.2	9.5	22.2	11.9	21.4	14.1	11.4	12.4	11.9	7.8	9.4	8.2	15.9	14.4	12.8	8.9	17.4	12.1	15.8	16.2	12.4	9.2	14.2	9.8	9.4	15.0	15.4	24.4	15.1	13.3	13.9	7.7	10.6	11.1	13.5	12.4	16.2	10.6	13.0	16.8	15.8	23.9	8.8	5.4	17.5	3.8	3.5	8.9	2.2	4.6	5.3	10.1	8.6	6.3	7.4	6.5	5.3	4.7	6.1	6.5	7.5	3.4	9.6	3.8	13.5	11.7	10.3	10.6	7.5	7.0	8.4	12.5	4.9	7.4	4.8	13.0	6.1	4.6	12.3	6.4	5.8	7.9	31.6	11.1	6.5	4.8	8.7	6.6	6.1	8.2	9.6	9.3	7.6	5.6	3.4	5.8	5.2	9.9	10.6	0.9	4.3	15.9	7.4	7.5	9.6	6.9	25.0	6.5	5.2	8.8	8.8	13.4	7.8	17.5	3.8	2.3	5.0	3.0	8.9	6.2	7.1	4.5	4.3	8.8	5.0	4.9	0.2	3.5	1.7	5.4	4.8	2.2	13.1	12.6	23.1	14.0	11.9	7.8	12.8	8.9	9.2	12.4
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557047-136792518	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol				Cytosol		"CAB007824: AB_598175, HPA063245: "	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favourable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	7.7	55.6	13.0	7.5	17.6	7.6	5.5	12.9	12.7	4.0	5.4	6.9	3.6	4.6	7.2	5.1	6.4	6.1	4.9	7.3	11.8	6.8	6.8	5.5	7.7	8.8	8.2	6.4	32.4	28.2	1.5	9.9	3.4	7.9	11.6	6.2	5.8	4.2	4.9	3.7	5.0	4.6	4.3	7.5	9.8	8.7	7.3	8.6	2.0	10.0	3.4	9.0	10.8	18.9	2.5	2.5	8.5	3.0	4.1	7.0	1.4	2.8	1.7	0.0	0.0	4.1	11.1	1.0	4.1	22.3	2.1	2.0	0.1	2.9	1.7	6.1	5.7	4.0	7.1	2.1	5.6	2.3	5.6	14.7	3.9	0.0	19.8	6.8	0.0	14.6	2.8	3.3	9.6	7.1	3.6	16.5	15.0	5.5	0.1	5.8	0.7	2.4	3.8	4.7	6.7	8.6	18.3	5.2	3.4	3.4	3.3	0.9	0.7	6.1	6.2	3.6	1.1	0.2	3.8	13.5	8.9	0.0	2.8	9.6	3.1	5.7	3.0	3.3	2.7	2.3	4.9	2.0	4.3	3.7	2.5	2.5	0.4	1.4	8.5	4.1	2.1	2.4	7.0	1.4	13.0	17.6	12.9	9.4	11.8	6.8	8.2	6.4	7.9	8.6
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: "	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.13e-4)"	"prognostic favourable (7.26e-4)"	"prognostic unfavourable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9.0	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5.0	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16.0	11.7	8.7	9.0	6.7	7.0	0.6	12.0	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.4	6.9	6.2	6.9	8.7	15.3	1.6	9.3	5.4	7.0	5.3	2.0	10.0	0.1	8.3	14.1	11.8	2.1	6.5	3.5	6.2	5.1	0.5	16.0	3.1	2.7	0.5	0.6	12.2	15.9	7.3	2.6	4.7	2.3	4.1	11.1	18.4	0.3	8.4	1.9	5.7	2.7	4.1	1.7	10.5	7.8	2.3	3.4	9.8	8.6	7.3	4.6	6.4	9.8	17.6	7.4	19.7	4.8	3.3	4.1	0.1	15.6	6.1	5.1	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0.0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7.0
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20.0	22.2	22.9	16.4	25.0	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17.0	23.3	24.3	18.7	14.7	19.4	23.0	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.7	6.9	20.1	17.2	14.7	19.7	14.2	15.6	18.1	14.1	17.8	8.8	7.5	17.3	10.0	16.9	8.3	12.6	12.2	24.0	8.8	13.4	15.4	9.5	11.7	15.4	17.1	11.9	16.2	14.9	13.7	16.9	13.2	30.8	14.2	20.1	9.5	7.9	14.5	16.5	8.7	13.7	36.1	8.4	11.8	8.7	10.2	14.5	10.9	7.6	11.8	7.5	30.5	12.6	11.5	7.3	10.5	14.5	12.7	11.3	7.5	17.6	18.8	16.8	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16.0	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30433937-30461833	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 104.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol				Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	28.0	7.6	3.6	15.6	4.1	104.6	26.1	1.5	2.6	8.2	8.4	2.7	11.3	3.4	11.5	16.5	13.8	19.5	15.3	20.1	4.3	2.9	6.3	7.6	29.0	33.7	4.3	2.0	9.8	3.6	2.8	4.1	27.5	8.3	7.9	6.8	9.4	6.1	18.4	8.6	15.3	9.6	23.4	9.7	25.6	10.7	6.7	3.6	2.4	7.0	13.2	17.2	13.2	15.6	19.6	13.8	23.7	16.8	12.4	7.8	4.0	7.9	7.1	1.9	4.1	10.3	8.7	9.1	2.0	11.9	4.4	5.3	4.9	18.5	5.2	5.1	4.2	14.9	4.5	1.9	1.6	12.0	2.3	9.7	12.1	15.7	8.7	3.0	24.0	10.8	1.1	4.4	0.8	1.9	4.3	7.8	0.7	4.5	0.1	11.6	0.7	2.5	0.6	1.6	3.0	4.4	16.1	0.2	0.8	7.1	6.1	0.9	2.0	6.4	0.1	2.7	2.3	9.7	0.3	11.9	11.1	1.5	3.9	13.2	0.1	17.9	7.0	23.7	7.8	12.0	4.3	9.6	1.7	4.9	6.6	19.6	0.1	3.0	16.7	12.4	16.8	13.8	0.4	4.0	3.6	4.1	1.5	2.6	4.3	2.9	4.3	2.0	8.3	3.6
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.5;skeletal muscle: 197.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038149, HPA038150"	Enhanced		Enhanced	"Plasma membrane,Microtubules,Cytosol"			120000	"Plasma membrane, Microtubules, Cytosol"		"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	39.3	14.8	60.5	18.2	50.9	6.3	16.4	29.3	56.0	26.9	26.4	80.8	15.8	13.6	25.8	27.4	27.0	24.6	20.1	110.2	63.7	57.5	20.8	13.8	22.7	12.4	86.8	26.1	26.8	18.9	14.6	9.3	24.0	59.5	21.8	18.8	25.2	14.0	34.9	197.9	25.1	15.2	35.0	131.5	18.3	16.2	21.2	41.8	7.3	15.4	31.3	14.2	24.3	18.1	9.9	8.9	6.3	19.7	10.7	13.4	6.7	21.9	17.6	22.1	16.7	32.6	58.2	9.3	41.2	45.0	34.9	39.2	14.8	13.8	18.6	9.6	62.1	14.7	28.2	37.3	39.2	26.8	11.9	12.6	19.7	19.1	44.3	8.7	10.2	48.6	46.7	42.3	51.9	45.7	16.2	21.6	27.4	12.4	12.3	10.6	13.3	36.5	6.6	20.8	23.1	22.3	18.4	8.8	13.7	31.6	12.8	21.8	9.4	8.1	61.7	33.0	25.5	34.4	26.3	15.2	11.8	8.8	42.4	10.7	31.2	6.3	5.3	2.8	13.4	9.0	6.5	9.9	9.0	10.9	5.7	9.4	4.3	6.7	2.2	10.7	19.7	8.9	10.2	6.7	60.5	50.9	29.3	51.8	63.7	57.5	86.8	26.1	59.5	41.8
MAP4K5	"GCKR, KHS, KHS1"	ENSG00000012983	"Mitogen-activated protein kinase kinase kinase kinase 5"		14	50418501-50561126	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 26.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036696	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA036696: AB_10672362"	"unprognostic (1.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.58e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.53e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.02e-2)"	17.4	11.8	23.4	12.1	44.4	16.5	19.7	24.6	32.3	25.8	17.1	43.5	13.4	11.3	29.9	12.1	18.7	17.4	19.3	10.3	24.4	14.0	10.9	8.7	15.2	9.9	48.8	17.1	29.9	13.3	16.7	17.5	17.3	26.0	16.6	15.1	9.1	16.9	19.9	10.7	24.8	12.7	22.3	30.7	13.0	14.4	6.8	51.1	8.4	15.3	8.7	11.2	19.3	21.2	5.0	2.7	26.1	1.8	5.4	3.9	1.0	23.1	7.0	17.1	14.7	15.9	16.7	16.8	27.3	24.7	18.6	16.6	8.8	16.3	16.0	16.3	25.0	16.6	15.9	14.7	28.5	13.2	11.6	9.8	12.3	7.9	13.5	8.7	15.5	12.1	12.1	16.4	17.2	24.4	9.2	10.5	27.3	8.7	11.8	8.4	8.3	13.8	14.3	26.1	6.0	18.4	18.1	5.5	12.6	15.4	10.8	10.6	12.0	6.7	24.8	24.3	17.0	16.5	12.8	7.7	7.8	10.7	9.1	6.1	17.3	26.1	1.5	13.5	3.9	1.8	2.2	3.2	2.4	3.3	1.6	5.0	2.6	2.7	0.6	5.4	1.1	2.7	0.5	1.0	23.4	44.4	24.6	32.3	24.4	14.0	48.8	17.1	26.0	51.1
MAP6D1	"FLJ12748, SL21"	ENSG00000180834	"MAP6 domain containing 1"	Q9H9H5	3	183815876-183825594	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 48.1;skeletal muscle: 33.5"	"Cell line enriched"	"Detected in many"	5	"T-47d: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037991	Enhanced	Supported	Approved	Cytosol				Cytosol		"HPA037991: AB_10672503"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (8.81e-12)"	"unprognostic (1.08e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.72e-2)"	1.1	1.2	11.8	1.5	16.0	1.1	2.0	30.9	32.1	1.5	1.4	48.1	0.0	1.9	1.4	2.0	1.1	1.5	1.3	1.9	18.8	9.2	1.2	1.3	1.4	1.7	24.7	8.7	1.7	6.0	1.8	0.5	1.3	18.4	2.7	1.4	0.0	1.6	2.0	33.5	4.6	1.5	1.4	37.7	1.5	1.2	1.3	20.4	2.2	1.1	0.0	1.4	1.1	0.2	0.5	0.3	0.2	0.2	0.0	2.7	0.3	1.8	1.3	2.1	0.4	0.5	0.7	1.6	2.3	0.4	4.5	3.0	1.8	0.1	0.2	3.0	3.5	1.4	4.4	1.1	3.0	1.3	6.6	0.2	0.0	0.0	1.3	2.4	0.8	0.3	0.3	1.1	0.4	0.9	0.3	0.0	0.6	8.2	5.7	3.3	2.0	3.8	2.8	3.3	0.0	0.2	0.0	7.0	1.3	1.7	1.3	2.4	38.9	2.3	0.4	1.0	1.6	1.6	3.5	1.4	0.8	1.1	0.3	0.4	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.5	2.7	0.3	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.3	11.8	16.0	30.9	19.9	18.8	9.2	24.7	8.7	18.4	20.4
MAP7	E-MAP-115	ENSG00000135525	"Microtubule associated protein 7"	Q14244	6	136342281-136550819	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.7;HeLa: 25.9;MCF7: 31.8;RT4: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029712, HPA029713"	Enhanced		Supported	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA029712: AB_10600303, HPA029713: AB_10601339"	"unprognostic (8.68e-3)"	"prognostic unfavourable (9.70e-5)"	"unprognostic (2.33e-3)"	"unprognostic (4.35e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-1)"	"prognostic favourable (9.22e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.33e-1)"	"prognostic favourable (5.07e-7)"	"unprognostic (1.62e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.51e-2)"	2.2	6.8	24.1	3.6	41.3	3.4	10.4	36.9	29.3	5.2	18.5	49.8	6.0	21.8	2.1	15.7	11.9	7.9	6.5	1.5	30.7	18.3	25.3	13.3	5.5	1.3	47.6	16.5	1.5	19.0	18.9	13.8	5.3	26.2	15.8	18.0	6.6	14.0	8.2	1.1	13.0	19.7	2.1	55.4	1.5	14.4	17.1	52.7	0.4	12.6	4.3	3.9	6.3	6.0	1.6	5.9	13.0	2.8	0.7	0.6	0.7	9.1	14.3	0.1	0.0	0.1	0.0	15.2	0.2	0.4	0.1	0.2	21.7	9.7	0.0	2.0	0.3	14.1	4.1	12.7	0.2	0.0	9.1	9.6	25.9	0.1	0.1	9.3	1.1	0.0	11.9	0.0	0.9	0.1	6.5	0.2	0.0	31.8	0.1	0.9	1.9	2.1	0.0	0.3	1.7	8.9	25.0	9.2	1.9	10.1	19.3	0.2	7.6	0.9	0.2	0.0	0.7	0.1	0.6	1.7	2.2	0.0	0.2	3.7	0.2	3.0	2.6	0.0	0.0	1.7	0.3	1.6	0.6	0.0	5.9	1.2	0.1	0.0	13.0	0.7	2.8	0.0	0.2	0.7	24.1	41.3	36.9	29.3	30.7	18.3	47.6	16.5	26.2	52.7
MAP7D1	"FLJ10350, FLJ39022, PARCC1, RPRC1"	ENSG00000116871	"MAP7 domain containing 1"	Q3KQU3	1	36155579-36180849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 144.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028075	Approved		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA028075: AB_10603778"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (1.49e-6)"	"unprognostic (6.00e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (8.56e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.32e-3)"	39.4	12.8	25.4	24.4	27.8	19.4	17.4	26.4	44.7	11.2	24.0	32.4	4.6	12.4	16.6	5.5	25.9	10.6	18.4	51.7	25.1	22.5	7.4	4.9	21.3	14.7	31.2	24.1	10.2	10.0	8.3	12.2	15.4	30.8	18.4	7.1	10.2	11.0	19.5	144.7	20.9	10.9	21.1	40.7	17.8	14.2	6.7	22.8	14.9	10.5	18.6	11.5	22.8	12.4	0.4	0.8	4.7	1.4	0.4	1.9	0.2	28.8	17.0	26.8	16.9	16.4	12.5	19.8	29.0	29.6	30.6	27.1	9.4	29.8	12.1	24.9	26.3	31.8	11.0	39.4	10.1	20.7	9.8	8.2	12.7	3.6	25.9	12.1	21.3	21.7	11.2	41.3	25.7	20.9	7.9	18.8	16.9	5.8	22.3	10.2	24.4	9.6	23.2	19.8	11.5	15.5	10.0	10.4	20.0	16.6	9.3	22.5	6.2	8.6	39.1	36.2	27.6	30.6	39.2	18.7	5.5	14.2	31.0	8.3	21.7	0.5	1.4	1.4	1.1	0.7	1.5	0.1	1.0	0.8	0.6	0.4	1.9	0.6	4.7	0.4	0.5	0.8	0.3	0.2	25.4	27.8	26.4	43.8	25.1	22.5	31.2	24.1	30.8	22.8
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;epididymis: 38.7"	"Cell line enhanced"	"Detected in some"		"A549: 8.6;CACO-2: 12.4;HEK 293: 17.0;HeLa: 14.7;Hep G2: 7.3;SCLC-21H: 19.6;SiHa: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051508: , HPA059537: "	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.7	3.6	11.1	0.9	18.5	1.3	1.0	12.9	30.8	0.7	1.3	0.8	0.7	1.3	1.2	38.7	0.9	3.0	1.1	0.9	16.5	10.3	4.1	0.7	0.9	0.8	10.4	15.0	0.8	1.7	0.7	3.0	8.1	24.2	1.5	1.5	0.8	0.8	2.8	1.0	1.5	1.8	1.0	7.1	0.7	8.9	9.7	2.1	0.0	0.6	0.0	0.9	0.7	0.5	0.0	0.8	5.5	0.1	0.0	0.3	0.0	0.0	8.6	0.8	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.1	12.4	0.3	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.6	17.0	0.0	14.7	7.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	0.2	0.0	0.0	1.0	0.0	19.6	3.3	8.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.9	0.0	0.9	5.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	11.1	18.5	12.9	21.7	16.5	10.3	10.4	15.0	24.2	2.1
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261825	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skeletal muscle: 104.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"NK-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"NK-cells: 3.0"	"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: "	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	3.0	1.6	4.5	2.1	4.5	1.0	1.8	9.0	7.0	2.1	1.4	2.1	1.6	2.0	5.4	5.1	3.3	2.9	2.4	5.1	3.9	3.6	2.5	1.0	2.1	2.0	3.5	5.7	3.0	1.4	1.2	7.0	2.3	2.6	2.9	1.1	2.2	1.4	3.7	104.2	0.9	1.5	4.2	2.6	1.6	1.5	1.6	2.4	0.0	1.3	10.8	1.1	2.4	1.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	10.3	6.4	2.4	7.4	5.6	6.2	3.5	7.9	6.9	13.3	8.5	9.2	3.2	19.4	10.8	8.7	6.9	11.0	1.6	2.5	5.6	15.4	12.7	19.3	11.4	17.9	11.9	25.2	13.4	2.9	3.0	0.0	15.0	11.2	18.1	6.1	5.7	0.0	15.9	7.5	10.4	18.1	6.7	19.7	7.9	1.4	8.5	2.9	6.1	0.2	9.8	3.3	13.8	7.8	13.7	12.4	2.9	4.9	4.2	3.2	10.4	3.5	11.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	4.5	4.5	9.0	7.0	3.9	3.6	3.5	5.7	2.6	2.4
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 45.7;RPMI-8226: 27.6;RT4: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 16.5;T-cells: 27.8"	"Region enhanced"	"Detected in some"		"cerebellum: 6.5"	"Region enriched"	"Detected in some"	15	"cerebellum: 59.9"	"HPA007667, CAB025854"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favourable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	6.5	22.0	2.2	5.4	4.0	2.9	6.8	2.8	7.3	6.8	18.9	0.5	36.8	18.8	1.9	10.3	41.1	2.4	12.0	1.2	1.7	1.8	6.5	2.8	9.6	11.2	0.8	3.8	3.9	24.6	18.8	12.4	10.5	2.5	6.8	16.0	2.4	20.7	26.3	0.9	28.6	37.7	2.1	0.8	5.9	12.2	23.7	1.1	5.0	13.8	16.0	18.5	7.3	13.9	16.5	0.1	5.2	0.3	2.8	27.8	6.7	19.3	0.1	0.3	0.2	1.1	5.6	2.7	1.5	0.2	0.2	0.5	16.2	19.1	4.6	1.2	1.5	15.1	0.0	45.7	0.4	11.8	5.1	0.1	0.5	16.0	1.9	0.1	1.2	4.8	16.2	2.9	0.6	3.0	0.3	5.2	0.5	10.2	0.1	1.2	0.1	0.3	11.4	0.2	27.6	8.8	28.6	19.3	0.3	1.7	0.3	0.1	21.7	2.5	4.0	1.4	0.2	0.5	0.3	0.3	6.9	1.4	0.0	0.5	0.1	5.2	0.3	4.5	16.2	0.0	10.5	10.8	11.6	13.0	0.1	16.5	10.6	11.9	3.9	2.8	0.0	0.0	27.8	6.7	2.2	4.0	2.8	7.3	1.7	1.8	0.8	3.8	2.5	1.1
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 32.1;neutrophil: 12.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"			7100000	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	21.5	20.6	11.7	18.4	15.5	49.9	20.7	26.5	18.1	22.0	20.5	12.5	11.9	16.9	38.8	12.1	24.0	18.9	16.0	16.4	9.3	9.5	16.0	29.8	21.5	29.0	12.0	11.3	17.7	18.5	15.0	27.2	27.3	10.2	23.4	18.3	17.0	16.7	16.5	21.2	25.6	22.5	26.0	10.6	35.5	18.2	11.1	10.3	34.1	20.9	17.6	20.8	25.0	30.0	2.3	4.0	32.1	4.9	3.0	2.8	2.1	18.3	10.1	10.9	17.5	24.8	24.8	24.0	19.2	25.0	22.8	23.8	24.7	9.5	14.9	19.1	21.1	13.2	18.0	16.6	23.9	16.8	14.3	34.4	14.4	20.6	13.7	21.6	20.8	17.4	16.2	16.4	16.3	25.8	19.0	18.7	15.5	8.7	22.2	26.0	6.7	10.1	26.4	17.7	13.8	16.1	25.3	8.2	7.0	17.3	13.0	20.1	15.3	40.4	18.1	20.5	11.9	12.9	17.6	9.2	21.0	14.9	9.3	42.8	16.8	32.1	4.9	3.0	2.4	3.5	2.8	1.5	2.2	2.6	4.0	2.3	2.5	2.4	12.3	3.0	4.7	1.9	2.6	2.1	11.7	15.5	26.5	18.1	9.3	9.5	12.0	11.3	10.2	10.3
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716259-143722458	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;epididymis: 27.6;fallopian tube: 29.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;HeLa: 14.0;MCF7: 13.6;T-47d: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2.0	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3.0	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.7	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	7.1	0.0	1.3	0.0	5.3	0.0	0.2	0.0	1.1	1.6	0.0	14.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	13.6	0.0	0.0	2.0	1.1	0.0	2.9	0.3	0.9	1.3	3.9	3.9	0.0	2.8	0.0	12.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4
MAPK1IP1L	C14orf32	ENSG00000168175	"Mitogen-activated protein kinase 1 interacting protein 1 like"	Q8NDC0	14	55051631-55070192	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034506	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA034506: AB_10669784"	"unprognostic (3.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.17e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"prognostic favourable (4.82e-5)"	"unprognostic (7.96e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.40e-2)"	37.7	27.1	22.9	23.9	23.7	65.9	27.9	25.7	29.3	26.3	24.7	24.2	20.0	17.3	32.1	28.6	28.6	31.5	24.9	32.6	20.1	25.8	41.9	32.6	27.6	33.6	21.3	18.0	41.1	21.2	25.7	32.8	36.4	22.8	23.9	23.6	28.5	33.8	30.6	38.5	26.7	29.5	32.8	19.9	33.3	26.7	30.8	17.4	37.7	25.9	26.6	39.1	32.9	24.2	27.5	30.8	28.8	30.4	21.4	30.7	19.6	19.5	17.3	30.5	19.4	24.7	24.4	23.7	22.0	23.5	27.4	31.9	13.8	17.4	22.7	18.7	29.3	21.6	32.7	33.3	38.5	20.5	20.9	21.8	16.9	20.7	27.1	26.7	24.1	31.5	25.2	22.8	36.4	36.3	20.2	20.2	39.5	23.6	22.4	20.7	22.1	29.2	19.3	33.6	13.6	37.6	22.1	19.9	23.1	21.3	15.3	19.8	27.2	15.5	27.3	28.2	37.0	17.4	19.6	12.5	18.0	30.0	22.5	14.0	20.2	28.8	22.2	25.7	21.4	30.4	28.2	27.5	25.5	23.1	23.9	23.6	23.8	23.4	16.5	21.4	28.1	30.8	30.7	19.6	22.9	23.7	25.7	29.3	20.1	25.8	21.3	18.0	22.8	17.4
MAPK6	"ERK3, HsT17250, p97MAPK, PRKM6"	ENSG00000069956	"Mitogen-activated protein kinase 6"	Q16659	15	51952106-52067372	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005184, HPA030262"	Approved	Supported	Enhanced	Cytosol				Cytosol		"CAB005184: AB_2140298, HPA030262: AB_10601868"	"unprognostic (6.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.31e-2)"	11.8	7.4	14.4	10.9	23.2	25.6	13.7	33.0	24.5	16.3	18.7	12.5	9.3	16.3	15.9	13.3	32.3	8.2	17.0	9.1	13.3	15.9	14.4	32.6	12.6	9.4	13.1	16.8	11.5	8.5	12.2	15.3	13.9	23.8	10.5	18.1	9.5	17.9	11.4	27.1	24.0	26.2	17.8	14.2	9.2	15.7	25.7	13.0	11.7	13.4	22.7	12.4	18.9	22.4	4.9	4.2	3.0	4.5	6.5	7.9	3.6	8.7	11.8	23.3	8.9	7.2	11.9	17.0	12.5	12.6	11.6	13.7	14.1	5.3	12.6	8.8	16.0	12.4	17.9	23.9	15.9	7.7	5.6	18.8	7.0	22.3	17.4	14.0	40.2	12.7	43.9	14.0	36.4	10.9	24.3	21.5	14.7	19.7	9.8	11.0	8.2	5.7	8.6	15.0	20.2	11.1	36.9	11.4	10.8	10.1	8.2	18.3	7.5	20.9	10.8	13.9	15.0	9.0	16.7	11.2	32.9	15.6	17.2	20.6	17.0	3.0	4.5	1.2	3.8	4.3	4.7	4.9	5.6	4.3	4.2	2.6	5.4	3.8	0.6	6.5	2.8	1.9	7.9	3.6	14.4	23.2	33.0	24.3	13.3	15.9	13.1	16.8	23.8	13.0
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: "	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.5	15.0	6.4	7.3	7.6	9.2	11.8	12.5	7.9	13.4	15.3	7.2	6.0	9.2	13.1	14.1	17.3	9.4	11.8	8.2	5.9	4.7	10.8	4.8	9.9	9.2	8.2	5.2	25.4	5.7	7.3	7.5	12.5	6.7	14.0	6.9	10.5	7.8	12.3	7.5	13.1	11.2	13.8	7.1	13.2	8.0	13.3	7.5	4.5	8.6	11.3	10.6	12.7	15.9	2.2	2.6	11.5	7.4	5.5	4.7	3.0	4.1	6.5	5.4	4.2	27.1	11.3	6.3	5.6	5.2	7.8	7.2	7.5	0.7	2.5	4.6	9.7	4.6	6.3	5.1	4.9	4.3	4.8	1.2	4.7	3.3	11.7	1.1	4.2	11.9	3.6	11.8	4.2	5.7	2.2	0.9	7.7	2.7	8.3	4.4	6.2	4.3	4.5	7.9	1.7	2.6	2.3	2.4	7.2	5.7	0.5	2.9	3.5	1.4	3.2	8.4	6.2	9.2	3.8	1.6	2.4	0.6	9.7	1.0	5.0	1.0	3.6	11.5	4.7	7.4	2.5	2.2	2.2	4.1	2.6	1.4	2.1	2.6	1.3	5.5	6.5	1.7	1.0	3.0	6.4	7.6	12.5	7.9	5.9	4.7	8.2	5.2	6.7	7.5
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"Mitogen-activated protein kinase associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favourable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	27.2	33.9	35.0	24.4	41.4	20.4	22.6	20.3	30.4	27.0	30.1	21.0	20.6	20.1	26.4	25.6	30.3	20.5	21.3	44.9	29.5	24.9	37.5	37.5	20.1	21.3	28.3	20.4	29.1	24.8	29.8	24.1	31.3	27.1	21.7	26.7	22.8	29.7	26.2	60.7	18.2	23.3	33.2	28.5	27.0	25.1	24.9	22.1	24.1	32.7	23.2	24.7	27.2	25.7	7.6	7.1	18.8	6.1	5.4	7.5	2.5	23.9	27.2	18.4	19.5	25.4	24.3	30.7	30.4	31.2	23.6	16.6	27.5	27.1	24.6	18.7	42.4	33.5	28.4	35.7	32.2	27.8	11.6	17.7	32.9	26.0	28.6	31.6	20.7	23.8	33.0	33.7	35.3	34.8	28.1	19.4	50.0	50.0	23.3	12.8	29.2	34.2	19.7	43.6	32.7	25.9	17.5	22.3	21.9	30.5	28.8	19.1	33.3	18.5	22.3	33.6	22.2	40.2	50.4	24.4	59.9	25.1	47.9	14.6	36.2	3.6	6.1	5.3	4.6	5.8	6.2	7.5	5.0	5.0	4.8	7.6	4.4	7.5	18.8	5.4	5.2	7.1	5.4	2.5	35.0	41.4	20.3	30.4	29.5	24.9	28.3	20.4	27.1	22.1
MAPKAPK5	PRAK	ENSG00000089022	"Mitogen-activated protein kinase-activated protein kinase 5"	Q8IW41	12	111841978-111902238	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	20.7	26.2	21.4	17.5	26.4	24.1	21.7	23.7	28.3	17.3	28.8	26.1	21.9	26.3	25.8	22.8	20.8	17.5	22.7	20.7	17.7	15.2	21.7	21.5	18.9	19.4	22.3	20.4	21.3	24.5	19.8	20.4	21.0	17.3	18.7	32.9	23.6	23.3	20.5	33.2	23.0	28.4	21.1	18.0	18.4	19.8	16.7	22.0	19.3	20.5	15.1	19.3	19.9	16.5	4.9	4.1	3.2	11.4	3.9	6.8	2.5	15.1	20.2	19.5	16.4	14.1	14.3	29.7	15.2	18.4	23.4	16.2	26.0	12.5	22.9	11.3	17.9	15.2	25.6	15.9	22.0	15.2	14.0	20.4	14.0	20.8	17.1	25.6	14.5	15.1	22.9	22.3	26.6	17.1	28.1	9.1	17.0	17.0	25.4	40.5	27.7	14.2	25.2	14.2	22.0	18.6	22.0	24.1	20.4	17.3	29.5	21.1	23.8	29.3	14.9	13.3	13.4	13.6	19.0	18.6	22.7	27.1	16.2	18.7	18.8	1.3	4.8	3.2	6.5	3.5	3.5	4.9	4.3	4.7	3.3	4.0	6.8	5.1	2.5	3.9	11.4	4.1	6.6	2.5	21.4	26.4	23.7	28.3	17.7	15.2	22.3	20.4	17.3	22.0
MAPRE1	EB1	ENSG00000101367	"Microtubule associated protein RP/EB family member 1"	Q15691	20	32819893-32850405	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003600, CAB009337, CAB019391"	Supported		Enhanced	"Centriolar satellite,Cytosol"			17000000	"Centriolar satellite, Cytosol"		"CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309"	"unprognostic (3.74e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (6.33e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.59e-3)"	35.4	23.4	30.9	30.9	28.7	77.5	27.2	12.3	25.3	26.1	39.3	34.0	25.9	18.3	40.0	29.8	30.0	28.4	27.4	31.7	26.9	25.0	33.6	14.2	30.3	31.9	36.6	17.5	29.5	22.1	19.7	20.0	35.2	27.9	29.1	28.1	24.7	22.0	35.3	20.4	19.3	25.8	42.5	37.1	38.5	29.1	31.7	24.1	48.4	35.2	26.1	31.0	39.1	30.0	19.7	25.7	66.8	41.4	27.3	30.3	42.1	30.5	28.1	31.5	18.0	17.1	15.5	44.9	30.0	18.7	46.8	34.6	81.2	28.5	46.7	30.2	26.9	28.1	37.6	33.5	51.4	15.7	14.6	89.9	19.6	43.4	18.1	32.3	40.0	16.7	16.8	38.2	25.6	29.1	40.4	26.7	41.0	19.0	44.2	28.3	22.7	26.1	29.8	55.9	25.0	25.5	21.2	19.7	20.7	53.8	23.9	30.8	34.5	24.1	25.7	52.8	28.5	26.3	38.6	23.6	32.4	50.3	28.0	74.1	29.3	55.1	33.6	66.8	28.1	39.3	29.1	19.7	26.9	25.9	25.7	18.9	27.3	30.3	36.8	27.3	41.4	23.6	27.0	42.1	30.9	28.7	12.3	25.3	26.9	25.0	36.6	17.5	27.9	24.1
MAPRE3	"EB3, RP3"	ENSG00000084764	"Microtubule associated protein RP/EB family member 3"	Q9UPY8	2	26970612-27027196	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 77.1;skeletal muscle: 62.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009263	Uncertain		Supported	Cytosol				Cytosol		"HPA009263: AB_1078716"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	14.4	17.3	38.5	5.7	46.6	1.7	10.0	39.5	77.1	7.3	9.7	13.4	6.5	5.8	12.0	8.4	7.3	30.2	9.6	22.2	34.6	40.9	9.3	11.3	9.2	4.5	27.7	46.0	22.1	9.6	17.9	25.9	8.2	32.8	12.0	7.8	8.8	7.7	11.8	62.3	17.2	4.5	9.9	15.7	5.7	10.3	25.4	15.9	0.5	9.8	6.3	5.2	6.6	6.0	1.4	1.7	7.0	3.2	1.0	1.5	1.3	10.4	8.1	7.5	13.0	13.7	7.7	2.1	8.2	6.6	7.0	7.2	2.9	13.9	0.0	8.0	10.2	5.4	4.1	8.7	4.1	8.6	10.1	1.5	4.4	0.7	12.6	1.2	20.1	6.3	15.7	3.5	6.6	1.7	10.0	8.2	4.2	4.7	0.0	0.5	3.2	13.0	0.0	0.2	1.1	4.8	6.9	19.0	9.4	5.7	4.2	5.7	4.4	0.7	1.7	6.2	6.3	8.7	7.2	6.3	2.2	0.0	22.2	0.8	12.2	0.2	2.8	0.5	1.5	2.9	1.0	1.4	0.8	0.5	1.7	0.7	1.3	0.3	7.0	1.0	3.2	0.0	0.2	1.3	38.5	46.6	39.5	57.3	34.6	40.9	27.7	46.0	32.8	15.9
MARCH10	"FLJ35757, MARCH-X, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 80.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;EFO-21: 7.2;HSkMC: 3.2;SCLC-21H: 12.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.2	0.1	0.7	0.2	1.6	0.0	0.1	0.1	0.3	0.5	0.1	1.9	0.6	0.0	0.3	4.8	0.1	7.9	0.1	0.1	1.0	1.0	0.6	0.1	1.4	0.1	0.2	0.5	1.0	0.1	0.3	4.5	0.1	1.8	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	80.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.6	3.4	0.3	0.1	0.0	0.2	0.0	0.0	0.2	3.8	1.6	0.2	1.2	0.3	0.0	0.1	0.0	7.2	0.5	0.0	0.0	0.4	1.3	0.0	0.0	1.2	0.7	0.0	1.5	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.4	0.1	0.1	0.3	0.2	0.0	0.0	0.2	1.1	0.0	12.4	0.0	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.7	0.3	0.7	0.1	0.6	1.8	0.0	0.6	0.0	0.0	0.7	0.3	0.7	1.6	0.1	0.3	1.0	1.0	0.2	0.5	1.8	0.3
MARCH2	"HSPC240, MARCH-II, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavourable (6.48e-4)"	"prognostic favourable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favourable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favourable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	37.7	12.4	30.7	13.5	28.3	17.5	23.9	8.6	39.1	9.8	29.8	20.7	9.7	11.2	12.5	39.0	19.3	10.0	11.4	38.9	23.5	21.9	11.0	17.9	18.2	15.0	30.8	19.8	8.2	10.0	10.5	11.3	13.9	20.2	16.0	10.3	12.7	13.4	21.8	46.9	12.7	11.7	28.5	27.8	18.9	13.3	8.6	13.3	8.4	21.3	14.1	10.0	20.4	9.7	3.6	26.5	20.4	14.6	3.7	7.3	10.1	5.4	7.0	3.2	14.7	19.5	6.4	5.4	6.0	7.3	4.8	5.0	3.4	2.6	2.2	17.6	12.8	3.9	4.1	8.4	3.7	10.9	9.7	16.7	3.3	7.6	10.5	2.4	25.1	7.6	9.7	4.6	4.1	18.7	2.3	12.3	3.7	10.5	3.3	7.9	6.6	17.0	5.3	1.0	5.5	11.0	6.5	1.6	8.9	0.4	6.4	11.3	4.9	5.2	18.8	6.7	4.1	22.3	5.0	11.0	13.0	2.5	10.9	5.0	5.1	20.4	10.0	15.4	5.7	14.6	5.9	3.6	5.9	4.6	6.7	3.5	4.0	5.4	12.5	3.7	12.8	26.5	7.3	10.1	30.7	28.3	8.6	39.1	23.5	21.9	30.8	19.8	20.2	13.3
MARCH7	"AXOT, MARCH-VII, RNF177"	ENSG00000136536	"Membrane associated ring-CH-type finger 7"	Q9H992	2	159712457-159771027	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014275, HPA022152"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA014275: AB_10599820, HPA022152: AB_10601107"	"unprognostic (2.42e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (1.84e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"	31.6	21.1	18.3	27.4	29.0	22.6	28.9	33.1	23.0	33.4	25.3	17.0	22.0	17.1	32.3	24.1	47.6	22.7	22.4	28.1	16.9	14.4	21.8	30.9	29.5	32.9	21.6	17.8	31.6	15.4	25.3	31.5	41.3	21.5	28.8	22.3	24.8	25.7	22.6	48.0	24.2	25.2	33.8	20.4	28.9	20.0	34.1	21.8	60.4	28.5	25.5	32.9	30.0	35.1	10.0	10.1	46.1	14.5	14.0	14.6	10.5	18.5	12.8	34.5	15.5	25.0	33.1	33.4	31.2	31.6	32.1	29.5	26.4	22.3	26.4	14.2	32.5	23.5	21.2	28.8	41.2	27.0	15.6	35.8	18.6	19.9	24.3	29.3	28.0	29.4	32.9	39.2	34.0	38.5	27.2	25.5	32.4	15.2	18.7	28.1	32.5	18.4	27.9	25.5	21.9	29.5	38.7	20.5	19.3	25.5	18.8	25.0	21.8	35.6	34.7	34.4	20.8	21.1	17.6	20.4	21.4	36.0	21.3	17.8	32.0	24.8	10.3	20.6	11.1	10.6	13.3	10.0	12.1	12.6	10.1	9.7	14.6	14.1	46.1	14.0	14.5	7.9	12.5	10.5	18.3	29.0	33.1	23.0	16.9	14.4	21.6	17.8	21.5	21.8
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857362-113863471	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 74.3;TIME: 58.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 10.1;neutrophil: 15.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"			17000000	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: , HPA067595: , HPA069443: "	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	13.0	5.0	11.2	17.0	12.9	26.9	16.0	18.5	43.3	12.1	23.2	17.9	0.9	11.6	9.7	4.0	17.0	8.4	10.9	9.7	10.5		5.3	8.7	12.9	13.3	8.8	15.9	12.6	11.2	1.2	6.5	39.5	13.8	14.1	21.6	11.4	8.2	5.6	5.0	9.5	12.9	9.1	42.3	20.9	18.8	5.2	8.5	30.0	4.9	7.9	13.6	23.5	7.8	3.9	0.9	15.0	10.1	0.0	0.0	0.4	6.8	4.0	74.3	4.0	25.1	16.4	0.4	22.0	31.0	15.6	26.1	7.2	9.7	0.0	4.6	40.6	21.2	12.2	6.4	20.3	0.0	7.3	0.0	4.3	9.3	16.7	1.7	0.1	16.9	12.6	15.0	14.3	43.9	0.8	19.6	22.1	0.0	0.2	0.0	9.6	5.3	0.0	7.4	0.7	4.9	13.1	10.3	30.1	14.1	7.2	15.1	0.3	2.0	58.3	14.5	0.0	23.7	37.5	53.0	3.8	2.0	11.1	9.8	27.7	0.0	3.4	0.0	0.0	10.1	0.0	3.9	0.0	0.0	0.9	1.6	0.0	0.0	15.0	0.0	5.5	0.0	0.0	0.4										
MARCKSL1	"F52, MacMARCKS, MLP, MLP1"	ENSG00000175130	"MARCKS like 1"	P49006	1	32333832-32336379	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 166.5"	"Cell line enhanced"	"Detected in many"		"AF22: 106.6;NTERA-2: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"eosinophil: 54.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 54.9"	"Low region specificity"	"Detected in all"							"CAB020787, HPA030528"	Enhanced		Supported	"Nucleoplasm,Actin filaments,Cytosol"			120000	Cytosol	"Nucleoplasm, Actin filaments"	"CAB020787: , HPA030528: "	"unprognostic (8.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.16e-3)"	"prognostic unfavourable (1.78e-6)"	"unprognostic (3.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-2)"	9.9	12.7	59.9	22.1	45.4	10.9	27.7	22.0	58.0	22.3	27.5	126.3	5.3	15.9	25.8	42.3	3.6	15.9	24.9	10.7	64.2	47.2	6.4	9.7	9.0	41.5	83.6	35.4	74.1	4.8	1.3	4.9	11.0	56.6	22.5	30.7	5.2	19.9	14.2	2.0	5.3	13.9	11.3	166.5	12.5	34.8	30.3	52.3	41.4	29.0	2.2	49.2	17.0	5.5	6.4	2.2	54.9	6.7	0.2	3.9	1.2	8.2	7.5	106.6	43.5	2.4	0.8	19.0	3.5	2.1	10.4	6.9	17.7	6.1	18.7	13.1	2.3	4.4	34.4	0.3	7.7	0.4	25.4	1.0	2.9	39.1	7.3	4.8	0.1	12.2	1.4	7.8	0.2	30.4	28.7	0.2	13.9	19.7	60.7	20.6	102.8	17.4	76.0	11.4	8.9	15.6	16.5	66.1	62.9	18.3	20.3	57.6	14.1	8.6	8.9	4.4	25.9	0.4	6.6	2.9	0.2	49.1	0.5	7.4	23.3	0.7	1.0	54.9	0.9	5.4	0.3	4.6	1.9	1.2	1.5	6.4	3.9	1.6	4.4	0.2	6.7	2.2	1.0	1.2	59.9	45.4	22.0	54.9	64.2	47.2	83.6	35.4	56.6	52.3
MARK4	"FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D"	ENSG00000007047	"Microtubule affinity regulating kinase 4"	Q96L34	19	45079288-45305283	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039186	Approved		Supported	Cytosol				Cytosol		"HPA039186: AB_10796223"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavourable (8.31e-8)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (3.05e-5)"	"unprognostic (1.90e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.89e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.02e-2)"	11.8	13.0	19.4	10.3	26.0	8.4	15.2	21.9	28.6	11.4	10.2	9.0	12.9	6.6	14.0	17.5	13.5	12.9	13.4	14.7	22.2	15.7	8.7	13.5	11.7	10.5	14.3	21.6	21.0	16.8	13.7	12.9	12.1	15.0	12.2	6.3	14.1	12.1	14.2	40.7	20.6	7.5	14.1	10.8	12.4	10.3	32.1	12.3	11.2	10.5	11.5	9.4	13.7	17.9	1.0	2.8	3.5	2.9	1.8	4.3	1.2	8.8	3.8	15.0	10.9	10.7	17.1	4.2	6.6	10.3	9.8	9.2	2.3	5.1	4.3	5.6	12.0	6.0	10.6	9.6	5.5	7.8	8.7	8.5	4.6	8.2	19.7	2.1	7.4	21.2	13.7	8.2	9.5	13.1	10.8	10.7	10.6	7.4	7.5	6.7	6.4	3.3	29.3	4.9	2.8	9.3	7.2	28.1	12.4	9.7	8.6	5.0	4.1	12.4	10.6	8.8	6.7	6.0	4.2	12.0	9.5	4.8	9.4	4.0	7.0	3.5	2.9	0.7	3.4	2.2	0.7	0.9	1.2	4.3	0.8	1.0	2.3	2.6	2.9	1.8	2.0	2.8	2.4	1.2	19.4	26.0	21.9	22.7	22.2	15.7	14.3	21.6	15.0	12.3
MARS	"CMT2U, MetRS, SPG70"	ENSG00000166986	"Methionyl-tRNA synthetase"	P56192	12	57475445-57517569	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004125, CAB017097"	Supported	Approved	Enhanced	Cytosol			21000	Cytosol		"CAB017097: , HPA004125: AB_1079312"	"prognostic unfavourable (1.73e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (4.55e-7)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-2)"	23.8	26.7	35.1	27.3	29.1	23.0	19.8	25.1	36.0	17.4	23.9	23.1	23.9	17.3	23.3	36.3	29.5	17.9	16.1	25.0	28.0	29.5	20.5	45.9	24.3	25.1	40.1	25.5	25.8	48.3	35.7	34.0	22.2	30.9	25.6	24.7	19.8	26.0	30.0	24.5	18.4	20.1	33.7	30.7	30.7	31.3	29.6	30.9	21.4	26.9	22.3	34.3	24.3	27.9	12.9	29.3	19.0	27.0	14.1	18.9	15.5	16.5	23.0	15.4	26.7	17.3	10.5	28.4	23.7	27.8	25.1	26.9	24.7	18.4	29.1	15.7	28.7	18.8	35.1	30.6	26.3	25.2	15.2	20.5	8.6	13.9	38.5	30.9	23.6	15.3	47.6	28.7	74.4	17.9	31.7	62.4	17.4	22.9	27.6	23.3	29.1	25.4	24.0	116.3	30.1	18.9	13.0	20.6	20.9	12.3	18.9	32.8	25.0	40.5	13.2	9.1	26.9	13.1	14.0	57.2	57.8	35.1	22.3	23.5	31.0	12.1	14.6	19.0	18.9	27.0	17.2	12.9	12.9	17.1	29.3	7.7	11.1	15.2	7.2	14.1	21.8	28.4	13.1	15.5	35.1	29.1	25.1	36.0	28.0	29.5	40.1	25.5	30.9	30.9
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 7.5;epididymis: 4.0"	"Cell line enriched"	"Detected in single"	39	"HEL: 3.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	7.5	1.3			0.4	1.2	4.0	2.1	0.2	1.2	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0		0.0	0.1	0.0	0.0	0.0		0.8	1.1		1.5	0.3	0.2	1.7	1.5	1.1	0.0	0.0	0.5	0.3			0.0		0.5	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Group enriched"	"Detected in some"	8	"BJ: 26.5;BJ hTERT+: 101.0"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	8673000000	1800000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favourable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	26.5	101.0	0.3	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7
MAST2	"KIAA0807, MAST205"	ENSG00000086015	"Microtubule associated serine/threonine kinase 2"	Q6P0Q8	1	45786987-46036124	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039722, HPA040155"	Approved		Approved	Cytosol				Cytosol		"HPA039722: AB_10795294, HPA040155: AB_10793957"	"unprognostic (7.80e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (4.31e-8)"	"unprognostic (8.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (6.85e-13)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.90e-1)"	8.9	4.3	7.0	9.9	8.1	3.7	7.1	7.1	11.8	13.6	15.2	8.4	6.6	11.2	16.7	7.7	8.8	9.5	9.9	25.5	5.0	7.6	4.8	6.1	5.9	4.4	8.9	7.3	19.8	3.6	9.1	10.5	5.5	10.1	13.9	13.9	7.2	8.3	8.6	83.3	5.5	21.3	14.9	5.8	2.5	9.0	24.8	4.8	3.5	5.7	27.4	7.5	16.3	10.6	0.5	1.9	1.4	4.3	1.4	1.4	0.5	15.2	12.4	12.5	9.6	16.4	23.6	13.9	16.3	11.8	15.1	16.9	14.2	5.0	23.9	7.7	19.9	7.6	15.1	9.3	16.0	11.5	8.1	10.8	14.0	13.0	14.3	5.8	13.9	18.1	12.1	25.3	20.3	14.1	8.3	7.3	18.0	10.4	8.4	6.0	10.3	14.2	12.4	21.0	4.5	7.8	8.3	17.5	10.4	19.2	25.1	8.2	11.4	5.7	13.7	29.3	18.9	15.3	16.1	10.0	8.9	8.7	19.6	7.9	12.1	0.0	1.1	1.4	1.4	0.6	1.4	0.2	0.7	1.4	1.9	0.5	0.5	1.0	0.0	1.4	4.3	0.1	0.0	0.5	7.0	8.1	7.1	11.8	5.0	7.6	8.9	7.3	10.1	4.8
MAST4	KIAA0303	ENSG00000069020	"Microtubule associated serine/threonine kinase family member 4"	O15021	5	66596361-67169595	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 17.5;HDLM-2: 22.2;HEL: 18.4;RT4: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000544	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA000544: AB_1079315"	"unprognostic (1.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favourable (5.18e-5)"	"unprognostic (9.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.08e-2)"	16.2	12.9	10.2	6.9	11.8	2.5	12.6	6.2	19.4	13.9	6.9	6.3	6.3	6.3	14.4	8.9	31.2	11.6	9.7	24.5	9.9	8.1	14.2	9.5	13.1	5.0	6.5	9.2	20.2	5.9	35.6	16.7	18.4	11.1	10.1	5.3	5.7	13.7	8.7	12.7	16.9	6.8	11.4	5.6	6.0	8.2	10.7	5.0	37.5	8.1	21.8	20.6	13.6	22.3	3.4	1.1	12.1	0.9	2.4	7.5	1.4	7.4	4.1	2.0	0.1	6.8	6.1	4.9	1.7	2.6	0.6	0.5	3.8	2.0	0.5	3.5	1.4	6.7	6.3	17.5	0.7	22.2	2.0	18.4	2.3	1.6	0.5	0.0	6.5	10.1	9.7	3.8	7.7	13.9	1.7	2.1	4.7	6.5	2.6	0.1	1.3	3.3	0.6	1.8	0.4	1.6	22.5	3.0	2.4	2.2	0.9	0.1	1.5	0.1	13.2	1.6	2.2	2.4	2.8	5.4	2.4	0.1	4.2	0.0	1.3	12.1	0.4	0.8	1.2	0.5	2.9	3.4	4.7	1.2	0.4	2.1	5.0	2.1	4.1	2.4	0.9	1.1	7.5	1.4	10.2	11.8	6.2	19.4	9.9	8.1	6.5	9.2	11.1	5.0
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539165-85545280	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 205.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol			950000	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavourable (4.87e-4)"	"prognostic favourable (8.94e-4)"	"prognostic unfavourable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	55.9	68.9	37.4	35.3	54.1	20.4	30.3	37.5	50.0	28.6	35.3	74.5	39.7	33.6	35.8	59.8	33.5	44.9	51.6	35.0	41.7	28.5	52.3	26.4	32.9	27.0	74.8	37.6	44.2	205.8	38.8	60.5	29.3	48.9	40.6	36.8	35.0	28.2	31.3	51.4	33.7	35.8	47.6	57.7	24.7	44.6	34.9	69.4	22.7	94.0	34.1	30.8	46.9	33.4	13.8	15.3	4.9	17.2	16.9	22.8	14.9	29.7	44.2	51.9	32.2	35.7	43.7	30.7	37.4	34.5	39.4	42.1	36.1	100.4	69.8	24.7	45.4	46.4	65.2	55.8	50.7	35.3	47.9	41.7	64.0	31.1	65.3	61.8	46.6	39.5	56.7	42.5	29.7	37.3	46.8	55.0	89.4	25.5	56.3	68.1	34.4	56.9	60.0	49.2	45.2	59.5	47.2	40.9	37.7	33.8	32.7	60.3	27.7	33.2	36.3	48.4	29.2	26.6	44.7	33.9	26.9	50.5	31.6	77.6	25.4	4.8	15.2	4.9	15.4	17.2	22.8	13.8	17.5	16.2	15.3	12.2	16.4	14.3	1.6	16.9	13.7	10.9	15.3	14.9	37.4	54.1	37.5	50.0	41.7	28.5	74.8	37.6	48.9	69.4
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.3;bone marrow: 19.1;brain: 27.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 40.7;HMC-1: 12.5;K-562: 18.1;MCF7: 13.2;NB-4: 28.4;SCLC-21H: 12.4;THP-1: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 19.4;NK-cell: 29.3"	"Group enriched"	"Detected in many"	54	"NK-cells: 29.3;T-cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"				Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favourable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	11.2	1.6	22.1	6.8	18.1	19.1	2.2	1.5	27.4	1.5	2.3	1.7	0.0	7.0	1.2	0.4	1.1	4.7	5.1	1.7	25.1	10.0	1.1	2.8	7.3	9.6	7.0	11.0	1.0	1.6	0.1	1.4	1.4	6.1	1.2	1.4	0.6	3.8	1.0	0.8	1.6	6.7	1.1	2.8	14.8	4.1	2.1	1.3	3.5	0.9	0.0	4.5	2.4	0.7	0.4	0.3	0.4	0.0	29.3	19.4	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	4.1	5.4	0.1	0.0	0.0	7.0	4.5	0.5	1.1	0.0	40.7	12.5	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	13.2	0.1	28.4	3.3	0.1	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	10.7	1.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	13.2	0.0	2.5	12.2	0.3	0.4	1.2	7.1	0.4	29.3	0.0	0.1	0.1	2.7	22.1	18.1	1.5	27.4	25.1	10.0	7.0	11.0	6.1	1.3
MB21D2	C3orf59	ENSG00000180611	"Mab-21 domain containing 2"	Q8IYB1	3	192796815-192918161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 34.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 6.6;T-reg: 5.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044026	Uncertain		Approved	Cytosol				Cytosol		"HPA044026: AB_10962840"	"unprognostic (3.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (3.74e-5)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (9.94e-4)"	"unprognostic (2.76e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.28e-2)"	5.7	6.0	4.4	4.4	6.9	1.6	5.1	11.1	10.9	5.8	6.9	5.6	2.7	12.0	7.3	2.9	3.2	5.3	10.1	7.6	3.9	5.0	5.8	2.3	5.9	3.1	4.4	3.5	6.5	2.8	5.6	8.6	34.9	4.6	4.9	4.3	4.0	3.1	3.9	4.9	8.6	15.7	7.8	3.5	3.0	5.1	11.4	3.3	1.2	3.3	2.5	2.5	8.7	5.0	0.3	0.6	0.0	0.6	0.0	6.6	1.8	9.6	1.4	2.4	7.2	1.5	2.3	4.3	7.0	6.6	12.7	7.6	6.2	1.5	0.0	4.2	17.2	4.3	5.4	1.8	13.9	42.1	3.0	1.2	0.7	0.7	2.9	0.1	0.6	2.9	2.8	3.5	2.2	2.4	0.0	0.6	2.2	7.2	0.1	0.0	5.0	17.4	0.2	4.0	2.0	2.9	5.5	3.7	1.9	1.5	4.8	0.7	7.5	0.1	0.8	2.4	7.2	4.2	13.4	18.7	14.7	0.0	1.7	1.4	3.2	0.0	0.3	0.0	0.3	0.6	2.9	0.3	6.6	1.7	0.6	0.0	4.2	1.2	0.0	0.0	0.0	0.0	5.5	1.8	4.4	6.9	11.1	10.9	3.9	5.0	4.4	3.5	4.6	3.3
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298558-36320676	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	10.4	11.7	11.4	5.7	17.0	15.4	12.9	16.4	14.9	15.4	12.2	11.5	3.6	8.6	14.0	11.3	14.0	9.1	8.6	7.2	10.7	13.0	19.5	15.0	46.2	8.1	9.9	8.9	20.0	9.0	10.4	25.1	9.8	13.3	13.8	11.7	10.1	7.7	8.9	6.0	14.3	13.2	11.0	13.6	9.8	19.0	8.8	11.8	14.4	61.2	4.0	7.9	12.4	9.3	12.0	10.4	5.1	9.3	8.3	17.9	9.6	16.5	8.7	18.5	18.6	18.6	18.0	14.0	14.2	17.7	18.8	19.8	17.7	16.6	15.7	21.7	18.2	12.6	19.4	13.1	23.2	22.6	14.6	9.2	8.6	30.0	20.3	18.7	10.2	18.4	20.2	12.2	15.9	11.7	15.6	19.6	13.8	15.9	17.9	15.2	15.6	25.8	8.6	16.2	10.9	21.2	12.8	27.7	11.0	11.6	11.3	18.7	18.4	12.2	9.1	21.0	13.7	15.3	14.6	16.3	18.7	24.5	8.0	9.6	14.5	1.4	9.3	2.0	11.2	6.8	14.1	12.0	13.7	13.8	9.2	8.7	17.9	14.5	5.1	8.3	5.3	10.4	16.1	9.6	11.4	17.0	16.4	14.9	10.7	13.0	9.9	8.9	13.3	11.8
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: "	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	55.9	17.5	14.5	50.8	17.0	28.5	43.8	11.8	14.5	46.4	44.0	10.8	18.0	15.2	41.1	23.6	33.3	22.3	27.5	29.9	14.3	12.9	18.6	16.5	39.6	45.6	18.0	9.1	30.5	12.5	12.5	16.0	10.4	12.6	30.5	26.0	12.7	18.3	25.1	87.6	22.8	29.5	59.8	22.1	39.6	23.1	14.6	17.4	71.9	18.5	34.5	46.0	64.4	29.3	25.0	30.7	38.2	27.4	33.6	39.9	40.2	27.7	22.9	3.7	8.4	29.5	30.5	2.7	34.8	28.3	23.0	19.4	10.1	16.3	28.6	17.8	48.9	12.8	6.9	20.1	34.1	22.2	9.4	31.2	11.6	4.7	16.5	37.3	22.8	14.2	10.9	26.5	20.7	47.2	15.8	39.0	22.3	9.6	34.7	13.7	1.5	18.4	35.5	11.5	35.8	11.6	14.0	3.0	3.4	15.1	8.2	14.7	11.4	56.9	39.6	31.6	12.1	20.9	30.0	40.8	23.3	32.9	18.4	46.6	17.0	32.6	22.7	38.2	37.2	27.4	39.9	25.0	30.5	30.9	30.7	24.1	38.9	33.3	35.4	33.6	22.8	11.1	27.0	40.2	14.5	17.0	11.8	14.5	14.3	12.9	18.0	9.1	12.6	17.4
MBOAT7	"BB1, hMBOA-7, LENG4, LPIAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol				Cytosol		"HPA055967: "	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavourable (5.55e-6)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favourable (4.31e-4)"	10.7	63.1	16.8	14.8	24.2	15.9	7.9	11.3	37.8	10.3	17.7	9.2	15.6	30.3	10.5	8.0	10.5	11.5	14.3	6.9	18.5	23.4	10.5	11.6	11.5	14.7	10.0	18.8	15.1	24.4	23.8	12.4	11.9	21.6	11.4	6.1	8.1	10.8	28.8	7.9	10.0	28.5	6.5	9.2	14.4	16.4	30.8	6.8	7.6	12.7	5.0	6.3	22.6	17.5	0.3	2.9	30.6	2.1	0.9	0.5	0.8	14.0	8.4	1.3	13.8	4.5	3.6	12.2	24.7	8.8	5.7	11.3	4.8	16.0	3.6	11.1	5.3	28.8	0.0	5.0	1.1	5.0	16.4	3.9	9.0	3.1	4.4	8.9	56.5	6.6	3.4	2.8	1.9	10.2	14.5	11.6	2.0	8.5	2.6	3.1	5.8	17.9	8.3	2.4	7.4	5.7	17.0	0.5	3.7	16.5	10.0	5.0	10.2	0.8	20.4	12.1	4.3	3.6	9.7	5.3	9.2	1.5	17.4	6.3	8.0	15.7	2.1	30.6	0.2	1.5	0.5	0.2	0.2	0.2	2.9	0.3	0.1	0.2	30.0	0.9	0.8	0.8	0.2	0.8	16.8	24.2	11.3	37.8	18.5	23.4	10.0	18.8	21.6	6.8
MBTD1	"FLJ20055, SA49P01"	ENSG00000011258	"Mbt domain containing 1"	Q05BQ5	17	51177425-51260163	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021876	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021876: AB_2140367"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-3)"	9.0	6.8	8.8	10.6	14.2	11.0	13.5	21.2	12.0	10.7	8.8	13.2	8.6	9.2	14.3	9.6	9.3	8.3	7.1	5.8	9.9	5.8	7.4	11.2	7.2	9.3	12.6	8.1	15.4	11.0	8.8	9.6	10.0	8.8	8.9	9.3	8.3	9.0	8.8	7.9	16.7	9.8	11.9	7.7	11.7	9.5	27.9	11.7	32.4	10.1	4.8	9.0	9.5	10.5	0.9	1.1	5.1	0.4	0.4	0.9	0.1	3.8	3.5	19.0	7.7	4.6	5.4	10.1	2.9	3.6	3.1	3.9	4.2	4.9	14.8	6.9	2.1	3.7	8.7	2.1	5.9	4.1	7.9	15.3	4.1	6.4	3.1	10.3	4.6	4.6	4.2	2.3	4.3	5.5	11.8	3.7	2.4	3.8	13.9	10.8	10.8	3.3	16.2	11.5	7.4	4.8	7.2	12.2	18.5	2.6	5.1	6.1	7.3	20.3	3.3	3.4	3.5	2.5	3.1	9.3	5.8	13.3	2.0	6.8	1.9	5.1	0.4	1.9	0.7	0.3	0.2	0.9	0.7	0.5	0.7	0.6	0.4	0.9	0.9	0.4	0.4	1.1	0.8	0.1	8.8	14.2	21.2	12.0	9.9	5.8	12.6	8.1	8.8	11.7
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839636-21885424	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	12.0	17.4	9.3	7.2	13.9	2.5	12.7	20.8	18.5	11.8	9.3	13.4	6.9	7.6	14.7	9.1	9.3	10.9	10.1	11.6	9.9	10.7	13.9	26.0	8.6	6.6	10.6	13.0	18.7	12.2	17.9	15.6	22.3	17.4	15.7	9.1	12.4	14.1	13.1	14.5	8.2	8.1	14.6	14.6	7.5	9.1	6.9	7.0	7.1	13.1	7.4	6.7	11.4	9.1	3.9	6.9	1.5	4.8	4.6	5.9	3.3	9.1	19.0	9.1	9.2	11.5	14.3	4.4	13.5	13.8	12.9	11.3	7.5	12.6	7.9	7.1	14.4	8.6	12.5	7.8	16.0	5.9	10.0	3.9	12.1	6.2	15.8	8.4	3.9	13.5	8.4	19.5	14.4	9.9	10.9	8.9	14.7	5.7	3.4	4.4	8.5	14.1	4.3	16.9	8.8	9.0	4.6	2.2	18.7	19.1	12.1	16.7	16.3	7.2	11.7	16.3	3.8	23.7	10.1	10.9	13.8	3.8	18.1	3.5	15.6	0.1	4.3	1.5	4.5	4.8	4.2	3.9	3.5	4.1	6.9	3.8	4.7	5.6	0.5	4.6	4.8	4.8	5.9	3.3	9.3	13.9	20.8	18.5	9.9	10.7	10.6	13.0	17.4	7.0
MCC		ENSG00000171444	"Mutated in colorectal cancers"	P23508	5	113022099-113488830	"Predicted intracellular proteins"	"Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 49.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 27.7;hTCEpi: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA037390, HPA037391"	Approved	Approved	Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				"Nucleoplasm, Cytosol"	"Cytoplasmic bodies"	"HPA037390: AB_2675451, HPA037391: AB_10671248"	"unprognostic (6.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.70e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.90e-1)"	7.1	2.3	6.9	3.2	6.1	0.5	7.8	11.4	8.1	11.8	3.2	3.4	5.9	1.7	12.5	4.7	9.1	7.4	4.4	8.4	9.2	5.0	3.9	12.7	4.6	3.0	7.6	5.1	49.4	4.5	28.9	5.2	7.1	7.8	7.7	2.4	15.1	6.7	9.5	5.0	13.9	2.6	9.1	5.8	3.4	3.6	6.5	5.2	1.3	3.2	6.1	4.3	9.3	11.8	0.2	6.3	1.3	0.2	0.1	1.6	0.1	0.4	0.1	7.0	0.6	6.1	5.7	7.8	1.1	3.1	1.3	1.6	0.2	6.4	0.0	7.5	0.5	8.6	4.3	27.7	0.6	2.2	2.6	0.0	2.4	1.8	1.8	0.3	0.1	7.6	18.6	3.5	13.2	8.2	0.0	10.5	2.9	0.6	0.1	0.1	3.8	0.5	0.1	6.1	1.9	0.1	17.3	3.1	6.7	5.7	0.0	15.2	2.3	0.0	9.8	4.8	4.5	7.5	2.1	3.0	0.0	0.0	12.9	0.0	5.1	0.0	0.2	0.1	0.5	0.2	1.6	0.2	0.5	0.6	0.0	0.2	0.4	0.5	1.3	0.1	0.1	6.3	1.5	0.1	6.9	6.1	11.4	8.1	9.2	5.0	7.6	5.1	7.8	5.2
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.4;brain: 23.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.2;Karpas-707: 8.1;REH: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"T-reg: 4.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.6"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655"	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.9	16.4	12.8	1.4	14.9	1.1	1.1	11.3	23.7	1.3	1.4	3.6	0.0	0.9	1.3	1.3	1.3	1.0	1.5	1.1	12.2	7.6	1.4	0.8	1.2	1.7	5.6	13.0	1.2	1.2	10.5	8.9	0.8	7.3	2.1	1.4	7.5	0.8	1.6	1.4	1.0	1.2	1.4	4.5	5.3	1.2	5.5	4.3	0.0	0.9	0.0	2.1	1.6	0.4	0.1	0.0	0.6	0.0	0.1	4.6	0.2	0.1	0.6	0.2	1.7	0.1	0.2	0.4	0.0	0.1	0.3	0.0	1.2	0.2	1.5	0.2	0.1	0.0	0.3	0.2	0.1	9.2	1.4	3.9	0.3	0.0	0.3	1.2	0.8	0.3	0.0	0.0	0.6	0.7	1.2	8.1	0.4	1.2	1.2	0.8	1.3	1.6	5.3	0.0	1.5	0.4	0.1	2.5	0.9	1.0	0.0	2.0	0.5	0.8	0.6	0.0	0.9	0.1	0.1	3.2	3.4	1.7	0.8	1.4	0.1	0.1	0.0	0.1	0.4	0.0	1.0	0.0	1.0	0.6	0.0	0.1	0.0	0.9	0.6	0.1	0.0	0.0	4.6	0.2	12.8	14.9	11.3	23.7	12.2	7.6	5.6	13.0	7.3	4.3
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235126-46286297	"Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: "	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	19.4	16.7	14.2	21.5	25.3	19.5	19.0	26.6	29.2	18.3	17.2	27.7	19.3	15.4	24.8	18.0	18.1	21.1	16.3	17.9	14.4	13.2	15.5	13.3	18.2	21.9	16.5	14.6	23.7	17.5	25.7	20.6	18.2	18.2	17.7	17.6	21.3	22.1	21.4	52.9	18.2	19.9	19.5	15.1	20.7	18.7	15.7	15.7	31.8	19.6	15.7	26.0	21.1	16.4	4.8	4.8	3.8	4.9	3.0	6.9	4.1	15.7	15.6	18.2	19.7	15.0	18.7	16.6	17.4	21.4	16.6	13.4	14.1	9.4	22.5	14.4	18.4	9.4	24.0	14.6	14.5	23.0	21.8	36.9	14.9	11.1	13.5	16.7	20.9	14.5	12.7	22.5	15.6	17.5	43.9	17.2	19.0	9.0	17.9	11.3	31.3	13.0	23.3	11.5	20.3	8.1	14.6	15.4	16.4	22.2	14.7	17.0	20.1	17.4	22.1	17.3	13.2	14.3	13.0	31.4	34.7	14.0	15.6	16.2	22.4	1.5	4.7	3.8	6.1	4.9	6.5	2.9	3.7	6.9	4.8	4.8	3.3	3.4	2.9	3.0	2.7	4.2	4.4	4.1	14.2	25.3	26.6	29.2	14.4	13.2	16.5	14.6	18.2	15.7
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"				Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavourable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	33.6	15.3	11.7	23.2	13.8	14.6	35.5	17.2	13.8	27.0	26.3	16.9	11.4	15.5	28.0	14.9	26.4	23.0	18.7	26.3	12.0	10.2	18.7	23.7	28.5	38.6	17.4	8.5	29.2	18.2	23.2	17.6	35.4	14.2	22.5	21.4	15.7	21.0	17.4	30.1	23.8	20.7	26.0	16.8	26.0	20.7	15.4	15.5	38.0	24.5	28.2	24.7	32.5	28.6	4.5	6.9	12.1	9.7	4.1	5.1	2.4	30.4	21.6	30.4	21.0	15.4	18.9	17.8	28.2	31.0	36.0	37.3	28.2	24.9	35.5	13.0	22.5	28.4	36.2	28.4	42.2	26.0	26.8	18.2	17.2	21.6	23.9	33.6	44.1	15.5	16.1	32.6	42.9	24.6	16.8	26.8	23.5	22.6	42.2	20.3	15.3	15.7	26.6	58.8	18.1	15.4	20.9	13.1	16.9	20.6	17.2	23.6	11.6	24.0	19.0	17.7	17.4	18.0	33.6	19.3	21.5	39.3	21.1	22.6	10.8	12.1	5.3	3.6	4.2	9.7	5.1	4.5	3.9	4.4	6.9	1.8	4.2	3.8	6.4	4.1	6.1	3.5	3.9	2.4	11.7	13.8	17.2	13.8	12.0	10.2	17.4	8.5	14.2	15.5
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048499	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.2;pituitary gland: 38.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.8;HAP1: 9.8;RH-30: 11.9;SK-MEL-30: 21.2"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 1.7"	"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: "	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	4.7	29.2	1.5	0.8	0.8	0.0	3.0	0.2	0.4	6.1	2.8	0.9	2.1	3.2	5.4	15.6	0.8	1.1	0.6	5.1	3.4	0.3	4.5	0.2	4.1	0.0	0.5	0.0	2.2	6.5	17.9	38.3	1.8	2.7	0.5	0.5	4.5	8.1	0.4	1.9	2.5	1.9	1.1	0.3	0.9	1.6	0.4	0.3	2.6	1.5	0.9	0.4	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.9	0.7	6.4	1.5	0.0	0.0	5.2	4.7	1.6	0.1	9.8	2.5	6.9	0.5	1.2	0.0	0.7	0.1	0.0	9.8	3.2	1.6	2.6	5.8	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.2	2.1	1.1	0.0	0.0	0.0	4.8	0.6	0.0	0.0	0.7	0.6	0.0	11.9	0.0	0.3	0.0	0.4	0.0	0.3	0.0	21.2	4.0	4.9	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.2	0.4	3.4	0.3	0.5	0.0	2.7	0.3
MCRIP1	"FAM195B, GRAN2, MCRIP"	ENSG00000225663	"MAPK regulated corepressor interacting protein 1"	C9JLW8	17	81822361-81833302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045542	Approved		Approved	Cytosol				Cytosol		"HPA045542: "	"unprognostic (3.11e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.08e-3)"	"prognostic favourable (2.26e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.86e-1)"	34.8	29.8	43.1	23.9	29.9	32.2	19.7	27.4	47.8	20.9	29.4	23.3	13.9	12.9	26.3	19.6	20.2	28.2	25.9	46.0	36.4	32.8	21.9	17.9	21.3	28.6	37.0	34.6	28.5	36.3	11.9	22.8	25.4	34.3	24.1	5.6	18.3	33.6	24.7	25.4	11.1	14.2	22.5	32.4	24.3	16.8	35.9	27.4	33.3	29.0	14.2	11.2	28.0	19.9	33.2	37.4	49.8	40.7	23.6	38.2	33.7	12.9	20.3	22.8	24.0	14.8	17.2	17.9	15.4	11.2	19.0	20.8	5.3	13.0	8.1	9.1	13.0	2.9	2.7	9.3	4.5	8.6	28.9	14.2	3.5	20.5	15.0	9.3	13.2	18.7	9.2	10.7	4.6	33.8	11.3	7.0	12.6	8.6	29.8	22.4	14.0	11.8	11.8	14.6	3.7	6.4	11.7	19.4	60.6	7.6	10.0	46.9	8.9	12.8	20.5	27.0	28.7	29.4	27.9	3.6	1.0	5.2	25.1	8.6	21.3	49.8	30.5	40.1	38.2	39.1	29.0	23.3	29.9	33.9	27.4	33.2	24.5	28.0	23.5	23.6	40.7	37.4	35.0	33.7	43.1	29.9	27.4	47.8	36.4	32.8	37.0	34.6	34.3	27.4
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 49.2;brain: 42.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 20.7;Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	41	"basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	49.2	2.7	6.5	11.4	42.4	36.9	18.3	18.3	16.5	6.9	7.2	0.3	4.4	5.0	11.1	9.2	6.5	4.1	16.7	4.6	8.5	7.4	3.0	3.8	11.3	5.5	4.1	3.8	3.3	3.4	3.1	5.2	7.1	3.9	5.9	7.3	1.0	4.3	2.7	5.1	4.5	4.8	10.9	5.7	8.2	5.3	4.0	8.1	5.5	5.0	21.2	4.3	17.3	12.6	0.3	10.1	18.7	19.2	0.2	0.2	3.3	0.1	2.0	1.3	0.0	19.9	8.0	0.0	0.1	9.8	0.9	3.2	0.0	5.2	7.2	7.7	0.0	0.0	0.1	0.1	1.1	0.0	1.4	4.3	4.8	0.0	2.6	8.9	5.8	2.9	0.0	3.6	13.1	20.7	0.1	28.3	7.4	0.2	0.5	6.8	1.6	8.2	0.3	0.0	28.0	21.3	11.3	4.0	0.2	0.6	0.0	14.6	0.0	8.4	0.1	3.6	5.6	0.1	1.6	2.0	0.0	0.0	16.9	14.9	3.5	11.5	12.9	5.8	0.0	19.2	0.0	0.3	0.0	0.1	10.1	0.1	0.2	0.0	18.7	0.2	17.6	5.3	0.0	3.3	6.5	42.4	18.3	12.2	8.5	7.4	4.1	3.8	3.9	8.1
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.6"	"Cell line enhanced"	"Detected in many"		"HEL: 14.2;HMC-1: 11.7;U-698: 15.5;U-87 MG: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA051176: , HPA070541: "	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	5.3	4.1	0.8	19.7	1.7	12.6	2.7	0.7	1.5	5.4	12.3	0.0	6.9	5.6	4.0	9.5	5.7	4.5	10.3	4.6	1.0	2.2	3.6	2.3	12.4	18.4	2.5	0.8	3.8	10.0	5.3	24.4	17.1	0.6	6.8	10.2	2.5	16.8	9.6	0.8	4.0	10.9	4.0	0.9	41.6	3.7	1.7	0.4	3.0	8.7	4.1	12.9	6.2	14.8	2.7	0.1	21.2	0.5	6.8	4.4	1.1	2.4	0.0	0.0	0.0	0.0	0.0	1.7	1.3	0.8	0.2	0.1	1.6	3.1	7.1	0.3	0.0	5.6	0.1	4.6	0.0	1.3	0.5	14.2	1.9	0.8	1.0	2.9	11.7	0.8	5.7	0.1	5.8	0.0	0.5	4.0	0.0	0.0	1.3	7.9	0.5	2.6	3.2	0.1	2.7	0.3	7.4	1.4	0.3	0.1	2.4	0.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	8.6	0.1	15.5	17.7	7.7	0.8	3.2	0.5	7.7	4.4	0.1	2.1	2.2	1.2	1.9	0.0	2.7	0.5	1.9	21.2	6.8	0.5	0.1	0.0	1.1	0.8	1.7	0.7	1.5	1.0	2.2	2.5	0.8	0.6	0.4
MCTS1	MCT-1	ENSG00000232119	"MCTS1, re-initiation and release factor"	Q9ULC4	X	120594010-120621074	"Predicted intracellular proteins"	"Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation"	"Initiation factor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001045			Supported	"Plasma membrane,Cytosol"			52000	Cytosol	"Plasma membrane"	"HPA001045: "	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (9.37e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavourable (3.27e-5)"	"unprognostic (2.94e-3)"	"unprognostic (9.59e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (4.35e-5)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	20.2	26.8	23.7	22.5	29.3	16.9	27.4	16.8	33.8	20.7	24.0	14.3	26.6	23.2	17.4	30.7	31.7	16.6	16.8	24.6	25.2	22.4	22.7	37.9	17.2	31.1	22.6	25.0	14.7	42.0	21.1	38.2	20.7	22.3	16.6	29.7	13.4	31.0	27.3	20.9	18.1	21.2	19.2	20.8	24.1	22.9	13.1	19.0	28.5	23.1	32.1	36.1	20.5	19.1	28.2	32.0	13.7	24.4	17.7	24.5	15.5	33.6	23.7	19.3	19.3	24.7	35.9	26.2	25.3	23.3	31.9	30.6	20.6	33.4	36.2	36.4	31.2	22.4	33.8	32.2	46.3	22.8	22.5	11.7	26.2	16.2	28.1	29.3	22.5	24.6	28.6	27.8	30.3	38.5	31.9	24.2	39.2	38.6	28.1	39.3	21.5	46.9	21.7	17.8	43.8	34.0	16.8	24.4	22.8	17.7	28.8	22.8	21.2	27.2	26.3	25.9	15.8	28.0	46.4	18.3	24.7	49.3	30.1	43.4	28.1	11.9	20.1	13.7	15.1	24.4	24.5	28.2	19.8	19.3	24.8	20.7	18.3	18.5	9.9	17.7	22.4	32.0	22.9	15.5	23.7	29.3	16.8	33.8	25.2	22.4	22.6	25.0	22.3	19.0
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol			63000000	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: "	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favourable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.0	36.1	48.8	31.9	69.4	51.4	50.6	34.7	51.3	52.9	53.7	42.7	39.1	55.5	20.6	45.4	38.8	54.9	64.3	75.9	33.6	42.4	52.1	33.8	67.8	38.1	59.9	41.3	50.9	43.9	49.5	29.3	40.3	28.8	40.4	69.5	26.5	52.4	60.5	28.6	45.0	41.9	57.5	54.4	87.5	41.8	45.3	27.0	29.1	46.9	66.5	34.2	62.5	23.4	40.6	39.8	33.7	43.6	50.4	44.2	67.9	50.1	54.2	33.5	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2
MDM1		ENSG00000111554	"Mdm1 nuclear protein"	Q8TC05	12	68272443-68332381	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA040411, HPA041594"	Uncertain		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA040411: AB_10805711, HPA041594: AB_10793968"	"unprognostic (7.41e-2)"	"prognostic favourable (6.01e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.63e-2)"	"unprognostic (5.23e-3)"	7.0	6.7	11.5	11.9	11.4	15.4	10.0	8.2	12.7	11.9	28.7	9.6	12.4	5.1	15.2	12.7	5.4	20.3	6.5	6.7	12.3	10.0	8.8	4.9	6.8	12.8	11.4	10.5	10.9	11.3	8.8	22.8	6.0	14.9	12.3	11.1	9.0	6.8	15.9	3.8	4.2	9.0	18.8	11.4	9.5	9.8	20.7	12.4	14.6	11.0	5.3	13.4	17.0	8.9	7.1	4.0	13.3	17.2	6.0	8.1	5.4	4.9	4.1	8.0	7.7	4.0	5.4	6.1	6.6	3.7	10.6	9.8	4.9	2.3	11.4	4.4	3.0	5.1	5.4	3.5	12.1	14.9	5.2	25.0	5.3	3.4	6.1	13.8	9.9	2.4	4.6	7.1	6.9	5.9	4.7	12.8	6.1	3.6	19.5	9.8	4.2	5.1	19.2	7.1	3.3	5.0	4.3	7.3	3.9	6.4	3.8	6.5	9.2	10.0	3.1	8.5	3.7	5.3	6.0	6.7	19.5	7.7	4.5	9.0	5.4	6.0	4.7	13.3	5.0	11.1	8.1	6.8	6.4	5.2	4.0	7.1	7.7	6.2	3.1	6.0	17.2	2.3	5.9	5.4	11.5	11.4	8.2	12.7	12.3	10.0	11.4	10.5	14.9	12.4
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642499-89819723	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 26.6;NTERA-2: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"				"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	10.0	8.8	8.6	10.1	18.2	16.1	14.9	19.2	18.7	9.1	7.5	14.8	8.6	5.9	14.1	10.0	9.2	10.2	6.4	8.6	9.4	9.6	9.4	15.1	7.3	10.9	13.1	12.4	22.3	10.7	19.0	10.9	5.9	15.9	8.1	8.6	9.4	9.3	8.3	16.2	19.6	8.8	9.2	12.7	9.0	8.2	14.0	13.7	8.4	12.8	8.2	12.7	7.5	7.8	3.8	8.9	6.7	1.0	3.3	4.2	0.3	4.5	4.5	4.7	4.4	7.7	7.4	4.7	3.1	2.3	3.6	4.4	10.3	1.7	13.7	3.6	3.2	4.0	12.1	4.2	6.4	5.3	8.1	14.9	5.8	6.7	3.0	19.2	3.7	4.5	3.6	9.5	8.8	6.3	26.6	3.3	3.5	5.5	3.0	7.3	25.9	4.0	6.0	8.9	3.4	3.1	6.5	8.6	3.8	4.4	2.7	2.8	1.9	8.5	8.0	2.4	4.4	3.2	7.2	3.8	4.2	6.7	3.3	11.0	4.1	6.7	1.0	1.9	2.4	0.8	2.1	3.0	3.3	2.6	0.6	3.8	4.2	3.3	0.2	3.3	1.0	8.9	1.3	0.3	8.6	18.2	19.2	18.7	9.4	9.6	13.1	12.4	15.9	13.7
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210389-83431071	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 15.6"	"Lineage enriched"	"Detected in many"	11	"T-cells: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"			3800000	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavourable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	30.7	35.3	16.3	4.6	17.7	0.8	27.1	5.5	13.1	5.9	6.7	5.4	39.2	18.1	3.8	7.4	24.5	4.2	13.5	21.3	10.5	14.0	3.6	12.4	7.7	6.0	16.8	11.8	10.0	3.3	30.0	11.1	2.9	16.3	7.9	10.1	9.3	7.8	30.2	25.7	10.1	8.7	18.7	17.2	6.3	20.0	13.4	7.2	1.4	6.3	20.9	4.5	13.7	14.9	0.0	0.0	0.0	1.4	0.0	15.6	0.5	9.5	19.8	0.4	0.0	16.9	15.8	0.0	6.2	15.9	6.6	12.9	46.4	8.4	0.0	16.2	14.5	10.1	14.7	5.5	7.3	0.0	8.3	0.0	12.7	0.0	21.7	4.6	17.4	17.2	11.1	13.3	9.1	10.3	6.6	0.0	8.9	10.7	0.0	5.3	0.0	7.8	0.0	16.7	9.2	19.6	4.6	2.0	5.1	10.5	15.6	0.3	0.0	11.4	10.9	4.1	4.9	1.3	0.0	3.7	4.2	0.0	0.0	0.0	12.1	0.0	1.4	0.0	0.8	0.3	15.6	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	16.3	17.7	5.5	13.1	10.5	14.0	16.8	11.8	16.3	7.2
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 109.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017921	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favourable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavourable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	16.8	17.4	26.6	13.9	23.4	11.8	17.4	13.1	29.9	16.2	14.3	17.2	14.0	12.7	20.1	25.2	16.8	20.5	17.2	12.5	20.9	25.4	16.5	18.7	15.2	14.2	21.9	20.8	22.7	26.7	13.2	17.7	17.3	17.5	20.9	17.0	19.6	16.6	20.3	14.6	15.2	13.1	19.5	15.7	12.8	13.0	109.4	8.7	19.1	15.8	13.4	21.2	21.5	14.1	61.2	40.9	70.6	51.0	46.6	51.7	59.9	46.1	26.7	40.0	31.6	36.6	24.5	16.0	30.9	32.9	38.7	42.5	39.7	12.1	24.2	32.5	37.7	23.5	30.8	42.1	36.4	27.6	41.8	44.8	29.2	42.7	18.9	32.6	23.6	19.5	21.0	51.3	33.5	23.2	30.2	27.1	42.3	88.4	43.6	37.8	18.8	23.6	21.5	23.8	24.0	26.7	43.8	38.7	27.1	23.8	20.5	35.2	31.2	35.8	17.2	42.7	34.4	27.6	53.3	30.9	25.6	40.4	21.4	24.5	34.6	64.5	39.2	70.6	46.7	44.5	42.9	61.2	42.9	45.6	40.9	56.8	43.2	45.8	35.9	46.6	51.0	40.0	51.7	59.9	26.6	23.4	13.1	29.9	20.9	25.4	21.9	20.8	17.5	8.7
MED17	"CRSP6, CRSP77, DRIP80, SRB4, TRAP80"	ENSG00000042429	"Mediator complex subunit 17"	Q9NVC6	11	93784227-93814963	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA046619			Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA046619: "	"prognostic unfavourable (4.94e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.48e-1)"	9.0	7.4	5.8	9.9	8.0	9.5	9.2	13.9	10.7	10.7	10.2	9.0	9.4	4.3	12.1	7.5	7.9	10.4	7.3	11.5	6.3	5.4	6.4	4.6	8.2	8.1	9.5	7.3	13.8	9.9	5.4	13.1	9.5	6.1	8.2	4.9	8.0	9.4	6.6	9.3	10.2	14.0	7.7	7.7	13.9	12.1	7.9	8.8	20.7	7.8	5.5	9.8	11.2	11.6	10.5	6.8	10.8	5.7	10.2	8.5	5.1	3.0	1.0	2.6	5.6	3.2	0.4	5.1	6.7	2.3	4.5	2.8	5.3	6.3	5.0	11.3	0.6	9.4	2.4	1.4	1.2	6.0	2.7	5.6	3.4	1.5	1.7	9.4	9.5	1.3	3.3	3.3	2.2	1.8	5.0	3.0	2.7	0.9	11.2	2.7	4.9	0.8	8.6	7.6	4.1	2.7	2.1	9.2	11.7	5.6	4.7	2.8	7.0	2.3	6.1	7.0	5.6	9.3	5.8	4.7	9.1	3.6	1.8	6.7	8.0	4.9	4.6	10.8	6.4	5.7	7.6	10.5	8.2	8.0	6.0	9.0	8.5	4.8	4.7	10.2	3.3	6.8	8.1	5.1	5.8	8.0	13.9	7.9	6.3	5.4	9.5	7.3	6.1	8.8
MED21	"SRB7, SURB7"	ENSG00000152944	"Mediator complex subunit 21"	Q13503	12	27022546-27066343	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017177	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA017177: AB_1857665"	"unprognostic (3.02e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.74e-8)"	"unprognostic (3.18e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-2)"	20.7	31.5	20.7	13.3	32.4	31.9	23.9	25.9	31.9	24.8	21.9	18.0	18.8	14.9	25.9	21.7	30.4	20.8	19.6	31.3	19.5	21.9	34.1	18.8	20.8	15.7	21.1	26.2	30.8	17.1	30.3	26.0	19.8	23.6	27.6	20.6	18.3	25.3	24.5	30.7	19.3	17.4	27.3	20.2	16.0	19.6	28.9	22.1	22.1	28.2	28.7	19.9	31.6	27.2	20.1	15.8	35.5	18.6	12.8	28.0	19.1	16.8	17.7	9.4	14.9	20.9	21.2	15.6	19.2	14.4	16.2	21.2	18.6	19.1	11.1	12.2	14.7	13.9	20.0	17.8	28.0	9.7	17.8	16.0	18.4	11.4	11.7	19.5	11.5	14.9	26.0	20.1	24.1	23.5	12.9	14.9	18.3	12.6	17.0	35.9	28.8	23.4	14.7	60.2	12.5	16.9	19.3	7.1	10.5	23.4	10.1	15.1	17.8	13.0	17.0	18.1	14.1	22.5	19.3	4.6	9.4	18.2	17.3	21.7	12.2	35.5	17.5	23.9	20.4	18.6	20.8	20.1	24.6	23.9	15.8	16.6	28.0	25.3	14.0	12.8	16.5	12.9	23.8	19.1	20.7	32.4	25.9	31.9	19.5	21.9	21.1	26.2	23.6	22.1
MED26	"CRSP7, CRSP70"	ENSG00000105085	"Mediator complex subunit 26"	O95402	19	16574907-16629062	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA057997, HPA071835"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA057997: , HPA071835: "	"unprognostic (2.02e-2)"	"prognostic favourable (2.46e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (5.50e-5)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.98e-3)"	5.5	4.6	5.9	8.3	6.2	14.0	7.3	8.7	6.2	6.0	5.1	4.2	5.2	4.0	5.7	6.0	6.2	4.3	4.4	4.0	5.1	4.5	3.7	5.9	9.0	7.6	4.8	4.5	6.2	6.8	6.8	5.4	7.9	4.9	5.4	3.3	3.8	7.2	7.9	9.9	7.1	4.8	4.2	4.5	6.8	5.1	34.7	4.6	8.5	5.0	6.0	6.9	4.8	5.7	2.6	4.4	2.3	1.0	1.2	2.3	0.4	9.1	3.5	3.3	7.1	4.3	3.4	9.6	5.3	3.8	5.8	5.3	5.3	5.5	14.7	5.7	3.4	6.9	5.1	5.4	4.0	10.7	10.4	5.7	3.3	4.2	4.2	6.5	5.5	4.0	5.3	4.9	5.2	3.1	9.4	17.7	3.6	9.1	6.8	6.1	7.8	11.5	7.2	5.0	15.9	3.4	3.6	8.7	4.6	4.6	4.6	5.3	3.3	8.6	3.7	7.4	5.9	8.9	7.1	12.4	10.0	11.8	5.2	8.6	4.3	2.3	0.4	0.4	1.6	1.0	0.3	1.4	0.2	0.7	0.8	2.6	1.0	0.2	1.2	1.2	0.4	4.4	2.3	0.4	5.9	6.2	8.7	6.2	5.1	4.5	4.8	4.5	4.9	4.6
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131860107-132079908	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favourable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	11.1	12.1	18.0	9.5	18.1	15.5	11.5	14.0	21.4	10.9	11.7	19.5	10.1	7.8	18.6	23.5	15.5	13.9	9.5	17.5	17.5	11.2	10.4	7.5	10.9	13.5	18.6	19.1	12.7	7.9	10.6	17.8	12.7	17.4	12.7	10.7	16.0	17.7	14.4	15.2	15.7	8.6	16.3	16.1	11.7	10.2	14.7	14.0	17.9	13.2	9.6	15.8	12.3	10.5	12.9	19.8	13.4	18.6	18.0	19.7	11.8	16.0	15.8	18.2	14.4	13.1	12.1	15.4	16.7	22.2	33.4	26.2	23.5	13.0	15.9	11.3	17.3	29.1	25.2	23.7	21.9	17.0	14.9	11.9	16.6	14.0	19.6	21.3	15.0	13.3	16.3	26.4	27.0	17.4	17.3	13.2	24.3	25.5	22.8	12.4	18.6	26.8	20.2	25.7	19.4	13.4	8.9	34.1	13.8	21.5	11.1	11.1	17.6	10.0	14.6	34.1	15.0	25.2	25.0	5.4	16.5	28.1	18.9	14.9	23.1	3.5	12.2	13.4	18.9	18.6	15.3	11.6	14.8	18.5	19.2	12.9	12.7	15.5	4.8	18.0	16.0	19.8	19.7	11.8	18.0	18.1	14.0	21.4	17.5	11.2	18.6	19.1	17.4	14.0
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145568-19170289	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"lymphoid tissue: 81.2"	"Group enriched"	"Detected in some"	12	"Daudi: 49.8;U-266/70: 50.0;U-698: 65.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	2.0	1.0	0.8	81.2	1.2	1.4	1.9	0.6	1.4	2.7	3.0	0.9	0.6	1.5	2.2	1.1	1.5	2.3	2.2	1.9	1.0	0.6	1.8	2.9	2.0	32.3	1.1	0.9	3.7	0.8	0.8	2.1	0.8	1.0	3.7	1.0	1.8	3.5	1.1	1.4	2.3	3.1	1.1	1.2	6.7	1.7	1.7	0.8	1.6	3.0	3.5	58.7	1.9	2.9	0.1	0.2	1.1	0.9	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	49.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.3	0.0	0.9	0.4	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.4	0.5	0.1	50.0	4.6	65.8	0.1	0.3	0.0	0.0	0.9	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.4	1.0	0.6	1.1	0.9	1.0	0.8
MEFV	"FMF, MEF, TRIM20"	ENSG00000103313	"MEFV, pyrin innate immunity regulator"	O15553	16	3242028-3256627	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	Actin-binding	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell line enriched"	"Detected in some"	6	"THP-1: 11.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"											HPA077497			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA077497: "	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.58e-7)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	4.2	1.2	0.5	9.8	1.0	9.7	0.9	0.4	0.9	1.1	1.4	0.3	0.0	1.0	0.6	2.7	1.2	1.6	1.8	4.2	0.5	0.5	1.3	1.5	11.4	14.8	2.8	0.1	1.2	1.8	0.2	0.7	1.8	0.8	0.9	0.6	1.7	0.8	0.7	1.7	0.6	1.3	1.6	2.2	23.3	1.0	2.2	1.3	1.2	1.7	0.2	1.4	2.7	4.1	0.4	2.1	10.0	6.5	0.5	0.3	1.3	0.1	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.1	11.8	0.1	0.3	0.1	0.1	0.1	0.5	0.4	0.2	0.4	2.0	0.0	2.5	3.8	0.2	0.1	4.2	0.1	0.2	0.2	0.1	2.1	0.4	0.1	0.3	10.0	0.5	6.5	0.3	0.1	1.3	0.5	1.0	0.4	0.9	0.5	0.5	2.8	0.1	0.8	1.3
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600813-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.1;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol			32000000	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: "	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favourable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	15.0	9.6	22.4	9.9	21.7	15.4	12.8	27.9	26.2	11.7	6.7	29.3	2.1	6.4	6.1	5.5	12.8	12.8	7.9	6.1	24.6	16.4	12.5	33.8	17.9	7.0	28.6	16.0	9.3	5.4	15.6	6.8	4.8	22.6	8.4	5.8	21.4	7.8	6.6	6.0	19.0	6.5	8.1	21.1	12.9	7.2	3.1	25.8	3.2	25.5	4.6	5.6	11.3	9.6	0.3	2.2	19.1	5.7	0.3	0.6	1.3	2.8	11.3	9.9	3.0	13.8	8.5	3.2	2.9	2.5	0.8	1.1	0.6	1.7	10.6	4.5	2.8	12.4	14.2	5.1	2.1	8.6	4.1	1.4	21.1	4.6	5.9	4.2	9.1	4.0	15.5	4.9	3.9	6.9	3.3	5.1	8.2	8.2	8.3	1.5	0.4	3.0	6.4	11.0	4.5	20.3	9.3	9.8	8.3	3.5	2.8	8.3	8.6	4.3	8.1	3.0	1.7	10.9	4.4	9.3	10.9	3.5	4.2	5.0	16.9	0.4	5.7	3.6	0.6	1.9	0.2	0.3	0.6	0.5	2.2	0.3	0.5	0.4	19.1	0.3	3.0	0.2	0.5	1.3	22.4	21.7	27.9	21.5	24.6	16.4	28.6	16.0	22.6	25.8
MEIS2	"HsT18361, MRG1"	ENSG00000134138	"Meis homeobox 2"	O14770	15	36889204-37101299	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 41.0;SH-SY5Y: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	49	"basophil: 4.8;eosinophil: 4.9"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 4.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 83.2;olfactory region: 364.7"	"HPA003256, CAB004999"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004999: AB_425545, HPA003256: AB_1079356"	"unprognostic (4.33e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.71e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (2.64e-7)"	"unprognostic (6.47e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.15e-1)"	6.3	16.5	9.6	6.5	36.8	0.4	7.7	7.4	12.4	26.4	17.0	4.3	12.0	15.1	35.6	6.3	10.6	17.8	16.9	11.3	6.7	3.9	7.3	5.9	7.5	5.2	3.9	6.9	16.4	10.0	2.8	19.8	6.4	10.7	28.8	5.2	6.4	39.0	16.7	1.0	2.9	5.2	34.6	6.2	5.6	11.3	2.6	8.6	2.2	3.5	4.6	3.2	19.5	16.9	0.0	0.0	4.9	0.0	0.0	0.0	0.0	4.6	4.3	5.6	16.0	6.4	7.9	1.3	10.2	5.7	12.1	6.8	6.1	3.9	2.7	0.2	41.0	8.1	9.9	2.6	6.8	3.8	6.3	20.7	5.8	5.0	10.8	6.1	21.2	10.4	2.3	8.1	2.4	6.9	6.9	0.0	2.4	5.0	0.0	2.4	0.0	1.4	0.0	4.1	1.4	0.0	9.2	4.3	38.8	3.8	2.6	2.9	1.2	4.9	9.7	14.0	1.7	3.7	4.3	2.8	2.7	5.2	16.5	3.4	3.5	4.8	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	36.8	7.4	8.0	6.7	3.9	3.9	6.9	10.7	8.6
MEN1		ENSG00000133895	"Menin 1"	O00255	11	64803510-64811294	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030342	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030342: AB_10610138"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-2)"	"prognostic favourable (6.31e-5)"	"unprognostic (1.40e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	12.1	20.6	13.2	15.6	17.7	11.8	12.5	25.8	26.9	15.5	14.9	16.4	22.2	16.9	14.8	18.4	18.9	17.6	14.7	9.0	12.4	11.5	15.9	23.0	12.8	22.1	12.5	15.6	19.7	25.9	16.8	18.0	16.1	16.0	15.9	11.6	16.6	23.3	19.9	8.4	21.6	15.8	11.0	9.8	20.6	15.3	21.2	12.3	33.2	23.9	6.2	20.3	13.7	15.5	5.2	2.9	3.4	1.5	1.8	4.8	1.0	16.4	22.1	14.1	22.2	15.8	10.3	16.6	11.8	11.8	18.5	12.4	12.7	16.2	23.4	19.4	9.1	23.5	19.1	16.4	11.1	19.9	28.3	19.4	17.7	17.0	14.0	12.4	13.2	11.8	12.3	15.5	12.9	17.1	28.1	8.9	10.2	30.7	31.4	25.2	18.5	33.2	24.4	16.1	22.4	11.9	15.2	20.0	17.6	14.0	19.8	14.4	29.5	13.9	10.8	17.5	16.8	20.9	10.0	14.1	16.3	11.8	13.8	9.7	11.1	0.9	1.3	3.4	3.7	1.5	4.8	3.7	2.6	4.6	1.3	5.2	4.5	2.6	0.2	1.8	0.5	2.9	1.9	1.0	13.2	17.7	25.8	26.9	12.4	11.5	12.5	15.6	16.0	12.3
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640388-43661954	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	13	"HeLa: 23.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 17.9"	"Lineage enriched"	"Detected in single"	66	"T-cells: 17.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	24.3	0.3	0.1	7.4	0.1	0.0	17.3	0.1	0.1	12.4	3.2	0.1	2.3	1.2	11.6	5.7	10.9	6.7	6.5	17.8	0.1	0.1	0.2	0.3	1.2	5.4	0.1	0.1	4.8	1.2	1.5	0.5	0.3	0.1	8.2	1.9	0.8	5.8	2.0	19.8	4.6	3.5	8.6	0.1	8.9	2.4	3.5	0.1	3.2	1.7	15.4	7.1	6.1	16.7	0.0	0.0	0.0	0.0	0.2	17.9	0.9	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.6	3.0	0.0	0.0	1.8	0.5	0.0	0.2	0.0	0.0	17.9	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.8;Hep G2: 21.6;HUVEC TERT2: 21.5;RT4: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 10.3;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"			29000000	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: "	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favourable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9.0	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2.0	8.4	14.1	26.6	0.0	0.2	0.1	10.3	0.0	0.0	0.3	0.5	0.9	4.3	9.7	0.2	0.1	6.9	0.0	0.1	0.5	1.0	20.8	1.3	0.1	4.6	0.0	0.1	5.7	0.0	0.8	0.8	3.0	3.7	0.0	21.6	0.1	0.1	0.8	0.2	0.0	5.0	0.3	21.5	1.1	2.0	1.6	0.9	0.0	4.9	2.7	3.4	1.4	1.2	1.6	10.9	12.9	0.1	4.1	0.1	0.3	1.7	0.0	0.2	3.2	0.6	2.0	0.0	0.0	1.7	2.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.4	0.1	0.0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8
MESD	"BOCA, KIAA0081, MESDC2"	ENSG00000117899	"Mesoderm development LRP chaperone"	Q14696	15	80946289-80989878	"Predicted intracellular proteins"	"Wnt signaling pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039414, HPA041721"	Approved		Supported	"Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		690000	"Endoplasmic reticulum"	"Nuclear bodies, Cytosol"	"HPA039414: AB_10674981, HPA041721: AB_2756310"	"unprognostic (9.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.02e-2)"	"prognostic favourable (2.31e-4)"	"unprognostic (4.93e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.09e-3)"	"unprognostic (4.04e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.88e-1)"	15.5	19.5	15.5	19.7	17.6	5.7	23.5	15.6	14.4	21.1	15.8	15.3	31.3	14.0	14.5	48.3	17.1	14.3	16.2	15.5	14.0	17.6	16.4	28.2	17.6	23.8	20.9	13.4	22.2	34.7	12.8	23.4	32.1	17.0	20.8	16.4	15.0	20.4	37.6	14.2	12.3	13.7	13.9	22.4	16.2	16.5	13.6	17.8	13.0	37.1	12.7	14.3	13.7	17.1	19.0	25.6	17.7	15.0	24.7	25.1	16.0	12.3	18.7	16.7	10.7	28.3	16.2	25.9	19.0	22.6	20.7	25.3	16.7	34.8	10.4	22.0	15.2	20.9	25.8	19.4	19.7	22.9	16.5	13.1	16.2	28.4	21.7	15.5	14.5	16.7	22.5	17.4	20.8	19.6	15.7	26.8	17.6	15.5	9.5	13.0	20.2	7.7	14.7	10.3	27.7	17.1	17.0	14.5	8.5	20.8	14.1	31.0	16.3	12.5	15.2	20.1	19.1	10.7	24.2	16.9	21.5	14.3	18.8	27.9	20.9	17.7	15.0	10.3	21.6	13.8	25.1	19.0	22.8	21.1	15.3	18.1	21.5	21.6	4.5	24.7	11.6	25.6	22.8	16.0	15.5	17.6	15.6	14.4	14.0	17.6	20.9	13.4	17.0	17.8
MEST	PEG1	ENSG00000106484	"Mesoderm specific transcript"	Q5EB52	7	130486171-130506465	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.8;placenta: 193.5"	"Cell line enriched"	"Detected in many"	6	"AN3-CA: 513.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 18.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005623			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Cytosol"		"HPA005623: AB_1079364"	"unprognostic (6.14e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.36e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.81e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (6.20e-5)"	"unprognostic (7.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.67e-2)"	44.9	26.0	7.8	4.7	12.9	3.4	63.8	2.6	22.7	2.4	7.5	3.4	1.1	7.9	7.3	4.6	2.6	5.2	6.6	3.7	7.9	8.0	6.7	13.7	18.8	4.1	3.3	9.0	7.8	13.0	2.5	15.4	193.5	15.5	4.1	6.1	8.4	7.0	2.5	2.2	2.1	7.2	5.3	3.2	22.4	3.0	10.1	3.3	2.0	4.3	2.5	1.9	4.5	3.7	3.1	6.7	8.6	2.0	2.7	18.8	5.3	3.1	1.7	8.3	513.1	0.1	0.0	0.0	3.5	1.6	3.6	1.7	9.8	4.8	1.5	1.1	0.1	0.4	0.1	0.0	1.4	0.0	0.0	2.7	2.6	1.6	14.1	0.1	0.0	0.2	0.1	2.7	0.0	1.3	3.0	0.0	6.9	4.4	0.3	3.4	5.2	0.8	0.0	92.3	1.0	3.9	2.9	29.2	0.0	3.0	10.0	0.0	0.3	2.3	1.3	1.2	0.0	11.5	0.2	0.1	0.3	0.0	4.4	0.0	0.4	8.6	1.9	6.2	0.7	2.0	1.7	3.1	2.0	1.4	6.7	2.8	7.6	18.8	1.1	2.7	1.2	0.3	0.1	5.3	7.8	12.9	2.6	22.7	7.9	8.0	3.3	9.0	15.5	3.3
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 45.4;CAPAN-2: 49.6;EFO-21: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	178550000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: "	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.4	26.1	0.0	0.1	2.0	2.0	1.8	26.0	10.6	14.0	11.8	5.4	49.6	2.0	43.3	16.3	12.0	4.5	24.7	28.7	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.1	9.6	0.9	0.2	25.9	1.0	0.0	0.0	3.9	26.7	0.0	22.0	0.0	24.6	5.2	3.8	0.0	10.7	3.4	10.1	0.0	0.2	17.7	20.9	7.4	11.0	20.1	0.5	4.0	0.2	23.0	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995620-99062813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			11000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: , HPA037998: "	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favourable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favourable (9.31e-4)"	12.1	8.3	10.0	16.0	10.1	11.8	18.6	9.2	13.8	16.0	17.9	7.0	22.9	13.4	24.1	25.9	37.2	14.0	12.3	27.9	9.5	7.1	14.3	13.7	10.7	12.6	7.9	9.8	11.3	13.0	7.8	14.4	9.2	9.9	19.1	19.3	7.5	19.0	21.5	27.2	16.4	15.2	27.8	10.1	13.9	11.6	46.8	8.1	27.0	10.8	21.8	19.1	36.6	22.6	12.7	11.7	10.4	11.1	12.5	19.2	10.8	21.7	21.5	18.9	20.2	15.0	24.1	21.0	31.2	20.1	26.7	25.5	24.1	32.5	32.2	12.5	25.2	21.9	33.1	31.2	37.1	22.5	15.8	28.8	15.7	25.8	16.3	38.9	24.1	17.3	22.7	22.6	24.1	21.9	22.5	19.5	28.5	16.5	34.0	18.6	23.2	17.5	22.4	29.5	17.2	42.8	28.2	25.9	15.3	10.4	32.3	12.3	12.4	14.9	17.8	21.6	27.5	19.7	27.1	14.1	19.9	25.5	18.6	19.9	21.4	10.4	9.4	4.2	14.9	11.1	19.2	12.7	15.4	14.5	11.7	10.1	15.1	13.5	2.3	12.5	10.7	5.8	13.4	10.8	10.0	10.1	9.2	13.8	9.5	7.1	7.9	9.8	9.9	8.1
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"			22000	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	24.2	36.4	25.8	49.9	33.7	39.1	25.1	25.9	32.3	23.9	26.2	16.3	102.5	16.6	28.7	25.4	30.1	22.5	21.7	30.7	29.6	24.0	26.0	46.8	22.1	32.6	29.1	23.4	29.4	31.9	21.0	36.1	25.1	42.9	24.2	24.0	10.1	22.1	140.7	94.4	28.7	19.7	26.1	48.2	25.2	22.2	26.3	27.7	32.1	24.1	29.0	55.2	33.4	37.3	39.4	31.8	21.3	27.1	25.7	32.0	16.2	33.2	28.1	30.1	23.3	18.3	29.4	23.1	32.8	23.0	32.4	23.0	40.8	16.0	97.0	20.7	23.4	21.5	33.8	25.1	37.3	23.0	29.1	43.4	21.4	28.7	19.6	53.7	21.3	25.4	26.9	30.6	30.1	34.4	56.1	11.0	24.0	21.9	39.7	36.7	36.8	42.0	31.3	26.0	31.8	22.2	35.4	23.4	30.7	29.2	23.9	28.7	28.8	25.6	29.5	18.6	18.1	20.8	34.6	15.9	41.4	104.0	10.6	30.3	23.4	21.3	27.1	11.1	23.8	19.1	29.2	39.4	26.7	26.6	24.4	37.6	32.0	29.7	1.2	25.7	22.3	31.8	25.3	16.2	25.8	33.7	25.9	32.3	29.6	24.0	29.1	23.4	42.9	27.7
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715115-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 52.2;PC-3: 40.4"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 549.1"	"Low region specificity"	"Detected in many"			HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: "	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	7.7	14.9	44.7	5.1	58.9	2.6	4.6	14.2	45.4	4.1	7.0	24.1	19.8	5.6	5.3	7.8	3.1	27.4	6.4	12.4	39.6	31.6	10.5	8.5	6.0	4.2	45.7	15.1	2.7	43.1	5.2	15.1	5.3	15.3	7.4	2.5	9.2	27.3	16.8	21.5	3.9	5.9	4.4	39.5	5.4	8.3	4.6	19.0	2.5	6.6	3.4	3.0	3.9	5.0	3.2	0.9	0.8	1.0	1.7	2.9	0.5	2.6	22.1	4.3	22.0	7.7	4.3	7.0	5.2	2.6	2.1	1.3	3.2	6.5	0.4	12.3	3.7	9.7	0.6	5.1	0.3	1.4	9.7	0.8	4.0	16.6	4.7	1.8	2.8	10.4	5.6	0.6	1.3	0.7	1.5	0.5	1.5	52.2	0.7	6.4	1.6	40.4	7.1	5.0	7.1	5.4	0.7	6.9	8.7	2.1	5.8	26.8	8.7	3.7	2.4	6.0	11.4	6.9	4.5	3.3	0.9	0.4	9.4	1.4	14.1	0.0	0.3	0.8	2.9	1.0	1.7	3.2	1.5	2.7	0.2	0.5	0.9	1.9	0.0	1.7	1.0	0.9	2.8	0.5	44.7	58.9	14.2	27.4	39.6	31.6	45.7	15.1	15.3	19.0
METTL13	"CGI-01, KIAA0859"	ENSG00000010165	"Methyltransferase like 13"	Q8N6R0	1	171781664-171814023	"Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044498, HPA053705"	Approved		Approved	Cytosol				Cytosol		"HPA044498: AB_10960884, HPA053705: "	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.40e-1)"	"prognostic unfavourable (5.68e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.12e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.12e-1)"	"unprognostic (6.86e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.13e-1)"	13.0	20.7	18.3	13.3	17.8	9.0	14.7	19.0	21.8	14.6	13.6	14.7	13.6	15.1	16.5	24.8	14.9	16.2	11.2	11.7	14.1	10.9	13.2	16.9	15.1	15.9	16.3	17.9	15.3	16.0	14.0	11.0	11.4	14.7	12.6	15.1	11.7	19.2	14.5	18.4	14.2	14.0	15.4	11.4	16.8	14.7	18.9	16.2	16.3	13.1	9.4	17.7	13.7	12.6	10.2	10.0	3.2	8.7	11.5	12.0	7.8	11.7	28.0	7.4	7.7	10.7	9.8	20.3	14.9	11.7	18.0	14.1	21.1	12.2	21.7	17.8	10.3	12.1	22.9	11.9	14.2	13.9	13.1	15.0	14.5	9.2	8.0	19.7	15.3	8.5	11.1	18.7	8.2	10.7	29.9	7.4	13.7	8.9	15.7	13.5	28.8	37.9	14.5	10.0	19.8	10.4	12.1	12.4	17.0	11.0	25.6	13.6	18.7	17.5	8.8	12.2	11.2	12.3	17.4	19.3	21.6	25.0	9.2	13.7	10.8	1.8	8.7	3.2	9.9	8.5	11.5	10.2	9.9	8.4	8.6	8.0	9.1	12.0	2.6	11.5	7.4	10.0	7.4	7.8	18.3	17.8	19.0	21.8	14.1	10.9	16.3	17.9	14.7	16.2
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favourable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	12.7	14.0	13.1	11.0	15.2	13.1	14.1	22.5	14.4	14.9	13.1	19.8	11.2	8.6	21.6	10.6	11.0	16.5	9.6	12.4	12.6	9.7	11.5	6.9	12.2	13.1	18.3	9.7	22.5	13.5	19.7	22.8	7.5	13.6	13.5	10.4	18.3	12.1	13.1	14.2	14.7	10.4	16.5	14.6	11.1	11.2	11.0	17.5	15.7	16.5	8.8	17.5	15.3	12.7	5.7	3.1	2.3	3.2	2.0	8.1	2.0	6.0	16.1	9.1	8.8	6.9	8.7	8.5	7.7	6.6	8.8	7.3	21.3	3.9	18.9	8.3	6.9	8.7	21.0	10.5	12.0	7.2	13.3	9.7	13.2	9.7	7.5	8.9	7.9	7.3	10.0	12.1	17.8	9.0	12.6	10.2	5.8	6.5	12.7	5.3	10.4	6.8	21.3	9.6	8.5	6.3	5.4	4.8	7.6	11.4	6.3	6.7	7.9	5.7	6.5	8.0	5.2	11.3	11.1	6.0	7.3	13.5	10.9	7.5	10.9	2.3	3.2	1.2	5.7	2.1	7.2	5.7	5.6	5.5	2.2	5.0	8.1	5.9	0.1	2.0	1.5	3.1	3.5	2.0	13.1	15.2	22.5	14.4	12.6	9.7	18.3	9.7	13.6	17.5
METTL18	"AsTP2, C1orf156, HPM1, MGC9084"	ENSG00000171806	"Methyltransferase like 18"	O95568	1	169792529-169794966	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035314	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA035314: AB_10601146"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (4.06e-4)"	"unprognostic (3.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.03e-2)"	"prognostic favourable (3.28e-4)"	8.7	7.3	12.1	9.9	9.0	3.8	11.5	13.5	11.8	6.5	6.8	3.5	8.4	5.6	7.7	9.8	7.8	8.2	5.2	10.2	8.5	6.8	8.6	8.5	5.9	16.5	11.1	10.1	10.4	9.4	31.9	9.4	6.3	9.2	11.2	6.8	3.4	8.4	7.5	5.0	6.5	9.2	6.3	12.7	14.3	8.2	6.7	11.2	9.8	10.0	8.0	11.8	7.8	8.9	13.4	5.4	12.2	5.8	12.4	19.3	9.8	9.1	5.3	8.7	6.0	5.1	9.5	6.0	4.3	5.0	5.5	4.8	6.8	15.0	15.7	12.0	5.7	10.6	8.7	9.8	7.5	9.4	7.0	11.2	4.8	5.5	10.5	11.8	5.2	4.3	10.4	5.6	6.2	10.5	11.8	7.5	7.4	4.5	12.5	8.1	10.9	13.4	9.3	8.6	11.8	8.9	9.2	6.5	9.9	9.2	10.4	12.7	13.8	13.0	4.7	7.0	6.7	6.9	10.0	14.6	19.0	21.3	5.1	9.5	7.0	9.3	5.2	12.2	14.6	5.8	18.5	12.1	16.3	17.0	5.4	13.4	19.3	18.3	3.0	12.4	3.4	4.2	18.4	9.8	12.1	9.0	13.5	11.8	8.5	6.8	11.1	10.1	9.2	11.2
METTL21A	"FAM119A, HCA557b, HSPA-KMT, LOC151194"	ENSG00000144401	"Methyltransferase like 21A"	Q8WXB1	2	207580631-207625928	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034712	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034712: AB_10670160"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (1.87e-5)"	"unprognostic (4.80e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (5.43e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	10.4	9.1	16.5	13.8	18.2	20.2	14.6	14.0	16.9	9.0	9.3	8.7	3.8	8.1	10.0	8.4	6.7	8.3	7.1	13.2	16.3	15.4	11.1	20.9	8.9	15.4	25.8	10.6	12.0	10.6	11.6	10.1	12.7	20.2	8.8	9.2	8.8	8.4	7.1	19.5	9.0	8.3	8.3	19.2	15.4	12.3	7.1	18.8	18.5	15.2	6.2	14.8	10.1	24.3	25.2	14.8	25.9	20.6	7.5	14.4	8.3	7.9	7.5	12.5	9.4	5.5	5.8	24.2	4.5	5.5	7.3	7.4	14.3	12.8	11.5	9.9	3.4	4.6	17.8	5.9	6.0	6.7	12.2	13.5	12.0	23.4	9.8	17.6	13.7	5.2	7.9	3.6	6.1	8.1	19.3	6.8	4.8	12.9	17.7	30.2	20.6	5.3	13.1	5.2	16.8	10.4	6.8	14.8	12.1	9.6	3.4	9.3	4.6	26.2	4.2	6.3	13.9	5.8	7.8	10.1	12.7	23.8	10.4	13.9	9.4	13.8	14.4	25.9	5.0	13.9	8.3	25.2	7.6	7.1	11.8	21.6	14.4	9.2	5.0	7.5	20.6	14.8	5.9	8.3	16.5	18.2	14.0	16.9	16.3	15.4	25.8	10.6	20.2	18.8
METTL25	"C12orf26, FLJ22789"	ENSG00000127720	"Methyltransferase like 25"	Q8N6Q8	12	82358497-82479236	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039534, HPA041207"	Uncertain		Uncertain	"Plasma membrane,Mitochondria,Cytosol"				"Plasma membrane, Mitochondria, Cytosol"		"HPA039534: AB_10794749, HPA041207: AB_10794406"	"unprognostic (1.60e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.00e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.44e-2)"	8.3	9.2	8.7	8.5	8.1	5.0	11.1	23.6	8.3	8.2	7.7	8.1	9.0	7.5	8.2	9.1	10.0	8.0	5.8	8.7	9.1	3.1	8.8	6.3	6.5	8.1	7.6	5.7	10.8	6.5	7.8	25.9	6.8	7.6	8.0	9.2	5.8	10.5	6.0	10.7	9.7	8.2	7.5	5.8	8.6	6.7	11.0	13.0	9.9	10.2	8.7	7.4	8.8	8.5	7.9	13.2	14.4	7.6	9.8	7.6	3.8	1.4	3.3	4.5	0.9	5.1	6.0	4.5	7.0	4.0	3.7	2.7	4.3	3.8	8.5	1.5	5.1	1.5	8.8	1.1	2.4	8.1	7.5	4.1	1.8	4.0	3.1	7.1	4.9	4.4	4.1	1.2	0.0	7.6	3.0	3.8	3.7	4.9	3.0	6.3	6.8	1.0	1.7	2.7	4.4	11.4	5.1	3.3	2.6	2.5	4.2	4.4	3.7	6.8	2.8	1.7	1.6	2.8	3.9	4.9	2.9	3.2	2.8	4.4	3.9	14.4	7.6	4.4	4.9	6.4	7.3	6.4	5.3	4.0	6.0	7.9	7.6	5.4	13.6	9.8	5.7	13.2	4.5	3.8	8.7	8.1	23.6	8.3	9.1	3.1	7.6	5.7	7.6	13.0
METTL5	HSPC133	ENSG00000138382	"Methyltransferase like 5"	Q9NRN9	2	169810081-169824931	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038223	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA038223: AB_10672509"	"unprognostic (2.55e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.73e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavourable (6.64e-5)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (3.06e-8)"	"unprognostic (8.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.87e-3)"	28.9	25.2	30.1	15.8	29.3	17.6	31.2	18.1	30.2	19.8	28.6	14.2	14.9	17.7	18.8	40.4	29.0	17.9	17.3	38.2	25.6	28.5	27.8	29.2	15.8	19.4	25.6	20.8	16.6	32.5	18.0	24.2	22.3	30.2	25.3	26.5	11.9	27.9	20.9	50.1	19.6	24.9	38.4	26.5	17.8	25.1	14.1	23.9	18.1	26.1	33.9	22.3	31.6	26.5	28.6	21.9	15.0	14.1	18.8	29.1	15.1	23.9	13.3	19.3	21.4	17.7	26.6	31.8	20.3	19.2	24.8	20.0	41.3	28.4	30.7	24.9	16.6	25.1	26.3	42.6	35.0	23.6	18.9	46.3	10.9	45.0	24.2	58.0	22.9	19.5	57.2	31.4	38.7	23.0	43.0	25.8	31.5	23.2	27.8	47.1	26.1	25.3	28.2	18.1	47.5	42.6	22.1	23.5	17.6	13.1	20.7	35.3	19.5	26.2	15.7	27.1	22.1	16.9	26.0	25.2	38.0	51.0	22.6	28.4	24.4	15.0	11.7	9.0	19.0	14.1	29.1	28.6	26.3	25.2	14.2	24.1	27.5	24.9	3.5	18.8	12.9	21.9	24.9	15.1	30.1	29.3	18.1	30.2	25.6	28.5	25.6	20.8	30.2	23.9
METTL8	"FLJ13984, TIP"	ENSG00000123600	"Methyltransferase like 8"	Q9H825	2	171317405-171434802	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035421	Uncertain		Approved	Cytosol				Cytosol		"HPA035421: AB_10670116"	"unprognostic (3.13e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.94e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.83e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (6.75e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.59e-3)"	10.8	8.0	7.4	8.4	9.6	6.8	8.8	6.2	8.5	9.4	12.6	10.4	9.2	4.6	8.4	6.3	21.0	5.9	7.2	6.7	8.7	6.4	8.6	8.6	5.5	6.0	13.2	4.5	6.4	8.1	6.1	5.0	7.8	10.9	10.9	14.1	5.2	6.2	11.6	6.9	15.1	8.2	20.5	12.5	7.8	6.3	11.2	10.1	4.0	4.7	13.5	8.9	13.7	10.3	6.6	10.1	1.2	4.4	7.0	7.5	3.6	8.3	6.4	3.1	9.5	10.3	12.3	17.1	10.4	8.0	9.9	12.3	13.9	11.7	17.4	8.3	4.9	8.5	11.1	16.9	12.4	9.1	5.8	9.6	5.6	19.6	8.3	14.6	7.5	12.1	18.8	15.6	24.5	19.4	17.7	4.0	13.4	9.2	10.3	3.6	13.0	5.7	5.5	12.1	18.8	7.3	8.2	11.4	4.5	11.0	8.4	7.6	6.0	5.5	9.5	8.6	6.8	6.1	5.7	2.1	9.3	10.5	6.9	10.4	8.9	0.8	3.0	0.9	5.4	4.4	7.5	4.3	6.3	5.0	4.0	6.6	2.9	3.3	1.2	7.0	2.1	10.1	6.3	3.6	7.4	9.6	6.2	8.5	8.7	6.4	13.2	4.5	10.9	10.1
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: , HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	24.0	45.5	29.6	18.8	34.9	50.0	45.1	12.2	31.9	34.2	19.1	18.7	15.5	14.9	23.4	35.6	30.2	23.8	19.4	32.0	22.2	20.0	61.0	8.7	24.0	38.8	26.8	8.4	22.8	28.8	37.2	25.0	25.4	17.7	23.8	20.3	32.5	22.1	19.3	30.6	21.5	20.6	21.1	25.0	29.6	18.8	10.8	18.1	39.8	37.8	20.0	25.9	24.9	24.6	4.9	14.1	30.5	24.5	5.6	7.3	7.6	13.4	10.3	26.0	22.5	26.9	48.8	9.3	21.6	31.0	17.1	20.7	7.4	24.6	23.7	18.5	37.8	8.4	17.2	19.3	23.4	18.0	14.1	10.2	10.4	27.5	19.3	8.0	21.3	28.7	20.6	17.6	23.1	32.6	15.1	19.5	33.8	14.9	20.8	13.4	23.3	10.7	30.4	20.3	21.5	28.2	13.2	15.1	27.3	18.3	12.7	46.0	12.9	4.2	18.4	28.5	12.4	17.3	13.3	16.6	26.6	19.0	27.9	19.9	20.0	30.5	24.5	10.7	4.0	4.5	4.8	4.6	6.8	7.3	14.1	4.9	7.3	5.4	12.5	5.6	3.9	4.4	5.4	7.6	29.6	34.9	12.2	31.9	22.2	20.0	26.8	8.4	17.7	18.1
MEX3A	"RKHD4, RNF162"	ENSG00000254726	"Mex-3 RNA binding family member A"	A1L020	1	156072013-156081998	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 7.2;ovary: 10.1"	"Cell line enhanced"	"Detected in many"		"AF22: 25.0;NTERA-2: 22.7;SCLC-21H: 23.6;SH-SY5Y: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062703			Supported	Cytosol				Cytosol		"HPA062703: "	"unprognostic (8.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (9.23e-8)"	"unprognostic (4.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.96e-2)"	0.4	0.2	1.8	1.0	1.8	0.8	2.5	3.3	5.1	2.5	1.3	1.4	0.2	0.7	7.2	0.7	1.4	1.7	1.1	0.2	3.5	1.0	1.1	1.8	0.6	3.4	1.9	2.1	10.1	0.6	0.4	0.4	0.8	2.2	1.7	1.0	1.0	2.0	0.6	0.2	0.7	0.6	1.7	1.0	1.4	0.5	3.1	2.0	3.6	1.5	0.2	1.1	1.9	1.4	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	25.0	6.2	0.3	0.4	2.9	0.6	0.1	1.0	0.9	1.4	0.3	0.7	2.9	0.3	0.5	10.8	0.4	1.2	1.2	2.9	0.6	1.1	2.4	0.5	0.3	0.5	0.7	0.8	0.5	0.4	4.7	5.6	0.0	1.4	1.6	2.8	0.4	22.7	3.2	9.2	2.0	0.1	0.8	1.1	23.6	43.1	0.7	2.8	1.4	4.8	1.8	1.6	1.5	3.9	0.4	1.4	0.5	0.4	1.3	0.1	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	3.3	2.0	3.5	1.0	1.9	2.1	2.2	2.0
MEX3B	"DKFZp434J0617, RKHD3, RNF195"	ENSG00000183496	"Mex-3 RNA binding family member B"	Q6ZN04	15	82041778-82046141	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 15.6;testis: 33.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 32.7;HEL: 24.0;SH-SY5Y: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041093	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041093: AB_10793868"	"unprognostic (2.42e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.93e-8)"	"unprognostic (1.24e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.51e-2)"	2.0	0.6	1.5	1.8	1.6	2.0	1.6	3.8	4.5	15.6	2.8	1.6	2.5	0.8	7.9	0.6	1.1	1.2	2.8	2.0	2.0	1.4	1.0	1.0	1.4	2.8	2.2	3.3	6.8	0.7	0.2	0.9	3.3	1.0	3.7	0.9	1.2	3.0	3.8	1.6	1.1	1.1	4.0	1.0	1.2	1.0	33.3	0.7	8.4	1.0	1.8	1.2	3.1	4.2	0.0	1.3	0.0	0.1	0.4	0.1	0.0	0.1	1.2	8.6	32.7	0.7	1.0	2.5	1.0	0.5	1.8	1.6	0.2	0.1	1.5	0.6	1.9	0.2	4.1	0.1	1.3	0.3	2.7	24.0	1.4	1.0	1.4	0.2	7.6	0.5	0.6	1.0	2.0	3.7	1.1	0.0	3.1	0.8	3.9	2.0	11.2	0.3	5.5	5.2	0.8	0.0	0.0	6.9	13.4	1.7	0.3	1.1	0.1	0.4	3.4	4.5	5.3	2.5	1.5	3.1	1.6	1.8	1.4	2.4	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	1.6	3.8	4.5	2.0	1.4	2.2	3.3	1.0	0.7
MFGE8	"BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10"	ENSG00000140545	"Milk fat globule-EGF factor 8 protein"	Q08431	15	88898683-88913411	"Cancer-related genes, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 177.8;ASC TERT1: 92.3;fHDF/TERT166: 62.5;HSkMC: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.6;NK-cells: 6.3;T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002753, HPA002807"	Supported		Approved	Cytosol	"Secreted to blood"	2831507	1100000	Cytosol		"CAB002753: , HPA002807: AB_1078072"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.99e-1)"	"prognostic unfavourable (6.06e-9)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (4.85e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.41e-3)"	34.2	23.2	5.4	14.5	11.2	0.9	73.4	5.7	14.8	43.4	15.8	9.6	11.3	5.2	73.2	38.6	32.8	56.2	30.2	115.4	5.6	4.1	12.4	3.9	20.8	14.9	6.0	8.3	49.8	6.6	2.9	8.1	23.1	10.8	29.5	7.3	59.5	15.6	50.7	57.8	18.3	15.4	39.6	8.8	6.5	22.2	23.6	4.4	8.5	21.7	21.1	12.6	32.8	68.3	1.2	0.0	3.6	0.2	6.3	13.3	2.0	1.8	7.0	7.6	9.3	177.8	92.3	0.6	45.8	13.7	9.1	10.9	6.1	2.2	0.0	14.1	62.5	0.9	2.6	9.1	3.1	7.3	4.6	13.3	0.4	0.6	46.9	0.0	4.7	93.6	24.5	7.2	12.1	3.5	2.1	4.0	17.8	0.1	2.0	0.3	39.0	2.4	2.0	7.3	2.4	3.2	0.6	0.8	4.0	2.5	0.2	20.8	0.2	0.9	3.8	22.9	12.3	5.8	3.3	14.0	2.7	1.4	3.0	1.1	8.8	3.6	0.2	0.4	1.2	0.0	4.2	1.2	4.2	3.0	0.0	0.8	4.4	3.1	0.0	6.3	0.1	0.0	13.3	2.0	5.4	11.2	5.7	14.8	5.6	4.1	6.0	8.3	10.8	4.4
MFHAS1	"LRRC65, MASL1, ROCO4"	ENSG00000147324	"Malignant fibrous histiocytoma amplified sequence 1"	Q9Y4C4	8	8783354-8893645	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Signal transduction inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.5;MAIT T-cell: 2.1;memory B-cell: 1.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive B-cell: 1.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.7;T-reg: 3.1"	"Group enriched"	"Detected in many"	5	"B-cells: 1.1;T-cells: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051213, HPA054471"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051213: , HPA054471: "	"unprognostic (1.33e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.23e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.01e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-1)"	8.0	2.7	10.1	14.9	10.2	12.5	5.8	10.3	10.0	8.7	16.6	5.0	5.0	7.6	7.7	4.8	7.6	9.9	10.7	7.6	10.0	6.5	15.8	10.5	12.5	12.1	6.2	4.7	6.8	6.3	6.2	3.3	11.1	7.4	8.9	14.9	5.4	7.6	6.1	4.4	8.5	9.5	10.4	3.6	13.5	9.0	7.6	5.2	24.9	10.8	3.6	10.6	9.3	15.0	1.1	0.5	0.0	0.3	0.4	3.9	0.9	7.7	5.9	3.6	2.7	3.4	4.4	11.9	3.2	7.0	2.3	3.2	9.4	1.5	11.5	4.0	3.1	2.6	3.7	2.9	2.1	14.8	3.3	0.8	2.2	6.1	4.0	3.2	1.2	2.3	6.3	3.2	3.2	5.2	5.3	0.0	1.9	2.8	50.5	2.9	7.0	2.5	6.9	5.5	1.8	16.5	8.1	5.7	4.6	1.9	3.0	5.1	2.0	4.5	2.2	2.8	4.3	11.4	6.2	0.6	2.7	9.0	5.3	4.4	1.7	0.0	0.3	0.0	2.5	0.1	2.1	1.1	3.9	2.2	0.5	1.0	1.9	1.7	0.0	0.4	0.0	0.1	3.1	0.9	10.1	10.2	10.3	10.0	10.0	6.5	6.2	4.7	7.4	5.2
MFSD13A	"bA18I14.8, C10orf77, FLJ22529, TMEM180"	ENSG00000138111	"Major facilitator superfamily domain containing 13A"	Q14CX5	10	102461395-102477045	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018031	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA018031: AB_2204891"	"unprognostic (2.24e-2)"	"prognostic favourable (8.29e-4)"	"unprognostic (7.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.16e-3)"	"unprognostic (4.70e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (8.51e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.02e-2)"	3.8	3.3	8.8	5.9	15.7	9.0	2.6	18.0	18.7	2.4	7.0	8.5	0.4	10.2	4.3	1.8	3.0	2.4	4.7	5.2	9.0	6.5	3.3	5.7	14.1	5.6	7.9	8.7	2.3	5.1	2.8	4.4	7.2	8.2	3.1	6.4	3.9	3.0	2.3	3.9	17.4	7.5	4.9	5.2	6.9	7.1	5.8	8.6	2.3	5.7	1.8	6.7	3.1	2.5	5.0	7.5	5.5	7.2	2.2	5.8	3.4	9.3	4.3	3.3	7.9	0.3	0.3	5.1	1.9	4.9	3.7	8.7	8.5	12.9	8.4	9.8	0.7	11.7	6.1	5.0	1.4	10.5	5.5	10.3	6.1	4.4	8.5	5.2	10.1	4.3	2.1	2.1	3.8	4.3	2.3	4.6	0.3	1.9	8.7	3.4	5.6	4.2	10.6	0.5	1.4	1.7	2.5	8.2	7.8	1.8	1.0	4.2	4.8	3.5	1.3	1.7	2.1	2.1	2.6	1.6	4.1	10.9	9.6	8.6	2.4	0.7	7.2	5.5	5.2	5.3	5.2	5.0	5.0	4.1	7.5	2.8	5.2	5.8	4.4	2.2	3.0	0.8	1.4	3.4	8.8	15.7	18.0	18.7	9.0	6.5	7.9	8.7	8.2	8.6
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374551-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	15.1	18.9	13.3	14.3	14.7	9.0	20.2	11.6	12.8	14.9	14.2	19.7	15.5	9.9	18.6	16.1	28.1	14.4	12.5	13.4	13.3	12.4	14.7	9.0	25.7	21.5	14.6	7.8	15.9	21.5	86.0	9.2	24.2	28.3	14.5	15.4	21.6	15.9	14.2	7.3	21.8	16.0	12.8	19.1	19.3	13.0	9.2	13.2	24.0	16.7	14.2	23.9	14.1	18.8	4.6	7.8	10.4	11.4	3.6	7.1	3.6	25.9	16.8	13.1	10.3	28.9	20.7	20.9	25.3	22.0	22.6	22.2	8.4	31.2	31.3	15.1	21.8	57.6	15.6	16.2	22.0	22.3	8.4	10.8	16.1	12.6	20.5	33.9	20.0	19.0	24.4	23.9	18.4	19.3	20.3	18.7	30.0	19.7	24.8	19.5	19.2	13.5	12.5	30.2	10.1	24.0	20.1	12.6	16.7	21.6	25.5	26.8	11.6	20.1	20.6	23.7	16.7	36.3	23.4	20.7	25.6	8.6	21.1	16.6	21.1	0.6	7.9	5.9	5.6	11.4	5.1	4.6	5.1	5.6	7.8	2.9	5.1	7.1	10.4	3.6	7.7	7.7	5.1	3.6	13.3	14.7	11.6	12.8	13.3	12.4	14.6	7.8	28.3	13.2
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.5;THP-1: 58.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"				Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.4	6.6	3.1	0.6	0.0	2.0	3.9	4.5	5.4	0.2	1.1	13.0	1.2	1.0	5.2	4.3	7.5	3.5	1.6	2.1	1.5	0.0	0.0	10.5	2.3	7.7	3.5	4.7	18.5	7.6	1.1	0.0	3.3	2.0	0.2	3.5	3.5	3.5	1.6	2.5	6.5	3.0	0.7	6.1	1.6	2.4	1.5	11.1	1.1	0.5	58.2	0.7	1.0	1.9	3.3	8.5	0.6	1.1	2.9	10.4	8.8	3.2	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3
MFSD6	FLJ20160	ENSG00000151690	"Major facilitator superfamily domain containing 6"	Q6ZSS7	2	190408355-190509205	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022274	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"				Cytosol	"Nucleoplasm, Actin filaments"	"HPA022274: AB_2142776"	"unprognostic (9.47e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (1.05e-4)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.14e-2)"	"unprognostic (9.18e-2)"	12.3	26.9	20.8	9.3	23.3	4.2	13.8	19.4	33.1	15.3	20.0	29.0	29.0	12.6	7.1	22.3	26.6	13.0	10.3	11.1	25.4	26.5	7.4	2.0	16.9	8.7	36.2	22.9	3.5	10.9	28.2	35.7	5.6	43.1	15.7	19.0	12.2	19.2	29.6	3.8	18.9	15.4	9.5	36.7	12.7	20.2	4.9	18.3	13.0	25.5	10.8	12.7	13.3	13.6	2.4	2.6	8.1	2.0	3.3	5.6	1.2	10.5	6.5	0.2	2.3	4.8	6.2	9.0	5.4	11.0	3.7	4.7	2.4	13.4	16.5	2.6	11.3	17.9	3.2	9.5	4.2	33.4	4.9	8.8	6.4	1.2	1.9	3.4	2.8	0.9	17.3	5.4	3.6	1.3	2.2	18.4	0.9	4.0	16.0	0.7	1.5	7.0	3.6	0.5	14.1	7.0	19.3	21.0	5.4	7.7	18.2	10.5	5.9	4.0	5.4	0.6	1.3	7.2	8.3	8.4	3.5	5.9	6.0	7.2	2.9	8.1	2.0	0.6	2.6	0.6	2.7	2.4	3.5	3.6	2.6	1.3	1.6	3.6	0.1	3.3	0.9	1.3	5.6	1.2	20.8	23.3	19.4	33.1	25.4	26.5	36.2	22.9	43.1	18.3
MGA	"FLJ12634, KIAA0518, MAD5, MXD5"	ENSG00000174197	"MGA, MAX dimerization protein"	Q8IWI9	15	41621224-41773081	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042278, HPA058183"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA042278: AB_10794647, HPA058183: "	"unprognostic (5.78e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.97e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.82e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.89e-1)"	9.3	11.3	13.8	13.6	15.3	14.3	13.0	28.2	16.9	14.5	10.1	13.3	12.2	6.8	14.2	11.5	9.8	11.3	7.8	10.1	11.2	7.7	10.1	8.5	8.5	12.7	18.7	10.5	22.7	12.0	18.0	27.6	12.4	13.7	11.0	9.7	7.2	10.3	10.8	11.8	11.2	10.6	11.8	16.1	12.5	9.8	16.4	14.7	22.4	13.9	5.3	13.4	11.6	11.5	5.0	4.1	4.9	4.9	9.8	5.0	1.5	1.4	8.4	10.6	6.9	8.3	6.6	8.5	4.2	4.2	5.0	5.0	8.9	4.9	9.9	7.6	4.8	5.8	16.3	3.6	6.9	4.7	5.3	21.0	13.8	7.8	7.4	19.2	10.5	5.0	4.6	6.9	6.9	6.4	24.4	4.5	4.4	4.1	11.6	7.5	6.5	4.3	13.2	10.8	5.1	2.6	6.0	10.0	9.8	14.9	5.2	2.7	4.2	12.3	6.8	6.1	8.6	6.2	4.9	6.2	9.2	9.7	3.8	7.4	3.0	4.9	2.3	2.5	4.7	1.8	4.6	4.8	3.7	5.0	2.4	5.0	3.9	4.3	1.2	9.8	4.9	4.1	1.8	1.5	13.8	15.3	28.2	16.9	11.2	7.7	18.7	10.5	13.7	14.7
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 61.2;pancreas: 15.6;salivary gland: 35.4"	"Cell line enriched"	"Detected in single"	7	"RH-30: 5.0"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"					"Low region specificity"	"Detected in all"			HPA055697	Enhanced		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA055697: "	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.2	0.1	0.1	2.5	0.1	0.2	1.3	0.1	0.1	0.1	28.8	0.0	0.0	15.0	0.1	0.4	0.1	0.3	7.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.1	15.6	0.0	0.1	0.0	0.1	0.1	1.4	0.7	35.4	0.0	0.1	0.2	61.2	0.0	0.5	1.5	0.7	1.0	0.0	0.0	0.1	1.7	0.8	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.0
MGEA5	"MEA5, NCOAT, OGA"	ENSG00000198408	"Meningioma expressed antigen 5 (hyaluronidase)"	O60502	10	101784443-101818465	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036141, HPA076501"	Approved		Supported	Cytosol				Cytosol		"HPA036141: AB_10672079, HPA076501: "	"unprognostic (4.34e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (8.69e-5)"	"unprognostic (4.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.23e-3)"	29.5	17.5	51.9	27.4	54.4	49.3	35.5	58.9	51.4	24.5	27.0	29.0	20.9	17.6	29.9	36.8	26.0	23.3	19.1	27.4	46.0	29.8	27.7	28.6	24.0	40.1	30.7	43.6	33.8	20.9	53.3	22.1	25.5	42.6	31.6	26.5	30.7	24.4	26.3	25.4	36.6	28.5	37.4	29.5	35.2	23.9	21.9	35.4	32.9	25.9	11.8	39.5	34.3	26.7	8.1	3.3	14.7	5.6	6.8	7.1	1.4	30.6	15.6	22.9	44.3	14.7	35.7	15.9	21.6	21.9	10.1	17.4	11.5	19.7	20.5	15.8	25.7	22.1	21.3	27.2	21.5	30.0	14.6	20.5	21.8	8.9	15.9	15.1	11.6	34.5	30.6	17.3	41.3	18.7	14.4	38.1	17.1	15.6	15.9	15.8	12.6	15.8	22.2	25.2	15.0	16.9	27.8	9.9	17.6	19.3	10.5	27.0	27.6	16.5	28.3	15.6	15.1	22.5	24.7	19.1	30.3	16.4	19.6	26.0	8.5	10.5	2.1	6.8	7.1	2.0	5.6	6.4	4.9	6.1	1.3	8.1	6.8	5.7	14.7	6.8	5.6	3.3	4.5	1.4	51.9	54.4	58.9	51.4	46.0	29.8	30.7	43.6	42.6	35.4
MICAL2	KIAA0750	ENSG00000133816	"Microtubule associated monooxygenase, calponin and LIM domain containing 2"	"O94851, Q6ZW33"	11	12094008-12359144	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 138.4"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 39.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 138.4;cerebral cortex: 39.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030437, HPA039895, HPA040438"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA030437: AB_10601873, HPA039895: , HPA040438: AB_10672896"	"unprognostic (2.68e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (6.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	4.1	3.3	15.4	7.3	15.1	6.8	2.9	138.4	39.8	6.6	14.7	2.7	2.9	7.2	14.7	7.7	11.5	5.4	11.1	24.8	22.0	6.9	2.9	3.9	12.8	2.3	5.6	17.9	3.9	4.4	0.7	2.4	5.0	5.5	3.3	15.1	2.8	2.9	8.4	14.6	9.3	10.8	22.7	7.6	2.6	5.9	24.6	0.6	0.0	4.5	1.9	2.2	7.8	3.2	0.2	5.5	12.2	6.7	3.7	3.5	2.1	11.6	6.2	0.2	1.4	1.6	2.9	7.4	18.6	21.1	7.3	11.4	13.0	8.4	0.3	4.0	13.0	8.2	2.2	30.0	18.2	13.5	1.5	11.0	1.2	0.9	14.1	2.0	1.4	5.2	5.3	32.2	31.5	16.6	19.3	0.5	11.7	0.7	0.1	1.0	0.4	5.8	0.1	7.4	7.8	1.5	14.7	6.1	0.5	6.1	17.1	1.2	1.7	0.6	29.7	39.8	15.0	6.5	16.2	0.4	0.9	0.4	24.2	2.9	0.8	0.1	6.7	0.5	2.8	1.7	3.5	0.2	1.7	1.7	5.5	0.2	0.2	0.9	12.2	3.7	0.5	1.0	2.1	2.1	15.4	15.1	138.4	39.8	22.0	6.9	5.6	17.9	5.5	0.6
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024559	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2"	"Group enriched"	"Detected in many"	6	"B-cells: 5.2;granulocytes: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"				"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: "	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	10.1	9.0	15.4	20.7	19.2	10.2	9.6	62.2	25.0	12.8	22.4	30.0	8.8	8.3	30.3	14.0	13.8	28.6	9.5	23.7	15.4	13.8	8.7	16.8	6.1	15.2	21.6	15.6	20.2	10.2	30.4	11.0	11.9	19.4	11.8	16.5	14.2	8.0	14.8	28.0	14.7	13.2	26.1	20.9	12.2	11.1	15.7	22.6	3.0	10.4	7.8	20.8	14.7	15.1	5.2	0.3	10.0	0.1	1.3	1.1	0.2	13.7	15.1	8.0	13.0	6.0	7.8	9.7	12.1	13.2	17.2	13.6	14.4	1.9	15.4	6.2	16.5	15.9	11.8	14.0	16.7	14.9	11.2	16.0	16.1	6.0	4.0	7.1	8.6	6.3	11.2	18.1	19.2	10.0	17.5	9.9	6.3	12.3	6.7	4.4	5.5	9.9	9.4	12.0	0.7	13.8	9.7	21.2	8.3	17.1	10.9	25.8	4.3	3.0	17.6	17.7	11.4	12.1	25.2	6.5	11.5	20.6	15.4	3.2	50.7	10.0	0.0	0.1	0.5	0.1	0.8	3.3	0.6	0.5	0.1	5.2	0.3	0.2	0.2	1.3	0.0	0.3	1.1	0.2	15.4	19.2	62.2	25.0	15.4	13.8	21.6	15.6	19.4	22.6
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Uncertain		Supported	"Cell Junctions,Centriolar satellite,Cytosol"				"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: "	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	8.0	4.8	5.3	10.1	10.3	6.3	12.6	5.9	7.3	19.1	25.2	21.4	17.6	6.1	21.3	11.0	32.3	11.1	14.4	6.0	7.5	5.5	6.4	5.7	11.8	9.2	17.4	5.1	6.8	14.2	19.2	4.3	29.6	12.5	15.3	7.5	8.7	13.4	25.2	8.5	24.4	9.2	43.5	18.7	5.9	28.5	7.4	11.1	5.3	9.4	15.5	13.5	21.4	17.5	2.8	3.3	2.3	1.6	4.1	2.6	1.6	10.7	6.0	6.5	7.0	6.5	5.6	26.0	15.3	8.7	15.0	11.3	8.2	5.8	4.7	4.7	10.1	28.0	5.0	29.9	10.9	8.0	13.2	1.9	6.3	8.0	10.7	5.3	5.4	4.7	46.8	17.9	37.2	10.3	3.3	4.5	13.1	5.1	1.3	2.4	2.3	4.5	7.1	12.4	2.5	3.9	29.9	4.5	8.0	9.5	8.4	8.1	5.0	5.1	14.2	25.2	20.8	16.7	12.4	4.6	1.5	3.0	22.8	2.4	12.2	0.4	1.1	0.6	1.8	1.6	2.3	2.5	1.4	2.2	1.7	2.8	2.6	1.3	2.3	4.1	0.6	3.3	0.9	1.6	5.3	10.3	5.9	7.3	7.5	5.5	17.4	5.1	12.5	11.1
MIER2	KIAA1193	ENSG00000105556	"MIER family member 2"	Q8N344	19	301444-344815	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041439	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041439: AB_2677481"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavourable (2.89e-4)"	"prognostic favourable (1.72e-5)"	"unprognostic (6.71e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (7.22e-6)"	"unprognostic (8.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.68e-2)"	15.5	6.8	9.1	9.3	11.8	4.3	9.7	14.4	12.5	8.6	7.5	10.0	6.6	9.8	12.0	7.8	9.4	7.9	8.5	9.1	9.8	6.7	6.4	3.4	12.5	8.5	9.1	7.8	8.5	11.6	3.7	9.8	13.5	9.1	10.9	3.3	8.3	12.9	10.9	17.0	18.4	9.3	6.4	6.4	17.2	10.3	31.5	12.1	4.6	8.3	7.1	6.6	9.1	16.5	2.2	6.6	6.4	5.8	1.6	3.3	3.0	8.8	5.6	5.0	5.8	1.8	2.8	10.9	7.3	3.5	5.5	5.8	8.6	2.8	4.6	3.9	3.8	7.5	3.2	4.3	1.7	11.0	15.6	2.7	4.5	6.5	5.5	0.0	21.9	3.6	3.3	4.5	1.6	6.2	7.7	0.0	3.0	9.3	7.2	9.9	13.0	0.0	6.3	1.6	1.2	2.6	5.0	8.1	7.3	4.2	3.2	7.2	3.6	4.9	6.5	7.5	5.3	11.4	8.0	13.4	6.6	3.7	7.1	3.9	7.4	6.4	5.8	4.2	2.0	5.2	1.8	0.9	2.7	3.0	6.6	2.2	3.3	2.2	0.5	1.6	5.8	3.7	1.1	3.0	9.1	11.8	14.4	12.5	9.8	6.7	9.1	7.8	9.1	12.1
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894004-23895227	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 127.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	13800000	14000000	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	30.6	49.8	43.9	42.0	39.9	46.0	71.6	19.0	66.1	23.0	42.7	10.4	55.6	39.9	22.5	113.3	51.9	23.3	42.5	60.7	42.8	40.3	71.8	58.8	46.2	113.9	33.5	43.7	24.5	80.2	16.2	41.1	30.5	45.2	54.8	11.6	15.0	57.3	101.2	36.0	63.3	50.6	26.7	78.3	42.5	56.2	24.9	19.2	19.0	28.9	43.7	16.7	21.4	44.6	56.8	42.5	17.6	23.8	38.3	52.7	66.0	48.9	10.9	2.4	11.0	0.9	2.2	18.4	18.5	3.1	5.9	7.7	8.1	8.1	23.3	14.7	1.3	21.8	2.5	11.2	0.7	19.6	127.1	8.8	9.9	16.9	4.8	34.0	20.7	4.7	6.7	3.5	1.7	4.7	13.6	11.8	2.0	24.6	23.1	63.0	14.0	59.3	29.7	4.1	65.3	4.6	3.4	31.9	37.2	11.8	12.5	30.5	16.1	10.2	13.5	5.2	35.0	3.1	0.4	51.4	18.1	24.0	21.1	12.7	10.6	16.3	23.8	17.6	37.4	22.3	52.7	56.8	51.8	40.4	31.6	49.1	46.1	38.0	7.1	38.3	14.6	42.5	48.3	66.0	43.9	39.9	19.0	66.1	42.8	40.3	33.5	43.7	45.2	19.2
MIF4GD	"AD023, MGC45027, MIFD, SLIP1"	ENSG00000125457	"MIF4G domain containing"	A9UHW6	17	75266228-75271227	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 67.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051222	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA051222: "	"unprognostic (1.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.15e-2)"	"prognostic favourable (2.70e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.31e-2)"	19.0	13.9	10.4	14.5	11.1	30.5	13.3	7.4	14.6	11.9	12.9	20.8	14.2	10.3	16.8	12.8	18.3	13.9	20.4	20.4	10.2	8.2	16.0	15.1	15.1	30.4	12.0	9.9	12.2	16.2	18.2	7.4	15.9	12.0	12.0	11.7	15.5	15.4	11.5	34.4	18.6	14.1	20.4	15.4	22.0	11.7	12.6	10.9	21.8	15.0	20.7	20.9	16.6	12.2	14.1	67.0	11.3	21.5	14.5	17.5	14.4	11.8	21.0	4.7	10.9	7.6	2.2	6.7	3.0	8.6	6.1	4.2	7.4	13.4	18.5	5.5	4.8	9.5	5.7	10.6	4.6	9.1	14.4	9.1	9.1	6.5	8.4	8.0	10.7	2.1	16.7	4.2	17.4	12.6	12.0	22.6	1.6	23.1	25.5	19.1	2.1	10.3	16.6	6.0	25.2	12.3	6.5	7.0	10.3	6.2	16.4	15.2	30.3	18.7	4.8	3.1	7.6	3.9	6.1	33.1	8.5	15.6	5.8	14.2	4.1	5.7	21.5	11.3	15.4	11.0	16.2	14.1	12.5	13.7	25.4	13.0	11.4	12.0	3.8	14.5	13.1	67.0	17.5	14.4	10.4	11.1	7.4	14.6	10.2	8.2	12.0	9.9	12.0	10.9
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"				Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favourable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	10.1	14.3	7.7	11.5	10.2	17.3	6.8	17.6	16.0	5.6	17.2	8.9	14.6	23.7	7.6	8.7	11.5	7.1	13.3	24.4	7.9	11.6	7.6	7.4	5.2	7.5	9.0	10.9	8.4	6.8	7.5	8.5	3.1	9.4	9.3	5.5	8.7	11.1	12.3	13.0	9.8	21.6	9.0	7.6	7.1	9.9	7.0	7.2	8.0	9.6	5.3	10.8	10.0	9.8	2.8	3.9	8.5	3.1	1.2	6.5	2.2	4.0	8.3	2.6	13.0	7.1	3.7	5.7	7.2	5.5	8.4	5.3	7.1	8.4	6.1	3.3	5.6	19.2	3.5	5.4	1.3	5.6	5.1	4.4	16.1	5.2	7.9	4.9	10.1	5.2	4.3	7.5	3.9	5.7	6.4	2.6	4.5	10.6	4.9	10.3	5.9	12.0	10.2	7.6	10.0	4.4	7.8	8.2	5.8	8.0	12.9	4.5	9.2	5.4	5.7	5.4	6.2	9.1	5.5	3.5	5.0	5.6	7.7	4.0	6.4	8.5	2.6	2.4	3.0	3.1	6.5	2.3	2.2	3.9	2.9	2.8	2.2	1.3	4.8	1.2	1.7	3.9	1.9	2.2	7.7	10.2	17.6	16.0	7.9	11.6	9.0	10.9	9.4	7.2
MIIP	"FLJ12438, IIp45"	ENSG00000116691	"Migration and invasion inhibitory protein"	Q5JXC2	1	12019466-12032045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"HDLM-2: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044948	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044948: AB_10795887"	"unprognostic (1.36e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (8.26e-7)"	"unprognostic (8.02e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	13.2	9.4	12.2	17.0	17.3	53.4	10.8	13.7	15.3	11.1	11.4	11.9	11.6	11.0	16.5	8.8	11.1	13.0	8.9	13.3	12.9	10.1	9.2	11.7	13.3	18.3	15.9	10.6	20.4	13.5	5.8	7.1	14.6	17.0	11.3	4.5	8.5	18.1	14.2	26.3	14.8	12.7	12.3	11.0	20.4	10.0	18.2	15.2	10.5	22.5	9.7	12.5	12.3	11.9	14.8	45.0	18.3	27.1	10.6	19.0	12.5	4.9	3.3	2.6	5.1	1.4	1.6	9.2	2.7	1.4	5.3	4.0	6.5	7.9	6.3	6.4	1.4	5.1	1.9	3.0	0.6	88.7	7.4	3.9	5.3	6.8	3.0	5.9	12.1	2.1	3.9	4.6	2.0	2.9	11.7	5.8	1.6	5.0	5.9	8.9	4.7	5.0	8.4	3.3	9.6	2.2	1.5	4.9	5.2	3.9	5.0	9.6	3.3	10.4	3.1	4.8	5.2	9.7	4.1	4.9	6.2	8.4	3.1	10.4	4.9	4.9	23.2	7.1	9.0	25.9	8.4	14.8	9.3	7.8	14.2	13.0	5.8	4.5	18.3	10.6	27.1	45.0	19.0	12.5	12.2	17.3	13.7	15.3	12.9	10.1	15.9	10.6	17.0	15.2
MINDY4	"C7orf67, FAM188B, FLJ22374"	ENSG00000106125	"MINDY lysine 48 deubiquitinase 4"	Q4G0A6	7	30771417-30892387	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 16.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;T-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019475, HPA030129, HPA030130"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	9.3	6.7	9.3	2.6	15.2	4.1	7.0	3.4	15.1	10.8	6.6	5.4	16.6	2.9	15.6	16.2	5.7	20.7	10.0	7.5	8.4	5.1	9.4	3.8	14.2	2.4	4.3	9.5	14.8	5.6	9.6	16.1	6.2	9.0	9.4	4.3	7.8	5.3	15.9	3.7	5.1	3.7	10.8	3.6	2.3	5.8	20.1	5.0	1.5	12.5	3.6	2.2	6.4	6.3	0.0	1.1	0.0	0.3	0.0	2.7	0.7	2.1	5.3	2.7	8.4	2.4	9.5	4.1	3.1	5.3	2.3	2.0	0.0	3.9	0.0	3.6	2.0	2.2	1.8	1.7	2.2	0.0	3.1	1.6	2.8	0.0	3.1	2.3	1.2	4.8	2.8	7.0	1.4	3.4	16.2	1.0	2.0	0.0	1.2	0.7	7.9	1.2	0.4	0.0	0.5	6.3	1.0	5.1	7.0	2.1	11.2	1.2	5.7	1.7	2.0	0.1	1.3	2.4	1.3	2.3	2.9	0.0	4.4	0.1	9.8	0.0	0.1	0.0	0.6	0.0	2.7	0.0	0.8	0.2	1.1	0.0	0.3	0.5	0.0	0.0	0.3	0.0	0.5	0.7	9.3	15.2	3.4	15.1	8.4	5.1	4.3	9.5	9.0	5.0
MIOS	"FLJ20323, MIO, Sea4"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566872-7608929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: "	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favourable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	9.9	7.8	6.7	14.4	9.5	10.3	9.6	11.7	10.3	9.9	7.0	7.3	10.3	5.5	8.8	8.7	17.1	8.1	6.4	8.0	7.3	5.6	12.0	11.2	7.4	13.9	5.7	7.2	9.0	16.2	24.6	14.9	11.0	16.8	14.7	8.7	10.9	12.3	14.3	67.7	15.3	8.9	8.0	8.8	15.2	10.6	11.9	7.8	14.0	6.8	14.6	19.0	9.3	12.2	10.5	8.3	8.9	11.0	6.4	7.5	4.2	19.1	8.6	10.4	12.4	8.2	17.6	8.7	15.1	12.0	9.6	9.7	10.6	7.5	16.9	4.7	8.9	17.4	10.5	11.0	12.8	6.8	9.2	4.2	10.3	7.0	11.5	18.1	4.8	14.6	13.9	8.5	21.6	8.6	21.1	13.9	40.6	13.3	4.0	8.3	21.0	9.2	12.6	15.9	16.2	8.7	9.8	10.9	17.7	7.9	22.9	8.9	12.5	16.4	7.4	15.0	16.1	8.3	12.7	12.5	13.7	15.2	13.1	10.6	17.4	0.0	5.9	8.9	5.1	11.0	4.3	10.5	5.5	4.7	8.3	9.5	7.5	5.8	0.6	6.4	5.3	5.0	5.4	4.2	6.7	9.5	11.7	10.3	7.3	5.6	5.7	7.2	16.8	7.8
MIPOL1	CCDC193	ENSG00000151338	"Mirror-image polydactyly 1"	Q8TD10	14	37197913-37552361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002893, HPA050179"	Enhanced		Approved	Cytosol				Cytosol		"HPA002893: AB_1079386, HPA050179: "	"unprognostic (3.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.61e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.85e-2)"	5.8	6.1	8.8	4.5	8.4	1.5	8.6	2.1	11.1	14.0	5.7	1.4	7.8	3.0	9.3	5.1	7.4	7.6	7.0	7.0	8.1	3.9	8.9	4.2	5.3	1.1	4.6	8.4	13.2	8.7	12.6	24.4	3.2	6.6	13.7	4.7	4.6	8.0	9.1	10.1	4.2	3.2	13.7	7.6	2.7	7.5	14.7	8.0	0.0	11.2	5.4	1.7	8.7	15.8	0.8	0.8	4.2	0.3	0.5	0.5	0.3	3.9	1.7	0.6	5.6	4.2	6.9	0.0	3.6	2.4	3.1	4.6	2.2	2.4	0.0	3.6	3.0	4.6	0.0	4.9	4.3	0.0	5.9	0.0	2.9	9.5	2.7	0.0	0.1	4.4	5.2	0.8	10.0	19.2	7.6	0.1	4.6	4.0	0.0	0.0	2.4	12.5	0.0	0.6	0.0	4.5	4.5	4.8	0.0	4.6	4.1	4.2	5.0	0.0	10.0	0.0	3.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	7.2	1.1	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.2	0.1	0.8	0.4	0.3	4.2	0.5	0.3	0.8	0.4	0.3	8.8	8.4	2.1	11.1	8.1	3.9	4.6	8.4	6.6	8.0
MIS18A	"B28, C21orf45, C21orf46, FASP1, hMis18alpha"	ENSG00000159055	"MIS18 kinetochore protein A"	Q9NYP9	21	32268219-32279069	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018286, HPA020585"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA018286: AB_1845693, HPA020585: AB_1845694"	"unprognostic (1.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.28e-1)"	5.5	7.5	7.8	6.6	10.7	13.8	7.4	16.4	8.3	6.1	8.9	5.4	1.9	7.9	6.6	6.3	11.4	5.6	5.3	3.9	6.8	4.7	6.7	5.7	3.7	9.7	6.8	9.3	9.8	5.8	3.3	4.3	7.1	6.6	5.5	10.6	4.4	6.0	4.1	4.0	7.8	8.5	7.7	6.2	7.3	6.1	26.6	5.4	19.3	3.9	6.8	11.3	5.3	6.5	18.5	13.2	8.2	11.7	10.4	15.5	6.4	20.9	5.2	15.1	14.5	2.3	4.0	23.2	11.1	5.7	10.9	9.5	10.4	11.7	23.0	8.2	4.2	7.1	14.8	8.4	13.1	13.1	16.5	26.3	5.5	13.3	1.5	22.5	8.9	1.7	3.7	9.1	6.6	7.6	30.6	19.4	10.6	14.3	25.7	20.5	31.2	15.4	22.5	22.6	21.4	7.5	7.2	18.2	8.9	16.9	14.4	10.3	17.4	13.8	4.4	13.7	25.4	10.6	11.3	10.5	16.6	28.9	8.7	36.2	12.4	2.4	5.3	8.2	10.2	6.8	10.2	18.2	11.2	11.7	4.9	18.5	15.5	11.5	1.7	10.4	11.7	13.2	14.6	6.4	7.8	10.7	16.4	8.3	6.8	4.7	6.8	9.3	6.6	5.4
MIS18BP1	"C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1"	ENSG00000129534	"MIS18 binding protein 1"	Q6P0N0	14	45203190-45253540	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA006504	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA006504: AB_1078317"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (3.83e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-1)"	10.3	5.2	5.1	22.5	5.7	26.3	14.1	1.8	5.7	9.0	11.8	2.3	7.6	6.0	9.8	9.5	10.2	8.6	5.7	5.3	5.1	2.8	5.0	4.3	14.3	23.9	4.5	4.1	12.5	7.1	1.8	5.2	9.5	6.7	7.9	7.6	1.9	12.5	10.2	3.0	8.4	10.7	7.3	10.2	22.5	6.9	9.5	3.1	38.4	7.1	8.2	15.5	8.2	7.7	13.1	14.7	23.6	22.6	4.5	4.8	4.0	20.6	7.8	16.2	7.1	5.0	7.2	12.0	14.4	7.6	12.0	14.9	4.1	20.1	28.6	6.3	7.1	14.5	9.5	7.2	22.6	15.1	6.0	17.1	9.6	5.3	3.3	39.4	16.0	5.1	3.0	7.1	6.7	14.6	7.5	6.8	11.6	7.6	16.4	17.4	12.3	9.8	19.7	6.6	11.0	6.1	8.6	11.4	5.0	5.8	9.8	5.2	11.7	22.6	7.9	6.4	19.5	7.8	6.3	6.1	8.1	13.3	3.6	16.5	8.9	23.6	14.2	16.2	3.9	13.2	4.1	13.1	3.6	3.2	9.6	12.9	2.4	2.5	8.5	4.5	22.6	14.7	4.8	4.0	5.1	5.7	1.8	5.7	5.1	2.8	4.5	4.1	6.7	3.1
MKL1	"BSAC, KIAA1438, MAL, MKL, MRTF-A"	ENSG00000196588	"Megakaryoblastic leukemia (translocation) 1"	Q969V6	22	40410281-40636702	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Actin-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 50.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 26.4;granulocytes: 50.9;monocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030782	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030782: AB_10600930"	"unprognostic (7.90e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavourable (1.58e-7)"	"unprognostic (9.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.98e-1)"	18.1	11.1	15.4	25.4	19.1	69.2	15.8	16.2	26.1	17.6	14.2	13.5	10.1	11.3	27.6	12.9	12.3	17.5	13.2	16.3	14.2	11.1	11.3	8.9	17.4	25.6	11.8	16.6	16.9	14.5	10.2	10.5	18.9	12.6	14.2	9.4	13.3	16.9	15.7	14.3	18.0	13.6	15.7	11.0	23.9	14.3	25.4	10.8	28.2	17.3	9.0	25.5	15.5	14.6	4.9	26.4	50.9	15.0	3.8	5.6	7.5	10.7	14.6	6.3	7.5	8.0	6.1	12.4	10.5	6.8	9.7	9.4	6.8	3.3	11.5	4.3	11.0	14.2	5.3	12.9	6.3	12.7	9.3	19.0	16.3	10.1	7.9	22.0	37.5	6.6	15.6	9.4	6.5	7.1	5.3	5.2	4.6	10.5	8.6	24.7	5.0	5.1	14.0	7.1	5.8	7.7	8.1	3.5	3.8	17.2	8.7	6.3	5.8	24.9	11.6	6.6	17.7	8.7	9.0	7.0	6.2	16.5	5.4	11.1	12.7	12.0	15.0	50.9	4.4	11.6	4.1	3.2	4.0	3.4	17.8	4.9	5.6	4.7	14.5	3.8	15.0	26.4	5.2	7.5	15.4	19.1	16.2	26.1	14.2	11.1	11.8	16.6	12.6	10.8
MKLN1	TWA2	ENSG00000128585	"Muskelin 1"	Q9UL63	7	131110096-131496636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022817, HPA041810"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"HPA022817: AB_1853974, HPA041810: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.32e-1)"	22.7	21.1	22.1	15.7	27.6	12.8	34.4	27.5	25.8	18.8	15.0	11.7	26.6	14.2	19.3	19.8	11.8	19.6	11.6	16.7	21.9	14.4	23.0	22.8	19.3	18.7	26.6	17.5	23.2	12.6	20.9	28.8	18.2	25.0	26.4	12.2	10.0	18.1	28.9	28.6	15.4	13.5	20.8	30.3	13.1	14.4	16.9	24.0	14.7	18.0	9.9	12.0	17.8	21.5	2.3	1.6	12.4	1.6	0.9	2.3	0.5	8.3	9.6	8.4	8.5	20.8	18.8	5.1	8.1	18.8	9.2	11.9	4.4	7.2	8.7	5.5	10.0	5.8	8.8	7.7	15.1	8.4	4.3	3.7	7.5	5.1	10.0	6.1	5.4	11.2	5.4	12.5	6.2	8.4	13.5	6.3	11.4	3.1	7.1	6.6	9.6	5.1	4.5	9.9	6.0	10.3	4.9	4.4	9.4	15.8	15.8	7.3	3.1	7.7	8.5	7.2	4.1	13.1	6.5	15.4	5.7	14.9	24.8	7.4	10.5	1.2	1.0	1.7	1.6	1.1	1.2	1.2	1.5	1.3	1.0	2.3	2.3	1.9	12.4	0.9	1.6	1.6	0.9	0.5	22.1	27.6	27.5	25.8	21.9	14.4	26.6	17.5	25.0	24.0
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453040-140479569	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	16.8	17.6	26.8	20.8	28.8	69.9	20.1	37.2	32.6	20.4	39.6	16.1	19.7	28.4	20.1	18.6	23.3	22.2	22.4	38.5	24.9	29.8	20.6	17.5	23.6	18.3	25.7	23.3	24.9	27.3	28.2	21.5	31.7	29.4	21.0	33.7	19.4	24.8	23.1	38.5	24.4	26.6	26.3	20.5	22.5	21.7	95.4	20.2	21.0	23.6	18.8	22.3	25.3	36.4	13.1	7.5	39.3	10.5	12.8	17.8	6.4	27.9	21.6	16.9	25.0	26.8	23.5	23.9	19.3	25.1	15.2	17.6	8.8	29.5	20.3	30.3	18.8	13.6	19.0	21.2	19.3	40.2	16.5	21.1	13.0	16.3	21.6	18.0	32.7	23.4	32.0	17.1	16.2	15.1	16.6	25.7	14.6	24.1	21.1	32.4	43.4	16.0	15.3	14.5	31.1	24.4	32.4	23.4	24.2	24.2	32.8	34.5	16.1	15.7	21.4	10.7	8.5	26.1	17.6	61.3	44.9	17.8	30.6	28.4	22.0	19.4	9.2	39.3	6.7	8.7	8.0	13.1	13.0	10.1	7.5	10.9	17.8	11.3	18.1	12.8	10.5	2.5	14.0	6.4	26.8	28.8	37.2	32.6	24.9	29.8	25.7	23.3	29.4	20.2
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557014-12583713	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favourable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	13.7	10.4	15.1	11.1	18.3	16.4	11.6	29.3	19.5	13.7	12.7	12.4	16.1	12.5	15.2	12.3	16.2	13.1	10.9	26.3	14.0	15.1	13.7	12.5	12.1	12.6	15.2	14.8	20.8	26.6	17.3	11.9	14.4	16.0	11.3	11.5	13.2	12.8	13.1	24.5	12.8	10.9	15.9	16.2	10.1	11.7	46.1	14.7	15.4	18.2	17.0	13.7	13.0	12.6	21.3	19.0	30.0	20.3	25.3	26.2	18.7	10.7	12.4	14.8	11.1	23.2	22.6	28.7	16.6	17.8	21.2	17.8	12.0	10.7	15.2	9.5	18.3	6.6	19.3	16.3	18.9	17.2	16.2	21.7	14.2	16.0	26.7	21.3	9.9	25.1	15.2	24.6	15.6	17.4	20.2	21.6	18.2	15.1	26.1	11.1	9.9	21.8	25.2	14.3	17.1	14.9	14.2	8.7	14.7	14.4	7.4	14.8	16.7	18.9	17.5	14.5	14.3	17.2	22.5	16.4	33.6	32.7	15.7	25.5	21.8	18.9	17.2	30.0	21.5	15.6	26.2	21.3	22.1	22.0	19.0	16.4	23.9	22.3	15.0	25.3	20.3	15.1	23.4	18.7	15.1	18.3	29.3	19.2	14.0	15.1	15.2	14.8	16.0	14.7
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565678-23630075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell line enhanced"	"Detected in many"		"K-562: 17.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.7"	"Low region specificity"	"Detected in many"							HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	1.0	0.7	5.1	1.2	10.4	4.0	1.2	1.0	11.1	0.5	1.1	8.4	0.0	1.3	1.3	3.2	5.6	0.9	0.8	0.8	6.4	3.4	1.1	0.7	1.0	1.9	14.4	3.0	1.2	1.7	0.5	3.8	8.5	5.1	1.2	0.8	3.1	5.2	1.0	1.4	1.2	1.9	0.8	8.2	1.5	0.9	5.7	13.3	5.0	0.9	1.1	1.7	0.7	0.6	1.0	0.9	1.3	0.5	0.4	5.7	0.7	4.7	3.4	3.0	3.1	0.0	0.0	7.1	0.3	0.0	2.9	2.0	8.5	0.0	0.2	0.1	0.0	8.2	1.3	0.0	0.7	0.0	0.3	6.8	9.1	0.3	0.2	8.0	6.1	0.1	0.0	6.0	0.0	0.0	17.5	7.5	0.8	0.0	8.4	3.5	0.0	10.4	6.0	1.1	4.2	0.0	0.1	0.7	2.4	0.0	3.4	0.0	2.7	2.4	0.1	8.0	6.7	0.4	5.6	9.4	11.5	5.6	4.7	0.1	0.1	1.3	0.5	0.4	1.8	0.2	1.0	1.0	0.6	1.4	0.2	0.9	2.0	5.7	1.3	0.4	0.3	0.9	0.4	0.7	5.1	10.4	1.0	6.8	6.4	3.4	14.4	3.0	5.1	13.3
MLF1		ENSG00000178053	"Myeloid leukemia factor 1"	P58340	3	158571163-158607252	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1"	"Cell line enhanced"	"Detected in many"		"A-431: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in single"	12	"T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069479			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA069479: "	"unprognostic (6.49e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (1.72e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (5.54e-4)"	"unprognostic (9.34e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.36e-2)"	3.5	2.6	6.0	1.8	11.9	0.9	5.3	3.4	7.1	3.1	2.7	6.5	0.5	0.8	4.9	5.6	3.5	18.3	4.9	41.4	6.3	6.3	5.7	1.2	5.2	1.0	4.9	6.3	6.2	3.1	5.2	10.4	1.0	20.1	2.0	1.7	2.8	2.2	1.6	53.6	1.8	1.3	4.5	4.7	1.2	1.9	101.1	5.7	0.0	5.3	18.9	1.4	4.2	1.5	0.6	0.3	0.4	0.3	0.8	10.4	2.3	34.1	4.5	11.5	0.0	6.1	7.2	3.4	3.5	3.4	13.0	11.8	0.0	19.5	0.0	13.5	6.1	6.6	0.1	6.0	17.3	0.0	7.5	2.0	3.3	0.3	4.2	0.0	2.6	4.4	8.8	6.2	3.4	3.0	2.5	0.0	8.5	5.0	0.0	0.1	2.7	10.0	0.0	6.4	0.4	9.9	2.4	14.9	8.8	16.1	5.7	16.9	16.4	3.4	1.1	12.1	12.4	14.3	13.7	6.1	3.8	0.0	8.7	0.0	8.7	0.0	0.0	0.0	3.6	0.0	1.6	0.6	8.3	8.7	0.3	0.3	2.1	4.4	0.4	0.8	0.3	0.2	10.4	2.3	6.0	11.9	3.4	7.1	6.3	6.3	4.9	6.3	20.1	5.7
MLF2	NTN4	ENSG00000089693	"Myeloid leukemia factor 2"	Q15773	12	6747996-6767475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010811, HPA010859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA010811: AB_1079389, HPA010859: AB_1079388"	"unprognostic (1.65e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.42e-1)"	"unprognostic (9.88e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.63e-1)"	31.4	45.6	55.8	23.3	65.4	36.9	24.9	50.5	100.5	28.6	30.9	44.0	23.9	36.5	32.1	30.5	39.3	31.7	28.6	44.1	54.4	47.2	37.9	77.4	24.8	21.5	40.2	42.5	28.3	33.4	43.3	31.1	32.5	44.8	38.4	27.6	28.2	43.1	36.7	45.3	33.6	35.1	35.9	33.7	21.8	27.7	21.0	30.7	26.0	36.3	28.9	29.4	29.3	23.6	17.0	38.9	86.7	20.1	11.8	14.8	16.9	39.0	64.6	33.2	58.5	31.1	31.7	51.1	38.4	46.2	66.2	58.1	62.4	38.8	28.2	10.2	50.0	32.8	40.9	55.6	41.2	44.4	37.9	19.9	34.2	35.7	34.4	21.1	27.5	29.7	45.4	51.1	39.2	26.9	25.0	11.8	46.0	55.4	29.0	32.7	107.4	22.3	18.6	30.6	25.0	55.2	49.3	21.2	42.0	34.7	61.4	37.1	17.8	35.0	26.5	39.5	52.6	41.6	56.1	14.3	16.2	37.4	52.7	18.4	46.4	35.4	20.1	73.9	14.8	18.0	14.3	15.3	11.5	13.9	22.6	17.0	12.2	13.5	86.7	11.8	19.5	38.9	11.2	16.9	55.8	65.4	50.5	100.5	54.4	47.2	40.2	42.5	44.8	30.7
MLLT11	AF1Q	ENSG00000213190	"MLLT11, transcription factor 7 cofactor"	Q13015	1	151057758-151068497	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.1"	"Cell line enhanced"	"Detected in many"		"AF22: 38.4;EFO-21: 29.2;SH-SY5Y: 42.1;U-698: 35.8"	"Cancer enhanced"	"Detected in all"		"glioma: 29.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000540	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA000540: "	"unprognostic (2.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (4.26e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (4.25e-12)"	"unprognostic (5.66e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-3)"	1.9	7.5	13.6	3.4	9.1	1.1	1.2	16.3	42.1	1.9	2.1	5.1	1.2	0.8	3.7	1.2	1.3	0.8	11.1	11.8	11.3	16.4	1.2	1.2	5.3	2.3	10.3	1.2	4.2	1.3	8.4	1.8	1.2	3.2	1.3	1.1	1.2	1.5	1.2	2.6	1.0	2.0	4.2	5.8	2.1	0.9	1.2	1.2	2.0	1.2	1.2	2.6	3.2	1.2	2.4	1.0	6.5	1.0	4.2	9.2	2.8	1.2	5.2	38.4	6.0	0.6	1.0	0.6	2.4	2.6	2.3	4.2	0.5	2.5	1.9	29.2	1.8	1.5	9.2	2.2	1.3	11.2	2.5	5.0	3.8	0.1	1.2	0.3	0.8	1.7	0.3	12.7	0.5	16.9	5.3	0.9	7.4	0.4	17.6	3.3	16.7	0.8	16.8	5.1	0.1	4.3	1.1	23.1	42.1	0.2	0.4	1.2	1.4	0.6	11.8	5.0	5.5	1.8	4.3	0.9	0.8	35.8	12.4	0.3	9.3	1.6	0.6	1.6	5.9	0.7	2.7	2.4	3.9	6.0	0.8	2.1	5.3	9.2	6.5	4.2	1.0	1.0	3.6	2.8	13.6	9.1	16.3	21.0	11.3	16.4	10.3	1.2	3.2	1.2
MLLT3	"AF-9, AF9, YEATS3"	ENSG00000171843	"MLLT3, super elongation complex subunit"	P42568	9	20341665-20622543	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.8;T-cells: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001824	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA001824: AB_1079394"	"unprognostic (3.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-1)"	8.6	17.3	18.0	10.4	25.8	19.7	11.4	34.6	20.3	12.3	20.9	7.2	10.6	7.2	13.6	7.9	10.2	11.5	12.7	8.6	18.0	12.8	10.1	2.1	10.7	9.1	14.8	13.8	10.5	4.6	18.3	24.7	10.3	13.2	11.7	22.8	7.4	21.3	12.1	9.1	7.9	12.3	13.5	12.0	5.9	15.3	3.6	21.4	22.1	22.5	6.1	6.5	12.9	10.4	1.4	0.7	1.6	0.3	3.8	14.4	2.8	2.5	7.1	2.5	2.9	5.9	3.7	1.6	6.7	11.3	3.0	3.4	6.9	2.4	9.8	3.6	3.1	1.3	2.4	11.6	2.7	20.2	6.2	72.2	21.9	3.2	4.3	1.3	6.1	2.7	4.5	1.0	7.3	3.0	0.0	12.7	6.3	1.9	7.0	4.2	1.6	2.1	0.0	4.6	2.6	13.9	3.8	8.2	2.9	5.4	2.7	2.9	2.8	1.9	1.9	0.0	1.7	1.7	2.3	5.7	5.2	4.0	0.0	3.1	1.4	1.6	0.3	0.5	3.9	0.2	3.6	0.5	7.0	5.3	0.7	1.4	14.4	8.3	0.1	3.8	0.3	0.4	7.3	2.8	18.0	25.8	34.6	20.3	18.0	12.8	14.8	13.8	13.2	21.4
MLX	"bHLHd13, MAD7, MXD7, TCFL4"	ENSG00000108788	"MLX, MAX dimerization protein"	Q9UH92	17	42567068-42573239	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025329, HPA052766, HPA064438"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB025329: , HPA052766: , HPA064438: "	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.55e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.25e-1)"	21.3	19.2	10.4	12.6	11.9	8.3	22.5	10.3	14.3	12.3	32.2	10.8	15.4	27.5	11.0	15.1	18.8	10.5	19.2	38.1	9.8	9.8	23.5	34.7	19.0	18.6	11.3	6.6	10.4	36.8	8.5	13.0	13.7	9.4	13.4	23.1	11.6	18.5	14.8	43.3	15.6	42.5	12.1	10.2	18.7	20.6	7.4	8.9	20.3	23.5	24.9	19.7	16.5	13.1	14.6	26.3	34.7	33.5	12.8	18.2	23.0	16.0	18.6	14.6	14.8	22.3	25.8	10.1	24.2	21.5	26.1	23.7	16.8	16.7	19.4	17.0	20.5	24.3	26.6	15.6	23.0	15.3	25.0	20.0	13.4	18.6	26.3	26.8	28.9	22.3	17.5	20.9	19.2	19.2	21.8	17.4	29.7	21.4	37.6	13.2	10.3	16.9	17.0	30.4	20.7	21.1	19.9	22.8	11.3	10.7	13.9	27.1	28.6	31.8	13.6	23.3	15.1	25.4	35.6	17.7	20.0	18.2	26.0	17.2	27.3	14.2	25.0	34.7	14.3	30.8	15.8	14.6	14.8	14.3	26.3	11.8	13.1	13.1	32.3	12.8	33.5	14.1	18.2	23.0	10.4	11.9	10.3	14.3	9.8	9.8	11.3	6.6	9.4	8.9
MMAA	cblA	ENSG00000151611	"Methylmalonic aciduria (cobalamin deficiency) cblA type"	Q8IVH4	4	145618263-145660035	"Disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037361	Approved		Approved	Cytosol				Cytosol		"HPA037361: AB_10672107"	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favourable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (3.21e-4)"	1.7	3.3	1.4	1.4	1.7	0.5	2.6	2.3	1.5	1.5	3.1			4.2	1.4	2.6	2.3	1.5	2.0	1.8	1.2	1.5	4.3	14.7	1.7	1.3	1.4		1.3	2.5	1.4	0.9	1.1		1.3	3.5		2.0	1.3	5.2	2.3	3.4	1.2	1.2	1.6	1.9	2.0			2.2		1.7	1.6	1.6	4.2	4.2	4.1	10.0	5.8	7.8	2.9	2.3	1.3	4.3	2.2	10.4	10.4	0.9	5.9	4.7	2.4	1.4	1.8	4.7	7.9	2.0	3.9	1.9	2.1	4.5	1.6	5.6	1.0	3.5	0.9	1.4	7.5	4.2	3.2	6.5	6.4	2.5	6.6	7.4	1.0	5.4	5.1	2.9	7.6	1.6	1.6	2.2	3.6	1.5	1.5	14.2	1.8	2.1	1.7	3.4	7.2	3.2	3.7	2.0	6.1	3.8	1.6	4.6	1.5	3.0	1.9	3.6	4.0	4.2	3.4	4.1	3.8	3.2	6.3	8.4	5.8	4.2	7.8	6.4	3.6	3.3	5.9	7.8	0.0	5.8	10.0	4.2	6.1	2.9										
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria"	Q9Y4U1	1	45500053-45513382	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	3.5	7.4	5.8	3.3	10.2	2.2	6.1	3.6	12.2	5.4	6.3	11.8	3.2	5.6	4.1	5.6	4.0	6.2	2.9	11.1	6.2	5.1	7.6	30.1	2.7	3.1	7.3	6.9	6.4	9.8	9.5	5.4	2.9	8.5	3.9	7.6	4.0	11.9	7.5	14.7	3.8	4.1	4.2	6.7	3.6	4.5	7.3	5.7	4.1	4.4	3.7	3.6	3.9	3.1	2.1	3.6	5.0	6.1	2.6	3.9	1.1	6.8	3.6	6.1	9.3	5.8	3.5	7.6	5.3	3.6	9.7	8.8	7.3	4.3	10.7	7.0	4.4	5.7	11.2	12.7	8.9	2.9	10.3	8.3	5.9	8.2	5.5	11.8	3.0	5.0	7.2	10.7	11.8	4.6	9.4	6.1	7.4	7.3	7.9	3.8	10.0	8.3	9.8	2.5	11.9	5.7	5.4	9.8	5.0	8.0	13.3	17.4	7.7	4.3	2.1	6.9	9.4	7.7	2.9	9.2	7.4	6.3	5.0	5.7	6.3	5.0	1.6	1.6	1.7	2.4	2.8	2.0	2.0	1.4	1.7	2.1	3.9	2.0	3.5	2.6	6.1	3.6	1.4	1.1	5.8	10.2	3.6	12.2	6.2	5.1	7.3	6.9	8.5	5.7
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770503-102780628	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"endometrium 1: 89.4"	"Cell line enhanced"	"Detected in some"		"BJ: 12.3;HUVEC TERT2: 15.8;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 102.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favourable (7.12e-4)"	0.1	0.1	0.0	2.6	0.2	0.1	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.4	89.4	0.1	0.2	0.1	0.5	0.1	0.0	0.1	0.1	3.6	11.0	0.1	0.0	0.0	0.5	0.3	0.1	0.9	19.8	2.8	3.2	0.2	0.0	2.9	0.1	0.1	0.1	0.7	0.1	0.0	0.2	3.3	0.5	0.0	1.2	0.1	0.0	1.9	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	12.3	0.7	0.1	0.1	0.3	0.0	0.0	3.6	1.9	2.8	0.0	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	15.8	0.7	0.0	0.0	0.0	0.0	0.3	2.9	1.7	0.0	0.0	0.0	0.0	0.7	5.0	0.0	2.5	0.0	0.0	0.0	0.0	2.0	3.8	1.2	0.4	0.5	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	2.8	0.0
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836557-22849027	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 98.0;HHSteC: 92.7;HSkMC: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"			570000	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: "	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	60.9	10.5	2.4	16.6	4.7	0.2	64.2	2.2	3.2	56.3	35.0	8.2	12.7	12.0	53.1	24.1	47.0	21.9	39.6	17.5	3.4	1.8	16.8	9.0	29.8	16.9	5.8	2.9	39.3	11.2	34.4	4.7	73.5	16.4	39.1	11.3	27.1	24.4	16.7	20.4	37.0	22.9	28.5	20.7	22.5	18.2	26.3	4.6	5.4	22.3	14.6	16.7	52.5	53.9	0.1	0.7	0.0	0.7	0.0	0.0	0.1	7.9	0.1	2.4	0.1	98.0	62.3	45.0	25.1	50.6	7.6	13.6	2.3	29.9	0.1	14.0	26.4	20.3	0.0	26.1	9.8	0.1	0.1	3.7	0.1	0.5	92.7	0.0	0.1	94.2	15.8	31.7	27.2	46.0	0.1	0.2	17.9	0.1	0.0	9.0	1.5	4.3	0.3	8.6	0.0	6.9	13.7	0.0	0.0	16.4	0.0	54.4	0.1	8.1	40.7	61.9	5.3	18.0	28.6	0.1	0.1	0.1	37.7	0.0	35.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	4.7	2.2	3.2	3.4	1.8	5.8	2.9	16.4	4.6
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025566-58046901	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 36.8;Hep G2: 19.1;SK-BR-3: 18.5;WM-115: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: "	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favourable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (3.08e-4)"	5.9	2.3	2.0	5.5	3.0	0.1	7.7	3.7	7.2	3.3	19.5	4.2	16.3	22.6	2.9	1.7	2.5	3.6	15.9	17.6	2.3	3.7	8.4	26.4	6.1	2.0	2.5	2.2	2.1	10.3	7.3	5.2	28.5	10.4	3.6	8.2	9.5	4.7	14.7	3.4	2.3	43.2	3.4	3.4	5.2	14.7	28.0	2.1	1.1	26.8	2.5	2.2	3.3	4.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.7	4.3	2.3	11.8	2.4	0.1	36.8	0.5	0.3	2.1	0.4	3.4	14.8	0.0	7.0	0.6	8.1	1.9	1.7	0.6	0.0	3.9	0.0	1.9	19.1	3.1	0.1	7.7	1.2	3.0	0.3	0.9	1.4	4.7	0.0	0.7	2.8	0.2	0.9	6.7	1.2	2.8	0.3	3.1	6.5	2.1	0.6	4.1	7.7	18.5	3.5	2.0	3.1	1.3	0.1	3.7	1.4	0.5	0.0	0.0	0.1	0.7	0.9	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	3.0	3.7	7.2	2.3	3.7	2.5	2.2	10.4	2.1
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032009-88328025	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.0;HUVEC TERT2: 8.7;SH-SY5Y: 11.1;U-138 MG: 9.5;WM-115: 19.5"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"			Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	2.4	1.3	11.0	1.4	6.8	0.5	4.9	8.3	15.9	5.3	2.2	2.9	0.7	0.8	4.9	2.1	1.7	2.1	7.3	2.7	8.7	6.9	0.8	0.9	1.0	1.0	5.5	9.1	3.3	2.1	1.5	1.7	3.0	6.3	3.2	1.7	0.6	1.2	2.4	0.7	1.1	1.3	4.0	4.6	1.5	1.4	1.5	5.5	0.0	3.2	0.7	1.0	2.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.4	20.0	0.7	1.4	0.0	7.3	1.0	2.1	1.2	0.0	0.0	0.0	0.0	3.3	0.0	3.9	0.0	2.5	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.3	1.0	0.0	3.0	0.9	8.7	0.0	0.7	1.1	0.0	0.0	0.0	1.1	2.0	0.2	0.4	0.0	0.4	0.0	0.1	11.1	0.0	0.0	0.1	0.8	0.0	4.8	9.5	5.4	0.1	2.7	0.0	0.0	0.0	3.8	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	6.8	8.3	14.1	8.7	6.9	5.5	9.1	6.3	5.5
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell line enriched"	"Detected in some"	12	"NB-4: 87.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"		57000000	Cytosol		"CAB000348: , CAB068199: , CAB068200: , CAB068201: , HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	87.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	2.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010651	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 43.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;EFO-21: 11.1;HEK 293: 8.8;RPMI-8226: 24.2;SCLC-21H: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: "	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.1	6.0	0.2	0.1	9.0	0.1	0.1	0.3	0.0	7.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	43.3	0.0	3.2	0.1	0.2	0.8	3.7	0.1	1.9	0.1	0.1	0.1	7.3	0.1	0.2	0.1	2.7	1.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	3.8	0.0	11.5	0.0	0.0	8.6	0.0	0.0	0.1	0.0	5.0	1.6	0.9	11.1	0.0	0.2	2.0	1.5	0.9	1.4	8.8	0.0	0.7	2.3	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	3.6	1.9	0.0	6.4	0.6	0.1	0.0	0.7	0.0	1.7	24.2	4.3	0.4	13.0	0.0	1.6	1.4	0.2	3.6	2.9	0.0	0.0	0.0	0.0	0.0	3.6	1.8	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: , HPA071690: "	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavourable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	32.2	18.0	12.2	41.5	16.3	36.6	36.2	10.8	11.3	24.5	21.5	12.6	16.1	19.7	27.1	19.8	28.9	22.0	19.9	20.9	11.0	10.4	34.7	21.4	28.4	65.1	14.7	6.9	28.4	12.6	13.8	11.5	20.9	15.9	21.0	20.7	14.3	18.1	18.8	12.8	22.9	30.2	31.6	21.8	51.1	18.7	17.9	12.8	57.0	25.4	16.9	42.4	29.2	24.6	22.3	22.2	32.3	42.8	20.6	15.9	25.2	20.7	11.9	15.0	16.1	24.7	27.0	17.7	16.7	22.5	21.8	21.6	16.2	15.1	42.6	14.3	20.9	17.4	19.1	19.1	33.2	29.9	11.4	38.4	8.2	17.1	19.7	33.2	62.1	22.8	18.7	17.4	14.8	22.8	16.4	15.8	21.1	11.2	41.6	28.3	13.9	9.8	28.7	51.5	22.6	18.7	26.0	7.6	9.9	23.7	17.6	15.2	14.0	15.8	21.6	28.4	15.0	19.8	26.4	11.8	10.4	32.7	19.1	28.4	15.1	30.8	24.0	32.3	14.8	39.0	15.9	22.3	13.3	15.7	22.2	17.2	12.3	14.6	24.0	20.6	42.8	15.5	13.4	25.2	12.2	16.3	10.8	11.3	11.0	10.4	14.7	6.9	15.9	12.8
MOB1B	"MOB4A, MOBKL1A"	ENSG00000173542	"MOB kinase activator 1B"	Q7L9L4	4	70902326-71022449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: , HPA071690: "	"unprognostic (1.05e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-3)"	9.8	10.1	15.7	17.8	13.0	30.9	11.1	10.4	20.0	10.5	9.7	17.3	4.8	6.1	13.9	8.6	9.9	11.8	9.1	11.1	19.8	10.6	29.3	8.3	20.6	13.4	15.5	18.6	13.8	11.0	18.0	10.9	11.2	12.8	12.7	8.5	8.0	11.1	8.6	10.8	11.2	8.4	14.1	17.4	10.6	10.1	7.6	15.4	52.3	14.4	8.2	12.8	10.8	9.8	0.6	5.3	2.5	3.1	0.7	1.4	1.2	3.8	3.1	11.9	9.7	6.5	8.3	9.8	11.7	6.4	6.6	5.8	4.1	7.4	21.6	5.6	10.4	2.7	7.4	9.8	16.0	11.4	2.6	33.8	3.6	3.2	6.5	7.3	6.8	6.8	5.4	7.3	6.0	7.7	20.7	7.1	10.4	4.1	22.8	4.6	3.9	4.2	7.3	11.6	2.9	10.9	6.8	4.2	8.0	5.0	2.2	15.7	5.3	4.8	9.2	18.3	9.4	8.2	4.7	4.6	1.5	9.2	6.4	5.4	8.4	0.8	3.1	2.5	1.3	1.6	1.1	0.5	0.6	0.6	4.0	0.6	0.8	0.7	0.4	0.7	0.9	5.3	1.4	1.2	15.7	13.0	10.4	20.0	19.8	10.6	15.5	18.6	12.8	15.4
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 57.3;urinary bladder: 51.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	9.2	4.2	2.4	17.0	2.5	3.0	12.1	2.5	3.2	14.9	30.9	1.8	6.7	2.5	12.5	8.7	17.3	13.8	26.8	8.1	2.8	1.9	3.2	3.0	4.1	8.2	2.1	2.1	8.6	5.8	6.8	1.8	4.2	2.9	21.2	6.7	4.3	12.9	20.1	7.1	9.4	10.6	57.3	2.5	3.7	9.9	4.2	2.0	2.0	4.3	3.2	4.4	51.8	21.2	10.6	10.8	11.2	12.5	11.6	17.3	9.0	13.9	15.2	9.4	7.6	23.6	16.6	8.7	11.0	16.1	21.3	16.8	9.7	19.2	10.3	8.5	25.9	17.1	14.6	24.8	13.0	13.8	21.8	7.8	5.5	12.3	15.9	10.2	12.3	13.4	29.8	11.3	13.4	22.5	12.6	10.7	10.8	9.9	13.2	17.4	11.6	14.2	9.6	9.7	10.7	17.7	13.4	17.6	18.8	13.7	17.2	13.3	7.9	10.3	18.5	13.0	6.6	4.2	7.0	10.6	10.3	10.7	9.0	9.9	9.9	8.2	8.6	11.2	17.3	8.7	14.6	8.2	14.9	13.8	10.8	10.6	12.5	10.5	7.1	11.6	12.5	6.9	12.8	9.0	2.4	2.5	2.5	2.5	2.8	1.9	2.1	2.1	2.9	2.0
MOB3A	"MOB-LAK, MOB1C, MOBKL2A, moblak"	ENSG00000172081	"MOB kinase activator 3A"	Q96BX8	19	2071038-2096673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 69.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057744			Uncertain	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (2.05e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (1.33e-6)"	"unprognostic (3.40e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.16e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (5.90e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-1)"	19.6	9.5	9.8	31.9	10.0	27.4	11.9	11.1	9.2	15.5	19.2	12.7	7.7	7.7	19.9	9.2	14.3	16.7	14.1	10.6	10.0	6.9	10.7	5.7	14.9	39.6	9.4	6.4	15.6	8.2	6.7	7.0	15.9	8.8	15.3	9.2	13.4	11.6	13.1	7.9	12.0	18.2	17.0	7.6	37.3	12.5	8.3	10.0	39.3	11.7	6.7	42.2	17.1	13.1	11.6	14.5	69.3	22.0	13.0	16.5	17.1	13.8	5.7	6.8	6.5	16.2	17.9	5.3	8.7	5.6	6.0	4.8	2.2	5.0	35.7	3.2	15.1	5.9	3.7	19.4	4.8	12.5	1.9	7.7	4.0	3.0	16.0	12.1	40.2	10.5	12.8	16.4	6.9	11.2	4.0	35.9	8.6	5.5	6.2	12.3	2.1	4.1	3.8	2.0	27.7	7.4	3.5	4.3	5.8	4.4	4.7	4.8	5.0	19.7	18.9	7.3	4.0	13.5	5.1	7.1	25.2	28.2	19.6	8.2	8.7	18.0	20.6	23.9	16.5	20.8	14.2	11.6	12.3	13.6	14.5	10.7	9.4	11.8	69.3	13.0	22.0	8.3	14.7	17.1	9.8	10.0	11.1	9.2	10.0	6.9	9.4	6.4	8.8	10.0
MOB3B	"C9orf35, FLJ13204, MOB1D, MOBKL2B"	ENSG00000120162	"MOB kinase activator 3B"	Q86TA1	9	27325209-27529781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2;ovary: 29.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 10.0;HAP1: 10.2;K-562: 29.2;SK-BR-3: 12.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA057744			Uncertain	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (6.96e-3)"	"unprognostic (9.60e-2)"	"unprognostic (5.10e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"prognostic favourable (2.33e-10)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (7.99e-2)"	6.0	2.3	6.2	4.2	18.0	1.0	7.0	5.0	13.9	7.8	13.2	32.6	2.8	19.0	10.9	6.1	4.3	9.4	5.8	2.0	9.8	6.4	8.6	1.9	7.5	4.2	19.7	6.2	29.9	4.5	0.9	1.8	5.3	17.2	2.8	14.9	5.7	3.9	3.8	8.5	7.1	16.6	7.5	33.2	8.6	6.2	3.7	17.5	0.6	7.0	2.9	6.2	4.0	5.2	5.9	4.6	0.0	1.4	0.0	0.1	0.5	2.0	1.5	4.7	0.0	1.2	0.1	10.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	2.0	0.0	6.6	10.2	8.0	0.0	4.6	1.6	2.9	6.2	0.0	0.0	0.0	0.6	2.1	8.5	0.0	1.5	0.0	29.2	0.1	0.0	0.0	0.0	0.0	6.0	0.5	1.9	0.4	0.0	2.8	3.9	0.0	1.5	1.6	12.3	2.8	0.8	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.9	0.0	0.0	1.4	0.0	4.8	0.0	0.0	4.6	5.9	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.5	6.2	18.0	5.0	12.0	9.8	6.4	19.7	6.2	17.2	17.5
MOB3C	"MOB1E, MOBKL2C"	ENSG00000142961	"MOB kinase activator 3C"	Q70IA8	1	46607715-46616891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057744			Uncertain	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (1.76e-3)"	"prognostic favourable (3.16e-5)"	"unprognostic (1.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.61e-3)"	16.9	9.0	8.8	8.0	14.7	4.1	12.1	19.7	7.5	10.7	11.2	9.3	11.8	8.8	8.4	12.9	12.6	9.6	10.8	12.3	10.1	5.6	9.1	8.8	13.3	7.8	13.2	6.8	12.6	29.8	10.4	10.9	12.8	12.5	12.2	9.3	9.5	16.8	12.5	20.2	6.0	12.5	9.8	5.5	14.7	10.9	4.2	9.4	3.1	11.1	19.1	11.4	10.8	16.0	9.3	7.1	15.1	9.0	16.1	21.5	11.4	7.4	3.0	1.5	4.5	14.9	11.6	0.6	4.2	10.7	7.7	7.5	0.9	5.3	0.6	4.6	7.1	10.7	1.6	5.4	4.0	11.1	0.2	17.5	4.0	1.1	7.8	1.5	6.6	9.5	8.4	7.3	2.0	5.0	2.6	4.4	3.2	3.1	0.7	2.3	0.5	9.0	1.9	4.9	3.2	4.3	13.5	0.6	1.8	6.5	4.6	5.2	2.8	5.9	3.7	3.9	2.7	6.4	3.7	4.1	0.9	0.5	5.8	2.6	3.2	2.1	8.4	15.1	12.2	9.0	21.5	6.9	12.0	12.3	5.8	9.3	10.7	10.8	6.0	16.1	5.7	7.1	8.1	11.4	8.8	14.7	19.7	7.5	10.1	5.6	13.2	6.8	12.5	9.4
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187519-36272157	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.0;liver: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.4;hTERT-HME1: 25.1;SiHa: 26.9;SK-MEL-30: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA039412: , HPA047958: "	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavourable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	3.7	12.7	0.6	1.6	0.5	0.2	6.4	0.4	0.4	1.4	10.4	0.7	8.0	6.7	1.3	4.6	4.8	1.9	5.8	1.3	0.4	0.5	1.7	36.6	1.8	0.2	0.4	0.1	17.2	3.2	1.1	9.4	11.2	2.2	2.8	1.8	2.1	2.5	7.2	1.3	2.6	33.0	1.0	0.4	0.7	1.7	1.3	0.2	0.0	1.2	2.9	3.5	2.6	1.7	0.4	0.3	1.9	0.3	1.1	0.3	0.1	6.8	2.3	0.1	0.0	2.2	2.8	1.4	4.0	2.2	1.9	5.0	1.5	2.1	0.0	1.2	6.5	4.2	1.4	6.3	2.7	1.1	1.1	0.1	6.8	5.6	7.5	0.0	1.9	4.4	20.4	7.6	25.1	0.3	2.3	0.0	3.1	1.7	0.0	0.0	0.4	2.0	0.0	0.0	0.0	2.7	9.0	0.0	0.6	26.9	1.7	18.7	1.2	0.1	1.3	1.5	1.9	3.3	0.6	0.0	0.0	0.0	3.9	0.0	0.6	1.7	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.2	0.3	1.9	1.1	0.2	0.3	0.1	0.1	0.6	0.5	0.4	0.4	0.4	0.5	0.4	0.1	2.2	0.2
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 1.5;T-cells: 2.9"	"Low region specificity"	"Detected in all"							"HPA045783, HPA058177, HPA075505"	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA045783: AB_10960058, HPA058177: , HPA075505: "	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	26.6	9.6	4.6	5.3	7.9	0.2	27.1	5.9	8.7	6.4	17.5	10.5	5.0	15.4	10.1	8.7	6.9	7.9	8.0	18.0	6.2	2.3	17.5	34.9	19.6	9.2	9.5	6.2	9.0	10.9	4.5	6.3	30.2	7.0	6.7	5.2	11.2	5.9	7.6	19.9	7.1	13.1	8.9	7.1	3.5	6.5	4.0	7.6	0.2	15.4	5.9	3.1	9.7	7.7	0.0	0.1	0.0	0.2	1.5	2.9	0.8	0.0	1.4	5.0	8.0	13.5	5.2	10.1	5.4	9.9	7.8	7.1	26.4	0.1	0.0	5.7	5.4	0.4	6.0	6.6	6.1	0.0	5.4	0.0	0.0	8.3	8.6	0.0	2.2	9.1	2.4	5.4	3.0	6.7	5.4	0.5	7.9	3.4	10.2	0.0	4.5	2.9	0.0	3.8	0.8	4.8	5.1	4.1	5.2	0.0	3.2	4.6	3.4	1.0	10.4	7.9	6.8	5.1	2.8	0.0	1.0	0.0	0.9	0.0	2.8	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.6	0.5	0.1	0.0	2.9	2.5	0.0	1.5	0.2	0.0	0.0	0.8	4.6	7.9	5.9	8.7	6.2	2.3	9.5	6.2	7.0	7.6
MOCS2	MOCO1	ENSG00000164172	"Molybdenum cofactor synthesis 2"	"O96007, O96033"	5	53095679-53110063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037679, HPA037680"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037679: AB_2675604, HPA037680: AB_10673635"	"unprognostic (3.27e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.68e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.86e-2)"	18.1	34.6	41.5	9.8	38.0	4.0	19.6	21.7	41.8	16.0	17.1	20.7	10.4	17.6	14.8	28.2	17.0	12.9	15.9	39.9	36.7	32.1	49.7	52.0	13.1	11.4	30.0	22.4	21.2	18.4	30.4	23.3	16.2	28.7	18.6	14.9	17.2	21.2	20.8	38.3	8.9	17.6	16.1	27.1	10.7	16.6	11.0	20.0	8.2	31.5	19.4	11.2	16.9	15.4	16.9	12.5	6.3	10.9	17.3	25.8	12.9	20.1	16.6	12.0	28.6	24.6	22.7	15.2	24.8	26.1	22.2	26.3	22.6	15.2	20.7	37.5	19.6	12.3	24.0	25.5	35.0	5.2	23.4	15.9	16.3	20.4	25.3	17.1	11.9	18.0	12.8	25.2	22.4	23.8	15.3	11.3	36.9	30.0	18.5	9.8	10.6	34.5	9.3	25.8	18.8	38.4	15.4	8.9	10.3	18.1	14.8	18.6	28.6	4.4	15.2	21.3	22.0	18.9	31.9	13.2	19.6	23.4	30.5	4.9	32.8	5.2	9.2	6.3	16.9	10.9	20.2	16.5	19.0	19.2	12.5	16.9	25.8	22.2	1.7	17.3	9.8	11.4	18.3	12.9	41.5	38.0	21.7	41.8	36.7	32.1	30.0	22.4	28.7	20.0
MON1A	"MGC13272, SAND1"	ENSG00000164077	"MON1 homolog A, secretory trafficking associated"	Q86VX9	3	49907160-49930173	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053752, HPA058032"	Uncertain		Approved	Cytosol				Cytosol		"HPA053752: , HPA058032: "	"unprognostic (1.81e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favourable (3.30e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-1)"	7.1	6.5	11.7	6.1	10.4	4.1	4.6	5.2	17.8	5.9	9.3	7.6	3.8	27.9	5.6	3.2	5.6	5.1	6.3	5.4	10.8	10.3	6.0	11.0	4.9	5.2	10.3	8.8	4.7	10.9	5.8	7.4	4.9	8.9	5.0	4.0	5.6	6.0	6.7	15.2	6.9	17.6	5.9	9.7	4.6	5.8	12.6	6.6	6.6	6.3	4.1	4.5	4.6	4.4	8.8	7.8	3.3	6.4	13.6	13.5	7.8	4.5	3.9	2.4	7.4	7.7	4.6	3.4	6.6	3.3	6.4	7.3	5.8	3.1	14.2	6.1	6.2	5.8	5.2	8.4	2.7	11.7	13.1	6.2	4.6	7.4	9.6	7.1	8.9	6.3	9.1	12.6	4.4	9.3	9.5	5.0	4.8	7.6	8.2	10.6	5.4	20.0	5.1	2.7	10.9	4.5	3.4	6.9	4.2	2.8	5.5	6.6	4.3	4.9	7.4	4.3	5.1	11.9	10.6	10.5	10.3	8.8	6.6	11.2	6.3	0.1	6.4	3.3	11.9	4.9	13.5	8.8	10.0	11.9	7.8	4.8	12.4	10.0	1.9	13.6	3.9	3.9	10.1	7.8	11.7	10.4	5.2	17.8	10.8	10.3	10.3	8.8	8.9	6.6
MON1B	"HSRG1, KIAA0872, SAND2"	ENSG00000103111	"MON1 homolog B, secretory trafficking associated"	Q7L1V2	16	77190835-77202405	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046285	Approved		Approved	Cytosol				Cytosol		"HPA046285: AB_10959467"	"unprognostic (1.73e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-2)"	"prognostic favourable (6.90e-4)"	"unprognostic (1.94e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"prognostic favourable (9.42e-5)"	"unprognostic (2.21e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.75e-1)"	15.7	12.3	21.8	19.1	22.5	16.5	12.4	17.5	22.9	14.7	19.1	25.3	18.5	17.1	14.6	14.4	16.7	13.6	16.1	12.5	21.7	19.4	17.4	26.9	14.9	19.3	26.8	17.9	11.5	17.7	25.1	13.0	11.8	19.9	23.7	15.7	15.2	22.9	13.3	11.5	15.9	23.1	11.6	28.0	18.0	16.9	10.8	24.0	23.5	23.2	11.2	17.7	15.1	12.0	5.7	7.2	19.8	14.5	9.2	8.6	6.7	8.1	19.3	7.4	8.2	8.2	8.1	10.4	6.9	9.0	7.1	7.0	11.0	12.4	13.0	13.6	5.5	14.9	7.6	7.3	5.8	10.3	7.8	9.2	6.8	10.8	11.3	9.7	28.2	8.4	14.2	10.3	8.6	12.7	13.0	4.6	5.7	15.3	14.6	11.6	7.8	4.8	18.3	5.2	13.9	7.3	5.7	11.4	9.4	13.3	5.1	8.8	13.1	14.7	13.0	8.5	10.2	10.2	7.0	16.7	10.6	37.0	14.0	10.7	10.8	10.4	8.3	14.1	8.6	14.5	8.6	5.7	6.8	8.4	7.2	5.4	5.2	6.6	19.8	9.2	8.7	3.9	8.4	6.7	21.8	22.5	17.5	22.1	21.7	19.4	26.8	17.9	19.9	24.0
MORC2	"AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1"	ENSG00000133422	"MORC family CW-type zinc finger 2"	Q9Y6X9	22	30925130-30968298	"Disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 10.3;MAIT T-cell: 9.1;memory CD4 T-cell: 14.3;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 8.9;T-reg: 17.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 17.7"					"Low region specificity"	"Detected in all"			HPA000436	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000436: AB_1079404"	"unprognostic (3.43e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.89e-3)"	"unprognostic (4.63e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (6.54e-8)"	"unprognostic (5.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.66e-3)"	6.7	5.3	4.6	6.0	7.0	5.2	16.9	6.4	7.5	6.8	7.1	6.5	14.8	4.7	7.4	5.9	6.1	6.3	4.7	7.7	4.7	5.0	5.3	9.6	6.3	8.8	4.8	4.1	8.1	7.5	9.4	8.1	7.7	7.7	8.0	4.5	7.7	11.0	7.9	9.8	10.4	5.6	6.7	5.3	7.3	5.9	50.5	5.0	5.5	6.6	6.1	6.6	6.8	9.7	1.7	2.2	0.8	2.0	1.2	17.7	3.9	18.5	17.0	20.1	22.2	21.1	15.6	15.2	13.8	10.8	14.2	14.6	22.1	9.0	16.7	12.4	12.0	16.0	18.0	8.5	11.8	13.1	21.9	17.4	13.5	25.9	18.2	14.2	18.0	14.9	12.6	14.8	19.3	14.2	22.8	17.3	14.8	30.3	15.1	29.0	18.6	12.6	28.9	11.8	21.4	13.7	17.0	18.0	14.1	14.6	23.9	10.5	12.8	24.1	14.2	17.2	17.0	12.1	12.1	15.5	19.0	18.8	12.6	10.1	12.2	0.5	1.1	0.8	10.3	1.9	9.1	1.5	14.3	8.3	1.2	1.7	14.7	8.9	0.3	1.2	2.0	2.2	17.7	3.9	4.6	7.0	6.4	7.5	4.7	5.0	4.8	4.1	7.7	5.0
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: "	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	13.8	22.3	13.0	7.7	12.8	17.4	9.8	9.0	16.9	14.7	9.1	14.5	13.9	9.9	12.0	12.9	22.5	12.0	14.9	10.2	11.2	10.8	19.3	29.8	11.1	18.5	10.6	11.6	13.1	17.1	6.7	9.8	7.8	12.0	12.9	4.8	14.9	19.1	11.3	11.3	24.4	10.6	10.3	9.5	11.8	14.7	37.0	9.9	16.6	12.2	13.6	16.8	12.4	13.4	11.6	17.9	22.2	16.7	20.9	29.7	8.0	5.9	8.1	6.5	11.2	3.4	2.5	4.6	4.5	5.4	4.7	4.8	7.4	8.0	3.7	10.0	4.1	4.6	3.8	6.5	0.8	9.7	5.0	3.8	6.0	11.1	4.4	2.9	14.9	7.2	5.6	4.0	2.4	8.0	9.0	7.7	4.8	17.6	8.3	22.6	5.9	12.2	7.7	6.7	8.9	7.4	8.9	3.6	21.3	8.5	13.1	4.5	8.0	8.8	9.1	9.2	14.4	18.9	4.3	6.0	5.7	2.5	9.1	33.1	11.2	18.5	16.7	22.2	18.8	12.4	22.2	11.6	21.8	21.8	17.9	11.3	13.0	13.5	12.3	20.9	8.5	12.0	29.7	8.0	13.0	12.8	9.0	16.9	11.2	10.8	10.6	11.6	12.0	9.9
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031627			Approved	Cytosol				Cytosol		"HPA031627: "	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	12.5	17.0	6.2	12.6	6.9	3.5	15.0	1.9	6.3	11.4	23.1	9.3	12.3	18.8	16.4	12.6	15.8	12.2	15.3	5.8	8.6	5.1	13.3	19.4	9.7	7.7	5.9	5.1	14.5	12.9	13.1	14.1	20.2	8.2	14.0	9.3	13.8	13.5	16.5	3.1	23.2	33.8	9.4	6.3	12.9	10.4	17.7	6.0	14.5	12.1	6.9	10.9	11.0	12.5	1.9	5.6	0.9	9.5	9.9	10.8	5.9	11.8	7.3	4.4	16.8	3.5	10.2	16.5	8.1	19.4	24.1	34.5	13.5	13.1	0.0	5.6	11.2	12.6	16.5	19.6	8.4	13.0	10.0	8.2	10.6	15.2	15.3	3.4	8.1	17.2	6.0	14.6	4.6	20.4	10.8	4.1	7.4	22.0	12.9	2.6	9.8	7.5	23.3	11.0	0.5	11.1	13.0	1.8	6.3	16.9	11.4	13.2	8.9	7.8	12.2	7.5	13.5	5.2	7.2	4.7	1.3	0.0	14.8	7.1	21.4	0.7	2.8	0.5	10.7	8.4	10.8	1.9	9.7	9.7	5.6	1.4	9.4	7.1	0.9	9.9	9.5	0.9	8.2	5.9	6.2	6.9	1.9	6.3	8.6	5.1	5.9	5.1	8.2	6.0
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401545	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 57.2;smooth muscle: 41.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 37.6;ASC TERT1: 30.3;BJ: 22.9;fHDF/TERT166: 42.6;HBF TERT88: 27.5;U-2197: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	47	"memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	58	"B-cells: 4.9;dendritic cells: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035740	Approved		Approved	Cytosol				Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favourable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	1.9	19.5	13.4	3.8	12.5	0.2	1.4	0.3	16.0	17.2	7.7	6.7	7.3	2.7	57.2	7.8	17.4	1.9	15.1	3.2	9.8	1.1	21.4	1.2	15.3	2.9	1.0	6.4	2.4	1.7	0.1	4.3	3.3	0.2	17.6	4.9	0.9	10.6	21.5	0.4	7.4	4.5	41.1	0.8	3.2	3.1	3.1	4.6	0.8	1.5	7.7	7.7	9.4	8.6	4.9	7.8	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	37.6	30.3	0.0	22.9	15.6	8.4	14.7	0.0	0.2	0.1	0.0	42.6	0.0	0.3	0.1	27.5	0.0	4.2	0.0	0.0	0.0	0.3	0.0	0.0	7.2	0.0	16.9	0.5	0.0	0.0	1.7	4.9	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	10.3	0.0	0.6	0.0	0.0	0.1	0.5	0.0	1.2	0.1	3.9	3.6	68.2	11.9	0.9	0.0	0.0	9.7	0.0	11.2	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.3	13.4	12.5	0.3	16.0	9.8	1.1	1.0	6.4	0.2	4.6
MPG	MDG	ENSG00000103152	"N-methylpurine DNA glycosylase"	P29372	16	77007-85853	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006531	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006531: AB_1854075"	"unprognostic (1.78e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.99e-2)"	"prognostic favourable (2.82e-5)"	"unprognostic (8.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.86e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	20.8	32.1	18.4	21.1	18.4	25.3	33.2	18.3	32.1	19.5	20.4	12.6	24.6	21.0	22.6	30.5	21.5	18.5	28.5	37.4	16.7	15.1	16.1	32.0	20.1	39.7	15.8	18.2	23.8	36.5	8.0	21.7	19.0	16.5	23.2	7.2	15.2	47.1	24.2	33.6	19.0	19.4	19.2	13.6	25.6	27.3	10.9	11.2	18.3	29.2	22.4	22.8	27.2	25.2	33.5	38.8	27.2	27.4	41.2	31.1	22.4	13.8	20.3	5.5	17.0	10.2	23.3	13.9	20.0	27.6	13.0	14.3	12.8	18.8	9.9	17.5	11.3	17.9	3.8	8.7	2.0	17.0	14.7	6.4	10.4	19.0	29.5	6.7	39.8	22.4	12.2	14.6	6.0	22.6	14.1	17.9	16.9	48.0	11.6	30.9	10.0	22.2	22.2	6.7	37.7	10.8	5.0	4.5	11.6	10.5	11.4	25.1	16.3	34.7	19.8	10.6	13.5	14.4	9.8	17.4	5.9	12.6	19.6	19.4	37.8	14.2	27.4	27.2	22.7	19.2	20.6	33.5	21.8	22.6	28.5	30.6	16.8	17.2	14.0	41.2	15.7	38.8	31.1	22.4	18.4	18.4	18.3	32.1	16.7	15.1	15.8	18.2	16.5	11.2
MPHOSPH8	"HSMPP8, mpp8"	ENSG00000196199	"M-phase phosphoprotein 8"	Q99549	13	19633681-19673459	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039701, HPA040035"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039701: AB_10805484, HPA040035: AB_10794207"	"unprognostic (4.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.90e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.02e-1)"	20.6	27.1	37.7	33.4	37.1	19.2	21.4	48.9	45.0	32.0	26.6	13.2	31.7	17.8	29.4	26.7	19.1	22.3	18.8	27.9	31.0	27.2	18.9	16.5	22.9	28.4	28.8	32.8	43.6	22.0	20.9	44.3	20.0	28.4	26.1	20.1	11.9	24.5	38.8	25.7	26.6	23.9	31.3	37.1	30.0	22.5	16.6	33.5	16.5	26.8	11.7	20.4	31.3	37.9	21.7	13.8	39.4	9.9	11.5	17.6	3.6	12.8	8.3	12.3	20.0	16.0	20.4	21.8	19.3	14.0	12.2	10.5	12.6	22.7	20.3	15.5	11.7	21.5	22.6	13.5	15.8	25.2	11.6	32.7	13.6	15.3	14.3	23.5	26.7	12.0	17.5	9.6	13.6	16.1	15.8	13.1	11.3	12.5	17.9	19.7	12.0	9.2	14.5	28.5	16.0	21.2	10.0	17.0	10.4	18.1	16.7	17.5	10.1	19.5	18.8	9.5	8.6	17.9	9.7	8.9	9.2	20.2	7.2	21.8	14.6	39.4	9.5	15.4	13.0	6.9	11.5	21.5	14.6	12.5	4.3	21.7	17.6	14.4	27.5	11.5	9.9	13.8	11.3	3.6	37.7	37.1	48.9	45.0	31.0	27.2	28.8	32.8	28.4	33.5
MPHOSPH9	MPP9	ENSG00000051825	"M-phase phosphoprotein 9"	Q99550	12	123152320-123244014	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037485	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037485: AB_10672792"	"unprognostic (2.98e-2)"	"unprognostic (5.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.17e-1)"	5.3	9.8	11.0	10.5	14.6	24.8	5.6	21.6	14.9	5.5	6.7	7.7	4.9	7.9	6.4	12.8	5.9	6.1	4.0	8.8	8.8	6.0	7.1	12.7	6.1	12.0	7.1	8.0	6.9	6.3	9.9	20.4	5.7	9.9	5.8	7.6	7.7	5.9	5.2	7.2	5.4	8.0	5.9	9.1	10.2	5.9	14.4	11.0	48.9	6.2	3.2	10.8	5.5	5.0	6.2	4.9	8.3	3.7	8.5	12.1	3.0	8.7	9.3	14.9	16.8	6.7	6.3	5.6	9.0	4.6	11.3	9.1	8.8	4.2	17.2	6.7	5.9	6.3	19.3	7.3	15.9	11.0	12.5	17.5	10.3	8.6	5.1	16.3	15.2	6.8	2.8	10.8	10.8	11.6	12.1	7.6	10.3	7.3	18.5	25.7	10.2	10.2	16.6	15.0	11.1	8.8	8.6	19.2	9.0	14.0	5.6	8.8	10.5	12.3	6.5	9.3	13.4	10.8	12.8	11.9	19.1	14.3	7.4	15.7	19.2	8.3	3.7	5.1	10.9	3.6	7.7	5.6	8.6	9.8	3.5	6.2	12.1	11.8	0.7	8.5	3.1	4.9	7.4	3.0	11.0	14.6	21.6	14.9	8.8	6.0	7.1	8.0	9.9	11.0
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"			170000	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	13.6	33.3	24.2	11.2	26.2	7.4	14.7	19.2	33.7	16.7	22.6	26.1	15.3	32.6	15.7	26.8	17.1	20.7	13.4	28.8	22.7	22.2	22.5	30.2	10.6	16.2	28.1	28.3	23.2	34.2	24.7	15.0	11.4	37.4	20.6	23.1	18.3	18.6	17.9	33.3	11.7	27.4	16.4	21.7	14.7	14.3	23.5	17.7	16.4	17.1	15.0	16.6	15.6	11.7	12.8	10.2	2.4	7.4	17.7	27.1	12.9	10.4	14.5	12.0	13.6	27.5	13.4	10.5	9.0	14.8	15.5	21.8	14.3	13.9	14.9	19.7	13.1	26.1	23.8	26.3	14.8	11.3	29.8	26.6	13.8	15.3	19.6	12.2	7.9	17.8	6.8	14.6	26.3	21.0	8.9	12.2	20.0	8.9	13.1	5.4	6.6	12.4	13.5	11.3	36.4	18.2	11.9	22.5	9.8	10.5	19.0	11.3	26.1	8.5	9.5	9.3	8.0	6.9	8.7	30.3	17.9	9.7	19.5	17.8	6.7	0.7	7.2	2.4	13.5	7.4	17.5	12.8	18.3	15.4	10.2	12.5	27.1	19.7	1.1	17.7	6.3	8.5	22.7	12.9	24.2	26.2	19.2	33.7	22.7	22.2	28.1	28.3	37.4	17.7
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.2"	"Cell line enriched"	"Detected in single"	17	"HEL: 11.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.0;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.8;NK-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"		7400000	"Endoplasmic reticulum, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA054404: , HPA073017: "	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.8	0.2	0.0	1.2	0.5	5.3	0.7	0.1	0.4	1.0	0.9	0.0	0.0	0.9	1.0	0.8	2.0	0.7	1.5	7.4	0.2	0.0	0.4	0.5	7.6	2.8	1.0	0.0	2.7	0.2	0.2	0.2	1.4	0.7	0.9	0.2	1.1	1.8	0.3	1.2	10.5	0.8	1.9	0.6	33.2	0.4	2.7	0.1	1.2	1.0	1.4	0.8	1.6	1.6	0.2	1.8	0.5	0.1	3.0	0.1	5.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.5	3.0	0.1	1.8	0.0	5.7	0.0	0.5	0.1	0.4	0.2	0.0	1.0	0.0	0.7	0.1
MPP2	"DKFZp761D0712, DLG2"	ENSG00000108852	"Membrane palmitoylated protein 2"	Q14168	17	43875357-43909711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026486	Approved		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA026486: AB_1854085"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-5)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (4.37e-2)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.89e-4)"	2.1	5.0	12.1	2.1	11.8	1.1	3.1	19.5	26.3	3.5	5.1	19.8	2.7	1.9	4.6	31.0	4.1	3.3	3.0	9.0	13.8	14.2	2.0	0.9	2.0	1.2	15.3	14.4	2.8	4.4	31.1	8.4	3.4	11.5	7.1	2.0	6.5	2.3	10.7	1.7	2.0	2.0	6.5	20.3	1.3	2.5	13.8	12.3	0.0	4.5	0.0	1.4	3.6	2.8	0.1	0.0	0.0	0.1	0.0	1.9	0.7	4.9	7.3	7.8	11.3	1.1	0.7	4.3	1.7	0.2	6.8	6.5	2.5	3.3	7.1	4.0	1.7	2.0	10.5	4.1	5.3	0.0	8.1	0.6	6.7	0.1	0.2	0.0	2.1	1.1	0.3	4.9	0.0	0.4	2.7	0.0	2.0	1.9	1.0	0.5	14.0	4.5	5.0	11.2	0.5	0.1	0.1	8.4	7.8	2.1	0.7	2.9	17.2	3.4	0.1	7.6	9.6	2.9	3.1	2.4	4.9	0.0	11.4	4.8	1.4	0.0	0.1	0.0	1.4	0.0	0.2	0.0	0.5	1.2	0.0	0.1	1.6	1.9	0.0	0.0	0.0	0.0	0.1	0.7	12.1	11.8	19.5	22.5	13.8	14.2	15.3	14.4	11.5	12.3
MPP3	DLG3	ENSG00000161647	"Membrane palmitoylated protein 3"	Q13368	17	43800799-43833170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 6.4;SCLC-21H: 13.0;T-47d: 6.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 46.7;pons and medulla: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021818, HPA024742"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021818: AB_1854086, HPA024742: AB_1854087"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.23e-5)"	"unprognostic (4.59e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.02e-11)"	"unprognostic (9.98e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.75e-2)"	5.1	2.0	4.8	2.1	2.9	0.6	5.1	46.7	5.2	3.3	1.7	2.2	4.5	1.4	3.5	4.0	3.0	2.7	5.4	12.3	2.7	5.0	2.1	1.2	7.4	1.3	3.0	1.5	1.7	5.9	3.0	2.6	2.1	13.0	3.0	1.1	1.7	1.6	4.3	1.5	2.4	1.3	3.5	2.5	2.2	4.3	3.7	1.1	0.0	1.7	0.9	1.4	1.6	4.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.6	3.0	0.8	0.7	1.8	1.4	0.0	1.5	0.6	1.2	0.7	1.2	1.9	0.0	0.6	1.3	1.5	1.2	2.3	1.7	0.0	1.5	1.5	3.7	0.7	0.1	0.0	0.1	0.9	3.1	2.1	6.4	1.5	0.9	0.0	0.6	0.9	0.0	0.0	0.8	1.2	0.0	1.0	0.4	4.3	0.6	13.0	3.4	0.7	2.8	0.5	6.9	1.5	1.4	3.4	3.2	0.9	3.0	0.9	0.4	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	2.9	46.7	3.3	2.7	5.0	3.0	1.5	13.0	1.1
MPP4	DLG6	ENSG00000082126	"Membrane palmitoylated protein 4"	Q96JB8	2	201644870-201698694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 78.2"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;LHCN-M2: 41.4;TIME: 8.2;U-87 MG: 10.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057393			Supported	"Actin filaments,Cytosol"				Cytosol	"Actin filaments"	"HPA057393: "	"unprognostic (1.42e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.33e-16)"	"unprognostic (1.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	0.4	1.7	0.3	0.5	0.6	0.0	0.3	4.9	1.1	1.2	0.2	0.2	0.2	0.0	0.8	0.4	0.3	0.1	0.4	0.2	0.5	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.0	0.7	0.7	0.3	0.3	0.3	78.2	0.2	0.5	0.6	4.1	0.2	0.3	0.2	3.8	0.1	2.2	0.2	0.2	0.6	0.6	0.2	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	5.3	1.3	3.3	3.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	11.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	10.2	0.0	6.0	0.0	0.0	41.4	0.0	0.0	0.0	0.3	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	4.2	1.2	0.9	3.7	0.0	0.0	0.0	10.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	4.9	0.6	0.5	0.4	0.2	0.2	0.3	0.2
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67241109-67335819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favourable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.1	9.2	14.8	6.8	29.2	7.0	10.1	9.4	18.0	9.0	12.5	15.9	13.7	18.5	6.9	20.8	14.4	7.2	9.0	7.3	16.4	17.0	28.8	17.2	11.5	4.5	30.6	10.2	6.4	8.6	22.9	11.4	27.9	20.5	15.8	11.6	7.6	15.9	18.6	14.6	8.6	18.7	11.9	23.3	6.2	9.7	8.2	25.4	6.8	24.1	6.9	5.8	9.1	9.1	3.6	2.4	3.7	2.8	6.7	4.4	1.2	53.7	8.6	8.7	7.0	5.1	4.6	7.7	16.4	8.6	12.1	8.1	8.5	16.5	4.6	7.8	13.3	11.3	5.0	9.4	18.5	2.2	3.4	4.2	9.1	5.8	5.9	1.6	3.2	4.8	3.6	7.0	8.9	6.7	4.4	2.0	19.2	7.2	5.1	1.9	2.9	5.9	4.6	13.9	5.5	10.9	13.4	4.9	3.5	10.2	10.0	5.6	10.3	3.3	10.3	15.4	32.7	5.4	7.2	3.2	2.8	7.0	10.2	3.7	5.3	0.4	2.2	3.7	1.7	2.8	1.4	3.6	2.0	1.9	2.4	1.9	4.4	2.4	0.8	6.7	2.3	2.4	1.1	1.2	14.8	29.2	9.4	18.0	16.4	17.0	30.6	10.2	20.5	25.4
MPRIP	"M-RIP, p116Rip, RHOIP3"	ENSG00000133030	"Myosin phosphatase Rho interacting protein"	Q6WCQ1	17	17042545-17217679	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 27.5"	"Lineage enriched"	"Detected in all"	6	"T-cells: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022034, HPA022901"	Enhanced		Supported	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA022034: AB_1854093, HPA022901: AB_2297761"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.81e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	46.5	38.7	46.7	33.7	58.8	27.7	47.4	47.7	62.0	48.4	35.3	45.8	31.9	36.1	54.9	40.9	51.6	32.9	38.2	63.7	46.9	39.7	30.2	31.3	40.2	34.5	46.8	44.9	33.5	46.6	55.0	35.8	37.4	36.5	33.4	29.0	41.0	34.0	46.8	66.7	35.1	32.9	63.0	38.2	35.3	45.9	31.4	47.7	19.9	38.4	30.1	35.4	39.8	55.3	4.4	4.8	1.5	1.2	1.9	27.5	5.0	62.6	45.9	19.8	16.1	20.9	15.7	29.7	32.5	22.3	25.6	19.2	35.6	46.1	24.7	33.3	47.4	60.3	25.0	43.0	27.0	25.4	13.3	13.4	39.4	12.4	14.2	7.1	10.7	15.0	26.0	28.7	22.1	26.4	8.3	13.9	40.9	20.7	28.8	24.2	9.5	53.0	25.6	32.1	9.1	19.5	28.9	11.4	18.5	34.4	28.2	15.5	13.2	11.1	25.5	23.9	27.0	63.3	55.3	10.9	8.6	11.4	43.2	12.8	56.9	1.1	1.2	1.5	4.5	0.8	9.2	4.4	17.5	7.3	1.1	3.8	12.6	6.0	0.5	1.9	0.8	4.8	27.5	5.0	46.7	58.8	47.7	62.0	46.9	39.7	46.8	44.9	36.5	47.7
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029822	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol			2800000	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (5.89e-4)"	8.7	7.2	4.5	6.8	6.4	10.5	22.7	2.6	5.4	8.8	39.1	8.0	2.8	36.8	6.1	3.0	19.8	4.3	15.3	14.1	4.6	2.3	14.1	106.2	10.3	5.4	8.8	3.8	12.6	20.7	0.7	2.7	4.2	5.6	6.6	5.7	3.8	13.4	3.9	11.5	15.9	33.7	4.8	4.8	4.1	12.8	24.9	7.1	2.1	6.3	6.2	5.1	8.7	11.6	9.6	37.1	18.5	26.5	28.8	16.1	12.5	14.1	16.7	8.2	16.9	9.6	6.0	13.0	7.7	6.9	8.4	11.4	15.9	6.3	22.3	11.2	5.5	9.9	7.1	11.2	1.2	13.4	39.7	8.6	7.3	37.4	30.6	9.2	12.1	10.5	21.9	5.5	5.1	17.0	15.3	6.5	2.3	11.0	0.8	31.5	15.4	17.4	23.9	9.7	16.6	8.5	4.6	4.2	31.6	5.1	8.1	14.7	8.7	15.0	13.1	7.3	20.7	8.0	5.2	11.4	5.3	6.7	2.6	11.3	3.7	15.3	26.5	18.5	11.8	9.4	16.1	9.6	7.7	9.9	37.1	9.6	1.1	4.1	7.9	28.8	4.3	6.0	15.2	12.5	4.5	6.4	2.6	5.4	4.6	2.3	8.8	3.8	5.6	7.1
MRAS	"M-RAs, R-RAS3, RRAS3"	ENSG00000158186	"Muscle RAS oncogene homolog"	O14807	3	138347648-138405534	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 69.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.7;BJ: 30.7;EFO-21: 38.2;fHDF/TERT166: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 18.9"	"Lineage enriched"	"Detected in many"	9	"monocytes: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042728	Approved		Approved	Cytosol				Cytosol		"HPA042728: AB_10796582"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (1.69e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.23e-2)"	49.3	32.6	32.0	6.4	37.6	1.3	17.7	12.3	37.3	6.4	5.4	9.4	1.7	2.3	11.9	5.2	5.1	6.8	8.6	69.1	29.0	23.9	8.9	3.7	8.9	3.3	31.3	18.0	17.2	3.4	7.6	4.7	6.9	25.2	7.6	3.4	8.2	8.0	12.0	22.5	2.7	2.7	16.9	21.5	7.3	3.4	5.9	19.3	0.0	12.1	2.4	2.8	10.0	6.4	0.0	2.1	0.3	18.9	0.6	0.0	0.5	0.2	2.5	6.6	8.6	28.7	13.2	13.6	30.7	7.7	3.2	3.9	1.1	1.0	0.1	38.2	30.0	0.0	3.2	0.7	2.5	2.7	1.0	0.1	1.6	6.2	7.2	0.0	0.6	18.9	2.9	0.2	0.5	0.5	3.4	0.2	14.1	1.1	0.0	7.5	7.2	0.9	0.3	12.0	0.0	13.8	0.6	6.9	15.2	20.1	0.2	16.1	5.9	14.9	0.1	8.0	9.1	8.7	0.8	0.0	0.3	0.3	8.1	0.0	4.4	0.1	1.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.6	18.9	0.1	0.0	0.5	32.0	37.6	12.3	28.9	29.0	23.9	31.3	18.0	25.2	19.3
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764532-13774282	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"			2600000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: "	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	14.5	18.5	12.5	21.8	18.3	16.6	16.8	24.5	21.8	21.5	17.2	23.6	23.5	19.0	24.2	21.3	20.7	19.9	17.6	13.5	14.6	12.1	24.4	20.1	15.4	19.5	16.5	14.3	24.0	20.5	21.3	17.3	24.2	17.2	17.8	13.4	18.5	23.4	21.6	13.0	28.6	18.5	13.3	16.6	22.0	19.8	5.0	16.7	20.0	21.8	10.5	18.2	18.1	20.6	5.7	8.9	6.9	5.8	5.0	6.6	3.6	10.5	7.9	3.9	9.4	4.3	8.1	9.7	12.6	7.3	11.4	10.4	8.3	8.5	5.7	5.0	4.7	17.9	18.3	13.0	7.0	10.0	31.7	4.5	12.5	8.9	3.8	13.7	10.6	8.1	7.2	5.8	4.6	10.6	8.7	0.3	4.9	15.5	15.1	8.7	6.5	22.5	14.3	5.3	12.9	5.9	8.3	7.9	7.1	4.6	10.3	9.8	8.0	5.0	6.4	5.9	5.5	20.8	6.1	7.8	8.2	1.7	5.0	15.9	7.0	6.9	5.5	1.9	6.2	5.8	6.0	5.0	5.3	6.6	4.7	5.7	4.3	3.3	4.1	5.0	3.2	8.9	4.8	3.6	12.5	18.3	24.5	21.8	14.6	12.1	16.5	14.3	17.2	16.7
MRNIP	"C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537"	ENSG00000161010	"MRN complex interacting protein"	Q6NTE8	5	179835133-179862173	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043975	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043975: "	"unprognostic (4.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (2.64e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-3)"	6.6	6.3	11.8	10.7	12.2	4.6	10.8	30.0	16.1	14.8	8.5	14.2	14.3	7.8	13.7	16.1	4.8	23.5	7.7	7.8	12.6	11.8	8.8	6.0	8.8	14.1	16.0	13.4	21.1	9.7	11.2	22.7	5.0	12.1	11.1	8.4	12.9	9.1	19.8	5.8	12.0	11.0	11.7	10.1	13.3	7.1	8.0	14.7	2.7	11.6	3.5	14.0	8.6	10.5	10.7	5.5	2.9	1.0	4.0	8.1	2.8	1.2	2.8	4.4	10.7	9.0	8.1	5.4	3.1	2.8	3.9	5.8	4.5	4.2	5.1	3.7	1.4	3.4	5.0	10.1	3.0	4.8	4.9	1.7	4.8	3.1	5.5	2.1	2.1	6.1	8.2	4.5	3.5	4.3	2.5	2.4	4.0	5.2	3.3	2.2	2.2	2.5	4.0	1.7	3.7	7.0	1.0	8.4	2.6	1.5	4.4	3.6	5.5	1.8	1.0	2.4	2.0	1.9	2.1	2.9	1.8	3.6	2.3	3.6	1.7	1.3	0.7	2.9	3.4	0.7	4.5	10.7	5.1	4.2	0.9	10.3	8.1	5.9	1.1	4.0	1.0	5.5	2.9	2.8	11.8	12.2	30.0	16.1	12.6	11.8	16.0	13.4	12.1	14.7
MROH2A	HEATR7B1	ENSG00000185038	"Maestro heat like repeat family member 2A"	A6NES4	2	233775679-233833423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 1.8;testis: 5.0;thyroid gland: 5.1"	"Cell line enriched"	"Detected in some"	7	"RT4: 11.4"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052107	Uncertain		Uncertain	Cytosol				Cytosol		"HPA052107: "	"unprognostic (7.00e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.06e-9)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	5.0			5.1		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MRPS16	CGI-132	ENSG00000182180	"Mitochondrial ribosomal protein S16"	Q9Y3D3	10	73248843-73252693	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050081, HPA054538"	Supported		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA050081: AB_2681007, HPA054538: AB_2682519"	"unprognostic (9.19e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (4.57e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.84e-2)"	16.6	28.4	16.4	16.9	15.8	15.8	28.6	12.6	26.6	13.3	22.1	12.4	18.0	20.8	16.3	16.8	22.7	16.5	20.8	42.2	17.6	15.7	23.4	35.1	17.7	30.0	16.2	16.0	16.5	37.0	15.7	15.5	17.0	15.9	15.4	21.1	14.4	18.4	19.0	53.2	16.8	18.4	18.0	14.7	18.4	18.3	13.7	9.8	32.7	16.9	26.1	20.1	15.5	13.9	30.0	28.3	17.0	24.2	17.7	22.3	24.3	22.5	32.7	12.7	16.7	10.1	8.3	18.6	10.4	18.2	14.6	15.2	38.6	22.2	27.4	11.6	11.0	21.2	14.5	20.8	9.2	15.4	14.2	17.2	17.6	29.2	17.2	22.2	15.4	12.6	15.9	14.9	35.8	15.9	25.1	15.4	15.1	25.1	23.9	20.5	15.3	61.4	21.7	17.0	19.7	15.3	13.5	8.5	15.7	11.9	49.4	22.9	34.7	11.8	12.6	13.9	24.3	15.0	20.2	23.1	24.5	21.3	15.2	25.8	9.4	16.7	22.7	17.0	19.0	24.2	20.5	28.7	20.8	17.8	18.5	30.0	22.3	19.6	10.4	17.7	19.1	28.3	20.6	24.3	16.4	15.8	12.6	26.6	17.6	15.7	16.2	16.0	15.9	9.8
MRPS35	"MDS023, MRPS28"	ENSG00000061794	"Mitochondrial ribosomal protein S35"	P82673	12	27710773-27756295	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038513	Supported		Approved	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA038513: AB_10794084"	"prognostic unfavourable (9.41e-4)"	"unprognostic (8.35e-2)"	"prognostic favourable (5.01e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.19e-2)"	"prognostic favourable (1.51e-5)"	"unprognostic (4.63e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	18.3	32.3	21.0	19.4	22.4	14.2	23.2	21.2	25.7	14.0	31.0	16.3	18.5	27.7	17.1	17.6	25.0	16.1	20.5	31.9	19.5	20.6	42.2	52.1	15.9	20.2	20.1	19.4	17.3	18.4	18.2	11.9	18.8	24.4	17.5	33.2	11.9	17.6	14.8	46.3	15.1	24.5	19.9	18.1	17.3	23.1	13.5	13.5	19.3	28.9	27.6	18.5	17.8	14.3	12.4	17.4	4.2	24.8	14.2	14.7	12.6	24.2	26.6	11.2	17.1	16.1	19.6	41.7	16.1	13.8	22.6	20.7	32.6	34.7	22.6	23.8	16.4	18.4	23.1	20.3	26.6	19.2	22.8	25.6	11.3	26.4	16.0	34.8	13.8	16.7	25.4	19.0	38.5	18.2	27.9	15.6	20.4	14.7	24.5	57.8	42.3	40.0	26.0	29.2	37.2	34.7	19.9	6.4	13.0	22.2	34.7	26.9	35.4	27.7	14.2	13.8	14.9	31.3	28.7	6.2	9.3	48.8	18.5	26.9	18.0	4.2	12.2	4.1	9.3	21.4	14.5	12.4	11.7	11.3	17.4	11.9	13.9	12.4	0.7	14.2	24.8	8.1	14.7	12.6	21.0	22.4	21.2	25.7	19.5	20.6	20.1	19.4	24.4	13.5
MRVI1	"IRAG, JAW1L"	ENSG00000072952	"Murine retrovirus integration site 1 homolog"	Q9Y6F6	11	10573091-10693988	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.6;BJ: 12.4;BJ hTERT+: 14.4;fHDF/TERT166: 5.6;REH: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 18.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 18.5"	"Region enriched"	"Detected in many"	5	"thalamus: 8.3"	"Low region specificity"	"Detected in many"			HPA008704	Uncertain		Approved	"Nuclear bodies,Cytosol"			280000	Cytosol	"Nuclear bodies"	"HPA008704: AB_1079413"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-3)"	"prognostic favourable (5.78e-4)"	"unprognostic (5.30e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (9.70e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-3)"	15.7	6.3	19.4	12.4	22.0	1.5	6.6	4.4	13.7	31.6	26.7	15.5	10.7	6.3	42.1	17.1	27.1	19.6	23.2	6.3	13.8	12.0	5.3	1.7	5.5	2.9	21.3	10.6	16.4	1.9	2.8	1.8	8.7	18.2	24.8	12.9	37.6	3.3	29.0	4.1	4.0	9.4	47.3	12.1	3.5	16.4	8.3	10.3	0.0	4.5	2.3	1.8	27.3	10.4	0.7	0.4	18.5	4.1	0.0	0.0	0.5	0.1	0.0	3.5	0.0	17.6	3.5	0.1	12.4	14.4	0.0	0.0	0.3	1.4	0.0	0.1	5.6	0.1	0.0	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.2	0.0	0.2	4.0	0.3	0.0	0.1	1.0	0.5	0.1	0.2	0.0	0.1	0.2	0.4	0.0	5.4	0.0	0.2	0.0	0.0	0.0	2.6	0.0	2.1	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.8	0.0	0.6	1.7	1.2	0.0	2.9	0.0	0.5	0.0	0.0	0.4	0.7	0.0	0.0	18.5	0.0	4.1	0.1	0.0	0.5	19.4	22.0	4.4	13.2	13.8	12.0	21.3	10.6	18.2	10.3
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 64.7;lymphoid tissue: 28.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;LHCN-M2: 2.1;NTERA-2: 3.0;RH-30: 4.2;U-2 OS: 1.7"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: "			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.1	0.0	0.1	28.6	0.1	0.0	0.1	0.1	0.1	0.1	57.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	64.7	0.1	0.1	0.1	0.1	0.0	0.2	1.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756953-60776732	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 9.9;lung: 32.4"	"Group enriched"	"Detected in some"	4	"HEL: 9.0;Karpas-707: 3.7;MOLT-4: 4.0;U-266/70: 13.2;U-266/84: 5.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 9.9"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.9"	"Region enriched"	"Detected in single"	28	"olfactory region: 205.0"	"Region enriched"	"Detected in single"	29	"olfactory region: 39.1"	HPA054563			Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.3	0.3	0.3	0.0	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	1.8	0.3	0.4	1.0	0.3	0.3	0.3	0.2	0.3	0.3	32.4	0.3	0.3	0.3	2.4	0.3	0.0	0.3	1.1	0.3	0.3	0.5	0.3	0.3	1.9	0.3	0.2	1.4	1.7	0.3	0.3	0.2	0.6	0.3	0.3	0.3	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.0	0.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.2	0.1	9.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.6	3.7	0.0	0.0	4.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	13.2	5.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.9	0.5	0.0	0.0	1.8	0.7	0.0	0.6	0.0	0.0	9.9	0.7	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3
MSI1		ENSG00000135097	"Musashi RNA binding protein 1"	O43347	12	120341330-120369180	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.3;skeletal muscle: 23.2"	"Cell line enhanced"	"Detected in some"		"AF22: 42.9;HAP1: 19.6;NTERA-2: 22.3;SCLC-21H: 31.8;SH-SY5Y: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074923, HPA075573"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA074923: , HPA075573: "	"unprognostic (1.21e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (5.99e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	0.8	6.8	8.7	0.6	7.4	0.4	1.2	3.9	14.2	1.9	1.5	8.6	2.2	7.8	4.3	2.7	1.5	3.1	1.4	4.0	11.3	5.9	0.7	1.0	1.0	0.6	4.7	6.1	2.9	7.3	1.3	12.8	1.4	4.6	4.5	1.5	27.3	1.3	2.5	23.2	0.5	5.2	2.2	4.7	0.7	3.1	12.5	5.4	0.0	1.3	0.0	0.4	0.9	0.9	0.1	0.4	0.6	0.2	0.2	0.3	0.0	0.0	0.5	42.9	10.8	0.0	0.0	5.4	0.0	0.0	0.2	0.5	7.5	0.2	0.0	0.6	0.0	0.1	19.6	0.0	0.1	0.2	4.4	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.0	0.1	22.3	0.2	0.1	0.0	0.1	0.0	0.0	31.8	15.5	0.0	0.3	0.3	6.6	0.0	0.0	0.1	5.9	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.6	0.2	0.2	0.4	0.1	0.0	8.7	7.4	3.9	7.2	11.3	5.9	4.7	6.1	4.6	5.4
MSI2		ENSG00000153944	"Musashi RNA binding protein 2"	Q96DH6	17	57255851-57684685	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022300	Approved		Supported	Cytosol				Cytosol		"CAB022300: "	"unprognostic (4.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (9.22e-8)"	"prognostic favourable (2.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-3)"	3.4	34.7	20.0	22.4	21.5	8.4	8.8	18.0	25.3	9.7	14.4	7.7	14.2	5.0	6.7	36.3	4.6	11.1	23.5	28.5	13.9	16.9	18.0	3.6	6.9	9.6	21.0	6.4	22.8	6.1	41.4	23.1	10.7	19.7	10.5	7.4	14.6	9.8	48.5	25.6	3.6	5.4	4.6	14.8	8.7	7.7	7.5	9.5	23.7	12.4	8.4	8.6	11.6	5.0	1.9	3.0	4.8	1.5	1.9	4.1	0.5	3.4	5.8	20.1	7.7	2.3	2.2	15.8	3.8	4.4	5.0	3.0	6.9	5.8	15.8	13.5	2.3	3.4	12.8	5.1	9.3	22.0	8.9	6.9	12.9	15.8	5.0	7.6	7.0	2.8	6.7	0.6	8.2	5.1	15.0	11.9	17.5	7.9	34.2	2.1	7.2	9.4	48.0	30.1	12.5	12.2	22.2	22.3	41.5	6.2	5.9	17.7	10.6	5.9	6.5	3.2	8.3	2.8	6.5	16.5	14.0	19.2	8.4	4.6	19.3	4.4	0.4	4.8	2.0	0.3	1.5	1.9	1.9	1.8	0.6	1.1	1.8	1.7	0.4	1.9	1.5	3.0	4.1	0.5	20.0	21.5	18.0	25.3	13.9	16.9	21.0	6.4	19.7	9.5
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 6.0;placenta: 5.7"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 34.3;PC-3: 43.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.9"	"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in male reproductive system"			Vesicles	Cytosol	"HPA055174: "																		0.5	0.0	1.2	1.1	0.6	0.0	0.8	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.1	0.1	0.4	0.0	0.4	0.9	3.9	0.0	0.0	0.0	0.0	6.0	5.7	0.8	0.7	0.5	0.0	0.0	0.3	1.3	0.5	1.5	0.3	2.2	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.1	0.0	0.1	3.2	0.3	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	1.2	0.3	0.1	0.3	0.4	1.2	0.6	0.0	0.6	0.1	0.1	3.9	0.0	0.8	0.0
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054268-10428891	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 78.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023804, HPA053069"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"		25000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023804: AB_1853826, HPA053069: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	7.0	8.1	8.0	5.2	7.5	36.1	5.9	78.4	13.7	3.6	5.9	4.3	2.2	5.9	4.8	3.7	5.5	4.2	4.4	8.5	8.9	5.5	32.4	22.9	5.7	6.8	6.8	9.5	4.2	10.2	2.9	3.4	4.6	8.1	3.4	4.0	3.9	6.0	5.0	4.7	3.8	12.7	4.9	6.7	7.2	4.9	8.5	5.5	3.5	4.4	2.6	3.8	3.9	2.7	1.1	2.3	9.0	3.2	1.1	0.8	0.3	0.1	1.1	1.8	5.4	1.6	1.8	0.6	3.3	0.7	0.5	2.2	0.7	2.7	0.0	0.8	3.0	2.9	0.5	0.2	1.7	0.4	0.0	0.5	1.7	2.5	5.3	1.0	15.2	0.5	3.9	0.4	0.0	0.9	0.5	0.3	5.9	0.2	0.0	0.3	0.8	1.0	1.8	1.7	2.3	1.3	1.3	3.1	2.0	5.4	0.2	0.7	2.8	3.3	3.2	2.2	2.6	0.5	1.6	0.2	0.1	0.9	5.9	1.0	4.1	0.8	3.2	9.0	0.7	2.2	0.6	1.1	0.8	0.5	2.3	0.4	0.6	0.5	3.8	1.1	1.6	0.3	0.5	0.3	8.0	7.5	78.4	13.7	8.9	5.5	6.8	9.5	8.1	5.5
MSS51	"FLJ39565, ZMYND17"	ENSG00000166343	"MSS51 mitochondrial translational activator"	Q4VC12	10	73423579-73433561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	13	"parathyroid gland: 34.4;skeletal muscle: 66.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"cerebellum: 2.7"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038564			Uncertain	Vesicles,Cytosol				Vesicles	Cytosol	"HPA038564: AB_10674687"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.50e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-7)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-2)"	2.8	0.3	0.4	0.4	0.4	0.3	0.4	2.7	0.4	0.5	0.5	0.4	0.4	0.2	0.6	0.4	0.9	0.6	0.4	3.9	0.4	0.1	0.4	0.4	0.6	0.4	0.4	0.4	1.1	0.5	34.4	0.7	0.4	0.4	0.8	0.3	0.4	2.3	0.4	66.9	0.8	0.8	0.4	0.4	1.4	0.4	0.4	0.4	0.6	0.4	1.2	0.4	0.5	0.6	0.1	0.0	0.0	0.5	0.0	1.7	0.4	1.2	1.3	3.0	4.7	4.2	6.0	2.6	1.4	1.1	0.6	1.3	0.7	1.5	3.8	0.5	1.5	2.3	1.9	0.4	1.7	1.8	1.5	3.3	2.0	1.1	1.5	2.2	3.1	4.7	1.5	1.3	3.5	0.6	1.1	2.0	2.5	0.5	1.8	3.0	0.9	1.6	1.1	7.7	0.2	1.8	1.9	0.6	1.2	1.0	2.2	1.7	1.9	1.8	2.6	2.3	1.4	0.9	3.0	1.2	3.4	2.0	1.0	3.8	0.6	0.0	0.4	0.0	1.7	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.3	1.2	0.0	0.0	0.5	0.0	0.0	0.4	0.4	0.4	2.7	0.4	0.4	0.1	0.4	0.4	0.4	0.4
MST1R	"CD136, CDw136, PTK8, RON"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 34.3;skin 1: 28.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.3;HaCaT: 19.5;HBEC3-KT: 21.2;hTCEpi: 29.8;RT4: 22.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol				Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favourable (2.33e-5)"	1.7	0.1	0.4	7.5	0.6	0.0	2.4	0.5	0.7	1.8	20.5	0.7	2.0	11.2	1.2	1.3	6.1	0.6	27.7	0.9	0.5	0.1	1.4	0.4	5.0	1.1	0.4	0.6	0.5	4.1	0.0	1.3	0.8	0.9	1.7	9.7	2.5	2.1	0.4	0.5	28.7	34.3	0.7	0.4	0.6	19.1	1.9	0.4	7.7	1.3	6.0	4.5	4.3	3.5	0.2	0.0	0.0	0.0	0.6	2.1	0.0	12.7	4.9	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.2	35.3	0.5	3.1	0.2	19.5	0.0	21.2	0.0	0.3	0.3	0.0	8.4	0.3	0.3	0.0	0.4	0.1	29.8	0.1	4.2	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.1	10.3	0.8	0.0	0.3	13.0	22.8	0.3	0.0	3.6	8.2	0.0	6.5	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.4	0.6	0.5	0.7	0.5	0.1	0.4	0.6	0.9	0.4
MT-ND3	"MTND3, NAD3, ND3"	ENSG00000198840	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3"	P03897	MT	10059-10404	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 357.8"	"Cell line enhanced"	"Detected in all"		"ASC diff: 639.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063296	Enhanced		Approved	Cytosol				Cytosol		"HPA063296: "	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (4.63e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-3)"	102.1	73.9	117.3	17.6	137.2	17.9	59.3	33.7	70.5	31.2	76.3			64.0	25.9	49.2	21.7	24.7	19.7	256.8	110.3	81.7	138.1	145.8	19.7	17.4	92.0		27.5	77.8	14.6	22.2	34.6		39.1	59.1		67.6	50.7	357.8	42.2	48.9	28.4	66.8	19.1	60.6	21.0			25.0		20.3	24.2	15.9	84.8	32.6	159.6	48.5	48.6	75.3	24.4	84.7	138.5	92.5	90.7	639.2	128.1	77.0	71.4	42.0	38.8	43.9	208.4	132.2	88.4	111.0	91.8	176.8	39.7	156.2	66.7	126.6	190.5	86.9	461.1	343.0	99.8	127.8	131.5	221.5	289.5	64.9	73.3	60.3	68.4	103.3	73.1	277.1	67.1	170.7	47.5	128.2	58.2	90.9	81.3	235.9	234.2	38.1	82.9	34.5	69.2	141.3	160.1	206.6	102.3	60.0	91.1	104.2	76.4	40.2	52.6	190.4	48.7	77.7	34.0	159.6	48.5	36.6	36.7	36.4	49.8	73.1	42.6	44.8	32.6	84.8	63.1	75.3	100.7	48.6	32.7	32.3	27.6	24.4										
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favourable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.4	20.1	22.4	24.7	24.3	22.0	22.9	33.8	23.4	17.9	18.9	21.9	22.5	22.3	22.1	21.3	14.9	22.5	20.0	27.7	22.1	17.3	14.8	15.1	20.1	22.3	22.8	18.4	31.4	31.1	15.7	26.5	16.1	19.4	21.9	10.6	22.2	28.7	24.8	29.1	20.0	19.8	27.1	15.0	23.6	18.9	31.4	24.1	27.3	21.1	16.1	16.3	19.3	20.5	1.8	3.7	2.8	0.9	1.8	1.8	0.6	13.1	10.5	19.6	19.5	7.5	12.9	17.4	10.5	8.0	10.4	10.1	13.6	17.8	25.8	11.0	7.6	18.2	14.2	10.0	7.1	16.9	23.9	13.4	9.5	13.9	16.6	16.8	10.4	14.4	12.7	7.4	17.0	14.8	15.2	11.3	5.4	23.6	30.3	33.4	28.3	22.3	28.7	11.9	8.4	8.3	10.3	31.7	33.0	14.1	16.5	15.0	14.8	16.1	10.6	8.5	9.0	13.9	10.9	23.0	11.1	16.4	10.5	11.4	14.7	0.5	0.9	2.8	1.4	0.9	1.2	1.5	1.2	1.1	1.1	1.8	1.5	1.8	0.2	1.8	0.5	3.7	0.9	0.6	22.4	24.3	33.8	23.4	22.1	17.3	22.8	18.4	19.4	24.1
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802543-21937651	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046915			Approved	Cytosol			3100000	Cytosol		"HPA046915: "	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavourable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	17.0	12.6	7.8	12.6	10.4	8.4	13.9	4.6	10.2	17.3	14.5	12.8	13.4	8.0	21.2	11.6	19.6	12.2	16.9	11.4	7.9	7.7	13.0	17.5	11.4	13.0	12.0	6.2	20.5	17.2	17.6	14.4	17.5	12.3	17.0	13.1	14.3	14.6	15.9	10.8	11.8	10.3	19.9	14.3	17.9	11.7	7.9	10.1	19.1	11.7	14.3	16.2	19.7	17.2	9.3	8.4	1.4	6.9	8.5	8.2	3.5	14.2	2.2	11.6	9.7	9.5	9.8	13.0	20.8	10.2	10.6	12.2	9.8	6.7	7.1	6.5	9.9	6.6	11.8	29.4	18.0	0.1	9.7	0.1	27.0	12.9	9.3	11.4	12.7	11.8	0.0	19.5	21.4	11.0	0.1	9.6	11.1	2.0	13.0	0.3	13.5	17.4	0.1	8.8	12.5	9.1	0.1	6.6	7.5	6.8	8.0	10.3	5.2	0.2	11.9	0.1	7.5	0.1	16.6	6.4	11.3	14.9	0.1	11.3	6.1	1.4	6.9	0.3	5.0	5.4	8.2	7.7	7.2	5.6	8.4	9.3	6.5	5.9	1.0	8.5	3.4	8.0	4.1	3.5	7.8	10.4	4.6	10.2	7.9	7.7	12.0	6.2	12.3	10.1
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027097	Uncertain		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favourable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	14.2	15.5	14.4	17.6	22.1	17.2	18.6	42.2	21.7	16.2	14.6	25.3	12.5	13.4	23.2	14.1	17.6	17.7	12.1	13.4	14.4	12.1	13.4	16.5	14.2	29.8	19.2	19.4	25.7	20.9	11.7	25.7	11.6	20.4	28.9	17.2	16.3	19.5	18.1	38.8	15.5	19.6	17.3	17.8	20.3	14.7	12.7	22.3	23.7	29.4	20.5	29.7	14.3	15.2	16.6	6.2	11.4	5.4	8.0	24.9	10.2	8.6	8.2	16.3	9.4	22.2	9.9	12.1	14.7	16.4	14.3	20.3	5.6	13.0	13.4	5.3	17.0	9.7	22.2	21.0	19.3	18.1	16.0	17.1	15.7	24.7	14.5	20.4	13.1	16.9	20.6	16.7	19.3	16.3	15.2	5.9	17.1	12.2	14.9	14.1	18.6	14.1	14.6	18.5	7.5	13.6	17.3	14.9	12.9	12.0	14.9	11.1	11.0	10.6	22.4	13.2	12.8	15.4	13.1	15.8	4.0	32.7	11.1	12.9	12.1	4.2	5.4	11.4	10.0	5.2	12.5	16.6	15.5	13.7	6.2	15.4	24.9	19.5	1.9	8.0	4.4	4.7	15.8	10.2	14.4	22.1	42.2	21.7	14.4	12.1	19.2	19.4	20.4	22.3
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	8.7	10.2	7.9	10.0	11.5	11.6	7.5	13.5	12.7	9.5	12.7	6.8	8.0	9.7	11.8	10.6	9.5	10.9	9.7	13.8	8.0	7.8	12.8	13.4	8.4	8.6	6.8	9.4	14.0	5.9	7.3	9.3	7.5	10.3	10.8	10.8	12.2	8.7	9.8	13.3	11.6	13.9	12.0	5.7	9.2	8.7	7.2	5.2	9.2	11.7	4.6	8.8	12.0	9.1	5.0	9.6	16.9	3.6	4.6	5.9	1.9	2.6	3.6	3.5	6.1	5.0	3.5	3.1	2.4	4.3	3.2	3.0	2.2	3.0	9.1	3.3	4.4	7.7	6.5	4.3	3.1	3.5	4.8	3.9	3.4	2.5	5.9	5.3	1.2	5.1	5.4	1.7	3.8	2.9	4.1	4.4	4.8	3.6	4.2	5.6	4.8	6.2	3.9	5.1	4.2	5.2	3.1	3.6	3.6	5.8	5.4	4.4	3.3	3.8	5.3	3.8	3.9	4.4	4.8	3.7	5.4	3.6	3.3	8.6	3.9	3.1	3.6	2.4	4.9	2.9	4.9	4.7	4.9	5.2	5.6	5.0	5.5	5.9	16.9	4.6	2.0	9.6	4.9	1.9	7.9	11.5	13.5	12.7	8.0	7.8	6.8	9.4	10.3	5.2
MTFR1	"CHPPR, FAM54A2, KIAA0009"	ENSG00000066855	"Mitochondrial fission regulator 1"	Q15390	8	65644734-65771261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023152, HPA056120"	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA023152: AB_1854176, HPA056120: "	"prognostic unfavourable (4.06e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.56e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.21e-4)"	"unprognostic (8.25e-2)"	10.7	17.7	6.6	5.5	11.7	3.9	9.5	10.1	8.8	9.7	10.7	10.8	14.2	11.1	9.9	11.9	12.3	7.2	6.2	8.7	6.8	5.5	28.4	37.7	7.1	3.9	10.3	5.4	7.9	19.1	8.0	15.0	16.2	9.7	8.1	11.2	14.8	11.0	11.5	11.7	8.3	16.2	8.8	11.3	6.5	13.2	16.8	11.7	5.4	13.0	11.2	9.3	10.5	9.7	1.7	3.1	4.3	2.8	0.8	2.9	1.7	14.4	10.8	8.5	10.0	12.0	11.7	6.9	9.5	8.8	11.9	12.5	9.2	15.1	8.1	3.1	9.2	9.5	19.5	13.0	16.1	2.9	10.5	10.0	8.0	18.4	14.9	2.6	4.9	8.0	14.0	15.2	48.7	14.4	13.6	8.4	13.7	13.0	8.8	6.1	9.1	9.7	4.5	11.8	6.7	14.6	13.1	3.8	5.7	9.6	16.3	12.6	17.9	5.7	10.8	7.2	10.0	17.1	8.2	8.2	5.3	5.9	8.8	10.6	9.5	4.3	2.8	1.2	2.0	2.5	2.9	1.7	2.6	2.2	3.1	1.4	2.6	2.9	0.7	0.8	1.2	1.9	2.5	1.7	6.6	11.7	10.1	8.8	6.8	5.5	10.3	5.4	9.7	11.7
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"	P11586	14	64388031-64463457	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 121.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol			250000	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: "	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	18.9	9.0	8.1	8.4	18.1	9.7	12.2	5.7	15.9	7.1	9.3	9.0	4.0	7.5	8.5	6.9	12.0	6.7	6.4	10.6	8.4	6.5	20.5	121.6	6.8	9.2	8.0	10.4	10.1	13.4	13.1	5.6	5.6	10.0	5.5	11.4	9.3	11.6	5.6	26.5	7.6	7.3	8.8	6.9	8.3	7.9	2.3	7.4	15.6	8.6	14.0	12.5	8.7	7.3	21.1	12.8	0.5	13.2	12.8	14.9	8.4	72.1	41.1	15.6	34.0	16.8	13.7	25.3	28.3	19.5	36.8	36.5	39.9	33.3	30.4	13.4	16.8	35.5	48.2	28.2	43.1	30.1	31.7	37.6	41.2	30.2	12.4	28.8	20.5	10.7	9.1	32.8	17.8	22.9	28.0	25.0	27.8	59.9	46.4	16.9	28.6	43.6	37.1	54.3	27.5	27.6	42.3	33.8	13.1	47.4	25.8	14.2	40.1	14.6	14.1	27.8	48.1	25.5	33.9	16.7	20.5	53.5	25.4	33.4	31.4	0.2	8.2	0.1	8.1	13.2	10.9	21.1	9.0	9.9	12.8	11.6	7.6	10.1	0.5	12.8	10.3	3.2	14.9	8.4	8.1	18.1	5.7	15.9	8.4	6.5	8.0	10.4	10.0	7.4
MTHFS	HsT19268	ENSG00000136371	"Methenyltetrahydrofolate synthetase"	P49914	15	79833585-79897379	"Enzymes, Predicted intracellular proteins"		Ligase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.7;liver: 120.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 88.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 88.7;monocytes: 25.4"									"HPA008067, HPA054177"	Approved		Supported	Cytosol				Cytosol		"HPA008067: AB_1078882, HPA054177: "	"unprognostic (4.57e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (9.13e-3)"	"prognostic favourable (1.29e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (2.04e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	10.0	6.6	4.5	7.6	4.4	2.5	5.7	3.9	2.8	4.4	12.4	3.7	6.8	8.3	4.3	6.2	4.5	4.0	7.9	5.2	4.1	5.0	27.9	120.9	6.4	5.4	5.5	1.7	3.3	18.8	11.4	9.4	13.9	3.9	8.6	3.7	6.5	10.6	7.6	6.0	1.9	18.3	4.4	6.1	7.6	6.3	5.9	3.3	5.3	12.0	3.1	5.7	4.0	9.9	9.7	9.3	88.7	25.4	12.4	12.6	13.8	11.0	27.9	2.5	1.4	9.9	8.3	11.2	7.7	10.2	13.6	10.4	21.7	21.7	13.8	23.5	9.6	17.8	23.8	7.6	10.4	14.4	15.8	11.9	16.2	25.7	17.1	5.6	0.4	12.6	22.3	5.6	14.2	5.1	26.3	11.4	10.7	23.7	8.6	23.1	11.9	10.5	9.4	13.7	21.0	24.8	20.7	6.8	3.3	21.5	12.9	28.4	16.5	10.3	3.3	5.2	11.1	2.4	5.1	5.7	18.5	14.0	2.6	22.0	4.0	9.8	16.6	43.5	7.7	19.0	9.9	9.7	10.8	9.0	9.3	8.7	12.6	9.7	88.7	12.4	25.4	7.0	11.2	13.8	4.5	4.4	3.9	2.8	4.1	5.0	5.5	1.7	3.9	3.3
MTMR10	FLJ20313	ENSG00000166912	"Myotubularin related protein 10"	Q9NXD2	15	30938941-30991607	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.0"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006081	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA006081: "	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (7.77e-12)"	"unprognostic (9.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-1)"	13.9	7.3	19.9	7.8	22.8	12.0	16.3	8.4	19.3	10.0	8.4	32.9	4.2	9.6	7.4	8.1	17.1	6.4	7.5	10.2	22.5	13.3	25.9	19.2	10.6	9.6	30.9	11.9	9.5	9.8	14.8	4.3	32.7	29.4	9.2	8.5	9.5	11.1	10.0	24.3	7.6	8.9	8.3	84.0	10.7	10.0	6.6	24.9	8.9	11.7	6.0	8.3	9.5	7.2	3.4	3.8	14.1	6.9	1.4	1.6	1.6	5.3	6.1	5.6	3.1	12.6	6.9	4.1	7.8	16.5	6.6	6.5	3.9	1.9	2.2	10.7	10.4	8.0	4.4	4.7	6.3	8.1	1.2	2.8	4.0	5.8	7.4	5.4	5.7	9.2	3.8	4.2	4.7	16.3	3.1	6.4	6.0	1.6	5.7	1.5	2.8	2.5	4.3	4.9	12.8	24.7	8.6	2.1	5.3	3.8	4.5	1.6	2.9	10.2	7.8	7.7	4.8	4.0	4.8	5.8	4.9	5.9	4.5	2.0	8.6	3.3	3.2	3.0	0.8	4.2	0.8	2.1	0.9	0.6	3.2	3.4	1.6	1.3	14.1	1.4	6.9	3.8	1.3	1.6	19.9	22.8	8.4	19.3	22.5	13.3	30.9	11.9	29.4	24.9
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883155-30030866	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	15.8	17.2	15.7	12.6	20.6	66.7	16.0	24.2	18.0	13.7	12.6	18.9	14.8	10.6	18.8	13.5	20.1	16.7	13.0	14.4	13.0	11.7	12.4	9.9	18.3	12.6	14.7	11.4	20.3	15.8	22.1	20.6	20.6	15.8	15.1	12.9	18.1	15.9	14.7	30.7	22.5	13.1	16.0	17.0	20.7	14.1	23.7	14.6	14.0	16.6	11.9	14.9	14.0	19.3	2.6	3.9	16.5	6.6	3.9	4.1	3.5	8.4	6.6	11.4	12.1	11.5	8.4	8.4	7.5	11.4	10.3	11.9	6.1	5.1	6.4	5.0	14.4	10.4	12.0	9.5	10.4	12.7	10.0	11.6	6.6	6.6	10.6	9.8	29.5	8.9	15.8	10.0	18.2	10.2	7.1	11.5	6.3	10.5	6.6	7.2	4.2	4.9	7.8	15.5	6.5	9.7	15.7	12.7	8.7	14.3	13.0	7.7	7.3	9.9	10.9	16.9	11.4	3.4	5.3	10.0	6.7	6.0	7.3	4.9	7.7	6.4	6.6	10.0	3.1	4.6	4.1	2.2	2.5	3.4	3.9	2.6	3.1	2.7	16.5	3.9	4.7	1.5	2.7	3.5	15.7	20.6	24.2	18.0	13.0	11.7	14.7	11.4	15.8	14.6
MTMR7		ENSG00000003987	"Myotubularin related protein 7"	Q9Y216	8	17298030-17413528	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;parathyroid gland: 17.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.3;SCLC-21H: 14.0;SH-SY5Y: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA075682			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA075682: "	"unprognostic (1.01e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.66e-3)"	1.4	4.9	10.9	1.9	16.7	3.4	0.9	16.2	25.8	1.2	1.3	16.0	0.0	2.0	1.8	0.8	1.5	1.5	1.6	1.7	7.5	7.8	2.4	2.2	1.4	1.7	9.2	9.5	3.5	2.6	17.9	10.3	1.8	19.5	1.2	1.3	4.7	1.4	1.1	2.1	2.6	1.9	1.1	11.2	1.4	1.8	2.9	9.4	0.0	6.5	0.0	0.8	1.4	0.7	0.7	0.2	0.8	0.2	0.3	1.4	0.1	0.7	0.6	1.1	1.0	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.9	0.2	0.8	0.5	0.0	0.4	4.1	0.0	0.0	0.1	3.0	1.2	1.6	0.5	1.0	0.7	0.9	0.2	0.0	0.0	0.0	0.2	0.6	0.7	0.0	0.6	1.3	1.7	5.3	0.5	0.4	1.8	0.5	0.0	3.3	14.0	8.1	0.6	0.8	0.9	0.4	0.9	1.5	0.9	0.5	2.0	1.1	0.4	0.4	0.6	2.6	1.3	0.7	0.0	0.1	0.7	0.2	0.2	0.1	0.7	0.1	0.2	0.1	0.0	0.5	0.3	0.8	0.3	0.2	0.2	1.4	0.1	10.9	16.7	16.2	15.2	7.5	7.8	9.2	9.5	19.5	9.4
MTO1		ENSG00000135297	"Mitochondrial tRNA translation optimization 1"	Q9Y2Z2	6	73461578-73509236	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030230, HPA030232"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030230: AB_10598910, HPA030232: AB_10600891"	"unprognostic (2.17e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.64e-1)"	10.4	11.0	11.1	13.5	13.7	14.7	11.5	21.8	13.6	14.0	14.0	11.3	12.4	12.7	12.6	11.2	12.1	10.0	8.1	13.3	10.0	10.9	19.7	28.4	9.8	15.8	19.3	10.0	14.5	12.1	24.6	15.6	8.7	13.9	12.2	12.7	10.1	10.7	12.3	15.8	9.8	13.6	11.9	12.1	18.6	11.9	20.5	15.0	13.0	14.0	11.0	16.6	12.1	15.0	10.4	7.4	5.3	7.8	10.5	14.0	8.7	5.0	4.6	6.4	5.2	9.3	10.8	5.8	10.5	9.6	10.3	12.6	9.5	3.9	13.2	8.2	9.8	8.7	11.7	8.4	15.8	7.7	7.7	10.1	11.2	10.3	12.2	18.2	6.9	9.3	13.3	11.1	12.5	7.7	17.3	12.8	10.7	8.8	5.0	15.7	4.7	4.7	8.4	18.3	21.9	8.2	7.9	5.4	3.3	5.4	9.1	9.4	6.0	19.2	4.9	6.1	6.0	3.5	10.0	8.3	12.8	5.3	3.1	13.6	8.0	1.7	6.4	5.3	9.7	7.2	11.9	10.4	11.7	9.8	7.4	7.9	12.9	10.5	1.8	10.5	7.8	5.5	14.0	8.7	11.1	13.7	21.8	13.6	10.0	10.9	19.3	10.0	13.9	15.0
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	"Mechanistic target of rapamycin kinase"	P42345	1	11106535-11262507	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069425, HPA071227"	Approved		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB069425: , HPA071227: "	"unprognostic (3.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.88e-1)"	"prognostic favourable (1.49e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.55e-2)"	11.3	13.9	18.7	13.0	22.5	12.3	14.9	25.2	25.2	11.3	14.5	18.2	10.4	11.2	13.8	23.6	13.1	10.5	15.7	14.2	14.5	13.6	15.8	19.4	10.8	14.3	14.0	14.4	10.7	16.6	26.5	16.0	12.5	15.5	15.2	17.1	14.4	14.2	15.2	24.6	16.5	13.6	15.2	10.4	15.4	13.1	38.6	13.1	16.6	13.2	9.9	15.7	11.7	10.2	3.9	4.0	3.0	6.4	2.6	5.6	2.3	15.2	13.8	18.7	14.1	22.6	10.8	9.3	12.9	12.4	17.2	17.0	14.2	14.1	16.9	11.1	15.2	18.2	25.2	19.7	22.3	13.5	18.4	22.5	28.6	17.9	14.2	21.9	16.8	13.8	15.0	24.6	25.0	21.8	25.1	14.6	12.0	17.4	15.1	16.7	14.1	13.1	15.2	22.0	11.3	15.2	13.8	18.9	13.8	27.6	14.9	16.9	12.1	13.0	23.2	15.1	13.7	11.5	17.2	14.4	13.4	33.3	10.9	23.7	15.8	0.7	2.9	3.0	5.2	6.4	4.3	3.9	3.0	2.7	4.0	3.4	3.6	3.1	2.0	2.6	3.3	3.1	5.6	2.3	18.7	22.5	25.2	25.2	14.5	13.6	14.0	14.4	15.5	13.1
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926761-135977353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"			48000000	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	31.0	22.1	40.2	28.5	53.2	55.1	39.6	34.4	50.0	30.9	21.4	20.4	16.0	17.2	29.5	21.9	62.1	27.0	23.7	31.6	38.0	31.6	25.1	20.5	31.6	49.3	24.2	32.4	22.0	10.7	29.2	22.5	26.3	22.9	23.4	23.6	21.5	22.2	24.0	27.4	19.1	23.1	27.9	23.3	42.4	17.6	23.4	19.9	36.4	36.9	24.9	42.8	26.1	30.5	37.9	24.6	50.6	43.5	12.8	16.7	17.0	27.2	21.6	23.9	35.7	34.3	40.8	12.5	43.2	43.9	27.7	30.4	24.6	29.4	48.1	32.0	53.1	17.4	22.3	33.9	51.4	35.6	22.0	32.9	23.4	16.0	28.2	44.0	47.4	29.8	33.6	33.0	31.0	43.1	39.0	29.1	52.2	20.8	44.4	32.6	33.8	30.7	25.8	18.3	39.2	30.1	22.6	30.8	56.2	35.2	21.9	33.2	16.1	26.9	46.2	42.0	19.2	41.7	40.7	24.3	35.7	71.1	67.1	38.7	89.2	25.4	21.4	22.6	16.7	28.9	14.3	30.9	10.4	12.5	24.6	37.9	6.9	9.9	50.6	12.8	43.5	24.2	9.0	17.0	40.2	53.2	34.4	50.0	38.0	31.6	24.2	32.4	22.9	19.9
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795281-236903981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044474, HPA054915"	Approved		Supported	Cytosol				Cytosol		"HPA044474: AB_10966696, HPA054915: "	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (5.75e-4)"	"unprognostic (8.10e-2)"	14.5	11.4	9.9	13.2	13.5	7.6	13.6	14.8	14.4	16.9	16.4	16.2	16.0	7.5	18.1	27.3	10.4	18.4	16.3	21.9	9.4	9.8	21.2	9.5	11.7	14.3	12.6	12.8	24.7	20.8	27.4	12.4	17.5	13.0	14.0	8.9	17.7	11.1	17.3	27.0	15.4	11.7	23.3	12.1	13.9	14.9	20.1	12.1	20.8	22.4	11.1	13.2	18.4	14.4	3.3	1.6	3.0	2.0	2.3	5.8	2.1	9.9	6.7	8.2	6.8	15.3	14.1	9.7	8.7	7.8	9.6	10.0	6.3	7.6	22.1	8.1	9.8	6.9	10.6	7.8	11.5	10.2	9.1	13.0	8.9	11.6	10.3	20.6	8.1	20.1	4.9	12.7	12.2	12.7	18.7	10.4	8.0	6.9	10.7	6.6	11.0	3.6	11.7	14.6	14.2	6.9	11.5	6.7	18.7	9.8	7.2	8.8	10.2	8.4	16.4	15.9	6.1	12.2	11.2	22.6	7.0	12.9	10.3	13.0	15.6	2.7	1.6	3.0	3.2	2.0	5.8	2.7	4.2	4.5	1.5	3.3	5.0	4.0	0.1	2.3	1.5	1.6	2.9	2.1	9.9	13.5	14.8	14.4	9.4	9.8	12.6	12.8	13.0	12.1
MTRR	cblE	ENSG00000124275	"5-methyltetrahydrofolate-homocysteine methyltransferase reductase"	Q9UBK8	5	7851186-7906025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038113	Supported		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA038113: AB_10671520"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (6.60e-4)"	"unprognostic (2.56e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	12.2	12.3	11.2	10.5	13.8	5.4	9.7	15.6	14.3	10.8	10.4	24.1	11.5	10.3	17.3	15.9	10.5	11.3	13.3	15.8	14.2	12.9	22.0	23.9	14.9	11.4	18.1	9.6	13.6	13.6	9.4	13.1	11.6	16.6	10.8	11.9	13.6	11.3	7.4	34.6	10.5	11.5	14.2	22.1	9.3	9.2	8.4	12.5	8.1	14.7	9.9	13.5	13.6	8.8	4.6	4.8	4.6	6.8	3.4	11.4	4.2	9.3	8.8	4.7	10.4	17.9	5.8	13.3	14.5	8.6	7.2	8.2	13.2	7.5	15.7	13.9	11.6	6.0	7.2	7.1	13.6	9.9	8.1	7.5	30.5	7.0	10.9	11.4	3.2	9.4	6.5	12.2	9.0	4.7	9.7	11.9	4.2	1.8	7.3	5.8	3.5	9.8	6.0	5.0	6.6	7.8	7.3	7.3	0.9	25.4	18.5	15.9	5.7	8.9	7.2	16.8	10.6	12.9	11.3	17.7	5.8	12.9	12.2	25.2	8.9	4.6	5.1	4.1	5.5	6.8	9.5	4.6	9.2	7.9	4.8	4.1	5.4	5.1	0.1	3.4	5.4	2.7	11.4	4.2	11.2	13.8	15.6	14.3	14.2	12.9	18.1	9.6	16.6	12.5
MTSS1	"KIAA0429, MIM, MIMA, MIMB"	ENSG00000170873	"MTSS1, I-BAR domain containing"	O43312	8	124550790-124728429	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 20.7;HDLM-2: 23.8;HEL: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 44.8"	"Group enriched"	"Detected in many"	4	"B-cells: 16.1;monocytes: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019613, HPA064003, HPA075540"	Approved	Supported	Uncertain	"Plasma membrane,Cytosol"			10000	"Plasma membrane, Cytosol"		"HPA019613: , HPA064003: , HPA075540: "	"unprognostic (1.70e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (2.11e-7)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-3)"	18.7	27.3	14.0	9.2	16.3	8.5	12.4	36.0	19.1	8.1	8.2	32.1	1.7	5.0	5.6	15.8	32.4	8.9	7.0	13.4	13.5	13.6	18.2	51.5	12.0	12.1	18.1	10.3	8.2	21.0	2.6	10.5	25.3	16.9	7.9	7.0	19.8	10.2	5.3	16.5	21.3	5.0	7.2	20.9	23.9	9.0	15.8	20.0	8.2	4.1	12.1	12.2	9.7	13.7	16.1	3.3	0.6	44.8	0.6	6.9	6.8	0.9	0.2	12.9	0.3	20.7	10.7	0.0	0.5	3.5	0.2	0.1	1.2	0.1	0.4	1.3	0.0	0.2	0.1	7.1	0.2	23.8	0.4	81.4	0.2	6.4	4.7	0.0	8.7	17.0	16.5	3.9	10.3	7.8	0.1	0.1	1.4	0.6	0.2	1.0	0.5	0.1	0.1	0.0	0.1	2.9	2.8	9.3	0.8	2.0	1.9	6.6	0.3	0.2	4.0	0.7	0.4	0.0	0.2	0.2	0.2	1.4	7.5	0.2	2.7	0.6	3.9	0.0	6.9	25.6	0.8	13.2	1.5	2.6	3.3	16.1	0.7	2.1	0.6	0.6	44.8	0.0	0.1	6.8	14.0	16.3	36.0	16.7	13.5	13.6	18.1	10.3	16.9	20.0
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99563761-99623999	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"intestine: 211.4;liver: 60.8"	"Group enriched"	"Detected in some"	6	"AF22: 12.5;Hep G2: 13.7"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA051170, HPA054862"	Uncertain		Approved	Cytosol	"Intracellular and membrane"		450000	Cytosol		"HPA051170: , HPA054862: "	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.1	0.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.0	53.2	0.2	0.1	53.4	0.0	0.0	0.2	0.2	0.4	0.4	0.3	0.4	2.7	60.8	0.1	0.0	0.4	0.1	1.1	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	211.4	0.7	0.4	0.1	0.2	1.8	0.2	0.1	0.1	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.5	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.3	0.5	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	2.3	0.2	0.3	0.1	13.7	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.3	0.3	0.2	1.2	0.0	0.0	0.8	0.9	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.3	0.4	0.4	0.1	0.3	0.2
MTURN	"C7orf41, Ells1, FLJ25903"	ENSG00000180354	"Maturin, neural progenitor differentiation regulator homolog"	Q8N3F0	7	30134810-30162762	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 189.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.6;HEL: 39.3;SCLC-21H: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 9.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.9;NK-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029507	Enhanced		Approved	Cytosol				Cytosol		"HPA029507: AB_10601149"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.11e-3)"	"prognostic favourable (7.64e-13)"	"unprognostic (9.50e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (3.26e-1)"	35.9	5.7	113.5	4.8	86.7	9.3	14.2	21.7	100.8	12.9	5.2	97.0	3.3	3.0	7.9	45.6	9.6	8.2	5.3	11.2	122.8	79.5	24.7	2.3	10.1	2.8	162.4	26.2	16.5	6.2	9.7	2.7	4.0	54.2	9.2	5.3	2.9	14.9	12.0	14.3	7.8	3.4	8.5	189.2	4.1	10.0	4.5	49.4	0.0	6.7	2.4	3.0	6.0	6.5	0.7	1.4	9.9	0.4	3.0	0.8	2.4	5.0	0.9	3.0	3.1	22.6	15.4	2.7	2.5	2.9	0.8	1.2	0.4	2.0	0.3	2.0	5.4	0.9	6.7	9.6	2.7	2.1	5.4	39.3	6.2	2.7	1.7	1.9	13.0	7.6	4.5	2.5	4.6	1.3	2.4	2.1	5.7	1.9	2.2	0.9	2.0	3.1	0.2	6.9	8.4	10.1	2.0	29.0	7.7	1.5	7.9	7.9	5.6	3.0	6.3	3.3	3.6	6.9	3.4	3.5	5.0	0.4	4.4	4.2	1.6	9.9	0.4	4.8	0.5	0.2	0.1	0.7	0.3	0.2	0.6	0.5	0.2	0.5	3.1	3.0	0.0	1.4	0.8	2.4	113.5	86.7	21.7	51.7	122.8	79.5	162.4	26.2	54.2	49.4
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720882-195741123	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 50.6"	"Cell line enriched"	"Detected in some"	8	"SK-BR-3: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"									HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		11000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	1.7	1.2	1.1	3.4	2.1	1.2	1.8	2.5	1.2	6.3	15.2	1.1	4.7	3.2	1.5	5.2	15.9	5.7	8.7	1.1	1.1	0.7	50.6	4.8	6.4	1.1	1.1	1.1	4.6	7.6	1.0	4.6	13.3	1.1	4.9	7.6	1.2	10.6	1.8	2.5	2.1	4.1	2.0	1.1	1.6	2.3	1.8	1.1	3.0	3.9	1.9	14.9	10.6	26.6	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.5	0.0	1.3	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.5	0.1	0.8	0.1	0.8	0.0	1.9	1.0	0.3	0.0	24.8	0.1	0.1	0.0	0.0	0.2	0.7	0.8	0.1	1.1	1.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	2.5	1.2	1.1	0.7	1.1	1.1	1.1	1.1
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508161	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favourable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	13.3	15.9	10.3	12.9	12.3	20.6	20.4	9.2	22.2	13.1	15.8	19.0	8.0	11.6	18.2	10.7	17.2	17.0	18.5	26.2	11.7	12.5	20.5	20.1	16.3	12.1	16.8	9.5	17.5	26.8	21.9	13.0	21.6	17.6	13.9	13.3	14.3	15.3	18.1	26.7	17.4	19.5	17.0	11.7	13.6	15.2	14.1	11.6	18.5	15.1	14.6	14.0	16.3	13.6	23.2	26.0	31.9	30.4	25.2	32.1	27.5	16.9	16.4	9.5	19.6	20.6	11.6	10.3	16.9	20.2	21.0	20.3	10.1	28.2	12.8	18.9	23.8	25.9	17.0	24.4	15.3	12.7	13.5	9.8	11.1	14.6	24.3	13.4	16.8	18.9	32.2	21.5	22.4	13.7	12.7	15.6	22.8	8.6	8.0	9.0	9.7	15.7	7.9	11.9	16.5	24.7	9.5	9.7	14.3	15.1	16.2	20.7	11.4	12.9	15.4	20.5	11.8	17.8	15.1	18.3	15.9	13.8	16.1	18.2	19.0	26.3	26.5	31.9	30.9	30.4	32.1	23.2	23.6	31.4	26.0	21.5	27.1	26.3	24.0	25.2	25.4	20.1	32.1	27.5	10.3	12.3	9.2	22.2	11.7	12.5	16.8	9.5	17.6	11.6
MUM1	"EXPAND1, MUM-1"	ENSG00000160953	"Melanoma associated antigen (mutated) 1"	Q2TAK8	19	1354711-1378431	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048063	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA048063: "	"unprognostic (2.50e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (4.82e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.84e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"prognostic favourable (2.25e-6)"	"unprognostic (1.60e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-3)"	6.7	5.3	14.4	3.6	20.9	2.1	5.6	21.9	19.2	7.0	5.8	13.6	4.5	3.7	10.4	5.6	4.3	13.0	5.4	5.3	13.6	9.1	4.9	8.3	6.8	3.6	14.2	11.5	18.4	4.0	7.7	7.5	6.0	11.5	6.7	4.8	5.8	6.7	8.7	5.5	8.1	4.8	11.5	10.5	6.0	4.8	19.9	13.1	1.9	6.0	0.9	4.5	5.6	11.5	4.3	3.9	11.8	2.6	3.8	4.5	1.3	7.1	9.2	13.0	13.8	10.5	14.1	15.9	12.5	7.8	11.5	8.6	6.3	4.8	14.6	5.9	16.1	8.2	13.0	8.1	8.8	15.7	8.2	7.9	9.5	9.6	10.1	6.0	17.7	9.2	5.1	6.5	4.7	11.8	12.1	7.4	11.0	8.0	10.4	6.4	14.6	5.3	16.7	10.8	6.1	7.7	10.5	9.4	21.4	11.0	13.1	8.4	6.4	14.0	11.3	10.5	14.5	8.5	11.6	14.9	12.6	6.7	13.9	9.9	14.1	11.8	1.1	6.8	4.5	2.6	3.8	3.9	2.5	3.3	2.1	4.3	3.7	4.0	2.2	3.8	2.2	3.9	1.6	1.3	14.4	20.9	21.9	19.2	13.6	9.1	14.2	11.5	11.5	13.1
MUT		ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463191	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol			110000	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favourable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	10.7	14.3	10.9	5.7	13.4	4.1	9.7	10.0	12.1	8.9	12.7	8.6	9.0	13.6	8.7	8.6	13.2	8.4	7.5	16.6	10.1	10.0	25.5	96.5	7.8	5.7	11.8	9.5	13.1	15.7	15.8	13.5	7.5	12.0	11.2	11.2	8.0	9.3	9.2	13.7	9.0	14.7	11.8	9.7	6.4	10.9	9.1	9.9	8.2	11.2	9.1	5.8	12.8	8.1	9.4	8.9	14.0	15.2	14.2	12.0	6.7	13.2	4.7	14.3	16.6	28.5	27.1	7.9	11.9	15.7	12.6	18.7	5.4	6.9	12.3	9.5	12.7	7.6	15.9	8.4	17.8	10.5	11.5	6.5	10.8	14.2	20.8	8.3	6.3	16.4	12.6	12.8	15.0	12.1	11.9	14.8	14.8	8.3	9.7	8.3	6.1	3.5	8.8	17.9	17.0	14.6	12.8	13.3	9.2	13.1	9.4	19.7	8.2	13.4	8.7	11.8	8.7	15.9	16.0	5.9	6.6	10.6	16.6	9.9	10.2	14.0	7.5	12.5	7.9	9.9	9.9	9.4	9.5	9.9	8.9	8.3	12.0	9.0	4.3	14.2	15.2	6.3	11.9	6.7	10.9	13.4	10.0	12.1	10.1	10.0	11.8	9.5	12.0	9.9
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"			30000	Cytosol	"Cell Junctions"	"HPA041404: , HPA048250: "	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	11.9	18.5	15.8	16.9	19.7	7.6	12.5	21.7	27.9	10.8	19.4	17.1	10.8	39.6	8.4	7.3	30.0	7.4	8.7	11.9	17.2	18.2	9.2	25.9	14.6	12.6	14.6	17.3	11.1	19.0	11.0	7.8	7.6	24.5	13.7	5.1	10.8	16.1	8.7	27.8	18.3	20.7	6.6	23.8	11.1	21.2	23.0	14.6	4.3	9.2	18.6	12.2	7.3	13.8	15.0	17.6	2.5	8.9	18.1	18.1	9.4	14.6	9.4	15.7	10.2	5.3	11.8	8.9	7.3	7.6	5.0	4.2	24.8	37.1	7.1	11.7	4.3	21.8	7.0	38.6	1.4	4.4	11.9	5.2	5.2	37.7	10.8	3.3	3.7	9.3	7.4	13.2	4.2	5.3	14.4	3.9	2.7	34.2	11.1	16.8	18.9	9.2	11.7	4.5	18.3	14.6	9.2	15.9	5.3	18.1	4.1	5.3	20.6	14.8	11.3	4.6	9.4	8.2	4.1	10.8	4.8	24.2	5.6	16.2	7.6	2.5	8.2	1.5	18.1	8.6	13.5	10.3	12.1	11.9	9.5	15.0	9.4	11.5	1.1	18.1	8.9	17.6	12.6	9.4	15.8	19.7	21.7	27.9	17.2	18.2	14.6	17.3	24.5	14.6
MVK	"LRBP, MK"	ENSG00000110921	"Mevalonate kinase"	Q03426	12	109573255-109598117	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016961, HPA044110"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA016961: AB_1854220, HPA044110: "	"unprognostic (3.10e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.28e-1)"	4.7	14.3	6.8	5.9	11.7	6.8	11.2	6.3	13.1	7.1	7.8	16.7	5.1	11.5	4.2	9.5	23.0	5.1	5.3	6.7	7.8	9.0	16.5	33.1	8.7	4.9	12.5	8.3	8.5	9.3	7.0	6.5	5.5	22.5	9.0	6.3	6.4	8.1	5.8	6.3	19.5	6.9	3.7	18.0	3.8	6.1	17.5	10.5	2.8	11.9	8.5	8.8	5.5	9.9	11.5	7.4	3.4	5.9	8.3	12.2	5.4	12.3	10.4	12.7	6.3	4.1	10.1	6.8	4.5	8.4	11.8	12.9	15.0	15.1	8.7	3.5	4.5	15.1	13.5	21.2	5.7	8.5	9.6	4.6	7.1	22.4	12.7	4.9	5.9	11.0	17.9	21.4	5.8	8.0	8.0	8.3	5.3	15.6	5.0	15.7	10.7	16.1	4.6	9.7	17.0	27.2	18.4	11.8	10.2	8.8	25.1	6.2	23.1	8.6	7.0	5.4	7.1	5.2	5.7	7.0	9.2	12.8	6.5	12.7	7.4	0.7	5.9	3.4	12.2	5.8	9.9	8.4	7.4	11.6	7.4	11.5	11.7	8.3	1.7	8.3	3.7	6.2	6.2	5.4	6.8	11.7	6.3	13.1	7.8	9.0	12.5	8.3	22.5	10.5
MVP	"LRP, VAULT1"	ENSG00000013364	"Major vault protein"	Q14764	16	29820394-29848039	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	Ribonucleoprotein	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002321, CAB002752, CAB022717, HPA064740"	Enhanced		Supported	Cytosol			38000	Cytosol		"CAB002752: , CAB022717: , HPA002321: AB_1079277, HPA064740: "	"prognostic favourable (4.51e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.86e-1)"	"prognostic favourable (5.49e-5)"	"unprognostic (2.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.65e-2)"	32.4	55.4	6.8	37.8	17.9	13.9	20.7	5.4	11.4	20.5	49.5	12.0	11.7	48.7	29.5	29.0	28.6	21.0	46.6	27.8	6.6	6.0	58.9	43.6	57.9	59.4	20.4	4.9	42.7	37.2	8.9	14.6	22.8	13.2	18.3	32.6	14.5	23.3	14.8	16.9	17.6	81.5	24.4	14.6	38.8	34.2	27.4	13.5	17.4	27.1	23.5	23.3	25.4	21.6	10.1	28.7	41.1	53.1	17.6	22.4	33.3	10.4	31.0	0.9	1.0	36.9	48.4	4.5	26.6	43.8	16.2	21.0	4.7	35.5	1.9	21.7	38.9	13.5	1.5	23.3	7.8	25.3	1.6	0.6	13.4	13.9	33.3	1.0	11.4	63.2	18.3	36.0	10.6	47.1	0.7	15.1	28.6	5.2	0.5	2.7	1.0	3.8	2.4	1.6	6.6	39.1	17.9	3.7	2.0	7.6	9.8	5.5	2.3	3.7	68.7	21.1	10.5	20.3	10.6	11.9	8.4	1.1	49.3	1.9	4.4	9.7	33.8	13.4	19.3	53.1	15.1	10.1	21.8	19.8	28.7	7.1	16.8	14.9	41.1	17.6	47.5	17.5	22.4	33.3	6.8	17.9	5.4	11.4	6.6	6.0	20.4	4.9	13.2	13.5
MX1	"IFI-78K, MxA"	ENSG00000157601	"MX dynamin like GTPase 1"	P20591	21	41420304-41459214	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 117.5;BJ hTERT+ SV40 Large T+ RasG12V: 105.8;Karpas-707: 27.1;SK-MEL-30: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030917, HPA030918, HPA049724"	Approved	Approved	Supported	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862"	"unprognostic (3.62e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.88e-2)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (9.95e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.81e-1)"	19.3	7.5	8.6	19.8	22.5	25.7	11.6	3.1	15.5	14.4	12.8	9.4	4.7	14.7	13.2	19.3	19.2	12.4	19.0	8.1	12.4	16.2	20.8	11.9	28.4	17.3	14.3	11.4	16.3	7.2	7.5	16.2	9.7	20.5	7.2	5.4	15.9	54.0	8.4	3.7	5.7	15.4	11.3	13.1	34.5	16.2	5.2	4.8	33.7	16.9	14.5	20.7	15.6	11.5	22.8	25.0	36.5	27.0	9.2	29.5	17.0	2.3	0.0	0.1	0.2	0.1	1.0	0.0	0.1	3.7	117.5	105.8	0.7	4.9	0.0	1.0	0.4	0.3	0.1	0.1	2.3	0.7	0.1	0.2	0.4	0.3	1.1	0.1	0.1	1.0	0.3	7.0	0.2	0.4	0.0	27.1	0.0	0.2	2.0	0.4	0.4	1.1	2.0	0.0	3.7	0.5	1.5	0.2	0.1	0.1	0.2	35.4	1.6	0.9	0.2	0.1	0.1	0.0	0.1	6.0	5.6	0.2	0.1	0.4	0.3	13.7	24.0	14.0	10.9	27.0	14.6	22.8	16.0	12.7	16.9	20.1	14.5	10.7	36.5	9.2	22.0	25.0	29.5	17.0	8.6	22.5	3.1	15.5	12.4	16.2	14.3	11.4	20.5	4.8
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;bone marrow: 72.8;esophagus: 64.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 81.1"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	6.9	2.2	2.7	18.7	3.8	72.8	3.7	5.7	4.1	15.8	19.6	4.7	0.9	13.6	2.9	2.6	64.8	3.8	4.9	10.8	3.0	2.9	3.0	5.5	17.0	14.3	5.9	2.4	3.3	2.5	3.6	4.0	15.8	3.1	3.3	14.0	5.1	8.8	1.4	3.1	5.9	50.2	4.6	4.3	15.8	8.2	3.6	3.7	9.4	4.0	20.8	34.0	6.3	21.6	0.2	0.8	81.1	1.6	0.4	0.4	0.6	3.4	1.5	2.2	1.6	4.9	2.4	8.2	3.8	2.2	1.9	1.3	4.9	2.7	2.0	2.0	1.5	12.3	4.2	7.7	2.0	1.1	5.0	4.1	4.4	4.8	16.4	4.9	4.1	2.8	13.0	4.3	20.0	2.4	7.1	7.9	1.2	2.8	2.4	9.9	0.6	2.5	1.1	2.2	4.9	2.5	4.1	7.1	3.0	5.1	6.8	2.7	1.0	2.9	9.4	2.7	0.7	2.9	3.6	5.4	9.1	0.7	2.8	8.7	1.0	17.0	1.6	16.8	0.3	1.0	0.4	0.1	0.2	0.2	0.8	0.2	0.2	0.3	81.1	0.4	0.8	0.2	0.2	0.6	2.7	3.8	5.7	4.1	3.0	2.9	5.9	2.4	3.1	3.7
MXD4	"bHLHc12, MAD4, MST149, MSTP149"	ENSG00000123933	"MAX dimerization protein 4"	Q14582	4	2247432-2262294	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053363			Supported	Cytosol				Cytosol		"HPA053363: "	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.54e-2)"	"prognostic favourable (2.21e-5)"	"unprognostic (1.64e-1)"	"unprognostic (5.94e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.39e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.12e-2)"	31.9	21.6	20.1	11.8	17.1	23.3	26.2	63.2	23.3	16.5	17.6	15.1	29.8	17.4	19.7	19.7	13.6	24.4	19.2	19.8	16.0	13.1	23.3	12.1	20.0	19.9	13.5	12.4	12.6	18.7	11.4	32.7	24.5	14.4	17.6	7.3	18.3	32.7	26.3	19.3	24.3	16.8	13.8	11.4	29.8	15.1	11.8	11.3	34.8	17.6	8.0	16.1	16.2	21.3	3.5	10.6	8.1	4.3	2.7	5.6	1.9	0.9	3.5	5.6	6.7	19.8	14.8	1.3	7.0	7.2	5.3	5.4	0.8	3.0	3.0	15.9	10.6	4.8	1.6	5.6	1.3	2.6	17.1	0.5	11.9	9.8	14.6	2.3	6.4	23.0	10.0	1.7	2.7	12.6	4.0	5.0	4.9	6.8	5.2	13.2	2.2	15.8	3.5	1.9	6.2	6.2	5.5	9.1	17.0	6.6	3.2	5.0	15.3	14.6	29.4	5.8	2.4	4.3	1.5	7.7	5.4	1.1	8.0	2.0	1.7	8.1	4.2	4.8	5.3	4.3	4.3	3.4	4.7	5.0	3.6	3.5	2.4	2.5	1.7	2.7	4.1	10.6	5.6	1.9	20.1	17.1	63.2	23.3	16.0	13.1	13.5	12.4	14.4	11.3
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 29.5;SK-MEL-30: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: "	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavourable (9.17e-4)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	16.9	19.4	37.2	7.5	34.9	32.7	26.5	56.4	36.9	20.3	26.4	33.9	20.1	12.0	26.0	23.8	39.5	19.1	17.4	36.0	35.1	26.6	23.9	30.5	16.5	7.1	37.0	25.9	46.4	23.1	25.6	12.1	14.4	26.2	24.5	22.1	15.8	41.2	32.7	22.8	25.4	22.5	18.2	44.7	7.8	14.7	13.5	38.1	7.0	29.2	13.4	9.8	32.8	33.9	4.5	2.2	11.0	4.7	1.4	8.6	2.3	5.5	2.2	5.7	11.4	9.0	6.8	2.5	3.2	11.0	2.1	6.8	1.0	10.0	7.3	5.2	5.6	7.2	6.8	7.7	5.7	3.7	9.2	1.9	4.5	4.1	5.9	3.9	4.4	7.2	29.5	3.7	15.0	2.1	7.3	15.9	3.5	3.6	2.6	7.9	2.4	6.8	1.6	7.5	11.6	7.5	0.5	9.7	15.9	3.2	2.4	53.2	2.7	12.7	2.1	3.8	6.5	4.0	1.7	13.2	6.9	2.6	10.1	14.5	4.0	2.2	3.1	11.0	3.1	2.5	5.8	3.9	6.7	3.6	1.7	4.5	8.6	2.2	7.8	1.4	4.7	2.2	5.0	2.3	37.2	34.9	56.4	36.9	35.1	26.6	37.0	25.9	26.2	38.1
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell line enhanced"	"Detected in many"		"HL-60: 38.9;MOLT-4: 70.8;NB-4: 36.9;REH: 43.7;THP-1: 61.8;U-937: 33.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favourable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favourable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	1.8	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	24.8	0.1	0.0	0.0	38.9	19.6	0.0	0.0	0.1	0.0	0.0	20.1	3.7	0.2	2.0	70.8	36.9	0.2	0.3	43.7	1.0	6.0	0.0	0.2	1.9	1.2	0.0	1.9	0.0	1.4	61.8	0.0	0.0	0.3	1.4	0.4	4.7	1.2	12.0	0.0	33.7	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716496	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2"	"Cell line enhanced"	"Detected in many"		"MCF7: 101.9"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	30	"plasmacytoid DC: 35.9"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 35.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017114: , HPA030530: , HPA055416: "	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.7	0.7	0.2	48.3	0.2	33.0	1.0	0.2	0.2	1.0	4.4	0.2	0.1	2.7	1.1	1.1	8.4	0.3	1.7	0.9	0.2	0.2	1.0	1.2	1.8	22.3	0.3	0.1	0.8	9.4	0.0	0.4	4.0	0.2	0.7	2.7	0.3	2.9	0.1	0.3	1.8	6.4	0.6	0.3	43.9	2.9	12.6	0.1	49.2	0.6	6.4	33.8	1.9	2.1	1.1	35.9	0.0	0.0	0.0	0.4	0.3	25.8	16.5	14.6	15.1	0.1	0.5	19.0	11.7	4.0	37.1	27.4	80.9	16.3	52.3	6.8	5.1	15.8	26.4	8.1	13.9	9.8	16.9	24.5	16.5	21.8	0.0	22.3	17.0	0.3	0.7	14.1	3.2	9.9	24.4	65.1	3.2	101.9	45.3	31.4	16.8	14.5	31.6	30.1	30.0	6.8	5.3	13.5	19.6	34.8	35.0	3.5	23.1	24.5	4.6	2.3	37.4	16.4	20.1	22.6	46.5	82.3	4.8	19.1	14.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	35.9	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1
MYD88		ENSG00000172936	"Myeloid differentiation primary response 88"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 68.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol				Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favourable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	25.0	11.3	5.9	19.5	6.9	18.1	14.7	5.2	4.6	10.0	13.4	5.8	5.0	15.1	9.5	12.3	25.5	9.8	12.4	10.4	5.3	3.2	15.1	47.9	25.6	40.1	6.2	3.5	13.3	10.3	5.4	10.4	17.8	6.7	11.3	14.3	8.8	13.9	5.4	3.9	12.5	30.4	10.7	7.0	39.0	12.5	5.8	5.1	28.5	10.4	17.5	30.8	13.9	13.7	7.8	34.7	49.0	68.0	8.3	14.3	34.6	8.1	12.0	1.8	10.7	8.5	11.1	3.7	8.0	13.1	22.6	24.0	7.5	9.9	17.4	4.8	14.3	10.2	14.2	8.0	7.6	13.5	2.9	9.4	6.1	11.4	7.0	11.9	24.6	12.7	8.5	12.8	4.8	12.8	4.1	7.1	11.8	8.2	19.6	3.8	7.6	12.0	8.5	2.3	7.5	11.6	19.0	0.8	3.9	11.3	54.5	7.1	8.5	13.5	11.9	4.4	2.7	20.4	7.6	10.5	11.7	12.9	8.6	20.9	9.6	38.3	37.6	48.1	12.2	56.5	10.4	7.8	11.0	12.2	34.7	6.7	7.7	10.9	49.0	8.3	68.0	16.6	14.3	34.6	5.9	6.9	5.2	4.6	5.3	3.2	6.2	3.5	6.7	5.1
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474205-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"			130000000	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: , HPA057198: "	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavourable (6.42e-4)"	18.3	12.3	12.6	5.4	24.7	7.9	9.6	15.6	30.8	16.9	7.3	5.4	5.3	1.9	19.9	12.4	5.0	18.0	18.2	25.7	15.1	12.9	23.7	13.0	40.0	4.2	9.5	16.7	21.8	6.9	14.7	18.4	35.9	19.2	12.9	3.1	8.6	4.7	19.6	3.3	5.1	3.9	15.7	4.9	3.3	7.1	5.3	5.9	2.7	9.7	2.6	3.0	9.8	7.4	0.5	0.2	2.8	0.1	0.0	1.1	0.2	13.6	9.0	57.2	19.1	7.5	9.0	25.7	11.4	10.4	13.8	14.9	24.2	2.1	0.1	7.6	11.3	1.3	28.4	13.7	15.6	0.3	23.1	15.8	5.8	21.0	17.5	1.3	1.1	12.8	5.0	17.9	6.9	22.3	21.9	0.0	8.6	5.4	16.7	0.4	26.9	2.0	26.8	17.0	0.0	15.7	5.7	4.7	25.7	17.9	0.9	18.3	4.8	0.9	0.7	13.0	9.6	0.1	9.8	2.2	2.6	3.4	0.0	1.3	29.2	0.0	0.1	0.1	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.2	1.1	0.5	2.8	0.0	0.0	0.2	0.3	0.2	12.6	24.7	15.6	30.8	15.1	12.9	9.5	16.7	19.2	5.9
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703172-15857033	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 507.4;urinary bladder: 394.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;NB-4: 3.8;U-698: 9.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 173.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 54.5"	"CAB002302, HPA014539, HPA015310"	Enhanced		Supported	"Plasma membrane,Cytosol"			130000000	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1854260, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	13.2	3.0	0.6	31.5	1.2	0.0	5.9	0.5	1.7	90.3	227.5	1.3	100.0	11.6	102.0	38.4	233.0	43.8	94.3	6.2	0.6	0.7	4.7	0.7	8.5	1.5	1.4	2.6	45.5	1.3	0.0	1.0	5.3	3.6	164.7	22.2	37.0	8.8	127.2	6.4	5.0	50.6	507.4	1.4	3.7	77.7	22.3	0.2	0.1	3.7	6.2	3.0	394.5	57.5	1.5	0.9	6.0	0.9	1.1	1.5	0.4	0.1	0.4	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.3	3.8	0.4	0.1	0.4	0.1	1.9	0.0	0.2	0.7	1.4	0.2	0.5	1.2	0.4	0.0	0.3	0.1	0.3	2.0	0.1	0.4	0.4	9.7	0.4	0.4	0.4	3.1	0.9	2.7	1.2	0.6	1.2	1.5	1.5	1.4	0.5	1.2	1.4	1.4	6.0	1.1	0.6	0.9	1.4	0.4	0.6	1.2	0.5	1.7	0.6	0.7	1.4	2.6	3.6	0.2
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281277-36388067	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"			3100000000	"Plasma membrane, Actin filaments"	Cytosol	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	115.5	26.1	11.9	43.7	12.9	55.6	59.0	9.3	16.8	67.1	44.6	18.0	26.4	26.9	120.8	39.7	48.3	45.6	66.9	39.2	11.0	8.1	45.0	42.8	74.4	57.7	15.1	9.2	56.4	43.9	19.0	15.4	65.7	17.9	47.6	23.6	32.4	66.2	27.2	36.9	40.3	49.8	46.7	13.5	91.5	37.1	25.8	11.9	76.0	42.5	38.4	65.0	56.0	53.7	6.9	8.2	28.5	11.5	4.2	16.6	19.3	60.6	28.2	9.0	7.6	16.8	21.1	45.7	40.7	52.7	58.2	43.7	30.4	17.5	15.7	24.2	68.1	42.1	13.1	79.7	60.0	35.4	12.4	30.3	30.3	25.9	51.5	34.4	48.6	24.9	24.6	78.6	66.8	47.9	6.6	21.3	46.5	16.1	12.2	20.3	5.3	17.4	23.3	27.9	14.6	32.9	59.1	13.5	5.5	57.2	22.5	26.2	16.8	17.8	137.0	129.1	39.2	24.7	73.5	14.1	11.1	13.3	48.9	17.4	37.4	26.8	10.4	28.5	16.6	9.6	14.7	6.9	12.0	13.2	8.2	6.4	9.6	10.1	19.7	4.2	11.5	3.8	12.6	19.3	11.9	12.9	9.3	16.8	11.0	8.1	15.1	9.2	17.9	11.9
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216939-44218236	"Predicted intracellular proteins"	Myogenesis			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"adipose tissue: 27.4;blood: 12.2;pancreas: 9.0"	"Cell line enriched"	"Detected in some"	31	"RH-30: 55.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"					"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	121	"dendritic cells: 12.2"	"Not detected"	"Not detected"							HPA051451	Approved		Approved	Vesicles,Mitochondria,Cytosol				Vesicles	"Mitochondria, Cytosol"	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	27.4	0.0	0.0	1.0	0.0	0.0	2.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.8	0.0		1.1	0.0	0.5	1.4	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.7	0.0	2.2	0.0	0.1	0.0	0.0	1.8	3.2	0.6	0.0	2.8	0.4	0.0	0.4	0.5	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	55.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.1										
MYO10	KIAA0799	ENSG00000145555	"Myosin X"	Q9HD67	5	16661914-16936276	"Plasma proteins, Predicted intracellular proteins"	Transport	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 38.8;SK-MEL-30: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015224, HPA024223"	Enhanced		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"CAB015224: , HPA024223: AB_1854248"	"unprognostic (1.13e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (8.93e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.84e-1)"	10.5	3.4	28.1	5.1	30.1	3.0	8.0	8.9	39.7	6.3	15.3	17.3	6.6	19.5	5.7	4.3	7.7	3.8	7.7	3.7	26.2	10.9	13.3	7.1	14.5	1.6	14.6	15.3	12.1	22.0	10.4	16.2	22.0	10.6	5.4	15.8	19.7	9.8	7.4	6.6	13.4	14.6	4.3	11.1	10.9	24.2	12.4	18.5	0.5	28.6	3.3	2.3	6.6	7.1	0.9	0.5	1.1	6.0	0.5	0.6	0.3	13.1	20.9	8.7	4.1	6.4	3.5	8.0	23.6	16.7	6.6	5.4	13.2	2.2	0.4	16.2	10.7	7.0	38.8	15.5	12.3	0.0	3.9	0.0	34.9	3.7	23.6	0.1	0.4	7.1	6.8	15.9	19.0	22.0	0.0	1.3	6.4	2.6	0.0	0.1	22.5	7.6	5.3	2.2	13.9	6.6	10.2	1.1	0.6	5.1	2.6	45.3	1.7	2.1	26.6	16.0	5.9	0.2	12.9	0.2	0.1	0.1	7.9	2.5	15.9	1.0	0.6	0.5	0.3	1.5	0.4	0.3	0.4	0.3	0.5	0.9	0.6	0.6	1.1	0.5	6.0	0.4	0.3	0.3	28.1	30.1	8.9	20.7	26.2	10.9	14.6	15.3	10.6	18.5
MYO15B	MYO15BP	ENSG00000266714	"Myosin XVB"		17	75588058-75626501	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in all"	10	"intestine: 155.3"	"Cell line enhanced"	"Detected in many"		"A549: 25.6;HEL: 10.7;HMC-1: 14.7;THP-1: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA022857, HPA023105"			Approved	Cytosol				Cytosol		"HPA022857: AB_1848813, HPA023105: AB_1859526"	"prognostic favourable (9.34e-4)"	"unprognostic (7.55e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.59e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-1)"	"prognostic favourable (6.90e-5)"	7.5	2.8	4.2	7.3	5.3	13.8	8.9	1.6	4.3	8.0	58.9	8.1	5.4	48.9	13.6	4.5	2.8	10.8	13.5	5.8	4.5	1.7	13.0	2.0	10.7	5.0	6.5	5.5	14.9	3.6	1.8	3.7	4.0	5.1	7.1	5.9	6.5	5.2	4.5	3.1	3.9	155.3	5.9	4.0	13.2	4.8	3.1	5.9	5.5	14.0	2.3	4.0	4.9	7.2	2.8	2.0	6.2	1.5	1.9	1.4	1.1	0.3	25.6	0.3	0.9	0.2	0.4	0.3	0.1	0.0	0.0	0.0	3.3	7.3	0.3	1.0	0.0	0.4	0.0	0.0	0.0	0.3	1.9	10.7	4.9	6.3	0.7	0.0	14.7	0.7	0.4	0.0	0.0	0.1	0.6	2.8	0.0	3.5	0.2	4.2	0.5	6.4	6.6	0.2	1.1	0.1	0.5	1.0	2.0	0.2	0.4	0.8	2.2	21.1	0.5	0.1	1.1	0.1	0.1	1.4	0.8	0.1	0.6	5.2	0.4	2.4	1.5	1.2	1.4	1.4	0.9	1.5	0.7	0.5	0.8	2.8	0.5	1.0	6.2	1.9	1.5	2.0	0.2	1.1	4.2	5.3	1.6	4.3	4.5	1.7	6.5	5.5	5.1	5.9
MYO19	"FLJ22865, MYOHD1"	ENSG00000278259	"Myosin XIX"	Q96H55	17	36495633-36543435	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059715	Approved		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA059715: "	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavourable (8.33e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.17e-2)"	5.2	1.9	3.1	5.4	6.2	7.8	4.7	2.7	6.5	4.7	7.7	7.0	6.8	7.5	4.3	4.1	9.8	3.4	4.1	1.4	4.7		5.7	7.0	3.8	5.2	6.1	3.1	2.9	5.8	9.8	7.2	8.1	5.0	2.8	11.2	4.8	9.5	9.3	6.3	13.1	7.9	5.2	5.4	3.0	8.3	8.0	5.7	5.8	4.2	5.6	7.2	3.3	2.8	2.2	3.4	1.7	1.7	3.7	3.9	1.4	13.8	17.0	8.1	9.3	4.5	4.5	9.9	13.8	11.0	22.0	22.5	16.8	14.5	8.7	5.5	9.4	21.0	19.2	14.5	15.8	6.2	13.0	13.9	18.6	10.5	3.0	13.5	15.2	4.2	7.2	15.7	17.2	9.8	16.3	9.2	11.1	10.5	9.4	11.0	9.0	10.0	10.9	13.1	10.3	10.3	11.3	14.0	8.7	18.4	11.3	5.8	18.5	5.5	6.3	12.4	14.0	16.8	24.3	7.1	14.0	8.0	7.7	8.3	14.4	1.7	1.7	1.7	3.8	1.2	2.8	2.2	2.4	2.6	3.4	1.7	1.7	3.9	0.1	3.7	0.5	1.9	2.0	1.4										
MYO1D	"KIAA0727, myr4, PPP1R108"	ENSG00000176658	"Myosin ID"	O94832	17	32492522-32877177	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 33.9;CACO-2: 45.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 2.6"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054744	Uncertain		Approved	Cytosol				Cytosol		"HPA054744: "	"unprognostic (3.83e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.70e-3)"	"unprognostic (3.95e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (5.01e-6)"	"unprognostic (1.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (4.53e-6)"	20.3	16.9	4.4	21.6	14.4	1.8	13.9	8.8	9.7	12.8	53.1	26.2	4.8	40.5	12.5	11.8	19.8	9.2	26.9	7.4	6.4	3.7	15.7	8.1	17.7	6.9	18.4	6.8	14.7	15.2	19.6	7.4	8.4	11.6	11.3	45.6	10.2	18.7	7.1	3.8	22.0	46.5	9.4	20.9	5.9	13.1	6.4	15.7	2.5	21.9	10.6	13.4	12.7	13.9	1.7	0.2	0.3	0.0	0.4	2.6	0.5	9.6	0.4	0.2	0.1	33.9	19.5	0.3	5.7	11.3	1.0	6.6	45.0	15.4	5.4	1.2	25.6	9.1	1.2	14.4	1.6	0.6	11.6	4.9	0.0	3.1	2.2	0.0	2.7	5.6	9.2	8.4	7.6	14.2	8.2	9.0	5.1	11.6	0.0	0.1	1.8	8.6	0.0	6.6	6.2	4.6	19.0	11.3	1.9	1.9	3.5	28.6	15.6	0.0	17.5	5.1	2.5	0.2	0.1	11.0	12.5	0.0	6.9	0.0	1.5	0.0	0.0	0.0	1.1	0.0	2.6	1.7	1.2	1.4	0.2	0.3	0.3	0.4	0.3	0.4	0.0	0.0	1.1	0.5	4.4	14.4	8.8	9.7	6.4	3.7	18.4	6.8	11.6	15.7
MYO5C	MGC74969	ENSG00000128833	"Myosin VC"	Q9NQX4	15	52192322-52295798	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 13.1;MCF7: 23.4;RT4: 13.6;SK-BR-3: 17.9;T-47d: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020790, HPA032115, HPA032116"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB020790: , HPA032115: , HPA032116: "	"unprognostic (1.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-2)"	"prognostic favourable (5.18e-5)"	"unprognostic (2.94e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.82e-2)"	"prognostic favourable (2.47e-5)"	"prognostic favourable (5.82e-4)"	"unprognostic (9.15e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.32e-1)"	11.2	1.5	2.7	4.0	4.0	0.4	10.7	14.7	3.4	11.1	10.0	3.4	9.5	3.7	3.7	9.8	6.6	8.6	12.2	1.7	2.5	1.7	6.4	2.7	11.4	1.2	2.6	3.0	2.6	33.9	18.5	7.8	2.1	7.5	7.8	13.2	6.5	22.6	12.8	2.1	4.3	4.1	4.2	4.3	2.7	14.2	4.7	3.4	0.5	15.1	3.7	3.8	4.5	18.4	1.2	1.6	1.5	0.0	0.0	2.9	0.1	10.8	13.1	1.8	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	2.0	4.6	0.6	2.8	0.0	1.8	2.7	3.8	0.0	0.5	4.4	0.0	9.3	8.0	0.0	0.0	0.1	0.0	3.8	0.0	3.6	2.9	0.0	0.2	0.0	23.4	0.6	0.1	0.7	6.2	8.9	1.1	5.4	10.4	13.6	1.9	2.0	0.8	17.9	0.0	21.5	0.0	0.0	0.0	0.1	0.0	1.7	0.3	0.3	1.1	0.1	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.2	0.2	1.0	0.4	0.4	0.3	1.5	0.0	0.0	1.6	2.9	0.1	2.7	4.0	14.7	3.4	2.5	1.7	2.6	3.0	7.5	3.4
MYO7A	"DFNA11, DFNB2, NSRD2, USH1B"	ENSG00000137474	"Myosin VIIA"	Q13402	11	77128264-77215241	"Disease related genes, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease mutation, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.3;retina: 30.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.3;CACO-2: 6.9;RH-30: 15.6;RPMI-8226: 10.2;SK-BR-3: 8.5;U-937: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 5.6;intermediate monocyte: 4.0;NK-cell: 1.4"	"Group enriched"	"Detected in many"	10	"monocytes: 5.6;NK-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA028918, CAB034059"	Uncertain		Approved	Cytosol				Cytosol		"CAB034059: AB_2148626, HPA028918: AB_10603022"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.03e-2)"	5.8	26.3	3.6	3.7	5.6	1.1	5.0	0.7	3.0	1.3	1.7	3.5	0.9	2.2	1.3	2.9	1.2	2.3	2.8	1.7	4.0	3.8	5.3	14.8	1.6	4.5	5.2	1.7	4.4	3.8	1.2	25.1	16.9	7.2	13.6	1.4	30.9	1.1	0.9	1.0	0.6	2.4	2.4	3.9	11.2	2.0	22.9	4.7	0.5	1.5	0.3	1.1	1.9	4.4	0.0	0.3	0.0	5.6	1.4	0.1	1.8	0.0	1.1	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	6.9	2.0	0.0	1.6	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.3	4.2	0.1	0.0	0.0	0.1	0.0	0.0	0.5	2.9	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.3	0.0	15.6	10.2	0.0	0.2	2.4	0.7	0.1	8.5	0.1	1.2	1.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	5.6	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	1.8	3.6	5.6	0.7	3.0	4.0	3.8	5.2	1.7	7.2	4.7
MYO9B	CELIAC4	ENSG00000099331	"Myosin IXB"	Q13459	19	17075781-17214537	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, GTPase activation, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037190, HPA042043"	Approved		Supported	Cytosol				Cytosol		"CAB037190: AB_477214, HPA042043: AB_10796897"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (5.66e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.53e-2)"	17.4	14.3	14.3	34.7	30.2	59.3	16.0	16.2	25.0	12.7	15.3	40.1	10.6	12.5	16.2	12.8	11.0	10.0	14.9	11.2	16.0	11.8	9.4	12.9	25.0	37.4	38.8	10.7	8.2	9.0	6.7	9.2	15.2	18.8	15.6	11.1	14.7	12.3	10.7	4.8	13.5	20.3	17.2	27.8	55.9	15.2	21.8	28.2	17.4	9.2	5.4	24.8	17.2	16.2	3.3	4.4	14.4	4.7	2.9	3.9	1.9	18.9	8.8	11.8	13.8	8.6	9.1	34.2	18.0	9.3	11.4	10.0	7.1	9.7	17.7	10.1	15.8	11.9	5.0	8.8	8.6	31.5	10.3	21.3	10.4	6.7	11.0	16.6	34.4	8.3	4.6	15.7	6.2	11.9	8.7	12.1	7.8	7.9	22.5	31.0	8.9	19.6	24.7	8.9	5.0	4.5	16.1	4.0	9.1	11.2	8.9	23.2	8.8	17.5	22.9	21.3	9.5	32.8	15.1	17.4	11.0	11.4	21.0	21.8	26.4	4.2	3.8	6.6	3.4	4.7	2.1	3.3	2.5	2.7	2.2	3.0	1.6	2.4	14.4	2.9	2.8	4.4	3.9	1.9	14.3	30.2	16.2	25.0	16.0	11.8	38.8	10.7	18.8	28.2
MYOZ2	"C4orf5, CS-1"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135784-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 219.1;skeletal muscle: 188.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.2;HSkMC: 3.7;SK-MEL-30: 9.3;U-87 MG: 9.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	3.7	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	2.4	2.6	0.2	0.1	219.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.9	0.1	188.6	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.0	13.9	3.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.6	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3"	"Cell line enhanced"	"Detected in some"		"BJ: 16.3;fHDF/TERT166: 45.8;HBF TERT88: 10.8;LHCN-M2: 19.7"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA036299: , HPA061494: "	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	4.5	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	2.1	0.0	0.0	23.6	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.1	2.1	0.0	114.9	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.9	46.3	3.4	0.0	0.0	0.3	0.1	3.8	0.1	0.2	0.1	0.0	1.1	0.5	0.0	0.0	0.3	1.7	0.0	16.3	8.2	6.1	2.3	0.0	0.0	0.0	0.0	45.8	0.3	0.0	0.1	10.8	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.8	0.0	3.3	0.3	0.1	0.0	0.1	19.7	3.4	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	0.4	0.3	0.0	1.7	0.0	0.0	0.0	0.0	1.9	0.0	1.7	3.8	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.2	0.0
MYRF	"C11orf9, MRF, Ndt80, pqn-47"	ENSG00000124920	"Myelin regulatory factor"	Q9Y2G1	11	61752642-61788518	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.7;stomach 1: 57.2"	"Cell line enhanced"	"Detected in some"		"A549: 18.3;CACO-2: 30.5;CAPAN-2: 17.6;EFO-21: 23.9;Hep G2: 12.9;HHSteC: 13.7;U-2 OS: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018310			Approved	Nucleoplasm,Cytosol			550000	Nucleoplasm	Cytosol	"HPA018310: AB_1845534"	"unprognostic (3.51e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	4.6	1.3	16.4	2.1	42.9	1.4	1.5	3.3	38.5	3.7	4.3	96.7	0.0	12.8	6.9	1.6	2.0	8.0	22.4	1.5	29.2	13.9	4.5	5.8	15.8	1.2	54.3	19.9	5.8	19.7	1.2	0.2	2.6	35.7	1.2	4.0	11.6	1.7	1.6	1.0	1.4	11.4	5.4	53.8	1.3	57.2	3.0	51.4	0.0	1.2	0.0	1.2	1.3	0.3	0.0	0.0	0.2	0.3	0.5	2.1	0.5	1.3	18.3	3.3	1.0	0.0	0.0	0.1	0.1	0.0	0.7	0.8	30.5	17.6	0.6	23.9	0.0	0.8	1.0	0.1	1.3	0.1	0.3	0.1	0.4	12.9	13.7	0.0	0.3	0.3	0.2	0.4	0.0	0.1	5.6	0.2	0.1	0.3	0.0	0.6	0.9	2.4	0.0	0.1	1.2	8.1	0.1	0.1	0.6	0.1	1.3	0.3	0.4	0.1	0.6	0.2	10.6	0.2	0.3	0.3	0.1	0.1	0.1	1.2	0.2	0.0	0.0	0.2	2.1	0.3	1.2	0.0	0.7	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.5	16.4	42.9	3.3	29.3	29.2	13.9	54.3	19.9	35.7	51.4
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 69.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;REH: 13.0;SCLC-21H: 16.2;SH-SY5Y: 4.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	13	"cerebellum: 69.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.4	7.4	4.3	0.5	5.0	2.4	0.4	69.5	11.0	0.3	0.7	2.7	0.0	0.9	0.4	0.5	0.3	0.6	0.5	0.8	4.2	5.3	0.6	0.4	0.4	0.4	3.7	2.2	0.4	4.7	0.4	3.7	0.4	5.1	0.6	0.6	3.7	0.3	0.4	0.3	0.4	0.6	0.4	2.0	0.5	1.0	2.1	4.8	0.0	1.4	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.6	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.4	0.0	0.7	0.2	13.0	0.0	0.0	0.0	0.0	16.2	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.3	5.0	69.5	3.1	4.2	5.3	3.7	2.2	5.1	4.8
MZT2A	"FAM128A, MOZART2A"	ENSG00000173272	"Mitotic spindle organizing protein 2A"	Q6P582	2	131464900-131492743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.9"	"Low lineage specificity"	"Detected in all"											"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA051758: , HPA052623: "	"prognostic favourable (3.04e-4)"	"unprognostic (3.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (3.04e-11)"	"unprognostic (1.51e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-1)"	17.7	17.1	34.7	22.1	22.6	31.3	17.1	9.6	25.1	17.5	20.3	7.6	23.0	30.0	11.9	22.3	23.5	14.0	17.5	57.5	28.0	20.7	14.4	15.9	7.5	15.6	18.9	16.4	20.8	55.4	5.6	7.2	5.3	8.8	16.4	3.4	9.3	48.5	19.7	40.7	12.6	22.8	17.3	12.0	15.5	24.0	11.1	5.5	28.3	17.8	23.8	17.0	16.2	12.8	11.9	5.4	31.9	1.0	2.6	9.3	2.2	35.6	19.2	0.4	7.4	0.5	1.3	7.7	12.1	2.8	4.7	4.6	47.2	12.3	23.1	15.7	0.5	16.1	1.2	8.1	0.1	9.1	58.8	9.5	21.6	55.8	2.9	16.6	3.6	3.7	4.4	3.0	1.4	3.8	18.7	24.4	1.1	32.2	23.0	70.0	12.5	44.1	19.6	6.7	51.7	2.9	16.5	28.0	3.5	12.3	8.4	22.0	13.1	30.0	10.6	12.3	29.8	5.2	11.8	22.8	16.9	18.6	17.2	10.8	7.3	6.9	1.0	31.9	3.8	0.6	4.2	11.9	8.5	4.9	3.4	6.2	9.3	4.5	0.4	2.6	0.3	5.4	8.4	2.2	34.7	22.6	9.6	23.1	28.0	20.7	18.9	16.4	8.8	5.5
MZT2B	"FAM128B, FLJ14346, MOZART2B"	ENSG00000152082	"Mitotic spindle organizing protein 2B"	Q6NZ67	2	130181737-130190729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA051758: , HPA052623: "	"unprognostic (8.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (9.65e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (9.37e-8)"	"unprognostic (1.67e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-1)"	28.9	39.1	50.8	23.9	33.5	63.4	23.8	19.5	35.1	24.3	31.3	14.4	27.7	34.2	24.7	24.0	30.6	19.4	26.7	56.6	33.7	29.3	22.5	31.1	14.4	27.8	32.8	33.3	31.0	104.2	10.9	17.1	16.2	19.7	28.4	11.6	18.6	63.6	24.9	87.5	20.9	32.1	31.8	21.7	26.8	33.8	26.1	15.4	35.3	36.0	27.1	22.2	24.4	34.9	15.3	21.7	31.7	9.3	12.1	13.3	4.9	40.8	17.3	4.4	21.0	1.7	6.4	20.4	19.6	7.3	7.6	5.5	35.3	21.3	22.5	30.6	4.4	23.2	2.3	6.4	1.2	33.3	53.5	12.1	25.3	38.5	7.5	16.0	12.1	6.9	9.1	5.1	2.5	8.3	16.0	33.7	5.4	47.4	35.8	93.1	14.0	31.7	41.8	11.0	70.6	4.5	13.5	30.5	37.2	11.8	21.4	31.8	25.3	47.3	14.8	21.9	35.5	17.5	18.5	41.1	25.6	27.7	33.0	23.7	15.8	0.1	9.3	31.7	7.7	9.1	6.2	15.3	11.3	10.7	11.2	14.8	13.3	10.7	4.6	12.1	8.4	21.7	8.7	4.9	50.8	33.5	19.5	35.1	33.7	29.3	32.8	33.3	19.7	15.4
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056826-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 35.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: , HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	3.5	3.1	3.4	7.4	5.1	7.0	5.8	6.1	3.2	5.5	4.3	1.2	7.1	4.7	7.0	6.6	5.2	4.8	3.8	3.5	2.5	3.6	3.2	11.3	7.5	9.2	1.9	1.6	7.0	13.1	2.5	14.3	11.9	2.8	4.9	4.5	4.3	10.7	11.0	2.9	5.4	5.3	3.2	3.1	4.3	3.8	3.5	2.1	35.6	7.2	3.5	7.8	5.6	5.2	2.4	8.1	5.7	1.2	10.6	4.5	1.2	1.5	1.6	9.3	1.5	0.6	3.1	7.6	1.7	1.9	1.0	2.2	2.9	3.1	8.2	3.4	1.6	1.1	5.9	1.9	2.4	2.6	1.9	3.7	1.4	1.4	1.6	9.9	8.8	3.4	2.7	1.7	3.7	2.7	8.1	3.6	2.0	1.5	20.0	4.3	4.6	1.3	11.7	11.0	1.9	0.8	3.6	3.8	6.6	1.6	1.3	1.5	1.1	2.7	3.6	1.1	5.9	0.7	1.3	5.9	5.9	5.6	1.1	3.6	2.3	5.7	1.1	0.5	2.3	1.2	2.4	1.7	3.0	1.7	1.7	2.4	4.5	2.5	0.3	10.6	1.0	8.1	1.3	1.2	3.4	5.1	6.1	3.2	2.5	3.6	1.9	1.6	2.8	2.1
N4BP2L1	CG018	ENSG00000139597	"NEDD4 binding protein 2 like 1"	Q5TBK1	13	32400723-32428311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 13.0;NB-4: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038971	Approved		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038971: AB_10673408"	"unprognostic (2.66e-3)"	"unprognostic (2.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.40e-2)"	"prognostic favourable (3.11e-4)"	"unprognostic (6.91e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.57e-3)"	12.1	9.4	19.6	10.5	22.2	29.5	22.1	24.5	21.8	12.3	11.0	9.4	4.2	11.6	14.6	12.8	8.3	14.0	9.6	6.3	15.0	16.6	7.4	57.8	17.3	17.6	12.1	18.8	30.1	11.0	7.3	21.2	10.0	11.0	11.3	11.3	7.3	7.6	9.5	11.0	17.5	13.4	11.3	10.6	19.2	7.2	3.6	15.5	14.2	10.4	5.1	12.9	13.5	16.5	15.9	28.0	24.2	25.5	15.2	13.5	17.4	0.5	0.1	0.7	0.2	2.9	2.3	0.2	0.3	1.2	0.7	1.1	2.1	2.9	5.6	0.8	0.6	0.0	2.1	0.2	0.9	8.4	1.3	13.0	0.6	6.2	4.5	4.8	0.8	1.6	0.5	0.5	0.6	0.4	0.0	10.4	0.5	0.4	9.9	32.8	1.0	0.3	9.5	0.3	4.7	2.8	1.0	1.9	2.4	2.1	0.0	0.9	0.3	9.3	0.2	0.2	0.1	0.1	0.1	5.9	3.5	0.3	0.3	1.8	0.4	24.2	25.5	6.6	9.8	23.1	8.5	14.0	9.5	11.9	21.9	15.9	13.1	11.3	6.2	15.2	15.8	28.0	13.5	17.4	19.6	22.2	24.5	21.8	15.0	16.6	12.1	18.8	11.0	15.5
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: "	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	31.8	33.6	6.3	20.6	9.1	9.5	18.0	11.2	6.6	15.3	13.5	21.8	10.1	24.2	37.4	9.3	15.3	13.3	13.5	6.0	10.1	61.9	8.7	23.5	21.9	12.4	16.9	19.3	7.2	15.2	14.3	14.8	17.3	17.4	10.3	10.1	41.9	27.0	25.3	10.6	46.6	21.5	16.4	26.6	11.2	14.7	13.6	16.4	4.4	17.7	26.5	9.5	14.1	10.0	6.4	22.1	22.3	34.0	21.8	24.3	45.5	8.7	21.9	18.7	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N(alpha)-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326050	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	166	"placenta: 32.1;testis: 30.5"	"Group enriched"	"Detected in some"	6	"K-562: 9.1;U-266/70: 26.0;U-266/84: 8.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	32.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	30.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	26.0	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
NAA15	"FLJ13340, NARG1, NATH, TBDN100"	ENSG00000164134	"N(alpha)-acetyltransferase 15, NatA auxiliary subunit"	Q9BXJ9	4	139301455-139420033	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023589, HPA050661"	Approved		Enhanced	Cytosol				Cytosol		"HPA023589: AB_1854311, HPA050661: "	"unprognostic (6.25e-3)"	"unprognostic (5.95e-2)"	"unprognostic (7.80e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (2.16e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.58e-1)"	13.7	12.9	13.7	17.8	14.2	18.6	15.2	21.0	18.9	10.8	12.3	7.8	9.0	10.1	13.4	9.8	20.5	11.4	9.7	14.8	16.6	10.1	10.3	14.5	13.3	17.7	15.6	10.7	13.1	11.4	16.8	20.3	14.0	13.8	11.6	12.6	6.7	13.8	10.4	54.4	13.8	10.3	19.3	22.2	12.2	11.4	17.6	15.9	18.0	12.2	22.3	19.9	15.3	15.1	8.7	7.1	4.1	5.6	6.8	9.4	3.1	16.9	12.4	12.0	19.4	8.8	10.8	14.9	16.4	10.8	15.9	12.3	17.5	14.9	34.8	10.1	13.5	11.0	31.5	20.1	22.9	16.2	11.6	18.7	12.0	11.4	9.4	34.0	12.2	7.6	12.3	20.0	15.7	15.8	34.5	15.3	16.8	13.5	32.4	10.2	20.1	9.9	20.3	16.2	18.0	12.7	14.3	15.7	12.3	11.0	18.1	10.9	10.9	13.4	13.5	15.4	10.8	14.5	18.7	18.6	33.1	34.6	13.2	24.9	14.6	4.1	5.4	1.7	8.0	5.6	9.3	7.4	8.4	9.4	7.1	8.7	8.3	9.3	4.1	6.8	5.3	6.0	8.0	3.1	13.7	14.2	21.0	18.9	16.6	10.1	15.6	10.7	13.8	15.9
NAA16	"FLJ22054, MGC40612, NARG1L, PRO2435"	ENSG00000172766	"N(alpha)-acetyltransferase 16, NatA auxiliary subunit"	Q6N069	13	41311205-41377030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039761, HPA040157"	Approved		Enhanced	Cytosol				Cytosol		"HPA039761: AB_10795112, HPA040157: AB_10793917"	"unprognostic (2.09e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-2)"	7.2	6.3	8.4	6.1	9.6	25.5	6.7	20.0	13.2	7.7	6.0	5.1	5.3	5.6	10.0	4.3	7.9	9.0	5.0	5.3	7.5	3.7	4.4	4.0	6.3	9.0	8.5	5.8	8.0	25.7	5.1	9.6	5.0	6.6	6.5	4.4	4.5	7.0	8.3	8.3	7.9	6.5	10.0	7.9	5.5	6.7	9.2	9.7	8.3	5.7	4.0	5.1	8.7	21.1	3.0	2.7	4.8	2.4	5.4	8.2	2.2	6.5	5.4	13.5	9.9	4.8	6.2	5.3	8.0	6.7	8.0	7.1	6.4	5.1	10.9	3.9	6.4	9.1	7.0	5.2	9.8	6.6	14.2	13.3	5.3	6.3	5.2	14.9	9.0	4.2	3.7	3.3	6.2	7.8	6.0	6.0	5.1	5.2	15.4	4.2	11.6	7.4	11.5	5.6	8.9	6.3	5.9	4.6	10.7	7.3	7.1	2.8	4.3	8.2	5.7	5.5	4.5	8.7	6.2	4.2	4.8	12.7	7.0	6.4	6.5	4.3	2.4	4.8	3.9	1.3	3.8	1.6	4.5	4.1	1.3	3.0	8.2	8.2	1.3	5.4	1.8	2.7	3.3	2.2	8.4	9.6	20.0	13.2	7.5	3.7	8.5	5.8	6.6	9.7
NAA20	"dJ1002M8.1, NAT3, NAT5"	ENSG00000173418	"N(alpha)-acetyltransferase 20, NatB catalytic subunit"	P61599	20	20017116-20033655	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063344			Supported	Cytosol				Cytosol		"HPA063344: "	"unprognostic (2.94e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	15.9	20.0	14.2	10.0	21.4	17.4	23.2	15.5	34.1	17.3	12.7	12.0	22.7	9.7	20.5	17.7	58.4	15.8	12.3	24.1	14.7	14.1	24.6	25.0	15.7	19.0	13.1	18.3	12.9	43.2	24.8	20.0	18.5	19.4	14.4	12.2	11.2	22.0	20.6	35.2	15.6	11.0	17.3	13.1	11.0	14.5	43.7	10.2	9.5	23.6	37.5	22.1	14.0	23.7	18.6	28.3	20.4	27.5	17.7	25.8	26.4	40.2	24.5	8.8	13.8	18.7	19.7	13.3	29.8	20.4	26.9	25.2	12.5	29.3	21.9	16.2	20.1	32.0	15.1	47.8	21.9	9.8	16.4	16.4	6.5	18.7	26.8	17.3	12.2	22.4	31.5	27.2	27.5	23.0	26.5	22.6	23.4	31.6	24.3	18.0	6.9	40.0	13.4	34.8	29.0	26.4	9.3	16.8	11.4	18.0	50.9	24.9	31.4	27.9	25.0	22.3	13.1	26.8	27.3	24.6	30.7	23.6	13.6	15.2	15.9	8.0	27.5	20.4	17.6	27.5	25.8	18.6	20.5	20.2	28.3	16.5	19.9	22.0	3.6	17.7	23.2	22.9	20.8	26.4	14.2	21.4	15.5	34.1	14.7	14.1	13.1	18.3	19.4	10.2
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N(alpha)-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112109022	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavourable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	12.8	11.4	12.7	12.3	19.3	18.4	14.9	21.0	17.0	10.4	11.7	17.9	11.2	8.3	18.1	10.3	14.7	11.3	8.5	10.7	11.6	10.7	8.0	10.2	9.0	12.9	21.7	12.4	15.8	15.1	14.3	13.5	11.4	16.3	11.7	9.4	15.6	9.5	10.5	25.9	15.7	8.8	11.9	16.7	10.3	9.2	10.8	17.9	8.7	12.5	10.8	14.2	10.2	12.1	4.7	5.5	0.5	3.6	2.3	7.0	2.5	10.4	10.4	9.8	7.5	5.4	9.5	11.8	9.9	8.0	12.5	8.3	10.9	5.4	18.3	9.9	7.9	12.6	21.9	8.2	16.7	10.4	15.0	14.9	10.6	9.6	9.1	21.0	9.3	8.3	10.4	14.2	14.4	10.6	21.7	2.3	11.1	8.6	12.3	15.8	15.1	12.5	13.5	10.0	12.6	9.4	17.5	12.5	6.9	11.4	12.9	9.4	12.8	8.6	8.5	10.1	9.2	11.2	13.6	9.7	18.6	21.5	13.3	9.4	9.9	0.0	2.7	0.5	4.0	3.1	6.1	4.1	4.7	3.6	5.4	4.7	7.0	6.5	0.1	2.3	3.6	5.5	3.6	2.5	12.7	19.3	21.0	17.0	11.6	10.7	21.7	12.4	16.3	17.9
NAA30	"C14orf35, FLJ35355, MAK3, Mak3p, NAT12"	ENSG00000139977	"N(alpha)-acetyltransferase 30, NatC catalytic subunit"	Q147X3	14	57390544-57415917	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057824	Uncertain		Supported	Cytosol				Cytosol		"HPA057824: "	"unprognostic (5.13e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (1.25e-8)"	"unprognostic (1.77e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.63e-1)"	10.7	10.3	15.8	10.7	18.3	15.0	16.4	18.1	18.9	9.9	15.0	9.2	8.6	11.4	12.1	8.8	13.5	9.1	12.5	18.8	13.9	15.6	14.7	19.1	8.2	9.6	12.9	16.4	18.1	10.5	16.2	13.4	15.4	12.0	12.3	9.6	9.6	10.8	12.8	34.9	10.5	13.5	13.0	9.9	9.8	8.6	21.4	10.1	15.0	12.6	13.6	10.3	12.8	13.7	2.6	1.5	1.7	5.3	5.5	4.2	0.8	13.8	13.3	7.7	12.4	12.9	17.0	12.9	16.3	15.8	12.5	11.4	12.0	10.3	10.2	14.4	13.4	14.7	13.7	10.5	20.8	17.7	7.0	8.2	7.7	10.4	13.5	16.5	9.6	11.5	15.6	11.3	18.9	19.1	8.0	10.2	16.4	16.0	13.7	9.6	8.2	14.9	11.0	22.0	7.9	12.8	12.7	16.5	8.6	13.7	13.6	16.4	17.5	8.6	16.6	19.6	20.5	10.7	10.3	7.5	9.2	12.5	13.0	8.3	13.8	1.7	0.9	0.5	2.9	2.1	3.0	2.3	2.8	4.2	0.8	2.6	3.0	2.8	0.4	5.5	5.3	1.5	3.7	0.8	15.8	18.3	18.1	18.9	13.9	15.6	12.9	16.4	12.0	10.1
NAA60	"FLJ14154, NAT15"	ENSG00000122390	"N(alpha)-acetyltransferase 60, NatF catalytic subunit"	Q9H7X0	16	3443611-3486963	"Enzymes, Predicted intracellular proteins"	"Chromosome partition"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040916	Approved		Uncertain	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA040916: AB_10794428"	"unprognostic (8.59e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.39e-1)"	"prognostic favourable (3.14e-4)"	"unprognostic (1.81e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.12e-2)"	"prognostic favourable (4.30e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.74e-3)"	18.5	28.7	24.2	17.9	30.8	26.6	16.2	38.1	40.2	17.1	29.4	29.1	34.0	36.8	24.3	18.6	21.3	21.7	23.7	26.2	25.6	21.3	35.8	40.3	23.6	19.4	21.6	17.7	21.2	41.8	46.4	29.0	27.0	24.4	23.7	21.4	29.1	20.7	31.6	38.9	16.9	42.2	19.9	25.7	28.1	34.8	25.3	19.0	22.8	21.8	21.8	24.1	21.7	22.1	8.5	11.2	34.8	13.2	11.6	13.4	10.0	8.1	32.0	22.7	23.8	18.1	12.4	20.3	15.6	16.6	16.1	14.6	21.9	17.6	16.9	15.9	17.7	19.1	22.4	18.2	15.8	25.5	15.1	20.6	20.2	25.6	19.7	26.4	27.3	15.2	14.1	11.1	21.4	25.9	21.7	24.2	11.4	37.3	16.6	19.4	27.7	9.4	20.8	17.2	25.6	16.7	17.2	12.0	26.0	23.2	25.9	12.3	23.0	18.6	19.1	20.8	17.8	6.7	14.4	20.2	18.7	16.5	6.6	16.3	15.8	19.8	10.5	34.8	11.8	12.3	12.5	8.0	10.8	11.5	11.2	8.5	9.3	10.8	13.2	11.6	13.2	7.8	13.4	10.0	24.2	30.8	38.1	40.2	25.6	21.3	21.6	17.7	24.4	19.0
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058549	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 49.5;intestine: 123.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.3;fHDF/TERT166: 6.7;HHSteC: 18.6;HSkMC: 12.2;SCLC-21H: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 49.5"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047123	Enhanced		Uncertain	Cytosol				Cytosol		"HPA047123: "	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	4.1	0.9	1.4	3.3	1.6	7.0	4.1	1.9	1.4	6.0	54.3	1.2	2.6	7.8	7.2	1.8	2.7	4.4	3.4	3.5	1.3	0.6	2.3	1.2	3.4	5.2	1.5	1.5	6.2	1.0	0.9	2.0	1.5	1.6	4.6	2.6	3.1	2.3	4.8	2.0	1.6	123.4	4.3	1.4	5.0	2.8	1.8	1.2	1.8	1.8	2.3	2.9	3.1	5.4	8.8	4.9	49.5	6.3	22.2	12.9	7.0	0.0	0.0	0.1	0.2	0.4	5.3	0.9	2.0	0.0	2.5	1.1	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.1	3.0	18.6	0.0	0.0	12.2	0.0	2.4	0.0	3.2	0.0	0.2	0.0	0.2	0.2	0.6	0.0	0.1	0.1	0.0	0.8	0.2	0.0	9.6	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.7	0.0	0.1	0.1	49.5	6.3	10.3	9.5	4.3	4.9	8.0	7.6	4.8	4.9	8.8	8.8	4.9	1.1	22.2	2.5	0.2	12.9	7.0	1.4	1.6	1.9	1.4	1.3	0.6	1.5	1.5	1.6	1.2
NAB2	MADER	ENSG00000166886	"NGFI-A binding protein 2"	Q15742	12	57088894-57095476	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004510, HPA027464"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004510: AB_627982, HPA027464: AB_10601138"	"prognostic favourable (7.41e-4)"	"unprognostic (4.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (9.38e-6)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (5.67e-3)"	"unprognostic (6.19e-3)"	9.5	12.6	11.7	9.9	14.2	4.8	7.9	33.3	20.4	18.7	13.7	5.3	9.6	8.2	22.8	18.9	10.5	15.6	14.5	9.6	8.6	6.8	8.4	18.7	12.8	9.1	4.4	14.6	29.2	8.5	14.5	17.0	13.4	6.8	15.0	4.4	8.5	5.6	14.5	7.1	18.6	7.1	14.5	4.1	8.0	8.2	11.8	7.0	12.4	9.8	7.7	8.6	14.5	26.5	4.2	1.2	0.9	5.4	0.9	2.5	1.2	5.5	3.5	18.7	17.1	16.8	22.0	2.0	16.6	15.0	10.5	8.8	5.7	3.2	3.5	6.8	16.3	10.0	6.4	12.2	5.6	1.4	1.7	4.1	2.7	5.8	12.8	3.3	10.0	24.5	13.5	12.5	4.3	2.8	9.4	3.6	12.2	25.7	5.0	16.1	3.8	6.2	3.7	24.6	1.8	4.5	2.1	2.1	4.9	8.0	4.7	34.9	10.5	7.3	3.1	15.5	13.0	11.0	4.8	8.6	2.1	1.8	15.1	2.2	9.3	0.0	2.3	0.3	1.2	5.3	1.4	2.1	2.0	1.5	1.2	4.2	2.5	2.5	0.9	0.9	5.4	0.0	1.9	1.2	11.7	14.2	33.3	20.4	8.6	6.8	4.4	14.6	6.8	7.0
NABP1	"DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2"	ENSG00000173559	"Nucleic acid binding protein 1"	Q96AH0	2	191678068-191696659	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054978, HPA067802"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054978: , HPA067802: "	"unprognostic (5.43e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.07e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (8.20e-7)"	"unprognostic (5.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.02e-2)"	20.8	4.9	2.4	26.0	2.3	4.2	22.2	1.1	2.1	4.4	14.1	1.9	1.6	13.3	6.7	9.2	12.1	4.9	8.1	6.9	4.7	2.0	8.8	8.7	18.6	39.6	3.9	1.3	4.9	6.3	0.8	4.4	28.0	6.1	4.7	5.2	2.6	6.2	3.9	3.1	4.3	30.6	4.7	5.3	40.0	4.6	18.4	1.5	7.4	3.6	12.1	23.0	8.7	8.8	3.8	2.2	18.6	7.7	1.6	14.2	1.9	14.7	2.3	0.3	0.4	11.2	13.6	3.9	23.0	18.9	14.3	8.6	12.2	8.3	0.8	18.3	13.8	4.2	2.1	9.8	15.8	7.7	1.9	7.3	4.7	3.1	8.2	3.4	8.4	17.8	12.3	20.5	14.7	5.4	10.3	32.6	22.3	1.2	1.1	3.9	1.3	11.6	2.5	2.5	6.9	21.4	10.9	0.5	0.1	7.9	2.7	6.4	0.7	2.2	13.6	12.0	10.1	6.3	14.4	10.7	4.4	3.0	9.9	4.1	2.1	2.5	4.0	1.9	6.4	6.7	8.7	3.8	8.6	6.6	2.2	0.6	2.2	3.8	18.6	1.6	7.7	1.4	14.2	1.9	2.4	2.3	1.1	1.9	4.7	2.0	3.9	1.3	6.1	1.5
NACA	NACA1	ENSG00000196531	"Nascent polypeptide-associated complex alpha subunit"	"E9PAV3, Q13765"	12	56712428-56731628	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	"Activator, Chaperone, DNA-binding"	Allergen	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA073152, HPA073648"			Approved	Cytosol				Cytosol		"HPA073152: , HPA073648: "	"unprognostic (3.35e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavourable (4.58e-11)"	"unprognostic (9.47e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.79e-2)"	106.9	85.3	72.2	77.6	63.0	120.7	149.8	71.7	65.5	115.5	89.1	40.5	76.7	57.3	83.3	107.7	142.6	95.2	69.2	111.5	58.9	52.7	79.8	130.1	68.5	148.3	63.7	51.3	213.8	119.9	58.1	61.3	80.8	63.7	112.3	79.7	45.9	95.5	72.9	241.6	124.5	71.2	115.1	74.1	81.9	72.3	53.2	53.8	97.8	109.0	149.1	125.1	144.8	139.1	91.8	101.6	45.4	160.0	66.3	97.4	146.6	79.6	92.8	110.6	87.3	132.4	226.8	109.9	80.0	115.4	109.0	75.8	111.8	88.6	143.4	89.6	74.9	70.1	97.9	128.4	116.1	70.2	152.3	104.0	65.0	111.2	124.1	146.7	67.2	179.3	165.2	88.4	180.6	120.2	128.9	187.5	106.4	77.5	94.7	181.3	112.8	103.6	107.8	93.2	152.1	151.3	80.9	82.1	88.7	59.3	141.6	122.7	154.1	168.7	77.8	57.6	70.7	61.2	80.3	89.8	100.0	127.7	84.5	100.6	73.2	33.2	88.1	45.4	58.5	124.6	85.6	91.8	83.4	72.5	94.4	74.6	97.4	83.9	33.2	66.3	160.0	101.6	85.9	146.6	72.2	63.0	71.7	65.5	58.9	52.7	63.7	51.3	63.7	53.8
NACA2	"MGC71999, NACAL"	ENSG00000253506	"Nascent polypeptide associated complex alpha subunit 2"	Q9H009	17	61590426-61591202	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 76.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 7.6;SK-MEL-30: 4.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA073152, HPA073648"			Approved	Cytosol				Cytosol		"HPA073152: , HPA073648: "	"unprognostic (2.37e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.14e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.53e-3)"	"unprognostic (5.45e-3)"	"unprognostic (3.09e-3)"	2.5	2.5	2.4	2.7	2.8	2.2	5.6	2.2	2.8	6.6	2.4	1.0	0.8	2.2	2.1	2.6	5.0	2.2	1.9	3.7	2.2	2.0	4.7	5.5	3.3	6.5	2.2	2.1	9.5	14.3	2.3	2.1	3.6	1.3	3.3	2.1	1.3	2.2	2.0	7.2	2.8	4.1	5.4	2.9	4.2	2.2	76.7	2.8	4.8	4.1	3.2	2.7	6.3	2.4	2.1	1.9	0.7	3.2	1.7	2.0	2.9	0.8	0.0	0.7	0.8	0.3	0.6	2.3	0.2	0.8	0.3	0.5	0.6	0.4	0.0	1.3	0.0	0.2	0.2	0.2	0.6	0.6	0.2	0.2	0.8	0.8	0.2	0.3	0.8	0.0	0.9	0.0	0.0	0.4	0.2	2.6	0.2	0.2	1.1	7.6	1.9	0.2	0.9	0.5	2.5	0.3	0.1	0.9	1.8	0.5	1.2	4.3	1.9	2.8	0.0	0.4	1.0	1.5	0.8	0.8	0.7	0.8	1.0	0.5	0.7	0.4	1.4	0.7	1.2	3.2	1.4	2.1	1.6	1.6	1.9	1.8	2.0	1.8	0.4	1.7	3.0	1.8	1.9	2.9	2.4	2.8	2.2	2.8	2.2	2.0	2.2	2.1	1.3	2.8
NACAD	KIAA0363	ENSG00000136274	"NAC alpha domain containing"	O15069	7	45080438-45088914	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 6.5;SCLC-21H: 21.5;SH-SY5Y: 14.9"	"Group enriched"	"Detected in many"	7	"glioma: 12.1;testis cancer: 16.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	12	"monocytes: 1.8;T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020981	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA020981: "	"unprognostic (5.54e-6)"	"unprognostic (1.89e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.72e-3)"	"unprognostic (2.72e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	4.7	8.9	11.5	2.7	19.4	1.1	2.1	16.7	45.0	4.8	3.5	43.1	0.1	2.1	6.9	2.3	3.9	4.8	3.7	5.1	16.7	15.9	2.2	1.2	3.0	1.9	30.2	12.9	10.4	2.4	3.2	11.7	3.8	26.7	4.7	2.3	1.1	3.2	5.7	2.0	2.1	2.7	7.4	30.8	2.7	2.5	4.5	21.5	0.0	1.4	0.0	1.5	3.2	2.3	0.1	0.0	0.0	1.8	0.0	1.4	0.1	0.0	0.0	2.1	0.0	1.3	0.6	0.0	2.3	2.9	6.5	4.1	0.2	0.1	0.0	1.9	4.2	0.2	1.8	1.6	2.3	0.0	0.6	0.0	1.4	0.0	1.6	0.0	0.0	1.4	0.0	2.8	0.3	2.0	0.0	2.9	1.6	0.0	0.0	0.0	1.9	1.8	0.0	0.8	0.0	0.2	0.0	21.5	14.9	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	0.4	1.5	0.8	0.0	1.2	0.0	4.4	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.1	11.5	19.4	16.7	24.1	16.7	15.9	30.2	12.9	26.7	21.5
NADSYN1	FLJ10631	ENSG00000172890	"NAD synthetase 1"	Q6IA69	11	71453109-71524107	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017798, HPA038523, HPA038524"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"				Vesicles	"Golgi apparatus, Cytosol"	"CAB017798: , HPA038523: , HPA038524: "	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (5.17e-6)"	"unprognostic (1.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavourable (8.72e-5)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-2)"	"prognostic favourable (5.10e-4)"	14.5	16.9	10.8	23.2	21.2	39.6	14.0	12.2	18.5	12.4	30.6	21.9	24.1	26.3	15.0	17.5	29.1	16.4	33.1	10.6	10.4	9.5	16.5	24.8	18.1	20.5	22.7	9.2	15.6	20.6	13.5	20.2	17.1	15.6	23.9	25.3	12.9	18.0	17.2	9.8	15.0	36.8	13.6	14.6	30.7	19.2	17.4	20.0	26.4	17.3	21.7	29.8	26.1	17.1	9.5	22.3	12.8	19.7	11.9	12.6	13.1	6.1	14.9	4.8	8.8	14.6	21.4	13.3	12.1	10.9	6.3	6.9	12.7	10.5	5.4	13.7	14.1	22.1	6.3	17.2	3.3	10.9	5.1	8.8	10.0	14.2	18.3	17.6	17.0	30.3	27.1	8.1	7.4	22.1	4.5	7.6	8.9	19.3	8.6	11.5	2.9	8.7	10.8	15.3	5.3	15.5	28.6	3.6	5.2	8.6	11.3	22.0	10.0	9.6	26.6	7.0	6.0	12.7	4.6	9.8	4.2	4.6	12.3	10.1	4.8	4.5	19.7	11.8	11.7	17.4	9.9	9.5	10.5	10.6	22.3	7.4	7.0	8.8	12.8	11.9	15.1	16.7	12.6	13.1	10.8	21.2	12.2	18.5	10.4	9.5	22.7	9.2	15.6	20.0
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166921	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036241: , HPA036242: AB_10673616, HPA066090: "	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	13.3	12.3	8.6	9.6	19.8	8.7	11.9	10.7	18.9	12.9	10.6	14.7	6.4	6.2	18.8	8.6	11.0	17.3	10.9	11.7	10.5	7.8	9.5	10.5	10.9	10.7	7.2	9.1	20.1	11.1	15.7	18.7	8.8	10.1	12.0	11.4	13.4	10.4	12.5	36.4	14.3	8.3	12.7	7.4	10.0	11.3	17.2	7.5	12.3	14.0	12.2	12.2	12.5	10.4	2.5	2.4	0.1	1.6	1.2	3.5	1.4	8.9	7.6	9.8	10.0	5.8	9.2	11.5	10.6	7.1	9.3	9.3	8.6	10.7	23.3	3.1	6.5	7.5	19.9	11.4	12.3	10.2	12.3	24.6	6.8	7.2	10.1	15.9	8.8	8.7	10.2	11.3	9.2	8.2	27.6	12.4	12.4	8.8	18.4	9.1	12.8	7.6	15.3	7.3	12.2	9.3	4.1	10.7	8.0	7.0	12.8	7.6	6.9	6.9	8.6	11.2	9.6	8.7	11.9	7.8	10.8	17.9	10.6	9.3	11.0	0.0	1.5	0.1	2.2	1.6	0.9	1.9	2.5	3.3	2.4	2.5	3.5	2.3	0.0	1.2	1.5	2.4	0.7	1.4	8.6	19.8	10.7	18.9	10.5	7.8	7.2	9.1	10.1	7.5
NAGK	GNK	ENSG00000124357	"N-acetylglucosamine kinase"	Q9UJ70	2	71064344-71079805	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035206, HPA035207"	Enhanced		Approved	Nucleoplasm,Cytosol			690000	Cytosol	Nucleoplasm	"HPA035206: AB_2674517, HPA035207: AB_10602031"	"unprognostic (6.15e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (6.88e-4)"	"unprognostic (2.44e-1)"	"prognostic favourable (5.87e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (8.60e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.13e-2)"	20.0	17.6	21.8	30.9	24.5	9.8	15.7	13.9	18.8	23.6	15.5	23.7	17.4	11.4	16.4	19.7	67.0	13.7	20.0	14.0	17.6	20.4	16.9	20.2	18.3	30.6	31.1	20.3	15.0	25.8	27.5	21.8	43.9	26.2	15.8	15.8	14.7	49.0	17.8	11.3	29.5	14.6	22.8	21.6	43.4	15.5	24.8	26.7	20.2	13.0	27.2	39.9	24.5	26.1	14.3	53.0	37.4	79.3	8.5	7.1	52.2	18.8	15.3	8.6	8.8	34.5	21.1	33.9	42.1	18.2	28.2	25.7	17.9	9.9	10.5	10.1	29.2	9.1	6.6	12.5	17.5	15.0	5.2	5.9	5.0	11.1	25.9	3.7	15.1	18.9	13.1	30.3	4.7	29.6	2.7	11.9	39.1	17.3	9.3	13.2	9.2	11.9	7.3	24.1	5.4	17.1	33.8	9.0	4.9	12.7	20.1	13.2	10.4	4.7	26.0	33.7	13.1	13.0	14.7	8.3	7.2	6.2	23.0	10.1	18.4	10.3	79.3	31.5	5.4	69.8	5.5	14.3	6.4	5.2	53.0	13.3	5.5	4.5	37.4	8.5	46.6	42.4	7.1	52.2	21.8	24.5	13.9	18.8	17.6	20.4	31.1	20.3	26.2	26.7
NAIF1	"bA379C10.2, C9orf90, DKFZp762G199"	ENSG00000171169	"Nuclear apoptosis inducing factor 1"	Q69YI7	9	128061233-128068206	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054898, HPA064931"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054898: , HPA064931: "	"unprognostic (7.09e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (1.60e-1)"	"unprognostic (6.15e-2)"	"unprognostic (9.41e-2)"	"prognostic favourable (1.02e-5)"	"unprognostic (3.08e-1)"	"prognostic favourable (8.30e-5)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.92e-2)"	7.1	7.2	4.5	5.1	4.5	11.3	10.3	5.6	5.5	6.0	4.5	2.4	10.9	6.0	6.3	5.1	7.1	5.4	6.6	7.4	5.5	3.4	5.2	8.3	9.3	8.3	3.8	4.2	5.4	7.3	3.4	4.5	7.3	5.3	6.0	3.7	5.5	6.5	9.5	7.1	5.5	6.2	5.2	4.8	9.0	5.5	15.6	2.9	12.5	6.2	6.1	7.8	5.5	16.3	3.4	2.2	4.5	3.0	1.6	3.4	1.5	4.8	4.1	2.6	6.8	2.5	2.2	6.0	3.7	2.2	3.1	2.5	3.3	3.8	5.8	3.2	2.3	3.6	2.7	2.8	2.6	17.8	3.7	4.3	5.0	1.9	4.1	5.9	12.2	2.0	3.3	2.4	3.9	2.8	10.1	3.7	2.9	5.5	5.7	7.2	2.9	7.1	5.5	4.2	5.3	2.4	3.0	3.8	4.4	3.5	5.0	3.8	3.9	5.9	1.9	3.7	11.7	3.1	4.2	6.1	12.7	3.9	3.5	3.9	4.9	0.0	2.2	3.3	1.7	2.0	1.4	1.1	3.4	2.5	2.2	3.4	2.6	2.2	4.5	1.6	3.0	1.7	0.9	1.5	4.5	4.5	5.6	5.5	5.5	3.4	3.8	4.2	5.3	2.9
NANOS1	"NOS1, ZC2HC12A"	ENSG00000188613	"Nanos C2HC-type zinc finger 1"	Q8WY41	10	119029716-119033732	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.7"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 38.7;SK-BR-3: 22.2;SK-MEL-30: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB012219	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB012219: "	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.22e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.64e-4)"	"unprognostic (7.89e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.52e-3)"	8.5	10.5	8.1	1.0	7.1	1.0	6.4	6.5	4.8	4.9	2.1	4.5	1.3	1.2	2.1	4.4	2.1	1.5	1.0	16.7	5.0	6.7	3.5	1.0	1.3	1.1	3.4	2.4	0.9	3.3	0.9	2.2	8.2	6.0	3.5	1.2	8.8	1.5	2.5	40.7	1.7	1.4	3.4	6.7	0.9	3.1	2.9	3.0	0.1	9.3	0.3	1.0	3.3	9.8	0.6	0.5	3.2	0.3	0.6	0.3	0.1	7.5	0.6	1.0	0.2	3.6	0.5	4.6	0.1	0.2	0.2	0.1	0.9	2.6	4.0	1.0	0.0	2.7	1.3	1.3	0.3	1.2	3.1	0.1	1.9	0.8	1.7	0.4	0.0	0.7	5.6	0.0	0.7	0.1	0.7	0.5	0.2	1.0	1.0	1.3	3.4	0.6	0.0	1.3	2.7	1.5	0.6	3.0	38.7	2.2	22.2	16.8	3.5	2.1	0.2	0.0	1.7	0.0	0.3	1.1	3.8	1.4	0.3	1.0	0.0	3.2	0.3	0.4	0.2	0.1	0.1	0.2	0.2	0.2	0.0	0.6	0.3	0.2	1.3	0.6	0.2	0.5	0.1	0.1	8.1	7.1	6.5	4.8	5.0	6.7	3.4	2.4	6.0	3.0
NAP1L2	"BPX, MGC26243"	ENSG00000186462	"Nucleosome assembly protein 1 like 2"	Q9ULW6	X	73212299-73214848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.0;Karpas-707: 10.0;NTERA-2: 12.8;U-2 OS: 7.5;U-2197: 10.4;U-266/84: 20.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054050, HPA057065"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA054050: , HPA057065: "	"unprognostic (1.12e-1)"	"unprognostic (6.64e-5)"	"unprognostic (4.22e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.95e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-2)"	2.3	5.8	15.7	2.2	20.0	0.9	3.2	37.5	49.8	4.5	2.8	2.0	0.2	1.3	4.9	8.0	2.8	4.2	2.5	7.2	21.0	22.8	8.0	1.3	2.5	2.9	15.7	28.7	8.6	2.6	10.5	10.2	0.5	20.5	10.4	3.1	2.6	3.1	5.9	1.1	4.9	1.7	4.6	8.3	3.9	2.0	2.2	4.9	0.0	8.0	0.0	1.8	2.6	2.5	0.9	0.0	0.0	0.0	1.2	3.6	1.4	0.0	3.3	0.1	6.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	12.0	0.0	0.7	2.4	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	0.3	0.9	0.1	1.7	0.2	0.2	10.0	0.0	1.2	3.9	0.0	12.8	5.9	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.1	0.0	7.5	10.4	0.8	4.7	20.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	0.9	3.4	2.3	0.0	0.1	1.6	3.6	0.0	1.2	0.0	0.0	2.6	1.4	15.7	20.0	37.5	42.1	21.0	22.8	15.7	28.7	20.5	4.9
NAP1L5	DRLM	ENSG00000177432	"Nucleosome assembly protein 1 like 5"	Q96NT1	4	88695915-88697829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.4"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA058227	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA058227: "	"unprognostic (1.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.39e-1)"	7.3	21.8	24.5	3.6	23.3	4.9	4.9	25.8	53.4	6.2	3.1	4.2	2.1	1.9	6.4	10.5	4.1	4.9	5.4	5.6	23.9	52.8	6.1	5.0	3.1	3.0	28.4	33.6	8.2	2.8	7.9	12.9	4.7	35.6	6.7	3.1	3.6	2.5	8.7	1.8	1.7	2.4	6.4	11.5	3.5	2.8	4.9	5.4	0.5	9.3	1.3	2.4	5.2	2.0	0.7	0.9	0.6	0.8	1.5	3.9	1.0	0.0	1.0	7.1	4.3	10.5	6.7	0.0	7.7	4.7	3.9	6.2	0.0	0.9	0.0	3.1	4.4	1.4	12.7	3.0	7.1	2.4	0.0	13.3	4.6	1.1	9.1	6.8	8.8	10.6	1.0	4.6	0.7	6.9	3.7	0.0	11.5	0.1	8.3	0.5	2.9	0.0	4.5	2.0	0.8	2.6	3.2	9.6	29.0	0.0	1.3	5.6	0.0	1.9	5.0	4.5	1.1	2.8	3.8	2.0	0.0	0.0	9.6	0.0	3.5	0.0	0.2	0.4	3.9	0.4	2.6	0.0	1.9	3.0	0.9	0.7	3.5	3.3	0.6	1.5	0.8	0.7	1.7	1.0	24.5	23.3	25.8	41.9	23.9	52.8	28.4	33.6	35.6	5.4
NAPA		ENSG00000105402	"NSF attachment protein alpha"	P54920	19	47487637-47515240	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010100, HPA046149, HPA050196"	Approved		Uncertain	Cytosol			5400000	Cytosol		"CAB010100: AB_628263, HPA046149: , HPA050196: "	"unprognostic (9.83e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.76e-3)"	"unprognostic (9.72e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.09e-3)"	"prognostic favourable (4.26e-9)"	"unprognostic (4.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.90e-2)"	28.1	52.4	35.5	24.5	49.1	43.6	29.3	70.2	86.9	30.9	29.9	34.8	31.0	26.5	37.6	29.0	56.0	29.1	33.4	47.3	41.8	29.6	35.8	73.8	30.3	24.6	28.1	39.4	28.8	41.2	40.4	35.4	30.3	52.6	49.0	21.7	35.5	52.3	45.5	56.9	45.6	27.4	31.8	25.1	24.8	28.8	38.5	20.8	44.8	36.4	39.0	28.4	31.4	29.1	15.7	44.5	68.2	41.1	24.1	23.5	40.6	17.1	22.6	11.0	19.1	23.2	20.0	8.1	19.5	23.5	43.5	54.8	17.0	9.9	13.0	10.2	25.5	12.8	17.9	22.6	17.3	21.0	19.4	16.8	22.5	20.7	61.1	18.9	29.7	29.8	15.6	18.1	11.3	21.1	13.8	34.4	28.6	14.3	25.8	50.6	9.2	17.4	17.1	10.5	18.2	33.7	33.0	40.1	15.2	24.8	29.2	17.1	23.9	29.8	22.6	22.2	11.8	18.9	20.9	22.1	32.0	18.5	41.8	19.9	22.9	35.6	35.6	68.2	22.7	41.1	18.8	15.7	19.3	22.0	30.1	15.2	20.5	20.0	39.6	24.1	41.0	44.5	23.5	40.6	35.5	49.1	70.2	86.9	41.8	29.6	28.1	39.4	52.6	20.8
NAPB	"SNAP-BETA, SNAPB"	ENSG00000125814	"NSF attachment protein beta"	Q9H115	20	23374519-23421519	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 110.9"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 24.0;U-937: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037225, CAB037227, HPA046149, HPA050196"	Supported		Uncertain	Cytosol				Cytosol		"CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: , HPA050196: "	"unprognostic (3.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.46e-3)"	"unprognostic (7.52e-3)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	3.2	15.5	32.7	3.8	32.7	6.0	4.4	46.0	110.9	4.0	4.0	4.4	2.6	3.8	4.7	6.3	3.7	4.6	3.8	3.7	30.5	32.0	4.4	3.8	3.9	4.0	26.1	40.1	6.4	3.4	6.1	4.6	5.9	50.2	4.0	5.0	6.1	4.0	4.6	3.4	5.0	5.5	4.5	9.7	4.5	4.3	5.3	4.0	0.7	5.1	0.1	3.4	3.6	2.3	2.4	1.9	6.0	2.1	1.5	5.1	2.1	4.2	2.7	4.5	4.7	5.1	4.7	6.4	5.5	3.0	4.4	3.9	3.2	3.8	6.2	6.5	3.2	5.4	5.8	3.7	5.4	2.0	4.3	6.8	3.6	7.6	6.0	5.0	4.0	4.7	4.9	3.1	4.0	3.3	5.7	8.2	7.0	2.8	5.1	4.6	1.9	5.0	3.4	3.6	4.6	5.8	4.6	24.0	7.6	3.1	3.1	5.1	3.2	3.1	3.8	4.3	3.2	4.7	3.9	6.0	4.7	2.8	2.2	23.9	4.2	6.0	1.2	0.0	5.1	1.3	1.5	1.7	2.0	2.4	1.9	2.4	2.0	3.3	1.5	1.5	2.1	1.5	2.5	2.1	32.7	32.7	46.0	57.7	30.5	32.0	26.1	40.1	50.2	4.0
NAPEPLD	"C7orf18, FMP30, NAPE-PLD"	ENSG00000161048	"N-acyl phosphatidylethanolamine phospholipase D"	Q6IQ20	7	103099776-103149560	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019832, HPA024338"	Approved		Enhanced	Cytosol				Cytosol		"HPA019832: AB_1844422, HPA024338: "	"unprognostic (3.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.21e-1)"	"prognostic favourable (7.32e-6)"	"unprognostic (8.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.41e-2)"	3.8	5.3	8.6	3.8	14.0	3.1	3.9	13.9	18.5	5.1	8.8	17.2	3.7	15.9	4.9	3.5	2.6	6.5	6.1	4.2	6.4	5.5	15.1	7.4	4.3	3.8	15.0	11.6	9.7	4.1	8.5	6.2	2.9	10.3	5.4	10.1	5.0	4.2	4.1	5.0	5.7	10.8	4.5	9.7	6.6	11.2	11.1	16.7	5.3	8.8	0.9	3.8	6.9	4.6	7.9	3.7	5.7	4.6	2.9	7.6	2.5	4.6	6.2	4.0	3.6	3.6	3.9	0.6	3.0	2.8	2.1	3.4	2.7	6.2	4.2	5.1	2.3	4.3	2.8	1.0	2.5	6.5	3.9	1.7	3.7	1.2	0.9	3.7	1.8	2.2	1.2	1.9	0.0	3.4	2.0	4.5	4.0	1.7	4.4	2.0	3.7	7.3	2.8	1.8	2.2	7.6	2.2	2.9	3.9	8.2	2.6	1.8	1.7	2.1	3.0	5.9	4.2	12.0	3.7	5.6	6.1	3.6	4.2	2.7	11.3	0.2	3.1	5.7	4.9	4.6	4.4	7.4	5.3	5.8	3.7	7.9	7.6	5.6	0.3	2.9	3.0	2.7	4.7	2.5	8.6	14.0	13.9	18.5	6.4	5.5	15.0	11.6	10.3	16.7
NAPG		ENSG00000134265	"NSF attachment protein gamma"	Q99747	18	10525905-10552761	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008208, HPA011389"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA008208: AB_1854305, HPA011389: AB_1854306"	"unprognostic (1.23e-1)"	"unprognostic (7.64e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.46e-3)"	"unprognostic (5.85e-2)"	"prognostic favourable (8.14e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.96e-2)"	11.0	14.0	20.5	9.1	31.2	6.1	12.1	24.0	40.2	11.6	11.6	17.8	4.9	9.3	11.0	12.7	12.3	11.3	13.5	19.3	26.3	20.8	16.9	13.3	9.6	8.7	24.1	21.4	7.6	12.4	12.8	10.5	13.7	54.1	14.3	14.1	10.1	10.7	11.6	9.0	8.8	10.3	12.5	25.2	8.5	13.4	7.1	11.9	6.9	14.8	8.2	10.6	12.6	8.7	8.4	4.7	15.2	7.1	6.6	7.1	3.6	5.7	3.4	6.1	5.2	17.5	12.0	8.9	12.3	17.7	12.0	15.4	7.6	8.8	7.7	9.9	16.8	5.7	8.0	11.1	17.3	6.6	4.9	5.6	6.0	7.8	16.8	15.5	10.6	12.6	12.9	13.8	10.3	11.3	9.1	18.3	17.5	8.0	11.9	6.6	4.7	5.2	5.3	10.1	12.8	14.1	13.6	24.3	6.4	10.0	10.6	14.1	4.9	10.3	12.6	19.1	9.2	17.4	12.9	11.8	12.1	8.5	12.8	10.9	8.7	11.3	5.7	15.2	6.5	7.1	5.8	8.4	5.2	6.3	4.2	4.1	7.1	6.1	9.7	6.6	6.9	4.7	5.1	3.6	20.5	31.2	24.0	40.2	26.3	20.8	24.1	21.4	54.1	11.9
NAPRT	"NAPRT1, PP3856"	ENSG00000147813	"Nicotinate phosphoribosyltransferase"	Q6XQN6	8	143574785-143578649	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Ligase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.9;SK-BR-3: 23.5;U-937: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023739, HPA024017, CAB068206, CAB068207"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"			2000000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB068206: , CAB068207: , HPA023739: AB_1854308, HPA024017: AB_1854309"	"unprognostic (7.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-2)"	"prognostic favourable (6.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-2)"	9.7	6.4	4.9	9.7	6.2	21.1	13.2	10.7	5.4	6.7	25.2	2.3	9.9	33.0	4.7	4.7	16.4	4.8	15.5	4.9	3.9	2.1	10.7	28.3	8.3	12.1	3.7	0.1	5.9	6.5	2.4	2.8	8.6	4.1	6.9	3.8	5.2	12.8	3.8	7.1	12.4	34.4	5.2	2.2	9.8	11.8	5.5	4.0	3.0	6.8	8.9	9.5	7.6	8.1	0.8	4.7	4.6	8.4	0.5	1.6	2.4	3.4	3.9	0.4	0.8	0.3	1.2	2.5	0.8	0.4	1.3	0.8	3.2	21.9	0.9	6.1	0.2	7.5	0.2	6.2	0.0	4.0	6.3	5.2	10.3	0.9	2.8	1.2	2.8	0.1	2.2	0.1	0.0	1.4	4.8	4.1	0.1	4.2	2.5	2.7	1.0	2.5	4.5	0.1	10.8	0.9	1.3	1.7	0.4	9.9	23.5	2.9	0.9	3.0	4.1	0.7	6.2	4.6	1.7	0.5	0.2	1.1	1.1	18.2	3.2	0.0	4.4	4.6	1.6	8.4	0.5	0.8	0.7	1.5	4.7	0.2	0.8	0.7	2.7	0.5	8.4	1.5	0.2	2.4	4.9	6.2	10.7	5.4	3.9	2.1	3.7	0.1	4.1	4.0
NARFL	"FLJ21988, HPRN, IOP1, NAR1, PRN"	ENSG00000103245	"Nuclear prelamin A recognition factor like"	Q9H6Q4	16	729753-741329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040851	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA040851: AB_10794427"	"unprognostic (6.31e-2)"	"prognostic favourable (1.32e-5)"	"unprognostic (7.61e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.02e-1)"	"prognostic favourable (9.83e-5)"	"unprognostic (2.49e-2)"	"unprognostic (8.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.33e-3)"	10.2	11.9	16.4	15.3	19.7	15.0	10.3	21.8	28.8	10.0	12.6	21.6	21.1	20.9	11.1	19.2	15.2	13.7	10.6	20.9	18.1	14.2	16.1	17.6	9.1	16.2	15.1	9.8	11.3	18.4	18.5	13.1	11.1	16.7	15.7	8.1	14.3	25.4	17.5	24.1	14.9	15.5	8.7	14.1	15.0	14.5	8.7	13.1	18.4	12.6	13.7	18.9	11.7	11.3	16.0	11.8	8.3	10.9	13.9	12.9	9.4	3.5	10.4	4.1	6.0	4.3	3.0	10.0	5.1	3.8	7.1	6.2	7.4	8.8	5.0	7.8	3.2	8.0	4.0	6.2	2.5	9.3	9.2	4.2	6.0	6.0	5.5	7.5	6.1	3.8	7.8	4.2	3.5	5.2	7.8	4.8	3.4	13.2	6.7	3.4	3.4	6.7	55.6	6.3	9.1	4.3	3.6	4.7	6.6	6.0	14.6	5.1	13.3	7.6	5.5	5.9	5.6	6.5	4.5	6.4	4.5	14.0	4.1	4.3	7.7	2.7	10.9	8.3	11.5	9.9	8.9	16.0	11.7	9.5	11.8	10.5	9.5	12.9	2.3	13.9	10.6	9.5	11.1	9.4	16.4	19.7	21.8	28.8	18.1	14.2	15.1	9.8	16.7	13.1
NARS	NARS1	ENSG00000134440	"Asparaginyl-tRNA synthetase"	O43776	18	57600656-57622213	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034257, HPA040017"	Enhanced		Supported	Cytosol				Cytosol		"CAB034257: AB_2151043, HPA040017: "	"unprognostic (9.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.23e-7)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"prognostic favourable (1.73e-7)"	"unprognostic (1.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.51e-1)"	30.9	36.9	35.0	28.8	42.6	19.5	31.6	47.1	51.4	28.1	49.7	24.8	31.1	42.5	30.8	31.6	40.2	27.4	26.8	40.6	40.5	36.5	66.0	41.9	26.0	23.0	39.5	39.2	29.4	29.4	52.0	35.7	25.6	49.5	33.1	46.1	18.5	33.7	30.9	76.6	26.9	35.2	29.9	40.6	25.7	36.0	14.9	36.3	25.0	44.5	31.9	29.2	34.6	35.3	20.0	26.6	15.6	40.8	15.8	23.4	23.7	35.9	23.8	22.4	32.7	28.8	22.1	34.9	50.3	26.3	29.7	36.9	17.1	16.9	45.4	24.2	34.8	41.0	35.2	31.1	43.6	22.0	12.2	34.7	18.3	26.9	48.7	71.9	35.9	23.4	54.5	40.7	39.0	24.6	42.6	33.9	33.3	13.4	27.8	17.4	32.9	19.1	22.1	26.4	38.3	55.6	40.6	24.6	27.0	24.4	31.5	52.8	17.6	40.0	26.9	33.2	22.2	14.0	37.2	76.1	94.1	44.1	30.5	47.3	38.6	15.6	40.8	14.2	16.4	35.1	20.2	20.0	17.3	17.4	26.6	18.8	23.4	21.2	12.7	15.8	26.6	25.1	17.2	23.7	35.0	42.6	47.1	51.4	40.5	36.5	39.5	39.2	49.5	36.3
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435961-78574874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favourable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	10.9	16.0	11.8	9.3	11.2	6.4	13.4	19.4	11.8	11.6	13.0	13.1	13.5	12.0	17.6	13.9	10.8	12.0	9.9	12.7	11.3	12.2	22.3	26.8	9.0	10.2	13.4	8.4	15.9	20.0	14.0	17.3	9.4	13.8	13.3	13.3	23.2	12.7	13.2	24.4	9.1	11.1	10.6	10.8	12.6	11.3	11.8	10.3	17.3	16.0	7.7	14.1	9.7	10.7	14.6	13.5	6.7	9.4	16.2	16.6	8.7	7.4	10.5	11.0	7.2	7.7	6.5	9.2	6.2	6.1	9.7	8.0	17.9	8.1	18.5	16.2	3.9	9.9	18.5	12.1	13.5	12.1	9.9	13.0	8.1	15.2	6.4	13.9	4.8	4.5	7.8	8.5	15.2	8.3	19.6	5.1	10.8	8.7	14.4	22.6	12.0	12.7	15.1	18.0	25.0	12.9	10.6	13.1	8.3	9.2	11.9	15.9	11.2	5.5	5.0	13.2	15.6	15.0	10.4	8.5	14.3	40.8	2.5	12.6	8.9	6.7	7.9	3.5	9.8	8.3	12.0	14.6	11.3	10.8	13.5	12.6	16.6	14.8	1.7	16.2	9.4	10.3	8.2	8.7	11.8	11.2	19.4	11.8	11.3	12.2	13.4	8.4	13.8	10.3
NAV3	"KIAA0938, POMFIL1"	ENSG00000067798	"Neuron navigator 3"	Q8IVL0	12	77324641-78213008	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.2;ovary: 29.6"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 23.4;THP-1: 20.5;U-138 MG: 15.7;WM-115: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 1.9;neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032111, HPA061392"	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane"	Cytosol	"HPA032111: AB_10603881, HPA061392: "	"unprognostic (3.51e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.68e-7)"	"unprognostic (6.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.29e-3)"	6.2	8.5	17.8	2.4	14.2	1.5	7.1	14.7	25.2	2.8	2.1	9.7	2.6	1.2	4.1	5.8	3.8	3.6	8.6	3.7	14.2	7.5	1.4	2.3	3.8	1.6	7.8	13.0	29.6	1.4	2.2	9.3	4.3	7.1	4.5	2.0	12.3	2.2	5.1	2.6	4.1	1.3	4.6	10.6	12.7	1.6	5.0	8.3	0.0	1.7	0.0	1.4	3.9	2.3	0.3	0.1	3.8	0.2	0.1	0.0	0.0	1.8	4.3	0.3	0.1	4.5	9.3	0.1	13.1	10.3	5.4	2.8	1.2	0.3	0.1	1.0	10.5	1.4	3.8	2.0	9.6	0.0	0.0	0.0	1.8	0.1	3.5	0.0	0.1	3.4	0.0	23.4	5.9	8.0	0.0	0.0	13.2	0.1	0.0	5.9	1.5	1.2	0.6	1.1	0.0	0.9	0.0	0.3	0.0	0.9	0.1	1.8	0.0	20.5	6.9	15.7	4.4	6.7	9.0	0.7	0.0	0.4	4.7	0.2	19.4	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.1	0.2	0.1	0.0	0.0	17.8	14.2	14.7	20.5	14.2	7.5	7.8	13.0	7.1	8.3
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591762-156594299	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Isomerase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"		3300000	Nucleoplasm	Cytosol	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	19.1	29.9	31.6	14.4	28.5	12.1	22.6	17.6	42.5	23.0	30.0	31.0	17.4	28.4	28.5	57.9	23.4	29.4	25.8	46.3	28.5	25.0	41.6	41.0	17.2	16.9	33.2	29.3	29.3	37.3	36.3	29.0	21.8	28.8	27.9	26.6	23.0	29.5	36.3	30.9	20.2	25.9	25.0	29.1	17.4	25.0	29.5	22.2	17.7	32.4	19.5	20.4	20.8	18.3	52.4	53.8	12.4	26.5	31.6	32.5	40.6	31.4	41.8	13.4	23.9	17.8	12.2	16.0	10.9	16.6	18.6	19.7	34.8	21.2	21.4	33.0	13.8	30.7	13.3	26.0	13.2	22.5	29.1	17.7	23.8	22.9	20.4	22.2	18.2	12.3	33.6	23.7	22.1	25.3	18.0	19.5	19.0	56.0	24.4	27.0	16.6	32.7	24.6	12.5	56.5	25.2	26.2	32.3	30.8	26.1	49.8	38.3	48.3	32.7	14.7	13.4	20.9	19.0	23.6	50.6	30.5	20.4	18.5	13.2	20.6	4.9	24.1	12.4	31.6	26.5	31.3	52.4	29.2	32.2	21.7	41.7	32.5	30.9	2.9	31.6	20.6	53.8	25.5	40.6	31.6	28.5	17.6	42.5	28.5	25.0	33.2	29.3	28.8	22.2
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942287-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 41.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favourable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	3.9	11.9	12.2	2.7	20.6	1.0	8.2	32.6	28.5	7.4	9.8	3.9	10.9	2.7	10.3	6.2	6.2	9.4	5.4	11.7	13.5	10.6	6.6	1.7	3.6	2.6	6.9	22.2	10.4	5.7	9.3	25.0	1.5	14.2	11.9	4.8	13.3	7.0	14.2	8.5	2.0	3.8	11.4	4.7	5.1	4.8	7.7	6.0	6.1	9.6	0.7	2.4	7.1	6.4	1.1	1.3	0.0	0.5	0.4	1.4	0.1	0.0	2.3	5.4	3.0	0.4	0.0	0.1	3.4	5.3	4.0	3.3	0.0	0.5	1.4	0.0	5.8	0.1	1.8	0.7	8.5	0.7	1.8	0.0	1.6	0.5	0.3	0.9	2.2	0.9	0.6	0.0	0.4	0.7	0.0	9.7	0.5	1.0	0.5	0.0	2.3	0.9	0.6	2.3	0.4	4.6	1.0	3.1	41.2	2.5	0.0	1.7	0.9	0.2	0.0	1.0	0.6	0.0	0.7	0.9	0.2	0.7	2.6	0.3	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.2	0.0	1.1	1.4	1.3	0.0	0.4	0.0	1.3	0.0	0.1	12.2	20.6	32.6	18.4	13.5	10.6	6.9	22.2	14.2	6.0
NBEAL1	"ALS2CR16, ALS2CR17, MGC164581"	ENSG00000144426	"Neurobeachin like 1"	Q6ZS30	2	203014879-203226378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA049189, HPA049447"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA049189: , HPA049447: "	"unprognostic (3.66e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.59e-2)"	11.2	7.8	5.2	7.3	7.9	2.7	13.4	7.5	6.0	9.2	14.5	6.5	8.4	9.9	19.1	7.0	8.7	7.9	8.9	8.2	4.8	2.9	14.4	12.3	14.7	3.3	5.1	2.7	8.8	8.5	9.2	13.6	10.2	7.0	6.7	14.4	9.7	8.1	10.6	6.9	6.6	11.7	11.9	7.3	5.0	14.7	9.9	6.2	2.8	10.1	6.4	5.3	9.8	9.5	0.9	0.7	0.9	0.6	0.6	3.0	0.2	4.9	4.6	1.9	1.7	12.0	9.4	2.7	4.7	3.5	2.5	3.9	5.2	2.6	1.1	3.9	7.9	4.0	3.8	5.5	5.9	2.2	1.6	1.9	6.9	2.9	2.9	1.7	2.3	3.6	3.7	4.2	5.2	4.0	3.3	1.7	5.7	3.4	0.7	0.9	0.9	4.3	0.8	3.2	1.1	7.1	9.2	1.2	0.9	4.1	3.0	3.1	3.5	1.7	6.7	6.7	5.7	3.2	2.1	2.9	2.2	1.5	4.0	0.8	2.3	0.0	0.5	0.9	0.8	0.4	1.0	0.4	0.9	0.5	0.4	0.9	0.7	0.5	0.3	0.6	0.6	0.7	3.0	0.2	5.2	7.9	7.5	6.0	4.8	2.9	5.1	2.7	7.0	6.2
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.1;testis: 8.8"	"Group enriched"	"Detected in some"	4	"BEWO: 8.0;K-562: 11.5;Karpas-707: 3.4;MCF7: 13.6;THP-1: 4.1"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA045044: , HPA046411: , HPA047447: , HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.6			0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.5	1.4		0.0	0.8		0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	3.4	0.0	13.6	0.0	0.0	0.6	0.0	0.0	2.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	1.6	0.2	4.1	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 1.9;testis: 7.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.7;K-562: 13.6;SK-BR-3: 3.3;SK-MEL-30: 2.4"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA045044: , HPA046411: , HPA047447: , HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.1			0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.6	1.4		0.0	0.9		0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.1			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	1.5	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.4	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.6;heart muscle: 67.7"	"Cell line enhanced"	"Detected in some"		"HEL: 19.1;RH-30: 43.1;SCLC-21H: 35.1;SH-SY5Y: 17.2;U-138 MG: 24.0;WM-115: 25.4"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"NK-cell: 27.2"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"		2800000000	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: "	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	3.5	36.4	22.7	3.0	35.7	1.8	2.1	20.2	110.6	13.3	9.0	55.8	0.3	3.4	24.7	3.0	4.8	8.3	3.6	67.7	22.5	19.2	2.3	2.6	2.0	1.7	45.0	27.1	21.9	2.3	1.1	9.1	1.4	38.8	8.4	4.6	5.5	2.5	10.9	14.6	1.8	5.3	25.6	27.6	3.4	6.7	2.9	39.2	0.0	16.9	0.7	1.7	7.0	6.5	0.0	0.0	0.4	0.1	27.2	2.0	0.9	0.0	0.0	6.7	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.4	0.1	0.1	0.9	6.0	6.3	0.1	0.0	0.0	0.0	0.1	3.8	19.1	0.0	0.0	0.7	0.0	3.1	4.1	0.0	0.0	6.1	0.0	0.0	0.3	6.7	0.0	0.0	1.6	0.5	0.1	0.0	43.1	3.1	0.0	0.0	35.1	17.2	0.0	0.1	0.0	0.0	0.2	0.0	24.0	11.2	0.1	10.0	0.0	0.1	0.0	2.7	9.0	25.4	0.0	0.1	0.0	2.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.4	27.2	0.0	0.0	0.1	0.9	22.7	35.7	20.2	41.6	22.5	19.2	45.0	27.1	38.8	39.2
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 84.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavourable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	6.8	8.8	6.5	24.6	12.7	16.7	7.7	7.7	9.0	8.0	11.3	16.2	7.0	10.6	11.5	8.8	17.7	8.1	6.5	6.2	7.5	5.4	7.0	5.1	7.7	20.4	16.5	6.2	7.7	7.2	9.6	6.3	13.9	8.7	8.2	12.4	8.1	10.5	8.3	7.0	14.8	13.0	8.2	12.7	16.4	9.9	17.2	11.4	84.1	11.4	12.4	24.3	10.9	9.5	5.0	4.8	7.2	2.8	7.8	7.4	3.2	21.9	20.4	21.9	15.8	5.7	6.0	25.6	15.1	12.2	24.6	19.9	18.3	23.3	23.1	4.5	9.9	19.4	36.0	17.7	47.0	41.8	20.2	21.1	23.3	10.4	2.4	26.2	15.3	3.8	6.6	19.2	19.6	16.2	13.4	9.4	21.7	10.9	29.6	17.2	34.2	15.9	25.3	49.8	12.2	8.2	12.3	9.0	9.5	22.6	10.7	8.1	4.7	16.5	10.1	16.2	26.6	10.9	29.4	7.4	9.9	32.9	9.5	15.2	20.0	7.2	2.0	3.6	6.3	2.8	5.6	5.0	6.2	7.3	3.0	3.8	7.4	7.2	1.9	7.8	1.9	4.8	7.2	3.2	6.5	12.7	7.7	9.0	7.5	5.4	16.5	6.2	8.7	11.4
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335787-96373845	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 5.6;T-reg: 8.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.6;T-cells: 8.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavourable (9.53e-6)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.3	1.1	0.8	13.2	0.9	17.2	1.7	0.7	1.2	1.5	3.9	0.7	0.4	2.9	0.7	1.1	7.4	0.4	1.0	0.8	0.8	0.7	0.9	0.9	1.5	10.6	1.0	0.6	0.8	0.6	0.1	0.5	3.4	1.0	0.7	5.1	0.6	1.9	0.4	0.6	2.7	3.5	1.4	1.2	6.7	2.1	60.4	0.8	41.3	0.6	6.4	12.2	1.7	2.2	1.3	0.5	5.6	1.0	0.1	8.7	0.8	30.9	11.8	29.9	15.5	1.1	1.6	19.8	14.7	10.3	28.4	30.0	21.8	17.4	28.9	10.4	6.4	14.0	25.6	10.0	30.5	25.4	17.0	29.8	12.3	19.6	0.2	27.5	25.5	0.5	1.1	22.0	9.3	11.2	20.6	21.5	13.4	14.6	40.4	28.7	21.4	14.9	31.4	27.2	23.5	5.6	12.0	17.8	13.6	8.5	12.0	5.2	8.8	20.4	6.5	21.0	32.1	19.6	23.7	11.5	16.3	30.8	9.1	27.6	23.7	5.6	0.0	0.3	1.3	1.0	0.2	1.3	1.9	1.5	0.5	0.9	0.0	0.7	0.3	0.1	0.0	0.0	8.7	0.8	0.8	0.9	0.7	1.2	0.8	0.7	1.0	0.6	1.0	0.8
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633626-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favourable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	18.5	17.2	19.8	27.4	26.2	37.2	23.6	25.5	27.1	17.0	21.9	18.7	19.8	18.0	19.2	15.3	21.7	15.9	16.3	20.4	23.7	17.8	17.9	22.7	17.3	25.9	16.6	23.8	22.8	22.0	17.1	26.9	20.3	22.6	18.4	25.7	18.1	18.3	17.7	25.5	22.4	19.3	16.3	18.7	20.5	19.4	26.8	17.8	36.1	22.5	15.1	25.0	18.5	19.4	7.6	13.7	12.9	14.6	14.9	10.0	7.7	24.5	16.9	19.0	17.7	13.4	13.5	18.6	18.8	10.9	17.2	16.2	22.6	12.8	21.2	8.1	16.9	27.8	30.2	21.4	24.7	14.1	9.7	19.5	25.5	14.1	13.1	26.0	20.3	10.1	10.7	20.0	15.5	17.8	28.7	11.9	28.8	17.7	18.8	13.8	20.6	18.3	18.1	44.1	8.5	14.0	18.3	24.2	16.3	18.8	16.5	9.8	10.2	15.9	14.9	13.5	12.6	26.8	19.3	11.5	14.1	11.0	12.4	20.2	17.7	12.9	11.4	11.0	8.7	14.6	9.9	6.5	9.9	9.1	13.7	7.6	8.7	10.0	3.5	14.9	14.3	5.9	8.6	7.7	19.8	26.2	25.5	27.1	23.7	17.8	16.6	23.8	22.6	17.8
NCDN	"NCDN-1, NCDN-2"	ENSG00000020129	Neurochondrin	Q9UBB6	1	35557473-35567274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 144.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023676	Enhanced	Supported	Supported	Cytosol				Cytosol		"HPA023676: AB_1854325"	"unprognostic (1.15e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (4.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.36e-2)"	"prognostic favourable (3.73e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.34e-3)"	"unprognostic (5.88e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-2)"	5.2	11.3	33.4	6.0	144.3	3.4	3.6	28.7	104.9	9.9	3.5	8.7	1.2	3.9	6.2	4.8	4.5	8.1	6.5	12.0	45.4	25.0	4.0	2.5	4.5	5.9	15.8	32.3	9.2	6.1	6.2	5.5	4.7	26.4	7.1	2.9	3.6	6.7	8.0	5.3	5.6	3.2	6.5	10.7	5.0	4.7	5.8	15.6	0.8	6.5	0.6	4.6	6.0	2.4	5.9	2.7	0.8	4.5	3.0	6.5	5.5	8.7	10.6	8.9	14.0	12.9	16.0	6.1	11.6	12.1	12.2	9.8	10.6	13.0	10.0	11.3	10.7	13.5	8.7	14.1	4.5	9.7	18.0	12.4	15.6	5.4	17.9	11.2	14.3	15.3	11.8	21.6	8.7	6.5	13.4	16.0	9.9	15.7	10.2	7.2	39.9	18.7	8.4	4.9	12.9	8.2	9.8	11.1	16.0	13.2	12.2	16.3	11.7	7.4	8.8	15.6	11.2	11.4	15.8	22.6	15.9	7.4	19.4	18.0	14.2	0.0	4.5	0.8	3.1	2.6	3.8	5.9	4.8	4.8	2.7	2.7	6.5	5.3	0.7	3.0	4.2	1.6	2.7	5.5	33.4	144.3	28.7	61.4	45.4	25.0	15.8	32.3	26.4	15.6
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555563-183590876	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in many"		"A-431: 13.1;HMC-1: 11.4;hTERT-HME1: 27.4;U-2 OS: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 125.2;neutrophil: 80.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	15.3	3.1	2.0	23.0	4.5	53.0	3.9	0.7	2.8	2.9	2.8	3.7	0.2	2.3	1.8	6.1	4.1	5.2	7.2	6.4	2.0	1.8	2.9	5.4	39.5	42.7	6.8	0.4	3.5	4.2	0.6	1.9	11.5	3.8	3.4	3.7	4.2	4.4	0.8	3.5	7.1	3.8	5.8	5.5	45.4	2.6	3.9	3.2	4.2	2.0	5.6	5.5	7.3	3.5	1.4	24.3	125.2	45.7	0.2	1.0	22.7	13.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.2	1.8	0.8	0.1	0.4	1.6	2.3	0.4	7.4	0.0	9.7	1.6	8.2	0.0	0.0	3.3	3.0	0.0	1.0	11.4	0.0	2.1	1.7	27.4	0.0	0.0	2.9	3.0	0.1	0.1	0.5	0.2	0.7	3.5	1.1	9.9	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.4	4.6	0.6	0.0	26.6	0.0	2.4	0.5	0.7	0.2	0.2	5.2	0.0	15.5	45.7	125.2	0.1	34.4	0.1	1.4	0.4	0.1	24.3	0.8	0.2	0.1	80.6	0.2	29.7	1.3	1.0	22.7	2.0	4.5	0.7	2.8	2.0	1.8	6.8	0.4	3.8	3.2
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878015	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0"	"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 86.9;NB-4: 30.8;REH: 15.8;RPMI-8226: 30.6;THP-1: 29.0;U-937: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 130.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB010146: AB_627989, HPA036156: , HPA057975: "	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	10.4	5.8	4.4	24.8	5.6	69.0	5.6	0.7	2.8	3.4	7.4	2.5	1.2	5.0	2.2	8.1	4.4	5.9	7.2	8.0	3.9	2.2	4.4	4.2	17.5	21.2	8.0	1.0	3.3	2.1	0.6	2.6	10.3	4.6	5.1	5.3	4.2	6.5	2.2	2.6	2.3	16.0	4.3	7.7	66.0	3.9	3.0	5.4	5.0	3.5	2.8	22.2	9.0	7.1	12.6	10.0	130.3	19.5	0.4	10.8	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	18.2	0.0	0.0	0.0	2.6	86.9	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	30.8	0.0	0.0	15.8	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	16.1	0.0	58.0	19.5	76.4	0.2	9.6	1.1	12.6	3.9	0.8	9.1	8.9	0.2	0.2	130.3	0.4	6.4	10.0	10.8	10.2	4.4	5.6	0.7	2.8	3.9	2.2	8.0	1.0	4.6	5.4
NCK1	"NCK, NCKalpha"	ENSG00000158092	"NCK adaptor protein 1"	P16333	3	136862208-136949823	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005063, HPA030766"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB005063: AB_562169, HPA030766: "	"unprognostic (7.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.77e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (9.14e-5)"	"unprognostic (5.96e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.17e-2)"	44.5	15.7	11.5	24.5	13.4	19.3	38.9	22.6	11.6	23.7	18.3	8.4	16.5	10.2	20.8	19.2	35.9	14.6	13.9	16.8	11.8	11.1	14.0	20.9	22.4	33.0	13.9	12.1	19.6	14.3	17.9	17.7	22.7	13.5	26.3	19.5	10.8	24.0	15.8	29.0	27.3	14.3	24.0	13.5	18.7	12.8	14.7	12.7	41.1	23.8	23.5	29.0	27.3	43.3	8.5	13.3	26.8	27.1	11.2	20.2	11.9	19.6	8.7	11.5	9.5	26.8	26.1	12.9	14.5	26.2	16.9	17.7	12.7	19.6	19.3	30.2	17.0	15.2	16.2	14.8	22.6	13.9	6.6	16.7	12.4	9.9	43.7	12.1	11.6	23.6	19.5	16.4	32.8	25.9	10.0	17.3	17.7	10.7	27.3	9.7	11.0	11.1	14.9	10.8	18.5	15.8	13.5	8.2	8.0	26.2	11.8	23.4	16.9	13.3	12.8	11.0	7.2	15.6	8.3	17.3	13.6	23.9	11.7	10.9	11.7	26.8	12.4	13.2	19.7	27.1	20.2	8.1	15.6	19.8	13.3	8.5	12.6	15.0	7.2	11.2	13.4	5.2	15.0	11.9	11.5	13.4	22.6	11.6	11.8	11.1	13.9	12.1	13.5	12.7
NCKAP1	"HEM2, Nap1, NAP125"	ENSG00000061676	"NCK associated protein 1"	Q9Y2A7	2	182909115-183038858	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020449	Enhanced		Approved	Cytosol			210000	Cytosol		"HPA020449: AB_1854327"	"unprognostic (7.92e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.12e-3)"	"prognostic unfavourable (9.71e-4)"	"unprognostic (5.06e-2)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (3.81e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.61e-2)"	25.2	23.7	35.8	12.6	49.7	0.6	25.5	32.9	47.2	30.8	29.1	12.9	17.8	28.2	27.9	28.6	42.6	22.6	22.0	46.1	34.0	26.8	37.0	20.8	20.5	4.9	25.8	36.4	24.5	21.9	47.9	26.2	29.4	25.5	30.0	25.6	16.9	24.2	35.9	45.4	26.2	28.5	38.2	20.0	10.2	28.4	16.0	20.4	4.3	44.3	21.0	12.2	33.3	40.9	0.2	0.2	2.8	0.2	0.5	0.9	0.3	23.2	14.7	22.6	14.4	32.0	31.2	25.2	30.5	27.8	20.7	26.2	22.7	20.0	0.1	20.6	36.2	22.2	19.0	28.8	34.7	5.6	14.9	5.2	16.5	18.7	32.9	0.0	4.5	23.2	35.6	30.0	49.4	32.9	12.6	0.0	39.1	14.9	0.4	0.1	23.2	25.5	1.5	24.7	0.1	29.3	31.5	16.7	15.9	27.6	22.0	28.5	11.8	0.1	35.7	35.4	19.9	19.8	18.6	3.0	5.6	0.1	27.4	0.0	17.9	2.1	0.2	2.8	0.8	0.1	0.7	0.1	0.6	0.6	0.2	0.2	0.2	0.8	0.9	0.5	0.2	0.2	0.9	0.3	35.8	49.7	32.9	42.3	34.0	26.8	25.8	36.4	25.5	20.4
NCKAP1L	HEM1	ENSG00000123338	"NCK associated protein 1 like"	P55160	12	54497711-54548238	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.1;lymphoid tissue: 56.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 32.9;HMC-1: 34.8;NB-4: 24.2;REH: 17.4;THP-1: 36.1;U-937: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039490, HPA040772"	Approved		Uncertain	"Plasma membrane,Cytosol"			52000	Cytosol	"Plasma membrane"	"HPA039490: , HPA040772: "	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.63e-2)"	"unprognostic (4.74e-2)"	18.1	5.0	5.9	22.0	10.5	16.9	7.2	1.2	5.8	3.1	15.0	8.1	0.6	4.0	3.1	4.3	4.8	4.0	5.1	6.5	4.1	3.5	3.9	6.5	19.7	56.7	9.3	2.5	2.2	2.4	4.4	2.3	7.3	6.6	4.8	6.9	3.0	4.3	4.0	1.5	2.8	15.4	7.0	13.9	44.7	4.7	1.7	7.9	47.2	2.8	1.8	30.0	22.2	3.3	11.2	25.4	18.4	39.1	12.3	15.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	11.9	0.1	14.2	0.0	0.0	0.0	32.9	34.8	0.0	0.0	0.0	0.0	0.2	2.2	13.3	0.0	0.0	13.8	24.2	0.0	0.0	17.4	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.7	0.8	11.6	0.0	21.1	0.0	8.6	23.3	18.4	11.9	36.4	9.8	11.2	10.7	12.1	25.4	11.0	6.9	10.0	5.9	12.3	39.1	14.4	15.2	19.2	5.9	10.5	1.2	5.8	4.1	3.5	9.3	2.5	6.6	7.9
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671799-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.3;lung: 19.2"	"Cell line enriched"	"Detected in some"	6	"AF22: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Low region specificity"	"Detected in all"							"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"				Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: "	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	3.6	2.0	6.6	1.5	6.3	0.2	5.4	5.2	5.6	3.1	5.8	6.2	0.9	3.8	3.6	6.2	6.9	1.0	1.5	4.6	6.0	3.9	16.3	6.7	19.2	2.2	6.6	4.7	4.5	1.8	2.2	1.3	4.6	4.2	1.6	1.9	7.5	7.8	1.0	1.1	3.7	18.3	1.0	6.3	2.9	3.0	2.1	6.6	0.3	2.1	5.4	2.3	1.3	3.1	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	1.5	31.7	0.0	0.0	0.3	0.1	0.5	5.6	0.5	0.5	0.0	0.0	2.4	0.0	0.3	0.1	0.2	0.4	1.8	0.0	0.2	0.0	4.7	0.0	0.0	0.0	0.0	0.3	2.6	3.0	0.4	0.5	0.0	0.0	0.9	0.3	0.0	0.0	0.7	1.0	0.3	0.0	1.2	0.7	0.7	0.1	1.0	0.0	1.1	1.6	0.5	0.0	1.6	0.2	0.2	4.6	0.0	0.1	0.0	0.9	0.3	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	6.3	5.2	5.6	6.0	3.9	6.6	4.7	4.2	6.6
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: , HPA070520: "	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	9.8	10.0	15.3	7.3	18.0	8.9	10.5	15.9	17.1	13.7	8.9	13.5	4.9	12.5	13.0	11.5	10.8	10.0	8.3	8.8	20.8	12.2	11.9	8.8	9.4	8.2	10.8	9.9	17.2	10.3	23.9	16.0	10.1	14.2	9.6	10.1	19.9	10.6	13.0	42.5	9.3	10.9	11.6	9.7	9.6	7.6	11.4	10.7	8.5	7.0	12.2	9.3	9.7	10.8	2.5	5.5	14.2	3.5	3.4	4.1	1.8	6.6	4.9	8.7	4.5	9.6	8.8	13.3	3.5	7.1	4.5	4.0	4.6	2.8	4.8	1.5	6.4	1.6	5.2	3.0	4.9	22.8	7.5	17.2	2.0	1.9	6.0	7.9	14.4	14.0	4.6	4.3	3.5	4.5	10.4	8.0	6.8	4.4	7.0	2.8	4.1	3.3	5.5	40.1	2.4	4.9	9.0	8.0	6.3	8.2	5.0	3.6	6.0	4.0	4.9	7.5	5.9	5.1	3.5	9.3	8.0	8.4	4.3	5.0	3.7	11.0	3.5	6.9	3.8	2.7	4.1	1.8	3.4	4.1	2.6	2.5	3.3	4.0	14.2	3.4	2.8	5.5	3.7	1.8	15.3	18.0	15.9	17.1	20.8	12.2	10.8	9.9	14.2	10.7
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501902-47656877	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	20.1	8.9	6.6	34.0	7.4	11.1	15.7	11.9	9.9	12.3	10.1	8.1	9.0	6.7	15.5	8.8	16.7	12.0	8.6	11.5	6.7	4.8	9.1	9.3	17.4	25.8	7.9	4.7	13.3	10.7	13.5	13.5	54.7	7.9	9.7	9.0	10.8	13.5	10.0	32.5	15.0	17.1	11.3	9.5	30.8	11.4	9.2	7.2	17.6	13.5	10.5	33.3	15.1	17.7	13.0	6.7	6.0	7.3	2.7	4.0	3.5	5.7	18.8	5.3	7.2	12.5	14.7	37.3	5.6	8.4	9.6	5.1	9.0	6.4	20.1	3.7	9.6	14.2	4.1	6.9	7.3	10.6	2.2	2.7	5.3	12.5	7.4	2.1	15.0	6.7	19.8	9.1	10.6	6.8	6.2	4.7	5.3	62.6	3.2	3.7	1.8	7.2	6.0	3.7	8.6	5.3	13.6	1.0	1.9	14.1	17.6	6.0	8.1	5.5	11.8	5.7	5.0	6.9	2.4	12.9	11.8	20.7	6.6	2.2	3.8	3.4	5.2	4.0	3.5	7.3	3.2	13.0	3.2	3.1	6.7	10.0	3.7	4.0	6.0	2.7	7.0	5.5	4.0	3.5	6.6	7.4	11.9	9.9	6.7	4.8	7.9	4.7	7.9	7.2
NCOA4	"ARA70, DKFZp762E1112, ELE1, PTC3, RFG"	ENSG00000266412	"Nuclear receptor coactivator 4"	Q13772	10	46005088-46030714	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 30.2;granulocytes: 100.1;monocytes: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051260, HPA065208"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA051260: , HPA065208: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.04e-2)"	"prognostic favourable (8.04e-6)"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	18.5	6.9	5.5	9.5	10.0	17.4	10.0	5.5	11.3	10.8	22.5	13.6	5.9	27.0	9.9	9.4	17.0	6.3	9.0	16.6	5.7		20.8	40.9	11.6	11.6	8.7	7.1	11.0	9.1	9.3	9.6	28.4	13.5	14.7	12.4	9.9	12.6	8.5	15.5	6.8	36.4	11.2	9.7	23.8	8.9	6.4	8.1	26.8	13.2	13.9	16.3	13.0	6.4	7.3	30.2	100.1	40.4	13.4	10.9	53.9	31.3	13.3	15.6	16.0	41.4	37.6	39.1	28.8	46.7	28.5	27.9	20.4	23.2	35.4	34.7	47.1	32.0	16.3	31.7	31.7	25.0	16.8	23.9	18.3	58.5	29.1	60.8	53.4	36.5	31.8	24.2	40.7	41.8	26.0	21.4	38.7	14.0	29.5	22.8	9.4	7.8	17.5	22.7	21.2	34.1	26.7	15.7	10.6	29.1	33.3	28.8	24.0	29.9	38.5	17.6	21.2	18.6	19.4	15.9	17.0	35.2	22.0	51.2	9.3	69.1	40.4	70.7	10.0	26.8	10.9	7.3	9.4	9.5	30.2	6.6	10.2	8.6	100.1	13.4	30.4	9.3	10.8	53.9										
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB072830: , HPA043246: , HPA050288: , HPA051168: "	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favourable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	19.6	21.2	25.4	24.0	30.8	27.0	25.0	41.8	31.5	24.0	30.6	19.6	18.6	33.2	29.0	19.5	25.0	20.5	21.9	17.8	22.4	17.8	25.6	33.8	20.1	19.5	25.1	19.1	25.9	24.3	39.9	39.8	19.8	21.6	20.8	29.7	17.1	20.9	29.1	43.0	23.8	36.9	29.7	26.4	23.7	29.8	22.1	26.4	38.8	25.3	15.7	23.8	29.6	27.0	43.4	29.9	78.2	24.8	30.4	35.5	19.7	23.8	39.9	28.5	23.7	23.5	17.9	14.2	17.6	19.9	19.4	17.6	21.3	10.9	25.1	12.4	30.7	18.3	35.0	21.3	28.8	33.4	25.9	25.0	34.5	25.0	23.0	15.6	29.8	18.3	22.4	30.0	35.2	26.9	21.8	10.4	19.0	15.5	27.5	10.1	14.1	10.9	27.5	28.9	11.7	20.1	27.1	9.7	16.2	29.1	12.7	13.8	12.2	17.9	23.4	20.0	11.8	14.6	24.2	7.2	8.3	14.7	19.0	18.6	17.1	78.2	24.8	52.2	31.3	19.5	25.9	40.7	35.5	34.1	17.5	43.4	34.7	34.8	48.5	30.4	24.0	29.9	31.7	19.7	25.4	30.8	41.8	31.5	22.4	17.8	25.1	19.1	21.6	26.4
NCSTN	"APH2, KIAA0253"	ENSG00000162736	Nicastrin	Q92542	1	160343272-160358952	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021982, HPA054846, HPA070642"	Approved		Approved	Cytosol			120000	Cytosol		"CAB021982: , HPA054846: , HPA070642: "	"unprognostic (1.08e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavourable (7.75e-9)"	"unprognostic (1.36e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.89e-2)"	25.6	23.8	12.7	15.3	20.9	12.8	23.3	15.8	24.3	21.8	24.1	39.0	16.5	31.7	24.1	23.3	23.3	19.9	19.5	23.7	13.8	13.9	25.3	37.8	24.7	19.8	28.2	14.2	29.5	41.3	38.9	21.8	63.3	21.5	18.5	24.6	25.1	49.2	19.6	24.2	20.2	38.5	20.7	25.4	25.8	21.4	22.4	22.8	20.3	25.9	13.6	20.6	26.1	20.1	12.5	28.8	27.0	30.5	13.1	11.1	16.8	10.5	12.9	22.3	18.2	68.3	34.6	24.6	21.6	39.6	21.0	24.7	10.0	30.9	7.8	45.0	44.2	17.9	10.1	20.6	17.8	12.3	8.8	7.4	16.0	15.1	27.1	15.9	33.9	35.1	20.5	20.0	20.9	30.7	13.6	22.3	29.9	7.4	5.6	8.3	18.2	7.2	7.7	13.7	21.8	29.4	14.6	7.4	16.8	23.3	26.6	15.8	23.8	39.7	24.7	15.7	10.3	10.9	16.4	28.9	40.9	7.7	24.6	10.1	28.7	17.8	29.9	25.0	11.1	30.5	10.4	12.5	9.5	9.5	28.8	11.2	9.9	9.4	27.0	13.1	27.9	16.9	10.0	16.8	12.7	20.9	15.8	24.3	13.8	13.9	28.2	14.2	21.5	22.8
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687330	"Plasma proteins, Predicted membrane proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 20.7;ASC diff: 20.4;HSkMC: 27.5;NTERA-2: 16.5;U-2 OS: 30.8;U-266/70: 19.5;U-266/84: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.5;plasmacytoid DC: 4.3"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA074457: "	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	29.9	35.5	19.2	7.7	39.1	1.3	25.0	2.6	28.2	32.7	12.9	12.9	8.1	8.0	29.9	17.7	12.3	21.4	19.1	20.3	18.1	40.3	6.9	3.0	10.3	8.9	14.8	17.6	50.7	7.1	2.1	23.2	22.4	19.0	18.8	8.1	16.5	9.2	29.3	9.2	4.7	8.4	23.5	11.8	11.8	8.6	16.4	7.3	7.1	8.4	8.7	4.9	13.1	17.3	0.0	4.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	20.7	0.0	20.4	7.8	0.0	13.1	0.0	0.3	3.6	0.0	0.0	0.0	0.0	3.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	12.0	27.5	0.0	3.8	0.0	0.0	0.4	0.0	6.7	0.0	9.8	0.0	16.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.1	0.0	3.5	0.0	0.0	1.0	30.8	0.0	0.0	19.5	18.1	0.0	2.1	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.6	4.3	0.0	0.0	19.2	39.1	2.6	28.2	18.1	40.3	14.8	17.6	19.0	7.3
NDOR1	"bA350O14.9, NR1"	ENSG00000188566	"NADPH dependent diflavin oxidoreductase 1"	Q9UHB4	9	137205685-137217009	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA024504	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA024504: AB_1854338"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.74e-3)"	9.6	11.4	10.6	18.4	17.4	29.2	10.0	15.0	16.2	9.4	10.4	18.7	7.4	19.1	11.4	10.5	11.2	11.0	10.4	7.4	11.6	7.7	12.1	9.4	11.6	20.5	18.6	8.6	10.2	14.7	9.7	12.2	9.2	13.5	13.0	6.8	12.5	17.3	16.1	6.5	18.5	16.5	8.7	14.2	19.9	13.9	22.2	14.2	20.6	14.4	4.9	15.8	9.7	9.4	2.7	3.7	6.6	4.8	1.6	4.0	3.0	7.1	10.8	7.4	11.3	3.1	3.2	22.4	10.5	4.9	10.3	7.1	10.8	8.5	10.0	8.3	4.1	26.8	5.3	7.4	2.1	12.9	8.3	8.9	26.0	5.8	5.3	10.0	19.1	4.3	5.3	11.5	4.3	4.7	14.4	10.7	3.7	12.9	10.3	17.7	11.8	13.5	19.1	8.7	14.3	3.2	6.3	9.3	9.2	8.7	8.9	5.4	14.2	11.6	6.2	19.0	12.4	21.8	11.7	6.6	13.1	10.5	8.2	9.1	10.7	1.7	4.4	6.3	3.2	4.8	2.7	1.3	2.8	2.7	3.7	2.7	1.6	1.4	6.6	1.6	3.8	2.4	4.0	3.0	10.6	17.4	15.0	16.2	11.6	7.7	18.6	8.6	13.5	14.2
NDRG1	"CAP43, DRG1, NDR1, RTP, TDD5"	ENSG00000104419	"N-myc downstream regulated 1"	Q92597	8	133237171-133302022	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 69.0;hTERT-HME1: 139.1;U-87 MG: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006881	Approved		Supported	Microtubules,Cytosol				Cytosol	Microtubules	"HPA006881: AB_1078392"	"unprognostic (6.96e-3)"	"unprognostic (3.31e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.47e-4)"	"unprognostic (3.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (4.13e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.28e-2)"	43.9	23.6	42.0	17.0	80.9	18.0	29.8	6.4	36.2	33.1	47.7	73.2	24.2	74.2	20.9	20.6	83.0	24.7	26.8	22.2	48.7	32.9	62.6	12.1	31.0	11.4	96.3	19.8	37.5	16.7	17.8	18.6	32.5	50.0	115.0	22.4	16.2	29.0	26.4	13.2	56.9	78.2	19.2	102.0	11.5	45.7	15.0	74.3	10.3	21.4	40.0	34.9	58.7	64.9	1.9	12.2	8.9	4.1	1.3	9.3	2.9	21.5	2.7	0.1	0.1	13.7	9.6	2.9	1.5	11.8	1.1	6.1	1.3	3.0	0.1	15.5	6.4	7.0	0.2	34.0	2.4	1.3	25.5	0.2	5.5	1.6	5.2	0.7	0.5	8.9	69.0	5.8	139.1	5.1	0.2	15.1	1.9	1.2	2.0	2.1	0.3	17.9	0.2	2.4	10.0	3.5	3.2	1.6	1.6	3.3	35.7	8.6	0.1	2.3	6.6	9.7	5.0	4.2	1.2	11.3	29.6	0.1	93.6	8.1	19.0	8.9	4.1	0.0	6.3	3.7	9.3	1.7	5.9	7.5	6.1	1.9	4.6	3.1	4.2	1.3	4.0	12.2	8.0	2.9	42.0	80.9	6.4	36.2	48.7	32.9	96.3	19.8	50.0	74.3
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 310.5;skeletal muscle: 253.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 27.9;HMC-1: 20.0"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"myeloid DC: 54.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"			150000	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favourable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favourable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	19.3	45.3	140.2	4.8	135.1	1.4	50.3	93.5	110.0	35.5	21.0	89.6	23.8	12.2	30.7	44.4	37.3	29.5	21.5	45.2	103.6	86.1	24.3	84.8	13.7	7.7	128.9	73.5	79.7	15.5	35.6	6.0	8.1	95.4	23.7	18.8	8.9	310.5	37.3	253.0	18.9	12.0	22.0	73.0	21.1	11.2	5.2	71.2	0.4	13.6	53.4	16.1	13.9	19.3	1.8	54.5	0.4	1.8	0.7	5.4	4.0	5.3	1.1	3.4	6.4	0.5	0.0	0.5	0.1	2.2	2.0	1.1	7.4	10.0	0.3	2.0	0.1	8.8	15.4	3.1	2.7	0.0	5.5	6.9	1.2	27.9	0.7	0.6	20.0	6.1	6.7	0.4	0.9	0.0	13.9	0.6	0.3	4.6	2.4	1.9	9.1	0.4	7.1	0.3	1.6	3.8	13.6	0.0	9.9	1.5	1.7	7.0	13.5	4.0	0.0	0.6	10.9	0.2	0.2	3.1	2.2	0.1	0.9	0.1	2.3	0.0	1.8	0.2	2.4	0.4	3.2	1.8	3.6	3.3	54.5	1.3	5.4	4.0	0.4	0.7	0.0	1.9	2.4	4.0	140.2	135.1	93.5	110.0	103.6	86.1	128.9	73.5	95.4	71.2
NDRG4	"KIAA1180, SMAP-8"	ENSG00000103034	"NDRG family member 4"	Q9ULP0	16	58462846-58513628	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 19.0;HUVEC TERT2: 12.1;SCLC-21H: 28.7"	"Cancer enriched"	"Detected in many"	6	"glioma: 23.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015313, HPA017587"	Enhanced		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA015313: AB_1854343, HPA017587: AB_1854344"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.17e-2)"	3.6	59.2	28.7	2.9	49.4	1.6	2.3	65.4	134.1	3.8	3.5	11.0	15.6	3.4	10.2	5.1	10.0	3.9	3.4	112.6	30.5	32.0	2.3	1.9	6.5	3.4	33.7	35.4	2.1	2.6	10.8	11.6	2.6	81.2	2.1	3.2	8.7	2.9	18.2	5.3	3.9	3.2	8.7	11.7	11.7	2.6	19.9	7.4	0.0	2.6	0.3	3.5	2.7	8.0	1.5	0.1	0.2	0.0	0.1	0.9	0.2	0.1	9.6	9.2	1.8	0.2	1.7	0.7	3.0	4.7	1.4	0.9	3.6	2.5	0.2	19.0	2.3	0.8	0.7	0.5	1.3	0.0	1.9	0.4	1.6	2.6	2.6	0.1	0.1	2.1	0.2	0.9	0.0	12.1	0.1	0.1	1.3	2.4	0.9	0.1	0.8	7.1	0.2	2.5	0.2	0.4	6.0	28.7	10.8	0.3	0.8	0.1	0.3	0.1	4.3	1.2	3.6	0.3	0.4	0.5	0.2	3.1	6.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.2	28.7	49.4	65.4	63.4	30.5	32.0	33.7	35.4	81.2	7.4
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 50.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA051515	Approved		Approved	Cytosol			72000	Cytosol		"HPA051515: "	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	12.6	14.6	7.9	19.2	11.3	37.5	11.8	30.2	12.2	16.6	10.7	13.8	13.4	8.9	18.4	14.8	14.4	12.8	15.5	9.3	9.6	8.4	11.0	9.4	14.7	21.9	7.3	8.8	15.1	12.3	17.3	26.5	14.1	9.2	13.6	10.5	14.7	20.1	17.2	16.4	15.1	14.4	13.4	7.5	31.8	11.8	13.5	9.2	35.3	12.2	8.2	19.3	12.3	13.3	3.1	6.8	5.8	5.3	2.2	7.1	3.2	4.3	3.6	7.4	11.4	9.2	10.6	3.8	5.0	10.8	5.8	6.0	1.9	5.3	3.9	3.1	9.6	5.0	3.6	5.3	4.8	10.3	3.6	3.9	2.7	3.0	16.2	4.9	50.2	10.1	6.5	10.1	10.4	7.6	3.6	14.9	7.4	3.3	5.8	5.5	2.1	15.2	3.5	3.7	2.4	5.0	3.0	2.5	4.2	4.5	10.6	3.5	8.1	7.6	12.2	2.9	3.5	3.9	3.6	7.5	3.3	5.1	3.4	7.6	2.3	1.4	5.3	2.1	5.5	3.7	6.5	2.5	4.7	4.8	4.0	3.1	5.6	7.1	5.8	2.2	3.5	6.8	3.1	3.2	7.9	11.3	30.2	12.2	9.6	8.4	7.3	8.8	9.2	9.2
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871487-119876662	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 144.8;skeletal muscle: 138.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029768, HPA054359"	Enhanced		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA029768: , HPA054359: "	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favourable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	24.5	30.1	37.9	20.1	42.5	25.2	23.8	27.9	37.8	19.7	38.4	8.7	27.3	41.0	13.5	25.8	21.6	15.9	24.8	144.8	30.1	28.5	46.0	40.2	21.1	22.2	34.6	32.8	14.6	40.4	22.7	21.7	15.4	29.5	17.9	31.1	15.5	38.4	29.6	138.8	12.1	34.6	19.3	31.5	17.1	28.1	7.7	21.1	9.2	16.2	67.4	16.7	14.0	14.9	66.3	90.5	96.3	85.7	49.8	75.5	73.8	34.5	37.3	26.7	28.4	32.2	20.4	33.4	27.3	24.9	19.2	23.9	20.8	28.9	28.1	42.1	28.5	33.4	37.4	26.2	22.0	38.9	51.7	29.2	68.1	46.7	25.0	44.6	32.5	33.2	35.7	20.4	15.9	23.8	15.8	43.8	26.3	61.1	31.7	42.3	39.4	66.7	32.1	25.4	84.6	57.8	49.2	19.5	25.7	56.1	69.6	37.4	17.6	52.6	30.6	16.4	16.6	34.0	53.2	40.4	50.0	36.8	29.7	53.0	20.2	96.3	79.0	91.6	60.2	80.4	57.1	66.3	67.1	62.8	84.0	52.7	56.1	65.7	94.6	49.8	85.7	90.5	75.5	73.8	37.9	42.5	27.9	37.8	30.1	28.5	34.6	32.8	29.5	21.1
NDUFAF1	"CGI-65, CIA30"	ENSG00000137806	"NADH:ubiquinone oxidoreductase complex assembly factor 1"	Q9Y375	15	41387349-41402519	"Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039933, HPA040064"	Supported		Enhanced	Cytosol				Cytosol		"HPA039933: AB_10795265, HPA040064: AB_10795687"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (2.88e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"prognostic favourable (3.34e-6)"	"unprognostic (1.68e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	11.1	22.0	15.0	6.4	14.0	3.0	9.8	13.3	17.8	7.8	7.7	12.4	5.3	8.4	8.3	10.7	9.6	7.9	7.1	29.7	13.2	13.4	21.9	27.5	7.0	8.5	14.7	14.4	7.0	7.7	11.9	9.7	7.0	13.1	8.5	8.1	8.4	8.5	9.8	38.6	6.2	7.7	10.3	13.5	7.5	8.5	14.1	12.0	6.5	9.6	15.8	9.1	8.8	5.8	14.5	19.1	25.2	16.2	13.9	15.9	8.7	9.0	6.5	8.5	8.9	19.7	20.1	9.4	17.4	14.2	15.3	12.8	12.0	5.0	10.4	24.2	15.2	15.0	11.6	11.7	13.8	19.5	13.4	14.7	13.6	7.0	16.8	15.7	10.5	22.3	11.2	12.7	12.7	10.9	22.4	11.3	22.4	8.4	12.5	13.0	6.9	10.9	9.8	11.5	21.5	23.3	14.8	10.3	8.1	8.9	19.8	6.6	16.2	30.3	11.3	12.4	5.7	18.7	14.3	9.2	19.9	15.7	13.9	24.9	11.9	25.2	13.7	16.4	9.6	16.2	9.9	14.5	11.5	12.3	12.1	12.6	13.0	10.3	12.8	13.9	12.4	19.1	15.9	8.7	15.0	14.0	13.3	17.8	13.2	13.4	14.7	14.4	13.1	12.0
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67606852-67612535	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 150.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Approved		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: "	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favourable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	23.3	28.9	27.3	20.7	33.9	20.3	18.9	32.9	48.8	18.5	33.0	23.1	19.2	40.6	19.4	21.5	25.5	22.5	23.4	93.0	26.5	24.1	39.0	41.5	15.9	20.6	31.5	40.5	24.6	38.3	49.2	18.8	15.7	34.8	16.1	25.1	17.6	27.3	27.0	150.8	28.4	30.3	22.7	23.1	21.5	28.2	30.2	24.3	18.3	23.4	67.9	20.3	18.7	18.6	23.8	41.2	13.5	30.7	36.2	28.2	24.3	26.2	28.2	14.4	28.8	18.0	18.1	26.9	16.4	15.8	25.7	17.2	53.3	31.8	48.5	34.6	14.1	35.4	30.3	25.6	8.1	24.6	23.9	19.9	38.3	26.3	25.5	27.0	22.2	26.8	24.8	20.9	18.7	22.7	36.1	39.7	15.6	39.4	31.5	53.5	14.1	35.5	36.6	27.9	78.7	20.8	19.7	22.9	21.6	20.7	72.5	54.7	36.8	27.5	18.0	24.9	18.6	35.4	17.2	38.8	22.1	24.2	29.0	28.6	23.9	12.6	26.7	13.5	25.9	30.7	28.2	23.2	21.7	24.5	41.2	23.8	20.2	25.1	4.8	36.2	17.4	26.5	27.8	24.3	27.3	33.9	32.9	48.8	26.5	24.1	31.5	40.5	34.8	24.3
NECAB1	EFCBP1	ENSG00000123119	"N-terminal EF-hand calcium binding protein 1"	Q8N987	8	90791550-90959408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 56.4"	"Cell line enhanced"	"Detected in many"		"HEL: 6.1;MOLT-4: 6.4;U-266/70: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB068208: , CAB068209: , CAB068210: , HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815"	"unprognostic (8.09e-3)"	"unprognostic (3.78e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.96e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.39e-3)"	2.7	4.9	19.7	2.0	27.3	3.2	1.5	0.5	56.4	1.4	3.7	12.1	0.3	1.7	4.1	4.4	3.6	1.6	3.1	10.9	19.5	9.8	3.4	1.1	6.8	1.4	16.0	30.7	3.8	1.3	1.9	1.9	2.8	10.8	2.6	1.1	4.1	2.5	2.0	1.3	1.9	1.8	1.3	18.7	2.4	2.1	5.2	17.4	0.0	2.9	0.0	1.0	4.2	1.2	0.5	1.8	0.3	0.0	0.7	0.9	0.2	0.2	0.1	2.3	0.4	0.0	0.1	0.1	2.5	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.0	0.0	0.1	0.0	4.7	6.1	2.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	4.1	4.4	0.0	4.9	6.4	3.1	0.9	0.1	0.0	4.0	0.0	0.0	0.0	4.1	4.4	0.1	0.0	2.1	0.0	0.2	1.5	3.9	3.8	0.0	1.6	6.1	3.7	3.2	3.8	0.0	1.8	0.0	0.0	0.1	0.6	0.0	0.4	0.2	0.4	0.6	0.1	0.5	0.6	0.9	0.3	0.7	0.0	1.8	0.9	0.2	19.7	27.3	0.5	37.1	19.5	9.8	16.0	30.7	10.8	17.4
NECAP1	DKFZP566B183	ENSG00000089818	"NECAP endocytosis associated 1"	Q8NC96	12	8076939-8097859	"Disease related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053980, HPA063300"	Uncertain		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA053980: , HPA063300: "	"unprognostic (1.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.56e-1)"	"unprognostic (5.79e-3)"	"unprognostic (5.72e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.94e-2)"	7.5	19.1	25.5	9.2	34.1	6.5	10.5	45.9	53.2	11.9	13.1	9.6	5.1	12.1	8.4	8.1	9.3	12.0	7.8	9.4	27.6	36.8	12.5	11.1	8.5	6.0	19.2	22.1	13.1	17.4	16.3	17.9	11.6	32.5	12.7	13.3	11.1	10.9	10.1	5.0	5.9	11.8	9.0	9.6	7.0	12.0	10.0	7.5	5.3	9.6	4.4	8.0	8.9	5.8	7.0	8.9	25.4	14.3	6.8	12.0	8.5	10.7	9.7	7.1	9.7	16.3	12.4	15.8	23.1	14.0	19.4	19.5	21.0	12.3	5.5	4.0	11.0	7.5	18.8	12.1	16.6	14.7	14.8	6.0	12.5	10.5	14.8	5.6	17.6	15.8	14.7	21.3	26.6	14.0	13.8	8.1	20.5	13.1	9.4	1.8	19.1	9.0	3.7	17.0	5.1	13.4	16.2	11.3	8.8	11.4	16.3	9.0	5.5	4.9	13.6	9.4	18.9	11.0	15.9	5.4	9.4	11.1	16.4	6.2	13.7	18.5	11.5	25.4	8.4	11.5	9.4	6.6	7.9	8.6	8.9	7.0	9.5	8.8	18.8	6.8	14.3	4.8	12.0	8.5	25.5	34.1	45.9	47.0	27.6	36.8	19.2	22.1	32.5	7.5
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase"	P46934	15	55826922-55993746	"Enzymes, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol				Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	14.1	4.1	2.5	3.1	3.3	4.5	8.7	1.5	2.7	9.9	9.4	2.8	3.4	3.4	10.1	4.1	8.2	3.8	4.5	4.1	2.9	2.4	8.6	21.5	7.2	2.1	3.5	1.3	6.6	2.8	6.5	6.7	20.1	3.5	8.4	3.4	5.4	4.0	6.4	57.7	7.1	15.2	10.9	6.0	5.9	4.4	2.6	3.1	9.4	5.7	9.0	3.3	11.9	8.9	0.1	1.6	1.2	2.8	1.2	2.9	0.9	7.3	11.4	3.1	3.0	4.1	6.8	5.1	14.1	22.3	10.4	10.5	5.1	2.2	1.8	3.7	5.3	12.2	3.4	9.3	17.1	4.1	2.1	9.1	2.7	2.6	21.9	4.0	0.9	11.5	23.0	12.5	21.1	8.5	3.9	0.0	30.5	3.8	5.3	0.0	0.8	1.7	3.9	24.7	1.0	4.3	14.6	0.3	2.0	6.3	4.5	5.6	5.6	3.0	29.6	23.2	7.7	4.9	22.9	1.2	2.6	4.8	15.7	8.5	5.5	0.6	1.0	0.0	1.3	2.8	2.9	0.1	1.5	1.2	0.8	0.0	1.4	1.6	1.2	1.2	1.9	1.6	1.3	0.9	2.5	3.3	1.5	2.7	2.9	2.4	3.5	1.3	3.5	3.1
NEDD8	Nedd-8	ENSG00000129559	"Neural precursor cell expressed, developmentally down-regulated 8"	Q15843	14	24216852-24232454	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol			5700000	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: , HPA060254: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	38.2	48.1	55.5	30.7	58.1	34.6	42.2	34.1	62.4	41.0	36.3	26.8	32.6	25.0	32.2	59.9	40.3	34.3	31.3	50.7	47.1	49.5	46.5	48.4	30.5	31.5	49.4	54.6	34.3	33.4	101.1	31.3	39.7	45.5	31.6	40.0	27.4	37.2	40.7	70.7	36.5	28.4	43.0	36.0	34.9	29.9	25.7	34.3	26.9	37.5	44.7	46.8	30.7	32.0	60.2	76.1	90.2	60.1	43.2	64.1	89.9	25.5	44.8	36.5	25.7	41.4	36.2	26.5	35.0	37.1	41.2	38.1	30.9	31.3	22.1	20.5	49.2	27.0	36.3	54.6	58.0	31.2	22.0	23.6	41.3	105.3	36.0	39.0	24.7	38.4	36.3	34.7	27.3	49.2	21.0	25.9	63.5	56.9	31.0	37.0	26.9	52.5	22.1	28.9	22.5	47.5	48.7	15.4	35.9	30.2	30.8	25.1	18.6	31.0	36.8	23.5	23.6	30.0	30.9	30.8	46.4	32.0	16.8	22.5	22.2	73.5	57.9	90.2	46.8	60.1	50.7	60.2	54.4	51.9	56.9	51.1	51.2	52.0	62.2	43.2	59.0	76.1	64.1	89.9	55.5	58.1	34.1	62.4	47.1	49.5	49.4	54.6	45.5	34.3
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 72.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 49.0;HSkMC: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009720, HPA038768, HPA039270"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"CAB009720: , HPA038768: , HPA039270: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	72.8	4.7	4.5	14.9	5.6	3.3	35.7	2.2	5.9	14.0	16.6	5.1	14.2	7.1	17.3	21.7	10.3	11.5	15.3	17.3	4.6	4.1	34.6	9.5	58.4	15.0	4.9	3.9	11.1	7.9	4.2	6.1	32.6	6.6	13.4	14.7	12.8	15.4	15.4	22.4	12.3	17.9	12.4	5.3	25.7	10.9	12.2	4.3	18.8	15.8	6.8	18.6	17.6	9.9	5.8	6.0	34.8	19.8	5.1	8.3	6.3	1.5	10.0	9.3	0.1	6.4	0.8	9.8	2.3	2.8	4.3	8.0	3.2	0.6	3.1	49.0	5.0	4.3	12.5	4.7	5.6	1.4	0.3	0.3	1.5	21.1	3.0	3.3	0.1	24.5	1.4	2.8	0.4	7.3	0.0	2.6	9.7	0.4	1.9	1.3	1.4	1.0	0.5	0.2	1.8	2.1	13.7	0.2	1.7	0.4	11.0	19.0	0.8	2.6	18.6	2.9	5.2	0.3	5.6	2.8	11.3	3.9	0.0	2.7	12.7	9.1	5.5	15.4	8.3	12.2	6.8	5.0	5.6	8.0	6.0	5.8	3.0	4.7	34.8	5.1	19.8	3.7	5.0	6.3	4.5	5.6	2.2	5.9	4.6	4.1	4.9	3.9	6.6	4.3
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395940-72282734	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.8;TIME: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"			390000000	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	17.5	7.8	18.1	7.6	16.3	2.2	7.3	24.1	41.5	8.0	14.7	2.6	2.4	3.8	7.1	5.9	13.6	5.9	13.5	10.7	11.2	14.8	8.8	1.1	5.4	2.4	8.7	26.3	8.4	6.0	1.5	4.6	4.1	5.9	9.9	10.3	3.2	3.6	7.6	5.9	5.5	6.3	25.5	10.2	1.5	7.6	4.4	3.0	0.3	3.8	1.5	1.6	20.1	9.1	0.5	3.3	1.1	0.4	0.4	0.4	0.1	0.2	0.1	0.4	0.2	15.8	12.5	0.1	11.0	4.1	6.1	7.4	0.1	0.1	0.2	0.1	12.1	0.3	0.0	0.0	13.2	0.2	0.1	0.1	2.2	0.1	1.3	0.2	0.3	6.0	0.0	5.1	0.9	7.1	0.1	0.5	11.2	0.1	0.1	0.2	1.8	6.3	7.6	11.8	0.2	1.0	0.2	0.8	1.0	3.8	0.1	0.1	0.1	0.2	16.1	1.3	13.4	0.6	13.6	0.3	0.2	0.1	3.0	7.3	4.7	1.1	0.4	0.3	0.4	0.2	0.3	0.3	0.3	0.3	3.1	0.5	0.3	0.3	0.8	0.4	0.4	3.3	0.2	0.1	18.1	16.3	24.1	31.8	11.2	14.8	8.7	26.3	5.9	3.0
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392857-169612629	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favourable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	9.6	10.5	13.5	9.2	15.8	6.0	8.7	20.7	14.5	13.6	8.4	12.5	7.1	5.4	12.4	9.1	7.9	15.7	10.2	11.4	13.7	13.2	10.2	6.9	7.7	8.0	15.9	11.3	16.3	6.6	15.3	16.5	7.2	16.0	11.6	7.7	8.9	6.4	10.6	7.1	4.7	5.7	11.1	18.2	8.0	8.1	18.3	14.8	14.7	13.3	6.4	7.4	10.0	8.2	4.5	3.3	6.7	3.3	2.2	5.3	1.3	4.2	1.9	7.8	8.4	12.1	13.6	2.5	9.0	8.1	7.2	6.9	2.4	5.1	11.3	1.7	7.8	1.4	7.3	7.6	8.2	12.4	5.0	7.6	7.8	2.9	7.2	7.7	6.1	10.8	4.4	7.3	12.9	7.0	13.5	21.6	9.2	2.7	9.9	3.4	2.5	4.5	6.1	5.1	3.6	7.6	5.0	8.5	9.7	6.5	3.2	6.0	4.0	3.4	8.4	4.6	4.2	4.8	6.0	8.7	13.4	8.7	7.6	3.8	8.0	6.7	2.1	1.8	4.4	3.3	4.8	4.4	3.4	2.7	1.5	4.5	5.1	5.3	1.1	2.2	1.6	3.3	3.2	1.3	13.5	15.8	20.7	12.9	13.7	13.2	15.9	11.3	16.0	14.8
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708449-52770949	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol				Cytosol		"HPA015750: AB_1854367, HPA058543: "	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	7.2	10.7	15.5	9.1	15.7	7.3	11.0	20.2	16.1	10.6	8.4	10.6	9.6	7.6	10.3	10.7	8.1	15.8	7.5	7.4	12.5	14.2	11.6	12.4	7.7	8.8	12.7	8.6	15.8	10.2	13.4	17.6	8.7	11.9	9.4	9.7	9.1	8.5	11.3	10.8	5.3	6.6	9.5	10.7	7.9	11.0	47.7	12.4	11.1	15.5	5.0	10.4	9.3	10.7	5.1	6.4	12.4	11.8	4.6	5.2	5.5	12.8	10.0	13.7	10.8	12.6	9.1	14.9	9.1	12.3	17.1	17.3	8.7	9.6	13.2	4.3	8.9	6.0	16.7	10.7	23.0	13.1	7.0	10.3	12.2	11.1	7.8	25.1	10.4	5.6	9.9	21.9	14.6	6.4	12.8	10.7	10.7	10.9	13.5	9.2	11.9	9.9	11.9	12.0	9.7	9.6	18.5	10.1	6.1	19.1	11.8	9.0	11.0	15.2	5.8	11.5	11.7	18.3	16.8	12.0	17.5	13.0	13.1	11.9	12.4	12.4	11.8	5.8	4.6	7.3	5.2	3.6	4.0	4.8	6.4	5.1	4.9	4.2	1.8	4.6	4.8	3.2	3.1	5.5	15.5	15.7	20.2	16.1	12.5	14.2	12.7	8.6	11.9	12.4
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB045993: AB_2150651, HPA056828: "	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	14.8	5.3	26.1	22.2	29.1	12.8	18.8	7.2	21.2	20.5	15.6	13.4	4.3	12.5	9.2	7.5	6.8	8.5	18.4	7.0	17.1	16.6	12.9	51.9	17.0	18.1	19.4	13.3	11.2	20.5	1.6	6.4	21.4	14.7	14.8	16.6	18.5	16.9	13.2	5.5	5.1	18.2	23.4	13.0	11.3	19.0	5.8	12.9	4.0	6.3	1.9	22.0	17.7	10.1	21.9	11.5	29.0	18.8	8.3	3.8	7.6	7.7	12.7	12.3	4.8	23.4	30.4	15.3	9.7	15.6	15.1	12.6	12.1	14.5	9.4	15.6	18.8	1.5	6.3	28.3	10.3	10.3	5.6	25.9	10.7	21.1	27.9	4.6	65.0	40.6	4.6	14.3	14.9	16.4	4.6	0.4	27.0	8.1	0.2	5.1	3.1	11.6	10.0	9.2	4.8	16.2	2.8	5.5	1.9	3.2	6.1	13.8	13.1	19.1	32.1	11.1	11.2	7.6	6.6	2.1	2.6	5.4	13.9	10.6	14.7	10.2	18.8	29.0	3.8	12.3	2.4	21.9	2.3	3.2	11.5	9.0	0.4	1.6	23.4	8.3	14.7	10.6	2.8	7.6	26.1	29.1	7.2	21.2	17.1	16.6	19.4	13.3	14.7	12.9
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"		20	58981208-58995133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262"			Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: , HPA066262: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	9.1	11.1	10.2	9.4	13.0	8.8	12.7	18.1	13.7	10.2	10.8	15.2	9.2	8.4	11.2	8.2	14.6	12.5	8.6	9.2	10.9	8.2	16.4	15.9	7.9	11.2	16.7	13.4	15.4	10.3	19.1	18.1	12.1	12.5	10.2	8.9	9.4	14.7	9.1	12.0	11.9	8.8	8.1	11.8	9.2	8.9	26.1	12.4	17.4	14.4	10.0	13.6	9.8	11.3	22.7	29.6	9.4	27.7	19.4	24.6	20.5	12.5	14.5	17.5	18.6	6.0	10.7	11.2	10.2	10.0	31.0	18.0	48.0	18.1	16.6	16.1	10.2	22.0	23.4	25.8	25.1	5.1	16.6	21.9	18.2	37.5	7.2	15.6	15.0	11.3	8.3	11.3	7.9	17.8	29.0	12.7	14.1	49.9	33.7	23.6	10.1	32.2	18.9	14.5	30.7	13.0	19.5	19.3	28.7	31.9	38.5	21.2	41.5	18.3	7.1	23.9	22.7	9.3	16.9	10.1	18.6	16.9	14.2	13.9	20.6	7.2	20.4	9.4	20.3	22.8	23.9	22.7	19.3	24.6	29.6	20.0	18.9	19.9	2.2	19.4	27.7	15.0	17.6	20.5	10.2	13.0	18.1	13.7	10.9	8.2	16.7	13.4	12.5	12.4
NEMF	"FLJ10051, NY-CO-1, SDCCAG1"	ENSG00000165525	"Nuclear export mediator factor"	O60524	14	49782083-49853203	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004160	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA004160: AB_1079884"	"unprognostic (9.92e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.15e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.81e-2)"	13.6	12.2	15.0	14.8	20.9	30.9	12.5	28.0	22.1	15.0	14.4	14.6	14.4	8.1	14.3	12.2	18.2	11.6	11.2	15.0	16.9	15.0	14.6	11.2	11.6	13.4	21.1	17.2	15.2	13.1	26.4	30.9	15.5	27.9	13.9	12.4	10.7	14.8	14.8	17.4	11.5	15.1	13.9	24.8	14.7	13.7	8.4	23.2	17.0	15.7	9.8	14.5	13.5	13.4	36.1	33.0	28.4	21.9	20.3	26.8	7.8	18.7	21.0	20.1	13.3	22.7	18.4	18.0	23.7	15.7	15.6	15.4	10.7	20.1	5.2	18.2	19.5	26.9	18.9	14.8	25.3	20.9	10.8	20.8	20.0	16.2	13.3	27.1	19.1	16.3	10.9	16.5	15.5	22.2	25.7	19.7	21.3	17.2	16.1	8.9	12.0	21.2	16.7	19.9	11.9	18.4	24.8	13.3	12.4	21.9	23.7	21.9	20.4	17.7	26.2	23.0	20.2	14.9	16.2	14.0	24.9	22.3	8.5	12.9	20.5	27.6	18.2	20.1	20.5	16.3	19.5	32.8	21.0	19.2	15.2	36.1	24.8	26.8	28.4	20.3	21.9	33.0	17.9	7.8	15.0	20.9	28.0	22.1	16.9	15.0	21.1	17.2	27.9	23.2
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925485	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;parathyroid gland: 9.0"	"Group enriched"	"Detected in some"	9	"HAP1: 6.5;Karpas-707: 10.5;SiHa: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"				Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: "	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.6	3.0	5.4	0.7	6.2	0.4	1.3	10.2	9.4	1.7	1.9	0.7	1.0	0.6	1.7	0.9	1.8	1.3	0.5	0.3	5.0	6.2	2.4	0.2	0.9	0.5	1.8	5.0	1.7	4.4	9.0	7.5	0.5	1.9	3.2	1.1	1.1	2.5	2.5	0.4	1.8	1.1	2.6	1.2	0.6	1.6	0.9	1.5	0.0	1.5	0.0	0.5	0.7	2.8	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.3	0.1	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	9.3	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.2	10.2	6.8	5.0	6.2	1.8	5.0	1.9	1.5
NF2	"ACN, BANF, merlin, SCH"	ENSG00000186575	"Neurofibromin 2"	P35240	22	29603556-29698598	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003097, CAB005385"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB005385: AB_2298548, HPA003097: AB_1079473"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.66e-1)"	"prognostic favourable (2.89e-5)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.62e-2)"	11.8	12.4	23.6	11.1	20.1	10.0	15.4	20.8	28.1	10.8	9.7	9.0	11.8	7.8	10.5	11.3	14.2	11.3	8.0	19.7	26.6	16.4	13.5	11.1	11.9	24.1	18.0	13.5	11.0	12.9	46.8	8.6	6.9	11.4	10.2	8.7	9.5	9.3	15.4	25.7	12.1	8.5	11.9	10.7	10.4	8.8	21.6	10.1	14.9	15.6	11.5	9.9	10.6	10.2	8.5	13.6	6.6	17.3	11.6	15.0	9.8	26.3	10.6	3.7	24.3	7.3	7.3	3.6	21.4	12.1	23.5	20.3	10.5	6.5	7.0	17.8	22.0	9.3	7.7	12.4	21.1	10.2	6.1	8.3	7.9	7.5	7.8	11.9	9.9	6.7	5.7	16.6	20.3	16.5	4.0	6.5	22.8	11.0	7.2	4.7	2.8	10.1	7.5	20.0	6.7	23.8	12.3	5.8	4.0	12.3	8.3	4.8	5.3	4.8	30.6	35.0	39.9	15.2	36.1	10.2	8.1	8.4	9.3	4.7	22.3	6.6	9.5	3.6	15.0	13.5	12.8	8.2	11.3	10.1	13.6	8.5	9.8	9.2	2.3	11.6	17.3	9.3	9.4	9.8	23.6	20.1	20.8	28.1	26.6	16.4	18.0	13.5	11.4	10.1
NFAT5	"KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP"	ENSG00000102908	"Nuclear factor of activated T cells 5"	O94916	16	69565094-69704666	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057304, HPA069711"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA057304: , HPA069711: "	"unprognostic (2.71e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.08e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.42e-2)"	15.4	19.1	19.0	17.0	17.1	25.1	15.8	22.4	18.0	19.3	11.9	11.9	12.5	7.7	18.7	19.5	15.7	15.0	11.7	11.6	15.6	8.2	15.7	10.2	15.6	10.5	13.0	12.7	15.6	13.8	35.6	24.2	30.8	13.1	14.7	12.8	13.9	20.1	15.6	12.1	26.5	14.0	12.5	10.5	11.6	12.0	10.1	14.4	10.3	21.9	7.7	10.8	19.6	30.4	2.1	2.9	5.5	4.6	1.1	2.6	0.5	11.0	14.5	7.1	8.8	10.7	12.9	7.8	11.5	13.8	12.2	8.9	10.9	9.1	5.0	6.8	13.9	9.6	6.3	6.5	12.8	2.9	2.5	4.0	5.3	13.4	8.7	3.9	7.5	9.0	4.4	9.2	11.3	11.9	7.7	2.7	11.2	4.9	2.9	5.6	4.2	1.7	5.2	3.1	2.8	11.7	19.0	3.9	2.4	24.7	2.7	6.8	5.4	3.1	14.8	10.7	6.6	5.7	3.9	5.8	4.5	8.9	7.1	3.3	6.3	3.5	1.3	1.4	2.2	0.8	1.6	2.1	1.1	2.6	0.6	1.9	0.9	0.8	5.5	1.1	4.6	2.9	1.6	0.5	19.0	17.1	22.4	18.0	15.6	8.2	13.0	12.7	13.1	14.4
NFATC2	"NF-ATP, NFAT1, NFATp"	ENSG00000101096	"Nuclear factor of activated T cells 2"	Q13469	20	51386957-51562831	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.2;HMC-1: 16.3;WM-115: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008789, CAB018567, HPA024369"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413"	"unprognostic (2.69e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.59e-2)"	8.6	2.4	4.1	44.6	8.2	4.4	9.8	1.1	5.1	8.4	7.8	6.8	3.9	8.4	7.0	7.6	4.0	5.6	19.4	8.5	4.1	3.3	3.4	6.7	6.1	25.2	8.4	0.7	5.0	8.7	3.9	3.7	8.1	10.4	5.4	4.1	6.2	7.9	7.2	5.4	7.0	11.7	5.9	6.5	16.0	11.0	4.5	6.5	8.6	7.0	13.2	18.7	4.5	4.9	1.6	1.7	3.8	0.7	7.6	7.7	1.6	1.5	1.7	0.0	2.1	0.0	0.0	4.5	0.2	1.1	0.7	0.3	8.2	1.5	10.9	1.3	0.5	0.0	0.5	0.0	0.6	14.2	0.2	4.6	1.2	2.1	0.0	1.3	16.3	0.0	0.0	0.6	0.0	5.0	4.5	7.3	0.0	1.8	1.9	7.7	0.1	3.9	0.8	0.0	4.8	0.2	0.0	0.1	0.0	5.1	1.2	11.9	2.0	3.1	0.5	1.0	1.9	2.5	0.1	6.2	4.0	11.2	1.0	5.1	24.5	0.3	0.0	3.8	7.7	0.7	3.2	1.6	4.3	6.1	1.7	1.6	2.4	4.4	0.2	7.6	0.2	0.6	2.3	1.6	4.1	8.2	1.1	5.1	4.1	3.3	8.4	0.7	10.4	6.5
NFATC3	"NFAT4, NFATX"	ENSG00000072736	"Nuclear factor of activated T cells 3"	Q12968	16	68084751-68229259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 129.5"	"Cell line enhanced"	"Detected in all"		"HMC-1: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050665			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA050665: "	"unprognostic (1.19e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-1)"	9.6	6.8	4.3	16.0	6.6	12.0	7.8	7.5	5.8	9.8	11.0	9.7	7.6	7.1	12.2	6.5	7.7	8.3	7.6	7.0	4.7	4.0	8.2	12.1	11.3	14.2	8.7	3.5	10.0	7.0	18.7	6.8	6.6	5.1	10.5	6.1	11.1	7.9	7.6	27.1	14.0	12.0	9.0	6.7	12.3	6.2	25.9	5.8	129.5	11.0	8.1	16.0	10.2	14.1	6.7	3.1	12.0	7.1	13.4	15.6	9.0	4.9	5.8	9.4	10.3	8.4	5.4	8.6	3.2	4.0	9.1	7.9	8.4	4.4	16.5	4.9	5.3	7.4	11.7	5.5	8.9	3.4	7.6	16.2	6.1	18.9	5.6	14.5	42.7	4.1	7.1	9.2	5.0	7.6	20.9	4.7	6.7	9.9	22.3	19.7	6.1	3.1	12.7	9.0	17.0	3.9	5.7	7.1	7.6	24.0	6.1	3.1	8.4	11.0	4.8	4.7	5.1	5.4	4.8	6.5	11.2	30.0	3.6	13.5	6.5	12.0	2.4	5.3	15.6	3.7	14.8	5.2	8.9	15.2	2.9	6.7	9.1	14.0	3.3	13.4	7.1	3.1	6.0	9.0	4.3	6.6	7.5	5.8	4.7	4.0	8.7	3.5	5.1	5.8
NFATC4	NFAT3	ENSG00000100968	"Nuclear factor of activated T cells 4"	Q14934	14	24365673-24379604	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 19.7;BJ hTERT+: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA031641, CAB032859, HPA076526"	Uncertain		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: "	"unprognostic (3.51e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (5.84e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavourable (1.81e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-2)"	9.0	11.3	4.3	5.5	6.7	0.4	10.9	4.2	5.1	28.2	14.0	3.3	8.9	3.4	19.0	11.4	9.1	13.8	21.6	7.8	4.9	1.3	6.4	0.9	5.6	3.3	8.0	4.1	33.1	2.7	8.4	8.6	14.0	6.3	14.8	3.9	9.3	4.0	13.5	4.6	6.9	5.9	20.9	2.8	4.2	7.7	9.6	3.1	1.5	11.0	5.9	5.8	22.3	14.7	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	13.4	19.7	0.0	8.8	25.4	12.0	10.5	0.0	7.4	7.4	0.2	12.6	0.0	3.6	0.1	7.3	0.0	0.3	5.7	9.2	0.0	6.5	0.0	0.0	14.2	0.1	7.2	0.0	9.3	1.8	0.0	2.3	0.4	0.0	0.8	1.1	0.0	0.5	0.8	1.0	0.0	0.1	1.5	6.3	0.0	1.7	2.9	5.3	2.3	5.3	11.2	2.3	10.5	0.0	5.4	0.7	5.2	2.3	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	6.7	4.2	5.1	4.9	1.3	8.0	4.1	6.3	3.1
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061487	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 194.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA063384: , HPA065424: "	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	24.2	25.7	15.5	13.1	15.5	4.6	50.3	9.1	19.8	18.8	17.5	17.4	32.3	17.4	31.4	30.5	21.4	22.7	16.3	85.5	18.2	19.2	27.9	18.4	13.9	12.6	21.7	21.2	26.2	11.1	16.6	16.3	16.6	25.0	16.5	13.6	22.6	17.7	26.1	194.7	19.9	18.3	24.3	27.5	17.7	13.9	18.8	16.5	5.8	22.4	58.9	10.7	17.3	24.2	4.1	9.4	19.7	9.4	2.1	2.6	0.9	18.9	42.3	27.7	23.4	58.2	28.4	20.8	31.0	43.1	22.0	24.6	51.5	21.9	21.8	62.9	39.0	39.4	19.6	24.7	23.7	37.4	16.3	12.3	28.6	17.2	69.1	27.3	19.9	38.7	61.7	40.1	45.0	34.4	21.7	60.6	27.0	16.2	17.3	8.5	17.9	16.1	12.3	39.2	20.8	24.3	28.4	17.1	25.9	21.2	14.2	43.6	28.1	18.8	45.9	54.0	23.4	18.2	31.0	101.3	67.8	20.4	51.3	11.6	30.6	7.9	9.4	2.7	2.6	4.8	1.5	3.8	2.5	2.6	1.9	4.1	1.9	2.1	19.7	2.1	5.6	9.4	0.9	0.9	15.5	15.5	9.1	19.8	18.2	19.2	21.7	21.2	25.0	16.5
NFE2L2	NRF2	ENSG00000116044	"Nuclear factor, erythroid 2 like 2"	Q16236	2	177227595-177392697	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002990, CAB020317, HPA043438"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"CAB020317: , HPA002990: AB_1079476, HPA043438: "	"unprognostic (2.11e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.83e-1)"	"prognostic favourable (2.26e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.77e-3)"	30.9	24.4	25.4	19.3	34.7	15.0	24.6	36.4	29.7	31.7	28.3	25.8	22.2	28.1	27.7	30.9	82.5	27.0	28.9	32.3	28.0	16.9	44.8	49.3	29.0	19.7	49.0	18.7	53.1	16.3	21.7	52.5	29.4	33.5	39.0	25.4	21.7	34.7	28.1	25.9	48.1	29.2	42.1	42.7	26.8	45.9	21.9	41.6	21.1	49.5	35.8	25.5	43.7	47.1	23.5	41.1	42.4	35.6	25.8	43.2	22.6	10.9	12.7	11.5	12.4	39.0	42.1	13.2	18.7	26.1	17.1	19.4	16.8	21.0	10.8	20.4	21.2	20.4	13.5	28.6	24.0	8.4	8.2	13.9	22.3	32.6	49.9	8.2	13.2	28.9	67.3	24.3	36.2	16.9	14.5	21.3	23.5	10.9	8.4	21.8	12.6	11.9	6.9	10.1	10.9	26.1	41.4	15.1	9.8	42.5	13.7	44.4	10.6	22.3	25.5	17.8	11.8	19.7	11.5	15.0	9.0	9.1	17.8	9.2	34.0	42.4	35.6	21.4	23.0	34.1	26.6	23.5	26.9	23.6	41.1	19.9	43.2	28.2	39.9	25.8	31.9	15.5	25.0	22.6	25.4	34.7	36.4	29.7	28.0	16.9	49.0	18.7	33.5	41.6
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501329-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	19.8	14.7	8.2	37.7	12.0	44.5	26.6	12.4	10.3	18.2	17.1	10.4	10.4	10.7	17.5	11.2	20.5	16.4	20.3	14.5	7.5	5.1	13.2	15.8	26.9	46.0	11.4	4.8	17.5	14.3	10.2	8.7	13.7	10.0	18.8	14.6	10.8	17.7	13.5	17.1	19.6	16.7	16.0	10.1	30.0	14.6	9.3	12.5	37.5	14.7	16.3	26.7	18.4	22.7	5.8	10.4	5.5	7.1	14.3	10.6	3.5	16.9	9.5	5.1	7.8	16.0	14.4	6.3	9.7	28.8	12.1	12.4	10.5	24.3	27.7	8.8	15.3	13.5	10.2	17.0	16.7	25.0	6.0	11.8	7.7	11.3	15.0	21.0	25.1	11.9	12.0	11.8	16.4	15.2	11.4	20.4	8.7	11.9	1.8	11.5	3.1	8.8	14.8	12.2	12.5	11.3	23.9	3.5	5.8	17.9	25.0	9.8	5.1	15.7	19.4	16.5	8.6	8.9	13.6	9.0	6.2	26.9	10.5	10.8	23.3	5.2	5.4	4.9	3.4	7.1	6.0	5.6	8.4	5.6	10.4	5.8	10.6	8.9	5.5	14.3	5.9	7.4	4.5	3.5	8.2	12.0	12.4	10.3	7.5	5.1	11.4	4.8	10.0	12.5
NFKB2	"LYT-10, NF-kB2, p105, p49/p100, p52"	ENSG00000077150	"Nuclear factor kappa B subunit 2"	Q00653	10	102394110-102402529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.5;Karpas-707: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008422, CAB022098, HPA023900"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435"	"unprognostic (1.10e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.98e-2)"	"prognostic favourable (8.45e-5)"	"unprognostic (4.04e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (6.69e-12)"	"unprognostic (2.37e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.56e-1)"	14.9	10.8	5.6	43.6	7.1	40.6	18.7	2.0	4.9	12.5	20.1	4.2	9.4	11.3	18.8	11.0	12.9	10.8	20.4	10.9	4.6	2.5	15.5	14.5	20.6	34.2	6.6	2.5	15.1	17.4	5.2	6.3	12.8	7.9	19.6	5.2	7.3	16.7	15.1	13.6	10.4	14.1	24.0	7.7	28.0	13.1	6.6	5.8	19.5	11.5	14.8	39.2	21.9	24.4	5.2	1.4	7.5	3.4	1.3	2.0	0.9	21.0	13.1	2.6	10.5	3.3	5.0	6.2	6.0	19.2	6.1	8.9	7.8	17.3	9.7	15.0	3.6	12.8	6.0	8.2	2.4	49.5	3.5	2.4	3.2	4.5	9.2	1.6	14.1	6.9	4.0	10.2	10.1	2.1	2.3	54.1	2.3	7.2	2.4	6.6	3.3	4.7	5.3	7.3	7.7	10.3	6.2	0.5	2.9	4.9	11.9	8.4	9.2	4.7	6.3	6.3	9.3	8.9	15.9	35.8	33.1	10.2	10.3	4.2	3.3	0.3	2.4	0.1	1.4	1.5	1.4	5.2	1.7	1.5	1.4	4.5	1.8	1.5	7.5	1.3	3.4	0.9	2.0	0.9	5.6	7.1	2.0	4.9	4.6	2.5	6.6	2.5	7.9	5.8
NFKBIA	"IkappaBalpha, IKBA, MAD-3, NFKBI"	ENSG00000100906	"NFKB inhibitor alpha"	P25963	14	35401511-35404749	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 209.1"	"Cell line enhanced"	"Detected in all"		"RT4: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003815, HPA029207"	Approved		Enhanced	Cytosol				Cytosol		"CAB003815: AB_344886, HPA029207: AB_10603122"	"prognostic favourable (1.33e-5)"	"unprognostic (3.39e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.80e-2)"	49.0	38.5	14.9	63.7	25.7	209.1	60.8	16.1	27.8	33.8	32.8	10.3	36.7	13.5	21.3	15.6	50.4	30.5	34.3	30.9	18.8	10.5	30.6	45.1	73.0	47.7	29.7	7.8	57.4	22.1	6.5	25.3	25.5	21.8	28.7	18.6	19.5	44.2	64.6	33.1	48.2	42.3	24.9	23.0	47.4	26.1	19.6	23.9	35.0	27.8	46.2	38.1	41.8	45.2	45.3	55.0	118.2	58.3	33.2	37.3	51.7	12.9	11.5	4.3	3.9	25.7	17.1	15.6	5.4	52.0	11.7	10.5	3.6	7.8	7.8	14.5	8.5	17.1	8.2	22.4	16.9	47.8	3.2	3.9	8.3	21.2	15.4	6.1	3.2	18.6	22.7	7.9	20.4	10.5	3.2	12.7	8.3	15.2	8.0	14.8	4.0	7.1	18.3	5.0	6.5	20.1	83.5	3.9	6.8	14.4	25.3	6.0	14.3	13.1	19.6	16.1	5.8	4.6	8.6	15.5	15.7	13.4	13.4	4.6	3.3	35.8	58.3	36.6	24.2	33.4	37.3	34.0	29.3	25.4	55.0	45.3	25.6	21.7	118.2	33.2	22.1	29.7	19.5	51.7	14.9	25.7	16.1	27.8	18.8	10.5	29.7	7.8	21.8	23.9
NFKBIB	"IKBB, TRIP9"	ENSG00000104825	"NFKB inhibitor beta"	Q15653	19	38899700-38908893	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 80.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063734			Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA063734: "	"unprognostic (2.73e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.50e-3)"	7.9	7.1	7.0	12.5	9.8	22.0	6.8	2.9	7.3	3.9	7.6	8.1	7.6	10.8	5.8	5.7	8.6	5.1	7.6	7.1	7.3	5.8	7.9	14.6	6.7	8.7	11.2	5.2	4.3	9.7	4.0	3.9	7.2	7.2	5.0	3.6	5.1	8.6	6.6	13.9	8.0	11.7	5.1	9.9	9.2	12.4	80.2	9.3	6.0	6.6	8.7	8.7	6.6	5.1	3.8	5.4	12.4	5.8	8.7	7.2	2.9	8.0	10.0	1.4	3.6	1.5	0.9	4.8	5.4	2.2	2.9	3.3	7.1	4.4	8.9	6.1	1.2	4.4	3.8	2.6	0.9	27.2	4.8	5.9	1.9	4.0	5.2	6.8	12.6	1.2	3.0	3.2	4.1	1.6	6.9	8.2	1.1	5.2	8.4	6.7	5.1	4.1	11.8	6.2	8.1	1.4	3.2	8.7	5.2	3.4	5.0	3.8	3.0	5.8	3.8	5.0	6.4	8.6	8.3	17.0	15.1	19.0	3.2	7.1	6.1	1.5	4.3	12.4	5.3	5.8	4.1	3.6	3.1	4.5	3.8	3.8	2.3	3.4	9.0	8.7	4.7	5.4	7.2	2.9	7.0	9.8	2.9	7.3	7.3	5.8	11.2	5.2	7.2	9.3
NFKBIE	IKBE	ENSG00000146232	"NFKB inhibitor epsilon"	O00221	6	44258166-44265788	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002692, HPA005941, CAB010272"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478"	"prognostic favourable (1.72e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (1.37e-6)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (8.07e-4)"	5.8	5.2	7.6	24.6	5.4	24.0	5.2	9.4	7.8	3.7	8.0	4.2	3.2	6.7	4.7	5.5	6.9	3.0	9.8	4.6	7.9	5.5	11.5	8.7	15.9	17.1	6.0	4.1	6.1	7.1	3.5	4.1	6.0	4.8	7.1	5.9	3.6	7.7	4.1	3.7	7.4	9.5	3.6	5.0	29.6	6.3	7.9	3.7	14.5	5.5	4.6	22.7	6.7	6.7	8.1	8.2	7.1	10.2	0.8	3.5	1.6	14.4	3.7	5.1	8.0	2.0	1.5	2.7	2.5	12.6	8.0	8.4	7.8	6.8	7.8	9.2	2.6	3.1	5.4	8.1	9.0	13.4	3.0	4.0	1.5	8.7	6.2	13.2	12.2	3.9	3.6	7.4	4.6	5.4	3.7	20.9	2.0	7.4	2.5	27.0	2.7	2.0	4.9	4.5	7.2	18.4	15.8	3.3	4.1	1.8	6.7	10.5	4.6	15.5	9.5	4.5	5.3	2.8	8.0	13.3	5.6	14.4	4.0	14.7	8.5	7.1	8.1	3.8	1.8	9.4	3.5	8.1	2.4	1.6	6.8	7.3	1.1	1.7	3.2	0.8	10.2	8.2	3.0	1.6	7.6	5.4	9.4	7.8	7.9	5.5	6.0	4.1	4.8	3.7
NFS1	"IscS, NifS"	ENSG00000244005	"NFS1, cysteine desulfurase"	Q9Y697	20	35668055-35699359	"Enzymes, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB034314, HPA051801, HPA054755"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594"	"unprognostic (1.72e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.93e-2)"	"prognostic favourable (4.72e-6)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.54e-2)"	10.2	28.0	16.9	6.7	19.3	3.7	9.7	15.3	20.8	11.2	11.7	12.0	10.0	11.0	8.4	9.9	10.1	11.7	9.9	19.2	14.6	14.0	36.9	33.0	7.8	7.0	16.5	15.5	12.5	14.0	20.7	14.8	7.8	14.3	9.5	13.0	12.2	12.6	12.2	19.7	9.5	9.6	10.1	12.4	6.6	10.3	25.3	15.8	4.9	10.2	8.4	10.4	8.1	7.7	10.4	11.2	7.4	8.1	12.8	11.4	6.1	13.3	16.7	5.8	6.1	15.9	14.6	11.8	10.2	10.8	15.5	10.1	30.0	7.6	11.4	20.1	9.5	16.9	19.9	20.6	14.0	5.1	9.3	24.4	17.8	23.3	13.3	10.2	4.7	11.7	19.8	12.1	13.4	11.5	17.4	7.7	10.8	20.5	11.5	10.8	6.7	25.1	4.6	18.9	19.2	15.7	9.1	7.3	6.7	25.5	24.7	16.6	22.1	9.2	8.4	17.5	8.3	10.2	10.0	11.1	15.2	10.4	14.8	11.1	8.6	2.5	8.1	7.4	7.6	7.7	9.7	10.4	8.8	11.2	11.2	7.6	10.3	9.3	3.4	12.8	6.0	5.6	11.4	6.1	16.9	19.3	15.3	20.8	14.6	14.0	16.5	15.5	14.3	15.8
NFU1	"CGI-33, HIRIP5, NifU, NIFUC"	ENSG00000169599	"NFU1 iron-sulfur cluster scaffold"	Q9UMS0	2	69395750-69437628	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035826	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA035826: "	"unprognostic (4.49e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.87e-1)"	32.3	26.0	24.9	14.7	23.5	14.9	59.9	19.7	40.4	14.7	20.0	12.1	16.0	15.9	17.1	31.8	13.9	17.6	15.9	83.2	21.4	23.6	32.8	20.0	23.0	20.8	24.1	29.7	18.5	21.7	22.9	23.0	19.1	23.7	17.5	20.8	12.2	19.1	19.8	69.3	9.7	16.3	28.9	24.8	13.9	18.7	16.5	16.8	7.8	21.4	28.3	14.4	19.0	19.4	18.2	17.7	16.0	17.5	12.9	18.2	8.0	20.0	18.6	19.4	19.4	24.8	23.5	21.2	21.6	19.1	19.0	14.3	40.3	17.6	12.2	11.3	17.8	9.1	19.9	20.3	26.6	25.6	19.5	13.6	15.9	36.7	25.4	24.8	20.7	19.6	11.9	20.5	14.1	24.3	23.4	14.9	34.2	4.2	13.0	42.5	17.7	20.9	14.4	30.4	4.9	29.1	21.2	15.7	12.4	11.8	10.9	33.7	13.1	17.3	23.9	24.2	17.3	18.8	29.0	19.6	16.5	8.0	18.3	25.1	18.6	13.5	8.5	16.0	12.1	12.4	11.8	15.9	12.3	14.4	8.6	18.2	12.8	14.4	2.8	12.9	17.5	17.7	18.2	8.0	24.9	23.5	19.7	40.4	21.4	23.6	24.1	29.7	23.7	16.8
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290511-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA056310: , HPA061382: , HPA073519: "	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	23.7	19.8	17.6	17.8	26.3	22.5	24.1	33.0	26.7	19.2	24.4	24.7	18.0	19.2	26.3	19.2	22.3	18.6	14.4	26.4	16.2	16.0	17.4	31.3	19.6	23.1	17.8	19.5	26.5	20.9	28.3	30.9	17.7	25.2	20.4	22.4	19.3	22.9	23.6	44.8	31.2	23.0	21.5	18.1	21.0	19.3	14.4	22.0	35.1	26.7	19.1	32.8	24.7	19.8	10.7	12.3	22.9	7.1	6.8	10.1	5.0	15.0	12.3	11.3	10.7	16.9	19.0	11.4	14.2	14.3	16.1	16.2	11.1	6.2	23.4	9.1	16.4	8.5	20.1	15.4	15.2	17.0	10.1	12.3	30.0	12.4	20.6	21.8	13.6	17.7	25.8	13.8	34.8	9.8	18.6	20.4	16.8	10.6	14.0	20.5	18.3	13.9	15.1	12.3	12.7	10.9	14.5	15.7	11.0	14.2	15.3	8.1	8.9	21.8	12.3	13.2	11.1	9.5	15.4	11.0	9.9	23.2	14.5	11.0	7.5	22.9	4.2	7.9	8.4	7.1	8.9	10.7	9.0	9.0	7.1	9.1	10.1	9.9	3.0	6.8	5.5	12.3	6.1	5.0	17.6	26.3	33.0	26.7	16.2	16.0	17.8	19.5	25.2	22.0
NGEF	ARHGEF27	ENSG00000066248	"Neuronal guanine nucleotide exchange factor"	Q8N5V2	2	232878686-233013272	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.1;brain: 55.6;intestine: 23.2"	"Cell line enhanced"	"Detected in many"		"A-431: 25.0;HDLM-2: 21.1;PC-3: 27.5;T-47d: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 177.2;basal ganglia: 332.1;cerebral cortex: 231.3;hippocampal formation: 147.2"	"Low region specificity"	"Detected in many"			HPA008160	Approved		Uncertain	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"		"HPA008160: AB_1854450"	"unprognostic (3.92e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.39e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.74e-1)"	0.8	29.1	15.8	1.4	55.6	0.3	1.4	0.8	53.8	1.4	7.9	1.6	0.0	23.2	2.8	2.6	5.3	3.1	2.0	0.9	7.0	5.1	4.2	9.7	0.6	0.3	3.2	26.7	1.5	1.8	7.9	0.9	0.4	5.4	1.3	6.1	0.0	0.8	0.7	0.7	16.5	16.6	4.0	1.4	0.5	6.2	2.3	12.0	0.0	0.8	1.0	0.4	0.9	1.6	0.0	0.5	0.5	0.3	0.0	0.0	0.0	25.0	7.3	0.2	0.1	0.1	4.1	0.4	0.4	0.0	0.2	0.0	0.3	2.5	0.0	7.5	5.1	3.3	5.6	1.4	0.2	21.1	1.8	0.0	10.2	7.8	0.1	0.0	0.1	0.0	0.1	1.7	0.3	0.9	0.1	0.1	0.2	1.8	0.0	0.0	0.6	27.5	0.0	0.0	0.0	0.5	0.6	0.9	0.2	3.1	1.6	0.0	15.5	0.2	0.0	0.2	2.3	0.1	0.5	0.2	0.1	0.0	1.8	0.0	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	15.8	55.6	0.8	53.8	7.0	5.1	3.2	26.7	5.4	12.0
NHP2	"FLJ20479, NOLA2"	ENSG00000145912	"NHP2 ribonucleoprotein"	Q9NX24	5	178149460-178153967	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044171, HPA050400"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044171: AB_2678844, HPA050400: AB_2681113"	"unprognostic (1.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavourable (4.97e-4)"	"unprognostic (4.05e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (5.24e-4)"	"unprognostic (8.87e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.63e-2)"	35.4	41.0	42.5	37.5	46.4	44.2	37.9	26.2	54.2	27.1	37.3	23.7	26.2	29.0	31.9	34.4	59.4	37.6	33.6	52.3	37.7	33.6	31.3	57.1	24.9	60.3	37.1	29.3	38.2	62.1	15.1	25.3	25.0	26.7	28.0	22.4	18.6	40.0	35.5	50.9	39.1	26.7	34.2	34.1	29.9	30.4	26.9	25.6	40.6	34.5	61.9	32.9	26.8	33.4	50.8	78.2	7.1	38.9	37.9	43.8	51.2	32.3	48.9	15.8	45.8	10.8	14.3	55.2	25.2	12.2	27.0	23.5	28.6	27.6	46.4	46.8	14.0	20.3	23.7	52.3	14.4	88.2	79.8	24.5	38.1	32.1	18.5	41.8	26.5	17.2	24.7	21.2	19.1	25.3	24.6	30.0	15.1	140.2	57.8	29.0	24.4	75.7	39.2	21.8	69.3	20.2	20.6	40.8	47.3	19.0	51.2	44.0	26.3	29.6	25.6	28.4	31.9	23.9	56.6	37.8	76.0	55.2	29.6	55.3	31.1	7.1	35.3	4.8	31.6	38.9	43.8	50.8	39.2	36.3	48.7	50.0	40.8	42.0	2.7	37.9	27.0	78.2	36.3	51.2	42.5	46.4	26.2	54.2	37.7	33.6	37.1	29.3	26.7	25.6
NIM1K	"MGC42105, NIM1"	ENSG00000177453	"NIM1 serine/threonine protein kinase"	Q8IY84	5	43192071-43280850	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 23.7;pituitary gland: 9.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HDLM-2: 4.8;PC-3: 5.5;U-87 MG: 6.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.2;T-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007695	Uncertain		Approved	Cytosol				Cytosol		"HPA007695: "	"unprognostic (7.97e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.84e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-5)"	"unprognostic (2.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.46e-3)"	"unprognostic (4.98e-3)"	1.4	3.5	9.4	1.6	10.9	0.9	1.3	4.9	23.7	1.6	1.4	6.3	0.0	1.1	1.2	1.6	1.6	1.4	1.5	1.8	8.7	7.7	1.4	1.2	3.6	1.2	5.6	5.8	1.2	1.5	1.2	9.7	1.8	6.4	1.4	1.7	1.7	2.3	2.4	2.0	1.8	1.2	1.3	4.9	1.0	3.0	1.4	8.1	0.0	2.7	0.0	1.0	1.1	0.8	0.1	1.2	0.0	0.0	0.2	3.2	0.0	0.2	0.6	0.1	0.1	0.9	0.5	0.0	1.0	3.1	1.1	4.4	0.1	0.0	0.4	0.6	0.8	0.3	0.6	0.0	2.7	4.8	0.3	0.1	0.6	0.2	1.6	0.2	0.6	1.9	0.1	0.5	0.0	0.0	0.2	0.3	0.9	0.2	0.3	0.2	0.0	5.5	0.2	0.3	0.5	0.1	0.7	0.9	0.1	1.7	0.5	0.3	0.4	1.5	0.0	0.9	0.8	0.7	0.7	1.6	0.4	0.3	6.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.2	3.2	0.0	9.4	10.9	4.9	11.6	8.7	7.7	5.6	5.8	6.4	8.1
NINL	"KIAA0980, NLP"	ENSG00000101004	"Ninein like"	Q9Y2I6	20	25452705-25585517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 14.7;Hep G2: 23.1;SCLC-21H: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"	"Low region specificity"	"Detected in many"							HPA000686	Uncertain		Approved	"Cytokinetic bridge,Cytosol"				"Cytokinetic bridge, Cytosol"		"HPA000686: AB_1079193"	"unprognostic (7.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.56e-2)"	"prognostic favourable (1.47e-4)"	"unprognostic (3.39e-1)"	"prognostic favourable (1.03e-5)"	"unprognostic (3.95e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.26e-2)"	3.8	7.5	5.9	7.6	10.7	0.8	4.2	17.2	4.2	10.3	6.7	5.5	3.9	4.1	13.0	9.7	4.7	4.1	7.5	4.0	5.8	6.3	17.1	5.9	5.3	2.7	4.5	4.2	18.5	5.0	14.8	12.1	2.0	7.5	8.8	2.8	13.8	4.7	5.2	5.2	2.7	3.6	9.7	5.5	5.3	6.5	10.5	2.0	17.2	8.2	2.6	3.9	2.8	6.6	0.2	0.0	0.0	0.0	0.0	2.2	0.2	0.6	6.7	14.7	9.6	1.7	4.9	4.6	2.2	2.0	2.0	2.9	1.7	4.7	0.3	3.2	3.5	0.5	2.1	0.4	1.7	0.3	3.0	1.0	3.1	23.1	3.5	0.3	0.0	6.1	0.4	2.3	0.0	4.3	1.1	0.1	2.4	5.9	13.0	0.4	4.1	0.7	0.3	11.4	0.5	1.0	0.8	14.6	10.3	5.1	1.9	5.5	3.1	3.9	0.2	0.1	5.7	0.0	0.1	1.5	2.6	0.0	0.1	0.3	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.8	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.2	5.9	10.7	17.2	4.2	5.8	6.3	4.5	4.2	7.5	2.0
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL, cohesin loading factor"	Q6KC79	5	36876759-37066413	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: "	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	16.8	13.9	13.3	21.9	15.7	22.7	15.8	22.9	15.9	17.3	19.2	10.8	20.1	10.4	18.7	16.5	16.6	14.3	15.9	12.4	13.5	7.1	12.6	13.2	16.0	16.0	17.2	11.1	21.2	14.6	30.0	20.9	17.4	13.5	15.1	13.2	8.5	17.1	24.7	18.9	18.2	18.4	13.2	11.9	18.5	14.7	14.1	19.0	42.5	18.1	14.0	16.9	17.6	29.2	4.8	4.6	11.1	4.3	3.8	4.9	1.9	10.1	6.0	15.7	7.4	10.0	11.0	11.6	8.2	9.1	9.0	7.5	8.4	10.5	15.4	5.3	10.1	8.9	13.4	7.5	13.0	12.6	7.0	18.7	26.7	6.1	6.9	21.8	12.5	8.1	9.3	10.1	13.4	11.3	17.8	11.6	8.4	4.9	14.9	8.3	7.5	5.2	12.8	24.7	5.9	6.4	14.5	11.7	8.2	39.5	10.6	8.4	10.8	12.7	12.2	11.9	13.0	10.1	6.1	8.4	11.2	18.3	6.6	15.0	8.9	10.0	4.1	5.7	4.8	3.2	4.4	4.0	3.9	4.2	3.3	4.8	4.3	4.9	11.1	3.8	4.3	4.6	2.9	1.9	13.3	15.7	22.9	15.9	13.5	7.1	17.2	11.1	13.5	19.0
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036999	Approved		Supported	Centrosome,Cytosol			960000	Cytosol	Centrosome	"HPA036999: AB_10672105"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.1	8.9	12.1	6.2	4.1	6.0	9.7	9.2	8.4	11.2	9.9	6.2	5.8	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.8	4.7	4.9	7.6	16.7	5.1	8.5	6.1	3.3	8.0	11.8	9.4	3.1	4.3	4.4	15.0	3.5	4.2	9.7	16.0	6.2	6.9	3.2	5.6	9.6	6.1	7.1	4.4	4.4	6.1	2.5	2.9	3.5	4.9	5.4	8.5	9.6	7.9	7.6	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123804141-124825657	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 43.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.8;HEK 293: 6.4;HEL: 8.0;Karpas-707: 13.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol				Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	2.2	1.6	12.9	1.1	12.1	1.9	1.3	17.3	43.2	1.4	1.7	24.9	0.0	1.1	1.2	1.6	1.4	1.4	1.3	2.6	17.5	8.8	1.3	1.2	1.3	1.3	18.1	10.9	1.2	1.0	1.0	1.1	1.2	18.0	1.4	1.3	0.5	1.1	1.3	4.8	1.1	1.5	1.5	42.9	1.1	1.0	1.6	16.1	0.0	1.2	0.5	1.3	1.5	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	6.4	8.0	0.0	0.0	0.5	0.0	0.0	1.6	0.2	0.0	0.5	0.0	0.0	13.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.1	17.3	15.3	17.5	8.8	18.1	10.9	18.0	16.1
NKAP	FLJ22626	ENSG00000101882	"NFKB activating protein"	Q8N5F7	X	119920672-119943772	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000916	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000916: AB_1079486"	"prognostic unfavourable (4.20e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	13.9	17.5	12.2	11.2	16.8	15.9	14.0	11.6	16.9	13.0	13.2	15.6	9.9	10.1	16.2	12.4	12.0	15.2	14.0	15.5	12.9	14.0	14.8	19.5	12.6	14.1	14.5	9.7	23.9	13.5	14.1	21.7	18.1	16.6	16.0	8.5	10.3	13.9	15.0	23.9	13.5	13.7	12.0	19.5	15.8	12.3	11.8	16.7	20.1	16.4	11.6	12.2	17.9	15.3	11.8	9.7	16.5	8.0	7.0	8.1	4.4	6.2	7.5	6.1	5.4	4.9	8.2	8.2	4.8	4.5	6.1	4.6	4.5	4.9	6.4	7.7	4.4	4.5	11.3	4.5	5.4	8.8	10.8	3.0	5.3	4.0	6.4	7.2	6.2	5.7	7.9	5.8	4.9	4.2	7.4	6.2	4.7	7.7	7.9	10.3	5.9	9.7	8.2	6.6	8.3	3.4	2.4	6.8	8.3	9.6	4.6	9.9	4.1	6.5	6.4	4.4	2.2	10.3	6.2	7.9	6.3	7.3	6.1	6.8	6.4	11.3	8.0	10.8	6.9	5.9	6.8	9.7	8.1	6.5	6.0	11.8	8.1	7.5	16.5	7.0	6.6	9.7	7.5	4.4	12.2	16.8	11.6	14.6	12.9	14.0	14.5	9.7	16.6	16.7
NKAPD1	"C11orf57, FLJ10726"	ENSG00000150776	"NKAP domain containing 1"	Q6ZUT1	11	112074086-112085150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039493, HPA039892"	Approved		Supported	Cytosol				Cytosol		"HPA039493: AB_10795036, HPA039892: AB_10795372"	"unprognostic (5.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.41e-1)"	20.6	16.2	20.6	14.1	19.1	13.5	20.6	34.8	21.6	21.5	16.0	13.9	13.1	13.4	19.3	15.7	18.1	17.6	15.6	14.7	19.6	21.1	21.7	14.5	13.4	17.6	20.7	14.7	26.0	17.9	17.4	15.8	24.0	20.7	18.9	14.6	13.2	18.0	14.8	28.2	14.6	16.2	23.3	19.6	19.6	13.9	18.8	15.9	29.7	26.7	15.6	16.4	21.6	19.4	9.1	19.4	7.5	7.7	12.2	11.2	4.3	7.8	5.3	11.3	18.1	11.7	13.6	8.3	11.6	10.0	9.8	11.3	16.4	14.3	22.2	17.9	10.5	11.4	13.5	12.5	12.8	15.8	9.4	17.0	5.3	7.8	10.8	25.6	11.2	13.8	17.3	11.8	27.4	8.7	25.0	13.8	9.8	4.8	22.8	15.9	11.2	11.8	17.7	13.9	18.1	11.4	7.1	9.5	17.3	12.1	15.0	10.9	18.7	10.7	8.8	13.2	14.9	8.1	10.0	10.3	22.7	45.6	5.6	24.3	13.3	7.5	7.2	4.3	9.9	7.1	10.1	8.3	10.5	6.7	7.6	9.1	11.2	9.5	3.8	12.2	7.7	19.4	8.1	4.3	20.6	19.1	34.8	21.6	19.6	21.1	20.7	14.7	20.7	15.9
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600614-42648741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: "	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favourable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (6.01e-4)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (1.05e-5)"	12.9	14.4	9.8	18.8	22.2	16.3	15.9	42.0	12.3	18.8	10.4	18.5	15.4	11.8	27.2	17.4	11.0	12.0	13.1	11.2	10.9	10.5	9.5	9.7	14.6	15.5	14.5	11.3	22.7	18.4	19.2	26.9	11.1	14.1	12.9	11.1	20.4	13.2	19.5	12.0	20.0	13.3	19.4	15.0	18.5	10.1	17.8	13.8	20.6	14.9	10.9	19.4	12.9	13.9	9.3	8.5	11.7	10.0	11.1	10.2	3.6	8.9	5.1	17.1	7.0	10.2	12.5	9.6	14.5	3.7	6.0	8.2	9.0	7.2	14.1	7.0	4.4	7.9	10.1	3.6	12.4	7.1	8.4	18.1	16.2	14.5	4.4	13.9	11.9	5.1	7.2	11.9	4.5	10.6	18.2	10.9	11.4	3.7	9.5	13.6	14.7	7.5	10.1	7.7	5.8	8.4	6.8	6.0	3.6	15.6	6.5	2.4	9.5	10.1	17.0	10.9	7.9	11.8	14.0	9.5	13.2	9.8	5.8	17.1	6.6	9.2	6.2	11.7	10.2	7.7	9.4	8.9	9.8	8.5	4.7	9.3	10.0	8.7	9.1	11.1	10.0	8.5	8.3	3.6	9.8	22.2	42.0	12.3	10.9	10.5	14.5	11.3	14.1	13.8
NKX2-3	"CSX3, NKX2.3, NKX2C, NKX4-3"	ENSG00000119919	"NK2 homeobox 3"	Q8TAU0	10	99532933-99536524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;NB-4: 4.7;REH: 6.0;THP-1: 1.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.3"	HPA047561	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA047561: "		"unprognostic (5.70e-2)"	"unprognostic (2.95e-1)"			"unprognostic (2.70e-4)"	"unprognostic (6.34e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	0.8	0.0	0.1	17.2	0.1	0.0	0.1	0.1	0.1	0.3	21.6	0.1	0.1	10.4	0.2	0.1	0.5	0.0	12.5	0.1	0.1	0.0	0.1	0.2	0.1	1.1	0.1	0.1	0.1	6.4	0.0	0.1	0.1	0.1	0.1	4.6	0.1	9.0	0.5	0.1	0.0	19.1	3.1	0.1	36.8	1.8	0.1	0.1	0.2	1.0	0.7	3.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	6.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NKX2-5	"CSX, CSX1, NKX2.5, NKX2E, NKX4-1"	ENSG00000183072	"NK2 homeobox 5"	P52952	5	173232109-173235357	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Atrial septal defect, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 95.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 20.5;NTERA-2: 7.4;SK-MEL-30: 9.1;U-2 OS: 16.9;U-251 MG: 12.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065034			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA065034: "	"unprognostic (3.81e-1)"	"unprognostic (8.53e-2)"		"unprognostic (2.62e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.22e-3)"		"unprognostic (6.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.31e-1)"			"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"		"unprognostic (1.77e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	95.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.1	0.0	0.0	0.2	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.0	1.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	20.5	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.3	4.2	0.0	9.1	0.0	0.0	0.0	3.9	16.9	5.2	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKX3-1	"BAPX2, NKX3.1, NKX3A"	ENSG00000167034	"NK3 homeobox 1"	Q99801	8	23678693-23682927	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"prostate: 95.3"	"Cell line enhanced"	"Detected in many"		"SiHa: 17.5;U-138 MG: 17.8;U-251 MG: 15.2"	"Cancer enriched"	"Detected in many"	65	"prostate cancer: 392.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"eosinophil: 23.5;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 23.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025693, HPA078571"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA025693: AB_1854522, HPA078571: "	"unprognostic (1.47e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.56e-6)"	"unprognostic (6.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.69e-1)"	0.6	1.3	0.3	0.6	0.9	0.6	1.5	0.1	0.8	1.1	0.6	0.2	0.5	0.5	0.7	0.5	1.2	0.7	0.8	2.4	0.8	0.3	0.4	1.6	0.8	0.7	0.6	0.2	1.6	0.6	0.5	0.4	0.3	1.2	95.3	0.2	0.5	17.9	0.7	2.0	0.2	0.4	0.7	0.6	0.3	0.5	12.3	0.7	0.0	0.6	3.2	20.5	0.7	2.5	1.0	0.0	23.5	0.0	0.2	1.2	0.1	3.2	2.4	0.0	5.9	2.2	0.5	4.9	4.4	2.8	9.5	11.2	1.4	3.7	0.0	0.6	3.3	0.8	2.3	5.1	7.5	0.0	1.2	2.2	1.8	3.5	4.2	0.0	0.8	0.8	1.3	9.6	0.5	0.5	0.1	0.0	3.7	1.0	7.6	0.6	1.4	1.7	0.0	3.8	0.3	0.5	3.8	1.1	0.3	17.5	3.3	0.3	2.3	0.3	0.6	17.8	6.3	1.3	15.2	0.0	0.0	0.0	8.7	1.7	2.1	3.4	0.0	23.5	0.5	0.0	0.1	1.0	0.2	0.5	0.0	0.9	0.7	1.2	23.4	0.2	0.0	0.0	0.0	0.1	0.3	0.9	0.1	0.8	0.8	0.3	0.6	0.2	1.2	0.7
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.2;HL-60: 12.9;HMC-1: 6.5;NB-4: 13.8;U-698: 19.9;U-937: 9.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"				Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: "	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	0.2	0.4	0.0	20.1	0.1	2.8	0.0	0.0	0.2	0.4	1.3	0.0	0.2	1.2	1.0	0.1	1.0	0.0	1.8	0.8	0.0		0.6	0.5	6.0	11.2	0.2	0.0	0.1	1.5	0.0	0.0	0.6	0.2	0.9	0.7	0.9	2.7	0.2	0.5	0.0	2.4	0.1	0.0	10.5	1.4	0.0	0.0	27.0	0.4	1.1	18.1	1.6	1.0	1.0	0.0	2.6	0.0	4.7	4.1	3.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.2	0.1	0.0	0.0	12.9	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	5.4	13.8	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	3.3	0.4	0.2	0.0	0.2	0.1	0.3	0.0	19.9	0.1	9.7	0.0	2.6	0.0	0.0	3.7	0.0	4.1	1.0	2.7	3.8	0.0	0.8	2.1	2.0	0.0	4.7	0.0	0.0	3.1	3.3										
NLRP1	"CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1"	ENSG00000091592	"NLR family pyrin domain containing 1"	Q9C000	17	5499427-5619424	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.3;Karpas-707: 41.2;U-266/70: 20.6"	"Cancer enhanced"	"Detected in all"		"glioma: 20.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB009189, HPA064431"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009189: , HPA064431: "	"unprognostic (4.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (7.57e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-2)"	19.5	2.5	2.4	39.9	3.1	15.1	16.4	0.9	2.8	19.1	6.1	5.3	5.6	4.0	16.2	10.2	12.4	7.6	15.5	8.6	4.9	1.8	6.3	3.4	19.1	31.2	4.2	1.9	4.5	2.3	2.2	2.9	8.3	5.2	10.2	5.7	6.3	8.1	11.3	17.8	35.2	18.3	13.1	6.8	34.4	4.4	6.9	3.2	15.9	13.7	11.9	30.8	17.5	16.8	5.3	4.6	16.8	7.5	3.8	7.0	3.7	6.2	0.0	0.0	0.0	3.3	4.6	0.7	2.6	2.5	1.0	2.2	0.1	2.4	2.2	9.7	2.5	2.8	0.0	10.1	1.6	23.3	0.0	0.6	2.0	0.2	3.1	0.0	0.7	2.8	6.4	8.5	6.2	10.8	5.4	41.2	5.0	0.0	0.0	1.8	0.0	0.1	2.4	1.6	9.7	0.0	2.0	0.2	0.0	0.0	0.1	0.2	0.0	0.2	10.5	2.1	1.3	1.3	0.4	20.6	6.6	1.6	3.5	0.2	0.1	13.8	6.3	4.4	6.0	4.5	6.6	4.4	4.9	6.1	4.6	5.3	5.5	5.0	16.8	3.8	7.5	0.4	7.0	3.7	2.4	3.1	0.9	2.8	4.9	1.8	4.2	1.9	5.2	3.2
NLRP11	"CLR19.6, NALP11, NOD17, PAN10, PYPAF6"	ENSG00000179873	"NLR family pyrin domain containing 11"	P59045	19	55785397-55836800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.2;RPMI-8226: 21.5;U-266/70: 38.0;U-266/84: 16.4;U-698: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			"HPA046402, HPA078027"	Uncertain		Supported	Cytosol				Cytosol		"HPA046402: AB_10962951, HPA078027: "	"unprognostic (2.36e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.95e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.61e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	4.0	0.1	0.3	0.2	0.1	0.1	0.0	0.7	3.3	0.1	0.6	0.1	0.1	0.9	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	1.2	0.1	0.1	0.3	0.5	3.6	0.1	0.1	0.1	0.1	4.5	0.1	0.1	1.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.7	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	38.0	16.4	27.6	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NLRP14	"CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8"	ENSG00000158077	"NLR family pyrin domain containing 14"	Q86W24	11	7020446-7071308	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 2.5;testis: 3.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HEK 293: 1.7;HUVEC TERT2: 4.1;U-698: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039477	Approved		Uncertain	Cytosol				Cytosol		"HPA039477: AB_10794748"	"unprognostic (6.46e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.20e-4)"	"unprognostic (5.57e-2)"	"unprognostic (8.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.17e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.25e-1)"	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.8	0.1	0.2			0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.3	1.6	2.5	0.4	0.2	0.4		1.3	0.0	1.7	0.1	0.0		0.1	0.2		0.3	0.0	0.0	0.0	0.2	0.0	1.2	0.3	0.0	3.4			0.3		0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.9	0.5	0.6	0.0	0.4	1.6	0.0	0.1	0.0	0.0	0.1	0.6	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.1	4.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	2.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NLRP2	"CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2"	ENSG00000022556	"NLR family pyrin domain containing 2"	Q9NX02	19	54953130-55001142	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 25.1;K-562: 10.4;U-266/84: 11.4"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 78.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA021183			Supported	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles, Cytosol"		"HPA021183: "	"unprognostic (1.66e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.60e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.57e-2)"	0.6	0.9	1.1	5.0	3.8	1.7	1.4	0.6	2.7	2.6	2.6	0.9	0.2	2.5	2.1	3.7	10.8	1.0	3.7	0.7	2.0	1.8	4.7	0.9	2.2	5.0	0.8	0.8	1.0	6.1	0.3	1.7	8.1	2.9	2.1	1.2	2.4	4.1	1.6	1.4	3.5	2.9	1.1	1.0	3.0	3.1	14.3	0.9	4.2	3.1	0.2	3.5	4.7	5.6	3.8	1.8	0.6	0.9	3.4	2.6	0.8	2.3	3.9	2.0	0.4	0.1	0.1	25.1	0.1	0.0	0.2	0.1	5.0	0.5	2.6	0.2	0.1	4.1	0.0	4.3	0.2	2.5	0.2	2.5	0.3	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.1	0.0	10.4	0.3	0.0	0.3	0.2	1.0	3.0	0.0	2.8	0.0	1.5	2.3	0.9	2.4	0.6	0.1	1.1	0.0	3.4	0.8	0.0	0.2	0.5	0.3	0.3	2.7	11.4	0.9	0.3	0.7	0.1	0.6	0.7	0.3	2.6	0.9	1.5	3.8	1.1	1.0	0.6	2.6	0.8	1.5	0.5	3.4	0.5	1.8	1.2	0.8	1.1	3.8	0.6	2.7	2.0	1.8	0.8	0.8	2.9	0.9
NMBR	"BB1, BB1R"	ENSG00000135577	"Neuromedin B receptor"	P28336	6	142058330-142088799	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 2.5;fallopian tube: 3.3;testis: 5.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;RPTEC TERT1: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026665			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA026665: AB_1854527"	"unprognostic (6.24e-2)"	"unprognostic (3.05e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.88e-2)"			"unprognostic (3.54e-2)"		"unprognostic (8.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.94e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.45e-2)"	0.1	0.0	0.6	0.0	2.5	0.0	0.4	0.0	0.8	0.5	0.0			0.0	0.2	0.3	0.6	3.3	0.0	0.0	0.5	1.6	0.2	0.0	0.2	0.0	0.6		0.3	0.0	0.0	0.0	0.1		0.0	0.0		0.2	0.6	0.0	0.0	0.0	0.2	0.8	0.1	0.2	5.1			0.4		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.9	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.5	0.0	0.4	0.0	0.2	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: "	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	47.6	95.2	32.9	45.9	13.8	22.1	55.3	37.2	25.8	77.1	58.5	74.9	28.9	83.9	38.8	34.4	25.6	62.8	63.2	66.0	40.7	84.6	55.0	73.9	103.9	28.0	60.2	25.2	21.0	39.8	58.0	54.3	46.4	81.1	27.9	45.6	80.7	71.5	69.3	39.4	86.8	43.9	64.9	77.2	59.2	33.3	45.7	52.6	19.5	53.4	34.6	55.6	40.8	29.2	49.8	45.2	30.9	76.3	36.0	83.0	98.8	30.1	51.1	37.8	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3
NME1-NME2	"NM23-LV, NMELV"	ENSG00000011052	"NME1-NME2 readthrough"		17	51153590-51171744	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB002169, HPA008467, HPA041113, CAB076057"	Approved		Approved	Cytosol				Cytosol		"CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: "	"unprognostic (2.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (5.13e-2)"	"prognostic favourable (6.66e-4)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-6)"	"unprognostic (1.84e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	12.8	29.3	19.7	35.5	16.7	20.6	8.5	13.9	31.2	5.4	7.2	6.7	4.9	14.7	10.6	6.2	10.6	7.4	6.8	8.0	23.0	17.0	10.4	31.3	7.8	18.3	16.9	18.7	8.1	24.1	6.5	11.4	13.6	21.5	6.7	5.7	7.7	23.5	4.7	10.1	8.2	10.7	11.7	11.0	11.9	14.8	5.8	5.6	10.0	8.6	17.9	12.7	9.5	7.6	19.6	37.6	1.0	21.1	14.6	21.9	16.2	28.4	1.9	9.2	33.9	8.7	4.4	7.3	22.6	7.3	6.0	3.7	3.7	19.3	16.7	23.6	11.6	17.8	9.0	14.5	3.9	25.1	13.5	13.9	3.5	7.1	10.5	23.3	23.1	8.0	10.9	7.5	10.8	9.5	10.9	21.6	3.8	4.7	57.2	16.1	27.7	2.8	33.9	22.7	49.4	7.0	3.7	29.8	17.5	11.9	51.6	25.9	52.8	39.7	19.0	38.0	27.8	36.9	46.1	37.0	40.0	32.5	21.9	16.8	32.7	0.2	15.1	0.3	15.0	21.1	21.9	19.6	14.7	16.1	37.6	18.4	13.7	16.8	1.0	14.6	11.6	25.7	13.7	16.2	19.7	16.7	13.9	26.4	23.0	17.0	16.9	18.7	21.5	5.6
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171747	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB036213: , CAB036214: , CAB036215: , HPA041113: "	"unprognostic (7.21e-3)"	"prognostic unfavourable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavourable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	62.1	54.6	42.3	58.2	44.1	44.2	188.9	20.1	43.7	58.9	74.0	16.3	67.7	52.5	65.0	52.0	104.3	56.8	65.3	115.1	38.2	32.1	77.3	115.7	59.0	174.7	45.0	23.7	90.7	234.3	17.5	30.4	37.9	34.0	64.0	62.7	29.9	109.4	65.8	105.3	63.3	45.1	88.3	34.6	69.4	50.2	32.3	24.4	42.5	66.9	102.0	56.6	81.3	140.8	49.3	71.3	8.3	43.7	32.6	34.5	38.2	91.8	135.0	32.3	56.4	72.3	105.5	89.2	63.7	66.3	97.5	74.3	108.9	48.9	77.3	103.2	65.2	58.8	67.8	86.9	80.3	93.1	200.5	65.0	94.2	157.6	79.0	102.5	45.5	95.5	101.5	62.9	110.7	58.0	88.9	52.1	70.2	163.4	51.3	128.2	48.2	207.4	49.2	107.1	123.4	105.6	116.1	73.7	45.7	39.2	98.5	95.6	67.9	78.7	58.8	94.0	68.0	66.8	101.2	91.1	118.3	88.5	50.8	52.2	47.1	8.3	35.1	2.0	24.7	43.7	34.5	49.3	33.0	26.9	61.5	36.2	23.8	25.6	2.1	32.6	38.0	71.3	29.9	38.2	42.3	44.1	20.1	43.7	38.2	32.1	45.0	23.7	34.0	24.4
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"		7900000	Nucleoplasm	Cytosol	"HPA041113: , HPA052733: "	"prognostic favourable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	20.6	45.6	18.0	12.9	19.8	6.6	20.0	21.9	18.2	16.6	18.0	11.0	31.6	25.7	14.4	19.1	12.9	14.3	21.5	11.8	17.5	16.1	17.7	11.2	17.3	11.3	18.4	15.9	22.1	26.8	15.1	24.1	9.7	14.4	26.9	6.4	13.8	34.3	41.4	15.2	9.2	24.6	14.6	14.1	20.4	17.5	7.2	14.6	5.1	24.1	11.7	8.8	11.5	17.9	19.3	34.1	15.5	25.6	20.1	24.4	20.0	0.7	11.6	0.2	9.5	2.7	1.4	1.1	6.8	2.0	1.2	0.9	0.0	13.8	0.1	18.9	0.9	9.8	0.6	3.8	0.1	13.5	30.8	0.0	5.4	5.5	5.1	2.3	4.3	6.3	3.4	1.2	0.6	2.4	4.6	1.9	1.1	16.8	0.2	4.5	12.3	9.4	6.4	0.1	18.0	2.0	0.5	13.5	10.4	20.4	15.4	1.6	14.7	5.6	8.5	2.5	9.6	8.1	4.6	4.9	1.5	1.0	3.5	0.4	5.8	4.9	25.6	15.5	17.5	22.9	17.1	19.3	24.4	16.4	22.0	16.3	21.4	16.8	5.3	20.1	24.5	34.1	21.8	20.0	18.0	19.8	21.9	18.2	17.5	16.1	18.4	15.9	14.4	14.6
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270465-151290057	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Cell line enhanced"	"Detected in many"		"NB-4: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 75.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	12.0	14.2	5.0	18.6	7.1	26.4	14.0	1.3	5.8	8.9	15.0	3.4	11.1	13.2	8.6	10.4	16.1	9.8	14.7	8.7	5.9	3.8	13.0	20.4	18.5	26.9	5.1	2.7	14.8	8.4	2.9	6.5	24.6	6.9	13.6	10.5	5.0	9.8	7.9	5.1	7.3	26.0	13.1	7.7	30.2	10.2	5.3	6.4	36.7	14.9	10.2	14.2	10.4	10.3	10.8	17.0	75.1	26.9	14.3	12.5	14.9	10.7	5.3	0.2	0.0	3.0	8.4	10.5	3.1	7.4	15.1	23.0	1.1	24.6	10.5	11.7	4.7	6.1	1.1	2.8	3.9	22.3	0.6	29.5	5.5	0.6	12.9	28.0	8.5	5.4	3.8	9.0	2.0	18.7	14.7	2.6	2.8	8.3	23.4	41.8	6.2	7.9	25.3	0.6	9.0	12.5	9.3	1.5	0.0	6.6	7.2	4.0	1.1	32.0	10.1	2.2	5.0	7.1	4.5	0.4	0.3	0.6	5.2	33.7	2.3	31.6	19.7	21.6	10.8	26.9	12.5	10.8	11.3	10.7	17.0	9.1	9.2	9.4	75.1	14.3	24.4	6.9	9.7	14.9	5.0	7.1	1.3	5.8	5.9	3.8	5.1	2.7	6.9	6.4
NMRK1	"bA235O14.2, C9orf95, FLJ20559, NRK1"	ENSG00000106733	"Nicotinamide riboside kinase 1"	Q9NWW6	9	75060573-75088217	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.6;Karpas-707: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049795	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA049795: "	"unprognostic (1.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.58e-2)"	"prognostic favourable (3.70e-6)"	"unprognostic (3.56e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (5.60e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.64e-2)"	15.5	7.7	11.1	15.9	10.7	6.9	14.3	21.5	14.6	13.2	15.2	5.8	20.1	12.2	8.1	15.6	24.6	9.4	10.9	9.4	10.2	9.7	22.1	40.3	15.4	19.9	10.8	9.7	15.2	30.6	45.8	18.1	19.7	10.2	15.9	10.3	10.9	29.5	17.7	15.0	15.6	26.6	8.3	8.7	18.8	13.6	6.7	8.9	14.4	31.6	11.2	22.0	12.6	14.8	6.7	8.8	7.3	6.7	8.2	24.2	10.1	5.0	1.1	1.5	3.5	12.1	16.3	8.3	7.4	11.7	1.9	3.0	0.0	13.5	3.0	4.5	7.1	8.9	1.6	5.0	6.0	29.6	1.8	2.1	2.4	2.6	10.8	2.0	0.4	11.3	12.7	3.1	6.4	12.9	0.2	36.5	13.1	3.8	1.9	1.8	1.9	4.7	0.6	13.4	19.2	15.2	9.1	1.0	0.2	3.2	3.3	4.1	8.4	2.1	8.9	6.4	1.2	5.9	2.0	16.2	12.9	1.8	10.5	2.2	6.5	7.3	2.7	4.5	13.9	2.5	16.7	6.7	24.2	16.0	3.1	3.9	22.1	16.7	5.2	8.2	6.7	8.8	15.4	10.1	11.1	10.7	21.5	14.6	10.2	9.7	10.8	9.7	10.2	8.9
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	45051610-45109016	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.8	32.6	44.9	28.2	37.3	12.0	26.1	34.5	64.3	23.7	24.4	17.2	22.9	23.4	27.3	29.3	26.6	30.9	17.3	26.8	37.7	29.6	28.8	36.6	26.7	27.2	27.7	43.6	29.3	21.8	41.6	23.7	32.7	38.1	23.7	23.1	18.1	34.9	30.1	75.5	28.8	24.8	30.1	36.6	28.2	23.4	26.1	34.0	20.7	29.4	18.6	30.9	25.1	43.3	10.2	18.2	7.6	9.3	7.4	10.0	3.3	16.9	22.4	19.4	17.1	35.1	22.7	20.4	18.9	25.0	36.8	30.4	25.0	14.6	20.4	27.4	26.0	16.0	33.3	26.5	34.2	51.8	23.2	20.3	15.0	24.7	23.1	26.1	24.5	28.6	24.1	27.4	21.8	24.7	32.2	10.4	20.5	14.5	31.7	17.8	18.1	23.5	21.7	28.9	15.5	29.1	15.7	16.2	14.6	11.9	10.9	17.1	23.6	20.7	19.8	22.5	17.3	18.1	25.1	16.1	22.8	20.4	24.1	14.7	23.8	6.5	8.1	7.6	7.9	9.3	7.2	10.2	7.8	9.3	6.6	7.6	10.0	7.6	5.3	7.4	6.9	18.2	7.5	3.3	44.9	37.3	34.5	64.3	37.7	29.6	27.7	43.6	38.1	34.0
NMT2		ENSG00000152465	"N-myristoyltransferase 2"	O60551	10	15102584-15168693	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 33.5;HMC-1: 28.0;TIME: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 8.7;eosinophil: 7.9;gdT-cell: 7.2;MAIT T-cell: 12.9;memory CD4 T-cell: 11.5;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 9.3;NK-cell: 12.9;T-reg: 17.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.7;NK-cells: 12.9;T-cells: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001303	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA001303: AB_1079494"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	29.3	5.4	18.9	6.5	17.3	3.8	19.2	35.6	25.3	12.0	9.9	6.0	4.7	7.4	14.5	5.0	8.2	8.9	8.1	9.6	12.8	9.2	10.8	18.5	7.2	9.0	8.8	15.0	18.2	7.1	28.5	7.9	5.1	10.3	10.7	10.7	8.3	5.8	9.4	18.8	11.5	11.9	12.5	10.3	10.1	8.8	14.5	9.9	23.7	6.9	4.5	8.9	10.1	20.1	1.9	0.3	8.7	0.5	12.9	17.5	3.9	2.7	3.6	4.1	3.1	11.4	12.3	0.8	6.1	5.0	5.6	7.7	3.5	12.6	0.1	4.3	33.5	3.5	3.7	3.4	9.6	3.7	4.8	7.5	1.7	4.7	7.6	0.5	28.0	10.9	3.6	8.0	2.4	21.8	3.5	0.5	21.0	3.4	5.7	1.4	3.0	3.5	4.3	6.1	0.5	4.2	0.6	1.2	4.8	7.4	1.2	2.0	3.8	2.3	48.6	5.6	8.3	24.8	4.4	4.3	4.5	0.3	6.9	2.0	4.1	8.7	0.3	7.9	7.2	0.4	12.9	1.4	11.5	8.3	0.3	1.9	14.7	9.3	1.2	12.9	0.5	0.2	17.5	3.9	18.9	17.3	35.6	25.3	12.8	9.2	8.8	15.0	10.3	9.9
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313285	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 97.7"	"Cell line enhanced"	"Detected in many"		"HSkMC: 67.4;LHCN-M2: 40.0;RPTEC TERT1: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"			15000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA059180: "	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.02e-6)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	23.7	1.4	0.6	8.8	0.9	0.1	14.6	0.6	1.7	13.1	8.5	0.7	4.9	0.5	15.8	8.7	12.0	8.3	15.3	8.2	1.6	0.0	4.7	97.7	10.0	3.4	1.1	0.6	11.2	2.0	0.6	2.6	8.6	3.3	9.6	3.3	1.6	3.6	6.7	18.3	8.2	4.3	12.4	1.5	5.8	5.1	7.3	0.6	1.3	5.3	2.2	3.1	10.9	35.3	0.6	0.1	0.7	0.2	0.0	0.9	0.0	0.0	4.7	0.0	4.2	24.3	31.6	0.0	6.0	15.9	9.6	19.1	0.0	6.5	0.0	21.4	12.2	0.0	0.0	2.1	9.7	0.0	0.0	0.0	7.4	0.0	33.1	0.0	0.0	67.4	23.3	6.8	10.1	13.2	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.1	0.0	26.8	0.0	103.7	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	9.3	5.5	22.1	8.5	1.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.2	0.0	0.2	0.1	0.9	0.2	0.0	0.2	0.1	0.6	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.9	0.6	1.7	1.6	0.0	1.1	0.6	3.3	0.6
NOB1	"ART-4, MST158, NOB1P, PSMD8BP1"	ENSG00000141101	"NIN1/PSMD8 binding protein 1 homolog"	Q9ULX3	16	69741867-69754940	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041522, HPA049430, HPA067411"	Approved		Approved	"Focal adhesion sites,Cytosol"				Cytosol	"Focal adhesion sites"	"HPA041522: , HPA049430: , HPA067411: "	"unprognostic (5.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.61e-3)"	"unprognostic (9.45e-2)"	"prognostic unfavourable (4.21e-5)"	"prognostic unfavourable (8.16e-4)"	"unprognostic (3.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.16e-1)"	18.2	31.6	9.9	14.5	18.0	17.4	18.9	13.4	16.2	18.8	19.4	12.5	12.4	20.3	21.3	15.5	25.4	29.2	19.0	13.3	9.6	9.7	18.4	23.4	13.3	21.3	12.9	7.5	37.5	68.5	13.9	10.1	13.1	13.5	21.5	12.7	13.0	20.4	14.8	26.3	25.1	15.5	18.0	10.1	21.5	20.5	11.6	15.4	23.7	28.9	25.8	29.0	25.6	18.4	21.0	20.3	2.0	15.0	24.5	26.1	17.3	14.6	32.2	7.6	21.5	16.9	26.7	15.1	11.8	16.5	22.2	20.2	36.4	24.2	32.8	18.4	13.1	21.9	20.8	26.4	13.1	8.2	24.3	12.7	15.2	46.7	30.0	23.5	10.8	33.8	22.5	25.5	32.6	18.6	29.0	10.2	11.0	38.4	29.5	47.2	23.3	19.2	32.8	7.8	41.4	16.4	14.4	19.8	9.8	37.1	13.1	18.4	14.2	21.3	14.1	15.1	13.7	13.7	19.2	16.8	12.8	57.7	15.1	21.5	16.6	0.1	15.0	2.0	17.6	12.7	24.6	19.4	21.4	16.1	20.3	21.0	23.1	21.0	0.7	24.5	9.5	10.5	26.1	17.3	9.9	18.0	13.4	16.2	9.6	9.7	12.9	7.5	13.5	15.4
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015789-139045939	"Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: , HPA053714: "	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavourable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavourable (6.23e-4)"	17.5	3.9	3.3	4.9	8.0	38.7	7.4	3.2	7.3	2.7	3.1	2.7	0.0	2.2	2.8	1.5	4.0	2.5	7.9	5.4	4.9	3.7	6.9	25.8	5.1	3.1	3.0	3.1	1.7	4.4	4.0	4.7	9.3	3.7	2.0	2.8	1.8	10.8	1.4	12.0	3.9	10.5	4.5	2.3	3.2	3.0	4.9	2.6	3.7	2.9	11.8	3.9	3.7	4.6	1.9	1.5	6.3	3.1	1.4	2.4	0.2	4.8	5.6	2.2	4.2	5.0	2.1	13.7	7.2	5.2	10.3	7.4	7.5	2.0	16.0	5.8	5.3	3.5	11.5	6.3	9.7	7.2	4.7	7.4	3.4	6.5	4.6	10.8	4.4	2.4	3.1	11.4	7.8	4.5	13.3	5.3	4.5	5.5	7.4	5.7	7.1	6.0	6.1	6.5	5.6	6.9	3.1	8.3	5.5	4.5	5.2	4.1	3.8	8.4	6.7	5.5	7.2	5.2	8.6	4.3	4.0	10.1	5.1	21.5	7.0	1.5	1.4	0.8	2.4	1.5	1.4	1.1	1.1	1.3	0.6	1.9	0.8	1.6	6.3	1.4	3.1	1.5	0.7	0.2	3.3	8.0	3.2	7.3	4.9	3.7	3.0	3.1	3.7	2.6
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;T-47d: 5.5;THP-1: 6.7;U-266/70: 15.4;U-266/84: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.3;eosinophil: 3.9;intermediate monocyte: 9.1;myeloid DC: 15.5;neutrophil: 6.3;non-classical monocyte: 5.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;granulocytes: 6.3;monocytes: 15.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	2.6	0.6	0.9	6.2	0.5	13.2	1.7	0.5	1.5	5.7	1.0	0.7	0.9	1.5	1.8	2.6	12.6	1.1	3.7	3.2	1.2	0.5	0.8	1.9	7.6	8.0	1.6	0.0	1.4	0.4	0.0	1.0	2.6	1.4	1.8	1.0	1.2	5.5	0.4	1.4	14.2	1.3	1.9	3.2	4.7	1.4	2.2	0.9	1.0	0.9	12.1	8.3	4.0	10.6	0.0	15.5	6.3	15.3	1.9	1.0	6.8	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	11.6	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	1.4	0.0	5.5	6.7	0.0	0.0	0.0	0.0	0.0	15.4	6.6	0.0	0.2	0.1	0.0	2.0	15.3	3.9	0.2	9.1	0.5	0.0	1.0	0.9	15.5	0.0	0.1	0.3	6.3	1.9	5.8	0.6	0.6	6.8	0.9	0.5	0.5	1.5	1.2	0.5	1.6	0.0	1.4	0.9
NOL3	"ARC, CARD2, MYP, NOP30"	ENSG00000140939	"Nucleolar protein 3"	O60936	16	67170154-67175735	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009208	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009208: AB_634091"	"unprognostic (2.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (6.43e-5)"	"unprognostic (5.74e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (1.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.48e-2)"	16.3	22.6	13.0	3.2	19.6	1.3	9.4	7.3	14.1	8.4	7.1	10.8	19.7	5.3	7.5	10.5	15.4	7.8	15.7	29.1	11.1	8.3	10.1	12.8	10.1	2.6	15.9	12.3	6.8	12.3	22.8	14.8	8.6	12.7	19.8	6.1	13.8	18.0	13.3	76.1	39.7	5.2	10.6	11.6	3.7	11.1	2.7	15.8	0.6	9.6	27.7	6.3	9.4	9.2	0.0	2.1	1.5	6.8	0.7	3.4	2.5	6.1	10.1	1.7	9.5	8.5	6.5	9.5	5.0	5.3	5.4	3.2	2.1	16.3	0.1	16.6	5.8	10.3	2.3	7.7	1.3	5.5	3.5	0.2	8.0	3.2	5.3	0.5	1.2	3.9	14.4	4.3	3.0	2.3	2.2	6.6	10.2	16.1	0.1	0.8	1.6	24.9	5.5	3.5	12.3	9.2	1.9	13.5	7.2	21.0	15.2	2.2	32.5	1.7	5.2	7.2	6.2	7.0	4.3	9.6	3.0	1.7	20.4	1.5	2.4	0.0	6.8	0.0	0.3	0.6	0.1	0.0	3.4	0.3	2.1	0.0	0.0	0.5	1.5	0.7	0.2	2.1	0.0	2.5	13.0	19.6	7.3	14.1	11.1	8.3	15.9	12.3	12.7	15.8
NOP9	C14orf21	ENSG00000196943	"NOP9 nucleolar protein"	Q86U38	14	24299862-24309124	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000850			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA000850: AB_1078287"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"prognostic favourable (9.39e-6)"	"unprognostic (7.03e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	12.0	12.9	11.3	11.4	11.4	14.4	10.0	13.3	17.5	11.3	14.4	16.8	9.6	16.5	11.1	10.1	16.6	10.3	13.8	19.4	10.9	10.6	9.7	14.2	9.5	15.1	13.7	10.0	13.3	13.3	20.1	8.9	11.6	10.9	10.8	12.3	13.0	12.5	11.5	29.7	13.5	12.4	12.3	12.3	18.8	10.9	13.0	10.7	11.8	11.2	18.3	14.9	12.1	9.4	1.6	2.1	1.8	5.2	0.4	1.6	1.4	5.1	10.2	8.3	10.4	7.2	6.2	8.3	9.1	6.8	10.8	8.5	7.6	9.0	13.1	5.2	8.3	13.3	16.4	11.3	11.3	8.3	6.2	9.6	14.1	17.5	5.8	22.0	11.0	6.2	8.9	7.9	7.4	10.0	8.1	6.5	7.5	8.8	10.1	8.3	3.7	13.1	12.8	5.0	8.4	6.6	11.7	8.4	6.4	12.8	15.0	2.8	6.3	5.8	10.2	7.3	6.0	6.0	8.6	9.2	8.1	9.9	4.0	10.1	5.7	1.4	2.3	1.8	1.5	2.4	1.6	1.2	1.4	0.7	2.1	1.6	1.0	1.0	0.5	0.4	5.2	1.1	1.2	1.4	11.3	11.4	13.3	17.5	10.9	10.6	13.7	10.0	10.9	10.7
NOSTRIN	MGC20702	ENSG00000163072	"Nitric oxide synthase trafficking"	Q8IVI9	2	168786539-168865514	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 51.2"	"Group enriched"	"Detected in some"	4	"BEWO: 6.8;HEL: 26.1;K-562: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044384, HPA076885"	Approved		Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA044384: , HPA076885: "	"unprognostic (4.74e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.02e-6)"	"unprognostic (4.89e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.98e-2)"	27.1	11.6	4.4	7.6	5.6	0.2	17.4	2.7	6.0	20.5	11.0	2.3	10.3	10.4	11.9	12.1	7.8	9.0	20.5	9.8	4.8	4.1	27.9	7.8	19.6	3.5	5.8	3.7	11.2	14.8	2.3	4.2	18.5	7.9	9.4	12.5	2.8	51.2	13.6	7.6	4.2	22.3	9.7	5.1	5.6	16.5	11.2	3.9	0.7	8.5	8.6	2.6	7.6	12.8	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.5	0.0	0.0	0.0	6.8	0.2	0.0	0.0	0.0	4.0	4.3	0.0	2.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	26.1	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	2.2	0.9	0.0	0.1	0.1	1.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	4.4	5.6	2.7	6.0	4.8	4.1	5.8	3.7	7.9	3.9
NOTCH3	"CADASIL, CASIL"	ENSG00000074181	"Notch 3"	Q9UM47	19	15159038-15200981	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 27.9;MCF7: 27.4;U-87 MG: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005393, HPA044392"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"			18000000	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB005393: AB_2151246, HPA044392: "	"unprognostic (4.97e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (5.92e-4)"	"unprognostic (9.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (2.53e-7)"	"unprognostic (3.35e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-3)"	35.9	3.7	4.7	6.4	6.4	0.5	53.7	2.7	7.5	25.9	7.3	6.2	9.2	3.7	22.9	23.1	33.8	14.6	22.7	25.0	4.6	3.6	9.2	1.6	16.2	11.7	5.0	6.4	14.1	6.9	10.1	4.9	37.3	6.4	13.4	3.0	8.3	11.4	11.4	16.6	48.3	6.2	11.0	2.8	11.8	5.5	10.1	3.9	44.4	14.9	36.7	10.3	14.9	24.6	0.1	2.4	1.0	0.1	0.1	0.1	0.0	5.2	3.3	27.9	12.7	3.9	3.2	12.6	4.2	0.2	0.2	0.1	6.3	5.5	0.1	3.3	7.7	6.2	5.0	0.1	0.2	0.0	1.3	0.1	5.2	1.4	1.9	0.0	0.5	3.6	3.1	6.5	0.7	0.3	0.2	0.2	0.5	27.4	6.3	0.0	16.3	0.0	0.0	1.6	0.1	0.0	16.9	0.8	9.0	0.0	15.9	0.0	16.9	0.0	0.0	0.8	9.1	0.1	0.1	0.0	0.3	0.0	19.5	0.1	0.4	1.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	2.4	0.0	0.0	4.7	6.4	2.7	7.5	4.6	3.6	5.0	6.4	6.4	3.9
NPDC1	"CAB-, CAB1, DKFZp586J0523"	ENSG00000107281	"Neural proliferation, differentiation and control 1"	Q9NQX5	9	137039470-137046203	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4"	"Lineage enriched"	"Detected in many"	7	"T-cells: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008189	Approved		Approved	Nucleoplasm,Cytosol			180000	Nucleoplasm	Cytosol	"HPA008189: AB_1854584"	"unprognostic (6.94e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (2.01e-5)"	"prognostic favourable (6.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.84e-2)"	35.4	21.7	33.1	11.9	35.5	4.1	21.6	59.7	65.6	27.8	27.1	18.4	23.8	22.2	26.7	10.8	11.6	25.4	32.3	20.4	34.5	35.3	12.7	5.9	18.9	11.5	25.1	49.0	12.0	28.6	17.2	47.7	20.1	29.5	73.1	13.3	10.6	58.0	35.5	19.0	17.7	23.0	16.4	30.3	32.4	59.6	10.4	14.5	0.8	11.5	8.6	7.2	12.8	20.2	0.1	2.0	0.5	0.4	0.1	13.6	2.6	9.4	11.4	2.8	18.4	6.6	6.7	0.7	20.4	6.4	4.6	1.8	4.6	5.2	9.4	15.5	7.8	35.6	2.4	5.5	0.5	7.6	11.6	3.8	29.2	3.3	9.5	3.3	0.0	4.7	8.6	2.5	5.0	11.8	0.2	0.2	0.9	35.9	0.2	0.3	6.1	19.0	5.6	0.0	36.0	7.7	6.1	22.7	15.7	5.4	18.2	12.2	39.3	4.7	20.2	3.4	6.2	24.2	6.2	0.0	0.1	0.3	5.0	0.3	2.9	0.0	0.4	0.5	8.4	0.0	10.7	0.1	13.2	13.6	0.7	0.0	0.3	2.3	0.0	0.1	0.0	2.0	10.4	2.6	33.1	35.5	59.7	65.6	34.5	35.3	25.1	49.0	29.5	14.5
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47623276	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol			2100000	Cytosol		"HPA021453: , HPA045649: "	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favourable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	16.0	26.0	27.2	15.9	27.7	11.1	56.1	36.5	33.8	17.1	17.7	9.8	14.6	14.6	16.9	17.1	47.7	17.2	16.3	22.2	24.0	15.6	18.8	11.1	30.3	24.1	16.0	29.7	20.8	16.8	21.2	15.3	17.6	27.2	18.6	20.0	13.3	21.8	16.5	52.3	29.6	17.3	20.4	22.8	15.7	16.2	15.3	16.1	7.0	14.5	14.8	18.1	19.0	30.5	6.9	9.0	23.2	8.6	9.3	9.2	5.4	32.6	21.5	21.7	15.2	25.1	25.3	45.8	14.4	18.7	21.9	21.3	13.8	37.6	19.5	22.4	21.0	19.9	23.8	13.3	34.1	8.7	20.6	23.5	22.2	16.1	14.5	13.2	15.2	19.3	13.1	15.9	8.3	22.5	19.8	11.4	31.0	8.8	17.5	11.8	13.3	19.6	14.2	30.5	17.2	27.3	24.0	17.4	15.0	18.6	10.8	12.8	80.9	9.2	28.7	14.6	10.5	21.8	10.1	23.3	22.4	11.9	20.7	7.0	9.6	10.2	8.6	10.7	9.1	6.6	9.2	6.8	7.3	8.5	8.7	6.9	6.5	7.6	23.2	9.3	6.8	9.0	8.4	5.4	27.2	27.7	36.5	33.8	24.0	15.6	16.0	29.7	27.2	16.1
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: "	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	5.6	4.7	7.3	4.7	11.2	7.2	4.9	6.3	12.0	5.4	3.5	4.9	8.9	4.4	5.2	11.9	3.7	17.4	5.7	3.7	6.6	3.9	4.5	2.5	6.7	4.6	2.8	6.4	7.0	4.9	7.1	17.8	3.7	5.4	4.5	2.9	8.3	4.1	5.7	3.7	9.6	4.5	5.3	3.5	4.6	4.3	11.4	3.7	5.8	14.9	3.7	2.6	4.3	4.5	0.5	0.4	2.6	1.0	0.5	0.8	0.4	7.5	4.2	5.6	4.4	5.1	7.4	4.4	4.0	4.1	5.6	4.4	4.0	6.7	4.0	10.0	4.5	7.1	2.8	6.8	2.8	4.9	6.4	3.3	7.7	3.6	3.5	6.6	5.2	5.9	3.4	6.6	4.2	3.9	6.1	4.3	2.5	5.6	8.0	6.6	0.9	4.5	6.9	3.6	6.5	2.5	1.0	17.9	5.5	6.2	4.6	6.6	6.1	7.2	3.5	8.1	3.4	13.3	4.8	5.2	6.8	4.0	3.4	8.3	2.1	2.6	1.0	0.0	0.5	0.2	0.8	0.3	0.5	0.0	0.4	0.5	0.4	0.0	1.4	0.5	0.8	0.3	0.2	0.4	7.3	11.2	6.3	12.0	6.6	3.9	2.8	6.4	5.4	3.7
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	21.7	23.0	15.3	18.7	16.1	22.0	15.4	14.7	24.1	13.2	15.9	18.6	14.2	14.7	18.9	16.3	25.1	14.7	14.4	35.4	16.2	13.5	20.2	28.2	18.4	18.3	16.4	15.5	13.9	18.2	17.8	17.1	25.6	17.2	16.7	13.3	21.0	16.4	14.9	89.8	24.2	16.4	19.4	14.9	22.0	17.6	31.0	13.4	19.7	14.7	17.1	20.6	15.7	16.6	4.6	5.9	5.7	18.1	2.5	4.6	7.8	28.6	37.8	15.1	23.5	18.7	15.6	18.8	23.8	26.6	39.6	36.8	28.7	26.0	21.3	19.1	27.8	23.3	14.8	20.0	34.5	13.4	19.6	24.7	30.7	25.4	17.9	26.0	31.6	15.3	19.4	36.9	13.2	40.4	26.0	32.5	23.9	18.6	35.0	14.1	17.7	23.9	23.1	24.3	17.4	14.2	27.8	20.3	23.4	29.9	41.8	27.0	32.7	19.2	28.9	52.1	36.2	28.3	38.2	24.8	17.5	26.3	41.5	17.5	33.4	3.0	18.1	3.9	4.6	4.6	2.8	4.6	3.2	3.6	5.9	3.7	2.9	3.8	5.7	2.5	2.8	4.6	3.0	7.8	15.3	16.1	14.7	24.1	16.2	13.5	16.4	15.5	17.2	13.4
NPM3		ENSG00000107833	"Nucleophosmin/nucleoplasmin 3"	O75607	10	101781325-101783413	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036295, HPA036296"	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"				"Nucleoli, Actin filaments, Cytosol"		"HPA036295: AB_10671244, HPA036296: AB_10672083"	"unprognostic (3.41e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (1.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.58e-2)"	9.8	17.0	14.3	20.9	8.5	17.2	14.3	1.5	16.8	13.3	12.3	2.4	6.2	6.0	15.7	15.0	22.7	11.7	12.4	8.9	9.9	7.3	13.6	13.7	8.8	26.3	7.3	11.4	17.7	39.0	11.3	11.1	12.0	9.1	11.5	15.1	3.7	13.2	7.1	11.7	14.0	8.7	15.0	4.8	14.7	11.0	16.4	7.7	18.5	9.8	23.7	18.8	13.0	13.9	4.5	8.3	0.1	3.7	7.0	10.4	5.7	17.1	21.8	6.5	42.7	14.9	15.7	6.9	9.3	14.2	14.5	12.4	23.4	22.0	28.5	17.4	10.3	18.5	36.2	39.5	11.4	12.0	37.6	22.8	10.2	37.4	16.8	51.9	16.7	13.6	19.2	20.0	80.4	18.9	28.1	15.8	11.9	31.7	21.6	67.6	11.5	16.8	17.0	34.2	28.9	14.1	8.5	13.4	8.6	5.8	13.7	25.9	17.8	10.8	7.4	5.7	18.4	8.5	17.2	6.8	7.1	32.7	8.0	48.3	5.9	0.0	2.7	0.0	3.8	3.7	7.0	4.3	6.3	7.2	6.3	4.5	10.4	10.4	0.1	7.0	0.8	8.3	2.6	5.7	14.3	8.5	1.5	16.8	9.9	7.3	7.3	11.4	9.1	7.7
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 125.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.9;HeLa: 16.8;Hep G2: 13.5;MCF7: 12.0;RPTEC TERT1: 19.6;T-47d: 26.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"			"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: "	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favourable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	5.4	1.6	3.4	2.4	4.4	0.0	8.3	0.7	2.5	13.3	11.0	1.9	4.2	16.4	8.7	11.4	5.7	5.9	19.0	2.5	2.5	2.7	22.7	1.3	34.9	0.9	7.5	2.4	4.1	11.6	0.0	14.6	3.0	2.2	26.3	7.6	16.9	2.8	5.7	2.6	2.1	37.7	4.0	0.9	4.4	4.0	3.0	2.8	3.4	125.3	3.7	2.3	3.7	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	14.9	0.1	0.0	0.0	0.0	7.4	9.7	0.1	0.4	0.1	0.9	3.7	0.0	0.0	0.0	3.8	0.3	16.8	13.5	0.0	0.0	0.1	1.6	1.3	0.0	0.0	0.0	0.0	0.2	0.0	12.0	0.2	0.7	0.1	6.0	0.0	0.0	0.1	19.6	0.8	0.8	0.3	0.9	7.2	0.0	26.3	0.6	0.0	0.3	0.2	0.2	0.5	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	0.7	2.5	2.5	2.7	7.5	2.4	2.2	2.8
NPR3	"ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC"	ENSG00000113389	"Natriuretic peptide receptor 3"	P17342	5	32689070-32791724	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 17.0;fHDF/TERT166: 10.3;HeLa: 36.7;HSkMC: 23.8;U-138 MG: 10.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 19.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA052702	Supported		Approved	Cytosol				Cytosol		"HPA052702: "	"unprognostic (8.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.46e-3)"	"prognostic favourable (5.43e-6)"	"unprognostic (6.00e-4)"	"unprognostic (5.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.38e-2)"	26.9	3.5	0.4	0.4	1.5	1.9	2.7	0.2	0.8	4.5	5.3	0.3	1.4	0.3	4.2	3.3	6.8	2.5	3.9	16.4	0.4	0.5	54.2	7.6	24.2	0.5	0.2	0.8	1.9	0.7	0.3	0.7	5.3	3.1	8.8	0.5	7.3	1.2	18.1	9.5	3.7	1.4	1.8	0.3	4.5	1.0	1.5	0.0	1.1	11.0	13.4	1.4	5.5	4.5	1.4	0.9	7.3	0.6	1.1	1.1	0.2	0.1	1.9	0.1	0.1	1.1	17.0	0.0	4.5	0.8	0.2	0.2	0.0	0.1	0.0	0.1	10.3	0.0	2.2	0.0	0.5	0.0	0.0	0.2	36.7	0.0	3.4	0.0	0.1	23.8	0.2	1.2	3.2	0.1	0.0	0.3	1.5	0.3	0.0	0.2	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	6.1	0.0	0.1	0.0	0.1	10.1	0.1	0.8	0.1	0.1	0.0	0.0	1.6	0.0	0.1	0.3	0.6	0.4	0.8	0.3	0.5	0.9	0.7	0.5	0.0	1.4	0.9	1.1	7.3	1.1	0.1	0.9	0.4	0.2	0.4	1.5	0.2	0.8	0.4	0.5	0.2	0.8	3.1	0.0
NPRL2	"NPR2, NPR2L, TUSC4"	ENSG00000114388	"NPR2 like, GATOR1 complex subunit"	Q8WTW4	3	50347330-50351091	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038196, HPA038197"	Approved		Supported	Cytosol				Cytosol		"HPA038196: AB_10675631, HPA038197: AB_10671523"	"unprognostic (7.25e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.06e-3)"	"prognostic favourable (1.59e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.06e-2)"	7.4	14.6	14.9	8.7	14.9	7.5	11.5	20.9	18.2	14.7	12.5	8.8	12.8	7.6	9.7	16.3	10.1	14.4	11.3	13.8	12.0	15.2	14.0	18.6	9.0	9.8	15.1	14.4	13.4	30.9	16.6	15.8	8.4	13.5	13.2	12.4	7.4	16.0	13.6	18.3	9.3	8.9	11.7	10.2	11.7	11.1	11.9	16.5	10.5	13.1	9.1	11.6	10.4	8.9	11.1	9.2	20.2	8.9	23.6	29.7	19.6	7.3	7.1	3.7	8.1	14.3	8.0	4.7	3.0	10.4	11.1	11.3	4.7	6.1	7.2	5.8	6.9	3.5	9.8	12.0	7.7	5.8	7.4	7.4	6.3	10.1	13.1	10.2	11.5	8.4	11.8	13.3	9.8	10.7	5.6	7.4	9.4	1.1	10.7	5.7	5.0	18.5	4.3	3.2	20.3	12.7	6.4	3.2	8.1	3.3	6.6	7.7	10.7	6.1	3.4	4.5	4.9	7.7	6.6	10.7	13.3	5.9	8.7	11.9	4.0	13.6	7.7	20.2	29.7	7.9	26.4	11.1	16.9	25.6	9.2	9.6	13.7	21.2	9.6	23.6	8.9	6.8	19.4	19.6	14.9	14.9	20.9	18.2	12.0	15.2	15.1	14.4	13.5	16.5
NPRL3	"C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11"	ENSG00000103148	"NPR3 like, GATOR1 complex subunit"	Q12980	16	84271-138860	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011741	Uncertain		Approved	Cytosol				Cytosol		"HPA011741: AB_1845577"	"unprognostic (1.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.50e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	11.0	16.8	17.1	10.0	17.1	16.5	9.6	20.5	18.9	11.4	7.4	11.8	9.2	6.9	12.3	6.8	10.0	15.1	6.7	9.8	15.9	6.8	8.4	10.3	8.1	7.9	12.6	20.2	16.1	11.9	21.7	14.9	6.8	13.0	7.5	5.9	8.6	11.3	9.8	22.6	8.2	8.3	8.9	10.4	9.5	9.4	15.7	13.7	5.7	13.2	6.5	7.6	12.5	9.1	4.8	5.5	1.4	5.5	3.4	6.5	3.2	7.0	14.5	6.9	14.0	19.2	10.2	10.8	7.6	9.7	12.6	9.5	22.4	13.0	14.1	12.1	14.2	7.8	11.8	16.9	7.5	13.7	7.5	19.8	7.9	16.7	18.9	8.1	10.8	12.5	13.2	16.4	14.8	11.6	20.3	13.3	11.3	24.5	8.4	4.6	5.0	9.9	13.2	5.6	20.2	12.2	6.4	15.1	8.1	11.8	13.9	6.6	11.1	3.6	9.1	15.9	9.0	9.6	6.2	14.8	7.5	19.7	0.5	8.1	7.2	0.1	4.1	1.4	6.0	3.6	6.5	4.2	4.9	4.9	5.3	4.8	5.6	6.4	1.2	3.4	5.5	5.5	5.1	3.2	17.1	17.1	20.5	18.9	15.9	6.8	12.6	20.2	13.0	13.7
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38843982	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 73.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.8;SiHa: 11.0;U-87 MG: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		280000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favourable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.3	3.8	39.1	1.8	17.5	0.8	1.9	16.2	73.6	5.8	2.6	4.3	0.5	1.5	5.6	3.3	2.7	6.1	2.0	10.5	57.4	15.2	1.3	0.8	1.7	1.6	5.6	20.7	6.2	3.6	5.9	2.0	0.9	4.5	6.2	1.7	1.0	3.2	5.6	0.9	1.2	1.4	5.7	3.3	2.1	2.0	1.6	4.0	0.0	2.5	0.0	1.6	2.5	1.9	0.3	0.2	0.6	0.2	0.6	2.3	0.4	0.4	2.9	0.1	0.8	5.9	0.6	0.0	1.9	0.4	3.8	1.3	2.9	0.6	0.0	3.4	0.5	0.4	0.8	0.1	1.2	0.2	1.0	0.0	0.1	4.4	0.6	0.0	0.1	1.9	0.1	3.4	0.0	0.1	3.5	0.1	0.1	4.4	0.0	0.2	3.5	1.0	0.7	0.0	6.9	0.9	7.9	14.8	0.9	11.0	0.0	0.3	4.7	1.1	0.2	6.8	4.2	0.0	0.3	1.0	0.0	0.0	42.5	8.6	3.5	0.5	0.2	0.1	1.8	0.0	1.3	0.1	1.0	2.3	0.0	0.3	1.5	1.2	0.6	0.6	0.1	0.2	0.0	0.4	39.1	17.5	16.2	49.0	57.4	15.2	5.6	20.7	4.5	4.0
NPY1R	NPYR	ENSG00000164128	"Neuropeptide Y receptor Y1"	P25929	4	163323961-163344832	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.2"	"Cell line enriched"	"Detected in some"	18	"HEL: 50.2"	"Cancer enriched"	"Detected in many"	13	"breast cancer: 65.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029903			Approved	Nucleoplasm,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoplasm	"HPA029903: AB_10601276"	"prognostic favourable (7.68e-5)"	"unprognostic (9.14e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.21e-1)"	18.0	15.9	5.2	1.5	17.1	0.2	17.5	0.9	11.4	6.2	3.1	0.7	3.9	0.7	5.0	5.4	2.3	4.3	2.4	2.6	7.1	4.2	16.6	8.3	1.2	7.2	1.5	5.8	1.8	14.5	1.1	3.9	2.7	3.5	1.9	2.4	2.0	11.0	4.5	1.5	5.0	0.9	3.1	3.7	55.2	1.2	2.7	6.0	0.0	4.4	1.4	0.6	3.4	3.3	0.5	0.3	1.2	0.4	0.3	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.9	0.7	0.4	1.2	0.5	0.1	0.6	0.4	0.7	0.9	0.0	0.5	0.7	1.2	1.1	0.3	0.2	0.3	0.3	0.0	5.2	17.1	0.9	11.4	7.1	4.2	1.5	5.8	3.5	6.0
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726951	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 142.1"	"Cell line enhanced"	"Detected in many"		"A549: 162.9;Hep G2: 143.8;SiHa: 185.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Enhanced	Cytosol			310000	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	31.3	24.2	12.8	6.4	20.7	0.6	77.1	2.7	9.1	7.6	23.2	7.8	5.7	29.5	3.9	8.6	36.3	8.2	77.2	9.3	9.9	7.5	44.7	1.2	17.2	6.9	11.3	6.0	3.7	2.5	7.0	3.7	3.5	25.5	9.8	20.8	20.2	10.5	7.6	7.6	2.3	17.7	22.7	10.4	6.0	142.1	3.8	4.9	0.1	25.7	69.7	16.2	21.2	18.9	5.2	3.2	0.9	3.2	15.1	12.3	4.4	14.3	162.9	13.7	61.0	34.1	49.4	5.1	24.3	43.7	25.1	38.8	19.8	93.0	0.4	28.9	125.7	15.0	5.3	27.4	12.9	5.8	0.2	0.7	40.4	143.8	45.2	3.4	11.7	11.6	17.4	43.5	5.0	62.2	5.9	1.0	134.1	46.5	0.6	6.3	7.2	15.9	1.1	2.9	6.6	50.0	52.2	4.9	1.1	185.1	26.3	108.3	42.5	11.4	42.1	25.3	10.5	9.4	19.1	0.8	3.2	0.6	32.4	1.8	125.1	0.6	3.2	0.2	5.7	0.3	2.9	5.2	6.6	7.2	3.2	2.1	2.1	4.7	0.9	15.1	0.3	1.2	12.3	4.4	12.8	20.7	2.7	9.1	9.9	7.5	11.3	6.0	25.5	4.9
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3028869	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol			6500000	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavourable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	24.7	45.6	18.2	11.0	17.6	27.2	21.9	44.3	28.1	12.9	11.5	8.9	8.8	15.6	10.4	15.4	12.1	11.2	12.8	38.2	16.0	13.3	82.9	47.0	11.7	17.5	17.0	23.5	13.5	18.4	12.1	9.3	12.1	24.5	12.7	9.0	18.0	24.5	13.5	41.3	20.2	15.5	10.7	11.8	15.3	12.8	7.7	12.5	7.0	11.9	13.9	7.9	10.4	11.0	3.2	16.6	62.1	25.2	7.3	9.3	13.1	12.6	21.4	13.0	28.7	23.1	13.7	14.0	12.3	15.8	11.3	12.8	22.5	4.8	11.1	44.9	21.1	9.7	13.4	8.5	8.9	25.8	11.4	6.8	26.3	22.5	18.8	6.8	21.8	8.4	10.2	13.8	12.8	11.0	38.9	6.6	9.4	28.1	7.8	12.7	17.7	17.8	14.6	15.6	32.4	17.1	6.8	2.8	5.1	18.6	8.0	39.0	10.9	4.7	19.0	10.7	4.2	14.3	5.3	14.5	32.8	3.4	12.6	20.8	21.1	5.6	25.2	13.5	9.2	15.7	6.6	3.2	8.3	8.3	16.6	2.1	5.0	5.7	62.1	7.3	13.9	1.7	9.3	13.1	18.2	17.6	44.3	28.1	16.0	13.3	17.0	23.5	24.5	12.5
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073703	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"				Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: , HPA035041: , HPA067767: "	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favourable (5.62e-5)"	11.6	15.8	15.9	11.8	14.7	15.5	12.4	38.3	23.9	12.5	11.2	12.5	12.9	11.2	17.6	20.2	8.3	15.5	11.1	14.8	14.6	9.3	10.3	14.0	14.2	9.9	11.7	15.2	16.3	12.5	16.4	15.4	11.2	13.7	10.7	12.7	14.6	8.0	17.4	19.6	11.0	11.2	15.7	14.2	14.3	10.5	22.2	14.9	12.3	18.0	9.0	10.2	12.3	10.7	4.5	6.2	3.5	4.2	3.5	9.0	3.9	8.0	10.0	15.9	7.4	3.7	6.6	22.6	7.9	5.7	7.9	7.4	8.8	4.5	9.7	2.8	5.2	8.6	7.8	6.1	6.0	4.2	16.6	11.8	8.0	10.5	8.4	7.9	5.2	7.6	5.0	5.4	6.7	8.4	9.0	3.8	9.2	5.3	8.5	18.3	10.7	17.5	8.2	11.1	5.8	8.8	9.3	8.2	6.5	12.6	5.4	5.8	9.5	5.0	7.9	6.4	6.3	7.8	4.4	5.6	9.1	9.4	1.6	9.2	3.0	0.5	4.1	3.5	7.1	4.2	9.0	3.7	5.7	6.0	6.2	4.5	7.2	5.0	2.6	3.5	3.7	6.2	3.7	3.9	15.9	14.7	38.3	23.9	14.6	9.3	11.7	15.2	13.7	14.9
NR2F1	"COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1"	ENSG00000175745	"Nuclear receptor subfamily 2 group F member 1"	P10589	5	93583224-93594615	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 57.8;AN3-CA: 22.9;HHSteC: 44.5;PC-3: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019281, HPA058974"			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB019281: , HPA058974: "	"unprognostic (8.07e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.75e-1)"	"unprognostic (7.68e-3)"	"unprognostic (3.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.24e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.28e-2)"	"prognostic unfavourable (1.47e-4)"	15.8	22.9	22.5	5.0	13.7	1.2	9.1	27.4	25.1	31.7	4.6	12.9	10.8	3.3	20.6	24.1	9.4	32.3	30.7	7.2	20.9	13.7	16.4	10.6	18.0	12.7	13.4	23.0	40.4	4.4	1.8	10.3	46.0	14.6	20.5	3.8	44.4	7.2	38.9	1.2	1.6	4.4	14.2	26.7	6.7	12.9	5.9	11.4	0.0	7.5	4.8	4.2	20.9	18.0	0.0	0.0	0.5	0.1	0.2	0.0	0.0	4.7	2.3	57.8	22.9	12.3	3.8	2.7	2.8	1.1	1.7	1.8	0.3	0.8	0.0	0.1	1.1	1.2	1.4	0.0	0.7	5.8	11.1	2.2	14.0	3.5	44.5	0.4	0.2	17.7	0.0	0.8	0.3	6.4	0.0	0.0	5.2	0.0	0.0	0.6	0.0	47.8	0.6	0.4	0.0	0.3	0.2	5.9	12.1	1.2	0.0	0.1	0.4	0.9	6.4	9.8	0.4	5.1	7.0	0.0	0.0	0.0	16.1	0.2	4.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	22.5	13.7	27.4	19.8	20.9	13.7	13.4	23.0	14.6	11.4
NR2F2	"ARP1, COUP-TFII, COUPTFB, NF-E3, SVP40, TFCOUP2"	ENSG00000185551	"Nuclear receptor subfamily 2 group F member 2"	P24468	15	96325938-96340263	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058974			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA058974: "	"unprognostic (9.28e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.28e-2)"	30.8	15.0	19.6	13.8	5.3	0.2	81.2	3.7	6.2	85.7	21.9	2.9	22.3	7.0	70.0	32.6	27.7	32.4	50.8	30.1	12.5	8.4	39.8	15.0	25.0	35.4	7.8	3.4	105.1	7.3	12.3	9.6	24.0	7.1	28.6	9.0	30.5	7.7	43.5	18.4	8.3	10.8	27.2	9.8	63.4	26.9	32.5	4.8	1.1	18.5	16.2	7.0	32.6	34.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	31.1	8.0	26.5	16.4	53.8	18.6	8.8	22.6	17.4	23.5	20.2	27.7	31.9	0.0	18.5	11.3	18.7	4.6	16.2	29.7	0.1	18.1	10.1	10.4	5.0	15.0	7.7	3.8	13.2	5.6	19.5	4.2	43.2	26.8	0.0	14.8	21.5	0.0	5.5	0.2	11.0	0.0	6.5	0.0	51.4	34.1	3.3	0.0	2.5	0.7	3.4	12.8	0.5	44.4	25.6	8.4	5.9	7.9	0.0	0.0	0.0	14.3	3.8	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	5.3	3.7	6.2	12.5	8.4	7.8	3.4	7.1	4.8
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavourable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	27.7	8.6	13.5	26.1	14.9	29.6	23.5	30.1	19.2	14.9	14.2	17.0	10.5	13.0	14.7	12.9	18.2	13.7	14.7	17.4	13.4	14.1	13.5	27.3	22.0	16.1	18.3	12.8	15.5	12.5	21.9	18.9	31.9	13.6	14.3	10.3	14.2	12.0	15.2	40.4	18.3	14.8	16.8	17.2	17.5	13.4	7.3	18.2	37.1	18.0	15.1	18.2	14.8	32.2	11.1	13.6	33.7	11.8	10.9	9.6	7.3	10.0	20.5	1.5	0.0	13.5	15.1	1.8	15.8	18.9	13.6	15.8	1.5	13.5	8.9	7.2	23.1	9.6	0.1	12.4	16.9	5.0	7.0	2.3	27.8	4.4	12.7	9.2	7.1	10.9	16.1	22.4	21.9	5.1	3.3	34.0	12.0	3.6	5.4	6.6	4.1	4.3	1.9	14.3	18.9	4.0	0.7	2.7	2.1	27.6	4.0	6.6	1.8	13.3	12.1	33.2	6.6	15.8	11.9	6.9	6.2	14.0	17.4	9.5	11.5	25.4	9.8	17.9	9.3	11.8	7.7	7.6	9.6	8.9	13.6	11.1	9.2	8.9	33.7	10.9	10.5	12.4	5.8	7.3	13.5	14.9	30.1	19.2	13.4	14.1	18.3	12.8	13.6	18.2
NR4A1	"GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3"	ENSG00000123358	"Nuclear receptor subfamily 4 group A member 1"	P22736	12	52022832-52059507	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 25.3;MCF7: 28.8;SK-BR-3: 27.3;SK-MEL-30: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 18.2;non-classical monocyte: 24.4"	"Lineage enriched"	"Detected in many"	13	"monocytes: 24.4"	"Group enriched"	"Detected in many"	5	"amygdala: 35.3;basal ganglia: 43.1;cerebral cortex: 77.4;hippocampal formation: 65.3;olfactory region: 79.3"	"Low region specificity"	"Detected in all"			"HPA059742, HPA070142"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA059742: AB_2684119, HPA070142: "	"unprognostic (2.40e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (6.99e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-2)"	"unprognostic (8.89e-3)"	69.1	111.3	4.0	58.1	12.9	5.7	25.0	5.4	10.9	32.3	23.3	21.1	46.0	5.6	49.8	33.9	28.1	63.3	99.9	76.7	4.8	5.0	17.9	12.1	50.1	8.3	7.5	5.9	177.3	16.1	28.9	51.8	7.6	13.1	88.3	13.8	43.7	66.8	203.2	32.3	23.4	24.3	98.4	6.8	5.1	32.8	11.8	6.4	11.9	34.7	35.8	14.9	71.4	54.5	0.4	1.8	0.2	24.4	0.1	0.2	0.7	1.8	9.5	1.8	3.4	1.3	0.4	7.2	1.8	3.6	1.4	2.0	9.3	1.8	2.0	0.8	3.2	1.0	5.6	0.8	0.8	0.1	2.0	2.6	25.3	2.6	1.4	1.0	8.9	0.3	1.1	1.4	0.1	0.4	2.5	0.4	0.1	28.8	0.7	2.7	5.2	1.0	0.8	0.3	4.7	0.0	0.7	1.5	4.7	5.9	27.3	47.6	1.7	3.0	0.0	1.4	4.6	0.9	1.5	16.1	7.6	4.1	0.9	0.7	7.9	0.1	0.6	0.0	0.1	18.2	0.1	0.4	0.0	0.0	1.8	0.4	0.2	0.0	0.2	0.1	24.4	0.1	0.1	0.7	4.0	12.9	5.4	10.9	4.8	5.0	7.5	5.9	13.1	6.4
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771310	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 47.0;CACO-2: 10.8;Hep G2: 10.5;K-562: 13.8;NTERA-2: 16.7;U-266/84: 10.1"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: , HPA045145: "	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.6	1.0	2.9	1.4	3.4	5.5	1.8	5.8	3.5	0.8	7.9	1.2	1.3	2.5	0.9	1.4	2.2	1.0	0.9	1.0	3.3	1.3	1.9	2.8	1.8	0.7	2.1	2.4	0.6	3.3	1.5	2.2	4.2	2.2	1.7	2.3	1.7	1.5	1.4	1.9	2.6	5.3	0.8	2.3	1.1	0.7	28.2	2.8	0.0	7.3	0.8	1.1	1.3	1.4	0.3	1.0	8.6	1.2	0.1	0.0	0.1	0.5	1.2	6.2	0.8	0.1	0.1	47.0	0.0	0.4	0.3	0.5	10.8	1.2	2.1	0.4	0.0	1.1	0.6	0.5	0.7	0.5	2.0	1.6	1.7	10.5	0.0	0.9	3.1	0.0	0.6	0.5	0.6	0.1	13.8	0.3	0.2	0.2	0.0	1.3	16.7	0.5	0.5	0.6	0.9	0.2	0.8	0.9	0.3	0.0	0.3	0.4	1.1	0.5	0.0	0.6	1.3	0.4	0.3	1.4	10.1	1.9	0.3	0.9	0.3	0.1	1.2	2.0	0.0	0.9	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	8.6	0.1	0.6	0.2	0.0	0.1	2.9	3.4	5.8	3.5	3.3	1.3	2.1	2.4	2.2	2.8
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137300482-137302251	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 41.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.3;HEK 293: 11.7;NTERA-2: 17.1;T-47d: 11.9;TIME: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	7.9	1.6	6.5	8.4	7.8	1.7	13.8	3.9	11.7	5.6	41.7	6.1	1.1	17.1	5.2	1.9	17.4	3.2	26.0	7.1	5.0	6.5	3.2	2.9	7.0	1.8	6.0	3.0	5.6	14.2	3.1	7.1	8.9	7.4	11.8	22.8	5.6	1.9	2.8	4.4	19.7	15.7	4.5	3.2	7.7	8.7	6.0	3.4	2.3	4.2	14.0	14.4	7.6	10.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.5	3.5	4.2	0.0	0.0	1.6	0.1	0.1	0.0	0.0	2.7	1.4	0.0	6.4	0.0	23.3	6.4	0.2	0.1	0.2	11.7	0.7	1.0	2.6	0.4	0.9	2.3	0.0	1.1	0.0	0.2	5.3	6.9	0.1	0.0	7.7	0.1	2.7	17.1	3.5	4.6	0.7	8.4	0.6	0.2	2.4	4.4	0.7	1.2	0.0	11.9	1.9	17.0	0.0	0.0	0.1	0.9	0.1	0.1	1.4	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	6.5	7.8	3.9	6.8	5.0	6.5	6.0	3.0	7.4	3.4
NRBF2	"COPR1, COPR2, DKFZp564C1664, FLJ30395"	ENSG00000148572	"Nuclear receptor binding factor 2"	Q96F24	10	63133247-63155031	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 100.9"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021670, HPA059477"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021670: , HPA059477: "	"unprognostic (7.71e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (2.36e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.59e-2)"	15.1	10.0	10.7	16.1	10.2	22.1	21.6	10.9	13.9	12.3	12.3	7.0	9.0	12.4	13.9	9.9	13.9	10.0	13.2	13.6	10.9	9.5	10.6	50.2	19.1	29.4	13.1	8.9	9.2	10.3	6.9	11.5	21.3	11.7	8.7	12.8	6.0	14.8	11.0	46.2	14.6	15.0	10.8	11.7	22.9	10.5	10.0	8.9	16.4	14.2	13.9	14.6	14.6	13.5	7.0	10.0	100.9	13.3	4.3	5.7	7.2	8.7	8.0	8.0	7.3	19.2	29.6	8.0	12.6	21.6	10.1	14.4	16.9	9.4	11.4	6.2	14.1	6.9	7.7	10.6	13.8	10.2	7.8	8.4	4.2	13.5	24.6	11.1	9.9	27.4	22.9	16.4	40.4	10.3	8.5	13.3	12.8	6.5	9.4	19.8	9.3	33.3	9.2	7.2	6.6	11.6	5.0	4.6	7.9	7.5	14.6	21.9	9.1	11.1	10.5	7.0	10.4	10.9	13.3	16.8	12.8	13.8	19.6	17.9	5.6	13.8	11.8	22.8	4.5	13.3	4.7	7.0	4.6	4.9	10.0	5.9	5.7	5.3	100.9	4.3	12.5	4.9	5.1	7.2	10.7	10.2	10.9	13.9	10.9	9.5	13.1	8.9	11.7	8.9
NRBP1	"BCON3, MADM, MUDPNP, NRBP"	ENSG00000115216	"Nuclear receptor binding protein 1"	Q9UHY1	2	27427790-27442259	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029527, CAB033078"	Supported		Supported	Cytosol			38000	Cytosol		"CAB033078: AB_2154375, HPA029527: AB_10601379"	"unprognostic (4.95e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavourable (2.22e-5)"	"unprognostic (7.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (5.84e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.48e-3)"	30.8	27.6	20.9	30.8	25.9	49.8	29.1	31.6	38.4	36.3	35.2	21.3	27.5	27.3	40.6	34.2	52.2	28.7	29.9	27.7	18.0	26.0	24.6	38.8	27.1	25.6	21.5	26.2	36.6	28.2	23.0	27.0	58.7	33.9	30.3	25.4	30.6	31.6	34.7	62.2	36.6	31.5	40.7	18.3	29.1	28.9	46.9	20.6	24.4	25.4	39.4	37.6	34.2	37.7	20.6	29.1	57.9	37.2	27.5	33.7	32.9	30.0	30.2	25.0	33.1	38.7	38.7	30.4	28.6	36.1	41.0	31.9	30.5	12.3	8.7	21.5	45.5	20.8	24.8	25.8	26.5	17.0	15.4	17.3	12.3	40.0	32.5	9.7	23.3	31.6	32.5	41.8	28.0	45.0	9.7	13.8	35.9	45.3	12.7	23.3	31.4	19.1	9.9	53.4	9.7	29.1	20.9	6.7	19.0	33.9	24.5	17.8	13.4	10.8	35.5	36.2	36.0	21.6	23.1	29.2	29.0	10.4	28.3	16.9	18.1	53.6	28.5	57.9	33.2	37.2	29.2	20.6	28.6	29.9	29.1	18.1	26.3	27.0	38.2	27.5	33.3	18.6	33.7	32.9	20.9	25.9	31.6	38.4	18.0	26.0	21.5	26.2	33.9	20.6
NRBP2	DKFZp434P086	ENSG00000185189	"Nuclear receptor binding protein 2"	Q9NSY0	8	143833594-143840974	"Enzymes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.5"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"CAB020944, HPA029051, HPA029052"	Approved		Approved	Cytosol				Cytosol		"CAB020944: , HPA029051: , HPA029052: AB_10602714"	"unprognostic (1.84e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (2.01e-5)"	"unprognostic (3.86e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.04e-1)"	18.5	10.7	21.6	6.8	21.1	1.9	10.0	17.5	32.6	7.6	13.3	47.5	8.7	8.8	11.2	10.0	9.9	14.6	11.3	15.2	23.5	14.9	14.0	18.9	14.9	4.9	30.9	23.6	10.7	10.4	8.4	8.8	6.1	30.2	17.8	6.9	10.1	22.1	15.5	7.6	23.0	9.3	12.3	54.1	7.5	10.1	6.1	27.5	1.0	9.0	3.6	3.8	8.2	7.8	0.5	0.0	0.0	0.4	0.0	1.5	0.3	5.8	7.3	6.7	8.2	10.4	16.1	1.5	12.0	5.2	4.3	6.4	1.7	5.5	0.6	3.2	14.3	9.5	3.9	4.2	1.7	7.1	2.9	1.1	19.4	3.0	10.7	0.0	2.8	20.6	9.9	2.2	2.2	6.0	3.7	7.8	9.2	2.5	0.5	0.3	2.5	4.1	2.0	6.2	2.7	5.9	2.0	2.4	4.9	15.3	7.8	6.0	11.2	0.4	13.9	2.6	7.9	12.4	3.8	4.3	0.2	0.1	13.8	2.4	3.5	0.0	0.4	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	21.6	21.1	17.5	21.4	23.5	14.9	30.9	23.6	30.2	27.5
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611714-129757082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	14.8	7.3	10.9	18.9	13.0	20.3	18.2	22.2	11.1	15.4	10.3	12.6	16.0	9.0	15.7	10.4	10.1	18.7	10.0	12.3	11.5	11.1	10.0	7.8	11.2	18.7	12.1	7.7	24.4	15.2	13.5	10.9	12.5	11.5	11.5	9.9	11.7	13.8	13.9	19.3	12.2	10.7	14.0	9.6	14.2	8.7	17.2	15.2	29.2	13.8	11.4	16.1	12.8	19.2	8.8	7.0	13.1	7.0	5.8	13.3	6.2	11.6	9.6	13.8	12.2	8.4	6.7	11.0	8.1	8.5	12.5	9.8	11.6	7.8	13.4	6.0	9.2	8.9	14.9	8.2	12.8	12.8	10.6	11.1	8.1	7.8	6.1	13.5	11.1	5.7	7.8	12.3	11.9	9.2	13.4	10.4	7.6	10.6	26.5	12.8	12.9	8.5	17.0	11.2	11.9	7.1	8.5	12.0	13.1	12.3	12.8	8.2	7.9	13.0	7.0	7.1	9.8	8.2	14.9	11.3	11.2	23.8	7.5	12.6	13.6	6.1	5.5	13.1	11.4	6.9	13.3	7.7	8.7	10.5	7.0	8.8	9.6	8.2	11.4	5.8	7.0	4.7	9.1	6.2	10.9	13.0	22.2	11.1	11.5	11.1	12.1	7.7	11.5	15.2
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: , HPA060036: "	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	29.0	15.0	10.8	12.6	7.5	19.6	18.4	20.8	10.5	23.1	21.2	6.7	8.5	14.5	16.6	13.4	13.1	18.8	9.0	11.8	9.3	5.8	16.0	22.7	9.3	8.9	5.9	7.3	14.4	15.8	8.3	11.2	16.8	7.2	13.9	15.8	12.7	10.3	7.7	36.5	7.6	30.3	17.3	12.9	17.0	8.4	6.8	7.7	22.1	7.3	12.4	5.9	13.0	14.9	2.6	1.7	0.5	1.4	1.2	5.6	0.7	9.6	20.4	16.1	0.0	8.1	5.2	5.7	11.5	5.1	7.6	5.8	3.8	7.6	0.0	6.5	10.9	5.0	1.0	6.8	15.4	0.0	4.4	14.5	7.1	11.7	4.8	7.2	3.2	6.4	9.5	7.9	9.3	5.6	10.3	8.0	5.0	5.4	3.3	0.0	6.5	6.1	40.9	12.6	0.3	4.4	16.6	1.4	0.0	9.5	5.0	3.8	12.2	5.5	9.7	6.2	4.2	9.6	4.6	3.8	0.0	0.0	13.6	0.0	3.1	0.0	1.4	0.5	1.0	0.8	5.6	0.9	1.0	1.1	1.7	2.6	1.7	0.6	0.3	1.2	1.4	1.7	0.5	0.7	10.8	7.5	20.8	10.5	9.3	5.8	5.9	7.3	7.2	7.7
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 48.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favourable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	5.1	5.8	3.9	20.1	4.3	3.9	48.5	20.9	6.0	4.2	13.5	1.1	2.9	9.8	9.9	3.0	5.9	7.4	6.2	9.7	7.3	9.2	1.6	2.0	4.6	27.6	5.6	11.7	2.5	0.5	2.6	3.3	11.9	3.2	3.8	4.6	4.3	6.6	5.4	3.2	4.1	6.4	7.2	8.0	3.3	2.6	27.7	0.7	5.9	3.0	3.0	3.8	6.3	2.1	0.8	5.9	1.1	1.1	2.3	0.3	0.8	1.7	2.9	1.7	0.0	0.0	3.7	2.1	0.0	0.0	0.0	4.4	2.2	2.3	0.6	0.0	1.7	0.0	0.0	0.0	1.6	2.6	3.7	4.6	0.5	0.0	4.5	2.8	0.1	0.0	0.0	0.0	0.0	2.1	5.4	0.0	1.8	2.8	2.4	3.0	0.8	1.7	3.1	1.4	0.0	3.0	2.3	3.4	1.6	2.4	0.5	1.7	0.8	2.3	1.2	1.5	1.8	3.1	0.9	0.2	3.5	3.0	2.2	1.5	5.9	1.1	0.4	1.7	0.7	0.9	2.1	1.3	1.5	0.7	2.0	2.3	1.0	0.5	1.1	0.4	0.8	0.5	0.3	5.8	20.1	48.5	20.9	9.7	7.3	27.6	5.6	11.9	27.7
NRIP3	C11orf14	ENSG00000175352	"Nuclear receptor interacting protein 3"	Q9NQ35	11	8980576-9004049	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 11.5;blood: 13.8;bone marrow: 12.7;brain: 28.4;testis: 30.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 25.8;SiHa: 16.7;U-87 MG: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058827, HPA072961"	Approved		Approved	Cytosol				Cytosol		"HPA058827: , HPA072961: "	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.03e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.88e-3)"	"unprognostic (1.30e-1)"	2.9	11.5	10.0	2.0	19.7	12.7	4.8	27.6	24.7	1.9	1.0	3.1	0.0	1.0	3.9	3.8	1.4	2.1	2.2	1.4	28.4	9.6	1.2	0.7	1.3	1.3	10.5	6.8	0.8	0.8	2.4	0.7	1.3	11.0	1.2	1.2	3.3	1.1	1.4	0.6	0.9	1.0	2.8	4.5	1.0	1.6	30.3	0.8	0.0	1.4	0.0	1.1	1.0	0.3	0.1	0.2	13.8	0.3	0.1	1.0	0.2	0.0	0.4	0.9	0.1	0.3	1.4	0.0	10.0	3.9	8.1	8.5	1.5	0.8	0.0	1.5	2.9	0.1	2.7	0.2	14.1	0.7	4.0	1.0	0.5	0.1	0.6	12.5	25.8	1.8	0.1	8.3	0.1	6.5	1.9	0.1	7.4	0.0	0.6	4.0	3.2	0.0	0.0	1.4	0.0	0.1	0.6	2.7	0.8	16.7	0.4	2.5	1.7	1.2	8.1	12.4	5.9	0.7	0.0	0.0	0.0	0.0	24.1	1.5	6.0	13.8	0.1	2.0	0.1	0.3	0.2	0.1	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	10.0	19.7	27.6	19.6	28.4	9.6	10.5	6.8	11.0	0.8
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 42.2;placenta: 64.8"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 32.4;HSkMC: 6.2;RH-30: 7.3;RPTEC TERT1: 19.9"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	28	"cerebellum: 16.0"	"Low region specificity"	"Detected in many"			HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	2.6	12.7	0.4	2.7	0.4	0.0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0.0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0.0	0.3	0.0	42.2	0.5	0.0	2.9	64.8	0.2	22.0	0.1	0.0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0.0	0.0	0.5	3.1	0.3	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	6.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	7.3	0.0	19.9	0.4	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0.0	0.2	0.0
NRL	"D14S46E, NRL-MAF, RP27"	ENSG00000129535	"Neural retina leucine zipper"	P54845	14	24080107-24115014	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"retina: 124.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026066, HPA064599"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB026066: , HPA064599: "	"unprognostic (2.71e-2)"	"unprognostic (8.17e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.88e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-5)"	"unprognostic (2.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	1.5	2.7	4.4	2.3	4.1	1.0	1.8	2.1	2.8	1.9	1.3	1.7	1.7	3.2	1.4	7.9	1.3	1.4	1.2	2.7	3.8	3.1	3.5	3.9	1.7	1.9	3.9	1.4	1.8	3.4	5.4	2.8	1.8	2.1	1.8	1.0	124.5	1.6	2.4	4.1	0.9	1.9	1.0	4.4	2.6	1.3	4.3	1.2	3.3	4.3	1.8	1.6	1.5	2.2	3.8	1.4	4.1	1.3	2.0	2.7	1.2	0.8	1.7	0.5	1.8	0.5	0.5	1.6	0.4	0.4	2.2	1.0	1.1	0.8	2.5	0.8	1.0	1.0	1.0	1.2	0.3	1.8	1.5	0.7	0.5	3.7	1.2	1.9	3.3	0.7	1.0	0.6	1.2	1.1	1.6	3.0	0.8	2.6	2.2	1.8	0.6	1.8	2.2	2.1	0.7	1.2	1.7	2.0	2.0	1.3	1.5	1.6	1.1	2.6	0.4	1.4	0.8	0.6	1.2	7.6	3.2	2.7	0.2	1.6	1.5	0.0	1.1	4.1	1.1	1.2	0.7	3.8	1.1	1.6	1.3	2.4	2.7	2.3	0.2	2.0	1.3	1.4	1.0	1.2	4.4	4.1	2.1	2.8	3.8	3.1	3.9	1.4	2.1	1.2
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126122-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 67.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.3;SH-SY5Y: 11.4"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: "	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		1.3	6.9	21.5	1.7	27.7	1.7	1.3	5.3	67.2	1.3	1.7	2.1	0.0	1.7	1.5	1.4	1.4	1.3	1.5	1.4	15.3	25.0	1.5	1.4	1.4	1.5	12.4	25.4	1.3	2.6	1.4	12.9	1.3	27.4	1.4	1.7	0.3	1.5	1.3	3.3	1.5	1.6	1.6	6.7	1.5	1.9	1.6	5.0	0.0	1.4	0.0	1.3	1.3	0.1	0.5	0.2	1.8	0.2	0.1	0.3	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.6	0.1	1.6	0.0	0.3	0.1	0.0	0.1	1.6	0.6	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.9	1.2	0.1	0.2	0.3	0.9	0.7	2.5	0.5	0.2	0.5	0.0	0.0	14.3	11.4	0.0	0.1	0.9	1.7	3.4	0.2	0.4	0.6	0.1	0.4	0.8	2.2	0.9	0.7	0.0	1.3	1.8	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.3	1.0	0.1	0.2	0.2	0.0	0.0	21.5	27.7	5.3	34.1	15.3	25.0	12.4	25.4	27.4	5.0
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favourable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	8.4	18.6	34.3	6.0	39.3	0.9	7.2	22.7	70.9	12.8	6.6	11.0	4.9	3.5	12.5	16.0	6.1	13.4	9.3	13.5	31.1	24.9	10.1	1.8	8.7	4.1	17.1	28.5	18.3	10.5	26.5	16.3	10.1	27.8	12.2	6.1	12.8	13.3	16.5	1.4	5.0	3.8	16.3	8.7	5.7	5.3	12.8	6.8	1.3	14.9	2.5	4.2	9.4	4.8	9.4	4.8	1.5	1.1	3.4	3.9	1.5	18.7	22.9	13.8	13.0	18.3	20.5	5.4	12.5	24.2	22.7	22.9	12.6	0.4	0.0	4.4	23.1	8.3	11.1	1.9	14.5	0.1	11.2	6.8	10.9	23.8	18.5	0.2	1.1	23.2	1.5	16.2	2.7	15.6	13.4	12.2	19.9	3.3	0.3	5.8	10.6	11.8	10.7	7.7	0.9	22.7	0.1	28.2	20.3	14.9	4.4	21.4	18.3	7.0	10.4	24.4	12.9	0.9	15.2	2.2	0.4	5.1	3.2	0.2	12.8	0.0	1.1	1.5	3.8	0.3	1.1	7.2	1.1	3.9	2.1	9.4	1.6	2.7	0.0	3.4	0.4	4.8	0.9	1.5	34.3	39.3	22.7	70.9	31.1	24.9	17.1	28.5	27.8	6.8
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Enhanced	Cytosol			6900	Cytosol		"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: "	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	1.9	3.6	11.2	2.7	19.1	1.6	2.6	14.1	35.4	2.5	4.0			1.4	1.9	2.7	3.9	2.2	2.8	1.5	13.9	14.4	3.4	2.5	2.2	3.1	12.6		1.3	3.5	6.5	5.5	2.6		2.8	5.5		2.4	2.1	4.3	2.4	3.2	2.2	3.1	1.6	3.0	3.1			3.6		3.4	3.3	1.0	7.2	15.5	10.4	13.3	6.7	11.1	8.8	6.1	13.6	9.1	0.6	5.4	7.6	7.4	8.4	9.8	8.1	7.9	9.3	0.0	15.0	15.1	18.6	1.1	10.2	3.1	13.3	5.3	13.3	0.5	9.8	12.7	8.0	0.4	3.3	6.9	4.3	16.4	6.8	12.7	10.0	8.2	17.9	12.0	10.0	3.9	5.1	16.2	7.2	8.8	14.0	9.2	12.8	8.4	9.5	12.4	0.0	5.9	15.5	18.6	10.3	22.9	8.1	12.1	12.5	17.6	10.1	8.8	6.4	8.1	16.1	10.4	13.3	7.8	8.2	12.1	8.9	6.8	8.2	10.5	15.5	7.2	6.9	8.1	6.0	6.7	12.1	6.2	11.1	8.8										
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			920000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	15.7	22.7	20.2	10.2	23.5	15.8	15.3	18.2	26.5	16.6	14.7	17.1	9.3	11.1	17.4	21.2	19.8	19.9	12.2	21.9	16.7	18.2	14.8	19.8	12.7	9.6	17.1	22.4	22.7	10.8	12.4	9.9	21.5	24.2	16.8	13.9	20.1	13.6	21.8	49.7	25.6	12.4	18.9	15.8	12.2	12.6	11.1	15.3	12.8	13.1	14.8	12.4	15.9	13.7	14.5	12.0	32.4	10.9	5.9	11.0	9.4	21.2	24.6	15.8	15.0	14.3	13.3	11.7	9.9	17.9	24.3	18.0	20.8	17.2	11.8	8.1	18.0	20.1	9.7	26.0	18.7	4.4	10.5	11.9	4.4	23.8	15.1	11.5	7.2	11.3	9.5	25.3	8.5	17.2	15.4	10.6	16.9	10.2	12.0	22.0	16.9	27.2	5.7	19.7	11.5	28.2	14.9	9.1	11.2	12.0	23.9	10.8	14.6	8.0	16.0	18.9	13.9	10.9	16.2	8.5	15.2	9.8	14.0	16.1	13.3	10.7	8.9	32.4	8.5	10.6	8.5	13.9	9.2	8.3	12.0	14.5	10.5	9.2	29.1	5.9	10.9	9.5	11.0	9.4	20.2	23.5	18.2	26.5	16.7	18.2	17.1	22.4	24.2	15.3
NT5C	"cdN, DNT-1, DNT1, PN-I, UMPH2"	ENSG00000125458	"5', 3'-nucleotidase, cytosolic"	Q8TCD5	17	75130225-75131795	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021581, HPA023632"	Approved		Supported	Cytosol			600000	Cytosol		"HPA021581: AB_1854663, HPA023632: AB_1854662"	"unprognostic (3.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"prognostic favourable (7.66e-4)"	14.5	16.7	10.7	32.5	10.5	14.4	15.2	16.0	13.8	16.3	27.3	18.5	16.2	25.1	18.0	18.7	21.6	15.9	21.0	16.7	9.6	11.0	21.0	13.5	19.9	30.1	12.3	11.0	19.7	28.0	10.4	9.7	11.6	10.9	17.5	14.2	18.0	17.9	17.7	27.1	16.0	30.1	16.7	13.7	20.5	24.5	11.4	12.0	17.2	22.0	30.4	24.5	20.5	17.1	30.7	16.8	46.7	15.8	22.7	14.3	9.7	21.1	33.2	10.9	11.4	3.3	6.9	15.0	12.6	11.1	12.8	8.2	12.4	25.0	14.8	9.2	8.8	14.9	7.6	15.7	7.3	6.9	23.9	16.2	25.8	20.7	16.6	15.7	7.4	10.0	7.5	9.1	25.6	14.1	15.7	7.2	13.0	21.2	11.4	15.9	11.3	22.0	10.4	14.3	20.5	16.6	11.4	13.0	26.6	12.2	15.0	17.4	21.0	11.6	8.2	11.1	27.5	4.2	16.7	14.4	2.1	16.4	10.3	9.6	17.2	46.7	10.2	15.2	13.8	15.8	9.7	30.7	9.0	11.6	12.7	29.1	7.9	11.9	4.6	22.7	15.5	16.8	14.3	9.7	10.7	10.5	16.0	13.8	9.6	11.0	12.3	11.0	10.9	12.0
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841197	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"			"Mitochondria, Cytosol"		"HPA041634: AB_10795597"	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (8.11e-4)"	4.2	5.4	14.8	3.2	10.5	23.9	5.4	2.7	16.2	12.2	52.0	2.9	9.4	2.0	17.9	8.4	8.9	3.5	2.6	2.2	13.3	5.7	2.2	4.0	2.8	2.3	2.8	11.7	3.8	3.5	1.8	4.2	4.5	10.4	9.8	12.5	3.7	3.9	9.1	7.0	2.8	4.2	32.9	2.1	1.9	6.6	3.5	2.7	0.0	2.9	0.9	2.4	22.4	5.2	4.1	4.9	2.4	1.6	1.5	3.3	0.8	3.2	5.9	3.4	3.9	4.9	3.8	6.4	5.4	3.2	3.8	2.5	4.0	0.9	5.5	1.1	6.4	3.8	4.8	10.7	5.6	4.1	3.9	6.9	2.2	4.7	2.7	3.6	1.8	3.4	2.4	5.0	21.6	2.2	10.8	2.8	8.6	2.9	3.2	5.9	4.2	6.4	4.4	6.0	2.1	6.1	2.2	4.6	1.9	4.6	5.1	6.4	2.9	3.5	2.9	3.8	4.6	5.2	10.8	2.5	3.1	4.1	3.6	5.6	5.5	0.8	1.5	0.1	1.7	1.6	3.3	3.5	2.4	1.4	3.8	4.1	2.1	1.8	2.4	1.5	1.0	4.9	0.6	0.8	14.8	10.5	2.7	16.2	13.3	5.7	2.8	11.7	10.4	2.7
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 108.8;TIME: 63.0;U-87 MG: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.4	2.9	5.0	0.1	11.5	36.7	0.0	35.5	38.9	17.5	32.9	0.0	54.5	0.0	12.8	31.0	2.8	0.0	35.7	41.7	0.0	0.0	0.0	0.8	0.6	5.7	0.0	0.0	9.4	0.4	35.7	22.8	14.5	0.0	0.1	108.8	0.9	0.0	0.0	0.1	3.9	0.1	1.1	0.1	37.9	2.4	0.0	0.6	0.4	2.2	12.0	0.0	0.9	63.0	14.3	0.1	18.0	57.7	2.7	1.7	0.0	98.1	0.0	44.8	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636131	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: "	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	10.2	25.7	11.9	11.5	13.1	13.8	10.0	13.2	15.3	8.9	10.7	9.0	14.4	11.7	8.8	13.6	10.2	7.8	16.6	31.8	11.5	11.5	11.7	16.8	8.9	11.5	15.7	11.3	8.8	19.5	9.4	10.8	12.1	13.8	10.2	7.4	9.4	13.0	11.4	54.6	10.7	10.2	13.6	10.3	13.1	10.5	56.2	10.7	10.8	12.3	22.1	9.8	12.3	14.5	27.1	28.4	20.3	34.2	14.8	26.6	19.4	16.6	34.5	14.3	24.2	9.1	13.6	15.4	31.7	18.8	32.1	27.8	28.3	21.9	21.4	16.3	22.6	32.5	30.0	27.9	20.2	16.5	16.1	8.9	31.1	28.5	29.3	18.0	13.6	14.5	14.2	33.6	16.8	17.5	32.8	16.1	16.7	55.1	20.3	24.3	18.7	30.2	19.3	16.9	43.0	12.9	9.5	29.1	15.2	15.6	29.3	21.6	24.4	9.4	11.8	38.6	19.6	35.8	33.2	12.7	15.1	32.6	17.6	18.7	22.1	15.1	27.3	20.3	25.2	28.7	24.8	23.4	25.5	26.6	26.4	27.1	26.4	22.0	7.6	14.8	34.2	28.4	23.4	19.4	11.9	13.1	13.2	15.3	11.5	11.5	15.7	11.3	13.8	10.7
NTPCR	"C1orf57, HCR-NTPase, MGC13186"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol				Cytosol		"HPA028125: AB_10601091, HPA054304: "	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	5.4	9.8	13.2	5.8	14.9	2.5	8.7	14.5	15.9	9.9	8.0	11.1	4.1	5.1	9.6	9.5	8.0	11.3	9.6	10.3	13.3	13.1	8.4	6.1	7.4	6.5	13.7	10.8	12.9	13.4	16.9	8.0	6.3	18.5	8.8	10.3	10.8	10.1	10.0	26.8	9.9	6.8	9.9	12.6	6.3	5.8	11.2	11.0	5.7	13.6	11.1	6.5	7.1	7.4	2.4	1.5	3.3	1.8	1.6	4.3	1.3	2.5	6.1	7.0	3.5	5.2	6.9	0.1	1.7	5.4	5.2	7.1	4.3	2.9	3.9	3.8	3.4	3.3	4.7	6.2	5.7	2.8	8.8	1.1	3.8	5.5	5.4	2.1	2.4	9.1	12.2	5.1	5.1	4.2	3.4	6.0	6.1	1.8	5.4	5.5	6.9	7.3	3.5	4.6	5.6	7.7	3.0	6.1	10.2	2.4	2.0	2.4	5.1	4.8	3.2	4.3	3.6	4.7	4.7	6.8	5.5	4.4	5.1	5.1	6.2	1.1	1.6	0.8	2.1	1.8	2.5	1.6	3.0	1.3	1.5	2.4	4.3	3.5	3.3	1.6	1.6	0.6	3.5	1.3	13.2	14.9	14.5	15.9	13.3	13.1	13.7	10.8	18.5	11.0
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 15.8;blood: 32.3;brain: 28.3"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 41.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enriched"	"Detected in many"	5	"pons and medulla: 28.3"	"Cell type enriched"	"Detected in single"	127	"basophil: 32.3"	"Lineage enriched"	"Detected in single"	323	"granulocytes: 32.3"	"Region enhanced"	"Detected in some"		"basal ganglia: 8.2"	"Low region specificity"	"Detected in all"			"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol			140000	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: , HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	1.0	15.8	0.5	0.8	6.0	0.9	0.4	0.0	0.7	0.9	1.1	0.1	0.0	0.8	1.6	2.0	0.7	0.6	2.1	1.5	0.0	1.2	2.9	0.2	1.9	0.3	2.1	0.6	0.3	0.3	0.3	1.1	0.5	28.3	2.2	0.2	3.1	1.2	0.5	0.7	0.2	0.4	1.1	1.2	0.2	1.0	2.4	1.5	0.4	0.3	0.0	0.4	0.7	0.8	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.6	0.0	6.6	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.0	1.1	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.7	9.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	32.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	0.0	0.6	0.0	1.2	2.1	0.6	28.3	1.5
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027070	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Epilepsy, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;thyroid gland: 63.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.6;SH-SY5Y: 13.3"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346"	Enhanced		Approved	Cytosol			13000000	Cytosol		"CAB010346: AB_2155274, HPA007637: AB_1080385"	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	19.8	2.7	66.1	2.0	56.7	1.2	33.2	15.1	133.8	6.4	4.4	27.4	0.0	1.4	3.0	3.3	5.6	3.7	18.7	5.8	61.0	30.7	12.5	2.1	6.3	2.7	32.4	41.4	6.6	18.9	1.6	3.0	2.1	34.1	3.8	3.1	2.0	8.6	11.9	2.0	7.2	1.6	3.0	22.1	6.5	1.4	2.4	34.1	0.0	63.4	2.6	3.4	3.5	3.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.6	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.8	0.9	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	66.1	56.7	15.1	45.6	61.0	30.7	32.4	41.4	34.1	34.1
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302059-205321791	"Enzymes, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;CACO-2: 12.9;RPMI-8226: 18.7;RPTEC TERT1: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.4"	"Group enriched"	"Detected in all"	4	"B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008958	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favourable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	1.4	2.8	0.8	12.5	2.4	8.3	0.9	9.2	1.5	18.9	10.4	3.9	2.4	13.6	2.7	3.8	31.3	3.4	1.3	1.1	1.7	1.0	14.5	3.6	16.2	20.3	5.5	1.5	3.3	13.2	0.1	2.3	7.2	2.0	1.5	7.5	9.8	9.7	2.0	0.7	12.9	15.4	0.9	2.7	10.4	2.0	5.6	2.4	5.5	14.5	20.1	31.7	2.8	24.6	15.3	3.6	42.4	5.6	5.7	10.7	5.4	2.2	12.3	7.5	0.3	0.2	0.3	24.3	2.9	3.0	8.1	3.3	12.9	0.4	3.7	1.8	0.8	4.5	1.7	4.4	3.5	0.0	0.2	0.0	0.7	2.2	5.2	0.0	0.0	1.4	3.3	4.7	2.8	0.3	0.5	0.9	1.5	0.5	0.0	0.0	4.8	0.4	0.0	0.5	18.7	22.2	0.0	1.1	0.1	0.8	3.5	0.3	3.6	0.0	0.9	2.9	1.4	0.3	4.6	6.6	1.0	2.3	0.4	0.0	1.1	3.4	5.6	13.2	3.9	4.2	2.8	14.2	4.8	4.6	3.6	15.3	10.7	8.1	42.4	5.7	4.1	1.4	2.8	5.4	0.8	2.4	9.2	1.5	1.7	1.0	5.5	1.5	2.0	2.4
NUBP1	"NBP1, NBP35"	ENSG00000103274	"Nucleotide binding protein 1"	P53384	16	10743786-10769351	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041656, HPA041799"	Enhanced		Supported	Cytosol				Cytosol		"HPA041656: AB_10960278, HPA041799: AB_10960692"	"unprognostic (2.51e-2)"	"prognostic favourable (2.81e-5)"	"unprognostic (4.01e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.30e-3)"	"unprognostic (8.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.50e-1)"	"prognostic favourable (7.61e-8)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.69e-2)"	16.1	31.4	10.8	25.0	11.2	18.3	19.3	12.8	11.4	17.7	19.0	15.8	20.4	14.8	18.8	20.7	15.2	18.4	18.2	31.8	10.2	9.6	26.8	39.6	15.0	24.2	11.0	8.8	21.7	24.8	25.1	14.2	25.3	14.4	20.3	14.2	18.2	23.3	20.3	26.3	11.8	21.0	19.8	13.7	25.4	21.1	15.4	10.7	16.8	23.2	20.6	24.6	19.0	22.7	27.1	33.5	14.8	32.4	12.5	17.2	18.1	13.6	25.0	17.0	10.5	7.8	14.6	16.3	13.4	12.6	23.6	19.5	21.7	14.9	23.5	28.0	16.3	15.0	15.7	13.7	17.7	37.3	20.1	13.3	17.9	35.1	15.9	12.0	15.7	13.6	10.5	16.0	8.9	15.5	18.5	14.4	17.3	31.6	7.8	17.5	21.0	13.6	31.7	22.0	25.7	16.8	16.7	10.5	15.4	23.3	17.5	13.1	17.8	13.3	13.9	18.5	19.0	22.8	16.8	25.7	22.2	18.4	17.0	24.4	21.6	1.4	31.9	14.8	15.6	32.4	14.4	27.1	14.0	15.7	33.5	26.5	12.3	12.7	3.8	12.5	23.7	16.3	17.2	18.1	10.8	11.2	12.8	11.4	10.2	9.6	11.0	8.8	14.4	10.7
NUBP2	CFD1	ENSG00000095906	"Nucleotide binding protein 2"	Q9Y5Y2	16	1782901-1789191	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041704	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041704: AB_10804006"	"unprognostic (1.94e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (9.63e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.83e-2)"	16.9	22.8	12.9	15.4	12.4	19.5	14.7	16.3	19.8	13.9	15.1	14.9	16.1	21.6	14.1	14.2	20.3	15.6	15.2	13.8	12.0	10.4	16.5	32.3	12.1	18.0	14.4	17.4	14.6	37.6	8.3	13.8	14.7	12.9	17.7	6.4	14.8	26.9	16.3	30.2	17.2	19.1	16.4	12.0	17.9	18.8	14.5	13.2	22.7	19.4	20.7	16.6	15.3	13.6	25.8	44.1	28.8	29.7	25.8	41.3	31.1	9.2	30.2	5.2	15.9	4.3	3.1	17.0	11.2	4.8	6.9	7.8	17.0	14.1	14.9	12.3	2.4	10.8	3.6	10.2	1.3	12.4	29.0	6.3	22.4	26.7	8.3	9.4	13.0	4.5	8.9	5.3	4.0	8.6	15.5	9.5	2.8	34.1	18.9	15.4	14.3	17.6	24.9	11.4	33.2	5.5	7.1	20.0	23.4	11.2	16.4	11.3	25.1	11.2	9.6	10.9	14.4	10.9	10.9	21.9	13.9	17.3	6.6	11.8	14.3	25.6	29.1	28.8	34.7	29.7	31.7	24.3	30.9	30.5	30.2	25.8	25.8	24.2	14.4	25.8	28.2	44.1	41.3	31.1	12.9	12.4	16.3	19.8	12.0	10.4	14.4	17.4	12.9	13.2
NUDC	NudC	ENSG00000090273	"Nuclear distribution C, dynein complex regulator"	Q9Y266	1	26900238-26946862	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027183, HPA028105"	Enhanced		Enhanced	Cytosol			18000	Cytosol		"HPA027183: AB_10600086, HPA028105: AB_10601988"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.10e-2)"	30.7	57.9	49.9	25.8	44.9	31.8	30.9	40.1	59.0	30.5	35.7	32.0	31.7	25.8	30.0	53.0	26.6	69.2	28.2	41.8	39.3	41.0	28.2	46.8	26.4	27.3	39.6	49.7	34.5	44.7	36.7	32.3	29.2	38.6	34.2	23.7	25.0	35.0	43.9	65.6	30.8	22.9	39.0	32.9	29.2	36.6	41.4	35.9	30.0	36.8	24.8	29.5	37.6	84.4	73.7	69.0	63.1	62.8	57.9	71.8	64.8	42.5	44.6	23.4	32.5	18.7	16.9	26.6	34.2	21.1	46.1	34.1	40.8	29.8	35.8	30.3	23.4	33.5	49.7	45.1	35.7	27.7	51.6	44.5	45.4	69.9	33.1	46.8	32.9	18.1	29.5	55.5	35.9	33.8	63.3	20.2	31.1	36.9	47.0	60.7	61.5	57.9	49.4	29.7	36.5	39.2	16.9	39.1	29.3	37.2	23.8	30.1	23.1	29.0	33.3	33.0	39.4	41.2	43.8	40.5	63.7	43.2	35.6	66.3	37.0	63.1	60.3	57.5	69.1	62.8	69.7	72.0	70.4	65.3	59.8	73.7	70.0	71.8	41.0	57.9	60.0	69.0	66.5	64.8	49.9	44.9	40.1	59.0	39.3	41.0	39.6	49.7	38.6	35.9
NUDCD1	"CML66, FLJ14991"	ENSG00000120526	"NudC domain containing 1"	Q96RS6	8	109240919-109334385	"Predicted intracellular proteins"	Immunity	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023183	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023183: AB_1854695"	"unprognostic (5.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavourable (1.39e-5)"	"prognostic unfavourable (4.37e-5)"	"unprognostic (2.13e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (6.94e-4)"	"unprognostic (8.22e-2)"	"prognostic unfavourable (8.71e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	22.1	9.2	9.4	10.2	12.7	3.2	17.1	16.4	12.2	14.0	9.1	4.4	9.0	5.0	14.4	9.8	10.9	12.3	9.0	10.9	9.9	8.4	13.6	10.8	12.3	14.1	12.6	8.9	12.0	13.1	9.1	15.2	25.4	9.7	10.7	12.1	4.8	11.4	12.7	10.9	7.5	8.6	13.8	8.6	19.0	10.3	20.1	8.4	19.5	15.6	11.0	14.0	13.8	13.4	4.4	4.4	1.2	4.2	5.1	5.2	2.3	13.2	7.9	11.3	6.4	6.6	8.8	6.2	9.7	11.6	27.2	25.7	8.8	10.4	8.9	6.2	10.2	7.9	17.1	15.7	37.9	11.3	6.2	13.6	5.4	8.9	13.1	5.9	5.2	5.8	8.7	13.4	18.9	24.6	15.0	4.7	22.9	11.2	15.8	6.9	8.0	10.9	10.0	9.4	8.7	16.7	6.9	9.4	8.3	4.3	11.6	9.3	9.2	4.6	6.7	13.4	8.1	6.2	8.3	3.5	4.4	10.5	5.1	10.1	11.3	0.0	1.9	1.2	3.3	4.1	4.4	4.4	3.7	4.9	4.4	3.8	4.6	5.2	0.1	5.1	4.2	3.2	4.0	2.3	9.4	12.7	16.4	12.2	9.9	8.4	12.6	8.9	9.7	8.4
NUDCD2	"DKFZp686E10109, NudCL2"	ENSG00000170584	"NudC domain containing 2"	Q8WVJ2	5	163446526-163460140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037384, HPA037385"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"				Microtubules	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA037384: , HPA037385: AB_10673630"	"unprognostic (3.96e-1)"	"unprognostic (3.69e-2)"	"prognostic favourable (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.85e-2)"	18.3	17.3	19.1	17.4	20.2	14.0	16.6	10.4	21.8	8.5	15.1	23.2	12.7	20.2	12.5	9.7	15.0	14.3	9.9	10.1	19.9	15.1	16.2	20.1	11.8	18.9	27.0	14.5	13.4	24.4	9.6	13.2	14.5	19.3	12.7	9.1	9.3	19.4	10.6	25.7	11.7	18.0	14.1	30.5	16.6	15.9	12.5	20.9	16.9	14.6	11.0	13.4	12.8	11.5	34.3	30.3	14.1	21.6	28.5	36.5	24.4	23.2	12.0	9.2	14.4	5.6	4.2	12.2	9.4	2.7	3.4	5.5	10.8	17.9	13.3	22.7	1.5	11.7	4.9	5.3	4.0	26.4	13.6	12.2	15.3	9.7	6.1	13.7	13.9	1.5	3.2	3.3	4.8	3.7	12.9	16.6	3.4	9.5	20.3	30.3	10.0	13.3	17.2	15.3	23.5	3.0	5.4	23.4	13.2	14.9	9.6	24.4	18.4	14.3	8.4	11.7	17.4	12.8	21.5	13.7	22.9	22.3	13.5	23.8	12.1	14.1	18.9	11.8	23.8	21.6	30.3	34.3	34.0	28.4	25.4	24.4	36.5	31.9	2.4	28.5	17.9	30.3	30.0	24.4	19.1	20.2	10.4	18.1	19.9	15.1	27.0	14.5	19.3	20.9
NUDCD3	"KIAA1068, NudCL"	ENSG00000015676	"NudC domain containing 3"	Q8IVD9	7	44379121-44490880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019136, HPA019528, HPA019529"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374"	"unprognostic (3.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.18e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.62e-2)"	"prognostic favourable (9.16e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.50e-2)"	8.3	6.3	15.3	5.4	20.8	7.3	7.2	10.9	26.0	7.8	5.8	7.7	6.4	4.0	6.9	7.3	8.0	10.3	6.7	19.5	15.2	13.0	6.0	5.8	7.2	6.2	12.5	16.8	9.3	6.8	12.8	4.7	5.3	10.1	8.4	5.7	6.1	7.1	9.9	18.3	7.0	5.0	8.8	10.1	5.8	5.9	9.9	7.1	4.1	8.1	4.8	6.6	6.3	5.3	4.7	2.8	3.2	3.1	2.5	4.7	3.5	3.1	5.9	4.3	7.8	5.4	4.5	1.7	5.1	5.0	5.9	6.3	4.0	2.2	10.0	3.8	6.7	3.7	5.9	6.8	3.5	5.7	6.3	2.8	3.6	2.9	5.0	4.8	1.8	3.9	4.6	4.4	5.2	7.3	7.1	3.2	4.4	2.8	2.1	4.5	5.4	7.8	3.2	4.7	3.7	3.4	4.8	4.7	13.4	3.0	5.6	2.3	4.2	6.9	7.0	4.2	4.4	2.7	4.1	9.2	9.5	5.1	4.5	5.7	7.3	2.0	2.8	3.2	4.6	2.7	4.7	3.5	4.4	3.8	2.6	4.7	4.6	4.0	1.8	2.5	3.1	2.8	4.4	3.5	15.3	20.8	10.9	26.0	15.2	13.0	12.5	16.8	10.1	7.1
NUDT1	MTH1	ENSG00000106268	"Nudix hydrolase 1"	P36639	7	2242222-2251146	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012636	Approved		Supported	Cytosol				Cytosol		"HPA012636: AB_1854696"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (2.15e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (1.30e-7)"	"unprognostic (1.29e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.70e-1)"	8.8	3.9	7.4	12.6	13.4	37.1	10.8	5.0	10.8	5.9	9.0	8.7	2.2	9.1	8.2	9.2	13.1	6.0	8.1	11.3	8.7	4.7	4.1	2.9	7.2	18.9	8.2	7.0	4.8	4.0	0.7	1.8	5.8	7.2	7.2	6.3	4.0	5.5	4.2	12.0	18.8	9.3	10.5	11.9	11.1	5.5	26.7	5.3	30.7	4.1	14.4	17.2	6.8	8.1	18.3	59.5	11.9	21.3	10.1	20.4	13.0	21.5	34.8	19.1	25.3	7.0	9.7	14.0	9.5	8.3	13.1	15.3	18.7	16.3	22.8	7.8	10.4	26.4	14.5	14.5	7.7	10.1	24.7	17.8	29.3	15.8	1.7	13.8	18.0	6.4	3.8	18.9	6.7	7.0	14.0	25.5	14.5	55.0	25.7	53.8	41.0	21.5	35.9	28.4	19.1	7.1	12.2	19.2	26.6	9.8	28.9	4.4	19.1	36.7	6.5	12.6	48.1	29.0	22.6	19.7	14.9	23.6	12.7	34.4	45.2	9.0	17.5	11.9	12.9	21.3	10.2	18.3	15.1	13.6	26.6	18.0	15.1	13.1	4.6	10.1	17.4	59.5	20.4	13.0	7.4	13.4	5.0	10.8	8.7	4.7	8.2	7.0	7.2	5.3
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2"	"Cell line enhanced"	"Detected in some"		"AF22: 6.1;HAP1: 11.4;HEK 293: 8.4;NTERA-2: 20.9;SH-SY5Y: 4.6;U-2 OS: 10.5"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"											"HPA047027, HPA057684"	Approved		Approved	Cytosol				Cytosol		"HPA047027: , HPA057684: "	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	1.0	2.3	9.3	1.4	10.7	1.8	1.4	6.0	13.1	4.4	2.0	0.9	28.8	1.1	5.5	18.3	1.7	3.4	2.0	0.9	4.9	13.6	3.1	1.9	0.7	0.9	5.3	8.0	19.2	0.6	0.5	4.5	0.5	6.2	17.9	1.3	0.8	1.0	36.3	0.5	1.0	1.2	4.9	1.9	3.1	1.1	27.2	1.2	0.0	0.8	0.0	0.9	2.8	2.9	0.8	0.1	0.0	0.7	2.1	1.0	0.3	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	11.4	0.5	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.8	1.0	0.0	0.1	0.3	0.0	0.6	0.0	2.1	0.5	0.0	0.0	0.3	9.3	10.7	6.0	11.7	4.9	13.6	5.3	8.0	6.2	1.2
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496596	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;testis: 35.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.1;NTERA-2: 20.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 3.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol				Cytosol		"HPA047027: , HPA057684: "	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.2	5.4	11.2	1.4	21.9	1.6	2.8	7.4	26.1	3.8	2.6	0.8	4.4	1.7	5.9	4.3	1.9	1.6	2.2	0.8	7.0	17.9	0.9	0.6	0.8	1.1	5.3	12.7	10.0	3.8	0.5	2.8	0.6	5.3	10.1	1.4	0.5	1.3	11.9	0.6	1.7	1.5	5.0	1.8	0.9	0.9	35.5	1.1	3.6	1.0	0.2	1.1	1.7	1.6	0.5	0.4	0.0	0.2	1.9	3.7	1.0	0.0	0.5	10.0	0.0	8.6	11.0	0.0	4.6	1.3	0.2	0.2	0.0	0.0	0.0	0.2	5.6	0.7	33.1	11.3	0.1	0.0	2.2	0.0	0.0	0.0	4.1	0.0	2.2	6.7	4.5	3.0	11.0	7.8	0.0	0.0	9.3	0.2	12.5	0.0	20.6	8.4	0.0	7.0	0.0	2.0	0.0	0.0	6.5	2.0	0.0	1.8	0.0	0.0	4.5	2.3	10.9	0.6	0.0	4.3	2.0	7.0	1.5	0.0	0.9	0.0	0.0	0.0	3.7	0.0	1.4	0.5	1.2	1.9	0.4	0.3	0.2	3.1	0.0	1.9	0.2	0.2	0.0	1.0	11.2	21.9	7.4	14.9	7.0	17.9	5.3	12.7	5.3	1.1
NUDT16L1	SDOS	ENSG00000168101	"Nudix hydrolase 16 like 1"	Q9BRJ7	16	4693694-4695859	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044186, HPA063605"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA044186: AB_10968571, HPA063605: "	"unprognostic (1.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.14e-1)"	"prognostic favourable (2.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (6.81e-2)"	"prognostic favourable (1.02e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.81e-3)"	11.2	21.7	19.3	13.2	22.1	19.3	11.0	25.3	33.1	13.6	20.6	15.9	25.5	21.7	10.4	17.1	14.0	16.5	16.8	31.8	19.7	17.5	20.1	27.2	15.2	18.5	18.3	15.8	13.9	14.8	15.7	19.6	10.5	13.4	19.7	12.2	16.3	16.8	16.3	22.4	10.9	18.6	8.9	16.2	15.9	15.3	13.0	15.9	18.2	21.6	14.2	15.9	10.5	9.8	30.1	40.4	44.9	27.0	28.5	39.6	42.7	7.3	12.2	11.1	14.9	8.4	6.5	10.2	8.8	6.7	10.7	6.8	13.6	5.9	7.7	12.9	10.5	8.6	11.9	12.0	5.0	11.3	20.1	8.5	10.5	16.4	9.2	12.1	10.1	10.0	11.2	9.0	5.6	7.9	15.4	9.7	10.4	28.6	18.2	18.0	17.6	14.0	25.5	11.8	12.1	12.8	9.2	22.0	16.5	12.9	13.5	5.8	20.0	28.5	10.2	8.8	13.4	20.8	8.0	16.9	10.0	12.9	5.5	16.3	18.0	23.1	27.0	44.9	27.2	22.5	32.6	28.8	33.3	32.4	24.5	30.1	39.6	33.6	33.3	28.5	24.0	40.4	36.7	42.7	19.3	22.1	25.3	33.1	19.7	17.5	18.3	15.8	13.4	15.9
NUDT17	FLJ34433	ENSG00000186364	"Nudix hydrolase 17"	P0C025	1	145845629-145848953	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 5.8;eosinophil: 11.5;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 18.4;granulocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030145	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA030145: AB_10603883"	"unprognostic (8.93e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.63e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.07e-3)"	"unprognostic (6.55e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.40e-2)"	"prognostic unfavourable (1.81e-7)"	"unprognostic (5.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.96e-1)"	4.6	3.3	8.3	3.9	13.5	6.7	4.9	8.9	10.9	3.8	3.4	5.1	1.5	1.2	4.6	3.1	3.5	7.0	4.4	8.4	6.6	7.7	3.8	2.6	3.4	9.0	5.9	8.1	6.8	6.2	6.2	4.7	2.2	5.4	4.2	2.9	8.0	6.3	5.8	6.7	4.3	3.3	11.1	5.5	6.0	3.3	7.1	2.2	3.5	5.7	3.4	7.7	4.1	3.2	0.9	18.4	11.5	1.8	0.2	1.1	0.7	4.3	3.1	2.9	1.6	1.6	2.5	3.0	2.1	3.4	2.2	3.0	1.9	3.2	6.3	2.3	3.5	0.8	2.1	1.2	1.5	0.7	3.7	2.4	2.5	2.9	4.7	2.0	8.2	2.6	2.0	1.5	2.4	4.3	5.3	5.9	3.9	6.9	2.1	3.7	2.4	0.3	5.5	1.2	2.0	3.4	1.0	1.4	3.3	1.3	2.6	3.5	14.8	8.8	2.6	2.6	1.7	1.3	0.8	5.2	2.4	1.6	2.4	2.7	1.9	5.8	0.6	11.5	0.6	1.8	0.4	0.9	0.5	0.3	0.6	0.6	1.1	0.8	0.1	0.2	1.1	18.4	0.5	0.7	8.3	13.5	8.9	10.9	6.6	7.7	5.9	8.1	5.4	2.2
NUDT19	RP2	ENSG00000213965	"Nudix hydrolase 19"	A8MXV4	19	32691961-32713796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042761			Uncertain	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA042761: "	"unprognostic (1.20e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.61e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.35e-4)"	9.9	18.7	7.2	11.1	7.0	10.8	10.7	7.4	7.6	5.6	12.8	6.1	8.4	10.2	6.6	8.8	16.9	6.3	7.6	19.3	6.1	6.5	10.5	16.4	15.9	9.2	6.2	5.5	8.5	18.9	9.5	9.3	6.6	6.1	11.2	10.7	9.4	14.7	11.8	29.5	13.2	12.9	6.9	5.6	8.9	11.3	6.8	6.6	6.8	5.9	13.1	13.0	9.9	8.4	8.4	11.9	9.0	23.6	18.7	14.8	6.5	13.6	16.0	1.8	15.9	5.5	7.2	0.3	7.8	2.9	5.8	5.5	9.0	7.6	0.2	9.4	8.9	8.9	10.9	9.0	7.7	15.8	6.6	17.7	6.4	3.3	7.6	13.3	5.5	5.8	12.0	4.9	12.0	8.5	13.6	10.2	10.4	9.1	0.1	12.2	1.9	7.6	0.1	3.5	7.7	9.5	10.2	7.2	10.3	13.8	11.8	9.8	6.5	16.3	6.8	8.1	5.2	8.0	13.8	11.9	10.1	4.5	9.7	12.8	7.3	6.6	17.3	9.0	11.9	21.7	12.8	8.4	12.5	14.8	11.9	5.9	10.0	13.8	3.3	18.7	23.6	9.5	13.8	6.5	7.2	7.0	7.4	7.6	6.1	6.5	6.2	5.5	6.1	6.6
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392674	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047027, HPA055953"	Uncertain		Approved	Cytosol			110000	Cytosol		"HPA047027: , HPA055953: "	"unprognostic (2.42e-1)"	"prognostic favourable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	10.5	11.4	38.8	9.3	28.6	8.8	12.6	33.4	40.0	15.4	11.4	16.8	10.3	7.7	11.4	25.9	10.8	15.2	8.5	16.9	33.8	30.0	15.3	10.1	11.2	10.5	29.4	25.6	17.4	9.1	27.9	9.3	8.9	26.1	11.4	9.7	11.2	9.4	15.6	50.7	11.2	8.0	11.2	20.3	13.0	8.4	7.3	21.3	5.4	21.3	8.7	12.1	8.6	9.9	4.5	6.4	12.4	5.9	2.1	3.9	2.6	5.4	4.0	10.7	21.0	7.2	12.2	4.7	3.9	6.7	4.1	3.0	4.8	3.8	19.5	5.4	7.1	4.6	6.1	10.7	7.7	7.2	7.7	21.5	5.6	10.3	7.1	20.2	11.2	10.9	10.0	5.0	9.4	11.8	21.3	7.1	6.6	5.7	14.0	23.7	6.9	4.0	12.2	8.9	20.3	9.4	11.4	15.2	16.9	8.8	12.5	15.9	12.5	14.5	12.9	8.3	3.0	7.2	8.6	6.1	14.0	14.3	5.0	20.7	12.9	1.9	5.8	12.4	3.4	5.9	3.9	3.4	3.4	3.2	6.4	4.5	3.2	3.7	4.1	2.1	5.8	3.2	2.4	2.6	38.8	28.6	33.4	40.0	33.8	30.0	29.4	25.6	26.1	21.3
NUDT4	"DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487"	ENSG00000173598	"Nudix hydrolase 4"	Q9NZJ9	12	93377883-93408146	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol				Cytosol		"HPA017593: AB_1854703, HPA047027: , HPA057684: "	"unprognostic (1.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.25e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.01e-1)"	"unprognostic (8.32e-3)"	17.2	29.7	14.1	14.7	9.5	37.4	20.4	7.0	29.0	15.2	14.7	6.7	17.5	6.5	13.6	24.8	13.7	12.8	40.0	140.7	12.4	12.4	47.9	11.2	11.3	10.9	9.4	13.7	41.9	21.1	16.1	11.9	19.2	13.9	27.1	16.9	25.1	65.2	14.8	40.3	8.1	12.7	13.8	12.6	9.2	13.1	10.6	6.3	14.6	25.5	22.4	8.9	19.6	32.9	6.0	4.1	13.6	3.6	7.6	6.6	2.5	5.8	5.1	9.2	10.3	34.3	14.2	11.6	16.4	13.1	9.4	7.0	47.4	14.7	8.2	3.6	13.1	7.4	25.8	8.3	14.5	12.6	5.4	30.9	4.4	24.1	33.1	16.1	7.5	30.8	27.8	9.7	21.8	53.6	31.4	11.6	10.8	6.0	14.9	15.4	14.5	12.1	12.6	8.2	8.9	11.4	42.7	7.4	9.6	13.3	26.2	36.9	19.0	21.0	20.3	8.1	4.7	12.1	10.4	6.5	8.1	12.2	4.2	12.7	24.7	8.2	2.8	13.6	3.9	3.6	6.6	6.0	5.8	3.9	2.6	4.7	6.2	5.8	2.4	7.6	2.9	4.1	5.2	2.5	14.1	9.5	7.0	29.0	12.4	12.4	9.4	13.7	13.9	6.3
NUDT4B	NUDT4P1	ENSG00000177144	"Nudix hydrolase 4B"		1	148748894-148750099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 22.9;RT4: 20.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.5"									"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol				Cytosol		"HPA017593: AB_1854703, HPA047027: , HPA057684: "					"unprognostic (1.24e-1)"									"unprognostic (4.01e-2)"				0.5	1.2		0.0		5.4	0.0		0.0	0.5	0.7			0.7	0.2	0.0	2.0	1.4	5.5	6.5			2.0	0.2	0.0	1.2			4.5	3.0	2.1		1.5		1.4	1.0		5.7	0.0	0.0	0.0	0.5	0.1		0.0	0.1	1.6			1.7		0.1	5.8		0.0	0.3	4.5	0.8	0.2	0.6	0.4	1.6	2.2	0.5	2.6	3.4	3.3	4.9	1.3	3.3	2.3	2.3	22.9	8.4	1.4	0.5	1.7	2.5	2.7	1.3	1.3	4.7	1.8	3.8	1.4	2.6	3.6	2.7	0.8	5.3	4.4	3.2	2.8	8.2	6.7	9.0	2.3	1.3	1.8	0.5	3.0	2.1	3.3	0.9	5.3	2.0	20.8	1.2	2.1	1.7	3.3	14.1	5.9	5.9	4.5	3.1	1.9	5.4	3.0	0.7	2.3	1.5	1.6	4.8	9.1	0.0	0.1	4.5	0.0	0.2	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.8	0.0	0.3	0.4										
NUDT8	FLJ41567	ENSG00000167799	"Nudix hydrolase 8"	Q8WV74	11	67627938-67629930	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041252, HPA041466"	Enhanced		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041252: AB_10794551, HPA041466: AB_10793967"	"unprognostic (8.31e-2)"	"unprognostic (7.26e-3)"	"unprognostic (7.31e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.69e-1)"	"unprognostic (4.12e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.74e-1)"	"prognostic favourable (3.70e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.19e-1)"	5.5	2.0	3.0	4.1	4.1	2.1	10.8	4.1	2.7	3.9	8.1	3.5	10.1	10.6	1.7	4.8	22.0	2.4	5.9	32.5	2.6	3.0	16.0	21.4	3.8	4.3	4.9	2.3	2.2	7.7	4.3	1.3	2.5	5.9	4.2	4.2	2.0	28.3	8.2	38.2	12.4	12.2	2.4	4.1	1.9	6.9	1.4	2.3	2.0	13.6	25.0	15.3	1.6	4.7	7.1	11.8	1.0	11.2	8.1	3.4	2.1	10.3	4.2	1.6	2.7	1.5	1.9	2.6	2.1	1.0	0.9	0.9	3.4	2.7	10.8	3.4	1.6	5.1	1.9	1.3	0.1	10.5	4.5	0.6	1.8	10.5	0.4	3.4	5.2	1.2	2.6	1.1	0.3	1.9	3.0	9.7	0.7	17.3	5.7	4.9	0.9	8.6	3.5	0.8	67.9	2.7	1.8	0.8	1.1	0.5	6.0	2.1	3.3	1.4	0.5	2.3	3.3	14.7	0.4	6.9	4.6	2.1	1.6	4.6	1.3	0.0	1.0	1.0	3.1	3.9	2.6	3.3	1.8	3.4	4.3	7.1	1.6	1.9	0.0	8.1	11.2	11.8	1.1	2.1	3.0	4.1	4.1	2.7	2.6	3.0	4.9	2.3	5.9	2.3
NUFIP2	"182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1"	ENSG00000108256	"NUFIP2, FMR1 interacting protein 2"	Q7Z417	17	29255836-29294118	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067443			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA067443: "	"unprognostic (6.51e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.04e-3)"	21.6	20.6	25.0	25.4	28.6	83.5	25.1	38.8	39.0	17.3	18.0	15.5	17.4	19.6	17.8	15.9	27.1	17.0	17.7	21.8	24.1	15.6	16.9	28.9	31.5	22.2	24.2	15.5	20.0	19.8	26.2	40.8	44.4	28.9	18.4	16.6	13.9	25.4	27.5	43.7	17.9	20.3	13.3	30.5	24.6	22.0	17.0	27.2	18.3	20.2	15.6	22.9	19.0	42.6	6.9	9.8	21.2	6.9	4.1	6.1	1.6	15.0	24.6	14.4	10.0	12.5	14.6	24.2	15.0	9.1	11.6	10.7	27.1	8.3	24.5	22.5	10.3	21.4	11.5	10.5	14.8	26.2	20.6	18.5	22.4	7.0	11.5	23.5	20.1	12.6	12.9	12.7	13.8	8.5	30.1	18.3	11.8	12.5	24.7	10.7	14.8	9.1	20.3	24.8	10.5	9.7	24.7	13.9	8.8	26.9	50.6	16.4	17.4	15.9	13.9	22.3	22.3	12.9	25.6	25.6	23.5	28.4	14.7	12.6	18.9	8.8	5.2	6.2	4.9	5.0	3.7	6.8	4.7	5.2	4.1	6.9	6.1	5.0	21.2	4.1	6.9	9.8	2.4	1.6	25.0	28.6	38.8	39.0	24.1	15.6	24.2	15.5	28.9	27.2
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: , HPA063942: "	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	10.2	11.1	7.6	12.6	9.2	14.3	14.0	13.3	8.7	9.2	9.3	10.1	9.6	5.8	9.8	6.7	16.6	8.3	7.6	9.2	5.6	6.3	8.1	9.6	13.1	16.6	6.5	6.7	10.8	13.3	12.6	13.6	9.1	7.3	9.5	9.3	11.2	9.9	8.3	10.9	16.4	9.0	11.0	7.7	12.2	9.5	60.3	7.3	26.5	9.2	11.3	17.3	8.5	10.5	6.1	7.9	6.3	10.7	6.0	12.0	7.0	10.8	20.7	17.2	23.4	13.0	13.0	15.4	15.2	12.0	27.9	18.6	24.9	8.7	19.0	5.7	16.7	32.1	38.5	18.8	20.9	15.2	18.5	16.9	38.7	19.7	8.3	28.8	17.1	9.0	8.9	29.3	15.0	16.0	37.0	13.5	19.7	27.4	24.6	11.8	23.0	19.9	22.6	37.2	19.3	8.6	12.3	24.2	11.7	39.4	15.0	5.8	16.5	10.6	12.9	23.2	16.5	23.3	27.2	11.6	21.3	25.7	13.5	18.5	17.1	6.3	5.3	1.9	9.3	10.7	12.0	6.1	7.9	9.0	7.9	5.9	8.1	8.6	0.8	6.0	5.9	3.3	9.5	7.0	7.6	9.2	13.3	8.7	5.6	6.3	6.5	6.7	7.3	7.3
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA061910: , HPA062595: "	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	21.6	12.9	13.7	22.1	14.2	17.9	19.1	43.0	17.9	17.1	17.2	17.2	12.5	16.1	24.1	16.9	19.6	19.0	15.8	14.7	12.7	8.8	14.9	19.8	17.5	25.4	17.5	12.7	21.4	18.5	12.0	13.5	18.8	13.9	17.3	21.8	15.3	16.8	16.3	17.0	23.5	18.4	20.1	15.6	24.6	16.1	24.5	14.1	28.5	17.8	14.0	26.2	15.8	18.2	17.1	19.0	17.6	20.8	12.6	20.5	13.5	22.3	25.4	18.7	12.9	7.2	11.3	26.1	16.2	12.9	38.1	35.9	21.7	21.5	20.6	9.4	13.9	19.3	30.5	17.2	34.0	6.4	24.7	17.1	29.3	19.0	5.9	17.6	14.4	10.8	10.6	26.6	11.6	29.2	21.0	13.3	18.5	24.6	33.0	21.7	14.0	23.4	23.1	40.5	18.7	14.5	16.3	14.2	13.6	20.0	25.7	14.2	29.0	20.1	10.7	28.6	26.5	18.3	25.7	8.2	6.8	26.4	14.7	16.1	17.5	5.2	20.8	17.6	14.6	18.1	20.5	14.2	15.7	14.0	17.1	17.1	15.5	11.8	6.7	12.6	12.9	19.0	13.3	13.5	13.7	14.2	43.0	17.9	12.7	8.8	17.5	12.7	13.9	14.1
NXN	"FLJ12614, NRX"	ENSG00000167693	Nucleoredoxin	Q6DKJ4	17	799313-979770	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.2;HHSteC: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023566	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA023566: AB_1854737"	"unprognostic (1.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.05e-3)"	11.9	4.9	5.8	11.5	5.9	1.0	12.8	5.0	5.0	21.7	27.1	4.7	16.9	4.0	21.5	19.2	14.0	13.8	14.5	7.6	6.0	4.2	5.1	3.8	15.8	7.2	3.9	3.1	13.9	23.1	1.1	3.2	10.0	5.6	18.9	3.6	12.3	10.9	19.0	48.9	10.6	8.1	25.8	4.4	2.9	13.0	6.4	4.3	6.0	5.7	17.4	11.8	20.8	26.3	0.9	1.2	1.5	0.2	1.8	1.6	0.3	4.3	6.5	25.7	16.5	1.7	0.3	1.4	13.8	9.1	14.6	23.5	15.4	4.6	0.1	26.5	17.6	31.2	16.5	25.8	11.7	0.2	9.6	0.0	4.1	13.5	34.4	0.1	0.7	10.4	23.9	1.9	11.5	13.1	2.2	0.0	3.8	1.7	0.8	0.3	12.3	0.4	1.9	0.6	0.1	10.3	6.3	6.6	4.3	6.5	0.0	0.3	4.6	3.9	0.0	0.3	6.2	0.1	3.8	2.3	1.5	0.1	0.1	0.5	0.2	0.8	0.2	0.1	0.2	0.1	0.1	0.9	0.4	0.2	1.2	0.3	1.6	0.2	1.5	1.8	0.1	1.2	1.4	0.3	5.8	5.9	5.0	5.0	6.0	4.2	3.9	3.1	5.6	4.3
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88535101-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 11.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 15.0"	"Group enriched"	"Detected in some"	7	"breast cancer: 1.7;endometrial cancer: 4.0;ovarian cancer: 7.2;renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045526	Uncertain		Approved	Cytosol				Cytosol		"HPA045526: AB_10961044"	"prognostic favourable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favourable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favourable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	7.2	0.4	1.6	1.0	1.6	4.4	3.2	0.6	1.1	6.7	0.5	2.0	0.4	0.6	6.2	9.7	0.8	6.6	0.7	0.5	1.8	2.9	4.4	5.1	0.4	0.4	1.3	1.0	11.7	0.5	0.0	0.7	3.9	1.2	0.8	0.0	2.0	1.4	3.7	1.0	1.3	0.5	0.4	1.8	0.8	0.5	2.2	0.4	0.4	1.2	0.4	0.4	1.2	1.5	1.2	1.1	4.8	1.0	1.7	2.4	0.7	1.9	4.1	1.7	1.5	0.1	1.1	1.2	3.8	1.0	0.5	0.7	0.8	1.3	1.0	1.6	0.4	2.0	0.6	0.2	1.3	0.6	1.2	1.9	4.0	1.3	0.8	1.1	1.4	0.8	0.3	0.4	0.4	0.0	1.3	4.1	1.0	0.9	1.1	1.8	2.1	0.9	0.8	0.8	1.4	15.0	1.4	1.1	0.7	2.3	1.2	0.7	1.7	1.0	1.4	1.4	2.8	2.1	0.8	1.4	1.2	1.1	1.2	1.6	1.0	4.8	1.0	2.3	2.1	0.5	2.1	0.8	1.2	2.4	0.3	1.2	2.1	2.4	2.8	1.7	0.5	1.1	2.0	0.7	1.6	1.6	0.6	1.1	1.8	2.9	1.3	1.0	1.2	0.4
NXT1	"MTR2, P15"	ENSG00000132661	"Nuclear transport factor 2 like export factor 1"	Q9UKK6	20	23350736-23354777	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047471			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047471: "	"unprognostic (6.44e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.15e-7)"	"unprognostic (2.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.11e-3)"	"unprognostic (9.31e-2)"	16.0	9.7	6.2	11.9	6.8	35.0	16.7	5.9	7.1	14.0	11.1	6.0	11.9	6.2	14.0	15.8	16.7	16.7	11.6	15.1	5.7	6.4	12.8	18.0	13.7	15.4	8.1	5.2	23.8	15.0	5.8	13.9	17.6	7.5	19.2	9.4	11.0	12.7	14.0	18.1	14.9	9.5	13.6	7.6	17.4	11.1	17.2	5.7	18.3	24.7	15.9	16.3	20.5	24.1	41.8	34.2	9.9	19.9	30.5	32.0	25.6	14.0	15.7	9.5	9.9	6.7	6.5	8.9	8.7	9.7	14.1	14.3	10.4	13.9	16.9	13.0	8.6	16.5	11.2	22.6	13.9	8.1	10.4	12.4	3.5	18.3	10.1	13.2	9.4	5.8	15.1	13.6	19.4	11.2	16.4	16.7	10.9	18.2	27.3	23.3	8.0	34.9	18.9	15.5	19.7	8.5	11.9	15.5	9.1	7.9	21.2	16.1	11.9	15.4	7.0	14.4	11.8	12.0	16.6	11.5	11.0	19.2	4.0	61.5	10.6	9.7	14.5	9.9	25.7	19.9	31.4	41.8	26.0	26.7	20.8	37.2	32.0	28.9	3.5	30.5	14.2	34.2	17.7	25.6	6.2	6.8	5.9	7.1	5.7	6.4	8.1	5.2	7.5	5.7
NXT2	P15-2	ENSG00000101888	"Nuclear transport factor 2 like export factor 2"	Q9NPJ8	X	109535781-109544690	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.7"	"Cell line enhanced"	"Detected in all"		"HL-60: 47.8;U-937: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024199, HPA072010"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA024199: AB_1854738, HPA072010: "	"unprognostic (1.72e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.59e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.90e-2)"	10.1	6.5	10.4	6.0	9.7	12.3	12.9	3.7	8.4	8.1	6.2	9.0	1.3	7.4	4.7	6.1	10.1	5.8	5.0	3.3	9.9	6.9	7.7	9.6	6.4	9.2	10.1	6.3	5.5	7.9	5.5	2.6	17.4	10.6	6.9	7.0	3.8	8.8	3.6	2.6	10.0	9.1	5.9	11.4	7.6	6.7	38.7	9.1	14.0	7.3	6.3	11.1	7.4	7.2	7.4	11.4	4.2	11.6	12.3	11.6	9.3	4.3	3.8	3.7	6.5	5.6	4.5	8.2	2.8	4.7	3.6	4.7	3.0	6.2	5.6	8.8	3.4	3.3	4.9	4.3	5.5	7.2	3.0	4.7	3.7	4.9	2.3	47.8	19.7	3.3	3.8	3.4	2.1	3.1	4.9	23.0	3.5	4.5	7.2	5.1	5.9	5.7	2.9	5.3	6.6	3.3	4.3	1.5	4.7	11.9	6.8	3.7	2.9	16.2	2.4	5.2	3.0	6.8	2.9	4.8	5.8	8.6	4.5	52.6	5.3	3.9	8.5	4.2	11.6	11.6	7.5	7.4	8.7	9.5	11.4	6.8	8.6	8.4	1.8	12.3	9.2	7.0	9.9	9.3	10.4	9.7	3.7	8.4	9.9	6.9	10.1	6.3	10.6	9.1
OAS1	"IFI-4, OIAS, OIASI"	ENSG00000089127	"2'-5'-oligoadenylate synthetase 1"	P00973	12	112906777-112933222	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 83.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 51.4;BJ hTERT+ SV40 Large T+ RasG12V: 73.9;U-266/70: 72.5;U-266/84: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 83.9"	"Low lineage specificity"	"Detected in all"											"HPA003657, CAB021104"	Uncertain		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"CAB021104: AB_10057722, HPA003657: AB_1854747"	"unprognostic (1.03e-1)"	"unprognostic (6.59e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.67e-2)"	"prognostic favourable (6.12e-6)"	31.2	7.3	6.1	16.6	7.1	5.7	8.4	2.1	6.0	16.4	25.4	11.0	2.6	23.6	5.8	21.0	39.1	5.1	10.7	5.1	4.2	5.7	18.3	23.3	20.7	17.3	5.9	5.3	7.4	3.2	4.3	6.1	18.8	8.6	11.5	20.5	11.7	31.8	4.2	2.9	6.3	27.2	7.6	9.4	30.1	22.7	4.2	6.2	21.6	9.4	13.5	27.3	20.9	13.0	18.2	24.4	4.1	83.9	4.5	16.8	29.0	1.0	5.8	0.0	0.0	2.0	1.6	0.4	0.0	7.6	51.4	73.9	3.3	6.2	8.0	2.3	0.0	2.6	0.0	0.7	0.7	5.9	0.0	0.2	10.5	1.3	0.6	0.1	0.4	0.1	2.2	1.9	0.0	2.7	0.0	3.5	0.0	0.1	0.2	3.6	0.3	5.1	1.7	0.0	3.3	2.6	16.6	0.1	0.3	0.8	1.0	19.6	0.2	1.3	10.1	0.0	0.1	0.7	0.1	72.5	55.0	5.5	0.6	2.3	0.4	1.0	40.9	0.5	4.9	63.6	4.6	18.2	6.5	6.1	24.4	13.6	2.5	3.3	4.1	4.5	83.9	22.1	16.8	29.0	6.1	7.1	2.1	6.0	4.2	5.7	5.9	5.3	8.6	6.2
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938352-112973249	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 64.0;BJ hTERT+ SV40 Large T+ RasG12V: 70.0;RT4: 17.5;U-266/84: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			21000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	36.9	4.9	5.1	11.2	5.4	18.3	7.0	2.9	5.5	10.5	6.8	5.5	3.2	7.3	10.0	11.8	17.9	4.2	9.4	6.7	4.5	5.3	10.3	7.1	19.9	13.3	5.1	5.1	6.1	3.2	3.3	4.6	19.3	8.7	5.6	6.9	8.9	24.7	3.4	3.3	6.0	9.3	8.3	6.2	22.0	9.5	3.0	3.3	21.3	9.9	6.7	13.5	9.9	8.2	2.6	4.8	10.1	14.7	5.0	3.8	3.9	6.3	9.5	0.0	1.5	0.3	1.4	0.8	1.2	8.3	64.0	70.0	7.2	5.8	0.4	2.3	2.9	5.4	1.2	7.7	5.4	4.7	0.3	4.9	4.4	2.3	1.2	1.7	2.7	0.5	2.5	9.1	0.5	3.3	0.1	1.0	0.8	4.1	2.7	0.9	0.5	5.5	3.9	3.4	0.1	3.0	17.5	0.2	0.0	5.8	2.2	5.7	7.6	0.5	2.2	1.7	1.2	1.5	2.6	0.5	19.1	0.1	1.4	4.8	5.2	0.9	7.9	1.6	2.0	8.6	2.5	2.6	3.0	3.0	4.8	1.3	2.2	2.6	10.1	5.0	14.7	0.2	3.8	3.9	5.1	5.4	2.9	5.5	4.5	5.3	5.1	5.1	8.7	3.3
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121019111-121039242	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;bone marrow: 33.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 51.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.5;hTEC/SVTERT24-B: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA001474	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavourable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavourable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	20.5	0.5	1.0	8.3	1.4	33.1	2.7	0.4	1.9	3.6	5.9	1.7	0.1	1.6	1.7	1.3	4.7	0.6	3.1	2.2	0.7	0.9	4.0	22.6	16.5	1.9	1.3	1.2	1.4	0.4	0.2	0.8	3.6	2.3	2.5	3.0	2.3	3.4	0.3	1.1	0.8	2.0	1.1	1.9	5.2	15.7	2.1	0.6	6.0	3.2	3.7	7.6	2.9	1.5	0.8	3.2	44.5	10.8	6.9	23.6	10.8	1.0	0.2	0.0	0.3	0.3	0.9	0.0	0.1	0.5	51.5	26.5	0.0	4.9	0.3	1.5	0.0	2.7	0.0	0.3	3.8	9.1	0.0	0.0	5.2	0.0	0.3	0.0	0.7	0.3	0.2	20.6	0.0	0.1	0.0	1.8	0.2	0.4	0.0	2.6	0.0	1.1	0.0	0.1	0.6	0.2	4.8	0.0	0.0	0.4	0.2	8.1	0.1	0.8	0.0	0.2	0.4	0.6	0.1	1.9	3.7	0.0	7.7	0.4	0.1	4.2	10.3	22.4	20.4	10.8	5.3	0.8	14.1	23.6	3.2	0.3	4.0	15.7	44.5	6.9	7.4	0.1	9.9	10.8	1.0	1.4	0.4	1.9	0.7	0.9	1.3	1.2	2.3	0.6
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 180.2;tongue: 48.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1.0	0.6	21.2	0.5	0.7	1.6	0.5	1.0	1.0	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1.0	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8.0	4.5	0.2	0.1	5.6	1.5	0.5	1.0	0.9	2.0	2.1	5.7	8.1	0.5	1.0	0.4	1.1	0.2	2.1	5.1	1.9	16.0	0.0	2.0	1.3	6.1	3.0	1.0	0.4	0.2	0.4	5.3	1.3	0.3	5.0	2.0	1.6	8.8	1.7	8.1	0.1	1.3	4.6	1.5	3.0	9.0	0.2	2.9	1.1	8.0	3.7	0.7	0.0	9.3	0.2	0.1	4.7	0.9	1.4	0.0	0.8	2.1	0.1	0.4	0.0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1.0	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099358	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.9;skin 1: 12.3"	"Group enriched"	"Detected in some"	6	"SH-SY5Y: 5.8;SK-MEL-30: 22.2"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036402			Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.4	0.1	0.9	1.3	4.8	0.0	0.3	0.2	2.9	2.4	0.3	3.6	0.2	0.0	0.4	1.7	2.9	1.6	0.5	0.2	1.3	3.6	0.4	0.4	1.2	3.1	0.3	0.4	0.4	0.2	0.0	1.0	2.9	9.5	0.9	0.2	37.9	1.9	2.7	0.4	12.3	0.2	0.2	0.2	2.0	0.1	2.6	0.2	0.3	7.0	0.5	1.5	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.5	0.0	0.0	0.1	5.8	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	4.8	0.2	2.9	1.3	3.6	0.3	0.4	9.5	0.2
OCRL	OCRL1	ENSG00000122126	"OCRL, inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"				Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavourable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	12.1	20.5	10.7	6.0	18.2	5.3	10.8	13.4	23.1	12.7	13.4	10.1	28.8	9.1	15.8	19.7	13.3	12.8	13.8	8.6	13.0	20.5	10.9	11.3	8.6	6.0	12.9	15.1	33.0	12.4	37.3	20.3	13.2	17.8	21.7	14.1	15.3	8.5	27.7	11.4	9.6	9.8	21.5	8.0	6.3	11.4	23.2	6.4	4.3	19.0	5.6	4.1	18.0	9.2	0.4	2.4	0.3	6.6	0.0	0.7	0.7	9.6	11.2	9.2	10.4	16.4	13.6	9.0	14.9	11.9	15.4	14.3	7.5	7.1	0.8	25.7	12.6	6.1	17.0	11.3	16.1	0.0	11.5	3.0	10.1	7.5	12.2	3.0	0.3	11.4	15.0	15.1	15.1	11.4	4.0	7.4	16.0	12.7	2.2	4.2	3.3	16.7	2.2	9.6	5.8	8.8	10.1	11.3	14.3	7.0	10.0	7.8	7.2	5.3	9.6	12.6	5.8	13.1	14.8	2.1	1.6	2.0	8.8	11.1	9.9	0.0	2.1	0.0	0.2	2.4	0.7	0.3	0.1	0.1	2.4	0.4	0.6	0.2	0.3	0.0	6.6	0.9	0.1	0.7	10.7	18.2	13.4	23.1	13.0	20.5	12.9	15.1	17.8	6.4
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"salivary gland: 157.7"	"Cell line enriched"	"Detected in some"	17	"Hep G2: 25.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.0	2.5	0.2	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.0	0.4	0.1	0.0	157.7	2.6	0.0	0.0	0.3	1.9	0.1	0.0	2.5	0.0	0.0	0.0	5.1	10.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448504	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	13.2	8.2	11.6	33.5	11.1	41.8	9.1	7.2	11.8	11.7	17.4	11.5	33.8	8.6	22.9	21.6	16.5	16.5	30.0	33.8	9.7	10.6	31.5	48.7	14.2	42.3	11.3	6.5	29.2	48.7	13.4	35.4	6.9	11.2	26.3	20.7	18.2	11.0	27.2	64.2	9.6	14.9	26.2	10.2	20.4	19.2	54.6	6.3	31.0	16.4	19.8	39.6	16.1	14.6	13.4	10.8	2.4	2.4	1.2	4.4	3.0	18.6	15.0	20.9	24.7	3.7	11.2	48.5	27.0	13.4	25.6	11.9	79.7	8.7	98.9	13.6	16.5	3.4	63.9	30.7	31.2	37.6	26.7	45.1	25.8	48.6	30.4	76.2	10.8	7.5	8.3	57.9	72.7	20.5	75.0	32.2	14.2	12.3	75.4	30.0	38.1	49.0	53.8	65.7	66.6	15.5	13.7	29.2	24.9	33.9	10.4	13.7	7.0	34.2	14.3	20.8	42.9	26.8	58.0	15.0	45.4	89.9	18.7	50.5	12.8	0.0	1.3	2.4	2.7	2.4	3.2	13.4	3.8	4.4	3.0	11.0	2.7	4.3	0.5	1.2	1.5	10.8	3.8	3.0	11.6	11.1	7.2	11.8	9.7	10.6	11.3	6.5	11.2	6.3
OGFOD1	"FLJ10826, KIAA1612, TPA1"	ENSG00000087263	"2-oxoglutarate and iron dependent oxygenase domain containing 1"	Q8N543	16	56451490-56479100	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003215, HPA003722"	Approved	Approved	Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003215: AB_1078881, HPA003722: "	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.48e-3)"	"prognostic unfavourable (6.65e-4)"	"prognostic unfavourable (7.02e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.49e-2)"	"unprognostic (7.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-2)"	8.8	13.4	10.0	8.0	11.6	3.3	9.4	10.3	14.3	10.8	7.0	12.4	6.0	7.4	9.5	8.4	18.1	10.1	7.8	12.9	7.7	11.1	12.9	13.9	7.5	7.5	9.1	10.4	10.2	6.5	13.7	13.1	8.3	15.6	8.0	8.9	8.5	8.4	10.0	56.1	8.8	5.8	15.1	11.1	8.6	7.4	8.2	6.2	10.6	9.3	12.6	13.0	9.6	8.3	7.8	7.5	11.8	8.9	8.7	12.1	6.5	11.1	13.2	13.0	16.1	14.7	17.8	12.2	18.2	14.7	25.9	18.8	16.1	8.2	20.4	9.3	14.5	16.1	27.5	12.4	29.3	6.3	14.8	14.8	11.5	16.5	11.3	16.0	17.5	11.8	14.1	19.2	16.0	21.0	20.6	3.9	21.8	7.2	12.7	9.2	22.0	22.8	23.8	19.9	23.8	11.6	8.0	10.4	11.6	22.5	14.6	12.2	13.3	13.3	13.6	14.4	11.5	11.1	16.0	8.0	15.5	30.1	11.5	11.6	11.4	11.8	4.7	4.8	8.8	6.3	11.9	7.8	11.2	10.4	7.1	6.1	12.1	10.0	1.7	8.7	8.9	7.5	9.3	6.5	10.0	11.6	10.3	14.3	7.7	11.1	9.1	10.4	15.6	6.2
OLA1	"GTPBP9, PTD004"	ENSG00000138430	"Obg like ATPase 1"	Q9NTK5	2	174072447-174248698	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035790, HPA041443"	Approved		Enhanced	Cytosol			3600000	Cytosol		"HPA035790: AB_10601977, HPA041443: AB_2677483"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"prognostic unfavourable (9.73e-8)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.75e-2)"	28.5	23.1	39.3	18.0	40.6	23.0	29.1	39.4	52.4	18.5	23.5	14.7	12.2	24.9	17.9	20.6	29.9	19.8	20.0	27.9	35.4	34.3	28.4	33.3	14.7	26.1	28.8	27.9	17.1	31.1	19.7	23.8	20.7	45.3	21.5	27.3	15.1	18.9	18.2	50.1	25.9	24.0	18.8	27.0	18.7	19.2	23.1	16.5	36.1	31.9	27.2	25.6	21.9	18.4	12.7	24.5	9.6	16.3	16.7	16.6	13.9	39.9	19.0	31.2	51.8	16.6	36.5	56.2	32.3	32.7	45.2	34.5	44.9	23.8	55.1	32.4	25.8	31.9	37.8	37.3	53.4	25.0	32.2	51.4	18.4	46.5	32.1	58.0	21.0	32.0	46.7	47.8	51.0	39.8	55.9	18.9	39.0	25.8	52.5	60.3	36.6	62.2	40.0	50.4	37.8	56.5	43.3	50.7	29.0	21.9	32.6	45.5	23.2	49.3	28.8	29.8	37.7	29.6	46.9	17.7	44.2	41.9	29.2	40.2	26.3	9.6	16.3	4.6	11.5	16.0	16.6	12.7	13.4	14.6	24.5	11.1	15.8	15.1	1.4	16.7	12.4	15.0	16.6	13.9	39.3	40.6	39.4	52.4	35.4	34.3	28.8	27.9	45.3	16.5
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121179	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 159.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.2;MCF7: 21.2;NTERA-2: 28.3;SCLC-21H: 40.8;SiHa: 33.8;T-47d: 52.4;U-2197: 22.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	51	"dendritic cells: 5.1;monocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"		130000000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: "	"unprognostic (6.77e-2)"	"prognostic favourable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	7.7	10.0	80.5	5.0	41.5	0.9	4.7	30.9	159.5	7.4	5.4	4.6	0.7	2.5	6.9	26.4	5.0	4.4	3.8	3.9	77.2	19.1	3.4	2.4	4.7	5.2	18.8	36.5	6.2	5.1	3.6	9.9	1.1	13.5	4.8	5.7	0.9	2.6	7.5	6.1	4.5	3.5	6.9	6.1	5.8	3.9	2.8	2.8	0.3	2.7	0.8	7.1	4.1	6.2	0.0	5.1	0.0	5.0	0.0	0.0	0.6	0.0	1.5	3.1	0.0	0.4	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.3	0.6	0.6	0.0	0.0	3.6	0.2	0.0	25.2	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	21.2	0.1	0.0	28.3	0.0	0.0	0.0	11.9	0.0	0.0	40.8	5.4	33.8	0.1	2.1	52.4	0.0	0.0	2.0	4.5	22.8	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	3.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	80.5	41.5	30.9	119.7	77.2	19.1	18.8	36.5	13.5	2.8
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028759-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 280.2;pancreas: 105.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;BJ hTERT+: 15.2;HaCaT: 21.3;RPMI-8226: 4.7"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted in other tissues"			"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: "	"prognostic favourable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	0.3	0.0	0.3	18.1	0.3	11.4	2.5	0.3	0.5	50.3	132.5	0.4	0.2	121.4	0.8	3.3	0.5	0.9	6.0	1.1	0.3	0.1	7.5	0.3	1.6	0.4	0.3	0.2	0.7	105.8	0.0	0.2	0.9	0.3	16.2	58.9	0.2	2.9	0.2	0.3	0.1	280.2	5.6	0.2	2.2	2.4	1.4	0.3	1.8	0.3	0.4	0.3	18.4	40.9	0.0	0.0	1.4	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	4.4	1.9	15.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	4.7	0.1	0.0	0.9	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.9	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.2	0.3	0.3
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777158-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.9;HeLa: 14.6;WM-115: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"			"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	17.3	2.1	1.0	7.4	1.7	0.1	10.9	1.9	3.4	34.2	18.9	3.1	6.3	2.3	29.2	8.3	11.8	4.2	7.6	12.5	1.2	1.0	3.0	0.6	10.3	1.5	2.1	1.5	13.2	3.4	3.6	2.1	5.0	4.0	16.1	4.6	18.9	4.7	9.5	9.8	11.6	5.0	33.7	1.6	23.8	4.0	3.1	0.6	3.7	20.0	11.9	5.0	22.0	10.4	1.4	0.7	2.6	0.9	0.6	0.6	0.4	0.3	5.2	0.4	0.1	6.0	57.9	0.0	0.8	2.8	1.2	1.2	0.0	0.7	0.0	1.5	0.0	9.7	0.1	0.3	1.4	0.0	0.0	0.0	14.6	0.0	0.3	0.0	0.0	4.1	0.9	3.6	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	0.5	0.0	3.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	1.4	1.3	0.1	0.0	1.8	1.9	2.0	0.2	0.7	0.0	0.0	5.5	0.3	22.6	1.9	0.9	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.7	1.4	0.4	0.6	2.6	0.6	0.3	0.6	0.3	0.4	1.0	1.7	1.9	3.4	1.2	1.0	2.1	1.5	4.0	0.6
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023854	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.7;HSkMC: 44.4;RH-30: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 8.8;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	10	"monocytes: 8.8"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 45.1"	"Low region specificity"	"Detected in many"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA054136: , HPA062739: "	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	19.6	6.6	1.7	12.8	3.0	0.3	12.3	0.6	4.1	13.0	14.5	2.9	6.5	1.5	14.2	21.8	3.2	9.8	33.7	25.4	2.9	1.6	3.9	1.2	12.8	24.1	2.9	1.2	7.0	2.3	3.2	2.6	27.6	2.2	6.6	2.2	14.5	9.0	6.1	6.1	8.9	5.0	15.1	3.6	22.4	3.4	12.5	2.1	1.9	18.3	13.7	8.5	12.4	7.3	0.0	0.8	0.3	8.8	0.0	0.1	0.2	0.0	0.1	2.5	0.8	8.2	15.7	0.0	0.8	4.0	1.6	4.5	0.0	0.0	0.0	0.1	9.5	0.0	0.2	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	44.4	0.0	2.0	0.0	0.2	0.0	0.4	7.3	0.0	0.0	0.0	0.8	0.3	0.0	33.8	3.2	0.6	0.0	0.3	0.1	3.4	0.0	0.2	0.0	0.0	0.0	1.0	0.2	1.5	1.3	0.0	0.0	0.0	9.7	1.0	0.5	0.0	0.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.3	0.0	6.5	0.0	0.0	0.2	1.7	3.0	0.6	4.1	2.9	1.6	2.9	1.2	2.2	2.1
OPA3	"FLJ22187, MGA3"	ENSG00000125741	"OPA3, outer mitochondrial membrane lipid metabolism regulator"	Q9H6K4	19	45527427-45602212	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044881	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA044881: AB_10964052"	"unprognostic (3.37e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (3.14e-3)"	"unprognostic (4.53e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.72e-3)"	"unprognostic (8.73e-2)"	"prognostic favourable (9.30e-12)"	"unprognostic (5.85e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-1)"	21.6	14.8	8.5	9.4	15.9	7.9	21.8	8.5	13.1	6.2	8.9	7.2	5.7	8.4	10.5	7.7	11.3	7.6	9.8	21.8	9.8	9.6	15.9	16.4	19.3	9.7	11.0	4.5	8.9	9.3	23.9	12.3	11.4	18.4	7.9	8.7	12.1	8.2	9.4	19.7	12.5	9.7	10.2	12.4	12.0	9.2	15.7	11.1	5.3	11.8	9.7	9.6	9.5	30.3	6.7	7.8	7.4	13.0	10.9	6.2	4.5	11.3	14.5	5.8	5.8	3.9	4.8	8.9	7.4	6.9	8.0	8.5	6.7	8.2	9.8	5.4	7.4	9.1	9.7	10.2	7.0	17.9	9.8	15.2	8.1	6.9	7.0	10.7	19.8	7.2	7.9	8.8	9.7	5.6	12.9	11.1	5.4	7.0	8.3	4.4	5.1	10.0	8.3	5.2	5.3	6.2	20.6	4.4	5.2	9.5	8.8	4.0	4.9	6.1	12.1	6.8	7.8	5.6	12.6	7.5	13.8	8.2	6.6	7.7	10.2	6.0	7.4	3.8	5.3	10.5	5.6	6.7	4.8	4.5	7.8	5.6	6.0	5.9	7.4	10.9	13.0	7.3	6.2	4.5	8.5	15.9	8.5	13.1	9.8	9.6	11.0	4.5	18.4	11.1
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772491-128775790	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 11.4;retina: 23.9"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (2.26e-8)"	"prognostic unfavourable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (9.33e-4)"	0.9	1.8	0.7	3.7	0.9	1.7	0.7	1.0	2.3	0.7	2.2	0.7	0.7	0.5	2.6	0.7	2.4	0.8	4.2	11.4	0.7	0.8	0.7	0.7	0.9	1.0	0.7	1.3	0.7	0.7	0.0	0.7	0.7	0.7	1.4	0.0	23.9	1.1	0.7	1.9	0.9	0.9	0.7	0.7	1.1	1.4	1.1	0.7	0.7	2.3	0.7	0.7	4.3	0.7	0.5	1.2	0.6	1.4	0.0	1.4	0.3	1.6	2.2	5.1	1.7	0.0	0.0	1.5	9.6	0.0	0.0	0.0	5.0	2.0	2.5	1.4	0.0	1.4	0.0	0.0	0.0	0.3	3.6	1.5	3.0	2.5	0.0	1.9	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.6	1.0	0.7	2.0	3.5	4.6	2.9	1.0	5.3	2.9	0.0	0.6	0.7	6.8	2.3	5.2	4.3	0.5	1.9	4.0	9.8	1.0	7.6	8.6	2.0	2.1	1.5	36.9	4.5	9.1	0.0	0.3	0.6	1.4	1.4	0.9	0.2	0.8	1.0	1.2	0.5	0.3	0.9	0.0	0.0	1.0	0.7	0.4	0.3	0.7	0.9	1.0	0.9	0.7	0.8	0.7	1.3	0.7	0.7
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225716-53251697	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.0;prostate: 6.7"	"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: "	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.7	0.7	15.9	0.3	18.0	0.4	0.3	2.2	8.8	0.4	0.4	0.3	0.0	0.4	0.4	0.6	0.5	0.7	0.4	0.8	4.5	6.2	0.3	0.5	0.8	0.4	1.7	5.8	0.4	0.3	0.4	0.8	2.8	3.1	6.7	0.4	0.0	0.3	0.4	3.8	0.4	0.5	0.5	0.5	0.6	0.3	2.8	1.6	0.2	0.9	0.0	0.3	0.3	0.1	0.2	0.8	1.2	0.2	0.1	0.4	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	1.2	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	15.9	18.0	2.2	8.8	4.5	6.2	1.7	5.8	3.1	1.6
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 170.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol				Cytosol		"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	19.3	21.4	16.1	8.4	15.4	9.6	17.9	17.1	20.4	9.5	11.8	9.4	5.8	14.3	9.4	6.9	14.5	7.3	10.1	32.5	11.9	13.6	16.6	16.7	12.0	9.5	16.2	18.0	22.1	8.2	8.9	9.9	13.0	21.0	9.9	13.4	5.8	10.2	10.2	170.7	17.6	16.0	10.3	16.9	12.4	12.7	16.0	12.5	4.9	6.4	24.5	8.4	11.0	19.8	6.0	1.8	11.9	1.1	16.0	34.5	9.2	18.5	5.3	3.0	4.1	41.1	42.4	3.5	22.4	25.6	17.0	28.2	9.3	24.9	0.1	8.9	30.5	17.4	3.9	21.5	13.0	43.2	2.1	3.8	7.4	5.0	42.1	0.1	14.0	22.7	17.0	16.2	17.0	14.4	4.7	28.8	22.8	3.9	1.8	0.5	1.2	2.4	0.3	5.9	1.9	20.7	13.3	0.8	3.2	19.4	5.9	14.5	12.7	2.6	39.2	14.0	6.9	18.9	6.2	14.9	5.1	0.1	21.0	3.2	2.6	11.9	0.8	0.1	19.7	0.5	15.0	6.0	24.9	22.6	0.1	3.4	10.1	12.3	0.7	16.0	1.1	1.8	34.5	9.2	16.1	15.4	17.1	20.4	11.9	13.6	16.2	18.0	21.0	12.5
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 26.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 34.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016583, HPA061823"	Approved		Enhanced	Cytosol				Cytosol		"HPA016583: AB_1848720, HPA061823: "	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favourable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	4.3	1.3	0.0	6.2	1.1	3.7	7.1	0.0	1.3	2.1	9.8	1.7	5.0	10.6	2.3	2.2	3.4	1.7	4.8	3.5	0.4		4.9	9.6	7.5	14.1	2.5	0.6	4.8	5.9	1.4	0.0	4.6	5.6	3.3	0.1	10.6	6.8	3.0	26.0	17.0	14.0	4.4	0.9	11.4	3.9	6.8	0.9	8.1	6.5	7.0	9.1	3.8	2.3	6.9	5.6	6.3	4.3	4.9	14.4	5.1	6.1	12.9	1.4	5.9	1.5	1.9	6.6	7.3	1.2	3.4	2.2	11.2	4.9	4.4	12.1	1.3	11.2	1.1	5.1	0.0	14.6	3.0	8.0	2.2	4.9	4.2	4.9	14.9	0.6	2.1	5.1	0.2	5.4	6.4	1.0	1.0	13.4	14.2	34.8	6.1	15.4	6.4	2.3	7.0	2.5	3.3	5.4	0.8	2.7	3.8	5.5	8.6	1.9	6.5	7.7	3.5	9.1	5.6	3.7	2.5	1.8	5.1	8.7	5.8	6.3	4.2	5.7	14.1	4.3	10.9	4.4	11.5	14.4	5.6	6.9	11.2	9.8	5.2	4.9	3.7	1.4	10.0	5.1										
ORAI3	"MGC13024, TMEM142C"	ENSG00000175938	"ORAI calcium release-activated calcium modulator 3"	Q9BRQ5	16	30949066-30956461	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015022	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA015022: AB_1854807"	"unprognostic (1.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.60e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (3.87e-5)"	"unprognostic (2.30e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.43e-3)"	"unprognostic (9.17e-3)"	13.4	22.9	5.5	13.0	5.6	12.4	14.8	6.0	8.1	17.0	12.8	9.1	13.3	7.5	12.4	16.9	19.9	13.6	16.5	10.8	4.9	5.1	16.5	39.6	15.4	20.7	5.9	3.6	16.9	14.5	13.5	12.1	14.8	5.8	26.2	7.3	13.3	10.3	15.3	9.4	10.2	9.9	16.4	5.1	20.0	10.4	19.7	5.2	14.2	25.6	6.3	13.7	29.1	15.2	5.1	6.8	17.9	8.5	8.1	2.8	2.2	1.0	5.8	3.0	4.0	26.1	23.5	0.2	3.4	23.0	2.5	6.5	0.5	9.6	1.4	7.8	6.5	4.7	0.5	6.4	1.7	4.4	1.9	3.7	1.8	5.7	36.5	4.0	11.5	25.2	17.3	4.9	9.7	4.3	4.1	7.7	8.2	3.8	0.2	15.0	2.4	1.6	3.1	2.3	10.9	9.7	2.5	0.7	5.0	3.1	0.9	5.2	7.3	16.5	3.1	1.9	1.3	4.2	0.8	19.0	1.3	1.1	9.6	9.5	2.9	14.1	6.5	17.9	2.5	6.3	2.8	5.1	1.4	2.0	6.1	4.8	1.7	2.3	10.9	8.1	8.5	6.8	1.9	2.2	5.5	5.6	6.0	8.1	4.9	5.1	5.9	3.6	5.8	5.2
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908973-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: "	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	11.7	10.6	8.3	15.9	14.0	9.0	14.0	19.0	14.6	12.6	16.1	11.8	15.1	15.7	18.4	12.9	12.3	10.3	10.7	14.6	9.8	9.2	10.8	9.5	9.5	13.5	8.6	10.4	14.6	14.3	13.7	18.0	14.4	12.9	11.8	12.3	10.3	18.1	22.0	16.1	14.6	16.9	8.9	9.0	14.1	12.1	33.2	6.8	20.3	14.7	12.7	14.2	10.9	11.7	8.1	6.9	5.1	3.6	4.6	8.9	2.2	11.2	8.0	8.9	8.9	3.6	6.3	15.2	11.6	7.3	10.6	10.5	16.4	9.0	6.9	8.4	6.7	9.1	19.4	13.0	16.0	15.5	18.3	16.2	14.1	20.0	7.2	12.8	11.6	5.9	7.7	10.7	13.2	12.1	25.7	8.6	9.2	10.6	17.7	12.1	21.7	19.0	12.7	9.1	10.2	11.0	9.0	14.4	10.8	10.0	8.9	6.3	6.4	6.4	9.2	9.3	9.7	7.9	11.5	6.2	14.7	11.4	7.3	12.4	8.7	0.3	3.6	5.1	5.0	1.4	6.3	8.1	6.8	4.7	3.0	7.2	8.9	6.0	1.8	4.6	2.4	6.9	4.6	2.2	8.3	14.0	19.0	14.6	9.8	9.2	8.6	10.4	12.9	6.8
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication, Photosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	12.4	13.7	10.6	9.3	17.9	6.2	16.3	18.7	21.6	12.9	14.2	12.1	9.0	10.1	14.4	17.5	14.1	11.3	8.5	8.2	13.0	12.9	12.6	20.3	10.2	13.7	10.1	11.8	13.8	17.4	10.8	15.9	11.4	17.6	21.5	16.0	14.0	11.8	13.8	10.9	14.8	11.0	14.2	8.6	12.0	12.3	27.3	10.0	20.5	12.6	7.9	15.8	13.4	12.7	14.0	7.2	6.8	7.4	12.5	18.6	8.2	16.3	17.1	9.9	18.0	10.6	10.6	8.9	14.5	13.8	16.4	13.7	11.1	10.7	24.1	12.2	9.0	15.5	19.9	13.9	19.6	13.1	12.9	8.8	9.8	11.3	14.7	16.8	7.9	10.0	13.3	18.8	17.4	15.3	28.9	14.0	13.8	23.2	23.4	17.0	10.7	17.9	9.8	18.0	23.9	12.6	12.2	13.4	11.2	13.6	27.8	18.5	9.3	13.0	8.9	14.9	17.4	24.2	18.2	15.5	33.3	31.8	10.7	22.8	18.7	6.8	6.3	4.5	13.1	7.4	17.1	14.0	13.6	15.0	7.2	11.9	17.2	18.6	0.8	12.5	6.0	7.0	11.3	8.2	10.6	17.9	18.7	21.6	13.0	12.9	10.1	11.8	17.6	10.0
OSBP	OSBP1	ENSG00000110048	"Oxysterol binding protein"	P22059	11	59574398-59616144	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039227, HPA043625"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039227: , HPA043625: "	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"prognostic favourable (2.08e-5)"	"unprognostic (7.80e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.22e-1)"	"prognostic favourable (3.08e-7)"	"unprognostic (1.25e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	15.6	36.6	12.3	10.6	16.3	13.8	16.5	14.7	18.0	16.1	18.8	13.7	35.4	17.3	15.9	19.9	15.9	13.8	19.5	14.7	10.3	11.6	26.3	54.8	12.9	9.7	12.4	12.7	16.6	30.2	31.4	14.7	29.4	17.9	16.1	17.3	12.6	27.7	26.2	32.5	20.9	22.3	15.1	9.5	12.5	19.1	11.3	12.1	18.8	19.6	12.5	13.8	16.7	13.7	4.6	7.9	3.5	3.1	4.0	6.1	2.1	17.5	14.7	10.9	14.7	25.9	24.3	12.1	14.3	18.7	17.3	15.6	16.6	17.8	17.7	19.3	16.5	18.4	20.1	19.1	19.5	17.1	9.3	11.9	11.5	11.1	27.7	15.2	23.7	18.5	23.8	16.2	42.8	18.4	20.5	16.6	15.3	8.1	14.3	11.2	12.4	14.5	13.9	17.6	12.3	20.5	20.4	13.0	9.2	17.0	21.3	19.6	29.8	9.8	19.9	14.8	10.4	22.1	9.6	23.2	18.8	18.1	16.7	11.0	11.9	3.5	3.1	2.8	5.9	2.9	5.5	4.6	6.1	4.6	3.2	3.4	5.6	4.7	3.0	4.0	2.5	7.9	2.6	2.1	12.3	16.3	14.7	18.0	10.3	11.6	12.4	12.7	17.9	12.1
OSBP2	"KIAA1664, ORP-4, ORP4, OSBPL1"	ENSG00000184792	"Oxysterol binding protein 2"	Q969R2	22	30693782-30907824	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.1;retina: 45.7"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HeLa: 54.7;hTERT-HME1: 14.6;SiHa: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021514	Uncertain		Approved	Cytosol				Cytosol		"HPA021514: AB_1854813"	"unprognostic (2.89e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (3.79e-6)"	"unprognostic (9.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	1.0	8.5	5.7	2.3	11.6	36.1	1.2	17.0	14.4	1.4	1.6	8.5	1.3	6.3	1.9	13.0	3.3	2.0	2.7	10.0	7.7	5.6	2.1	0.7	1.8	1.9	7.1	6.2	1.7	4.9	8.8	14.1	4.0	7.3	2.2	1.7	45.7	2.5	2.4	2.3	4.6	4.6	1.2	6.4	3.4	3.2	19.6	5.5	0.0	2.9	0.3	1.3	4.3	2.2	1.9	1.6	2.5	3.1	2.7	3.2	6.2	2.6	5.7	0.5	2.5	0.3	2.2	0.6	0.5	1.2	1.8	1.8	5.1	1.4	4.5	2.2	0.7	1.5	2.3	0.2	1.3	2.4	0.7	15.2	54.7	0.9	0.3	0.1	0.9	0.1	6.3	4.5	14.6	4.5	9.5	0.2	4.1	2.8	0.4	1.6	1.4	5.2	1.3	0.2	0.2	0.2	0.9	6.4	2.6	14.6	1.5	0.1	1.8	0.8	3.2	1.3	6.9	1.2	2.5	1.2	1.6	0.8	5.1	0.0	1.0	0.6	1.8	1.1	1.5	3.1	3.1	1.7	2.9	1.4	1.6	1.9	3.0	3.2	2.5	2.7	2.3	0.7	1.9	6.2	5.7	11.6	17.0	14.4	7.7	5.6	7.1	6.2	7.3	5.5
OSBPL10		ENSG00000144645	"Oxysterol binding protein like 10"	Q9BXB5	3	31657890-32077580	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 39.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 31.4;RPTEC TERT1: 33.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"memory B-cell: 11.5;naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	22	"B-cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003636			Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA003636: AB_1079529"	"unprognostic (5.28e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.15e-1)"	"prognostic favourable (1.51e-4)"	"unprognostic (5.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (4.85e-4)"	11.7	3.5	3.8	8.7	4.3	1.0	6.7	1.4	7.6	8.6	5.6	0.4	5.9	2.5	11.8	6.7	10.0	5.5	16.7	2.9	2.6	2.6	14.5	1.6	4.6	8.2	3.1	3.6	4.1	2.5	1.3	12.0	16.5	2.5	12.8	6.0	8.5	7.3	16.6	2.0	5.5	7.3	39.6	1.2	9.5	4.4	24.0	1.2	0.4	4.3	4.3	15.1	25.2	11.8	11.5	0.1	0.5	0.0	0.0	0.0	0.2	6.1	3.5	0.6	12.4	1.1	2.3	20.9	1.7	1.9	1.6	2.3	8.6	4.5	14.6	16.7	0.4	3.7	2.7	14.6	1.9	0.1	2.7	0.0	8.6	5.5	0.9	0.0	0.1	2.4	12.4	2.5	31.4	7.1	0.0	0.0	6.8	5.1	0.0	0.0	7.8	8.9	0.1	0.2	0.2	33.1	2.5	0.9	0.1	3.1	5.4	1.7	3.6	0.0	5.0	2.0	21.5	0.2	8.2	1.4	1.0	14.0	2.8	0.0	12.6	0.2	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	6.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3.8	4.3	1.4	7.6	2.6	2.6	3.1	3.6	2.5	1.2
OSBPL1A	"ORP-1, ORP1, OSBPL1B"	ENSG00000141447	"Oxysterol binding protein like 1A"	Q9BXW6	18	24162044-24397880	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	18	"basophil: 33.7"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040959, HPA043401"	Supported		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA040959: AB_10964295, HPA043401: AB_10960208"	"unprognostic (1.75e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.53e-2)"	"prognostic favourable (4.98e-13)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (2.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.56e-1)"	32.3	14.3	33.3	5.9	28.9	7.0	23.8	6.2	43.1	27.7	13.8	33.9	6.2	10.2	24.4	9.0	15.5	15.2	10.6	24.7	37.6	22.6	21.7	6.6	11.9	5.0	40.6	27.7	14.3	8.3	21.0	8.8	4.2	29.9	12.0	11.5	16.6	23.3	13.9	73.2	8.7	9.8	20.4	49.0	4.8	9.7	6.9	29.0	1.0	14.6	9.9	4.1	12.0	29.7	0.2	1.8	33.7	1.8	0.1	0.4	0.6	15.2	4.6	11.0	20.4	25.7	21.1	10.3	5.7	16.7	5.2	4.3	2.9	16.0	0.0	6.8	10.2	15.6	4.3	10.0	4.8	0.0	8.1	4.8	3.3	0.0	12.8	12.0	2.5	27.2	14.4	3.9	16.2	6.5	0.0	0.1	6.4	6.4	2.7	3.6	9.0	15.2	0.0	8.8	1.3	1.4	11.3	7.1	7.0	13.3	15.6	18.2	5.7	8.7	1.4	19.4	4.0	6.2	5.5	0.1	2.1	0.4	9.4	3.5	11.0	33.7	1.8	0.4	0.1	0.9	0.0	0.0	0.4	0.2	1.7	0.2	0.2	0.2	0.7	0.1	0.3	1.8	0.3	0.6	33.3	28.9	6.2	43.1	37.6	22.6	40.6	27.7	29.9	29.0
OSBPL2	"DFNA67, KIAA0772, ORP-2"	ENSG00000130703	"Oxysterol binding protein like 2"	Q9H1P3	20	62231922-62296213	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 38.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041127, HPA042659"	Uncertain		Approved	Cytosol				Cytosol		"HPA041127: AB_10962008, HPA042659: AB_10960683"	"unprognostic (1.00e-3)"	"unprognostic (7.20e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.82e-3)"	"prognostic favourable (4.20e-5)"	"unprognostic (3.86e-2)"	"unprognostic (8.13e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.32e-2)"	12.7	12.7	17.0	13.2	22.7	25.8	17.4	41.6	28.8	15.5	21.2	23.3	16.9	20.0	14.8	16.6	35.0	14.7	20.3	22.0	16.4	16.0	15.4	14.9	13.8	11.6	17.4	15.2	15.1	34.7	26.8	21.3	19.5	24.3	17.0	20.6	15.7	27.3	18.5	16.2	35.1	19.6	20.0	19.1	19.3	24.2	15.2	17.1	14.7	20.0	13.2	19.5	19.8	22.4	6.0	4.0	38.7	4.6	6.5	6.7	4.1	11.4	8.2	9.6	9.0	9.9	9.9	9.2	6.9	13.7	23.4	16.2	29.5	11.7	5.5	18.7	13.8	20.1	9.2	20.8	13.0	6.6	8.7	14.6	10.3	15.0	9.7	5.6	13.3	9.0	30.6	10.4	11.8	9.4	9.5	10.4	6.7	9.4	8.1	9.3	3.1	7.3	7.6	11.7	7.2	12.0	23.4	12.8	8.4	12.6	24.0	11.8	15.8	10.1	6.4	11.7	8.6	12.3	8.3	12.2	17.2	8.2	13.0	4.0	7.2	6.0	3.7	13.6	5.5	4.6	5.0	6.0	4.6	5.9	4.0	4.7	4.2	5.0	38.7	6.5	4.0	2.8	6.7	4.1	17.0	22.7	41.6	28.8	16.4	16.0	17.4	15.2	24.3	17.1
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796539-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: "	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	3.7	2.2	3.9	18.2	9.5	3.8	6.6	1.2	16.0	12.1	6.1	6.2	0.7	9.8	3.8	3.7	10.2	6.2	10.4	5.3	4.3	4.3	14.4	1.9	9.0	10.9	4.2	7.4	8.4	3.9	23.1	4.2	6.3	3.1	4.3	6.7	3.7	6.9	2.9	6.7	12.8	10.4	4.0	6.7	10.2	8.7	3.5	4.1	13.9	16.8	7.2	14.7	12.4	9.6	3.7	3.5	6.3	2.1	8.1	9.8	2.4	14.4	3.9	2.9	5.4	6.6	13.4	6.6	16.4	18.3	7.7	12.2	9.8	19.2	8.0	2.3	17.5	12.7	8.8	12.3	11.9	4.8	3.6	1.9	5.8	7.3	9.4	5.4	43.0	6.5	10.3	10.0	12.1	11.5	10.0	11.2	13.0	0.0	3.3	6.7	5.7	5.1	2.7	8.1	3.3	7.7	10.3	0.6	6.1	11.1	8.0	2.4	4.1	0.5	13.6	3.4	6.8	18.5	12.2	7.8	11.3	20.2	7.4	9.0	37.9	6.3	2.1	1.5	9.8	1.8	8.4	3.7	6.2	6.3	3.5	1.7	2.1	4.2	0.4	8.1	1.2	2.5	9.8	2.4	3.9	9.5	1.2	16.0	4.3	4.3	4.2	7.4	3.1	4.1
OSBPL7	"MGC71150, ORP7"	ENSG00000006025	"Oxysterol binding protein like 7"	Q9BZF2	17	47807372-47821834	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 37.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036076, HPA053083"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036076: AB_10601042, HPA053083: "	"unprognostic (3.88e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavourable (8.30e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.08e-1)"	"prognostic favourable (1.19e-5)"	4.1	3.4	9.0	9.6	13.4	7.3	3.9	10.7	11.9	6.8	16.8	12.0	7.5	24.6	6.7	3.7	2.8	6.1	10.5	4.6	9.7	7.3	7.2	1.4	6.3	7.9	13.9	9.8	7.4	11.4	5.3	7.8	3.2	10.3	10.1	10.3	7.7	8.8	10.1	20.2	1.9	32.2	6.2	6.6	12.3	37.9	1.4	16.4	7.9	8.4	2.9	8.1	6.8	5.2	2.6	2.9	1.7	1.4	1.1	5.5	2.1	3.9	4.7	2.0	2.3	2.3	3.3	1.7	1.5	2.2	2.5	2.9	4.6	12.0	4.0	5.9	2.1	29.2	1.1	3.2	0.8	13.2	1.6	2.9	8.7	3.1	2.1	6.1	0.1	5.1	0.6	1.7	1.1	5.1	2.8	5.4	3.9	5.0	6.1	6.5	1.2	5.9	5.6	3.1	5.4	3.4	3.0	2.1	4.8	2.4	0.8	2.3	4.3	3.9	6.0	3.9	3.4	0.0	1.2	10.0	3.6	3.9	4.2	5.2	1.5	0.0	1.4	1.7	5.5	1.0	2.3	2.6	2.2	3.1	1.7	1.4	1.6	2.3	0.9	1.1	0.0	2.9	2.7	2.1	9.0	13.4	10.7	11.9	9.7	7.3	13.9	9.8	10.3	16.4
OSBPL8	"MST120, MSTP120, ORP8, OSBP10"	ENSG00000091039	"Oxysterol binding protein like 8"	Q9BZF1	12	76351797-76559809	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001309	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA001309: AB_1079530"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (9.79e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-3)"	29.3	11.4	13.9	18.4	41.9	23.1	17.2	13.7	20.2	20.0	11.5	6.8	8.4	7.5	18.5	10.7	20.1	10.4	15.0	19.3	13.4	12.9	30.2	15.2	20.5	22.7	12.1	13.2	14.9	11.2	12.4	16.5	14.4	13.9	16.2	9.7	9.2	15.8	11.1	21.5	22.9	12.6	15.5	14.8	24.9	12.4	12.8	14.7	41.0	11.7	10.6	24.8	18.0	24.5	11.7	15.8	57.2	15.0	9.9	10.9	8.1	12.3	7.9	17.6	12.5	24.6	34.8	11.2	19.1	26.7	12.2	11.2	11.4	5.1	17.3	10.9	22.6	5.2	13.1	11.0	18.5	14.8	11.6	46.5	7.8	6.8	15.2	29.4	19.0	18.3	21.0	18.2	22.8	10.5	31.8	8.0	20.1	8.5	19.6	14.0	8.6	7.9	10.3	24.1	9.9	9.4	10.5	9.7	10.1	16.3	6.0	11.8	4.5	18.0	24.6	19.9	9.9	20.4	10.2	8.0	12.6	19.1	7.5	16.6	11.5	27.5	15.0	20.1	9.0	10.8	8.5	11.7	9.6	7.3	13.2	11.6	8.7	7.1	57.2	9.9	11.7	15.8	10.9	8.1	13.9	41.9	13.7	19.9	13.4	12.9	12.1	13.2	13.9	14.7
OSCAR		ENSG00000170909	"Osteoclast associated, immunoglobulin-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.3;HHSteC: 9.1;hTERT-HME1: 4.7;NB-4: 5.3;U-937: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	34	"classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2"	"Group enriched"	"Detected in many"	75	"dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		72000000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	4.5	1.0	1.4	3.8	2.8	18.9	1.4	0.4	1.5	1.3	0.9	3.5	0.0	0.4	0.7	1.3	1.2	2.2	2.3	1.1	3.8	1.9	1.0	1.7	40.4	4.7	3.5	0.4	1.2	0.7	0.3	0.5	2.2	4.0	0.8	0.7	1.0	1.3	0.8	0.7	1.9	1.0	2.8	5.6	20.2	1.3	0.6	2.4	1.7	1.0	0.0	1.2	1.7	3.1	0.0	9.4	18.3	20.6	0.0	0.2	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.4	0.0	13.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.1	0.7	0.0	0.0	0.2	0.6	4.7	0.0	0.0	0.4	0.1	0.1	0.0	5.3	0.3	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.8	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.5	0.5	16.5	0.0	0.0	20.6	11.7	0.1	12.8	0.0	0.0	0.1	0.2	9.4	0.0	0.0	0.0	18.3	0.0	11.2	0.4	0.1	7.0	1.4	2.8	0.4	1.4	3.8	1.9	3.5	0.4	4.0	2.4
OSGIN1	"BDGI, OKL38"	ENSG00000140961	"Oxidative stress induced growth inhibitor 1"	Q9UJX0	16	83948282-83966332	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 25.2;Hep G2: 37.9;T-47d: 28.2;WM-115: 23.6"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 65.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.5;monocytes: 12.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019239			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA019239: AB_1854779"	"unprognostic (8.36e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.28e-2)"	"prognostic favourable (4.89e-5)"	"unprognostic (3.31e-3)"	"unprognostic (9.14e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.89e-1)"	4.0	9.8	1.7	3.0	6.5	0.8	28.2	0.6	3.7	1.7	17.4	2.1	0.7	18.1	1.3	1.7	5.6	1.8	5.1	6.9	1.3	1.4	13.8	63.5	8.2	1.6	13.4	0.0	3.2	5.2	2.5	1.4	1.2	6.6	2.1	1.8	5.1	2.0	1.7	7.8	1.6	21.3	5.5	13.7	5.4	5.0	5.6	1.9	0.0	5.2	13.5	2.9	6.0	10.6	0.0	1.0	4.5	12.3	0.0	0.0	0.8	1.7	25.2	0.2	1.1	1.6	2.3	1.9	2.9	2.7	2.6	0.9	6.2	9.2	0.0	6.8	2.4	4.6	1.0	1.8	1.0	0.3	0.3	0.4	5.6	37.9	5.5	0.8	9.9	1.4	1.5	6.9	1.6	2.5	2.2	2.5	3.4	11.7	0.3	0.3	0.2	5.8	0.8	2.6	1.2	1.8	2.1	0.1	0.6	6.1	1.9	12.3	28.2	1.0	8.7	4.1	6.2	6.0	1.9	1.1	0.4	0.0	13.7	1.3	23.6	0.1	2.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.5	0.0	12.3	0.0	0.0	0.8	1.7	6.5	0.6	3.7	1.3	1.4	13.4	0.0	6.6	1.9
OSTF1	"bA235O14.1, OSF, SH3P2"	ENSG00000134996	"Osteoclast stimulating factor 1"	Q92882	9	75088543-75147265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020514	Approved		Supported	Cytosol			190000	Cytosol		"HPA020514: "	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.54e-2)"	"prognostic favourable (3.67e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.76e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	25.8	18.5	19.1	29.8	22.7	24.2	30.6	12.2	25.5	18.5	19.9	16.7	9.0	18.0	11.5	19.4	62.0	11.9	20.7	21.7	19.5	14.4	20.3	30.9	32.5	36.9	21.5	18.6	10.6	14.8	33.4	12.7	41.5	21.5	14.0	22.6	12.4	24.0	13.8	7.4	31.0	24.8	13.8	22.5	52.9	19.1	9.6	17.8	21.3	16.1	17.2	38.9	26.1	30.1	18.7	25.4	84.5	40.1	27.2	30.8	40.9	16.7	3.9	1.9	2.8	11.8	10.9	20.7	17.9	11.7	6.8	6.3	2.0	12.7	17.3	9.0	14.6	27.9	3.2	12.9	19.8	73.3	4.0	9.6	6.2	10.3	9.6	17.2	36.1	7.5	12.5	8.0	5.6	22.9	3.2	40.0	16.4	8.7	25.6	10.8	3.6	7.7	4.8	13.3	15.3	14.4	24.0	1.6	0.1	13.2	18.7	8.6	24.5	19.5	21.4	14.3	5.0	27.4	7.5	7.6	12.4	6.5	17.2	20.1	11.6	50.9	30.8	75.5	29.3	33.0	30.8	18.7	20.5	24.0	25.4	16.5	11.8	20.6	84.5	27.2	40.1	19.0	27.5	40.9	19.1	22.7	12.2	25.5	19.5	14.4	21.5	18.6	21.5	17.8
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteopetrosis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol			130000	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavourable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavourable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (1.34e-6)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.3	21.9	9.0	18.1	13.5	5.5	16.7	13.7	17.2	14.4	17.8	12.8	9.9	8.4	21.8	10.3	14.1	15.0	13.5	23.2	10.4	16.5	22.0	15.9	17.0	17.2	11.0	10.5	15.6	9.7	11.8	26.0	24.7	20.0	15.4	12.4	29.7	10.8	19.0	18.0	10.4	12.9	24.7	13.1	21.7	14.3	11.1	10.7	13.6	12.4	8.1	13.9	21.0	19.4	10.8	12.4	20.9	28.1	14.5	16.4	16.9	2.2	6.5	7.8	11.3	23.3	7.6	11.0	16.2	16.3	11.9	19.8	3.9	3.7	5.1	13.4	11.3	4.2	7.6	5.5	18.4	11.7	6.0	10.7	4.2	4.8	18.1	11.8	25.1	11.1	13.8	14.6	11.7	6.0	8.5	18.7	19.2	3.1	2.5	2.7	3.1	5.0	4.2	11.2	2.7	8.5	5.9	0.8	4.6	13.1	3.3	29.0	3.8	17.1	7.3	10.4	3.8	23.0	22.9	7.2	12.3	4.4	30.8	8.0	23.0	16.8	13.9	15.2	15.0	19.9	16.0	10.8	12.8	16.4	12.4	6.2	12.0	15.0	20.9	14.5	28.1	8.9	15.4	16.9	9.0	13.5	13.7	17.2	10.4	16.5	11.0	10.5	20.0	10.7
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380879	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.8;U-2 OS: 2.5;U-87 MG: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	4	"amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 5.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA040364: AB_10795365, HPA053392: "	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.4	0.2	3.5	0.2	4.3	0.1	0.4	0.2	5.8	0.4	2.7	0.0	0.0	0.2	0.5	3.1	0.5	0.5	0.4	9.8	1.0	0.4	13.3	0.1	0.3	0.5	0.5	3.6	0.2	0.7	0.2	21.0	1.4	0.3	0.5	0.3	1.4	0.3	0.5	1.0	0.3	0.6	0.6	0.3	0.4	0.4	0.8	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	1.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.5	2.5	0.0	0.2	0.9	0.0	0.1	7.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	0.2	5.8	1.0	0.4	0.5	3.6	0.3	0.0
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol			630000	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	19.8	24.7	41.9	24.1	61.6	32.6	20.8	41.8	101.9	24.3	25.0	31.9	22.3	24.7	21.9	23.6	37.8	34.5	21.6	31.6	46.9	37.8	27.2	27.6	23.0	31.9	33.1	45.4	23.4	23.0	26.0	21.6	30.7	60.4	23.8	24.1	24.2	30.4	27.7	26.7	36.9	26.0	23.1	26.7	25.7	23.9	22.1	21.2	27.8	29.9	24.5	32.8	27.1	22.9	46.0	60.8	56.1	71.3	44.8	64.5	78.2	30.5	55.2	30.5	26.9	20.6	22.8	23.4	18.4	27.4	41.0	30.3	37.0	29.3	16.3	35.0	29.5	38.2	39.3	45.8	25.5	18.8	30.5	27.1	33.1	46.8	28.9	26.9	29.8	24.2	29.8	31.3	20.0	38.6	18.9	18.5	27.5	62.8	29.3	35.6	35.7	26.3	24.1	11.9	27.8	42.6	44.7	23.1	33.3	20.8	32.0	33.6	49.6	23.8	27.9	21.9	21.3	29.3	24.1	21.8	13.7	23.3	28.3	17.5	20.9	55.1	56.3	54.3	53.1	71.3	41.4	46.0	49.1	48.6	60.8	41.9	38.4	42.6	56.1	44.8	60.9	42.1	64.5	78.2	41.9	61.6	41.8	101.9	46.9	37.8	33.1	45.4	60.4	21.2
OTUD3	"DUBA4, KIAA0459"	ENSG00000169914	"OTU deubiquitinase 3"	Q5T2D3	1	19882513-19912945	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028543, HPA028544"	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA028543: AB_10599302, HPA028544: AB_10602277"	"unprognostic (6.45e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.15e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-2)"	6.5	11.0	15.0	6.9	19.2	11.4	10.0	19.3	23.2	10.6	8.9	6.6	6.4	10.2	14.2	13.0	6.1	8.2	7.2	5.2	12.6	7.3	7.1	4.8	8.5	7.0	9.9	12.5	11.2	7.2	9.3	20.2	5.4	9.0	9.8	8.3	6.9	6.2	9.2	9.2	13.0	9.6	11.9	8.1	7.7	7.3	28.4	9.7	6.0	6.9	2.9	6.3	7.0	7.6	1.7	0.6	0.8	0.4	0.6	2.2	0.3	5.0	1.9	8.6	10.3	3.7	3.3	8.5	5.4	3.1	2.8	2.7	9.0	4.8	8.0	4.4	11.9	5.0	8.0	3.1	5.5	5.2	10.7	7.7	10.2	6.2	2.0	5.6	7.1	2.7	3.1	4.4	5.7	3.7	5.4	3.4	4.8	2.7	4.3	5.6	4.1	5.1	10.0	22.0	3.0	4.7	5.5	7.6	5.4	3.9	3.1	4.2	4.7	4.2	4.4	6.7	8.6	7.4	4.6	4.0	3.4	5.0	4.7	7.6	3.1	0.8	0.4	0.1	1.5	0.3	1.4	1.7	1.7	1.4	0.3	1.3	2.2	1.8	0.7	0.6	0.1	0.6	0.9	0.3	15.0	19.2	19.3	23.2	12.6	7.3	9.9	12.5	9.0	9.7
OTUD4	"DUBA6, HSHIN1, KIAA1046"	ENSG00000164164	"OTU deubiquitinase 4"	Q01804	4	145110838-145180161	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036623	Uncertain		Supported	Cytosol				Cytosol		"HPA036623: AB_10696780"	"unprognostic (1.67e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-1)"	14.3	11.8	16.6	11.6	16.7	24.7	12.0	22.7	15.9	14.0	15.3	16.0	10.1	10.0	13.9	13.3	14.8	14.9	11.2	15.6	12.0	9.2	11.1	17.7	15.5	13.1	14.1	8.4	14.3	13.4	22.4	12.2	17.9	12.7	10.6	11.2	10.6	12.7	11.0	36.2	13.6	16.2	12.4	10.1	13.5	10.8	26.8	18.8	13.1	13.4	13.6	12.3	11.5	12.8	3.3	2.8	2.8	2.8	1.6	3.5	1.0	14.9	8.5	10.2	9.4	12.1	14.8	13.7	13.1	14.8	16.9	13.5	9.2	18.5	27.5	6.0	18.3	9.1	17.6	18.3	22.2	11.7	8.4	13.2	10.4	8.4	14.2	27.6	10.0	11.5	18.7	20.6	27.2	14.9	21.7	20.6	16.6	8.9	17.1	12.1	11.4	9.8	14.1	11.3	6.4	16.3	10.9	9.9	8.2	12.1	18.3	13.1	6.0	11.4	18.0	19.1	12.2	9.8	17.3	15.2	15.0	18.2	13.2	19.6	18.4	0.0	1.7	2.8	3.5	2.1	2.6	3.3	2.7	2.8	1.6	2.4	2.7	2.4	0.5	1.6	2.8	2.8	2.0	1.0	16.6	16.7	22.7	15.9	12.0	9.2	14.1	8.4	12.7	18.8
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922028-48958386	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"U-266/70: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favourable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favourable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	23.5	27.5	32.4	26.8	40.9	38.4	21.9	35.0	52.4	21.3	22.9	28.2	23.4	30.5	25.5	26.8	20.5	25.1	20.9	16.6	29.8	31.3	22.6	24.5	25.2	30.8	25.4	29.8	30.0	25.4	29.6	26.8	23.1	29.4	24.0	17.8	20.4	26.9	27.4	24.4	24.5	29.1	27.1	21.4	34.5	22.3	12.7	24.0	34.8	24.5	14.4	27.2	22.1	22.7	7.8	6.3	8.6	5.1	18.6	7.5	3.5	6.1	9.3	4.3	10.7	7.4	6.6	5.0	5.4	6.3	6.8	7.4	4.6	6.8	6.9	3.5	6.8	7.5	6.5	5.4	6.4	8.0	7.9	5.2	9.4	5.3	6.2	4.9	5.8	7.3	5.1	7.1	4.8	5.4	6.5	10.9	4.8	6.1	7.7	10.7	7.8	7.3	6.1	6.4	8.9	4.8	5.5	4.2	7.4	7.1	4.6	7.1	6.1	4.5	7.6	4.4	5.6	11.7	4.4	182.8	45.6	6.6	6.9	6.9	3.0	5.2	3.4	7.0	7.0	5.1	5.8	7.8	5.5	6.0	4.8	6.0	5.2	7.5	8.6	18.6	4.7	6.3	7.0	3.5	32.4	40.9	35.0	52.4	29.8	31.3	25.4	29.8	29.4	24.0
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU domain containing 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavourable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	11.4	11.3	14.6	14.1	18.2	8.9	13.2	13.8	19.6	12.3	11.3	9.9	10.3	9.2	12.1	9.0	13.2	9.1	8.6	14.0	14.9	13.7	11.0	10.5	10.0	13.8	18.5	15.5	12.5	9.9	11.2	14.4	14.9	16.2	11.6	11.3	6.0	9.5	14.8	35.3	11.2	9.1	12.4	19.9	11.3	8.8	11.9	17.4	13.9	11.8	11.0	11.9	11.9	14.0	7.2	12.9	8.8	7.8	7.8	6.8	2.9	16.0	9.3	8.3	6.2	3.7	2.8	8.7	12.7	4.8	11.9	7.7	7.9	10.1	17.1	6.2	6.7	5.5	17.2	10.4	18.5	13.7	10.5	23.2	9.6	6.0	8.0	11.8	12.3	4.7	5.0	9.6	22.7	9.6	23.2	10.7	10.1	8.7	19.8	7.7	4.5	18.4	8.9	8.0	15.2	9.3	11.6	2.0	7.5	1.2	28.3	12.3	14.5	5.7	9.8	7.1	10.7	10.8	12.1	10.7	20.4	25.0	10.4	14.8	13.6	8.8	6.5	4.3	5.9	7.8	6.8	7.2	4.8	5.7	8.1	6.8	6.7	5.9	0.9	7.8	5.8	12.9	3.6	2.9	14.6	18.2	13.8	19.6	14.9	13.7	18.5	15.5	16.2	17.4
OTUD7A	"C15orf16, CEZANNE2, OTUD7"	ENSG00000169918	"OTU deubiquitinase 7A"	Q8TE49	15	31475398-31870789	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044554	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA044554: AB_10794895"	"unprognostic (3.61e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-11)"	"unprognostic (6.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.79e-1)"	2.6	2.0	12.4	1.7	13.9	5.9	1.5	13.2	17.0	1.8	3.4	16.0	0.0	1.5	1.9	1.9	1.9	2.0	2.3	2.1	10.0	4.6	2.3	1.0	1.5	3.5	20.4	7.1	2.0	2.5	4.6	1.7	0.9	10.5	1.2	3.1	0.7	1.6	2.0	1.8	3.2	2.1	2.9	9.1	2.2	2.3	8.2	17.4	0.0	2.3	0.0	2.4	1.9	1.3	0.1	3.2	0.3	1.4	0.1	0.7	0.4	3.6	4.1	4.5	6.0	0.4	1.3	3.2	2.5	1.3	3.9	1.9	2.5	3.2	2.9	2.2	0.9	4.6	4.8	2.0	3.2	5.9	6.6	3.7	8.3	2.0	0.3	4.0	5.7	0.0	0.2	3.8	4.3	3.5	6.0	5.4	1.8	2.9	3.1	3.9	2.0	2.0	5.6	3.0	1.4	1.6	3.9	10.9	6.0	3.4	3.0	1.0	2.5	4.3	2.3	5.3	5.2	3.0	6.2	3.3	2.4	3.0	2.9	5.8	4.5	0.0	0.4	0.3	0.6	0.5	0.3	0.0	0.3	0.7	0.2	0.1	0.2	0.2	0.0	0.1	1.4	3.2	0.0	0.4	12.4	13.9	13.2	13.8	10.0	4.6	20.4	7.1	10.5	17.4
OTX1		ENSG00000115507	"Orthodenticle homeobox 1"	P32242	2	63050057-63057836	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3"	"Cell line enriched"	"Detected in many"	9	"THP-1: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	113	"neutrophil: 11.3"	"Lineage enriched"	"Detected in single"	113	"granulocytes: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB012341, HPA052122"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"CAB012341: AB_2157155, HPA052122: "	"unprognostic (2.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.71e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.64e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.80e-4)"	"unprognostic (3.67e-3)"	0.5	0.4	8.2	0.4	4.3	0.4	1.1	0.2	7.2	0.4	0.4	5.8	0.0	0.6	0.4	0.4	1.4	0.5	0.5	0.4	9.0	1.4	0.4	0.5	0.8	0.4	2.0	3.4	0.6	0.6	0.4	0.1	0.4	0.1	2.3	0.4	18.9	19.6	0.4	0.4	14.3	0.4	0.4	0.1	0.6	1.0	0.9	4.4	0.0	0.4	4.4	5.6	0.6	0.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	1.4	0.8	2.7	1.6	0.0	0.1	3.8	0.0	0.2	0.2	0.2	2.8	1.4	0.1	0.5	0.0	1.9	1.8	1.2	0.3	0.6	1.6	1.7	1.4	3.1	0.0	1.2	1.3	0.0	0.5	0.0	0.5	0.0	1.5	0.0	0.1	1.3	1.6	2.9	0.0	1.0	1.4	2.3	0.4	0.7	0.5	0.3	0.3	1.1	0.1	0.9	0.6	33.9	0.1	0.6	1.1	0.0	0.5	1.0	0.7	2.5	0.2	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	8.2	4.3	0.2	7.2	9.0	1.4	2.0	3.4	0.1	4.4
OVCA2		ENSG00000262664	"OVCA2, serine hydrolase domain containing"	Q8WZ82	17	2041936-2043430	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059002			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA059002: "																		17.0	25.7	13.6	22.3	16.4	23.1	14.4	11.2	17.2	15.4	20.5	12.1	12.1	20.0	12.2	19.1	23.6	12.0	28.4	17.6	12.2	11.3	31.0	46.4	15.6	37.2	11.5	11.8	14.2	25.5	9.6	21.7	26.5	13.3	16.6	17.5	24.5	30.2	21.1	20.4	18.5	32.1	12.4	8.3	28.9	19.0	28.1	9.6	29.7	22.3	34.8	30.3	22.0	12.6	26.2	30.7	12.5	30.7	29.9	43.0	28.4	21.2	21.0	8.8	17.8	10.9	14.5	14.3	14.1	15.4	15.6	14.7	24.1	14.0	4.6	14.4	19.1	16.6	9.4	22.6	11.4	11.2	23.9	10.5	12.8	8.9	29.8	7.1	21.6	18.8	20.4	15.0	10.2	26.0	5.8	22.7	23.1	14.9	10.3	11.9	7.6	13.4	8.7	8.9	7.2	23.7	14.1	5.8	21.6	9.2	14.5	19.0	16.9	14.2	20.5	22.7	7.3	16.3	27.4	13.7	14.0	4.0	20.4	15.9	22.3	8.5	30.7	12.5	26.8	26.6	26.9	26.2	26.7	28.3	26.5	21.5	18.5	18.0	8.6	29.9	20.4	30.7	43.0	28.4	13.6	16.4	11.2	17.2	12.2	11.3	11.5	11.8	13.3	9.6
OVOL2	"bA504H3.3, CHED, CHED1, HOVO2, ZNF339"	ENSG00000125850	"Ovo like zinc finger 2"	Q9BRP0	20	17956979-18059188	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 6.7;CACO-2: 5.2;CAPAN-2: 8.9;HaCaT: 6.6;SCLC-21H: 10.3;SK-BR-3: 6.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 10.5;hippocampal formation: 6.8"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 7.6;hippocampal formation: 5.8"	HPA038531	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038531: AB_10673012"	"unprognostic (2.85e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-4)"	"unprognostic (4.77e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.76e-2)"	0.0	0.0	0.0	3.4	0.0	0.0	3.7	0.0	0.6	3.0	9.8	0.0	18.2	5.0	1.0	3.3	7.6	1.6	8.9	0.0	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.6	8.7	1.0	1.8	2.5	0.0	7.0	2.6	0.0	10.5	14.2	0.1	7.6	8.7	0.5	0.0	0.0	14.7	1.5	0.0	0.3	18.1	5.0	4.4	2.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	5.2	8.9	0.0	1.2	0.0	6.6	1.6	1.7	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.1	3.2	10.3	0.0	0.0	6.9	0.1	3.5	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
OXLD1	"C17orf90, MGC104712"	ENSG00000204237	"Oxidoreductase like domain containing 1"	Q5BKU9	17	81665036-81666635	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA056878, HPA057019"	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA056878: , HPA057019: "	"unprognostic (1.08e-1)"	"prognostic favourable (2.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-2)"	13.7	12.2	11.0	10.1	11.5	16.0	8.4	6.0	15.1	6.4	12.4	7.0	16.0	14.0	6.5	11.8	10.3	8.7	9.2	11.4	10.2	8.5	9.2	11.9	7.7	9.9	9.6	6.5	4.2	19.6	2.7	4.6	8.2	8.0	8.2	1.9	9.4	27.7	10.8	17.3	12.9	10.3	4.7	7.1	15.1	11.2	18.5	7.1	11.6	10.2	7.2	11.4	7.8	5.6	22.8	23.7	13.3	18.5	25.1	27.9	18.7	7.9	29.3	0.3	6.9	1.8	0.5	5.1	3.2	0.1	0.1	1.1	7.8	7.8	2.4	6.5	0.0	7.0	0.0	4.5	0.0	4.0	14.5	2.2	13.5	19.0	12.5	1.5	6.0	3.1	3.9	1.7	1.8	2.9	3.7	4.1	0.6	19.3	5.8	6.1	3.9	12.7	4.8	0.2	10.3	1.5	4.4	1.5	6.5	1.6	10.5	14.6	15.8	9.0	2.1	6.0	4.2	6.5	4.5	10.5	3.7	3.2	8.2	6.1	6.1	12.9	18.5	13.3	19.1	15.1	20.0	19.7	25.9	22.2	17.2	22.8	27.9	21.5	13.1	25.1	15.6	23.7	21.8	18.7	11.0	11.5	6.0	15.1	10.2	8.5	9.6	6.5	8.0	7.1
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favourable (1.35e-4)"	"prognostic favourable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.2	13.7	6.7	9.8	10.5	3.7	10.3	8.3	11.9	6.0	11.8	6.2	13.7	10.1	6.4	16.2	10.3	7.7	7.9	13.5	6.6	6.4	14.9	26.1	10.0	7.7	6.6	6.5	6.4	18.7	8.3	13.0	7.3	7.0	8.0	13.8	10.4	15.5	15.6	19.4	8.3	8.9	5.8	6.7	9.6	8.9	19.9	8.0	8.1	11.7	12.3	11.3	7.9	6.4	8.4	9.0	3.7	6.5	10.3	11.8	6.6	7.6	12.9	2.7	7.6	8.0	8.8	7.9	6.2	9.0	11.6	8.3	9.8	9.2	14.3	8.4	5.6	8.1	11.3	11.8	11.0	8.5	11.5	15.7	10.9	11.8	9.8	12.7	10.0	8.2	14.8	9.3	9.7	10.0	16.1	11.6	9.8	11.5	9.2	9.8	0.5	14.8	12.4	7.2	23.3	17.1	4.8	3.9	7.2	9.8	16.9	12.6	18.5	11.8	6.1	7.3	8.7	9.5	8.9	11.1	12.7	4.5	10.3	11.2	7.4	2.1	5.4	3.7	9.4	6.0	10.8	8.4	9.7	11.6	8.6	8.2	11.4	11.8	0.9	10.3	6.5	9.0	6.0	6.6	6.7	10.5	8.3	11.9	6.6	6.4	6.6	6.5	7.0	8.0
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	"Oxidative stress responsive 1"	O95747	3	38165089-38255488	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol			21000000	Cytosol		"CAB017181: , HPA008237: AB_1079540"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.99e-3)"	17.6	16.8	9.4	18.3	13.4	24.2	15.9	17.4	14.9	16.8	15.4	9.2	35.7	12.4	14.9	14.7	31.6	11.6	18.9	15.5	11.9	9.0	18.3	17.6	14.6	13.9	13.6	9.3	16.7	12.3	23.7	15.3	21.4	12.3	16.5	16.8	13.0	15.1	23.9	32.6	17.4	21.4	17.0	12.9	15.8	14.0	11.2	13.2	26.2	14.2	24.1	19.6	23.5	19.2	2.3	4.4	10.1	4.8	5.0	4.7	1.6	17.5	8.0	16.1	11.2	11.2	13.0	18.3	15.6	21.4	22.5	24.5	10.3	11.5	19.5	7.9	18.6	10.9	21.6	16.0	29.8	20.6	8.8	21.3	17.1	11.3	13.5	13.1	13.0	10.3	18.9	20.8	33.7	14.0	16.1	11.2	38.5	4.9	25.3	9.5	16.9	9.6	8.8	13.5	15.0	13.9	13.4	8.4	12.9	17.0	43.2	10.6	14.2	8.6	12.7	14.2	14.1	21.5	23.0	8.6	10.2	14.3	19.4	16.4	28.2	10.1	2.8	6.1	3.3	4.8	3.5	1.9	4.0	3.1	4.4	2.3	3.0	3.7	5.5	5.0	4.1	2.5	4.7	1.6	9.4	13.4	17.4	14.9	11.9	9.0	13.6	9.3	12.3	13.2
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696404	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;Karpas-707: 15.5;RPMI-8226: 27.0;U-698: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"memory B-cell: 28.1;naive B-cell: 30.4"	"Lineage enriched"	"Detected in many"	19	"B-cells: 30.4"									"HPA021948, HPA067827"	Supported		Supported	Cytosol				Cytosol		"HPA021948: AB_1854878, HPA067827: "	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.6	0.3	2.2	32.0	4.9	4.8	0.5	4.1	5.1	0.3	1.4	0.0	0.4	0.9	0.2	0.2	2.4	0.2	0.8	4.9	1.8	3.0	0.8	0.4	1.0	39.1	1.5	2.1	0.2	0.8	0.1	1.2	0.2	1.7	0.5	1.2	0.0	5.4	0.1	11.4	0.2	12.0	0.4	0.6	29.6	1.8	0.6	0.2	9.3	0.5	1.9	27.6	2.2	0.3	30.4	0.1	0.7	0.0	0.0	1.6	1.6	3.8	3.2	0.0	0.0	0.1	0.6	0.0	4.0	1.8	0.4	1.3	2.4	4.7	24.0	2.4	1.9	2.0	8.6	0.0	0.8	0.4	1.5	1.2	8.5	2.9	0.6	1.6	2.1	1.0	0.9	0.1	5.6	0.0	0.2	15.5	8.7	0.0	10.8	3.6	2.4	9.7	0.4	0.0	27.0	0.1	2.9	2.0	0.0	3.3	1.1	1.8	1.0	1.5	0.0	0.0	2.2	0.1	0.7	5.5	11.7	22.3	0.0	2.3	0.2	0.0	0.0	0.7	1.1	0.0	1.6	28.1	1.0	0.8	0.1	30.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.6	2.2	4.9	4.1	5.1	1.8	3.0	1.5	2.1	1.7	0.2
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.4"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 8.2;RH-30: 5.1;U-87 MG: 14.6"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA028776: , HPA028777: "	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.2	1.6	0.0	0.2	0.2	0.0	0.0	0.9	3.2	0.0	0.0			0.0	0.1	0.0	0.1	0.3	1.1	1.9	0.2	0.8	0.1	0.0	0.2	0.0	0.6		0.3	0.0	0.0	1.6	1.1		0.2	0.0		0.1	1.1	12.4	0.0	0.0	0.0	0.8	2.3	0.1	1.2			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.8	0.3	0.1	0.0	1.0	0.1	2.0	0.8	1.5	0.0	0.0	0.0	1.4	0.5	1.7	0.0	0.1	0.1	0.3	0.0	2.2	0.8	0.0	3.6	0.0	3.0	0.4	0.0	1.5	0.1	0.0	2.4	0.7	8.2	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.2	0.0	0.0	0.2	3.8	1.5	0.1	0.7	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.3	0.0	0.0	14.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0										
P2RY2	P2U	ENSG00000175591	"Purinergic receptor P2Y2"	P41231	11	73218298-73236352	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.1;skeletal muscle: 29.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.1;HL-60: 15.2;MCF7: 12.1;NB-4: 12.4;PC-3: 12.6;SK-BR-3: 14.0;THP-1: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 28.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 28.1;monocytes: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB022642	Uncertain		Uncertain	Cytosol				Cytosol		"CAB022642: "	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (6.50e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (9.69e-2)"	"unprognostic (4.92e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.57e-3)"	0.4	2.3	0.9	1.4	1.2	10.8	1.3	0.3	1.1	5.5	3.1	1.1	0.3	2.2	1.3	2.3	20.0	1.2	2.8	11.7	0.6	0.3	0.9	2.6	2.9	1.5	1.2	0.6	1.7	1.7	6.1	1.1	10.3	1.0	1.7	2.4	3.3	4.0	1.6	29.5	3.4	10.8	0.4	0.4	6.6	0.6	0.7	0.6	0.6	20.2	20.6	12.8	2.1	10.9	0.0	1.6	28.1	10.4	0.0	0.0	1.2	3.5	3.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	8.2	2.8	0.0	5.5	0.2	16.1	0.4	7.5	0.0	0.0	0.3	1.2	0.2	1.5	0.0	15.2	0.0	0.0	3.5	1.2	0.2	0.7	0.6	0.0	0.0	12.1	0.0	12.4	0.2	12.6	0.0	0.0	0.5	1.2	8.6	0.0	0.0	0.2	14.0	0.0	6.5	35.6	5.2	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	2.7	0.0	0.2	3.4	28.1	0.0	10.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	1.2	0.9	1.2	0.3	1.1	0.6	0.3	1.2	0.6	1.0	0.6
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828410-6839851	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 22.2;NTERA-2: 15.8;U-251 MG: 15.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;naive CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 17.6"	HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.7	3.1	1.2	2.2	2.6	0.3	3.0	10.7	2.5	12.1	2.7	0.0	7.6	1.1	11.0	8.5	2.5	2.1	5.6	4.4	1.2		1.1	0.4	1.6	1.9	0.0	2.2	9.3	3.6	12.1	7.4	2.5	0.8	5.6	0.5	8.1	5.9	6.5	0.5	1.8	1.7	8.8	0.5	1.0	2.8	2.1	0.1	0.0	3.5	1.2	1.4	5.9	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.9	4.2	8.0	4.9	6.0	0.1	22.2	12.8	7.1	7.8	0.3	0.0	0.0	0.3	8.3	0.0	2.5	0.2	1.6	0.0	10.6	0.5	2.3	1.0	3.5	0.5	0.0	6.5	0.2	3.4	1.9	7.4	2.0	0.0	3.3	0.0	0.0	0.2	15.8	0.6	0.0	3.9	0.1	0.3	0.0	1.6	6.0	0.0	0.0	2.5	0.1	0.1	13.0	6.9	10.3	10.6	15.3	0.0	0.1	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.9	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0										
P4HTM	"EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4"	ENSG00000178467	"Prolyl 4-hydroxylase, transmembrane"	Q9NXG6	3	48989886-49007154	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007199	Supported		Uncertain	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA007199: AB_1855272"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.47e-2)"	"prognostic favourable (8.18e-4)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-2)"	"prognostic favourable (3.28e-5)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.65e-3)"	7.4	25.5	22.1	6.4	28.5	4.7	8.9	17.6	32.9	13.5	10.8	15.9	13.8	10.4	9.7	18.9	5.4	34.7	13.0	18.6	23.0	26.5	14.1	5.4	10.6	5.6	18.7	20.3	11.4	29.9	20.8	35.7	9.6	15.7	15.5	6.7	14.1	16.0	16.5	10.0	4.3	7.8	7.0	14.3	6.3	15.7	11.7	16.4	3.4	21.5	3.3	6.7	7.5	6.1	9.8	7.8	6.7	7.6	4.9	14.4	4.8	3.8	10.5	2.0	0.0	5.9	7.0	0.1	6.9	9.1	5.2	5.6	2.3	20.7	3.3	7.2	8.4	2.0	4.4	2.3	1.5	12.3	7.8	0.0	15.6	0.0	15.7	3.2	0.1	4.0	2.3	5.2	0.4	5.8	0.0	14.3	2.5	16.4	0.4	0.4	2.8	12.4	0.0	0.0	19.2	9.2	5.9	8.2	0.1	7.7	8.3	0.0	7.3	5.3	4.0	3.1	2.7	7.7	5.4	20.4	11.2	0.0	23.0	0.3	3.2	6.7	7.6	4.8	6.4	2.7	8.7	7.0	11.6	10.3	7.8	9.8	12.0	8.3	0.8	4.9	3.6	1.4	14.4	4.8	22.1	28.5	17.6	32.9	23.0	26.5	18.7	20.3	15.7	16.4
PA2G4		ENSG00000170515	"Proliferation-associated 2G4"	Q9UQ80	12	56104319-56113907	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB011711, CAB012428, HPA016484"	Supported		Approved	Cytosol			1200000	Cytosol		"CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912"	"unprognostic (5.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.87e-1)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (6.31e-7)"	"unprognostic (4.25e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (4.59e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.67e-2)"	41.1	32.1	26.6	41.4	29.8	52.5	38.5	35.1	38.8	33.7	39.2	31.0	27.1	34.4	36.1	22.4	69.4	31.2	31.9	55.6	26.6	25.5	36.1	51.6	32.6	43.3	26.7	28.0	43.3	44.3	42.8	20.5	39.0	28.2	40.3	44.2	23.6	34.6	33.4	77.3	53.0	31.7	39.4	32.3	46.7	34.4	27.9	23.9	70.8	39.7	57.2	54.0	45.5	39.6	25.5	27.1	13.5	25.1	37.4	48.9	36.0	53.3	47.4	32.6	35.8	15.1	22.9	65.4	56.5	27.1	69.6	38.8	57.9	39.7	106.8	38.1	26.7	44.0	74.2	63.1	68.0	30.3	63.6	82.1	32.3	49.4	29.5	111.3	30.4	23.1	32.3	60.2	54.5	42.2	99.6	49.7	38.1	47.3	86.5	58.2	53.4	58.3	71.3	58.9	72.4	35.2	40.1	48.9	29.6	37.2	58.9	34.5	63.5	43.3	33.8	34.0	48.0	39.1	62.4	30.5	41.9	104.6	30.7	67.1	44.0	7.8	23.0	13.5	36.6	25.1	48.9	25.5	38.9	39.4	27.1	22.2	37.6	37.3	3.7	37.4	20.0	26.3	43.3	36.0	26.6	29.8	35.1	38.8	26.6	25.5	26.7	28.0	28.2	23.9
PAAF1	"FLJ11848, Rpn14, WDR71"	ENSG00000175575	"Proteasomal ATPase associated factor 1"	Q9BRP4	11	73876699-73931124	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039952, HPA040020"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039952: AB_10793925, HPA040020: "	"unprognostic (3.13e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.42e-1)"	9.5	12.8	32.4	6.9	30.6	5.2	12.3	18.0	23.2	11.7	8.7	34.4	7.6	7.8	11.5	17.2	10.0	13.9	8.0	9.9	30.5	27.4	16.0	13.8	7.9	7.6	37.4	19.6	17.8	19.8	16.8	10.1	7.7	25.4	14.5	11.5	12.9	9.9	14.5	11.9	12.8	7.8	12.1	38.9	7.1	6.8	18.8	27.0	8.2	13.0	2.1	11.1	7.9	6.3	22.6	19.3	22.1	15.1	16.5	22.6	15.1	5.6	13.1	11.9	9.3	13.0	13.4	6.8	9.7	11.3	15.6	11.1	25.6	4.5	17.1	15.2	9.9	13.0	14.5	11.7	23.2	12.7	9.0	17.4	12.9	21.0	15.6	16.2	6.7	13.7	18.4	17.0	20.9	11.7	21.0	14.7	14.4	11.0	14.3	16.9	5.5	10.3	13.3	31.8	27.9	11.5	9.8	12.7	14.9	11.5	7.7	30.0	23.1	9.2	8.4	11.0	7.0	15.5	9.4	18.2	20.4	34.8	7.7	10.6	11.4	22.1	15.1	17.4	16.0	9.5	17.5	22.6	17.5	16.2	19.3	18.8	22.6	19.4	1.3	16.5	3.4	14.0	19.6	15.1	32.4	30.6	18.0	22.3	30.5	27.4	37.4	19.6	25.4	27.0
PABPC1	"PAB1, PABP1, PABPC2, PABPL1"	ENSG00000070756	"Poly(A) binding protein cytoplasmic 1"	P11940	8	100685816-100722809	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB011536, HPA045423, HPA067156"	Supported		Supported	Cytosol			2700000	Cytosol		"CAB011536: AB_777008, HPA045423: , HPA067156: "	"unprognostic (5.00e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-1)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (2.51e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (5.70e-12)"	"unprognostic (6.22e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.98e-3)"	"unprognostic (1.40e-2)"	85.6	49.6	33.6	66.1	38.8	94.2	80.5	35.8	32.5	84.2	80.7	41.9	57.2	64.1	85.3	48.8	195.5	54.6	56.4	35.1	32.3	19.3	43.6	83.2	72.8	156.2	40.6	24.3	111.1	106.9	31.8	34.1	50.6	36.8	88.2	71.5	43.4	192.9	79.0	35.1	95.4	104.0	89.9	65.2	135.3	73.4	98.7	37.6	137.2	65.4	63.0	157.9	120.9	116.4	70.8	98.4	32.3	106.7	65.9	106.0	90.6	180.2	45.1	35.3	64.1	66.2	131.6	61.0	44.1	63.9	47.5	51.8	53.9	84.9	228.8	172.1	77.6	70.0	55.3	86.3	81.3	69.9	36.5	118.0	34.0	69.3	82.1	50.5	83.5	122.2	136.7	44.2	217.6	74.2	99.1	88.1	70.4	52.5	251.4	105.3	79.1	64.1	83.0	42.9	82.6	57.4	117.4	49.3	54.9	29.4	46.0	103.0	82.8	83.8	69.1	42.8	79.9	62.8	74.2	86.4	59.8	128.2	50.4	113.5	43.0	27.6	83.3	28.8	39.7	99.9	84.2	70.8	78.3	64.4	98.4	62.6	106.0	85.1	32.3	65.9	106.7	65.5	67.4	90.6	33.6	38.8	35.8	32.5	32.3	19.3	40.6	24.3	36.8	37.6
PABPC1L	"C20orf119, dJ1069P2.3, ePAB, PABPC1L1"	ENSG00000101104	"Poly(A) binding protein cytoplasmic 1 like"	Q4VXU2	20	44910062-44959035	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Group enriched"	"Detected in many"	5	"B-cells: 3.3;granulocytes: 3.9;T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066650			Approved	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA066650: "	"unprognostic (4.98e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.92e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.96e-2)"	"prognostic unfavourable (4.00e-15)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.63e-2)"	"prognostic favourable (8.84e-4)"	4.7	8.1	9.8	29.3	20.4	14.0	16.0	3.4	6.0	8.4	5.7	6.2	20.4	6.9	8.3	26.1	7.6	9.1	13.0	3.7	8.6	4.2	21.7	29.2	14.6	16.3	5.6	9.3	16.9	29.3	7.7	23.7	5.1	7.1	15.2	6.4	7.6	10.2	14.7	0.9	10.3	10.0	6.2	10.9	12.5	10.0	9.2	6.5	20.3	28.1	6.3	12.9	9.0	12.1	3.3	0.4	3.9	0.5	0.3	1.9	0.1	6.5	8.5	11.4	16.6	4.4	9.3	26.3	14.4	2.9	5.6	7.5	23.3	12.0	8.5	24.3	5.7	15.2	5.1	13.2	4.6	5.1	10.4	6.8	23.4	21.5	9.9	5.8	2.8	9.7	23.4	11.9	21.1	1.3	7.6	12.4	6.7	18.6	7.3	14.0	4.5	15.0	9.4	2.5	4.5	7.9	8.1	7.1	7.1	5.7	18.0	19.5	35.1	4.7	4.6	25.0	16.8	10.9	6.9	16.3	16.2	4.3	8.1	2.4	8.2	0.1	0.5	0.1	0.9	0.1	1.9	1.4	0.2	0.7	0.2	3.3	0.3	0.5	3.9	0.3	0.2	0.4	0.5	0.1	9.8	20.4	3.4	6.0	8.6	4.2	5.6	9.3	7.1	6.5
PABPC3	"PABP3, PABPL3, tPABP"	ENSG00000151846	"Poly(A) binding protein cytoplasmic 3"	Q9H361	13	25095868-25099254	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 50.9"	"Cell line enriched"	"Detected in single"	14	"U-266/84: 11.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA045423, HPA067156"	Approved		Approved	Cytosol				Cytosol		"HPA045423: , HPA067156: "	"unprognostic (2.17e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (8.00e-4)"	"unprognostic (5.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.61e-3)"	0.5	0.2	0.2	0.5	0.8	0.2	1.0	0.1	1.1	0.7	0.5	0.1	0.0	0.2	0.2	0.3	0.7	0.2	0.2	0.2	0.3	0.1	0.2	0.2	1.2	2.0	0.2	0.4	0.4	0.3	0.1	0.4	0.2	0.3	0.4	0.2	0.0	0.6	0.9	0.2	0.4	0.5	0.2	0.1	0.4	0.2	50.9	0.0	0.8	0.3	0.0	0.2	0.3	0.4	1.6	1.9	0.5	2.2	1.8	2.5	1.9	0.4	0.0	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.5	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.7	0.7	0.2	0.0	0.2	0.0	0.1	0.0	0.5	0.7	0.2	0.0	0.2	0.4	0.2	0.0	0.0	0.1	0.1	0.4	0.2	0.3	11.4	0.2	0.1	0.3	0.1	0.4	1.4	0.5	0.7	2.1	1.6	1.6	1.7	1.3	1.9	1.3	2.5	2.2	0.5	1.8	2.2	1.1	1.5	1.9	0.2	0.8	0.1	1.1	0.3	0.1	0.2	0.4	0.3	0.0
PABPC4	"APP-1, iPABP"	ENSG00000090621	"Poly(A) binding protein cytoplasmic 4"	Q13310	1	39560816-39576790	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 137.3;skeletal muscle: 117.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027301, HPA056496"	Approved		Enhanced	Cytosol				Cytosol		"HPA027301: , HPA056496: "	"unprognostic (6.81e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (1.14e-7)"	"unprognostic (2.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavourable (3.00e-10)"	"unprognostic (1.87e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.08e-1)"	30.0	19.2	9.0	23.0	7.9	20.8	19.6	7.2	9.6	19.1	26.0	14.0	22.0	12.4	22.2	21.1	20.3	13.7	20.2	32.0	8.6	7.2	12.3	28.8	24.9	38.2	8.3	7.3	28.6	137.3	9.1	8.2	16.2	8.6	20.7	11.5	15.4	16.4	22.9	117.8	12.9	21.1	22.4	16.4	27.5	28.0	29.2	6.4	21.5	18.1	51.1	21.0	25.3	20.3	13.9	13.7	6.7	21.2	8.2	21.4	5.5	56.9	15.5	16.5	27.4	41.3	82.1	54.3	33.7	23.7	26.2	19.5	31.0	29.9	49.2	33.5	42.3	30.5	31.4	37.6	33.9	25.1	25.9	41.5	17.7	30.9	41.5	27.4	27.9	71.2	44.6	31.8	48.5	32.8	43.9	27.3	42.0	22.2	28.4	35.4	51.1	17.8	21.8	52.9	37.3	25.3	56.3	15.6	23.7	23.5	22.5	51.0	23.9	81.3	29.6	25.5	35.4	61.7	42.5	70.4	77.2	38.3	37.8	27.8	14.5	6.7	13.9	3.5	9.9	18.0	10.6	13.8	16.1	10.3	13.7	13.9	21.4	15.1	1.4	8.2	21.2	13.5	11.2	5.5	9.0	7.9	7.2	9.6	8.6	7.2	8.3	7.3	8.6	6.4
PACS1	"FLJ10209, KIAA1175"	ENSG00000175115	"Phosphofurin acidic cluster sorting protein 1"	Q6VY07	11	66070363-66244747	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038914	Approved		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA038914: AB_10672831"	"unprognostic (7.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.46e-1)"	20.0	14.6	18.0	33.7	23.1	17.7	25.5	33.6	25.5	17.7	16.6	12.5	12.8	10.5	17.4	16.9	19.6	18.1	19.8	33.1	17.3	15.0	17.7	7.4	20.7	42.3	12.8	19.0	26.2	16.7	19.9	16.9	14.6	12.8	21.3	8.5	19.0	66.8	18.8	15.2	16.2	15.1	23.5	11.7	24.0	16.0	28.4	13.6	33.9	21.6	15.6	33.7	21.9	17.7	7.2	1.9	11.2	3.7	2.9	5.8	3.6	16.7	17.8	8.3	5.5	15.9	19.0	9.7	22.8	16.8	16.9	10.5	10.9	13.9	10.6	15.4	40.2	11.0	6.2	17.3	21.5	16.9	7.0	17.1	15.6	15.7	19.3	2.4	14.2	19.4	8.1	15.3	19.2	15.8	6.4	20.9	18.2	31.8	18.2	6.6	3.9	8.5	12.2	8.5	18.7	11.8	16.9	11.9	13.6	23.8	14.2	11.8	15.9	3.3	20.8	21.7	9.5	28.9	9.8	10.6	6.8	2.8	18.3	4.0	10.6	5.2	2.0	3.9	5.2	1.5	3.5	4.6	4.9	4.5	1.9	7.2	5.6	5.0	11.2	2.9	3.7	1.2	5.8	3.6	18.0	23.1	33.6	25.5	17.3	15.0	12.8	19.0	12.8	13.6
PACSIN2	SDPII	ENSG00000100266	"Protein kinase C and casein kinase substrate in neurons 2"	Q9UNF0	22	42835412-43015145	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049854, HPA056520"	Enhanced		Supported	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"			83000	"Nuclear speckles, Vesicles, Cytosol"	"Plasma membrane"	"HPA049854: AB_2680915, HPA056520: AB_2683163"	"unprognostic (5.62e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (4.48e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (1.09e-13)"	"unprognostic (2.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.95e-1)"	20.1	42.0	19.4	19.4	20.7	14.3	22.9	32.3	21.3	18.7	28.4	17.5	21.1	22.5	20.8	18.9	19.3	17.5	33.3	28.0	17.9	19.5	32.5	20.7	25.8	16.9	20.6	15.7	17.4	77.3	14.3	21.5	33.8	32.4	24.6	23.5	26.6	31.7	16.6	23.9	19.4	25.6	25.1	17.8	22.5	27.8	12.6	19.2	13.1	31.0	15.8	18.4	17.7	17.6	4.7	8.3	37.9	12.6	6.7	4.5	5.0	24.7	26.0	21.9	14.0	11.3	12.1	18.0	22.6	13.7	20.5	17.1	27.0	14.6	11.5	19.2	16.7	17.6	14.3	24.0	13.5	11.7	14.2	18.5	13.3	38.4	16.1	13.0	40.4	11.6	23.7	26.9	11.8	16.7	16.0	8.4	17.5	16.2	13.8	20.5	12.0	11.0	17.0	32.8	7.7	23.5	14.7	14.3	6.4	27.0	18.7	50.7	13.5	17.4	24.7	15.3	19.5	16.9	13.3	6.3	8.6	12.6	14.6	11.6	33.2	7.9	7.0	17.4	2.8	12.6	3.0	4.2	3.2	2.4	8.3	4.7	3.2	2.4	37.9	6.7	12.1	3.1	4.5	5.0	19.4	20.7	32.3	21.3	17.9	19.5	20.6	15.7	32.4	19.2
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177525-47186443	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	4.1	17.0	3.9	2.2	5.7	0.4	4.3	3.5	4.7	6.5	8.5	8.6	7.1	1.6	6.7	7.6	12.6	4.8	5.8	40.6	4.0	2.4	2.9	10.0	3.9	0.8	7.6	3.6	6.3	14.6	4.8	1.0	8.0	4.4	8.6	1.1	4.6	11.3	6.7	121.6	11.9	1.9	7.4	8.3	1.5	6.0	1.6	6.5	0.3	8.5	44.6	7.1	6.4	5.7	0.0	0.1	0.0	0.9	0.0	0.2	0.9	16.4	8.3	3.8	16.6	3.3	3.3	18.6	5.1	7.4	10.8	6.1	12.3	2.3	0.1	1.6	2.8	27.1	7.6	12.5	4.3	2.5	12.9	2.5	31.3	28.2	6.5	0.5	2.6	9.3	16.8	5.7	9.1	4.8	5.4	0.2	4.4	32.6	0.3	12.1	4.7	16.6	10.1	14.4	2.6	4.5	15.6	0.1	13.0	8.1	5.8	7.6	41.0	2.2	2.3	18.9	19.0	2.4	14.1	2.8	1.3	1.5	6.1	5.7	9.7	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.9	5.7	3.5	4.7	4.0	2.4	7.6	3.6	4.4	6.5
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205126-17246005	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 48.7;lymphoid tissue: 60.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.3;EFO-21: 4.5;HaCaT: 2.8;LHCN-M2: 3.6;RPTEC TERT1: 4.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Low region specificity"	"Detected in some"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA062294: "	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavourable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.3	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.1	0.0	4.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	60.2	1.3	6.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.1	9.3	0.0	4.5	0.4	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAFAH1B2		ENSG00000168092	"Platelet activating factor acetylhydrolase 1b catalytic subunit 2"	P68402	11	117144267-117176894	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051836	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"			1600000	Cytosol	"Nucleoli, Plasma membrane"	"HPA051836: "	"unprognostic (1.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.21e-3)"	"prognostic unfavourable (9.44e-4)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.01e-1)"	"prognostic favourable (4.25e-4)"	"prognostic unfavourable (7.79e-5)"	"unprognostic (8.18e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	21.5	34.1	30.6	19.2	29.7	33.5	32.3	43.5	41.3	21.6	20.2	33.3	12.7	21.1	23.4	22.8	23.3	20.8	19.3	26.2	31.9	36.8	24.6	22.5	20.5	17.7	39.3	31.6	23.6	23.0	23.1	24.2	26.9	39.6	22.2	19.6	17.3	19.3	17.4	14.1	20.8	18.0	19.9	51.6	18.3	21.4	29.9	26.3	15.1	30.9	10.8	20.4	25.9	20.3	26.8	21.6	36.8	35.7	18.9	31.4	26.9	14.8	17.0	19.7	28.3	22.0	15.4	15.3	25.0	21.9	13.9	12.7	31.0	32.8	16.1	35.9	29.9	23.9	28.5	32.3	18.4	14.3	11.0	41.3	15.6	19.9	19.7	14.2	15.8	17.0	25.6	27.8	35.1	22.8	21.9	12.3	21.3	9.5	13.7	21.0	18.0	13.4	15.4	22.3	17.6	21.3	23.3	21.9	29.1	28.8	21.8	9.5	24.3	12.3	36.4	25.5	16.9	12.4	17.7	3.9	5.9	21.6	10.3	27.4	21.4	32.1	30.8	26.7	24.2	33.3	28.2	26.8	28.0	25.3	21.6	25.4	29.3	31.4	36.8	18.9	35.7	15.8	19.5	26.9	30.6	29.7	43.5	37.8	31.9	36.8	39.3	31.6	39.6	26.3
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464579	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Uncertain		Approved	Cytosol			340000	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favourable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (2.16e-1)"	15.5	27.1	21.6	20.4	17.4	21.4	29.3	15.8	20.6	17.5	22.5	18.5	18.4	17.2	19.6	12.6	29.0	19.6	11.4	13.4	16.7	22.6	26.5	63.7	11.3	25.6	26.4	19.2	23.3	27.7	26.2	17.9	24.3	29.8	17.5	30.5	13.1	15.7	16.8	23.8	20.0	16.1	19.4	23.5	19.8	12.8	18.3	15.9	44.9	17.8	26.8	33.1	18.7	18.9	13.7	12.8	3.2	6.4	10.9	14.4	6.7	33.9	25.5	52.8	32.6	11.3	25.6	45.5	29.5	21.4	42.3	41.8	40.5	40.5	78.8	34.3	19.7	21.0	83.2	42.8	72.7	15.7	29.3	42.8	39.1	44.8	21.7	76.0	19.1	21.6	31.1	44.9	34.0	34.7	73.8	29.4	36.4	22.7	87.3	38.1	60.4	32.0	70.9	22.6	51.8	40.1	23.9	56.7	33.9	29.0	40.6	17.8	26.8	24.4	18.6	33.6	43.9	33.0	60.2	20.8	17.8	82.9	35.4	55.7	36.9	3.2	3.7	0.3	4.1	6.4	11.8	13.7	11.5	7.3	11.4	8.9	14.4	12.1	0.9	10.9	4.8	12.8	8.3	6.7	21.6	17.4	15.8	20.6	16.7	22.6	26.4	19.2	29.8	15.9
PAIP1		ENSG00000172239	"Poly(A) binding protein interacting protein 1"	Q9H074	5	43526267-43557758	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073653, HPA076187"	Approved		Approved	"Plasma membrane,Cytosol"			18000	"Plasma membrane, Cytosol"		"HPA073653: , HPA076187: "	"unprognostic (4.70e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (4.79e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	30.1	26.6	26.9	15.4	26.0	20.6	35.9	22.7	32.6	30.2	27.8	25.0	19.6	18.3	28.4	26.0	26.1	22.8	23.3	45.6	26.8	24.4	34.0	38.3	21.3	20.8	28.6	21.5	24.8	23.5	30.9	24.0	29.0	23.0	32.1	24.3	21.3	23.4	31.7	62.8	16.6	24.2	38.7	33.4	21.0	23.8	44.3	27.3	29.9	38.5	20.6	18.6	31.5	36.8	14.1	35.0	23.4	12.4	12.5	16.4	10.9	22.6	20.2	39.7	38.4	41.7	33.0	32.5	20.0	44.7	38.3	33.4	18.8	28.0	15.1	34.8	28.3	14.9	61.9	24.1	39.1	12.5	24.0	11.9	40.5	29.6	36.8	17.7	18.8	34.9	46.9	25.8	48.8	36.4	27.5	20.5	38.1	24.4	19.5	24.5	19.7	26.1	15.3	30.0	21.2	47.5	28.0	22.6	34.3	64.2	24.8	44.4	35.3	25.8	20.2	34.8	28.8	17.3	25.1	15.5	26.3	22.7	20.3	27.5	29.9	17.4	12.4	23.4	10.5	10.4	14.0	14.1	13.1	14.5	12.4	13.2	16.4	13.0	4.6	12.5	11.1	35.0	11.4	10.9	26.9	26.0	22.7	32.6	26.8	24.4	28.6	21.5	23.0	27.3
PAIP2B	KIAA1155	ENSG00000124374	"Poly(A) binding protein interacting protein 2B"	Q9ULR5	2	71182739-71227083	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9;pancreas: 47.8;skeletal muscle: 39.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 9.1;RPMI-8226: 13.0;SCLC-21H: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA046784, HPA072371"	Approved		Approved	Cytosol				Cytosol		"HPA046784: , HPA072371: "	"unprognostic (8.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (8.17e-5)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (6.96e-12)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.61e-2)"	2.8	2.4	36.3	2.3	28.8	1.8	4.8	11.9	15.7	3.3	4.2	50.9	5.1	4.0	3.5	2.5	6.2	7.4	1.8	17.8	39.5	25.1	9.9	16.6	3.3	2.5	47.7	9.7	11.6	47.8	6.4	2.1	1.4	21.9	5.2	4.2	2.7	29.9	5.6	39.4	15.1	3.2	3.4	44.9	2.7	6.7	2.7	24.6	0.6	11.1	3.5	4.7	2.7	2.3	5.8	4.5	1.0	0.9	1.5	4.6	1.2	2.1	0.5	0.9	3.1	0.3	0.5	3.9	0.3	0.1	0.3	0.1	0.8	0.9	2.7	0.6	0.0	1.7	5.2	3.1	1.0	1.4	4.3	2.6	0.3	0.1	1.4	0.7	0.2	0.6	2.9	0.1	3.2	0.5	4.5	2.6	0.1	2.6	0.8	1.4	2.3	2.0	0.0	9.1	13.0	1.6	1.4	20.2	1.2	2.2	1.5	0.9	6.5	0.1	0.1	0.2	1.7	1.7	0.9	5.3	4.4	3.3	0.2	1.0	0.5	1.0	0.7	1.0	2.0	0.9	2.6	4.9	2.8	2.0	0.8	5.8	4.6	4.0	0.5	1.5	0.8	4.5	1.1	1.2	36.3	28.8	11.9	15.7	39.5	25.1	47.7	9.7	21.9	24.6
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77321707-77474635	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.0;brain: 71.4"	"Cell line enhanced"	"Detected in many"		"U-266/70: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"			200000	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	5.4	6.0	30.5	13.8	39.5	22.9	7.8	49.1	71.4	9.8	18.2	8.4	2.3	18.2	9.1	13.3	9.9	9.8	13.2	5.3	19.0	16.9	11.3	6.0	6.9	7.5	12.8	40.6	10.4	9.2	11.8	10.8	11.9	39.2	12.2	20.2	5.4	10.4	8.8	34.0	6.7	18.9	11.6	7.8	11.7	17.1	11.1	6.6	7.6	17.7	3.9	9.4	10.5	10.4	2.7	42.3	70.0	30.4	4.3	2.4	12.2	11.8	8.0	17.4	7.8	7.1	11.9	13.9	13.6	9.7	12.9	15.2	11.4	15.9	10.6	5.0	11.7	6.1	12.1	14.4	20.4	12.2	9.8	11.2	5.4	0.7	4.7	18.9	16.6	8.8	8.7	15.1	22.5	3.0	7.4	18.7	23.4	0.8	12.0	8.7	25.7	6.9	18.5	22.5	0.4	3.3	9.9	7.5	7.4	7.3	3.1	5.7	13.9	8.6	0.2	8.6	14.9	45.9	11.3	51.4	26.4	7.0	7.2	12.6	9.3	0.3	29.3	45.0	1.9	28.7	1.5	2.7	1.4	1.8	42.3	1.9	1.3	2.4	70.0	4.3	30.4	3.6	1.1	12.2	30.5	39.5	49.1	71.4	19.0	16.9	12.8	40.6	39.2	6.6
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.2;pancreas: 46.5;pituitary gland: 37.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;HAP1: 8.7;HDLM-2: 10.9;NTERA-2: 8.5;SCLC-21H: 11.1;SH-SY5Y: 6.9;U-2197: 6.7;U-251 MG: 11.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 4.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Cytosol				Cytosol		"HPA044791: , HPA060219: "	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	2.0	6.8	17.6	2.5	17.5	1.0	6.4	1.8	24.6	3.7	1.6	0.9	9.1	1.0	6.8	7.6	1.7	3.7	2.6	1.2	26.2	20.8	1.6	1.1	1.8	2.5	7.9	21.9	7.9	46.5	0.9	37.2	1.6	12.9	4.8	1.7	1.4	3.0	7.1	2.4	2.0	1.4	6.1	5.8	2.9	3.0	3.6	1.9	0.0	7.7	0.0	1.7	2.0	1.5	0.1	0.1	0.6	0.1	0.2	4.3	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	9.7	1.0	0.0	8.7	0.5	1.2	10.9	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	8.5	1.9	0.1	4.0	0.0	0.8	0.0	11.1	6.9	0.0	0.4	0.0	0.0	0.0	0.0	0.6	4.3	6.7	11.6	0.0	0.1	0.1	1.2	0.0	0.1	0.6	0.1	0.1	0.1	0.0	4.3	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.0	17.6	17.5	1.8	18.5	26.2	20.8	7.9	21.9	12.9	1.9
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497066-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 203.3"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Actin filaments"	Cytosol	"CAB070159: AB_1726016, HPA035905: "	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.28e-4)"	17.3	8.9	8.5	19.6	7.5	0.1	28.1	2.1	6.7	58.4	71.9	5.7	46.4	6.7	82.2	25.6	84.3	31.3	30.8	95.0	9.2	3.2	12.7	3.6	24.9	17.0	4.6	4.7	28.0	3.0	25.6	3.9	14.0	6.0	71.4	17.9	9.2	11.4	50.9	30.5	8.9	16.8	203.3	6.7	25.8	31.4	14.1	6.9	2.2	12.7	17.2	5.8	140.3	82.7	0.2	2.2	13.6	3.2	0.6	5.1	1.5	17.6	8.7	19.4	12.0	17.9	19.5	27.3	12.1	30.5	10.7	15.2	0.2	1.0	7.6	3.1	5.2	3.7	11.8	30.8	13.7	16.0	3.6	0.1	25.1	2.2	31.3	0.0	0.2	29.7	19.2	19.1	28.7	4.5	0.0	0.1	64.4	0.8	5.1	0.3	5.6	5.2	1.7	18.0	0.1	1.2	3.5	2.0	10.5	22.8	1.7	1.6	10.8	0.1	14.5	11.2	42.4	4.7	19.6	10.9	0.1	0.3	9.4	0.2	3.1	13.6	3.2	0.0	5.1	1.9	0.2	0.1	0.6	2.7	2.2	0.2	0.6	2.0	0.8	0.6	1.2	0.2	0.5	1.5	8.5	7.5	2.1	6.7	9.2	3.2	4.6	4.7	6.0	6.9
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 304.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 76.6;fHDF/TERT166: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"		59000000	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: "	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	16.5	24.5	8.2	6.5	16.4	0.8	17.3	6.6	16.5	74.9	14.0	5.4	9.5	5.8	21.3	83.8	11.7	10.6	11.5	304.2	8.8	23.5	13.7	2.1	13.2	5.8	10.0	7.6	17.0	16.4	49.5	18.3	26.3	15.5	13.4	9.5	8.7	53.8	29.4	22.0	8.5	8.5	18.5	4.8	8.9	17.2	7.2	4.6	1.8	21.7	13.2	7.3	15.8	15.3	0.5	2.0	10.1	5.3	16.2	14.1	6.3	14.9	2.2	27.6	12.2	76.6	45.9	11.0	42.6	63.8	12.6	38.5	7.3	19.9	0.0	9.2	98.2	5.1	1.5	18.7	34.9	1.8	6.2	3.1	9.0	2.3	11.6	0.9	3.4	25.1	8.1	9.2	7.0	26.0	0.1	2.1	35.7	3.0	0.0	0.4	4.9	8.3	1.1	15.4	8.3	48.7	1.7	13.1	9.0	18.1	1.1	11.1	4.7	1.0	20.0	40.1	10.4	18.8	12.6	4.7	1.1	0.0	46.0	4.2	34.5	1.9	5.3	0.1	14.1	0.9	10.0	0.5	8.5	10.4	2.0	0.3	2.9	4.8	10.1	16.2	1.9	1.1	12.1	6.3	8.2	16.4	6.6	16.5	8.8	23.5	10.0	7.6	15.5	4.6
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929882	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol				Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	15.2	21.5	18.7	18.5	18.9	20.8	19.7	21.8	24.8	14.7	14.4	16.8	10.7	11.8	15.5	15.5	28.9	19.1	14.3	11.0	17.4	18.6	18.8	20.3	16.1	18.5	16.2	16.2	14.4	13.5	15.3	15.7	18.1	20.8	14.5	16.4	17.0	15.8	13.2	14.4	12.8	14.5	16.6	12.3	20.6	12.1	28.9	14.1	23.2	17.0	10.5	24.6	17.3	16.4	5.8	8.6	8.0	12.8	8.3	6.4	3.1	21.4	13.9	15.0	7.6	18.0	15.6	8.2	14.1	15.5	18.6	24.1	18.7	11.5	17.4	6.5	15.8	17.7	16.1	27.4	23.8	5.1	7.1	23.8	9.9	34.9	15.1	15.8	7.9	13.7	12.0	20.7	13.4	17.4	17.5	16.3	20.0	5.3	13.6	14.0	15.0	10.4	11.2	20.9	11.0	11.5	19.7	19.6	9.6	17.5	19.2	34.9	11.6	12.8	11.9	22.3	11.2	29.1	21.6	9.2	26.6	13.3	6.6	14.5	17.4	1.6	11.2	4.7	4.4	12.8	4.3	4.7	4.3	4.5	8.6	5.8	4.4	4.0	8.0	8.3	10.7	3.0	6.4	3.1	18.7	18.9	21.8	24.8	17.4	18.6	16.2	16.2	20.8	14.1
PANK4	FLJ10782	ENSG00000157881	"Pantothenate kinase 4"	Q9NVE7	1	2508533-2526628	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.1"	"Cell line enhanced"	"Detected in many"		"BJ: 8.9;HDLM-2: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011723, HPA012036, HPA027961"	Uncertain		Approved	Cytosol				Cytosol		"HPA011723: , HPA012036: AB_1854952, HPA027961: AB_10602042"	"unprognostic (1.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.29e-2)"	"prognostic favourable (1.57e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-2)"	5.3	14.4	10.7	17.8	12.6	4.2	5.4	14.9	12.4	5.5	7.1	6.8	4.9	4.2	7.0	4.2	9.8	5.6	9.2	11.8	8.0	5.2	7.2	7.0	6.7	12.5	9.0	6.8	5.7	5.8	4.2	8.3	6.7	7.4	5.8	6.1	8.9	5.6	5.3	43.1	19.0	7.6	9.1	4.4	8.1	6.3	11.0	9.7	9.4	6.8	6.8	7.2	7.2	5.7	4.5	4.8	11.7	6.9	11.4	8.9	5.3	2.4	6.6	2.3	0.0	0.0	2.7	1.5	8.9	0.0	8.0	7.6	0.0	0.0	1.1	3.0	2.4	3.8	1.9	0.0	1.7	9.2	5.6	0.0	3.8	5.5	2.5	0.0	4.6	0.0	0.0	0.0	0.0	1.9	2.5	0.0	2.1	0.0	1.3	0.2	0.0	2.8	0.0	0.0	1.8	0.0	0.0	2.0	0.0	5.0	1.8	0.0	0.0	3.3	0.0	0.0	1.9	4.6	2.1	1.3	4.5	5.9	3.0	0.9	0.0	11.7	4.9	4.5	6.2	6.6	5.1	4.5	3.9	6.4	4.8	3.0	7.4	8.0	6.4	11.4	6.9	0.9	8.9	5.3	10.7	12.6	14.9	12.4	8.0	5.2	9.0	6.8	7.4	9.7
PAPD4	"FLJ38499, GLD2, TUT2"	ENSG00000164329	"Poly(A) RNA polymerase D4, non-canonical"	Q6PIY7	5	79612120-79686648	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054468			Approved	Cytosol				Cytosol		"HPA054468: "	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.37e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.67e-3)"	25.4	21.1	15.8	34.4	22.1	42.1	27.9	20.9	30.3	23.8	22.6	24.7	22.7	19.2	34.4	28.1	22.0	20.7	23.3	16.5	16.5	14.6	20.0	25.3	25.6	34.7	19.4	20.2	29.6	21.4	18.0	23.1	25.7	17.2	20.6	23.3	23.8	21.4	28.3	21.0	25.5	25.4	23.1	22.2	37.4	21.0	26.0	21.2	33.8	24.9	21.3	29.3	22.6	21.9	20.2	19.5	22.3	22.1	19.3	29.9	15.7	11.4	8.0	8.9	14.1	15.7	18.3	14.3	13.9	21.4	16.3	26.1	7.1	13.7	21.5	7.3	15.3	11.0	11.4	15.4	18.7	15.9	10.5	12.2	9.9	11.0	20.4	18.0	16.9	16.1	16.8	11.5	21.6	13.7	13.9	15.9	17.9	6.2	20.5	23.2	8.3	5.7	18.4	9.0	23.9	15.8	16.5	5.9	10.8	11.0	12.1	21.8	10.4	28.6	12.6	8.8	6.0	8.5	15.3	16.7	13.9	21.3	15.6	19.0	12.3	22.3	19.1	18.6	18.2	22.1	29.9	20.2	19.9	19.9	19.5	16.2	19.3	19.8	17.3	19.3	21.7	10.7	20.2	15.7	15.8	22.1	20.9	30.3	16.5	14.6	19.4	20.2	17.2	21.2
PAQR7	"MPRA, mSR"	ENSG00000182749	"Progestin and adipoQ receptor family member 7"	Q86WK9	1	25861210-25871253	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.7;HaCaT: 24.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046936	Approved		Approved	Cytosol				Cytosol		"HPA046936: "	"unprognostic (1.12e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (1.47e-1)"	"unprognostic (4.59e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.05e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.54e-2)"	1.2	9.5	1.8	0.7	2.3	1.0	1.4	1.8	1.8	2.8	1.6			6.7	4.1	10.2	6.1	6.8	2.1	0.6	1.7	2.6	11.9	1.9	1.6	0.6	2.0		13.2	1.8	3.9	2.1	6.9		2.4	0.4		1.5	8.9	0.2	10.7	5.7	2.9	1.4	3.5	2.3	16.2			1.4		1.0	6.3	4.6	3.2	5.5	10.8	11.7	2.4	1.4	0.8	11.5	2.3	2.3	7.6	2.8	6.1	8.2	7.6	6.8	7.6	6.9	3.8	29.7	0.1	5.4	7.5	24.4	1.2	12.8	4.6	4.5	1.3	9.8	3.2	4.6	4.8	0.1	1.2	6.1	17.2	5.4	4.1	2.9	1.0	0.8	5.6	2.7	0.0	0.7	3.6	3.9	0.8	0.2	1.4	15.5	8.9	1.2	4.6	12.4	16.2	5.6	4.6	1.7	3.1	1.2	3.9	4.1	2.0	0.1	0.1	0.5	5.8	0.3	2.6	3.1	5.7	10.8	1.1	10.2	1.1	3.2	0.6	0.8	5.5	1.2	1.0	1.4	2.6	2.4	11.7	0.6	0.2	0.8										
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662778	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.8;pancreas: 31.0"	"Cell line enhanced"	"Detected in many"		"REH: 17.6;RPMI-8226: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"				"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: "	"prognostic favourable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	2.7	6.1	11.7	3.5	12.4	2.1	2.8	26.8	16.1	2.0	3.0	2.2	3.7	2.0	2.4	3.6	2.7	2.5	3.1	2.3	13.8	7.2	5.5	3.1	3.5	4.0	7.9	5.7	3.3	31.0	5.3	13.9	1.5	7.4	2.7	2.0	1.4	3.8	4.6	7.0	1.5	2.5	2.7	3.7	3.7	3.2	16.9	3.4	2.5	2.3	1.4	3.4	2.9	3.1	11.4	5.3	3.7	1.0	1.2	8.5	2.1	5.6	6.1	1.7	14.9	1.2	0.2	3.1	0.1	0.7	2.2	2.1	3.0	2.4	9.5	2.9	0.1	4.5	3.4	0.7	0.5	4.4	3.2	3.8	2.8	3.5	1.6	1.6	9.0	0.1	0.3	2.1	0.8	1.1	0.3	2.2	0.4	5.5	9.7	2.0	2.0	4.0	17.6	1.1	15.3	5.9	3.3	14.5	7.8	0.9	2.1	2.3	13.1	0.6	0.9	0.2	0.5	1.4	2.9	2.3	7.4	8.4	1.7	3.4	0.6	2.1	1.0	0.4	4.5	0.5	8.5	11.4	6.4	5.9	1.2	7.4	3.2	2.4	3.7	1.2	0.1	5.3	6.1	2.1	11.7	12.4	26.8	16.1	13.8	7.2	7.9	5.7	7.4	3.4
PARD6B	PAR-6B	ENSG00000124171	"Par-6 family cell polarity regulator beta"	Q9BYG5	20	50731544-50756795	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 40.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.4;MCF7: 27.2;T-47d: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013376	Uncertain		Supported	Cytosol				Cytosol		"HPA013376: AB_1854972"	"unprognostic (1.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavourable (8.38e-4)"	"unprognostic (2.27e-1)"	"prognostic favourable (6.38e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.07e-2)"	3.7	2.3	1.6	3.1	2.3	2.6	7.9	3.5	2.0	2.7	13.9	1.4	11.3	4.5	2.2	12.1	5.8	5.7	6.6	2.1	2.0	1.9	40.0	8.0	15.4	1.9	1.5	1.3	3.4	9.9	7.3	3.7	24.1	2.7	4.0	3.0	12.2	3.6	17.2	4.3	3.8	17.5	1.0	1.6	2.4	8.3	6.4	0.5	2.9	14.4	1.0	5.8	3.5	5.5	3.6	3.1	3.4	1.5	3.8	6.1	1.1	2.8	3.3	0.9	2.0	0.6	0.2	4.4	0.2	0.3	0.5	0.4	15.4	6.8	1.3	3.0	0.0	2.3	1.4	2.1	0.8	0.6	0.8	0.7	1.0	6.1	0.6	0.4	0.7	0.0	1.0	0.3	0.9	0.0	1.6	0.9	0.0	27.2	1.3	1.2	1.6	1.3	0.7	0.9	1.1	7.0	3.2	0.6	0.9	2.2	5.2	1.5	26.6	0.7	0.1	0.3	1.8	0.3	0.5	1.1	0.7	1.0	0.7	0.5	0.6	2.9	0.7	3.4	3.6	0.9	4.0	2.9	3.7	3.6	0.8	3.6	6.1	3.8	2.8	3.8	1.5	3.1	2.3	1.1	1.6	2.3	3.5	2.0	2.0	1.9	1.5	1.3	2.7	0.5
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: "	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	4.0	5.6	4.3	4.2	5.4	1.4	5.3	7.8	6.3	4.8	5.1			6.7	4.9	3.0	6.2	4.3	3.6	6.6	4.6	5.9	9.2	5.2	3.5	5.8	4.5		4.7	3.5	8.1	4.7	5.8		4.9	6.1		4.7	5.1	8.1	6.7	5.1	4.7	4.0	5.9	4.7	5.8			4.9		6.9	4.4	4.8	6.9	7.0	12.5	7.7	8.3	9.4	5.5	12.7	10.6	18.7	13.7	9.0	11.2	13.7	12.7	14.0	14.8	14.2	8.5	11.9	9.6	8.3	10.8	14.5	15.7	8.0	16.0	14.7	14.6	9.8	8.7	9.3	10.2	14.1	8.2	7.2	15.5	12.4	20.5	9.0	16.6	8.5	11.1	7.1	15.6	12.7	18.4	24.3	18.6	21.2	11.1	12.0	8.2	12.9	16.3	10.3	16.4	13.3	18.9	7.9	9.1	9.3	11.3	9.6	14.2	9.4	14.1	20.5	15.9	15.0	6.7	12.5	6.2	3.0	5.2	5.5	7.9	6.9	7.1	6.7	7.0	6.9	9.4	9.1	3.0	8.3	7.7	5.4	5.5	5.5										
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol			69000000	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	44.6	67.9	69.3	38.1	64.9	33.7	45.4	57.2	62.7	34.0	36.4	33.4	43.2	27.3	35.8	56.6	40.9	39.0	41.6	71.7	56.9	57.2	60.5	77.1	28.6	46.1	61.6	57.2	45.9	60.4	66.6	48.4	44.6	41.2	44.7	39.5	38.6	46.5	39.4	128.7	19.8	27.5	48.1	52.5	37.5	37.2	38.2	32.2	38.8	71.6	43.3	46.5	41.3	43.4	49.5	141.8	38.8	61.0	52.8	87.2	90.6	68.2	61.5	61.3	70.4	66.0	63.5	30.1	63.6	59.6	62.6	50.6	56.0	74.8	84.7	71.9	68.2	49.0	66.1	85.0	81.4	75.3	71.4	91.0	91.9	83.1	57.0	86.8	56.1	59.8	36.3	63.8	76.7	65.6	88.3	63.1	86.8	63.9	60.4	110.3	50.0	63.5	46.5	82.3	116.1	98.2	35.1	71.7	60.2	63.6	98.3	99.2	54.8	64.7	62.1	57.8	46.1	53.3	69.7	61.3	98.3	120.5	76.2	132.9	81.8	22.7	61.0	38.8	52.6	55.4	49.7	49.5	52.7	62.2	73.9	38.6	45.6	52.4	21.0	52.8	44.1	141.8	87.2	90.6	69.3	64.9	57.2	62.7	56.9	57.2	61.6	57.2	41.2	32.2
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 23.9;Karpas-707: 23.4;U-266/70: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	15	"B-cells: 10.1;dendritic cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (2.23e-1)"	23.1	21.5	5.7	25.0	15.2	0.3	16.4	1.3	29.4	18.7	36.0	1.2	28.5	2.8	20.3	18.0	5.8	12.2	11.5	39.8	6.9	13.0	27.5	1.1	15.1	10.2	3.3	10.3	11.9	29.2	23.2	32.1	16.1	4.8	35.0	45.8	70.2	25.6	27.6	7.4	6.2	8.3	29.3	2.4	9.7	5.5	11.2	1.2	6.3	79.8	3.7	8.0	24.9	19.7	10.1	4.6	0.1	0.5	0.0	0.0	0.7	0.5	1.0	0.9	0.0	23.9	0.1	0.1	0.0	0.1	0.0	0.0	2.0	0.2	0.0	0.1	0.0	0.0	7.8	0.0	0.0	0.1	1.7	0.0	0.0	0.0	4.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	23.4	0.4	0.2	2.5	0.1	2.2	1.4	0.0	2.1	5.9	0.1	4.8	1.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	1.5	0.1	2.1	26.2	2.5	6.6	2.5	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	10.1	0.0	0.0	4.6	6.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.7	5.7	15.2	1.3	29.4	6.9	13.0	3.3	10.3	4.8	1.2
PARP10	FLJ14464	ENSG00000178685	"Poly(ADP-ribose) polymerase family member 10"	Q53GL7	8	143977153-144012772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.4"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA028122, HPA052427"	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA028122: AB_10601979, HPA052427: "	"unprognostic (9.80e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.63e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.30e-3)"	14.2	18.8	8.8	27.4	9.5	15.7	18.6	5.3	8.7	14.4	16.5	9.3	20.7	20.5	20.3	18.3	15.8	18.0	21.8	6.4	8.9	4.1	20.5	19.1	21.4	23.6	10.4	6.8	22.4	15.3	9.3	14.2	10.4	9.2	17.7	3.8	12.7	27.7	14.9	12.5	14.3	21.8	9.6	8.9	31.1	13.1	15.8	9.8	27.8	15.4	10.4	21.6	8.8	12.9	2.4	16.4	3.2	2.8	1.9	4.6	2.4	8.4	0.8	0.6	1.5	4.2	3.8	4.6	1.4	1.8	9.5	10.7	0.4	14.8	10.5	20.2	4.5	3.2	0.2	5.0	0.4	23.7	0.0	11.6	4.9	5.3	4.1	4.5	14.0	2.4	5.0	4.7	1.9	1.4	0.2	8.4	1.8	10.3	15.7	7.9	0.5	6.8	14.8	1.7	14.1	3.9	10.7	0.5	0.5	9.8	1.0	18.6	11.0	6.8	6.5	4.9	7.4	8.2	5.2	14.3	8.4	2.4	7.1	15.4	2.6	0.0	1.9	3.2	4.6	2.8	3.0	1.2	2.2	3.7	2.3	2.4	1.6	2.3	1.1	1.9	2.7	16.4	1.6	2.4	8.8	9.5	5.3	8.7	8.9	4.1	10.4	6.8	9.2	9.8
PARP11	C12orf6	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	7.1	14.5	11.2	8.6	9.2	3.7	8.3	11.0	9.1	6.4	5.4	5.6	4.8	4.9	10.2	7.5	5.0	6.3	5.6	5.1	6.1	5.7	5.7	5.7	6.3	12.8	5.0	5.7	13.1	6.6	10.0	10.4	4.1	7.6	12.0	5.7	7.2	6.6	6.0	4.1	3.9	6.5	7.2	6.1	9.2	4.2	12.8	5.6	16.9	12.3	2.7	12.1	8.3	5.8	10.7	10.2	18.3	10.2	8.2	12.5	7.1	2.5	2.1	13.6	2.1	4.3	6.9	3.8	3.0	5.1	5.3	5.3	7.8	2.0	7.4	1.9	6.6	2.1	4.5	4.5	8.6	14.9	4.5	10.6	0.0	5.7	4.9	7.1	4.0	5.5	3.5	4.2	11.8	3.9	2.8	6.0	7.4	3.5	3.8	2.7	5.0	0.3	7.6	9.3	1.7	2.5	5.7	0.9	3.1	2.9	2.6	3.9	0.5	6.5	7.7	4.6	4.5	7.0	4.0	2.9	6.3	10.5	4.4	4.0	1.2	18.3	10.2	10.2	9.2	8.5	12.5	10.7	10.2	6.7	10.2	10.1	11.7	9.4	10.2	8.2	6.4	8.9	4.3	7.1	11.2	9.2	11.0	9.1	6.1	5.7	5.0	5.7	7.6	5.6
PARP14	"KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680618-122730840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol				Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	21.6	10.3	5.6	15.8	7.2	11.7	9.3	2.3	6.0	11.6	13.3	5.9	6.4	11.4	10.6	12.7	11.7	7.2	10.0	6.5	5.2	4.8	13.7	21.5	26.0	16.7	7.3	5.2	10.0	6.7	7.2	6.8	17.5	6.3	12.3	6.7	7.5	8.5	5.5	5.2	5.7	22.3	11.9	6.8	29.7	7.6	4.6	4.9	18.7	20.4	6.4	18.9	12.8	12.4	15.9	4.2	20.8	10.5	7.4	7.0	2.8	5.9	4.9	3.1	3.3	4.4	10.6	0.0	2.3	15.5	29.2	45.1	2.6	11.7	0.0	9.7	5.1	4.6	4.6	4.7	6.0	9.0	0.5	5.4	2.3	4.0	10.8	2.4	2.7	6.4	2.4	5.1	2.0	12.6	2.5	8.8	1.0	3.0	9.1	1.6	0.4	4.2	12.7	3.2	1.6	7.1	6.1	0.2	0.0	5.9	1.3	6.6	2.2	4.3	8.6	1.5	3.9	0.9	2.1	3.4	0.6	1.0	4.7	5.7	2.7	8.3	8.2	4.0	6.9	10.5	6.0	10.2	3.8	4.5	4.2	15.9	3.2	3.4	20.8	7.4	9.3	0.6	7.0	2.8	5.6	7.2	2.3	6.0	5.2	4.8	7.3	5.2	6.3	4.9
PARP4	"ADPRTL1, p193, VAULT3, VPARP, VWA5C"	ENSG00000102699	"Poly(ADP-ribose) polymerase family member 4"	Q9UKK3	13	24420926-24512810	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Ribonucleoprotein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011739	Approved		Supported	Cytosol				Cytosol		"HPA011739: AB_1854986"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.97e-2)"	"prognostic favourable (1.21e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.84e-3)"	25.3	24.7	6.6	16.7	12.9	11.6	14.6	2.3	7.0	17.8	39.4	16.7	21.6	22.9	19.1	11.2	22.2	14.9	23.8	11.3	7.9	5.6	28.8	17.3	17.8	16.5	14.6	4.4	15.9	15.5	11.2	12.6	14.8	12.5	16.1	24.1	14.0	17.7	30.9	6.5	10.2	49.9	15.5	20.5	28.4	20.4	7.0	12.1	28.8	18.2	11.3	26.2	23.3	13.2	9.0	16.4	26.1	18.6	11.8	12.9	10.6	15.0	13.5	6.6	11.9	18.3	26.1	5.6	17.5	23.0	15.4	13.8	5.5	39.2	11.2	17.5	15.9	17.5	9.8	17.7	12.6	25.8	6.9	16.1	12.5	12.6	10.4	20.6	16.0	15.0	6.0	12.7	6.8	25.2	4.5	5.0	18.2	6.9	13.0	9.9	7.5	16.7	12.3	12.4	15.8	28.6	31.0	6.0	7.7	12.8	5.2	12.1	2.5	17.1	35.7	7.0	7.3	8.9	17.8	5.7	6.6	14.8	12.7	10.9	15.2	25.2	12.4	26.1	12.9	15.3	12.9	9.0	10.8	12.8	16.4	5.1	8.1	9.6	14.3	11.8	18.6	6.2	12.7	10.6	6.6	12.9	2.3	7.0	7.9	5.6	14.6	4.4	12.5	12.1
PARP8	"FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846522	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"				Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favourable (1.12e-4)"	6.2	7.8	8.8	17.1	9.5	33.5	5.3	2.4	18.7	5.6	5.5	3.3	0.6	6.8	5.2	5.4	5.2	7.4	12.3	3.6	12.8	8.0	5.8	4.2	10.9	18.2	4.9	11.0	5.9	7.1	9.8	14.4	5.6	5.4	6.1	4.3	4.1	7.6	4.2	1.7	4.2	14.2	5.4	7.0	20.1	10.2	6.4	2.8	9.9	21.9	1.1	12.3	8.8	7.0	7.1	3.9	13.1	5.9	15.5	32.0	9.5	11.7	0.0	5.4	8.6	1.5	2.7	8.6	1.9	7.0	1.9	5.6	0.3	15.4	6.9	8.2	0.2	5.8	0.9	5.9	4.5	9.7	7.5	5.1	4.7	0.5	2.9	11.9	0.1	3.3	4.9	3.8	2.7	0.1	0.7	4.2	2.6	3.8	14.3	15.1	5.8	2.9	7.2	11.5	8.0	3.5	5.8	6.0	9.3	6.3	10.3	1.6	0.4	42.2	0.0	0.4	7.3	0.5	5.7	3.1	0.1	13.5	6.5	3.4	8.0	10.3	5.9	13.1	20.6	1.6	32.0	6.0	16.1	23.0	3.9	7.1	10.0	16.7	12.3	15.5	1.1	1.8	9.5	9.5	8.8	9.5	2.4	18.7	12.8	8.0	4.9	11.0	5.4	2.8
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.9;BJ hTERT+ SV40 Large T+ RasG12V: 41.8;SK-MEL-30: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: "	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favourable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.2	13.0	0.9	2.7	14.7	34.9	41.8	4.2	8.9	1.8	6.0	5.4	8.9	2.3	4.8	7.3	13.9	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.5	4.7	4.9	1.2	7.4	0.8	7.5	1.4	3.5	8.9	3.5	0.4	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.1	1.2	32.3	3.8	3.1	4.4	1.5	4.4	0.3	1.6	4.6	2.4	3.3	5.2	3.0	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3
PARVA	"FLJ10793, FLJ12254, MXRA2"	ENSG00000197702	"Parvin alpha"		11	12377185-12530801	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 4.0;memory CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	40	"T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005964	Approved		Supported	"Actin filaments,Focal adhesion sites,Cytosol"				"Actin filaments, Focal adhesion sites"	Cytosol	"HPA005964: AB_1079569"	"unprognostic (3.87e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.30e-2)"	"prognostic favourable (1.76e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.38e-2)"	"unprognostic (6.78e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.82e-2)"	30.5	8.3	7.1	14.4	6.5	0.0	44.0	3.9	8.3	29.2	39.2	3.5	25.8	6.9	40.5	17.6	27.0	17.2	35.2	21.3	6.4	5.3	15.3	10.7	13.2	8.5	5.3	7.8	22.7	16.2	10.1	6.3	16.3	5.5	31.7	16.4	18.3	13.4	35.1	6.4	7.7	13.1	55.9	5.0	8.4	24.2	8.4	2.8	0.4	10.5	8.1	5.0	38.8	33.4	0.0	0.0	0.0	0.0	0.0	4.0	0.1	7.6	7.6	7.1	9.2	36.4	28.3	16.6	29.4	30.3	20.8	19.5	5.6	12.0	0.0	9.8	53.4	4.7	0.0	15.3	24.8	0.1	3.8	0.0	10.8	4.2	28.0	0.0	0.2	22.3	6.2	8.7	13.7	25.8	0.0	0.0	30.9	4.6	0.0	0.0	3.3	6.6	0.0	17.8	0.0	11.5	7.5	1.1	0.0	22.6	9.1	15.1	4.3	0.2	31.9	25.1	10.5	13.5	8.0	0.0	0.0	0.0	13.9	0.0	27.6	0.0	0.0	0.0	0.5	0.0	4.0	0.0	1.3	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	7.1	6.5	3.9	8.3	6.4	5.3	5.3	7.8	5.5	2.8
PARVB	CGI-56	ENSG00000188677	"Parvin beta"	Q9HBI1	22	43999211-44172949	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 43.7;RPMI-8226: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062601, HPA072217"	Enhanced		Approved	Cytosol			90000000	Cytosol		"HPA062601: , HPA072217: "	"unprognostic (2.41e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.65e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.05e-3)"	15.9	10.7	6.4	9.7	7.3	16.8	17.4	3.1	8.3	8.0	7.2	3.5	6.3	3.7	8.6	8.7	7.3	6.8	5.3	28.5	5.6	8.8	7.3	7.3	12.6	19.7	8.0	6.3	13.4	4.8	8.6	9.3	10.2	5.8	7.8	4.4	9.3	5.3	7.2	82.1	5.1	6.3	11.9	8.3	15.2	5.4	5.7	4.5	2.3	4.9	22.4	7.9	11.7	26.0	6.3	14.1	4.8	6.4	0.7	2.2	8.3	6.3	7.5	0.1	5.3	8.0	10.2	0.0	8.9	5.5	5.8	4.4	7.8	3.8	0.0	4.9	23.8	0.2	12.7	0.5	3.2	8.9	7.9	27.1	13.2	0.0	13.4	20.4	24.4	15.9	6.7	4.2	0.0	43.7	9.7	18.6	6.3	4.2	0.1	13.4	2.7	5.2	0.0	0.2	42.7	0.1	0.1	6.9	4.8	2.3	0.4	22.4	4.4	8.3	27.2	5.3	5.7	8.2	0.9	4.6	4.0	0.2	23.4	6.0	29.3	4.5	6.1	1.4	1.0	6.4	1.6	6.0	1.7	1.4	6.8	6.3	0.4	0.9	4.8	0.7	2.6	14.1	2.2	8.3	6.4	7.3	3.1	8.3	5.6	8.8	8.0	6.3	5.8	4.5
PASK	"KIAA0135, PASKIN, STK37"	ENSG00000115687	"PAS domain containing serine/threonine kinase"	Q96RG2	2	241106099-241150264	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 24.1;testis: 22.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 24.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA016450, HPA021079"	Uncertain		Supported	Cytosol				Cytosol		"HPA016450: AB_1854992, HPA021079: AB_1854993"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.99e-6)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.38e-3)"	1.5	1.1	2.4	10.3	24.1	8.9	3.1	6.3	5.2	2.2	2.1	2.2	2.1	3.8	2.9	6.7	3.1	7.2	3.3	1.1	2.9	2.7	3.7	1.3	3.0	14.5	1.3	1.6	1.9	3.3	4.4	4.9	1.1	3.6	12.1	2.8	4.7	2.7	1.8	2.0	4.9	3.9	1.4	1.6	4.4	3.4	22.0	7.2	9.0	4.8	1.9	9.9	2.7	1.9	7.1	1.1	4.8	1.0	2.7	6.0	3.0	4.9	6.7	9.1	11.5	0.7	1.4	12.1	4.8	1.5	4.4	6.2	5.4	5.0	2.6	1.0	1.1	12.5	10.3	4.1	3.2	10.4	9.7	7.1	12.4	9.6	0.5	9.7	11.2	0.6	3.3	4.6	1.3	3.1	9.2	3.5	3.1	5.6	11.5	10.2	10.1	4.1	18.3	9.2	3.2	1.7	11.2	16.1	4.9	2.8	5.5	2.1	4.6	7.0	4.1	6.1	5.5	7.7	6.4	4.8	4.8	12.2	3.8	7.3	5.6	4.8	1.0	0.7	1.7	0.6	1.5	7.1	5.9	5.3	1.1	6.6	3.7	3.9	1.3	2.7	1.0	0.7	6.0	3.0	2.4	24.1	6.3	5.2	2.9	2.7	1.3	1.6	3.6	7.2
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833275-37034185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 21.6;lymphoid tissue: 33.4"	"Group enriched"	"Detected in some"	8	"Daudi: 21.0;REH: 61.0;U-698: 27.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 1.6"	"Group enriched"	"Detected in some"	209	"memory B-cell: 20.1;naive B-cell: 21.6"	"Lineage enriched"	"Detected in single"	216	"B-cells: 21.6"	"Region enriched"	"Detected in single"	11	"midbrain: 4.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2"	"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: , HPA068498: "	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.4	0.2	0.2	33.4	0.2	5.5	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.4	0.2	0.2	0.3	0.5	0.3	0.3	23.2	1.6	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.3	0.3	0.4	2.5	0.0	0.6	0.2	8.7	0.0	0.3	16.5	0.7	0.9	0.0	2.3	0.4	0.2	30.1	1.3	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.1	61.0	0.1	0.1	0.0	0.0	4.3	1.0	0.0	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	0.0	0.2	0.0
PAXBP1	"C21orf66, fSAP105, GCFC, GCFC1"	ENSG00000159086	"PAX3 and PAX7 binding protein 1"	Q9Y5B6	21	32733899-32771858	"Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003757	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003757: AB_10600796"	"unprognostic (8.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.38e-3)"	"unprognostic (2.54e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavourable (9.43e-4)"	"prognostic unfavourable (1.50e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	8.9	10.6	11.9	16.6	19.6	42.0	11.6	25.7	20.0	13.5	14.1	11.3	10.1	15.8	16.3	12.4	10.3	11.6	10.1	8.3	11.2	9.7	11.3	10.3	10.1	13.7	22.7	10.0	19.8	12.3	11.6	19.3	13.2	14.7	11.2	12.6	6.9	10.2	10.5	15.2	12.6	12.8	10.8	19.0	11.2	9.5	12.9	19.7	18.5	11.3	5.0	12.3	11.2	18.9	2.2	1.6	0.3	1.3	0.7	3.1	0.4	7.3	6.1	12.3	9.6	4.8	3.9	17.5	5.5	3.5	7.2	5.3	12.8	6.7	8.8	4.3	3.1	7.6	12.3	5.1	7.6	7.1	10.1	15.1	10.0	9.3	2.3	17.0	9.0	2.1	7.7	8.4	3.7	4.7	17.6	8.1	5.3	6.5	11.6	9.9	34.7	6.2	10.8	11.7	12.8	5.6	6.8	10.1	5.7	7.9	9.1	6.2	5.8	9.5	4.2	5.4	7.4	6.2	8.5	8.0	10.0	16.3	3.9	15.5	5.4	0.0	1.3	0.3	2.2	0.6	3.1	1.6	2.5	1.9	1.6	2.2	2.7	2.6	0.0	0.7	0.8	1.1	1.4	0.4	11.9	19.6	25.7	20.0	11.2	9.7	22.7	10.0	14.7	19.7
PBDC1	"CXorf26, MGC874"	ENSG00000102390	"Polysaccharide biosynthesis domain containing 1"	Q9BVG4	X	76172936-76178204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003155	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol			88000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003155: AB_1078592"	"unprognostic (6.95e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-3)"	"unprognostic (8.82e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.98e-2)"	"prognostic favourable (8.57e-4)"	"unprognostic (1.62e-1)"	24.9	25.4	12.7	15.1	14.3	28.9	17.1	15.3	14.9	21.3	31.5	10.0	14.8	28.5	21.3	18.4	26.9	15.1	14.2	14.7	12.5	12.5	36.3	39.1	16.6	17.0	17.6	8.8	23.1	16.1	15.2	22.8	21.9	15.0	22.3	20.9	10.3	18.0	14.3	19.2	19.5	48.9	22.3	22.7	23.8	17.8	8.4	14.6	21.1	22.5	21.2	18.2	20.8	17.6	28.1	24.0	17.0	27.8	27.1	30.6	17.1	12.1	17.8	15.2	10.4	19.5	19.5	13.1	21.6	18.6	20.0	17.2	17.0	16.9	16.7	14.6	21.8	17.6	25.4	24.2	26.1	12.3	16.1	12.3	10.0	25.4	30.7	36.2	18.1	15.5	20.0	27.3	23.3	25.3	17.4	8.3	24.3	14.3	17.0	26.5	42.3	27.9	14.6	16.0	2.1	29.1	22.6	8.9	11.5	9.6	15.9	0.1	9.7	13.7	21.8	14.9	15.0	17.7	19.8	14.7	25.8	9.9	16.6	12.7	11.7	6.7	17.6	17.0	30.6	25.6	22.2	28.1	27.5	29.7	22.5	23.7	28.2	26.9	3.3	27.1	27.8	24.0	22.5	17.1	12.7	14.3	15.3	14.9	12.5	12.5	17.6	8.8	15.0	14.6
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809620-27838095	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 19.4;testis: 67.9"	"Cell line enhanced"	"Detected in many"		"A-431: 60.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 1.6"	"Group enriched"	"Detected in many"	10	"NK-cells: 2.1;T-cells: 1.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol				Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	0.6	0.8	0.2	7.7	0.3	3.3	1.3	0.3	0.4	1.1	3.8	0.3	0.2	3.7	0.4	0.6	6.2	0.3	0.8	3.3	0.3	0.2	0.7	0.9	1.2	5.4	0.3	0.2	0.4	0.4	0.0	0.2	2.2	0.3	0.4	4.6	0.2	1.1	0.2	0.4	1.9	3.6	0.9	0.6	1.7	1.7	67.9	0.2	19.4	0.3	4.7	5.3	0.7	1.9	0.1	0.0	0.0	0.0	2.1	1.6	0.5	60.7	19.8	19.5	12.3	1.9	3.4	8.2	27.9	13.3	28.8	24.3	6.9	11.3	32.4	9.9	10.7	16.1	18.7	9.4	31.6	7.9	10.2	7.8	14.1	10.0	0.1	5.0	11.6	0.9	7.7	13.3	7.1	14.5	11.4	21.8	33.9	6.9	19.2	5.9	3.5	17.2	12.0	27.2	8.7	10.8	9.4	7.7	12.1	10.4	12.2	15.6	12.9	7.7	8.4	18.9	45.6	23.9	29.6	3.1	8.6	15.0	11.5	8.9	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	1.6	0.5	0.2	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 30.5;NTERA-2: 29.9;SK-BR-3: 61.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	13.2	17.3	14.9	8.3	15.0	1.4	16.4	14.1	17.4	73.4	26.3	11.2	15.9	13.6	67.2	15.3	20.8	35.1	25.8	12.6	10.9	9.7	15.4	4.2	10.4	2.3	11.6	14.6	35.2	29.4	21.3	12.4	9.6	8.1	27.6	9.3	10.2	19.6	25.1	16.8	6.0	14.6	56.8	8.0	5.1	13.9	9.7	8.7	2.7	17.4	8.5	6.6	32.2	24.7	0.0	0.1	2.9	0.0	0.3	0.2	2.5	1.1	22.3	22.1	5.9	14.9	7.2	1.3	9.3	6.1	2.5	1.8	4.3	4.0	0.0	1.9	12.7	7.8	8.6	2.4	1.0	1.1	9.3	30.5	17.9	0.0	9.8	0.0	7.8	7.1	0.0	1.6	0.7	0.1	0.0	0.0	0.6	14.7	0.0	0.1	29.9	1.1	0.0	7.3	8.9	1.8	13.3	0.8	13.1	10.8	61.6	0.0	23.4	0.0	0.1	1.3	3.1	8.7	2.7	2.8	21.1	0.0	0.1	0.0	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.1	0.0	2.5	14.9	15.0	14.1	17.4	10.9	9.7	11.6	14.6	8.1	8.7
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 16.1"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 16.1"	"Region enhanced"	"Detected in all"		"olfactory region: 205.0"	"Region enriched"	"Detected in many"	4	"olfactory region: 287.4"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	8.0	25.0	4.4	16.2	11.6	3.0	10.4	6.6	3.4	16.6	18.9	3.7	6.5	3.1	10.7	10.9	9.1	5.9	22.8	16.1	2.9	6.3	3.4	7.6	9.4	6.1	9.5	3.4	35.0	12.9	86.7	6.8	3.1	13.0	18.8	6.1	7.1	10.5	12.3	3.6	8.2	6.0	21.2	17.6	5.5	10.0	5.1	6.2	6.8	14.7	5.5	3.8	13.3	12.0	1.8	16.1	2.9	1.8	3.8	2.1	1.0	4.6	4.5	20.5	19.0	5.7	9.3	3.7	12.3	7.0	8.6	6.2	5.8	9.3	4.6	1.5	9.8	3.6	11.5	5.0	17.0	4.9	8.2	3.9	3.5	2.3	7.3	4.4	7.2	4.8	5.6	6.7	4.3	9.6	0.2	4.4	17.7	2.5	4.0	2.0	15.1	3.1	7.6	30.6	0.5	6.5	2.8	11.0	19.2	8.5	1.6	3.7	7.0	36.0	11.5	17.4	4.8	10.2	22.9	3.2	4.9	4.9	8.3	6.2	8.9	2.9	1.8	2.3	0.9	1.6	1.2	1.4	1.2	1.0	2.1	1.8	2.1	1.0	1.7	3.8	1.3	16.1	1.8	1.0	4.4	11.6	6.6	3.4	2.9	6.3	9.5	3.4	13.0	6.2
PBXIP1	HPIP	ENSG00000163346	"PBX homeobox interacting protein 1"	Q96AQ6	1	154944076-154956123	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"Karpas-707: 156.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006949	Approved		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA006949: AB_1079572"	"unprognostic (6.17e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (8.94e-2)"	"unprognostic (2.16e-1)"	"prognostic favourable (7.19e-4)"	"unprognostic (1.62e-1)"	"prognostic favourable (8.99e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.46e-1)"	"prognostic favourable (2.64e-4)"	"unprognostic (1.20e-2)"	"prognostic favourable (9.22e-6)"	"unprognostic (3.89e-1)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.26e-3)"	25.3	48.1	35.4	24.9	54.9	13.7	19.9	18.3	31.4	26.8	36.2	26.1	28.1	25.5	28.3	29.8	23.6	22.8	31.1	21.9	46.6	28.6	18.1	13.3	22.6	28.6	41.8	34.4	50.1	17.6	42.4	56.7	21.2	47.8	26.4	14.3	38.6	20.7	48.3	57.2	13.2	28.6	52.6	29.0	27.5	28.1	15.9	33.8	27.9	33.1	22.4	26.8	37.5	25.7	9.2	4.0	42.9	6.6	13.0	46.8	14.4	0.9	2.6	4.2	2.8	14.8	4.6	3.1	3.5	7.8	1.7	3.4	0.7	3.5	4.3	11.4	4.2	3.7	1.0	2.2	1.2	2.3	1.6	0.9	3.5	2.7	6.8	1.1	12.0	7.0	3.7	2.1	0.4	6.4	0.5	156.1	4.2	1.5	2.3	3.7	1.6	2.0	2.7	6.1	9.3	4.7	1.9	0.7	5.4	4.5	1.4	3.5	4.4	5.0	6.0	1.7	1.2	1.0	1.0	21.4	17.9	1.0	6.1	1.7	1.3	26.7	2.5	42.9	11.0	3.6	30.4	9.2	29.5	17.2	2.2	5.7	19.7	12.1	23.7	13.0	6.6	4.0	46.8	14.4	35.4	54.9	18.3	31.4	46.6	28.6	41.8	34.4	47.8	33.8
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888784	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 67.5;Hep G2: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Approved		Enhanced	Nucleoplasm,Cytosol			210000	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: "	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	18.3	25.5	18.1	9.6	15.6	4.3	19.7	13.2	14.8	13.9	18.4	7.8	24.3	12.6	13.9	21.4	26.5	25.6	22.9	32.5	10.8	23.7	38.7	99.0	14.0	7.8	16.7	12.3	18.5	73.0	15.8	15.5	11.7	16.4	26.9	20.3	16.3	16.2	20.7	23.1	5.8	17.2	18.1	14.5	10.2	19.2	7.0	8.7	4.3	36.8	16.2	12.3	22.4	31.8	11.8	20.9	3.5	19.4	8.0	16.9	7.5	20.4	48.5	2.9	30.1	11.0	10.3	3.9	6.6	11.0	10.3	8.2	67.5	36.2	4.2	19.2	7.2	13.6	18.3	10.6	7.0	10.9	33.1	3.7	7.7	66.3	11.6	3.6	13.6	10.0	11.6	10.2	4.8	27.6	7.2	0.3	7.1	34.1	0.4	12.2	4.1	45.4	2.0	4.0	13.4	43.2	21.1	12.7	21.5	5.5	37.6	14.3	10.9	7.1	11.4	1.7	14.4	2.5	16.2	0.1	0.8	0.1	9.4	11.9	2.6	0.0	10.7	3.5	8.8	19.4	6.9	11.8	11.6	12.6	20.9	4.1	3.8	7.9	0.6	8.0	13.3	15.3	16.9	7.5	18.1	15.6	13.2	14.8	10.8	23.7	16.7	12.3	16.4	8.7
PCBP2	"hnRNP-E2, HNRNPE2, HNRPE2"	ENSG00000197111	"Poly(rC) binding protein 2"	Q15366	12	53452102-53481162	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038356	Uncertain		Supported	Nucleoplasm,Cytosol			2000000	Nucleoplasm	Cytosol	"HPA038356: AB_10697248"	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (1.82e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.05e-2)"	"prognostic favourable (8.23e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.20e-2)"	105.3	106.7	110.8	85.7	93.4	158.1	180.8	136.5	131.5	84.1	67.2	50.5	75.7	69.2	101.7	84.5	75.3	89.5	71.0	112.1	105.0	53.1	112.6	108.3	83.8	118.8	94.5	88.9	124.5	148.2	98.1	88.7	62.4	93.2	61.7	71.0	65.0	88.3	61.2	96.5	94.4	71.3	90.8	115.4	73.0	86.2	98.7	104.2	106.8	91.2	57.1	93.5	76.8	132.5	20.9	31.5	17.2	18.5	12.4	28.8	13.7	57.4	89.5	87.5	70.4	127.5	98.7	67.1	61.2	84.0	100.5	72.0	104.1	86.6	103.1	59.9	91.7	56.5	96.4	83.4	96.2	63.8	69.5	103.6	69.9	102.1	128.6	101.1	68.4	113.5	70.0	84.9	136.7	96.3	88.4	185.2	89.7	156.3	94.9	113.9	111.8	62.9	76.4	79.5	120.8	79.4	90.0	86.4	75.9	83.8	75.5	59.8	105.7	88.1	70.2	52.1	71.5	47.5	62.1	103.1	71.0	95.3	61.2	64.9	56.6	8.3	18.1	13.1	15.9	18.5	26.1	20.9	24.5	20.5	22.5	20.9	28.8	23.6	17.2	12.4	17.0	31.5	27.4	13.7	110.8	93.4	136.5	131.5	105.0	53.1	94.5	88.9	93.2	104.2
PCBP4	"LIP4, MCG10"	ENSG00000090097	"Poly(rC) binding protein 4"	P57723	3	51957454-51974016	"Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.5"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 48.5;SK-MEL-30: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"B-cells: 4.6;granulocytes: 4.6;T-cells: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057754			Supported	Cytosol				Cytosol		"HPA057754: "	"unprognostic (7.17e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.94e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.72e-2)"	19.5	16.6	27.2	9.6	21.9	3.0	10.6	86.0	56.3	12.7	16.7	36.2	16.0	15.1	15.4	12.1	14.5	10.4	18.3	36.5	29.2	29.9	21.2	38.9	13.9	17.0	28.9	13.0	16.3	22.0	22.9	15.8	7.8	16.4	20.1	8.6	47.3	20.3	19.6	97.5	13.6	29.0	14.4	44.4	10.9	13.3	10.6	19.7	11.9	17.3	11.0	15.7	13.3	9.6	4.6	0.3	4.6	0.0	0.1	10.2	2.4	10.0	3.4	13.8	20.1	6.3	11.3	2.3	23.1	11.3	13.9	9.0	12.8	3.6	0.3	3.4	18.3	2.4	12.9	8.1	6.5	15.9	2.0	1.2	11.6	13.2	10.2	1.3	9.8	15.3	15.1	8.9	3.9	6.9	0.6	4.5	22.3	4.7	0.5	1.5	6.7	9.3	7.0	6.7	1.8	4.9	7.2	27.3	48.5	6.3	3.4	41.0	6.4	4.9	13.8	15.0	28.3	4.7	12.3	3.0	1.9	2.0	17.3	2.8	21.7	4.6	0.0	3.1	10.2	0.0	7.1	4.6	9.6	9.8	0.3	2.3	4.6	3.5	0.0	0.1	0.0	0.1	10.0	2.4	27.2	21.9	86.0	24.2	29.2	29.9	28.9	13.0	16.4	19.7
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631810-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in some"		"AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"			31000	Cytosol	"Vesicles, Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	2.0	2.4	8.0	2.1	11.2	0.3	0.9	4.6	18.2	2.9	1.2	6.2	0.3	1.1	2.6	1.3	1.7	2.5	3.6	2.3	6.5	12.1	1.6	1.4	13.5	0.9	7.4	4.8	0.8	6.2	2.0	1.0	4.7	4.4	1.2	1.2	1.1	1.0	1.1	1.8	0.6	0.7	2.6	4.4	32.7	1.8	8.9	7.7	0.0	3.4	0.4	0.8	3.4	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.7	0.0	0.0	1.8	0.0	0.0	0.0	9.9	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	1.0	0.0	0.0	0.0	6.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	11.2	4.6	7.8	6.5	12.1	7.4	4.8	4.4	7.7
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 35.0;ASC diff: 42.3;ASC TERT1: 47.1;BJ hTERT+: 20.7;fHDF/TERT166: 33.4;HHSteC: 31.2;HSkMC: 47.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.3;memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"			1200000	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (4.71e-4)"	28.4	3.5	4.2	7.2	4.0	0.0	16.2	2.0	2.7	30.4	13.3	2.1	9.8	6.0	34.0	8.7	11.2	8.6	14.9	8.9	2.7	3.6	5.4	3.0	5.9	2.6	5.2	1.4	14.9	2.4	1.8	3.5	29.0	5.4	23.3	9.5	21.8	6.3	9.5	10.3	5.1	9.0	25.4	5.4	4.0	5.5	9.7	4.0	1.0	8.2	7.7	1.9	17.5	16.3	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	35.0	0.0	42.3	47.1	0.0	6.3	20.7	1.2	1.8	0.0	0.0	0.0	0.0	33.4	0.0	8.1	0.1	0.6	0.0	0.2	0.0	0.0	0.0	31.2	0.0	0.0	47.9	0.0	2.2	0.9	0.2	0.0	0.1	0.6	0.0	0.9	0.0	0.0	0.6	2.6	1.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	16.4	1.0	3.3	0.1	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.2	4.0	2.0	2.7	2.7	3.6	5.2	1.4	5.4	4.0
PCDH19	"EFMR, EIEE9, KIAA1313"	ENSG00000165194	"Protocadherin 19"	Q8TAB3	X	100291644-100410273	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 27.1"	"Cell line enriched"	"Detected in some"	6	"AF22: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027533	Approved		Approved	Cytosol				Cytosol		"HPA027533: AB_10602043"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.37e-1)"	4.9	1.1	19.8	1.3	10.5	0.7	3.7	1.0	22.5	5.5	4.0	1.9	0.0	1.2	3.8	1.3	2.9	2.2	2.0	1.6	27.1	12.8	1.4	0.9	1.0	1.3	3.7	14.2	3.6	1.1	1.2	2.1	1.0	7.3	1.4	5.5	6.4	2.1	1.6	2.4	3.3	1.8	3.1	3.7	0.8	2.0	2.3	1.0	0.0	1.1	0.7	0.9	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	19.6	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	3.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	10.5	1.0	22.5	27.1	12.8	3.7	14.2	7.3	1.0
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 20.6"	"Cell line enriched"	"Detected in some"	4	"AF22: 22.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.8	0.9	11.5	1.1	18.6	0.8	0.8	0.4	20.6	0.9	1.0	1.1	0.0	0.9	1.0	0.8	0.8	0.8	0.8	0.8	18.2	4.8	0.8	0.8	0.9	0.8	3.6	8.4	0.8	0.8	0.8	1.4	0.8	0.8	1.7	0.9	0.8	0.8	0.8	1.4	0.8	1.1	0.9	0.9	0.8	1.2	2.3	2.5	0.0	1.4	0.0	0.8	0.9	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	1.6	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.6	0.4	20.6	18.2	4.8	3.6	8.4	0.8	2.5
PCDHA12	PCDH-ALPHA12	ENSG00000251664	"Protocadherin alpha 12"	Q9UN75	5	140875302-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6"	"Cell line enhanced"	"Detected in some"		"A549: 10.0;AN3-CA: 4.0;hTCEpi: 6.2;PC-3: 7.6;RT4: 7.5;SH-SY5Y: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035812	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035812: "	"unprognostic (3.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.74e-2)"			"unprognostic (2.24e-2)"		"unprognostic (2.08e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.18e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.97e-2)"	1.0	1.7	0.9	0.3	1.2	0.0	0.9	14.6	3.7	3.5	0.4	1.1	0.0	0.1	1.0	0.5	0.2	1.9	4.3	0.3	1.0	0.7	3.8	1.7	5.7	0.2	0.5	0.8	0.3	2.4	0.9	4.6	0.0	2.3	0.4	0.1	1.5	5.7	0.3	0.1	0.2	0.2	0.6	0.8	0.2	0.3	2.1	0.2	0.0	3.4	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	2.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.4	7.6	0.0	0.0	0.0	0.3	7.5	0.3	4.3	0.0	0.9	0.1	1.6	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	14.6	3.7	1.0	0.7	0.5	0.8	2.3	0.2
PCDHA4	"CNR1, CNRN1, CRNR1, PCDH-ALPHA4"	ENSG00000204967	"Protocadherin alpha 4"	Q9UN74	5	140806929-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1"	"Cell line enhanced"	"Detected in some"		"A549: 8.9;AF22: 8.7;EFO-21: 7.6;T-47d: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043180, HPA073478"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"HPA043180: AB_10806381, HPA073478: "	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.90e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.00e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.94e-5)"	"unprognostic (5.01e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.29e-3)"	"unprognostic (4.79e-2)"	0.9	0.8	5.1	0.9	6.5	3.2	1.7	12.1	8.7	2.1	1.1	1.6	0.4	0.9	2.3	2.0	0.6	1.6	5.1	1.2	4.5	3.2	2.0	0.6	1.7	1.5	1.9	2.1	1.1	4.1	1.0	1.4	0.7	3.9	1.8	1.1	0.4	1.1	1.3	1.1	2.0	0.9	1.1	3.0	1.1	1.0	1.4	2.4	0.0	1.3	0.1	0.7	1.3	0.8	1.5	1.3	2.0	0.7	0.8	1.1	0.0	0.2	8.9	8.7	0.4	0.1	0.3	0.3	0.2	0.1	0.1	0.1	0.2	1.8	0.3	7.6	0.2	0.3	0.0	0.1	0.2	0.2	0.1	0.3	0.6	0.3	0.1	0.3	0.5	0.4	2.3	0.2	0.4	0.5	0.2	1.2	0.3	0.2	0.2	0.3	2.5	1.2	0.2	0.2	0.3	0.3	0.4	0.4	3.7	0.1	1.9	0.8	7.6	0.3	0.9	1.9	1.2	0.7	0.2	0.5	0.2	0.2	0.3	0.4	0.8	1.8	0.7	0.7	1.1	0.4	0.8	0.8	0.8	0.7	0.3	1.5	0.8	1.1	2.0	0.8	0.7	1.3	0.6	0.0	5.1	6.5	12.1	6.6	4.5	3.2	1.9	2.1	3.9	2.4
PCDHB4	PCDH-BETA4	ENSG00000081818	"Protocadherin beta 4"	Q9Y5E5	5	141121799-141125623	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 12.7;SH-SY5Y: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"									HPA014466	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"				"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA014466: AB_1855058"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.03e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-4)"	"unprognostic (5.18e-3)"	7.1	5.3	13.0	2.0	12.0	0.6	5.9	11.3	11.4	8.0	3.4	12.9	0.1	1.9	12.3	9.1	4.0	5.8	5.7	4.3	10.9	6.3	4.1	1.3	5.1	1.4	13.1	11.3	9.9	18.2	7.3	5.1	0.9	11.0	6.1	2.7	3.7	5.0	5.1	3.8	3.1	2.6	7.9	21.1	2.0	2.6	1.6	12.3	0.0	2.8	1.5	1.1	5.6	5.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	2.1	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	12.7	8.5	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	13.0	12.0	11.3	11.4	10.9	6.3	13.1	11.3	11.0	12.3
PCDHB6	PCDH-BETA6	ENSG00000113211	"Protocadherin beta 6"	Q9Y5E3	5	141150022-141153287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 13.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 16.5;SH-SY5Y: 7.0;T-47d: 5.3;U-2197: 7.5;WM-115: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029566	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA029566: AB_10601385"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.65e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.64e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (8.60e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.52e-2)"	2.5	2.4	3.9	1.0	5.1	0.4	2.5	4.2	8.4	2.3	1.5	2.6	0.0	0.6	4.5	3.7	0.7	2.1	1.4	1.6	3.5	1.9	1.6	1.4	1.7	0.7	2.6	3.6	3.7	1.5	13.4	6.4	1.5	2.9	1.5	0.9	0.7	2.5	1.5	1.4	2.4	1.0	3.0	3.3	1.5	0.9	5.4	3.1	0.0	1.1	1.0	0.7	1.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	16.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.0	0.0	0.1	3.5	5.3	2.1	0.0	0.6	1.3	7.5	0.0	0.0	0.0	0.0	3.8	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.1	4.2	8.4	3.5	1.9	2.6	3.6	2.9	3.1
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 6.9;T-47d: 11.3;WM-115: 5.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	1.4	1.3	2.7	0.9	11.7	1.0	1.1	6.8	7.9	1.4	1.2	2.7	0.5	1.0	2.8	3.9	1.3	1.1	0.8	3.9	3.5	2.8	1.2	0.5	1.2	1.0	2.5	2.5	2.9	2.5	2.8	6.1	2.3	5.4	1.5	0.9	2.4	1.1	1.0	1.7	1.5	0.6	1.8	2.4	1.1	0.8	2.7	1.1	0.0	1.3	0.6	0.7	1.2	0.9	1.2	0.9	2.7	0.5	0.8	1.0	0.2	0.1	0.4	0.5	1.9	1.2	2.0	0.3	1.7	1.1	0.5	1.0	0.4	0.2	0.5	2.8	1.0	0.2	0.2	0.3	1.1	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.2	1.7	0.5	0.0	0.7	0.1	0.2	0.8	6.9	0.1	0.2	0.8	0.3	0.3	3.0	2.6	0.3	0.3	0.3	1.7	2.1	0.2	0.9	1.7	11.3	0.4	0.8	3.2	0.7	1.6	0.4	0.3	1.0	0.2	3.8	0.2	5.1	2.7	0.5	0.5	0.7	0.4	0.4	0.7	0.7	0.5	0.2	1.2	1.0	0.8	1.1	0.8	0.5	0.9	0.6	0.2	2.7	11.7	6.8	6.1	3.5	2.8	2.5	2.5	5.4	1.1
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 33.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	5.2	4.2	7.9	1.6	11.4	1.2	2.7	2.4	33.7	3.6	2.9	9.8	1.2	2.4	3.0	2.4	4.3	3.6	3.7	2.3	9.1	4.4	2.0	6.5	3.5	1.7	5.1	7.2	3.6	1.9	1.4	2.4	7.4	5.3	3.6	2.6	4.9	4.1	4.6	2.0	4.7	2.9	3.1	6.7	2.5	4.7	2.0	6.5	0.0	4.9	1.5	3.3	2.5	3.5	0.9	1.1	1.5	0.7	0.8	1.0	0.2	0.0	0.0	12.0	6.1	5.3	2.3	5.7	2.0	0.1	2.9	4.7	0.2	0.7	0.6	7.9	2.9	0.3	2.8	1.9	2.3	0.7	0.0	0.0	0.3	0.0	2.1	1.2	0.2	13.5	0.3	2.0	0.8	1.1	0.0	0.1	7.3	0.0	0.1	0.3	1.1	0.1	0.1	1.0	0.0	2.0	0.0	1.6	0.6	0.3	0.0	0.3	16.0	1.5	2.6	5.5	0.3	9.4	0.1	0.2	0.9	0.1	2.8	0.0	0.3	1.5	0.3	0.3	1.0	0.4	1.0	0.6	0.4	0.6	0.1	0.9	0.4	0.9	0.9	0.8	0.7	1.1	0.3	0.2	7.9	11.4	2.4	8.5	9.1	4.4	5.1	7.2	5.3	6.5
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	3.4	2.5	7.4	2.8	9.4	0.5	2.1	4.1	8.5	2.4	2.5	8.5	0.0	1.2	2.6	1.7	3.1	2.1	2.1	3.4	11.6	1.9	1.9	1.2	2.3	1.8	4.5	5.2	3.8	2.3	1.3	1.9	8.3	5.0	2.5	1.5	3.3	2.8	3.4	2.8	6.6	1.2	3.3	4.9	1.6	1.8	2.2	7.1	0.1	3.4	0.6	1.7	1.7	2.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.4	14.9	16.1	0.5	3.2	6.2	2.5	4.0	0.0	0.1	0.3	5.4	3.2	2.1	0.1	0.3	4.0	0.1	1.4	0.0	0.0	0.0	2.5	0.2	0.0	11.5	0.1	4.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	9.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.3	1.8	4.5	0.5	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.4	9.4	4.1	8.5	11.6	1.9	4.5	5.2	5.0	7.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430589-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9"	"Cell line enhanced"	"Detected in some"		"BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"											"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	5.1	12.7	14.8	2.8	18.9	0.7	2.4	4.7	13.8	4.9	1.8	8.6	0.6	1.4	5.4	2.3	3.5	2.7	11.3	6.5	15.7	5.6	3.1	2.8	6.5	1.6	4.7	7.3	6.2	3.6	2.0	2.7	6.5	8.4	3.5	1.7	3.4	1.7	4.9	1.9	5.1	1.5	5.3	8.4	3.7	2.2	1.6	12.4	0.4	3.0	0.6	1.7	4.5	3.6	3.7	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.6	1.2	0.1	7.6	12.6	0.0	0.0	0.0	0.0	0.4	0.0	18.7	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	14.0	0.0	3.7	0.0	4.4	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	6.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.8	18.9	4.7	10.4	15.7	5.6	4.7	7.3	8.4	12.4
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA038625: "	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.9	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.4	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.1	0.2	0.1	0.3	2.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AF22: 11.0;BJ: 3.6;EFO-21: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	4.0	4.5	11.7	1.4	10.5	0.7	2.5	6.9	13.7	4.7	1.3	7.9	0.0	0.7	4.5	3.5	1.5	2.9	3.5	12.2	8.5	5.8	2.5	2.5	2.6	1.0	6.6	7.7	8.6	3.6	1.8	6.3	5.7	8.7	3.0	1.3	4.6	2.9	3.2	1.5	1.9	1.1	3.6	6.0	1.5	1.2	5.2	3.8	0.0	3.3	1.3	1.0	1.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.1	0.2	1.5	0.0	3.6	0.3	0.0	0.1	0.0	0.0	0.1	8.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	10.5	6.9	13.7	8.5	5.8	6.6	7.7	8.7	3.8
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355025-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.2;BJ: 5.6;HSkMC: 5.9;HUVEC TERT2: 5.6;U-87 MG: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	5.4	4.7	6.5	1.8	8.3	0.5	3.0	8.5	11.2	4.8	2.0	10.4	1.5	1.2	5.0	3.0	1.9	3.4	3.1	4.8	6.3	5.9	2.0	2.7	3.6	0.9	5.6	8.1	5.8	6.7	8.5	3.4	2.8	6.1	4.1	1.4	3.5	4.3	4.2	1.5	1.8	1.2	5.0	5.9	1.3	1.4	2.7	4.0	0.0	2.6	2.7	0.9	2.3	2.5	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	1.0	0.6	4.5	10.2	0.0	5.6	4.5	0.3	1.1	0.0	0.1	0.9	1.9	4.7	0.1	0.1	0.2	0.6	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.4	5.9	0.2	0.1	0.0	5.6	0.2	0.3	2.4	0.8	0.3	0.2	0.2	0.2	0.3	1.6	0.1	0.3	0.0	0.8	1.7	0.2	0.3	1.1	2.1	0.0	3.6	2.4	0.7	3.1	0.4	0.2	0.3	0.2	8.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.3	8.5	9.3	6.3	5.9	5.6	8.1	6.1	4.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.1"	"Group enriched"	"Detected in some"	7	"ASC diff: 18.4;ASC TERT1: 7.3"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	4.0	2.7	6.1	1.8	9.1	0.9	3.9	19.1	9.6	9.0	2.7	7.7	4.1	1.0	7.6	3.2	3.3	4.7	4.5	4.9	6.9	4.0	1.5	1.2	3.3	1.3	3.2	3.8	6.6	1.7	3.3	3.7	2.7	4.6	5.6	1.6	4.1	2.5	4.0	1.5	3.0	1.5	4.3	6.3	1.4	1.7	1.7	3.7	0.0	1.8	0.9	1.0	2.5	4.2	0.9	0.8	1.6	0.6	1.9	0.7	0.2	0.0	0.4	0.3	0.1	18.4	7.3	0.0	0.8	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	1.8	0.2	0.0	0.0	0.6	0.1	0.6	0.7	0.3	0.5	0.7	0.1	0.3	0.9	0.6	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.3	1.6	0.0	1.0	0.6	0.2	1.0	0.7	0.1	1.0	0.1	0.3	0.2	0.7	1.5	0.6	0.6	0.7	0.3	0.3	0.6	0.6	0.4	0.1	0.9	0.7	0.7	1.6	1.9	0.2	0.8	0.4	0.2	6.1	9.1	19.1	9.6	6.9	4.0	3.2	3.8	4.6	3.7
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373914-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 11.0;T-47d: 6.4;WM-115: 13.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	4.1	3.8	6.1	2.3	8.4	0.8	2.9	19.6	10.8	7.9	3.4	8.3	2.9	1.0	6.9	4.7	2.6	4.3	3.6	3.7	5.0	4.3	2.8	1.7	3.3	1.4	2.9	4.7	9.7	2.5	2.5	4.5	6.9	3.3	4.0	1.6	5.8	4.1	5.3	2.1	4.7	1.5	6.1	2.8	2.8	1.7	2.2	2.9	0.2	3.8	1.2	1.5	4.6	3.6	1.3	0.7	2.8	0.6	0.5	0.8	0.2	0.1	0.3	3.1	0.5	1.5	5.3	0.1	2.3	0.8	1.2	1.2	0.0	0.2	2.1	3.0	3.6	0.5	0.1	0.5	0.8	0.0	0.3	0.0	0.3	0.3	0.8	0.1	0.1	5.7	0.4	0.3	0.1	1.8	0.3	1.3	0.4	0.5	0.7	1.8	0.3	0.1	1.5	0.4	0.0	0.4	0.1	11.0	0.9	0.1	0.3	0.7	6.4	0.1	5.4	0.9	0.4	0.8	0.8	0.4	1.8	0.4	0.9	0.7	13.7	1.8	0.6	0.3	0.8	0.3	0.3	0.8	0.6	0.2	0.1	1.3	0.3	0.5	2.8	0.5	0.3	0.7	0.5	0.2	6.1	8.4	19.6	10.8	5.0	4.3	2.9	4.7	3.3	2.9
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ hTERT+: 17.3;SH-SY5Y: 15.5;T-47d: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	1.7	2.0	3.1	1.3	9.0	0.6	2.1	5.3	14.9	3.5	3.0	7.1	2.1	1.0	4.2	4.1	2.2	3.3	1.9	3.0	5.1	3.3	3.2	1.9	2.2	1.0	5.1	6.6	4.7	2.5	4.6	3.4	4.8	5.4	3.7	1.5	5.8	2.6	3.3	1.6	3.8	1.2	3.0	6.3	1.3	1.4	2.1	5.1	0.0	6.6	1.5	1.0	2.4	2.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	1.9	0.0	5.8	9.9	0.0	2.6	17.3	3.5	5.2	0.0	0.0	0.4	4.3	0.5	0.1	0.0	0.1	2.9	0.0	0.3	0.0	0.4	0.1	1.0	0.0	0.0	4.3	0.1	0.0	0.6	1.4	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	15.5	0.0	0.1	0.1	6.8	0.0	5.2	0.1	0.1	2.5	0.0	0.1	1.5	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.0	5.3	7.7	5.1	3.3	5.1	6.6	5.4	5.1
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 7.1"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 2.9;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.6	0.7	0.8	0.7	0.6	2.5	0.7	2.3	2.2	1.2	1.2	1.0	7.1	0.4	2.3	1.5	2.1	0.7	0.9	2.0	1.4	0.5	0.5	0.9	1.1	0.7	0.5	0.4	2.6	0.6	0.2	1.9	1.4	3.5	0.9	0.8	0.4	0.8	0.5	2.2	2.5	1.1	0.7	1.6	0.7	0.7	1.0	1.3	1.1	2.4	0.4	0.6	0.6	1.2	0.7	0.4	2.9	0.4	0.5	0.3	0.1	0.3	0.2	1.1	0.6	1.1	2.6	0.6	2.4	1.6	1.7	0.7	0.2	0.4	1.1	1.0	1.8	0.4	0.0	0.0	1.3	0.3	0.2	0.3	0.5	0.3	0.1	0.4	0.8	1.4	0.1	0.5	0.1	0.4	0.2	0.9	0.2	0.2	0.5	0.7	2.7	0.1	1.0	0.2	0.1	0.1	0.3	0.7	0.7	0.3	0.9	0.4	1.2	1.7	2.5	2.6	0.9	0.6	0.2	0.3	0.3	0.4	1.3	0.4	1.3	2.9	0.4	0.5	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.2	0.3	2.8	0.5	0.3	0.4	0.2	0.1	0.8	0.6	2.3	2.2	1.4	0.5	0.5	0.4	3.5	1.3
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.9;HSkMC: 6.6;TIME: 7.2;U-87 MG: 8.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	5.6	5.4	12.0	2.6	12.6	0.9	3.7	11.5	17.3	6.9	2.7	11.2	0.1	2.1	7.6	3.9	4.8	6.3	6.5	3.2	10.3	8.5	3.0	2.8	5.0	2.1	9.6	7.1	9.1	3.0	3.8	3.0	3.6	10.9	5.2	2.7	7.7	3.8	7.3	1.9	5.5	2.0	5.9	13.0	3.6	2.9	2.0	5.9	0.0	4.6	1.4	2.5	4.8	3.7	0.5	0.3	1.0	0.5	0.2	1.0	0.0	0.0	0.3	1.0	2.5	0.2	0.5	0.4	1.2	0.0	1.0	1.1	0.4	0.6	2.0	5.9	3.1	0.1	0.2	0.3	1.1	0.1	0.5	0.0	0.2	0.0	1.8	0.1	0.4	6.6	0.3	0.6	0.5	1.6	0.1	0.3	0.5	0.6	0.3	0.7	0.3	0.1	0.3	0.7	0.0	0.3	0.3	0.7	1.8	0.6	0.1	0.8	1.5	0.7	7.2	0.5	0.5	0.1	3.9	0.3	0.1	0.1	8.3	0.2	1.4	1.0	0.5	0.3	1.0	0.3	0.6	0.3	0.4	0.2	0.1	0.5	0.4	0.7	1.0	0.2	0.2	0.3	0.1	0.0	12.0	12.6	11.5	16.2	10.3	8.5	9.6	7.1	10.9	5.9
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: , HPA077526: "	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	4.9	3.6	11.3	2.2	9.7	0.9	3.7	8.7	12.2	7.2	2.4	11.6	0.3	1.2	9.2	3.2	3.2	5.6	6.2	4.6	9.3	7.0	2.7	2.7	5.4	1.4	7.0	8.6	9.0	2.6	7.5	3.0	3.9	7.3	4.4	2.8	3.1	2.4	4.4	1.9	2.9	2.1	5.0	7.0	2.2	2.0	1.8	7.8	0.1	2.6	1.3	1.4	2.8	3.3	0.9	0.9	0.5	0.0	0.0	0.7	0.0	0.1	0.3	2.1	0.2	14.4	10.5	0.1	2.2	3.0	0.6	3.4	0.0	0.3	3.8	1.0	1.7	0.5	0.5	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.6	0.2	0.2	2.7	0.5	0.2	0.1	1.7	0.2	1.2	8.5	0.4	2.9	0.6	0.1	0.9	7.8	2.7	0.2	0.2	0.3	1.6	1.7	0.2	0.4	0.4	3.1	0.2	6.0	3.0	0.7	4.6	3.9	0.2	2.2	0.7	3.3	1.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.9	0.0	0.0	11.3	9.7	8.7	10.6	9.3	7.0	7.0	8.6	7.3	7.8
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370264-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.2;ASC TERT1: 10.7;TIME: 6.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA035822: , HPA035823: "	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	4.1	1.7	3.3	1.6	6.5	0.5	3.1	3.5	5.6	3.0	3.0	7.2	0.7	0.7	4.9	3.7	3.3	3.3	2.9	4.6	3.3	2.3	2.9	2.0	2.5	3.7	1.9	3.8	5.2	4.2	4.6	5.4	2.3	2.6	2.6	2.2	3.1	6.6	2.6	1.9	3.3	1.4	4.3	2.9	2.4	2.3	1.5	2.8	0.3	3.4	3.2	3.5	2.7	4.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.4	0.3	13.2	10.7	0.2	1.4	2.4	0.9	1.1	0.0	0.0	2.2	0.4	4.3	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.3	0.1	0.6	0.1	0.0	2.6	0.6	0.2	0.1	1.2	0.3	1.0	0.3	0.4	0.7	1.0	0.1	0.1	1.8	0.7	0.0	0.2	0.1	3.0	0.6	0.0	0.0	0.3	0.8	0.0	6.7	0.6	0.1	0.7	0.7	0.3	2.0	0.2	0.6	0.6	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	6.5	3.5	5.6	3.3	2.3	1.9	3.8	2.6	2.8
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 28.5;TIME: 14.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	7	"NK-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	2.4	2.2	2.4	0.7	4.2	0.0	1.2	1.8	2.1	2.6	1.4			0.2	3.2	3.5	1.1	2.1	0.8	2.8	2.3	4.1	2.9	3.3	2.1	0.0	1.8		5.1	1.9	3.0	2.5	6.2		2.6	0.7		3.0	3.1	1.2	3.4	0.3	1.9	2.0	0.6	0.4	0.9			3.6		0.2	1.6	2.0	0.0	0.2	0.0	0.0	1.6	0.2	0.2	0.0	0.7	7.0	0.0	4.6	5.9	0.8	6.8	28.5	2.8	1.9	0.0	0.0	0.2	5.5	0.2	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	1.6	1.8	0.0	0.0	5.7	0.0	2.7	0.0	4.3	0.2	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.6	2.6	14.3	3.8	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2										
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.2;ASC TERT1: 24.3;BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.1	1.9	0.8	0.3	3.2	0.0	3.6	2.0	4.3	1.4	0.4	2.5	1.9	0.0	2.1	2.5	1.1	2.1	0.8	1.9	0.0		1.6	3.1	6.8	2.6	0.9	1.5	4.9	2.8	11.2	2.1	9.5	1.5	2.2	0.2	3.7	3.2	3.2	1.4	2.6	0.0	1.9	3.0	0.5	0.7	1.0	2.2	0.8	3.5	0.0	0.7	1.9	1.4	0.5	0.2	0.0	0.3	0.0	1.9	0.1	0.0	1.1	0.1	0.0	32.2	24.3	0.6	8.5	0.0	13.9	15.6	1.3	4.6	4.8	11.1	9.4	6.4	0.0	3.5	7.8	0.0	1.4	0.0	0.0	0.0	3.3	0.0	3.1	8.5	0.7	0.8	4.5	4.2	0.1	0.0	0.4	3.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	9.0	0.0	4.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.3	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1										
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.6"	"Cell line enhanced"	"Detected in some"		"AF22: 18.2;EFO-21: 6.2;HSkMC: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	6.7	7.2	8.8	2.6	9.9	1.6	4.4	6.1	26.6	5.8	4.1	10.1	0.3	1.8	7.2	5.7	3.0	5.1	4.4	4.6	8.9	5.7	3.2	9.4	4.4	2.2	6.9	4.4	13.3	5.2	16.1	4.7	6.8	5.9	4.0	2.3	9.0	5.3	5.9	5.7	4.7	2.2	4.8	4.1	4.0	2.5	2.1	6.7	0.3	6.1	1.9	2.1	4.2	5.1	0.8	0.5	3.2	0.4	0.5	0.9	0.2	0.0	0.1	18.2	0.1	0.6	0.7	0.9	1.6	0.0	0.4	1.0	0.2	0.2	1.5	6.2	1.0	0.3	0.0	0.3	1.2	0.0	0.3	0.0	0.2	0.1	1.5	0.1	0.1	4.2	2.0	0.9	0.1	0.6	0.1	0.3	0.1	0.3	0.1	1.2	0.8	0.0	0.2	0.1	0.1	2.9	0.2	0.2	0.3	0.0	0.1	0.1	1.4	0.4	2.9	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.8	1.1	0.4	0.2	0.9	0.3	0.2	0.6	0.4	0.2	0.1	0.8	0.4	0.3	3.2	0.5	0.3	0.5	0.2	0.2	8.8	9.9	6.1	7.9	8.9	5.7	6.9	4.4	5.9	6.7
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AN3-CA: 42.5;HSkMC: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	10.1	9.8	12.6	3.8	13.5	0.8	8.0	19.1	12.9	10.2	7.0	16.1	1.2	2.3	11.6	5.0	6.8	7.8	9.2	8.5	14.5	7.9	5.4	3.5	11.6	2.6	10.4	7.3	17.3	5.5	9.5	5.3	11.0	9.4	8.3	3.8	15.5	7.1	12.0	5.6	6.8	3.2	10.5	20.1	5.3	4.5	4.2	14.3	0.6	8.4	3.0	2.3	4.6	6.9	0.2	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	42.5	1.0	0.2	0.4	2.8	0.3	1.0	2.1	0.0	2.6	0.3	2.3	5.6	0.7	0.1	0.5	1.0	0.0	0.3	0.0	0.0	0.0	3.2	0.2	0.0	13.5	0.3	0.8	0.4	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	4.7	0.9	0.0	0.1	0.0	4.6	6.3	0.1	0.0	0.0	0.4	0.4	5.5	5.1	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.6	13.5	19.1	12.9	14.5	7.9	10.4	7.3	9.4	14.3
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 23.6"	"Cell line enhanced"	"Detected in some"		"REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.7	2.9	5.7	0.7	9.5	0.5	0.8	23.6	21.9	1.0	1.1	2.3	0.0	0.6	0.9	1.2	0.8	1.0	1.0	1.3	4.1	10.1	0.6	0.6	1.0	0.9	3.3	4.5	0.8	1.2	0.8	1.3	0.8	8.6	0.8	0.8	1.9	1.0	0.7	1.2	1.5	0.7	0.9	2.3	0.8	0.7	1.5	0.8	0.0	0.7	0.0	1.0	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.2	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.3	0.9	0.9	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.5	0.0	9.7	0.6	0.0	0.0	0.1	8.2	15.9	0.1	0.0	0.2	0.1	0.3	0.1	0.9	0.1	0.2	0.7	0.2	0.0	0.2	0.6	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.5	23.6	15.6	4.1	10.1	3.3	4.5	8.6	0.8
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489121-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 43.7"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0"	"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4"					"HPA008755, HPA010580, HPA076140"	Supported		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	1.0	1.1	7.4	1.1	34.5	0.9	1.1	3.0	43.7	1.1	1.0	2.8	0.0	0.9	1.4	1.3	1.0	1.2	1.2	2.8	11.8	2.8	0.9	0.9	1.1	0.9	2.2	10.0	1.1	1.0	1.0	1.1	1.0	2.3	1.3	1.0	0.0	0.9	1.6	1.6	1.5	0.9	2.0	0.8	1.0	1.0	1.3	1.1	0.0	1.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.7	0.2	0.8	0.6	0.5	0.6	0.0	0.0	0.5	1.6	2.4	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.9	0.8	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.1	16.3	0.2	0.2	7.0	0.0	0.0	0.0	10.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	34.5	3.0	39.2	11.8	2.8	2.2	10.0	2.3	1.1
PCED1A	"bA12M19.1, C20orf81, FAM113A, FLJ22376"	ENSG00000132635	"PC-esterase domain containing 1A"	Q9H1Q7	20	2835314-2841190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050816	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA050816: "	"unprognostic (3.20e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.91e-3)"	"prognostic unfavourable (7.31e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.99e-1)"	"prognostic favourable (5.96e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.97e-3)"	18.0	17.3	25.5	21.9	29.1	13.1	14.4	18.7	29.0	17.6	13.4	27.6	18.8	17.1	23.8	20.3	12.6	22.4	23.0	9.7	24.2	17.1	23.1	21.0	16.4	23.5	30.0	20.8	28.4	16.1	38.2	27.0	16.4	25.1	25.4	9.1	21.6	23.7	18.3	6.9	12.7	18.2	15.2	14.5	33.1	20.0	9.4	28.7	14.2	36.0	4.8	16.7	15.8	17.6	9.4	8.2	3.1	7.4	14.2	12.0	6.8	12.4	16.4	16.7	9.2	17.5	24.2	12.1	12.0	13.7	12.9	14.0	11.4	22.9	3.7	8.3	8.1	20.5	4.0	11.2	6.0	18.0	12.2	14.3	18.2	15.8	14.2	2.7	4.8	32.1	23.9	15.8	21.0	9.2	11.2	17.2	9.4	8.6	1.9	18.1	18.4	9.8	9.9	5.5	7.5	14.5	10.4	15.5	24.0	11.9	15.7	20.6	20.1	9.7	8.8	12.6	8.7	13.0	5.7	28.3	14.1	1.0	3.1	10.2	14.8	2.9	7.4	3.1	11.0	6.6	10.6	8.6	6.4	9.3	8.2	9.4	12.0	10.6	0.6	14.2	6.1	7.1	4.5	6.8	25.5	29.1	18.7	29.0	24.2	17.1	30.0	20.8	25.1	28.7
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18029944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Enhanced	"Nuclear membrane,Centrosome,Cytosol"				Centrosome	"Nuclear membrane, Cytosol"	"CAB058695: , HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	19.6	19.0	26.2	26.7	40.4	25.1	25.1	29.2	29.0	25.0	21.1	21.6	22.8	12.4	23.3	27.3	16.4	26.4	17.8	23.0	22.9	18.4	18.8	22.0	19.1	21.1	24.5	24.9	29.1	27.0	42.0	35.8	19.8	26.4	20.2	16.3	16.2	19.4	25.3	63.1	17.6	18.3	26.7	27.2	20.8	17.9	80.0	28.0	40.2	28.2	19.1	20.4	27.0	22.6	11.5	14.9	19.9	7.5	11.2	13.0	4.3	20.3	21.7	33.4	44.2	18.9	19.7	17.3	17.2	21.2	18.4	20.8	14.7	12.2	26.7	11.9	17.1	14.8	21.3	15.8	31.4	8.8	8.2	45.8	15.4	29.8	21.1	20.0	11.8	17.1	16.9	21.3	23.7	21.1	30.9	20.8	22.4	10.2	42.9	33.2	27.5	6.3	25.9	29.9	9.5	15.2	28.3	25.6	19.3	18.4	10.1	26.4	15.9	29.3	18.8	16.8	13.7	20.5	14.5	8.9	19.6	23.9	14.2	22.1	17.1	19.9	6.0	14.4	11.5	3.8	12.0	11.1	10.4	13.0	5.9	11.5	11.6	11.6	6.4	11.2	7.5	14.9	10.3	4.3	26.2	40.4	29.2	29.0	22.9	18.4	24.5	24.9	26.4	28.0
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol			8200000	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavourable (4.02e-7)"	"prognostic unfavourable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.88e-4)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavourable (6.38e-4)"	19.1	18.4	35.7	13.0	43.0	28.5	19.3	33.5	58.3	20.2	16.9	19.2	12.4	14.7	16.0	22.2	17.9	15.8	11.0	43.9	35.0	38.8	21.3	29.5	15.1	14.6	35.1	46.0	16.2	14.6	16.4	15.5	17.2	57.4	22.1	18.1	11.6	17.2	21.4	69.5	14.7	13.6	19.6	28.6	12.0	12.7	29.1	19.2	18.1	19.3	15.9	17.9	14.4	13.7	31.6	53.0	51.2	58.0	30.0	37.4	51.6	21.4	17.0	17.4	21.8	37.5	31.0	19.4	35.3	20.2	28.1	35.5	49.3	16.4	27.2	30.0	29.8	26.8	29.9	35.2	40.6	18.9	43.3	41.5	32.0	48.2	25.1	49.4	51.1	15.4	26.1	32.0	34.6	26.5	59.3	26.7	33.5	63.9	24.0	37.7	14.2	19.1	19.9	22.6	19.5	27.3	15.8	33.2	12.8	26.8	42.8	22.9	25.9	35.2	19.7	16.6	21.0	31.4	38.3	16.9	26.2	27.8	26.1	33.0	32.8	40.0	58.0	51.2	30.2	53.6	30.1	31.6	30.6	32.7	53.0	24.2	28.5	32.5	30.8	30.0	52.2	23.9	37.4	51.6	35.7	43.0	33.5	58.3	35.0	38.8	35.1	46.0	57.4	19.2
PCNX3	"FLJ22427, PCNXL3"	ENSG00000197136	"Pecanex homolog 3"	Q9H6A9	11	65615773-65637439	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018084	Uncertain		Approved	Cytosol				Cytosol		"HPA018084: AB_1855083"	"unprognostic (9.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.69e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.82e-1)"	11.0	14.0	11.6	17.0	12.5	20.4	11.8	18.1	16.8	10.3	14.4	13.5	15.6	18.4	16.4	12.6	15.4	13.9	13.6	9.0	11.9	7.1	12.4	18.8	15.1	17.6	12.6	10.6	13.1	18.1	13.9	13.9	16.1	11.7	13.0	7.8	12.1	16.9	13.3	8.2	14.5	18.8	12.1	11.1	18.0	15.3	26.6	11.7	21.6	15.3	8.8	14.2	13.7	10.9	2.6	3.3	6.0	2.5	1.7	3.6	1.3	12.1	18.2	6.7	16.6	5.3	4.1	15.2	8.6	7.5	8.5	6.2	8.7	13.8	8.9	16.7	7.6	20.0	7.1	9.9	2.5	7.5	12.5	11.7	16.9	7.1	5.9	11.3	14.3	7.7	5.0	8.3	6.6	8.2	13.3	7.6	4.9	18.1	9.6	8.8	13.6	11.7	13.5	6.0	11.6	3.7	19.7	8.3	12.4	9.1	12.1	10.2	21.2	7.8	11.7	14.7	13.9	12.1	8.6	12.5	7.4	8.1	11.8	5.5	12.8	6.0	2.5	1.5	3.6	1.2	3.0	1.5	2.0	2.1	1.3	2.6	1.5	2.1	3.5	1.7	1.7	3.3	0.8	1.3	11.6	12.5	18.1	16.8	11.9	7.1	12.6	10.6	11.7	11.7
PCNX4	"C14orf135, PCNXL4"	ENSG00000126773	"Pecanex homolog 4"	Q63HM2	14	60091911-60169133	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002076, HPA003390"	Uncertain		Approved	Cytosol				Cytosol		"HPA002076: AB_1078322, HPA003390: AB_2066703"	"unprognostic (2.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.81e-1)"	"prognostic favourable (6.84e-5)"	"unprognostic (2.13e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.59e-2)"	12.0	16.5	13.6	14.7	18.2	9.1	14.3	19.4	18.6	18.8	10.2	15.2	14.0	8.2	21.2	13.6	10.4	22.7	14.2	17.8	12.7	13.6	20.6	11.1	12.2	11.0	12.5	12.4	27.4	12.1	26.3	39.8	13.7	16.1	21.3	11.2	17.7	12.7	17.2	15.2	13.0	11.3	16.2	14.5	13.1	10.0	23.0	11.6	24.6	16.5	11.1	11.7	11.6	13.9	7.3	7.7	5.3	8.1	13.4	11.4	5.3	39.4	6.2	11.9	8.1	10.2	12.1	5.3	13.1	21.6	15.9	20.0	6.6	12.0	7.0	5.5	11.0	5.2	7.9	7.8	27.0	8.9	3.6	11.2	4.5	5.1	21.6	11.6	8.2	9.8	5.4	11.0	18.6	7.4	5.7	9.9	24.6	5.2	16.0	4.1	6.1	8.0	9.4	15.2	2.9	8.7	5.4	9.0	10.6	12.2	4.8	9.6	10.7	5.1	14.7	32.6	24.9	7.7	10.1	3.2	3.2	9.5	12.4	4.2	15.8	4.8	6.9	5.3	8.7	7.2	11.4	7.3	6.3	7.5	7.0	5.5	7.2	8.0	3.2	13.4	8.1	7.7	6.2	5.3	13.6	18.2	19.4	18.6	12.7	13.6	12.5	12.4	16.1	11.6
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889203	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 55.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;RPMI-8226: 13.2;U-2197: 28.4;U-266/70: 28.2;U-266/84: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"			"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavourable (1.08e-4)"	35.2	1.2	1.0	2.0	0.5	5.5	29.0	0.3	0.7	12.4	3.6	0.5	9.1	0.0	3.9	6.0	16.8	2.1	3.8	55.6	1.4	1.2	7.3	7.9	6.9	1.6	0.6	0.7	2.5	0.6	0.1	13.8	20.1	0.4	14.2	2.1	2.5	2.7	3.9	6.3	2.7	1.5	41.6	0.8	1.2	2.0	1.9	0.3	0.0	3.5	6.2	0.9	28.2	30.6	0.0	0.0	1.4	0.2	0.0	0.0	0.3	0.5	4.2	1.4	0.0	25.4	7.0	0.0	0.3	0.1	1.1	1.5	0.2	0.5	0.0	1.2	1.9	0.0	5.0	0.0	1.4	0.0	8.4	0.8	2.8	0.0	0.0	0.5	0.0	2.8	0.0	2.6	0.6	0.0	0.2	0.0	0.5	0.7	1.5	0.4	2.1	8.8	0.0	3.2	13.2	1.2	0.0	2.7	1.7	6.6	0.0	2.4	0.0	1.7	0.0	2.2	5.1	28.4	2.1	28.2	13.0	0.0	6.3	0.7	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.5	0.3	0.7	1.4	1.2	0.6	0.7	0.4	0.3
PDAP1	"HASPP28, PAP, PAP1"	ENSG00000106244	"PDGFA associated protein 1"	Q13442	7	99392048-99408829	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021103, HPA050294, HPA060836"	Approved		Enhanced	"Plasma membrane,Cytosol"			40000	Cytosol	"Plasma membrane"	"CAB021103: AB_10057973, HPA050294: , HPA060836: "	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavourable (6.67e-4)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.97e-2)"	26.7	25.7	25.5	25.0	23.9	23.0	22.4	23.4	28.5	22.8	25.9	18.3	21.6	21.1	25.8	21.6	32.2	20.5	23.4	30.2	23.4	20.4	25.2	31.8	20.5	20.2	23.2	23.5	23.4	28.2	23.3	18.0	28.8	24.2	23.0	22.0	19.0	27.8	26.4	103.5	24.8	19.6	26.9	22.2	20.5	22.6	19.7	24.3	20.1	22.4	37.2	25.2	24.1	28.2	11.3	15.8	24.2	11.9	20.4	14.2	4.6	30.7	26.9	18.2	23.2	14.1	14.7	11.8	25.6	14.8	20.7	17.5	27.2	15.4	13.6	22.7	24.1	16.7	21.9	25.6	20.2	19.3	24.3	13.7	26.0	23.6	20.7	25.7	13.6	15.4	19.3	22.7	37.3	20.6	32.3	24.8	20.2	64.2	35.7	35.1	23.3	29.2	16.5	18.2	23.5	20.9	23.7	18.7	37.4	19.1	30.5	13.0	13.4	13.5	18.6	27.9	30.9	33.0	39.9	23.9	27.3	30.1	22.4	23.1	29.1	7.6	9.4	8.6	12.4	11.9	11.1	11.3	11.5	8.9	7.4	11.1	8.3	10.3	24.2	20.4	10.6	15.8	14.2	4.6	25.5	23.9	23.4	28.5	23.4	20.4	23.2	23.5	24.2	24.3
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510570-5571254	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 25.4;BJ hTERT+: 39.9;HDLM-2: 30.5;TIME: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Approved	Cytosol	"Secreted - unknown location"		34000000	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	15.2	1.8	1.2	7.7	1.4	0.2	9.5	0.7	1.2	7.0	1.9	2.3	0.0	0.8	2.9	7.2	3.9	3.8	4.0	5.8	1.2	1.3	2.5	6.4	13.3	10.8	1.6	0.5	4.1	1.8	0.5	1.1	12.9	1.9	5.0	2.5	2.4	2.9	1.7	5.5	3.6	2.5	4.6	3.7	19.5	1.9	4.2	1.2	8.1	3.5	3.5	8.1	6.0	5.4	0.5	0.9	4.1	3.6	0.0	3.0	0.7	2.0	0.0	0.0	0.0	1.7	2.0	0.0	25.4	39.9	12.3	14.9	0.0	0.1	0.0	0.0	10.3	0.2	0.0	3.4	12.2	30.5	0.0	0.0	0.0	0.0	9.9	0.0	0.0	1.8	0.0	5.7	6.7	8.0	0.0	3.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	17.6	8.8	0.5	4.2	7.0	0.4	0.0	0.0	5.0	0.0	1.0	4.1	0.9	0.0	1.4	3.6	1.9	0.5	2.2	0.9	0.9	0.3	0.0	1.0	2.0	0.0	0.5	0.0	3.0	0.7	1.2	1.4	0.7	1.2	1.2	1.3	1.6	0.5	1.9	1.2
PDCD5	"MGC9294, TFAR19"	ENSG00000105185	"Programmed cell death 5"	O14737	19	32581068-32587452	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018471	Enhanced		Approved	Nucleoplasm,Cytosol			31000	Cytosol	Nucleoplasm	"HPA018471: AB_1855108"	"unprognostic (1.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (2.02e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (6.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.54e-2)"	34.1	40.6	42.1	32.3	35.9	18.9	28.9	28.7	33.0	21.2	31.7	16.4	27.0	31.4	22.9	24.8	33.8	21.4	23.1	63.7	33.0	34.2	37.0	52.0	20.6	25.9	32.9	31.9	25.8	47.6	14.7	38.8	29.5	31.0	23.2	27.6	14.7	27.3	24.5	107.4	23.9	27.1	32.1	26.4	26.8	28.0	52.4	23.5	15.2	25.4	42.7	26.6	30.6	31.8	34.6	29.1	11.2	44.8	24.2	49.8	26.9	69.1	86.1	20.8	22.3	35.1	54.2	26.8	51.0	32.9	41.5	35.8	69.7	26.6	37.7	74.6	24.9	18.5	28.7	38.9	31.8	67.9	46.1	56.9	37.8	41.6	41.8	72.5	22.9	34.4	37.1	28.1	46.2	27.6	51.7	41.4	34.9	44.3	32.4	37.7	22.7	29.2	31.9	31.9	45.6	31.8	18.0	43.8	24.9	48.5	47.2	35.2	20.6	42.5	42.6	37.3	41.7	40.2	82.3	40.2	56.9	65.5	44.3	66.5	32.9	6.9	23.1	11.2	26.7	34.9	33.9	34.6	42.9	33.0	28.5	25.5	30.4	29.3	3.2	24.2	44.8	29.1	49.8	26.9	42.1	35.9	28.7	33.0	33.0	34.2	32.9	31.9	31.0	23.5
PDCD6	"ALG-2, PEF1B"	ENSG00000249915	"Programmed cell death 6"	O75340	5	271621-353856	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047221			Approved	Cytosol			2100000	Cytosol		"HPA047221: "	"unprognostic (1.32e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (5.47e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (5.16e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-1)"	"prognostic favourable (2.19e-4)"	28.3	48.5	44.6	36.3	42.1	21.0	44.6	42.1	52.0	37.1	47.3	33.7	35.7	41.4	31.5	59.7	58.0	38.9	46.5	23.5	44.4	39.7	35.5	37.1	39.8	48.1	39.2	38.6	36.9	46.2	28.8	36.2	35.4	39.3	32.9	51.0	26.8	40.3	40.4	19.2	31.1	44.3	31.4	38.4	36.6	32.0	31.7	35.1	31.0	42.3	31.9	41.2	31.3	37.7	69.8	67.2	79.9	62.3	70.6	69.9	89.4	26.8	37.9	16.6	24.8	30.2	27.3	34.2	21.0	27.9	27.0	25.4	26.7	34.1	21.2	52.3	28.2	20.5	25.1	52.7	22.0	71.5	31.1	18.8	97.4	34.5	36.9	27.2	24.1	24.4	32.5	21.9	39.3	25.3	23.6	16.7	24.1	42.1	22.0	47.5	17.6	53.5	18.1	15.5	30.2	63.8	34.8	16.0	21.6	53.3	57.2	39.0	39.8	37.8	19.5	17.9	14.5	15.4	17.9	22.3	27.5	25.1	26.1	35.6	23.7	40.8	62.3	79.9	49.6	58.7	61.7	69.8	62.2	55.8	67.2	60.9	69.9	56.2	69.0	70.6	56.1	53.8	66.7	89.4	44.6	42.1	42.1	52.0	44.4	39.7	39.2	38.6	39.3	35.1
PDCL	"DKFZp564M1863, PhLP"	ENSG00000136940	"Phosducin like"	Q13371	9	122798389-122828631	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021571, HPA021647, CAB026473"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115"	"unprognostic (3.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"prognostic favourable (7.00e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-1)"	20.7	14.8	17.5	14.1	21.0	23.8	23.0	20.5	21.9	19.6	15.1	23.7	11.4	13.2	21.5	12.8	18.4	15.9	14.9	14.6	18.4	17.3	13.7	10.1	19.7	17.5	20.2	17.1	15.5	13.0	17.5	13.7	20.6	22.2	17.1	15.9	13.9	21.7	14.7	8.1	15.4	14.7	17.2	22.8	18.4	15.5	12.1	18.8	19.1	17.3	13.3	17.6	15.8	16.4	12.6	14.7	20.6	16.3	16.2	25.3	10.8	9.4	13.1	22.6	8.4	20.6	13.9	12.5	13.3	14.1	12.3	12.6	8.7	12.6	15.8	10.9	15.9	18.5	13.9	13.0	13.7	15.4	7.1	16.2	17.5	14.4	10.6	13.7	32.3	11.9	9.5	12.0	6.1	25.2	16.3	9.3	13.8	14.6	14.6	12.4	16.6	10.3	15.4	21.5	11.6	14.9	0.0	18.2	16.2	17.9	10.2	7.9	15.4	9.5	27.4	11.5	13.6	16.7	12.8	7.2	14.3	16.8	9.8	11.0	10.9	20.6	11.9	19.6	13.9	10.4	15.0	11.4	16.7	12.8	12.3	12.6	17.5	15.2	9.8	16.2	16.3	14.7	25.3	10.8	17.5	21.0	20.5	21.9	18.4	17.3	20.2	17.1	22.2	18.8
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562690-100576735	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favourable (4.23e-4)"	12.9	15.9	14.7	16.4	16.2	12.0	18.0	10.7	16.5	12.7	18.8	14.3	15.3	10.5	20.1	23.5	22.5	14.9	13.1	17.6	14.6	15.8	20.9	12.2	13.5	14.0	24.4	15.9	15.4	10.4	10.8	11.4	17.1	17.4	19.6	17.9	10.2	12.0	15.4	35.7	22.0	12.1	49.6	18.3	14.5	13.3	14.0	14.5	13.4	13.0	18.8	19.6	29.9	16.8	26.5	33.4	22.2	43.6	25.6	31.4	23.3	13.2	18.5	19.5	16.9	6.3	8.8	21.8	16.5	10.2	29.8	18.6	23.2	8.2	21.3	25.1	19.3	11.1	24.1	15.9	23.7	34.2	20.8	22.5	10.0	27.2	16.7	23.8	24.1	9.8	29.1	26.4	16.9	18.3	18.7	14.5	22.1	22.5	23.8	36.5	25.6	27.3	23.3	20.9	14.9	18.3	30.7	18.4	16.1	12.9	17.7	18.1	13.9	16.5	14.3	18.8	19.9	14.5	22.6	8.8	16.3	22.4	11.6	27.8	14.7	18.6	19.3	22.2	19.4	34.9	22.1	26.5	29.7	21.5	33.4	20.8	31.0	23.8	2.1	25.6	43.6	18.4	31.4	23.3	14.7	16.2	10.7	16.5	14.6	15.8	24.4	15.9	17.4	14.5
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0;lymphoid tissue: 65.4"	"Cell line enriched"	"Detected in some"	8	"HeLa: 105.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.7;T-cells: 9.6"					"Group enriched"	"Detected in many"	5	"amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol				Cytosol		"CAB009752: AB_2268159, HPA031192: "	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favourable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	27.8	18.4	30.4	3.0	34.2	2.5	25.4	1.0	48.0	8.9	7.7	3.8	1.9	3.5	9.4	4.9	10.2	11.6	12.0	11.3	18.0	6.1	7.0	10.4	5.1	3.8	3.8	27.0	3.4	2.4	4.4	3.4	6.6	6.7	4.8	5.2	3.0	2.3	6.3	6.6	4.8	4.2	10.3	2.1	65.4	4.2	2.9	7.4	0.1	7.0	3.9	2.2	8.3	11.2	3.7	1.2	0.2	1.0	0.1	9.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	105.0	0.1	0.2	0.0	1.6	0.0	0.2	0.5	4.3	2.3	0.1	0.1	0.0	0.0	0.0	0.0	1.5	2.9	0.0	0.0	0.2	0.0	0.0	9.4	0.5	0.0	0.0	0.4	0.0	0.0	13.4	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	9.6	1.0	5.6	3.7	5.7	5.6	1.2	2.5	3.7	3.0	0.2	0.1	0.5	0.0	2.3	1.9	30.4	34.2	1.0	48.0	18.0	6.1	3.8	27.0	6.7	7.4
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.9;HUVEC TERT2: 35.9;NTERA-2: 21.8;SK-MEL-30: 21.6;TIME: 20.0;U-266/84: 18.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 36.6"	"Group enriched"	"Detected in all"	5	"B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	14.9	2.9	21.5	28.4	29.0	48.2	15.0	12.7	31.9	6.4	6.6	39.2	0.7	3.9	6.7	2.1	3.9	3.5	8.1	16.1	20.7	18.8	3.7	8.7	10.0	15.9	36.3	14.2	2.0	1.7	1.7	3.4	13.1	32.2	18.3	8.6	6.6	15.9	10.3	28.2	6.2	8.5	9.5	37.4	18.5	4.2	3.2	36.9	2.3	5.5	5.5	14.7	16.1	3.9	16.1	2.6	36.6	2.8	4.4	13.3	3.7	0.0	6.8	13.5	23.9	0.7	0.7	0.0	4.4	5.2	4.2	5.5	0.0	0.0	2.0	0.1	8.2	0.0	0.1	0.0	4.1	5.8	0.0	0.1	1.9	0.0	0.5	4.8	0.0	1.4	0.2	2.1	0.1	35.9	0.0	1.3	1.8	0.1	0.0	2.8	21.8	0.3	0.9	2.4	1.3	3.3	0.0	0.1	10.4	0.0	1.1	21.6	0.1	1.7	20.0	3.3	0.8	1.8	0.7	0.6	18.8	7.3	3.4	5.0	1.4	2.7	2.8	8.4	4.4	2.4	8.4	15.4	8.3	6.2	2.4	16.1	9.4	6.5	36.6	4.4	2.1	2.6	13.3	3.7	21.5	29.0	12.7	24.6	20.7	18.8	36.3	14.2	32.2	36.9
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell line enhanced"	"Detected in many"		"A549: 24.8;AN3-CA: 28.5;HeLa: 41.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 28.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favourable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.2	1.9	4.4	6.8	8.6	46.2	5.3	4.2	13.0	13.5	18.6	1.4	14.7	4.1	17.1	14.0	10.3	6.6	12.7	15.5	4.5	5.8	12.8	3.4	11.1	3.7	5.2	6.6	5.3	2.9	7.0	9.0	11.8	2.7	18.2	11.2	8.6	24.4	16.5	60.0	5.1	7.5	35.8	5.0	3.8	10.2	2.6	2.8	4.4	6.2	11.3	9.5	20.0	11.2	6.1	0.7	28.1	1.1	0.1	0.8	0.5	0.0	24.8	5.2	28.5	0.9	1.8	4.1	0.6	0.7	1.4	2.0	9.7	0.8	1.9	0.1	0.2	4.2	0.0	1.1	2.4	1.1	2.8	3.6	41.0	2.1	3.8	1.7	0.2	3.8	0.9	3.9	0.7	2.9	0.0	0.6	2.4	1.7	1.3	4.0	0.9	1.3	0.4	6.5	4.1	6.5	9.3	0.9	3.3	6.5	11.0	5.6	0.8	3.7	3.4	0.3	0.1	4.9	1.3	1.4	0.0	0.2	4.2	6.8	1.1	2.0	1.1	28.1	0.8	0.0	0.8	6.1	0.7	0.3	0.7	6.1	0.5	0.4	1.5	0.1	0.1	0.0	0.4	0.5	4.4	8.6	4.2	13.0	4.5	5.8	5.2	6.6	2.7	2.8
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494395-119628991	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;HHSteC: 35.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	"Centriolar satellite,Cytosol"			3100000	Cytosol	"Centriolar satellite"	"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favourable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavourable (1.17e-4)"	12.3	4.9	2.0	28.2	2.3	0.4	8.1	3.0	2.3	21.3	28.0	1.7	20.1	6.5	17.3	21.4	30.7	10.7	13.3	5.3	2.0	2.8	3.8	1.2	11.4	4.1	2.4	3.4	10.0	7.8	5.1	3.4	8.9	4.4	31.8	11.7	20.2	8.5	23.7	6.8	4.2	15.6	45.6	2.0	2.1	9.1	7.6	1.2	0.9	9.1	8.1	2.2	25.9	15.9	1.5	0.5	1.4	0.4	0.6	2.1	4.2	8.0	0.4	5.7	0.6	1.9	2.9	1.0	5.4	24.3	0.2	0.5	0.5	0.7	0.8	0.2	6.7	2.9	1.8	0.8	0.7	0.2	3.7	9.0	1.4	0.4	35.0	1.9	0.9	3.2	1.7	0.6	0.0	0.7	1.0	1.5	0.8	0.4	2.4	0.3	1.2	1.4	0.3	2.9	2.1	2.1	2.4	2.2	4.5	6.3	7.9	0.6	1.4	1.0	1.2	3.2	2.8	1.7	0.7	2.1	1.0	0.7	3.1	0.5	0.4	0.0	0.3	0.0	0.6	0.1	2.1	1.5	1.3	0.4	0.2	1.0	0.6	0.9	1.4	0.6	0.4	0.5	0.4	4.2	2.0	2.3	3.0	2.3	2.0	2.8	2.4	3.4	4.4	1.2
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625584-670782	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.2;retina: 64.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol				Cytosol		"HPA054148: , HPA059929: "	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favourable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.6	1.9	12.1	4.6	19.1	6.7	3.8	2.3	13.2	2.3	1.3	30.2	1.5	0.8	2.5	3.9	1.4	9.6	3.2	5.2	18.1	10.2	4.6	0.7	4.2	12.0	29.6	9.8	2.6	1.4	9.1	3.2	2.6	14.5	2.5	1.0	64.2	3.5	2.9	0.7	1.8	2.2	2.1	20.2	8.7	2.5	3.6	22.4	4.3	11.4	0.2	8.3	4.1	1.1	16.5	14.1	11.2	5.8	10.2	13.1	7.1	0.0	0.2	0.8	0.4	0.2	0.3	0.2	0.0	0.0	0.5	1.4	0.0	0.1	0.2	8.0	0.2	0.1	1.7	0.4	0.0	0.1	0.0	0.6	0.2	0.0	4.1	0.1	0.3	0.5	0.1	2.4	0.0	0.7	0.1	0.6	0.0	0.2	20.5	0.2	6.5	0.2	11.1	0.2	0.4	1.4	0.9	14.0	8.2	0.0	0.3	0.1	0.4	0.0	0.2	0.1	0.8	0.1	0.3	5.4	15.2	0.2	0.2	0.2	0.1	11.2	4.2	0.6	11.5	5.8	10.5	10.0	7.7	7.9	6.6	16.5	12.2	13.1	1.1	10.2	5.6	14.1	11.4	7.1	12.1	19.1	2.3	10.0	18.1	10.2	29.6	9.8	14.5	22.4
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77429807	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"thyroid gland: 67.7"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 12.1;HeLa: 27.8;SK-BR-3: 7.4"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA036911: , HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	6.8	2.5	9.9	0.7	14.2	0.4	3.8	1.1	16.3	6.3	1.2	2.3	0.3	1.2	11.3	3.2	1.1	10.1	2.1	7.9	8.2	9.2	3.1	1.2	2.2	0.7	5.4	8.3	1.9	4.2	0.3	3.8	13.1	8.6	10.5	0.8	2.0	5.3	7.1	0.4	0.7	1.3	10.3	2.3	0.4	1.5	1.5	5.7	0.3	67.7	0.3	0.7	0.8	1.4	0.2	0.8	1.4	2.3	0.4	0.4	0.1	0.3	3.3	1.3	0.3	1.2	0.0	0.5	1.1	12.1	0.2	0.1	1.3	0.2	0.5	0.2	0.1	0.9	0.1	0.0	0.2	0.2	1.0	0.7	27.8	0.3	0.0	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.6	0.7	0.8	0.1	0.8	1.4	0.7	0.0	0.3	3.7	1.0	1.6	7.4	0.8	1.6	1.1	0.6	0.4	0.2	0.2	0.6	0.9	0.5	0.6	1.6	0.7	0.4	0.0	0.3	1.4	0.3	2.2	0.1	0.2	0.2	0.3	0.8	0.2	0.4	0.0	0.3	0.4	2.3	0.5	0.1	0.1	9.9	14.2	1.1	16.3	8.2	9.2	5.4	8.3	8.6	5.7
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971394	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.4;fHDF/TERT166: 28.1;U-138 MG: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"			"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.35e-5)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (3.17e-4)"	11.5	9.1	3.2	6.5	3.4	0.7	7.9	1.3	3.5	21.8	6.1	1.9	8.4	2.2	21.3	9.4	6.1	9.0	12.7	3.6	2.4	2.0	9.7	10.3	6.9	4.3	2.2	3.8	10.4	9.8	28.0	2.2	4.9	1.9	17.7	2.4	5.5	26.6	9.3	6.5	4.1	5.4	11.9	2.0	4.1	5.6	4.3	1.7	2.2	10.4	4.4	1.5	8.3	4.7	0.0	0.2	0.0	2.1	0.0	0.0	0.7	1.0	1.6	18.4	12.1	3.4	6.7	0.4	9.6	10.2	5.8	7.8	1.0	4.3	0.0	1.7	28.1	1.1	5.1	6.3	8.0	0.0	2.3	11.2	1.7	1.0	9.0	1.7	0.1	6.9	3.2	14.7	10.6	2.8	0.0	0.0	14.3	0.0	0.0	0.0	0.2	0.7	0.0	3.8	0.0	11.0	0.4	0.0	0.0	0.0	0.0	0.1	1.4	0.5	12.4	20.0	0.2	5.0	7.8	0.0	0.0	0.0	7.6	0.0	0.7	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.7	3.2	3.4	1.3	3.5	2.4	2.0	2.2	3.8	1.9	1.7
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		53000000	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.20e-4)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	26.9	32.7	16.7	25.0	29.9	19.9	28.7	11.3	16.8	33.4	26.1	13.9	53.7	20.4	30.4	76.1	27.1	25.5	22.4	32.7	14.2	13.9	42.1	118.4	30.4	36.3	17.8	12.7	26.5	141.6	24.9	23.3	39.5	19.0	22.6	30.1	14.6	53.4	45.0	15.7	16.1	28.4	26.5	14.3	35.1	30.9	12.4	19.5	18.1	97.9	20.1	29.7	21.9	30.6	45.2	61.0	52.0	46.2	51.5	52.2	59.7	33.9	36.9	52.9	82.9	68.1	58.9	94.0	82.7	76.8	43.4	58.5	52.3	67.1	55.2	58.2	80.8	27.9	39.7	69.2	46.7	43.2	31.3	44.7	28.9	84.9	73.7	45.8	33.6	42.5	53.2	42.0	75.8	97.8	38.4	119.1	42.8	40.2	17.6	47.5	44.1	29.2	42.3	53.9	99.9	61.8	41.1	33.9	67.9	32.6	47.8	46.4	16.9	77.7	48.0	40.8	52.1	36.7	47.8	112.4	69.3	35.8	55.1	57.6	57.0	52.0	44.4	20.5	47.5	46.2	52.2	45.2	37.7	44.7	48.6	33.1	18.4	31.0	8.1	51.5	33.9	61.0	37.7	59.7	16.7	29.9	11.3	16.8	14.2	13.9	17.8	12.7	19.0	19.5
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535612	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 447.7"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 50.0;RH-30: 12.3;U-266/70: 40.2;U-266/84: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol			270000	Cytosol		"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.13e-6)"	"unprognostic (2.78e-3)"	7.8	1.2	1.6	5.2	1.9	0.1	3.7	2.2	1.0	6.6	16.5	1.4	7.9	2.3	22.2	17.0	27.2	9.3	9.9	29.5	1.5	1.6	0.8	0.8	5.6	1.4	1.6	1.0	11.1	2.1	0.1	1.9	2.2	1.6	15.2	3.6	4.8	5.3	18.7	447.7	1.0	6.1	49.5	1.4	3.4	10.2	3.9	0.7	0.1	6.2	87.3	9.1	28.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.4	1.9	5.5	0.0	0.0	3.9	0.0	1.2	0.0	4.1	0.0	0.0	50.0	0.0	0.0	0.0	0.9	0.3	0.0	12.3	0.1	0.0	0.0	7.4	5.6	0.0	0.0	2.9	0.2	0.0	2.7	0.0	3.0	0.0	2.5	40.2	11.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	2.2	1.0	1.5	1.6	1.6	1.0	1.6	0.7
PDLIM4	RIL	ENSG00000131435	"PDZ and LIM domain 4"	P50479	5	132257671-132273454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 27.5;HBEC3-KT: 32.1;HHSteC: 31.9;hTEC/SVTERT24-B: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011912	Uncertain		Approved	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA011912: AB_1856277"	"unprognostic (1.36e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.40e-3)"	11.5	5.0	7.1	12.8	13.1	0.6	30.4	2.4	5.9	11.5	32.9	7.4	8.9	5.0	33.4	28.7	27.9	16.2	19.1	21.8	12.2	6.9	6.9	0.6	3.4	8.2	6.5	3.8	15.0	4.8	4.6	10.1	19.8	35.9	17.3	3.7	9.6	19.8	21.9	3.8	21.2	8.7	44.8	23.4	2.8	13.4	6.9	3.8	3.5	4.8	25.2	10.6	22.6	13.8	0.0	0.0	0.0	0.0	1.3	0.0	0.3	13.3	0.0	2.9	0.0	4.0	11.3	1.0	3.9	1.8	3.8	1.2	0.0	1.2	0.1	2.7	19.9	27.5	0.0	32.1	1.8	0.0	1.4	0.0	0.0	0.6	31.9	0.0	0.0	14.3	2.3	35.3	13.2	21.9	5.6	0.0	17.0	0.0	0.0	0.1	1.0	8.2	0.6	19.8	0.0	8.6	0.0	0.0	12.1	8.7	0.0	0.0	0.0	1.4	13.9	14.0	15.4	14.7	21.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	7.1	13.1	2.4	5.9	12.2	6.9	6.5	3.8	35.9	3.8
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.2;TIME: 33.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavourable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favourable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	8.9	4.4	9.6	4.0	8.0	14.6	3.2	7.0	7.8	8.3	9.8	4.6	33.2	5.0	23.7	11.2	19.9	4.1	5.9	12.3	0.5	2.0	2.3	5.5	1.6	9.1	1.1	3.3	9.4	11.8	14.1	22.6	18.7	0.8	8.2	10.1	2.1	6.9	3.6	4.4	5.7	1.7	5.7	0.9	5.7	6.2	0.8	4.2	4.6	0.5	21.6	1.5	1.4	33.2	10.1	6.5	23.6	8.3	4.6	1.9	4.2	12.9	4.2	8.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8
PDSS1	"COQ1, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697659-26746798	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 22.4;lymphoid tissue: 31.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol				Cytosol		"HPA038032: AB_10670650, HPA042741: "	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavourable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	3.1	2.6	2.4	7.0	3.1	5.6	3.5	5.6	5.1	3.1	18.2	1.5	1.2	20.6	3.8	2.1	8.3	3.4	3.7	4.2	2.2	2.2	8.6	7.2	4.0	7.8	2.1	2.3	2.8	3.8	1.7	2.5	2.8	2.9	2.3	17.0	3.2	3.5	1.8	10.4	2.7	22.4	3.6	3.1	5.7	3.8	3.0	1.6	31.8	2.1	4.7	5.0	2.9	4.0	3.2	5.2	0.9	5.3	0.8	3.4	1.3	7.5	5.9	4.5	8.2	1.5	2.8	6.2	7.0	1.8	10.2	7.0	9.0	4.2	17.3	3.7	3.4	9.6	14.3	10.7	8.7	7.2	12.0	14.9	5.1	6.5	2.2	9.9	5.9	3.5	4.6	9.5	2.5	5.3	13.7	4.6	7.1	11.9	31.2	7.0	9.0	5.7	14.5	12.9	12.5	6.0	3.6	13.2	8.1	6.8	14.0	7.6	4.9	11.6	3.4	5.7	9.1	11.7	11.1	1.8	6.7	12.6	5.6	25.2	4.4	0.0	5.3	0.9	0.9	4.1	2.1	0.5	1.8	1.3	5.2	3.2	3.4	1.5	0.3	0.8	2.1	1.4	0.1	1.3	2.4	3.1	5.6	5.1	2.2	2.2	2.1	2.3	2.9	1.6
PDSS2	"bA59I9.3, C6orf210"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152557-107459564	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Enhanced	Cytosol				Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favourable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favourable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	10.6	27.3	7.2	17.0	8.3	8.3	19.6	9.0	10.3	10.4	12.7	9.0	13.7	9.6	13.1	11.4	11.5	9.2	11.2	16.0	7.0	6.8	22.1	27.4	18.2	18.3	9.2	5.3	10.8	14.0	11.4	19.4	7.0	9.6	15.6	13.9	12.0	19.9	19.9	13.1	9.0	10.1	11.0	8.1	9.1	10.5	12.8	10.1	11.3	14.1	11.1	10.6	10.9	12.9	8.5	9.4	4.1	12.1	4.6	8.3	4.3	5.6	7.6	6.5	10.1	11.3	14.5	15.0	10.0	12.7	9.6	9.3	7.5	8.2	10.8	9.2	11.1	7.8	15.7	12.5	13.2	6.9	7.7	10.7	9.0	12.5	12.0	13.8	8.7	10.7	14.9	15.2	12.1	10.1	15.2	14.7	9.4	7.0	4.0	14.6	4.1	9.9	7.2	5.8	8.7	11.9	7.8	6.4	5.6	6.8	12.0	14.3	9.8	16.7	6.3	6.9	4.1	9.6	8.5	4.1	5.0	8.4	12.8	20.6	12.6	4.1	6.6	3.5	5.3	7.6	8.3	6.6	5.6	6.8	9.4	8.5	7.3	6.9	0.9	4.6	12.1	4.5	7.1	4.3	7.2	8.3	9.0	10.3	7.0	6.8	9.2	5.3	9.6	10.1
PDZD2	"KIAA0300, PDZK3"	ENSG00000133401	"PDZ domain containing 2"	O15018	5	31639410-32110931	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;SiHa: 12.4;SK-BR-3: 11.5;T-47d: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020784, HPA036503, HPA036504, HPA064387, HPA076072"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane"	"CAB020784: , HPA036503: , HPA036504: , HPA064387: , HPA076072: "	"unprognostic (3.65e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.42e-5)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.79e-1)"	16.3	1.3	7.8	1.0	28.8	0.3	5.6	3.6	18.1	2.9	1.9	5.1	2.4	0.8	3.0	7.4	6.1	2.8	1.2	19.6	6.6	4.8	9.5	0.4	10.0	0.5	5.4	8.8	16.7	1.5	0.8	2.6	11.9	11.5	2.0	1.1	4.3	2.3	2.5	2.6	11.1	1.1	2.9	3.2	0.5	2.0	6.2	6.1	0.3	1.3	0.7	2.0	1.1	2.9	0.4	0.7	0.7	0.6	0.2	1.0	0.0	0.1	0.0	3.4	0.1	0.0	0.0	8.9	0.0	0.0	0.6	0.6	0.0	0.0	0.0	5.0	0.0	4.7	1.8	1.0	0.0	0.0	0.4	0.0	2.7	0.0	0.0	0.0	2.7	0.3	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.8	0.0	0.0	0.0	3.9	0.1	0.1	0.8	12.4	11.5	0.0	6.0	0.0	0.0	0.0	2.4	0.0	0.5	0.0	0.0	2.9	0.0	0.0	1.2	0.4	0.5	0.4	0.5	0.1	1.0	0.1	0.3	0.1	0.1	0.4	0.1	0.1	0.7	0.2	0.6	0.7	0.0	0.0	7.8	28.8	3.6	18.1	6.6	4.8	5.4	8.8	11.5	6.1
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 49.2;kidney: 124.3"	"Group enriched"	"Detected in some"	4	"RPTEC TERT1: 42.1;T-47d: 109.4"	"Group enriched"	"Detected in many"	12	"breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in single"	17	"cerebellum: 10.0"	"Cell type enriched"	"Detected in many"	4	"NK-cell: 7.6"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 7.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favourable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.1	0.6	0.2	0.2	0.3	0.0	5.8	10.0	0.2	0.3	16.5	0.2	0.8	13.2	0.3	6.7	0.1	0.1	10.6	0.1	0.2	0.2	124.3	25.7	0.4	0.1	0.3	0.2	0.2	4.2	0.0	0.1	0.9	0.5	0.1	1.3	1.2	0.1	0.1	0.1	0.7	49.2	0.1	0.4	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.0	1.1	0.5	0.2	7.6	1.8	0.5	1.2	0.2	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	18.5	0.1	0.1	0.2	1.1	0.5	0.0	0.0	0.1	1.7	0.3	0.1	0.4	7.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.1	0.2	0.2	0.5	0.0	1.2	0.2	42.1	0.0	0.1	1.2	0.2	0.3	0.0	109.4	0.1	0.1	0.2	0.2	0.1	0.1	1.5	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.1	1.5	0.2	0.6	1.0	0.4	1.8	0.2	1.0	0.4	0.7	0.4	7.6	0.1	1.1	0.1	0.5	0.2	0.3	10.0	0.2	0.2	0.2	0.3	0.2	0.5	0.1
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183593-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 281.3"	"Group enriched"	"Detected in some"	6	"EFO-21: 30.8;RPTEC TERT1: 102.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"				Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavourable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	2.7	1.2	0.6	2.4	0.6	3.9	4.1	0.6	0.6	9.2	9.1	0.6	0.6	2.2	1.3	4.8	30.4	2.9	23.9	0.7	0.5	0.0	281.3	1.6	7.2	0.5	0.6	0.5	2.3	16.8	0.0	0.6	3.2	0.6	2.1	3.4	0.8	33.9	12.4	0.7	19.9	9.5	0.5	0.5	0.7	9.0	1.4	0.6	1.1	1.0	18.3	18.5	4.1	8.3	0.1	0.5	2.1	1.1	0.2	0.3	42.4	10.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.4	0.0	30.8	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	102.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.1	0.2	0.0	0.5	0.3	42.4	0.6	0.6	0.6	0.6	0.5	0.0	0.6	0.5	0.6	0.6
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205337-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 199.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 30.6"	"Group enriched"	"Detected in all"	6	"B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Approved	Nucleoplasm,Cytosol			240000	"Nucleoplasm, Cytosol"		"HPA028356: AB_10602814, HPA070820: "	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	45.3	20.4	105.3	28.7	83.6	3.8	25.3	30.5	173.1	25.1	15.5	68.1	5.0	8.0	21.5	21.8	22.6	19.2	22.1	53.9	70.5	81.3	14.8	10.4	23.8	16.6	106.5	67.0	19.7	9.7	14.9	10.2	25.1	74.1	24.4	15.3	18.2	12.3	31.1	10.2	16.9	8.8	47.4	199.4	23.8	10.0	17.5	53.7	1.6	12.6	6.0	22.9	22.4	17.5	7.6	22.1	1.8	30.6	3.1	3.5	5.4	16.7	5.8	24.3	10.5	45.1	25.3	8.1	72.8	63.6	60.6	42.6	12.8	9.1	7.8	26.4	90.8	18.3	9.0	22.8	47.4	4.2	5.0	6.4	4.1	3.2	55.7	2.1	7.9	21.2	12.9	33.3	42.5	45.5	6.6	14.3	81.0	8.3	2.5	5.0	16.1	16.8	4.2	25.6	5.3	22.0	8.8	4.8	12.9	38.6	26.4	22.2	16.2	15.1	60.6	40.3	31.6	30.0	31.2	11.3	6.9	14.8	37.1	4.1	57.0	0.3	15.3	1.8	3.5	30.6	2.7	7.6	2.6	2.8	22.1	5.0	1.6	1.8	0.7	3.1	13.9	9.7	2.9	5.4	105.3	83.6	30.5	78.2	70.5	81.3	106.5	67.0	74.1	53.7
PEF1	PEF1A	ENSG00000162517	"Penta-EF-hand domain containing 1"	Q9UBV8	1	31629862-31644896	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061608			Approved	Nucleoplasm,Vesicles,Cytosol			660000	"Nucleoplasm, Cytosol"	Vesicles	"HPA061608: "	"unprognostic (2.92e-2)"	"prognostic favourable (3.95e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.40e-2)"	"prognostic unfavourable (2.88e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-3)"	34.0	27.0	26.9	15.3	28.7	17.0	27.1	22.5	40.8	26.6	23.4	25.9	21.1	16.2	27.1	46.5	29.7	29.0	26.1	26.4	24.3	23.8	28.3	38.7	24.9	20.8	25.0	17.3	31.1	20.8	31.6	21.6	44.2	28.6	29.8	24.2	25.7	24.8	33.4	25.5	32.5	20.7	31.9	22.4	23.6	20.5	17.8	16.5	27.4	85.9	20.3	30.7	23.7	21.9	39.1	40.4	60.9	39.5	42.0	49.2	48.7	17.3	20.4	17.0	13.1	20.1	21.1	16.4	16.6	28.4	40.1	35.4	12.0	26.3	18.5	23.2	36.9	18.2	32.9	42.3	32.5	23.2	35.6	15.3	16.4	24.0	35.5	14.9	14.5	21.7	48.9	39.2	36.7	38.7	15.8	19.2	28.7	20.5	22.7	14.6	23.6	23.2	22.2	16.6	20.2	31.3	18.9	24.4	14.1	18.9	17.8	24.7	15.8	11.0	20.4	17.4	15.0	29.6	21.8	12.4	12.5	20.0	21.9	22.1	20.8	60.9	39.5	46.2	49.2	35.3	47.5	37.8	42.1	44.6	40.4	39.1	39.9	40.0	40.1	42.0	32.7	37.4	41.9	48.7	26.9	28.7	22.5	40.8	24.3	23.8	25.0	17.3	28.6	16.5
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4"	"Cell line enhanced"	"Detected in many"		"AF22: 93.1;HAP1: 120.8;Hep G2: 93.1;SCLC-21H: 59.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 143.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 130.3"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: , HPA051038: "	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	2.3	67.5	32.0	2.1	143.8	1.4	10.6	25.6	16.8	4.2	2.1	7.4	0.0	1.5	3.3	1.9	2.0	5.1	2.4	1.8	21.0	47.0	4.0	2.0	7.3	2.9	13.1	21.3	27.0	5.4	2.3	102.6	171.4	27.4	2.2	1.9	1.8	4.3	2.2	1.9	1.4	1.6	2.6	14.4	1.8	2.1	19.8	11.1	1.5	5.4	0.0	2.3	1.8	1.0	2.6	0.0	0.0	0.0	2.7	0.7	0.2	2.6	13.1	93.1	39.3	1.9	3.5	5.4	7.1	4.2	5.1	7.0	21.8	4.3	0.2	0.2	8.2	0.8	120.8	5.0	7.2	0.3	12.7	0.0	15.0	93.1	1.4	14.8	0.0	7.8	1.6	12.7	8.9	3.0	0.0	29.1	10.0	0.6	0.0	0.0	42.6	8.4	5.6	29.8	7.8	23.4	9.7	59.1	3.4	0.0	2.0	7.0	12.6	0.0	0.0	4.1	0.2	0.5	5.4	7.8	5.2	11.6	9.3	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.7	0.0	2.6	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.2	32.0	143.8	25.6	14.4	21.0	47.0	13.1	21.3	27.4	11.1
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 95.7;liver: 103.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042375	Approved		Approved	Cytosol				Cytosol		"HPA042375: AB_10796905"	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favourable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	21.8	7.5	5.6	2.8	6.2	4.2	26.5	2.9	8.1	16.1	6.1	6.4	13.2	7.4	8.7	95.7	5.6	10.5	4.7	5.3	5.3	6.1	8.5	103.5	5.5	6.7	6.3	4.8	7.7	11.4	4.4	5.7	7.1	6.2	7.3	2.2	7.3	12.7	12.9	7.4	7.3	5.8	4.0	6.4	2.8	4.6	19.1	3.2	3.8	9.9	6.3	5.4	3.9	5.2	12.8	17.0	1.6	23.4	15.1	14.4	11.6	14.3	27.5	7.2	19.0	15.5	10.9	10.9	9.2	8.2	12.6	10.0	16.0	9.8	12.6	16.8	9.4	17.1	10.7	5.5	3.2	9.3	37.3	6.2	15.1	23.0	17.1	5.6	9.4	11.1	11.6	8.4	12.8	6.7	6.0	5.3	5.6	27.5	9.9	10.0	10.2	22.6	9.3	11.7	11.5	10.4	5.3	7.3	17.3	6.5	4.4	16.4	6.8	2.1	5.9	12.4	12.5	20.7	8.0	7.4	4.9	2.3	11.5	7.8	10.2	1.0	23.4	1.1	10.1	20.8	14.4	12.6	13.2	12.7	17.0	12.8	10.6	11.9	1.6	15.1	14.2	15.5	12.0	11.6	5.6	6.2	2.9	8.1	5.3	6.1	6.3	4.8	6.2	3.2
PER1	"PER, RIGUI"	ENSG00000179094	"Period circadian regulator 1"	O15534	17	8140472-8156506	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 23.2;hTCEpi: 27.1;hTERT-HME1: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047947, HPA067064"			Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA047947: , HPA067064: "	"unprognostic (7.64e-2)"	"prognostic favourable (3.89e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (2.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.21e-3)"	"unprognostic (6.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.09e-3)"	"prognostic unfavourable (1.94e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-2)"	39.4	33.4	13.2	21.6	15.0	27.3	31.3	19.5	23.9	27.8	24.6	20.9	27.8	6.9	19.5	17.2	31.6	25.2	36.9	24.0	13.3	6.3	14.2	18.6	25.8	10.8	15.6	11.3	50.1	61.8	19.3	29.8	12.7	20.1	23.1	8.1	36.6	23.3	43.5	70.3	47.9	16.9	29.3	17.5	16.7	23.6	13.8	17.1	4.6	28.5	33.1	12.1	30.2	25.0	1.6	4.9	3.3	3.6	0.5	2.1	1.2	1.0	3.8	4.4	6.3	14.5	10.7	2.5	1.5	2.7	1.9	2.3	3.8	2.5	7.1	1.2	2.2	3.1	4.4	23.2	1.3	2.2	5.5	3.7	8.3	1.1	20.0	1.5	5.7	16.0	27.1	3.3	26.5	4.2	4.7	9.9	3.5	3.5	4.3	2.9	3.8	2.5	6.0	2.5	3.7	4.6	0.8	1.9	4.7	3.2	3.7	3.0	2.7	1.1	7.2	2.2	4.3	0.8	1.3	5.8	2.2	2.5	3.0	1.8	1.6	0.0	3.6	1.7	1.9	2.5	2.1	1.0	1.7	1.2	4.9	1.6	1.6	1.1	3.3	0.5	1.2	0.7	1.1	1.2	13.2	15.0	19.5	23.9	13.3	6.3	15.6	11.3	20.1	17.1
PER3		ENSG00000049246	"Period circadian regulator 3"	P56645	1	7784320-7845177	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019530	Approved		Supported	Cytosol				Cytosol		"HPA019530: AB_1855201"	"unprognostic (5.11e-2)"	"prognostic favourable (7.14e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.34e-4)"	"unprognostic (3.87e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-2)"	"prognostic favourable (2.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.62e-1)"	10.2	9.1	10.9	6.0	15.6	0.5	10.4	42.4	17.5	13.5	14.5	22.5	11.2	5.0	16.2	8.9	13.9	10.8	13.5	17.2	10.1	9.4	10.4	20.5	9.6	3.3	11.2	10.7	15.7	13.3	16.0	15.2	2.1	13.4	13.0	5.5	23.2	18.8	17.7	20.4	11.1	7.4	18.5	16.2	6.7	14.0	8.7	10.9	0.9	19.0	15.6	7.1	13.2	9.5	1.3	1.8	1.1	3.3	0.9	5.1	1.6	4.2	1.2	3.7	1.1	0.6	0.3	1.1	1.8	3.3	3.4	4.7	5.0	16.6	1.9	1.0	7.3	1.9	13.3	0.8	5.1	0.1	0.7	13.3	4.9	0.7	4.2	0.4	4.6	1.8	1.4	3.7	3.7	1.2	10.7	3.5	1.4	3.3	7.3	5.9	2.0	3.5	6.4	1.3	0.1	1.9	0.8	4.8	5.2	15.6	0.0	6.7	4.0	0.5	2.5	9.2	13.4	2.8	2.4	0.5	0.3	1.6	6.4	21.2	12.7	0.9	1.6	1.1	4.2	2.0	5.1	1.3	2.0	3.8	1.8	0.8	1.7	2.1	0.2	0.9	3.3	1.4	3.1	1.6	10.9	15.6	42.4	17.5	10.1	9.4	11.2	10.7	13.4	10.9
PEX5	"PTS1R, PXR1"	ENSG00000139197	"Peroxisomal biogenesis factor 5"	P50542	12	7188685-7218574	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039259, HPA039260"	Enhanced		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA039259: AB_10673419, HPA039260: AB_2676417"	"unprognostic (7.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.31e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.13e-1)"	24.8	20.7	24.5	13.4	27.3	7.8	16.9	23.4	28.8	14.4	12.2	20.8	13.2	12.3	15.1	12.6	13.7	17.3	20.2	15.6	25.5	22.2	22.5	27.0	14.4	17.6	28.3	21.0	25.2	26.7	22.0	26.5	10.6	17.4	13.3	12.5	13.1	16.5	15.4	41.4	17.3	12.4	16.6	26.3	9.7	11.4	31.4	15.1	22.3	15.7	13.5	19.4	12.3	18.4	4.5	9.2	4.6	7.3	5.2	7.8	4.2	6.6	13.5	5.8	15.2	13.8	9.1	11.5	6.8	8.7	8.4	8.5	16.9	10.4	67.5	3.5	8.1	9.0	10.7	9.5	8.2	10.1	10.0	6.3	8.8	11.6	7.3	8.9	6.2	11.4	15.7	6.0	16.7	6.8	12.3	2.5	6.5	8.6	22.4	8.5	18.6	7.1	10.6	12.3	9.8	6.3	9.5	5.2	11.1	9.4	20.8	8.6	4.9	5.3	6.3	8.6	14.8	6.9	7.7	4.2	4.8	24.0	8.4	9.4	5.6	0.1	3.3	4.6	6.5	2.9	7.8	4.5	4.8	5.7	5.3	3.7	6.5	5.8	2.9	5.2	7.3	9.2	1.9	4.2	24.5	27.3	23.4	28.8	25.5	22.2	28.3	21.0	17.4	15.1
PFDN1	PFD1	ENSG00000113068	"Prefoldin subunit 1"	O60925	5	140245039-140303121	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006499	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"			10000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006499: AB_1079596"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.66e-3)"	"prognostic unfavourable (8.81e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.00e-1)"	36.1	24.8	39.5	18.8	38.8	26.4	25.8	28.5	48.7	23.1	27.0	29.3	15.8	20.9	28.2	29.6	26.8	22.5	18.6	46.7	38.2	34.7	32.7	20.2	24.2	21.6	38.8	35.3	20.6	18.1	26.5	19.9	26.9	45.6	24.3	23.0	19.8	23.1	24.4	69.5	20.9	22.0	32.1	37.1	23.1	19.2	19.6	24.1	23.7	24.4	28.7	25.5	23.0	19.2	38.9	36.3	45.6	46.4	39.5	45.1	37.2	38.5	18.1	32.4	18.6	21.2	21.8	31.3	52.8	26.3	40.7	45.3	38.6	24.7	26.0	53.4	28.1	14.4	23.4	51.9	47.9	27.5	23.6	23.1	18.6	24.9	24.9	47.5	18.1	23.2	27.6	34.5	36.4	44.6	20.7	17.1	34.1	17.2	32.3	32.6	21.4	27.2	22.8	46.1	19.1	45.4	17.7	18.3	19.4	39.6	34.8	30.2	23.7	28.1	57.3	28.7	28.5	16.9	47.2	16.6	42.7	67.5	29.0	31.4	33.3	43.2	31.1	45.6	33.4	46.4	35.3	38.9	38.4	38.4	36.3	35.9	38.5	34.6	5.1	39.5	44.1	33.9	45.1	37.2	39.5	38.8	28.5	48.7	38.2	34.7	38.8	35.3	45.6	24.1
PFDN2		ENSG00000143256	"Prefoldin subunit 2"	Q9UHV9	1	161100556-161118111	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028700, HPA058304"	Approved		Enhanced	Cytosol			60000	Cytosol		"HPA028700: AB_10603983, HPA058304: "	"unprognostic (2.56e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (9.10e-4)"	"unprognostic (9.59e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (4.39e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.66e-2)"	36.5	30.4	47.2	22.7	41.7	40.9	20.9	25.1	38.8	19.6	19.9	27.8	15.1	19.1	20.8	29.1	19.7	18.5	16.0	38.2	41.4	48.6	25.9	41.1	18.5	23.5	52.2	32.9	18.5	20.8	13.6	29.3	25.1	42.7	20.1	17.9	12.9	21.2	20.8	62.2	15.0	18.4	19.4	48.6	21.2	17.8	22.1	31.8	14.7	18.3	20.9	24.3	22.7	26.2	34.4	61.7	33.4	37.3	18.2	28.5	21.0	42.8	28.8	22.4	28.9	20.4	19.5	24.5	31.9	28.9	27.6	21.9	37.8	32.6	29.0	37.5	20.7	31.8	33.9	39.1	33.2	31.6	34.9	32.1	40.9	53.4	60.1	44.0	32.2	21.8	51.5	44.3	126.2	31.0	47.1	20.5	24.7	43.4	32.9	52.3	43.8	72.0	28.3	22.6	34.7	29.8	25.7	29.5	49.3	24.5	32.4	50.8	26.7	55.6	27.2	28.6	41.9	35.8	66.6	31.6	29.9	55.8	34.8	30.1	39.1	24.7	32.7	33.4	19.2	31.4	21.8	34.1	23.5	23.1	39.1	34.4	24.8	24.1	16.2	18.2	37.3	61.7	28.5	21.0	47.2	41.7	25.1	38.8	41.4	48.6	52.2	32.9	42.7	31.8
PFDN5	"MM-1, PFD5"	ENSG00000123349	"Prefoldin subunit 5"	Q99471	12	53295291-53299450	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008587	Approved		Supported	"Intermediate filaments,Cytosol"			110000	"Intermediate filaments, Cytosol"		"HPA008587: AB_1079597"	"unprognostic (3.56e-3)"	"unprognostic (2.31e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (5.45e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (5.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.01e-3)"	75.9	73.7	105.0	82.3	85.4	119.3	142.4	53.8	66.7	97.0	77.1	56.3	102.5	39.7	94.3	156.8	80.3	94.6	91.0	77.0	82.7	76.7	81.8	83.5	64.9	117.2	94.3	69.2	134.5	155.8	49.6	81.2	67.3	63.3	96.1	65.4	60.1	116.4	99.9	87.0	71.6	54.1	108.1	91.0	83.8	64.7	60.5	64.9	60.5	128.1	108.9	101.1	91.8	144.9	163.9	98.0	63.7	127.8	69.4	158.4	329.0	35.4	54.7	53.0	47.7	102.9	143.2	38.7	88.9	121.1	82.9	56.1	50.0	54.7	48.0	53.7	95.5	32.6	46.1	63.7	80.3	45.4	64.5	43.7	67.7	68.6	66.2	71.0	47.8	136.5	93.6	58.5	45.8	73.6	51.0	64.8	82.2	125.4	49.7	106.0	50.0	84.6	40.6	57.5	56.8	94.5	52.5	44.9	51.2	57.1	50.5	64.5	65.6	90.8	64.4	46.9	35.8	22.1	39.7	48.6	51.8	70.6	51.4	56.9	42.8	63.7	127.8	46.5	80.9	97.0	110.9	163.9	123.2	97.6	98.0	156.8	158.4	125.9	38.3	69.4	100.2	91.0	95.8	329.0	105.0	85.4	53.8	66.7	82.7	76.7	94.3	69.2	63.3	64.9
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137712	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol			4500000	Cytosol		"HPA018257: AB_10960391, HPA056484: "	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.55e-4)"	"prognostic unfavourable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	14.6	7.9	29.6	22.0	28.9	9.2	8.1	34.2	61.4	9.7	20.5	11.5	7.9	26.8	19.2	11.0	36.0	12.8	19.8	62.0	29.3	32.9	20.0	2.8	9.2	18.2	22.2	29.8	9.3	8.8	1.5	16.8	8.8	21.3	20.3	19.4	14.7	13.4	36.5	24.4	16.5	31.1	34.3	21.1	11.3	20.7	71.8	14.8	9.6	19.3	11.7	13.3	26.9	15.6	8.9	12.5	16.2	4.7	14.3	20.4	8.9	47.4	66.8	4.5	0.1	4.5	9.4	58.3	29.6	10.6	30.0	36.1	70.4	50.6	5.7	23.6	21.3	38.6	22.8	46.1	31.5	16.0	17.6	20.5	32.2	3.8	10.6	8.3	34.6	4.3	10.4	31.4	15.7	57.7	5.7	0.2	33.2	37.1	28.1	8.9	7.3	23.4	22.1	7.4	22.9	32.5	18.7	12.3	10.6	21.0	17.8	26.2	14.7	13.0	69.4	20.5	11.0	61.7	32.2	32.5	29.3	20.4	52.5	15.9	12.5	16.2	4.7	1.6	15.9	2.3	12.6	8.2	15.9	14.8	8.0	8.9	6.0	9.5	0.7	14.3	0.9	12.5	20.4	8.9	29.6	28.9	34.2	51.7	29.3	32.9	22.2	29.8	21.3	14.8
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 509.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB037134, CAB037140"	Enhanced		Supported	Cytosol			1100000000	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	65.2	48.2	24.0	125.4	36.7	118.0	61.3	15.6	25.9	63.8	102.3	33.1	46.7	66.4	97.4	52.9	96.6	67.5	87.8	40.7	22.0	19.6	80.5	137.3	70.5	159.4	37.4	17.3	53.7	37.2	18.3	27.5	82.8	28.5	62.0	68.2	39.3	46.0	52.6	51.6	51.2	96.4	119.4	33.3	138.7	70.4	27.2	30.5	199.3	46.6	65.3	116.3	97.9	54.4	154.4	263.4	356.5	322.9	223.0	288.9	509.4	138.1	166.6	62.6	50.2	32.3	40.3	93.9	118.1	77.6	102.6	77.8	64.5	48.8	100.4	102.7	99.8	87.3	55.8	120.4	82.7	174.6	109.7	102.8	85.3	83.7	88.7	64.8	244.6	47.8	52.9	79.5	79.3	92.0	56.7	73.3	122.9	68.7	123.4	139.7	97.3	102.3	123.7	84.0	64.6	99.4	73.9	25.7	76.3	79.3	49.8	72.3	46.6	55.0	112.5	89.7	83.3	67.3	171.6	52.3	53.0	80.9	77.4	77.8	136.3	168.7	216.8	356.5	286.3	278.7	190.1	154.4	236.8	270.9	263.4	135.2	154.8	221.1	255.4	223.0	322.9	212.4	288.9	509.4	24.0	36.7	15.6	25.9	22.0	19.6	37.4	17.3	28.5	30.5
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol			60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: , HPA060173: "																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	4.2	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1
PGAP3	"CAB2, MGC9753, PER1, PERLD1, PP1498"	ENSG00000161395	"Post-GPI attachment to proteins 3"	Q96FM1	17	39671122-39696797	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016591	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA016591: AB_1855203"	"unprognostic (1.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"prognostic favourable (3.94e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (6.82e-4)"	"unprognostic (1.57e-2)"	"unprognostic (7.79e-2)"	"prognostic favourable (3.89e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.94e-2)"	6.8	8.2	8.9	7.6	14.3	3.4	10.2	6.4	17.3	11.3	19.2	10.0	15.1	12.5	8.3	16.5	16.2	14.0	19.7	9.9	11.3	7.3	13.7	20.7	9.5	6.5	6.3	10.7	9.7	22.7	16.0	10.1	39.2	6.1	11.2	11.7	14.2	16.7	15.6	5.0	16.0	20.7	7.3	5.5	8.1	13.4	9.0	7.3	4.4	20.3	8.7	15.8	8.1	8.9	7.8	5.3	4.0	10.5	9.0	15.1	6.3	1.4	3.8	3.1	2.9	3.3	3.4	3.2	1.7	4.1	2.7	2.5	2.2	9.6	1.6	8.1	3.3	5.0	1.0	1.1	1.3	3.4	3.1	2.0	2.2	3.6	4.5	5.0	5.2	6.3	6.2	1.3	2.8	0.9	1.9	3.8	2.4	3.4	1.0	4.5	3.1	0.8	1.2	1.9	4.6	4.4	4.8	2.9	1.9	4.7	54.7	2.7	4.6	4.9	1.3	2.9	3.1	1.4	1.3	3.4	0.7	0.5	3.3	1.9	3.3	2.4	6.7	4.0	15.1	10.5	8.3	7.8	10.6	12.3	5.3	7.6	10.5	10.1	1.7	9.0	3.8	3.6	5.1	6.3	8.9	14.3	6.4	17.3	11.3	7.3	6.3	10.7	6.1	7.3
PGBD1	"dJ874C20.4, HUCEP-4, SCAND4"	ENSG00000137338	"PiggyBac transposable element derived 1"	Q96JS3	6	28281572-28302549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5;plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007267	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA007267: AB_1079601"	"unprognostic (2.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.28e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (5.38e-3)"	"prognostic favourable (6.79e-4)"	"unprognostic (7.32e-3)"	"prognostic unfavourable (4.97e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.68e-1)"	6.1	4.5	7.4	3.8	7.2	2.8	8.5	9.6	12.8	6.1	7.4	4.0	1.3	3.0	9.2	6.0	4.5	4.3	4.0	7.0	7.1	6.3	5.9	5.1	5.4	3.1	7.0	7.7	6.0	4.0	6.6	8.6	4.3	5.1	6.0	4.6	4.4	3.8	7.4	4.1	3.0	4.0	11.7	7.0	4.9	4.8	5.2	3.6	8.9	4.0	3.1	3.4	5.2	3.8	1.0	4.4	3.5	0.2	1.2	1.2	0.3	5.1	2.8	9.1	12.9	7.3	5.3	3.0	6.8	4.6	8.6	9.8	3.2	2.2	3.4	4.3	4.6	2.3	9.9	5.5	11.2	3.7	5.7	6.2	5.7	4.0	3.5	7.7	0.8	4.3	2.6	8.4	2.9	10.5	8.0	0.4	9.5	1.5	6.5	9.7	3.4	5.7	11.2	11.6	0.0	4.2	2.8	6.3	12.0	4.6	0.8	5.1	2.5	4.8	7.4	12.9	8.6	0.9	10.6	3.3	3.3	4.4	2.9	4.5	6.0	3.5	0.1	0.0	0.6	0.2	0.3	0.5	0.2	1.2	0.7	1.0	0.1	0.5	0.0	1.2	0.1	4.4	0.5	0.3	7.4	7.2	9.6	12.8	7.1	6.3	7.0	7.7	5.1	3.6
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 115.1;esophagus: 123.8"	"Cell line enhanced"	"Detected in all"		"A549: 177.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 115.1;monocytes: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"			59000000	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	29.8	12.7	10.9	14.2	11.8	85.5	23.7	8.0	19.1	16.0	14.1	13.8	8.1	22.9	6.3	12.5	123.8	8.4	24.9	14.3	10.3	12.1	15.4	23.2	25.6	34.9	12.4	11.4	14.3	8.3	16.2	10.8	17.0	19.3	7.9	12.9	19.7	31.8	6.8	8.5	10.6	25.3	9.5	12.6	27.6	13.4	27.0	7.4	16.8	21.2	68.8	49.9	14.8	26.1	3.9	15.9	115.1	32.0	2.0	3.0	19.0	22.6	177.4	44.2	47.5	67.3	41.7	9.6	15.3	27.2	21.2	29.1	26.0	26.1	22.2	18.9	15.7	19.2	32.3	27.5	14.3	15.3	28.2	30.0	31.9	54.6	20.5	49.6	33.4	29.7	13.8	33.5	8.3	50.1	40.1	19.7	27.2	25.7	40.9	24.8	26.6	15.6	31.8	40.6	40.9	29.7	12.2	23.8	20.8	13.1	20.8	18.1	22.9	42.6	46.9	11.2	20.0	13.3	16.9	14.9	27.3	39.9	24.5	53.9	10.1	98.6	32.0	115.1	2.6	15.3	3.0	3.9	2.5	2.4	15.9	2.3	2.4	2.6	38.4	2.0	10.9	11.4	2.4	19.0	10.9	11.8	8.0	19.1	10.3	12.1	12.4	11.4	19.3	7.4
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955784	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 177.3"	"Group enriched"	"Detected in some"	6	"BEWO: 91.3;HUVEC TERT2: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	12380		Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	4.3	2.7	1.9	4.4	2.4	0.0	4.3	1.6	3.5	13.1	2.3	2.3	4.0	1.3	2.9	6.3	3.9	9.2	3.4	5.1	2.4	4.1	3.1	2.6	3.6	4.9	2.9	2.0	3.8	1.9	5.4	2.0	177.3	4.6	7.5	1.1	3.5	3.8	6.7	3.3	6.0	4.3	4.6	1.7	1.2	1.7	3.3	2.0	1.4	24.2	4.4	2.9	5.1	5.9	0.7	0.7	1.1	1.0	0.0	2.4	0.2	0.3	0.3	0.3	0.2	0.4	0.0	91.3	0.8	0.8	0.4	0.5	2.1	0.1	0.0	2.0	0.6	0.1	0.4	4.1	0.3	0.0	0.5	0.0	0.0	2.2	0.3	0.0	2.4	1.0	1.0	1.6	0.4	43.0	0.0	0.0	12.1	0.1	0.0	0.1	0.4	0.7	0.0	11.3	0.0	0.1	0.2	6.9	3.7	0.0	0.1	1.6	0.0	0.1	8.7	0.0	2.3	0.0	3.6	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	1.1	2.4	1.0	0.0	0.7	0.3	0.7	0.3	0.3	0.6	1.0	0.0	0.0	0.8	0.7	0.5	0.2	1.9	2.4	1.6	2.2	2.4	4.1	2.9	2.0	4.6	2.0
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289135-296107	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"pancreas: 148.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA039383: AB_10796225, HPA058829: "	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.12e-4)"	5.6	1.8	6.0	16.7	9.3	6.3	10.5	2.9	7.7	12.7	5.6	3.3	10.4	21.1	6.9	14.9	5.6	8.4	8.3	4.4	6.3	1.7	14.8	17.0	15.7	24.6	7.6	2.5	3.5	148.7	2.6	3.6	3.4	8.0	8.5	3.0	7.1	8.9	21.8	5.6	2.4	23.2	5.2	10.1	24.2	4.7	2.3	7.5	6.3	18.0	6.4	15.4	7.3	8.7	2.3	2.5	4.9	4.2	6.9	8.5	2.7	3.4	3.7	7.0	7.7	2.8	2.5	5.3	2.7	2.2	1.6	1.4	3.2	9.8	0.0	3.5	3.3	2.1	0.6	1.2	0.2	8.3	2.6	1.6	2.4	4.2	3.6	0.2	15.1	9.4	1.0	0.6	0.4	5.3	6.5	10.5	0.8	4.9	14.3	7.6	5.4	0.6	13.5	1.4	4.8	3.7	1.2	0.0	1.6	1.0	5.1	4.7	3.7	1.9	4.9	3.3	4.7	1.0	0.3	22.8	0.6	3.6	0.5	2.7	3.8	1.5	0.9	1.2	8.5	4.2	7.2	2.1	1.3	4.7	0.6	2.3	3.1	6.1	4.9	6.9	3.2	2.5	0.2	2.7	6.0	9.3	2.9	7.7	6.3	1.7	7.6	2.5	8.0	7.5
PGGT1B	"BGGI, GGTI"	ENSG00000164219	"Protein geranylgeranyltransferase type I subunit beta"	P53609	5	115204012-115262872	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030646	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Endoplasmic reticulum"	Cytosol	"HPA030646: AB_10602019"	"unprognostic (2.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (7.34e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.15e-2)"	10.5	12.4	7.3	13.3	10.1	10.9	13.9	8.8	22.1	10.8	13.8	7.7	7.9	12.3	9.2	4.6	14.9	7.3	7.0	13.5	9.5	5.9	8.2	13.7	22.2	22.2	10.2	10.0	9.6	10.1	12.0	13.4	7.8	8.2	8.4	15.1	5.7	10.6	8.4	10.2	9.9	10.4	9.5	6.9	10.4	11.0	5.1	10.5	10.2	8.8	9.9	10.1	9.6	10.5	8.0	11.5	21.8	16.7	6.7	6.3	6.4	10.1	11.1	12.6	16.3	7.4	6.2	6.2	12.6	7.4	10.5	10.8	12.0	10.9	20.7	17.1	8.8	8.0	16.6	16.5	15.8	22.8	9.2	11.9	14.4	9.6	9.9	16.3	17.6	9.3	10.2	10.3	10.8	10.5	9.6	8.9	12.0	15.8	14.3	5.4	9.4	8.6	15.7	16.9	20.9	11.0	19.2	12.4	9.4	14.9	11.4	12.0	15.3	12.2	12.0	10.8	10.2	7.4	14.6	14.8	16.5	10.9	7.8	17.0	14.9	8.3	12.8	21.8	5.0	16.6	5.6	6.8	5.7	6.3	11.5	8.0	5.4	5.0	13.1	6.7	16.7	10.3	4.9	6.4	7.3	10.1	8.8	22.1	9.5	5.9	10.2	10.0	8.2	10.5
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511629-17521288	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol			10000000	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	27.3	31.5	15.6	23.6	13.9	29.3	33.7	9.0	20.1	23.8	29.5	16.0	17.9	21.9	16.6	18.7	38.0	25.9	27.8	18.5	13.9	11.6	25.9	42.7	27.5	60.0	14.3	11.8	32.0	42.1	19.1	16.4	26.5	10.9	23.5	13.5	16.8	31.5	20.7	10.9	27.2	30.8	13.3	16.8	31.4	20.8	15.8	12.2	46.6	26.7	19.2	27.6	18.5	21.6	17.6	46.4	45.8	44.5	17.4	14.9	22.4	18.6	16.8	10.6	7.2	16.2	27.0	20.3	12.8	20.9	12.9	16.6	8.0	28.3	20.7	14.4	20.0	12.9	5.9	20.0	3.9	10.3	23.2	9.7	7.8	14.3	27.9	10.3	10.8	31.7	27.7	7.7	23.2	17.3	11.0	5.1	15.8	20.5	22.6	29.0	14.1	70.6	15.3	6.8	13.1	17.4	15.1	13.5	16.2	8.2	9.1	18.0	13.2	18.7	16.2	13.4	3.7	26.7	7.2	9.0	6.3	8.8	19.1	26.5	13.1	15.2	40.8	45.8	14.9	44.5	12.1	16.4	13.2	13.2	46.4	17.6	12.5	12.6	39.6	17.4	41.5	34.4	14.0	22.4	15.6	13.9	9.0	20.1	13.9	11.6	14.3	11.8	10.9	12.2
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol			20000000	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: "	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	30.2	12.7	4.8	15.7	31.7	23.4	38.9	12.5	17.0	13.6	22.3	10.5	14.1	9.6	26.2	19.2	7.2	6.6	26.3	16.1	11.7	8.8	20.2	21.5	10.8	26.2	17.7	1.2	29.5	17.0	15.9	25.2	8.1	0.0	12.8	21.8	1.8	5.1	9.7	21.8	20.4	7.2	22.3	3.1	19.8	9.5	2.9	18.7	27.3	28.6	41.6	8.9	6.7	0.8	20.2	10.3	17.9	10.6	8.1	11.9	15.6	33.0	15.6	8.6	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol			73000	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavourable (8.78e-4)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	15.5	16.7	11.2	10.4	13.7	4.8	12.3	19.1	13.3	15.4	10.1	9.0	30.7	8.9	10.6	26.2	10.3	8.8	14.2	12.2	11.0	8.6	12.2	44.9	13.4	6.3	13.5	9.9	15.5	36.3	9.3	36.2	27.6	18.1	30.9	13.7	7.4	29.2	23.4	5.5	7.5	11.6	11.1	9.7	8.1	14.4	16.8	11.3	4.0	14.9	7.6	8.7	11.1	10.0	8.2	7.4	11.1	6.5	5.3	8.7	3.9	10.0	6.6	12.9	15.4	21.0	22.4	14.9	34.3	24.9	16.6	26.2	17.2	4.7	5.3	7.3	34.2	6.4	11.7	14.4	31.9	3.9	11.4	6.8	13.1	28.8	23.8	6.6	3.4	14.2	11.9	29.3	37.1	19.5	22.1	5.8	17.9	10.4	1.1	4.4	5.7	9.1	4.7	28.8	3.1	12.9	9.9	5.1	8.0	9.9	8.8	6.8	7.7	7.4	28.5	11.5	6.3	23.0	18.4	11.3	4.4	3.8	9.0	5.3	17.9	11.1	6.4	3.8	5.0	6.0	6.7	8.2	5.2	6.2	5.5	5.0	8.7	8.2	2.7	5.3	6.5	7.4	3.6	3.9	11.2	13.7	19.1	13.3	11.0	8.6	13.5	9.9	18.1	11.3
PGM5	PGMRP	ENSG00000154330	"Phosphoglucomutase 5"	Q15124	9	68328308-68531061	"Predicted intracellular proteins"	"Carbohydrate metabolism, Cell adhesion, Glucose metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 123.0"	"Group enriched"	"Detected in some"	5	"PC-3: 29.9;RH-30: 20.7;SK-BR-3: 25.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	89	"neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	89	"granulocytes: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034397, HPA046329, HPA067102"	Enhanced		Uncertain	Cytosol			380000	Cytosol		"CAB034397: AB_1118633, HPA046329: , HPA067102: "	"unprognostic (3.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.28e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.28e-2)"	"prognostic favourable (1.83e-5)"	"unprognostic (3.04e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.73e-2)"	5.9	13.6	0.8	7.5	1.3	0.0	4.1	2.1	1.5	25.9	52.2	1.8	26.1	2.9	36.9	10.3	22.6	20.9	11.1	31.6	1.0	0.4	2.0	1.5	2.7	5.9	0.9	1.3	9.3	1.9	0.5	1.2	1.7	1.3	37.1	7.6	4.3	2.9	51.1	8.5	2.2	15.4	123.0	1.5	1.7	16.6	4.3	0.9	0.9	2.8	4.5	1.5	57.4	24.5	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	4.2	3.4	2.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	29.9	0.0	20.7	0.9	0.9	0.0	0.0	0.1	0.0	25.9	1.4	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.8	1.3	2.1	1.5	1.0	0.4	0.9	1.3	1.3	0.9
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"			64000	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favourable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favourable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	47.9	29.5	18.3	13.3	20.4	12.8	38.3	17.7	19.3	27.3	46.6	14.8	42.5	46.8	26.1	20.2	32.8	21.1	31.2	27.2	18.4	18.4	36.5	64.7	22.4	13.6	17.4	18.5	24.1	41.6	25.6	34.4	95.6	18.0	29.4	24.8	22.0	29.8	33.4	17.9	46.0	69.1	29.5	16.3	16.7	35.1	19.3	19.2	15.3	33.1	15.7	16.2	35.1	33.8	3.2	6.0	4.7	2.5	2.6	4.8	1.4	23.5	8.7	16.0	12.9	69.6	36.7	16.1	32.3	36.1	24.0	32.1	9.0	24.3	16.6	37.9	41.5	13.7	14.6	16.0	30.2	9.5	8.4	11.1	22.9	17.0	88.1	16.1	8.3	28.8	32.4	20.1	24.9	21.5	18.5	21.0	34.4	7.3	14.8	7.5	12.6	7.8	11.9	12.8	11.4	35.4	8.3	12.7	12.0	18.1	20.5	18.3	15.8	7.3	39.8	20.3	16.6	20.7	14.9	24.3	19.7	17.8	22.2	14.4	13.8	4.7	2.5	4.6	3.9	2.1	1.9	3.2	4.8	3.9	1.4	2.7	4.4	4.0	2.2	2.6	1.8	6.0	4.7	1.4	18.3	20.4	17.7	19.3	18.4	18.4	17.4	18.5	18.0	19.2
PHACTR4	"FLJ13171, PPP1R124"	ENSG00000204138	"Phosphatase and actin regulator 4"	Q8IZ21	1	28369582-28500369	"Predicted intracellular proteins"	Neurogenesis	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028985	Approved		Approved	"Plasma membrane,Intermediate filaments,Cytosol"				"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA028985: AB_10602142"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-1)"	"prognostic favourable (1.05e-4)"	"unprognostic (9.65e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.26e-2)"	11.0	12.3	10.0	17.2	17.4	11.5	11.6	18.7	15.2	17.2	14.2	16.5	11.7	9.9	22.7	12.1	37.0	15.1	12.6	10.7	11.4	7.9	16.4	18.7	13.8	10.4	15.3	8.9	15.3	15.4	22.3	18.1	11.6	12.1	13.7	15.8	15.4	18.1	10.3	14.9	19.1	15.4	15.7	13.6	14.4	12.1	15.7	18.5	17.8	15.2	18.1	30.0	12.1	20.6	5.3	5.6	4.0	6.3	4.8	7.7	3.4	12.2	8.4	19.0	13.6	4.8	5.4	2.8	8.8	9.0	19.4	20.2	8.1	13.9	11.8	8.1	10.5	8.7	13.1	8.8	17.4	8.8	7.3	24.6	14.5	12.5	7.3	14.6	28.4	4.8	8.2	12.4	21.9	25.5	12.4	8.2	12.3	3.8	10.3	3.7	14.4	5.8	10.9	18.1	8.8	10.0	11.1	10.1	12.6	19.8	8.2	10.3	11.1	5.4	16.5	9.5	17.7	6.6	17.0	6.3	9.0	10.0	9.1	12.4	9.9	3.4	4.6	4.0	7.7	4.1	6.8	3.3	5.9	7.2	4.5	5.3	4.0	5.4	3.5	4.8	6.3	5.6	2.7	3.4	10.0	17.4	18.7	15.2	11.4	7.9	15.3	8.9	12.1	18.5
PHF14	KIAA0783	ENSG00000106443	"PHD finger protein 14"	O94880	7	10973336-11169630	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000538, HPA017376"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA000538: AB_1079604, HPA017376: "	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.73e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.33e-1)"	12.5	10.9	25.0	12.4	20.4	6.4	18.4	21.4	23.8	14.0	12.7	10.7	7.2	10.3	17.9	11.0	10.6	12.4	12.6	7.7	24.7	22.1	12.2	14.8	11.3	12.0	18.5	15.5	20.2	9.8	18.4	21.4	11.0	20.0	13.9	14.3	7.1	10.0	11.5	9.3	11.3	10.1	14.9	16.2	12.9	13.3	12.0	14.9	31.5	12.7	7.6	12.9	11.9	10.6	3.9	5.8	1.6	2.0	3.4	4.6	0.8	6.7	14.1	20.7	21.4	7.3	7.1	9.9	5.3	4.5	6.5	7.1	12.5	12.2	26.5	9.9	5.0	9.5	18.4	6.3	7.1	9.6	7.0	13.1	12.5	16.3	6.7	28.9	12.4	6.4	6.8	7.5	13.8	9.3	17.3	9.5	7.7	8.7	11.4	12.8	17.3	10.1	19.4	13.3	8.3	6.7	13.2	18.6	26.0	8.2	28.1	8.9	14.9	21.3	8.6	9.1	12.1	5.7	10.4	12.1	20.9	18.5	6.3	24.6	21.1	1.6	2.0	1.2	2.9	1.8	2.3	3.9	3.2	3.7	1.2	3.4	4.6	3.8	0.1	3.4	1.6	5.8	4.1	0.8	25.0	20.4	21.4	23.8	24.7	22.1	18.5	15.5	20.0	14.9
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950381	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	19.1	11.6	14.0	16.8	19.0	14.1	17.2	25.1	19.2	15.9	15.9	16.1	8.1	8.1	19.1	11.6	16.5	14.2	14.8	15.2	14.1	13.8	11.2	11.1	16.5	17.3	14.9	13.0	18.9	9.4	17.9	20.0	15.6	15.0	14.7	11.7	14.7	15.3	15.7	46.6	12.9	12.3	17.2	18.9	20.8	12.7	17.4	15.2	19.4	14.2	14.5	20.8	18.7	21.8	12.0	8.2	23.6	11.9	13.0	12.4	6.5	9.6	7.7	13.5	19.9	9.8	11.3	12.6	11.0	10.5	11.1	9.7	22.4	7.3	16.1	10.0	14.6	6.0	12.4	15.3	13.6	7.2	5.3	30.0	14.7	8.3	9.9	14.3	11.7	8.8	21.6	11.7	18.1	12.1	12.2	10.4	12.7	5.7	14.5	8.4	6.7	9.6	10.6	20.0	9.5	8.8	6.7	12.3	10.0	19.6	22.8	10.1	18.0	10.7	16.9	24.6	5.6	12.7	11.2	9.6	11.4	11.8	18.2	10.5	12.6	11.9	8.6	23.6	10.6	9.0	11.3	12.0	10.5	11.9	8.2	9.8	12.0	12.4	20.5	13.0	11.9	7.7	5.5	6.5	14.0	19.0	25.1	19.0	14.1	13.8	14.9	13.0	15.0	15.2
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744226	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 16.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			9000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: , HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (1.48e-4)"	"prognostic favourable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	18.8	1.9	33.3	4.4	32.1	4.4	13.8	7.8	27.2	11.9	5.8	49.7	9.4	4.2	6.1	41.0	16.7	24.5	3.9	5.3	26.7	20.5	14.0	53.2	4.3	5.7	42.0	20.7	17.3	58.2	67.5	5.7	6.4	23.3	24.5	4.7	8.7	62.9	16.4	1.7	35.9	3.0	8.1	28.3	1.9	9.0	8.6	38.1	9.9	15.8	7.3	7.3	7.9	14.1	6.7	3.2	2.9	0.7	1.2	16.5	3.2	13.5	5.5	14.5	34.9	8.3	11.0	27.1	12.3	22.2	17.6	29.2	28.7	2.4	0.0	5.3	32.9	18.3	26.9	25.6	12.4	0.1	24.5	4.3	19.5	19.8	17.3	27.4	0.1	15.8	42.8	16.8	20.0	12.6	7.8	32.5	7.7	53.3	18.3	8.4	36.3	42.3	16.1	25.2	2.3	1.1	16.2	15.7	14.3	9.0	6.0	98.9	12.2	46.8	0.1	2.9	15.3	17.9	13.7	26.8	6.7	27.4	35.6	38.3	22.6	2.9	0.7	0.2	2.9	0.2	0.2	6.7	1.8	4.9	3.2	2.7	9.1	16.5	2.0	1.2	0.2	1.8	2.4	3.2	33.3	32.1	7.8	27.2	26.7	20.5	42.0	20.7	23.3	38.1
PHKG2		ENSG00000156873	"Phosphorylase kinase catalytic subunit gamma 2"	P15735	16	30748270-30761176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 44.5;testis: 95.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065618, HPA068751"			Supported	Cytosol				Cytosol		"HPA065618: AB_2685520, HPA068751: AB_2686025"	"unprognostic (7.63e-3)"	"prognostic favourable (7.90e-4)"	"prognostic unfavourable (9.92e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-2)"	"prognostic favourable (8.02e-4)"	"unprognostic (6.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	4.3	8.3	8.7	6.9	8.0	15.9	5.8	9.1	12.0	4.7	7.9	7.3	9.0	6.8	5.6	7.8	5.3	6.8	7.2	6.4	9.0	9.3	8.2	11.0	5.8	6.8	8.6	9.2	4.7	5.1	17.3	8.5	6.3	11.8	7.7	7.6	6.4	7.0	9.9	6.4	8.4	7.3	6.3	5.8	6.9	7.2	95.4	7.3	5.5	8.6	5.5	7.7	5.2	4.7	8.8	21.2	44.5	22.7	23.5	16.8	17.6	13.5	8.9	7.5	9.2	7.1	5.7	16.9	9.5	14.3	13.0	14.9	7.7	6.8	11.7	11.3	9.8	13.0	7.8	12.1	10.5	6.3	21.7	6.4	14.8	21.6	10.9	9.9	9.2	7.7	6.6	12.5	5.9	13.2	8.7	6.8	9.4	31.2	11.7	14.6	10.3	10.4	15.8	11.7	15.6	14.9	15.3	10.1	7.0	7.7	21.5	9.1	16.9	8.6	7.8	8.0	8.9	10.0	8.7	13.8	7.5	8.0	15.9	19.4	6.5	14.0	22.7	44.5	16.2	22.4	13.3	8.8	11.6	16.4	21.2	8.5	10.4	12.1	18.2	23.5	15.9	18.2	16.8	17.6	8.7	8.0	9.1	12.0	9.0	9.3	8.6	9.2	11.8	7.3
PHLDB2	"FLJ21791, LL5b, LL5beta"	ENSG00000144824	"Pleckstrin homology like domain family B member 2"	Q86SQ0	3	111732497-111976517	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 104.0"	"Cell line enhanced"	"Detected in many"		"A-431: 31.9;HaCaT: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035146, HPA035147"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035146: AB_10600927, HPA035147: "	"unprognostic (2.83e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.53e-1)"	"prognostic favourable (7.03e-8)"	"unprognostic (3.24e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.83e-1)"	15.5	3.8	1.3	13.2	1.9	0.4	9.9	1.6	2.9	13.9	22.8	1.4	8.4	2.8	17.4	10.1	10.7	10.7	9.1	21.7	1.3	1.2	36.6	24.6	14.4	2.2	2.1	1.9	8.5	6.4	0.9	5.3	104.0	7.1	16.7	4.4	6.9	7.0	14.3	6.0	5.8	6.5	49.3	2.4	7.9	11.4	4.3	0.4	1.7	5.9	6.8	2.3	33.8	17.8	1.0	1.0	0.4	0.1	1.7	5.6	1.3	31.9	3.5	20.1	0.0	6.5	10.8	8.2	18.5	9.1	12.3	14.6	10.0	2.3	0.0	19.5	7.1	33.3	0.3	11.9	22.5	0.4	0.4	0.0	8.6	3.3	7.1	0.0	0.1	12.6	7.1	8.4	15.8	19.7	0.0	0.1	3.7	0.0	1.3	0.0	8.1	6.2	2.8	25.9	0.0	7.3	7.7	0.5	1.5	18.3	0.3	1.9	0.6	0.1	17.2	3.3	28.2	8.8	4.5	1.7	0.0	0.0	3.4	0.0	6.3	0.2	0.0	0.0	5.2	0.0	3.7	0.4	3.6	5.6	0.1	1.0	0.0	2.3	0.4	1.7	0.1	1.0	0.8	1.3	1.3	1.9	1.6	2.9	1.3	1.2	2.1	1.9	7.1	0.4
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favourable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (4.11e-5)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	2.7	8.5	6.6	11.7	5.9	3.6	6.0	2.1	5.2	8.7	4.8	1.8	7.1	5.8	8.8	6.5	28.4	7.3	15.9	4.5	5.2	2.9	4.8	9.6	4.0	7.8	3.5	5.8	9.5	7.7	6.8	7.9	6.4	3.2	11.7	2.2	6.7	11.1	7.6	9.0	28.7	9.4	7.5	3.0	6.4	5.4	18.7	3.0	12.2	5.7	15.2	23.2	9.3	14.8	4.4	8.1	0.9	3.3	2.6	5.5	2.3	5.3	5.6	2.4	5.9	2.1	4.4	15.3	3.8	3.4	3.9	2.7	5.7	5.6	3.2	12.2	2.3	6.2	1.7	6.7	0.7	7.5	5.3	3.5	5.4	6.8	5.3	1.3	6.8	3.7	8.6	4.1	2.5	3.4	6.2	4.9	1.9	8.4	5.4	0.3	1.4	4.6	6.4	3.1	2.1	1.8	18.1	0.1	5.1	4.9	10.7	4.6	7.6	4.5	4.3	2.5	6.7	3.0	3.6	12.6	13.7	3.5	2.3	2.6	4.1	0.3	3.3	0.5	4.0	2.3	2.9	3.7	3.7	3.0	6.9	4.4	5.5	4.8	0.9	2.6	0.2	8.1	3.6	2.3	6.6	5.9	2.1	5.2	5.2	2.9	3.5	5.8	3.2	3.0
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2a"	O14813	11	72239077-72245664	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7"	"Cell line enriched"	"Detected in single"	228	"SH-SY5Y: 112.7"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in single"	96	"pons and medulla: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"pons and medulla: 0.8"	"Low region specificity"	"Detected in some"			"HPA053810, HPA065621, HPA078004"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA053810: , HPA065621: , HPA078004: "			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.4	24.6	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.5	0.0	0.4	0.1	0.0	1.4	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	12.1	0.9	0.7	1.7	0.7	3.7	0.0	0.0	3.2	0.3	2.1	0.1	1.6	5.2	0.0	0.0	0.0	0.0	0.0	2.6	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	112.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013584, HPA020952"	Approved		Approved	"Nuclear bodies,Cytosol"			430000	Cytosol	"Nuclear bodies"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	15.8	26.4	31.5	12.1	28.0	11.7	15.3	14.7	27.2	19.2	15.7	18.5	13.7	14.7	11.2	21.7	13.7	21.1	14.2	59.1	22.7	19.3	18.4	12.6	12.1	12.7	27.0	21.0	13.7	46.5	15.6	21.2	14.7	20.8	20.2	11.6	14.1	30.5	22.6	86.0	9.2	16.3	16.9	24.3	10.3	13.4	13.8	18.6	7.5	20.7	19.8	10.4	12.0	9.8	24.9	48.8	3.3	35.4	20.0	24.3	32.1	7.1	52.2	29.8	19.0	19.3	35.0	43.8	16.7	21.3	20.4	18.1	19.0	16.3	15.2	20.3	20.6	19.0	6.5	37.7	6.4	13.6	13.2	4.8	34.3	41.7	24.0	9.5	19.6	43.6	31.0	11.7	14.1	26.7	11.5	14.2	31.6	40.7	13.9	20.1	23.6	22.5	11.5	13.0	25.1	32.2	11.9	14.6	13.9	17.9	21.1	8.7	16.0	26.5	21.7	42.6	13.2	11.8	15.4	9.4	9.1	9.3	24.1	6.9	25.5	2.9	35.4	3.3	24.3	34.2	20.9	24.9	21.1	21.9	37.5	16.5	15.0	21.3	1.7	20.0	24.0	48.8	22.9	32.1	31.5	28.0	14.7	27.2	22.7	19.3	27.0	21.0	20.8	18.6
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 18.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA012312: "	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (5.53e-2)"	7.5	4.5	5.6	15.1	8.6	7.7	5.9	8.7	10.3	7.0	5.9	8.9	5.3	3.2	7.3	4.6	6.4	5.7	7.8	9.1	7.0	5.2	5.4	4.7	6.8	13.7	7.0	6.3	7.4	4.7	27.7	8.2	11.4	9.3	5.9	5.1	4.7	5.7	6.9	67.0	5.5	7.8	8.5	8.2	12.1	4.7	9.1	5.8	9.2	5.7	18.2	15.5	7.9	6.3	6.7	2.1	9.2	18.2	3.8	6.2	2.0	15.0	6.9	9.5	19.3	8.3	9.2	7.9	26.7	24.5	16.0	18.2	11.8	12.3	13.6	2.2	20.6	12.5	13.5	6.9	22.8	9.1	10.8	5.5	7.6	3.4	9.0	7.3	15.3	5.4	6.6	9.3	14.1	5.7	9.0	24.1	17.0	9.5	6.0	4.8	8.6	8.2	6.0	19.3	11.0	4.4	20.4	9.2	12.8	14.9	17.0	9.7	18.0	5.7	5.6	27.6	14.9	15.4	15.6	11.4	13.3	16.9	8.7	11.8	23.7	9.2	2.1	3.4	1.5	9.2	3.0	6.7	4.7	1.4	2.1	4.2	1.4	1.5	1.2	3.8	18.2	1.0	6.2	2.0	5.6	8.6	8.7	10.3	7.0	5.2	7.0	6.3	9.3	5.8
PHYHIPL	"Em:AC025038.1, KIAA1796"	ENSG00000165443	"Phytanoyl-CoA 2-hydroxylase interacting protein like"	Q96FC7	10	59176590-59247774	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.8;Hep G2: 24.3;SCLC-21H: 4.4;SH-SY5Y: 14.5;SK-BR-3: 6.1"	"Group enriched"	"Detected in many"	5	"glioma: 21.1;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038746	Uncertain		Approved	Cytosol				Cytosol		"HPA038746: AB_10673293"	"unprognostic (6.34e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.60e-7)"	"unprognostic (1.29e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	1.9	23.1	22.2	2.0	22.4	1.6	1.8	17.6	70.3	2.1	2.1	25.4	0.4	11.2	2.5	3.8	2.0	2.5	1.8	1.7	20.8	21.4	14.8	2.7	1.7	1.6	28.0	25.0	2.5	5.6	1.6	4.4	10.6	24.8	4.4	2.0	7.6	2.2	4.9	1.6	1.6	11.5	1.7	27.4	1.6	2.2	8.9	31.0	0.0	1.6	0.0	1.6	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	14.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	22.4	17.6	32.6	20.8	21.4	28.0	25.0	24.8	31.0
PI15	P25TI	ENSG00000137558	"Peptidase inhibitor 15"	O43692	8	74824537-74855029	"Predicted secreted proteins"		"Developmental protein, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 15.7;SH-SY5Y: 15.6;SK-MEL-30: 20.7;U-266/70: 5.4"	"Group enriched"	"Detected in many"	7	"breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006593, HPA030057"	Uncertain		Approved	Vesicles,Cytosol	"Secreted in other tissues"			Vesicles	Cytosol	"HPA006593: AB_1078568, HPA030057: AB_10602143"	"unprognostic (2.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.63e-14)"	"unprognostic (2.54e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	4.2	1.4	3.7	33.4	6.5	0.2	23.4	0.5	2.2	17.3	8.8	0.0	6.5	0.3	26.5	33.8	1.8	18.5	1.2	18.8	1.3	0.9	2.5	0.4	2.3	4.6	3.5	0.0	28.7	0.5	0.2	0.7	0.4	5.9	21.4	3.3	0.0	1.9	5.2	0.6	0.5	8.3	30.7	6.0	15.2	1.0	2.6	1.7	0.1	0.8	0.9	0.3	7.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	15.6	0.0	0.0	20.7	0.3	0.4	0.0	0.0	0.3	0.0	0.1	5.4	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	6.5	0.5	2.2	1.3	0.9	3.5	0.0	5.9	1.7
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25233975-25279092	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 49.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA004099	Approved		Supported	Cytosol				Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favourable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	9.2	7.1	3.4	13.6	2.9	3.9	8.0	3.2	2.3	8.7	48.4	4.1	11.3	19.4	7.4	8.0	13.5	4.9	9.5	4.2	3.1	2.7	12.9	38.6	14.3	9.4	3.5	2.3	6.9	10.5	4.2	5.7	7.7	2.9	6.4	9.8	3.3	22.6	12.0	4.4	8.6	49.3	6.9	4.5	13.8	11.3	8.0	2.7	18.6	16.2	12.9	14.1	7.8	10.3	1.4	1.8	1.5	1.0	0.4	4.1	0.4	11.3	2.0	4.8	5.1	6.5	12.1	11.8	17.1	16.1	15.0	19.2	3.6	12.2	29.4	3.9	12.9	4.7	10.9	8.6	14.9	8.9	3.8	9.4	5.1	9.1	6.2	18.9	7.3	8.1	7.8	5.6	5.9	10.1	6.2	24.7	14.5	4.4	18.2	16.9	8.4	4.6	11.0	18.9	17.1	13.2	8.1	10.1	2.2	8.7	6.9	3.5	9.8	11.0	10.4	10.7	2.7	6.5	11.0	28.4	13.5	22.4	12.5	16.1	10.8	1.5	0.4	0.0	1.3	1.0	0.9	1.4	1.5	1.2	0.3	1.0	1.4	1.3	0.2	0.4	0.9	1.8	4.1	0.4	3.4	2.9	3.2	2.3	3.1	2.7	3.5	2.3	2.9	2.7
PICK1	"dJ1039K5, MGC15204, PRKCABP"	ENSG00000100151	"Protein interacting with PRKCA 1"	Q9NRD5	22	38056311-38075701	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA067384, HPA072674"	Approved		Approved	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA067384: , HPA072674: "	"unprognostic (1.97e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.79e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.56e-2)"	"prognostic favourable (5.26e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.61e-3)"	7.7	11.9	16.9	5.7	32.7	5.3	14.9	18.4	26.2	8.9	12.5	21.3	18.6	10.8	11.3	15.5	13.0	18.1	10.0	14.7	17.2	14.8	12.4	14.5	10.8	8.1	47.4	21.5	15.6	16.1	36.6	22.7	8.7	24.7	25.5	13.4	11.4	19.1	18.9	18.0	11.5	9.8	12.5	17.6	8.1	15.0	18.6	36.5	2.5	13.4	6.8	8.5	8.9	8.6	2.5	4.6	1.9	2.7	1.4	3.2	1.7	10.5	7.6	4.3	5.6	3.0	2.4	6.4	5.9	7.2	12.8	13.0	8.0	6.7	4.7	6.6	7.2	11.6	11.7	24.0	11.0	2.9	18.8	1.7	9.2	9.2	11.2	5.4	11.6	7.7	14.1	8.4	12.5	4.9	3.4	3.4	2.6	6.7	3.2	0.5	6.8	8.3	2.8	0.2	4.2	14.8	17.2	17.9	9.1	6.7	16.3	6.0	9.5	4.0	1.3	3.6	6.9	4.9	3.5	7.8	1.8	1.3	7.9	1.8	5.3	0.0	2.7	0.0	1.8	1.5	0.6	1.1	1.8	3.2	4.6	2.5	3.1	1.8	1.9	1.4	1.5	0.9	1.7	1.7	16.9	32.7	18.4	26.2	17.2	14.8	47.4	21.5	24.7	36.5
PIDD1	"DKFZp434D229, LRDD, MGC16925, PIDD"	ENSG00000177595	"P53-induced death domain protein 1"	Q9HB75	11	799179-809753	"Predicted intracellular proteins"	Apoptosis	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB012647, HPA055473"	Supported		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"CAB012647: , HPA055473: "	"unprognostic (1.38e-1)"	"prognostic favourable (8.19e-5)"	"unprognostic (5.07e-3)"	"prognostic favourable (3.32e-5)"	"unprognostic (7.25e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (8.17e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.17e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.22e-2)"	3.4	3.0	3.3	6.7	3.7	15.0	3.9	7.7	10.0	4.4	4.3	2.2	0.4	7.1	3.2	4.1	6.8	3.3	3.0	2.2	4.7	2.9	2.9	5.6	3.1	7.0	4.4	10.9	2.9	5.6	3.0	2.8	10.1	3.2	5.2	2.0	2.7	6.1	3.5	7.1	7.9	6.5	2.0	5.9	5.3	5.9	5.0	1.9	21.9	3.9	4.3	9.2	3.3	2.8	1.9	3.1	0.1	1.8	0.4	3.3	1.2	4.1	4.8	2.3	4.9	0.5	1.8	21.3	5.9	1.6	2.2	2.9	4.4	8.0	3.4	1.8	0.8	6.2	1.7	2.3	0.4	6.9	9.8	2.9	3.3	9.0	5.6	3.2	7.5	6.9	4.2	1.1	0.3	3.9	3.4	2.6	0.9	1.9	9.1	5.4	3.2	3.4	14.9	3.3	6.6	0.8	1.4	4.0	5.4	2.5	6.5	1.6	4.8	5.6	2.2	2.8	6.2	2.0	3.8	8.4	4.7	6.6	3.5	2.7	4.4	0.0	1.7	0.1	1.9	1.8	1.8	1.5	1.4	1.5	3.1	1.9	1.7	1.7	0.0	0.4	1.6	0.8	3.3	1.2	3.3	3.7	7.7	10.0	4.7	2.9	4.4	10.9	3.2	1.9
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11148762	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							"HPA015986, HPA031974, HPA031975, HPA040616"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: "	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	0.9	0.3	3.1	0.9	2.3	0.0	1.9	0.1	3.6	0.9	3.3			0.0	0.3	1.6	5.8	0.8	5.9	0.0	5.2	2.1	0.9	4.5	7.4	0.5	5.8		0.6	1.7	0.0	0.6	0.0		3.4	1.3		0.0	3.3	0.0	0.8	0.9	1.9	10.3	2.7	1.4	0.9			1.3		0.2	4.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	9.4	0.0	0.0	0.0	0.0	0.5	2.7	10.5	14.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.7	0.0	0.3	0.0	23.4	5.5	3.3	0.0	0.0	0.0	0.1	2.7	0.7	3.2	0.0	0.2	1.6	0.0	0.1	0.0	2.9	0.0	0.0	0.0	4.1	0.0	3.2	8.1	0.0	0.1	0.0	0.5	0.0	2.7	0.0	0.0	3.8	0.2	0.5	14.9	0.1	9.7	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PIGB		ENSG00000069943	"Phosphatidylinositol glycan anchor biosynthesis class B"	Q92521	15	55318960-55355648	"Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039929	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039929: AB_10673539"	"unprognostic (1.91e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.24e-2)"	9.5	11.9	5.7	13.0	11.9	11.2	10.4	3.9	9.3	7.1	8.5	8.2	6.6	9.1	10.5	13.2	11.1	9.5	10.0	6.3	5.9	5.9	12.4	10.3	8.8	20.1	6.9	6.8	8.7	8.1	19.2	12.5	8.7	8.6	9.7	9.4	13.0	9.6	8.4	3.2	8.1	11.6	7.0	8.9	14.2	9.3	17.4	6.0	11.5	16.3	6.2	16.2	10.7	9.3	8.4	8.1	20.1	11.5	5.6	8.9	6.4	7.3	8.6	3.9	3.1	4.3	8.8	5.6	6.2	12.5	7.0	11.2	3.8	7.7	7.2	8.3	8.6	12.5	2.5	6.5	5.9	7.2	5.6	7.1	10.7	4.7	7.8	20.1	6.2	9.2	8.0	5.5	7.1	8.7	8.4	6.1	9.2	6.5	2.5	7.9	2.5	4.3	3.2	3.8	16.4	10.9	8.2	2.3	4.4	5.7	9.2	10.8	9.9	14.7	6.6	9.5	3.1	2.4	12.5	6.1	11.0	6.4	8.4	22.7	6.8	10.5	8.9	4.1	8.3	10.4	8.9	8.4	8.3	8.6	8.1	5.4	7.0	7.8	20.1	5.6	11.5	6.3	8.6	6.4	5.7	11.9	3.9	9.3	5.9	5.9	6.9	6.8	8.6	6.0
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavourable (2.57e-4)"	"prognostic unfavourable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	17.3	12.6	11.1	14.3	18.8	8.6	18.0	14.6	15.6	12.9	13.0	17.6	12.8	17.1	19.8	20.2	12.6	13.1	12.7	8.8	8.5	7.5	11.2	18.5	12.5	12.0	14.5	10.7	16.5	16.5	11.9	18.1	10.3	13.6	14.0	14.4	15.5	14.8	16.3	13.4	20.0	15.8	10.1	9.7	12.3	14.8	11.1	13.6	13.7	15.7	11.1	20.4	10.9	12.3	5.2	7.4	5.5	3.7	5.4	9.3	3.3	8.2	11.8	8.0	6.6	11.5	10.8	3.3	4.6	5.5	7.7	13.8	12.0	10.6	4.0	9.4	4.4	12.1	9.8	5.8	11.1	8.6	25.7	8.0	8.2	14.3	12.3	3.4	5.2	9.1	15.2	13.5	15.4	8.8	9.5	5.1	6.1	8.2	6.2	8.0	3.1	6.1	6.1	6.7	11.6	8.7	4.5	4.2	6.0	4.8	3.4	9.4	3.7	3.1	5.7	7.0	4.3	4.6	13.0	3.6	0.1	6.5	8.8	8.5	4.4	0.0	3.7	5.5	6.5	3.2	5.6	5.2	8.5	5.0	2.7	4.4	9.3	7.5	0.0	5.4	2.4	7.4	6.7	3.3	11.1	18.8	14.6	15.6	8.5	7.5	14.5	10.7	13.6	13.6
PIGN	"MDC4, PIG-N"	ENSG00000197563	"Phosphatidylinositol glycan anchor biosynthesis class N"	O95427	18	61905255-62187118	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039922, HPA040374"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039922: AB_10805597, HPA040374: AB_10794738"	"unprognostic (1.93e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (6.51e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.71e-1)"	12.6	14.1	8.3	10.2	13.2	13.7	13.5	10.5	12.4	15.1	13.2	16.6	12.2	12.0	18.3	12.7	33.2	9.2	11.0	12.8	9.6	7.8	11.2	15.9	9.0	9.5	10.4	8.8	12.9	16.6	19.7	27.2	17.1	11.9	15.2	15.7	14.7	20.3	13.7	15.2	19.0	12.7	9.6	15.4	9.3	17.4	16.2	12.2	18.6	15.3	12.7	18.6	16.8	18.1	13.1	13.4	14.8	10.0	16.3	11.5	4.5	16.8	10.1	10.1	12.8	12.6	17.1	13.5	16.8	13.2	11.0	13.2	13.1	17.2	18.7	24.6	12.7	23.3	13.5	14.2	17.5	15.5	9.1	11.4	15.6	10.2	9.0	23.3	13.3	10.0	9.5	11.1	13.0	13.9	13.4	28.0	12.1	15.3	11.6	7.1	17.1	9.4	12.5	18.8	18.1	13.6	26.0	11.5	11.8	22.4	15.9	7.1	25.2	14.9	15.7	22.4	16.4	8.8	12.5	29.7	27.6	9.3	12.3	13.3	21.8	11.4	10.0	7.6	9.6	8.5	9.9	10.3	9.7	9.2	10.8	13.1	11.2	11.5	14.8	16.3	9.0	13.4	7.8	4.5	8.3	13.2	10.5	12.4	9.6	7.8	10.4	8.8	11.9	12.2
PIGU	"bA346K17.2, CDC91L1, GAB1"	ENSG00000101464	"Phosphatidylinositol glycan anchor biosynthesis class U"	Q9H490	20	34560542-34698790	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041706, HPA046766"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041706: , HPA046766: "	"unprognostic (1.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (1.49e-7)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-3)"	"unprognostic (7.94e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.86e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.27e-2)"	"unprognostic (4.21e-3)"	16.8	17.6	18.9	12.9	23.6	10.0	15.2	15.7	26.5	14.7	21.5	43.0	10.8	13.3	21.8	22.8	20.0	28.2	12.7	17.4	21.4	20.2	18.4	16.3	11.3	11.6	21.5	11.9	23.9	16.2	34.4	21.7	17.3	26.9	14.1	24.9	20.1	17.9	15.9	16.4	14.0	14.2	19.6	30.5	11.1	11.5	22.1	18.1	16.5	14.7	15.9	19.5	14.2	15.0	10.0	10.8	9.4	6.3	12.1	15.0	6.7	11.7	15.0	19.1	13.9	12.6	15.1	19.2	12.1	14.4	20.6	18.1	27.7	25.0	15.2	19.7	11.9	21.9	17.4	22.9	21.0	6.2	9.4	34.2	9.9	31.1	11.6	20.7	8.2	13.4	14.7	11.8	13.5	14.8	17.1	13.5	17.4	13.2	17.6	21.2	9.6	22.7	12.8	24.0	24.2	18.2	11.0	12.3	11.6	22.6	41.2	14.7	22.7	14.6	8.7	33.9	12.0	18.2	12.1	9.1	12.7	10.1	20.7	21.7	14.6	9.4	4.4	1.9	13.4	6.3	12.2	9.2	12.4	15.0	10.8	10.0	12.7	12.5	0.9	12.1	5.3	10.6	11.2	6.7	18.9	23.6	15.7	26.5	21.4	20.2	21.5	11.9	26.9	18.1
PIGV	FLJ20477	ENSG00000060642	"Phosphatidylinositol glycan anchor biosynthesis class V"	Q9NUD9	1	26787472-26798398	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054181			Approved	"Endoplasmic reticulum,Cytosol"				Cytosol	"Endoplasmic reticulum"	"HPA054181: "	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.44e-2)"	"prognostic favourable (7.60e-7)"	"unprognostic (1.71e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (5.96e-3)"	6.2	14.6	8.1	5.3	8.9	4.6	9.2	6.1	10.3	10.5	7.5	9.9	9.3	7.3	8.3	14.7	8.7	10.6	8.9	4.4	7.2	6.6	10.6	24.6	6.8	5.1	11.6	6.8	9.0	13.5	15.8	13.5	9.3	9.7	11.5	8.4	6.6	9.9	10.6	5.0	10.1	10.7	7.1	7.5	7.2	7.7	31.3	10.0	7.2	20.0	8.2	7.8	9.3	7.6	8.3	9.7	23.5	12.9	18.0	19.1	9.2	9.3	5.6	4.5	3.9	8.8	10.9	3.8	6.5	15.3	6.1	7.5	3.1	19.3	5.5	5.9	8.0	16.7	2.4	7.5	7.6	9.4	4.0	4.8	7.5	7.7	9.9	8.8	12.0	11.2	31.2	8.4	10.3	4.6	8.8	8.9	11.0	5.2	4.3	5.0	6.8	4.5	3.1	5.3	10.5	9.7	2.4	6.5	3.5	6.3	3.2	6.2	10.8	4.4	7.7	11.1	4.8	5.4	2.2	3.1	2.1	3.0	9.1	9.4	6.5	23.5	10.3	7.7	13.3	10.1	19.1	7.4	9.0	13.0	9.7	8.3	9.1	11.1	12.5	18.0	12.9	3.8	7.7	9.2	8.1	8.9	6.1	10.3	7.2	6.6	11.6	6.8	9.7	10.0
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029409	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029409: AB_10610280"	"unprognostic (8.83e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	19.1	13.7	25.1	12.7	25.5	9.3	19.2	16.9	25.8	13.1	15.5	13.1	7.8	12.3	15.2	18.5	16.6	12.6	12.7	13.9	23.2	25.4	18.1	12.5	15.6	27.0	24.8	13.4	10.9	16.0	28.1	18.2	17.7	14.5	18.6	17.1	16.3	12.9	18.5	18.6	12.3	11.8	17.1	21.7	18.4	10.6	9.0	14.2	24.6	15.5	10.6	14.7	13.6	10.7	1.7	3.2	34.5	4.4	3.6	2.1	1.5	21.9	10.0	13.1	9.2	13.9	10.6	7.5	9.9	12.0	12.2	12.7	9.7	14.3	10.8	33.3	9.9	12.1	11.2	9.4	15.1	9.8	10.4	8.9	6.9	6.5	12.9	10.0	16.7	7.9	14.8	9.8	9.3	6.6	6.1	21.7	11.1	19.9	25.8	13.0	5.9	11.3	14.0	15.5	15.6	12.6	7.4	12.7	14.1	16.7	11.5	13.6	39.8	9.4	3.4	11.7	5.1	12.8	15.2	27.4	31.5	20.4	10.6	12.3	12.0	15.5	3.0	34.5	1.5	4.4	1.3	1.7	1.4	2.1	3.2	1.7	1.6	1.4	8.6	3.6	4.4	1.4	1.7	1.5	25.1	25.5	16.9	25.8	23.2	25.4	24.8	13.4	14.5	14.2
PIH1D1	"FLJ20643, NOP17"	ENSG00000104872	"PIH1 domain containing 1"	Q9NWS0	19	49446298-49453497	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047258	Approved		Approved	Cytosol				Cytosol		"HPA047258: AB_10964561"	"unprognostic (2.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	23.1	24.3	29.5	21.1	24.4	22.3	23.7	31.1	36.9	27.3	31.9	25.8	32.9	31.9	23.2	18.1	29.0	30.6	23.0	21.1	25.2	23.2	26.7	41.6	19.2	28.4	23.4	24.7	21.4	36.9	24.4	23.2	27.6	24.8	25.8	22.4	23.0	40.8	27.3	44.7	31.4	27.3	19.9	19.2	25.8	24.9	16.8	23.7	43.6	37.2	34.0	30.6	23.8	24.2	38.6	35.9	49.7	36.4	33.0	52.5	32.6	36.1	18.6	24.0	36.6	11.8	10.9	15.3	14.8	19.4	22.7	35.2	19.9	24.9	24.4	13.9	15.8	22.2	12.5	27.0	13.3	23.2	23.8	21.8	24.7	25.0	18.2	23.5	32.9	12.7	11.4	16.8	16.0	21.1	32.1	21.6	14.2	16.3	26.3	46.8	28.5	17.8	22.5	26.8	24.5	18.4	29.7	31.1	45.0	15.1	25.7	14.5	12.2	28.5	12.5	19.1	15.0	7.5	23.0	58.6	45.7	13.3	10.5	25.6	13.3	49.7	36.4	39.3	32.4	34.9	27.4	38.6	36.3	34.4	35.9	34.2	29.5	27.4	4.2	33.0	34.6	34.2	52.5	32.6	29.5	24.4	31.1	36.9	25.2	23.2	23.4	24.7	24.8	23.7
PIH1D2		ENSG00000150773	"PIH1 domain containing 2"	Q8WWB5	11	112064010-112074274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 41.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039496			Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039496: AB_10959385"	"unprognostic (8.74e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.82e-2)"	"unprognostic (9.05e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	0.7	1.0	1.5	0.3	3.3	0.2	1.6	0.9	2.0	1.6	0.8	3.2	2.3	0.4	1.5	8.1	1.0	14.4	1.2	0.9	2.6	2.0	4.9	0.5	2.8	0.3	1.1	1.8	2.5	1.2	4.4	10.5	0.5	9.7	1.4	0.7	2.7	1.1	1.5	0.9	0.9	0.5	0.9	0.8	0.4	0.8	41.9	1.2	0.1	5.8	0.6	0.3	0.9	0.8	1.2	1.0	0.7	1.2	0.3	0.3	0.2	2.9	1.4	4.5	2.0	2.3	2.5	3.1	1.1	3.7	3.7	3.6	5.6	9.2	1.3	3.9	2.1	3.7	1.0	2.4	3.7	1.4	3.8	2.1	2.5	2.4	2.1	2.2	1.3	1.6	2.8	6.9	3.9	1.9	2.7	0.8	2.2	1.1	0.9	2.7	1.3	2.5	1.8	2.9	3.1	9.6	1.4	5.7	1.5	3.7	1.3	1.9	12.3	0.6	1.1	2.1	2.4	1.3	1.0	1.1	0.4	1.6	3.1	0.3	1.7	0.0	0.3	0.7	0.0	1.2	0.3	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.2	1.5	3.3	0.9	2.0	2.6	2.0	1.1	1.8	9.7	1.2
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593312-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.1;NB-4: 17.4;REH: 51.7;THP-1: 26.4;U-698: 32.9;U-937: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9"	"Group enriched"	"Detected in all"	6	"B-cells: 17.5;monocytes: 38.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	Nucleoplasm	"CAB026136: , HPA038452: "	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	5.8	2.2	2.9	16.8	7.1	14.7	4.8	1.0	3.0	1.4	2.2	3.2	0.0	1.9	1.3	2.3	1.3	2.0	8.5	3.3	3.1	2.4	6.2	38.4	6.0	19.5	5.3	0.5	3.3	16.1	0.3	3.0	10.9	5.1	1.8	2.7	1.6	29.7	0.8	1.1	1.5	6.6	2.4	7.3	32.0	1.9	1.7	4.3	2.0	2.4	0.6	19.2	4.1	2.2	17.5	4.4	4.7	38.9	4.5	4.8	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.4	24.1	2.5	0.0	0.0	5.1	0.0	0.2	13.4	0.8	3.7	0.0	0.4	0.0	10.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	17.4	0.2	0.3	51.7	1.2	5.6	0.0	0.0	1.0	0.6	0.0	0.0	0.3	0.0	26.4	0.0	0.0	0.8	0.0	0.2	0.2	0.0	32.9	0.0	27.1	0.0	1.7	5.4	3.3	4.8	15.5	1.7	17.5	0.1	1.5	4.4	16.2	0.0	1.2	4.7	4.5	38.9	3.9	0.1	4.2	2.9	7.1	1.0	3.0	3.1	2.4	5.3	0.5	5.1	4.3
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.9;RT4: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: "	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (1.16e-4)"	12.9	4.5	11.0	16.0	19.3	5.3	11.0	9.1	17.5	7.4	17.0	36.0	9.6	15.5	10.5	5.8	14.6	7.7	14.7	10.7	14.4	9.1	7.6	5.8	18.0	23.9	24.2	11.2	3.9	6.1	4.7	4.3	20.4	14.5	7.3	14.5	6.3	8.0	14.1	20.0	22.6	15.7	11.2	16.2	14.2	20.7	2.4	23.0	31.8	9.8	8.1	23.1	13.1	11.8	7.4	0.3	0.5	0.2	1.6	2.0	0.4	3.2	6.5	5.8	5.3	3.4	0.3	31.9	0.4	1.3	1.3	0.9	3.8	8.5	5.5	1.2	0.7	8.1	3.4	2.3	0.5	3.3	0.9	0.1	12.9	1.4	0.2	1.9	4.2	0.4	2.4	0.3	0.2	8.5	2.0	3.7	0.1	7.2	6.6	5.5	5.3	4.1	7.2	1.4	1.0	1.6	33.3	6.4	3.5	11.5	16.2	3.7	7.2	1.0	0.3	0.2	2.1	0.6	0.1	4.0	1.1	7.2	0.2	2.9	0.8	0.1	0.2	0.0	1.2	0.0	1.0	2.9	1.3	0.8	0.3	7.4	0.7	0.6	0.5	1.6	0.0	0.1	2.0	0.4	11.0	19.3	9.1	17.5	14.4	9.1	24.2	11.2	14.5	23.0
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Approved	Cytosol				Cytosol		"CAB017804: , HPA009985: AB_1079610"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-2)"	20.1	12.3	13.7	11.5	13.4	25.7	22.4	17.1	24.5	12.9	14.0	5.2	5.7	6.5	15.3	7.9	11.6	11.1	13.2	14.2	18.4	9.7	11.7	10.8	13.2	13.8	9.8	15.7	15.4	9.2	24.7	11.6	16.5	16.3	10.7	8.9	7.2	10.9	10.9	15.2	12.0	10.5	12.8	14.4	16.2	10.6	9.3	9.8	29.6	11.0	7.3	13.9	15.1	15.7	6.2	2.6	7.8	3.8	2.4	5.0	1.1	14.4	4.9	7.9	7.3	18.7	21.8	5.7	9.2	12.5	9.1	14.4	4.2	10.7	13.2	15.8	11.0	5.9	6.4	8.0	13.2	22.0	5.7	18.1	5.3	3.7	8.9	10.1	10.3	13.7	8.5	10.0	11.5	13.0	9.0	14.7	13.0	5.7	7.7	9.1	6.2	6.7	11.8	8.0	15.8	7.2	8.8	4.4	7.6	10.0	8.9	12.0	14.9	8.7	13.8	8.6	5.6	13.5	9.2	7.1	10.1	23.7	7.7	7.6	5.0	2.1	3.8	1.6	5.0	2.9	3.9	5.8	4.2	2.8	2.2	6.2	4.6	3.8	7.8	2.4	3.0	2.6	4.1	1.1	13.7	13.4	17.1	24.5	18.4	9.7	9.8	15.7	16.3	9.8
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106907145	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.2;HMC-1: 15.2;Karpas-707: 12.6;MOLT-4: 23.0;U-266/70: 30.9;U-937: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA069976: "	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	5.0	1.8	2.2	16.0	3.1	27.8	2.3	0.8	1.7	1.7	4.1	2.7	0.0	2.8	1.7	2.0	2.0	1.8	3.5	1.7	1.7	1.5	1.9	1.5	4.3	13.1	3.0	1.0	1.7	1.5	0.6	1.4	2.0	2.5	2.2	2.6	1.9	3.1	0.5	1.1	1.3	6.1	1.9	6.4	17.4	2.5	7.6	3.0	40.8	2.3	0.9	21.2	4.1	1.5	6.2	5.6	14.2	24.5	5.3	5.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	0.0	0.0	11.9	15.2	0.0	0.0	0.0	0.0	4.7	8.5	12.6	0.0	0.0	23.0	4.6	0.0	0.0	6.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	0.0	0.1	0.0	0.0	30.9	0.0	11.5	0.0	21.8	2.9	4.6	3.4	14.2	5.6	10.6	5.1	4.7	2.6	4.2	5.6	6.2	2.8	3.8	13.9	5.3	24.5	4.9	2.6	3.6	2.2	3.1	0.8	1.7	1.7	1.5	3.0	1.0	2.5	3.0
PIK3R1	"GRB1, p85, p85-ALPHA"	ENSG00000145675	"Phosphoinositide-3-kinase regulatory subunit 1"	P27986	5	68215720-68301821	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Protein transport, Stress response, Transport"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001216, CAB004268"	Approved		Approved	Cytosol				Cytosol		"CAB004268: AB_628126, HPA001216: AB_1079612"	"unprognostic (5.74e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"prognostic favourable (8.09e-4)"	"unprognostic (3.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.59e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.54e-1)"	26.2	13.4	26.0	13.0	24.3	51.6	42.3	15.3	50.3	27.1	20.3	12.8	12.8	8.1	41.3	22.1	20.8	33.0	18.1	33.9	24.0	13.4	17.9	46.5	16.3	12.0	22.0	40.8	25.8	6.8	22.3	9.4	15.0	18.2	15.2	10.8	8.7	54.6	16.2	48.9	19.1	16.1	36.3	17.6	18.8	13.1	7.6	23.6	16.2	12.8	8.5	10.8	25.2	24.4	2.2	2.1	10.6	4.1	8.2	14.8	4.0	1.0	2.1	6.3	18.7	71.7	21.0	2.7	6.0	2.8	2.3	2.5	5.2	1.9	5.5	10.3	8.2	2.6	1.7	12.1	2.9	23.0	2.3	6.6	1.7	4.2	24.1	6.7	5.3	22.1	27.6	4.2	22.5	3.0	1.0	4.2	2.1	2.8	16.4	2.6	1.8	1.1	15.4	3.0	4.3	3.0	12.3	1.2	5.7	0.9	1.6	3.9	9.0	4.8	3.6	2.7	2.8	4.5	3.7	4.7	7.0	6.4	2.9	8.5	2.0	10.6	1.2	5.9	9.2	1.7	12.7	1.2	11.5	8.4	2.1	2.2	14.8	10.8	1.5	8.2	4.1	0.9	8.5	4.0	26.0	24.3	15.3	50.3	24.0	13.4	22.0	40.8	18.2	23.6
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 28.0;U-937: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA044505: , HPA052247: , HPA052412: "	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	13.8	4.1	2.0	13.0	3.4	51.0	7.2	0.6	1.8	2.1	5.6	3.6	0.0	2.5	1.9	3.1	3.1	3.8	5.7	3.1	3.4	1.6	2.7	2.4	16.4	22.9	5.0	0.6	2.5	1.8	0.7	1.3	2.3	3.0	2.7	2.1	2.4	3.1	1.0	1.0	1.8	10.4	2.9	5.3	23.8	2.6	4.0	2.5	17.6	2.2	1.9	12.4	4.5	2.8	3.6	8.0	23.8	12.1	5.7	13.6	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.3	1.0	0.0	0.0	0.0	0.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.8	0.4	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	4.9	10.6	3.7	13.6	10.0	8.8	3.2	7.5	11.4	8.0	3.6	5.8	8.9	23.8	5.7	12.1	6.4	9.2	9.5	2.0	3.4	0.6	1.8	3.4	1.6	5.0	0.6	3.0	2.5
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802723-8867677	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 12.2"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 57.5"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in many"	4	"eosinophil: 32.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	2.2	0.0	2.1	12.2	5.4	5.3	1.0	0.0	3.7	1.5	1.9	2.5	1.4	3.5	2.6	2.3	1.2	0.4	6.6	2.6	3.1		0.0	0.6	3.4	4.4	2.5	0.0	0.3	0.8	0.3	0.0	1.4	3.2	2.4	1.5	1.4	0.9	0.7	1.0	1.8	5.2	2.2	3.1	6.3	2.3	1.1	2.7	6.9	0.0	0.8	6.4	3.0	3.3	1.3	4.9	32.1	4.3	0.5	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	7.3	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.7	3.4	32.1	0.2	4.3	0.2	1.3	0.0	0.1	4.9	0.1	0.0	0.1	0.5	0.5	3.3	0.0	0.0	1.4										
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170203-37175426	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 34.8;HMC-1: 64.9;U-698: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 64.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 64.6;T-cells: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	39.3	5.4	7.4	18.5	8.9	80.9	20.1	8.1	9.9	23.0	17.9	4.7	4.2	17.9	15.4	9.8	56.3	21.6	24.7	20.8	8.2	3.7	7.5	24.5	14.5	35.7	7.4	2.2	20.0	9.6	2.0	5.6	28.7	12.7	15.6	8.8	6.9	12.8	4.5	26.5	31.3	26.1	31.6	10.7	21.4	12.1	6.8	7.6	15.0	7.2	20.1	28.8	32.6	31.2	1.7	1.4	64.6	1.7	8.4	19.0	8.5	3.0	1.2	2.0	1.1	4.6	2.4	23.5	1.0	3.3	2.2	3.6	4.5	4.2	6.0	1.7	1.2	3.5	2.0	3.2	2.0	27.5	1.3	34.8	1.3	5.8	4.7	0.6	64.9	8.3	4.0	2.0	1.3	0.6	29.9	9.8	0.3	0.7	1.9	3.1	3.7	1.9	4.6	3.6	7.1	0.6	18.4	9.7	1.9	2.3	0.2	0.6	0.5	1.0	1.1	1.3	3.9	5.8	1.3	4.6	2.4	116.6	0.5	8.8	1.3	64.6	1.7	24.4	14.7	1.6	19.0	1.7	13.1	12.9	1.4	1.3	11.9	9.0	14.1	8.4	0.9	0.4	9.4	8.5	7.4	8.9	8.1	9.9	8.2	3.7	7.4	2.2	12.7	7.6
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 63.4;lymphoid tissue: 71.2"	"Group enriched"	"Detected in many"	5	"HDLM-2: 58.9;Karpas-707: 73.0;RPMI-8226: 71.9;U-266/70: 133.0;U-266/84: 117.5"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol				Cytosol		"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favourable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	3.6	3.4	4.3	37.2	7.2	30.4	3.4	7.1	7.9	4.5	13.4	2.1	2.2	29.5	2.8	4.3	10.0	5.6	8.3	3.1	5.6	6.7	5.2	5.4	10.6	59.7	3.8	4.6	5.4	3.0	1.0	4.9	2.4	6.7	3.6	17.7	6.1	16.9	4.9	1.5	3.0	19.2	2.2	3.1	71.2	14.7	5.7	1.3	39.4	4.8	3.6	47.9	24.6	3.3	26.0	2.9	46.9	3.0	17.0	63.4	13.2	1.8	1.5	0.8	1.6	0.3	0.2	1.2	1.1	1.4	1.6	1.4	1.4	1.3	7.8	0.5	0.5	1.1	2.6	1.0	1.5	58.9	2.1	9.4	1.6	1.4	0.7	2.2	6.4	0.6	0.9	1.6	1.0	0.5	10.0	73.0	0.9	1.3	0.8	4.7	17.8	2.4	1.0	0.5	71.9	1.6	0.2	0.5	0.8	1.2	0.8	0.8	2.0	3.1	0.3	0.3	0.2	0.3	1.1	133.0	117.5	15.0	1.5	2.0	0.3	46.9	1.5	14.3	12.5	1.9	21.2	26.0	34.4	17.6	2.5	15.9	36.9	23.0	38.3	17.0	3.0	2.9	63.4	13.2	4.3	7.2	7.1	7.9	5.6	6.7	3.8	4.6	6.7	1.3
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960513-49964080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol				Cytosol		"HPA068758: "	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	32.5	15.5	6.8	19.9	16.7	62.4	50.5	7.6	11.9	16.4	22.6	11.3	20.9	15.9	14.4	17.6	25.0	15.9	37.8	23.6	7.5	7.9	29.1	25.7	38.3	29.4	21.1	4.9	13.9	36.4	4.8	14.9	31.4	15.1	28.4	7.6	9.7	27.6	22.7	39.9	31.3	20.9	12.2	10.1	25.4	33.6	13.0	13.5	9.7	19.1	19.9	19.0	25.6	18.3	6.1	5.7	16.9	4.0	1.2	4.5	1.9	7.2	4.8	3.2	6.1	2.5	1.9	18.5	4.6	7.4	5.4	3.9	8.0	6.2	12.9	5.8	1.2	6.2	6.2	3.4	1.9	9.7	25.7	5.3	11.5	9.6	12.0	11.5	10.3	3.6	11.5	3.3	5.7	17.6	7.3	45.7	1.6	16.2	5.8	20.6	6.8	7.7	27.2	5.4	15.3	2.9	5.5	11.6	8.1	8.9	40.6	28.4	5.3	15.3	4.6	3.4	14.8	5.6	7.4	23.5	14.9	11.0	8.6	6.5	9.2	0.0	3.1	0.1	1.9	3.2	2.3	3.4	4.4	3.8	2.5	6.1	4.1	1.7	16.9	1.2	4.0	5.7	4.5	1.9	6.8	16.7	7.6	11.9	7.5	7.9	21.1	4.9	15.1	13.5
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849682	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004528, CAB009326, HPA068650, HPA070887"	Approved		Enhanced	Nucleoplasm,Cytosol			30000	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: , HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favourable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favourable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	24.5	36.3	40.0	18.7	38.8	25.6	9.3	27.4	66.0	9.2	15.8	18.1	8.5	22.9	14.0	8.3	11.3	16.4	10.1	25.9	38.0	35.2	17.4	14.5	13.2	14.8	38.7	37.2	13.9	21.1	9.5	13.6	13.3	57.3	23.2	6.5	14.1	21.3	15.7	50.2	10.2	21.7	11.1	19.6	15.4	19.6	24.8	15.0	19.7	9.9	8.1	9.3	11.1	9.7	36.4	72.8	88.2	44.9	40.7	53.8	46.2	25.9	23.8	17.8	16.5	6.2	5.6	10.5	19.4	8.4	14.5	14.0	22.1	8.3	16.1	31.0	7.2	13.3	12.2	11.7	4.6	34.3	52.0	41.8	29.3	19.0	10.1	19.5	24.6	7.6	7.9	9.4	4.4	11.8	18.9	24.5	8.7	18.2	29.5	76.2	17.0	36.6	27.0	18.5	27.0	10.4	12.8	22.4	26.4	18.7	9.4	21.7	12.0	23.4	19.9	20.1	16.1	31.1	31.1	31.6	29.7	21.7	21.5	25.0	24.7	52.2	43.4	88.2	42.0	44.9	39.2	35.6	41.5	42.1	39.7	36.4	33.1	37.2	26.8	40.7	41.7	72.8	53.8	46.2	40.0	38.8	27.4	66.0	38.0	35.2	38.7	37.2	57.3	15.0
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534849-22714555	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 92.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"			8800000	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: , HPA068771: "	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	13.0	7.3	43.8	20.3	63.8	17.3	6.9	6.6	41.4	13.2	7.8	75.5	1.0	5.9	9.9	5.6	9.2	7.2	15.1	5.9	56.0	31.7	7.6	8.3	11.5	33.4	65.7	22.9	4.3	4.9	29.5	4.2	10.5	36.5	4.4	9.0	5.7	3.9	6.3	2.6	4.0	8.1	14.4	92.0	26.6	8.4	5.4	59.8	10.1	5.9	1.0	38.5	11.5	5.8	14.7	12.0	26.3	16.6	38.4	46.7	39.3	8.7	8.7	10.1	3.2	16.3	22.2	7.7	16.4	17.5	8.9	11.0	8.1	14.2	18.5	6.0	32.9	3.1	8.8	4.6	9.0	40.9	9.1	34.7	6.4	17.9	28.9	6.6	27.3	11.1	4.1	12.1	11.7	13.1	19.3	36.1	16.4	3.6	26.6	6.0	4.1	6.2	10.7	14.5	25.1	13.2	1.7	1.8	4.3	5.2	2.7	26.1	2.3	11.6	15.8	6.9	10.1	12.7	10.0	23.0	13.0	13.5	18.6	20.2	5.3	16.1	8.8	26.3	34.5	15.6	46.7	14.7	27.5	40.0	11.6	8.6	18.6	34.9	10.9	38.4	16.6	12.0	19.6	39.3	43.8	63.8	6.6	30.3	56.0	31.7	65.7	22.9	36.5	59.8
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	18.1	19.5	15.7	15.4	21.0	9.6	20.2	22.6	27.6	19.8	18.0	20.3	14.7	16.4	24.8	22.6	20.7	19.4	20.7	18.9	17.3	13.4	17.8	18.3	21.7	17.1	12.7	17.5	20.4	16.6	21.8	25.3	44.6	14.6	17.3	15.6	29.5	17.8	15.2	26.1	20.4	20.4	27.2	16.1	20.1	16.8	42.1	14.0	19.3	20.1	13.9	22.3	16.2	17.7	9.1	8.7	11.7	6.2	4.7	5.9	6.3	17.7	13.8	21.4	24.6	14.1	14.9	21.0	23.4	33.0	43.8	39.3	25.1	17.2	16.1	25.0	24.9	15.1	27.7	16.1	38.4	24.3	19.8	12.8	18.2	11.9	26.7	22.9	16.2	19.9	14.9	27.2	34.5	17.8	12.5	13.8	22.0	24.8	22.8	11.4	31.7	21.4	22.1	18.7	12.0	22.5	10.3	14.3	19.0	31.6	24.4	20.6	25.5	21.7	17.0	17.4	24.4	16.0	28.1	19.3	32.1	36.4	16.9	6.7	20.8	0.1	5.5	7.3	5.3	6.2	4.1	9.1	5.0	5.9	8.4	4.6	5.4	4.2	11.7	4.7	4.8	8.7	3.9	6.3	15.7	21.0	22.6	27.6	17.3	13.4	12.7	17.5	14.6	14.0
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favourable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favourable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favourable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	16.1	10.2	20.5	12.8	25.8	4.5	8.0	58.6	46.3	10.7	23.5	8.5	14.8	10.9	19.8	10.0	12.3	12.8	12.7	13.8	22.8	10.7	7.5	3.8	11.5	7.5	11.3	17.1	11.5	17.2	10.0	9.2	13.7	19.0	16.7	6.4	16.9	20.0	33.4	13.5	10.2	11.5	19.2	6.3	15.8	13.6	23.9	8.7	5.3	9.3	3.9	6.0	17.3	19.0	2.5	3.2	3.6	3.0	1.7	2.8	2.0	9.0	8.6	6.8	8.8	13.3	10.8	10.2	17.5	11.1	7.5	6.1	7.6	2.6	3.8	6.7	18.8	8.1	3.2	5.6	3.1	13.5	5.7	4.4	7.1	6.2	11.0	4.4	13.5	12.0	5.4	6.1	2.3	12.8	6.6	7.1	7.1	7.5	5.3	3.3	7.0	12.0	10.0	5.2	5.2	5.6	7.8	6.8	5.9	9.1	4.9	5.3	3.9	6.6	28.0	10.6	6.0	37.3	8.1	8.2	6.5	1.7	14.3	9.3	7.6	3.6	2.8	0.0	2.8	2.6	1.2	2.5	2.1	2.0	3.2	1.3	1.0	1.6	2.2	1.7	3.0	2.2	1.4	2.0	20.5	25.8	58.6	46.3	22.8	10.7	11.3	17.1	19.0	8.7
PIP5KL1	"bA203J24.5, MGC46424"	ENSG00000167103	"Phosphatidylinositol-4-phosphate 5-kinase like 1"	Q5T9C9	9	127920879-127930797	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Karpas-707: 28.9;RPMI-8226: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 1.2;MAIT T-cell: 1.0;memory B-cell: 1.0;myeloid DC: 1.0;naive B-cell: 2.4;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA056240	Uncertain		Supported	Cytosol				Cytosol		"HPA056240: "	"unprognostic (2.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.51e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.95e-8)"	"unprognostic (1.87e-1)"	"unprognostic (7.21e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.59e-1)"	0.6	0.7	3.1	0.6	1.0	1.4	2.5	2.4	5.3	2.1	0.6	1.9	0.6	0.5	1.3	0.6	3.7	1.8	1.2	0.6	2.1	2.9	1.3	0.6	2.9	0.6	1.4	2.6	0.7	1.3	6.5	4.8	1.6	8.3	3.3	0.2	1.0	8.7	4.1	0.6	4.7	0.6	1.0	1.5	0.6	2.4	2.5	1.2	0.6	2.9	0.6	0.6	1.2	4.0	2.4	1.3	0.0	1.2	0.0	1.0	0.3	0.0	0.4	0.4	0.5	0.5	1.3	2.7	0.6	0.5	0.1	0.1	0.2	3.5	0.3	1.1	2.3	1.1	0.0	2.6	0.1	0.3	1.7	0.0	0.8	0.0	0.8	0.0	0.1	1.4	1.7	0.3	0.0	0.0	0.0	28.9	0.0	2.4	0.0	1.0	0.2	0.4	0.2	0.0	18.9	0.0	0.0	0.9	1.7	0.1	0.7	0.0	1.0	1.3	0.3	0.3	1.0	0.6	0.1	2.6	1.7	0.6	5.2	0.4	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.0	0.1	0.0	1.0	2.4	0.2	0.1	0.0	0.0	0.1	1.3	0.0	0.3	3.1	1.0	2.4	5.3	2.1	2.9	1.4	2.6	8.3	1.2
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 117.9;SK-MEL-30: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol				Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favourable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	20.9	16.1	14.1	5.9	16.8	5.7	26.5	8.5	13.5	8.1	7.5	14.0	21.8	7.7	11.2	18.8	20.7	16.2	13.4	14.0	11.7	12.1	13.9	23.7	18.6	8.6	20.8	9.8	13.0	2.6	5.4	9.1	12.1	15.6	12.1	8.3	25.0	7.5	18.0	9.8	13.7	6.9	24.6	26.0	15.5	13.8	7.2	14.4	1.3	12.1	19.9	9.1	26.5	11.7	0.0	0.5	1.0	0.5	0.0	2.2	0.3	2.3	13.0	7.8	11.5	4.6	5.2	2.5	0.7	4.5	1.9	4.3	3.6	20.4	0.0	25.9	2.0	16.6	9.1	3.6	0.7	0.0	2.0	1.4	14.7	10.5	6.0	0.7	5.2	1.5	12.6	7.3	2.5	117.9	1.0	3.3	1.6	4.9	0.5	0.6	8.4	8.2	0.0	1.5	6.4	3.8	23.0	3.0	8.3	6.3	3.5	44.3	7.3	4.5	7.3	1.0	1.9	4.9	1.4	1.5	6.4	0.0	5.0	2.6	10.3	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.3	14.1	16.8	8.5	13.5	11.7	12.1	20.8	9.8	15.6	14.4
PIRT		ENSG00000233670	"Phosphoinositide interacting regulator of transient receptor potential channels"	P0C851	17	10822475-10838445	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.3;brain: 24.8;intestine: 7.5"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.4"	"Cancer enriched"	"Detected in single"	40	"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042337	Uncertain		Uncertain	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA042337: AB_10794795"	"unprognostic (2.95e-1)"		"unprognostic (2.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.58e-3)"						"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"		"unprognostic (2.85e-3)"				0.4	7.3	9.9	3.2	14.0	0.3	0.3	5.6	5.2	0.4	6.3	10.8	0.0	2.9	0.4	0.4	0.8	0.9	0.7	0.3	13.1	11.6	0.3	0.3	0.4	0.3	12.5	2.3	0.4	0.3	0.3	0.1	0.3	24.8	0.4	7.5	0.0	0.4	0.4	0.4	0.4	5.2	2.5	19.9	0.3	4.9	0.5	12.8	0.0	0.3	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	14.0	5.6	5.2	13.1	11.6	12.5	2.3	24.8	12.8
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favourable (5.27e-5)"	38.3	12.3	9.5	15.1	10.9	20.9	18.5	34.5	12.3	5.9	7.3	6.2	7.4	11.4	9.6	14.4	7.0	10.0	9.5	6.9	6.4	6.9	11.9	8.4	12.9	14.6	8.3	10.1	7.5	10.9	6.0	11.7	38.1	8.6	8.2	3.3	7.7	7.9	7.9	6.4	10.2	8.0	6.2	5.8	16.5	9.7	17.8	7.7	4.2	10.6	5.3	9.8	6.2	7.0	6.9	11.0	28.6	12.9	5.7	6.8	7.9	10.4	9.6	2.9	2.9	8.9	3.4	6.7	8.5	6.8	6.0	6.5	13.9	3.3	6.3	9.1	4.3	11.8	3.9	7.6	1.0	6.9	8.4	6.6	5.9	11.4	18.5	13.7	17.3	6.4	4.3	10.7	4.6	5.3	19.0	3.7	3.4	39.0	5.9	5.9	2.8	4.0	8.4	3.2	6.3	3.8	9.2	7.2	4.2	4.9	16.0	5.5	13.2	7.5	10.3	7.6	9.0	4.8	7.9	4.5	6.2	7.8	7.2	9.2	6.0	9.9	12.9	9.3	6.8	9.5	6.5	6.9	4.9	5.7	11.0	6.3	6.7	5.5	28.6	5.7	5.0	5.4	4.7	7.9	9.5	10.9	34.5	12.3	6.4	6.9	8.3	10.1	8.6	7.7
PITPNA	"PITPN, VIB1A"	ENSG00000174238	"Phosphatidylinositol transfer protein alpha"	Q00169	17	1517718-1562816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000528	Uncertain		Approved	Vesicles,Cytosol			100000	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (1.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (2.29e-4)"	"unprognostic (7.88e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.17e-2)"	"prognostic favourable (1.80e-6)"	"unprognostic (7.41e-2)"	"prognostic favourable (9.35e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.81e-3)"	20.2	22.2	31.1	28.1	34.0	38.5	20.8	43.5	54.1	27.5	22.3	21.0	35.0	27.0	29.2	29.8	37.7	33.1	22.2	18.7	30.2	34.2	20.4	22.7	22.5	17.5	34.0	37.5	18.0	17.4	29.3	21.1	31.2	60.7	27.6	27.7	88.0	38.7	33.2	14.3	44.1	42.4	27.0	26.4	21.9	19.7	25.0	18.8	12.4	31.9	15.4	26.8	21.0	23.5	6.4	5.2	12.3	4.0	5.3	7.5	2.5	20.6	23.1	23.6	20.3	26.1	29.0	37.2	23.2	27.0	24.6	18.2	26.6	8.5	26.8	21.1	32.1	26.1	22.5	23.4	34.7	21.9	22.8	14.4	19.9	11.8	26.0	10.0	17.8	21.0	32.0	24.7	26.2	41.9	20.0	14.9	26.4	11.7	25.4	9.1	16.5	11.3	20.4	9.1	15.0	24.6	24.4	8.5	18.6	27.3	20.3	16.6	17.3	8.1	38.3	15.2	13.4	43.6	31.6	9.1	15.4	9.1	26.5	15.7	19.3	5.0	3.7	4.6	3.4	4.0	6.4	6.4	5.1	4.6	5.2	4.2	4.8	4.1	12.3	5.3	2.8	4.1	7.5	2.5	31.1	34.0	43.5	54.1	30.2	34.2	34.0	37.5	60.7	18.8
PITPNB	VIB1B	ENSG00000180957	"Phosphatidylinositol transfer protein beta"	P48739	22	27851669-27920134	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000528	Uncertain		Approved	Vesicles,Cytosol			150000	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (9.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (5.28e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.64e-1)"	32.5	22.2	29.6	24.8	29.3	14.8	25.0	20.8	38.0	23.9	37.8	16.2	24.5	17.1	32.9	23.8	42.2	21.7	28.4	31.3	24.7	24.5	20.5	43.8	23.9	24.6	25.7	29.0	24.8	22.3	21.8	26.9	38.1	27.2	26.5	24.6	15.1	20.2	31.2	16.1	23.5	21.2	49.6	22.6	20.6	28.8	14.7	21.1	19.9	20.0	15.2	30.9	45.3	43.3	24.4	17.1	20.4	14.7	17.7	27.2	16.9	29.9	13.0	23.9	17.8	21.2	25.7	18.2	29.1	25.5	32.0	31.0	20.5	14.2	20.8	15.5	27.9	31.7	34.0	29.0	45.1	35.5	32.1	21.2	21.1	18.8	22.9	48.3	34.5	22.9	28.4	38.7	40.4	31.1	30.0	43.4	29.2	16.0	20.4	23.8	18.1	17.2	26.1	37.8	30.4	26.5	28.6	28.1	35.2	19.9	24.1	23.5	13.0	17.2	30.4	32.1	47.0	24.3	30.3	17.8	20.8	40.9	27.6	24.0	27.1	20.4	12.8	12.4	22.7	14.7	25.0	24.4	22.2	23.6	17.1	20.8	21.6	21.1	11.6	17.7	13.7	15.4	27.2	16.9	29.6	29.3	20.8	38.0	24.7	24.5	25.7	29.0	27.2	21.1
PITPNC1	"RDGB-BETA, RDGBB, RDGBB1"	ENSG00000154217	"Phosphatidylinositol transfer protein, cytoplasmic 1"	Q9UKF7	17	67377281-67697261	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026563, HPA031250"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA026563: AB_1855409, HPA031250: "	"unprognostic (1.33e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.17e-2)"	"prognostic favourable (4.85e-5)"	"unprognostic (6.57e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-2)"	20.8	10.0	22.9	18.0	31.0	11.3	16.6	18.9	33.5	12.0	7.5	18.7	7.0	4.6	10.7	11.7	11.0	22.4	12.5	11.7	23.4	19.1	17.3	14.3	13.5	24.3	21.4	17.0	16.7	23.3	5.4	12.3	19.0	22.7	11.2	9.1	31.2	18.3	13.1	5.1	5.2	8.1	11.7	14.8	13.9	11.8	5.1	17.8	14.5	10.4	6.0	27.0	12.0	16.8	1.6	1.6	16.1	5.5	7.2	16.4	5.0	5.8	2.2	5.9	11.4	5.1	7.0	6.8	6.6	5.3	1.3	1.0	0.0	8.7	7.2	2.2	6.1	2.4	10.3	9.9	1.4	13.2	6.0	0.8	9.7	4.7	1.3	1.4	13.6	5.5	4.4	0.8	5.3	5.1	0.6	26.2	5.0	12.7	16.8	6.1	9.9	12.0	21.3	1.3	6.4	12.5	7.1	7.2	19.0	2.6	5.0	5.9	3.7	7.2	5.1	3.1	1.2	4.0	3.1	17.1	8.5	5.6	19.9	5.9	2.5	1.1	2.5	16.1	16.4	4.0	9.6	1.0	10.7	15.5	1.6	1.6	12.3	13.0	3.1	7.2	5.5	0.4	4.0	5.0	22.9	31.0	18.9	25.3	23.4	19.1	21.4	17.0	22.7	17.8
PITPNM1	"DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1"	ENSG00000110697	"Phosphatidylinositol transfer protein membrane associated 1"	O00562	11	67491768-67506263	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060227	Approved		Supported	"Cytosol,Cytoplasmic bodies"				"Cytosol, Cytoplasmic bodies"		"HPA060227: "	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.68e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.69e-2)"	6.5	14.3	20.1	19.6	17.6	20.4	3.5	23.2	30.7	6.0	12.1	6.4	11.0	16.0	7.0	7.2	10.0	20.5	8.0	10.6	16.6	21.6	14.7	7.3	8.6	21.9	17.8	14.2	3.0	6.4	9.3	15.0	6.9	18.6	5.6	6.7	15.6	5.2	9.9	4.6	3.5	17.7	5.2	6.3	15.2	13.6	4.9	8.0	9.3	11.1	4.5	14.6	12.1	4.7	1.6	2.1	2.9	6.8	0.2	2.5	2.0	5.6	14.3	8.8	6.4	9.7	5.8	14.3	5.6	9.9	6.9	3.9	12.8	10.4	5.6	13.5	7.9	14.8	6.7	12.3	2.3	40.6	2.7	7.6	24.7	4.8	7.7	8.5	16.6	7.2	7.9	10.4	6.9	8.3	5.8	5.1	5.7	8.5	14.6	20.3	8.9	6.2	10.6	2.8	7.6	11.6	11.4	8.5	5.4	12.4	17.5	13.6	3.4	7.6	8.1	12.5	9.6	7.9	3.9	7.5	3.5	5.0	17.6	10.3	4.9	0.0	2.6	1.8	2.5	6.8	2.2	1.6	1.7	2.2	2.1	1.2	0.7	1.7	2.9	0.2	5.3	0.8	1.5	2.0	20.1	17.6	23.2	30.7	16.6	21.6	17.8	14.2	18.6	8.0
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 7.5;testis: 29.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.8;U-266/70: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA041903: , HPA043634: "	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.5	1.5	2.0	0.6	2.5	2.2	1.2	1.7	1.9	0.5	0.3	0.7	0.7	0.3	0.5	1.0	0.5	0.4	0.6	1.7	1.0	0.8	0.4	0.3	0.4	1.3	1.2	1.3	0.6	1.1	0.0	1.5	0.2	1.8	0.5	0.1	0.2	0.7	0.0	3.3	0.8	0.3	0.0	0.7	1.0	0.6	29.3	0.4	0.0	1.0	0.0	0.2	0.4	0.6	3.9	3.5	7.5	1.7	1.9	1.9	0.8	1.6	1.2	0.2	0.1	0.4	0.5	1.7	0.6	0.0	0.0	0.0	0.1	3.2	2.3	3.4	0.0	0.7	0.1	0.0	0.1	1.5	1.0	1.3	4.2	0.1	0.0	0.4	1.8	0.1	0.2	0.0	0.0	0.6	1.5	5.8	0.8	0.5	1.1	2.3	0.6	1.0	0.0	0.1	0.0	0.0	2.3	0.8	0.9	1.4	0.2	0.9	0.4	0.5	0.5	1.0	1.8	0.6	1.0	4.6	3.3	0.4	2.2	0.7	1.7	7.1	1.7	3.0	1.8	1.2	1.0	2.5	1.6	1.4	0.9	3.9	1.9	1.7	7.5	1.9	1.0	3.5	1.1	0.8	2.0	2.5	1.7	1.9	1.0	0.8	1.2	1.3	1.8	0.4
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 102.0;HSkMC: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 58.2;naive B-cell: 62.1"	"Lineage enriched"	"Detected in many"	10	"B-cells: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: "	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	21.1	25.1	39.2	22.7	31.9	7.5	18.4	12.9	37.7	28.0	44.0	13.5	15.4	12.5	31.8	19.3	31.7	31.4	29.3	107.1	23.0	17.2	22.9	14.4	39.0	17.9	16.7	25.9	17.2	13.3	13.8	19.5	32.6	14.3	30.2	13.3	26.2	18.8	32.5	25.6	8.0	17.9	52.8	11.9	13.2	24.1	41.5	11.4	3.2	25.8	18.6	18.2	42.2	20.3	62.1	6.2	0.4	0.3	0.7	1.6	3.1	5.1	5.3	8.7	5.6	13.1	26.8	1.2	12.5	102.0	14.2	10.7	12.2	2.4	20.1	10.3	10.9	2.0	1.7	2.7	4.6	10.1	3.2	3.1	0.8	8.6	12.2	0.4	0.2	41.4	5.5	6.9	1.5	31.6	2.4	0.5	1.3	6.6	3.1	5.1	4.6	7.7	0.5	0.2	0.4	7.8	1.0	3.5	11.5	3.2	1.5	8.4	4.0	2.5	20.4	19.5	8.7	8.6	6.0	2.7	7.5	14.1	9.7	0.3	8.3	0.4	0.3	0.1	0.2	0.2	0.2	58.2	0.3	0.3	1.5	62.1	1.0	1.6	0.4	0.7	0.2	6.2	0.1	3.1	39.2	31.9	12.9	37.7	23.0	17.2	16.7	25.9	14.3	11.4
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell line enriched"	"Detected in some"	9	"K-562: 47.4"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Low region specificity"	"Detected in some"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"			2900000	"Golgi apparatus, Cytosol"		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: "	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol			540000000	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (1.30e-4)"	"prognostic unfavourable (2.74e-6)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.5	209.8	42.3	50.0	50.9	57.2	35.0	88.5	206.7	142.1	143.9	59.0	100.5	62.1	89.6	165.6	118.9	133.7	180.0	111.4	109.0	63.2	38.0	105.5	48.8	35.5	49.3	82.0	51.9	83.9	109.5	45.0	83.6	9.5	49.8	224.1	50.7	18.4	21.2	52.3	80.1	54.7	135.4	118.3	188.7	105.0	44.0	48.0	115.4	71.2	90.5	49.9	35.9	65.1	161.9	88.6	158.2	160.5	64.0	90.4	54.7	199.3	81.6	158.6	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	"Protein kinase N1"	Q16512	19	14433053-14471867	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003982, CAB010278"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	"unprognostic (3.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.24e-2)"	28.8	19.5	19.1	27.6	26.7	39.6	25.3	21.9	19.2	19.2	26.0	20.9	16.5	10.0	25.4	19.7	16.6	22.2	22.5	38.3	17.1	17.6	17.9	16.3	27.9	42.2	19.5	16.3	21.7	32.3	15.8	18.7	22.7	19.2	22.6	6.9	21.5	22.6	22.7	43.2	7.6	16.9	22.5	19.4	39.7	24.2	21.5	18.9	39.2	17.8	13.8	24.0	22.1	30.5	11.5	17.0	24.1	30.6	13.5	20.7	15.2	37.2	22.2	8.3	17.2	13.4	15.8	13.7	13.4	16.1	14.2	13.6	8.6	21.4	35.6	34.8	23.0	8.6	13.2	6.0	5.5	28.8	17.1	42.6	14.2	18.4	44.5	16.7	26.8	11.4	4.3	8.6	13.5	32.9	18.8	24.7	10.4	15.3	25.2	15.5	15.0	25.4	33.9	11.3	25.6	7.0	6.1	30.2	42.8	8.3	10.6	21.7	9.6	29.2	49.2	28.3	12.1	34.1	20.3	32.5	29.6	19.4	18.5	33.6	22.1	15.4	17.3	24.1	20.7	24.2	15.7	10.7	14.0	14.2	17.0	11.5	13.1	14.3	21.3	13.5	30.6	11.1	15.9	15.2	19.1	26.7	21.9	17.3	17.1	17.6	19.5	16.3	19.2	18.9
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"				"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: , HPA057913: "	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.3	9.2	18.2	10.9	12.2	13.9	11.8	13.8	12.8	15.6	16.2	9.7	16.8	9.2	16.5	13.1	18.4	17.7	10.5	21.3	3.3	12.9	6.8	19.0	8.3	10.7	6.7	2.0	11.4	11.0	12.2	14.8	17.7	11.3	6.7	16.7	4.7	7.7	5.8	9.1	10.7	7.4	27.7	3.8	13.8	46.0	8.8	5.8	20.7	12.0	17.8	8.9	6.1	16.5	13.2	11.9	16.9	14.4	3.7	3.2	6.3	5.5	6.6	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828953-186988981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1"	"Cell line enhanced"	"Detected in many"		"A549: 16.7;HeLa: 24.3;RPMI-8226: 30.2;U-2197: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Cytosol			78000	Cytosol		"CAB010050: AB_631312, HPA050062: , HPA054206: "	"prognostic favourable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	6.0	8.6	3.4	3.5	5.3	2.2	3.8	1.5	4.7	8.5	10.9	2.9	52.6	5.4	7.7	7.4	7.0	12.3	4.2	6.6	3.3	2.5	6.7	1.1	4.9	5.2	6.5	1.4	5.1	3.8	63.5	2.7	2.9	5.6	10.9	4.2	2.9	5.8	56.1	0.6	6.1	10.3	14.6	7.5	4.2	5.1	2.7	5.3	0.4	2.7	5.9	2.3	19.4	9.4	0.0	7.8	7.7	8.4	1.1	0.2	1.5	0.0	16.7	0.0	0.0	10.5	4.2	0.0	0.6	6.4	0.8	1.4	0.1	6.6	0.0	0.0	0.0	1.2	10.4	3.1	0.3	5.1	0.2	3.1	24.3	0.0	6.5	4.5	1.6	2.3	2.2	8.4	1.7	7.0	6.8	2.5	0.0	0.0	0.0	0.0	0.9	2.2	0.0	0.0	30.2	0.0	2.3	0.1	0.0	2.5	0.8	2.9	0.3	6.2	1.4	6.2	0.8	28.5	1.3	1.0	0.0	0.0	2.3	13.6	8.8	0.1	7.1	7.7	0.0	8.4	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.6	1.1	3.9	3.2	0.0	1.5	3.4	5.3	1.5	4.7	3.3	2.5	6.5	1.4	5.6	5.3
PLA2G4C	cPLA2-gamma	ENSG00000105499	"Phospholipase A2 group IVC"	Q9UP65	19	48047843-48110817	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.8;skeletal muscle: 45.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 8.0;HHSteC: 13.1;TIME: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 7.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA043083	Approved		Approved	Cytosol				Cytosol		"HPA043083: AB_10795714"	"unprognostic (1.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.01e-2)"	4.0	11.7	8.9	4.2	23.2	0.4	3.0	12.9	14.5	3.4	3.5	23.4	2.0	5.1	6.8	5.2	3.6	4.3	4.6	18.5	10.0	10.0	4.4	3.8	5.9	7.2	31.8	8.5	2.0	4.1	14.8	4.6	4.1	16.9	5.7	2.9	5.4	3.1	6.7	45.0	4.9	6.7	8.1	18.6	8.1	2.4	2.4	17.1	0.7	3.3	7.5	4.3	4.9	2.1	5.4	2.0	0.0	7.9	1.5	0.8	2.0	0.6	1.1	0.0	0.3	5.1	3.0	0.1	1.3	8.0	1.2	3.4	0.0	2.1	0.0	1.7	3.2	0.2	0.0	0.2	1.9	0.8	0.1	0.0	0.3	1.1	13.1	0.0	1.7	0.6	0.3	0.5	5.3	5.0	0.0	7.2	1.9	2.0	0.0	0.1	0.1	0.1	0.1	1.8	0.6	2.4	0.3	0.7	0.1	1.4	2.5	6.2	0.7	1.8	18.3	2.2	0.7	2.5	0.9	0.4	1.3	0.2	1.6	0.0	4.3	0.0	3.2	0.0	0.2	7.9	0.6	5.4	0.8	0.0	2.0	1.6	0.0	0.0	0.0	1.5	2.0	1.4	0.2	2.0	8.9	23.2	12.9	14.5	10.0	10.0	31.8	8.5	16.9	17.1
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38205690	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 31.4;HMC-1: 20.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favourable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favourable (1.55e-4)"	16.2	17.7	15.6	8.5	20.5	13.1	15.6	15.9	26.3	14.8	7.9	36.9	18.5	9.8	16.3	20.5	8.7	21.6	25.3	6.3	19.7	7.2	18.1	8.6	9.0	12.4	19.3	16.7	21.3	12.8	24.2	12.7	6.8	19.5	17.6	6.3	12.9	20.2	17.4	7.4	18.1	8.7	7.8	14.9	12.1	9.5	30.0	23.2	16.3	45.7	4.1	11.3	12.1	11.2	1.8	5.4	4.1	0.9	8.8	5.7	1.9	0.7	2.8	3.0	7.7	10.0	4.9	8.1	0.9	0.9	0.8	1.1	3.1	1.8	5.8	6.6	2.3	3.6	3.4	1.9	1.0	8.9	13.1	31.4	3.8	3.5	2.8	3.5	20.1	16.1	4.3	2.8	4.4	1.0	5.1	10.6	1.5	4.6	6.5	2.1	2.5	1.8	4.8	1.1	4.5	2.9	6.9	5.7	2.4	1.3	3.1	7.1	3.2	2.5	1.2	2.6	4.4	1.1	0.5	17.4	3.1	3.1	3.7	4.0	1.5	4.1	0.9	0.4	3.8	0.3	1.9	1.8	3.1	5.7	1.5	1.5	1.4	3.9	3.3	8.8	0.6	5.4	3.7	1.9	15.6	20.5	15.9	26.3	19.7	7.2	19.3	16.7	19.5	23.2
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062610	"Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.4;ASC TERT1: 12.7;BJ hTERT+: 10.1;TIME: 29.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"		99000	Cytosol		"CAB068217: , CAB068218: "	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.6	2.1	0.6	2.3	1.1	0.0	9.4	19.5	1.9	11.3	7.0	1.0	2.4	2.4	17.8	4.7	4.7	4.8	6.9	2.7	0.7	1.0	15.0	0.9	2.3	1.8	0.8	0.7	8.7	0.8	14.5	2.6	6.6	3.3	3.3	2.0	7.8	46.1	2.0	0.8	9.6	9.4	5.7	2.5	3.0	1.6	1.3	0.2	0.3	27.6	6.6	5.1	4.5	9.4	0.6	0.6	2.3	0.8	1.0	0.6	0.2	0.1	1.0	0.4	0.0	9.4	12.7	0.0	4.2	10.1	0.8	1.1	0.0	2.1	0.0	0.2	4.4	2.0	0.0	3.0	0.9	0.0	0.0	0.0	7.1	0.0	0.7	0.0	0.0	5.1	3.4	1.2	1.3	5.8	0.0	0.0	1.4	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	7.3	1.4	0.0	1.6	0.1	29.2	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.5	0.5	0.5	0.6	0.5	0.4	0.3	0.3	0.6	0.6	0.6	2.3	1.0	0.8	0.6	0.4	0.2	0.6	1.1	19.5	1.9	0.7	1.0	0.8	0.7	3.3	0.2
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26904083-26947463	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			5300	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favourable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	13.6	20.1	9.4	12.4	13.1	29.6	11.9	12.9	18.0	13.4	12.3	11.1	13.5	10.5	15.6	12.8	16.2	10.8	13.6	26.2	10.1	10.2	15.0	19.6	14.4	16.4	9.6	10.9	12.3	12.9	15.0	10.0	17.4	13.4	12.1	13.1	9.5	13.4	11.6	52.6	13.5	12.3	16.1	10.0	16.1	12.0	15.7	7.9	27.0	13.0	18.2	14.6	14.9	12.7	13.2	12.2	19.2	17.9	13.5	16.5	8.6	27.2	16.2	20.5	20.7	13.9	17.8	15.4	25.7	14.7	19.7	19.3	5.7	13.1	24.7	21.5	19.6	11.0	20.3	20.3	21.8	32.5	8.6	15.3	26.6	10.9	14.2	12.3	20.9	15.8	12.2	24.0	17.6	19.6	9.3	25.1	21.1	11.4	23.7	12.0	29.7	14.1	16.9	12.9	14.6	15.3	16.4	13.2	22.5	13.8	16.3	8.0	11.3	9.5	23.7	0.0	24.4	12.7	20.7	8.3	17.9	25.7	13.9	17.6	10.2	19.2	11.9	18.7	11.2	16.8	12.5	13.2	11.6	11.3	12.2	11.5	10.7	12.2	11.2	13.5	17.9	6.3	16.5	8.6	9.4	13.1	12.9	18.0	10.1	10.2	9.6	10.9	13.4	7.9
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta specific 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8"	"Cell line enhanced"	"Detected in many"		"A-431: 31.5;CAPAN-2: 91.0;HL-60: 56.4;NB-4: 27.7;RPMI-8226: 40.7;THP-1: 32.8;U-937: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 181.6"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol				Cytosol		"HPA040465: AB_10794875, HPA077912: "	"unprognostic (6.82e-5)"	"prognostic favourable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	2.3	1.3	1.7	47.9	5.9	62.0	1.6	0.7	4.1	6.1	44.1	0.6	0.2	14.6	1.0	0.9	34.5	3.1	7.5	2.4	1.4	1.9	1.6	12.4	23.4	51.6	2.5	0.2	1.9	1.2	0.0	1.3	32.3	3.0	2.0	31.4	1.3	9.7	1.0	0.8	0.7	66.5	3.1	5.2	74.8	21.8	0.7	2.7	18.2	1.5	1.4	53.1	3.4	2.5	41.5	181.6	7.0	47.8	77.6	32.9	36.0	31.5	0.2	0.1	0.2	0.0	0.0	5.2	0.8	0.2	2.0	2.4	0.6	91.0	5.3	0.2	9.2	3.3	0.5	0.2	7.5	0.0	0.1	0.1	6.3	2.6	0.3	56.4	0.3	0.1	0.6	0.3	0.4	0.1	0.0	0.4	5.2	0.1	10.7	27.7	0.1	0.1	1.4	1.9	40.7	0.1	0.9	4.6	0.0	0.2	5.2	0.1	0.3	32.8	0.2	0.2	5.9	0.1	0.1	0.3	0.0	14.1	0.4	26.0	0.0	2.7	11.0	7.0	32.9	47.8	24.9	41.5	15.7	18.7	10.0	38.4	19.4	22.0	2.4	77.6	25.8	181.6	1.0	36.0	1.7	5.9	0.7	4.1	1.4	1.9	2.5	0.2	3.0	2.7
PLAG1	ZNF912	ENSG00000181690	"PLAG1 zinc finger"	Q6DJT9	8	56160904-56211324	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.0;ASC TERT1: 17.2;HSkMC: 12.2;hTERT-HME1: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA072290			Supported	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"				"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA072290: "	"unprognostic (1.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.14e-2)"	1.9	3.6	2.4	3.5	2.9	2.1	2.5	11.0	2.7	7.6	3.8	4.1	9.0	3.4	3.4	9.8	2.0	7.5	2.1	6.8	1.9	1.8	3.7	1.2	4.6	6.7	4.8	2.1	11.6	2.2	2.1	17.8	8.0	4.6	5.1	1.6	7.9	7.5	9.2	1.4	3.4	5.5	2.5	6.3	6.2	3.0	5.2	4.5	11.7	3.5	1.5	5.2	4.8	7.0	3.5	0.2	1.1	0.5	0.7	4.6	1.0	1.5	0.0	9.5	0.1	13.0	17.2	3.0	4.2	5.5	2.0	0.9	0.6	4.9	0.2	4.1	2.3	0.3	2.6	5.6	2.0	0.1	5.8	6.0	0.5	1.4	2.7	1.9	1.8	12.2	3.1	1.1	12.6	3.7	2.5	0.1	4.2	0.0	0.5	3.6	2.7	1.4	4.7	0.7	3.7	2.6	0.5	0.1	0.0	0.1	0.0	0.3	0.1	1.8	5.6	2.9	3.8	4.7	1.0	1.5	1.1	2.2	3.3	0.7	0.8	1.1	0.1	1.1	0.3	0.1	0.2	3.5	1.0	0.6	0.1	2.0	4.6	4.3	1.0	0.7	0.5	0.2	0.2	1.0	2.4	2.9	11.0	2.7	1.9	1.8	4.8	2.1	4.6	4.5
PLAGL2	ZNF900	ENSG00000126003	"PLAG1 like zinc finger 2"	Q9UPG8	20	32192503-32207791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 11.7;non-classical monocyte: 20.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 20.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005900	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005900: AB_1079629"	"unprognostic (9.40e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.09e-1)"	5.9	5.1	6.1	9.0	7.8	30.2	5.8	10.5	7.7	6.9	10.6	6.8	5.6	11.5	9.6	6.6	17.9	10.9	5.8	5.6	6.2	4.0	7.0	6.1	9.3	9.0	5.8	4.9	11.7	11.6	8.5	12.9	5.4	7.2	7.6	9.2	9.8	10.2	6.7	10.1	10.4	24.8	8.3	4.2	10.4	10.1	33.2	7.4	16.4	7.9	13.7	12.9	6.8	11.4	0.9	1.4	1.4	20.7	0.3	1.0	1.2	7.8	4.5	12.0	4.3	4.5	3.4	7.5	3.1	4.9	6.7	6.2	33.5	3.9	8.0	4.3	3.2	7.7	14.9	7.1	9.0	4.7	6.7	32.5	3.6	16.0	5.4	14.2	7.2	4.2	6.4	5.4	3.8	4.8	11.4	7.3	3.5	4.4	15.5	9.8	5.6	5.1	10.1	15.5	5.1	2.9	6.0	5.4	6.0	7.6	4.1	6.7	6.2	17.4	3.6	8.2	8.8	5.9	6.3	20.1	11.1	10.4	4.8	30.1	5.0	1.4	2.1	0.5	0.5	11.7	1.0	0.9	0.6	1.0	1.4	0.6	0.8	0.4	0.6	0.3	20.7	0.3	0.5	1.2	6.1	7.8	10.5	7.7	6.2	4.0	5.8	4.9	7.2	7.4
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.5;lymphoid tissue: 36.3"	"Cell line enhanced"	"Detected in some"		"HEL: 30.8;HMC-1: 38.5;THP-1: 11.1;U-937: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298"	Approved		Approved	Cytosol				Cytosol		"CAB009443: AB_632197, HPA041298: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	6.3	3.6	8.1	17.6	11.6	30.5	2.9	1.1	7.5	2.9	3.3	16.2	1.7	4.0	2.8	3.2	2.4	4.6	6.5	3.3	6.9	5.1	3.3	4.2	12.5	17.2	12.7	2.4	1.6	2.0	1.3	2.9	4.6	9.3	3.2	5.5	4.1	5.2	2.9	1.3	1.5	10.2	4.8	17.9	36.3	3.6	1.4	10.9	12.2	2.8	1.8	17.6	6.9	2.5	1.0	4.5	8.5	4.3	1.8	3.1	2.0	0.1	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	7.7	0.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	6.5	38.5	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	1.8	3.5	0.4	0.1	5.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.1	4.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.0	21.1	0.0	2.7	4.2	8.5	3.1	4.3	2.0	0.7	1.6	1.6	4.5	1.0	1.6	1.8	6.9	1.8	4.2	1.6	2.9	2.0	8.1	11.6	1.1	7.5	6.9	5.1	12.7	2.4	9.3	10.9
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009914, HPA038139, HPA038140"	Enhanced		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				Cytosol	"Nuclear membrane, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.5	2.1	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.5	1.9	0.2	1.2	0.6	3.0	0.1	1.9	0.5	2.7	1.0	1.1	2.2	1.8	0.4	1.2	0.7	3.4	0.9	0.8	0.5	4.3	3.0	2.3	21.1	1.0	0.8	0.3	2.5	0.5	6.0	1.5	1.2	0.7	0.7	0.5	0.8	0.9	4.6	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	94030812-94332823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.6"	"Cell line enhanced"	"Detected in many"		"RT4: 18.7;U-2 OS: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol				Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.2	2.4	4.1	9.1	5.5	0.0	2.2	1.8	7.9	9.2	13.8	3.1	1.6	5.0	11.4	4.6	4.5	4.2	3.8	12.8	4.1	2.6	6.3	0.7	7.2	0.4	2.4	6.8	3.2	12.8	0.1	5.2	3.1	6.4	3.3	12.6	44.6	2.1	7.7	4.3	0.7	4.6	5.8	2.4	5.8	8.7	1.7	2.3	0.0	15.1	7.3	1.1	7.9	5.4	3.2	1.2	0.8	0.9	1.1	2.3	0.5	6.0	8.3	1.8	1.0	1.0	5.9	2.3	3.7	1.0	0.8	1.2	5.4	1.5	0.7	1.9	3.0	2.6	4.2	1.0	1.3	0.4	2.1	0.4	4.6	0.5	0.1	0.8	0.3	2.4	0.0	2.2	0.0	0.0	0.4	0.3	7.2	0.2	0.7	0.8	0.6	8.7	0.1	5.7	0.2	0.2	18.7	0.8	1.5	4.4	6.0	0.5	5.1	0.5	0.6	3.9	11.2	2.3	4.9	0.5	0.2	0.3	3.1	1.0	3.5	0.4	0.5	0.1	1.5	0.9	1.3	2.6	1.6	1.1	0.6	3.2	2.3	1.8	0.8	1.1	0.8	1.2	0.6	0.5	4.1	5.5	1.8	7.9	4.1	2.6	2.4	6.8	6.4	2.3
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 4.0;T-cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol				Cytosol		"CAB004277: AB_628119, HPA036681: , HPA036682: "	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	20.2	15.1	25.1	20.9	22.1	8.3	34.9	52.6	26.8	19.9	13.9	23.4	12.5	16.5	27.6	13.9	13.5	17.0	18.7	20.9	25.4	13.6	15.3	6.8	19.3	30.7	18.5	20.5	28.7	9.1	16.9	14.2	22.2	18.7	18.4	13.2	20.0	13.2	20.6	13.4	22.3	17.1	22.2	15.4	20.1	12.4	19.9	23.9	48.1	28.5	11.9	21.9	17.1	21.1	0.7	0.0	0.0	0.0	4.0	8.0	3.3	5.3	6.8	32.9	24.1	13.2	9.3	10.5	8.8	11.4	17.8	15.2	16.4	1.8	12.0	10.9	9.6	10.0	14.3	15.8	10.4	3.4	7.6	0.8	11.4	19.3	10.0	4.7	3.3	11.8	8.9	13.1	10.3	19.9	8.9	7.9	16.1	40.1	28.9	3.7	12.2	12.6	23.1	24.0	5.9	9.8	9.9	11.7	22.4	15.8	7.4	15.9	8.6	5.5	21.4	42.7	13.9	13.6	10.7	8.9	3.9	10.0	10.2	5.1	17.7	0.0	0.0	0.0	5.9	0.0	8.0	0.3	5.2	4.9	0.0	0.7	5.7	5.4	0.0	4.0	0.0	0.0	4.4	3.3	25.1	22.1	52.6	26.8	25.4	13.6	18.5	20.5	18.7	23.9
PLCXD1	FLJ11323	ENSG00000182378	"Phosphatidylinositol specific phospholipase C X domain containing 1"	Q9NUJ7	X	276322-303356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.3"	"Cell line enhanced"	"Detected in many"		"HEL: 53.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA007721	Approved		Approved	Cytosol				Cytosol		"HPA007721: AB_1079630"	"unprognostic (2.73e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (3.80e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.11e-3)"	"prognostic unfavourable (7.82e-14)"	"unprognostic (6.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	7.4	1.5	6.5	5.3	42.3	18.8	8.7	24.6	19.1	8.9	3.7	2.1	2.1	5.3	9.1	2.1	11.4	3.5	5.3	2.8	7.1	4.2	3.1	5.4	3.5	10.0	4.8	3.6	19.3	4.3	2.3	5.5	12.5	29.2	3.5	3.5	2.1	7.0	2.4	4.5	11.6	5.9	2.1	22.2	10.5	17.3	3.6	6.7	2.1	5.1	2.1	5.4	4.7	7.9	5.8	2.9	6.3	11.9	1.8	4.1	2.7	8.7	33.4	8.1	12.1	1.7	1.3	6.4	7.9	0.9	4.2	4.1	13.5	9.5	11.2	5.5	3.4	2.7	2.0	5.2	2.2	6.7	14.9	53.0	10.8	18.0	5.2	5.4	20.9	6.9	0.7	15.6	1.6	3.2	13.8	6.1	3.0	2.7	16.3	8.0	17.2	6.5	9.3	4.4	16.4	1.3	4.1	8.7	4.6	8.0	4.8	7.3	9.1	7.5	2.3	5.6	9.0	6.1	8.6	2.1	5.5	26.0	3.7	14.4	6.0	4.3	3.8	6.3	2.8	8.1	3.9	2.3	2.2	3.4	2.9	5.8	2.8	2.7	4.9	1.8	11.9	2.7	4.1	2.7	6.5	42.3	24.6	19.1	7.1	4.2	4.8	3.6	29.2	6.7
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 149.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Supported	"Endoplasmic reticulum,Cytosol"			490000	"Endoplasmic reticulum, Cytosol"		"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favourable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	45.7	57.5	44.6	23.1	79.0	12.8	21.9	35.5	126.1	31.2	23.5	25.4	17.1	22.6	26.3	35.0	18.3	30.0	30.8	33.0	46.4	73.4	22.1	25.6	49.7	25.2	44.7	53.9	44.8	42.5	32.9	122.1	38.9	62.2	29.6	16.1	31.6	35.3	37.2	27.4	24.2	23.5	25.6	28.6	48.9	23.0	17.0	19.3	11.9	20.6	11.2	12.9	27.3	20.7	3.6	23.0	149.2	24.6	9.7	7.8	16.8	13.9	43.2	28.0	44.0	77.9	37.1	21.3	34.7	35.4	25.2	28.9	8.2	15.8	6.1	36.4	30.1	6.5	6.7	13.6	11.0	22.6	24.6	6.5	14.8	10.3	53.2	2.7	75.0	70.6	28.5	19.2	13.2	21.1	23.0	24.6	18.1	18.3	4.7	13.0	18.2	8.9	6.0	21.3	24.9	12.9	10.5	20.1	33.4	16.6	10.3	18.5	14.2	47.0	37.2	21.3	10.2	18.0	7.7	25.6	27.3	6.3	34.2	10.9	13.1	149.2	24.6	35.3	7.8	12.8	6.4	3.6	6.2	6.9	23.0	3.1	6.5	6.5	2.5	9.7	5.7	3.3	6.1	16.8	44.6	79.0	35.5	126.1	46.4	73.4	44.7	53.9	62.2	19.3
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524696	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 54.8;retina: 37.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;AF22: 13.7;HDLM-2: 6.8;SH-SY5Y: 3.8;U-2 OS: 4.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 54.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol				Mitochondria	"Vesicles, Cytosol"	"HPA028389: AB_10602145, HPA050367: "	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	1.1	5.4	5.0	0.4	3.7	0.4	1.6	54.8	7.6	2.2	0.8	7.7	0.0	0.4	3.5	0.9	1.6	1.8	0.8	0.8	4.4	4.6	1.5	0.5	0.8	3.3	5.4	2.5	6.6	3.1	1.4	7.2	1.5	12.7	2.7	0.6	37.7	2.2	9.3	0.8	0.6	0.5	2.9	6.0	2.2	0.8	4.2	6.2	0.0	1.0	0.0	1.5	0.4	1.0	0.4	0.2	1.0	0.2	0.3	0.4	0.0	0.0	3.9	13.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	6.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.5	2.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.2	0.3	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.4	0.3	0.4	1.0	0.3	0.2	0.2	0.2	0.0	5.0	3.7	54.8	5.5	4.4	4.6	5.4	2.5	12.7	6.2
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915147-143976734	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease mutation, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 144.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Enhanced	"Intermediate filaments,Focal adhesion sites,Cytosol"			7100000	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	20.9	11.0	15.9	16.5	13.3	27.9	13.1	15.0	20.7	20.7	17.7	14.6	16.7	13.1	20.2	16.8	25.1	18.2	29.0	23.4	18.9	10.7	11.2	10.9	16.6	15.0	9.9	13.0	18.0	14.0	8.8	12.0	24.2	13.2	17.5	9.8	13.0	17.8	14.8	144.9	36.4	24.1	24.7	11.0	16.9	21.4	6.7	12.7	16.3	9.2	44.2	24.5	20.2	19.2	1.5	3.4	0.8	4.1	0.7	2.9	3.2	16.3	51.2	3.3	4.1	6.0	13.4	11.7	24.0	10.7	6.4	3.6	7.1	17.1	1.6	18.7	35.1	19.4	2.2	33.6	2.5	12.2	1.8	6.2	52.0	5.8	9.5	2.0	5.2	15.4	6.6	17.2	33.6	7.4	3.0	5.3	7.4	28.7	1.2	3.4	2.2	72.1	0.3	9.4	4.4	10.7	30.3	3.4	3.4	40.9	8.7	3.9	10.7	2.4	23.8	24.8	44.9	21.8	28.4	0.8	0.6	1.2	23.6	2.6	35.2	0.0	4.1	0.2	1.4	3.8	2.8	1.4	2.7	2.0	3.4	1.5	2.0	1.1	0.8	0.7	2.7	2.8	2.9	3.2	15.9	13.3	15.0	17.3	18.9	10.7	9.9	13.0	13.2	12.7
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386983-67412200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 26.4;CAPAN-2: 28.2;HBEC3-KT: 52.6;PC-3: 19.2;TIME: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.0;naive CD4 T-cell: 6.5"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol				Vesicles	Cytosol	"HPA001208: AB_1079631"	"unprognostic (4.41e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (8.26e-5)"	"unprognostic (1.06e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.59e-2)"	1.7	28.8	0.5	7.6	1.1	4.1	1.5	0.5	0.8	2.4	14.9	1.4	1.6	12.4	1.1	14.9	9.7	0.4	7.4	0.5	0.5	0.2	6.0	29.1	1.9	0.5	0.5	0.5	1.0	16.5	2.5	0.9	2.6	0.7	5.1	12.7	0.9	6.9	2.3	1.4	12.1	28.1	1.2	0.7	0.6	8.5	2.4	0.5	13.9	28.6	6.5	6.5	4.8	4.4	0.0	0.8	0.0	0.1	0.0	6.5	1.2	26.4	4.0	0.0	0.0	0.0	0.3	2.6	5.3	0.8	1.2	1.5	14.4	28.2	0.0	5.2	0.7	12.6	0.0	52.6	3.0	0.0	0.2	0.0	6.1	0.1	1.1	0.0	0.0	0.6	3.8	1.4	16.9	4.4	0.1	0.1	0.9	8.4	0.0	0.0	0.1	19.2	0.0	0.0	4.1	9.0	0.7	0.2	0.0	5.0	2.3	1.5	3.5	0.2	20.5	0.0	16.5	0.1	0.1	0.0	0.0	0.1	3.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.7	0.8	0.0	6.5	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.5	1.1	0.5	0.8	0.5	0.2	0.5	0.5	0.7	0.5
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 6.9;NK-cells: 11.6;T-cells: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: "	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	11.7	7.4	18.2	8.7	30.2	2.6	13.6	15.8	37.9	13.6	14.9	25.4	11.4	17.1	17.9	14.5	26.7	8.8	16.3	19.4	19.8	16.6	27.1	25.4	24.4	9.0	15.6	24.4	13.9	18.1	18.8	22.9	30.6	20.7	12.7	13.9	9.5	16.0	13.6	22.5	43.9	17.2	16.0	19.6	8.7	14.0	25.5	15.0	3.4	18.7	13.9	11.7	16.1	16.1	6.9	1.8	1.3	1.6	11.6	16.5	6.2	7.7	7.1	7.2	5.0	10.5	12.0	8.7	8.6	15.1	5.2	5.7	6.0	9.7	4.8	4.2	7.7	17.0	6.8	26.3	4.8	3.4	6.7	0.0	7.0	7.0	6.9	0.8	2.3	6.5	21.8	4.3	18.4	17.5	7.1	0.0	4.8	2.9	4.3	0.7	5.6	4.8	1.2	10.3	0.9	63.5	8.6	9.9	4.8	11.1	8.3	8.7	4.6	0.0	16.6	4.4	3.6	4.8	4.3	0.0	0.0	1.6	6.8	0.0	2.7	0.1	1.5	1.3	16.5	1.4	10.8	2.9	10.0	13.2	1.8	6.9	15.9	13.5	0.5	11.6	1.6	0.9	6.6	6.2	18.2	30.2	15.8	37.9	19.8	16.6	15.6	24.4	20.7	15.0
PLEKHA2	TAPP2	ENSG00000169499	"Pleckstrin homology domain containing A2"		8	38901235-38973909	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004706	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA004706: AB_1079633"	"unprognostic (2.78e-1)"	"unprognostic (8.80e-3)"	"unprognostic (4.15e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.61e-2)"	"unprognostic (9.07e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.59e-2)"	"prognostic unfavourable (1.95e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.60e-3)"	7.7	9.7	8.8	19.1	6.6	14.2	6.4	3.4	6.9	8.6	8.2	4.8	11.8	3.7	9.0	11.5	6.7	6.9	8.9	17.7	7.0	4.7	7.3	4.0	9.7	29.9	6.6	6.9	10.5	4.5	15.3	6.9	6.9	4.8	9.0	5.0	16.7	5.9	10.3	5.4	5.4	8.8	9.9	8.0	16.3	6.4	5.0	5.7	5.2	7.8	3.2	26.2	12.8	8.6	14.2	5.3	7.5	2.0	3.8	2.7	0.9	9.4	2.2	1.4	3.4	3.6	7.1	1.5	11.5	9.1	8.8	7.5	1.2	6.5	52.8	13.7	10.5	6.0	3.7	7.3	13.3	13.3	0.3	26.9	18.7	1.3	13.0	8.6	11.0	16.2	5.0	4.6	8.2	1.5	2.6	15.3	8.2	1.2	17.6	4.1	1.3	3.3	4.5	7.4	11.2	10.7	8.2	0.1	2.1	13.4	2.5	9.2	5.7	4.3	2.1	6.4	5.0	1.1	9.1	4.8	4.5	24.6	10.2	9.4	1.4	5.2	1.5	7.5	2.0	2.0	2.1	8.9	2.3	2.3	1.8	14.2	1.5	2.7	3.4	3.8	2.0	5.3	1.9	0.9	8.8	6.6	3.4	6.9	7.0	4.7	6.6	6.9	4.8	5.7
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.4;ASC TERT1: 18.7;BJ hTERT+ SV40 Large T+ RasG12V: 21.8;SK-MEL-30: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: , HPA048473: "	"prognostic favourable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	14.0	10.2	5.0	10.1	7.7	0.3	11.4	4.5	5.5	9.4	14.6	6.1	3.5	4.7	13.2	5.6	8.7	10.2	9.7	19.3	3.9	3.0	9.7	10.8	9.6	5.7	28.9	2.6	22.8	11.4	3.1	13.3	5.2	12.4	9.7	3.4	12.5	6.0	8.1	8.9	5.9	5.1	23.3	13.5	8.0	7.9	6.2	4.4	7.4	12.9	5.8	6.3	11.0	7.3	7.4	2.0	1.4	0.7	1.2	5.3	1.6	3.7	0.2	4.3	27.4	6.3	18.7	3.5	3.0	10.7	11.7	21.8	2.5	1.0	0.1	5.2	4.1	1.1	1.5	1.5	1.8	0.0	1.4	0.9	0.6	2.7	4.9	0.0	6.2	9.6	0.9	6.8	0.4	3.4	3.9	2.3	3.2	2.3	1.3	0.2	0.6	0.3	0.1	13.7	0.2	3.6	0.0	0.0	4.8	1.2	1.1	31.5	1.7	1.2	0.5	3.7	3.0	4.8	0.7	12.4	10.3	2.2	4.4	0.3	9.9	0.0	0.6	1.4	3.1	0.7	2.3	3.0	3.0	2.0	0.2	7.4	5.3	4.7	0.3	1.2	0.5	2.0	1.0	1.6	5.0	7.7	4.5	5.5	3.9	3.0	28.9	2.6	12.4	4.4
PLEKHA5	"FLJ10667, KIAA1686, PEPP2"	ENSG00000052126	"Pleckstrin homology domain containing A5"	Q9HAU0	12	19129752-19376400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.0;NTERA-2: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 14.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035923, HPA035924, HPA041455"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: "	"unprognostic (3.16e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.85e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (5.41e-5)"	"unprognostic (3.71e-1)"	"prognostic unfavourable (7.42e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.07e-2)"	7.7	52.3	13.8	7.8	22.0	2.9	11.9	13.0	22.4	23.5	9.8	7.2	19.4	10.0	23.1	25.7	16.0	16.0	16.7	25.2	11.2	11.5	32.2	12.1	9.9	2.4	10.7	16.3	26.1	11.3	27.2	14.4	10.2	15.0	17.6	10.8	22.2	11.4	22.7	2.0	13.2	10.0	23.1	23.7	2.8	13.7	14.8	13.0	6.1	11.5	5.9	4.3	18.1	18.1	0.4	2.7	14.8	0.4	1.7	6.4	0.4	11.0	5.4	20.0	0.2	6.8	9.2	7.1	4.7	10.3	2.9	4.6	8.1	10.0	0.2	1.6	5.2	4.7	13.4	8.8	6.0	28.0	4.8	6.5	12.1	3.9	6.3	0.2	0.9	5.3	9.2	8.2	15.7	3.0	2.8	0.4	3.0	3.4	4.3	0.8	28.6	2.8	0.1	9.3	0.1	20.1	13.1	1.8	4.1	4.6	2.7	16.9	3.3	1.5	4.6	1.9	7.9	0.5	0.2	0.3	0.2	0.2	4.4	0.1	3.6	14.8	0.4	0.3	2.7	0.3	6.4	0.2	2.5	2.3	1.8	0.4	0.4	1.9	1.0	1.7	0.2	2.7	2.1	0.4	13.8	22.0	13.0	22.4	11.2	11.5	10.7	16.3	15.0	13.0
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777317-17014443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.4;HaCaT: 28.7;RT4: 39.3;SK-BR-3: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 6.8;MAIT T-cell: 4.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 6.8;T-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: "	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favourable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	6.8	1.2	5.3	6.6	8.0	0.1	10.7	2.9	4.9	7.7	18.1	10.9	10.0	17.7	4.7	6.0	30.6	6.0	15.1	13.6	7.5	4.2	18.1	9.0	6.4	1.2	7.2	4.6	8.1	18.9	19.1	3.2	18.7	14.5	6.0	11.5	18.2	15.0	16.3	2.7	8.9	32.0	2.7	8.1	1.7	15.2	7.4	7.9	1.4	7.2	1.9	5.5	10.7	12.4	0.5	0.9	6.8	0.3	0.2	4.5	0.3	5.1	4.6	4.9	2.2	0.2	0.0	8.1	0.0	0.1	1.7	3.2	7.9	43.4	0.0	2.0	0.6	28.7	6.5	0.0	1.2	1.5	6.3	13.3	3.7	5.4	0.1	0.0	0.1	0.2	2.5	0.0	0.1	0.0	0.5	0.1	0.7	3.3	3.0	0.1	2.7	4.5	4.1	0.0	1.0	4.2	39.3	3.1	0.3	5.9	16.9	0.2	4.3	1.5	1.1	0.0	1.6	1.2	1.0	2.9	0.9	5.8	0.0	0.2	0.0	0.2	0.3	6.8	0.6	0.1	4.5	0.5	0.8	0.6	0.3	0.2	0.2	0.4	0.6	0.2	0.1	0.9	0.1	0.3	5.3	8.0	2.9	4.9	7.5	4.2	7.2	4.6	14.5	7.9
PLEKHG2	"ARHGEF42, CLG, FLJ00018"	ENSG00000090924	"Pleckstrin homology and RhoGEF domain containing G2"	Q9H7P9	19	39412585-39428415	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Leukodystrophy, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 31.9;REH: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017973, HPA048054"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA017973: , HPA048054: "	"unprognostic (3.55e-1)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavourable (3.79e-8)"	"unprognostic (8.01e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	15.7	6.1	2.9	30.8	4.4	14.8	14.2	2.8	4.0	18.7	12.4	3.9	5.6	5.9	20.3	10.1	9.7	12.6	17.6	13.5	3.5	2.6	10.7	5.1	21.4	20.2	4.5	2.2	17.5	4.4	5.8	7.6	17.4	7.4	12.3	3.9	13.6	6.8	15.0	7.1	4.4	9.6	14.1	6.9	24.8	8.8	8.7	3.6	49.3	11.1	9.5	24.6	13.0	10.1	3.9	4.2	2.8	1.8	1.4	4.4	2.7	3.5	17.5	31.9	17.3	3.0	4.0	4.6	9.4	7.4	6.5	5.6	11.2	6.4	6.2	6.9	12.2	1.2	4.8	8.3	3.5	20.5	4.4	8.1	9.1	5.1	5.3	0.9	10.1	9.2	1.4	7.8	3.8	8.3	5.4	7.3	10.4	7.1	10.0	3.1	7.5	1.7	36.1	3.9	1.8	5.6	6.6	0.8	10.3	2.1	0.7	3.1	9.4	9.2	10.6	17.2	13.5	6.3	6.0	5.4	1.6	9.1	9.5	3.6	9.5	2.8	1.4	0.4	4.4	0.8	2.6	3.9	2.1	2.5	1.0	3.6	2.8	3.5	2.6	1.4	1.8	4.2	3.9	2.7	2.9	4.4	2.8	4.0	3.5	2.6	4.5	2.2	7.4	3.6
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: , HPA065323: , HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favourable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	12.8	2.9	17.2	7.8	36.9	11.4	19.8	7.3	29.4	15.2	15.9	67.3	9.3	10.2	31.6	9.9	26.4	19.8	17.5	12.5	24.2	12.8	19.5	16.5	8.4	4.0	40.7	21.6	16.8	22.7	17.9	3.7	22.3	19.5	12.3	12.1	13.6	19.6	31.6	5.9	19.6	10.0	20.7	24.5	16.0	11.5	5.1	40.9	1.2	14.5	6.4	5.3	16.6	17.1	0.0	0.7	16.7	1.9	6.4	12.2	2.9	28.5	13.3	11.1	16.8	1.2	0.0	19.3	3.2	3.8	5.1	4.1	14.0	12.6	0.0	5.8	3.1	27.6	7.5	25.4	1.7	0.0	6.5	12.7	16.4	3.3	1.5	0.4	6.1	1.5	14.8	1.0	9.2	3.3	0.0	0.1	1.7	13.5	0.0	11.6	3.7	14.2	0.1	5.5	1.9	14.0	20.9	3.8	6.8	6.6	9.9	9.5	10.8	2.8	6.4	2.2	23.0	0.1	4.4	0.0	0.0	0.0	0.2	1.3	3.9	4.5	1.9	11.7	12.2	1.1	8.6	0.0	3.7	5.2	0.7	0.0	0.4	2.7	16.7	6.4	0.7	0.0	1.1	2.9	17.2	36.9	7.3	29.4	24.2	12.8	40.7	21.6	19.5	40.9
PLEKHH2	"KIAA2028, PLEKHH1L"	ENSG00000152527	"Pleckstrin homology, MyTH4 and FERM domain containing H2"	Q8IVE3	2	43637273-43767987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.1;RPTEC TERT1: 8.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077225			Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA077225: "	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.82e-2)"	10.1	2.7	3.7	9.2	6.5	0.3	7.5	5.4	5.6	27.2	8.5	2.9	3.6	4.1	30.0	9.5	5.2	9.8	8.1	3.7	4.2	2.7	8.7	1.8	21.7	3.0	3.4	3.3	19.4	2.5	9.6	1.8	4.2	8.3	7.9	5.0	7.4	3.8	7.8	5.4	6.9	5.7	13.1	9.7	4.7	4.1	4.2	4.0	0.0	4.7	4.7	4.3	11.1	8.6	0.8	0.6	1.4	0.4	0.7	1.0	0.0	0.6	5.1	2.1	0.1	4.2	10.1	0.4	0.7	2.6	1.0	2.7	0.0	1.8	1.3	0.3	0.8	3.4	0.6	0.8	2.0	0.1	1.5	0.1	0.7	0.2	0.6	0.0	0.7	2.9	0.8	2.6	0.1	2.3	4.8	0.2	0.9	1.4	0.9	0.2	1.1	5.1	0.0	6.1	0.1	8.3	0.3	1.6	0.8	0.5	0.0	5.1	0.7	0.2	0.2	6.0	1.7	0.3	1.8	1.2	0.3	0.0	2.4	0.0	0.6	0.8	0.4	0.4	0.4	0.2	0.4	0.3	0.7	0.5	0.2	0.8	1.0	0.6	1.4	0.7	0.3	0.6	0.5	0.0	3.7	6.5	5.4	5.6	4.2	2.7	3.4	3.3	8.3	4.0
PLEKHM3	"DAPR, PLEKHM1L"	ENSG00000178385	"Pleckstrin homology domain containing M3"	Q6ZWE6	2	207821288-208025560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035046	Uncertain		Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA035046: AB_10603128"	"unprognostic (3.62e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.06e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.86e-4)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.33e-2)"	6.5	10.9	10.0	4.1	11.2	11.1	5.1	11.8	16.8	5.6	5.0	10.6	2.1	3.3	6.2	3.4	4.2	4.5	4.5	6.6	7.3	7.8	5.1	6.8	6.2	4.3	6.2	11.4	9.1	4.8	17.3	7.2	4.6	13.1	6.4	4.9	6.5	5.4	4.8	5.1	5.2	3.9	5.9	8.6	4.9	4.6	5.3	7.5	4.1	10.6	2.3	4.5	4.8	5.4	2.3	1.9	6.7	2.1	2.0	2.7	0.6	1.5	1.3	3.4	1.9	5.6	5.7	5.1	3.1	3.3	2.5	2.3	1.7	1.3	1.3	3.1	3.5	1.6	3.4	4.4	3.3	2.4	5.3	2.6	4.2	2.7	3.4	2.8	1.5	4.8	5.5	2.8	3.3	2.6	1.6	3.6	3.1	0.8	3.4	1.9	3.3	1.6	2.7	2.9	2.7	1.3	1.7	7.2	3.8	2.8	0.3	3.0	0.9	2.3	3.7	3.9	2.4	2.4	2.0	4.0	4.7	1.3	4.5	1.7	2.9	3.0	2.1	0.9	2.5	0.8	1.0	2.3	2.3	2.2	1.9	1.7	2.7	2.3	6.7	2.0	1.7	1.9	1.3	0.6	10.0	11.2	11.8	16.8	7.3	7.8	6.2	11.4	13.1	7.5
PLEKHO2	"DKFZp761K2312, PLEKHQ1, PP1628, pp9099"	ENSG00000241839	"Pleckstrin homology domain containing O2"	Q8TD55	15	64841883-64868007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6"									HPA040055	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			450000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA040055: AB_10793954"	"unprognostic (4.32e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.85e-3)"	22.1	17.4	12.9	19.9	16.6	29.4	12.4	6.2	9.9	10.3	12.2	11.5	5.2	6.8	11.9	13.3	10.7	13.0	17.4	9.3	13.3	8.0	8.1	8.2	22.4	19.6	10.1	8.7	10.4	5.7	5.1	6.4	22.6	17.2	10.5	5.6	17.0	6.1	10.2	5.9	6.0	9.4	16.9	14.5	57.9	10.2	7.0	11.3	5.1	18.6	6.6	13.8	17.1	14.1	4.0	10.4	30.2	26.6	2.7	5.4	10.3	2.7	1.8	3.4	3.4	30.8	17.7	8.1	8.0	12.0	8.5	8.8	2.1	1.7	7.3	4.2	16.2	0.9	3.9	3.2	5.0	11.2	1.2	7.3	0.8	2.5	23.7	8.1	10.9	12.8	2.9	10.6	3.4	11.8	2.1	26.1	11.3	0.8	1.7	8.8	6.6	1.6	6.3	8.3	5.2	1.3	1.9	0.2	3.0	3.3	1.1	10.9	1.2	11.1	15.2	6.6	6.1	6.2	3.3	9.7	15.2	2.5	7.1	10.6	3.8	7.0	14.3	9.2	5.4	20.4	5.0	4.0	3.1	5.0	10.4	2.6	1.3	2.7	30.2	2.7	26.6	1.2	4.1	10.3	12.9	16.6	6.2	9.9	13.3	8.0	10.1	8.7	17.2	11.3
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 75.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Supported	"Vesicles,Lipid droplets,Plasma membrane,Cytosol"			11000	"Lipid droplets, Plasma membrane"	"Vesicles, Cytosol"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (8.31e-4)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	75.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.4	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460260	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 42.9;T-47d: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavourable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	11.4	3.7	19.6	4.0	40.2	4.4	23.4	1.3	39.4	20.6	5.7	3.7	5.0	5.1	19.2	7.1	17.7	9.5	18.2	28.1	18.8	5.1	6.9	17.6	17.7	3.8	4.2	20.6	11.8	12.6	3.8	3.3	25.9	8.7	8.7	8.7	12.6	22.1	6.2	8.7	20.9	6.1	15.4	2.7	54.7	4.7	19.8	7.4	1.0	8.9	16.6	7.5	14.2	15.5	1.2	2.9	3.0	1.6	10.4	1.2	0.6	22.9	20.7	7.2	0.5	3.8	6.2	2.8	4.9	8.2	16.3	9.5	1.5	20.3	0.0	32.3	17.6	28.8	0.3	11.3	14.9	0.0	0.6	0.0	9.3	1.7	20.7	0.1	0.6	3.6	15.7	6.3	17.6	32.8	0.0	0.8	32.2	8.3	0.0	0.0	1.3	3.4	1.1	20.0	0.0	42.9	4.6	0.4	0.9	15.1	3.0	13.2	72.3	0.3	41.8	4.5	12.2	2.0	39.1	0.0	0.0	0.0	3.5	0.0	20.0	3.0	0.7	2.3	0.1	1.6	0.0	1.2	0.7	0.0	2.9	0.9	1.2	0.6	1.9	10.4	0.6	2.0	0.5	0.6	19.6	40.2	1.3	39.4	18.8	5.1	4.2	20.6	8.7	7.4
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA017327: , HPA035026: AB_10602080, HPA043198: "	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.6	5.5	20.7	10.6	0.7	2.0	9.4	11.4	8.1	15.2	15.8	7.7	12.0	15.7	4.2	6.3	7.7	14.6	9.1	23.5	12.2	6.0	14.2	8.8	7.2	0.2	20.0	16.9	0.6	0.9	13.9	6.4	11.7	16.5	21.0	12.8	8.1	30.8	9.0	9.6	6.3	16.1	14.5	5.4	5.0	7.4	11.5	9.4	7.2	6.6	3.5	5.3	8.7	5.0	12.0	11.6	8.1	14.2	10.9	11.9	22.4	6.1	15.3	13.2	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 85.3;U-87 MG: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavourable (7.64e-10)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (4.99e-11)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	17.0	12.2	3.8	1.2	13.9	15.0	9.7	60.4	18.5	32.9	62.1	0.9	1.7	0.0	11.8	10.2	3.6	4.4	51.9	85.3	0.0	7.0	4.2	11.9	8.4	35.8	0.0	0.0	26.2	7.5	28.5	13.9	45.4	5.6	0.2	58.1	6.2	0.0	0.0	2.4	5.2	0.0	2.5	0.0	13.8	0.8	1.9	0.0	48.1	5.2	5.1	14.1	0.5	57.0	40.8	12.4	12.9	36.0	18.5	2.6	0.0	76.0	0.0	7.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9
PLPBP	PROSC	ENSG00000147471	"Pyridoxal phosphate binding protein"	O94903	8	37762593-37779767	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017033, HPA023646, HPA023733"	Approved		Enhanced	Cytosol			20000	Cytosol		"CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742"	"unprognostic (1.55e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.85e-2)"	23.3	18.2	22.0	14.6	23.3	8.4	20.6	19.7	23.2	15.7	29.1	16.1	18.3	21.3	17.2	16.2	14.0	18.9	16.4	30.1	19.7	21.4	37.0	48.2	16.5	14.7	20.7	20.3	17.8	38.4	26.2	17.9	13.2	15.3	19.5	25.5	15.2	18.6	19.2	32.6	11.0	24.7	19.4	18.5	15.1	20.0	7.2	15.4	16.6	30.6	15.7	18.3	20.1	28.8	27.4	40.0	46.1	46.5	24.1	39.2	34.2	17.9	17.6	14.6	13.2	11.0	13.5	11.4	20.5	18.6	14.2	16.2	20.9	9.3	21.6	24.6	16.3	16.4	27.1	21.5	23.9	17.9	11.4	29.9	7.0	19.9	21.6	13.6	20.3	9.8	20.1	13.8	22.4	21.5	15.7	17.2	11.9	13.2	43.8	12.6	17.3	14.4	28.8	17.9	12.7	23.3	23.5	8.7	9.4	16.9	8.2	21.4	17.9	17.8	19.0	7.9	24.1	26.5	13.3	16.9	33.3	16.1	11.1	19.9	14.0	46.1	38.4	45.6	31.8	43.8	33.3	27.4	32.6	30.5	40.0	22.9	29.2	27.8	16.2	24.1	46.5	23.7	39.2	34.2	22.0	23.3	19.7	23.2	19.7	21.4	20.7	20.3	15.3	15.4
PLPP6	"FLJ46512, FLJ90191, PDP1, PPAPDC2"	ENSG00000205808	"Phospholipid phosphatase 6"	Q8IY26	9	4662315-4665258	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018096	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA018096: AB_1855609"	"unprognostic (2.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (3.99e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.88e-2)"	4.0	8.3	4.4	7.2	6.8	1.1	7.3	11.9	9.7	5.7	9.4	6.2	4.2	10.2	4.9	13.2	9.2	4.1	9.7	3.0	4.9	4.8	6.3	20.0	4.7	8.3	8.6	6.3	4.2	19.2	8.7	5.5	13.1	9.4	16.9	10.0	4.7	10.4	8.5	2.2	8.6	15.4	3.3	4.9	7.1	10.7	8.4	3.4	16.2	7.2	6.9	9.6	7.4	5.5	4.3	5.1	8.5	5.1	4.7	13.0	5.1	3.8	4.0	4.3	5.3	3.5	3.9	4.3	2.6	3.4	2.1	2.5	1.0	2.6	3.7	1.1	2.6	4.8	3.0	3.7	2.3	46.6	2.8	7.4	3.8	5.3	3.1	2.7	5.6	4.3	3.0	1.6	3.7	3.2	1.2	3.9	2.7	4.1	2.5	7.0	4.0	1.4	2.5	0.0	2.8	3.7	4.4	10.9	5.5	3.1	2.8	1.6	4.0	6.0	3.7	1.9	1.6	2.6	1.7	0.8	2.9	0.9	3.0	1.9	1.7	8.5	5.1	4.1	4.2	4.4	4.6	3.5	7.4	6.3	5.1	4.3	13.0	9.2	2.1	4.7	4.9	3.9	10.0	5.1	4.4	6.8	11.9	9.7	4.9	4.8	8.6	6.3	9.4	3.4
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821977	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6"	"Group enriched"	"Detected in some"	6	"NB-4: 23.5;THP-1: 49.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: , HPA057034: "	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.7	0.7	20.5	1.2	30.0	18.2	2.1	0.1	21.3	0.9	0.7	0.7	0.0	0.7	1.3	0.7	0.7	12.6	1.1	0.7	14.4	13.1	0.7	0.7	2.6	0.9	3.9	14.9	1.0	0.7	0.7	0.1	0.8	4.7	0.9	0.7	0.1	0.7	0.8	0.9	0.8	1.0	0.7	1.1	0.9	0.9	3.0	3.1	0.0	0.7	0.0	0.7	0.8	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	4.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.1	0.9	0.0	0.0	0.0	2.0	0.0	0.6	0.0	0.2	1.6	0.1	0.6	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.4	0.0	23.5	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.2	0.1	0.0	0.0	2.1	49.8	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	3.8	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	30.0	0.1	21.3	14.4	13.1	3.9	14.9	4.7	3.1
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 18.6;testis: 5.5"	"Group enriched"	"Detected in some"	7	"PC-3: 12.0;SH-SY5Y: 21.5"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: "	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavourable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.5	1.8	7.8	0.7	8.7	0.5	0.5	0.8	18.6	1.4	0.6	2.1	0.0	0.7	0.7	0.5	0.6	0.5	0.6	0.5	8.0	6.6	0.7	0.5	0.7	0.5	2.5	4.5	0.6	1.6	0.5	0.3	0.5	3.6	0.6	0.8	1.8	0.5	1.0	0.9	0.6	0.7	0.6	1.0	0.5	0.7	5.5	1.8	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	12.0	0.0	0.0	0.0	0.5	0.1	0.4	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	8.7	0.8	11.6	8.0	6.6	2.5	4.5	3.6	1.8
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 13.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 13.1;NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"			110000000	"Plasma membrane, Cytosol"		"HPA020433: , HPA076083: "	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.72e-4)"	"prognostic unfavourable (7.04e-4)"	41.9	11.0	11.8	9.8	12.5	0.2	24.6	3.6	16.7	43.8	14.3	13.9	24.1	6.0	37.4	27.6	54.4	21.5	23.6	18.8	12.2	8.2	40.7	100.5	64.7	6.0	14.7	13.7	44.4	8.9	2.7	4.6	21.9	22.7	21.6	9.2	10.6	16.6	31.4	17.7	38.4	8.2	34.6	14.5	31.6	13.3	14.9	13.0	5.1	64.8	34.7	12.5	38.7	29.0	0.0	13.1	0.4	0.1	4.2	1.5	0.2	27.8	28.7	25.1	7.3	25.4	23.8	38.3	29.1	32.9	27.9	33.8	31.1	23.2	0.1	84.2	23.9	35.9	26.6	47.3	45.4	0.4	33.3	2.7	35.6	13.0	23.0	0.0	1.3	15.0	22.8	43.2	30.4	60.4	0.0	0.0	26.6	8.1	0.0	0.3	33.3	34.4	0.0	16.8	0.6	33.3	15.1	0.0	5.2	61.1	15.2	12.2	8.4	0.4	66.0	45.3	7.7	46.1	58.1	1.1	4.0	0.5	19.8	0.1	18.7	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.1	4.2	0.0	13.1	1.5	0.2	11.8	12.5	3.6	16.7	12.2	8.2	14.7	13.7	22.7	13.0
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351448-17377350	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.3"	"Cell line enriched"	"Detected in some"	28	"EFO-21: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"			53000	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	128.3	9.8	0.8	16.4	0.9	0.0	56.3	0.4	1.5	28.7	29.8	3.2	12.8	20.2	32.0	19.8	27.4	16.6	43.1	18.9	1.1	0.4	33.7	4.6	13.1	34.6	0.9	0.5	14.3	22.9	13.8	16.1	12.6	2.7	26.1	5.2	26.3	16.0	10.4	20.7	11.5	23.7	13.5	1.2	77.8	22.1	9.5	0.7	3.8	88.3	13.9	15.2	30.1	87.7	0.0	22.1	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	22.1	0.0	0.3	0.8	0.9	0.4	1.5	1.1	0.4	0.9	0.5	2.7	0.7
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol			2600000	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavourable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	4.6	2.1	4.4	3.8	2.5	0.0	3.1	5.2	9.3	3.6	2.5	2.5	2.5	1.6	3.8	5.2	3.7	3.3	2.7	10.2	6.2	5.3	2.5	5.3	6.3	3.1	2.9	5.0	5.0	4.9	18.7	2.5	4.9	3.9	3.7	0.7	2.5	7.9	4.1	5.6	8.8	2.5	2.9	2.5	5.6	2.3	5.2	2.5	2.5	3.2	2.5	2.5	3.5	12.6	0.6	0.0	0.0	0.9	0.0	1.1	0.5	17.7	8.4	9.3	7.4	12.3	13.8	14.9	10.6	9.1	6.1	6.1	27.9	8.3	2.0	16.0	11.4	27.5	4.8	20.8	2.5	2.8	7.5	0.2	4.9	7.2	8.1	2.1	1.5	13.8	14.6	11.3	8.8	3.0	10.2	3.7	6.5	10.3	4.1	3.9	9.0	7.5	5.5	23.9	5.5	5.3	35.8	8.3	9.1	7.7	7.3	10.1	11.7	13.5	11.2	9.8	12.6	17.8	11.1	2.2	1.5	3.9	14.1	4.0	10.3	0.0	0.0	0.0	0.7	0.1	1.1	0.5	0.6	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.9	0.0	0.8	0.5	4.4	2.5	5.2	9.3	6.2	5.3	2.9	5.0	3.9	2.5
PMM1	Sec53	ENSG00000100417	"Phosphomannomutase 1"	Q92871	22	41576894-41589890	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030712, HPA074950"	Uncertain		Supported	Cytosol				Cytosol		"HPA030712: AB_10669600, HPA074950: "	"unprognostic (2.66e-1)"	"prognostic favourable (5.92e-4)"	"unprognostic (3.25e-2)"	"prognostic favourable (6.09e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.78e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (6.56e-3)"	"unprognostic (5.76e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.70e-1)"	20.8	25.1	24.3	15.2	28.8	15.3	15.0	15.5	27.9	24.7	29.5	12.6	14.1	25.3	12.1	20.1	36.5	24.8	14.7	17.7	19.6	20.6	32.8	32.2	21.7	10.8	20.3	25.5	34.8	30.5	7.7	8.7	9.7	17.8	13.7	13.9	11.8	13.0	17.3	6.6	13.6	22.0	14.3	15.2	6.0	24.5	27.6	13.2	8.8	8.9	12.7	14.7	15.2	13.2	10.6	13.2	24.5	12.7	6.8	27.1	10.3	5.2	9.8	6.7	14.4	19.4	30.2	7.8	21.0	24.0	19.4	21.4	7.8	5.1	4.9	7.0	25.0	7.9	8.8	13.6	10.9	10.3	13.4	1.2	12.3	16.4	30.7	7.4	8.1	25.1	13.2	20.1	8.4	3.1	5.4	17.8	26.3	13.9	5.6	10.7	2.1	13.2	4.3	7.2	10.2	8.2	5.7	1.9	3.8	17.1	6.1	25.1	7.0	8.2	2.4	22.0	12.1	20.4	10.7	11.2	10.7	7.9	24.5	6.2	13.2	9.6	12.7	24.5	16.3	10.2	13.8	10.4	16.8	13.8	13.2	10.6	18.3	12.9	16.6	6.8	12.0	5.0	27.1	10.3	24.3	28.8	15.5	27.9	19.6	20.6	20.3	25.5	17.8	13.2
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849331	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 52.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 52.2"	"Low region specificity"	"Detected in all"							"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	14.8	13.1	6.8	15.4	9.0	4.3	13.6	8.2	8.2	11.4	19.4	7.0	11.6	18.9	9.7	13.1	22.7	10.0	13.9	10.7	4.7	2.9	14.6	43.3	11.8	11.2	6.6	4.3	7.8	40.4	7.8	28.3	19.9	6.6	12.0	20.4	8.8	21.2	13.5	12.5	13.2	19.6	9.5	5.7	12.0	15.2	9.7	7.8	7.6	10.0	12.0	22.0	10.5	12.2	2.9	3.5	52.2	4.9	1.6	3.6	3.0	10.9	24.5	5.4	14.2	9.7	15.3	12.1	17.1	20.7	17.2	18.6	18.3	13.6	17.5	7.2	29.8	15.2	11.1	20.9	17.6	13.0	13.0	5.8	14.8	31.2	18.4	15.3	13.9	22.8	14.9	18.3	16.9	17.5	7.8	17.1	11.4	28.7	15.6	14.1	23.0	15.9	19.9	12.1	34.8	19.1	19.4	10.3	19.5	14.1	31.1	10.2	20.2	13.4	20.3	12.4	14.0	33.4	16.7	21.2	17.7	22.0	10.3	19.3	16.4	52.2	4.9	0.9	2.5	3.7	3.6	2.9	2.2	3.2	3.5	2.4	2.5	2.4	7.8	1.6	2.3	3.2	1.6	3.0	6.8	9.0	8.2	8.2	4.7	2.9	6.6	4.3	6.6	7.8
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4;seminal vesicle: 38.5"	"Cell line enriched"	"Detected in some"	8	"AN3-CA: 26.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17.0	1.0	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0.0	0.5	0.0	0.7	10.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	26.5	0.0	0.0	2.8	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.1	0.0	0.1	2.1	0.2	0.3	0.0	0.2	1.1	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.4	3.7	23.2	19.5	17.0	6.1	15.5	3.8	1.7
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99398051-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favourable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favourable (1.09e-4)"	24.7	28.5	48.9	28.3	49.8	53.7	29.9	123.3	69.7	35.5	38.3	22.8	39.9	26.7	43.1	58.7	19.8	29.4	22.3	31.0	46.9	17.5	25.5	21.7	26.6	42.2	48.0	29.8	49.3	24.7	34.7	83.9	21.7	41.0	34.1	28.2	24.1	30.8	34.5	39.4	31.9	34.4	31.5	61.0	39.3	28.2	17.4	57.1	32.1	44.7	18.0	30.7	29.5	30.3	18.0	13.1	20.4	7.4	15.6	12.3	2.2	11.3	7.7	41.3	28.3	14.7	21.9	19.1	18.0	9.9	10.8	13.4	13.8	20.7	34.9	12.1	10.1	17.4	20.7	15.7	21.9	28.6	23.1	20.2	38.3	13.8	11.2	28.0	28.7	21.5	22.4	12.0	15.7	15.7	23.5	22.9	14.2	11.4	13.3	32.2	23.1	7.1	26.9	11.6	12.4	21.2	19.7	16.7	22.1	9.0	11.7	15.4	15.6	24.7	17.3	10.9	12.8	10.6	15.4	15.9	11.0	32.0	16.4	28.9	12.6	6.9	7.4	6.6	8.6	4.2	8.5	12.0	8.4	6.8	3.3	18.0	12.3	11.8	20.4	15.6	4.8	13.1	7.7	2.2	48.9	49.8	123.3	69.7	46.9	17.5	48.0	29.8	41.0	57.1
PNMA8A	"FLJ10781, KIAA1183L, PNMAL1"	ENSG00000182013	"PNMA family member 8A"	Q86V59	19	46466491-46471563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.0"	"Cell line enhanced"	"Detected in many"		"HAP1: 17.7;K-562: 18.7;LHCN-M2: 19.4;SH-SY5Y: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012956	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA012956: AB_1844328"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.76e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.48e-3)"	1.2	17.4	18.6	1.2	26.4	1.1	3.9	24.8	61.0	2.9	1.6	5.1	1.2	1.2	9.7	12.7	1.5	16.7	4.3	10.7	16.6	29.9	7.2	0.9	1.8	0.8	14.1	25.7	13.5	5.0	3.8	14.5	2.4	19.5	7.1	1.1	5.4	4.4	8.1	1.2	1.5	1.3	5.9	8.9	0.9	1.4	16.1	4.4	4.3	11.7	0.0	1.0	1.9	0.7	1.1	1.1	3.0	0.5	0.8	2.6	0.3	0.0	7.4	10.7	10.6	3.1	7.1	1.9	0.7	0.1	1.3	0.6	0.1	0.8	0.0	10.0	0.5	0.1	17.7	2.8	0.9	0.0	6.6	0.0	0.2	0.2	5.2	0.1	0.1	1.8	3.5	4.5	0.0	1.0	18.7	0.1	19.4	0.0	0.1	0.1	9.0	0.0	0.0	11.7	0.0	4.5	0.0	8.7	17.1	0.0	0.2	0.0	0.1	0.2	0.6	0.0	0.1	0.1	3.6	0.0	0.0	0.1	0.1	0.0	1.1	3.0	0.5	0.3	0.3	0.3	0.2	1.1	0.3	0.9	0.1	0.7	0.4	2.6	1.3	0.8	0.1	1.1	0.2	0.3	18.6	26.4	24.8	37.2	16.6	29.9	14.1	25.7	19.5	4.4
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477094	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 153.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 81.4;U-937: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol			100000000	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	24.7	7.6	9.5	15.0	14.0	69.4	15.7	13.9	11.8	9.5	19.1	6.2	25.2	29.4	5.9	153.1	34.0	7.8	15.7	12.1	11.5	8.4	49.7	24.2	18.3	13.2	13.5	3.4	3.6	11.0	8.7	8.4	45.3	17.7	6.0	16.1	3.8	9.2	7.9	3.3	10.6	32.0	9.8	16.3	18.0	17.0	4.5	12.5	7.0	7.1	21.7	19.1	7.5	14.7	13.1	20.7	4.1	12.4	15.7	33.7	12.1	13.2	17.9	3.8	8.6	4.3	3.5	11.7	13.6	6.4	11.1	11.0	10.3	12.2	35.4	15.8	7.2	14.3	20.1	25.6	14.8	11.4	17.7	29.6	15.3	17.0	4.0	81.4	15.4	2.3	9.3	33.5	14.8	47.3	14.5	22.1	13.9	12.3	23.9	48.0	10.8	29.9	20.2	5.7	13.7	39.4	12.6	16.6	3.7	26.0	33.2	2.1	12.2	14.5	37.9	7.6	10.1	17.1	23.0	10.2	17.0	40.1	6.5	92.8	0.7	4.0	12.4	4.1	18.1	11.5	33.7	11.2	20.3	20.0	20.7	13.1	12.9	16.3	1.6	15.7	10.6	11.7	6.9	12.1	9.5	14.0	13.9	11.8	11.5	8.4	13.5	3.4	17.7	12.5
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Cell line enhanced"	"Detected in many"		"AF22: 13.3;LHCN-M2: 15.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol				Nucleoli	"Mitochondria, Cytosol"	"HPA058058: "	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.2	13.3	5.4	3.8	4.2	0.4	2.4	1.4	3.3	7.1	3.8	7.0	0.0	2.0	4.0	3.3	8.3	3.9	2.7	0.0	0.7	0.2	3.1	7.1	6.1	0.0	0.2	4.8	3.0	10.4	0.5	0.4	0.0	0.0	15.0	0.6	0.2	0.0	9.1	0.0	0.0	7.2	0.1	1.4	0.2	1.2	0.1	2.7	1.0	3.7	4.2	4.5	0.4	1.3	4.0	0.1	0.1	0.0	0.0	0.0	11.4	0.0	4.7	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3
PNPLA7	"C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2"	ENSG00000130653	"Patatin like phospholipase domain containing 7"	Q6ZV29	9	137459953-137550534	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	23	"HMC-1: 42.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6;T-reg: 3.5"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009130	Uncertain		Uncertain	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA009130: AB_2268411"	"unprognostic (1.49e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.72e-3)"	"unprognostic (5.14e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (2.24e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.45e-3)"	9.3	5.6	10.6	2.8	11.0	2.8	6.3	17.0	11.4	6.4	4.5	6.7	3.8	3.1	7.6	2.1	2.2	5.8	4.7	4.8	8.4	2.6	2.3	7.4	4.1	5.4	9.7	9.7	9.7	17.7	3.3	7.1	1.1	6.6	14.7	2.1	5.4	18.7	4.8	19.1	15.4	4.8	7.2	6.7	5.4	9.6	1.8	11.6	0.4	7.6	4.2	2.8	7.8	3.7	3.6	0.7	0.0	0.4	0.0	3.5	0.5	0.0	0.5	0.1	0.2	0.4	0.3	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.8	0.4	0.4	0.4	0.1	0.2	0.2	42.8	0.6	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.8	0.1	0.7	0.0	0.4	1.0	0.7	1.3	0.0	0.1	0.8	0.2	0.0	0.3	0.1	1.9	0.6	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.6	0.4	0.0	0.0	0.4	0.0	0.8	0.3	0.0	0.8	0.5	0.4	0.7	3.6	1.2	0.9	0.0	0.0	0.1	0.4	3.5	0.5	10.6	11.0	17.0	11.4	8.4	2.6	9.7	9.7	6.6	11.6
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470422-108569666	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favourable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	21.5	35.7	29.3	12.4	28.9	51.5	15.0	15.6	27.2	15.4	13.4	9.5	9.3	8.6	13.4	13.7	18.3	9.7	15.9	17.9	23.0	22.1	23.1	24.6	16.7	12.0	20.7	17.5	15.6	10.1	20.7	33.4	25.2	23.2	14.4	11.4	6.0	11.4	13.9	29.8	11.4	10.8	15.3	20.3	19.5	11.1	10.8	21.1	16.1	22.6	13.0	15.3	22.5	12.8	20.0	19.3	16.7	26.8	14.6	12.5	13.7	14.0	6.3	11.2	10.0	25.0	17.2	16.6	13.4	23.7	11.0	18.4	6.1	8.1	7.8	16.9	13.1	5.3	19.0	8.5	16.8	11.7	5.2	5.3	10.4	4.5	18.3	3.7	11.1	15.6	16.2	14.8	13.7	14.8	6.3	22.5	13.7	9.2	8.6	8.8	4.9	9.0	3.2	11.8	16.6	13.2	17.8	9.3	13.1	12.8	13.9	16.0	5.8	6.3	12.0	18.2	8.1	27.0	7.3	19.1	19.3	11.6	17.3	5.7	11.7	14.1	19.7	16.7	10.5	21.8	12.5	20.0	10.3	10.3	19.3	18.7	11.2	10.7	16.5	14.6	26.8	7.6	12.5	13.7	29.3	28.9	15.6	27.2	23.0	22.1	20.7	17.5	23.2	21.1
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Enhanced	Nucleoplasm,Cytosol			150000	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	6.0	13.1	9.9	5.1	13.0	2.9	8.6	8.3	16.5	6.2	7.0	8.6	6.9	8.5	4.2	9.6	8.1	8.4	10.1	10.2	8.7	12.0	26.0	64.7	5.3	7.7	11.2	9.9	8.0	13.7	17.3	7.4	5.8	11.1	6.9	7.4	8.4	8.3	7.1	14.7	5.5	9.6	5.2	7.1	6.8	6.7	6.4	6.0	5.2	14.4	8.2	6.1	5.4	5.2	6.8	12.2	2.4	16.4	7.7	8.2	8.7	17.5	14.5	1.1	2.7	7.4	5.7	0.0	5.9	3.9	6.7	5.8	23.8	13.0	16.7	28.5	5.9	10.6	9.1	16.2	9.7	20.3	7.8	11.8	6.8	24.7	8.0	10.4	8.1	7.6	12.7	12.4	15.4	8.7	11.1	5.8	7.8	13.1	10.5	3.4	2.1	18.0	8.9	5.1	12.2	18.5	9.1	5.9	4.9	5.4	8.8	5.0	15.6	3.8	9.1	10.8	6.3	10.7	12.4	13.8	15.2	8.8	8.8	9.1	5.5	2.1	11.0	2.4	6.8	16.4	8.0	6.8	6.2	7.4	12.2	5.7	8.2	7.9	1.1	7.7	10.4	8.9	6.4	8.7	9.9	13.0	8.3	16.5	8.7	12.0	11.2	9.9	11.1	6.0
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468938-119494708	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"			"Endoplasmic reticulum"	Cytosol	"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favourable (2.23e-4)"	11.9	12.1	7.6	10.7	12.0	3.9	10.9	13.9	10.6	10.1	9.5	9.8	27.4	5.9	13.7	11.7	9.3	10.1	6.9	8.3	7.3	8.9	8.3	10.3	9.1	14.3	15.0	5.6	10.5	29.2	12.1	14.5	11.5	10.9	9.4	10.9	8.7	7.8	25.7	5.1	14.0	12.1	15.2	14.0	14.9	8.2	4.7	8.9	11.7	8.6	4.1	15.6	10.6	10.2	9.9	14.3	9.4	11.5	19.8	16.0	10.3	7.4	5.0	8.7	9.6	22.0	12.6	6.2	11.9	12.2	9.7	13.3	8.1	4.9	11.5	16.2	15.0	8.8	11.6	11.8	15.4	9.9	7.5	13.5	7.9	8.8	14.3	14.8	15.9	12.9	7.7	9.6	13.5	11.0	7.3	14.1	9.8	7.5	8.4	14.3	8.9	9.2	8.4	8.8	16.9	8.4	9.6	9.5	14.6	5.7	3.6	9.2	9.5	12.4	13.9	9.5	5.9	2.8	6.1	19.4	16.8	15.7	8.3	15.0	13.4	1.9	11.5	9.4	12.0	10.8	13.8	9.9	13.6	12.5	14.3	7.0	16.0	15.2	0.9	19.8	7.0	8.0	14.7	10.3	7.6	12.0	13.9	10.6	7.3	8.9	15.0	5.6	10.9	8.9
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693919-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	10.5	5.5	8.0	15.0	10.2	14.3	10.9	12.0	9.6	10.1	9.7	11.8	5.8	5.7	11.2	7.7	10.2	8.9	5.5	9.3	7.8	6.6	6.1	4.9	7.2	12.7	10.3	4.5	12.9	7.3	8.5	8.5	10.7	8.7	7.3	11.0	7.5	7.9	9.3	22.4	9.3	7.5	9.7	13.1	9.0	7.9	5.7	10.0	30.1	7.0	8.5	14.7	9.9	10.6	4.6	2.5	1.2	4.6	2.7	3.8	1.7	14.0	10.5	13.9	11.2	2.6	3.1	3.1	10.5	5.8	11.3	13.0	8.7	7.4	18.0	3.6	4.5	11.6	26.4	8.5	15.3	9.3	11.2	13.4	20.5	6.5	1.1	17.5	7.2	2.0	1.8	14.1	4.1	5.8	12.3	9.2	7.8	9.8	19.0	5.9	13.5	8.8	17.1	36.5	13.6	4.1	9.3	12.6	7.8	12.4	5.9	5.6	11.6	5.8	4.6	10.0	6.9	19.1	10.0	5.5	7.9	14.5	5.8	8.3	11.1	0.0	2.0	1.2	3.0	4.6	2.9	4.6	3.4	3.8	2.5	3.2	2.4	2.4	0.6	2.7	1.3	1.6	3.6	1.7	8.0	10.2	12.0	9.6	7.8	6.6	10.3	4.5	8.7	10.0
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958492-74970128	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054979: , HPA071815: "	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	19.2	14.5	23.6	15.2	17.3	27.1	21.4	4.4	15.5	18.4	13.4	8.6	7.0	9.0	10.4	9.0	10.0	9.7	13.1	18.1	15.9	10.6	11.6	18.8	10.7	17.0	13.9	12.6	12.8	12.5	2.8	3.9	9.6	12.2	12.0	8.8	13.9	16.2	11.2	28.1	8.1	12.4	14.1	11.7	12.2	12.5	11.0	10.0	5.5	13.1	15.1	10.4	13.9	31.9	14.7	14.7	8.0	22.2	4.4	9.9	12.3	11.7	11.2	1.0	1.0	3.8	8.6	0.0	8.0	9.9	12.8	10.9	14.9	5.2	11.5	6.7	9.0	5.3	5.3	6.6	15.0	5.2	14.4	8.9	6.5	14.7	13.9	12.6	14.1	8.7	13.0	5.3	11.8	5.5	10.9	6.8	9.7	11.4	3.7	35.6	7.8	21.1	4.5	9.6	9.3	10.6	0.3	3.5	5.3	11.0	4.6	6.3	3.4	4.1	6.2	2.9	3.3	2.0	7.6	2.4	1.6	4.2	10.5	18.9	14.1	2.3	22.2	8.0	6.3	13.2	7.0	14.7	8.9	7.8	12.9	13.7	9.9	6.9	1.6	4.4	12.4	14.7	8.5	12.3	23.6	17.3	4.4	15.5	15.9	10.6	13.9	12.6	12.2	10.0
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576150-43615660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	7.4	9.4	7.5	9.7	10.4	4.6	7.2	10.5	10.5	8.5	8.4	12.7	8.0	5.7	9.6	7.1	11.4	7.8	6.2	6.7	5.3	4.4	7.2	7.5	9.8	16.3	8.9	8.1	7.4	13.0	7.1	9.7	5.1	7.9	6.9	10.1	8.9	8.6	5.6	9.5	11.7	7.9	11.8	6.9	9.2	7.6	24.7	6.8	22.1	9.9	6.2	18.3	8.6	8.4	8.6	4.3	4.5	2.6	6.8	7.2	3.2	20.2	4.7	6.3	9.2	9.0	14.9	15.0	21.7	6.8	12.7	14.7	5.3	3.6	22.5	5.5	8.8	5.1	6.4	13.7	15.8	11.3	4.9	6.6	13.1	15.4	6.7	11.2	8.9	10.0	16.7	10.4	5.6	12.0	10.4	13.5	16.0	6.7	10.2	2.9	1.9	3.5	11.2	6.5	5.6	4.8	15.2	7.1	2.4	6.9	5.8	3.4	8.2	5.0	16.2	11.8	11.4	5.5	10.9	12.7	8.8	40.6	5.6	6.6	12.8	4.5	2.6	4.1	7.2	2.5	6.4	7.8	6.0	5.2	2.1	8.6	5.0	5.2	2.0	6.8	1.9	4.3	7.0	3.2	7.5	10.4	10.5	10.5	5.3	4.4	8.9	8.1	7.9	6.8
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.5;lymphoid tissue: 21.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.2"	"HPA048931, HPA053359"			Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA048931: , HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favourable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.5	0.8	0.2	8.2	0.7	9.5	0.6	0.6	0.4	0.9	3.5	0.2	0.8	2.0	0.9	0.6	6.0	0.3	0.4	0.8	0.3	0.2	0.4	0.6	0.9	4.7	0.3	0.0	0.4	0.4	0.0	0.2	2.8	0.3	0.4	3.7	0.1	1.1	0.8	1.2	2.4	3.9	0.5	0.4	2.6	1.1	5.8	0.6	21.4	0.3	5.6	7.5	0.6	1.7	0.5	1.1	1.6	0.4	0.0	0.4	0.0	13.3	9.1	7.8	5.5	0.7	0.9	7.1	6.3	2.4	7.5	10.1	7.2	5.0	15.9	2.9	3.4	10.6	9.2	4.1	12.8	4.6	5.0	10.2	5.6	4.5	0.0	11.0	9.3	0.1	0.3	6.8	4.2	3.7	6.7	12.1	7.8	5.2	9.9	6.4	7.4	4.4	8.4	9.4	5.6	2.4	7.7	4.3	3.8	7.3	4.0	2.6	3.7	10.9	2.8	6.6	8.7	2.6	8.2	6.1	4.9	16.5	3.2	8.2	4.9	1.6	0.2	0.0	0.3	0.2	0.0	0.3	0.4	0.3	0.4	0.5	0.0	0.2	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.7	0.6	0.4	0.3	0.2	0.3	0.0	0.3	0.6
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.4	9.9	6.3	13.0	6.8	6.6	11.8	7.1	5.4	12.0	10.5	22.2	5.6	22.7	10.6	4.7	13.3	26.4	14.5	13.9	10.2	13.3	13.1	9.9	16.7	7.2	20.9	9.1	6.2	10.5	12.5	19.3	9.3	23.7	8.2	6.3	8.3	9.4	13.6	30.6	19.7	14.2	10.4	24.1	8.3	9.0	15.9	14.8	6.5	16.5	9.0	7.6	7.4	8.4	7.4	10.9	6.8	10.4	11.1	18.3	19.6	5.6	13.4	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462387-57472010	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favourable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	26.2	30.1	24.2	18.4	26.9	23.9	25.8	34.1	37.6	27.2	22.9	28.8	23.1	21.5	26.0	45.0	26.2	30.3	29.9	32.6	24.5	25.9	38.3	44.8	29.9	30.2	25.0	30.1	37.2	39.4	33.7	35.0	29.2	25.5	29.2	26.0	29.6	30.4	31.4	47.5	23.7	27.9	26.1	24.1	22.4	25.2	26.4	21.9	30.5	35.8	27.3	27.1	27.5	22.2	21.8	16.2	41.7	19.8	26.2	28.6	21.9	17.4	28.8	24.1	21.9	21.9	19.7	21.4	23.0	25.1	37.0	24.5	36.8	22.1	19.7	27.1	25.3	18.3	31.9	24.2	41.2	9.1	23.7	15.1	17.2	42.0	24.9	27.4	29.1	17.6	20.0	28.2	26.1	22.2	26.2	11.1	24.1	24.1	30.3	29.0	36.1	43.9	44.3	28.6	34.9	29.9	17.3	30.7	35.8	37.3	20.8	24.1	15.9	25.3	17.1	23.4	23.8	17.7	26.2	25.8	22.0	40.1	23.5	23.7	30.8	24.8	17.3	29.0	20.7	16.4	22.6	21.8	23.6	19.1	16.2	20.9	28.6	26.8	41.7	26.2	19.8	13.2	22.5	21.9	24.2	26.9	34.1	37.6	24.5	25.9	25.0	30.1	25.5	21.9
POLR3G	"RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514553	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.2"	"Cell line enhanced"	"Detected in all"		"WM-115: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010109, HPA052658"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB010109: AB_2165718, HPA052658: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	2.7	1.6	7.1	3.6	10.2	4.4	3.8	7.2	7.2	3.7	2.6	6.7	1.4	2.8	2.7	8.4	7.3	2.7	2.4	2.7	7.7	7.7	1.7	4.0	2.9	8.1	10.3	6.1	4.1	4.1	11.1	3.9	3.1	20.2	2.9	3.1	2.6	4.2	1.5	4.4	7.4	2.3	4.2	16.0	3.3	2.1	8.0	8.1	1.0	5.9	8.5	3.2	4.4	4.7	3.9	2.1	6.8	2.8	5.4	3.2	0.8	10.5	6.1	7.2	1.9	2.2	4.1	3.3	5.3	1.7	8.4	6.9	3.5	7.9	29.0	1.8	2.2	4.4	9.0	8.5	30.3	13.3	8.1	10.6	2.9	5.4	3.8	7.4	2.7	2.7	3.9	14.1	10.7	10.4	15.1	2.6	3.0	5.2	7.7	4.7	34.4	27.3	6.9	3.2	16.3	2.5	1.0	9.2	2.5	2.1	4.0	14.6	2.2	2.1	12.4	4.6	8.9	6.5	19.9	6.6	17.2	21.3	10.2	9.9	36.7	6.8	0.6	0.3	3.2	0.8	1.6	3.9	1.1	2.0	0.9	2.4	2.4	2.6	1.6	5.4	2.8	2.1	0.5	0.8	7.1	10.2	7.2	7.2	7.7	7.7	10.3	6.1	20.2	8.1
POLR3K	RPC11	ENSG00000161980	"RNA polymerase III subunit K"	Q9Y2Y1	16	46407-53628	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA005891	Approved		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005891: AB_1079653"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.03e-3)"	"unprognostic (9.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.63e-2)"	7.3	12.4	15.4	16.6	17.6	11.3	8.3	14.3	18.8	8.0	9.1	9.0	11.9	9.8	8.3	9.3	9.8	9.3	7.4	12.0	13.7	15.4	9.1	10.3	7.6	19.6	11.9	15.5	9.1	11.0	12.1	7.5	8.0	9.0	10.0	9.2	5.9	11.1	12.7	21.8	5.7	9.3	8.2	9.8	14.0	9.1	5.7	7.9	13.7	11.5	12.4	18.6	9.9	8.6	39.6	25.3	32.2	18.9	13.5	30.0	18.2	10.7	18.5	11.8	12.2	4.9	2.9	9.4	15.3	4.9	13.7	9.0	23.8	11.6	27.9	11.7	5.4	10.7	27.4	7.1	9.8	16.7	25.2	20.5	13.9	16.9	3.7	18.4	20.2	2.9	6.2	15.1	7.7	6.7	29.1	8.9	8.8	26.7	22.1	12.2	19.3	17.7	26.9	13.6	29.1	7.7	7.7	17.3	10.2	10.5	19.7	9.0	11.6	16.7	6.3	8.8	10.8	11.8	18.5	5.7	13.7	54.9	3.8	13.5	13.1	9.0	13.6	32.2	15.8	18.9	16.2	39.6	20.3	18.2	12.4	35.1	18.4	17.2	9.8	13.5	17.3	25.3	30.0	18.2	15.4	17.6	14.3	18.8	13.7	15.4	11.9	15.5	9.0	7.9
POMK	"FLJ23356, SgK196"	ENSG00000185900	"Protein-O-mannose kinase"	Q9H5K3	8	43093506-43123434	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013321	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA013321: AB_2668809"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.10e-2)"	4.7	5.5	9.8	5.6	14.3	12.5	5.1	12.3	18.6	6.9	4.8	8.3	2.2	4.5	6.9	4.4	7.1	6.2	4.8	3.8	7.7	7.0	3.4	4.5	5.5	6.0	4.8	11.1	5.8	9.3	6.3	7.4	6.1	10.5	5.6	5.9	6.1	6.8	4.0	6.2	7.1	5.6	6.4	6.7	7.6	6.8	7.1	7.2	7.5	7.4	3.2	7.4	4.6	5.0	2.6	2.6	6.7	2.9	1.0	3.3	1.3	3.5	7.5	5.8	15.1	2.8	3.4	5.5	2.1	3.1	5.5	4.0	5.5	9.1	4.9	4.6	3.8	5.8	8.2	6.3	5.3	1.9	1.4	13.9	5.5	2.4	2.0	4.7	7.8	3.8	2.7	7.3	5.3	5.4	3.2	14.8	3.7	1.6	9.9	2.0	11.8	1.0	6.8	6.8	2.8	1.5	9.8	5.6	4.1	9.1	3.1	3.0	9.7	3.2	7.4	8.4	8.4	8.6	4.2	4.8	8.5	9.3	3.5	3.2	9.9	0.8	2.9	1.9	2.3	2.4	3.3	1.8	1.3	1.3	2.6	2.6	1.8	2.3	6.7	1.0	1.5	2.5	1.1	1.3	9.8	14.3	12.3	18.6	7.7	7.0	4.8	11.1	10.5	7.2
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105158280-105179995	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"heart muscle: 23.9;skeletal muscle: 68.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 13.2;RH-30: 14.7;SH-SY5Y: 12.2;U-87 MG: 13.3;WM-115: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012514			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.9	0.8	2.2	1.4	4.5	0.6	2.5	0.4	6.8	0.8	1.4	2.1	0.8	0.7	1.3	2.2	2.1	0.7	1.1	23.9	3.7	2.3	0.6	0.6	0.7	0.7	6.1	3.5	0.7	0.6	0.6	3.2	1.2	4.0	1.2	0.6	1.9	1.0	0.8	68.9	0.6	0.6	0.6	3.6	0.6	1.6	3.6	4.0	0.0	0.8	8.8	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.6	0.4	0.1	2.7	6.9	0.6	2.7	2.8	4.7	5.8	0.0	1.5	0.1	1.1	5.4	0.0	1.3	1.2	3.9	0.0	2.9	0.0	1.0	0.0	0.1	0.0	0.0	2.7	0.2	7.6	1.0	0.3	2.8	8.1	13.2	0.0	0.0	1.0	3.0	4.6	0.4	14.7	0.0	0.0	0.0	6.7	12.2	0.0	0.0	9.5	0.0	5.2	6.0	2.9	0.0	1.9	9.9	0.0	0.0	0.0	13.3	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.5	0.4	6.8	3.7	2.3	6.1	3.5	4.0	4.0
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	12.8	48.2	7.4	7.5	10.8	3.6	15.0	5.3	16.4	11.0	20.8	9.6	32.1	24.9	9.0	8.2	13.4	12.8	9.9	8.4	7.1	7.2	12.0	78.4	13.7	9.9	5.2	10.1	14.4	12.8	12.1	18.5	18.6	7.1	9.3	5.3	10.8	7.8	58.7	13.1	10.0	24.3	7.0	5.2	11.7	9.8	22.4	5.0	8.2	33.3	9.9	8.6	9.8	10.2	5.7	20.6	26.7	18.4	11.2	9.9	13.9	12.7	27.9	12.8	23.7	48.5	18.4	21.4	5.3	17.5	10.1	14.1	20.9	56.7	12.2	4.9	11.6	6.2	16.8	8.4	4.3	10.4	12.4	5.6	8.2	38.7	33.7	5.6	10.1	37.8	10.6	13.3	9.7	9.4	16.9	5.3	9.1	18.7	6.1	10.1	15.9	15.8	8.7	8.4	13.1	11.4	15.4	13.4	12.8	14.4	73.3	19.3	21.0	9.6	8.4	9.5	10.5	14.3	10.5	5.2	8.0	8.3	13.4	8.6	12.2	26.7	18.4	25.3	9.9	17.7	8.3	5.4	8.4	9.2	20.6	5.7	8.4	7.1	24.3	11.2	13.0	5.8	8.7	13.9	7.4	10.8	5.3	16.4	7.1	7.2	5.2	10.1	7.1	5.0
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;SK-BR-3: 5.2;T-47d: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.1	7.1	0.3	2.6	0.0	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.1	0.0	1.8	0.4	0.1	0.1	5.2	0.0	9.4	0.4	0.8	0.0	0.2	0.3	0.1	0.1	0.0	0.0	1.1	0.1	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"HAP1: 52.5;NTERA-2: 139.7"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: "	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favourable (2.04e-5)"	1.2	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	2.3	2.3	1.2	1.2	4.9	3.1	5.7	1.2	5.2	4.3	1.2	1.2	0.0	11.1	5.0	2.0	1.2	1.2	1.2	1.2	8.8	0.0	1.2	1.2	1.2	4.7	1.0	1.2	1.2	3.0	1.2	1.8	5.9	1.2	1.2	1.2	6.3	2.2	1.2	1.2	1.2	1.2	1.2	11.2	1.2	3.0	1.8	1.8	1.0	1.1	0.9	0.3	0.6	0.2	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.7	52.5	0.6	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	139.7	0.0	0.1	0.1	0.1	1.0	1.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.1	1.4	1.0	0.5	0.8	0.7	0.5	1.0	0.4	0.4	0.2	3.0	0.9	0.6	1.8	1.1	0.5	1.8	0.3	0.3	1.2	1.2	1.2	1.2	1.2	0.0	1.2	1.2	1.2	1.2
PPCDC	"FLJ14585, MDS018"	ENSG00000138621	"Phosphopantothenoylcysteine decarboxylase"	Q96CD2	15	75023555-75117462	"Enzymes, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 19.9;granulocytes: 40.4;monocytes: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045667	Approved		Approved	Cytosol				Cytosol		"HPA045667: AB_2679412"	"unprognostic (8.66e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-3)"	10.4	18.5	7.7	11.1	9.3	16.7	14.5	10.8	10.2	8.4	10.8	16.0	15.1	9.4	16.3	13.3	17.5	10.9	12.1	7.8	7.3	7.9	12.5	12.0	13.9	14.0	16.8	5.9	9.2	22.1	14.4	11.3	8.9	11.0	12.0	9.3	15.6	17.5	8.0	10.5	8.3	11.6	6.1	13.6	18.0	10.7	9.7	11.3	7.4	11.0	11.5	16.5	14.2	9.4	4.2	19.9	40.4	18.1	4.5	5.6	4.2	5.9	11.2	4.7	3.6	2.8	2.6	4.0	6.0	2.7	8.1	6.4	6.5	16.2	6.8	10.8	3.0	6.2	7.6	10.0	4.2	23.8	9.2	11.9	6.9	7.0	8.1	6.9	15.5	3.5	6.7	8.3	12.8	6.4	8.0	53.0	5.8	11.4	4.1	10.7	7.5	5.2	6.9	9.2	14.5	6.1	8.6	11.3	3.3	8.8	12.4	12.9	15.3	9.0	3.6	8.3	5.8	4.2	10.6	16.2	10.6	11.2	5.1	17.6	9.3	10.9	6.5	40.4	3.4	17.5	5.6	4.2	3.1	3.8	4.9	2.3	3.6	4.3	39.3	4.5	18.1	19.9	3.3	4.2	7.7	9.3	10.8	10.2	7.3	7.9	16.8	5.9	11.0	11.3
PPFIA1	"LIP.1, LIPRIN"	ENSG00000131626	"PTPRF interacting protein alpha 1"	Q13136	11	70270700-70385312	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 78.4;SK-MEL-30: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017032, HPA042271"	Uncertain		Supported	"Focal adhesion sites,Cytosol"				Cytosol	"Focal adhesion sites"	"CAB017032: , HPA042271: "	"unprognostic (1.89e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.58e-4)"	"unprognostic (7.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavourable (8.26e-4)"	"unprognostic (1.14e-1)"	"prognostic favourable (3.76e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.14e-2)"	28.9	18.6	20.9	17.5	20.8	20.8	40.5	22.8	24.1	15.9	18.3	27.7	18.5	15.5	26.2	20.4	19.4	16.9	23.9	19.3	19.7	12.0	18.1	15.5	25.4	15.9	18.9	17.8	21.0	17.7	21.2	34.1	24.9	20.7	13.8	16.3	21.9	19.0	18.5	38.7	24.2	17.8	18.4	30.0	14.7	15.6	29.8	22.5	17.0	25.2	10.0	13.6	18.7	18.6	2.6	2.8	10.0	4.8	1.1	2.2	1.0	78.4	10.6	9.7	6.6	9.1	5.7	10.3	9.2	7.5	11.5	7.6	20.0	7.0	7.3	12.0	7.4	11.4	8.2	7.9	9.9	4.9	5.7	5.9	11.1	6.4	9.3	7.7	7.2	7.2	12.7	14.7	12.1	7.4	9.9	6.0	9.9	10.7	5.3	4.6	5.8	9.1	6.1	24.5	6.4	5.6	10.8	9.5	6.4	13.7	17.3	45.1	11.6	8.2	10.1	11.5	9.0	15.9	9.7	7.3	4.6	10.3	9.5	5.4	13.4	0.0	3.6	1.7	1.3	1.9	2.2	2.6	2.2	1.9	2.8	2.3	1.7	1.0	10.0	1.1	4.8	2.8	2.1	1.0	20.9	20.8	22.8	21.4	19.7	12.0	18.9	17.8	20.7	22.5
PPFIBP1	"hSGT2, hSgt2p, L2, SGT2"	ENSG00000110841	"PPFIA binding protein 1"	Q86W92	12	27523431-27695564	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001924	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA001924: AB_1079665"	"unprognostic (5.27e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.11e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (2.56e-4)"	"unprognostic (1.92e-2)"	"prognostic favourable (5.11e-7)"	"unprognostic (8.54e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.09e-2)"	21.3	17.1	15.5	8.0	16.8	2.2	22.6	4.9	25.0	18.3	15.4	13.3	13.0	7.1	28.1	9.3	17.1	16.5	12.2	43.3	17.1	9.0	23.8	15.7	25.0	7.8	13.1	16.4	53.1	13.7	12.7	22.2	34.5	15.3	15.3	11.1	8.1	14.2	18.4	13.7	17.8	10.0	20.5	11.2	16.6	15.1	7.1	13.3	6.2	23.9	14.9	6.2	17.2	18.4	7.0	2.0	1.5	0.6	0.3	1.8	0.6	4.5	9.2	7.5	6.4	12.5	34.9	13.4	16.6	18.7	9.8	14.2	24.2	13.9	3.4	19.4	33.6	11.4	4.0	15.2	17.7	7.8	2.2	7.6	7.0	3.5	5.4	2.3	4.3	27.1	10.6	28.5	29.3	33.5	4.0	3.5	34.8	3.5	2.1	0.6	13.4	7.1	3.5	18.7	1.3	14.5	10.1	0.6	3.1	8.3	4.4	23.1	5.7	3.5	32.5	27.7	9.3	15.1	16.9	0.0	0.0	0.2	30.7	3.3	43.6	1.5	0.6	0.3	0.7	0.2	1.4	0.7	1.3	0.7	0.6	7.0	1.3	1.3	1.5	0.3	0.2	2.0	1.8	0.6	15.5	16.8	4.9	25.0	17.1	9.0	13.1	16.4	15.3	13.3
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.3	14.3	14.4	19.7	21.4	16.1	21.8	15.2	8.3	14.0	10.6	18.5	10.5	16.2	6.8	14.1	11.8	43.6	17.4	17.1	53.7	15.2	29.0	12.9	25.5	16.6	18.2	21.8	10.1	14.2	12.0	17.9	15.2	36.2	29.0	15.5	14.7	26.0	16.5	19.8	19.1	11.8	7.1	13.9	15.4	7.7	24.4	16.3	11.4	23.7	21.6	10.9	17.4	14.7	14.0	15.8	15.4	20.0	16.7	34.6	20.7	17.8	19.7	14.0	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584340-169641406	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: "	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.2	25.3	28.5	23.8	45.3	39.2	26.7	45.0	40.7	33.1	27.1	14.6	26.0	25.3	27.1	28.1	29.4	24.3	21.2	24.2	30.0	20.3	26.0	41.1	25.5	30.4	27.7	35.9	29.5	22.8	39.4	56.7	26.0	38.0	29.3	23.9	13.8	28.6	28.8	27.8	24.5	30.8	31.9	39.7	29.7	24.1	19.8	33.7	24.1	28.4	22.6	29.9	37.4	27.6	36.4	23.7	41.7	24.7	18.7	29.6	13.3	19.1	9.1	25.8	14.1	14.3	17.6	24.3	21.9	16.5	16.2	16.8	24.9	22.1	33.1	20.2	15.8	18.5	20.2	18.0	24.0	23.0	16.3	49.8	13.6	30.3	13.8	46.8	22.2	14.8	20.4	22.0	24.7	17.8	48.0	27.6	18.5	15.5	34.5	28.7	37.0	9.3	31.8	25.8	32.3	20.1	28.9	22.6	14.9	23.6	17.6	23.8	16.4	27.1	20.4	21.2	16.2	14.1	18.0	16.1	23.1	46.2	15.6	25.1	19.4	20.7	20.0	29.9	20.3	20.1	23.2	27.6	27.0	23.8	14.9	36.4	29.6	23.7	41.7	18.7	24.7	23.7	22.9	13.3	28.5	45.3	45.0	40.7	30.0	20.3	27.7	35.9	38.0	33.7
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;ASC diff: 10.6;ASC TERT1: 13.2;hTCEpi: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.5	1.4	5.5	1.1	8.6	0.7	3.6	5.0	4.8	4.6	1.7	7.2	7.4	1.9	3.8	12.7	2.0	36.5	1.7	2.6	6.0	5.4	4.9	1.2	8.9	1.1	3.4	3.2	6.3	4.3	6.6	7.6	1.6	18.3	1.8	1.6	2.6	2.8	5.0	3.9	1.7	1.1	5.4	3.2	1.3	2.3	20.4	5.3	0.0	17.2	1.4	1.1	2.9	2.0	5.1	1.7	2.0	1.3	1.7	1.3	1.1	1.8	1.1	1.2	6.6	10.6	13.2	1.2	0.0	2.4	0.6	0.2	0.1	1.8	0.0	0.5	0.6	1.2	1.0	0.0	0.4	0.5	0.9	0.5	0.1	0.0	5.3	0.6	0.3	2.7	6.3	0.2	4.0	0.8	0.9	0.4	0.4	0.6	0.1	0.6	0.2	1.3	0.8	0.0	0.6	5.1	0.1	1.5	2.5	0.2	0.3	4.4	0.5	1.0	0.4	0.1	0.2	1.1	0.2	0.3	0.1	0.1	2.2	0.1	0.4	2.0	1.2	1.2	0.9	1.3	0.9	5.1	1.2	1.1	1.7	3.2	1.1	1.0	1.6	1.7	1.1	1.7	1.3	1.1	5.5	8.6	5.0	4.8	6.0	5.4	3.4	3.2	18.3	5.3
PPIP5K1	"HISPPD2A, IPS1, KIAA0377, VIP1"	ENSG00000168781	"Diphosphoinositol pentakisphosphate kinase 1"	Q6PFW1	15	43533462-43590253	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039380	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039380: AB_10673528"	"unprognostic (8.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.59e-3)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.85e-3)"	"prognostic favourable (7.14e-8)"	"unprognostic (2.67e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.95e-3)"	1.7	5.2	3.4	1.8	6.4	1.1	3.4	28.4	7.0	2.8	6.1			9.1	2.2	5.6	3.7	3.1	2.5	2.1	3.6	5.0	2.5	1.4	1.4	2.0	3.3		3.0	2.9	13.4	7.6	0.9		3.4	6.5		4.7	2.7	6.3	7.2	8.8	2.3	2.8	2.3	5.3	4.5			5.0		3.0	3.3	2.7	5.3	3.2	4.3	2.8	3.5	3.8	3.0	8.5	5.6	4.9	9.1	3.0	1.9	8.5	4.2	5.4	6.1	9.0	6.5	8.1	8.0	6.5	5.8	23.2	9.6	18.5	6.2	7.8	7.6	12.0	17.0	3.5	6.9	13.6	12.5	3.4	16.3	7.4	11.5	6.5	8.6	11.9	4.5	6.6	4.5	7.7	2.4	6.1	9.8	5.0	4.0	6.7	15.4	14.9	4.6	11.0	10.5	4.2	19.3	11.5	2.8	5.4	6.4	6.7	10.3	2.6	3.2	9.9	10.1	15.7	5.1	4.3	1.4	0.0	2.7	2.8	3.8	5.3	3.3	3.6	3.2	3.6	2.7	2.5	1.0	3.5	2.1	2.4	0.8	3.0										
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.6;HaCaT: 55.8;MCF7: 20.4;SiHa: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			310000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: , HPA059859: "	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	10.8	0.7	2.2	1.4	0.7	0.2	6.8	0.6	3.0	23.5	2.9	0.2	4.1	1.7	2.6	5.1	126.9	2.9	5.8	1.8	1.8	0.2	3.0	3.3	4.7	0.2	0.0	0.9	1.7	2.8	1.6	2.8	2.9	0.5	4.6	1.0	0.7	24.3	3.3	3.2	30.7	2.0	5.0	0.0	0.2	2.1	1.5	0.0	0.5	7.2	57.8	60.9	5.0	39.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.8	2.5	0.0	0.0	18.3	26.6	8.8	0.0	0.4	0.0	0.1	11.3	17.4	0.1	4.0	0.3	55.8	0.3	6.7	0.0	0.0	0.3	0.0	13.5	2.0	1.1	0.0	0.0	1.3	6.2	0.0	2.1	0.0	0.0	0.0	0.0	20.4	0.0	0.0	1.7	5.3	0.0	0.0	8.6	13.3	10.9	9.2	0.1	29.9	10.0	0.1	5.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	3.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.6	3.0	1.8	0.2	0.0	0.9	0.5	0.0
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"			850000	Cytosol	"Plasma membrane"	"HPA029209: "	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	16.2	11.7	13.8	15.0	18.3	64.0	15.1	20.5	28.6	15.5	32.4	13.3	9.4	19.1	17.4	12.7	15.2	10.7	10.8	37.1	13.5	16.1	22.8	26.7	14.6	11.8	15.6	19.1	12.1	13.3	18.2	12.2	15.8	24.3	16.5	19.4	12.3	18.7	13.5	56.1	16.7	25.2	15.0	13.8	11.6	14.9	29.7	12.7	23.4	13.3	11.6	13.4	15.2	16.5	4.0	2.7	8.0	2.1	4.7	4.5	1.9	47.8	10.8	9.4	8.0	14.4	13.4	12.0	13.2	15.5	9.8	9.3	6.1	14.1	28.8	12.6	14.9	10.7	9.7	13.6	17.2	25.9	5.5	17.7	7.7	9.5	12.1	20.0	12.7	11.3	16.3	11.5	15.8	9.6	9.8	23.0	11.9	21.0	26.0	4.7	8.8	9.1	9.4	21.8	9.3	11.8	23.0	16.0	12.0	13.7	16.0	11.1	16.1	8.8	13.2	20.5	20.5	8.9	9.3	17.9	10.1	33.7	9.4	7.9	10.3	6.7	1.8	5.1	3.5	1.8	3.8	1.7	2.8	3.1	2.7	4.0	2.2	2.1	8.0	4.7	2.1	1.6	4.5	1.9	13.8	18.3	20.5	28.6	13.5	16.1	15.6	19.1	24.3	12.7
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016745	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	23.7	13.8	31.2	12.2	33.8	24.7	15.2	32.6	25.2	16.3	18.2	26.0	13.6	13.2	15.7	20.4	14.9	12.7	14.3	21.1	29.6	24.6	19.4	27.7	13.4	16.6	34.6	22.4	15.8	20.9	34.6	17.9	12.1	22.9	20.7	19.0	24.3	16.4	16.4	72.0	12.5	14.3	21.1	27.3	16.1	14.8	13.3	34.1	19.1	15.0	13.1	16.8	18.2	15.9	6.5	5.5	11.1	5.0	4.7	9.5	1.6	17.3	15.5	20.7	15.1	25.9	12.1	23.5	13.5	15.6	14.0	12.4	20.9	11.3	19.1	21.2	15.5	9.5	23.1	8.8	20.8	19.3	9.0	20.2	9.3	14.3	20.9	18.0	16.9	11.6	15.5	11.1	18.9	11.4	14.7	20.3	12.5	14.4	17.8	29.0	25.5	5.2	19.0	23.1	12.8	32.6	17.6	16.7	21.0	12.1	18.2	15.6	9.8	12.6	10.4	12.3	17.7	10.1	12.9	17.8	11.6	17.9	6.5	30.0	8.8	8.3	3.3	11.1	7.2	4.5	6.2	5.8	6.9	6.1	5.5	6.5	9.5	6.4	9.2	4.7	5.0	5.3	6.2	1.6	31.2	33.8	32.6	24.9	29.6	24.6	34.6	22.4	22.9	34.1
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078907	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"HDLM-2: 34.9;U-266/70: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavourable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	7.7	8.5	7.4	3.5	11.5	3.3	6.3	15.8	23.2	11.3	7.0	5.5	1.1	3.0	6.2	3.7	8.7	6.1	12.6	9.9	6.3	7.8	8.4	6.0	4.6	1.9	8.0	10.1	3.7	5.4	33.6	26.3	11.5	13.8	9.6	5.9	5.6	18.9	3.7	25.7	7.6	3.6	16.4	4.6	3.4	8.4	2.8	3.7	5.6	14.4	9.6	3.5	16.6	10.8	0.7	1.3	4.9	7.6	1.1	2.6	2.0	1.1	0.7	4.0	2.1	2.3	0.0	2.5	0.2	0.1	0.4	0.1	0.2	0.2	0.2	0.4	0.1	3.6	3.3	0.2	0.1	34.9	3.5	3.4	3.3	0.4	0.1	2.1	4.0	0.4	1.6	0.1	0.2	0.2	0.1	5.5	0.0	1.8	0.8	0.2	2.3	0.8	4.1	0.7	0.8	0.1	3.7	4.8	4.1	2.0	2.3	0.1	2.7	2.1	0.2	0.4	0.4	0.3	1.3	34.9	0.1	1.9	0.6	1.7	0.8	0.7	2.3	4.9	2.6	5.5	0.2	0.2	0.6	1.7	1.3	0.7	1.0	1.8	0.2	1.1	7.6	0.8	0.0	2.0	7.4	11.5	15.8	17.9	6.3	7.8	8.0	10.1	13.8	3.7
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398183-67421183	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 177.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			8100000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: "	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favourable (1.17e-4)"	"unprognostic (7.60e-2)"	28.4	35.4	24.2	42.0	32.3	42.1	25.1	19.6	33.4	23.9	39.6	22.1	29.9	33.9	19.6	25.8	59.7	22.8	28.6	33.0	21.8	17.1	43.7	55.0	27.6	49.3	19.9	19.9	20.1	53.3	23.1	21.6	44.0	19.3	27.2	33.2	23.2	49.7	31.1	39.0	34.4	47.3	20.5	21.3	53.7	35.1	15.7	19.4	77.7	38.5	40.5	63.9	25.5	25.7	78.8	76.6	126.2	118.0	68.2	113.9	177.2	46.2	53.4	31.7	46.6	15.8	19.4	32.3	22.9	26.9	46.3	35.2	76.3	55.9	39.8	39.1	34.8	40.5	36.6	47.7	28.5	41.8	24.8	38.2	25.2	40.0	34.5	48.5	49.4	21.8	31.6	39.4	23.2	46.4	35.5	33.0	37.4	105.5	61.5	95.4	52.5	42.3	43.7	43.9	34.5	45.4	38.3	24.8	41.2	26.6	47.8	70.7	57.2	33.6	33.0	35.7	36.6	42.1	29.6	33.1	30.6	45.2	42.8	33.4	37.6	81.4	80.1	126.2	88.6	100.5	69.3	78.8	79.8	90.5	76.6	77.0	49.1	69.2	93.3	68.2	118.0	54.4	113.9	177.2	24.2	32.3	19.6	33.4	21.8	17.1	19.9	19.9	19.3	19.4
PPP1CB	"PP-1B, PP1B, PP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			7700000	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB022558: , CAB069426: , HPA065425: "	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	28.5	22.6	30.0	20.5	37.6	29.5	32.4	19.1	29.8	51.1	39.3	21.1	30.7	24.4	58.0	31.8	86.0	37.0	33.3	67.1	27.8	27.9	32.0	20.0	35.3	22.3	27.4	24.4	39.7	21.9	48.9	28.7	42.3	22.0	46.4	27.7	25.2	36.5	38.6	99.6	25.1	30.0	100.8	27.5	25.2	31.4	25.5	21.4	28.1	27.5	32.9	25.3	82.1	50.5	15.6	25.4	41.5	42.7	23.5	28.3	17.9	36.4	23.0	80.2	24.8	27.5	25.6	46.7	19.6	22.4	19.1	18.9	20.4	21.6	29.2	24.7	20.3	22.6	22.8	26.2	22.8	46.3	11.8	22.0	28.2	22.0	59.9	24.9	10.4	19.6	37.3	20.6	43.2	23.1	20.0	29.0	25.0	18.3	26.4	21.6	26.3	18.2	26.0	71.1	22.2	62.2	44.1	22.0	27.2	30.5	33.9	26.6	16.4	14.0	27.6	25.6	28.2	18.3	23.6	20.7	32.5	59.8	27.2	26.9	18.9	22.5	24.8	32.1	16.8	37.8	21.3	15.6	25.5	19.6	25.4	13.4	22.7	25.5	41.5	23.5	42.7	19.6	28.3	17.9	30.0	37.6	19.1	29.8	27.8	27.9	27.4	24.4	22.0	21.4
PPP1R12A	"M130, MBS, MYPT1"	ENSG00000058272	"Protein phosphatase 1 regulatory subunit 12A"	O14974	12	79773563-79935460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041296, HPA071956"	Approved		Supported	"Actin filaments,Cytosol"			300000	"Actin filaments, Cytosol"		"HPA041296: , HPA071956: "	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.19e-2)"	"prognostic unfavourable (1.72e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.38e-1)"	20.1	8.9	17.2	19.4	17.2	23.8	15.9	18.3	18.3	28.0	45.2	6.5	20.9	10.1	36.6	16.5	34.2	28.1	17.0	13.7	12.6	8.8	8.7	6.6	15.8	13.3	9.9	15.4	17.3	7.0	11.0	15.2	18.9	10.4	33.1	17.2	24.0	11.4	42.1	13.7	12.9	19.3	73.7	8.8	14.6	23.2	10.8	10.4	18.8	14.2	9.9	12.4	47.6	29.3	14.9	11.0	50.6	16.9	25.5	18.7	10.8	15.5	12.9	19.1	10.9	14.8	14.6	16.7	32.0	17.9	20.7	13.9	12.1	7.8	13.6	13.1	43.4	12.4	14.8	12.4	25.5	18.3	9.0	37.0	15.4	8.8	11.5	24.0	23.3	12.0	9.5	20.9	19.5	14.3	15.0	16.6	22.2	9.9	26.4	12.7	14.8	9.6	21.8	21.2	10.1	12.3	25.6	9.1	6.7	24.7	8.7	10.8	12.1	11.6	21.0	22.2	11.6	15.2	17.8	10.6	10.0	18.4	7.6	13.6	18.9	35.6	11.7	50.0	17.9	12.5	16.1	14.9	17.1	18.7	11.0	13.5	13.8	17.7	50.6	25.5	16.9	9.3	18.0	10.8	17.2	17.2	18.3	18.3	12.6	8.8	9.9	15.4	10.4	10.4
PPP1R13B	"ASPP1, KIAA0771, p53BP2-like, p85"	ENSG00000088808	"Protein phosphatase 1 regulatory subunit 13B"	Q96KQ4	14	103733752-103847590	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006394, CAB015454"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB015454: AB_2252775, HPA006394: AB_1079668"	"unprognostic (1.20e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (3.22e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.62e-3)"	"prognostic favourable (3.28e-11)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.23e-1)"	7.1	5.5	12.1	5.0	13.2	1.0	7.7	23.3	16.6	8.6	9.0	7.8	6.4	8.7	9.1	4.5	13.5	12.3	5.8	24.5	10.0	6.5	8.3	5.9	11.9	3.3	5.3	9.8	13.3	13.2	12.2	15.6	7.1	10.5	13.3	7.3	13.9	11.6	8.2	7.6	12.9	11.2	6.7	5.2	13.0	11.9	21.2	6.3	1.1	28.4	4.3	7.9	10.1	7.3	0.7	0.0	0.0	0.0	0.2	2.0	0.3	3.9	3.4	0.4	4.6	0.8	0.3	1.7	2.5	1.9	3.5	1.6	2.6	3.6	1.0	9.7	2.1	8.3	4.8	3.6	2.9	2.0	3.3	0.0	1.2	4.4	3.2	0.4	3.7	0.9	4.2	0.3	4.0	6.7	0.5	1.7	2.2	16.1	0.0	0.3	0.8	4.3	10.1	2.7	2.3	7.1	9.9	5.5	14.6	7.8	6.2	1.9	15.3	0.6	5.6	2.5	3.3	2.0	2.4	3.7	4.4	6.7	1.5	2.5	1.2	0.0	0.0	0.0	1.4	0.0	2.0	0.7	1.3	0.0	0.0	0.5	0.2	0.5	0.0	0.2	0.0	0.0	0.9	0.3	12.1	13.2	23.3	16.6	10.0	6.5	5.3	9.8	10.5	6.3
PPP1R13L	"IASPP, RAI"	ENSG00000104881	"Protein phosphatase 1 regulatory subunit 13 like"	Q8WUF5	19	45379634-45406349	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 78.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.1;hTCEpi: 51.3;hTERT-HME1: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB005016, HPA041231, HPA059883"	Approved		Enhanced	Cytosol				Cytosol		"CAB005016: AB_2168576, HPA041231: , HPA059883: "	"unprognostic (1.87e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-3)"	"prognostic unfavourable (3.39e-5)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (5.40e-4)"	"unprognostic (2.52e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.69e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	6.7	6.6	2.5	3.6	4.1	0.6	14.5	3.5	3.4	13.2	6.2	2.4	8.5	2.9	5.8	8.2	51.6	3.6	4.7	37.2	4.0	1.2	8.0	5.7	8.5	1.6	3.9	2.5	4.4	12.4	6.6	6.6	38.7	3.9	11.5	3.8	5.1	17.8	15.7	3.8	78.3	7.1	3.8	3.3	2.5	4.4	1.6	6.1	2.7	10.6	24.4	25.6	13.2	22.9	0.6	0.7	0.0	1.5	0.0	2.3	0.2	20.8	2.9	1.2	1.0	1.2	0.8	18.2	3.8	0.6	4.7	6.5	6.0	19.5	2.4	1.7	3.0	28.0	1.0	35.1	4.3	6.4	1.5	0.3	9.6	2.2	2.7	0.2	0.9	1.1	51.3	7.4	35.6	8.8	2.1	0.9	0.3	17.1	0.4	0.4	1.4	4.9	1.9	1.4	0.4	6.1	25.1	0.6	2.1	19.3	18.6	0.4	16.3	0.5	13.4	6.0	18.4	0.4	18.4	10.5	10.7	1.6	0.9	0.7	1.4	0.0	0.0	0.0	1.5	0.4	0.7	0.6	2.3	0.4	0.2	0.2	0.1	0.7	0.0	0.0	1.5	0.7	1.3	0.2	2.5	4.1	3.5	3.4	4.0	1.2	3.9	2.5	3.9	6.1
PPP1R2	"IPP2, PPP1R2A"	ENSG00000184203	"Protein phosphatase 1 regulatory inhibitor subunit 2"	P41236	3	195514425-195543386	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043729: , HPA059420: "	"unprognostic (1.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.13e-1)"	16.4	12.7	19.9	17.7	26.0	45.2	18.3	16.2	22.9	16.1	21.2	11.4	17.4	19.5	18.9	20.7	25.6	15.3	15.8	23.3	18.6	21.7	16.7	13.0	21.7	30.4	16.5	15.4	17.1	12.0	9.5	17.6	16.1	21.2	17.0	16.0	13.7	15.0	19.0	57.1	14.1	22.6	17.7	15.4	24.2	13.9	21.8	7.0	38.1	19.1	25.2	23.5	26.5	15.5	26.0	26.6	63.2	16.9	22.8	50.2	30.1	11.4	2.5	4.2	4.8	7.1	7.7	7.7	7.1	10.4	7.6	6.6	38.6	5.1	4.5	28.6	8.7	5.1	4.4	7.2	9.4	8.9	8.3	5.1	4.2	12.9	11.0	5.4	5.4	9.3	5.6	5.7	11.6	6.5	3.9	9.7	6.7	8.0	9.6	6.0	4.4	11.6	4.5	7.4	13.4	9.1	8.7	10.0	5.5	8.6	9.5	12.8	15.0	5.5	7.2	4.9	5.7	8.0	9.7	66.1	28.7	21.7	6.9	9.9	9.5	26.3	16.7	63.2	19.6	16.9	26.9	26.0	41.2	27.0	17.6	23.6	50.2	34.0	39.4	22.8	16.4	26.6	41.7	30.1	19.9	26.0	16.2	22.9	18.6	21.7	16.5	15.4	21.2	7.0
PPP1R2B	"MGC87149, PPP1R2P3"	ENSG00000231989	"PPP1R2 family member B"		5	156850538-156852528	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	33	"testis: 36.0"	"Cell line enriched"	"Detected in single"	13	"U-266/84: 5.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043729: , HPA059420: "	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.2	0.3		0.3	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	36.0	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.5	0.4	0.9	0.5	0.5	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.2	0.0	0.1	0.0	0.0	0.5	0.1	0.9	0.2	0.5	0.5	0.5	0.6	0.5	0.4	0.2	1.1	0.5	0.6	0.5	0.2	0.1	0.7	0.2										
PPP1R37	LRRC68	ENSG00000104866	"Protein phosphatase 1 regulatory subunit 37"	O75864	19	45091396-45148077	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"memory B-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041500	Approved		Approved	Cytosol				Cytosol		"HPA041500: AB_10795122"	"unprognostic (8.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.89e-3)"	"unprognostic (7.72e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.71e-2)"	"prognostic favourable (2.04e-4)"	12.7	19.2	17.3	9.8	17.5	8.1	12.6	27.9	27.2	12.8	13.3	10.4	23.0	20.7	11.6	11.2	13.3	10.1	18.8	11.7	15.9	11.4	13.8	9.3	11.0	8.6	12.9	19.1	10.4	18.2	11.5	28.3	11.1	11.4	13.7	7.0	13.9	25.5	17.0	25.2	19.2	19.2	8.4	10.2	13.1	27.4	16.6	11.2	10.7	14.7	10.3	8.8	18.3	14.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	13.1	12.9	4.9	7.1	6.2	4.2	9.5	9.6	5.6	6.7	7.7	5.8	7.3	3.6	6.9	5.1	10.5	3.3	7.5	2.0	4.6	8.4	3.1	6.2	6.8	7.8	2.8	5.2	5.4	5.8	6.4	4.1	5.4	5.2	2.9	3.7	16.7	6.8	4.4	4.7	7.9	8.2	5.6	2.6	4.3	34.9	15.0	6.9	8.2	17.4	14.5	11.1	4.7	8.5	8.1	9.6	4.7	8.5	4.9	3.1	2.7	10.5	3.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	17.5	27.9	27.2	15.9	11.4	12.9	19.1	11.4	11.2
PPP1R3B	"FLJ14005, GL, PPP1R4"	ENSG00000173281	"Protein phosphatase 1 regulatory subunit 3B"	Q86XI6	8	9136255-9151574	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 26.1;TIME: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"basophil: 18.0;eosinophil: 7.4;neutrophil: 25.3"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 25.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028731	Enhanced		Approved	Cytosol				Cytosol		"HPA028731: AB_10602120"	"unprognostic (4.97e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (4.08e-7)"	"prognostic unfavourable (6.03e-5)"	"unprognostic (3.33e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	26.6	4.3	1.2	3.2	3.4	4.4	21.4	0.8	1.7	19.7	8.3	1.5	10.3	1.9	22.8	11.0	12.8	6.5	4.3	17.3	1.5	1.4	4.7	58.5	7.8	6.9	3.3	1.0	16.2	4.1	40.7	2.4	18.7	4.7	25.3	4.0	3.3	12.9	15.5	34.8	6.7	4.5	33.7	5.1	5.4	6.3	8.6	2.8	1.6	11.5	6.8	4.5	37.0	21.7	0.8	0.8	25.3	0.7	0.9	1.5	0.6	3.6	1.4	4.0	1.4	10.2	8.7	14.8	1.3	4.3	1.6	2.0	5.5	1.7	1.2	2.2	2.7	0.6	0.7	1.0	1.7	3.9	0.6	2.2	0.6	0.0	4.6	1.0	9.6	7.1	3.3	1.4	8.2	26.1	1.6	3.1	0.6	2.2	5.9	2.0	5.9	1.2	2.4	5.2	2.2	15.9	14.7	0.0	7.6	2.4	0.1	10.3	1.9	2.2	18.0	4.8	1.6	0.9	1.7	1.7	3.9	0.0	8.3	3.4	1.4	18.0	0.7	7.4	1.1	0.6	0.9	0.8	1.0	0.6	0.4	0.7	1.5	0.7	25.3	0.9	0.3	0.8	0.7	0.6	1.2	3.4	0.8	1.7	1.5	1.4	3.3	1.0	4.7	2.8
PPP2R1A	"PP2A-Aalpha, PP2AA, PR65A"	ENSG00000105568	"Protein phosphatase 2 scaffold subunit Aalpha"	P30153	19	52190039-52229533	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Chromosome partition"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018599			Approved	Cytosol			3400000	Cytosol		"CAB018599: AB_628178"	"unprognostic (1.78e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (1.76e-4)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (4.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.28e-2)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.19e-2)"	25.3	57.3	60.7	20.5	71.0	18.0	21.4	47.5	82.1	29.6	31.2	26.6	21.5	33.4	26.4	37.9	37.7	47.0	39.9	74.7	70.2	44.8	31.0	29.3	20.0	27.5	44.0	50.9	45.8	24.3	37.8	29.5	24.6	51.0	31.0	29.8	31.0	24.3	35.6	50.6	33.5	25.3	34.5	25.2	20.5	19.8	21.7	18.1	29.0	28.9	35.9	30.6	27.3	23.1	52.8	62.8	51.9	67.2	69.8	56.3	67.8	30.4	51.7	41.3	36.7	33.6	35.2	21.7	25.7	33.7	34.4	30.0	26.0	24.1	26.7	18.5	40.8	22.0	44.2	38.7	20.0	19.7	119.9	19.6	28.5	29.2	30.7	21.1	18.7	47.2	32.1	32.1	29.6	32.6	22.7	18.8	38.0	35.2	29.5	40.3	40.9	45.7	29.0	24.0	29.8	55.2	50.2	31.2	33.4	31.4	31.4	19.1	28.4	37.3	30.9	27.3	24.6	13.3	29.3	19.5	28.5	31.3	29.3	21.4	34.3	45.0	55.3	51.9	50.4	67.2	45.8	48.4	45.1	47.1	62.8	52.8	37.7	43.0	33.7	69.8	59.8	39.0	56.3	67.8	60.7	71.0	47.5	82.1	70.2	44.8	44.0	50.9	51.0	18.1
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.9"	"Cell line enhanced"	"Detected in all"		"U-698: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane, Centrosome"	"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favourable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	31.6	7.2	7.1	7.6	9.8	7.7	13.5	14.8	7.1	7.9	8.2	13.6	5.7	7.7	6.3	5.6	7.9	5.0	7.8	4.6	7.4	5.0	10.3	94.9	5.4	6.2	12.6	3.4	8.7	18.5	5.4	19.4	6.7	9.8	4.6	8.5	6.6	8.8	4.0	6.2	6.7	9.4	5.9	8.7	4.2	11.9	28.6	13.9	10.1	6.1	7.2	9.4	6.0	5.1	11.5	14.7	9.9	11.9	14.1	14.3	12.0	12.8	8.6	12.4	8.4	12.5	6.8	12.5	12.7	8.9	9.5	8.7	29.2	13.5	16.3	9.6	8.2	12.2	18.4	10.4	12.2	11.2	5.7	15.9	5.1	12.7	6.2	18.5	12.7	7.7	6.3	10.7	7.9	11.7	19.2	21.7	10.4	4.2	20.0	7.5	15.3	9.4	15.4	8.3	19.9	14.1	14.2	4.1	11.0	11.4	10.5	2.1	12.1	6.9	12.6	11.1	13.4	5.5	8.1	2.3	5.7	59.6	3.9	21.7	14.0	5.4	10.0	9.9	13.7	11.9	13.4	10.4	13.9	12.7	14.7	11.5	12.3	13.1	2.5	14.1	10.7	6.3	14.3	12.0	7.1	9.8	14.8	7.1	7.4	5.0	12.6	3.4	9.8	13.9
PPP2R2A	"B55A, B55alpha, PR52A, PR55A, PR55alpha"	ENSG00000221914	"Protein phosphatase 2 regulatory subunit Balpha"	P63151	8	26291491-26372680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, CAB079289"	Approved		Approved	Cytosol				Cytosol		"CAB079289: AB_659890, HPA042122: , HPA042770: "	"unprognostic (1.17e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.16e-1)"	26.1	14.8	25.1	19.1	30.3	21.2	41.7	23.7	28.0	25.2	18.2	27.9	16.0	23.4	20.5	16.0	50.3	19.1	16.8	24.6	21.2	16.2	21.5	32.0	21.7	17.6	28.9	22.3	22.5	13.3	19.3	18.3	39.4	24.8	20.6	18.4	11.3	24.3	18.3	41.6	31.7	16.2	21.1	22.6	15.9	15.3	19.2	32.1	18.3	21.6	29.1	30.4	21.8	29.9	8.0	4.8	6.5	4.8	7.9	10.1	3.6	19.3	18.8	24.2	17.3	15.2	21.7	25.9	30.1	19.4	28.3	27.2	23.0	14.3	26.7	9.2	16.1	23.2	29.3	24.5	38.8	11.8	15.4	20.2	18.7	12.1	23.9	11.6	15.7	17.3	34.6	24.4	34.0	44.0	27.5	26.0	25.8	12.3	26.4	13.0	32.0	13.2	18.9	18.1	22.2	17.7	29.2	10.2	13.4	14.4	14.6	23.5	15.4	10.5	23.7	17.7	22.0	18.1	21.0	9.4	12.3	34.5	21.1	21.2	29.9	3.1	2.3	6.1	4.3	4.4	5.4	8.0	6.0	7.6	4.3	6.8	6.1	7.9	6.5	7.9	4.8	4.8	10.1	3.6	25.1	30.3	23.7	28.0	21.2	16.2	28.9	22.3	24.8	32.1
PPP2R2B	"B55beta, PR52B, PR55-BETA, SCA12"	ENSG00000156475	"Protein phosphatase 2 regulatory subunit Bbeta"	Q00005	5	146581146-147084784	"Disease related genes, Predicted intracellular proteins"	Apoptosis		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 73.2"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 46.4"	"Cancer enriched"	"Detected in some"	8	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0"	"Group enriched"	"Detected in many"	33	"NK-cells: 9.5;T-cells: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038118, HPA042122, HPA042770"	Approved		Approved	Cytosol				Cytosol		"HPA038118: AB_10697238, HPA042122: , HPA042770: "	"unprognostic (4.54e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.73e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.49e-8)"	"unprognostic (2.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.48e-5)"	"unprognostic (1.14e-4)"	2.0	9.7	30.8	2.5	35.2	2.9	1.8	10.2	73.2	1.6	2.7	26.0	0.0	3.0	1.7	1.8	2.9	14.5	2.9	2.9	26.4	20.9	4.7	2.4	2.5	4.3	25.5	22.4	1.6	2.9	16.0	6.4	2.6	27.5	2.7	2.8	4.6	2.0	2.9	1.5	4.9	2.3	3.5	18.6	2.9	2.2	15.7	29.3	0.0	4.2	0.0	2.4	6.8	1.1	0.0	0.0	0.3	0.0	9.5	16.1	4.1	0.4	0.4	2.4	1.0	0.1	0.1	0.2	0.5	0.2	1.1	1.5	1.3	4.7	0.2	0.1	0.0	10.0	0.8	1.0	1.1	46.4	0.2	0.6	2.7	0.5	0.1	0.0	0.2	0.1	0.6	0.0	0.2	0.1	0.6	0.5	0.7	0.3	0.0	0.0	6.1	1.0	0.7	0.1	0.1	4.1	10.7	1.9	0.2	0.3	0.0	0.2	0.4	0.1	0.3	0.2	0.7	2.5	0.4	0.3	0.2	0.0	1.7	4.2	1.3	0.2	0.0	0.0	15.1	0.0	13.8	0.0	7.1	16.1	0.0	0.0	1.3	12.0	0.3	9.5	0.0	0.0	8.0	4.1	30.8	35.2	10.2	34.1	26.4	20.9	25.5	22.4	27.5	29.3
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4"	"Cell line enhanced"	"Detected in some"		"A-431: 15.4;A549: 22.7;CAPAN-2: 15.2;MCF7: 18.7;PC-3: 21.5;SCLC-21H: 20.8;U-2 OS: 12.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Enhanced	Cytosol				Cytosol		"HPA042122: , HPA042770: , HPA060473: "	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	1.5	6.6	28.2	1.6	33.9	1.1	2.4	17.0	78.4	11.8	1.5	13.8	0.5	1.7	25.3	7.0	25.2	10.5	1.4	1.9	25.8	19.5	1.2	1.1	1.1	1.3	25.6	19.3	1.3	1.7	1.1	5.9	1.1	19.1	5.5	1.4	0.4	1.4	14.4	1.7	28.8	2.0	11.8	32.0	1.3	1.9	4.7	13.5	0.0	1.1	3.9	3.6	1.5	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.4	22.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	9.9	0.0	7.1	11.1	0.3	0.0	0.0	1.3	0.0	1.5	1.7	0.3	0.0	0.0	3.3	5.9	0.0	0.0	0.0	0.0	0.0	3.0	18.7	0.0	0.0	1.1	21.5	0.0	0.0	0.6	0.0	0.0	20.8	4.0	0.7	0.0	0.0	9.6	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	33.9	17.0	40.2	25.8	19.5	25.6	19.3	19.1	13.5
PPP2R2D	"B55D, B55delta, MDS026"	ENSG00000175470	"Protein phosphatase 2 regulatory subunit Bdelta"	Q66LE6	10	131900644-131959834	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA042122, HPA042770"	Approved		Approved	Cytosol				Cytosol		"HPA042122: , HPA042770: "	"unprognostic (7.75e-3)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.90e-2)"	4.5	8.1	5.4	4.0	6.6	1.6	11.4	13.5	12.5	3.7	5.2	5.4	2.4	5.3	3.9	5.2	4.2	4.6	4.7	7.9	5.5	4.7	4.9	4.3	5.5	6.0	4.9	5.2	8.5	34.3	9.9	6.3	5.3	4.7	4.8	5.4	4.9	7.8	5.7	11.4	6.8	5.8	6.0	4.4	5.1	4.4	4.4	5.1	6.3	6.1	3.0	4.4	5.6	6.4	0.4	0.0	0.3	0.6	0.1	0.3	0.0	5.1	4.6	2.5	1.5	3.5	2.5	4.0	1.8	3.6	3.4	3.6	3.1	3.6	2.1	1.3	1.9	9.1	3.7	0.6	3.5	5.3	5.2	3.6	3.9	1.5	0.8	3.1	3.4	0.9	8.3	3.8	5.6	2.1	4.6	0.7	3.6	2.1	1.6	8.8	1.8	4.4	2.1	1.8	0.4	2.7	0.4	2.1	2.9	2.3	1.9	2.0	1.2	2.9	3.1	1.8	0.6	2.7	9.4	3.2	1.8	2.5	1.7	2.1	0.6	0.0	0.2	0.0	0.2	0.4	0.1	0.4	0.1	0.3	0.0	0.0	0.1	0.3	0.3	0.1	0.6	0.0	0.1	0.0	5.4	6.6	13.5	9.2	5.5	4.7	4.9	5.2	4.7	5.1
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: "	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	14.5	12.5	19.1	15.5	23.8	26.4	12.2	17.9	22.1	12.9	13.8	11.4	9.5	14.1	10.9	11.0	8.9	10.0	12.5	14.8	17.9	11.4	10.1	10.5	12.1	18.9	28.4	17.2	12.6	9.5	11.3	30.8	12.7	20.6	11.8	14.7	6.8	10.2	9.7	20.0	6.5	15.3	14.5	22.8	21.5	13.1	46.8	24.1	18.9	8.7	7.5	16.4	14.7	10.4	12.2	12.7	32.1	19.2	13.9	14.7	11.4	15.5	8.5	14.8	13.2	9.8	19.7	11.1	12.6	10.7	14.8	18.2	6.7	11.3	16.7	5.0	12.0	6.7	6.7	4.8	22.1	18.3	7.8	9.3	4.6	24.8	14.3	17.3	18.4	15.1	4.5	11.1	6.9	20.1	9.8	17.0	21.3	11.3	18.2	16.2	13.5	9.9	18.1	11.4	13.7	5.2	9.1	16.0	13.9	15.4	11.1	20.2	7.4	20.7	17.0	16.2	6.9	13.6	14.4	15.2	20.0	34.0	8.2	16.6	18.4	20.0	15.0	32.1	10.7	19.2	11.7	12.2	10.8	13.8	12.7	11.0	9.6	11.7	28.1	13.9	16.4	8.1	14.7	11.4	19.1	23.8	17.9	22.1	17.9	11.4	28.4	17.2	20.6	24.1
PPP2R5A	"B56A, B56alpha, PR61A"	ENSG00000066027	"Protein phosphatase 2 regulatory subunit B'alpha"	Q15172	1	212285537-212361863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059288			Supported	Cytosol				Cytosol		"HPA059288: "	"unprognostic (3.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	40.9	8.4	21.9	23.2	24.1	46.6	26.5	13.7	17.6	19.5	23.9	19.6	18.9	15.9	21.2	13.4	36.7	12.9	25.7	31.9	17.5	16.6	22.4	34.0	37.9	17.1	25.6	14.2	11.8	27.5	17.0	14.4	21.5	16.4	30.6	23.2	16.5	22.2	20.0	24.3	20.0	27.6	28.5	21.1	28.6	26.4	10.0	24.4	35.2	27.6	29.2	18.3	28.8	38.8	2.1	1.6	14.5	3.0	3.1	4.9	1.4	17.3	7.2	3.7	7.5	40.7	24.9	30.0	7.6	14.6	8.5	8.1	21.5	17.4	12.1	5.8	11.9	12.3	7.0	10.6	8.9	10.5	9.2	7.8	8.0	7.8	13.2	16.0	12.1	10.3	14.5	7.8	11.4	20.4	11.2	12.8	4.7	7.4	6.3	10.9	6.2	15.7	8.2	5.8	15.1	15.2	7.9	5.3	3.6	10.3	32.6	24.6	20.3	14.5	4.3	6.0	6.2	9.4	8.2	20.4	15.6	15.7	7.2	12.5	4.4	14.5	2.0	9.4	4.6	2.2	3.1	1.4	3.6	4.1	1.3	2.1	2.1	4.2	9.9	3.1	3.0	1.6	4.9	1.4	21.9	24.1	13.7	16.1	17.5	16.6	25.6	14.2	16.4	24.4
PPP2R5C	"B56G, B56gamma, PR61G"	ENSG00000078304	"Protein phosphatase 2 regulatory subunit B'gamma"	Q13362	14	101761798-101927989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027553	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA027553: AB_10602081"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.72e-1)"	25.5	29.4	52.6	37.7	45.3	48.1	27.4	25.7	38.9	27.8	31.1	25.6	30.1	22.4	24.0	29.2	32.7	22.3	25.4	48.4	49.3	35.6	25.5	38.1	34.5	53.8	44.7	32.4	28.4	25.6	27.6	35.3	19.5	27.5	23.1	33.3	26.6	28.9	27.8	30.5	28.9	31.7	27.7	45.5	36.8	25.4	27.6	29.5	51.4	29.6	28.3	52.1	33.2	21.9	20.1	24.9	35.3	25.3	16.8	60.5	20.9	20.7	14.3	24.3	23.4	22.0	31.0	23.5	19.7	26.0	24.7	23.7	14.3	36.3	56.9	19.0	25.5	21.9	22.1	20.8	32.2	25.6	10.4	16.5	16.9	13.9	16.3	25.2	35.4	20.4	27.0	16.9	15.8	22.1	34.2	24.1	23.5	31.7	25.3	27.9	14.1	23.9	21.5	27.3	14.0	23.6	23.6	19.0	35.6	26.7	17.7	33.2	32.4	19.4	21.8	15.6	14.9	59.9	19.4	33.7	50.3	94.8	23.4	18.7	17.3	20.1	19.8	18.2	60.5	24.3	38.9	20.1	39.7	47.5	16.9	17.8	28.6	44.1	35.3	16.8	25.3	24.9	39.7	20.9	52.6	45.3	25.7	38.9	49.3	35.6	44.7	32.4	27.5	29.5
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984499-43012342	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	17.9	14.4	19.7	17.0	31.5	15.1	14.2	28.3	41.0	20.2	24.5	13.7	15.9	31.1	20.7	11.4	18.1	19.0	14.3	22.0	17.7	18.4	15.7	15.8	15.0	16.2	16.6	25.1	20.7	16.5	17.4	11.2	16.6	26.3	18.4	18.6	16.5	13.7	19.2	41.0	17.9	36.4	20.8	11.2	14.4	14.9	27.1	13.1	35.5	13.4	11.1	14.7	19.1	18.5	9.2	12.5	17.9	11.3	11.8	19.7	15.3	26.6	14.0	21.5	28.0	13.3	18.4	12.1	14.8	10.5	29.6	26.2	22.8	7.3	20.0	14.4	17.9	15.1	28.9	17.0	26.5	17.0	25.2	23.8	17.4	21.4	9.3	16.4	17.6	10.1	11.2	23.6	10.7	22.5	24.9	15.5	17.0	11.4	42.2	15.0	9.6	13.4	29.6	26.7	13.0	9.0	12.6	27.3	17.9	20.1	13.4	15.9	18.7	15.4	21.3	21.4	19.8	22.3	23.5	16.0	20.1	40.9	8.4	15.3	18.4	14.8	11.3	17.9	16.8	9.8	17.6	9.2	15.3	19.0	11.6	9.0	11.8	14.1	6.9	11.8	7.4	12.5	19.7	15.3	19.7	31.5	28.3	41.0	17.7	18.4	16.6	25.1	26.3	13.1
PPP2R5E	"B56E, B56epsilon"	ENSG00000154001	"Protein phosphatase 2 regulatory subunit B'epsilon"	Q16537	14	63371357-63543374	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006034, CAB072342"	Approved		Supported	Cytosol				Cytosol		"CAB072342: , HPA006034: AB_1079670"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.62e-2)"	"prognostic favourable (4.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.22e-2)"	20.9	19.3	18.1	27.2	18.8	16.9	26.5	27.6	32.7	21.3	22.3	11.7	14.2	14.1	20.5	19.2	29.2	16.3	18.9	20.2	19.2	20.5	20.1	22.9	27.7	19.1	16.4	20.1	21.5	14.7	29.0	18.8	21.0	18.5	18.5	27.3	15.7	17.3	28.3	31.2	19.2	17.6	23.2	17.7	20.2	16.6	25.1	13.5	35.5	27.4	21.3	21.7	28.5	20.8	3.3	3.6	2.7	3.4	9.2	5.1	1.1	38.7	11.4	20.9	9.8	14.5	17.1	20.0	16.3	13.5	17.8	17.8	14.4	15.6	17.1	10.0	16.6	16.0	21.3	15.1	30.9	15.5	5.2	11.1	8.6	11.9	15.5	17.7	13.7	12.5	17.0	17.4	19.4	17.8	14.1	18.7	19.5	25.9	17.7	8.0	15.8	20.8	18.0	21.4	12.9	17.1	29.7	11.9	23.3	20.9	17.4	10.8	25.6	9.0	16.6	28.0	31.3	14.2	14.3	6.8	10.2	22.3	12.9	11.4	18.9	2.7	2.5	2.4	4.2	2.7	3.9	2.3	4.6	5.1	2.3	3.3	3.6	3.9	2.0	9.2	3.4	3.6	2.6	1.1	18.1	18.8	27.6	32.7	19.2	20.5	16.4	20.1	18.5	13.5
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol			35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.4	21.6	16.4	7.4	21.4	19.7	8.7	9.2	7.9	24.3	9.2	9.0	19.3	9.7	13.9	28.5	14.8	22.6	6.4	14.7	19.7	10.2	15.8	23.5	7.5	16.9	15.0	18.9	21.7	16.3	5.7	25.5	13.9	23.3	4.9	17.7	6.4	8.9	9.0	34.9	10.7	8.4	15.4	30.3	11.5	17.7	15.2	10.2	13.6	13.4	18.9	20.6	23.4	18.8	14.1	11.9	12.2	16.4	11.4	13.3	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Approved	"Plasma membrane,Cytosol"			43000	"Plasma membrane, Cytosol"		"CAB005610: AB_325975, HPA047157: "	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	25.8	20.1	43.3	15.9	66.2	32.3	25.7	47.9	78.2	14.8	14.0	7.7	6.9	13.1	16.6	14.2	15.7	10.5	14.7	10.2	56.2	28.7	11.3	29.6	15.5	18.8	23.7	45.1	13.6	9.8	9.4	8.9	18.5	25.4	14.3	14.8	6.8	12.1	16.6	41.7	17.1	12.0	18.5	21.6	16.5	12.6	10.4	16.5	12.7	12.6	7.7	20.1	14.4	13.3	1.0	1.8	6.4	1.4	0.9	1.4	0.9	17.4	14.9	20.2	13.9	14.0	16.2	20.6	25.5	21.7	28.7	25.4	21.5	15.9	24.4	8.8	17.2	11.9	21.3	18.4	35.1	17.2	15.2	79.3	12.2	19.8	27.6	31.1	26.8	16.3	16.7	22.3	22.9	19.2	19.1	27.9	20.9	15.1	26.3	27.4	23.7	12.7	19.2	26.7	38.9	17.8	18.7	26.7	18.8	14.6	20.8	18.3	9.8	14.5	20.2	24.8	22.8	18.7	21.9	15.8	17.4	36.2	18.1	32.7	15.5	3.2	1.2	2.9	0.7	0.8	1.4	0.5	0.8	0.5	1.3	1.0	0.9	1.4	6.4	0.9	1.4	1.8	0.9	0.9	43.3	66.2	47.9	78.2	56.2	28.7	23.7	45.1	25.4	16.5
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591615-101595021	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 81.9"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA047157: "												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085377	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: "	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	24.7	26.6	13.5	26.1	14.1	26.7	18.6	16.0	15.9	19.2	28.4	14.5	20.5	22.5	19.2	28.4	39.1	17.7	31.9	28.5	12.6	12.1	28.9	52.3	27.4	25.3	12.5	12.8	22.5	26.3	23.9	16.2	51.6	11.9	18.3	17.4	18.8	22.0	14.9	26.0	26.1	38.8	15.9	11.9	36.2	22.6	39.0	9.5	59.7	27.1	26.5	37.9	22.2	21.1	19.5	30.3	57.3	28.2	12.4	23.6	12.0	30.3	34.1	22.8	31.8	21.6	18.2	35.4	27.1	30.2	35.7	39.7	30.0	39.7	23.7	34.9	31.9	24.8	28.2	33.6	21.1	29.6	50.5	16.1	21.2	66.2	32.8	22.6	30.5	26.4	29.8	32.5	20.6	41.4	31.3	21.7	27.2	87.6	39.3	41.2	43.3	18.2	44.0	23.7	41.2	33.7	31.3	22.2	32.8	13.3	40.2	23.1	37.0	38.5	26.3	20.9	21.9	16.8	20.8	37.2	40.9	27.7	29.8	29.1	25.2	21.4	26.9	57.3	18.3	28.2	13.1	17.0	19.2	20.6	30.3	19.5	17.2	15.2	56.9	12.4	24.5	23.5	23.6	12.0	13.5	14.1	16.0	15.9	12.6	12.1	12.5	12.8	11.9	9.5
PPP4R3A	"FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1"	ENSG00000100796	"Protein phosphatase 4 regulatory subunit 3A"	Q6IN85	14	91457611-91510554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002568, HPA063917"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA002568: AB_1079207, HPA063917: "	"unprognostic (5.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.34e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.53e-2)"	19.0	14.2	22.1	25.7	19.7	48.5	20.1	33.2	22.6	20.6	22.7	15.0	22.0	19.8	22.0	17.7	22.7	21.0	23.4	15.7	19.4	14.2	20.7	27.8	21.4	29.0	20.8	16.8	23.4	21.7	25.6	24.0	25.1	16.3	21.6	20.9	14.7	20.5	29.1	34.8	25.4	27.1	19.9	18.0	29.1	21.2	25.3	18.3	44.6	19.6	20.3	27.5	19.9	25.6	9.0	7.4	8.5	4.7	12.1	10.0	3.6	14.6	17.5	22.1	15.5	12.1	12.1	30.2	12.6	12.4	14.3	14.2	15.1	19.2	33.0	16.1	11.1	15.9	21.5	16.3	22.5	26.8	8.8	16.9	12.3	12.4	13.7	33.1	18.5	8.4	25.2	11.1	16.9	14.5	15.2	24.5	15.9	23.6	24.9	16.0	16.2	12.4	28.9	23.8	14.1	14.4	23.8	25.9	14.2	18.7	45.8	15.8	24.0	19.2	14.3	12.8	11.5	13.1	16.0	18.9	28.3	38.0	15.3	15.6	19.9	8.5	3.1	3.6	7.2	3.5	10.0	7.1	7.3	6.5	2.9	9.0	9.0	7.3	3.4	12.1	4.7	7.4	9.3	3.6	22.1	19.7	33.2	22.6	19.4	14.2	20.8	16.8	16.3	18.3
PPP4R4	"CFAP14, KIAA1622, PP4R4"	ENSG00000119698	"Protein phosphatase 4 regulatory subunit 4"	Q6NUP7	14	94146128-94279735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3;testis: 14.0"	"Group enriched"	"Detected in some"	4	"RH-30: 16.3;T-47d: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041866, HPA050321"	Approved		Supported	Cytosol				Cytosol		"HPA041866: AB_10804120, HPA050321: "	"unprognostic (2.65e-3)"	"unprognostic (3.06e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.49e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.24e-2)"	1.0	1.7	15.2	1.3	15.5	1.1	3.5	4.9	21.3	6.9	1.0	1.9	0.1	1.0	2.1	4.0	1.4	4.0	1.5	1.1	11.1	6.9	1.3	3.0	3.1	1.2	4.7	9.8	11.5	1.6	1.1	7.1	1.7	8.0	1.4	1.1	2.3	1.2	1.8	1.0	2.0	1.0	1.3	5.2	1.0	2.1	14.0	4.1	0.0	1.3	0.0	1.8	1.2	1.3	0.3	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	1.7	0.9	0.4	0.0	0.5	0.2	1.5	1.0	0.4	0.1	0.5	0.9	0.0	0.0	0.0	4.0	4.1	0.4	0.2	0.4	0.0	0.0	1.0	0.2	0.0	0.3	0.0	0.4	0.0	3.8	0.0	0.0	0.1	0.4	0.5	0.0	0.1	1.0	0.9	0.1	16.3	0.0	0.2	0.9	0.2	0.1	0.0	0.0	0.1	17.3	0.0	0.0	3.1	1.7	0.1	0.1	0.8	0.1	0.3	1.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	15.2	15.5	4.9	13.2	11.1	6.9	4.7	9.8	8.0	4.1
PPP5C	"PP5, PPP5"	ENSG00000011485	"Protein phosphatase 5 catalytic subunit"	P53041	19	46346994-46392981	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022641, HPA029065, HPA056933"	Approved		Supported	Vesicles,Cytosol			47000	"Vesicles, Cytosol"		"CAB022641: , HPA029065: AB_10610284, HPA056933: "	"unprognostic (8.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (3.45e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	18.9	24.7	23.0	18.1	28.8	13.4	15.9	25.2	50.8	20.4	21.1	19.4	15.2	18.0	23.0	15.2	20.1	27.8	20.5	48.2	20.8	23.9	22.6	22.1	17.4	19.3	21.9	29.8	16.7	21.5	26.3	23.9	17.3	34.5	19.5	17.5	19.7	21.0	21.4	40.8	16.4	15.3	23.5	16.2	21.7	20.6	19.0	15.3	15.6	18.1	20.5	16.1	17.1	18.1	10.6	11.1	1.9	14.1	14.0	19.8	8.9	19.5	36.8	22.0	16.6	16.6	17.8	10.2	24.3	19.8	29.6	26.7	26.4	15.6	30.0	13.3	17.7	16.1	28.9	28.7	8.9	20.8	39.2	25.0	27.0	18.7	18.5	33.8	17.5	16.2	13.6	20.8	15.5	25.4	24.0	15.5	16.8	21.2	18.9	63.4	16.6	20.1	28.2	19.0	24.0	17.7	26.8	31.3	23.0	20.4	26.0	8.7	16.3	21.6	21.1	13.0	21.6	9.6	25.4	12.5	28.7	36.0	13.9	28.4	21.6	0.0	6.8	1.9	19.8	12.1	12.7	10.6	9.2	15.3	11.1	8.7	8.9	12.0	0.1	14.0	14.1	7.9	9.3	8.9	23.0	28.8	25.2	50.8	20.8	23.9	21.9	29.8	34.5	15.3
PPP5D1		ENSG00000230510	"PPP5 tetratricopeptide repeat domain containing 1"	E7EU14	19	46480796-46601200	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.2"	"Low lineage specificity"	"Detected in all"											HPA073186	Uncertain		Uncertain	Cytosol				Cytosol		"HPA073186: "	"unprognostic (2.84e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.00e-4)"	"unprognostic (3.90e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	1.9	4.5	8.9	0.9	6.8	1.5	2.2	3.6	7.5	3.5	1.5	5.8	6.6	0.9	3.9	7.4	1.1	6.8	2.6	2.8	6.5	8.7	1.6	1.2	2.2	1.4	6.9	5.9	5.8	2.3	2.8	6.9	2.3	4.1	4.4	0.9	3.7	7.2	4.3	2.4	2.2	0.9	1.9	5.4	1.9	1.8	5.3	4.7	1.0	5.8	0.6	1.4	1.9	2.4	2.0	2.2	6.2	1.4	2.6	1.8	0.5	1.7	1.0	1.3	1.0	0.9	3.0	0.3	1.0	0.9	2.6	0.6	0.1	1.2	1.8	1.7	3.4	1.0	2.3	0.4	1.4	2.0	5.8	3.0	1.5	1.7	1.4	1.0	2.3	2.3	3.6	0.4	1.2	0.8	1.2	1.4	2.3	6.7	1.0	3.0	0.7	1.4	3.2	0.5	0.5	1.3	1.0	4.3	1.6	1.0	0.6	0.7	0.8	1.6	1.9	0.2	0.6	0.4	0.8	0.9	0.8	1.5	0.9	3.0	0.7	6.2	1.4	0.7	0.9	1.0	0.5	1.7	0.4	0.7	2.2	2.0	0.8	1.8	2.0	2.6	0.4	0.9	0.4	0.5	8.9	6.8	3.6	7.5	6.5	8.7	6.9	5.9	4.1	4.7
PPP6R1	"KIAA1115, SAP190, SAPS1"	ENSG00000105063	"Protein phosphatase 6 regulatory subunit 1"	Q9UPN7	19	55229780-55258995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043989, HPA063681"	Approved		Enhanced	Cytosol				Cytosol		"HPA043989: AB_10987309, HPA063681: "	"unprognostic (1.15e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (3.82e-6)"	"unprognostic (2.22e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.20e-1)"	13.2	18.4	27.8	30.8	26.2	49.7	9.8	12.5	28.0	11.2	20.7	14.0	9.0	22.9	13.5	11.3	17.5	16.8	17.7	12.8	27.3	12.4	12.5	25.1	14.6	45.2	13.0	14.0	11.9	12.5	13.9	15.3	15.8	9.8	11.7	7.8	11.5	13.7	14.4	18.4	13.3	22.9	11.3	9.2	31.6	25.1	39.9	13.4	57.3	14.0	13.4	31.0	17.7	12.6	2.6	21.2	4.4	3.0	6.1	9.2	4.2	20.1	29.4	6.0	9.6	7.2	6.6	15.3	12.9	11.4	13.6	11.7	19.3	14.0	52.8	7.1	11.5	9.9	2.1	13.5	5.3	19.6	50.1	40.0	14.1	14.2	12.4	59.0	39.5	9.7	7.8	13.5	9.2	8.7	20.8	23.4	8.8	12.9	43.1	21.2	8.2	24.2	26.5	11.8	43.6	9.6	25.8	17.2	9.5	12.0	14.5	12.7	7.9	44.5	11.3	21.5	10.6	8.2	19.4	11.7	21.1	37.4	19.6	48.7	16.3	0.0	2.0	4.4	9.2	3.0	5.3	2.6	3.8	7.2	3.0	2.3	4.0	5.9	2.3	6.1	2.4	21.2	2.7	4.2	27.8	26.2	12.5	28.0	27.3	12.4	13.0	14.0	9.8	13.4
PPP6R2	"dJ579N16.1, KIAA0685, SAP190, SAPS2"	ENSG00000100239	"Protein phosphatase 6 regulatory subunit 2"	O75170	22	50343304-50445090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030656, CAB034919"	Uncertain		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB034919: AB_2183817, HPA030656: AB_10602926"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.70e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (7.51e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.77e-3)"	16.8	22.1	21.3	19.6	20.7	17.9	32.2	39.0	52.7	13.0	15.8	18.5	20.6	23.1	17.2	13.3	18.6	16.2	17.3	25.6	19.8	18.3	18.7	40.6	19.0	32.8	19.8	22.4	16.8	23.7	19.7	26.7	14.9	19.4	19.8	11.7	20.2	26.3	18.2	47.3	25.8	20.0	21.2	20.4	21.2	22.5	37.8	17.3	21.1	21.1	11.7	18.5	15.6	13.6	9.8	12.3	16.0	10.3	6.4	14.3	8.5	16.1	9.5	14.9	18.9	11.0	11.8	13.4	16.2	17.3	17.3	17.6	8.0	10.0	19.5	8.0	16.0	13.2	9.1	12.0	6.5	10.0	16.9	10.4	18.3	19.7	14.4	24.3	28.6	17.5	13.1	10.4	5.6	15.1	10.6	17.1	12.5	26.1	16.6	17.7	6.1	11.9	23.4	11.4	12.7	12.7	19.2	9.4	12.6	16.6	25.9	13.1	9.3	18.6	17.3	16.2	14.7	13.4	10.6	18.4	4.4	17.2	16.9	12.0	22.2	4.0	9.6	6.3	10.8	10.3	12.7	9.5	7.6	11.5	9.8	9.8	7.4	9.5	16.0	6.4	7.4	12.3	14.3	8.5	21.3	20.7	39.0	52.7	19.8	18.3	19.8	22.4	19.4	17.3
PPP6R3	"C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3"	ENSG00000110075	"Protein phosphatase 6 regulatory subunit 3"	Q5H9R7	11	68460731-68615334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017183, HPA038467, HPA038468"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"CAB017183: , HPA038467: , HPA038468: "	"unprognostic (9.46e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.29e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (1.54e-2)"	"unprognostic (6.43e-2)"	33.0	29.8	16.7	25.7	24.1	36.5	26.8	35.7	25.8	33.2	29.6	27.9	24.9	21.5	43.8	24.3	29.9	26.6	24.6	27.5	17.3	16.5	28.8	28.2	27.9	26.8	25.0	18.5	36.4	23.8	49.0	48.1	40.0	23.7	28.3	27.5	28.2	28.2	29.2	46.4	25.8	31.5	35.5	24.3	31.1	27.7	28.2	24.0	45.5	39.2	34.8	31.8	34.3	26.9	14.8	15.0	16.9	16.7	11.7	17.7	7.1	24.9	29.6	30.6	21.4	16.4	16.7	23.8	21.9	21.3	25.5	23.5	51.2	25.4	28.8	21.6	20.4	23.6	33.7	24.8	33.8	27.8	14.1	33.3	30.0	17.3	15.7	31.5	29.7	16.5	16.7	26.2	28.4	23.2	28.0	21.5	18.2	33.4	31.6	24.3	15.3	17.6	29.7	41.8	28.0	17.0	36.3	17.4	20.7	31.1	24.7	45.2	36.6	16.9	23.0	25.2	23.9	26.7	18.6	17.0	23.7	37.8	18.2	14.0	26.7	14.6	11.5	14.4	14.7	15.2	14.0	14.1	15.6	14.4	7.4	14.8	17.7	16.1	16.9	11.7	16.7	15.0	15.0	7.1	16.7	24.1	35.7	25.8	17.3	16.5	25.0	18.5	23.7	24.0
PPTC7	TA-PP2C	ENSG00000196850	"PTC7 protein phosphatase homolog"	Q8NI37	12	110533245-110583320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.43e-5)"	"prognostic unfavourable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favourable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	10.4	15.3	6.5	10.3	9.6	26.2	10.3	8.3	12.9	9.7	11.8	5.7	4.9	7.5	9.3	4.6	12.6	7.8	8.8	35.3	9.0	9.0	12.6	11.9	13.1	10.9	10.4	6.8	8.9	7.5	13.0	12.7	6.9	15.3	7.7	9.8	8.0	12.9	8.2	53.8	13.4	11.7	13.1	7.4	9.4	8.4	8.2	6.5	16.1	8.0	15.5	13.1	12.4	12.4	2.1	1.4	6.1	1.7	1.7	2.4	0.6	12.0	6.9	5.9	6.2	14.8	13.1	8.5	5.6	7.4	6.1	6.2	7.8	4.8	21.2	5.8	5.4	11.8	11.9	12.9	12.4	15.4	9.8	18.8	7.4	8.4	14.1	20.7	15.5	11.2	21.3	8.6	25.5	11.6	13.9	6.1	9.9	3.1	18.3	17.8	8.4	12.9	15.3	8.0	12.9	25.4	13.6	9.6	7.5	10.5	14.6	12.3	6.9	11.1	13.2	5.6	6.0	17.1	9.3	17.6	19.4	23.7	9.5	11.5	11.0	0.1	1.7	1.3	2.3	1.5	2.4	1.3	1.9	1.8	1.3	2.1	2.2	1.9	6.1	1.7	1.1	1.4	1.3	0.6	6.5	9.6	8.3	12.9	9.0	9.0	10.4	6.8	15.3	6.5
PQLC3	"C2orf22, MGC33602"	ENSG00000162976	"PQ loop repeat containing 3"	Q8N755	2	11155198-11178874	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061607			Approved	Cytosol				Cytosol		"HPA061607: "	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.00e-2)"	26.9	21.3	5.1	16.5	6.2	4.2	16.7	2.4	6.2	22.2	14.4	11.3	8.6	5.6	19.7	27.0	18.1	15.4	19.5	14.9	5.4	5.1	20.6	9.8	21.0	26.9	7.9	5.8	20.7	33.3	5.3	5.4	15.5	7.8	18.5	10.5	15.5	14.1	11.2	14.0	9.8	16.5	19.8	13.1	26.3	12.7	12.0	5.7	12.0	17.6	13.0	15.0	15.7	14.7	11.4	36.9	37.0	46.9	14.4	18.4	33.0	3.1	10.7	1.9	6.0	30.3	20.7	7.2	6.5	8.6	3.1	3.6	1.9	12.3	1.1	4.9	12.7	4.1	3.0	3.4	3.1	19.6	1.6	2.9	1.3	1.3	12.1	1.4	9.2	15.0	11.4	1.9	4.4	6.9	2.8	6.9	8.3	14.1	2.2	2.9	4.3	3.8	2.7	3.3	3.3	11.4	5.3	0.7	3.4	5.5	17.3	12.2	15.4	5.4	9.7	4.5	1.9	4.7	1.8	11.8	8.6	0.5	11.7	7.0	8.6	15.1	37.3	37.0	18.4	45.7	16.1	11.4	18.2	18.0	36.9	7.7	10.1	13.9	2.3	14.4	46.9	7.1	18.2	33.0	5.1	6.2	2.4	6.2	5.4	5.1	7.9	5.8	7.8	5.7
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722522	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 62.1;prostate: 40.3"	"Cell line enriched"	"Detected in some"	33	"PC-3: 90.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"											HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047871: "			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.6	2.0	30.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	40.3	62.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	9.9	5.1	0.8	0.0	2.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	90.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.5	0.0	0.2	0.5	0.0	0.4	0.0	0.8	0.1	0.1	2.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1
PRDX4	AOE37-2	ENSG00000123131	"Peroxiredoxin 4"	Q13162	X	23664262-23686399	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 127.6;pancreas: 320.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008659, CAB027389, CAB047362"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		11000000	"Endoplasmic reticulum, Cytosol"		"CAB008659: AB_1620984, CAB027389: , CAB047362: "	"unprognostic (3.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (7.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.10e-2)"	11.6	14.8	3.8	7.0	6.4	3.9	11.2	3.3	5.4	13.2	10.7	6.5	17.4	8.9	11.5	10.5	13.1	9.6	12.9	17.6	3.8	4.0	11.8	127.6	8.9	16.9	7.2	4.0	14.6	320.8	6.1	15.8	21.9	7.4	9.3	11.4	8.0	25.4	14.1	7.8	7.2	10.6	8.8	8.1	12.6	12.8	25.2	6.1	4.7	12.0	10.0	15.0	10.8	8.7	27.9	31.4	2.0	39.3	24.1	22.7	21.3	24.2	33.5	14.2	27.4	77.4	39.6	20.0	32.7	35.7	29.7	43.4	35.1	30.6	20.9	15.4	42.4	29.4	40.8	20.3	28.5	12.7	78.5	14.8	29.6	44.3	32.3	19.0	14.1	41.9	26.3	28.9	29.0	37.2	28.5	77.1	27.4	36.1	9.7	29.8	49.0	49.2	13.5	35.5	117.8	26.5	8.5	20.8	17.7	30.1	35.8	24.1	37.8	24.3	24.5	21.2	14.0	54.7	24.5	25.3	30.6	22.3	38.0	24.7	30.2	1.7	20.6	2.0	17.8	32.2	21.8	27.9	22.7	18.6	31.4	16.2	16.4	16.7	1.5	24.1	39.3	22.0	22.1	21.3	3.8	6.4	3.3	5.4	3.8	4.0	7.2	4.0	7.4	6.1
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"			180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	51.2	15.8	26.2	29.0	101.5	49.6	22.1	104.7	35.7	43.7	31.1	29.7	34.5	33.4	33.5	85.8	29.9	34.2	33.7	35.6	29.3	31.6	22.1	27.0	33.5	57.3	23.1	7.3	41.1	34.2	24.0	33.7	42.8	49.2	6.9	49.6	10.5	15.7	30.5	57.5	97.9	18.8	30.3	34.0	65.5	11.7	12.2	22.6	36.1	42.5	24.0	35.9	32.7	28.8	17.1	19.5	25.8	28.4	10.5	15.4	27.4	20.4	20.1	15.5	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105277565-105403084	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol			1400000	Cytosol		"CAB025414: , HPA031388: , HPA031389: , HPA031390: "	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	13.0	14.2	10.1	22.2	10.1	10.4	36.2	10.9	24.9	11.9	27.2	5.2	11.2	20.2	13.2	10.9	16.4	10.5	15.0	19.0	8.8	7.1	8.9	14.6	23.9	31.4	8.3	15.4	13.6	18.8	16.1	11.1	15.4	9.7	9.4	33.0	8.9	14.9	11.5	58.0	24.2	19.0	15.3	8.5	11.9	14.0	20.1	8.8	17.4	10.2	18.5	13.3	18.2	21.0	8.3	15.3	7.1	18.7	16.6	16.3	11.2	10.8	13.3	14.2	15.9	33.6	19.9	14.0	14.6	13.7	19.3	20.5	16.9	6.9	13.9	14.4	17.1	16.9	20.9	42.8	22.0	21.0	20.4	18.7	11.2	19.2	13.0	18.8	13.7	18.5	26.1	13.9	35.8	18.0	31.8	24.9	23.3	17.6	12.5	19.1	13.7	13.3	19.4	24.5	9.1	14.4	25.9	18.6	26.5	12.8	21.5	10.2	9.2	30.2	18.1	8.9	12.3	11.1	17.9	7.3	4.8	18.2	15.7	20.5	27.6	4.8	13.6	7.1	16.0	15.4	15.6	8.3	13.7	16.3	15.3	6.8	12.9	15.2	0.7	16.6	18.7	6.5	12.0	11.2	10.1	10.1	10.9	24.9	8.8	7.1	8.3	15.4	9.7	8.8
PREX1	"KIAA1415, P-REX1"	ENSG00000124126	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1"	Q8TCU6	20	48624252-48827883	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.7;brain: 35.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 43.2;SK-BR-3: 45.3;T-47d: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001927	Supported		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA001927: AB_1079674"	"unprognostic (8.07e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.47e-2)"	"prognostic favourable (8.56e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.86e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-2)"	10.8	8.1	20.5	25.1	24.9	32.7	12.4	11.4	25.0	9.6	5.1	35.5	0.2	4.6	3.2	2.7	4.8	3.7	9.5	4.9	21.8	15.5	4.1	4.0	17.7	28.3	26.2	12.1	2.2	3.9	5.2	5.8	8.4	17.4	3.9	4.6	7.7	4.0	2.8	4.6	2.7	8.6	5.6	27.6	28.7	6.1	4.5	23.9	2.8	6.7	1.0	15.1	10.3	2.5	2.0	2.1	11.7	2.7	2.1	9.3	2.2	0.6	1.6	22.0	0.0	0.3	1.6	7.7	0.7	0.9	3.1	0.8	0.1	0.0	4.4	14.0	1.9	0.2	1.1	0.0	2.1	1.0	0.5	0.6	2.5	0.0	1.3	2.3	14.4	1.8	0.0	7.2	0.0	19.0	0.0	0.1	4.1	43.2	0.0	6.8	0.8	1.8	6.4	6.4	2.6	0.1	0.0	4.6	0.7	4.0	45.3	5.0	40.5	18.5	21.2	1.2	4.5	0.0	1.2	0.2	0.9	5.4	20.6	4.8	6.7	5.2	2.3	2.5	5.0	2.7	3.0	2.0	2.7	4.2	2.1	1.7	0.4	1.5	11.7	2.1	2.3	1.7	9.3	2.2	20.5	24.9	11.4	17.7	21.8	15.5	26.2	12.1	17.4	23.9
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602775	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease mutation, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 100.3;lymphoid tissue: 38.7"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"gdT-cell: 100.3;MAIT T-cell: 70.9;memory CD8 T-cell: 54.9;naive CD8 T-cell: 36.1;NK-cell: 65.1"	"Group enriched"	"Detected in many"	48	"NK-cells: 65.1;T-cells: 100.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"		960000	Cytosol		"CAB002436: AB_563955, HPA037940: "	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favourable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	8.8	1.3	0.9	5.5	1.1	15.3	2.4	0.5	0.7	1.7	3.8	0.4	0.2	1.4	4.4	2.9	2.7	1.7	5.3	4.1	0.8	0.9	1.8	6.5	19.6	11.3	2.5	0.3	2.1	1.6	0.0	1.1	3.1	1.2	3.3	0.8	3.9	2.5	3.3	2.6	0.9	5.1	1.2	1.4	38.7	3.1	1.6	0.2	12.7	2.8	1.0	10.3	3.2	1.7	0.4	0.3	1.7	0.2	65.1	100.3	46.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.4	0.0	2.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	100.3	0.1	70.9	0.4	14.6	54.9	0.2	0.2	6.2	36.1	1.7	65.1	0.2	0.3	11.1	46.7	0.9	1.1	0.5	0.7	0.8	0.9	2.5	0.3	1.2	0.2
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788481	"Predicted membrane proteins"	"Neurotransmitter degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.3;Hep G2: 4.7;NTERA-2: 3.0;SCLC-21H: 12.9;SH-SY5Y: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 16.2"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046671: , HPA060047: "	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavourable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	4.6	6.0	4.2	5.9	16.7	0.4	2.4	4.5	8.2	7.7	26.2	21.7	4.2	4.6	7.9	7.9	13.7	10.7	3.3	4.8	5.8	3.3	1.2	0.7	1.0	0.7	20.2	4.0	6.9	1.2	0.6	0.3	2.2	15.5	8.6	7.6	9.9	4.6	10.2	0.7	2.1	11.6	14.9	24.3	0.7	12.1	1.8	14.7	0.0	1.3	0.9	4.4	4.7	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	0.0	0.0	0.2	0.4	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.0	0.0	0.0	0.0	0.3	0.0	0.0	12.9	7.3	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	16.7	4.5	8.2	5.8	3.3	20.2	4.0	15.5	14.7
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649613-184694963	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 18.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA054372: "	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	12.3	12.6	8.3	17.0	11.5	9.1	13.5	14.6	11.0	17.7	14.3	15.4	18.1	6.9	25.4	13.1	12.0	15.1	14.6	12.0	8.0	8.3	8.6	9.9	11.3	10.8	8.4	11.5	18.7	9.0	9.8	14.0	10.8	10.2	14.8	13.2	12.0	11.0	17.9	10.3	10.0	11.2	14.8	14.7	11.9	11.0	8.0	10.2	15.0	12.1	6.4	10.8	16.3	15.9	3.3	2.5	18.6	4.1	3.6	4.9	2.6	9.3	3.8	9.5	10.9	12.7	16.6	6.5	9.1	15.1	16.1	14.1	3.0	9.1	5.3	3.5	7.1	5.6	7.7	9.7	17.0	10.8	3.9	5.6	5.4	3.6	8.2	4.8	8.4	10.4	8.0	14.7	9.7	8.4	11.2	18.6	11.4	3.1	9.3	4.2	3.1	3.4	8.5	6.9	6.0	8.1	5.6	7.2	9.0	5.7	1.6	10.3	4.9	8.5	4.5	5.4	7.2	4.4	6.2	9.4	6.7	2.7	7.9	6.2	13.3	7.8	2.0	18.6	3.5	1.9	4.9	3.1	3.2	3.4	2.5	3.3	2.7	2.7	1.0	3.6	4.1	2.2	3.7	2.6	8.3	11.5	14.6	11.0	8.0	8.3	8.4	11.5	10.2	10.2
PRKAB1		ENSG00000111725	"Protein kinase AMP-activated non-catalytic subunit beta 1"	Q9Y478	12	119667753-119681630	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004247, CAB005058"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB005058: AB_562038, HPA004247: AB_1078149"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.42e-2)"	"prognostic favourable (8.66e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"prognostic favourable (5.40e-9)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.32e-2)"	16.3	17.2	8.1	16.6	11.9	23.4	13.8	12.5	20.7	16.8	22.8	14.6	6.7	20.4	13.6	13.2	17.9	11.6	19.3	9.2	8.3	7.2	40.1	12.3	21.4	20.6	8.9	9.8	14.2	21.7	11.7	10.8	19.1	11.1	9.7	22.7	20.6	15.3	10.7	12.0	10.6	23.9	12.5	10.5	20.7	25.0	33.4	8.3	20.0	17.5	9.4	16.6	16.3	10.6	26.4	17.4	38.8	19.9	22.1	20.9	18.3	4.7	12.8	10.1	9.6	8.7	7.5	13.4	7.7	10.0	12.5	9.6	13.4	10.8	15.9	10.2	10.5	6.7	10.2	15.9	11.6	10.1	9.4	24.9	5.6	19.4	15.7	11.5	31.6	11.3	13.5	11.4	15.3	9.3	37.9	6.2	9.7	13.1	26.0	12.9	14.3	14.3	15.1	8.7	9.2	14.3	15.1	8.1	13.8	10.2	3.9	10.5	12.5	15.1	11.0	7.7	8.2	5.9	7.7	20.0	17.5	11.8	7.6	7.8	11.0	24.8	16.4	38.8	17.2	18.4	20.9	26.4	18.3	18.3	17.4	21.7	19.9	18.6	19.1	22.1	19.9	15.4	19.7	18.3	8.1	11.9	12.5	20.7	8.3	7.2	8.9	9.8	11.1	8.3
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	Cytosol			1300000	Cytosol		"CAB010361: AB_2268772, HPA071185: "	"unprognostic (1.08e-1)"	"prognostic favourable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavourable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	25.6	43.4	19.6	17.8	22.7	9.1	34.1	29.1	39.6	20.6	17.5	16.0	16.2	13.4	19.8	15.6	20.9	18.8	16.4	91.6	20.7	29.4	14.7	34.5	16.5	28.2	21.6	27.5	47.0	15.6	20.8	24.6	15.4	26.9	16.6	16.2	18.4	15.5	24.9	92.4	13.4	14.4	29.0	16.2	28.1	13.9	24.4	11.1	15.2	15.7	26.2	14.8	21.1	17.3	1.7	2.4	8.6	5.3	0.7	1.7	1.2	25.7	15.0	34.0	40.5	30.1	32.0	6.1	27.4	25.4	39.0	35.8	18.2	9.2	11.1	22.2	43.4	16.9	23.9	26.0	37.1	20.3	12.0	20.5	28.3	17.6	25.8	12.6	21.7	30.4	12.5	31.0	10.8	32.8	19.2	29.2	39.8	38.2	28.4	9.5	12.2	33.4	25.7	31.4	25.7	19.0	16.3	26.8	17.1	24.8	15.2	11.3	21.7	12.2	25.4	46.1	12.9	61.6	25.6	20.2	20.7	16.4	30.9	19.2	17.2	0.3	3.4	0.4	1.7	5.3	0.8	1.7	0.9	1.1	2.4	1.3	1.2	1.7	8.6	0.7	4.6	1.6	0.8	1.2	19.6	22.7	29.1	39.6	20.7	29.4	21.6	27.5	26.9	11.1
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	Cytosol			1500000	Cytosol		"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: "	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favourable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	7.0	21.5	40.0	10.5	57.0	6.2	8.0	54.7	85.5	9.4	23.6	16.9	3.9	4.8	8.7	17.6	8.1	5.2	11.5	10.1	43.1	52.1	10.6	9.0	6.9	16.2	38.3	33.5	8.3	11.9	12.2	18.3	5.1	35.5	13.8	22.6	4.9	32.9	12.7	3.2	2.6	6.3	12.6	47.7	14.6	14.2	3.6	25.9	25.5	11.1	1.8	15.3	13.5	4.6	13.5	7.1	17.1	5.4	25.9	27.6	22.0	3.1	6.2	9.9	11.9	11.5	10.1	4.6	15.4	11.7	7.8	7.4	0.1	2.8	16.3	10.6	12.0	2.1	4.6	5.0	8.4	15.9	2.5	35.9	8.5	1.2	11.3	14.2	0.8	6.0	2.2	7.6	4.3	36.1	1.1	9.4	12.8	0.5	18.4	7.5	9.8	4.4	14.3	15.5	9.9	19.1	11.1	3.2	12.7	8.5	3.3	9.4	3.0	3.0	32.0	10.9	8.5	11.1	11.6	7.0	8.4	16.5	5.2	15.1	13.6	17.1	2.7	5.8	23.3	3.6	18.7	13.5	17.3	20.6	7.1	10.2	26.4	27.6	1.5	25.9	5.4	4.1	15.9	22.0	40.0	57.0	54.7	58.2	43.1	52.1	38.3	33.5	35.5	25.9
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012529-69014113	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 27.4"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004530, HPA071185"	Supported		Approved	Cytosol				Cytosol		"CAB004530: AB_628137, HPA071185: "					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRKAG1		ENSG00000181929	"Protein kinase AMP-activated non-catalytic subunit gamma 1"	P54619	12	49002274-49019197	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA077805			Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA077805: "	"unprognostic (3.24e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (2.84e-7)"	"unprognostic (1.45e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.49e-2)"	"prognostic favourable (1.83e-4)"	"unprognostic (3.40e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.57e-2)"	23.8	30.3	18.5	13.6	18.6	22.6	25.5	14.2	27.0	19.2	18.8	19.6	18.0	13.3	16.0	23.9	26.8	14.1	14.2	39.4	15.2	18.2	27.1	30.8	13.9	14.9	19.7	18.4	18.9	19.6	19.2	22.2	18.9	22.1	19.1	17.0	20.3	18.4	21.0	58.4	21.7	19.8	20.4	15.9	18.7	17.4	19.2	10.7	22.5	22.5	24.9	23.0	23.2	15.7	29.2	41.0	44.0	35.9	40.1	36.9	37.9	21.5	13.4	15.3	24.1	39.2	40.2	8.7	23.7	31.2	24.3	15.6	13.2	19.3	13.9	21.4	27.3	18.9	11.1	30.6	23.5	15.9	18.3	18.9	20.8	10.5	32.5	25.0	14.9	31.6	24.1	17.6	37.1	23.3	14.3	20.0	32.5	13.9	10.3	9.5	9.4	28.2	5.8	13.5	17.6	32.5	18.2	12.8	16.3	16.8	31.0	36.0	37.8	14.0	21.6	11.4	15.4	26.0	17.9	32.9	32.1	9.3	27.7	18.0	10.3	41.1	35.9	33.6	31.5	34.2	30.3	29.2	28.4	29.4	41.0	26.4	25.9	26.8	44.0	40.1	33.0	27.6	36.9	37.9	18.5	18.6	14.2	27.0	15.2	18.2	19.7	18.4	22.1	10.7
PRKAR1A	"CNC1, PRKAR1, TSE1"	ENSG00000108946	"Protein kinase cAMP-dependent type I regulatory subunit alpha"	P10644	17	68511780-68551319	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019378, HPA049979"	Approved		Approved	Cytosol			11000000	Cytosol		"CAB019378: , HPA049979: "	"unprognostic (8.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	47.1	48.0	41.7	34.5	54.8	14.6	38.7	40.4	57.4	48.2	23.8	44.9	31.4	15.1	43.6	37.7	29.6	43.2	37.4	122.7	42.5	52.3	49.2	43.4	47.3	29.5	50.1	43.6	62.5	19.1	107.8	41.9	47.3	57.7	35.6	24.2	32.2	47.5	43.6	99.8	22.8	19.3	39.4	52.8	35.3	25.1	36.9	40.1	28.2	51.8	23.6	29.2	33.8	33.4	11.3	26.9	52.6	28.7	18.5	13.0	22.9	16.4	31.6	40.6	24.3	54.2	61.6	6.1	22.2	45.8	34.7	30.7	12.3	22.2	16.7	15.3	48.4	13.6	30.0	36.0	49.9	11.3	10.7	25.8	27.5	40.2	39.3	19.7	29.0	44.0	37.4	40.0	33.8	57.6	11.6	26.3	42.0	31.1	21.7	10.6	15.0	21.6	15.2	67.3	18.4	52.6	35.8	14.8	20.0	20.3	37.2	85.5	29.0	27.9	40.8	49.0	23.4	22.1	20.6	21.9	15.5	24.9	29.6	18.8	30.5	31.1	26.1	46.3	13.0	25.5	13.0	11.3	9.8	11.6	26.9	8.5	8.9	9.8	52.6	18.5	28.7	8.8	12.3	22.9	41.7	54.8	40.4	57.4	42.5	52.3	50.1	43.6	57.7	40.1
PRKCA	PKCA	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302636-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"			1900000	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	4.0	19.6	26.5	9.0	22.8	2.5	3.0	10.8	33.9	7.0	13.8	19.0	3.5	14.6	14.8	6.7	4.7	6.1	10.8	5.8	31.6	15.6	16.7	6.5	6.0	8.4	18.7	15.6	20.4	5.5	1.7	6.0	6.5	17.6	17.2	11.2	7.0	3.1	22.3	6.6	3.8	12.7	13.7	15.0	7.9	7.9	3.7	14.4	0.4	4.5	1.3	5.9	9.5	9.5	0.0	1.4	0.1	2.7	0.1	4.0	1.0	2.3	12.3	2.5	2.6	6.2	15.9	0.3	13.3	8.7	9.6	8.2	1.4	1.5	3.1	3.6	21.4	0.3	1.3	1.5	20.9	5.1	3.0	0.0	7.3	6.4	8.5	3.8	20.9	6.9	0.6	12.0	10.3	8.2	8.0	0.0	14.8	0.7	7.7	2.3	1.0	6.6	1.4	18.8	0.0	3.4	2.0	1.5	8.5	4.4	2.5	0.1	0.3	5.4	24.5	16.7	9.7	10.4	8.3	0.0	0.0	0.3	53.0	0.0	8.2	0.1	0.6	0.0	0.5	0.8	1.5	0.0	2.5	1.2	1.1	0.0	4.0	2.3	0.0	0.1	2.7	1.4	0.5	1.0	26.5	22.8	10.8	28.2	31.6	15.6	18.7	15.6	17.6	14.4
PRKCB	"PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835946-24220611	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.2;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in some"		"HEL: 40.8;HMC-1: 40.9;K-562: 58.1;THP-1: 18.4;U-937: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol			3400000	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: , HPA054203: "	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.0	1.9	13.9	20.8	55.6	20.4	1.8	14.1	57.2	4.1	4.7	4.4	0.6	4.9	3.5	1.2	3.2	2.6	3.9	1.5	23.4	7.8	1.8	3.7	5.4	31.0	11.0	20.4	1.2	1.4	0.9	1.4	2.5	8.3	6.2	4.4	3.5	1.9	8.4	1.2	4.6	9.1	5.8	7.3	31.2	3.8	6.4	6.4	24.1	3.9	0.0	27.7	7.6	1.7	23.6	18.5	21.8	14.6	20.1	19.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.8	40.8	1.9	0.0	0.0	5.9	40.9	0.0	0.1	0.0	0.0	0.0	58.1	0.1	0.0	0.0	12.9	12.9	0.3	0.0	12.3	0.1	2.3	0.1	3.6	7.1	0.0	0.0	0.0	0.6	0.0	18.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	16.4	0.0	17.5	7.6	14.4	14.5	10.7	6.7	23.6	9.5	17.2	6.2	22.1	7.8	19.0	21.8	20.1	14.6	18.5	6.7	7.5	13.9	55.6	14.1	57.2	23.4	7.8	11.0	20.4	8.3	6.4
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 63.3;THP-1: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in all"	7	"dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 124.2;thalamus: 366.1"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"			300000	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavourable (2.24e-4)"	"prognostic favourable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	27.8	33.4	9.4	29.7	11.5	30.3	17.6	5.7	10.7	10.3	27.8	10.1	43.7	21.4	5.5	21.3	18.3	16.1	33.7	11.9	8.3	3.7	16.5	4.5	29.2	24.5	10.2	5.6	8.1	13.4	6.1	5.1	7.5	7.1	17.9	16.1	10.3	14.1	40.7	3.9	17.1	42.9	17.4	10.2	32.1	24.8	9.6	8.0	10.5	26.9	13.4	26.3	22.9	12.7	3.1	17.6	20.7	22.9	2.4	1.5	6.4	7.7	3.0	1.2	2.0	9.0	5.2	11.2	4.7	5.9	5.8	5.7	7.3	7.6	20.0	2.1	10.2	3.5	7.9	11.5	4.7	17.4	6.0	11.1	4.1	7.8	5.7	14.6	25.1	4.1	8.4	5.9	5.5	5.0	2.2	2.9	8.3	19.1	1.6	24.9	3.1	5.5	1.7	3.0	4.7	6.3	16.7	2.0	1.4	3.6	63.3	9.7	5.3	45.2	7.2	2.8	3.6	3.7	4.4	4.4	6.8	10.2	6.7	25.2	5.4	17.7	22.9	17.0	1.5	22.2	1.0	3.1	1.1	1.2	17.6	2.9	0.8	0.7	20.7	2.4	15.3	8.5	1.1	6.4	9.4	11.5	5.7	10.7	8.3	3.7	10.2	5.6	7.1	8.0
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.9;HUVEC TERT2: 39.2;MOLT-4: 26.0;RT4: 16.5;TIME: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6"	"Group enriched"	"Detected in many"	14	"NK-cells: 27.3;T-cells: 35.3"	"Group enriched"	"Detected in many"	6	"basal ganglia: 25.0;thalamus: 19.5"	"Low region specificity"	"Detected in many"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: "	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	17.5	5.4	5.0	21.6	22.0	11.2	14.7	2.8	6.1	13.6	10.3	6.2	6.9	5.1	19.1	7.0	20.1	8.6	12.7	10.1	6.8	4.4	8.1	5.5	24.1	27.6	5.9	2.5	7.1	5.9	8.8	15.5	22.7	7.2	9.8	5.0	9.1	24.7	10.8	9.1	15.9	16.0	10.5	5.7	25.9	6.0	4.3	6.4	54.6	15.1	10.6	34.6	13.2	14.4	0.4	2.2	1.5	0.7	27.3	35.3	17.9	6.2	2.2	0.3	1.7	1.0	0.2	29.9	0.1	0.5	0.3	0.3	0.6	3.7	0.1	4.5	0.0	4.4	0.2	4.8	0.5	0.7	2.8	0.0	0.7	0.2	0.4	0.0	0.9	0.8	5.0	0.2	3.4	39.2	0.0	0.1	2.2	11.5	26.0	0.2	0.5	3.0	2.2	1.1	0.0	0.0	16.5	1.1	1.9	0.7	5.8	3.6	5.7	0.5	25.7	0.7	5.2	0.7	0.3	0.5	0.1	0.2	1.1	0.3	1.2	0.1	0.7	0.5	30.0	0.4	23.9	0.4	23.0	35.3	2.2	0.3	28.5	27.6	1.5	27.3	0.2	0.7	18.6	17.9	5.0	22.0	2.8	6.1	6.8	4.4	5.9	2.5	7.2	6.4
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222365-170305981	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"				Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: "	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavourable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favourable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	10.3	7.5	11.4	5.9	15.5	2.1	9.5	14.8	16.6	12.5	11.1	7.0	6.0	10.4	13.1	8.4	20.6	15.1	10.5	10.1	9.5	7.7	13.0	6.7	14.8	3.9	5.6	9.4	15.2	7.7	12.4	14.7	9.8	11.0	16.3	12.2	7.3	25.8	12.6	12.7	11.0	11.6	12.5	6.8	6.1	30.2	15.0	5.3	12.6	23.1	8.4	9.9	16.3	13.0	1.9	1.8	1.0	1.3	5.8	4.8	1.4	35.9	9.1	9.2	9.8	8.2	11.4	14.9	9.2	13.7	12.3	13.3	13.3	17.6	11.0	30.5	13.0	16.9	17.3	18.1	21.1	8.0	10.7	10.2	11.6	7.4	13.0	9.2	4.6	10.2	12.7	10.4	16.5	9.5	11.2	9.1	12.3	12.4	13.3	3.6	19.3	10.2	9.6	14.2	18.2	19.3	11.0	14.6	11.9	20.0	26.3	9.0	28.9	6.3	10.1	12.8	9.9	11.9	15.2	15.7	15.1	15.7	9.2	7.2	5.0	0.1	1.3	1.0	2.6	1.2	4.0	1.8	3.6	4.8	1.8	1.9	3.9	2.2	0.7	5.8	1.1	1.8	2.3	1.4	11.4	15.5	14.8	16.6	9.5	7.7	5.6	9.4	11.0	5.3
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050470-2185395	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.6;placenta: 93.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 15.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favourable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.2	7.8	15.9	3.0	31.8	1.4	3.9	39.8	43.6	3.2	8.6	17.1	2.3	20.0	1.7	5.5	10.1	6.5	3.1	6.4	15.5	6.4	11.3	6.8	22.3	5.0	12.2	23.6	1.9	8.5	9.8	12.0	93.0	27.3	5.8	7.5	2.6	7.0	3.0	0.4	8.8	18.4	1.2	8.4	6.9	6.1	17.5	13.5	0.6	14.1	0.9	5.0	4.0	4.6	0.4	0.3	15.0	0.3	0.8	2.6	0.3	7.5	4.8	1.7	8.9	0.0	0.0	23.5	0.5	0.2	5.6	0.3	12.1	16.4	0.0	14.9	1.9	13.2	10.1	12.5	4.0	0.5	11.2	0.0	7.7	16.1	1.6	0.0	5.8	0.3	7.5	0.0	4.3	0.0	3.3	0.1	0.1	9.2	0.4	0.0	3.4	11.7	0.0	0.0	2.6	9.6	7.9	12.3	9.9	6.1	13.7	2.6	9.6	2.0	0.0	0.0	7.1	0.1	0.0	3.5	0.6	0.1	0.6	0.1	8.5	0.3	0.0	15.0	0.6	0.3	2.6	0.3	1.0	0.6	0.0	0.4	0.8	0.4	1.2	0.8	0.0	0.3	0.8	0.3	15.9	31.8	39.8	43.6	15.5	6.4	12.2	23.6	27.3	13.5
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;fHDF/TERT166: 19.0;HSkMC: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (3.89e-1)"	7.4	10.6	8.0	5.3	9.7	0.7	19.0	4.9	8.9	5.1	8.7	5.1	24.1	3.1	8.3	9.0	3.5	6.8	9.0	6.3	9.8	5.9	15.1	2.3	14.9	1.6	5.6	6.6	15.7	7.3	35.7	9.2	4.5	10.8	20.1	3.5	4.9	3.5	24.4	3.1	2.7	3.5	19.7	16.4	2.4	4.8	16.1	8.6	0.5	8.2	2.9	1.8	14.1	12.2	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	4.0	17.8	16.7	0.1	12.1	9.3	12.4	6.7	0.0	0.5	0.0	1.2	19.0	0.1	5.9	1.4	6.8	0.0	4.1	0.0	0.1	0.4	9.0	0.0	0.1	17.7	0.6	0.8	1.4	2.5	1.2	0.4	11.6	1.3	0.0	0.0	2.5	6.2	0.0	7.0	3.2	13.2	5.6	3.6	7.1	2.1	0.0	4.7	0.0	0.1	6.3	11.7	4.8	1.0	3.5	0.0	0.0	0.0	3.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	8.0	9.7	4.9	8.9	9.8	5.9	5.6	6.6	10.8	8.6
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favourable (9.15e-4)"	17.1	7.6	7.0	25.8	6.5	18.1	18.0	2.5	6.8	16.8	13.7	5.8	18.7	13.7	14.8	16.5	23.4	15.6	17.4	7.4	6.3	3.1	13.2	9.1	21.3	24.8	7.5	2.7	17.0	12.5	10.3	17.2	20.1	6.6	14.8	7.7	11.9	15.6	21.5	7.5	26.8	19.8	11.7	6.8	34.8	15.2	6.6	7.2	41.5	18.7	10.5	33.0	17.4	37.5	6.6	0.4	7.3	1.0	2.9	6.1	1.9	8.6	13.4	5.3	6.5	4.4	3.6	6.8	4.5	7.1	9.4	10.3	7.4	8.5	10.1	7.9	6.0	12.9	4.7	12.0	2.9	8.6	7.0	10.6	4.2	3.9	5.8	7.7	15.7	4.3	5.8	5.4	4.6	16.5	6.8	14.6	3.9	9.1	14.8	25.0	4.5	6.8	9.7	2.5	16.3	5.8	12.9	3.4	10.8	8.4	7.0	1.8	5.6	3.1	7.8	4.0	8.0	3.4	3.6	14.3	56.9	5.0	4.2	6.4	4.2	0.9	1.0	3.4	5.6	0.9	4.9	6.1	5.7	6.1	0.4	6.6	5.1	4.9	7.3	2.9	0.7	0.0	4.0	1.9	7.0	6.5	2.5	6.8	6.3	3.1	7.5	2.7	6.6	7.2
PRKD3	"EPK2, PRKCN"	ENSG00000115825	"Protein kinase D3"	O94806	2	37250502-37324808	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029529	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029529: AB_10602082"	"unprognostic (1.39e-1)"	"unprognostic (7.34e-2)"	"prognostic favourable (4.84e-4)"	"unprognostic (1.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-1)"	16.1	22.1	9.5	20.7	10.7	5.3	35.1	4.8	9.2	17.2	18.0	7.2	7.2	6.0	19.2	16.0	9.8	11.3	10.0	11.6	12.7	6.1	9.9	8.4	20.4	22.3	11.4	3.7	15.0	7.6	12.9	20.7	11.1	10.3	14.4	8.3	27.8	11.1	13.3	19.1	11.5	12.1	16.5	15.4	22.0	10.5	16.8	10.8	16.2	11.8	9.3	21.2	12.4	17.7	16.4	8.2	5.7	8.3	6.3	11.5	3.4	12.6	5.4	14.3	11.8	10.9	18.4	10.5	8.2	15.3	9.3	9.5	8.6	4.5	18.6	6.9	12.3	5.0	9.7	10.1	12.6	24.0	14.2	12.2	8.3	5.8	4.5	8.7	7.5	8.6	5.2	14.7	9.7	16.5	10.2	22.9	10.8	2.1	3.8	6.8	15.1	5.2	12.8	22.6	15.9	6.2	14.3	10.8	28.0	7.9	4.5	48.2	4.9	8.0	15.9	26.7	13.9	10.6	9.2	26.2	48.5	21.7	9.3	3.7	16.0	5.7	8.3	5.5	10.5	6.6	9.1	12.4	8.8	8.4	7.8	16.4	10.4	11.5	1.5	6.3	3.3	8.2	4.1	3.4	9.5	10.7	4.8	9.2	12.7	6.1	11.4	3.7	10.3	10.8
PRKG1	"PGK, PKG, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase, cGMP-dependent, type I"	Q13976	10	50990891-52298350	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.3;BJ hTERT+: 15.5;fHDF/TERT166: 12.9;U-138 MG: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"basophil: 8.0"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol			33000	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	8.0	10.9	5.2	6.6	7.3	0.8	6.9	2.8	5.4	19.2	14.4	2.1	6.8	2.9	22.8	10.7	6.0	9.9	12.6	14.8	7.0	4.9	4.4	2.1	19.5	2.6	3.1	4.8	8.9	2.6	13.7	8.4	11.0	4.6	9.5	6.2	6.2	6.4	9.4	24.9	2.8	5.3	28.2	2.7	2.7	5.9	5.0	3.1	0.2	9.2	12.7	1.2	13.4	15.8	0.1	0.1	8.0	0.1	0.3	0.0	0.1	0.0	0.1	1.4	11.3	5.4	5.2	0.0	4.9	15.5	1.6	2.3	0.1	0.7	0.2	0.0	12.9	0.1	0.0	0.0	1.4	0.0	4.2	0.8	0.3	0.0	4.7	0.0	0.0	6.6	0.0	4.1	0.1	0.0	0.0	0.1	4.3	0.1	0.0	0.0	3.2	1.9	0.0	3.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.1	0.0	0.0	9.5	1.7	4.8	2.9	1.2	0.5	0.0	8.4	0.0	2.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.1	5.2	7.3	2.8	5.4	7.0	4.9	3.1	4.8	4.6	3.1
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347420-162727771	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;HEL: 9.0;Karpas-707: 5.7;RPMI-8226: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: "	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favourable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	6.8	7.1	7.9	2.3	12.2	1.5	4.2	7.2	13.4	5.3	4.3	6.3	4.6	2.8	7.8	4.4	6.1	3.4	4.3	17.7	9.2	6.2	17.4	3.6	2.6	3.0	5.8	5.2	6.4	3.0	5.6	8.6	2.0	5.5	4.0	2.4	8.3	3.5	4.8	41.8	4.0	3.3	6.6	5.9	2.7	3.5	10.3	6.8	0.6	3.8	4.7	2.7	4.9	2.1	4.6	1.2	4.2	0.8	1.8	4.6	1.3	0.0	0.3	1.2	3.6	0.9	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	9.0	0.2	0.0	0.8	0.2	0.1	3.1	0.1	0.0	0.5	0.0	0.4	5.7	0.9	0.5	0.1	0.1	0.2	0.8	0.0	0.0	5.7	0.6	0.1	0.9	2.5	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.3	0.1	0.3	0.8	0.1	0.0	0.1	0.1	2.2	2.8	0.8	4.2	2.1	0.5	3.5	1.5	2.0	2.2	1.2	4.6	4.4	4.6	1.5	1.8	0.4	0.3	0.2	1.3	7.9	12.2	7.2	11.7	9.2	6.2	5.8	5.2	5.5	6.8
PRKRA	"DYT16, HSD14, PACT, RAX"	ENSG00000180228	"Protein activator of interferon induced protein kinase EIF2AK2"	O75569	2	178431414-178451512	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	RNA-binding	"Disease mutation, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004648, HPA034996, HPA034997"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (8.33e-5)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.99e-2)"	"prognostic favourable (5.45e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.78e-2)"	15.7	14.5	18.3	11.3	20.3	13.0	31.2	17.1	30.9	15.7	18.7	16.9	10.8	11.0	18.0	19.4	16.6	13.9	13.1	22.2	17.4	17.5	18.0	14.5	13.7	12.1	18.3	17.2	14.9	19.8	17.4	21.5	8.7	18.8	17.4	14.8	13.2	13.8	18.1	55.3	18.2	10.9	33.1	20.2	9.4	15.2	23.5	15.7	13.8	16.7	14.8	14.1	18.5	17.7	19.4	29.2	13.5	13.9	13.5	20.1	16.4	10.8	8.3	24.6	12.0	22.7	26.0	19.3	16.8	16.3	21.1	23.1	23.1	15.6	22.2	19.0	19.1	10.2	19.2	13.2	23.6	19.8	12.5	13.6	10.0	22.0	26.4	10.7	7.6	15.0	30.4	19.8	22.2	20.0	12.5	19.0	28.5	11.3	21.0	27.5	22.3	16.8	18.5	41.2	22.4	23.7	12.4	15.4	19.3	10.9	10.6	21.7	14.8	14.0	11.6	17.7	20.1	16.1	13.9	26.2	16.3	27.0	20.5	16.4	10.4	3.1	13.9	13.5	11.0	13.5	15.9	19.4	17.2	13.4	19.9	15.3	19.5	15.9	3.7	13.5	13.2	29.2	20.1	16.4	18.3	20.3	17.1	30.9	17.4	17.5	18.3	17.2	18.8	15.7
PRKRIP1	"C114, FLJ13902, KRBOX3"	ENSG00000128563	"PRKR interacting protein 1"	Q9H875	7	102363872-102426676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051146	Uncertain		Supported	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA051146: "	"unprognostic (4.78e-3)"	"unprognostic (7.23e-3)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (8.25e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.79e-3)"	"prognostic unfavourable (4.39e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.88e-1)"	"prognostic favourable (1.94e-4)"	14.9	19.3	20.1	21.1	22.6	31.0	15.2	28.0	23.0	15.9	14.0	19.2	24.2	14.9	17.6	20.4	15.0	16.2	13.9	16.5	19.0	21.2	16.7	12.3	14.6	22.4	19.1	20.3	18.9	17.0	26.6	18.9	18.1	17.9	17.7	11.6	17.1	21.5	17.8	20.7	27.0	14.5	16.6	20.1	19.1	14.6	43.7	19.0	15.8	16.8	12.4	19.6	14.1	14.4	15.3	18.5	21.7	15.7	14.7	15.1	10.7	12.5	8.7	10.8	13.7	6.4	5.6	10.4	9.6	8.1	14.4	13.6	12.0	12.3	11.7	16.5	7.7	11.0	6.9	8.4	9.2	13.4	12.7	5.8	9.6	8.8	9.8	8.8	7.9	5.3	8.9	11.6	8.5	8.1	13.8	26.8	11.1	26.1	22.6	27.3	10.8	8.9	15.0	8.9	18.8	7.8	8.6	8.8	17.5	15.2	21.1	12.9	10.1	11.2	9.1	16.5	16.1	18.6	12.4	23.3	19.1	22.4	12.3	14.0	19.9	5.3	12.7	20.1	13.8	12.4	13.0	15.3	13.1	14.2	8.1	15.1	15.1	14.1	21.7	14.7	15.7	18.5	13.4	10.7	20.1	22.6	28.0	20.8	19.0	21.2	19.1	20.3	17.9	19.0
PRMT2	"HRMT1L1, MGC111373"	ENSG00000160310	"Protein arginine methyltransferase 2"	P55345	21	46635167-46665124	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018976, HPA029591"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA018976: AB_1855719, HPA029591: AB_10601250"	"unprognostic (1.82e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.76e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.23e-1)"	19.9	14.7	37.1	21.8	43.6	18.7	28.4	21.4	37.2	25.5	25.2	35.4	12.0	14.7	24.5	15.9	30.7	27.1	23.4	29.4	37.4	53.1	19.9	8.5	21.7	28.7	44.8	32.2	48.5	15.1	19.9	20.1	26.2	44.9	22.0	17.1	20.6	21.0	28.0	9.5	28.1	20.0	28.5	69.6	25.6	17.4	10.1	40.3	13.8	20.1	7.4	28.3	23.1	26.0	18.9	27.6	64.2	26.1	50.8	60.2	41.6	22.7	19.5	39.5	14.7	28.8	28.2	9.7	21.5	24.2	24.4	22.3	27.4	18.6	13.4	27.3	38.3	6.7	18.4	27.1	14.2	33.4	17.7	34.7	16.5	20.4	13.9	10.3	16.5	17.4	27.0	29.6	21.2	35.2	22.0	25.2	37.3	25.4	14.8	19.4	21.6	23.0	19.1	10.0	8.8	19.0	19.5	28.6	17.8	22.7	10.4	41.0	14.0	10.7	31.8	23.9	16.4	12.6	14.1	6.7	6.1	8.5	21.9	28.1	34.4	44.2	19.6	64.2	60.2	26.0	43.6	18.9	40.5	51.0	27.6	16.7	49.9	56.9	26.3	50.8	26.1	23.8	29.0	41.6	37.1	43.6	21.4	37.2	37.4	53.1	44.8	32.2	44.9	40.3
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920511-22929585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: "	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavourable (1.82e-4)"	"prognostic unfavourable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (1.04e-4)"	17.0	21.6	18.3	17.8	22.8	12.0	21.2	18.4	24.9	20.3	25.0	18.1	24.9	16.1	24.9	19.6	33.1	28.0	16.6	22.3	15.3	13.2	25.7	22.2	15.8	15.6	17.2	15.2	30.2	30.9	30.8	17.4	24.3	15.9	21.1	22.6	16.9	19.0	21.7	42.0	21.7	14.5	22.2	13.4	17.9	19.5	22.1	17.3	22.7	30.9	19.6	22.1	20.8	22.0	17.6	23.8	4.3	17.6	9.8	15.6	15.5	40.0	38.7	28.0	27.7	13.3	15.2	30.5	27.6	20.5	42.9	36.4	35.4	37.3	39.1	22.6	20.3	32.0	55.4	46.4	49.6	25.1	26.8	24.3	26.1	54.4	25.6	51.0	21.2	15.0	24.8	33.2	60.6	20.3	34.4	21.4	22.1	36.2	36.4	22.8	25.0	49.0	43.1	34.0	28.4	20.8	27.5	30.2	19.8	30.1	32.4	14.1	21.8	19.3	19.0	18.2	26.0	25.9	35.1	29.4	62.6	52.0	11.5	24.8	28.4	1.7	16.8	0.2	8.2	17.6	13.4	17.6	11.3	13.5	23.8	15.5	15.6	12.5	4.3	9.8	13.2	14.1	9.4	15.5	18.3	22.8	18.4	24.9	15.3	13.2	17.2	15.2	15.9	17.3
PRMT9	"FLJ46629, PRMT10"	ENSG00000164169	"Protein arginine methyltransferase 9"	Q6P2P2	4	147637785-147684230	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036844, HPA042537"	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol				Microtubules	"Nucleoplasm, Cytosol"	"HPA036844: AB_10672341, HPA042537: "	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.33e-1)"	"prognostic favourable (3.58e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.30e-2)"	6.0	17.2	6.0	5.2	8.6	12.4	6.9	8.0	8.9	5.6	4.5	4.2	7.9	2.5	8.6	7.6	5.0	7.5	8.4	6.5	5.6	5.0	7.5	5.8	7.6	5.3	5.8	5.3	22.6	7.2	16.3	10.0	5.0	7.1	6.0	4.5	9.8	5.8	11.3	6.7	5.6	4.3	6.1	4.6	4.5	5.9	11.2	3.9	11.6	15.8	2.8	5.4	5.5	5.2	9.6	6.0	10.8	6.1	5.1	10.4	2.7	3.5	2.3	5.6	4.3	4.4	7.4	4.9	3.9	6.2	5.9	6.3	1.8	3.9	12.1	1.8	3.3	2.4	6.5	3.3	8.2	4.4	3.8	6.7	4.4	3.0	3.3	9.7	3.7	5.1	3.5	3.6	3.2	4.9	6.5	7.0	5.0	2.0	8.2	3.8	2.9	4.2	5.6	4.8	4.4	4.8	2.8	3.5	5.3	6.2	4.9	3.2	2.1	2.1	4.2	3.8	3.1	4.2	4.2	8.0	6.4	7.9	4.3	6.0	2.8	7.4	6.0	10.8	6.7	6.1	6.5	9.5	8.1	8.2	4.0	9.6	10.4	9.0	4.2	5.1	4.4	6.0	6.8	2.7	6.0	8.6	8.0	8.9	5.6	5.0	5.8	5.3	7.1	3.9
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686236-4701590	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 108.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"	"Intracellular and membrane"		2200000	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: "	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.96e-4)"	"prognostic unfavourable (4.64e-4)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	24.6	27.3	63.4	14.2	73.1	19.8	30.5	87.5	116.1	42.0	43.4	61.6	8.5	10.6	36.3	17.7	23.0	24.1	31.4	54.1	64.6	48.9	38.5	22.2	22.2	14.7	47.2	65.6	49.6	11.8	20.7	24.9	18.7	71.6	43.8	20.9	34.1	17.1	45.0	21.8	26.7	13.5	40.8	53.1	20.3	18.1	19.1	51.4	2.9	25.6	11.8	16.4	27.0	22.3	4.6	10.5	108.1	11.7	3.6	16.7	10.0	24.2	20.0	4.6	7.1	37.3	22.8	4.1	40.2	57.9	19.5	19.9	6.6	18.8	4.4	9.3	78.3	56.5	5.0	54.7	36.6	3.6	4.3	0.0	2.3	20.6	45.9	7.9	1.8	20.6	78.9	83.4	65.2	16.7	2.3	15.8	22.4	5.4	3.1	4.8	3.7	29.8	3.8	12.2	4.0	9.8	4.3	5.4	0.8	11.4	16.0	57.1	3.3	4.1	25.1	31.8	14.6	17.7	32.6	7.3	14.7	14.8	25.6	5.8	114.4	108.1	11.7	0.8	11.9	9.7	16.7	4.2	9.8	9.4	10.5	4.6	5.8	6.8	0.7	3.6	7.6	3.7	11.4	10.0	63.4	73.1	87.5	90.4	64.6	48.9	47.2	65.6	71.6	51.4
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"kidney: 51.2;liver: 49.3"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 25.9"	"Group enriched"	"Detected in some"	50	"liver cancer: 28.1;renal cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051287: "							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.7	0.1	0.0	0.3	0.1	0.1	0.0	51.2	49.3	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PROSER1	"bA50D16.2, C13orf23, FLJ12661"	ENSG00000120685	"Proline and serine rich 1"	Q86XN7	13	39009866-39038076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034225, HPA055687"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB034225: AB_1564157, HPA055687: "	"unprognostic (6.75e-3)"	"unprognostic (9.56e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.95e-1)"	10.8	9.9	10.6	12.8	13.3	26.8	11.3	22.6	14.3	8.5	13.7	17.4	9.6	12.9	11.9	11.8	14.5	9.2	8.0	8.8	10.7	6.9	12.6	11.3	15.0	15.2	14.8	9.0	10.0	19.0	7.0	19.5	35.4	12.2	13.4	17.3	11.0	17.9	8.3	11.8	18.5	15.0	9.9	16.3	16.6	12.8	19.0	15.0	26.1	14.3	8.2	17.3	10.8	11.2	4.1	4.8	6.0	4.4	7.5	6.4	4.2	7.1	5.6	17.6	12.1	6.0	4.8	27.9	6.8	6.0	6.9	7.4	17.7	11.3	16.8	5.5	6.6	12.5	18.8	12.2	11.3	25.4	15.4	24.8	6.1	12.2	13.8	25.8	15.3	6.4	14.8	10.9	24.9	11.2	12.2	10.2	7.3	12.5	15.6	13.8	26.2	6.1	16.5	18.6	10.6	6.9	11.3	9.9	11.4	4.8	12.5	10.1	13.5	14.9	10.2	4.0	6.5	7.8	8.6	9.6	9.8	18.3	6.5	14.4	7.8	6.0	3.4	0.6	5.7	3.2	6.4	4.1	5.5	6.1	4.1	3.1	4.9	5.3	0.9	7.5	4.4	4.8	3.0	4.2	10.6	13.3	22.6	14.3	10.7	6.9	14.8	9.0	12.2	15.0
PROSER2	"C10orf47, MGC35403"	ENSG00000148426	"Proline and serine rich 2"	Q86WR7	10	11823339-11872277	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.8"	"Cell line enhanced"	"Detected in many"		"A-431: 32.3;CAPAN-2: 38.7;HBEC3-KT: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 32.0"	HPA041337	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041337: AB_10794663"	"unprognostic (2.36e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.60e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.69e-2)"	2.7	1.1	0.7	1.8	1.4	9.5	9.8	1.0	1.3	3.7	2.5	0.4	2.4	1.2	2.5	1.7	6.2	3.0	2.2	1.4	1.5	0.7	8.6	40.8	10.2	0.2	1.4	0.3	1.7	21.7	0.0	1.5	9.2	1.2	7.3	2.0	9.9	4.5	2.7	1.7	3.2	1.1	1.3	1.0	8.2	7.1	7.5	0.5	4.3	12.0	3.6	5.6	6.5	9.9	0.0	1.9	0.0	1.0	0.0	0.7	0.9	32.3	4.6	0.2	0.1	1.0	1.2	1.9	1.4	0.7	1.1	0.6	10.7	38.7	0.0	6.0	0.1	8.5	3.3	24.7	0.6	0.0	7.9	3.7	2.0	6.8	5.8	0.0	2.3	1.4	5.4	7.0	8.0	3.6	5.5	0.0	1.6	4.4	0.0	1.2	2.0	2.6	5.2	4.2	0.0	2.6	1.6	0.0	0.4	2.4	9.8	4.1	5.1	2.0	2.4	0.0	7.9	12.9	0.1	0.0	0.0	0.0	0.0	1.3	1.8	0.0	1.0	0.0	0.0	0.3	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.9	0.7	1.4	1.0	1.3	1.5	0.7	1.4	0.3	1.2	0.5
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041502	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 72.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 15.7;RH-30: 8.3;SH-SY5Y: 40.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000842, HPA001030"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000842: , HPA001030: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	2.3	9.6	3.7	2.1	8.1	1.0	2.9	14.0	5.8	1.8	3.0	13.1	0.3	2.7	1.9	2.0	1.5	3.0	2.6	13.1	6.2	4.1	5.4	72.4	2.0	13.5	8.4	4.3	7.3	13.9	1.0	11.4	1.3	5.5	1.4	3.2	2.4	1.1	1.3	4.1	1.5	3.1	1.7	9.6	14.9	2.8	5.9	9.2	0.0	7.5	0.6	1.5	1.6	2.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.3	0.0	15.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.8	2.7	0.0	0.2	0.0	0.2	0.0	0.8	0.7	0.0	8.3	1.2	0.1	0.2	1.2	40.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	8.1	14.0	5.8	6.2	4.1	8.4	4.3	5.5	9.2
PRPF18	hPrp18	ENSG00000165630	"Pre-mRNA processing factor 18"	Q99633	10	13586927-13630868	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA037599, HPA047950"	Supported		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA037599: AB_10795137, HPA047950: "	"unprognostic (5.82e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.63e-1)"	21.7	20.4	22.8	21.1	21.3	40.5	22.6	29.3	22.9	18.5	18.5	15.9	25.3	18.3	20.8	32.1	20.7	15.6	17.1	19.5	17.1	14.8	22.8	23.5	17.9	17.9	17.2	21.4	18.4	19.8	20.1	40.8	20.2	21.6	16.4	20.5	9.8	22.3	28.5	34.1	20.9	20.1	20.9	21.9	17.4	18.6	19.4	22.0	25.6	26.2	16.0	20.7	18.0	21.9	20.0	19.9	30.3	25.0	27.0	25.8	11.6	16.5	12.4	11.0	9.5	15.5	15.2	13.9	19.4	9.7	21.3	20.5	11.8	25.5	13.9	10.9	17.7	13.8	14.6	16.0	24.7	20.4	14.6	16.3	10.6	9.2	18.6	12.7	19.5	11.7	26.1	18.5	9.0	20.6	16.7	18.8	19.3	17.1	23.5	8.7	10.4	6.2	16.9	13.5	17.2	14.0	7.1	7.8	19.4	15.2	11.0	16.4	17.0	20.8	17.4	13.3	15.6	21.4	14.5	18.5	19.7	19.9	19.6	16.0	9.0	16.9	20.4	25.9	21.6	18.1	18.6	20.0	19.7	18.5	19.9	18.2	21.0	25.8	30.3	27.0	25.0	17.4	23.6	11.6	22.8	21.3	29.3	22.9	17.1	14.8	17.2	21.4	21.6	22.0
PRPF40B	HYPC	ENSG00000110844	"Pre-mRNA processing factor 40 homolog B"	Q6NWY9	12	49568218-49644666	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038426, HPA038599"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Aggresome,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Aggresome, Cytosol"	"HPA038426: AB_10674684, HPA038599: AB_10674689"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.50e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.80e-2)"	6.2	12.3	16.6	5.8	12.6	1.5	9.7	15.6	20.3	12.8	8.8	11.7	13.2	5.5	14.7	13.8	8.5	15.2	8.3	16.3	12.6	10.6	12.9	5.5	6.6	4.1	13.3	14.5	22.0	10.3	30.3	17.5	11.8	12.0	11.0	4.9	10.4	14.2	17.9	22.3	13.1	4.7	10.4	9.6	7.3	8.9	25.1	12.9	2.3	19.4	5.5	5.2	9.9	9.1	1.8	1.5	0.0	0.4	3.1	3.5	0.8	5.1	7.5	7.6	7.4	6.3	4.1	7.0	4.2	5.9	4.5	2.3	8.7	11.5	4.1	9.0	5.5	3.0	4.6	14.6	2.3	3.0	1.8	4.3	2.8	3.1	8.0	1.4	5.8	5.8	12.4	4.5	16.4	3.5	2.1	2.2	5.4	4.8	1.0	2.9	3.2	2.8	3.6	1.2	3.3	9.5	4.7	8.1	9.8	3.4	9.5	5.1	18.0	4.0	1.5	2.8	11.3	3.6	1.8	5.3	3.0	1.6	8.4	1.1	2.5	0.0	0.4	0.0	2.4	0.3	3.5	1.1	2.3	1.1	0.6	1.8	2.7	2.9	0.0	3.1	0.2	1.5	1.0	0.8	16.6	12.6	15.6	20.3	12.6	10.6	13.3	14.5	12.0	12.9
PRPSAP1	PAP39	ENSG00000161542	"Phosphoribosyl pyrophosphate synthetase associated protein 1"	Q14558	17	76309486-76384521	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062396			Approved	Cytosol				Cytosol		"HPA062396: "	"unprognostic (1.12e-1)"	"unprognostic (3.37e-2)"	"prognostic favourable (1.39e-5)"	"unprognostic (3.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.51e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.37e-2)"	18.4	20.5	19.7	14.9	21.3	15.4	27.9	25.7	24.7	16.4	17.3	22.4	16.8	12.9	17.9	22.8	26.1	16.9	14.7	15.4	19.4	22.8	21.0	52.7	23.6	12.8	32.4	20.6	16.3	18.5	27.2	17.1	16.1	27.4	16.5	20.2	22.1	49.2	22.0	11.6	16.9	14.6	18.3	21.1	11.8	16.2	28.1	23.6	12.8	38.3	16.1	19.3	15.0	25.1	16.5	13.1	19.3	15.2	16.7	22.2	11.6	13.7	16.9	20.4	9.9	13.8	12.4	8.0	12.3	17.3	20.8	17.3	12.2	11.9	15.8	6.8	18.5	8.1	18.3	14.8	20.9	6.1	16.4	11.6	13.8	53.4	17.2	9.9	9.3	13.5	12.1	15.0	13.2	40.7	14.1	14.9	13.7	14.7	17.8	9.2	5.1	15.2	14.6	26.4	11.7	15.9	15.9	11.6	19.1	13.6	13.9	27.5	22.7	11.7	15.4	24.1	17.7	14.2	15.2	10.1	6.3	11.2	10.7	9.2	10.2	14.4	15.2	19.3	16.2	13.2	17.1	16.5	16.3	15.5	13.1	11.9	14.1	13.6	5.0	16.7	12.3	13.0	22.2	11.6	19.7	21.3	25.7	24.7	19.4	22.8	32.4	20.6	27.4	23.6
PRPSAP2	PAP41	ENSG00000141127	"Phosphoribosyl pyrophosphate synthetase associated protein 2"	O60256	17	18840085-18931287	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021881	Approved		Approved	Nucleoplasm,Cytosol			28000	"Nucleoplasm, Cytosol"		"HPA021881: AB_1855782"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (3.71e-4)"	"unprognostic (4.57e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.08e-2)"	9.5	15.5	18.9	22.7	20.0	16.0	12.7	42.9	23.0	13.6	16.1	27.2	13.7	19.0	16.3	14.6	15.9	16.6	16.6	13.9	20.5	22.0	22.9	16.2	13.7	35.9	23.6	19.4	20.9	16.2	18.5	24.9	10.4	20.2	13.1	19.1	16.2	13.4	13.6	9.8	15.3	16.4	13.5	35.0	14.8	17.0	22.7	22.6	28.1	20.5	10.3	41.1	12.7	13.5	26.0	18.9	17.0	14.7	21.4	29.9	16.7	15.9	17.5	25.5	18.3	11.2	7.1	26.2	12.0	9.4	15.7	14.8	22.0	7.6	40.7	12.4	10.3	19.5	29.9	15.1	17.3	18.3	24.0	12.7	14.7	18.3	15.5	8.1	11.5	8.1	10.2	19.9	15.3	14.7	18.8	6.8	14.0	17.6	17.1	9.5	18.2	11.7	24.1	42.1	18.0	9.7	10.1	15.0	19.5	18.3	7.2	18.5	20.2	11.8	9.7	6.6	12.9	22.0	14.8	11.1	13.0	16.9	13.4	11.9	13.3	12.7	13.8	17.0	16.7	14.1	18.5	26.0	21.2	17.1	18.9	24.3	29.9	22.3	5.8	21.4	14.7	13.1	21.1	16.7	18.9	20.0	42.9	20.1	20.5	22.0	23.6	19.4	20.2	22.6
PRR12	KIAA1205	ENSG00000126464	"Proline rich 12"	Q9ULL5	19	49591643-49626439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011959	Approved		Approved	Cytosol				Cytosol		"HPA011959: AB_10610286"	"unprognostic (8.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.20e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.40e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.52e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.32e-2)"	"unprognostic (9.65e-3)"	15.3	14.3	17.3	14.6	16.3	11.1	11.3	33.6	21.9	14.0	11.9	12.7	14.7	13.7	17.0	10.1	11.6	14.4	13.7	8.9	16.5	10.7	10.5	6.2	11.7	15.4	11.6	17.3	17.3	12.0	12.0	22.4	10.5	10.3	14.0	5.7	13.2	19.9	25.5	27.7	27.0	13.1	8.6	7.5	21.1	16.7	8.9	14.6	20.0	15.8	7.9	12.3	14.7	15.3	0.5	1.8	0.4	0.5	0.4	0.9	0.4	10.7	16.8	9.2	10.1	4.2	3.8	7.3	6.8	3.4	3.8	3.1	6.3	6.4	11.0	5.8	4.8	10.0	4.2	5.9	1.2	9.3	12.5	11.2	8.5	6.3	3.0	10.5	17.0	4.8	6.0	4.3	2.9	4.2	7.7	6.5	3.3	8.1	11.9	12.8	13.1	15.6	15.6	7.2	4.1	3.4	13.5	7.4	13.7	9.9	9.3	4.7	6.5	7.7	9.9	13.4	12.8	5.0	11.1	8.4	9.8	7.5	8.3	6.1	8.1	0.0	0.4	0.0	0.4	0.2	0.8	0.3	0.3	0.9	0.1	0.5	0.3	0.5	0.4	0.4	0.5	1.8	0.3	0.4	17.3	16.3	33.6	21.9	16.5	10.7	11.6	17.3	10.3	14.6
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 113.1;pancreas: 75.4;thyroid gland: 61.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.4;MCF7: 12.4;SCLC-21H: 7.8;SK-BR-3: 23.5;T-47d: 15.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.2"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 19.0"	HPA022918	Approved		Approved	Cytosol				Cytosol		"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (6.29e-13)"	"prognostic favourable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	0.9	0.2	0.2	13.5	0.2	0.0	10.0	0.2	0.3	3.2	88.7	0.6	22.9	44.9	0.6	8.3	4.9	6.6	21.2	0.3	0.4	0.2	37.3	1.6	20.3	0.2	0.2	0.2	1.9	75.4	0.0	8.5	0.2	2.2	8.1	32.0	0.4	38.7	26.7	0.2	3.7	113.1	0.5	0.2	0.2	27.2	1.3	0.2	0.3	61.0	2.5	5.8	2.1	2.4	1.3	0.5	0.0	0.2	1.2	2.2	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.5	3.8	0.1	0.2	0.0	13.4	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.6	0.0	0.2	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	0.2	0.0	0.5	0.2	0.0	0.9	0.7	1.6	7.8	0.3	0.0	23.5	0.0	15.8	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.4	0.2	2.2	0.1	0.0	0.5	0.5	1.3	0.8	0.6	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	2.2	0.2
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464278-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 24.9;BJ hTERT+: 25.9;fHDF/TERT166: 31.2;HSkMC: 20.0;LHCN-M2: 30.2;U-138 MG: 37.2"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol				Nucleoplasm	"Midbody, Cytosol"	"HPA049254: "	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.6	4.4	4.7	7.0	4.9	0.9	11.3	21.1	7.6	20.3	5.2	2.2	1.8	2.9	15.7	4.6	4.1	5.8	8.2	16.9	4.7	3.8	3.6	1.5	10.0	3.1	2.3	4.9	6.9	2.4	1.8	2.5	12.8	9.6	10.9	6.7	1.4	3.2	3.9	30.4	4.4	4.9	11.6	3.0	4.3	4.3	3.2	1.6	0.0	4.9	14.2	1.8	8.7	23.2	0.5	1.4	0.7	3.2	0.2	0.2	1.0	1.1	0.0	2.5	0.0	7.1	24.9	0.0	11.2	25.9	16.2	12.4	0.0	0.0	0.0	0.0	31.2	0.0	2.5	0.2	17.0	0.0	0.6	0.0	0.3	0.0	6.8	0.0	0.0	20.0	2.8	4.8	15.2	0.5	0.0	0.0	30.2	0.0	0.0	0.0	0.2	0.4	0.0	1.9	0.0	1.3	0.0	0.0	5.0	0.0	0.0	0.3	0.0	0.0	0.1	37.2	4.3	1.2	5.8	0.1	0.0	0.0	2.1	0.0	1.2	0.5	3.2	0.2	0.1	1.8	0.1	0.2	0.1	0.0	1.4	0.5	0.1	0.2	0.7	0.2	1.1	0.5	0.1	1.0	4.7	4.9	21.1	7.6	4.7	3.8	2.3	4.9	9.6	1.6
PRR22	MGC24975	ENSG00000212123	"Proline rich 22"	Q8IZ63	19	5782960-5784765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"testis: 82.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044157	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA044157: AB_10960694"	"unprognostic (8.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.19e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.42e-3)"	"unprognostic (9.37e-3)"	"unprognostic (4.18e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-3)"	1.1	1.0	1.1	1.7	1.5	2.0	1.1	1.1	1.7	1.1	1.3	1.2	1.1	3.1	1.1	1.1	1.6	2.5	1.1	1.1	1.1	0.7	2.4	4.4	1.1	1.5	1.1	1.1	1.1	2.7	1.0	1.2	1.1	1.1	2.7	0.3	1.1	3.2	1.1	1.1	5.4	3.3	1.1	1.1	2.7	2.4	82.5	1.1	1.1	2.3	1.1	1.1	1.1	1.1	0.2	0.0	0.0	0.2	0.0	0.9	0.1	1.8	3.1	1.3	6.6	0.0	0.2	6.5	1.3	0.5	1.0	1.6	3.1	1.8	2.9	3.7	0.2	2.3	1.0	1.3	0.2	4.5	10.2	1.3	1.3	1.1	0.5	3.1	15.9	0.8	1.1	1.4	0.4	0.2	7.1	0.0	0.8	6.8	3.5	3.8	8.1	3.2	3.4	1.2	4.5	0.2	2.1	1.7	3.2	0.3	2.4	3.6	2.7	2.5	1.0	2.4	6.7	8.6	1.6	9.3	7.2	5.5	0.2	6.2	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.9	0.4	0.0	0.0	0.2	0.0	0.0	0.1	1.1	1.5	1.1	1.1	1.1	0.7	1.1	1.1	1.1	1.1
PRR3	"CAT56, Em:AB014077.1, Em:AB023052.2"	ENSG00000204576	"Proline rich 3"	P79522	6	30556886-30563723	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.0;HAP1: 12.6;U-266/84: 8.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064061			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA064061: "	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.25e-2)"	"unprognostic (3.73e-2)"	"prognostic favourable (6.49e-6)"	"prognostic favourable (5.61e-5)"	"unprognostic (4.71e-2)"	"prognostic unfavourable (7.84e-7)"	"unprognostic (2.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.21e-3)"	7.6	5.6	9.7	5.5	7.4	4.0	3.5	15.0	13.8	5.4	4.5	5.6	3.1	2.5	7.3	15.3	3.6	6.2	4.0	3.2	10.1	12.1	4.3	3.8	4.9	6.1	5.9	7.6	13.5	5.4	10.6	8.8	3.4	8.0	4.4	5.3	6.9	2.6	6.9	3.1	6.5	3.4	3.8	4.6	5.0	5.9	8.6	5.7	11.1	4.9	1.7	5.6	6.4	4.0	2.0	2.3	1.5	1.2	1.3	1.9	0.4	0.6	1.6	5.3	10.0	2.6	0.9	0.0	0.0	0.0	0.0	0.0	4.6	0.5	4.6	3.9	0.9	0.6	12.6	1.0	0.0	2.7	4.6	6.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	0.0	7.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	6.8	2.3	0.6	0.0	0.0	3.1	0.7	4.0	0.0	0.0	0.0	7.6	8.5	4.5	0.0	2.6	2.9	1.5	1.2	0.3	0.5	0.3	1.0	1.0	1.6	1.2	1.0	2.0	0.9	1.9	1.0	1.3	0.6	2.3	0.0	0.4	9.7	7.4	15.0	13.8	10.1	12.1	5.9	7.6	8.0	5.7
PRR5L	"FLJ14213, PROTOR-2"	ENSG00000135362	"Proline rich 5 like"	Q6MZQ0	11	36296288-36465204	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.1;intestine: 25.7;lymphoid tissue: 26.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 16.3;HMC-1: 27.1;hTERT-HME1: 28.2;SiHa: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070174			Approved	"Cytokinetic bridge,Cytosol"				"Cytokinetic bridge, Cytosol"		"HPA070174: "	"unprognostic (6.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	"prognostic favourable (7.30e-5)"	"unprognostic (2.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (7.71e-8)"	"prognostic unfavourable (4.86e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.98e-2)"	2.9	1.5	4.2	8.1	15.5	3.1	2.4	1.7	9.5	9.5	25.7	34.1	1.1	2.5	2.6	1.6	1.4	4.9	5.3	1.6	7.2	5.1	3.8	2.3	10.4	6.2	24.9	3.8	11.4	2.0	1.0	2.7	2.8	16.6	2.3	21.4	3.3	6.3	1.6	0.7	1.6	9.3	4.8	22.8	26.1	2.6	1.2	19.7	1.1	3.0	0.2	2.6	3.6	3.6	1.1	4.2	16.9	12.3	4.6	20.1	7.2	0.0	2.8	4.9	0.1	0.7	0.0	0.0	5.9	4.6	12.6	13.0	0.0	0.0	0.0	1.9	7.3	0.2	0.9	3.0	6.1	2.3	1.7	0.6	16.3	0.0	1.6	0.0	27.1	2.0	4.3	1.2	28.2	5.2	0.0	0.0	6.4	1.5	0.3	0.0	0.3	1.1	1.7	0.5	0.5	12.8	3.0	0.0	0.2	18.6	0.0	1.1	0.0	0.2	3.6	10.7	3.3	0.0	7.4	0.1	0.0	0.0	4.6	0.6	3.2	16.9	1.1	13.3	20.1	11.8	4.6	0.0	7.2	16.8	1.3	1.1	1.6	10.8	6.5	4.6	12.3	4.2	0.0	7.2	4.2	15.5	1.7	9.5	7.2	5.1	24.9	3.8	16.6	19.7
PRR7	MGC10772	ENSG00000131188	"Proline rich 7, synaptic"	Q8TB68	5	177446445-177456286	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046636	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046636: "	"unprognostic (3.69e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-3)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (8.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.69e-1)"	1.9	2.4	12.5	3.2	22.0	15.1	1.7	4.1	28.5	1.1	2.9	9.8	0.0	2.9	1.7	1.3	1.9	3.2	1.9	1.1	14.1	7.6	1.5	2.2	2.0	3.6	4.8	8.4	1.2	4.0	2.6	6.2	1.3	6.2	2.0	1.4	4.7	5.2	1.5	1.7	8.8	2.6	1.2	4.4	4.9	4.6	3.2	4.6	1.2	1.2	0.8	2.3	1.5	0.9	3.2	3.0	10.8	0.6	2.0	7.3	1.5	7.1	2.8	0.8	5.6	0.0	0.4	2.4	3.4	0.6	1.0	1.3	0.6	3.8	6.9	8.9	0.5	6.0	0.4	3.0	0.4	6.0	8.9	2.1	2.6	2.1	0.6	4.1	5.0	0.6	1.3	0.4	0.2	0.4	1.0	4.9	0.9	9.6	3.4	10.6	1.3	17.1	9.8	2.6	6.9	1.2	0.5	13.9	9.9	1.3	3.3	15.9	3.0	0.6	2.6	5.7	9.5	5.0	8.1	2.7	1.5	3.3	5.5	6.7	4.1	2.4	0.1	10.8	3.0	0.5	7.3	2.1	3.4	5.1	0.1	3.2	3.2	4.1	4.8	2.0	0.6	3.0	2.5	1.5	12.5	22.0	4.1	28.5	14.1	7.6	4.8	8.4	6.2	4.6
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620720-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 25.9;HEK 293: 47.2;U-266/70: 24.3;U-266/84: 25.8;U-698: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: , HPA066501: "	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	10.9	18.4	20.7	28.9	22.1	5.0	12.2	25.2	29.1	15.0	24.6	18.4	11.9	4.8	19.7	51.5	47.2	32.3	13.8	24.2	18.4	13.2	16.0	10.2	41.7	14.9	14.3	20.4	29.3	12.2	4.8	18.5	8.6	15.9	30.9	7.1	15.0	12.3	15.9	35.1	28.8	23.0	12.8	11.5	43.5	34.6	46.3	16.7	27.1	16.8	10.4	14.4	16.0	13.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	11.7	11.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.4	13.1	0.0	0.0	25.9	0.0	0.0	47.2	0.1	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	24.3	25.8	24.6	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	22.1	25.2	29.1	18.4	13.2	14.3	20.4	15.9	16.7
PRRC2B	"BAT2L, BAT2L1, KIAA0515, LQFBS-1, MGC10526"	ENSG00000130723	"Proline rich coiled-coil 2B"	Q5JSZ5	9	131373636-131500197	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021022, HPA064301"	Uncertain		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA021022: AB_1852324, HPA064301: "	"unprognostic (4.78e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.02e-1)"	"prognostic favourable (5.42e-9)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-2)"	27.4	29.1	43.3	30.3	44.1	30.3	22.1	54.6	56.3	29.4	26.3	32.7	27.3	18.9	33.8	19.7	35.7	36.1	27.5	28.0	39.0	34.1	24.7	18.1	22.5	31.8	26.8	36.8	51.4	30.2	42.0	35.5	23.6	28.9	28.2	15.1	31.8	23.0	29.9	29.4	42.4	23.0	27.2	21.4	27.4	22.2	21.9	26.9	28.1	29.9	18.3	28.1	26.0	29.5	10.3	6.9	4.1	4.5	5.8	7.4	3.0	17.5	34.1	36.5	25.2	27.9	28.8	36.5	17.8	17.5	20.8	17.3	32.0	15.0	30.5	21.1	20.4	42.4	36.4	15.2	15.8	31.3	19.7	19.0	60.1	14.0	18.8	25.1	25.1	28.2	20.2	22.5	26.3	24.0	34.4	22.8	18.7	36.9	21.0	16.2	26.5	14.0	40.8	37.2	29.3	15.1	27.6	49.3	31.0	43.2	26.4	17.9	53.4	15.6	34.7	46.7	21.7	20.6	23.3	10.1	25.0	41.0	16.4	13.6	23.1	4.1	4.5	2.7	7.4	1.9	5.5	5.5	4.4	6.6	2.3	10.3	7.2	6.3	3.2	5.8	1.1	6.9	3.6	3.0	43.3	44.1	54.6	54.7	39.0	34.1	26.8	36.8	28.9	26.9
PRRC2C	"BAT2D1, BAT2L2, KIAA1096, XTP2"	ENSG00000117523	"Proline rich coiled-coil 2C"	Q9Y520	1	171485551-171593511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025766, HPA028659"	Approved		Enhanced	Cytosol				Cytosol		"HPA025766: AB_1845277, HPA028659: AB_10600786"	"unprognostic (4.16e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.66e-3)"	"unprognostic (8.71e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (7.76e-6)"	"unprognostic (7.03e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.34e-2)"	33.1	21.2	32.9	40.1	35.7	61.2	32.6	44.3	37.0	35.1	26.0	19.8	41.4	21.2	32.9	38.8	37.3	28.5	26.3	23.5	27.4	25.4	25.5	30.2	35.2	39.8	33.8	30.2	37.3	29.6	47.2	43.7	35.9	30.6	28.7	32.4	18.2	31.4	53.9	24.5	38.5	33.2	32.9	36.7	37.3	27.6	27.3	36.9	45.3	29.5	30.3	41.1	35.3	33.8	4.8	4.4	7.5	2.9	5.8	3.0	1.0	26.5	20.6	29.0	19.0	20.5	24.0	21.5	15.4	22.0	18.1	16.6	31.5	19.1	39.2	24.3	22.5	23.9	31.3	24.5	27.9	22.0	16.7	29.8	15.9	21.9	21.4	48.2	24.4	23.1	18.9	30.5	45.8	26.2	39.3	21.7	20.5	12.7	28.8	20.5	38.2	36.0	21.8	21.6	19.2	25.6	29.9	18.7	19.3	23.4	28.0	17.8	19.0	34.0	32.6	20.6	19.0	19.9	31.9	18.3	19.5	57.7	13.1	23.9	18.4	3.4	2.9	1.5	2.9	2.7	3.0	3.7	2.8	2.8	1.2	4.8	2.6	3.0	7.5	5.8	2.8	4.4	2.1	1.0	32.9	35.7	44.3	37.0	27.4	25.4	33.8	30.2	30.6	36.9
PRRG2	PRGP2	ENSG00000126460	"Proline rich and Gla domain 2"	O14669	19	49580646-49591015	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 8.6;CAPAN-2: 12.0;RT4: 9.2;SK-BR-3: 10.8;T-47d: 11.6;U-266/84: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010702	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA010702: AB_1079693"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (3.82e-9)"	"unprognostic (4.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.68e-2)"	0.9	0.4	0.5	1.1	0.6	0.0	4.8	1.1	1.3	4.0	14.3	0.4	17.5	8.3	1.9	9.6	13.7	3.3	9.8	0.7	0.5	0.4	15.0	12.1	5.2	0.4	0.7	0.4	1.9	13.4	13.8	16.1	8.6	0.7	5.4	5.3	0.7	24.9	14.6	1.2	10.1	23.2	1.4	0.5	1.0	7.1	1.7	0.4	2.1	21.9	9.8	7.8	4.2	4.2	1.2	4.2	2.1	0.9	0.0	1.4	0.4	8.6	0.3	0.2	0.7	1.1	0.0	3.7	0.2	0.0	0.3	0.3	1.7	12.0	0.5	1.3	0.1	7.0	0.2	6.8	0.3	0.8	0.9	0.4	0.5	0.6	0.7	0.3	0.9	0.7	6.0	0.2	0.2	2.7	0.2	0.6	0.0	1.9	0.1	0.7	0.5	1.1	0.2	0.3	6.7	5.3	9.2	1.9	0.2	1.0	10.8	0.1	11.6	0.1	0.4	0.7	0.5	0.3	0.1	4.2	14.0	0.4	0.1	0.3	0.3	0.0	0.9	0.4	1.4	0.1	0.7	1.2	0.6	0.6	0.1	0.7	0.8	0.7	2.1	0.0	0.7	4.2	0.6	0.4	0.5	0.6	1.1	1.3	0.5	0.4	0.7	0.4	0.7	0.4
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952394	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.5;MCF7: 15.8;SK-BR-3: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		18000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA035127: AB_10602822, HPA035128: , HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	1.4	2.9	8.4	1.8	11.9	2.1	2.0	13.4	26.0	2.4	1.4	4.2	0.0	1.0	2.0	2.2	1.7	10.8	1.9	1.6	5.9	3.2	1.5	0.9	1.4	1.8	2.7	8.3	2.9	2.9	24.7	6.9	0.8	11.4	4.0	0.8	1.8	2.0	2.9	1.5	2.5	1.2	1.7	2.3	1.5	1.5	3.9	3.2	1.2	3.4	0.0	2.0	2.1	1.8	1.8	1.5	0.9	0.6	1.7	3.8	1.0	0.2	0.7	2.5	3.3	12.5	1.7	0.8	1.2	2.4	1.4	3.3	0.2	2.4	1.3	0.3	2.9	0.2	0.9	3.1	0.6	6.7	1.4	0.5	1.3	0.0	1.2	0.3	1.2	3.2	0.2	1.2	0.5	0.6	0.7	3.3	1.8	15.8	3.0	0.2	6.1	1.5	1.8	0.3	1.3	0.7	0.2	4.8	3.2	1.2	23.8	0.4	6.4	0.2	0.6	0.3	3.4	0.6	0.9	4.3	4.4	0.4	7.9	0.2	0.9	0.9	0.6	0.5	3.3	0.3	3.7	1.6	3.4	3.3	0.2	1.8	3.8	3.5	0.8	1.7	0.4	1.5	0.6	1.0	8.4	11.9	13.4	26.0	5.9	3.2	2.7	8.3	11.4	3.2
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 21.0;salivary gland: 20.9;testis: 37.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.2;HEL: 11.3;HeLa: 29.2;K-562: 13.4;U-698: 41.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 10.5;eosinophil: 21.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	27	"basal ganglia: 6.7"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.8	0.0	0.2	0.2	0.2	5.5	1.0	0.4	0.4	1.4	0.4	0.2	1.4	0.2	0.3	0.2	0.8	2.2	2.1	0.2	0.2	0.0	0.2	0.2	2.1	3.3	0.2	0.2	0.3	0.9	1.7	0.2	0.3	0.4	1.8	0.2	0.2	20.9	0.2	0.5	0.4	0.4	0.2	0.2	0.9	0.4	37.5	0.2	0.9	0.2	1.2	1.1	0.3	0.6	0.8	1.4	21.0	2.3	1.0	3.3	1.3	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	11.3	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	10.5	2.3	21.0	2.2	1.6	3.3	0.8	1.1	1.8	0.6	0.6	1.5	2.2	0.2	1.0	0.3	1.4	0.5	1.3	0.2	0.2	0.4	0.4	0.2	0.0	0.2	0.2	0.4	0.2
PRTFDC1	HHGP	ENSG00000099256	"Phosphoribosyl transferase domain containing 1"	Q9NRG1	10	24848607-24952604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 29.6;CAPAN-2: 37.3;HEL: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 7.9"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 7.9"									HPA021458	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA021458: AB_1855793"	"unprognostic (2.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (9.49e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.94e-2)"	4.1	18.3	18.1	3.3	18.2	0.6	6.1	6.1	24.0	8.1	7.7	29.0	2.4	13.9	12.9	6.1	4.5	5.9	11.8	8.6	16.8	13.0	4.0	2.2	3.4	2.8	18.1	12.6	17.1	3.6	10.2	11.0	2.3	16.2	6.5	9.2	6.0	7.2	6.9	0.9	1.4	13.2	8.0	22.5	2.3	13.8	1.7	20.7	2.3	3.7	1.1	2.4	6.0	4.6	0.0	0.3	0.1	0.0	7.9	1.1	1.7	7.4	16.2	12.1	4.9	2.0	10.1	0.0	7.9	6.0	5.7	7.8	29.6	37.3	0.0	1.2	9.3	4.2	13.7	0.0	8.9	0.0	0.5	21.7	3.0	0.0	6.0	0.0	0.0	2.9	0.1	3.1	0.0	8.9	7.0	4.2	2.7	0.2	3.3	0.0	8.3	0.3	3.7	0.0	0.0	5.1	0.2	8.7	0.4	7.6	0.0	0.0	0.4	1.7	4.8	2.5	6.4	9.2	4.7	0.4	0.0	0.0	6.8	0.0	0.3	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.4	0.5	0.3	0.0	0.1	0.3	0.1	7.9	0.0	0.2	0.0	1.7	18.1	18.2	6.1	15.8	16.8	13.0	18.1	12.6	16.2	20.7
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611546-55743090	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.5;thyroid gland: 23.9"	"Cell line enriched"	"Detected in many"	6	"AF22: 57.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	1.3	2.2	1.5	1.1	1.8	0.6	2.4	1.2	2.2	4.7	1.4	3.6	1.1	0.7	11.0	4.6	0.7	2.4	1.0	1.3	1.6	1.6	2.6	0.6	5.0	0.6	3.0	2.0	4.5	0.6	6.4	2.7	6.5	4.3	1.4	0.9	16.5	0.9	1.4	3.9	0.6	0.9	2.9	3.5	0.5	1.5	6.5	2.3	0.0	23.9	0.8	0.9	1.2	1.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.5	1.2	57.4	1.2	0.0	0.0	5.8	0.4	1.7	1.4	2.1	9.6	0.3	0.0	2.4	0.0	0.0	0.2	0.1	2.0	0.0	3.0	0.4	0.4	3.6	0.4	0.4	0.0	0.2	0.0	0.6	1.0	1.0	1.0	0.0	0.8	0.8	0.0	0.0	2.3	1.4	0.0	9.1	0.0	1.1	0.1	0.7	3.3	0.5	0.7	3.1	0.2	0.1	0.1	0.8	0.6	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	1.8	1.2	2.2	1.6	1.6	3.0	2.0	4.3	2.3
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol			210000	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	9.3	9.7	9.3	8.8	11.6	3.7	16.0	15.7	16.4	15.0	12.5	10.9	16.2	11.7	17.9	15.7	11.5	15.6	12.8	31.3	10.5	10.3	18.0	12.8	10.1	11.8	11.9	9.2	17.1	16.2	16.5	16.2	7.2	8.8	12.2	14.0	12.7	13.3	18.2	24.4	10.5	11.8	14.7	7.9	11.0	10.5	16.3	8.6	15.0	41.6	8.5	12.9	13.8	13.6	12.1	9.5	14.7	8.9	14.3	19.0	18.3	3.8	4.1	7.4	7.1	9.2	2.5	4.1	1.8	4.0	6.9	6.0	5.1	4.6	7.9	8.0	2.4	5.6	7.2	4.8	5.5	8.6	8.2	9.3	4.3	7.2	5.1	6.1	4.7	3.1	9.2	3.6	3.6	3.2	7.3	6.7	3.2	9.3	9.3	5.0	6.9	5.4	8.5	4.7	7.6	4.9	5.3	10.7	8.7	6.2	8.6	5.7	11.9	9.3	2.2	2.4	2.9	2.7	2.9	16.4	13.8	61.0	2.4	4.7	6.1	12.5	6.4	13.4	14.0	6.0	16.9	12.1	15.5	15.7	9.5	11.6	19.0	15.0	14.7	14.3	8.9	5.1	14.5	18.3	9.3	11.6	15.7	16.4	10.5	10.3	11.9	9.2	8.8	8.6
PSAPL1		ENSG00000178597	"Prosaposin like 1 (gene/pseudogene)"	Q6NUJ1	4	7430294-7434973	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skin 1: 42.2;stomach 1: 23.9;testis: 19.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;HaCaT: 3.8;hTCEpi: 4.8;RPMI-8226: 20.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA038013: AB_10673652, HPA038482: "		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	1.4	0.6	0.0	1.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297143-78330093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 56.0;liver: 112.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 148.4;SK-MEL-30: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol			1700000	Cytosol		"CAB014882: , CAB040567: , HPA042924: "	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	3.1	25.0	44.6	3.8	33.4	1.7	3.0	8.5	50.5	2.4	3.3	44.8	0.9	3.2	2.7	28.4	9.3	16.0	1.6	1.4	33.9	22.3	56.0	112.2	1.6	4.5	42.2	24.6	3.7	54.6	4.8	2.1	2.2	21.9	5.3	3.3	8.1	26.2	2.8	1.1	24.7	2.8	2.3	29.8	2.4	7.0	5.1	35.0	2.2	13.7	4.9	5.9	4.2	2.6	3.0	0.2	0.2	0.1	0.0	13.3	3.1	26.8	18.1	15.2	27.0	4.5	5.3	36.0	22.8	16.3	11.6	21.8	4.6	5.2	17.4	10.1	51.3	26.7	26.0	25.2	17.4	17.0	9.2	5.9	8.3	35.5	41.8	33.2	10.7	16.9	148.4	15.4	41.3	10.6	6.4	45.0	9.6	10.0	11.3	5.3	34.9	19.8	5.6	9.9	20.5	15.8	6.2	6.9	16.1	6.3	11.0	90.8	5.2	41.9	2.4	2.9	9.5	10.8	18.5	30.6	28.2	0.1	34.3	26.3	13.9	0.0	0.0	0.0	4.9	0.0	5.7	3.0	4.8	6.5	0.2	1.0	7.9	7.3	0.2	0.0	0.1	0.0	13.3	3.1	44.6	33.4	8.5	24.9	33.9	22.3	42.2	24.6	21.9	35.0
PSD	"EFA6, EFA6A, KIAA2011, PSD1, TYL"	ENSG00000059915	"Pleckstrin and Sec7 domain containing"	A5PKW4	10	102402617-102421539	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.8"	"Cell line enhanced"	"Detected in some"		"HSkMC: 10.1;MOLT-4: 5.4;SCLC-21H: 9.4;SH-SY5Y: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059237	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA059237: "	"unprognostic (2.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	1.2	9.8	48.7	4.3	59.4	1.6	1.5	8.0	66.8	6.7	21.5	1.7	0.0	6.7	23.9	2.4	3.2	11.1	9.4	1.9	48.7	12.2	1.5	1.4	1.7	1.8	7.6	26.7	5.6	4.7	2.5	13.6	1.8	4.2	6.2	4.4	3.7	1.5	2.2	1.2	2.1	5.8	20.7	1.8	1.5	4.8	4.6	7.0	0.0	1.2	0.0	1.5	11.7	3.0	0.8	0.0	1.1	0.2	0.9	1.3	0.0	0.3	0.1	3.8	3.4	1.4	0.8	0.3	0.3	0.0	0.1	0.0	2.6	0.4	0.3	2.4	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.1	2.1	0.0	0.1	10.1	0.3	0.6	0.1	0.0	0.5	0.9	0.0	2.0	5.4	0.3	0.5	0.0	1.4	0.0	0.1	0.0	0.2	9.4	8.3	0.1	0.1	0.2	0.6	0.5	0.0	2.8	4.6	0.2	0.0	2.4	0.3	0.1	0.3	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.2	0.3	0.0	0.8	0.3	1.3	1.1	0.9	0.0	0.0	0.0	0.0	48.7	59.4	8.0	41.2	48.7	12.2	7.6	26.7	4.2	7.0
PSD3	"DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942"	ENSG00000156011	"Pleckstrin and Sec7 domain containing 3"	Q9NYI0	8	18527301-19084730	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.6;LHCN-M2: 22.4;U-87 MG: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA002455	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA002455: "	"unprognostic (3.87e-2)"	"unprognostic (2.52e-2)"	"prognostic favourable (7.55e-4)"	"prognostic unfavourable (5.76e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.45e-1)"	2.3	15.5	18.3	2.7	40.5	1.3	5.2	51.6	50.7	11.3	5.7	13.4	2.5	4.2	7.8	3.6	4.8	2.6	6.5	21.8	23.2	9.3	2.1	15.6	4.1	2.2	10.0	27.6	16.0	8.3	9.5	9.6	5.6	10.7	3.7	6.5	5.4	3.2	5.5	1.3	3.9	4.3	5.2	7.4	8.4	8.0	12.7	11.4	0.0	5.4	1.4	3.1	6.1	3.3	3.1	0.6	2.3	1.3	1.9	2.0	0.7	5.0	2.6	11.9	0.0	4.3	26.6	0.6	2.7	4.2	2.4	5.1	1.5	2.0	3.0	1.7	10.9	0.4	3.4	4.7	4.7	0.0	3.1	0.2	2.1	0.2	7.8	0.0	0.1	7.0	3.0	13.5	2.4	3.2	0.3	2.4	22.4	1.7	0.0	0.5	2.3	7.0	2.3	10.4	1.3	6.2	6.5	5.1	5.7	1.1	0.5	1.8	0.0	1.2	13.1	7.6	5.3	17.9	2.3	0.2	0.3	6.9	24.0	1.2	2.6	2.3	1.3	1.3	1.0	0.8	1.3	1.6	1.0	0.6	0.5	3.1	0.5	0.6	1.5	1.9	1.1	0.6	2.0	0.7	18.3	40.5	51.6	50.7	23.2	9.3	10.0	27.6	10.7	11.4
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86048373-86088621	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"kidney: 1.9;placenta: 1.2;testis: 2.0"	"Cell line enriched"	"Detected in single"	18	"HEL: 13.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015095, HPA056839"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome subunit alpha 4"	P25789	15	78540405-78552419	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol			12000000	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: , HPA060613: "	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	41.2	38.8	24.9	36.7	25.8	33.4	33.0	25.3	37.5	32.4	38.0	17.9	23.7	39.4	35.3	32.5	49.9	27.1	24.4	37.7	29.8	27.6	55.7	76.3	37.4	45.1	25.5	26.9	31.2	24.4	20.2	25.9	55.4	33.8	35.3	41.3	19.1	26.0	25.0	60.3	26.3	49.1	36.6	28.1	45.5	31.5	36.5	21.4	61.6	42.6	75.0	44.8	41.3	28.3	29.4	61.9	31.4	75.6	37.7	40.0	61.4	40.1	58.2	50.4	44.4	31.8	30.1	39.5	37.8	30.4	46.6	50.0	60.5	58.7	87.7	55.9	34.8	55.0	101.6	41.0	45.1	35.9	70.8	73.6	43.6	48.7	51.6	74.8	45.5	24.3	25.7	39.2	39.1	50.2	78.9	34.4	38.0	57.8	50.4	70.2	47.4	34.2	43.9	66.7	29.4	47.2	70.4	44.5	32.5	60.6	44.3	46.1	40.9	61.6	39.9	34.8	46.5	38.3	64.3	31.5	74.2	82.7	32.6	112.5	38.3	18.8	47.4	31.4	27.8	75.6	28.5	29.4	29.2	29.0	61.9	22.9	23.3	28.3	21.7	37.7	69.7	35.3	40.0	61.4	24.9	25.8	25.3	37.5	29.8	27.6	25.5	26.9	33.8	21.4
PSMA5	ZETA	ENSG00000143106	"Proteasome subunit alpha 5"	P28066	1	109399031-109426427	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028392, HPA028398, HPA028441"	Approved		Supported	Cytosol			22000000	Cytosol		"HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003"	"unprognostic (3.82e-2)"	"unprognostic (3.09e-3)"	"prognostic favourable (1.45e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.05e-1)"	12.1	23.7	13.2	17.3	15.0	7.7	16.2	8.2	40.5	13.3	16.1	9.8	16.7	15.1	15.8	23.0	21.5	17.6	16.7	20.8	13.8	13.5	27.5	41.9	17.1	24.2	13.4	14.9	13.6	21.4	12.6	11.5	20.9	12.8	12.3	14.9	10.2	16.8	14.2	31.6	15.8	21.8	14.4	12.9	18.5	15.2	16.3	10.3	31.5	27.9	23.4	19.8	14.0	11.7	2.1	1.2	7.3	2.2	2.8	7.1	1.6	1.2	1.0	1.6	1.2	3.8	4.1	1.4	0.9	9.1	6.0	3.5	1.2	1.1	5.2	1.2	4.0	1.6	2.3	3.1	3.7	1.1	1.5	2.2	0.9	1.5	2.9	2.9	1.2	1.9	3.0	1.8	3.0	2.2	1.8	1.4	2.5	1.5	30.5	1.2	1.4	1.5	0.8	3.1	0.8	4.8	1.6	1.4	1.1	1.6	5.4	1.9	1.2	2.6	1.4	1.0	0.7	2.1	1.2	0.8	1.8	6.6	6.6	6.6	1.0	7.3	1.0	0.7	4.0	2.2	4.8	1.8	5.8	4.9	1.2	2.1	7.1	6.5	0.3	2.8	2.0	0.8	5.3	1.6	13.2	15.0	8.2	17.5	13.8	13.5	13.4	14.9	12.8	10.3
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome subunit beta 10"	P40306	16	67934502-67937087	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 117.3"	"Cell line enhanced"	"Detected in many"		"REH: 36.0;U-266/70: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA030224, HPA030225, CAB034384"	Enhanced		Supported	Vesicles,Cytosol			1400000	Cytosol	Vesicles	"CAB034384: AB_2171876, HPA030224: , HPA030225: AB_10603231"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-2)"	"prognostic favourable (5.44e-4)"	11.5	13.0	9.1	24.9	11.8	23.9	11.4	4.0	7.8	8.0	21.6	5.6	8.5	42.4	9.3	9.5	10.6	12.4	16.6	12.0	6.9	4.9	16.9	17.2	19.5	38.3	9.5	5.6	8.7	61.5	0.9	6.9	11.2	8.5	13.5	6.3	5.8	27.9	11.6	6.9	7.0	35.6	7.7	6.5	49.7	23.8	2.5	7.8	39.2	13.1	10.4	20.5	13.2	8.4	50.8	75.2	100.0	98.1	69.1	68.8	117.3	5.9	5.3	0.4	0.8	0.4	3.5	21.0	2.0	8.5	6.9	9.8	2.7	29.1	21.6	3.7	2.7	8.7	0.1	1.9	0.5	9.6	0.5	7.7	1.8	3.0	12.0	14.3	23.6	5.3	1.2	3.0	0.0	4.0	0.7	8.3	1.9	7.4	28.1	14.7	0.3	2.0	36.0	2.2	29.5	4.7	10.4	0.3	0.4	6.7	11.8	2.6	2.4	31.0	6.7	4.4	1.2	1.9	2.3	40.3	7.2	14.4	10.9	18.7	9.5	57.1	89.4	67.1	68.8	98.1	50.2	50.8	54.0	57.3	74.6	49.1	45.3	50.1	100.0	69.1	71.4	75.2	60.8	117.3	9.1	11.8	4.0	7.8	6.9	4.9	9.5	5.6	8.5	7.8
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome subunit beta 6"	P28072	17	4796144-4798503	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol			2800000	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: "	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavourable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	28.6	35.0	33.7	23.2	36.4	31.7	34.0	24.2	41.5	29.6	31.7	26.7	26.8	22.6	33.4	47.1	41.9	30.3	24.2	72.0	30.4	30.5	41.4	67.1	25.7	35.3	33.4	34.0	25.3	41.8	40.8	26.6	49.6	35.9	26.4	36.1	23.5	30.6	36.6	97.4	33.6	23.2	40.5	29.7	29.0	31.2	27.0	28.0	35.8	34.6	53.8	39.6	27.9	26.0	93.9	96.3	51.1	95.3	60.4	81.2	107.9	46.0	80.6	43.5	37.1	37.1	33.4	50.2	24.4	51.1	74.7	58.6	59.9	37.6	35.8	48.5	58.4	46.7	66.1	68.4	72.9	46.6	69.7	21.2	53.0	69.6	42.8	21.9	33.9	31.5	52.5	65.2	62.1	72.5	32.4	54.5	57.2	54.8	38.7	36.6	36.9	56.0	43.4	30.9	47.4	56.0	31.1	25.5	31.3	35.0	27.4	25.1	33.4	24.6	34.5	36.9	27.9	49.5	59.0	22.8	30.3	21.8	52.8	40.1	44.3	51.1	95.3	50.5	57.1	87.5	57.8	93.9	62.3	62.6	96.3	79.8	53.7	56.1	32.9	60.4	78.0	89.7	81.2	107.9	33.7	36.4	24.2	41.5	30.4	30.5	33.4	34.0	35.9	28.0
PSMB7		ENSG00000136930	"Proteasome subunit beta 7"	Q99436	9	124353466-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Supported	Nucleoplasm,Cytosol			2700000	Nucleoplasm	Cytosol	"HPA052408: , HPA054902: "	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	36.9	56.9	51.0	32.8	55.1	53.4	41.9	33.7	52.7	26.6	33.3	34.0	27.9	32.5	33.6	52.1	41.9	32.6	29.2	59.6	44.5	41.3	53.7	87.1	27.0	33.6	43.6	46.9	32.7	67.1	38.5	24.1	53.2	47.3	28.8	37.1	31.1	48.2	26.9	76.7	48.7	32.2	31.4	39.9	28.6	33.1	50.3	36.5	48.2	32.7	67.7	39.5	32.3	30.8	53.4	67.9	45.2	62.7	53.6	66.2	69.0	51.9	63.5	43.5	52.5	30.7	36.7	62.7	50.6	69.8	73.4	50.7	83.4	50.8	59.3	40.9	47.3	74.4	54.1	53.6	67.4	57.0	46.7	37.1	101.0	69.2	69.5	73.6	37.1	43.9	47.3	76.4	76.6	61.5	75.7	42.2	56.6	90.4	52.8	49.5	64.3	90.9	46.8	64.9	69.3	51.9	34.0	51.3	41.8	48.1	61.7	74.9	71.1	32.4	48.7	47.5	38.3	60.6	75.7	45.8	128.3	59.8	79.4	45.4	66.7	40.4	61.7	45.2	41.8	62.7	45.0	53.4	48.1	46.1	67.9	47.5	46.3	44.9	27.3	53.6	58.4	57.8	66.2	69.0	51.0	55.1	33.7	52.7	44.5	41.3	43.6	46.9	47.3	36.5
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome subunit beta 9"	P28065	6	32844136-32859585	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 69.1;lymphoid tissue: 54.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 29.1;REH: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol			420000	Cytosol		"CAB015180: AB_2172368, HPA042818: , HPA053280: "	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	13.3	9.7	5.0	30.0	7.9	10.7	11.6	1.6	5.3	7.6	16.5	6.0	3.4	15.7	8.8	7.1	10.8	7.4	10.8	8.9	5.1	4.7	12.2	12.2	17.7	32.7	7.3	3.7	9.2	5.4	1.2	4.5	5.5	6.3	12.5	5.8	7.7	9.0	3.5	6.2	7.6	36.1	5.7	9.8	54.9	11.2	3.0	6.7	35.4	14.4	9.3	35.2	15.9	8.8	31.8	17.2	69.1	30.5	23.4	31.1	45.7	0.0	1.4	0.0	0.1	1.1	2.9	2.0	0.2	3.2	4.2	9.7	0.0	9.1	29.1	0.4	2.6	5.9	0.4	6.2	0.5	16.4	0.0	17.7	0.5	1.1	15.7	3.1	1.3	1.3	0.2	2.6	0.4	1.5	0.7	5.4	1.4	0.4	13.4	4.1	0.0	0.9	21.5	0.0	6.9	2.8	0.5	0.0	0.0	2.7	1.7	1.9	2.3	6.5	1.5	4.5	0.4	8.5	2.5	10.1	15.3	9.3	4.6	11.8	3.8	21.9	22.4	39.3	28.7	30.5	23.8	31.8	23.3	27.5	17.2	23.4	17.5	22.9	69.1	23.4	29.4	12.7	31.1	45.7	5.0	7.9	1.6	5.3	5.1	4.7	7.3	3.7	6.3	6.7
PSMC1	"p56, S4"	ENSG00000100764	"Proteasome 26S subunit, ATPase 1"	P62191	14	90256495-90275429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 178.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000872	Approved		Enhanced	Nucleoplasm,Cytosol			46000	"Nucleoplasm, Cytosol"		"HPA000872: AB_1079705"	"unprognostic (4.10e-1)"	"unprognostic (9.70e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-2)"	23.7	21.6	28.2	16.7	26.6	26.9	24.6	17.1	39.1	18.4	21.0	11.8	14.3	12.7	23.7	27.9	23.4	18.0	13.7	34.5	37.8	19.1	22.8	29.7	17.9	16.2	19.8	29.3	16.1	20.4	21.8	15.9	25.3	37.2	19.0	23.0	12.1	18.9	22.8	178.0	22.9	17.2	23.2	31.3	19.3	20.0	42.1	15.6	14.4	18.0	29.2	25.4	23.3	17.2	21.4	37.7	57.0	38.1	28.7	36.4	37.8	31.8	30.2	34.8	36.3	30.6	28.2	36.6	30.9	43.3	68.3	51.6	27.9	36.0	27.2	47.2	37.3	33.1	42.5	36.0	80.0	32.4	18.6	21.3	20.3	23.9	26.4	32.2	28.6	25.2	28.6	44.4	32.7	41.1	30.0	16.4	46.9	60.4	24.0	42.0	30.7	37.5	28.8	45.1	22.2	38.4	33.2	36.6	24.5	25.2	65.6	25.8	41.2	28.5	31.1	26.3	23.6	28.2	44.6	28.4	44.7	40.3	38.1	29.4	40.1	30.9	37.6	57.0	26.6	34.1	26.2	21.4	27.5	27.2	37.7	20.7	25.3	24.8	41.7	28.7	38.1	26.4	36.4	37.8	28.2	26.6	17.1	39.1	37.8	19.1	19.8	29.3	37.2	15.6
PSMC2	"MSS1, Nbla10058, S7"	ENSG00000161057	"Proteasome 26S subunit, ATPase 2"	P35998	7	103344254-103369395	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019238, HPA049621"	Supported		Supported	"Cytosol,Cytoplasmic bodies"			39000	"Cytosol, Cytoplasmic bodies"		"HPA019238: AB_1855834, HPA049621: "	"unprognostic (4.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.41e-1)"	29.3	35.8	29.4	27.2	35.3	41.6	24.4	25.9	39.7	23.2	23.4	26.2	22.0	22.8	28.2	26.6	29.9	22.5	19.5	38.5	30.1	24.7	36.9	58.8	24.4	26.2	32.0	29.9	23.7	18.5	27.8	33.6	31.1	37.0	23.1	24.8	23.2	24.1	24.8	83.5	31.2	23.2	29.2	31.5	28.4	24.9	23.4	34.3	27.5	25.5	35.2	31.8	26.5	22.2	25.7	40.7	65.7	52.3	29.6	50.2	35.1	51.5	36.2	31.0	45.6	33.4	25.0	28.6	38.5	35.7	44.9	45.1	43.9	45.9	34.8	82.5	33.8	31.8	39.1	27.4	47.2	55.4	26.4	31.1	30.0	31.9	29.4	50.7	38.8	22.2	22.4	44.8	15.0	33.5	72.0	47.4	38.4	73.8	50.1	33.6	38.6	38.2	28.2	38.8	40.7	30.5	32.3	28.2	25.3	36.1	53.6	33.6	24.7	25.9	35.7	39.5	47.9	74.4	60.7	42.6	99.0	68.1	43.7	53.5	60.6	65.7	30.5	28.1	26.5	44.2	30.1	25.7	31.0	28.2	40.7	20.1	27.5	27.6	4.6	29.6	52.3	23.8	50.2	35.1	29.4	35.3	25.9	39.7	30.1	24.7	32.0	29.9	37.0	34.3
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Supported	Nucleoplasm,Cytosol			180000	"Nucleoplasm, Cytosol"		"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	27.9	25.9	37.3	24.1	49.3	31.8	26.2	25.6	39.7	25.1	28.2	24.9	21.1	20.3	27.2	26.0	29.4	25.0	21.8	45.7	32.8	28.0	30.7	60.2	21.5	22.8	36.1	27.3	21.0	25.2	31.0	16.8	39.8	28.2	22.6	24.0	21.3	32.1	29.8	134.7	34.8	20.9	30.8	24.3	25.7	24.9	24.0	22.9	33.5	27.1	38.3	28.8	25.5	25.3	39.2	45.1	32.6	54.7	45.0	51.1	61.3	39.0	44.5	42.8	31.5	20.6	22.2	41.7	32.6	48.5	82.1	58.3	39.6	22.9	31.7	20.3	41.0	39.3	37.5	42.7	37.1	47.2	48.4	30.5	54.5	38.2	26.6	35.5	32.6	24.7	23.1	33.3	37.6	46.0	43.1	30.0	50.0	87.1	44.7	45.2	41.9	53.8	47.3	84.2	27.8	38.2	29.5	31.3	27.1	26.7	37.7	20.5	46.5	37.1	32.5	47.1	59.6	66.6	83.5	32.5	37.5	36.7	48.6	35.6	58.8	24.4	43.5	32.6	47.9	53.1	43.7	39.2	40.4	43.8	45.1	32.8	35.6	36.2	9.8	45.0	54.7	45.1	51.1	61.3	37.3	49.3	25.6	39.7	32.8	28.0	36.1	27.3	28.2	22.9
PSMC4	"MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7"	ENSG00000013275	"Proteasome 26S subunit, ATPase 4"	P43686	19	39971005-39981441	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002044, HPA005471"	Approved		Supported	Nucleoplasm,Cytosol			66000	"Nucleoplasm, Cytosol"		"HPA002044: AB_1079707, HPA005471: AB_1855838"	"unprognostic (1.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-1)"	24.0	31.3	23.4	26.1	26.9	15.0	20.3	23.9	37.1	22.8	25.0	26.1	24.9	26.4	29.8	34.0	29.9	25.1	22.2	35.9	24.1	25.4	40.4	65.6	20.1	21.3	25.6	27.4	22.7	19.6	33.1	22.1	29.7	32.3	22.5	24.6	21.8	21.1	28.1	57.3	25.8	24.8	27.1	26.0	25.2	24.1	29.7	25.5	27.9	30.2	28.0	28.5	28.9	20.1	18.1	34.4	16.0	43.1	19.8	28.1	25.8	22.4	72.9	14.8	19.3	12.7	10.6	17.0	13.3	16.3	29.6	23.0	42.1	16.3	11.2	26.0	15.7	12.1	19.8	18.0	22.5	19.8	20.8	16.5	13.7	34.2	18.7	17.1	19.8	11.1	14.6	24.1	16.5	19.3	21.1	17.1	18.1	33.9	20.3	9.9	26.7	22.2	17.8	17.8	16.1	19.7	33.8	19.2	24.7	15.1	24.0	12.0	16.6	15.1	12.8	19.4	19.4	17.7	32.3	20.7	35.9	17.2	24.6	18.2	21.4	14.8	20.5	16.0	23.6	32.2	20.0	18.1	21.1	23.9	34.4	16.9	17.1	17.6	11.1	19.8	43.1	17.1	28.1	25.8	23.4	26.9	23.9	37.1	24.1	25.4	25.6	27.4	32.3	25.5
PSMC5	"p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1"	ENSG00000087191	"Proteasome 26S subunit, ATPase 5"	P62195	17	63827152-63832026	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017871, HPA064293"	Enhanced		Supported	"Plasma membrane,Cytosol"			100000	"Plasma membrane, Cytosol"		"HPA017871: AB_1857638, HPA064293: AB_2685234"	"unprognostic (9.65e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (9.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	36.8	43.1	44.8	35.8	42.6	26.7	30.3	47.7	48.3	29.5	36.5	30.3	40.8	26.2	32.0	42.4	46.0	32.2	42.0	41.7	38.6	42.9	52.3	48.7	26.3	33.5	50.1	42.2	28.2	36.7	77.0	32.6	42.9	41.8	32.7	36.7	26.7	36.0	41.7	94.2	45.2	28.9	41.8	39.3	33.4	33.2	32.7	35.7	33.0	37.8	60.4	43.9	33.3	32.4	30.4	31.2	30.9	40.9	34.2	57.7	40.5	41.6	62.8	43.9	28.4	30.8	32.6	36.2	42.5	30.5	51.5	40.9	67.5	26.1	28.1	29.3	42.4	31.1	44.1	39.4	73.9	25.2	46.6	61.9	51.5	55.0	30.8	61.9	41.4	32.5	29.6	52.7	48.8	46.4	46.4	36.1	47.7	73.1	45.7	23.4	38.6	54.3	42.9	87.1	40.8	36.3	49.1	36.9	50.3	29.1	51.4	24.0	50.7	30.0	43.5	63.2	59.4	29.1	85.2	38.3	59.1	45.5	37.9	44.6	40.1	22.8	25.6	30.9	37.8	37.2	51.4	30.4	44.8	40.4	31.2	24.4	37.7	42.2	8.1	34.2	40.9	22.4	57.7	40.5	44.8	42.6	47.7	48.3	38.6	42.9	50.1	42.2	41.8	35.7
PSMC6	p42	ENSG00000100519	"Proteasome 26S subunit, ATPase 6"	P62333	14	52707172-52728587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042823	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			190000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042823: "	"unprognostic (2.38e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.14e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.67e-1)"	30.4	31.1	29.1	23.0	36.8	19.9	30.7	30.1	40.9	26.4	26.4	19.7	29.8	25.6	27.8	27.0	38.0	26.1	19.3	39.7	30.6	28.3	36.1	45.7	21.6	25.7	29.9	35.0	27.8	25.2	26.5	34.7	37.1	44.0	25.5	28.8	14.7	23.4	25.3	73.3	23.0	26.4	29.5	30.1	28.2	24.9	15.5	31.1	30.0	28.6	44.9	32.9	31.6	24.5	37.6	43.1	37.0	40.9	29.8	48.5	40.6	46.5	30.2	36.4	26.9	25.4	26.6	39.3	36.7	35.3	59.7	45.0	37.8	38.3	40.6	46.0	31.8	35.6	46.2	32.1	62.8	38.9	20.1	29.7	24.8	40.3	30.8	42.1	28.9	19.7	32.2	30.1	30.5	37.4	44.1	17.6	43.4	42.7	32.8	29.2	29.3	41.6	28.0	63.8	18.1	39.3	47.5	26.2	19.4	32.6	20.5	31.3	42.1	30.8	28.6	33.3	46.7	25.7	37.6	12.5	31.6	45.4	21.5	28.9	30.1	35.8	36.5	37.0	32.1	40.9	37.1	37.6	39.6	34.9	43.1	34.2	38.2	37.3	30.6	29.8	39.9	22.4	48.5	40.6	29.1	36.8	30.1	40.9	30.6	28.3	29.9	35.0	44.0	31.1
PSMD10	p28	ENSG00000101843	"Proteasome 26S subunit, non-ATPase 10"	O75832	X	108084207-108091618	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002920, CAB010434"	Approved		Supported	"Intermediate filaments,Cytosol"			82000	Cytosol	"Intermediate filaments"	"CAB010434: AB_640866, HPA002920: AB_1079708"	"unprognostic (1.59e-3)"	"unprognostic (4.12e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.95e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	15.8	23.6	35.5	14.3	32.1	14.2	20.9	27.4	31.1	21.7	19.0	30.3	13.4	14.8	22.4	29.8	21.6	27.1	15.1	14.7	32.0	50.2	20.5	19.0	16.5	18.0	38.9	29.6	19.9	11.1	20.3	20.9	26.1	39.0	19.4	19.8	17.1	14.6	19.0	13.3	15.3	17.4	21.6	38.9	14.8	15.7	15.6	23.8	21.2	24.3	12.2	21.8	22.0	16.1	28.1	30.7	40.2	38.8	32.2	32.4	35.1	31.0	31.6	21.7	19.5	33.0	24.9	19.7	25.6	21.3	23.2	20.3	18.8	20.0	26.5	39.3	24.4	16.9	34.1	24.7	35.8	28.7	29.4	15.5	30.7	23.6	16.8	24.0	17.4	18.9	27.0	21.5	26.1	57.2	29.9	36.0	28.9	40.7	22.6	21.0	39.4	43.1	22.9	31.1	28.0	24.9	20.2	14.0	13.4	39.2	16.3	25.7	17.6	20.8	41.0	18.5	10.7	31.1	18.9	28.8	39.5	28.1	25.6	33.5	21.7	38.3	26.9	40.2	28.2	33.0	30.2	28.1	28.6	30.1	30.4	27.2	28.8	32.2	13.2	32.2	38.8	30.7	32.4	35.1	35.5	32.1	27.4	31.1	32.0	50.2	38.9	29.6	39.0	23.8
PSMD12	"p55, Rpn5"	ENSG00000197170	"Proteasome 26S subunit, non-ATPase 12"	O00232	17	67337916-67366627	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023119	Approved		Approved	Nucleoplasm,Microtubules,Cytosol			44000	Microtubules	"Nucleoplasm, Cytosol"	"HPA023119: AB_1855845"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-2)"	"prognostic favourable (4.39e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-3)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-2)"	"prognostic favourable (6.32e-4)"	"unprognostic (2.63e-1)"	"unprognostic (7.32e-3)"	"prognostic unfavourable (4.73e-6)"	"unprognostic (1.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	16.4	18.0	16.0	12.3	16.0	11.8	14.1	19.5	26.7	11.7	11.8	8.8	11.5	9.4	12.5	13.3	16.4	9.9	11.4	14.9	17.0	19.7	17.1	31.4	10.8	11.3	23.6	15.3	12.6	17.6	15.7	12.9	13.7	32.5	12.8	13.8	8.1	12.5	11.0	42.3	11.6	10.8	15.7	13.4	12.0	12.4	15.5	11.3	12.7	12.2	18.9	16.7	17.2	19.6	8.8	10.8	12.1	18.1	11.4	14.0	8.9	28.1	17.2	13.6	14.9	10.5	12.7	18.7	20.1	12.9	22.4	19.9	17.8	12.5	16.2	13.0	16.3	16.7	23.6	20.6	33.6	7.8	17.6	18.9	14.3	18.3	13.6	19.6	11.7	14.1	13.7	21.2	16.7	22.0	25.1	9.7	20.9	19.3	17.9	18.9	16.4	22.8	9.2	35.1	14.6	16.7	23.5	13.1	18.9	14.8	29.1	19.4	20.8	16.7	22.5	23.8	16.0	17.8	36.2	9.9	15.2	13.7	28.1	20.8	13.7	12.1	10.6	8.8	9.9	17.4	14.0	8.6	13.0	11.1	10.8	8.8	11.7	12.3	7.6	11.4	18.1	7.0	12.1	8.9	16.0	16.0	19.5	26.7	17.0	19.7	23.6	15.3	32.5	11.3
PSMD13	"p40.5, Rpn9"	ENSG00000185627	"Proteasome 26S subunit, non-ATPase 13"	Q9UNM6	11	236546-252984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038691, HPA038692"	Approved		Approved	"Nuclear speckles,Cytosol"			49000	"Nuclear speckles"	Cytosol	"HPA038691: AB_2676153, HPA038692: AB_10671749"	"unprognostic (1.32e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.19e-2)"	"prognostic favourable (5.74e-4)"	"unprognostic (2.24e-2)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (4.76e-5)"	"unprognostic (7.54e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (1.52e-13)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	24.2	17.9	18.4	20.9	21.3	29.1	28.6	22.1	25.6	24.0	23.6	19.2	20.0	15.6	25.3	20.3	26.8	20.6	19.1	31.8	19.6	20.4	23.4	34.9	23.0	29.8	17.1	19.1	18.1	26.5	15.1	18.0	31.7	21.8	24.0	19.5	16.8	20.9	21.1	56.5	25.5	20.5	21.3	17.0	26.9	18.8	21.2	12.9	32.8	23.3	30.0	27.0	20.5	17.9	20.8	33.5	25.1	32.6	26.4	26.6	39.0	30.9	18.5	22.1	22.7	22.3	20.3	12.7	21.3	30.2	46.7	34.5	16.3	41.8	29.4	20.7	25.9	29.4	27.8	32.1	37.1	23.7	21.2	13.0	7.2	11.2	24.8	31.7	27.6	17.9	23.0	23.3	20.2	42.3	32.9	23.0	35.7	12.2	26.4	19.5	29.5	26.8	20.5	21.7	20.7	27.4	8.3	17.9	14.1	15.6	16.7	16.5	10.2	19.6	27.8	13.7	13.1	6.9	24.8	20.8	24.1	38.2	24.7	25.4	22.6	22.2	31.4	20.5	23.5	30.6	26.3	20.8	24.1	23.6	33.5	18.5	21.3	23.3	25.1	26.4	32.6	22.7	26.6	39.0	18.4	21.3	22.1	25.6	19.6	20.4	17.1	19.1	21.8	12.9
PSMD3	"P58, Rpn3, S3, TSTA2"	ENSG00000108344	"Proteasome 26S subunit, non-ATPase 3"	O43242	17	39980797-39997960	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017038, HPA048972"	Approved		Supported	Nucleoplasm,Cytosol			380000	Nucleoplasm	Cytosol	"CAB017038: , HPA048972: "	"unprognostic (3.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.36e-3)"	"unprognostic (5.75e-3)"	"unprognostic (7.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavourable (4.47e-7)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.45e-2)"	25.1	27.7	20.0	25.0	26.1	22.0	21.3	30.0	40.3	22.5	28.1	22.4	16.8	23.2	26.8	21.2	27.7	22.7	23.7	36.1	20.6	21.4	23.8	54.4	20.8	22.3	19.2	23.7	24.0	23.6	28.1	20.8	33.8	24.5	23.2	25.4	21.4	22.5	21.9	93.2	33.2	23.5	24.7	17.6	26.9	21.1	19.9	17.5	35.7	24.3	39.2	26.3	20.7	21.2	15.6	24.3	14.4	17.0	13.1	17.7	12.0	32.1	40.2	22.1	31.7	18.0	11.7	26.3	23.8	24.7	42.9	33.3	33.2	27.8	38.8	59.8	25.4	50.5	39.1	31.0	29.1	38.9	43.6	22.4	20.6	32.8	16.4	30.1	25.2	15.5	26.5	45.3	19.9	24.2	45.6	24.2	19.8	23.4	46.6	20.8	30.6	23.9	34.4	30.7	36.3	21.4	21.8	29.2	22.1	22.7	139.3	19.5	31.3	26.1	21.5	18.6	32.9	27.4	42.4	26.4	33.5	43.2	28.4	22.8	29.9	6.6	16.8	14.4	15.1	17.0	15.1	14.4	14.6	17.7	24.3	15.6	13.7	16.5	5.5	13.1	14.3	16.7	12.6	12.0	20.0	26.1	30.0	40.3	20.6	21.4	19.2	23.7	24.5	17.5
PSMD4	"AF, AF-1, Rpn10, S5A"	ENSG00000159352	"Proteasome 26S subunit, non-ATPase 4"	P55036	1	151254703-151267479	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038807, HPA039252, CAB047300"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418"	"unprognostic (3.83e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (6.66e-10)"	"unprognostic (9.80e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.91e-1)"	27.5	28.0	44.3	24.4	46.4	25.5	29.9	25.7	50.4	21.9	28.6	28.3	16.5	22.7	25.1	41.5	26.7	31.4	21.8	38.7	37.5	36.8	25.3	44.7	20.2	28.2	47.5	44.8	26.7	27.7	27.4	19.3	30.0	43.2	23.0	28.1	24.3	25.6	31.2	86.7	28.0	20.5	39.3	29.6	26.3	25.8	35.9	29.1	23.1	23.7	25.7	36.2	28.0	19.8	62.7	65.1	111.6	76.0	54.2	74.2	88.2	41.8	50.5	37.3	30.5	40.7	30.2	40.7	28.5	34.9	45.5	36.3	66.0	48.0	34.1	69.9	40.1	43.9	47.9	43.0	38.9	55.5	41.8	33.2	43.0	68.0	45.0	39.0	38.8	32.7	35.8	51.9	48.0	39.6	51.7	43.3	38.1	123.6	35.9	47.5	70.9	51.1	30.5	36.3	61.5	44.6	36.0	29.3	50.0	31.6	46.4	37.6	48.5	77.2	34.8	22.7	35.7	27.8	48.5	51.9	64.5	72.7	37.6	36.8	41.3	59.6	71.5	111.6	43.0	76.0	48.4	62.7	50.5	47.3	65.1	61.1	46.4	46.0	95.8	54.2	75.5	39.2	74.2	88.2	44.3	46.4	25.7	50.4	37.5	36.8	47.5	44.8	43.2	29.1
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842984	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol			12000000	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	14.1	20.1	10.2	12.2	16.2	14.7	32.5	20.7	21.8	14.6	12.9	10.2	12.3	10.3	14.8	14.1	17.3	13.8	10.6	12.7	11.7	12.3	11.5	21.0	34.8	23.6	9.8	14.1	16.7	32.2	13.3	11.7	10.5	14.5	16.1	12.5	8.8	15.1	15.7	10.0	16.7	11.2	24.5	9.9	12.3	14.4	11.3	8.1	13.0	12.6	9.2	15.5	14.9	13.5	17.5	14.4	15.2	17.9	14.2	25.2	14.2	13.2	17.3	8.4	15.6	18.8	18.7	9.9	19.7	15.5	18.7	17.1	15.3	8.8	13.6	9.0	20.0	19.9	0.0	19.4	21.8	12.4	1.9	11.3	24.0	8.5	14.2	3.9	4.3	15.6	12.6	18.1	19.4	10.8	41.4	9.1	17.4	16.5	12.1	8.2	12.4	12.4	11.1	18.3	10.7	17.2	11.7	11.5	7.4	23.8	20.3	9.4	24.3	9.7	16.7	0.0	10.1	7.8	17.4	5.5	5.5	14.9	11.6	13.1	16.4	15.2	14.9	12.3	17.1	16.5	18.6	17.5	19.9	20.5	14.4	13.2	19.4	15.1	8.1	14.2	17.9	10.5	25.2	14.2	10.2	16.2	20.7	21.8	11.7	12.3	9.8	14.1	14.5	8.1
PSMD8	"HIP6, HYPF, Nin1p, p31, Rpn12, S14"	ENSG00000099341	"Proteasome 26S subunit, non-ATPase 8"	P48556	19	38374536-38383824	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006702, CAB021101"	Supported		Approved	"Nuclear speckles,Cytosol"				Cytosol	"Nuclear speckles"	"CAB021101: AB_10061018, HPA006702: AB_1079710"	"unprognostic (9.50e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-2)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.58e-3)"	"unprognostic (4.84e-2)"	53.0	35.1	30.0	23.9	35.6	32.9	43.0	28.1	49.4	26.5	31.8	25.8	30.1	31.5	30.9	40.9	39.1	32.5	28.0	75.3	32.2	29.3	40.9	71.1	28.8	28.8	27.1	37.0	24.4	48.2	30.6	29.2	56.6	30.0	33.6	32.9	24.6	32.6	29.7	157.1	42.2	33.2	34.5	25.0	27.6	28.9	55.8	21.4	38.1	35.4	50.1	33.9	28.3	27.1	40.4	60.8	32.0	68.1	38.8	65.6	68.7	61.1	97.6	38.5	43.9	62.8	50.6	20.2	44.6	60.9	68.7	71.9	66.9	36.9	43.2	46.6	59.3	21.3	64.3	55.4	62.1	71.1	42.4	46.9	32.2	41.2	81.2	47.2	41.7	50.9	55.4	59.1	78.8	53.9	58.4	48.6	75.4	60.9	44.5	26.6	29.9	53.3	46.5	61.9	34.3	48.6	51.0	40.3	41.0	46.2	59.9	43.2	31.3	44.6	39.6	52.6	48.6	55.0	65.2	49.2	56.8	57.6	79.1	48.6	58.3	32.0	55.2	29.2	46.1	59.9	39.1	40.4	40.4	44.2	60.8	37.0	33.6	32.6	20.8	38.8	68.1	42.3	65.6	68.7	30.0	35.6	28.1	49.4	32.2	29.3	27.1	37.0	30.0	21.4
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888731-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"			330000	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	25.6	10.7	11.5	12.9	12.1	27.8	18.7	15.3	12.0	9.6	22.1	9.2	14.8	19.5	14.4	13.6	12.3	10.7	12.5	13.9	10.6	11.2	19.2	19.8	12.3	14.8	10.6	9.0	13.0	28.6	4.9	8.3	8.7	12.7	9.5	4.8	9.4	15.3	14.2	28.6	12.4	16.3	15.7	11.6	14.8	24.7	13.6	8.7	13.8	10.9	17.1	9.2	8.2	11.8	24.5	36.7	29.6	26.3	14.9	25.9	27.3	20.5	31.6	2.6	4.8	4.4	4.5	5.5	21.0	6.8	10.5	6.0	23.0	2.5	15.3	17.8	10.8	8.4	7.5	11.0	6.3	29.6	16.6	12.5	14.7	11.4	11.0	8.8	8.9	8.0	5.2	11.8	4.5	6.3	11.2	2.2	6.6	24.1	17.5	6.6	5.5	24.7	13.4	7.2	9.4	5.1	20.7	5.5	7.7	21.1	3.1	11.3	9.1	4.4	16.6	10.1	11.6	19.7	14.6	12.0	25.9	22.3	18.1	11.5	9.2	20.3	26.3	29.6	20.9	25.4	16.7	24.5	20.1	18.9	22.2	19.5	15.8	13.6	24.1	14.9	22.0	36.7	25.9	27.3	11.5	12.1	15.3	12.0	10.6	11.2	10.6	9.0	12.7	8.7
PSME1	"IFI5111, PA28alpha"	ENSG00000092010	"Proteasome activator subunit 1"	Q06323	14	24136158-24138967	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006632	Approved		Approved	"Nuclear bodies,Cytosol"			8600000	Cytosol	"Nuclear bodies"	"HPA006632: AB_1079686"	"prognostic favourable (8.87e-5)"	"unprognostic (1.02e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-1)"	"unprognostic (7.04e-2)"	"unprognostic (9.63e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.50e-1)"	"prognostic favourable (4.60e-4)"	"unprognostic (1.62e-3)"	37.6	59.1	19.1	64.4	23.0	37.2	59.7	9.9	16.9	34.8	53.9	15.3	47.4	48.2	40.3	50.4	45.4	39.4	53.4	59.1	19.6	17.2	67.7	70.3	61.7	114.2	24.8	17.4	46.7	47.2	26.4	30.6	42.7	21.3	39.2	44.8	28.4	38.0	57.0	38.0	33.7	82.3	45.0	20.4	82.8	38.9	14.5	22.5	70.5	58.4	54.3	52.0	35.8	40.4	68.2	72.2	112.1	93.3	81.2	87.8	132.3	17.4	14.6	11.1	21.3	24.2	28.0	17.0	11.2	36.5	35.9	51.6	9.3	42.7	45.1	8.4	18.6	25.4	15.8	23.2	24.1	37.6	9.7	20.0	7.2	51.5	53.3	25.5	25.6	24.4	14.9	16.2	14.3	27.1	3.1	40.3	14.0	44.4	65.5	31.1	1.0	25.2	52.1	22.8	32.4	45.3	46.4	7.1	12.6	14.2	37.1	21.6	24.3	25.1	15.2	9.9	11.7	11.2	16.6	37.7	38.7	21.3	13.4	22.8	15.9	53.2	74.4	89.4	87.0	93.3	87.0	68.2	82.0	82.6	72.2	61.6	59.4	72.7	112.1	81.2	89.4	68.5	87.8	132.3	19.1	23.0	9.9	16.9	19.6	17.2	24.8	17.4	21.3	22.5
PSMF1	PI31	ENSG00000125818	"Proteasome inhibitor subunit 1"	Q92530	20	1113263-1189415	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041122, HPA041300"	Approved		Enhanced	Cytosol			270000	Cytosol		"HPA041122: AB_10805838, HPA041300: AB_10794370"	"unprognostic (1.79e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.03e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.32e-2)"	27.3	21.5	23.4	23.9	26.4	27.3	23.0	22.9	32.7	21.8	26.5	26.9	19.8	27.2	24.6	24.1	29.3	22.5	27.4	27.7	21.6	21.2	25.1	63.7	23.7	29.9	23.2	19.8	28.2	48.3	23.7	20.4	20.5	28.2	21.2	19.3	26.2	33.6	24.0	67.2	25.3	28.4	23.9	23.4	22.8	25.7	86.2	19.2	31.9	27.7	42.1	24.5	26.2	25.7	31.4	28.7	51.5	33.9	24.1	33.6	26.2	38.3	35.0	8.4	20.0	18.1	19.2	14.7	23.5	17.8	21.2	19.0	32.9	27.0	19.6	15.8	24.2	34.9	21.7	39.7	26.7	11.4	13.0	27.9	6.2	59.7	24.3	32.7	9.5	19.1	23.1	24.0	37.3	22.9	27.8	39.4	17.2	20.4	41.6	28.6	12.5	21.6	20.1	17.9	32.0	18.8	32.6	21.5	15.2	25.8	45.3	21.2	30.4	11.9	27.2	27.3	18.7	31.6	31.5	24.5	47.9	20.9	12.1	22.7	20.8	43.2	28.6	51.5	23.0	33.9	26.5	31.4	30.8	25.0	28.7	27.6	28.4	24.7	31.1	24.1	33.2	16.4	33.6	26.2	23.4	26.4	22.9	32.7	21.6	21.2	23.2	19.8	28.2	19.2
PSMG1	"c21-LRP, DSCR2, LRPC21, PAC1"	ENSG00000183527	"Proteasome assembly chaperone 1"	O95456	21	39174769-39183851	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057193, HPA070225"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA057193: , HPA070225: "	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.38e-2)"	"unprognostic (5.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (2.84e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.17e-3)"	7.0	11.0	8.2	8.7	8.0	15.1	6.9	7.7	13.1	7.0	10.2	4.7	5.2	9.2	8.2	9.2	12.5	6.9	9.4	7.6	7.5	8.9	11.7	21.4	6.1	8.1	6.9	10.2	7.9	21.5	5.1	10.0	7.5	8.5	5.7	10.0	7.3	8.0	5.2	13.0	7.0	8.4	8.3	7.1	7.0	7.1	67.3	4.6	7.8	10.6	10.4	7.6	6.7	7.4	11.4	11.5	7.3	7.9	6.7	14.9	7.9	26.8	8.8	6.4	8.8	3.2	3.6	17.1	14.9	6.5	11.6	7.5	16.1	7.1	29.1	7.9	4.2	7.7	10.1	7.9	7.6	12.4	15.9	54.9	13.7	20.9	5.8	26.1	11.0	5.0	5.9	12.3	12.5	6.1	40.4	16.7	6.9	14.2	16.1	14.1	22.2	13.7	26.2	8.0	29.6	4.8	8.0	20.5	6.0	18.7	10.5	14.7	10.0	13.1	6.9	13.4	4.6	18.0	20.9	12.8	20.3	25.2	11.4	44.2	10.3	7.3	6.4	3.5	10.6	7.8	12.2	11.4	14.9	12.2	11.5	9.0	11.9	10.4	0.5	6.7	7.9	10.5	12.6	7.9	8.2	8.0	7.7	13.1	7.5	8.9	6.9	10.2	8.5	4.6
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol				Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavourable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavourable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favourable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	7.5	13.4	14.1	5.9	16.6	5.1	11.0	10.1	14.6	5.4	8.0	13.2	11.4	6.9	7.0	9.0	11.0	26.3	10.6	12.8	13.2	12.5	14.7	9.8	5.4	7.4	14.8	10.0	13.9	15.9	7.8	17.1	6.4	11.1	10.6	6.9	6.9	6.8	11.5	6.8	6.4	6.2	8.5	15.2	5.7	8.5	9.1	13.3	10.2	12.2	6.9	8.5	7.1	16.0	7.8	11.9	6.8	8.5	5.3	6.2	5.8	46.3	14.2	8.7	32.5	7.3	9.8	6.0	11.7	6.9	6.6	11.7	12.7	8.1	22.9	7.9	10.8	9.7	19.2	9.9	6.8	17.4	10.8	6.4	3.8	21.4	15.7	6.4	9.8	12.3	18.8	10.4	12.0	6.4	15.3	14.8	9.8	6.2	9.8	15.3	13.9	19.9	12.8	5.2	13.1	6.2	2.4	15.9	18.4	8.5	5.2	23.4	15.7	13.5	5.4	5.7	9.0	17.6	10.7	10.2	17.8	26.0	8.2	14.1	17.9	2.2	7.7	6.8	4.2	5.3	3.0	7.2	4.0	5.1	11.9	7.8	6.2	5.5	3.6	5.3	8.5	11.3	5.1	5.8	14.1	16.6	10.1	14.6	13.2	12.5	14.8	10.0	11.1	13.3
PSRC1	DDA3	ENSG00000134222	"Proline and serine rich coiled-coil 1"	Q6PGN9	1	109279556-109283186	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"glioma: 50.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 12.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3"	"Group enriched"	"Detected in some"	6	"amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3"	"Low region specificity"	"Detected in all"			"HPA049315, HPA056561"	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA049315: , HPA056561: "	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.76e-2)"	"prognostic unfavourable (1.36e-9)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (9.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	1.7	2.4	17.1	4.3	21.6	8.3	3.0	3.8	27.3	2.0	4.0	31.2	0.3	5.1	3.0	3.4	6.3	3.2	3.7	2.0	25.9	11.2	1.7	2.6	2.2	4.0	29.8	12.9	3.6	1.4	0.8	1.7	4.8	16.8	4.0	3.3	4.5	2.9	5.9	1.0	6.1	5.3	4.7	30.6	2.3	2.4	8.6	20.7	5.5	2.0	0.4	5.0	2.6	2.3	0.0	5.4	7.3	12.3	0.2	0.7	3.2	18.4	9.5	39.1	18.9	1.5	3.1	10.7	14.7	11.9	20.1	19.3	14.7	7.7	9.4	5.4	7.2	13.3	21.1	12.0	16.9	3.6	10.1	5.9	12.8	12.0	1.8	6.2	6.7	3.5	1.1	7.9	5.6	9.8	13.3	4.3	16.0	16.8	9.5	4.2	16.2	10.9	14.7	37.7	3.1	6.7	4.8	16.5	9.5	8.3	12.7	15.0	7.6	6.0	5.0	12.4	20.6	8.7	24.1	3.4	2.2	3.2	10.0	15.0	34.5	0.0	12.3	1.8	0.7	4.8	0.5	0.0	0.7	0.2	5.4	0.0	0.4	0.4	7.3	0.2	2.6	0.0	0.7	3.2	17.1	21.6	3.8	16.4	25.9	11.2	29.8	12.9	16.8	20.7
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47878028-48068689	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3"	"Cell line enhanced"	"Detected in some"		"AF22: 10.8;BEWO: 14.4;Hep G2: 24.0;LHCN-M2: 11.4;TIME: 12.1;WM-115: 10.5"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favourable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	2.1	0.7	4.6	0.1	7.4	0.2	1.3	2.7	11.3	3.8	1.2	0.3	0.0	0.6	1.7	3.7	1.9	3.2	1.4	1.4	2.2	1.3	2.2	2.1	3.1	0.2	1.4	5.5	1.1	1.1	0.4	3.9	1.9	1.8	2.3	1.2	1.6	2.1	6.4	0.6	0.3	0.4	1.9	1.3	0.2	0.5	0.9	0.8	0.0	3.6	0.0	0.3	2.8	1.3	0.4	0.4	0.8	0.2	0.1	0.2	0.0	0.0	0.0	10.8	0.0	1.8	5.3	14.4	1.6	3.4	0.1	0.4	0.0	0.7	0.0	0.0	0.9	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.3	24.0	0.5	0.0	0.0	7.9	7.7	0.0	0.1	1.6	0.0	0.0	11.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	12.1	2.6	1.7	0.0	0.2	0.0	0.0	0.0	3.6	0.0	10.5	0.8	0.1	0.5	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.1	0.2	0.4	0.0	0.0	4.6	7.4	2.7	11.3	2.2	1.3	1.4	5.5	1.8	0.8
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863113-87971930	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: "	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	42.4	24.1	17.7	20.9	17.7	13.5	32.8	39.9	19.7	43.1	26.7	9.9	19.0	15.1	29.8	22.8	26.8	30.3	21.0	19.1	16.0	17.4	19.6	32.4	27.2	30.4	15.7	19.5	29.1	21.3	16.4	23.6	36.4	14.2	35.3	17.7	21.6	16.8	20.8	16.8	20.4	25.4	26.0	11.7	40.9	17.8	18.7	12.5	49.7	25.2	13.3	18.6	29.6	30.9	4.3	5.1	29.6	11.0	4.3	4.7	2.0	10.4	4.9	5.7	5.1	13.1	9.0	5.1	5.6	12.5	6.6	9.3	5.0	12.9	12.3	3.8	9.2	6.3	7.5	6.4	10.5	6.2	2.1	4.1	12.8	6.1	14.0	13.8	7.1	6.1	17.9	8.3	10.8	9.3	3.1	33.6	6.0	8.0	7.7	25.1	2.1	0.0	12.0	3.0	9.1	10.3	6.0	2.0	9.2	7.5	3.5	9.4	9.9	20.0	8.1	21.9	5.1	8.5	4.5	11.1	14.3	14.1	6.8	13.1	1.3	8.3	7.9	12.2	3.6	11.0	3.9	4.3	4.0	3.5	5.1	3.7	4.7	4.5	29.6	4.3	7.2	4.2	3.5	2.0	17.7	17.7	39.9	19.7	16.0	17.4	15.7	19.5	14.2	12.5
PTER		ENSG00000165983	"Phosphotriesterase related"	Q96BW5	10	16436943-16513745	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 21.6;cerebellum: 8.9;cerebral cortex: 30.8;hippocampal formation: 22.7;hypothalamus: 8.9"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038044, HPA038045"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038044: , HPA038045: AB_10672616"	"unprognostic (5.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.86e-1)"	"prognostic favourable (6.52e-6)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.36e-3)"	11.1	5.4	21.6	10.6	2.9	1.3	8.7	8.9	30.8	6.2	12.1	1.6	14.5	9.2	5.8	8.1	6.9	3.4	3.8	7.8	22.7	8.9	31.3	21.9	9.2	12.6	4.2	1.3	5.3	17.9	11.1	3.4	11.2	3.1	11.3	5.4	6.8	10.6	12.9	6.2	4.0	21.9	5.7	2.6	11.8	9.2	2.9	1.5	17.2	12.0	3.9	9.6	7.7	10.9	15.3	11.7	6.9	16.7	7.6	19.5	9.4	16.1	9.7	0.1	2.9	4.1	8.1	9.7	4.8	0.5	1.8	2.7	8.9	15.3	17.0	4.0	3.2	7.4	5.5	3.2	2.7	16.6	7.2	15.8	4.6	3.6	4.9	5.1	4.8	5.9	10.4	5.5	0.9	0.8	10.8	6.0	2.8	5.4	11.9	5.1	3.9	2.4	8.9	1.3	8.9	25.5	5.1	12.3	0.8	8.5	2.4	14.0	5.7	16.2	2.1	0.1	4.3	3.9	0.1	4.5	5.6	18.0	2.0	9.4	6.0	3.5	11.7	6.9	12.7	16.7	13.5	15.3	14.6	12.6	11.7	8.8	11.0	10.9	2.2	7.6	14.5	9.9	19.5	9.4	21.6	2.9	8.9	30.8	22.7	8.9	4.2	1.3	3.1	1.5
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 358.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol			580000	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavourable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavourable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favourable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	44.7	41.4	56.0	41.2	55.7	39.6	175.0	44.2	51.7	49.0	51.9	38.1	49.5	46.4	57.7	52.0	52.6	69.8	36.0	46.0	54.6	57.2	52.1	67.1	46.4	62.0	67.0	41.4	82.3	55.1	43.2	49.2	50.3	57.0	60.7	55.3	24.0	36.6	49.4	64.2	37.0	46.7	64.7	72.5	42.7	36.6	39.7	65.1	53.5	72.5	36.7	55.1	72.7	358.9	40.6	36.9	27.3	74.8	29.2	42.5	60.5	79.9	69.8	56.6	33.7	41.7	37.9	86.3	52.4	40.1	67.5	50.5	59.1	84.4	88.7	79.7	44.7	51.6	106.1	68.5	85.6	65.1	70.6	69.2	44.1	68.2	30.6	82.2	50.3	27.4	50.1	51.0	61.9	69.4	111.0	85.0	65.9	49.9	81.6	78.1	96.7	81.5	71.4	53.4	119.0	59.4	62.6	73.4	42.9	53.5	77.2	45.4	88.9	69.1	41.6	40.6	47.2	48.7	72.4	35.8	98.6	71.3	44.2	67.9	73.0	27.3	37.5	23.2	32.0	59.0	42.0	40.6	42.5	38.1	36.9	28.5	42.3	36.4	14.8	29.2	74.8	31.3	42.5	60.5	56.0	55.7	44.2	51.7	54.6	57.2	67.0	41.4	57.0	65.1
PTGES3L-AARSD1		ENSG00000108825	"PTGES3L-AARSD1 readthrough"	Q9BTE6	17	42950526-42980528	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 46.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 6.6;THP-1: 13.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 5.3"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 5.3"	"Low region specificity"	"Detected in all"							"HPA021408, HPA022869, HPA023714"	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (6.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.34e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.13e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.91e-4)"	"unprognostic (1.83e-1)"	0.7	0.1	0.7	1.2	4.5	1.2	0.5	0.6	1.6	1.5	5.5	0.3	0.1	1.7	4.7	2.4	2.2	1.6	3.6	13.8	0.5	0.7	0.3	0.2	0.6	0.7	0.6	0.8	0.7	0.3	0.4	1.5	0.4	0.4	2.0	3.2	1.6	0.7	3.1	46.6	0.2	1.6	10.6	0.2	0.4	2.4	3.8	0.2	0.5	0.5	14.4	0.8	5.1	1.4	0.1	5.3	0.0	0.0	0.0	0.0	0.4	1.0	0.0	2.7	2.6	0.3	0.0	0.8	2.2	1.9	1.2	1.1	1.7	0.3	0.3	1.7	0.2	0.0	0.4	1.1	1.8	1.0	0.4	5.5	2.2	4.0	0.0	0.5	3.9	0.1	0.7	1.9	0.1	0.6	1.9	0.4	2.2	0.0	1.8	1.4	0.7	0.5	1.5	6.6	0.7	0.3	0.5	1.3	3.4	1.4	0.5	1.4	0.9	13.0	0.0	0.9	1.7	0.0	0.7	3.6	1.1	0.3	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.4	0.7	4.5	0.6	1.6	0.5	0.7	0.6	0.8	0.4	0.2
PTHLH	"HHM, PLP, PTHR, PTHRP"	ENSG00000087494	"Parathyroid hormone like hormone"	P12272	12	27958084-27972705	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.6"	"Group enriched"	"Detected in some"	4	"HaCaT: 63.2;HBEC3-KT: 78.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"T-reg: 3.0"	"Lineage enriched"	"Detected in single"	30	"T-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035982	Approved	Approved	Supported	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted in other tissues"			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA035982: AB_10794631"	"unprognostic (1.67e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavourable (1.82e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.87e-3)"	2.9	1.0	6.5	3.5	5.3	0.0	20.2	1.4	8.7	11.0	2.3	1.4	2.1	2.4	11.2	2.0	17.0	1.2	45.6	4.0	4.3	3.5	0.4	0.2	1.3	1.1	1.4	4.3	2.6	1.7	0.7	2.3	3.6	3.1	5.5	1.8	2.4	5.3	2.6	0.7	1.5	1.6	13.4	0.8	3.6	1.9	1.3	1.0	0.1	1.4	15.8	3.4	8.0	12.3	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.3	2.1	0.0	0.0	0.6	0.6	0.0	0.0	0.2	0.1	0.2	0.0	1.7	0.0	0.1	0.5	63.2	0.2	78.1	0.0	1.5	0.3	0.1	0.4	0.0	0.1	0.0	0.1	0.0	4.3	2.0	7.7	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.3	0.1	7.6	0.0	0.0	0.0	3.5	0.0	0.4	0.1	0.0	1.2	0.3	1.9	1.1	16.6	1.0	0.0	2.5	1.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	6.5	5.3	1.4	6.2	4.3	3.5	1.4	4.3	3.1	1.0
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"			32000	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavourable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	22.6	20.4	36.0	14.4	42.3	3.1	19.3	20.5	40.8	24.9	17.9	55.7	23.5	14.5	20.2	29.9	14.6	18.7	18.4	20.0	43.5	23.9	22.3	17.0	21.5	13.0	41.4	31.4	19.4	18.2	33.1	13.0	42.1	30.0	19.2	20.7	11.0	21.9	25.5	17.9	13.5	16.3	21.9	38.0	12.2	17.5	21.2	46.1	2.8	22.5	10.2	14.0	22.2	17.8	8.6	7.2	1.8	3.9	5.2	5.7	4.1	14.6	23.4	32.5	11.7	13.7	14.7	21.0	14.5	20.2	13.6	13.4	10.2	12.2	8.9	33.0	18.6	17.4	19.1	33.3	20.6	0.1	8.9	19.7	12.9	14.0	18.7	0.0	9.4	10.0	16.4	17.0	24.0	40.1	19.8	0.2	18.2	25.5	0.2	0.2	12.6	26.2	13.1	17.8	0.4	28.7	33.5	12.9	16.1	22.7	7.3	14.7	17.2	0.3	24.2	13.4	25.3	15.8	16.3	0.0	0.1	0.9	17.4	0.1	18.1	1.8	3.9	0.0	0.3	1.6	0.0	6.8	0.8	0.1	5.3	8.6	5.7	2.0	1.7	5.2	0.9	7.2	0.2	4.1	36.0	42.3	20.5	40.8	43.5	23.9	41.4	31.4	30.0	46.1
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.7;brain: 65.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.0;REH: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5"	"Low region specificity"	"Detected in many"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"			84000	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favourable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (5.11e-4)"	"unprognostic (3.33e-3)"	7.2	4.7	20.4	24.3	30.0	46.7	4.9	65.2	48.3	5.4	14.5	7.8	5.0	16.6	4.3	4.7	7.9	6.8	6.4	4.7	30.5	7.0	6.8	5.0	11.5	35.6	4.3	25.4	2.4	5.4	5.2	5.3	4.1	3.9	10.1	11.9	8.3	12.6	6.7	2.2	15.1	18.4	5.5	4.8	32.0	10.8	4.3	3.7	37.8	5.6	2.9	35.4	13.0	6.0	26.9	18.7	24.0	25.8	14.7	19.0	21.5	10.9	3.0	0.8	0.9	23.5	1.7	6.4	0.8	0.5	0.6	0.8	2.9	6.3	37.0	1.2	1.7	10.1	0.3	9.2	0.3	2.5	0.2	7.6	2.9	0.5	4.8	8.2	13.8	12.7	13.8	0.8	5.3	0.3	8.9	25.7	0.6	1.1	14.0	16.5	0.6	0.8	41.0	0.2	25.3	2.6	8.6	5.8	1.0	3.9	2.7	1.4	3.3	21.2	5.2	0.4	0.8	0.7	0.3	20.7	8.9	20.0	1.6	17.8	0.7	22.3	23.7	18.0	19.0	22.4	12.5	25.5	9.6	13.3	18.7	26.9	12.1	14.2	24.0	14.7	25.8	6.2	9.5	21.5	20.4	30.0	65.2	48.3	30.5	7.0	4.3	25.4	3.9	3.7
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell line enhanced"	"Detected in some"		"A-431: 11.3;CAPAN-2: 21.8;HaCaT: 17.7;hTCEpi: 24.0;RT4: 13.8;T-47d: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	11.3	1.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	21.8	0.0	3.9	0.0	17.7	0.0	0.0	0.0	2.8	0.2	0.0	4.5	0.0	0.0	0.0	3.6	0.0	24.0	0.0	0.1	0.0	0.1	1.3	0.1	6.3	0.0	0.1	0.1	8.2	0.0	0.6	0.2	0.0	13.8	0.2	1.2	1.3	4.3	0.0	13.3	0.8	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.2	0.2	0.6	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713541	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047183	Approved		Supported	Nucleoplasm,Cytosol			610000	Nucleoplasm	Cytosol	"HPA047183: "	"unprognostic (1.49e-3)"	"prognostic favourable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	72.8	37.7	60.0	78.4	65.2	161.4	76.1	38.2	64.2	75.0	80.9	53.9	33.9	56.3	84.8	59.9	83.7	66.7	47.2	38.7	66.3	48.3	67.3	73.5	63.5	104.0	68.7	59.6	80.5	79.5	31.3	97.9	59.1	54.2	50.0	82.7	42.2	55.5	53.4	60.6	92.5	62.8	58.4	86.6	90.1	69.2	113.9	67.2	127.5	73.4	50.4	118.6	70.0	69.9	189.1	134.7	114.4	126.9	117.0	167.3	255.0	97.8	58.8	83.9	74.8	25.5	34.1	86.2	66.8	56.1	58.4	61.3	56.9	114.7	155.0	76.6	52.1	51.8	118.0	82.3	74.3	122.8	92.8	199.7	48.5	91.9	31.7	226.6	85.5	49.3	30.9	51.7	42.8	95.2	116.0	66.0	50.9	139.8	318.2	309.0	126.3	49.1	219.3	59.8	105.4	71.5	87.5	171.3	105.4	76.8	76.9	58.4	57.9	180.2	70.6	49.3	87.5	60.2	71.8	80.0	39.3	310.3	33.7	139.0	78.9	114.4	113.6	75.3	99.1	114.0	143.5	189.1	143.8	120.6	126.3	160.4	160.6	134.8	23.1	117.0	126.9	134.7	167.3	255.0	60.0	65.2	38.2	64.2	66.3	48.3	68.7	59.6	54.2	67.2
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol			4800000	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	16.5	35.1	41.6	19.8	41.2	18.1	23.9	32.0	74.2	27.5	27.4	27.2	30.1	18.3	26.7	26.0	31.8	30.1	28.7	42.1	38.0	32.4	32.6	41.0	22.1	19.8	30.8	35.5	23.2	22.4	55.0	22.5	21.4	37.0	33.4	21.7	20.8	36.0	41.5	110.7	27.2	18.8	35.3	21.9	24.4	23.8	62.4	17.6	23.7	27.2	37.0	21.3	22.1	23.9	12.6	19.2	7.8	15.5	17.7	18.4	14.9	24.8	44.1	27.2	50.4	18.4	22.6	27.2	26.0	29.5	35.8	25.0	23.6	30.7	25.9	19.7	44.1	40.5	28.4	32.1	30.8	46.0	15.5	16.0	46.7	22.4	54.8	27.6	34.8	27.0	31.7	26.1	24.9	36.4	23.7	28.8	30.0	64.5	25.1	17.1	42.7	43.9	25.1	25.1	47.6	37.5	31.2	29.5	20.9	52.7	54.4	32.5	57.7	12.0	26.7	29.7	26.9	30.6	36.7	26.3	67.3	23.4	36.6	18.0	40.9	5.8	15.5	7.8	18.4	15.5	17.6	9.6	14.0	16.4	19.2	12.6	13.1	13.1	5.4	17.7	14.4	13.8	14.0	14.9	41.6	41.2	32.0	74.2	38.0	32.4	30.8	35.5	37.0	17.6
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase, non-receptor type 11"	Q06124	12	112418351-112509913	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"			160000	Nucleoli	"Nucleoplasm, Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	25.4	16.8	38.6	14.4	39.0	17.7	30.8	17.5	39.5	18.3	14.7	26.9	9.9	11.9	19.1	13.3	17.6	11.1	13.1	30.1	38.0	32.2	18.0	23.1	15.1	14.5	45.3	22.5	13.1	14.0	29.3	12.9	16.6	26.2	16.2	13.9	9.4	12.0	20.0	34.0	14.1	11.1	28.0	45.7	10.9	12.8	7.6	32.1	10.9	21.2	8.2	13.7	17.4	15.4	17.3	17.1	22.0	11.8	11.3	15.4	6.3	34.8	33.3	24.3	23.0	35.4	34.6	28.8	42.4	46.3	33.4	25.2	33.1	13.5	36.9	22.1	39.2	20.9	31.2	37.6	55.7	28.0	25.7	53.7	31.0	18.1	35.4	43.0	34.3	28.0	37.9	35.9	51.1	27.6	40.7	13.0	32.2	25.2	30.2	20.9	29.4	21.8	31.1	35.9	21.2	30.8	39.2	16.9	20.8	40.8	31.3	26.0	36.0	29.9	33.6	39.4	35.3	23.4	37.1	25.2	41.5	36.9	32.7	30.2	36.8	22.0	11.0	15.0	14.8	9.5	14.1	15.5	13.4	12.1	12.6	17.3	15.4	11.8	10.3	11.3	11.8	17.1	9.8	6.3	38.6	39.0	17.5	39.5	38.0	32.2	45.3	22.5	26.2	32.1
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase, non-receptor type 12"	Q05209	7	77537275-77640071	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"			1100000	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	29.6	15.1	14.3	20.5	19.6	29.7	25.1	15.7	22.7	20.0	28.9	8.1	13.8	8.8	20.7	9.6	22.0	18.1	19.8	45.6	17.3	12.6	16.9	14.8	34.7	17.4	15.3	13.4	19.0	10.7	12.4	19.8	36.0	18.6	14.1	13.8	9.9	12.8	17.1	17.6	17.6	14.6	23.0	24.0	25.0	14.4	13.9	17.7	9.7	16.7	11.9	12.9	23.2	61.2	2.5	3.9	9.9	4.9	12.8	3.8	2.8	17.5	10.8	25.7	13.1	18.1	18.9	13.8	18.4	23.4	14.5	20.7	5.3	27.6	2.1	5.9	21.5	12.6	8.6	18.4	29.3	5.1	4.8	11.0	10.9	21.7	17.7	6.2	7.4	15.4	20.6	31.5	40.8	30.6	13.2	3.1	46.2	12.0	0.8	17.4	20.7	12.4	3.7	20.6	1.1	24.9	9.5	3.2	17.1	22.6	20.7	17.9	10.0	23.0	22.2	31.4	19.0	11.4	34.6	3.2	1.7	5.4	18.5	16.3	54.4	3.7	4.2	6.6	3.6	2.9	1.4	2.5	1.2	2.7	3.9	1.1	0.6	3.8	9.9	12.8	4.9	0.3	1.5	2.8	14.3	19.6	15.7	22.7	17.3	12.6	15.3	13.4	18.6	17.7
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase, non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 44.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	10.3	5.9	10.8	2.7	16.9	0.7	9.9	5.7	11.6	15.9	4.1	13.0	7.6	1.2	10.8	21.2	18.7	11.4	6.5	5.3	10.4	5.7	22.1	1.6	18.0	4.3	16.9	7.9	24.1	4.3	26.6	38.3	3.0	14.2	12.0	2.4	39.0	5.9	9.4	1.0	43.0	2.3	8.7	10.3	3.5	3.6	12.2	17.6	1.9	16.9	12.4	11.8	15.7	17.6	0.0	0.5	0.1	4.9	0.1	2.3	0.1	5.0	2.5	44.4	4.3	18.8	16.4	0.0	9.3	19.1	3.5	4.5	0.0	2.5	0.0	2.0	10.3	16.7	7.7	14.1	6.9	0.1	5.7	4.2	5.5	0.0	2.3	7.4	0.0	10.5	4.5	2.6	8.6	0.0	0.0	7.2	0.0	2.2	0.6	2.7	10.1	1.9	1.5	0.0	0.0	13.5	21.2	2.6	3.7	2.8	6.2	5.1	3.6	0.2	0.0	3.4	2.7	0.0	1.2	7.6	0.0	0.0	3.6	0.0	1.5	0.0	0.2	0.0	0.2	3.0	2.3	0.0	2.2	0.3	0.5	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.1	0.1	10.8	16.9	5.7	11.6	10.4	5.7	16.9	7.9	14.2	17.6
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase, non-receptor type 21"	Q16825	14	88465778-88554733	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus, Centriolar satellite"	"CAB011468: AB_442979, HPA073999: "	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favourable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.5	4.7	5.3	8.6	7.3	0.0	13.2	4.4	5.8	10.7	8.7	10.7	7.4	4.9	10.6	10.7	8.9	8.3	12.7	17.4	7.4	4.2	8.1	6.0	15.3	1.6	6.6	4.2	15.8	7.8	10.6	3.9	15.6	6.4	11.9	6.5	12.6	6.5	10.5	8.8	24.2	10.5	15.7	7.3	3.7	7.4	15.2	6.5	0.8	16.0	8.4	3.1	12.0	26.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	3.5	2.9	7.6	2.9	8.1	7.0	7.8	9.6	7.4	5.7	7.9	5.1	6.5	0.0	2.3	12.2	3.4	1.1	3.4	8.4	0.2	1.7	0.0	3.1	2.1	9.0	0.0	0.1	4.7	6.7	4.8	5.7	4.6	1.1	0.1	14.6	2.9	0.0	0.1	2.2	5.6	0.0	22.7	0.0	4.9	2.6	0.5	8.8	5.5	13.8	3.2	6.8	1.4	9.0	10.6	8.4	4.3	6.5	0.3	1.1	0.0	3.9	0.1	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.3	4.4	5.8	7.4	4.2	6.6	4.2	6.4	6.5
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase, non-receptor type 4"	P29074	2	119759631-119983818	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"NK-cells: 12.2;T-cells: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	6.8	6.9	10.0	5.9	12.2	7.3	7.2	37.4	16.9	9.6	5.5	7.2	5.2	8.1	7.2	6.6	6.9	8.9	6.3	8.9	10.2	8.4	12.0	6.6	8.0	7.9	7.3	13.1	8.9	6.3	11.6	16.3	4.1	8.3	6.2	4.0	7.1	7.9	6.6	11.2	5.8	5.5	4.7	7.3	9.2	8.9	7.7	6.5	18.9	22.5	6.8	6.5	5.3	5.8	0.5	0.3	0.9	0.4	12.2	19.3	4.7	7.3	4.3	5.7	7.6	5.1	5.3	9.7	3.3	9.4	1.9	5.2	6.4	11.4	5.3	8.0	3.7	6.5	4.4	5.2	5.1	12.3	3.7	3.6	4.1	6.1	3.4	3.7	2.7	4.8	9.8	8.8	4.0	8.3	6.2	5.4	5.0	5.6	5.1	4.3	7.5	7.1	3.5	9.8	7.4	6.9	10.0	7.4	9.2	4.6	5.9	3.8	2.8	2.4	10.4	0.2	6.5	2.2	4.0	9.3	13.0	6.7	4.9	0.2	3.1	0.2	0.2	0.9	19.3	0.3	15.6	0.5	9.6	15.1	0.3	0.5	3.2	11.0	0.7	12.2	0.4	0.3	5.6	4.7	10.0	12.2	37.4	16.9	10.2	8.4	7.3	13.1	8.3	6.5
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase, receptor type Q"		12	80402178-80680271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 12.6;urinary bladder: 19.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.2;BJ: 6.1;HBF TERT88: 4.3;RH-30: 4.8;RT4: 5.3;U-2197: 5.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	24	"basal ganglia: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol				Cytosol		"HPA053245: "	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	4.6	0.2	0.3	1.0	12.6	0.0	5.2	0.2	0.3	1.7	1.3	0.0	1.6	0.0	0.5	4.7	1.6	4.1	0.5	1.3	0.4	0.5	6.5	0.2	5.4	2.1	0.2	0.0	0.9	0.6	0.0	1.1	6.4	0.0	6.5	0.0	0.0	0.4	0.5	0.5	0.3	0.2	4.0	0.2	0.2	0.2	5.8	0.0	0.0	3.9	0.0	0.6	19.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.2	0.0	6.1	1.3	1.9	1.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.9	0.0	0.8	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	5.3	0.0	0.0	3.0	0.1	0.0	0.3	0.0	0.0	0.5	0.1	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.6	0.2	0.3	0.4	0.5	0.2	0.0	0.0	0.0
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 14.0;RT4: 26.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: "	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favourable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.5	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	26.7	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 40.7;HaCaT: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"		92000000	"Plasma membrane, Cytosol"		"HPA054747: "	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.6	20.9	18.9	40.7	8.7	7.1	2.5	6.3	7.5	7.7	6.3	0.2	2.0	0.0	15.0	10.6	41.3	5.0	0.0	3.4	0.4	8.0	0.0	8.6	13.0	4.0	0.0	4.7	7.5	1.8	1.6	0.3	0.2	5.8	0.0	3.1	15.4	1.6	3.9	10.6	8.9	0.0	4.2	0.0	1.5	7.3	14.5	19.9	6.0	1.1	11.5	7.3	1.5	0.8	6.9	11.9	15.7	7.6	2.1	0.0	12.0	3.5	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Group enriched"	"Detected in some"	9	"AF22: 92.1;NTERA-2: 25.6;WM-115: 40.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	1.1	0.0	0.1	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6
PTS	PTPS	ENSG00000150787	"6-pyruvoyltetrahydropterin synthase"	Q03393	11	112226365-112269955	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001481	Uncertain		Approved	Cytosol				Cytosol		"HPA001481: AB_1079716"	"unprognostic (2.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.66e-3)"	"unprognostic (8.38e-3)"	"unprognostic (4.58e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.65e-1)"	6.7	37.1	13.9	6.3	16.6	12.2	13.9	8.9	16.5	10.4	12.7	10.2	6.1	10.7	9.3	20.3	17.9	8.2	14.7	11.6	11.8	28.9	21.9	40.7	5.6	10.4	23.5	14.3	6.7	11.9	12.1	21.5	12.1	18.8	14.9	14.4	9.9	10.9	11.4	11.7	11.5	10.9	12.4	16.8	5.1	18.8	6.7	9.8	3.6	16.3	13.2	7.7	9.3	16.1	6.3	6.8	1.9	5.5	3.4	5.9	2.9	10.7	11.3	12.4	5.3	8.9	10.6	16.4	32.0	14.6	17.6	18.7	25.5	10.8	11.4	24.5	18.8	15.6	17.5	20.6	19.0	9.3	14.7	2.9	17.5	20.9	28.1	7.0	1.6	18.4	29.2	16.8	19.9	13.1	11.0	6.2	11.0	11.8	5.4	9.2	9.2	22.4	3.6	2.4	16.4	37.8	15.4	14.0	14.1	18.0	17.6	10.0	13.2	6.3	16.6	17.3	18.9	20.6	25.2	4.3	8.6	27.4	12.0	7.5	18.0	0.9	2.1	1.9	3.8	2.3	3.8	5.5	5.0	4.7	3.6	6.3	3.5	4.5	1.0	3.4	5.5	6.8	5.9	2.9	13.9	16.6	8.9	16.5	11.8	28.9	23.5	14.3	18.8	9.8
PTTG1	"EAP1, HPTTG, PTTG, securin, TUTR1"	ENSG00000164611	"Pituitary tumor-transforming 1"	O95997	5	160421822-160428744	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.5;testis: 100.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.5"	"Lineage enriched"	"Detected in all"	7	"T-cells: 54.5"									"CAB008373, HPA008890, HPA045034"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: "	"unprognostic (6.48e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.46e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (7.50e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.35e-2)"	1.5	1.7	2.1	16.2	5.5	34.1	2.9	1.4	4.6	3.8	8.2	1.0	0.7	5.8	1.3	2.6	24.1	1.0	1.9	2.3	5.1	2.7	1.7	1.4	3.8	19.2	1.5	2.2	1.1	1.2	0.2	2.0	5.0	2.2	1.6	11.3	1.5	4.5	1.1	1.2	8.7	5.8	4.5	1.4	7.5	3.4	100.1	1.0	29.8	23.9	23.2	35.1	3.3	7.2	8.1	6.1	2.4	2.1	3.3	54.5	4.7	45.5	23.7	53.6	38.4	9.1	8.9	16.7	24.2	55.5	64.3	70.5	45.8	40.1	49.8	21.6	27.5	23.9	33.2	67.3	92.3	56.9	30.2	26.2	32.1	27.5	1.8	23.8	23.1	4.2	11.3	43.6	26.5	45.3	21.0	38.8	66.0	21.4	28.4	58.5	27.0	34.5	26.5	63.0	42.7	32.8	9.3	33.4	21.2	34.9	21.3	71.9	43.5	26.1	19.3	29.1	38.9	22.7	70.6	33.4	29.8	56.9	31.3	41.2	51.5	1.9	0.7	2.4	7.0	2.1	2.5	8.1	14.4	16.2	6.1	5.5	3.6	8.9	0.8	3.3	1.4	5.8	54.5	4.7	2.1	5.5	1.4	4.6	5.1	2.7	1.5	2.2	2.2	1.0
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960435-37961125	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;MOLT-4: 3.0;U-698: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4;T-reg: 1.0"	"Low lineage specificity"	"Detected in many"											"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA008890: AB_1079717, HPA045034: "	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	1.0	0.4	0.9	5.2	1.2	5.0	0.5	2.2	2.4	1.1	3.9	0.2	0.0	0.0	1.6	2.2	3.3	1.8	1.5	2.5	1.0	0.4	0.7	0.5	0.9	1.0	0.7	0.4	1.2	1.0	1.4	0.4	1.8	0.3	0.8	0.7	0.0	0.2	1.4	1.9	0.6	3.1	2.0	0.9	2.3	1.0	5.3	0.0	15.8	1.3	7.5	7.3	1.8	0.7	0.4	0.0	1.4	0.4	0.0	1.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.7	0.5	0.9	0.0	0.4	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	0.9	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	1.4	0.0	0.0	0.0	1.0	0.1	0.9	1.2	2.2	2.4	1.0	0.4	0.7	0.4	0.3	0.0
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favourable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	25.1	26.3	30.1	17.1	35.0	36.3	27.0	38.1	35.9	24.0	20.8	28.1	16.5	17.6	27.6	24.5	22.6	29.1	18.3	22.0	24.2	29.7	23.6	20.3	20.4	18.8	22.8	25.5	33.9	21.8	38.1	31.7	31.4	33.1	22.8	24.0	25.8	25.4	23.9	40.7	29.7	22.8	25.9	20.1	19.1	20.6	15.9	22.1	27.9	28.3	15.6	27.1	23.4	24.1	18.9	25.2	27.6	24.8	28.5	27.1	22.0	17.2	23.1	37.7	23.9	29.7	25.7	25.8	20.8	25.3	21.5	24.6	24.2	29.9	20.4	21.9	27.9	25.4	30.9	22.9	27.9	16.9	26.8	22.0	27.1	28.8	20.8	26.7	21.2	27.4	29.0	28.6	30.4	29.4	30.3	19.3	24.6	14.4	26.1	19.3	38.5	16.2	27.2	25.7	21.7	31.5	26.2	31.2	23.8	28.6	22.2	24.5	22.3	20.4	30.6	18.0	16.3	23.9	20.5	15.5	14.2	22.5	16.1	19.9	22.7	27.6	24.8	18.5	25.7	23.8	26.3	18.9	23.2	25.0	25.2	18.8	26.6	26.9	14.8	28.5	24.6	14.6	27.1	22.0	30.1	35.0	38.1	35.9	24.2	29.7	22.8	25.5	33.1	22.1
PUM2	"KIAA0235, PUMH2"	ENSG00000055917	"Pumilio RNA binding family member 2"	Q8TB72	2	20248691-20352234	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030316, HPA049670"	Approved		Enhanced	Cytosol				Cytosol		"HPA030316: AB_10610289, HPA049670: "	"unprognostic (2.41e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.87e-2)"	20.3	20.7	21.1	35.2	20.0	18.3	25.2	41.2	26.0	31.4	35.4	19.5	13.5	20.5	26.1	20.5	25.1	19.9	25.7	25.7	22.1	19.8	22.9	25.6	24.6	26.8	20.7	21.1	29.1	23.2	32.9	24.2	39.3	17.5	24.3	22.9	21.8	22.7	42.6	19.2	27.7	27.8	20.5	18.5	25.4	23.5	14.6	20.2	56.2	35.7	21.7	28.1	26.8	29.0	6.6	5.6	15.3	8.6	9.4	10.0	4.8	23.5	17.3	21.1	15.1	13.0	13.8	22.7	17.2	17.1	15.4	14.0	14.3	11.1	31.6	3.9	14.5	13.2	21.2	11.8	23.8	29.5	13.6	32.2	12.7	19.5	14.3	33.9	30.9	9.9	25.1	14.7	26.6	17.8	24.6	26.6	18.2	11.3	30.4	19.7	18.6	11.3	26.0	36.6	23.8	14.2	21.4	18.2	26.1	14.4	18.9	14.9	11.1	19.0	17.8	20.2	19.7	12.8	21.1	31.7	38.3	59.9	12.2	24.5	17.3	11.8	5.5	7.4	8.1	6.7	9.8	6.4	9.0	9.8	5.6	6.6	10.0	8.0	15.3	9.4	8.6	4.7	6.8	4.8	21.1	20.0	41.2	26.0	22.1	19.8	20.7	21.1	17.5	20.2
PUS3	FKSG32	ENSG00000110060	"Pseudouridylate synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: "	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.6	8.8	5.9	7.4	7.7	2.3	8.7	9.0	8.4	7.4	9.2	3.6	4.6	9.9	8.4	8.6	8.1	6.4	5.9	7.6	8.0	6.4	9.6	36.6	6.1	11.0	8.7	7.2	7.7	17.9	8.2	21.1	7.6	7.7	10.4	7.4	5.4	10.6	5.1	15.2	8.2	11.5	13.9	9.7	8.9	9.3	5.3	7.3	9.6	12.4	10.6	9.2	11.1	7.3	13.0	8.8	9.9	12.3	13.0	16.5	7.1	3.5	4.3	13.3	14.9	13.7	17.5	6.4	11.9	10.0	6.8	7.6	14.1	13.4	18.1	19.6	5.2	12.4	21.6	11.0	6.9	15.4	10.4	18.6	5.5	10.1	14.5	11.7	5.5	13.8	13.3	8.1	17.4	12.5	18.9	9.5	7.3	2.1	13.0	12.5	11.5	8.5	2.6	12.2	10.2	11.2	5.6	15.5	13.8	8.1	11.4	6.5	24.3	7.6	8.4	14.4	5.9	6.8	9.8	7.1	10.6	19.1	3.9	18.8	9.8	9.9	9.7	7.8	13.0	9.4	15.2	13.0	12.8	12.5	8.8	12.2	16.5	15.6	3.7	13.0	12.3	7.8	12.9	7.1	5.9	7.7	9.0	8.4	8.0	6.4	8.7	7.2	7.7	7.3
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2, small subunit processome component"	Q15269	21	44107290-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 30.5;Daudi: 26.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA024573	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	6.1	6.1	11.3	7.7	14.6	3.6	6.3	9.7	12.8	4.0	9.0	9.6	2.4	4.4	7.8	9.2	8.2	5.9	4.8	4.6	6.8	4.8	6.9	8.7	5.0	7.9	15.4	5.7	5.0	12.8	1.4	4.0	7.6	8.9	8.1	1.8	4.9	8.2	5.2	8.0	14.7	5.6	2.2	6.4	8.8	10.6	5.3	17.2	3.6	4.8	8.6	16.8	5.0	5.7	6.8	2.6	2.9	4.3	3.4	6.9	5.0	1.1	0.4	0.3	1.2	3.5	3.6	9.2	11.8	6.2	15.7	10.6	30.5	0.5	26.4	0.4	0.0	1.3	0.5	8.9	9.1	6.4	19.0	3.1	5.5	7.0	2.3	2.3	0.9	0.2	0.0	10.9	0.0	0.5	10.1	10.6	5.2	0.3	0.1	0.7	0.3	1.1	1.5	0.1	13.6	0.0	0.4	9.2	1.6	0.6	1.0	7.4	0.0	1.0	6.0	6.4	1.1	14.2	1.4	14.3	17.0	1.2	0.4	2.8	9.1	0.2	2.2	2.9	6.0	3.1	6.6	6.8	4.9	6.9	1.6	4.1	4.9	6.1	1.2	3.4	4.3	2.6	3.5	5.0	11.3	14.6	9.7	12.8	6.8	4.8	15.4	5.7	8.9	17.2
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319578-51809445	"Enzymes, Predicted intracellular proteins"	"Hydrogen peroxide"	"Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"heart muscle: 59.1"	"Group enriched"	"Detected in some"	7	"AF22: 10.8;Daudi: 8.1;SH-SY5Y: 8.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA007919: AB_1855966"	"prognostic unfavourable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.1	0.1	0.3	0.1	0.2	0.0	0.2	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.3	7.9	0.4	0.1	0.7	59.1	0.2	0.3	1.0	0.1	0.2	0.3	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.8	1.1	0.3	0.9	0.2	0.2	0.1	0.2	0.3	0.1	5.2	0.0	0.1	0.2	2.5	0.3	0.2	0.1	1.5	0.3	0.3	0.0	0.0	0.1	0.0	0.6	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.9	0.2	0.3	0.3	0.3	0.3	0.0
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426126	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 81.1"	"Cell line enhanced"	"Detected in many"		"U-937: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Approved		Supported	"Plasma membrane,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favourable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	9.3	9.4	20.7	17.0	51.4	33.6	7.6	22.6	31.4	28.9	8.9	81.1	2.4	6.3	14.2	5.3	6.6	8.0	9.6	7.5	33.7	19.9	10.4	5.7	8.2	23.8	68.6	23.4	11.1	8.5	13.7	6.1	17.5	43.9	6.0	6.4	4.4	8.8	7.7	7.6	7.5	7.7	11.8	55.9	13.5	8.3	6.7	56.6	3.7	40.3	2.5	26.1	9.8	13.1	31.3	18.8	31.8	22.5	8.7	11.2	13.4	4.2	2.5	1.9	3.5	26.6	23.6	5.6	6.9	14.6	6.6	9.3	1.2	0.9	22.6	1.6	11.6	1.3	6.0	4.3	7.0	5.6	3.8	3.9	3.0	1.7	31.0	33.5	6.9	20.2	10.5	8.3	14.4	5.8	4.7	7.4	11.8	1.6	7.3	34.6	2.3	6.3	12.6	3.3	4.0	4.2	2.4	1.7	1.2	4.7	3.3	5.4	11.4	34.7	5.9	8.3	3.4	15.7	7.2	5.8	5.7	22.5	12.0	47.6	3.4	14.6	20.1	29.4	11.2	16.2	9.9	29.0	8.1	9.4	18.8	31.3	7.1	8.4	31.8	8.7	22.5	13.5	8.7	13.4	20.7	51.4	22.6	31.4	33.7	19.9	68.6	23.4	43.9	56.6
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 49.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"				"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: "	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavourable (1.09e-4)"	"prognostic unfavourable (3.72e-5)"	"prognostic unfavourable (7.12e-5)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	35.4	26.2	17.9	26.7	16.5	31.6	45.9	15.5	18.6	25.0	29.0	12.4	31.7	25.6	27.6	30.9	16.0	29.8	31.8	26.2	18.0	7.6	27.6	13.1	35.8	42.9	15.7	8.1	14.8	16.3	17.6	13.9	34.0	15.8	24.9	23.5	24.7	22.1	40.1	98.5	19.7	34.7	44.4	20.3	34.0	20.6	19.8	14.4	9.9	26.7	22.8	11.6	30.1	45.7	0.5	7.6	49.5	12.3	14.4	26.3	14.5	32.6	16.2	5.8	5.8	11.7	30.4	39.3	27.6	24.1	22.5	11.9	18.9	20.5	2.2	18.2	28.1	23.3	4.0	50.3	18.0	1.8	3.6	0.4	11.9	6.7	16.9	0.5	0.7	14.8	33.0	23.6	26.8	40.0	5.7	3.7	44.0	21.6	2.0	0.7	8.2	56.3	4.8	9.6	2.0	23.1	31.4	9.5	2.8	24.8	7.6	14.9	18.8	2.7	52.7	15.7	17.2	19.5	32.9	4.0	2.2	0.8	45.1	4.9	30.6	9.8	12.3	13.4	26.3	4.4	14.2	0.5	12.1	17.2	7.6	0.4	9.6	12.8	49.5	14.4	0.2	1.2	9.1	14.5	17.9	16.5	15.5	18.6	18.0	7.6	15.7	8.1	15.8	14.4
PYCARD	"ASC, CARD5, TMS-1"	ENSG00000103490	"PYD and CARD domain containing"	Q9ULZ3	16	31201485-31203450	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 130.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 33.9;NB-4: 53.4;THP-1: 39.4;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4"									"CAB006853, CAB015948, HPA049074, HPA054496"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol			1100000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506"	"unprognostic (1.00e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavourable (6.09e-7)"	"unprognostic (4.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.97e-2)"	11.6	4.4	3.6	16.7	4.6	22.4	8.6	3.6	3.3	8.2	26.8	6.8	4.1	38.7	5.4	7.9	20.7	6.8	8.5	6.6	2.4	2.6	5.6	6.8	15.0	32.8	6.4	1.8	6.6	6.1	1.3	3.2	6.6	4.0	9.7	4.4	4.7	9.6	5.6	3.5	31.2	29.9	3.5	6.4	34.1	13.3	3.7	3.3	20.6	5.5	22.3	26.3	7.9	11.8	17.1	66.8	130.8	90.4	16.0	16.0	53.1	5.6	13.3	0.1	0.0	1.3	3.0	0.1	2.8	3.9	1.8	1.2	0.0	7.1	2.3	0.0	2.7	15.7	0.6	10.5	0.0	17.0	0.0	2.2	1.6	4.3	4.6	19.8	15.7	3.9	5.5	0.8	0.1	3.8	9.7	3.6	0.5	33.9	0.0	53.4	3.6	0.0	17.2	0.0	7.4	0.1	5.5	0.1	0.0	2.4	0.0	2.7	3.3	39.4	2.5	0.1	0.2	2.3	0.0	0.1	0.0	0.0	1.3	24.4	0.0	37.8	90.4	71.4	15.1	87.5	9.5	17.1	12.7	15.5	66.8	15.2	8.9	12.3	130.8	16.0	85.0	61.0	16.0	53.1	3.6	4.6	3.6	3.3	2.4	2.6	6.4	1.8	4.0	3.3
PYCR3	"FLJ13852, PYCRL"	ENSG00000104524	"Pyrroline-5-carboxylate reductase 3"	Q53H96	8	143603913-143609773	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063416, HPA069706"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA063416: , HPA069706: "	"unprognostic (2.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.54e-1)"	6.1	8.1	11.5	6.7	9.7	4.8	5.6	5.3	13.4	6.9	5.4	6.1	10.8	4.4	4.7	5.2	6.1	10.1	6.3	4.4	12.2	8.5	7.7	20.5	5.9	6.7	7.6	12.1	6.7	10.6	4.3	9.1	3.5	9.7	7.5	4.0	4.5	13.7	9.1	4.8	4.7	4.9	4.0	4.4	5.9	7.0	8.6	4.5	3.8	9.5	6.3	6.1	3.6	3.1	11.1	5.4	0.4	1.4	3.2	3.2	2.1	5.8	11.0	2.0	4.2	1.9	1.2	4.1	5.2	2.2	4.2	2.4	4.8	5.8	7.7	7.0	3.7	4.9	1.9	6.1	0.8	5.2	6.7	3.8	4.2	3.2	1.9	1.7	1.1	2.1	1.6	4.8	2.7	2.4	5.9	2.4	2.0	18.0	7.3	1.3	1.8	17.7	5.1	1.9	11.5	3.9	3.8	7.1	2.4	8.4	10.8	1.9	13.3	2.2	2.1	3.8	7.9	5.9	4.9	4.2	1.0	4.8	4.4	2.4	3.5	0.3	1.4	0.2	3.2	1.1	3.1	5.8	2.1	2.6	2.1	11.1	3.0	3.0	0.4	3.2	1.0	5.4	1.8	2.1	11.5	9.7	5.3	13.4	12.2	8.5	7.6	12.1	9.7	4.5
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248069-25298014	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 101.9"	"Cell line enhanced"	"Detected in all"		"PC-3: 70.3;SK-MEL-30: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol			16000000	Cytosol		"HPA031067: "	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.37e-4)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.43e-4)"	19.0	11.3	24.2	12.1	22.9	6.1	28.4	38.3	34.8	14.3	47.0	21.5	19.0	12.5	15.9	13.8	49.6	14.1	21.1	72.5	21.1	21.3	13.5	4.4	14.8	8.1	22.9	24.7	11.9	9.7	8.0	18.2	6.2	28.0	42.2	33.8	11.0	58.4	52.0	5.0	23.9	13.1	101.9	17.8	8.2	24.1	14.5	17.4	9.5	21.1	8.4	10.3	56.7	14.8	4.5	11.2	5.2	16.8	8.1	10.6	16.0	5.2	37.6	6.8	6.6	17.4	32.8	5.0	10.6	13.9	8.9	7.5	8.4	6.5	6.2	12.5	14.1	21.1	7.6	28.2	4.9	3.5	4.7	5.0	3.1	14.4	20.6	7.3	7.0	19.0	26.5	22.7	33.6	11.4	2.7	15.8	12.5	14.5	7.3	5.7	6.1	70.3	5.6	12.3	8.2	48.9	9.6	10.2	6.3	7.2	12.8	88.2	8.9	4.7	25.0	10.6	6.4	11.3	21.5	6.1	9.5	2.4	11.9	5.8	57.6	2.6	10.2	5.2	8.5	15.5	8.3	4.5	6.8	7.5	11.2	4.2	8.8	10.6	2.5	8.1	16.8	5.5	7.5	16.0	24.2	22.9	38.3	34.8	21.1	21.3	22.9	24.7	28.0	17.4
PYGL		ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944736	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 56.1;HMC-1: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 36.0;neutrophil: 41.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"			17000000	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	47.6	9.9	4.9	9.7	6.8	40.0	28.1	1.3	3.9	17.2	10.1	3.0	23.7	1.7	10.9	7.3	24.8	7.8	5.5	15.0	3.9	3.4	6.8	58.8	19.6	25.6	6.5	1.6	15.4	4.1	12.5	3.7	23.3	5.3	11.4	10.3	17.8	11.8	55.2	7.1	15.3	3.5	11.2	8.7	38.8	4.5	6.8	5.4	2.4	7.1	9.1	7.3	18.4	24.3	0.0	7.3	41.4	13.8	0.1	0.0	5.5	28.3	8.0	2.1	13.2	9.8	11.8	23.0	5.7	4.8	15.7	24.0	21.1	3.6	0.0	11.1	33.8	56.1	21.4	28.8	27.3	0.1	9.0	5.4	12.8	16.4	17.6	20.6	62.0	25.1	11.8	21.3	9.0	13.9	2.2	0.1	11.1	28.3	0.0	28.4	7.9	29.7	0.5	7.3	1.1	21.8	19.0	0.9	0.9	25.8	9.0	0.3	4.2	40.4	0.6	6.1	10.2	11.4	18.3	0.2	0.0	0.0	5.6	21.3	3.2	11.3	13.8	36.0	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	41.4	0.1	3.9	0.3	0.0	5.5	4.9	6.8	1.3	3.9	3.9	3.4	6.5	1.6	5.3	5.4
PYGO1		ENSG00000171016	"Pygopus family PHD finger 1"	Q9Y3Y4	15	55538890-55588947	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 26.6"	"Cell line enhanced"	"Detected in many"		"U-698: 25.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042248	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042248: AB_10794272"	"unprognostic (5.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-6)"	"unprognostic (3.36e-4)"	"unprognostic (4.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.80e-2)"	3.0	3.8	3.8	1.6	8.2	0.6	3.1	10.1	5.1	10.8	5.1	2.8	8.2	0.9	9.8	5.8	3.3	4.2	3.9	2.6	5.2	4.3	1.8	0.6	3.2	1.0	4.2	2.8	14.2	2.3	26.6	6.9	3.2	5.0	7.9	1.9	5.5	1.9	9.4	18.7	1.5	1.8	7.9	5.2	0.8	2.8	6.0	3.2	0.0	10.1	5.7	1.0	7.6	9.2	0.6	0.2	0.9	0.2	0.3	0.4	0.0	2.7	5.0	8.8	4.6	3.3	7.6	3.7	6.0	6.6	4.8	5.5	3.3	0.0	0.0	1.8	3.8	0.0	9.0	0.0	6.1	0.0	3.0	1.3	1.4	0.2	4.8	4.9	0.0	4.0	4.7	4.3	0.6	2.4	0.0	0.0	7.4	0.1	0.2	0.0	2.4	2.6	0.0	11.2	0.0	1.5	1.9	4.8	5.7	5.4	0.0	4.2	1.7	1.4	0.0	11.9	5.4	0.2	7.0	0.1	0.1	25.5	3.7	0.0	2.7	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.3	0.0	0.0	0.6	0.3	0.4	0.9	0.3	0.1	0.2	0.1	0.0	3.8	8.2	10.1	2.8	5.2	4.3	4.2	2.8	5.0	3.2
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"				"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: , HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.34e-4)"	17.5	21.4	16.2	21.2	14.8	13.2	20.3	16.3	17.1	15.2	21.2	14.2	27.1	21.8	16.1	30.8	46.7	16.3	21.5	13.6	14.0	14.7	19.4	31.3	14.4	28.6	14.7	14.0	13.3	24.8	15.3	19.8	21.5	12.8	20.7	21.5	18.3	22.9	24.5	18.2	27.2	29.9	16.3	13.2	25.5	15.8	21.1	14.1	26.3	22.5	31.2	39.1	16.5	19.9	29.5	35.9	21.6	27.2	14.4	53.6	24.1	17.4	13.9	20.4	11.3	12.4	16.2	33.5	12.8	15.5	12.2	10.3	20.3	20.8	21.9	19.6	12.4	13.7	15.7	27.5	9.8	16.9	11.7	17.8	11.9	25.0	15.2	20.6	16.3	14.5	17.8	13.7	20.6	12.9	15.2	24.4	14.2	26.2	13.2	36.8	35.6	7.3	11.9	8.1	25.1	24.9	24.8	13.8	15.9	16.4	22.1	11.5	26.9	43.7	10.0	7.4	10.4	11.4	9.3	12.9	19.5	33.8	12.6	14.3	11.4	3.9	24.5	21.6	18.7	27.2	22.9	29.5	34.0	26.1	35.9	25.2	22.6	22.6	5.8	14.4	18.5	19.6	53.6	24.1	16.2	14.8	16.3	17.1	14.0	14.7	14.7	14.0	12.8	14.1
QARS		ENSG00000172053	"Glutaminyl-tRNA synthetase"	P47897	3	49095932-49105135	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol			21000	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favourable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favourable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	20.9	16.3	9.7	19.3	10.2	18.4	22.7	15.8	13.2	17.6	27.3	13.1	27.7	17.2	12.3	19.8	35.1	16.4	20.0	22.0	9.8	9.6	27.1	26.0	15.0	33.9	12.4	7.2	21.6	33.8	20.3	13.7	25.7	9.6	16.2	29.9	15.2	31.7	28.7	33.3	26.7	31.8	16.7	11.2	21.1	16.9	30.1	11.3	36.8	16.5	34.8	33.3	19.4	18.5	20.4	40.0	8.9	32.3	21.8	24.0	19.6	18.6	19.0	31.6	45.3	40.8	44.4	32.6	20.7	47.4	41.2	40.5	23.9	24.2	57.6	13.3	34.3	23.7	44.9	34.1	29.6	16.4	35.9	45.4	30.4	41.8	21.5	36.9	28.0	46.7	29.9	31.7	27.0	44.9	20.2	25.6	30.1	10.0	26.6	33.1	27.2	29.6	17.5	26.6	42.5	27.6	27.8	11.6	32.4	18.4	46.7	28.6	38.7	43.1	25.9	18.8	26.6	30.9	23.1	22.1	37.6	32.3	19.2	33.3	11.9	8.9	23.1	8.7	13.5	32.3	18.1	20.4	16.8	14.9	40.0	15.2	15.5	15.4	2.6	21.8	26.1	16.9	24.0	19.6	9.7	10.2	15.8	13.2	9.8	9.6	12.4	7.2	9.6	11.3
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37344574-37373322	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6;blood: 137.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.5;SCLC-21H: 23.8;SK-MEL-30: 80.0;U-266/84: 62.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 137.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 137.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	3.2	77.6	4.3	5.4	5.8	17.0	6.4	1.2	11.6	9.2	11.3	2.2	1.5	2.2	6.2	43.7	2.4	1.9	5.5	2.9	6.7	17.9	12.4	1.3	6.1	7.4	3.9	5.0	1.4	5.5	9.6	31.6	7.8	5.9	3.5	4.2	21.2	14.7	2.8	4.0	14.2	2.3	3.4	3.0	8.5	3.4	2.6	0.5	2.3	1.8	4.4	4.8	7.0	2.9	0.2	10.7	137.6	29.7	0.0	0.0	12.1	0.1	7.9	0.0	0.0	1.0	2.6	0.0	1.0	17.5	1.3	2.1	0.5	1.4	0.0	0.6	5.9	0.0	0.5	0.0	2.1	0.1	15.3	3.5	0.0	1.5	0.1	0.5	0.0	1.5	0.0	9.7	0.0	5.2	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.1	8.6	2.1	23.8	0.0	1.3	0.0	80.0	0.1	0.5	3.7	0.0	0.0	0.0	0.1	3.0	62.5	0.0	5.3	0.0	0.0	0.6	29.7	0.2	0.0	3.4	0.0	0.2	0.0	0.0	10.7	0.1	0.0	0.0	137.6	0.0	0.3	0.2	0.0	12.1	4.3	5.8	1.2	11.6	6.7	17.9	3.9	5.0	5.9	0.5
QSER1	FLJ21924	ENSG00000060749	"Glutamine and serine rich 1"	Q2KHR3	11	32893178-32993316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005682	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005682: AB_1855985"	"unprognostic (2.94e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (7.94e-5)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (5.27e-5)"	"unprognostic (6.77e-2)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-2)"	10.8	8.3	13.6	9.1	11.3	8.3	22.0	21.3	14.9	13.1	8.7	9.8	9.5	5.4	13.8	13.1	15.9	11.2	8.9	10.0	12.5	7.1	9.3	9.5	9.1	8.2	13.1	10.9	21.4	15.6	16.5	11.4	9.0	11.5	11.5	9.2	10.9	16.7	9.7	9.8	20.1	7.9	10.4	11.5	10.1	9.3	14.2	12.8	14.2	14.2	14.0	10.1	11.8	24.8	2.0	2.2	0.3	2.4	1.7	1.1	0.4	11.2	13.9	16.3	15.0	6.3	12.4	7.8	9.8	8.8	7.2	8.8	12.1	5.3	11.8	6.3	11.9	14.7	14.9	8.8	15.3	5.0	9.6	11.0	13.4	10.0	4.8	13.2	6.0	5.9	9.4	9.1	14.9	9.8	16.8	5.3	11.1	10.0	6.3	5.3	17.2	8.5	10.6	32.2	4.9	7.4	12.4	8.5	12.2	18.5	9.9	6.2	10.2	7.0	9.7	17.4	17.5	31.3	21.0	3.6	4.9	12.3	11.2	6.3	11.2	0.0	1.2	0.3	1.1	2.4	0.5	2.0	0.7	1.0	1.1	0.9	0.6	0.7	0.0	1.7	0.6	2.2	0.2	0.4	13.6	11.3	21.3	14.9	12.5	7.1	13.1	10.9	11.5	12.8
R3HCC1	DKFZp564N123	ENSG00000104679	"R3H domain and coiled-coil containing 1"	Q9Y3T6	8	23270120-23296279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023073, HPA023153"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA023073: AB_1855987, HPA023153: AB_2237834"	"unprognostic (5.80e-2)"	"unprognostic (4.70e-3)"	"prognostic favourable (4.08e-4)"	"unprognostic (7.46e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.02e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.92e-1)"	"prognostic favourable (8.66e-4)"	"unprognostic (7.65e-2)"	"prognostic favourable (6.80e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.43e-1)"	14.8	14.2	21.4	14.8	20.9	18.4	24.6	16.5	36.3	13.9	18.4	26.0	14.8	14.5	16.4	18.2	12.5	17.9	16.4	23.8	21.5	16.9	13.2	16.6	18.8	15.9	30.1	16.3	22.1	50.3	16.0	14.7	10.4	20.7	14.8	12.0	15.3	24.8	20.7	36.6	16.3	14.4	18.3	33.7	13.0	16.9	17.4	21.4	15.8	13.6	14.7	13.9	12.9	12.6	28.5	29.7	41.6	27.1	29.7	36.5	25.7	20.9	26.3	21.2	20.5	9.1	12.4	14.4	13.9	13.4	23.8	17.4	18.3	9.9	21.2	14.8	17.0	15.8	22.3	25.9	16.1	13.6	21.9	19.7	18.1	15.3	21.5	13.4	14.8	14.6	20.5	20.3	9.6	18.1	22.8	17.9	13.9	17.2	30.3	22.5	16.9	19.2	20.7	25.8	12.6	11.4	23.0	27.2	23.3	15.8	18.8	22.6	17.1	16.1	15.4	21.9	18.2	18.2	28.2	13.3	11.8	21.8	16.9	18.8	27.1	17.8	27.1	41.6	36.5	22.6	31.5	28.5	29.6	30.4	29.7	21.0	23.2	26.6	16.6	29.7	24.2	27.7	30.5	25.7	21.4	20.9	16.5	36.3	21.5	16.9	30.1	16.3	20.7	21.4
R3HDM1	"KIAA0029, R3HDM"	ENSG00000048991	"R3H domain containing 1"	Q15032	2	135531455-135725270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030936			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA030936: AB_10670835"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-3)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavourable (5.83e-7)"	"unprognostic (1.16e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.47e-1)"	6.5	6.4	23.2	8.3	27.8	13.4	5.3	22.2	57.6	6.7	7.5	4.5	2.4	4.5	6.9	6.6	6.2	5.5	6.3	5.3	17.9	15.5	6.0	6.2	5.0	11.0	11.5	32.7	5.3	8.4	20.1	13.2	4.2	7.7	5.4	10.3	4.3	4.3	6.1	13.5	5.3	5.6	8.6	7.9	6.6	5.4	14.3	7.6	14.2	8.7	3.6	13.2	8.4	4.3	6.5	12.7	3.5	8.4	9.6	9.6	5.0	20.5	12.6	17.9	20.7	9.6	13.2	10.6	12.9	13.5	13.0	14.3	22.6	14.3	32.7	10.3	18.3	9.3	23.4	24.0	22.9	20.5	11.7	26.3	16.1	22.5	11.6	22.4	17.1	12.4	10.7	22.9	29.5	20.9	27.2	28.1	14.9	21.2	38.8	15.4	13.8	14.9	23.2	12.4	19.5	12.9	18.2	18.3	14.2	20.8	8.5	9.3	11.4	12.0	15.2	12.1	12.1	15.2	16.2	22.5	30.8	30.7	13.6	18.4	15.4	3.5	7.8	3.0	6.1	8.4	5.8	6.5	6.6	9.1	11.2	4.4	6.4	7.2	1.0	9.6	7.1	12.7	9.6	5.0	23.2	27.8	22.2	57.6	17.9	15.5	11.5	32.7	7.7	7.6
R3HDM4	"C19orf22, MGC16353"	ENSG00000198858	"R3H domain containing 4"	Q96D70	19	896503-913245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 93.1"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 93.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043025, HPA048638"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043025: , HPA048638: "	"unprognostic (9.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.28e-2)"	"prognostic favourable (7.33e-6)"	"unprognostic (4.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.74e-2)"	15.4	11.7	23.3	33.2	19.5	57.7	15.4	12.7	26.6	15.9	16.5	16.3	10.0	17.1	15.3	13.2	33.0	15.7	20.1	12.5	20.2	11.9	18.8	24.1	22.7	43.3	14.8	11.9	19.2	34.9	10.0	16.2	18.5	12.8	17.7	12.6	15.5	24.2	14.5	21.6	22.4	18.0	13.4	10.3	41.1	24.1	8.1	12.5	31.9	14.6	19.6	43.0	20.6	19.0	6.4	2.2	93.1	2.0	1.2	7.7	3.8	17.9	10.5	11.3	15.2	7.2	12.7	18.5	12.2	9.7	12.3	10.9	11.1	15.4	13.0	10.2	13.8	16.4	6.5	14.5	5.6	19.9	13.8	17.9	9.2	19.5	21.6	9.7	31.7	16.9	28.0	8.0	16.8	14.1	33.0	26.6	11.4	32.1	13.9	18.8	14.5	17.3	13.8	5.4	24.7	20.3	18.9	19.9	19.3	10.7	23.8	19.9	20.9	23.6	14.2	22.5	12.5	26.2	12.1	29.6	15.4	19.0	14.4	14.1	19.6	14.6	2.0	16.2	2.5	1.5	3.9	6.4	5.0	3.4	2.2	3.8	4.8	3.3	93.1	1.2	2.0	0.9	7.7	3.8	23.3	19.5	12.7	26.6	20.2	11.9	14.8	11.9	12.8	12.5
RAB13		ENSG00000143545	"RAB13, member RAS oncogene family"	P51153	1	153981617-153986358	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 7.7;myeloid DC: 10.7;plasmacytoid DC: 12.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 12.0;monocytes: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003996	Approved		Supported	"Plasma membrane,Cytosol"			4600000	"Plasma membrane, Cytosol"		"HPA003996: AB_1079728"	"unprognostic (4.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.80e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (1.28e-2)"	49.0	40.4	18.1	28.7	30.2	29.7	52.1	13.6	23.5	33.1	33.6	13.7	46.6	17.8	28.5	47.1	43.2	25.0	46.7	36.9	21.9	17.0	61.3	51.5	40.8	36.7	22.9	11.1	39.2	65.6	28.4	11.1	29.0	29.1	41.5	24.5	21.6	47.4	44.4	26.8	25.0	28.7	35.3	31.3	44.8	34.5	24.0	24.7	5.9	54.8	35.0	24.9	41.0	78.4	1.0	12.0	0.9	7.7	0.0	0.7	2.4	17.1	21.1	19.2	20.1	64.4	115.1	6.2	20.9	49.5	18.9	19.3	21.3	14.6	0.0	31.5	24.9	11.8	11.3	19.0	26.3	11.0	8.8	14.3	13.3	11.9	27.0	0.0	10.1	83.7	16.5	32.6	14.5	32.9	3.0	0.0	32.1	35.6	0.0	7.3	30.8	20.2	4.1	24.9	0.0	42.6	18.1	1.2	15.8	27.3	23.7	42.1	38.9	11.4	60.9	34.4	20.4	21.3	22.6	0.1	0.0	0.2	53.6	2.4	52.2	0.0	7.7	0.1	0.0	1.4	0.1	0.8	0.1	0.1	10.7	1.0	0.1	0.7	0.9	0.0	0.2	12.0	0.0	2.4	18.1	30.2	13.6	23.5	21.9	17.0	22.9	11.1	29.1	24.7
RAB1A	"RAB1, YPT1"	ENSG00000138069	"RAB1A, member RAS oncogene family"	P62820	2	65070701-65130106	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005331, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Cytosol"			19000000	"Endoplasmic reticulum, Cytosol"		"CAB005331: AB_632290, HPA056141: "	"unprognostic (4.78e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (1.55e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.63e-2)"	53.0	57.6	54.6	34.8	58.4	80.8	54.0	47.7	63.2	49.2	50.3	24.8	53.8	52.7	46.7	75.8	58.8	40.7	40.9	49.9	48.1	52.8	77.8	75.4	48.2	40.7	44.0	55.3	37.1	53.5	38.5	59.7	108.6	47.3	40.5	52.2	34.0	68.7	57.1	43.8	35.5	51.6	47.6	49.6	34.5	53.2	30.9	42.4	21.5	56.9	53.1	34.9	52.2	45.1	19.1	33.2	45.0	37.1	24.4	25.1	22.2	39.2	29.1	35.8	20.8	86.6	51.0	56.4	58.4	39.7	25.9	27.5	50.2	26.0	15.9	33.6	57.6	25.2	32.5	51.9	41.0	19.6	19.5	20.1	23.2	73.6	55.0	20.8	18.3	45.0	53.0	33.9	30.3	50.8	28.6	18.5	50.8	35.1	12.2	25.1	28.2	26.2	12.5	33.9	25.3	50.0	44.0	25.8	23.0	26.8	43.9	49.2	27.3	19.6	48.7	33.4	42.6	35.2	32.6	28.9	17.8	38.3	44.4	32.2	32.3	35.3	37.1	32.2	19.5	36.8	21.5	19.1	21.1	21.0	33.2	13.9	20.5	20.4	45.0	24.4	31.6	27.6	25.1	22.2	54.6	58.4	47.7	63.2	48.1	52.8	44.0	55.3	47.3	42.4
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222314	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Developmental protein"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 62.4;urinary bladder: 48.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.0;U-2197: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	6.0	3.0	6.7	5.7	5.1	0.2	4.0	7.3	4.8	23.1	32.9	5.1	9.6	3.0	34.1	8.0	9.7	8.1	12.4	7.0	7.4	4.5	3.3	1.8	4.9	1.7	6.4	5.4	8.2	1.6	2.9	3.5	12.3	6.7	24.9	7.5	3.6	2.8	26.9	4.7	3.1	7.0	62.4	6.6	1.1	8.7	4.3	7.2	1.4	15.1	3.9	1.7	48.9	11.2	0.3	1.5	1.3	0.6	0.9	2.0	0.3	4.7	1.9	6.8	4.8	10.5	32.0	6.3	14.0	24.3	12.3	12.8	4.1	2.3	0.9	4.4	22.4	1.7	7.1	5.1	14.7	3.5	3.3	3.4	3.1	3.2	6.5	1.8	0.5	11.9	5.9	15.3	14.4	6.4	5.2	2.9	13.6	4.0	1.5	1.9	2.5	2.6	1.7	10.1	1.4	8.5	3.3	3.5	2.4	7.0	3.3	3.6	3.0	2.0	8.5	19.2	6.0	56.4	8.1	2.5	2.8	2.3	10.8	3.8	9.4	0.3	0.4	1.3	0.3	0.4	0.0	0.3	1.1	0.5	0.3	0.3	2.0	0.8	0.0	0.9	0.6	1.5	0.0	0.3	6.7	5.1	7.3	4.8	7.4	4.5	6.4	5.4	6.7	7.2
RAB25	CATX-8	ENSG00000132698	"RAB25, member RAS oncogene family"	P57735	1	156061160-156070514	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.9;CAPAN-2: 26.2;HaCaT: 23.8;hTCEpi: 23.5;MCF7: 36.3;RT4: 33.0;SK-BR-3: 53.7;T-47d: 50.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010872, CAB033645"	Enhanced		Uncertain	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"CAB033645: AB_1128883, HPA010872: AB_1079729"	"unprognostic (2.43e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (1.38e-6)"	"unprognostic (2.31e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.94e-2)"	0.4	0.3	0.3	10.9	0.3	0.0	10.8	0.5	0.4	23.6	28.4	0.3	28.1	14.8	4.0	15.9	98.3	9.7	33.3	0.3	0.3	0.3	18.2	1.0	19.1	0.6	0.3	0.2	2.3	27.4	8.6	9.5	19.1	0.3	13.3	16.2	0.4	44.1	26.8	0.4	48.0	43.0	2.1	0.4	0.3	16.2	1.1	0.2	3.7	36.1	74.6	60.9	13.0	31.8	0.1	0.0	0.0	0.0	0.0	3.4	0.8	19.7	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	19.3	26.2	0.0	0.0	0.0	23.8	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	33.0	2.9	0.0	0.0	53.7	0.0	50.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	2.8	0.8	0.0	0.0	3.4	2.9	0.0	0.0	0.0	0.0	0.9	0.8	0.3	0.3	0.5	0.4	0.3	0.3	0.3	0.2	0.3	0.2
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;stomach 1: 36.6"	"Cell line enhanced"	"Detected in many"		"HEL: 20.5;hTCEpi: 15.6;hTERT-HME1: 19.0;U-87 MG: 55.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.6;NK-cell: 5.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.0;T-cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"			37000000	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	1.1	2.4	13.8	2.3	11.3	1.0	10.8	0.8	30.0	4.5	4.4	0.3	0.0	4.5	1.1	0.7	17.0	1.3	9.8	0.9	12.0	7.9	0.8	1.4	6.2	0.7	4.6	18.4	0.7	5.3	1.3	3.6	2.4	8.6	18.0	4.8	0.0	12.8	3.3	0.6	13.2	4.3	1.1	2.1	1.8	36.6	4.8	0.4	0.1	0.7	13.9	5.9	6.8	7.1	0.0	0.0	1.1	0.0	5.0	4.6	3.4	2.5	7.3	0.2	0.0	0.5	6.7	0.0	0.5	4.4	0.6	0.4	0.0	2.8	0.4	0.0	1.2	4.8	0.0	2.9	0.1	0.0	0.1	20.5	1.7	0.0	0.8	1.1	2.2	5.3	15.6	8.6	19.0	0.2	0.0	1.3	5.4	2.5	0.0	2.4	0.1	4.9	0.0	0.0	0.1	1.3	9.4	0.0	3.5	0.7	4.4	0.0	2.7	0.1	0.1	6.4	0.2	3.3	0.6	0.1	0.0	0.0	55.6	11.6	0.3	1.1	0.0	0.2	4.6	0.0	1.1	0.0	1.5	2.3	0.0	0.0	0.6	2.3	0.5	5.0	0.0	0.0	0.0	3.4	13.8	11.3	0.8	30.0	12.0	7.9	4.6	18.4	8.6	0.4
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543693-146554965	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 26.5"	"Group enriched"	"Detected in many"	40	"dendritic cells: 16.0;granulocytes: 26.5;monocytes: 17.3"	"Low region specificity"	"Detected in all"							HPA025731	Approved		Approved	Cytosol			330000	Cytosol		"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favourable (1.56e-4)"	"prognostic unfavourable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	18.4	9.0	5.2	11.0	4.9	57.8	29.9	1.1	4.4	8.4	14.6	6.6	6.3	6.7	14.8	12.8	10.2	10.2	11.2	15.3	5.2	3.0	10.7	23.0	16.5	26.4	6.2	3.5	11.0	7.4	1.5	2.8	5.9	7.4	12.5	14.9	11.3	10.1	6.9	6.3	10.2	9.0	28.2	7.5	29.4	10.6	20.8	5.5	10.4	5.8	7.0	5.6	15.6	15.2	0.0	16.0	26.5	17.3	0.5	0.0	4.9	12.0	6.4	7.5	12.5	11.3	19.4	0.0	23.4	26.1	32.2	53.6	3.9	6.0	0.0	8.6	24.6	16.0	0.4	15.1	43.5	0.0	5.8	15.3	16.1	14.1	49.6	21.0	22.7	17.1	25.4	18.4	26.2	20.8	2.9	0.0	17.5	2.8	9.5	11.5	0.9	12.3	0.0	8.0	0.1	12.6	8.4	0.0	9.9	27.4	3.3	40.5	6.4	17.1	16.6	9.8	13.4	25.7	28.5	0.0	1.7	0.0	22.5	15.9	13.2	26.5	17.3	2.9	0.0	7.7	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	6.3	0.5	5.3	0.8	0.0	4.9	5.2	4.9	1.1	4.4	5.2	3.0	6.2	3.5	7.4	5.5
RAB3A		ENSG00000105649	"RAB3A, member RAS oncogene family"	P20336	19	18196784-18204074	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 114.7"	"Cell line enhanced"	"Detected in many"		"PC-3: 13.5;SCLC-21H: 24.7;SH-SY5Y: 11.8;U-2197: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, CAB009949, CAB078998"	Enhanced	Supported	Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731"	"unprognostic (1.82e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.80e-3)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (6.14e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.14e-2)"	2.3	13.0	32.3	2.6	50.5	2.0	2.0	39.1	114.7	2.8	3.1	6.3	0.0	3.6	2.7	2.6	2.4	3.2	2.8	17.0	40.8	32.7	4.1	2.2	2.5	2.4	31.5	35.6	8.0	2.3	5.0	7.5	2.4	38.2	3.8	2.8	5.8	4.2	4.4	7.5	2.5	3.0	2.9	7.0	2.5	2.5	2.2	4.8	0.0	2.9	0.1	2.1	2.9	0.7	4.6	6.0	5.1	3.0	0.7	4.2	2.6	0.9	1.0	2.3	3.2	3.8	1.0	1.4	2.0	1.2	1.4	1.9	0.9	0.5	3.3	2.2	1.6	2.7	10.7	1.3	0.7	0.7	3.4	1.3	3.9	3.7	0.9	2.2	4.1	3.1	1.3	0.8	0.4	0.4	0.7	1.1	1.3	3.2	5.0	0.6	1.9	13.5	3.5	0.2	2.8	1.5	0.5	24.7	11.8	1.0	4.3	2.3	0.9	0.4	0.4	1.2	0.9	17.1	1.1	2.1	4.5	0.8	3.2	1.7	1.1	0.0	3.0	3.8	3.0	2.2	4.0	4.6	3.2	3.0	6.0	2.2	4.1	4.2	5.1	0.7	2.7	5.5	1.8	2.6	32.3	50.5	39.1	95.0	40.8	32.7	31.5	35.6	38.2	4.8
RAB3C		ENSG00000152932	"RAB3C, member RAS oncogene family"	Q96E17	5	58582221-58859394	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 13.6;brain: 47.4;pituitary gland: 14.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEL: 3.4;SCLC-21H: 14.3;SH-SY5Y: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA003160, HPA048156"	Enhanced		Approved	Cytosol				Cytosol		"HPA003160: AB_1079731, HPA048156: "	"unprognostic (1.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.52e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.70e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.61e-3)"	2.5	13.6	19.8	2.5	36.1	1.1	1.3	7.7	47.4	1.3	1.8	2.1	0.0	3.1	2.1	1.0	1.3	1.3	1.9	1.1	22.9	23.6	1.2	1.2	1.2	1.3	14.5	23.6	1.2	3.3	1.4	14.1	1.2	25.6	1.1	2.1	0.0	1.1	1.1	1.1	1.1	3.3	2.0	3.2	1.0	2.3	1.3	4.1	0.0	1.1	0.0	1.4	1.7	0.4	0.3	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.7	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	14.3	5.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.8	36.1	7.7	32.4	22.9	23.6	14.5	23.6	25.6	4.1
RAB3GAP1	"KIAA0066, RAB3GAP, RAB3GAP130, WARBM1"	ENSG00000115839	"RAB3 GTPase activating protein catalytic subunit 1"	Q15042	2	135052265-135176394	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034494, HPA034495"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034494: , HPA034495: AB_10670158"	"unprognostic (1.02e-2)"	"unprognostic (2.43e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.15e-1)"	24.1	18.4	22.1	20.8	32.9	27.3	21.8	27.1	37.2	25.1	24.0	21.2	20.0	15.7	42.2	27.0	26.1	20.1	18.3	28.4	21.4	29.1	20.1	16.9	18.6	19.7	24.5	28.1	31.3	29.4	31.7	50.0	33.0	34.5	26.0	24.0	23.2	37.3	25.4	37.4	25.1	19.4	26.4	26.0	17.5	22.7	19.6	21.3	28.8	26.2	20.9	24.6	25.2	24.8	9.1	5.4	9.3	7.1	3.6	10.7	2.4	19.4	7.9	14.0	11.5	27.5	23.5	12.9	29.9	24.7	23.8	23.6	17.5	16.0	29.0	18.6	30.5	16.5	14.7	27.6	29.2	13.8	14.9	14.4	10.0	15.2	19.2	17.7	15.7	20.5	36.5	21.9	39.7	17.1	18.6	16.9	21.6	11.5	9.0	6.9	10.7	13.3	15.6	17.9	12.1	14.0	17.4	11.3	8.9	20.3	12.2	14.1	10.7	12.9	20.6	24.2	18.4	10.3	12.5	12.0	6.8	21.8	15.8	10.7	13.4	9.3	5.0	7.6	2.0	6.7	1.8	7.0	5.0	2.8	5.4	9.1	10.7	5.3	2.0	3.6	7.1	2.9	6.5	2.4	22.1	32.9	27.1	37.2	21.4	29.1	24.5	28.1	34.5	21.3
RAB3GAP2	"DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69"	ENSG00000118873	"RAB3 GTPase activating non-catalytic protein subunit 2"	Q9H2M9	1	220148293-220272454	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cataract, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026273, HPA027299"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA026273: AB_1856007, HPA027299: AB_1856008"	"prognostic unfavourable (3.05e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.76e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	16.7	16.2	14.9	19.6	18.7	14.3	17.8	24.2	22.4	15.6	13.5	14.3	13.9	12.2	16.8	14.9	15.6	12.8	12.8	15.3	16.5	18.8	18.9	15.6	14.3	18.2	17.1	15.6	16.2	14.5	35.6	28.3	19.8	21.9	14.2	13.5	11.6	15.6	15.8	19.9	13.1	15.0	14.9	15.2	14.9	14.5	10.1	15.5	26.1	20.5	11.9	21.7	16.0	15.8	7.1	5.2	12.3	5.1	3.6	8.9	4.6	13.8	10.6	12.8	9.6	14.8	17.6	14.6	14.3	13.6	13.0	15.3	9.7	11.6	17.3	10.1	13.8	13.3	13.3	10.9	15.1	14.4	8.7	13.5	14.1	9.0	19.5	19.2	13.9	13.9	12.5	12.6	19.6	11.8	23.2	11.2	14.6	3.9	14.7	6.8	27.6	6.3	8.1	17.7	15.4	11.0	11.5	12.8	15.5	14.8	14.5	23.2	15.1	18.4	17.1	14.2	6.6	9.7	15.2	10.0	12.1	15.2	12.2	16.3	16.6	12.3	3.9	7.5	7.1	4.9	8.6	7.1	7.0	8.9	5.2	5.5	6.3	7.4	2.5	3.6	5.1	3.3	8.0	4.6	14.9	18.7	24.2	22.4	16.5	18.8	17.1	15.6	21.9	15.5
RAB3IL1	GRAB	ENSG00000167994	"RAB3A interacting protein like 1"	Q8TBN0	11	61897301-61920269	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.7;K-562: 20.2;RPMI-8226: 20.9;U-2197: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039723	Uncertain		Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA039723: AB_10795406"	"unprognostic (1.62e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavourable (6.08e-4)"	"unprognostic (1.97e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (1.61e-7)"	"unprognostic (7.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (1.59e-3)"	24.1	7.1	8.2	6.8	8.0	12.9	13.3	4.0	6.5	18.5	7.8	6.8	4.5	4.3	18.0	9.5	7.2	13.3	10.0	11.2	8.2	3.4	10.0	7.4	6.2	5.9	10.1	3.8	28.6	3.2	6.1	5.4	14.0	8.7	11.9	2.6	13.4	6.7	5.1	9.1	8.5	5.0	8.5	7.7	22.7	5.4	22.1	6.9	6.6	8.8	6.5	2.4	13.4	26.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	3.2	6.9	0.2	3.5	13.4	9.9	0.7	2.6	6.7	3.9	2.7	0.9	0.7	0.0	4.9	4.0	1.7	4.6	0.2	0.7	0.0	1.0	6.6	2.5	3.3	18.7	0.2	0.1	5.6	3.4	2.0	4.4	0.4	20.2	0.2	2.2	5.8	0.0	0.0	2.0	6.9	0.3	0.9	20.9	0.3	0.3	0.2	2.4	1.6	1.4	11.9	1.1	0.7	0.5	14.5	6.6	27.6	1.1	0.2	0.9	0.0	2.8	7.5	6.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.2	8.0	4.0	6.2	8.2	3.4	10.1	3.8	8.7	6.9
RAB9A	RAB9	ENSG00000123595	"RAB9A, member RAS oncogene family"	P51151	X	13689125-13710506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003094, CAB016411"	Supported		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016411: AB_630176, HPA003094: AB_1079736"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.88e-2)"	"prognostic favourable (3.35e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.68e-2)"	17.1	36.0	17.7	20.3	17.1	30.6	48.4	16.2	24.1	14.8	17.6	20.2	19.7	9.3	18.8	14.3	19.7	11.9	14.5	23.1	16.9	14.3	19.6	15.6	17.3	21.0	24.7	13.8	18.9	23.6	19.1	11.3	17.8	18.1	13.5	16.2	8.0	22.8	17.6	12.0	21.2	12.3	15.3	25.5	15.1	14.2	6.4	23.4	9.8	16.8	13.2	19.3	16.1	19.7	13.1	19.1	17.7	25.7	19.8	27.3	13.9	12.4	6.7	8.6	20.3	28.9	23.2	7.7	7.0	24.6	10.7	15.7	7.2	14.0	11.3	17.4	10.9	12.8	12.8	14.9	10.6	25.0	19.9	3.6	14.8	8.2	17.4	6.3	9.8	24.9	26.4	13.5	14.5	9.9	6.9	16.8	11.5	8.6	5.9	10.3	9.2	12.7	8.2	9.1	33.8	29.5	11.6	7.1	5.0	14.8	21.1	24.1	11.7	6.7	7.7	8.2	4.2	28.9	4.2	13.3	23.1	4.5	8.2	5.4	8.0	17.7	25.7	11.1	27.3	16.6	21.1	13.1	15.0	22.4	17.6	10.0	11.3	19.4	15.3	19.8	14.5	19.1	11.7	13.9	17.7	17.1	16.2	24.1	16.9	14.3	24.7	13.8	18.1	23.4
RABEP2	"FLJ23282, FRA"	ENSG00000177548	"Rabaptin, RAB GTPase binding effector protein 2"	Q9H5N1	16	28904421-28936526	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047641	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA047641: "	"unprognostic (4.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (5.84e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.86e-2)"	"prognostic favourable (1.24e-6)"	"unprognostic (7.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.92e-3)"	4.7	13.7	5.4	19.8	10.0	8.5	6.0	4.4	8.6	5.6	7.8	9.9	17.3	14.3	5.9	7.3	11.6	5.3	14.1	8.7	6.5	5.8	10.8	6.6	6.7	35.5	11.9	6.0	5.5	11.3	10.3	11.2	9.1	8.1	17.3	4.1	11.2	16.7	13.9	5.1	17.8	17.5	7.1	6.9	31.5	9.3	8.8	8.4	8.3	9.2	7.5	23.0	10.2	7.6	14.9	3.6	2.4	3.0	5.1	3.5	2.7	8.2	14.0	3.5	6.4	1.9	3.0	6.3	10.1	6.1	7.2	7.0	9.6	7.5	16.0	15.9	3.8	10.5	1.3	5.9	1.2	6.1	5.8	6.2	10.0	13.6	4.3	4.3	19.6	5.0	5.1	8.5	1.4	9.9	3.0	5.8	5.2	19.4	5.6	10.0	4.6	6.5	19.7	3.2	10.8	4.8	11.0	5.5	7.0	4.5	21.6	4.4	17.5	9.7	16.3	11.3	5.4	7.5	9.8	9.0	2.8	12.1	11.8	11.4	8.0	0.5	2.5	2.4	3.5	2.8	2.6	12.2	2.5	3.3	3.6	14.9	2.3	2.1	0.7	5.1	3.0	2.1	2.1	2.7	5.4	10.0	4.4	8.6	6.5	5.8	11.9	6.0	8.1	8.4
RABGAP1	"GAPCenA, TBC1D11"	ENSG00000011454	"RAB GTPase activating protein 1"	Q9Y3P9	9	122940833-123104866	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041651, HPA064860, HPA072273"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA041651: AB_10794673, HPA064860: , HPA072273: "	"prognostic unfavourable (8.09e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.90e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (6.06e-6)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.05e-2)"	16.9	12.6	24.2	12.5	31.0	5.1	17.1	16.9	36.3	18.8	27.6	19.5	16.4	9.5	23.6	20.9	25.5	18.2	15.2	20.0	22.4	20.8	16.2	9.0	15.0	14.0	23.9	25.0	19.6	12.6	29.1	17.7	18.5	23.9	24.1	18.6	19.4	18.1	25.4	23.7	17.3	12.8	25.6	23.0	13.5	17.8	16.4	17.5	11.4	31.2	8.6	16.2	22.9	16.4	4.1	3.9	6.1	5.5	2.1	4.5	1.4	8.9	12.1	19.1	15.8	22.1	18.0	11.8	9.4	17.1	14.7	13.8	13.9	8.8	12.5	7.6	14.7	30.6	12.1	11.8	15.8	11.6	7.3	9.7	19.5	10.6	18.9	7.8	8.4	17.4	18.2	12.6	14.3	16.6	8.3	9.5	17.6	20.0	10.2	6.2	7.0	9.3	16.9	34.9	10.5	12.2	10.0	10.8	8.3	16.9	15.3	8.6	29.0	4.4	12.7	12.5	7.4	13.6	9.4	9.3	15.2	13.0	11.7	4.0	10.9	6.1	3.6	4.3	2.6	5.5	2.0	3.0	2.7	2.3	2.8	4.1	4.5	2.9	5.6	2.1	2.4	3.9	3.1	1.4	24.2	31.0	16.9	36.3	22.4	20.8	23.9	25.0	23.9	17.5
RABGEF1	"rabex-5, RABEX5"	ENSG00000154710	"RAB guanine nucleotide exchange factor 1"	Q9UJ41	7	66682164-66811464	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA001407			Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA001407: AB_1856024"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (4.06e-5)"	"unprognostic (3.77e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.64e-4)"	"unprognostic (6.45e-2)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.55e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	18.4	15.2	13.0	14.7	14.4	59.2	12.0	22.4	16.8	16.9	14.1	12.6	9.4	9.1	16.4	9.5	20.6	12.0	13.5	10.8	13.5	15.6	14.9	17.2	10.5	10.6	12.8	12.1	14.7	13.2	13.3	10.2	18.8	13.5	13.1	11.0	13.8	10.6	16.1	12.1	21.9	15.5	15.3	11.9	15.3	11.9	21.5	9.8	13.1	22.3	20.7	18.2	19.1	16.3	15.7	10.4	18.1	13.5	15.4	10.9	7.6	20.2	6.1	5.3	8.9	14.4	20.2	5.3	17.8	22.9	18.8	17.9	5.6	13.2	9.9	7.0	25.8	8.5	7.3	9.7	26.3	6.7	5.8	5.3	7.1	5.6	11.5	9.1	7.5	10.0	12.5	24.3	26.9	4.9	9.7	7.2	18.7	10.2	6.0	12.6	7.0	8.8	5.4	9.3	7.4	16.4	9.3	6.1	9.5	8.3	18.3	9.6	10.5	5.7	6.4	30.6	6.4	18.7	13.9	9.4	12.2	11.7	14.2	10.1	9.7	18.1	7.8	9.4	8.6	6.9	9.3	11.2	8.1	10.9	7.3	15.7	8.8	8.2	15.1	15.4	13.5	10.4	6.7	7.6	13.0	14.4	22.4	16.8	13.5	15.6	12.8	12.1	13.5	9.8
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favourable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favourable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	20.8	17.7	31.0	21.6	42.8	32.9	17.9	43.6	41.4	12.5	25.1	18.0	14.8	29.4	13.7	14.6	17.9	12.8	22.2	29.4	28.2	22.2	17.1	7.3	17.2	18.5	22.7	21.6	13.9	39.6	17.4	23.3	16.0	16.7	24.3	16.6	13.1	24.8	16.9	98.6	21.5	29.4	15.6	20.6	20.0	24.5	16.5	17.2	20.9	13.9	22.6	13.9	13.8	19.9	4.7	4.1	2.9	5.7	6.1	5.2	1.4	19.0	25.3	18.1	21.2	7.4	8.4	47.7	17.3	11.1	16.8	12.3	28.2	20.2	27.0	10.9	13.4	41.7	20.2	15.2	5.8	28.0	26.0	16.5	31.6	32.9	13.4	30.5	21.2	9.3	15.8	10.4	11.6	17.4	35.8	13.2	11.5	38.0	32.6	21.1	34.0	21.8	42.7	21.7	26.3	11.1	16.9	59.8	24.8	30.5	35.9	21.3	30.8	30.8	21.1	21.8	19.0	22.9	27.9	11.3	12.9	21.9	18.3	14.9	20.3	1.2	4.8	2.9	3.7	5.7	3.8	4.5	3.9	3.6	3.3	4.7	3.2	4.1	2.3	6.1	2.0	4.1	5.2	1.4	31.0	42.8	43.6	41.4	28.2	22.2	22.7	21.6	16.7	17.2
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374523-6403977	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol			44000000	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: "	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (1.74e-5)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	45.2	35.0	71.0	28.4	64.0	24.4	46.5	42.1	93.0	48.7	58.9	75.5	22.5	51.6	48.7	49.5	93.4	47.2	40.0	48.4	73.8	59.8	47.8	42.9	45.6	38.3	76.7	60.9	45.1	29.2	51.0	25.2	55.8	54.9	40.5	64.0	37.2	43.3	48.9	57.4	58.6	49.8	57.3	88.2	35.0	49.7	28.1	47.1	41.3	40.9	42.8	50.7	52.2	54.0	11.0	32.0	49.1	31.9	7.3	11.8	10.7	73.9	33.6	34.7	37.7	41.2	52.7	20.7	41.7	51.3	55.7	56.8	32.9	70.0	20.9	27.1	58.2	52.8	37.0	50.6	71.4	9.7	30.7	21.0	27.2	23.8	49.6	18.9	17.2	35.1	45.3	40.1	45.0	49.0	37.4	16.5	60.0	53.9	10.4	44.4	62.2	40.3	18.4	35.3	30.6	71.6	46.9	26.3	44.3	29.4	107.9	33.5	60.8	56.9	51.4	36.6	55.1	44.8	48.1	12.6	13.8	19.6	33.7	36.1	69.3	7.6	31.9	16.4	7.2	22.2	4.5	11.0	8.1	9.2	32.0	11.0	9.8	6.5	49.1	7.3	22.1	18.2	11.8	10.7	71.0	64.0	42.1	93.0	73.8	59.8	76.7	60.9	54.9	47.1
RAD23A	"HHR23A, MGC111083"	ENSG00000179262	"RAD23 homolog A, nucleotide excision repair protein"	P54725	19	12945855-12953642	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 225.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026418, HPA053901, HPA057003, HPA065599"	Approved		Enhanced	Nucleoplasm,Cytosol			3100000	Nucleoplasm	Cytosol	"HPA026418: , HPA053901: , HPA057003: , HPA065599: "	"unprognostic (2.09e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.32e-3)"	"unprognostic (9.99e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.59e-3)"	19.6	15.2	19.1	13.4	17.7	19.9	16.0	15.1	25.3	12.9	18.0	14.6	10.7	13.6	15.3	14.3	19.9	17.7	13.6	34.3	16.6	16.0	13.2	24.5	14.2	14.1	15.4	15.6	17.1	21.1	14.0	12.3	17.3	15.5	15.1	10.7	12.6	18.6	15.8	225.3	19.8	11.9	16.5	15.4	15.7	14.9	19.1	12.5	14.6	17.2	37.7	13.8	20.7	17.0	29.5	30.0	22.7	35.6	26.5	32.1	22.5	31.4	11.6	13.5	13.9	22.5	25.8	22.6	15.4	31.0	36.6	33.3	13.0	22.7	26.8	35.5	23.1	24.4	18.4	32.0	13.9	37.8	23.4	10.8	15.0	12.5	43.8	23.3	31.7	26.3	48.0	26.4	50.6	25.1	27.7	24.7	32.9	30.7	29.0	28.9	18.5	28.8	15.3	14.0	43.5	28.5	12.6	25.0	19.7	17.0	31.1	34.0	24.2	40.5	19.7	52.7	14.0	62.5	47.0	35.8	29.9	19.5	43.4	44.1	43.2	10.4	27.9	22.7	29.7	35.6	32.1	29.2	25.3	25.1	23.4	29.5	24.6	27.8	3.9	26.5	34.9	30.0	27.0	22.5	19.1	17.7	15.1	25.3	16.6	16.0	15.4	15.6	15.5	12.5
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332194	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol			8200000	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	41.0	30.1	21.9	23.5	24.5	37.0	28.9	33.3	28.1	28.9	31.4	18.4	28.2	21.8	27.0	38.0	45.3	22.6	24.1	45.5	22.2	23.0	29.7	82.0	27.7	20.7	20.8	23.3	31.6	45.9	21.0	24.8	66.1	25.6	31.1	25.9	17.3	28.7	25.8	98.2	38.2	29.1	29.4	22.6	29.8	23.0	38.5	18.6	32.8	30.4	34.0	27.1	42.1	32.6	5.2	2.5	7.1	2.7	5.0	4.9	1.2	33.3	29.7	42.1	27.0	29.0	46.0	47.5	51.8	42.7	46.2	31.8	49.2	36.6	46.9	21.0	56.6	47.0	58.0	46.1	46.7	31.8	19.0	24.4	31.3	37.5	38.6	43.6	21.0	38.5	43.1	44.1	66.6	32.1	39.3	35.3	41.6	54.5	42.4	22.2	44.8	34.7	31.7	55.3	22.2	39.7	31.6	38.5	26.1	35.8	50.7	31.9	51.7	17.9	29.4	34.5	33.9	42.5	38.7	24.3	44.4	25.3	36.8	26.0	36.1	1.7	2.7	2.3	4.4	2.7	4.9	4.0	2.6	3.7	2.2	5.2	4.4	3.5	7.1	5.0	1.7	2.5	4.6	1.2	21.9	24.5	33.3	27.4	22.2	23.0	20.8	23.3	25.6	18.6
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.9;testis: 24.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB010381, HPA039310"	Enhanced		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"CAB010381: AB_2253533, HPA039310: "	"prognostic unfavourable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	1.0	0.9	0.4	6.6	0.9	5.3	1.0	0.7	0.9	1.1	5.7	0.4	0.3	1.7	0.8	2.0	4.9	0.5	1.7	1.8	0.5	0.5	1.0	1.0	1.9	7.4	0.5	0.3	0.9	0.7	0.0	0.4	6.2	0.7	0.8	7.6	0.4	1.4	0.3	1.3	2.1	2.6	1.2	1.1	5.0	1.5	24.0	0.5	27.9	0.6	3.7	9.7	1.0	1.9	3.1	1.7	2.7	2.2	2.2	8.8	1.7	12.5	5.6	13.4	5.0	1.4	3.6	12.1	22.3	6.1	19.8	19.9	13.1	8.6	7.1	11.0	7.9	26.7	25.2	10.4	19.3	14.8	8.6	17.8	10.9	10.0	0.1	14.4	12.2	0.5	1.8	13.3	5.9	10.7	23.3	20.0	17.1	11.0	20.5	13.3	15.3	7.0	23.5	18.9	11.9	7.2	17.0	6.0	11.2	9.8	17.3	3.5	10.5	12.0	4.5	14.3	9.1	20.0	11.4	5.0	24.9	23.7	6.2	30.1	12.5	2.0	0.9	2.7	4.1	2.0	0.8	3.1	4.3	5.5	1.7	1.6	1.2	2.1	1.3	2.2	2.2	1.2	8.8	1.7	0.4	0.9	0.7	0.9	0.5	0.5	0.5	0.3	0.7	0.5
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"				"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: "	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	11.1	22.7	22.1	10.1	20.8	19.4	15.4	20.8	31.0	12.3	13.7	16.0	11.1	7.3	14.3	23.1	13.2	11.8	10.9	24.9	20.2	17.4	13.7	13.9	8.9	19.6	17.2	21.4	13.4	11.2	20.0	18.3	15.1	28.9	18.3	15.0	13.2	10.6	12.7	15.5	10.3	9.6	14.4	14.0	14.4	13.2	18.9	12.7	23.8	12.6	11.7	18.6	12.6	11.8	14.4	13.0	18.8	11.3	11.2	21.7	9.2	15.4	18.0	11.1	12.2	6.1	5.3	25.4	8.5	3.9	11.4	14.5	7.6	10.0	9.1	12.6	5.8	5.9	14.9	12.0	21.3	22.2	30.7	12.8	20.2	28.9	6.0	16.5	11.5	3.1	10.8	12.7	10.3	12.7	19.9	12.5	9.7	77.6	23.3	23.0	3.0	16.7	15.1	17.6	17.2	6.9	9.7	13.8	12.8	6.8	3.3	12.8	10.1	17.5	4.0	9.6	25.6	8.7	10.3	11.8	43.8	26.7	9.8	16.3	11.0	18.8	7.5	9.8	13.7	11.3	13.3	14.1	15.0	14.9	13.0	14.4	16.4	15.4	4.6	11.2	9.8	11.7	21.7	9.2	22.1	20.8	20.8	31.0	20.2	17.4	17.2	21.4	28.9	12.7
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: , HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.4	4.1	3.3	3.5	4.3	5.2	4.1	7.8	4.3	3.6	4.4			2.2	5.3	4.6	3.6	3.9	2.5	3.1	3.4	3.5	3.4	8.8	4.2	3.8	3.4		5.6	5.0	5.3	3.9	4.9		3.8	3.5		3.7	4.2	7.3	4.6	4.1	4.3	4.1	4.7	4.4	4.7			4.2		5.2	3.8	3.5	6.9	5.2	6.5	7.1	6.3	8.3	4.0	5.6	4.4	11.4	11.2	6.4	4.6	6.0	4.8	6.8	6.6	6.3	7.8	3.3	14.8	1.4	8.4	4.4	17.9	6.0	8.2	7.8	4.0	12.7	9.5	5.1	5.8	14.1	7.6	5.2	4.8	10.1	9.8	7.3	8.3	8.1	5.2	4.3	12.6	6.4	9.0	4.8	5.8	8.8	2.0	3.3	7.3	4.7	8.9	7.6	7.3	4.9	4.8	8.5	9.5	7.0	8.0	7.1	9.3	8.7	8.8	15.0	7.5	8.0	8.8	6.5	4.8	4.7	8.1	6.0	8.3	4.3	7.1	6.6	5.2	6.9	4.7	5.4	2.2	6.3	7.1	5.2	6.3	4.0										
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.5;HeLa: 21.4;hTCEpi: 15.5;SiHa: 7.4;U-87 MG: 6.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"			"Focal adhesion sites"	Cytosol	"HPA054022: "	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	1.6	0.5	0.2	0.5	0.2	0.0	1.4	0.2	0.2	10.4	0.3	0.2	0.2	0.2	0.8	0.6	39.7	0.6	0.2	0.2	0.2	0.0	2.8	0.2	0.6	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.5	0.2	0.4	0.3	0.2	7.0	0.2	0.7	14.6	0.3	0.3	0.2	0.6	0.2	0.5	0.3	0.3	0.2	19.8	22.5	1.3	12.6	0.6	0.4	2.3	0.6	0.5	0.7	0.1	1.5	0.9	0.0	0.0	0.1	1.3	0.1	0.1	0.9	0.1	0.3	0.0	3.7	0.0	2.1	3.0	1.6	0.0	15.5	0.2	0.4	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.3	15.5	0.9	3.2	0.1	0.0	1.3	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.7	0.2	0.0	7.4	2.0	0.0	1.1	0.0	2.9	1.1	0.4	0.1	0.9	0.0	0.0	0.0	6.7	0.3	0.0	2.0	0.6	0.4	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.6	0.7	0.4	2.3	0.5	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3
RAI14	"DKFZp564G013, KIAA1334, NORPEG, RAI13"	ENSG00000039560	"Retinoic acid induced 14"	Q9P0K7	5	34656237-34832627	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 64.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036949, HPA036950"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"				Nucleoplasm	"Actin filaments, Cytosol"	"HPA036949: AB_10670568, HPA036950: AB_10669721"	"unprognostic (7.63e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.75e-2)"	"unprognostic (5.49e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.58e-2)"	"prognostic unfavourable (9.75e-4)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.81e-2)"	"unprognostic (4.34e-2)"	5.6	4.5	3.9	8.3	5.9	0.5	5.1	4.4	3.2	23.3	9.1	5.5	14.1	2.5	29.2	8.2	8.8	6.8	8.8	3.6	4.4	3.5	7.7	11.2	10.4	5.1	6.9	1.5	9.5	4.8	6.4	2.7	64.4	5.6	10.4	4.0	8.2	8.4	10.8	2.0	7.6	3.6	34.7	17.0	21.2	6.0	26.6	5.7	2.1	6.7	2.7	3.8	22.5	14.9	0.8	0.6	2.5	0.8	2.5	3.3	0.3	2.7	10.8	12.4	8.3	6.6	23.4	15.9	32.5	26.2	18.8	18.9	8.1	3.5	0.6	13.0	15.9	1.8	14.1	24.0	40.8	0.0	6.7	4.4	10.1	4.9	20.7	0.1	0.4	21.8	7.5	33.7	26.9	59.5	6.2	0.2	24.4	2.1	0.4	0.1	9.7	10.4	3.9	19.0	0.1	21.8	15.5	3.3	1.8	19.2	2.8	8.7	3.3	0.5	38.3	30.6	16.4	7.5	14.1	0.7	0.0	0.0	25.9	0.0	11.9	2.5	0.8	0.3	3.3	0.3	0.4	0.5	1.0	0.2	0.2	0.8	0.3	0.6	1.6	2.5	0.1	0.6	0.1	0.3	3.9	5.9	4.4	3.2	4.4	3.5	6.9	1.5	5.6	5.7
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538116	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	10	"neutrophil: 55.1"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"				Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: "	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	19.7	14.6	23.2	14.8	24.3	17.9	19.1	27.1	27.2	17.1	20.7	14.0	54.7	12.5	15.9	16.7	33.7	17.5	13.7	21.4	24.7	19.6	30.6	14.2	15.1	14.6	23.1	13.7	18.8	10.4	19.8	15.3	28.8	19.6	24.3	17.4	9.8	17.6	44.8	24.3	47.5	13.4	22.7	20.6	19.3	17.4	8.5	23.1	15.4	15.7	23.4	16.4	24.3	26.3	2.5	5.5	55.1	4.5	4.3	3.2	1.2	22.7	15.4	13.7	15.5	15.8	24.9	18.1	27.6	15.0	14.2	15.3	17.0	22.6	29.0	20.2	25.2	13.1	18.9	20.7	17.8	28.8	18.3	15.4	14.2	12.7	12.9	45.0	17.8	17.3	20.8	19.8	19.8	23.9	21.9	26.8	22.3	18.0	27.0	19.8	10.6	15.7	36.4	24.5	21.3	19.6	31.7	18.5	15.1	23.9	20.9	12.2	12.9	20.9	28.5	42.1	32.4	29.1	32.7	16.6	16.5	31.4	18.3	21.4	15.9	3.1	2.8	4.3	3.2	2.9	2.7	2.5	2.7	2.6	2.4	2.4	2.3	2.9	55.1	4.3	4.5	5.5	1.7	1.2	23.2	24.3	27.1	27.2	24.7	19.6	23.1	13.7	19.6	23.1
RALGAPA1	"DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1"	ENSG00000174373	"Ral GTPase activating protein catalytic alpha subunit 1"	Q6GYQ0	14	35538352-35809304	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000851	Approved		Approved	Mitochondria,Cytosol				Cytosol	Mitochondria	"HPA000851: AB_1078945"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.90e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"prognostic favourable (9.76e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.46e-1)"	13.9	21.8	19.5	13.1	25.6	8.3	22.5	31.7	28.3	20.2	18.3	23.2	13.6	10.7	21.0	19.2	15.1	15.0	13.0	11.7	21.8	22.2	17.1	13.9	13.4	11.7	21.5	17.9	28.1	15.4	43.6	42.6	10.1	28.1	20.4	20.2	14.2	15.0	15.2	15.9	27.0	13.8	17.5	23.6	11.6	14.1	13.7	21.3	14.9	21.3	12.2	13.0	15.0	19.2	1.6	1.5	0.1	1.1	2.3	3.3	0.5	5.7	6.7	9.0	7.9	13.7	10.6	5.8	4.3	4.8	5.4	5.0	4.2	5.1	5.7	6.4	5.6	9.5	10.8	8.2	5.5	12.1	4.7	5.2	8.6	20.1	7.1	8.6	8.4	7.6	14.9	4.8	12.0	7.5	5.0	14.4	5.0	9.1	6.5	4.1	3.9	10.7	5.3	6.4	3.4	10.9	9.1	8.4	13.7	9.1	15.2	7.3	14.6	4.2	6.9	5.5	4.1	6.2	5.2	11.7	10.6	7.2	2.6	5.7	5.9	0.0	0.6	0.1	2.4	1.1	3.3	1.6	2.5	3.1	1.1	1.3	1.8	2.5	0.1	2.3	0.9	1.5	2.7	0.5	19.5	25.6	31.7	26.0	21.8	22.2	21.5	17.9	28.1	21.3
RALGAPA2	"AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2"	ENSG00000188559	"Ral GTPase activating protein catalytic alpha subunit 2"	Q2PPJ7	20	20389552-20712488	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"RT4: 46.9;SCLC-21H: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042707, HPA043622"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042707: , HPA043622: "	"unprognostic (7.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"prognostic favourable (3.77e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.33e-2)"	26.5	7.0	7.3	9.9	8.1	19.4	16.9	11.4	8.7	10.6	12.7	9.6	14.9	10.5	15.2	9.6	8.9	10.7	13.0	7.8	8.3	4.2	11.0	26.4	26.5	13.0	10.8	4.4	8.0	18.5	14.1	20.9	18.5	7.4	13.2	13.5	8.2	22.6	12.8	26.0	15.3	10.0	9.6	8.4	8.2	18.1	8.6	9.3	8.2	23.2	6.0	10.2	13.9	15.7	1.7	2.0	7.0	2.1	2.6	2.4	0.6	3.4	2.2	4.6	2.4	2.3	1.8	5.2	0.9	0.9	1.1	1.5	1.8	4.8	1.5	3.1	1.4	3.6	4.8	4.0	2.2	7.0	2.3	5.3	1.1	3.3	0.9	6.8	3.2	1.6	3.0	1.8	0.8	6.6	1.1	3.0	1.8	2.3	2.5	9.0	1.9	2.1	3.8	3.1	2.1	4.1	46.9	26.2	2.3	3.5	2.6	3.0	1.8	6.5	1.7	1.8	1.8	1.4	1.2	1.7	1.2	0.7	1.6	4.5	2.6	5.9	2.1	6.0	1.7	0.7	2.4	1.4	1.1	1.6	1.0	1.7	2.1	1.5	7.0	2.6	1.6	2.0	1.4	0.6	7.3	8.1	11.4	8.7	8.3	4.2	10.8	4.4	7.4	9.3
RALGPS2	"FLJ10244, FLJ25604, KIAA0351"	ENSG00000116191	"Ral GEF with PH domain and SH3 binding motif 2"	Q86X27	1	178725147-178921841	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Alzheimer disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.7"	"Cell line enhanced"	"Detected in many"		"U-266/84: 61.3;U-698: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 17.8;naive B-cell: 14.6"	"Lineage enriched"	"Detected in many"	12	"B-cells: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027143, HPA028328"	Enhanced		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA027143: AB_10602071, HPA028328: AB_10601889"	"unprognostic (8.13e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.45e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.97e-2)"	5.5	6.4	5.0	27.9	10.5	6.2	5.4	8.9	5.1	8.0	9.9	1.2	7.2	5.8	8.2	7.3	14.0	8.7	4.7	4.7	6.0	3.2	6.1	16.4	3.7	25.3	2.2	4.1	11.5	5.0	6.2	8.4	4.6	3.8	5.3	6.4	9.9	9.2	7.4	2.1	10.0	19.7	6.1	3.2	26.1	6.8	37.7	2.1	16.0	4.3	4.7	29.4	7.5	8.4	17.8	0.5	1.4	0.1	0.3	0.5	0.8	10.1	3.3	10.3	0.1	11.5	16.9	4.0	8.8	19.7	7.2	6.5	4.0	10.0	21.5	3.0	26.1	8.4	4.5	2.2	9.5	0.0	2.7	0.0	2.2	3.7	1.9	2.8	0.1	7.5	2.0	9.3	6.6	6.2	5.1	0.8	4.7	1.6	4.2	0.8	7.0	3.5	6.0	10.6	0.1	2.4	6.4	1.6	4.6	5.8	6.5	12.5	7.7	1.4	4.6	3.3	3.2	12.1	4.2	24.5	61.3	50.2	1.9	1.4	3.7	0.5	0.1	1.4	0.2	0.0	0.2	17.8	0.1	0.1	0.2	14.6	0.5	0.1	0.8	0.3	0.0	0.5	0.0	0.8	5.0	10.5	8.9	5.1	6.0	3.2	2.2	4.1	3.8	2.1
RANBP1	HTF9A	ENSG00000099901	"RAN binding protein 1"	P43487	22	20115938-20127357	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 213.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065868, HPA065931"	Supported		Enhanced	Cytosol			910000	Cytosol		"HPA065868: , HPA065931: "	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavourable (1.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (2.40e-2)"	"unprognostic (3.95e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.30e-2)"	26.4	28.6	27.9	34.7	28.0	57.1	26.0	32.4	46.0	23.3	33.3	25.7	17.2	30.5	29.6	15.7	38.7	26.4	23.1	18.2	25.1	28.3	22.5	41.1	21.8	50.4	28.4	34.9	26.8	37.0	16.0	22.0	26.8	28.4	20.5	25.7	18.1	24.1	21.9	22.8	23.0	27.8	30.7	24.4	30.4	24.9	58.3	26.7	58.2	22.0	27.6	40.7	22.2	25.9	37.6	37.7	24.2	33.7	29.7	37.1	31.4	38.5	19.8	44.7	24.2	7.5	9.0	37.7	35.5	15.6	46.4	33.6	36.2	13.9	60.2	15.9	14.3	35.9	41.4	31.1	25.4	25.8	98.6	50.4	20.3	38.0	11.5	80.9	27.5	9.9	14.8	36.7	13.1	20.9	213.8	24.2	20.8	30.1	58.5	55.3	50.8	35.1	59.6	63.0	15.4	15.9	21.2	44.8	33.2	32.6	18.2	20.3	12.7	33.9	16.0	32.2	62.7	24.1	39.3	24.4	33.0	95.5	17.5	36.6	26.9	6.6	32.8	24.2	25.8	33.7	28.3	37.6	37.0	32.7	37.7	33.8	37.1	28.3	3.3	29.7	29.6	35.0	36.9	31.4	27.9	28.0	32.4	46.0	25.1	28.3	28.4	34.9	28.4	26.7
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nuclear membrane,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	1.6	4.9	1.3	1.8	2.1	0.8	1.8	10.4	3.6	1.8	2.0	2.9	1.1	1.5	5.3	2.8	1.0	2.2	2.7	1.5	1.4	2.2	2.4	1.8	4.1	2.4	1.5	1.7	1.8	7.2	3.6	9.4	5.0	5.3	2.4	2.3	5.4	5.1	2.7	1.0	1.1	2.6	2.4	3.1	1.0	2.5	16.3	0.4	0.1	4.7	0.1	1.4	1.5	1.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.1	5.4	4.5	1.5	0.5	3.4	3.9	1.8	2.8	1.7	2.3	0.0	0.1	3.3	3.8	0.0	0.0	1.7	5.7	0.0	4.3	1.1	2.1	0.0	1.5	0.0	0.0	4.4	0.3	0.3	0.0	2.6	0.4	0.0	1.6	2.7	0.0	0.0	0.4	0.5	0.0	3.5	0.0	0.9	1.4	0.3	2.0	0.0	5.4	2.8	0.9	1.5	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	2.1	10.4	3.6	1.4	2.2	1.5	1.7	5.3	0.4
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB033767: AB_2176959, HPA050007: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favourable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favourable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	12.4	12.7	15.1	14.0	13.6	30.1	24.8	13.1	24.0	14.5	14.4	9.8	9.8	8.3	13.2	14.3	40.8	9.7	15.5	12.2	15.0	16.0	11.8	16.0	17.9	10.5	18.0	14.3	12.4	11.9	14.7	10.6	15.7	13.7	13.9	11.4	8.3	14.4	11.4	31.8	16.9	9.1	14.7	12.4	9.5	11.0	60.1	12.6	20.9	10.7	20.0	18.0	14.4	21.0	2.0	2.3	3.8	2.0	2.7	8.1	1.2	16.4	7.2	17.5	17.6	23.8	22.1	18.5	20.2	22.8	21.2	22.4	11.0	9.8	14.6	33.0	23.5	9.0	13.4	11.7	29.3	24.5	12.5	14.7	14.3	20.3	32.9	22.9	11.0	22.3	15.2	25.1	20.8	17.2	31.0	11.7	23.5	16.6	26.1	19.1	7.7	10.2	21.0	13.7	20.7	16.8	19.1	22.1	15.5	16.3	30.3	29.9	16.1	19.5	16.9	19.4	13.7	15.8	20.7	28.2	34.3	19.8	8.9	14.6	35.7	0.8	1.3	3.8	1.9	1.8	3.8	2.0	4.0	2.0	1.4	1.7	3.8	2.6	1.8	2.7	2.0	2.3	8.1	1.2	15.1	13.6	13.1	24.0	15.0	16.0	18.0	14.3	13.7	12.6
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41245611-41286251	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"				"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favourable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	12.2	30.7	23.5	16.9	28.4	28.5	16.1	17.6	41.1	8.5	11.8	23.1	7.3	12.7	9.5	9.4	26.1	11.5	13.7	11.5	26.9	30.4	12.0	25.1	11.5	19.5	31.7	28.6	10.6	20.2	11.0	17.7	16.1	28.1	11.4	9.6	7.1	16.3	13.3	12.5	51.6	12.8	12.3	22.0	14.2	16.0	64.3	28.3	22.1	12.7	14.4	21.7	13.3	29.2	8.7	7.6	8.2	14.8	7.1	13.1	9.7	58.7	30.9	20.1	21.0	10.9	9.0	24.5	51.0	27.9	51.4	27.0	37.5	19.4	31.7	41.1	37.3	54.7	36.6	40.1	31.1	25.6	56.8	26.8	30.1	29.2	13.6	43.3	20.2	8.7	19.1	36.6	32.5	26.9	34.4	22.6	29.2	50.4	25.2	35.2	22.0	36.8	31.0	19.9	33.4	20.1	33.7	18.3	12.2	36.2	32.1	18.6	18.9	17.5	41.6	39.4	37.8	21.7	41.8	16.8	22.4	30.2	27.5	30.8	22.7	2.8	9.5	8.2	11.2	11.2	13.1	7.9	11.3	10.3	7.1	8.7	10.5	8.0	2.7	7.1	14.8	7.6	11.6	9.7	23.5	28.4	17.6	41.1	26.9	30.4	31.7	28.6	28.1	28.3
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288497-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA057280: , HPA057888: "	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	14.5	14.7	24.7	11.7	29.1	11.8	26.5	10.9	19.2	31.5	15.4	7.9	13.5	10.5	20.0	22.5	10.6	21.5	10.9	23.4	15.1	17.8	17.0	11.5	18.9	26.9	16.2	19.2	21.0	6.3	16.2	17.1	14.6	18.8	15.9	10.8	17.2	6.0	19.4	11.4	9.8	11.9	18.8	12.2	15.4	16.7	70.1	15.9	16.8	11.6	9.1	20.3	14.1	10.5	26.8	22.3	25.3	16.3	21.8	40.2	18.2	15.9	18.9	13.9	14.2	10.1	12.9	11.7	9.4	18.5	25.9	24.3	10.1	6.4	30.6	10.2	11.3	18.2	25.5	12.6	18.7	21.3	32.3	15.2	14.8	13.9	23.0	9.5	22.3	12.5	23.1	22.1	21.2	20.5	6.6	8.6	15.8	0.4	29.3	31.3	9.7	7.3	25.8	10.8	18.2	14.1	7.1	5.4	15.1	7.6	11.3	19.9	0.9	9.3	11.3	5.7	9.9	11.0	18.9	14.8	11.6	36.8	12.0	19.1	8.2	4.9	16.2	25.3	24.2	16.3	22.6	24.2	29.3	27.4	17.3	26.8	26.2	22.4	2.1	21.8	12.5	22.3	40.2	18.2	24.7	29.1	10.9	19.2	15.1	17.8	16.2	19.2	18.8	15.9
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.3;thyroid gland: 72.5"	"Cell line enhanced"	"Detected in many"		"A549: 24.0;Hep G2: 11.2;K-562: 14.8;SCLC-21H: 27.8;SK-BR-3: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 286.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol				Cytosol		"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favourable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.9	38.2	30.2	1.9	89.3	1.1	3.1	27.1	40.1	4.7	10.5	5.7	0.0	6.9	1.7	1.8	2.9	3.0	13.4	2.7	17.8	12.9	33.2	10.3	7.8	1.2	8.6	20.6	1.6	49.3	7.1	8.2	5.8	14.6	7.4	9.4	2.4	43.9	1.2	0.7	2.1	11.6	1.1	3.2	0.9	28.4	2.1	14.2	0.0	72.5	0.9	1.6	2.5	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.3	3.1	24.0	0.2	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	3.3	0.0	2.4	0.1	4.1	2.3	0.1	0.0	0.5	1.2	1.1	2.3	11.2	0.4	0.0	3.5	0.1	1.6	0.0	0.0	0.0	14.8	0.6	0.0	7.9	3.8	0.3	1.5	3.7	2.2	0.6	0.5	5.5	1.7	27.8	5.0	4.0	14.5	4.6	1.4	2.7	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	30.2	89.3	27.1	30.4	17.8	12.9	8.6	20.6	14.6	14.2
RAP1GAP2	"GARNL4, KIAA1039"	ENSG00000132359	"RAP1 GTPase activating protein 2"	Q684P5	17	2755705-3037739	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.5;pancreas: 26.0"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022148, HPA022896"	Approved		Supported	"Nuclear membrane,Cytosol"			110000	"Nuclear membrane, Cytosol"		"HPA022148: AB_1849474, HPA022896: AB_1849476"	"unprognostic (1.85e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.52e-5)"	"unprognostic (1.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.36e-6)"	"unprognostic (3.44e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.50e-2)"	1.2	4.6	6.7	2.9	13.5	16.8	3.1	27.5	22.9	2.7	5.3	2.2	0.0	5.9	3.7	1.0	2.5	5.8	2.7	9.9	6.5	6.3	3.9	0.7	3.4	3.4	4.3	16.4	3.3	26.0	4.5	8.0	3.3	15.8	2.6	5.6	2.6	9.0	3.5	0.8	2.7	5.5	2.3	4.3	3.2	15.4	2.3	3.1	1.6	2.1	0.3	3.0	1.6	2.2	0.5	3.0	7.2	6.3	2.9	5.2	2.0	4.4	5.6	1.1	4.6	0.0	0.0	9.2	6.0	2.8	0.8	0.7	12.3	2.0	1.6	1.7	0.7	6.2	3.6	11.3	0.2	0.0	3.9	2.0	7.8	5.5	1.1	0.4	2.2	0.2	9.8	3.2	8.1	0.1	11.6	0.8	0.0	5.0	1.6	1.1	6.7	5.4	7.4	4.0	4.3	3.4	2.3	12.5	30.3	8.7	9.1	3.9	4.5	1.3	1.3	5.3	8.4	0.9	5.0	0.0	0.0	0.6	0.3	3.8	8.6	1.5	2.3	3.3	5.2	4.7	2.0	0.5	1.7	3.7	1.8	0.4	0.3	1.9	7.2	2.9	6.3	3.0	1.6	2.0	6.7	13.5	27.5	22.9	6.5	6.3	4.3	16.4	15.8	3.1
RAP1GDS1	SmgGDS	ENSG00000138698	"Rap1 GTPase-GDP dissociation stimulator 1"	P52306	4	98261384-98443861	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019060	Approved		Supported	Cytosol			120000	Cytosol		"HPA019060: AB_1856068"	"unprognostic (8.12e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.44e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.60e-1)"	"prognostic favourable (2.00e-4)"	"unprognostic (7.11e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	11.3	9.7	25.8	12.9	28.2	9.0	13.1	28.0	43.6	9.3	12.0	20.0	9.0	7.3	8.9	8.7	13.7	6.1	8.6	6.8	29.7	28.0	12.3	15.2	10.1	15.3	36.9	20.5	7.9	13.8	8.4	15.3	9.6	30.1	8.0	14.0	8.0	8.6	11.9	3.6	10.5	9.0	16.3	37.0	12.5	8.2	15.5	26.2	16.2	13.0	4.8	17.0	12.5	7.6	13.9	31.9	16.0	14.7	19.5	22.7	8.4	17.7	10.3	13.2	11.3	17.1	20.5	5.3	30.2	16.8	18.0	14.2	7.7	23.0	21.1	9.8	22.5	10.1	16.3	27.6	24.4	21.5	6.7	13.0	13.3	10.0	33.9	21.6	9.1	23.8	16.9	15.9	24.7	23.6	8.6	18.1	44.6	9.3	35.7	10.7	4.8	7.5	14.9	7.9	7.1	18.3	13.9	19.6	11.9	12.6	28.4	16.7	6.4	14.1	23.2	18.7	13.5	8.6	17.9	6.2	10.8	17.7	15.5	16.2	24.3	16.0	10.6	5.7	14.2	14.6	14.3	13.9	14.5	13.6	16.7	11.0	7.8	11.9	1.6	19.5	14.7	31.9	22.7	8.4	25.8	28.2	28.0	30.5	29.7	28.0	36.9	20.5	30.1	26.2
RAPGEF3	"bcm910, cAMP-GEFI, EPAC"	ENSG00000079337	"Rap guanine nucleotide exchange factor 3"	O95398	12	47734367-47771040	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 21.8;HUVEC TERT2: 9.3;NB-4: 10.7;RPTEC TERT1: 10.5;TIME: 9.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004386, HPA040365, HPA043518"	Approved		Approved	Cytosol				Cytosol		"CAB004386: AB_627521, HPA040365: , HPA043518: "	"unprognostic (2.12e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.37e-2)"	"prognostic favourable (6.67e-7)"	"unprognostic (9.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.61e-3)"	"unprognostic (3.38e-2)"	26.5	2.8	18.2	3.0	19.7	1.9	22.1	3.9	23.0	12.7	4.8	28.8	19.4	4.7	10.6	11.9	10.4	15.9	13.7	15.9	20.7	7.3	22.8	1.6	6.9	4.7	24.2	14.9	30.9	5.4	4.9	3.0	9.8	19.1	7.1	3.2	3.3	20.5	16.9	10.6	6.9	4.8	6.0	12.0	10.9	6.3	2.5	27.4	0.0	27.3	4.8	2.7	8.6	11.5	1.1	0.6	0.5	0.7	0.0	1.2	0.4	1.7	0.5	0.6	1.9	0.2	1.8	0.6	1.3	1.0	0.5	0.3	0.2	4.6	0.1	21.8	2.3	1.9	0.7	3.3	0.2	2.3	0.3	0.2	1.6	0.1	0.1	0.3	0.2	0.7	0.3	1.0	0.6	9.3	0.1	2.3	0.4	1.1	0.0	10.7	0.5	3.0	0.3	0.1	0.7	10.5	2.0	0.2	0.3	0.2	1.3	0.3	5.0	0.4	9.3	5.4	0.9	1.2	0.4	1.0	0.3	0.1	3.3	2.3	0.5	0.0	0.7	0.0	0.1	0.4	0.6	0.5	0.1	1.2	0.3	1.1	0.2	0.3	0.5	0.0	0.5	0.6	0.4	0.4	18.2	19.7	3.9	23.0	20.7	7.3	24.2	14.9	19.1	27.4
RAPGEF6	"PDZ-GEF2, PDZGEF2, RA-GEF-2"	ENSG00000158987	"Rap guanine nucleotide exchange factor 6"	Q8TEU7	5	131423921-131635236	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA037982, HPA037983"	Approved		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: "	"unprognostic (1.86e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.72e-3)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.81e-4)"	7.2	7.3	8.4	15.2	11.2	15.7	9.9	34.1	12.7	7.2	6.7	13.7	6.1	5.0	6.9	5.9	6.5	6.1	7.7	6.6	9.4	10.5	6.2	8.4	9.5	24.6	13.1	9.0	8.6	6.2	12.5	9.5	8.0	17.1	7.2	7.8	5.4	6.9	7.9	6.9	8.1	7.3	6.9	10.9	11.3	6.5	19.7	14.5	21.2	7.1	5.5	22.0	7.7	7.2	5.4	1.6	8.7	2.0	5.3	14.2	5.4	6.9	5.0	7.1	6.6	3.7	4.2	6.8	7.7	6.1	6.6	10.0	9.1	4.9	16.2	5.2	5.1	5.6	9.9	8.0	13.4	7.9	5.4	10.2	7.3	4.9	3.0	7.1	10.8	3.1	3.8	9.6	9.3	5.8	5.8	9.8	5.8	3.5	7.3	5.7	3.1	3.8	10.9	10.2	8.6	4.8	5.5	24.5	5.6	8.0	3.6	9.5	5.1	6.2	5.7	8.7	6.2	7.0	8.8	5.7	6.8	17.7	5.0	9.4	7.4	1.4	1.7	6.3	6.3	2.0	10.7	4.5	8.5	6.8	1.4	5.4	14.2	10.1	8.7	5.3	1.5	1.6	9.6	5.4	8.4	11.2	34.1	12.7	9.4	10.5	13.1	9.0	17.1	14.5
RAPH1	"ALS2CR18, ALS2CR9, KIAA1681"	ENSG00000173166	"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1"	Q70E73	2	203394345-203535410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.8;non-classical monocyte: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA016744, HPA020027"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"				"Nuclear bodies, Plasma membrane"	Cytosol	"HPA016744: AB_1844781, HPA020027: AB_1844782"	"unprognostic (9.78e-2)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.79e-1)"	11.0	6.1	7.3	6.3	7.6	2.7	17.6	8.4	12.7	9.8	7.9	3.7	6.8	6.9	6.8	8.4	9.2	6.3	12.5	8.3	5.2	5.0	8.2	51.1	17.2	6.8	4.2	8.4	3.6	5.8	4.0	9.9	11.1	6.0	7.2	6.7	8.5	11.2	4.4	8.3	10.2	10.2	7.1	4.8	26.7	7.8	7.9	3.1	1.7	25.8	7.9	5.6	9.6	8.7	0.0	1.1	0.0	2.8	1.1	0.6	0.3	5.4	3.8	8.0	4.6	6.3	8.2	7.0	7.6	5.6	7.9	10.0	17.5	5.8	0.0	1.8	11.5	2.7	4.1	6.5	16.5	1.1	2.3	0.0	9.1	3.0	15.8	0.0	0.1	11.3	5.5	14.5	15.3	12.3	0.4	4.2	15.7	3.0	0.0	0.0	4.7	4.8	0.1	11.3	3.0	5.7	17.6	2.8	3.8	5.2	5.0	6.3	2.8	0.2	14.5	19.5	6.3	9.3	8.0	2.0	3.4	0.0	16.1	0.1	4.3	0.0	0.8	0.0	0.2	2.8	0.6	0.0	0.5	0.1	1.1	0.0	0.4	0.1	0.0	1.1	2.6	0.1	0.5	0.3	7.3	7.6	8.4	12.7	5.2	5.0	4.2	8.4	6.0	3.1
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437757-47449178	"Disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"skeletal muscle: 45.3;tongue: 14.8"	"Cell line enriched"	"Detected in some"	4	"RH-30: 71.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	1.7	0.8	0.2	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	2.7	0.7	0.1	0.1	1.4	0.4	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.4	0.0	0.3	0.8	0.0	45.3	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.4	14.8	0.4	0.0	0.0	0.2	0.1	2.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	71.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.7	0.0	2.6	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.7	0.0	0.3	0.1
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309192-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 63.1;SK-BR-3: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 26.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058282			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA058282: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	27.6	13.5	5.0	18.6	7.6	32.3	23.7	11.5	15.2	30.2	29.6	5.0	16.8	18.0	23.8	23.9	17.3	23.3	30.2	24.3	5.9	6.1	14.6	24.0	32.0	23.4	4.6	7.8	50.0	9.3	7.4	18.1	16.6	6.5	22.9	8.5	26.8	12.1	32.7	43.1	14.3	31.6	18.6	3.7	31.1	14.3	21.8	2.9	9.7	16.3	15.4	20.2	31.5	20.3	1.0	6.1	26.6	9.3	2.5	2.6	1.9	5.0	11.9	3.6	6.0	7.0	10.8	3.6	4.2	6.3	6.2	4.0	8.2	4.4	2.7	6.6	9.4	14.9	4.1	9.9	3.5	20.2	6.1	7.7	6.0	8.0	11.3	2.7	24.4	15.1	2.9	6.5	8.3	9.1	4.8	5.9	6.9	63.1	1.7	9.4	3.1	3.8	3.6	21.1	10.2	3.6	4.0	1.5	12.2	8.9	40.1	12.2	37.8	11.1	10.6	7.7	13.2	13.5	4.5	14.2	4.7	2.3	12.9	5.5	22.8	8.7	4.2	15.7	1.6	6.9	2.6	1.0	1.7	1.7	6.1	0.9	0.8	1.3	26.6	2.5	9.3	1.8	1.4	1.9	5.0	7.6	11.5	15.2	5.9	6.1	4.6	7.8	6.5	2.9
RARS	DALRD1	ENSG00000113643	"Arginyl-tRNA synthetase"	P54136	5	168486445-168519299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.59e-5)"	"prognostic unfavourable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	21.8	26.3	16.0	18.3	15.3	6.2	22.6	17.1	18.4	21.2	29.4	9.1	20.4	33.3	22.9	21.4	34.7	19.5	14.4	21.7	19.8	12.3	29.8	33.5	18.7	18.6	13.9	15.2	21.3	33.0	19.9	34.5	30.3	15.8	18.9	27.4	15.5	34.0	15.4	27.8	27.9	48.7	21.5	14.5	22.1	24.4	17.2	11.8	20.5	21.5	32.3	23.7	22.4	22.6	11.1	21.8	5.2	17.7	16.8	16.3	11.7	27.1	32.2	23.9	26.4	33.1	37.9	41.1	40.0	34.4	41.7	48.8	54.7	29.6	28.9	32.8	38.0	26.4	31.2	53.8	54.4	30.0	21.5	19.4	29.4	34.3	28.7	45.7	20.7	29.1	28.8	45.4	21.8	33.3	28.9	14.7	44.6	25.1	19.0	18.3	39.2	22.0	8.4	34.8	27.4	37.1	31.0	22.8	28.0	30.6	35.4	41.2	32.1	19.2	33.0	30.2	27.8	23.3	46.6	14.6	26.8	29.6	32.9	32.7	28.7	3.4	14.4	5.2	12.5	17.7	14.3	11.1	12.6	13.3	21.8	6.6	15.6	16.3	4.0	16.8	16.4	10.3	12.8	11.7	16.0	15.3	17.1	18.4	19.8	12.3	13.9	15.2	15.8	11.8
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 64.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.3;EFO-21: 10.9;REH: 12.0;RPMI-8226: 26.8;RPTEC TERT1: 10.7;U-698: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7"	HPA041650	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: "	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.9	10.4	8.6	2.5	11.2	1.2	1.6	0.4	18.2	2.5	2.1	18.8	3.7	1.2	0.9	0.9	16.9	2.2	1.8	0.8	11.8	4.9	7.4	0.9	0.9	1.7	7.3	10.9	0.8	1.4	64.0	3.9	1.0	4.0	0.9	1.7	0.0	22.4	7.4	0.8	8.0	1.1	0.9	1.8	1.0	9.6	1.1	8.4	0.0	8.0	6.0	5.0	1.0	3.7	0.4	0.2	1.3	0.2	0.3	1.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.1	8.3	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.3	0.0	12.0	0.0	26.8	10.7	0.0	0.3	0.0	0.0	4.0	0.0	1.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	1.3	0.2	0.1	0.1	0.0	1.6	0.2	0.9	0.4	0.0	0.4	1.2	0.5	0.4	0.3	0.0	0.2	0.4	0.3	8.6	11.2	0.4	18.2	11.8	4.9	7.3	10.9	4.0	8.4
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540868-35554001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.0;seminal vesicle: 25.2"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.0;SK-BR-3: 9.2;U-2 OS: 5.3;U-87 MG: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"basal ganglia: 527.8"	"Region enriched"	"Detected in all"	8	"basal ganglia: 265.8"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavourable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.6	7.9	8.6	2.5	71.0	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5.0	0.8	0.5	1.5	0.6	3.4	8.0	0.8	1.0	0.9	1.0	0.4	2.1	9.6	4.4	3.5	4.0	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0.0	1.4	0.1	1.4	3.8	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	3.5	0.0	0.6	0.0	0.0	0.1	0.9	0.3	1.4	1.1	0.2	0.7	0.0	0.2	3.0	0.2	0.2	0.0	1.3	0.0	0.9	0.0	0.2	0.0	1.7	0.0	0.1	0.2	4.0	2.7	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.2	0.4	1.5	0.0	1.1	0.0	0.0	2.4	0.4	2.6	9.2	0.0	0.7	0.3	0.1	2.2	5.3	0.2	1.0	2.3	0.7	0.0	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.6	71.0	1.8	23.5	4.1	5.0	3.4	8.0	2.1	15.3
RASGRP1	"CalDAG-GEFII, RASGRP"	ENSG00000172575	"RAS guanyl releasing protein 1"	O95267	15	38488103-38565575	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.1;lymphoid tissue: 55.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.8;MOLT-4: 27.2;REH: 7.6;U-698: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039389			Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039389: "	"unprognostic (3.44e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.30e-2)"	1.7	1.0	5.7	9.9	17.0	7.8	1.9	33.1	18.5	1.4	1.6	0.8	0.0	2.5	1.6	1.6	6.7	4.7	2.7	1.6	6.1	3.2	5.9	1.2	4.2	20.0	3.0	6.2	0.8	2.0	0.3	1.2	4.9	22.3	1.0	2.3	1.4	2.5	1.0	0.8	7.3	3.7	0.7	1.6	8.6	4.8	2.2	1.1	55.8	1.2	1.6	16.3	4.3	2.4	1.2	0.0	0.8	0.0	2.4	10.4	1.4	0.0	0.2	0.5	0.1	0.0	0.0	0.0	2.2	0.7	1.1	0.9	2.4	0.0	6.1	0.5	0.1	0.1	1.3	0.0	1.0	28.8	1.2	0.4	0.2	0.0	0.3	0.2	0.4	0.0	0.1	0.6	0.0	0.0	0.2	1.9	0.0	0.9	27.2	0.0	0.4	0.0	7.6	0.1	0.0	1.1	0.0	2.6	0.9	1.4	0.1	0.1	0.6	0.0	0.1	0.2	0.9	3.1	0.4	4.8	2.3	7.3	0.1	0.0	0.3	0.0	0.0	0.8	5.7	0.0	4.2	1.2	6.4	5.7	0.0	0.7	6.0	6.0	0.3	2.4	0.0	0.0	10.4	1.4	5.7	17.0	33.1	11.7	6.1	3.2	3.0	6.2	22.3	1.1
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1"	"Group enriched"	"Detected in some"	5	"HEL: 18.9;HMC-1: 18.9;U-937: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	4.5	1.8	2.4	8.0	3.3	23.3	5.4	0.7	1.8	1.8	1.7	2.8	0.1	1.4	1.6	2.9	1.6	2.6	3.4	6.2	2.0	1.3	1.5	1.8	11.8	23.1	3.4	0.2	1.1	1.6	0.5	0.9	3.0	1.8	1.7	1.2	1.7	1.6	0.8	1.5	1.4	2.4	2.7	4.2	19.2	1.9	0.8	2.4	0.5	1.0	0.2	1.0	2.6	3.1	0.1	5.2	22.4	9.5	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.9	0.0	0.0	0.0	0.1	18.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	6.0	7.1	10.6	0.0	8.5	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.0	22.4	0.0	9.5	0.4	0.7	2.1	2.4	3.3	0.7	1.8	2.0	1.3	3.4	0.2	1.8	2.4
RASSF10		ENSG00000189431	"Ras association domain family member 10"	A6NK89	11	13009577-13012106	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.3"	"Group enriched"	"Detected in some"	5	"A549: 9.3;CAPAN-2: 8.3;HaCaT: 12.8;HMC-1: 6.4;RPTEC TERT1: 13.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040406			Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA040406: "	"unprognostic (6.71e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.41e-3)"	"unprognostic (6.25e-3)"	"prognostic favourable (2.76e-4)"		"unprognostic (3.43e-3)"	"unprognostic (8.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (4.12e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.65e-2)"	0.2	0.0	0.4	0.2	1.0	0.0	3.9	0.0	1.7	1.1	1.4	1.0	0.0	1.8	0.0	1.3	9.3	5.2	2.5	0.2	1.0		4.7	0.0	1.8	0.0	0.0	0.6	1.2	0.0	3.8	0.1	0.0	0.6	1.6	0.5	0.4	8.0	0.1	0.8	4.1	0.6	0.0	0.1	0.0	5.6	2.4	1.0	1.1	0.1	8.1	7.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	9.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.3	0.0	0.6	0.0	12.8	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.0	13.0	1.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823645	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.2;BEWO: 20.1;Daudi: 20.5;HL-60: 24.1;NB-4: 31.2;U-937: 38.4"	"Cancer enhanced"	"Detected in all"		"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: "	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	8.3	5.1	26.5	21.5	26.9	38.6	3.6	10.2	45.8	14.9	4.1	59.5	0.1	2.7	13.0	11.6	5.2	9.8	7.8	2.4	33.2	22.4	2.0	3.0	10.1	26.2	54.7	8.7	3.5	1.7	0.7	2.6	4.5	39.7	3.9	5.0	19.8	2.0	4.8	1.2	2.2	5.7	18.6	106.1	14.9	3.3	9.9	27.3	4.7	2.5	0.6	34.2	10.7	2.7	7.9	14.1	42.1	17.9	2.4	4.7	10.6	0.0	4.8	11.9	19.2	0.1	0.0	20.1	1.1	3.3	0.2	0.0	1.1	0.0	20.5	1.9	1.0	0.0	1.7	0.0	0.3	7.3	0.7	13.4	0.0	0.2	0.0	24.1	13.7	0.0	0.0	0.4	0.0	7.8	0.0	8.1	0.0	0.0	3.5	31.2	2.6	0.3	5.5	1.3	7.8	0.0	9.5	0.1	0.9	0.0	0.3	0.6	0.0	15.4	0.2	0.5	2.6	0.2	1.5	0.1	1.9	12.6	0.1	38.4	0.1	21.1	17.9	29.5	2.4	15.4	4.7	7.9	3.9	3.3	14.1	5.3	2.6	2.1	42.1	2.4	16.8	9.4	3.4	10.6	26.5	26.9	10.2	19.3	33.2	22.4	54.7	8.7	39.7	27.3
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697567	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 44.4"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	22.4	13.8	4.2	24.0	4.5	5.9	48.4	2.5	4.5	15.3	64.1	6.5	21.6	8.3	18.5	12.5	27.0	9.4	30.1	37.4	4.6	4.4	5.8	6.4	19.4	22.2	7.4	2.9	13.6	10.0	1.0	4.3	16.0	7.6	26.5	17.8	14.1	18.9	21.2	16.0	5.0	18.0	80.1	10.8	25.7	25.6	6.9	5.5	7.6	5.3	6.3	14.5	57.4	30.9	5.5	3.2	44.4	6.6	4.1	7.9	0.9	9.7	11.0	3.5	6.7	3.8	5.5	21.4	4.3	22.3	5.8	6.8	7.9	10.4	15.4	9.1	3.0	4.3	10.6	4.4	7.0	12.6	4.1	10.0	4.9	8.9	10.5	10.6	7.1	3.7	3.9	13.2	9.9	24.5	5.3	7.6	6.7	9.3	6.9	6.9	7.8	6.7	11.2	11.3	6.5	7.5	11.9	7.9	8.3	7.2	1.4	50.9	6.3	6.7	35.4	4.7	5.8	4.9	4.6	7.1	7.5	10.0	5.7	9.3	13.6	5.9	6.6	4.2	5.1	6.3	4.2	5.5	7.6	5.6	3.2	3.7	7.7	7.9	44.4	4.1	5.9	3.0	7.7	0.9	4.2	4.5	2.5	4.5	4.6	4.4	7.4	2.9	7.6	5.5
RASSF8	"C12orf2, HoJ-1"	ENSG00000123094	"Ras association domain family member 8"	Q8NHQ8	12	25959029-26079892	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038163, HPA038164"	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA038163: , HPA038164: AB_10672621"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.58e-2)"	9.8	14.1	14.6	6.4	14.0	1.3	14.6	8.0	10.4	20.9	12.7	10.3	7.0	2.5	23.9	10.5	6.7	10.0	14.6	11.9	16.0	8.5	19.7	5.2	12.5	2.2	15.1	8.0	26.3	5.2	4.3	16.1	10.6	14.8	14.2	4.6	14.7	4.4	12.7	12.0	3.3	4.4	17.3	19.9	5.0	7.0	44.7	13.6	0.3	9.7	5.2	2.2	10.1	18.8	0.6	4.1	0.9	0.3	1.4	0.6	0.1	3.2	2.6	11.5	1.4	18.0	20.4	16.1	17.9	26.2	7.6	8.4	5.7	1.0	0.2	14.2	19.3	1.3	2.5	2.1	9.7	1.2	3.3	0.5	6.5	0.3	9.0	2.0	0.1	12.1	2.1	16.8	11.3	9.0	0.6	2.3	8.7	4.4	2.3	0.4	11.5	24.8	3.0	11.2	0.1	4.6	4.9	0.5	8.3	9.4	0.1	8.8	1.7	1.7	10.6	15.0	7.8	38.0	13.4	1.0	0.6	0.3	13.9	0.2	21.0	0.7	0.3	0.2	0.6	0.1	0.2	0.3	0.2	0.2	0.0	0.6	0.3	0.2	0.9	1.4	0.1	4.1	0.1	0.1	14.6	14.0	8.0	10.4	16.0	8.5	15.1	8.0	14.8	13.6
RB1CC1	"ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131"	ENSG00000023287	"RB1 inducible coiled-coil 1"	Q8TDY2	8	52622456-52745843	"Predicted intracellular proteins"	"Autophagy, Cell cycle, Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024391, HPA053049"	Approved		Supported	"Nuclear membrane,Cytosol"				Cytosol	"Nuclear membrane"	"HPA024391: , HPA053049: "	"unprognostic (1.58e-2)"	"unprognostic (7.51e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (3.22e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.56e-3)"	"unprognostic (7.67e-2)"	"unprognostic (4.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.42e-1)"	16.2	13.7	36.6	9.8	19.8	38.0	15.0	21.8	36.8	14.5	13.3	7.9	11.9	11.0	15.5	11.9	15.0	11.0	12.2	22.7	31.1	17.0	15.2	18.3	13.5	10.5	16.5	22.5	18.4	14.6	21.5	15.2	13.3	17.0	14.2	10.1	7.6	12.9	11.4	35.9	13.2	13.2	13.4	12.2	11.7	12.0	28.2	17.0	21.6	15.7	10.3	10.9	16.4	14.1	7.1	7.6	25.5	9.7	8.5	8.4	6.6	13.7	12.3	15.2	13.2	16.9	19.3	8.7	10.5	21.5	11.1	13.9	8.5	15.6	10.1	17.7	15.4	18.4	18.7	9.8	21.1	7.6	16.4	17.2	12.8	11.8	20.9	6.1	9.7	18.0	20.3	11.0	30.3	15.0	20.4	16.5	13.5	9.0	15.5	9.1	15.0	6.3	8.0	7.3	10.2	10.2	10.8	14.7	15.3	10.9	12.6	23.2	14.3	11.2	17.6	10.7	15.0	16.8	9.2	16.4	14.1	10.1	16.9	10.7	11.9	22.3	8.0	14.7	7.8	7.6	7.8	7.1	6.5	7.9	7.6	6.2	8.0	7.4	25.5	8.5	9.7	3.9	8.4	6.6	36.6	19.8	21.8	36.8	31.1	17.0	16.5	22.5	17.0	17.0
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713338	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6"	"Cell line enriched"	"Detected in some"	15	"RH-30: 24.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		1.2	2.4	19.9	1.5	33.0	1.6	1.3	31.5	57.2	1.4	1.9	1.9	0.0	1.3	1.3	5.0	2.0	2.2	1.3	17.6	16.4	6.7	1.5	1.3	1.2	1.2	3.7	21.7	1.4	1.3	1.2	0.5	1.3	13.5	2.6	1.7	0.0	1.7	4.9	67.6	1.5	1.4	1.2	3.5	1.2	1.4	1.7	5.6	0.0	1.3	9.7	1.2	1.5	0.3	1.7	0.7	3.1	0.7	1.2	1.4	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	1.4	0.0	0.0	24.5	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	2.4	0.6	2.0	1.1	0.3	0.7	1.0	0.9	0.8	0.3	1.7	1.4	1.0	3.1	1.2	0.7	0.7	1.0	0.0	19.9	33.0	31.5	34.3	16.4	6.7	3.7	21.7	13.5	5.6
RBFOX2	"FOX-2, HNRBP2, HRNBP2, RBM9"	ENSG00000100320	"RNA binding fox-1 homolog 2"	O43251	22	35738736-36028425	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006240	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006240: AB_1079750"	"unprognostic (3.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.08e-2)"	14.0	11.6	25.7	7.6	30.5	0.4	12.7	58.4	37.2	26.4	23.2	7.4	11.2	7.9	38.5	13.8	22.9	20.4	16.7	20.8	19.6	15.9	10.2	10.6	12.7	3.7	12.0	26.3	43.3	9.3	20.5	20.6	21.3	22.8	18.3	13.6	9.7	10.3	20.5	40.7	12.6	10.6	32.6	9.7	5.4	13.3	10.4	10.1	1.8	18.7	5.7	5.3	18.1	15.9	0.0	0.7	0.0	0.0	0.1	3.1	0.1	14.8	9.7	31.8	18.6	20.0	33.7	13.1	28.0	37.5	20.9	23.0	18.7	6.4	9.6	13.5	31.7	14.5	11.6	12.8	26.7	7.6	13.3	5.3	8.7	6.9	6.0	1.5	4.0	24.4	16.6	19.9	22.7	25.4	4.0	1.2	22.8	5.8	1.4	0.8	12.4	13.5	2.2	28.3	2.2	14.4	16.7	9.8	37.4	31.9	5.0	9.9	5.9	1.8	31.3	29.9	17.6	17.7	12.9	1.0	3.1	11.8	14.0	2.2	16.8	0.0	0.0	0.0	1.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.1	25.7	30.5	58.4	37.2	19.6	15.9	12.0	26.3	22.8	10.1
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781364-27891098	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.2;RPTEC TERT1: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Cytosol				Cytosol		"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	14.4	22.2	2.5	2.4	5.2	4.1	2.2	2.1	4.1	2.6	3.0	1.7	4.9	12.4	4.7	4.7	3.1	7.4	10.7	3.5	3.7	4.3	15.1	22.6	10.4	0.8	3.0	2.4	24.2	2.4	3.5	10.3	6.2	12.3	6.9	2.4	2.2	1.4	16.8	7.6	1.0	11.8	3.8	4.7	1.7	1.6	4.8	1.4	0.3	4.5	2.8	1.1	4.8	12.0	5.8	5.1	5.6	3.8	4.9	6.5	3.4	3.0	2.0	0.3	0.4	0.4	0.7	2.0	0.8	0.6	0.4	0.6	4.7	1.5	1.0	10.2	1.7	1.2	0.2	1.0	0.8	0.4	0.2	0.1	0.5	4.0	1.5	0.8	0.2	1.0	1.7	2.6	3.6	0.6	0.1	1.3	2.0	4.0	0.6	2.2	0.0	1.7	0.9	0.2	0.7	21.6	0.2	0.8	1.2	2.9	3.9	1.7	1.7	4.5	0.1	0.7	0.5	1.8	1.2	6.6	7.7	2.0	1.9	3.0	0.1	5.6	3.8	1.9	3.0	1.6	6.1	5.8	4.0	6.5	5.1	4.6	4.2	3.6	5.6	4.9	0.8	0.8	5.8	3.4	2.5	5.2	2.1	4.1	3.7	4.3	3.0	2.4	12.3	1.4
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491649	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favourable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	27.8	20.6	15.7	22.2	20.0	11.1	25.5	24.1	18.7	26.3	23.7	24.7	25.6	15.4	30.0	20.2	21.5	25.1	19.5	19.9	15.5	11.7	23.8	34.2	24.0	31.6	25.8	13.7	29.3	30.7	55.3	22.6	12.4	15.8	28.2	18.9	20.2	26.2	30.5	28.3	20.8	24.6	26.1	17.9	27.2	24.9	28.6	22.8	54.4	31.0	10.3	31.6	36.5	26.8	9.1	8.0	20.2	9.8	26.2	35.1	24.5	12.6	8.6	11.5	10.6	30.2	29.2	5.4	9.3	13.3	11.6	4.0	5.6	15.9	18.5	14.1	15.7	15.9	8.6	14.4	18.5	6.6	11.9	8.3	8.7	10.4	13.0	11.5	26.1	18.5	17.7	7.9	11.3	17.9	6.7	11.6	12.9	3.7	22.9	15.5	4.7	7.8	16.7	21.0	21.2	11.4	12.9	9.4	7.8	21.1	9.3	9.1	12.0	15.2	14.8	14.4	7.7	11.9	6.9	17.9	10.5	21.7	18.0	14.4	9.9	16.4	8.2	20.2	21.2	5.9	23.7	8.7	23.8	24.3	8.0	9.1	35.1	29.6	15.7	26.2	9.8	4.9	17.5	24.5	15.7	20.0	24.1	18.7	15.5	11.7	25.8	13.7	15.8	22.8
RBM14-RBM4		ENSG00000248643	"RBM14-RBM4 readthrough"		11	66616626-66646469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047849	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047849: "	"unprognostic (2.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-4)"	"unprognostic (3.92e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.77e-4)"	"unprognostic (5.74e-7)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.10e-2)"	7.3	5.9	5.7	7.4	7.7	13.9	5.0	12.3	8.2	5.4	7.5	6.9	7.5	2.8	8.1	11.4	6.4	4.9	7.1	12.2	5.9	5.4	6.2	14.7	6.3	6.4	8.5	4.9	6.0	7.9	2.8	9.1	5.9	5.5	7.6	4.8	7.5	5.8	5.8	9.3	4.0	6.3	7.3	5.3	7.5	7.7	11.9	6.5	13.2	7.2	4.9	9.2	6.7	5.7	8.6	10.8	7.5	6.4	4.3	5.4	4.4	2.1	1.4	0.8	1.8	1.5	0.2	1.1	1.1	0.5	2.0	0.4	3.4	0.6	0.7	1.2	0.2	3.6	1.4	0.4	0.5	0.0	0.6	3.2	1.3	2.3	0.6	1.8	1.7	0.0	0.3	0.9	0.2	0.0	4.6	1.5	1.1	3.7	2.5	12.1	1.2	4.6	1.8	5.1	0.6	0.4	2.3	2.6	0.9	0.6	1.7	6.8	0.8	1.3	0.0	2.6	2.5	1.7	1.4	0.2	0.6	1.5	0.9	1.1	0.8	6.4	6.4	7.5	5.4	5.6	3.8	8.6	3.6	4.1	6.7	8.0	1.3	3.1	3.5	4.3	5.3	10.8	2.3	4.4	5.7	7.7	12.3	8.2	5.9	5.4	8.5	4.9	5.5	6.5
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237624-122264839	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Midbody,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Midbody, Cytosol"	"HPA057281: , HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favourable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	12.8	14.8	16.5	9.1	16.5	15.1	24.6	18.1	20.3	14.4	13.4	10.5	13.7	10.4	13.6	16.2	11.8	11.6	11.7	27.2	16.7	18.6	17.3	12.2	10.7	10.9	17.8	13.2	15.1	13.7	16.0	18.2	16.2	16.3	17.2	12.6	8.2	12.6	13.9	29.4	10.1	10.8	13.2	16.0	12.4	12.3	7.6	15.0	11.9	15.3	13.5	11.1	13.0	14.4	8.7	9.5	16.0	13.0	7.7	10.0	8.2	5.8	6.1	8.4	9.3	12.5	15.4	7.4	13.3	11.0	9.2	8.5	7.0	5.8	10.2	5.8	8.6	13.8	13.1	13.9	11.6	10.5	6.0	7.6	10.2	5.9	14.0	15.2	10.6	13.1	15.8	9.6	19.7	13.1	10.4	8.1	13.7	6.4	7.9	9.4	6.5	10.2	7.0	17.5	13.9	12.8	6.6	17.7	9.3	10.0	14.2	15.1	8.2	8.6	7.2	8.6	4.9	13.7	13.0	11.8	21.7	8.6	14.2	9.4	10.3	6.8	9.2	16.0	10.0	10.5	9.6	8.7	8.9	9.7	9.5	6.0	9.3	9.7	9.7	7.7	13.0	6.9	9.1	8.2	16.5	16.5	18.1	20.3	16.7	18.6	17.8	13.2	16.3	15.0
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281346-17293875	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 11.1;LHCN-M2: 28.6;RH-30: 29.5;T-47d: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA066927: , HPA067231: "	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7.0	2.7	0.1	3.0	0.5	9.7	7.3	3.4	7.8	1.7	41.0	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.7	4.5	5.9	0.0	0.0	0.0	0.0	9.0	3.3	6.1	6.5	0.0	0.5	0.0	2.8	6.4	0.0	5.6	0.2	11.1	0.0	0.2	0.0	0.5	3.0	0.2	0.0	0.5	3.2	0.0	1.2	0.2	0.7	0.0	0.0	28.6	1.3	0.0	0.0	2.0	0.7	0.0	29.5	0.0	0.0	0.0	3.9	0.4	0.0	0.0	0.1	13.8	0.2	0.0	2.1	4.9	0.0	7.7	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391407-57409333	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.3;skeletal muscle: 107.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.8;U-698: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favourable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.83e-1)"	4.4	3.5	4.5	22.8	4.9	64.3	4.3	10.0	5.2	9.2	28.1	6.4	7.1	5.9	13.0	6.7	16.3	10.4	6.5	24.4	4.2	3.9	5.3	6.7	9.8	23.3	4.7	2.3	17.2	5.9	1.9	4.4	9.9	5.0	12.2	3.4	10.9	11.6	8.3	107.9	2.7	12.9	27.4	3.4	22.0	8.1	16.7	4.1	26.8	4.1	18.9	28.0	25.1	11.4	6.4	2.2	3.5	2.9	5.5	7.6	3.4	5.4	5.6	2.8	7.1	0.0	0.4	16.1	1.8	0.4	3.9	1.0	23.0	5.9	38.8	15.4	0.5	5.0	2.3	2.2	0.6	7.8	9.6	32.9	2.1	14.5	1.7	15.8	15.5	0.5	1.1	1.6	0.3	2.6	26.8	7.1	0.4	23.6	11.4	16.3	10.4	7.1	22.2	7.0	31.5	2.9	2.5	11.7	7.5	4.3	14.3	7.2	7.9	22.3	4.6	1.3	12.4	1.6	7.5	17.0	22.5	40.8	0.3	11.4	1.2	0.0	1.0	3.5	5.4	2.9	3.5	5.6	4.5	3.7	1.8	6.4	5.7	5.0	1.3	5.5	2.7	2.2	7.6	3.4	4.5	4.9	10.0	5.2	4.2	3.9	4.7	2.3	5.0	4.1
RBM4	"LARK, RBM4A, ZCCHC21, ZCRB3A"	ENSG00000173933	"RNA binding motif protein 4"	Q9BWF3	11	66638617-66666682	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042174, HPA047849"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042174: , HPA047849: "	"unprognostic (8.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.07e-3)"	41.6	50.3	37.1	34.4	37.2	57.5	38.3	55.5	43.9	40.6	39.1	35.5	43.4	33.9	42.2	48.3	44.5	37.4	33.6	33.0	32.1	31.0	40.9	37.2	34.3	44.7	30.1	32.7	51.1	63.9	44.9	41.5	42.5	31.1	42.7	33.2	41.3	54.6	33.2	40.8	37.4	36.2	36.7	26.9	48.5	42.1	47.3	32.2	68.2	59.5	37.9	48.7	36.5	37.2	51.4	45.0	61.7	51.9	57.5	72.7	54.3	26.5	35.2	53.5	30.1	19.7	21.4	32.5	28.1	22.8	29.6	21.3	58.7	34.7	34.4	38.8	28.1	29.7	57.1	33.4	31.8	34.1	29.7	46.8	36.0	34.9	39.0	32.0	20.4	31.3	29.1	34.1	48.4	39.2	36.8	25.5	30.9	54.9	52.6	32.9	67.2	38.8	49.2	50.2	38.0	39.3	43.1	45.1	32.5	49.5	36.3	78.7	69.0	32.2	39.8	31.0	27.3	19.1	22.7	32.0	33.4	55.6	24.8	25.3	44.2	61.7	45.7	48.6	56.8	46.8	51.0	48.0	59.0	61.8	45.0	51.4	63.8	63.5	53.6	57.5	51.9	40.6	72.7	54.3	37.1	37.2	55.5	43.9	32.1	31.0	30.1	32.7	31.1	32.2
RBM41	FLJ11016	ENSG00000089682	"RNA binding motif protein 41"	Q96IZ5	X	107064420-107118823	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042881	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA042881: AB_10794536"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.92e-1)"	10.0	10.3	9.2	9.1	10.8	5.0	9.5	23.7	14.2	13.4	11.9	10.1	8.2	12.7	12.2	11.5	11.1	12.4	7.6	8.8	8.7	6.8	11.8	13.7	8.3	8.9	9.7	9.4	9.7	10.6	21.0	14.1	12.0	11.6	10.8	11.2	9.0	10.7	9.0	14.6	11.6	15.5	11.2	14.2	11.5	8.2	15.6	12.8	12.2	15.7	8.0	9.9	12.4	9.8	6.3	4.8	10.6	7.0	8.6	6.3	3.4	14.1	11.4	7.3	5.9	4.9	8.6	8.5	8.4	8.3	6.2	8.4	7.5	11.9	7.8	15.9	6.1	11.8	10.6	7.8	9.5	9.6	15.7	9.5	20.6	9.2	5.5	9.6	7.5	6.0	15.6	7.5	7.6	9.3	16.3	10.9	7.5	6.8	8.1	5.5	10.8	13.1	6.6	6.1	6.7	9.2	9.0	6.1	9.6	10.5	7.6	6.7	6.9	5.0	9.0	8.7	5.1	10.3	6.6	5.1	9.4	8.7	4.9	4.4	6.5	10.6	7.0	10.6	6.3	3.7	3.9	6.3	5.5	6.3	4.7	6.3	4.1	2.8	1.0	8.6	3.7	4.8	4.9	3.4	9.2	10.8	23.7	14.2	8.7	6.8	9.7	9.4	11.6	12.8
RBM42	MGC10433	ENSG00000126254	"RNA binding motif protein 42"	Q9BTD8	19	35629030-35637686	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043671	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043671: AB_10794890"	"unprognostic (4.77e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.26e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.33e-2)"	26.0	22.0	16.6	20.3	16.0	29.2	23.6	12.1	23.4	20.4	27.3	22.6	18.8	24.2	25.5	21.8	25.5	18.3	23.6	24.9	13.7	12.0	22.2	33.3	19.3	19.2	15.7	17.6	27.6	17.7	20.7	15.0	41.3	16.0	19.5	9.9	15.9	25.1	24.6	44.6	31.5	24.7	18.6	18.1	25.4	22.0	23.7	16.0	41.1	25.8	21.9	21.3	21.2	22.4	43.6	49.1	61.3	48.9	38.9	45.6	33.9	32.4	51.1	11.4	15.5	10.4	8.3	31.2	22.3	12.4	26.4	20.8	30.1	21.2	18.1	40.9	14.2	13.4	13.1	15.7	7.7	46.8	23.4	24.9	17.0	24.6	27.1	22.0	24.1	11.7	12.6	19.4	10.7	14.4	25.9	14.9	11.9	36.9	27.8	29.1	13.0	21.1	30.4	15.6	18.0	12.5	15.1	15.0	21.7	25.4	20.9	17.0	16.7	34.7	21.9	18.8	25.8	24.9	38.8	36.5	38.4	27.8	18.2	21.0	26.3	46.1	42.1	61.3	45.6	48.9	39.3	41.0	37.9	45.5	49.1	43.6	34.2	37.7	38.6	38.9	45.4	45.4	41.9	33.9	16.6	16.0	12.1	23.4	13.7	12.0	15.7	17.6	16.0	16.0
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.6;BEWO: 49.6;CAPAN-2: 21.8;SK-BR-3: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 42.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 11.3;granulocytes: 42.4;monocytes: 14.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA006347	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	8.2	33.6	1.9	8.2	2.4	2.6	10.9	0.8	1.2	5.4	22.9	3.3	28.7	24.1	2.6	15.4	27.3	5.3	12.7	4.0	2.4	1.1	37.0	16.1	14.5	11.3	3.0	0.3	4.6	19.2	8.0	2.9	27.2	6.6	13.2	17.3	9.2	60.8	36.0	0.9	6.0	42.8	2.2	4.1	15.0	22.2	7.1	2.2	1.6	31.5	13.7	20.6	7.8	9.7	2.0	11.3	42.4	14.2	0.1	0.1	4.8	11.5	16.6	0.0	0.5	0.0	0.0	49.6	0.3	0.3	0.1	0.1	9.7	21.8	0.0	8.7	0.3	4.6	0.3	3.3	0.1	0.0	2.7	0.0	1.2	2.6	0.2	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.6	2.5	0.0	6.5	0.0	0.3	5.1	0.9	0.0	0.0	12.8	15.3	14.6	0.5	0.1	6.6	16.6	0.1	7.3	3.0	0.0	0.1	0.6	0.1	0.3	8.8	13.0	1.4	1.5	1.3	0.0	0.1	14.2	0.1	0.0	10.9	0.1	2.0	0.0	0.0	11.3	1.2	0.1	0.0	42.4	0.1	8.1	4.6	0.0	4.8	1.9	2.4	0.8	1.2	2.4	1.1	3.0	0.3	6.6	2.2
RBM4B	"MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B"	ENSG00000173914	"RNA binding motif protein 4B"	Q9BQ04	11	66664998-66677921	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042174, HPA047849"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042174: , HPA047849: "	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.22e-2)"	"prognostic favourable (2.10e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.71e-2)"	7.1	12.3	17.6	9.6	17.3	4.0	10.2	35.9	19.3	13.4	10.0	22.8	13.5	9.3	19.0	20.2	10.1	18.3	9.8	9.2	17.5	17.4	9.9	9.8	8.8	13.8	15.4	16.2	29.8	11.8	15.7	25.6	12.2	17.3	14.6	11.5	14.5	14.1	15.0	13.9	17.4	10.3	14.0	16.4	11.8	9.8	17.0	18.7	8.5	12.3	7.6	15.5	11.3	11.5	21.8	11.4	26.8	15.1	13.2	12.5	8.4	13.5	13.6	29.8	24.9	14.7	15.1	10.1	13.0	13.1	14.6	15.0	19.0	14.2	15.1	18.7	16.4	17.6	19.6	17.9	15.5	14.6	13.3	16.5	17.1	20.2	10.8	16.6	16.3	15.7	12.3	14.9	12.7	14.0	12.5	15.2	19.6	21.7	10.3	12.8	17.8	18.3	21.1	23.8	15.5	13.3	13.7	18.4	16.8	15.6	8.0	29.1	21.3	15.8	12.9	16.2	16.6	15.7	11.6	7.5	12.6	15.5	14.9	11.8	14.2	12.7	9.6	26.8	10.8	14.1	10.4	21.8	10.1	10.4	11.4	18.6	12.5	9.2	6.1	13.2	15.1	9.4	7.4	8.4	17.6	17.3	35.9	19.3	17.5	17.4	15.4	16.2	17.3	18.7
RBMS1	"C2orf12, DKFZp564H0764, HCC-4, MSSP-1, MSSP-2, MSSP-3, SCR2, YC1"	ENSG00000153250	"RNA binding motif single stranded interacting protein 1"	P29558	2	160272151-160493794	"Predicted intracellular proteins"	"DNA replication"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047943, HPA061791"			Enhanced	Cytosol				Cytosol		"HPA047943: , HPA061791: "	"unprognostic (2.81e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.81e-3)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (6.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.16e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (1.33e-7)"	"unprognostic (1.84e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.32e-1)"	29.4	8.7	4.0	15.6	9.4	11.6	23.0	2.6	7.1	25.9	19.1	2.9	11.4	4.4	29.1	13.5	15.8	17.0	17.5	30.1	4.1	4.1	16.2	8.1	22.8	25.3	4.0	2.9	22.9	4.4	24.3	12.7	74.2	7.2	18.6	5.9	11.2	11.7	16.0	10.5	14.1	9.7	21.7	5.3	23.3	11.5	7.1	5.6	15.7	12.3	11.7	7.8	23.9	23.9	1.2	7.3	24.2	11.0	6.6	16.8	5.7	13.6	5.0	18.1	2.3	26.1	45.6	21.9	17.4	24.9	12.1	12.5	13.9	10.3	0.1	21.8	29.4	8.3	8.7	12.7	19.9	11.0	6.5	5.1	12.6	11.1	23.9	8.3	0.3	54.5	10.1	20.9	9.4	18.9	0.3	6.4	28.9	10.6	7.7	8.4	11.1	11.2	5.8	15.8	6.8	18.4	16.8	2.3	6.1	10.8	6.5	16.0	3.3	13.1	22.6	21.6	13.6	19.7	15.6	3.4	0.1	5.8	17.4	12.6	13.7	2.1	11.0	13.5	5.0	6.3	16.8	0.5	8.7	7.6	7.3	1.2	14.2	6.4	24.2	6.6	3.5	4.1	1.3	5.7	4.0	9.4	2.6	7.1	4.1	4.1	4.0	2.9	7.2	5.6
RBMS2	SCR3	ENSG00000076067	"RNA binding motif single stranded interacting protein 2"	Q15434	12	56521929-56596196	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039225, HPA058784"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA039225: AB_10963056, HPA058784: "	"unprognostic (1.35e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.15e-1)"	"prognostic favourable (3.22e-4)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.63e-2)"	24.5	7.2	5.7	5.8	10.0	3.6	31.3	8.5	8.7	12.2	9.9	6.0	6.1	4.7	17.5	11.9	9.3	10.4	10.4	19.3	8.6	5.1	12.4	4.4	53.1	8.0	7.5	5.2	12.6	7.5	11.5	12.1	24.8	11.4	9.6	9.6	14.3	10.3	9.8	9.3	7.5	7.5	12.9	19.2	13.2	8.0	4.8	7.4	2.7	16.5	8.1	5.3	11.7	19.2	1.1	4.9	3.0	8.3	2.1	2.3	1.5	11.5	9.7	4.2	6.1	10.2	9.9	4.2	14.7	15.2	11.3	10.0	7.6	20.6	0.2	17.6	14.9	8.4	3.8	23.4	12.7	3.8	3.1	1.4	7.5	2.3	6.6	1.6	2.7	8.8	5.9	11.8	13.9	20.8	0.7	2.8	19.2	1.5	1.6	1.9	2.5	3.6	0.9	4.6	0.2	14.0	2.8	0.4	3.2	17.1	6.2	2.1	6.6	3.1	31.8	7.1	15.1	3.9	3.4	2.5	1.1	0.8	2.5	0.4	9.8	1.0	8.3	2.6	1.6	2.6	1.7	0.6	0.7	2.3	4.9	1.1	1.8	1.2	3.0	2.1	0.6	1.3	0.9	1.5	5.7	10.0	8.5	8.7	8.6	5.1	7.5	5.2	11.4	7.4
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 161.0;pancreas: 107.4;retina: 85.3"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 134.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 56.8"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	1.9	43.1	6.5	3.3	11.3	0.1	7.5	5.1	7.8	7.8	3.2	11.5	8.4	4.5	26.8	11.3	3.3	58.4	42.7	7.5	7.7	8.1	3.7	20.1	4.9	6.5	10.4	4.9	161.0	107.4	4.3	26.2	20.6	31.5	9.8	2.1	85.3	4.7	6.4	1.8	2.9	4.8	17.5	8.7	4.7	2.8	12.9	4.3	0.9	3.3	2.6	2.0	7.7	7.2	0.5	0.5	2.1	0.9	0.7	0.4	0.2	1.2	0.3	1.1	26.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	8.6	0.0	0.0	6.0	0.1	0.0	0.0	0.7	0.0	0.4	11.0	25.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	5.1	0.0	0.0	0.0	3.1	134.2	5.5	0.0	0.0	0.5	0.1	0.0	0.0	19.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.9	0.8	0.4	0.8	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	2.1	0.7	0.5	0.5	0.1	0.2	6.5	11.3	5.1	7.8	7.7	8.1	10.4	4.9	31.5	4.3
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016020	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 68.1;breast: 210.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.3;SK-MEL-30: 6.9;T-47d: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6"	"Group enriched"	"Detected in many"	30	"granulocytes: 60.6;monocytes: 54.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	68.1	3.7	3.8	3.0	11.4	7.5	210.2	2.1	5.5	4.3	10.9	8.7	2.7	0.5	6.4	4.5	7.2	2.4	14.7	29.7	5.3	2.8	7.6	2.5	2.5	4.5	7.6	3.0	2.6	3.7	14.7	3.5	4.4	6.2	4.7	1.2	3.5	4.8	2.7	5.9	6.6	2.0	4.4	8.9	21.5	3.0	2.6	5.2	1.2	11.3	1.8	1.4	4.5	17.5	0.0	1.8	60.6	54.1	0.0	0.1	15.0	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.8	1.8	2.3	0.0	10.3	1.0	0.0	0.0	0.7	3.3	0.0	2.5	0.0	0.1	0.9	1.2	0.0	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	4.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	1.9	0.1	6.9	26.2	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	54.1	0.4	0.0	23.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	60.6	0.0	11.1	0.3	0.1	15.0	3.8	11.4	2.1	5.5	5.3	2.8	7.6	3.0	6.2	5.2
RBPMS	HERMES	ENSG00000157110	"RNA binding protein, mRNA processing factor"	Q93062	8	30384479-30572261	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.5;RPTEC TERT1: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056999	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA056999: "	"unprognostic (1.65e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.47e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.16e-3)"	71.3	20.4	2.3	28.4	6.9	0.2	112.8	1.4	2.9	81.7	66.1	4.4	46.3	6.9	90.8	31.8	66.2	35.7	50.4	53.8	2.8	2.7	69.1	34.5	36.7	19.3	5.4	3.4	65.5	15.0	12.2	10.4	29.2	9.3	77.3	13.7	41.2	22.9	59.8	14.5	11.8	22.3	181.8	10.3	28.9	38.1	27.4	2.9	4.8	54.1	8.5	10.9	155.4	88.9	0.5	3.9	0.3	0.2	0.7	0.3	0.0	0.1	11.1	12.6	0.1	71.5	21.5	31.5	15.8	21.7	19.5	16.2	16.2	6.6	0.1	8.5	20.2	6.3	14.4	11.4	23.6	0.0	3.0	0.3	5.2	16.6	30.8	0.1	2.5	24.8	2.9	18.7	2.5	11.2	0.1	0.0	9.5	6.8	0.0	0.2	32.4	7.3	0.7	3.5	0.9	49.4	18.8	0.2	2.5	1.6	11.8	7.8	2.5	0.0	10.3	9.7	0.9	16.6	2.6	0.0	0.0	0.0	15.9	0.0	4.3	0.0	0.1	0.0	0.2	0.2	0.3	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.3	0.7	0.0	3.9	0.1	0.0	2.3	6.9	1.4	2.9	2.8	2.7	5.4	3.4	9.3	2.9
RC3H1	"KIAA2025, RNF198, roquin, RP5-1198E17.5"	ENSG00000135870	"Ring finger and CCCH-type domains 1"	Q5TC82	1	173931214-174022297	"Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027428, HPA027434, HPA027448"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683"	"unprognostic (6.91e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.43e-3)"	"unprognostic (6.83e-3)"	10.4	7.8	11.8	8.0	10.3	32.6	10.6	26.7	14.0	9.9	10.3	12.3	8.3	6.9	10.9	8.4	11.8	9.4	8.1	9.0	11.9	7.4	8.1	11.2	11.3	8.8	10.4	7.1	10.8	9.8	10.2	14.6	9.1	12.4	8.7	8.6	13.3	9.0	7.6	19.1	14.0	10.6	8.4	9.3	13.6	9.1	9.7	9.0	15.2	9.9	7.7	13.6	8.4	9.8	2.8	1.6	10.4	3.9	2.3	2.7	1.1	7.3	10.2	5.7	8.8	10.8	8.4	7.8	5.0	7.1	5.8	5.1	9.3	8.2	10.4	9.0	8.1	7.1	8.5	7.0	8.2	7.2	2.1	9.0	7.6	7.8	6.6	11.6	10.5	8.0	5.5	8.4	5.7	8.9	10.2	6.4	7.0	5.5	7.0	10.6	9.7	1.1	7.7	10.2	7.6	10.3	14.2	6.8	6.1	9.5	12.2	4.8	8.2	11.8	12.8	7.6	7.6	6.4	6.4	8.0	8.0	13.4	5.1	5.3	7.5	4.5	3.2	4.0	2.0	3.2	2.1	2.1	1.9	2.3	1.6	2.8	2.7	2.3	10.4	2.3	3.9	1.3	1.5	1.1	11.8	10.3	26.7	14.0	11.9	7.4	10.4	7.1	12.4	9.0
RCAN1	DSCR1	ENSG00000159200	"Regulator of calcineurin 1"	P53805	21	34513142-34615142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 220.2"	"Group enriched"	"Detected in many"	4	"SK-MEL-30: 153.1;WM-115: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037218, HPA068436"	Enhanced		Approved	Cytosol				Cytosol		"CAB037218: AB_2179743, HPA068436: "	"unprognostic (3.83e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.27e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.60e-3)"	21.5	7.9	22.2	15.8	25.8	2.8	20.7	14.8	19.6	29.3	12.2	27.7	3.2	10.6	10.6	7.4	10.1	4.2	18.8	18.6	22.4	22.4	27.1	77.3	15.0	7.5	27.2	11.1	5.0	20.3	220.2	11.2	30.4	18.1	8.9	13.3	12.6	6.9	5.9	10.9	9.7	13.5	15.4	41.3	5.2	13.1	3.7	19.4	19.9	19.8	12.2	6.9	19.8	6.9	1.6	5.2	8.0	3.9	0.2	1.9	0.9	5.6	1.1	5.9	3.7	3.2	2.0	3.6	21.4	22.1	8.8	8.8	6.5	5.4	0.1	1.0	12.5	0.5	4.2	4.3	11.9	3.2	2.6	1.1	2.0	3.0	12.5	1.8	3.7	5.2	3.9	10.4	7.3	2.9	2.1	5.6	5.8	2.7	17.0	1.4	3.3	2.8	6.4	4.6	2.6	2.8	9.9	2.8	1.2	15.6	10.1	153.1	13.7	3.0	3.1	29.8	3.1	4.9	5.2	4.9	3.0	1.0	9.8	5.3	99.9	0.0	2.0	8.0	1.3	3.4	1.9	1.6	1.6	1.2	2.7	1.2	0.7	1.3	1.0	0.2	3.9	5.2	1.8	0.9	22.2	25.8	14.8	19.6	22.4	22.4	27.2	11.1	18.1	19.4
RCC1L	WBSCR16	ENSG00000274523	"RCC1 like"	Q96I51	7	75027122-75074228	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052184, HPA060643"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA052184: , HPA060643: "	"unprognostic (9.73e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (8.91e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-1)"	7.4	8.5	4.4	7.0	5.1	4.2	3.3	4.3	5.6	5.8	6.4	7.0	7.2	6.4	5.0	4.8	7.4	4.8	7.7	11.5	3.7		7.9	12.0	3.9	5.5	5.6	4.0	7.1	9.1	4.9	3.3	6.5	3.8	7.2	3.2	7.3	7.8	6.4	33.4	4.3	6.0	9.5	2.3	6.8	4.8	5.4	5.7	3.6	8.7	8.4	6.8	5.8	7.7	6.8	5.5	4.8	4.9	6.7	9.2	2.6	15.1	23.4	12.4	20.9	8.8	7.2	17.0	14.9	10.7	12.8	10.6	23.5	18.8	16.1	6.8	12.0	18.0	10.4	10.0	5.3	17.8	16.6	12.0	15.6	21.9	12.6	19.0	19.4	9.0	8.2	11.1	9.1	11.3	38.1	10.5	9.9	32.4	0.8	28.9	28.8	18.3	9.2	10.0	33.8	11.1	13.8	13.4	20.1	19.9	42.3	18.2	29.8	19.9	12.7	16.9	14.2	15.1	19.3	11.8	9.4	25.5	13.0	20.2	22.3	4.8	3.8	2.2	7.3	4.9	5.7	5.7	7.8	6.4	5.3	6.8	7.5	9.2	1.4	6.7	3.5	5.5	5.9	2.6										
RCCD1	MGC14386	ENSG00000166965	"RCC1 domain containing 1"	A6NED2	15	90954870-90963125	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039683, HPA040776"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039683: AB_10794752, HPA040776: AB_10795478"	"unprognostic (1.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.63e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	5.2	9.9	6.1	12.5	8.1	6.1	17.3	14.3	7.0	5.3	9.2	3.3	5.8	8.0	6.4	5.9	9.2	6.2	8.7	6.2	5.5	6.7	8.5	11.3	6.6	5.7	8.4	1.5	8.2	12.1	9.3	3.2	9.4	6.0	5.6	7.4	3.1	8.2	6.2	5.2	11.8	9.7	8.6	5.6	10.1	6.5	18.9	7.2	21.9	11.0	8.3	14.5	6.4	5.7	3.1	2.3	0.1	2.0	1.7	2.9	0.8	4.8	7.2	1.7	3.6	4.2	5.1	12.8	5.6	1.0	1.6	1.7	3.4	9.3	17.1	9.1	3.4	10.5	5.5	1.5	2.8	14.3	11.3	12.3	12.2	4.9	3.5	5.9	4.9	3.7	5.0	1.7	2.3	2.7	9.3	11.3	4.9	1.6	7.0	6.1	6.5	3.0	8.4	8.6	18.2	7.6	2.2	5.6	6.4	9.7	6.3	6.6	7.2	11.4	4.2	1.0	7.2	4.1	0.2	20.3	8.3	10.2	1.9	13.0	4.8	0.1	0.7	0.1	0.8	2.0	2.1	3.1	1.7	2.7	1.6	2.1	2.9	1.0	0.1	1.7	1.1	2.3	2.1	0.8	6.1	8.1	14.3	7.0	5.5	6.7	8.4	1.5	6.0	7.2
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favourable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favourable (7.89e-5)"	8.8	12.1	15.7	9.9	20.1	15.6	17.8	20.7	16.8	10.2	12.7	9.8	8.7	9.0	11.0	7.5	8.4	12.9	7.2	17.6	14.1	16.2	17.1	12.5	10.4	12.2	15.9	15.7	16.2	10.6	14.9	13.0	10.5	17.1	12.0	14.2	7.7	12.3	11.3	29.7	5.9	9.2	12.4	16.7	12.2	10.3	13.4	15.4	14.9	20.3	8.0	12.7	9.7	12.1	4.4	7.4	18.9	8.8	4.6	7.4	4.3	6.0	3.1	9.4	8.7	9.9	8.7	5.4	4.1	9.6	8.5	10.0	8.6	7.5	10.1	7.8	5.9	3.6	23.8	7.2	13.0	8.2	7.8	13.1	5.9	11.0	8.5	17.6	7.2	8.0	9.1	9.7	9.2	17.1	12.0	10.3	19.8	9.8	16.1	7.1	15.6	5.5	8.7	22.1	8.5	13.2	10.4	14.5	8.0	6.7	15.8	17.4	8.9	8.0	6.7	5.6	5.6	5.0	6.8	10.9	7.8	14.3	6.8	12.5	8.8	18.9	8.8	8.5	4.3	5.2	7.4	4.4	5.3	5.0	7.4	2.2	3.9	5.5	3.7	4.6	4.7	3.8	5.2	4.3	15.7	20.1	20.7	16.8	14.1	16.2	15.9	15.7	17.1	15.4
RCOR3	FLJ10876	ENSG00000117625	"REST corepressor 3"	Q9P2K3	1	211258377-211316385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007413, HPA007621, HPA071997"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.07e-2)"	"prognostic favourable (1.35e-5)"	"unprognostic (4.02e-3)"	"unprognostic (2.28e-2)"	"prognostic favourable (5.75e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-3)"	15.1	15.0	17.2	14.9	19.6	25.8	18.9	33.7	21.7	17.3	16.2	17.3	26.8	11.8	19.1	21.9	13.5	16.0	17.1	20.8	16.3	14.4	15.7	13.5	15.8	15.3	18.8	20.8	27.5	18.2	21.4	23.8	14.1	18.6	23.7	13.4	17.3	18.0	35.5	55.3	17.7	16.5	23.6	18.1	17.5	14.4	31.4	21.3	20.6	30.0	16.4	13.4	17.9	16.3	10.0	9.5	27.3	8.5	11.8	10.7	5.4	9.8	7.7	15.8	8.8	13.7	12.8	17.5	11.2	11.2	12.7	13.2	7.6	12.9	14.5	7.9	14.4	14.8	12.6	11.0	9.8	14.8	7.4	13.1	13.9	10.0	15.3	19.9	12.7	14.2	10.5	13.7	17.0	7.8	13.6	18.1	18.3	6.5	10.2	11.5	17.3	9.5	11.2	30.5	16.5	10.5	17.0	10.1	22.0	28.7	15.0	20.9	18.7	14.3	10.7	11.3	12.8	14.5	12.5	16.0	10.5	18.1	9.4	11.9	9.9	15.3	8.1	27.3	6.0	7.5	7.9	10.0	6.5	6.2	8.5	8.0	10.7	7.6	13.7	11.8	8.5	9.5	7.6	5.4	17.2	19.6	33.7	21.7	16.3	14.4	18.8	20.8	18.6	21.3
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"			"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favourable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.4	6.8	4.0	6.0	6.6	5.5	4.2	8.7	9.4	7.5	8.3	3.5	9.0	5.1	5.0	5.0	17.6	4.2	7.1	11.4	3.0	5.4	8.8	7.5	5.6	5.1	4.7	5.2	3.8	10.7	8.8	6.1	34.0	10.0	5.7	4.0	6.4	11.6	13.1	9.4	18.0	6.9	5.2	2.2	6.8	9.5	4.4	3.0	2.1	7.2	8.6	8.9	8.5	10.2	7.4	6.0	5.4	6.7	6.1	8.5	3.5	3.1	3.6	0.6	1.9	0.4	0.4	5.8	2.9	0.3	2.1	1.5	5.4	3.6	1.8	2.4	0.7	3.2	3.8	2.3	0.2	1.6	10.2	2.0	4.7	3.8	0.9	4.8	1.4	1.3	0.9	1.9	1.4	2.8	4.0	1.0	0.7	5.2	0.8	3.2	0.8	4.7	2.5	1.0	10.1	1.3	5.5	2.2	2.7	2.8	8.0	3.6	3.9	4.7	2.9	0.3	1.1	0.2	3.9	2.0	3.6	2.2	1.5	3.4	2.0	4.1	4.1	5.4	8.5	6.7	7.7	6.1	7.0	7.7	4.5	7.4	8.4	6.8	2.6	6.1	5.9	6.0	5.7	3.5	4.0	6.6	8.7	9.4	3.0	5.4	4.7	5.2	10.0	3.0
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560680	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056686	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA056686: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	13.8	16.2	10.7	8.7	14.3	5.1	14.0	14.2	15.4	11.3	14.1	11.0	9.6	12.7	16.2	14.3	16.0	12.7	11.0	29.0	12.2	10.4	23.0	22.1	12.5	14.6	11.7	9.0	11.7	21.0	23.5	13.5	14.2	13.2	20.7	12.0	10.6	13.8	13.1	27.8	9.9	16.3	22.9	10.3	15.4	15.9	11.1	8.8	17.4	18.1	13.6	10.7	18.1	17.9	9.9	7.6	7.2	2.0	3.7	7.6	1.6	18.3	5.8	4.9	4.0	14.8	15.8	16.6	11.2	11.6	10.2	10.2	4.5	9.6	18.1	6.7	6.7	10.0	7.1	13.1	11.9	10.0	19.5	7.1	6.4	13.6	12.7	8.6	9.6	12.0	13.4	9.8	15.5	9.3	12.6	6.2	16.6	5.9	7.4	15.1	13.3	16.6	10.8	13.4	7.8	19.9	12.0	7.6	13.2	6.1	13.5	15.9	6.7	4.9	9.4	14.5	8.9	11.4	13.3	17.6	14.5	13.4	10.3	5.9	11.3	1.7	1.8	7.2	4.4	2.0	7.6	7.4	5.1	6.3	2.3	9.9	7.3	6.0	0.8	3.7	1.9	7.6	5.8	1.6	10.7	14.3	14.2	15.4	12.2	10.4	11.7	9.0	13.2	8.8
RDM1	"MGC33977, RAD52B"	ENSG00000278023	"RAD52 motif containing 1"	Q8NG50	17	35918066-35930773	"Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.7;lymphoid tissue: 6.2;testis: 24.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.6;T-47d: 17.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 5.7"	"Group enriched"	"Detected in many"	14	"NK-cells: 1.5;T-cells: 5.7"	"Low region specificity"	"Detected in all"							"HPA024794, HPA067546"	Enhanced		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA024794: AB_1856039, HPA067546: "	"unprognostic (9.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-8)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.53e-1)"	0.0	0.0	0.9	0.9	1.2	0.6	0.0	0.0	1.8	0.0	0.9	0.1	0.0	1.3	0.2	0.7	0.3	0.1	0.3	0.0	1.0		0.1	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	0.2	1.7	0.0	0.0	0.0	0.0	1.1	1.5	0.1	0.2	0.1	1.1	24.0	0.0	6.2	0.3	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	1.5	5.7	0.3	6.0	7.1	1.3	2.5	0.1	0.0	2.1	1.4	0.1	0.8	1.3	10.6	6.0	6.6	2.9	0.4	0.9	4.1	1.7	4.1	1.5	8.3	4.2	1.8	0.0	0.0	0.2	3.0	0.0	0.8	0.5	0.4	0.1	1.8	0.0	0.6	2.4	2.3	2.3	0.9	2.6	0.8	0.0	0.0	1.6	3.4	4.8	0.8	1.9	1.8	2.6	17.4	0.4	0.0	0.1	2.1	0.0	0.4	5.5	2.0	2.3	3.4	2.4	1.1	0.0	0.0	0.0	1.4	0.0	2.3	0.1	1.6	5.7	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	1.5	0.3										
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favourable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.4	12.9	12.6	11.7	16.0	10.0	9.8	11.4	17.7	9.4	10.6	24.4	17.4	22.9	10.5	13.2	20.4	11.8	12.4	6.7	12.9	8.6	14.9	15.8	8.4	16.8	14.5	11.0	14.3	10.8	17.6	21.9	32.3	14.3	12.2	9.8	13.2	15.6	14.0	6.8	21.1	23.2	9.6	13.2	16.6	23.8	21.0	17.0	12.1	21.4	6.2	16.0	12.1	12.8	5.2	16.4	6.0	3.9	3.8	4.2	3.2	11.0	20.5	8.3	11.7	11.6	7.8	19.1	8.2	6.9	10.7	9.5	9.0	11.8	13.1	8.9	7.2	10.5	8.6	9.8	10.2	7.0	16.1	23.9	24.8	13.0	11.6	7.7	11.9	11.0	12.1	10.6	12.8	13.9	12.0	11.7	7.9	9.8	15.8	10.5	5.4	15.9	12.8	19.4	13.2	9.0	13.2	10.0	9.7	8.9	16.1	11.0	28.9	6.2	7.0	13.8	15.9	7.5	8.4	16.7	9.5	12.6	11.3	7.7	9.9	6.0	3.1	4.4	4.2	3.9	2.7	3.6	2.7	3.1	3.8	5.2	4.1	2.9	2.1	3.8	1.9	16.4	2.2	3.2	12.6	16.0	11.4	17.7	12.9	8.6	14.5	11.0	14.3	17.0
REEP4	"C8orf20, FLJ22246, FLJ22277, PP432, Yip2c"	ENSG00000168476	"Receptor accessory protein 4"	Q9H6H4	8	22138020-22141951	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042683	Approved		Approved	Cytosol				Cytosol		"HPA042683: AB_2571730"	"unprognostic (2.38e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavourable (4.14e-5)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.88e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.65e-2)"	6.3	4.3	3.9	9.2	6.2	18.1	22.9	2.3	4.3	12.8	11.9	6.9	4.0	8.4	5.6	5.4	39.8	5.5	11.1	4.5	3.4	2.9	5.2	6.4	18.0	16.5	7.2	2.5	4.9	11.0	3.2	5.6	35.8	5.7	9.2	8.8	4.5	11.0	6.0	3.0	43.1	8.6	5.2	7.5	19.9	12.3	19.1	6.8	14.5	10.8	20.4	24.9	12.4	20.8	4.4	17.7	25.9	23.6	9.8	10.9	10.2	12.2	25.4	8.2	12.9	3.5	3.6	14.5	11.0	6.2	14.4	13.2	14.6	12.4	14.9	14.4	6.0	31.5	9.8	18.9	7.4	8.3	11.2	16.0	13.4	14.9	3.9	7.3	24.7	3.3	36.6	10.9	9.3	8.7	12.5	52.1	7.4	18.7	18.9	26.5	11.9	15.9	10.7	6.8	30.5	6.5	13.2	6.6	12.1	8.9	10.4	15.8	20.6	11.2	9.0	9.5	15.6	21.3	15.4	11.9	9.0	9.8	10.8	16.6	18.9	17.7	23.6	25.9	10.9	23.0	8.5	4.4	9.6	9.1	17.7	2.2	4.5	5.9	6.8	9.8	15.3	6.9	6.1	10.2	3.9	6.2	2.3	4.3	3.4	2.9	7.2	2.5	5.7	6.8
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"intestine: 354.2;pancreas: 502.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.2;EFO-21: 11.5;HDLM-2: 10.6;NB-4: 11.9;RPMI-8226: 15.3;SH-SY5Y: 10.0;U-2 OS: 19.0;U-266/84: 10.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"		22000000	Cytosol		"HPA047894: , HPA048334: , HPA060705: "			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				0.2	0.4	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0.0	1.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	15.3	0.0	0.0	1.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	3.7	7.1	0.0	10.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
REG3G	"LPPM429, PAP1B, UNQ429"	ENSG00000143954	"Regenerating family member 3 gamma"	Q6UW15	2	79025686-79028505	"Predicted secreted proteins"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 262.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.0;SK-MEL-30: 3.1;U-2 OS: 1.6;U-266/84: 1.3"	"Cancer enriched"	"Detected in many"	13	"pancreatic cancer: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Uncertain		Approved	Cytosol	"Secreted to digestive system"			Cytosol		"HPA047894: , HPA048334: , HPA060705: "									"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"		"unprognostic (8.82e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.64e-2)"			0.1	3.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.8	0.6	0.1	61.1	0.1	0.0	0.1	0.1	0.1	0.0	7.1	0.1	0.1	0.1	0.1	0.1	0.1	262.6	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	2.8	0.3	0.1	0.1	0.0	19.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	1.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
RELA	"NFKB3, p65"	ENSG00000173039	"RELA proto-oncogene, NF-kB subunit"	Q04206	11	65653596-65663094	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004264, CAB005030, HPA063461"	Supported		Enhanced	Cytosol				Cytosol		"CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: "	"unprognostic (9.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (9.18e-4)"	"unprognostic (1.30e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (5.66e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.53e-1)"	36.2	23.1	21.4	27.6	32.0	50.2	37.8	21.5	28.2	35.6	32.3	22.9	23.6	23.6	36.9	26.8	36.4	32.8	33.6	28.9	21.1	12.9	28.4	38.5	37.7	30.8	35.6	13.3	51.9	29.0	27.3	19.3	27.1	22.6	31.1	19.7	23.9	32.8	39.2	46.5	35.2	26.7	33.5	29.5	38.1	31.8	20.6	30.1	34.3	26.3	30.6	36.4	54.7	38.8	15.2	13.2	18.3	14.4	21.3	23.3	12.4	26.1	26.9	12.0	16.7	19.2	18.7	12.2	20.1	24.4	23.2	18.8	12.2	26.6	19.8	33.8	28.2	23.4	13.8	24.4	16.4	23.3	19.9	21.8	20.1	17.7	21.2	16.1	30.9	21.5	24.1	25.8	30.6	28.1	21.8	23.1	18.6	34.9	29.2	13.6	7.8	23.7	24.4	11.8	29.6	19.4	23.7	9.9	22.8	17.2	27.0	26.8	31.4	10.6	38.3	25.1	21.5	38.3	19.1	35.0	32.2	21.1	28.4	11.1	23.9	10.5	11.3	15.1	20.5	14.4	23.3	15.2	18.2	20.4	13.2	13.7	17.3	18.2	18.3	21.3	12.5	13.1	17.8	12.4	21.4	32.0	21.5	28.2	21.1	12.9	35.6	13.3	22.6	30.1
RELB	REL-B	ENSG00000104856	"RELB proto-oncogene, NF-kB subunit"	Q01201	19	45001430-45038198	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.0;HDLM-2: 31.8;U-698: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007753, HPA040506"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB007753: AB_562340, HPA040506: "	"prognostic favourable (1.55e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.02e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavourable (2.99e-6)"	"unprognostic (2.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.20e-2)"	8.0	6.8	2.2	27.6	3.6	27.8	6.8	1.2	3.1	4.9	12.2	2.1	1.6	8.8	8.5	4.7	6.4	5.2	10.9	11.9	1.8	1.6	10.1	7.4	12.8	18.2	3.6	0.9	7.8	12.3	1.9	2.1	4.7	2.8	9.9	3.4	3.6	7.3	4.8	8.1	8.3	13.0	8.4	3.9	17.2	8.3	3.7	1.7	17.7	5.6	7.2	24.8	8.8	6.1	8.2	3.9	14.5	5.0	2.1	2.2	1.7	8.7	5.3	0.5	2.3	1.1	3.9	1.8	1.6	11.4	2.5	4.0	1.8	9.7	25.0	4.6	2.6	4.0	0.2	3.6	2.1	31.8	0.8	0.9	0.3	1.0	10.2	1.9	14.9	6.4	1.5	5.1	6.0	1.6	0.2	16.3	0.9	2.1	0.4	5.9	0.8	0.9	1.9	1.3	3.0	4.1	13.6	0.0	0.8	1.6	4.7	4.5	1.6	4.8	5.1	6.0	3.0	2.2	5.8	20.6	12.1	26.8	6.6	0.7	3.3	0.0	5.0	2.1	1.4	3.2	2.1	8.2	2.2	2.0	3.6	7.9	1.8	0.9	14.5	2.1	2.6	3.9	1.1	1.7	2.2	3.6	1.2	3.1	1.8	1.6	3.6	0.9	2.8	1.7
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: "	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	9.5	9.4	18.9	11.5	22.0	15.5	18.4	25.9	25.5	12.9	12.9	14.8	15.3	11.7	17.5	32.5	20.9	14.6	14.0	17.7	17.7	17.6	12.1	23.1	11.5	13.3	15.1	19.4	17.0	13.9	32.8	28.3	14.0	20.0	13.6	13.7	13.6	21.6	13.4	12.1	22.6	12.2	16.3	10.8	15.8	12.4	27.7	11.7	30.7	13.9	13.5	18.4	14.7	14.3	4.6	6.2	8.0	7.5	5.2	6.9	2.0	12.7	10.1	19.4	24.1	10.9	19.6	21.2	12.5	13.8	14.7	17.7	24.0	11.2	15.5	10.6	17.3	15.1	22.0	18.8	19.5	16.4	18.9	13.0	6.1	14.5	16.6	41.1	21.1	15.9	15.5	26.8	32.6	15.1	17.3	16.0	18.7	21.6	23.2	22.5	18.4	9.6	27.3	11.9	8.8	12.1	19.4	17.3	17.1	11.5	17.6	16.4	8.4	28.4	14.7	8.2	13.7	22.2	17.1	15.8	14.3	21.7	9.7	17.0	11.9	8.0	2.3	3.2	4.2	6.5	6.9	4.6	5.4	5.8	3.4	3.4	5.5	6.5	1.5	5.2	7.5	6.2	5.4	2.0	18.9	22.0	25.9	25.5	17.7	17.6	15.1	19.4	20.0	11.7
REST	"NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966678	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB068222: , HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	14.4	11.4	6.0	15.6	8.9	21.5	39.7	2.1	6.3	13.7	11.0	5.6	13.0	6.5	14.2	13.7	14.5	11.2	13.8	22.1	6.1	4.5	13.9	12.0	18.2	35.6	8.2	3.0	13.9	15.9	22.4	4.5	14.4	11.8	17.3	7.6	7.2	14.0	27.6	13.8	11.6	12.0	16.3	15.2	18.7	10.4	15.3	8.2	43.4	13.4	8.3	14.0	15.6	19.5	16.7	10.7	9.0	8.4	16.7	15.3	4.2	7.0	9.0	12.5	12.4	9.4	11.9	15.8	10.5	9.4	11.3	10.3	8.9	10.9	16.9	16.9	11.4	6.5	9.2	11.1	17.8	8.9	5.5	15.4	7.1	7.9	11.5	19.4	9.2	11.7	10.0	10.8	11.2	13.9	9.8	18.2	13.0	11.2	22.3	13.2	10.6	5.9	19.8	10.7	5.2	12.8	12.8	0.2	5.7	12.7	12.4	9.4	13.2	12.7	19.6	14.4	12.8	8.0	9.4	7.3	5.4	10.2	9.2	11.0	7.4	9.0	3.6	7.7	10.6	5.3	8.9	12.0	10.5	10.4	8.1	16.7	15.3	9.3	3.7	16.7	8.4	10.7	10.3	4.2	6.0	8.9	2.1	6.3	6.1	4.5	8.2	3.0	11.8	8.2
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077027-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 63.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 17.6;NB-4: 11.6;SH-SY5Y: 89.7;THP-1: 26.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;monocytes: 6.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"midbrain: 95.5"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"			260000	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9.0	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1.0	1.2	1.5	5.8	1.0	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2.0	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2.0	0.0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0.0	6.7	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	11.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	89.7	0.0	0.0	0.0	1.2	26.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9.0	1.5	5.8	17.5	1.2	16.8	0.0
RETREG2	"C2orf17, FAM134A, MAG-2, MGC3035"	ENSG00000144567	"Reticulophagy regulator family member 2"	Q8NC44	2	219176225-219185479	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011170, HPA011844"	Approved		Approved	Cytosol				Cytosol		"HPA011170: AB_1845713, HPA011844: "	"unprognostic (2.63e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (7.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (8.74e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.45e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.70e-2)"	14.8	22.4	27.8	14.8	34.2	23.8	22.3	38.5	56.9	20.9	20.0	24.1	20.0	18.6	19.9	28.8	18.7	23.8	18.9	10.8	28.2	28.7	31.2	24.0	17.4	18.1	26.6	35.7	32.7	29.5	38.0	20.2	16.6	26.7	18.4	23.5	20.0	20.7	19.1	10.6	19.5	18.1	20.7	21.5	17.4	17.6	61.4	16.5	15.1	28.0	12.8	19.7	18.6	24.7	6.8	5.8	21.1	7.3	4.2	8.7	2.9	12.9	13.8	11.9	18.0	45.2	19.2	12.7	15.9	27.4	19.4	16.9	13.8	22.3	10.6	16.0	29.9	16.7	14.3	14.2	21.4	14.8	12.0	14.1	19.2	22.7	26.0	15.2	19.5	20.8	37.2	21.7	21.0	17.4	9.7	24.4	26.7	19.0	9.1	16.5	8.7	16.1	11.7	13.2	8.5	16.0	15.3	17.1	17.6	10.2	19.7	37.5	16.4	17.0	13.7	21.7	11.7	30.7	11.8	24.8	14.1	11.9	22.8	15.2	12.0	8.5	5.7	5.3	8.5	7.3	7.8	6.8	7.0	8.7	3.8	5.8	6.4	8.1	21.1	4.2	6.6	5.8	8.1	2.9	27.8	34.2	38.5	56.9	28.2	28.7	26.6	35.7	26.7	16.5
RETREG3	"DKFZp686B1036, FAM134C, FLJ33806"	ENSG00000141699	"Reticulophagy regulator family member 3"	Q86VR2	17	42579513-42610623	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016492	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA016492: AB_1853027"	"unprognostic (6.79e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.78e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (5.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (6.82e-4)"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.43e-2)"	23.2	17.4	11.9	15.8	15.6	5.8	16.3	23.1	21.9	17.0	18.8	13.2	15.5	13.1	25.4	20.9	21.6	15.0	20.8	10.0	11.2	12.3	16.0	28.7	16.2	19.0	11.3	9.8	17.4	43.2	19.6	16.5	29.4	13.7	19.4	16.1	32.5	24.6	14.1	18.5	31.1	17.5	15.7	7.8	24.0	17.1	27.2	8.5	29.9	17.8	16.7	26.3	14.8	17.1	14.1	7.8	22.6	11.4	13.7	27.8	16.6	6.4	20.2	8.9	14.4	22.9	12.7	12.7	9.3	12.7	11.1	13.1	9.5	14.1	14.3	13.1	15.1	25.5	11.4	14.0	10.8	15.3	10.9	5.8	12.3	16.9	15.7	9.9	15.0	19.4	19.2	12.1	12.4	11.9	11.8	14.3	8.7	11.2	14.5	14.5	5.6	5.0	7.9	13.8	14.6	12.7	21.0	16.0	11.0	10.0	8.2	14.1	23.2	7.8	14.9	12.1	7.4	11.9	8.8	24.6	29.2	12.7	11.0	6.4	9.1	22.6	8.0	17.7	24.2	10.0	21.2	13.0	20.0	23.0	7.8	14.1	19.8	22.2	7.2	13.7	11.4	7.7	27.8	16.6	11.9	15.6	23.1	21.9	11.2	12.3	11.3	9.8	13.7	8.5
REV1	REV1L	ENSG00000135945	"REV1, DNA directed polymerase"	Q9UBZ9	2	99400475-99490035	"Predicted intracellular proteins"	"DNA damage, DNA repair, DNA synthesis"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044534, HPA051036"	Uncertain		Approved	Cytosol				Cytosol		"HPA044534: , HPA051036: "	"unprognostic (3.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-3)"	12.0	15.5	11.0	15.8	16.9	7.8	14.5	32.5	15.6	14.1	10.4	12.2	13.4	7.6	18.3	23.1	13.7	14.8	10.3	14.4	10.1	9.1	11.3	12.4	14.1	12.2	10.5	11.3	16.5	11.1	13.7	16.7	9.1	10.8	14.9	12.1	14.1	12.1	16.2	17.8	12.9	14.3	15.4	10.5	11.2	10.1	11.8	11.1	10.1	13.3	12.8	15.7	16.0	18.2	1.6	1.1	0.4	0.6	1.3	3.3	0.6	6.9	1.8	11.2	4.3	8.8	8.8	12.2	7.9	9.7	9.1	10.4	4.0	6.7	14.2	6.4	8.1	9.8	8.3	10.3	14.1	6.5	6.8	7.4	6.4	9.1	9.9	9.2	15.2	8.4	12.5	8.1	11.9	11.5	8.4	4.8	9.9	4.5	9.6	16.7	8.2	5.9	15.3	8.6	6.1	11.1	11.8	7.4	7.9	7.1	5.8	10.0	5.9	13.3	8.7	10.8	9.1	4.5	5.0	6.6	6.7	11.5	4.4	11.8	8.2	0.0	0.6	0.2	1.3	0.6	0.8	0.4	1.8	1.6	1.1	1.6	3.3	2.8	0.4	1.3	0.5	0.6	1.1	0.6	11.0	16.9	32.5	15.6	10.1	9.1	10.5	11.3	10.8	11.1
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 48.4;bone marrow: 40.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.4;HMC-1: 66.0;NB-4: 21.1;U-937: 18.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 48.4"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: , HPA060388: "	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	6.8	1.6	1.9	4.1	2.3	40.9	5.6	1.1	1.5	2.6	4.9			1.8	4.2	2.2	1.1	2.1	2.7	3.7	2.1	1.5	2.7	1.7	5.2	2.9	1.8		1.8	1.0	0.8	1.3	6.3		3.6	1.1		1.2	1.7	2.8	1.9	3.2	3.6	2.3	4.1	3.2	0.9			3.0		2.7	4.5	1.4	0.0	2.5	48.4	2.1	0.5	3.0	1.0	8.6	2.3	1.1	5.5	3.9	2.8	6.1	14.1	6.2	4.7	2.3	0.1	0.3	0.0	0.3	27.4	0.8	3.2	0.3	4.3	0.0	1.9	0.3	0.4	0.6	5.7	3.2	66.0	1.5	0.1	1.4	0.5	4.7	1.3	0.1	5.2	0.1	0.1	21.1	2.5	0.0	0.9	2.5	0.0	0.8	0.0	0.1	12.9	5.7	0.0	5.0	0.1	9.9	0.9	3.7	3.3	2.2	0.0	2.1	2.1	0.0	0.0	18.3	5.7	48.4	2.1	21.6	1.8	1.4	1.8	0.0	1.8	1.5	0.6	0.0	3.0	2.7	10.2	0.5	1.8	2.5	1.1	1.0										
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8"	"Cell line enriched"	"Detected in some"	17	"U-2 OS: 43.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"classical monocyte: 12.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 12.7"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA046368: "							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0	0.0	5.2	0.0	0.1	0.2	0.0	0.0	0.0	0.4	7.1	0.0	0.8	0.0		0.1	0.4	0.0	0.1	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.4	3.8			0.0		0.1	0.0	0.0	0.0	3.8	1.7	12.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	43.7	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	12.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	1.7	0.0	0.8	0.0	0.0	2.8										
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769141-55773179	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5"	"Cell line enriched"	"Detected in some"	24	"U-2 OS: 24.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.5;monocytes: 5.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA046368: "															"unprognostic (8.87e-2)"			0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1			0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.0	0.0	0.3	3.0	0.0	0.4	0.0		0.6	0.7	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.3	0.0	0.1	2.3	0.2	1.5			0.3		0.0	0.3	0.0	0.0	2.5	0.4	5.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.2										
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621394-74666881	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA048258: , HPA075649: "	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	7.3	5.2	4.2	12.2	6.1	33.9	7.8	7.8	5.6	7.4	6.7	8.4	8.4	5.5	9.7	10.0	12.8	6.3	5.5	5.4	3.9	3.7	6.5	5.6	6.5	12.0	6.1	4.8	7.7	9.6	8.5	7.5	11.5	5.3	6.5	8.1	7.2	8.0	8.4	4.5	11.6	7.8	5.6	4.8	9.7	6.2	35.1	7.2	40.5	7.0	7.5	18.0	7.2	8.6	9.3	7.1	13.8	10.9	9.1	11.7	6.5	13.9	17.9	13.5	9.8	2.8	3.9	15.3	12.6	9.7	20.2	17.6	23.3	14.7	19.5	10.3	9.8	16.8	22.1	13.1	24.8	6.1	13.2	17.2	14.6	13.1	2.5	17.3	18.0	2.8	4.2	25.4	15.7	8.5	26.0	8.8	15.1	22.2	25.2	15.9	26.6	8.7	39.3	9.2	17.2	7.2	14.8	10.1	10.7	20.3	7.2	9.0	13.2	14.8	8.3	14.8	14.2	8.3	15.8	11.9	22.1	58.4	10.6	13.4	17.9	13.8	6.8	9.9	9.3	6.3	10.2	7.8	7.7	8.6	7.1	9.3	11.7	8.1	7.7	9.1	10.9	5.5	10.9	6.5	4.2	6.1	7.8	5.6	3.9	3.7	6.1	4.8	5.3	7.2
RFX2	FLJ14226	ENSG00000087903	"Regulatory factor X2"	P48378	19	5993164-6199572	"Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 51.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.0;SCLC-21H: 19.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"neutrophil: 18.3"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048969	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA048969: AB_2680577"	"unprognostic (1.31e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (6.72e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.84e-2)"	"prognostic favourable (7.36e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.07e-1)"	6.7	2.0	8.4	5.3	9.4	8.6	6.4	8.3	7.0	6.9	11.3	7.2	0.7	4.1	15.7	7.0	9.0	22.0	6.4	5.4	9.5	3.6	1.9	2.5	10.0	2.1	4.4	4.0	7.2	5.3	2.9	12.9	2.2	9.9	4.1	2.6	3.1	2.4	3.3	2.5	6.6	5.7	14.8	9.0	2.1	5.9	51.5	7.5	4.1	3.0	12.1	3.1	8.7	5.3	0.3	1.6	18.3	2.0	0.5	0.5	0.6	3.9	3.2	5.2	10.2	2.7	1.6	3.1	2.5	3.6	2.2	3.5	1.4	5.0	4.5	2.8	3.3	6.2	1.3	5.1	3.0	1.1	0.7	7.1	3.2	1.4	3.1	3.1	16.0	1.8	4.5	4.8	2.5	3.3	4.5	0.2	2.1	2.0	6.1	4.2	1.4	2.0	1.6	3.1	0.5	2.8	7.8	19.8	2.5	2.5	1.9	1.3	3.3	3.4	4.7	0.9	4.6	3.6	2.5	6.6	2.1	2.5	2.7	11.5	1.9	0.0	2.0	0.8	0.1	0.4	0.0	0.3	0.4	0.3	1.6	0.1	0.4	0.5	18.3	0.5	1.1	0.0	0.0	0.6	8.4	9.4	8.3	7.0	9.5	3.6	4.4	4.0	9.9	7.5
RGL3	FLJ32585	ENSG00000205517	"Ral guanine nucleotide dissociation stimulator like 3"	Q3MIN7	19	11384341-11419342	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.1;thyroid gland: 38.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.5;CACO-2: 8.2;RT4: 17.0;SK-BR-3: 7.6;T-47d: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Region enriched"	"Detected in single"	6	"cerebellum: 10.1"					"HPA042763, HPA043615, HPA064578"	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: "	"prognostic favourable (7.35e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.19e-3)"	"unprognostic (5.99e-2)"	"prognostic favourable (6.61e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.12e-3)"	4.3	6.2	5.3	1.2	7.9	0.7	4.3	1.9	6.8	7.6	1.9	3.4	23.3	1.8	4.9	14.5	1.1	5.3	6.5	5.2	8.2	1.3	20.7	6.0	7.5	1.2	6.7	3.0	1.6	12.1	65.1	9.1	5.8	7.9	4.1	1.8	7.3	3.5	23.9	5.0	1.1	1.2	1.4	9.5	5.1	6.8	1.1	7.3	0.0	38.2	0.4	0.9	4.5	4.5	0.3	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.1	14.5	0.9	1.1	0.5	1.6	8.2	5.9	0.0	5.2	1.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	3.0	2.5	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.6	1.6	5.0	17.0	0.8	4.3	0.2	7.6	2.5	12.5	0.0	0.0	2.6	0.0	2.0	0.6	0.0	0.4	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	5.3	7.9	1.9	6.8	8.2	1.3	6.7	3.0	7.9	7.3
RGMA	"RGM, RGMa"	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0;skeletal muscle: 85.5"	"Cell line enhanced"	"Detected in some"		"AF22: 30.4;BEWO: 8.9;MOLT-4: 9.0;NTERA-2: 13.6"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"		1400000	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: , HPA044222: "	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favourable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	12.2	3.3	17.4	17.6	24.7	1.8	9.3	11.0	59.0	21.0	22.2	22.2	0.9	9.1	21.8	9.4	23.1	12.1	9.5	7.7	19.3	16.2	2.3	1.6	2.8	3.1	23.0	12.8	16.6	9.1	1.9	2.1	2.5	30.9	5.5	6.5	2.3	16.2	7.0	85.5	4.9	12.3	46.9	36.8	2.2	26.6	15.8	23.1	0.2	2.9	12.2	5.6	4.1	8.8	1.3	0.7	1.7	1.0	0.7	0.5	0.2	1.2	0.2	30.4	0.5	6.4	3.6	8.9	0.2	0.0	0.0	0.0	0.3	0.4	0.1	0.1	0.2	2.0	5.0	0.1	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.1	3.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	9.0	0.1	13.6	0.0	7.9	7.0	0.0	0.0	0.3	3.2	1.8	0.3	0.1	0.0	2.4	1.6	0.0	0.0	6.6	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.8	1.4	0.7	0.6	0.4	1.0	0.3	0.6	0.5	0.5	0.1	1.3	0.4	0.5	1.7	0.7	0.4	0.7	0.3	0.2	17.4	24.7	11.0	21.3	19.3	16.2	23.0	12.8	30.9	23.1
RGP1	KIAA0258	ENSG00000107185	"RGP1 homolog, RAB6A GEF complex partner 1"	Q92546	9	35749287-35758575	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020414, HPA021085"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA020414: AB_1852289, HPA021085: AB_1852291"	"unprognostic (2.10e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (2.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.81e-3)"	"unprognostic (9.77e-2)"	"prognostic favourable (8.55e-13)"	"unprognostic (2.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.18e-1)"	13.4	18.2	12.0	11.4	16.8	7.1	12.3	13.7	24.8	12.2	17.7	18.3	23.8	14.9	15.3	12.5	14.0	12.3	12.1	17.6	11.6	11.2	16.7	14.2	13.2	9.8	10.7	14.8	15.0	17.6	32.6	18.3	14.1	13.0	12.9	19.1	15.4	18.3	22.5	25.8	13.1	17.2	14.1	10.6	12.8	16.5	13.2	13.7	11.2	17.3	11.9	13.0	13.5	10.6	4.0	2.1	3.4	1.9	3.7	3.7	0.9	11.7	11.0	12.9	10.7	12.1	13.1	7.6	9.3	13.5	12.9	12.1	9.4	4.5	9.1	6.7	11.8	6.7	12.3	17.5	10.7	12.1	7.3	7.8	21.1	7.0	11.4	8.4	11.1	13.1	22.5	13.6	16.6	15.3	5.3	5.1	11.7	5.5	2.6	3.0	5.4	13.0	8.6	9.2	6.4	11.3	8.2	9.5	10.2	8.2	11.6	7.5	9.6	4.0	19.3	10.4	13.2	7.1	7.7	7.6	10.5	9.7	14.8	3.6	13.3	3.4	0.9	1.4	2.6	1.5	3.7	2.8	1.9	3.0	0.6	4.0	2.3	2.4	2.3	3.7	1.9	2.1	1.6	0.9	12.0	16.8	13.7	24.8	11.6	11.2	10.7	14.8	13.0	13.7
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: , HPA067421: "	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favourable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	4.7	4.4	20.7	4.1	22.0	2.3	4.4	10.2	37.2	5.4	2.9	10.2	1.5	5.3	6.4	5.6	13.5	7.5	4.4	4.7	13.4	5.6	4.4	6.7	6.5	3.4	12.3	16.3	8.9	3.1	3.1	6.1	4.1	9.4	6.8	2.2	3.1	6.5	5.7	6.8	20.6	4.6	3.0	18.9	4.1	3.2	5.5	9.9	4.3	3.8	3.4	3.6	5.5	7.9	1.0	1.5	1.6	3.9	0.4	1.3	0.7	3.9	5.0	10.1	7.3	3.4	2.7	4.2	4.3	3.4	4.4	3.3	4.0	2.4	0.9	2.7	3.7	3.9	2.0	13.6	1.4	0.1	1.6	0.4	2.8	9.8	3.1	0.3	5.6	2.3	9.3	2.3	3.1	9.7	4.6	0.2	4.0	3.4	0.7	10.6	4.8	4.8	10.0	3.9	3.2	2.3	11.8	11.4	11.8	2.7	1.9	9.0	4.6	6.7	7.3	8.6	5.6	1.7	4.5	5.0	3.9	2.2	5.1	5.9	6.1	1.0	1.2	0.3	0.9	3.9	0.3	0.2	0.8	0.5	1.5	1.0	1.3	0.5	1.6	0.4	3.7	0.8	0.6	0.7	20.7	22.0	10.2	37.2	13.4	5.6	12.3	16.3	9.4	9.9
RGS16	"A28-RGS14, RGS-r"	ENSG00000143333	"Regulator of G protein signaling 16"	O15492	1	182598623-182604408	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"thyroid gland: 67.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 31.3;NB-4: 17.2;SCLC-21H: 32.7;U-266/70: 37.0;U-698: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 87.4"	"Group enriched"	"Detected in many"	6	"midbrain: 92.1;pons and medulla: 72.2;thalamus: 126.3"	"HPA053250, HPA055824"	Uncertain		Approved	Cytosol				Cytosol		"HPA053250: , HPA055824: "	"unprognostic (4.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.07e-3)"	"unprognostic (5.39e-2)"	17.8	7.5	4.5	18.6	9.8	3.0	5.2	3.3	9.9	2.4	6.4	20.7	7.2	2.3	2.6	3.7	4.5	8.0	10.8	3.6	7.4	12.3	6.7	6.8	13.3	10.8	12.0	1.3	2.9	4.3	6.0	28.1	7.9	16.5	3.7	4.1	9.1	3.3	40.8	5.2	3.0	3.5	8.0	25.0	6.1	5.1	1.2	10.7	0.3	67.5	16.2	4.9	6.1	4.2	5.8	11.5	2.2	0.9	3.4	5.4	1.4	0.2	0.0	1.9	0.0	0.3	0.0	14.5	0.0	0.5	0.0	0.0	0.0	0.1	31.3	0.1	0.0	0.1	3.5	0.3	0.0	3.5	2.5	3.3	0.3	0.0	0.5	5.2	2.8	0.7	5.3	0.0	0.2	0.0	0.1	5.5	0.0	3.5	0.1	17.2	10.1	1.0	0.0	10.4	7.4	0.0	1.5	32.7	3.4	0.0	2.7	0.0	1.0	4.1	0.0	0.1	0.7	0.9	1.6	37.0	1.6	46.2	0.1	3.3	1.7	2.2	0.4	0.7	0.4	0.5	0.8	5.8	5.4	0.6	0.6	2.3	2.5	0.8	1.4	3.4	0.9	11.5	3.2	1.4	4.5	9.8	3.3	9.9	7.4	12.3	12.0	1.3	16.5	10.7
RGS2	G0S8	ENSG00000116741	"Regulator of G protein signaling 2"	P41220	1	192809039-192812283	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Translation regulation"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 39.1;hTERT-HME1: 27.0;Karpas-707: 25.6;PC-3: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 135.8;neutrophil: 234.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 234.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013385			Supported	Cytosol				Cytosol		"HPA013385: "	"prognostic favourable (2.43e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.49e-2)"	"prognostic unfavourable (2.90e-5)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	22.7	62.0	8.1	39.2	20.1	84.9	23.3	6.0	10.0	20.7	57.5	4.5	50.6	23.2	43.3	34.2	45.5	27.4	35.0	14.2	8.2	13.2	9.4	10.8	24.3	32.6	8.9	6.6	25.1	84.3	1.9	52.6	16.7	16.9	99.8	19.1	44.0	5.0	54.5	4.4	6.4	33.9	135.0	19.0	50.6	22.5	13.0	7.9	3.9	4.2	5.7	6.2	72.1	28.5	0.3	6.2	234.2	26.6	0.1	1.8	12.2	0.0	5.3	7.0	0.6	13.8	2.1	0.4	2.6	3.3	0.8	0.9	4.7	3.2	0.4	0.7	2.4	2.6	4.5	4.7	0.8	0.6	3.3	1.2	3.5	0.1	6.1	3.1	0.7	2.2	39.1	1.8	27.0	6.5	1.1	25.6	2.7	0.0	1.7	4.4	9.3	61.8	1.7	1.6	1.3	4.5	4.3	2.5	13.1	1.8	0.1	2.9	0.2	1.6	1.8	1.3	1.2	1.4	1.3	15.3	0.4	1.3	18.8	0.6	4.7	135.8	26.6	38.0	0.8	10.5	1.8	0.3	0.5	0.5	6.2	0.1	0.3	0.3	234.2	0.1	17.7	0.8	0.3	12.2	8.1	20.1	6.0	10.0	8.2	13.2	8.9	6.6	16.9	7.9
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775515-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.5;brain: 38.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.0;HaCaT: 6.8;hTERT-HME1: 8.3;RH-30: 7.3;SH-SY5Y: 6.4;U-2 OS: 7.3;U-251 MG: 7.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol				Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.7	11.5	9.1	0.8	18.3	0.7	0.9	27.6	38.1	0.9	0.8	1.6	1.7	1.0	1.0	0.8	0.9	0.7	1.3	0.7	11.5	8.3	4.2	0.8	0.9	1.1	3.6	8.9	1.3	1.4	0.7	2.8	0.7	4.7	0.8	0.9	1.3	0.7	1.4	0.7	0.9	0.9	0.7	1.4	1.0	4.6	7.8	1.8	0.0	0.7	0.0	1.0	0.7	0.1	0.7	3.6	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.9	0.0	2.7	5.2	7.0	0.5	0.0	0.0	0.0	0.4	3.6	6.8	0.0	0.1	3.5	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.3	0.5	0.0	0.0	2.2	0.0	0.0	0.0	3.8	0.2	0.0	7.3	0.0	0.0	0.0	5.9	6.4	0.4	0.3	0.3	0.0	0.0	2.8	0.0	7.3	0.4	7.9	0.0	4.2	0.0	1.1	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	9.1	18.3	27.6	20.7	11.5	8.3	3.6	8.9	4.7	1.8
RGS7BP	R7BP	ENSG00000186479	"Regulator of G protein signaling 7 binding protein"	Q6MZT1	5	64506257-64612312	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.1"	"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 15.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039600	Approved		Uncertain	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039600: "	"unprognostic (2.93e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.81e-3)"	"unprognostic (1.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.50e-3)"	2.8	4.7	10.2	1.1	22.6	0.4	1.1	10.4	31.1	6.0	1.3	1.5	0.5	1.6	3.7	5.7	2.7	10.9	2.7	3.7	10.8	4.3	3.3	1.7	2.2	0.8	4.0	16.0	3.8	0.8	0.7	1.7	0.4	8.2	7.8	1.4	1.8	2.7	10.9	0.7	1.0	1.7	2.3	1.9	1.3	1.5	1.5	6.7	0.0	1.0	0.0	0.6	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	22.6	10.4	25.1	10.8	4.3	4.0	16.0	8.2	6.7
RHOA	"ARH12, ARHA, Rho12, RhoA, RHOH12"	ENSG00000067560	"Ras homolog family member A"	P61586	3	49359145-49412998	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Host-virus interaction"	Hydrolase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005052	Approved		Supported	"Plasma membrane,Cytosol"			65000000	"Plasma membrane, Cytosol"		"CAB005052: AB_562216"	"unprognostic (1.50e-1)"	"unprognostic (3.38e-1)"	"prognostic favourable (3.08e-4)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.15e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.44e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (3.21e-6)"	"unprognostic (5.14e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.52e-2)"	141.1	89.5	63.0	79.8	60.6	91.4	93.1	34.3	77.3	80.3	79.1	100.4	48.9	63.6	84.4	66.4	116.7	67.8	74.2	72.5	57.6	54.8	104.0	80.7	104.6	102.4	74.0	43.8	102.7	64.9	45.8	48.2	105.3	68.8	76.0	80.3	81.6	66.5	72.0	86.0	73.9	90.8	88.9	97.3	116.0	73.4	57.3	60.3	127.1	108.1	80.1	99.8	103.4	75.7	42.6	78.4	124.2	125.7	38.3	50.5	151.5	54.9	42.4	53.2	57.0	61.1	92.6	41.6	119.6	76.7	83.6	77.2	35.9	57.6	80.6	34.4	143.6	31.3	58.4	65.2	85.9	62.1	34.8	77.0	57.0	42.1	65.5	75.8	57.7	72.3	46.4	68.4	55.1	107.0	41.0	50.7	99.1	26.2	82.6	74.0	50.8	54.0	38.2	53.5	63.4	72.3	62.8	19.5	44.4	71.8	52.0	53.8	33.7	85.5	115.5	67.1	60.8	88.6	86.0	50.4	102.2	92.6	65.5	74.7	76.7	52.5	99.7	106.8	49.1	125.7	41.6	42.6	41.4	47.6	78.4	37.5	32.2	40.1	124.2	38.3	120.4	58.7	50.5	151.5	63.0	60.6	34.3	77.3	57.6	54.8	74.0	43.8	68.8	60.3
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.9;skeletal muscle: 63.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;NK-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040205: , HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.6	9.8	2.7	2.0	5.8	0.5	4.5	0.8	5.0	8.8	4.7	7.2	16.5	3.4	10.2	4.9	1.9	6.8	6.3	6.6	3.7	2.5	20.5	3.4	5.4	1.4	6.7	2.3	6.9	6.0	7.4	2.2	50.9	4.6	4.9	2.6	13.3	1.4	20.3	63.5	1.9	3.5	7.7	3.8	7.4	11.7	8.5	5.7	0.6	2.3	5.2	0.9	5.0	5.2	0.5	1.6	0.7	0.6	1.3	0.0	1.3	0.1	6.1	9.3	0.0	4.4	3.9	0.0	2.7	2.5	2.2	3.4	0.3	0.1	0.0	11.5	14.3	0.1	2.7	0.8	2.7	0.0	2.5	0.5	4.5	33.9	4.9	0.6	0.2	5.7	1.5	1.4	1.4	10.7	5.0	0.0	9.9	0.2	2.5	0.0	4.0	4.0	2.2	13.1	3.2	7.4	0.3	2.6	10.0	3.2	3.6	3.5	0.7	1.2	9.5	4.4	11.5	0.1	2.9	0.0	0.0	0.0	2.1	2.0	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.7	1.3	0.6	0.0	0.0	1.3	2.7	5.8	0.8	5.0	3.7	2.5	6.7	2.3	4.6	5.7
RHOQ	"ARHQ, RASL7A, TC10"	ENSG00000119729	"Ras homolog family member Q"	P17081	2	46541806-46583121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.0;ASC TERT1: 48.5;SK-MEL-30: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044938			Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA044938: "	"unprognostic (1.24e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (9.60e-5)"	"unprognostic (2.01e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.52e-2)"	43.3	13.1	20.9	14.1	19.4	4.9	16.7	6.5	15.1	16.4	16.6	12.7	11.7	4.9	15.5	32.9	9.8	13.8	15.0	65.2	16.8	13.0	13.9	6.0	14.2	10.0	19.5	14.9	16.0	12.9	20.4	8.2	13.8	20.4	14.6	6.9	16.0	9.6	19.2	63.8	7.2	8.9	19.3	15.4	13.2	9.3	6.3	13.4	8.0	18.0	17.2	9.1	17.7	12.1	3.9	2.9	8.9	4.8	0.7	0.8	1.3	4.1	4.3	7.2	10.1	62.0	48.5	0.9	11.9	30.1	5.8	9.1	2.0	1.3	10.1	13.0	21.0	1.7	7.5	3.5	10.6	3.4	5.1	2.3	3.2	7.0	30.3	3.0	3.6	42.9	6.1	7.7	8.3	6.8	4.0	16.8	12.5	2.8	2.3	5.4	7.5	5.4	1.6	13.1	3.4	7.9	8.0	5.7	18.5	4.4	5.9	52.7	3.2	6.9	4.7	19.0	17.7	18.5	4.8	17.3	6.2	10.6	27.7	7.4	6.7	2.7	4.6	7.8	0.7	4.8	0.6	3.4	0.4	0.8	2.9	3.9	0.1	0.6	8.9	0.7	3.4	1.3	0.6	1.3	20.9	19.4	6.5	15.1	16.8	13.0	19.5	14.9	20.4	13.4
RIC8A	"synembryn, synembryn-A"	ENSG00000177963	"RIC8 guanine nucleotide exchange factor A"	Q9NPQ8	11	207511-215113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041491, CAB046012"	Approved		Supported	Cytosol				Cytosol		"CAB046012: AB_11129402, HPA041491: "	"unprognostic (3.93e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (8.60e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (1.11e-6)"	"unprognostic (2.13e-3)"	"unprognostic (8.70e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.63e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.60e-1)"	30.9	30.2	31.4	27.1	35.4	28.8	27.5	27.8	51.7	29.3	31.4	25.9	32.5	24.1	35.8	36.6	36.5	35.4	33.2	31.9	27.0	25.5	33.9	39.5	28.4	28.7	23.8	30.0	35.1	38.0	34.9	30.2	43.7	27.4	29.8	26.1	33.2	29.4	36.1	22.5	32.2	35.1	41.3	21.2	32.5	28.4	40.3	18.6	43.9	33.2	24.9	33.3	33.3	27.3	31.3	20.7	40.2	26.6	31.9	40.1	37.2	50.7	24.8	20.2	20.0	27.7	22.9	14.0	36.7	29.7	50.4	35.0	21.3	36.1	20.3	15.4	55.6	27.6	22.9	38.9	28.2	24.4	22.9	11.4	17.5	19.7	22.4	19.0	38.3	25.0	34.5	31.2	28.3	24.7	19.5	19.8	38.6	20.5	22.7	15.2	18.4	30.8	21.4	19.9	13.8	29.2	13.4	21.0	18.9	28.5	32.2	19.6	22.8	15.4	27.6	33.4	29.4	12.2	34.1	22.0	32.5	19.5	32.9	17.3	24.9	27.5	19.7	40.2	40.1	23.0	39.3	31.3	35.9	34.6	20.7	27.2	31.1	31.4	28.8	31.9	26.6	17.0	29.8	37.2	31.4	35.4	27.8	51.7	27.0	25.5	23.8	30.0	27.4	18.6
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 43.4;pituitary gland: 29.2"	"Group enriched"	"Detected in some"	9	"CACO-2: 6.4;SCLC-21H: 3.5;SH-SY5Y: 6.9;SK-BR-3: 11.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favourable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.5	2.7	4.0	0.5	9.3	0.5	1.1	0.5	5.6	1.6	1.1	0.8	1.2	0.6	2.1	6.1	0.7	43.4	0.9	0.5	4.6	5.1	0.6	0.5	3.1	0.5	2.5	5.2	2.6	1.2	1.1	29.2	0.5	3.6	1.0	1.3	1.2	0.5	1.9	0.5	0.6	0.8	1.1	0.5	0.5	2.0	14.7	2.1	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	3.5	6.9	0.0	11.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.3	0.5	5.6	4.6	5.1	2.5	5.2	3.6	2.1
RILPL1	FLJ39378	ENSG00000188026	"Rab interacting lysosomal protein like 1"	Q5EBL4	12	123470054-123533718	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041314	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041314: AB_10795587"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.81e-1)"	6.1	5.7	9.9	3.5	12.3	3.0	3.7	5.2	11.3	4.8	4.7	12.6	4.4	2.1	6.6	5.0	4.8	5.0	4.3	43.8	9.6	7.5	3.8	3.0	5.5	2.3	21.1	5.8	7.2	3.2	5.7	3.6	7.1	11.1	6.2	2.2	4.9	8.0	7.8	66.2	6.2	2.7	9.8	14.4	3.8	3.0	2.9	15.1	0.3	8.2	9.7	1.9	4.7	5.3	1.6	1.2	4.6	1.2	1.2	2.0	0.7	6.0	8.5	7.7	6.0	8.7	8.2	8.1	10.9	6.1	6.0	5.3	5.3	1.4	0.3	5.5	10.6	6.6	5.7	5.2	2.4	6.1	10.4	0.8	5.5	7.7	15.2	0.3	2.3	9.3	10.4	6.7	9.7	6.0	4.8	0.4	6.0	10.0	0.7	1.9	5.6	9.0	1.0	4.2	0.3	4.2	6.3	1.2	7.2	5.8	5.1	13.0	6.8	0.2	12.0	7.8	3.9	11.3	6.9	1.3	0.6	0.2	8.0	0.1	4.9	1.4	1.0	0.7	0.9	0.5	0.8	0.9	1.0	0.8	0.3	1.6	2.0	1.6	4.6	1.2	1.2	1.2	0.9	0.7	9.9	12.3	5.2	9.9	9.6	7.5	21.1	5.8	11.1	15.1
RILPL2	"FLJ30380, FLJ32372, MGC7036"	ENSG00000150977	"Rab interacting lysosomal protein like 2"	Q969X0	12	123410683-123436717	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 34.9;THP-1: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028958	Uncertain		Supported	Cytosol				Cytosol		"HPA028958: AB_10602124"	"unprognostic (1.94e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favourable (5.24e-7)"	"unprognostic (2.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.74e-2)"	14.8	5.6	5.8	13.2	7.1	42.9	13.6	3.8	5.7	25.1	7.7	5.3	12.8	4.1	17.8	10.6	10.2	14.2	13.4	7.4	6.3	5.1	12.8	7.8	21.6	15.3	6.3	4.7	12.2	5.0	6.0	7.0	7.7	7.2	18.2	3.8	8.2	21.4	15.6	4.4	6.5	9.8	9.6	7.6	29.9	7.6	7.8	5.8	8.6	25.7	7.4	14.3	14.0	22.0	8.5	13.6	26.2	19.0	3.1	9.0	7.8	2.5	2.4	1.2	4.5	5.1	4.1	2.8	3.0	6.3	2.4	2.0	2.7	1.4	1.6	2.5	4.2	2.0	1.8	2.0	2.4	5.0	2.0	16.2	2.5	3.8	5.3	12.3	9.5	3.3	1.6	2.5	1.9	2.4	2.2	1.9	2.1	1.7	4.4	34.9	1.1	2.5	3.6	2.6	2.8	2.5	4.2	0.6	1.6	3.5	0.8	2.7	3.5	22.3	3.0	2.5	2.8	4.2	1.8	2.2	1.7	3.1	2.5	8.7	1.1	12.5	19.0	21.5	3.8	14.4	3.5	8.5	7.8	6.5	13.6	5.7	3.4	3.7	26.2	3.1	15.7	6.9	9.0	7.8	5.8	7.1	3.8	5.7	6.3	5.1	6.3	4.7	7.2	5.8
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 17.2;SH-SY5Y: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"B-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041494: , HPA044114: "	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favourable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.9	11.9	14.1	1.1	13.0	0.6	0.6	1.1	24.7	6.1	1.5	1.6	0.0	2.5	2.5	2.4	0.8	6.6	1.1	0.4	15.3	11.0	2.8	0.6	0.7	0.5	5.6	12.9	2.1	2.3	49.1	42.7	0.4	4.9	1.3	1.8	4.1	0.6	1.4	0.5	2.4	2.3	2.3	5.6	1.1	5.2	2.3	1.6	0.0	0.9	0.0	0.5	0.8	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.2	4.1	0.0	0.0	17.2	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	13.0	1.1	24.7	15.3	11.0	5.6	12.9	4.9	1.6
RIMS2	"KIAA0751, OBOE, RAB3IP3, RIM2"	ENSG00000176406	"Regulating synaptic membrane exocytosis 2"	Q9UQ26	8	103500748-104256094	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 51.1;brain: 28.7"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;Daudi: 11.7;RT4: 8.4;SCLC-21H: 20.7;U-2 OS: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA046538, HPA066498, CAB079049"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB079049: , HPA046538: , HPA066498: "	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (8.01e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.67e-5)"	"unprognostic (8.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	0.9	51.1	15.8	1.0	21.8	1.1	1.8	14.5	28.7	8.5	0.9	0.5	0.9	1.2	1.4	1.7	1.0	6.3	1.7	0.9	10.3	4.9	1.1	0.9	1.0	1.1	3.1	17.5	2.8	1.6	0.9	12.4	1.1	8.6	2.8	1.0	5.8	1.0	1.8	1.0	1.0	1.4	2.0	4.0	0.9	1.7	3.9	8.7	0.0	2.9	0.0	1.0	1.5	1.6	0.7	0.7	2.9	0.6	1.6	0.6	0.2	3.7	0.0	6.0	0.0	0.0	0.0	0.0	0.4	0.3	1.1	1.4	0.1	0.3	11.7	0.1	0.0	0.3	1.8	0.7	1.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.9	0.0	0.1	0.5	0.0	0.5	0.8	0.0	4.6	0.6	0.0	0.0	0.0	0.0	8.4	20.7	5.0	0.0	0.1	0.5	0.3	0.2	0.0	0.0	5.5	0.1	0.1	1.5	0.0	0.1	0.4	0.2	0.2	2.7	0.6	0.6	0.6	0.3	0.4	0.4	0.3	0.4	0.1	0.7	0.3	0.5	2.9	1.6	0.4	0.7	0.3	0.2	15.8	21.8	14.5	28.7	10.3	4.9	3.1	17.5	8.6	8.7
RIN2	RASSF4	ENSG00000132669	"Ras and Rab interactor 2"	Q8WYP3	20	19886521-20002457	"Disease related genes, Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.2;granulocytes: 2.2;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034641	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Cytosol	"Nucleoli, Golgi apparatus"	"HPA034641: AB_10671230"	"unprognostic (8.23e-3)"	"unprognostic (8.09e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.27e-2)"	"prognostic favourable (8.34e-6)"	"unprognostic (3.10e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.02e-3)"	"unprognostic (3.63e-2)"	19.2	6.7	9.9	6.1	8.7	4.0	24.4	4.3	10.2	11.7	21.6	9.5	7.6	10.5	12.7	6.6	11.1	9.7	14.7	13.7	10.0	6.2	12.2	4.6	26.8	4.3	8.3	4.4	12.7	5.1	4.2	4.9	16.7	9.3	8.0	10.4	16.5	12.0	11.3	10.9	6.6	23.4	13.2	7.7	17.5	6.5	3.5	9.9	0.3	13.1	5.5	3.7	9.9	15.6	0.3	1.2	2.2	3.3	0.1	0.3	0.4	3.4	11.2	2.1	6.7	12.3	7.5	6.9	2.7	11.5	2.9	1.7	5.3	3.1	0.0	12.2	7.0	12.4	0.1	17.8	3.3	1.4	0.0	0.0	1.9	0.4	2.7	0.0	0.0	11.0	3.0	5.6	6.2	15.9	0.0	0.2	8.8	2.5	0.0	0.2	0.3	24.8	0.0	7.4	1.8	3.8	4.8	1.8	0.4	2.7	11.0	0.0	1.0	0.9	17.2	6.2	1.4	3.7	4.6	0.0	0.0	0.0	4.0	0.0	0.9	0.6	3.3	0.2	0.2	2.7	0.2	0.2	0.2	0.2	1.2	0.3	0.3	0.3	2.2	0.1	2.8	0.6	0.1	0.4	9.9	8.7	4.3	10.2	10.0	6.2	8.3	4.4	9.3	9.9
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208495-33212722	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	26.7	22.6	17.8	15.9	21.3	12.0	14.6	27.6	24.2	22.2	17.6	22.0	21.0	18.2	31.9	17.3	14.5	18.8	21.4	14.4	17.3	18.2	19.3	21.6	16.8	14.5	24.0	15.4	25.0	18.3	24.0	34.0	14.9	17.0	21.8	7.6	20.0	19.0	20.5	18.0	21.7	19.5	22.9	18.5	23.2	24.1	16.9	20.8	25.5	29.3	13.1	14.3	13.9	17.1	1.2	2.2	0.8	1.5	0.2	2.2	0.2	4.2	3.5	4.2	4.0	4.2	1.4	9.7	11.1	6.8	4.5	4.6	3.8	3.1	6.9	4.6	4.4	7.6	3.6	3.3	3.2	8.5	2.9	8.3	5.8	7.1	9.6	4.7	6.8	0.0	3.4	4.0	7.5	1.6	11.9	5.3	4.7	0.0	0.3	3.7	1.9	4.6	4.5	6.9	7.6	5.0	3.7	8.3	5.2	4.0	4.3	11.5	4.9	8.3	2.3	5.0	3.8	0.0	9.1	6.0	6.2	6.6	3.7	4.3	3.1	0.0	1.5	0.8	2.2	0.4	0.4	1.1	0.7	1.0	0.7	1.2	1.7	0.9	0.3	0.2	0.5	2.2	0.4	0.2	17.8	21.3	27.6	24.2	17.3	18.2	24.0	15.4	17.0	20.8
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389496-7418037	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nucleoli, Nuclear speckles"	Cytosol	"HPA017866: , HPA051446: "	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	13.8	10.6	7.7	13.2	13.0	17.5	13.1	12.2	13.5	12.7	11.6	7.3	4.0	7.3	15.4	6.0	15.6	12.3	8.5	11.8	8.0	8.1	8.7	11.7	10.1	14.2	11.6	9.4	13.8	15.3	7.7	17.8	13.9	13.3	10.7	9.6	7.2	10.2	10.3	18.8	12.5	9.9	15.5	9.4	14.4	10.3	21.3	9.2	19.2	10.1	14.7	16.8	10.9	12.6	15.4	14.9	7.7	11.1	18.6	15.0	8.2	7.5	4.4	7.1	16.7	11.1	9.1	10.9	9.5	6.4	8.9	7.4	12.8	3.9	19.7	16.9	7.7	7.7	17.9	7.6	11.4	13.0	19.3	10.5	7.1	13.7	9.4	30.2	13.8	6.7	10.6	9.6	19.8	7.8	26.8	4.6	8.3	9.9	20.5	14.3	15.3	10.4	15.8	9.3	21.4	5.0	7.4	23.7	11.7	8.0	4.8	13.8	7.3	10.0	7.8	9.8	7.4	6.4	14.3	6.4	12.1	29.3	3.0	15.6	14.9	7.7	8.5	5.9	11.5	11.1	13.8	15.2	11.9	12.1	14.9	15.4	13.7	15.0	1.7	18.6	9.7	12.4	11.3	8.2	7.7	13.0	12.2	13.5	8.0	8.1	11.6	9.4	13.3	9.2
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183260	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	22.2	20.1	14.8	17.1	17.5	24.4	19.7	26.3	18.6	19.1	17.0	8.9	14.0	17.3	17.5	17.1	17.0	15.0	10.7	19.6	15.7	13.4	21.0	23.6	13.3	17.6	20.0	11.1	20.7	21.5	15.1	37.5	15.8	19.7	19.5	17.3	10.3	18.7	16.6	24.9	13.3	20.2	16.3	20.7	22.5	16.4	14.8	18.6	25.8	21.7	20.7	17.4	20.7	21.0	15.2	17.8	9.4	18.7	17.8	24.1	13.5	8.8	10.4	9.7	18.8	12.8	14.0	15.5	22.3	13.8	15.8	21.0	14.2	15.6	19.6	25.4	10.0	10.5	16.5	13.0	21.7	13.8	9.1	9.8	20.1	19.8	11.5	18.6	13.8	9.2	10.2	19.3	19.6	12.8	14.8	12.7	18.1	14.8	21.7	22.2	11.5	11.2	24.5	18.9	28.8	12.4	8.1	12.1	9.0	13.5	14.0	15.3	14.7	17.7	13.7	20.3	14.1	16.1	24.2	12.5	16.2	44.0	12.1	19.1	18.4	7.0	16.0	9.4	16.3	18.7	22.3	15.2	20.7	17.8	17.8	11.0	22.5	24.1	3.2	17.8	13.4	17.8	18.5	13.5	14.8	17.5	26.3	18.6	15.7	13.4	20.0	11.1	19.7	18.6
RIOK3	SUDD	ENSG00000101782	"RIO kinase 3"	O14730	18	23452823-23486603	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	"unprognostic (7.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.20e-1)"	"prognostic unfavourable (4.10e-4)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.71e-2)"	10.1	8.7	6.9	11.7	7.7	52.4	10.9	8.9	10.1	14.7	21.4	8.5	5.9	15.6	8.8	9.3	41.0	7.8	10.7	11.5	6.1	5.5	10.5	19.9	10.1	10.7	9.1	6.2	7.6	10.7	7.5	11.6	21.4	11.6	6.8	14.7	6.0	14.9	7.0	40.0	13.3	36.5	15.2	10.5	8.9	12.9	22.7	7.6	11.1	7.3	16.0	16.5	13.7	21.5	11.7	11.0	21.7	21.5	8.3	11.2	10.0	14.7	5.8	6.0	7.8	11.0	12.3	10.9	14.8	10.9	10.5	10.1	6.6	15.9	10.2	19.4	16.4	19.3	10.2	16.8	16.2	10.1	4.2	9.5	10.8	8.3	27.5	26.7	8.3	14.7	32.0	18.6	25.8	14.5	13.7	12.9	15.7	7.8	9.2	4.4	5.6	11.6	10.4	12.6	12.4	12.0	19.3	14.0	10.1	18.9	8.6	10.8	7.6	14.5	22.9	17.3	4.3	7.6	9.6	23.2	19.6	15.2	10.2	12.4	12.9	21.7	13.5	8.0	9.1	19.6	6.9	8.2	7.6	7.9	11.0	11.7	6.1	6.9	9.3	8.3	21.5	5.1	11.2	10.0	6.9	7.7	8.9	10.1	6.1	5.5	9.1	6.2	11.6	7.6
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063991-3115187	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favourable (6.71e-4)"	24.5	12.0	6.9	15.7	12.4	10.5	28.0	11.9	11.0	16.4	18.9	9.6	22.9	14.5	16.8	17.7	17.1	13.5	17.9	12.3	7.5	6.8	18.5	36.7	16.7	19.8	11.8	6.6	13.2	19.9	14.4	17.9	24.4	10.2	17.8	16.6	10.9	21.1	18.7	11.4	18.9	24.8	21.3	6.9	19.4	15.8	9.0	9.4	18.6	18.5	15.2	19.2	15.0	20.4	4.1	3.2	6.6	3.9	6.6	7.6	2.1	9.5	6.9	10.4	10.7	22.2	14.2	5.7	15.1	20.5	16.0	18.4	9.3	6.6	9.0	14.6	21.6	11.0	12.9	12.4	17.5	18.6	7.0	11.5	4.5	6.7	12.5	10.0	14.8	19.2	11.1	14.8	10.7	13.8	13.0	5.2	15.4	12.4	6.9	10.9	6.5	8.6	8.4	7.7	10.1	14.3	19.2	9.0	8.8	9.9	6.3	16.7	11.4	7.1	16.7	17.5	9.4	6.6	11.1	8.0	10.3	9.6	7.3	5.5	19.4	1.1	3.0	6.4	6.1	3.7	4.9	2.0	4.9	7.6	3.2	4.1	4.1	5.4	6.6	6.6	3.9	2.9	5.7	2.1	6.9	12.4	11.9	11.0	7.5	6.8	11.8	6.6	10.2	9.4
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757747-89791063	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol				Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavourable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favourable (8.05e-4)"	12.0	5.5	9.3	11.2	7.9	13.6	10.0	3.0	9.3	9.7	7.9	10.6	5.2	3.5	10.9	7.8	8.3	7.0	17.3	11.6	9.2	8.6	7.7	10.4	18.7	10.9	11.8	5.8	8.9	13.2	14.7	7.3	20.8	9.1	10.7	5.6	4.6	10.2	5.8	3.1	10.4	6.9	10.4	16.5	14.2	8.3	5.6	11.5	5.1	8.5	4.9	11.8	15.0	7.6	7.5	6.9	19.4	11.2	3.8	5.5	4.3	10.1	3.5	1.8	2.6	4.4	6.1	3.3	11.3	19.3	6.0	7.8	3.1	5.3	7.9	17.6	6.3	2.4	4.8	3.7	11.1	5.6	4.9	6.6	1.7	3.1	12.4	2.4	3.2	4.9	3.0	8.5	27.7	6.3	3.2	2.6	5.5	2.1	0.0	5.0	1.0	8.4	1.7	2.5	3.8	14.0	4.6	0.3	2.0	2.7	7.1	5.3	6.8	3.0	5.6	3.7	3.5	6.2	5.2	5.2	2.3	4.7	9.0	0.2	2.4	8.8	5.7	19.4	3.6	10.6	4.1	7.5	5.5	4.7	6.9	4.3	5.2	5.5	4.5	3.8	11.2	2.3	1.2	4.3	9.3	7.9	3.0	7.4	9.2	8.6	11.8	5.8	9.1	11.5
RIPOR1	"FAM65A, FLJ13725"	ENSG00000039523	"RHO family interacting cell polarization regulator 1"	Q6ZS17	16	67518418-67546788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 8.2;eosinophil: 6.4;intermediate monocyte: 12.0;memory B-cell: 12.3;myeloid DC: 7.6;naive B-cell: 8.1;neutrophil: 4.9;non-classical monocyte: 10.4;plasmacytoid DC: 10.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005923	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA005923: AB_1078809"	"unprognostic (7.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (5.00e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (5.82e-8)"	"unprognostic (8.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.46e-2)"	26.6	16.7	21.2	20.8	28.5	21.9	23.7	31.8	35.1	18.8	16.6	13.1	8.4	8.7	24.2	11.4	15.1	17.6	20.4	35.6	21.2	15.8	30.8	11.7	27.8	17.6	12.8	18.6	20.6	22.4	20.4	14.4	27.9	16.9	15.7	7.6	27.1	15.8	20.7	24.3	12.1	15.6	24.0	10.0	37.5	13.4	11.6	12.5	6.7	19.0	13.1	16.2	17.0	22.6	12.3	10.8	6.4	12.0	1.1	1.4	3.7	15.5	13.2	6.0	9.4	15.2	13.7	13.3	16.6	16.5	19.3	16.2	27.2	11.6	2.1	23.3	28.5	8.9	12.0	15.1	12.5	6.8	6.1	20.7	18.3	6.1	17.2	1.6	10.5	13.5	7.0	26.0	17.6	20.3	2.2	2.3	14.2	17.0	4.8	5.1	1.6	10.7	16.7	10.8	11.1	14.7	8.0	4.5	11.9	31.0	5.2	10.4	11.1	3.9	35.1	22.0	13.0	18.5	11.5	3.3	2.3	6.4	14.7	4.0	11.7	0.0	8.2	6.4	1.0	12.0	1.4	12.3	0.8	0.4	7.6	8.1	0.6	0.5	4.9	1.1	10.4	10.8	0.5	3.7	21.2	28.5	31.8	35.1	21.2	15.8	12.8	18.6	16.9	12.5
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221751	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"retina: 164.1"	"Cell line enriched"	"Detected in single"	48	"SK-MEL-30: 21.4"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Group enriched"	"Detected in many"	4	"amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7"	"Group enriched"	"Detected in some"	7	"basophil: 3.3;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: , HPA044083: "	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1.0	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.0	3.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	6.9	10.6	0.6	7.0	3.7	1.3	1.6	0.6	0.4	0.1
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74585217-74614617	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (1.20e-1)"	11.8	14.3	17.5	10.6	25.6	37.4	12.4	12.6	20.5	12.2	7.4	8.3	5.6	6.4	10.6	8.0	10.2	9.5	10.7	10.5	17.1	16.6	11.6	9.7	13.8	9.2	12.4	13.7	12.4	9.7	19.5	18.5	10.5	28.6	11.9	7.6	5.2	8.9	8.7	11.2	10.2	7.1	10.1	13.9	9.8	8.4	6.9	12.4	9.7	13.0	6.2	10.1	10.5	9.3	3.5	4.8	16.3	7.4	5.2	4.6	3.0	13.5	13.8	13.4	11.2	13.5	14.3	13.2	13.1	15.2	11.7	14.5	10.7	14.2	7.3	15.3	16.4	11.8	26.9	15.7	18.0	6.6	14.2	12.8	24.3	6.5	12.0	19.3	22.9	13.8	9.9	16.7	28.7	13.6	11.1	13.3	15.4	10.3	14.3	10.9	20.6	13.3	13.7	28.4	12.3	10.9	16.2	9.9	11.5	24.5	11.9	15.2	6.7	15.2	18.0	14.2	13.8	14.5	11.4	7.1	13.6	11.7	15.5	19.6	13.8	16.3	5.9	5.6	3.2	7.4	3.3	3.0	4.1	4.0	4.8	3.5	4.5	4.1	11.4	5.2	5.4	2.6	4.6	3.0	17.5	25.6	12.6	20.5	17.1	16.6	12.4	13.7	28.6	12.4
RMDN2	"FAM82A, FAM82A1, FLJ32954, RMD2"	ENSG00000115841	"Regulator of microtubule dynamics 2"	Q96LZ7	2	37923187-38067142	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 38.4"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA034705, HPA034706"	Enhanced		Supported	"Golgi apparatus,Mitotic spindle,Cytosol"				"Mitotic spindle, Cytosol"	"Golgi apparatus"	"HPA034705: , HPA034706: AB_10696362"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.06e-2)"	"prognostic favourable (2.63e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.34e-1)"	4.6	38.4	6.1	8.7	6.8	1.9	8.9	6.2	8.2	6.3	9.7	1.8	5.9	6.8	7.0	9.2	3.7	4.3	5.5	4.6	5.9	3.5	6.6	24.0	8.2	3.3	3.2	5.1	3.2	4.2	3.2	8.6	3.1	4.6	8.1	8.7	5.2	5.7	10.2	5.0	2.9	14.7	7.7	4.8	14.1	4.6	15.6	4.0	2.1	4.7	3.6	2.1	4.3	9.0	7.5	6.0	4.8	8.0	6.3	6.1	2.3	3.3	3.9	2.6	1.7	11.9	12.2	1.5	7.1	9.2	3.6	3.7	1.0	11.2	2.3	3.1	10.6	3.9	0.9	4.8	4.5	4.6	2.6	4.0	1.5	3.4	6.2	0.0	4.1	17.4	3.8	4.9	0.7	2.0	4.7	2.0	6.4	1.3	0.7	4.0	5.1	3.9	0.0	0.6	0.4	9.3	3.0	2.0	7.8	5.6	0.6	6.3	1.2	5.4	2.8	5.0	5.3	2.6	2.8	3.9	6.7	4.7	5.9	0.9	5.0	0.0	4.9	1.0	4.0	8.0	6.1	7.5	1.9	2.5	3.3	5.0	2.0	4.3	4.8	6.3	6.1	6.0	0.2	2.3	6.1	6.8	6.2	8.2	5.9	3.5	3.2	5.1	4.6	4.0
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11351762	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.7;testis: 29.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;T-cells: 3.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favourable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.0	1.8	4.2	18.0	5.1	4.8	2.8	0.7	4.1	2.8	7.3	1.0	0.4	4.3	2.5	3.2	11.8	1.0	2.6	1.9	2.5	1.5	3.1	2.3	2.9	17.9	1.6	5.6	3.6	1.6	0.7	1.1	13.2	1.2	2.6	9.0	0.8	2.9	1.7	1.1	8.7	5.6	1.1	1.4	4.2	4.0	29.6	1.2	31.7	1.4	2.8	20.4	3.6	4.5	6.5	0.6	0.9	0.0	0.3	3.0	0.3	19.0	12.8	25.1	10.7	1.1	5.5	10.5	11.1	8.8	10.5	17.6	4.9	22.7	26.5	9.6	5.2	11.2	10.7	10.6	17.1	5.2	10.0	14.5	7.6	32.4	0.4	5.6	6.5	1.2	2.0	4.5	4.4	5.7	20.0	21.1	5.5	22.0	19.2	26.0	21.1	5.1	23.3	27.1	28.3	6.2	12.4	14.5	11.5	9.4	15.8	8.2	26.7	8.4	1.8	8.5	7.9	16.2	1.6	5.8	9.5	31.4	7.9	18.4	15.5	0.0	0.0	0.9	0.6	0.0	0.0	6.5	0.2	0.0	0.4	2.5	1.8	0.7	0.2	0.3	0.0	0.6	3.0	0.3	4.2	5.1	0.7	4.1	2.5	1.5	1.6	5.6	1.2	1.2
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806556-12815201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favourable (1.18e-4)"	"prognostic favourable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favourable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavourable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	6.5	5.5	6.4	11.4	10.6	21.9	6.6	11.0	7.5	6.8	6.6	9.2	1.6	8.6	6.8	4.4	14.1	6.0	5.7	5.1	6.7	4.8	8.7	5.9	5.5	9.2	10.6	5.8	7.3	7.0	6.2	4.1	11.8	6.1	5.3	5.7	5.5	8.8	4.3	7.1	13.4	7.1	4.4	7.8	12.0	7.4	14.1	8.4	44.8	8.6	13.4	17.4	6.0	8.0	11.3	7.8	7.1	6.8	12.9	8.6	5.0	14.8	11.2	6.8	6.8	1.0	1.9	8.4	6.9	2.9	10.4	12.1	8.8	5.7	15.9	10.5	1.6	8.9	5.5	6.8	5.7	8.6	15.0	7.6	11.9	6.8	0.7	7.0	7.1	1.0	1.7	8.8	3.2	4.0	10.5	4.7	4.9	25.5	12.8	6.9	6.7	19.6	13.8	9.8	11.4	2.6	5.9	14.1	8.2	7.5	2.7	3.1	7.4	4.3	3.8	12.4	6.2	17.6	11.4	11.5	12.7	12.6	7.3	11.2	10.0	7.1	6.8	6.4	8.6	6.6	7.0	9.8	7.0	6.1	4.2	11.3	6.6	6.5	6.8	12.9	5.9	7.8	5.5	5.0	6.4	10.6	11.0	7.5	6.7	4.8	10.6	5.8	6.1	8.4
RNASEK-C17orf49		ENSG00000161939	"RNASEK-C17orf49 readthrough"		17	7012635-7017520	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 5.2;THP-1: 6.1;U-87 MG: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA022961, HPA024457"	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (4.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.37e-5)"	"unprognostic (4.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.26e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-1)"	4.8	4.8	2.8	3.5	3.5	5.3	2.9	3.6	4.0	2.0	2.8	0.4	1.5	1.4	4.9	3.3	2.3	2.7	3.2	6.3	2.5	3.3	6.6	14.5	16.7	20.3	2.9	2.4	2.4	7.9	1.4	4.7	2.5	1.8	1.8	1.4	0.4	1.6	5.0	4.2	1.9	6.3	2.3	1.7	9.1	1.6	6.4	0.7	4.1	2.0	4.6	3.4	2.3	1.6	1.9	4.0	7.5	4.3	0.9	1.7	2.8	1.1	3.5	0.5	0.5	0.0	0.0	1.1	2.3	1.9	2.8	2.1	2.3	1.0	1.8	0.2	0.0	0.6	0.7	5.2	0.7	0.0	4.3	0.0	2.9	1.0	2.7	0.0	0.6	0.0	0.0	1.6	0.0	0.7	0.6	0.0	0.0	1.2	1.9	2.2	2.2	1.2	1.4	0.0	0.0	0.7	0.7	0.5	1.8	0.0	0.0	0.2	0.6	6.1	0.0	0.0	0.2	3.5	0.9	0.0	0.8	0.2	6.8	0.5	0.0	3.6	4.3	3.4	1.2	3.0	1.7	1.9	1.5	0.8	3.8	1.8	1.4	1.2	7.5	0.9	3.1	4.0	0.9	2.8	2.8	3.5	3.6	4.0	2.5	3.3	2.9	2.4	1.8	0.7
RNASEL	"PRCA1, RNS4"	ENSG00000135828	"Ribonuclease L"	Q05823	1	182573634-182589256	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002633, CAB010906"	Approved		Supported	Cytosol				Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	"unprognostic (3.46e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.81e-1)"	8.1	10.8	7.4	9.5	10.9	3.7	8.3	5.7	7.7	12.5	9.3	6.7	8.5	8.0	12.4	11.9	10.0	8.8	8.0	5.8	7.0	5.3	9.9	3.9	8.4	10.1	7.7	3.3	14.0	5.3	13.5	18.0	8.5	10.1	10.5	10.8	13.3	10.5	10.3	4.1	6.3	12.2	9.6	7.4	10.5	8.8	3.5	6.7	13.3	13.3	2.8	11.0	13.9	11.0	5.0	7.2	26.9	13.5	5.0	9.2	4.9	2.3	3.3	1.4	0.5	7.6	13.3	2.6	4.5	5.6	4.6	4.3	1.9	5.1	5.1	7.9	5.1	4.3	3.3	4.6	1.8	4.0	2.8	5.9	1.2	0.2	3.9	11.0	11.7	9.4	10.6	2.4	0.7	2.0	2.1	3.9	4.0	3.3	3.2	4.6	1.1	0.9	4.8	1.1	2.6	4.9	3.1	0.7	0.2	4.0	4.9	3.8	5.0	12.3	2.5	2.4	1.9	2.5	2.4	3.5	1.2	0.6	3.8	6.8	3.5	16.8	7.2	24.6	4.9	7.6	6.4	5.0	5.8	5.2	6.0	3.8	9.2	6.7	26.9	5.0	13.5	7.2	4.6	4.9	7.4	10.9	5.7	7.7	7.0	5.3	7.7	3.3	10.1	6.7
RNF111	"ARK, Arkadia, DKFZP761D081, FLJ38008"	ENSG00000157450	"Ring finger protein 111"	Q6ZNA4	15	58865175-59097419	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038576, HPA038577"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038576: AB_10964492, HPA038577: AB_10960052"	"unprognostic (7.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.74e-2)"	12.8	11.2	15.3	15.6	19.3	21.2	12.7	24.1	21.9	15.1	9.8	18.8	10.9	11.4	16.4	9.8	16.2	12.6	13.0	11.0	13.0	13.0	12.9	14.8	13.3	13.9	15.7	15.5	16.8	14.8	20.8	19.2	16.7	17.8	12.7	10.3	12.9	14.9	12.5	15.0	14.1	10.9	11.7	14.2	14.3	12.0	15.7	16.9	14.9	16.4	6.5	17.8	15.8	14.8	7.9	5.2	26.7	9.9	3.3	6.1	2.0	9.7	22.7	14.5	12.4	12.6	14.2	12.4	12.8	15.0	12.8	16.5	9.9	6.5	12.0	14.5	17.8	19.2	3.9	9.5	16.0	12.4	8.1	14.9	9.2	7.6	13.7	8.6	16.8	11.1	10.4	13.8	15.3	14.2	13.7	12.1	15.7	4.7	11.4	5.6	11.9	8.8	11.5	20.7	9.8	9.8	17.5	11.9	17.4	11.5	11.4	11.1	8.9	10.7	16.3	20.5	17.2	10.7	12.2	8.7	11.9	14.3	12.5	14.0	15.4	6.4	9.9	9.3	4.8	7.0	4.8	7.4	4.9	4.3	5.2	7.9	5.5	4.2	26.7	3.3	7.6	4.9	6.1	2.0	15.3	19.3	24.1	21.9	13.0	13.0	15.7	15.5	17.8	16.9
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953892	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (3.01e-4)"	"unprognostic (1.36e-2)"	23.2	21.3	24.4	18.3	25.7	31.2	20.6	26.7	23.1	24.0	29.7	32.6	21.1	29.5	20.3	23.4	20.2	23.6	20.1	21.9	23.0	25.3	30.3	31.6	24.4	24.0	28.3	19.4	28.4	36.8	16.1	21.6	40.6	23.7	24.5	21.3	27.1	27.8	24.1	43.8	15.2	33.9	17.6	29.3	36.3	24.2	101.9	24.1	28.3	37.9	20.0	24.1	22.6	25.0	28.5	32.5	43.4	44.6	23.7	29.4	34.9	15.6	15.4	7.9	8.3	16.3	11.3	23.3	14.0	15.9	29.0	12.3	45.7	12.9	7.6	28.0	7.4	12.6	11.8	14.1	10.0	13.7	8.6	9.6	10.3	32.1	14.3	17.4	11.6	9.8	13.0	11.1	7.6	6.9	18.0	8.9	8.5	52.6	14.6	18.1	8.2	22.1	16.0	8.3	13.7	15.3	12.8	12.1	8.7	17.1	108.1	21.6	28.8	16.2	9.1	26.3	12.2	13.8	16.1	18.3	19.1	14.4	14.9	11.4	14.5	38.5	42.5	35.7	22.0	39.2	24.6	28.2	24.6	22.4	32.5	28.5	29.4	23.7	43.4	23.7	44.6	26.7	28.8	34.9	24.4	25.7	26.7	23.1	23.0	25.3	28.3	19.4	23.7	24.1
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689499-49721529	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Approved		Approved	Cytosol				Cytosol		"HPA065983: , HPA071879: "	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favourable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	5.3	8.0	7.7	8.0	10.4	17.5	5.0	13.8	13.6	5.2	6.8	6.2	7.8	12.7	6.4	8.0	7.5	6.4	7.0	12.9	8.5	6.8	8.4	21.8	5.7	6.1	7.3	6.6	5.1	7.7	8.9	8.4	7.3	6.6	7.3	4.8	7.6	6.9	6.7	81.2	7.7	12.5	6.2	6.7	7.6	6.9	8.8	7.8	8.3	6.2	12.0	9.1	6.6	4.8	11.3	12.7	11.8	10.9	7.7	11.4	5.3	6.7	9.5	11.4	11.7	17.3	10.7	12.3	8.8	11.7	11.2	12.5	10.1	11.7	16.4	8.0	12.5	8.5	8.6	13.3	7.9	10.9	11.7	13.4	18.8	22.2	17.3	12.9	14.5	13.5	13.1	10.5	12.3	11.6	14.0	14.3	9.5	10.1	13.6	21.0	6.2	15.4	6.4	6.9	17.0	15.4	11.4	7.8	15.6	12.1	10.8	13.4	11.1	23.3	11.9	9.9	12.1	8.9	10.8	19.4	19.0	6.6	14.0	16.4	14.8	11.8	10.9	7.9	11.4	9.5	6.8	9.8	7.2	6.8	8.6	11.3	8.7	8.2	6.3	7.7	9.7	12.7	5.5	5.3	7.7	10.4	13.8	13.6	8.5	6.8	7.3	6.6	6.6	7.8
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663277	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	14.2	14.2	13.4	17.0	13.7	18.7	14.5	12.2	24.7	9.8	16.0	14.8	7.4	24.3	10.4	9.2	19.8	9.5	13.1	14.2	13.1	10.2	11.6	27.9	10.4	19.9	11.4	11.6	12.1	22.4	5.9	10.0	14.1	12.3	10.0	6.3	10.1	13.2	9.3	50.3	21.9	20.3	9.9	10.0	18.6	21.0	33.6	9.3	16.1	8.6	19.5	18.6	13.1	11.2	15.9	13.6	7.5	13.8	17.1	17.3	9.2	25.9	8.6	7.3	10.4	1.7	2.4	12.5	13.7	5.2	7.9	7.5	17.4	9.1	21.5	8.9	5.7	17.5	4.4	10.2	2.2	14.2	31.8	10.9	9.0	14.4	6.6	21.7	16.1	4.1	8.1	6.5	5.1	7.2	21.9	21.7	4.1	20.9	22.1	10.2	19.5	17.0	16.1	6.3	33.9	6.0	14.5	17.5	13.6	10.3	13.6	14.0	8.7	17.1	9.4	14.4	10.4	21.1	23.3	38.4	19.0	25.2	18.3	12.7	14.8	0.6	9.8	7.5	17.3	11.5	14.2	15.9	15.7	16.7	12.4	15.6	12.2	11.4	2.2	17.1	13.8	13.6	16.8	9.2	13.4	13.7	12.2	24.7	13.1	10.2	11.4	11.6	12.3	9.3
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812708-149962139	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: "	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	24.0	21.3	30.6	19.0	39.4	9.8	28.5	19.9	30.4	19.0	17.7	39.9	16.2	14.3	16.8	33.7	16.8	15.9	20.4	16.4	40.5	29.7	35.8	39.2	31.7	19.6	60.9	26.8	18.1	19.6	23.5	14.9	32.4	40.7	25.5	20.3	19.5	36.1	20.9	18.0	18.4	16.3	20.4	102.2	25.5	17.0	12.5	51.2	13.3	32.1	18.8	15.9	21.4	16.5	8.8	15.7	72.4	31.5	7.8	8.5	14.6	19.4	12.1	8.2	9.3	32.3	19.8	13.7	10.8	27.8	10.4	15.5	10.6	28.0	8.1	15.8	13.2	18.5	11.0	13.8	14.7	9.9	8.0	9.7	5.6	10.3	21.5	10.4	13.9	20.9	26.3	8.8	23.9	11.5	3.0	16.5	9.3	10.9	7.5	6.9	5.5	9.5	5.4	8.8	34.3	20.2	9.1	4.3	12.5	8.9	13.4	34.7	25.5	11.1	12.0	14.2	5.7	15.0	6.9	28.0	18.4	16.7	11.9	9.8	7.6	12.9	20.3	16.6	6.8	25.2	8.5	8.8	7.6	7.6	15.7	8.3	7.3	7.5	72.4	7.8	31.5	11.2	8.3	14.6	30.6	39.4	19.9	29.2	40.5	29.7	60.9	26.8	40.7	51.2
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990291	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008716	Approved		Supported	Cytosol				Cytosol		"HPA008716: AB_1856337"	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.06e-2)"	21.2	29.5	23.7	11.2	33.9	7.8	22.0	22.5	40.2	18.4	18.7	26.2	16.0	15.3	21.0	21.5	15.6	14.3	15.4	32.9	23.6	24.7	31.3	31.3	13.8	13.3	28.9	17.3	15.9	17.1	26.3	28.8	23.6	47.7	21.6	19.8	20.9	18.1	20.1	27.7	11.9	20.9	20.5	26.3	13.8	15.7	33.7	15.0	16.2	26.3	13.3	14.9	16.7	14.0	12.3	17.1	32.6	18.8	16.8	17.0	12.2	12.5	21.0	14.8	29.0	26.6	27.9	9.9	25.8	14.4	18.2	20.2	17.4	14.7	22.2	30.3	26.5	6.9	18.8	25.4	16.3	16.7	16.2	14.1	11.0	7.9	29.3	15.5	12.6	20.9	22.4	24.1	30.4	22.5	17.1	31.1	37.2	15.0	15.0	4.9	6.2	24.0	9.9	16.4	24.1	25.0	21.8	16.3	13.3	22.6	41.5	43.9	28.9	12.1	23.2	24.2	7.8	11.4	24.4	19.6	22.8	20.4	20.7	19.0	29.8	32.6	13.4	13.0	17.0	15.8	16.5	12.3	15.0	16.9	16.2	10.6	11.5	16.7	3.3	16.8	18.8	17.1	16.7	12.2	23.7	33.9	22.5	40.2	23.6	24.7	28.9	17.3	47.7	15.0
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavourable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	13.3	20.1	23.9	15.6	23.0	7.1	24.1	30.2	27.3	11.3	11.7	5.7	5.3	4.7	12.6	13.6	26.7	11.4	20.8	16.8	22.0	8.4	8.2	6.1	30.7	36.3	17.5	9.7	14.1	6.0	26.9	29.0	21.9	18.5	11.8	12.6	10.2	17.8	14.8	5.5	14.9	11.0	13.8	12.4	12.7	11.2	7.9	18.0	12.4	14.3	8.0	19.6	19.3	15.7	8.9	2.7	14.4	2.6	2.1	6.2	1.3	20.1	20.0	30.7	36.8	32.5	14.5	6.0	16.2	28.3	15.0	24.4	6.9	16.8	6.9	29.1	14.2	26.5	24.2	21.3	26.5	28.5	8.6	14.6	22.7	5.7	13.9	9.6	14.0	8.9	38.5	13.9	20.5	14.7	14.5	26.8	14.0	0.5	10.9	3.0	13.2	10.2	14.6	13.4	13.8	20.0	7.0	11.2	20.7	16.3	17.5	26.6	12.3	8.8	15.6	16.8	15.5	13.4	28.6	5.9	8.3	6.5	19.6	12.0	36.0	2.8	2.6	14.4	3.2	2.5	3.7	8.9	4.7	3.8	1.9	4.4	6.2	4.3	9.7	2.1	2.2	2.7	5.7	1.3	23.9	23.0	30.2	27.3	22.0	8.4	17.5	9.7	18.5	18.0
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favourable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favourable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.7	24.8	9.7	18.9	30.2	10.1	14.5	9.1	8.4	10.0	13.4	15.4	7.1	7.9	8.8	14.8	11.5	6.9	12.7	8.4	12.7	24.5	7.5	9.0	21.6	18.7	11.4	22.8	17.7	13.6	9.8	22.2	10.6	7.3	13.6	9.7	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.1	7.3	10.4	11.6	7.1	26.0	20.8	17.8	5.9	18.4	13.3	14.2	8.8	6.6	13.6	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696495-88706421	"Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.9"	"Cell line enhanced"	"Detected in all"		"NB-4: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	9.2	8.1	9.2	22.8	8.9	63.9	10.5	13.7	15.3	6.7	7.2	11.2	3.7	12.0	8.1	8.3	6.4	9.1	12.3	10.0	8.6	7.3	9.6	9.7	20.8	30.5	8.9	6.5	9.7	11.4	5.3	8.5	7.5	8.4	8.9	4.9	11.0	12.1	6.0	14.8	8.2	16.0	8.3	11.1	47.2	10.9	9.2	9.1	21.6	8.8	7.8	23.8	9.7	6.7	2.0	11.8	28.7	12.5	5.5	17.1	9.7	4.1	6.7	5.2	8.2	2.5	2.2	9.9	4.2	2.7	5.0	2.3	4.5	2.7	5.0	5.5	2.4	4.6	3.0	2.8	2.0	2.6	9.0	6.8	4.9	7.6	6.8	6.7	8.7	2.6	2.7	4.0	3.2	5.2	11.3	3.7	2.0	8.2	15.6	43.8	8.5	9.0	14.7	3.3	13.0	2.2	1.9	4.8	5.4	9.6	2.0	5.2	5.7	22.9	7.2	3.8	5.6	5.6	5.1	8.4	4.9	12.2	3.3	25.5	5.2	3.0	12.5	28.7	17.1	9.1	14.8	2.0	10.4	14.8	11.8	1.9	8.7	12.5	20.4	5.5	10.5	7.3	10.5	9.7	9.2	8.9	13.7	15.3	8.6	7.3	8.9	6.5	8.4	9.1
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748868-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA058368"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA038505: , HPA046138: , HPA058368: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	12.3	7.0	12.0	11.6	14.0	23.1	12.0	22.6	15.6	13.1	11.2	12.2	6.3	7.4	14.2	8.2	20.6	10.7	10.8	9.2	12.6	5.9	8.9	9.3	16.9	11.3	15.4	9.1	14.6	10.7	17.5	10.4	8.6	13.9	10.5	10.0	8.4	12.4	8.8	15.0	14.1	10.3	14.2	10.1	12.6	10.3	7.2	14.9	12.6	11.5	7.4	12.5	13.1	15.8	0.6	0.8	5.0	1.9	1.2	1.6	0.6	8.1	6.3	7.6	7.5	5.0	6.6	3.1	6.4	6.1	7.2	6.3	10.5	6.2	14.6	6.6	7.7	7.9	10.3	7.7	9.5	7.3	6.6	10.1	11.6	4.1	5.7	5.3	8.5	6.1	6.1	8.2	18.7	11.6	8.9	11.8	7.2	6.9	9.1	9.6	3.0	4.1	8.6	18.2	8.0	4.6	8.6	3.4	6.2	8.7	6.6	13.9	8.2	6.9	7.7	12.0	10.1	7.5	5.7	8.6	4.5	17.4	2.4	5.9	6.9	2.8	1.9	1.5	1.6	1.1	1.2	0.3	1.5	0.9	0.8	0.6	1.1	0.9	5.0	1.2	1.0	0.8	1.2	0.6	12.0	14.0	22.6	15.6	12.6	5.9	15.4	9.1	13.9	14.9
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165844-64372869	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 54.0"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 24.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol				Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favourable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	8.1	8.1	9.9	3.1	12.8	1.6	6.3	6.0	13.0	10.1	7.1	5.5	20.1	3.4	12.7	11.8	6.9	8.1	7.3	10.4	7.4	10.6	12.4	7.2	6.1	3.4	9.4	9.3	12.0	6.6	54.0	16.1	2.0	10.7	11.5	3.0	11.3	7.3	16.4	4.4	6.6	3.2	15.0	11.0	5.1	5.0	8.1	7.1	0.0	20.6	2.5	2.4	10.9	7.9	2.4	1.0	4.2	1.8	2.0	4.2	0.3	0.0	0.1	1.3	0.0	0.0	0.0	0.3	1.1	0.5	1.1	0.6	0.0	0.1	0.0	0.1	0.8	0.2	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.1	2.6	0.0	0.1	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.5	1.3	0.1	3.3	24.9	1.8	0.3	0.3	0.1	0.0	0.3	0.0	1.3	0.1	0.1	0.0	3.2	0.1	2.8	0.0	0.0	0.0	0.5	0.0	3.5	3.0	1.8	4.2	1.9	0.6	2.5	1.4	3.0	3.2	0.6	2.4	4.2	3.9	2.6	2.0	0.8	1.0	1.8	0.3	9.9	12.8	6.0	11.7	7.4	10.6	9.4	9.3	10.7	7.1
RNF181	HSPC238	ENSG00000168894	"Ring finger protein 181"	Q9P0P0	2	85595725-85597613	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046112, HPA062121"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046112: , HPA062121: "	"unprognostic (3.79e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (1.06e-6)"	"unprognostic (3.24e-1)"	"unprognostic (2.04e-1)"	"prognostic favourable (4.59e-5)"	"unprognostic (1.49e-2)"	32.9	41.5	42.2	26.4	36.2	32.8	40.4	19.0	38.7	34.4	40.5	33.0	36.0	34.5	28.1	44.5	40.2	33.3	34.8	52.4	34.5	32.9	57.8	85.1	36.0	33.1	41.2	29.3	31.6	85.1	21.8	20.2	50.7	36.0	34.2	35.4	32.1	42.1	45.7	47.0	30.4	46.5	33.2	42.2	37.2	35.7	36.3	31.3	31.0	43.7	39.2	42.6	43.8	29.4	53.2	80.2	78.6	94.7	39.3	54.4	83.3	32.2	32.7	25.5	27.6	26.1	32.3	41.2	27.3	53.8	58.3	55.4	49.9	34.3	30.8	53.7	40.5	30.3	22.0	43.7	62.7	35.0	27.1	23.4	16.9	59.9	45.8	25.9	32.1	33.7	58.1	38.8	65.0	48.4	27.4	32.1	78.6	51.7	24.4	60.3	17.8	49.4	26.1	53.6	43.7	54.4	30.1	15.2	20.1	23.1	33.6	44.8	33.3	34.3	41.8	28.6	20.4	57.2	38.9	44.8	37.3	38.6	44.7	39.1	25.1	40.4	94.7	71.6	40.7	69.3	37.7	53.2	42.6	39.1	71.0	44.3	36.7	36.8	78.6	39.3	51.8	80.2	54.4	83.3	42.2	36.2	19.0	38.7	34.5	32.9	41.2	29.3	36.0	31.3
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487061-228495766	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030098	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	15.7	30.3	25.6	12.5	28.1	12.3	10.3	33.2	54.7	11.4	10.7	15.5	12.5	14.7	12.9	12.2	18.0	14.2	14.5	17.7	25.2	24.9	16.2	20.4	11.5	9.8	20.2	29.3	20.2	19.4	22.3	16.4	8.8	22.7	15.0	6.6	12.3	30.3	12.6	55.5	15.5	13.2	8.6	16.3	19.0	14.2	9.5	11.4	11.1	27.9	19.4	11.2	10.0	13.1	2.0	1.7	8.7	2.1	1.0	2.3	0.6	9.3	7.0	4.9	10.3	5.4	3.5	9.5	7.8	4.8	4.9	3.7	3.6	6.5	21.2	16.3	8.9	7.4	6.2	6.6	1.8	9.6	8.0	6.4	5.2	4.6	14.7	7.3	12.6	6.1	11.8	3.8	5.1	4.3	10.2	41.5	3.5	5.2	11.6	6.5	11.0	7.2	9.9	4.5	20.0	3.5	5.9	10.9	11.0	7.9	16.5	21.0	11.6	17.5	9.9	6.1	6.3	6.6	7.4	75.5	22.6	11.6	16.4	7.7	10.2	0.0	1.1	8.7	1.3	2.1	1.5	1.2	1.5	2.3	1.4	2.0	1.4	1.2	0.3	1.0	1.4	1.7	1.3	0.6	25.6	28.1	33.2	47.3	25.2	24.9	20.2	29.3	22.7	11.4
RNF19B	"FLJ90005, IBRDC3"	ENSG00000116514	"Ring finger protein 19B"	Q6ZMZ0	1	32936445-32964685	"Enzymes, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 54.7"	"Cell line enhanced"	"Detected in all"		"Daudi: 38.4;Karpas-707: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049587	Approved		Approved	Cytosol				Cytosol		"HPA049587: "	"unprognostic (2.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"prognostic favourable (3.39e-4)"	"prognostic unfavourable (5.41e-6)"	"unprognostic (8.78e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.39e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.23e-2)"	8.6	11.3	8.0	13.1	10.5	36.4	12.0	14.1	14.1	9.9	13.2	10.1	4.8	14.1	10.8	6.9	23.3	7.9	10.1	8.5	6.0	7.2	12.0	6.5	13.8	12.9	9.6	9.3	7.1	7.0	6.4	5.7	9.4	10.2	7.4	15.3	9.0	10.8	5.7	10.2	13.6	15.5	10.6	8.0	9.0	7.4	54.7	8.3	6.8	8.2	11.1	16.7	11.3	12.8	1.3	1.3	16.1	2.0	0.8	1.6	0.7	6.6	5.1	4.4	4.0	2.7	3.8	29.3	3.0	3.8	5.6	6.0	5.9	19.9	38.4	5.3	4.0	9.5	5.4	7.3	5.1	14.1	3.5	3.3	4.0	5.9	8.6	5.0	7.0	3.1	13.7	12.2	15.1	11.7	4.1	46.2	5.4	2.1	3.3	6.3	7.0	5.8	4.5	6.3	3.9	4.3	9.6	7.0	3.5	9.8	3.4	21.9	2.8	7.4	12.7	3.0	4.2	7.7	5.3	11.1	5.6	13.6	4.4	5.2	4.5	5.3	2.0	3.5	1.6	1.8	1.2	1.2	1.4	0.8	1.3	1.3	0.4	0.6	16.1	0.8	1.5	0.6	1.5	0.7	8.0	10.5	14.1	14.1	6.0	7.2	9.6	9.3	10.2	8.3
RNF207	"C1orf188, FLJ32096, FLJ46380"	ENSG00000158286	"Ring finger protein 207"	Q6ZRF8	1	6205475-6221299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 24.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;HaCaT: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028378, HPA042535"	Uncertain		Approved	Cytosol				Cytosol		"HPA028378: AB_10601157, HPA042535: "	"unprognostic (5.53e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	1.6	2.1	0.6	6.6	1.5	0.3	1.9	5.6	1.8	5.7	5.8	0.9	13.3	2.8	3.6	3.8	4.4	4.7	6.6	24.2	0.7	2.1	5.9	4.3	2.0	2.2	0.7	0.2	3.3	5.3	3.3	4.0	9.2	0.9	7.7	2.4	10.6	6.1	16.6	2.5	1.1	8.2	7.6	1.2	1.9	3.5	1.2	0.6	1.4	6.4	2.8	8.7	5.0	5.0	0.0	0.0	0.0	2.7	0.0	0.3	0.1	2.3	4.4	0.4	3.2	0.2	0.4	2.9	1.5	1.1	0.3	0.4	2.2	17.5	0.3	1.2	1.2	7.5	0.4	1.0	0.1	2.4	1.8	0.1	5.4	2.3	1.5	1.8	0.1	1.3	0.3	0.0	0.0	0.1	0.6	3.9	0.1	1.7	0.2	0.2	0.2	4.0	0.0	0.8	3.1	2.5	3.9	0.5	1.2	2.4	1.6	1.1	2.8	0.1	0.5	0.0	0.7	0.5	0.0	3.7	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.2	0.1	0.6	1.5	5.6	1.8	0.7	2.1	0.7	0.2	0.9	0.6
RNF213	"C17orf27, KIAA1554, KIAA1618, MYMY2, NET57"	ENSG00000173821	"Ring finger protein 213"	Q63HN8	17	80260866-80398786	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Ubl conjugation pathway"	"Hydrolase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003347, HPA026790"	Approved		Supported	Cytosol				Cytosol		"HPA003347: AB_1079204, HPA026790: AB_10602296"	"unprognostic (8.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.97e-3)"	"prognostic unfavourable (4.65e-5)"	"unprognostic (7.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-2)"	17.0	15.1	7.4	16.9	10.3	22.4	10.2	4.7	7.5	11.0	12.2	15.6	14.9	8.5	16.6	13.0	13.2	9.7	12.1	8.5	7.8	7.8	17.1	11.6	15.4	17.9	10.9	5.6	11.5	9.0	41.1	11.4	15.1	10.0	11.2	8.0	12.3	11.7	12.5	9.0	8.7	14.8	13.6	14.3	17.0	10.6	5.9	8.7	24.5	15.9	7.5	18.2	13.6	15.4	7.2	13.9	37.9	9.6	11.4	12.1	1.8	16.1	28.7	2.9	2.0	10.5	16.1	2.2	4.1	8.9	18.5	15.8	3.0	7.5	1.0	3.5	8.5	9.4	3.9	5.3	6.3	36.5	1.7	2.5	11.6	5.3	4.5	2.6	2.6	8.8	3.6	10.4	4.5	14.2	4.6	6.0	6.9	3.9	10.5	1.1	2.1	6.6	7.2	6.7	1.2	5.1	14.0	2.8	3.9	9.9	21.1	7.5	4.8	3.3	18.3	10.3	8.2	6.0	4.2	2.6	2.4	2.9	7.7	3.1	3.7	6.9	9.6	4.2	12.1	8.0	8.1	6.2	8.6	9.7	2.3	7.2	6.9	8.5	37.9	11.4	6.9	13.9	6.4	1.8	7.4	10.3	4.7	7.5	7.8	7.8	10.9	5.6	10.0	8.7
RNF214	DKFZp547C195	ENSG00000167257	"Ring finger protein 214"	Q8ND24	11	117232625-117286445	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 17.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.3;T-cells: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039332	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA039332: AB_10671874"	"unprognostic (7.36e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (6.03e-5)"	"unprognostic (2.06e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	12.9	14.0	13.3	10.5	18.5	11.8	12.3	19.7	21.3	15.4	11.2	22.3	11.7	11.0	17.6	11.8	10.1	11.5	9.6	11.3	13.9	11.3	11.1	12.7	11.6	12.1	14.9	17.4	17.1	28.0	21.5	16.3	12.8	16.6	10.8	12.1	16.8	13.4	13.3	18.4	10.9	10.7	22.2	17.7	12.5	12.9	22.3	14.9	10.9	15.5	11.1	13.6	13.3	12.6	1.8	2.2	4.3	2.1	0.9	17.2	1.3	6.4	8.2	18.4	10.8	9.8	11.1	9.5	12.4	10.4	11.1	12.0	12.9	16.5	8.8	18.2	12.9	9.5	20.3	9.3	14.0	14.7	5.4	27.4	7.1	9.8	18.7	14.5	10.4	8.9	11.0	13.9	20.6	13.9	16.3	9.3	13.6	5.2	10.8	12.9	9.8	7.0	11.7	12.6	11.9	11.3	11.6	11.4	12.8	13.2	8.6	6.1	15.9	11.1	13.7	11.0	9.4	7.3	8.4	5.3	4.2	11.1	4.7	11.6	14.4	4.3	2.1	2.2	2.1	2.0	1.2	1.8	7.2	3.6	1.7	1.7	1.9	1.9	0.9	0.9	1.8	2.2	17.2	1.3	13.3	18.5	19.7	21.3	13.9	11.3	14.9	17.4	16.6	14.9
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.4	15.6	12.8	21.8	15.3	13.3	8.8	15.5	16.3	16.1	14.9	11.3	8.3	12.7	8.0	17.3	10.4	13.3	10.9	13.2	7.9	11.6	9.8	9.5	11.4	18.4	16.0	16.8	13.7	14.0	12.3	15.1	12.7	19.6	8.9	17.8	22.2	6.0	25.5	17.6	13.0	15.3	18.1	7.1	9.6	12.2	9.8	15.6	9.8	24.6	8.8	9.7	16.4	13.8	16.3	29.4	16.6	13.9	7.2	5.4	10.3	12.2	14.9	25.9	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3
RNF219	"C13orf7, FLJ13449"	ENSG00000152193	"Ring finger protein 219"	Q5W0B1	13	78614291-78659179	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034785, HPA034786"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034785: AB_10601496, HPA034786: AB_2674331"	"unprognostic (2.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavourable (4.99e-6)"	"unprognostic (6.87e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-2)"	17.6	7.7	10.7	8.9	15.5	3.4	10.6	24.2	16.3	11.9	8.0	4.7	7.3	7.4	11.3	7.8	8.7	9.1	7.1	10.6	10.7	10.3	7.6	6.7	8.0	13.9	11.9	12.1	12.3	6.6	5.0	11.5	12.2	12.7	10.2	8.5	4.0	7.1	10.1	8.7	8.5	8.7	12.7	13.4	13.6	6.8	21.7	13.4	21.8	9.5	8.5	16.7	12.8	9.2	10.5	7.0	8.2	10.6	12.3	13.3	7.8	11.0	4.3	19.0	11.1	6.7	6.5	8.7	9.2	6.9	9.1	11.5	8.6	8.3	18.6	4.5	5.8	11.0	14.9	7.2	16.0	11.6	10.9	28.5	5.5	7.5	5.6	27.5	8.9	6.1	8.1	7.6	8.2	7.5	7.3	2.5	11.8	3.0	16.6	9.4	0.0	4.8	19.5	15.6	7.2	6.1	5.9	13.9	7.8	6.4	8.1	6.9	4.1	22.2	6.1	7.9	7.2	5.2	7.6	2.7	3.0	17.9	12.7	16.8	8.5	4.8	6.0	8.2	9.5	9.7	11.3	10.5	10.7	11.6	7.0	10.1	13.3	11.9	2.0	12.3	10.6	5.9	10.4	7.8	10.7	15.5	24.2	16.3	10.7	10.3	11.9	12.1	12.7	13.4
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663864-218672411	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA036420: , HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	13.4	12.7	13.9	11.1	16.1	6.2	13.7	13.4	27.6	17.3	13.3	17.1	9.8	4.3	16.6	16.2	12.2	16.8	11.8	17.2	13.1	16.5	13.7	15.6	11.9	12.1	12.1	11.6	17.8	13.0	19.3	14.8	17.7	15.4	14.7	9.0	15.3	13.6	17.9	16.9	15.7	10.3	16.0	10.0	12.9	11.8	18.4	9.1	15.3	16.8	12.7	16.8	14.0	11.8	13.3	8.2	23.3	11.2	14.8	15.0	13.9	5.9	7.6	6.9	8.0	10.5	6.4	7.4	6.7	17.0	23.2	21.7	12.6	4.0	3.9	5.4	14.2	5.4	7.9	13.2	10.1	4.3	10.9	5.4	5.6	11.9	12.9	4.7	5.9	14.2	12.4	21.1	14.2	12.7	9.0	6.2	14.9	16.9	5.3	5.8	10.9	8.7	7.5	4.3	5.8	14.2	6.3	7.0	7.9	5.2	5.8	10.0	6.9	8.8	7.3	13.2	6.3	5.1	9.6	5.3	4.2	6.6	11.1	5.9	8.0	23.3	10.6	14.9	13.9	10.3	12.6	11.9	13.7	13.6	8.2	13.3	15.0	11.7	8.9	14.8	11.2	7.4	11.5	13.9	13.9	16.1	13.4	27.6	13.1	16.5	12.1	11.6	15.4	9.1
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337313	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favourable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (7.73e-4)"	19.0	21.5	13.6	15.4	21.6	25.6	16.9	18.4	38.9	19.8	22.0	17.6	14.5	20.3	31.2	15.6	26.0	24.4	19.8	15.1	17.1	13.8	22.3	28.7	17.3	17.5	15.0	16.6	25.6	18.5	31.4	14.3	27.5	27.2	19.2	18.2	20.2	20.0	28.5	17.6	19.8	21.4	27.0	14.3	19.8	24.3	27.6	13.0	26.7	20.6	14.0	21.1	25.8	18.1	13.8	14.2	7.1	15.5	9.8	16.7	16.2	15.6	17.3	16.2	19.1	16.0	12.7	17.3	17.0	18.4	19.9	15.8	29.2	32.8	13.8	23.6	20.2	28.5	23.0	25.6	12.5	16.5	12.6	36.4	8.1	24.1	12.3	15.2	15.2	13.1	13.2	24.8	22.4	15.1	17.6	21.7	13.6	34.1	13.9	15.8	16.2	22.2	14.5	16.7	11.0	12.2	11.3	11.6	11.2	13.7	17.5	4.5	39.5	12.8	9.9	24.1	16.1	12.6	15.5	5.2	8.5	0.1	8.0	25.8	18.7	7.1	15.5	3.9	16.7	14.5	11.0	9.0	12.7	14.5	14.2	13.8	14.5	12.4	1.1	9.8	14.1	8.1	6.6	16.2	13.6	21.6	18.4	38.9	17.1	13.8	15.0	16.6	27.2	13.0
RNF31	"FLJ10111, FLJ23501, HOIP, Paul, ZIBRA"	ENSG00000092098	"Ring finger protein 31"	Q96EP0	14	24146683-24160661	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB009063, HPA048745"	Approved		Approved	Cytosol				Cytosol		"CAB009063: AB_2127706, HPA048745: "	"unprognostic (3.58e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	14.4	18.5	11.7	21.5	17.4	20.0	15.1	20.0	26.4	17.7	17.3	18.4	19.9	13.4	22.4	22.3	15.4	17.4	17.2	14.5	10.7	9.8	17.2	14.8	15.3	19.3	11.0	18.0	20.6	23.6	20.0	19.2	18.7	13.4	16.4	14.1	16.9	19.6	23.1	39.5	29.1	16.1	19.7	9.1	27.3	16.5	21.8	11.0	33.6	17.4	13.1	24.9	16.3	13.5	2.4	4.6	3.8	3.7	2.5	4.8	1.3	4.4	10.3	9.7	12.0	6.6	6.9	19.7	7.8	11.5	15.3	12.2	9.4	11.2	8.8	4.9	11.0	7.6	5.5	11.0	9.1	9.3	4.2	8.2	10.6	20.6	10.8	13.8	14.7	12.5	9.5	6.9	10.9	9.7	4.8	11.7	6.8	13.8	13.0	8.1	5.2	11.3	8.8	7.2	5.6	7.8	18.4	8.6	10.8	7.1	18.9	9.4	6.6	10.2	9.5	10.8	8.2	7.8	7.3	15.6	13.8	8.6	4.1	5.5	10.0	0.0	2.1	1.5	1.9	3.7	4.8	2.4	1.9	2.1	1.8	1.1	2.3	1.3	3.8	2.5	2.1	4.6	3.0	1.3	11.7	17.4	20.0	26.4	10.7	9.8	11.0	18.0	13.4	11.0
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353972-37394738	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA050731: , HPA064925: "	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	8.0	11.7	13.1	8.2	17.8	8.9	11.5	25.7	18.7	9.2	9.5	10.6	6.8	6.9	13.5	5.7	18.3	12.0	8.8	17.6	13.4	14.8	11.8	7.5	10.8	8.3	12.0	16.0	13.2	6.5	11.9	16.4	10.2	13.7	8.6	8.2	8.0	10.2	11.9	15.2	9.9	8.4	10.7	9.6	7.7	7.6	19.8	13.8	6.6	8.0	9.4	13.3	12.9	15.2	8.8	8.3	2.6	8.1	7.6	10.8	5.5	6.5	3.9	9.5	11.3	7.7	11.1	2.7	6.8	8.4	12.9	14.2	5.8	3.7	8.1	4.2	6.6	6.2	13.2	8.6	13.6	8.5	12.8	14.0	6.9	8.7	4.4	7.4	10.3	5.5	8.3	7.7	9.0	12.4	9.4	2.8	7.4	4.3	9.0	9.2	6.6	5.2	7.1	8.8	5.6	6.6	4.6	18.8	6.3	5.1	5.8	9.4	5.2	7.3	5.6	8.5	7.6	8.0	10.0	8.4	11.1	40.0	4.2	10.6	9.8	1.0	4.6	2.6	10.8	6.0	10.0	8.8	8.1	10.2	8.3	6.0	7.1	9.4	0.6	7.6	8.1	3.6	9.3	5.5	13.1	17.8	25.7	18.7	13.4	14.8	12.0	16.0	13.7	13.8
RNFT2	"FLJ14627, TMEM118"	ENSG00000135119	"Ring finger protein, transmembrane 2"	Q96EX2	12	116738178-116853631	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064161	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA064161: "	"unprognostic (1.56e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.14e-5)"	"unprognostic (8.62e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.36e-3)"	"unprognostic (4.01e-4)"	1.7	3.2	8.8	2.6	15.1	3.5	1.4	13.6	21.0	1.5	1.6	6.6	0.0	2.0	1.5	4.3	1.5	1.5	1.6	1.4	9.9	12.1	2.0	1.0	1.5	4.1	9.7	9.8	1.7	1.4	2.6	7.5	2.9	19.0	1.2	1.7	3.6	2.6	1.2	2.1	2.7	1.8	1.4	6.2	2.9	1.9	7.0	3.4	2.5	2.1	0.0	4.4	1.2	0.4	4.3	2.2	4.0	1.1	2.8	3.1	0.9	1.5	9.0	4.7	15.3	0.2	0.0	7.9	0.6	0.7	1.9	1.7	3.6	1.7	7.9	2.2	0.1	1.9	10.0	0.7	1.8	7.5	5.0	1.5	7.3	4.8	2.0	0.6	4.6	0.2	0.2	3.1	1.0	0.3	6.0	2.9	0.2	7.6	7.7	1.9	4.7	1.8	5.0	2.7	4.1	3.7	1.8	7.3	6.6	2.2	1.2	2.2	7.2	1.7	0.5	1.3	5.2	3.1	3.1	3.6	12.0	8.3	5.7	0.8	1.0	4.0	1.1	1.3	2.0	0.7	0.6	4.3	1.8	1.4	0.6	3.3	2.9	3.1	3.4	2.8	0.8	2.2	1.1	0.9	8.8	15.1	13.6	20.9	9.9	12.1	9.7	9.8	19.0	3.4
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol			27000000	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favourable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	39.8	35.7	18.5	27.6	25.7	40.8	57.9	14.7	33.1	34.9	27.8	43.0	25.9	27.3	36.6	34.2	51.4	30.5	32.8	49.5	20.4	16.5	32.6	46.2	36.1	36.6	37.1	25.3	36.2	32.4	25.7	21.1	35.1	24.3	30.7	8.7	25.6	37.5	33.2	41.6	60.7	26.0	37.7	31.7	29.8	25.3	37.9	29.6	17.1	41.4	41.9	25.8	35.5	38.6	12.9	47.8	10.3	53.3	9.8	12.1	35.3	21.1	30.1	3.3	11.2	18.3	26.1	12.4	19.9	13.8	18.1	15.7	16.8	25.9	11.7	15.4	37.8	19.9	5.7	19.9	2.8	14.9	27.4	7.9	8.3	15.4	61.8	10.4	25.4	22.2	29.6	10.5	13.1	12.3	10.3	19.9	10.3	21.1	8.0	19.7	5.5	30.7	10.2	7.3	15.0	11.1	7.7	9.6	6.6	11.9	17.3	19.8	12.4	32.8	22.0	31.1	9.1	11.2	13.3	12.7	13.5	8.6	33.9	23.6	20.4	5.7	44.4	10.3	10.4	53.3	12.1	12.9	11.2	10.4	47.8	9.5	10.5	9.3	3.2	9.8	48.7	13.9	10.7	35.3	18.5	25.7	14.7	33.1	20.4	16.5	37.1	25.3	24.3	29.6
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179761-11348330	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol			3700000	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	26.9	7.8	14.6	9.5	21.9	4.4	21.4	26.1	26.4	16.6	16.5	5.6	8.6	12.3	22.4	11.0	12.4	13.2	11.9	12.3	13.4	7.6	11.4	12.3	16.7	6.8	7.2	16.7	15.1	8.6	12.9	14.8	18.4	10.3	14.4	20.3	5.6	10.3	14.4	28.0	8.7	13.8	42.9	7.1	12.6	10.7	5.8	9.6	5.9	10.5	5.1	6.2	22.1	20.8	2.5	3.0	3.6	2.2	3.5	3.3	0.9	6.5	15.9	13.2	12.9	23.8	16.7	8.4	15.5	14.5	10.1	10.7	15.0	14.3	8.2	9.2	24.5	7.3	9.5	8.9	16.0	11.7	5.7	16.4	27.4	30.0	8.6	9.1	4.7	13.0	5.7	12.4	8.9	16.1	14.2	3.3	15.0	5.5	6.7	4.7	7.3	9.8	8.1	29.0	2.6	5.5	18.5	6.2	6.6	30.4	10.6	10.6	4.3	5.1	21.9	20.9	15.1	8.3	13.6	2.6	3.2	7.3	9.0	10.8	29.1	3.6	1.8	1.7	2.7	2.2	3.3	1.6	2.2	1.8	1.3	2.5	1.9	2.1	3.0	3.5	1.7	3.0	1.8	0.9	14.6	21.9	26.1	26.4	13.4	7.6	7.2	16.7	10.3	9.6
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615120	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 108.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.8;U-266/84: 18.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028910	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028910: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favourable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	9.4	4.6	16.3	2.3	15.0	0.9	3.6	5.7	18.8	4.9	3.1	5.1	3.3	2.0	3.8	5.7	4.7	7.4	5.2	2.7	14.7	9.2	2.4	3.2	3.0	2.3	18.1	4.7	13.2	3.2	4.8	2.1	1.6	8.7	3.8	3.0	108.1	2.5	5.9	2.2	3.7	1.7	6.3	21.6	2.5	2.4	3.7	7.7	0.7	3.0	2.2	2.6	3.1	9.2	1.1	0.8	0.8	1.2	5.6	3.2	1.4	2.1	1.2	2.2	4.6	3.2	15.6	0.4	1.4	2.5	3.1	2.0	0.6	3.6	2.0	10.0	8.1	2.7	1.0	2.8	0.8	3.6	1.8	1.8	5.3	2.5	9.2	0.7	0.6	17.8	4.1	3.1	6.4	4.7	2.6	4.6	6.2	5.3	1.1	1.5	0.5	3.2	1.1	1.8	12.7	3.4	1.2	2.3	3.3	3.5	4.0	1.6	5.6	0.9	5.4	5.1	1.9	5.9	1.6	2.0	18.7	1.6	9.5	2.1	1.0	0.0	1.2	0.8	0.9	0.3	2.4	0.7	3.2	0.8	0.6	1.1	1.5	1.8	0.4	5.6	1.1	0.8	0.9	1.4	16.3	15.0	5.7	8.4	14.7	9.2	18.1	4.7	8.7	7.7
RP9	PAP-1	ENSG00000164610	"RP9, pre-mRNA splicing factor"	Q8TA86	7	33094797-33109401	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: "	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"	10.1	13.8	11.7	9.4	16.0	20.7	14.9	17.1	16.0	10.9	12.2	13.0	7.0	10.3	14.6	18.8	8.1	10.0	10.7	19.2	11.1	10.1	11.4	11.5	9.7	19.4	17.4	8.6	14.2	16.9	10.4	14.2	11.7	11.0	14.0	11.8	12.8	15.0	14.4	34.7	10.7	12.5	15.7	11.8	17.2	10.5	15.2	12.6	13.6	15.6	9.0	18.2	13.4	16.0	34.1	11.7	8.1	5.0	5.9	8.4	3.3	9.7	14.0	14.8	16.9	9.4	8.9	7.0	12.4	10.6	14.5	11.6	12.4	7.2	12.4	8.2	10.3	9.8	17.9	10.7	18.6	5.6	11.1	9.1	11.1	11.6	16.6	12.1	6.3	8.9	10.1	16.4	32.5	11.8	16.2	11.4	14.4	20.2	12.9	33.2	12.4	10.1	13.0	12.9	8.2	10.4	9.4	14.3	19.7	8.7	19.6	21.2	10.3	16.8	9.4	14.3	20.1	12.7	20.2	18.6	16.8	24.7	10.1	17.2	27.6	6.4	5.0	8.1	6.6	3.6	6.1	22.0	7.0	7.4	5.3	34.1	8.4	7.8	0.9	5.9	4.6	11.7	5.9	3.3	11.7	16.0	17.1	16.0	11.1	10.1	17.4	8.6	11.0	12.6
RPAP1	"DKFZP727M111, FLJ12732, KIAA1403, MGC858"	ENSG00000103932	"RNA polymerase II associated protein 1"	Q9BWH6	15	41517176-41544269	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041739	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041739: "	"unprognostic (8.83e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (4.30e-3)"	10.1	10.2	12.8	8.5	12.4	4.7	8.1	7.8	15.6	7.8	10.2	12.6	7.9	8.5	10.7	6.0	12.3	10.4	6.9	9.5	10.9	6.1	6.7	10.8	7.3	9.8	12.3	10.1	12.4	9.4	12.9	9.4	8.7	11.9	9.4	7.1	9.5	9.8	9.2	27.0	10.3	8.0	10.1	8.0	9.1	9.4	12.6	11.8	11.2	8.3	7.9	10.7	11.2	8.4	5.9	4.5	0.0	5.9	4.9	7.2	3.3	7.1	8.5	11.7	12.3	9.8	7.1	9.9	7.0	6.1	9.1	9.0	23.1	6.5	5.6	11.6	7.8	16.9	21.1	10.3	7.8	9.8	10.2	10.6	11.9	10.1	6.2	8.6	6.7	7.2	13.1	10.9	7.6	10.2	24.6	6.4	8.4	4.5	9.3	5.3	20.6	7.9	16.9	10.1	6.0	4.0	16.8	10.7	14.4	9.0	9.5	4.8	15.6	10.8	9.3	14.4	9.4	14.3	11.2	10.8	29.6	6.3	10.3	9.4	13.5	0.0	2.6	0.0	7.2	3.5	6.6	4.8	4.3	4.5	4.5	5.9	6.1	5.3	0.0	4.9	5.9	2.9	4.4	3.3	12.8	12.4	7.8	15.6	10.9	6.1	12.3	10.1	11.9	11.8
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92298965-92402056	"Enzymes, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA046443: "	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	6.8	7.0	7.8	7.3	10.5	12.0	7.6	27.2	11.6	8.4	6.3	7.1	7.2	6.6	11.1	11.5	5.6	6.3	5.5	5.9	8.1	8.6	8.1	10.6	5.2	8.2	7.7	6.7	8.2	8.6	9.4	16.1	6.7	11.7	7.6	5.8	6.4	7.2	7.1	10.5	10.7	6.3	7.4	9.9	7.6	6.4	6.7	8.7	12.8	9.4	6.5	6.3	6.6	7.6	4.4	3.5	4.9	2.4	4.0	4.8	1.2	6.2	3.8	6.7	6.1	5.5	7.1	5.7	4.9	3.4	3.2	2.7	2.7	2.8	9.3	8.5	3.6	4.3	5.5	3.2	5.0	6.3	4.0	5.7	6.9	3.6	3.3	9.8	5.7	3.6	3.9	4.2	4.1	3.4	5.8	6.2	4.9	3.2	8.3	6.2	5.2	4.3	6.2	8.9	4.0	4.2	5.6	6.2	4.6	8.0	7.3	4.0	3.9	7.5	6.0	4.9	6.2	5.6	6.9	6.0	7.0	4.9	3.4	6.2	3.3	4.8	2.4	1.9	4.1	1.7	4.8	3.4	3.2	3.5	1.8	4.4	3.5	3.8	4.9	4.0	1.9	3.5	2.8	1.2	7.8	10.5	27.2	11.6	8.1	8.6	7.7	6.7	11.7	8.7
RPAP3	"FLJ21908, hSpagh, spag"	ENSG00000005175	"RNA polymerase II associated protein 3"	Q9H6T3	12	47661249-47706061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038311, HPA038312"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA038311: AB_10671527, HPA038312: AB_10672512"	"unprognostic (5.76e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.47e-1)"	"prognostic unfavourable (2.01e-5)"	"unprognostic (9.89e-2)"	"unprognostic (9.87e-3)"	"unprognostic (6.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.11e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-2)"	12.1	13.2	20.3	17.0	19.9	10.6	15.3	23.5	23.2	13.2	16.2	6.7	14.9	13.0	15.7	14.7	16.4	15.2	11.7	15.4	18.4	14.8	12.9	16.0	10.3	25.7	18.8	18.4	23.3	12.1	15.7	24.6	12.3	20.5	14.2	12.5	5.2	14.4	12.8	47.6	11.1	12.8	15.1	22.8	18.2	12.1	14.3	19.1	21.5	13.4	14.4	26.7	16.8	13.2	15.1	10.2	22.7	16.9	9.3	11.5	6.2	15.7	14.8	18.0	12.3	9.7	13.9	15.2	15.7	16.3	20.0	17.2	20.4	18.0	35.0	21.7	13.9	15.8	15.5	9.3	23.4	18.6	14.6	23.6	10.0	9.9	8.4	25.0	16.5	6.8	11.5	23.3	8.5	12.4	25.8	10.8	17.6	11.3	21.4	18.1	19.3	12.7	17.4	21.7	17.1	16.3	14.4	13.0	9.5	18.4	15.2	15.7	15.5	15.1	8.9	13.9	18.4	15.2	17.3	8.5	15.8	25.0	13.0	55.6	8.5	2.6	7.6	22.7	7.9	14.4	8.1	15.1	8.9	8.5	10.2	14.0	11.5	10.3	14.2	9.3	16.9	7.1	10.9	6.2	20.3	19.9	23.5	23.2	18.4	14.8	18.8	18.4	20.5	19.1
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022259	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: , HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	19.4	26.9	20.6	16.7	28.0	14.6	22.6	26.4	27.7	18.7	19.7	23.3	20.7	17.4	27.8	21.5	24.0	17.6	17.3	17.2	21.1	21.0	26.7	23.3	19.4	21.6	21.7	21.7	22.9	14.1	14.8	41.9	24.4	18.6	20.5	26.6	18.9	18.3	27.9	12.3	17.2	16.0	27.1	25.8	15.6	19.8	11.9	19.7	23.5	25.2	14.5	23.2	24.1	20.2	8.6	28.9	8.0	20.5	30.5	10.7	11.3	21.0	27.2	17.7	17.8	28.8	27.9	30.4	27.7	22.2	26.3	35.4	39.2	32.2	14.2	18.2	21.4	20.7	26.0	29.5	40.3	17.0	18.4	26.2	40.0	36.5	39.3	27.8	20.2	19.5	29.4	30.2	39.4	34.2	26.4	19.8	21.6	33.5	15.1	24.2	26.0	20.0	19.0	21.1	20.3	30.4	31.4	21.3	12.2	23.4	22.9	18.5	19.7	32.0	28.0	35.4	23.5	17.2	25.5	11.8	15.0	30.4	25.6	27.5	22.8	6.9	17.3	8.0	10.2	20.5	8.9	8.6	8.0	9.6	28.9	8.4	10.7	9.6	1.7	30.5	13.7	10.6	10.7	11.3	20.6	28.0	26.4	27.7	21.1	21.0	21.7	21.7	18.6	19.7
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;brain: 1.2;pituitary gland: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NB-4: 1.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: , HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.1	0.1	1.0	0.3	0.1	0.1	1.2	0.2	0.0	0.0			0.3	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.4	0.1		0.0	0.8	0.0	1.2	0.2		0.1	0.0		0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.2			0.1		0.1	0.0	0.0	0.4	1.0	0.3	0.7	1.4	0.6	0.2	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.4	0.7	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.3	1.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.7	0.0	0.0	0.1	0.3	0.5	0.2	0.3	0.1	0.3	0.4	0.2	0.1	0.4	0.0	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.7	0.4	0.1	0.3	0.7	0.2	0.5	0.7	0.5	0.4	0.4	0.3	1.0	0.4	0.5	0.6	0.0	1.4	0.4	0.3	0.4	0.2										
RPGRIP1L	"CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134"	ENSG00000103494	"RPGRIP1 like"	Q68CZ1	16	53598153-53703938	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039405, HPA040530"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039405: AB_10794636, HPA040530: "	"prognostic unfavourable (6.93e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.92e-4)"	"unprognostic (5.95e-2)"	3.0	6.5	8.0	3.8	13.8	2.7	6.1	5.3	12.7	6.3	3.3	2.4	6.8	2.4	7.3	7.8	3.9	11.7	4.9	3.3	9.1	9.9	5.5	2.2	3.5	3.1	5.9	13.2	6.5	3.2	18.5	25.8	3.8	9.0	5.2	3.5	1.7	3.4	5.3	2.3	3.6	2.0	6.3	3.5	1.9	3.5	20.9	4.7	3.1	7.6	2.3	3.1	4.4	3.6	4.9	2.0	1.8	1.0	2.1	5.6	1.3	8.9	11.2	10.1	9.2	12.1	11.8	4.4	10.0	6.6	9.4	2.7	6.1	7.3	6.0	7.2	10.3	10.5	8.4	9.6	16.7	3.6	5.9	2.2	9.4	6.1	5.0	5.4	4.1	7.4	5.9	10.5	6.5	7.0	5.5	3.5	13.8	3.4	8.9	3.8	6.4	5.3	15.1	13.8	7.2	12.1	2.4	17.5	6.6	12.4	5.2	4.6	7.9	4.3	6.3	10.2	7.3	8.4	8.9	4.6	5.2	10.7	15.5	3.3	6.0	1.7	0.9	1.1	3.6	1.0	3.5	3.2	2.6	3.3	0.8	4.9	2.6	5.6	1.8	2.1	1.0	2.0	2.1	1.3	8.0	13.8	5.3	12.7	9.1	9.9	5.9	13.2	9.0	4.7
RPL10	"DXS648, DXS648E, FLJ23544, L10, NOV, QM"	ENSG00000147403	"Ribosomal protein L10"	P27635	X	154389955-154409168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB010339, HPA011311"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"		"CAB010339: AB_2181277, HPA011311: AB_1856431"	"unprognostic (2.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (7.67e-6)"	"unprognostic (6.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.68e-2)"	103.6	65.3	41.4	108.0	48.5	103.7	152.6	82.4	70.7	118.2	80.6	44.6	107.8	51.3	100.4	75.5	105.2	122.3	52.6	82.5	38.2	31.9	112.1	155.0	97.6	190.2	48.2	37.4	223.5	242.3	35.0	51.9	87.4	53.1	83.6	77.1	66.7	109.9	101.5	125.9	121.8	108.9	78.7	51.4	93.9	90.5	33.9	47.2	158.9	198.9	137.9	134.4	86.9	119.3	252.9	168.6	64.4	124.1	149.1	304.9	445.3	187.8	87.1	87.3	66.8	198.2	375.4	77.2	72.2	167.6	139.1	177.0	77.2	84.5	372.4	175.0	120.5	73.0	170.8	173.0	119.6	81.8	135.4	50.2	62.4	84.6	233.1	107.9	74.4	283.3	274.0	83.6	261.3	218.2	70.7	119.0	135.8	94.3	117.5	105.0	68.7	150.6	140.9	82.7	206.9	151.8	67.1	70.0	117.0	17.4	153.8	213.5	56.0	150.9	105.0	48.7	92.6	109.6	159.9	283.6	204.8	370.4	74.0	155.8	60.8	64.4	124.1	18.1	149.9	107.7	256.2	252.9	251.6	186.2	151.2	243.2	304.9	231.1	13.0	149.1	94.9	168.6	178.0	445.3	41.4	48.5	82.4	70.7	38.2	31.9	48.2	37.4	53.1	47.2
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468408-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			360000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: "	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	55.0	41.7	35.5	80.8	28.0	79.0	96.9	25.3	37.6	71.5	76.4	22.8	62.3	35.0	91.2	62.5	88.7	91.0	72.6	45.2	28.1	23.1	45.4	71.1	44.8	94.0	28.5	38.0	155.3	141.2	18.6	35.6	56.6	25.6	86.5	55.2	34.7	104.5	66.1	98.5	92.9	47.2	56.8	27.3	51.4	55.5	33.2	20.1	70.6	62.0	121.6	76.5	77.4	86.4	165.3	104.4	8.5	62.8	101.1	186.5	235.1	65.8	68.0	77.4	72.7	116.0	211.6	87.7	68.3	140.6	96.3	76.8	98.4	63.8	197.7	63.0	92.5	58.5	104.2	155.8	80.1	68.5	91.8	75.9	63.0	137.4	171.8	110.6	63.3	245.9	182.7	70.6	237.0	141.0	89.4	97.8	109.2	116.4	116.7	134.5	81.2	60.1	92.4	74.6	153.0	121.7	109.0	54.6	80.0	42.0	96.6	192.8	104.5	201.8	81.3	31.5	56.9	41.8	85.9	61.8	100.6	130.6	39.5	129.1	56.3	8.5	62.8	5.9	82.7	61.2	146.9	165.3	137.8	106.1	104.4	146.8	186.5	145.8	6.1	101.1	52.4	98.5	104.4	235.1	35.5	28.0	25.3	37.6	28.1	23.1	28.5	38.0	25.6	20.1
RPL10L		ENSG00000165496	"Ribosomal protein L10 like"	Q96L21	14	46651010-46651821	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"testis: 45.5"	"Cell line enriched"	"Detected in single"	45	"U-2 OS: 29.6"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 6.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011311	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA011311: AB_1856431"	"unprognostic (7.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.70e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.3	0.6	0.4	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.4	0.3	0.5	1.0	0.6	0.8	0.2	0.7	0.9	0.9	0.0	0.4	0.2	0.4	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560657-89566828	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"			53000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: "	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	82.5	56.0	46.7	105.0	38.4	112.7	150.9	37.7	44.0	114.5	114.9	31.3	76.9	65.5	118.4	85.4	144.0	98.4	101.6	85.2	38.6	32.1	60.8	118.3	90.4	385.1	38.8	37.4	231.3	255.8	36.5	57.5	66.0	27.0	136.2	44.4	43.0	267.3	87.6	197.4	137.7	66.7	90.2	44.8	104.7	71.1	106.5	24.6	135.0	102.4	129.6	98.6	109.3	156.8	277.8	163.1	26.9	96.9	120.7	299.0	355.4	66.8	74.4	52.9	85.7	95.2	158.6	110.8	42.3	91.7	88.4	35.9	112.3	103.8	94.1	87.4	71.7	93.1	62.8	111.2	44.1	26.3	174.3	32.0	41.5	148.9	203.8	38.9	39.1	192.1	237.1	56.6	142.9	92.1	97.8	53.7	67.9	209.5	106.4	305.2	108.1	79.1	158.7	56.0	132.2	107.3	56.2	74.6	109.1	58.6	76.5	126.9	150.5	231.1	53.7	57.1	61.7	50.3	57.9	81.4	76.5	96.0	74.6	137.3	60.0	26.9	96.9	15.3	129.1	74.9	239.2	252.5	234.3	176.5	116.8	277.8	299.0	230.2	10.7	120.7	56.7	163.1	163.7	355.4	46.7	38.4	37.7	44.0	38.6	32.1	38.8	37.4	27.0	24.6
RPL13A	"L13A, TSTA1"	ENSG00000142541	"Ribosomal protein L13a"	P40429	19	49487554-49492308	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA038751	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA038751: AB_10962004"	"unprognostic (2.35e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (9.97e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (7.81e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.87e-1)"	85.4	87.0	45.7	114.3	46.9	132.5	106.4	38.9	41.2	103.8	145.5	38.8	89.2	84.1	129.4	80.7	117.7	83.5	119.9	112.5	37.2	31.2	65.4	113.9	71.8	265.3	41.5	37.0	203.8	334.9	21.8	54.2	76.7	44.1	114.3	46.8	65.4	169.0	95.4	216.0	122.9	77.0	121.1	44.2	121.4	87.8	54.5	27.8	124.0	119.8	147.0	115.0	112.7	196.5	284.6	144.9	40.5	81.3	148.0	268.3	354.3	119.8	147.3	70.1	204.6	133.7	211.9	83.5	104.9	129.9	75.6	82.1	124.9	92.1	304.0	84.4	78.4	79.5	87.4	151.7	44.8	85.1	205.9	153.4	95.9	178.0	163.0	230.4	122.0	245.0	253.4	53.6	182.2	121.9	132.1	114.7	87.0	104.2	161.0	234.1	135.5	132.6	156.6	160.0	132.5	102.7	203.6	120.2	158.1	54.8	244.2	231.7	107.7	265.9	150.1	95.5	103.1	59.2	138.0	116.1	157.4	137.2	59.7	158.0	87.6	40.5	81.3	20.7	132.2	70.3	194.3	284.6	226.2	180.3	126.7	264.8	268.3	212.3	13.6	148.0	60.4	144.9	165.3	354.3	45.7	46.9	38.9	41.2	37.2	31.2	41.5	37.0	44.1	27.8
RPL14	"CTG-B33, hRL14, L14, RL14"	ENSG00000188846	"Ribosomal protein L14"	P50914	3	40457292-40468587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 92.6;hTCEpi: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004136	Approved		Supported	"Endoplasmic reticulum,Cytosol"			210000	"Endoplasmic reticulum, Cytosol"		"HPA004136: AB_1079839"	"unprognostic (1.36e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.15e-1)"	49.9	33.5	28.3	57.4	43.8	47.2	134.4	28.7	57.6	85.4	68.2	21.4	48.0	29.8	87.0	30.9	66.0	61.0	56.7	46.7	40.8	22.8	42.5	69.8	44.6	61.7	24.7	22.2	151.9	117.3	48.4	34.4	60.8	40.6	81.8	42.0	36.2	162.9	73.6	72.3	66.7	39.0	59.1	24.7	69.6	52.4	23.8	11.7	42.9	63.3	100.2	58.5	48.7	77.0	26.6	16.0	4.6	11.6	14.3	38.3	47.9	9.5	5.3	32.5	11.5	26.3	92.6	18.9	14.7	49.3	55.5	42.1	11.1	3.8	41.9	12.4	14.5	2.9	16.5	25.7	32.7	14.2	18.2	20.1	9.2	10.6	40.3	28.5	10.8	44.8	96.7	15.8	33.5	50.8	23.6	5.9	38.4	9.2	9.4	26.0	9.3	17.3	4.4	12.3	20.3	41.1	7.1	10.1	16.3	7.7	7.5	22.3	11.7	15.7	16.9	11.3	8.2	14.3	18.6	18.3	22.0	22.9	5.0	21.5	10.4	3.7	11.6	4.6	21.1	11.6	35.5	26.6	31.7	27.7	16.0	24.1	38.3	34.9	1.8	14.3	9.9	14.6	24.9	47.9	28.3	43.8	28.7	57.6	40.8	22.8	24.7	22.2	40.6	11.7
RPL17	"L17, rpL23"	ENSG00000265681	"Ribosomal protein L17"	P18621	18	49488453-49492523	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043724, HPA046385"	Supported		Supported	"Endoplasmic reticulum,Cytosol"			28000	"Endoplasmic reticulum, Cytosol"		"HPA043724: , HPA046385: "	"unprognostic (1.11e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavourable (3.60e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-3)"	59.6	60.0	40.5	57.8	58.1	101.1	127.2	41.7	42.9	66.7	64.4	26.3	67.8	40.9	64.1	65.5	84.9	76.7	79.7	49.5	32.2	31.1	99.4	184.2	48.0	106.0	42.9	32.3	177.4	203.2	21.7	72.5	77.1	43.6	60.7	53.1	39.8	83.3	83.8	67.6	76.3	69.7	43.7	38.1	78.5	66.8	92.7	32.9	66.6	81.7	146.2	75.2	58.2	70.4	140.6	102.8	22.2	59.2	95.1	158.9	142.2	98.1	62.5	91.1	107.5	150.7	308.0	86.8	110.5	128.7	104.8	79.5	84.0	47.9	170.4	76.3	109.2	117.9	123.5	198.2	112.3	70.6	127.7	89.9	74.3	114.4	131.4	291.6	72.3	293.3	224.7	109.1	258.9	143.1	87.9	125.1	130.0	79.8	105.2	187.3	92.7	51.4	104.6	118.7	219.3	141.9	117.7	69.8	84.2	40.8	85.1	170.8	80.5	191.1	113.6	77.8	66.2	38.1	115.9	112.9	105.2	157.8	74.4	177.7	74.0	22.2	59.2	15.2	82.8	53.2	158.9	140.6	134.5	109.0	93.7	117.9	150.4	127.9	12.7	95.1	43.8	102.8	104.8	142.2	40.5	58.1	41.7	42.9	32.2	31.1	42.9	32.3	43.6	32.9
RPL17-C18orf32		ENSG00000215472	"RPL17-C18orf32 readthrough"		18	49481681-49492479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043724, HPA046385"	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA043724: , HPA046385: "	"unprognostic (1.62e-1)"	"unprognostic (1.67e-2)"			"unprognostic (1.70e-3)"	"unprognostic (3.83e-4)"		"unprognostic (1.95e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"		"unprognostic (2.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"		"unprognostic (5.42e-2)"		7.8	34.4	16.3	17.1	12.5	7.2	8.5	23.6	28.6	9.7	10.7	3.5	11.5	22.8	10.4	9.9	14.8	5.9	13.8	13.7	11.8	14.8	17.6	34.0	8.9	18.9	14.8	4.6	10.5	37.7	3.4	13.7	13.3	6.8	9.6	5.3	6.1	12.6	14.6	11.4	5.6	15.2	5.8	14.1	13.5	10.4	16.3	4.7	11.2	14.2	26.7	12.9	9.1	7.0	6.7	10.6	9.7	9.3	5.8	9.7	10.2	6.6	3.2	13.3	15.7	15.2	9.7	0.3	6.8	5.7	2.6	7.8	2.1	13.7	3.9	3.6	7.2	7.6	10.6	2.2	9.3	8.3	3.5	7.3	2.1	2.8	3.4	7.4	17.2	16.1	5.7	4.1	9.5	3.6	1.5	17.6	15.9	3.2	11.2	5.8	5.9	0.3	6.3	6.1	12.1	22.7	0.7	12.7	23.9	3.1	11.8	15.9	14.8	17.2	1.5	7.6	3.5	8.0	3.8	6.7	8.7	6.5	11.1	4.7	9.7	3.5	9.3	4.9	7.1	6.4	9.2	6.7	9.2	9.4	10.6	6.2	6.3	9.7	9.7	5.8	6.1	7.1	8.4	10.2	16.3	12.5	23.6	11.7	11.8	14.8	14.8	4.6	6.8	4.7
RPL18	L18	ENSG00000063177	"Ribosomal protein L18"	Q07020	19	48615328-48619536	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"NB-4: 548.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046572	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			100000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA046572: "	"unprognostic (2.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.27e-2)"	56.2	57.3	50.3	79.1	40.8	122.4	84.9	35.2	51.1	89.8	76.6	44.8	60.8	66.1	100.6	56.1	129.6	78.2	99.2	43.4	38.3	33.1	56.4	101.9	62.1	194.1	40.3	27.0	206.5	260.5	19.8	57.1	74.8	26.8	100.5	39.6	54.6	136.7	62.3	78.8	108.6	60.5	69.1	39.7	88.7	64.0	45.8	28.6	114.9	115.8	116.5	122.2	91.2	90.5	137.1	84.5	19.0	57.5	71.1	144.1	148.6	57.1	89.2	32.9	57.0	33.5	66.1	48.0	26.3	43.8	54.5	45.9	80.4	53.2	83.7	27.6	25.1	47.4	29.8	59.7	20.8	35.6	103.8	30.3	41.7	76.8	67.8	42.1	47.3	77.9	87.7	29.2	39.4	53.6	42.7	73.7	34.2	72.6	66.2	548.2	52.3	44.5	69.4	26.4	75.8	44.1	70.7	46.7	60.9	23.7	83.6	79.3	47.1	82.1	30.5	40.5	45.0	25.0	60.2	61.3	71.4	49.9	25.4	65.1	47.6	19.0	57.5	12.2	65.7	47.6	115.3	130.3	116.4	88.1	79.2	137.1	144.1	113.9	8.6	71.1	37.3	84.5	89.6	148.6	50.3	40.8	35.2	51.1	38.3	33.1	40.3	27.0	26.8	28.6
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859876-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 430.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055259	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA055259: "	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	48.8	33.8	24.9	42.2	43.0	85.7	53.6	27.8	61.1	49.9	46.0	26.5	28.1	40.4	47.8	36.4	65.5	56.5	38.9	31.5	22.6	16.2	50.0	85.9	34.8	83.7	22.3	26.1	109.2	106.6	9.3	30.5	46.9	30.9	41.8	26.8	30.4	99.8	31.6	157.7	90.1	43.3	36.6	21.9	57.6	50.1	67.3	17.6	59.5	65.3	107.9	54.0	45.0	57.1	395.8	193.6	24.8	110.7	126.0	278.4	430.5	126.2	98.4	65.8	92.7	98.8	162.8	166.6	77.5	98.6	102.7	97.9	135.8	127.2	191.2	179.9	66.7	95.2	77.5	165.1	35.9	97.7	208.8	89.3	94.7	154.6	171.1	128.4	97.8	203.2	217.7	56.8	122.4	112.2	113.4	124.0	64.8	197.0	173.7	169.6	154.7	151.8	156.3	69.8	226.6	93.7	120.2	95.3	143.0	27.5	192.2	240.0	91.2	249.6	86.0	63.6	74.1	127.0	130.0	166.3	151.2	123.4	83.6	205.6	78.9	24.8	110.4	16.5	134.8	110.7	234.6	368.3	232.2	167.1	166.6	395.8	278.4	212.5	11.3	126.0	85.6	193.6	195.9	430.5	24.9	43.0	27.8	61.1	22.6	16.2	22.3	26.1	30.9	17.6
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204727	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"SK-BR-3: 937.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol			100000	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: "	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	72.3	57.7	51.3	56.7	56.9	122.5	94.7	41.8	88.6	72.2	64.5	42.2	62.7	48.7	67.0	56.7	77.7	78.1	65.9	87.3	49.2	37.0	62.3	124.4	70.7	229.5	50.5	53.0	156.4	124.4	33.1	51.7	57.3	58.7	60.0	52.5	48.1	113.8	67.6	91.4	95.8	58.8	57.5	57.1	74.4	66.1	45.2	34.1	53.0	63.3	94.9	103.4	63.1	75.9	208.2	143.4	40.4	108.7	116.2	236.3	325.8	47.0	64.0	46.4	56.3	85.0	107.5	48.1	44.3	90.4	91.7	73.8	69.7	44.5	115.2	78.0	63.2	80.0	69.8	91.6	47.3	46.7	122.5	41.1	47.8	90.7	132.6	100.6	56.9	119.7	100.6	70.6	127.9	79.1	71.4	67.4	63.3	46.4	133.2	140.6	47.5	47.7	79.0	66.1	115.1	82.7	59.0	56.5	62.8	26.6	937.7	138.3	90.8	128.1	46.5	35.9	48.5	54.6	81.4	89.0	88.1	84.7	48.7	76.8	46.1	36.7	108.7	40.4	116.1	90.3	180.1	208.2	187.2	146.8	143.4	193.1	236.3	190.8	17.1	116.2	72.6	132.4	146.2	325.8	51.3	56.9	41.8	88.6	49.2	37.0	50.5	53.0	58.7	34.1
RPL21	"DKFZp686C06101, FLJ27458, L21, MGC104274, MGC104275, MGC71252"	ENSG00000122026	"Ribosomal protein L21"	P46778	13	27251309-27256691	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047252	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			22000	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA047252: "	"unprognostic (4.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.55e-2)"	"unprognostic (7.72e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-1)"	54.7	44.0	57.3	52.2	68.7	133.6	105.9	39.8	50.7	63.7	61.7	46.3	32.7	42.7	57.8	53.0	59.3	57.7	55.0	63.9	48.0	36.8	64.3	148.7	44.8	100.9	53.6	44.4	142.9	109.8	19.0	48.2	57.8	61.2	52.5	57.2	36.5	85.7	47.2	68.0	72.2	66.3	64.4	48.7	72.8	58.0	46.4	50.0	60.5	58.3	87.6	92.6	59.1	64.9	178.1	103.2	34.8	57.9	95.6	224.2	258.9	56.3	47.4	83.9	67.7	87.5	166.6	71.1	102.5	94.0	80.5	52.3	114.2	105.2	216.5	39.6	81.4	75.6	96.1	104.3	95.2	68.3	87.5	169.2	48.2	88.2	82.8	230.9	67.2	148.0	171.2	52.6	134.1	90.1	69.8	53.9	91.2	80.5	116.3	143.6	109.5	79.6	87.0	161.2	90.8	75.1	67.9	72.7	67.7	47.6	95.8	83.1	64.4	206.6	99.5	35.8	46.7	56.1	83.6	36.5	51.2	161.3	45.8	147.7	60.6	34.8	55.8	22.1	101.6	56.9	162.9	178.1	153.1	125.7	75.9	164.1	224.2	177.8	11.9	95.6	57.9	103.2	104.1	258.9	57.3	68.7	39.8	50.7	48.0	36.8	53.6	44.4	61.2	50.0
RPL23	"L23, rpL17"	ENSG00000125691	"Ribosomal protein L23"	P62829	17	38847865-38853843	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003373	Approved		Supported	Cytosol			76000	Cytosol		"HPA003373: AB_1856436"	"unprognostic (1.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (4.19e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.45e-1)"	103.1	79.0	47.1	86.5	56.3	125.2	175.1	35.2	54.6	117.2	86.6	26.4	106.1	48.7	93.4	115.8	132.6	92.1	119.4	163.9	58.9	39.5	79.6	107.5	112.3	239.3	52.1	51.0	240.1	329.6	33.8	55.3	68.4	73.2	99.9	76.1	52.5	114.5	101.3	150.0	119.8	69.5	192.7	72.8	95.5	80.1	49.2	42.6	89.3	95.2	117.3	132.0	152.4	207.2	160.0	168.4	29.0	94.3	87.5	176.7	163.2	90.9	91.6	121.0	102.4	216.4	284.5	84.9	91.4	138.5	115.3	86.8	132.0	81.4	202.8	91.1	100.4	161.1	104.8	177.3	141.6	70.1	156.6	74.5	120.1	187.8	162.6	205.1	78.4	266.6	221.1	100.0	209.9	122.0	117.8	102.9	148.0	81.6	179.8	219.7	88.3	55.8	122.6	177.5	199.0	161.0	116.0	82.4	122.5	49.1	84.9	184.0	140.4	258.1	85.2	53.2	81.8	83.1	151.5	66.7	102.4	158.8	81.5	123.3	68.4	29.0	94.3	19.6	82.3	76.6	101.9	160.0	130.7	100.1	134.8	149.7	176.7	145.4	15.2	87.5	65.5	168.4	95.4	163.2	47.1	56.3	35.2	54.6	58.9	39.5	52.1	51.0	73.2	42.6
RPL23A	L23A	ENSG00000198242	"Ribosomal protein L23a"	P62750	17	28719393-28724359	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 261.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051754, HPA077474"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			15000	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA051754: , HPA077474: "	"unprognostic (1.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (5.16e-6)"	"unprognostic (3.91e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.68e-1)"	49.1	38.5	48.6	43.3	62.1	67.9	87.0	40.6	75.5	63.8	47.0	27.3	48.5	34.8	53.2	44.0	56.5	64.1	35.1	48.8	56.6	28.7	39.5	93.2	62.3	108.0	42.6	39.6	142.1	63.3	21.4	45.3	51.0	40.5	44.9	48.8	27.6	61.3	41.7	64.9	70.5	44.6	39.8	63.4	59.1	47.8	108.1	35.7	56.1	44.4	78.8	84.9	51.1	61.0	261.4	139.2	30.6	75.3	142.1	254.7	206.1	58.8	120.4	72.8	90.3	96.5	155.5	71.0	55.4	97.1	93.8	79.3	122.4	57.2	133.3	52.2	76.8	80.6	95.9	123.5	97.3	70.5	265.1	63.7	118.3	130.3	87.9	132.2	66.7	151.2	159.1	74.6	118.0	101.5	82.6	90.5	93.8	97.4	147.6	174.4	69.3	73.4	87.5	131.6	157.5	101.6	120.5	75.3	87.8	39.3	285.5	123.9	141.9	155.4	60.1	51.6	73.6	60.1	97.8	112.9	104.2	77.9	81.8	73.2	56.9	30.6	66.3	19.4	156.5	75.3	232.3	261.4	227.4	203.4	108.7	227.4	254.7	229.5	9.4	142.1	59.6	139.2	154.0	206.1	48.6	62.1	40.6	75.5	56.6	28.7	42.6	39.6	40.5	35.7
RPL24	L24	ENSG00000114391	"Ribosomal protein L24"	P83731	3	101681091-101686782	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA051653	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			19000	"Endoplasmic reticulum, Cytosol"		"HPA051653: "	"unprognostic (7.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (2.72e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.08e-1)"	"prognostic favourable (8.25e-4)"	"unprognostic (5.37e-2)"	61.3	58.9	60.6	99.3	68.8	87.9	135.5	73.0	90.1	94.7	64.0	15.8	84.3	49.6	74.2	98.0	75.5	65.4	82.9	110.0	45.6	43.8	58.3	70.3	122.0	256.0	50.7	46.3	174.7	211.4	25.9	65.5	68.2	53.4	69.0	54.7	30.4	133.9	109.9	175.9	66.2	46.2	98.7	80.7	51.4	60.5	30.2	44.1	61.3	84.7	134.3	71.7	105.1	175.4	128.2	107.7	29.6	65.6	85.5	173.8	214.1	163.5	54.4	83.4	92.0	91.5	164.0	126.3	94.3	105.4	127.5	93.5	108.2	72.5	180.5	117.0	72.1	87.1	96.6	116.8	127.8	96.7	96.9	107.0	47.2	80.9	89.9	120.3	56.7	159.1	149.9	80.2	143.3	107.9	97.9	90.1	117.2	109.3	128.2	184.3	150.1	118.2	113.1	82.3	172.4	130.1	73.0	178.7	83.1	49.1	88.3	209.1	107.9	221.4	78.8	55.6	103.2	30.4	114.6	79.2	101.1	315.6	74.5	127.4	93.2	29.6	65.6	16.3	86.1	57.1	125.2	128.2	136.4	104.2	90.5	127.0	173.8	132.3	10.9	85.5	56.9	107.7	121.1	214.1	60.6	68.8	73.0	90.1	45.6	43.8	50.7	46.3	53.4	44.1
RPL26	L26	ENSG00000161970	"Ribosomal protein L26"	P61254	17	8377516-8383250	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 586.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030449, CAB037301"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"CAB037301: AB_796168, HPA030449: AB_10602125"	"unprognostic (2.02e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.38e-1)"	122.5	64.5	70.2	102.5	49.8	132.2	170.4	44.4	52.4	127.6	131.6	34.8	68.1	53.1	76.4	97.0	161.2	87.6	98.6	68.1	54.8	42.5	100.6	138.3	97.5	117.5	61.6	32.6	183.0	586.0	32.2	41.1	82.2	47.7	129.0	84.0	41.5	95.3	87.4	170.8	106.3	98.6	103.6	62.9	129.0	75.9	53.0	45.1	104.9	131.6	145.8	107.9	154.7	127.6	154.9	120.8	25.1	92.1	93.0	158.2	165.0	101.9	93.8	92.3	109.2	174.4	287.2	90.3	88.6	131.8	120.3	90.9	99.1	52.5	178.2	101.9	104.9	113.3	117.4	181.5	141.7	66.5	211.4	69.5	103.6	114.3	203.9	103.2	90.2	244.7	363.4	99.6	299.5	148.1	78.7	53.7	126.3	70.1	113.8	141.3	86.8	62.3	113.7	93.8	110.8	161.7	76.6	38.4	82.0	47.7	89.2	204.8	91.2	138.3	92.8	48.7	60.8	67.1	155.0	43.2	50.4	77.9	79.7	146.9	72.1	25.1	92.1	18.2	89.9	78.3	130.5	154.9	134.3	116.8	120.8	140.1	158.2	136.0	10.9	93.0	69.5	104.5	111.3	165.0	70.2	49.8	44.4	52.4	54.8	42.5	61.6	32.6	47.7	45.1
RPL26L1	RPL26P1	ENSG00000037241	"Ribosomal protein L26 like 1"	Q9UNX3	5	172958729-172969771	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030449	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA030449: AB_10602125"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (2.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-3)"	11.2	23.0	17.9	14.7	17.9	18.0	15.2	10.5	21.1	13.1	12.8	8.2	14.4	13.5	14.5	21.6	18.1	14.7	11.9	19.5	20.7	16.8	20.0	25.9	10.5	16.7	16.2	18.0	14.1	25.5	9.1	15.4	14.2	16.3	12.1	14.6	11.5	18.4	16.7	19.0	9.7	10.8	14.0	12.8	13.3	12.2	73.6	11.8	20.0	16.2	18.2	14.9	13.1	11.9	19.7	40.0	17.5	36.2	14.6	21.7	20.9	29.6	26.9	24.4	33.5	16.9	17.9	31.7	28.4	16.7	41.1	36.7	32.8	32.0	22.4	73.0	38.9	19.3	40.2	56.4	38.0	28.5	52.3	16.5	31.6	40.1	33.3	24.0	14.7	22.3	23.9	42.3	29.7	23.5	22.6	18.9	29.2	65.9	29.3	38.0	15.5	42.9	21.4	37.8	29.7	23.9	18.7	24.6	15.1	26.0	23.9	37.7	29.3	25.9	24.7	47.0	26.1	27.4	21.3	16.9	26.3	41.8	37.0	30.2	27.8	7.8	36.2	15.5	14.3	31.4	18.3	19.7	17.4	19.6	40.0	15.1	14.5	18.4	17.5	14.6	26.8	27.5	21.7	20.9	17.9	17.9	10.5	21.1	20.7	16.8	16.2	18.0	16.3	11.8
RPL27A	L27A	ENSG00000166441	"Ribosomal protein L27a"	P46776	11	8682411-8714759	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 555.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060776, HPA063379"	Supported		Enhanced	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA060776: , HPA063379: "	"prognostic favourable (7.84e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (2.83e-10)"	"unprognostic (2.28e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-2)"	65.9	58.8	49.6	116.1	81.5	146.4	149.4	47.8	80.5	69.7	69.9	25.1	64.2	60.1	73.2	74.9	98.4	76.4	88.5	103.5	59.9	33.9	57.0	71.3	111.1	316.9	44.5	49.3	132.2	278.5	10.4	54.6	64.8	64.0	70.1	75.7	42.1	115.8	70.1	124.6	97.9	69.2	109.2	47.1	92.0	72.4	56.8	28.5	74.6	89.3	127.5	120.5	71.0	128.7	341.9	188.5	71.3	122.3	161.9	351.8	555.6	168.0	117.0	74.8	89.7	103.0	197.1	113.1	109.3	138.1	125.4	96.4	147.9	157.1	238.4	86.4	95.6	123.0	98.6	152.4	94.5	87.0	212.0	105.0	114.3	182.4	171.0	190.1	123.6	215.3	272.6	19.7	209.3	124.2	108.0	75.3	105.9	126.6	141.6	286.6	121.5	122.6	124.0	78.6	144.9	117.8	168.5	85.6	153.9	40.5	155.7	169.7	68.8	217.9	112.7	40.8	110.2	105.0	138.0	85.8	187.9	195.0	93.9	130.3	74.1	71.3	122.3	37.8	208.1	119.1	266.8	341.9	295.7	244.4	188.5	301.2	351.8	290.3	29.7	161.9	108.1	180.0	198.2	555.6	49.6	81.5	47.8	80.5	59.9	33.9	44.5	49.3	64.0	28.5
RPL28	"FLJ43307, L28"	ENSG00000108107	"Ribosomal protein L28"	P46779	19	55385345-55403250	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA050459	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA050459: "	"unprognostic (4.70e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.53e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (6.61e-5)"	"unprognostic (4.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.93e-3)"	91.7	86.3	81.9	112.8	68.3	166.7	88.9	32.8	84.1	117.1	107.7	86.7	71.1	89.9	144.6	81.3	224.2	105.0	118.0	72.9	66.2	54.4	87.1	228.8	133.0	398.1	70.4	50.7	200.5	198.5	25.5	73.7	88.7	53.2	122.7	61.2	88.0	143.3	77.9	102.1	136.4	108.1	76.8	70.7	205.5	85.8	75.9	27.4	375.5	144.6	108.5	269.6	131.8	121.7	139.5	93.6	27.8	77.2	66.7	146.6	190.9	119.3	139.0	48.4	96.1	86.5	139.3	81.7	81.1	77.6	71.0	65.9	135.4	63.8	179.5	58.4	73.4	75.2	55.0	104.2	31.5	69.4	312.4	110.7	87.9	164.7	143.9	128.7	97.6	195.4	149.9	52.7	106.9	76.2	85.6	147.8	63.2	138.0	143.8	119.7	115.9	152.1	146.0	69.8	136.6	89.9	239.2	61.7	102.0	51.6	170.2	122.1	70.7	138.0	92.3	63.5	71.6	50.8	128.5	121.9	175.6	112.0	81.1	157.6	53.5	27.8	77.2	21.9	77.0	67.8	119.7	137.8	129.9	101.2	93.6	139.5	146.6	130.8	24.4	66.7	56.3	88.3	117.7	190.9	81.9	68.3	32.8	84.1	66.2	54.4	70.4	50.7	53.2	27.4
RPL29	"HIP, HUMRPL29, L29, RPL29P10"	ENSG00000162244	"Ribosomal protein L29"	P47914	3	51993600-51995942	"Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 434.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA069064	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA069064: "	"unprognostic (3.77e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	91.6	61.7	42.5	64.6	33.0	110.2	111.0	30.1	39.7	102.4	98.1	30.3	57.1	53.6	59.6	72.8	124.7	76.0	68.7	72.1	33.8	26.0	55.7	122.9	64.8	219.4	36.0	26.0	150.1	434.1	16.3	34.3	50.7	26.3	91.1	41.2	38.9	103.7	54.8	160.8	102.5	73.8	80.2	38.1	83.9	59.7	58.7	25.2	85.9	83.3	123.3	92.4	88.5	87.1	137.9	98.1	32.8	80.0	74.8	132.2	202.9	69.2	90.1	69.5	105.9	123.9	194.9	98.1	77.5	95.8	106.5	88.7	107.2	106.5	193.8	33.8	78.7	63.1	100.2	164.9	51.0	78.8	136.3	100.3	116.5	178.9	147.0	145.5	96.8	238.2	234.6	78.5	139.9	119.2	78.2	148.9	78.5	158.2	126.2	189.2	115.4	153.0	58.7	76.6	187.9	136.2	144.9	56.2	109.7	58.0	133.9	132.4	100.2	248.9	103.3	59.8	80.4	92.2	115.5	97.1	137.7	137.8	79.1	174.5	79.0	32.8	80.0	22.6	68.8	61.7	115.0	137.9	112.2	87.6	98.1	128.2	132.2	109.9	10.8	74.8	48.4	82.8	100.8	202.9	42.5	33.0	30.1	39.7	33.8	26.0	36.0	26.0	26.3	25.2
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol			120000	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: "	"unprognostic (9.79e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.32e-2)"	71.7	71.8	51.3	72.3	50.3	107.0	134.5	50.8	49.3	102.2	94.4	42.7	78.1	63.1	207.5	79.6	126.9	101.6	96.2	54.5	41.4	38.8	66.6	102.5	74.5	205.9	47.4	57.7	217.8	453.1	50.9	75.0	74.5	58.0	138.7	57.0	74.8	216.3	68.5	48.9	118.1	62.6	115.6	50.7	84.3	74.4	76.4	23.3	105.5	158.5	82.3	109.8	119.9	105.7	198.9	114.8	18.9	56.4	150.3	249.0	326.4	86.4	80.1	91.6	101.3	117.3	254.3	123.5	67.0	127.6	67.1	60.3	100.6	66.1	357.7	92.9	80.7	57.6	97.7	143.3	44.7	60.8	96.3	90.0	95.8	150.5	173.2	127.9	76.0	245.7	194.2	58.0	206.7	130.4	101.3	124.4	96.9	111.3	129.8	186.2	95.8	55.9	104.3	88.9	179.5	123.9	128.2	83.9	99.1	42.0	137.6	219.3	103.7	208.6	129.2	45.1	71.3	47.2	76.3	95.6	72.2	158.4	101.6	113.1	50.9	18.9	56.4	11.9	132.5	51.7	205.6	198.9	192.1	153.7	101.2	175.8	249.0	195.2	8.1	150.3	44.5	114.8	126.1	326.4	51.3	50.3	50.8	49.3	41.4	38.8	47.4	57.7	58.0	23.3
RPL30	L30	ENSG00000156482	"Ribosomal protein L30"	P62888	8	98024851-98046469	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002651	Approved		Approved	"Endoplasmic reticulum,Cytosol"			52000	"Endoplasmic reticulum, Cytosol"		"HPA002651: AB_1079842"	"unprognostic (3.28e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.76e-2)"	"prognostic unfavourable (1.41e-9)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.97e-3)"	146.2	68.8	77.6	75.4	56.2	153.1	195.1	54.3	62.0	158.8	123.2	64.1	96.3	57.5	146.1	120.3	164.9	126.6	113.5	147.3	64.5	53.1	75.7	140.6	121.2	383.2	78.6	46.4	284.8	344.3	44.6	62.1	97.5	49.3	154.7	96.3	66.2	172.7	131.4	191.2	144.8	90.1	164.3	85.2	146.6	96.3	79.5	58.7	168.1	170.4	102.5	176.5	153.6	197.4	180.4	94.5	42.1	70.0	94.2	238.2	179.6	146.7	100.8	108.6	104.1	156.6	290.4	104.6	86.7	151.6	146.4	128.6	111.2	138.8	192.1	227.0	123.7	96.3	135.2	161.0	152.5	75.8	112.9	167.3	100.9	145.7	230.5	89.1	83.7	246.3	255.8	108.4	311.0	150.2	119.4	127.5	124.2	195.2	207.8	167.2	97.1	146.4	112.6	82.7	176.7	119.4	136.4	157.0	134.5	50.2	125.5	197.9	165.2	212.1	83.4	57.3	61.7	85.5	103.7	134.5	108.9	157.3	80.5	182.3	83.7	42.1	70.0	31.6	104.4	63.1	154.1	180.4	181.2	138.9	94.5	171.7	238.2	186.0	26.3	94.2	55.6	94.0	117.8	179.6	77.6	56.2	54.3	62.0	64.5	53.1	78.6	46.4	49.3	58.7
RPL32	L32	ENSG00000144713	"Ribosomal protein L32"	P62910	3	12834485-12841588	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 406.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047501, HPA051994"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"			140000	"Endoplasmic reticulum, Cytosol"		"HPA047501: AB_2680070, HPA051994: AB_2681686"	"unprognostic (6.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.44e-2)"	80.5	42.2	62.9	55.4	44.5	106.7	109.0	33.2	50.8	101.5	58.9	34.9	38.3	37.3	63.1	91.5	94.8	82.3	49.5	53.5	46.5	36.5	68.4	132.9	63.7	117.4	50.1	41.1	167.0	406.2	20.4	38.6	48.6	32.8	62.6	68.4	41.8	67.9	43.3	121.4	90.5	48.6	78.0	48.4	77.7	52.0	55.9	30.7	103.9	66.9	87.7	121.5	91.2	68.9	230.3	119.2	38.8	86.1	104.4	281.7	293.2	73.3	88.3	77.1	98.2	121.3	217.4	254.8	60.7	113.1	128.3	88.0	116.6	75.3	128.1	55.5	87.1	46.1	87.4	126.1	105.6	59.1	146.3	74.4	112.0	126.0	181.4	119.9	75.6	195.0	275.4	97.8	189.2	111.9	91.3	119.1	104.7	221.5	134.7	207.3	129.9	167.7	107.7	69.3	166.7	129.6	122.3	49.0	98.0	40.8	109.8	130.4	160.7	231.2	64.5	55.7	71.2	73.1	111.3	80.6	126.5	223.9	70.9	172.2	82.9	38.8	86.1	22.9	99.1	66.7	178.3	230.3	197.2	143.1	119.2	214.7	281.7	213.1	12.7	104.4	53.6	118.2	147.0	293.2	62.9	44.5	33.2	50.8	46.5	36.5	50.1	41.1	32.8	30.7
RPL34	L34	ENSG00000109475	"Ribosomal protein L34"	P49207	4	108620566-108630412	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 400.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035139	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA035139: AB_10602925"	"unprognostic (1.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-2)"	"prognostic favourable (2.76e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.72e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.96e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	68.5	52.6	65.9	77.6	63.7	118.0	165.2	43.7	52.9	82.0	70.1	25.5	57.5	47.3	106.0	111.1	76.4	75.2	61.9	59.2	53.7	41.4	60.2	98.4	56.1	110.1	54.6	49.7	157.4	305.1	17.8	68.3	63.8	59.0	74.3	61.0	35.2	129.9	60.2	87.1	77.6	57.6	87.5	57.5	70.8	60.3	43.2	32.2	63.3	82.2	109.5	95.4	67.6	102.3	300.5	153.8	56.2	116.4	134.2	331.0	400.6	58.6	42.9	77.9	110.7	169.1	267.7	76.7	90.7	115.2	74.8	62.7	108.6	104.4	178.5	54.6	88.1	41.9	83.7	141.4	98.3	65.8	134.1	74.5	90.1	166.2	142.4	186.8	83.5	238.0	202.1	61.1	139.0	134.5	130.5	102.5	123.2	114.0	114.4	228.2	89.3	86.8	105.2	83.7	108.1	156.2	99.0	83.6	107.1	37.0	216.2	127.0	71.9	170.9	99.3	51.3	69.6	53.6	80.1	76.6	99.9	143.9	69.9	116.8	62.7	56.2	116.4	35.6	122.0	86.8	207.8	300.5	247.8	165.5	121.2	257.1	331.0	244.9	24.9	134.2	74.9	153.8	176.2	400.6	65.9	63.7	43.7	52.9	53.7	41.4	54.6	49.7	59.0	32.2
RPL35	L35	ENSG00000136942	"Ribosomal protein L35"	P42766	9	124857880-124861981	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA006047	Approved		Approved	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA006047: AB_1856443"	"unprognostic (1.16e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.58e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	91.6	70.1	81.9	116.6	59.2	178.1	156.1	49.2	55.6	109.3	118.5	45.8	86.8	63.0	95.1	98.9	158.5	98.4	89.9	97.0	60.2	55.0	77.5	140.3	89.1	228.4	65.9	48.1	189.1	492.3	25.7	67.0	71.8	45.8	118.3	56.6	63.9	150.9	98.5	247.1	142.7	75.6	131.5	60.8	113.4	78.2	60.5	46.0	113.3	128.4	154.6	130.1	125.5	176.4	201.4	172.2	31.1	82.2	105.1	165.8	281.7	93.3	145.8	82.8	113.5	90.5	192.0	113.6	73.7	119.1	153.8	105.0	240.5	92.6	140.1	76.7	82.0	181.0	96.0	161.3	56.5	85.7	166.0	56.6	198.0	155.3	161.6	125.8	75.7	176.7	252.5	90.9	161.8	112.8	121.3	177.8	115.2	303.3	148.1	288.7	155.1	179.8	126.5	127.7	311.6	131.9	110.8	112.1	91.0	66.9	158.7	149.3	161.3	207.8	57.8	68.6	72.6	119.0	149.5	100.3	233.6	208.8	96.4	132.6	115.2	28.5	82.2	31.1	116.6	72.1	155.1	201.4	156.5	133.8	121.0	189.4	165.8	143.9	10.8	105.1	58.8	172.2	122.6	281.7	81.9	59.2	49.2	55.6	60.2	55.0	65.9	48.1	45.8	46.0
RPL36	"DKFZp566B023, L36"	ENSG00000130255	"Ribosomal protein L36"	Q9Y3U8	19	5674947-5691876	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047153	Supported		Uncertain	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA047153: "	"unprognostic (2.81e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	52.2	101.2	56.3	80.9	43.1	120.2	88.4	40.8	71.1	59.7	63.4	21.2	58.0	60.4	72.2	64.9	79.6	63.2	66.2	69.6	39.7	33.9	48.4	59.7	58.6	201.6	38.7	52.9	225.0	196.1	12.9	48.0	38.6	34.9	65.0	36.7	29.4	129.4	70.4	78.7	101.9	61.4	60.8	39.5	75.3	64.7	53.8	32.3	39.9	40.9	106.1	55.5	48.4	103.1	163.2	79.0	29.1	57.6	68.6	180.7	220.0	100.2	50.3	35.3	87.3	42.2	81.6	52.3	55.3	36.2	56.4	46.5	93.3	51.2	68.5	134.1	26.1	70.8	31.7	65.8	17.1	51.8	223.2	43.1	51.7	76.8	93.6	92.8	60.6	69.5	108.2	34.9	73.4	47.5	55.2	223.1	32.8	107.1	115.1	128.8	118.7	171.3	71.6	41.5	185.9	54.3	67.2	62.9	84.3	32.6	93.6	154.5	72.2	159.9	50.8	37.2	49.9	54.3	120.6	110.1	100.0	107.3	70.7	149.0	51.8	29.1	57.6	21.4	77.3	48.3	125.2	161.4	157.2	113.1	79.0	163.2	180.7	146.6	8.0	68.6	40.4	74.6	120.6	220.0	56.3	43.1	40.8	71.1	39.7	33.9	38.7	52.9	34.9	32.3
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396154	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: , HPA077586: "	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavourable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	62.9	40.7	50.7	81.5	53.8	139.8	136.1	27.7	46.8	65.3	71.0	25.1	53.4	45.6	67.5	71.4	77.1	59.0	60.6	54.9	43.1	31.1	47.3	60.1	43.4	190.1	42.1	50.6	165.3	171.4	15.0	35.1	44.7	41.8	55.9	68.3	26.1	158.1	71.5	125.7	96.5	54.1	65.5	44.6	67.9	54.6	26.3	32.6	60.8	69.3	118.6	104.0	71.9	74.0	162.9	113.2	13.7	74.2	86.7	175.5	199.2	121.7	65.9	101.3	49.9	124.9	224.1	64.8	93.8	103.0	123.1	188.2	78.1	62.6	236.0	93.9	77.9	82.3	151.4	131.4	128.4	83.0	166.1	109.1	116.3	71.9	179.6	198.4	105.2	212.6	248.2	99.7	185.0	113.9	131.8	126.9	99.2	175.4	91.8	236.7	134.6	134.1	86.2	221.7	184.9	112.6	50.8	68.0	135.8	87.6	98.4	167.9	47.5	224.6	105.1	36.6	89.6	101.1	95.1	108.0	154.2	186.5	45.0	295.8	39.0	12.5	74.2	13.7	86.6	73.6	140.3	162.9	162.3	120.6	111.4	134.0	175.5	156.7	7.2	86.7	70.4	113.2	84.9	199.2	50.7	53.8	27.7	46.8	43.1	31.1	42.1	50.6	41.8	32.6
RPL36A-HNRNPH2		ENSG00000257529	"RPL36A-HNRNPH2 readthrough"		X	101391011-101412297	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: "	"unprognostic (3.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"		"unprognostic (4.65e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.04e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-1)"	6.7	6.0	3.7	8.5	5.0	7.2	6.1	15.3	5.2	5.9	9.9	1.4	4.9	1.5	6.7	7.2	6.9	4.5	5.8	5.1	3.7	5.4	4.3	5.8	4.5	22.1	4.6	4.6	12.7	19.7	1.5	3.6	4.2	3.5	5.2	4.5	1.5	18.1	7.2	14.0	5.3	4.4	6.4	5.0	6.5	4.3	2.5	2.3	5.9	6.9	13.1	6.2	7.3	7.5	16.2	19.8	13.6	16.1	10.6	14.3	22.4	3.7	0.0	5.1	1.0	2.3	5.1	1.7	14.6	0.7	3.0	2.2	0.0	2.2	3.4	4.5	2.0	0.4	4.3	0.6	1.0	4.3	1.7	4.1	2.7	1.3	3.9	3.5	1.7	5.5	2.8	1.6	1.1	1.8	1.4	4.3	3.9	0.6	5.6	2.2	0.3	2.0	7.1	5.3	2.8	1.3	0.6	3.1	4.5	1.8	1.6	1.8	1.7	2.0	2.1	0.5	2.8	2.5	2.5	3.7	6.3	1.2	1.4	3.4	3.1	7.5	14.9	13.6	13.1	16.1	11.5	16.2	12.3	12.4	19.8	15.4	14.3	13.6	4.7	10.6	9.9	10.7	9.0	22.4	3.7	5.0	15.3	5.2	3.7	5.4	4.6	4.6	3.5	2.3
RPL36AL	RPL36A	ENSG00000165502	"Ribosomal protein L36a like"	Q969Q0	14	49618519-49620685	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: "	"unprognostic (1.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.80e-1)"	"prognostic favourable (2.83e-4)"	"unprognostic (1.00e-1)"	60.3	55.8	45.9	46.5	40.9	68.2	66.5	35.9	37.7	69.3	74.3	29.2	56.6	52.1	54.9	102.1	61.8	45.9	31.5	48.2	38.0	34.4	69.9	139.2	54.8	63.6	45.3	34.1	105.3	131.9	35.7	62.0	56.9	40.3	62.9	50.5	30.8	85.2	68.6	82.4	40.8	99.8	71.1	48.0	78.8	61.8	36.7	41.8	65.4	72.5	67.6	71.0	87.6	63.9	105.8	112.7	119.5	66.7	84.5	132.0	139.8	72.2	54.5	39.5	22.8	56.8	78.5	23.1	59.7	66.0	56.0	63.5	56.7	50.1	95.3	57.0	49.4	52.2	33.4	50.9	65.6	32.7	38.5	59.8	57.6	73.2	72.0	95.3	51.4	80.3	78.2	42.8	57.9	70.8	37.9	84.9	43.0	93.3	56.1	85.7	22.2	56.1	35.5	62.1	51.1	84.9	110.0	34.6	21.4	52.6	41.7	59.9	90.4	53.1	54.5	35.1	55.9	45.6	45.9	51.8	52.9	96.3	25.4	43.2	33.4	119.5	66.7	99.6	98.6	63.2	132.0	105.8	129.3	123.0	68.7	79.9	120.7	112.6	74.0	84.5	55.9	112.7	118.2	139.8	45.9	40.9	35.9	37.7	38.0	34.4	45.3	34.1	40.3	41.8
RPL37A	L37A	ENSG00000197756	"Ribosomal protein L37a"	P61513	2	216498189-216579180	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065327	Approved		Approved	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA065327: "	"unprognostic (9.94e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.84e-2)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.67e-1)"	115.0	109.4	130.0	114.9	104.2	153.1	252.9	78.4	82.8	134.5	129.9	66.0	80.5	79.8	188.5	123.9	154.9	131.5	90.7	154.0	91.2	81.7	81.0	116.7	100.7	283.5	108.6	91.0	281.8	423.2	47.3	84.3	74.1	89.0	134.7	115.2	77.9	265.7	107.8	307.2	159.0	76.6	171.8	98.6	97.6	99.0	130.3	60.1	117.2	123.7	186.1	154.7	137.2	195.1	215.6	197.7	39.6	103.3	119.1	222.5	229.2	82.4	70.6	153.4	103.2	160.5	282.9	114.0	112.5	151.2	114.8	98.3	178.9	80.5	91.2	158.0	138.0	86.7	144.9	165.8	118.9	103.7	153.6	149.0	128.0	252.5	274.9	163.5	93.9	306.4	349.5	99.3	280.6	158.2	116.0	134.0	148.5	166.4	155.0	336.8	177.5	80.7	112.6	115.3	111.0	159.9	145.4	99.6	112.1	41.5	130.2	256.2	82.3	283.2	106.0	83.1	90.8	81.4	122.8	142.5	200.7	174.0	92.7	114.6	84.0	39.6	103.3	24.2	122.9	77.1	168.0	215.2	190.4	151.9	143.0	215.6	222.5	198.2	13.5	119.1	63.9	197.7	136.5	229.2	130.0	104.2	78.4	82.8	91.2	81.7	108.6	91.0	89.0	60.1
RPL38	L38	ENSG00000172809	"Ribosomal protein L38"	P63173	17	74203582-74210655	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052543	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA052543: "	"unprognostic (1.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (2.51e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.71e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (6.17e-8)"	"unprognostic (1.89e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-2)"	105.7	85.6	114.6	92.9	94.2	140.7	148.5	58.8	142.3	91.1	107.6	42.6	88.1	74.9	88.2	104.6	89.3	88.2	86.2	152.3	87.3	69.2	67.5	83.5	132.5	313.8	111.4	104.1	258.2	305.8	26.7	59.9	62.8	95.4	73.0	79.4	41.2	118.9	101.8	283.6	108.0	73.8	150.8	162.9	108.0	77.7	99.6	108.3	77.1	67.7	143.5	133.2	92.9	195.6	174.9	141.2	54.0	106.3	80.4	217.6	213.6	95.1	94.6	91.2	93.0	125.0	148.2	90.4	103.7	67.0	95.0	66.6	106.1	73.1	168.5	72.7	88.6	86.1	108.7	134.6	74.5	46.9	174.4	96.3	80.3	136.9	146.0	179.7	86.1	284.4	189.4	89.1	145.3	138.8	118.1	94.0	79.3	100.2	174.0	217.4	106.6	143.4	126.0	193.5	149.6	112.5	74.7	82.7	154.3	43.3	181.3	224.3	138.1	187.3	90.7	79.5	129.5	73.1	135.3	127.8	197.0	173.9	65.1	119.2	75.5	54.0	106.3	37.3	112.2	84.4	132.9	174.9	190.5	140.5	115.2	174.7	217.6	185.8	34.0	80.4	74.5	141.2	117.4	213.6	114.6	94.2	58.8	142.3	87.3	69.2	111.4	104.1	95.4	108.3
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034600	Uncertain		Supported	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"			830000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	63.6	33.4	37.0	59.0	40.4	70.6	88.2	34.5	42.2	73.6	60.5	33.5	42.3	18.8	67.3	49.8	81.3	65.7	39.4	38.8	31.7	26.4	53.2	84.5	46.1	103.9	35.1	26.3	139.1	159.9	33.1	42.0	52.0	34.1	67.6	50.9	35.9	66.2	51.0	87.2	77.1	36.4	67.3	47.9	60.3	46.3	42.8	20.0	81.3	66.1	91.7	102.8	74.2	55.9	72.5	58.7	5.9	40.9	45.0	97.0	135.7	44.2	89.4	37.8	63.7	170.4	309.9	66.8	54.1	111.7	83.8	65.1	98.8	77.7	175.4	61.7	128.8	80.6	270.2	209.1	92.7	48.4	162.0	107.5	80.1	82.0	240.2	112.6	53.9	304.0	272.6	91.0	363.9	133.9	98.4	69.0	125.2	73.0	75.0	50.1	82.7	64.0	84.1	86.3	170.2	115.1	87.9	67.3	70.4	33.3	94.9	133.6	70.1	162.8	78.4	43.8	66.2	40.7	85.9	67.9	105.2	117.3	53.9	151.6	49.3	3.5	40.9	5.9	38.2	36.2	71.1	72.5	74.6	53.7	58.7	60.5	97.0	75.7	2.7	45.0	33.5	37.4	57.0	135.7	37.0	40.4	34.5	42.2	31.7	26.4	35.1	26.3	34.1	20.0
RPL5	"L5, PPP1R135"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92831983-92841924	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043717: AB_10964719, HPA054444: "	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	119.4	80.3	50.0	70.0	50.1	113.8	140.5	46.9	46.8	158.6	111.4	45.0	75.1	61.7	135.2	114.6	159.4	100.5	73.1	73.0	43.5	43.1	99.7	114.9	89.9	148.2	54.5	36.2	296.8	306.5	40.8	90.3	90.2	44.3	175.4	78.8	64.3	121.5	73.2	109.1	97.8	95.3	153.4	61.9	130.1	90.0	68.8	45.7	156.6	210.0	97.7	118.9	191.2	146.6	104.5	85.2	12.8	45.9	72.4	143.0	142.1	116.8	50.2	89.5	75.5	116.4	235.3	143.6	69.9	93.6	87.1	62.4	133.0	51.1	220.5	112.3	78.5	74.7	102.6	131.0	111.3	69.8	140.4	114.4	83.6	122.4	139.7	175.1	48.2	192.4	206.7	77.3	170.2	120.2	141.6	116.3	99.7	66.3	139.4	198.6	138.2	94.9	128.1	173.4	142.4	105.6	97.3	76.3	91.3	45.5	127.1	203.3	70.0	240.9	73.0	44.0	80.4	83.1	126.0	72.0	68.3	149.2	29.8	151.0	29.8	12.8	45.9	7.2	60.9	44.8	122.1	104.5	111.5	91.6	85.2	88.4	143.0	123.9	4.4	72.4	38.3	71.1	83.2	142.1	50.0	50.1	46.9	46.8	43.5	43.1	54.5	36.2	44.3	45.7
RPL7	"humL7-1, L7"	ENSG00000147604	"Ribosomal protein L7"	P18124	8	73290267-73295789	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 536.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 627.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA058373	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"			170000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA058373: "	"unprognostic (3.75e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.31e-1)"	54.7	36.5	54.6	37.9	49.3	67.6	86.9	55.9	54.1	57.5	46.2	36.4	41.0	33.6	54.9	50.6	59.5	50.6	26.5	36.7	32.1	22.0	46.4	67.6	40.3	53.3	55.9	20.5	125.8	87.5	22.9	67.7	33.4	55.0	43.6	44.9	44.1	51.8	36.6	61.9	72.7	37.0	49.5	46.9	46.5	51.2	135.1	54.9	33.7	42.6	69.0	66.6	50.8	58.5	338.1	231.5	66.1	171.7	205.0	464.0	536.3	98.1	71.3	76.7	92.3	156.6	200.7	75.5	107.9	86.8	73.7	58.3	85.7	102.8	292.0	88.3	87.0	94.2	101.2	137.7	115.1	78.5	84.0	159.8	93.3	88.2	94.1	112.6	82.0	187.8	162.8	68.2	213.6	119.5	142.4	110.8	104.6	83.3	178.7	172.3	89.4	76.7	120.9	87.9	113.8	114.9	98.5	106.2	77.4	50.7	627.9	151.0	158.7	148.1	112.1	56.7	86.8	72.1	99.6	64.1	90.8	188.4	59.3	139.9	93.1	66.1	171.7	41.1	179.1	138.9	322.3	338.1	314.4	232.5	231.5	282.6	464.0	327.0	22.3	205.0	118.6	192.4	237.0	536.3	54.6	49.3	55.9	54.1	32.1	22.0	55.9	20.5	55.0	54.9
RPL8	L8	ENSG00000161016	"Ribosomal protein L8"	P62917	8	144789765-144792587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045095, HPA050165"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			240000000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA045095: AB_2679213, HPA050165: AB_2681038"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.13e-2)"	65.9	45.5	32.1	53.7	34.7	120.1	115.2	31.0	61.9	63.9	78.4	26.4	51.1	95.2	106.4	57.1	76.0	51.2	68.9	78.7	27.2	23.6	48.2	62.6	54.5	169.4	29.0	28.8	125.7	349.6	11.8	45.2	38.4	28.8	61.3	15.7	45.6	174.7	57.3	202.1	89.0	82.8	84.9	29.2	79.7	96.4	48.9	17.0	61.2	73.2	103.2	72.8	64.7	100.0	174.8	117.5	31.1	82.7	77.9	136.8	251.3	120.4	142.3	10.2	44.2	11.4	26.0	97.8	87.3	16.5	26.7	19.0	124.2	65.2	162.1	126.4	10.3	73.0	13.3	30.4	4.9	70.4	161.9	96.2	109.6	87.5	28.6	63.0	52.5	28.0	34.7	12.0	20.6	19.6	129.5	37.6	11.3	322.1	89.9	85.4	95.0	161.3	88.2	58.9	152.4	14.2	91.4	62.3	104.0	83.8	45.7	119.9	105.8	61.0	78.4	35.5	135.2	74.1	104.9	68.8	58.7	140.2	70.7	104.8	48.6	24.1	80.3	31.1	70.5	82.7	117.9	166.8	119.3	86.9	117.5	174.8	136.8	105.0	9.8	77.9	78.5	64.5	113.8	251.3	32.1	34.7	31.0	61.9	27.2	23.6	29.0	28.8	28.8	17.0
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452521-39458949	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			24000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	52.6	35.2	42.2	73.9	44.4	179.1	202.3	35.7	51.6	63.0	59.8	34.5	42.2	69.8	50.4	226.8	49.9	48.1	69.7	58.2	42.3	27.6	47.4	73.2	35.8	48.7	34.7	51.7	158.5	126.2	37.4	44.7	38.7	42.5	47.8	59.1	31.7	93.7	71.4	66.3	62.9	38.8	49.5	34.0	45.2	46.5	56.9	25.9	36.0	63.2	70.1	59.0	46.0	56.6	118.3	72.5	26.2	41.4	63.0	145.0	148.9	3.2	2.8	122.4	2.8	6.6	9.0	4.7	57.6	87.0	71.9	54.6	8.0	65.4	142.9	6.6	57.9	65.1	5.4	6.2	78.7	52.0	115.0	4.5	24.1	7.8	8.5	9.3	37.8	11.9	180.9	4.4	82.7	5.4	109.2	66.7	5.0	4.3	77.5	9.8	109.2	3.8	71.6	122.7	4.9	89.4	3.7	4.6	48.8	1.9	47.3	7.3	104.4	6.7	4.1	3.0	4.6	83.7	7.9	102.5	143.9	124.1	83.1	86.9	3.3	26.2	41.4	12.3	52.1	40.1	101.2	118.3	102.2	71.4	57.2	103.8	145.0	111.7	6.9	63.0	31.2	72.5	77.0	148.9	42.2	44.4	35.7	51.6	42.3	27.6	34.7	51.7	42.5	25.9
RPLP0	"L10E, LP0, P0, PRLP0, RPP0"	ENSG00000089157	"Ribosomal protein lateral stalk subunit P0"	P05388	12	120196686-120201235	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 408.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003512, HPA073501"	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA003512: AB_1079844, HPA073501: "	"unprognostic (2.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (7.66e-12)"	"unprognostic (2.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.47e-1)"	67.3	59.5	20.6	76.6	31.6	100.5	119.8	26.8	26.0	58.4	76.8	22.0	61.8	50.5	95.9	66.0	128.3	74.8	88.6	49.8	28.9	16.2	47.1	121.7	55.4	59.7	21.9	26.6	117.5	408.6	13.5	36.6	70.1	41.5	72.4	60.8	32.8	138.5	54.6	101.0	113.9	57.3	63.8	23.4	60.0	69.0	73.0	18.7	89.6	90.8	162.5	82.8	64.2	116.6	135.9	143.3	10.7	63.4	82.7	172.4	193.3	126.0	109.1	92.8	158.8	189.6	312.3	132.4	97.1	168.7	152.0	99.1	120.6	77.6	276.3	98.2	169.9	100.2	164.3	201.7	96.3	106.7	125.2	131.8	72.4	103.0	204.5	177.0	99.7	281.5	345.4	106.5	316.4	179.5	161.4	80.1	144.5	136.4	178.2	119.7	176.8	146.2	130.0	130.6	216.4	152.0	145.6	99.1	120.7	70.0	104.8	190.8	187.1	214.1	120.6	71.7	109.4	90.8	120.4	181.1	190.6	137.9	128.8	127.4	60.3	10.7	63.4	5.3	71.5	58.3	172.4	135.9	131.9	97.1	137.0	123.2	131.4	104.4	5.0	82.7	35.1	143.3	83.4	193.3	20.6	31.6	26.8	26.0	28.9	16.2	21.9	26.6	41.5	18.7
RPLP1	LP1	ENSG00000137818	"Ribosomal protein lateral stalk subunit P1"	P05386	15	69452784-69456194	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1030.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003368			Supported	"Endoplasmic reticulum,Cytosol"			1000000	"Endoplasmic reticulum, Cytosol"		"HPA003368: AB_1079845"	"unprognostic (5.04e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (2.30e-9)"	"unprognostic (7.75e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.83e-2)"	59.6	57.2	47.5	76.8	42.9	171.7	451.2	68.8	103.3	70.1	79.0	20.8	57.9	87.5	73.5	76.3	100.7	65.7	80.6	341.6	35.5	29.7	55.8	69.9	290.9	1030.2	42.4	33.3	134.3	209.0	8.6	36.0	52.3	45.6	71.0	33.3	61.3	102.8	60.7	262.9	155.2	74.3	128.2	38.8	77.4	77.1	45.7	32.7	73.0	50.8	146.9	71.8	72.3	95.5	329.0	226.3	79.6	176.1	169.8	267.2	368.8	82.7	84.7	38.0	87.6	54.5	65.8	81.7	72.9	43.3	40.8	32.7	85.9	84.4	115.9	109.0	38.3	113.3	58.5	57.3	8.9	116.2	179.0	97.6	97.3	83.8	95.5	86.4	89.2	82.7	100.5	29.7	55.7	49.2	91.8	98.9	28.8	77.6	94.2	254.8	142.1	81.7	96.7	124.2	169.6	39.3	89.7	60.9	118.7	73.2	90.6	297.4	74.7	199.0	86.3	59.2	132.5	70.6	118.3	202.7	323.2	98.3	70.9	220.7	48.8	79.6	176.1	60.4	119.5	124.7	220.2	329.0	247.2	162.7	215.0	278.5	267.2	223.0	26.2	169.8	70.2	226.3	202.7	368.8	47.5	42.9	68.8	103.3	35.5	29.7	42.4	33.3	45.6	32.7
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306247-58324695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favourable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (5.78e-2)"	7.1	8.5	8.3	5.7	12.9	5.3	7.1	15.8	10.7	6.6	8.6	5.9	6.6	10.2	8.2	7.8	8.5	7.4	6.2	11.8	7.2	6.8	11.2	15.0	5.6	7.6	6.5	9.9	8.4	11.9	10.8	9.4	6.0	7.2	7.4	8.2	9.0	8.5	7.0	53.5	7.4	9.1	11.7	5.5	7.7	7.7	9.1	5.9	6.3	8.1	18.5	8.5	7.2	7.0	4.6	6.6	4.7	9.8	9.8	6.4	3.5	10.1	8.0	9.4	7.4	7.8	8.4	10.3	8.6	9.2	12.3	13.9	12.2	6.7	12.1	2.0	11.5	6.2	14.0	12.7	12.0	8.4	7.4	11.5	9.6	6.6	7.7	19.8	9.6	9.2	12.3	14.6	14.0	9.7	9.9	8.7	11.9	5.5	13.4	7.0	12.3	15.3	5.5	7.4	11.7	9.0	14.5	5.9	10.4	8.0	9.6	11.5	9.2	9.6	8.8	9.3	10.4	9.8	16.2	13.0	22.2	17.5	10.7	13.9	6.6	3.0	5.7	4.7	4.2	4.9	5.6	4.1	5.5	5.8	6.6	4.6	6.4	6.2	2.6	9.8	9.8	6.2	3.0	3.5	8.3	12.9	15.8	10.7	7.2	6.8	6.5	9.9	7.2	5.9
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871716-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"				"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	24.2	19.0	20.9	16.8	20.3	27.2	22.3	26.0	24.0	18.9	19.0	16.2	16.3	11.5	25.2	18.6	23.8	19.2	16.0	26.6	19.8	16.8	20.6	18.4	17.1	23.2	18.5	20.4	23.9	17.7	37.7	23.6	23.6	19.3	18.8	19.3	18.7	19.2	16.5	35.9	23.5	16.4	20.6	19.2	21.3	19.2	32.0	21.6	31.2	18.1	24.0	26.3	21.7	18.9	19.4	22.2	16.2	19.5	14.2	20.3	16.2	28.0	18.7	19.6	23.6	12.8	13.8	6.9	20.1	18.1	33.7	35.4	31.6	22.6	16.6	15.4	12.8	19.7	26.1	17.8	34.7	26.6	18.0	11.1	12.0	24.9	12.1	22.5	14.1	11.3	11.6	25.3	28.8	19.1	22.1	15.2	22.2	17.3	26.1	30.7	12.1	21.3	14.6	16.7	17.4	12.7	13.3	10.6	10.7	11.7	8.5	23.6	23.0	14.3	10.8	16.8	16.8	9.5	41.4	10.3	26.3	35.6	21.1	12.2	12.9	4.3	19.5	16.2	17.1	18.7	18.6	19.4	19.6	18.7	22.2	16.7	17.0	18.5	2.2	14.2	15.3	20.7	20.3	16.2	20.9	20.3	26.0	24.0	19.8	16.8	18.5	20.4	19.3	21.6
RPS10	"MGC88819, S10"	ENSG00000124614	"Ribosomal protein S10"	P46783	6	34417454-34426125	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047268, HPA048084"	Approved		Approved	Cytosol			170000	Cytosol		"HPA047268: , HPA048084: "	"unprognostic (1.92e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.82e-1)"	"prognostic unfavourable (2.57e-6)"	"unprognostic (4.98e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.45e-1)"	84.5	76.6	68.1	142.7	49.5	158.8	142.0	35.9	54.3	130.3	132.7	48.2	97.2	65.1	149.8	103.9	169.7	113.6	74.7	84.9	51.3	44.1	80.7	122.5	96.3	180.1	54.8	31.9	189.4	323.2	20.3	59.1	88.0	39.5	129.7	64.5	59.4	248.9	75.5	153.2	131.9	76.4	105.6	49.4	132.5	85.3	66.7	41.0	110.5	151.0	158.8	127.4	127.1	169.7	150.1	105.0	31.6	61.5	83.1	176.2	227.6	99.0	64.2	66.8	151.4	115.1	169.8	110.5	81.7	113.1	135.1	97.8	155.7	50.6	191.5	84.7	90.5	74.8	124.6	139.8	81.4	80.3	222.1	85.7	70.8	147.5	159.3	135.4	92.2	187.6	243.7	94.6	179.7	117.8	146.0	97.1	100.9	154.6	110.1	203.5	100.7	94.7	104.4	78.2	180.6	101.5	109.6	111.7	68.4	58.7	99.1	226.2	128.8	347.0	80.8	60.9	78.0	69.3	132.7	80.4	179.0	160.5	33.2	176.1	109.3	31.6	61.5	18.8	78.9	50.6	116.3	150.1	136.2	111.1	88.7	147.7	176.2	136.7	13.6	83.1	47.2	105.0	90.2	227.6	68.1	49.5	35.9	54.3	51.3	44.1	54.8	31.9	39.5	41.0
RPS10-NUDT3		ENSG00000270800	"RPS10-NUDT3 readthrough"		6	34284887-34426071	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 21.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.2"									"HPA047027, HPA047268, HPA048084, HPA055953"	Uncertain		Approved	Cytosol				Cytosol		"HPA047027: , HPA047268: , HPA048084: , HPA055953: "	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.28e-2)"	"unprognostic (6.85e-2)"		"unprognostic (8.95e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.17e-8)"	"unprognostic (5.80e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.42e-1)"	14.5	10.9	28.0	24.9	21.7	35.6	12.1	9.9	25.4	22.6	23.0	7.3	16.4	9.5	26.2	17.7	29.9	10.0	12.2	20.8	23.7	23.2	13.4	21.1	16.3	31.8	25.2	4.3	33.2	58.4	5.3	7.6	18.8	5.7	22.5	7.7	9.4	44.6	12.4	49.4	6.4	12.9	18.0	17.2	23.0	14.4	23.4	6.0	18.9	26.4	27.9	22.0	22.0	29.9	3.7	4.7	21.2	4.8	2.9	2.3	2.1	9.6	2.9	8.0	14.3	6.0	4.0	8.3	6.7	3.4	5.1	5.2	3.2	4.5	9.3	12.9	4.2	6.2	11.0	3.4	6.3	7.5	4.8	16.5	6.0	10.1	1.2	15.8	21.0	1.6	7.3	7.3	15.2	4.9	16.1	12.5	6.2	8.4	17.9	9.2	4.5	1.7	10.0	6.7	5.2	4.9	10.4	12.5	4.1	4.7	5.3	17.6	7.9	33.2	3.8	7.6	12.6	3.8	10.1	6.6	9.2	15.1	1.0	9.5	12.5	6.9	3.9	21.2	2.1	4.8	2.1	3.7	2.3	2.0	4.7	3.5	2.3	1.9	3.1	2.9	4.1	3.3	2.2	2.1	28.0	21.7	9.9	25.4	23.7	23.2	25.2	4.3	5.7	6.0
RPS11	S11	ENSG00000142534	"Ribosomal protein S11"	P62280	19	49496365-49499689	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049719	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA049719: "	"unprognostic (1.49e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.50e-7)"	"unprognostic (5.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-3)"	103.0	76.8	80.6	187.8	68.7	161.8	165.7	50.4	75.3	138.6	134.1	43.2	105.8	67.0	149.4	132.4	142.8	132.3	133.0	135.9	63.2	53.5	84.3	105.7	101.9	354.2	71.5	64.2	242.4	490.0	41.7	89.7	72.2	63.4	116.6	103.4	72.7	193.2	104.0	223.4	140.8	88.1	198.4	69.9	132.6	96.3	67.2	48.3	137.3	119.0	190.7	169.5	145.6	230.6	232.4	173.3	45.1	96.7	91.3	161.6	231.8	110.2	171.9	130.6	201.7	188.9	286.0	87.5	93.8	185.4	133.7	128.2	119.0	92.1	270.6	58.6	127.7	74.3	154.0	185.9	131.9	115.3	267.3	163.6	113.1	171.0	176.5	289.0	121.6	283.7	303.3	89.3	230.0	192.9	161.5	144.3	144.2	123.2	134.8	217.7	120.6	177.3	130.1	165.4	143.9	191.9	260.5	139.6	186.3	63.9	215.3	139.5	70.0	300.6	110.4	106.2	95.5	51.5	123.4	144.4	219.6	192.4	44.2	199.1	90.6	45.1	96.7	29.9	95.6	82.8	127.6	232.4	137.5	110.9	144.1	221.1	161.6	135.7	25.9	91.3	70.6	173.3	109.8	231.8	80.6	68.7	50.4	75.3	63.2	53.5	71.5	64.2	63.4	48.3
RPS12	S12	ENSG00000112306	"Ribosomal protein S12"	P25398	6	132814441-132817564	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA006124, HPA006365"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"			280000	Cytosol	"Golgi apparatus, Vesicles"	"HPA006124: AB_1856460, HPA006365: "	"unprognostic (6.58e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.04e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.66e-2)"	95.6	65.1	66.4	169.3	53.2	199.6	187.3	49.6	66.9	98.4	83.8	42.5	93.7	73.1	106.1	99.2	129.4	88.0	113.7	152.2	56.1	44.6	78.0	108.8	182.0	515.8	67.8	42.0	222.2	403.5	23.2	46.3	87.7	44.5	94.4	82.1	56.5	220.6	71.5	100.5	153.8	79.5	162.6	71.8	122.9	85.4	62.6	52.5	139.6	116.7	155.1	130.9	109.7	196.8	159.2	101.3	17.4	54.3	70.9	211.8	222.0	66.7	50.8	78.9	122.4	152.4	193.7	93.8	85.2	114.9	90.6	87.7	104.4	64.1	148.0	118.2	108.9	65.2	85.6	142.6	83.2	96.9	110.2	100.9	66.6	147.4	170.8	283.6	78.8	207.4	233.9	78.3	277.5	119.0	165.2	98.5	110.0	136.2	119.4	165.2	97.3	83.0	135.2	63.1	93.7	120.4	69.5	67.2	54.8	28.7	184.7	227.9	78.3	288.7	103.5	38.7	111.1	129.7	157.1	148.0	120.5	110.4	127.9	161.1	55.2	17.4	54.3	7.8	95.6	50.7	147.0	159.2	168.0	123.1	73.4	139.3	211.8	174.2	5.7	70.9	40.7	101.3	90.8	222.0	66.4	53.2	49.6	66.9	56.1	44.6	67.8	42.0	44.5	52.5
RPS14	"EMTB, S14"	ENSG00000164587	"Ribosomal protein S14"	P62263	5	150442635-150449756	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 708.0;pancreas: 483.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018504	Approved		Supported	"Endoplasmic reticulum,Cytosol"			540000	"Endoplasmic reticulum, Cytosol"		"HPA018504: AB_1856463"	"unprognostic (5.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (1.47e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.14e-2)"	60.9	43.2	50.1	64.3	39.1	92.8	111.6	22.6	37.2	85.1	70.3	28.0	50.6	33.6	59.6	86.4	79.4	91.7	57.2	59.2	35.7	30.3	53.6	74.7	57.0	96.6	39.8	32.5	115.1	483.0	17.4	38.9	62.0	35.3	69.7	61.5	41.1	61.8	50.8	93.4	95.0	60.6	67.0	37.0	68.4	58.3	48.5	33.8	84.5	93.9	71.2	83.6	87.1	65.2	360.5	205.3	51.0	166.0	157.4	465.9	708.0	87.6	160.8	83.7	170.4	128.2	241.2	137.4	67.4	113.0	110.0	100.4	219.1	113.1	199.0	99.3	127.2	70.3	125.2	299.6	74.8	92.3	151.2	72.3	149.2	164.5	182.4	206.4	74.9	183.1	117.3	112.0	264.2	152.8	95.4	78.8	139.2	236.7	89.1	174.1	86.2	136.6	87.5	96.4	213.1	143.9	161.3	92.3	105.1	48.8	244.4	193.4	107.7	226.5	94.7	59.5	50.0	50.3	90.6	107.0	150.4	130.7	74.2	202.4	39.2	51.0	166.0	36.7	186.2	114.2	261.9	360.5	313.3	226.8	181.1	299.4	465.9	319.4	25.7	157.4	97.0	205.3	196.8	708.0	50.1	39.1	22.6	37.2	35.7	30.3	39.8	32.5	35.3	33.8
RPS15	"MGC111130, RIG, S15"	ENSG00000115268	"Ribosomal protein S15"	P62841	19	1438358-1440494	"Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA054510, HPA057793"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"			170000	"Endoplasmic reticulum, Cytosol"		"HPA054510: AB_2682510, HPA057793: AB_2683528"	"unprognostic (4.47e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.08e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.33e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-2)"	61.7	61.2	63.0	67.5	51.4	123.6	74.2	46.0	87.5	56.2	66.4	46.1	41.2	69.0	73.6	52.3	80.9	61.2	73.7	72.1	50.4	40.5	64.8	103.7	43.0	95.3	52.1	52.6	144.8	136.0	21.6	59.3	60.9	45.2	66.9	37.1	61.2	123.7	53.2	154.9	102.4	67.6	51.8	51.0	76.2	63.5	60.8	24.9	70.7	74.2	127.6	82.9	47.6	70.9	237.3	149.5	48.6	106.7	103.8	218.1	269.2	103.1	110.2	48.5	65.9	45.5	66.3	83.6	54.1	43.2	64.9	50.9	176.9	36.5	128.1	48.7	34.7	65.8	47.2	67.0	25.5	106.5	246.9	41.9	101.0	167.0	48.2	106.6	80.0	81.4	81.0	43.9	43.1	57.1	85.0	184.5	40.5	181.6	88.0	143.3	109.7	141.8	91.7	57.9	167.3	58.9	113.7	78.1	92.7	45.6	78.7	155.1	60.2	143.7	57.6	55.0	63.0	109.6	119.3	160.3	158.6	124.5	54.6	97.4	62.8	48.6	106.7	44.5	116.2	89.5	160.8	237.3	179.3	146.1	149.5	222.5	218.1	177.4	21.6	103.8	68.2	124.2	162.9	269.2	63.0	51.4	46.0	87.5	50.4	40.5	52.1	52.6	45.2	24.9
RPS16	S16	ENSG00000105193	"Ribosomal protein S16"	P62249	19	39433207-39435948	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA064222	Approved		Supported	"Endoplasmic reticulum,Cytosol"			36000	"Endoplasmic reticulum, Cytosol"		"HPA064222: "	"unprognostic (4.63e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.28e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.62e-2)"	89.8	60.8	49.0	123.2	46.1	127.3	126.9	39.8	46.8	124.8	120.7	48.6	80.0	67.2	97.9	80.8	150.1	108.1	105.9	118.7	41.7	35.7	81.5	147.6	103.7	243.2	49.2	29.9	248.1	457.6	19.9	48.8	97.0	35.5	129.5	52.8	73.8	130.5	87.6	205.5	113.4	110.9	126.3	52.2	136.7	92.1	57.4	37.7	153.9	125.1	183.6	151.0	143.8	159.8	153.7	106.4	17.6	71.8	71.7	179.1	225.5	138.3	296.6	79.7	90.4	120.1	148.1	74.0	63.8	74.7	83.4	76.9	188.7	76.9	117.3	82.9	79.6	46.3	93.2	155.3	52.8	137.0	220.6	92.6	101.0	194.9	122.6	135.1	62.9	172.7	242.1	73.5	117.4	106.9	118.2	132.7	86.9	213.9	184.6	136.3	98.4	108.6	123.8	82.4	141.9	91.5	156.3	81.1	116.8	47.9	215.8	164.1	61.9	262.6	64.2	69.6	91.3	73.7	138.8	185.0	191.5	148.7	72.0	129.3	67.1	17.6	71.8	11.0	84.5	57.9	120.9	153.7	140.8	105.6	91.9	143.2	179.1	143.0	13.2	71.7	48.2	106.4	94.7	225.5	49.0	46.1	39.8	46.8	41.7	35.7	49.2	29.9	35.5	37.7
RPS17	"MGC72007, RPS17L, RPS17L1, RPS17L2, S17"	ENSG00000182774	"Ribosomal protein S17"	P08708	15	82536750-82540564	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055060	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"			39000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA055060: "	"unprognostic (3.37e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (2.83e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.31e-1)"	40.1	37.3	23.9	41.5	28.0	78.5	93.7	20.5	39.7	41.3	35.4	18.0	32.7	12.0	34.4	69.6	58.2	48.5	36.3	36.2	24.9	16.0	33.0	56.8	30.4	75.5	22.2	22.4	100.0	160.7	8.0	28.1	28.7	29.1	32.2	54.1	21.2	64.2	38.1	47.5	60.8	33.0	54.2	26.6	40.9	38.1	29.3	19.2	36.1	38.5	85.2	82.2	34.1	55.8	42.1	34.6	12.5	19.7	26.5	48.5	63.4	10.2	74.1	23.9	15.5	40.5	56.4	18.6	5.6	10.4	17.7	16.3	105.6	33.8	14.7	10.5	22.6	32.5	57.7	57.2	32.0	8.9	146.2	2.6	76.6	70.9	55.3	12.9	14.1	72.5	105.7	21.9	75.0	37.5	10.0	39.1	27.3	82.5	16.6	45.7	36.0	59.2	11.1	6.1	26.3	52.9	93.5	17.4	11.2	2.2	31.4	30.9	38.2	39.9	9.7	27.7	20.2	17.1	12.3	11.8	18.2	12.8	22.6	33.5	15.1	12.5	19.7	4.5	16.6	17.2	43.6	39.9	41.3	26.8	27.2	42.1	48.5	42.4	2.5	26.5	14.8	34.6	23.7	63.4	23.9	28.0	20.5	39.7	24.9	16.0	22.2	22.4	29.1	19.2
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272010-33276510	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 484.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050159, HPA055007"	Approved		Supported	Cytosol			90000	Cytosol		"HPA050159: , HPA055007: "	"prognostic favourable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	67.0	49.1	43.4	126.4	32.2	109.6	132.5	20.9	37.7	99.8	105.5	17.8	48.6	44.6	83.1	109.2	120.3	66.7	92.9	71.5	31.2	26.1	48.1	69.1	69.1	263.7	34.5	35.4	154.5	484.7	8.9	33.0	56.3	26.6	95.9	65.2	37.0	168.4	53.7	107.6	140.4	56.9	99.6	35.8	89.9	56.8	40.2	32.3	94.1	94.3	155.9	90.6	101.6	114.8	98.8	55.7	7.8	30.3	49.6	92.4	130.1	51.4	29.8	39.6	103.9	67.9	134.5	63.8	51.6	75.2	67.9	51.4	75.1	30.1	169.7	55.6	54.7	37.9	62.1	81.7	53.4	53.2	97.6	63.3	35.6	98.8	132.5	109.3	33.8	145.3	161.9	51.8	154.9	64.4	84.0	53.3	59.9	86.2	55.1	121.7	54.5	43.1	65.9	64.0	113.6	62.4	66.7	45.5	67.1	20.1	103.4	162.3	70.9	190.5	53.2	32.0	37.4	33.9	67.5	64.0	129.8	130.0	17.9	119.2	38.9	7.8	30.3	3.9	42.7	27.4	72.8	98.8	83.0	60.9	55.7	80.2	92.4	78.5	3.1	49.6	20.2	50.6	61.4	130.1	43.4	32.2	20.9	37.7	31.2	26.1	34.5	35.4	26.6	32.3
RPS19BP1	"FLJ21770, MGC52010"	ENSG00000187051	"Ribosomal protein S19 binding protein 1"	Q86WX3	22	39529093-39532855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042874	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA042874: AB_10793988"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.65e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.32e-2)"	32.8	38.8	38.9	29.5	30.6	36.9	47.5	24.2	34.7	26.4	28.0	19.2	40.6	31.4	18.8	25.2	24.1	18.0	25.0	30.5	38.9	28.4	30.8	40.7	22.5	29.4	40.3	27.0	23.4	45.0	15.4	18.8	21.9	31.9	31.6	14.4	19.2	65.2	35.4	55.0	19.8	30.9	28.5	31.1	27.1	32.6	28.8	24.6	16.3	40.8	28.0	23.7	24.3	54.5	64.2	73.5	67.3	57.7	42.8	60.3	50.5	21.2	26.3	12.6	17.8	14.2	9.3	26.6	24.4	19.9	21.4	17.0	29.0	14.0	26.6	25.5	14.4	17.2	19.9	25.0	7.4	38.2	63.5	25.5	22.3	25.6	20.9	37.3	33.3	13.9	18.9	18.3	22.5	14.5	28.5	19.2	13.5	23.5	17.8	37.2	22.0	50.3	28.4	16.5	39.9	22.3	21.0	28.2	15.8	19.8	31.5	43.8	22.7	30.2	17.2	17.8	40.7	19.9	31.8	33.5	30.7	41.2	24.2	25.9	41.6	42.1	57.7	67.3	53.4	52.1	49.2	62.0	54.4	55.2	46.3	64.2	53.2	54.1	63.4	42.8	42.0	73.5	60.3	50.5	38.9	30.6	24.2	34.7	38.9	28.4	40.3	27.0	31.9	24.6
RPS2	"LLREP3, S2"	ENSG00000140988	"Ribosomal protein S2"	P15880	16	1962052-1964860	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 284.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA055133	Approved		Approved	"Endoplasmic reticulum,Cytosol"			140000	"Endoplasmic reticulum, Cytosol"		"HPA055133: "	"unprognostic (2.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (7.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-1)"	"prognostic unfavourable (3.04e-7)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.47e-1)"	46.1	41.0	28.0	101.8	40.4	97.6	65.9	34.7	30.7	48.2	47.0	22.2	28.8	39.9	45.7	27.1	100.7	61.7	55.7	38.2	19.5	16.0	34.2	107.4	71.1	104.2	36.6	18.6	112.6	284.3	9.6	32.2	45.4	30.1	43.6	32.5	18.3	53.6	28.9	67.3	78.3	47.5	25.8	22.4	131.9	47.8	18.9	28.1	115.2	50.3	114.5	78.3	51.6	77.6	137.5	69.0	18.2	44.9	53.6	125.4	54.7	81.0	117.7	68.2	219.3	99.1	244.6	120.8	55.7	133.9	146.3	103.9	209.6	56.8	155.5	89.2	96.2	101.9	98.5	186.8	55.0	98.1	194.8	52.4	131.3	187.7	242.1	123.0	86.5	326.4	267.9	122.2	203.4	141.8	107.1	88.4	100.8	376.2	154.3	215.6	216.7	106.4	189.2	110.5	185.9	133.5	77.2	122.3	111.1	54.5	171.3	132.0	115.5	216.0	64.7	78.9	104.0	18.9	116.4	34.4	56.6	197.9	42.5	106.6	99.0	4.9	37.6	18.2	50.7	44.9	84.6	137.5	99.9	78.4	68.7	117.9	125.4	93.8	7.6	53.6	36.0	69.0	68.1	54.7	28.0	40.4	34.7	30.7	19.5	16.0	36.6	18.6	30.1	28.1
RPS20	S20	ENSG00000008988	"Ribosomal protein S20"	P60866	8	56067295-56074581	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003570	Approved		Supported	"Endoplasmic reticulum,Cytosol"			100000	"Endoplasmic reticulum, Cytosol"		"HPA003570: AB_1856466"	"unprognostic (2.57e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (1.21e-8)"	"unprognostic (3.64e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-2)"	164.6	74.7	74.1	177.3	61.8	191.2	193.8	30.4	57.8	148.1	118.9	49.5	104.1	58.3	100.6	108.4	161.3	91.2	108.3	140.0	57.3	47.0	88.0	136.5	124.0	280.9	67.7	41.8	267.4	218.0	28.5	69.2	77.9	48.1	136.7	60.5	70.2	165.9	104.1	161.5	132.2	86.1	152.5	75.9	157.1	98.5	79.6	47.5	168.0	141.7	143.6	140.8	179.7	157.7	214.3	142.6	64.0	77.1	78.0	248.9	267.6	142.9	128.2	126.5	122.9	181.6	209.9	107.4	96.4	143.2	114.7	105.5	132.8	139.0	211.1	119.3	101.4	90.4	78.8	152.1	97.1	91.3	109.5	175.0	118.1	165.6	174.5	97.6	115.2	205.0	159.3	75.0	216.9	138.8	139.9	126.5	112.9	176.5	266.9	195.4	169.6	55.4	146.7	46.6	109.0	137.7	155.4	42.3	131.5	41.6	113.3	188.5	164.3	203.1	90.8	86.7	149.1	114.2	152.2	138.0	118.7	154.1	131.6	171.2	77.2	64.0	77.1	31.3	101.6	64.5	144.7	214.3	189.1	135.6	100.5	180.9	248.9	181.3	14.6	78.0	59.0	142.6	125.7	267.6	74.1	61.8	30.4	57.8	57.3	47.0	67.7	41.8	48.1	47.5
RPS21	S21	ENSG00000171858	"Ribosomal protein S21"	P63220	20	62387116-62388520	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003371	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA003371: AB_1079846"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (8.46e-4)"	"unprognostic (6.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.60e-1)"	69.0	66.0	93.6	140.3	61.5	191.6	177.7	59.2	89.7	93.5	105.1	24.3	84.0	72.0	121.5	85.7	99.6	93.3	97.8	66.0	65.6	47.3	62.9	86.1	66.4	199.9	74.0	86.6	189.4	321.2	12.8	49.2	53.0	52.7	76.3	61.9	33.1	164.2	97.3	172.3	129.6	71.5	120.0	51.1	94.9	73.3	92.9	60.0	92.9	86.3	175.2	90.8	84.4	229.7	170.4	122.5	18.1	59.8	71.0	175.9	158.2	99.5	104.1	53.1	100.4	59.2	105.1	70.1	64.4	51.6	161.6	61.6	347.1	133.6	122.4	133.4	49.6	139.9	58.8	179.3	55.8	30.4	153.0	201.5	149.2	263.9	120.8	154.8	90.9	116.8	251.0	61.1	111.3	74.9	102.9	102.0	55.3	151.5	173.8	220.5	81.3	318.5	118.0	135.0	185.0	75.8	112.7	97.8	96.9	66.2	296.6	134.7	126.1	203.4	78.7	95.6	126.4	80.9	125.9	163.2	185.3	133.2	114.3	94.6	50.6	18.1	59.8	13.9	85.7	50.5	122.2	170.4	146.0	112.6	87.6	170.0	175.9	152.7	9.4	71.0	40.0	122.5	92.7	158.2	93.6	61.5	59.2	89.7	65.6	47.3	74.0	86.6	52.7	60.0
RPS23	S23	ENSG00000186468	"Ribosomal protein S23"	P62266	5	82273358-82278577	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054853	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"		"HPA054853: "	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (6.61e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (3.87e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-1)"	114.6	62.1	72.6	129.7	54.8	139.2	191.8	45.1	53.7	141.2	118.9	46.5	83.5	62.2	131.8	94.1	145.2	118.3	114.4	79.4	61.4	52.9	92.8	134.8	90.1	200.7	74.4	34.7	269.5	211.6	41.6	65.6	94.6	51.9	134.3	89.8	52.9	126.7	84.7	205.4	134.3	97.0	129.6	77.7	150.1	83.8	61.4	51.5	194.5	141.5	171.9	173.8	160.7	165.8	140.7	110.8	11.1	56.6	63.8	136.1	158.2	91.4	36.1	104.0	79.7	175.1	236.9	106.1	87.9	133.4	133.1	132.4	50.6	62.6	215.9	61.7	113.8	47.2	155.5	252.9	138.3	78.3	87.8	88.3	53.4	49.1	231.4	127.4	64.1	227.3	301.0	101.5	266.8	171.4	91.7	68.0	114.9	59.5	140.4	129.4	66.5	84.1	94.1	149.1	194.0	129.2	38.7	66.9	87.5	45.3	78.9	178.1	59.9	197.7	121.6	19.0	73.9	46.2	138.0	97.9	143.0	151.7	44.8	165.1	41.6	11.1	56.6	8.7	60.1	52.4	92.2	140.7	103.0	81.1	97.6	130.8	136.1	112.3	6.0	63.8	43.3	110.8	73.4	158.2	72.6	54.8	45.1	53.7	61.4	52.9	74.4	34.7	51.9	51.5
RPS24	S24	ENSG00000138326	"Ribosomal protein S24"	P62847	10	78033732-78056813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003364	Approved		Approved	"Nuclear bodies,Endoplasmic reticulum,Cytosol"			70000	"Endoplasmic reticulum, Cytosol"	"Nuclear bodies"	"HPA003364: AB_1079847"	"prognostic favourable (1.50e-4)"	"unprognostic (1.58e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.10e-10)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.22e-2)"	171.6	122.0	127.7	80.8	79.0	186.2	231.3	56.2	68.4	242.4	201.1	37.9	112.4	86.2	159.2	148.8	277.8	125.1	128.5	123.9	90.4	83.8	134.4	176.6	147.0	263.8	100.6	70.2	369.4	279.3	49.1	86.1	139.3	64.6	251.6	130.0	49.8	176.0	139.5	320.4	192.3	148.9	182.4	111.7	175.8	85.3	87.9	79.5	197.1	221.4	130.0	123.5	271.7	237.7	171.5	180.5	49.6	123.2	156.4	187.3	213.6	110.2	43.1	108.6	169.5	134.6	237.7	97.9	118.6	163.4	125.4	110.3	62.0	77.9	229.3	65.2	102.6	86.0	125.0	152.8	115.0	76.3	141.7	93.4	28.7	59.1	152.7	223.1	53.2	225.2	229.1	88.6	322.0	148.8	126.7	45.9	135.1	44.9	119.0	368.0	76.1	403.5	80.9	130.0	110.2	160.0	51.8	54.9	107.5	59.7	200.8	146.5	113.2	248.1	126.1	38.0	90.6	51.5	156.9	60.5	122.2	176.7	46.9	311.1	31.1	49.6	123.2	46.5	102.4	118.3	167.4	171.5	140.6	129.8	180.5	145.4	187.3	168.2	16.9	156.4	91.0	155.4	112.3	213.6	127.7	79.0	56.2	68.4	90.4	83.8	100.6	70.2	64.6	79.5
RPS25	S25	ENSG00000118181	"Ribosomal protein S25"	P62851	11	119015712-119018691	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031801	Approved		Approved	"Endoplasmic reticulum,Cytosol"			54000	"Endoplasmic reticulum, Cytosol"		"HPA031801: AB_10610419"	"unprognostic (1.60e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.75e-3)"	"prognostic unfavourable (3.00e-7)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.20e-1)"	72.3	68.1	54.9	99.5	60.7	117.7	140.7	38.1	62.2	84.9	69.4	26.8	87.7	53.5	79.6	93.4	92.9	68.0	78.6	87.3	44.4	41.7	58.6	76.5	88.4	256.5	57.1	48.1	190.0	274.5	34.3	67.5	52.5	54.3	77.1	52.2	41.6	113.5	131.7	173.6	82.0	57.7	125.4	68.3	80.7	68.3	35.3	47.3	78.5	83.9	128.8	86.4	112.2	110.6	136.6	83.3	30.0	43.2	64.7	166.9	150.1	38.9	22.4	48.3	48.3	65.1	100.7	39.7	52.8	47.6	31.2	27.2	59.3	68.5	98.7	92.3	36.7	54.2	42.7	56.8	35.5	48.5	46.6	140.6	19.8	49.8	50.5	99.8	43.9	90.6	101.3	29.8	74.4	56.6	73.0	59.6	43.3	80.3	78.0	137.1	49.8	54.3	68.4	50.7	107.2	57.5	34.3	35.5	67.5	28.1	87.5	54.6	70.3	108.9	53.8	30.6	35.6	30.9	50.6	50.5	41.2	81.5	21.2	99.3	36.1	30.0	43.2	27.1	75.8	42.5	120.7	136.6	133.4	102.4	69.1	112.6	166.9	128.2	11.7	64.7	37.2	83.3	88.7	150.1	54.9	60.7	38.1	62.2	44.4	41.7	57.1	48.1	54.3	47.3
RPS26	S26	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044676	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: "	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	36.5	66.6	33.3	29.0	48.8	39.2	49.7	23.8	73.7	44.5	45.6	34.9	20.5	20.0	35.9	50.4	49.9	43.5	28.4	39.8	25.8	24.8	61.8	154.3	29.5	56.0	31.4	26.2	75.8	80.4	25.6	29.7	28.7	45.1	35.4	49.1	28.5	38.0	41.1	62.2	50.9	57.5	36.9	30.0	51.6	40.3	47.0	32.5	47.3	58.4	60.0	78.4	46.7	41.2	93.0	69.8	29.8	42.8	63.6	107.4	108.8	52.8	65.1	74.2	27.5	102.8	152.5	74.4	53.9	80.1	89.9	52.6	99.9	24.0	118.0	34.1	56.9	24.9	83.3	46.4	61.6	46.6	133.6	62.3	43.4	59.6	94.9	40.4	34.2	92.3	148.7	47.4	54.0	68.2	42.4	39.4	72.7	82.0	30.3	73.5	72.8	147.4	41.3	22.3	72.6	75.1	53.6	27.9	48.2	21.1	46.6	30.6	41.2	45.3	22.1	22.4	45.8	28.5	43.2	33.9	64.9	63.7	24.8	80.8	28.6	29.8	41.4	27.1	74.6	42.8	83.8	93.0	97.8	81.8	55.3	79.8	107.4	99.3	17.0	63.6	38.2	69.8	101.7	108.8	33.3	48.8	23.8	73.7	25.8	24.8	31.4	26.2	45.1	32.5
RPS27	"MPS-1, MPS1, S27"	ENSG00000177954	"Ribosomal protein S27"	P42677	1	153990755-153992155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 778.4;lymphoid tissue: 769.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066851			Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: "	"prognostic favourable (9.69e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.05e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (4.86e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.81e-2)"	120.7	72.5	74.9	188.7	118.6	186.7	268.2	51.3	91.4	172.5	114.2	35.9	136.4	58.1	169.0	135.6	107.5	129.0	144.1	176.5	59.6	50.1	98.6	102.5	167.8	769.0	92.1	76.0	317.8	227.2	44.6	91.5	67.5	71.2	117.6	113.6	63.5	248.2	116.1	243.8	160.1	115.9	254.3	65.6	159.3	111.5	119.0	81.9	118.2	113.0	224.0	270.9	162.9	286.0	720.2	296.5	132.9	139.9	324.1	750.5	778.4	104.0	122.0	161.3	87.8	379.9	374.5	100.0	126.2	302.5	170.0	153.7	244.4	115.1	236.9	106.0	182.0	104.8	142.1	208.9	143.7	115.1	183.2	93.3	161.8	158.5	251.8	207.4	123.1	363.6	410.9	135.2	249.1	139.3	113.9	128.9	161.3	261.5	223.2	131.3	195.4	178.0	143.0	118.2	184.3	157.0	210.8	85.8	191.2	72.3	254.7	219.3	141.9	416.9	82.3	58.8	97.3	93.6	126.1	258.9	263.9	287.2	102.0	116.5	80.6	132.9	139.9	68.1	393.0	138.9	473.7	720.2	594.4	502.0	179.5	637.3	750.5	579.6	32.4	324.1	127.0	296.5	397.8	778.4	74.9	118.6	51.3	91.4	59.6	50.1	92.1	76.0	71.2	81.9
RPS27A	"S27A, Uba80, UBCEP80"	ENSG00000143947	"Ribosomal protein S27a"	P62979	2	55231903-55235853	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033319, HPA041344, HPA049132, HPA054087"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"CAB033319: AB_793618, HPA041344: , HPA049132: , HPA054087: "	"unprognostic (7.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.75e-2)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (2.60e-6)"	"unprognostic (1.09e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.60e-1)"	54.1	45.0	46.8	66.0	85.5	111.5	120.1	33.3	77.9	74.5	60.0	21.4	43.0	37.3	66.0	57.8	68.3	61.4	51.2	47.1	57.0	32.7	71.1	172.7	43.9	84.3	42.4	68.3	167.1	88.9	20.7	53.7	57.1	52.1	57.7	52.5	25.3	70.5	46.9	101.9	69.1	52.5	46.3	40.4	77.1	58.9	48.6	36.4	62.8	64.0	144.0	82.1	52.1	71.1	194.8	130.9	42.2	62.9	122.8	253.3	267.6	104.8	61.0	66.9	111.2	93.4	178.5	127.9	82.7	95.2	90.9	57.6	113.8	119.1	146.9	139.9	78.9	99.7	96.6	113.1	106.3	124.5	111.8	135.3	65.6	152.2	135.9	201.7	92.7	160.5	225.1	61.0	166.4	123.2	120.6	134.9	103.8	82.1	117.9	243.0	160.7	78.2	112.5	170.5	173.6	102.8	100.4	88.5	70.2	56.8	247.2	184.4	109.9	172.3	117.3	83.4	126.9	74.3	140.0	121.5	84.2	95.5	119.3	171.7	83.0	42.2	62.9	24.1	129.3	59.1	183.5	194.8	197.3	154.8	91.1	179.3	253.3	206.8	14.4	122.8	52.5	130.9	120.7	267.6	46.8	85.5	33.3	77.9	57.0	32.7	42.4	68.3	52.1	36.4
RPS27L		ENSG00000185088	"Ribosomal protein S27 like"	Q71UM5	15	63125872-63158021	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066851			Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: "	"unprognostic (4.62e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.38e-1)"	"prognostic favourable (9.08e-6)"	"unprognostic (1.75e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.10e-3)"	46.8	64.2	21.3	19.8	29.7	18.2	53.6	16.3	23.4	29.4	58.5	15.5	30.4	46.0	30.2	49.3	40.4	27.0	38.3	47.1	22.8	22.2	61.0	75.2	31.7	23.4	32.6	19.2	26.5	65.9	19.2	38.8	35.6	43.9	56.2	55.3	18.3	99.8	46.0	47.1	18.1	80.4	54.8	39.9	28.2	41.9	15.7	27.3	19.4	53.9	25.7	19.8	55.0	36.3	34.5	30.9	51.5	47.6	27.2	75.4	38.3	17.1	48.0	43.5	11.7	63.7	75.5	43.6	54.2	38.7	11.9	29.2	8.8	23.9	16.1	19.4	51.8	6.6	14.7	26.7	20.1	11.9	19.9	13.3	40.5	62.7	73.4	10.5	36.9	59.0	35.9	26.9	20.5	67.5	12.2	16.2	99.3	23.7	13.5	16.5	12.8	14.0	10.6	20.9	18.2	33.5	34.7	6.3	9.6	19.7	8.3	38.3	18.4	24.5	71.4	63.3	59.6	13.6	24.0	18.3	15.6	14.3	67.1	29.2	57.0	51.5	34.3	40.0	27.5	35.9	33.9	34.5	41.6	32.0	30.9	26.9	32.9	33.1	11.4	27.2	47.6	30.8	75.4	38.3	21.3	29.7	16.3	23.4	22.8	22.2	32.6	19.2	43.9	27.3
RPS28	S28	ENSG00000233927	"Ribosomal protein S28"	P62857	19	8321158-8323340	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047132	Approved		Approved	Cytosol				Cytosol		"HPA047132: AB_10962147"	"unprognostic (3.47e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.49e-1)"	"prognostic favourable (2.47e-4)"	"unprognostic (3.09e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.81e-2)"	20.3	19.0	24.1	19.2	22.0	45.2	29.7	23.4	38.9	18.2	16.9	8.2	16.3	23.5	20.4	17.5	32.5	23.1	17.4	35.6	15.1	14.5	18.7	45.0	17.5	35.8	18.4	23.1	49.5	71.9	6.4	17.7	17.0	22.4	20.4	8.6	21.1	42.4	12.2	40.7	36.3	20.7	16.3	13.7	29.3	20.9	48.6	11.2	22.2	25.0	35.9	17.7	21.9	33.5	30.3	26.5	5.3	16.6	11.1	30.8	38.4	33.3	13.5	12.3	27.9	17.8	27.0	19.6	21.9	20.2	25.5	20.9	18.4	14.7	50.1	27.1	12.7	25.5	16.3	37.7	3.7	30.3	108.8	24.2	14.7	18.2	32.2	27.7	26.9	43.2	43.5	18.5	16.8	23.5	33.8	57.1	11.3	20.9	42.3	98.6	36.9	83.1	30.2	13.2	53.0	16.8	16.0	23.8	23.2	15.7	29.3	38.9	22.2	46.9	29.3	21.2	18.1	40.9	36.4	66.8	35.0	34.1	22.4	53.4	14.2	5.3	16.6	3.5	16.9	10.6	22.8	30.3	27.1	19.7	15.8	26.8	30.8	21.4	2.6	11.1	9.8	26.5	16.4	38.4	24.1	22.0	23.4	38.9	15.1	14.5	18.4	23.1	22.4	11.2
RPS29	S29	ENSG00000213741	"Ribosomal protein S29"	P62273	14	49570984-49599164	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 526.9;pancreas: 892.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004107	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA004107: AB_1079848"	"prognostic favourable (2.66e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.48e-3)"	"unprognostic (7.71e-2)"	59.9	53.6	54.5	108.8	58.9	140.0	155.5	34.4	88.2	68.6	89.6	17.9	67.6	71.4	54.9	67.9	75.3	56.1	63.5	108.2	43.1	33.8	54.5	75.3	74.3	232.1	64.3	56.2	128.3	892.4	8.5	41.6	44.5	53.1	50.6	58.9	29.2	86.0	67.9	177.4	102.6	70.9	76.3	74.6	98.1	63.3	94.0	60.6	53.2	45.6	136.9	101.6	47.1	83.8	303.1	164.3	62.9	102.0	123.1	363.7	526.9	147.8	98.1	102.7	91.9	118.1	201.4	135.9	101.5	86.7	92.8	76.1	98.9	137.2	135.0	116.3	85.2	129.7	117.9	144.4	103.3	88.0	213.0	105.7	89.0	172.2	144.7	269.6	91.9	208.2	236.5	60.9	177.8	132.0	117.8	177.5	89.8	196.7	184.0	168.0	125.2	277.2	154.7	127.9	154.5	111.8	132.6	77.8	89.8	72.0	133.3	235.1	173.8	235.9	121.7	71.1	190.8	66.0	89.6	205.0	227.5	182.7	50.1	111.4	68.4	62.9	102.0	46.1	175.8	81.1	219.7	303.1	322.1	227.3	122.6	281.3	363.7	295.6	24.4	123.1	73.4	164.3	181.8	526.9	54.5	58.9	34.4	88.2	43.1	33.8	64.3	56.2	53.1	60.6
RPS3	"FLJ26283, FLJ27450, MGC87870, S3"	ENSG00000149273	"Ribosomal protein S3"	P23396	11	75399486-75422280	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063339	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"			430000	"Endoplasmic reticulum, Cytosol"		"HPA063339: "	"unprognostic (3.62e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (6.92e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-1)"	72.2	52.7	36.6	108.4	41.2	122.2	136.6	32.1	33.8	105.1	102.0	32.5	65.2	65.8	102.4	84.7	136.5	92.2	107.7	58.5	29.7	26.5	52.9	78.1	71.0	218.6	47.6	30.6	224.7	288.7	13.8	51.3	75.9	35.0	105.7	65.7	47.6	151.0	61.8	86.9	117.6	78.0	110.6	42.1	121.4	75.4	54.1	36.5	126.5	119.4	134.7	130.1	110.3	118.9	104.5	69.7	22.6	44.5	64.6	144.2	213.9	85.5	53.1	75.5	83.1	95.5	170.4	97.7	82.1	105.8	109.0	71.1	153.1	102.5	299.4	100.6	73.7	124.1	97.4	152.7	100.5	79.2	76.1	122.6	53.0	67.6	142.6	197.9	80.4	199.9	208.7	74.5	207.1	142.9	122.1	85.3	97.9	94.0	118.7	95.2	94.8	63.0	112.8	264.9	218.1	107.0	71.6	65.0	92.2	60.5	143.9	83.5	146.9	151.7	114.4	52.7	87.8	71.8	74.1	78.3	96.5	331.7	31.6	111.1	53.2	22.6	44.5	14.7	94.2	31.6	129.1	104.5	123.0	99.4	69.7	95.6	144.2	111.8	11.2	64.6	30.1	60.8	78.2	213.9	36.6	41.2	32.1	33.8	29.7	26.5	47.6	30.6	35.0	36.5
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099573-151104652	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 440.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"			63000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	71.7	46.9	48.4	69.2	47.7	124.7	160.3	40.4	43.5	114.1	98.4	30.4	61.9	45.0	75.3	84.4	142.8	73.3	53.9	51.1	36.8	33.3	72.8	94.2	79.4	102.5	42.6	43.5	179.5	143.8	18.1	49.3	70.5	38.0	113.3	62.4	39.0	113.8	48.5	116.8	97.1	73.5	62.0	43.1	94.2	64.2	61.9	30.7	120.4	126.8	111.6	90.6	111.4	86.3	211.6	187.7	44.3	92.8	142.9	282.7	440.7	79.4	58.5	111.6	109.6	143.6	281.1	113.9	84.8	130.9	120.2	74.4	113.0	116.2	360.7	42.4	92.4	52.8	113.1	141.5	114.2	79.4	109.4	77.9	72.3	130.5	166.3	184.8	80.8	208.5	292.1	73.9	196.6	142.5	125.2	188.9	142.6	118.7	199.5	219.6	104.7	45.3	146.2	108.9	120.6	139.1	96.6	107.3	106.2	38.1	139.5	186.6	93.3	224.7	86.5	58.8	77.8	64.8	93.2	146.9	236.3	220.8	75.5	135.0	69.6	44.3	92.8	27.2	120.6	74.5	203.9	211.6	203.1	157.9	156.5	185.7	282.7	226.9	15.1	142.9	62.1	187.7	145.5	440.7	48.4	47.7	40.4	43.5	36.8	33.3	42.6	43.5	38.0	30.7
RPS5	S5	ENSG00000083845	"Ribosomal protein S5"	P46782	19	58386400-58394806	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 495.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055878, HPA061979"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"			860000	"Endoplasmic reticulum, Cytosol"		"HPA055878: AB_2682954, HPA061979: AB_2684650"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-1)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (2.79e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.01e-1)"	93.2	62.4	40.6	71.7	36.4	118.0	111.7	28.4	34.9	105.3	100.7	34.6	69.1	51.1	108.4	66.2	159.0	103.7	81.4	50.9	33.3	28.9	63.1	160.1	79.1	162.1	37.8	30.9	199.2	376.8	19.4	45.0	72.5	31.9	112.3	50.9	45.5	145.6	54.9	162.7	122.7	63.3	81.1	39.0	103.1	66.0	66.8	34.0	136.8	134.5	144.1	129.6	104.5	131.0	150.0	86.6	16.9	44.9	64.8	138.0	156.5	75.0	110.5	42.2	67.1	82.3	106.6	66.1	42.0	69.9	51.8	33.1	82.3	55.5	156.3	53.0	59.5	49.0	67.0	103.5	21.5	42.4	495.1	61.8	61.5	103.8	102.1	103.6	52.7	135.2	172.2	53.7	122.8	67.5	78.5	83.7	55.2	61.0	100.1	71.2	70.0	149.3	97.3	60.5	137.0	57.2	95.0	63.4	79.1	29.4	84.6	86.3	48.8	125.9	42.5	78.3	57.5	31.2	91.4	112.5	190.6	115.2	49.0	77.6	42.9	16.9	44.9	8.6	54.2	41.1	99.7	150.0	94.6	70.4	82.9	141.7	138.0	106.0	6.5	64.8	30.1	86.6	74.7	156.5	40.6	36.4	28.4	34.9	33.3	28.9	37.8	30.9	31.9	34.0
RPS6	S6	ENSG00000137154	"Ribosomal protein S6"	P62753	9	19375715-19380254	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 573.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004027, HPA031153"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			100000	"Endoplasmic reticulum, Cytosol"		"CAB004027: AB_2238583, HPA031153: AB_10602245"	"unprognostic (3.95e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.34e-2)"	"prognostic favourable (4.12e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.06e-3)"	90.0	65.3	64.1	110.2	70.2	166.3	152.8	37.0	50.4	125.4	149.9	38.8	57.4	73.0	91.6	97.7	166.8	87.7	81.5	70.0	51.5	44.4	88.5	91.3	104.0	243.5	66.0	36.2	206.6	441.2	26.1	64.0	67.9	64.7	152.5	83.9	53.3	109.1	72.1	129.5	139.9	96.3	157.8	84.5	137.8	87.5	67.2	53.2	127.9	147.0	119.7	125.8	207.4	143.4	237.2	135.7	30.1	75.5	129.7	274.9	399.9	106.2	69.9	71.1	83.2	120.6	186.1	85.4	71.9	93.8	86.4	72.3	58.1	49.3	244.4	71.2	68.6	52.3	79.6	110.6	93.9	127.3	76.2	161.1	90.5	105.3	147.3	85.3	80.5	154.3	202.4	57.5	169.7	103.8	67.6	99.8	93.2	64.0	180.6	573.5	133.3	47.6	141.4	71.9	116.2	119.6	91.5	71.1	95.6	27.2	115.8	148.5	75.4	311.8	76.1	49.8	53.3	51.5	112.3	47.2	91.4	165.9	33.7	128.3	29.0	30.1	75.5	23.3	111.6	67.1	193.2	237.2	205.0	150.5	135.7	196.8	274.9	215.8	12.8	129.7	60.6	126.1	152.7	399.9	64.1	70.2	37.0	50.4	51.5	44.4	66.0	36.2	64.7	53.2
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 29.6;U-937: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 60.4"	"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favourable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.84e-4)"	"prognostic favourable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favourable (8.33e-4)"	11.0	8.2	6.3	24.2	9.7	15.8	5.0	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6.0	8.0	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10.0	7.4	3.3	8.6	8.6	15.8	3.6	19.0	5.5	1.1	9.0	45.2	2.8	7.9	27.0	9.7	2.7	9.0	15.9	13.9	4.9	17.3	6.2	4.5	5.0	22.0	40.1	18.0	7.9	8.3	17.1	9.7	3.4	2.8	3.7	0.1	0.0	3.7	0.8	1.5	4.2	4.0	4.0	8.1	18.3	4.5	0.5	11.5	6.3	22.7	3.0	15.1	4.1	20.1	8.5	7.0	1.3	23.7	29.6	0.7	8.3	3.8	6.9	1.8	3.4	6.7	0.2	5.4	0.8	23.3	7.2	11.0	12.6	3.6	8.0	12.0	2.7	4.1	1.6	6.9	6.6	3.2	4.2	20.3	1.2	0.2	5.3	0.7	3.3	4.1	4.9	10.0	2.5	31.8	4.0	9.6	18.0	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22.0	5.0	3.9	5.5	34.5	7.9	17.3	8.6	6.0	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9.0
RPS6KA3	"CLS, HU-3, MRX19, RSK, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	19.7	12.5	9.9	23.0	12.5	8.2	16.5	15.2	12.1	11.4	23.2	4.4	22.1	13.7	12.4	10.1	13.6	12.7	15.7	21.3	9.7	8.8	14.1	25.8	21.6	34.0	9.9	10.0	12.7	14.0	36.6	9.8	11.0	10.2	14.5	18.8	7.7	14.3	11.3	45.2	11.7	23.7	16.1	11.7	25.8	11.8	4.8	9.7	29.4	13.5	15.0	18.2	20.3	19.0	4.2	8.6	12.5	6.9	8.3	11.3	2.7	12.6	22.2	8.4	4.3	8.2	14.5	2.5	11.0	16.8	8.2	11.3	25.1	16.4	8.3	3.8	11.5	9.0	9.6	9.3	15.3	7.0	7.6	9.8	14.0	67.5	8.4	19.0	10.2	9.2	7.5	12.9	16.3	29.8	6.4	23.9	8.6	6.0	12.3	5.8	6.0	13.4	6.6	17.8	9.6	7.1	10.6	3.9	3.8	14.8	4.5	16.0	0.0	5.7	16.6	9.0	6.3	28.5	6.2	19.1	11.6	9.3	17.0	9.5	21.2	12.5	4.7	9.5	6.3	6.9	11.3	2.9	7.3	6.9	7.0	4.2	5.0	6.0	7.5	8.3	6.9	8.6	3.5	2.7	9.9	12.5	15.2	12.1	9.7	8.8	9.9	10.0	10.2	9.7
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavourable (8.17e-4)"	"prognostic unfavourable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	14.9	9.1	13.3	15.7	17.1	13.2	7.6	37.6	22.7	7.7	12.4	13.1	5.8	14.0	11.0	6.9	18.5	8.1	10.5	7.8	10.9	10.1	8.7	9.6	10.9	15.0	16.7	9.9	6.5	9.2	5.7	4.7	16.6	9.8	8.3	8.4	10.0	10.9	8.9	16.3	17.3	15.4	9.8	11.5	22.2	18.3	3.3	13.5	7.6	6.7	16.7	16.4	9.7	8.8	0.5	12.6	1.4	3.0	0.3	1.0	2.1	27.7	15.5	2.2	5.7	5.0	4.7	32.1	14.7	7.8	11.6	5.8	15.4	14.6	2.8	17.3	8.5	25.7	2.7	12.0	5.7	8.7	5.2	6.5	13.3	7.8	5.0	6.6	12.2	4.7	11.3	9.8	8.1	7.0	2.6	4.0	5.9	25.4	5.9	10.3	2.5	32.9	11.7	9.3	9.3	8.0	12.9	3.3	2.6	15.3	9.4	12.9	11.0	8.2	13.9	15.8	19.9	28.6	13.2	4.8	3.7	2.9	10.5	7.6	8.0	1.1	3.0	1.4	0.9	2.4	1.0	0.5	0.7	0.7	2.7	0.4	0.4	0.4	0.2	0.3	1.4	12.6	0.6	2.1	13.3	17.1	37.6	22.7	10.9	10.1	16.7	9.9	9.8	13.5
RPS6KB2	"KLS, P70-BETA, p70S6Kb, STK14B"	ENSG00000175634	"Ribosomal protein S6 kinase B2"	Q9UBS0	11	67428460-67435408	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010010, CAB019404"	Approved		Supported	Cytosol				Cytosol		"CAB019404: AB_331355, HPA010010: AB_1856469"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.01e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.03e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.66e-1)"	8.7	14.1	8.5	12.8	9.2	18.0	11.2	12.9	11.5	13.1	13.0	12.5	12.3	19.8	10.2	10.1	36.1	11.0	10.7	10.7	8.8	4.2	11.3	27.8	10.7	12.0	11.4	8.7	9.5	18.7	9.6	11.7	13.8	8.7	17.2	9.9	11.7	18.1	15.8	25.0	41.4	17.7	8.8	7.6	18.6	17.1	7.5	8.8	21.8	11.4	28.6	21.8	10.1	15.6	15.7	27.1	16.4	28.3	17.8	20.7	20.2	21.7	16.5	9.0	15.2	4.2	8.1	11.8	10.5	13.2	19.7	13.7	25.7	14.6	8.0	18.3	10.3	16.2	10.1	16.0	8.0	13.8	27.0	12.9	21.0	20.9	14.2	16.3	16.0	10.3	16.9	10.4	10.7	14.6	20.7	21.5	9.9	33.3	25.1	25.7	9.7	21.2	18.6	12.5	38.0	9.1	12.5	13.6	14.6	10.8	30.1	22.4	35.4	13.6	6.1	10.3	11.0	24.8	11.7	19.3	15.8	12.9	16.9	10.3	12.8	9.7	22.6	16.4	15.7	25.2	15.9	15.7	14.9	15.3	27.1	14.3	10.9	11.9	15.1	17.8	28.3	18.7	20.7	20.2	8.5	9.2	12.9	11.5	8.8	4.2	11.4	8.7	8.7	8.8
RPS7	S7	ENSG00000171863	"Ribosomal protein S7"	P62081	2	3575205-3580919	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056586	Approved		Approved	"Endoplasmic reticulum,Cytosol"			1000000	"Endoplasmic reticulum, Cytosol"		"HPA056586: "	"unprognostic (3.28e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (6.41e-2)"	"unprognostic (6.02e-3)"	"unprognostic (7.08e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavourable (1.34e-8)"	"unprognostic (3.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	54.0	42.1	41.7	57.4	47.8	91.9	112.1	35.1	52.6	57.9	54.4	22.5	35.3	38.3	49.4	70.5	75.2	60.6	80.9	42.7	35.6	28.9	88.1	184.7	40.5	73.8	35.4	49.9	128.7	94.3	19.0	42.3	56.0	46.5	49.6	61.0	27.5	61.1	46.8	96.7	74.9	53.8	46.2	35.2	74.2	55.7	120.7	30.3	59.0	49.0	129.1	89.6	54.8	62.3	124.7	91.6	22.4	53.7	83.8	117.9	145.9	62.2	61.0	94.0	100.9	93.5	205.2	154.4	75.6	132.1	125.9	73.5	105.4	98.5	208.4	126.5	87.4	68.7	106.2	122.8	111.3	65.2	143.3	76.1	44.8	151.5	225.7	131.6	79.2	172.2	185.4	78.0	169.7	147.0	117.3	105.9	127.3	83.9	145.8	293.8	138.7	94.7	116.5	95.9	185.3	142.2	76.6	107.2	161.3	40.0	154.2	230.1	84.8	191.0	68.6	75.8	49.9	52.1	121.1	119.0	216.7	204.2	79.7	158.7	84.4	22.4	53.7	19.9	74.4	47.3	109.5	124.7	107.1	94.6	91.6	107.1	117.9	103.2	11.4	83.8	44.3	87.8	90.6	145.9	41.7	47.8	35.1	52.6	35.6	28.9	35.4	49.9	46.5	30.3
RPS8	S8	ENSG00000142937	"Ribosomal protein S8"	P62241	1	44775251-44778779	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029266			Enhanced	"Endoplasmic reticulum,Cytosol"			52000	"Endoplasmic reticulum, Cytosol"		"HPA029266: AB_10601611"	"unprognostic (9.70e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (1.02e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (9.05e-9)"	"unprognostic (1.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.57e-2)"	55.7	60.7	44.8	44.4	46.3	100.1	82.0	50.1	65.5	69.6	47.8	33.8	37.0	40.7	61.9	48.4	78.0	66.7	43.9	36.8	34.6	23.7	41.6	74.1	36.5	77.7	34.8	34.6	195.0	98.3	13.1	37.2	45.4	36.8	53.5	42.5	32.3	61.0	72.7	53.7	91.2	45.6	39.4	35.6	57.0	47.4	71.9	29.0	64.8	40.9	97.3	72.0	52.7	71.2	146.1	98.0	15.3	50.2	61.2	128.4	168.5	100.6	50.4	81.1	106.7	141.0	221.9	132.7	74.1	117.5	104.8	84.4	86.5	110.3	191.0	81.7	89.7	69.1	103.9	129.0	77.6	69.1	181.5	71.2	71.8	114.9	200.4	141.4	69.8	176.5	214.1	69.8	187.5	125.1	105.7	134.3	97.4	79.7	155.4	151.4	177.1	87.3	125.3	99.3	213.1	117.5	86.6	86.8	100.2	40.0	224.7	293.7	78.5	284.6	85.3	52.1	91.4	79.9	125.8	106.0	103.9	144.4	63.7	169.9	62.4	10.3	50.2	15.3	55.1	49.1	94.1	146.1	101.4	76.7	79.2	124.5	128.4	106.7	5.0	61.2	38.1	98.0	84.2	168.5	44.8	46.3	50.1	65.5	34.6	23.7	34.8	34.6	36.8	29.0
RPSA	"37LRP, LAMR1, LRP, p40, SA"	ENSG00000168028	"Ribosomal protein SA"	P08865	3	39406689-39412542	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB009561	Approved		Supported	"Plasma membrane,Cytosol"			710000	"Plasma membrane, Cytosol"		"CAB009561: AB_2182543"	"unprognostic (3.67e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-1)"	47.5	42.9	48.8	88.4	56.9	107.0	76.7	26.3	56.2	50.9	63.6	29.1	65.6	48.4	73.5	50.1	93.4	82.4	52.2	67.3	43.2	33.7	44.1	63.8	67.5	300.2	41.7	37.7	145.1	264.7	35.7	42.2	45.0	43.5	58.9	71.5	31.4	148.1	50.2	60.4	70.5	53.0	73.9	48.1	76.8	58.4	60.2	26.8	83.5	72.8	105.2	112.4	53.8	80.4	92.4	64.0	6.9	24.8	61.5	101.2	114.8	92.6	84.9	73.9	121.8	65.0	148.4	116.2	66.2	107.5	151.0	88.5	92.9	80.8	209.9	40.7	130.3	37.1	159.7	152.9	130.2	75.7	83.6	95.0	80.7	90.1	126.0	133.4	89.6	164.7	254.9	116.1	186.3	155.4	98.6	101.8	109.0	64.8	154.9	99.8	247.1	146.1	73.2	105.9	154.0	105.6	42.9	53.5	109.2	36.1	279.0	114.8	81.4	185.7	61.2	46.4	85.6	77.1	161.0	78.7	119.6	125.2	74.4	130.0	61.3	6.9	20.6	4.8	53.8	24.8	93.5	92.4	89.8	71.4	58.1	89.5	101.2	88.4	3.0	61.5	20.4	64.0	66.1	114.8	48.8	56.9	26.3	56.2	43.2	33.7	41.7	37.7	43.5	26.8
RPUSD1	"C16orf40, MGC19600, RLUCL"	ENSG00000007376	"RNA pseudouridylate synthase domain containing 1"	Q9UJJ7	16	784974-788397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041144, HPA041938"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cell Junctions, Cytosol"	"HPA041144: AB_10794265, HPA041938: AB_10795601"	"unprognostic (1.51e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.07e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.25e-2)"	"unprognostic (8.07e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-1)"	9.5	9.7	12.0	16.5	14.8	20.9	10.4	15.3	23.8	7.4	11.2	9.4	6.2	17.6	10.5	14.0	13.9	8.6	11.2	8.1	12.7	10.4	10.7	13.4	8.2	18.2	9.5	11.3	10.0	15.3	9.9	8.9	8.2	11.2	11.3	5.1	10.9	19.8	10.5	11.1	16.8	12.8	8.3	7.0	17.4	15.1	6.2	9.2	15.5	8.5	15.1	15.6	10.8	10.7	17.3	23.1	17.7	19.9	18.0	20.4	15.8	10.5	12.5	3.1	13.9	2.7	3.2	14.3	8.8	5.1	11.6	8.5	29.1	10.0	14.8	9.7	4.2	18.2	7.1	8.9	2.1	13.4	28.8	7.3	19.2	10.5	4.4	13.4	12.3	4.7	8.6	10.0	2.6	8.0	17.0	6.7	3.9	33.6	16.7	14.1	15.7	21.6	29.8	8.3	30.4	4.2	6.5	16.1	11.6	10.2	16.7	9.7	8.6	16.8	9.0	11.6	15.1	12.1	12.7	10.7	10.7	17.0	5.6	10.5	9.5	17.5	19.9	17.7	18.3	18.0	18.1	14.9	15.5	20.4	23.1	17.3	16.2	16.3	12.7	18.0	17.4	21.2	18.7	15.8	12.0	14.8	15.3	23.8	12.7	10.4	9.5	11.3	11.2	9.2
RRAS2	TC21	ENSG00000133818	"RAS related 2"	P62070	11	14277926-14364506	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 12.3"	"Group enriched"	"Detected in many"	5	"B-cells: 12.3;NK-cells: 3.5;T-cells: 6.2"	"Low region specificity"	"Detected in all"							"CAB010420, HPA050942"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB010420: AB_2253855, HPA050942: "	"unprognostic (6.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (7.80e-4)"	"prognostic unfavourable (3.31e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (4.50e-2)"	"unprognostic (4.15e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	22.3	11.8	8.3	27.5	7.8	2.3	22.6	9.5	7.0	14.1	16.9	6.4	7.8	11.9	16.2	9.8	13.5	11.1	12.9	29.8	8.7	8.1	25.6	33.0	18.1	15.2	6.5	7.6	16.6	18.5	13.5	7.4	50.8	8.4	16.7	11.0	14.5	15.1	12.9	31.4	9.2	37.7	31.4	7.6	17.6	13.7	21.0	5.2	11.3	26.2	14.4	20.8	27.3	15.0	12.3	0.4	1.5	0.0	3.5	6.2	0.9	15.1	6.5	6.2	5.5	22.4	22.0	9.4	53.3	27.9	46.0	58.5	13.3	18.8	17.4	9.0	35.8	17.4	10.6	19.1	46.4	15.4	10.3	1.1	3.9	10.5	24.1	0.0	0.1	23.3	36.2	18.3	59.0	22.8	7.6	0.0	39.9	7.3	3.7	0.9	17.9	6.2	3.6	20.8	0.3	23.6	8.3	1.7	3.2	12.8	8.2	7.2	5.3	1.1	52.1	24.9	13.8	47.8	14.4	0.0	0.0	8.2	10.0	0.0	5.0	1.5	0.0	0.0	6.2	0.0	2.6	12.3	1.1	3.2	0.0	6.9	0.6	2.5	0.4	3.5	0.0	0.4	0.0	0.9	8.3	7.8	9.5	7.0	8.7	8.1	6.5	7.6	8.4	5.2
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138876	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Enhanced	Cytosol			13000	Cytosol		"CAB022093: , HPA057265: , HPA064297: "	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	13.9	25.3	8.0	15.2	12.2	18.5	14.4	18.0	12.6	15.7	15.9	11.1	11.5	11.9	13.0	9.8	25.4	10.7	8.7	11.9	7.9	9.0	9.2	13.1	11.0	20.2	9.0	10.3	13.6	10.7	24.2	11.2	22.7	18.4	14.0	18.9	12.0	15.4	10.7	28.3	26.8	12.5	17.5	10.7	12.4	13.8	10.5	9.1	78.6	9.8	28.0	27.1	17.5	18.5	5.6	4.3	3.3	8.3	5.7	24.3	6.0	45.4	24.7	40.5	23.5	6.2	12.4	15.7	41.9	20.8	47.7	49.2	22.2	34.6	49.2	10.2	20.9	36.6	37.5	30.1	56.5	24.2	39.8	25.0	37.1	17.3	2.5	42.8	18.4	5.8	8.1	26.1	18.8	22.8	32.6	23.3	39.7	20.6	50.3	9.3	25.6	25.1	40.8	31.7	17.6	13.1	12.9	34.7	19.0	36.9	22.3	6.7	22.0	15.0	13.0	44.9	23.5	44.4	30.7	15.2	21.1	53.8	24.9	28.7	27.8	3.3	2.5	2.6	7.7	6.5	13.3	5.6	14.2	10.7	4.3	3.5	11.3	9.2	0.0	5.7	8.3	2.7	24.3	6.0	8.0	12.2	18.0	12.6	7.9	9.0	9.0	10.3	18.4	9.1
RRM2		ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10131419	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 120.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.4"									HPA056994	Enhanced		Supported	Cytosol				Cytosol		"HPA056994: "	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	4.7	2.2	0.4	32.6	0.4	29.0	4.2	0.4	0.9	3.5	9.3	0.4	0.4	5.2	2.1	1.7	21.6	0.7	5.0	3.3	0.4	0.5	2.0	3.9	5.7	16.4	0.6	0.1	0.9	2.9	0.0	0.7	5.4	0.3	1.0	10.6	0.1	2.9	0.0	0.5	2.8	11.3	3.2	0.8	19.8	5.4	8.0	0.0	120.9	0.8	22.3	33.1	3.8	5.2	1.4	0.3	0.6	0.2	1.8	10.4	2.6	29.1	17.7	25.0	17.1	2.2	4.1	24.8	47.7	23.6	34.1	37.1	29.5	14.0	26.8	6.6	14.9	14.3	40.5	24.6	41.8	60.0	15.6	51.6	17.0	26.0	0.1	38.2	24.8	1.4	0.5	41.7	3.5	27.5	21.6	79.5	42.4	22.0	42.2	20.5	20.2	20.7	31.8	54.6	18.4	16.7	22.2	24.8	20.4	39.2	27.9	4.8	15.0	6.9	9.6	26.1	38.0	19.5	66.8	51.6	40.5	54.7	18.5	32.4	37.5	0.3	0.1	0.1	3.7	0.0	0.0	1.4	2.6	2.9	0.2	0.4	0.2	1.2	0.6	1.8	0.2	0.3	10.4	2.6	0.4	0.4	0.4	0.9	0.4	0.5	0.6	0.1	0.3	0.0
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102239118	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, DNA replication"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB006854: , HPA028812: AB_10602246"	"unprognostic (7.76e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.17e-2)"	11.8	18.6	11.7	11.5	11.4	4.3	9.3	8.5	13.5	9.5	10.1	9.8	9.5	10.2	8.2	10.8	8.0	9.7	8.2	11.3	17.5	12.8	17.5	15.1	15.8	12.6	14.9	10.6	9.7	9.5	34.7	24.8	11.6	23.1	11.2	11.1	7.7	9.7	10.9	34.6	7.4	7.6	8.2	26.1	10.6	7.1	6.6	9.4	6.3	37.1	8.1	13.1	10.7	7.0	7.4	6.2	18.3	8.4	3.0	3.3	2.8	5.6	10.1	12.0	7.1	17.0	16.4	9.6	13.2	16.0	7.1	8.3	3.6	4.6	36.4	12.5	14.6	2.1	5.8	13.4	10.1	5.9	6.3	9.1	4.3	7.6	13.8	2.8	19.5	20.8	25.3	7.8	11.9	19.8	6.7	5.6	22.7	5.6	4.8	5.3	6.7	7.5	3.1	4.9	7.3	16.5	6.5	3.0	6.0	6.9	3.7	7.9	9.9	6.3	15.1	11.0	21.4	7.6	3.6	5.9	5.4	33.1	16.2	4.3	11.6	10.0	5.1	5.3	2.2	4.5	3.3	5.6	2.0	2.8	6.2	7.4	2.3	2.5	18.3	3.0	8.4	1.8	1.4	2.8	11.7	11.4	8.5	13.5	17.5	12.8	14.9	10.6	23.1	9.4
RRNAD1	"C1orf66, CGI-41, METTL25B"	ENSG00000143303	"Ribosomal RNA adenine dimethylase domain containing 1"	Q96FB5	1	156728442-156736960	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047426	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA047426: "	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.60e-5)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.03e-3)"	14.1	19.4	12.4	22.6	19.0	8.7	19.1	15.3	18.8	17.6	25.7	20.8	31.2	22.5	20.3	22.9	18.4	24.4	20.2	12.5	13.3	10.9	15.9	25.8	14.5	14.4	19.9	14.5	24.5	29.2	24.3	18.8	20.5	16.1	21.8	14.8	20.2	22.5	24.5	21.9	23.9	26.6	12.9	14.7	18.5	19.3	25.9	17.7	11.9	30.3	13.5	15.9	21.7	27.9	4.9	5.9	7.0	4.0	6.5	8.6	2.9	5.9	11.8	8.7	8.5	23.6	10.8	13.3	4.5	13.8	7.8	5.9	6.3	27.5	10.2	13.5	7.1	25.5	12.2	10.6	3.1	20.1	10.2	6.1	11.1	4.7	14.8	9.0	16.8	16.7	20.3	7.7	14.8	6.5	14.6	22.9	4.1	14.4	4.6	10.7	10.1	3.6	7.6	5.8	23.5	9.2	6.4	11.4	16.4	8.0	16.4	9.7	21.7	19.5	6.2	4.8	6.0	7.5	6.0	26.8	26.2	12.5	5.4	10.2	5.8	6.7	3.3	4.7	6.8	2.5	6.9	3.4	6.6	4.8	5.9	4.9	5.3	6.0	7.0	6.5	4.0	2.2	8.6	2.9	12.4	19.0	15.3	18.8	13.3	10.9	19.9	14.5	16.1	17.7
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: , HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.8	21.1	5.6	12.1	4.3	5.1	12.4	10.0	6.0	10.4	8.1	22.9	14.7	17.4	13.0	6.3	20.4	15.4	11.6	7.0	9.4	18.5	13.4	7.9	17.8	7.2	20.9	17.7	5.3	16.4	25.6	23.7	5.8	19.2	11.7	5.9	20.5	14.1	13.5	24.2	14.3	15.6	7.7	17.2	7.2	8.8	7.6	16.2	8.0	7.7	10.0	18.6	10.9	7.6	7.0	12.0	15.6	31.5	23.9	20.8	20.5	10.0	26.9	7.4	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1
RRP8	"KIAA0409, NML"	ENSG00000132275	"Ribosomal RNA processing 8"	O43159	11	6595075-6603620	"Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038487, HPA057562"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA038487: AB_10672518, HPA057562: "	"unprognostic (9.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (3.10e-7)"	"unprognostic (4.64e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.87e-2)"	13.8	11.9	13.9	15.8	14.8	32.1	17.9	18.1	15.3	15.9	24.9	16.1	10.5	14.0	15.5	21.3	13.8	11.9	15.4	16.2	16.0	10.3	13.3	24.7	14.3	16.0	18.4	13.6	12.4	12.7	12.0	12.3	12.8	14.2	19.8	14.4	11.8	10.9	19.7	18.6	15.5	12.8	19.5	11.0	17.7	15.1	12.3	18.6	11.8	14.2	9.7	16.6	20.2	13.9	13.3	14.4	20.3	12.0	14.4	13.8	10.2	10.2	10.2	4.1	5.3	8.6	7.5	5.8	5.3	6.6	12.3	11.6	10.5	12.0	14.4	5.2	5.0	10.4	11.7	9.3	13.1	6.9	16.8	6.8	12.3	11.8	9.8	12.3	9.5	6.4	12.2	5.8	10.7	12.6	13.4	8.4	9.7	12.7	11.9	18.4	10.1	9.3	10.7	3.3	3.2	11.5	8.2	6.3	7.4	7.6	15.5	8.6	8.4	10.8	6.5	11.7	5.4	11.3	10.2	9.4	8.5	13.7	9.9	12.4	7.5	20.3	11.0	10.7	13.7	11.8	13.2	10.9	13.5	12.6	14.4	13.3	13.3	13.8	4.4	14.4	12.0	11.0	12.6	10.2	13.9	14.8	18.1	15.3	16.0	10.3	18.4	13.6	14.2	18.6
RSAD1	FLJ11164	ENSG00000136444	"Radical S-adenosyl methionine domain containing 1"	Q9HA92	17	50478800-50485975	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA022436, HPA022967"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA022436: AB_2180789, HPA022967: AB_1856484"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.13e-2)"	"prognostic favourable (5.04e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-2)"	13.5	22.2	16.1	16.8	23.9	8.9	14.1	32.2	20.3	16.8	13.1	12.7	13.5	13.9	13.8	15.1	8.8	12.9	13.6	25.7	13.7	11.6	18.5	28.2	14.0	16.6	19.0	13.7	20.9	46.0	20.3	12.9	10.1	16.3	12.8	14.9	12.6	21.4	14.0	37.0	13.5	12.0	13.7	23.6	16.7	16.0	8.8	19.1	11.6	15.8	20.9	14.0	11.7	12.4	7.4	5.8	3.8	4.6	6.7	10.9	5.1	6.2	21.4	10.3	16.9	17.6	14.5	3.7	11.0	10.8	14.2	12.1	21.1	8.0	17.1	24.5	7.7	6.0	11.6	15.4	12.3	18.8	21.1	22.9	9.6	20.5	12.3	13.8	16.1	10.5	17.0	9.4	18.3	13.8	17.6	16.3	11.9	14.7	23.0	10.1	4.1	23.1	9.5	11.8	15.3	17.2	9.6	5.6	19.3	2.8	13.3	14.2	19.9	14.1	9.7	14.9	15.9	11.3	12.9	25.4	17.8	6.6	11.1	19.8	10.3	1.1	4.1	3.8	9.5	4.6	9.9	5.1	8.2	9.4	5.1	7.4	10.9	10.5	0.0	6.7	4.3	5.8	6.2	5.1	16.1	23.9	32.2	20.3	13.7	11.6	19.0	13.7	16.3	19.1
RSPH3	"dJ111C20.1, RSHL2, RSP3"	ENSG00000130363	"Radial spoke head 3 homolog"	Q86UC2	6	158972871-159000187	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039109, HPA040230"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"		"HPA039109: AB_10794423, HPA040230: AB_10796119"	"unprognostic (6.18e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	4.9	9.0	7.1	3.8	9.8	3.1	6.2	6.3	12.7	6.8	8.2	7.0	14.3	11.3	7.4	12.8	15.5	10.7	6.0	6.6	8.0	6.8	10.7	5.4	8.5	2.6	4.8	10.6	7.3	8.6	25.9	14.4	5.5	10.4	8.9	6.5	5.5	10.3	14.9	3.8	7.6	12.2	6.6	6.0	3.9	7.5	24.3	7.0	2.1	12.8	5.1	3.9	9.1	8.4	2.3	5.8	13.0	7.7	1.8	1.8	1.6	9.9	5.1	2.3	5.4	5.4	6.9	2.9	7.1	8.2	2.8	3.7	2.0	6.0	2.1	6.5	7.5	7.6	1.5	6.6	3.2	4.8	4.4	2.7	5.0	3.4	5.2	2.5	1.9	8.5	11.8	4.6	8.9	2.7	3.1	3.4	4.6	5.6	1.5	3.1	1.5	3.4	2.4	0.4	2.1	8.8	3.2	3.5	4.4	13.2	4.4	2.5	5.4	6.2	6.4	2.9	7.4	5.6	3.8	3.6	6.9	1.8	12.5	3.3	4.6	0.7	5.2	0.6	0.8	3.6	1.8	1.3	1.2	1.6	5.4	2.3	1.0	1.4	13.0	1.8	7.7	5.8	1.4	1.6	7.1	9.8	6.3	12.7	8.0	6.8	4.8	10.6	10.4	7.0
RSRC2	FLJ11021	ENSG00000111011	"Arginine and serine rich coiled-coil 2"	Q7L4I2	12	122503458-122527000	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040070, HPA048183"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA040070: AB_10673430, HPA048183: "	"unprognostic (4.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.90e-2)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-2)"	18.5	19.4	24.8	20.2	31.9	82.6	20.1	34.9	45.9	19.3	21.0	16.0	19.9	14.3	21.4	21.4	26.9	19.6	21.0	20.2	28.9	21.4	20.6	18.2	19.1	23.0	24.9	24.1	25.2	19.0	11.3	43.2	20.6	28.1	20.0	18.6	10.7	19.1	21.3	36.8	18.7	19.2	20.4	45.1	18.6	16.0	20.7	29.4	21.1	23.5	17.7	15.7	25.0	28.0	24.6	16.3	22.3	18.4	16.4	19.3	9.8	11.7	14.2	13.5	5.7	10.7	7.0	9.7	21.8	7.0	9.4	5.3	19.9	5.0	13.4	18.6	7.6	7.6	14.7	6.1	9.2	12.6	13.6	23.4	17.2	21.2	5.9	20.1	14.3	8.7	7.2	8.0	13.6	6.6	14.9	8.4	8.2	9.4	14.5	15.0	11.1	11.7	11.1	12.2	8.7	12.1	22.1	10.9	9.8	17.0	5.7	12.0	9.2	7.4	9.9	9.6	11.6	10.6	11.9	9.6	22.3	21.6	6.1	11.6	5.4	19.8	16.6	22.3	16.4	13.5	13.9	22.8	15.0	13.3	16.3	24.6	19.3	15.2	17.7	16.4	18.4	15.4	19.0	9.8	24.8	31.9	34.9	45.9	28.9	21.4	24.9	24.1	28.1	29.4
RTCB	"C22orf28, FAAP, HSPC117"	ENSG00000100220	"RNA 2',3'-cyclic phosphate and 5'-OH ligase"	Q9Y3I0	22	32387582-32412255	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000535, HPA001103"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol			43000	Nucleoplasm	"Vesicles, Cytosol"	"HPA000535: , HPA001103: AB_1078351"	"unprognostic (1.84e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.07e-2)"	"prognostic favourable (4.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	26.4	30.1	20.1	20.4	29.7	15.1	29.2	22.9	34.5	25.7	35.6	35.2	32.7	51.6	29.7	25.8	30.8	26.9	22.9	26.4	19.6	24.6	42.4	55.1	23.1	22.7	29.1	26.2	29.0	29.4	38.4	29.9	33.7	36.7	27.0	42.3	27.1	29.9	28.6	40.9	46.6	61.7	31.8	24.4	29.3	29.7	30.8	25.5	32.0	32.7	30.1	46.6	26.5	24.2	44.6	51.5	29.0	47.7	37.0	40.5	44.0	31.7	28.6	35.9	26.9	31.4	23.5	28.6	27.9	33.7	44.7	42.5	37.1	13.0	7.9	18.7	32.5	21.7	41.0	40.5	57.9	39.8	41.2	22.5	24.3	33.7	21.6	52.5	20.6	23.0	26.9	44.1	43.0	40.1	26.6	22.5	32.5	26.5	22.3	18.2	20.5	26.2	34.7	38.8	40.6	30.7	27.7	37.1	20.5	30.2	19.6	35.4	21.5	20.5	30.1	24.7	36.4	21.4	26.7	15.7	12.5	28.5	25.5	23.8	32.1	29.0	43.5	27.4	31.7	47.7	35.5	44.6	33.3	33.0	51.5	43.6	39.9	34.6	4.3	37.0	35.5	28.9	40.5	44.0	20.1	29.7	22.9	34.5	19.6	24.6	29.1	26.2	36.7	25.5
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006714	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	20.4	27.8	27.6	21.6	33.8	34.3	20.4	40.5	34.5	23.7	22.5	14.3	17.6	16.9	25.7	18.4	22.4	18.5	18.4	24.8	26.5	21.4	17.6	19.6	17.2	23.0	17.0	35.1	27.7	15.2	37.0	20.3	36.9	27.2	22.0	20.6	15.4	19.5	23.2	55.2	24.8	20.7	24.7	14.9	23.5	19.0	25.4	13.5	25.3	26.7	15.6	21.6	27.8	20.2	8.0	7.4	11.6	4.3	8.6	5.7	1.4	15.2	10.0	33.0	26.8	18.8	22.3	15.6	20.4	23.0	28.0	23.4	19.4	9.7	14.5	16.6	21.3	27.1	19.1	16.9	24.0	22.0	17.8	30.4	22.6	14.5	13.2	27.0	17.8	16.0	17.2	14.9	15.2	22.5	23.0	16.8	22.9	11.5	25.8	16.7	17.8	13.8	28.1	25.8	13.8	18.2	32.7	17.0	22.5	18.3	23.4	9.2	19.2	26.2	18.4	27.5	17.5	27.3	22.3	19.4	29.9	24.1	19.8	25.8	16.7	5.9	4.3	8.4	4.8	2.8	4.4	8.0	4.7	4.1	3.0	6.5	5.7	4.7	11.6	8.6	3.3	7.4	5.4	1.4	27.6	33.8	40.5	34.5	26.5	21.4	17.0	35.1	27.2	13.5
RTL1	"HUR1, Mar1, MART1, PEG11, SIRH2"	ENSG00000254656	"Retrotransposon Gag like 1"	A6NKG5	14	100880655-100884847	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 5.0;brain: 7.6;placenta: 8.3"	"Cell line enriched"	"Detected in some"	31	"SH-SY5Y: 118.2"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 2.1"					"HPA066979, HPA077601"	Enhanced		Approved	Cytosol				Cytosol		"HPA066979: , HPA077601: "					"unprognostic (1.61e-1)"					"unprognostic (3.30e-1)"	"unprognostic (1.26e-1)"			"unprognostic (1.42e-3)"	"unprognostic (2.10e-1)"			0.0	5.0	0.2	0.0	0.9	0.0	0.0	0.5	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.6	0.0	0.0	0.0	0.0	1.8		1.3	0.1	0.0	0.3	8.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"kidney: 3.5;liver: 4.7"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.0"	"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.5	4.7	0.0	0.0	0.7		0.0	0.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2			0.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RTL6	"dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3"	ENSG00000188636	"Retrotransposon Gag like 6"	Q6ICC9	22	44492572-44498298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005697	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA005697: AB_1079244"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	11.6	14.1	19.3	7.7	17.4	3.2	10.2	16.2	30.0	13.6	12.2	14.7	15.2	9.7	17.8	14.2	9.4	19.1	12.4	16.7	17.1	16.1	10.9	4.9	10.4	6.3	16.9	11.4	22.6	12.1	18.9	9.9	5.9	11.9	11.5	10.4	9.2	7.7	16.3	15.5	3.7	9.2	19.0	16.5	7.9	10.7	12.6	9.5	14.4	11.6	7.2	5.3	11.8	10.2	0.2	1.1	0.1	1.4	0.9	4.5	2.1	6.9	9.7	12.6	16.7	9.9	8.1	3.3	9.2	11.0	13.0	10.3	3.2	4.1	0.0	5.8	17.2	6.1	8.5	9.1	8.1	3.3	16.5	0.0	18.7	0.0	12.2	0.9	4.6	8.7	8.9	11.9	9.2	11.6	3.9	0.0	8.8	12.3	22.1	2.0	7.7	10.4	6.1	6.7	0.0	11.2	8.1	13.6	15.9	15.1	7.3	9.3	7.3	9.8	11.9	10.2	13.9	13.5	7.4	4.4	1.7	0.0	15.2	2.3	15.2	0.0	1.4	0.1	4.3	0.6	4.5	0.0	2.5	3.6	1.1	0.2	1.0	2.5	0.0	0.9	0.8	0.1	0.4	2.1	19.3	17.4	16.2	27.8	17.1	16.1	16.9	11.4	11.9	9.5
RUBCN	"KIAA0226, rubicon, rundataxin"	ENSG00000145016	"RUN and cysteine rich domain containing beclin 1 interacting protein"	Q92622	3	197671393-197749727	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Endocytosis, Immunity, Phagocytosis"		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050908, HPA054497"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA050908: , HPA054497: "	"unprognostic (2.91e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (6.65e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (9.91e-5)"	"unprognostic (1.99e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.23e-1)"	10.7	8.4	19.3	15.5	24.0	10.7	6.8	30.0	24.6	7.9	9.8	12.4	6.4	10.7	9.1	6.5	14.5	7.7	10.4	10.3	18.1	18.8	7.8	5.7	12.4	19.8	14.6	19.4	14.0	11.0	13.3	16.6	8.5	18.3	7.4	8.8	8.3	7.1	11.2	9.7	11.7	12.0	11.4	15.1	22.3	11.3	22.0	15.8	7.9	7.4	7.0	22.3	9.6	8.0	7.8	14.7	12.8	4.1	1.5	4.4	1.2	14.8	3.5	4.2	8.5	7.4	4.2	4.3	6.9	4.5	8.2	7.0	6.2	4.1	17.1	13.5	7.4	8.1	7.8	3.8	6.7	4.4	6.9	10.4	6.0	2.3	4.3	5.9	8.7	3.5	4.9	7.2	8.6	5.1	5.7	42.7	5.5	12.0	7.0	3.7	3.6	11.5	7.0	4.3	10.6	4.8	6.5	17.0	4.1	5.0	9.8	5.5	14.5	3.9	6.8	5.0	4.8	13.6	9.1	20.2	16.2	13.0	6.6	10.9	4.3	0.6	2.4	12.8	3.6	3.5	2.3	6.6	3.0	4.4	1.4	7.8	2.2	3.0	2.7	1.5	4.1	14.7	3.6	1.2	19.3	24.0	30.0	24.6	18.1	18.8	14.6	19.4	18.3	15.8
RUBCNL	"C13orf18, FLJ21562, KIAA0226L"	ENSG00000102445	"RUN and cysteine rich domain containing beclin 1 interacting protein like"	Q9H714	13	46342000-46438190	"Predicted intracellular proteins"	"Autophagy, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.1;lymphoid tissue: 24.0"	"Group enriched"	"Detected in some"	5	"Daudi: 39.1;U-698: 64.6"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"memory B-cell: 29.9;naive B-cell: 31.1;neutrophil: 31.1;plasmacytoid DC: 22.5"	"Group enriched"	"Detected in many"	17	"B-cells: 31.1;dendritic cells: 22.5;granulocytes: 31.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Supported	Cytosol				Cytosol		"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favourable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"	3.7	1.6	4.5	21.2	4.3	15.0	5.7	2.9	3.6	5.5	8.1	2.9	1.3	1.5	3.0	3.2	1.0	2.0	3.8	1.5	3.4	3.7	1.5	1.7	5.5	20.2	4.5	2.7	0.9	1.2	0.1	2.7	3.3	5.2	2.2	11.2	3.0	6.5	1.8	0.8	2.7	14.9	2.8	8.8	24.0	1.6	15.9	3.7	10.1	2.2	0.2	21.7	2.9	2.0	31.1	22.5	31.1	1.6	0.3	0.0	1.2	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	1.5	0.0	39.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.4	11.2	0.0	1.6	0.0	0.0	0.8	0.0	0.1	0.0	0.6	0.0	9.0	0.0	0.0	0.3	0.0	0.1	0.2	9.0	64.6	0.4	0.1	0.0	0.0	1.0	0.0	0.0	1.6	0.0	29.9	0.0	0.0	1.0	31.1	0.0	0.0	31.1	0.3	0.9	22.5	0.0	1.2	4.5	4.3	2.9	3.6	3.4	3.7	4.5	2.7	5.2	3.7
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550558-179610026	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"			9600	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	20.9	27.9	19.7	24.7	22.4	21.1	36.9	22.4	18.9	18.2	20.2	16.9	27.9	16.9	22.5	16.9	25.9	18.8	20.7	14.8	19.7	14.8	23.9	17.5	20.8	23.1	18.8	17.1	19.4	19.8	22.6	21.5	17.3	19.7	20.9	15.5	16.4	21.2	18.3	26.7	24.2	18.8	17.5	14.7	27.9	18.6	12.2	20.5	20.1	27.3	14.1	20.1	20.7	34.3	3.2	3.4	7.9	4.5	1.2	2.9	21.5	7.1	11.8	6.3	8.3	12.2	10.1	7.2	12.7	9.1	7.5	8.8	11.4	16.7	11.6	7.2	15.4	6.6	11.5	16.6	8.9	36.6	8.7	20.2	9.0	8.2	12.5	11.2	11.1	10.2	9.2	5.1	14.6	8.2	8.2	11.1	6.7	21.6	11.9	7.8	6.7	5.5	10.7	4.5	10.7	12.6	11.7	6.3	9.0	18.6	12.0	6.6	9.6	13.8	9.8	10.0	3.3	5.3	9.9	6.9	10.6	20.8	9.2	20.3	9.1	7.4	3.4	7.9	1.7	3.6	1.0	2.7	2.0	1.7	3.0	3.2	1.4	1.8	5.9	1.2	4.5	3.4	2.9	21.5	19.7	22.4	22.4	18.9	19.7	14.8	18.8	17.1	19.7	20.5
RUFY3	"KIAA0871, RIPx, Singar1, ZFYVE30"	ENSG00000018189	"RUN and FYVE domain containing 3"	Q7L099	4	70704204-70807315	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022952, HPA022970"	Enhanced		Supported	Cytosol				Cytosol		"HPA022952: , HPA022970: AB_1856307"	"unprognostic (4.33e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"prognostic favourable (1.28e-4)"	"prognostic unfavourable (8.95e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.50e-2)"	"prognostic favourable (8.02e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.45e-3)"	"unprognostic (5.41e-1)"	10.9	24.5	39.1	11.8	53.4	6.9	12.5	36.4	66.3	12.3	8.7	24.1	6.7	8.1	20.6	16.3	15.3	9.3	12.7	8.9	64.5	34.4	15.5	13.6	14.8	13.6	37.0	51.3	25.5	9.8	8.5	61.4	12.0	54.2	13.8	11.4	12.8	10.1	11.5	15.4	29.9	9.9	15.1	80.2	16.0	12.8	25.3	32.5	7.1	31.6	5.9	11.5	9.3	12.3	3.5	6.0	0.0	3.1	2.2	2.8	1.0	3.7	2.6	31.0	7.3	15.0	17.5	12.4	12.1	4.6	3.9	4.5	4.4	9.2	14.9	5.0	10.0	3.8	4.7	5.3	6.3	8.1	6.0	3.2	3.6	4.9	8.5	3.7	1.9	12.3	8.4	5.3	6.2	8.4	8.8	15.4	8.7	4.6	23.0	3.9	7.4	3.3	5.7	9.7	6.8	7.7	3.6	29.0	14.3	4.4	7.8	7.3	5.3	1.8	7.1	13.5	9.4	4.0	2.8	17.2	7.8	15.9	14.0	2.7	2.7	0.0	3.1	0.0	2.2	3.0	2.8	3.5	1.5	2.0	6.0	3.1	1.5	1.6	0.0	2.2	2.8	4.8	1.0	1.0	39.1	53.4	36.4	66.3	64.5	34.4	37.0	51.3	54.2	32.5
RUNDC1	DKFZp761H0421	ENSG00000198863	"RUN domain containing 1"	Q96C34	17	42980565-42993690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023726	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA023726: AB_2184078"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.39e-2)"	"prognostic favourable (6.93e-5)"	"unprognostic (9.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.77e-3)"	7.3	11.0	23.4	8.7	23.1	8.4	14.7	18.6	24.6	13.0	12.9	7.9	12.2	9.0	12.3	17.9	9.0	20.9	9.5	8.7	17.2	13.0	12.1	6.6	9.6	9.3	9.2	16.9	7.7	14.2	17.7	17.2	6.7	12.2	17.9	11.0	8.9	11.1	12.9	14.5	9.1	10.0	12.3	7.5	10.7	13.9	11.9	12.5	9.6	14.5	4.4	10.4	12.7	8.1	5.6	7.5	10.0	5.2	1.4	2.6	1.2	11.3	19.8	8.0	10.9	13.8	8.3	8.6	10.9	11.4	15.7	11.8	12.5	6.6	7.6	10.0	10.8	14.2	10.2	11.1	17.6	8.6	16.1	5.1	11.2	11.9	8.9	11.0	10.9	6.2	13.6	13.9	9.3	8.4	9.7	4.9	9.0	8.2	13.5	7.8	9.0	12.6	9.8	11.3	7.6	13.2	15.2	11.8	10.9	8.6	8.3	9.0	15.9	12.3	6.9	14.4	9.0	8.5	13.0	11.6	11.2	6.7	10.2	5.9	8.9	5.0	3.3	10.0	1.9	5.2	2.4	4.6	2.3	1.6	2.5	5.6	2.3	2.5	7.6	1.4	3.6	7.5	2.6	1.2	23.4	23.1	18.6	24.6	17.2	13.0	9.2	16.9	12.2	12.5
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"Runt related transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.5;lymphoid tissue: 47.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 38.7;Karpas-707: 52.1;SK-MEL-30: 28.9;U-266/70: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB025416: , HPA004195: , HPA059006: "	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavourable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.0	1.1	0.9	25.4	1.1	31.5	3.4	0.5	1.0	11.9	8.0	1.2	0.3	2.5	1.7	1.4	3.5	1.7	6.2	1.3	0.9	1.1	2.2	2.3	11.7	28.8	2.8	0.7	1.3	1.0	0.0	1.0	1.3	1.8	2.3	2.3	2.8	6.5	2.2	2.2	9.5	13.7	1.3	1.8	30.6	2.7	2.1	0.8	14.2	1.8	3.1	47.6	8.9	2.2	4.5	1.0	4.3	4.6	18.1	15.1	3.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	6.2	6.1	5.3	0.1	3.6	0.0	0.2	38.7	0.6	0.1	0.6	0.0	0.0	1.4	13.4	0.0	0.0	0.0	0.3	0.0	0.0	52.1	0.0	0.0	0.4	12.0	0.2	1.0	0.0	0.0	7.3	0.0	0.1	1.2	0.0	2.4	0.0	28.9	0.0	8.3	0.0	0.0	0.5	0.0	0.1	18.1	12.5	5.9	0.0	13.5	1.4	0.4	0.7	4.3	15.1	3.0	8.1	4.5	5.7	13.2	0.9	3.8	2.8	10.3	0.9	18.1	4.6	1.0	5.7	3.1	0.9	1.1	0.5	1.0	0.9	1.1	2.8	0.7	1.8	0.8
RUSC1	NESCA	ENSG00000160753	"RUN and SH3 domain containing 1"	Q9BVN2	1	155320896-155331114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028510, HPA029922, HPA029923"	Approved		Enhanced	Cytosol				Cytosol		"HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288"	"unprognostic (1.98e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (7.78e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavourable (2.65e-4)"	"prognostic unfavourable (9.24e-6)"	"unprognostic (7.59e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.40e-1)"	10.9	15.9	24.8	8.7	24.1	8.9	12.2	46.1	45.4	16.6	20.2	5.6	9.2	17.5	13.0	7.4	21.8	12.4	13.6	12.2	18.5	22.3	12.9	4.9	11.0	7.4	14.4	26.4	13.3	12.5	11.5	21.5	14.7	26.1	16.3	19.0	8.7	18.1	18.1	8.7	22.7	19.5	15.3	8.9	7.6	14.2	3.1	6.2	12.6	8.4	11.4	8.8	12.1	16.1	3.4	7.5	5.1	18.9	2.6	6.4	4.2	23.4	14.9	8.5	12.6	10.7	11.6	16.6	11.2	7.2	14.8	16.7	17.0	15.6	4.6	8.6	11.3	32.8	13.3	16.3	6.4	6.3	16.9	6.7	14.7	8.9	8.8	6.6	11.6	11.9	10.3	14.9	5.1	15.3	10.0	3.2	12.8	44.8	8.2	8.4	16.8	23.8	11.3	5.9	8.2	14.0	18.0	8.8	14.5	9.5	26.8	5.7	39.9	11.4	6.9	19.1	15.8	18.0	22.1	2.6	5.8	2.8	13.4	8.9	5.1	5.1	6.8	3.2	5.8	8.1	6.4	3.4	4.7	5.8	7.5	1.5	2.6	5.5	0.9	2.6	18.9	7.1	4.7	4.2	24.8	24.1	46.1	45.4	18.5	22.3	14.4	26.4	26.1	6.2
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol			47000	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	17.6	15.1	10.7	15.8	14.2	11.9	13.9	7.9	14.0	12.5	11.6	12.9	14.3	8.4	19.2	11.4	19.2	37.3	11.3	18.6	11.4	13.6	20.9	13.7	12.9	18.7	10.0	9.8	15.4	13.6	26.5	14.2	19.9	13.0	12.0	14.1	11.5	10.2	12.0	12.9	11.8	10.2	16.1	8.8	21.9	10.9	44.7	10.3	33.4	15.2	18.1	23.9	12.6	15.0	10.6	8.7	1.5	7.9	10.9	20.2	7.2	26.7	24.3	14.9	24.3	11.7	11.4	19.6	13.1	11.3	25.3	17.5	25.4	15.9	38.0	13.1	12.5	21.3	39.8	27.8	29.5	15.5	19.5	31.5	14.1	17.0	12.1	29.4	10.1	11.6	14.7	21.3	27.4	16.9	25.8	8.9	14.4	38.1	31.5	22.3	37.6	20.8	25.9	18.1	26.4	15.1	10.1	25.1	22.5	14.5	12.0	20.1	21.8	21.8	10.9	11.5	14.1	17.3	19.8	9.1	14.5	37.3	14.2	18.1	14.4	0.8	4.8	1.5	11.3	7.9	14.6	10.6	13.6	14.0	7.7	10.2	11.5	12.8	0.2	10.9	7.4	8.7	20.2	7.2	10.7	14.2	7.9	14.0	11.4	13.6	10.0	9.8	13.0	10.3
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993448-49015995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	6.9	5.3	6.7	7.5	7.1	13.4	4.8	8.2	10.4	4.8	9.9	7.6	6.3	11.2	8.3	5.5	16.1	5.5	7.2	9.1	6.9	6.0	7.6	10.3	5.5	8.2	7.7	8.1	6.5	8.7	1.6	6.4	5.5	6.7	6.0	3.2	6.5	10.0	6.6	27.8	7.7	10.0	3.7	7.1	6.9	10.7	59.0	5.8	14.6	8.8	9.4	8.1	6.4	12.9	12.6	16.4	5.6	14.3	11.0	12.5	15.2	28.8	29.7	3.5	20.0	1.5	2.7	9.4	15.6	6.8	17.9	11.8	15.4	12.5	27.1	12.1	3.1	15.3	2.1	10.2	2.1	16.4	12.2	17.7	8.9	7.8	5.0	34.7	12.4	3.1	2.0	4.0	2.1	6.6	30.6	11.5	1.6	5.9	30.6	4.1	10.7	4.4	25.4	16.0	17.4	3.2	11.1	14.2	20.5	15.7	13.1	5.6	11.6	13.3	9.7	11.4	16.7	7.5	38.6	23.4	26.7	28.0	8.4	17.0	16.3	5.6	14.3	4.2	11.1	11.1	11.2	10.9	11.1	9.1	16.4	12.6	12.2	8.0	1.0	11.0	10.8	12.5	12.5	15.2	6.7	7.1	8.2	10.4	6.9	6.0	7.7	8.1	6.7	5.8
RYK	"D3S3195, JTK5, JTK5A, RYK1"	ENSG00000163785	"Receptor-like tyrosine kinase"		3	134065303-134250744	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034117, HPA045503, HPA075430"	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"CAB034117: AB_2183048, HPA045503: , HPA075430: "	"unprognostic (7.84e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.85e-2)"	23.8	13.2	8.5	12.1	9.3	6.3	27.5	10.6	9.5	26.5	19.3	12.7	18.2	8.8	25.8	19.1	21.1	16.7	15.8	17.1	8.1	6.7	12.9	12.7	12.4	9.1	10.8	7.3	39.7	17.7	14.1	17.9	18.8	8.6	26.9	12.1	16.4	15.2	21.5	15.3	15.5	13.3	28.6	8.4	13.8	14.3	20.3	10.0	13.6	23.2	11.4	15.2	27.5	31.9	2.8	0.7	6.7	1.6	3.1	4.3	1.1	25.6	6.8	21.6	16.5	27.9	29.7	16.7	17.0	39.7	22.8	25.7	21.6	19.7	5.0	28.4	21.0	24.1	15.3	21.5	32.7	8.4	6.9	13.3	7.4	13.9	21.8	6.5	11.8	19.6	25.3	14.1	28.4	19.0	4.6	2.5	22.3	12.2	9.0	8.4	18.2	8.2	4.4	16.6	10.5	18.7	19.0	10.6	15.7	20.7	15.1	25.8	18.9	11.8	14.0	18.9	17.2	19.7	13.7	1.1	1.3	2.7	12.0	10.9	13.3	6.7	1.6	3.1	2.5	1.6	2.9	1.5	4.2	3.0	0.7	2.8	4.3	3.4	0.6	3.1	1.6	0.0	1.0	1.1	8.5	9.3	10.6	9.5	8.1	6.7	10.8	7.3	8.6	10.0
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433699-38587564	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 231.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.7;RH-30: 11.3;SiHa: 22.3;U-2 OS: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;monocytes: 6.3"	"Low region specificity"	"Detected in some"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: "	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	5.3	0.7	3.0	0.6	1.9	0.4	0.6	2.7	1.7	0.6	0.4	2.7	0.0	0.4	0.4	6.7	3.0	0.6	0.5	0.4	1.8	4.0	0.5	0.4	0.7	0.6	1.5	1.3	0.4	0.4	0.3	0.3	0.6	1.9	0.9	0.4	0.4	2.2	0.6	231.0	2.4	0.5	0.4	1.1	0.6	0.5	1.6	1.9	0.0	1.6	55.1	3.2	0.6	0.5	0.7	5.3	0.1	6.3	0.0	0.6	0.6	0.0	5.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.0	0.3	0.3	4.7	0.0	13.7	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.4	1.3	5.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	11.3	1.0	0.6	0.0	0.0	1.1	22.3	0.0	0.0	0.5	4.2	0.0	0.0	9.4	0.2	0.0	0.3	0.9	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.4	3.2	0.5	0.4	0.3	0.6	5.3	0.7	0.0	0.0	0.1	0.0	6.3	0.0	0.6	0.6	3.0	1.9	2.7	1.7	1.8	4.0	1.5	1.3	1.9	1.9
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042205-237833988	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 106.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 10.4;K-562: 3.2;NB-4: 2.7;NTERA-2: 3.9;U-937: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0.0	1.2	0.7	1.1	0.7	1.8	1.0	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1.0	7.3	2.2	4.2	0.5	2.0	1.1	1.6	2.0	0.8	0.2	0.9	1.4	0.9	1.0	1.0	4.6	1.0	1.0	1.2	1.1	3.0	0.0	2.7	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.3	0.5	0.0	0.0	7.7	10.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	2.7	3.9	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	18.7	14.8	10.5	5.7	1.1	1.0	7.3	1.6	3.0
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 99.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.4;NK-cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	38.2	20.9	49.6	13.8	48.3	1.2	61.8	11.5	28.2	39.1	32.3	25.0	13.9	9.4	23.5	25.0	19.9	34.5	32.0	56.3	30.3	32.0	28.0	20.2	23.3	12.7	54.2	32.7	29.9	13.9	45.9	9.7	21.6	37.7	23.0	19.3	21.1	19.8	21.7	73.8	14.1	13.7	27.2	38.9	13.7	11.9	10.3	28.5	2.4	79.0	28.2	14.6	21.1	16.0	2.6	8.4	3.0	1.5	19.4	0.9	0.8	22.1	18.6	21.5	13.6	19.0	55.8	7.7	30.8	48.9	18.7	21.5	18.0	24.8	0.5	58.6	52.3	21.2	8.9	19.2	16.5	0.0	8.3	1.4	23.3	15.3	12.6	0.6	4.8	44.8	7.3	16.7	18.1	42.2	7.1	0.0	58.0	78.7	0.0	0.4	17.3	56.1	3.5	22.3	0.1	99.4	17.0	6.6	0.2	66.0	34.0	66.6	27.7	0.8	59.7	12.9	7.2	17.2	37.1	0.2	0.5	1.0	23.1	0.3	7.5	3.0	1.5	0.1	0.3	0.7	0.6	2.6	0.3	0.2	5.0	1.6	0.5	0.3	0.2	19.4	0.9	8.4	0.9	0.8	49.6	48.3	11.5	28.2	30.3	32.0	54.2	32.7	37.7	28.5
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.0;tongue: 189.3"	"Group enriched"	"Detected in some"	10	"A-431: 62.5;HaCaT: 86.8;HBEC3-KT: 123.0;hTCEpi: 183.4;SK-BR-3: 129.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"			110000	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	0.6	0.0	0.6	4.3	0.6	0.0	6.4	0.6	0.6	38.0	19.2	0.6	3.9	21.4	5.7	2.6	256.0	1.2	7.9	0.6	0.6	0.0	2.4	1.2	7.5	0.6	0.6	0.6	0.7	4.6	6.6	0.8	1.4	0.7	1.9	19.6	0.7	41.8	3.1	0.6	41.4	23.8	1.0	0.6	0.6	9.4	0.9	0.6	8.9	9.6	189.3	71.0	2.2	79.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.8	11.4	0.0	0.1	0.0	86.8	0.0	123.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	183.4	0.0	1.7	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	4.1	0.0	0.0	0.1	129.6	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.7	0.6
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 223.9;tongue: 102.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 118.0;SK-BR-3: 143.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"							HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"			92000	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (3.18e-4)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	20.1	5.5	9.3	8.0	7.2	0.0	11.9	3.4	8.3	37.2	21.1	8.3	3.2	16.2	8.7	7.2	223.9	7.6	18.2	9.5	6.7	5.4	14.3	27.0	18.3	7.5	7.1	5.7	15.3	4.1	6.5	3.3	14.9	7.2	9.3	14.5	5.1	35.5	5.4	9.8	43.1	31.2	10.6	5.9	13.4	10.6	12.3	4.6	3.2	11.3	102.1	87.5	11.3	51.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	56.5	27.2	1.4	3.2	9.4	35.7	3.7	32.4	29.8	26.6	23.7	25.5	31.6	0.0	52.0	48.4	41.5	0.0	72.6	15.6	0.1	0.0	0.0	23.7	7.5	10.8	0.0	0.0	16.9	69.7	64.4	50.7	118.0	0.7	0.0	58.5	75.0	0.0	0.1	6.0	73.7	0.0	16.4	0.1	100.3	20.3	0.0	0.1	23.8	143.0	4.7	44.4	0.3	63.3	16.0	25.7	15.4	73.1	0.0	0.2	0.1	47.6	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	7.2	3.4	8.3	6.7	5.4	7.1	5.7	7.2	4.6
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 656.0;RT4: 256.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"			130000	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: "	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	24.8	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.2	0.5	61.7	0.0	656.0	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	87.4	0.7	99.7	0.4	0.0	0.0	1.4	0.1	0.0	0.0	0.0	4.8	0.0	15.6	0.0	15.5	256.5	0.5	0.0	1.0	0.1	0.2	0.1	0.1	0.1	0.3	21.7	2.9	8.4	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4
S100A3	S100E	ENSG00000188015	"S100 calcium binding protein A3"	P33764	1	153547329-153549372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.7"	"Cell line enhanced"	"Detected in many"		"A549: 33.4;HBEC3-KT: 17.8;HeLa: 21.7;U-2197: 19.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 26.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 3.6;non-classical monocyte: 6.9;plasmacytoid DC: 8.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 8.9;monocytes: 6.9"					"Low region specificity"	"Detected in many"			"HPA042674, HPA056140"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"			390000	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA042674: AB_10796581, HPA056140: "	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.34e-3)"	"unprognostic (3.97e-3)"	"prognostic unfavourable (1.61e-6)"	"unprognostic (8.13e-2)"	"unprognostic (3.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (8.10e-2)"	4.7	0.6	0.6	3.3	3.1	1.5	2.2	0.6	1.7	3.7	1.2	1.3	0.1	0.4	2.4	1.6	7.4	1.6	1.6	7.9	0.5	0.7	10.2	0.1	14.2	4.6	1.7	0.1	1.2	5.3	0.0	0.3	5.6	3.5	3.6	1.0	0.3	2.0	1.6	2.5	44.7	1.0	1.8	1.5	2.1	0.7	1.4	0.4	0.5	1.7	2.1	4.9	3.7	4.0	0.7	8.9	0.0	6.9	0.0	0.3	0.4	2.8	33.4	0.0	0.0	3.2	2.1	0.0	2.3	12.2	2.9	4.9	0.9	1.0	0.0	7.5	5.8	8.8	0.0	17.8	1.6	0.1	0.0	0.1	21.7	6.0	0.8	0.0	0.1	1.5	9.1	7.1	8.0	0.6	0.0	0.0	15.7	0.2	0.0	0.0	0.2	4.1	0.0	2.4	1.8	9.7	7.2	0.5	0.0	2.1	2.5	0.7	0.1	0.2	3.0	1.2	1.9	19.5	2.4	0.5	0.6	0.0	15.6	0.2	7.4	0.0	0.2	0.0	0.0	3.6	0.3	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.9	8.9	0.1	0.4	0.6	3.1	0.6	1.7	0.5	0.7	1.7	0.1	3.5	0.4
S100A6	"2A9, CABP, CACY, PRA"	ENSG00000197956	"S100 calcium binding protein A6"	P06703	1	153534599-153536244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 375.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002601, HPA007575, CAB040549, CAB047354"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			5100000	"Plasma membrane, Cytosol"		"CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859"	"unprognostic (8.80e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-2)"	"prognostic favourable (7.56e-4)"	126.4	32.6	14.8	104.9	29.9	73.8	223.6	13.3	14.6	95.4	176.8	10.1	51.2	70.2	65.0	135.5	126.5	42.2	264.5	112.3	13.0	22.5	103.4	6.0	151.9	61.5	45.6	7.9	38.1	13.5	0.5	17.7	100.1	27.3	85.1	85.5	28.5	58.7	55.2	59.1	45.1	98.1	88.9	35.5	27.5	69.9	29.6	17.8	4.9	76.9	183.0	36.2	150.9	145.0	30.7	130.1	303.7	180.7	9.1	69.2	201.7	77.6	86.9	0.0	7.2	146.3	189.8	0.2	95.2	237.8	48.3	63.4	6.0	162.4	0.1	30.2	141.3	33.7	1.5	136.7	22.8	31.9	0.0	16.2	58.1	5.3	55.4	0.7	11.2	88.5	113.7	51.7	89.5	107.1	0.0	0.1	120.3	11.7	0.2	6.6	0.1	143.0	0.0	10.8	28.1	375.0	72.1	22.4	3.9	129.5	131.9	97.9	18.1	25.2	156.4	46.7	12.2	95.3	154.5	0.2	0.2	0.2	181.3	17.4	99.6	139.8	180.7	74.1	62.0	96.8	67.3	30.7	58.5	60.3	130.1	17.2	37.3	49.5	303.7	9.1	86.9	68.3	69.2	201.7	14.8	29.9	13.3	14.6	13.0	22.5	45.6	7.9	27.3	17.8
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9"	"Group enriched"	"Detected in some"	5	"HaCaT: 7.3;SK-BR-3: 16.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"		17000000	Cytosol		"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	2.2	0.1	0.1	45.2	0.1	0.1	0.1	0.0	3.7	3.9	116.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	6.2	0.1	0.1	45.7	0.1	0.2	0.1	0.1	0.0	0.3	0.1	1.2	0.1	409.9	156.7	0.2	85.3	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	7.3	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.8	16.9	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
S100A7A	"S100A15, S100A7f, S100A7L1"	ENSG00000184330	"S100 calcium binding protein A7A"	Q86SG5	1	153416524-153423225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"tongue: 178.1"	"Cell line enriched"	"Detected in single"	8	"SK-BR-3: 3.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006997	Supported		Uncertain	Cytosol				Cytosol		"HPA006997: AB_1079860"	"unprognostic (2.18e-1)"	"unprognostic (1.26e-1)"				"unprognostic (3.73e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"				"unprognostic (1.17e-1)"			"unprognostic (4.40e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	11.5	0.0	0.0	0.0	0.0	1.9	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	178.1	12.5	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391188	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1"	"Group enriched"	"Detected in some"	28	"hTCEpi: 27.5;SK-BR-3: 100.9;THP-1: 53.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.7;neutrophil: 720.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 720.9;monocytes: 320.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	10876880	530000000	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	14.0	0.8	0.8	30.5	2.6	718.8	1.1	0.5	1.6	123.0	2.8	0.7	0.4	0.4	12.0	1.2	532.3	5.5	2.1	36.7	1.5	0.5	1.4	4.3	26.2	37.3	3.3	0.4	2.1	2.7	0.1	0.9	4.7	3.3	1.4	0.4	1.3	92.4	0.3	2.5	6.2	1.0	9.0	1.8	72.4	2.0	1.9	0.9	2.6	4.6	597.1	257.6	5.0	224.1	0.6	63.7	720.9	320.7	0.3	0.6	244.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.6	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	27.5	0.0	0.9	0.0	1.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	100.9	0.0	0.6	53.6	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.6	0.0	8.2	320.7	38.9	0.4	26.5	0.6	0.6	0.3	0.2	63.7	0.3	0.3	0.3	720.9	0.3	6.4	2.5	0.4	244.7	0.8	2.6	0.5	1.6	1.5	0.5	3.3	0.4	3.3	0.9
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 227.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 381.5;neutrophil: 638.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 638.3;monocytes: 381.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	10597950	1400000000	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavourable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4.0	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169.0	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2.0	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228.0	24.3	237.0	0.5	87.5	638.3	381.5	0.3	1.0	323.2	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	35.7	0.0	2.1	0.0	14.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	12.4	0.0	0.8	0.0	0.6	0.3	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.4	7.5	0.0	9.2	0.1	0.0	0.3	227.6	0.1	3.6	28.9	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	6.5	0.0	5.3	381.5	46.4	0.5	31.6	1.0	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15.0	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598962-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 342.0"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 81.0;WM-115: 159.2"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 78.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 78.0"	"Low region specificity"	"Detected in all"							"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol			120000	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: , HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	67.7	14.0	60.9	5.6	51.0	2.0	13.2	39.4	151.2	5.2	9.1	101.0	3.0	4.7	1.5	7.6	8.6	2.1	8.3	6.6	74.6	65.4	1.5	1.6	2.9	9.8	152.0	36.5	2.4	3.0	1.1	3.1	1.4	90.3	3.0	8.3	7.4	10.1	15.3	1.3	5.7	7.5	4.3	342.0	5.7	4.3	1.5	46.4	0.0	1.3	1.8	10.8	8.2	1.6	0.1	3.4	0.7	1.9	11.0	78.0	10.6	0.1	0.0	17.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	81.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	1.0	159.2	0.0	0.1	0.0	78.0	1.8	22.4	0.0	0.2	14.5	3.4	0.1	0.6	33.3	0.7	11.0	1.9	0.8	0.0	10.6	60.9	51.0	39.4	37.6	74.6	65.4	152.0	36.5	90.3	46.4
SAC3D1	"HSU79266, SHD1"	ENSG00000168061	"SAC3 domain containing 1"		11	65040901-65044828	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"testis: 26.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042677	Uncertain		Approved	Cytosol				Cytosol		"HPA042677: AB_10797506"	"unprognostic (1.35e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.00e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (9.67e-6)"	"unprognostic (4.11e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavourable (5.66e-5)"	"unprognostic (2.97e-3)"	"unprognostic (5.71e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.49e-1)"	6.3	6.1	5.1	5.1	5.8	7.1	10.9	7.1	8.4	3.7	7.7	3.0	5.0	5.8	4.3	4.2	5.1	4.0	6.4	4.2	4.8	4.5	3.7	6.6	4.7	4.4	5.1	3.0	3.2	8.6	2.6	4.1	3.0	6.5	4.2	3.5	1.4	6.7	5.7	12.4	6.4	3.9	4.9	4.4	4.5	5.0	26.3	4.6	16.2	3.3	6.2	4.8	3.6	4.6	2.3	3.6	0.4	3.6	0.1	2.7	0.8	18.6	11.0	7.6	7.2	4.0	2.8	4.8	12.1	3.1	9.4	7.9	7.8	4.8	9.9	8.5	4.6	10.3	6.3	8.8	1.2	12.3	10.3	7.8	7.1	14.0	3.0	5.2	2.8	0.8	7.9	7.1	3.2	3.3	10.9	5.5	3.2	10.2	8.3	21.5	2.5	22.4	6.1	5.5	10.9	4.0	4.3	9.4	7.8	9.2	10.2	6.7	8.0	7.6	3.1	4.5	13.6	14.4	7.7	13.3	9.3	7.4	2.7	6.9	2.0	0.0	3.1	0.4	1.6	2.6	1.5	2.3	1.9	1.2	1.5	2.2	2.7	1.8	0.3	0.1	3.6	3.6	2.2	0.8	5.1	5.8	7.1	8.4	4.8	4.5	5.1	3.0	6.5	4.6
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;kidney: 26.8;liver: 32.0"	"Cell line enhanced"	"Detected in some"		"AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"olfactory region: 64.6"	"Low region specificity"	"Detected in many"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: , HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favourable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favourable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.8	0.7	12.2	1.2	14.5	0.7	0.9	1.7	18.9	16.1	3.1	31.9	0.0	1.6	17.8	1.5	0.8	10.4	1.1	1.2	13.6	5.5	26.8	32.0	0.6	0.6	21.8	9.1	5.2	1.6	0.9	4.3	4.3	17.6	1.3	3.2	0.0	0.9	2.3	0.6	0.7	1.4	9.4	19.7	0.7	3.0	2.2	19.4	0.0	23.7	0.0	0.6	2.2	4.8	1.0	1.9	2.3	3.1	0.1	1.1	1.1	0.0	0.8	14.8	0.1	0.4	0.3	0.0	4.9	12.7	0.3	0.7	0.0	0.0	0.0	5.7	6.9	0.0	9.2	0.0	0.4	0.0	5.6	0.0	0.0	8.9	0.3	0.0	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	1.8	0.9	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	23.5	0.0	4.9	0.6	3.1	2.3	0.7	2.0	0.7	1.0	1.0	0.9	1.9	0.8	0.6	0.6	1.8	0.1	1.5	1.9	1.1	1.1	12.2	14.5	1.7	10.3	13.6	5.5	21.8	9.1	17.6	19.4
SAMD1		ENSG00000141858	"Sterile alpha motif domain containing 1"		19	14087840-14091036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041662, HPA049059"	Uncertain		Approved	Mitochondria,Cytosol	"Intracellular and membrane"			Cytosol	Mitochondria	"HPA041662: , HPA049059: "	"unprognostic (2.93e-2)"	"prognostic favourable (7.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (1.96e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.00e-1)"	"prognostic unfavourable (7.98e-5)"	"prognostic favourable (8.31e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.45e-1)"	16.0	9.5	23.5	17.4	20.2	19.6	47.9	17.2	21.2	15.3	21.3	19.7	12.2	20.6	14.7	9.8	18.2	14.0	12.8	16.8	21.2	17.9	13.1	11.1	15.9	20.1	20.9	10.3	14.5	20.3	7.2	7.3	11.3	16.5	12.7	15.5	7.8	15.4	16.1	27.2	25.9	21.5	12.4	21.3	18.0	16.7	11.4	16.1	79.1	14.8	10.8	17.9	12.9	20.5	3.5	2.3	4.5	2.9	8.0	2.7	1.5	22.6	17.3	15.2	21.5	9.6	9.8	23.2	12.5	3.0	12.7	10.3	13.0	11.2	39.5	17.0	8.1	18.4	16.6	9.3	6.5	26.4	13.7	17.2	22.9	23.4	8.6	10.1	10.8	6.8	15.5	8.8	3.0	7.5	20.9	10.8	7.4	34.1	21.5	39.9	31.3	15.3	29.3	13.5	28.3	10.8	11.0	28.0	28.0	11.0	15.0	8.3	9.4	21.8	8.1	22.4	20.6	22.4	15.7	20.5	17.6	32.6	13.4	27.7	9.0	0.3	2.9	4.5	1.7	0.9	2.0	3.5	1.9	2.0	2.3	2.1	2.7	2.0	0.5	8.0	1.0	1.8	2.1	1.5	23.5	20.2	17.2	19.6	21.2	17.9	20.9	10.3	16.5	16.1
SAMD12	FLJ39458	ENSG00000177570	"Sterile alpha motif domain containing 12"	Q8N8I0	8	118189459-118621995	"Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 23.2;U-266/70: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 6.8;dendritic cells: 4.3;T-cells: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024634	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA024634: AB_1856549"	"unprognostic (6.96e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.01e-1)"	"prognostic favourable (1.52e-6)"	"unprognostic (3.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.35e-3)"	2.1	3.0	14.1	3.1	16.2	1.1	5.0	13.8	20.2	4.6	6.9	7.7	8.9	7.1	2.7	8.0	9.7	8.8	6.7	10.8	10.8	7.0	8.3	4.0	6.2	2.3	9.6	13.7	2.1	4.7	12.7	20.8	0.9	13.7	6.3	8.1	2.6	5.7	12.8	2.0	2.3	4.8	1.9	10.9	4.2	9.5	3.2	8.6	0.7	15.8	2.5	4.5	10.8	3.0	6.8	4.3	0.2	0.0	1.1	3.7	0.9	7.4	0.3	0.6	0.0	0.0	0.0	2.0	3.5	5.4	6.2	3.2	1.6	7.0	10.3	0.7	4.3	1.8	2.4	4.0	9.0	0.2	0.8	0.1	4.6	0.0	0.0	0.0	0.3	0.2	1.3	4.5	0.7	0.2	0.0	6.1	3.1	1.8	2.2	0.0	1.0	1.1	0.0	0.0	7.2	2.8	11.2	3.2	0.0	2.2	23.2	0.3	1.7	0.0	0.0	0.1	3.0	1.3	0.8	11.9	9.7	0.8	1.4	0.0	1.2	0.1	0.0	0.0	0.6	0.0	3.7	6.8	2.6	1.7	0.3	2.9	3.7	1.8	0.2	1.1	0.0	4.3	2.4	0.9	14.1	16.2	13.8	20.2	10.8	7.0	9.6	13.7	13.7	8.6
SAMD4A	"DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA"	ENSG00000020577	"Sterile alpha motif domain containing 4A"	Q9UPU9	14	54567097-54793315	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 48.7;testis: 44.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.9;non-classical monocyte: 3.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043061, HPA065309"	Approved		Approved	"Cell Junctions,Cytosol"				"Cell Junctions"	Cytosol	"HPA043061: , HPA065309: "	"unprognostic (1.46e-1)"	"unprognostic (8.10e-3)"	"unprognostic (9.66e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	7.5	2.9	7.8	9.0	6.0	0.5	4.0	5.6	7.0	8.9	10.1	8.0	3.0	2.3	11.1	5.5	5.4	4.2	6.5	28.2	5.5	7.3	2.5	7.6	6.4	2.9	10.6	5.2	2.1	4.1	4.8	2.0	6.0	10.8	7.7	3.3	3.4	2.4	6.3	48.7	2.6	3.3	23.8	26.5	4.6	3.9	44.6	6.1	0.7	2.4	1.3	4.8	15.9	5.8	0.9	2.6	0.0	3.9	0.0	0.4	0.8	16.7	1.7	3.3	1.7	7.1	11.3	6.2	14.6	21.0	11.6	11.9	17.3	4.0	1.0	7.5	20.2	11.7	3.2	7.3	16.4	9.6	1.6	0.0	2.0	3.5	4.0	0.0	0.1	6.3	2.5	8.3	12.4	9.0	1.3	0.0	5.4	1.1	0.2	0.0	1.6	4.1	0.5	6.7	0.0	5.4	5.4	0.5	5.5	2.3	2.8	7.6	11.1	0.2	18.3	13.8	22.8	3.4	4.5	0.1	0.0	0.0	3.9	0.3	4.4	0.0	2.3	0.0	0.0	3.9	0.0	0.3	0.0	0.0	2.6	0.9	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.8	7.8	6.0	5.6	5.7	5.5	7.3	10.6	5.2	10.8	6.1
SAMD4B	"FLJ10211, hSmaug2, MGC99832, SMGB"	ENSG00000179134	"Sterile alpha motif domain containing 4B"	Q5PRF9	19	39342396-39385710	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016800, HPA059385"	Approved		Enhanced	Cytosol				Cytosol		"HPA016800: AB_1856552, HPA059385: "	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavourable (2.17e-6)"	"unprognostic (3.41e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.24e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.91e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-2)"	24.9	24.6	34.8	19.5	43.9	15.0	19.5	24.9	34.3	26.3	19.5	40.0	18.8	15.9	24.5	15.2	32.7	27.9	22.5	18.8	29.2	19.5	16.5	14.1	20.4	11.8	37.3	24.0	35.2	22.5	37.5	23.5	21.9	32.6	21.1	13.7	20.9	19.9	30.4	18.1	25.1	18.4	23.7	28.7	19.0	18.9	23.0	37.7	13.6	21.2	12.3	15.2	21.8	24.2	3.0	2.5	6.8	2.8	2.1	3.7	1.2	30.9	42.6	21.8	16.5	21.3	25.7	18.0	17.9	19.7	14.4	12.0	37.2	17.4	10.3	23.5	28.6	15.0	21.5	16.4	9.9	20.8	35.0	10.4	17.5	15.4	22.1	11.2	10.9	25.2	19.4	23.5	17.6	13.5	30.6	11.4	17.5	21.2	12.1	5.5	17.3	17.3	14.7	14.0	9.0	12.0	25.2	22.4	21.8	23.5	16.2	12.8	13.1	12.1	17.7	23.6	17.2	50.9	31.3	21.4	19.2	11.6	31.4	8.8	23.0	2.9	2.8	3.9	3.0	1.1	2.2	3.0	2.2	2.4	2.0	2.0	3.7	2.6	6.8	2.1	0.9	2.5	0.9	1.2	34.8	43.9	24.9	34.3	29.2	19.5	37.3	24.0	32.6	37.7
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.6;lymphoid tissue: 35.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	9.6	4.0	2.3	9.2	2.4	5.2	2.6	1.0	1.6	9.3	6.8	0.6	0.9	4.3	2.8	3.0	34.6	2.7	4.3	2.5	1.3	1.5	6.3	3.5	7.8	10.8	2.5	1.1	6.3	2.3	0.1	6.4	11.3	3.1	5.3	7.0	0.7	5.7	1.6	2.4	1.5	12.7	2.2	2.5	21.7	6.3	2.5	1.7	35.4	3.3	9.9	9.5	4.8	9.7	5.5	3.0	15.6	9.8	7.4	7.6	2.6	12.2	1.6	0.4	0.1	5.5	7.0	0.1	4.8	20.1	23.0	30.5	0.1	13.6	5.1	7.6	11.8	14.5	0.0	4.4	7.8	17.4	0.6	7.4	8.2	0.0	2.5	8.3	10.4	3.1	6.4	7.6	2.1	3.4	0.5	12.8	4.8	0.0	12.3	6.8	0.0	3.5	4.1	4.1	5.8	0.1	1.5	2.0	0.2	3.7	1.4	3.9	0.4	4.1	14.8	5.4	1.9	16.1	2.6	7.6	1.4	4.7	5.6	4.9	5.3	15.6	3.6	12.7	7.6	7.0	7.3	5.0	5.9	6.5	3.0	5.5	6.3	5.7	15.5	7.4	9.8	2.1	7.2	2.6	2.3	2.4	1.0	1.6	1.3	1.5	2.5	1.1	3.1	1.7
SAMD9L	"C7orf6, FLJ39885, KIAA2005"	ENSG00000177409	"Sterile alpha motif domain containing 9 like"	Q8IVG5	7	93130055-93148369	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 20.8;HDLM-2: 18.4;Karpas-707: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019461, HPA019465, HPA019488"	Enhanced		Approved	Cytosol				Cytosol		"HPA019461: AB_1856555, HPA019465: AB_2183384, HPA019488: AB_1856557"	"unprognostic (6.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.03e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (6.63e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.22e-1)"	25.1	6.8	6.0	16.5	7.9	5.9	7.1	5.1	5.7	10.0	6.7	3.3	3.2	7.4	5.9	11.4	8.8	7.0	9.4	5.5	5.7	3.3	9.1	3.7	14.8	17.3	4.5	5.9	11.1	3.9	1.2	6.4	11.3	7.4	8.8	7.7	4.2	8.1	4.5	3.6	2.6	13.2	5.8	6.5	28.4	9.3	3.9	6.0	26.7	11.7	5.5	10.3	9.1	7.8	11.2	4.5	21.7	9.7	5.9	10.1	2.4	2.6	0.1	0.0	0.1	3.6	7.3	0.0	2.3	9.6	13.1	20.8	0.0	5.9	1.7	2.9	6.1	1.1	0.0	0.8	2.1	18.4	0.0	1.5	0.6	0.0	2.9	3.3	2.5	2.8	0.3	2.6	0.4	5.6	0.0	49.6	5.5	0.0	5.4	3.1	0.2	0.6	2.3	0.8	4.0	0.7	0.2	0.0	0.1	0.4	0.0	3.5	0.1	1.8	13.1	3.9	0.8	11.2	1.4	13.8	4.6	0.5	4.0	3.1	3.8	14.3	4.9	11.4	10.1	9.7	8.9	11.2	5.8	7.4	4.5	7.9	3.3	5.7	21.7	5.9	8.9	3.3	8.2	2.4	6.0	7.9	5.1	5.7	5.7	3.3	4.5	5.9	7.4	6.0
SAP18	"2HOR0202, MGC27131, SAP18p"	ENSG00000150459	"Sin3A associated protein 18"	O00422	13	21140514-21149084	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011352, CAB012273"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB012273: , HPA011352: AB_1856563"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.78e-2)"	35.3	67.0	55.2	45.3	57.4	81.0	38.0	35.2	49.1	30.0	44.8	43.9	37.6	53.1	37.5	40.3	59.5	32.4	33.0	66.3	68.4	61.3	63.2	47.5	34.8	41.7	64.9	50.2	37.3	52.3	16.2	38.8	43.1	54.9	34.4	23.8	26.4	50.1	34.5	121.6	31.4	48.6	48.1	73.5	31.6	41.6	79.2	49.3	34.0	34.9	51.0	24.4	37.3	48.6	90.1	107.4	97.9	96.4	70.0	94.1	143.8	30.0	17.0	27.5	29.7	29.9	25.1	42.7	38.5	28.6	35.7	26.4	30.6	58.3	31.2	47.6	31.8	31.6	33.8	24.1	40.4	47.6	17.1	44.4	22.4	50.6	34.0	60.3	36.0	25.2	27.6	27.2	32.7	26.8	21.0	17.8	32.2	38.4	68.0	99.1	34.6	18.7	43.2	43.5	31.0	50.0	27.0	32.1	28.0	24.7	36.8	47.6	35.6	88.5	32.5	22.0	24.5	39.8	44.8	27.7	38.5	85.9	21.4	35.9	40.3	69.6	82.9	97.9	70.0	89.0	70.6	90.1	86.2	82.4	81.2	77.6	84.2	83.2	83.4	70.0	96.4	107.4	94.1	143.8	55.2	57.4	35.2	49.1	68.4	61.3	64.9	50.2	54.9	49.3
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062124-137070588	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavourable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	1.0	0.4	11.5	10.5	7.0	3.3	2.6	1.4	14.4	2.5	6.2	10.1	0.0	7.6	1.0	0.4	7.8	0.8	5.4	0.4	9.6	7.5	1.2	0.4	2.7	4.7	8.0	3.8	0.3	0.8	0.3	0.4	1.8	5.4	5.4	3.5	0.0	7.3	0.4	0.4	5.4	7.7	1.0	7.0	2.7	4.6	1.5	2.7	9.2	0.6	3.5	10.0	1.0	1.9	0.5	0.8	0.5	1.7	0.0	0.4	0.4	16.4	8.9	3.5	10.5	0.1	0.2	19.0	2.7	1.8	2.9	1.3	16.9	7.6	17.2	8.9	1.3	23.5	11.1	3.1	0.6	11.9	12.8	7.5	9.9	18.9	0.0	8.5	13.1	0.0	0.5	1.0	1.9	4.7	10.4	7.8	0.8	38.9	2.4	23.1	6.6	20.4	26.4	13.5	19.2	3.6	4.8	18.5	10.9	10.5	29.4	4.0	23.7	16.3	3.0	2.6	9.1	8.0	13.4	2.7	7.8	8.3	6.2	10.2	8.4	0.2	1.7	0.0	0.0	0.5	0.4	0.5	0.3	0.0	0.8	0.2	0.1	0.0	0.5	0.0	0.8	0.2	0.3	0.4	11.5	7.0	1.4	6.1	9.6	7.5	8.0	3.8	5.4	2.7
SARS	SERS	ENSG00000031698	"Seryl-tRNA synthetase"	P49591	1	109213918-109238169	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Uncertain		Enhanced	Cytosol			100000	Cytosol		"HPA016939: AB_1856585, HPA064668: "	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favourable (9.47e-4)"	"prognostic unfavourable (5.75e-4)"	"prognostic unfavourable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	35.8	42.6	46.1	28.2	45.9	16.3	38.3	42.6	60.6	40.1	37.6	31.2	30.9	33.5	39.4	36.0	42.0	39.6	28.7	43.9	55.9	47.3	37.6	58.6	44.5	28.8	46.4	56.0	44.4	68.7	55.3	40.1	44.9	64.1	34.3	41.0	22.0	54.2	42.3	72.3	46.1	31.1	42.9	41.0	29.4	46.0	20.9	35.0	25.3	75.0	32.9	38.7	41.8	60.4	54.3	45.9	48.6	48.3	41.0	66.1	88.9	32.7	12.9	24.8	37.3	37.3	33.9	42.7	34.5	35.8	30.0	37.5	24.9	10.1	35.4	17.9	48.7	18.0	38.6	48.8	35.0	25.0	23.5	13.7	16.0	18.0	75.0	17.2	15.4	41.6	85.5	35.4	77.0	35.7	31.3	44.4	29.2	31.4	19.1	8.8	10.3	30.5	15.8	31.7	15.8	22.8	17.5	34.5	18.3	16.5	26.7	93.6	15.1	20.6	28.1	17.9	22.6	25.4	24.1	33.9	13.7	29.0	56.5	18.9	60.8	35.6	44.5	48.6	56.0	48.2	58.4	54.3	59.3	55.4	45.9	52.5	61.8	57.7	21.3	41.0	48.3	29.6	66.1	88.9	46.1	45.9	42.6	60.6	55.9	47.3	46.4	56.0	64.1	35.0
SASH1	"dJ323M4.1, KIAA0790, SH3D6A"	ENSG00000111961	"SAM and SH3 domain containing 1"	O94885	6	148272304-148552050	"Predicted intracellular proteins"			"Disease mutation, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 58.9;ASC TERT1: 22.3;WM-115: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 2.9;intermediate monocyte: 5.5;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	32	"monocytes: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029947, HPA029949"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029947: AB_10598915, HPA029949: AB_10602280"	"unprognostic (9.71e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.79e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.53e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.54e-1)"	41.4	5.4	19.6	5.3	21.7	0.7	25.7	9.9	28.1	16.8	9.2	22.2	4.4	5.6	11.2	9.3	35.6	10.0	15.6	13.2	21.9	14.2	13.5	7.7	16.7	4.7	26.3	11.4	5.3	7.7	15.0	3.5	23.5	22.8	9.8	8.3	9.2	12.2	8.1	10.6	17.5	6.7	13.2	28.6	10.3	6.0	4.8	22.3	0.2	30.9	10.4	8.2	13.2	17.9	0.0	0.0	0.1	5.5	0.0	0.1	0.6	1.3	0.8	6.8	2.2	58.9	22.3	1.1	7.7	18.7	5.9	9.0	1.7	1.6	0.0	4.1	20.6	1.6	2.0	1.8	4.9	0.0	1.5	0.0	3.9	1.5	1.8	0.0	0.3	10.3	1.9	8.8	2.4	21.3	0.1	0.0	5.5	1.5	0.0	0.0	2.0	1.0	0.0	4.9	0.0	4.3	4.2	0.2	0.0	2.3	8.8	6.1	0.6	3.9	18.5	5.7	1.1	18.2	1.6	0.0	0.0	0.0	9.2	0.0	27.2	0.1	2.9	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.6	19.6	21.7	9.9	17.9	21.9	14.2	26.3	11.4	22.8	22.3
SASS6	"DKFZp761A078, FLJ22097, SAS-6, SAS6"	ENSG00000156876	"SAS-6 centriolar assembly protein"	Q6UVJ0	1	100083563-100132955	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028187	Uncertain		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite"	Cytosol	"HPA028187: AB_10602220"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.76e-8)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.54e-1)"	6.2	3.8	3.8	6.1	5.4	10.9	5.9	17.8	6.9	6.4	6.1	5.0	8.3	6.4	4.8	5.5	6.2	4.3	2.5	3.2	5.4	3.5	3.3	3.5	3.3	8.5	5.5	3.3	5.3	4.2	10.2	12.0	5.9	5.8	6.9	6.4	3.1	5.1	4.8	3.8	4.5	7.0	4.9	6.2	7.3	4.6	15.0	6.9	17.1	4.6	5.0	7.7	4.5	4.8	5.1	1.4	8.1	2.3	2.3	3.6	1.4	11.2	3.8	9.3	8.9	1.1	2.0	13.5	7.1	3.5	9.4	11.3	5.9	6.1	12.1	6.2	2.9	10.5	12.5	4.3	12.7	6.7	12.6	10.3	8.2	7.6	0.6	17.4	10.4	1.0	2.0	7.8	6.9	4.9	16.6	12.0	4.3	3.3	15.5	8.4	12.0	7.7	11.1	18.1	6.3	4.5	5.2	6.6	9.9	7.1	11.6	6.0	5.7	10.5	2.4	6.5	8.3	7.6	10.0	6.0	12.2	17.0	5.4	11.5	3.6	8.1	1.2	4.8	3.5	2.3	3.6	5.1	3.4	2.9	1.4	3.9	3.1	3.0	3.5	2.3	1.7	1.4	3.1	1.4	3.8	5.4	17.8	6.9	5.4	3.5	5.5	3.3	5.8	6.9
SAV1	"salvador, WW45, WWP4"	ENSG00000151748	"Salvador family WW domain containing protein 1"	Q9H4B6	14	50632058-50668331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001808	Approved		Supported	Cytosol				Cytosol		"HPA001808: "	"prognostic favourable (2.92e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.20e-2)"	"prognostic favourable (3.83e-6)"	"unprognostic (2.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.90e-3)"	28.5	13.5	13.9	10.8	16.2	5.0	30.3	11.9	13.9	23.3	18.9	19.9	13.8	11.7	19.3	15.5	13.9	17.1	20.7	23.1	15.6	12.5	18.4	13.5	22.1	10.9	17.3	11.1	30.8	31.3	24.5	11.2	17.0	15.6	29.2	10.1	18.6	34.0	19.8	25.6	15.9	18.3	16.0	20.1	16.6	16.5	22.5	17.7	5.5	32.1	12.1	11.0	23.5	36.7	7.1	2.3	1.1	0.7	0.9	1.9	0.9	36.3	4.2	7.1	4.9	17.6	16.3	8.9	10.3	34.1	13.5	17.4	6.1	18.7	5.7	25.5	10.1	16.7	10.0	11.2	25.2	17.3	7.8	6.2	6.7	4.4	8.7	6.7	5.7	10.1	14.5	6.0	13.5	9.6	10.2	2.9	16.7	6.8	5.7	4.2	13.3	6.5	6.5	19.7	2.4	8.5	5.2	8.9	6.9	18.3	10.9	15.3	8.0	6.9	6.9	6.5	22.2	8.8	6.2	4.4	5.7	3.5	4.5	2.7	8.6	1.1	0.7	0.1	1.7	0.6	1.9	6.2	1.4	1.2	0.7	7.1	1.1	1.4	1.1	0.9	0.7	2.3	1.6	0.9	13.9	16.2	11.9	13.9	15.6	12.5	17.3	11.1	15.6	17.7
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS, ribosome maturation factor"	Q9Y3A5	7	66987677-66995601	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol			55000	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavourable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	40.9	34.5	37.7	18.7	44.0	41.7	44.5	23.6	43.2	30.7	37.5	35.3	20.2	39.1	35.6	27.3	40.8	27.7	34.0	70.0	39.2	40.9	36.9	38.4	32.1	16.7	50.6	36.6	31.9	27.5	50.4	26.9	38.6	44.6	35.1	35.7	20.1	23.5	40.5	130.7	26.1	34.4	52.0	63.2	16.7	32.8	15.9	48.2	7.2	33.9	38.7	15.6	54.0	38.0	21.6	15.5	20.8	12.6	16.6	39.1	19.4	31.0	13.2	11.7	10.6	42.7	31.9	13.1	52.9	43.6	40.5	31.2	27.1	16.0	11.5	40.2	48.3	15.1	19.7	31.4	43.6	11.0	26.0	5.7	24.6	16.2	38.0	14.4	7.9	28.8	42.3	30.8	53.6	24.9	41.7	12.6	62.9	18.6	7.6	21.0	13.0	31.4	5.8	25.2	24.2	42.7	13.9	18.0	12.4	26.5	45.9	35.1	34.2	12.2	33.1	54.8	18.7	27.7	38.5	7.8	9.2	26.4	18.8	23.7	30.3	20.8	11.1	20.2	23.4	12.6	29.6	21.6	30.6	27.2	11.3	18.7	39.1	31.5	4.7	16.6	11.2	15.5	25.9	19.4	37.7	44.0	23.6	43.2	39.2	40.9	50.6	36.6	44.6	48.2
SBF2	"CMT4B2, DENND7B, KIAA1766, MTMR13"	ENSG00000133812	"SET binding factor 2"	Q86WG5	11	9778667-10294207	"Disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050933	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA050933: "	"unprognostic (2.26e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.36e-2)"	"unprognostic (5.55e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.43e-1)"	"prognostic favourable (3.66e-5)"	"unprognostic (3.72e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.11e-2)"	26.2	12.7	19.8	8.9	22.5	6.1	17.9	26.7	17.4	23.6	15.6	18.4	13.2	9.8	19.1	14.2	16.9	15.3	14.9	13.7	16.3	12.3	20.8	13.8	13.8	8.7	14.6	12.0	26.8	8.0	33.9	23.2	20.5	13.7	16.8	15.3	15.6	14.7	17.7	8.8	13.2	11.1	22.0	16.1	12.4	13.3	15.3	19.1	7.8	24.0	9.1	9.2	20.2	25.5	0.6	1.0	3.9	3.9	0.9	0.6	0.5	6.6	5.9	9.4	6.6	12.6	16.8	48.2	5.1	9.4	6.2	8.7	3.9	8.1	2.5	2.8	9.1	4.4	5.6	4.2	10.8	2.6	4.0	1.0	4.3	5.3	5.1	2.3	3.5	8.6	5.6	3.2	12.0	10.0	2.1	2.4	7.2	1.9	3.4	0.7	4.0	6.0	3.2	6.6	3.3	5.5	6.0	3.1	6.9	7.1	10.0	4.4	3.0	1.7	10.9	11.1	5.5	10.9	4.2	0.8	1.9	3.6	8.2	1.1	7.7	0.0	1.9	0.1	0.2	1.8	0.6	0.3	0.2	0.4	1.0	0.6	0.3	0.1	3.9	0.9	3.9	0.4	0.2	0.5	19.8	22.5	26.7	17.4	16.3	12.3	14.6	12.0	13.7	19.1
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292453-121308694	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 143.5"	"Cell line enhanced"	"Detected in all"		"AF22: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: , HPA070248: "	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	10.9	15.3	16.9	5.5	18.4	2.7	23.3	10.4	26.9	9.4	9.4	17.8	24.5	17.4	6.8	30.1	19.5	7.2	7.4	9.4	18.7	19.6	19.7	143.5	10.1	5.5	20.8	17.8	7.8	8.9	17.5	14.7	6.3	40.8	40.3	8.6	8.2	9.5	24.0	3.9	7.7	13.4	7.6	43.4	4.1	8.8	9.7	16.0	3.7	10.4	8.2	8.1	14.0	14.6	6.0	9.8	7.5	6.3	6.8	10.0	3.8	7.1	3.6	53.9	11.5	21.0	18.2	7.6	8.0	15.1	5.4	9.6	22.5	26.6	6.7	25.4	8.7	26.7	16.8	20.3	5.3	3.3	22.9	10.0	23.5	17.9	17.1	6.3	3.4	14.9	16.7	17.1	17.6	8.2	6.5	9.8	24.9	7.4	2.5	8.2	16.8	11.4	3.5	13.6	5.7	38.0	32.0	14.2	8.0	18.4	4.2	10.5	16.8	10.9	15.5	5.2	8.4	9.2	3.7	1.8	3.1	9.0	2.0	13.9	9.0	7.5	4.8	1.2	5.0	6.3	8.5	6.0	6.8	6.0	8.5	6.0	10.0	9.5	0.4	6.8	4.5	9.8	6.9	3.8	16.9	18.4	10.4	26.9	18.7	19.6	20.8	17.8	40.8	16.0
SCAF1	"FLJ00034, SR-A1"	ENSG00000126461	"SR-related CTD associated factor 1"	Q9H7N4	19	49642125-49658642	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046828, HPA054593"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046828: AB_10961907, HPA054593: "	"unprognostic (1.16e-1)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (9.59e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.18e-2)"	21.6	15.6	22.2	17.0	30.5	14.4	12.9	24.9	48.3	14.1	15.0	27.0	7.4	18.2	18.9	7.4	27.2	24.0	17.2	21.3	21.4	18.9	12.4	13.9	13.9	17.7	17.5	21.6	24.1	21.1	13.7	17.5	18.4	26.1	15.0	8.6	14.1	20.8	11.8	28.4	18.5	17.0	14.6	14.8	20.2	17.0	15.9	15.7	19.7	18.4	8.4	13.1	16.9	13.6	5.1	5.1	7.8	2.9	1.9	4.2	3.2	26.2	46.2	12.7	20.9	6.0	5.8	15.5	19.9	6.5	9.3	7.9	25.0	16.4	15.4	13.6	7.3	20.3	9.1	12.2	2.7	23.7	26.0	17.2	22.9	12.5	10.4	16.3	17.1	9.6	7.7	11.2	8.0	7.5	22.1	15.8	7.3	16.9	16.3	8.7	16.2	27.7	20.3	17.6	15.8	6.1	38.1	18.9	20.6	20.5	21.6	7.3	15.1	9.2	20.5	34.0	19.7	12.1	29.1	22.4	33.3	14.6	20.5	10.4	19.2	4.0	2.9	2.7	4.2	2.5	2.7	5.1	2.4	2.8	2.3	4.7	2.2	2.4	7.8	1.9	2.2	5.1	0.5	3.2	22.2	30.5	24.9	48.3	21.4	18.9	17.5	21.6	26.1	15.7
SCAND1	"RAZ1, SDP1"	ENSG00000171222	"SCAN domain containing 1"	P57086	20	35953617-35959472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047138			Supported	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Actin filaments"	Cytosol	"HPA047138: "	"unprognostic (3.88e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.15e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.48e-2)"	38.7	31.8	23.5	25.4	22.0	50.3	21.6	13.7	37.7	18.1	30.3	12.3	22.4	45.3	19.3	32.8	21.0	17.0	27.1	19.8	21.6	22.7	30.7	39.6	18.0	26.5	21.0	18.4	19.8	30.7	8.8	21.2	16.9	14.5	26.8	7.2	19.1	36.2	27.8	50.7	19.5	35.4	15.4	16.5	31.9	40.6	23.8	13.4	34.8	26.8	26.2	15.9	14.8	17.3	42.0	60.9	70.6	61.6	30.4	47.2	43.2	13.0	9.7	3.8	7.3	2.0	2.4	24.4	9.1	3.6	4.0	4.7	8.9	9.7	10.1	23.6	1.5	12.2	0.8	4.3	0.4	3.6	21.7	24.9	5.3	19.0	7.0	7.8	10.3	4.2	3.4	3.3	0.7	6.4	10.8	8.1	2.4	13.1	21.8	55.4	12.8	38.3	16.6	11.8	16.5	3.8	5.2	18.8	27.8	15.0	24.0	20.2	16.3	14.8	12.8	13.4	12.0	12.9	8.9	24.3	11.9	14.2	15.6	8.4	10.4	70.6	61.6	57.3	35.1	40.9	27.7	36.6	35.0	30.9	45.8	42.0	29.7	29.0	53.3	30.4	39.6	60.9	47.2	43.2	23.5	22.0	13.7	37.7	21.6	22.7	21.0	18.4	14.5	13.4
SCAPER	"Zfp291, ZNF291"	ENSG00000140386	"S-phase cyclin A associated protein in the ER"	Q9BY12	15	76347904-76905444	"Predicted intracellular proteins"			"Disease mutation, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046253, HPA061180"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046253: , HPA061180: "	"unprognostic (3.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.02e-1)"	"prognostic favourable (2.69e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.89e-3)"	9.0	10.9	17.0	9.3	15.6	8.8	9.4	26.0	20.7	10.3	8.3	10.7	9.8	8.9	10.0	10.8	12.1	9.0	7.5	17.8	15.9	17.2	12.6	9.9	8.4	7.1	17.3	13.2	16.8	10.9	24.1	36.3	24.6	15.6	9.9	6.3	7.7	9.7	9.5	17.9	9.8	8.3	10.4	20.6	7.5	7.9	25.7	14.7	12.6	16.3	8.7	7.7	9.4	9.5	13.2	6.6	20.4	4.6	12.0	14.3	2.8	5.0	4.7	6.6	3.7	3.3	6.1	5.4	6.9	4.9	3.2	4.5	4.9	4.1	5.0	6.1	2.3	5.5	15.3	2.8	4.8	11.7	7.5	2.7	5.7	2.4	4.2	7.1	6.3	5.0	5.1	3.8	6.1	4.2	3.8	14.5	5.4	2.1	6.9	2.2	1.9	2.7	6.3	10.4	1.7	2.9	5.1	15.5	7.5	9.1	3.2	7.4	4.7	5.9	5.1	7.3	6.9	3.4	6.0	8.8	18.4	7.5	4.3	9.0	4.8	20.4	4.6	11.5	8.6	2.5	9.8	11.0	8.7	7.6	2.5	13.2	14.3	9.1	7.7	12.0	2.9	6.6	6.6	2.8	17.0	15.6	26.0	17.1	15.9	17.2	17.3	13.2	15.6	14.7
SCARA3	"APC7, CSR, CSR1, MSLR1, MSRL1"	ENSG00000168077	"Scavenger receptor class A member 3"	Q6AZY7	8	27633868-27676776	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 52.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 49.6;HeLa: 54.6;HUVEC TERT2: 37.8;U-2 OS: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029861, HPA047386"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA029861: , HPA047386: "	"unprognostic (2.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (6.03e-3)"	7.5	4.6	16.4	9.0	27.3	0.4	10.6	10.3	26.8	19.9	11.2	7.7	14.2	3.4	33.8	9.4	14.5	52.2	18.4	4.8	16.2	13.0	3.8	2.7	7.8	7.4	16.4	10.3	13.1	2.8	2.2	3.6	11.8	21.2	12.4	5.4	8.6	13.7	42.6	1.1	6.0	5.1	40.5	21.8	2.0	5.9	3.9	12.1	3.2	19.2	4.7	13.2	11.3	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.1	2.5	0.0	13.5	49.6	11.3	6.5	10.2	7.0	5.2	5.9	4.2	0.0	15.3	13.0	12.1	0.0	12.0	3.3	0.0	1.4	4.7	54.6	0.2	1.4	0.0	0.0	20.8	0.7	10.8	0.5	37.8	0.0	0.0	3.9	2.9	0.0	0.0	3.4	6.2	0.0	0.0	0.0	2.2	7.2	0.0	1.6	1.5	8.6	0.0	8.4	0.1	13.4	5.8	35.0	21.4	3.4	0.0	0.0	0.0	9.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	27.3	10.3	22.5	16.2	13.0	16.4	10.3	21.2	12.1
SCARB2	"CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII"	ENSG00000138760	"Scavenger receptor class B member 2"	Q14108	4	76158733-76234536	"Disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 18.3;granulocytes: 6.2;monocytes: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015415, HPA018014"	Supported		Approved	Cytosol				Cytosol		"CAB015415: AB_831511, HPA018014: AB_1852881"	"prognostic unfavourable (2.82e-5)"	"unprognostic (2.73e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.89e-2)"	33.6	20.6	30.7	13.0	32.9	4.1	34.1	22.9	42.8	40.1	34.9	63.7	21.4	22.7	26.8	37.0	20.3	24.9	34.5	29.7	35.7	30.3	29.0	51.6	43.8	21.7	43.9	31.6	37.0	32.3	47.5	14.5	41.0	44.1	44.2	32.7	23.1	40.3	34.1	54.3	16.5	27.6	24.4	70.5	26.7	36.1	16.1	40.7	6.2	39.2	16.5	10.8	31.7	40.3	2.6	18.3	6.2	15.3	0.7	3.0	3.6	5.6	4.5	7.1	13.8	87.5	42.7	6.1	19.2	44.0	16.7	31.2	8.1	15.8	0.0	15.2	41.0	4.8	5.1	11.9	17.8	24.6	5.7	0.5	4.1	3.8	21.4	3.0	2.0	31.6	12.0	17.8	10.2	29.9	2.7	28.9	25.8	8.7	0.2	0.6	1.6	4.4	3.6	14.6	4.9	11.8	3.8	17.0	17.6	16.4	11.4	16.5	5.1	2.9	19.7	17.0	8.5	14.0	5.9	26.9	16.9	0.0	19.7	3.9	25.0	6.2	8.8	2.1	1.8	15.3	1.9	2.6	1.5	1.1	5.2	2.0	1.8	3.0	1.5	0.7	14.7	18.3	1.8	3.6	30.7	32.9	22.9	41.1	35.7	30.3	43.9	31.6	44.1	40.7
SCARF2	"HUMZD58C02, SREC-II, SREC2"	ENSG00000244486	"Scavenger receptor class F member 2"	Q96GP6	22	20424815-20437826	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 13.9;SH-SY5Y: 15.5;SK-MEL-30: 15.4;U-138 MG: 21.4;U-2 OS: 22.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035079	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			360000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035079: AB_10670287"	"unprognostic (2.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (4.38e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavourable (4.28e-4)"	6.5	2.4	0.0	4.1	0.3	0.1	9.2	0.0	1.2	10.6	3.2	0.4	2.9	1.4	8.1	6.6	1.8	2.6	11.3	3.4	0.6		3.2	1.1	5.9	5.1	0.8	0.4	12.6	1.6	0.0	0.6	5.6	0.9	5.5	0.0	9.2	1.1	6.8	1.8	2.2	1.9	9.9	0.5	5.3	1.4	2.5	0.0	0.0	5.4	3.3	1.4	7.1	10.9	0.1	0.1	0.9	0.0	0.0	1.8	0.0	0.4	0.2	3.1	5.4	1.9	2.6	1.2	13.9	5.7	3.3	1.7	0.0	0.0	0.2	8.1	6.7	0.1	1.8	0.0	0.4	0.4	11.7	1.1	0.2	2.5	11.6	0.0	0.6	4.6	0.0	1.6	0.8	1.7	0.1	0.1	1.2	0.5	0.0	0.2	4.2	1.8	0.3	8.9	0.0	0.0	0.0	1.3	15.5	0.0	0.0	15.4	0.5	0.0	2.0	21.4	22.4	0.5	3.1	0.6	0.2	0.2	0.1	0.3	10.6	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	1.8	0.0										
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 145.6;skin 1: 70.8;tongue: 62.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.9;HaCaT: 24.3;HBEC3-KT: 11.6;RPTEC TERT1: 47.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favourable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (1.73e-5)"	0.4	0.0	0.1	0.2	0.4	0.0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0.0	0.8	0.2	145.6	0.0	0.3	0.1	0.1	0.0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0.0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0.0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.8	0.0	24.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	47.3	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
SCFD1	"C14orf163, KIAA0917, RA410, SLY1, STXBP1L2"	ENSG00000092108	"Sec1 family domain containing 1"	Q8WVM8	14	30622112-30735812	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003579	Approved		Approved	Nucleoplasm,Cytosol			59000	Nucleoplasm	Cytosol	"HPA003579: AB_1079872"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.32e-2)"	22.4	22.7	20.6	17.6	29.7	15.5	21.7	21.9	28.1	27.7	20.0	12.6	19.3	17.1	20.5	23.3	25.9	19.0	13.4	20.9	19.2	17.8	24.5	33.9	18.8	16.6	16.5	19.4	21.8	33.8	28.5	68.5	29.4	26.0	20.3	21.9	14.5	34.5	22.3	24.7	15.7	22.0	19.6	15.6	20.4	18.8	18.8	17.1	24.4	31.0	18.0	19.0	17.2	22.3	14.3	16.3	18.8	17.2	19.4	15.9	9.2	24.1	10.5	13.4	8.9	22.2	25.0	19.6	18.1	25.2	26.7	31.7	17.0	18.2	13.4	8.7	28.5	14.0	16.5	19.1	31.2	18.7	9.1	9.2	14.7	57.3	27.8	17.2	11.9	18.5	14.7	16.4	27.9	18.1	15.1	25.5	26.2	28.5	10.6	10.0	12.8	18.5	9.3	14.7	16.1	21.5	20.9	14.0	11.7	17.5	17.4	17.9	25.6	12.8	14.5	18.5	14.2	15.4	15.1	17.6	16.4	18.2	8.7	13.3	19.1	18.8	13.4	15.6	9.6	14.4	12.4	14.3	11.1	12.0	16.3	12.3	10.5	10.7	4.3	19.4	17.2	13.3	15.9	9.2	20.6	29.7	21.9	28.1	19.2	17.8	16.5	19.4	26.0	17.1
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"			Cytosol		"CAB004005: , CAB044060: , CAB062563: , CAB068232: , HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 16.9;HUVEC TERT2: 20.0;NTERA-2: 10.3;SH-SY5Y: 58.2"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	58	"dendritic cells: 9.7;granulocytes: 3.1"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: "	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favourable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	3.9	30.1	1.5	22.0	2.0	1.9	23.9	55.0	3.7	3.6	21.1	0.0	2.2	4.7	2.0	4.2	3.4	3.0	65.9	29.6	17.9	3.5	1.9	3.1	1.7	22.8	24.1	1.8	1.6	1.4	6.0	10.3	15.6	6.2	2.3	0.7	2.9	2.6	54.5	1.4	1.9	5.9	28.9	5.1	2.0	2.7	24.3	0.0	2.0	7.6	1.6	1.9	0.6	0.0	9.7	3.1	0.0	0.1	0.0	0.1	0.0	0.0	9.3	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.3	0.1	3.9	20.0	0.0	0.0	1.2	0.0	0.0	0.0	10.3	0.0	0.0	1.9	0.0	0.4	0.0	0.0	58.2	0.0	0.0	0.0	0.0	1.0	3.7	0.2	0.5	0.1	0.8	0.7	0.0	0.0	0.2	0.7	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.1	30.1	22.0	23.9	28.9	29.6	17.9	22.8	24.1	15.6	24.3
SCMH1	Scml3	ENSG00000010803	"Scm polycomb group protein homolog 1"	Q96GD3	1	41027200-41242154	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048898, HPA053292"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA048898: , HPA053292: "	"unprognostic (6.02e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.08e-2)"	"prognostic favourable (5.80e-4)"	12.5	13.1	14.7	18.2	15.3	11.2	21.3	15.9	13.9	15.8	27.9	6.7	23.4	9.0	21.4	16.7	11.1	16.5	17.2	27.2	12.6	8.8	14.8	9.5	11.4	10.5	7.6	12.5	24.8	30.2	26.5	23.0	7.8	10.7	22.7	12.6	16.8	19.2	23.8	28.4	8.4	12.7	36.9	7.4	8.7	18.5	26.6	6.7	11.3	14.3	11.1	8.3	22.7	25.7	4.3	7.6	2.2	2.2	2.9	4.2	1.7	8.9	6.0	14.3	13.1	6.6	12.6	0.0	7.2	12.6	12.1	12.6	5.7	11.6	16.4	5.5	13.1	2.2	11.0	9.7	10.5	11.3	8.4	7.6	8.1	14.3	28.7	16.3	12.6	13.6	9.9	8.0	19.5	12.1	7.1	12.8	11.8	4.8	16.3	14.1	13.2	6.4	18.1	15.0	9.7	9.7	11.2	10.1	10.8	12.5	10.0	10.4	8.9	42.0	8.9	12.8	10.0	7.8	13.1	13.1	7.3	17.9	8.0	14.7	11.6	1.3	1.2	2.2	3.3	2.2	4.2	4.3	3.9	3.1	3.7	2.1	2.9	2.4	0.0	2.9	0.5	7.6	2.7	1.7	14.7	15.3	15.9	13.9	12.6	8.8	7.6	12.5	10.7	6.7
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239314-18354727	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 20.0;REH: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 7.0"					"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: "	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	2.4	7.7	3.1	2.1	4.1	8.6	3.1	3.4	3.8	3.7	3.7	3.7	2.0	2.1	4.9	2.5	2.3	2.9	2.8	2.0	2.3	2.0	1.5	2.6	1.3	2.0	3.6	0.5	9.5	3.9	3.2	8.0	7.1	2.3	2.9	2.3	3.6	10.0	2.2	2.0	3.4	2.0	6.5	2.2	2.3	1.7	19.0	4.2	12.5	4.3	2.3	2.1	2.7	4.2	0.8	7.0	0.2	0.2	0.9	0.7	0.2	0.9	3.3	11.8	3.0	0.9	1.5	3.5	2.0	1.4	4.0	4.5	4.8	0.7	0.0	0.4	0.9	0.0	16.5	0.2	4.9	0.0	13.5	0.0	3.0	2.1	0.5	10.3	2.7	0.6	0.6	2.9	3.4	0.2	7.7	0.0	2.8	1.5	16.5	5.5	20.0	4.2	17.8	5.9	2.4	0.0	0.2	7.2	8.4	3.5	3.3	0.0	4.2	4.6	0.3	3.6	2.6	8.0	1.8	0.0	9.4	16.5	1.2	7.1	2.7	0.0	0.2	0.2	0.7	0.2	0.7	0.2	0.3	0.2	0.9	0.8	0.2	0.1	0.2	0.9	0.1	7.0	0.0	0.2	3.1	4.1	3.4	3.8	2.3	2.0	3.6	0.5	2.3	4.2
SCN3B	HSA243396	ENSG00000166257	"Sodium voltage-gated channel beta subunit 3"	Q9NY72	11	123629187-123655244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 70.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 2.9;hTCEpi: 9.4;RH-30: 4.2;SCLC-21H: 9.4;SH-SY5Y: 7.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041707			Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"HPA041707: "	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.13e-4)"	"unprognostic (3.93e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.29e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.34e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.16e-4)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.43e-2)"	2.2	8.5	17.7	1.5	23.5	1.3	2.0	2.8	70.3	1.6	1.5	1.2	0.0	1.6	1.5	1.5	1.5	1.8	1.4	1.9	26.2	13.2	1.6	1.0	1.4	1.2	5.2	18.8	1.7	1.9	3.9	12.6	1.1	3.8	1.8	1.6	3.7	1.2	1.4	5.8	1.7	1.5	2.1	1.5	1.3	1.4	2.2	1.2	0.0	3.7	0.0	1.2	1.1	0.4	1.2	1.3	2.7	0.6	1.1	0.8	0.1	0.0	0.2	0.3	0.2	0.1	0.1	0.3	0.2	0.3	0.0	0.0	2.9	0.1	0.3	1.4	0.4	0.2	1.0	0.1	0.1	0.1	0.6	0.0	0.5	0.3	0.1	0.0	0.5	0.4	9.4	0.1	0.1	0.3	0.4	0.5	0.0	0.1	0.1	0.2	0.8	0.1	0.2	4.2	0.0	0.0	0.2	9.4	7.0	0.6	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.6	0.6	0.5	0.6	0.4	0.4	0.7	0.7	0.7	0.3	1.2	0.5	0.8	2.7	1.1	0.5	1.3	0.4	0.1	17.7	23.5	2.8	39.5	26.2	13.2	5.2	18.8	3.8	1.2
SCRN1	KIAA0193	ENSG00000136193	"Secernin 1"	Q12765	7	29920103-29990289	"Enzymes, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.8"	"Cell line enhanced"	"Detected in many"		"WM-115: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024517	Enhanced		Approved	Cytosol			110000	Cytosol		"HPA024517: AB_2184811"	"prognostic unfavourable (8.32e-4)"	"prognostic unfavourable (8.46e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (4.00e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.15e-5)"	"unprognostic (2.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (2.60e-4)"	6.8	14.8	32.0	6.3	31.5	3.6	7.6	62.8	55.4	12.4	8.1	23.2	4.5	3.4	13.3	8.8	10.0	13.9	8.5	9.8	26.6	30.7	12.8	1.5	8.3	6.7	42.7	26.6	17.5	18.5	42.9	12.1	8.0	26.3	15.0	5.6	7.8	8.4	20.2	1.0	5.7	5.0	17.7	42.9	5.2	7.1	11.4	23.3	8.2	7.1	1.5	10.6	9.4	5.8	10.4	7.8	6.9	16.7	4.8	8.1	2.2	22.3	16.2	26.4	10.6	18.8	28.9	0.1	20.9	28.1	22.7	24.6	18.6	17.8	2.7	18.6	26.8	10.1	30.0	8.9	33.3	0.1	6.3	9.3	10.9	12.0	24.0	0.0	0.1	24.0	12.8	20.6	11.1	20.9	0.1	7.3	32.0	12.6	3.2	0.0	24.0	17.4	0.0	28.2	0.2	15.9	11.0	9.7	22.9	21.6	14.1	24.1	18.9	1.4	23.0	29.5	25.5	0.3	26.4	2.4	36.2	0.2	13.9	0.1	71.2	2.2	2.3	6.9	0.6	10.2	8.1	10.4	0.1	0.8	7.7	5.0	0.6	1.0	0.4	4.8	16.7	7.8	0.0	2.2	32.0	31.5	62.8	43.1	26.6	30.7	42.7	26.6	26.3	23.3
SCRN3	FLJ23142	ENSG00000144306	"Secernin 3"	Q0VDG4	2	174395730-174429575	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034689, HPA034690"	Approved		Approved	Vesicles,Cytosol			9300	"Vesicles, Cytosol"		"HPA034689: , HPA034690: AB_10670574"	"unprognostic (5.39e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	12.4	15.9	19.2	7.6	18.4	3.7	11.4	13.2	27.0	8.4	10.4	16.7	12.5	15.4	10.3	10.1	14.2	9.1	9.4	21.2	20.2	20.0	17.4	18.0	10.1	10.5	23.5	21.1	11.7	12.1	26.6	20.6	10.9	25.9	13.4	11.3	8.7	10.6	12.3	30.3	11.5	11.5	11.8	27.9	9.3	10.2	8.4	20.2	10.4	17.3	6.2	9.5	11.2	9.1	9.9	6.9	18.5	4.6	5.5	7.5	2.2	9.0	5.6	14.5	13.4	11.3	12.8	8.2	14.0	10.8	10.9	13.0	5.5	6.7	1.7	9.2	13.9	9.1	11.2	12.1	14.0	19.7	10.1	16.9	12.2	4.3	17.0	12.9	8.9	14.3	15.1	20.0	14.7	12.5	11.1	6.6	14.7	10.1	10.6	12.5	7.1	23.8	5.3	15.2	9.9	12.1	9.3	9.4	26.5	9.6	9.6	17.6	12.8	12.5	9.1	12.6	6.6	14.8	11.7	17.5	18.1	0.2	13.8	6.4	12.7	4.8	4.6	1.9	4.6	2.7	3.3	7.0	4.7	4.3	4.3	9.9	7.5	5.9	18.5	5.5	3.6	6.9	4.8	2.2	19.2	18.4	13.2	27.0	20.2	20.0	23.5	21.1	25.9	20.2
SCYL1	"GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP"	ENSG00000142186	"SCY1 like pseudokinase 1"	Q96KG9	11	65525077-65538704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015015	Uncertain		Supported	Cytosol				Cytosol		"HPA015015: AB_1856643"	"unprognostic (5.56e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (6.49e-3)"	"unprognostic (4.27e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.29e-3)"	24.1	35.5	24.1	20.2	24.4	22.8	49.4	24.6	47.3	25.0	21.6	19.0	27.8	22.5	26.9	30.0	24.1	26.7	21.4	35.8	25.1	21.1	24.1	61.4	22.4	22.9	21.7	23.9	34.1	40.7	27.0	24.3	30.7	19.6	24.7	14.3	24.9	34.0	30.3	51.2	23.6	19.8	23.0	17.1	24.7	24.4	31.4	20.6	18.0	27.3	20.2	20.2	24.9	24.1	10.7	15.5	27.9	13.7	11.1	14.7	12.1	19.8	17.1	13.8	19.1	25.3	22.1	18.9	24.7	33.6	29.5	23.1	24.6	12.0	14.3	25.1	32.0	18.2	14.5	18.5	10.3	16.8	18.6	16.8	18.8	28.2	36.0	11.0	24.3	30.6	18.4	25.3	18.9	19.3	17.5	20.3	18.3	43.2	14.7	25.4	13.3	23.9	15.0	10.7	26.2	18.1	17.8	12.8	13.6	15.2	33.7	26.8	33.4	14.0	19.0	23.5	15.8	38.0	14.5	28.1	19.5	14.9	27.2	9.2	16.4	1.9	13.7	17.6	14.7	13.2	11.8	10.0	13.8	14.6	15.5	10.7	11.2	10.5	27.9	11.1	8.5	11.3	9.5	12.1	24.1	24.4	24.6	47.3	25.1	21.1	21.7	23.9	19.6	20.6
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493351-96611780	"CD markers, Predicted membrane proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.1;thyroid gland: 111.2"	"Cell line enhanced"	"Detected in many"		"AF22: 101.9;EFO-21: 47.8;fHDF/TERT166: 44.1;RPTEC TERT1: 53.2;U-138 MG: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA044416"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB025123: , HPA044416: "	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.23e-1)"	43.2	9.9	13.9	9.1	16.9	2.5	17.0	12.7	8.4	43.4	18.7	7.3	21.2	5.8	21.9	15.3	13.3	21.0	15.0	19.1	12.0	12.6	23.9	115.1	14.4	4.4	9.7	9.3	45.9	16.8	1.6	24.0	31.3	10.7	25.9	10.7	51.4	6.3	28.1	9.4	6.5	9.6	34.3	9.5	7.5	11.9	8.7	9.3	0.5	111.2	13.8	3.5	35.9	26.3	0.0	1.3	13.9	1.9	0.0	0.2	0.5	0.0	0.0	101.9	0.0	36.8	34.4	0.1	14.7	17.5	8.6	9.5	3.0	0.0	0.0	47.8	44.1	0.0	17.6	0.2	7.4	0.0	6.9	0.0	9.8	37.4	1.1	0.2	0.4	13.3	0.4	19.4	0.5	0.3	9.6	0.0	3.5	0.8	0.0	2.5	10.8	0.1	0.1	16.0	0.3	53.2	8.7	3.0	7.9	0.0	0.0	0.7	4.3	11.4	8.0	49.4	15.1	0.2	8.2	0.9	0.0	0.1	15.7	0.0	15.4	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	13.9	0.0	0.1	0.0	0.0	0.5	13.9	16.9	12.7	8.4	12.0	12.6	9.7	9.3	10.7	9.3
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582860	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 99.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 166.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 166.5;monocytes: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"		1500000	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	106.2	32.0	28.5	37.6	45.2	51.5	67.4	20.9	29.0	42.7	28.4	18.8	22.2	19.7	38.4	28.2	37.8	28.0	47.9	36.9	32.1	25.8	41.4	41.7	73.1	49.7	33.4	16.9	35.5	20.1	36.4	16.4	68.5	47.6	35.5	33.6	53.0	41.5	20.7	22.5	24.7	34.3	37.9	39.0	70.1	31.0	25.4	22.2	34.3	44.4	23.4	21.4	50.0	44.2	5.9	21.7	166.5	44.8	3.4	9.8	29.7	14.4	22.4	23.9	12.4	89.4	77.1	10.5	14.9	53.2	21.6	28.5	8.9	30.3	0.0	24.0	19.9	6.0	12.9	17.1	26.8	2.6	11.0	21.7	19.9	7.1	99.4	5.5	35.4	52.6	23.2	21.7	65.3	51.8	10.7	12.7	49.0	3.8	12.2	6.5	14.9	6.4	5.9	7.3	2.8	34.4	15.2	10.4	18.9	15.9	6.8	73.0	6.2	15.2	44.5	20.9	9.0	24.6	9.5	3.8	5.1	8.7	53.2	0.0	18.7	52.9	44.8	43.7	5.7	30.0	7.1	5.9	7.6	6.0	21.7	5.4	9.8	7.4	166.5	3.4	26.4	6.0	8.5	29.7	28.5	45.2	20.9	29.0	32.1	25.8	33.4	16.9	47.6	22.2
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329239	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 104.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.4;HBEC3-KT: 12.8;RT4: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054554, HPA064490"	Enhanced		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA054554: , HPA064490: "	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.37e-4)"	1.7	0.4	5.2	10.6	6.7	0.2	1.5	1.5	4.9	6.6	59.4	1.2	0.9	46.1	1.5	9.1	32.4	0.9	35.1	1.3	3.5	3.6	2.5	3.8	3.7	0.9	2.8	1.0	1.2	4.4	0.2	1.4	1.9	1.4	3.7	19.0	1.0	6.4	1.9	1.1	13.4	104.7	2.5	1.1	1.1	34.0	1.5	1.6	1.0	4.0	12.5	24.3	17.0	9.8	1.2	2.6	4.4	2.0	2.1	5.3	1.8	8.7	0.4	1.2	0.4	5.1	4.5	0.8	2.7	5.3	2.5	2.4	1.9	15.4	0.9	1.8	1.0	6.8	0.4	12.8	1.2	0.3	0.9	0.7	0.6	1.2	5.2	0.9	1.0	1.6	9.1	1.9	1.9	8.4	1.2	0.7	0.9	2.1	1.4	2.5	1.2	0.6	1.3	0.6	1.7	1.0	11.9	2.1	1.6	1.3	7.8	3.0	0.4	0.7	5.6	1.3	0.5	2.4	1.0	2.4	2.2	0.9	0.6	3.4	0.8	0.4	2.0	4.4	2.4	0.7	1.8	0.6	3.2	2.5	2.6	1.2	2.7	4.7	2.2	2.1	1.3	1.7	5.3	1.8	5.2	6.7	1.5	4.9	3.5	3.6	2.8	1.0	1.4	1.6
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999331	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"				"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	25.6	11.2	10.7	13.3	12.8	33.6	21.6	10.8	11.5	12.3	10.6	17.9	9.0	11.0	15.1	11.5	14.3	12.8	13.4	12.2	10.8	11.0	11.9	17.9	16.2	13.9	14.1	9.8	16.2	14.2	15.6	13.9	14.5	12.5	12.9	11.6	11.1	12.0	11.2	20.9	18.0	12.9	12.7	13.5	14.4	11.5	14.1	14.4	33.9	15.8	11.0	14.1	15.6	16.9	8.2	7.8	17.9	7.2	12.5	11.2	6.3	8.4	6.2	10.1	10.7	7.0	7.9	12.5	9.1	8.6	12.5	9.6	8.9	9.8	12.5	14.2	7.6	11.0	12.6	7.9	15.2	9.5	10.2	13.7	5.3	8.2	12.9	13.5	16.7	8.6	11.5	13.2	16.8	8.5	25.0	15.2	9.2	2.5	18.7	10.7	14.0	6.6	15.8	13.0	16.1	7.5	6.0	9.0	15.0	10.3	11.3	17.1	11.2	16.6	8.3	10.6	7.5	13.7	19.8	9.1	6.5	15.4	11.0	8.4	21.0	16.3	6.0	5.5	8.2	6.2	11.2	8.2	8.3	7.9	6.7	7.1	8.6	8.0	17.9	12.5	7.2	7.8	6.4	6.3	10.7	12.8	10.8	11.5	10.8	11.0	14.1	9.8	12.5	14.4
SDHAF2	"C11orf79, FLJ20487, PGL2, SDH5"	ENSG00000167985	"Succinate dehydrogenase complex assembly factor 2"	Q9NX18	11	61430042-61447529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039464, HPA039732"	Supported		Approved	Nucleoli,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoli	"HPA039464: AB_10962146, HPA039732: AB_10962868"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-3)"	"unprognostic (4.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.48e-2)"	23.7	33.0	22.2	22.4	27.2	34.1	24.8	19.9	33.8	20.5	22.1	23.4	21.0	22.3	23.3	33.5	25.3	25.8	21.1	32.5	20.8	26.9	26.8	39.1	19.9	36.7	24.3	25.0	25.7	22.7	23.3	38.4	26.7	25.2	26.1	24.9	32.0	28.1	21.5	31.4	22.9	27.9	26.6	20.8	32.2	24.3	19.2	21.1	36.1	27.0	20.2	30.9	24.0	19.2	31.3	23.2	44.6	25.4	32.7	43.7	26.7	15.3	22.0	13.1	9.1	19.0	15.5	10.2	11.9	17.2	16.1	12.4	20.6	16.5	15.4	21.8	17.1	16.6	17.0	16.9	17.3	22.8	16.1	13.3	18.1	29.6	19.8	15.6	18.5	19.2	20.7	17.5	17.1	25.9	15.2	19.9	19.4	33.8	15.9	35.5	20.2	32.4	17.2	16.9	28.5	22.9	22.7	14.0	17.5	16.3	19.1	33.0	29.7	18.7	16.1	16.4	13.3	19.4	14.1	12.3	19.0	19.6	15.9	13.9	17.1	41.9	25.4	44.6	32.4	22.8	38.4	31.3	35.9	34.7	20.3	29.9	39.5	38.4	37.0	32.7	17.9	23.2	43.7	26.7	22.2	27.2	19.9	33.8	20.8	26.9	24.3	25.0	25.2	21.1
SDK1	FLJ31425	ENSG00000146555	"Sidekick cell adhesion molecule 1"	Q7Z5N4	7	3301448-4269000	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.0;BEWO: 9.9;RPTEC TERT1: 8.3;RT4: 10.3;SH-SY5Y: 7.3;U-2 OS: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	28	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011392	Approved		Approved	Cytosol			2700000	Cytosol		"HPA011392: AB_1856648"	"unprognostic (2.39e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-1)"	"prognostic favourable (4.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.37e-1)"	5.8	1.1	2.2	6.1	1.7	1.4	5.8	0.9	3.1	16.6	6.2	1.4	6.8	1.8	6.1	10.9	2.9	4.5	4.8	1.9	3.4	2.2	3.9	0.7	7.0	8.7	1.6	1.4	4.3	22.4	1.5	6.3	2.9	2.1	6.9	2.4	5.6	2.6	9.4	1.8	2.9	4.2	16.5	1.9	16.3	3.6	7.7	1.9	1.8	1.5	3.6	3.4	9.5	13.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.0	1.7	8.0	0.0	0.0	0.0	9.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.8	0.0	0.2	0.0	4.6	0.0	0.3	0.2	4.0	0.0	0.0	1.6	0.0	0.3	0.5	0.6	0.0	0.0	3.9	2.0	0.0	0.0	2.7	0.0	5.6	5.6	0.0	8.3	10.3	5.0	7.3	0.0	0.0	0.0	0.0	2.5	0.2	0.0	12.4	0.0	3.4	0.0	0.0	0.0	0.0	1.6	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.9	3.1	3.4	2.2	1.6	1.4	2.1	1.9
SDR39U1	"C14orf124, HCDI"	ENSG00000100445	"Short chain dehydrogenase/reductase family 39U member 1"	Q9NRG7	14	24439766-24442905	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044294	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044294: AB_10961400"	"unprognostic (2.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.87e-3)"	"prognostic favourable (2.34e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.32e-2)"	19.5	29.3	21.6	12.4	24.1	21.4	15.6	47.7	26.9	13.9	13.5	23.0	17.1	14.8	16.3	16.5	12.0	19.6	10.4	37.1	21.7	18.5	22.2	18.6	11.8	17.0	32.5	19.6	19.2	22.3	17.2	27.9	12.9	22.0	17.2	8.7	19.5	31.1	21.9	64.2	16.2	14.9	13.9	18.8	22.4	16.5	15.2	29.8	13.3	18.0	17.0	12.2	13.9	14.7	25.8	30.6	17.2	19.5	27.5	24.5	15.6	10.9	18.2	12.9	15.1	18.0	13.9	13.2	6.5	8.2	13.5	15.6	14.1	13.7	14.8	16.0	6.6	19.1	11.5	14.5	5.9	20.1	20.2	12.9	13.5	35.8	8.8	11.8	13.1	15.4	17.5	9.6	13.9	14.3	11.6	12.7	13.1	19.1	19.4	19.1	12.4	16.9	25.0	6.7	10.3	23.6	13.7	22.6	19.6	15.9	28.4	13.9	19.6	17.5	7.6	4.2	14.1	12.2	8.0	21.8	13.7	17.7	11.0	15.0	11.2	17.2	19.5	11.5	21.9	11.6	21.0	25.8	16.6	17.1	21.9	25.2	23.7	24.5	6.0	27.5	9.5	30.6	19.3	15.6	21.6	24.1	47.7	26.9	21.7	18.5	32.5	19.6	22.0	29.8
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 276.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.4;SK-BR-3: 3.3"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"myeloid DC: 12.8"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 12.8"	"Low region specificity"	"Detected in single"							HPA039230	Uncertain		Approved	Mitochondria,Cytosol				Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favourable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	0.9	0.9	2.2	1.4	5.9	0.5	0.4	0.6	2.1	0.5	0.9	0.8	0.0	0.7	0.4	0.2	0.2	0.2	1.4	0.2	1.7	2.5	0.2	276.9	0.6	0.6	4.2	0.7	0.3	0.4	0.1	0.0	1.0	2.8	0.3	0.8	1.3	0.3	0.2	0.2	0.2	0.7	0.3	1.3	0.5	0.9	0.3	0.8	0.1	0.3	0.0	0.3	0.8	0.0	0.0	12.8	0.6	0.8	0.2	0.0	0.3	0.0	0.4	0.2	1.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.2	0.4	2.3	0.0	0.4	0.0	0.0	0.0	0.5	0.5	1.3	0.6	0.6	0.1	0.8	5.4	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	1.4	0.1	0.4	0.8	0.9	0.0	0.8	0.1	0.2	0.5	0.1	0.1	1.6	3.3	0.7	1.2	1.7	0.6	0.0	0.9	1.1	0.3	0.7	0.4	0.2	1.1	0.8	0.3	0.1	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.6	0.2	0.1	1.3	0.0	0.3	2.2	5.9	0.6	1.6	1.7	2.5	4.2	0.7	2.8	0.8
SDSL	"cSDH, SDS-RS1"	ENSG00000139410	"Serine dehydratase like"	Q96GA7	12	113422237-113438276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.2;MCF7: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 13.2;monocytes: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005740	Approved		Approved	Cytosol				Cytosol		"HPA005740: AB_10601486"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-2)"	"prognostic favourable (8.58e-4)"	"unprognostic (2.93e-1)"	"prognostic favourable (3.09e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.33e-2)"	3.1	15.3	4.2	3.8	5.1	1.4	2.8	1.5	7.1	2.6	7.1	5.5	6.2	10.0	2.5	9.7	1.3	4.6	5.2	7.2	3.6	6.1	15.5	53.2	2.8	2.8	9.5	4.2	4.6	15.3	5.0	7.6	3.1	7.8	4.2	5.0	4.6	4.9	4.5	2.1	0.7	7.8	2.9	8.8	3.0	5.2	7.0	2.6	1.5	20.3	1.3	1.6	4.0	1.5	1.1	13.2	0.3	7.1	1.3	0.2	1.7	3.5	14.0	1.9	5.8	0.4	0.8	1.4	2.0	0.5	2.2	1.8	5.9	3.8	0.1	10.5	3.3	3.6	0.9	4.7	0.7	8.4	3.5	9.0	3.4	2.5	11.8	1.1	22.2	1.9	6.7	5.4	8.0	3.2	6.9	2.7	2.6	38.0	0.0	4.5	2.0	6.0	0.0	2.9	6.7	5.7	4.4	0.6	0.2	8.6	9.8	8.3	12.0	10.2	2.9	2.7	5.2	11.9	1.8	0.6	0.5	0.1	11.4	3.7	3.3	0.1	6.5	0.0	0.0	7.1	0.0	1.1	0.0	0.0	13.2	0.1	0.0	0.0	0.3	1.3	0.9	12.8	0.2	1.7	4.2	5.1	1.5	7.1	3.6	6.1	9.5	4.2	7.8	2.6
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77086716-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 90.8;TIME: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 71.8"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021463: , HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	40.8	34.0	25.4	25.3	39.1	33.4	40.6	42.3	33.2	27.7	11.1	21.9	12.2	13.3	15.8	18.9	18.8	15.9	21.2	18.2	27.0	19.5	25.1	15.8	38.4	25.8	31.6	20.6	12.6	18.3	17.3	18.6	49.3	22.5	10.8	10.5	24.2	21.4	12.9	51.0	11.9	12.2	16.2	25.8	33.9	18.4	35.4	24.4	10.0	24.0	14.4	26.0	15.7	14.7	2.4	2.3	71.8	6.2	1.5	2.0	1.9	11.7	8.6	15.2	23.3	6.4	7.9	5.4	10.7	9.2	12.6	10.9	11.4	7.7	31.4	21.5	14.7	4.5	6.7	10.4	16.4	5.8	6.1	16.4	6.6	14.8	10.8	3.3	7.7	11.1	4.2	10.5	11.0	90.8	10.0	26.5	17.7	5.9	5.7	4.4	5.5	7.8	4.4	24.4	23.3	21.4	4.7	11.7	9.1	11.8	6.2	6.6	5.2	3.6	56.7	14.3	13.5	7.8	7.6	15.2	11.9	16.5	6.2	3.4	4.2	4.2	3.2	9.2	0.7	5.5	0.6	2.4	0.7	0.5	2.3	1.2	0.8	0.5	71.8	1.5	6.2	0.8	2.0	1.9	25.4	39.1	42.3	33.2	27.0	19.5	31.6	20.6	22.5	24.4
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396857-30425317	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 43.0;liver: 112.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.3;hTCEpi: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.1"									HPA064466	Approved		Supported	Nucleoplasm,Cytosol			190000	Nucleoplasm	Cytosol	"HPA064466: "	"prognostic favourable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	1.9	1.2	13.6	1.9	14.2	2.4	22.7	7.3	15.0	2.2	5.7	12.6	7.3	10.1	2.4	43.0	8.0	2.3	4.3	1.1	10.8	10.4	3.6	112.3	1.8	2.1	16.1	10.4	1.3	1.9	3.7	5.0	1.5	10.6	25.7	1.4	24.2	4.0	7.8	1.0	2.9	13.5	2.4	8.9	1.0	3.4	1.2	10.4	1.1	4.3	0.6	2.7	1.8	2.9	0.8	0.9	0.5	0.2	0.1	7.1	1.5	9.9	2.4	2.0	2.7	3.0	7.5	0.1	8.1	6.5	4.8	5.0	0.6	6.7	0.2	2.4	9.8	7.7	1.2	38.3	5.3	0.9	1.9	0.2	2.4	3.6	4.1	0.0	2.6	5.2	20.9	4.4	7.9	12.0	0.0	0.2	9.6	1.7	1.0	0.2	0.0	3.4	0.4	3.5	0.2	8.5	3.3	1.2	1.4	5.0	1.1	4.5	6.5	0.1	18.2	6.7	4.3	2.7	4.9	0.1	0.0	0.3	14.7	0.0	5.3	0.1	0.2	0.4	0.9	0.2	0.4	0.8	2.6	0.6	0.1	0.6	7.1	4.7	0.5	0.1	0.1	0.9	1.1	1.5	13.6	14.2	7.3	13.4	10.8	10.4	16.1	10.4	10.6	10.4
SEC14L5	"KIAA0420, PRELID4B"	ENSG00000103184	"SEC14 like lipid binding 5"	O43304	16	4958317-5019158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.1;RPMI-8226: 4.1;SCLC-21H: 6.4;T-47d: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041492, HPA041825"			Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA041492: AB_10794519, HPA041825: AB_10794526"	"unprognostic (1.90e-3)"	"unprognostic (4.08e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.33e-3)"	"unprognostic (8.71e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	1.1	1.7	7.4	1.3	17.5	1.5	1.2	2.2	22.1	2.8	1.7	29.4	0.0	1.4	0.9	1.2	2.0	2.2	1.1	7.5	13.5	6.1	1.1	0.8	1.0	1.4	25.8	8.8	1.7	1.8	0.8	1.7	1.3	15.2	1.7	2.1	0.3	1.9	1.1	11.0	2.9	1.1	0.9	25.2	1.2	3.7	1.4	15.6	0.0	0.9	0.5	1.7	0.9	0.4	0.1	0.4	1.6	0.0	0.1	0.2	2.9	0.0	0.4	0.6	0.3	0.6	4.1	0.5	0.1	0.0	0.1	0.0	0.5	0.2	0.2	0.3	0.5	0.6	0.2	0.1	0.0	0.0	0.5	1.9	0.4	1.0	0.2	0.0	0.4	0.6	0.8	0.1	0.1	0.1	0.2	0.4	0.1	0.3	0.0	0.2	1.3	0.3	0.1	0.4	4.1	0.3	0.1	6.4	0.2	0.4	0.3	0.4	4.2	0.0	0.5	0.2	0.4	0.3	0.0	0.2	0.0	0.2	1.1	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	1.6	0.1	0.0	0.4	0.0	2.9	7.4	17.5	2.2	20.0	13.5	6.1	25.8	8.8	15.2	15.6
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818661-82901166	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol			22000	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (2.69e-4)"	41.3	40.6	22.5	28.0	29.2	30.6	34.5	27.4	30.6	46.4	36.0	26.4	39.2	35.7	53.6	50.2	37.7	34.8	36.1	42.8	23.7	23.8	47.3	57.8	33.9	26.6	25.3	25.3	67.1	79.1	42.7	62.7	54.1	36.0	37.2	38.1	32.6	47.8	46.0	38.7	34.1	51.4	46.2	24.5	28.4	35.9	23.3	23.3	35.7	50.0	31.0	39.5	47.1	37.6	29.4	34.6	34.8	36.0	40.5	40.0	30.5	24.8	11.3	32.7	23.1	58.3	72.7	23.8	46.4	52.0	26.1	32.4	19.5	32.0	32.3	20.4	92.5	11.9	32.2	30.7	36.2	32.9	12.8	19.7	19.4	51.1	58.0	21.0	25.1	69.5	39.0	39.9	45.9	42.3	29.9	32.1	46.4	21.8	27.7	17.0	22.4	10.3	20.7	17.7	23.9	42.1	14.4	21.1	23.5	18.4	32.1	29.9	25.0	23.8	43.2	34.4	17.9	30.1	29.0	24.1	10.3	44.4	34.4	25.4	39.5	34.8	31.1	23.3	32.6	34.8	40.0	29.4	29.2	31.8	34.6	24.4	29.3	28.0	9.5	40.5	36.0	28.9	24.0	30.5	22.5	29.2	27.4	30.6	23.7	23.8	25.3	25.3	36.0	23.3
SEC31B	"DKFZP434M183, SEC31B-1, SEC31L2"	ENSG00000075826	"SEC31 homolog B, COPII coat complex component"	Q9NQW1	10	100486642-100519864	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035882, HPA040819, HPA060052"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles, Cytosol"		"HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: "	"unprognostic (1.23e-1)"	"unprognostic (3.13e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.10e-4)"	"unprognostic (8.23e-3)"	"prognostic unfavourable (6.41e-7)"	"unprognostic (2.31e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-4)"	2.8	2.4	3.3	3.2	5.0	6.4	2.6	12.1	11.8	2.7	2.8	5.4	4.3	1.9	3.0	3.5	1.4	2.9	2.6	5.6	3.1	3.6	2.7	3.4	2.4	4.3	3.3	5.6	3.9	0.8	3.9	5.0	2.4	6.3	2.9	2.7	6.1	2.8	2.5	13.6	2.4	2.9	3.2	3.4	4.9	1.9	16.2	3.4	0.0	2.6	5.2	3.6	2.3	1.9	0.9	0.0	0.1	0.2	0.0	2.1	0.1	0.4	0.4	4.5	1.5	1.4	2.5	0.4	0.9	2.0	0.4	1.4	0.4	0.7	1.0	1.3	0.0	0.5	2.4	0.6	1.2	5.5	1.3	2.2	2.9	0.5	1.9	1.6	1.9	3.8	2.3	0.3	2.7	0.8	0.6	2.7	0.1	0.0	2.8	4.9	0.0	0.9	4.3	0.1	1.8	1.4	0.0	0.3	1.5	0.5	0.1	0.9	1.2	0.6	0.0	0.6	0.7	0.4	0.3	2.1	1.0	1.2	0.1	5.3	0.7	0.0	0.1	0.0	0.5	0.2	2.1	0.0	0.0	0.4	0.0	0.9	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	3.3	5.0	12.1	11.8	3.1	3.6	3.3	5.6	6.3	3.4
SELENOF	SEP15	ENSG00000183291	"Selenoprotein F"		1	86862445-86914424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054937			Approved	Nucleoli,Cytosol	"Intracellular and membrane"			Nucleoli	Cytosol	"HPA054937: "	"unprognostic (6.15e-2)"	"unprognostic (6.98e-3)"	"prognostic favourable (6.53e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (8.17e-4)"	"prognostic unfavourable (1.98e-5)"	"unprognostic (1.65e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.34e-2)"	41.5	48.9	34.7	32.4	33.2	27.1	41.4	20.4	33.9	44.3	37.0	28.9	42.7	32.9	34.9	62.0	36.9	36.8	36.1	31.4	33.4	35.8	68.4	85.3	47.8	45.4	36.0	25.1	47.6	38.5	20.6	46.9	65.6	34.3	41.5	37.4	30.8	35.8	33.7	22.0	21.7	51.1	30.2	45.0	58.7	32.3	36.4	29.0	57.0	100.7	22.8	33.7	40.0	29.7	68.9	57.5	44.3	41.8	26.8	41.3	51.1	38.5	26.5	22.1	24.5	72.6	86.4	36.2	48.7	55.7	45.8	46.7	37.4	47.0	47.6	62.5	43.1	24.3	25.0	27.1	54.0	44.4	35.3	48.5	25.3	35.4	45.9	63.3	33.1	55.4	43.0	30.5	46.0	38.5	44.8	49.8	44.4	17.3	46.0	42.6	32.5	36.7	38.5	41.0	46.5	63.5	39.9	28.8	23.8	48.4	44.2	64.1	19.3	55.2	40.1	33.6	25.0	64.6	53.1	30.0	30.4	48.8	19.6	52.4	39.3	44.3	40.0	36.8	32.8	38.4	41.3	56.7	35.8	34.7	39.0	68.9	37.1	37.5	36.7	26.8	41.8	57.5	38.3	51.1	34.7	33.2	20.4	33.9	33.4	35.8	36.0	25.1	34.3	29.0
SELENOK	SELK	ENSG00000113811	"Selenoprotein K"	Q9Y6D0	3	53884410-53891988	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 78.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 78.6"	"Low region specificity"	"Detected in all"							HPA008196	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA008196: AB_1856665"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.85e-1)"	"prognostic favourable (7.18e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-2)"	"prognostic favourable (3.76e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.56e-3)"	20.4	33.5	29.2	19.0	30.2	38.8	24.1	19.7	21.7	18.9	20.5	20.9	28.3	17.3	15.8	49.4	15.0	16.3	17.1	43.2	25.3	26.2	27.6	38.5	18.0	15.1	32.8	16.8	24.8	72.6	20.0	33.0	18.4	27.9	19.3	22.1	27.3	34.2	20.6	41.0	11.5	20.4	16.7	30.1	16.9	18.4	16.8	27.4	8.7	37.7	18.6	20.3	20.2	18.7	12.4	13.4	78.6	10.9	9.9	15.2	15.4	8.6	5.9	12.9	9.6	19.9	12.2	15.2	12.5	14.6	14.8	18.3	13.2	13.3	13.1	5.6	8.1	5.4	14.4	8.3	13.6	22.9	20.4	8.1	26.5	31.2	17.7	10.7	19.7	7.0	14.8	10.7	14.6	13.3	7.9	35.5	14.3	9.8	6.9	13.1	13.4	22.2	4.5	8.1	24.4	18.5	15.1	7.0	20.2	8.0	11.9	12.4	7.8	17.6	8.4	10.1	11.6	25.0	17.6	24.5	28.7	11.5	15.2	14.1	15.1	78.6	8.9	21.9	15.2	9.4	14.6	12.4	14.1	15.1	7.5	9.9	12.3	14.1	19.6	9.9	10.9	13.4	14.3	15.4	29.2	30.2	19.7	21.6	25.3	26.2	32.8	16.8	27.9	27.4
SELENOM	"SELM, SEPM"	ENSG00000198832	"Selenoprotein M"	Q8WWX9	22	31104772-31120069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 39.6;BJ hTERT+: 38.0;HHSteC: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 23.0;MAIT T-cell: 29.7;memory B-cell: 32.4;memory CD4 T-cell: 38.3;memory CD8 T-cell: 27.4;naive B-cell: 24.2;naive CD4 T-cell: 51.6;naive CD8 T-cell: 30.4;T-reg: 34.7"	"Group enriched"	"Detected in all"	6	"B-cells: 32.4;T-cells: 51.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008667, HPA019601"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"		110000	"Nucleoplasm, Cytosol"		"CAB008667: AB_1622762, HPA019601: AB_1856666"	"unprognostic (5.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.51e-3)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (2.55e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.19e-2)"	35.9	19.5	19.8	31.3	20.6	2.4	33.4	13.5	20.8	83.5	66.2	9.1	38.3	22.0	67.5	34.2	53.4	46.1	67.2	25.5	19.1	20.6	19.2	6.6	18.2	35.1	20.7	11.7	49.9	38.1	18.1	27.2	22.1	15.9	59.5	10.7	41.4	57.3	89.1	29.4	11.6	24.0	76.2	14.1	18.2	35.2	21.9	8.8	1.4	45.7	12.2	12.8	92.5	36.1	32.4	1.3	2.4	7.5	7.5	51.6	21.9	3.2	6.7	1.9	11.2	18.7	22.0	21.9	39.6	38.0	18.5	13.4	0.2	0.5	0.4	8.2	23.2	0.3	1.8	2.4	1.2	1.7	6.7	0.7	2.1	3.3	50.1	0.0	3.5	21.3	7.2	8.8	3.3	2.3	0.6	3.8	4.6	1.7	0.1	0.4	2.5	7.1	0.0	0.0	4.5	2.9	0.0	4.3	9.5	12.3	11.0	0.1	15.2	0.2	8.0	5.6	15.8	20.6	0.0	3.5	1.6	0.2	22.3	0.0	3.6	2.4	2.2	0.9	23.0	3.8	29.7	32.4	38.3	27.4	1.3	24.2	51.6	30.4	1.6	7.5	7.5	0.4	34.7	21.9	19.8	20.6	13.5	20.8	19.1	20.6	20.7	11.7	15.9	8.8
SELENON	"MDRS1, RSMD1, RSS, SELN, SEPN1"	ENSG00000162430	"Selenoprotein N"	Q9NZV5	1	25800176-25818224	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Desmin-related myopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058076	Approved		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA058076: "	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-1)"	"prognostic favourable (2.23e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (3.40e-5)"	"unprognostic (1.94e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.56e-3)"	"unprognostic (5.89e-2)"	41.4	27.2	26.3	26.4	24.8	12.4	53.6	22.0	29.7	32.2	21.9	26.5	26.3	14.3	30.7	20.4	25.4	34.3	27.4	29.3	26.3	16.3	33.0	15.1	35.2	47.8	19.2	18.2	35.3	39.9	23.0	23.7	31.6	22.0	37.5	17.8	30.0	29.1	35.0	30.0	18.0	16.5	45.8	21.0	29.1	24.4	11.6	19.1	10.7	31.4	17.6	16.8	26.1	28.0	1.7	2.1	5.9	3.3	0.7	2.6	1.0	11.9	11.5	38.4	32.8	25.0	44.0	13.0	14.5	22.0	16.2	13.0	2.9	12.7	0.0	9.7	21.9	11.7	10.0	15.4	12.4	12.7	7.7	11.7	4.4	3.6	18.1	2.4	27.9	46.8	10.4	16.9	8.5	50.5	4.1	1.7	15.2	6.1	0.5	3.5	14.4	7.9	10.3	16.7	1.4	6.6	3.4	8.0	13.6	9.2	8.4	12.2	8.4	8.3	42.0	16.5	11.3	30.1	8.5	1.4	0.0	0.3	22.8	3.7	19.8	5.9	3.3	3.8	1.8	2.6	1.1	1.7	1.7	1.3	2.1	1.1	2.6	1.6	0.5	0.7	2.5	0.3	1.7	1.0	26.3	24.8	22.0	29.7	26.3	16.3	19.2	18.2	22.0	19.1
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690667-169711698	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 227.5;lymphoid tissue: 77.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.3;EFO-21: 7.1;MOLT-4: 13.4;U-266/70: 25.2;U-698: 11.7;U-937: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol			8100000000	Cytosol		"CAB002144: AB_563862, HPA051972: "	"prognostic favourable (3.76e-4)"	"prognostic favourable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favourable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favourable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavourable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"	6.9	0.9	2.0	25.1	4.6	30.3	1.5	1.1	2.5	0.9	1.4	1.1	0.0	0.4	1.0	1.1	4.2	3.2	5.4	4.1	2.5	2.2	2.3	2.5	11.4	77.8	5.2	0.2	0.8	1.0	10.7	7.9	3.4	2.7	1.2	1.3	3.8	12.1	0.1	0.9	0.8	8.8	2.9	5.2	67.7	1.7	1.0	2.3	43.8	1.9	1.3	64.0	8.1	6.1	40.4	40.7	227.5	49.7	130.8	69.5	90.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	7.3	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.0	0.9	0.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.8	13.4	0.1	0.0	0.2	5.1	0.1	0.3	4.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	25.2	0.0	11.7	1.3	7.3	0.1	170.8	49.7	88.6	16.5	11.2	4.5	33.8	30.7	17.0	40.7	40.4	69.5	39.6	227.5	130.8	4.5	32.8	52.7	90.1	2.0	4.6	1.1	2.5	2.5	2.2	5.2	0.2	2.7	2.3
SEM1	"C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1"	ENSG00000127922	"SEM1, 26S proteasome complex subunit"	"P60896, Q6ZVN7"	7	96481626-96709891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA020429, HPA072648"	Uncertain		Approved	Cytosol				Cytosol		"HPA020429: AB_1859527, HPA072648: "	"unprognostic (5.41e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (2.52e-4)"	"unprognostic (4.55e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (8.00e-5)"	44.1	58.5	33.3	38.6	48.7	23.1	29.0	25.0	36.3	29.6	48.4	16.8	44.0	41.5	33.5	44.1	45.4	24.0	29.5	69.9	34.8	27.9	34.7	91.6	24.3	28.2	31.7	31.8	45.7	43.6	14.8	51.2	63.5	32.2	32.2	27.8	22.0	43.4	34.5	109.5	34.2	39.0	42.1	43.8	25.0	40.0	52.5	28.8	28.8	28.7	61.8	28.0	31.5	34.0	50.6	94.9	36.7	65.7	42.0	79.0	48.9	62.6	37.0	51.6	53.6	22.1	19.3	27.8	51.2	25.2	21.6	27.1	33.5	52.2	41.4	127.4	24.9	32.5	43.2	34.6	30.7	48.1	32.6	49.6	54.5	52.0	20.2	73.3	37.1	24.5	27.1	32.3	33.1	28.8	64.2	51.1	21.9	79.4	82.7	103.9	69.8	33.9	32.2	66.5	48.9	30.6	62.4	42.5	53.8	95.7	80.4	52.2	22.9	55.9	59.2	42.7	74.3	78.8	63.9	32.2	86.3	119.6	46.6	64.8	58.7	36.7	61.3	15.8	45.5	65.7	43.2	50.6	59.3	53.1	86.3	45.3	46.9	47.2	4.1	42.0	55.4	94.9	79.0	48.9	33.3	48.7	25.0	36.3	34.8	27.9	31.7	31.8	32.2	28.8
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 46.6;T-47d: 52.8;U-2197: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"basophil: 25.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"			"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavourable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	27.1	4.1	3.7	11.9	5.6	0.2	25.1	1.2	6.8	37.0	31.7	7.6	21.6	4.3	26.9	25.1	20.0	7.1	16.4	12.4	5.2	6.1	5.8	1.1	12.3	0.3	13.1	3.0	23.5	1.5	0.0	4.1	5.9	25.5	29.6	14.1	27.4	13.6	19.7	7.3	9.7	10.6	48.8	8.5	8.9	13.3	11.6	6.0	0.2	2.5	15.2	1.5	35.5	14.5	0.0	2.0	25.8	3.2	0.0	0.0	0.8	1.2	15.0	31.3	0.1	7.0	17.1	0.0	10.2	11.8	5.2	6.6	2.4	28.4	0.0	0.4	3.4	6.1	0.1	9.2	8.5	0.0	3.1	1.9	13.5	0.1	8.5	0.1	0.0	7.4	6.1	12.7	12.6	0.1	0.1	0.0	8.7	21.8	0.0	0.0	0.2	2.4	0.0	15.1	0.2	27.1	46.6	0.1	16.1	28.6	7.4	1.7	52.8	0.0	24.5	28.4	13.0	68.4	17.9	0.2	0.0	0.0	10.7	0.0	28.1	25.8	3.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	1.0	1.8	0.0	0.8	3.7	5.6	1.2	6.8	5.2	6.1	13.1	3.0	25.5	6.0
SEMA5B	"FLJ10372, KIAA1445, SEMAG, SemG"	ENSG00000082684	"Semaphorin 5B"	Q9P283	3	122909193-123028605	"Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;heart muscle: 11.7"	"Cell line enhanced"	"Detected in some"		"AF22: 41.4;NTERA-2: 8.0;SH-SY5Y: 11.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066548	Enhanced		Supported	Cytosol				Cytosol		"HPA066548: "	"unprognostic (7.34e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.92e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (1.31e-3)"	"unprognostic (5.96e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-1)"	1.5	1.2	12.0	0.7	12.3	0.3	1.1	0.8	13.6	2.1	1.5	4.3	0.4	1.9	2.8	5.5	1.5	3.0	4.7	11.7	13.0	3.3	6.1	1.4	2.2	1.1	2.5	3.3	1.3	3.1	1.1	2.5	5.0	2.0	1.8	1.8	6.0	0.9	3.1	1.6	1.2	1.3	3.8	1.7	0.5	0.7	1.1	5.7	0.1	2.2	2.5	1.3	3.3	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	41.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	11.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.0	12.3	0.8	13.2	13.0	3.3	2.5	3.3	2.0	5.7
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 124.1;tongue: 43.4"	"Cell line enhanced"	"Detected in many"		"AF22: 11.7;HUVEC TERT2: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"		290000	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favourable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	3.2	1.9	2.3	1.5	3.0	1.3	3.4	16.8	5.8	4.2	2.6	1.5	0.8	6.7	4.1	3.5	3.2	2.9	3.9	12.7	2.3	3.5	3.0	3.3	1.9	3.4	1.7	3.3	4.8	1.7	1.7	4.3	1.6	2.7	2.8	1.6	3.4	3.1	1.9	124.1	3.4	5.2	3.6	1.1	1.3	1.6	15.0	0.6	0.5	1.3	43.4	2.9	2.2	3.6	0.9	0.6	0.7	0.0	0.1	1.4	0.2	0.7	0.8	11.7	4.5	4.9	1.6	1.0	0.8	0.4	0.8	1.1	0.2	0.5	0.5	3.4	2.7	1.1	1.1	0.4	0.7	1.0	3.4	6.1	0.5	0.9	0.6	0.1	2.3	2.8	1.4	1.0	0.5	20.4	0.5	0.6	1.9	0.4	1.0	0.8	5.2	1.3	7.2	2.6	0.2	0.4	0.3	5.9	7.7	1.1	0.5	0.9	1.3	1.0	9.5	2.0	2.8	2.9	0.4	4.9	0.9	5.0	0.5	0.2	0.7	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.6	0.3	0.2	2.3	3.0	16.8	5.8	2.3	3.5	1.7	3.3	2.7	0.6
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO1/sentrin/SMT3 specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol				Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavourable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	10.3	10.1	16.0	7.6	19.8	13.8	11.6	18.8	20.2	8.7	8.8	13.8	7.8	9.2	9.5	15.4	9.3	9.7	7.0	10.9	15.2	15.1	11.3	14.2	9.5	8.6	14.6	12.0	16.0	9.1	15.6	16.7	13.4	13.9	9.7	9.6	9.1	11.0	10.3	24.6	13.9	8.5	9.2	12.9	9.2	9.4	34.9	17.1	11.0	11.2	7.3	8.9	8.5	9.3	4.2	4.4	7.8	3.2	5.1	3.8	1.9	15.2	3.1	7.6	8.6	13.7	9.3	9.9	7.2	8.1	9.0	9.6	11.6	4.9	8.2	13.5	6.4	8.1	15.8	5.8	13.3	6.1	7.5	5.6	6.4	6.9	7.3	8.2	3.7	5.7	8.7	5.1	6.2	6.2	6.6	11.8	7.7	7.6	6.9	9.1	28.1	5.3	8.2	10.4	13.7	4.9	5.1	7.9	8.8	5.9	13.2	11.0	18.1	11.0	3.9	6.0	6.5	10.9	11.2	13.6	16.2	15.2	9.8	8.8	8.1	7.2	3.0	5.4	3.7	2.8	3.8	3.0	3.1	3.0	2.2	4.2	3.7	3.6	7.8	5.1	3.2	4.4	2.7	1.9	16.0	19.8	18.8	20.2	15.2	15.1	14.6	12.0	13.9	17.1
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO1/sentrin specific peptidase 6"	Q9GZR1	6	75601509-75718278	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (2.83e-5)"	"unprognostic (1.72e-1)"	25.9	20.0	24.3	21.8	24.5	27.1	25.9	35.0	24.3	32.5	27.7	23.5	24.9	16.8	37.7	21.2	21.0	27.4	21.5	20.0	22.8	19.8	24.1	22.5	22.5	21.1	29.6	20.3	38.7	21.8	40.1	44.2	26.8	27.0	27.7	21.8	23.0	20.4	25.7	27.8	22.0	24.1	43.0	27.2	24.7	21.3	26.1	28.6	28.5	34.8	15.8	23.9	27.1	34.0	9.9	10.9	19.4	13.1	9.8	11.2	5.5	10.7	11.3	25.7	18.4	20.0	26.7	19.1	19.4	21.7	16.4	20.6	15.5	10.4	18.3	18.4	22.4	13.8	24.1	12.9	25.5	26.8	20.8	27.7	13.6	14.4	27.8	24.0	20.4	20.6	21.6	15.4	34.4	27.1	33.4	20.3	20.1	13.1	9.5	13.0	15.6	9.6	18.0	13.6	26.6	17.6	16.1	22.5	23.2	16.6	14.7	16.8	13.2	23.0	22.6	14.7	16.1	7.5	20.0	23.3	23.1	14.6	7.4	23.0	15.5	5.2	7.4	19.4	7.7	7.9	11.2	9.3	7.8	10.2	8.7	9.9	11.2	9.9	14.7	9.8	13.1	10.9	6.5	5.5	24.3	24.5	35.0	24.3	22.8	19.8	29.6	20.3	27.0	28.6
SENP7		ENSG00000138468	"SUMO1/sentrin specific peptidase 7"	Q9BQF6	3	101324205-101513241	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027259	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA027259: AB_1856679"	"unprognostic (1.50e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.44e-2)"	"prognostic favourable (4.23e-4)"	"unprognostic (1.38e-3)"	"unprognostic (9.25e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.08e-3)"	"unprognostic (3.27e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.23e-2)"	17.0	9.0	11.0	19.1	14.5	19.5	16.5	35.5	19.5	21.7	13.1	11.8	8.2	6.4	24.3	15.2	11.9	18.6	12.8	10.0	13.2	9.1	10.5	7.7	11.5	19.0	12.9	10.8	27.9	15.9	22.4	24.4	17.0	18.7	15.1	10.0	9.2	10.2	11.1	11.1	18.6	13.8	16.0	17.3	14.1	13.6	7.9	16.8	32.1	16.0	9.4	15.4	17.2	14.0	6.8	3.2	24.5	4.1	6.2	7.6	3.8	6.9	4.7	23.4	12.9	4.5	6.9	4.3	4.1	3.0	6.8	8.4	3.1	6.5	5.4	6.3	3.9	7.1	7.3	3.7	13.7	10.0	2.1	9.8	3.7	4.2	3.7	5.6	9.6	5.2	6.8	3.4	7.8	9.7	8.0	13.9	6.4	4.6	10.3	6.6	4.8	5.1	11.6	6.2	4.9	8.1	4.1	9.1	7.0	3.8	3.8	5.1	6.3	7.6	7.9	9.5	5.8	3.1	4.0	9.9	5.9	12.7	3.3	7.5	7.7	24.5	4.1	3.8	4.2	3.6	5.2	4.2	5.6	4.2	3.2	6.8	7.6	5.1	12.6	6.2	3.8	2.8	4.5	3.8	11.0	14.5	35.5	19.5	13.2	9.1	12.9	10.8	18.7	16.8
SEPT11	FLJ10849	ENSG00000138758	"Septin 11"	Q9NVA2	4	76949703-77040384	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Approved		Approved	Cytosol			6500000	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (1.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.70e-5)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"prognostic favourable (2.40e-4)"	"unprognostic (5.70e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	39.9	6.4	25.0	12.1	36.6	3.2	28.0	24.8	49.7	21.1	22.8	9.9	7.8	10.1	16.7	12.2	10.9	11.1	21.8	14.6	17.2	13.7	25.5	16.0	18.8	10.3	11.4	27.1	10.2	10.4	7.8	5.7	39.1	14.3	12.3	19.5	7.9	8.5	13.1	17.4	6.7	16.2	19.2	10.5	11.6	11.5	4.5	13.9	2.7	10.1	5.9	10.3	15.9	16.8	2.7	12.0	18.2	3.8	21.2	6.9	3.7	12.7	5.2	50.1	44.5	30.0	24.0	14.4	74.4	57.6	16.9	23.9	9.5	9.4	0.3	15.5	89.6	5.4	16.5	11.0	26.4	16.6	5.5	25.1	6.9	6.8	26.2	13.4	10.7	30.4	5.2	24.4	9.2	25.4	10.3	7.1	49.8	7.4	17.7	0.4	16.8	2.7	20.9	57.0	1.4	9.5	14.0	17.2	12.8	14.5	8.2	11.8	7.5	5.4	27.6	56.8	17.0	27.8	13.7	4.3	3.4	0.1	21.6	1.4	11.5	6.6	1.4	18.2	5.1	1.2	3.1	2.0	5.8	6.9	4.5	2.7	2.2	5.9	0.4	21.2	3.8	12.0	3.2	3.7	25.0	36.6	24.8	49.7	17.2	13.7	11.4	27.1	14.3	13.9
SEPT5	"H5, HCDCREL-1, PNUTL1"	ENSG00000184702	"Septin 5"	Q99719	22	19714464-19724224	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.2;parathyroid gland: 86.4"	"Cell line enhanced"	"Detected in many"		"K-562: 65.7;THP-1: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"eosinophil: 11.9;neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	46	"granulocytes: 11.9"									"CAB016120, HPA029095, HPA063885"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"			1600000	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB016120: AB_628240, HPA029095: , HPA063885: "	"unprognostic (4.07e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavourable (6.87e-6)"	"unprognostic (3.39e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.30e-2)"	4.2	6.4	60.7	2.3	62.9	12.5	5.1	31.2	86.2	12.2	3.0	5.5	1.1	2.2	7.4	17.0	15.0	14.1	5.5	50.9	52.9	14.6	2.0	1.1	3.7	3.0	12.4	38.7	9.0	5.5	86.4	11.1	4.4	14.9	4.3	2.7	5.3	3.6	4.0	2.8	42.9	2.5	6.4	3.6	2.2	3.4	6.2	9.5	1.9	6.7	4.1	3.1	3.5	5.6	0.0	0.2	11.9	0.1	0.0	0.2	6.3	0.1	3.0	12.0	18.5	1.1	3.9	0.1	4.6	5.8	5.2	3.0	0.2	1.6	0.4	1.8	10.2	1.7	8.7	1.7	2.6	3.1	1.0	0.2	0.6	0.0	4.8	0.2	12.7	5.2	2.1	1.7	0.7	2.1	65.7	0.1	8.1	1.2	1.3	7.3	1.6	3.2	13.3	0.3	2.0	0.3	0.4	19.2	15.6	0.6	0.9	0.8	4.8	21.1	0.8	13.7	18.4	0.5	0.9	1.3	0.0	0.1	1.7	0.6	4.4	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	4.4	0.0	0.0	0.2	0.0	6.3	60.7	62.9	31.2	86.2	52.9	14.6	12.4	38.7	14.9	9.5
SEPT6	"KIAA0128, MGC16619, MGC20339, SEP2, SEPT2"	ENSG00000125354	"Septin 6"	Q14141	X	119615724-119693370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 145.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 56.9;REH: 52.4;SH-SY5Y: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Supported		Approved	Cytosol			10000000	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (6.35e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.24e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.60e-2)"	5.1	39.1	6.9	34.0	6.5	20.6	5.6	23.6	13.1	6.1	22.5	3.8	5.6	5.4	6.7	7.2	9.5	7.3	9.9	8.8	6.7	17.2	8.2	9.8	7.0	42.9	9.5	6.9	6.0	2.2	3.4	5.5	14.1	13.3	6.5	7.3	8.4	12.4	16.7	2.3	3.8	17.6	9.3	5.4	31.8	9.5	24.7	3.3	145.4	4.3	4.5	43.8	9.8	5.3	24.3	22.6	13.0	12.9	27.5	38.5	16.8	1.2	2.0	7.6	13.7	0.7	1.6	10.8	3.7	8.3	6.3	10.9	0.6	2.8	25.3	2.9	4.7	0.7	11.9	2.4	4.4	15.4	2.7	11.2	4.1	4.4	1.8	12.6	5.9	2.8	0.5	5.0	0.1	9.2	8.2	13.6	3.7	0.9	56.9	7.1	8.0	6.1	52.4	6.3	20.5	6.7	1.3	3.4	79.9	9.7	3.5	4.1	4.8	6.5	5.7	1.7	3.5	5.5	0.9	6.8	2.7	33.5	0.1	13.4	1.2	9.8	5.6	13.0	22.3	9.4	23.3	24.3	28.4	25.6	12.0	22.9	30.5	26.0	4.4	27.5	12.9	22.6	38.5	16.8	6.9	6.5	23.6	13.1	6.7	17.2	9.5	6.9	13.3	3.3
SEPT7	"CDC10, CDC3, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Enhanced	"Nucleoli,Actin filaments,Midbody,Cytosol"			16000000	"Actin filaments"	"Nucleoli, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	35.5	28.5	89.0	26.8	77.8	31.9	29.5	41.9	81.5	35.1	28.7	54.3	11.5	15.7	37.8	36.2	31.7	25.4	34.2	47.5	86.4	58.1	24.3	21.5	28.3	38.8	79.6	66.2	42.8	11.2	22.9	31.9	41.0	72.0	28.4	28.2	9.6	14.9	29.9	21.7	29.1	20.1	42.6	76.8	29.5	18.1	19.3	98.2	33.0	22.6	17.3	41.4	36.9	24.0	40.4	24.0	47.3	24.8	69.1	56.8	48.6	36.6	17.7	45.1	29.6	50.8	52.6	23.1	47.3	43.7	40.4	34.8	27.4	28.5	34.7	32.2	48.1	27.9	31.8	31.5	57.7	23.7	16.7	27.9	24.7	14.8	29.7	33.6	30.9	34.1	24.7	31.7	31.3	42.1	21.9	27.5	65.5	17.1	33.9	56.5	48.3	25.0	35.1	42.9	19.9	39.1	27.4	24.2	42.5	33.0	42.6	28.3	31.4	37.3	35.5	40.8	48.4	25.0	52.0	32.4	29.5	87.6	26.1	56.3	86.1	47.3	20.7	34.9	55.4	24.0	56.8	40.4	39.6	50.5	24.0	37.4	35.6	44.9	39.3	69.1	24.8	17.2	34.2	48.6	89.0	77.8	41.9	81.5	86.4	58.1	79.6	66.2	72.0	98.2
SEPT8	"KIAA0202, SEP2"	ENSG00000164402	"Septin 8"	Q92599	5	132750817-132807241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 150.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005665, HPA036534"	Approved		Approved	"Actin filaments,Cytosol"				Cytosol	"Actin filaments"	"HPA005665: AB_1079910, HPA036534: "	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (6.98e-5)"	"unprognostic (2.86e-2)"	"unprognostic (4.30e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.70e-1)"	9.5	8.4	43.1	7.0	49.4	2.9	7.1	27.8	74.9	9.3	10.2	66.8	5.2	10.7	6.7	8.2	13.4	7.0	10.7	13.1	56.3	37.0	9.2	4.3	8.4	5.6	76.1	29.3	10.9	9.4	15.9	5.0	18.5	45.8	8.1	11.5	7.9	13.6	9.3	4.1	20.4	10.5	9.0	150.3	5.9	11.0	2.9	64.1	1.5	9.5	5.2	7.5	18.3	6.2	0.8	2.4	1.1	2.0	0.3	5.2	1.7	17.1	8.3	12.0	24.4	16.7	16.4	39.4	18.6	17.8	17.7	21.7	14.5	12.4	0.1	16.6	17.9	13.3	22.4	30.4	19.5	21.9	16.1	16.8	10.5	12.5	12.2	5.9	24.5	11.8	9.8	8.1	11.6	24.5	25.7	3.3	9.4	16.3	19.1	5.5	6.3	5.4	17.6	14.0	1.4	10.3	44.2	16.1	10.0	15.7	3.6	10.4	32.1	7.8	25.4	19.7	12.9	4.8	13.2	4.6	4.3	0.6	12.6	8.8	14.8	1.1	2.0	0.0	4.1	1.1	4.2	0.8	3.4	5.2	2.4	0.3	0.9	2.2	0.0	0.3	0.5	0.0	3.6	1.7	43.1	49.4	27.8	44.6	56.3	37.0	76.1	29.3	45.8	64.1
SERBP1	"CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1"	ENSG00000142864	"SERPINE1 mRNA binding protein 1"	Q8NC51	1	67407810-67430415	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020559, CAB026297"	Supported		Enhanced	Cytosol			430000	Cytosol		"CAB026297: AB_425924, HPA020559: AB_1856701"	"unprognostic (1.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.59e-1)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.76e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.34e-3)"	38.3	30.4	22.5	35.7	30.0	33.8	36.9	25.4	27.7	35.4	32.8	25.5	28.6	30.9	36.4	35.2	68.4	25.9	39.4	32.6	22.3	19.1	30.6	48.4	27.5	47.9	29.7	18.6	33.5	56.1	52.2	21.8	28.7	25.0	34.8	27.1	23.2	41.8	28.5	87.5	50.5	29.9	42.0	26.8	31.9	31.5	35.8	28.7	48.9	42.6	54.1	41.3	36.0	40.7	34.3	35.4	16.8	30.2	46.7	44.4	33.9	58.5	35.8	38.5	38.2	34.3	31.5	57.0	61.8	24.3	43.0	36.5	69.0	26.2	113.4	46.4	33.4	45.2	60.3	57.9	46.7	50.6	72.5	104.4	67.2	61.1	30.0	84.5	40.1	32.1	39.1	55.2	50.4	46.6	116.3	40.0	34.3	40.8	63.6	51.3	133.8	47.3	73.5	84.5	56.7	33.3	48.9	65.0	45.6	48.0	52.3	56.0	28.6	51.7	48.5	39.5	48.1	56.9	83.1	37.3	47.7	101.8	32.5	80.3	44.1	9.8	27.4	16.8	35.0	30.2	44.4	34.3	35.2	35.3	35.4	33.4	41.4	37.4	9.0	46.7	27.4	32.3	41.7	33.9	22.5	30.0	25.4	27.7	22.3	19.1	29.7	18.6	25.0	28.7
SERGEF	"DelGEF, Gnefr"	ENSG00000129158	"Secretion regulating guanine nucleotide exchange factor"	Q9UGK8	11	17788048-18013162	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037811, HPA037812, HPA074086"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037811: AB_10672726, HPA037812: , HPA074086: "	"unprognostic (2.67e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.82e-2)"	8.2	14.2	30.1	7.5	22.3	4.7	15.2	24.4	31.4	13.1	10.7	9.5	4.3	6.1	11.8	17.7	9.6	13.9	10.3	9.9	28.6	24.1	15.6	12.3	10.0	8.0	27.9	18.1	26.1	17.4	17.7	19.3	4.8	23.0	13.6	11.5	10.1	12.3	17.1	11.8	11.1	6.2	14.4	10.4	7.6	10.1	3.9	10.7	7.8	25.3	8.8	11.8	9.5	15.6	15.4	14.4	8.9	11.8	11.3	22.0	14.1	6.6	7.7	7.3	13.7	12.7	13.1	4.4	5.3	12.0	6.2	8.2	5.5	2.2	6.0	7.0	6.7	8.7	25.9	17.0	5.4	13.1	21.1	9.2	7.0	22.7	14.2	8.1	10.6	11.7	18.7	3.0	13.4	6.7	5.5	11.6	9.5	10.3	7.8	17.7	5.6	9.2	11.3	8.0	6.6	15.1	10.0	17.1	4.0	9.9	9.9	10.0	4.7	7.6	3.4	6.5	7.6	8.4	6.3	8.0	9.6	7.7	10.0	9.4	6.2	7.2	11.8	8.9	21.1	9.3	17.4	15.4	21.3	16.0	14.4	11.1	21.7	19.2	1.2	11.3	9.4	5.9	22.0	14.1	30.1	22.3	24.4	31.4	28.6	24.1	27.9	18.1	23.0	10.7
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443354-122471822	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol				Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	49.0	62.0	72.0	21.6	74.5	31.4	39.6	67.3	96.4	40.4	25.1	61.5	17.0	23.9	36.7	27.8	23.8	27.0	31.6	39.1	75.5	78.4	48.7	58.1	38.9	20.6	91.6	57.7	42.7	24.4	56.4	32.9	47.0	109.2	36.0	25.2	29.7	22.5	37.8	37.4	20.5	27.2	35.4	120.6	28.4	23.1	15.6	57.5	12.9	50.8	13.0	18.7	33.2	22.8	10.0	12.6	44.1	20.4	17.7	20.7	17.4	7.3	9.1	23.1	21.1	87.8	48.2	12.3	38.9	48.8	21.3	33.1	10.6	20.0	4.9	30.6	43.8	14.7	13.6	16.8	32.0	15.8	16.1	14.0	15.5	19.3	39.3	14.0	28.0	50.0	33.0	26.5	36.7	18.4	13.9	28.3	44.0	8.5	6.3	9.3	7.5	11.6	7.7	11.4	11.9	45.9	13.0	12.1	21.9	17.2	19.2	26.3	13.2	19.7	37.4	25.7	11.2	21.0	20.1	21.5	24.0	6.6	34.0	11.4	30.0	44.1	15.0	31.4	16.8	18.8	18.1	10.0	17.6	16.2	12.6	8.7	20.7	17.9	38.9	17.7	20.4	9.9	18.6	17.4	72.0	74.5	67.3	86.9	75.5	78.4	91.6	57.7	109.2	57.5
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256079	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.6;RT4: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: "	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	6.9	21.1	9.0	7.8	11.2	3.0	6.7	5.3	15.6	10.2	16.3	28.8	11.2	5.1	6.9	12.9	9.7	9.6	8.4	4.1	9.5	7.3	5.3	26.3	8.0	9.3	13.4	7.0	9.8	7.8	4.2	5.3	24.7	12.1	20.3	17.5	3.6	9.8	8.4	3.1	10.9	9.5	4.4	9.7	8.3	9.7	18.9	15.0	7.8	5.2	6.7	12.3	9.3	7.7	0.8	4.0	6.2	6.9	0.4	17.5	4.7	5.1	9.2	3.1	2.0	4.3	4.6	9.3	4.2	2.8	1.8	1.9	18.5	26.6	0.8	4.3	5.4	14.9	4.2	11.1	2.7	0.7	2.2	0.6	1.1	9.9	1.6	0.6	1.9	5.2	6.2	4.8	12.6	3.4	1.6	4.4	4.9	8.8	10.3	2.5	4.3	3.2	12.3	2.7	1.4	5.5	25.4	0.2	3.0	3.7	8.7	16.3	3.8	3.2	3.7	5.4	1.5	5.4	5.2	5.7	1.6	13.3	10.2	1.8	22.0	6.2	6.9	4.4	1.6	3.4	1.2	0.5	13.9	4.2	4.0	0.8	17.5	10.5	3.6	0.4	1.0	0.9	4.5	4.7	9.0	11.2	5.3	10.9	9.5	7.3	13.4	7.0	12.1	15.0
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280455-94293271	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	223	"liver: 169.5"	"Cell line enriched"	"Detected in many"	8	"Hep G2: 20.7"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	3955000000	5900000000	Nucleoplasm	Cytosol	"HPA048739: "	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	169.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.1	0.1	0.2	0.0	0.6	0.3	2.0	0.7	0.8	0.7	0.5	0.5	0.6	0.9	0.9	2.5	0.6	2.2	0.3	0.4	0.3	2.4	0.5	1.4	0.9	1.4	2.1	0.7	20.7	0.5	1.7	1.2	0.7	0.5	0.3	0.8	1.1	0.5	1.4	1.1	0.3	1.4	1.1	0.9	0.6	0.9	1.1	0.9	0.5	0.7	1.0	0.9	0.5	0.5	0.2	1.5	0.9	0.5	0.8	0.4	0.7	0.6	1.2	0.5	1.0	1.0	1.9	0.5	0.7	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 43.9;tongue: 15.3"	"Cell line enriched"	"Detected in some"	7	"U-937: 47.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2"					"Low region specificity"	"Detected in all"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol			42000	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: "	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	1.3	0.1	0.0	2.3	0.2	43.9	0.1	0.3	0.1	1.1	0.7	0.0	0.0	0.1	0.2	0.3	3.1	0.1	0.1	5.5	0.0	0.0	0.0	0.2	3.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	4.8	0.2	0.1	0.1	0.0	1.0	0.1	1.3	2.5	0.1	0.1	0.0	2.8	0.1	0.1	0.1	4.0	0.9	15.3	1.5	0.1	1.3	0.3	2.1	3.3	4.2	0.3	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.2	4.2	3.3	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.3	0.1	0.1	1.8	0.3	0.0	2.1	0.1	0.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.1
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1"	"Group enriched"	"Detected in some"	132	"HaCaT: 64.1;hTCEpi: 24.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"			59000	"Nuclear speckles, Cytosol"		"HPA052630: , HPA057129: "		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.1	37.7	0.1	0.0	0.0	0.1	3.1	0.1	70.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	10.9	0.1	0.2	5.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.0	0.1	107.2	54.2	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661963	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;HaCaT: 8.9;SiHa: 5.5;U-2197: 11.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 186.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"			11000000	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: , HPA049988: , HPA055992: "		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavourable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.7	0.2	0.2	0.2	0.0	3.8	0.2	140.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	5.4	0.2	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	1.1	0.0	0.2	13.0	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.2	21.3	3.1	13.1	80.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.1	8.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63969925-64019779	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.6"	"Cell line enhanced"	"Detected in many"		"HL-60: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	12.4	7.4	2.9	9.3	4.2	16.0	6.1	1.3	5.5	7.7	7.4	7.1	0.0	3.7	4.1	4.3	20.6	3.7	13.7	4.5	3.1	3.3	7.1	23.7	8.2	10.1	4.7	4.0	8.1	4.2	1.1	5.0	9.5	7.4	4.2	6.1	3.4	8.1	2.1	4.5	36.6	8.7	4.4	6.0	9.8	4.2	2.9	3.5	4.2	5.0	17.5	11.3	9.6	11.0	5.1	25.3	5.9	20.5	2.1	4.2	5.0	7.4	1.5	1.3	9.2	4.6	6.5	0.6	24.3	23.6	15.4	15.4	0.3	3.4	0.1	8.9	14.5	12.2	0.2	15.4	22.1	10.3	0.3	0.0	2.8	0.8	10.5	37.3	3.2	6.2	13.4	20.8	6.8	16.4	0.2	4.3	10.6	0.6	0.6	4.1	0.5	7.5	0.5	3.4	0.6	6.9	8.5	0.7	0.7	4.8	0.7	8.9	0.3	14.0	25.4	23.6	5.0	2.8	9.7	1.9	0.3	0.0	24.2	21.7	20.3	1.1	20.5	0.8	3.8	16.1	3.4	3.6	3.1	2.3	25.3	5.1	1.7	2.6	5.9	2.1	8.0	13.7	4.2	5.0	2.9	4.2	1.3	5.5	3.1	3.3	4.7	4.0	7.4	3.5
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887266-2903280	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.0;lymphoid tissue: 39.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 66.8;HUVEC TERT2: 14.6;TIME: 15.2;U-266/84: 13.7;U-698: 28.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol			4900000	Nucleoplasm	Cytosol	"HPA030067: "	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavourable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	5.6	5.1	3.3	15.9	4.1	7.2	2.6	3.6	6.7	3.9	2.1	4.4	1.3	1.7	1.9	1.9	4.6	4.1	5.3	4.9	3.4	3.6	2.5	7.6	13.7	39.6	4.8	3.9	3.8	1.3	4.7	4.9	24.5	4.7	2.6	2.9	3.5	7.5	1.3	2.0	1.0	5.5	2.4	7.1	14.4	2.0	4.4	2.0	6.4	4.2	2.1	18.9	3.4	3.8	10.3	6.4	2.9	38.0	18.8	17.9	12.3	0.0	2.8	0.1	0.0	0.2	0.1	66.8	0.5	0.1	0.6	1.0	0.8	5.4	10.9	6.8	0.6	0.0	8.0	0.0	0.6	3.5	0.8	1.0	1.0	1.5	3.9	0.0	0.0	3.0	0.0	1.2	0.0	14.6	4.9	0.1	0.5	0.2	0.0	0.0	9.3	0.0	1.0	0.0	0.1	0.4	0.0	0.4	0.1	6.5	0.0	0.0	0.0	0.1	15.2	0.0	0.1	0.0	0.0	0.0	13.7	28.7	0.0	0.0	0.0	1.7	18.3	0.1	17.9	38.0	14.7	8.3	13.0	16.8	6.1	10.3	12.1	17.5	2.9	18.8	22.0	6.4	13.0	12.3	3.3	4.1	3.6	6.7	3.4	3.6	4.8	3.9	4.7	2.0
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127089-101139266	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 253.6"	"Cell line enhanced"	"Detected in many"		"BJ: 140.2;HUVEC TERT2: 162.7;LHCN-M2: 157.1;TIME: 402.3;U-138 MG: 191.5;U-251 MG: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"NK-cell: 10.8"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 10.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"		14000000	Cytosol		"CAB068501: AB_1642775, HPA050039: "	"unprognostic (5.02e-2)"	"prognostic unfavourable (5.01e-4)"	"prognostic unfavourable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavourable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavourable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (5.88e-8)"	"prognostic unfavourable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (5.51e-4)"	45.5	14.0	1.1	16.7	1.8	0.1	11.4	0.5	1.5	13.3	7.0	3.4	3.3	1.2	6.6	14.4	6.8	9.3	69.6	29.2	1.5	0.6	7.8	65.3	56.3	3.3	4.1	1.8	19.7	24.7	1.4	2.6	253.6	5.9	7.6	0.9	2.3	2.4	6.2	12.4	4.1	2.3	13.5	4.1	5.8	6.6	8.6	2.2	0.6	11.3	3.7	2.8	71.7	18.1	0.2	0.4	0.5	0.2	10.8	0.3	1.0	3.0	2.5	0.0	0.2	32.1	64.0	3.6	140.2	26.5	70.7	61.8	0.3	0.2	0.1	33.6	44.6	0.7	0.0	10.8	73.1	0.1	0.0	0.0	0.2	2.4	64.6	0.0	0.1	25.0	4.3	108.5	57.1	162.7	0.2	0.1	157.1	0.0	0.0	0.0	0.7	1.6	0.0	0.2	0.1	0.2	1.2	0.0	0.0	11.5	3.1	0.3	0.1	0.3	402.3	191.5	8.4	65.2	168.3	0.0	0.1	0.1	47.8	0.0	1.8	0.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.1	0.2	10.8	0.0	0.4	0.0	1.0	1.1	1.8	0.5	1.5	1.5	0.6	4.1	1.8	5.9	2.2
SERPINI1	"neuroserpin, PI12"	ENSG00000163536	"Serpin family I member 1"	Q99574	3	167735243-167825568	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 96.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.6;HeLa: 16.2;Karpas-707: 18.1;U-266/84: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001565, HPA056092"	Enhanced		Approved	Cytosol	"Secreted in brain"		200000	Cytosol		"HPA001565: AB_1079924, HPA056092: "	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (4.25e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.11e-1)"	5.9	8.2	31.9	2.4	27.9	1.3	6.1	3.6	96.0	4.2	2.8	7.1	0.4	1.5	4.3	4.3	3.2	3.9	3.4	6.4	35.9	35.3	14.5	2.5	3.4	2.3	36.9	35.7	4.0	16.3	3.7	10.3	3.5	22.9	5.8	2.5	2.4	9.9	3.6	1.7	2.1	2.5	3.1	51.6	4.1	3.6	7.0	15.9	0.0	5.2	0.3	3.8	3.1	1.6	15.4	4.4	1.0	0.4	6.0	16.0	3.4	0.4	1.9	3.2	0.2	5.9	1.5	0.2	1.1	1.8	0.8	1.3	0.7	3.8	15.6	6.0	0.8	0.8	2.1	2.1	0.8	4.9	4.5	5.3	16.2	6.6	0.4	0.8	0.6	2.2	0.8	0.4	0.7	0.2	9.9	18.1	0.6	1.5	0.4	1.1	2.0	2.4	1.8	0.1	2.0	6.7	0.5	1.3	8.2	2.2	4.3	5.0	6.4	2.4	0.5	3.4	0.3	0.3	5.5	13.7	16.7	11.4	2.9	4.0	1.9	1.0	0.2	0.5	6.2	0.4	4.5	12.7	6.5	6.6	0.3	15.4	4.7	5.7	0.6	6.0	0.3	4.4	16.0	3.4	31.9	27.9	3.6	78.9	35.9	35.3	36.9	35.7	22.9	15.9
SERTAD2	"KIAA0127, Sei-2, TRIP-Br2"	ENSG00000179833	"SERTA domain containing 2"	Q14140	2	64631621-64751005	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019021, HPA020904"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA019021: AB_1856740, HPA020904: AB_1856741"	"unprognostic (1.40e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (4.03e-4)"	"unprognostic (2.15e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.55e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.21e-3)"	"unprognostic (6.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.84e-1)"	14.3	5.5	4.3	11.3	5.5	52.1	10.4	6.4	5.9	12.4	8.6	9.1	5.6	4.6	9.6	7.6	24.7	7.8	8.4	10.9	4.7	3.5	6.7	11.0	11.8	12.5	7.2	4.4	12.1	5.8	8.4	6.2	17.4	6.0	8.6	6.5	10.2	18.4	7.5	10.8	18.8	9.9	9.5	6.7	24.5	7.2	7.4	8.4	53.8	7.6	16.7	25.7	22.0	16.7	5.4	8.8	3.8	3.1	2.6	4.2	1.4	14.3	4.2	8.0	8.0	6.9	17.6	9.2	11.5	11.1	6.8	6.5	10.8	11.0	12.2	6.4	18.8	5.7	5.2	7.0	14.6	1.1	7.9	8.0	4.0	7.8	1.5	7.0	4.1	11.9	9.3	15.7	10.2	4.1	5.0	6.8	15.9	3.4	7.5	7.7	4.4	11.3	6.6	13.7	4.7	9.3	13.2	9.3	3.6	8.1	5.7	14.4	3.8	5.7	12.4	37.2	19.2	21.7	9.3	11.7	4.4	14.1	13.8	13.0	14.5	2.3	2.7	3.8	1.8	2.8	1.1	4.7	1.8	2.0	2.8	5.4	4.2	3.1	3.8	2.6	3.1	8.8	0.9	1.4	4.3	5.5	6.4	5.8	4.7	3.5	7.2	4.4	6.0	8.4
SESN2	"DKFZp761M0212, HI95, SES2, SEST2"	ENSG00000130766	"Sestrin 2"	P58004	1	28259527-28282491	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 22.7;SK-MEL-30: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018191	Uncertain		Approved	Cytosol				Cytosol		"HPA018191: AB_1856750"	"unprognostic (7.05e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (8.97e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	9.2	7.7	7.0	6.8	6.7	32.0	7.6	6.1	11.1	6.1	9.6	3.5	4.6	14.3	7.2	4.0	15.2	6.2	7.6	4.3	4.5	6.1	12.5	18.4	7.7	4.1	8.4	4.5	22.4	10.4	7.5	5.4	9.3	7.6	5.2	8.3	6.9	14.5	4.6	5.8	4.9	12.6	6.2	10.9	5.8	7.2	9.2	4.3	4.8	7.0	4.2	9.7	7.3	14.9	1.9	2.8	6.2	2.7	3.9	9.6	2.5	2.6	1.4	3.5	5.7	5.6	4.4	18.8	5.0	4.6	3.0	3.6	2.0	1.9	2.9	2.1	2.2	2.6	4.0	3.5	2.1	2.6	3.7	1.2	2.0	3.3	18.4	4.4	6.7	14.0	22.7	8.2	19.7	3.4	6.9	14.2	2.8	1.5	1.6	1.2	2.7	2.9	2.5	0.9	6.5	2.0	4.4	1.2	1.3	1.4	1.1	27.3	3.1	6.3	1.9	1.5	4.8	3.5	3.0	18.5	4.6	4.6	3.7	4.5	3.5	0.0	2.3	1.9	9.6	1.9	4.7	1.9	3.4	4.6	2.4	1.4	2.1	4.3	6.2	3.9	2.7	2.8	3.9	2.5	7.0	6.7	6.1	11.1	4.5	6.1	8.4	4.5	7.6	4.3
SESN3	"MGC29667, SEST3"	ENSG00000149212	"Sestrin 3"	P58005	11	95165513-95232541	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 14.6;ASC diff: 24.8;ASC TERT1: 27.1;HSkMC: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037935			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037935: AB_10670534"	"unprognostic (2.72e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.09e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.34e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.42e-2)"	7.3	14.2	22.3	10.4	38.6	11.9	11.6	10.2	20.8	10.3	6.8	11.1	3.3	5.2	9.3	11.7	7.6	7.0	9.9	5.1	15.9	12.9	8.7	6.0	7.2	17.3	12.6	12.0	18.4	3.3	27.7	10.7	6.6	13.9	8.5	5.4	19.7	9.1	4.8	5.4	8.4	10.6	7.6	11.6	12.7	3.9	41.6	14.1	11.3	17.3	4.0	18.3	10.0	7.7	4.2	1.1	1.0	3.5	0.8	4.5	0.8	0.0	0.5	14.6	0.0	24.8	27.1	0.0	0.1	0.0	0.0	0.0	0.6	0.4	3.8	1.7	0.0	2.9	8.8	6.3	0.0	3.1	4.6	1.9	7.7	0.5	0.5	1.6	0.3	14.9	11.1	0.0	3.3	0.5	0.2	0.7	1.2	0.1	1.2	4.5	5.9	0.6	2.8	0.9	0.3	3.3	9.6	1.9	4.1	0.1	0.1	0.8	0.0	5.5	0.1	1.7	3.8	0.3	0.5	0.1	0.0	0.5	0.7	2.0	3.5	1.0	0.8	0.6	0.7	1.7	0.8	4.2	2.3	1.3	0.7	2.7	4.5	1.7	0.8	0.8	3.5	1.1	4.0	0.8	22.3	38.6	10.2	20.8	15.9	12.9	12.6	12.0	13.9	14.1
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"AF22: 9.3;Karpas-707: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.9;naive B-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: , HPA057259: "	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favourable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	10.6	2.9	3.8	13.2	8.7	2.1	9.8	16.0	12.6	16.9	14.6	4.2	19.9	2.5	14.0	17.5	6.6	11.0	7.9	6.8	3.6	3.5	15.0	7.2	9.8	7.0	2.9	7.4	12.8	8.2	9.1	5.1	10.2	3.2	12.2	5.3	14.0	6.9	21.3	14.5	6.6	6.9	19.9	3.7	5.9	9.1	5.5	1.2	3.4	8.4	8.7	8.8	11.9	13.3	7.5	4.3	0.2	1.6	0.0	0.6	0.2	0.0	1.6	9.3	0.0	2.7	0.7	0.6	0.7	1.7	0.9	0.7	0.1	0.0	0.5	0.3	1.0	2.7	1.0	2.9	0.6	0.8	0.4	0.0	1.0	0.6	0.0	0.0	0.0	2.2	1.1	0.0	1.8	0.3	0.0	37.1	0.2	0.5	0.0	0.0	1.3	0.6	3.0	0.0	3.2	3.1	2.1	4.7	2.5	0.0	0.0	0.5	1.3	0.0	0.0	5.5	2.1	0.0	4.3	4.9	0.3	0.0	3.3	0.1	3.1	0.2	0.0	0.0	0.6	1.1	0.0	4.9	0.1	0.5	0.1	7.5	0.0	0.2	0.0	0.0	1.6	4.3	0.0	0.2	3.8	8.7	16.0	12.6	3.6	3.5	2.9	7.4	3.2	1.2
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2"	Q9BYW2	3	47016429-47163967	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favourable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	13.2	10.5	12.2	15.2	15.4	20.0	11.7	22.4	16.4	13.4	14.0	9.1	12.9	9.5	15.8	7.5	10.8	11.4	8.7	8.8	10.6	6.8	11.4	10.3	10.4	11.8	11.7	9.5	16.0	13.4	21.4	16.3	10.7	11.3	12.4	10.9	7.7	12.7	14.8	27.6	12.5	11.5	11.9	9.8	13.8	10.4	12.8	12.8	23.2	15.8	5.5	12.8	16.1	15.5	4.8	2.6	6.0	2.3	7.1	3.9	1.0	11.4	9.0	15.2	7.8	9.1	10.6	6.4	10.6	10.3	12.4	11.3	9.5	7.5	25.3	6.6	14.5	7.0	16.4	10.1	16.8	14.5	6.5	25.9	15.1	7.3	6.8	19.4	15.0	9.1	9.7	12.2	15.2	11.4	16.6	9.6	10.1	6.0	14.2	2.6	11.5	7.5	9.4	14.7	13.1	6.2	15.1	6.6	10.5	17.8	7.0	6.6	7.4	14.4	14.6	13.6	10.2	11.6	16.8	12.2	13.6	25.5	7.9	11.1	7.9	2.4	2.2	5.2	3.9	2.3	2.4	3.7	2.4	3.0	2.5	4.8	3.5	3.0	6.0	7.1	1.9	2.6	1.0	1.0	12.2	15.4	22.4	16.4	10.6	6.8	11.7	9.5	11.3	12.8
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017093: , HPA035574: "	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	18.9	21.9	33.1	18.2	29.1	13.2	40.9	58.0	38.9	21.7	20.7	15.4	22.1	14.0	24.0	27.0	20.7	22.0	18.4	18.3	29.6	13.8	15.4	22.1	26.5	29.8	23.0	30.1	29.7	22.7	25.6	31.4	23.0	25.1	20.6	20.4	16.7	22.3	22.7	16.6	29.0	19.8	24.1	22.8	22.5	18.7	21.3	26.6	21.0	25.9	14.8	24.2	20.4	37.5	3.7	4.0	4.7	2.0	4.3	4.1	1.0	9.8	11.8	24.4	11.0	14.4	15.0	58.1	9.7	13.1	14.1	16.2	11.7	12.2	21.4	5.8	14.1	8.2	22.7	12.8	15.6	15.0	11.3	20.9	19.9	10.9	14.6	15.9	13.9	14.5	20.9	21.3	25.3	14.9	20.4	14.1	12.0	14.4	14.0	13.3	18.4	9.6	16.4	19.2	9.5	11.0	15.8	9.7	15.2	14.1	11.7	8.7	15.6	11.7	17.6	14.8	17.0	8.0	11.5	10.2	12.8	35.7	10.6	11.5	13.9	2.3	2.0	1.7	3.8	1.2	2.5	3.4	2.5	4.1	1.3	3.7	2.4	2.2	4.7	4.3	1.4	4.0	1.0	1.0	33.1	29.1	58.0	38.9	29.6	13.8	23.0	30.1	25.1	26.6
SETD6	FLJ21148	ENSG00000103037	"SET domain containing 6"	Q8TBK2	16	58515479-58521181	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041481, HPA053546"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041481: AB_10804004, HPA053546: "	"unprognostic (1.32e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (3.74e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.73e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.55e-1)"	7.8	11.3	7.7	7.4	8.8	4.3	12.6	18.6	11.8	8.4	7.1	6.6	17.0	7.0	10.2	14.0	11.5	10.3	9.6	8.6	8.8	7.0	11.7	12.1	7.9	7.9	8.9	9.0	9.0	20.0	22.1	17.1	7.0	8.3	12.2	8.2	7.2	15.5	19.7	14.7	14.4	7.8	9.2	7.7	9.2	9.6	10.2	9.7	5.5	13.6	9.5	8.8	7.4	10.3	3.2	3.9	3.8	3.0	8.6	4.9	2.7	1.8	3.7	0.8	7.2	2.8	2.0	13.5	3.1	3.4	4.4	2.5	6.4	3.7	13.5	4.9	3.1	5.7	5.7	4.1	3.2	1.7	20.3	0.6	6.2	11.5	2.9	9.8	6.1	2.5	8.2	3.7	5.6	3.1	10.7	1.7	0.9	6.6	0.2	11.8	15.3	8.3	0.2	1.7	18.3	4.6	0.2	13.5	9.4	13.4	10.2	5.0	6.6	1.2	2.7	1.7	4.8	2.0	5.1	9.3	5.6	10.0	3.4	4.8	3.3	3.8	2.4	0.2	4.6	3.0	3.3	3.2	3.9	4.9	3.9	3.1	4.8	4.8	0.1	8.6	2.9	3.8	3.2	2.7	7.7	8.8	18.6	11.8	8.8	7.0	8.9	9.0	8.3	9.7
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Cell line enhanced"	"Detected in many"		"A-431: 68.6;HaCaT: 108.3;HBEC3-KT: 166.7;hTCEpi: 111.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	Nucleoli,Cytosol	"Secreted in other tissues"		54000000	Cytosol	Nucleoli	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	68.6	11.6	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	36.2	0.6	3.0	0.0	108.3	0.0	166.7	0.0	16.4	0.5	0.0	11.6	12.2	0.0	0.0	0.1	0.0	111.9	0.0	29.3	0.0	0.1	0.4	0.0	14.6	0.0	0.0	0.2	19.3	0.0	0.0	3.8	25.9	15.8	0.0	0.0	16.6	2.9	0.1	7.7	0.1	0.0	0.0	31.7	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261958-41309497	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 105.4;BJ hTERT+ SV40 Large T+: 30.5;HBF TERT88: 43.2;hTCEpi: 39.4;NTERA-2: 31.5;RPTEC TERT1: 64.8;WM-115: 42.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"		1600000	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: "	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favourable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (3.12e-4)"	20.1	3.4	4.6	2.4	7.5	0.3	73.2	10.8	5.6	58.4	6.1	15.2	8.0	3.0	35.6	19.3	9.7	25.9	15.5	43.9	7.8	2.5	30.6	1.5	1.8	0.9	4.5	6.7	12.5	1.5	0.6	0.7	9.9	24.1	12.8	7.8	19.3	73.2	27.1	1.9	20.8	5.4	21.4	2.8	5.0	11.0	11.1	13.7	0.0	3.3	18.4	5.1	10.9	41.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	11.6	0.3	10.6	0.6	2.2	20.0	105.4	30.5	29.1	0.0	2.6	0.0	0.1	0.1	0.1	1.6	8.0	43.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.1	1.8	39.4	3.0	3.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	31.5	0.0	0.0	2.4	0.0	64.8	0.0	0.6	2.8	0.8	0.0	6.1	0.0	0.3	0.2	0.0	3.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	7.5	10.8	5.6	7.8	2.5	4.5	6.7	24.1	13.7
SFSWAP	"SFRS8, SWAP"	ENSG00000061936	"Splicing factor SWAP"	Q12872	12	131711081-131799737	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039362, HPA040063"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039362: AB_10794089, HPA040063: AB_10795413"	"unprognostic (1.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.33e-8)"	"unprognostic (7.50e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	20.2	15.0	17.7	23.2	24.0	47.1	17.9	31.1	23.8	16.6	15.7	31.1	11.6	20.4	25.7	15.1	15.7	15.7	16.5	11.9	20.5	15.9	15.7	12.3	16.4	20.7	27.0	17.2	21.4	19.8	19.5	18.0	16.6	16.6	14.7	9.9	16.9	22.1	15.5	27.4	30.0	19.0	17.3	21.1	23.7	18.4	17.5	26.4	21.9	17.1	15.9	16.8	16.7	20.5	6.6	11.0	8.5	6.4	8.4	5.5	2.6	13.7	12.4	8.8	9.3	7.1	5.9	19.8	10.7	7.4	12.7	8.7	12.1	6.7	16.9	10.0	7.9	12.9	12.4	9.8	7.4	5.2	19.5	15.3	6.7	14.1	7.6	19.7	15.2	6.6	11.3	11.4	13.8	7.8	21.2	6.7	5.6	17.2	16.6	30.0	23.0	20.7	19.4	8.9	13.3	7.3	10.1	13.8	15.6	10.1	8.5	12.7	12.3	15.5	10.0	10.5	13.8	8.1	11.8	19.3	21.0	17.1	10.4	13.6	14.0	3.0	6.4	2.6	5.2	4.4	5.0	3.5	4.6	4.2	4.5	6.6	4.9	5.5	8.5	8.4	5.0	11.0	3.8	2.6	17.7	24.0	31.1	23.8	20.5	15.9	27.0	17.2	16.6	26.4
SFT2D1	"C6orf83, MGC19825, pRGR1"	ENSG00000198818	"SFT2 domain containing 1"	Q8WV19	6	166319728-166342591	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014677	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA014677: AB_2238986"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.77e-2)"	"prognostic unfavourable (7.47e-4)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (3.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (4.20e-2)"	"unprognostic (5.05e-2)"	"prognostic favourable (5.90e-4)"	"unprognostic (2.75e-2)"	21.1	24.6	33.6	21.7	31.8	16.4	24.5	15.6	25.0	20.2	27.9	43.4	23.4	23.5	14.7	37.0	19.6	18.8	18.6	15.6	34.9	26.2	27.6	12.5	27.2	23.9	43.9	18.6	18.3	32.6	13.4	11.8	25.9	27.8	27.3	26.8	15.0	38.0	19.4	11.2	12.5	24.9	16.0	61.2	24.6	27.6	18.3	32.8	20.6	24.9	15.3	23.7	17.1	16.1	25.5	57.6	50.1	30.1	14.9	21.7	24.2	13.2	13.0	10.6	22.2	19.5	17.4	16.7	20.6	17.8	14.6	22.1	27.0	27.3	11.7	15.8	16.9	16.2	15.5	17.0	22.3	16.2	28.3	13.8	10.9	37.9	17.6	34.9	28.2	16.3	20.2	16.8	14.7	7.8	25.6	11.8	22.5	21.4	10.2	59.7	10.4	12.7	7.2	12.3	27.4	35.7	13.9	2.0	9.3	14.1	23.1	18.4	12.5	63.3	7.2	9.1	17.6	24.2	21.4	11.3	8.2	12.8	19.4	22.0	22.3	29.5	28.5	34.7	18.1	28.1	11.3	25.5	14.7	15.1	30.4	21.2	15.9	15.9	50.1	14.9	30.1	57.6	21.7	24.2	33.6	31.8	15.6	25.0	34.9	26.2	43.9	18.6	27.8	32.8
SGCB	"A3b, LGMD2E, SGC"	ENSG00000163069	"Sarcoglycan beta"	Q16585	4	52020706-52038482	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011422, HPA058656"	Enhanced		Approved	Cytosol				Cytosol		"HPA011422: AB_1856795, HPA058656: "	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (5.53e-6)"	"unprognostic (3.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (7.61e-4)"	17.7	13.2	17.6	5.4	19.0	0.5	8.8	18.6	20.7	14.9	18.3	17.5	3.7	7.7	17.1	7.0	13.2	11.5	11.6	32.4	16.5	14.5	20.5	6.4	9.0	3.4	20.4	12.9	12.6	4.0	29.9	17.5	13.9	17.9	15.4	9.9	7.9	7.8	17.0	54.1	4.4	8.7	21.8	24.7	6.3	9.0	9.2	20.3	0.9	7.9	10.4	2.8	13.5	11.8	4.3	1.7	0.9	2.0	0.5	6.6	2.0	3.5	4.3	9.0	3.4	34.7	26.2	3.2	19.8	25.5	11.2	11.8	1.1	4.7	0.9	3.8	26.1	1.7	6.6	7.3	12.0	5.8	2.5	0.0	4.1	2.1	14.2	2.0	1.1	28.8	5.1	9.7	5.6	14.7	0.0	0.0	23.8	1.3	4.6	0.0	3.2	6.5	0.0	4.8	0.0	9.4	1.2	5.3	9.2	12.6	0.6	4.3	1.6	1.3	14.8	16.6	5.6	7.7	17.6	4.8	6.2	1.7	12.3	0.7	19.0	0.4	2.0	0.1	3.9	0.8	3.7	4.3	4.6	4.1	0.9	3.6	3.3	4.1	0.9	0.5	0.6	1.7	6.6	2.0	17.6	19.0	18.6	17.5	16.5	14.5	20.4	12.9	17.9	20.3
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"		10	50305586-50625163	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favourable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	14.7	19.6	16.9	12.3	19.4	17.6	13.2	17.5	20.1	15.8	12.8	24.0	11.9	11.7	12.5	18.1	13.7	14.8	13.6	16.6	18.2	14.6	17.9	23.5	18.6	11.6	22.9	14.0	16.9	19.1	64.6	22.9	20.7	18.6	17.6	10.7	15.5	19.8	15.8	13.2	25.6	13.7	15.2	31.7	13.6	12.8	9.6	24.9	11.4	21.5	8.7	14.9	15.2	21.3	5.3	3.7	20.1	6.7	7.6	11.0	4.2	15.8	7.5	2.2	4.9	8.0	10.6	10.4	10.6	10.7	7.5	7.0	6.2	16.5	11.7	6.2	13.9	10.1	5.2	11.1	7.8	10.2	5.5	16.9	10.1	4.8	9.3	3.8	4.2	6.8	13.1	9.9	12.1	10.5	32.5	17.7	8.0	6.7	1.7	2.2	5.0	7.2	2.8	10.2	4.5	10.9	16.8	3.4	2.7	7.7	7.8	4.0	11.7	1.4	14.6	8.1	9.9	7.7	7.7	6.0	4.7	3.3	10.1	6.4	6.6	2.4	6.7	20.1	3.7	3.4	8.2	5.3	4.9	5.4	3.7	5.0	6.8	4.3	12.5	7.6	2.7	2.3	11.0	4.2	16.9	19.4	17.5	20.1	18.2	14.6	22.9	14.0	18.6	24.9
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186292	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 40.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035501: , HPA069302: , HPA069857: "	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.6	0.6	0.4	9.1	0.4	8.9	1.0	0.4	1.5	0.9	3.4	0.3	0.6	2.7	0.8	0.5	4.0	0.3	1.7	0.4	0.3	0.4	0.8	1.0	0.9	6.9	0.4	0.1	0.5	0.5	0.0	0.4	3.7	0.2	0.6	3.5	0.1	1.0	0.1	0.3	1.1	3.4	0.8	0.4	4.9	1.5	8.6	0.2	40.1	0.5	2.4	7.4	1.2	1.5	9.0	4.5	8.3	0.2	0.3	2.7	0.6	9.4	10.8	14.7	9.0	0.7	1.3	10.0	10.2	5.2	14.9	16.3	7.6	11.7	14.5	5.1	4.2	5.5	13.9	5.6	18.8	18.4	9.2	16.4	7.4	6.1	0.1	14.9	14.2	0.1	0.4	16.3	6.9	8.8	14.0	25.9	12.3	9.3	23.4	8.4	15.7	8.2	15.0	18.9	8.4	3.7	6.9	7.3	7.7	11.2	13.9	6.7	9.0	10.5	2.4	11.3	13.5	10.0	20.3	11.1	25.9	16.8	6.2	15.1	16.9	8.3	0.1	1.5	0.3	0.2	0.1	8.6	0.7	0.8	0.4	9.0	0.2	0.4	1.6	0.3	0.2	4.5	2.7	0.6	0.4	0.4	0.4	1.5	0.3	0.4	0.4	0.1	0.2	0.2
SGSM2	"KIAA0397, RUTBC1"	ENSG00000141258	"Small G protein signaling modulator 2"	O43147	17	2337498-2381058	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 8.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021641, HPA024553"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021641: AB_2188702, HPA024553: AB_1856512"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.88e-2)"	"prognostic favourable (3.11e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.84e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.90e-1)"	"prognostic favourable (9.00e-6)"	"unprognostic (2.78e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-2)"	11.1	15.3	51.8	13.3	45.8	17.3	15.9	14.4	43.7	11.6	12.1	12.6	14.9	10.8	13.3	38.6	16.5	12.7	15.1	12.3	43.2	24.9	12.6	6.6	14.7	15.4	13.9	34.8	11.3	14.8	25.4	30.7	11.1	18.9	20.6	7.4	13.6	23.0	18.1	13.4	23.0	13.0	14.2	13.7	16.6	14.2	10.0	17.6	9.4	15.7	6.0	10.8	16.1	10.9	0.6	0.9	8.6	0.4	1.3	2.1	0.7	10.1	15.7	14.4	20.0	8.2	9.9	21.4	8.8	10.4	12.3	12.5	15.8	19.6	4.9	9.6	12.8	14.4	8.8	10.4	4.3	7.2	18.0	8.6	23.8	16.7	7.0	5.1	13.0	10.6	6.9	12.4	7.2	12.7	5.1	7.4	7.3	21.6	10.9	6.9	7.0	6.9	24.0	7.3	3.9	15.8	21.4	7.0	16.6	11.0	8.3	6.6	21.5	6.2	14.8	9.9	11.3	14.5	11.6	6.1	0.9	4.5	8.6	6.8	8.7	8.6	0.4	2.1	1.7	0.3	1.5	0.1	0.7	1.0	0.7	0.6	2.1	1.1	0.2	1.3	0.0	0.9	1.0	0.7	51.8	45.8	14.4	43.7	43.2	24.9	13.9	34.8	18.9	17.6
SH2B2	APS	ENSG00000160999	"SH2B adaptor protein 2"		7	102285091-102321711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 37.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.0;Karpas-707: 22.4;RPMI-8226: 16.4;U-266/70: 20.9;U-266/84: 36.5;U-698: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 5.2;neutrophil: 3.9"	"Group enriched"	"Detected in many"	5	"B-cells: 5.2;granulocytes: 3.9;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051131	Uncertain		Approved	Cytosol				Cytosol		"HPA051131: "	"unprognostic (2.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (6.99e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.02e-3)"	"unprognostic (3.42e-2)"	5.5	1.3	4.2	11.8	5.1	3.9	2.4	6.5	4.3	2.9	2.0	1.3	0.0	3.1	3.3	1.1	2.3	2.9	2.2	1.7	2.7	5.0	3.2	1.1	9.2	12.6	3.6	1.5	2.2	2.6	1.9	1.9	5.7	4.3	2.9	1.1	0.9	2.0	1.5	37.8	2.4	3.5	1.9	5.0	16.7	2.9	2.2	4.1	0.6	2.8	2.6	10.4	3.1	3.9	5.2	0.7	3.9	3.3	0.0	0.2	0.1	1.3	1.0	1.1	2.4	0.2	0.1	10.2	0.4	0.1	0.3	0.2	0.3	0.2	23.0	2.4	0.1	1.3	0.2	0.3	0.1	2.9	1.0	0.0	0.6	0.2	0.2	0.1	0.8	0.2	0.3	0.2	0.0	0.0	0.1	22.4	0.4	2.4	0.1	4.0	2.6	4.2	2.9	1.2	16.4	0.8	0.3	1.1	4.2	0.8	2.0	0.5	0.3	3.0	0.0	0.3	2.3	4.0	0.4	20.9	36.5	31.0	1.4	0.8	0.5	0.0	0.6	0.0	0.2	3.3	0.0	1.4	0.0	0.0	0.7	5.2	0.0	0.0	3.9	0.0	1.3	0.0	0.0	0.1	4.2	5.1	6.5	2.9	2.7	5.0	3.6	1.5	4.3	4.1
SH2D4A	"FLJ20967, PPP1R38, SH2A"	ENSG00000104611	"SH2 domain containing 4A"	Q9H788	8	19313617-19396218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 50.6;U-2197: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.4;neutrophil: 5.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.4;granulocytes: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001871, HPA001919"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA001871: AB_1079949, HPA001919: AB_1079947"	"unprognostic (9.08e-2)"	"unprognostic (8.40e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.70e-2)"	"unprognostic (8.84e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (6.02e-8)"	"unprognostic (1.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	4.1	8.5	2.1	6.8	1.8	0.0	3.3	0.7	3.2	7.4	8.9	1.7	15.2	6.3	2.5	3.7	17.5	4.6	12.8	2.9	3.7	1.3	10.0	20.0	8.8	2.2	1.8	2.0	20.5	12.8	6.1	3.6	13.5	2.2	7.6	5.5	5.1	16.3	20.1	2.6	5.9	10.6	6.5	1.4	1.8	15.6	3.2	2.4	0.6	20.7	14.6	9.9	11.9	14.1	0.7	1.4	5.3	0.0	0.4	0.6	0.1	16.5	18.8	0.0	0.0	1.9	2.3	12.9	20.7	10.3	20.3	19.8	15.4	15.0	0.0	5.0	50.6	8.6	0.7	5.6	21.3	0.0	0.2	0.0	11.7	2.3	11.2	0.4	0.0	2.2	7.0	13.8	2.5	0.1	0.0	0.0	3.3	7.4	0.0	0.1	4.5	7.2	0.0	0.0	5.3	5.5	17.4	1.1	0.0	18.6	20.1	0.0	3.8	1.4	0.3	6.6	0.0	37.4	6.2	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	1.4	0.7	0.6	0.0	5.3	0.4	0.0	0.1	0.4	0.1	2.1	1.8	0.7	3.2	3.7	1.3	1.8	2.0	2.2	2.4
SH2D5		ENSG00000189410	"SH2 domain containing 5"	Q6ZV89	1	20719732-20732837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 19.5;placenta: 14.8;testis: 9.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.9;hTERT-HME1: 31.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030182			Supported	Cytosol				Cytosol		"HPA030182: AB_10670431"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.80e-6)"	"unprognostic (1.11e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-2)"	0.4	0.9	4.5	1.3	19.5	0.4	0.3	0.5	19.2	0.6	0.5	0.3	0.0	1.2	1.4	0.3	0.5	0.5	0.6	0.3	3.9	4.1	0.4	0.3	0.4	0.3	1.5	7.3	1.7	0.3	0.6	0.1	14.8	2.1	0.5	0.3	0.0	0.4	1.8	0.3	0.6	0.5	1.2	0.3	0.4	0.6	9.4	0.7	0.0	2.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.6	3.8	0.8	0.0	0.0	0.0	0.1	4.6	6.5	4.5	3.0	1.6	1.5	0.0	1.2	1.3	0.4	3.3	24.9	1.8	0.0	1.7	0.0	0.5	1.2	3.7	0.0	0.0	0.2	5.2	8.4	31.9	0.0	0.0	0.0	1.9	0.9	0.5	0.0	1.5	5.0	0.1	0.1	0.2	4.7	0.6	1.4	0.2	0.3	0.1	1.5	0.0	0.0	0.0	5.5	9.7	8.2	2.2	0.0	0.0	0.4	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	19.5	0.5	12.3	3.9	4.1	1.5	7.3	2.1	0.7
SH3BGR	21-GARP	ENSG00000185437	"SH3 domain binding glutamate rich protein"	P55822	21	39445855-39515506	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 219.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 15.3;U-87 MG: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7"	"Low region specificity"	"Detected in all"			"CAB003685, HPA030690"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB003685: AB_425682, HPA030690: "	"unprognostic (3.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.68e-3)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.75e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.16e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-2)"	2.4	5.2	7.2	1.2	7.3	0.9	2.9	1.1	4.3	2.9	6.1	3.0	2.0	1.9	2.1	6.6	5.3	2.1	5.0	30.0	6.6	5.4	3.2	2.8	1.5	0.9	7.5	5.0	1.8	2.8	2.1	4.5	1.1	6.1	5.8	2.0	1.2	3.2	5.2	219.7	0.9	1.4	12.4	7.9	1.2	2.9	3.7	5.9	0.1	3.9	41.5	2.2	7.3	8.6	2.7	11.5	2.6	1.7	2.8	4.0	1.2	1.0	1.3	1.7	2.5	3.7	4.3	0.5	1.9	0.9	0.9	0.7	0.7	2.2	3.3	5.1	5.0	0.1	0.9	1.5	1.4	2.0	3.4	3.3	0.6	1.3	7.6	1.2	0.7	3.5	6.2	3.2	6.3	1.0	2.5	4.3	3.5	4.1	2.2	1.9	1.7	2.9	3.5	6.4	2.1	4.6	0.8	4.8	2.0	2.9	2.4	3.1	9.0	0.6	0.8	2.5	0.3	1.5	3.7	15.3	3.2	3.3	47.5	2.9	3.3	2.3	0.7	0.0	1.2	1.7	3.1	2.7	1.1	1.8	1.9	1.4	4.0	3.0	2.6	2.8	1.7	11.5	0.7	1.2	7.2	7.3	1.1	4.3	6.6	5.4	7.5	5.0	6.1	5.9
SH3BP1	ARHGAP43	ENSG00000100092	"SH3 domain binding protein 1"	Q9Y3L3	22	37634654-37656119	"Predicted intracellular proteins"	Phagocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 19.9;HMC-1: 20.5;NB-4: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA000757	Supported		Approved	Cytosol				Cytosol		"HPA000757: AB_1079951"	"unprognostic (7.81e-3)"	"unprognostic (7.91e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavourable (9.55e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.78e-1)"	"prognostic unfavourable (3.48e-7)"	"prognostic favourable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.37e-2)"	"unprognostic (8.48e-3)"	4.1	3.0	3.2	17.9	4.5	12.8	2.6	5.0	5.7	7.9	12.0	3.6	2.0	20.6	2.6	3.6	25.1	3.2	4.2	2.2	2.9	2.1	2.8	2.2	6.2	11.7	3.1	2.9	4.3	2.2	1.9	1.8	9.1	3.2	5.7	5.0	2.7	7.0	2.6	1.1	16.8	18.2	2.4	4.2	19.9	5.1	3.8	4.1	15.4	2.0	15.2	23.4	9.8	13.5	0.6	2.1	7.3	5.9	1.6	2.8	1.1	9.8	0.5	1.7	1.4	0.4	1.7	14.0	1.6	2.8	2.6	3.0	2.6	1.0	5.6	1.3	1.0	19.9	0.8	10.8	1.1	17.3	6.5	7.9	0.3	3.5	1.4	11.3	20.5	2.1	2.7	3.4	0.4	0.4	2.7	2.1	0.2	5.3	1.3	20.7	3.4	1.6	7.2	1.4	4.8	0.3	10.4	1.8	4.7	0.5	2.4	8.3	2.9	10.0	0.5	1.0	5.3	0.2	0.1	14.7	5.2	4.3	1.4	11.7	5.6	3.2	2.7	7.3	2.0	3.2	2.2	0.6	2.2	2.2	1.4	0.3	1.4	2.8	1.8	1.6	5.9	2.1	2.1	1.1	3.2	4.5	5.0	5.7	2.9	2.1	3.1	2.9	3.2	4.1
SH3D19	"DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19"	ENSG00000109686	"SH3 domain containing 19"	Q5HYK7	4	151102751-151325632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 54.3;ASC TERT1: 46.4;HSkMC: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016424, HPA058562"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA016424: AB_1856814, HPA058562: "	"unprognostic (1.09e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.86e-1)"	"prognostic favourable (1.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.64e-2)"	56.0	9.5	6.8	11.2	14.2	0.0	24.2	4.4	9.2	19.2	28.5	20.1	10.7	20.3	22.8	13.9	23.6	17.3	29.6	31.7	7.8	5.1	12.8	23.1	26.1	3.7	13.6	5.5	27.2	7.8	15.4	6.0	16.8	12.7	18.8	23.0	12.4	14.1	19.8	12.8	17.4	35.9	26.6	7.7	3.1	14.6	12.3	15.1	0.3	15.6	12.8	6.7	27.7	23.8	0.0	2.3	0.0	0.0	0.0	0.2	0.0	7.0	5.2	3.3	2.6	54.3	46.4	7.2	8.7	9.3	3.9	4.0	6.7	8.7	0.0	3.5	8.1	5.2	3.5	10.0	3.8	0.0	2.8	0.0	6.3	7.1	13.1	0.0	0.0	36.8	7.7	5.8	9.0	22.5	0.0	0.0	10.1	2.9	0.0	0.1	6.7	7.6	0.0	0.2	0.1	4.8	4.9	0.2	4.6	6.2	6.4	5.1	2.0	0.0	16.3	12.3	4.4	5.4	3.4	0.0	0.0	0.0	6.3	0.0	15.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	6.8	14.2	4.4	9.2	7.8	5.1	13.6	5.5	12.7	15.1
SH3GL1	"CNSA1, EEN, MGC111371, SH3D2B, SH3P8"	ENSG00000141985	"SH3 domain containing GRB2 like 1, endophilin A2"	Q99961	19	4360370-4400547	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021485	Approved		Enhanced	Cytosol				Cytosol		"HPA021485: AB_1856816"	"unprognostic (1.32e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (6.85e-2)"	"prognostic favourable (1.86e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (9.36e-8)"	"unprognostic (5.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	20.5	22.4	12.8	17.7	14.5	28.9	17.5	19.1	25.9	21.6	18.7	13.3	11.9	25.4	16.9	12.1	66.0	15.0	16.1	13.2	13.0	8.0	13.8	19.7	14.8	13.0	11.4	13.0	23.5	20.5	5.6	17.3	33.9	9.4	17.1	6.2	14.9	22.1	16.8	8.6	40.4	29.8	18.8	9.0	19.5	16.4	13.7	11.3	10.1	14.2	19.1	33.0	22.2	30.0	6.1	6.5	9.7	5.1	3.8	7.4	3.4	31.7	14.4	15.0	19.8	17.6	27.5	27.7	27.7	23.9	24.7	24.6	22.4	16.8	7.2	11.7	27.4	26.3	10.6	30.4	6.6	9.5	17.7	8.6	19.8	29.3	25.4	7.7	9.8	23.0	21.2	20.8	12.8	29.0	22.3	16.4	19.8	26.6	7.5	8.1	37.6	16.1	5.9	20.9	12.5	19.5	28.1	14.8	22.8	24.4	24.4	17.3	16.8	12.3	43.7	23.8	17.4	49.8	28.0	10.5	6.4	7.6	34.3	20.1	32.6	1.0	3.8	4.8	5.0	1.9	4.8	6.1	7.4	6.9	5.0	4.5	4.2	4.5	9.7	3.8	5.1	6.5	6.6	3.4	12.8	14.5	19.1	25.9	13.0	8.0	11.4	13.0	9.4	11.3
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol			18000	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavourable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	42.3	19.9	15.0	22.1	18.8	23.7	50.5	13.7	16.9	20.1	24.1	17.8	25.7	20.0	19.9	25.6	42.4	15.2	20.0	48.1	15.4	12.6	22.4	24.0	27.6	40.2	18.2	14.8	18.0	28.5	18.2	18.4	23.7	20.3	19.7	24.8	11.7	30.2	24.5	89.7	19.4	24.4	26.6	24.5	33.6	16.1	45.4	16.2	19.0	20.0	29.7	20.8	28.5	35.6	8.9	10.4	69.7	16.3	13.9	14.5	10.0	19.1	7.0	11.3	10.3	47.4	41.2	18.6	29.0	29.1	27.6	29.3	20.3	16.0	9.8	18.7	35.9	11.2	10.0	18.9	26.3	21.1	7.1	23.4	10.8	21.5	28.7	12.5	23.9	29.4	22.0	30.4	33.5	43.5	8.7	27.7	36.9	5.7	11.3	8.0	11.0	12.1	13.0	47.5	7.2	23.7	33.1	12.4	9.0	16.3	21.1	34.5	8.3	12.8	38.0	26.6	16.1	33.2	23.9	14.6	13.5	14.5	13.2	12.9	16.1	29.4	13.7	14.7	10.6	14.5	10.4	8.9	9.9	10.6	10.4	8.1	4.8	8.5	69.7	13.9	16.3	10.2	14.5	10.0	15.0	18.8	13.7	16.9	15.4	12.6	18.2	14.8	20.3	16.2
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favourable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favourable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favourable (4.28e-4)"	9.3	18.8	36.9	11.7	27.0	30.4	16.6	31.3	47.2	15.8	16.4	33.0	43.7	25.7	14.4	14.2	29.5	21.0	13.6	14.8	34.2	24.4	15.8	6.6	14.9	13.6	28.8	37.9	20.0	35.9	29.1	26.8	45.2	26.3	21.3	10.1	13.4	30.0	33.8	19.4	46.6	20.4	16.6	30.9	14.9	25.8	7.8	24.1	16.9	16.4	15.0	15.8	27.8	18.1	7.7	7.6	6.6	4.6	5.0	4.9	2.8	13.2	11.2	5.5	7.5	3.3	4.2	16.5	4.6	10.5	9.2	8.5	7.0	22.9	14.0	3.7	8.2	32.7	1.7	10.0	2.6	8.9	7.5	3.5	18.0	6.1	7.0	3.1	8.6	3.0	11.5	4.7	4.2	7.7	4.7	18.7	4.6	32.6	18.0	8.4	4.9	7.9	36.6	10.4	62.6	10.3	16.1	17.4	14.1	6.7	17.5	7.2	25.1	4.7	7.0	4.3	7.4	10.9	10.1	18.2	8.9	8.9	10.0	3.9	2.3	4.4	3.3	6.6	4.1	1.6	4.9	7.7	4.7	3.8	2.7	3.8	3.4	3.0	2.7	5.0	4.6	7.6	3.9	2.8	36.9	27.0	31.3	47.2	34.2	24.4	28.8	37.9	26.3	24.1
SH3KBP1	CIN85	ENSG00000147010	"SH3 domain containing kinase binding protein 1"	Q96B97	X	19533975-19887601	"Predicted intracellular proteins"	"Apoptosis, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003351, HPA003355, CAB021892"	Enhanced		Supported	Cytosol				Cytosol		"CAB021892: , HPA003351: AB_1079956, HPA003355: AB_1079954"	"unprognostic (1.17e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.96e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (2.10e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.92e-2)"	25.0	6.6	17.2	31.0	23.7	32.2	25.3	3.3	18.1	10.6	19.3	23.6	2.6	7.1	6.3	6.6	4.6	6.6	11.3	14.4	17.2	20.1	7.9	8.2	16.6	32.9	30.2	11.4	5.7	3.6	13.1	10.2	17.0	22.6	5.1	19.1	6.8	12.5	4.1	6.1	14.7	12.2	7.9	28.8	22.0	9.6	3.0	27.0	19.5	11.5	5.5	34.9	10.7	17.1	13.6	35.8	51.3	24.5	17.8	51.2	39.4	12.4	13.1	2.1	4.7	10.6	20.5	11.0	11.3	16.5	5.8	9.3	8.9	25.8	23.3	11.9	16.3	1.4	4.8	4.5	9.4	7.6	3.3	5.0	3.4	7.1	6.9	31.6	40.0	12.0	4.5	12.0	35.7	8.7	1.8	28.2	14.7	5.6	18.8	32.1	3.6	17.5	11.7	20.4	2.1	6.7	2.5	1.5	1.5	10.5	1.4	16.0	1.3	37.2	27.6	10.2	8.8	12.9	12.4	41.3	27.3	20.7	21.7	26.3	45.0	10.4	24.5	39.6	46.1	18.7	36.0	13.6	45.1	47.7	31.9	12.2	37.6	37.3	51.3	17.8	21.5	35.8	51.2	39.4	17.2	23.7	3.3	18.1	17.2	20.1	30.2	11.4	22.6	27.0
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129348-109504632	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 13.8;RPMI-8226: 13.2;TIME: 15.3;U-266/84: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA044822: , HPA048444: "	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	17.4	5.6	2.7	3.4	4.4	0.6	18.3	1.7	5.4	5.3	3.6	3.3	2.5	1.0	5.5	2.2	3.4	4.8	5.6	6.4	3.0	2.1	2.5	0.8	6.0	2.9	4.3	1.5	3.0	1.8	0.6	2.6	6.5	3.8	3.4	1.6	4.6	2.4	5.9	6.4	2.9	2.3	4.6	2.8	2.0	2.7	4.3	2.9	1.5	3.4	3.6	4.0	4.6	3.4	0.4	0.4	1.8	0.2	0.0	0.6	0.3	0.0	0.0	0.1	1.4	6.3	4.8	0.0	2.8	8.2	2.1	0.8	0.7	0.0	0.0	2.1	2.0	0.0	0.1	1.2	0.9	0.0	2.8	0.0	0.1	0.0	13.8	0.0	0.0	8.3	1.9	9.6	4.3	7.6	0.0	7.9	4.8	0.0	0.0	4.2	0.7	7.9	1.7	0.0	13.2	0.0	0.0	0.4	1.7	0.0	0.0	0.3	0.1	0.0	15.3	2.7	8.2	7.8	3.6	2.7	17.8	0.0	0.0	4.1	3.7	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	0.6	1.8	0.0	0.0	0.4	0.0	0.3	2.7	4.4	1.7	3.3	3.0	2.1	4.3	1.5	3.8	2.9
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.0;MOLT-4: 26.0;SK-MEL-30: 14.9;U-2197: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6"	"Low region specificity"	"Detected in many"							"HPA038132, HPA056807"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: "	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	16.8	4.2	3.7	12.7	7.6	7.5	8.5	0.9	4.0	5.7	3.2	8.6	3.3	1.9	3.2	7.9	9.7	3.9	10.0	4.5	6.6	3.5	19.9	11.2	10.1	14.2	7.4	1.0	2.8	8.6	1.1	3.3	5.8	7.2	5.9	2.4	6.4	5.9	6.0	2.0	3.3	5.6	4.1	9.6	17.0	9.6	1.7	5.8	24.4	5.6	3.8	14.5	9.9	6.3	6.5	14.5	1.0	8.6	0.4	2.0	2.6	2.1	3.4	0.1	0.0	0.0	0.3	2.5	0.2	0.2	0.3	0.4	1.7	1.3	3.0	3.0	0.0	1.3	0.0	6.4	0.0	7.9	0.1	0.0	2.7	2.8	2.6	0.0	0.4	0.1	8.0	0.1	6.5	15.0	0.4	4.2	0.3	2.4	26.0	2.1	0.1	2.8	1.7	0.8	0.8	0.3	0.4	0.2	1.4	0.9	0.3	14.9	0.0	0.5	6.1	0.0	1.7	11.3	0.2	0.1	0.6	2.6	0.1	1.2	2.0	0.0	7.5	1.0	0.7	6.9	0.7	4.2	1.5	0.9	6.2	6.5	0.7	0.6	0.2	0.4	8.6	14.5	2.0	2.6	3.7	7.6	0.9	4.0	6.6	3.5	7.4	1.0	7.2	5.8
SH3TC2	"CMT4C, KIAA1985"	ENSG00000169247	"SH3 domain and tetratricopeptide repeats 2"	Q8TF17	5	148923639-149063163	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.1;placenta: 22.7;testis: 14.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.1;RT4: 9.7;SK-MEL-30: 8.7;WM-115: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037683, HPA037684"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037683: , HPA037684: AB_10672603"	"unprognostic (6.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.18e-2)"	"unprognostic (4.53e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.40e-1)"	1.3	0.8	3.3	0.8	15.4	1.2	1.4	0.9	8.6	2.2	1.0	32.1	0.0	0.6	1.0	1.7	2.0	1.3	1.3	3.7	6.0	3.0	0.6	0.7	1.0	0.7	22.7	4.6	0.6	0.5	0.8	0.5	22.7	12.0	0.9	1.8	0.0	1.4	1.4	1.5	1.1	0.7	1.3	12.9	1.0	0.7	14.4	15.6	0.0	0.8	0.0	1.0	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.6	0.2	0.0	0.0	0.0	0.1	0.1	2.9	1.2	0.5	0.2	6.1	5.0	0.0	5.5	0.3	4.2	0.0	4.1	0.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.4	2.0	1.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	5.5	0.0	3.8	0.0	2.0	9.7	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.3	0.2	1.1	0.2	3.5	0.0	0.0	0.0	0.2	1.2	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	15.4	0.9	8.6	6.0	3.0	22.7	4.6	12.0	15.6
SHARPIN	"DKFZP434N1923, SIPL1"	ENSG00000179526	"SHANK associated RH domain interactor"	Q9H0F6	8	144098633-144108124	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 99.4"	"Cell line enhanced"	"Detected in all"		"PC-3: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044453	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044453: AB_10962490"	"unprognostic (4.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.00e-1)"	12.0	14.5	15.8	7.9	11.7	13.2	10.9	9.0	15.3	11.3	12.3	13.7	17.3	11.5	11.4	14.7	11.4	12.9	10.3	14.7	14.0	8.9	14.1	25.7	10.0	9.3	14.6	11.3	11.9	14.0	11.7	10.2	9.6	13.3	12.2	7.2	10.5	16.8	11.8	25.5	13.5	10.7	9.4	9.2	12.5	12.0	99.4	12.3	6.1	10.9	10.8	7.1	10.1	9.5	12.7	22.4	26.1	21.2	17.3	22.1	11.0	8.5	12.6	7.1	5.6	11.5	11.9	8.1	8.0	9.5	10.7	10.6	8.9	13.9	3.7	14.7	9.7	9.8	3.5	12.1	3.0	11.2	9.5	9.3	14.5	10.5	20.4	3.2	8.7	13.3	20.0	8.9	10.2	11.4	6.2	8.8	9.7	14.1	11.0	9.2	2.9	46.0	7.7	5.4	12.4	11.3	9.8	7.2	11.1	13.7	20.7	13.2	21.7	12.0	9.6	8.4	13.3	12.0	10.7	10.8	8.2	5.0	12.2	8.0	6.6	12.5	18.1	26.1	16.7	21.2	18.6	12.7	16.6	22.1	16.6	12.3	13.8	15.0	9.3	17.3	18.4	22.4	16.5	11.0	15.8	11.7	9.0	15.3	14.0	8.9	14.6	11.3	13.3	12.3
SHB		ENSG00000107338	"SH2 domain containing adaptor protein B"	Q15464	9	37919134-38069211	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	71	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.1"									"CAB010161, HPA049911, HPA052108"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				Cytosol	"Nucleoplasm, Cytoplasmic bodies"	"CAB010161: AB_2187742, HPA049911: , HPA052108: "	"unprognostic (4.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.96e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-1)"	8.6	5.6	7.5	5.3	15.9	7.2	8.0	1.4	12.5	8.2	8.4	16.1	3.2	10.1	6.1	5.6	19.6	5.9	29.4	20.2	8.9	5.0	13.6	34.2	11.6	3.1	17.9	5.3	5.6	17.8	13.7	13.1	7.7	12.6	12.9	7.0	7.6	18.9	11.3	6.4	13.0	9.5	11.9	7.6	6.7	14.1	3.5	16.3	2.7	7.7	10.3	11.1	10.7	11.9	0.0	0.0	8.1	0.0	0.0	0.1	0.0	9.2	14.7	1.5	0.2	1.7	4.1	2.6	10.2	12.5	7.1	5.5	3.5	6.4	0.0	12.4	8.8	8.9	5.8	15.0	5.1	7.8	11.7	0.0	5.1	10.8	11.3	0.4	0.5	3.6	4.8	11.2	8.6	7.3	3.7	3.1	8.3	6.2	1.1	0.4	3.8	14.0	0.5	4.3	0.5	14.8	3.3	15.7	12.6	1.3	11.2	2.5	7.0	0.5	9.0	3.3	12.0	1.7	16.2	0.9	0.3	0.1	19.7	0.9	3.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	15.9	1.4	12.5	8.9	5.0	17.9	5.3	12.6	16.3
SHC1	"p66, SHC, ShcA"	ENSG00000160691	"SHC adaptor protein 1"	P29353	1	154962298-154974395	"Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001844, CAB005374, CAB016305"	Supported		Enhanced	Cytosol				Cytosol		"CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826"	"unprognostic (4.12e-2)"	"prognostic unfavourable (6.74e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.94e-3)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (7.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-1)"	45.1	36.4	14.6	27.8	15.9	20.4	43.6	11.8	12.6	33.9	30.5	11.1	32.9	23.1	34.8	28.1	31.4	32.5	30.5	23.4	11.7	8.5	30.1	54.7	37.5	36.5	13.9	8.7	36.1	21.5	23.0	44.7	47.3	18.9	31.9	23.7	31.5	22.4	24.9	22.1	20.3	39.5	35.4	16.0	38.6	25.8	16.2	11.1	19.9	37.7	21.1	29.8	40.4	31.2	13.9	21.8	31.9	27.0	12.7	23.7	19.8	13.9	29.0	22.3	35.9	24.5	49.2	11.7	51.1	46.6	29.7	22.6	10.3	33.8	7.5	41.9	61.4	12.0	5.9	50.6	26.8	9.2	3.2	19.3	23.9	18.2	64.1	6.2	22.0	73.0	60.1	37.0	46.2	65.1	8.5	60.9	62.1	11.5	7.1	3.8	19.5	12.3	6.4	7.4	15.5	14.3	10.6	2.8	77.8	30.6	17.1	16.7	25.0	13.1	77.1	47.0	29.4	9.9	26.7	27.5	17.6	12.8	45.8	8.4	60.7	17.0	20.8	31.9	23.7	27.0	23.5	13.9	19.0	20.9	21.8	13.3	15.6	14.1	17.0	12.7	25.7	10.0	14.1	19.8	14.6	15.9	11.8	12.6	11.7	8.5	13.9	8.7	18.9	11.1
SHC2	"SCK, SHCB, SLI"	ENSG00000129946	"SHC adaptor protein 2"	P98077	19	416583-460996	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 44.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.4;HHSteC: 6.3;SCLC-21H: 13.8;SH-SY5Y: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006136	Approved		Approved	Cytosol				Cytosol		"HPA006136: AB_1856827"	"unprognostic (2.54e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (8.53e-4)"	"unprognostic (4.45e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.86e-2)"	"unprognostic (4.43e-2)"	9.8	11.3	18.5	2.7	15.1	1.0	6.8	5.0	17.6	7.9	6.3	10.2	3.7	8.9	11.7	5.9	2.6	8.1	14.6	7.9	15.7	15.2	3.8	20.6	6.5	2.8	15.2	11.3	5.1	44.8	7.8	18.6	10.7	15.6	13.7	1.4	9.9	19.5	8.2	3.4	8.5	6.2	4.7	9.6	11.5	10.5	6.0	15.0	0.0	9.7	0.7	1.3	3.8	6.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.6	0.5	2.7	0.3	0.0	0.0	0.5	0.0	5.4	0.0	0.4	1.2	0.0	0.0	1.1	1.8	0.0	0.0	3.0	6.3	0.0	2.1	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	2.0	0.0	13.8	12.5	0.0	0.0	0.0	0.3	2.1	0.0	0.5	3.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.5	15.1	5.0	17.6	15.7	15.2	15.2	11.3	15.6	15.0
SHC4	"RaLP, SHCD"	ENSG00000185634	"SHC adaptor protein 4"	Q6S5L8	15	48823735-48963444	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7;testis: 19.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.3;SK-MEL-30: 17.5;WM-115: 15.0"	"Cancer enhanced"	"Detected in some"		"melanoma: 9.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Low region specificity"	"Detected in all"							HPA074146			Approved	Cytosol				Cytosol		"HPA074146: "	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-5)"	"unprognostic (9.84e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.36e-2)"	1.5	2.3	9.0	2.3	24.8	0.7	3.7	2.0	15.8	2.5	2.5	18.9	0.3	1.1	1.3	2.5	1.5	1.9	3.2	6.6	11.2	6.2	1.2	0.8	1.2	1.1	25.7	9.4	1.6	0.9	0.7	1.1	1.3	13.2	1.3	1.6	1.7	4.8	3.3	2.0	1.3	1.1	1.9	16.2	0.9	1.0	19.5	23.8	0.0	1.1	0.0	0.8	1.7	0.9	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.3	0.9	9.3	0.4	1.3	0.0	1.3	2.6	0.6	1.1	0.0	0.2	0.1	2.3	0.5	0.0	0.2	0.4	0.8	1.8	0.1	0.6	0.0	0.0	1.0	0.0	0.1	1.8	0.0	1.2	0.1	0.1	0.0	0.2	1.3	1.5	0.3	0.2	0.1	3.5	0.2	2.5	0.3	2.0	0.3	0.5	0.7	0.2	0.1	17.5	0.0	0.1	0.0	0.8	0.4	0.5	0.9	0.7	0.1	0.0	0.8	0.5	15.0	0.2	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	24.8	2.0	13.4	11.2	6.2	25.7	9.4	13.2	23.8
SHD		ENSG00000105251	"Src homology 2 domain containing transforming protein D"	Q96IW2	19	4278601-4290724	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"blood: 14.8;brain: 23.1;heart muscle: 17.3"	"Group enriched"	"Detected in some"	46	"RH-30: 18.8;SH-SY5Y: 60.6"	"Cancer enhanced"	"Detected in some"		"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	148	"plasmacytoid DC: 14.8"	"Lineage enriched"	"Detected in single"	148	"dendritic cells: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017955	Uncertain		Uncertain	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA017955: AB_1856828"	"unprognostic (2.41e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.16e-4)"	0.5	0.7	4.0	1.4	2.5	1.2	0.4	4.1	23.1	0.4	0.9	2.4	0.0	0.7	0.4	0.4	0.4	0.4	0.6	17.3	3.3	4.5	0.4	1.7	0.5	1.2	4.7	2.3	0.4	0.5	0.4	0.2	0.4	6.1	0.5	0.7	0.0	0.5	0.4	0.8	0.4	0.6	0.4	2.5	0.6	0.4	0.5	1.1	0.0	0.4	0.0	0.8	0.5	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	18.8	0.0	0.0	0.0	0.1	60.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	4.0	2.5	4.1	20.4	3.3	4.5	4.7	2.3	6.1	1.1
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397839-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 30.0"	"Group enriched"	"Detected in some"	7	"AN3-CA: 69.1;PC-3: 40.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"memory B-cell: 2.1;naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.4"	"Region enriched"	"Detected in single"	24	"olfactory region: 63.3"	"Low region specificity"	"Detected in some"			HPA054754			Approved	"Lipid droplets,Cytosol"				Cytosol	"Lipid droplets"	"HPA054754: "	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.5	2.1	1.0	2.3	3.5	0.1	1.8	0.7	1.3	0.9	5.0	0.1	2.9	2.9	0.3	6.2	8.6	0.4	4.2	12.9	0.9	1.5	30.0	1.0	4.7	15.4	8.3	0.7	1.4	0.3	0.1	0.5	0.2	3.3	2.6	4.1	0.3	1.2	1.5	3.4	0.4	8.4	10.7	1.0	0.6	3.5	2.0	2.2	0.0	4.6	2.6	1.1	6.8	4.7	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	7.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	3.1	40.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	3.5	0.7	1.3	0.9	1.5	8.3	0.7	3.3	2.2
SHISA7		ENSG00000187902	"Shisa family member 7"	A6NL88	19	55428740-55442863	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 24.9"	"Group enriched"	"Detected in some"	5	"HEL: 6.5;HMC-1: 6.9;THP-1: 3.5"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058935	Uncertain		Approved	Cytosol				Cytosol		"HPA058935: "	"unprognostic (3.98e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"		"unprognostic (3.08e-1)"	"unprognostic (4.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.87e-7)"	"unprognostic (7.53e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.04e-1)"	0.7	1.7	11.3	0.7	16.7	2.6	0.7	4.0	24.9	0.7	0.8	7.2	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.7	11.2	8.2	0.7	0.7	0.7	0.7	8.3	3.1	0.7	0.8	0.7	2.4	0.7	5.5	0.7	0.8	0.0	0.7	0.7	0.7	0.8	0.8	0.7	4.0	0.7	0.8	2.2	14.6	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	6.5	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	1.2	0.6	0.0	1.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	16.7	4.0	10.9	11.2	8.2	8.3	3.1	5.5	14.6
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243667-44312851	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9"	"Cell line enhanced"	"Detected in some"		"SiHa: 16.7;U-2197: 37.9;U-87 MG: 22.0;WM-115: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA051178: "	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	0.7	1.3	13.8	1.3	3.6	0.0	0.5	1.6	13.0	22.5	7.7	0.5	6.9	1.4	34.2	4.5	1.5	1.9	2.3	0.5	5.4	9.1	0.5	0.5	0.6	0.5	3.6	0.5	1.7	0.6	0.1	0.8	5.7	0.5	5.8	1.5	0.5	0.5	8.9	0.5	0.4	0.8	31.9	0.5	0.5	0.5	1.5	0.5	0.5	0.5	0.5	0.5	11.9	3.3	0.0	0.1	0.7	0.0	0.2	0.1	0.0	0.0	0.1	1.6	0.5	0.0	0.0	0.0	0.4	1.1	1.1	0.6	0.0	0.0	0.0	0.0	1.0	0.0	2.3	0.1	0.1	0.0	1.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	6.1	0.0	16.7	0.0	0.1	0.0	0.1	0.0	6.2	0.9	37.9	0.2	0.0	0.0	0.0	22.0	0.0	12.7	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	13.8	3.6	1.6	11.8	5.4	9.1	3.6	0.5	0.5	0.5
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 57.8;liver: 108.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA023314	Enhanced		Supported	Nucleoplasm,Cytosol			240000	"Nucleoplasm, Cytosol"		"HPA023314: AB_1856830"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favourable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	10.9	3.2	2.2	4.9	4.1	2.1	10.4	6.5	3.0	4.6	15.2	5.3	7.3	12.3	2.8	7.4	16.3	3.9	4.0	2.0	2.6	1.8	57.8	108.3	4.3	3.8	3.5	1.9	4.1	3.5	30.1	1.6	2.8	3.6	3.4	3.5	7.2	9.8	8.0	5.7	6.2	15.1	2.3	2.9	8.6	3.9	6.3	3.8	11.1	10.9	10.8	8.7	4.3	6.3	8.6	6.7	6.2	10.6	13.0	18.7	7.9	23.7	24.1	7.6	12.0	19.5	12.2	28.3	5.0	6.2	16.9	18.7	23.9	10.6	18.5	15.0	4.3	23.5	16.0	20.2	9.6	11.0	23.3	8.3	18.9	18.0	4.9	5.5	9.0	10.1	8.0	13.1	5.9	11.6	7.0	4.2	6.0	17.5	27.4	7.6	9.6	7.9	22.5	30.3	15.7	26.9	16.2	10.5	5.5	34.2	6.5	8.6	26.6	7.8	2.7	3.3	9.8	29.9	15.8	8.6	8.2	7.4	6.4	13.0	7.8	6.0	8.2	6.2	10.1	10.6	17.1	8.6	12.3	12.8	6.7	6.9	12.3	13.0	0.1	13.0	7.5	3.1	18.7	7.9	2.2	4.1	6.5	3.0	2.6	1.8	3.5	1.9	3.6	3.8
SHOC2	"KIAA0862, SOC-2, SOC2, SUR-8, SUR8"	ENSG00000108061	"SHOC2, leucine rich repeat scaffold protein"	Q9UQ13	10	110919547-111013667	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009164, HPA048134"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA009164: AB_1079960, HPA048134: "	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.97e-3)"	"unprognostic (8.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.67e-1)"	22.9	13.2	22.3	17.2	32.4	31.2	18.0	24.9	25.2	19.3	16.7	8.9	12.1	12.5	17.3	17.4	19.1	14.1	15.8	14.6	19.0	24.8	20.9	18.2	16.8	20.9	22.3	20.1	21.9	15.7	26.5	33.4	17.9	17.7	18.1	17.0	9.8	13.9	14.4	21.7	15.8	24.2	25.0	23.3	23.2	13.9	26.7	17.7	29.4	21.5	9.4	23.3	23.7	17.1	16.4	11.3	34.6	13.7	9.8	9.6	11.2	11.2	7.1	9.1	15.2	20.9	21.4	5.9	13.8	20.7	12.9	15.7	6.4	10.2	24.6	6.9	24.7	9.6	11.0	9.9	18.9	13.4	6.5	11.2	11.0	6.2	15.2	19.0	20.1	23.6	15.7	14.9	28.1	13.0	6.9	17.6	18.3	6.0	9.3	15.3	5.6	7.4	13.4	18.2	6.9	13.6	7.7	4.8	9.5	12.0	6.0	13.5	30.8	16.2	13.1	10.4	9.3	13.1	9.4	16.3	16.6	39.4	12.4	19.7	7.4	20.9	12.0	16.7	7.0	13.7	8.4	16.4	8.3	8.1	11.3	13.0	8.8	8.5	34.6	9.8	13.5	8.1	9.6	11.2	22.3	32.4	24.9	25.2	19.0	24.8	22.3	20.1	17.7	17.7
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786456-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 12.4;RT4: 12.9;WM-115: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA051646, HPA061435"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: , HPA061435: "	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favourable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	1.3	3.6	6.8	1.3	7.7	0.5	2.5	2.8	17.0	4.7	3.2	3.7	4.6	1.8	3.3	5.8	7.2	3.6	6.3	1.5	7.4	5.5	5.3	7.6	8.1	1.0	5.7	9.1	13.8	7.2	5.5	6.1	14.3	5.8	10.6	3.0	3.6	6.0	5.8	0.7	7.9	1.4	2.1	7.9	1.7	2.6	5.8	2.5	1.8	3.1	3.4	3.4	6.4	4.3	0.0	0.9	1.1	0.0	0.0	0.2	0.0	4.0	0.5	7.6	1.0	0.4	1.2	4.3	0.4	1.3	1.6	2.7	5.0	0.0	0.0	1.4	1.0	3.3	3.9	10.8	1.9	0.0	2.9	0.0	0.0	0.8	2.5	0.0	5.2	0.2	7.5	12.4	0.5	9.3	0.0	0.0	2.6	4.3	0.0	0.0	6.6	0.0	0.0	8.3	0.0	7.0	12.9	1.1	0.6	0.3	0.1	12.0	4.4	0.2	4.3	12.1	1.5	0.0	0.4	0.0	0.0	0.0	7.9	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	6.8	7.7	2.8	17.0	7.4	5.5	5.7	9.1	5.8	2.5
SHTN1	"KIAA1598, shootin-1, shootin1"	ENSG00000187164	"Shootin 1"	A0MZ66	10	116881482-117126586	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9"	"Group enriched"	"Detected in many"	43	"dendritic cells: 13.2;monocytes: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037942, HPA037943"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA037942: AB_2675748, HPA037943: AB_10671637"	"unprognostic (1.00e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.08e-6)"	3.5	6.5	51.5	6.8	50.1	1.6	8.7	9.8	34.1	5.5	7.0	42.3	0.3	6.7	4.4	8.4	5.4	5.2	6.5	2.6	58.9	37.0	7.8	12.1	9.8	4.5	67.8	22.7	6.8	10.9	18.6	20.4	5.4	36.3	7.3	8.6	2.0	9.9	3.0	0.9	9.6	7.8	3.8	67.4	7.0	9.0	9.9	54.5	0.4	11.9	1.4	4.1	4.0	2.4	0.0	13.2	0.3	14.0	0.0	0.2	3.5	15.6	8.8	0.9	1.9	0.0	0.0	8.8	1.3	3.5	2.7	5.2	9.9	10.4	0.0	2.7	4.9	8.1	7.0	5.9	2.8	0.0	7.3	0.0	9.3	6.1	1.2	2.8	2.5	0.4	5.2	2.7	5.1	6.5	4.3	0.0	1.9	6.3	0.0	0.1	3.4	6.0	0.0	11.9	3.5	7.3	2.1	9.8	3.9	10.6	15.4	9.6	12.4	2.5	11.2	0.9	6.6	0.0	7.7	1.7	0.0	0.0	4.9	0.0	4.8	0.0	14.0	0.1	0.0	8.8	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.3	0.0	4.0	8.9	0.2	3.5	51.5	50.1	9.8	30.2	58.9	37.0	67.8	22.7	36.3	54.5
SIGIRR	"IL-1R8, TIR8"	ENSG00000185187	"Single Ig and TIR domain containing"	Q6IA17	11	405716-417455	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 67.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023188	Approved		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"		"HPA023188: AB_1856856"	"unprognostic (6.21e-3)"	"prognostic favourable (7.44e-5)"	"unprognostic (7.30e-2)"	"prognostic favourable (1.34e-5)"	"unprognostic (6.85e-2)"	"prognostic favourable (9.08e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (7.61e-6)"	"unprognostic (1.00e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.63e-2)"	"prognostic favourable (1.54e-5)"	11.0	3.2	11.8	19.3	12.3	18.1	17.7	2.4	12.3	10.7	16.9	11.2	16.2	18.6	11.0	14.5	13.7	16.3	12.8	12.9	11.1	10.1	29.4	67.0	14.9	25.6	11.7	8.5	9.6	22.7	10.0	7.3	6.2	15.6	14.2	9.2	15.2	22.1	13.4	6.4	4.5	20.4	11.2	17.7	28.7	17.7	7.4	10.2	12.4	15.4	8.8	18.0	11.3	13.3	11.4	12.9	17.4	16.7	27.8	38.9	22.8	7.8	21.5	1.3	7.5	1.2	6.4	15.7	1.2	1.8	3.6	3.2	9.9	49.4	2.2	5.8	6.8	11.3	3.5	4.0	0.6	6.7	13.1	4.3	4.3	0.2	4.0	3.5	7.5	3.4	0.8	0.6	0.5	10.5	4.4	0.1	1.0	26.4	10.4	12.2	7.8	11.8	13.4	0.0	7.7	2.6	5.3	13.3	6.5	0.1	7.3	9.4	9.3	2.9	12.1	1.2	1.5	1.8	0.0	2.7	4.5	5.4	4.9	8.3	4.2	17.4	13.0	11.2	38.9	13.9	30.9	11.4	32.5	33.7	12.9	8.6	29.8	28.9	7.0	27.8	16.7	4.9	29.9	22.8	11.8	12.3	2.4	12.3	11.1	10.1	11.7	8.5	15.6	10.2
SIGLEC10	"MGC126774, PRO940, SIGLEC-10, SLG2"	ENSG00000142512	"Sialic acid binding Ig like lectin 10"	Q96LC7	19	51410021-51417803	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 99.9;lymphoid tissue: 74.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.8;HEL: 10.6;HMC-1: 8.5;NB-4: 6.5;U-698: 15.3;U-937: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 99.9;monocytes: 66.7"									"CAB025807, HPA027093"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"			Cytosol	"Plasma membrane, Actin filaments"	"CAB025807: , HPA027093: AB_1856858"	"unprognostic (7.18e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.95e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.05e-2)"	2.6	6.2	4.5	24.6	9.8	9.1	1.4	0.7	4.9	2.7	3.7	5.7	0.0	5.3	1.3	0.7	2.2	2.7	2.7	1.6	3.3	3.0	2.6	7.2	7.7	74.6	6.6	1.8	1.2	2.4	0.2	2.5	1.1	7.7	2.6	3.3	0.7	2.3	0.7	0.6	0.9	9.6	3.2	7.4	37.0	3.1	0.9	4.8	2.0	1.2	0.2	13.2	4.8	1.3	5.8	5.1	99.9	66.7	0.0	0.1	4.4	0.1	0.0	0.4	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	20.8	0.6	0.0	0.4	0.0	0.1	0.0	6.4	1.5	10.6	0.2	0.1	0.0	4.8	8.5	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.0	0.4	0.1	6.5	0.6	0.3	1.3	0.1	0.4	0.0	0.2	0.3	0.3	0.3	0.1	0.2	0.1	3.9	0.5	0.5	1.0	0.4	0.2	1.0	0.2	15.3	0.4	8.8	0.3	1.5	5.6	99.9	0.1	33.9	0.0	5.8	0.0	0.0	5.1	3.6	0.0	0.0	11.5	0.0	66.7	0.2	0.1	4.4	4.5	9.8	0.7	4.9	3.3	3.0	6.6	1.8	7.7	4.8
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 63.0"	"Cell line enriched"	"Detected in some"	45	"HMC-1: 57.4"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	42	"eosinophil: 63.0"	"Lineage enriched"	"Detected in single"	623	"granulocytes: 63.0"									HPA012556	Uncertain		Uncertain	Cytosol				Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.6	6.7	5.8	2.4	8.4	0.7	2.3	0.7	7.0	1.4	2.9	7.4	0.0	2.9	1.0	1.1	1.1	1.1	2.7	0.3	8.6	4.8	0.4	1.6	4.1	9.6	8.3	3.6	0.3	0.7	0.7	1.2	0.1	7.5	1.0	2.8	0.1	1.1	0.9	0.3	0.8	4.5	1.5	14.8	9.2	2.1	0.5	6.2	0.6	0.7	0.0	4.1	2.0	0.7	0.0	0.0	63.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	57.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.5	0.1	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.8	8.4	0.7	5.6	8.6	4.8	8.3	3.6	7.5	6.2
SINHCAF	"C12orf14, FAM60A, TERA"	ENSG00000139146	"SIN3-HDAC complex associated factor"	Q9NP50	12	31280584-31327058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 83.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038167, HPA057585"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038167: AB_10675629, HPA057585: "	"unprognostic (2.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (1.15e-1)"	"prognostic favourable (7.89e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.75e-2)"	13.1	6.5	1.6	21.4	5.1	7.9	11.1	4.5	1.9	25.4	15.8	3.4	15.8	6.7	28.3	16.8	19.8	14.6	8.4	5.6	2.9	1.8	16.6	3.3	17.0	22.5	3.4	0.9	18.5	19.6	7.6	19.6	18.9	5.2	18.6	8.3	6.0	16.3	20.1	3.2	12.7	17.0	11.7	3.8	18.5	7.0	13.6	3.7	39.0	14.9	12.3	27.3	19.3	13.6	22.8	28.3	7.9	8.0	19.0	15.1	10.4	3.4	5.1	17.3	3.4	1.0	2.1	32.0	1.8	1.3	3.5	4.7	13.8	9.0	11.9	14.7	0.5	6.2	14.4	6.9	6.9	12.7	6.4	8.2	3.5	8.6	4.3	13.4	8.1	1.9	10.9	3.0	14.7	8.2	11.3	4.7	1.5	2.6	23.9	9.8	83.4	2.8	20.3	8.3	10.2	7.9	10.3	24.1	16.2	4.2	7.6	9.9	3.2	7.9	8.9	0.8	5.2	0.4	6.0	5.3	7.6	24.0	2.4	5.1	4.6	7.9	4.8	7.5	8.8	5.8	10.3	22.8	12.3	10.4	10.4	17.9	15.1	11.8	1.5	19.0	8.0	28.3	5.8	10.4	1.6	5.1	4.5	1.9	2.9	1.8	3.4	0.9	5.2	3.7
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884669-67918390	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: "	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	17.2	32.3	12.6	21.1	17.8	17.0	18.1	22.6	14.5	24.2	20.5	15.7	14.0	9.2	19.0	12.7	12.7	15.1	15.2	14.7	14.1	10.4	13.9	17.3	12.6	16.1	17.0	10.1	26.6	14.4	16.4	13.3	14.7	12.1	21.7	12.5	12.1	12.3	16.1	19.9	12.9	15.0	21.0	17.7	13.5	13.2	25.4	16.3	28.1	15.2	9.3	14.7	21.6	37.5	4.9	3.9	3.8	3.5	3.6	7.1	1.8	8.2	9.4	15.0	16.7	14.3	11.1	9.4	11.5	11.9	15.8	14.1	10.4	7.1	17.4	6.2	7.6	6.6	18.6	3.8	17.0	9.3	10.8	9.2	7.1	8.1	13.1	9.9	7.1	10.2	9.3	9.5	16.4	6.3	11.7	9.5	11.5	6.6	9.2	13.7	18.6	15.2	16.7	11.8	6.8	7.4	5.1	9.7	13.3	21.0	13.9	14.5	10.1	9.2	5.3	12.3	11.5	10.9	11.1	8.0	9.5	34.5	6.3	15.1	5.0	3.8	2.4	3.2	3.4	3.0	4.9	4.9	3.7	4.7	3.9	3.3	7.1	4.2	3.1	3.6	3.5	3.5	2.9	1.8	12.6	17.8	22.6	14.5	14.1	10.4	17.0	10.1	12.1	16.3
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.6;skeletal muscle: 108.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	14.1	11.0	30.2	8.1	36.0	10.7	9.1	14.3	38.8	11.0	8.4	78.1	4.0	9.3	9.7	7.8	17.1	12.9	10.7	20.3	36.9	23.5	9.0	12.0	10.8	8.8	52.3	20.5	17.3	9.5	10.1	6.2	7.7	40.8	9.8	7.6	5.8	14.9	11.2	108.7	13.7	9.3	12.8	86.6	9.9	9.0	7.9	46.3	3.2	10.1	23.4	8.9	10.6	7.1	13.2	21.5	28.0	33.0	16.6	23.5	22.1	8.1	5.1	4.4	11.0	25.3	17.4	3.0	6.0	10.7	9.4	12.2	9.2	5.2	2.8	13.1	11.2	4.4	8.0	12.9	5.7	13.0	8.3	5.5	5.8	5.5	17.8	3.8	12.2	18.1	15.6	7.7	9.2	16.4	5.2	22.6	14.3	4.6	7.7	3.0	0.7	7.2	10.2	12.4	7.8	7.5	7.3	11.1	5.0	7.0	9.4	6.6	4.2	9.9	15.6	12.7	2.8	19.6	8.9	9.3	4.5	6.5	10.2	9.6	11.7	19.5	27.3	28.0	23.5	33.0	14.6	12.2	11.4	16.1	21.1	13.2	7.5	12.5	20.7	16.6	25.8	21.5	15.5	22.1	30.2	36.0	14.3	38.8	36.9	23.5	52.3	20.5	40.8	46.3
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176602	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 41.6;testis: 12.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Enhanced	"Microtubules,Mitotic spindle,Centrosome,Cytosol"				Microtubules	"Mitotic spindle, Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.8	0.6	0.6	6.4	0.6	6.2	0.9	0.4	1.6	0.8	2.8	0.3	0.0	1.1	1.0	0.8	5.1	0.2	0.3	0.4	0.8	0.5	0.8	0.5	1.0	6.1	0.6	0.3	0.5	0.4	0.0	0.6	2.6	0.8	0.4	4.0	0.2	0.9	0.0	0.5	2.4	3.1	1.1	0.5	2.6	1.4	12.6	0.3	41.6	0.3	5.7	6.4	0.5	1.4	0.4	0.2	0.3	0.3	1.9	2.3	0.6	11.2	5.9	10.7	9.1	0.0	2.3	8.4	15.2	6.4	19.2	13.1	9.8	12.1	15.4	4.5	8.4	10.6	14.3	6.2	21.0	13.1	7.3	20.5	3.9	5.5	0.0	15.8	7.9	0.4	0.4	15.4	5.1	9.4	10.6	6.6	12.7	8.7	24.0	14.2	12.4	11.1	15.8	23.0	7.1	4.3	4.4	13.7	5.0	5.0	7.9	3.2	7.1	12.2	3.7	7.6	11.0	7.1	18.2	4.0	8.4	15.4	1.8	12.4	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.8	1.4	0.2	0.0	0.8	0.3	0.0	1.9	0.3	0.0	2.3	0.6	0.6	0.6	0.4	1.6	0.8	0.5	0.6	0.3	0.8	0.3
SKAP1	"SCAP1, SKAP55"	ENSG00000141293	"Src kinase associated phosphoprotein 1"	Q86WV1	17	48133440-48430275	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.9;lymphoid tissue: 52.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.6;HDLM-2: 10.1;HMC-1: 8.6;Karpas-707: 10.7;RPMI-8226: 12.6;RPTEC TERT1: 15.6;U-266/70: 9.7;U-266/84: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002969, CAB025882, CAB055513"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"CAB025882: , CAB055513: , HPA002969: AB_1079870"	"prognostic favourable (5.07e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (3.14e-4)"	1.9	9.4	0.5	28.0	0.6	2.9	4.5	0.4	0.6	5.9	3.8	0.6	10.9	1.1	2.2	10.6	2.1	8.0	6.2	2.1	1.3	1.1	12.9	2.0	5.2	20.0	0.7	0.4	2.4	2.8	11.6	17.5	0.7	1.2	3.0	2.4	1.6	10.2	7.4	0.5	1.2	6.1	1.2	1.9	11.7	2.2	7.8	0.6	52.1	1.8	1.3	27.7	5.1	4.3	11.9	0.1	2.1	0.2	22.3	50.9	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	19.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	15.6	0.0	0.0	0.0	1.0	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	9.7	6.9	0.0	0.0	0.0	0.0	2.1	0.1	0.3	35.9	0.0	30.1	2.8	29.6	32.2	0.1	11.9	26.1	28.9	0.7	22.3	0.2	0.1	50.9	22.3	0.5	0.6	0.4	0.6	1.3	1.1	0.7	0.4	1.2	0.6
SKAP2	"RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R"	ENSG00000005020	"Src kinase associated phosphoprotein 2"	O75563	7	26667062-26995239	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005560, HPA024045"	Enhanced		Supported	Nucleoplasm,Cytosol			3200000	Nucleoplasm	Cytosol	"HPA005560: AB_2667360, HPA024045: AB_2671416"	"unprognostic (8.52e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.51e-2)"	20.8	22.5	11.5	29.4	12.9	12.8	28.5	6.0	12.8	7.7	15.3	7.6	11.0	10.5	5.2	15.4	14.0	9.4	9.6	12.6	9.5	12.1	20.4	7.8	31.6	36.4	12.0	8.9	13.3	6.1	25.1	10.9	5.3	15.5	10.2	15.0	2.5	5.8	9.8	8.3	8.6	16.5	21.1	42.6	31.8	11.7	10.1	11.5	6.4	6.1	1.9	19.3	19.3	28.1	9.9	12.3	37.3	18.0	8.3	5.1	6.7	11.5	6.1	0.6	15.3	2.9	2.4	3.8	4.7	7.1	2.3	5.9	4.9	46.9	9.0	20.9	8.9	6.3	8.4	4.8	5.0	5.1	13.5	9.9	1.8	6.4	3.9	18.2	35.0	10.5	4.5	6.9	9.4	14.3	5.2	4.7	9.3	2.1	0.0	9.2	0.5	6.0	11.8	1.5	0.7	29.0	9.1	7.6	0.2	8.6	4.7	6.2	6.4	9.6	20.8	3.9	0.1	13.1	4.9	7.4	9.4	15.8	9.4	23.7	15.1	8.2	12.6	19.4	3.7	15.0	5.1	9.9	2.1	3.0	9.6	8.0	0.5	2.9	37.3	8.3	18.0	12.3	3.5	6.7	11.5	12.9	6.0	12.8	9.5	12.1	12.0	8.9	15.5	11.5
SKIDA1	"C10orf140, FLJ45187"	ENSG00000180592	"SKI/DACH domain containing 1"		10	21513478-21526368	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"thyroid gland: 9.6"	"Cell line enhanced"	"Detected in some"		"AF22: 22.6;AN3-CA: 5.8;BEWO: 10.5;SH-SY5Y: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039208, HPA040439"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA039208: AB_10795034, HPA040439: AB_10796122"	"unprognostic (5.36e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.45e-4)"	"unprognostic (9.97e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.93e-2)"	"unprognostic (3.38e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.20e-2)"	"unprognostic (8.52e-3)"	0.9	1.9	1.9	0.4	3.3	1.7	2.2	3.1	5.9	1.3	1.7	0.0	0.0	0.3	1.0	1.0	0.9	1.7	0.6	5.5	2.5	1.8	4.1	4.3	1.0	0.3	1.4	3.4	4.2	1.5	7.3	1.8	2.5	3.0	1.1	0.6	4.1	2.6	2.0	0.5	2.9	0.5	1.0	1.2	0.4	0.6	4.6	0.3	0.9	9.6	0.7	0.3	1.1	1.1	0.6	0.5	1.5	0.6	0.5	0.3	0.1	0.4	0.9	22.6	5.8	0.5	0.2	10.5	0.4	0.3	0.0	0.0	2.1	0.1	0.2	0.9	0.3	1.4	2.0	0.4	0.0	0.0	2.5	0.1	1.0	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.9	0.7	0.1	1.3	0.0	0.3	0.7	0.0	0.4	0.5	2.5	5.2	0.8	3.9	0.1	0.4	4.5	0.3	0.2	0.7	0.2	0.5	0.1	0.0	0.2	1.4	0.0	0.2	1.5	0.3	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.3	0.6	0.3	0.3	1.3	0.5	0.6	0.5	0.2	0.1	1.9	3.3	3.1	5.9	2.5	1.8	1.4	3.4	3.0	0.3
SKIL	"SNO, SnoA, SnoN"	ENSG00000136603	"SKI like proto-oncogene"	P12757	3	170357678-170396835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008472	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA008472: AB_1856933"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (1.19e-7)"	"unprognostic (2.94e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.34e-1)"	16.2	15.0	10.5	21.1	14.7	22.8	12.4	5.0	18.2	14.0	11.8	12.2	13.4	15.9	17.1	12.7	14.4	12.0	26.8	21.7	11.2	11.4	15.0	18.0	23.8	15.2	11.6	10.6	17.8	11.4	9.6	21.1	26.6	16.0	15.8	11.7	14.8	14.2	17.0	19.5	10.3	28.0	13.5	17.3	12.6	17.9	14.4	8.3	14.0	18.9	13.5	21.1	15.3	16.3	5.7	2.9	5.4	11.3	3.2	2.6	2.3	8.2	10.2	6.8	4.4	8.8	3.9	12.6	8.3	5.7	5.8	4.6	2.1	18.0	10.3	26.8	7.6	19.0	4.2	3.8	9.2	17.8	4.1	13.7	9.9	4.5	7.6	5.7	7.6	6.6	3.8	8.5	6.6	14.6	6.0	11.7	12.1	8.8	2.3	1.8	26.7	3.6	5.6	23.1	2.1	8.8	13.1	5.1	6.2	20.7	21.1	4.4	14.1	6.3	27.9	16.8	15.6	14.2	15.4	15.6	7.2	19.8	6.4	3.0	7.8	3.4	4.3	2.0	1.6	9.8	2.3	4.6	1.4	2.1	2.9	5.7	2.5	2.6	5.4	3.2	11.3	2.0	0.5	2.3	10.5	14.7	5.0	18.2	11.2	11.4	11.6	10.6	16.0	8.3
SKP1	"EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L"	ENSG00000113558	"S-phase kinase associated protein 1"	P63208	5	134148935-134177038	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB012982, HPA053745, HPA058134"	Approved		Supported	Nucleoplasm,Cytosol			600000	Nucleoplasm	Cytosol	"CAB012982: AB_2533076, HPA053745: , HPA058134: "	"prognostic unfavourable (7.53e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (5.72e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (5.20e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.40e-1)"	63.7	90.2	101.8	35.1	113.6	59.2	110.3	109.3	152.1	94.0	70.5	78.8	55.7	43.6	73.9	99.3	72.9	84.5	64.4	116.0	112.7	100.7	113.8	83.5	52.8	52.3	109.9	121.7	98.4	44.6	116.8	81.4	83.1	114.2	84.8	69.1	68.5	54.7	113.4	141.7	59.9	55.2	82.3	106.3	47.0	58.8	69.3	79.7	57.5	108.0	82.1	60.9	71.8	58.2	113.5	78.4	136.3	90.7	96.4	157.1	209.1	67.4	52.7	78.6	105.7	121.8	99.5	56.1	78.7	100.1	92.5	95.8	80.9	65.8	50.0	118.2	106.1	37.8	78.5	118.9	107.8	45.7	55.5	39.4	82.8	57.5	57.5	30.2	49.0	85.1	95.9	81.0	64.2	98.8	47.5	44.2	138.2	53.3	65.1	32.5	45.6	56.8	36.0	84.1	61.2	103.3	76.0	64.4	50.5	106.7	27.3	71.8	79.1	47.4	74.2	59.8	37.1	62.4	79.7	27.5	45.8	74.3	83.2	58.0	64.7	132.3	83.2	136.3	91.3	78.3	102.0	113.5	131.3	111.8	78.4	99.8	157.1	123.5	78.0	96.4	90.7	69.6	130.2	209.1	101.8	113.6	109.3	152.1	112.7	100.7	109.9	121.7	114.2	79.7
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36184319	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.1"	"Cell line enhanced"	"Detected in all"		"BEWO: 73.6;RH-30: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.72e-7)"	"prognostic favourable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	6.5	6.9	7.8	8.0	7.5	12.9	6.5	11.5	9.0	7.5	7.7	10.3	3.7	10.2	9.9	6.3	13.5	8.1	4.9	4.1	7.3	5.1	4.2	14.0	5.8	9.4	8.8	7.4	7.7	6.1	3.9	12.5	49.1	6.5	7.2	9.5	6.1	6.3	5.4	3.4	7.6	7.7	6.4	7.4	9.4	5.3	3.9	7.4	19.5	5.0	7.5	11.7	7.9	8.4	6.5	16.0	14.7	7.9	7.7	8.5	5.0	7.4	3.7	15.8	17.6	3.9	6.2	73.6	9.7	7.3	24.8	18.8	20.6	5.9	10.8	2.6	7.8	7.8	17.7	12.3	26.7	4.8	10.1	6.3	13.8	9.7	1.9	13.9	2.9	5.7	3.2	4.5	3.1	6.8	10.8	2.5	8.9	3.6	16.1	8.0	14.4	5.7	16.0	92.3	6.9	1.8	7.9	13.6	16.3	30.4	6.6	4.3	6.7	7.9	3.1	9.3	10.8	3.5	6.7	3.1	3.0	13.4	4.2	17.1	6.7	10.3	7.9	14.7	5.4	7.2	8.5	5.6	5.7	5.8	16.0	6.5	7.9	6.0	1.5	7.7	4.1	4.3	5.3	5.0	7.8	7.5	11.5	9.0	7.3	5.1	8.8	7.4	6.5	7.4
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341322-48426212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol			13000	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: "	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (5.77e-4)"	"prognostic favourable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	14.8	9.3	6.8	11.7	8.6	7.0	12.6	9.2	10.7	18.4	20.7	6.1	11.7	6.9	18.1	12.2	24.0	14.3	12.3	21.3	7.3	5.6	12.8	16.1	14.0	10.6	7.6	7.2	16.4	10.4	17.2	9.4	29.7	8.0	19.0	13.1	14.1	15.2	17.3	49.2	20.1	15.5	30.6	6.2	11.4	13.2	23.6	5.8	23.8	12.1	22.2	16.9	24.9	23.7	7.7	8.5	10.9	8.6	10.7	13.5	4.2	12.6	5.0	9.1	8.9	14.1	17.4	6.4	19.5	25.0	17.6	18.3	4.9	10.7	7.6	12.1	22.4	8.4	37.0	18.4	31.0	6.3	3.8	13.4	7.4	5.6	15.1	12.2	13.7	14.7	27.2	20.3	23.7	10.3	8.5	8.6	17.6	6.4	14.0	10.1	3.8	7.2	8.0	17.7	4.8	15.4	14.0	6.0	7.7	7.9	6.0	8.3	7.5	8.7	13.0	19.3	18.3	12.2	19.9	11.7	12.1	6.5	15.1	14.0	13.8	10.9	8.0	9.6	8.8	5.8	9.9	6.1	11.0	13.5	8.5	7.7	9.1	9.8	7.5	10.7	8.6	2.9	7.1	4.2	6.8	8.6	9.2	10.7	7.3	5.6	7.6	7.2	8.0	5.8
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.6;lymphoid tissue: 51.9"	"Group enriched"	"Detected in some"	5	"Daudi: 32.6;U-698: 48.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA051363: , HPA051903: "	"prognostic favourable (9.42e-4)"	"prognostic favourable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favourable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favourable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"	3.9	0.8	0.4	21.0	0.4	1.2	1.0	0.4	0.4	1.1	3.8	0.3	0.4	1.1	1.0	0.6	2.3	1.6	2.8	1.2	0.4	0.4	2.1	1.6	4.7	51.9	0.6	0.4	0.6	0.8	0.0	0.6	1.7	0.7	1.4	1.5	1.5	5.6	1.0	0.5	0.7	11.9	0.4	0.8	29.6	2.3	0.9	0.2	12.9	1.8	0.6	30.4	4.1	1.3	15.2	0.3	8.4	1.0	15.9	28.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	48.1	0.0	0.2	0.0	2.5	0.1	8.4	22.9	0.3	15.8	14.7	14.6	28.6	0.1	15.2	8.2	16.4	1.0	15.9	1.0	0.3	16.8	7.4	0.4	0.4	0.4	0.4	0.4	0.4	0.6	0.4	0.7	0.2
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692800-1712555	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	19.8	18.1	26.9	30.4	28.0	60.7	27.5	23.8	30.0	19.3	19.3	14.2	20.7	16.3	20.4	21.9	25.0	19.0	15.8	17.9	25.1	26.5	23.7	21.2	18.7	43.9	19.9	24.0	23.1	17.8	13.0	19.5	27.7	16.0	20.0	21.3	17.9	24.7	21.2	15.1	24.7	17.0	20.5	17.1	26.1	18.2	50.6	12.4	52.4	24.9	17.7	42.8	23.7	26.6	24.4	24.1	45.3	29.8	19.8	36.1	30.4	28.8	11.9	17.1	18.0	15.2	17.4	17.8	25.4	21.7	30.9	31.3	24.5	33.7	38.2	15.2	21.0	17.7	34.4	23.0	36.2	15.6	18.6	47.8	14.8	24.6	18.8	44.2	23.4	12.0	18.5	23.5	15.6	17.5	34.2	37.7	37.8	10.4	68.0	40.3	21.3	21.1	51.3	28.0	24.1	29.7	22.0	19.5	15.0	21.5	14.0	15.0	23.2	29.2	14.8	25.9	14.9	27.3	39.5	22.0	39.9	91.2	24.3	37.9	25.5	9.3	29.8	21.8	23.6	22.3	21.4	24.4	30.8	33.2	24.1	18.0	26.5	25.1	45.3	19.8	19.8	19.1	36.1	30.4	26.9	28.0	23.8	30.0	25.1	26.5	19.9	24.0	16.0	12.4
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229996-34338060	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 9.4;neutrophil: 18.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 18.5"					"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favourable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	8.7	5.8	7.4	12.4	11.1	27.5	7.0	10.2	14.1	14.7	8.0	12.7	3.6	8.3	6.3	8.7	24.9	4.7	6.3	6.9	6.8	6.9	18.6	4.9	11.5	10.9	9.9	8.4	5.8	5.1	5.4	10.9	5.2	12.5	5.0	7.4	9.7	9.3	4.9	10.5	8.6	10.2	6.0	9.2	11.1	8.0	38.5	10.9	18.2	10.6	8.2	13.6	8.2	21.2	2.0	1.0	18.5	1.4	0.6	2.3	0.7	2.6	3.1	2.0	2.8	6.3	7.4	1.3	3.9	9.1	3.0	4.4	1.8	4.3	1.8	3.7	4.1	26.7	4.7	3.2	3.6	0.7	3.2	14.2	8.0	4.1	3.9	8.5	15.6	4.3	5.7	8.9	18.0	9.2	3.1	4.2	4.1	0.9	0.9	6.8	1.5	3.4	4.3	3.4	1.8	3.4	6.7	4.3	3.2	4.3	0.1	0.9	1.9	2.9	5.7	3.5	2.6	12.2	0.9	3.7	4.1	1.1	4.2	6.3	1.5	9.4	1.1	2.3	0.5	1.4	0.3	1.2	0.8	0.7	0.7	2.0	1.3	1.1	18.5	0.6	0.6	1.0	2.3	0.7	7.4	11.1	10.2	14.1	6.8	6.9	9.9	8.4	12.5	10.9
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050376-1112035	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041652	Approved		Uncertain	Cytosol				Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavourable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favourable (3.16e-5)"	10.1	6.4	5.7	14.1	7.3	4.3	13.0	2.4	8.3	6.5	11.5	5.6	6.6	28.0	7.2	7.6	4.7	8.9	29.4	27.9	6.1	3.8	20.4	31.3	10.0	10.3	5.8	3.2	8.5	12.4	8.2	11.5	3.8	7.9	10.2	7.0	15.5	10.9	8.7	3.2	7.9	20.3	8.2	4.9	17.9	15.2	14.5	7.4	12.2	13.3	5.5	6.9	7.1	34.5	1.4	4.2	0.5	6.9	2.5	2.7	2.2	2.1	5.9	3.3	10.2	0.5	0.5	5.1	0.1	0.7	0.4	0.0	14.1	3.7	0.0	11.6	0.1	4.4	2.7	3.5	0.0	12.8	3.5	2.7	7.4	4.9	7.4	0.0	6.2	1.1	0.5	0.0	1.1	3.2	3.9	0.1	0.0	6.8	8.2	0.0	7.0	9.4	24.9	14.2	11.6	3.9	8.5	1.8	2.2	3.1	0.0	3.5	5.7	1.6	2.7	0.0	3.4	0.0	0.0	0.2	0.0	1.4	0.0	0.3	1.7	0.5	3.4	0.0	2.5	5.4	2.6	1.1	2.4	2.7	4.2	1.4	2.5	2.5	0.0	2.5	6.9	1.8	2.4	2.2	5.7	7.3	2.4	8.3	6.1	3.8	5.8	3.2	7.9	7.4
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684713-6713567	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	65	"liver: 150.4;salivary gland: 153.9"	"Cell line enriched"	"Detected in single"	61	"Hep G2: 35.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	0.8	1.0	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0.0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0.0
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752654	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 134.9"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 29.5;SK-BR-3: 29.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	51.7	0.2	0.3	42.7	1.9	2.2	0.9	0.1	16.6	0.1	0.1	0.1	6.3	8.2	0.2	0.1	0.1	0.1	0.2	7.1	4.3	0.3	1.0	0.3	0.9	0.5	0.2	0.3	0.3	0.1	9.9	134.9	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.7	0.4	0.5	1.9	1.1	1.1	2.3	0.7	1.2	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	29.5	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.6	1.7	0.6	0.1	0.3	0.0	29.4	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.7	0.9	0.3	0.8	0.8	0.7	0.7	0.2	1.1	0.9	0.8	2.2	1.2	0.4	1.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036075-7040121	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 55.9"	"Cell line enhanced"	"Detected in many"		"A549: 17.9;HaCaT: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA065245: "	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	2.5	1.3	1.4	3.5	0.8	0.2	1.6	1.5	1.0	1.8	4.9	0.7	1.2	8.0	1.1	1.4	5.0	1.5	3.2	1.3	1.2	0.7	12.0	55.9	2.9	7.6	0.8	0.5	1.7	2.8	2.7	1.0	3.3	0.7	1.5	1.3	1.8	3.5	1.5	0.5	4.5	10.2	0.7	0.6	4.8	1.6	0.7	0.3	3.6	3.0	2.4	5.8	1.8	2.4	6.8	2.8	2.4	2.2	2.7	3.9	1.3	10.0	17.9	4.2	2.6	2.6	1.5	1.8	1.0	2.6	2.3	5.3	5.8	11.3	6.4	1.7	1.6	15.9	3.3	5.5	0.9	7.9	2.2	2.6	1.4	13.8	3.0	0.9	6.2	1.7	6.3	3.4	2.8	9.5	3.0	1.8	2.4	5.0	3.8	1.6	1.7	1.4	1.8	1.4	1.1	2.2	2.8	0.2	1.1	3.1	1.8	1.4	4.8	1.4	3.5	1.5	3.5	2.4	1.5	3.2	6.6	0.4	4.4	2.3	0.7	0.0	2.0	2.2	3.2	1.9	2.3	2.3	2.9	3.9	2.1	6.8	3.1	2.9	2.4	2.7	2.2	2.8	3.0	1.3	1.4	0.8	1.5	1.0	1.2	0.7	0.8	0.5	0.7	0.3
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362848-110391082	"Predicted membrane proteins"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.4;placenta: 76.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.6;BJ hTERT+: 12.7;CAPAN-2: 18.8;HHSteC: 12.6;SK-MEL-30: 19.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.0"	"Group enriched"	"Detected in many"	4	"B-cells: 5.0;granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"				"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: , HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	3.8	2.4	1.9	2.1	2.8	0.6	3.4	2.3	1.7	2.7	4.5	2.9	2.7	4.7	2.3	11.9	4.3	2.4	9.6	4.0	2.6	2.1	61.4	7.9	6.1	1.4	2.7	1.4	21.3	0.8	0.5	3.5	76.5	6.9	3.7	0.9	17.3	1.9	3.2	1.1	0.8	14.0	1.8	3.6	2.0	2.5	4.0	1.8	0.0	8.0	1.3	1.3	3.1	3.0	5.0	0.1	1.3	0.6	0.0	0.7	0.3	0.2	6.0	1.3	1.9	4.3	8.5	12.6	3.3	12.7	1.1	3.2	1.8	18.8	0.3	3.5	10.3	0.3	0.1	1.2	1.2	0.3	1.5	0.3	1.3	1.9	12.6	0.4	0.3	6.3	0.2	1.9	0.1	2.6	0.3	0.6	2.1	0.6	0.2	0.3	0.4	0.2	0.1	0.9	0.1	2.2	0.3	0.7	0.4	0.3	6.1	19.3	0.3	0.0	0.3	0.7	0.5	0.2	0.9	0.3	0.1	0.9	0.6	0.3	3.5	0.0	0.6	0.3	0.5	0.2	0.2	5.0	0.6	0.1	0.1	1.0	0.6	0.7	1.3	0.0	0.2	0.0	0.2	0.3	1.9	2.8	2.3	1.7	2.6	2.1	2.7	1.4	6.9	1.8
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73654155	"Disease related genes, Predicted membrane proteins"	"Amino-acid transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 155.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.9;ASC TERT1: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.09e-1)"	7.2	5.8	6.4	2.9	6.8	2.9	9.6	6.3	6.8	4.9	7.8	4.7	12.5	6.5	5.1	17.2	5.0	3.4	6.2	6.2	4.5	6.7	24.3	13.2	7.6	4.9	5.0	4.5	3.4	8.7	155.6	9.3	12.6	6.7	6.9	8.6	6.6	15.5	8.6	3.5	4.8	12.9	4.6	5.9	4.3	6.0	4.1	4.7	3.0	30.5	2.6	7.1	5.9	4.3	5.2	9.9	12.4	10.6	12.0	9.4	6.0	2.7	3.8	3.8	6.1	40.9	30.5	5.1	9.2	23.1	2.5	8.7	2.5	6.8	2.5	4.4	12.8	4.9	5.3	2.3	4.4	1.8	6.1	1.1	2.0	5.8	8.2	2.1	4.3	13.9	3.4	5.6	3.9	6.3	2.7	2.8	8.6	1.8	0.8	1.2	2.8	2.2	1.8	4.7	10.9	6.4	7.7	1.5	2.7	1.8	5.5	5.3	2.5	13.0	9.2	1.2	1.1	4.9	2.1	8.0	11.2	0.7	4.1	4.5	3.6	12.4	10.6	4.2	8.5	9.7	8.3	5.2	9.4	8.1	9.9	3.7	7.8	8.6	7.4	12.0	6.0	7.4	8.2	6.0	6.4	6.8	6.3	6.8	4.5	6.7	5.0	4.5	6.7	4.7
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132798553	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 23.4;RPTEC TERT1: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029747, HPA049659"	Approved		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA029747: AB_10600797, HPA049659: "	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favourable (3.55e-4)"	"prognostic unfavourable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.3	7.3	26.2	6.0	21.9	4.5	11.0	13.1	20.6	9.4	9.5	18.8	3.1	14.4	7.0	7.8	10.7	10.1	11.5	4.2	21.6	15.8	11.8	6.0	5.7	7.2	19.5	10.8	7.4	7.8	13.0	6.9	15.5	17.0	5.0	11.4	7.4	11.7	4.9	4.8	10.5	10.4	5.8	21.7	7.0	14.9	2.3	16.3	8.3	10.1	5.9	8.6	10.6	5.5	7.5	15.6	0.6	11.3	2.8	9.4	6.5	3.9	3.7	6.4	0.0	0.8	2.4	3.9	1.4	4.5	2.9	9.2	8.3	8.2	0.1	5.8	0.8	11.1	8.7	9.7	2.3	5.8	16.3	2.1	6.9	10.0	4.9	1.9	0.2	6.5	9.4	4.5	9.8	9.2	23.4	1.5	2.4	5.6	6.0	0.2	8.5	5.3	9.7	7.0	6.5	23.7	7.0	12.9	0.0	7.7	15.3	12.2	5.3	0.0	4.2	1.3	3.4	1.3	3.8	5.1	0.4	0.2	7.0	0.2	1.0	0.0	11.3	0.5	3.7	2.5	6.7	5.5	5.7	5.2	15.6	7.5	8.2	5.6	0.6	2.8	0.2	12.1	9.4	6.5	26.2	21.9	13.1	20.6	21.6	15.8	19.5	10.8	17.0	16.3
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169486003	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol				Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favourable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favourable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	23.1	11.1	1.9	5.3	4.4	4.8	14.2	7.4	6.1	5.9	5.4	2.8	2.7	2.1	5.0	9.0	7.5	10.0	17.5	14.8	2.7	2.1	8.6	23.4	9.2	3.1	2.8	1.7	10.3	14.4	6.8	16.3	22.1	4.7	9.4	2.8	16.4	10.4	4.6	75.7	7.5	6.6	11.3	3.7	1.8	9.4	7.3	1.8	3.6	7.9	21.6	3.9	10.4	9.8	1.4	1.9	3.0	4.6	2.6	3.3	0.7	4.4	3.1	7.2	5.6	22.3	8.2	15.8	3.6	2.6	2.9	4.2	12.8	4.7	4.0	4.1	2.4	4.8	8.6	5.2	3.3	11.3	8.1	3.8	10.2	11.7	12.2	9.4	3.7	9.7	7.7	4.7	12.0	4.3	15.0	2.5	4.9	3.0	4.8	4.2	16.2	4.8	0.0	15.5	4.5	7.7	9.5	6.2	8.4	4.9	8.5	17.4	5.3	6.1	3.6	3.5	4.9	4.3	6.9	3.5	3.3	1.3	5.2	3.7	4.6	0.0	1.7	3.0	0.9	0.7	3.3	1.4	1.1	2.1	1.9	1.2	3.1	3.0	1.1	2.6	4.6	0.7	1.0	0.7	1.9	4.4	7.4	6.1	2.7	2.1	2.8	1.7	4.7	1.8
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718031	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.2;breast: 78.2;placenta: 27.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	48.2	0.6	2.2	1.8	2.4	1.2	78.2	1.5	1.9	0.5	6.1	1.0	0.5	7.7	0.6	0.4	0.6	0.6	8.9	1.9	2.3	2.4	2.1	16.0	5.6	1.3	3.0	0.7	0.9	1.3	0.2	0.3	27.5	2.6	0.5	1.6	0.7	0.9	0.2	0.7	1.6	4.5	0.5	2.6	0.5	0.5	0.6	1.5	0.0	0.5	0.4	0.4	1.0	2.3	2.6	1.8	8.6	1.8	4.3	1.1	0.4	0.3	1.6	0.3	1.0	14.1	0.4	7.2	0.1	0.2	0.3	0.6	18.4	0.5	0.4	0.2	0.1	0.5	0.5	0.5	0.8	0.1	1.2	0.1	0.9	0.7	1.7	0.2	0.2	3.2	0.4	0.1	0.9	0.0	0.2	0.8	0.0	1.8	0.1	0.6	3.2	0.3	0.3	0.2	0.2	0.2	0.3	1.0	0.1	0.5	2.0	0.5	0.3	0.2	0.5	0.5	0.5	4.1	0.3	0.2	0.1	0.6	1.4	0.3	0.4	8.6	1.8	1.7	1.0	1.2	0.6	1.6	0.8	0.9	0.4	2.6	1.0	1.1	6.1	4.3	1.1	1.8	0.4	0.4	2.2	2.4	1.5	1.9	2.3	2.4	3.0	0.7	2.6	1.5
SLC22A23	"C6orf85, FLJ22174"	ENSG00000137266	"Solute carrier family 22 member 23"	A1A5C7	6	3268962-3457022	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014697	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA014697: AB_1844371"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.57e-4)"	"unprognostic (5.16e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.53e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (2.39e-4)"	"unprognostic (8.91e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	7.4	2.2	9.0	4.6	16.2	8.1	9.3	8.4	14.8	5.6	17.4	30.8	3.4	19.6	3.6	11.8	16.8	11.3	7.5	2.2	11.0	8.1	6.9	12.6	8.0	3.9	28.6	8.7	3.0	14.9	14.8	6.5	8.3	17.8	14.2	14.4	5.7	10.0	2.8	5.9	14.9	20.3	3.0	17.5	4.6	26.0	7.2	21.0	5.2	4.1	9.8	9.9	3.8	9.9	0.1	0.7	0.8	0.3	0.3	1.4	1.9	2.4	5.7	12.6	14.0	4.5	5.0	16.1	0.4	0.1	0.7	0.3	12.6	0.4	0.6	1.5	2.7	3.6	2.5	6.7	0.2	2.0	7.8	5.9	2.2	11.1	0.6	0.3	0.4	1.2	13.2	12.2	0.6	0.4	5.3	3.4	0.4	2.9	0.5	1.4	4.3	2.3	1.3	0.8	10.0	0.0	15.4	1.4	0.2	3.3	4.8	4.1	18.7	0.1	3.1	7.4	2.3	9.5	1.5	7.6	0.1	0.2	12.9	0.4	4.5	0.0	0.3	0.0	0.4	0.0	0.2	0.0	1.0	0.4	0.2	0.1	1.4	0.9	0.8	0.3	0.2	0.7	0.0	1.9	9.0	16.2	8.4	14.8	11.0	8.1	28.6	8.7	17.8	21.0
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348268-160452581	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 98.6"	"Cell line enhanced"	"Detected in some"		"A549: 17.4;HeLa: 23.4;Hep G2: 14.5;RPTEC TERT1: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029750	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavourable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavourable (7.26e-4)"	4.1	6.9	1.0	2.1	1.3	0.0	5.2	1.8	0.9	7.6	4.1	0.9	4.1	0.2	14.2	11.8	4.1	9.0	9.0	1.1	1.2	1.3	2.4	15.2	12.7	9.7	2.2	0.9	10.3	1.3	0.0	0.9	17.8	1.9	18.9	0.6	0.9	34.5	23.0	98.6	5.1	2.7	10.8	4.4	0.3	2.9	3.4	0.6	0.4	3.4	5.7	2.1	3.2	7.3	0.0	0.0	0.8	0.0	0.1	1.5	0.0	0.0	17.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	4.5	0.0	0.0	0.2	0.0	0.0	0.0	23.4	14.5	0.8	0.0	0.0	0.5	4.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.9	0.0	0.0	0.0	8.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.0	1.0	1.3	1.8	0.9	1.2	1.3	2.2	0.9	1.9	0.6
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171784370-171999859	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	6.4	6.7	8.8	6.2	18.2	2.9	9.2	17.9	25.0	10.6	12.2	5.7	5.2	4.2	10.4	7.1	11.5	6.9	5.9	42.4	9.9	13.4	10.7	1.9	5.2	6.5	10.4	12.4	10.0	3.5	16.4	14.7	4.7	15.2	10.6	10.0	11.0	21.7	14.8	84.7	7.6	5.7	14.3	7.1	5.6	9.0	4.3	6.2	5.8	10.1	23.8	8.4	10.0	6.7	6.4	3.6	5.1	4.6	6.6	8.1	2.9	7.1	5.3	5.6	12.8	16.5	18.7	0.1	9.1	15.5	12.4	11.9	2.8	6.7	22.6	6.0	10.6	9.0	11.7	11.4	15.6	13.8	10.9	9.8	7.6	6.6	6.3	19.8	9.8	16.3	11.3	14.4	4.1	12.8	6.8	10.4	7.9	4.3	13.9	8.3	4.5	7.4	14.5	8.0	11.8	13.0	6.3	7.8	2.5	5.7	13.5	7.2	4.9	5.9	8.8	10.3	4.5	11.5	6.2	14.0	9.0	22.9	14.3	10.5	7.0	5.1	3.0	1.6	6.5	3.9	7.3	6.4	4.5	6.8	3.6	3.9	6.3	8.1	0.2	6.6	4.6	0.6	4.5	2.9	8.8	18.2	17.9	25.0	9.9	13.4	10.4	12.4	15.2	6.2
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856931-48898993	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.8;liver: 58.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.6;RPMI-8226: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Supported	Mitochondria,Cytosol			13000	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	11.9	13.7	6.7	5.6	7.3	3.4	10.2	3.0	5.6	3.3	19.7	4.7	5.2	25.0	4.7	3.1	3.3	5.0	9.9	37.1	7.3	4.6	16.8	58.3	6.6	4.9	8.5	5.1	2.7	16.8	5.9	5.1	3.3	5.8	5.0	9.1	5.4	7.4	3.7	27.4	4.0	32.2	5.7	5.5	8.8	7.5	4.4	6.6	9.1	5.5	5.5	5.9	4.5	9.8	9.4	33.3	57.8	29.0	17.3	28.4	24.7	1.4	4.4	3.5	4.9	11.3	4.3	0.7	7.8	4.2	5.5	5.7	5.5	6.8	6.5	5.5	12.3	1.4	8.7	3.5	4.1	16.4	4.1	9.0	6.9	6.9	5.1	9.4	17.4	5.5	4.0	7.4	1.2	7.0	8.0	34.6	7.2	3.7	10.3	4.7	1.8	9.9	3.7	2.1	47.7	5.9	3.4	1.4	5.0	7.2	0.0	4.0	11.0	4.4	5.7	6.2	1.1	9.1	5.7	12.9	8.9	7.5	9.0	6.7	8.2	13.8	29.0	57.8	28.4	21.0	18.1	9.4	16.1	20.8	27.0	7.8	12.7	21.3	13.5	17.3	21.4	33.3	16.1	24.7	6.7	7.3	3.0	5.6	7.3	4.6	8.5	5.1	5.8	6.6
SLC25A36	"FLJ10618, PNC2"	ENSG00000114120	"Solute carrier family 25 member 36"	Q96CQ1	3	140941830-140979933	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027036	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoplasm	"HPA027036: AB_1857048"	"unprognostic (4.12e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.03e-2)"	"prognostic favourable (1.55e-4)"	20.2	16.9	14.9	13.4	20.5	36.5	25.2	18.7	31.3	23.5	19.4	18.3	17.3	22.3	25.6	37.3	12.2	25.1	13.7	29.5	15.9	19.0	29.0	3.1	22.4	18.6	15.6	16.7	32.6	33.9	29.7	26.3	19.1	21.6	20.6	14.8	21.1	17.5	17.7	60.6	16.2	17.2	20.4	18.5	14.1	23.6	24.4	12.2	15.4	23.7	15.1	12.7	20.7	18.5	17.0	14.9	15.7	13.1	18.1	16.6	10.9	23.5	5.3	17.4	14.2	15.9	20.4	21.8	8.9	11.4	10.0	14.2	14.8	11.2	19.6	22.2	7.5	15.8	20.9	8.7	20.4	15.0	17.0	16.3	12.9	9.3	24.0	23.1	10.1	23.0	29.3	7.3	22.5	10.5	8.6	12.7	14.5	10.2	13.8	15.9	17.2	10.0	15.0	15.4	27.9	11.7	8.1	11.2	18.3	12.0	21.9	38.7	15.2	13.2	10.6	13.9	7.8	24.6	8.5	25.9	16.9	23.0	18.0	9.7	6.9	10.5	10.4	15.7	11.4	13.1	13.3	17.0	11.7	12.5	14.9	16.0	16.6	15.7	1.8	18.1	13.1	10.9	10.2	10.9	14.9	20.5	18.7	31.3	15.9	19.0	15.6	16.7	21.6	12.2
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528805-23575463	"Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.8"	"Cell line enriched"	"Detected in all"	4	"HEL: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 28.9"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 28.9"	"Low region specificity"	"Detected in all"							HPA045680	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8.0	15.0	8.6	1.9	9.0	5.9	5.7	13.9	33.0	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.9	4.3	4.6	4.2	6.1	7.5	6.9	3.1	4.1	2.3	2.6	4.3	8.5	6.4	3.8	2.6	5.1	4.2	8.5	3.2	1.0	2.2	49.4	7.2	1.5	5.1	2.7	1.9	6.4	8.3	5.0	5.0	3.6	10.8	3.2	3.6	1.7	3.3	11.7	2.4	3.4	3.5	2.3	2.5	7.1	2.2	1.4	2.0	4.3	6.6	3.1	1.8	4.3	5.7	11.2	1.7	6.6	6.0	2.6	1.0	4.0	10.6	6.8	7.0	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 60.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.7;Karpas-707: 18.6;RPMI-8226: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA050821	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA050821: "	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favourable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	2.2	1.8	2.1	4.0	2.3	3.1	3.2	1.0	2.6	1.7	4.5	4.0	4.7	4.1	1.0	5.4	1.5	1.3	1.3	2.8	2.5	1.1	3.9	7.7	5.3	9.4	1.8	2.3	1.3	60.5	4.2	4.7	1.2	2.3	2.5	1.2	3.5	5.0	1.3	4.1	2.0	11.0	1.5	2.3	9.6	1.9	2.4	2.0	5.8	9.0	2.8	8.2	1.9	1.7	10.8	19.2	6.0	10.1	13.5	11.4	2.5	0.3	4.6	0.2	6.8	1.3	0.6	3.4	0.8	2.1	0.4	0.4	1.0	2.2	4.1	3.9	1.9	0.5	0.5	0.3	0.0	13.7	1.0	4.4	2.5	0.3	0.8	1.4	4.7	1.6	0.1	0.5	0.4	0.7	0.6	18.6	0.7	1.5	3.2	0.1	0.3	2.1	6.0	0.9	13.4	0.7	0.0	2.3	3.0	1.4	3.6	0.7	1.8	0.7	1.3	0.5	1.7	4.4	0.3	7.7	4.8	1.1	1.4	1.0	2.6	6.0	5.5	3.9	7.9	9.0	8.4	8.9	7.0	7.5	5.7	10.8	11.4	8.5	3.3	13.5	10.1	19.2	6.3	2.5	2.1	2.3	1.0	2.6	2.5	1.1	1.8	2.3	2.3	2.0
SLC26A6	DKFZp586E1422	ENSG00000225697	"Solute carrier family 26 member 6"	Q9BXS9	3	48625723-48635493	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048363	Approved		Uncertain	Cytosol				Cytosol		"HPA048363: AB_2680371"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.92e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.66e-3)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.58e-2)"	5.3	5.7	6.4	12.3	9.8	18.8	5.7	6.8	6.9	6.3	24.8	6.0	7.3	9.7	6.8	7.4	6.5	4.7	6.3	6.7	4.9	3.1	13.6	6.2	7.8	7.4	9.4	3.1	6.7	14.9	6.8	5.8	6.5	9.3	10.2	25.4	7.7	9.6	7.4	8.8	6.7	19.5	6.8	4.8	10.6	19.7	7.7	9.9	7.7	5.5	5.4	6.3	5.1	6.6	0.9	8.8	5.2	10.7	0.5	3.3	4.5	4.4	5.0	7.3	8.1	22.9	11.5	6.2	7.4	9.8	14.5	15.5	9.6	4.2	6.4	2.6	6.3	6.0	6.7	6.9	4.2	4.8	6.7	5.8	14.3	18.5	16.6	2.8	9.1	15.6	24.6	9.8	7.1	4.4	4.5	7.4	3.5	5.3	5.3	14.6	10.3	9.8	2.7	2.7	7.8	10.6	4.4	1.8	3.5	9.7	12.0	13.9	6.2	10.4	3.6	6.2	5.2	8.4	16.9	8.7	9.1	2.9	5.3	10.9	15.7	5.2	10.7	2.1	3.1	10.0	2.8	0.9	1.9	2.0	8.8	0.2	1.1	1.6	1.5	0.5	8.9	5.0	3.3	4.5	6.4	9.8	6.8	6.9	4.9	3.1	9.4	3.1	9.3	9.9
SLC27A1	"ACSVL5, FATP, FATP1, FLJ00336, MGC71751"	ENSG00000130304	"Solute carrier family 27 member 1"	Q6PCB7	19	17468769-17506168	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.5;SK-MEL-30: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076520			Approved	"Plasma membrane,Mitochondria,Cytosol"				"Plasma membrane"	"Mitochondria, Cytosol"	"HPA076520: "	"unprognostic (1.48e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"prognostic favourable (4.70e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	14.5	14.3	13.1	5.2	13.9	2.0	9.3	20.1	19.3	11.8	6.4	44.1	10.1	4.6	8.9	6.4	5.9	14.7	11.0	18.3	12.9	10.0	5.2	5.2	8.5	6.7	22.0	17.2	23.2	14.5	26.1	9.8	7.5	16.1	11.0	2.6	9.6	26.7	13.0	24.2	13.7	3.7	5.5	13.4	7.1	10.9	9.6	19.3	1.3	9.9	4.7	5.3	6.9	8.8	0.5	7.4	0.3	9.9	1.7	3.2	4.6	3.6	1.8	2.5	6.0	17.5	9.8	2.1	2.6	6.9	3.0	4.5	0.2	11.2	1.2	5.0	4.3	4.4	0.2	4.1	0.7	1.4	0.8	0.7	0.2	1.3	3.4	0.3	4.0	9.0	2.9	3.0	1.2	2.0	0.4	0.7	1.9	1.5	1.9	2.9	0.7	3.2	2.8	2.0	0.8	1.9	1.1	0.8	1.8	1.8	0.9	28.9	3.2	0.9	1.2	5.9	3.8	4.6	1.8	2.5	1.8	0.4	6.0	3.1	4.1	0.0	9.9	0.3	1.7	4.7	3.2	0.5	1.2	2.1	7.2	0.3	1.6	2.1	0.0	1.7	1.8	7.4	0.7	4.6	13.1	13.9	20.1	19.3	12.9	10.0	22.0	17.2	16.1	19.3
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.7;epididymis: 41.0;testis: 19.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6"	"Group enriched"	"Detected in many"	7	"amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: , HPA067637: "	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.5	1.9	15.8	0.5	11.4	0.5	0.4	0.4	28.7	0.5	0.5	0.0	1.9	0.4	0.5	41.0	0.4	0.7	0.4	5.0	10.2	0.8	0.4	0.5	0.5	0.8	1.1	12.1	0.5	0.4	0.6	0.4	0.4	1.6	0.6	0.5	0.7	0.4	0.9	0.4	0.4	0.5	0.5	0.7	0.5	0.4	19.5	0.0	0.0	0.4	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.0	1.5	0.0	0.2	0.1	0.0	0.0	1.0	1.0	0.3	0.4	0.0	0.0	0.0	0.2	8.8	0.0	0.2	0.0	1.0	5.0	0.2	11.7	0.2	0.1	2.0	0.0	0.0	0.5	0.0	0.7	1.4	0.0	0.1	3.8	0.0	0.3	1.4	0.0	18.9	9.8	1.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.7	0.0	0.2	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	15.8	11.4	0.4	28.7	10.2	0.8	1.1	12.1	1.6	0.0
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Group enriched"	"Detected in some"	12	"HEL: 6.6;U-937: 4.3"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"				"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: , HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.2	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in some"	81	"BEWO: 12.3;EFO-21: 46.6;RPTEC TERT1: 33.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037989	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus"	"HPA037989: AB_10670536"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0
SLC35E4		ENSG00000100036	"Solute carrier family 35 member E4"	Q6ICL7	22	30635652-30669016	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 20.2;testis: 22.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.7;U-2197: 14.2;U-87 MG: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049558	Approved		Approved	Cytosol				Cytosol		"HPA049558: "	"unprognostic (2.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-4)"	"unprognostic (5.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-7)"	"unprognostic (2.77e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.05e-3)"	4.0	2.5	5.6	3.3	11.8	3.4	2.6	4.0	11.4	2.7	5.9	8.1	2.1	2.7	4.2	3.5	4.5	3.1	2.9	5.6	5.2	4.7	2.0	1.1	2.4	2.1	13.0	6.3	2.8	4.1	3.1	2.8	1.6	6.6	2.9	4.2	2.4	2.6	3.5	20.2	7.3	2.5	3.5	2.6	2.4	3.8	22.5	10.1	0.0	2.0	6.6	2.1	3.6	7.6	0.7	3.6	1.6	2.8	2.1	3.2	0.9	6.4	2.8	1.1	2.1	2.9	7.5	0.6	4.2	3.7	2.9	2.7	0.2	1.8	0.4	2.3	4.3	4.1	1.9	2.4	1.5	14.7	2.1	0.1	2.1	0.2	4.2	0.3	1.8	2.4	1.1	11.7	3.7	9.9	0.6	1.9	4.5	1.8	0.2	1.3	1.3	10.7	1.1	2.2	0.2	1.3	0.5	5.8	2.3	4.4	1.9	2.0	1.3	0.5	13.1	12.5	3.9	14.2	4.0	0.6	0.5	0.2	15.2	0.2	3.2	1.6	2.1	0.3	0.9	2.8	1.4	0.3	2.1	3.2	3.6	0.7	2.1	1.7	0.8	2.1	2.2	1.0	2.3	0.9	5.6	11.8	4.0	11.4	5.2	4.7	13.0	6.3	6.6	10.1
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907526-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 41.9"	"Group enriched"	"Detected in some"	9	"AF22: 23.3;WM-115: 39.2"	"Group enriched"	"Detected in some"	16	"glioma: 15.1;melanoma: 3.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"				Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	2.8	2.7	13.8	2.1	14.5	0.9	1.2	3.6	41.9	1.7	3.5	4.3	0.0	1.6	2.7	5.5	1.8	1.5	1.8	5.3	10.4	10.2	1.7	1.0	1.1	1.0	9.3	15.3	1.4	1.4	1.0	0.6	1.0	5.6	2.3	2.3	2.6	1.7	2.9	1.2	1.6	1.8	2.6	4.1	1.6	1.4	1.8	5.6	0.0	1.8	0.0	1.0	1.4	2.6	0.2	0.6	1.0	0.1	0.3	0.9	0.1	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	2.9	3.3	0.0	0.0	0.1	0.0	39.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.0	0.3	0.0	0.6	0.0	0.1	13.8	14.5	3.6	17.4	10.4	10.2	9.3	15.3	5.6	5.6
SLC35F6	"ANT2BP, C2orf18, FLJ20555, TANGO9"	ENSG00000213699	"Solute carrier family 35 member F6"	Q8N357	2	26764284-26781231	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 47.8;Karpas-707: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034655	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA034655: AB_10696359"	"unprognostic (2.26e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.11e-4)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-2)"	37.3	24.1	9.7	10.5	11.7	6.5	42.2	8.3	15.6	17.9	14.5	16.0	12.4	10.4	14.1	14.0	25.2	12.5	14.4	15.0	10.4	11.6	37.4	25.4	15.3	22.0	12.3	9.3	20.4	12.6	13.1	12.2	26.6	11.9	15.3	9.0	13.8	16.7	14.2	16.7	30.9	14.7	15.4	11.4	14.8	16.3	11.7	9.1	10.5	24.1	20.4	15.5	13.8	18.2	3.1	7.1	7.8	19.0	8.6	8.8	5.9	8.1	14.5	4.4	11.2	15.2	6.9	6.8	4.7	7.2	6.0	5.5	9.1	15.8	2.2	7.9	6.5	10.3	6.3	9.3	4.3	3.8	3.1	2.4	5.6	7.6	47.8	2.7	12.6	10.9	9.6	6.8	22.8	6.9	4.6	42.1	6.0	13.3	3.3	2.4	2.4	3.8	3.0	12.7	3.4	15.9	6.6	3.3	4.4	7.8	12.9	8.4	4.8	2.8	6.3	7.8	8.4	10.7	5.1	8.1	10.2	4.3	8.4	4.6	7.1	7.0	12.0	5.3	8.8	16.5	5.0	3.1	6.1	8.0	7.1	2.5	4.2	6.0	7.8	8.6	19.0	5.5	3.8	5.9	9.7	11.7	8.3	15.6	10.4	11.6	12.3	9.3	11.9	9.1
SLC36A4	"FLJ38932, PAT4"	ENSG00000180773	"Solute carrier family 36 member 4"	Q6YBV0	11	93144171-93197964	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017887	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017887: AB_2190238"	"unprognostic (1.23e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.04e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.45e-3)"	"unprognostic (4.20e-2)"	8.0	11.0	16.0	12.6	19.3	24.1	6.5	20.7	20.2	8.0	7.3	8.7	2.1	3.0	10.4	3.6	7.8	6.2	8.4	9.2	14.2	14.8	13.7	11.0	8.2	7.0	16.8	10.3	8.6	8.0	8.0	17.2	8.7	17.6	7.5	9.4	5.4	5.4	9.1	3.4	5.9	4.2	11.5	20.0	5.7	6.4	6.0	13.4	5.6	12.7	2.3	9.2	8.6	7.7	1.6	2.9	8.1	7.7	0.8	2.6	1.8	5.1	9.1	18.7	3.7	6.6	13.6	10.5	8.8	14.8	13.2	16.1	7.3	16.8	6.2	5.1	8.2	6.3	5.7	3.2	12.2	10.3	6.7	7.1	19.2	4.8	5.2	17.9	10.6	6.5	10.3	7.6	4.8	7.1	0.6	0.1	13.5	1.3	7.8	13.5	7.5	9.3	3.5	11.1	2.5	4.4	7.6	17.4	22.6	12.9	5.0	3.2	9.2	5.2	7.8	25.0	7.7	14.7	12.9	2.6	5.2	0.0	5.6	7.5	12.9	0.2	7.7	8.1	1.3	3.9	1.8	1.3	1.0	1.6	2.9	1.6	2.6	1.7	2.5	0.8	2.5	1.1	0.8	1.8	16.0	19.3	20.7	20.2	14.2	14.8	16.8	10.3	17.6	13.4
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 107.8"	"Group enriched"	"Detected in some"	4	"Hep G2: 31.7;SCLC-21H: 10.5"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"					"Cell type enhanced"	"Detected in some"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol				Cytosol	Microtubules	"HPA031871: "	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	0.7	0.3	3.4	0.3	5.2	0.5	0.7	2.4	10.5	0.3	0.3	10.3	0.0	0.7	0.4	0.4	0.6	0.4	0.4	2.0	4.1		1.5	107.8	0.3	0.4	3.4	4.0	2.4	11.6	1.8	0.7	0.6	7.8	0.4	0.3	22.2	0.9	0.3	10.4	0.5	0.4	0.3	4.7	0.3	0.9	0.7	5.2	0.0	0.6	1.9	0.4	0.3	0.0	1.1	1.0	5.6	0.8	1.5	0.8	0.2	0.0	0.0	0.8	4.8	0.0	0.0	1.2	0.0	0.0	0.9	0.4	2.9	0.1	0.1	0.8	0.0	0.0	1.2	0.0	0.6	0.1	0.4	0.0	0.6	31.7	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.4	0.5	0.0	0.4	0.3	0.0	0.1	0.2	10.5	0.9	0.5	0.1	0.0	1.3	0.2	0.0	0.2	0.9	0.0	0.6	0.3	0.0	0.1	0.1	0.2	0.1	5.6	0.8	0.9	0.6	0.2	0.4	0.7	0.5	0.4	0.2	1.1	0.6	0.8	3.3	1.5	0.2	1.0	0.4	0.2										
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470256	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 87.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 53.2;HeLa: 52.4;hTCEpi: 39.6;Karpas-707: 46.8;RPMI-8226: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	1.5	0.9	5.3	4.7	7.1	17.3	0.9	3.5	11.6	4.0	4.9	7.7	0.1	5.1	1.8	1.3	3.7	2.0	1.5	2.4	6.9	5.7	0.7	0.4	9.4	3.3	7.0	2.7	3.7	87.7	0.4	0.4	2.8	14.6	5.1	6.4	1.5	4.4	3.7	0.4	8.0	3.5	2.8	7.3	4.8	4.5	0.5	4.6	2.4	7.9	3.6	3.4	4.8	3.1	7.4	8.3	0.3	0.4	5.4	16.2	5.7	22.5	0.0	0.0	0.2	0.4	2.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	23.7	0.0	9.9	34.9	27.0	53.2	0.0	7.5	0.0	12.9	52.4	16.3	3.9	26.3	0.0	3.7	39.6	0.4	0.1	0.4	23.6	46.8	5.3	0.0	5.7	9.1	12.2	0.1	20.9	0.1	86.2	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	8.5	0.2	0.1	0.1	0.0	0.2	0.2	11.5	0.4	16.2	7.4	12.6	10.8	1.5	4.7	6.0	7.7	0.3	5.4	0.0	8.3	13.0	5.7	5.3	7.1	3.5	11.6	6.9	5.7	7.0	2.7	14.6	4.6
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58685104	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041777	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782"	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favourable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favourable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	7.0	11.1	10.6	6.7	10.0	2.7	7.2	7.7	13.7	6.2	5.3	10.6	6.8	4.8	6.0	7.4	6.0	4.2	6.5	13.8	7.2	7.2	7.4	12.1	5.2	4.3	6.1	11.0	4.7	5.0	16.9	10.2	8.4	8.3	5.2	6.9	8.9	6.1	5.6	9.6	5.3	4.9	8.5	5.8	10.3	5.4	27.1	6.6	4.2	8.0	8.1	5.1	6.5	6.3	2.8	6.1	2.5	8.6	2.3	5.2	6.6	4.3	6.8	6.8	10.4	14.2	8.5	12.8	10.3	12.0	14.5	10.2	6.4	6.8	2.7	5.9	14.3	10.6	6.5	7.2	8.6	1.7	5.9	3.1	5.7	10.3	21.5	6.5	9.0	17.1	15.2	10.1	6.7	14.9	9.2	4.2	10.5	5.2	2.5	3.8	7.4	10.2	9.4	7.3	7.5	6.4	10.1	5.0	7.6	15.5	10.7	4.5	5.0	2.7	11.6	8.0	6.1	13.8	3.1	6.2	4.0	3.2	10.8	3.9	5.9	0.2	8.6	2.5	5.2	8.4	3.1	1.9	3.3	3.8	6.1	2.8	2.7	2.9	0.8	2.3	7.5	2.1	2.2	6.6	10.6	10.0	7.7	13.7	7.2	7.2	6.1	11.0	8.3	6.6
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.0;thyroid gland: 39.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			49000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: , HPA036513: AB_10670801, HPA066087: "	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favourable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavourable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	6.6	10.9	16.0	6.0	24.8	3.7	6.2	10.8	41.0	9.8	3.8	4.2	4.9	3.6	9.4	3.3	3.5	8.5	7.6	4.7	15.0	11.2	7.8	2.1	6.3	6.5	8.5	24.4	7.4	5.7	5.8	5.7	10.7	15.7	16.7	4.0	1.4	4.8	6.5	3.3	5.7	5.7	6.7	10.2	14.4	4.3	7.9	6.2	10.6	39.9	1.7	6.4	6.1	4.9	9.4	18.4	19.3	2.7	11.0	4.6	1.5	3.1	10.5	20.2	5.5	3.9	9.4	10.4	14.6	7.1	7.1	3.5	15.7	11.3	4.3	22.3	8.3	4.5	12.3	13.5	8.9	2.3	9.1	4.9	16.4	12.9	4.4	17.9	2.1	5.5	2.0	7.8	9.0	15.8	14.1	6.1	11.3	3.0	5.1	5.6	23.5	8.3	12.0	7.1	10.8	30.7	5.2	7.8	10.7	14.6	29.9	7.6	4.8	11.1	15.4	12.9	14.9	8.4	7.6	2.1	1.3	2.6	10.4	8.4	13.0	19.3	2.7	1.9	4.5	2.5	3.5	6.8	4.0	3.7	3.3	9.4	3.5	4.6	0.5	11.0	1.8	18.4	3.9	1.5	16.0	24.8	10.8	39.7	15.0	11.2	8.5	24.4	15.7	6.2
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108532-36129385	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"breast cancer: 361.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: "	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	11.1	12.6	14.3	8.6	13.4	4.3	63.5	19.4	14.7	15.7	8.7	16.0	68.7	4.1	24.7	24.5	9.8	27.7	10.3	8.2	14.2	17.5	12.3	7.7	7.9	8.2	18.3	8.7	30.5	15.5	32.1	23.9	52.5	16.0	55.2	5.9	25.1	15.5	51.5	7.7	22.6	5.7	12.7	21.7	11.2	8.1	9.9	13.5	8.0	15.7	10.7	11.3	23.8	20.2	12.6	25.2	22.2	14.6	12.9	15.6	9.7	10.2	13.0	31.2	18.3	33.1	24.5	8.2	28.1	33.4	18.9	22.2	7.2	11.5	11.2	14.2	27.0	25.1	27.3	26.3	28.7	24.8	9.9	4.8	18.3	10.5	21.0	16.3	12.2	22.3	58.3	28.6	25.0	2.8	2.5	22.5	26.5	15.8	15.9	3.6	7.5	7.4	16.6	17.9	14.6	21.0	34.8	32.9	29.0	34.6	10.2	47.5	13.8	7.7	4.5	46.0	7.7	8.7	14.1	21.2	20.6	8.5	15.9	11.5	24.2	19.5	9.8	22.2	13.0	14.6	15.6	12.6	11.1	11.5	12.2	12.3	9.8	14.2	7.5	12.9	13.7	25.2	12.2	9.7	14.3	13.4	19.4	12.4	14.2	17.5	18.3	8.7	16.0	13.5
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856102-62888875	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 129.8;SiHa: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			210000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB010455: AB_638288, HPA017980: "	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favourable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (1.48e-4)"	28.5	30.8	34.6	23.0	36.8	62.4	30.8	18.7	34.8	26.0	26.8	25.3	30.4	34.3	29.2	41.2	31.2	23.8	19.9	14.7	31.3	27.1	71.4	31.8	33.5	17.8	37.8	24.1	29.9	39.2	138.6	19.3	75.5	32.9	28.3	13.9	52.5	39.0	27.5	32.5	32.1	33.8	19.6	38.0	21.9	28.2	33.4	30.8	13.6	33.7	33.4	22.2	20.6	56.6	16.6	73.9	11.6	36.2	20.3	39.8	37.3	16.1	68.1	6.9	21.6	8.4	6.8	64.4	28.1	10.8	14.8	13.0	65.1	30.6	17.8	31.2	16.5	56.0	12.7	55.1	7.9	32.3	12.0	12.7	49.6	28.7	78.4	14.9	18.6	14.8	129.8	18.0	55.0	8.6	24.6	39.4	9.0	77.8	15.3	19.0	11.6	23.0	15.9	10.5	34.7	10.3	9.0	11.9	5.7	132.3	49.6	95.4	17.8	19.6	15.7	15.0	22.4	22.0	19.8	49.0	54.3	56.4	14.7	23.5	42.8	8.5	36.2	11.6	30.1	34.8	39.8	14.4	27.7	30.8	22.1	16.6	23.5	25.2	7.5	20.3	27.6	73.9	26.2	37.3	34.6	36.8	18.7	34.7	31.3	27.1	37.8	24.1	32.9	30.8
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560579-189583758	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.4;lymphoid tissue: 170.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 91.2;CACO-2: 20.8;HEL: 73.9;HMC-1: 19.5;T-47d: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA065634: "	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favourable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	18.2	126.4	3.9	10.1	5.5	3.9	47.4	1.8	3.5	20.0	25.7	3.7	13.9	34.4	24.7	24.3	6.3	25.9	25.2	37.1	4.1	4.3	14.4	42.1	45.9	170.2	5.1	1.9	50.9	24.0	4.6	9.8	51.3	6.4	18.4	15.8	11.6	10.2	16.6	12.3	4.9	44.7	13.6	5.8	76.4	11.3	16.2	3.5	17.0	20.8	6.4	8.8	11.1	20.4	0.1	22.7	64.7	20.8	0.8	17.3	20.1	0.0	1.2	0.1	0.0	91.2	0.6	4.4	0.0	1.1	0.3	0.5	20.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.3	73.9	0.3	7.6	0.3	0.2	19.5	6.4	0.0	0.2	0.0	2.2	7.5	0.2	1.1	0.0	3.0	4.8	0.2	0.3	0.0	0.8	0.4	0.9	3.0	0.1	0.9	0.1	6.1	0.0	36.0	1.0	0.0	0.1	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	20.8	32.9	0.4	4.7	0.6	0.0	11.3	1.0	22.7	0.1	17.3	3.7	64.7	0.8	0.4	3.7	1.0	20.1	3.9	5.5	1.8	3.5	4.1	4.3	5.1	1.9	6.4	3.5
SLC44A5	"CTL5, MGC34032"	ENSG00000137968	"Solute carrier family 44 member 5"	Q8NCS7	1	75202131-75611116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.4;RPTEC TERT1: 7.3;SH-SY5Y: 11.4;TIME: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047455, HPA051011"	Uncertain		Approved	Cytosol				Cytosol		"HPA047455: , HPA051011: AB_2681309"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.19e-2)"	"prognostic unfavourable (6.52e-4)"	"unprognostic (1.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.30e-1)"	1.0	0.4	2.4	1.0	1.5	0.0	6.3	1.0	3.6	1.0	1.8	1.0	1.0	0.9	1.0	1.0	7.7	3.7	1.0	2.2	2.8	2.8	2.0	1.0	1.0	1.0	2.3	1.0	1.0	1.8	5.6	3.7	3.8	1.0	1.0	2.9	1.0	1.6	1.0	1.5	11.3	1.0	1.0	1.0	1.0	1.3	32.6	1.0	1.0	1.0	1.0	1.8	2.2	1.9	3.2	0.3	0.6	0.3	0.5	1.1	0.3	0.2	0.2	4.6	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	2.7	0.0	0.0	0.9	0.0	0.0	0.0	4.6	0.6	1.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.5	2.6	0.0	0.0	1.8	0.0	4.6	0.6	0.0	0.0	2.2	7.3	5.0	1.1	11.4	0.0	4.7	0.0	0.2	0.0	14.1	0.4	1.3	0.0	1.4	2.1	1.9	3.1	0.2	0.0	0.7	0.4	0.3	0.2	0.4	0.1	0.9	3.2	0.8	1.1	0.1	2.4	0.6	0.4	0.6	0.5	0.2	0.3	0.6	0.3	2.4	1.5	1.0	3.4	2.8	2.8	2.3	1.0	1.0	1.0
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394756-28407197	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.7"	"Cell line enriched"	"Detected in many"	5	"CACO-2: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	3.1	17.8	4.6	2.5	7.0	1.3	5.1	13.2	5.2	2.9	43.8	5.2	9.4	45.4	2.2	4.5	1.8	6.7	3.0	2.2	4.4	6.0	3.8	17.9	3.2	4.9	4.0	4.0	4.4	5.0	8.1	7.8	5.0	5.0	3.7	2.7	6.1	5.7	5.8	2.0	2.0	52.7	2.6	4.6	4.9	2.3	2.2	4.2	2.2	4.0	0.4	1.2	2.4	2.4	2.7	2.6	7.1	5.9	2.9	1.7	0.8	1.7	7.3	2.4	4.0	2.0	0.4	7.6	2.0	1.5	1.7	1.9	66.1	2.1	0.2	1.2	1.1	5.6	2.7	4.6	1.4	4.2	6.4	0.0	4.5	5.6	0.7	0.0	3.3	0.9	8.5	1.8	5.3	0.1	2.8	0.4	0.3	2.3	0.0	0.2	1.4	0.9	0.1	2.0	0.8	1.3	3.8	6.5	3.4	14.2	6.6	0.9	5.1	1.1	0.2	0.2	2.9	0.4	2.1	3.0	3.4	0.1	0.4	0.4	1.5	7.1	1.6	1.1	0.8	5.9	1.4	2.7	0.9	0.7	2.6	1.7	1.0	1.7	2.3	2.9	4.3	1.1	1.6	0.8	4.6	7.0	13.2	5.2	4.4	6.0	4.0	4.0	5.0	4.2
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 62.9;liver: 50.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 20.4;T-47d: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favourable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	6.9	14.2	3.8	5.9	5.7	1.4	6.4	7.6	6.5	8.3	19.6	6.9	2.8	24.0	5.2	7.4	3.1	4.1	12.7	8.1	4.2	4.2	10.4	50.0	6.0	11.4	4.7	3.9	5.0	5.5	4.2	18.2	5.0	6.6	5.3	10.1	17.4	10.3	5.6	8.2	4.0	62.9	4.5	5.1	11.6	4.8	9.3	3.7	11.8	6.8	3.0	6.9	6.1	4.7	9.1	10.4	22.6	15.9	5.6	11.2	7.4	0.0	2.0	0.0	5.5	4.5	1.8	0.1	2.0	11.1	2.2	3.2	0.1	4.7	3.8	3.7	2.8	0.4	2.5	1.0	3.3	2.8	4.9	2.5	0.0	0.0	8.4	0.0	3.3	7.2	2.1	3.3	5.4	4.0	2.7	0.0	10.5	2.0	6.2	0.4	0.2	1.7	2.6	9.9	0.1	20.4	0.6	0.9	0.3	0.0	10.1	4.0	15.0	3.3	1.5	1.1	2.1	0.3	11.7	3.1	1.5	0.5	0.6	0.0	2.0	22.6	8.0	3.0	9.8	11.5	8.4	6.6	7.9	9.6	10.4	9.1	11.2	10.6	8.2	5.6	15.9	9.7	9.2	7.4	3.8	5.7	7.6	6.5	4.2	4.2	4.7	3.9	6.6	3.7
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.6	51.8	10.2	21.0	10.2	6.0	23.3	19.0	10.3	15.6	13.5	29.5	25.1	9.4	41.8	9.0	15.4	10.4	9.2	2.9	27.1	15.5	12.3	25.2	15.0	16.7	6.3	39.8	8.7	8.1	17.7	4.5	8.7	38.2	8.0	12.0	30.1	18.2	11.0	24.3	19.3	14.4	5.6	11.0	12.7	11.9	8.4	30.6	17.4	32.9	16.2	13.6	12.6	18.6	21.0	10.7	20.6	28.0	8.6	11.6	5.3	32.1	16.0	42.1	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 48.5"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"				"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	14.5	5.0	3.2	10.5	4.6	3.3	17.0	4.0	4.8	10.8	38.2	5.0	8.8	48.5	8.1	12.6	8.4	6.5	12.5	9.3	5.0	3.8	15.3	3.7	9.3	10.3	4.8	1.9	9.0	3.3	2.4	4.4	5.6	4.5	10.3	6.9	20.0	8.3	8.4	5.6	5.6	43.4	18.2	5.8	9.7	7.8	6.1	5.5	6.8	6.3	14.7	15.5	15.0	14.9	1.8	2.0	0.1	0.9	2.4	3.9	0.7	5.8	10.9	9.9	4.6	4.6	8.3	7.1	20.0	9.3	7.7	6.0	3.0	3.0	13.4	1.7	7.7	2.5	9.4	9.7	12.3	11.3	3.1	6.1	7.5	3.2	8.0	13.8	5.4	6.6	4.2	11.7	37.8	12.6	4.0	4.7	15.8	2.1	13.8	3.2	6.5	10.9	9.4	7.9	2.6	18.1	4.2	2.5	6.2	9.1	6.8	3.1	15.4	5.4	8.8	18.2	5.1	12.5	15.4	1.8	1.9	7.7	15.9	9.8	8.3	0.0	0.5	0.0	3.0	0.6	2.0	1.2	3.8	3.9	1.4	1.8	1.5	2.7	0.1	2.4	0.9	2.0	3.2	0.7	3.2	4.6	4.0	4.8	5.0	3.8	4.8	1.9	4.5	5.5
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Predicted membrane proteins"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 48.0;intestine: 21.8"	"Group enriched"	"Detected in some"	6	"Hep G2: 18.4;Karpas-707: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.6	0.6	4.3	0.6	21.8	0.5	2.8	1.9	11.2	0.6	1.7	29.7	0.0	10.9	0.6	0.5	0.5	0.6	1.4	0.7	12.1	7.4	9.9	1.0	0.6	0.7	48.0	2.4	0.6	0.5	0.5	0.2	0.5	18.3	0.6	0.8	0.0	0.6	0.8	0.7	0.5	21.8	0.5	34.7	0.6	0.6	0.8	22.9	0.0	0.6	0.0	0.7	0.6	0.1	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.3	21.8	1.9	8.0	12.1	7.4	48.0	2.4	18.3	22.9
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073570-34106262	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	10.1	9.5	10.5	7.3	11.0	3.6	26.6	8.0	10.1	6.5	7.6	4.6	9.4	5.0	11.3	9.1	7.5	8.5	4.9	6.8	11.6	6.8	46.0	9.5	8.5	7.6	11.7	4.7	9.0	5.8	6.3	6.6	15.8	13.6	7.0	8.8	11.3	6.4	6.9	7.8	10.1	7.4	5.9	14.7	4.9	7.8	10.6	9.0	5.9	42.7	4.4	8.0	6.5	22.1	0.8	2.3	0.7	1.0	1.0	2.6	0.7	6.2	5.6	11.8	8.3	9.9	8.1	5.7	7.2	21.8	4.5	6.8	9.3	13.8	10.1	5.8	14.5	3.2	14.3	4.1	7.6	10.5	3.7	10.4	5.2	3.1	2.6	4.4	4.4	3.9	10.6	12.2	4.9	2.6	10.3	2.4	11.5	4.2	4.7	3.6	5.9	5.5	4.8	2.1	4.6	17.6	8.8	6.2	2.8	14.9	4.0	3.4	2.4	4.8	2.5	8.8	6.8	16.8	2.8	12.5	10.8	7.6	17.7	6.6	5.9	0.0	1.0	0.2	2.6	0.9	2.1	0.8	1.4	1.7	0.9	0.8	1.9	2.6	0.7	1.0	0.4	2.3	0.4	0.7	10.5	11.0	8.0	10.1	11.6	6.8	11.7	4.7	13.6	9.0
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 77.3"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 17.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	33.0	0.1	0.8	26.0	0.1	7.2	0.1	0.2	2.2	0.1	0.0	0.0	3.1	4.9	2.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	1.0	77.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.1"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: , HPA052726: "	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	10.1	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.4;placenta: 41.8"	"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 104.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"pons and medulla: 8.2"	"Region enriched"	"Detected in single"	32	"pons and medulla: 23.1"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol				Cytosol	Mitochondria	"CAB078195: , HPA004057: AB_1080012, HPA076311: "	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	2.4	20.4	0.3	0.1	0.1	0.0	1.8	0.1	0.3	3.2	0.3	0.3	0.1	0.0	4.5	7.2	0.8	0.4	0.4	0.1	0.1	0.0	0.4	1.0	0.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	41.8	9.7	0.5	0.1	0.1	1.6	1.7	0.1	11.4	0.4	1.0	0.2	0.1	0.2	8.3	0.2	0.1	0.2	0.9	0.5	0.5	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.8	104.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	9.7	0.2
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 76.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 33.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favourable (5.22e-5)"	"prognostic unfavourable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.2	25.9	5.7	18.0	16.5	46.4	8.1	11.1	12.2	11.3	9.5	8.7	3.6	8.5	14.5	4.4	7.0	7.0	14.5	23.2	5.6	4.6	16.6	2.3	18.6	12.9	18.0	7.6	31.3	2.8	3.8	9.6	18.0	13.3	5.0	4.1	76.4	15.7	7.7	26.6	16.8	22.2	8.2	11.1	20.3	14.0	4.0	12.6	6.2	10.4	11.3	11.2	8.8	6.1	1.6	1.9	33.2	6.9	0.7	3.9	2.3	4.6	17.1	6.2	4.7	8.0	2.5	12.7	6.9	27.5	8.2	6.1	6.2	7.9	13.4	6.4	10.9	3.7	4.2	5.7	7.4	1.5	5.2	12.7	22.5	9.3	0.2	3.4	27.5	1.3	1.7	7.5	1.9	8.9	7.1	2.7	7.2	4.9	9.7	6.7	9.5	5.0	6.9	7.3	20.9	45.1	9.6	11.4	4.1	5.2	2.8	1.5	10.6	1.9	22.5	10.5	5.6	2.6	5.0	3.0	3.4	4.9	24.5	6.8	32.1	2.5	5.1	5.0	1.3	4.2	0.7	1.6	1.4	1.7	1.9	0.9	0.2	0.3	33.2	0.7	6.9	0.7	3.9	2.3	5.7	16.5	11.1	12.2	5.6	4.6	18.0	7.6	13.3	12.6
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.0;SCLC-21H: 7.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: "	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.2	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	1.8	0.0	0.1	1.2	0.2	0.0	0.2	7.0	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.1	7.0	2.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869488	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 71.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 106.7;hTCEpi: 183.4;MCF7: 99.4;SiHa: 150.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 15.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"HPA052673: , HPA056077: "	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	8.2	3.2	18.3	14.7	24.5	71.2	4.3	15.9	45.8	7.9	4.6	16.7	8.9	6.2	5.3	30.4	38.7	3.3	6.4	8.2	19.8	22.1	3.6	9.7	3.8	11.1	23.9	9.6	5.1	12.1	1.5	9.0	28.4	23.4	4.3	3.4	34.9	11.5	15.4	11.2	10.7	5.7	4.8	17.7	6.4	12.7	34.9	19.8	3.7	4.2	16.7	15.0	11.5	7.7	0.5	15.9	0.6	0.0	0.2	1.4	0.4	14.6	55.6	1.0	15.6	0.4	0.9	40.1	11.8	4.3	7.2	4.6	36.2	21.0	13.4	10.5	15.0	66.2	11.5	106.7	5.0	14.1	5.8	11.0	52.2	25.9	16.8	10.2	20.3	3.0	183.4	8.8	65.7	1.4	16.4	15.1	5.7	99.4	12.3	15.1	5.1	13.5	11.9	4.3	20.6	8.0	1.2	9.0	3.5	150.7	30.1	32.3	13.8	13.6	1.1	2.5	16.8	10.4	9.1	19.6	16.0	58.1	9.9	25.5	24.0	0.6	0.0	0.0	1.0	0.0	1.2	0.5	0.5	0.8	0.3	0.0	0.1	0.4	0.1	0.2	0.0	15.9	1.4	0.4	18.3	24.5	15.9	28.1	19.8	22.1	23.9	9.6	23.4	19.8
SLC7A6OS	FLJ13291	ENSG00000103061	"Solute carrier family 7 member 6 opposite strand"	Q96CW6	16	68284503-68310946	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041533	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041533: AB_10794298"	"unprognostic (1.43e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.44e-4)"	"unprognostic (2.05e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-2)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	19.8	14.1	15.7	16.1	20.0	20.1	17.4	29.1	18.2	13.2	13.1	20.2	10.9	13.9	15.5	18.0	12.4	13.4	10.7	16.5	14.6	11.7	13.4	9.3	13.8	24.7	19.8	14.2	17.0	14.7	18.8	13.1	15.9	18.1	13.4	13.4	14.2	14.1	15.0	24.5	15.5	16.3	12.3	17.4	20.3	13.7	12.2	24.5	17.0	15.7	8.7	19.8	14.0	21.6	13.3	11.2	21.8	13.3	12.7	14.9	10.6	7.9	8.2	12.0	9.0	7.1	9.7	13.8	10.1	5.8	12.1	10.7	20.8	11.6	14.0	9.3	6.7	14.5	11.3	8.6	11.0	5.2	6.9	9.3	13.1	17.1	9.1	13.1	10.2	7.4	9.6	9.9	16.1	9.0	14.4	6.3	11.0	12.0	16.9	13.3	8.6	7.0	20.1	7.4	17.1	7.6	10.5	12.8	9.3	19.5	4.5	11.4	12.2	12.2	13.2	9.7	8.3	9.4	8.0	15.6	12.6	20.9	10.0	15.9	9.9	21.5	11.4	21.8	13.4	13.3	14.9	13.1	13.4	12.0	8.7	13.3	14.5	11.4	10.3	12.7	10.8	11.2	13.3	10.6	15.7	20.0	29.1	18.2	14.6	11.7	19.8	14.2	18.1	24.5
SLC9A5	NHE5	ENSG00000135740	"Solute carrier family 9 member A5"	Q14940	16	67237683-67272190	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.5;lymphoid tissue: 14.5"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 8.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041004, HPA041329"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA041004: AB_10794433, HPA041329: AB_10794373"	"unprognostic (8.90e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (9.85e-11)"	"unprognostic (9.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.07e-2)"	1.7	1.7	2.9	1.1	8.8	0.5	1.1	13.5	8.6	0.9	1.4	0.5	3.6	1.3	1.1	3.2	0.6	0.6	1.9	2.3	2.9	3.6	1.1	0.6	2.9	2.1	2.1	2.3	1.4	1.5	0.5	0.6	1.7	4.3	1.0	1.1	0.5	1.0	2.5	1.7	4.2	0.9	0.6	2.7	14.5	0.8	3.3	1.2	0.0	1.0	0.0	1.3	1.6	0.4	1.5	0.8	1.0	0.5	0.6	0.9	0.1	0.5	4.1	3.7	1.2	6.8	4.7	0.4	1.3	5.8	3.4	3.1	0.2	2.9	0.0	0.8	1.6	0.2	1.0	0.7	1.3	1.2	1.2	3.2	0.3	0.9	0.8	1.4	6.7	5.3	1.4	1.9	0.4	0.7	0.7	1.9	2.2	2.3	0.1	0.3	2.5	0.4	0.0	0.8	0.9	0.6	0.7	2.1	0.9	3.5	0.2	1.8	1.4	0.3	1.0	8.8	1.4	1.6	0.6	3.6	0.9	1.8	6.3	0.7	2.2	0.0	0.4	0.0	0.0	0.0	0.6	1.5	0.4	0.9	0.1	0.0	0.4	0.4	1.0	0.6	0.5	0.8	0.0	0.1	2.9	8.8	13.5	8.6	2.9	3.6	2.1	2.3	4.3	1.2
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296549	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 55.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 7.9;RPTEC TERT1: 44.8;U-937: 11.3"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favourable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.4	0.3	0.7	0.7	5.4	0.3	0.2	1.8	0.3	1.9	0.0	5.2	1.4	0.2	0.6	0.3	0.3	1.6	1.1	0.3	0.4	55.9	5.2	11.0	0.2	0.3	1.0	0.3	0.9	0.0	0.7	0.1	0.2	0.4	0.5	0.0	3.2	11.8	0.3	0.6	2.1	0.0	0.3	1.6	0.4	1.3	0.0	1.5	1.0	0.3	0.1	0.7	1.1	0.1	0.4	10.0	1.1	2.6	4.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.5	44.8	0.0	0.3	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	11.3	0.0	7.9	1.1	7.5	4.3	0.0	0.4	0.0	0.7	2.3	0.4	0.1	0.2	1.5	10.0	2.6	0.0	0.3	0.0	1.0	0.3	0.7	0.2	1.8	0.3	0.4	0.3	1.0	0.2	0.0
SLFNL1	FLJ23878	ENSG00000171790	"Schlafen like 1"	Q499Z3	1	41015597-41023237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 49.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054956			Approved	Cytosol				Cytosol		"HPA054956: "	"unprognostic (7.01e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.11e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.40e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-4)"	"unprognostic (2.70e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.43e-1)"	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.3	0.2	0.4	0.2	0.2	0.2	0.5	2.6	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.8	1.9	0.2	0.2	0.2	0.6	0.3	0.1	0.3	0.2	0.2	0.6	0.0	0.2	3.4	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.1	49.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	1.3	0.0	0.0	0.7	0.0	1.0	1.6	0.7	1.1	0.0	0.3	4.9	2.1	0.1	0.0	0.1	10.0	1.0	1.8	1.8	0.1	1.7	0.1	0.0	0.0	1.3	3.0	1.3	2.4	1.3	0.7	1.9	1.2	0.2	0.2	0.1	0.0	0.2	1.1	2.2	0.1	0.8	1.1	2.0	1.8	2.6	2.5	1.3	1.0	0.0	2.7	1.3	0.5	0.4	0.9	0.8	0.6	1.1	0.8	2.0	2.4	1.0	1.4	1.1	0.6	2.2	0.3	2.1	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.4	0.3	0.2	0.0	0.2	0.2	0.2	0.2
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967201-104029233	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"			17000	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	15.2	11.2	13.7	11.0	36.7	14.6	16.1	16.7	13.1	16.6	19.0	9.9	10.9	9.1	17.0	12.1	40.2	12.1	13.6	17.2	10.6	7.1	14.9	12.2	17.1	10.1	11.2	13.4	17.2	12.5	22.6	13.1	17.4	12.8	19.3	13.6	11.4	19.8	12.7	19.3	16.6	15.5	29.8	13.0	12.1	15.7	10.2	12.8	12.0	15.8	21.6	12.5	24.9	23.6	1.4	2.2	6.5	1.4	1.3	3.6	0.7	21.2	12.4	14.9	10.6	16.1	22.5	6.3	13.3	17.7	9.9	9.3	7.9	22.9	11.3	8.3	13.7	23.2	7.8	16.8	14.5	9.0	10.8	11.5	10.2	6.6	12.1	13.7	10.0	11.5	22.1	13.4	39.2	17.8	14.3	7.8	13.0	7.4	9.6	7.6	3.7	8.0	9.4	18.3	5.8	13.0	24.5	3.5	6.1	11.5	11.2	11.0	5.8	9.9	26.9	7.3	7.6	13.4	15.5	9.5	11.6	7.2	10.8	18.4	4.7	1.2	1.4	3.3	3.6	1.2	3.6	1.1	2.2	2.2	1.2	1.4	1.5	2.5	6.5	1.3	1.0	2.2	1.4	0.7	13.7	36.7	16.7	13.1	10.6	7.1	11.2	13.4	12.8	12.8
SLX4	"BTBD12, FANCP, KIAA1784, KIAA1987"	ENSG00000188827	"SLX4 structure-specific endonuclease subunit"	Q8IY92	16	3581181-3611598	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 19.9;testis: 25.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049421, HPA066238"	Approved		Supported	"Nucleoplasm,Cell Junctions,Cytosol"				Nucleoplasm	"Cell Junctions, Cytosol"	"HPA049421: , HPA066238: "	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.28e-5)"	"unprognostic (6.52e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.74e-2)"	2.9	3.1	5.3	6.1	8.5	6.0	2.4	19.9	11.8	2.5	2.9	9.8	2.5	4.9	6.5	3.3	3.4	3.0	2.8	2.2	7.4	4.3	2.9	2.7	3.0	8.6	3.8	8.1	2.7	3.1	3.7	8.6	2.6	7.4	3.3	2.2	5.4	3.0	2.6	5.5	4.2	4.0	3.1	3.3	4.8	3.7	25.0	3.2	5.8	2.6	1.0	6.5	3.1	2.7	0.6	0.2	3.0	1.1	0.6	0.6	0.7	2.9	9.2	6.0	7.5	2.3	2.4	6.3	4.8	2.4	5.6	6.1	4.6	3.7	10.9	4.8	2.4	6.7	4.1	3.3	3.3	9.1	5.1	7.4	6.7	2.9	2.0	7.2	10.5	1.8	2.5	5.2	2.9	4.0	7.1	5.9	4.4	5.1	4.4	6.3	5.0	3.5	8.9	10.0	3.0	2.2	2.1	5.1	4.6	4.1	3.0	1.5	7.3	5.6	4.7	6.4	9.0	5.5	5.6	5.4	4.2	12.7	2.1	7.3	6.3	3.0	0.4	0.0	0.6	0.5	0.4	0.3	0.3	0.3	0.2	0.6	0.3	0.5	0.5	0.6	1.1	0.2	0.3	0.7	5.3	8.5	19.9	11.8	7.4	4.3	3.8	8.1	7.4	3.2
SLX4IP	"C20orf94, dJ1099D15.3"	ENSG00000149346	"SLX4 interacting protein"	Q5VYV7	20	10435303-10636829	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046372	Approved		Approved	Cytosol				Cytosol		"HPA046372: "	"unprognostic (4.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.56e-3)"	"unprognostic (3.91e-1)"	"prognostic unfavourable (9.51e-4)"	"unprognostic (6.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.55e-2)"	4.9	6.4	4.7	7.1	8.1	4.2	5.9	6.6	7.9	5.5	5.7	9.9	9.1	5.1	5.2	13.1	7.2	6.1	5.2	4.2	5.3	5.4	6.7	6.9	5.7	5.5	7.3	4.1	5.2	8.4	13.8	25.4	4.4	6.8	5.6	6.4	9.5	6.2	6.4	9.9	9.6	5.8	3.0	6.1	6.2	6.1	6.1	7.7	11.2	7.2	3.9	9.1	6.4	6.0	3.9	5.6	2.5	4.4	3.7	4.0	1.3	3.7	7.1	3.6	9.7	2.1	2.8	3.0	1.9	2.2	3.0	3.3	5.2	4.8	5.9	3.1	2.2	7.4	5.4	5.6	4.8	0.0	2.0	5.4	2.4	7.1	3.5	5.7	3.2	3.9	4.9	3.8	7.4	2.9	4.3	5.1	3.6	3.1	8.6	8.5	6.5	2.4	6.2	9.5	5.3	4.4	3.7	6.5	4.9	5.5	8.7	5.6	9.5	3.0	4.3	2.4	5.1	3.0	2.2	5.4	12.2	7.5	1.8	5.5	4.2	0.7	2.9	1.2	2.3	3.8	3.8	3.6	3.3	2.7	3.5	3.9	3.4	2.7	2.5	3.7	4.4	5.6	4.0	1.3	4.7	8.1	6.6	7.9	5.3	5.4	7.3	4.1	6.8	7.7
SMAD1	"JV4-1, MADH1, MADR1"	ENSG00000170365	"SMAD family member 1"	Q15797	4	145481194-145558079	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 22.2;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.2;monocytes: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005389	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005389: AB_656608"	"unprognostic (8.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.15e-2)"	20.4	7.8	19.9	7.9	21.3	3.8	21.1	17.9	17.8	18.5	15.5	14.3	13.6	11.9	33.2	22.7	16.2	20.3	13.7	10.3	13.5	10.3	12.7	37.4	11.0	11.9	9.3	10.0	12.3	13.1	33.7	14.7	8.7	12.2	13.6	16.9	7.8	17.5	16.0	22.6	20.2	15.3	24.6	12.6	10.1	11.4	10.5	14.3	15.3	15.2	14.9	10.3	16.5	21.9	0.0	4.0	22.2	11.9	1.2	0.7	0.8	3.8	5.0	9.5	11.4	3.7	5.4	4.7	5.5	13.3	9.0	6.9	2.4	14.2	3.3	3.3	12.6	5.6	10.7	12.3	5.4	0.0	5.4	0.0	4.2	5.0	9.9	6.4	1.0	7.4	14.6	4.8	9.5	45.6	4.3	0.1	11.4	3.7	9.6	0.1	8.8	6.2	18.5	8.8	11.5	9.8	6.8	14.8	7.1	7.8	17.1	3.4	5.8	0.0	13.7	4.4	6.1	4.5	3.4	12.6	0.0	22.3	7.0	0.1	4.5	22.2	2.1	0.8	0.0	5.3	0.0	0.0	0.4	0.0	4.0	0.0	0.2	0.0	0.0	1.2	11.9	0.0	0.7	0.8	19.9	21.3	17.9	14.9	13.5	10.3	9.3	10.0	12.2	14.3
SMAD2	"JV18-1, MADH2, MADR2"	ENSG00000175387	"SMAD family member 2"	Q15796	18	47808957-47931146	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025507, HPA067203, CAB073546"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"CAB025507: , CAB073546: , HPA067203: "	"unprognostic (1.55e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.82e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (9.44e-5)"	"unprognostic (1.91e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.28e-2)"	38.5	39.2	29.0	26.2	25.9	19.6	31.4	19.5	28.9	28.8	34.2	29.4	28.9	21.5	26.6	26.3	33.5	28.8	25.7	31.1	26.1	27.1	26.4	20.9	28.3	23.8	30.9	24.3	36.6	28.1	25.7	24.4	34.8	28.6	27.8	29.8	31.7	29.7	28.7	33.9	28.0	26.4	34.6	35.4	34.1	26.3	29.2	26.2	60.7	46.1	23.6	31.5	35.1	35.7	12.0	21.8	28.9	24.7	24.5	25.9	19.7	22.4	32.2	19.7	19.0	31.5	38.5	22.5	24.5	29.4	25.6	29.9	12.3	21.5	34.9	17.6	31.0	24.8	22.1	27.3	34.3	37.9	11.3	29.6	48.7	19.9	36.7	41.1	30.3	28.4	35.3	21.9	50.7	28.2	13.7	29.3	31.4	14.6	28.2	19.8	9.6	7.7	20.6	28.7	23.8	57.4	38.7	18.2	21.4	29.5	20.2	24.0	15.3	27.4	31.5	38.0	21.9	10.3	17.8	28.7	27.5	30.4	26.3	28.1	27.7	28.9	22.6	25.0	16.9	24.7	21.2	12.0	23.1	20.9	21.8	9.4	25.8	19.8	22.7	24.5	20.8	15.5	25.9	19.7	29.0	25.9	19.5	28.9	26.1	27.1	30.9	24.3	28.6	26.2
SMAD3	"HsT17436, JV15-2, MADH3"	ENSG00000166949	"SMAD family member 3"	P84022	15	67063763-67195195	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008094, HPA046386, HPA067203, CAB069409"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: , HPA067203: "	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (2.93e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-2)"	25.3	4.6	12.2	18.5	12.4	12.4	21.6	5.0	12.7	20.9	17.9	7.6	9.5	12.7	19.9	16.6	35.3	14.3	27.7	19.7	7.5	4.8	15.6	13.6	13.9	14.0	6.0	7.5	23.0	12.6	7.0	10.8	11.5	8.2	20.5	9.2	30.8	12.5	10.8	37.3	19.6	19.0	23.2	5.5	11.2	15.8	7.0	7.7	10.5	21.8	23.4	29.7	31.4	24.6	4.8	2.5	3.2	1.9	0.4	6.3	1.8	12.5	42.1	7.9	3.8	13.9	32.1	6.2	7.3	30.0	10.1	8.2	8.7	33.7	4.2	9.8	20.7	29.8	8.2	30.7	10.1	3.3	3.1	0.4	11.9	6.5	10.5	1.6	0.7	29.0	7.2	8.9	7.6	34.1	10.1	11.7	12.6	6.5	0.3	6.3	4.7	13.2	0.4	2.3	1.5	6.8	40.4	0.2	2.7	9.6	5.3	8.3	1.4	7.8	28.7	13.7	12.8	9.8	8.2	4.5	1.2	5.2	12.4	1.8	12.2	0.0	1.9	3.2	5.5	1.5	5.7	2.1	6.2	6.3	1.8	4.8	2.8	2.4	0.1	0.4	1.5	2.5	3.1	1.8	12.2	12.4	5.0	12.7	7.5	4.8	6.0	7.5	8.2	7.7
SMAD4	"DPC4, MADH4"	ENSG00000141646	"SMAD family member 4"	Q13485	18	51028394-51085045	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019154	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA019154: AB_1853480"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.00e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (4.40e-2)"	"prognostic favourable (1.92e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	25.6	17.5	16.0	14.0	16.7	11.4	24.9	29.7	16.0	27.9	22.6	17.9	21.3	15.1	28.2	18.8	21.7	20.5	17.5	19.6	15.3	11.5	21.0	22.0	20.1	16.0	17.2	13.3	30.5	25.0	30.0	28.9	30.6	14.2	27.8	17.4	18.4	23.1	22.8	39.7	18.2	23.4	27.6	13.9	21.7	19.3	17.6	18.4	38.8	35.0	13.9	18.1	29.0	24.1	3.6	3.6	3.4	1.8	2.9	4.7	1.3	8.5	11.3	30.7	8.8	12.7	19.6	17.3	15.0	16.5	20.2	25.4	6.9	2.0	14.2	4.5	13.0	14.1	17.2	6.7	21.5	12.3	9.7	9.8	11.3	7.9	12.6	17.1	7.7	8.9	11.4	9.9	14.6	14.6	11.0	13.1	11.9	4.5	10.1	4.9	16.0	7.1	13.2	15.6	13.9	9.7	3.7	19.0	11.3	14.0	2.6	9.3	7.0	10.0	11.0	17.1	7.9	4.3	9.9	19.7	13.7	12.3	11.1	6.7	11.3	0.8	1.8	1.8	3.2	1.1	3.7	2.2	3.3	2.6	3.6	3.6	4.0	4.7	3.4	2.9	1.3	2.9	4.3	1.3	16.0	16.7	29.7	16.0	15.3	11.5	17.2	13.3	14.2	18.4
SMAD5	"Dwfc, JV5-1, MADH5"	ENSG00000113658	"SMAD family member 5"	Q99717	5	136132845-136188747	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 33.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058931	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA058931: "	"unprognostic (6.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.99e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.15e-1)"	22.6	14.2	13.7	10.2	14.6	8.6	18.2	27.5	15.7	27.9	16.7	19.8	15.9	12.4	33.5	15.8	20.8	17.3	14.0	15.9	14.9	12.4	15.7	20.2	16.7	10.4	18.0	12.2	33.5	15.3	25.2	23.0	24.1	16.4	23.0	16.9	22.0	16.9	18.8	19.3	27.5	12.7	25.7	16.7	16.3	14.4	11.5	19.0	8.4	19.2	15.2	15.7	25.6	27.9	7.3	7.4	33.1	6.1	9.3	7.2	2.4	13.8	11.7	14.4	12.7	15.7	24.1	15.2	19.3	13.6	12.9	20.0	51.4	10.1	15.3	16.2	14.9	12.8	16.8	22.0	21.1	6.6	10.4	10.2	12.7	9.6	13.1	6.2	10.9	17.3	13.4	20.3	14.1	16.0	9.7	10.6	14.2	5.6	5.0	6.3	8.6	5.9	10.6	27.9	9.0	7.8	14.3	13.0	13.6	16.8	4.4	16.8	9.8	7.6	18.4	19.6	12.5	14.4	19.1	12.0	14.3	19.4	12.6	8.0	14.8	33.1	6.1	13.0	7.2	3.9	5.5	6.5	4.2	4.6	6.1	7.3	1.4	4.3	1.0	9.3	4.4	7.4	1.1	2.4	13.7	14.6	27.5	15.7	14.9	12.4	18.0	12.2	16.4	19.0
SMAD7	"MADH7, MADH8"	ENSG00000101665	"SMAD family member 7"	O15105	18	48919853-48950711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026212, HPA028897"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB026212: , HPA028897: AB_10600811"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (8.15e-2)"	"unprognostic (5.35e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-1)"	9.5	3.3	3.1	7.4	4.3	8.6	11.6	8.0	7.7	11.4	11.5	4.2	5.1	5.5	6.5	3.0	2.8	4.2	5.7	27.0	5.8	3.1	7.4	6.5	13.7	2.8	6.1	4.4	4.5	5.6	14.6	3.9	11.2	6.0	9.3	7.0	7.1	5.3	11.5	4.9	4.4	15.0	5.0	6.3	2.9	7.2	3.2	2.8	3.6	10.0	5.7	3.4	6.8	19.4	0.1	0.3	8.3	0.8	2.6	1.9	0.4	2.3	1.9	1.6	5.4	9.5	4.0	13.7	10.9	4.6	4.3	1.9	0.6	3.3	0.2	20.6	7.9	12.4	3.9	3.6	2.3	23.6	6.2	0.1	5.8	5.1	1.7	4.7	11.8	3.4	3.3	4.8	5.2	0.8	3.9	15.5	6.4	0.8	0.0	1.4	11.4	0.8	1.4	1.7	5.2	6.6	2.5	3.0	6.5	4.9	2.3	4.7	1.9	3.7	10.4	11.5	6.3	3.2	10.6	8.4	4.1	1.3	5.0	3.0	1.7	5.8	0.2	8.3	1.4	0.8	1.2	0.1	1.4	1.3	0.3	0.0	0.4	0.9	0.0	2.6	0.2	0.0	1.9	0.4	3.1	4.3	8.0	7.7	5.8	3.1	6.1	4.4	6.0	2.8
SMAD9	"MADH6, MADH9, SMAD8, SMAD8/9"	ENSG00000120693	"SMAD family member 9"	O15198	13	36844831-36920765	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8.6;SH-SY5Y: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009119, HPA031162"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009119: AB_2286517, HPA031162: "	"unprognostic (2.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.68e-3)"	"unprognostic (3.50e-3)"	"prognostic favourable (5.99e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.71e-3)"	"unprognostic (4.23e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.07e-3)"	"unprognostic (3.74e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (2.47e-2)"	4.4	3.1	7.0	3.2	6.2	0.6	4.1	10.7	11.8	6.3	8.2	14.3	4.1	2.6	10.0	11.3	5.8	5.1	7.4	6.9	15.0	6.2	5.0	1.4	5.3	2.6	10.7	8.9	10.1	1.3	3.0	6.2	6.7	10.2	14.9	6.0	11.9	17.7	12.4	13.8	2.1	4.0	8.4	15.5	1.5	5.9	2.7	11.0	0.0	38.9	1.9	3.4	7.7	12.6	1.7	1.7	1.1	0.8	0.7	1.4	0.2	0.0	0.1	0.5	5.8	1.7	0.8	0.2	6.6	0.7	1.8	1.1	0.0	0.1	0.2	4.2	8.6	0.3	5.8	0.1	2.0	0.2	8.2	0.0	3.0	4.6	1.8	0.5	0.1	3.0	0.5	0.0	0.0	3.5	0.0	0.0	4.2	0.3	0.1	0.5	0.8	0.6	0.1	6.2	0.0	0.0	0.9	5.1	27.6	1.3	0.2	0.3	0.4	0.2	6.3	2.7	2.2	1.5	1.6	0.1	0.0	0.0	1.9	0.2	0.4	1.1	0.4	0.3	1.2	0.8	0.8	1.0	1.2	1.3	0.2	1.7	1.2	1.4	0.9	0.7	0.5	1.7	0.4	0.2	7.0	6.2	10.7	7.8	15.0	6.2	10.7	8.9	10.2	11.0
SMAP1	"FLJ13159, SMAP-1"	ENSG00000112305	"Small ArfGAP 1"	Q8IYB5	6	70667776-70862015	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030574	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA030574: AB_10601589"	"unprognostic (1.55e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.22e-1)"	18.7	14.8	19.9	17.8	25.1	15.1	15.3	20.7	30.2	14.4	25.2	14.5	18.5	24.5	16.2	17.7	29.3	10.5	16.3	20.5	20.5	18.6	14.1	17.2	14.4	18.3	19.2	18.1	15.2	33.9	27.1	11.5	14.8	25.0	17.2	27.0	13.0	18.6	15.2	32.6	21.0	29.6	18.7	15.7	14.8	20.7	29.6	13.0	26.6	20.0	17.5	20.1	18.9	16.6	12.5	11.7	24.0	15.5	20.2	21.9	16.3	26.2	8.3	13.3	16.1	12.3	16.3	21.4	11.8	13.6	9.9	9.8	12.4	7.9	13.8	12.9	14.5	8.4	12.5	12.6	16.9	15.9	17.4	15.2	7.8	10.4	8.2	11.1	13.0	10.6	14.6	11.1	13.6	15.6	14.5	16.9	15.5	15.4	8.3	13.6	9.8	9.8	15.7	49.3	22.7	17.9	16.2	18.6	13.2	7.5	10.8	7.5	14.3	16.8	14.9	8.0	13.8	5.2	10.4	15.8	14.1	7.1	6.1	13.1	11.0	24.0	13.7	14.6	16.3	15.0	18.5	12.5	21.9	18.6	11.7	11.1	11.2	14.4	19.3	20.2	15.5	11.5	20.5	16.3	19.9	25.1	20.7	30.2	20.5	18.6	19.2	18.1	25.0	13.0
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 35.4"	"Cell line enhanced"	"Detected in some"		"A-431: 9.0;EFO-21: 4.3;SiHa: 18.7;U-266/70: 4.2"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.2	0.0	0.5	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.0	18.7	0.1	0.0	0.1	1.6	0.1	0.0	0.0	0.5	0.0	4.2	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.7	0.4	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.3	0.6	0.0	0.0	0.0	0.2	0.0
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434962	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (4.20e-5)"	"prognostic unfavourable (9.00e-4)"	"prognostic unfavourable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	4.8	5.5	3.0	25.4	4.4	15.1	4.0	3.1	3.2	5.3	10.1	1.7	5.3	6.5	5.2	4.9	19.3	4.6	7.0	5.7	2.4	1.7	4.4	6.3	7.9	16.5	3.1	1.3	4.7	4.2	1.7	10.8	7.4	2.6	4.4	6.9	2.7	5.7	6.9	5.9	4.6	7.0	6.2	3.1	13.1	5.7	20.7	3.2	70.2	5.1	7.6	14.3	7.8	6.3	8.8	6.1	30.5	7.6	7.8	15.8	4.8	62.1	11.5	26.2	12.1	5.0	5.1	12.1	31.0	14.7	35.9	31.2	14.5	35.8	39.4	18.1	12.7	36.0	29.8	15.0	57.8	52.2	20.8	38.1	19.7	4.7	2.8	25.2	31.2	2.6	2.2	19.0	15.5	15.2	21.9	45.8	21.4	11.2	30.9	6.2	15.4	27.1	31.4	41.2	28.6	6.7	7.7	15.8	16.4	23.7	21.9	10.8	26.3	18.9	14.4	23.0	19.2	20.9	56.5	30.6	31.3	71.9	16.4	25.9	25.5	30.5	3.2	12.1	6.7	4.7	6.5	8.8	10.5	8.0	3.5	7.2	6.7	6.0	5.7	7.8	7.6	6.1	15.8	4.8	3.0	4.4	3.1	3.2	2.4	1.7	3.1	1.3	2.6	3.2
SMG6	"C17orf31, EST1A, KIAA0732, SMG-6"	ENSG00000070366	"SMG6, nonsense mediated mRNA decay factor"	Q86US8	17	2059839-2303771	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042932	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA042932: AB_10964261"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.30e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.30e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.08e-2)"	12.7	16.6	18.1	18.9	17.6	11.9	10.9	19.1	18.4	15.0	10.6	15.1	13.2	9.0	26.2	11.9	16.1	22.2	16.7	16.4	12.8	15.9	11.5	7.3	11.5	10.7	13.4	16.1	38.7	9.3	16.2	17.2	10.1	14.5	14.5	9.5	18.6	10.4	13.3	14.0	15.3	10.3	18.9	12.8	9.0	9.7	39.2	11.5	22.3	11.6	8.4	16.8	12.7	12.4	2.0	3.3	4.8	3.6	4.6	4.3	1.5	8.4	13.0	18.8	12.1	20.3	16.5	9.7	13.7	15.1	15.6	13.3	15.8	4.3	8.9	4.9	20.1	12.4	13.7	11.7	16.4	8.9	8.6	8.7	6.9	7.7	11.6	4.6	6.3	23.3	8.6	12.6	11.2	14.2	7.1	10.9	11.6	6.7	11.6	3.7	6.0	6.8	12.1	12.0	3.5	9.0	7.8	3.2	9.6	14.3	4.2	5.9	6.5	3.4	18.6	14.4	7.9	15.2	14.3	9.5	5.7	4.2	11.5	5.2	8.3	4.8	1.8	2.0	3.7	0.8	3.7	1.2	3.1	3.5	1.0	2.0	4.3	2.9	1.4	4.6	3.6	3.3	1.8	1.5	18.1	17.6	19.1	18.4	12.8	15.9	13.4	16.1	14.5	11.5
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7, nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	14.6	14.3	20.7	17.1	25.3	30.9	17.6	35.8	29.3	17.6	18.1	19.9	6.6	16.8	16.6	13.6	19.1	22.1	12.9	20.0	17.8	14.8	18.2	18.7	15.6	19.7	16.0	23.1	22.7	18.7	25.9	20.2	18.7	15.9	15.1	20.4	15.9	17.2	14.5	19.2	20.5	17.8	15.2	14.4	18.9	18.3	52.1	15.1	31.6	19.9	12.7	23.9	14.5	22.3	9.3	11.7	11.2	9.6	9.5	10.3	8.0	21.5	13.2	19.0	14.9	13.0	12.4	31.8	13.3	24.5	14.9	11.4	19.5	16.9	30.5	15.3	16.4	23.5	25.6	19.7	17.7	13.5	11.2	24.6	14.3	15.8	13.2	32.2	15.8	11.2	18.1	20.3	47.2	16.2	30.5	21.6	15.4	21.9	22.6	14.2	33.0	7.6	14.3	21.3	23.8	11.4	20.2	25.7	20.1	20.5	29.2	15.9	29.1	13.2	15.4	16.9	17.5	16.7	18.8	23.6	27.7	25.3	13.7	18.3	18.0	3.1	9.3	9.5	9.7	9.6	8.9	9.3	8.8	9.5	10.7	8.5	9.9	10.3	11.2	9.5	5.0	11.7	7.8	8.0	20.7	25.3	35.8	29.3	17.8	14.8	16.0	23.1	15.9	15.1
SMG9	"C19orf61, FLJ12886"	ENSG00000105771	"SMG9, nonsense mediated mRNA decay factor"	Q9H0W8	19	43727992-43754990	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041763, HPA042096"	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA041763: , HPA042096: "	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.55e-2)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (2.71e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.24e-3)"	"unprognostic (3.88e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (8.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"prognostic favourable (8.09e-4)"	10.0	14.6	18.1	16.9	24.5	12.4	14.9	25.0	24.8	13.2	12.0	21.6	11.5	13.4	11.6	13.8	11.2	10.9	11.7	9.4	16.5	15.6	10.2	8.5	11.9	19.3	36.0	14.2	10.2	8.1	14.9	14.2	16.6	23.1	14.7	11.0	9.2	14.0	12.7	9.1	12.3	11.7	13.9	20.4	17.1	14.2	40.9	29.6	13.2	10.8	4.1	19.3	11.1	12.0	9.2	8.0	3.6	12.2	4.6	8.3	10.7	12.5	13.9	10.2	6.5	7.2	10.2	6.8	18.0	10.8	20.2	15.3	9.7	16.8	13.8	8.9	12.3	5.5	11.9	10.0	13.2	10.6	6.7	24.9	9.9	6.5	8.4	18.7	13.6	5.4	8.6	14.6	15.8	8.2	18.6	12.3	9.3	9.0	19.8	5.3	4.9	9.4	10.6	8.4	6.2	10.7	10.4	17.1	8.4	18.8	14.3	10.6	8.6	10.4	9.9	31.7	18.6	11.6	13.7	6.0	12.9	16.5	9.5	14.4	25.7	1.0	6.1	3.6	6.3	9.0	5.6	9.2	6.4	5.3	8.0	6.7	8.3	5.7	1.5	4.6	12.2	7.0	4.6	10.7	18.1	24.5	25.0	24.8	16.5	15.6	36.0	14.2	23.1	29.6
SMIM20	"C4orf52, MITRAC7, PNX"	ENSG00000250317	"Small integral membrane protein 20"	Q8N5G0	4	25861830-25929874	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016552	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA016552: AB_1859536"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.86e-1)"	"prognostic favourable (8.97e-5)"	"unprognostic (5.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.12e-3)"	14.9	20.5	21.8	15.6	26.7	7.1	25.0	11.4	28.0	12.9	16.4	8.3	12.8	24.1	13.7	46.4	11.9	15.1	22.5	33.7	17.9	16.2	27.1	22.7	18.5	26.0	19.2	14.3	19.5	50.0	8.7	10.0	9.5	22.8	13.6	16.1	11.3	20.4	15.7	51.3	6.9	23.8	24.0	22.6	12.7	18.8	17.7	13.5	9.3	21.3	15.3	14.5	14.5	15.9	27.1	21.4	13.3	20.3	18.1	31.1	18.2	12.7	10.7	14.4	13.9	16.0	34.8	19.2	12.4	15.2	10.7	13.7	9.5	22.7	21.0	21.7	13.8	3.7	16.7	15.9	15.1	11.9	13.3	12.1	7.8	18.0	27.1	14.4	8.1	24.6	32.0	13.7	20.8	8.2	19.3	6.9	13.2	8.2	15.6	24.5	27.2	16.0	12.9	18.8	13.5	23.9	9.4	18.6	17.3	8.0	5.6	27.4	11.6	20.5	13.7	11.7	13.8	13.1	15.8	13.6	11.2	22.0	17.7	15.3	14.7	13.3	18.2	8.4	15.7	20.3	20.5	27.1	22.7	19.7	20.5	26.8	31.1	24.7	9.2	18.1	15.2	21.4	23.2	18.2	21.8	26.7	11.4	28.0	17.9	16.2	19.2	14.3	22.8	13.5
SMIM22		ENSG00000267795	"Small integral membrane protein 22"	K7EJ46	16	4788397-4796491	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.3"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 72.8;RT4: 26.8;SCLC-21H: 19.0;SK-BR-3: 54.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA077331			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA077331: "	"unprognostic (6.55e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.69e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.73e-3)"	0.8	0.0	0.8	14.4	0.8	0.2	10.9	0.8	0.8	10.8	47.0	0.9	37.8	27.5	2.5	12.1	2.6	18.0	28.1	0.8	0.8	0.0	6.2	0.9	6.8	0.8	0.8	0.8	2.8	36.2	0.0	12.1	4.1	0.8	10.2	28.1	0.8	42.2	35.3	0.8	2.2	54.3	1.7	0.8	0.8	41.7	27.2	0.8	1.0	0.9	2.8	4.5	18.5	3.6	1.9	1.5	3.9	1.3	0.9	1.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	72.8	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.2	0.0	0.2	0.1	6.2	0.3	26.8	19.0	0.3	0.1	54.7	0.0	4.3	0.0	0.0	0.2	0.2	0.3	0.0	0.1	0.1	0.1	0.0	0.2	0.1	3.9	1.3	1.6	1.3	0.5	0.6	0.7	1.3	0.6	0.3	1.9	1.6	0.7	3.3	0.9	0.6	1.5	0.9	0.3	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	0.8	0.8
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480542	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 160.8;intestine: 204.2;kidney: 76.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 45.8;HEL: 21.6;Hep G2: 34.2;MOLT-4: 32.6;REH: 17.9;U-937: 25.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 78.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.1	0.7	0.6	0.9	7.0	0.3	0.2	2.2	0.2	137.0	0.4	2.4	71.4	0.2	160.8	0.3	0.3	46.7	0.3	0.4	0.5	76.9	7.2	0.3	0.3	0.4	0.6	0.3	1.6	0.0	0.9	0.2	0.3	0.3	2.0	0.2	0.3	0.4	0.2	0.3	204.2	0.2	0.6	0.4	24.8	1.2	0.3	8.8	0.2	0.2	0.2	0.2	0.2	3.2	2.4	3.0	0.0	8.6	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	45.8	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.2	34.2	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	32.6	4.6	0.0	0.0	17.9	0.0	1.2	0.4	0.0	0.4	0.7	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	25.7	0.0	3.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.1	0.6	0.7	1.7	0.0	8.6	0.0	2.4	2.1	1.1	0.7	0.9	0.2	2.2	0.4	0.5	0.4	0.6	0.3	0.3
SMIM26	"LINC00493, LOC388789"	ENSG00000232388	"Small integral membrane protein 26"	A0A096LP01	20	18567347-18569563	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA068733			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA068733: "	"unprognostic (1.20e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.18e-1)"	"prognostic favourable (7.84e-5)"	6.8	13.2	8.4	6.8	11.6	9.9	15.6	9.2	13.2	8.8	8.8	5.0	11.9	8.6	9.0	20.4	9.3	11.2	10.8	15.0	9.2		13.2	16.4	6.7	13.4	9.2	10.9	17.2	29.4	6.9	10.6	7.4	14.7	9.5	9.7	6.9	16.8	15.7	32.3	7.7	10.9	11.7	8.9	6.2	8.3	5.4	10.8	7.7	12.0	18.7	9.6	11.4	12.6	49.2	52.0	75.1	42.9	29.6	49.8	37.5	23.4	30.5	22.9	24.0	21.1	29.1	27.1	17.5	20.7	20.3	23.3	18.8	27.1	23.2	20.1	18.8	25.8	21.6	28.6	23.1	10.0	27.3	30.9	14.2	62.0	40.5	20.2	23.7	24.7	38.2	23.1	37.2	30.5	22.6	21.9	25.1	28.8	23.8	55.8	13.2	36.9	15.6	27.1	31.7	45.5	23.5	23.0	24.6	18.4	35.5	67.6	26.0	29.9	15.9	14.3	15.2	17.8	18.3	21.3	51.3	25.8	13.0	13.1	10.8	34.8	42.9	32.2	33.2	36.2	34.7	49.2	45.0	37.6	52.0	45.1	49.8	46.7	75.1	29.6	33.3	48.6	45.4	37.5										
SMN1	"BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A"	ENSG00000172062	"Survival of motor neuron 1, telomeric"	Q16637	5	70925030-70953942	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.3;MOLT-4: 37.1;T-47d: 28.7;WM-115: 38.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB016324, HPA045271, CAB069888, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: , HPA073601: "	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavourable (6.62e-13)"	"unprognostic (2.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.14e-2)"	4.3	3.3	5.1	4.7	4.4	23.9	5.1	6.0	4.3	6.1	4.0			2.8	5.2	7.4	4.7	5.7	8.0	3.5	5.2	5.0	6.8	7.0	3.7	16.4	4.6		8.0	5.3	6.4	5.2	4.7		4.6	6.0		3.8	3.5	5.8	5.9	3.1	9.2	5.2	5.2	6.1	6.9			4.9		2.5	10.7	5.1	15.8	14.7	5.2	11.3	9.0	16.1	7.1	2.8	0.6	1.1	1.3	3.0	4.5	15.1	1.1	1.7	1.7	1.3	1.3	1.3	1.4	23.3	2.2	1.5	1.7	1.2	1.5	0.3	1.7	21.0	1.7	1.9	0.4	2.4	1.9	0.5	3.7	0.6	0.6	0.9	0.9	2.1	0.9	1.0	37.1	15.5	1.4	0.6	1.9	4.6	11.0	0.9	1.6	1.7	3.6	1.5	4.1	19.5	28.7	3.9	10.5	10.9	1.2	1.0	2.3	1.3	0.9	13.9	1.6	1.5	38.2	5.2	9.1	3.4	10.1	11.3	16.1	15.8	10.3	9.4	13.4	12.5	14.2	13.4	3.1	9.0	10.5	14.7	12.5	7.1										
SMN2	"BCD541, GEMIN1, SMNC, TDRD16B"	ENSG00000205571	"Survival of motor neuron 2, centromeric"	Q16637	5	70049612-70078522	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 37.7;MOLT-4: 33.8;NB-4: 31.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009344, HPA045271, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"CAB009344: AB_2193083, HPA045271: , HPA073601: "	"unprognostic (2.07e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.98e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.19e-1)"	3.9	2.7	5.4	3.7	4.8	10.4	4.2	5.6	9.8	3.9	4.0			0.2	4.9	19.1	10.0	2.9	11.5	3.2	5.2	5.1	6.6	5.4	6.2	8.6	4.1		7.0	7.9	11.4	5.0	3.8		4.7	6.9		8.5	5.4	5.2	3.3	2.6	12.1	5.5	4.0	5.4	9.8			5.1		0.0	10.9	4.8	15.0	14.0	4.7	14.9	9.2	15.6	6.2	16.6	0.1	0.1	0.0	6.6	7.9	37.7	8.9	5.7	11.5	11.4	0.1	0.1	0.3	25.7	9.1	7.5	0.2	0.0	7.7	0.2	0.3	18.1	0.0	0.6	0.0	0.3	0.0	0.0	14.8	0.0	0.3	0.2	0.0	0.1	0.0	0.1	33.8	31.7	0.1	0.1	0.0	13.0	19.3	7.5	0.0	9.4	20.7	16.9	3.7	23.7	12.0	7.5	15.8	7.8	0.3	0.1	0.2	0.1	0.3	21.3	0.1	0.0	21.5	3.9	6.1	4.7	8.1	14.9	15.0	13.7	13.1	9.3	13.1	15.0	15.6	13.1	1.2	9.2	10.1	14.0	13.1	6.2										
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane"	Cytosol	"HPA046279: , HPA049426: "	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavourable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavourable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (1.73e-4)"	"prognostic unfavourable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	13.2	16.1	12.4	17.1	20.7	39.1	14.8	22.1	25.1	19.9	15.8	31.4	15.3	15.5	22.5	14.1	19.3	19.5	12.7	13.4	13.2	16.0	14.3	18.5	14.7	20.5	21.3	12.2	22.2	22.2	24.1	31.2	24.3	19.5	16.3	16.7	17.7	17.1	15.2	17.0	17.5	15.2	18.3	16.0	16.4	14.5	23.6	21.6	27.9	22.8	19.6	27.1	16.9	16.6	10.5	9.8	14.5	11.4	11.7	15.2	9.7	31.7	15.7	19.8	14.6	10.2	7.5	25.8	16.9	12.6	25.0	20.9	45.4	16.3	20.7	15.0	17.0	18.1	25.3	22.4	17.4	27.4	24.4	23.3	16.9	36.0	8.7	26.0	14.9	8.8	15.0	28.0	11.2	14.4	28.9	16.8	13.9	17.2	27.1	13.1	30.4	20.9	28.8	15.1	22.5	10.6	15.1	27.6	15.4	16.7	20.4	7.4	13.9	11.4	11.1	21.4	20.8	14.0	19.8	14.7	16.4	27.8	19.3	14.9	15.2	1.8	9.3	14.5	13.9	11.4	15.2	9.5	10.4	12.4	9.8	10.5	10.2	11.4	4.5	11.7	8.0	6.4	9.4	9.7	12.4	20.7	22.1	25.1	13.2	16.0	21.3	12.2	19.5	21.6
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.6;CAPAN-2: 17.4;NTERA-2: 13.5;RPMI-8226: 14.0;SK-BR-3: 22.6;T-47d: 16.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"		330000	"Golgi apparatus, Cytosol"		"HPA030561: AB_10604095"	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.5	1.2	0.0	0.1	0.0	0.0	22.6	0.0	0.5	0.3	1.7	5.7	17.4	0.8	4.1	0.0	2.8	1.8	1.5	0.2	0.0	11.6	3.7	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.4	0.2	0.4	0.5	0.2	0.0	9.2	0.0	0.3	13.5	2.1	0.2	0.1	14.0	12.2	4.5	11.7	0.2	0.0	22.6	0.6	16.3	0.7	0.0	0.0	3.9	0.0	0.0	0.1	5.9	0.3	0.3	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3
SMS	"MRSR, SPMSY, SpS, SRS"	ENSG00000102172	"Spermine synthase"	P52788	X	21940573-21994835	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Polyamine biosynthesis"	Transferase	"FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029849, HPA029852"	Approved		Approved	"Nuclear bodies,Cytosol"			26000	"Nuclear bodies"	Cytosol	"HPA029849: AB_10602072, HPA029852: AB_10611521"	"unprognostic (2.51e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (7.49e-4)"	"prognostic unfavourable (7.79e-8)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (7.85e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"	21.7	48.1	29.7	18.7	25.0	18.6	28.4	36.6	35.4	20.8	23.1	8.1	26.0	23.5	20.8	31.3	19.2	13.3	20.9	26.3	22.3	25.0	55.1	19.5	17.6	18.5	25.6	28.5	42.4	16.7	13.6	19.2	63.6	24.2	61.3	24.4	15.7	20.7	20.6	18.0	9.7	25.1	36.8	17.4	18.9	18.8	18.4	11.0	19.6	27.6	11.7	20.8	28.2	16.5	13.2	19.4	37.0	25.7	11.7	20.3	12.3	90.6	23.2	39.6	15.0	10.5	17.8	12.3	24.9	14.9	38.3	36.7	28.8	29.7	32.9	8.6	25.4	19.9	38.7	45.4	75.8	15.2	18.1	17.0	28.0	20.4	19.3	32.9	15.0	11.7	13.9	39.3	73.9	36.6	36.2	4.6	52.1	19.3	24.3	33.0	67.1	34.5	24.3	27.2	25.0	51.0	12.9	18.9	15.3	19.9	25.6	65.5	23.1	13.7	32.3	27.8	28.0	57.6	40.4	3.5	7.0	19.6	54.2	14.7	38.5	2.9	21.4	37.0	7.6	22.1	9.4	13.2	12.0	13.2	19.4	8.3	7.9	9.3	21.1	11.7	25.7	4.0	20.3	12.3	29.7	25.0	36.6	35.4	22.3	25.0	25.6	28.5	24.2	11.0
SMUG1	"FDG, HMUDG, UNG3"	ENSG00000123415	"Single-strand-selective monofunctional uracil-DNA glycosylase 1"	Q53HV7	12	54121277-54189008	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026804, HPA065892"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA026804: , HPA065892: "	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.58e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (6.12e-2)"	"prognostic favourable (1.31e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.73e-1)"	9.5	15.2	17.3	7.0	16.4	4.9	15.5	13.2	16.1	9.8	11.1	11.7	13.5	9.2	9.5	24.1	19.2	14.2	9.2	10.7	15.0	7.8	13.8	23.5	7.8	17.0	11.5	15.0	10.3	23.6	8.3	11.5	14.9	14.4	11.9	10.5	14.2	16.2	10.9	13.6	16.4	16.2	9.2	10.4	11.2	15.2	12.1	14.1	12.6	12.4	6.1	13.1	10.0	9.8	24.2	23.8	38.0	25.0	13.0	20.8	17.0	12.9	23.9	9.4	9.7	17.5	13.7	16.0	10.0	13.1	15.8	14.5	23.9	29.0	7.7	25.8	14.4	17.0	6.5	26.4	10.2	8.1	13.9	11.6	19.1	17.0	20.9	7.7	14.5	15.6	41.2	18.6	18.5	12.7	19.3	17.0	17.3	24.9	9.7	15.2	11.7	21.6	7.1	9.6	13.9	19.6	19.0	14.0	16.7	11.5	19.9	17.5	31.0	14.6	6.1	10.7	11.8	9.5	11.4	15.9	12.5	5.2	15.4	6.1	16.0	38.0	25.0	28.7	15.8	19.7	15.7	24.2	15.6	17.0	21.1	18.8	14.1	14.1	24.5	13.0	15.8	23.8	20.8	17.0	17.3	16.4	13.2	16.1	15.0	7.8	11.5	15.0	14.4	14.1
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 75.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	"Intermediate filaments,Mitochondria,Cytosol"				Cytosol	"Intermediate filaments, Mitochondria"	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	5.9	5.7	8.8	5.6	7.3	2.7	10.0	5.0	23.9	4.9	4.7	2.1	3.1	4.8	3.8	6.7	7.3	10.4	4.5	75.7	7.0	8.4	7.7	9.7	8.1	8.0	5.3	10.0	4.7	7.8	2.9	7.5	10.6	6.9	4.6	5.8	3.1	6.2	3.0	29.5	4.3	4.7	3.8	4.7	6.2	6.2	8.9	2.2	8.0	7.8	5.1	5.6	5.2	4.0	9.3	5.5	8.1	5.9	17.6	14.5	7.3	24.1	7.0	9.5	6.7	9.9	17.2	40.6	13.6	11.3	17.3	19.7	27.5	20.7	12.5	14.1	15.4	11.4	9.0	25.4	16.8	10.4	10.5	4.0	11.8	21.9	8.9	17.6	2.8	18.4	14.3	12.0	9.6	12.5	12.7	3.2	15.5	12.6	12.2	11.1	8.6	9.5	7.6	23.1	10.6	17.1	17.7	9.4	22.0	10.6	38.3	28.2	29.8	11.7	14.4	13.5	19.9	7.4	21.1	12.9	4.8	14.4	17.5	14.0	15.3	6.7	5.9	8.1	9.5	3.2	11.2	9.3	14.5	12.7	5.5	4.8	12.7	11.6	0.6	17.6	1.2	3.8	14.5	7.3	8.8	7.3	5.0	23.9	7.0	8.4	5.3	10.0	6.9	2.2
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 92.9;K-562: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB012229: , HPA045821: , HPA054352: "	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	6.0	12.0	9.9	9.7	16.2	7.6	10.6	25.9	14.7	8.9	6.5	6.4	3.7	4.5	8.7	21.8	6.1	10.0	7.7	5.8	10.3	12.0	8.9	5.5	9.2	6.3	12.0	10.2	8.0	7.2	6.7	11.9	4.6	15.3	6.8	8.3	9.5	5.3	5.9	9.5	6.7	5.2	7.6	6.8	5.3	6.1	10.5	8.1	7.5	18.8	3.6	9.3	8.3	6.6	11.3	5.9	8.3	3.4	19.4	12.9	8.7	4.6	2.8	4.1	3.5	4.7	6.4	4.1	6.5	4.9	7.7	17.3	3.7	5.4	7.6	5.3	6.0	3.0	3.7	7.3	25.9	4.0	3.8	4.4	4.2	4.4	8.8	4.4	92.9	17.3	1.7	10.2	6.6	5.2	35.1	2.6	7.5	1.6	8.5	8.6	3.7	4.5	7.9	5.0	10.9	5.6	6.8	9.8	4.7	3.1	0.4	5.9	3.8	7.6	4.0	3.7	2.6	2.6	7.7	13.3	3.6	3.9	7.1	6.1	4.3	8.1	3.4	8.3	10.5	3.0	10.8	11.3	11.1	12.8	5.9	11.1	12.3	12.9	2.4	19.4	3.3	3.8	11.8	8.7	9.9	16.2	25.9	14.7	10.3	12.0	12.0	10.2	15.3	8.1
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	10.6	10.0	8.6	13.8	9.6	4.8	11.0	16.3	11.8	9.9	10.8	9.6	9.6	11.5	15.3	8.7	6.3	10.1	7.1	11.0	6.3	6.1	6.1	7.4	8.5	10.4	7.4	6.7	15.5	21.7	5.4	11.3	7.7	9.2	10.1	8.3	10.7	14.1	15.5	19.3	10.6	12.9	10.0	9.2	10.0	7.6	9.2	8.2	12.8	9.1	5.6	12.2	10.8	12.8	6.1	6.3	11.5	4.3	4.1	7.9	3.0	6.0	11.3	11.4	8.1	7.8	5.4	13.3	9.8	5.7	10.5	10.8	18.0	5.2	16.1	6.7	4.0	11.7	10.8	6.4	13.1	4.6	10.9	5.9	12.0	4.8	3.9	5.9	5.8	3.8	5.8	10.7	9.5	5.1	6.1	6.3	8.1	3.7	10.9	4.2	5.2	5.6	13.5	5.8	4.1	4.2	7.3	4.7	6.5	9.1	3.8	9.4	5.5	3.7	5.0	10.3	5.3	8.6	8.5	4.4	5.9	5.8	5.8	5.3	10.0	11.5	3.6	3.2	7.9	4.3	6.5	6.1	4.6	5.0	2.1	3.8	5.3	7.6	2.1	4.1	3.3	6.3	4.8	3.0	8.6	9.6	16.3	11.8	6.3	6.1	7.4	6.7	9.2	8.2
SNAI1	"SLUGH2, SNA, SNAH, SNAIL, SNAIL1"	ENSG00000124216	"Snail family transcriptional repressor 1"	O95863	20	49982999-49988886	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 17.6;TIME: 24.5;WM-115: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB005883, HPA056831, HPA069985, CAB078687"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB005883: AB_443967, CAB078687: , HPA056831: , HPA069985: "	"unprognostic (4.60e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (4.76e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.61e-5)"	"unprognostic (3.34e-3)"	"unprognostic (9.85e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (2.63e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (8.82e-7)"	"unprognostic (1.88e-2)"	18.3	8.0	1.8	5.9	3.8	5.5	11.1	2.9	2.7	5.9	3.4	5.8	2.6	1.6	5.4	4.2	4.0	8.2	22.2	11.8	3.1	1.2	5.2	7.2	14.3	5.9	3.1	1.3	6.8	7.0	3.6	4.9	15.9	2.9	6.1	1.3	11.0	3.4	3.8	3.6	3.2	2.3	4.3	6.3	8.1	4.5	4.5	3.6	0.7	18.7	4.1	2.0	10.8	13.9	0.0	4.1	0.0	0.6	0.0	0.0	0.1	0.7	0.6	3.4	0.5	1.1	0.6	6.9	2.9	3.7	0.6	0.4	5.5	0.8	0.4	8.1	5.2	0.1	1.0	0.0	0.3	0.0	0.7	0.4	1.2	3.3	8.9	0.9	2.8	2.0	0.2	1.3	0.0	8.8	4.2	0.1	0.0	1.2	0.1	1.0	4.6	2.4	1.5	0.9	0.4	4.1	0.0	1.5	3.5	17.6	4.5	0.7	0.9	4.0	24.5	0.0	4.4	0.0	0.0	0.1	0.1	4.5	1.4	1.3	15.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	1.8	3.8	2.9	2.7	3.1	1.2	3.1	1.3	2.9	3.6
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10218830-10307418	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 356.9"	"Group enriched"	"Detected in some"	4	"Karpas-707: 10.8;SCLC-21H: 35.7;SH-SY5Y: 21.3;U-87 MG: 25.7"	"Group enriched"	"Detected in many"	6	"glioma: 28.9;pancreatic cancer: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.64e-3)"	"unprognostic (7.26e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-7)"	"unprognostic (6.86e-3)"	"unprognostic (5.87e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-2)"	2.2	16.4	81.0	3.3	60.0	2.1	3.4	202.9	356.9	2.2	2.8	3.4	3.7	3.2	4.6	6.4	2.2	4.0	2.8	2.4	86.5	37.1	2.5	2.3	2.6	2.2	46.7	65.2	3.7	4.1	2.1	5.5	2.3	97.7	3.1	2.8	4.0	2.2	11.9	2.1	2.2	3.3	4.7	13.9	2.1	4.3	3.2	7.4	0.0	2.3	0.0	2.2	2.6	0.1	0.0	1.6	0.7	0.0	0.0	0.6	0.3	0.0	2.1	1.7	0.0	0.2	0.0	0.0	0.9	0.0	2.2	0.6	0.0	0.0	0.0	1.9	0.0	0.4	0.2	0.0	4.4	0.2	0.1	0.0	2.9	0.3	1.6	0.0	0.2	2.0	0.0	1.8	0.0	0.0	0.0	10.8	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	35.7	21.3	0.3	0.0	0.0	0.0	2.9	0.0	2.3	3.1	0.0	1.0	0.0	5.5	0.0	25.7	0.0	2.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.3	81.0	60.0	202.9	163.5	86.5	37.1	46.7	65.2	97.7	7.4
SNAP29	"CEDNIK, SNAP-29"	ENSG00000099940	"Synaptosome associated protein 29"	O95721	22	20858983-20891218	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		"Ichthyosis, Neuropathy, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031823, CAB037092, HPA056492"	Supported		Supported	Nucleoplasm,Cytosol			34000	Cytosol	Nucleoplasm	"CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: "	"unprognostic (1.76e-1)"	"prognostic favourable (6.99e-4)"	"unprognostic (3.72e-3)"	"unprognostic (3.26e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.51e-3)"	"unprognostic (6.08e-2)"	19.4	18.8	15.9	15.5	15.3	15.7	15.5	13.4	19.7	16.0	18.8	15.3	17.1	16.5	15.2	11.6	21.7	12.3	19.9	23.1	13.8	13.0	17.7	36.1	13.4	20.1	15.1	12.3	15.7	16.6	13.1	11.5	26.4	13.7	13.6	17.7	19.0	17.7	17.1	27.6	17.6	16.8	17.6	15.9	24.1	17.4	47.0	14.9	18.3	15.1	15.9	18.2	15.3	16.3	10.8	20.0	23.0	33.2	26.1	14.9	14.0	15.5	6.4	9.1	7.5	10.3	15.1	11.8	14.8	13.4	16.7	16.9	8.8	5.5	9.7	9.5	13.9	9.2	11.9	10.0	18.1	14.0	9.1	16.2	7.2	9.4	14.8	14.3	13.2	11.9	14.2	17.5	12.7	11.7	70.2	14.0	15.4	10.7	13.0	13.8	3.0	6.7	12.5	20.4	3.9	9.8	8.4	7.4	8.9	15.9	10.0	16.7	15.7	11.5	10.1	17.1	15.6	11.7	11.5	14.3	23.2	17.9	12.8	9.7	12.2	19.5	20.0	23.0	10.6	27.4	11.0	10.8	10.5	11.4	17.4	9.2	9.7	9.8	22.6	26.1	33.2	20.0	14.9	14.0	15.9	15.3	13.4	19.7	13.8	13.0	15.1	12.3	13.7	14.9
SNAP47	"C1orf142, SNAP-47, SVAP1"	ENSG00000143740	"Synaptosome associated protein 47"	Q5SQN1	1	227728539-227781231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028167	Supported		Approved	Cytosol				Cytosol		"HPA028167: AB_10603032"	"unprognostic (3.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-1)"	7.4	23.8	21.2	10.8	27.8	6.7	16.2	21.2	29.0	12.4	10.0	10.7	6.9	8.3	21.3	13.4	10.8	15.7	9.8	30.7	21.0	15.1	11.9	14.7	10.0	13.5	12.9	17.4	29.5	17.1	20.7	15.8	16.2	11.6	11.3	8.5	12.6	14.8	10.4	20.4	11.2	8.0	16.6	8.4	9.0	9.2	25.5	11.4	11.6	15.6	9.2	11.9	11.5	9.9	15.4	14.7	20.2	15.1	18.2	29.8	14.7	17.0	23.6	14.9	14.2	18.3	14.4	19.1	11.1	17.8	18.2	15.2	15.6	15.8	12.3	20.3	17.9	18.7	19.0	21.0	15.6	24.1	33.6	10.5	16.7	10.6	11.2	15.2	9.7	16.5	17.5	23.5	12.7	15.2	19.0	12.6	18.8	11.2	15.4	14.5	23.8	34.4	17.3	16.8	18.9	13.1	15.6	29.6	17.5	17.1	24.1	16.7	29.3	14.7	11.4	17.3	20.8	16.6	27.0	16.0	11.6	14.9	15.7	11.9	22.0	10.1	13.0	20.2	19.2	12.4	18.4	15.4	21.8	22.0	14.3	13.9	18.6	17.0	4.7	18.2	15.1	14.7	29.8	14.7	21.2	27.8	21.2	29.0	21.0	15.1	12.9	17.4	11.6	11.4
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 81.9"	"Group enriched"	"Detected in some"	13	"SCLC-21H: 21.3;SH-SY5Y: 13.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol				"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	1.2	8.0	17.8	1.9	25.5	1.1	1.7	44.2	81.9	2.1	1.7	3.4	0.0	1.4	1.7	1.2	1.3	1.8	2.0	1.3	19.2	19.9	1.2	1.1	1.4	3.3	14.3	20.5	3.1	2.4	1.1	9.3	1.6	34.7	3.9	1.7	4.5	1.6	1.7	1.2	1.3	1.7	1.8	7.0	2.2	1.9	10.8	2.9	0.0	2.0	0.0	2.7	1.3	0.2	0.0	6.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	1.2	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.1	0.2	21.3	13.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	17.8	25.5	44.2	43.6	19.2	19.9	14.3	20.5	34.7	2.9
SNAPC2	"PTFdelta, SNAP45"	ENSG00000104976	"Small nuclear RNA activating complex polypeptide 2"	Q13487	19	7920316-7923250	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049843, HPA077597"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049843: , HPA077597: "	"unprognostic (4.56e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (4.89e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.78e-2)"	12.5	15.1	11.0	14.2	17.1	20.3	12.0	19.3	19.8	30.8	20.0	13.2	11.9	14.2	32.4	11.8	20.3	21.8	12.1	12.1	11.7	11.6	15.6	11.1	12.3	12.4	10.6	13.6	24.2	15.1	12.0	16.5	13.6	12.2	24.8	6.0	10.8	18.0	27.0	8.1	16.4	11.3	22.8	9.1	14.8	11.9	28.7	12.3	18.3	17.5	10.4	11.4	29.9	16.1	11.5	20.1	14.7	20.9	17.7	15.5	10.4	9.0	10.5	5.0	19.4	7.0	14.9	4.6	9.6	10.4	9.6	8.7	4.8	7.9	7.8	12.0	11.3	11.2	3.5	7.2	2.8	10.0	8.9	10.9	4.6	6.8	12.7	6.8	18.1	12.1	11.2	11.3	7.0	10.8	10.7	13.2	5.8	8.1	8.7	19.3	6.4	23.6	10.3	4.9	7.7	8.8	3.2	5.9	13.2	5.0	5.4	21.6	8.8	7.4	14.0	32.5	11.5	30.2	12.0	12.6	20.6	4.7	20.3	14.1	10.2	4.5	16.4	14.7	13.7	20.9	13.7	11.5	11.7	11.8	20.1	11.0	12.2	12.2	2.4	17.7	20.7	13.3	15.5	10.4	11.0	17.1	19.3	19.8	11.7	11.6	10.6	13.6	12.2	12.3
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652180-128092609	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol			1200000	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favourable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	21.5	29.8	25.3	25.3	19.8	22.5	45.4	28.1	28.1	33.3	20.0	13.0	57.7	21.3	36.1	38.4	24.8	26.7	25.3	28.3	20.9	16.6	17.3	39.6	38.8	64.2	20.2	19.0	39.7	130.3	22.2	30.3	33.7	27.6	24.5	20.2	13.9	37.5	66.7	20.5	21.5	19.2	41.0	40.1	24.9	30.8	37.0	18.0	22.3	26.6	13.5	24.9	26.5	24.2	28.1	34.9	16.1	30.0	21.0	30.9	28.5	27.9	25.4	19.5	35.3	29.5	30.9	26.7	33.0	39.0	30.2	34.0	32.8	24.3	37.2	16.7	40.4	23.5	27.4	35.8	29.6	20.3	23.2	20.5	30.4	31.4	53.8	31.7	20.2	45.5	39.9	25.8	43.3	37.5	22.7	37.4	30.1	20.9	34.5	23.8	21.8	31.7	24.1	17.4	83.2	23.7	19.8	24.5	26.5	23.9	111.1	38.2	13.9	22.6	37.2	24.6	16.1	44.6	25.6	46.1	17.3	39.1	49.4	27.4	44.5	16.1	30.0	5.9	26.1	28.1	30.9	28.1	19.8	21.0	32.3	16.2	14.3	15.8	2.2	21.0	22.8	34.9	15.8	28.5	25.3	19.8	28.1	28.1	20.9	16.6	20.2	19.0	27.6	18.0
SNF8	"Dot3, EAP30, VPS22"	ENSG00000159210	"SNF8, ESCRT-II complex subunit"	Q96H20	17	48929316-48945117	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059320	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA059320: "	"unprognostic (7.85e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (7.64e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (2.81e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.38e-1)"	22.5	27.8	24.9	20.6	26.2	25.2	32.4	12.9	22.6	17.9	23.5	16.6	29.7	22.1	18.9	28.7	23.0	17.7	24.9	31.5	20.1	19.2	30.8	39.0	18.2	27.3	23.9	21.5	22.3	26.7	17.9	17.4	21.7	19.0	17.6	26.8	18.3	25.2	23.1	40.7	19.2	24.0	25.7	18.2	20.7	24.7	19.8	16.0	28.3	24.0	30.9	26.2	20.5	33.8	5.2	8.3	11.2	6.7	1.7	5.7	1.5	16.1	32.4	20.2	25.8	21.1	12.3	32.0	13.6	18.9	26.7	24.1	79.6	16.9	14.9	24.0	25.7	10.8	18.8	19.2	29.9	21.2	30.4	16.4	41.1	33.5	18.5	22.2	18.7	15.2	19.3	25.5	19.7	25.0	16.2	15.1	27.2	32.3	23.8	19.0	9.9	27.7	15.7	36.9	17.5	16.0	18.1	13.4	26.8	16.4	7.7	19.4	19.5	27.5	20.8	29.0	23.1	18.0	25.5	22.2	25.3	17.7	25.5	12.1	22.4	2.3	5.7	11.2	3.2	6.2	1.8	5.2	4.8	3.7	6.4	5.2	3.2	2.7	2.3	1.7	6.7	8.3	5.7	1.5	24.9	26.2	12.9	22.6	20.1	19.2	23.9	21.5	19.0	16.0
SNIP1	PML1	ENSG00000163877	"Smad nuclear interacting protein 1"	Q8TAD8	1	37534449-37554344	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, RNA-mediated gene silencing"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036896	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036896: AB_10670244"	"unprognostic (1.37e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.24e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.34e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	10.6	13.4	10.6	13.3	12.4	15.9	15.0	18.4	14.4	12.8	10.8	10.0	14.2	8.5	14.2	11.9	13.5	11.9	10.0	8.5	11.1	9.0	9.9	20.6	10.2	11.7	10.8	10.5	12.7	15.3	9.8	13.1	13.2	9.9	13.3	9.0	12.3	11.7	11.5	13.5	13.2	12.3	11.6	7.9	14.9	11.8	21.7	11.6	16.9	10.5	11.1	14.0	11.7	17.0	3.7	4.3	4.6	3.5	3.1	5.5	1.8	6.1	3.5	6.9	6.8	8.3	7.9	4.7	7.9	9.0	7.6	6.7	3.4	5.6	8.5	6.2	8.4	6.5	6.4	7.2	6.3	7.6	9.3	13.1	6.1	6.9	9.5	12.0	7.4	7.6	8.5	7.5	9.6	7.3	9.2	7.9	5.3	4.6	7.1	9.4	11.2	8.1	7.5	11.6	7.1	5.5	5.9	5.6	11.2	8.4	5.5	10.3	4.9	6.6	12.1	6.0	6.7	7.5	7.8	9.4	10.9	7.0	7.1	8.6	5.4	4.1	3.1	3.9	5.5	2.8	5.4	3.7	3.7	5.3	2.6	3.6	5.1	4.5	4.6	3.1	3.5	4.3	4.2	1.8	10.6	12.4	18.4	14.4	11.1	9.0	10.8	10.5	9.9	11.6
SNN		ENSG00000184602	Stannin	O75324	16	11668414-11679159	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Cell line enhanced"	"Detected in many"		"AF22: 30.9;REH: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011055	Approved		Approved	Cytosol				Cytosol		"HPA011055: AB_1857326"	"unprognostic (1.94e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (1.85e-6)"	"unprognostic (4.51e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.14e-1)"	"prognostic favourable (1.83e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-1)"	"unprognostic (4.72e-2)"	29.2	16.6	34.7	10.0	51.5	11.0	13.7	27.2	52.2	6.9	4.4	11.2	1.8	4.9	6.8	11.5	10.5	5.9	12.0	13.2	33.0	15.5	7.0	5.1	9.2	15.0	29.8	25.2	9.8	4.7	4.5	4.6	4.5	15.6	8.1	3.3	6.9	9.9	12.9	29.1	4.5	4.4	6.6	15.2	17.4	4.6	2.2	11.4	6.1	9.5	4.8	14.2	9.3	6.1	7.0	9.0	24.1	20.3	0.3	3.0	7.4	2.9	2.9	30.9	8.4	20.5	5.8	3.0	1.2	2.7	3.7	3.8	4.7	2.1	3.1	12.7	4.2	5.9	9.2	3.6	2.9	0.8	2.1	10.2	3.1	6.1	5.5	0.7	6.2	5.1	16.8	2.0	4.2	6.8	1.6	4.9	3.4	5.0	8.1	2.3	16.0	2.1	28.9	4.1	21.2	3.5	8.8	18.4	7.4	7.0	9.3	4.5	3.7	6.1	6.1	4.3	9.0	25.2	1.3	1.9	1.2	7.3	2.5	8.7	5.4	0.0	9.5	6.9	0.3	16.3	0.3	7.0	1.6	0.7	9.0	6.8	3.0	2.1	24.1	0.3	20.3	3.6	0.9	7.4	34.7	51.5	27.2	39.3	33.0	15.5	29.8	25.2	15.6	11.4
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53010-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.9;skeletal muscle: 63.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: , HPA044248: "	"unprognostic (7.87e-2)"	"prognostic favourable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	7.1	10.1	31.4	11.5	25.4	15.6	7.4	15.7	31.2	7.1	9.7	6.8	5.4	7.2	6.6	9.6	8.8	8.8	6.3	28.7	25.0	22.6	11.7	16.4	5.4	16.4	28.1	20.3	10.9	10.8	7.7	10.8	4.9	24.7	9.8	10.1	7.5	12.6	8.4	63.7	4.3	6.4	8.6	13.5	6.6	10.2	6.4	7.7	9.4	9.4	11.0	16.4	6.8	4.8	18.0	56.9	23.2	9.9	5.2	6.5	5.7	11.4	26.1	14.5	16.8	5.2	6.1	7.1	9.7	6.3	21.8	18.5	35.0	11.2	36.4	11.6	7.9	11.8	26.5	17.9	16.8	13.1	20.6	21.1	36.4	35.0	5.5	38.4	25.0	7.8	6.4	19.4	5.4	11.7	31.4	8.7	12.4	54.3	20.1	16.0	17.3	12.7	32.6	15.5	43.4	11.5	8.1	15.9	10.3	22.0	28.5	4.7	18.4	18.7	9.2	9.7	12.1	12.4	15.5	9.0	21.4	56.4	5.1	20.6	14.7	2.8	6.6	23.2	4.0	9.9	5.0	17.5	4.2	4.9	12.8	18.0	4.5	4.5	4.5	5.2	8.5	56.9	6.5	5.7	31.4	25.4	15.7	31.2	25.0	22.6	28.1	20.3	24.7	7.7
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590199-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029234	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavourable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	9.5	7.1	12.3	11.7	14.9	15.6	12.6	28.9	13.3	10.5	10.3	7.0	13.6	9.9	11.7	8.6	9.4	9.2	7.1	12.2	11.9	7.5	10.7	12.7	8.6	11.7	14.1	8.1	14.4	10.5	7.3	11.0	9.2	11.4	10.5	10.1	5.9	10.1	13.0	15.8	11.0	11.5	10.5	17.8	11.2	9.6	5.3	14.3	15.3	10.4	7.1	10.0	9.9	30.2	3.3	2.7	6.0	2.0	2.7	3.7	1.7	5.7	4.6	9.6	17.9	5.2	7.7	6.5	6.6	6.1	7.1	7.9	9.7	4.7	13.5	7.1	5.4	7.4	11.9	7.0	11.0	10.4	11.6	9.7	14.6	18.7	5.5	11.6	6.5	5.4	10.9	8.0	6.2	6.1	13.6	2.1	9.9	3.2	18.9	16.8	13.0	5.2	20.4	8.3	18.1	6.5	5.1	14.9	4.1	12.7	3.3	11.2	6.4	4.1	6.8	9.5	4.3	5.6	11.2	3.5	19.3	8.3	3.2	9.3	17.0	0.4	2.0	1.0	2.0	1.4	3.4	1.7	2.4	2.6	2.4	3.3	2.1	3.7	6.0	2.7	0.8	2.7	1.7	1.7	12.3	14.9	28.9	13.3	11.9	7.5	14.1	8.1	11.4	14.3
SNRPD2	"Sm-D2, SNRPD1"	ENSG00000125743	"Small nuclear ribonucleoprotein D2 polypeptide"	P62316	19	45687454-45692569	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041437	Supported		Supported	Cytosol				Cytosol		"HPA041437: AB_10795119"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (8.58e-5)"	"unprognostic (1.95e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.12e-2)"	37.2	45.7	57.1	66.4	63.2	75.8	73.2	26.0	66.6	51.9	47.1	17.7	54.3	33.3	43.4	60.2	51.2	55.7	48.8	47.5	49.7	43.6	43.2	36.3	33.9	76.7	45.2	66.7	85.3	68.6	19.9	43.8	38.6	55.1	42.8	46.2	26.6	38.6	40.9	55.7	48.5	33.4	61.5	51.1	44.7	39.7	45.0	47.1	62.3	45.6	56.5	67.7	40.4	89.0	104.7	74.4	22.0	44.8	68.8	113.4	127.2	75.8	108.2	71.7	76.0	68.6	62.0	38.5	50.2	57.0	70.2	74.6	59.4	49.4	85.9	40.6	59.8	45.9	90.0	90.9	67.5	55.0	119.0	82.9	65.4	86.4	47.2	99.7	55.5	71.1	65.3	63.1	60.6	70.9	74.1	61.3	57.7	102.3	101.4	91.5	68.3	64.8	69.0	73.5	69.7	61.9	97.2	64.0	71.9	65.7	73.1	63.7	43.1	109.2	48.7	38.9	60.7	33.7	94.5	62.1	141.7	145.9	53.8	80.9	59.3	20.1	44.8	22.0	72.7	40.3	92.0	104.7	97.5	85.6	65.9	88.7	113.4	97.5	5.4	68.8	30.9	74.4	91.3	127.2	57.1	63.2	26.0	66.6	49.7	43.6	45.2	66.7	55.1	47.1
SNRPD3	"Sm-D3, SMD3"	ENSG00000100028	"Small nuclear ribonucleoprotein D3 polypeptide"	P62318	22	24555503-24609980	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001170	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			360000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA001170: AB_1080042"	"unprognostic (3.30e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.28e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	23.7	31.8	23.8	28.9	23.3	29.7	29.5	27.1	27.4	29.3	38.3	24.7	29.8	27.9	31.6	30.6	41.8	30.8	27.1	31.6	21.8	24.2	38.5	61.6	26.5	36.4	24.3	26.8	33.9	34.0	27.8	31.8	33.3	22.6	27.8	33.1	27.9	42.9	27.3	59.0	26.7	35.5	29.6	25.5	32.3	27.8	22.4	23.1	46.8	39.2	61.0	42.7	27.1	30.2	42.5	39.0	38.1	34.9	36.6	33.2	29.8	40.7	14.0	44.0	15.9	16.5	14.2	16.6	39.8	18.3	39.7	37.0	19.9	15.8	36.4	18.8	24.9	30.8	55.8	48.8	40.5	27.7	57.0	39.1	28.2	30.0	18.0	96.4	24.6	16.3	22.7	43.0	22.6	28.9	26.8	18.5	16.2	20.8	41.0	24.0	24.3	20.2	39.5	46.0	18.9	35.4	31.7	20.6	22.9	25.5	16.7	21.2	25.1	26.2	30.4	33.1	33.3	16.6	29.4	19.1	36.9	66.9	16.3	33.2	22.3	12.2	31.4	38.1	28.2	34.9	31.3	42.5	30.7	30.6	39.0	36.3	29.4	33.2	15.7	36.6	34.7	37.1	28.9	29.8	23.8	23.3	27.1	27.4	21.8	24.2	24.3	26.8	22.6	23.1
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	30.5	23.4	20.3	24.0	24.8	59.5	28.3	32.1	26.2	26.1	27.6	29.6	21.5	24.6	32.5	24.3	29.1	25.4	20.5	26.3	20.6	18.3	23.5	25.3	24.8	31.5	23.9	26.7	32.1	26.5	19.8	31.6	32.3	26.8	29.8	24.9	22.3	23.4	17.6	41.8	33.3	30.7	30.8	23.7	32.3	24.2	36.3	24.3	37.5	34.1	24.2	30.4	33.0	25.0	32.5	38.2	47.8	44.1	47.6	47.1	35.5	39.4	29.2	30.0	31.8	24.8	27.9	34.9	27.1	23.9	29.9	27.6	29.0	36.2	38.5	24.9	20.2	38.9	36.0	25.8	40.7	30.6	28.5	31.1	26.4	29.0	35.6	21.7	36.9	21.4	34.5	27.1	37.4	29.0	44.5	29.0	22.8	40.4	38.7	37.0	33.6	39.4	41.9	38.8	26.4	27.7	36.6	32.3	35.0	37.4	33.1	37.3	47.4	41.8	30.6	32.8	37.6	29.5	32.4	28.7	40.6	42.9	29.8	35.1	36.2	42.0	38.0	47.8	32.1	40.6	36.0	30.9	36.2	36.3	38.2	32.5	38.3	36.0	36.1	47.6	44.1	22.7	47.1	35.5	20.3	24.8	32.1	26.2	20.6	18.3	23.9	26.7	26.8	24.3
SNX11		ENSG00000002919	"Sorting nexin 11"	Q9Y5W9	17	48103357-48123074	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044787, HPA054660"	Approved		Approved	Cytosol				Cytosol		"HPA044787: AB_10795988, HPA054660: "	"unprognostic (1.75e-1)"	"unprognostic (6.86e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.22e-3)"	"unprognostic (9.02e-3)"	"unprognostic (2.70e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.89e-2)"	16.8	12.1	15.1	18.7	23.5	21.0	11.9	12.9	19.5	8.8	13.8	20.2	11.0	9.2	11.6	16.6	19.6	10.4	10.2	12.5	16.2	15.4	16.0	14.4	12.8	21.5	17.2	15.0	9.7	12.3	12.1	13.7	14.9	13.7	12.5	14.0	13.7	15.6	11.3	12.3	11.5	12.2	17.5	18.1	25.5	12.6	11.5	17.0	15.0	21.3	12.2	28.9	14.2	11.3	9.8	11.7	39.8	21.0	6.6	8.4	9.2	11.9	15.2	12.6	12.3	11.4	5.0	14.5	12.1	8.8	16.6	18.0	22.5	10.6	12.7	16.2	14.5	10.1	12.0	12.7	17.0	29.3	15.1	17.5	9.4	10.8	12.5	19.7	13.1	8.2	14.2	14.9	14.6	14.3	11.0	11.9	10.8	11.1	12.3	15.2	7.4	13.0	7.4	22.0	13.8	10.6	11.9	9.2	17.5	8.2	5.8	22.1	12.1	15.3	11.1	17.0	10.6	11.7	15.4	20.5	29.6	14.3	12.4	9.6	11.0	11.4	14.5	13.9	8.4	18.1	6.1	9.8	4.7	5.9	11.7	9.4	4.1	6.6	39.8	6.6	21.0	5.5	4.2	9.2	15.1	23.5	12.9	19.5	16.2	15.4	17.2	15.0	13.7	17.0
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Cytosol				Cytosol		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	23.4	25.9	19.9	16.0	21.9	16.6	26.7	25.2	30.1	20.1	23.3	16.1	17.8	17.7	23.8	37.0	17.1	17.8	17.4	17.4	19.5	24.2	33.2	41.0	23.8	17.7	21.6	18.0	17.9	27.7	27.2	35.5	29.6	30.8	21.1	22.2	19.9	17.7	20.2	9.6	17.1	31.0	15.8	20.7	24.6	26.8	49.1	17.1	16.1	26.1	11.2	18.2	22.6	15.1	8.9	16.4	20.0	24.1	13.4	13.3	8.9	14.9	9.1	15.0	22.0	34.4	25.2	15.8	19.2	26.5	15.1	23.4	16.5	25.3	19.7	23.8	24.7	20.3	10.3	19.8	23.9	17.4	6.0	21.5	12.7	24.7	28.4	20.1	22.4	22.0	15.0	17.6	17.9	26.8	21.7	17.1	32.8	17.4	1.2	38.5	6.0	10.3	8.1	30.6	9.4	36.8	27.8	6.6	15.1	11.7	26.0	17.8	16.1	36.1	23.9	12.0	7.5	14.9	19.9	17.2	27.3	7.3	24.6	23.8	24.1	18.1	13.6	20.0	13.3	20.3	10.0	8.9	9.0	11.9	16.4	8.8	8.2	10.3	6.3	13.4	24.1	4.8	10.2	8.9	19.9	21.9	25.2	30.1	19.5	24.2	21.6	18.0	30.8	17.1
SNX15		ENSG00000110025	"Sorting nexin 15"	Q9NRS6	11	65027408-65040572	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038955	Approved		Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Nucleoli, Cytosol"	"Vesicles, Plasma membrane"	"HPA038955: AB_10672834"	"unprognostic (2.00e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.93e-1)"	"unprognostic (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.06e-3)"	"unprognostic (4.45e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.79e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-4)"	17.9	13.6	17.1	12.7	18.3	11.6	23.5	25.7	21.9	13.2	22.7	16.7	9.5	19.7	14.2	8.9	15.9	11.4	13.9	15.1	16.2	14.3	15.7	9.8	14.1	14.7	16.3	14.5	18.3	17.7	13.7	8.4	9.5	13.4	15.1	11.6	11.2	15.6	15.4	25.2	17.2	20.4	15.0	17.6	11.3	13.5	7.6	15.8	12.4	14.4	10.1	11.5	14.9	12.5	7.7	8.0	10.9	18.3	3.2	7.1	5.7	17.4	12.9	8.4	8.2	10.1	7.5	4.7	1.7	7.9	13.8	12.7	10.1	13.7	17.8	9.9	9.9	9.8	9.8	8.7	3.8	26.7	8.1	8.9	10.6	16.9	11.0	4.6	14.4	6.3	13.0	14.6	8.4	8.2	15.0	11.4	7.2	10.5	16.3	20.7	9.0	12.8	13.5	5.0	19.1	10.2	3.8	15.2	11.4	14.9	13.5	12.9	13.6	10.7	16.1	14.0	13.4	14.1	7.4	12.3	21.0	17.0	13.7	7.3	4.8	7.8	11.3	10.9	6.9	13.6	5.6	7.7	7.1	6.1	8.0	6.1	5.2	4.7	1.6	3.2	18.3	5.5	6.7	5.7	17.1	18.3	25.7	21.9	16.2	14.3	16.3	14.5	13.4	15.8
SNX18	"SH3PX2, SH3PXD3B, SNAG1"	ENSG00000178996	"Sorting nexin 18"	Q96RF0	5	54517759-54546585	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037800	Approved		Approved	Cytosol				Cytosol		"HPA037800: AB_10672465"	"unprognostic (2.22e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.81e-3)"	"prognostic favourable (1.58e-4)"	"unprognostic (6.79e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	16.2	9.0	10.1	9.2	13.5	50.3	17.8	5.8	9.9	13.0	12.1	20.3	13.8	8.1	14.7	7.6	11.4	11.5	11.8	13.1	10.3	9.0	11.6	13.9	12.1	18.7	18.3	7.0	23.8	8.1	17.4	5.3	18.4	12.7	14.5	5.2	10.9	11.4	13.9	7.7	9.6	8.8	12.5	23.3	26.0	11.7	13.5	15.0	6.7	15.0	5.4	6.6	15.1	26.2	1.2	4.2	6.7	6.1	1.7	1.3	0.6	3.9	3.3	5.2	5.9	12.2	13.1	28.4	6.6	16.7	3.4	5.8	4.0	7.3	0.1	11.1	10.2	3.7	4.9	6.5	4.4	2.1	3.7	1.1	2.1	2.5	20.4	2.2	1.2	20.6	7.9	4.7	5.0	7.2	2.1	27.6	6.0	3.7	2.0	2.5	2.6	3.5	5.5	2.9	6.3	3.4	11.5	6.5	3.9	5.5	6.4	7.2	7.5	3.7	2.4	13.1	6.6	9.6	6.9	18.8	18.1	1.1	5.0	5.2	13.5	0.0	1.6	0.2	1.3	2.6	0.3	1.2	0.6	0.8	1.9	1.2	0.3	1.0	6.7	1.7	6.1	4.2	0.3	0.6	10.1	13.5	5.8	7.9	10.3	9.0	18.3	7.0	12.7	15.0
SNX27	"KIAA0488, MGC20471, MY014"	ENSG00000143376	"Sorting nexin family member 27"	Q96L92	1	151612006-151699091	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045816			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045816: "	"unprognostic (3.35e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.04e-1)"	10.9	12.5	21.5	12.5	28.6	13.4	12.6	25.0	27.7	14.8	15.9	23.4	13.5	9.1	12.1	16.2	12.1	13.9	11.5	12.1	23.0	21.3	24.2	12.8	13.6	10.4	23.7	19.2	17.2	10.0	26.0	14.8	17.5	20.3	14.8	13.0	13.1	9.7	20.6	25.6	16.0	10.1	21.3	23.1	17.0	11.2	12.8	18.7	8.8	12.8	7.7	10.8	17.4	21.7	2.5	8.4	20.3	18.6	1.7	3.6	7.3	5.8	8.7	9.3	11.7	14.7	10.9	20.7	3.2	6.6	5.6	6.0	7.1	7.8	5.6	6.9	5.1	7.3	11.9	6.4	7.1	7.9	4.5	8.9	5.1	7.9	9.8	10.6	6.1	8.6	4.8	6.4	7.4	6.3	5.4	34.5	7.3	10.5	6.3	7.3	16.4	5.6	6.6	9.0	7.2	8.7	8.9	9.3	8.0	8.5	15.9	6.1	10.2	9.0	8.3	8.0	5.4	8.3	6.6	7.2	7.3	11.3	9.5	6.9	8.9	9.5	18.6	2.6	2.6	16.1	3.6	1.8	3.2	2.3	8.4	2.5	3.1	2.5	20.3	1.7	16.9	2.1	2.5	7.3	21.5	28.6	25.0	24.6	23.0	21.3	23.7	19.2	20.3	18.7
SNX30	ATG24A	ENSG00000148158	"Sorting nexin family member 30"	Q5VWJ9	9	112750838-112881671	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019346	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA019346: AB_2286395"	"unprognostic (1.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (1.01e-7)"	"unprognostic (4.48e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-2)"	4.9	4.4	12.2	7.7	12.6	8.3	7.7	18.1	18.5	10.9	11.1	25.6	3.6	7.9	6.4	4.1	5.3	3.8	5.4	3.4	14.2	12.0	23.7	5.2	23.4	8.8	14.8	12.8	6.9	5.2	6.9	6.3	5.1	14.7	4.1	11.7	4.9	7.1	4.3	2.6	5.7	8.9	7.5	20.3	7.4	4.7	12.7	11.8	2.3	3.1	2.6	8.7	5.4	4.6	0.7	4.2	1.5	5.1	0.8	1.7	1.6	6.0	3.7	6.5	5.1	8.2	7.5	5.5	5.2	10.8	4.4	4.2	13.3	1.4	10.0	4.4	13.3	7.2	7.9	3.0	6.8	3.2	3.7	3.0	3.4	5.4	5.9	3.1	5.5	6.1	4.3	6.7	5.0	3.7	4.8	5.7	5.9	4.2	2.0	3.6	7.2	4.0	4.3	15.2	2.5	8.5	10.5	9.7	3.1	6.7	9.3	12.9	6.9	5.5	4.2	6.5	7.0	19.1	4.4	14.9	13.7	4.8	8.4	2.9	12.7	0.0	5.1	1.5	0.8	2.0	1.7	0.0	0.8	1.0	4.2	0.7	0.7	0.6	0.7	0.8	2.1	0.7	1.6	1.6	12.2	12.6	18.1	18.5	14.2	12.0	14.8	12.8	14.7	11.8
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572882-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0"	"Cell line enriched"	"Detected in single"	50	"RT4: 41.9"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"thalamus: 2.9"	"Group enriched"	"Detected in some"	4	"basal ganglia: 0.8;olfactory region: 3.1"	"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: "	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.5	0.0	0.6	0.1	0.7	0.1	0.4	0.6	2.3	1.7	0.3	0.3	0.1	0.2	0.3	0.2	6.2	0.3	0.9	1.8	0.8	0.7	0.3	0.4	0.3	0.3	0.9	0.3	0.3	0.2	0.1	0.2	0.1	0.6	13.8	0.1	0.4	1.4	0.1	1.0	0.5	0.1	7.4	0.8	0.1	0.6	3.3	0.5	0.1	0.4	2.6	21.4	25.4	16.0	1.1	0.3	3.0	0.5	1.6	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	2.5	0.5	0.2	0.3	0.2	0.1	1.1	0.1	0.2	0.2	0.5	0.1	0.3	3.0	1.6	0.0	0.3	0.0	0.0	0.6	0.7	0.6	0.3	0.8	0.7	0.9	0.3	0.6	0.5
SNX5		ENSG00000089006	"Sorting nexin 5"	Q9Y5X3	20	17941597-17968980	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020679, HPA051187, HPA076450"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB020679: , HPA051187: , HPA076450: "	"unprognostic (6.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavourable (2.30e-10)"	"unprognostic (1.67e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.99e-1)"	23.0	30.7	19.0	29.1	19.7	26.5	20.6	12.8	17.8	17.4	21.1	16.4	16.3	27.3	17.9	40.9	18.5	17.0	17.3	20.0	17.2	14.0	35.9	30.3	18.7	43.8	20.4	14.8	29.4	18.7	17.7	15.4	24.4	15.6	17.6	22.9	17.8	18.1	14.8	34.9	14.5	23.6	14.0	21.8	46.4	18.2	9.8	17.8	25.6	64.4	19.6	27.3	20.5	19.0	32.8	28.8	33.4	34.5	15.2	26.7	19.5	18.4	20.2	8.6	9.4	6.1	10.6	51.6	14.8	8.3	9.5	10.9	19.5	26.2	30.6	9.2	9.3	20.8	12.0	23.2	13.0	7.7	10.7	27.2	8.3	115.7	9.5	19.0	32.8	10.0	10.3	10.3	18.8	13.7	13.1	20.7	11.4	14.4	16.7	16.8	9.2	10.1	19.9	21.9	22.8	11.7	21.5	8.6	4.9	14.1	21.7	19.0	11.8	12.4	10.8	15.1	18.7	9.3	18.5	14.7	22.3	24.8	7.4	6.9	13.1	23.5	23.5	33.4	23.8	32.0	21.6	32.8	21.8	23.2	28.8	30.5	13.2	19.2	1.9	15.2	34.5	14.8	26.7	19.5	19.0	19.7	12.8	17.8	17.2	14.0	20.4	14.8	15.6	17.8
SNX7		ENSG00000162627	"Sorting nexin 7"	Q9UNH6	1	98661701-98760500	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037419, HPA054338"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"		"HPA037419: AB_10671754, HPA054338: "	"unprognostic (3.19e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (5.10e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (9.59e-7)"	"unprognostic (1.53e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.77e-1)"	19.2	13.6	12.0	8.2	11.3	0.2	22.4	3.1	9.8	18.6	24.7	9.7	12.5	19.4	18.7	18.7	17.7	13.5	15.4	18.0	12.0	15.6	22.1	13.0	9.6	4.7	13.6	9.3	13.8	13.7	14.7	13.2	13.9	15.6	17.7	25.4	6.6	15.0	14.8	5.8	11.5	27.2	21.8	17.3	6.4	13.9	14.7	12.7	2.0	13.9	10.3	7.4	18.7	21.9	0.6	0.3	0.0	1.4	0.0	0.3	0.3	16.1	8.7	5.3	7.2	18.9	30.0	3.0	10.3	18.8	15.5	20.2	5.0	6.1	0.0	13.4	25.2	4.7	5.6	14.6	15.5	0.0	10.7	0.0	13.9	8.7	11.2	0.0	0.0	15.0	15.7	12.7	5.6	21.5	0.0	0.0	24.4	3.3	0.1	0.0	5.1	12.6	0.0	11.9	0.0	15.4	13.0	2.6	31.7	13.7	13.0	7.4	0.0	0.5	14.7	15.2	8.5	11.7	20.7	0.0	0.0	0.0	21.5	0.0	7.3	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	12.0	11.3	3.1	9.8	12.0	15.6	13.6	9.3	15.6	12.7
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA031410: AB_10603339, HPA057203: "	"unprognostic (1.63e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	44.7	18.9	13.0	16.5	14.7	17.2	35.4	6.7	16.2	27.4	24.6	19.8	43.5	18.1	32.1	19.5	31.4	17.2	26.4	20.4	12.2	10.8	17.8	25.4	14.6	22.5	19.7	11.4	19.8	22.5	17.7	10.8	45.0	13.3	25.0	17.7	11.1	25.2	41.7	16.5	21.2	28.0	44.6	16.4	19.8	21.5	10.9	18.4	5.0	18.4	17.9	20.3	34.0	40.2	4.1	11.2	1.3	7.3	0.5	6.7	1.0	7.8	5.1	5.5	6.4	27.4	24.4	11.6	15.7	44.3	10.7	14.4	4.5	8.0	0.0	7.8	24.3	5.2	6.4	10.5	9.0	6.4	7.5	4.9	7.9	6.8	13.7	2.6	10.0	14.4	9.4	11.0	10.8	14.8	24.9	0.0	5.2	4.4	0.0	3.9	4.3	6.7	0.0	5.5	8.9	17.3	4.6	3.5	6.4	10.0	4.6	24.0	2.2	5.6	12.0	11.9	5.4	38.0	8.3	0.0	0.0	0.0	23.8	2.0	6.9	0.0	1.0	1.3	0.6	3.2	2.4	4.1	1.7	1.3	2.0	3.4	6.7	2.1	0.1	0.5	7.3	11.2	2.8	1.0	13.0	14.7	6.7	16.2	12.2	10.8	19.7	11.4	13.3	18.4
SOCS3	"CIS3, Cish3, SOCS-3, SSI-3"	ENSG00000184557	"Suppressor of cytokine signaling 3"	O14543	17	78356778-78360077	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.9;HSkMC: 24.9;U-266/70: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.6;T-cells: 4.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB012220, HPA068569"	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB012220: AB_443287, HPA068569: "	"prognostic favourable (4.80e-4)"	"unprognostic (2.67e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (9.34e-9)"	"unprognostic (1.08e-2)"	"unprognostic (8.80e-2)"	"unprognostic (7.59e-3)"	"unprognostic (8.40e-2)"	94.9	16.8	6.3	42.5	21.4	33.9	25.7	3.0	12.8	27.6	26.6	5.6	1.9	6.2	13.9	9.2	22.7	88.0	59.6	23.5	11.4	5.1	13.5	30.4	52.1	30.2	13.9	0.1	31.2	14.5	13.9	13.4	23.5	38.0	20.8	9.2	10.3	9.2	6.7	26.0	12.1	15.6	39.0	29.6	36.7	32.2	12.1	8.7	5.6	14.2	40.9	10.3	38.1	41.1	0.0	1.3	11.6	1.3	0.4	4.3	0.6	2.0	3.3	2.4	1.2	0.9	15.2	6.3	10.2	9.3	10.7	4.5	2.1	1.4	0.0	2.2	2.4	0.6	0.5	1.0	4.2	48.9	0.3	1.8	7.2	0.4	4.9	0.0	0.9	24.9	0.8	8.3	3.1	4.6	5.4	19.2	4.9	1.0	1.0	0.3	1.7	4.2	0.0	12.2	0.3	17.0	2.0	0.1	1.5	3.1	0.8	0.4	0.9	0.4	2.7	21.1	6.0	7.3	5.9	25.3	14.2	0.0	17.3	0.2	1.3	0.0	1.3	0.3	1.0	0.1	2.6	0.0	2.8	1.2	1.3	0.0	4.3	0.8	11.6	0.4	0.0	1.2	1.6	0.6	6.3	21.4	3.0	12.8	11.4	5.1	13.9	0.1	38.0	8.7
SOCS4	SOCS7	ENSG00000180008	"Suppressor of cytokine signaling 4"	Q8WXH5	14	55027230-55049488	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013478, HPA057961"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB013478: , HPA057961: "	"unprognostic (7.18e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.74e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.82e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.13e-1)"	14.5	11.1	12.5	16.0	21.2	12.7	12.2	12.6	19.1	11.4	12.0	14.0	8.7	11.1	13.6	9.3	13.2	13.9	15.0	13.9	15.5	10.9	17.6	10.6	16.7	18.0	22.6	10.5	12.6	10.2	12.8	18.5	12.4	17.0	11.7	12.8	7.2	11.9	10.3	12.3	10.5	13.2	17.5	29.6	16.4	15.1	9.5	19.6	16.2	15.3	6.5	16.0	16.1	18.9	3.8	4.1	4.5	5.8	6.0	4.9	2.0	10.7	9.3	12.7	14.8	8.4	9.7	10.1	12.6	9.3	8.0	13.2	7.6	11.6	16.2	8.9	9.4	15.1	17.2	10.2	18.8	16.6	7.0	9.6	12.1	4.5	8.6	11.0	17.0	7.7	10.6	14.4	10.6	14.4	5.7	16.3	14.6	10.7	16.4	8.0	10.0	10.1	15.2	19.8	6.2	11.4	11.9	16.9	14.5	12.7	7.7	12.0	10.7	8.1	14.7	20.6	20.9	10.1	10.7	5.9	6.2	15.7	13.3	8.9	15.8	1.7	4.2	4.5	3.2	4.9	4.9	3.0	4.0	3.0	3.1	3.8	2.2	2.4	2.6	6.0	5.8	4.1	3.6	2.0	12.5	21.2	12.6	19.1	15.5	10.9	22.6	10.5	17.0	19.6
SOCS5	"CIS6, Cish5, CISH6, KIAA0671, SOCS-5"	ENSG00000171150	"Suppressor of cytokine signaling 5"	O75159	2	46698952-46763129	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 44.9;fHDF/TERT166: 43.7;U-138 MG: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020884, CAB025510"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025510: , HPA020884: AB_1857356"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (7.28e-4)"	"unprognostic (4.52e-2)"	"unprognostic (9.13e-2)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	12.2	10.1	16.9	5.6	24.9	6.2	21.3	26.4	14.9	13.6	9.4	6.3	7.6	4.8	14.0	8.8	8.2	9.6	11.2	11.2	11.9	8.1	9.1	6.3	10.1	9.9	9.1	10.8	23.8	6.0	14.8	9.0	6.9	11.8	9.9	6.5	5.8	9.3	13.0	8.8	6.9	6.8	13.6	10.8	8.1	7.2	9.5	8.8	10.9	9.8	5.0	6.1	9.4	9.0	4.8	1.3	6.3	3.7	2.3	3.3	1.6	5.1	3.9	3.4	5.0	11.0	15.9	4.2	24.2	44.9	11.9	7.0	3.7	2.5	2.6	4.7	43.7	2.5	3.7	3.8	15.2	2.6	3.4	4.1	3.7	4.4	6.8	2.4	4.6	12.6	5.8	10.1	4.0	4.0	3.6	2.9	7.5	1.8	2.1	3.9	3.8	3.2	2.7	5.8	3.3	4.8	3.9	2.7	7.4	5.9	3.9	4.6	1.6	3.4	4.5	29.7	6.6	9.8	4.7	3.6	2.2	2.2	13.5	4.7	9.2	1.2	1.1	6.3	2.4	1.0	3.0	4.5	1.5	1.6	1.2	4.8	2.7	3.3	1.1	2.3	3.7	1.3	2.5	1.6	16.9	24.9	26.4	14.9	11.9	8.1	9.1	10.8	11.8	8.8
SOCS6	"CIS4, Cish4, HSPC060, SOCS4, SSI4, STAI4, STATI4"	ENSG00000170677	"Suppressor of cytokine signaling 6"	O14544	18	70288901-70330200	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.0;myeloid DC: 6.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							CAB010189	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB010189: AB_661195"	"unprognostic (1.76e-3)"	"unprognostic (6.83e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-2)"	"prognostic favourable (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.80e-2)"	9.1	8.8	12.7	5.1	16.3	10.2	12.8	13.8	11.6	15.0	14.6	20.1	9.8	14.1	12.9	6.7	17.7	11.8	12.6	9.8	12.8	7.8	8.9	26.1	8.8	2.8	21.4	10.1	10.6	12.4	18.1	7.2	21.1	14.9	8.7	13.5	14.3	17.3	7.8	17.7	8.4	20.4	13.3	20.3	4.2	12.7	6.1	18.0	2.5	10.8	10.3	7.5	10.6	11.8	0.5	6.3	4.6	6.0	1.5	1.1	1.7	10.1	22.5	9.6	6.6	9.1	10.8	10.8	22.0	13.5	13.4	10.1	8.4	17.3	1.1	2.0	20.4	12.1	7.0	7.1	13.1	0.0	4.2	7.6	8.0	12.9	10.9	4.1	8.7	8.7	8.6	11.6	9.8	6.7	4.5	5.3	9.1	4.9	3.6	3.1	6.2	9.7	4.2	9.3	1.9	8.2	8.4	4.4	11.1	11.3	12.6	10.2	3.7	7.3	8.2	14.8	7.5	3.0	8.8	0.0	0.0	2.8	16.5	0.3	9.9	0.0	6.0	4.6	0.4	1.2	0.2	0.5	0.8	0.1	6.3	0.0	1.1	0.6	0.0	1.5	0.1	0.6	0.0	1.7	12.7	16.3	13.8	11.6	12.8	7.8	21.4	10.1	14.9	18.0
SOCS7	"NAP4, NCKAP4"	ENSG00000274211	"Suppressor of cytokine signaling 7"	O14512	17	38352228-38405593	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9;testis: 19.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004475	Approved		Approved	Cytosol				Cytosol		"HPA004475: "	"prognostic unfavourable (7.49e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (7.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.62e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.88e-1)"	2.4	1.9	6.1	2.5	6.7	2.1	3.2	22.9	7.8	2.6	2.3	3.5	3.3	2.2	3.6	4.2	3.5	3.2	2.3	2.7	5.1		2.4	0.9	2.6	1.8	3.3	5.1	5.1	9.1	5.1	0.9	2.2	2.9	3.1	2.7	2.9	3.6	3.2	6.0	5.2	2.1	3.6	1.4	1.7	1.4	19.7	4.3	4.7	5.2	1.8	2.8	2.4	2.4	0.8	1.0	0.2	0.9	0.7	2.6	0.3	8.7	9.9	11.2	8.6	6.3	5.3	9.2	3.8	3.3	4.7	3.8	7.7	2.7	6.0	5.9	6.1	5.9	9.5	2.7	6.0	11.2	8.5	6.4	11.2	8.0	2.1	14.0	11.0	3.3	11.1	4.9	6.8	4.0	5.2	4.1	5.8	4.8	12.0	9.2	3.6	1.5	12.0	18.7	5.5	3.1	10.8	19.7	10.7	9.5	6.2	6.8	11.5	7.9	3.9	4.7	4.2	8.5	11.8	14.5	10.0	8.9	6.4	7.1	9.5	0.2	0.9	0.1	2.1	0.5	2.6	0.8	0.7	0.3	0.4	0.7	0.4	0.6	0.2	0.7	0.5	1.0	1.1	0.3										
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659622-31668931	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 282.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			91000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	39.2	86.5	71.1	29.1	74.3	24.6	108.6	35.6	74.9	26.8	37.7	19.1	35.4	62.5	24.6	42.2	25.8	36.0	46.8	96.5	77.8	73.1	84.0	282.6	23.0	26.8	80.2	67.0	53.9	27.2	27.1	30.4	29.7	96.1	35.1	32.6	19.3	19.7	39.3	83.9	20.5	45.5	45.2	88.2	19.2	25.8	22.2	43.8	12.3	30.1	34.7	25.6	25.4	124.0	57.6	32.3	24.9	57.2	29.6	95.6	55.6	55.6	48.7	34.2	34.2	45.8	31.9	28.4	47.0	28.1	32.0	24.2	63.1	35.4	66.7	49.5	43.3	20.2	49.0	34.6	26.4	49.2	60.9	107.6	63.9	90.2	30.3	47.5	40.3	33.1	26.4	44.8	24.9	35.9	74.2	85.3	38.5	90.4	51.0	47.9	51.4	52.0	43.9	69.0	103.7	62.5	34.2	37.4	31.4	87.1	46.1	45.2	53.0	42.0	42.0	24.9	55.1	33.6	34.6	65.2	141.0	79.0	50.8	69.3	33.0	22.1	21.9	24.9	45.0	30.2	51.6	57.6	73.1	56.9	28.6	40.9	76.2	59.3	5.1	29.6	57.2	32.3	95.6	55.6	71.1	74.3	35.6	74.9	77.8	73.1	80.2	67.0	96.1	43.8
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777442-36863686	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"			"Nucleoli, Cytosol"		"HPA043992: "	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.2	11.4	10.8	4.5	10.6	1.4	6.0	55.5	12.5	11.3	8.3	20.5	7.2	2.5	8.8	5.3	7.2	9.4	9.9	6.7	9.9	7.5	4.7	1.3	6.1	3.0	12.7	8.9	12.6	3.7	11.5	4.4	7.9	8.7	10.7	3.9	6.7	4.4	12.3	2.9	11.0	4.6	14.1	7.9	5.3	5.3	14.8	14.7	0.9	16.0	4.7	4.1	8.0	10.5	1.0	2.1	1.4	0.7	0.7	0.2	0.2	7.4	10.2	12.4	13.3	7.2	6.6	3.2	6.6	7.1	9.3	5.6	4.1	1.2	3.3	2.4	11.5	10.1	9.9	6.1	9.8	0.5	1.9	5.3	9.5	5.4	3.8	1.2	5.2	3.7	7.5	8.9	6.4	6.1	3.7	0.7	10.2	7.2	3.7	2.8	3.1	7.9	8.9	11.5	1.2	5.5	2.2	14.8	9.2	13.6	15.0	4.3	19.1	8.0	9.2	23.5	4.6	11.5	14.3	1.4	0.3	3.3	10.0	1.6	14.8	1.4	0.7	0.2	0.1	0.4	0.2	1.0	0.1	0.1	0.4	1.0	0.2	0.2	1.4	0.7	0.3	2.1	0.1	0.2	10.8	10.6	55.5	12.0	9.9	7.5	12.7	8.9	8.7	14.7
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;pituitary gland: 11.9"	"Cell line enhanced"	"Detected in some"		"AF22: 7.4;SCLC-21H: 23.9;SH-SY5Y: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.3"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035388: , HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.8	2.8	5.0	1.8	5.3	0.4	0.4	11.4	15.3	1.0	0.8	3.7	0.0	0.5	2.1	0.2	2.0	1.0	1.9	0.8	4.2	4.5	0.6	0.6	1.7	0.8	6.7	5.0	3.3	1.7	0.2	11.9	1.2	7.9	1.1	0.6	0.7	1.1	0.5	0.3	1.0	1.9	0.6	11.4	1.4	3.9	1.8	4.3	0.0	1.9	0.0	0.3	1.6	0.8	0.3	0.2	0.0	0.0	0.0	2.3	0.0	0.2	3.3	7.4	1.1	0.0	0.6	0.3	0.7	0.9	0.9	2.3	0.2	0.3	0.4	0.2	0.1	0.0	0.8	0.0	0.6	0.7	0.1	0.6	0.0	0.1	0.0	0.2	0.1	1.2	0.0	3.6	0.0	0.0	0.3	0.2	0.5	0.5	4.8	0.0	3.3	0.8	0.4	1.8	0.0	0.1	0.0	23.9	13.7	0.0	0.0	0.1	0.0	0.3	0.2	5.9	1.2	0.4	1.7	0.2	0.1	0.1	4.5	1.1	5.8	0.0	0.0	0.0	0.3	0.0	0.4	0.3	2.3	0.8	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.0	5.3	11.4	8.2	4.2	4.5	6.7	5.0	7.9	4.3
SORBS3	"SCAM-1, SH3D4, vinexin"	ENSG00000120896	"Sorbin and SH3 domain containing 3"	O60504	8	22544986-22575788	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015849	Approved		Approved	"Focal adhesion sites,Cytosol"			6600	Cytosol	"Focal adhesion sites"	"HPA015849: AB_1857365"	"unprognostic (6.15e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (4.88e-4)"	"unprognostic (4.21e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.53e-5)"	52.2	22.6	25.0	16.8	23.2	3.3	56.5	31.4	27.0	49.3	28.9	21.9	19.2	19.6	40.6	32.0	27.5	33.8	42.8	32.8	27.3	12.8	28.1	41.8	38.9	28.7	21.3	18.0	49.0	21.7	27.0	24.1	43.3	22.8	38.0	23.7	45.8	36.6	34.5	29.5	32.0	34.5	41.9	24.1	28.6	20.4	36.0	21.2	3.4	29.7	36.2	15.7	38.4	44.7	0.8	5.6	0.4	3.2	4.0	17.4	3.3	22.4	28.3	15.5	17.4	25.1	33.6	15.8	23.1	35.9	27.1	16.9	28.7	10.1	0.1	15.8	36.0	19.4	23.2	21.1	14.1	15.8	10.1	1.9	16.0	13.1	28.6	0.2	0.1	21.1	15.8	9.4	13.9	20.9	4.9	0.7	19.2	8.8	1.9	0.7	5.4	11.9	21.5	10.5	2.1	12.3	4.4	0.9	13.9	11.3	2.7	14.3	4.7	8.0	32.5	24.1	17.3	17.5	16.2	0.4	0.6	3.0	14.1	5.3	16.3	0.0	1.6	0.4	8.6	3.2	17.4	0.6	9.4	9.9	5.6	0.8	9.7	5.6	0.4	4.0	0.7	1.9	0.4	3.3	25.0	23.2	31.4	27.0	27.3	12.8	21.3	18.0	22.8	21.2
SORCS1	sorCS1	ENSG00000108018	"Sortilin related VPS10 domain containing receptor 1"	Q8WY21	10	106573663-107164534	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 18.5"	"Group enriched"	"Detected in some"	12	"RH-30: 33.2;SH-SY5Y: 43.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"intermediate monocyte: 2.4"	"Lineage enriched"	"Detected in single"	24	"monocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011948	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA011948: AB_1857366"	"unprognostic (5.86e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.82e-3)"	"unprognostic (5.81e-2)"	"unprognostic (6.48e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-4)"	1.4	5.8	6.0	4.5	14.1	0.4	1.8	0.5	13.2	2.2	10.7	1.1	1.9	1.4	2.1	1.2	2.0	3.2	2.8	4.2	2.6	4.7	8.0	0.5	0.5	1.9	2.1	6.6	1.2	3.0	0.6	1.2	0.4	3.3	2.7	3.6	6.5	2.4	4.9	0.8	2.3	4.5	2.7	2.1	1.7	3.4	2.3	2.7	0.2	18.5	1.1	2.7	4.7	3.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	33.2	0.0	0.0	0.0	0.0	43.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	14.1	0.5	11.3	2.6	4.7	2.1	6.6	3.3	2.7
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.5;HaCaT: 16.3;HMC-1: 12.3;RPMI-8226: 7.2;SiHa: 11.7;THP-1: 6.9;U-937: 7.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061916			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA061916: "	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	4.9	2.6	12.0	6.4	16.6	3.3	1.8	4.8	22.4	13.8	4.0	32.1	3.2	3.1	6.0	8.2	4.7	3.5	7.1	3.2	10.7	6.9	7.4	5.2	8.3	2.0	9.9	11.2	7.4	1.7	0.8	2.7	0.9	11.2	7.5	2.6	7.5	2.6	5.3	2.4	1.9	4.2	11.5	11.2	1.3	1.9	3.4	11.3	0.8	6.2	2.2	2.7	5.2	3.7	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.9	1.1	0.2	0.1	0.0	0.0	0.1	0.0	1.4	0.4	0.1	0.5	0.0	6.5	4.1	16.3	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.2	0.1	0.0	12.3	0.2	3.6	5.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.3	0.7	0.0	1.3	7.2	0.2	0.0	0.7	0.6	11.7	0.0	0.0	0.0	6.9	0.0	4.2	1.2	0.0	0.1	0.0	0.0	0.0	1.4	7.1	0.2	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	12.0	16.6	4.8	17.7	10.7	6.9	9.9	11.2	11.2	11.3
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023104-45077185	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 72.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 36.4"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol			430000	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favourable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.4	10.2	3.0	1.5	3.2	1.0	7.1	3.1	3.8	66.3	5.5	6.2	39.2	2.6	2.6	3.2	6.7	3.5	3.9	3.4	3.0	3.0	20.9	98.4	1.6	2.2	4.2	2.3	1.6	7.3	1.2	1.8	0.5	5.0	48.5	3.8	2.3	7.6	46.7	1.4	8.0	8.7	2.0	5.0	2.4	5.6	2.5	3.9	3.1	116.3	3.8	3.5	4.2	4.4	1.6	2.4	36.4	2.7	0.4	1.0	1.3	15.8	13.9	3.5	11.4	3.1	5.4	3.7	4.4	3.0	10.0	8.5	11.5	8.6	2.0	9.9	5.4	23.8	18.2	16.6	8.0	34.3	11.3	15.9	18.2	25.5	2.3	27.5	26.6	6.9	12.6	5.7	9.2	9.3	17.7	5.6	9.4	6.3	16.6	14.9	13.6	14.8	0.0	23.0	7.7	7.3	15.4	25.0	13.1	8.9	14.1	6.7	20.3	11.3	8.3	8.0	7.0	17.8	10.5	1.0	6.9	2.0	12.9	24.4	20.7	5.0	2.7	36.4	0.6	2.5	1.0	1.2	0.6	0.8	2.4	1.6	0.5	0.6	1.4	0.4	2.5	1.3	0.6	1.3	3.0	3.2	3.1	3.8	3.0	3.0	4.2	2.3	5.0	3.9
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397951	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.1;epididymis: 75.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.0;non-classical monocyte: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favourable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	22.9	6.5	24.0	6.2	35.5	10.1	15.5	6.4	40.6	10.1	15.2	50.3	18.1	11.5	11.9	75.2	22.0	14.8	9.5	31.8	45.2	19.8	21.1	3.7	19.2	3.6	57.9	22.8	3.6	9.3	24.2	5.7	22.9	27.1	10.3	14.4	12.2	11.8	24.8	36.4	8.3	11.3	14.6	71.1	5.4	9.5	21.6	42.2	1.1	22.5	5.1	5.4	8.7	8.2	0.0	4.5	2.3	10.0	0.4	0.0	1.7	11.6	4.7	11.8	14.3	34.4	6.8	34.0	8.7	13.9	8.6	9.2	12.1	4.3	0.1	11.1	3.6	2.9	13.9	6.9	12.4	0.3	6.6	3.2	7.6	13.0	13.5	0.0	10.6	17.1	1.1	10.5	2.3	1.3	24.1	1.2	12.0	12.4	8.2	0.2	4.4	1.9	9.2	27.8	5.6	16.4	8.5	12.1	6.9	5.1	34.2	36.7	14.4	2.0	0.3	1.8	7.0	0.3	14.5	11.6	9.5	0.0	3.1	0.0	7.5	0.0	7.1	2.3	0.0	9.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.9	0.4	10.0	1.6	0.0	1.7	24.0	35.5	6.4	33.9	45.2	19.8	57.9	22.8	27.1	42.2
SOS1	"GF1, GINGF, HGF"	ENSG00000115904	"SOS Ras/Rac guanine nucleotide exchange factor 1"	Q07889	2	38981396-39124345	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005396	Uncertain		Approved	Cytosol				Cytosol		"CAB005396: AB_2270724"	"unprognostic (6.68e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-2)"	25.9	13.2	19.2	18.8	18.1	12.0	26.1	33.3	18.6	18.6	21.9	12.1	15.3	18.3	19.1	14.6	17.4	17.0	18.1	16.4	17.9	14.1	14.6	15.2	19.9	19.9	18.2	14.0	28.1	13.0	33.5	21.7	21.5	17.8	18.4	16.8	14.6	15.9	18.1	26.2	15.0	23.1	22.3	14.6	16.2	20.1	12.7	20.1	23.1	19.4	12.9	21.8	25.1	22.0	3.2	1.4	3.2	2.0	6.2	4.6	0.9	9.7	6.0	9.4	6.7	12.7	15.2	9.8	6.2	7.6	4.9	4.7	6.5	5.9	14.2	4.2	8.0	5.8	11.0	5.6	9.2	14.2	4.9	22.0	5.2	8.9	5.2	7.0	55.8	9.3	9.0	6.7	6.5	7.7	9.3	6.7	6.3	5.3	7.5	6.5	5.8	4.3	8.4	8.5	4.1	5.2	7.9	9.1	9.1	7.3	13.2	7.6	4.2	3.7	8.6	8.2	6.7	6.4	6.1	7.9	8.0	7.5	6.6	6.9	4.9	0.0	1.2	3.2	3.2	1.8	4.6	3.2	3.3	3.3	1.0	2.4	3.7	3.4	1.4	6.2	2.0	1.4	1.9	0.9	19.2	18.1	33.3	18.6	17.9	14.1	18.2	14.0	17.8	20.1
SOWAHC	"ANKRD57, C2orf26, FLJ21870"	ENSG00000198142	"Sosondowah ankyrin repeat domain family member C"	Q53LP3	2	109614334-109618990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 54.7;hTCEpi: 18.2;RT4: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA056131	Enhanced		Approved	Cytosol				Cytosol		"HPA056131: "	"unprognostic (6.76e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (5.11e-3)"	"prognostic favourable (3.56e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.54e-2)"	4.9	2.7	2.7	3.7	2.7	0.1	6.5	0.8	2.3	8.9	11.8	3.5	5.3	3.3	3.7	6.4	30.4	3.6	7.2	2.2	2.5	3.2	11.5	35.4	5.1	3.7	5.7	0.8	9.2	4.1	4.1	2.2	20.7	3.6	9.8	5.9	3.9	8.1	6.3	1.1	14.4	17.9	7.8	5.7	3.6	4.4	7.8	2.8	3.2	5.3	30.4	15.9	11.5	10.5	0.8	0.5	1.3	2.3	0.5	1.1	0.5	6.5	1.2	3.8	2.1	1.9	3.2	12.6	14.5	8.5	2.5	2.7	5.9	2.1	0.0	6.0	2.2	6.3	0.9	9.4	2.7	54.7	6.3	0.0	3.0	8.3	1.7	0.0	1.7	1.7	18.2	5.4	3.9	0.6	0.1	0.0	1.9	2.2	0.0	0.5	2.7	5.7	0.0	0.8	0.1	3.8	23.1	4.8	2.1	4.9	0.9	3.8	1.9	0.1	0.9	2.0	7.7	1.1	1.0	1.9	1.8	0.0	2.3	0.2	4.6	1.3	2.3	0.3	0.3	0.9	0.4	0.8	0.7	0.3	0.2	0.6	0.5	0.7	1.2	0.5	0.8	0.5	1.1	0.5	2.7	2.7	0.8	2.3	2.5	3.2	5.7	0.8	3.6	2.8
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428034-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: "	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	5.8	4.7	7.9	8.9	11.0	10.2	6.3	25.9	9.5	8.6	4.4	6.4	3.8	3.1	9.2	5.8	4.1	7.8	4.6	6.5	8.3	6.1	5.4	3.4	6.0	11.7	8.6	6.9	19.8	5.2	17.1	11.8	3.7	6.7	7.3	4.3	6.0	5.0	5.7	10.5	5.0	5.6	5.3	6.8	9.1	4.9	6.0	10.0	27.0	13.1	4.8	11.2	6.8	6.3	5.4	1.5	7.2	1.8	3.5	8.3	3.1	2.2	1.7	5.0	7.9	1.5	0.9	1.4	2.3	1.6	2.6	3.6	3.4	2.6	9.0	1.4	1.5	2.8	7.4	2.1	5.3	2.6	2.8	4.8	3.2	1.4	1.1	3.9	5.6	1.1	1.9	2.8	3.3	5.3	5.9	6.9	2.2	1.0	9.1	2.9	12.0	2.1	20.5	8.5	3.2	0.9	1.6	6.5	8.1	5.2	2.4	1.8	2.6	2.9	2.3	4.3	5.4	2.7	4.1	9.1	7.1	14.2	2.5	6.3	6.0	4.3	0.8	7.2	6.8	0.9	8.3	3.7	6.4	6.6	0.9	5.4	7.6	7.1	1.9	3.5	1.8	1.5	7.6	3.1	7.9	11.0	25.9	9.5	8.3	6.1	8.6	6.9	6.7	10.0
SPAG1	"CILD28, CT140, FLJ32920, HSD-3.8, SP75, TPIS"	ENSG00000104450	"Sperm associated antigen 1"	Q07617	8	100157906-100259278	"Disease related genes, Predicted intracellular proteins"	Fertilization	Hydrolase	"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023748, HPA053682"	Enhanced		Supported	Cytosol				Cytosol		"HPA023748: , HPA053682: "	"unprognostic (9.95e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (9.11e-3)"	"unprognostic (8.83e-3)"	"unprognostic (1.54e-1)"	"prognostic favourable (2.62e-4)"	2.0	1.5	3.9	3.5	6.8	9.1	3.6	6.4	5.9	6.0	12.8	7.8	13.5	3.0	3.0	8.5	8.1	10.4	4.4	5.4	5.6	6.1	7.5	10.8	10.0	2.6	4.1	2.6	4.5	3.3	13.0	21.2	1.9	26.2	4.8	19.3	2.8	6.1	14.4	0.7	8.0	3.4	2.0	5.7	2.7	6.5	18.2	5.4	1.3	4.5	0.5	4.3	5.6	3.9	2.9	0.8	2.5	0.6	3.2	0.6	0.2	20.2	5.5	0.3	1.2	1.3	1.1	3.1	3.8	2.3	4.6	4.9	5.4	9.0	0.8	13.7	1.2	10.8	4.0	7.3	4.3	11.8	4.1	3.4	6.2	2.0	1.7	0.9	3.0	0.9	3.9	5.7	4.5	3.9	0.1	11.0	0.7	7.2	1.9	0.9	0.3	6.1	0.3	0.8	3.1	17.7	9.8	3.2	2.4	5.2	4.3	4.5	6.2	3.8	3.5	4.6	6.7	2.4	9.7	7.4	5.7	0.5	4.4	3.2	2.3	0.0	0.4	1.8	0.5	0.0	0.3	2.9	0.4	0.5	0.4	1.2	0.1	0.6	2.5	3.2	0.6	0.8	0.0	0.2	3.9	6.8	6.4	5.9	5.6	6.1	4.1	2.6	26.2	5.4
SPAG16	"DKFZp666P1710, FLJ22724, PF20, WDR29"	ENSG00000144451	"Sperm associated antigen 16"	Q8N0X2	2	213284379-214410501	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA037542	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA037542: AB_10672353"	"unprognostic (4.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (4.90e-4)"	"prognostic favourable (3.82e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.17e-1)"	11.1	13.0	28.2	5.4	29.8	1.7	15.8	12.0	22.0	16.7	11.5	21.9	23.1	13.7	14.0	24.8	16.0	34.8	17.0	15.7	27.7	24.6	22.6	13.8	8.1	7.7	31.5	22.0	20.2	11.2	24.0	32.8	7.3	25.7	17.1	13.1	11.1	11.8	19.8	6.1	18.2	7.9	14.3	36.9	5.7	19.2	34.3	18.1	10.5	19.9	11.4	9.8	14.8	11.9	7.5	4.1	1.1	1.1	12.1	10.6	3.0	12.3	4.9	14.2	0.0	9.7	17.5	0.1	6.8	8.2	8.8	9.4	9.8	13.7	5.2	8.1	7.5	8.8	6.4	8.2	18.9	0.0	5.1	2.7	12.6	12.6	10.9	2.9	0.0	14.9	11.4	7.9	4.6	3.6	8.6	5.9	8.8	0.0	9.7	0.0	7.8	4.1	10.4	14.9	0.2	14.2	12.1	10.4	12.3	7.8	7.2	9.6	33.7	1.2	3.7	8.6	5.1	4.5	7.0	9.7	4.4	0.2	14.0	0.0	3.8	1.1	0.2	0.7	7.1	1.1	10.1	7.5	8.0	8.9	2.5	7.3	10.6	9.2	0.4	12.1	0.8	4.1	7.4	3.0	28.2	29.8	12.0	22.0	27.7	24.6	31.5	22.0	25.7	18.1
SPAG9	"CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1"	ENSG00000008294	"Sperm associated antigen 9"	O60271	17	50962174-51120865	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 6.3;neutrophil: 13.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040446, HPA061458"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA040446: AB_10671691, HPA061458: "	"unprognostic (1.36e-1)"	"unprognostic (6.61e-2)"	"unprognostic (6.04e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.27e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.67e-2)"	"prognostic unfavourable (8.10e-4)"	21.6	16.4	32.1	12.5	42.6	15.8	13.8	32.7	46.6	15.9	15.6	44.8	7.6	14.0	19.6	9.1	20.7	12.3	18.8	15.1	33.1	25.5	23.6	22.8	20.5	8.7	55.7	25.9	22.2	21.0	25.8	14.6	21.8	37.1	13.2	14.1	12.2	9.9	14.4	39.6	14.2	14.2	19.1	50.2	12.1	10.5	33.3	55.2	8.5	28.2	9.5	10.6	15.0	13.6	1.0	1.3	13.4	1.3	0.5	1.8	0.4	17.5	19.7	25.4	12.3	24.1	21.4	22.4	14.5	14.2	16.3	20.3	17.7	12.1	9.5	10.1	23.7	15.2	16.6	12.1	30.3	14.4	19.7	7.9	15.6	13.1	18.1	11.4	9.3	15.4	14.2	21.9	39.4	13.3	17.5	10.6	22.9	8.8	7.2	4.8	6.7	25.7	8.2	28.3	8.4	14.9	33.5	19.7	27.5	12.7	11.9	13.1	9.7	13.7	18.5	45.4	10.7	34.9	21.1	15.1	21.7	15.6	15.5	6.8	15.7	6.3	1.3	0.8	1.4	0.8	1.0	1.0	1.2	1.3	1.3	1.0	0.7	0.9	13.4	0.5	0.5	1.1	1.8	0.4	32.1	42.6	32.7	34.9	33.1	25.5	55.7	25.9	37.1	55.2
SPART	"KIAA0610, SPG20, TAHCCP1"	ENSG00000133104	Spartin	Q8N0X7	13	36301638-36370180	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 45.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039053, HPA039054"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039053: AB_10672769, HPA039054: "	"unprognostic (3.73e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.18e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.79e-2)"	28.7	34.7	23.2	12.1	28.0	14.5	44.9	21.3	26.7	37.1	22.5	23.1	26.2	9.1	29.9	48.4	17.7	26.1	26.2	17.5	24.7	22.3	33.7	13.7	18.4	12.9	31.8	19.4	46.1	10.3	13.2	29.8	32.2	28.9	26.6	10.0	17.2	11.9	27.0	20.6	12.4	9.7	37.0	35.7	20.2	14.4	18.3	32.5	7.0	25.1	8.7	7.8	31.4	58.7	3.2	6.0	45.8	6.8	4.1	8.3	5.3	0.0	6.0	16.3	0.0	36.0	30.3	11.7	14.6	22.0	14.8	14.7	0.0	0.0	0.0	9.1	17.6	8.4	22.1	10.1	16.0	1.1	12.8	18.2	7.9	3.8	36.2	18.9	36.9	29.9	16.4	12.2	17.2	21.6	7.9	3.2	26.5	1.3	5.6	31.8	8.2	2.1	0.0	27.4	0.6	17.2	7.5	1.7	4.0	12.4	5.0	15.4	2.9	22.4	17.8	11.1	5.6	15.3	8.5	3.9	0.0	0.0	12.3	16.5	19.3	45.8	6.7	8.7	4.4	6.7	4.3	3.2	6.2	1.8	4.8	3.2	8.3	4.4	10.6	4.1	6.8	6.0	1.5	5.3	23.2	28.0	21.3	26.7	24.7	22.3	31.8	19.4	28.9	32.5
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063547-32157637	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	12.7	9.6	18.4	14.8	16.4	13.4	9.8	21.1	21.9	14.7	12.7	15.1	12.5	11.5	12.3	8.7	11.1	10.4	10.2	6.2	20.2	18.5	9.4	14.6	9.7	18.9	20.6	10.0	15.1	10.9	11.8	12.3	11.5	17.5	10.3	12.0	6.8	9.3	13.7	15.4	11.5	17.6	11.6	27.0	15.5	9.7	14.4	14.6	21.5	13.4	6.2	13.8	11.3	10.1	5.0	7.1	9.5	9.0	6.6	7.6	4.3	10.6	7.7	12.6	12.4	8.0	9.4	11.4	5.9	8.7	6.2	5.6	10.4	9.3	18.6	5.5	8.2	7.6	12.4	6.0	7.7	12.5	7.5	20.5	4.2	12.7	7.3	14.2	14.4	5.2	7.9	7.9	7.6	13.7	16.6	6.3	6.8	4.5	22.8	12.0	13.1	4.5	12.1	17.8	12.1	8.4	6.6	18.0	19.3	10.0	8.5	9.8	5.5	9.8	11.8	6.9	10.6	6.1	6.9	9.5	17.7	15.1	7.5	12.3	8.2	3.4	6.3	6.7	3.6	9.0	5.2	5.0	5.8	5.6	7.1	3.9	5.9	6.0	9.5	6.6	6.3	3.2	7.6	4.3	18.4	16.4	21.1	15.8	20.2	18.5	20.6	10.0	17.5	14.6
SPATA12		ENSG00000186451	"Spermatogenesis associated 12"	Q7Z6I5	3	57060441-57075432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"testis: 26.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 2.8;RH-30: 3.5;RPTEC TERT1: 2.2;U-2 OS: 2.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"									"HPA043323, HPA075578"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA043323: AB_10796792, HPA075578: "	"unprognostic (2.31e-1)"	"unprognostic (2.18e-4)"	"unprognostic (3.47e-4)"	"unprognostic (2.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.71e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-3)"	0.2	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.8	0.1	0.3	2.4	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.4	26.6	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.4	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.5	0.5	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.8	0.7	0.0	0.0	1.3	0.2	0.5	0.0	0.1	2.8	0.0	0.7	0.2	0.1	0.0	0.0	1.7	1.7	0.0	3.5	0.1	2.2	1.3	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.9	0.1	2.3	0.4	0.3	0.0	0.3	1.1	0.7	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0
SPATA13	"ARHGEF29, FLJ31208"	ENSG00000182957	"Spermatogenesis associated 13"	Q96N96	13	23979805-24307074	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 19.4;HDLM-2: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA040185, HPA041208"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040185: AB_10795521, HPA041208: AB_10794193"	"unprognostic (8.80e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.21e-1)"	"prognostic favourable (1.16e-4)"	5.5	11.8	14.7	13.9	23.7	21.4	11.8	5.5	15.2	9.2	8.8	33.7	10.9	9.4	7.8	11.9	3.2	8.2	9.8	6.4	15.3	10.5	13.1	17.8	15.3	16.8	27.9	7.4	12.1	29.7	6.1	8.3	13.7	17.7	12.1	10.2	7.5	6.8	9.8	2.4	6.3	11.5	6.2	25.7	47.8	13.8	5.2	27.2	11.9	10.7	3.1	12.8	6.5	4.5	1.2	2.5	19.3	4.7	9.6	17.7	5.8	1.7	2.9	15.2	1.9	0.5	1.3	0.6	4.4	19.4	2.3	1.9	3.7	7.7	11.6	2.4	4.0	3.3	4.3	1.3	5.8	26.2	5.2	2.8	2.2	4.2	0.7	4.4	2.2	1.7	0.2	2.5	1.4	3.8	0.0	9.8	2.4	6.4	8.1	1.5	4.9	3.7	7.1	5.8	6.1	10.3	5.7	5.5	4.2	0.9	9.6	8.6	1.3	2.6	4.4	3.0	2.4	0.2	3.1	2.2	0.0	0.0	2.6	4.3	14.2	2.4	3.1	0.0	17.3	4.0	13.5	1.2	14.7	17.7	2.2	1.0	15.6	16.0	19.3	9.6	4.7	2.5	13.8	5.8	14.7	23.7	5.5	15.2	15.3	10.5	27.9	7.4	17.7	27.2
SPATA21	"spergen-2, spergen2"	ENSG00000187144	"Spermatogenesis associated 21"	Q7Z572	1	16387117-16437424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"blood: 4.6;testis: 11.3"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 10.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.6"	"Low lineage specificity"	"Detected in many"											HPA032080			Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA032080: "	"unprognostic (3.09e-1)"	"unprognostic (8.26e-2)"	"unprognostic (5.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.74e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.71e-2)"	0.0	0.2	0.0	0.0	0.1	1.3	0.0	1.1	0.0	0.1	0.0			0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1		0.1	0.7	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.9	0.1	0.0	0.1	0.2	0.3	11.3			0.0		0.0	0.3	0.0	1.3	0.6	4.6	0.8	0.9	0.8	0.4	0.2	0.7	0.3	0.7	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	1.5	10.7	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.2	0.1	0.5	0.2	0.3	0.4	0.3	0.1	0.2	0.0	0.3	0.2	0.0	0.0	1.1	0.6	0.5	0.2	0.3	0.2	0.1	0.4	0.0	0.4	0.4	0.2	0.3	0.3	0.0	4.6	0.5	0.9	0.7	0.8	0.5	1.1	0.7	0.6	0.4	1.3	0.8	0.3	2.3	0.9	0.5	0.6	0.7	0.4										
SPATA24	"CCDC161, T6441"	ENSG00000170469	"Spermatogenesis associated 24"	Q86W54	5	139396563-139404088	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044000	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044000: AB_10959668"	"unprognostic (2.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	1.0	2.8	3.6	1.0	3.2	0.3	1.4	1.5	2.7	1.3	1.6	2.7	1.8	2.5	1.6	9.4	1.4	6.4	2.9	8.5	3.4	2.6	6.2	1.9	1.9	2.5	2.4	2.1	1.6	2.2	6.1	7.0	1.0	3.2	2.2	0.9	1.7	3.2	1.5	8.7	0.9	2.6	1.9	2.7	1.9	1.5	52.2	2.1	1.8	2.9	3.4	1.9	1.8	3.5	5.7	3.6	2.0	3.1	2.4	7.7	2.5	6.4	4.1	5.8	3.1	1.7	3.2	4.7	1.6	3.1	3.4	6.0	9.3	8.6	10.3	4.8	3.1	3.6	4.4	7.2	3.8	41.2	5.1	3.1	7.7	7.0	6.4	0.7	5.7	2.8	3.6	5.1	6.2	4.1	3.1	18.2	4.6	3.7	6.5	4.9	4.2	3.5	15.2	3.8	13.9	8.1	3.3	4.5	4.1	6.3	12.2	2.9	3.5	7.1	7.6	2.0	2.8	3.9	4.6	4.4	4.2	9.5	4.0	5.4	1.7	0.0	3.1	2.0	4.6	2.3	6.5	5.7	4.9	5.5	3.6	3.3	5.5	7.7	0.2	2.4	0.9	2.1	2.4	2.5	3.6	3.2	1.5	2.7	3.4	2.6	2.4	2.1	3.2	2.1
SPATA2L	"C16orf76, MGC26885, tamo"	ENSG00000158792	"Spermatogenesis associated 2 like"	Q8IUW3	16	89696343-89701705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041182, HPA042453"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA041182: AB_2677352, HPA042453: AB_2678005"	"unprognostic (1.22e-1)"	"unprognostic (9.04e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.86e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.86e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.55e-1)"	6.8	5.3	6.3	5.4	10.3	8.8	3.7	6.8	14.1	4.1	6.9	1.6	4.9	12.3	4.7	7.2	3.9	4.6	7.7	2.8	7.2	4.9	7.5	11.4	6.3	3.6	3.4	7.6	5.4	17.0	5.1	12.9	6.5	2.8	4.2	2.2	4.9	6.1	3.4	1.8	5.0	10.7	3.3	2.0	5.6	7.7	4.6	2.6	6.7	5.6	0.7	5.4	4.0	2.2	5.8	5.9	16.5	7.8	2.4	7.3	4.7	5.2	4.2	1.4	6.9	1.1	1.2	8.1	3.6	1.7	1.7	1.1	7.8	4.5	1.8	4.9	1.1	9.1	1.3	2.0	0.3	1.7	14.8	1.2	1.4	10.6	3.8	0.9	3.7	1.2	2.5	2.7	0.8	1.8	5.4	1.2	1.2	23.8	3.1	5.6	4.2	5.6	6.7	0.7	5.1	2.4	1.8	8.1	5.3	3.8	3.9	4.5	10.1	4.0	4.7	1.7	6.3	0.3	1.7	3.1	1.9	1.6	5.2	2.9	3.2	3.3	4.9	6.0	7.3	7.8	5.1	4.8	5.2	5.3	5.3	5.8	4.6	4.9	16.5	2.4	5.8	5.9	3.9	4.7	6.3	10.3	6.8	14.1	7.2	4.9	3.4	7.6	2.8	2.6
SPATA5	"AFG2, SPAF"	ENSG00000145375	"Spermatogenesis associated 5"	Q8NB90	4	122923074-123319450	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Hydrolase"	"Deafness, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036450, HPA036451"	Approved		Approved	Cytosol				Cytosol		"HPA036450: , HPA036451: AB_10670107"	"unprognostic (4.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (1.95e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.79e-1)"	8.2	4.7	5.8	8.5	9.3	6.0	7.8	20.7	8.0	8.3	6.1	6.4	5.6	3.8	12.8	5.5	5.7	6.0	4.4	5.3	5.5	4.6	5.9	5.2	5.3	8.0	7.1	5.2	6.4	5.1	11.2	13.5	5.9	6.9	6.0	6.1	7.4	6.1	5.3	6.4	7.4	4.8	9.1	7.4	7.3	11.6	11.3	9.0	13.6	6.7	5.0	9.3	6.2	7.0	2.9	2.8	2.3	1.9	2.5	2.8	0.7	2.9	3.1	3.9	7.9	3.1	2.1	2.5	4.1	1.8	3.2	3.0	2.1	4.3	4.3	2.8	2.6	2.7	5.1	2.8	6.2	6.1	1.3	3.7	5.8	3.4	1.4	6.4	4.7	1.5	1.5	4.4	4.2	3.0	7.3	7.7	5.4	3.1	10.7	4.4	2.3	1.6	3.8	8.3	2.4	2.5	2.0	5.8	4.2	3.8	3.4	2.3	2.3	2.5	3.7	8.4	5.6	5.3	5.0	5.0	5.2	3.1	4.3	5.8	7.2	2.3	1.2	1.1	2.7	1.9	1.6	2.0	2.2	2.3	0.9	2.9	2.4	2.8	1.8	2.5	1.1	2.8	1.1	0.7	5.8	9.3	20.7	8.0	5.5	4.6	7.1	5.2	6.9	9.0
SPATA7	"HSD3, LCA3"	ENSG00000042317	"Spermatogenesis associated 7"	Q9P0W8	14	88384924-88470350	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038082, HPA038083"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"HPA038082: AB_10671738, HPA038083: AB_10671519"	"unprognostic (2.09e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.50e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-3)"	"prognostic favourable (4.16e-5)"	"unprognostic (2.88e-1)"	"prognostic favourable (2.50e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.81e-2)"	6.3	7.2	7.8	2.8	10.3	2.2	7.1	18.0	12.5	6.1	4.5	6.5	4.5	2.9	7.7	8.5	3.7	9.6	6.5	5.3	8.1	7.4	10.5	5.9	5.0	3.0	6.4	9.7	13.6	6.9	9.2	15.0	3.6	13.3	5.8	4.1	5.5	4.6	5.9	4.7	6.6	2.8	6.4	5.8	3.7	4.3	55.6	5.9	3.3	13.5	3.9	2.0	5.7	4.4	3.7	4.4	1.7	3.0	0.9	5.6	2.2	2.1	3.4	5.1	7.1	8.5	16.0	5.2	3.9	8.7	4.9	3.2	0.9	4.2	1.5	2.3	5.2	2.2	2.4	3.7	4.6	2.6	1.7	0.1	1.7	1.2	12.6	3.6	0.3	7.6	6.1	2.0	3.7	8.9	1.2	2.5	4.4	2.6	1.6	3.3	0.6	4.3	3.7	5.3	0.8	7.8	1.4	3.0	4.6	4.9	6.7	4.0	5.7	3.8	4.6	3.0	3.9	5.0	2.1	2.5	1.2	0.5	6.0	1.1	2.5	0.0	2.2	0.6	4.8	3.0	5.6	3.7	4.0	2.2	4.4	0.9	2.2	4.2	1.7	0.9	1.8	4.3	1.4	2.2	7.8	10.3	18.0	12.5	8.1	7.4	6.4	9.7	13.3	5.9
SPATC1L	C21orf56	ENSG00000160284	"Spermatogenesis and centriole associated 1 like"	Q9H0A9	21	46161148-46184476	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.6"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018979, HPA019165, HPA029394"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"		"HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148"	"unprognostic (1.46e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (2.16e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.58e-1)"	4.7	11.5	21.5	4.2	31.7	5.1	4.3	13.1	19.0	8.2	5.1	5.6	8.9	5.3	5.3	6.5	4.6	4.0	5.7	5.5	14.4	9.4	4.3	1.5	4.4	5.7	7.8	16.5	10.9	11.7	5.8	7.8	4.7	7.5	16.7	3.6	2.6	9.5	10.1	8.8	7.0	6.3	5.6	5.2	8.1	8.3	23.5	13.6	2.2	3.7	5.0	4.3	4.4	6.4	4.8	5.9	23.6	4.2	4.0	6.9	2.7	1.8	0.0	2.4	4.5	1.4	3.3	1.3	2.6	1.4	1.5	1.1	0.0	1.2	5.8	5.4	3.3	0.3	0.0	2.1	0.4	5.2	4.3	13.8	0.8	3.2	0.1	0.0	5.8	3.4	1.0	0.0	0.0	4.8	23.8	8.7	2.1	3.6	4.4	1.6	9.9	11.8	9.9	3.2	6.4	2.3	0.5	0.7	4.6	2.1	1.2	5.2	3.8	5.3	0.3	4.4	5.3	6.2	4.0	14.6	7.8	4.2	5.8	7.7	4.1	1.0	3.9	23.6	3.0	4.2	3.9	4.7	4.4	4.3	5.9	4.8	6.9	6.8	0.2	4.0	2.9	4.8	4.2	2.7	21.5	31.7	13.1	19.0	14.4	9.4	7.8	16.5	7.5	13.6
SPATS2	"FLJ13117, SCR59, SPATA10"	ENSG00000123352	"Spermatogenesis associated serine rich 2"	Q86XZ4	12	49366584-49527424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038642, HPA038643, HPA076823"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA038642: , HPA038643: AB_10672523, HPA076823: "	"unprognostic (2.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (9.57e-8)"	"unprognostic (4.55e-2)"	"unprognostic (6.32e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (5.20e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.81e-1)"	7.7	8.2	10.6	19.9	12.4	5.6	9.4	25.7	18.0	13.5	12.1	4.0	7.7	11.2	19.0	8.3	9.1	6.7	11.0	7.5	11.7	8.9	9.1	5.1	8.0	14.2	9.0	11.0	9.0	12.1	30.6	24.8	8.6	15.6	10.1	11.5	9.8	19.2	9.2	9.7	15.8	10.5	11.6	6.1	11.1	12.2	24.2	4.5	8.8	13.6	5.4	19.1	13.7	13.8	7.8	10.2	1.9	1.8	1.6	2.3	1.5	7.5	17.0	14.7	17.2	8.6	13.5	4.8	8.9	12.6	15.3	12.4	15.7	17.3	18.8	20.8	7.9	9.1	12.6	16.9	19.8	14.2	7.3	16.9	13.0	12.3	15.6	4.5	10.2	11.5	8.4	24.0	22.7	35.7	9.0	17.4	15.7	13.2	9.1	6.8	15.3	17.3	14.0	24.6	22.5	14.2	9.7	16.5	14.9	18.8	12.6	21.4	21.8	5.2	32.2	6.7	16.5	6.0	5.6	23.1	26.1	15.4	8.8	7.8	9.7	1.9	1.8	0.6	2.3	0.5	2.3	7.8	1.9	1.5	5.0	4.9	1.7	1.5	1.3	1.6	0.3	10.2	1.4	1.5	10.6	12.4	25.7	18.0	11.7	8.9	9.0	11.0	15.6	4.5
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482263	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA055427: , HPA066310: "	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	25.0	13.5	22.4	14.3	20.1	4.2	46.1	15.7	25.7	33.1	34.5	14.5	27.2	34.3	20.4	20.7	28.0	34.8	46.9	46.4	18.4	18.8	37.7	44.9	22.4	14.7	21.9	20.9	30.0	24.3	17.1	24.7	26.9	20.3	27.3	34.6	14.9	63.4	28.8	26.5	15.6	44.6	20.6	23.4	22.1	42.2	11.5	16.7	14.3	21.6	17.5	12.3	25.4	46.5	2.2	9.8	22.9	3.3	4.2	17.0	1.6	27.1	15.7	18.5	2.3	12.4	15.9	6.9	48.7	16.3	31.7	23.8	42.4	29.9	0.1	11.3	30.9	27.0	5.6	28.4	20.9	16.3	7.8	0.2	14.3	50.8	22.3	4.6	2.0	19.5	28.3	21.2	20.3	12.3	6.3	19.6	42.1	8.3	0.7	1.3	4.5	36.2	0.1	65.9	1.9	76.5	22.2	0.5	5.2	12.7	7.1	19.8	3.8	6.5	20.4	21.1	21.3	6.5	27.7	5.8	5.6	0.3	18.0	2.2	29.6	22.9	3.1	4.2	3.6	3.3	8.3	1.6	3.9	3.6	9.8	2.2	1.7	2.0	3.1	4.2	2.5	7.6	17.0	1.6	22.4	20.1	15.7	25.7	18.4	18.8	21.9	20.9	20.3	16.7
SPC25	"AD024, MGC22228, SPBC25"	ENSG00000152253	"SPC25, NDC80 kinetochore complex component"	Q9HBM1	2	168834132-168913371	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 38.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.1;T-cells: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047144, HPA050544"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA047144: , HPA050544: "	"unprognostic (3.52e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (8.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (4.74e-6)"	"prognostic unfavourable (9.44e-5)"	"unprognostic (1.84e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.11e-16)"	"unprognostic (9.91e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.57e-1)"	0.9	1.6	3.6	7.2	2.2	6.7	2.1	0.4	3.5	1.3	4.0	0.9	0.0	6.8	1.3	1.5	8.5	0.6	1.0	1.1	2.7	1.6	1.5	1.6	1.9	7.5	1.2	2.5	1.2	2.6	0.7	0.2	3.3	1.1	0.8	3.1	1.3	2.1	0.0	0.7	2.1	3.8	1.8	0.7	4.1	3.0	5.9	1.1	38.0	0.6	5.6	8.0	1.5	2.7	1.1	0.0	0.4	0.1	0.0	2.5	0.4	1.0	8.4	19.5	10.9	0.9	0.9	7.0	11.2	4.3	11.3	9.1	4.3	7.8	6.9	4.9	1.8	10.4	7.5	0.0	10.1	4.7	11.5	13.9	5.3	1.9	0.0	10.3	4.2	0.0	0.5	7.2	0.1	5.7	1.1	7.9	3.2	5.1	7.5	12.5	0.6	11.2	13.5	19.4	3.1	4.5	6.6	14.6	0.9	10.0	6.8	1.8	0.5	7.3	1.6	1.7	20.6	6.6	9.4	15.2	26.5	6.9	2.2	1.6	6.6	0.0	0.1	0.2	0.0	0.1	0.0	0.9	0.4	0.0	0.0	1.1	0.2	0.5	0.4	0.0	0.0	0.0	2.5	0.4	3.6	2.2	0.4	3.5	2.7	1.6	1.2	2.5	1.1	1.1
SPDL1	"CCDC99, FLJ20364, hSpindly"	ENSG00000040275	"Spindle apparatus coiled-coil protein 1"	Q96EA4	5	169583634-169604778	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA044700, HPA048146"	Enhanced		Approved	Cytosol				Cytosol		"HPA044700: , HPA048146: "	"unprognostic (2.61e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.59e-3)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (1.48e-6)"	"unprognostic (2.63e-3)"	"unprognostic (5.70e-3)"	"unprognostic (8.27e-3)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (2.13e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.93e-1)"	5.5	4.7	6.5	9.0	11.5	9.9	8.0	14.5	11.0	5.5	5.6	6.6	3.4	5.9	6.4	4.4	9.7	4.9	4.9	4.0	7.8	5.8	5.1	3.6	4.7	13.9	8.3	7.1	7.2	4.1	5.6	8.0	8.4	11.6	4.1	6.0	2.0	5.1	3.6	5.0	5.3	5.9	7.7	16.7	8.2	5.3	33.7	10.4	23.9	4.5	8.5	13.6	5.4	5.8	10.7	16.5	3.2	4.6	6.4	9.3	3.0	14.3	17.3	17.8	12.4	4.7	4.5	15.7	45.9	6.1	34.4	31.2	22.8	9.8	13.6	30.5	37.5	10.1	14.4	19.7	37.7	14.0	16.0	15.8	31.2	8.8	2.2	16.6	13.7	2.1	1.7	14.4	9.0	15.6	9.9	10.1	36.6	14.0	13.5	7.1	12.9	16.8	16.0	17.4	10.0	22.5	5.1	11.4	8.3	21.3	6.1	9.0	6.8	11.1	11.0	39.2	12.4	11.1	35.6	8.0	16.7	18.3	9.5	15.4	13.1	3.2	2.2	2.9	7.3	3.0	7.7	8.8	6.6	7.7	2.2	10.7	9.3	7.4	0.4	6.4	4.6	16.5	6.4	3.0	6.5	11.5	14.5	11.0	7.8	5.8	8.3	7.1	11.6	10.4
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20009344-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9"	"Cell line enhanced"	"Detected in many"		"SiHa: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	10.7	8.3	21.3	7.2	38.0	29.9	8.1	16.0	30.8	7.0	14.9	49.9	0.7	9.5	15.4	6.1	11.4	7.3	20.0	4.1	23.1	15.4	4.3	2.0	5.6	5.7	35.8	21.2	17.0	8.3	3.0	6.8	4.8	29.3	7.3	15.5	3.0	5.9	4.9	4.3	4.8	11.4	11.5	28.2	17.3	9.8	25.8	41.5	0.2	6.7	1.4	6.0	7.0	4.2	2.9	14.7	18.9	9.4	8.5	3.4	3.0	17.2	18.0	9.8	3.2	7.4	3.8	21.1	7.0	5.8	7.1	8.8	29.3	15.4	1.0	22.9	6.0	12.9	7.4	16.7	3.5	5.2	7.9	7.1	19.7	3.2	2.7	0.7	4.2	4.0	17.0	10.0	11.3	0.1	0.8	8.7	5.5	14.7	0.2	3.9	7.8	4.3	4.2	19.7	9.9	17.3	8.7	3.2	3.2	36.8	17.7	7.8	15.6	4.6	0.5	0.9	10.8	1.0	19.0	3.4	4.3	1.4	10.4	5.9	4.1	18.9	9.4	17.8	3.1	5.3	2.9	2.4	1.9	3.4	14.7	2.9	1.8	2.4	8.1	8.5	4.6	4.4	0.9	3.0	21.3	38.0	16.0	30.8	23.1	15.4	35.8	21.2	29.3	41.5
SPG11	"FLJ21439, KIAA1840"	ENSG00000104133	"SPG11, spatacsin vesicle trafficking associated"	Q96JI7	15	44562696-44663678	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040412, HPA040947"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA040412: AB_10795418, HPA040947: AB_10796232"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.99e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.19e-2)"	"prognostic favourable (6.28e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.06e-2)"	23.8	24.6	16.6	26.4	22.2	25.8	23.4	21.2	21.2	20.8	26.0	31.7	25.8	17.9	18.6	28.1	22.9	19.0	20.2	19.3	16.1	15.2	22.0	25.1	22.6	26.9	26.3	15.6	20.5	25.5	33.4	25.9	15.7	22.1	22.3	21.6	18.7	22.7	26.6	19.0	31.8	26.2	21.5	22.1	39.2	22.8	22.1	23.1	35.8	30.9	12.6	26.0	23.0	19.4	12.8	7.1	13.6	13.0	6.7	8.3	3.8	8.1	5.5	14.2	13.8	22.2	21.9	10.2	8.6	11.1	8.4	10.8	6.7	7.9	6.0	10.8	11.4	18.7	9.8	13.2	8.3	18.0	6.0	13.8	13.1	10.1	15.7	13.7	12.7	16.7	15.1	6.9	19.9	11.9	17.5	15.5	11.9	7.1	6.1	12.7	7.5	7.6	8.1	11.9	6.5	17.9	21.4	9.3	10.9	9.4	15.0	8.0	14.2	18.8	12.9	11.2	5.6	13.9	10.3	15.5	13.7	12.0	11.5	18.2	11.4	6.0	8.8	12.3	7.8	10.2	8.3	10.9	6.5	5.8	6.9	12.8	5.4	6.4	13.6	6.7	13.0	7.1	6.6	3.8	16.6	22.2	21.2	21.2	16.1	15.2	26.3	15.6	22.1	23.1
SPG21	"ACP33, BM-019, GL010, MAST"	ENSG00000090487	"SPG21, maspardin"	Q9NZD8	15	64963021-64990310	"Disease related genes, Predicted intracellular proteins"			"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 47.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040407, HPA040436"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA040407: , HPA040436: AB_10796454"	"unprognostic (7.47e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.40e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.19e-1)"	34.2	34.0	22.4	27.6	24.3	28.2	48.6	12.6	23.7	31.1	28.7	25.1	38.7	23.8	31.6	73.3	29.4	34.9	30.6	25.3	23.4	22.9	39.2	66.3	33.3	40.4	25.7	17.8	35.6	25.3	26.3	28.4	48.2	18.8	30.0	28.3	33.7	31.9	47.0	35.4	28.9	37.8	30.4	29.3	31.7	31.1	26.8	19.3	33.5	50.1	28.9	26.1	31.4	24.7	9.4	20.4	47.7	35.8	3.9	5.5	11.5	22.3	33.5	16.9	32.0	43.8	43.4	21.2	14.0	47.8	28.0	32.7	15.0	34.9	25.8	21.9	32.8	30.0	48.5	32.9	26.7	10.6	15.6	22.3	22.7	27.0	55.6	21.0	19.8	29.5	37.7	22.2	42.1	33.4	18.5	21.0	34.1	31.9	19.3	18.5	18.7	17.6	20.1	18.1	45.1	28.7	27.2	20.8	18.6	16.6	35.3	31.8	24.1	35.9	16.3	23.8	24.8	33.8	20.9	15.1	25.6	15.1	30.8	56.0	20.0	2.1	35.8	3.8	4.0	21.3	3.7	9.4	3.8	4.1	20.4	8.1	5.5	3.1	47.7	3.9	17.2	6.6	4.3	11.5	22.4	24.3	12.6	23.7	23.4	22.9	25.7	17.8	18.8	19.3
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 33.7;U-251 MG: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 11.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	9.3	2.2	4.7	10.5	3.5	15.0	20.4	0.4	3.2	5.5	5.0	4.0	0.4	1.9	6.3	8.3	13.8	5.3	12.7	10.5	5.3	2.1	4.1	2.4	12.9	10.1	4.4	1.5	5.5	15.1	3.1	2.7	7.4	4.7	4.3	1.1	11.0	11.5	1.7	6.8	8.7	6.3	5.2	4.0	2.7	3.8	3.7	6.3	3.0	9.4	16.2	12.1	5.6	7.0	0.2	8.0	2.4	3.4	0.1	1.4	1.3	9.6	1.0	4.2	0.2	2.1	2.0	4.4	22.3	14.8	18.8	11.4	5.2	1.0	0.4	2.0	16.4	2.0	3.2	28.6	4.6	0.4	1.7	0.1	7.1	33.7	4.7	0.3	0.8	3.8	0.5	29.3	11.6	18.1	4.5	0.0	3.7	12.3	0.9	0.1	0.2	8.1	0.6	1.1	0.7	1.0	0.1	0.5	1.0	2.2	0.2	19.3	0.8	1.3	29.4	29.6	5.7	22.7	37.7	0.4	0.1	0.4	22.5	1.7	4.4	2.4	3.4	0.0	1.4	1.7	0.4	0.0	0.2	0.4	1.0	0.2	0.0	0.3	0.4	0.1	0.3	8.0	0.0	1.3	4.7	3.5	0.4	3.2	5.3	2.1	4.4	1.5	4.7	6.3
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 27.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavourable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	3.9	3.2	4.2	5.1	4.4	13.8	13.7	2.3	5.4	5.1	5.9	6.7	2.0	3.5	6.7	4.7	16.8	3.9	3.5	3.2	4.7	6.1	3.3	2.4	16.8	7.6	4.5	2.3	6.6	4.2	4.8	4.7	12.3	5.2	7.2	6.9	4.8	27.4	2.9	1.2	3.5	4.9	5.8	5.2	5.9	3.9	3.4	3.5	11.2	5.6	6.4	11.8	4.3	8.2	1.2	1.4	3.7	2.1	6.0	1.5	0.8	16.1	4.1	9.7	7.8	2.1	3.0	7.0	8.1	3.4	4.7	5.7	2.7	16.1	0.0	3.6	3.8	5.4	12.5	5.9	8.7	6.9	3.9	20.8	5.6	2.5	0.9	17.9	16.3	1.4	2.1	7.9	4.3	5.2	6.3	20.3	10.8	5.4	5.9	9.7	10.0	6.1	8.4	20.9	4.4	3.5	4.3	0.0	5.4	14.5	4.2	1.5	9.2	8.6	2.2	9.6	10.8	15.9	5.0	4.5	5.2	10.7	5.1	14.8	5.6	1.7	1.8	3.7	1.5	2.1	0.7	1.2	0.8	0.9	1.4	1.1	0.5	1.0	0.0	6.0	1.7	0.0	0.5	0.8	4.2	4.4	2.3	5.4	4.7	6.1	4.5	2.3	5.2	3.5
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 121.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.3;HaCaT: 58.6;hTCEpi: 41.7;RT4: 47.5;SK-BR-3: 88.0;T-47d: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		3400000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: "	"prognostic unfavourable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.2	0.5	0.9	11.6	1.2	0.0	12.6	2.9	0.8	12.9	64.4	1.2	38.6	31.9	3.6	25.5	71.1	6.4	30.7	0.8	0.8	0.7	27.9	1.5	18.5	3.7	0.9	0.6	3.4	25.0	28.8	9.7	85.5	1.3	17.5	17.9	3.2	50.8	24.0	0.6	39.1	121.0	2.3	1.0	3.1	17.6	1.9	0.7	4.8	15.4	26.9	44.3	12.8	21.5	5.1	19.0	15.3	10.9	3.6	1.8	3.8	18.8	0.1	0.0	0.1	0.0	0.0	51.3	0.3	0.4	0.6	0.3	30.0	31.5	0.0	22.5	0.0	58.6	4.8	28.2	0.4	0.1	1.6	0.8	0.5	1.6	0.3	3.3	14.9	0.0	41.7	0.6	2.6	2.3	0.4	0.1	0.0	14.6	0.1	2.5	5.8	2.7	1.9	0.0	3.7	28.4	47.5	12.6	0.6	1.4	88.0	2.3	42.0	2.4	0.0	0.0	0.3	0.1	0.0	0.1	3.5	0.1	0.1	2.4	0.1	0.0	10.9	7.9	0.3	9.3	0.5	5.1	1.8	0.8	19.0	3.9	0.7	0.2	15.3	3.6	9.6	2.3	0.2	3.8	0.9	1.2	2.9	0.8	0.8	0.7	0.9	0.6	1.3	0.7
SPINT2	"HAI-2, Kop"	ENSG00000167642	"Serine peptidase inhibitor, Kunitz type 2"	O43291	19	38244035-38292614	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 81.3;CAPAN-2: 120.0;hTCEpi: 66.8;RPTEC TERT1: 89.5;RT4: 69.4;SK-BR-3: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011101, CAB018969"	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"				"Plasma membrane, Intermediate filaments, Cytosol"		"CAB018969: , HPA011101: AB_1079039"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.68e-2)"	1.5	7.2	11.9	15.1	14.0	10.7	29.2	14.3	20.8	24.0	46.3	4.7	63.2	38.3	7.1	44.9	60.6	30.4	51.8	3.3	10.4	22.9	47.5	2.8	25.6	10.3	9.3	14.6	15.3	78.7	30.2	82.7	77.3	11.0	29.6	40.3	15.3	143.1	61.6	0.7	41.7	82.3	13.1	5.6	9.4	34.1	87.0	2.8	15.0	95.6	32.0	37.5	27.1	25.0	23.1	73.9	70.7	17.9	2.6	13.2	17.6	81.3	59.1	0.3	0.3	0.0	0.0	38.7	1.5	0.1	0.1	0.2	41.8	120.0	0.6	6.6	0.4	27.0	4.2	57.9	0.1	0.7	4.9	15.3	1.5	0.0	0.1	0.1	0.0	0.0	66.8	0.0	28.3	0.2	0.3	0.0	0.1	63.0	2.4	0.2	5.9	16.6	8.3	0.0	36.6	89.5	69.4	22.3	0.3	24.2	78.7	0.2	35.1	10.1	0.0	0.1	0.4	0.3	0.3	5.5	7.0	4.5	0.1	1.0	0.1	57.2	17.9	70.7	0.5	12.5	1.1	20.0	6.5	3.2	41.7	23.1	13.2	11.9	7.8	2.6	8.4	73.9	2.5	17.6	11.9	14.0	14.3	20.8	10.4	22.9	9.3	14.6	11.0	2.8
SPIRE1	"KIAA1135, spir-1"	ENSG00000134278	"Spire type actin nucleation factor 1"	Q08AE8	18	12446512-12658134	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 40.5;U-2197: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040737, HPA040942"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA040737: AB_10960987, HPA040942: AB_10960492"	"unprognostic (3.39e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (3.66e-3)"	"prognostic unfavourable (7.92e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-1)"	8.4	20.2	20.6	4.7	16.2	1.7	10.6	20.5	35.3	10.8	6.5	15.0	3.4	2.5	9.2	7.0	8.8	5.6	8.6	22.0	21.6	14.8	12.7	5.5	12.2	3.3	21.3	20.5	9.8	8.5	15.7	8.2	7.5	17.3	10.1	4.3	9.4	10.0	9.9	17.5	7.7	3.5	9.9	17.7	5.3	5.5	34.8	17.5	0.4	15.0	3.6	4.9	8.8	10.7	1.0	1.0	0.0	1.1	0.9	0.6	0.2	7.4	3.3	7.3	8.0	8.2	7.3	0.4	8.1	8.4	8.0	7.6	0.3	1.6	3.5	9.2	10.4	1.6	9.7	7.2	10.2	5.3	4.8	2.2	6.9	4.2	16.9	1.5	5.6	5.0	13.8	13.8	40.5	10.7	5.5	0.1	11.9	9.9	0.4	2.0	3.0	8.2	0.0	8.9	7.4	9.7	10.2	10.7	4.4	8.8	7.3	18.3	2.3	4.6	13.0	13.3	3.9	31.0	9.6	2.7	0.2	0.2	10.7	0.9	3.5	0.0	1.1	0.0	0.4	0.8	0.2	0.0	0.2	0.6	1.0	1.0	0.0	0.4	0.0	0.9	1.1	0.0	0.0	0.2	20.6	16.2	20.5	24.3	21.6	14.8	21.3	20.5	17.3	17.5
SPNS1	"HSpin1, LAT, nrs, PP2030, SPIN1, SPINL"	ENSG00000169682	"Sphingolipid transporter 1 (putative)"	Q9H2V7	16	28974221-28984548	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041995, HPA042988"	Enhanced		Approved	"Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol"				Vesicles	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA041995: AB_10959609, HPA042988: AB_10964587"	"unprognostic (3.54e-2)"	"unprognostic (4.57e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.66e-1)"	"unprognostic (7.86e-5)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.85e-7)"	"unprognostic (1.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.12e-2)"	23.4	23.9	14.5	22.0	15.9	38.3	24.2	21.0	22.8	18.2	22.1	24.1	20.1	26.9	25.1	21.3	20.9	17.1	26.8	16.1	14.9	12.1	24.1	28.3	33.4	22.6	15.4	17.0	18.3	20.8	29.5	17.2	40.7	15.4	20.1	12.6	19.8	20.8	22.8	21.3	30.9	22.3	26.3	14.5	27.3	20.7	22.3	17.2	31.0	22.0	24.5	17.2	21.2	19.5	3.1	15.6	7.2	23.5	4.2	7.9	10.1	10.2	24.3	9.2	21.4	17.7	9.8	26.3	11.5	11.9	19.2	17.2	22.2	24.7	6.6	28.4	10.3	21.8	14.9	12.7	6.9	7.5	25.3	9.5	23.7	27.5	30.1	10.5	20.6	16.4	17.1	20.7	8.8	17.7	21.3	11.9	9.6	27.4	11.5	30.1	21.8	16.1	14.6	11.1	29.3	10.4	10.0	16.5	21.4	8.2	24.5	17.9	24.4	12.8	14.9	15.7	11.9	21.8	8.8	18.0	14.1	6.1	20.1	16.1	12.6	6.4	18.2	7.2	6.0	23.5	5.0	3.1	6.0	7.9	15.6	2.8	6.2	4.1	3.3	4.2	15.7	6.5	6.8	10.1	14.5	15.9	21.0	22.8	14.9	12.1	15.4	17.0	15.4	17.2
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.9;urinary bladder: 13.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.6;hTEC/SVTERT24-B: 19.3;RT4: 32.6;TIME: 16.9;U-87 MG: 32.1"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.9"					"Low region specificity"	"Detected in some"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: , HPA031715: "	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favourable (4.05e-5)"	28.9	0.5	1.8	5.1	1.6	0.3	1.6	0.4	3.9	2.0	0.7	1.5	0.1	1.6	2.4	2.8	0.3	2.1	1.6	0.4	1.2	1.6	0.5	0.2	12.9	0.9	2.6	0.3	1.8	0.1	0.1	1.6	3.5	8.2	1.8	0.9	1.8	0.1	0.3	0.4	0.1	0.9	2.4	3.1	1.9	1.1	11.9	0.6	0.1	0.4	0.8	0.2	13.7	2.1	0.0	0.0	1.9	0.1	0.0	0.0	7.3	10.6	0.3	0.0	0.0	0.2	1.5	0.5	13.9	18.6	13.5	9.0	0.2	0.6	0.1	1.9	15.6	1.4	0.0	0.2	4.3	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.2	6.8	0.2	19.3	0.6	9.1	0.2	0.2	7.9	0.0	0.1	0.0	0.2	0.3	0.0	1.4	0.0	0.0	32.6	0.0	0.0	0.3	0.0	0.9	8.0	0.0	16.9	14.2	1.4	9.2	5.2	0.0	0.1	0.0	32.1	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	1.8	1.6	0.4	0.6	1.2	1.6	2.6	0.3	8.2	0.6
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887360-72892158	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 61.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 9.9;monocytes: 9.3"	"Low region specificity"	"Detected in all"							HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol			52000	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	13.3	22.6	6.3	6.1	8.2	0.0	36.2	2.0	6.4	6.0	17.1	3.1	8.9	11.4	5.7	19.1	13.4	13.2	11.4	16.1	6.4	6.0	20.3	43.5	7.2	5.3	7.9	5.0	8.7	61.7	16.7	5.5	3.9	7.9	17.3	16.2	4.5	20.9	8.8	16.0	3.3	15.1	9.5	4.9	4.7	15.4	4.9	7.2	1.0	31.7	6.2	3.6	9.5	41.4	0.0	9.9	0.7	9.3	0.0	0.4	2.5	13.9	39.2	0.2	6.1	16.1	5.8	9.8	6.6	9.6	4.9	4.6	24.9	14.5	10.2	7.9	7.8	13.2	17.5	10.5	4.1	2.9	13.6	15.3	9.7	25.5	6.0	2.4	4.2	5.2	11.8	5.4	6.1	12.9	15.7	2.0	6.4	29.4	0.9	9.1	3.3	37.5	0.0	25.5	6.0	26.0	21.9	2.4	4.6	12.1	27.3	8.9	12.3	2.9	15.8	5.4	13.2	9.4	11.5	2.2	4.9	0.7	7.7	5.2	9.3	0.0	9.3	0.7	0.4	2.6	0.4	0.0	0.2	0.1	9.9	0.0	0.2	0.4	0.0	0.0	1.0	0.9	0.0	2.5	6.3	8.2	2.0	6.4	6.4	6.0	7.9	5.0	7.9	7.2
SPRED2	"FLJ21897, FLJ31917, Spred-2"	ENSG00000198369	"Sprouty related EVH1 domain containing 2"	Q7Z698	2	65310851-65432637	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 3.2;plasmacytoid DC: 7.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.7;NK-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038256, HPA064394"	Approved		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038256: , HPA064394: "	"unprognostic (1.49e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.21e-3)"	"unprognostic (5.43e-2)"	25.1	13.5	21.0	19.3	17.8	6.7	26.2	26.2	28.9	16.9	18.9	9.0	5.8	17.2	20.1	12.3	12.8	13.8	18.3	17.5	19.0	14.3	16.1	28.1	22.0	14.8	15.3	19.0	18.3	20.6	29.5	15.1	18.1	20.5	15.1	18.7	15.1	17.9	13.6	9.6	13.6	20.7	13.7	16.5	11.0	22.6	8.1	12.9	40.3	22.1	10.4	17.1	21.2	30.5	0.1	7.7	1.2	1.2	3.2	1.2	1.5	26.6	14.1	15.4	15.6	20.0	20.1	11.1	8.0	11.8	5.2	7.1	18.5	7.6	20.5	4.2	9.9	9.0	8.7	17.9	10.5	23.5	6.4	4.2	3.7	19.9	10.1	13.0	8.7	16.0	10.6	18.3	17.6	3.2	18.2	8.0	8.3	18.0	10.1	12.2	7.6	16.5	8.1	13.9	10.6	16.0	22.5	6.6	23.4	8.4	7.2	21.3	6.8	11.1	5.0	13.1	17.6	11.6	12.7	15.9	6.4	33.6	21.2	12.6	25.2	0.0	0.4	0.0	1.2	1.2	0.1	0.0	0.2	1.0	0.8	0.1	0.2	0.3	1.2	3.2	0.6	7.7	0.0	1.5	21.0	17.8	26.2	26.7	19.0	14.3	15.3	19.0	20.5	12.9
SPRED3		ENSG00000188766	"Sprouty related EVH1 domain containing 3"	Q2MJR0	19	38388421-38399587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.7"	"Cell line enhanced"	"Detected in many"		"TIME: 15.0;U-87 MG: 9.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071521			Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA071521: "	"unprognostic (1.09e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.71e-3)"	"unprognostic (3.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.09e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-11)"	"unprognostic (6.21e-4)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.45e-3)"	2.0	1.2	4.3	2.7	10.1	0.9	1.2	2.8	10.7	0.9	0.6	1.7	0.0	4.7	1.2	1.2	0.9	0.7	2.0	1.1	5.0	4.7	1.2	0.4	0.9	0.5	2.8	4.6	0.5	2.9	4.5	5.8	0.8	4.7	1.2	0.8	0.9	0.8	1.1	0.9	2.3	3.7	2.3	1.7	0.5	1.3	1.7	0.9	0.0	1.8	0.0	0.6	0.9	0.8	0.8	0.7	2.2	0.6	0.9	0.5	0.3	0.2	1.1	3.9	3.2	0.6	1.9	2.2	7.7	5.1	2.6	2.4	0.4	0.8	0.2	2.8	2.6	0.1	0.6	0.9	2.3	0.7	1.4	0.0	0.2	0.4	1.4	2.1	0.1	1.3	0.9	6.0	1.8	8.0	0.6	1.4	7.8	0.4	0.0	0.1	1.8	3.9	0.9	1.4	0.1	5.6	0.6	0.2	3.0	0.1	0.2	0.3	0.6	0.1	15.0	2.8	8.8	2.3	4.2	0.6	0.2	0.5	9.6	0.3	4.8	1.6	0.6	0.4	0.4	0.2	0.3	0.3	0.5	0.3	0.1	0.8	0.4	0.3	2.2	0.9	0.5	0.7	0.2	0.3	4.3	10.1	2.8	9.8	5.0	4.7	2.8	4.6	4.7	0.9
SPRY1	hSPRY1	ENSG00000164056	"Sprouty RTK signaling antagonist 1"	O43609	4	123396795-123403760	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.1"	"Cell line enhanced"	"Detected in many"		"AF22: 29.6;AN3-CA: 59.8;ASC diff: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 29.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013538, HPA051369, HPA070554"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	Nucleoplasm	"CAB013538: AB_2533452, HPA051369: , HPA070554: "	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.21e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	139.1	12.6	3.3	14.7	4.3	5.8	69.0	4.9	3.5	28.5	24.8	1.9	18.0	4.5	18.6	28.0	38.1	19.1	27.1	34.1	2.6	1.7	10.2	6.4	23.1	9.1	3.3	2.8	32.2	9.8	17.0	9.5	15.6	2.9	25.0	8.8	11.8	14.6	16.5	48.1	25.5	8.1	20.7	2.8	7.1	11.6	28.4	1.5	13.0	29.6	16.3	8.6	60.8	39.9	29.9	0.7	2.8	0.1	6.1	15.5	0.9	1.8	0.5	29.6	59.8	24.3	16.5	1.9	0.1	1.5	0.1	0.6	1.8	3.1	0.0	13.3	0.8	0.3	0.7	1.4	0.2	0.0	3.0	0.6	0.0	9.2	6.9	4.1	0.0	6.7	0.7	0.2	0.6	2.5	0.5	0.5	1.4	0.2	4.8	10.3	7.1	9.8	2.1	3.2	0.0	4.0	4.3	4.5	3.8	0.0	6.0	5.7	0.6	0.0	6.1	0.3	0.0	0.1	0.8	0.3	0.0	0.0	0.4	0.8	0.9	0.0	0.1	2.8	0.5	0.0	15.5	9.6	1.8	4.2	0.0	29.9	2.7	2.9	0.1	6.1	0.0	0.7	0.0	0.9	3.3	4.3	4.9	3.5	2.6	1.7	3.3	2.8	2.9	1.5
SPRY3	HSPRY3	ENSG00000168939	"Sprouty RTK signaling antagonist 3"	O43610	X	155767812-155782459	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.4;EFO-21: 4.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB013505	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB013505: "	"unprognostic (3.70e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.52e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.49e-2)"	1.6	2.1	1.3	0.4	1.8	2.8	1.2	7.5	1.5	1.3	0.8			1.2	1.5	5.8	0.8	1.1	0.8	0.9	1.3	1.5	0.9	0.7	0.9	0.3	1.1		2.8	0.4	1.3	1.1	1.9		0.9	1.4		1.1	1.2	1.2	0.4	1.1	1.2	1.2	1.4	0.7	0.1			1.0		0.5	0.8	0.7	0.0	0.5	0.4	0.5	0.2	0.2	0.0	0.5	0.2	2.3	8.4	1.7	0.8	0.0	2.0	1.3	0.6	1.0	0.2	1.4	0.0	4.1	1.1	0.3	0.9	0.6	0.6	0.2	0.4	1.0	2.1	0.1	0.7	0.4	0.4	2.0	1.1	0.8	0.5	1.3	0.1	0.6	1.6	0.3	0.2	0.3	0.8	0.0	0.5	0.2	2.0	0.9	0.7	0.6	0.6	1.0	0.0	0.5	0.5	0.6	2.1	0.6	0.9	0.3	0.6	0.6	0.1	1.8	2.0	1.0	1.1	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.0										
SPRY4		ENSG00000187678	"Sprouty RTK signaling antagonist 4"	Q9C004	5	142310427-142326455	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 35.2;WM-115: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008086, HPA055471, HPA072661"	Enhanced		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"CAB008086: AB_2195454, HPA055471: , HPA072661: "	"unprognostic (9.54e-3)"	"prognostic unfavourable (7.12e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.89e-2)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (6.29e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.59e-2)"	"unprognostic (8.21e-2)"	27.3	20.8	9.0	6.8	9.0	0.7	32.9	6.2	8.3	7.1	8.0	4.9	3.6	8.7	8.3	6.2	4.9	6.5	11.3	17.1	7.4	8.0	12.5	11.5	24.3	3.7	6.5	7.6	5.7	7.4	10.6	28.7	21.8	8.5	13.0	7.5	10.7	4.6	7.3	10.6	3.6	11.7	8.8	6.7	10.7	7.8	2.4	3.9	0.2	17.8	4.0	2.4	12.7	29.1	0.0	0.9	0.0	0.0	0.2	0.1	0.0	1.1	1.8	17.1	35.2	10.2	7.4	4.7	12.8	4.4	2.1	2.2	1.8	1.7	0.0	9.5	3.1	0.9	0.0	3.7	2.5	0.0	0.0	0.0	0.0	7.5	3.5	0.0	0.0	6.1	0.0	5.6	3.1	2.0	4.3	0.0	7.5	1.4	0.0	4.6	8.0	12.2	0.4	2.4	0.4	6.1	11.0	0.2	5.4	0.2	1.6	14.6	0.1	0.7	2.8	4.5	0.1	0.9	11.5	0.0	0.6	0.0	7.1	0.0	49.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	9.0	9.0	6.2	8.3	7.4	8.0	6.5	7.6	8.5	3.9
SPRYD3	FLJ14800	ENSG00000167778	"SPRY domain containing 3"	Q8NCJ5	12	53064316-53079420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039426, HPA039685"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Actin filaments, Cytosol"		"HPA039426: AB_10673358, HPA039685: AB_2676623"	"unprognostic (7.73e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavourable (9.46e-4)"	"unprognostic (1.27e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.14e-2)"	"prognostic favourable (1.78e-15)"	"unprognostic (9.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.41e-1)"	16.8	15.7	30.4	10.1	51.9	3.3	11.6	27.1	59.3	15.3	11.4	14.9	10.6	10.8	14.1	21.7	15.9	26.8	11.7	23.1	28.3	27.0	11.3	8.0	13.1	8.8	21.5	34.9	26.4	20.4	26.5	20.3	8.0	34.2	18.3	10.0	15.6	23.3	25.1	7.4	13.0	9.8	18.3	14.0	9.8	13.4	4.9	12.2	3.7	20.2	6.6	11.4	12.4	11.4	9.4	9.4	26.7	18.4	9.7	21.0	15.6	12.4	19.4	2.5	5.1	20.7	10.3	3.3	19.2	9.9	7.2	4.6	3.2	10.5	8.0	15.9	23.4	11.6	3.3	14.5	4.8	8.7	5.1	5.1	11.8	7.3	15.6	9.6	9.1	9.3	23.0	10.3	15.9	14.9	4.4	20.4	12.6	26.9	6.8	5.0	1.4	13.7	3.0	4.3	16.5	9.2	10.0	4.3	4.2	16.5	15.3	7.8	14.3	7.5	20.6	8.3	8.4	18.6	13.0	11.5	10.2	2.3	24.3	8.5	10.0	15.5	9.8	26.7	21.0	17.5	20.1	9.4	14.5	16.9	9.4	7.5	12.5	14.6	15.5	9.7	18.4	4.5	8.0	15.6	30.4	51.9	27.1	59.3	28.3	27.0	21.5	34.9	34.2	12.2
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6"	"Group enriched"	"Detected in some"	5	"HEL: 23.0;K-562: 27.5;U-937: 8.3"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol			43000000	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	1.9	1.6	3.2	0.7	11.6	32.2	0.7	25.2	10.4	0.8	0.7	0.8	0.3	0.6	0.7	5.2	1.8	0.8	0.8	14.7	3.1	3.2	1.2	0.6	0.9	0.6	2.8	3.5	0.7	2.2	6.5	4.7	4.7	16.4	1.5	0.7	1.1	1.9	1.3	67.6	0.7	0.7	1.0	1.7	1.1	0.7	1.0	1.4	0.0	0.7	17.4	0.6	0.8	0.5	0.0	0.6	0.9	0.0	0.0	0.2	1.5	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.4	3.8	0.1	0.0	0.2	2.2	23.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	27.5	0.0	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.1	3.7	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	4.2	0.0	0.4	0.9	4.3	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	1.5	3.2	11.6	25.2	10.4	3.1	3.2	2.8	3.5	16.4	1.4
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66685248-66729226	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7;skin 1: 36.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 19.9;NTERA-2: 23.1;SCLC-21H: 23.5;T-47d: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Cell Junctions,Cytosol"			4800000	"Cell Junctions, Cytosol"		"CAB009844: AB_2194521, HPA039293: , HPA043529: "	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	0.8	4.9	26.2	1.0	38.3	1.7	4.5	29.6	46.7	9.6	0.9	2.0	0.0	1.0	1.1	1.2	12.7	2.6	1.2	0.7	19.7	8.2	12.7	7.1	0.9	0.5	6.5	24.7	0.8	8.3	12.2	3.9	0.7	14.4	6.8	0.7	1.7	13.4	3.1	0.7	36.9	0.9	1.2	1.9	0.9	1.2	18.9	6.2	0.0	0.5	0.1	3.3	1.1	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.4	3.3	1.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.1	8.0	0.0	1.7	0.0	7.7	11.7	1.1	0.0	0.0	4.6	0.0	19.9	1.1	0.3	3.3	0.3	0.1	5.4	0.0	3.5	2.9	3.2	0.0	0.0	12.5	2.6	1.5	23.1	10.3	10.7	1.3	6.6	4.4	1.1	23.5	13.8	6.5	16.4	1.5	18.7	0.9	0.6	0.0	4.1	0.6	5.1	0.3	1.2	6.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.2	38.3	29.6	46.7	19.7	8.2	6.5	24.7	14.4	6.2
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA018038: , HPA020762: "	"unprognostic (1.37e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.12e-2)"	"unprognostic (9.51e-3)"	"unprognostic (4.63e-1)"	"prognostic unfavourable (7.42e-4)"	"unprognostic (4.76e-3)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (3.45e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavourable (5.70e-4)"	"unprognostic (9.71e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.74e-3)"	4.6	15.7	11.1	9.9	13.9	10.4	12.1	8.9	19.9	15.1	11.5	28.8	4.4	15.8	8.9	5.1	40.3	10.0	6.3	4.2	15.4	14.5	7.8	38.1	16.0	8.6	10.8	9.7	17.5	6.3	16.5	9.5	24.7	28.5	13.8	10.1	9.3	10.4	4.7	1.3	23.8	8.7	6.6	36.0	5.6	11.5	29.3	18.7	9.8	5.7	24.2	15.0	5.3	21.6	15.1	12.4	1.2	9.7	9.5	9.0	6.1	25.5	9.9	59.4	17.0	18.5	31.4	6.0	6.7	20.7	9.2	16.9	13.4	37.3	17.6	9.7	8.3	19.5	24.7	37.2	10.7	14.5	52.3	50.2	6.7	34.2	27.2	5.9	14.8	21.4	39.8	27.4	22.6	10.0	28.6	34.3	7.4	42.1	20.3	7.4	24.6	6.8	8.9	10.9	23.9	64.7	29.4	18.6	9.4	13.8	44.4	13.8	11.8	15.4	9.8	3.8	13.4	4.5	6.0	6.2	12.6	24.1	6.4	17.9	6.5	1.2	5.1	0.5	9.0	8.5	4.4	13.6	5.4	8.3	12.4	15.1	7.5	7.8	0.1	9.5	9.7	8.8	5.6	6.1	11.1	13.9	8.9	16.4	15.4	14.5	10.8	9.7	28.5	18.7
SQSTM1	"A170, OSIL, p60, p62, p62B, PDB3"	ENSG00000161011	"Sequestosome 1"	Q13501	5	179806398-179838078	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Differentiation, Immunity"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 196.4;HHSteC: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004587, HPA064165, HPA068843"	Supported		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB004587: AB_628279, HPA064165: , HPA068843: "	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (2.31e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.01e-1)"	47.8	74.5	12.4	21.6	16.0	19.5	60.4	26.2	23.4	25.2	31.7	20.9	39.8	22.9	29.4	27.7	30.8	23.1	45.2	51.9	13.9	12.8	38.6	88.3	33.3	33.4	23.2	16.3	32.3	51.8	22.7	33.6	72.7	15.6	36.2	15.2	28.9	39.0	36.2	102.8	15.3	22.0	36.3	15.5	25.6	40.0	18.9	17.9	18.8	60.4	45.3	17.5	47.9	64.0	27.8	34.2	100.4	58.3	28.2	38.7	52.4	13.9	79.8	3.8	11.4	56.5	39.0	57.4	20.4	61.0	16.2	20.8	15.6	57.7	2.2	56.7	31.2	17.3	7.5	17.2	7.6	196.4	11.7	6.6	28.9	24.4	135.4	6.7	36.3	32.7	21.9	30.3	46.9	16.6	7.0	46.9	34.6	11.0	2.6	6.5	9.4	24.9	5.2	8.4	21.8	24.0	61.1	8.4	7.4	30.2	29.5	72.8	14.7	11.6	36.9	28.4	12.6	26.9	26.1	70.2	73.5	7.3	64.7	11.4	31.5	90.0	58.3	59.9	32.7	39.6	38.7	27.8	28.9	29.2	34.2	27.1	24.0	24.0	100.4	28.2	36.6	14.8	38.7	52.4	12.4	16.0	26.2	23.4	13.9	12.8	23.2	16.3	15.6	17.9
SRA1	"SRA, STRAA1"	ENSG00000213523	"Steroid receptor RNA activator 1"	Q9HD15	5	140537340-140558252	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Receptor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 26.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044598, HPA050153"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA044598: , HPA050153: "	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.69e-2)"	"prognostic favourable (8.01e-6)"	"unprognostic (9.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-1)"	4.8	9.9	2.5	4.8	3.0	5.6	2.7	13.3	3.5	2.5	3.3			3.1	3.0	4.1	2.5	2.6	3.5	4.3	2.7	3.0	3.5	14.4	4.4	3.5	2.2		4.9	2.7	4.5	7.7	3.7		3.7	3.0		5.5	4.4	4.4	3.9	3.4	3.4	2.1	5.7	4.6	6.8			4.1		3.1	2.3	2.3	9.0	15.6	26.9	16.4	7.5	11.3	14.2	6.1	14.8	7.9	8.2	3.8	5.3	11.0	10.6	6.1	6.9	7.3	27.1	3.9	5.3	7.8	4.0	4.2	1.4	7.8	2.8	8.1	9.2	4.6	16.1	10.2	8.2	8.3	6.3	10.1	4.1	3.7	1.9	3.1	4.7	8.1	4.5	18.8	6.8	13.1	2.4	11.9	7.5	6.7	5.0	3.6	7.4	5.6	6.6	6.1	5.6	7.1	7.0	9.5	4.9	6.6	3.4	5.7	8.5	10.2	6.7	5.5	8.1	10.9	4.3	8.1	16.4	12.0	7.0	14.3	6.5	9.0	6.8	6.7	15.6	7.4	5.6	6.4	26.9	7.5	13.3	9.3	11.3	14.2										
SRBD1	FLJ10379	ENSG00000068784	"S1 RNA binding domain 1"	Q8N5C6	2	45388680-45612165	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030567, HPA030568"	Approved		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA030567: AB_10611244, HPA030568: AB_10601856"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.20e-3)"	"unprognostic (4.14e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.29e-1)"	11.7	9.8	5.5	12.2	7.5	6.8	10.9	6.3	6.8	13.8	10.4	6.3	15.7	6.7	19.3	14.9	8.0	8.6	7.4	9.4	5.5	5.8	11.6	13.2	8.7	11.0	6.4	4.7	11.2	14.9	25.1	20.9	11.5	8.7	12.7	9.9	8.4	16.6	14.5	9.5	8.4	10.7	8.3	7.3	13.9	9.9	12.2	8.0	16.5	12.5	6.1	11.3	9.7	9.4	6.1	7.0	14.3	13.0	9.2	7.7	4.9	13.7	7.1	14.7	9.8	5.4	12.0	11.6	10.6	9.3	10.2	9.4	6.0	5.9	11.9	7.9	7.6	6.5	14.4	13.4	18.9	16.2	8.0	15.8	5.7	12.7	6.4	13.1	9.3	7.2	5.6	12.0	14.1	12.3	11.2	9.1	15.1	12.5	17.5	10.0	16.8	7.8	12.1	21.1	10.8	11.6	9.0	13.0	10.6	9.3	10.1	10.3	6.2	4.8	11.3	14.3	11.4	6.9	9.1	9.6	3.5	7.2	8.0	13.1	10.2	3.4	7.2	14.3	6.6	7.9	5.8	6.1	4.9	7.7	7.0	5.3	6.9	6.2	2.6	9.2	13.0	6.7	5.0	4.9	5.5	7.5	6.3	6.8	5.5	5.8	6.4	4.7	8.7	8.0
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.5;HBEC3-KT: 33.0;PC-3: 32.1;RT4: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.3;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.0;monocytes: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Plasma membrane,Cell Junctions,Cytosol"			20000000	"Plasma membrane, Cell Junctions"	Cytosol	"CAB004023: AB_2106059, HPA030875: "	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (1.63e-4)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (5.22e-5)"	6.9	17.5	12.8	11.1	12.0	5.4	9.9	6.4	16.0	16.0	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7.0	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4.0	6.6	10.5	10.4	26.4	20.0	0.3	3.0	0.1	5.3	0.6	0.1	1.6	7.6	35.5	8.1	7.3	3.1	4.9	17.0	7.1	6.1	8.6	5.5	13.3	6.9	0.2	4.4	12.8	14.0	4.9	33.0	3.4	0.0	4.4	1.9	1.2	20.7	7.4	0.1	3.0	5.3	11.2	5.6	7.5	7.8	0.2	0.0	1.4	5.2	1.8	0.2	3.8	32.1	8.3	2.1	0.2	3.6	34.0	7.6	27.5	8.0	11.3	8.8	10.1	2.8	11.5	10.4	7.0	3.8	6.3	0.1	0.2	0.1	7.3	0.0	7.7	0.0	2.6	0.0	0.0	5.3	0.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.1	0.6	4.4	3.0	0.1	1.6	12.8	12.0	6.4	16.0	11.3	6.6	3.3	9.9	5.1	4.8
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346109-55373096	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favourable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	13.8	12.2	11.5	5.9	13.4	6.6	17.8	7.3	18.3	22.9	11.3	20.3	3.5	6.9	13.8	9.6	24.4	5.9	22.6	10.5	13.2	10.7	12.3	15.0	12.4	10.1	15.5	12.0	3.5	26.8	14.0	7.0	8.8	13.6	8.9	10.9	6.8	16.3	6.6	5.8	15.6	8.3	6.2	22.1	6.9	13.8	4.0	15.3	10.0	7.6	9.9	12.1	12.1	12.1	5.9	28.4	10.3	25.2	3.6	9.2	10.3	4.9	3.3	6.0	5.7	20.0	12.8	3.0	5.4	6.3	2.3	3.7	3.3	10.4	11.8	6.1	8.5	3.9	4.2	5.0	2.8	3.4	7.5	6.4	3.7	8.8	5.3	11.9	3.6	11.7	9.3	3.9	3.6	9.2	10.9	26.5	12.9	6.5	17.4	5.2	7.5	4.4	5.6	1.8	6.6	7.6	5.4	9.2	5.1	5.8	43.6	3.9	5.3	10.5	4.5	14.6	2.6	1.0	4.1	14.1	7.7	4.3	18.5	16.4	14.2	10.3	16.5	4.9	7.9	25.1	9.2	5.9	6.0	7.4	14.1	5.2	5.3	7.1	0.8	3.6	25.2	28.4	5.8	10.3	11.5	13.4	7.3	18.3	13.2	10.7	15.5	12.0	13.6	15.3
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837002	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.7;SK-BR-3: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"CAB005406: AB_2194226, HPA043343: , HPA043878: "	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favourable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	34.0	78.2	16.4	9.3	17.9	14.8	15.5	5.8	22.3	15.7	13.8	31.9	30.4	28.9	8.6	23.4	20.5	15.7	17.6	10.2	13.5	10.3	9.0	49.9	11.9	14.4	20.3	16.7	20.5	7.7	9.6	12.5	16.0	11.8	18.0	6.4	15.1	72.7	33.0	16.8	14.5	27.4	7.1	13.1	7.3	13.6	16.8	16.2	15.2	9.5	13.6	13.8	11.9	15.0	0.6	0.4	4.7	0.8	0.4	2.2	0.5	13.7	32.5	4.0	25.0	8.2	15.2	7.0	5.1	16.2	4.4	10.8	6.6	26.9	8.6	4.8	4.0	39.3	4.6	13.6	1.1	5.3	2.0	4.7	27.0	6.9	10.3	0.6	9.1	11.8	5.8	6.2	3.8	5.0	9.1	31.1	1.0	34.0	11.4	7.9	5.4	6.5	8.1	2.9	49.7	3.6	7.2	4.8	19.9	6.0	48.2	14.3	16.3	9.1	5.7	2.4	12.0	5.7	3.2	9.1	0.8	3.9	14.0	6.8	12.4	0.0	0.8	0.4	1.8	0.5	0.4	0.6	0.8	0.3	0.4	0.4	1.6	2.2	4.7	0.4	0.6	0.3	0.2	0.5	16.4	17.9	5.8	22.3	13.5	10.3	20.3	16.7	11.8	16.2
SRGAP1	"ARHGAP13, KIAA1304"	ENSG00000196935	"SLIT-ROBO Rho GTPase activating protein 1"	Q7Z6B7	12	63844293-64162221	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 17.2;hTERT-HME1: 27.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052416, HPA078079"	Uncertain		Approved	Cytosol				Cytosol		"HPA052416: , HPA078079: "	"unprognostic (3.05e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (3.54e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.56e-2)"	11.4	5.4	6.6	6.2	9.6	1.2	8.2	6.6	7.7	7.4	6.1	7.1	2.0	3.2	6.2	4.7	7.0	5.3	5.8	4.2	8.6	3.8	5.5	2.5	11.2	2.2	7.0	3.1	7.5	11.3	17.7	6.1	4.2	10.4	3.8	5.9	4.1	13.4	2.4	3.4	3.1	3.9	5.5	12.1	4.9	4.2	9.4	10.9	0.0	9.4	0.3	2.3	5.2	8.9	1.2	0.8	2.9	1.4	1.2	0.8	0.2	2.9	6.3	10.2	1.0	7.9	13.9	2.1	9.3	8.4	3.5	3.0	3.3	2.5	0.0	3.9	17.2	1.9	0.8	5.4	3.6	2.3	1.0	0.1	4.4	3.4	9.8	0.0	0.1	12.8	5.1	9.7	27.5	3.1	0.0	0.1	4.6	1.7	0.0	0.1	0.8	3.7	0.0	1.9	0.0	4.3	1.6	1.6	3.1	3.6	3.9	2.5	1.0	0.1	6.6	7.2	1.3	7.6	4.2	0.1	0.0	0.0	6.1	0.7	2.8	2.1	0.9	0.5	0.6	1.4	0.7	0.7	0.7	0.4	0.4	1.2	0.8	0.8	2.9	1.2	0.8	0.8	0.4	0.2	6.6	9.6	6.6	7.7	8.6	3.8	7.0	3.1	10.4	10.9
SRGAP2	"ARHGAP34, FNBP2, KIAA0456, SRGAP2A"	ENSG00000266028	"SLIT-ROBO Rho GTPase activating protein 2"	O75044	1	206203345-206464443	"Disease related genes, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA028191, HPA028196, HPA078079"	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: "	"unprognostic (2.57e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.22e-2)"	"prognostic unfavourable (9.61e-5)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavourable (4.61e-7)"	"unprognostic (2.70e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.18e-3)"	3.5	2.4		2.2		3.3	0.7		4.3	1.3	0.0			0.0	1.4	2.0	1.2	1.7	1.5	0.5			0.7	0.5	2.4	1.9			3.1	0.5	7.4		3.4		0.1	0.1		0.0	0.9	0.0	8.5	0.0	2.3		4.2	0.6	1.0			0.0		1.8	1.1		4.8	12.7	14.1	9.9	1.4	3.0	2.2	19.0	12.8	43.6	11.1	20.7	18.7	17.1	16.4	12.3	14.4	15.8	8.7	14.6	7.4	9.5	18.2	15.5	12.9	10.9	14.5	9.2	10.5	15.3	23.0	13.1	8.6	10.5	17.2	17.0	9.4	18.5	12.9	24.9	12.6	24.3	9.1	13.2	8.3	9.3	14.0	14.8	19.0	17.8	17.6	6.2	3.5	14.5	6.6	14.0	10.5	20.5	13.0	18.7	24.7	14.2	17.2	17.4	15.1	16.1	14.4	7.0	17.1	14.7	34.4	0.6	9.3	0.5	2.6	9.4	1.0	2.2	2.1	2.6	6.3	4.8	0.8	1.8	14.1	1.4	9.9	12.7	3.0	2.2										
SRGAP2B	SRGAP2P2	ENSG00000196369	"SLIT-ROBO Rho GTPase activating protein 2B"	P0DMP2	1	144887265-145095528	"Predicted intracellular proteins"	Neurogenesis			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 9.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA078079			Approved	Cytosol				Cytosol		"HPA078079: "	"unprognostic (1.13e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.48e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-5)"	"unprognostic (3.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-1)"	2.5	3.4		1.5		1.6	0.6		2.7	1.3	0.0			0.0	1.4	0.6	1.2	1.7	1.2	0.6			2.2	0.5	2.4	0.9			2.7	0.3	4.4		3.3		0.4	0.0		0.0	0.8	1.9	6.6	0.0	1.8		3.7	0.0	0.2			0.5		0.3	1.2		1.4	4.6	5.0	9.6	0.5	1.6	1.1	6.7	14.5	31.5	6.5	15.2	13.2	10.0	7.5	6.6	6.4	7.4	4.4	12.4	3.4	10.0	4.4	11.7	8.0	4.3	7.9	3.1	8.2	4.9	10.6	6.1	10.6	4.3	6.5	9.3	6.6	15.8	14.0	12.8	2.6	12.0	3.4	7.5	1.9	5.1	5.8	5.3	5.1	6.8	5.8	5.5	2.9	3.9	5.0	9.9	3.6	16.5	7.5	11.2	23.2	13.8	14.3	12.2	8.7	5.0	6.2	2.1	5.0	6.0	19.6	1.4	5.1	0.7	0.9	6.9	0.7	1.2	1.4	1.6	3.5	1.4	1.0	1.1	5.0	0.5	9.6	4.6	1.4	1.1										
SRGAP2C	SRGAP2P1	ENSG00000171943	"SLIT-ROBO Rho GTPase activating protein 2C"	P0DJJ0	1	121184810-121392822	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 16.5"	"Cell line enhanced"	"Detected in many"		"WM-115: 39.1"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA078079			Approved	Cytosol				Cytosol		"HPA078079: "	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.48e-6)"	"unprognostic (2.40e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.18e-4)"	"unprognostic (6.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.71e-7)"	"unprognostic (4.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.66e-2)"	4.7	4.5	3.5	2.8	4.4	4.2	2.7	7.8	6.0	3.5	2.0	8.5	3.3	1.0	3.5	1.2	5.4	3.2	3.0	2.9	3.3		4.6	2.9	5.5	2.5	6.3	4.0	4.8	1.1	16.5	4.6	6.5	6.2	2.1	1.7	2.1	1.3	3.2	1.3	10.9	1.7	3.9	6.4	7.0	1.8	1.3	4.7	4.5	2.0	1.9	2.2	3.1	2.7	1.7	4.2	5.2	7.7	1.0	2.3	1.4	5.1	6.8	15.0	3.3	11.7	10.2	8.3	5.9	4.8	5.1	6.6	0.1	5.3	3.2	5.3	8.1	2.8	5.3	4.3	6.7	4.3	5.5	4.7	11.8	5.2	6.7	3.1	5.6	7.6	4.4	6.4	8.3	11.9	4.3	6.2	3.7	3.1	2.0	4.0	4.7	3.2	2.9	17.7	2.9	4.7	3.1	2.9	1.8	10.3	3.6	18.4	4.7	9.3	10.6	9.5	9.4	14.2	8.6	3.6	2.6	2.0	8.3	6.5	39.1	0.5	5.9	1.0	1.9	4.6	1.3	1.7	2.3	2.1	4.2	1.7	1.1	1.6	5.2	1.0	7.7	3.8	2.0	1.4										
SRGAP3	"ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP"	ENSG00000196220	"SLIT-ROBO Rho GTPase activating protein 3"	O43295	3	8980591-9363053	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;HBEC3-KT: 8.2;hTCEpi: 8.2;RT4: 10.9;T-47d: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036959, HPA044074, HPA078079"	Enhanced		Uncertain	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: "	"unprognostic (3.63e-3)"	"unprognostic (1.12e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.39e-3)"	1.8	6.1	10.6	1.7	20.4	1.2	3.2	32.4	34.9	9.7	2.1	10.5	0.0	1.9	4.4	3.4	2.6	18.5	2.3	2.7	10.0	11.2	4.9	1.4	2.2	2.3	7.5	9.8	7.2	2.4	2.7	5.7	1.9	15.5	4.7	2.5	4.8	5.7	3.2	2.5	4.0	1.7	2.0	6.1	1.7	2.9	4.4	4.8	0.4	3.3	0.6	2.1	6.7	1.4	0.0	1.9	1.9	0.4	1.0	1.3	0.1	0.5	0.5	9.5	0.4	0.6	1.3	1.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.5	0.0	4.8	0.2	8.2	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	5.1	0.8	8.2	0.7	0.8	0.0	0.0	0.0	0.0	0.1	0.2	2.0	0.9	0.7	1.1	0.0	0.0	4.1	10.9	1.1	1.2	0.2	2.9	0.1	10.6	0.0	0.0	0.0	0.4	0.1	0.1	2.8	0.1	0.0	0.8	1.7	0.3	1.2	0.4	1.9	0.0	0.1	0.0	0.0	0.2	0.0	1.9	0.0	0.2	0.0	0.0	1.0	0.1	0.5	1.3	0.1	10.6	20.4	32.4	34.9	10.0	11.2	7.5	9.8	15.5	4.8
SRI		ENSG00000075142	Sorcin	P30626	7	88205118-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 140.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Supported	Nucleoplasm,Cytosol			1400000	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favourable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	20.6	22.0	47.7	24.6	53.5	18.7	22.4	18.9	43.6	24.1	140.7	32.5	7.0	45.3	18.1	33.1	15.6	39.4	14.2	19.4	35.9	40.2	21.7	14.6	21.9	16.6	45.0	44.8	23.3	18.4	12.1	18.3	21.2	36.9	19.5	115.0	11.1	17.7	18.4	8.7	11.1	62.8	25.2	41.9	14.6	16.2	10.0	28.0	9.2	19.7	9.4	19.4	27.0	18.7	29.7	34.5	95.4	42.1	36.3	36.4	32.7	34.1	13.1	35.5	36.5	57.6	48.6	17.8	20.5	33.3	23.2	27.6	12.2	77.6	38.0	21.7	31.1	34.6	44.6	46.5	30.4	30.6	20.0	19.7	36.2	0.0	34.9	26.2	21.1	49.7	42.6	24.5	35.7	69.5	17.4	33.0	31.8	21.6	38.2	18.0	31.2	26.5	15.9	50.3	21.0	43.2	34.2	25.7	30.5	62.6	36.0	28.6	17.0	11.7	43.4	43.5	36.5	39.9	36.5	30.9	14.3	40.7	42.7	25.1	73.7	86.5	26.1	95.4	31.0	36.5	36.4	29.7	34.5	35.2	34.5	24.9	25.8	29.8	16.3	36.3	42.1	27.5	34.7	32.7	47.7	53.5	18.9	43.6	35.9	40.2	45.0	44.8	36.9	28.0
SRM	"SPS1, SRML1"	ENSG00000116649	"Spermidine synthase"	P19623	1	11054584-11060024	"Enzymes, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 107.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA015746	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA015746: AB_1857472"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (2.25e-5)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavourable (3.80e-8)"	"unprognostic (1.74e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.98e-2)"	26.7	17.7	20.3	29.0	35.4	15.2	16.9	10.2	30.8	14.3	13.3	14.0	11.5	10.8	18.8	9.8	17.7	15.8	14.2	24.9	19.6	16.9	13.9	45.3	14.0	31.0	15.3	15.0	22.8	107.4	8.0	14.5	14.8	15.6	13.1	11.7	15.0	36.0	17.6	43.6	18.2	9.8	22.9	11.7	21.1	14.5	14.4	14.1	17.9	11.9	21.2	20.8	20.2	19.8	10.7	10.2	0.3	6.0	5.0	10.3	2.0	24.9	36.3	12.1	40.4	24.1	26.1	19.0	38.8	19.9	55.5	29.8	44.7	15.1	48.2	22.9	33.6	19.6	38.6	31.2	18.4	23.7	58.3	30.4	40.2	50.4	35.5	50.9	27.9	26.2	22.6	53.7	47.1	23.4	49.4	40.9	26.9	54.7	43.4	44.5	26.3	70.4	32.7	12.5	78.7	19.7	9.9	23.3	22.3	20.0	43.3	30.3	15.1	25.9	19.4	36.2	28.5	62.7	43.5	33.0	33.2	72.2	25.2	68.5	41.7	0.0	5.4	0.3	7.0	6.0	10.3	10.7	7.1	9.1	6.4	9.3	8.4	9.7	0.2	5.0	3.1	10.2	7.5	2.0	20.3	35.4	10.2	30.8	19.6	16.9	15.3	15.0	15.6	14.1
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.7;HaCaT: 2.6;MCF7: 4.9;RT4: 10.1;T-47d: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"				"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: "	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.3	0.0	0.3	0.5	0.3	0.0	1.1	1.1	0.3	0.3	1.8	0.3	0.3	0.4	0.3	10.2	0.4	0.0	0.3	0.3	0.3	0.0	0.9	0.3	0.3	0.3	0.3	0.3	0.3	2.7	0.0	0.3	0.3	0.3	2.2	0.0	0.3	2.5	0.3	0.3	1.7	0.8	0.3	0.3	2.5	4.2	0.9	0.3	0.3	0.3	0.3	0.8	1.5	0.3	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	5.7	0.2	2.3	0.0	2.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.2	0.0	0.8	0.0	0.2	0.0	0.0	10.1	0.8	1.0	0.3	2.1	0.4	2.6	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.1	0.3	0.3	0.0	0.3	0.3	0.3	0.3
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029567	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA048977: , HPA062044: "	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	18.4	27.5	18.6	21.3	21.0	13.6	22.5	18.2	26.0	24.6	19.2	23.2	31.2	19.3	24.1	25.5	22.6	18.0	17.1	21.8	18.7	22.5	34.4	67.8	19.4	24.0	23.7	17.1	21.1	43.2	30.1	47.1	26.4	29.4	23.2	21.7	19.2	48.1	31.2	28.4	19.6	24.4	20.0	22.3	23.5	22.3	30.8	19.4	32.3	23.6	22.5	27.9	23.9	17.6	20.5	23.4	26.3	30.1	29.5	33.4	19.7	20.3	22.0	21.1	19.8	21.8	22.5	25.4	29.2	26.6	30.2	38.8	26.5	22.9	29.7	29.8	27.8	21.5	28.9	23.0	43.9	29.5	14.5	24.0	21.0	62.1	33.9	25.6	24.3	18.8	22.7	22.2	39.6	30.4	21.2	32.5	31.4	33.8	27.4	14.4	16.2	21.4	21.9	25.8	23.7	36.0	31.1	20.1	21.6	20.9	27.2	26.6	36.1	17.8	23.0	18.4	19.8	21.9	20.1	28.2	37.8	37.2	13.1	16.5	21.9	15.9	19.8	26.3	23.6	24.0	29.3	20.5	23.6	26.0	23.4	18.6	22.3	21.7	19.3	29.5	30.1	16.0	33.4	19.7	18.6	21.0	18.2	26.0	18.7	22.5	23.7	17.1	29.4	19.4
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072653	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol				Cytosol		"HPA023303: AB_1857477, HPA055617: "	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (2.18e-4)"	"prognostic unfavourable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (4.02e-3)"	23.2	23.8	39.8	20.3	41.1	17.5	22.9	35.4	44.1	25.4	28.1	16.6	26.3	18.4	25.7	34.4	37.6	26.0	16.4	25.5	32.4	24.9	24.9	28.9	21.8	22.1	23.8	32.2	32.3	43.1	33.4	29.1	32.0	34.5	24.4	25.0	16.6	27.6	25.8	71.7	35.4	19.7	30.8	30.3	22.6	25.2	18.4	32.4	20.6	32.0	20.4	34.5	25.6	27.3	17.5	20.4	20.2	16.4	26.3	24.5	10.5	38.1	33.8	20.9	21.8	29.8	24.1	37.8	27.9	20.5	33.4	26.2	28.5	21.3	30.2	14.4	28.3	26.0	39.3	29.6	50.0	12.6	43.7	28.1	27.3	41.8	35.3	33.0	21.9	21.2	33.1	29.3	25.8	38.8	40.0	28.5	28.0	23.3	31.8	20.5	19.3	35.7	27.0	55.9	30.9	27.9	33.7	25.7	25.2	25.6	41.5	30.7	37.0	30.1	24.8	36.5	27.9	16.8	37.2	28.2	12.8	34.1	26.4	24.6	27.1	3.7	16.4	20.2	15.2	15.0	16.5	17.5	21.5	23.3	20.4	14.6	24.5	18.2	2.6	26.3	14.8	15.8	18.8	10.5	39.8	41.1	35.4	44.1	32.4	24.9	23.8	32.2	34.5	32.4
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavourable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	13.5	7.1	8.1	15.4	11.7	32.1	11.7	22.5	17.8	12.8	23.8	7.8	10.8	20.3	15.2	7.9	24.9	8.9	10.8	8.7	8.9	7.8	17.8	18.9	14.9	14.6	8.0	8.3	9.5	26.0	11.7	17.7	27.9	9.6	10.5	28.7	12.4	17.6	9.4	19.9	26.2	25.7	11.3	7.9	19.0	13.9	32.7	7.6	21.0	8.5	17.0	19.8	15.2	15.7	4.3	2.8	24.6	3.4	5.0	6.7	2.9	29.3	11.1	16.4	24.5	9.2	12.0	20.8	18.0	17.4	16.9	18.0	31.3	9.9	39.2	15.3	11.1	15.1	32.0	21.5	30.3	26.7	23.1	20.6	13.1	27.1	8.2	30.4	10.1	7.7	11.7	19.4	25.4	21.1	43.6	16.6	14.1	10.4	31.3	23.7	13.4	12.2	22.1	19.7	24.2	16.9	49.3	35.1	12.9	18.5	17.6	12.5	9.9	20.3	15.2	15.9	12.4	10.7	22.6	9.8	21.6	36.8	6.3	35.4	14.1	24.5	2.1	13.7	4.3	2.5	6.1	4.3	5.7	5.7	2.8	3.3	4.8	5.2	24.6	5.0	3.4	1.6	6.7	2.9	8.1	11.7	22.5	17.8	8.9	7.8	8.0	8.3	9.6	7.6
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	9.9	12.1	24.8	10.1	27.6	7.1	13.3	28.4	47.1	12.7	9.4	21.0	7.8	8.2	13.2	11.9	11.9	10.9	11.6	10.4	26.4	28.6	10.3	10.1	9.2	11.5	27.2	30.2	13.0	10.5	11.9	15.3	12.0	27.3	14.0	10.9	7.9	10.1	11.1	7.9	16.9	8.2	13.3	23.1	12.0	11.3	69.3	32.3	22.1	11.3	4.7	14.0	13.6	9.7	12.2	7.3	58.2	8.1	10.0	11.9	6.0	13.1	8.7	13.9	27.6	14.9	16.9	7.8	12.8	15.1	12.9	15.1	6.8	11.2	8.3	16.4	16.6	7.9	14.1	13.6	16.5	14.4	12.5	11.8	8.2	5.9	17.3	11.2	17.7	11.7	25.3	10.9	20.6	22.1	11.6	34.2	14.2	24.8	41.5	8.5	11.5	9.6	13.5	15.4	18.2	18.6	20.4	20.5	14.2	14.6	22.0	13.5	8.2	7.8	14.5	23.8	17.4	22.6	12.0	37.6	37.0	20.5	9.3	11.6	17.7	11.2	8.1	26.0	11.9	5.5	7.1	12.2	9.0	8.9	7.3	11.6	8.5	9.7	58.2	10.0	6.2	6.4	10.1	6.0	24.8	27.6	28.4	38.7	26.4	28.6	27.2	30.2	27.3	32.3
SRRD	"HC/HCC, SRR1L"	ENSG00000100104	"SRR1 domain containing"	Q9UH36	22	26483877-26494658	"Predicted intracellular proteins"	"Biological rhythms, Heme biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA002945	Uncertain		Approved	Cytosol				Cytosol		"HPA002945: AB_1079265"	"unprognostic (3.25e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (9.00e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.96e-1)"	8.7	7.2	12.5	7.1	14.3	9.6	11.3	20.0	17.2	10.6	10.9	10.4	10.5	6.6	12.7	11.5	9.9	10.3	6.9	16.2	10.5	10.1	11.5	15.7	9.5	11.4	10.5	11.8	13.3	14.9	11.8	10.6	9.4	9.4	12.7	9.6	9.6	13.1	13.7	30.0	10.8	7.8	12.5	9.6	9.7	9.0	13.8	7.5	10.4	18.8	11.4	12.4	10.0	9.1	3.2	1.6	1.4	1.4	2.6	3.8	1.0	7.2	4.4	7.6	7.7	7.8	4.7	4.3	5.2	7.3	10.5	9.7	4.3	3.2	16.2	3.7	6.7	6.7	11.6	10.8	10.3	8.3	11.6	7.2	3.7	6.9	5.5	15.7	5.6	4.5	9.5	7.4	11.8	9.0	11.6	10.3	6.8	6.3	7.0	4.9	4.6	5.6	15.9	9.4	11.7	6.9	5.3	8.0	5.5	6.0	5.4	13.3	6.5	6.2	6.9	8.2	27.1	4.6	9.0	6.8	5.5	13.6	5.6	6.5	10.6	0.6	1.4	0.8	2.3	1.4	3.4	3.2	2.8	3.3	1.6	2.4	3.8	3.8	1.4	2.6	1.2	1.2	0.7	1.0	12.5	14.3	20.0	17.2	10.5	10.1	10.5	11.8	9.4	7.5
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737374	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049905	Supported		Approved	Nucleoplasm,Cytosol			140000	Nucleoplasm	Cytosol	"HPA049905: "	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavourable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavourable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (9.87e-4)"	35.4	40.2	20.6	56.6	30.3	73.1	35.3	33.3	36.2	42.1	37.7	34.0	19.5	41.8	37.0	33.6	51.1	35.1	34.8	32.4	19.9	22.6	36.9	66.7	37.3	64.3	21.6	24.0	47.1	34.2	29.1	33.8	51.2	29.5	31.3	36.5	35.5	35.6	40.5	44.9	41.1	46.6	25.5	23.9	52.5	35.6	29.2	18.9	105.3	41.1	41.3	64.5	30.6	35.7	11.1	30.2	4.2	23.5	15.6	12.7	12.2	47.7	38.5	45.7	31.9	11.2	9.5	47.5	30.9	22.9	35.9	33.3	40.4	33.5	73.6	22.6	29.0	43.3	45.3	35.7	36.1	30.8	79.0	55.2	37.3	46.9	12.7	61.0	33.1	10.5	8.1	29.7	8.6	28.0	56.1	32.5	28.0	38.2	66.9	66.6	53.5	55.0	67.8	49.2	54.3	24.0	34.4	39.0	55.7	35.2	30.3	16.6	37.1	44.6	29.2	33.1	42.7	22.0	49.9	42.8	32.2	85.2	29.8	48.5	27.3	1.0	17.5	4.2	12.3	23.5	12.6	11.1	8.5	12.7	30.2	9.8	9.8	9.0	2.1	15.6	14.7	22.4	10.6	12.2	20.6	30.3	33.3	36.2	19.9	22.6	21.6	24.0	29.5	18.9
SRSF5	"HRS, SFRS5, SRP40"	ENSG00000100650	"Serine and arginine rich splicing factor 5"	Q13243	14	69726900-69772005	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043484, HPA056523"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA043484: AB_10797143, HPA056523: "	"unprognostic (2.08e-3)"	"prognostic favourable (7.91e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.07e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	66.6	60.1	67.1	60.9	74.4	131.5	70.3	111.7	88.8	54.3	63.3	67.8	77.1	42.6	71.3	74.6	66.3	79.3	50.1	48.5	66.2	43.0	40.5	60.8	69.4	63.3	86.4	62.1	76.6	41.0	56.4	124.8	59.2	74.0	59.0	54.7	69.2	68.5	75.6	76.0	78.1	74.1	59.7	68.6	66.5	62.0	35.3	75.6	47.8	70.8	52.3	69.1	69.6	55.8	41.2	37.4	60.8	45.1	30.8	38.2	24.4	69.2	20.2	49.6	22.3	30.7	26.5	27.5	33.4	36.0	27.3	29.0	25.4	44.5	71.8	17.7	45.3	33.1	37.5	47.7	32.3	61.3	20.6	54.1	54.3	27.8	35.7	50.4	41.0	55.1	30.4	31.5	33.8	37.8	37.5	42.8	16.9	56.2	57.9	34.2	29.1	18.7	49.7	23.6	27.6	34.7	85.3	25.9	37.0	56.7	34.4	43.1	37.4	42.5	46.6	16.0	42.9	17.4	31.2	41.7	27.2	116.1	37.7	43.0	22.0	39.0	24.1	37.2	37.3	43.4	38.2	41.2	33.2	33.4	26.2	40.6	33.2	31.5	60.8	30.8	45.1	37.4	27.4	24.4	67.1	74.4	111.7	88.8	66.2	43.0	86.4	62.1	74.0	75.6
SRSF8	"SFRS2B, SRP46"	ENSG00000263465	"Serine and arginine rich splicing factor 8"	Q9BRL6	11	95067197-95071224	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA049905	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA049905: "	"unprognostic (2.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (9.99e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.75e-3)"	5.5	6.4	6.1	4.9	9.6	5.3	9.6	6.0	14.3	8.7	6.9	8.0	9.2	7.1	8.0	8.0	6.8	7.4	6.8	6.4	6.5		9.5	6.8	6.1	8.7	6.1	9.5	10.7	10.4	9.7	8.2	6.5	7.2	9.4	7.5	10.1	11.4	8.6	5.4	6.6	7.8	7.1	4.8	9.0	7.1	3.0	5.0	3.7	11.6	5.3	6.5	6.1	5.5	7.9	3.8	7.0	2.0	5.6	12.4	3.7	4.3	4.6	11.6	0.0	15.5	9.8	13.1	6.6	7.4	3.1	3.4	10.8	14.4	23.4	19.7	10.1	9.6	9.7	14.4	3.6	14.1	10.5	19.8	5.4	9.7	11.4	19.8	10.8	12.6	15.4	3.3	15.6	9.7	14.9	13.0	6.1	6.0	10.2	17.7	6.1	12.8	12.8	3.5	18.7	12.3	14.7	14.7	15.1	8.2	14.6	9.5	5.8	11.0	8.9	6.1	8.2	8.2	6.7	7.0	10.7	12.6	3.1	13.3	13.3	7.0	2.0	0.6	5.7	1.1	8.2	7.9	9.6	8.2	3.8	6.9	12.4	9.5	0.6	5.6	1.0	3.5	9.9	3.7										
SS18	"SSXT, SYT"	ENSG00000141380	"SS18, nBAF chromatin remodeling complex subunit"	Q15532	18	26016253-26091217	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055741, HPA059539"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA055741: , HPA059539: "	"unprognostic (2.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-1)"	"prognostic favourable (4.86e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.30e-1)"	26.1	40.5	18.7	30.4	26.4	15.5	26.6	17.6	20.2	24.8	21.4	31.8	32.1	14.0	31.7	32.7	29.8	27.2	23.4	22.4	21.6	16.1	30.0	30.9	21.9	25.8	32.6	16.3	39.4	20.6	39.4	41.8	43.2	25.3	28.6	18.7	26.1	26.0	33.5	10.3	31.3	22.6	31.0	23.7	24.7	22.5	28.3	32.6	27.8	35.6	24.7	35.2	25.5	25.9	15.9	13.1	19.9	17.1	20.7	17.6	13.1	19.0	13.8	33.9	16.6	27.0	24.5	17.1	23.4	21.3	20.7	19.8	9.0	15.8	33.2	18.7	27.4	24.9	18.4	22.7	25.6	21.2	8.8	16.4	20.3	14.6	21.4	25.2	25.5	31.4	26.8	26.0	28.5	15.5	12.0	17.1	28.6	19.1	10.3	14.6	6.4	13.4	12.0	26.4	15.9	21.9	22.5	14.5	21.9	35.8	16.6	10.1	16.9	14.9	17.7	43.6	8.7	10.0	22.9	30.8	20.6	24.0	20.4	17.5	23.1	19.9	11.7	16.5	15.1	17.1	17.6	15.9	14.6	15.7	13.1	13.0	15.5	17.4	5.6	20.7	16.7	7.4	15.7	13.1	18.7	26.4	17.6	20.2	21.6	16.1	32.6	16.3	25.3	32.6
SS18L1	"CREST, KIAA0693"	ENSG00000184402	"SS18L1, nBAF chromatin remodeling complex subunit"	O75177	20	62143795-62182484	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011827, HPA059046"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB011827: AB_778216, HPA059046: "	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.57e-2)"	"prognostic favourable (8.00e-5)"	"unprognostic (1.39e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-3)"	6.6	8.9	11.9	7.7	12.7	7.7	8.6	35.9	15.8	7.0	7.0	9.9	12.2	9.5	9.7	10.9	9.3	6.9	7.2	6.4	11.5	10.9	11.5	33.3	8.2	7.4	11.2	14.5	10.0	10.4	8.4	10.7	8.8	13.1	8.7	7.8	7.4	8.6	11.8	19.2	23.7	9.0	7.7	9.9	9.2	8.8	10.7	10.9	6.0	8.3	6.7	7.1	6.8	8.6	3.6	1.3	2.5	2.7	1.6	2.8	0.5	6.4	7.7	10.7	9.7	4.8	5.6	7.8	6.1	2.4	10.2	5.1	26.3	6.0	3.9	8.1	3.4	16.7	6.6	5.8	9.3	2.7	4.3	17.5	16.1	13.6	3.6	6.3	15.6	3.4	12.8	5.2	4.4	4.6	11.7	7.6	5.7	7.6	9.6	9.9	4.3	8.8	10.7	13.9	4.4	7.6	8.2	20.4	11.3	10.9	13.3	9.1	12.5	10.2	5.4	19.5	11.8	7.2	8.5	8.5	7.6	3.5	9.7	6.3	6.4	0.3	1.6	0.6	1.7	1.1	1.1	0.7	0.9	1.4	1.3	3.6	2.8	0.9	2.5	1.6	2.7	0.8	0.8	0.5	11.9	12.7	35.9	15.8	11.5	10.9	11.2	14.5	13.1	10.9
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519098	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 19.2;BJ: 18.2;fHDF/TERT166: 18.4;U-87 MG: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"		44000000	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavourable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	10.7	2.1	3.3	4.9	1.8	0.1	8.1	3.5	1.9	33.0	18.4	1.6	6.3	2.1	33.1	15.2	9.8	11.0	30.9	10.6	1.4	0.6	2.5	1.8	5.8	1.2	1.2	1.6	17.0	1.8	0.3	13.4	2.5	3.0	6.8	3.2	4.7	1.9	15.7	4.7	3.8	5.8	23.8	3.2	7.3	6.9	5.7	1.4	0.5	2.4	4.2	1.6	19.3	10.9	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.3	0.0	2.3	19.2	0.0	18.2	4.1	2.6	3.0	0.2	0.0	0.7	0.2	18.4	0.0	0.0	0.0	1.4	0.0	0.1	3.2	0.8	0.0	3.7	0.1	5.7	9.0	0.0	3.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.4	0.6	0.1	0.4	0.9	0.1	2.0	0.0	2.0	0.2	0.2	0.0	0.3	0.2	0.7	7.3	0.8	1.0	0.7	2.9	0.2	0.0	0.1	19.6	0.2	4.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	1.8	3.5	1.9	1.4	0.6	1.2	1.6	3.0	1.4
SSFA2	"CS-1, KIAA1927, KRAP, SPAG13"	ENSG00000138434	"Sperm specific antigen 2"	P28290	2	181891833-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 85.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: , HPA039989: "	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favourable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (5.79e-5)"	14.2	10.1	23.3	11.8	27.0	16.1	21.6	25.8	22.5	17.7	24.4	26.2	9.4	17.5	13.0	8.9	12.0	10.7	18.7	13.6	23.7	19.1	22.8	36.0	23.0	11.2	31.3	17.7	7.2	85.5	10.5	10.2	40.9	24.8	18.1	24.1	22.3	29.2	10.0	16.6	50.6	19.5	14.2	27.8	14.7	26.0	16.7	23.8	9.3	19.6	12.2	7.9	14.3	23.5	1.2	3.8	8.1	6.4	1.0	1.4	1.8	16.1	8.1	23.6	4.0	20.6	17.1	6.7	28.7	27.9	10.1	13.4	8.3	18.7	0.3	9.3	20.2	14.0	5.7	13.8	19.6	7.4	6.4	16.3	34.7	6.7	15.2	8.3	15.3	10.1	20.3	17.4	23.7	52.8	7.3	9.0	28.1	8.1	7.3	11.7	1.6	19.1	5.5	9.5	5.6	28.6	4.9	4.1	3.6	16.8	6.0	25.7	4.3	18.3	21.0	24.0	11.6	8.6	14.9	6.2	2.7	6.5	11.2	5.0	17.8	8.1	3.9	5.7	1.4	3.9	0.9	0.6	1.0	0.9	3.8	1.2	1.3	1.1	6.6	1.0	6.4	3.1	0.6	1.8	23.3	27.0	25.8	22.5	23.7	19.1	31.3	17.7	24.8	23.8
SSH1	KIAA1298	ENSG00000084112	"Slingshot protein phosphatase 1"	Q8WYL5	12	108778192-108857590	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019845	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA019845: AB_1857497"	"unprognostic (1.18e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavourable (5.80e-5)"	"unprognostic (3.28e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.22e-2)"	7.3	7.8	8.5	7.4	8.1	10.6	9.3	20.3	8.8	7.4	8.5	6.8	13.1	4.4	9.8	7.9	7.6	8.2	8.3	10.1	8.0	6.9	5.8	7.4	10.1	8.7	7.7	5.2	7.9	8.0	9.7	6.8	7.8	8.4	6.5	6.5	15.0	5.9	8.0	21.4	7.1	6.5	10.4	8.1	8.6	7.1	5.2	6.6	2.0	7.0	7.9	6.6	10.0	13.3	1.8	2.0	5.7	4.0	2.1	2.9	1.2	5.1	6.8	4.5	3.5	8.5	7.2	4.0	6.6	14.1	6.0	5.4	3.4	2.5	2.4	4.7	15.5	5.1	2.7	11.1	4.9	4.9	2.6	5.7	3.1	2.1	4.5	2.9	15.1	9.9	3.8	5.5	12.2	5.5	1.3	2.0	15.8	2.9	3.3	4.2	3.1	5.4	2.4	5.3	3.2	2.4	9.2	3.3	4.5	5.8	1.5	12.7	2.1	2.6	4.3	10.9	4.6	6.5	3.7	3.9	3.5	3.0	5.7	2.4	34.2	4.2	2.4	4.8	2.9	4.0	2.7	1.6	1.5	2.5	1.6	1.8	1.4	1.6	5.7	2.1	3.2	2.0	1.7	1.2	8.5	8.1	20.3	8.8	8.0	6.9	7.7	5.2	8.4	6.6
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303448-67312607	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 23.6;RT4: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.8;eosinophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	8.6	5.5	5.6	6.8	9.7	8.1	13.5	17.8	9.4	14.6	15.9	15.4	19.5	12.4	10.1	10.6	27.0	15.2	20.5	7.7	6.0	6.1	10.3	7.5	9.0	3.5	13.6	5.4	17.1	12.0	11.3	7.4	20.0	8.5	19.8	9.2	11.9	19.1	30.5	5.2	18.2	13.6	13.1	9.3	6.9	13.9	4.2	9.7	0.8	12.8	14.0	13.2	33.3	18.6	0.3	1.6	10.8	2.3	1.5	2.2	1.0	6.1	6.7	0.1	0.2	4.7	4.9	7.3	4.0	5.4	2.1	2.0	7.2	16.3	0.3	12.5	3.7	23.6	2.2	17.0	1.1	1.3	2.5	1.5	10.8	2.9	3.3	0.3	6.0	4.3	15.8	3.1	3.2	2.4	0.0	0.6	2.5	20.8	0.2	3.0	1.5	5.4	7.6	0.2	1.1	6.9	35.7	1.4	2.2	9.4	14.0	4.4	19.6	5.2	3.8	1.7	3.7	4.7	1.1	0.6	0.3	0.2	4.8	2.7	1.6	10.8	1.4	10.5	2.2	2.3	1.7	0.3	2.1	1.8	1.6	0.2	0.8	0.9	4.5	1.5	1.1	1.1	1.8	1.0	5.6	9.7	17.8	9.4	6.0	6.1	13.6	5.4	8.5	9.7
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325985-57335877	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol			8300	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	25.3	23.2	23.5	37.7	25.1	32.0	38.4	28.5	27.6	27.2	30.5	19.4	28.8	23.0	34.9	28.2	34.6	34.4	33.1	28.4	22.7	20.3	22.6	27.8	26.5	33.7	21.6	20.7	41.8	39.3	39.7	31.2	34.8	22.0	26.6	33.0	17.2	32.8	27.5	47.7	32.9	26.2	28.9	17.1	28.3	29.3	28.3	25.2	44.0	45.9	37.0	42.5	28.7	51.7	10.2	10.3	4.5	5.2	6.9	12.0	4.7	57.1	55.2	52.4	38.3	16.5	18.5	25.6	31.5	30.4	55.0	39.5	37.9	42.7	69.5	33.7	27.6	44.2	83.1	49.0	69.5	48.4	46.6	44.3	40.7	40.7	26.1	73.4	33.3	18.5	30.0	56.5	78.8	35.9	60.2	35.2	37.4	38.7	74.3	65.0	68.8	34.0	62.8	88.6	67.5	25.7	41.3	54.9	46.5	44.6	38.3	46.4	46.4	29.0	27.0	37.6	49.7	50.6	53.8	41.1	40.6	71.8	31.8	41.5	49.5	0.8	4.3	4.5	9.4	5.2	9.1	8.7	8.1	10.2	6.1	10.2	8.9	12.0	1.2	6.9	5.0	10.3	9.6	4.7	23.5	25.1	28.5	27.6	22.7	20.3	21.6	20.7	22.0	25.2
SSSCA1	p27	ENSG00000173465	"Sjogren syndrome/scleroderma autoantigen 1"	O60232	11	65570430-65573942	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039789, HPA064670"	Uncertain		Approved	Cytosol				Cytosol		"HPA039789: , HPA064670: "	"unprognostic (9.32e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.03e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.34e-2)"	17.6	21.6	20.0	24.6	23.3	34.0	17.9	19.9	39.1	16.6	22.2	15.2	14.6	18.7	23.1	15.4	23.2	19.9	20.9	28.4	19.5	13.8	20.5	40.4	18.1	24.2	15.1	21.7	22.9	50.3	15.7	15.7	21.4	18.7	20.1	7.6	16.8	36.6	20.8	70.5	19.5	17.0	16.9	10.6	20.9	18.7	44.1	12.0	27.6	17.7	25.0	19.6	21.6	16.6	39.6	35.7	10.6	26.9	32.8	29.3	21.2	26.2	20.8	12.6	22.7	7.3	6.3	21.2	18.1	10.5	17.1	12.0	20.6	26.6	25.5	32.7	9.0	22.1	8.8	19.9	5.2	17.8	15.4	22.2	19.4	15.6	11.6	27.0	18.1	10.5	13.2	12.7	12.1	13.6	24.9	31.6	8.9	38.0	31.1	23.6	21.3	39.6	24.7	9.5	45.7	9.8	13.4	25.3	26.5	11.0	27.3	26.6	36.7	13.5	15.2	30.1	17.5	35.8	22.7	23.6	31.3	21.5	24.3	18.8	27.4	5.7	26.9	10.6	24.6	21.9	25.9	39.6	25.5	25.0	21.6	33.9	29.3	26.1	8.5	32.8	14.2	35.7	27.1	21.2	20.0	23.3	19.9	39.1	19.5	13.8	15.1	21.7	18.7	12.0
SSTR2		ENSG00000180616	"Somatostatin receptor 2"	P30874	17	73165012-73176633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.6"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007264	Uncertain		Supported	Cytosol				Cytosol		"HPA007264: AB_1080053"	"unprognostic (2.13e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.55e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (9.04e-7)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.95e-2)"	4.5	7.4	6.1	2.3	15.8	2.5	4.2	23.1	26.6	1.4	2.2	0.5	0.6	3.3	1.9	4.1	1.5	2.3	1.8	2.2	9.3	5.3	13.6	3.3	1.4	2.7	2.6	13.1	1.5	2.0	1.4	5.7	1.0	4.9	2.8	2.7	1.1	1.8	3.6	1.7	1.9	2.5	2.2	3.3	8.3	7.2	1.4	1.9	0.3	2.3	0.0	2.9	2.0	1.9	1.4	1.0	4.7	0.9	0.9	1.0	0.3	0.3	0.5	0.6	1.1	0.2	0.2	0.7	0.2	0.3	0.5	0.5	0.5	0.5	0.7	0.3	0.1	0.5	0.1	0.1	0.2	0.6	0.9	0.6	1.0	0.5	0.1	0.4	2.2	0.2	0.1	0.2	0.0	0.0	0.7	1.2	0.2	0.6	0.4	1.3	1.5	0.6	0.7	0.8	0.4	0.4	0.6	16.8	1.4	0.3	0.3	0.2	2.1	0.3	0.3	0.4	2.2	0.6	0.3	0.8	0.4	1.6	0.3	1.7	0.4	3.8	0.9	1.2	1.0	0.7	0.8	0.8	0.8	0.8	0.3	1.4	0.8	0.9	4.7	0.9	0.8	1.0	0.5	0.3	6.1	15.8	23.1	22.1	9.3	5.3	2.6	13.1	4.9	1.9
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574869	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA069290: , HPA070604: "	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	44.1	32.5	48.0	33.6	51.5	29.3	73.9	42.3	51.5	37.2	40.1	25.4	39.3	41.3	32.6	51.8	45.7	46.2	35.3	44.4	40.7	42.5	38.0	50.9	37.5	49.0	39.4	39.0	38.0	61.8	33.9	39.9	35.8	36.9	33.9	35.9	34.1	54.2	35.8	107.1	36.9	40.8	35.4	35.0	41.7	38.5	28.0	28.4	37.0	50.9	45.3	36.3	30.8	42.2	35.5	30.1	62.0	28.8	20.7	46.5	28.1	40.6	26.0	18.8	29.0	32.5	31.3	19.3	35.3	27.6	30.9	32.2	24.4	47.2	41.4	19.4	27.8	31.8	30.3	29.1	30.2	34.4	35.9	25.9	22.9	38.6	36.7	32.8	22.7	27.9	24.6	33.1	31.6	28.9	44.8	32.0	24.4	36.2	37.5	52.7	32.9	39.6	29.9	30.4	57.8	33.8	12.5	34.8	23.9	23.9	61.5	104.3	32.0	28.6	21.9	29.8	18.9	33.5	30.3	39.1	46.9	51.6	31.2	52.3	14.4	37.1	28.3	53.6	25.9	28.8	31.9	35.5	34.4	30.7	30.1	33.1	42.2	34.1	62.0	20.7	25.4	19.0	46.5	28.1	48.0	51.5	42.3	51.5	40.7	42.5	39.4	39.0	36.9	28.4
ST13	"FAM10A1, HIP, HSPABP1, P48, SNC6"	ENSG00000100380	"ST13, Hsp70 interacting protein"	P50502	22	40824535-40857022	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043233, HPA046412, HPA047114, HPA047116"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.74e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.54e-2)"	"prognostic favourable (3.10e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.40e-2)"	43.0	46.0	36.8	26.2	32.0	20.9	39.9	32.2	35.3	45.0	36.4	41.3	33.0	23.9	57.1	37.9	32.9	46.5	32.7	44.0	33.8	33.6	63.2	72.0	23.7	25.0	40.8	28.8	141.6	31.8	38.6	38.1	35.9	36.6	45.1	27.6	30.4	34.8	37.8	75.3	28.3	25.9	42.4	52.0	25.6	31.9	29.3	40.5	38.7	50.3	38.5	30.2	49.4	76.7	41.3	29.4	23.3	36.6	28.2	62.1	39.0	45.4	36.7	55.5	48.3	51.6	80.2	50.5	43.1	55.2	53.6	46.9	65.9	27.2	65.6	37.4	43.1	33.3	72.9	42.3	63.7	41.8	46.6	47.1	73.6	74.6	47.1	68.0	38.1	71.2	44.8	48.2	32.8	55.1	56.2	28.7	51.0	34.1	59.5	32.4	31.5	24.2	68.7	47.3	51.6	54.3	69.0	18.5	18.7	49.8	40.1	61.6	38.9	43.0	41.4	44.8	43.7	37.5	34.9	33.2	65.3	61.5	61.3	31.9	43.1	23.3	21.4	22.5	24.9	29.3	37.8	41.3	39.1	29.6	29.4	36.6	62.1	46.7	7.4	28.2	36.6	20.7	32.7	39.0	36.8	32.0	32.2	33.8	33.8	33.6	40.8	28.8	36.6	40.5
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230103	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 101.1"	"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favourable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	11.1	20.0	12.9	5.0	18.0	12.0	12.3	63.0	25.7	16.7	10.7	9.2	21.6	9.8	12.3	31.2	8.5	15.8	10.0	19.8	10.9	12.3	23.1	31.5	20.0	5.4	11.1	18.7	15.9	30.8	17.6	30.1	21.8	14.9	11.7	10.1	11.0	24.9	19.3	10.1	9.7	9.7	11.3	8.1	9.1	13.5	15.9	8.2	2.9	23.8	7.6	7.0	10.0	9.8	2.6	6.2	1.6	3.3	7.6	10.6	3.2	13.0	7.5	12.3	10.7	14.3	9.8	5.7	10.3	13.0	10.6	15.8	10.0	15.5	3.4	11.3	9.0	10.7	10.5	11.0	14.4	4.6	15.1	10.2	12.6	8.9	9.9	11.5	17.5	7.5	11.2	13.7	9.6	11.1	15.0	24.6	10.0	7.5	0.1	8.8	11.8	9.0	2.9	8.3	14.3	11.3	7.0	18.4	15.1	11.7	51.5	13.6	4.4	9.5	8.4	12.4	4.9	13.4	10.1	15.5	11.8	12.8	10.1	10.3	12.4	1.6	3.3	0.4	8.3	1.2	5.9	2.6	5.1	7.3	6.2	0.9	3.5	3.6	0.1	7.6	1.2	6.2	10.6	3.2	12.9	18.0	63.0	25.7	10.9	12.3	11.1	18.7	14.9	8.2
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 90.8"	"Group enriched"	"Detected in some"	47	"HUVEC TERT2: 33.1;NB-4: 45.7;TIME: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	68	"classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8"	"Group enriched"	"Detected in many"	69	"dendritic cells: 2.8;monocytes: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			60000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	39.5	37.6	8.0	26.7	12.8	6.5	41.3	3.2	6.8	13.1	23.4	6.9	4.2	16.1	13.6	26.4	9.7	15.5	16.8	19.7	5.4	4.2	19.2	35.8	21.7	80.7	9.1	2.7	9.9	7.1	4.9	11.9	32.1	10.2	13.5	18.0	23.7	10.4	9.7	8.0	5.1	18.7	18.3	7.2	90.8	11.6	9.7	8.7	2.6	11.9	11.4	11.1	15.9	15.4	0.0	2.8	0.0	10.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	6.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	8.0	12.8	3.2	6.8	5.4	4.2	9.1	2.7	10.2	8.7
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766727	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 71.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.7;HaCaT: 4.3;RH-30: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA026871	Enhanced		Supported	Cytosol			210000	Cytosol		"HPA026871: AB_1857536"	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.6	0.2	0.1	0.5	0.1	0.4	0.5	0.1	0.1	0.7	1.4	0.1	0.1	0.1	1.1	1.1	2.5	0.9	0.6	0.4	0.1	0.1	0.1	11.7	0.5	19.9	0.1	0.1	0.4	0.2	0.0	0.2	0.4	0.2	0.5	0.2	0.1	2.1	0.3	0.1	0.2	0.3	0.2	0.1	71.3	0.3	1.5	0.1	0.2	0.7	0.5	0.4	0.3	0.4	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.7	0.2	0.0	0.0	15.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	4.3	0.0	0.0	0.0	0.0	1.1	0.4	0.7	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.1	2.5	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.1	0.3	0.1	0.6	0.8	0.4	0.0	1.1	0.2	0.2	0.0	0.3	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251193	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"skeletal muscle: 222.7;tongue: 107.8"	"Cell line enriched"	"Detected in some"	23	"RH-30: 224.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 8.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 8.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039285: , HPA039527: AB_10673424"	"unprognostic (6.16e-2)"	"prognostic favourable (2.01e-4)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	3.7	0.2	0.1	0.6	0.1	1.6	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	10.3	3.2	0.2	0.1	0.1	0.1	0.1	0.2	0.4	0.6	0.7	0.2	0.0	0.1	0.1	0.4	0.2	0.2	0.0	2.3	0.2	0.1	5.4	0.0	222.7	0.2	0.3	0.1	0.3	1.1	0.1	1.2	0.0	0.1	1.2	107.8	3.8	0.1	0.1	1.1	4.9	0.5	8.0	0.0	0.3	1.8	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	2.6	0.0	0.0	0.0	1.6	9.6	1.0	0.1	0.0	0.0	0.0	0.2	0.2	0.7	0.5	0.1	3.4	0.0	0.1	1.2	224.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.9	0.1	3.1	0.0	0.0	6.1	0.5	0.0	8.0	0.1	1.1	0.0	0.3	4.9	0.5	0.0	0.1	0.3	0.0	4.0	1.4	0.3	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0
STAM2	Hbp	ENSG00000115145	"Signal transducing adaptor molecule 2"	O75886	2	152116801-152175992	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035528, HPA035529"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA035528: AB_10601606, HPA035529: AB_10672868"	"unprognostic (1.53e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	17.8	19.1	17.2	12.4	19.9	4.9	21.3	16.1	19.5	19.6	16.7	17.6	17.2	15.1	18.5	16.0	17.8	21.6	15.6	16.1	15.3	15.4	24.6	17.8	17.6	13.0	19.9	14.4	20.6	20.5	23.1	34.0	16.7	20.4	22.1	18.4	14.5	19.5	19.3	14.3	17.6	19.6	19.8	20.0	14.0	18.8	24.3	21.2	16.0	23.8	13.2	14.7	19.5	16.6	2.3	3.3	14.0	6.5	2.5	2.2	1.7	5.4	5.2	4.9	5.9	12.9	15.4	5.3	11.3	13.0	7.3	9.3	5.2	5.2	7.1	9.0	16.0	5.5	5.4	10.4	11.8	8.7	4.3	5.1	3.7	7.8	14.8	7.4	10.0	11.8	10.0	13.6	18.4	7.8	3.3	5.0	14.9	5.3	3.9	5.8	3.0	7.6	3.2	6.0	3.8	11.4	9.3	2.6	4.0	6.2	5.6	9.3	7.5	6.9	10.2	16.3	5.3	12.8	6.8	4.2	4.3	4.6	12.4	6.0	8.9	14.0	3.5	4.4	1.9	4.7	1.8	1.7	2.0	2.0	2.7	2.3	1.7	2.1	8.8	2.5	6.5	3.3	2.2	1.7	17.2	19.9	16.1	19.5	15.3	15.4	19.9	14.4	20.4	21.2
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 158.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			11000	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: "	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	12.9	12.8	22.1	13.9	23.0	10.5	17.8	20.1	21.8	18.1	18.4	35.0	13.6	17.8	23.1	15.4	22.7	16.5	14.7	19.0	23.3	21.2	19.6	16.9	13.4	15.3	33.0	14.3	16.3	15.1	20.9	17.8	20.6	26.3	20.2	20.7	14.6	18.3	15.7	30.1	14.4	25.2	19.0	54.7	13.8	15.6	13.3	22.3	18.4	20.1	15.9	19.0	16.8	16.4	17.6	16.9	27.8	17.8	16.7	20.7	12.3	5.3	6.2	4.9	4.5	4.6	5.5	5.6	3.3	4.5	6.0	5.8	10.3	5.1	4.4	5.2	2.7	4.2	5.2	11.5	6.9	7.8	5.9	6.0	4.3	8.0	6.4	4.9	7.2	4.4	8.3	7.1	10.3	3.5	6.5	6.8	158.8	6.5	7.6	4.4	7.8	3.3	5.3	12.9	6.3	6.5	6.0	9.0	6.6	4.0	4.9	6.9	4.6	2.9	3.1	5.4	6.5	3.3	5.8	6.5	6.2	3.4	6.7	5.3	6.3	22.6	16.2	27.8	14.4	17.8	15.4	17.6	16.7	14.0	16.9	16.2	17.5	13.2	24.1	16.7	15.7	16.4	20.7	12.3	22.1	23.0	20.1	21.2	23.3	21.2	33.0	14.3	26.3	22.3
STARD10	"CGI-52, NY-CO-28, PCTP2, SDCCAG28"	ENSG00000214530	"StAR related lipid transfer domain containing 10"	Q9Y365	11	72754729-72794168	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 130.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 34.5;Hep G2: 35.2;MCF7: 100.1;SK-BR-3: 71.7;T-47d: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026661	Uncertain		Supported	Cytosol				Cytosol		"HPA026661: AB_1857538"	"prognostic favourable (6.92e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.04e-1)"	4.5	34.0	11.3	6.8	16.0	2.0	16.0	17.6	15.9	18.6	42.8	5.5	16.6	11.5	6.5	26.2	10.9	6.2	28.7	15.5	10.3	6.8	11.1	130.6	10.0	3.1	10.6	5.4	8.2	47.3	16.4	9.5	22.6	10.1	17.6	46.0	9.1	21.7	12.1	15.0	12.7	15.0	6.7	4.4	4.6	47.4	40.0	14.8	3.3	21.3	12.0	9.3	7.8	10.2	2.9	2.0	15.8	1.8	5.6	1.3	0.6	8.2	2.5	1.3	4.8	1.6	1.6	16.6	0.9	4.3	2.9	2.9	34.5	6.1	0.7	2.8	3.1	5.2	3.9	7.7	3.4	4.5	1.5	0.9	1.8	35.2	6.1	0.2	1.5	1.1	21.5	3.2	4.5	2.9	1.9	3.6	0.6	100.1	0.7	1.8	0.5	3.4	0.7	2.2	0.5	3.9	10.1	2.2	1.6	1.4	71.7	10.2	39.5	1.0	2.1	2.9	1.9	1.0	1.6	3.6	3.0	1.2	0.7	0.9	0.9	7.9	1.8	11.4	1.2	0.9	1.0	2.9	1.1	1.3	0.8	2.3	1.1	1.3	15.8	5.6	0.4	2.0	1.2	0.6	11.3	16.0	17.6	15.9	10.3	6.8	10.6	5.4	10.1	14.8
STARD5	MGC10327	ENSG00000172345	"StAR related lipid transfer domain containing 5"	Q9NSY2	15	81309053-81324183	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 7.6;RPMI-8226: 7.6;U-266/70: 9.3;U-937: 8.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 20.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040662	Approved		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA040662: AB_10959593"	"unprognostic (5.35e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.84e-3)"	"unprognostic (7.55e-3)"	2.8	1.0	1.2	8.6	1.5	5.9	2.7	20.8	3.4	14.3	7.7	1.5	6.6	3.5	7.3	22.3	9.2	4.3	4.4	1.9	1.0	1.1	1.4	59.6	4.3	11.1	1.1	1.0	3.2	1.1	0.6	1.0	9.3	1.2	6.1	5.9	1.5	3.2	6.6	0.9	12.4	7.7	3.6	1.9	10.8	3.3	4.4	1.4	1.7	2.5	10.6	9.8	6.1	7.9	2.1	4.8	6.9	4.6	4.8	7.6	5.6	0.4	0.1	0.1	1.2	2.9	3.1	0.2	0.4	0.4	1.0	1.6	0.1	0.1	6.0	0.0	1.8	5.1	1.4	1.2	0.8	0.1	0.5	2.3	0.3	0.5	0.6	3.4	7.6	2.5	2.5	0.3	0.8	0.1	0.7	1.7	0.6	0.2	0.6	4.9	0.4	0.0	0.1	0.9	7.6	0.4	1.7	0.4	0.1	0.2	0.7	0.7	0.7	0.8	0.2	1.7	0.9	1.7	0.1	9.3	1.9	2.4	1.2	8.6	0.5	6.9	3.0	4.2	5.8	4.6	5.0	2.1	5.4	6.1	4.8	1.6	7.6	7.5	2.4	4.8	4.0	2.5	6.3	5.6	1.2	1.5	20.8	3.4	1.0	1.1	1.1	1.0	1.2	1.4
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190964358-191020960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 88.9;BJ hTERT+ SV40 Large T+ RasG12V: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol			22000	"Nucleoplasm, Cytosol"		"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favourable (1.75e-4)"	"prognostic unfavourable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	27.9	27.2	17.4	47.8	17.8	19.5	20.4	15.0	21.7	21.0	19.8	14.9	17.5	22.7	17.1	27.4	23.3	14.5	29.0	25.5	15.6	22.2	34.9	35.7	29.4	57.9	16.9	18.8	24.3	18.7	20.0	24.0	24.3	23.6	23.6	20.3	17.9	47.5	18.0	20.1	17.4	24.6	24.8	21.8	49.0	24.2	13.5	10.4	58.7	36.2	18.5	30.2	29.3	16.5	10.8	16.2	55.0	47.1	22.7	54.1	44.6	8.8	9.4	4.4	7.4	19.5	26.4	14.4	13.4	41.1	88.9	100.1	14.9	10.2	3.6	8.5	28.7	7.5	5.0	10.7	17.6	30.1	4.1	16.3	7.4	8.7	13.6	8.4	10.2	17.5	6.8	16.4	5.8	10.7	8.9	21.6	16.3	7.2	6.3	10.6	6.2	15.5	5.3	12.1	4.4	11.7	11.0	6.2	6.0	15.8	6.0	41.2	6.3	10.4	9.4	17.7	10.4	15.3	8.6	36.8	53.8	3.4	13.5	7.2	8.1	13.0	36.9	27.0	14.7	47.1	19.9	10.8	35.1	21.0	16.2	8.6	35.8	26.0	55.0	22.7	27.6	7.4	54.1	44.6	17.4	17.8	15.0	21.7	15.6	22.2	16.9	18.8	23.6	10.4
STAT2	STAT113	ENSG00000170581	"Signal transducer and activator of transcription 2"	P52630	12	56341597-56360155	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003858, HPA018888"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB003858: AB_562227, HPA018888: AB_1857550"	"unprognostic (3.03e-1)"	"unprognostic (8.59e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavourable (4.78e-13)"	"unprognostic (1.88e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.46e-3)"	30.8	14.7	10.4	24.2	20.8	11.9	18.4	21.3	18.6	21.4	13.8	39.8	12.2	15.1	24.0	12.6	13.9	16.7	23.0	11.6	10.9	9.2	12.8	25.7	22.1	19.9	27.3	13.3	22.9	13.1	18.3	28.0	18.7	29.1	15.8	15.1	24.5	18.7	12.4	10.6	15.2	17.3	22.9	29.2	29.4	13.9	7.0	22.1	19.9	20.3	7.6	23.1	24.2	16.7	6.6	8.5	8.2	16.9	3.5	6.8	8.1	4.7	2.5	5.9	4.7	30.5	21.1	9.6	8.6	30.4	34.0	33.6	3.5	6.3	6.2	8.0	13.8	6.5	6.9	5.0	6.7	5.2	2.1	9.4	4.7	3.5	20.9	2.1	9.1	31.5	4.5	7.7	7.7	7.9	5.1	17.4	10.9	2.8	3.2	2.6	1.8	3.3	3.0	7.0	4.9	6.9	6.9	1.7	3.5	12.2	6.7	12.7	6.3	5.3	5.2	11.8	4.2	4.0	1.5	13.8	10.0	3.2	10.9	2.7	4.0	8.2	11.2	7.6	5.8	16.9	5.8	3.7	5.7	5.9	8.5	6.6	4.4	3.7	5.7	3.5	12.6	7.6	6.8	8.1	10.4	20.8	21.3	18.6	10.9	9.2	27.3	13.3	29.1	22.1
STAT3	APRF	ENSG00000168610	"Signal transducer and activator of transcription 3"	P40763	17	42313324-42388568	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001671, CAB003859, HPA058603, CAB068241, CAB068242"	Supported		Supported	Nucleoplasm,Cytosol			220000	"Nucleoplasm, Cytosol"		"CAB003859: AB_347629, CAB068241: , CAB068242: , HPA001671: AB_1080102, HPA058603: "	"unprognostic (1.83e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	44.6	30.7	23.2	34.4	27.5	35.3	49.3	15.7	23.5	25.1	31.5	18.4	21.7	20.5	33.2	27.4	36.4	32.7	34.0	82.9	20.1	14.7	34.5	90.0	45.7	45.5	26.0	11.1	40.6	32.1	18.6	27.9	24.6	27.6	28.9	21.8	24.3	29.3	22.9	53.4	28.4	28.6	49.7	25.1	41.4	29.4	15.4	25.7	16.8	38.0	31.2	28.8	40.4	53.1	10.8	13.7	69.7	20.2	13.9	21.7	26.7	16.6	31.7	14.0	13.8	30.0	28.6	10.2	19.6	24.9	17.0	16.6	8.3	16.2	5.2	19.4	19.4	25.5	12.7	20.0	13.9	43.0	8.7	36.2	19.3	17.1	22.2	8.8	23.6	44.6	19.7	13.5	19.6	23.0	22.2	16.6	11.2	11.8	32.6	8.8	8.1	0.0	7.2	37.4	7.7	26.9	21.7	12.9	8.4	22.6	53.6	8.1	28.1	13.3	19.4	26.3	13.5	15.6	16.0	25.7	20.0	4.4	16.3	9.4	11.6	26.2	19.4	24.9	21.7	20.2	17.3	10.8	16.0	16.8	13.7	10.4	16.6	15.8	69.7	13.9	18.7	7.5	12.0	26.7	23.2	27.5	15.7	23.5	20.1	14.7	26.0	11.1	27.6	25.7
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.3;HEL: 38.3;HMC-1: 22.3;K-562: 63.7;MOLT-4: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Approved		Enhanced	Nucleoplasm,Cytosol			140000	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: , HPA049883: , HPA051156: "	"prognostic favourable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	44.0	21.5	3.6	16.5	8.1	30.0	24.1	3.4	4.0	12.6	12.8	6.3	10.5	5.1	11.0	11.4	11.6	9.6	15.3	9.8	3.9	4.7	8.9	5.5	12.8	26.7	9.1	3.2	15.6	8.3	1.9	7.0	11.3	6.1	13.9	5.8	11.9	11.9	11.7	18.3	9.7	11.6	13.6	7.4	17.3	7.9	8.5	6.1	21.9	8.6	9.1	17.0	19.9	20.2	7.2	15.0	15.2	18.5	14.3	16.2	8.8	1.0	1.2	0.1	0.0	9.1	4.4	0.0	0.5	2.0	1.0	0.6	0.1	1.0	0.0	2.3	2.0	0.0	0.2	0.0	0.2	25.3	0.0	38.3	2.9	0.3	3.7	3.2	22.3	10.2	0.7	0.3	0.5	3.0	63.7	0.0	0.5	0.1	46.2	18.2	0.3	0.0	1.1	0.3	3.3	0.3	0.7	0.1	0.0	2.3	1.1	4.2	0.7	4.1	1.7	2.3	0.6	1.1	0.0	0.0	0.0	0.0	0.2	6.2	0.5	6.8	11.8	5.9	9.1	15.1	12.8	7.2	15.8	13.2	15.0	6.7	16.2	13.0	15.2	14.3	18.5	5.7	11.2	8.8	3.6	8.1	3.4	4.0	3.9	4.7	9.1	3.2	6.1	6.1
STAT6	"D12S1644, IL-4-STAT"	ENSG00000166888	"Signal transducer and activator of transcription 6"	P42226	12	57095408-57132139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001861	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA001861: AB_1080106"	"unprognostic (3.43e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.37e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.55e-1)"	"prognostic favourable (7.76e-4)"	"prognostic favourable (1.14e-4)"	33.6	34.9	10.4	35.9	12.8	12.8	27.9	4.6	11.6	37.8	47.3	6.2	28.4	23.9	44.5	26.6	40.8	31.8	33.8	20.9	10.2	3.9	35.0	31.0	34.9	25.2	13.3	12.0	41.9	21.2	18.1	9.2	22.0	9.8	42.3	26.2	23.3	30.1	26.5	11.4	39.1	59.4	43.8	12.2	48.4	32.1	13.3	7.9	29.3	31.1	24.4	42.8	43.1	34.0	6.2	9.6	27.6	13.0	4.7	5.9	14.0	16.8	16.8	4.1	6.8	41.0	39.8	11.9	13.4	29.5	14.9	10.9	7.6	22.9	40.4	21.0	29.7	23.5	5.1	26.0	11.0	18.1	1.9	9.3	17.9	9.4	24.5	10.7	30.5	55.4	21.5	18.1	16.1	26.3	6.5	5.7	19.2	5.7	11.7	12.0	6.3	3.4	13.6	0.3	13.7	25.8	28.1	0.1	0.4	12.5	10.5	12.6	15.6	24.7	21.8	0.3	8.8	15.5	0.2	0.1	0.4	10.1	13.5	10.5	17.9	9.8	12.5	6.8	5.9	13.0	5.2	6.2	4.8	4.8	9.6	6.2	4.7	4.3	27.6	4.7	11.0	4.6	4.9	14.0	10.4	12.8	4.6	11.6	10.2	3.9	13.3	12.0	9.8	7.9
STAU1	"PPP1R150, STAU"	ENSG00000124214	"Staufen double-stranded RNA binding protein 1"	O95793	20	49113339-49188367	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020839, HPA049892"	Approved		Supported	Cytosol				Cytosol		"CAB020839: , HPA049892: "	"unprognostic (7.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.17e-3)"	"prognostic unfavourable (4.41e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-2)"	30.8	34.2	33.3	32.6	30.8	34.9	59.4	28.7	38.3	28.7	35.7	31.4	24.3	34.3	34.1	25.2	31.1	43.2	31.2	37.4	30.0	27.1	55.7	77.1	30.9	26.9	33.9	28.8	31.2	44.4	58.1	20.9	31.1	39.7	30.9	30.7	26.0	31.3	31.5	51.0	30.1	38.8	34.8	45.4	25.3	33.1	28.6	28.8	39.1	48.6	20.6	28.6	45.6	36.7	14.0	13.1	29.9	15.0	11.1	17.4	9.9	25.8	19.8	21.6	9.5	22.0	27.4	24.1	19.7	23.7	59.1	26.9	67.5	28.6	17.7	34.1	24.6	28.5	28.8	35.2	49.8	6.9	16.6	14.5	15.4	53.6	18.6	11.7	14.3	21.9	30.3	24.0	28.2	28.9	25.2	11.1	22.3	16.5	20.4	19.5	17.7	27.8	15.7	28.5	17.1	24.2	22.8	25.1	22.3	49.0	47.3	28.5	30.1	16.9	26.3	35.8	31.1	22.0	23.3	10.0	11.5	20.2	26.2	12.6	20.6	19.6	15.0	14.6	14.9	12.5	16.7	14.0	16.0	15.8	13.1	13.0	14.8	13.9	29.9	11.1	14.5	12.5	17.4	9.9	33.3	30.8	28.7	38.3	30.0	27.1	33.9	28.8	39.7	28.8
STAU2	39K2	ENSG00000040341	"Staufen double-stranded RNA binding protein 2"	Q9NUL3	8	73420369-73747708	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019155, CAB020836"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB020836: , HPA019155: AB_1857565"	"unprognostic (5.75e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.62e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.25e-2)"	17.8	15.0	25.5	10.3	24.4	14.0	11.7	27.2	46.1	10.8	12.1	13.2	8.4	9.3	11.9	12.8	22.6	11.0	15.7	42.7	24.3	23.0	18.9	15.9	11.4	11.0	27.9	15.4	12.2	10.2	17.8	19.9	11.1	27.3	13.9	12.0	10.0	13.0	14.0	60.3	9.5	15.4	14.9	18.1	13.3	10.1	10.3	16.3	18.6	14.7	21.3	13.4	14.8	10.4	11.9	15.9	26.1	13.3	27.6	19.2	7.9	12.4	14.8	23.7	13.0	13.9	10.1	7.3	11.4	10.5	10.3	13.8	5.9	13.5	19.8	11.8	8.9	10.2	16.1	10.7	15.4	20.2	8.1	26.9	7.9	9.4	7.4	10.1	9.8	7.0	8.4	8.8	5.8	20.3	18.1	9.4	13.9	8.5	56.0	8.1	11.9	9.8	16.1	11.3	17.3	22.2	13.9	9.1	15.1	6.0	16.7	10.1	19.2	12.1	15.7	10.4	17.8	10.1	8.4	14.8	14.1	19.0	11.5	15.6	8.1	13.9	11.7	26.1	19.2	11.4	14.6	10.1	13.1	16.4	11.6	11.9	11.7	15.1	19.8	27.6	13.3	15.9	15.9	7.9	25.5	24.4	27.2	46.1	24.3	23.0	27.9	15.4	27.3	16.3
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.7;Karpas-707: 30.9;U-266/70: 19.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Supported	Cytosol				Cytosol		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.7	1.8	0.2	2.4	5.2	1.4	3.3	4.1	2.5	1.6	1.9	1.7	4.4	0.0	3.3	2.7	2.3	0.7	0.9	0.6	14.7	1.0	0.2	2.2	2.2	0.7	2.1	2.7	0.8	2.6	1.3	0.6	0.0	0.1	30.9	2.8	2.4	0.2	1.7	0.4	2.0	0.0	0.8	2.5	0.9	1.8	0.8	4.3	3.2	4.1	0.0	1.1	0.7	0.7	3.1	2.0	7.3	2.3	19.9	3.6	0.0	4.3	1.3	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4										
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Predicted membrane proteins"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 82.3;parathyroid gland: 47.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.9;U-87 MG: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol			28000	Cytosol	Nucleoli	"HPA050510: "	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	8.1	2.8	2.5	1.2	4.2	5.1	9.2	3.0	2.2	6.4	6.1	3.0	3.7	7.9	1.3	3.1	5.1	4.0	2.8	6.6	2.9	1.4	3.4	82.3	3.9	4.9	3.9	0.4	5.2	9.0	47.4	5.1	4.3	6.1	4.8	2.4	2.1	12.6	9.1	10.9	3.0	9.8	0.9	6.4	1.0	6.7	1.5	3.2	0.2	3.3	6.9	4.0	4.2	3.7	0.8	7.0	0.7	4.3	2.1	0.2	1.5	6.5	7.9	0.0	2.7	3.9	36.9	7.0	2.1	2.3	4.2	3.8	6.0	9.0	0.0	15.9	11.9	11.2	3.4	6.9	4.7	0.0	11.2	12.8	7.1	11.7	9.7	3.1	2.4	21.8	12.2	24.7	8.9	3.6	6.2	1.3	11.7	6.2	0.0	1.8	10.8	16.5	0.0	4.6	5.6	5.1	16.7	13.3	2.4	5.8	20.2	1.5	4.0	4.2	15.3	26.0	15.3	5.5	11.4	0.0	0.0	0.0	47.8	8.1	5.4	0.0	4.0	0.7	0.2	4.3	0.0	0.8	0.0	0.0	7.0	0.2	0.0	0.0	0.1	2.1	0.6	0.3	0.0	1.5	2.5	4.2	3.0	2.2	2.9	1.4	3.9	0.4	6.1	3.2
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL, centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.0;testis: 23.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046543			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA046543: "	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.2	1.4	1.3	10.8	2.4	11.0	2.9	1.4	2.2	1.2	4.1	0.9	2.5	3.6	1.5	2.2	5.8	0.9	1.7	2.0	1.4	1.2	1.5	1.6	1.7	5.0	1.3	1.5	1.2	1.5	0.9	0.9	5.5	1.1	1.7	6.4	0.8	3.6	0.5	0.8	4.2	4.0	1.3	1.2	3.4	2.2	23.8	1.0	36.0	1.1	3.5	7.1	1.3	2.1	1.9	1.6	5.4	0.7	3.3	1.2	0.5	16.9	9.1	13.1	11.7	0.9	2.3	8.3	15.0	7.2	16.8	17.7	9.8	8.4	20.0	7.1	7.4	11.3	15.3	7.8	18.1	14.9	6.9	22.5	11.3	8.6	0.5	18.1	11.5	0.8	1.3	14.4	9.4	11.1	15.9	19.0	12.6	7.7	17.6	5.7	15.8	7.5	11.5	21.3	9.6	4.7	10.2	11.7	7.0	16.1	11.9	7.7	7.7	10.4	6.5	15.8	16.1	11.4	20.2	6.3	13.0	19.6	7.4	13.9	14.7	4.3	0.7	1.1	1.1	0.4	0.5	1.7	1.2	1.0	0.5	1.9	0.8	0.8	5.4	3.3	0.3	1.6	1.1	0.5	1.3	2.4	1.4	2.2	1.4	1.2	1.3	1.5	1.1	1.0
STIMATE	"MGC52022, TMEM110"	ENSG00000213533	"STIM activating enhancer"	Q86TL2	3	52836219-52897596	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA051855	Uncertain		Approved	Cytosol				Cytosol		"HPA051855: "	"unprognostic (1.45e-1)"	"unprognostic (7.93e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.55e-4)"	"unprognostic (3.34e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	12.0	13.0	8.9	12.0	13.9	26.4	12.8	11.6	16.1	12.5	10.7	17.8	8.8	7.8	14.4	7.9	9.2	17.7	9.6	8.3	9.5	6.7	9.9	34.7	15.2	18.1	9.9	8.1	12.2	19.2	7.7	8.9	7.8	13.0	10.2	6.7	13.0	12.8	11.5	17.9	10.5	10.1	16.5	10.2	14.9	11.2	8.4	9.5	18.0	11.8	6.8	13.2	12.5	12.5	1.7	4.0	1.7	5.8	0.7	4.6	1.4	6.8	5.9	9.1	15.7	20.7	13.1	18.3	10.0	11.2	13.6	12.4	7.3	7.1	6.7	2.0	11.4	6.4	10.7	9.7	9.5	14.7	8.2	10.8	7.5	11.2	13.8	16.2	8.3	10.4	13.5	15.1	6.8	11.0	3.7	6.7	11.3	5.6	8.8	9.1	8.2	12.2	4.8	7.0	4.5	6.4	8.8	2.0	6.8	10.1	6.9	9.4	5.9	14.1	11.1	10.8	6.4	14.1	11.8	12.9	8.3	6.2	9.4	16.4	8.2	0.0	3.3	1.7	2.2	5.8	1.8	1.7	3.5	2.4	4.0	1.5	1.9	1.4	0.3	0.7	5.5	2.3	4.6	1.4	8.9	13.9	11.6	16.1	9.5	6.7	9.9	8.1	13.0	9.5
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 168.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			3700000	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.23e-4)"	"prognostic unfavourable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	27.3	49.7	32.2	32.0	40.5	25.8	41.5	45.3	41.9	28.3	25.5	29.2	20.6	19.2	30.1	25.2	31.5	36.2	21.6	34.4	32.2	42.8	24.7	27.8	25.4	31.9	47.7	22.5	34.1	24.1	39.1	38.3	37.0	40.7	30.1	28.5	20.3	22.6	29.5	51.9	27.6	20.7	33.2	39.7	26.5	24.4	56.4	49.0	29.8	46.1	23.4	41.2	26.0	168.2	32.2	26.8	20.9	39.6	39.5	35.9	39.5	49.0	76.6	48.4	40.3	27.0	18.0	43.6	44.6	24.0	64.8	37.8	56.1	42.1	58.7	52.5	35.3	52.1	121.3	44.7	71.3	46.1	49.5	82.7	51.5	51.5	23.5	43.6	52.3	18.2	28.1	53.6	40.5	45.6	81.6	33.8	37.2	71.8	65.6	59.5	58.3	64.8	64.5	46.1	59.5	45.2	43.5	39.5	35.1	50.9	53.9	41.4	57.2	30.2	40.9	41.2	51.0	53.8	60.0	30.8	66.5	62.0	53.4	43.9	59.3	19.0	25.3	20.9	35.9	36.2	35.7	32.2	27.2	32.0	26.8	26.0	30.5	33.8	7.7	39.5	39.6	22.2	24.0	39.5	32.2	40.5	45.3	41.9	32.2	42.8	47.7	22.5	40.7	49.0
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228435	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: "	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favourable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favourable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	13.4	13.7	13.5	11.8	12.4	19.3	16.7	17.8	16.0	12.2	16.1	8.3	19.8	18.1	10.8	8.7	15.1	10.0	11.8	15.3	12.6	9.8	10.7	22.1	9.4	12.5	9.7	10.4	11.0	16.8	10.7	11.6	12.2	9.9	12.2	5.3	11.9	16.0	12.2	49.2	16.8	18.0	7.7	7.6	16.9	15.5	59.8	7.5	11.8	12.4	14.5	19.0	11.4	9.8	2.7	1.9	11.7	6.3	1.9	1.8	0.5	21.1	10.2	7.8	14.7	7.4	6.7	16.5	10.3	10.8	9.7	10.4	8.3	14.8	13.9	11.5	10.8	13.7	7.6	15.9	3.0	25.9	18.7	14.2	0.6	10.5	15.9	14.2	23.8	12.2	11.6	7.5	11.1	9.7	26.5	19.1	5.5	15.8	13.7	14.4	14.9	12.6	21.7	8.3	15.5	8.8	15.5	18.1	13.0	0.0	7.7	11.1	12.1	23.4	13.1	10.1	11.4	19.7	16.4	37.6	15.8	10.4	10.0	19.0	10.3	2.0	4.2	4.5	0.6	6.0	0.4	2.7	1.0	1.8	1.9	1.0	1.0	0.9	11.7	1.9	6.3	1.0	0.7	0.5	13.5	12.4	17.8	16.0	12.6	9.8	9.7	10.4	9.9	7.5
STK16	"MPSK, PKL12"	ENSG00000115661	"Serine/threonine kinase 16"	O75716	2	219245455-219250337	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029450	Approved		Approved	Cytosol				Cytosol		"HPA029450: AB_10603118"	"unprognostic (1.99e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.84e-2)"	"prognostic favourable (6.09e-4)"	"unprognostic (6.21e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	10.2	19.0	15.7	12.8	20.3	13.3	14.6	8.8	21.0	11.5	16.2	15.2	20.5	17.2	11.4	22.1	16.0	18.3	15.5	13.0	14.5	11.9	19.5	30.1	11.4	24.6	14.2	13.2	13.2	24.5	16.5	15.1	14.0	13.3	14.3	13.7	12.8	19.0	16.3	9.9	12.2	14.2	11.5	12.3	15.9	16.8	18.9	12.7	27.2	19.8	12.8	17.0	12.9	10.3	7.9	7.8	5.8	7.6	14.5	11.2	9.7	7.3	9.6	8.4	7.2	21.2	20.7	9.7	9.5	13.1	8.1	8.1	11.2	16.4	4.2	13.3	15.7	7.6	9.8	15.7	4.3	10.4	11.4	9.6	8.7	9.6	19.2	9.1	11.2	22.0	25.3	11.1	29.4	9.8	11.9	11.6	13.8	13.5	9.9	19.8	7.9	5.9	9.3	9.5	12.4	16.8	8.5	6.8	8.7	3.4	13.5	19.3	14.1	19.2	7.5	11.0	7.8	8.9	9.0	14.3	6.1	10.1	12.2	9.6	9.6	2.0	7.6	5.8	6.0	4.2	6.8	7.8	7.5	11.2	7.8	7.9	7.8	10.0	5.2	14.5	3.6	6.7	8.4	9.7	15.7	20.3	8.8	21.0	14.5	11.9	14.2	13.2	13.3	12.7
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 35.5;HMC-1: 36.0;Karpas-707: 33.4;U-698: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 71.1"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	21.0	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5.0	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6.0	4.6	1.4	72.2	7.5	7.0	56.2	11.3	6.0	16.9	13.6	62.0	27.0	10.3	28.4	19.0	3.1	2.2	3.3	1.2	14.7	5.6	3.7	7.6	11.4	8.3	8.7	6.6	1.1	35.5	7.0	4.3	2.2	1.4	3.2	10.2	6.2	3.8	3.3	2.8	0.6	4.4	13.4	36.0	7.1	3.2	10.3	5.4	3.4	2.6	33.4	20.6	1.7	17.4	30.4	1.9	5.1	2.9	20.3	10.7	4.9	7.5	1.2	1.3	1.9	1.9	1.6	1.3	7.0	4.1	8.1	4.0	5.8	4.2	13.7	22.2	38.7	6.1	4.6	3.6	35.9	19.7	40.2	12.0	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62.0	10.3	27.0	9.7	18.5	19.0	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol			2800000	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavourable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favourable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	28.6	14.2	15.0	29.7	16.9	19.1	34.8	12.2	21.0	36.3	37.4	12.1	23.0	31.9	24.6	26.5	68.4	20.4	41.3	30.0	14.7	12.8	30.5	14.2	23.9	31.2	10.6	10.1	20.0	20.6	12.4	13.9	38.4	14.7	28.3	28.8	36.8	30.8	21.6	18.8	60.6	67.9	34.8	9.2	31.7	30.2	22.1	7.6	38.2	28.2	41.6	48.5	39.2	45.4	8.1	11.2	11.4	13.4	1.5	13.7	6.7	36.0	11.2	20.0	18.5	30.8	18.4	28.4	16.9	23.8	23.7	23.2	32.9	49.0	25.7	8.6	21.1	32.7	18.5	37.2	22.7	64.0	9.5	27.4	14.4	18.8	43.5	27.6	19.5	11.9	59.5	18.6	54.8	20.3	9.9	17.8	15.5	15.7	20.6	11.4	17.9	8.5	26.1	12.3	13.9	22.8	32.6	11.7	16.8	10.7	17.2	22.8	20.8	26.9	27.4	15.1	11.0	12.3	19.4	17.4	9.1	9.6	23.5	16.7	24.8	5.8	13.4	6.1	6.1	10.6	7.2	6.6	11.4	8.7	11.2	8.1	7.8	6.1	11.4	1.5	12.7	7.5	13.7	6.7	15.0	16.9	12.2	21.0	14.7	12.8	10.6	10.1	14.7	7.6
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023265-132075943	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: "	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	5.4	1.4	1.1	13.5	5.1	25.9	3.3	3.8	1.1	18.0	6.4	0.3	34.8	3.7	42.3	29.6	11.7	6.0	5.2	1.9	1.2	2.3	3.5	3.2	6.7	12.8	1.2	0.3	4.7	4.0	10.2	5.8	50.7	1.2	11.5	4.8	2.2	6.3	22.4	1.2	5.1	6.1	19.1	1.5	8.5	4.7	5.2	0.8	44.7	2.3	6.8	10.2	18.0	6.6	8.4	6.2	26.4	11.6	22.0	13.3	10.2	9.0	3.1	0.3	0.0	1.5	1.4	20.7	0.3	1.1	0.1	0.1	8.3	8.2	12.3	5.6	2.0	10.3	23.0	14.4	0.0	10.6	18.8	17.7	7.8	7.8	1.4	37.0	1.4	2.0	8.6	0.0	9.8	4.0	7.8	11.6	3.4	7.9	38.0	34.4	18.4	1.2	27.5	11.4	15.8	9.3	14.5	7.7	8.5	5.4	4.9	0.2	6.3	9.8	0.1	3.7	4.0	11.2	13.2	8.9	14.0	13.7	3.4	40.3	1.8	26.4	5.1	16.6	13.3	6.7	13.0	8.4	9.1	11.3	6.2	7.3	11.8	12.2	10.0	22.0	11.6	2.3	4.0	10.2	1.1	5.1	3.8	1.1	1.2	2.3	1.2	0.3	1.2	0.8
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 34.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;HEK 293: 12.0;Karpas-707: 13.2;SCLC-21H: 14.8;U-251 MG: 14.9;U-266/84: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 7.1;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: "	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favourable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	0.9	6.1	4.7	1.6	7.5	1.1	0.6	6.1	4.4	5.4	5.3	6.8	7.7	2.6	9.6	15.3	2.3	30.7	4.5	11.4	6.6	6.1	7.7	0.4	5.3	2.3	4.9	2.7	10.3	4.6	20.4	29.9	0.3	17.7	5.3	1.3	14.8	1.6	8.9	2.6	0.3	2.5	7.0	6.7	1.2	4.4	34.4	4.6	4.5	14.6	1.5	1.8	3.7	1.4	7.1	0.7	0.0	0.0	0.2	1.4	0.3	0.0	2.0	9.8	0.0	0.0	0.0	0.0	1.7	1.9	4.2	3.9	1.2	0.0	14.1	7.4	0.3	0.0	4.3	1.3	3.7	0.0	12.0	0.0	2.6	3.3	1.6	7.8	0.0	0.4	0.0	0.1	0.0	0.3	0.0	13.2	0.1	0.0	0.3	0.0	7.0	0.0	5.3	1.3	8.9	3.8	0.0	14.8	3.9	0.0	0.0	0.1	0.0	0.8	0.0	0.0	6.7	0.1	14.9	3.1	12.5	0.2	4.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.1	0.0	1.4	0.0	4.4	0.0	1.1	0.0	0.2	0.0	0.7	0.2	0.3	4.7	7.5	6.1	4.4	6.6	6.1	4.9	2.7	17.7	4.6
STK36	"FU, KIAA1278"	ENSG00000163482	"Serine/threonine kinase 36"	Q9NRP7	2	218672026-218702716	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027409, HPA027453, HPA030058"	Approved		Supported	Cytosol				Cytosol		"HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225"	"unprognostic (8.11e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (5.20e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.83e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-3)"	4.8	10.0	7.5	4.7	11.4	2.0	6.4	7.9	11.1	9.1	7.4	7.0	11.9	4.1	14.4	13.3	5.0	13.9	9.8	3.3	6.3	3.5	10.1	4.4	6.9	3.9	2.3	6.6	13.6	9.7	12.3	23.2	3.9	7.6	9.5	6.3	9.3	7.3	8.3	3.3	4.6	5.8	7.8	5.5	4.9	7.9	63.2	4.2	3.5	11.4	3.7	5.0	9.3	7.1	1.8	1.6	3.2	1.9	2.2	1.6	1.7	2.7	6.4	14.0	11.9	15.2	11.9	8.5	7.6	6.1	9.7	9.2	8.3	4.6	3.7	10.6	7.9	5.6	9.5	7.9	8.6	1.6	7.9	3.6	19.1	11.4	7.4	5.0	6.1	12.8	5.9	9.5	6.8	7.2	8.3	4.7	8.0	6.4	3.0	6.3	8.4	4.1	5.6	6.0	3.7	11.9	14.0	11.4	9.7	5.9	9.6	3.9	9.8	4.1	6.9	13.5	5.0	5.1	5.2	6.0	4.6	1.9	8.4	2.4	5.6	0.0	1.9	3.2	1.5	1.2	0.9	1.8	1.1	1.3	1.6	0.6	1.1	1.6	0.2	2.2	1.4	1.3	1.0	1.7	7.5	11.4	7.9	11.1	6.3	3.5	2.3	6.6	7.6	4.2
STK38	NDR	ENSG00000112079	"Serine/threonine kinase 38"	Q15208	6	36493892-36547470	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol				Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: "	"unprognostic (3.58e-3)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (9.44e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.13e-3)"	19.1	8.4	12.4	39.8	10.0	19.4	32.8	18.8	12.7	16.0	26.3	7.8	14.9	17.0	18.8	16.4	28.1	14.6	18.3	15.3	12.1	7.0	15.0	17.3	21.7	45.9	11.9	6.4	12.3	9.5	7.8	11.0	15.4	9.0	17.0	27.1	11.3	24.8	18.7	14.9	21.8	29.1	28.1	13.1	25.1	16.4	24.4	11.0	34.3	10.6	13.4	28.5	22.4	19.8	10.6	13.1	33.2	30.5	25.8	27.6	22.4	17.6	13.0	13.8	14.8	27.9	21.3	12.0	19.7	16.0	20.5	20.7	10.0	12.1	23.7	15.3	29.3	18.9	11.4	8.2	24.3	9.7	9.8	17.0	16.9	9.0	13.8	6.4	9.4	14.0	21.6	15.9	10.2	12.8	13.8	13.9	29.2	10.6	10.3	16.7	5.7	11.6	40.2	16.7	6.3	19.4	22.2	16.1	7.6	24.0	11.1	13.8	11.8	16.9	12.3	16.7	14.8	13.3	12.7	11.7	20.7	16.7	3.8	25.0	16.0	33.2	19.8	15.0	27.6	22.6	21.5	10.6	22.9	24.1	13.1	8.1	20.5	22.3	27.1	25.8	30.5	6.6	21.4	22.4	12.4	10.0	18.8	12.7	12.1	7.0	11.9	6.4	9.0	11.0
STK38L	"KIAA0965, NDR2"	ENSG00000211455	"Serine/threonine kinase 38 like"	Q9Y2H1	12	27243968-27325959	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 19.3;granulocytes: 32.2;monocytes: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038623, HPA051324"	Approved		Approved	Cytosol				Cytosol		"HPA038623: AB_10967059, HPA051324: "	"unprognostic (2.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (5.82e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.05e-2)"	21.2	8.4	11.0	14.6	10.9	10.9	27.2	9.6	14.6	13.0	26.3	5.7	9.7	8.4	23.9	18.2	16.8	14.8	18.2	30.2	10.9	7.8	8.9	8.5	10.8	7.8	11.1	11.8	9.6	8.9	30.2	15.2	10.6	11.9	15.3	15.0	6.8	14.0	10.9	9.1	10.8	14.6	52.3	17.0	7.6	15.6	7.5	10.1	10.0	8.8	10.5	9.8	21.9	22.7	4.5	19.3	32.2	13.0	4.0	4.0	5.3	4.1	5.7	14.9	6.6	6.8	4.7	11.0	2.7	3.9	1.7	2.4	7.2	3.1	9.7	6.4	2.3	7.8	6.7	4.6	2.7	56.9	5.5	6.0	6.9	3.6	5.7	14.7	7.0	5.6	4.8	6.3	8.1	13.7	7.3	7.7	3.4	3.0	9.7	16.0	17.6	8.7	3.6	17.3	7.5	2.5	8.0	2.4	7.9	12.0	7.4	4.6	3.6	5.0	5.4	5.9	5.2	8.4	7.3	2.8	2.7	10.2	2.9	6.9	2.4	6.0	13.0	22.9	4.0	11.1	2.8	4.5	3.1	3.9	19.3	3.4	3.8	3.1	32.2	4.0	8.1	8.2	4.0	5.3	11.0	10.9	9.6	14.6	10.9	7.8	11.1	11.8	11.9	10.1
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168248141	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: , HPA062802: "	"prognostic favourable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	6.2	2.1	8.4	4.6	11.0	1.3	3.5	9.3	14.1	4.3	9.1	8.3	1.7	10.5	2.3	4.7	14.1	1.9	5.9	7.6	9.8	7.4	2.9	0.8	2.4	7.3	12.3	9.7	3.2	9.9	5.0	8.2	1.2	14.2	9.9	11.7	7.1	22.8	3.8	2.2	3.4	6.1	4.3	19.0	2.5	11.2	35.5	5.5	7.2	2.2	1.8	8.0	5.6	5.3	0.7	1.0	0.0	0.7	1.9	3.4	0.5	6.6	4.0	15.2	4.8	9.4	13.8	1.5	16.7	12.3	11.2	10.4	0.0	21.6	18.3	4.6	10.8	17.3	9.7	12.2	14.1	5.8	6.0	7.6	4.4	13.5	17.4	10.2	0.8	9.5	17.3	13.3	13.9	7.6	0.1	0.0	23.4	3.8	17.7	3.6	10.5	8.5	25.4	6.0	1.5	8.4	16.5	22.5	9.5	5.8	0.8	6.8	3.0	7.5	7.1	13.6	4.2	9.6	10.9	0.0	0.0	14.7	10.3	9.1	9.1	0.0	0.7	0.0	2.5	0.4	1.3	0.7	1.9	3.4	1.0	0.7	0.4	2.0	0.0	1.9	0.3	0.3	3.3	0.5	8.4	11.0	9.3	14.1	9.8	7.4	12.3	9.7	14.2	5.5
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966474-45079959	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	9.5	8.8	10.4	24.5	11.5	39.5	8.1	7.5	13.4	7.8	8.6	10.3	5.4	8.1	9.3	6.5	8.9	7.3	9.4	6.1	9.3	8.8	6.3	7.4	18.8	30.6	10.5	9.1	8.3	6.4	5.9	9.3	8.2	7.7	7.5	10.6	7.4	9.3	8.7	4.2	11.4	16.1	8.2	12.0	29.1	9.6	7.4	9.6	32.3	8.0	4.9	36.6	11.5	8.7	10.8	6.9	40.6	13.3	10.3	14.5	7.9	11.6	7.9	10.1	7.2	6.2	7.8	7.0	10.3	15.8	17.5	15.9	22.4	6.4	28.6	9.0	7.3	12.4	10.7	13.8	22.5	12.8	5.7	20.8	11.6	15.7	10.9	26.7	29.6	6.3	11.4	16.4	17.9	6.4	9.6	16.5	8.8	9.2	19.9	18.1	6.2	5.4	12.9	11.2	13.3	6.4	8.0	4.8	5.9	15.3	8.9	11.7	8.1	16.9	8.2	13.2	12.9	15.2	11.9	21.6	16.9	31.8	12.9	12.8	9.7	24.4	7.6	20.5	14.5	7.7	14.4	10.3	13.8	13.3	6.9	10.8	14.3	11.9	40.6	10.3	13.3	3.9	13.3	7.9	10.4	11.5	7.5	13.4	9.3	8.8	10.5	9.1	7.7	9.6
STK40	"MGC4796, SgK495"	ENSG00000196182	"Serine/threonine kinase 40"	Q8N2I9	1	36339624-36385896	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 19.2;monocytes: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008026	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA008026: AB_1857603"	"unprognostic (3.32e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.69e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.96e-2)"	"prognostic favourable (5.59e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	22.9	7.2	9.8	15.3	9.4	9.2	26.5	8.9	11.1	10.2	19.1	7.4	16.7	9.4	11.8	12.2	22.3	11.3	18.2	25.6	10.0	7.1	14.3	23.5	16.6	15.4	13.1	7.4	22.2	34.4	9.2	14.7	19.2	12.1	15.7	9.1	9.0	25.1	17.7	53.9	17.2	10.8	26.0	10.3	17.2	17.0	32.0	8.9	9.2	14.6	20.7	16.6	19.5	26.6	2.4	2.7	19.2	8.5	1.6	2.9	2.4	7.0	3.1	15.6	16.2	11.1	6.4	8.8	7.2	9.8	8.7	9.4	17.1	10.2	30.0	5.9	6.7	7.1	14.2	3.1	6.4	13.0	11.1	19.6	2.9	21.8	11.0	11.4	26.2	5.8	11.8	6.7	3.5	5.4	24.0	10.9	5.4	11.1	11.8	15.1	10.0	4.3	13.6	10.6	19.9	5.4	8.0	19.1	9.7	5.5	8.7	23.9	5.9	13.5	9.0	5.5	11.5	16.1	15.8	11.4	6.4	25.3	28.6	10.0	18.0	1.0	3.0	4.9	2.6	6.7	2.9	2.3	1.7	1.7	2.7	2.4	1.0	1.5	19.2	1.6	8.5	2.6	1.0	2.4	9.8	9.4	8.9	11.1	10.0	7.1	13.1	7.4	12.1	8.9
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 143.4;lymphoid tissue: 117.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 79.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 79.3;T-cells: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010107	Enhanced		Supported	Cytosol			210000	Cytosol		"CAB010107: AB_628297"	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavourable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	7.3	13.2	91.7	17.5	47.4	40.7	10.9	54.1	124.8	6.2	16.7	47.0	2.5	12.7	24.7	7.8	13.0	7.3	9.4	9.5	67.9	88.4	13.2	6.4	11.0	42.8	86.5	58.0	33.6	3.5	4.6	12.1	21.7	43.4	5.2	20.7	7.7	5.3	6.3	3.8	9.5	15.9	18.8	143.4	10.9	9.7	58.2	27.1	117.1	6.1	7.2	43.1	13.0	8.1	8.6	79.3	4.0	1.5	10.1	26.2	9.3	67.5	15.2	151.7	60.6	9.1	8.8	15.4	52.7	41.9	75.3	72.9	10.4	69.5	83.1	29.6	38.4	20.7	42.0	30.5	113.3	25.1	20.8	51.5	26.9	36.3	3.6	64.8	36.8	5.4	4.5	30.3	34.6	56.6	69.5	82.9	97.5	17.6	213.2	95.3	93.0	20.5	126.2	118.3	49.3	36.4	6.1	102.8	89.2	47.9	24.0	42.0	34.4	82.6	27.2	50.6	60.1	43.8	43.9	48.9	77.6	103.2	24.9	126.8	54.5	2.0	0.7	4.0	10.4	1.5	6.3	6.4	9.3	13.1	4.2	8.6	15.3	13.7	0.3	10.1	0.7	79.3	26.2	9.3	91.7	47.4	54.1	124.8	67.9	88.4	86.5	58.0	43.4	27.1
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338988-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 104.0;hTCEpi: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"			140000000	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	96.0	27.5	29.3	29.7	41.6	89.2	78.6	15.0	19.4	28.7	46.4	23.2	14.6	14.4	35.7	26.7	34.9	28.2	45.2	46.4	27.2	18.5	35.4	114.4	66.0	40.2	24.2	15.1	31.5	11.8	21.0	11.3	77.0	28.1	36.8	16.7	27.7	23.0	28.3	50.6	25.4	25.0	50.4	37.8	48.3	34.5	17.4	23.3	4.4	29.6	25.1	16.1	56.6	51.8	1.4	8.6	5.2	13.2	33.2	43.4	25.8	1.4	9.7	0.8	4.4	104.0	29.9	0.0	25.9	25.7	7.3	11.5	1.2	1.9	11.8	6.4	32.2	2.5	5.4	24.0	13.0	7.2	2.2	27.4	21.3	3.7	56.4	10.1	5.8	49.5	85.0	11.4	15.2	26.0	5.9	15.8	15.8	7.7	0.3	7.7	11.8	3.0	1.4	0.0	25.6	5.7	0.2	1.0	0.1	21.6	19.2	11.1	6.5	8.4	33.0	16.9	5.3	16.8	2.4	6.7	7.3	0.7	6.5	10.2	9.0	3.4	8.5	0.9	43.4	13.2	42.8	1.4	22.0	38.9	8.6	1.1	4.1	22.0	5.2	33.2	9.0	1.5	2.0	25.8	29.3	41.6	15.0	19.4	27.2	18.5	24.2	15.1	28.1	23.3
STOML1	"FLJ36370, hUNC-24, SLP-1, STORP"	ENSG00000067221	"Stomatin like 1"	Q9UBI4	15	73978923-73994622	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042353	Approved		Approved	Cytosol				Cytosol		"HPA042353: AB_10797387"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.67e-2)"	11.1	10.2	19.2	6.2	18.8	4.2	8.1	7.8	35.3	7.7	6.9	8.3	3.1	5.9	4.6	6.0	7.0	6.2	9.1	14.4	19.0	18.0	4.5	6.1	6.9	8.7	13.4	14.3	9.0	9.9	6.8	8.5	7.9	10.2	7.0	3.7	4.0	7.7	9.7	13.2	7.3	6.5	7.7	12.3	6.3	7.9	6.7	5.9	6.2	10.4	3.6	5.6	6.2	4.4	6.1	11.0	2.2	15.5	6.8	9.4	5.3	3.6	6.9	4.2	5.7	8.5	5.4	3.5	11.8	4.6	6.4	5.4	2.0	20.3	3.6	18.7	9.5	12.2	3.9	8.3	2.0	12.1	4.3	3.7	5.8	2.2	8.4	2.4	3.0	9.6	6.5	10.1	9.6	6.0	9.0	7.0	9.3	5.5	4.6	1.8	2.0	5.5	2.8	4.2	5.5	13.7	4.0	8.0	5.2	5.3	7.1	7.5	5.9	2.8	9.2	14.8	4.8	16.9	15.7	7.2	3.5	1.9	13.6	7.6	7.5	0.7	4.0	2.2	5.3	7.0	4.4	4.3	4.4	7.0	6.2	6.1	8.9	9.4	2.0	6.8	15.5	11.0	7.4	5.3	19.2	18.8	7.8	35.3	19.0	18.0	13.4	14.3	10.2	5.9
STOML2	"HSPC108, SLP-2"	ENSG00000165283	"Stomatin like 2"	Q9UJZ1	9	35099776-35103195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015944, HPA062016"	Supported		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"		98000	"Plasma membrane, Cytosol"		"CAB015944: , HPA062016: "	"unprognostic (2.49e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (4.77e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (3.00e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.26e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.47e-2)"	23.2	38.6	20.5	24.8	20.7	26.9	25.3	20.9	30.3	22.1	30.8	19.9	17.4	26.6	26.6	25.5	32.9	28.2	35.4	49.6	18.6	19.1	38.6	67.1	17.1	31.7	18.8	18.8	30.9	48.3	20.4	17.4	28.5	20.7	25.6	33.6	25.0	32.1	25.5	59.2	26.3	39.0	26.7	13.8	23.1	28.7	23.2	14.3	32.4	34.8	46.3	33.8	24.8	21.1	34.7	44.4	20.5	27.1	33.8	40.3	37.7	46.5	54.0	29.0	43.3	21.4	25.7	31.1	23.0	34.0	65.8	48.2	60.8	21.9	39.4	16.3	29.4	20.0	44.3	51.7	44.0	33.6	40.5	24.1	45.8	57.5	62.5	45.6	27.7	32.5	40.5	53.3	64.2	42.9	39.1	24.2	32.1	37.6	40.5	80.9	45.4	34.2	35.5	24.6	42.1	35.6	28.1	27.0	32.8	13.0	35.0	29.8	24.3	29.4	23.1	22.5	31.8	18.6	40.6	17.0	29.0	37.1	29.9	29.0	30.2	20.5	27.1	14.8	25.5	23.1	30.0	34.7	28.8	28.7	35.8	30.2	27.8	25.3	4.7	33.8	16.6	44.4	40.3	37.7	20.5	20.7	20.9	30.3	18.6	19.1	18.8	18.8	20.7	14.3
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 42.8;HMC-1: 24.3;Karpas-707: 22.0;RT4: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 3.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003086	Enhanced		Supported	Nucleoli,Cytosol			9800	Cytosol	Nucleoli	"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	6.1	1.2	26.8	1.5	23.5	5.6	11.5	2.0	22.4	4.3	5.3	18.1	1.6	4.7	1.8	6.7	11.3	13.6	7.1	4.0	26.1	11.6	17.5	3.7	5.0	1.3	10.3	11.5	3.7	1.3	0.6	7.9	4.3	9.6	2.6	6.1	7.9	4.6	3.8	9.5	9.2	4.9	2.2	4.5	18.7	6.8	4.0	15.9	0.3	13.1	4.9	3.4	6.8	6.6	0.0	0.5	0.8	3.6	0.0	0.1	3.2	1.7	1.3	4.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	4.2	1.5	0.0	2.2	0.0	11.8	6.5	14.7	0.0	0.2	2.3	42.8	7.9	1.6	0.0	0.0	24.3	0.6	13.0	0.0	4.4	0.0	15.7	22.0	0.4	2.6	2.1	0.0	4.7	1.1	0.0	6.9	1.3	3.1	17.7	11.5	0.7	5.2	0.2	0.0	0.6	0.1	0.1	0.9	3.6	3.9	1.0	2.5	4.5	0.0	3.2	0.1	1.1	0.0	2.4	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	3.2	26.8	23.5	2.0	17.5	26.1	11.6	10.3	11.5	9.6	15.9
STOX1	"C10orf24, FLJ25162"	ENSG00000165730	"Storkhead box 1"	Q6ZVD7	10	68827541-68895432	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;fallopian tube: 19.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.9;HAP1: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;T-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037844, HPA037845"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Intracellular and membrane"			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA037844: , HPA037845: AB_10671369"	"prognostic favourable (3.37e-5)"	"unprognostic (5.53e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"prognostic favourable (2.08e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.33e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.46e-2)"	8.7	6.4	17.8	1.7	13.4	0.6	4.8	1.8	13.4	2.0	2.6	6.8	1.3	2.0	2.8	11.9	2.5	19.1	1.7	0.9	16.1	9.3	4.5	0.9	2.2	1.8	11.5	10.2	1.9	1.6	6.1	8.8	1.5	5.6	2.3	2.8	5.0	2.6	2.1	1.9	1.4	2.8	2.5	2.4	0.9	2.2	3.8	7.3	3.3	8.7	0.0	1.7	1.6	0.9	0.7	3.5	0.0	0.0	0.2	3.0	0.2	2.2	2.4	5.4	10.9	2.3	0.0	3.2	0.2	0.1	1.6	1.7	2.3	3.3	2.1	3.1	0.0	0.6	10.1	0.0	0.8	2.5	4.2	0.2	0.5	3.1	0.3	2.7	3.9	0.2	0.2	0.3	0.0	0.1	0.5	0.3	0.2	2.2	4.6	3.4	1.8	1.5	3.4	0.1	0.0	3.2	5.7	1.7	4.9	3.9	1.0	0.7	2.4	2.2	0.0	0.0	0.2	0.0	1.5	1.0	1.9	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.4	0.8	0.6	0.0	0.7	3.0	1.4	0.0	0.2	0.0	3.5	0.3	0.2	17.8	13.4	1.8	12.5	16.1	9.3	11.5	10.2	5.6	7.3
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 11.4;HeLa: 9.7;NTERA-2: 14.4;SH-SY5Y: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Uncertain	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: , HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	3.0	2.8	12.0	1.2	12.6	8.4	3.1	20.3	17.5	3.9	2.1	18.2	1.6	1.6	3.2	5.9	8.2	4.7	4.5	4.9	9.6	8.3	3.4	4.0	3.5	1.1	16.2	18.0	5.8	10.6	12.0	8.1	2.4	11.8	4.1	1.7	2.5	11.0	4.2	3.2	6.2	1.8	3.2	9.2	6.2	3.7	1.6	16.4	0.8	9.6	0.8	1.9	4.3	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.7	3.6	11.4	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	1.5	0.0	2.3	0.0	0.2	6.3	1.0	0.0	0.0	5.0	0.0	9.7	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.1	14.4	0.5	0.1	4.2	0.0	2.7	3.5	5.9	13.8	2.7	0.0	0.0	0.2	0.3	0.0	0.0	2.5	0.0	0.1	0.1	3.1	1.8	0.6	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	12.0	12.6	20.3	16.6	9.6	8.3	16.2	18.0	11.8	16.4
STPG4	"C2orf61, FLJ40172"	ENSG00000239605	"Sperm-tail PG-rich repeat containing 4"	Q8N801	2	47045538-47155378	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 29.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047366, HPA052691"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047366: , HPA052691: "	"unprognostic (6.74e-3)"	"unprognostic (5.81e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.36e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.64e-6)"	"unprognostic (5.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	29.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.1	0.0	0.2	0.4	0.0	0.2	0.7	0.5	0.4	0.4	0.4	0.0	0.2	0.0	0.6	0.5	0.5	0.6	0.0	0.1	0.0	0.0	0.6	0.0	1.1	0.9	0.1	0.3	0.1	6.5	0.8	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.4	1.7	0.4	0.0	0.0	0.3	0.1	0.0	0.2	0.6	0.3	0.9	0.1	0.2	0.8	0.2	0.0	0.0	0.6	0.2	0.0	0.1	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	2.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20-related kinase adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favourable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavourable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favourable (6.43e-4)"	13.3	17.7	19.4	14.6	23.7	17.5	13.0	25.0	28.4	15.2	13.2	27.1	8.7	9.5	16.1	20.6	14.3	20.9	14.5	15.1	18.9	20.2	14.7	13.0	13.9	19.6	20.9	21.7	18.5	12.5	21.9	17.5	14.4	26.0	13.8	13.1	22.2	12.6	16.7	10.3	20.1	12.0	19.1	19.4	20.7	12.6	55.4	21.4	16.2	13.3	8.9	21.3	12.9	12.8	11.2	16.2	18.6	10.0	15.6	11.7	7.5	7.2	21.7	18.9	19.0	18.6	13.9	7.4	13.8	12.7	19.9	17.8	5.6	8.4	11.0	8.6	11.7	6.0	12.5	13.3	19.8	12.2	12.1	21.8	15.2	13.4	13.2	20.6	15.7	14.5	11.5	22.6	13.0	22.0	13.9	11.8	18.8	13.4	24.2	14.1	9.4	12.3	15.8	30.1	13.5	17.8	14.3	20.7	23.2	9.4	15.5	15.1	11.4	15.0	17.6	19.0	13.5	15.3	11.4	11.8	12.5	13.9	14.1	12.5	14.9	18.6	9.5	8.6	10.5	7.1	9.7	11.2	9.7	11.7	16.2	9.0	9.6	8.5	11.4	15.6	10.0	13.7	7.2	7.5	19.4	23.7	25.0	28.4	18.9	20.2	20.9	21.7	26.0	21.4
STRADB	"ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK"	ENSG00000082146	"STE20-related kinase adaptor beta"	Q9C0K7	2	201387858-201480846	"Enzymes, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026549, HPA028520"	Approved		Supported	Aggresome,Cytosol				Cytosol	Aggresome	"HPA026549: AB_1844779, HPA028520: AB_10604100"	"unprognostic (6.34e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.65e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.83e-2)"	"prognostic favourable (4.45e-4)"	"unprognostic (4.93e-2)"	13.8	28.6	13.8	7.9	11.7	32.7	9.2	8.8	13.5	6.4	13.7	16.9	4.9	18.8	10.3	9.5	8.9	5.7	7.9	15.2	15.3	11.5	35.2	50.5	7.2	10.1	15.8	11.0	7.8	9.1	3.9	14.1	11.6	12.7	7.1	15.9	10.1	7.1	7.7	48.3	4.4	21.3	7.4	21.0	7.3	4.7	7.8	9.4	8.3	9.7	7.8	7.7	6.2	6.2	24.1	10.4	9.7	8.6	16.3	10.4	9.6	3.9	6.8	11.8	15.1	19.3	24.5	8.3	8.0	13.9	11.1	16.8	8.9	3.8	0.0	5.2	12.6	4.0	11.4	7.5	20.2	4.6	9.3	4.7	3.2	19.7	14.6	5.6	5.4	20.7	6.9	14.2	12.8	8.3	10.1	1.7	59.9	2.1	5.1	9.8	15.9	7.0	7.0	4.6	2.9	9.4	3.2	1.9	9.7	5.5	4.2	23.4	2.2	10.7	8.0	6.8	5.2	8.6	6.1	6.6	11.7	1.8	11.5	2.5	6.4	3.4	8.0	9.7	6.0	8.6	5.4	16.7	8.0	8.6	10.4	24.1	10.4	10.3	1.6	16.3	7.5	4.6	9.5	9.6	13.8	11.7	8.8	13.5	15.3	11.5	15.8	11.0	12.7	9.4
STRAP	"MAWD, pt-wd, UNRIP"	ENSG00000023734	"Serine/threonine kinase receptor associated protein"	Q9Y3F4	12	15882391-15903478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027320, HPA055557, HPA073876"	Approved		Enhanced	Cytosol			290000	Cytosol		"HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639"	"unprognostic (4.64e-3)"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (6.83e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (9.07e-4)"	"prognostic unfavourable (5.10e-4)"	36.7	39.8	43.5	28.1	43.2	24.1	46.4	38.1	55.3	30.5	29.4	19.3	29.2	24.7	31.8	29.1	33.7	24.7	25.8	54.0	55.7	44.9	46.4	42.9	27.7	30.4	35.8	48.3	25.5	38.7	40.4	36.7	34.4	47.1	27.8	29.5	20.5	26.0	32.2	109.2	25.3	23.6	37.4	51.5	20.7	28.9	32.9	27.5	27.9	42.6	36.6	29.4	28.6	29.8	36.9	44.6	30.8	41.8	29.2	43.4	38.5	32.6	38.5	36.8	31.3	32.6	32.6	49.1	39.2	27.3	35.4	33.1	55.0	28.8	36.4	19.5	39.8	23.8	43.9	43.0	52.3	48.6	35.6	36.8	30.6	24.1	53.5	42.6	17.9	31.3	36.7	39.0	44.0	41.1	28.2	11.1	46.0	22.8	35.4	20.4	129.7	25.2	27.3	50.6	21.0	41.0	33.7	23.7	40.4	31.6	21.9	42.7	40.8	22.9	34.4	26.5	31.5	28.0	48.0	12.8	17.3	59.8	32.6	23.7	33.4	26.8	36.7	30.8	34.6	41.8	38.9	36.9	36.0	33.3	44.6	30.8	35.4	37.3	17.0	29.2	35.9	27.4	43.4	38.5	43.5	43.2	38.1	55.3	55.7	44.9	35.8	48.3	47.1	27.5
STRIP1	"FAM40A, FAR11A, FLJ14743, KIAA1761"	ENSG00000143093	"Striatin interacting protein 1"	Q5VSL9	1	110031577-110074641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060302, HPA060498"	Approved		Supported	Cytosol				Cytosol		"HPA060302: , HPA060498: "	"unprognostic (2.75e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.23e-2)"	14.7	15.8	25.6	11.8	20.2	21.7	14.1	30.3	30.7	16.6	14.6	19.7	10.1	14.0	21.0	17.8	15.6	17.7	13.0	13.5	22.3	19.0	12.3	10.0	13.7	15.1	17.7	18.1	24.7	15.7	24.8	16.7	21.2	24.5	13.5	15.0	15.3	14.6	16.2	13.6	18.0	19.8	20.1	11.1	23.8	13.8	21.9	16.4	18.6	14.5	10.9	17.3	16.2	15.2	13.0	13.5	15.9	15.7	17.3	18.4	13.1	12.1	8.1	22.1	15.0	19.4	12.9	16.0	19.2	16.8	20.1	17.5	8.4	7.1	9.9	10.5	17.0	11.6	11.7	13.6	14.2	21.1	14.2	16.5	14.3	11.0	10.8	14.9	16.6	13.7	16.4	16.9	18.7	16.0	14.6	12.8	19.3	14.4	17.0	15.7	17.9	11.0	16.7	28.5	8.8	14.0	17.9	28.6	16.5	16.4	20.9	12.3	10.4	13.6	16.3	15.2	14.6	17.5	12.7	13.1	7.2	10.1	17.3	16.1	21.8	12.2	11.5	15.9	17.7	12.7	15.5	12.8	15.1	18.4	13.5	13.0	17.5	15.5	10.7	17.3	15.7	6.2	13.3	13.1	25.6	20.2	30.3	30.7	22.3	19.0	17.7	18.1	24.5	16.4
STRIP2	"FAM40B, FAR11B, KIAA1170"	ENSG00000128578	"Striatin interacting protein 2"	Q9ULQ0	7	129434433-129488399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6;retina: 55.6;skeletal muscle: 27.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.9;U-2197: 23.8;U-87 MG: 21.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019657	Approved		Approved	Cytosol				Cytosol		"HPA019657: AB_1848399"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.87e-6)"	"prognostic favourable (5.41e-4)"	"unprognostic (4.06e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.50e-2)"	0.7	2.4	1.9	2.0	36.6	3.7	0.8	7.0	10.0	0.4	0.8	3.0	0.0	0.8	0.8	1.6	1.1	0.4	1.2	10.3	1.5	2.1	5.6	0.6	1.0	2.7	2.2	2.9	0.7	1.3	0.4	4.7	1.3	7.6	1.6	1.4	55.6	1.7	0.5	27.4	1.5	1.0	0.8	1.2	1.5	1.0	13.5	9.4	0.2	0.8	2.1	2.1	0.9	0.3	0.6	0.7	2.5	0.6	0.4	0.9	0.4	7.8	3.4	3.1	4.9	1.2	1.1	13.6	3.2	4.1	5.4	5.3	1.8	4.4	3.3	0.4	1.3	8.8	3.3	2.9	8.3	19.1	2.8	2.5	5.6	1.9	0.8	1.6	13.4	1.3	1.0	9.2	5.8	9.3	10.9	2.1	20.9	0.4	4.1	4.0	3.0	7.0	2.8	5.8	0.7	2.0	2.9	0.7	0.7	7.4	0.6	1.6	0.9	3.9	3.3	3.2	3.1	23.8	9.2	1.9	1.3	4.0	21.2	4.1	4.5	2.5	0.6	0.6	0.9	0.4	0.3	0.3	0.6	0.3	0.2	0.6	0.5	0.4	2.0	0.4	0.5	0.7	0.9	0.4	1.9	36.6	7.0	4.8	1.5	2.1	2.2	2.9	7.6	9.4
STRN	"PPP2R6A, STRN1"	ENSG00000115808	Striatin	O43815	2	36843640-36966472	"Cancer-related genes, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017286	Approved		Approved	Nucleoplasm,Cytosol			11000	Cytosol	Nucleoplasm	"HPA017286: AB_1857618"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.43e-2)"	11.8	8.1	11.4	11.0	22.1	17.4	13.3	16.4	14.2	11.2	14.0	10.9	8.9	10.1	8.6	7.1	25.9	6.8	8.4	25.7	16.2	10.2	11.6	10.2	10.3	9.6	16.9	9.4	9.9	7.1	11.3	6.3	12.6	10.5	8.1	13.7	5.6	16.2	6.9	16.0	16.1	13.2	11.1	34.3	10.9	11.4	9.8	14.8	18.6	8.1	15.5	16.7	11.3	14.4	1.5	0.8	3.7	1.5	0.5	2.1	0.4	23.0	11.7	15.6	6.6	8.6	12.0	15.7	9.3	8.8	9.1	8.4	11.9	7.5	15.3	7.5	11.8	11.0	13.1	10.3	11.3	17.3	10.1	24.8	10.3	6.1	8.2	14.9	13.9	7.2	9.0	14.5	11.5	11.6	18.5	12.2	11.2	6.6	14.7	6.5	12.5	5.9	9.6	24.7	6.7	7.5	19.1	2.9	9.5	14.0	10.8	8.8	7.7	5.8	15.4	16.4	16.5	10.1	12.2	12.3	18.6	13.5	8.3	14.9	11.3	3.4	0.8	1.4	2.1	1.5	0.7	1.5	1.5	1.3	0.4	0.9	0.8	0.9	3.7	0.5	1.4	0.8	0.3	0.4	11.4	22.1	16.4	13.0	16.2	10.2	16.9	9.4	10.5	14.8
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"			15000	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favourable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.5	14.3	15.9	12.1	16.2	10.9	13.5	23.4	17.7	15.8	17.4	11.5	16.5	8.8	14.7	14.8	16.5	10.8	14.0	21.5	14.4	12.1	15.2	22.7	11.6	7.2	12.9	10.1	12.6	13.1	18.0	20.2	14.1	13.9	16.2	14.0	11.4	12.6	17.2	52.0	12.6	11.3	22.0	11.8	11.9	12.9	22.4	14.6	9.3	14.9	13.5	9.7	25.1	20.5	7.0	10.5	8.5	7.9	7.4	10.0	2.4	17.7	15.3	17.1	12.3	14.6	11.1	14.2	16.9	12.5	14.2	14.4	20.4	12.0	10.3	12.4	12.3	9.8	19.0	10.8	21.1	8.9	6.4	10.2	10.5	39.4	15.8	8.7	11.4	11.7	11.4	11.3	13.8	11.4	12.3	9.8	13.7	12.1	11.3	8.5	8.4	14.2	8.3	20.1	2.7	21.3	25.5	10.8	8.9	18.8	13.8	9.2	15.8	7.5	13.7	14.0	12.5	8.8	6.7	9.3	10.7	10.2	6.9	6.4	11.1	6.3	7.1	8.3	6.8	7.9	8.9	7.0	8.5	7.7	5.8	6.9	8.6	10.0	8.5	7.4	6.2	10.5	6.4	2.4	15.9	16.2	23.4	17.7	14.4	12.1	12.9	10.1	13.9	14.6
STRN4	"PPP2R6C, ZIN"	ENSG00000090372	"Striatin 4"	Q9NRL3	19	46719507-46746994	"Predicted intracellular proteins, Predicted membrane proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043051, HPA043527, HPA056706"	Supported		Approved	Cytosol			34000	Cytosol		"HPA043051: , HPA043527: AB_10959664, HPA056706: "	"unprognostic (3.57e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavourable (6.06e-8)"	"unprognostic (8.31e-3)"	"unprognostic (5.34e-2)"	"prognostic unfavourable (2.98e-4)"	"unprognostic (1.56e-1)"	"unprognostic (9.41e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.74e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.84e-1)"	21.8	13.7	22.6	17.8	26.6	27.0	18.7	10.5	34.9	15.3	18.0	17.9	17.8	19.0	19.9	12.6	23.8	16.9	17.0	20.7	23.1	13.4	15.8	11.4	17.4	16.2	15.1	21.4	16.9	26.6	12.7	12.3	22.2	11.8	17.3	11.3	15.7	25.2	18.4	16.6	22.0	20.6	18.5	12.8	22.9	20.2	48.8	15.7	15.0	14.6	11.6	15.5	18.4	16.6	3.1	3.3	10.1	9.8	1.5	1.2	5.7	21.1	28.2	24.8	18.3	7.1	7.9	17.4	18.3	9.9	19.0	16.7	20.9	18.9	10.6	11.1	15.1	15.0	11.7	17.8	7.6	15.2	23.9	23.3	18.6	17.8	22.8	18.8	25.5	12.8	17.9	12.2	16.9	16.9	20.3	13.9	7.9	14.4	20.9	49.4	18.7	13.3	19.2	15.0	8.2	12.7	38.2	30.7	32.8	25.8	24.1	12.1	18.1	21.3	22.8	14.4	21.5	9.8	27.0	17.6	25.1	15.7	12.5	11.8	29.6	3.1	6.5	2.9	1.2	9.8	0.3	1.7	1.0	0.8	3.3	3.1	0.5	1.1	10.1	1.5	6.0	3.0	0.3	5.7	22.6	26.6	10.5	34.9	23.1	13.4	15.1	21.4	11.8	15.7
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3A, catalytic subunit of the oligosaccharyltransferase complex"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 202.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	20.6	20.5	8.3	13.1	11.7	8.3	16.9	10.7	13.9	27.8	19.3	17.7	39.6	12.0	30.5	41.4	19.6	20.8	15.1	19.5	8.3	9.1	26.2	67.1	18.7	14.9	9.3	7.7	30.1	59.0	202.3	27.5	35.9	11.6	22.2	17.4	20.8	50.7	41.4	9.5	12.9	19.8	17.1	12.3	21.8	17.7	17.1	6.7	19.2	38.6	13.6	20.8	19.5	18.0	15.0	53.2	27.0	15.5	17.2	27.5	13.4	20.7	18.9	24.2	33.2	45.6	35.4	26.0	38.0	45.4	31.0	38.8	57.5	56.2	27.1	46.2	55.9	38.4	33.5	33.3	41.2	21.1	17.8	63.8	13.1	39.7	50.5	38.1	29.9	27.3	24.2	42.8	83.7	34.5	26.8	40.6	39.0	15.3	15.3	12.2	15.5	20.6	18.2	20.6	40.7	33.8	32.3	15.1	13.0	26.9	44.0	13.5	51.5	27.5	30.8	44.6	16.1	18.8	29.8	12.8	14.9	20.9	17.2	38.6	35.4	27.0	15.5	11.6	19.7	14.8	27.5	15.0	19.1	18.2	21.6	11.6	13.8	16.0	5.4	17.2	13.0	53.2	14.1	13.4	8.3	11.7	10.7	13.9	8.3	9.1	9.3	7.7	11.6	6.7
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favourable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	29.4	43.7	52.2	20.1	43.2	19.3	40.5	39.1	53.3	25.1	24.8	18.1	27.6	24.1	19.7	34.9	35.2	31.1	25.5	45.2	43.2	38.6	24.0	25.9	23.6	28.1	42.0	42.5	29.4	43.4	39.8	27.2	12.1	35.0	23.4	17.7	18.6	37.7	29.7	92.5	33.7	20.9	24.5	34.5	19.7	22.8	13.8	25.4	13.1	29.1	30.2	19.4	22.3	35.9	18.0	21.0	19.4	14.5	10.3	16.9	6.9	17.8	24.2	16.4	27.7	37.5	34.4	9.4	24.4	28.7	29.0	25.8	30.1	22.8	18.1	17.3	40.8	15.3	20.2	36.7	12.1	19.9	66.8	11.2	35.0	25.1	54.1	18.9	22.4	40.8	39.4	33.9	21.5	29.3	18.1	30.3	44.8	70.7	20.5	18.6	18.3	26.5	31.7	10.7	44.5	38.7	17.9	28.6	23.2	19.5	43.0	30.6	27.4	36.3	23.2	26.6	23.3	22.0	29.3	30.0	31.0	29.2	21.0	17.2	30.0	11.9	14.5	19.4	16.9	11.9	15.4	18.0	14.6	14.7	11.7	17.3	13.6	12.9	14.0	10.3	12.4	21.0	12.2	6.9	52.2	43.2	39.1	53.3	43.2	38.6	42.0	42.5	35.0	25.4
STUM	"C1orf95, DKFZp761P211"	ENSG00000203685	"Stum, mechanosensory transduction mediator homolog"	Q69YW2	1	226548800-226609214	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.2"	"Cell line enriched"	"Detected in some"	6	"HEL: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4"	"Group enriched"	"Detected in many"	4	"amygdala: 176.7;basal ganglia: 134.5;cerebral cortex: 191.4;hippocampal formation: 216.5"	HPA074381			Approved	Cytosol				Cytosol		"HPA074381: "	"unprognostic (3.23e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (6.40e-4)"	"unprognostic (1.14e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-3)"	2.8	2.2	30.4	2.1	16.2	0.6	3.5	2.4	32.2	3.7	8.1	6.3	0.0	2.8	3.7	3.0	8.9	3.1	1.6	2.5	21.8	7.0	5.8	0.7	1.2	0.9	6.8	15.9	2.7	1.0	1.9	4.2	1.2	18.2	6.2	3.7	1.4	2.0	2.4	5.0	3.7	3.5	8.7	3.0	1.8	1.8	2.0	7.4	0.0	0.8	0.4	1.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	4.1	0.3	25.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.2	0.0	3.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	16.2	2.4	30.0	21.8	7.0	6.8	15.9	18.2	7.4
STX17	FLJ20651	ENSG00000136874	"Syntaxin 17"	P56962	9	99906633-99970341	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001204	Approved		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA001204: AB_1080118"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (1.62e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	15.1	15.8	13.5	16.4	16.3	13.6	16.1	10.8	17.8	19.4	18.5	14.2	29.3	13.4	21.7	25.2	19.9	12.0	14.9	14.5	13.8	13.2	14.3	26.0	13.2	11.9	15.4	14.2	18.2	17.8	25.5	37.1	17.6	14.1	18.2	14.6	16.3	20.6	28.7	28.5	20.6	18.9	20.4	19.1	13.3	15.0	12.0	10.4	17.0	21.8	18.3	15.9	18.8	17.8	7.4	4.9	15.5	8.1	14.3	10.4	4.5	10.6	9.7	10.0	11.9	11.4	11.6	19.9	8.2	12.2	9.2	7.9	12.2	14.4	20.9	8.2	8.7	12.3	8.3	11.5	7.4	18.3	6.8	13.5	12.8	7.4	13.2	19.8	4.9	11.4	13.3	10.0	15.1	10.8	18.6	11.6	6.9	13.1	11.7	5.4	8.8	7.9	10.1	17.7	9.6	12.3	12.5	5.8	10.3	16.5	12.7	8.1	12.6	5.4	8.5	6.2	8.8	9.9	6.6	16.5	20.1	4.2	8.7	8.3	6.7	15.5	4.2	7.3	7.4	4.5	10.3	7.4	9.1	8.2	4.9	5.9	10.4	9.8	4.3	14.3	8.1	3.1	4.9	4.5	13.5	16.3	10.8	17.8	13.8	13.2	15.4	14.2	14.1	10.4
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014369-94028610	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.4;HaCaT: 2.2;hTCEpi: 7.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.4	0.2	0.3	7.0	0.4	0.0	4.0	1.8	3.5	3.9	11.7	0.1	1.5	5.7	0.5	13.6	12.8	0.8	2.3	0.3	0.5	0.3	1.0	0.4	7.1	0.1	0.3	0.7	0.5	7.7	7.1	0.5	0.7	0.1	4.3	10.6	0.1	9.8	3.2	0.2	6.9	20.9	0.1	0.4	1.0	6.0	0.4	0.1	0.4	0.4	5.0	1.5	0.7	4.1	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	10.4	0.1	0.1	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.1	7.1	0.0	0.7	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.4	1.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.5	1.2	0.7	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	1.8	3.5	0.5	0.3	0.3	0.7	0.1	0.1
STX2	"EPIM, EPM, STX2A, STX2B, STX2C"	ENSG00000111450	"Syntaxin 2"	P32856	12	130789600-130839266	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038189, HPA069176, CAB079007"	Uncertain	Supported	Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB079007: , HPA038189: , HPA069176: "	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavourable (5.15e-5)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-3)"	15.9	14.5	16.0	15.4	13.4	8.8	27.0	12.5	18.7	13.1	18.8	15.3	8.8	6.1	18.1	15.4	9.6	19.4	14.5	16.4	15.5	11.4	12.2	12.0	18.3	11.9	12.7	12.4	16.0	10.7	11.9	16.3	18.0	17.9	10.2	10.2	9.8	5.2	15.7	6.3	6.1	10.7	23.5	24.8	12.3	11.7	23.2	12.3	9.7	12.6	6.9	9.4	13.5	22.2	2.6	1.6	4.6	2.4	1.4	3.1	0.9	4.7	9.5	13.8	10.7	12.8	29.1	1.4	20.1	16.2	24.9	16.5	2.6	3.3	6.1	3.2	22.0	1.3	12.6	3.3	25.9	9.2	4.3	3.2	8.3	7.4	13.8	4.7	8.0	10.8	4.1	12.1	9.7	12.2	12.7	5.7	21.2	2.8	6.6	4.8	9.2	13.1	7.0	9.0	3.2	13.7	1.0	13.2	12.9	10.2	0.9	8.5	3.2	3.0	16.4	14.3	10.1	15.7	8.8	4.2	3.3	4.0	16.5	5.2	11.2	4.6	2.2	2.8	2.4	2.4	2.4	2.6	2.7	2.7	1.5	1.7	2.9	3.1	3.0	1.4	1.2	1.6	1.9	0.9	16.0	13.4	12.5	18.7	15.5	11.4	12.7	12.4	17.9	12.3
STX8	CARB	ENSG00000170310	"Syntaxin 8"	Q9UNK0	17	9250471-9576591	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001540	Approved		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA001540: AB_1080168"	"unprognostic (8.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.14e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.51e-1)"	28.6	24.7	26.0	16.5	25.9	23.7	28.1	20.2	33.6	28.3	28.9	23.7	21.9	15.8	36.9	42.5	26.3	19.9	18.1	28.4	20.8	21.1	29.6	29.9	18.7	19.4	23.9	22.4	24.4	30.0	14.9	21.0	20.0	29.0	24.5	23.7	25.8	40.6	26.0	38.4	20.9	20.3	28.4	25.3	19.7	23.2	43.9	20.2	30.0	29.2	17.8	21.4	23.3	23.0	35.4	45.2	48.5	46.2	49.0	59.3	55.7	11.2	19.5	22.4	9.6	27.5	31.9	7.9	16.7	17.9	15.2	19.0	6.8	8.9	13.4	12.8	28.2	14.7	11.4	23.7	23.1	22.9	16.4	8.3	4.9	14.4	36.6	6.6	17.9	29.0	35.1	15.2	22.7	18.9	3.7	6.9	16.6	6.1	13.2	11.5	5.0	10.9	21.2	16.4	8.3	21.1	10.2	2.0	11.5	9.5	6.0	15.5	6.6	8.8	23.7	14.8	9.0	8.0	18.1	6.5	6.3	5.8	21.5	14.7	13.7	31.7	46.2	48.5	42.2	38.4	38.4	35.4	45.6	46.5	45.2	32.2	29.2	34.3	14.0	49.0	39.2	38.0	59.3	55.7	26.0	25.9	20.2	33.6	20.8	21.1	23.9	22.4	29.0	20.2
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 127.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 47.1;SK-MEL-30: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol			6400	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.47e-4)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favourable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	14.1	16.0	32.4	4.7	42.2	1.5	5.1	86.8	127.4	8.1	4.6	6.5	1.9	3.7	13.2	4.7	6.3	17.9	6.7	12.7	35.0	31.5	7.1	2.7	16.8	3.7	24.6	55.5	14.3	13.2	8.1	22.3	7.9	61.9	6.5	5.3	12.6	8.1	6.6	5.0	5.6	4.6	11.7	13.3	5.9	5.2	5.4	5.3	0.0	10.7	0.9	4.3	5.7	7.6	0.0	0.5	0.0	0.4	0.0	3.4	0.6	4.0	8.5	8.2	9.2	18.6	16.0	7.4	14.3	7.3	8.6	7.6	0.4	4.8	4.0	8.0	9.3	1.4	7.2	8.8	10.6	9.2	4.8	5.4	23.1	1.5	9.4	0.5	4.7	12.1	4.9	22.6	11.0	10.2	5.4	6.2	14.5	7.5	3.8	1.7	7.0	11.8	2.3	3.9	9.7	7.1	0.2	47.1	22.9	24.1	11.9	40.8	1.8	1.7	15.2	9.8	5.0	19.2	5.3	13.4	22.1	5.4	19.2	5.8	9.0	0.0	0.4	0.0	0.8	0.1	0.3	0.0	2.2	3.4	0.5	0.0	1.4	1.7	0.0	0.0	0.1	0.3	0.3	0.6	32.4	42.2	86.8	87.7	35.0	31.5	24.6	55.5	61.9	5.3
STXBP2	"Hunc18b, UNC18B"	ENSG00000076944	"Syntaxin binding protein 2"	Q15833	19	7636881-7647873	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.5;lymphoid tissue: 101.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 55.2;U-937: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 25.5;classical monocyte: 58.1;eosinophil: 35.5;intermediate monocyte: 73.1;myeloid DC: 30.2;neutrophil: 45.6;non-classical monocyte: 101.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 30.2;granulocytes: 45.6;monocytes: 101.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015564, HPA063868"	Approved		Enhanced	Cytosol			53000000	Cytosol		"HPA015564: AB_1857626, HPA063868: "	"unprognostic (1.20e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (4.65e-4)"	"unprognostic (4.22e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (7.68e-4)"	"prognostic favourable (5.13e-6)"	7.2	7.9	5.5	17.9	9.9	49.5	9.9	2.0	5.8	6.5	17.7	5.4	15.9	19.0	3.0	10.4	23.4	9.6	14.3	18.4	5.2	2.0	20.2	19.0	46.4	61.5	12.2	1.3	4.6	28.0	10.9	9.8	24.9	5.8	16.4	10.5	8.7	24.6	9.7	1.5	15.3	32.0	3.7	16.9	101.5	20.6	22.5	8.0	73.4	19.5	5.4	17.8	11.4	18.0	6.7	30.2	45.6	101.5	9.0	9.9	31.9	24.0	8.5	0.2	0.1	0.0	0.2	16.9	3.1	0.3	0.6	1.6	20.1	15.3	6.4	12.4	2.4	16.6	0.9	14.7	0.6	26.5	10.3	27.5	10.2	11.8	14.7	17.7	55.2	1.0	15.1	3.0	8.6	12.9	17.1	21.9	0.0	15.2	8.6	41.1	6.3	15.1	8.9	0.0	24.4	12.3	27.9	2.6	0.1	7.4	11.0	0.5	13.7	45.8	13.5	0.1	5.0	0.3	0.1	24.4	12.0	8.2	0.2	48.4	0.6	25.5	58.1	35.5	9.6	73.1	7.7	6.3	7.3	8.6	30.2	6.7	5.2	6.2	45.6	9.0	101.5	11.5	9.9	31.9	5.5	9.9	2.0	5.8	5.2	2.0	12.2	1.3	5.8	8.0
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809526	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol			160000	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	18.3	18.4	29.8	18.7	42.1	15.2	20.9	21.9	27.1	19.4	20.5	26.3	15.6	18.7	20.3	19.9	18.8	16.0	20.8	14.3	30.4	22.1	30.2	17.8	16.8	18.2	48.0	28.0	16.2	20.5	31.9	18.0	20.3	31.4	18.1	21.9	9.8	17.5	21.3	15.4	19.7	23.8	18.4	56.6	19.8	18.0	11.3	42.5	20.0	27.8	14.6	17.8	20.2	18.3	5.9	8.3	26.2	11.6	8.7	10.2	5.9	21.9	8.7	15.0	7.9	18.3	17.8	21.2	20.4	18.9	13.8	14.1	8.0	8.9	19.5	13.9	16.5	13.2	10.1	12.0	19.4	21.7	14.0	16.1	11.9	10.4	14.5	25.1	27.7	13.8	17.1	15.4	16.9	17.0	11.9	19.3	19.1	14.9	15.8	20.2	16.0	13.8	13.3	21.9	10.7	22.4	18.4	9.0	8.3	25.1	24.3	29.7	9.7	23.9	19.1	18.1	10.6	25.0	17.5	12.9	11.2	16.2	32.5	19.3	27.4	26.2	8.8	20.8	7.8	10.6	9.9	5.9	9.2	7.8	8.3	5.4	7.9	7.5	24.3	8.7	11.6	3.9	10.2	5.9	29.8	42.1	21.9	27.1	30.4	22.1	48.0	28.0	31.4	42.5
STXBP4	"MGC50337, Synip"	ENSG00000166263	"Syntaxin binding protein 4"	Q6ZWJ1	17	54968727-55173632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 36.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007760, HPA022138, HPA022888, HPA024227"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630"	"unprognostic (5.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.00e-5)"	"unprognostic (4.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	7.7	6.4	5.5	4.3	6.0	3.4	5.2	10.6	4.7	9.9	6.4	4.2	7.5	6.3	12.0	7.2	5.1	7.3	6.6	5.9	6.7	4.7	14.5	3.8	8.0	3.2	4.2	4.5	9.9	5.4	19.3	36.3	4.7	6.8	9.5	4.6	7.6	4.5	9.4	4.0	3.7	5.1	13.2	8.6	5.0	5.5	5.6	5.1	7.2	7.9	2.7	3.5	9.6	8.2	3.2	2.9	4.0	1.2	5.1	2.9	0.7	5.4	8.2	7.5	6.7	6.4	6.3	3.1	4.3	4.1	5.6	5.5	4.8	3.0	3.7	9.1	4.2	3.3	9.7	4.3	10.3	5.6	5.5	4.9	5.6	9.8	2.7	3.0	1.5	7.2	1.3	8.0	1.9	5.5	7.8	3.0	6.6	2.4	10.0	1.9	5.4	5.9	4.3	8.8	2.2	9.9	3.3	7.3	5.5	6.6	1.1	3.6	9.6	2.1	4.3	7.8	6.2	4.8	4.5	2.6	2.5	6.4	5.1	4.0	4.7	4.0	1.1	0.1	2.6	0.8	2.9	2.1	2.3	1.7	1.4	3.2	2.1	2.7	0.3	5.1	1.2	2.9	2.1	0.7	5.5	6.0	10.6	4.7	6.7	4.7	4.2	4.5	6.8	5.1
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 82.7"	"Cell line enhanced"	"Detected in many"		"HEL: 55.4;HMC-1: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol			11000	Cytosol		"CAB079016: , HPA039991: AB_10673368, HPA049727: "	"prognostic unfavourable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavourable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	4.4	9.1	4.3	6.6	5.9	14.0	9.0	7.8	9.0	6.7	17.6	2.0	22.1	3.9	4.6	6.5	10.2	3.8	9.2	3.5	3.6	4.3	2.0	2.4	3.8	3.5	3.3	4.7	3.0	10.9	82.7	15.5	3.1	4.3	5.7	7.8	6.5	5.7	21.0	7.0	10.9	35.1	5.3	2.7	4.7	4.0	9.6	2.3	2.2	4.2	5.6	4.6	5.3	9.1	0.9	0.5	11.2	0.6	0.5	1.7	0.3	2.8	2.5	1.3	4.5	6.5	13.8	1.5	6.5	9.8	4.9	5.5	2.1	1.9	2.0	1.5	13.0	3.4	3.8	5.8	6.0	4.4	3.0	55.4	7.3	2.3	7.5	18.9	60.6	10.0	4.1	9.7	20.0	6.2	14.9	2.6	9.6	4.1	3.0	4.9	1.0	5.8	0.4	6.9	0.7	2.6	4.9	2.9	2.1	5.1	3.6	2.2	1.0	7.4	7.2	7.0	2.5	3.4	5.9	2.1	0.0	2.4	3.9	6.9	5.0	4.7	0.3	11.2	1.2	0.5	1.3	0.5	0.7	1.4	0.5	0.9	1.2	1.7	4.0	0.5	0.6	0.4	0.3	0.3	4.3	5.9	7.8	9.0	3.6	4.3	3.3	4.7	4.3	2.3
SUCO	"C1orf9, CH1, OPT, SLP1"	ENSG00000094975	"SUN domain containing ossification factor"	Q9UBS9	1	172532349-172611833	"Predicted membrane proteins"	Osteogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047251	Approved		Approved	"Nucleoli fibrillar center,Cytosol"			14000	"Nucleoli fibrillar center, Cytosol"		"HPA047251: "	"unprognostic (1.28e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	"unprognostic (7.05e-2)"	8.8	9.2	8.0	6.2	9.8	43.4	9.0	7.9	8.4	8.9	7.6	6.5	48.6	6.1	8.1	39.5	8.3	9.9	7.3	8.0	7.6	8.3	11.2	8.0	6.4	5.5	7.5	5.1	13.4	24.7	16.9	24.7	18.2	8.7	9.0	5.9	9.4	13.0	52.5	2.8	8.7	22.9	6.1	8.8	7.1	8.0	14.3	8.0	11.1	11.0	6.0	7.1	10.7	9.1	9.5	7.7	11.3	6.7	10.4	8.9	4.6	15.7	7.1	20.6	18.4	10.6	10.2	23.3	19.1	11.2	12.2	14.9	12.6	16.8	7.9	11.6	10.9	24.9	8.8	7.5	21.0	4.5	6.3	6.2	4.4	7.7	12.4	9.8	8.9	9.2	7.7	15.0	12.3	10.5	4.0	11.3	18.3	3.7	6.5	6.7	18.7	16.5	6.6	11.9	5.0	18.9	22.1	11.1	14.3	8.8	15.3	16.8	15.0	10.7	13.7	11.1	11.7	10.6	19.4	17.1	13.7	14.3	10.7	5.2	17.3	9.4	6.6	11.3	8.6	6.0	8.3	8.3	7.8	7.2	5.4	9.5	8.7	8.9	6.1	10.4	6.7	7.7	5.6	4.6	8.0	9.8	7.9	8.4	7.6	8.3	7.5	5.1	8.7	8.0
SUDS3	"FLJ00052, SAP45, SDS3"	ENSG00000111707	"SDS3 homolog, SIN3A corepressor complex component"	Q9H7L9	12	118376380-118418031	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040402, HPA041972"	Approved		Supported	"Nuclear bodies,Cytosol"	"Intracellular and membrane"			"Nuclear bodies, Cytosol"		"HPA040402: , HPA041972: "	"unprognostic (1.49e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-1)"	12.4	15.6	20.6	10.2	19.1	13.3	17.6	13.3	22.0	17.1	17.2	10.7	10.5	12.9	20.4	15.6	24.7	17.3	12.1	12.9	15.8	11.0	15.3	12.7	13.9	12.2	8.9	18.7	18.6	34.2	22.9	12.2	15.1	14.5	15.7	17.3	13.1	20.4	15.6	15.1	18.7	14.6	20.9	13.4	12.1	14.7	21.6	13.2	13.6	20.5	8.3	17.3	19.9	18.2	9.7	7.7	14.4	4.9	4.6	7.9	4.1	16.4	12.5	17.2	17.0	9.6	12.7	18.4	12.9	13.3	15.1	12.0	13.6	10.7	22.4	13.8	12.4	19.7	20.4	13.6	17.9	19.7	12.1	15.5	10.1	12.1	11.1	17.1	12.0	8.7	14.6	7.5	13.4	12.8	16.9	8.1	13.8	11.2	20.2	22.5	17.7	9.8	18.4	15.4	15.8	13.8	24.2	13.4	13.3	18.2	10.9	11.2	35.5	14.0	10.6	10.3	9.8	11.5	8.7	15.4	17.2	16.6	11.5	10.9	12.3	2.0	4.9	6.2	5.9	3.1	7.3	9.7	6.4	6.8	5.2	9.3	7.9	5.3	14.4	4.6	3.0	7.7	5.9	4.1	20.6	19.1	13.3	22.0	15.8	11.0	8.9	18.7	14.5	13.2
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: "	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	22.7	29.9	40.0	23.1	44.8	26.2	27.9	39.7	42.7	17.9	24.0	23.0	14.9	25.8	19.4	20.6	27.1	19.2	18.9	33.8	34.0	28.8	30.8	34.3	19.8	23.5	35.9	28.9	20.8	28.6	14.0	39.8	24.4	36.0	18.1	26.5	14.2	22.5	16.8	26.1	23.1	24.8	21.4	31.1	21.3	23.1	31.2	43.5	15.2	21.6	19.5	27.4	21.8	48.3	17.5	23.4	29.0	19.1	17.5	25.3	13.6	15.2	16.7	24.8	18.8	24.6	20.1	23.8	33.7	22.3	21.1	16.9	36.4	38.5	33.6	9.6	20.8	26.5	30.5	19.3	31.1	27.8	12.7	31.2	21.9	27.5	17.9	24.2	23.5	13.9	17.6	21.8	16.6	35.3	29.1	11.1	32.2	10.8	22.5	44.5	29.0	16.1	26.0	14.4	14.5	36.6	17.2	8.2	10.5	17.4	14.3	15.8	14.7	23.1	25.3	17.7	20.7	20.3	28.7	8.7	12.3	30.0	10.6	19.5	25.3	29.0	16.8	26.8	14.9	19.1	14.6	17.5	19.4	20.0	18.6	16.3	14.9	16.5	2.3	17.5	18.2	23.4	25.3	13.6	40.0	44.8	39.7	42.7	34.0	28.8	35.9	28.9	36.0	43.5
SULT1C4	"SULT1C, SULT1C2"	ENSG00000198075	"Sulfotransferase family 1C member 4"	O75897	2	108377911-108388057	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 29.2"	"Group enriched"	"Detected in many"	6	"glioma: 7.1;renal cancer: 20.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA034530			Approved	Cytosol				Cytosol		"HPA034530: AB_10670170"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-3)"	"prognostic favourable (9.99e-7)"	"unprognostic (1.79e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.38e-1)"	5.2	2.2	9.5	1.1	14.5	0.7	4.5	7.8	16.3	20.6	3.2	13.0	1.8	1.6	9.9	5.4	2.5	8.4	24.8	9.5	9.2	11.4	15.8	3.2	13.9	1.7	12.7	6.8	25.0	3.1	1.0	6.8	11.3	13.6	6.1	2.2	10.6	1.7	7.7	2.7	0.9	3.1	5.1	8.3	1.4	2.2	2.3	10.0	1.1	4.4	1.1	1.4	4.0	5.6	0.3	0.3	1.4	0.2	0.7	0.4	0.2	0.0	0.1	6.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.7	0.4	0.0	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.2	0.1	0.1	0.2	0.3	0.2	0.0	0.3	0.2	0.4	1.4	0.7	0.1	0.3	0.1	0.2	9.5	14.5	7.8	7.1	9.2	11.4	12.7	6.8	13.6	10.0
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860152	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.8;liver: 26.2;vagina: 15.8"	"Group enriched"	"Detected in some"	19	"HHSteC: 37.1;HSkMC: 16.8;hTCEpi: 14.0;HUVEC TERT2: 10.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"pons and medulla: 3.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"											"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0.0	1.5	26.2	2.0	0.1	0.3	0.3	0.2	0.1	0.0	0.4	0.1	3.3	1.0	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1.0	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.1	0.0	0.0	16.8	14.0	0.0	0.4	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.3	0.3	3.3	0.1
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870466-47886397	"Enzymes, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 211.7"	"Group enriched"	"Detected in some"	34	"Hep G2: 26.0;RT4: 17.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 5.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol			210000	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	46.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.4	1.1	1.1	8.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	211.7	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.6	0.0	0.1	0.1	3.9	0.1	0.0	42.7	0.1	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.1	0.1	0.6	0.2	1.3	1.0	5.3	0.8	2.3	1.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	26.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.2	0.0	17.7	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	5.3	0.8	0.7	0.9	0.4	0.6	0.7	1.0	0.6	0.3	1.3	1.3	1.0	3.1	2.3	0.4	1.0	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;CAPAN-2: 34.1;MCF7: 20.9;T-47d: 17.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB033013, HPA041724, HPA043539"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB033013: AB_661450, HPA041724: AB_2677638, HPA043539: AB_2678540"	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	5.6	7.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	34.1	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.0	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	20.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	2.9	0.1	17.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone"	Q7KZ85	17	28662091-28702684	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: "	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavourable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	27.6	30.0	30.0	24.1	32.8	56.3	25.6	31.9	35.7	28.0	30.1	28.5	23.2	19.9	38.6	28.4	24.4	24.1	25.0	23.8	25.7	22.0	24.1	32.6	26.3	26.0	25.7	32.8	33.1	28.8	40.7	34.5	31.9	24.3	26.9	21.8	33.2	28.2	29.2	50.1	38.6	28.7	40.0	29.8	33.1	28.5	23.4	29.0	27.2	27.6	18.4	29.4	30.7	27.1	5.7	8.2	14.4	6.1	5.4	5.6	3.4	17.7	37.2	18.7	21.3	22.8	15.3	14.4	24.4	26.1	28.8	25.9	34.5	7.9	18.9	12.8	24.3	21.2	27.3	17.7	29.9	35.1	24.3	26.4	30.0	21.3	19.1	27.6	29.5	21.0	10.7	30.6	20.4	18.9	25.8	22.4	20.5	21.2	27.3	11.8	14.5	12.1	14.0	34.4	15.4	14.2	35.2	14.3	18.9	28.6	45.2	15.5	27.7	19.6	29.7	22.8	18.8	21.6	31.0	28.5	21.8	27.7	25.7	12.5	18.8	14.4	5.9	5.4	5.2	3.9	5.5	5.6	4.3	5.6	4.8	5.7	4.4	3.8	9.0	5.4	6.1	8.2	3.8	3.4	30.0	32.8	31.9	35.7	25.7	22.0	25.7	32.8	24.3	29.0
SV2A	"KIAA0736, SV2"	ENSG00000159164	"Synaptic vesicle glycoprotein 2A"	Q7L0J3	1	149903318-149917882	"FDA approved drug targets, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3;parathyroid gland: 34.0"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 26.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 27.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002226, HPA007863"	Enhanced		Approved	Cytosol				Cytosol		"CAB002226: AB_564144, HPA007863: AB_1080135"	"unprognostic (8.05e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.24e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.81e-3)"	2.0	7.3	20.4	2.8	24.7	4.5	1.5	36.8	75.3	3.2	2.3	4.8	0.9	1.9	5.6	18.0	2.0	3.2	3.2	1.5	22.3	30.5	1.7	1.2	1.8	2.3	21.6	25.1	2.6	1.9	34.0	7.2	1.9	32.9	3.1	2.2	3.1	1.7	3.7	1.1	1.5	2.2	6.6	16.8	2.0	2.0	1.6	6.0	0.3	4.0	0.0	2.0	2.5	1.2	1.2	0.8	2.1	0.7	1.7	2.5	0.6	0.1	0.0	10.2	0.0	1.0	3.0	1.1	4.3	15.1	12.9	18.7	0.3	0.4	0.1	3.9	6.5	0.2	0.1	0.9	11.2	0.0	2.4	13.4	0.7	0.7	9.9	0.1	0.2	6.7	0.1	20.6	1.5	1.1	0.1	14.0	8.5	0.1	12.9	0.6	26.0	0.0	4.5	6.5	0.2	0.1	0.3	21.5	17.3	0.0	0.1	9.8	0.1	8.1	0.0	12.0	12.1	0.5	15.7	0.1	0.1	0.0	21.1	0.1	4.7	1.5	0.7	0.4	1.8	0.3	1.9	0.7	1.9	1.1	0.2	1.2	1.0	2.2	2.1	1.7	0.3	0.8	2.5	0.6	20.4	24.7	36.8	40.0	22.3	30.5	21.6	25.1	32.9	6.0
SVBP	"CCDC23, MGC45441"	ENSG00000177868	"Small vasohibin binding protein"	Q8N300	1	42807052-42817252	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008507	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Secreted to blood"			"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA008507: AB_2072066"	"prognostic favourable (6.33e-4)"	"unprognostic (2.68e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	20.1	14.1	25.6	11.1	18.9	32.3	20.1	24.0	20.4	16.2	15.7	17.6	10.4	9.7	20.5	23.9	13.0	20.1	15.5	19.6	21.8	19.7	16.0	15.9	13.8	17.8	23.5	22.3	34.4	9.1	10.7	20.0	23.5	20.4	16.8	14.5	13.6	11.6	14.5	21.1	10.1	11.8	17.1	26.9	14.3	11.5	38.2	18.7	29.2	15.5	16.1	19.4	16.2	15.1	24.5	16.0	30.2	16.8	14.3	44.8	9.7	10.4	5.0	33.1	11.9	13.4	21.4	16.0	9.0	7.4	12.3	12.7	9.3	8.4	11.4	9.9	12.1	7.3	5.8	9.7	16.6	20.2	10.0	22.9	5.0	18.3	10.8	17.1	15.0	13.4	15.5	6.9	7.1	12.4	17.8	6.1	15.7	4.9	17.1	20.5	18.1	6.1	12.5	25.2	8.0	13.0	11.5	19.8	17.7	10.8	6.3	12.9	4.9	48.5	9.5	10.9	12.3	8.7	14.6	5.9	7.3	8.2	7.0	11.7	10.3	20.8	16.6	30.2	11.4	15.9	10.3	22.1	20.4	14.0	16.0	24.5	19.2	16.4	29.3	14.3	16.8	13.4	44.8	9.7	25.6	18.9	24.0	20.4	21.8	19.7	23.5	22.3	20.4	18.7
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736781	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 235.1;tongue: 93.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 40.1;U-2197: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.2;monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (5.70e-5)"	11.9	2.1	0.7	10.5	1.1	3.7	4.5	0.6	0.9	18.7	42.3	0.6	10.7	1.7	34.3	13.3	18.2	8.9	15.5	25.5	0.5	0.6	2.8	2.0	3.8	2.3	0.8	0.7	13.9	2.4	5.1	4.1	2.9	1.7	12.6	5.3	10.0	10.6	15.3	235.1	4.7	9.1	36.4	1.3	1.5	14.2	5.5	0.5	4.6	6.9	93.5	11.6	28.6	9.9	0.1	0.7	15.2	4.2	1.2	1.7	0.6	17.3	7.5	3.4	1.2	9.9	26.6	5.5	2.8	6.7	1.1	1.1	8.8	17.2	0.0	12.3	1.1	40.1	1.9	6.6	1.1	0.2	3.7	0.0	9.5	5.7	6.0	1.5	0.3	24.4	6.5	12.4	4.5	19.9	0.0	0.1	1.7	5.4	1.4	0.8	1.7	2.7	3.2	10.1	0.1	11.8	5.8	4.1	3.4	2.5	0.3	8.8	3.1	1.8	12.8	5.7	5.9	28.1	8.4	0.1	0.0	0.0	22.0	3.4	19.5	2.9	1.1	5.2	1.2	1.9	1.5	0.0	1.1	0.6	0.7	0.1	1.7	1.1	15.2	1.2	4.2	0.2	0.1	0.6	0.7	1.1	0.6	0.9	0.5	0.6	0.8	0.7	1.7	0.5
SWI5	"bA395P17.9, C9orf119, SAE3"	ENSG00000175854	"SWI5 homologous recombination repair protein"	Q1ZZU3	9	128275379-128288990	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA052032, HPA055472"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA052032: , HPA055472: "	"unprognostic (1.27e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.15e-1)"	"prognostic favourable (9.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.38e-2)"	10.2	11.7	14.7	11.8	15.9	6.0	17.9	18.0	13.2	18.2	9.0	12.3	48.0	9.9	13.0	44.8	13.5	20.4	12.7	14.8	12.5	13.2	14.2	18.0	12.5	8.7	16.7	11.0	19.6	13.2	26.5	23.8	10.7	13.6	14.6	8.1	14.1	15.2	50.7	14.1	10.3	9.5	12.8	13.7	7.7	9.2	57.1	16.2	8.9	27.8	12.5	10.5	12.4	17.1	12.6	14.2	28.1	9.6	13.4	15.3	10.0	9.5	17.1	10.1	11.7	27.5	25.1	11.4	16.8	22.4	21.8	14.8	21.8	11.3	9.1	22.4	27.3	16.0	16.1	22.4	14.9	13.6	12.0	6.9	32.6	17.0	35.4	4.4	6.5	21.1	10.8	36.5	19.7	20.9	16.2	14.7	22.2	38.8	9.5	6.3	6.8	35.5	9.0	14.0	14.4	14.6	5.0	11.7	6.5	20.9	13.4	19.9	22.3	4.7	12.9	15.9	13.2	30.8	14.1	15.6	23.4	12.1	21.7	6.9	17.1	28.1	9.6	16.4	10.2	5.7	12.0	12.6	10.1	10.2	9.8	12.5	12.2	15.3	6.4	13.4	5.6	14.2	10.0	10.0	14.7	15.9	18.0	13.2	12.5	13.2	16.7	11.0	13.6	16.2
SWT1	"C1orf26, FLJ20121, HsSwt1"	ENSG00000116668	"SWT1, RNA endoribonuclease homolog"	Q5T5J6	1	185157080-185291765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024214, HPA027334"	Enhanced		Approved	Cytosol				Cytosol		"HPA024214: AB_1845642, HPA027334: AB_1845643"	"unprognostic (2.67e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.41e-3)"	"unprognostic (5.71e-3)"	"unprognostic (9.26e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-1)"	"prognostic favourable (5.63e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.35e-2)"	5.0	4.8	4.1	3.4	6.0	8.7	8.4	6.5	5.9	5.0	5.8	5.7	7.1	5.6	6.6	5.4	3.8	4.1	4.5	4.4	4.2	4.7	5.7	4.7	5.4	7.6	5.2	4.6	7.7	12.4	5.8	9.9	18.1	6.8	5.7	4.1	3.2	6.7	7.9	5.0	3.9	5.4	4.0	9.1	4.8	6.1	39.1	6.5	7.6	6.1	3.2	3.6	5.2	9.1	4.5	1.5	12.0	4.8	1.0	7.2	1.5	1.9	1.7	4.7	2.6	8.0	6.2	4.0	1.9	3.4	2.5	3.8	1.4	1.6	1.9	3.9	1.5	1.7	2.9	2.6	3.1	5.1	2.0	2.0	1.2	1.8	3.9	0.6	1.7	4.5	2.7	2.7	2.4	6.0	4.3	9.7	2.5	0.6	2.2	1.8	5.1	1.0	1.8	4.3	4.7	2.4	1.2	1.0	7.4	1.6	2.4	6.8	2.8	1.3	2.8	3.2	2.2	3.1	1.2	17.6	13.4	0.7	3.6	1.2	1.2	12.0	2.5	3.4	2.0	2.2	3.7	3.1	4.0	3.0	1.5	4.5	3.9	2.9	7.2	1.0	4.8	1.4	7.2	1.5	4.1	6.0	6.5	5.9	4.2	4.7	5.2	4.6	6.8	6.5
SYAP1	"FLJ14495, PRO3113"	ENSG00000169895	"Synapse associated protein 1"	Q96A49	X	16719632-16765336	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000175, HPA000882, HPA048047"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA000175: AB_1080142, HPA000882: , HPA048047: "	"unprognostic (4.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-3)"	17.6	31.3	13.1	12.9	12.3	26.2	16.5	10.2	14.0	17.1	23.8	12.2	16.1	20.6	17.0	13.7	18.5	14.4	20.7	25.7	13.5	13.7	28.7	51.4	17.6	11.4	15.8	11.0	19.9	14.3	22.8	15.9	18.9	18.4	16.2	16.1	10.7	15.9	21.3	22.5	12.6	33.0	12.3	17.3	13.7	16.9	10.1	11.2	15.3	16.2	13.3	15.1	17.9	13.5	12.6	11.1	17.8	15.0	13.8	15.2	9.1	16.0	13.6	9.8	18.3	13.4	15.2	4.5	12.8	9.2	10.8	10.8	12.7	13.4	12.6	18.9	12.5	9.6	11.9	16.8	14.4	8.2	23.9	5.0	14.6	12.1	9.6	8.5	7.8	10.4	8.0	18.6	15.8	14.8	10.8	7.1	14.5	18.9	4.6	9.2	11.4	15.0	5.0	12.4	12.6	15.9	10.6	10.1	12.4	23.9	17.1	12.7	22.6	7.7	11.6	13.9	7.3	28.1	10.4	7.8	6.6	14.6	13.6	4.3	11.3	9.2	10.5	12.7	15.2	11.3	12.3	12.6	13.0	13.9	11.1	10.8	13.1	13.6	17.8	13.8	15.0	9.2	14.4	9.1	13.1	12.3	10.2	14.0	13.5	13.7	15.8	11.0	18.4	11.2
SYCE1	"bA108K14.6, C10orf94, CT76"	ENSG00000171772	"Synaptonemal complex central element protein 1"	Q8N0S2	10	133553901-133569835	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 75.4"	"Group enriched"	"Detected in some"	8	"K-562: 17.0;U-2 OS: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040208	Enhanced		Uncertain	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA040208: AB_10796450"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"		"unprognostic (1.85e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.75e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	1.8	1.8	4.9	0.7	5.4	0.3	1.3	8.1	8.2	0.4	0.7	0.9	0.0	0.4	0.8	0.5	0.6	1.4	1.6	0.7	4.0	3.3	0.9	3.9	0.5	1.1	1.5	6.7	1.1	1.5	0.2	0.3	8.6	3.5	1.8	0.6	0.2	0.4	0.6	0.9	0.3	0.5	0.7	1.7	0.8	0.5	75.4	0.0	0.1	1.4	0.1	0.7	0.4	0.0	1.3	2.0	0.3	2.6	0.2	3.2	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.7	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.1	0.0	0.5	0.3	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.2	0.1	0.1	0.1	15.8	0.2	0.3	0.2	0.3	0.4	0.0	0.1	0.0	0.0	1.7	0.3	3.2	1.8	3.0	0.9	2.4	0.8	1.2	1.3	1.4	2.7	0.0	0.2	2.6	2.0	2.2	1.8	4.9	5.4	8.1	8.2	4.0	3.3	1.5	6.7	3.5	0.0
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863563-59933655	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 11.1;testis: 41.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.2;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: , HPA065613: "	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	2.2	0.5	1.3	0.9	2.3	1.4	11.1	2.5	5.7	1.3	1.2	1.0	0.8	1.1	1.1	0.9	0.8	0.8	2.0	2.1	1.2	1.2	3.3	0.8	1.6	3.1	1.8	2.7	0.4	4.9	1.3	3.0	2.9	3.9	2.9	0.8	0.6	3.0	0.7	0.8	2.0	1.7	0.6	1.6	2.3	4.5	41.7	0.8	3.0	1.9	0.2	1.5	1.3	1.0	0.9	0.1	2.6	0.3	0.0	2.7	0.5	0.1	0.5	0.1	0.5	0.2	0.3	0.6	1.6	0.4	0.7	0.1	10.2	1.0	0.0	1.6	0.7	0.2	0.2	0.0	0.4	3.2	0.2	0.1	2.0	0.1	0.0	0.1	7.6	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	4.9	21.1	1.1	0.2	0.1	0.0	0.0	0.1	0.9	2.4	0.1	1.8	37.2	5.4	1.1	33.6	1.9	0.2	0.0	1.1	4.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	2.5	0.3	2.3	2.6	0.0	2.7	0.7	1.5	1.7	0.1	0.9	0.9	1.5	2.6	0.0	0.1	0.1	1.0	0.5	1.3	2.3	2.5	5.7	1.2	1.2	1.8	2.7	3.9	0.8
SYDE1	"7h3, FLJ13511, SYD1"	ENSG00000105137	"Synapse defective Rho GTPase homolog 1"	Q6ZW31	19	15107403-15114988	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.0"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013328	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA013328: AB_1848705"	"unprognostic (9.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.65e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (5.63e-7)"	"unprognostic (1.82e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (8.27e-4)"	15.6	7.7	3.5	5.9	4.3	0.1	19.9	2.0	3.5	19.5	13.9	4.4	3.8	4.3	18.6	6.8	10.7	12.2	10.5	9.3	4.0	1.8	9.6	3.3	9.4	4.9	3.1	2.4	17.9	4.6	2.3	3.8	60.0	5.0	11.8	2.9	22.0	3.3	13.6	5.9	4.4	5.7	14.2	2.5	7.6	7.9	7.4	4.3	0.9	8.2	5.8	2.8	12.9	12.8	0.2	0.3	0.0	0.0	0.0	0.5	0.0	4.0	6.3	3.4	8.8	7.7	7.2	2.7	17.2	12.7	17.0	14.4	1.4	2.4	0.0	11.4	17.3	2.6	2.6	3.0	9.5	0.1	3.0	0.6	11.7	2.7	14.7	0.0	0.0	12.5	2.2	10.1	4.6	3.1	0.0	0.0	12.6	2.0	0.0	0.0	5.6	6.5	0.0	8.5	0.0	4.2	0.5	0.1	6.8	9.6	5.9	11.5	0.7	0.4	6.5	40.8	12.4	18.6	18.5	0.0	0.1	0.0	11.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	2.0	3.5	4.0	1.8	3.1	2.4	5.0	4.3
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.7;HEL: 22.3;HL-60: 30.8;HMC-1: 20.5;REH: 25.8;THP-1: 23.7;U-698: 18.3;U-937: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"			1000000	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.2	3.3	6.0	38.1	9.6	18.2	6.7	1.1	4.5	3.7	10.3	6.7	1.5	12.3	2.3	6.7	16.2	6.9	6.6	5.5	7.2	3.2	8.6	2.5	13.7	36.4	9.1	2.5	2.1	8.9	25.9	3.1	5.0	6.1	4.1	8.3	2.8	8.9	1.8	1.4	8.3	22.2	3.5	11.3	38.5	7.4	5.5	7.9	30.5	18.1	7.8	32.2	8.6	7.5	23.1	24.9	32.8	21.4	8.7	0.1	10.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	38.7	1.1	0.0	6.0	0.8	3.2	0.0	0.0	5.3	22.3	0.0	0.0	0.0	30.8	20.5	0.0	4.4	0.0	0.4	0.0	0.6	3.1	0.0	4.7	0.0	13.5	0.2	0.0	25.8	0.0	10.6	0.8	5.8	2.0	1.8	0.0	2.7	0.0	2.5	23.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.3	0.0	21.7	0.0	1.4	21.4	23.3	0.1	19.0	0.1	23.1	0.0	0.0	24.9	17.5	0.0	0.0	32.8	8.7	16.4	18.5	0.0	10.2	6.0	9.6	1.1	4.5	7.2	3.2	9.1	2.5	6.1	7.9
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863290	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: "	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	14.7	15.9	15.3	23.7	24.2	20.7	15.2	25.1	32.2	17.1	18.2	25.3	20.3	18.6	22.6	18.9	17.4	19.3	17.6	14.6	17.3	18.0	15.0	21.6	15.6	27.2	19.3	16.8	21.6	16.3	20.5	24.0	34.8	19.9	17.4	12.2	16.1	21.5	17.5	33.4	21.1	18.0	13.9	18.7	23.0	19.4	38.0	22.0	28.5	20.5	11.6	23.4	16.8	16.7	7.9	9.2	6.5	7.1	4.2	5.2	2.7	19.2	34.1	14.0	10.6	13.7	17.6	23.6	15.5	10.8	15.8	18.0	15.1	17.7	34.1	10.6	17.3	15.9	18.8	16.8	14.2	26.4	21.1	19.7	23.4	15.9	15.8	21.6	23.2	12.8	10.3	16.9	19.4	16.3	25.9	22.3	13.7	18.1	19.9	22.8	11.9	7.9	21.5	16.3	21.1	11.3	35.0	16.0	20.3	18.9	12.3	12.4	16.9	29.9	18.0	13.1	21.1	10.1	22.5	29.6	55.9	27.6	15.0	14.5	21.5	2.1	5.1	2.2	3.4	3.8	3.2	4.7	3.0	5.2	4.2	7.9	2.6	2.4	6.5	4.2	7.1	9.2	2.3	2.7	15.3	24.2	25.1	32.2	17.3	18.0	19.3	16.8	19.9	22.0
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607785-85643792	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275"	Supported		Supported	Nucleoplasm,Cytosol			77000	Nucleoplasm	Cytosol	"CAB010895: AB_261964, HPA041275: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavourable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favourable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	29.1	28.3	27.9	31.3	36.2	30.4	28.4	35.6	37.9	32.9	29.4	19.2	31.8	20.4	32.7	18.9	48.8	24.5	21.9	31.3	29.3	19.0	25.2	31.3	25.7	35.0	31.9	23.1	26.2	34.9	37.5	27.9	31.3	28.2	23.1	29.6	17.3	31.4	32.8	41.4	27.2	23.7	53.5	28.1	24.7	25.4	19.8	30.1	38.1	42.0	29.8	41.7	31.2	39.4	13.2	20.9	4.6	20.0	18.1	18.6	12.6	31.9	24.0	40.0	23.3	26.3	31.4	25.4	47.4	39.1	43.0	42.7	39.2	21.0	75.5	34.6	45.6	31.0	58.5	47.1	75.5	25.9	26.8	67.3	28.9	26.9	22.2	82.1	29.0	25.7	27.1	49.2	50.7	45.3	67.4	35.6	49.7	35.2	38.4	35.0	38.3	25.5	57.7	64.0	32.0	35.2	51.2	37.7	30.6	33.0	27.9	19.4	24.2	51.2	41.5	29.2	23.9	30.5	56.6	22.3	43.9	49.8	26.8	49.7	40.6	1.0	13.0	4.6	17.7	18.6	18.6	13.2	16.8	15.9	20.9	11.9	15.3	16.6	1.6	18.1	20.0	15.5	16.7	12.6	27.9	36.2	35.6	37.9	29.3	19.0	31.9	23.1	28.2	30.1
SYNGR1		ENSG00000100321	"Synaptogyrin 1"	O43759	22	39349925-39385588	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 21.0;monocytes: 18.9;T-cells: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029673, CAB034277"	Enhanced		Supported	Cytosol				Cytosol		"CAB034277: AB_2255766, HPA029673: AB_10670430"	"unprognostic (2.68e-3)"	"unprognostic (1.84e-3)"	"unprognostic (5.90e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-2)"	"prognostic favourable (2.41e-4)"	"unprognostic (1.16e-1)"	"prognostic favourable (4.98e-7)"	"unprognostic (1.32e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.04e-1)"	4.4	11.4	19.4	2.7	31.4	39.9	8.0	66.9	62.0	15.6	6.3	8.5	1.0	3.3	9.2	6.5	17.3	9.8	6.1	21.6	31.6	22.3	5.5	2.0	3.3	3.8	17.4	35.1	38.8	14.5	10.3	4.1	3.7	23.5	10.9	2.6	19.5	23.5	10.4	13.4	26.2	3.0	7.2	7.0	4.1	4.8	7.2	5.4	0.7	4.6	4.6	5.2	7.8	9.0	2.4	21.0	0.8	18.9	2.6	15.2	7.8	2.6	4.7	8.6	15.4	0.8	2.2	3.8	11.4	20.1	14.5	13.4	1.0	0.3	0.1	2.6	3.0	3.7	5.8	0.2	4.4	0.0	18.0	0.2	0.3	0.5	2.5	0.7	5.3	3.3	0.9	4.0	0.0	0.7	5.1	0.3	2.2	6.0	2.3	2.1	1.7	9.2	6.7	0.0	0.7	0.4	7.3	13.6	2.8	2.9	12.4	11.8	18.3	13.4	0.2	0.0	10.1	0.1	0.0	3.1	0.1	7.2	0.4	14.5	15.5	0.2	18.9	0.3	15.2	5.5	0.9	2.4	0.6	4.4	21.0	2.2	0.7	8.2	0.8	2.6	0.2	15.3	0.1	7.8	19.4	31.4	66.9	62.0	31.6	22.3	17.4	35.1	23.5	5.4
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728048	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	5.5	6.8	13.6	5.0	25.9	20.6	4.2	19.5	39.0	4.8	4.8	6.5	0.8	3.9	4.6	5.3	3.9	4.0	5.2	5.2	18.3	18.2	7.4	5.5	6.5	5.7	16.6	18.4	4.6	4.5	10.6	10.9	9.3	33.5	3.6	5.5	7.0	3.8	4.0	4.4	5.0	4.6	5.0	7.3	6.0	4.2	9.0	5.7	3.2	6.8	1.5	4.8	4.7	3.3	0.4	3.1	11.5	6.0	0.5	3.0	1.1	5.5	2.8	5.1	5.6	8.9	7.2	10.3	11.5	6.6	7.0	5.9	6.3	2.6	2.0	3.9	6.9	5.2	9.1	6.7	8.4	6.5	8.7	13.8	9.0	3.5	4.8	5.7	12.3	4.0	5.0	12.2	6.2	10.9	10.3	11.9	9.0	5.6	5.3	4.7	3.6	6.3	5.8	11.1	7.2	7.4	4.0	5.8	4.5	14.1	9.0	5.5	7.8	7.4	12.1	10.9	5.4	8.7	6.3	6.2	7.2	4.3	8.2	10.8	8.6	3.7	3.4	7.9	1.6	6.0	2.7	0.2	2.4	2.6	3.1	0.4	2.9	2.8	11.5	0.5	5.3	1.6	3.0	1.1	13.6	25.9	19.5	28.7	18.3	18.2	16.6	18.4	33.5	5.7
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981887-158099176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 62.0"	"Cell line enhanced"	"Detected in many"		"TIME: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol				Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavourable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	2.8	3.9	12.2	4.9	25.1	15.3	6.7	3.0	18.7	3.9	8.7	50.5	3.7	5.8	5.2	9.4	6.0	4.6	8.0	8.5	17.8	10.9	3.2	4.0	2.8	4.4	46.8	8.8	2.9	6.6	1.1	2.9	2.6	33.0	5.3	8.9	1.4	13.5	5.1	4.3	3.1	5.6	6.6	62.0	3.3	7.0	6.5	24.4	3.0	4.4	1.4	5.3	5.9	3.0	3.2	1.1	9.3	1.3	2.4	3.8	0.8	5.9	20.9	1.7	2.7	1.3	4.3	9.3	11.0	22.4	13.2	15.6	10.7	5.1	0.2	7.5	21.2	5.7	3.7	6.9	15.4	8.3	3.4	11.6	10.9	11.3	2.5	4.0	12.6	2.2	3.7	20.1	4.7	22.9	8.8	2.6	6.0	2.8	5.0	4.5	2.0	11.7	2.2	7.2	5.3	4.4	6.9	13.3	0.7	8.5	5.4	2.1	4.2	2.5	40.5	10.0	10.3	23.1	13.3	1.1	2.8	0.3	18.8	6.4	6.9	4.5	1.3	1.1	1.9	0.6	3.8	1.9	2.6	1.7	1.1	3.2	2.2	1.7	9.3	2.4	0.8	1.1	2.1	0.8	12.2	25.1	3.0	18.7	17.8	10.9	46.8	8.8	33.0	24.4
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659220	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 25.8;EFO-21: 21.3;HUVEC TERT2: 20.9;TIME: 50.7;U-87 MG: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 2.9;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	27	"B-cells: 3.3"	"Group enriched"	"Detected in many"	6	"amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1"	"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: "	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	17.3	14.6	17.7	4.4	18.9	0.6	5.7	1.4	24.9	4.3	5.5	2.4	0.8	6.6	5.1	4.8	6.7	4.4	6.8	66.1	16.6	4.0	15.8	7.8	11.7	2.4	4.5	5.6	23.3	6.8	2.5	2.8	63.4	3.7	7.6	4.1	16.4	2.6	6.7	222.7	1.8	7.6	8.2	4.8	14.5	4.7	17.4	3.9	0.5	4.0	5.7	2.6	6.2	17.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.1	1.0	0.9	25.8	3.9	5.4	1.3	1.1	6.0	2.8	0.0	21.3	5.6	2.5	0.0	3.8	0.5	0.0	0.0	0.0	10.4	1.3	5.8	0.0	0.2	1.1	6.2	1.5	1.1	20.9	0.0	0.0	1.2	0.4	0.0	0.1	0.8	3.3	0.1	0.2	0.0	1.0	0.5	2.4	11.5	5.6	6.2	0.2	0.4	1.8	50.7	5.1	15.9	0.1	1.0	0.2	0.0	0.3	44.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.7	18.9	1.4	24.9	16.6	4.0	4.5	5.6	3.7	3.9
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"				"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: , HPA057142: "	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.2	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.5	0.7	0.3	0.5	0.9	0.1	0.1	0.0	0.4	0.1	0.2	0.3	0.6	0.4	0.6	0.2	0.2	6.0	0.1	1.2	0.1	0.0	0.3	0.3	0.3	0.3	0.2	1.8	0.2	0.7	0.2	5.8	0.2	0.0	0.6	0.3	0.4	0.1	6.1	0.1	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
SYNRG	"AP1GBP1, MGC104959, SYNG"	ENSG00000275066	"Synergin gamma"	Q9UMZ2	17	37514797-37609496	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023554, HPA023555"	Approved		Approved	Cytosol				Cytosol		"HPA023554: AB_1844892, HPA023555: AB_2058337"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.91e-2)"	"prognostic favourable (3.96e-4)"	6.3	5.9	5.4	10.3	9.4	4.8	5.2	9.4	8.6	5.5	6.0	10.4	4.3	5.4	7.4	8.7	5.4	5.0	5.8	6.2	4.8		7.0	5.6	5.7	14.2	6.9	6.3	5.8	6.4	9.6	14.5	5.9	10.8	5.8	6.8	6.2	6.2	6.2	7.3	4.6	5.7	4.8	8.5	10.4	7.5	10.9	8.2	22.7	7.0	3.8	14.2	6.5	4.0	10.4	11.4	8.0	3.4	13.8	13.8	3.2	5.3	8.6	11.7	7.5	7.3	8.0	5.6	8.0	8.1	9.1	11.0	7.7	8.7	9.7	7.6	7.3	5.3	10.1	4.4	12.8	8.9	7.1	5.2	5.4	4.5	9.4	8.4	12.1	9.4	9.1	11.1	5.7	13.0	11.3	8.7	9.7	4.0	19.3	5.1	4.9	3.6	12.1	9.8	6.3	7.5	9.5	9.9	8.4	7.9	2.5	6.3	7.2	6.4	11.6	6.4	8.1	5.4	7.3	10.1	12.5	17.7	7.9	4.6	6.5	8.0	3.4	7.2	10.4	2.6	13.8	8.9	9.1	10.5	2.9	10.4	9.4	9.2	7.0	13.8	2.5	11.4	9.2	3.2										
SYPL2	Mg29	ENSG00000143028	"Synaptophysin like 2"	Q5VXT5	1	109466628-109482137	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 102.5;tongue: 25.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.8;ASC TERT1: 8.3;BJ: 8.4;BJ hTERT+: 26.7;fHDF/TERT166: 13.8;HAP1: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076657			Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA076657: "	"unprognostic (1.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.90e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (3.05e-4)"	"unprognostic (2.54e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.39e-4)"	0.9	3.9	0.8	0.3	0.7	0.1	1.4	0.5	1.2	1.6	1.9	0.3	0.8	0.3	2.5	4.3	1.6	0.4	1.1	7.4	0.8	0.2	6.0	4.7	0.6	0.3	0.3	0.0	1.1	3.2	3.7	0.4	1.2	0.8	1.2	0.5	1.7	1.6	2.2	102.5	0.2	0.6	3.5	0.1	0.4	1.1	6.0	0.2	0.0	5.1	25.6	1.2	2.5	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	19.8	8.3	0.0	8.4	26.7	2.6	1.0	0.0	0.0	0.0	0.0	13.8	0.0	7.1	0.0	0.5	0.0	3.1	0.0	0.2	0.1	0.4	0.0	0.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	2.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	1.2	0.8	0.2	0.3	0.0	0.8	0.2
SYT16	"CHR14SYT, Strep14, SYT14L, yt14r"	ENSG00000139973	"Synaptotagmin 16"	Q17RD7	14	61811974-62112550	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 20.8;testis: 6.8"	"Cell line enhanced"	"Detected in some"		"A-431: 10.4;PC-3: 5.4;RPTEC TERT1: 6.3;RT4: 16.7;U-2 OS: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004199, HPA076871"	Enhanced		Approved	Cytosol				Cytosol		"HPA004199: AB_1080156, HPA076871: "	"unprognostic (2.55e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (8.88e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.08e-2)"		"unprognostic (9.57e-2)"	"unprognostic (9.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.15e-1)"	0.4	1.3	7.2	0.4	17.2	0.6	0.6	0.7	20.8	0.4	0.4	0.4	0.0	0.4	1.0	2.1	0.4	0.7	0.5	0.5	3.3	3.4	0.7	0.4	0.5	0.5	1.6	12.3	0.4	4.0	0.4	1.9	1.1	1.8	4.6	0.4	0.0	0.4	0.6	0.4	0.5	0.5	0.4	0.9	0.5	2.6	6.8	0.7	0.0	0.5	0.0	0.4	0.9	0.6	0.2	0.1	0.6	0.1	0.1	0.2	0.0	10.4	0.2	0.3	0.0	0.0	0.0	0.1	0.7	1.0	1.0	0.6	0.0	0.0	0.1	0.2	0.0	0.5	0.0	1.0	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	5.4	0.0	0.0	0.0	6.3	16.7	0.3	2.9	0.5	0.7	0.0	0.0	0.0	0.0	2.8	6.8	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.6	0.1	0.1	0.1	0.0	0.0	7.2	17.2	0.7	18.9	3.3	3.4	1.6	12.3	1.8	0.7
SYT17		ENSG00000103528	"Synaptotagmin 17"	Q9BSW7	16	19167971-19268334	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.2;CAPAN-2: 19.9;Daudi: 8.7;MCF7: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 4.1;memory B-cell: 5.1;naive B-cell: 14.7;non-classical monocyte: 13.4"	"Group enriched"	"Detected in many"	8	"B-cells: 14.7;monocytes: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042059			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042059: "	"unprognostic (3.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.32e-2)"	"unprognostic (4.95e-3)"	3.8	5.2	16.5	1.4	9.2	0.4	4.7	1.0	25.2	3.5	2.4	6.1	1.2	4.3	1.2	3.1	4.0	2.5	1.3	1.3	15.5	16.5	3.8	12.1	7.8	3.2	13.9	10.2	0.8	2.5	21.3	13.4	3.9	7.5	9.7	3.0	7.6	1.5	3.8	0.4	9.9	2.1	1.0	5.5	1.4	4.3	0.6	7.4	0.0	7.1	0.8	4.7	4.2	3.8	14.7	1.6	0.4	13.4	0.0	0.0	0.6	0.0	7.3	0.1	0.0	0.2	0.5	10.2	0.0	0.0	0.0	0.0	0.3	19.9	8.7	2.4	0.0	3.5	0.5	0.3	0.0	0.0	1.4	0.0	7.3	0.1	0.0	0.0	0.0	0.7	1.8	0.1	0.0	0.3	0.0	0.0	0.0	15.0	0.0	0.0	0.8	4.1	0.0	0.8	0.6	2.5	4.4	1.5	0.9	2.8	7.9	0.4	7.8	1.8	0.0	0.0	5.2	0.1	0.0	1.4	0.0	8.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	4.1	0.0	5.1	0.0	0.0	1.6	14.7	0.0	0.0	0.1	0.0	13.4	0.2	0.0	0.6	16.5	9.2	1.0	22.9	15.5	16.5	13.9	10.2	7.5	7.4
SYTL5		ENSG00000147041	"Synaptotagmin like 5"	Q8TDW5	X	38006582-38128819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;MCF7: 6.3;SK-MEL-30: 16.4;U-2 OS: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026074	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA026074: AB_1857697"	"unprognostic (3.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	0.5	6.0	10.5	3.4	11.0	0.0	2.9	0.5	2.5	7.0	7.3	0.5	0.5	2.3	2.6	1.0	12.2	0.2	2.9	0.9	9.2	8.9	1.0	6.1	2.4	0.5	2.4	0.5	0.5	6.4	0.0	1.1	17.0	0.5	2.0	3.5	1.5	7.1	1.7	0.5	0.0	14.3	3.9	1.3	0.8	13.8	0.7	0.5	0.7	0.9	1.2	5.9	1.3	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	6.8	1.6	0.0	0.0	0.6	0.7	0.0	0.0	0.1	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.1	0.1	0.2	0.3	6.3	0.0	0.0	2.9	0.0	0.0	2.3	0.0	0.0	0.4	3.6	0.1	0.3	1.4	16.4	0.0	0.0	0.0	0.2	5.5	0.0	3.6	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.5	11.0	0.5	2.5	9.2	8.9	2.4	0.5	0.5	0.5
SZRD1	"C1orf144, DKFZp566C0424"	ENSG00000055070	"SUZ RNA binding domain containing 1"	Q7Z422	1	16352575-16398145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024221	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA024221: AB_10603450"	"unprognostic (3.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (5.98e-6)"	"unprognostic (2.53e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.60e-2)"	34.9	30.7	23.1	25.0	26.3	37.5	33.1	17.1	20.6	30.7	29.0	20.8	15.4	23.0	38.5	23.2	33.7	26.5	30.5	37.0	23.5	14.3	39.8	41.4	26.2	27.2	27.4	11.8	36.3	25.1	32.2	16.8	46.4	22.4	24.8	20.9	27.9	20.8	23.7	55.2	24.9	39.3	31.3	20.9	40.6	27.1	18.3	25.0	32.1	35.0	27.6	33.6	34.3	35.1	30.4	19.2	34.3	36.7	20.0	25.5	29.6	37.4	28.8	39.9	27.6	34.1	39.4	13.2	38.4	50.0	45.7	35.6	28.8	33.4	32.9	43.1	51.2	20.7	35.7	42.3	33.9	56.6	30.9	37.7	31.0	22.6	30.8	36.6	37.2	39.7	35.5	49.8	33.4	39.5	33.7	31.0	41.7	36.4	35.7	27.9	27.8	33.0	36.6	42.1	38.6	31.0	17.6	31.6	33.0	33.6	21.7	48.6	22.5	24.2	44.0	31.2	36.5	48.6	38.1	17.2	18.9	39.6	34.8	50.1	41.2	15.0	24.3	34.3	24.5	33.2	24.2	28.3	21.2	22.8	19.2	30.4	19.6	21.1	27.1	20.0	36.7	14.9	25.5	29.6	23.1	26.3	17.1	20.6	23.5	14.3	27.4	11.8	22.4	25.0
TAB1	MAP3K7IP1	ENSG00000100324	"TGF-beta activated kinase 1 (MAP3K7) binding protein 1"	Q15750	22	39399741-39437060	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032328, HPA039988, HPA057104"	Approved		Enhanced	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB032328: AB_2281637, HPA039988: , HPA057104: "	"unprognostic (1.76e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.73e-3)"	"unprognostic (9.23e-3)"	"unprognostic (4.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	12.2	14.9	18.3	13.6	20.8	13.6	12.5	24.7	28.1	16.9	16.2	32.0	10.9	16.9	18.8	10.7	13.6	17.9	19.2	18.9	17.9	15.7	12.4	14.8	13.7	15.8	22.7	18.8	26.7	19.5	16.3	12.5	13.8	15.9	16.9	9.1	19.6	21.6	19.1	27.8	17.3	15.7	14.3	17.2	17.2	14.4	11.9	20.6	13.0	13.3	10.9	13.0	16.8	14.3	5.9	8.2	6.1	8.7	5.2	7.6	6.3	12.0	12.5	12.8	14.6	13.6	11.5	11.3	10.1	12.6	15.6	14.8	11.5	8.7	18.3	8.0	9.8	14.8	12.9	14.8	6.2	14.1	20.7	8.0	15.4	11.3	11.9	15.0	15.4	11.6	13.2	11.7	12.8	11.3	14.6	12.6	7.7	7.8	11.5	12.5	8.9	12.8	20.9	18.2	18.2	12.0	12.9	11.4	8.4	14.4	17.9	12.6	14.6	16.6	9.7	10.9	17.3	8.3	8.2	19.9	12.8	13.3	12.8	10.7	10.6	1.4	8.7	6.1	7.6	7.2	6.2	5.9	4.6	6.1	8.2	5.9	7.5	6.7	1.3	5.2	6.7	3.8	4.6	6.3	18.3	20.8	24.7	28.1	17.9	15.7	22.7	18.8	15.9	20.6
TAB3	MAP3K7IP3	ENSG00000157625	"TGF-beta activated kinase 1 and MAP3K7 binding protein 3"	Q8N5C8	X	30827442-30975084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034980, HPA034981"	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA034980: AB_10602708, HPA034981: "	"unprognostic (4.39e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.51e-1)"	"prognostic favourable (8.45e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.75e-1)"	6.1	8.0	5.9	6.6	6.9	10.1	6.5	9.1	9.2	7.6	6.5	4.2	17.9	5.2	40.3	7.4	13.2	9.2	10.6	6.9	6.1	5.3	16.9	23.3	8.0	8.1	6.7	6.6	11.3	17.3	25.0	9.4	39.3	9.1	12.9	6.7	9.3	11.5	15.0	8.8	8.1	7.4	9.6	5.2	7.1	8.4	26.7	3.6	8.3	7.7	14.5	15.6	6.6	7.9	1.0	0.6	0.8	1.1	3.9	1.0	0.4	22.8	5.5	5.7	5.8	4.4	6.7	6.0	7.0	8.9	4.8	5.4	6.2	19.6	10.4	4.3	8.2	11.9	8.7	18.1	7.0	17.7	8.4	9.7	6.4	15.1	3.9	10.1	7.5	4.8	10.9	8.2	21.0	7.9	11.0	8.5	6.2	11.0	8.0	5.1	6.8	9.3	5.2	10.0	7.7	8.0	6.7	4.7	6.7	7.9	12.0	15.3	10.3	4.1	7.6	5.3	7.8	26.6	6.5	11.1	8.4	10.3	8.3	4.8	7.4	0.2	0.5	0.8	0.7	1.1	0.9	0.8	1.0	0.4	0.6	1.0	1.0	1.0	0.8	3.9	0.8	0.3	0.6	0.4	5.9	6.9	9.1	9.2	6.1	5.3	6.7	6.6	9.1	3.6
TACC1		ENSG00000147526	"Transforming acidic coiled-coil containing protein 1"	O75410	8	38728186-38853028	"Predicted intracellular proteins"	"Cell cycle, Cell division"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017041, HPA024702, HPA056841"	Approved		Approved	Cytosol				Cytosol		"CAB017041: , HPA024702: AB_1857723, HPA056841: "	"unprognostic (1.83e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.31e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.94e-2)"	"prognostic favourable (1.06e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.18e-1)"	55.9	12.8	15.0	15.3	16.7	23.3	39.4	8.2	20.4	32.1	31.9	16.8	25.7	8.3	44.9	16.1	28.7	29.9	18.9	19.9	14.6	12.4	21.3	9.1	26.6	15.0	17.5	13.1	19.5	17.4	13.6	8.1	28.8	15.2	22.8	18.0	23.9	11.8	32.0	20.5	10.4	17.5	36.6	17.4	28.0	20.2	14.2	16.5	8.1	18.5	15.5	13.3	40.0	39.6	1.6	21.2	19.0	8.0	2.3	4.1	3.1	10.5	20.4	15.0	4.6	16.1	11.3	9.7	13.7	17.9	13.2	13.5	9.4	1.6	10.7	8.4	13.5	10.1	8.9	6.2	27.4	7.6	3.3	42.0	6.3	6.0	19.0	8.3	19.4	20.5	5.8	21.3	6.9	47.2	4.3	27.1	39.7	7.8	19.6	4.8	2.1	9.6	4.4	33.6	1.9	4.4	10.4	1.0	1.1	11.1	11.5	9.3	5.3	6.5	37.8	16.0	9.7	20.4	11.0	14.1	9.2	9.7	14.6	9.7	19.3	6.4	6.9	9.0	3.8	6.2	4.1	1.3	2.6	3.1	4.5	1.6	2.2	2.4	19.0	2.3	8.0	21.2	2.0	3.1	15.0	16.7	8.2	20.4	14.6	12.4	17.5	13.1	15.2	16.5
TACC2	AZU-1	ENSG00000138162	"Transforming acidic coiled-coil containing protein 2"	O95359	10	121989174-122254545	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 109.4"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA031020, HPA031021, HPA061394"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			110000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA031020: AB_10669988, HPA031021: , HPA061394: "	"unprognostic (3.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-2)"	"prognostic favourable (2.50e-10)"	"unprognostic (7.02e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (8.45e-4)"	"unprognostic (1.61e-1)"	8.2	5.8	9.6	2.4	11.7	0.6	7.8	17.7	16.6	6.9	17.2	2.6	4.0	6.3	8.4	4.3	13.4	9.6	7.7	43.3	8.0	4.8	19.3	3.8	54.1	0.8	3.1	9.0	4.7	6.3	11.9	41.0	45.4	6.8	12.0	8.6	4.8	18.5	6.0	109.4	28.9	8.2	8.9	3.2	1.3	10.2	2.2	3.9	0.1	19.6	4.4	2.5	15.1	8.8	0.1	0.1	0.3	0.0	0.1	0.2	0.0	7.0	22.4	11.0	6.2	3.1	3.2	13.3	3.1	8.5	4.4	3.1	9.1	11.8	0.0	2.9	4.9	23.8	3.5	8.5	4.6	1.1	1.8	0.0	2.8	17.4	4.9	0.0	0.1	1.4	35.9	2.3	15.4	9.1	1.7	0.2	4.2	9.3	0.0	3.9	6.5	10.2	0.1	6.3	3.3	11.8	10.9	7.3	6.0	5.1	21.5	11.4	4.2	0.1	8.4	2.0	1.4	4.9	5.8	1.0	4.4	0.1	3.7	0.0	5.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	9.6	11.7	17.7	16.6	8.0	4.8	3.1	9.0	6.8	3.9
TACC3	ERIC1	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1721490-1745176	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.8"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: , HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	3.8	2.7	1.1	39.1	1.1	26.0	3.4	2.1	1.4	1.9	4.4	1.1	0.8	4.5	1.8	2.7	8.8	1.6	3.5	2.0	1.4	1.3	2.5	2.4	4.3	20.1	1.3	0.7	1.6	1.0	0.5	1.8	5.7	1.1	1.6	4.9	1.6	3.0	1.2	2.0	2.6	7.7	2.5	1.8	15.6	3.4	58.1	0.9	64.3	1.6	7.3	27.9	3.2	3.0	4.0	10.4	54.8	19.9	3.8	17.9	16.1	25.2	21.0	32.2	18.5	1.7	3.6	18.2	28.6	15.3	32.9	21.8	23.2	30.5	32.2	12.2	15.6	17.1	34.0	20.8	33.5	14.1	18.4	27.3	17.4	21.4	1.6	36.9	23.2	1.5	1.4	20.7	12.0	24.9	24.6	25.5	31.2	20.6	48.6	52.8	34.8	27.6	34.4	22.8	12.9	18.7	38.2	25.1	15.8	17.2	10.9	8.0	21.4	21.4	14.6	19.2	23.0	17.3	43.1	17.9	23.6	51.6	11.1	35.7	27.1	24.7	19.9	17.9	5.5	9.0	6.0	4.0	12.3	7.6	10.4	3.8	17.9	9.8	54.8	3.8	5.5	3.1	17.5	16.1	1.1	1.1	2.1	1.4	1.4	1.3	1.3	0.7	1.1	0.9
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876327	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"				Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	6.5	10.6	13.8	7.1	18.5	17.8	10.2	18.2	20.0	11.3	9.1	17.0	3.4	8.3	10.5	8.6	10.1	9.8	6.6	9.2	13.2	14.6	12.9	28.9	6.7	10.1	11.1	14.3	12.7	7.5	11.3	13.7	12.5	15.0	9.2	10.2	13.4	8.7	8.4	10.7	8.5	9.0	8.5	10.8	7.3	8.0	12.0	10.3	16.7	11.5	7.1	10.9	8.6	7.8	13.4	13.0	8.1	8.2	16.2	19.5	15.1	8.1	7.8	14.8	8.7	4.5	5.7	8.8	4.3	5.2	7.2	6.2	7.1	6.6	15.5	8.4	5.0	6.3	11.9	7.6	5.8	9.8	11.3	5.1	6.7	11.6	6.6	14.4	9.5	4.3	8.8	4.3	10.8	5.9	18.3	9.4	5.6	5.6	17.7	11.5	22.4	8.8	15.0	6.5	19.6	9.6	10.9	9.5	16.6	7.7	10.0	9.0	13.6	15.2	4.3	5.9	6.8	6.4	9.0	13.5	18.3	29.0	4.1	6.6	5.5	1.8	8.1	8.1	14.0	8.2	15.5	13.1	15.2	15.8	13.0	13.4	19.5	15.3	1.3	16.2	6.2	8.5	14.3	15.1	13.8	18.5	18.2	20.0	13.2	14.6	11.1	14.3	15.0	10.3
TAF6	"MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85"	ENSG00000106290	"TATA-box binding protein associated factor 6"	P49848	7	100107070-100119841	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006566	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006566: AB_1080194"	"unprognostic (5.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavourable (6.06e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.37e-1)"	14.1	19.8	21.5	15.4	23.6	13.9	12.0	23.5	35.8	19.4	17.5	12.7	12.6	12.1	24.1	17.6	16.8	23.6	16.8	17.2	20.5	16.3	16.1	10.2	12.9	14.3	13.1	15.9	26.2	16.6	22.6	21.7	19.5	19.3	15.8	13.7	15.6	17.9	23.3	23.1	17.9	13.2	23.7	13.1	14.6	14.0	27.3	14.7	21.7	21.3	11.5	17.0	19.6	14.9	15.3	14.3	13.2	25.7	14.0	18.7	13.1	17.1	32.2	20.8	34.2	27.5	14.6	29.2	18.9	21.2	24.3	22.6	23.9	20.9	15.7	21.6	28.9	14.5	28.6	22.5	26.2	25.6	18.6	15.1	31.2	15.7	27.3	14.5	14.3	14.8	14.1	35.7	39.5	19.7	26.1	29.0	21.9	60.9	30.9	23.7	30.8	25.9	22.9	25.6	23.2	17.3	14.0	19.0	27.6	23.8	37.1	15.8	13.5	14.5	19.5	37.0	38.0	47.8	24.4	17.9	31.0	26.4	25.1	20.5	31.8	12.7	11.0	13.2	15.6	11.4	18.7	10.2	15.0	15.7	14.3	15.3	15.3	14.3	6.4	14.0	25.7	8.5	13.9	13.1	21.5	23.6	23.5	35.8	20.5	16.3	13.1	15.9	19.3	14.7
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.9;bone marrow: 55.6;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.1;HMC-1: 20.6;Karpas-707: 21.4;U-266/84: 9.6;U-698: 19.8;U-937: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Uncertain	Cytosol				Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	4.4	2.3	1.5	16.9	2.1	55.6	2.5	0.9	2.0	1.9	2.5	7.9	1.3	1.7	9.7	1.8	2.7	2.1	4.1	2.0	1.9	3.7	2.2	2.4	8.4	32.7	5.0	1.1	1.9	1.0	0.4	1.4	2.8	3.9	1.9	3.6	3.2	3.2	1.8	0.8	1.4	11.8	12.2	9.2	22.1	2.7	1.7	3.0	32.6	2.2	4.0	32.1	6.8	1.9	14.9	7.8	47.9	7.7	12.0	22.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.1	0.0	0.0	0.0	7.3	20.6	0.1	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	1.9	3.8	5.8	0.0	0.6	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	2.3	9.6	19.8	0.0	15.8	0.0	38.7	7.7	23.6	16.4	5.5	18.5	13.9	22.0	19.0	7.8	14.9	17.4	12.1	47.9	12.0	7.0	2.6	15.5	14.4	1.5	2.1	0.9	2.0	1.9	3.7	5.0	1.1	3.9	3.0
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199321-117204782	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 136.3;BJ hTERT+ SV40 Large T+: 129.6;CACO-2: 122.3;EFO-21: 162.6;fHDF/TERT166: 138.9;LHCN-M2: 95.9;U-138 MG: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 19.0;non-classical monocyte: 26.6"	"Lineage enriched"	"Detected in many"	10	"monocytes: 26.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 176.0"	"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol			8000000	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	73.3	22.6	2.3	67.6	5.9	0.2	60.8	2.1	7.7	278.3	328.7	6.1	156.2	22.3	399.7	156.8	337.9	133.3	227.5	48.7	3.1	3.0	49.5	12.9	44.1	38.6	7.1	11.8	159.2	9.3	1.5	8.0	36.2	14.9	237.5	51.6	39.1	24.1	347.5	36.6	17.9	81.0	481.9	9.1	26.0	114.7	65.1	2.1	1.1	47.3	30.0	11.2	473.0	78.1	2.6	1.4	0.8	26.6	0.0	0.3	0.9	1.2	0.3	21.4	0.5	10.0	9.0	18.0	136.3	59.1	129.6	48.5	122.3	1.9	0.2	162.6	138.9	3.2	0.3	1.1	36.9	0.4	0.2	0.3	4.5	8.3	55.7	0.1	0.3	23.7	4.6	18.9	2.4	0.2	0.2	0.4	95.9	0.2	0.1	1.0	6.5	0.1	0.1	1.6	0.6	0.2	1.7	0.1	0.5	2.1	0.7	0.1	0.6	0.3	14.6	126.3	21.3	0.9	5.8	0.6	0.4	1.0	0.7	0.4	0.3	0.8	1.1	0.0	0.1	19.0	0.2	1.6	0.0	0.0	1.4	2.6	0.1	0.0	0.1	0.0	26.6	0.7	0.3	0.9	2.3	5.9	2.1	7.7	3.1	3.0	7.1	11.8	14.9	2.1
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925732	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"		540000000	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavourable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	80.6	26.4	19.7	57.5	25.6	47.9	62.8	7.9	18.3	49.1	45.9	16.6	54.5	43.3	39.2	49.4	96.3	36.3	63.6	57.3	15.9	18.5	68.0	178.2	107.7	65.0	24.3	9.8	45.7	51.2	8.8	18.1	122.2	24.8	43.8	43.0	24.7	67.2	62.9	35.3	62.6	74.6	36.2	20.0	95.8	96.8	46.4	20.2	60.5	37.7	150.7	76.5	57.2	62.0	53.0	114.4	220.7	42.4	44.0	41.7	106.7	109.5	59.2	1.8	0.6	21.2	52.7	68.4	61.7	71.0	134.4	65.4	61.4	86.0	68.1	52.6	73.3	86.0	30.3	76.9	82.9	77.6	24.6	90.7	57.5	3.6	25.0	63.7	102.2	52.3	59.8	79.1	41.0	80.9	38.8	47.9	45.8	41.7	28.8	40.2	51.1	101.1	0.2	31.6	101.7	27.8	43.0	28.4	26.9	72.4	118.6	31.8	62.6	62.8	92.8	80.5	93.6	72.9	166.2	19.3	8.6	39.9	104.1	40.9	49.5	66.9	42.4	177.0	34.7	25.2	30.6	53.0	38.6	33.4	68.5	39.7	20.4	22.4	220.7	44.0	18.9	114.4	41.7	106.7	19.7	25.6	7.9	18.3	15.9	18.5	24.3	9.8	24.8	20.2
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663112	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"blood: 8.8;kidney: 4.6;skeletal muscle: 17.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.8;K-562: 12.6"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"					"Group enriched"	"Detected in some"	21	"memory B-cell: 8.8;naive B-cell: 7.9;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	18	"B-cells: 8.8;dendritic cells: 2.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol				Cytosol		"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favourable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"	0.1	0.3	0.5	0.1	0.7	0.0	0.0	0.3	0.6	0.2	0.0			0.0	0.2	0.9	0.1	0.2	0.0	0.3	0.4	0.5	4.6	0.3	0.0	0.2	0.7		0.3	0.1	0.0	0.8	0.1		0.1	0.1		0.0	0.2	17.3	0.1	0.1	0.0	0.8	0.3	0.0	0.6			0.1		0.4	0.1	0.0	8.8	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.6	2.5	0.7	0.3	0.0	0.3	0.1	0.3	0.1	0.4	3.3	0.2	0.1	0.2	0.0	0.1	4.8	0.0	0.1	0.6	0.5	1.1	0.0	0.0	0.2	0.5	1.8	0.2	0.5	0.1	0.2	0.0	12.6	0.3	0.4	0.3	0.8	0.7	0.2	0.2	0.1	0.1	0.0	0.0	0.0	2.8	1.1	0.2	0.2	0.2	0.2	2.0	0.5	0.3	0.8	0.7	1.0	0.9	1.9	0.1	0.2	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.1										
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747329-765024	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 148.6;neutrophil: 204.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol			39000000	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	39.0	24.2	26.6	34.8	31.3	117.4	44.2	20.6	38.3	27.7	28.5	51.2	18.8	34.2	20.4	20.7	90.0	23.2	33.2	37.5	29.2	23.6	45.8	48.4	37.9	60.0	46.5	26.6	23.4	31.9	14.6	15.8	34.3	30.7	28.3	23.7	15.5	38.3	19.5	31.2	38.4	29.4	40.4	47.5	45.6	35.8	14.8	33.0	34.1	42.2	82.4	43.1	51.4	37.5	8.5	36.1	204.6	60.8	5.9	10.4	45.3	41.9	53.1	15.4	29.1	31.9	18.6	45.4	31.9	41.1	31.6	26.1	22.6	91.6	23.4	43.4	41.8	45.4	24.3	34.4	16.5	30.6	49.3	40.5	20.6	78.8	34.1	64.7	60.5	15.2	27.8	21.2	17.2	43.4	52.5	39.2	29.3	40.1	37.6	76.8	24.2	43.1	31.4	18.1	83.9	57.4	24.5	38.0	13.3	29.7	61.5	30.9	29.2	49.3	57.6	14.5	13.6	11.4	29.9	16.6	16.1	27.8	32.1	56.6	58.4	64.7	60.8	148.6	5.6	23.2	6.1	8.5	7.5	6.8	36.1	6.8	6.1	5.7	204.6	5.9	23.2	14.8	10.4	45.3	26.6	31.3	20.6	38.3	29.2	23.6	46.5	26.6	30.7	33.0
TAMM41	"C3orf31, DKFZp434E0519, MGC16471"	ENSG00000144559	"TAM41 mitochondrial translocator assembly and maintenance homolog"	Q96BW9	3	11790442-11846919	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036834, HPA044861"	Uncertain		Approved	Cytosol				Cytosol		"HPA036834: AB_10672270, HPA044861: "	"unprognostic (2.40e-2)"	"unprognostic (4.41e-2)"	"prognostic favourable (1.23e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.59e-3)"	13.9	12.9	21.8	15.9	27.5	9.1	15.7	25.6	19.8	12.5	12.2	14.2	12.5	11.5	17.7	23.7	15.2	12.4	10.0	13.8	13.9	11.5	12.4	12.0	18.7	25.0	11.3	15.3	21.7	12.9	12.5	15.4	9.9	11.4	10.7	12.0	11.2	11.7	14.2	15.2	17.3	10.4	15.0	13.7	12.3	10.1	14.1	14.8	12.7	10.8	8.4	17.4	13.8	13.8	8.7	8.9	7.7	7.1	7.1	11.3	5.0	4.1	7.9	9.6	6.6	10.4	13.2	17.8	6.5	4.6	9.9	9.9	9.4	6.9	16.0	9.5	6.7	5.2	16.0	9.7	12.9	5.9	15.2	9.5	7.6	10.9	12.2	17.4	5.1	7.5	14.4	9.3	10.5	15.3	13.9	4.9	12.6	12.1	9.8	13.0	7.7	16.8	9.8	5.5	14.1	15.1	10.3	4.4	3.8	5.6	7.3	10.7	9.5	7.9	4.0	5.2	5.9	15.5	9.2	3.8	9.4	8.3	6.3	14.9	4.7	2.2	5.3	7.7	7.2	3.6	9.2	8.7	11.3	7.0	8.9	8.0	10.4	10.6	0.2	7.1	7.1	6.6	8.7	5.0	21.8	27.5	25.6	19.8	13.9	11.5	11.3	15.3	11.4	14.8
TANC2	"DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA"	ENSG00000170921	"Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2"	Q9HCD6	17	63009556-63427699	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 31.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023274	Uncertain		Approved	Cytosol				Cytosol		"HPA023274: AB_2199727"	"unprognostic (8.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.09e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.01e-1)"	3.4	3.9	4.4	3.1	8.5	6.2	2.7	2.1	19.5	4.5	1.5	2.8	1.5	1.0	2.7	7.0	3.4	2.5	3.1	2.0	5.2	5.4	3.1	1.5	7.9	1.5	5.2	3.5	3.0	2.3	31.6	5.1	2.8	2.7	2.6	1.1	1.9	3.5	3.4	1.5	4.8	2.0	4.1	7.5	2.7	1.8	10.9	3.4	4.6	2.1	4.4	1.9	6.4	2.9	0.8	1.6	1.1	0.1	2.9	2.2	0.1	12.0	11.4	7.1	1.2	3.6	8.8	13.7	7.7	7.6	7.6	9.5	0.6	3.5	0.0	2.4	13.2	1.7	11.4	22.7	17.4	4.7	5.2	17.7	16.8	0.6	3.2	4.7	0.0	13.4	13.3	8.9	25.9	2.4	2.1	0.0	10.9	9.3	3.1	0.8	0.8	7.4	2.4	14.2	0.9	6.8	16.8	12.0	13.1	4.3	8.2	3.3	3.7	1.2	12.3	18.7	9.8	1.2	9.4	0.0	0.0	0.0	6.9	1.3	6.7	0.0	0.1	0.0	2.2	0.1	1.7	0.1	1.2	1.7	0.1	0.8	0.5	1.1	1.1	2.9	0.0	1.6	0.0	0.1	4.4	8.5	2.1	19.5	5.2	5.4	5.2	3.5	2.7	3.4
TANGO6	"FLJ12688, KIAA1746, TMCO7"	ENSG00000103047	"Transport and golgi organization 6 homolog"	Q9C0B7	16	68843604-69085180	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041312	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA041312: AB_10796342"	"unprognostic (8.55e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (3.20e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (6.02e-2)"	12.5	7.7	8.0	9.6	13.1	7.0	10.7	10.9	15.0	10.2	8.2	14.7	7.2	6.0	12.8	5.6	8.5	8.3	8.0	7.8	7.3	7.7	13.1	27.6	8.4	10.8	9.8	10.6	10.0	11.2	21.6	13.2	7.9	9.3	9.7	7.1	12.1	7.7	10.3	18.5	9.2	7.0	11.1	9.4	9.7	9.1	9.3	12.1	14.5	7.9	5.8	12.6	12.8	12.7	4.0	6.6	2.6	9.0	2.5	6.5	3.8	5.6	11.7	3.9	8.3	6.6	7.5	2.8	7.7	6.5	9.7	7.9	7.5	4.7	12.9	4.3	10.9	4.7	8.8	10.4	12.1	3.0	5.3	2.3	4.7	6.9	5.4	6.3	5.9	5.5	5.7	13.7	12.5	9.3	8.4	2.2	9.0	5.7	6.6	5.1	8.4	6.3	7.0	5.7	14.4	7.2	3.2	4.1	4.7	19.0	1.1	5.1	3.7	7.2	5.3	9.2	3.3	9.2	5.5	4.0	3.5	8.8	5.7	2.4	6.0	0.0	4.8	2.6	4.9	9.0	5.2	4.0	4.9	5.0	6.6	3.7	3.1	5.0	0.3	2.5	7.9	1.7	6.5	3.8	8.0	13.1	10.9	15.0	7.3	7.7	9.8	10.6	9.3	12.1
TANK	"I-TRAF, TRAF2"	ENSG00000136560	"TRAF family member associated NFKB activator"	Q92844	2	161136908-161236221	"Predicted intracellular proteins"	"DNA damage, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010345, HPA037675, HPA037676"	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB010345: AB_2199871, HPA037675: , HPA037676: "	"unprognostic (1.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (2.78e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.30e-2)"	35.9	23.6	17.2	32.0	21.1	43.0	34.2	17.7	16.8	19.6	22.3	11.7	18.0	15.8	20.6	21.8	23.2	20.9	25.1	18.4	16.2	17.2	22.7	37.2	35.4	28.8	20.1	12.7	19.7	15.4	17.0	33.3	41.7	18.2	26.0	21.5	15.7	21.9	15.5	49.5	21.4	22.6	32.2	21.3	42.1	18.2	13.5	19.1	29.2	29.0	25.1	29.0	37.3	38.6	22.4	20.7	54.0	27.9	13.3	28.1	14.7	11.9	7.6	10.1	11.5	29.4	38.8	14.5	17.1	27.1	12.5	18.9	9.3	15.7	17.0	12.5	20.3	8.6	6.2	13.4	19.0	39.3	6.5	9.2	7.4	23.8	24.0	15.1	10.3	31.1	21.6	18.9	14.8	32.1	9.1	22.4	24.0	9.0	9.1	15.3	5.8	6.9	5.3	14.8	11.0	28.4	19.5	8.6	10.0	11.1	13.2	18.5	5.5	18.6	33.7	15.8	9.7	8.0	10.2	15.2	13.9	25.7	21.0	12.0	12.0	28.1	21.6	26.4	12.1	25.1	18.5	22.1	19.5	17.5	20.7	22.4	12.9	13.2	54.0	13.3	27.9	12.1	28.1	14.7	17.2	21.1	17.7	16.8	16.2	17.2	20.1	12.7	18.2	19.1
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973641-29992261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.51e-4)"	"prognostic favourable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favourable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	27.8	24.1	26.2	15.1	26.7	12.3	17.7	29.2	30.6	13.5	13.6	21.5	11.8	18.5	16.8	13.0	12.4	14.1	15.1	17.6	25.0	18.2	13.9	10.4	23.0	14.4	22.1	22.7	15.8	16.3	26.2	18.7	22.5	20.7	13.6	9.6	15.0	17.1	15.9	22.8	20.0	19.3	14.8	14.9	26.3	16.0	21.2	20.2	14.0	15.9	9.8	11.5	12.8	18.0	2.6	3.3	4.8	2.8	2.0	3.2	2.0	11.2	21.5	11.8	18.5	13.8	9.3	18.1	20.6	11.0	14.0	13.1	17.2	15.0	12.2	17.5	14.8	17.5	10.7	10.4	7.5	18.9	22.7	13.1	21.7	17.2	10.1	12.8	25.2	10.9	9.0	14.8	6.0	23.3	11.7	12.4	13.3	20.7	14.9	18.3	11.4	14.5	27.7	17.1	11.3	8.8	10.6	13.9	11.1	11.8	15.8	6.1	19.8	14.6	32.5	24.1	11.2	17.1	11.9	18.1	11.6	11.5	14.8	14.8	17.5	1.3	2.8	1.5	2.9	2.7	3.1	2.0	2.9	2.6	1.8	2.6	1.6	1.4	4.8	2.0	1.4	3.3	3.2	2.0	26.2	26.7	29.2	30.6	25.0	18.2	22.1	22.7	20.7	20.2
TARS		ENSG00000113407	"Threonyl-tRNA synthetase"	P26639	5	33440696-33469539	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Supported	"Actin filaments,Cytosol"			170000	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavourable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavourable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavourable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	17.4	25.6	10.2	16.0	13.1	19.2	17.7	14.4	17.2	12.7	22.1	12.3	18.7	11.6	18.3	19.7	31.0	12.2	11.9	19.1	10.3	10.9	19.2	57.0	17.2	12.7	17.5	7.8	21.3	27.6	21.3	27.0	18.5	16.8	13.9	24.7	10.8	42.1	15.8	25.1	11.7	21.7	21.2	19.5	18.3	21.2	9.6	15.4	17.6	22.8	27.3	21.2	21.8	21.9	13.1	16.0	14.2	12.6	24.0	15.0	9.7	29.4	24.7	20.7	29.2	13.7	25.9	30.1	33.1	28.1	25.1	28.4	30.1	18.4	11.7	12.1	27.3	21.0	44.1	32.7	51.7	17.3	16.0	17.0	63.3	17.2	42.6	27.3	18.2	24.7	52.7	34.5	44.7	26.8	33.3	31.6	32.0	16.3	21.3	9.4	22.0	18.3	18.1	36.7	17.2	28.5	23.6	12.1	13.8	30.7	22.5	21.9	11.8	24.4	14.1	19.7	29.4	15.5	23.2	18.6	36.6	18.3	22.0	36.1	21.3	14.2	11.6	10.5	15.0	12.6	14.1	13.1	12.7	15.0	16.0	11.5	11.6	14.7	1.5	24.0	10.1	8.8	12.1	9.7	10.2	13.1	14.4	17.2	10.3	10.9	17.5	7.8	16.8	15.4
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	10.7	21.1	16.5	10.5	17.8	9.2	11.3	17.5	21.4	10.2	10.9	14.8	12.9	9.4	10.5	14.7	15.7	13.0	11.8	20.9	18.1	12.3	15.6	26.8	9.1	14.0	15.0	19.7	13.3	11.5	20.4	12.2	9.4	16.5	9.8	12.5	13.3	11.3	10.9	36.0	13.3	10.5	10.9	13.8	15.1	12.4	10.7	16.6	10.6	12.3	12.2	15.7	12.5	10.8	21.5	17.4	20.4	18.6	21.5	20.9	12.2	17.0	14.3	9.7	14.5	10.9	10.0	18.4	8.3	9.1	16.5	16.7	11.6	16.0	24.8	18.4	6.2	17.8	23.4	19.3	12.7	14.9	20.3	11.7	13.5	11.7	10.8	16.1	18.0	8.8	16.2	12.5	17.1	10.6	20.3	17.4	11.5	20.7	13.6	13.2	11.9	21.3	14.1	12.3	30.6	11.2	8.1	13.7	16.0	12.6	27.9	19.6	22.5	25.3	6.2	9.7	10.3	7.9	14.0	16.8	19.8	18.7	14.4	18.8	9.3	15.1	11.0	20.4	15.7	18.3	15.6	21.5	15.4	15.5	17.4	18.6	15.1	15.8	1.7	21.5	18.6	11.7	20.9	12.2	16.5	17.8	17.5	21.4	18.1	12.3	15.0	19.7	16.5	16.6
TARSL2	FLJ25005	ENSG00000185418	"Threonyl-tRNA synthetase like 2"	A2RTX5	15	101653598-101724604	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 9.7;NK-cells: 9.0;T-cells: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066697	Approved		Approved	Cytosol				Cytosol		"HPA066697: "	"unprognostic (9.33e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.76e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.79e-2)"	7.4	6.9	15.1	6.4	20.2	4.8	7.5	15.8	16.2	7.2	7.1	20.2	5.5	6.2	6.5	6.0	6.3	6.5	5.9	21.0	16.9	13.8	8.3	5.9	6.2	6.5	20.0	11.2	11.0	9.8	12.9	10.5	3.7	15.7	9.2	6.2	4.0	7.1	9.7	47.7	4.9	6.5	6.9	19.9	6.2	8.5	5.4	18.9	3.9	9.6	8.0	7.1	7.0	7.8	9.7	2.0	1.6	1.7	9.0	6.1	1.0	2.1	4.1	7.0	3.8	7.5	5.9	3.5	7.5	5.0	5.9	3.7	5.9	2.0	2.8	3.0	9.1	6.3	12.3	4.3	5.4	3.3	19.7	6.9	2.6	4.7	3.5	3.1	1.4	4.1	4.0	2.7	3.4	4.2	6.8	6.1	5.8	3.6	1.7	6.1	8.5	2.9	3.5	10.6	7.3	4.9	2.2	11.2	6.9	10.1	3.9	4.1	2.5	6.4	5.6	2.8	6.7	5.7	2.4	8.6	9.6	3.5	7.3	5.7	5.2	0.9	1.1	1.6	3.4	1.7	3.4	4.8	6.1	5.2	0.8	9.7	5.9	3.2	0.3	9.0	0.7	2.0	1.0	1.0	15.1	20.2	15.8	16.2	16.9	13.8	20.0	11.2	15.7	18.9
TAX1BP1	"CALCOCO3, TXBP151"	ENSG00000106052	"Tax1 binding protein 1"	Q86VP1	7	27739331-27844564	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024432	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA024432: AB_1857783"	"unprognostic (1.38e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (3.69e-1)"	"prognostic favourable (2.80e-6)"	"unprognostic (1.76e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.03e-1)"	28.5	63.0	31.1	19.5	49.8	34.9	30.7	33.5	48.4	33.8	33.4	16.1	26.7	23.7	27.4	35.5	46.6	30.7	28.2	47.4	30.8	31.9	51.0	35.3	28.7	23.0	41.0	34.8	32.0	29.7	46.3	69.4	65.8	54.1	36.4	31.1	18.7	32.3	32.6	50.3	23.5	41.0	48.8	41.7	34.5	30.3	30.3	35.2	34.2	44.5	27.0	24.6	51.3	29.0	21.1	17.5	59.7	31.3	17.3	33.0	22.5	40.0	22.2	22.8	21.5	36.1	26.4	15.5	30.0	36.9	22.5	28.3	17.9	32.7	8.5	28.3	43.7	28.6	21.3	19.6	35.3	16.0	11.0	23.1	23.9	35.7	34.1	33.6	27.5	22.3	40.8	26.1	30.1	24.2	25.7	26.3	45.4	14.7	14.7	33.3	25.6	20.9	12.3	24.5	17.4	31.8	45.4	15.1	24.6	42.0	55.0	62.5	25.6	50.8	26.0	21.3	33.3	26.4	19.7	48.4	33.5	16.0	24.9	64.0	48.7	37.4	24.2	59.7	21.8	29.3	26.3	21.1	25.9	25.3	17.5	17.9	24.0	24.0	48.9	17.3	31.3	16.2	33.0	22.5	31.1	49.8	33.5	48.4	30.8	31.9	41.0	34.8	54.1	35.2
TBC1D15	"DKFZp761D0223, FLJ12085"	ENSG00000121749	"TBC1 domain family member 15"	Q8TC07	12	71839707-71927248	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013388, HPA015592"	Supported		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA013388: AB_2199233, HPA015592: AB_1857789"	"unprognostic (3.87e-2)"	"prognostic favourable (7.06e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (5.34e-4)"	"unprognostic (5.73e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	37.4	27.4	20.2	14.3	22.5	35.2	26.4	19.6	23.7	21.8	20.2	17.0	19.8	15.1	22.9	15.4	20.2	15.1	20.4	15.4	16.9	16.4	22.3	32.9	24.5	19.0	28.9	18.7	22.7	26.3	19.1	38.0	25.4	23.8	18.0	14.8	12.0	20.6	14.4	44.0	19.2	20.8	19.5	26.3	21.4	17.8	19.4	27.5	22.2	25.9	14.5	18.6	27.5	16.3	5.9	6.3	13.9	8.8	7.2	13.5	6.7	13.8	13.8	11.6	11.9	23.4	23.4	17.7	15.0	34.0	18.7	23.7	9.7	11.7	17.6	10.1	13.7	8.7	14.3	10.4	20.5	15.5	12.1	16.7	13.3	9.9	19.7	21.2	12.2	22.7	13.3	14.3	27.1	15.5	16.1	9.9	15.9	10.2	14.1	13.2	24.1	12.0	11.2	13.4	19.6	14.1	13.4	12.8	11.0	19.8	17.5	16.7	17.9	15.5	15.7	16.1	7.3	18.3	8.9	25.4	23.4	22.5	9.7	14.1	14.5	2.0	6.8	8.6	8.1	7.0	9.3	5.7	10.1	7.9	6.3	5.9	12.9	11.1	13.9	7.2	8.8	3.8	13.5	6.7	20.2	22.5	19.6	23.7	16.9	16.4	28.9	18.7	23.8	27.5
TBC1D2	"Armus, PARIS1, TBC1D2A"	ENSG00000095383	"TBC1 domain family member 2"	Q9BYX2	9	98198999-98255721	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 27.2;HaCaT: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030871	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA030871: AB_10670046"	"unprognostic (2.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (2.77e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.30e-1)"	13.1	4.1	6.6	7.0	15.6	14.5	7.6	7.7	7.6	7.8	12.0	17.8	6.0	15.5	4.4	4.3	25.3	4.4	5.3	2.2	9.5	7.4	4.6	12.6	27.4	4.5	15.2	5.3	4.3	3.0	4.5	3.1	11.9	9.0	8.1	5.9	6.2	10.1	8.8	3.3	18.8	15.2	5.7	14.3	6.7	5.1	3.1	12.2	4.7	7.1	14.7	16.8	14.7	11.6	0.9	7.0	8.1	18.4	0.7	3.9	6.4	27.2	4.0	0.1	0.9	3.1	6.0	9.0	12.1	6.7	8.8	7.4	2.5	12.0	0.4	9.2	7.0	35.9	0.2	13.4	3.1	0.9	0.5	0.2	13.9	1.9	14.4	0.6	1.0	8.3	22.2	8.8	22.0	3.1	0.8	0.3	7.0	3.5	0.1	1.6	0.5	2.3	0.4	1.7	0.0	13.4	17.0	0.3	0.5	4.1	9.0	1.2	2.9	0.9	18.8	10.8	3.2	1.7	4.8	0.6	0.5	0.2	10.9	1.0	1.1	1.1	18.4	5.5	1.9	10.8	1.3	0.9	2.8	1.6	7.0	0.6	1.2	1.4	8.1	0.7	8.0	0.9	3.9	6.4	6.6	15.6	7.7	7.6	9.5	7.4	15.2	5.3	9.0	12.2
TBC1D22B	"C6orf197, dJ744I24.2, FLJ20337"	ENSG00000065491	"TBC1 domain family member 22B"	Q9NU19	6	37257772-37332970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027908, HPA027909, HPA027910"	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203"	"unprognostic (9.83e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavourable (8.15e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.53e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.73e-2)"	11.5	17.9	9.6	11.0	12.1	26.0	12.8	15.2	17.1	9.7	13.1	11.2	14.3	13.1	13.9	13.0	19.8	14.1	16.8	11.2	10.5	10.5	13.3	8.7	11.7	9.0	8.9	9.9	15.0	20.9	16.8	11.8	13.3	13.1	12.3	13.3	12.2	21.6	11.8	32.7	20.7	16.1	11.5	8.3	11.1	10.6	19.9	8.2	20.7	13.0	10.5	14.4	10.4	13.3	4.6	7.7	8.0	6.6	5.7	6.2	4.6	6.9	2.9	5.4	5.9	5.1	5.1	7.8	3.9	8.1	7.3	9.0	6.7	4.6	6.5	4.1	4.9	4.8	6.9	6.2	8.2	10.5	5.6	10.3	4.9	9.0	7.3	5.8	8.8	4.4	9.1	7.1	8.5	10.2	11.6	1.7	5.2	6.2	8.6	4.4	7.1	2.7	5.6	5.0	5.0	7.5	5.1	7.2	4.6	4.2	6.1	7.5	4.4	10.5	9.9	4.4	6.8	3.0	5.1	6.1	6.3	42.9	3.1	8.8	6.8	2.4	5.0	8.0	4.8	6.6	5.6	3.6	5.3	4.6	7.7	4.6	6.2	5.0	2.2	5.7	2.9	2.2	3.6	4.6	9.6	12.1	15.2	17.1	10.5	10.5	8.9	9.9	13.1	8.2
TBC1D2B	KIAA1055	ENSG00000167202	"TBC1 domain family member 2B"	Q9UPU7	15	77984036-78077724	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041833, HPA048174, HPA052663"	Approved		Enhanced	Cytosol				Cytosol		"HPA041833: , HPA048174: , HPA052663: "	"unprognostic (3.13e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-3)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.19e-2)"	26.0	14.1	9.3	12.0	10.0	11.9	21.4	8.4	8.4	22.8	16.7	8.4	7.3	7.6	20.2	13.0	9.3	18.2	20.0	7.8	7.7	4.3	8.2	18.3	22.7	12.5	8.3	5.6	31.2	16.6	17.7	7.1	28.9	7.2	13.6	10.8	20.7	8.6	14.0	5.0	10.5	14.3	15.5	9.7	19.9	12.6	11.0	7.3	20.4	10.4	5.8	14.4	17.1	18.4	0.4	3.2	3.7	2.1	3.8	4.2	1.3	5.0	4.0	4.8	4.5	33.9	27.1	8.4	11.5	17.4	10.8	12.0	5.0	2.0	7.7	4.6	9.7	7.3	10.4	12.7	8.3	14.6	8.1	4.9	3.8	3.4	16.1	12.4	7.5	26.3	8.9	7.2	4.8	12.3	2.5	5.4	14.0	5.5	4.6	8.1	3.8	3.9	7.0	22.1	1.7	5.6	19.1	2.5	7.0	10.7	7.3	13.6	2.4	13.0	15.0	11.9	7.8	3.7	6.1	9.1	9.6	4.2	4.1	16.8	6.2	0.0	2.1	0.9	3.9	1.8	2.2	0.2	2.6	4.2	1.4	0.4	1.9	1.5	3.7	3.8	0.5	3.2	1.5	1.3	9.3	10.0	8.4	8.4	7.7	4.3	8.3	5.6	7.2	7.3
TBC1D30	KIAA0984	ENSG00000111490	"TBC1 domain family member 30"	Q9Y2I9	12	64781193-64881032	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 23.0;RPMI-8226: 13.6;RT4: 17.7;SCLC-21H: 16.6;SK-BR-3: 17.0;T-47d: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039772, HPA040043"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA039772: AB_10795409, HPA040043: AB_10795411"	"unprognostic (1.85e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (3.61e-5)"	"unprognostic (9.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.65e-5)"	"prognostic favourable (5.08e-4)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.67e-3)"	"unprognostic (7.80e-3)"	1.8	1.6	4.7	2.3	11.4	0.5	5.3	13.4	15.8	7.6	3.3	1.5	12.4	5.0	3.1	2.5	1.2	2.1	4.8	1.1	7.1	5.5	3.9	1.7	3.9	0.9	4.7	7.0	1.5	19.8	8.9	6.5	1.4	16.5	3.7	3.5	2.0	14.4	11.6	0.9	1.3	3.5	2.4	3.0	2.5	6.9	3.2	2.8	0.0	3.3	0.2	0.7	4.9	1.9	0.0	0.0	2.4	1.1	0.0	1.3	0.3	6.9	1.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.1	6.5	2.2	0.3	1.1	0.0	0.1	6.8	0.1	0.0	0.0	6.7	0.3	1.2	0.3	0.1	2.3	1.4	0.4	0.0	0.0	0.2	5.7	0.0	2.4	0.2	23.0	0.0	0.4	0.9	6.8	0.1	0.1	13.6	0.8	17.7	16.6	1.3	1.4	17.0	0.2	12.4	1.1	5.4	0.0	1.0	0.5	3.4	0.0	0.0	0.2	0.1	0.7	0.3	0.0	1.1	0.0	0.4	1.1	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.3	4.7	11.4	13.4	15.8	7.1	5.5	4.7	7.0	16.5	2.8
TBC1D4	"AS160, DKFZp779C0666, KIAA0603"	ENSG00000136111	"TBC1 domain family member 4"	O60343	13	75284665-75482114	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"GTPase activation"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;HUVEC TERT2: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 17.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.2;T-cells: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040145, HPA059885"	Approved		Supported	Cytosol				Cytosol		"HPA040145: , HPA059885: "	"unprognostic (5.44e-3)"	"unprognostic (5.23e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (1.07e-11)"	"unprognostic (6.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.88e-2)"	"unprognostic (3.45e-1)"	12.0	43.9	6.7	6.7	7.0	1.2	17.5	9.3	10.7	6.9	5.7	4.6	4.2	1.9	5.4	10.1	6.1	5.9	8.5	25.5	8.0	4.1	15.6	5.3	8.5	14.9	5.4	7.0	22.5	8.5	9.5	4.2	9.5	11.1	7.4	4.9	2.0	20.8	2.4	40.1	10.8	6.3	4.7	4.8	9.6	6.1	3.3	4.4	1.1	17.7	17.3	14.8	4.7	8.7	0.5	7.2	2.6	0.3	0.3	17.4	1.8	5.5	6.5	4.1	0.2	9.7	10.5	5.3	4.8	2.5	3.9	4.3	36.9	6.8	1.1	1.1	6.8	5.2	10.4	4.8	4.1	18.3	10.5	18.0	8.8	11.1	2.4	8.5	0.2	11.4	8.9	4.3	10.2	27.3	5.0	0.6	4.4	2.6	12.4	1.5	5.8	3.9	11.2	3.9	6.5	3.8	4.0	7.6	2.3	2.1	6.5	3.5	2.2	0.2	11.4	4.4	5.5	2.3	5.6	0.3	0.0	0.1	7.9	8.0	6.5	2.6	0.3	0.0	0.5	0.1	0.0	0.5	8.6	1.8	0.4	0.4	8.0	3.7	0.3	0.3	0.1	7.2	17.4	1.8	6.7	7.0	9.3	10.7	8.0	4.1	5.4	7.0	11.1	4.4
TBC1D8B	"FLJ20298, GRAMD8B, RP11-321G1.1"	ENSG00000133138	"TBC1 domain family member 8B"	Q0IIM8	X	106802680-106876145	"Predicted intracellular proteins"		"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023883, HPA027527"	Enhanced		Approved	Cytosol				Cytosol		"HPA023883: AB_1857794, HPA027527: AB_2199395"	"unprognostic (6.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.69e-3)"	"unprognostic (8.15e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.16e-2)"	3.8	24.5	4.6	3.5	7.9	3.3	3.9	1.2	7.9	6.0	6.6	2.6	21.5	6.0	5.1	10.4	3.7	4.4	9.6	4.7	4.2	2.5	12.4	14.5	4.1	2.0	6.8	3.3	7.2	10.7	10.0	28.6	4.5	9.0	6.1	5.6	2.2	10.1	16.8	1.8	2.9	13.3	4.1	4.7	2.7	8.5	7.6	7.6	0.5	7.9	3.1	1.8	4.9	4.8	4.7	2.8	5.2	2.2	1.5	2.0	0.4	10.1	3.3	1.6	5.0	15.9	22.6	5.8	11.4	11.8	2.0	6.1	5.4	9.0	3.6	9.3	11.4	5.3	4.1	5.7	5.2	1.9	4.5	4.9	4.1	5.2	4.1	1.4	2.0	9.9	4.7	4.2	2.0	5.5	1.6	6.2	7.0	5.1	3.2	1.9	6.9	5.1	1.6	2.8	1.5	5.6	7.4	2.6	2.1	9.0	7.0	4.1	7.9	1.7	7.0	7.5	8.3	9.8	4.1	5.7	6.1	1.1	14.4	1.2	9.2	3.7	2.2	1.1	2.0	1.2	1.6	2.2	1.7	1.5	0.7	4.7	1.4	1.7	5.2	1.5	1.1	2.8	0.7	0.4	4.6	7.9	1.2	7.9	4.2	2.5	6.8	3.3	9.0	7.6
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620765-140756120	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.0"	"Group enriched"	"Detected in many"	38	"B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA000262: , HPA006503: "	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favourable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	15.9	6.2	8.1	9.2	10.0	1.0	33.6	37.6	13.7	9.2	6.7	3.8	32.1	5.2	5.5	6.4	5.9	6.7	9.4	5.7	7.5	13.9	10.7	8.0	10.4	9.6	9.6	8.2	10.9	6.0	9.9	5.7	13.1	11.0	9.8	4.3	10.6	7.3	27.4	1.7	2.8	9.9	5.0	5.3	20.4	10.0	2.9	3.8	1.6	4.3	3.0	12.2	11.1	8.9	9.0	4.6	0.1	2.4	0.1	0.0	0.9	0.4	6.3	5.9	5.1	14.5	13.7	12.1	8.1	8.8	5.9	7.6	1.3	5.6	0.0	5.2	10.6	1.2	7.4	5.8	5.6	0.0	4.1	3.6	4.6	5.4	5.3	0.4	0.5	11.3	9.7	5.1	20.6	16.3	0.0	0.0	5.5	6.3	0.8	0.0	0.9	5.6	3.9	9.7	9.3	6.7	11.7	8.7	6.2	8.4	14.9	5.5	3.5	0.2	25.3	15.7	4.7	10.1	6.9	0.0	0.0	0.0	9.5	0.7	8.5	0.0	2.4	0.0	0.0	1.9	0.0	9.0	0.0	0.0	4.0	4.0	0.0	0.0	0.1	0.1	0.7	4.6	0.0	0.9	8.1	10.0	37.6	13.7	7.5	13.9	9.6	8.2	11.0	3.8
TBCB	"CG22, CKAP1, CKAPI"	ENSG00000105254	"Tubulin folding cofactor B"	Q99426	19	36114289-36125947	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041428, HPA041722"	Approved		Supported	Cytosol			340000	Cytosol		"HPA041428: AB_10794517, HPA041722: AB_10804007"	"unprognostic (3.88e-3)"	"unprognostic (3.05e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.25e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.15e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (3.11e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.02e-1)"	23.0	30.2	59.1	26.0	48.8	23.2	20.0	30.9	67.6	22.1	22.3	64.3	14.3	16.8	20.7	20.9	18.0	27.7	14.9	29.2	55.8	56.7	21.0	14.1	19.9	20.7	63.5	43.8	33.9	11.2	15.1	23.1	19.0	49.7	20.0	17.4	14.7	12.2	22.7	34.5	12.8	17.6	29.8	85.5	21.0	16.3	24.1	44.4	15.0	12.2	13.7	23.9	16.2	15.0	64.6	73.4	79.4	101.2	59.7	96.3	80.6	31.7	93.6	36.2	24.2	25.7	27.3	12.7	24.8	19.1	43.1	30.0	41.1	17.2	23.4	46.6	40.9	15.1	30.1	26.4	26.1	54.8	29.2	21.0	26.1	62.6	28.0	24.5	47.2	25.7	20.0	34.5	24.3	24.9	9.1	39.9	38.3	48.1	37.6	27.2	21.7	30.7	34.9	18.6	22.6	40.3	30.9	36.4	37.7	22.3	31.8	28.2	16.7	32.9	27.4	44.7	46.9	26.3	51.0	18.1	46.1	27.6	39.1	23.7	23.7	66.4	65.0	79.4	78.8	85.2	53.0	64.6	73.6	69.1	70.9	54.8	44.0	55.2	27.6	59.7	101.2	73.4	96.3	80.6	59.1	48.8	30.9	61.4	55.8	56.7	63.5	43.8	49.7	44.4
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744481-42746096	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035073, HPA035074"	Approved		Supported	Cytosol				Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	5.8	6.1	8.6	9.4	8.0	19.0	6.2	10.9	15.7	7.6	7.6	7.9	6.9	7.4	8.7	7.1	6.4	8.5	8.5	8.0	6.6	7.1	7.0	5.6	5.9	14.1	7.7	8.4	8.0	7.8	3.0	7.3	7.2	10.9	6.9	5.0	6.0	7.4	6.8	13.5	8.7	7.9	5.5	6.6	8.5	7.4	8.4	6.6	9.4	7.8	4.1	10.0	7.7	6.6	31.6	46.3	54.8	30.2	52.1	48.8	49.5	17.1	5.7	8.8	16.3	12.7	8.6	11.6	11.9	13.4	13.2	14.5	8.8	6.8	15.6	9.6	11.5	15.1	11.8	11.8	7.4	8.4	12.9	8.1	8.4	14.8	14.5	8.8	13.3	14.0	14.4	10.2	8.5	10.4	18.5	14.2	11.7	21.1	7.2	17.0	8.2	15.7	7.3	10.6	10.1	12.5	9.4	33.9	14.7	7.7	13.4	20.3	14.6	30.1	11.1	12.7	11.4	10.2	16.2	18.9	21.1	26.2	6.2	12.1	12.1	37.6	30.2	54.8	37.2	25.3	37.7	31.6	39.4	40.3	27.3	30.7	46.1	42.6	53.4	52.1	22.6	46.3	48.8	49.5	8.6	8.0	10.9	15.7	6.6	7.1	7.7	8.4	10.9	6.6
TBCEL	"LRRC35, MGC10233"	ENSG00000154114	"Tubulin folding cofactor E like"	Q5QJ74	11	121024072-121090775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA038593, HPA038594"	Approved		Uncertain	Cytosol				Cytosol		"HPA038593: AB_10669647, HPA038594: "	"unprognostic (9.06e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.02e-1)"	12.4	10.8	9.2	8.3	11.9	6.6	12.2	12.5	13.8	10.8	11.4	15.6	25.8	7.3	18.4	18.3	8.1	11.5	10.8	12.8	9.6	9.1	11.7	19.6	13.7	9.1	12.5	11.1	15.3	10.8	30.8	22.8	14.3	15.8	12.8	8.3	13.2	12.9	17.7	11.0	7.6	9.6	13.1	11.8	14.1	10.2	26.1	12.3	9.5	14.6	6.1	9.6	10.5	10.2	1.1	2.1	0.8	1.4	2.8	2.2	1.0	4.4	4.2	7.3	6.3	13.5	12.8	5.6	8.5	10.5	6.6	9.7	4.3	7.2	5.5	13.2	10.5	1.2	8.0	2.8	8.9	6.5	5.9	9.5	3.3	4.3	16.7	6.7	6.7	14.0	9.6	6.4	6.9	10.7	2.8	10.7	9.2	3.1	2.7	5.6	4.3	4.2	2.4	10.8	2.5	8.8	2.8	3.9	9.1	8.3	8.8	5.6	8.5	5.8	13.9	14.6	3.2	5.8	4.6	4.2	3.0	2.9	2.1	0.0	5.4	0.0	1.1	0.5	1.5	1.4	2.1	0.5	2.1	2.1	1.3	1.1	2.2	1.4	0.8	2.8	1.0	2.1	1.0	1.0	9.2	11.9	12.5	13.8	9.6	9.1	12.5	11.1	15.8	12.3
TBL2	"DKFZP43N024, WBSCR13, WS-betaTRP"	ENSG00000106638	"Transducin beta like 2"	Q9Y4P3	7	73568932-73578791	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007477, HPA051533"			Supported	Cytosol	"Secreted in male reproductive system"			Cytosol		"HPA007477: AB_1080214, HPA051533: "	"unprognostic (9.04e-2)"	"unprognostic (6.61e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (4.93e-4)"	"unprognostic (2.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.88e-5)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	8.9	12.1	3.7	5.4	3.3	1.8	5.9	2.7	5.3	8.7	6.6	3.4	11.6	6.1	6.5	10.9	7.3	5.5	6.3	5.4	2.5	2.5	6.1	14.2	6.5	4.7	3.5	2.1	10.7	27.0	8.5	7.0	13.0	3.4	6.5	6.9	5.1	16.3	8.0	4.9	6.9	6.3	5.4	3.0	5.4	8.2	70.5	3.7	6.2	11.8	4.2	5.2	8.5	6.2	4.2	14.4	13.2	11.4	8.3	6.7	7.6	12.0	13.9	4.8	7.1	13.1	12.6	6.0	14.6	10.9	5.5	10.0	21.2	13.1	9.9	3.2	12.8	9.3	10.1	5.8	11.0	3.9	6.9	3.6	7.3	13.8	18.8	7.2	13.2	7.9	10.1	17.0	13.6	6.3	14.5	7.8	8.5	11.7	7.0	7.1	4.9	11.4	4.6	8.6	21.9	7.1	8.5	5.0	8.1	14.5	39.6	9.1	10.4	5.5	10.7	10.5	5.1	9.7	14.6	15.8	9.8	11.1	13.4	8.9	12.2	13.2	11.4	5.2	6.6	7.9	6.5	3.4	5.6	6.0	14.4	4.2	6.7	4.2	1.0	8.3	7.0	10.8	6.5	7.6	3.7	3.3	2.7	5.3	2.5	2.5	3.5	2.1	3.4	3.7
TBX2		ENSG00000121068	"T-box 2"	Q13207	17	61399896-61409466	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 47.6;MCF7: 27.9;SH-SY5Y: 22.2;SK-MEL-30: 15.1;WM-115: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008586, CAB013636"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB013636: , HPA008586: AB_1080222"	"unprognostic (6.18e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.34e-3)"	11.5	3.4	2.0	2.9	3.1	0.4	9.9	1.3	2.3	14.8	4.4	1.9	30.4	4.9	12.2	37.0	5.9	11.3	16.8	6.8	1.8	1.8	28.9	4.6	35.7	1.3	3.6	1.5	8.3	1.8	1.8	3.7	30.4	3.6	15.1	2.2	33.7	2.2	38.1	5.8	2.9	5.5	16.4	1.7	8.8	8.1	9.6	1.5	0.0	8.6	5.0	1.8	19.5	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	47.6	1.5	1.7	5.8	7.3	7.7	0.4	0.1	1.3	0.1	0.0	0.6	1.2	0.0	0.8	0.0	0.1	0.0	2.8	0.8	0.0	2.3	5.3	0.1	0.7	3.0	0.1	8.7	0.5	0.0	0.1	0.0	0.5	27.9	0.0	0.1	0.0	3.3	0.0	1.9	0.2	0.0	11.3	0.1	22.2	0.0	0.0	15.1	0.6	0.9	0.0	1.1	0.0	2.7	1.6	0.0	0.1	0.0	6.6	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.1	1.3	2.3	1.8	1.8	3.6	1.5	3.6	1.5
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box 3"	O15119	12	114670254-114684164	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 117.7"	"Cell line enhanced"	"Detected in many"		"BJ: 33.8;BJ hTERT+: 32.2;RT4: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favourable (3.28e-4)"	4.3	60.5	0.9	3.3	1.9	0.0	19.9	0.7	2.3	18.2	12.2	1.7	69.6	14.2	13.1	18.7	1.9	7.5	5.0	6.2	1.2	1.5	4.1	15.1	12.6	0.8	1.2	0.5	15.6	1.1	0.3	5.3	67.8	1.6	32.3	1.5	2.6	7.3	117.7	4.2	4.8	19.4	9.7	1.4	2.6	2.2	3.5	1.2	0.5	36.3	7.3	3.5	24.6	25.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	5.9	0.0	0.0	8.9	12.3	13.4	33.8	32.2	13.1	13.0	5.3	1.4	0.0	0.5	5.8	1.5	2.8	1.2	16.2	0.0	4.0	0.0	1.5	15.4	2.9	0.0	0.0	5.4	0.8	4.4	9.1	0.1	1.2	0.0	1.1	0.5	0.0	0.1	0.0	1.8	0.0	0.0	0.8	0.0	42.2	2.2	6.5	4.8	2.2	1.1	1.6	0.0	0.0	4.0	2.6	2.2	10.9	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.7	2.3	1.2	1.5	1.2	0.5	1.6	1.2
TCEAL2	"my048, MY0876G05, WEX1"	ENSG00000184905	"Transcription elongation factor A like 2"	Q9H3H9	X	102125688-102127711	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;ovary: 46.5"	"Group enriched"	"Detected in some"	4	"HAP1: 7.2;SCLC-21H: 7.9;U-2 OS: 14.2"	"Cancer enhanced"	"Detected in many"		"glioma: 22.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.1"									HPA076317			Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA076317: "	"unprognostic (2.34e-3)"	"unprognostic (1.35e-2)"	"unprognostic (7.59e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.47e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.11e-3)"	2.4	19.6	34.1	2.6	44.6	1.1	2.4	40.9	84.0	5.8	7.0	8.5	1.8	3.1	19.5	8.6	5.3	7.3	6.4	5.1	30.0	37.9	8.2	1.3	4.4	1.6	25.4	26.5	46.5	3.7	2.8	38.3	1.1	30.1	19.4	3.8	6.6	16.4	21.6	1.2	1.7	3.2	14.0	16.1	2.9	4.2	19.7	9.6	0.0	25.6	0.0	2.1	4.3	2.6	0.1	0.1	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.1	0.0	0.0	7.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.8	0.1	1.7	0.0	0.1	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.1	0.4	34.1	44.6	40.9	41.8	30.0	37.9	25.4	26.5	30.1	9.6
TCEAL5	WEX4	ENSG00000204065	"Transcription elongation factor A like 5"	Q5H9L2	X	103273691-103276872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;testis: 45.9"	"Group enriched"	"Detected in some"	7	"SCLC-21H: 7.3;SH-SY5Y: 22.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045564, HPA058982, HPA072199"	Supported		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA045564: , HPA058982: , HPA072199: "	"unprognostic (1.30e-3)"	"unprognostic (2.41e-1)"		"prognostic unfavourable (9.09e-4)"	"unprognostic (9.68e-2)"	"unprognostic (8.75e-4)"		"unprognostic (1.21e-1)"		"unprognostic (8.11e-2)"	"prognostic favourable (8.60e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.03e-4)"	2.0	11.2	21.9	2.1	31.8	1.3	3.3	32.7	56.4	4.7	2.2	6.6	0.0	1.9	6.0	7.8	1.5	1.6	2.0	2.0	22.3	23.1	1.5	1.3	1.5	1.3	13.0	24.0	5.0	2.1	1.3	23.1	1.3	19.8	3.7	2.0	1.4	2.3	5.4	1.4	1.3	2.4	4.3	11.0	1.3	1.5	45.9	8.4	0.0	3.4	0.0	1.3	2.1	1.1	0.7	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.2	0.0	0.1	0.0	0.0	21.9	31.8	32.7	31.9	22.3	23.1	13.0	24.0	19.8	8.4
TCEAL9	"DKFZp313K1940, WBP5, WEX6"	ENSG00000185222	"Transcription elongation factor A like 9"	Q9UHQ7	X	103356489-103358462	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011790	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA011790: AB_2214932"	"unprognostic (1.26e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.31e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.58e-2)"	28.2	61.0	17.9	14.7	20.9	3.7	42.1	20.7	24.0	30.8	20.6	10.9	35.0	7.6	32.3	59.6	21.4	20.1	25.6	29.4	19.5	20.5	38.8	12.6	25.9	9.5	23.7	15.0	93.4	15.7	19.6	54.5	67.1	40.3	27.6	17.7	15.2	15.7	45.4	7.8	12.1	11.7	30.2	44.1	26.4	23.1	27.5	23.6	5.4	58.6	18.5	7.6	35.5	75.7	1.8	18.6	0.9	1.3	1.1	3.5	1.3	17.8	8.8	27.9	14.2	60.6	59.0	20.9	37.6	50.4	26.7	43.7	16.9	19.0	0.0	55.8	30.7	10.8	4.8	23.9	36.0	0.0	10.4	18.3	21.5	10.8	41.7	0.0	0.0	40.4	23.3	35.6	35.7	44.3	16.1	1.3	63.3	0.0	8.9	0.1	17.3	16.9	0.0	55.8	0.0	32.2	33.2	12.6	15.2	23.6	0.7	24.5	3.8	1.0	36.1	23.9	10.4	71.7	10.4	0.0	1.0	0.1	57.9	0.0	18.9	0.9	1.3	0.0	0.2	0.7	0.0	1.8	1.5	0.5	1.0	1.0	3.5	2.9	0.0	1.1	0.1	18.6	0.9	1.3	17.9	20.9	20.7	24.0	19.5	20.5	23.7	15.0	40.3	23.6
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222331-55664787	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease mutation, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.5;SH-SY5Y: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"memory B-cell: 29.7;naive B-cell: 22.0;plasmacytoid DC: 85.8"	"Group enriched"	"Detected in many"	36	"B-cells: 29.7;dendritic cells: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavourable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavourable (9.95e-4)"	34.6	16.0	20.3	14.4	17.0	10.7	23.5	48.7	32.4	35.4	13.5	14.9	12.0	6.6	27.4	9.6	12.5	16.9	20.4	19.9	23.5	11.9	6.0	6.2	21.9	16.8	16.7	20.3	31.8	7.2	16.2	15.7	32.8	16.1	9.5	10.1	9.2	9.4	13.2	12.1	12.2	10.7	28.4	15.0	14.6	7.4	17.0	17.5	6.4	16.4	12.7	17.0	18.3	14.5	29.7	85.8	0.3	1.2	1.5	0.1	1.7	0.0	1.1	11.7	3.6	2.8	4.9	0.0	5.9	13.1	4.2	5.6	7.3	1.1	9.0	0.0	13.0	1.5	5.4	5.2	2.9	41.5	4.1	3.5	0.0	0.0	1.3	1.5	0.9	6.4	1.6	5.9	0.2	15.3	5.8	6.8	3.6	0.0	2.2	0.0	3.5	0.7	13.2	4.9	20.1	0.0	0.2	4.2	52.7	0.0	0.5	0.0	0.5	0.4	15.4	16.0	5.6	0.6	4.6	5.1	9.6	8.0	3.5	1.6	4.6	0.1	1.1	0.1	0.1	1.2	0.1	29.7	0.0	0.0	3.3	22.0	0.0	0.0	0.3	1.5	1.1	85.8	0.1	1.7	20.3	17.0	48.7	26.9	23.5	11.9	16.7	20.3	16.1	17.5
TCF7L1	TCF3	ENSG00000152284	"Transcription factor 7 like 1"	Q9HCS4	2	85133410-85310388	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 17.9;NTERA-2: 41.8;RH-30: 19.0;T-47d: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071298			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA071298: "	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (6.16e-5)"	"unprognostic (1.79e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (2.06e-4)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (5.38e-4)"	21.0	3.9	3.3	6.5	6.4	4.2	28.7	5.1	5.3	28.2	14.7	7.5	14.5	4.1	21.2	11.8	13.8	10.4	9.1	11.6	6.0	3.0	9.3	7.6	11.1	5.5	4.5	3.8	20.3	3.2	11.6	5.7	4.8	6.3	14.0	4.3	16.8	8.8	19.6	13.4	8.3	6.9	17.8	5.9	7.9	6.8	7.3	5.5	2.2	18.6	8.7	6.1	18.0	20.4	3.7	2.0	8.4	1.2	1.8	2.2	0.4	0.9	0.7	14.2	10.8	5.4	1.1	8.7	1.0	3.5	2.4	2.3	2.1	0.9	0.4	1.7	2.3	2.2	10.8	17.9	1.7	0.8	1.7	0.3	0.8	0.9	0.5	0.8	2.1	0.9	3.3	0.2	0.6	4.7	0.3	0.8	2.8	0.6	0.0	0.8	41.8	0.3	0.3	19.0	0.2	1.1	1.6	0.4	4.4	1.6	7.2	0.5	18.6	0.3	5.1	2.8	4.1	0.2	1.3	0.5	0.2	0.3	0.1	0.5	2.2	8.4	1.2	2.2	1.2	1.0	1.5	2.1	1.4	1.6	0.4	3.7	1.7	2.2	3.4	1.8	1.0	2.0	1.1	0.4	3.3	6.4	5.1	4.0	6.0	3.0	4.5	3.8	6.3	5.5
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950250-113167678	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 12.1;non-classical monocyte: 33.1"	"Lineage enriched"	"Detected in many"	13	"monocytes: 33.1"	"Group enriched"	"Detected in many"	8	"midbrain: 84.5;thalamus: 98.3"	"Group enriched"	"Detected in all"	5	"midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	27.4	10.3	8.7	18.7	10.0	7.3	46.4	5.4	10.3	27.4	34.2	15.4	28.1	21.0	26.6	14.9	12.6	18.2	15.3	13.5	8.1	17.9	10.2	22.9	26.9	13.9	8.5	9.0	25.6	13.9	16.5	17.9	24.0	10.2	14.4	23.7	13.9	14.9	52.8	13.7	17.6	40.4	18.0	13.9	27.3	24.0	10.6	10.1	6.6	14.3	9.3	7.0	21.5	16.3	0.0	1.7	2.5	33.1	0.0	0.6	1.1	7.0	18.5	20.3	19.6	10.6	7.1	24.2	5.0	9.8	3.5	4.3	12.2	21.5	0.0	5.7	9.4	5.0	6.9	8.7	4.5	0.8	6.4	5.0	12.3	11.3	11.3	1.9	1.8	12.5	3.2	5.5	9.3	5.9	5.1	0.3	4.1	13.8	3.1	1.2	14.6	10.7	8.9	14.9	3.2	7.6	9.9	0.4	6.2	7.6	7.6	8.1	4.9	1.0	13.6	3.3	9.6	8.4	10.3	1.3	0.1	0.1	3.3	4.2	7.4	0.1	1.8	0.1	0.6	12.1	0.4	0.0	0.1	0.5	1.7	0.0	0.1	0.3	2.5	0.0	33.1	0.0	0.0	1.1	8.7	10.0	5.4	10.3	8.1	17.9	8.5	9.0	10.2	10.1
TCHP	"MGC10854, TpMs"	ENSG00000139437	"Trichoplein keratin filament binding"	Q9BT92	12	109900264-109983841	"Predicted intracellular proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038638, HPA061543"	Supported		Supported	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA038638: AB_10670785, HPA061543: "	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.52e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	8.6	10.4	16.0	11.3	29.3	8.3	9.3	22.9	25.0	10.2	11.2	19.0	7.5	9.9	13.0	10.9	18.3	8.7	8.3	10.3	15.9	11.0	8.5	7.0	10.0	14.5	23.8	13.9	11.3	12.7	12.1	12.1	10.4	18.6	10.7	9.6	11.0	13.4	11.6	10.8	36.1	10.2	15.0	15.9	15.0	10.2	12.5	24.2	10.9	12.0	7.7	15.1	11.4	15.4	3.2	3.3	4.5	5.2	9.2	7.4	4.4	16.3	14.6	7.9	9.5	7.0	7.6	10.7	15.5	8.3	13.6	7.6	9.2	5.8	23.0	4.6	9.1	13.8	8.6	9.8	12.3	12.3	8.5	16.6	9.1	8.9	8.5	22.5	12.8	6.2	12.0	14.3	10.8	12.1	17.9	4.7	11.2	11.2	20.5	22.9	9.5	14.9	18.9	15.6	19.4	6.2	14.7	11.8	12.4	11.4	12.3	11.0	11.1	16.4	13.4	14.0	9.7	8.9	19.8	13.4	17.0	16.5	14.9	18.7	14.5	0.0	4.2	3.4	6.2	2.7	4.3	3.2	5.4	7.4	3.3	2.3	5.4	4.2	4.5	9.2	5.2	2.4	7.2	4.4	16.0	29.3	22.9	25.0	15.9	11.0	23.8	13.9	18.6	24.2
TCIM	"C8orf4, hTC-1, TC-1, TC1"	ENSG00000176907	"Transcriptional and immune response regulator"	Q9NR00	8	40153455-40155308	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 14.4;AF22: 40.9;BJ: 15.4;BJ hTERT+: 40.4;EFO-21: 26.8;HeLa: 25.7;RPTEC TERT1: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027188	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027188: AB_10601150"	"unprognostic (8.88e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.48e-2)"	23.5	5.9	1.8	23.2	4.5	0.0	16.0	0.6	5.9	32.1	24.1	1.0	15.6	6.0	14.3	20.3	22.2	4.3	22.1	38.3	2.0	1.7	44.5	54.7	96.5	5.0	2.7	4.3	11.9	24.4	28.9	6.2	50.2	2.3	29.6	15.2	7.9	89.9	16.3	20.2	4.0	21.2	72.4	4.3	26.7	10.7	4.9	1.4	1.3	15.8	14.4	4.8	35.8	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	40.9	0.0	0.0	0.0	0.0	15.4	40.4	0.0	0.2	0.2	0.0	0.0	26.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.7	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	12.9	0.0	0.3	0.1	0.2	0.3	0.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.5	0.6	5.9	2.0	1.7	2.7	4.3	2.3	1.4
TCL1A	TCL1	ENSG00000100721	"T cell leukemia/lymphoma 1A"	P56279	14	95709967-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"blood: 179.4;lymphoid tissue: 63.7"	"Group enriched"	"Detected in some"	157	"Daudi: 69.4;REH: 90.3;U-698: 92.2"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	381	"memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8"	"Group enriched"	"Detected in many"	487	"B-cells: 179.4;dendritic cells: 79.8"					"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	0.4	0.2	0.2	53.4	0.2	4.8	0.3	0.2	0.2	0.2	0.9	0.0	0.2	0.0	0.3	0.0	0.8	0.3	0.6	0.3	0.2	0.2	1.1	0.4	3.2	63.7	0.2	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.4	0.2	0.1	2.9	0.0	0.2	0.2	10.4	0.1	0.2	33.5	0.5	5.3	0.0	4.7	0.8	1.2	53.6	3.6	0.3	179.4	79.8	0.2	0.1	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.5	92.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	45.6	0.0	0.0	0.1	179.4	0.1	0.0	0.2	0.0	0.1	79.8	0.0	6.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TCL1B	TML1	ENSG00000213231	"T cell leukemia/lymphoma 1B"	O95988	14	95686417-95692643	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3"	"Cell line enriched"	"Detected in some"	7	"U-698: 102.4"	"Cancer enriched"	"Detected in single"	72	"testis cancer: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"naive B-cell: 13.0;plasmacytoid DC: 5.9"	"Group enriched"	"Detected in many"	23	"B-cells: 13.0;dendritic cells: 5.9"					"Not detected"	"Not detected"			HPA053163	Uncertain		Approved	Cytosol				Cytosol		"HPA053163: AB_2682064"															"unprognostic (1.55e-1)"			0.1	0.2	0.1	0.9	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	1.4	0.4	0.1	0.0	0.1	0.1	0.1	1.1	0.1	0.1	5.3	0.1	0.0	0.2	0.1	0.0	0.1	12.7	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.1	1.8	0.1	7.3	0.0	0.0	0.1	0.0	5.4	0.1	0.1	13.0	5.9	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	102.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.3	0.4	0.0	5.9	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TCN2	"D22S676, D22S750, TC2"	ENSG00000185339	"Transcobalamin 2"	P20062	22	30606838-30627278	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 34.6;HUVEC TERT2: 40.5;Karpas-707: 52.7;RPTEC TERT1: 20.5;TIME: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 19.2;intermediate monocyte: 29.0;non-classical monocyte: 9.8"	"Lineage enriched"	"Detected in many"	8	"monocytes: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000837			Approved	Cytosol	"Secreted to blood"		13000000	Cytosol		"HPA000837: AB_1080235"	"unprognostic (6.43e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (1.53e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (2.64e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.95e-3)"	"unprognostic (4.94e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	39.8	15.2	6.5	7.2	8.1	2.2	30.0	3.4	10.9	13.1	14.8	9.2	9.6	10.9	15.0	23.9	7.0	11.2	31.7	15.8	6.6	7.3	73.2	8.7	21.7	43.3	8.6	8.5	7.8	6.3	5.7	7.9	8.7	10.7	9.6	13.5	13.5	6.8	23.0	5.4	4.5	30.4	17.6	9.0	24.8	8.4	9.7	5.1	1.9	12.8	4.8	4.6	11.6	10.9	0.0	3.4	0.6	29.0	0.0	0.3	6.5	0.0	2.5	11.8	0.0	7.0	34.6	0.4	0.8	8.7	2.2	3.7	1.2	6.0	0.1	13.1	1.6	0.4	1.0	0.6	0.7	0.0	0.6	0.0	0.3	0.5	17.0	0.1	9.7	5.6	0.6	1.7	1.5	40.5	0.2	52.7	3.5	0.0	0.0	0.9	4.6	0.2	1.3	1.7	17.7	20.5	0.3	4.1	0.5	0.0	0.1	3.4	0.1	0.5	23.7	7.6	1.0	0.9	0.3	1.4	0.3	0.0	2.7	0.4	0.1	0.0	19.2	0.0	0.0	29.0	0.3	0.0	0.3	0.2	3.4	0.0	0.1	0.2	0.6	0.0	9.8	0.6	0.1	6.5	6.5	8.1	3.4	10.9	6.6	7.3	8.6	8.5	10.7	5.1
TCP11L1	FLJ11336	ENSG00000176148	"T-complex 11 like 1"	Q9NUJ3	11	33039417-33105943	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005769	Approved		Approved	Cytosol				Cytosol		"HPA005769: AB_2202398"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.99e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.50e-3)"	12.0	10.1	13.0	10.2	19.2	12.8	14.1	15.0	25.3	10.4	15.1	14.7	9.3	11.7	11.1	6.9	9.8	8.2	15.5	10.6	13.9	14.9	11.6	8.1	9.4	8.8	16.8	16.1	11.1	12.6	9.9	12.5	13.3	21.2	10.3	14.4	7.4	8.7	14.4	6.6	10.4	22.9	16.8	16.2	9.8	10.0	10.3	11.1	8.1	7.4	5.0	10.7	10.6	10.9	2.6	11.1	13.1	6.1	4.5	5.7	3.1	6.6	12.2	6.2	5.8	10.8	12.2	4.2	9.8	8.2	7.5	10.2	6.2	3.2	6.7	2.7	18.8	10.8	8.3	7.6	10.7	8.7	6.5	4.4	13.5	4.5	7.0	4.2	6.3	9.8	9.5	7.7	14.8	7.4	2.8	8.2	18.8	9.7	4.5	1.7	4.6	4.5	5.3	12.9	1.2	6.8	2.5	5.1	10.5	24.7	16.1	4.5	3.9	1.9	11.1	13.3	19.4	14.9	10.1	10.3	10.1	7.8	9.6	2.3	10.4	13.1	6.1	8.3	3.6	3.7	3.5	2.2	2.0	4.0	5.9	2.6	2.0	2.6	3.6	4.5	0.9	11.1	5.7	3.1	13.0	19.2	15.0	22.9	13.9	14.9	16.8	16.1	21.2	11.1
TCTA		ENSG00000145022	"T cell leukemia translocation altered"	P57738	3	49412206-49416475	"Disease related genes, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007342	Approved		Approved	Cytosol				Cytosol		"HPA007342: AB_2202399"	"unprognostic (5.58e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.17e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (6.76e-4)"	"unprognostic (3.74e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (5.00e-15)"	"unprognostic (1.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.41e-3)"	15.4	29.3	21.8	9.2	21.9	7.9	16.3	12.5	26.1	18.3	16.9	23.1	19.5	14.0	13.6	46.9	12.8	20.1	19.3	13.1	20.6	20.8	35.6	27.2	17.2	14.3	23.2	18.5	19.4	18.5	17.9	28.4	19.1	22.2	25.2	21.8	23.3	16.0	20.0	10.5	7.8	19.4	16.5	25.6	15.1	16.3	9.3	12.8	12.6	34.1	10.2	11.4	13.0	8.9	9.5	10.1	14.6	28.0	13.4	13.0	13.4	5.8	7.2	4.7	7.0	20.8	9.1	6.1	12.1	9.0	12.3	10.4	4.2	6.4	7.0	8.9	28.5	6.8	9.1	12.2	10.1	10.4	6.3	11.6	9.4	5.4	12.6	5.0	15.3	19.6	12.7	13.7	11.0	12.7	4.2	16.0	30.0	5.4	6.0	4.5	3.8	16.8	3.7	5.0	16.3	21.1	7.8	12.6	4.1	14.4	16.0	13.1	13.6	4.7	11.4	9.3	5.7	19.2	4.5	8.8	11.5	4.7	21.9	8.8	12.8	12.7	11.5	14.6	13.0	21.9	7.6	8.0	8.4	10.0	6.6	9.5	10.4	11.0	13.2	13.4	28.0	10.1	10.7	13.4	21.8	21.9	12.5	26.1	20.6	20.8	23.2	18.5	22.2	12.8
TCTEX1D2	MGC33212	ENSG00000213123	"Tctex1 domain containing 2"	Q8WW35	3	196291219-196318299	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 37.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 16.6;dendritic cells: 10.9;T-cells: 18.3"									HPA049555			Approved	Cytosol				Cytosol		"HPA049555: "	"unprognostic (1.16e-1)"	"prognostic favourable (7.83e-4)"	"unprognostic (5.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.61e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (6.23e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	4.3	7.4	20.5	5.1	21.6	5.3	7.0	15.0	18.3	5.2	5.3	7.0	7.2	4.7	8.4	10.4	10.7	37.4	6.3	6.3	15.4	18.6	11.8	2.3	9.1	9.1	12.1	15.8	8.7	6.6	6.8	18.8	4.1	10.6	6.4	4.9	6.8	7.6	6.2	3.1	9.2	3.0	5.3	8.7	4.1	5.2	24.2	8.1	6.8	11.2	5.1	6.5	4.9	5.9	16.6	10.9	1.4	2.3	2.9	18.3	5.6	13.4	10.1	15.5	10.0	4.1	8.0	2.1	5.6	3.2	5.9	6.6	3.4	16.4	8.7	10.1	3.9	14.2	6.3	5.0	5.5	7.6	5.6	3.4	9.9	1.4	4.4	2.2	0.3	3.9	13.3	4.9	6.1	3.5	4.8	4.3	11.3	33.1	11.4	11.1	11.0	19.2	14.4	3.1	3.5	12.6	5.5	19.5	16.5	12.5	6.3	11.0	38.4	6.4	7.8	5.7	2.5	2.3	6.4	7.4	14.1	18.6	17.2	4.2	9.8	0.0	2.3	1.2	9.2	0.8	5.6	16.6	11.6	7.3	6.0	9.5	7.4	7.3	1.4	2.9	0.6	10.9	18.3	5.6	20.5	21.6	15.0	18.3	15.4	18.6	12.1	15.8	10.6	8.1
TDGF1	"CR, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582463	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 45.5"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 6.4;testis cancer: 27.1"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 12.5;pons and medulla: 9.1"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"			Vesicles	Cytosol	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.6	3.9	0.6	0.6	0.8	0.0	0.6	0.6	0.6	0.6	2.1	0.6	0.6	0.2	0.7	1.3	0.6	0.0	0.6	0.6	1.0	0.6	9.9	0.8	0.6	0.6	0.9	0.6	9.7	0.6	0.0	0.6	0.6	0.6	0.6	4.3	1.1	0.6	0.6	1.0	0.0	0.6	0.8	1.0	16.7	2.4	0.6	0.6	5.2	2.1	0.6	0.6	0.6	0.6	1.0	0.7	3.7	0.6	1.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	10.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.6	0.5	0.5	0.3	0.3	0.6	0.4	0.3	0.1	1.0	0.6	0.4	3.7	1.5	0.4	0.7	0.2	0.1	0.6	0.8	0.6	0.6	1.0	0.6	0.9	0.6	0.6	0.6
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 187.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.4;HDLM-2: 16.4;U-87 MG: 9.6"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebellum: 7.0;hippocampal formation: 5.9"	"Not detected"	"Not detected"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.2	0.5	0.2	2.5	0.5	0.0	0.1	0.1	2.0	0.1	0.2	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	1.5	0.2	0.2	187.9	0.8	2.9	0.2	0.7	0.1	0.1	0.0	5.8	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.1	0.4	0.2	1.5	0.3	0.1	0.0	0.0	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.1	0.3	0.4	0.0	2.6	0.0	0.0	9.6	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	2.0	1.5	0.2	0.2	0.7	0.1	0.0
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: "	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favourable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	13.7	12.0	13.0	10.3	14.7	6.9	16.9	13.8	14.2	16.7	17.2	11.7	14.2	12.9	15.2	14.2	16.5	14.4	12.7	16.7	12.9	10.6	16.2	13.5	16.9	11.3	13.5	14.8	20.6	21.3	15.3	15.4	12.4	17.7	15.5	15.5	11.1	12.5	14.8	42.4	15.2	16.7	19.0	16.8	12.9	14.8	15.9	15.0	18.7	16.9	18.6	12.1	19.0	15.4	3.8	7.2	2.3	3.5	3.0	6.9	2.1	4.4	4.9	10.9	25.4	4.4	9.5	6.4	5.1	5.8	6.0	3.9	3.2	7.4	10.9	2.1	7.5	6.3	8.9	7.5	6.5	8.1	6.8	20.2	9.4	6.2	8.5	14.2	10.6	6.4	10.7	3.5	10.6	8.1	4.5	6.6	6.4	4.8	12.6	7.4	8.3	3.8	6.7	5.2	7.2	8.1	5.9	9.6	11.6	7.3	9.0	18.4	4.6	6.2	6.8	3.8	3.9	4.3	5.6	13.3	11.5	9.4	3.6	7.4	11.6	0.5	2.3	2.3	5.5	3.5	3.8	3.8	6.2	6.2	3.3	2.7	5.2	6.4	0.1	3.0	2.5	7.2	6.9	2.1	13.0	14.7	13.8	14.2	12.9	10.6	13.5	14.8	17.7	15.0
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 46.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.7	3.5	8.8	4.2	10.9	1.6	4.6	18.0	9.9	2.6	3.3	6.3	7.5	2.5	2.0	6.2	2.1	2.4	2.3	3.6	8.8	8.9	3.1	3.7	4.4	5.4	8.1	7.8	1.4	3.5	46.5	5.5	3.7	15.9	6.2	4.3	2.9	6.4	6.7	4.5	2.5	2.5	3.1	7.6	5.9	3.1	19.3	4.9	8.0	7.3	1.0	5.2	3.7	2.0	3.8	5.3	5.3	7.0	7.3	13.1	4.2	6.3	5.5	4.9	11.4	0.3	0.5	4.8	1.1	0.6	3.4	2.3	3.6	9.2	7.4	10.1	0.4	3.9	7.2	7.5	5.3	19.2	5.1	7.4	1.6	2.5	2.2	1.4	1.2	0.6	3.0	7.3	3.1	3.6	5.7	6.7	1.0	17.2	11.7	2.2	3.8	9.6	1.4	3.1	15.4	6.0	3.1	7.2	11.8	8.0	6.4	7.4	14.0	5.6	1.4	1.6	2.9	5.0	6.1	13.8	16.9	8.3	7.4	6.0	2.2	5.3	0.9	1.9	8.8	4.3	13.1	3.8	8.2	8.8	2.0	3.6	6.0	7.5	0.7	7.3	7.0	5.3	9.4	4.2	8.8	10.9	18.0	9.9	8.8	8.9	8.1	7.8	15.9	4.9
TDRP	"C8orf42, INM01, TDRP1, TDRP2"	ENSG00000180190	"Testis development related protein"	Q86YL5	8	489792-545781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 41.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;HBEC3-KT: 14.2;hTCEpi: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA008462	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA008462: AB_1845777"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (9.37e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.46e-4)"	"unprognostic (2.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-1)"	5.7	9.0	7.7	6.1	13.1	0.5	11.0	10.4	9.2	8.5	4.9	3.6	8.4	2.3	9.4	9.8	5.7	12.9	9.9	3.7	7.4	10.3	14.3	9.4	9.6	3.9	6.3	3.6	13.0	13.7	15.2	11.1	41.9	8.4	12.5	2.8	17.7	6.2	12.3	2.3	3.3	2.8	5.0	4.6	2.6	3.6	8.1	3.2	3.0	22.7	3.2	6.3	9.9	12.8	0.4	0.0	0.0	0.1	0.0	0.2	1.1	4.9	5.0	8.8	0.0	0.0	0.0	29.5	2.9	1.8	2.7	2.5	0.0	0.0	0.0	1.2	0.9	1.1	0.0	14.2	3.5	0.0	0.4	0.0	0.0	7.4	3.4	0.0	2.1	3.4	11.3	0.0	5.3	0.4	0.6	0.0	2.9	0.0	0.0	0.0	10.4	1.0	0.0	0.0	0.0	9.1	7.4	2.6	4.2	0.0	8.9	2.1	2.9	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	7.7	13.1	10.4	7.5	7.4	10.3	6.3	3.6	8.4	3.2
TEDC1	C14orf80	ENSG00000185347	"Tubulin epsilon and delta complex 1"	Q86SX3	14	105489855-105499575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039049, HPA039050"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039049: , HPA039050: AB_10670918"	"unprognostic (8.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.73e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-3)"	5.1	2.0	10.5	8.5	13.6	10.8	5.2	5.1	10.3	3.3	7.6	10.7	2.0	9.4	5.5	5.0	5.2	4.0	5.5	3.4	10.3	7.4	2.9	4.0	6.2	8.8	7.9	4.6	2.7	6.4	2.5	4.5	7.9	7.1	3.7	3.2	3.9	5.8	4.6	3.9	10.1	8.3	2.1	7.4	5.9	10.6	9.1	9.5	16.0	5.1	7.1	11.8	6.1	3.5	0.8	5.7	1.4	2.2	0.1	3.7	0.7	7.9	18.3	4.3	6.5	0.4	0.7	11.8	6.3	2.5	7.6	7.3	6.6	15.0	12.0	13.3	1.0	21.1	1.5	6.8	1.5	14.1	7.5	3.1	10.1	6.4	0.3	6.1	8.9	0.1	2.2	5.1	1.6	3.0	5.0	15.1	1.2	30.5	12.5	13.8	5.7	19.5	10.3	6.8	8.3	2.1	6.8	12.5	7.3	6.5	7.7	4.6	12.3	6.0	3.7	5.3	9.1	16.3	10.4	8.8	3.7	7.2	6.8	6.9	8.6	0.0	1.2	1.4	1.5	2.2	1.0	0.3	2.2	3.7	1.7	0.8	1.4	0.4	0.4	0.1	2.0	5.7	1.6	0.7	10.5	13.6	5.1	10.3	10.3	7.4	7.9	4.6	7.1	9.5
TELO2	"hCLK2, KIAA0683, TEL2"	ENSG00000100726	"Telomere maintenance 2"	Q9Y4R8	16	1493344-1510457	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041348, HPA041473"	Approved		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA041348: AB_10794514, HPA041473: AB_10795593"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.15e-3)"	13.8	11.7	9.2	14.2	9.0	19.3	14.3	21.9	14.9	11.1	11.3	15.7	11.4	17.3	11.7	14.8	12.9	11.8	13.4	9.6	9.9	9.1	9.6	11.1	8.8	14.4	10.2	15.9	12.1	18.5	8.6	10.3	12.1	10.9	12.3	3.6	11.1	18.6	11.0	18.9	23.5	16.2	10.4	8.3	20.7	14.0	9.0	10.4	17.3	10.6	11.2	14.8	10.6	10.5	8.3	8.2	3.2	11.4	3.8	5.1	5.0	8.1	12.2	3.8	7.2	1.5	1.6	14.7	13.0	2.5	6.3	4.6	15.6	7.8	12.0	11.3	2.0	8.6	2.7	4.9	1.2	7.0	23.6	6.9	14.1	9.0	2.5	8.7	10.4	3.1	1.9	5.8	1.2	3.7	17.7	4.3	2.5	27.5	10.2	23.3	12.2	10.3	30.6	5.3	12.2	2.3	7.7	16.0	9.0	11.2	10.7	4.0	9.9	10.5	5.8	13.7	9.6	13.2	10.7	7.9	5.0	21.9	4.3	12.3	11.4	0.0	6.8	3.2	5.1	8.6	5.1	5.4	3.6	4.3	8.2	8.3	4.2	3.2	0.5	3.8	11.4	5.0	3.3	5.0	9.2	9.0	21.9	14.9	9.9	9.1	10.2	15.9	10.9	10.4
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295069	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 61.2;fHDF/TERT166: 58.1;HBEC3-KT: 118.1;hTEC/SVTERT24-B: 74.6;LHCN-M2: 33.7;TIME: 96.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: , HPA065897: "	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	7.1	0.9	3.4	0.0	0.0	0.2	0.1	1.1	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	1.0	0.4	5.0	0.0	12.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	30.6	61.2	0.5	0.0	23.3	4.2	7.9	0.1	0.1	0.7	0.0	58.1	0.0	0.2	118.1	5.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.0	3.0	74.6	0.8	0.2	0.6	0.1	33.7	0.0	0.2	1.6	0.4	0.2	0.8	0.0	0.8	3.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	96.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 50.9;hTCEpi: 57.6;SK-BR-3: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in some"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"				"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favourable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.2	5.1	5.8	0.0	2.6	6.6	13.7	12.7	6.2	2.3	2.3	12.8	27.0	0.0	50.9	8.8	24.9	3.1	18.6	5.8	12.0	10.0	2.4	12.0	6.3	15.6	11.0	0.0	14.8	57.6	8.2	20.9	6.6	2.4	8.6	0.6	5.0	0.0	0.1	3.8	14.7	0.0	0.0	9.5	24.0	9.3	2.7	25.2	18.5	57.8	14.0	0.0	4.5	11.2	0.1	0.3	18.7	0.1	20.3	9.8	0.2	1.6	5.6	19.2	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7
TESC	"CHP3, FLJ20607, TSC"	ENSG00000088992	Tescalcin	Q96BS2	12	117038923-117099479	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.8;salivary gland: 92.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.5;NB-4: 103.7;U-937: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 55.8"	"Lineage enriched"	"Detected in all"	5	"monocytes: 55.8"					"Low region specificity"	"Detected in all"			HPA053200	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053200: "	"unprognostic (4.53e-3)"	"unprognostic (5.98e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.67e-3)"	1.8	8.4	5.0	2.4	12.1	25.5	2.3	1.2	6.8	1.8	1.2	1.8	19.4	1.8	1.3	32.9	1.3	1.3	45.8	13.2	6.2	2.2	4.6	1.9	2.9	1.8	2.4	3.3	1.5	40.5	0.7	4.0	2.5	2.2	2.5	0.7	0.3	92.6	24.4	1.3	1.8	1.7	1.4	1.6	2.7	34.4	5.0	2.2	1.2	2.1	1.2	2.5	6.5	2.3	1.9	8.5	11.3	55.8	2.5	2.3	3.9	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	2.3	0.7	0.0	0.1	1.2	0.0	0.0	6.3	4.1	17.7	1.4	12.1	0.0	7.5	64.5	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.3	14.6	103.7	1.4	0.0	0.0	0.0	8.3	8.9	2.3	2.7	0.9	0.0	0.0	0.5	0.0	8.1	0.0	0.0	0.2	0.0	0.0	2.7	6.1	0.0	0.0	34.4	0.0	0.0	11.9	11.3	1.8	14.9	0.1	1.3	0.6	2.3	8.5	1.9	0.0	1.0	3.0	2.5	55.8	0.6	0.7	3.9	5.0	12.1	1.2	6.8	6.2	2.2	2.4	3.3	2.2	2.2
TET3	"hCG_40738, MGC22014"	ENSG00000187605	"Tet methylcytosine dioxygenase 3"	O43151	2	73986404-74108176	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050845	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA050845: "	"unprognostic (1.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (2.05e-1)"	"unprognostic (5.30e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.10e-1)"	2.9	2.3	7.2	6.1	10.8	20.9	3.9	26.0	17.1	3.2	5.1	20.6	0.5	6.7	2.9	1.9	10.2	3.0	3.3	1.6	7.1	3.3	2.6	5.1	5.6	4.3	12.0	9.5	2.9	3.6	3.5	4.2	5.7	12.4	3.6	5.5	5.9	5.9	1.8	1.8	18.9	7.2	2.7	5.3	5.5	5.3	2.1	11.7	0.6	3.4	1.7	5.1	4.0	5.0	1.1	1.4	2.5	2.2	0.4	0.9	0.9	6.1	5.4	10.4	6.3	0.9	1.0	19.1	1.3	1.7	2.5	1.9	11.6	5.8	10.3	2.5	1.7	6.6	9.2	3.6	2.6	4.4	3.6	13.2	4.5	3.9	3.8	13.8	8.2	1.5	9.7	3.0	7.2	3.7	9.0	3.4	1.4	10.2	6.8	9.0	5.8	1.9	10.3	6.5	3.6	2.7	11.5	13.0	11.1	2.8	7.4	3.5	4.7	11.2	4.7	2.6	11.2	1.2	4.6	3.0	1.3	9.0	1.7	9.7	3.4	0.5	2.0	1.0	0.4	2.2	0.9	1.1	0.5	0.5	1.4	0.9	0.7	0.6	2.5	0.4	0.7	1.4	0.0	0.9	7.2	10.8	26.0	17.1	7.1	3.3	12.0	9.5	12.4	11.7
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 52.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.9;Karpas-707: 11.6;MCF7: 4.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA030620: AB_10601598, HPA077020: "	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.2	0.1	0.3	1.5	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0.0	52.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.2	0.1	0.0	0.2	2.5	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.0	0.2	8.9	1.3	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.0	0.1	11.6	0.0	4.7	0.4	0.1	0.6	0.1	0.5	0.4	1.7	0.0	0.1	1.4	0.2	0.0	0.0	0.6	0.4	0.1	0.0	0.1	0.3	0.0	0.0	2.0	0.5	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.1	0.4	0.1
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913003	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;HEL: 19.7;K-562: 5.5;NTERA-2: 3.7;SCLC-21H: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.1	0.1	0.7	0.2	5.4	0.1	0.1	0.1	1.1	1.2	0.1	0.0	0.0	0.1	10.0	0.6	0.2	0.1	0.8	0.1	1.7	0.5	0.1	0.1	0.1	0.1	0.3	0.3	0.4	0.1	0.1	6.9	0.1	0.9	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.2	8.5	0.4	0.4	0.9	21.3	1.4	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	8.7	1.1	0.0	1.1	3.1	19.7	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.1	0.1	0.1	3.7	0.3	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	3.7	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.1	1.1	1.7	0.5	0.3	0.3	0.9	1.4
TEX261	"MGC32043, TEG-261"	ENSG00000144043	"Testis expressed 261"	Q6UWH6	2	70985938-70994945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA016631	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA016631: AB_2240434"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (6.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (4.23e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-1)"	22.9	27.1	14.5	11.1	15.4	9.3	22.2	13.4	21.4	19.9	15.9	21.6	20.9	13.8	17.3	27.2	17.3	20.9	21.2	21.6	14.4	12.0	25.1	36.9	19.8	16.1	17.0	10.9	23.7	50.8	36.1	20.1	19.3	15.0	18.9	18.9	28.7	22.3	21.0	33.5	12.9	23.6	19.6	17.4	16.0	18.4	23.8	15.3	15.5	31.7	14.3	16.3	14.9	13.9	3.8	4.4	12.0	5.3	3.4	6.7	2.8	19.9	18.9	13.3	16.8	40.6	20.7	15.0	23.1	22.1	27.0	17.1	22.2	16.6	16.3	8.8	40.6	15.1	25.2	27.6	39.3	12.3	21.0	19.5	9.8	23.4	23.9	22.7	16.4	18.6	18.5	25.9	17.7	27.4	24.2	10.9	31.5	15.7	19.5	12.6	8.8	22.4	13.9	41.1	14.0	19.6	17.5	21.8	11.5	24.0	24.0	15.1	15.6	13.5	21.9	33.2	28.8	17.7	30.7	8.5	7.5	19.4	29.0	30.0	27.8	12.0	5.3	10.0	5.1	5.3	4.3	2.6	5.4	6.7	4.0	3.8	6.2	4.9	4.0	3.4	5.2	4.4	4.3	2.8	14.5	15.4	13.4	21.4	14.4	12.0	17.0	10.9	15.0	15.3
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favourable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favourable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.7	21.6	3.8	19.9	40.4	19.7	7.9	10.1	24.0	16.9	17.1	11.6	28.0	17.0	7.4	14.5	11.5	11.0	20.5	8.2	13.6	17.5	16.2	13.5	15.3	36.1	10.2	18.2	25.9	32.7	19.1	19.6	12.3	8.5	29.6	17.3	13.6	16.2	23.6	4.2	24.3	7.9	5.1	32.0	26.6	16.4	5.6	9.1	12.4	34.3	15.6	16.7	21.5	9.0	17.0	7.1	17.8	13.4	20.7	22.3	8.3	20.9	21.4	16.9	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5
TEX9		ENSG00000151575	"Testis expressed 9"	Q8N6V9	15	56244009-56445997	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 49.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 4.1;memory B-cell: 14.4;naive B-cell: 6.8"	"Group enriched"	"Detected in many"	11	"B-cells: 14.4;granulocytes: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039415	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039415: AB_10672775"	"unprognostic (3.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	1.7	5.4	5.3	9.0	14.8	2.0	7.6	4.0	2.3	7.0	4.6	7.8	6.0	8.5	5.7	11.6	7.3	21.6	6.2	1.6	6.1	7.5	11.9	1.2	5.8	4.1	4.0	3.2	7.5	4.1	13.5	49.7	1.0	25.2	5.4	3.5	9.2	9.0	4.5	0.9	4.1	9.6	2.3	4.9	5.5	9.0	19.3	4.0	2.0	14.8	2.0	8.2	2.7	2.2	14.4	0.3	4.1	0.6	0.4	0.8	0.8	5.7	5.2	11.6	10.3	2.9	8.4	1.5	1.3	4.8	3.6	4.4	1.4	5.1	11.5	5.5	0.9	5.2	4.9	5.4	4.2	1.4	6.0	6.6	5.3	3.8	0.9	3.0	1.3	4.6	10.1	4.1	3.1	0.1	3.7	1.3	1.9	3.2	4.7	2.6	5.6	2.3	1.9	5.4	4.2	12.1	3.3	18.5	7.4	6.4	3.9	4.0	11.0	3.4	0.6	15.5	4.7	5.0	4.6	1.6	11.7	8.8	6.1	1.3	3.0	4.1	0.1	0.1	0.3	0.6	0.1	14.4	0.4	0.3	0.2	6.8	0.2	0.8	0.3	0.4	0.3	0.3	0.5	0.8	5.3	14.8	4.0	2.3	6.1	7.5	4.0	3.2	25.2	4.0
TFCP2	"CP2, LBP-1C, LSF, TFCP2C"	ENSG00000135457	"Transcription factor CP2"	Q12800	12	51093663-51173134	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070247			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA070247: "	"unprognostic (6.27e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.31e-2)"	17.4	16.7	21.1	29.3	21.6	9.6	17.7	22.7	21.6	20.2	19.0	20.5	20.8	15.7	19.3	18.9	16.7	21.1	20.7	17.7	20.0	18.7	17.2	12.5	14.1	20.4	19.4	24.9	20.8	14.6	29.2	23.2	22.4	15.4	20.3	21.7	16.4	17.8	19.0	26.6	15.4	15.9	23.8	21.3	18.4	16.1	11.2	18.6	32.1	17.9	12.9	25.9	19.0	18.1	4.5	8.2	9.1	9.4	9.4	6.1	5.0	7.4	12.8	19.2	17.2	11.0	13.9	28.2	14.5	7.8	12.7	7.5	24.4	16.0	0.6	12.7	12.6	14.3	24.5	15.5	12.7	16.0	14.2	22.5	12.3	10.2	9.2	25.5	21.9	9.5	14.1	13.1	20.9	11.8	22.8	0.0	13.4	0.0	23.0	16.9	27.8	23.3	17.8	10.6	0.1	16.6	17.9	18.3	16.0	17.9	14.7	11.7	5.5	21.3	11.9	11.7	12.7	12.1	12.5	13.9	23.5	0.0	11.1	15.9	8.4	9.1	9.2	9.0	3.9	7.7	6.1	4.5	4.1	4.2	8.2	3.4	4.9	4.0	3.5	9.4	9.4	3.5	5.4	5.0	21.1	21.6	22.7	19.4	20.0	18.7	19.4	24.9	15.4	18.6
TFDP1	"DILC, Dp-1, DP1, DRTF1"	ENSG00000198176	"Transcription factor Dp-1"	Q14186	13	113584721-113641470	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.4"	"Low lineage specificity"	"Detected in all"											"CAB033605, HPA044754, HPA068909"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB033605: AB_783105, HPA044754: , HPA068909: "	"unprognostic (4.28e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (5.50e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (7.57e-4)"	"prognostic favourable (6.17e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	16.0	13.3	20.1	28.0	21.1	71.6	16.4	24.4	22.4	19.3	19.6	16.3	28.6	16.0	16.8	20.5	36.2	18.0	27.0	26.3	19.0	16.8	17.9	20.9	16.5	32.5	18.0	12.7	14.4	26.7	9.9	16.3	21.8	15.2	16.0	23.0	20.2	18.9	24.2	26.9	22.3	21.3	18.4	23.5	25.6	16.4	37.5	10.3	38.8	21.7	32.7	34.4	18.5	20.8	3.6	4.7	20.4	4.0	1.6	5.4	2.0	62.0	15.3	19.8	16.8	26.9	24.0	22.5	35.0	31.8	45.5	42.1	31.8	29.2	57.9	11.7	33.5	29.9	34.3	31.1	44.7	39.4	39.9	33.6	25.0	19.9	16.9	84.3	29.7	19.8	28.0	28.8	16.8	30.5	27.6	15.6	40.4	21.3	37.0	32.8	18.2	19.7	25.3	17.6	33.1	17.3	23.8	51.2	15.1	15.7	43.2	10.5	29.7	68.0	21.2	14.8	23.6	31.3	38.5	13.3	16.3	59.7	33.0	52.3	25.0	20.4	2.3	3.6	2.6	3.0	2.9	3.6	3.5	3.1	4.7	2.6	5.4	2.7	3.1	1.6	4.0	2.4	4.2	2.0	20.1	21.1	24.4	22.4	19.0	16.8	18.0	12.7	15.2	10.3
TFE3	"bHLHe33, TFEA"	ENSG00000068323	"Transcription factor binding to IGHM enhancer 3"	P19532	X	49028726-49043486	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023881	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023881: AB_1857931"	"unprognostic (2.68e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (6.03e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (2.19e-8)"	"unprognostic (1.93e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.25e-1)"	31.3	20.9	12.6	18.2	14.4	22.6	53.1	16.5	18.1	22.6	17.7	16.6	30.0	9.9	22.8	21.9	20.5	18.8	16.4	15.1	11.3	11.8	21.6	14.1	22.8	10.3	13.2	9.4	24.4	15.9	16.5	16.3	22.0	15.9	21.2	10.4	15.7	12.6	30.6	13.6	14.1	13.5	21.2	14.8	23.0	14.7	10.4	15.2	4.2	21.7	10.8	10.5	28.6	20.5	1.2	1.9	10.5	4.4	0.4	1.4	1.6	11.9	15.3	5.1	14.8	16.7	15.1	5.1	15.7	18.2	16.1	13.8	9.4	9.5	4.5	6.7	23.1	9.8	9.7	14.2	13.0	9.8	5.2	4.1	11.4	8.7	22.5	4.3	10.2	13.1	9.2	26.3	18.9	7.7	7.9	19.7	13.7	7.0	2.8	4.0	13.9	13.8	4.3	8.9	10.2	10.2	5.5	4.9	4.9	16.8	7.2	5.5	10.3	3.9	16.3	17.6	18.9	17.6	8.6	12.1	11.4	3.7	21.0	5.3	12.0	0.0	3.5	1.6	0.5	4.3	0.9	0.6	0.9	0.5	1.9	1.2	0.6	0.4	10.5	0.4	4.4	0.4	1.4	1.6	12.6	14.4	16.5	14.9	11.3	11.8	13.2	9.4	15.9	15.2
TFG	"FLJ36137, SPG57, TF6"	ENSG00000114354	"TRK-fused gene"	Q92734	3	100709331-100748966	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019473, HPA052206"	Approved		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA019473: AB_1857936, HPA052206: "	"unprognostic (1.14e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (3.31e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.45e-2)"	36.4	40.3	27.2	21.9	33.8	29.7	31.0	28.1	40.5	31.2	34.7	33.3	44.2	52.5	31.2	45.8	46.7	29.0	40.8	46.2	28.1	30.7	44.6	68.6	29.9	25.4	28.2	21.5	33.5	49.2	52.3	45.1	63.3	33.7	27.5	40.7	31.9	39.6	45.8	38.6	31.0	67.1	37.5	31.7	28.3	28.9	33.5	23.0	27.6	43.6	42.9	41.2	29.5	30.1	25.8	27.8	43.2	28.4	27.7	26.8	21.8	48.4	26.4	32.9	20.9	41.6	47.2	40.7	35.1	47.3	45.9	54.8	33.3	24.2	6.5	25.8	43.6	36.4	35.4	40.1	54.7	29.8	20.8	24.4	20.3	30.9	46.5	18.0	14.6	38.6	54.1	27.5	48.5	40.6	17.5	18.1	47.4	33.9	15.8	14.3	31.3	39.8	14.0	19.3	21.1	55.7	32.7	26.0	23.8	23.1	30.1	40.9	35.4	24.4	27.1	27.8	33.6	12.8	25.4	15.4	15.5	23.3	44.4	19.7	32.6	43.2	28.3	27.0	21.8	28.4	26.4	25.8	22.6	24.4	27.8	22.9	21.6	21.6	18.7	27.7	26.4	19.4	26.8	21.8	27.2	33.8	28.1	40.5	28.1	30.7	28.2	21.5	33.7	23.0
TFIP11	"DKFZP434B194, Spp382, TIP39"	ENSG00000100109	"Tuftelin interacting protein 11"	Q9UBB9	22	26491225-26512505	"Plasma proteins, Predicted intracellular proteins"	"Biomineralization, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027085			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA027085: AB_1857964"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	11.8	13.5	12.7	12.7	13.8	43.9	10.9	13.8	15.4	9.4	9.5	13.1	8.9	9.9	11.8	8.9	14.5	10.7	10.3	11.8	13.2	9.6	12.3	24.7	11.0	17.7	15.5	12.0	10.3	16.3	11.1	12.0	11.5	12.2	10.5	9.8	11.9	10.9	8.7	34.2	16.3	12.7	10.2	10.6	17.8	11.1	40.6	12.3	23.8	15.4	11.0	19.0	11.1	11.5	23.8	15.5	35.4	23.8	19.6	25.5	17.8	10.9	12.9	11.2	12.6	18.0	10.9	11.3	13.5	17.2	21.1	20.0	9.8	8.0	21.4	8.4	16.7	16.3	16.0	13.0	15.7	15.6	15.2	13.1	8.3	9.9	16.5	30.4	16.9	13.9	17.6	20.0	15.8	16.1	17.7	20.5	14.1	13.4	13.8	16.7	10.8	10.8	21.0	17.3	18.9	12.2	11.1	8.5	12.3	16.1	11.6	15.8	9.4	14.5	15.8	17.8	29.2	11.2	12.3	15.1	19.3	42.4	14.1	12.3	13.2	35.4	16.9	28.6	23.8	18.2	22.1	22.9	21.1	22.2	15.5	23.8	20.2	18.4	26.8	19.6	23.8	9.7	25.5	17.8	12.7	13.8	13.8	15.4	13.2	9.6	15.5	12.0	12.2	12.3
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.2;placenta: 192.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 55.2;HUVEC TERT2: 103.8;LHCN-M2: 63.6;TIME: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.5;plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005575, CAB020842"	Supported		Approved	"Intermediate filaments,Cytosol"	"Secreted to blood"		95000000	Cytosol	"Intermediate filaments"	"CAB020842: , HPA005575: AB_1080290"	"unprognostic (8.75e-2)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (7.95e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.81e-2)"	52.8	5.0	1.3	5.2	2.2	1.6	18.5	1.9	2.4	22.8	32.1	0.3	7.2	12.8	13.3	14.8	25.9	12.5	15.0	14.0	1.2	1.1	35.6	98.2	89.7	40.2	2.4	1.0	17.3	7.7	0.9	4.9	192.3	2.3	18.2	6.9	3.8	6.0	3.8	15.8	6.6	37.0	13.6	5.4	16.5	7.7	13.7	1.6	3.4	22.6	10.4	4.0	30.0	14.7	1.5	5.1	5.5	0.6	1.0	0.6	4.9	5.0	3.5	4.1	0.1	32.1	38.5	0.0	9.1	21.7	5.9	9.2	3.2	27.0	0.0	3.6	7.1	0.3	1.2	0.4	15.5	0.2	1.0	1.6	10.9	27.4	55.2	0.1	0.0	17.6	0.7	32.1	8.6	103.8	4.0	0.1	63.6	4.7	0.6	0.1	2.5	8.8	0.0	5.7	0.0	10.1	0.2	0.0	0.0	7.4	0.2	0.4	0.1	0.0	62.1	4.3	4.0	8.5	1.7	0.0	0.1	0.0	34.6	0.0	4.9	5.5	0.6	0.5	0.5	0.3	0.2	0.9	0.4	0.2	0.5	1.5	0.5	0.6	2.6	1.0	0.3	5.1	0.2	4.9	1.3	2.2	1.9	2.4	1.2	1.1	2.4	1.0	2.3	1.6
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574051-94596257	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	11.1	12.2	7.9	11.4	11.8	5.8	13.4	8.0	7.8	11.9	9.0	9.0	13.4	11.1	13.7	13.2	10.3	10.5	8.7	7.7	7.0	7.0	11.8	31.9	7.8	12.5	11.8	6.8	13.9	14.1	6.2	24.3	10.8	10.1	10.5	10.6	15.4	12.5	12.7	7.6	7.9	11.1	10.3	12.6	11.9	9.8	7.2	12.6	27.1	15.8	8.9	12.5	10.9	9.2	9.9	8.0	10.5	7.0	10.4	17.4	6.7	7.2	3.0	5.1	4.6	7.6	6.1	6.4	6.6	6.4	6.3	6.1	8.4	7.1	11.2	6.7	4.6	4.6	9.0	5.2	6.5	8.9	3.6	9.0	3.6	7.8	9.6	30.8	6.2	7.1	4.2	3.5	10.1	5.8	8.8	3.9	5.6	4.4	8.4	15.9	6.7	3.9	7.2	5.2	6.6	7.9	3.2	7.3	4.0	5.0	10.5	18.6	4.7	16.7	5.3	2.5	6.6	3.9	5.5	8.9	4.8	41.2	6.9	11.4	6.8	10.5	5.3	9.6	9.6	6.2	14.5	9.9	11.3	10.5	8.0	7.3	17.4	12.4	1.5	10.4	7.0	7.1	12.5	6.7	7.9	11.8	8.0	7.8	7.0	7.0	11.8	6.8	10.1	12.6
TGFB1	"CED, DPD1, TGFB, TGFbeta"	ENSG00000105329	"Transforming growth factor beta 1"	P01137	19	41301587-41353911	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000361, HPA073356"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	1288167	38000000	"Golgi apparatus"	Cytosol	"CAB000361: AB_2201910, HPA073356: "	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.75e-3)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (8.51e-3)"	"unprognostic (5.63e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (1.19e-8)"	"unprognostic (1.65e-3)"	"unprognostic (2.79e-2)"	"unprognostic (6.39e-2)"	"unprognostic (4.86e-3)"	24.3	14.4	7.7	29.8	11.9	53.1	19.0	2.2	8.2	27.8	15.3	14.3	11.5	11.4	24.1	12.8	24.5	13.0	15.6	17.6	8.8	6.5	19.2	10.4	32.4	33.3	12.0	4.1	15.3	8.2	6.9	9.7	54.7	11.7	17.2	5.8	10.3	10.9	15.9	8.7	14.0	17.6	14.6	12.8	55.8	12.8	9.5	12.3	30.6	10.3	9.1	30.6	28.7	24.6	0.7	1.4	7.5	2.2	0.5	1.7	1.3	14.5	22.9	1.2	0.1	10.6	9.4	2.9	21.1	19.0	6.8	4.6	9.7	9.0	14.4	22.7	28.6	7.9	4.1	13.5	2.4	19.1	4.5	48.5	5.5	12.3	13.7	13.3	33.1	12.2	4.3	13.1	8.4	34.1	26.0	36.3	6.2	10.7	11.4	19.5	2.5	13.7	12.3	3.2	21.6	12.1	6.3	0.2	1.6	5.8	0.3	4.1	0.5	11.9	43.1	26.7	20.9	5.6	22.9	20.1	7.8	9.4	26.1	26.7	4.7	1.5	1.9	7.5	1.7	2.2	1.3	0.4	0.9	0.9	1.4	0.7	0.7	0.9	4.7	0.5	2.0	1.4	0.5	1.3	7.7	11.9	2.2	7.6	8.8	6.5	12.0	4.1	11.7	12.3
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"			13000000	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (7.73e-5)"	16.8	4.1	1.0	14.4	1.4	0.3	18.5	1.2	1.6	42.9	51.1	1.8	22.1	5.8	80.7	22.7	34.1	28.9	36.2	11.8	0.9	0.7	8.6	2.8	11.2	10.6	1.1	1.3	40.3	2.2	5.1	1.8	11.5	2.3	37.7	10.4	11.1	7.1	34.7	5.7	5.9	12.8	71.9	1.8	11.5	19.6	10.9	0.9	0.7	5.8	7.8	3.6	69.9	23.5	1.3	0.5	8.8	0.0	0.0	2.5	2.3	4.3	5.4	9.0	0.0	8.9	16.3	0.1	23.5	22.0	14.7	10.0	2.3	1.5	0.0	22.1	20.1	6.5	1.8	4.3	19.4	0.0	0.0	5.2	10.1	1.2	22.6	0.0	6.7	10.5	6.4	9.1	5.4	9.7	0.5	0.0	17.9	0.0	0.0	0.6	0.4	5.6	0.0	10.7	0.0	4.1	2.2	0.0	6.4	9.1	0.0	4.5	0.0	0.5	26.1	26.5	6.5	7.4	10.2	0.0	0.0	0.0	11.7	0.2	16.3	8.8	0.0	0.1	0.3	0.0	0.5	1.3	1.4	0.2	0.1	0.5	0.2	1.0	0.2	0.0	0.0	0.5	2.5	2.3	1.0	1.4	1.2	1.6	0.9	0.7	1.1	1.3	2.3	0.9
TGFBR3	"betaglycan, BGCAN"	ENSG00000069702	"Transforming growth factor beta receptor 3"	Q03167	1	91680343-91906335	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.7;ASC TERT1: 32.0;U-2197: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	22	"NK-cells: 9.0;T-cells: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008257, CAB018971"	Supported		Approved	Cytosol	"Secreted to blood"		29000000	Cytosol		"CAB018971: , HPA008257: AB_1080258"	"unprognostic (7.57e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (9.39e-3)"	"prognostic favourable (4.84e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.99e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (1.08e-2)"	40.1	15.9	3.2	6.8	3.1	1.6	63.5	1.8	4.4	30.1	15.2	3.5	30.0	3.4	17.6	21.0	22.2	17.6	23.3	16.3	3.9	1.9	12.5	11.9	18.4	18.1	2.6	2.0	62.4	8.9	4.4	4.4	25.1	4.5	21.7	5.6	8.8	14.7	46.5	19.2	13.4	9.8	34.4	4.1	27.1	11.1	14.0	3.0	1.1	7.5	6.5	3.1	39.2	42.1	0.0	0.6	0.6	0.6	9.0	21.3	3.9	2.7	2.6	4.0	0.6	65.7	32.0	12.7	2.0	10.0	2.3	2.8	1.2	0.4	0.0	0.5	3.6	0.4	1.0	0.2	1.8	9.3	2.1	0.0	3.3	11.1	1.4	0.1	0.0	7.7	1.3	5.1	1.1	1.1	6.4	0.2	0.6	0.0	0.0	0.0	1.6	0.9	0.1	1.3	0.5	0.9	16.0	0.1	0.0	0.9	0.0	5.5	0.3	1.0	3.6	3.9	1.0	22.3	0.4	9.9	0.9	0.0	0.8	0.5	0.4	0.6	0.0	0.0	21.3	0.1	11.6	0.0	5.4	11.4	0.0	0.0	1.7	8.0	0.3	9.0	0.6	0.6	2.4	3.9	3.2	3.1	1.8	4.4	3.9	1.9	2.6	2.0	4.5	3.0
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127387-38166578	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 187.6;placenta: 212.7"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 160.1;EFO-21: 53.8;HUVEC TERT2: 72.7;TIME: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"			1700000	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	33.3	9.5	6.0	18.3	8.1	1.0	7.7	4.3	7.5	94.3	12.6	4.0	4.7	8.4	54.6	21.7	15.8	58.7	62.8	77.1	7.5	3.4	25.3	187.6	61.2	16.4	6.9	3.0	18.7	5.0	5.2	25.6	212.7	8.5	33.6	6.3	57.4	1.9	17.1	19.3	0.7	12.8	43.9	5.7	20.4	13.6	7.4	6.4	0.8	17.0	3.4	3.1	38.2	21.6	1.9	2.4	0.0	2.5	0.0	0.0	0.2	6.5	4.9	0.0	0.1	5.1	0.5	2.5	9.9	4.8	0.0	0.1	8.0	160.1	0.0	53.8	0.1	0.1	0.0	23.2	0.3	0.0	0.0	1.0	0.2	3.5	20.9	0.0	0.0	0.5	0.0	4.2	0.0	72.7	2.1	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.2	0.0	0.0	0.1	23.2	0.0	0.8	0.2	0.0	94.8	0.1	6.0	0.7	4.7	0.0	0.0	0.0	6.5	0.0	1.9	0.0	0.2	0.0	0.0	2.5	0.0	1.9	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	8.1	4.3	7.5	7.5	3.4	6.9	3.0	8.5	6.4
TGS1	"NCOA6IP, PIMT"	ENSG00000137574	"Trimethylguanosine synthase 1"	Q96RS0	8	55773142-55825448	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025024, HPA029824"	Supported		Supported	Cytosol				Cytosol		"HPA025024: AB_1854330, HPA029824: "	"unprognostic (4.13e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.94e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.85e-2)"	12.1	10.0	7.2	18.2	9.1	13.3	12.6	18.1	10.2	11.6	14.1	7.2	18.2	7.6	14.3	16.0	13.5	14.1	9.4	8.5	8.8	6.7	12.6	8.8	10.7	18.8	5.3	6.9	14.8	9.6	12.3	13.8	10.2	7.4	11.9	10.1	7.1	11.6	20.0	19.6	14.1	16.8	11.5	6.3	17.7	10.5	10.8	8.0	29.7	11.6	13.2	18.3	14.5	14.5	10.4	10.1	10.0	7.6	6.3	13.1	4.8	9.1	6.9	8.2	9.1	7.2	7.2	8.6	8.6	8.8	9.2	9.4	6.4	8.9	20.8	6.0	5.7	8.8	17.3	11.0	11.7	11.6	6.6	22.2	7.7	3.6	10.2	12.4	7.7	7.1	7.5	8.8	18.1	7.0	18.1	8.2	7.5	7.0	27.9	8.1	30.0	2.8	19.9	5.9	6.6	8.4	9.2	8.4	11.5	11.0	6.7	9.9	9.2	7.6	6.9	6.8	8.6	8.1	7.8	7.2	4.7	26.3	6.7	9.7	8.6	10.0	5.5	8.8	11.6	6.3	13.1	9.8	11.6	11.2	5.5	10.4	11.9	12.4	6.3	6.3	7.6	10.1	9.2	4.8	7.2	9.1	18.1	10.2	8.8	6.7	5.3	6.9	7.4	8.0
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171877	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"adrenal gland: 83.5;brain: 41.4"	"Group enriched"	"Detected in some"	32	"PC-3: 35.1;SK-BR-3: 12.5"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 4.0"	"Group enriched"	"Detected in many"	6	"hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory region: 220.1"	"Region enriched"	"Detected in many"	19	"midbrain: 692.0"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol				Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: "	"unprognostic (1.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.75e-4)"	"unprognostic (8.82e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.18e-2)"	1.3	83.5	0.0	0.3	5.4	0.2	0.2	0.0	0.7	1.8	0.2	6.2	0.0	0.2	0.3	0.3	0.2	0.3	0.4	0.2	0.3	15.5	0.2	0.2	0.2	0.2	41.4	0.0	0.3	0.3	0.2	0.2	0.9	41.2	0.6	0.2	0.3	0.2	2.0	0.2	0.5	0.4	0.2	0.0	0.3	0.2	0.3	1.5	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	35.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.3	15.5	41.4	0.0	41.2	1.5
THADA	"ARMC13, FLJ21877, GITA, KIAA1767"	ENSG00000115970	"THADA, armadillo repeat containing"	Q6YHU6	2	43230836-43596046	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035191, HPA035192"	Uncertain		Approved	Cytosol				Cytosol		"HPA035191: AB_10670290, HPA035192: "	"unprognostic (1.20e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.26e-1)"	"prognostic unfavourable (6.48e-4)"	"unprognostic (8.27e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.14e-1)"	15.7	12.5	8.6	14.2	11.9	12.0	15.8	8.8	10.6	15.0	10.6	13.8	20.2	6.6	25.3	16.8	12.8	15.8	9.7	11.8	7.5	7.1	12.6	18.5	13.5	20.0	10.9	6.1	15.8	17.1	27.2	29.9	9.6	10.9	16.4	10.1	12.7	17.7	12.6	12.7	16.2	11.7	12.4	11.4	17.2	11.1	12.3	10.0	23.1	17.9	12.3	23.3	12.6	19.4	4.9	5.2	14.7	4.7	6.5	5.4	2.6	13.2	15.9	7.2	0.2	19.7	17.0	10.5	8.9	7.4	8.4	7.2	9.2	8.0	12.2	15.3	10.5	12.3	11.2	15.2	14.5	10.0	11.1	8.6	6.4	12.3	6.9	13.4	7.0	11.1	13.8	17.7	23.3	11.4	15.4	6.5	10.1	16.6	13.2	15.0	14.5	9.1	6.1	13.1	9.2	13.3	11.9	9.6	14.9	8.4	8.2	7.9	8.4	7.0	9.6	13.9	10.3	10.6	16.0	16.6	10.3	13.7	11.3	13.4	11.2	14.7	3.3	1.4	4.5	4.7	4.8	4.8	5.0	5.4	5.2	4.9	4.7	5.3	2.6	6.5	3.4	4.1	5.3	2.6	8.6	11.9	8.8	10.6	7.5	7.1	10.9	6.1	10.9	10.0
THAP10		ENSG00000129028	"THAP domain containing 10"	Q9P2Z0	15	70881342-70892785	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.3"									HPA041416	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041416: AB_10795592"	"unprognostic (1.00e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.15e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.71e-2)"	"prognostic favourable (3.05e-5)"	"unprognostic (1.25e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.44e-3)"	3.3	4.6	7.5	2.5	10.9	0.3	3.9	13.4	16.0	4.8	4.1	9.9	0.8	4.3	4.2	4.0	3.9	6.3	3.0	9.4	7.8	10.3	5.8	3.7	3.6	1.8	9.5	6.5	7.8	3.7	8.7	4.6	3.6	11.7	5.7	3.8	7.0	3.7	6.5	3.8	2.4	2.4	4.1	11.6	1.8	5.1	6.2	7.6	0.2	7.0	1.8	1.6	5.5	3.8	0.6	1.1	0.0	7.3	0.8	0.4	0.2	4.6	8.2	5.2	6.8	2.7	3.2	0.1	9.1	4.0	7.9	9.3	1.2	6.4	0.0	5.7	2.4	7.2	11.1	2.1	7.0	0.0	5.7	1.7	4.6	0.5	1.4	0.4	3.4	1.1	3.4	4.3	4.2	3.7	0.5	0.0	5.1	3.6	0.0	1.6	7.7	3.2	0.0	6.6	0.2	3.1	3.9	5.6	6.0	6.2	2.7	3.9	3.1	3.8	2.9	5.6	3.7	27.3	6.3	2.3	2.6	0.0	3.3	0.6	7.7	0.0	0.6	0.0	0.1	0.9	0.1	0.6	0.4	0.0	1.1	0.3	0.0	0.3	0.0	0.8	7.3	0.0	0.3	0.2	7.5	10.9	13.4	16.0	7.8	10.3	9.5	6.5	11.7	7.6
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842082-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	15.2	12.1	13.4	13.5	14.5	8.5	31.4	15.0	17.2	23.8	19.1	16.7	13.0	12.0	19.9	13.3	18.9	18.0	16.7	29.5	12.4	12.4	13.9	13.5	14.9	22.2	11.8	9.7	22.6	23.1	17.2	13.3	14.2	12.7	20.4	11.0	17.2	14.8	20.6	40.7	17.7	16.0	19.8	10.4	21.0	15.8	11.8	9.8	30.2	29.0	17.3	18.0	21.7	27.1	10.3	8.7	8.5	10.8	11.5	19.9	10.6	12.3	16.2	11.3	10.6	15.8	10.9	11.9	6.4	11.0	15.3	13.3	20.7	9.6	27.1	13.2	6.4	14.6	19.8	11.7	8.8	10.0	22.6	10.8	9.4	25.1	14.5	13.7	12.3	9.9	11.6	10.6	9.3	11.3	15.4	6.4	9.3	19.3	14.8	24.7	22.8	14.2	29.2	13.5	24.4	7.7	8.0	15.8	17.9	18.5	6.7	13.3	16.5	14.1	9.0	9.9	12.0	8.8	7.8	25.4	25.2	26.7	7.6	15.2	10.6	3.5	8.4	8.5	16.8	10.8	13.4	8.9	15.4	15.4	8.7	10.3	19.9	15.8	2.5	11.5	9.7	7.0	18.4	10.6	13.4	14.5	15.0	17.2	12.4	12.4	11.8	9.7	12.7	9.8
THBD	CD141	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049741	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease mutation, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.9;CAPAN-2: 20.0;EFO-21: 17.5;HaCaT: 16.8;hTCEpi: 22.2;THP-1: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol			690000	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.96e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.81e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.58e-3)"	"unprognostic (9.71e-2)"	27.0	6.3	1.4	10.5	6.7	6.9	11.8	1.2	2.7	13.2	14.4	1.4	4.3	2.9	9.7	11.5	21.7	15.8	18.2	24.3	5.0	1.5	7.0	10.0	61.9	26.8	2.5	0.1	10.2	7.2	10.0	10.9	16.4	6.2	6.1	3.3	8.8	6.0	4.2	55.5	32.4	14.1	8.5	7.7	44.4	14.4	15.8	2.4	2.1	18.3	32.2	10.4	14.2	10.4	0.0	7.8	17.7	6.2	1.5	0.0	1.1	5.6	5.0	0.1	0.0	12.9	0.7	0.1	0.1	0.0	0.0	0.0	0.0	20.0	0.0	17.5	1.7	16.8	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.1	0.6	22.2	0.3	1.4	5.6	2.1	0.0	0.5	0.4	0.0	2.1	0.0	0.8	0.0	0.0	2.4	0.1	8.2	0.3	0.0	4.7	0.6	8.7	0.0	12.5	11.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	1.0	2.9	0.4	0.0	2.8	0.0	0.0	6.2	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	17.7	1.5	5.8	7.8	0.0	1.1	1.4	6.7	1.2	2.7	5.0	1.5	2.5	0.1	6.2	2.4
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.9;ASC TERT1: 56.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.2;HSkMC: 30.3;hTEC/SVTERT24-B: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		22000000	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: "	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.5	0.3	81.9	56.2	0.0	15.6	21.4	21.6	27.2	0.1	0.0	0.0	0.0	18.6	0.0	0.6	0.8	12.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	30.3	0.0	29.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.1	22.0	1.8	0.0	0.3	0.0	6.1	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2
THEM6	"C8orf55, DSCD75"	ENSG00000130193	"Thioesterase superfamily member 6"	Q8WUY1	8	142727203-142736927	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 28.6;RT4: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023255	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"			"Nuclear speckles, Cytosol"		"HPA023255: AB_1845782"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.76e-2)"	"prognostic favourable (6.66e-7)"	"unprognostic (7.02e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.39e-2)"	"prognostic favourable (4.49e-4)"	11.9	13.9	9.4	5.6	13.4	6.0	21.6	9.0	20.7	10.8	11.8	12.8	16.6	14.4	5.6	7.1	14.9	12.5	15.0	12.6	10.7	11.5	16.7	35.2	11.0	7.4	8.8	11.7	4.5	30.7	13.4	10.0	10.7	11.6	9.8	6.7	10.0	18.5	15.3	11.3	11.7	14.3	4.8	9.3	8.7	15.1	3.0	7.5	10.3	14.4	15.6	10.6	19.7	7.9	6.5	3.8	4.5	7.4	8.4	14.6	7.5	9.8	8.2	1.2	8.6	4.0	1.4	6.1	5.1	4.2	7.8	5.4	5.0	14.8	4.1	11.6	1.9	23.0	3.6	11.0	1.3	3.4	10.1	3.1	4.6	10.0	4.4	1.8	3.3	2.0	3.9	1.5	2.2	6.6	1.4	2.1	1.3	28.6	7.4	0.4	1.9	26.9	8.7	0.8	9.5	9.3	40.4	19.4	7.6	7.8	23.4	6.5	11.5	1.5	3.8	3.4	2.5	9.7	0.8	1.4	1.9	1.8	3.5	9.0	4.1	4.5	4.0	2.0	9.7	7.4	14.6	4.6	10.3	12.5	3.8	6.5	12.5	11.5	0.5	8.4	7.1	2.9	9.1	7.5	9.4	13.4	9.0	20.7	10.7	11.5	8.8	11.7	11.6	7.5
THNSL1	"FLJ22002, TSH1"	ENSG00000185875	"Threonine synthase like 1"	Q8IYQ7	10	25016658-25026664	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037585	Uncertain		Approved	"Nuclear bodies,Mitochondria,Cytosol"				"Nuclear bodies"	"Mitochondria, Cytosol"	"HPA037585: AB_10696940"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.11e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.06e-2)"	2.2	8.0	8.6	2.4	10.1	0.8	4.7	4.6	10.4	5.5	3.5	5.4	3.6	3.3	4.7	6.5	2.6	7.2	2.7	4.6	8.9	6.6	12.3	26.0	2.1	5.5	9.5	5.5	9.6	8.7	7.9	13.0	2.3	8.5	3.8	4.0	2.8	4.4	3.7	5.2	2.9	3.0	3.0	9.1	3.2	3.5	7.0	7.7	5.1	10.5	2.1	3.3	2.9	3.9	5.2	3.8	0.6	0.7	11.5	10.4	3.3	5.3	6.1	3.9	7.8	4.0	5.0	1.0	2.6	1.0	2.9	1.9	4.0	6.8	24.6	8.4	1.2	3.0	5.6	4.9	3.0	3.3	3.1	9.0	1.7	2.5	4.5	0.0	1.5	3.1	9.1	2.1	4.5	2.0	7.7	2.9	6.2	8.3	4.9	1.7	7.2	3.0	2.6	1.0	10.5	8.3	1.2	6.5	3.7	5.2	4.7	9.3	4.6	0.5	1.9	3.5	3.1	4.6	2.4	2.1	2.8	0.0	5.8	5.0	2.7	0.1	0.4	0.0	3.0	0.5	5.4	5.2	4.4	4.0	2.2	4.0	10.4	6.8	0.6	11.5	0.7	3.8	2.0	3.3	8.6	10.1	4.6	10.4	8.9	6.6	9.5	5.5	8.5	7.7
THOC7	"FLJ23445, fSAP24, NIF3L1BP1"	ENSG00000163634	"THO complex 7"	Q6I9Y2	3	63833870-63863903	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044143	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA044143: AB_10794892"	"unprognostic (4.33e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.31e-1)"	24.3	28.5	41.1	19.7	34.7	29.0	33.3	20.6	37.6	24.6	29.6	14.8	24.1	27.7	22.2	24.6	43.6	18.7	27.2	36.1	38.5	28.3	30.5	32.5	17.2	25.9	33.9	35.2	21.1	35.6	18.0	23.8	42.0	33.7	24.6	30.4	14.8	30.4	22.8	52.9	27.0	34.9	31.1	27.2	20.4	21.5	24.6	15.5	34.4	21.3	43.0	27.6	28.4	22.8	25.4	31.4	32.2	24.8	27.6	32.1	17.7	19.5	12.0	13.8	3.4	18.5	25.4	13.2	17.3	17.9	20.3	20.4	14.4	21.7	23.4	7.3	22.2	11.5	15.5	27.2	28.4	23.9	11.3	20.9	15.7	16.6	19.5	29.1	10.3	18.3	22.9	17.4	30.8	22.2	16.0	22.8	24.6	144.9	25.5	26.4	17.5	9.7	18.6	13.0	31.9	35.1	18.7	6.9	16.0	15.0	21.1	23.4	13.5	40.5	16.0	14.8	15.8	18.3	30.5	15.0	22.0	28.4	18.4	37.3	19.2	32.2	21.9	17.1	22.2	24.8	30.7	25.4	27.6	30.0	31.4	17.4	23.8	24.8	13.1	27.6	20.7	28.9	32.1	17.7	41.1	34.7	20.6	37.6	38.5	28.3	33.9	35.2	33.7	15.5
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785460-2815807	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol			1400000	Cytosol		"CAB025497: , HPA035262: "	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	8.2	9.4	19.1	12.3	19.8	18.4	6.2	21.7	26.1	5.2	11.8	14.1	5.8	24.6	7.5	8.4	11.0	8.4	6.7	11.6	18.5	15.4	7.1	30.4	6.2	11.9	14.1	15.2	11.1	7.8	7.0	12.7	22.3	13.1	18.1	8.2	11.9	13.7	6.8	29.1	11.9	20.0	7.1	10.7	9.8	7.8	27.3	10.9	17.0	7.5	11.5	11.3	5.8	6.8	7.5	9.8	8.0	7.5	3.9	9.5	3.2	29.2	21.8	8.5	18.2	4.4	4.3	30.4	18.3	6.8	18.2	14.8	25.6	9.4	26.4	9.0	7.1	23.8	12.6	15.0	7.7	0.1	26.5	9.3	24.0	30.2	4.7	18.0	14.6	4.8	5.4	15.1	6.8	10.3	21.7	12.9	7.7	22.7	20.0	33.8	25.1	30.1	16.7	11.3	25.0	7.6	17.0	23.1	18.5	16.0	14.4	8.9	14.0	17.5	11.7	14.0	12.1	29.8	30.9	22.7	19.0	17.8	15.6	30.3	16.6	8.0	3.5	1.6	5.5	3.9	4.5	5.6	4.0	7.4	4.9	7.5	5.1	4.3	1.7	3.9	7.5	9.8	9.5	3.2	19.1	19.8	21.7	26.1	18.5	15.4	14.1	15.2	13.1	10.9
THRA	"AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3"	ENSG00000126351	"Thyroid hormone receptor, alpha"	P10827	17	40058290-40093867	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009654, CAB023349"	Approved		Supported	Cytosol				Cytosol		"CAB023349: AB_619577, HPA009654: AB_1854603"	"unprognostic (2.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.41e-3)"	"prognostic favourable (1.84e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-2)"	"prognostic favourable (6.05e-8)"	"unprognostic (3.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.88e-3)"	17.1	20.7	58.6	5.7	90.7	9.9	12.9	37.4	73.1	19.8	12.6	24.1	8.2	15.1	19.3	11.5	9.7	29.3	12.7	30.1	43.8	38.1	12.1	2.7	11.6	4.5	34.3	45.5	46.5	12.3	13.0	10.7	8.5	29.6	12.4	9.6	10.4	13.7	18.8	38.5	10.0	16.7	17.4	29.4	6.1	11.9	7.8	43.6	1.8	12.5	7.9	3.3	10.0	18.6	1.0	1.5	3.7	0.7	5.1	4.7	1.4	2.1	17.2	5.4	13.4	37.1	13.6	1.9	8.8	10.6	9.2	8.6	14.3	12.5	2.5	14.7	17.2	5.2	10.5	5.4	5.0	0.9	9.9	4.6	20.5	6.1	12.5	7.5	5.2	21.6	4.4	8.6	3.3	12.3	9.3	2.4	7.6	3.2	10.0	12.4	4.9	5.4	14.4	10.6	12.4	3.1	1.5	9.1	8.3	6.8	10.9	15.4	12.7	8.9	8.5	9.2	9.2	8.2	2.6	5.6	3.9	1.5	5.7	8.7	4.9	0.3	0.6	3.7	4.7	0.3	2.0	0.6	1.9	2.8	0.8	1.0	3.4	4.1	2.5	5.1	0.7	1.5	2.2	1.4	58.6	90.7	37.4	41.8	43.8	38.1	34.3	45.5	29.6	43.6
THSD1	TMTSP	ENSG00000136114	"Thrombospondin type 1 domain containing 1"	Q9NS62	13	52377167-52406494	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 12.0;HBEC3-KT: 12.1;hTCEpi: 12.0;hTERT-HME1: 12.3;HUVEC TERT2: 25.1;LHCN-M2: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012611, CAB020796"	Uncertain		Supported	Cytosol	"Intracellular and membrane"		810000	Cytosol		"CAB020796: , HPA012611: AB_1857990"	"unprognostic (1.21e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.90e-2)"	9.7	1.8	8.3	1.8	7.2	0.4	11.1	2.9	6.4	7.6	2.6	1.9	3.6	1.2	6.8	4.9	4.4	5.7	4.9	9.0	8.1	2.2	2.0	2.1	19.8	4.7	2.2	4.6	2.3	1.2	2.5	3.4	16.8	2.1	8.5	2.3	5.5	3.9	3.2	9.7	6.0	2.3	7.4	2.2	6.6	1.9	2.7	1.1	0.7	5.2	5.2	2.5	5.9	4.5	0.3	0.0	0.0	0.0	0.4	0.7	0.0	0.5	2.4	0.2	2.1	2.0	6.5	0.5	5.1	2.5	2.0	3.2	0.0	0.3	0.2	0.6	12.0	2.7	0.0	12.1	3.1	5.6	1.7	0.3	0.0	0.0	1.2	1.2	0.3	2.6	12.0	9.7	12.3	25.1	0.0	0.1	11.5	0.0	0.4	0.2	0.1	0.5	0.3	2.7	0.0	2.7	0.1	0.0	0.4	0.1	0.0	0.4	0.2	0.2	5.8	0.6	1.1	0.0	3.8	0.3	0.0	0.0	1.1	0.3	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.5	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.3	7.2	2.9	6.4	8.1	2.2	2.2	4.6	2.1	1.1
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;epididymis: 11.6;retina: 14.9"	"Group enriched"	"Detected in some"	8	"Daudi: 10.1;SCLC-21H: 21.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051416: , HPA056745: "	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	4.7	0.3	1.7	0.3	1.6	0.1	2.6	0.7	3.2	0.9	0.5	1.1	0.8	0.3	0.9	11.6	1.6	2.8	0.8	1.4	1.8	3.3	2.7	0.6	0.5	0.2	1.8	1.5	0.4	0.3	1.3	3.0	0.7	24.2	2.1	0.3	14.9	1.2	0.7	0.3	0.2	1.5	2.2	3.2	0.2	0.3	1.1	0.3	0.1	2.1	0.0	0.3	0.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.1	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	0.7	3.2	1.8	3.3	1.8	1.5	24.2	0.3
THUMPD1	"FLJ20274, Tan1"	ENSG00000066654	"THUMP domain containing 1"	Q9NXG2	16	20702816-20742084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027851	Approved		Approved	Cytosol				Cytosol		"HPA027851: AB_10670036"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (2.99e-4)"	"unprognostic (1.48e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.45e-1)"	"prognostic favourable (8.52e-8)"	"unprognostic (1.98e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-2)"	22.0	20.1	17.5	17.6	24.2	17.8	36.7	23.6	24.7	27.2	23.6	12.4	25.9	12.8	29.1	27.2	16.7	23.3	17.7	16.5	17.6	15.8	22.8	16.6	16.0	18.3	14.2	20.7	29.2	21.9	37.1	27.6	20.3	19.2	33.1	19.2	12.9	18.5	28.7	17.3	16.6	19.7	31.9	13.3	18.6	27.0	15.9	17.2	27.6	23.3	15.0	19.9	25.5	22.0	10.0	5.9	17.8	7.3	13.4	19.6	8.5	9.7	10.7	18.8	10.7	15.9	13.9	11.3	9.8	9.7	9.0	8.8	8.2	10.3	24.2	18.6	10.9	9.2	11.9	12.9	14.1	13.8	7.0	22.4	9.6	18.0	10.4	35.5	44.9	11.7	17.1	9.9	11.3	10.3	43.0	18.6	10.1	10.9	16.6	12.8	15.8	6.4	22.8	18.0	18.7	10.0	8.4	14.6	10.0	8.3	14.3	9.4	10.3	11.7	10.5	13.3	7.7	8.9	9.3	19.8	18.3	18.1	10.2	9.8	10.6	7.1	6.0	17.8	15.4	7.0	18.8	10.0	14.7	14.4	5.9	9.5	19.6	16.8	2.8	13.4	7.3	5.0	11.3	8.5	17.5	24.2	23.6	24.7	17.6	15.8	14.2	20.7	19.2	17.2
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362842-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: "	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favourable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	17.4	17.2	13.3	12.9	14.8	22.2	14.2	13.4	19.6	15.2	14.4	13.8	12.5	12.8	14.0	15.8	16.5	12.3	10.9	19.3	12.3	13.9	20.7	23.9	11.1	13.5	18.3	11.0	14.3	14.8	22.2	27.8	14.4	23.2	15.9	15.1	14.0	16.1	14.9	29.4	13.4	14.9	12.3	15.8	14.5	12.5	42.8	14.8	22.3	18.2	17.5	13.2	16.2	11.7	13.9	15.4	12.5	19.3	11.7	22.3	10.1	12.5	17.2	12.0	6.2	15.9	15.3	48.4	15.4	12.7	15.7	12.0	12.9	13.4	12.9	12.1	13.9	8.3	21.9	15.8	16.0	14.4	12.7	16.3	17.4	11.2	15.5	20.7	11.7	12.2	17.8	18.6	19.4	10.3	25.4	18.9	20.7	17.9	24.3	8.9	23.1	16.7	15.5	20.6	18.5	10.4	19.1	5.0	16.2	12.8	9.2	13.7	14.9	13.4	7.3	15.1	13.1	18.2	16.9	24.1	56.2	41.7	18.3	19.4	21.7	10.6	13.2	12.5	16.2	17.4	21.1	12.3	14.1	16.8	15.0	13.9	22.3	16.8	2.7	11.7	19.3	15.4	13.2	10.1	13.3	14.8	13.4	19.6	12.3	13.9	18.3	11.0	23.2	14.8
THYN1	THY28	ENSG00000151500	"Thymocyte nuclear protein 1"	Q9P016	11	134248279-134253370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038732, HPA038733"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA038732: AB_10697397, HPA038733: "	"unprognostic (5.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.48e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.01e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.61e-2)"	20.1	22.4	36.7	13.3	39.3	21.4	26.1	29.6	43.6	22.8	22.7	16.0	20.8	16.8	22.8	45.2	16.0	27.9	17.3	27.8	30.2	30.4	22.4	31.6	15.8	20.4	24.9	38.1	37.6	15.6	13.6	25.2	12.3	24.5	29.7	26.0	17.5	14.3	32.7	14.3	15.5	16.7	24.5	23.2	17.7	18.7	24.3	23.1	35.0	29.9	15.6	23.9	22.6	15.7	27.8	30.6	74.0	24.4	29.7	50.7	34.4	8.1	5.0	18.5	14.8	18.0	20.6	10.9	7.0	15.6	16.6	15.7	27.6	20.1	15.2	23.8	9.8	12.7	28.0	21.4	16.3	15.6	7.8	42.4	7.1	24.8	25.8	33.6	14.0	15.5	11.5	19.7	13.0	26.0	19.5	7.4	14.9	4.5	39.0	62.0	21.5	18.5	18.5	13.7	12.9	22.7	14.4	17.7	14.3	14.6	3.6	8.3	20.7	17.1	13.7	7.2	11.1	6.5	10.6	8.3	8.6	32.4	10.6	43.9	8.2	37.6	21.7	74.0	36.0	24.4	43.1	27.8	38.3	36.2	23.1	21.8	44.3	50.7	11.3	29.7	22.5	30.6	44.7	34.4	36.7	39.3	29.6	43.6	30.2	30.4	24.9	38.1	24.5	23.1
TIA1		ENSG00000116001	"TIA1 cytotoxic granule associated RNA binding protein"	P31483	2	70209444-70248660	"Disease related genes, Predicted intracellular proteins"	Apoptosis	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056961			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA056961: "	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.51e-3)"	"unprognostic (3.37e-3)"	"prognostic favourable (6.79e-5)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (8.05e-7)"	"unprognostic (4.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"prognostic favourable (1.02e-5)"	15.6	20.4	15.9	29.3	20.5	14.8	28.2	36.3	22.0	30.2	23.6	25.3	24.6	20.6	42.1	43.5	15.9	28.4	21.6	16.0	17.2	14.7	20.7	18.0	19.1	26.4	21.9	16.5	46.9	24.3	26.0	48.7	21.2	19.0	26.2	24.1	27.1	27.8	24.2	13.2	23.4	25.9	24.9	21.0	30.8	20.8	13.4	25.2	65.3	29.3	15.1	21.2	23.1	23.5	9.7	11.6	12.4	7.9	10.9	9.8	5.6	7.2	8.1	42.3	23.6	12.0	20.5	20.4	12.9	9.2	12.6	12.5	10.8	11.2	16.5	11.2	9.6	11.9	20.5	7.0	17.9	15.3	9.0	16.9	14.0	25.8	9.7	16.9	9.6	15.2	10.5	7.1	8.0	23.2	13.1	15.1	17.6	6.2	31.2	26.9	34.4	9.7	38.2	23.0	16.8	19.2	14.3	25.7	22.0	15.3	18.2	12.4	10.8	12.6	18.9	15.5	16.3	7.2	12.7	12.6	12.6	30.4	9.1	21.6	20.5	12.4	7.9	10.8	8.3	6.5	7.8	9.7	8.0	8.2	11.6	8.0	7.3	7.9	3.0	10.9	3.8	6.0	9.8	5.6	15.9	20.5	36.3	22.0	17.2	14.7	21.9	16.5	19.0	25.2
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.9;HEL: 18.3;HMC-1: 16.0;RT4: 19.0;SCLC-21H: 17.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	11.9	0.7	0.2	2.8	18.9	0.0	0.0	1.4	0.5	0.1	2.1	4.0	0.8	0.3	2.8	1.4	2.4	2.4	0.3	6.5	18.3	0.3	0.1	0.3	0.0	16.0	1.2	0.8	8.1	3.2	0.0	0.0	6.0	6.0	7.7	2.8	0.1	3.8	5.1	3.6	3.7	0.0	1.8	19.0	17.9	4.4	0.8	6.2	0.7	2.5	0.0	0.1	1.7	6.9	0.0	0.8	6.7	5.0	3.6	4.0	1.4	13.1	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1
TIAM2	STEF	ENSG00000146426	"T cell lymphoma invasion and metastasis 2"	Q8IVF5	6	154832697-155257723	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8"	"Cell line enhanced"	"Detected in many"		"AF22: 34.4;HDLM-2: 14.7;RH-30: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3"	"Group enriched"	"Detected in many"	5	"amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6"	"Low region specificity"	"Detected in many"			"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.6	2.1	5.3	1.7	9.4	0.7	1.5	7.9	21.1	1.5	11.6	0.7	0.1	11.0	1.2	0.8	1.0	1.2	4.0	3.5	4.7	2.0	0.7	0.7	0.9	2.0	1.7	9.5	0.9	1.8	0.2	1.8	0.8	0.6	3.0	1.1	1.3	2.4	3.6	3.0	1.0	27.4	1.4	0.9	1.2	4.0	15.6	1.9	0.0	7.8	0.0	2.5	2.3	1.2	3.3	0.9	8.3	11.3	0.8	1.8	0.4	4.3	0.8	34.4	4.0	1.5	4.2	0.4	1.8	1.1	1.7	2.9	0.5	2.5	1.0	1.8	3.1	0.6	1.2	0.0	1.2	14.7	1.9	0.2	0.6	2.0	0.9	0.3	1.0	2.8	0.1	0.6	0.1	2.4	0.5	0.1	3.8	0.4	0.4	0.9	2.5	0.9	4.4	22.4	0.4	0.1	0.2	0.9	7.9	0.1	0.4	0.2	0.3	0.5	0.8	0.3	8.7	0.3	0.9	0.2	1.7	0.2	0.1	0.5	2.2	0.4	0.2	3.1	0.2	3.2	0.3	3.3	0.5	0.3	0.9	1.0	0.6	0.4	8.3	0.8	11.3	0.3	1.8	0.4	5.3	9.4	7.9	21.1	4.7	2.0	1.7	9.5	0.6	1.9
TIFA	"MGC20791, T2BP, T6BP, TIFAA"	ENSG00000145365	"TRAF interacting protein with forkhead associated domain"	Q96CG3	4	112274542-112285903	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 45.1;U-698: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045889	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA045889: AB_10963785"	"unprognostic (2.41e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.49e-3)"	5.7	6.4	3.3	16.7	3.8	19.2	7.4	6.1	4.5	7.0	3.9	2.0	8.4	3.4	3.6	2.3	14.3	4.0	4.2	7.9	4.7	2.1	4.1	14.6	6.7	22.9	5.4	1.6	9.2	32.2	4.1	3.3	7.4	3.9	6.6	3.7	5.4	21.3	4.5	4.0	9.0	8.7	4.7	4.0	20.3	7.1	3.0	4.8	12.5	14.8	7.8	23.2	7.2	7.3	23.2	7.0	11.3	3.8	9.1	17.7	6.1	6.8	1.7	2.6	4.3	3.2	2.6	5.2	5.5	10.4	3.5	6.0	0.9	6.2	21.1	4.5	2.1	2.0	3.5	4.2	7.4	17.1	2.1	2.1	4.2	1.9	2.1	6.6	2.9	3.5	2.3	3.7	4.1	5.5	2.1	45.1	4.6	3.4	11.6	3.6	0.5	2.2	20.1	6.5	14.0	7.7	4.7	6.0	6.2	4.4	9.3	2.1	4.0	9.5	4.1	5.5	6.6	4.6	4.3	28.2	25.9	38.9	5.2	4.4	4.1	2.9	3.8	2.0	6.3	2.7	10.3	21.2	11.7	11.0	7.0	23.2	5.4	6.6	11.3	9.1	3.2	6.5	17.7	6.1	3.3	3.8	6.1	4.5	4.7	2.1	5.4	1.6	3.9	4.8
TIGAR	C12orf5	ENSG00000078237	"TP53 induced glycolysis regulatory phosphatase"	Q9NQ88	12	4307763-4354593	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Autophagy"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034010, HPA040354, HPA044111"	Approved		Supported	Cytosol				Cytosol		"CAB034010: AB_1128227, HPA040354: , HPA044111: "	"unprognostic (1.76e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (3.18e-4)"	"unprognostic (5.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.05e-1)"	14.3	14.3	8.3	12.3	10.8	10.5	7.1	3.7	17.8	6.3	10.4	10.1	6.4	6.7	7.5	7.3	10.3	5.7	8.5	9.8	9.5	7.9	7.7	11.0	10.4	12.3	13.5	7.9	6.0	5.2	9.0	14.4	14.6	12.2	7.5	13.5	8.4	8.2	9.5	13.6	6.2	8.7	12.5	12.3	14.9	8.5	8.4	8.3	8.9	6.0	6.6	12.6	13.9	8.9	3.7	14.0	4.7	15.5	3.2	5.7	3.6	5.7	9.2	7.5	8.6	7.0	6.9	39.3	9.9	8.4	7.6	10.3	11.1	5.9	6.3	1.4	6.8	7.2	7.9	16.9	9.5	8.3	5.8	0.2	6.1	9.1	15.0	3.5	1.3	12.3	20.4	8.8	16.0	15.3	0.7	4.8	15.2	8.4	3.1	1.8	16.0	2.8	4.5	12.1	2.3	7.4	11.6	0.3	4.5	9.3	4.7	12.2	1.5	3.1	13.2	10.2	13.2	8.0	5.5	4.1	4.0	10.9	7.2	2.4	8.1	0.5	8.2	0.7	3.6	14.4	3.4	3.7	2.8	3.9	14.0	2.9	1.9	3.2	4.7	3.2	15.5	5.5	5.7	3.6	8.3	10.8	3.7	17.8	9.5	7.9	13.5	7.9	12.2	8.3
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779764	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.1;testis: 11.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.5;U-266/70: 6.6;U-266/84: 12.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035649	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA035649: AB_10670956"	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.7	1.0	2.2	0.7	8.6	0.2	2.1	3.5	3.6	2.5	0.8	2.1	3.9	1.1	2.0	4.2	0.6	5.5	0.8	1.0	4.8	2.1	2.0	0.6	3.5	0.5	1.6	3.2	1.7	0.9	5.4	14.1	0.5	5.8	1.3	0.9	5.4	2.0	1.1	1.2	1.3	0.8	0.9	2.7	0.8	1.0	11.8	1.3	0.3	2.1	0.6	0.5	1.0	0.8	0.4	0.0	1.6	1.1	2.1	1.3	0.0	0.6	0.5	2.9	1.2	0.2	0.4	0.3	0.1	0.7	0.3	0.6	0.5	1.3	1.0	0.1	0.1	0.5	1.1	0.5	0.5	1.0	0.2	1.5	0.7	0.3	0.2	0.6	0.3	0.1	0.5	0.5	0.3	0.1	0.4	4.5	0.3	0.3	2.8	0.3	1.3	0.4	0.5	0.6	0.0	2.0	0.1	1.4	1.6	0.2	0.3	2.8	0.7	0.2	0.0	0.4	0.6	0.5	0.6	6.6	12.9	0.6	1.0	1.5	2.1	0.0	0.3	0.8	0.0	1.1	0.2	0.0	0.3	1.3	0.0	0.4	0.1	0.4	1.6	2.1	0.2	0.0	0.0	0.0	2.2	8.6	3.5	3.6	4.8	2.1	1.6	3.2	5.8	1.3
TIGD7	Sancho	ENSG00000140993	"Tigger transposable element derived 7"	Q6NT04	16	3298832-3305729	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041357, HPA041474"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041357: AB_10794992, HPA041474: AB_10795696"	"unprognostic (7.69e-2)"	"unprognostic (3.04e-4)"	"unprognostic (6.56e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.04e-1)"	"unprognostic (5.90e-3)"	"unprognostic (3.12e-2)"	3.7	5.6	7.7	8.2	7.6	1.3	11.7	8.6	6.8	8.5	5.9	5.3	5.8	3.1	9.3	8.2	5.2	8.8	4.7	7.7	7.1	8.3	6.8	3.9	4.6	4.8	7.1	3.7	17.4	4.4	16.9	17.6	5.3	7.5	8.4	3.6	3.8	4.1	8.9	5.5	3.5	4.0	6.9	6.7	6.5	3.7	12.5	7.3	8.5	11.0	2.8	5.0	11.0	6.1	4.9	1.1	6.3	2.8	3.8	5.7	1.5	0.8	2.0	5.5	2.9	2.9	4.2	4.5	2.9	1.7	4.4	4.1	0.3	1.7	2.0	4.6	2.1	0.5	1.9	0.8	5.6	0.1	2.8	5.7	1.7	0.1	3.3	0.9	7.6	4.4	1.4	4.1	1.3	3.3	2.8	3.6	3.7	1.2	1.8	8.7	6.2	4.9	10.1	1.3	8.3	2.4	0.5	7.5	2.8	6.7	0.9	2.5	3.2	3.3	1.1	2.6	6.4	2.7	1.6	7.6	7.7	6.3	1.6	3.3	3.0	1.0	1.4	6.3	3.3	1.0	5.7	1.6	2.8	4.8	1.0	4.9	5.5	3.6	3.5	3.8	2.8	1.1	2.9	1.5	7.7	7.6	8.6	6.8	7.1	8.3	7.1	3.7	7.5	7.3
TIPRL	"dJ69E11.3, MGC3794, TIP41, TIPRL1"	ENSG00000143155	"TOR signaling pathway regulator"	O75663	1	168178933-168202114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027995, HPA054282"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA027995: AB_10602900, HPA054282: "	"unprognostic (3.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-3)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (1.45e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.61e-2)"	19.6	22.3	17.0	18.6	29.6	29.7	21.4	18.4	29.1	19.4	21.9	11.2	12.9	18.9	25.9	17.7	28.5	17.5	17.1	23.1	17.4	20.5	22.9	38.3	16.2	20.2	18.0	19.3	21.6	22.2	23.8	31.9	19.8	23.1	19.9	22.7	11.4	17.9	18.6	32.0	16.2	23.2	23.5	16.0	19.0	16.1	22.8	12.4	35.2	17.8	21.1	21.2	23.3	18.5	17.7	21.5	36.2	21.4	19.3	23.9	17.7	26.4	11.5	18.2	16.5	14.9	21.6	10.8	19.8	20.9	21.7	19.5	17.9	19.7	18.5	27.4	18.9	32.0	13.5	19.3	21.0	17.8	13.8	17.9	12.0	8.6	26.2	35.6	24.8	17.4	24.8	18.9	25.3	22.8	25.8	26.4	18.7	9.2	31.8	18.5	14.6	20.7	15.6	18.6	25.3	19.5	13.0	11.8	26.3	15.3	21.7	38.8	23.7	36.7	20.7	18.4	21.1	17.2	26.7	28.9	29.9	41.3	12.0	23.6	21.0	36.2	18.7	24.2	16.2	21.4	16.2	17.7	19.0	17.2	21.5	17.7	17.1	16.9	24.2	19.3	21.4	16.1	23.9	17.7	17.0	29.6	18.4	29.1	17.4	20.5	18.0	19.3	23.1	12.4
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: "	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	8.8	10.4	5.2	11.9	5.4	3.9	16.8	7.2	8.0	11.9	18.9	4.6	13.2	11.6	11.1	11.1	9.7	8.7	14.2	11.6	4.4	6.5	9.2	14.8	16.8	17.6	6.5	5.8	13.4	18.7	14.0	8.8	9.2	5.1	11.1	8.9	10.5	15.3	21.1	10.5	8.4	17.3	13.6	4.7	13.4	8.7	3.5	2.4	3.3	8.0	6.4	9.8	11.8	7.3	6.5	8.7	8.8	10.5	4.4	8.3	6.2	1.9	6.3	3.4	5.6	5.8	8.1	4.1	5.1	8.4	3.6	3.4	9.8	7.5	5.0	8.9	5.3	5.6	3.5	4.0	1.4	13.3	3.3	13.6	3.5	6.2	4.6	8.3	7.3	6.1	5.6	6.8	4.8	5.9	3.6	11.7	4.1	3.5	0.2	1.3	1.6	5.7	1.7	1.0	4.7	2.8	6.9	4.1	5.3	6.1	6.0	4.2	16.5	4.3	5.8	2.0	1.9	4.1	3.8	3.3	4.7	3.7	3.1	6.7	6.3	7.7	10.5	4.9	7.7	8.7	7.4	4.3	6.1	8.3	8.7	6.5	5.0	4.9	8.8	4.4	5.7	5.9	6.1	6.2	5.2	5.4	7.2	8.0	4.4	6.5	6.5	5.8	5.1	2.4
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333210-61353295	"Enzymes, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.2;liver: 42.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 39.8;RPMI-8226: 42.0;T-47d: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol			4800000	"Nucleoplasm, Cytosol"		"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favourable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	3.1	34.7	3.6	6.1	5.3	5.3	4.6	3.7	7.3	3.4	43.4	7.6	8.0	69.5	4.6	7.8	6.2	5.9	8.8	2.8	3.1	2.6	17.4	42.8	3.5	5.2	3.3	5.3	4.5	9.8	3.0	5.5	3.9	4.4	5.0	2.3	7.3	7.2	7.1	4.6	6.1	90.2	2.6	3.1	5.4	5.7	17.1	3.4	5.5	6.4	6.3	6.7	5.4	3.9	9.7	18.4	5.4	11.4	5.3	10.9	7.8	6.0	15.3	2.7	9.3	3.4	3.7	7.6	3.5	3.8	3.3	2.1	6.9	14.6	7.5	12.4	2.5	8.5	5.0	6.6	1.1	12.9	6.7	4.6	8.1	39.8	5.8	3.9	7.8	5.8	4.5	3.1	11.0	3.3	8.1	14.5	2.4	27.4	3.4	3.6	7.4	10.5	6.1	4.2	42.0	5.3	10.7	10.4	9.3	6.5	11.4	5.9	42.0	2.8	3.9	6.6	6.9	5.2	2.1	26.9	22.2	6.7	6.8	3.6	6.0	2.3	11.4	5.4	6.7	6.8	8.6	9.7	7.8	6.5	18.4	9.7	5.6	5.9	0.9	5.3	5.3	9.0	10.9	7.8	3.6	5.3	3.7	7.3	3.1	2.6	3.3	5.3	4.4	3.4
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295671-154330350	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"blood: 28.6;testis: 103.6"	"Cell line enriched"	"Detected in single"	157	"THP-1: 100.4"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 28.6;gdT-cell: 12.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 28.6;T-cells: 12.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA000505, CAB032191"	Enhanced		Supported	Cytosol				Cytosol		"CAB032191: , HPA000505: AB_1858022"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.1	3.3	12.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	100.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.0	28.6	12.0	0.1	1.8	0.0	1.4	1.1	0.0	0.0	3.1	2.7	0.4	3.3	0.1	0.1	1.5	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0
TLDC1	KIAA1609	ENSG00000140950	"TBC/LysM-associated domain containing 1"	Q6P9B6	16	84476421-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	5.5	4.9	7.6	7.1	10.7	1.8	7.3	8.1	11.5	8.1	7.1	6.3	5.2	6.0	14.0	8.8	24.4	6.9	6.5	4.7	6.3	4.5	7.6	5.1	6.4	6.1	5.0	9.4	8.7	5.2	11.3	4.4	15.8	10.7	7.8	7.8	12.9	7.7	6.1	4.5	11.0	9.3	10.7	4.0	5.4	6.8	8.1	3.4	8.3	7.6	6.5	10.0	10.4	12.1	3.3	2.7	13.6	3.5	3.1	8.7	2.6	14.4	10.2	9.0	4.8	4.1	7.2	4.2	10.7	9.6	11.0	3.2	5.8	17.5	2.0	5.8	20.6	16.1	2.5	28.7	14.6	1.0	2.1	1.6	5.0	5.0	5.1	1.2	5.0	5.0	12.5	10.3	13.6	4.6	2.6	2.5	7.4	3.4	1.1	1.2	2.7	3.5	4.5	2.3	0.6	9.8	8.1	2.9	2.1	9.7	6.9	4.8	10.0	1.9	11.2	7.8	3.5	4.1	4.4	2.0	3.4	5.3	4.6	0.6	2.6	13.6	3.1	4.4	3.8	2.7	3.7	3.3	6.8	5.5	2.7	2.7	7.6	4.7	3.1	3.1	3.5	0.8	8.7	2.6	7.6	10.7	8.1	11.5	6.3	4.5	5.0	9.4	10.7	3.4
TLN1	"ILWEQ, TLN"	ENSG00000137076	"Talin 1"	Q9Y490	9	35696948-35732395	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002006, HPA004748"	Supported		Supported	"Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol"			3600000000	"Focal adhesion sites, Cytosol"	"Plasma membrane, Centriolar satellite"	"CAB002006: , HPA004748: AB_1857760"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (7.21e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.83e-2)"	"unprognostic (8.83e-3)"	47.4	23.7	10.9	29.3	16.6	25.1	38.1	9.6	11.8	34.7	64.0	18.8	22.8	13.0	57.4	20.6	41.2	38.3	48.4	30.3	11.1	7.1	30.5	36.1	33.0	26.0	17.9	7.3	39.0	12.8	19.6	14.6	30.4	14.4	39.5	15.5	22.8	14.9	43.6	24.5	16.5	27.6	87.0	12.4	54.1	38.2	17.3	14.1	33.4	20.7	12.5	20.7	72.5	49.6	3.3	6.8	12.7	9.2	4.8	7.1	7.1	11.3	19.0	11.8	16.2	40.6	30.9	13.5	31.7	34.9	30.8	27.9	15.7	5.1	13.8	10.5	58.5	6.2	13.8	19.7	22.6	31.1	8.9	31.3	24.7	13.9	25.2	18.9	52.4	37.3	9.4	45.3	21.5	47.2	10.7	14.2	40.6	5.0	12.7	4.9	9.6	14.7	17.1	6.9	8.0	15.4	9.1	2.6	11.3	15.4	8.6	10.1	7.3	13.1	56.9	49.2	19.1	15.0	25.5	4.9	4.8	9.6	38.1	10.2	44.3	6.7	7.0	8.4	7.1	7.8	5.9	3.3	4.2	5.4	5.3	3.2	2.0	4.2	12.7	4.8	9.2	6.8	2.8	7.1	10.9	16.6	9.6	11.8	11.1	7.1	17.9	7.3	14.4	14.1
TLN2	"ILWEQ, KIAA0320"	ENSG00000171914	"Talin 2"	Q9Y4G6	15	62390526-62844631	"Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.4;hTERT-HME1: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017194, HPA051828, HPA054787"	Enhanced		Supported	"Focal adhesion sites,Cytosol"			81000000	"Focal adhesion sites, Cytosol"		"CAB017194: , HPA051828: , HPA054787: "	"prognostic favourable (6.53e-4)"	"unprognostic (2.61e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.81e-6)"	"prognostic favourable (7.74e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.30e-1)"	12.5	3.1	7.0	12.1	7.0	2.3	5.3	5.4	18.9	5.6	24.3	4.0	1.7	3.3	6.5	4.2	3.4	3.2	6.3	8.5	6.8	6.0	36.9	1.8	1.9	1.3	6.2	4.2	7.0	3.3	2.3	3.0	2.4	4.5	3.1	5.4	5.5	5.4	1.6	16.9	1.6	16.6	6.9	9.6	0.8	4.1	3.5	1.3	0.9	29.0	4.5	1.3	4.3	7.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.8	2.6	3.9	4.5	29.4	2.8	4.3	6.5	5.1	6.0	6.0	7.1	0.9	2.2	3.0	11.3	1.1	4.9	1.0	5.3	7.0	0.5	0.2	10.7	4.7	1.0	0.7	0.2	5.1	2.7	8.0	23.9	0.2	0.2	0.1	10.0	3.4	0.3	0.3	6.8	1.9	2.7	9.8	2.7	3.1	5.4	0.9	4.5	5.0	0.5	1.7	1.4	1.7	1.8	10.9	14.8	17.5	16.5	0.1	0.4	1.4	4.9	1.6	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	7.0	7.0	5.4	12.9	6.8	6.0	6.2	4.2	4.5	1.3
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Group enriched"	"Detected in some"	55	"Daudi: 37.3;REH: 12.5;U-698: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4
TLR5	"FLJ10052, MGC126430, MGC126431, SLEB1, TIL3"	ENSG00000187554	"Toll like receptor 5"	O60602	1	223109406-223143282	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 4.4;HaCaT: 6.7;SK-BR-3: 4.3;T-47d: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0"	"Low region specificity"	"Detected in many"							CAB009013			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB009013: AB_2240732"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (1.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	3.8	2.4	5.3	4.8	7.3	0.4	9.7	0.8	5.3	7.1	2.7	3.4	1.7	1.7	2.4	6.2	9.0	5.6	4.8	5.8	5.0	2.6	4.6	2.2	6.5	12.5	7.0	0.8	22.5	5.3	6.6	6.3	3.5	6.8	6.2	2.3	3.2	12.6	2.9	1.4	3.7	2.3	3.7	12.8	6.7	4.5	2.3	8.1	1.2	4.3	3.5	5.7	5.9	7.8	0.1	12.8	13.4	17.0	0.2	1.4	5.7	4.4	0.4	0.7	0.4	0.3	0.0	0.6	0.2	0.0	0.1	0.1	0.0	1.3	0.0	0.9	0.4	6.7	0.1	0.5	0.4	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.1	1.9	0.2	0.9	0.0	0.0	0.6	1.0	0.3	2.5	0.0	0.1	0.0	0.2	2.1	0.8	1.8	0.4	1.3	4.3	0.1	4.8	0.0	0.0	0.1	0.1	0.0	1.2	0.2	0.0	0.2	0.0	0.7	0.5	0.0	17.0	0.2	0.1	15.7	0.2	0.1	0.9	0.2	12.8	0.0	1.4	0.4	13.4	0.2	6.3	0.2	0.6	5.7	5.3	7.3	0.8	5.3	5.0	2.6	7.0	0.8	6.8	8.1
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054064: "	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	17.8	25.1	32.8	14.1	33.1	15.4	26.0	30.7	46.7	24.9	16.9	21.3	15.3	15.2	26.3	29.1	15.3	22.5	18.7	28.3	35.3	49.8	20.6	32.8	17.5	23.0	28.2	35.8	37.6	28.2	23.5	25.7	19.6	26.8	21.5	15.6	19.1	20.9	24.0	22.6	16.8	15.0	20.7	22.7	17.0	15.8	20.6	19.1	16.0	29.1	14.2	19.2	19.2	16.1	21.4	14.3	38.4	20.2	24.1	24.1	18.0	8.7	21.8	11.7	21.1	33.6	25.1	14.3	11.6	19.2	13.8	15.5	11.7	25.0	14.3	16.1	15.7	20.6	18.2	15.0	11.0	13.6	40.0	21.4	18.9	19.8	22.2	16.6	25.6	20.7	30.4	8.3	17.3	19.0	17.5	21.7	21.7	17.7	12.1	17.6	18.0	7.3	14.8	14.8	22.2	27.9	23.2	15.8	14.4	16.0	17.0	23.1	16.1	22.0	15.1	14.6	15.0	9.7	12.7	20.6	30.4	15.5	12.4	20.9	12.0	14.8	20.2	38.4	21.7	19.9	24.1	15.5	17.9	16.5	14.3	21.4	23.9	22.1	34.4	24.1	15.0	12.1	18.0	18.0	32.8	33.1	30.7	46.7	35.3	49.8	28.2	35.8	26.8	19.1
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 29.1;EFO-21: 61.5;HUVEC TERT2: 20.3;NTERA-2: 14.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.8"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA053639, HPA069378"	Approved		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA053639: , HPA069378: "	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favourable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	17.9	4.8	7.1	4.0	8.8	0.1	14.4	3.7	7.3	7.9	3.5	1.7	4.7	3.1	7.6	7.2	5.4	5.6	9.0	10.8	8.4	6.2	26.6	9.7	7.4	8.0	9.3	1.5	5.4	8.0	4.2	7.4	14.1	12.3	9.1	2.9	11.9	3.5	5.6	9.3	2.7	3.9	12.3	7.4	34.6	3.5	2.6	8.2	0.6	12.0	5.7	4.0	6.0	5.8	0.9	0.6	1.2	0.4	2.8	0.5	0.0	0.0	29.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	61.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.3	0.0	0.0	1.9	0.2	0.0	0.0	14.6	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.7	1.2	0.4	0.4	0.3	0.2	0.1	0.5	0.4	0.2	0.0	0.9	0.4	0.5	0.5	2.8	0.3	0.6	0.1	0.0	7.1	8.8	3.7	7.3	8.4	6.2	9.3	1.5	12.3	8.2
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149473974-149503281	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 196.0;intestine: 126.4;liver: 81.8"	"Group enriched"	"Detected in some"	6	"A549: 15.9;RPTEC TERT1: 24.6"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA046430: "	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	68.2	0.0	0.0	70.3	0.2	0.1	0.3	0.3	196.0	0.2	0.2	0.2	0.4	81.8	0.3	0.0	0.2	0.0	0.2	24.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.2	126.4	0.0	0.2	0.3	2.3	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.4	0.2	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.0	0.3	0.9	24.6	0.0	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TM7SF3		ENSG00000064115	"Transmembrane 7 superfamily member 3"	Q9NS93	12	26973195-27014434	"Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057640			Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA057640: "	"unprognostic (4.24e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-3)"	"unprognostic (8.80e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	12.0	27.6	12.1	8.1	17.4	18.5	15.9	7.9	18.9	12.4	17.2	18.1	13.1	10.7	10.9	16.6	27.8	12.7	16.4	10.6	11.7	11.6	69.8	39.9	15.9	15.0	13.0	11.6	12.1	52.6	15.4	33.2	11.0	10.7	14.5	19.7	20.5	21.9	14.2	5.8	15.4	12.8	13.2	13.9	12.0	14.9	11.0	10.6	31.2	14.1	12.3	17.1	15.3	16.5	10.5	10.6	16.0	6.9	11.8	11.4	3.9	8.5	20.5	12.2	14.7	18.5	12.3	64.1	10.6	17.3	8.8	15.1	11.2	36.7	11.5	13.7	10.0	9.4	12.7	72.0	12.2	11.3	7.6	17.3	25.7	21.3	12.3	62.3	12.2	7.5	61.4	18.8	16.9	23.1	7.4	7.9	13.3	17.6	30.4	36.2	24.8	12.2	28.5	19.2	20.4	15.2	39.3	2.0	10.8	13.1	7.1	18.7	19.4	13.2	8.7	7.7	12.6	21.1	13.1	4.8	12.3	21.6	14.8	21.2	11.6	8.6	6.9	16.0	6.0	6.9	5.7	7.3	7.6	7.8	10.2	10.5	10.9	7.2	7.8	11.8	3.5	10.6	11.4	3.9	12.1	17.4	7.9	18.9	11.7	11.6	13.0	11.6	10.7	10.6
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331217-81374213	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	15	"parathyroid gland: 66.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 4.6"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 1.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol				Cytosol		"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.0	0.1	0.0	1.7	0.0	0.3	0.2	0.4	1.4	1.5	1.5	0.0	0.0	0.2	0.8	4.6	0.7	0.8	0.2	0.2	0.0	0.1	0.1	1.3	0.0	0.1	0.0	0.0	0.2	0.2	66.9	1.5	0.7	1.6	1.0	0.1	0.4	0.2	2.9	0.0	0.2	0.5	1.7	1.9	0.1	0.8	3.0	0.0	0.0	1.5	0.0	0.0	1.3	3.6	1.6	0.7	0.2	0.2	0.2	1.8	0.7	0.9	1.0	0.5	2.7	0.4	0.2	1.9	0.8	0.3	0.2	0.3	0.7	1.9	2.3	0.1	0.0	0.7	0.3	0.2	0.1	1.7	1.4	1.9	1.1	0.9	0.3	1.5	1.1	0.5	0.1	0.4	0.3	0.0	0.6	2.8	0.2	0.8	1.0	1.4	1.5	0.9	0.7	1.0	4.3	0.2	0.6	1.1	2.0	0.9	1.0	2.0	2.3	1.1	0.4	1.5	1.8	1.3	0.5	4.6	1.8	1.4	1.1	2.5	0.9	0.1	0.0	0.2	0.7	0.1	0.6	1.2	0.8	0.4	0.1	1.6	1.8	1.3	0.2	0.2	0.2	0.7	0.9	0.7	0.0	0.0	0.4	1.4	0.0	0.1	0.0	0.0	1.6	0.0
TMCO3	"C13orf11, FLJ20623"	ENSG00000150403	"Transmembrane and coiled-coil domains 3"	Q6UWJ1	13	113490995-113554590	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 17.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039561, HPA048126"	Uncertain		Approved	Cytosol				Cytosol		"HPA039561: , HPA048126: "	"unprognostic (7.89e-2)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (6.78e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (2.93e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.47e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.27e-3)"	"prognostic unfavourable (4.10e-4)"	16.1	20.5	15.1	11.1	14.2	40.3	14.5	38.7	14.6	21.3	15.7	18.6	16.7	13.0	23.1	15.5	13.1	17.2	23.2	17.0	14.4	13.0	18.0	15.5	13.8	9.4	17.4	9.6	16.9	46.1	18.6	18.6	23.2	21.2	16.1	14.1	17.1	25.8	14.5	10.2	7.7	17.6	18.9	20.7	14.8	27.8	11.0	11.3	7.2	7.5	13.4	11.3	13.2	23.9	2.6	5.0	17.4	8.5	4.1	1.8	2.0	27.0	9.1	13.4	9.2	27.6	40.9	7.3	29.7	28.4	13.1	13.3	10.0	12.1	6.5	7.6	32.5	11.0	7.0	10.7	20.4	13.2	7.2	5.8	14.8	10.0	26.1	9.5	12.2	33.1	25.6	9.8	20.4	21.4	8.3	9.2	22.9	4.9	4.9	5.7	6.7	14.6	6.2	8.1	4.6	21.9	3.7	11.8	9.7	9.2	20.3	9.4	12.0	18.0	33.2	14.8	15.9	10.8	12.5	11.5	6.5	4.1	49.0	5.0	7.1	2.4	6.9	6.8	1.1	4.4	1.4	2.6	1.4	1.8	5.0	1.4	1.5	1.5	17.4	4.1	8.5	1.1	1.2	2.0	15.1	14.2	38.7	14.6	14.4	13.0	17.4	9.6	21.2	11.3
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039739			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039739: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favourable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	11.0	10.9	8.4	7.3	14.2	5.1	58.9	6.3	16.5	22.7	11.4	13.7	7.7	8.4	33.3	14.5	15.1	19.2	15.4	12.4	8.7	8.6	37.2	12.0	11.4	16.1	9.5	9.4	13.0	27.8	10.7	8.5	17.8	11.6	13.9	8.6	11.5	20.9	59.7	15.5	13.8	9.5	11.6	10.1	11.0	13.6	16.9	8.9	10.0	25.4	12.9	13.2	12.5	11.6	23.8	25.9	11.7	25.0	23.8	27.2	17.8	9.6	23.7	8.5	7.0	20.3	19.6	8.5	10.1	15.4	20.1	19.2	17.6	25.3	10.9	2.8	10.4	14.9	9.8	17.6	15.4	11.8	19.8	8.2	19.0	35.6	17.5	13.1	14.3	17.5	20.1	14.2	20.2	17.5	16.8	21.5	12.5	12.9	14.1	15.1	4.0	26.8	12.3	18.4	19.8	16.7	7.9	11.1	8.8	6.5	0.2	24.1	11.7	25.3	10.5	18.5	12.4	8.0	19.8	22.4	15.4	5.0	19.4	12.5	16.4	11.7	24.9	8.6	19.4	25.0	21.8	22.7	24.5	22.3	25.9	23.8	27.2	22.1	9.1	23.8	17.8	25.2	25.1	17.8	8.4	14.2	6.3	16.5	8.7	8.6	9.5	9.4	11.6	8.9
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;LHCN-M2: 6.5;SCLC-21H: 10.0;SH-SY5Y: 44.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: "	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.4	0.8	3.9	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.3	0.0	0.1	1.8	0.0	0.0	2.2	0.0	0.5	0.0	10.0	44.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.8	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3
TMEM109	MGC5508	ENSG00000110108	"Transmembrane protein 109"	Q9BVC6	11	60913874-60923443	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011785	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA011785: AB_1858075"	"unprognostic (5.23e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavourable (2.68e-4)"	40.2	21.2	7.7	22.4	11.5	10.4	45.4	13.4	17.4	39.7	28.8	17.0	17.7	12.0	43.1	25.9	38.0	30.0	32.0	32.7	9.9	8.3	27.0	31.7	30.0	26.0	16.5	9.5	42.6	28.5	23.2	18.9	36.2	12.4	38.5	11.8	44.1	43.4	27.5	41.9	28.4	19.2	38.0	10.5	28.8	25.1	16.6	12.1	21.5	36.9	35.2	33.0	35.6	44.7	25.5	83.1	9.5	13.7	19.9	36.2	21.9	24.2	21.4	13.8	23.1	35.2	16.2	11.6	22.8	20.6	24.2	21.0	19.1	25.8	28.0	42.6	25.3	31.9	14.4	9.8	14.7	21.8	19.1	19.8	10.1	4.2	10.4	40.1	17.7	11.0	12.5	18.8	9.4	29.3	10.2	73.7	17.2	44.1	29.5	17.2	23.7	21.9	29.4	27.0	40.2	11.9	12.4	5.7	10.0	18.1	43.9	21.6	24.6	7.3	30.0	31.2	15.0	39.4	20.7	25.3	18.6	15.0	27.8	17.3	36.1	6.2	13.7	9.5	35.8	12.1	36.2	22.3	20.8	30.3	40.8	25.5	19.0	24.3	1.5	19.9	8.8	83.1	15.5	21.9	7.7	11.5	13.4	17.4	9.9	8.3	16.5	9.5	12.4	12.1
TMEM110-MUSTN1		ENSG00000248592	"TMEM110-MUSTN1 readthrough"		3	52833121-52897562	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;Karpas-707: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA051855	Uncertain		Approved	Cytosol				Cytosol		"HPA051855: "	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.95e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.11e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.01e-6)"	"unprognostic (5.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.09e-5)"	13.3	6.7	3.8	5.4	7.6	5.2	5.8	5.2	9.6	4.9	5.5	8.6	3.7	4.1	8.6	3.4	6.4	4.2	3.8	5.8	4.1	3.7	8.0	23.6	5.0	8.6	6.6	3.4	5.2	9.2	2.0	3.8	3.9	6.0	4.1	2.6	6.0	5.5	3.1	58.0	4.2	7.9	7.8	4.8	5.7	5.0	3.9	4.1	8.6	4.4	2.7	6.1	5.8	5.7	0.9	1.6	1.6	1.7	0.0	2.3	0.4	1.5	0.8	1.6	6.1	0.5	0.0	0.0	3.2	1.0	0.2	0.4	0.0	1.0	1.1	0.5	0.0	1.4	1.6	1.6	0.0	8.2	3.2	2.0	0.0	0.0	0.2	1.4	3.1	0.0	0.6	0.6	1.3	0.3	0.9	9.0	0.1	0.9	1.9	1.1	1.1	4.2	0.3	0.0	1.9	0.3	0.0	0.6	0.4	0.8	0.9	1.9	0.7	3.1	0.9	1.1	2.9	1.2	1.8	4.2	3.8	1.2	1.4	4.0	1.7	0.0	0.2	1.6	0.4	1.7	2.3	0.9	0.7	0.9	0.8	0.3	0.0	0.0	0.4	0.0	0.0	1.6	0.6	0.4	3.8	7.6	5.2	7.6	4.1	3.7	6.6	3.4	6.0	4.1
TMEM120B		ENSG00000188735	"Transmembrane protein 120B"	A0PK00	12	121712752-121783001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 23.1;cerebellum: 35.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014066	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	Cytosol	"HPA014066: AB_1845296"	"unprognostic (8.80e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.66e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.29e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.86e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.72e-2)"	7.9	7.0	5.6	4.7	23.1	9.3	5.6	35.6	6.9	11.1	4.4	3.3	8.6	4.2	10.0	5.4	2.8	12.2	4.5	3.9	5.9	3.8	4.5	4.7	5.3	4.0	4.5	4.3	5.0	14.3	5.9	11.6	2.4	6.0	5.2	3.1	5.5	14.9	6.2	17.2	5.7	3.8	8.0	2.9	4.3	4.9	3.4	5.8	1.9	10.6	4.0	3.8	3.6	7.1	4.1	4.0	3.6	1.6	2.4	3.4	1.3	4.8	16.6	3.9	11.4	4.8	6.4	8.0	6.4	7.4	6.2	5.0	10.5	5.6	5.2	4.0	6.5	8.3	9.1	7.7	3.3	3.1	8.4	7.2	5.2	6.4	6.7	5.1	5.7	6.0	6.9	7.0	5.1	3.8	6.4	3.8	3.7	7.8	8.4	7.0	7.0	10.2	10.0	16.1	6.9	3.2	5.3	15.0	10.7	6.3	5.0	5.6	11.2	4.1	5.3	8.3	9.4	5.3	5.5	8.9	3.1	3.8	10.6	6.6	8.3	3.1	1.4	1.7	3.4	1.6	2.8	2.9	3.3	2.7	1.6	4.1	2.4	2.8	3.6	2.4	1.5	4.0	2.8	1.3	5.6	23.1	35.6	6.9	5.9	3.8	4.5	4.3	6.0	5.8
TMEM121	"hole, MGC4659, TMEM121A"	ENSG00000184986	"Transmembrane protein 121"	Q9BTD3	14	105526603-105530202	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 12.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.4;MCF7: 8.7;PC-3: 11.4;REH: 7.3;SCLC-21H: 6.0;WM-115: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049857	Uncertain		Approved	Cytosol				Cytosol		"HPA049857: "	"unprognostic (4.25e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.48e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (5.87e-4)"	"unprognostic (5.90e-2)"	3.2	2.6	7.2	2.5	8.8	1.5	1.7	3.3	12.6	2.5	1.6	7.9	1.9	1.5	3.0	2.9	1.6	3.1	1.3	2.3	7.4	6.0	2.5	3.0	1.9	2.5	5.0	3.9	2.7	2.9	2.5	3.5	1.6	3.0	3.8	0.8	2.7	2.8	2.7	1.1	2.1	1.9	1.6	4.3	7.1	3.4	1.6	1.6	0.0	2.9	0.4	1.0	1.1	4.7	4.7	0.5	0.0	0.0	1.8	3.1	0.6	0.0	4.4	0.4	4.1	0.0	0.2	0.8	2.8	0.6	0.4	0.0	0.0	1.5	1.3	9.4	0.0	0.4	0.4	0.1	0.0	0.6	2.2	0.1	0.4	1.5	0.7	0.0	1.6	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.2	8.7	0.2	0.0	1.4	11.4	7.3	0.0	0.1	0.1	0.0	6.0	2.2	0.5	0.0	2.1	2.7	0.3	1.6	1.3	2.4	0.2	0.4	0.6	0.0	0.0	0.1	0.5	6.1	0.0	0.0	0.0	1.8	0.0	2.6	4.7	3.1	1.6	0.5	1.7	1.9	1.2	0.0	1.8	0.0	0.0	0.2	0.6	7.2	8.8	3.3	8.2	7.4	6.0	5.0	3.9	3.0	1.6
TMEM123	"KCT3, PORIMIN"	ENSG00000152558	"Transmembrane protein 123"	Q8N131	11	102396332-102470384	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 140.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026001, HPA062862"			Supported	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026001: , HPA062862: "	"unprognostic (2.64e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.36e-4)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.65e-2)"	21.3	23.1	18.8	30.1	23.3	39.8	38.6	7.4	18.8	35.2	38.2	19.1	15.1	12.4	65.3	20.8	31.9	21.6	20.8	36.8	20.7	14.0	27.0	95.4	39.5	55.5	22.6	13.7	27.8	24.7	14.5	8.5	23.9	21.1	34.9	19.9	13.9	53.3	22.2	13.2	29.7	17.6	29.7	22.4	39.9	23.7	22.9	24.6	71.9	66.0	20.1	27.1	43.7	39.8	23.3	30.3	48.3	29.2	52.4	55.5	51.3	28.8	25.9	26.8	24.9	34.3	28.1	18.2	22.5	48.8	46.1	51.3	32.8	140.1	48.7	58.1	52.1	31.3	29.1	37.1	51.0	29.3	10.6	25.3	10.2	48.7	30.3	53.7	19.0	31.3	42.3	32.9	49.3	51.5	16.9	0.1	38.0	9.3	46.6	16.8	16.0	23.7	28.7	74.1	46.7	43.9	28.6	12.7	15.0	27.3	37.4	14.8	23.1	21.0	60.3	31.0	34.8	26.8	16.9	18.9	10.5	49.5	9.0	59.9	20.4	30.1	26.8	48.3	26.3	29.2	40.0	16.7	41.3	31.8	30.3	23.3	55.5	46.9	17.6	52.4	24.2	8.1	42.9	51.3	18.8	23.3	7.4	18.8	20.7	14.0	22.6	13.7	21.1	24.6
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269994-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 73.6;salivary gland: 47.8"	"Cell line enhanced"	"Detected in some"		"A-431: 13.5;BEWO: 11.6;CACO-2: 10.6;CAPAN-2: 25.2;SK-BR-3: 21.7;T-47d: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015796			Approved	Midbody,Cytosol				"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favourable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favourable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.8	0.0	5.3	4.6	7.1	0.0	4.9	0.9	5.0	7.4	14.4	1.0	20.7	15.1	1.8	12.5	3.3	6.6	18.9	1.0	8.9	4.3	9.4	1.4	42.5	0.8	10.7	0.8	2.0	73.6	9.6	15.7	5.6	1.1	8.8	9.1	1.5	47.8	19.0	0.8	3.7	29.4	0.8	21.1	0.8	11.6	1.2	0.8	1.1	33.6	3.8	5.0	1.4	3.5	0.0	0.8	0.0	0.0	1.8	0.9	0.2	13.5	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.6	25.2	0.0	0.6	0.0	6.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.2	4.3	6.6	0.0	0.0	21.7	0.0	17.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.9	0.2	0.0	1.8	0.0	0.8	0.0	0.2	5.3	7.1	0.9	1.9	8.9	4.3	10.7	0.8	1.1	0.8
TMEM126A	"DKFZp586C1924, OPA7"	ENSG00000171202	"Transmembrane protein 126A"	Q9H061	11	85647967-85656547	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046648	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA046648: "	"unprognostic (3.79e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (8.60e-5)"	"unprognostic (8.25e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.17e-1)"	18.3	17.4	24.9	15.9	23.3	23.7	20.0	13.2	30.0	13.9	16.2	9.5	15.6	19.8	13.2	20.6	17.2	12.5	16.0	44.4	20.9	20.7	22.0	28.5	12.6	15.0	21.8	22.9	13.7	27.7	13.1	19.9	14.1	19.9	14.0	18.3	8.9	25.2	15.7	49.5	12.2	15.1	16.5	18.0	14.1	19.1	21.4	18.8	10.5	16.5	36.4	15.6	14.0	18.7	14.5	19.1	6.3	15.3	8.4	16.5	11.1	15.9	20.1	18.1	12.5	24.4	24.6	14.8	19.0	20.7	28.6	28.3	24.8	25.8	9.2	22.7	22.9	17.6	18.6	20.1	26.5	23.4	10.4	25.3	24.0	27.0	30.7	31.8	21.4	21.2	24.7	25.3	27.0	26.0	17.8	15.2	31.7	21.2	17.2	40.6	18.5	23.0	17.6	18.2	29.8	20.0	21.1	13.0	13.2	17.2	27.2	15.8	33.7	21.9	15.4	27.8	19.8	52.0	21.8	10.2	17.8	24.2	14.6	22.9	32.9	2.9	13.4	6.3	12.5	15.3	16.5	14.5	16.4	14.6	19.1	13.2	15.6	15.4	1.2	8.4	13.1	14.4	14.1	11.1	24.9	23.3	13.2	30.0	20.9	20.7	21.8	22.9	19.9	18.8
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.5"	"Group enriched"	"Detected in some"	6	"AF22: 5.9;ASC diff: 8.5;Daudi: 9.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"gdT-cell: 5.4"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Supported	Centrosome,Cytosol			110000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	37.5	4.2	9.6	1.1	7.0	0.8	23.3	5.0	6.6	22.0	2.5	4.2	8.9	1.2	5.9	5.7	4.7	13.4	5.1	3.5	5.0	3.8	1.3	0.8	1.6	2.0	4.9	3.1	7.9	4.1	0.9	0.6	5.1	4.6	3.7	1.3	5.3	2.9	9.1	1.9	2.2	1.4	2.1	3.9	1.1	1.5	2.1	5.4	0.0	1.1	0.9	1.3	3.8	10.5	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	5.9	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.6	7.0	5.0	6.6	5.0	3.8	4.9	3.1	4.6	5.4
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Predicted membrane proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;kidney: 8.8"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 30.9"	"Group enriched"	"Detected in some"	8	"glioma: 7.6;renal cancer: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 1.4;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"			140000	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: "	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.4	0.5	4.9	0.4	4.1	0.2	0.3	17.3	8.7	1.2	0.4	1.7	0.3	4.9	0.6	0.5	0.4	0.4	0.8	0.5	2.9	5.1	8.8	1.3	0.4	0.7	4.5	2.8	0.5	0.2	0.3	0.0	0.9	5.3	0.4	0.5	0.0	0.8	0.8	0.3	0.8	2.8	0.6	20.0	0.7	0.6	2.4	2.2	0.0	0.4	0.0	0.6	0.7	0.1	0.0	0.0	0.0	0.0	1.4	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	3.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.4	0.5	0.0	0.0	2.6	1.8	0.0	1.4	0.0	0.0	0.0	0.4	4.9	4.1	17.3	6.9	2.9	5.1	4.5	2.8	5.3	2.2
TMEM134	FLJ21749	ENSG00000172663	"Transmembrane protein 134"	Q9H6X4	11	67461710-67469272	"Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA043744	Approved		Supported	Cytosol				Cytosol		"HPA043744: AB_10794773"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.43e-3)"	7.1	15.3	11.2	11.9	14.9	4.8	7.8	6.5	12.7	10.1	11.2	13.4	16.1	8.8	7.2	16.4	30.2	10.3	14.1	22.7	9.7	7.9	13.1	23.7	8.1	10.9	12.9	7.9	6.9	42.1	6.9	4.7	10.7	10.1	15.6	5.1	7.1	16.9	14.0	46.2	31.8	10.2	6.9	12.5	12.3	14.0	12.0	9.7	11.1	8.3	20.7	21.6	10.4	13.2	51.9	23.9	25.9	44.5	22.7	32.2	19.2	7.0	2.7	3.8	8.3	2.6	4.5	4.3	1.5	2.7	1.7	0.7	3.3	8.4	6.7	16.3	3.6	5.9	1.7	6.2	1.1	6.4	2.9	1.2	2.4	3.4	4.0	1.3	2.0	4.4	8.0	1.3	4.6	1.8	1.6	3.9	3.8	16.7	7.4	4.9	6.5	9.5	3.7	2.3	21.7	6.6	7.2	3.7	8.0	5.3	8.4	15.4	20.4	1.3	3.4	6.3	5.5	7.4	1.9	16.6	10.5	4.4	9.3	1.7	5.0	12.5	15.4	25.9	20.9	34.7	22.9	51.9	25.0	23.3	18.2	50.3	25.5	23.9	7.2	22.7	44.5	23.9	32.2	19.2	11.2	14.9	6.5	12.7	9.7	7.9	12.9	7.9	10.1	9.7
TMEM136	MGC17839	ENSG00000181264	"Transmembrane protein 136"	Q6ZRR5	11	120325129-120333682	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 5.7"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074432			Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA074432: "	"unprognostic (1.02e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (6.65e-4)"	"unprognostic (1.65e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.28e-2)"	4.4	18.9	9.1	2.7	13.8	1.0	5.7	5.8	15.1	4.6	2.9	13.8	3.2	2.1	7.6	14.0	2.6	7.4	5.6	19.1	8.2	5.7	4.8	1.9	4.9	4.0	13.0	7.7	9.0	9.7	9.4	7.9	10.4	12.0	8.4	2.3	9.0	2.4	5.9	1.8	2.0	3.1	6.9	13.7	4.2	2.8	5.4	8.8	0.0	7.8	0.7	2.9	3.2	4.1	0.0	5.7	0.0	0.0	0.0	0.9	0.0	1.7	4.5	8.4	8.0	8.4	13.2	2.1	3.7	9.2	6.0	9.7	2.2	7.5	0.0	11.6	2.3	1.2	7.4	2.8	6.7	0.0	4.6	5.5	4.0	3.9	9.4	0.0	0.0	11.4	2.1	8.4	13.1	6.9	1.5	11.1	8.0	2.1	0.0	0.0	3.6	2.8	4.2	3.4	0.6	7.9	1.6	5.4	5.3	5.2	0.6	1.0	6.9	0.2	4.9	6.6	6.7	1.4	2.2	0.1	0.0	0.0	1.9	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.9	0.0	9.1	13.8	5.8	11.5	8.2	5.7	13.0	7.7	12.0	8.8
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291870-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 48.5"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	1.4	3.8	12.4	1.5	16.8	1.4	1.4	5.9	48.5	1.4	1.5	41.8	0.0	1.5	1.4	1.4	1.4	1.4	2.8	1.6	22.7	14.3	1.4	1.4	1.4	1.4	21.2	13.1	1.5	2.4	1.8	3.3	1.4	22.2	1.4	1.4	1.0	1.5	1.4	1.4	1.4	1.5	1.4	43.2	1.4	3.9	1.6	13.6	0.0	1.4	0.0	1.4	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	18.2	4.1	0.5	0.0	0.3	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.4	16.8	5.9	31.1	22.7	14.3	21.2	13.1	22.2	13.6
TMEM161A	"FLJ20422, FLJ39645"	ENSG00000064545	"Transmembrane protein 161A"	Q9NX61	19	19119169-19138513	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043365	Approved		Approved	Cytosol				Cytosol		"HPA043365: AB_10796793"	"unprognostic (4.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.15e-2)"	"prognostic favourable (2.99e-4)"	"unprognostic (4.18e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.89e-3)"	10.4	18.3	10.6	9.2	13.5	8.1	10.3	12.8	11.7	12.2	10.5	9.8	15.8	10.0	17.2	8.6	11.7	12.4	15.5	12.7	8.6	6.9	12.7	21.1	9.1	12.1	13.4	8.4	14.2	18.6	17.3	6.6	6.4	9.9	12.8	5.3	12.7	17.1	13.6	34.5	13.5	9.1	9.9	7.8	8.8	10.6	5.3	11.6	15.0	20.8	13.8	9.1	10.8	12.6	6.8	23.5	1.5	7.2	6.7	13.5	5.4	16.0	11.2	6.4	13.7	13.8	9.2	10.1	6.8	8.3	8.4	11.1	9.4	20.0	14.0	33.4	5.1	13.0	10.2	15.7	5.5	6.3	37.3	5.4	6.2	12.7	18.4	7.1	9.0	14.4	13.2	8.4	12.4	9.4	17.9	17.0	5.9	19.4	10.2	14.9	6.1	18.4	16.4	5.4	27.8	6.5	6.6	8.7	8.7	10.2	13.0	8.2	10.4	12.6	5.5	7.8	3.8	17.6	12.6	15.8	9.8	8.4	8.6	14.6	11.3	1.5	7.2	1.4	10.0	6.3	8.8	5.7	9.1	8.1	10.1	6.8	10.8	9.1	0.8	6.7	6.3	23.5	13.5	5.4	10.6	13.5	12.8	11.7	8.6	6.9	13.4	8.4	9.9	11.6
TMEM168	"DKFZp564C012, FLJ13576"	ENSG00000146802	"Transmembrane protein 168"	Q9H0V1	7	112762382-112790592	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020389, HPA077143"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA020389: AB_1858101, HPA077143: "	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.30e-3)"	"prognostic favourable (4.07e-6)"	"unprognostic (1.60e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.30e-2)"	14.4	14.9	9.0	11.4	14.6	5.6	15.4	6.9	15.7	15.7	21.2	17.9	17.6	13.2	17.4	18.3	19.1	15.0	12.1	18.9	11.8	8.2	18.8	11.8	13.5	21.3	12.6	7.8	17.5	9.9	28.2	12.7	26.3	15.5	16.6	24.3	18.4	19.6	14.5	11.0	25.5	18.4	19.7	15.7	16.4	14.3	13.9	12.4	17.8	17.5	12.6	17.4	14.7	16.9	15.4	17.9	16.5	16.9	13.7	22.4	10.0	9.1	7.8	7.3	6.6	12.6	25.8	10.4	10.2	9.6	3.8	3.4	9.9	9.8	9.8	6.9	10.1	10.0	7.4	8.9	10.0	15.3	7.6	8.2	9.6	5.6	8.5	9.4	10.8	12.5	23.2	4.4	6.6	11.2	11.3	9.0	13.9	14.7	8.0	5.9	5.9	6.0	5.4	3.6	14.2	9.7	17.6	5.5	10.9	13.4	18.4	7.8	10.3	8.3	15.9	18.7	9.4	8.6	13.1	15.4	13.0	11.0	12.1	8.3	23.4	16.5	16.9	12.5	14.2	13.7	16.9	12.4	15.3	13.8	17.9	15.4	22.4	15.5	9.4	13.7	13.5	12.2	13.7	10.0	9.0	14.6	6.9	15.7	11.8	8.2	12.6	7.8	15.5	12.4
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell line enhanced"	"Detected in some"		"AF22: 8.3;LHCN-M2: 6.7;RPTEC TERT1: 12.2;SCLC-21H: 10.5;SH-SY5Y: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: , HPA062797: , HPA070657: , HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	1.7	2.9	5.9	2.5	6.2	1.3	0.9	9.7	16.8	2.1	1.3	3.9	1.6	1.9	1.1	1.9	0.9	2.9	2.5	1.1	5.5	6.3	4.9	4.2	2.1	2.4	5.5	4.8	1.1	1.0	0.8	2.4	0.7	9.1	1.4	1.2	4.9	0.9	1.1	1.5	1.6	1.7	1.2	6.6	2.6	1.0	1.3	2.5	0.7	6.7	0.0	2.0	1.1	0.7	3.0	0.2	4.3	5.7	0.7	6.3	1.3	0.1	0.4	8.3	0.2	0.9	0.1	0.0	0.3	0.2	0.2	0.8	0.4	2.4	0.1	6.1	0.3	0.2	1.1	0.0	0.2	1.2	0.4	2.7	0.1	1.5	1.8	0.2	0.6	0.6	0.6	0.6	0.8	0.0	0.0	0.4	6.7	0.7	0.2	0.3	4.3	0.1	1.5	2.4	0.2	12.2	0.0	10.5	15.1	0.2	0.2	6.0	0.4	1.1	0.1	0.2	0.4	0.2	0.4	1.9	2.0	0.4	1.9	0.2	1.5	1.3	1.8	0.3	2.3	1.5	1.7	2.4	4.0	2.7	0.0	3.0	4.2	1.9	4.3	0.7	5.7	0.2	6.3	1.3	5.9	6.2	9.7	11.5	5.5	6.3	5.5	4.8	9.1	2.5
TMEM173	"ERIS, FLJ38577, MITA, MPYS, NET23, STING"	ENSG00000184584	"Transmembrane protein 173"	Q86WV6	5	139475534-139482935	"Disease related genes, Predicted membrane proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.8;EFO-21: 37.4;HDLM-2: 79.4;Karpas-707: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038116, HPA038534"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA038116: AB_2675841, HPA038534: AB_2676067"	"unprognostic (1.45e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (3.59e-8)"	"unprognostic (9.18e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.34e-1)"	22.9	6.5	6.3	17.4	6.7	18.1	15.9	1.2	4.5	22.5	9.4	6.0	13.3	6.4	16.7	18.1	16.0	24.4	13.5	26.3	3.8	3.1	12.5	8.1	32.0	41.3	7.9	2.3	30.7	3.9	1.9	8.1	13.9	6.8	20.3	8.8	14.7	16.6	14.6	10.3	9.6	10.9	16.2	7.1	35.8	8.0	11.1	6.3	15.8	13.0	16.5	29.7	17.7	17.9	0.3	26.9	5.8	29.1	39.8	28.9	26.1	1.1	0.5	0.0	0.0	1.2	4.0	0.1	6.4	24.8	3.2	10.3	0.0	8.9	0.0	37.4	19.3	4.7	0.1	9.5	1.2	79.4	0.9	5.4	2.5	0.3	2.2	1.6	0.1	5.7	0.4	2.1	2.6	11.0	1.6	24.9	11.5	0.0	0.8	8.3	0.0	1.8	0.3	2.3	7.4	2.8	2.4	2.5	0.0	2.2	2.3	6.2	0.3	21.5	8.0	0.8	0.4	2.5	1.9	0.0	7.5	0.0	0.1	23.2	2.8	5.8	29.1	0.0	28.8	19.4	14.2	0.3	28.2	23.2	26.9	0.2	19.4	17.5	2.4	39.8	7.8	9.2	28.9	26.1	6.3	6.7	1.2	4.5	3.8	3.1	7.9	2.3	6.8	6.3
TMEM184B	"C22orf5, DKFZP586A1024, FM08, HS5O6A"	ENSG00000198792	"Transmembrane protein 184B"	Q9Y519	22	38219291-38273034	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024076	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA024076: AB_1858106"	"unprognostic (1.52e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavourable (5.94e-6)"	"unprognostic (1.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.96e-1)"	21.8	16.5	23.9	14.7	24.1	6.0	27.5	26.4	40.0	22.4	14.4	31.2	12.2	18.5	12.1	9.5	11.0	14.2	16.1	17.8	25.8	21.5	13.0	7.4	20.5	8.6	26.1	22.2	10.8	18.0	27.3	21.9	41.2	23.8	12.3	12.5	20.1	16.8	17.3	19.0	10.9	16.5	15.7	41.2	14.1	19.3	5.8	20.9	3.9	16.7	10.6	9.2	20.0	15.4	1.6	7.3	12.4	3.1	6.2	5.8	2.6	17.0	14.9	8.8	6.9	17.6	14.2	20.4	18.5	26.3	15.2	13.5	10.9	7.9	3.2	14.5	27.5	21.1	7.9	18.2	10.3	11.6	14.2	6.4	10.9	9.0	18.5	5.0	9.0	11.8	16.1	17.8	20.0	18.9	4.1	11.4	13.2	9.7	3.2	4.3	7.1	13.7	5.5	7.9	3.2	11.2	18.9	19.2	3.4	13.9	20.3	9.8	11.1	3.7	27.9	15.5	15.9	13.6	11.2	23.9	58.9	2.6	22.5	3.7	13.3	12.4	3.1	4.6	5.8	2.4	5.3	1.6	3.3	4.3	4.7	1.2	2.3	2.7	11.2	6.2	1.6	7.3	1.0	2.6	23.9	24.1	26.4	35.4	25.8	21.5	26.1	22.2	23.8	20.9
TMEM187	"CXorf12, DXS9878E, ITBA1"	ENSG00000177854	"Transmembrane protein 187"	Q14656	X	153972327-153983195	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA038134	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA038134: AB_10669517"	"unprognostic (1.51e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.41e-2)"	"prognostic favourable (9.14e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.04e-2)"	8.8	13.0	9.2	6.8	10.2	3.4	10.5	13.2	9.0	7.6	9.0	10.5	13.9	6.8	8.8	9.3	9.5	12.0	6.8	8.1	9.6	6.0	7.6	10.2	7.7	10.2	10.4	9.0	10.9	24.4	7.5	13.0	7.3	11.0	10.3	4.5	6.7	14.1	10.1	8.5	10.7	10.9	6.8	8.0	10.0	8.0	5.9	8.7	8.4	10.8	2.9	9.9	7.9	7.4	13.4	19.6	17.8	9.8	10.1	22.5	10.9	8.3	9.5	2.1	7.6	8.2	7.4	1.1	3.4	1.7	1.0	3.4	1.9	14.4	1.3	19.7	2.7	7.6	2.9	5.0	0.8	10.7	3.9	2.3	5.0	3.1	7.0	1.1	2.6	8.3	7.6	2.9	4.3	2.6	2.0	10.8	4.3	9.0	4.4	1.5	1.5	10.6	4.1	1.1	13.9	5.3	2.7	2.8	2.8	5.0	4.2	3.6	8.0	2.7	4.8	1.7	1.8	6.9	1.9	7.6	5.1	1.7	5.1	5.0	0.9	17.8	9.8	11.9	14.7	7.3	14.7	9.7	18.1	15.9	7.4	13.4	22.5	13.9	9.5	10.1	6.9	19.6	17.6	10.9	9.2	10.2	13.2	9.0	9.6	6.0	10.4	9.0	11.0	8.7
TMEM214	FLJ20254	ENSG00000119777	"Transmembrane protein 214"	Q6NUQ4	2	27032910-27041695	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034551			Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Golgi apparatus, Cytosol"		"HPA034551: AB_10602481"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (2.39e-10)"	"unprognostic (1.54e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.92e-2)"	21.8	20.8	9.9	16.3	13.2	9.4	21.0	10.4	13.6	23.2	19.8	11.6	34.5	13.7	23.0	33.4	15.8	18.2	22.6	22.3	8.7	9.7	22.1	47.5	18.9	10.5	10.8	9.4	24.0	57.7	29.1	31.8	30.8	12.7	19.1	20.4	16.9	56.0	36.8	16.9	18.0	20.2	21.7	8.5	19.4	19.4	13.5	11.7	11.4	23.3	10.8	21.1	22.5	16.9	4.1	7.6	8.7	5.7	8.7	8.1	3.1	24.5	16.4	9.9	21.0	32.4	33.4	21.7	32.4	44.0	23.7	26.8	15.6	20.5	11.3	16.4	47.5	17.7	12.0	22.9	19.3	10.7	13.6	14.9	13.0	32.2	40.9	13.6	25.3	28.9	16.4	20.6	35.2	25.6	13.4	23.2	26.5	17.6	6.9	10.1	7.1	13.2	9.3	18.3	27.1	17.8	17.2	8.6	10.0	15.1	25.8	11.6	14.1	8.2	21.9	17.2	16.9	17.4	18.1	31.3	21.1	17.8	22.3	17.0	23.9	8.7	5.1	3.9	6.3	5.7	8.1	4.1	4.9	4.4	4.3	3.8	2.4	3.6	0.9	8.7	3.2	7.6	3.6	3.1	9.9	13.2	10.4	13.6	8.7	9.7	10.8	9.4	12.7	11.7
TMEM218		ENSG00000150433	"Transmembrane protein 218"	A2RU14	11	125096545-125111763	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038489	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038489: AB_10672748"	"unprognostic (3.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (3.63e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.95e-2)"	"prognostic favourable (5.50e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.72e-2)"	24.2	19.0	14.0	13.2	15.7	7.0	13.5	11.9	12.4	14.7	12.3	16.8	12.3	12.5	17.5	16.3	12.8	20.8	16.5	10.4	14.1	9.3	13.1	13.6	11.9	13.7	13.6	10.0	17.8	19.7	12.8	17.4	8.8	10.5	17.4	9.4	18.0	15.0	11.1	9.7	8.8	12.4	14.7	11.7	17.5	13.3	7.8	11.3	10.0	13.0	12.0	12.4	14.2	13.6	18.0	28.7	18.5	25.2	19.1	14.0	15.4	7.7	15.2	9.7	11.7	9.0	12.5	5.8	7.7	5.9	6.0	7.9	1.5	23.0	9.8	19.5	4.7	9.0	6.0	7.4	8.0	13.6	8.6	21.9	4.2	6.2	8.8	6.8	8.2	9.8	9.8	10.7	12.8	8.8	8.8	12.5	10.4	4.0	1.7	14.4	7.9	14.5	10.1	11.7	7.4	5.4	7.8	8.4	12.6	10.6	4.2	5.4	20.2	9.9	11.1	7.4	6.8	8.7	8.4	7.2	6.0	8.0	6.0	14.3	13.0	18.5	25.2	10.1	14.0	18.8	12.2	18.0	13.3	13.2	28.7	13.7	11.5	13.5	9.6	19.1	17.4	24.9	11.7	15.4	14.0	15.7	11.9	12.4	14.1	9.3	13.6	10.0	10.5	11.3
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA016579: , HPA059374: "	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	18.4	22.0	28.0	12.0	31.4	19.5	17.8	23.2	45.4	18.1	17.1	32.1	13.2	14.4	16.5	25.0	22.8	29.8	21.3	27.5	28.9	30.8	20.6	35.0	18.8	15.0	26.0	20.8	22.3	24.6	19.9	22.4	20.0	26.7	22.9	14.3	26.4	21.7	25.2	19.9	15.6	21.3	18.6	21.5	15.2	16.7	20.7	16.4	19.4	24.0	14.9	19.1	17.8	13.3	22.8	19.9	36.5	21.0	19.2	23.2	15.7	12.2	14.9	12.6	20.6	19.6	14.3	10.1	19.0	21.9	26.1	22.2	6.1	25.8	7.8	14.9	20.2	17.0	13.7	18.5	10.9	10.3	26.4	13.0	12.4	14.1	29.2	12.9	13.1	24.8	10.5	24.9	14.3	17.3	9.8	18.1	16.2	10.9	18.5	13.6	23.5	18.7	15.4	8.7	15.7	25.2	7.2	27.0	23.8	14.7	20.8	18.4	20.6	20.9	15.8	15.4	13.0	24.7	17.9	19.6	17.4	8.1	23.3	25.1	22.1	19.3	13.7	17.0	22.3	20.3	17.0	22.8	20.7	17.0	12.0	18.9	20.9	21.4	36.5	19.2	21.0	19.9	23.2	15.7	28.0	31.4	23.2	45.4	28.9	30.8	26.0	20.8	26.7	16.4
TMEM245	"C9orf5, CG-2"	ENSG00000106771	"Transmembrane protein 245"	Q9H330	9	109015152-109119945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023892	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023892: AB_1845828"	"unprognostic (1.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (4.46e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-2)"	16.5	35.5	14.4	7.2	18.1	4.0	24.2	15.7	20.6	14.0	19.2	14.7	22.0	7.7	18.4	17.3	14.6	18.7	15.3	25.2	12.6	14.9	29.0	16.2	20.5	12.3	14.5	14.8	29.0	20.3	43.2	14.9	17.5	13.7	16.4	10.7	22.1	14.5	22.3	29.8	9.2	16.8	23.1	13.6	10.4	17.2	12.2	14.3	12.3	52.1	8.9	7.5	20.8	11.2	3.5	3.5	6.3	3.3	5.4	9.0	2.7	13.5	18.1	13.4	4.5	31.6	18.2	29.6	19.6	15.2	21.2	16.8	24.3	27.3	12.3	20.2	14.9	21.5	17.0	12.6	25.1	15.9	7.3	15.2	15.1	14.3	13.8	11.5	12.0	19.4	12.9	20.6	19.1	17.7	10.1	13.6	24.0	8.9	15.3	5.3	14.9	16.4	8.8	26.6	7.6	22.6	13.3	7.4	7.3	13.0	13.0	13.0	17.3	6.5	19.4	16.5	12.4	15.4	22.3	9.1	23.4	3.9	23.0	6.2	23.9	6.3	2.6	2.2	4.0	1.8	4.9	2.7	6.8	5.6	2.5	3.5	9.0	6.2	1.0	5.4	3.3	3.5	6.5	2.7	14.4	18.1	15.7	20.6	12.6	14.9	14.5	14.8	13.7	14.3
TMEM258	C11orf10	ENSG00000134825	"Transmembrane protein 258"	P61165	11	61768501-61792802	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044602	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA044602: AB_10961423"	"unprognostic (6.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.48e-2)"	"prognostic favourable (4.37e-4)"	"unprognostic (1.34e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.58e-1)"	15.3	23.1	18.9	16.5	22.5	23.9	31.0	16.2	25.2	28.2	21.6	19.7	34.6	17.7	21.2	81.8	18.1	26.7	22.4	36.6	19.5	15.8	19.0	32.0	33.2	35.9	24.7	19.0	32.2	117.2	6.8	29.1	19.8	18.8	20.0	24.5	13.3	54.0	31.0	22.2	14.0	16.1	18.4	20.1	19.7	21.2	19.9	19.4	17.3	25.3	24.8	22.9	15.7	19.1	53.3	107.7	87.4	51.7	31.0	51.4	50.2	24.0	41.7	36.3	28.8	56.5	55.1	20.2	19.3	31.8	19.2	22.3	35.9	43.5	17.1	36.8	45.4	26.0	31.4	37.1	25.4	25.1	28.0	14.4	45.7	55.2	53.4	30.0	16.8	46.6	57.4	23.7	62.5	35.4	35.4	65.8	31.1	80.0	21.1	52.4	45.1	28.6	23.6	24.4	109.4	39.8	39.5	28.7	30.1	17.3	36.9	34.1	40.9	60.2	17.5	22.0	19.9	28.3	13.7	42.9	33.8	28.3	31.1	18.4	22.8	87.4	51.7	59.1	40.6	43.7	49.7	53.3	48.3	45.1	42.6	42.3	41.6	41.1	39.8	31.0	42.2	107.7	51.4	50.2	18.9	22.5	16.2	25.2	19.5	15.8	24.7	19.0	18.8	19.4
TMEM260	"C14orf101, FLJ20392"	ENSG00000070269	"Transmembrane protein 260"	Q9NX78	14	56488354-56650606	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 61.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003502	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA003502: AB_1078314"	"unprognostic (4.63e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (7.11e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.81e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-2)"	7.8	7.4	7.3	11.0	10.6	3.8	9.1	13.3	9.9	61.0	8.8	13.7	11.6	8.1	11.8	12.1	6.7	11.4	10.3	6.0	8.9	8.6	10.7	8.7	8.4	8.8	10.8	7.5	14.8	13.6	12.4	17.2	8.7	9.7	8.7	9.1	8.7	7.4	13.0	5.2	8.6	10.7	8.9	12.2	9.2	8.4	10.1	8.3	17.6	12.6	4.6	8.8	10.1	9.7	2.0	4.6	2.9	2.8	6.3	3.5	2.0	7.3	5.2	4.0	8.5	14.3	11.8	7.9	7.9	8.8	5.2	6.2	2.4	5.5	6.0	7.8	5.9	8.6	9.3	5.7	8.2	7.4	4.7	3.9	2.4	3.2	10.1	5.4	9.3	14.5	10.4	2.9	10.1	6.8	4.7	6.5	6.8	4.9	2.8	2.0	3.7	8.3	4.0	6.4	2.0	8.8	11.0	8.5	4.2	8.9	6.4	5.2	8.2	8.4	9.5	10.6	4.0	7.9	3.9	3.9	3.1	3.5	6.6	4.0	5.2	0.0	2.8	2.9	3.5	1.9	2.4	1.8	2.4	1.8	2.2	2.0	3.2	2.3	1.4	6.3	1.7	4.6	2.9	2.0	7.3	10.6	13.3	9.9	8.9	8.6	10.8	7.5	9.7	8.3
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059837-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 50.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.9;HEK 293: 3.6;NTERA-2: 3.6;U-937: 3.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	12	"cerebellum: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	6	"cerebellum: 65.8"	"Region enriched"	"Detected in all"	6	"cerebellum: 66.4"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: "	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.1	1.9	1.1	0.2	1.9	0.2	0.4	50.7	4.2	0.2	0.2	0.6	0.0	0.3	0.2	0.1	0.3	0.3	0.1	0.1	0.9	1.3	0.9	0.1	1.1	0.3	0.7	0.3	0.1	2.4	0.2	5.1	2.4	1.9	0.4	0.2	1.1	0.2	0.1	10.6	1.5	0.1	0.1	0.4	0.6	0.3	1.4	0.0	0.0	0.2	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.8	0.8	0.0	1.9	3.6	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	50.7	4.2	0.9	1.3	0.7	0.3	1.9	0.0
TMEM268	"C9orf91, DKFZp547P234, FLJ38045"	ENSG00000157693	"Transmembrane protein 268"	Q5VZI3	9	114611206-114646422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017199	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA017199: AB_1845845"	"unprognostic (8.57e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.33e-2)"	"prognostic favourable (3.61e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	9.1	9.0	9.6	8.5	15.8	3.8	9.7	4.4	31.0	7.3	6.6	5.1	3.4	4.3	7.7	7.6	4.8	5.7	4.8	3.7	12.5	9.1	3.8	6.3	6.6	10.6	8.5	15.3	10.2	5.6	15.1	4.6	5.9	8.7	15.9	6.8	11.1	8.9	9.1	5.0	4.3	6.4	8.8	7.7	15.5	7.5	4.8	5.0	10.3	7.9	2.0	11.4	7.8	5.4	4.3	8.4	2.3	2.5	1.5	1.9	0.9	2.5	4.6	2.2	4.6	6.2	4.6	1.7	2.5	4.5	3.5	3.6	3.4	1.0	11.5	2.2	2.9	4.5	4.3	2.1	3.0	5.8	2.9	3.6	3.4	2.1	10.7	7.4	1.7	4.0	3.7	4.9	5.2	2.3	7.1	30.1	2.5	7.7	8.7	2.2	5.7	4.5	9.9	2.5	9.7	2.0	2.1	7.5	4.7	8.5	11.1	22.8	14.8	6.9	1.3	3.4	4.1	1.4	4.6	16.7	15.6	12.4	1.9	6.3	6.4	0.5	2.5	0.5	1.3	2.1	0.5	2.3	1.3	0.7	1.4	4.3	1.9	1.5	2.3	1.5	1.8	8.4	0.2	0.9	9.6	15.8	4.4	31.0	12.5	9.1	8.5	15.3	8.7	5.0
TMEM35A	"FLJ14084, TMEM35"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078720-101096364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;seminal vesicle: 46.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.3;HUVEC TERT2: 31.7;SH-SY5Y: 8.1"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced		Supported	"Vesicles,Focal adhesion sites,Cytosol"				Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: "	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.6	6.7	12.8	1.7	28.2	0.7	1.3	21.2	28.6	3.3	17.3	2.5	6.8	3.5	7.4	3.9	10.4	4.3	3.6	1.1	14.4	33.8	1.1	0.7	2.6	0.8	12.2	10.0	7.7	0.9	6.1	1.5	0.8	30.0	20.5	9.1	2.9	1.0	46.4	1.3	0.9	4.1	11.8	3.9	1.3	3.4	1.8	2.3	0.0	1.3	0.0	0.9	13.3	2.7	0.2	0.0	0.2	0.1	0.6	0.8	0.4	0.0	0.0	3.3	0.0	2.4	6.3	0.0	0.6	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.0	2.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.1	0.0	1.1	0.0	31.7	0.0	0.0	4.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	1.4	8.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.4	0.2	0.6	0.1	0.0	0.8	0.4	12.8	28.2	21.2	28.6	14.4	33.8	12.2	10.0	30.0	2.3
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438520	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 110.5;kidney: 82.5"	"Group enriched"	"Detected in some"	5	"EFO-21: 13.1;Hep G2: 34.4;RPTEC TERT1: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.8;naive CD4 T-cell: 3.3"	"Group enriched"	"Detected in many"	31	"monocytes: 2.8;T-cells: 3.3"	"Low region specificity"	"Detected in many"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA053794: "	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	18.5	5.2	0.6	5.9	1.0	0.0	10.0	0.5	1.2	6.7	60.3	1.8	3.8	16.2	3.1	3.8	2.8	1.4	18.5	5.7	1.0	0.4	82.5	40.8	9.5	8.7	0.9	0.7	5.9	5.8	20.1	0.7	13.4	1.3	4.5	5.6	6.3	2.8	6.5	1.6	4.4	110.5	1.9	1.4	11.5	6.6	6.4	0.7	1.2	21.0	1.6	2.2	3.4	2.4	0.0	0.0	0.0	2.8	0.0	3.3	0.6	0.0	3.4	0.3	0.1	2.1	0.2	0.5	0.1	0.0	0.0	0.0	5.3	3.0	0.0	13.1	1.6	0.8	1.4	0.0	0.0	0.0	1.3	0.4	2.0	34.4	2.9	0.0	0.0	4.8	0.0	0.0	0.0	2.8	0.1	5.2	0.0	0.3	0.0	0.3	2.5	0.1	0.0	0.0	4.5	28.8	2.3	0.4	0.2	0.1	1.4	0.0	0.6	0.8	1.8	0.0	5.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.6	1.0	0.5	1.2	1.0	0.4	0.9	0.7	1.3	0.7
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733525-12769457	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 72.0;hTCEpi: 16.2;hTERT-HME1: 20.5;RT4: 10.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044165	Enhanced		Approved	Cytosol			7000000	Cytosol		"HPA044165: AB_10961279"	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.0	0.0	0.0	0.0	0.2	1.4	1.8	0.0	0.0	11.7	0.0	0.0	0.4	0.0	0.9	0.6	62.9	1.6	0.1	1.6	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	53.6	0.1	2.3	0.0	0.0	6.6	1.4	0.4	24.0	0.0	0.7	0.0	1.1	0.0	0.4	0.0	0.4	0.0	40.5	41.8	10.6	18.6	0.0	0.5	4.5	0.6	0.0	0.3	21.1	7.2	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.3	0.4	0.2	1.1	0.0	0.0	0.0	2.1	0.0	72.0	1.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	16.2	0.0	20.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.4	10.1	0.0	0.0	0.0	9.0	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.0	0.0	0.5	0.0	21.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 54.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059101: , HPA059790: "	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavourable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	8.1	23.9	7.8	4.8	10.2	9.3	10.1	4.9	11.5	10.6	26.8	11.7	6.3	24.5	9.1	11.1	20.6	9.0	8.6	8.3	7.5	8.4	15.8	26.1	11.3	9.0	8.1	5.4	14.2	10.7	6.7	5.7	9.0	8.6	10.1	8.6	11.9	11.2	9.4	8.3	16.6	54.4	8.0	8.7	12.4	8.7	11.2	7.4	11.3	9.0	18.1	16.7	8.8	12.5	12.8	16.4	7.8	8.4	8.5	16.7	6.5	20.6	7.5	5.0	6.2	8.0	8.6	14.8	8.0	7.0	10.1	7.4	19.5	8.2	6.4	15.3	7.4	14.4	13.8	8.5	10.2	10.7	12.7	11.1	4.5	19.6	8.9	12.0	6.3	8.0	12.8	9.1	10.5	7.7	19.7	16.0	6.4	8.0	7.3	6.9	8.3	11.9	7.4	7.7	11.7	8.7	15.2	5.1	6.5	6.9	17.7	12.1	21.1	9.4	5.6	6.0	7.5	12.5	16.6	23.7	36.0	12.9	9.1	7.2	7.2	7.8	6.3	5.1	13.2	6.6	16.7	12.8	13.6	14.3	7.0	12.4	15.0	16.1	2.4	8.5	8.4	16.4	11.1	6.5	7.8	10.2	4.9	11.5	7.5	8.4	8.1	5.4	8.6	7.4
TMEM44	DKFZp686O18124	ENSG00000145014	"Transmembrane protein 44"	Q2T9K0	3	194587673-194633689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 3.2;NK-cell: 11.5"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.2;NK-cells: 11.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043718	Uncertain		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA043718: AB_10794662"	"unprognostic (8.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.31e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.78e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavourable (6.55e-13)"	"unprognostic (1.23e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.66e-2)"	13.2	2.8	4.8	6.2	11.8	10.6	21.2	1.9	7.3	6.6	11.8	2.4	9.2	4.6	6.8	22.9	5.1	4.9	7.9	5.9	6.1	6.3	5.6	3.6	15.1	6.3	5.2	7.8	5.1	3.3	1.3	2.3	12.0	6.7	4.8	11.9	3.3	7.0	5.8	6.7	3.4	6.0	5.6	3.7	9.0	6.7	4.1	3.3	4.1	5.3	5.5	3.7	5.0	6.7	0.3	0.6	3.2	0.4	11.5	0.8	0.0	6.3	5.2	7.9	8.4	3.0	10.0	7.0	5.0	9.3	4.1	6.6	2.9	12.7	1.1	23.5	5.8	7.4	2.6	3.8	2.7	10.6	3.8	7.2	5.4	2.1	5.4	2.2	11.4	6.4	4.2	9.4	4.1	16.8	2.0	0.3	13.4	5.9	3.3	5.7	4.1	8.5	6.4	5.0	0.2	4.3	3.6	2.2	4.8	3.5	1.1	7.3	5.3	4.8	19.9	12.4	4.6	3.8	6.4	0.9	0.7	2.2	18.7	8.7	6.2	3.2	0.3	0.3	0.5	0.2	0.1	0.2	0.2	0.8	0.0	0.3	0.1	0.3	0.8	11.5	0.4	0.6	0.0	0.0	4.8	11.8	1.9	7.3	6.1	6.3	5.2	7.8	6.7	3.3
TMEM50A	SMP1	ENSG00000183726	"Transmembrane protein 50A"	O95807	1	25337917-25362361	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065192			Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA065192: "	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-3)"	"prognostic favourable (8.64e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (3.34e-4)"	"unprognostic (7.39e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.39e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-3)"	"unprognostic (3.44e-2)"	36.2	45.6	29.2	23.2	39.1	19.4	43.4	30.5	29.4	29.7	32.7	21.5	25.6	26.5	29.4	31.5	36.7	23.5	30.9	32.6	30.9	23.6	39.1	31.8	34.2	36.3	29.3	18.5	22.6	29.7	21.7	13.6	40.4	19.9	32.8	38.6	19.1	56.5	33.0	21.5	25.7	39.6	27.8	38.1	39.4	26.5	17.5	20.4	32.7	39.2	29.6	28.1	37.1	31.0	13.0	14.0	56.5	26.8	19.2	25.0	23.1	8.4	9.6	16.1	8.3	30.3	27.3	5.7	17.0	27.3	32.4	36.4	7.7	21.1	9.7	9.6	60.6	12.2	12.6	13.9	35.4	25.5	18.1	20.7	10.5	11.8	22.4	15.8	16.8	29.8	20.5	24.0	13.9	23.3	13.8	15.3	30.6	5.9	10.3	19.3	18.9	7.9	9.1	17.7	17.2	32.6	6.2	13.5	8.6	17.6	12.4	13.6	6.4	10.4	34.4	18.1	7.6	29.6	7.0	10.7	11.6	9.0	23.6	23.7	10.0	56.5	19.1	26.3	24.0	23.0	25.0	13.0	21.1	24.4	14.0	10.1	15.5	21.1	39.7	19.2	26.8	13.0	23.4	23.1	29.2	39.1	30.5	29.4	30.9	23.6	29.3	18.5	19.9	20.4
TMEM51	"C1orf72, FLJ10199"	ENSG00000171729	"Transmembrane protein 51"	Q9NW97	1	15152532-15220480	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	23	"dendritic cells: 1.7;monocytes: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014547, HPA019441"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA014547: AB_1858121, HPA019441: AB_2670142"	"unprognostic (1.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (7.81e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.91e-2)"	"prognostic favourable (8.16e-8)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.67e-3)"	4.6	14.1	4.7	7.7	4.4	0.4	7.0	14.2	5.1	9.7	22.4	4.5	14.3	15.9	5.3	7.6	12.0	7.2	25.3	3.7	5.0	2.2	23.5	3.9	10.4	7.4	4.1	3.4	15.4	36.7	14.5	5.2	7.5	4.2	12.3	7.8	16.1	7.5	15.5	1.2	5.3	22.9	8.9	5.7	7.1	18.9	3.4	3.9	2.0	3.8	12.3	8.4	18.5	22.2	0.0	1.7	0.0	2.8	0.0	0.0	0.3	18.9	10.1	5.8	1.4	1.0	2.2	0.0	2.2	9.2	6.8	9.2	13.3	21.4	0.0	7.2	1.4	18.4	2.0	7.1	3.9	0.0	5.1	0.4	0.5	13.2	8.5	0.0	18.6	0.7	6.4	8.8	9.7	6.2	2.9	0.0	3.4	6.5	0.0	0.0	1.0	3.9	2.6	3.7	3.3	17.2	19.7	0.9	17.3	1.8	7.5	18.2	1.0	2.0	4.3	7.1	6.2	3.1	6.8	0.2	0.2	0.0	7.0	0.2	8.2	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	4.7	4.4	14.2	5.1	5.0	2.2	4.1	3.4	4.2	3.9
TMEM74	"FLJ30668, NET36"	ENSG00000164841	"Transmembrane protein 74"	Q96NL1	8	108606850-108787615	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.1;NTERA-2: 6.4;SCLC-21H: 14.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory B-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015672	Uncertain		Approved	Cytosol				Cytosol		"HPA015672: AB_1858132"	"unprognostic (8.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.75e-4)"	"unprognostic (8.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.46e-3)"	1.3	1.4	4.8	1.1	4.2	0.4	0.9	13.1	12.0	0.7	2.7	10.4	0.0	0.9	0.7	0.7	2.9	1.0	0.9	7.5	5.9	2.8	0.7	2.2	0.8	0.8	3.2	6.1	0.9	2.7	0.4	1.1	0.5	9.3	1.0	1.3	1.0	0.9	1.1	5.5	2.0	1.4	2.9	14.1	0.6	0.9	2.7	6.8	0.7	0.8	0.8	0.9	0.9	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.5	0.0	0.1	0.1	2.9	0.7	0.0	0.4	5.1	1.9	0.8	0.3	0.1	0.5	0.7	0.0	0.0	0.1	0.1	0.5	0.0	0.2	0.0	0.0	0.2	0.0	6.4	3.7	0.0	3.6	0.0	0.0	0.0	14.0	0.1	0.0	0.5	0.0	0.2	0.2	0.0	1.7	3.0	0.0	0.3	0.5	0.1	0.0	2.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.2	13.1	7.3	5.9	2.8	3.2	6.1	9.3	6.8
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742422-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 35.6;liver: 30.1"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 8.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA060282: "	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favourable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	7.5	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.7;brain: 11.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.3;EFO-21: 5.6;hTCEpi: 3.8;SH-SY5Y: 4.8"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	1.2	11.7	6.7	0.7	2.9	0.0	0.5	2.7	7.0	0.8	0.9	2.3	0.4	0.6	0.8	1.2	2.2	1.0	0.4	1.0	5.9	11.4	1.4	0.9	1.8	1.2	5.8	4.8	2.8	0.4	0.0	8.1	0.7	3.8	0.9	0.6	1.1	0.8	1.8	5.8	1.3	0.6	0.7	5.2	1.2	0.3	1.6	1.0	0.4	0.8	1.7	1.3	0.8	0.4	0.0	0.3	0.0	0.1	0.0	6.1	1.2	2.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	6.3	0.0	5.6	0.0	0.2	0.4	0.5	0.0	0.0	0.0	1.6	0.1	0.0	1.8	0.0	0.0	0.0	3.8	0.0	2.5	1.0	0.0	0.5	0.0	0.3	0.1	0.0	0.4	0.3	2.4	0.0	0.5	0.2	0.1	0.7	4.8	0.7	0.8	0.1	0.2	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.0	1.8	1.0	0.3	0.0	6.1	0.9	0.0	0.0	0.0	0.0	1.0	1.2	6.7	2.9	2.7	7.0	5.9	11.4	5.8	4.8	3.8	1.0
TMOD3	UTMOD	ENSG00000138594	"Tropomodulin 3"	Q9NYL9	15	51829628-51947295	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001849	Approved		Approved	"Actin filaments,Cytosol"			21000000	Cytosol	"Actin filaments"	"HPA001849: AB_1080313"	"unprognostic (6.31e-2)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (3.38e-5)"	"unprognostic (7.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.58e-3)"	23.0	9.6	7.3	14.2	9.7	7.7	14.1	7.5	7.7	16.4	16.0	4.6	32.4	13.3	13.4	11.8	53.1	12.0	12.0	10.5	7.7	6.3	16.6	14.6	25.4	10.3	8.1	4.2	12.7	9.3	8.0	9.2	20.2	8.5	11.0	13.9	6.9	20.8	21.4	5.9	15.4	21.7	11.1	8.7	20.5	14.4	6.6	8.0	19.6	11.4	21.9	22.7	16.5	27.2	14.4	17.6	28.3	21.9	10.7	15.1	9.4	23.1	23.3	9.4	2.4	9.3	15.7	10.7	10.8	14.8	11.3	10.2	9.0	17.6	5.6	8.8	11.5	34.1	8.6	24.3	14.5	9.4	3.8	8.4	25.7	7.2	10.4	10.7	9.2	10.5	23.7	9.1	28.3	19.9	8.8	8.7	13.6	17.2	7.1	7.2	5.2	3.8	8.5	11.1	14.6	18.4	16.0	2.3	6.1	18.0	12.1	6.4	8.2	8.6	21.7	14.5	9.6	11.7	12.5	5.2	15.2	6.3	9.3	19.6	8.5	22.7	17.7	24.0	14.8	20.9	13.1	12.0	12.8	12.9	12.4	14.4	11.1	10.3	28.3	10.7	21.9	17.6	15.1	9.4	7.3	9.7	7.5	7.7	7.7	6.3	8.1	4.2	8.5	8.0
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 44.9;HaCaT: 19.2;RPTEC TERT1: 31.5;RT4: 39.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.3	0.3	0.2	14.2	0.3	0.0	0.3	0.3	0.2	11.4	23.5	0.1	0.0	16.1	3.1	2.8	60.9	0.6	45.4	0.3	0.3	0.3	17.7	0.3	3.2	0.0	0.2	0.0	0.3	0.4	0.0	0.3	0.8	0.1	9.9	26.2	0.2	4.0	0.0	0.3	2.4	27.4	4.2	0.2	0.3	13.7	0.7	0.0	0.6	0.3	13.7	41.0	43.9	22.3	0.5	0.1	4.5	0.7	0.2	0.1	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	44.9	0.0	1.7	0.0	19.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.0	31.5	39.3	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.9	0.2	0.7	0.1	0.1	0.0	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.0
TMSB4X	"TB4X, TMSB4"	ENSG00000205542	"Thymosin beta 4, X-linked"	P62328	X	12975108-12977227	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 1074.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB033806	Approved		Approved	Nucleoplasm,Vesicles,Cytosol			400000000	"Nucleoplasm, Vesicles, Cytosol"		"CAB033806: AB_2256019"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (6.20e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	122.3	97.5	79.8	105.4	76.4	169.0	87.1	33.2	74.8	92.3	93.3	62.0	59.7	38.5	83.7	67.2	62.7	53.0	92.5	54.9	90.8	67.8	69.6	50.8	134.4	205.2	111.4	84.0	61.9	51.0	4.4	23.4	53.4	74.3	46.6	86.6	31.2	42.3	100.4	28.9	39.6	71.5	75.1	195.6	205.7	98.9	26.4	63.8	96.8	34.4	48.6	154.5	112.2	62.1	296.5	495.3	775.0	554.0	272.7	521.9	1074.5	141.5	118.6	233.1	367.2	285.8	313.3	0.5	75.1	196.5	58.3	100.5	24.4	119.2	33.9	72.6	227.8	62.4	34.5	50.3	78.5	198.2	1.9	42.2	70.3	0.3	66.6	164.9	350.9	145.8	72.2	69.0	60.4	350.3	5.3	0.5	206.3	50.4	196.0	357.9	83.8	81.8	151.1	82.5	138.5	347.1	41.5	24.8	10.5	108.8	5.1	13.8	136.7	167.5	281.7	85.2	42.2	482.6	74.5	110.6	80.3	65.8	130.3	68.4	61.3	544.9	512.5	775.0	364.8	524.7	309.6	296.5	407.3	391.0	495.3	275.6	345.8	349.0	576.0	272.7	554.0	204.1	521.9	1074.5	79.8	76.4	33.2	74.8	90.8	67.8	111.4	84.0	74.3	63.8
TMTC1	"ARG99, FLJ31400, FLJ41625, OLF"	ENSG00000133687	"Transmembrane and tetratricopeptide repeat containing 1"	Q8IUR5	12	29500840-29784759	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 28.6;HSkMC: 19.4;hTERT-HME1: 35.0;LHCN-M2: 19.5;RH-30: 40.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 2.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016720	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA016720: AB_1858155"	"unprognostic (1.67e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (1.63e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (5.49e-4)"	"unprognostic (5.89e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.51e-3)"	29.3	12.8	12.9	4.6	30.8	0.5	25.8	2.2	9.0	11.4	8.4	2.9	4.3	3.0	7.4	2.9	6.1	12.6	6.2	15.7	15.2	8.1	13.1	2.4	6.7	2.4	5.4	7.8	8.7	2.9	10.0	18.7	2.7	9.1	6.4	5.4	7.1	3.7	8.3	13.7	2.9	4.6	12.7	4.9	34.1	7.4	2.8	6.2	0.8	3.7	4.4	2.0	8.9	10.5	0.1	0.1	0.4	2.3	0.1	0.1	0.3	0.0	0.0	5.1	0.0	16.3	10.9	0.0	5.3	10.9	1.4	1.1	0.0	0.0	0.0	2.7	3.3	0.0	0.1	0.1	0.0	0.1	1.5	0.0	15.3	0.2	28.6	0.6	0.0	19.4	1.9	13.5	35.0	0.7	0.0	0.7	19.5	0.0	0.0	0.0	3.9	7.0	0.0	40.9	0.7	0.0	0.1	0.4	0.4	0.6	0.0	1.3	0.0	0.2	2.1	1.3	0.8	0.7	4.2	7.1	0.0	0.0	9.3	0.0	0.1	0.2	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	2.3	0.1	0.0	0.3	12.9	30.8	2.2	7.6	15.2	8.1	5.4	7.8	9.1	6.2
TMUB1	"C7orf21, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081080-151083546	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	10.6	15.2	10.3	16.1	11.0	13.7	17.8	9.1	16.0	9.7	27.5	9.0	17.0	31.8	10.4	15.4	21.6	9.6	18.0	17.3	10.6	9.6	25.5	35.5	12.9	15.6	10.2	10.0	13.1	51.5	9.5	21.1	18.9	8.3	16.1	6.0	12.7	29.6	12.9	33.8	15.1	39.2	12.8	8.7	16.1	24.0	11.5	8.5	23.9	23.6	12.9	19.1	18.7	11.8	8.0	4.2	18.2	3.6	3.1	9.5	1.8	24.1	21.8	5.1	26.5	3.4	4.2	19.3	9.9	8.3	8.8	9.9	18.8	29.5	16.2	21.3	4.8	16.5	5.7	8.7	1.9	29.6	20.2	6.9	20.2	28.4	8.6	8.5	24.5	6.4	7.3	7.4	2.0	6.5	43.0	22.1	3.9	39.0	28.3	36.7	22.0	13.2	17.7	6.5	29.9	9.1	18.8	18.9	21.0	8.0	12.4	12.9	9.7	11.9	7.9	11.3	8.2	14.1	16.3	34.9	19.1	11.1	26.0	16.0	14.2	3.5	2.7	18.2	5.4	3.6	4.7	4.4	8.0	5.8	2.8	8.0	7.8	4.5	4.7	3.1	2.2	4.2	9.5	1.8	10.3	11.0	9.1	16.0	10.6	9.6	10.2	10.0	8.3	8.5
TMUB2	MGC3123	ENSG00000168591	"Transmembrane and ubiquitin like domain containing 2"	Q71RG4	17	44186970-44191731	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043137	Approved		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA043137: AB_10794388"	"unprognostic (4.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.78e-3)"	22.5	27.0	21.2	22.6	26.7	39.9	37.6	32.4	39.0	27.3	24.0	25.9	30.5	25.2	27.4	26.4	31.0	24.2	26.6	21.2	21.2	20.4	28.9	29.4	22.9	24.7	19.9	23.1	27.9	33.5	30.7	25.2	38.9	21.0	30.3	23.6	23.3	30.7	34.1	22.9	29.0	29.6	23.4	18.8	40.0	25.8	46.0	19.6	21.1	34.6	20.9	23.1	26.0	25.0	10.0	10.2	29.9	13.3	5.5	8.1	8.2	11.3	22.5	14.3	13.3	22.6	18.0	11.3	15.1	16.4	28.2	28.9	11.6	21.4	7.9	16.4	18.7	21.8	10.1	14.3	17.8	19.4	20.9	8.2	20.4	17.7	23.5	9.2	18.6	21.7	21.0	19.2	12.0	19.7	9.4	23.8	18.4	8.1	12.8	12.4	4.7	19.0	11.7	17.4	12.8	17.9	12.9	11.5	11.7	7.9	7.5	14.9	21.9	12.0	16.2	23.6	14.5	16.5	13.4	17.5	12.7	7.7	18.1	7.9	15.9	29.9	13.3	24.1	8.1	11.7	6.8	7.7	6.7	7.7	8.5	10.0	6.5	7.3	29.3	5.5	11.7	10.2	7.6	8.2	21.2	26.7	32.4	39.0	21.2	20.4	19.9	23.1	21.0	19.6
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712600-57740973	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: "	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (3.64e-4)"	"prognostic unfavourable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favourable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavourable (3.37e-4)"	29.5	40.5	33.6	21.0	39.0	13.7	30.8	26.5	60.5	28.0	40.6	50.7	29.0	33.3	22.5	36.7	32.7	25.5	20.0	33.0	32.6	32.1	47.4	71.7	24.4	22.1	40.4	30.4	25.9	40.6	49.8	25.8	26.2	45.3	31.1	49.3	38.4	27.9	34.4	21.9	21.9	34.0	26.1	42.3	25.4	29.9	19.1	31.3	24.0	34.4	25.8	27.0	22.2	22.6	17.7	23.1	17.9	37.5	16.5	21.8	18.8	28.8	33.9	19.5	35.0	36.4	19.5	21.4	34.9	27.1	34.4	29.2	32.2	49.8	27.1	39.0	28.0	53.4	49.4	27.9	36.5	19.4	21.5	26.1	27.4	32.2	30.1	36.5	36.1	23.9	40.9	38.0	60.6	19.5	44.9	32.0	38.3	14.8	21.5	41.6	37.8	46.5	29.3	24.5	57.4	42.8	32.6	22.3	31.9	26.8	62.6	38.7	55.9	24.2	16.3	32.5	21.2	43.2	36.0	31.5	61.5	27.4	36.5	26.0	48.1	15.9	19.6	17.9	17.1	33.1	21.6	17.7	17.3	20.0	19.0	15.3	21.8	21.8	5.2	16.5	37.5	23.1	14.3	18.8	33.6	39.0	26.5	60.5	32.6	32.1	40.4	30.4	45.3	31.3
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103123442-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RT4: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 25.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: "	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (4.10e-4)"	"prognostic favourable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favourable (7.17e-5)"	27.3	17.0	3.8	58.2	5.7	20.1	19.3	2.5	3.6	23.5	12.9	2.8	4.7	8.1	16.7	18.7	35.5	14.3	30.9	12.7	2.9	3.6	18.8	13.6	32.0	17.9	4.6	3.0	9.7	9.0	17.4	3.5	33.0	6.1	21.7	6.1	16.3	25.1	7.1	12.5	13.2	11.3	28.0	3.8	35.9	8.3	13.0	2.9	11.0	8.5	31.4	48.6	39.8	16.3	0.1	5.0	25.9	9.8	0.1	0.1	1.9	5.4	26.9	0.1	0.1	1.7	7.7	9.0	1.6	6.9	4.3	1.5	0.2	24.4	0.0	20.1	7.8	17.4	1.9	0.0	2.1	0.9	0.1	2.4	18.8	0.1	3.3	1.2	3.4	2.9	0.2	1.4	0.0	2.2	2.4	5.9	0.6	0.5	0.0	1.9	1.6	2.2	1.0	3.1	3.9	13.8	126.5	0.2	0.3	24.7	8.6	0.3	13.9	8.0	4.6	0.9	2.3	5.0	5.0	5.3	0.3	0.1	6.5	5.5	2.6	2.5	8.8	4.6	0.0	9.8	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	25.9	0.1	6.9	0.2	0.0	1.9	3.8	5.7	2.5	3.6	2.9	3.6	4.6	3.0	6.1	2.9
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.0;smooth muscle: 47.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 12.6;ASC TERT1: 32.2;HUVEC TERT2: 27.5;LHCN-M2: 25.8;TIME: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA077484: "	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (3.51e-4)"	4.6	2.4	11.8	4.1	3.8	0.8	10.5	0.6	5.8	9.8	4.1	1.8	2.8	1.2	47.0	9.9	11.5	20.9	3.7	5.5	11.4	3.1	1.9	1.5	6.6	5.4	1.9	5.6	17.5	1.6	0.6	1.8	1.4	3.3	6.6	5.0	0.6	1.9	3.5	2.1	10.7	3.2	47.0	1.5	14.7	2.9	3.4	1.1	0.0	2.5	4.7	2.4	12.3	18.8	1.4	1.0	3.7	1.5	1.7	0.8	0.3	0.0	0.1	0.0	0.0	12.6	32.2	0.1	0.1	0.0	0.3	0.5	0.0	0.3	0.0	0.6	1.7	0.0	0.4	0.3	0.1	0.0	0.3	0.0	0.9	2.0	3.3	0.1	0.7	11.8	2.5	2.4	9.3	27.5	0.0	0.0	25.8	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	36.8	2.9	0.2	9.4	0.7	0.1	0.0	0.0	6.0	0.0	0.0	2.8	1.5	0.7	0.5	0.7	0.6	0.8	0.6	0.5	0.3	1.4	0.6	0.8	3.7	1.7	1.0	1.0	0.4	0.3	11.8	3.8	0.6	5.8	11.4	3.1	1.9	5.6	3.3	1.1
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391292	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 51.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: "	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	6.5	1.7	1.7	4.8	1.2	0.2	4.3	0.4	2.3	1.5	18.4	0.8	7.6	23.1	0.9	1.9	3.8	1.3	28.7	1.1	1.3	0.7	0.9	0.8	2.3	7.4	1.0	1.0	0.7	2.9	0.1	10.1	2.8	0.7	2.1	13.9	1.3	34.3	12.9	0.6	3.3	23.9	1.3	2.9	1.2	4.3	1.2	0.8	0.7	2.0	1.8	2.3	2.3	2.3	0.0	0.6	0.2	0.0	8.9	1.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.0	1.5	0.1	0.9	3.5	0.3	0.1	51.3	2.3	0.0	0.5	0.7	0.0	0.2	0.5	0.1	0.1	0.3	1.3	1.3	0.0	0.0	0.0	0.4	0.0	0.0	2.5	8.1	0.1	0.0	0.2	0.6	0.6	8.7	0.3	0.2	1.3	0.0	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	8.9	0.0	0.6	1.0	0.0	1.7	1.2	0.4	2.3	1.3	0.7	1.0	1.0	0.7	0.8
TNFRSF12A	"CD266, FN14, TweakR"	ENSG00000006327	"TNF receptor superfamily member 12A"	Q9NP84	16	3018445-3022383	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 25.0"	"Group enriched"	"Detected in many"	8	"eosinophil: 38.1;neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA007853	Approved		Approved	"Plasma membrane,Cytosol"			170000	"Plasma membrane, Cytosol"		"HPA007853: AB_1858463"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.06e-3)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (7.04e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (2.98e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.17e-2)"	10.8	14.2	2.4	11.3	5.1	2.7	21.2	0.9	3.0	8.0	18.9	3.2	4.1	14.5	11.6	10.2	10.7	6.4	28.1	27.0	5.0	2.6	50.4	36.2	23.0	2.6	4.8	0.5	6.4	47.0	51.1	20.0	81.3	25.0	11.1	1.9	2.8	17.3	6.9	23.3	5.0	31.0	16.8	4.3	3.9	13.2	5.3	3.3	1.2	11.5	11.5	4.7	14.8	5.2	0.0	4.1	38.1	3.5	2.0	2.4	1.1	24.3	19.8	2.2	4.1	4.0	9.2	13.1	51.3	37.2	44.0	28.3	8.5	43.5	0.1	68.0	34.1	27.0	0.5	37.5	16.9	0.9	1.3	0.1	6.6	7.2	27.8	0.4	1.8	8.5	26.0	46.2	55.4	12.7	2.7	0.3	46.3	46.0	0.0	3.2	10.7	43.4	0.2	24.7	1.0	44.5	4.8	2.5	0.8	36.6	17.0	30.3	8.9	0.7	22.3	79.3	36.6	52.4	84.2	0.8	0.3	0.3	24.7	2.2	62.3	3.5	3.5	38.1	1.8	2.0	2.4	0.0	0.8	1.5	4.1	0.0	0.4	0.8	29.9	2.0	1.3	0.1	1.0	1.1	2.4	5.1	0.9	3.0	5.0	2.6	4.8	0.5	25.0	3.3
TNFRSF14	"ATAR, CD270, HVEA, HVEM, LIGHTR, TR2"	ENSG00000157873	"TNF receptor superfamily member 14"	Q92956	1	2555639-2565382	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.3;HDLM-2: 14.4;HHSteC: 16.9;Karpas-707: 13.3;SK-MEL-30: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA006404, CAB026150, CAB030007"	Approved		Approved	"Cytosol,Rods & Rings"				Cytosol	"Rods & Rings"	"CAB026150: , CAB030007: AB_2303380, HPA006404: AB_1851348"	"prognostic favourable (4.39e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"prognostic favourable (8.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (6.83e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	"prognostic favourable (7.79e-6)"	15.9	24.9	4.9	38.9	2.8	11.0	21.9	2.0	4.5	16.8	36.3	3.2	18.5	36.3	15.2	20.5	13.7	12.3	36.7	12.7	4.9	2.5	19.3	20.5	30.3	33.2	3.6	5.7	12.8	7.3	3.5	9.3	8.3	3.9	21.5	8.2	44.1	20.9	22.6	5.2	8.4	41.9	14.6	4.1	36.7	16.7	5.9	2.7	23.5	10.8	10.6	25.0	15.4	17.2	18.2	9.7	30.2	25.8	8.1	25.1	14.2	1.3	0.1	0.1	2.3	5.0	2.7	0.7	0.7	2.3	1.3	1.9	0.2	14.3	0.8	0.1	2.1	1.3	0.0	0.8	0.2	14.4	0.0	8.4	0.4	2.6	16.9	1.1	10.4	2.6	1.4	0.7	0.1	3.7	1.1	13.3	1.2	0.0	4.6	1.3	0.0	1.2	3.8	0.0	4.1	0.2	2.0	0.4	0.0	0.5	0.1	27.9	0.4	0.3	9.4	0.2	0.6	0.2	0.1	10.8	2.6	0.4	2.3	1.2	1.0	3.0	15.1	8.2	17.2	25.8	14.9	16.6	18.0	14.8	9.7	18.2	17.3	14.9	30.2	8.1	24.1	8.7	25.1	14.2	4.9	2.8	2.0	4.5	4.9	2.5	3.6	5.7	3.9	2.7
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.4"	"Cell line enhanced"	"Detected in many"		"RT4: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	35	"plasmacytoid DC: 31.6"	"Lineage enriched"	"Detected in single"	309	"dendritic cells: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"			1300000	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favourable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	25.9	3.7	9.7	8.7	13.6	5.9	7.8	7.4	20.8	9.6	19.3	26.9	1.0	6.4	9.1	3.0	21.8	9.9	18.7	4.1	13.8	16.0	26.2	4.6	9.5	11.5	26.8	7.9	5.0	17.9	35.6	4.4	17.0	29.5	10.2	18.5	3.0	15.2	2.4	3.5	2.7	10.2	8.2	63.4	11.6	30.4	5.8	10.1	11.5	2.9	19.2	16.5	41.2	11.6	0.0	31.6	0.1	0.0	0.0	0.0	0.2	29.9	9.7	9.5	3.0	26.1	7.7	10.8	3.5	6.9	1.1	0.4	16.8	21.2	2.2	14.2	2.5	18.1	1.4	12.9	0.6	0.0	2.9	0.0	1.2	16.9	15.3	0.4	0.1	13.7	15.5	0.6	11.8	5.1	0.7	0.0	0.3	5.9	2.6	0.2	7.4	10.1	5.6	2.9	3.2	18.1	102.3	6.8	1.5	3.0	2.8	2.4	2.2	2.1	1.0	2.8	2.6	0.1	3.2	0.0	0.0	3.1	4.7	2.1	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.2	9.7	13.6	7.4	20.8	13.8	16.0	26.8	7.9	29.5	10.1
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784635-114806126	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;kidney: 16.2;salivary gland: 28.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.5;hTEC/SVTERT24-B: 7.6;HUVEC TERT2: 14.5;RT4: 14.2;TIME: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	1112540		"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: "	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	1.2	1.3	0.3	3.1	0.5	0.0	0.7	0.2	0.9	1.9	7.3	0.1	1.3	10.8	0.9	1.3	2.8	0.8	2.0	0.3	1.7	0.3	16.2	0.5	5.2	0.5	0.4	0.1	0.7	1.4	0.2	0.5	6.0	0.7	9.8	2.2	0.6	28.7	4.4	0.3	0.6	15.0	2.0	0.4	1.5	3.0	0.6	0.1	0.9	1.3	1.8	2.4	6.4	1.6	0.3	2.8	1.2	1.8	0.3	0.1	0.4	0.4	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.2	2.7	1.4	0.0	0.0	11.5	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	7.6	0.0	14.5	0.0	0.8	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0	0.0	0.7	0.0	1.1	0.0	6.6	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.8	0.1	0.1	1.8	0.0	0.3	0.1	0.0	2.8	0.3	0.1	0.1	1.2	0.3	0.2	1.5	0.0	0.4	0.3	0.5	0.2	0.9	1.7	0.3	0.4	0.1	0.7	0.1
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171061339-171460408	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9"	"Cell line enhanced"	"Detected in many"		"AF22: 19.6;HEL: 26.6;HMC-1: 30.3;HUVEC TERT2: 19.5;WM-115: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3"	"Group enriched"	"Detected in many"	29	"granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol			9100	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	2.2	5.4	29.0	7.4	30.9	4.9	3.6	21.1	26.1	1.9	10.9	12.2	4.1	25.8	4.3	2.1	5.6	4.3	7.1	11.2	30.9	14.8	5.6	4.6	11.3	7.9	11.4	18.3	2.6	5.2	0.7	9.0	3.1	13.6	5.6	9.5	3.5	2.9	7.3	23.2	1.6	25.6	6.0	14.5	5.8	9.2	10.7	21.1	3.7	7.1	2.2	6.9	6.4	2.6	0.2	0.0	10.5	0.1	2.7	6.7	1.1	0.3	0.5	19.6	2.0	0.3	0.0	4.6	4.1	1.1	3.2	2.2	17.5	7.3	0.0	1.4	3.7	6.0	2.8	1.1	3.5	0.1	4.3	26.6	1.5	0.0	9.4	5.2	30.3	2.8	2.9	1.9	0.4	19.5	9.6	0.0	0.5	0.4	1.6	6.7	8.0	7.6	0.0	5.0	7.0	6.3	0.0	0.9	1.0	2.5	0.2	4.3	8.8	1.3	0.2	0.0	3.4	8.9	3.0	0.0	0.0	0.0	0.9	5.9	22.7	4.4	0.1	10.5	4.2	0.0	5.2	0.0	5.0	3.7	0.0	0.2	6.7	3.8	0.1	2.7	0.1	0.0	5.3	1.1	29.0	30.9	21.1	22.2	30.9	14.8	11.4	18.3	13.6	21.1
TNIP1	"ABIN-1, KIAA0113, NAF1, VAN"	ENSG00000145901	"TNFAIP3 interacting protein 1"	Q15025	5	151029945-151093577	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037893, HPA037894, HPA071950"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: "	"prognostic favourable (5.69e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-1)"	"prognostic favourable (6.86e-5)"	"unprognostic (7.45e-3)"	"unprognostic (2.94e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.84e-2)"	49.8	16.8	8.9	32.2	10.7	35.8	68.8	10.1	11.4	16.5	38.8	10.2	22.9	23.8	13.6	21.2	28.9	11.2	33.2	30.1	8.9	8.7	27.8	34.3	29.0	35.1	11.2	7.2	14.6	42.2	16.4	9.5	15.7	10.6	18.5	17.4	13.9	18.2	27.6	61.7	19.5	37.2	21.0	10.7	39.5	20.6	9.9	10.9	21.0	19.6	27.7	41.9	20.6	35.0	10.9	7.7	26.0	7.4	7.0	12.5	5.3	23.7	17.0	3.2	11.7	12.6	12.9	8.6	11.5	36.9	10.4	19.6	16.1	32.6	19.9	39.0	15.4	14.5	5.3	84.8	12.7	34.0	7.4	7.9	9.5	10.4	24.4	8.9	36.3	18.4	15.7	17.2	35.7	14.7	4.9	19.8	25.7	8.8	9.7	12.3	2.9	9.4	8.0	25.1	26.4	32.3	17.5	4.6	10.8	8.9	27.9	11.8	14.3	11.2	22.6	35.1	11.6	6.1	16.3	39.9	20.5	8.9	38.0	13.2	8.4	9.7	7.4	20.4	7.8	6.8	9.1	8.4	9.0	7.7	5.6	10.9	4.7	5.1	26.0	7.0	6.1	7.7	12.5	5.3	8.9	10.7	10.1	11.4	8.9	8.7	11.2	7.2	10.6	10.9
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756376	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB020818: , HPA049886: , HPA063197: "	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favourable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	16.7	10.3	7.8	14.5	14.0	18.9	32.5	3.4	12.4	9.8	26.4	7.3	7.1	16.4	11.9	10.1	14.5	9.6	13.7	26.6	7.4	6.5	23.4	16.6	16.0	17.9	11.2	4.7	12.3	24.2	3.5	11.4	15.3	12.4	13.6	10.1	9.7	10.7	13.5	21.9	10.5	37.2	23.9	12.2	17.8	15.3	11.7	11.1	8.1	14.2	12.3	18.2	15.1	33.7	9.8	7.3	20.9	11.8	4.4	11.2	4.7	12.3	17.0	5.4	8.1	17.3	11.9	23.4	13.6	12.2	12.7	12.4	19.4	20.2	11.4	15.5	14.8	8.2	9.6	15.6	7.5	8.9	12.1	13.6	10.0	21.4	21.6	11.1	17.3	15.3	14.2	14.0	12.7	18.0	13.8	16.1	8.8	25.8	14.6	27.5	14.1	29.1	9.6	8.2	5.9	13.6	14.0	8.1	9.1	10.6	11.1	14.9	12.1	16.4	20.9	9.8	10.9	15.4	20.8	16.8	11.3	8.2	18.0	20.1	10.6	6.4	7.2	20.9	6.7	11.2	7.2	7.8	10.2	11.2	7.3	9.8	8.4	7.0	7.1	4.4	11.8	3.4	10.2	4.7	7.8	14.0	3.4	12.4	7.4	6.5	11.2	4.7	12.4	11.1
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	"Tyrosine kinase non receptor 2"	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041954	Approved		Approved	Cytosol				Cytosol		"HPA041954: AB_10794164"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-3)"	"prognostic unfavourable (8.96e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (6.82e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.00e-4)"	9.2	7.6	36.3	16.2	27.6	38.9	8.5	20.7	43.7	6.0	6.3	17.6	3.8	6.6	8.0	6.6	13.0	10.7	6.5	10.6	28.4	21.8	4.1	7.2	9.3	18.1	21.6	31.8	8.6	7.8	5.1	19.3	8.4	20.0	10.8	3.9	5.3	16.8	8.2	30.5	37.1	6.9	7.6	10.3	17.0	12.1	7.7	21.8	3.4	4.6	9.8	12.8	7.7	12.3	6.1	3.1	6.3	3.2	0.9	1.9	1.2	31.3	3.0	5.1	5.4	7.1	4.5	30.5	6.0	5.8	3.6	3.3	4.8	24.3	9.1	21.2	8.2	11.2	4.4	7.5	1.1	21.4	5.6	8.2	10.2	3.5	3.2	4.2	4.1	3.3	11.9	5.0	6.0	4.6	3.3	12.7	3.4	23.1	1.8	15.4	4.8	11.3	5.3	6.1	9.2	3.2	15.2	6.2	6.3	3.9	15.9	7.8	26.0	5.3	7.5	8.4	4.9	4.4	16.8	27.6	3.0	5.6	7.5	13.8	6.2	2.0	2.4	0.9	1.9	3.2	1.1	2.7	1.8	1.0	1.1	6.1	1.4	1.3	6.3	0.9	2.8	3.1	0.2	1.2	36.3	27.6	20.7	33.3	28.4	21.8	21.6	31.8	20.0	21.8
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	367	"heart muscle: 419.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 8.6;HMC-1: 14.4;K-562: 26.2;THP-1: 6.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 1.0"	"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol			1700000	Cytosol	Vesicles	"CAB009349: AB_793465, HPA046428: "	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	419.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.7	0.8	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.2	1.1	4.5	0.0	0.6	0.9	0.2	0.0	0.0	8.6	2.0	0.0	1.2	0.4	0.0	14.4	0.0	0.4	0.0	0.2	0.0	26.2	0.5	0.0	0.4	0.1	0.0	0.5	0.3	1.1	0.3	0.0	1.3	0.0	0.0	1.5	0.0	0.0	0.2	2.0	6.6	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132794-55149354	"Disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 1047.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 119.1;RH-30: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 53.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 53.3"	"Region enriched"	"Detected in many"	5	"thalamus: 136.6"	"Low region specificity"	"Detected in many"			"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: "	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavourable (4.66e-4)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	3.2	0.0	1.6	0.0	1.0	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.0	0.1	0.0	24.4	22.3	0.4	0.1	6.1	0.9	0.4	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	7.2	0.0	0.0	11.5	0.0	1047.7	1.8	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	9.2	124.4	17.8	0.3	0.1	0.1	9.9	53.3	11.6	0.1	0.1	2.6	24.3	14.3	0.1	3.1	0.0	0.2	4.7	1.1	4.2	1.6	4.7	5.2	16.2	0.3	9.5	0.4	12.4	3.4	10.6	1.3	1.6	27.0	4.6	1.5	0.9	0.5	0.3	119.1	5.3	17.2	0.4	18.3	0.0	23.1	22.6	1.5	23.2	0.4	0.0	3.0	28.4	15.5	89.7	2.9	3.7	0.8	0.9	7.0	1.5	0.2	7.8	14.8	14.2	0.5	23.6	35.1	0.9	1.7	0.1	0.9	1.1	24.8	3.6	7.1	0.5	11.6	53.3	0.0	5.9	0.1	0.0	0.1	0.0	9.9	0.1	0.1	0.1	0.5	0.1	2.6	0.2	0.0	2.6	1.6	1.0	0.1	1.0	0.9	0.4	0.5	0.0	0.0	0.0
TNPO1	"IPO2, KPNB2, MIP, MIP1, TRN"	ENSG00000083312	"Transportin 1"	Q92973	5	72816312-72916733	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016325	Approved		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"			47000	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"CAB016325: AB_675691"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavourable (6.55e-5)"	"unprognostic (8.93e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.49e-2)"	23.9	29.3	20.1	26.2	24.5	20.7	52.3	18.5	21.9	18.5	21.6	15.7	32.3	16.4	25.4	25.4	26.5	17.9	22.8	21.9	22.5	16.5	26.2	20.8	24.2	22.4	22.9	16.4	22.5	28.9	54.1	36.5	34.9	27.0	21.2	24.4	19.4	26.1	35.3	38.0	15.9	19.9	32.0	31.2	21.7	25.3	30.9	20.8	25.2	32.6	18.0	23.6	27.5	30.8	11.1	10.7	8.9	13.3	14.1	18.3	10.6	21.6	28.6	41.6	24.9	31.0	38.5	24.6	25.7	35.0	25.6	26.4	24.3	18.6	25.3	17.6	40.3	15.8	28.3	22.9	37.1	14.7	15.7	15.6	38.0	12.3	21.0	17.2	11.5	27.8	16.6	34.2	48.8	62.1	23.3	13.5	72.7	10.3	15.7	6.6	22.3	21.9	19.0	37.5	15.9	15.8	29.0	21.6	22.3	41.3	13.2	30.3	16.3	14.2	58.8	21.7	25.6	32.7	28.7	12.4	19.4	33.8	17.3	17.7	39.8	7.3	8.3	6.9	13.4	11.5	18.3	11.1	12.2	10.0	10.7	11.0	13.4	13.4	8.9	14.1	13.3	5.0	8.1	10.6	20.1	24.5	18.5	21.9	22.5	16.5	22.9	16.4	27.0	20.8
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.6"					"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"				"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: , HPA024251: "	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	17.9	11.8	18.1	17.9	17.2	29.4	20.6	35.1	23.6	35.0	29.9	16.7	17.9	16.4	36.0	19.5	19.6	27.5	29.2	13.6	14.2	9.6	15.6	11.8	19.2	12.9	15.5	16.7	30.3	18.4	36.9	14.7	19.7	13.2	25.4	15.1	25.2	17.0	24.4	13.6	18.9	16.9	40.1	12.6	15.3	21.4	14.0	16.6	7.2	20.6	12.8	9.4	27.0	21.4	2.0	4.3	17.6	3.2	2.6	1.5	0.1	21.3	19.1	15.9	13.3	13.4	16.0	41.1	15.2	14.4	8.4	9.0	7.8	18.8	14.6	15.0	22.2	23.9	9.1	18.2	7.1	6.4	5.8	9.3	16.3	12.7	11.7	30.5	34.3	16.1	21.5	16.8	19.6	9.5	13.1	8.3	10.7	35.5	7.1	37.3	1.4	14.6	8.0	7.9	10.8	6.9	27.3	6.9	16.6	11.8	31.3	11.3	32.7	31.6	23.6	24.5	34.5	14.5	10.9	11.9	12.3	13.8	13.7	21.7	28.5	9.4	3.2	2.7	1.4	1.2	1.0	1.6	1.0	0.8	1.1	2.0	0.7	1.5	17.6	2.6	1.5	4.3	1.4	0.1	18.1	17.2	35.1	23.6	14.2	9.6	15.5	16.7	13.2	16.6
TOB2	"APRO5, bK223H9, TOB4, TOBL, TROB2"	ENSG00000183864	"Transducer of ERBB2, 2"	Q14106	22	41433492-41447023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016603, HPA054112"	Approved		Approved	Cytosol				Cytosol		"HPA016603: , HPA054112: "	"unprognostic (1.21e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (3.08e-5)"	"unprognostic (3.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.18e-6)"	"unprognostic (1.50e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.13e-2)"	27.3	20.7	25.4	12.5	27.6	5.4	14.1	53.5	22.0	18.0	16.1	23.2	12.2	14.0	14.5	9.8	17.1	25.2	24.4	16.4	25.5	9.9	16.0	13.4	13.5	10.6	35.8	13.6	21.8	18.1	26.2	13.2	13.8	23.1	17.6	10.1	17.6	9.6	15.1	47.3	13.9	16.1	13.3	18.3	12.2	17.7	9.1	36.5	13.6	23.2	17.0	12.1	12.8	21.1	13.4	10.3	4.9	10.0	4.6	9.9	5.7	17.0	7.9	13.8	9.3	32.5	22.8	13.5	11.4	17.6	14.5	12.9	10.3	8.1	10.5	11.6	16.4	15.0	12.8	6.3	13.3	10.7	16.5	5.7	11.0	15.5	22.3	15.4	7.7	20.9	10.9	17.3	7.5	14.5	8.6	11.8	11.8	19.0	6.4	8.9	11.8	8.5	14.0	9.3	9.0	10.3	11.9	6.4	4.3	28.6	15.5	20.8	8.6	7.7	18.0	14.4	13.5	11.1	10.6	11.3	4.9	5.8	8.7	6.6	9.5	4.2	6.9	4.8	9.9	10.0	9.2	13.4	8.2	8.1	6.5	10.3	4.3	6.1	4.9	4.6	9.3	10.3	6.9	5.7	25.4	27.6	53.5	22.0	25.5	9.9	35.8	13.6	23.1	36.5
TOLLIP	IL-1RAcPIP	ENSG00000078902	"Toll interacting protein"	Q9H0E2	11	1274371-1309654	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038621, HPA038622"	Enhanced		Approved	"Plasma membrane,Cytosol"			34000	"Plasma membrane, Cytosol"		"HPA038621: AB_10673177, HPA038622: AB_10675946"	"unprognostic (8.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (8.89e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.11e-16)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-2)"	15.3	16.7	31.2	8.8	32.5	9.0	11.9	28.3	63.0	10.7	12.7	12.9	8.6	18.6	8.3	10.3	29.4	10.7	13.7	15.8	28.0	20.3	20.9	37.1	12.3	9.6	18.1	32.1	12.8	41.8	13.7	18.7	9.9	17.4	15.6	6.6	12.9	15.9	16.8	23.4	24.0	15.7	9.0	13.5	13.2	15.1	24.5	11.8	5.9	12.6	11.8	10.9	14.6	14.8	13.9	26.9	49.0	34.8	11.1	12.6	18.3	15.6	16.6	8.5	9.6	18.1	11.4	7.4	13.9	12.7	16.4	14.6	18.0	10.0	7.3	13.5	12.8	14.2	7.6	17.1	4.5	15.0	15.5	6.0	3.6	26.9	25.9	11.3	15.2	17.1	20.1	9.7	9.4	10.2	9.8	20.0	13.4	13.1	14.3	13.9	10.3	22.1	10.9	8.7	7.2	10.8	21.0	22.8	13.4	12.5	15.2	15.3	12.0	12.9	18.6	17.8	7.6	7.5	8.0	20.3	18.0	8.9	28.1	7.5	13.9	9.5	34.8	35.9	9.6	30.0	8.0	10.9	10.3	8.9	26.9	13.9	8.1	7.6	49.0	11.1	27.5	14.1	12.6	18.3	31.2	32.5	28.3	63.0	28.0	20.3	18.1	32.1	17.4	11.8
TOM1		ENSG00000100284	"Target of myb1 membrane trafficking protein"	O60784	22	35299275-35347994	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000818, HPA001749"	Approved		Approved	"Plasma membrane,Centriolar satellite,Cytosol"			14000	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA000818: , HPA001749: AB_1080323"	"unprognostic (3.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"prognostic favourable (2.20e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.16e-2)"	"prognostic favourable (3.72e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.31e-2)"	17.0	21.2	9.5	10.2	13.8	31.1	13.7	10.2	24.6	16.0	14.6	12.0	7.5	17.4	14.1	15.5	31.6	11.7	15.4	19.1	8.8	15.2	16.1	27.4	17.5	8.2	11.6	11.3	12.1	11.8	21.8	16.8	39.0	23.2	10.2	6.4	17.5	37.0	10.1	83.8	29.1	18.6	7.1	8.4	10.6	8.4	13.6	8.7	10.0	14.8	25.9	19.9	12.1	17.6	4.6	15.2	40.9	31.2	4.6	14.7	17.0	6.6	6.7	3.9	6.3	27.9	16.6	18.4	6.5	19.7	12.7	14.3	9.3	6.2	2.6	12.1	20.3	3.1	4.0	6.8	4.6	7.5	9.1	2.2	7.6	19.3	26.3	4.2	10.1	22.4	8.6	17.9	6.1	8.8	4.3	6.6	6.2	6.4	3.4	9.9	3.0	3.9	6.2	5.6	5.6	5.0	5.0	6.7	5.2	14.8	15.4	14.5	7.8	7.0	9.2	15.1	13.1	11.5	3.2	7.7	4.8	6.8	20.3	4.4	4.9	5.9	31.2	13.1	6.4	18.9	5.3	4.6	9.8	6.1	15.2	4.0	7.9	5.3	40.9	4.6	19.4	8.1	14.7	17.0	9.5	13.8	10.2	24.6	8.8	15.2	11.6	11.3	23.2	8.7
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA036231: , HPA036232: "	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	16.0	25.3	13.6	16.9	15.6	19.7	20.6	17.7	27.0	10.2	20.5	10.9	10.1	20.0	11.8	10.5	22.9	13.5	11.4	21.5	15.3	14.9	16.5	36.9	15.1	22.3	15.6	13.3	18.2	19.2	16.2	11.9	15.3	20.2	11.2	16.7	11.5	11.5	13.5	32.3	14.7	15.1	11.6	11.9	12.7	12.6	12.3	8.8	14.2	11.6	18.6	15.6	10.9	12.5	7.3	7.0	5.1	6.8	4.7	8.7	2.0	30.8	52.3	19.1	26.3	7.1	6.4	24.3	22.2	12.3	42.1	30.2	56.8	21.4	45.6	23.9	14.6	33.4	49.5	31.9	19.2	17.6	44.9	30.6	20.5	44.7	15.2	39.0	27.5	10.1	18.1	32.6	20.7	14.5	48.2	15.9	16.4	38.5	42.3	28.7	33.4	32.6	43.3	21.7	26.5	19.3	42.9	29.8	19.1	23.6	49.8	15.8	16.7	39.6	11.9	29.2	29.6	20.3	57.9	17.2	35.6	44.7	21.7	41.5	30.7	0.7	5.5	5.1	4.7	6.8	5.2	7.3	4.5	6.5	7.0	4.2	7.9	8.7	1.1	4.7	5.9	6.9	4.8	2.0	13.6	15.6	17.7	27.0	15.3	14.9	15.6	13.3	20.2	8.8
TOR1B	"DQ1, MGC4386"	ENSG00000136816	"Torsin family 1 member B"	O14657	9	129803153-129811281	"Predicted intracellular proteins"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013403, HPA013697, CAB022709"	Approved		Approved	"Nuclear speckles,Cytosol"	"Intracellular and membrane"			"Nuclear speckles"	Cytosol	"CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196"	"unprognostic (2.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.69e-3)"	14.2	14.4	9.7	13.8	12.2	14.0	18.4	23.6	11.9	11.3	22.5	10.5	11.6	12.3	14.0	8.2	13.5	10.5	15.0	13.3	11.7	11.5	11.8	35.3	13.0	10.8	9.4	9.0	10.8	21.1	13.3	13.6	20.0	10.6	12.9	25.8	10.8	12.8	13.7	13.5	13.0	18.1	14.2	8.9	12.4	14.9	19.5	8.3	16.8	16.4	10.0	11.9	14.9	18.0	4.6	6.2	17.2	14.6	7.3	12.3	8.4	5.3	12.3	5.2	13.8	26.0	19.5	12.0	19.3	12.6	13.2	13.2	10.2	12.3	3.8	12.3	18.9	22.0	5.6	7.9	13.6	14.0	5.9	3.4	10.5	7.2	11.2	6.3	15.0	11.0	14.0	18.9	9.4	11.7	11.6	8.9	12.3	15.0	8.6	10.0	10.9	9.8	3.6	9.1	11.6	10.2	5.6	7.2	8.3	12.4	14.4	7.6	20.7	6.2	10.7	25.1	12.0	29.8	16.5	6.5	24.3	3.2	13.8	8.3	17.0	6.3	11.5	17.2	12.2	14.6	12.3	3.9	9.5	10.5	6.2	4.6	7.1	7.1	14.2	7.3	8.5	3.8	9.1	8.4	9.7	12.2	23.6	11.9	11.7	11.5	9.4	9.0	10.6	8.3
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52438005-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 18.7"	"Cell line enhanced"	"Detected in some"		"AF22: 19.7;HAP1: 9.6;Hep G2: 8.6;RT4: 37.5;SCLC-21H: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favourable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favourable (3.95e-4)"	0.7	3.1	7.1	5.0	4.7	0.0	3.9	0.6	6.0	7.0	13.5	6.0	0.2	9.4	1.3	9.2	0.9	3.0	14.8	0.2	3.2	5.3	9.5	5.8	2.7	0.1	5.4	3.6	1.0	7.8	0.0	5.8	0.3	5.1	1.8	15.1	2.7	11.0	0.7	0.3	1.1	13.5	0.9	7.0	0.2	18.7	0.7	4.7	0.0	0.2	0.3	2.1	7.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.7	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	3.4	0.1	4.6	37.5	13.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	4.7	0.6	4.3	3.2	5.3	5.4	3.6	5.1	4.7
TP53BP2	"53BP2, ASPP2, PPP1R13A"	ENSG00000143514	"Tumor protein p53 binding protein 2"	Q13625	1	223779899-223845972	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021603, HPA050429"	Supported		Enhanced	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA021603: AB_1844384, HPA050429: "	"unprognostic (1.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-1)"	10.0	8.3	26.5	17.2	28.7	38.8	20.8	9.3	17.9	10.9	12.0	12.6	8.1	7.9	11.9	9.8	15.9	9.4	17.4	10.9	17.3	14.7	10.1	13.9	21.4	18.6	18.7	8.6	15.5	13.0	16.4	8.3	8.2	12.9	9.6	9.5	17.7	10.2	8.1	12.0	9.9	9.5	12.2	13.0	10.6	9.7	10.2	14.9	17.3	22.1	7.4	11.7	11.8	14.8	2.2	2.9	6.7	2.7	7.2	4.0	2.0	15.3	7.7	21.0	13.2	7.5	7.3	13.4	9.9	14.1	14.5	12.5	15.9	9.3	0.0	8.7	8.2	10.5	16.3	5.9	19.5	29.6	16.1	20.3	7.5	5.4	15.2	16.7	14.3	8.7	6.5	13.3	13.7	8.5	25.7	15.4	12.0	4.4	12.7	10.3	18.1	7.5	16.9	21.9	1.7	13.0	9.7	18.2	23.5	10.9	13.6	14.3	7.7	23.0	9.9	14.9	10.5	16.0	18.5	7.6	7.9	12.7	9.0	11.3	16.9	6.7	2.7	1.6	2.3	2.6	2.8	2.2	2.6	4.0	2.9	1.9	2.7	1.9	3.2	7.2	2.0	1.7	1.6	2.0	26.5	28.7	9.3	17.9	17.3	14.7	18.7	8.6	12.9	14.9
TP53INP1	"DKFZp434M1317, FLJ22139, P53DINP1, SIP, Teap, TP53INP1A, TP53INP1B"	ENSG00000164938	"Tumor protein p53 inducible nuclear protein 1"	Q96A56	8	94925972-94949411	"Predicted intracellular proteins"	"Apoptosis, Autophagy, Transcription, Transcription regulation"	"Activator, Antioxidant"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.5;U-266/70: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 25.7"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;granulocytes: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005856	Uncertain		Supported	Cytosol				Cytosol		"HPA005856: AB_10600832"	"unprognostic (1.39e-2)"	"unprognostic (4.47e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.31e-2)"	"prognostic favourable (1.11e-4)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.18e-2)"	"prognostic favourable (5.45e-5)"	8.2	8.3	5.1	21.0	7.6	17.9	14.3	5.9	5.9	8.3	11.1	7.4	11.5	8.4	10.2	11.6	10.6	8.4	11.2	8.6	5.5	3.1	7.8	50.0	21.0	51.9	6.9	3.5	7.4	42.7	6.7	6.9	12.4	5.7	14.9	10.4	8.4	13.3	15.3	17.9	9.1	24.8	9.9	5.3	28.9	12.3	22.3	7.4	39.8	7.9	4.6	31.4	15.5	6.6	6.8	0.8	25.7	2.1	2.9	3.6	1.3	0.2	1.0	9.8	3.8	12.3	11.6	10.2	2.3	5.4	1.0	2.5	0.8	0.2	2.1	5.1	4.4	1.7	0.0	3.8	2.4	0.1	1.2	1.3	2.0	5.8	8.2	0.0	6.9	19.0	9.1	2.8	1.1	16.0	0.7	32.5	5.0	0.6	1.5	0.5	0.9	0.2	1.3	0.7	11.3	2.6	10.5	1.3	8.0	1.4	0.8	2.0	4.8	1.3	11.0	2.0	2.4	0.0	0.3	35.1	7.2	0.9	3.4	0.0	0.0	25.7	2.1	6.1	0.8	2.0	0.8	6.8	2.4	1.6	0.7	5.9	0.5	0.4	9.6	2.9	1.2	0.8	3.6	1.3	5.1	7.6	5.9	5.9	5.5	3.1	6.9	3.5	5.7	7.4
TPD52	"D52, hD52, N8L"	ENSG00000076554	"Tumor protein D52"	P55327	8	80034745-80231232	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 46.3;SK-BR-3: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.3"	"Group enriched"	"Detected in many"	6	"B-cells: 24.3;NK-cells: 6.8;T-cells: 11.1"									"HPA028427, HPA062167"	Enhanced		Approved	"Golgi apparatus,Cytosol"			42000	Cytosol	"Golgi apparatus"	"HPA028427: AB_10610561, HPA062167: AB_2684704"	"prognostic unfavourable (1.11e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.77e-3)"	"unprognostic (8.24e-2)"	"unprognostic (3.75e-1)"	"unprognostic (7.99e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (4.77e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-2)"	3.2	3.9	33.9	20.2	23.2	3.2	30.9	37.5	43.3	8.3	45.2	19.7	7.3	38.1	4.1	23.2	18.1	6.3	13.2	4.5	35.4	26.9	18.4	15.1	7.8	15.8	27.4	24.0	1.5	26.0	19.1	19.1	13.6	20.3	42.5	51.3	17.4	33.5	8.0	3.1	18.2	40.3	4.4	31.4	9.8	32.7	2.1	19.8	3.5	25.8	7.3	22.2	9.5	10.0	24.3	2.4	2.5	0.0	6.8	11.1	4.1	23.1	6.2	0.2	4.2	0.0	0.0	9.5	1.5	2.3	6.4	3.2	3.2	6.8	33.8	8.4	0.1	9.5	9.6	6.5	4.6	4.1	8.0	4.7	8.9	5.2	0.0	1.5	0.1	0.0	4.6	0.0	2.2	0.3	0.0	46.3	0.0	7.6	7.4	6.9	2.1	15.7	0.0	0.1	21.4	11.1	5.6	12.0	8.2	7.2	105.2	19.4	10.2	6.0	0.3	0.0	6.6	0.1	5.4	17.4	15.0	27.7	4.2	0.0	0.4	0.2	0.0	2.5	6.4	0.0	11.1	24.3	6.4	5.5	1.1	22.4	4.2	4.8	0.2	6.8	0.0	2.4	4.1	4.1	33.9	23.2	37.5	43.3	35.4	26.9	27.4	24.0	20.3	19.8
TPD52L1	"D53, hD53"	ENSG00000111907	"Tumor protein D52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 95.2;salivary gland: 104.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 51.4;hTCEpi: 45.3;MCF7: 67.2;RPTEC TERT1: 52.1;SK-BR-3: 36.3;T-47d: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favourable (3.97e-4)"	"prognostic unfavourable (5.34e-4)"	10.3	95.2	31.5	4.3	47.5	1.0	25.7	2.6	32.9	10.5	8.5	9.2	31.0	4.3	6.2	27.6	43.3	13.9	10.8	26.0	21.4	9.5	11.7	22.0	4.7	2.9	15.4	12.8	9.0	18.0	10.3	8.7	4.0	16.1	16.6	5.8	13.0	104.6	32.7	34.4	11.8	4.6	27.1	5.5	1.4	10.3	2.6	18.2	0.0	23.5	20.1	11.0	18.1	14.6	1.1	0.9	5.9	1.2	5.3	1.7	1.0	6.9	7.9	0.0	51.4	0.4	0.1	12.2	1.1	1.1	0.0	0.1	12.5	8.9	0.0	26.4	5.8	15.9	1.5	11.0	0.0	0.1	11.0	0.1	11.0	0.1	1.1	0.0	0.0	1.4	45.3	0.0	5.9	0.0	5.5	0.1	0.9	67.2	0.0	0.1	0.8	4.3	0.0	0.0	0.0	52.1	1.8	1.7	0.0	13.3	36.3	0.8	31.0	0.1	0.0	0.3	1.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	2.7	1.2	0.8	0.8	0.6	0.8	0.8	1.3	0.6	0.5	1.1	1.7	1.2	5.9	5.3	0.3	0.9	0.4	1.0	31.5	47.5	2.6	32.9	21.4	9.5	15.4	12.8	16.1	18.2
TPD52L2	"D54, hD54"	ENSG00000101150	"Tumor protein D52 like 2"	O43399	20	63865228-63891545	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047489	Approved		Approved	Vesicles,Cytosol			1500000	Vesicles	Cytosol	"HPA047489: "	"unprognostic (1.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (3.63e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavourable (1.74e-8)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.15e-3)"	48.6	40.9	28.1	33.5	33.6	55.4	43.3	33.4	40.2	40.1	35.8	35.0	34.6	25.3	38.4	29.7	52.2	33.9	32.2	45.3	27.6	30.0	31.0	24.7	30.3	38.3	26.6	34.1	33.4	30.1	20.5	30.6	42.9	33.8	33.8	24.2	29.0	27.4	43.7	32.3	33.9	25.0	48.0	27.4	36.5	28.1	35.0	24.7	19.4	40.9	32.8	31.8	40.9	55.6	13.0	17.6	50.5	25.4	16.7	14.4	23.1	32.7	17.0	10.6	12.9	24.5	39.2	15.8	37.9	33.5	67.6	28.7	62.7	37.6	13.3	42.0	38.1	32.4	21.5	51.6	39.4	7.4	9.0	12.6	22.4	37.9	26.1	16.1	13.1	28.1	58.2	27.1	43.8	30.9	26.2	19.6	26.5	18.2	15.4	20.4	15.3	60.3	21.4	11.7	21.2	26.6	14.7	16.2	18.3	44.7	34.6	30.8	23.5	32.5	32.7	54.4	15.6	31.5	27.6	12.6	19.8	16.1	51.0	15.0	16.7	18.8	25.4	16.7	11.6	19.9	14.4	13.0	12.7	13.1	17.6	11.9	13.0	11.7	50.5	16.7	16.5	8.8	13.8	23.1	28.1	33.6	33.4	40.2	27.6	30.0	26.6	34.1	33.8	24.7
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 4.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Approved		Uncertain	Cytosol				Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.7	0.0	0.7	0.7	0.7	0.6	0.9	0.7	4.2	0.7	7.1	0.7	0.7	8.2	0.7	0.7	0.7	1.5	0.7	0.7	0.7	0.3	0.7	0.7	0.7	0.7	0.7	0.7	1.0	0.7	0.0	5.4	0.7	0.7	1.3	16.2	0.7	0.7	0.7	0.7	1.0	9.1	0.7	0.7	1.0	13.3	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	1.4	0.8	1.5	0.5	0.9	1.6	0.2	0.4	0.1	1.7	1.5	0.1	0.0	0.6	0.6	0.5	0.2	1.1	1.8	0.3	1.4	0.3	0.0	0.6	0.4	1.5	0.7	1.3	3.1	2.2	0.8	3.5	0.0	4.5	1.2	0.0	1.8	0.2	0.6	0.7	0.9	0.8	0.1	0.5	1.0	0.7	0.5	0.3	1.7	0.3	0.0	0.0	1.0	1.3	0.9	0.2	0.4	0.9	0.3	2.9	0.2	0.4	1.3	0.5	1.7	0.2	0.3	1.1	0.2	1.0	1.4	1.5	0.4	0.4	1.6	0.2	0.8	0.5	0.5	0.4	0.1	1.4	0.6	0.6	1.5	0.9	0.5	0.8	0.6	0.2	0.7	0.7	0.7	4.2	0.7	0.3	0.7	0.7	0.7	0.7
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 544.2;skeletal muscle: 589.5"	"Cell line enhanced"	"Detected in many"		"BJ: 123.0;fHDF/TERT166: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 23.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"			280000000	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: , HPA053624: "	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavourable (7.30e-4)"	17.9	5.7	5.5	32.4	5.2	1.2	15.2	5.6	5.1	48.1	119.7	2.4	84.2	14.6	72.4	38.3	121.6	36.2	75.3	544.2	4.1	2.6	14.5	4.4	10.5	3.3	3.3	7.0	27.0	29.3	1.9	3.2	17.7	4.1	72.5	28.0	19.1	12.9	81.3	589.5	6.5	39.5	245.2	2.7	6.5	51.7	9.6	2.3	0.4	7.7	121.7	5.9	193.8	38.7	2.7	8.4	23.8	11.6	1.2	3.4	9.9	43.6	28.8	34.8	1.7	12.2	7.7	114.6	123.0	45.3	75.7	56.3	20.2	8.7	0.1	56.5	122.9	24.2	29.5	19.7	50.4	1.1	4.1	6.4	31.0	9.8	34.2	0.2	1.4	10.7	11.4	62.2	16.6	19.8	0.6	1.5	57.8	22.5	1.9	0.5	41.5	5.0	0.7	12.3	1.2	108.1	24.1	8.3	5.7	14.7	23.3	5.2	17.0	1.2	91.2	100.1	49.2	14.9	87.2	0.4	0.3	0.5	28.3	1.7	69.3	23.8	6.1	2.9	2.5	11.6	2.0	2.7	2.4	2.7	8.4	2.6	2.6	2.3	6.7	1.2	7.9	1.7	3.4	9.9	5.5	5.2	5.6	5.1	4.1	2.6	3.3	7.0	4.1	2.3
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease mutation, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 738.4;tongue: 203.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"			410000000	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: , HPA053624: "	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavourable (6.73e-6)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favourable (2.39e-5)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	10.1	7.3	10.8	10.8	10.5	26.5	6.2	6.4	11.2	4.6	9.6	3.9	3.2	7.9	4.1	27.9	18.3	4.4	6.7	29.7	7.7	8.1	7.2	6.8	9.6	12.9	8.9	5.8	4.8	23.2	3.6	3.2	6.7	5.0	5.7	10.7	4.4	20.5	2.5	738.4	5.9	8.2	5.2	7.7	11.7	6.9	5.4	4.4	6.7	9.3	203.6	28.6	6.8	4.9	38.9	72.6	154.8	95.9	35.4	54.4	146.1	67.5	33.7	43.2	28.3	36.6	47.8	43.5	58.1	53.7	77.1	58.2	62.8	63.4	50.9	47.3	65.5	62.6	42.8	61.1	82.2	35.2	23.3	62.6	32.9	42.2	29.1	91.6	83.2	36.0	33.5	67.9	52.3	118.6	47.0	54.7	95.1	40.5	71.3	94.6	97.2	73.3	61.1	30.0	72.1	55.6	51.6	30.3	56.9	44.1	58.8	57.6	82.0	109.5	88.6	67.5	48.9	64.7	91.0	46.6	76.5	68.0	61.0	69.0	106.6	70.8	64.7	154.8	54.4	87.8	48.6	38.9	48.5	51.1	72.6	30.1	36.6	47.3	74.9	35.4	95.9	36.0	52.1	146.1	10.8	10.5	6.4	11.2	7.7	8.1	8.9	5.8	5.0	4.4
TPM4		ENSG00000167460	"Tropomyosin 4"	P67936	19	16067021-16103005	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 225.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004685, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"			950000000	"Actin filaments"	Cytosol	"CAB004685: AB_425723, HPA047089: , HPA053624: "	"unprognostic (1.27e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-3)"	"unprognostic (7.38e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.61e-1)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.26e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	66.2	17.9	13.3	60.0	13.7	10.8	47.4	46.2	11.5	90.2	40.5	14.6	56.4	17.4	87.1	63.3	149.3	49.4	108.4	39.2	14.5	12.4	32.4	12.2	69.7	27.1	16.0	10.5	102.4	15.4	8.4	16.2	65.0	19.7	84.1	31.8	18.6	47.6	64.6	29.9	39.0	25.2	127.2	22.5	99.7	37.5	30.6	11.7	11.5	20.0	92.2	60.1	177.3	70.5	22.2	35.0	40.7	32.7	24.7	52.5	48.6	58.7	23.3	45.1	27.5	104.9	156.3	56.6	82.3	99.9	69.8	72.0	24.2	61.4	2.7	64.3	102.7	31.7	18.8	47.2	91.3	38.7	10.8	29.6	33.5	19.4	57.7	5.3	70.8	96.7	15.3	57.0	65.6	79.7	3.4	37.3	96.3	20.0	15.9	18.6	23.6	28.4	21.8	38.8	12.7	16.1	50.4	8.2	25.8	55.3	24.8	29.2	0.5	8.2	93.4	121.6	15.4	225.9	76.1	6.5	15.3	13.1	84.3	15.6	41.1	40.7	30.1	2.2	34.8	32.7	26.3	22.2	26.9	31.2	35.0	18.8	7.8	18.3	35.2	24.7	16.2	27.4	52.5	48.6	13.3	13.7	46.2	11.5	14.5	12.4	16.0	10.5	19.7	11.7
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102597003-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"			410000	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: "	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	19.9	12.4	10.8	21.4	14.5	24.7	18.1	23.1	18.4	16.8	14.7	12.2	50.3	13.1	20.0	21.8	14.4	16.7	13.5	17.0	11.7	9.7	12.9	22.8	18.4	32.8	11.7	13.8	21.6	16.3	15.7	15.7	19.2	15.3	13.9	21.0	12.9	15.6	34.5	35.7	14.1	17.4	19.2	13.4	20.7	15.4	34.5	14.0	23.8	21.9	16.0	19.7	17.0	16.0	6.0	5.8	9.2	6.9	10.9	12.1	4.7	15.9	6.4	18.5	15.7	12.5	17.3	13.2	16.3	11.9	10.5	13.2	13.5	21.5	17.5	5.6	13.1	15.7	14.3	11.5	19.0	12.2	12.7	33.3	16.8	10.8	10.6	37.6	20.3	13.4	5.2	11.8	15.8	15.0	19.8	19.6	14.8	5.0	17.3	28.2	15.0	8.9	19.2	14.0	15.8	13.6	13.2	17.2	14.1	10.2	17.1	7.3	9.8	42.2	12.0	10.0	7.3	6.4	13.5	19.3	23.3	15.3	16.7	27.2	12.9	9.2	6.0	4.0	9.1	6.9	10.7	6.0	10.3	10.1	5.8	5.5	12.1	11.5	1.3	10.9	5.7	4.6	10.9	4.7	10.8	14.5	23.1	18.4	11.7	9.7	11.7	13.8	15.3	14.0
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693395	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 77.5"	"Cell line enhanced"	"Detected in some"		"A549: 8.4;AN3-CA: 6.2;SCLC-21H: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.5;NK-cell: 1.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favourable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.5	5.8	27.0	1.3	29.6	1.0	2.7	17.0	77.5	2.1	3.2	69.0	0.1	4.6	2.3	1.3	9.0	8.6	2.1	6.0	33.9	23.9	3.2	2.3	8.3	1.0	25.8	25.0	1.8	5.2	2.4	4.4	2.4	30.1	2.4	2.2	0.2	4.8	3.7	6.2	5.6	7.5	3.5	24.7	2.7	3.8	1.6	4.3	0.0	6.0	1.9	1.8	3.4	0.6	0.0	0.2	1.5	0.0	1.0	0.5	0.1	0.3	8.4	0.4	6.2	0.9	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.9	0.2	0.6	0.0	3.3	3.4	0.0	0.0	1.7	2.9	0.2	3.6	0.2	0.9	0.3	0.4	0.0	0.8	0.0	0.2	0.1	0.1	3.1	0.0	0.3	0.2	0.5	0.2	0.8	0.3	0.1	1.2	0.3	1.1	15.5	1.9	0.9	0.4	4.1	0.8	0.2	0.1	0.2	3.3	0.1	0.2	1.2	0.3	0.0	0.6	0.7	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.2	0.1	0.1	27.0	29.6	17.0	40.8	33.9	23.9	25.8	25.0	30.1	4.3
TPRG1L	"FAM79A, FLJ21811, RP11-46F15.3"	ENSG00000158109	"Tumor protein p63 regulated 1 like"	Q5T0D9	1	3625002-3630127	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063163, CAB079051"		Supported	Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB079051: , HPA063163: "	"unprognostic (1.92e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.46e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-3)"	"prognostic favourable (1.76e-9)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	18.3	19.1	34.3	9.7	46.6	14.5	17.4	23.1	57.7	19.3	24.0	12.9	17.2	24.5	16.5	21.2	28.7	24.8	19.3	25.0	32.9	32.8	32.1	34.9	16.8	14.6	25.7	41.7	25.9	17.4	11.7	20.5	12.7	41.4	17.1	23.4	19.1	18.7	25.0	29.5	25.4	28.3	18.1	13.2	13.4	17.4	8.7	13.6	8.0	21.9	17.3	18.2	17.1	16.3	5.1	7.9	17.0	3.2	2.6	7.1	3.2	11.3	8.1	5.0	8.9	38.1	26.5	4.6	16.9	23.4	15.7	10.4	15.2	10.4	4.2	15.1	23.0	17.9	6.0	15.6	13.3	13.3	9.6	5.8	9.5	17.6	23.1	8.5	6.9	19.9	23.0	13.0	13.3	22.1	4.1	15.0	21.8	5.2	6.1	8.8	6.7	19.1	5.1	7.5	10.0	16.2	11.9	14.1	13.9	9.0	18.8	17.9	11.7	7.4	25.1	13.2	3.9	30.0	4.7	13.6	17.6	4.7	7.8	18.7	1.7	12.8	3.2	4.9	5.6	2.6	7.1	4.2	6.4	5.5	2.8	5.1	5.9	6.8	17.0	2.6	2.5	7.9	3.4	3.2	34.3	46.6	23.1	57.7	32.9	32.8	25.7	41.7	41.4	13.6
TPRKB	"CGI-121, CGI121"	ENSG00000144034	"TP53RK binding protein"	Q9Y3C4	2	73729104-73737400	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035712	Approved		Supported	Cytosol				Cytosol		"HPA035712: AB_10669674"	"unprognostic (1.11e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.21e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.16e-3)"	"unprognostic (3.01e-3)"	"unprognostic (5.10e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.68e-3)"	"unprognostic (5.66e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.03e-2)"	15.5	13.9	13.5	9.9	16.2	30.2	23.3	24.1	17.0	18.0	16.7	11.1	21.1	19.9	16.5	19.9	22.4	29.3	10.7	24.5	15.6	12.0	24.3	23.6	14.4	17.5	17.6	12.6	22.2	19.2	8.4	21.3	14.8	18.2	16.6	18.0	8.7	20.3	13.0	36.8	13.3	24.1	20.6	16.6	15.5	15.9	25.1	15.9	21.9	14.7	30.6	16.6	14.3	17.5	20.6	22.0	24.3	21.9	19.4	22.3	14.6	23.8	19.0	18.7	20.7	6.9	9.8	14.6	14.7	9.3	18.8	13.7	28.9	15.5	15.3	12.1	8.0	15.3	14.4	17.8	29.7	9.8	20.6	31.2	12.1	21.9	6.9	38.0	18.0	6.9	11.7	18.3	20.1	19.5	28.6	24.2	19.2	15.2	33.1	33.1	24.5	25.2	19.9	51.4	22.8	17.4	22.6	16.2	20.5	12.4	20.4	26.6	14.4	20.0	9.0	14.9	24.2	29.1	43.2	17.1	22.7	40.6	14.4	29.9	18.0	14.3	17.1	24.3	14.9	21.9	19.8	20.6	20.1	18.0	19.4	17.6	22.3	21.2	13.8	19.4	17.1	22.0	18.6	14.6	13.5	16.2	24.1	17.0	15.6	12.0	17.6	12.6	18.2	15.9
TPT1	"fortilin, TCTP"	ENSG00000133112	"Tumor protein, translationally-controlled 1"	P13693	13	45333471-45341370	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB008364, HPA039437"	Approved		Supported	Cytosol			3000000	Cytosol		"CAB008364: AB_591904, HPA039437: "	"prognostic favourable (5.90e-5)"	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (2.35e-4)"	"unprognostic (3.25e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.56e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (1.47e-1)"	"unprognostic (8.48e-2)"	"prognostic favourable (4.31e-5)"	"unprognostic (6.51e-2)"	197.3	108.4	81.7	126.7	74.3	156.7	185.4	35.2	41.3	173.3	229.7	66.5	131.7	101.9	197.9	162.6	234.4	97.1	168.2	292.9	74.4	58.0	141.0	317.4	179.5	286.0	85.1	27.1	273.2	671.6	32.3	97.4	188.3	46.3	203.4	91.6	77.5	460.5	124.6	772.2	98.5	178.1	169.1	101.1	180.2	107.7	95.9	52.1	211.5	306.1	322.2	178.4	211.5	356.3	106.0	111.8	76.0	91.7	110.6	165.2	205.6	58.1	52.8	89.4	58.4	264.1	368.4	106.3	124.0	193.3	79.2	83.2	118.5	151.5	124.1	104.7	128.7	101.5	72.1	182.0	109.8	57.3	63.1	99.4	48.0	131.5	266.9	135.2	155.8	302.0	370.5	50.4	305.1	163.5	73.6	34.3	161.5	106.2	163.7	323.1	101.9	56.3	103.3	84.8	92.7	203.0	122.3	38.1	102.1	41.1	131.8	189.2	75.6	394.4	106.5	36.6	52.1	59.3	76.0	84.7	85.6	117.3	97.6	108.1	28.4	76.0	91.7	44.6	82.3	71.6	149.6	106.0	154.6	111.3	87.2	84.4	165.2	133.5	42.2	110.6	65.9	111.8	134.7	205.6	81.7	74.3	35.2	41.3	74.4	58.0	85.1	27.1	46.3	52.1
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	69	"testis: 78.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;K-562: 8.7;Karpas-707: 7.1;MCF7: 5.2;PC-3: 5.3;RPMI-8226: 9.6;U-2 OS: 4.7;U-266/70: 8.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"				Cytosol	"Endoplasmic reticulum"	"HPA049690: , HPA068342: "															"unprognostic (3.63e-2)"			0.1	0.0	0.0	0.7	0.2	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0		0.1	0.8	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.4	0.0	0.9	0.0	78.6	0.0	0.4	0.1	0.4	0.8	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	7.1	0.0	5.2	0.0	0.0	1.2	5.3	0.0	0.0	9.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	4.7	2.4	0.0	8.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 12.3"	"Group enriched"	"Detected in some"	4	"HDLM-2: 9.9;Karpas-707: 2.9"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA068342			Approved	"Endoplasmic reticulum,Cytosol"				Cytosol	"Endoplasmic reticulum"	"HPA068342: "	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.0	0.1	0.4	0.2	1.0	0.0	0.1	0.7	0.8	0.0	0.1			0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.4		0.0	0.0	0.0	0.1	0.1		0.0	0.1		0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	12.3			0.0		0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.9	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	2.9	0.0	0.3	0.3	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0										
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185915906-185938136	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol			40000	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: , HPA064972: "	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favourable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	36.2	38.0	34.9	52.5	32.4	34.5	34.1	29.8	29.1	30.5	39.5	20.3	31.7	22.4	37.8	32.3	36.5	27.1	31.0	26.4	29.9	30.1	33.0	37.1	27.1	36.9	29.8	21.9	28.9	31.0	28.6	31.3	38.0	20.9	31.6	27.5	26.1	26.6	32.3	50.8	22.7	24.9	35.7	27.1	31.9	28.7	38.4	25.1	57.2	29.6	47.3	42.8	34.0	50.3	34.5	37.0	30.7	21.0	20.6	25.0	10.7	31.3	13.0	32.6	16.6	9.5	7.5	17.9	25.5	16.4	28.2	22.3	20.8	16.6	30.4	30.7	13.0	20.5	35.6	24.8	33.1	25.5	22.6	28.4	11.7	27.6	12.7	30.1	23.0	7.2	12.3	16.6	16.1	21.5	27.1	19.4	21.5	16.5	74.5	43.7	48.5	20.2	45.2	26.3	35.5	27.3	13.7	24.2	24.1	16.8	23.7	30.0	23.9	33.4	12.2	19.1	25.0	15.9	38.2	35.8	87.2	56.7	19.6	35.0	30.0	30.7	21.0	16.1	20.2	17.1	18.1	31.7	19.8	18.7	18.3	34.5	25.0	22.7	22.1	20.6	18.6	37.0	18.5	10.7	34.9	32.4	29.8	29.1	29.9	30.1	29.8	21.9	20.9	25.1
TRADD	Hs.89862	ENSG00000102871	"TNFRSF1A associated via death domain"	Q15628	16	67154180-67160298	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004602, HPA071341"	Enhanced		Approved	Cytosol				Cytosol		"CAB004602: AB_2209061, HPA071341: "	"unprognostic (2.66e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.23e-2)"	"prognostic favourable (1.40e-4)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.83e-1)"	12.2	13.3	8.7	15.9	10.5	5.6	10.1	2.1	6.9	11.9	12.3	10.8	13.0	10.2	10.4	11.1	17.4	11.6	14.5	7.3	6.5	3.1	15.0	11.8	11.6	14.4	10.5	4.4	12.8	17.9	9.7	8.4	14.9	9.5	13.7	7.4	9.0	15.4	10.5	6.6	14.8	12.1	8.7	7.2	20.3	21.8	4.4	9.8	9.7	19.5	11.0	22.4	11.7	12.0	20.8	21.4	25.6	20.0	10.5	50.5	14.3	8.6	7.3	0.1	2.9	6.8	5.8	9.5	6.8	5.0	3.2	5.1	4.6	7.1	4.6	11.7	5.9	15.9	1.1	5.9	2.6	13.2	6.8	3.0	3.4	4.5	8.5	3.8	7.9	6.0	8.7	4.4	1.6	6.1	4.4	7.4	4.8	8.0	4.5	7.6	0.1	22.3	9.0	3.6	18.2	5.5	5.6	1.4	4.4	15.2	3.5	4.3	6.0	5.4	7.0	4.4	4.7	7.2	4.8	14.8	4.7	5.5	10.7	3.4	5.1	12.0	12.3	25.6	16.7	15.3	25.1	20.8	50.5	28.9	15.2	18.5	14.8	11.9	21.6	10.5	20.0	21.4	22.2	14.3	8.7	10.5	2.1	6.9	6.5	3.1	10.5	4.4	9.5	9.8
TRAF2	"RNF117, TRAP3"	ENSG00000127191	"TNF receptor associated factor 2"	Q12933	9	136881912-136926607	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004603, HPA009972, HPA010634"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347"	"unprognostic (7.77e-2)"	"unprognostic (4.54e-3)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (4.91e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	7.3	6.6	8.7	20.3	10.4	15.9	8.6	16.0	10.0	7.3	8.7	7.4	7.3	11.1	12.3	6.9	12.3	9.0	8.3	8.3	7.5	6.5	8.5	12.3	11.5	19.7	11.2	8.3	6.8	13.9	5.9	8.8	12.1	8.1	10.2	6.2	7.5	13.0	10.1	6.4	13.0	10.4	10.6	8.2	13.8	10.7	13.7	6.4	16.4	14.7	5.2	15.9	8.4	37.5	12.6	11.5	6.7	8.3	10.1	17.4	6.2	10.6	32.9	8.9	7.9	2.5	4.0	17.4	8.8	4.9	12.9	8.8	20.3	19.3	13.3	11.5	5.5	28.1	12.2	14.4	5.3	20.2	9.9	10.0	29.7	12.6	3.7	9.8	10.4	3.0	4.4	10.5	6.0	6.0	16.8	15.2	5.7	15.5	15.9	14.1	14.5	14.8	15.1	13.7	18.1	7.9	8.4	14.6	6.8	11.0	25.8	10.0	18.5	11.6	6.8	16.9	10.9	11.0	14.7	6.3	10.3	13.2	6.0	8.1	12.4	1.3	3.7	6.7	10.4	4.2	14.6	12.6	11.1	13.0	4.9	10.0	9.1	10.9	3.3	10.1	8.3	11.5	17.4	6.2	8.7	10.4	16.0	10.0	7.5	6.5	11.2	8.3	8.1	6.4
TRAFD1	FLN29	ENSG00000135148	"TRAF-type zinc finger domain containing 1"	O14545	12	112125501-112153609	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039254, HPA039266"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039254: AB_10805358, HPA039266: AB_10795142"	"unprognostic (7.80e-2)"	"prognostic favourable (5.73e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (9.26e-6)"	"unprognostic (1.07e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.33e-3)"	"prognostic favourable (3.92e-5)"	15.1	13.1	11.0	21.9	19.2	20.5	16.6	11.9	19.8	15.6	31.6	42.1	15.2	12.7	15.1	12.8	26.0	12.8	14.0	16.9	12.2	10.8	12.7	12.5	21.2	25.5	26.2	10.7	15.3	10.2	15.3	14.9	15.5	22.2	18.5	16.8	22.7	16.4	16.7	10.3	28.1	16.0	20.5	25.0	25.0	15.2	30.9	23.4	28.2	13.0	13.0	29.7	25.6	17.4	13.2	11.4	59.1	21.4	14.8	13.8	19.3	10.6	12.1	19.6	18.2	13.3	12.8	10.1	12.1	17.7	17.3	13.7	12.9	9.7	12.1	10.5	12.8	21.6	19.0	11.9	11.6	21.1	18.1	19.6	17.1	7.0	23.2	12.1	30.7	16.4	20.3	12.3	16.8	15.1	21.9	7.5	10.9	17.9	13.3	16.7	16.0	14.3	19.0	12.0	20.4	11.2	40.1	16.6	12.8	25.3	25.0	6.7	16.2	16.9	9.6	7.9	5.7	7.7	6.4	18.3	16.1	13.0	8.4	9.6	8.5	59.1	21.4	48.3	10.7	19.4	7.3	13.2	10.5	9.6	11.4	12.2	9.7	8.9	42.8	14.8	20.0	7.5	13.8	19.3	11.0	19.2	11.9	19.8	12.2	10.8	26.2	10.7	22.2	23.4
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828599-49856574	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavourable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	4.8	1.6	3.4	6.0	10.7	9.5	3.0	7.4	3.0	3.5	3.7	2.0	3.2	2.3	3.8	2.4	4.5	3.0	2.9	1.5	2.7	2.7	1.6	1.2	1.3	8.1	2.0	2.8	3.4	1.6	1.6	2.0	2.5	3.0	2.9	4.8	2.7	3.1	1.7	2.8	6.7	3.4	3.4	5.1	3.7	1.9	25.0	3.4	11.5	2.2	3.1	6.8	1.9	3.0	5.1	1.6	0.6	3.0	2.7	4.9	1.6	6.4	7.9	11.3	11.3	1.0	1.6	9.3	7.8	3.7	16.5	15.8	9.5	7.4	15.9	5.5	4.5	8.5	11.8	8.9	12.4	9.1	7.8	11.9	9.6	8.5	0.4	9.7	10.0	1.1	1.3	13.2	7.0	4.3	8.6	11.5	7.3	9.3	16.1	12.4	9.0	13.0	8.9	7.6	9.2	3.0	9.0	5.5	9.4	8.6	7.3	5.5	6.6	13.9	3.3	10.6	12.6	14.5	15.2	8.5	20.2	17.0	5.3	13.2	9.4	0.0	1.5	0.6	2.3	0.8	2.0	5.1	1.3	4.9	1.3	3.8	1.7	2.6	0.3	2.7	3.0	1.6	0.8	1.6	3.4	10.7	7.4	3.0	2.7	2.7	2.0	2.8	3.0	3.4
TRAM2	KIAA0057	ENSG00000065308	"Translocation associated membrane protein 2"	Q15035	6	52497402-52576915	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 53.8;ASC TERT1: 57.7;fHDF/TERT166: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA035092, HPA057925"	Approved		Approved	Cytosol				Cytosol		"HPA035092: AB_10610562, HPA057925: "	"unprognostic (2.32e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (1.12e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-1)"	"prognostic unfavourable (1.41e-9)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.19e-2)"	17.3	4.9	2.0	11.8	3.7	2.7	29.4	2.0	3.3	13.3	12.5	4.3	4.4	9.2	12.7	9.0	8.3	11.5	11.8	10.5	3.3	2.2	7.7	23.7	12.6	13.1	4.0	2.2	15.6	6.8	1.9	4.0	46.7	6.0	9.9	10.2	12.0	6.2	4.0	6.3	7.6	15.9	17.6	5.3	20.0	8.4	11.6	2.7	4.9	11.7	6.0	12.1	14.0	19.6	3.6	3.1	2.8	5.4	2.0	2.8	1.8	9.0	4.0	4.7	4.7	53.8	57.7	8.3	26.7	27.1	22.5	20.9	8.7	1.9	2.2	4.5	51.8	2.0	3.1	16.7	28.4	4.9	1.6	4.8	4.0	11.0	15.4	1.2	2.7	20.9	1.6	19.6	8.7	25.7	2.9	16.3	32.1	3.2	1.7	3.5	2.1	1.8	2.1	12.5	18.3	5.3	1.5	1.1	1.8	6.1	2.7	6.4	4.3	2.6	40.7	37.7	8.2	13.6	14.6	11.1	19.0	6.4	13.7	3.2	22.9	0.2	2.8	2.8	2.8	3.4	1.5	3.6	2.2	1.7	3.1	2.0	1.2	2.0	0.8	2.0	5.4	1.5	0.8	1.8	2.0	3.7	2.0	3.3	3.3	2.2	4.0	2.2	6.0	2.7
TRAPPC2L	HSPC176	ENSG00000167515	"Trafficking protein particle complex 2 like"	Q9UL33	16	88856220-88862686	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041714	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA041714: AB_10793930"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (3.75e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.94e-2)"	22.7	46.1	29.5	18.6	29.2	19.8	22.4	15.9	37.4	18.5	21.8	25.5	16.0	16.2	15.8	40.4	17.4	19.0	25.0	26.0	22.9	24.4	20.2	21.9	13.9	24.3	24.9	22.5	21.5	25.6	8.7	16.0	13.7	22.1	15.8	15.7	20.0	17.3	17.3	53.8	19.0	14.7	14.1	27.3	18.3	21.5	33.9	18.1	11.5	19.2	25.1	16.6	16.1	16.4	41.2	45.6	10.8	39.0	24.6	47.7	40.9	15.8	11.1	18.9	14.3	14.2	18.2	19.5	14.3	16.4	22.2	8.5	30.9	21.0	12.2	25.4	18.2	17.0	25.7	20.6	16.1	10.6	15.4	8.1	11.2	39.0	21.0	22.9	6.5	17.6	13.0	29.9	15.2	17.8	24.2	9.8	15.1	49.5	30.5	70.9	19.0	20.8	29.4	15.7	12.6	17.0	18.4	20.5	10.1	48.6	15.0	13.1	38.5	24.4	14.0	14.7	16.1	19.3	16.2	13.8	23.3	56.7	17.6	34.2	17.5	10.0	39.0	10.8	34.0	31.2	34.2	41.2	39.2	36.6	37.7	35.2	36.9	31.4	6.8	24.6	29.7	45.6	47.7	40.9	29.5	29.2	15.9	37.4	22.9	24.4	24.9	22.5	22.1	18.1
TRAPPC3	BET3	ENSG00000054116	"Trafficking protein particle complex 3"	O43617	1	36136570-36156053	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028408	Approved		Approved	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA028408: AB_10601826"	"unprognostic (3.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (2.70e-6)"	"unprognostic (7.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.10e-3)"	"unprognostic (6.53e-2)"	28.7	53.5	31.9	29.4	31.9	17.8	41.0	27.3	33.6	28.4	33.6	21.9	33.6	24.3	28.9	46.3	39.7	27.8	33.4	39.4	26.3	29.4	39.7	36.6	26.0	24.4	28.7	26.1	19.9	37.0	29.0	32.4	42.8	30.2	29.9	31.7	28.8	30.8	35.6	34.2	32.4	27.2	36.6	26.8	28.3	31.1	33.7	23.3	28.0	48.4	35.6	37.4	32.4	38.6	37.6	52.6	56.9	55.4	35.9	51.6	55.6	32.5	23.6	15.9	24.7	41.7	33.6	31.4	29.9	38.4	35.9	34.9	19.5	31.5	13.9	28.5	32.8	24.2	24.5	40.1	41.0	27.1	37.5	25.9	27.5	28.2	48.8	27.1	27.5	28.6	35.2	33.4	33.0	44.7	31.3	23.5	43.0	25.1	31.9	25.4	21.3	35.0	22.4	22.6	31.0	45.4	26.9	24.4	17.7	24.4	27.6	47.4	17.8	20.5	33.2	21.1	24.1	41.1	39.7	28.8	29.0	22.7	36.2	30.7	21.2	54.0	53.1	56.9	36.3	55.4	37.5	37.6	43.2	38.1	52.6	33.9	41.9	37.8	53.9	35.9	43.6	43.3	51.6	55.6	31.9	31.9	27.3	33.6	26.3	29.4	28.7	26.1	30.2	23.3
TRAPPC4	"PTD009, SBDN, TRS23"	ENSG00000196655	"Trafficking protein particle complex 4"	Q9Y296	11	119018432-119025454	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039752, HPA041371"	Approved		Approved	Cytosol				Cytosol		"HPA039752: AB_2676664, HPA041371: "	"unprognostic (5.26e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.18e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavourable (2.03e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	20.4	26.8	17.1	11.8	21.2	16.3	14.8	15.6	20.1	16.1	20.4	16.1	33.7	20.4	13.6	20.4	16.3	14.3	19.4	15.4	16.1	20.1	30.1	20.3	16.3	15.3	17.5	16.2	16.4	19.4	11.9	21.1	16.2	16.5	20.2	13.8	16.2	14.4	24.8	26.4	12.7	23.8	14.5	17.1	15.5	18.1	19.6	12.1	16.4	18.2	10.0	18.1	18.1	10.6	29.9	28.6	39.7	28.0	26.3	47.2	29.4	7.7	7.9	9.0	9.3	11.0	7.7	4.2	30.8	17.0	18.9	15.1	18.3	3.1	8.9	21.9	11.5	7.3	13.8	11.3	14.5	16.0	8.3	14.9	7.7	20.1	15.9	12.0	7.5	11.2	10.2	18.1	13.7	16.4	16.7	3.5	10.8	17.5	13.6	11.5	7.1	21.7	12.3	7.0	10.7	13.1	10.1	3.5	8.4	6.0	6.8	7.4	27.7	10.8	12.1	5.2	10.1	6.5	9.9	4.8	9.3	22.2	5.7	9.6	8.5	29.8	20.8	39.7	28.9	22.9	29.3	29.9	33.7	32.9	20.0	26.7	31.4	34.0	17.9	26.3	28.0	28.6	47.2	29.4	17.1	21.2	15.6	20.1	16.1	20.1	17.5	16.2	16.5	12.1
TRAPPC8	"GSG1, HsT2706, KIAA1012, TRS85"	ENSG00000153339	"Trafficking protein particle complex 8"	Q9Y2L5	18	31829173-31953136	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041107	Approved		Approved	Microtubules,Cytosol				Cytosol	Microtubules	"HPA041107: AB_10793869"	"unprognostic (4.04e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.35e-3)"	"prognostic favourable (1.85e-9)"	"unprognostic (3.55e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.92e-1)"	16.2	17.0	12.9	18.1	16.5	13.6	15.4	20.8	19.5	16.0	18.1	16.3	15.3	15.0	16.9	13.0	18.8	14.8	13.8	15.5	12.9	12.1	20.1	26.4	14.1	17.5	15.6	12.7	14.5	15.7	24.1	19.8	19.3	19.2	14.8	16.6	17.5	17.0	17.5	25.0	20.5	25.5	15.1	14.6	19.8	15.7	40.7	13.6	28.2	18.7	13.3	19.0	16.1	18.7	2.7	2.8	9.9	2.8	3.0	4.3	1.1	8.5	7.4	8.5	6.5	12.9	12.3	9.4	11.3	12.1	10.7	10.6	5.0	6.5	12.1	9.1	11.0	13.2	12.3	6.4	15.0	13.7	5.8	10.0	7.3	6.1	9.9	29.1	11.8	10.9	8.9	9.9	14.4	12.1	14.5	11.2	10.7	5.8	12.4	10.0	8.6	6.2	13.1	10.1	12.8	10.7	13.5	6.6	7.8	14.5	8.8	10.2	9.7	12.9	14.6	11.4	5.7	4.1	6.9	14.3	15.8	18.1	11.0	12.7	11.7	9.9	2.7	2.8	2.0	2.8	4.3	2.5	2.7	2.4	2.8	2.7	2.4	2.6	4.5	3.0	2.7	2.1	2.9	1.1	12.9	16.5	20.8	19.5	12.9	12.1	15.6	12.7	19.2	13.6
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: "	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 53.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: , HPA051273: , HPA059943: "	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	4.9	8.7	9.3	7.7	8.7	16.7	4.0	18.1	10.8	12.0	5.1	2.9	9.7	4.2	10.0	4.0	12.6	7.2	6.9	2.8	4.5	3.9	5.2	1.4	4.0	9.2	2.5	4.7	10.2	2.5	7.5	9.3	3.4	3.5	8.8	4.7	7.3	3.7	5.2	1.3	8.4	6.6	8.6	4.9	9.0	5.6	11.2	4.8	23.4	3.3	3.6	12.7	13.3	11.0	0.4	1.4	8.1	1.1	2.7	3.0	1.1	5.1	3.5	4.0	5.1	1.8	4.2	5.7	3.9	6.2	4.5	3.7	0.0	2.7	4.7	0.8	5.8	6.2	5.1	4.8	3.6	53.8	0.4	5.1	2.9	0.0	1.3	9.4	16.5	1.7	6.8	4.0	1.6	0.0	0.0	1.6	1.9	1.1	2.4	16.0	4.4	3.7	4.4	0.3	1.7	2.6	6.3	3.2	1.7	2.3	0.0	0.4	2.3	12.8	1.7	2.5	3.0	4.1	1.1	0.6	3.4	5.2	1.7	8.6	0.0	2.1	1.1	8.1	3.0	0.4	2.9	0.4	2.2	2.7	1.4	0.0	1.9	2.0	3.8	2.7	0.2	1.2	2.1	1.1	9.3	8.7	18.1	10.8	4.5	3.9	2.5	4.7	3.5	4.8
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol				Cytosol		"HPA035437: AB_10672092, HPA046721: "																		14.2	14.3	16.7	14.6	10.6	20.7	17.2	13.0	16.9	13.4	11.0	12.8	17.5	10.3	8.1	14.9	16.6	14.5	12.3	9.8	14.4	14.2	11.6	12.7	12.5	26.2	14.6	17.4	7.3	13.0	6.8	31.2	11.6	11.2	15.4	9.3	10.8	32.2	19.3	10.8	22.9	10.9	8.2	12.6	25.5	12.4	4.6	10.1	18.5	7.4	18.3	21.7	13.3	10.6	24.9	35.5	23.3	41.8	8.6	13.1	20.1	8.0	7.4	6.2	4.4	7.7	7.9	0.0	2.6	13.1	22.0	31.0	0.1	9.6	9.5	5.4	11.1	9.4	0.4	11.8	3.1	8.0	0.7	5.5	26.6	0.4	9.7	5.0	3.9	6.9	1.1	11.1	4.4	9.3	0.0	14.6	9.3	0.1	7.0	3.6	0.0	4.6	5.8	1.6	18.6	5.8	1.6	0.0	3.7	9.6	13.0	6.3	0.4	8.4	9.8	4.1	3.9	8.7	6.1	11.8	6.8	4.0	9.1	10.7	3.3	2.1	41.8	3.0	9.8	32.5	5.6	24.6	13.1	9.4	35.5	24.9	12.4	10.3	23.3	8.6	24.3	28.0	11.6	20.1	16.7	10.6	13.0	16.9	14.4	14.2	14.6	17.4	11.2	10.1
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430321-125438405	"Enzymes, Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 84.2;thyroid gland: 90.7"	"Cell line enhanced"	"Detected in many"		"HEL: 54.0;U-266/70: 33.1;U-266/84: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1"	"Group enriched"	"Detected in many"	11	"granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA063982: "	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	26.7	6.5	5.9	17.6	6.5	84.2	13.3	4.3	6.1	10.4	12.4	4.4	6.6	4.9	6.2	6.7	10.9	10.9	21.0	11.1	4.3	4.0	16.6	63.5	28.9	14.6	4.2	3.9	6.4	23.6	20.9	7.2	15.5	4.5	12.1	13.3	15.0	14.5	9.1	22.3	10.4	16.9	11.3	3.1	15.9	18.5	5.6	3.1	9.2	90.7	17.6	12.1	12.4	9.0	0.2	0.5	10.8	3.7	0.0	3.1	0.1	4.0	4.6	0.6	1.3	1.3	2.6	7.3	2.6	3.7	1.9	0.6	6.2	5.4	7.4	2.5	1.9	3.1	2.0	2.6	1.7	3.2	9.7	54.0	2.0	12.0	3.4	27.0	4.9	2.5	3.9	8.1	18.4	5.7	4.7	23.5	0.2	4.3	2.5	4.2	4.5	9.0	5.1	0.9	8.0	15.9	15.5	3.9	1.4	6.5	7.1	25.7	1.8	1.3	2.9	2.1	2.8	2.1	3.3	33.1	33.0	10.3	3.8	0.1	5.0	0.0	0.9	10.8	0.0	1.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	5.8	0.0	3.7	0.3	3.1	0.1	5.9	6.5	4.3	6.1	4.3	4.0	4.2	3.9	4.5	3.1
TRIB2	"GS3955, TRB2"	ENSG00000071575	"Tribbles pseudokinase 2"	Q92519	2	12716889-12742734	"Enzymes, Predicted membrane proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 40.2;HEL: 39.4;K-562: 53.6;SK-MEL-30: 39.1;WM-115: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 24.8"	"Group enriched"	"Detected in many"	9	"B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001305	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA001305: AB_1080371"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.31e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.13e-2)"	19.6	30.9	13.2	17.7	13.3	7.0	23.2	23.2	23.0	10.8	12.3	10.5	6.7	8.7	23.0	22.6	8.1	11.6	14.5	18.2	15.0	10.8	24.8	10.6	18.9	33.0	13.4	16.2	52.3	14.4	6.6	11.3	23.0	15.5	16.3	6.9	35.7	9.9	13.6	6.9	8.2	11.9	17.6	10.4	38.9	19.5	13.9	10.1	37.3	12.1	6.2	33.4	21.9	23.2	7.1	0.6	1.5	0.1	9.5	24.8	4.5	0.0	0.0	30.6	40.2	11.0	10.2	0.0	1.7	1.6	1.0	1.7	0.1	3.3	3.4	1.2	3.6	0.5	2.2	3.4	0.9	3.8	6.3	39.4	0.1	0.5	13.7	2.2	15.1	9.4	3.5	4.4	1.2	4.8	53.6	0.0	1.7	0.3	5.0	9.4	14.5	3.9	0.0	10.2	1.4	7.0	5.0	26.4	12.6	0.2	1.6	39.1	0.0	0.2	3.0	14.6	7.3	0.1	3.8	0.0	0.0	4.9	7.8	7.7	53.8	0.8	0.1	1.5	7.3	0.0	8.8	5.3	14.4	7.7	0.6	7.1	8.5	5.2	0.3	9.5	0.1	0.0	24.8	4.5	13.2	13.3	23.2	23.0	15.0	10.8	13.4	16.2	15.5	10.1
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: "	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	8.8	9.2	8.9	13.8	16.5	33.2	23.8	45.2	11.5	8.7	11.2	6.4	15.1	10.1	8.7	10.6	13.3	9.4	13.9	6.9	9.2	8.5	7.7	7.1	27.5	18.6	9.0	8.0	9.0	11.9	8.5	7.2	9.4	7.1	10.5	9.7	6.0	14.4	18.2	5.0	12.5	11.8	8.6	6.0	16.5	12.6	9.5	7.8	20.0	9.0	9.7	13.1	9.5	24.3	6.4	6.9	10.0	11.4	9.4	11.8	5.4	13.8	13.2	7.1	9.7	5.3	4.4	33.5	9.1	6.1	10.6	8.5	16.0	12.1	10.4	10.2	6.1	22.6	8.5	8.7	4.5	11.6	20.5	8.6	12.2	8.6	14.5	10.9	13.2	5.9	14.0	10.9	5.5	5.2	19.7	13.5	5.4	9.0	13.1	17.2	18.1	11.7	12.9	6.4	12.6	6.9	17.0	11.8	21.7	7.6	21.6	12.0	15.2	18.2	5.8	6.7	9.5	15.7	18.8	13.9	9.2	9.2	8.4	8.7	10.6	6.1	6.9	8.3	9.6	8.2	10.2	5.8	10.7	11.8	6.9	6.4	6.3	8.4	10.0	9.4	11.4	5.5	9.8	5.4	8.9	16.5	45.2	11.5	9.2	8.5	9.0	8.0	7.1	7.8
TRIM14	KIAA0129	ENSG00000106785	"Tripartite motif containing 14"	Q14142	9	98069275-98119212	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053217	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA053217: "	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.55e-3)"	"unprognostic (4.57e-2)"	9.2	3.3	6.4	20.2	7.6	6.4	6.2	1.4	5.4	5.2	15.4	4.2	1.1	18.1	3.8	4.9	16.8	3.8	10.8	4.1	5.9	4.4	13.4	19.8	14.3	24.4	5.2	3.5	4.5	3.9	15.0	5.0	5.7	5.6	8.2	10.7	4.7	7.7	3.5	1.0	6.0	31.8	5.3	5.8	30.4	7.0	6.2	5.7	35.2	3.2	3.7	19.5	8.9	7.4	4.4	8.0	2.4	27.7	6.2	11.5	7.5	10.2	5.3	0.2	4.8	0.0	1.7	3.6	6.0	11.8	33.8	29.2	10.2	6.2	13.7	5.0	6.6	11.8	10.4	6.9	10.4	17.4	8.5	4.0	8.5	10.0	7.4	21.4	4.5	1.0	3.4	4.9	6.4	4.2	15.8	6.5	3.0	13.3	16.8	6.8	6.0	16.7	10.8	0.6	6.9	2.7	6.4	1.7	1.4	8.6	18.2	5.8	4.8	12.4	2.9	1.4	3.6	0.5	8.3	2.8	3.3	4.6	3.9	16.9	4.7	0.4	7.4	1.0	8.1	14.5	8.9	4.4	9.3	8.4	7.9	3.3	7.4	6.2	2.4	6.2	27.7	8.0	11.5	7.5	6.4	7.6	1.4	5.4	5.9	4.4	5.2	3.5	5.6	5.7
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"gallbladder: 12.1;intestine: 29.3;liver: 14.1"	"Cell line enriched"	"Detected in single"	24	"HEL: 19.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA047527	Uncertain		Approved	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	8.6	0.0	0.2	0.2	0.0	12.1	0.0	0.0	0.0	4.3	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	29.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 52.9"	"Cell line enhanced"	"Detected in many"		"A549: 64.1;HaCaT: 51.8;HeLa: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"T-reg: 25.1"	"Lineage enriched"	"Detected in many"	11	"T-cells: 25.1"									"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: "	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (6.71e-4)"	6.1	13.5	7.4	4.8	12.8	7.0	6.7	7.4	11.7	16.0	5.0	7.8	6.6	10.2	7.0	2.8	52.9	4.0	7.5	6.5	8.0	4.4	5.7	2.2	6.2	10.9	11.3	5.6	3.7	6.2	1.9	5.7	15.8	9.8	4.1	5.2	5.0	14.7	5.7	11.4	15.6	5.5	5.4	5.9	4.6	14.4	5.5	7.8	4.7	7.4	5.3	16.3	11.7	23.3	0.4	1.5	0.6	2.3	0.5	25.1	1.3	20.1	64.1	2.0	4.4	9.5	11.0	2.1	3.3	11.8	4.1	5.8	3.8	26.3	2.1	12.7	14.5	51.8	5.8	14.9	2.8	26.6	3.7	1.0	46.7	2.0	15.9	1.1	2.2	6.0	9.4	9.0	5.2	8.8	1.2	10.5	11.2	7.1	4.4	2.6	3.0	3.9	1.9	16.6	1.5	21.3	26.1	1.4	4.1	14.6	16.6	5.0	2.5	2.8	13.7	5.2	6.2	2.5	11.4	2.5	2.7	0.2	8.1	2.8	13.2	0.1	2.3	0.6	0.8	0.6	0.5	0.3	3.0	0.9	1.5	0.4	0.8	1.6	0.5	0.5	0.3	0.3	25.1	1.3	7.4	12.8	7.4	11.7	8.0	4.4	11.3	5.6	9.8	7.8
TRIM16L	TRIM70	ENSG00000108448	"Tripartite motif containing 16 like"	Q309B1	17	18697998-18736118	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.5"	"Cell line enhanced"	"Detected in many"		"A549: 48.6;CAPAN-2: 20.9;HaCaT: 24.8;HeLa: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA066431	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA066431: "	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.89e-3)"	"unprognostic (5.66e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (7.08e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (1.13e-2)"	2.8	4.4	2.0	1.0	3.1	0.5	7.1	1.0	3.0	2.2	3.6	1.3	1.0	2.0	1.4	3.2	10.5	3.3	8.1	16.8	2.0	2.5	3.5	2.8	2.4	1.0	4.7	1.0	1.3	1.3	0.1	1.0	1.8	3.1	3.6	1.0	2.1	2.6	3.7	22.5	0.8	1.1	6.5	4.7	1.0	3.0	2.9	1.4	1.0	4.5	12.7	3.4	6.7	11.8	1.5	0.8	0.4	1.4	2.7	2.1	1.8	5.2	48.6	0.3	2.0	5.9	2.4	3.8	0.4	4.0	1.8	3.7	0.8	20.9	0.5	3.8	13.9	24.8	0.5	1.1	0.9	0.2	0.7	0.3	38.8	0.5	14.6	0.0	0.5	2.5	1.4	2.7	1.0	0.5	0.0	0.0	4.7	5.1	0.1	0.5	0.5	1.0	0.5	2.5	0.0	3.5	3.0	0.1	1.1	5.5	1.1	2.9	2.5	0.4	10.9	1.2	6.3	1.9	7.0	0.6	0.6	0.0	4.1	0.4	9.2	0.1	0.7	0.4	0.7	1.4	1.0	1.5	1.0	0.6	0.8	1.1	1.6	1.5	0.3	2.7	0.5	0.2	2.1	1.8	2.0	3.1	1.0	1.9	2.0	2.5	4.7	1.0	3.1	1.4
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56887909-56914038	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 20.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			35000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favourable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	20.0	19.7	7.5	23.6	8.9	32.6	19.3	11.6	7.8	15.3	22.5	5.0	8.0	15.3	13.4	12.6	17.7	15.3	18.4	8.3	5.8	6.3	10.1	27.0	20.8	15.9	6.7	5.5	13.3	15.3	13.6	11.5	55.0	7.4	12.2	14.3	12.5	14.5	11.5	11.7	23.1	20.7	10.1	5.2	35.8	14.1	12.8	6.5	26.2	11.8	15.1	18.5	10.6	35.9	1.7	2.4	20.0	2.3	0.8	1.5	0.7	28.8	14.3	3.5	11.9	26.7	22.6	0.0	11.4	23.1	27.3	23.6	13.9	15.9	28.2	23.7	10.9	17.2	17.2	15.3	15.3	24.0	13.6	18.2	11.1	15.4	23.0	21.7	13.1	10.1	25.8	14.2	30.3	18.1	4.4	17.3	13.8	19.3	24.2	15.7	2.2	27.8	17.4	11.9	17.7	15.9	22.8	6.9	6.4	9.0	14.5	26.5	19.6	17.7	12.0	12.8	9.2	19.6	11.8	9.8	18.7	4.7	12.4	15.0	5.0	3.0	2.3	0.9	0.9	1.9	1.1	1.7	0.8	0.8	2.4	1.4	0.6	0.8	20.0	0.8	1.4	1.7	1.5	0.7	7.5	8.9	11.6	7.8	5.8	6.3	6.7	5.5	7.4	6.5
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044975: , HPA050456: "	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favourable (3.25e-5)"	11.9	12.6	10.6	20.0	12.2	13.8	13.2	17.6	14.9	10.7	16.1	15.9	14.5	18.5	12.9	18.4	21.5	21.1	18.6	8.4	10.8	11.3	19.5	19.2	12.2	21.3	13.1	8.1	10.9	15.3	16.3	11.5	10.8	12.3	13.4	9.8	17.7	18.4	20.6	9.9	21.5	21.9	14.2	13.1	17.6	15.2	10.9	14.0	13.7	15.8	10.7	21.7	14.7	24.6	3.6	3.8	1.7	4.2	2.1	4.1	3.6	10.2	2.2	0.0	14.5	4.8	2.8	4.7	2.8	3.3	7.2	7.2	0.0	0.4	22.9	8.2	7.1	11.7	0.0	10.0	2.3	0.0	6.7	3.5	1.6	8.3	4.5	4.5	2.9	3.0	3.5	7.3	4.6	4.5	1.6	0.0	0.0	0.0	7.5	11.1	0.0	3.9	9.9	6.9	3.3	6.0	9.6	0.4	6.2	10.5	4.6	2.9	3.6	1.5	7.5	5.6	3.9	0.0	0.1	9.2	16.4	12.1	0.0	13.0	8.9	1.7	3.1	0.5	3.9	4.2	3.2	3.2	2.9	3.8	3.8	3.6	1.8	2.7	1.7	2.1	2.6	1.9	4.1	3.6	10.6	12.2	17.6	14.9	10.8	11.3	13.1	8.1	12.3	14.0
TRIM36	"HAPRIN, RBCC728, RNF98"	ENSG00000152503	"Tripartite motif containing 36"	Q9NQ86	5	115124762-115180546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 88.8"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.5;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	43	"dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061321			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA061321: "	"unprognostic (6.36e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.33e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.82e-13)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.80e-3)"	1.0	1.4	6.8	1.4	7.6	0.8	3.2	0.6	11.7	1.4	4.8	7.7	0.0	8.2	1.1	1.0	0.8	1.9	1.0	0.7	10.1	7.2	0.9	0.9	1.6	0.8	7.1	8.6	3.5	1.5	0.7	8.2	1.3	18.3	5.7	4.8	5.1	1.0	1.0	0.7	1.0	7.9	1.1	8.7	0.9	2.0	88.8	4.7	0.0	0.8	0.0	0.9	0.8	1.0	0.1	7.5	4.2	7.7	0.0	0.0	0.8	2.4	0.7	1.2	6.2	0.1	0.1	1.5	0.5	2.1	1.1	1.3	0.9	1.2	0.0	1.0	0.1	0.6	5.8	1.1	0.8	0.4	1.9	4.3	2.5	1.2	0.2	4.2	3.6	0.1	1.1	0.5	1.5	0.0	0.1	5.9	1.7	3.3	1.1	3.8	4.9	2.8	0.9	17.8	1.4	0.6	0.0	19.9	14.5	3.8	0.4	2.3	4.2	5.3	0.5	1.7	1.3	1.3	1.9	0.9	0.5	0.0	1.9	2.4	0.8	0.0	1.7	4.2	0.0	1.6	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.3	0.0	7.7	1.6	0.0	0.8	6.8	7.6	0.6	11.7	10.1	7.2	7.1	8.6	18.3	4.7
TRIM39	RNF23	ENSG00000204599	"Tripartite motif containing 39"	Q9HCM9	6	30326479-30343729	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051120, HPA059496"	Uncertain		Supported	Cytosol				Cytosol		"HPA051120: , HPA059496: "	"unprognostic (2.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.38e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.39e-3)"	8.6	7.6	5.2	14.3	6.4	11.8	7.4	8.6	7.6	10.2	11.2	7.3	9.7	7.1	10.0	15.2	11.9	8.5	13.6	6.1	5.4	5.5	7.6	9.6	11.1	6.7	7.7	6.3	10.3	9.1	8.9	11.4	11.6	7.1	7.9	7.1	11.4	8.2	15.5	9.9	6.5	10.9	8.8	6.0	13.1	8.0	14.1	7.2	7.8	8.9	8.3	10.1	9.1	12.3	3.4	1.6	8.4	2.5	4.4	5.2	2.1	4.4	0.2	3.8	6.8	1.8	1.8	3.9	2.0	2.5	3.0	2.7	5.3	0.6	5.6	4.1	3.8	1.4	4.4	3.1	3.1	4.4	4.8	4.5	0.7	1.9	3.9	6.6	5.0	2.1	2.6	3.8	4.2	1.9	6.6	4.5	3.9	4.0	1.4	1.4	5.1	3.2	3.1	0.8	4.2	3.3	4.3	8.3	4.1	1.6	3.3	3.9	4.4	1.7	1.7	3.3	2.7	4.0	6.8	8.2	10.0	5.8	2.0	2.4	5.1	1.4	1.7	6.8	5.2	2.5	4.6	3.4	3.7	3.8	1.6	3.3	4.4	4.1	8.4	4.4	2.4	1.2	2.9	2.1	5.2	6.4	8.6	7.6	5.4	5.5	7.7	6.3	7.1	7.2
TRIM39-RPP21		ENSG00000248167	"TRIM39-RPP21 readthrough"		6	30328907-30346854	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"esophagus: 1.8;testis: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.4;LHCN-M2: 2.2;MCF7: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051120	Uncertain		Approved	Cytosol				Cytosol		"HPA051120: "	"unprognostic (1.20e-1)"	"unprognostic (7.35e-2)"			"unprognostic (2.56e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.60e-1)"	"unprognostic (1.33e-1)"			"unprognostic (1.56e-1)"	"unprognostic (5.84e-4)"		"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-2)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	1.8	0.6	0.0	0.0			0.4	0.0	0.2	0.0			0.3	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919600	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	19.1	22.6	13.5	22.1	15.9	6.7	22.1	20.1	15.5	19.5	17.3	12.4	22.5	13.9	21.9	18.8	16.4	19.0	19.8	11.1	13.3	9.3	16.6	17.9	21.1	22.4	15.3	8.8	35.0	23.2	18.9	27.4	16.1	12.2	21.9	15.7	18.4	19.4	33.8	9.4	20.7	18.3	18.1	11.9	18.2	17.4	16.2	14.5	18.4	20.5	11.9	18.8	20.0	28.9	18.6	17.0	20.0	19.2	13.9	30.3	17.4	9.5	11.5	6.9	5.7	18.1	17.0	3.1	16.1	19.7	13.5	15.7	6.1	9.5	14.0	0.1	13.7	11.4	9.1	9.9	13.8	14.2	0.7	11.4	6.1	9.6	25.6	16.4	16.3	18.1	21.2	10.5	26.6	11.8	16.6	21.6	11.2	11.9	12.1	14.8	5.2	9.9	6.9	9.8	15.9	14.9	12.4	8.1	5.7	12.3	18.9	19.2	8.7	9.5	14.3	15.0	13.4	28.6	15.5	18.2	19.9	11.3	9.8	18.5	19.8	20.0	19.2	15.3	20.6	19.2	23.8	18.6	21.6	23.5	17.0	18.6	30.3	22.2	8.2	13.9	16.6	12.7	21.5	17.4	13.5	15.9	20.1	15.5	13.3	9.3	15.3	8.8	12.2	14.5
TRIM45	"FLJ13181, RNF99"	ENSG00000134253	"Tripartite motif containing 45"	Q9H8W5	1	117111060-117122587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030266, HPA054308"	Uncertain		Supported	"Cytokinetic bridge,Cytosol"				Cytosol	"Cytokinetic bridge"	"HPA030266: AB_10795476, HPA054308: "	"prognostic favourable (1.58e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (1.27e-2)"	2.3	5.4	6.3	1.4	3.6	1.9	4.9	2.4	7.2	3.4	4.5	5.8	8.0	3.8	9.0	8.0	3.3	9.4	9.3	12.4	3.9	2.6	3.8	1.1	2.6	0.9	2.6	7.5	8.5	8.9	7.3	8.8	9.4	4.5	8.3	2.3	6.0	3.4	7.4	26.6	5.9	3.1	13.3	3.4	2.4	6.1	5.4	4.1	0.7	9.9	9.0	2.1	6.3	4.5	0.4	0.7	0.6	0.4	2.8	2.2	0.0	3.2	2.9	12.1	5.7	1.0	2.8	9.2	3.6	1.5	2.5	2.5	1.3	2.9	0.1	2.7	1.7	2.9	2.8	2.9	3.4	1.8	2.9	1.9	8.9	1.5	1.8	1.7	2.8	3.6	2.9	4.2	3.0	3.1	2.3	2.4	2.3	13.9	1.0	2.1	6.5	2.6	4.6	23.9	0.7	3.4	2.9	9.2	2.3	2.9	2.7	2.2	4.7	2.3	1.0	3.5	5.1	2.1	3.1	6.7	2.5	0.2	4.6	1.6	8.9	0.6	0.4	0.2	0.3	0.2	0.2	0.3	0.3	0.1	0.7	0.4	0.2	0.2	0.5	2.8	0.1	0.3	2.2	0.0	6.3	3.6	2.4	7.2	3.9	2.6	2.6	7.5	4.5	4.1
TRIM47	"GOA, RNF100"	ENSG00000132481	"Tripartite motif containing 47"	Q96LD4	17	75874161-75878575	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 23.3;RPTEC TERT1: 17.6;U-266/70: 20.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014933	Uncertain		Supported	Cytosol				Cytosol		"HPA014933: AB_10603219"	"prognostic favourable (6.54e-4)"	"unprognostic (8.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (5.59e-5)"	"unprognostic (2.08e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (9.69e-5)"	"unprognostic (3.94e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.98e-2)"	18.8	5.2	11.2	11.6	14.3	1.3	51.5	5.9	26.9	12.5	14.9	10.4	2.6	16.0	16.1	9.5	15.3	9.0	15.9	11.3	11.3	8.5	17.6	8.8	11.2	15.4	14.9	9.4	11.6	18.4	14.5	4.6	5.3	12.4	11.0	9.0	6.2	13.4	9.8	9.3	16.3	9.4	19.9	11.3	15.6	19.7	7.5	13.2	2.6	6.5	13.3	8.1	20.7	13.5	3.5	1.7	1.8	0.0	2.9	7.2	0.7	10.0	7.5	0.0	0.0	1.7	1.8	0.2	0.4	0.8	0.6	0.5	1.4	5.2	0.0	6.6	0.3	11.5	1.8	2.8	0.0	6.5	4.7	0.0	5.1	13.7	2.8	0.0	0.0	1.4	0.8	1.2	1.0	5.2	1.0	15.5	0.3	1.7	0.9	0.1	0.8	14.7	0.7	0.8	23.3	17.6	0.3	3.0	0.2	3.0	14.8	3.9	1.7	0.3	7.8	9.3	5.8	0.9	3.5	20.1	5.7	1.1	4.1	0.0	0.8	0.0	0.0	1.8	2.6	0.0	6.8	3.5	6.0	3.3	0.2	2.0	4.0	2.5	0.0	2.9	0.0	1.7	7.2	0.7	11.2	14.3	5.9	12.8	11.3	8.5	14.9	9.4	12.4	13.2
TRIM5	"RNF88, TRIM5alpha"	ENSG00000132256	"Tripartite motif containing 5"	Q9C035	11	5663557-5938619	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"CAB013497, HPA023420, HPA023422"	Approved		Supported	Cytosol				Cytosol		"CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379"	"unprognostic (2.60e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.48e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.12e-2)"	12.5	15.0	3.7	11.6	6.7	3.0	10.7	2.4	5.1	14.2	8.5	4.8	20.1	8.4	16.1	19.9	12.0	11.9	9.9	7.8	5.6	2.9	15.1	16.2	15.2	9.2	6.5	2.9	15.3	24.8	6.1	9.2	12.2	8.8	11.8	8.3	11.8	22.0	12.4	3.0	6.5	13.2	12.0	9.0	19.8	9.5	7.7	6.5	24.9	20.5	7.9	13.3	14.8	12.3	3.9	11.7	13.8	9.8	5.9	5.4	4.6	4.6	7.2	12.3	8.6	13.7	12.6	3.6	9.9	18.6	20.3	27.5	7.3	9.3	3.0	7.8	9.7	7.6	10.0	14.5	9.2	6.4	2.7	9.0	5.0	5.8	12.2	6.6	9.7	9.5	13.0	6.7	17.8	31.3	9.4	6.1	17.0	2.1	5.4	3.0	5.6	5.1	8.4	2.6	0.8	14.1	8.9	0.3	0.7	7.0	10.1	4.4	5.2	3.8	23.6	9.6	12.7	1.8	2.4	5.5	3.8	1.2	8.9	4.4	9.8	10.2	9.8	12.9	5.4	9.8	5.3	3.9	4.1	4.3	11.7	3.9	3.4	4.9	13.8	5.9	9.2	9.7	3.3	4.6	3.7	6.7	2.4	5.1	5.6	2.9	6.5	2.9	8.8	6.5
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312539-73328082	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"pancreas: 17.2;stomach 1: 22.8"	"Cell line enriched"	"Detected in single"	33	"Hep G2: 12.0"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019862, HPA047843"	Uncertain		Approved	Cytosol				Cytosol		"HPA019862: AB_1858305, HPA047843: "	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0		0.0	17.2	0.2	0.0	0.3		0.0	0.0		0.0	0.0	1.8	0.0	1.0	0.0	0.0	0.1	22.8	4.4			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282392-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 187.1"	"Group enriched"	"Detected in some"	9	"HAP1: 8.2;NTERA-2: 17.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Cell type enriched"	"Detected in single"	16	"NK-cell: 7.0"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 7.0"	"Region enhanced"	"Detected in some"		"amygdala: 3.2"	"Group enriched"	"Detected in some"	11	"cerebral cortex: 1.4;hippocampal formation: 0.8"	HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	2.1	1.8	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.9	0.1	6.3	1.6	0.0	0.0	35.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.0	187.1	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0	1.3	40.3	2.2	0.1	0.0	0.3	0.0	0.0	0.0	7.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	1.4	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.6	0.0	0.6	0.7	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175487	"Predicted intracellular proteins, Predicted membrane proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4"	"Cell line enriched"	"Detected in some"	15	"LHCN-M2: 96.9"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.3"	"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"olfactory region: 0.5"	"Group enriched"	"Detected in some"	9	"hippocampal formation: 0.8;pons and medulla: 1.1"	"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA038793: AB_10673289, HPA053691: "	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	2.1	0.0	0.3	0.2	0.2	0.0	0.1	3.3	0.1	0.4	0.1	0.1	0.3	0.0	0.0	6.6	0.8	3.0	0.1	34.3	0.4	0.1	2.7	22.0	0.1	0.4	0.1	0.1	0.5	0.1	0.0	2.0	1.4	0.8	0.3	0.0	0.1	1.0	0.0	37.0	0.3	0.1	0.0	0.1	0.1	0.1	3.8	0.0	0.0	0.9	24.4	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	96.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.3	6.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	3.3	0.1	0.4	0.1	0.1	0.1	0.8	0.0
TRIM56	RNF109	ENSG00000169871	"Tripartite motif containing 56"	Q9BRZ2	7	101085439-101097967	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024358	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA024358: AB_1858308"	"unprognostic (6.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.44e-3)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (2.63e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (2.13e-4)"	14.3	12.0	6.2	15.7	9.3	4.7	24.5	3.2	11.1	14.9	15.0	6.8	22.3	9.7	14.3	13.1	12.9	12.8	13.7	8.7	7.5	5.2	10.8	10.4	23.7	11.7	15.8	5.2	17.3	10.8	10.7	15.2	14.0	8.8	12.5	8.3	7.5	12.2	22.1	8.7	13.2	12.8	15.2	8.5	17.2	10.3	5.6	12.0	9.7	14.0	9.1	12.0	13.6	22.0	3.3	2.1	7.4	2.4	7.7	3.6	1.0	9.9	12.5	5.4	6.9	12.5	13.0	6.5	8.3	7.4	13.5	12.6	5.9	14.5	11.8	9.0	6.9	11.5	2.2	7.6	9.1	11.8	3.5	7.4	15.7	4.4	11.2	13.1	16.9	8.2	11.1	8.8	14.4	7.1	12.9	15.0	9.3	13.6	11.0	14.6	5.4	10.4	10.2	8.8	7.7	7.1	10.4	0.3	0.2	9.2	25.8	7.0	5.9	8.6	13.4	19.0	16.9	14.2	8.9	7.4	7.4	9.3	9.4	10.7	14.8	2.5	2.4	2.1	3.6	1.5	2.6	2.0	2.7	2.3	0.8	3.3	2.6	3.4	7.4	7.7	2.1	2.1	1.1	1.0	6.2	9.3	3.2	11.1	7.5	5.2	15.8	5.2	8.8	12.0
TRIM65		ENSG00000141569	"Tripartite motif containing 65"	Q6PJ69	17	75880335-75897003	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021575, HPA021578, HPA064820"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: "	"unprognostic (1.82e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (4.74e-6)"	"unprognostic (5.36e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.00e-3)"	"prognostic unfavourable (1.82e-5)"	"unprognostic (2.86e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-3)"	"unprognostic (7.50e-3)"	15.5	8.2	12.8	12.1	20.0	10.8	13.6	26.7	16.6	15.7	12.7	17.6	11.9	13.9	15.7	9.3	14.0	14.4	12.9	11.0	16.5	12.3	11.3	8.2	13.3	14.6	22.4	8.1	17.7	15.7	14.9	12.7	8.1	16.1	12.4	12.0	15.8	14.7	15.2	16.5	21.6	12.8	13.0	11.4	17.2	12.7	5.4	21.3	11.7	13.1	11.0	14.8	12.7	15.4	5.3	3.4	4.4	3.0	5.2	5.9	1.6	13.4	14.7	5.3	14.8	9.7	13.5	2.6	5.5	7.2	9.2	6.8	5.2	11.6	14.6	4.0	5.8	9.4	11.0	12.2	4.0	6.5	19.7	11.7	13.4	7.8	10.3	12.3	12.6	9.7	9.8	6.2	9.9	20.3	18.0	14.6	5.6	14.5	22.3	19.9	12.1	12.2	20.9	7.1	22.9	6.8	5.1	11.8	11.3	8.7	13.2	14.5	15.7	15.0	10.9	19.4	8.9	8.6	10.1	12.3	4.5	3.8	12.3	20.0	8.2	2.8	3.0	4.4	5.2	2.7	5.9	4.1	3.9	5.3	2.7	5.3	4.3	4.2	3.1	5.2	1.5	3.4	3.5	1.6	12.8	20.0	26.7	16.6	16.5	12.3	22.4	8.1	16.1	21.3
TRIM68	"FLJ10369, RNF137, SS-56"	ENSG00000167333	"Tripartite motif containing 68"	Q6AZZ1	11	4598672-4608259	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023455	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023455: AB_1858319"	"unprognostic (4.77e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.78e-2)"	"prognostic favourable (4.14e-6)"	"unprognostic (4.23e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"	7.7	11.3	11.1	8.0	11.1	3.1	10.6	15.2	12.8	16.3	10.9	12.6	18.2	10.3	10.6	12.2	8.0	12.6	10.3	9.4	9.6	7.9	14.9	12.7	11.7	7.6	13.1	10.5	17.3	9.9	12.6	10.5	9.8	10.0	16.8	10.1	9.9	12.0	17.5	8.7	7.6	9.8	9.8	11.9	10.7	12.4	13.2	9.5	10.0	17.8	6.7	8.9	11.7	8.4	9.1	5.9	8.9	5.2	5.5	12.8	7.6	8.3	9.3	3.9	6.3	6.3	10.3	0.0	9.2	6.7	8.3	7.6	1.2	8.6	5.7	5.6	4.6	9.8	3.8	6.4	7.2	14.1	7.4	6.9	2.4	0.0	7.3	11.1	9.8	7.9	9.4	4.9	7.4	10.5	6.4	3.0	7.4	2.0	9.1	3.0	4.5	7.7	7.3	5.5	0.2	5.4	3.7	2.0	3.7	0.0	9.3	5.8	4.0	5.6	8.4	11.2	7.7	11.2	4.0	11.7	12.6	8.3	7.7	4.9	10.5	6.4	2.7	8.9	9.0	5.1	10.1	9.1	9.9	10.0	5.9	7.9	12.8	10.1	0.3	5.5	5.2	4.0	8.7	7.6	11.1	11.1	15.2	12.8	9.6	7.9	13.1	10.5	10.0	9.5
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 81.8;tongue: 34.0"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.2;HDLM-2: 23.8;PC-3: 13.2;TIME: 10.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	16	"cerebellum: 21.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 4.9;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	1.3	0.9	0.1	0.9	0.5	0.5	3.4	21.7	1.3	2.5	0.8	0.3	1.1	0.5	1.0	6.4	13.0	0.6	1.7	2.2	0.1	0.8	2.2	0.5	0.9	0.6	0.2	0.2	0.6	4.2	1.6	1.9	0.5	0.5	2.0	0.6	0.6	5.9	1.1	81.8	9.5	0.6	0.9	0.3	0.8	1.4	0.9	0.2	0.1	3.3	34.0	13.5	1.6	2.9	0.7	0.8	0.1	4.9	0.5	2.2	1.1	6.1	2.9	0.0	0.3	0.5	0.5	0.1	1.4	0.0	0.5	1.2	0.2	8.0	0.4	4.3	1.7	11.2	3.2	9.2	0.1	23.8	1.3	0.5	7.8	0.1	1.6	0.0	1.3	0.1	7.1	0.2	4.6	2.6	0.3	1.3	0.2	0.8	0.3	0.2	0.0	13.2	0.3	4.2	0.9	3.3	0.0	0.3	0.7	2.9	0.1	4.0	0.7	0.2	10.8	0.1	2.4	0.4	4.2	1.9	0.2	0.7	0.3	0.4	1.0	0.0	4.9	0.1	1.4	1.9	2.2	0.4	1.2	1.4	0.8	0.7	2.2	1.8	0.1	0.5	1.4	0.6	2.2	1.1	0.1	0.5	21.7	1.3	0.1	0.8	0.2	0.2	0.5	0.2
TRIM73	TRIM50B	ENSG00000178809	"Tripartite motif containing 73"	Q86UV7	7	75395063-75410996	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 11.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.7;Hep G2: 13.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA047843, HPA051845"	Uncertain		Uncertain	Cytosol				Cytosol		"HPA047843: , HPA051845: "	"unprognostic (1.01e-2)"	"unprognostic (9.85e-5)"	"unprognostic (4.72e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.46e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-3)"	1.9	1.6	0.3	1.2	0.9	2.4	1.6	4.0	0.6	2.4	0.6			4.2	1.7	0.3	0.3	3.8	1.0	0.9	0.4	0.5	1.7	2.3	1.1	2.3	0.2		2.3	7.2	1.3	1.7	0.1		2.1	0.0		1.9	1.9	2.6	2.4	2.2	0.0	0.5	1.8	11.5	5.4			2.4		0.2	0.7	1.3	1.3	1.4	2.0	0.8	1.7	2.2	1.3	1.3	4.0	1.7	2.4	0.0	0.8	0.6	0.5	0.1	0.1	1.0	0.0	1.9	2.3	0.3	0.2	1.3	0.3	0.0	0.2	5.0	7.7	1.4	3.0	13.1	0.9	0.8	5.5	2.2	0.0	0.3	0.4	0.1	0.7	6.4	0.0	0.9	2.0	2.6	0.2	1.3	3.5	0.2	1.2	0.4	0.0	2.0	1.6	2.5	0.9	2.1	0.6	2.4	1.6	1.1	1.9	1.7	1.1	3.0	1.7	2.4	1.7	3.2	1.5	1.1	0.8	0.7	2.2	0.6	1.2	1.1	1.3	0.4	0.4	1.3	2.1	1.6	2.0	1.7	0.2	1.4	2.0	1.3										
TRIM74	"MGC45440, TRIM50C"	ENSG00000155428	"Tripartite motif containing 74"	Q86UV6	7	72959485-72969466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 10.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.5;Hep G2: 5.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.2"	"Low lineage specificity"	"Detected in many"											HPA047843			Approved	Cytosol				Cytosol		"HPA047843: "	"unprognostic (8.78e-3)"	"unprognostic (3.78e-4)"	"unprognostic (5.84e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.78e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-3)"	1.1	1.6	0.6	1.0	1.4	1.7	1.0	4.8	0.7	1.1	0.5			2.4	1.3	2.5	0.4	2.3	0.8	0.5	0.6	0.8	1.3	2.3	0.6	1.9	0.4		1.7	5.0	0.2	1.6	0.1		1.6	0.5		1.2	1.0	0.8	1.5	1.2	0.8	0.7	1.6	10.9	6.0			1.5		0.5	0.4	1.0	2.2	0.2	0.7	0.1	0.0	1.1	0.0	0.0	0.3	1.3	1.5	0.4	0.0	0.0	0.8	0.0	0.2	0.5	1.9	1.5	1.0	0.2	0.0	0.7	0.1	0.1	0.1	0.8	7.5	1.2	0.0	5.3	0.2	2.4	3.2	0.7	0.3	0.0	0.4	0.0	1.0	4.5	0.1	2.1	0.9	3.7	0.1	1.7	1.7	0.6	0.8	2.2	0.8	0.6	0.7	0.8	0.0	1.7	0.1	1.1	2.7	0.3	1.0	0.5	0.0	3.4	2.7	0.6	1.2	1.3	0.7	0.7	0.0	0.7	1.0	0.0	1.1	2.2	0.7	0.2	0.0	0.1	0.8	0.2	0.0	0.0	0.1	0.2	0.5	0.0										
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102642310-102660680	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	31.7	18.4	26.1	23.9	25.2	17.0	18.0	26.1	31.6	31.8	19.5	22.9	15.4	15.8	18.0	14.3	17.8	21.6	19.8	25.0	23.2	18.0	27.2	21.9	23.0	25.4	20.1	20.0	19.3	35.9	24.7	14.7	17.5	16.3	17.4	8.1	19.4	28.5	18.5	34.8	14.6	23.7	13.6	15.7	22.5	21.2	11.7	21.9	48.3	26.6	14.5	30.3	21.4	15.9	9.0	11.9	17.8	5.3	5.5	7.2	3.9	27.6	6.5	6.4	10.5	7.1	14.4	6.0	9.9	20.2	10.8	8.7	11.7	33.4	8.9	26.7	22.0	10.2	4.3	13.3	8.9	9.0	8.4	22.5	5.4	26.7	18.1	5.0	9.0	16.5	7.4	23.7	14.0	14.3	4.2	13.4	8.4	18.0	9.5	16.9	3.5	13.2	4.8	14.4	4.4	12.8	19.5	3.9	7.6	5.5	6.8	13.1	19.2	10.0	26.6	14.5	6.5	8.1	22.2	12.3	8.0	5.2	22.1	12.6	3.6	10.7	4.8	2.6	6.8	4.4	6.7	9.0	7.2	5.3	4.1	7.0	6.4	5.5	17.8	5.5	5.3	11.9	6.9	3.9	26.1	25.2	26.1	31.6	23.2	18.0	20.1	20.0	16.3	21.9
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 9.8;testis: 6.2"	"Cell line enhanced"	"Detected in some"		"A549: 21.1;BEWO: 11.7;hTCEpi: 13.7;NTERA-2: 21.7"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.1	0.1	0.2	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	9.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	21.1	0.0	0.0	0.0	0.1	11.7	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	4.0	0.1	0.0	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1
TRIO	ARHGEF23	ENSG00000038382	"Trio Rho guanine nucleotide exchange factor"	O75962	5	14143702-14532128	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008157, HPA064664"	Supported		Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: "	"unprognostic (6.65e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (9.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.23e-1)"	29.7	13.7	27.6	15.8	18.9	5.8	30.3	32.6	29.7	13.7	18.5	11.3	9.2	8.3	23.1	19.3	10.4	12.2	25.2	15.1	18.9	15.0	11.7	12.6	15.8	10.9	11.0	17.7	28.9	11.5	17.2	19.6	13.7	12.3	16.3	16.5	23.3	10.5	14.0	19.8	16.0	15.6	22.7	11.6	24.2	13.7	11.3	11.5	7.4	10.0	11.9	12.3	15.6	16.9	3.8	2.7	0.3	1.9	4.3	0.6	0.4	12.2	4.4	10.6	5.0	22.7	29.8	12.1	11.3	13.5	9.1	10.5	2.8	4.8	2.8	8.5	15.4	3.7	1.7	5.3	18.9	7.8	2.5	1.5	11.8	3.5	11.8	3.7	4.2	13.9	5.6	32.2	10.3	8.0	0.3	1.9	22.0	2.3	0.0	2.6	2.6	4.0	2.8	6.4	9.4	8.9	5.5	4.8	19.5	9.6	2.5	5.0	1.5	0.5	18.6	17.6	11.2	12.7	13.3	0.0	0.6	3.6	62.5	2.4	4.1	0.3	1.5	0.0	0.1	1.9	0.3	2.0	0.0	0.0	1.4	3.8	0.0	0.0	0.0	4.3	1.4	2.7	0.6	0.4	27.6	18.9	32.6	29.7	18.9	15.0	11.0	17.7	12.3	11.5
TRIP6	"MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1"	ENSG00000087077	"Thyroid hormone receptor interactor 6"	Q15654	7	100867138-100873454	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046454, CAB046460, HPA052813"	Approved		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"			12000	"Plasma membrane, Focal adhesion sites, Cytosol"		"CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: "	"unprognostic (7.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	15.5	14.7	10.9	16.2	11.2	6.0	18.1	4.2	7.3	36.7	14.6	9.4	22.5	4.4	28.2	30.8	27.2	18.5	43.5	14.5	8.7	7.7	21.6	24.1	18.4	5.8	11.7	9.4	22.0	19.2	28.0	6.5	13.6	9.7	22.1	3.9	22.7	23.0	38.2	8.3	23.9	6.5	25.5	9.7	7.9	9.9	17.5	7.8	7.3	26.6	30.6	12.6	25.0	23.6	3.1	7.7	0.2	4.7	0.0	1.7	0.5	26.6	11.0	5.7	27.3	8.6	10.1	28.7	16.6	17.8	22.8	21.4	10.4	30.7	1.1	17.6	18.7	19.9	8.4	32.1	5.9	3.8	11.4	0.1	18.3	0.1	22.8	12.8	1.5	18.2	21.1	15.2	23.9	11.7	16.7	0.2	19.7	46.8	0.2	20.2	19.7	9.8	10.0	5.7	2.7	14.1	6.6	2.1	0.3	13.9	42.1	16.5	4.5	16.4	17.9	33.6	31.7	36.4	38.8	0.2	0.4	0.1	20.9	1.6	50.5	0.0	1.9	0.2	0.2	3.0	0.6	3.1	1.5	1.3	3.1	2.5	1.7	0.7	0.2	0.0	4.7	7.7	1.3	0.5	10.9	11.2	4.2	7.3	8.7	7.7	11.7	9.4	9.7	7.8
TRIT1	"FLJ20061, IPT"	ENSG00000043514	"TRNA isopentenyltransferase 1"	Q9H3H1	1	39841022-39883511	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA024174	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA024174: AB_1858346"	"unprognostic (4.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-3)"	"prognostic unfavourable (8.80e-4)"	"unprognostic (4.00e-2)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (5.34e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.68e-3)"	"prognostic unfavourable (7.08e-8)"	"unprognostic (6.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.90e-2)"	9.5	10.3	12.9	10.4	19.1	8.0	19.8	25.8	18.4	15.1	13.4	15.9	22.7	11.4	19.3	21.3	19.8	18.4	9.1	15.9	12.5	12.0	14.6	13.2	11.9	14.8	13.9	10.4	16.7	27.7	14.1	26.7	17.6	14.4	21.4	15.8	13.5	15.1	23.9	10.1	22.9	11.7	18.0	9.8	14.0	12.9	17.3	17.9	15.4	19.2	9.4	14.7	17.2	17.5	3.9	13.4	0.9	6.6	2.4	5.2	2.8	14.5	6.7	14.6	14.9	7.3	11.0	22.0	9.7	13.0	15.6	17.6	12.9	19.2	8.4	12.8	8.2	14.8	21.0	16.7	21.9	10.3	10.6	18.0	15.6	8.0	16.9	17.5	9.9	9.3	15.1	19.5	19.3	12.5	24.4	10.2	9.7	7.1	13.3	18.8	19.6	6.1	14.2	18.3	19.3	14.8	18.7	16.6	11.1	13.9	9.5	10.6	10.5	30.0	8.9	10.4	12.8	18.0	16.0	13.8	10.8	17.1	13.2	17.9	9.0	0.0	6.6	0.9	2.7	4.9	5.2	3.9	2.6	2.9	13.4	3.2	3.4	3.5	0.1	2.4	5.8	11.6	2.7	2.8	12.9	19.1	25.8	18.4	12.5	12.0	13.9	10.4	14.4	17.9
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavourable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	15.5	15.0	19.1	19.8	23.5	23.1	16.6	19.5	22.6	15.0	16.3	17.3	15.5	14.9	19.2	19.0	17.6	19.6	19.4	13.2	15.7	13.4	14.4	17.3	13.5	26.8	22.1	14.7	29.1	23.8	16.3	14.4	14.4	21.9	18.1	14.5	10.9	14.9	15.6	21.4	22.1	16.1	16.5	12.4	25.0	16.3	16.8	20.1	12.2	15.6	12.1	19.6	17.3	18.8	11.2	14.9	3.1	15.7	4.3	10.2	8.5	15.3	10.4	11.3	19.1	11.5	14.7	16.2	17.3	8.7	19.1	16.6	11.1	12.7	19.3	22.7	9.3	14.3	18.8	15.2	8.9	12.6	26.3	15.3	26.7	18.6	20.8	30.7	18.1	20.8	20.5	19.9	18.7	14.0	33.2	6.2	11.8	17.0	12.4	33.2	26.7	24.4	21.0	14.5	26.6	11.9	15.7	26.8	12.2	10.8	22.5	18.0	8.7	17.2	15.6	27.6	10.7	16.6	30.3	10.7	20.7	17.8	12.9	32.5	14.3	1.2	15.7	0.5	8.1	11.9	7.7	10.4	8.6	7.7	14.9	11.2	10.2	7.7	3.1	4.3	7.5	8.8	5.6	8.5	19.1	23.5	19.5	22.6	15.7	13.4	22.1	14.7	21.9	20.1
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"				"Nucleoli, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA047601: , HPA058241: "	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.6	4.7	9.2	4.7	5.5	7.7	6.7	8.1	3.1	5.7	4.3	3.9	8.3	9.2	3.1	4.8	3.9	10.7	5.1	8.8	11.7	4.7	6.3	4.1	6.4	5.2	16.0	6.8	4.9	13.2	5.7	12.5	5.8	14.6	8.3	4.8	7.7	13.5	3.3	5.5	4.6	7.8	8.8	5.9	7.7	5.5	5.8	5.0	4.4	24.6	8.1	8.0	6.9	4.2	5.8	6.0	4.7	9.2	5.8	9.7	8.4	4.4	9.4	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150497	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavourable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	13.0	12.2	13.9	21.7	24.1	5.9	18.3	26.5	22.5	17.4	13.1	18.2	24.2	13.6	17.4	15.4	13.7	13.9	9.6	12.0	14.4	9.0	12.1	13.0	9.6	20.9	23.1	12.8	21.4	18.1	23.8	26.8	13.2	15.6	14.9	14.4	10.8	14.3	17.4	16.9	17.9	14.2	14.3	19.4	16.5	12.6	11.1	25.8	17.8	16.5	12.0	17.6	13.9	15.8	15.1	9.6	2.2	4.5	5.4	13.6	3.9	10.6	6.2	10.5	7.3	5.7	11.2	11.5	11.3	4.5	8.6	7.2	7.4	4.4	17.6	14.1	9.0	9.7	19.3	8.7	15.0	17.7	15.3	10.5	13.8	7.1	10.3	18.1	9.9	7.8	10.0	16.3	21.5	7.8	22.0	11.4	8.6	4.0	14.8	9.6	14.6	12.6	15.9	15.9	9.6	7.1	8.5	6.9	11.5	10.4	10.0	13.3	5.9	16.1	8.1	11.5	7.7	9.6	15.0	14.6	11.8	20.9	13.0	14.6	4.4	0.1	4.5	2.2	8.5	4.4	10.4	14.8	9.0	8.3	5.2	15.1	13.6	11.1	1.9	5.4	3.5	9.6	6.2	3.9	13.9	24.1	26.5	22.5	14.4	9.0	23.1	12.8	15.6	25.8
TRMT2A	HTF9C	ENSG00000099899	"TRNA methyltransferase 2 homolog A"	Q8IZ69	22	20111866-20117392	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001077	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA001077: AB_1079092"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.19e-3)"	"unprognostic (5.93e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (2.99e-8)"	"unprognostic (4.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.14e-3)"	14.3	22.5	12.6	18.8	13.6	14.3	13.4	16.3	19.7	13.9	16.6	17.4	15.4	18.2	13.1	15.6	16.1	15.3	17.1	12.8	13.1	11.4	13.2	22.8	11.1	22.8	12.4	14.4	15.2	23.6	10.8	18.5	15.8	11.2	16.8	6.1	14.2	36.5	16.1	14.8	18.4	16.2	12.4	12.7	23.2	16.7	16.9	13.4	26.8	15.6	12.7	18.3	13.1	11.0	9.7	14.0	7.0	14.9	9.5	15.2	11.5	6.3	7.4	2.8	4.6	2.9	2.1	9.8	5.7	2.9	4.6	4.1	8.7	5.5	8.8	4.9	2.6	10.0	2.1	3.2	0.6	9.1	24.0	10.1	9.8	7.9	7.9	15.8	10.2	3.8	4.3	4.8	1.8	4.7	37.9	6.1	3.1	10.1	8.9	10.0	5.4	9.4	10.4	4.9	3.6	2.6	7.2	7.6	5.8	3.5	9.1	9.1	6.3	13.5	4.4	5.6	7.5	4.3	4.9	21.9	9.7	6.7	7.5	6.7	5.6	6.6	11.5	7.0	10.5	14.9	15.2	9.7	10.9	12.1	14.0	6.8	12.2	11.5	1.5	9.5	12.0	12.4	8.5	11.5	12.6	13.6	16.3	19.7	13.1	11.4	12.4	14.4	11.2	13.4
TRMT61B	FLJ20628	ENSG00000171103	"TRNA methyltransferase 61B"	Q9BVS5	2	28849821-28870301	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026747, HPA026751"	Enhanced		Uncertain	Cytosol				Cytosol		"HPA026747: AB_1848782, HPA026751: AB_1848784"	"unprognostic (1.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (2.36e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-2)"	"prognostic favourable (9.61e-5)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.34e-1)"	11.6	19.5	20.4	12.8	22.5	10.9	18.5	33.7	21.0	13.8	11.7	17.4	10.9	19.2	15.6	20.4	12.6	11.8	10.1	16.3	17.2	18.4	19.8	16.9	9.0	13.8	17.0	15.6	13.7	10.0	21.1	25.4	12.2	17.8	15.2	13.2	14.2	12.6	11.8	17.9	11.9	18.6	14.4	14.7	13.2	12.4	14.6	18.7	12.6	12.8	10.4	14.5	14.8	10.8	11.9	6.8	2.7	7.0	13.9	12.4	6.3	17.8	10.8	10.9	19.3	15.0	12.9	13.2	10.6	13.2	13.6	12.8	12.3	9.7	19.0	9.8	9.3	14.0	15.2	12.9	14.1	14.2	10.3	5.8	8.9	16.1	17.0	12.2	6.6	13.1	14.5	10.8	14.8	13.0	11.7	7.3	11.2	7.1	10.7	18.5	20.3	17.3	8.0	17.7	16.3	11.9	11.6	18.6	19.7	11.5	18.2	17.5	9.3	4.3	10.1	9.1	15.3	8.9	13.3	9.1	14.9	29.4	12.1	18.4	12.2	0.0	6.6	2.7	9.8	7.0	12.1	11.9	11.1	10.5	6.4	11.6	12.4	8.9	0.9	13.9	5.7	6.8	11.6	6.3	20.4	22.5	33.7	21.0	17.2	18.4	17.0	15.6	17.8	18.7
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 64.7;thyroid gland: 26.5"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;BJ: 10.0;fHDF/TERT166: 13.4;RPTEC TERT1: 4.7;SCLC-21H: 5.1;U-266/84: 4.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Group enriched"	"Detected in all"	7	"cerebellum: 64.7;pons and medulla: 31.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 77.4"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favourable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	2.1	0.9	2.0	1.1	4.1	1.2	3.5	64.7	6.0	2.0	1.8	6.6	0.8	1.4	1.9	2.5	1.3	2.4	2.7	6.0	6.7	2.9	2.7	1.7	1.7	1.0	2.0	2.8	0.6	1.7	2.3	1.2	7.1	31.5	1.2	2.1	5.8	2.3	1.9	4.4	5.1	1.5	0.9	1.9	1.6	1.5	1.8	1.0	0.0	26.5	1.3	0.7	1.3	0.9	1.0	0.6	2.8	0.6	1.9	0.6	0.0	0.1	0.2	7.0	0.0	0.0	0.0	1.7	10.0	2.3	1.4	0.7	0.1	0.3	0.2	0.5	13.4	0.3	0.1	0.3	1.5	0.1	0.4	0.4	0.4	0.1	0.0	0.2	0.7	0.2	3.5	0.0	0.1	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.8	0.0	1.1	0.1	0.1	4.7	0.2	5.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.9	1.0	0.1	0.4	4.8	0.1	0.1	0.2	1.8	2.6	0.6	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.2	1.0	0.5	0.6	2.8	1.9	0.3	0.6	0.2	0.0	2.0	4.1	64.7	5.0	6.7	2.9	2.0	2.8	31.5	1.0
TRNAU1AP	"FLJ20503, SECP43, TRSPAP1"	ENSG00000180098	"TRNA selenocysteine 1 associated protein 1"	Q9NX07	1	28553085-28578545	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032068, HPA032069"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA032068: , HPA032069: AB_10603998"	"unprognostic (4.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (2.22e-4)"	"unprognostic (4.93e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavourable (8.64e-5)"	"unprognostic (5.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.28e-3)"	"prognostic unfavourable (1.16e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.72e-1)"	"prognostic favourable (9.45e-4)"	"unprognostic (2.76e-1)"	11.4	10.5	12.6	11.3	14.7	9.3	13.4	19.6	14.1	12.4	10.9	15.4	12.0	7.0	11.7	14.8	10.8	13.2	8.7	12.3	11.7	12.1	11.4	8.7	13.2	15.7	19.3	13.3	12.8	11.6	14.0	9.2	10.8	13.6	10.3	11.6	10.7	10.5	14.0	7.9	17.3	9.4	14.0	12.8	11.1	10.2	7.2	17.1	15.4	8.4	9.0	16.9	12.9	9.5	4.8	4.3	9.1	5.9	12.9	7.5	2.7	4.4	2.7	7.9	5.3	7.2	13.8	3.7	6.1	12.3	11.2	10.1	4.1	7.0	6.8	2.4	6.6	3.4	8.5	9.6	11.3	6.0	9.7	5.1	9.4	2.8	6.7	3.9	4.4	14.8	8.4	8.7	6.9	15.8	5.9	5.6	10.9	3.0	6.6	4.6	5.5	5.9	4.9	5.5	4.8	12.2	4.6	4.6	6.0	7.2	6.4	6.6	7.0	4.8	4.5	3.0	2.8	4.6	5.4	7.3	9.2	4.2	7.1	8.6	8.2	6.9	3.5	9.1	5.7	5.9	6.0	4.8	6.2	7.2	4.3	4.7	7.5	4.8	2.2	12.9	3.5	2.8	4.0	2.7	12.6	14.7	19.6	14.1	11.7	12.1	19.3	13.3	13.6	17.1
TROVE2	"Ro60, SSA2"	ENSG00000116747	"TROVE domain family member 2"	P10155	1	193059422-193091777	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002835, HPA005142"	Uncertain		Approved	Nucleoplasm,Cytosol			28000	Cytosol	Nucleoplasm	"HPA002835: AB_1857490, HPA005142: "	"unprognostic (1.91e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (3.31e-4)"	"unprognostic (5.62e-2)"	21.2	13.7	13.3	11.4	16.2	29.7	18.5	13.7	16.5	16.9	12.3	13.2	11.7	8.4	15.3	10.9	16.8	11.3	10.9	18.0	13.9	7.7	14.3	13.6	15.0	13.0	19.6	11.8	19.8	12.1	16.8	13.0	13.6	15.1	17.3	9.4	11.4	14.8	14.7	23.4	16.5	11.6	22.7	20.4	14.7	10.9	24.3	17.0	15.1	14.9	8.7	12.9	19.9	19.8	19.1	13.9	38.3	14.6	19.6	24.3	14.5	8.8	15.9	18.4	17.1	15.9	14.7	11.2	13.5	12.6	9.5	12.7	8.1	12.1	18.4	12.5	15.1	13.7	14.4	10.3	16.7	22.7	11.0	22.2	15.2	10.8	14.6	25.8	16.3	13.7	12.2	17.3	19.3	15.3	24.1	24.7	16.2	14.5	15.4	6.8	13.8	5.2	12.9	15.8	20.9	9.2	18.4	6.5	12.9	16.6	20.2	17.4	16.7	8.9	20.4	18.0	6.6	16.9	17.2	14.5	14.8	17.4	9.7	12.9	27.7	38.3	13.9	17.4	24.3	13.1	23.4	19.1	17.9	20.3	13.9	17.2	19.0	21.2	22.7	19.6	14.6	12.2	17.9	14.5	13.3	16.2	13.7	16.0	13.9	7.7	19.6	11.8	15.1	17.0
TRPC4AP	"C20orf188, dJ756N5.2, DKFZp586C1223, DKFZP727M231, PPP1R158, TRRP4AP"	ENSG00000100991	"Transient receptor potential cation channel subfamily C member 4 associated protein"	Q8TEL6	20	35002404-35092871	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051197, HPA065061"	Uncertain		Approved	Cytosol				Cytosol		"HPA051197: , HPA065061: "	"unprognostic (3.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (6.25e-8)"	"unprognostic (1.33e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	36.5	43.3	26.3	30.1	38.2	51.4	35.1	36.7	48.3	27.7	31.9	64.0	36.9	30.7	33.9	31.8	31.5	28.4	30.1	30.1	29.0	31.0	30.4	41.9	38.7	32.3	43.5	34.0	30.4	45.3	41.3	47.9	48.1	43.6	32.9	31.6	29.2	39.9	33.1	50.5	35.0	31.8	32.5	31.9	43.7	37.3	24.5	38.8	46.9	34.8	23.0	34.9	29.0	28.5	10.9	23.2	28.6	20.9	14.2	15.9	13.3	16.1	19.8	17.7	18.2	27.5	26.5	27.2	26.3	31.0	30.2	34.9	43.3	24.3	15.1	25.2	30.3	21.6	16.0	37.5	23.5	8.0	12.5	38.6	17.0	39.5	27.4	22.4	26.5	29.4	23.7	22.6	19.4	33.5	18.1	18.3	24.0	12.2	27.0	25.4	13.9	27.1	17.0	25.6	15.4	26.0	21.1	15.7	15.8	28.3	48.2	18.4	17.4	18.3	32.8	37.8	17.1	20.3	15.7	16.8	9.0	12.6	40.8	11.1	19.2	16.4	16.7	28.1	14.8	18.3	15.8	10.9	12.4	15.9	23.2	10.1	11.0	11.5	28.6	14.2	20.9	10.1	14.0	13.3	26.3	38.2	36.7	48.3	29.0	31.0	43.5	34.0	43.6	38.8
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Cell line enhanced"	"Detected in all"		"U-2197: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: "	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.3	8.3	7.0	7.7	20.2	15.2	8.5	10.6	14.7	6.7	8.9	11.4	4.6	18.2	5.2	12.2	14.1	9.3	7.8	9.7	10.1	5.6	14.5	12.8	6.0	18.4	15.0	11.3	14.1	9.2	7.6	14.4	5.4	16.4	14.0	12.2	13.1	9.6	7.3	5.3	5.1	10.6	9.7	8.9	9.4	19.8	5.8	7.4	7.3	11.6	14.2	7.3	16.3	8.2	10.7	5.1	49.9	12.1	9.5	21.0	17.5	11.7	30.7	9.9	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557995	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 15.4;skeletal muscle: 29.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.3;CACO-2: 4.2;RH-30: 13.0;T-47d: 5.5;U-266/70: 3.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.4"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.0"	HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: "	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.4	0.2	0.4	3.2	2.4	0.9	4.1	0.3	1.2	0.6	10.6	0.1	0.3	3.2	0.2	0.2	2.3	0.3	0.8	0.3	0.4	0.3	0.2	1.1	0.3	0.5	0.4	0.2	0.3	0.9	0.0	0.7	0.4	0.0	0.2	2.9	0.3	0.5	0.4	29.1	8.4	15.4	0.5	0.5	0.4	1.6	0.8	0.0	0.0	0.2	9.7	3.0	0.7	2.1	0.7	0.6	2.9	0.6	0.6	0.7	0.1	3.5	0.0	0.5	0.1	0.2	0.6	5.3	0.2	0.0	0.0	0.0	4.2	0.9	0.2	1.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.6	0.1	0.2	0.8	0.3	0.0	0.7	1.8	0.0	0.1	0.1	0.0	0.7	0.1	0.2	0.1	0.5	0.1	13.0	0.2	0.0	0.2	0.1	0.0	0.2	0.6	0.0	5.5	0.2	0.1	0.1	0.2	0.1	0.1	3.5	2.7	0.0	0.1	0.1	0.0	2.9	0.4	0.4	0.7	0.2	0.5	0.7	0.4	0.7	0.1	0.5	0.4	0.6	1.0	0.6	0.6	0.6	0.2	0.1	0.4	2.4	0.3	1.2	0.4	0.3	0.4	0.2	0.0	0.0
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol				Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: "	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavourable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favourable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favourable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	10.4	13.6	15.8	8.8	26.8	13.6	11.4	32.1	28.3	12.7	10.8	22.6	7.9	9.1	14.6	12.3	10.9	12.4	9.7	17.6	13.0	12.1	13.1	9.4	11.6	10.2	12.5	15.1	21.2	12.1	15.9	19.5	15.8	21.1	11.8	12.6	13.1	11.6	10.4	20.0	13.8	11.2	14.2	12.4	13.7	10.6	36.2	14.9	10.5	16.2	8.6	14.2	10.9	11.1	2.8	3.1	4.8	7.0	4.9	7.1	2.6	6.1	7.3	10.0	8.2	10.3	9.8	18.8	8.3	13.4	8.7	8.6	12.4	7.2	14.4	3.6	15.8	16.0	11.7	8.4	8.9	6.9	6.2	4.6	14.5	10.1	12.3	6.7	6.2	10.5	6.4	11.1	13.6	10.0	8.0	7.9	9.9	11.4	6.0	5.8	13.7	6.1	7.3	18.9	8.1	3.9	8.1	5.0	7.7	9.7	6.1	4.8	11.0	4.0	10.3	14.3	8.6	8.5	5.6	4.4	9.8	14.0	8.1	4.0	6.3	4.1	4.4	4.8	6.5	7.0	7.1	1.9	3.6	5.7	3.1	2.8	5.9	5.3	1.7	4.9	3.2	1.8	5.7	2.6	15.8	26.8	32.1	28.3	13.0	12.1	12.5	15.1	21.1	14.9
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047465-2089487	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol				Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: "	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favourable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	13.9	11.9	16.9	12.4	20.0	10.9	13.2	35.1	26.9	20.5	17.0	19.4	17.9	14.0	20.1	12.2	13.0	18.6	15.0	14.0	13.3	8.8	11.8	9.8	12.7	10.1	13.8	14.7	21.1	16.1	20.0	18.1	10.6	14.6	13.8	10.8	16.7	22.9	19.6	31.7	14.5	13.2	13.5	11.4	12.9	16.6	21.4	12.9	14.1	20.1	11.3	10.9	18.0	14.0	4.7	5.6	7.7	4.9	3.6	7.0	3.7	7.2	11.6	16.1	18.2	19.2	16.2	13.6	17.4	11.9	13.1	11.2	13.9	13.8	10.9	15.5	14.3	12.0	9.6	12.6	9.8	8.3	15.8	10.3	22.5	5.7	13.2	12.8	12.5	19.1	8.0	10.6	7.9	12.3	10.0	9.8	11.6	14.4	15.2	3.8	16.7	11.4	24.2	17.6	13.9	5.3	6.5	12.2	23.1	24.8	16.4	8.8	15.0	9.5	19.4	13.8	9.4	12.3	8.8	21.9	21.8	21.8	5.7	5.2	16.3	6.2	4.9	5.4	7.0	4.7	6.7	4.4	4.4	4.1	5.6	4.7	3.1	4.8	7.7	3.6	3.7	1.5	3.2	3.7	16.9	20.0	35.1	26.9	13.3	8.8	13.8	14.7	14.6	12.9
TSC22D2	"KIAA0669, TILZ4a, TILZ4b, TILZ4c"	ENSG00000196428	"TSC22 domain family member 2"	O75157	3	150408335-150466431	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004926	Approved		Approved	Cytosol				Cytosol		"HPA004926: AB_1080401"	"unprognostic (4.65e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (2.74e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.28e-3)"	"unprognostic (8.32e-2)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (1.10e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.49e-1)"	22.4	13.5	15.3	18.6	15.2	33.3	13.7	20.5	28.2	15.5	14.3	12.3	10.0	6.7	25.3	16.5	23.0	13.4	25.0	23.7	14.2	13.2	17.3	31.7	15.5	10.6	15.9	14.6	16.4	12.2	11.7	12.8	17.8	14.5	14.0	13.9	12.6	11.3	18.5	17.3	10.9	13.8	28.2	13.7	14.0	15.7	23.9	15.7	19.4	15.3	11.6	10.9	16.7	23.8	4.1	2.9	5.6	6.9	5.0	4.8	2.7	21.1	2.9	9.5	9.0	12.4	6.1	27.3	21.1	8.0	15.6	19.3	11.7	10.7	6.9	12.2	15.8	8.9	9.4	7.7	31.2	5.4	5.3	7.4	5.4	5.8	14.2	4.5	5.1	11.1	6.0	10.1	15.3	9.7	12.6	11.5	10.8	7.4	4.8	5.5	12.1	5.9	5.1	17.3	8.1	9.9	12.5	5.5	4.9	9.7	5.2	20.6	4.9	6.0	15.6	10.3	10.7	12.2	19.4	15.5	3.0	9.6	7.0	13.8	6.0	1.2	3.5	4.4	3.0	4.2	4.8	3.0	3.8	3.2	2.8	4.1	2.9	2.9	5.6	5.0	6.9	2.9	1.5	2.7	15.3	15.2	20.5	28.2	14.2	13.2	15.9	14.6	14.5	15.7
TSC22D3	"DIP, DSIPI, GILZ, hDIP, TSC-22R"	ENSG00000157514	"TSC22 domain family member 3"	Q99576	X	107713221-107777342	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.8;ASC TERT1: 39.8;HHSteC: 95.7;hTCEpi: 85.2;Karpas-707: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001916, CAB034364"	Approved		Approved	"Nuclear speckles,Golgi apparatus,Cytosol"				Cytosol	"Nuclear speckles, Golgi apparatus"	"CAB034364: AB_2272198, HPA001916: "	"unprognostic (3.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (3.49e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.73e-3)"	"unprognostic (4.40e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-1)"	"unprognostic (9.64e-2)"	69.1	48.4	18.2	72.7	21.0	72.4	142.4	31.8	32.7	53.3	49.0	10.6	36.7	16.7	37.2	26.6	58.7	45.4	47.8	42.6	18.8	12.2	33.8	20.9	83.3	98.8	22.0	16.2	54.6	20.0	7.1	18.8	31.3	20.8	51.8	37.2	39.8	172.4	40.7	163.5	65.2	54.6	45.4	22.9	55.7	49.3	20.3	19.2	29.7	59.8	36.1	62.7	75.3	89.6	47.9	31.7	191.5	62.4	69.0	82.4	105.1	1.5	2.6	1.3	3.7	57.8	39.8	0.5	2.4	2.0	1.1	1.2	0.0	5.2	3.3	6.0	1.9	7.8	2.8	7.8	0.5	1.0	1.3	1.6	11.0	0.1	95.7	0.3	5.6	36.2	85.2	0.9	23.8	4.3	0.5	53.8	9.8	5.3	0.1	5.7	2.4	1.7	0.1	3.4	7.0	3.8	1.0	0.3	3.0	2.4	13.2	18.1	2.5	7.5	6.4	3.5	1.0	0.7	0.4	11.8	5.1	1.5	1.8	6.7	0.9	42.7	34.0	126.9	55.2	40.4	40.6	47.9	63.4	53.6	31.7	45.5	59.6	55.4	191.5	69.0	62.4	6.4	82.4	105.1	18.2	21.0	31.8	32.7	18.8	12.2	22.0	16.2	20.8	19.2
TSC22D4	"THG-1, TILZ2"	ENSG00000166925	"TSC22 domain family member 4"	Q9Y3Q8	7	100463359-100479279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.2"	"Cell line enhanced"	"Detected in all"		"NB-4: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006757	Uncertain		Approved	Cytosol				Cytosol		"HPA006757: AB_1080403"	"unprognostic (2.34e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (9.45e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.81e-3)"	11.2	11.9	77.8	16.4	83.5	32.4	7.7	17.8	92.4	9.7	9.9	96.1	3.4	12.4	9.1	6.2	10.3	9.9	8.0	10.2	69.5	53.8	8.9	5.1	10.2	18.7	97.2	40.6	11.7	9.7	8.8	7.1	12.2	60.5	11.5	6.2	11.8	49.2	13.0	7.8	17.2	12.5	8.0	89.8	24.0	11.7	8.0	62.3	6.7	5.8	1.7	12.2	8.6	5.7	6.9	7.5	32.2	11.4	10.2	13.8	8.8	12.1	9.2	3.1	10.4	11.2	13.3	5.9	9.2	15.6	8.9	8.3	4.9	7.5	11.0	11.0	7.5	9.5	3.8	8.3	3.2	18.9	7.6	9.8	9.6	4.1	17.8	13.0	26.3	14.9	7.6	10.3	10.3	18.4	21.7	20.3	7.2	22.1	16.3	59.7	4.3	13.1	26.9	2.5	15.2	7.3	6.6	2.7	7.3	12.8	24.6	19.2	6.9	19.2	15.2	12.2	12.4	29.7	6.7	12.8	12.1	7.7	11.2	20.1	14.7	5.0	10.9	15.6	11.7	11.4	9.1	6.9	10.0	10.8	7.2	6.6	9.6	10.0	32.2	10.2	10.8	7.5	13.8	8.8	77.8	83.5	17.8	65.4	69.5	53.8	97.2	40.6	60.5	62.3
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484432-12539623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favourable (3.49e-4)"	8.8	10.6	9.7	8.8	19.1	6.7	10.9	16.5	14.0	10.4	9.8	12.7	8.4	5.8	14.0	9.9	7.9	12.8	10.3	14.3	10.5	12.3	9.8	7.3	7.3	10.9	11.5	7.6	18.0	11.9	14.3	15.3	4.9	10.2	10.5	10.9	13.5	7.2	13.1	16.7	15.3	6.1	12.3	12.3	6.1	8.5	11.3	9.1	9.9	12.5	9.6	8.1	8.6	8.3	8.5	7.1	2.6	4.2	5.0	13.7	5.6	8.0	14.0	7.5	9.9	12.8	13.6	17.4	7.6	6.7	8.1	5.9	7.9	8.6	9.7	5.3	6.2	7.5	12.5	13.0	9.3	7.6	15.6	10.6	18.8	8.1	9.9	16.6	4.1	11.7	15.1	14.8	18.2	6.5	15.6	5.3	9.4	15.1	12.6	7.6	10.6	16.9	9.6	5.2	19.3	12.2	8.2	4.9	8.6	7.0	6.3	5.9	11.4	11.6	5.8	5.2	5.1	7.1	11.7	5.0	12.7	12.0	7.0	16.7	6.5	2.4	4.2	0.3	6.4	4.2	10.9	8.5	9.8	7.4	5.9	8.3	13.7	11.7	2.6	5.0	3.6	7.1	3.5	5.6	9.7	19.1	16.5	14.0	10.5	12.3	11.5	7.6	10.2	9.1
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18527232	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"			14000	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favourable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	24.7	30.5	18.4	14.2	25.5	23.5	27.6	22.7	25.9	22.5	23.1	23.7	21.6	20.5	25.8	27.7	34.3	23.9	18.4	31.8	17.7	20.6	33.4	29.0	20.1	23.4	21.6	21.4	23.2	39.5	33.2	23.5	38.5	24.6	21.9	28.4	19.4	25.4	22.4	44.5	27.3	25.7	23.1	21.7	20.5	23.0	33.7	20.2	27.5	32.3	37.1	25.5	24.2	25.5	20.5	18.2	42.3	29.2	14.3	22.0	22.2	14.3	23.7	21.0	14.6	24.9	26.0	19.5	22.3	30.1	27.3	27.0	16.2	7.6	19.4	13.7	24.8	22.0	20.9	20.2	30.4	27.2	25.5	12.0	12.5	23.8	32.0	18.0	20.8	22.4	41.1	14.2	38.8	22.4	19.5	16.5	33.0	25.9	11.4	19.6	12.9	24.0	10.3	21.2	16.1	18.3	20.5	15.0	26.9	21.4	18.0	28.5	17.9	18.1	12.0	18.3	11.2	38.2	16.5	10.6	20.4	15.4	18.9	10.0	23.4	42.3	19.5	40.7	14.9	21.7	15.0	20.5	14.4	15.9	18.2	18.0	15.4	16.4	34.5	14.3	29.2	15.4	22.0	22.2	18.4	25.5	22.7	25.9	17.7	20.6	21.6	21.4	24.6	20.2
TSGA10	"CEP4L, CT79"	ENSG00000135951	"Testis specific 10"	Q9BZW7	2	98997261-99154964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 55.7"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036879			Approved	Cytosol				Cytosol		"HPA036879: AB_10671715"	"unprognostic (1.71e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-6)"	"unprognostic (1.06e-2)"	"unprognostic (9.91e-3)"	"unprognostic (9.79e-2)"	"unprognostic (8.37e-4)"	2.2	2.2	4.9	1.7	7.1	1.7	2.6	9.5	6.4	2.5	2.0	6.1	2.7	2.1	2.3	3.6	1.7	15.1	2.2	1.3	4.7	3.4	3.3	1.6	2.9	2.1	5.9	4.5	1.7	3.2	2.9	12.2	1.5	4.7	2.2	2.5	1.0	2.3	1.8	1.1	3.1	1.7	1.3	4.2	1.9	2.5	55.7	6.6	1.8	4.5	0.7	1.9	2.3	2.3	2.5	1.2	0.6	0.7	2.3	3.5	0.9	1.4	0.5	2.4	0.9	1.5	1.5	1.9	0.0	0.1	0.4	0.5	0.3	1.8	1.4	0.6	0.0	0.4	0.5	0.2	0.7	1.7	1.5	0.0	0.0	0.5	0.2	1.0	3.5	1.7	2.0	0.2	0.3	0.0	0.0	0.1	1.6	0.3	0.5	0.5	0.4	0.4	0.6	0.3	0.3	8.9	1.4	3.4	0.4	1.7	1.4	0.2	0.4	0.5	0.8	0.4	0.9	0.1	0.3	1.2	0.3	0.3	0.8	2.1	0.9	0.3	0.7	0.6	1.9	0.1	2.1	2.1	2.2	2.6	0.1	2.5	3.5	2.1	0.0	2.3	0.0	1.2	2.2	0.9	4.9	7.1	9.5	6.4	4.7	3.4	5.9	4.5	4.7	6.6
TSNAX	TRAX	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528653-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"			100000	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	27.4	29.9	23.9	17.1	26.7	12.0	23.4	28.0	33.1	19.7	16.2	21.9	17.2	15.8	20.0	24.6	18.0	16.4	16.7	22.7	25.1	23.9	29.1	23.0	18.4	22.6	22.1	22.1	18.6	14.6	32.3	36.0	18.3	28.5	21.3	18.0	19.6	17.5	19.9	52.5	20.6	14.8	18.9	28.2	24.0	15.5	17.5	24.4	24.5	26.7	25.4	22.0	19.1	17.3	10.0	11.7	54.6	17.5	18.7	13.5	11.0	11.0	9.1	13.9	11.4	10.3	12.7	15.8	12.6	19.1	16.2	14.0	7.8	15.6	15.6	21.3	13.7	12.1	11.0	11.4	21.1	13.9	19.2	15.0	9.4	10.3	14.2	24.8	31.9	15.5	12.6	15.7	12.1	11.8	24.3	11.1	21.9	4.5	15.9	12.1	20.5	11.1	15.8	15.3	21.1	18.1	12.8	13.3	25.6	13.2	16.7	42.4	24.3	42.0	10.9	11.2	10.2	22.4	22.6	18.9	24.9	17.4	18.3	19.6	30.6	54.6	11.2	29.2	11.4	13.5	10.8	10.0	12.3	11.2	11.7	9.9	13.2	12.7	11.4	18.7	17.5	6.8	13.5	11.0	23.9	26.7	28.0	33.1	25.1	23.9	22.1	22.1	28.5	24.4
TSNAXIP1	TXI1	ENSG00000102904	"Translin associated factor X interacting protein 1"	Q2TAA8	16	67806765-67832148	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.2;testis: 40.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.9;SiHa: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA053516			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053516: "	"unprognostic (9.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"prognostic favourable (2.22e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.59e-3)"	0.9	1.9	4.8	1.1	9.2	0.6	0.9	2.0	3.9	1.3	0.9	3.3	1.9	0.5	1.8	3.6	0.7	14.2	1.2	0.7	3.8	3.3	1.6	0.8	2.1	0.7	1.2	3.7	2.5	2.2	2.9	6.9	0.7	6.3	1.0	0.7	1.0	1.0	2.0	0.5	0.8	0.6	1.2	0.9	0.8	1.2	40.6	2.5	0.0	1.1	0.0	0.7	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.4	1.1	0.4	2.5	6.9	3.5	0.9	0.9	0.0	1.6	0.5	2.4	0.7	0.8	1.0	1.0	0.2	1.3	1.0	1.1	1.5	0.3	0.9	0.0	0.8	0.1	1.1	1.6	0.2	0.8	0.9	3.5	0.5	0.0	0.5	0.3	0.0	0.0	0.3	0.6	0.7	0.4	1.7	0.7	0.1	3.5	0.6	2.0	2.1	4.4	0.1	0.4	1.8	0.1	0.8	0.4	0.1	0.3	0.2	1.2	2.1	0.2	0.3	0.2	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.8	9.2	2.0	3.9	3.8	3.3	1.2	3.7	6.3	2.5
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451473-69507669	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.8;EFO-21: 48.5;MCF7: 36.6;PC-3: 60.3;SK-BR-3: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 17.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044657	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044657: AB_10967927"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavourable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	34.2	3.1	11.5	9.7	22.7	0.9	24.9	40.4	17.0	8.9	30.4	49.2	12.5	24.0	15.1	8.4	7.1	16.2	17.1	8.3	18.0	9.2	10.2	3.0	20.4	4.9	33.1	11.2	3.0	10.8	1.4	3.3	17.7	16.8	17.6	24.9	5.4	16.8	17.0	9.9	4.6	21.5	23.0	43.0	13.5	46.4	4.0	28.3	0.8	6.7	2.7	4.8	22.6	6.8	0.0	2.7	0.0	0.0	0.1	17.4	0.5	11.1	23.1	0.4	0.0	0.5	0.0	2.7	0.0	0.4	0.6	1.5	9.9	34.8	0.0	48.5	0.5	22.7	1.6	2.5	0.7	9.1	4.6	0.6	0.7	2.2	0.2	0.0	0.4	0.5	0.7	0.3	0.3	8.9	0.2	0.0	0.2	36.6	0.1	0.2	0.6	60.3	0.8	0.4	0.4	6.7	20.6	7.9	3.0	0.1	30.6	3.8	13.4	0.5	7.7	0.0	0.1	0.0	3.8	0.2	1.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	17.4	0.0	2.7	2.5	2.7	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.9	0.5	11.5	22.7	40.4	17.0	18.0	9.2	33.1	11.2	16.8	28.3
TSPAN31	SAS	ENSG00000135452	"Tetraspanin 31"	Q12999	12	57738013-57750211	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 59.0"	"Cancer enhanced"	"Detected in all"		"glioma: 54.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030758, HPA057489"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA030758: , HPA057489: "	"unprognostic (2.66e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (4.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.79e-1)"	"prognostic favourable (9.91e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.58e-1)"	27.0	26.4	19.4	18.2	22.5	5.4	21.8	14.3	20.5	21.9	20.1	30.5	23.0	16.3	23.1	37.6	21.3	27.7	23.3	23.3	19.1	17.8	32.1	29.2	20.7	14.5	20.3	16.0	32.0	32.1	31.4	22.7	31.5	19.4	23.3	19.0	32.1	24.6	22.0	19.8	15.2	24.0	17.5	24.3	23.1	18.2	11.4	17.1	14.6	42.4	16.5	20.7	20.2	16.8	17.6	35.4	18.6	24.8	23.7	22.0	18.8	3.5	8.7	8.9	2.2	20.7	13.6	5.8	5.6	7.5	3.0	3.0	6.0	19.2	3.2	12.6	13.0	7.4	2.3	12.0	4.3	8.5	6.3	4.4	7.2	2.5	20.4	4.3	7.6	12.0	14.2	5.9	12.5	8.0	3.1	9.4	9.8	7.2	3.3	2.5	1.9	2.8	4.2	59.0	8.4	12.5	7.3	3.1	7.6	6.1	8.9	4.4	16.8	6.8	10.9	4.9	4.1	2.6	3.0	11.7	2.6	1.5	13.3	2.9	7.4	18.6	15.7	11.1	22.0	15.7	21.3	17.6	17.8	18.9	15.6	16.8	17.8	16.7	5.3	23.7	24.8	35.4	12.1	18.8	19.4	22.5	14.3	18.5	19.1	17.8	20.3	16.0	19.4	17.1
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627109-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 88.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 42.7;RT4: 64.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 34.2"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	27.0	9.8	7.0	4.4	6.6	0.1	33.0	2.9	4.9	15.9	17.8	12.6	6.4	9.7	11.1	10.4	27.1	24.2	10.0	5.7	7.4	7.3	26.7	68.2	8.3	3.6	6.9	4.1	27.6	25.1	19.6	17.7	23.6	34.2	15.5	20.3	16.7	88.4	6.7	3.5	4.7	11.6	4.7	10.4	8.6	8.0	17.5	6.6	2.9	24.6	11.0	19.8	17.2	11.5	0.3	0.2	0.8	0.2	0.3	6.6	1.4	7.8	10.5	28.3	14.3	12.4	6.7	11.5	4.5	7.0	8.9	20.8	23.5	13.7	0.0	18.8	4.6	6.4	0.1	8.5	10.5	0.0	15.2	1.4	6.8	26.1	6.9	0.0	1.1	13.2	4.1	7.8	3.0	18.9	0.0	0.0	9.1	8.1	0.0	0.1	42.7	7.9	0.0	13.4	0.0	13.9	64.4	1.8	7.7	4.4	3.9	6.0	5.7	1.0	5.3	5.6	8.5	9.1	2.9	0.0	0.0	0.0	4.9	0.0	3.9	0.5	0.1	0.2	1.0	0.1	3.5	0.3	2.4	0.8	0.0	0.2	6.6	3.8	0.8	0.3	0.2	0.2	0.1	1.4	7.0	6.6	2.9	4.9	7.4	7.3	6.9	4.1	34.2	6.6
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.2;heart muscle: 58.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 62.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.2"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 125.3"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"			1900000	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	12.7	5.3	2.6	4.0	5.9	0.3	16.2	58.2	11.5	17.6	6.6	3.0	16.1	3.6	20.9	11.2	6.8	8.8	13.8	58.5	2.9	2.7	21.3	25.3	13.6	3.9	2.8	3.3	15.3	6.5	17.4	3.8	27.7	4.5	10.7	2.7	21.8	8.4	17.7	7.1	13.3	5.4	9.5	2.6	8.4	5.6	5.7	2.3	6.0	9.4	9.4	4.3	8.1	13.6	0.0	0.0	0.6	0.1	0.0	1.1	3.6	0.4	3.5	5.9	5.0	4.9	4.6	13.9	6.7	20.3	4.3	5.7	8.1	3.1	0.2	6.7	3.9	0.9	2.3	2.5	2.6	1.0	2.6	9.1	2.7	5.7	13.3	0.0	0.7	5.9	2.1	8.9	4.2	14.8	0.2	0.2	3.8	5.2	0.0	0.2	8.3	1.8	2.7	62.6	0.8	18.1	1.5	10.5	7.1	4.4	11.3	4.3	3.9	0.0	8.7	2.4	7.2	3.8	6.3	0.0	0.0	0.0	6.0	0.1	2.6	0.0	0.1	0.0	1.1	0.1	0.3	0.0	0.2	0.6	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	3.6	2.6	5.9	58.2	11.5	2.9	2.7	2.8	3.3	4.5	2.3
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS"	ENSG00000100300	"Translocator protein"	"B1AH88, P30536"	22	43151514-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 139.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011232, HPA046260"	Uncertain		Approved	Vesicles,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Vesicles	"CAB011232: , HPA046260: "	"unprognostic (5.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-3)"	33.9	21.2	9.8	17.8	11.0	117.3	48.7	2.7	8.1	24.9	23.9	12.3	10.3	20.5	12.3	13.6	83.2	14.3	36.8	32.1	8.0	5.4	18.0	22.0	39.8	40.0	15.4	5.2	13.3	13.2	4.0	6.7	15.5	9.7	23.1	9.7	16.4	34.6	9.2	13.2	46.6	23.0	12.7	11.4	27.2	39.0	10.5	10.0	9.4	17.9	44.3	50.0	19.1	41.3	22.9	99.9	91.4	139.5	28.5	43.8	104.8	47.1	23.4	1.6	22.2	8.9	29.6	1.7	35.3	17.3	17.8	18.9	4.5	36.1	0.0	24.4	27.3	39.1	4.4	27.3	2.3	7.9	18.4	4.8	25.7	1.6	32.4	10.7	24.2	22.9	45.1	10.5	9.4	42.0	3.9	8.9	18.2	39.4	0.1	29.9	1.9	58.4	10.6	0.0	80.5	22.6	28.5	2.3	10.9	16.7	33.4	41.1	12.5	41.5	43.3	22.0	16.5	22.5	14.8	3.6	0.6	0.4	28.6	34.8	28.2	43.8	139.5	75.3	28.4	86.3	22.2	16.3	39.5	27.8	99.9	22.9	30.4	24.5	91.4	28.5	57.1	17.7	43.8	104.8	9.8	11.0	2.7	8.1	8.0	5.4	15.4	5.2	9.7	10.0
TSPY1	"CT78, TSPY"	ENSG00000258992	"Testis specific protein, Y-linked 1"	Q01534	Y	9466955-9469748	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	105	"testis: 10.5"	"Group enriched"	"Detected in some"	361	"U-266/70: 63.4;U-266/84: 59.3"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049384	Supported		Approved	Cytosol				Cytosol		"HPA049384: "															"unprognostic (2.91e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	59.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TSPY10		ENSG00000236424	"Testis specific protein, Y-linked 10"		Y	9527880-9530682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	11	"testis: 6.3"	"Cell line enriched"	"Detected in some"	5	"U-266/84: 35.7"	"Cancer enriched"	"Detected in single"	13	"testis cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049384	Supported		Approved	Cytosol				Cytosol		"HPA049384: "															"unprognostic (5.36e-1)"			0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TSPY2	TSPYQ1	ENSG00000168757	"Testis specific protein, Y-linked 2"	A6NKD2	Y	6246223-6249019	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	104	"testis: 13.5"	"Group enriched"	"Detected in some"	416	"U-266/70: 41.0;U-266/84: 42.2"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049384	Supported		Approved	Cytosol				Cytosol		"HPA049384: "															"unprognostic (3.69e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TSPY3	CT78	ENSG00000228927	"Testis specific protein, Y-linked 3"	P0CV98	Y	9398421-9401223	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	4	"testis: 7.6"	"Group enriched"	"Detected in some"	75	"U-266/70: 49.7;U-266/84: 45.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049384	Supported		Approved	Cytosol				Cytosol		"HPA049384: "															"unprognostic (4.19e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.2	0.0	1.8	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	49.7	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TSPY4		ENSG00000233803	"Testis specific protein, Y-linked 4"	"P0CV99, P0CW01"	Y	9337464-9340284	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	222	"testis: 28.0"	"Group enriched"	"Detected in some"	604	"U-266/70: 174.1;U-266/84: 183.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049384	Supported		Approved	Cytosol				Cytosol		"HPA049384: "																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	174.1	183.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TSPY8		ENSG00000229549	"Testis specific protein, Y-linked 8"	P0CW00	Y	9357797-9360599	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	10	"testis: 4.1"	"Cell line enriched"	"Detected in single"	230	"U-266/84: 75.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049384	Supported		Approved	Cytosol				Cytosol		"HPA049384: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPYL5	KIAA1750	ENSG00000180543	"TSPY like 5"	Q86VY4	8	97273474-97277964	"Predicted intracellular proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Cell line enhanced"	"Detected in some"		"K-562: 13.7;SCLC-21H: 29.2;SH-SY5Y: 22.6;U-2 OS: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031347	Enhanced		Approved	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA031347: AB_10601454"	"prognostic favourable (1.21e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.40e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.31e-2)"	"unprognostic (3.13e-1)"	5.5	8.3	9.0	4.0	19.7	1.3	11.3	8.4	24.0	11.5	8.0	9.3	20.1	1.9	14.2	14.9	4.5	11.9	6.3	11.1	9.1	15.0	8.5	1.9	6.6	5.5	8.6	9.1	23.9	8.0	5.5	12.8	4.1	17.4	14.6	3.4	7.1	8.7	17.7	10.5	3.8	3.7	13.3	7.1	6.4	7.4	46.4	5.2	6.3	7.9	4.4	6.6	9.8	4.6	1.5	2.3	0.7	0.5	1.0	1.3	0.4	0.0	7.4	0.0	0.0	0.2	0.2	0.0	5.8	0.0	5.8	3.8	0.0	0.2	0.0	8.1	6.9	2.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	9.4	0.0	8.2	0.0	0.0	13.7	0.0	0.2	10.7	0.0	0.0	0.0	0.1	10.5	0.0	0.0	4.9	0.0	29.2	22.6	0.0	1.9	0.0	0.0	0.9	0.0	0.0	12.7	0.0	0.0	6.9	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.5	0.0	0.7	0.5	0.1	2.3	1.5	1.3	0.5	0.0	1.0	0.2	2.2	1.1	0.4	9.0	19.7	8.4	24.0	9.1	15.0	8.6	9.1	17.4	5.2
TSPYL6		ENSG00000178021	"TSPY like 6"	Q8N831	2	54253184-54256272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 41.1"	"Cell line enriched"	"Detected in single"	131	"K-562: 13.1"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034699, HPA034700"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA034699: , HPA034700: AB_10670159"	"unprognostic (8.21e-2)"				"unprognostic (4.25e-1)"			"unprognostic (1.06e-2)"		"unprognostic (1.00e-1)"			"unprognostic (5.54e-6)"	"unprognostic (4.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2, ribosome maturation factor"	Q969E8	X	54440401-54445487	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favourable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	20.8	25.0	52.9	13.8	53.1	15.3	19.2	27.6	44.3	18.2	17.2	30.8	16.9	13.9	18.4	33.9	16.2	21.1	14.8	22.2	45.3	46.2	26.5	23.7	17.5	14.9	53.8	34.4	22.9	17.2	30.7	19.0	19.8	31.0	20.8	20.6	19.0	16.6	25.4	35.5	17.2	14.7	19.7	54.3	18.1	16.5	8.4	27.5	10.2	23.9	10.8	22.0	17.7	16.8	39.6	15.4	28.7	21.2	24.7	41.4	21.1	20.4	26.2	19.2	17.4	17.3	12.5	17.1	20.3	16.5	18.9	16.3	24.7	22.4	22.4	14.1	17.7	21.2	46.9	28.1	25.3	29.1	23.2	18.2	19.6	19.2	10.7	31.5	19.1	11.6	15.4	26.4	27.3	13.2	18.5	16.8	19.2	37.5	24.0	24.8	30.5	29.8	21.6	35.7	18.9	20.1	18.2	24.2	16.8	38.6	19.3	21.5	39.3	11.0	17.9	13.9	24.5	29.2	17.3	18.0	27.1	26.8	20.5	25.1	20.8	24.5	15.3	28.7	35.1	20.5	28.8	38.7	33.3	31.8	13.9	39.6	41.4	31.7	9.4	24.7	21.2	15.4	35.5	21.1	52.9	53.1	27.6	44.3	45.3	46.2	53.8	34.4	31.0	27.5
TSR3	"C16orf42, MGC24381"	ENSG00000007520	"TSR3, acp transferase ribosome maturation factor"	Q9UJK0	16	1349240-1351911	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040760, HPA046265"	Uncertain		Approved	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA040760: , HPA046265: AB_10963942"	"unprognostic (4.04e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.14e-1)"	25.1	17.9	23.3	16.6	23.2	13.0	26.1	14.3	28.0	13.1	19.1	18.4	19.7	21.8	14.1	18.2	19.9	15.1	15.4	25.2	21.6	16.9	17.5	19.3	15.7	28.6	22.7	14.2	15.2	39.6	13.0	12.7	13.9	16.4	16.8	8.4	14.2	35.0	18.9	64.6	16.3	17.7	19.3	18.0	17.1	21.3	12.2	13.5	14.5	15.0	20.8	17.6	15.7	17.8	8.9	5.5	11.9	4.5	2.4	7.1	1.8	21.0	23.5	9.7	12.9	11.6	14.2	16.5	19.7	8.7	14.0	13.0	25.9	21.5	13.4	26.4	13.1	22.2	8.8	16.3	4.9	26.0	40.5	5.9	19.3	20.3	21.1	12.7	11.7	14.9	23.5	12.6	12.4	15.2	18.8	11.8	11.5	37.6	18.5	21.5	16.4	28.6	33.1	11.9	36.2	12.3	8.4	15.4	19.9	15.1	19.0	24.6	18.2	15.9	16.6	23.3	25.1	19.8	23.9	25.3	16.8	17.7	11.8	15.3	15.7	11.1	4.5	11.9	5.3	3.7	6.7	7.2	6.7	4.9	3.6	8.9	7.1	6.5	11.8	2.4	3.9	5.5	4.8	1.8	23.3	23.2	14.3	28.0	21.6	16.9	22.7	14.2	16.4	13.5
TSSC4		ENSG00000184281	"Tumor suppressing subtransferable candidate 4"	Q9Y5U2	11	2400488-2403878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041801, HPA058763"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041801: AB_10793934, HPA058763: "	"unprognostic (1.98e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (9.91e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.38e-2)"	25.6	11.7	12.1	13.9	12.5	33.0	13.2	10.7	20.9	17.5	21.5	12.7	10.9	15.9	20.6	13.3	16.7	16.4	15.1	23.2	11.9	11.0	14.1	19.4	13.8	16.8	15.2	12.7	17.7	20.9	10.3	14.7	19.8	11.2	18.2	5.6	13.1	20.2	19.0	32.5	16.2	16.1	19.0	10.5	18.5	14.0	29.1	10.7	21.7	22.7	25.2	14.7	20.2	36.2	54.0	44.9	55.3	44.7	43.0	49.0	37.3	19.5	24.6	8.0	12.8	6.8	5.0	15.5	13.4	9.3	16.3	11.3	18.1	25.4	14.3	11.9	10.6	19.5	9.3	15.5	3.1	16.3	25.6	8.3	13.0	18.4	18.7	14.2	17.5	12.0	22.4	10.4	10.0	11.3	18.8	16.0	7.7	25.3	16.9	25.9	23.4	28.9	19.3	7.2	12.7	8.2	16.5	21.0	21.4	11.4	25.9	15.6	13.6	16.8	14.8	21.7	11.2	20.1	15.5	32.4	27.8	12.0	18.6	14.6	22.5	55.3	44.7	43.8	46.1	38.2	49.0	43.5	45.9	47.2	44.9	54.0	41.4	39.0	43.2	43.0	40.1	43.3	47.8	37.3	12.1	12.5	10.7	20.9	11.9	11.0	15.2	12.7	11.2	10.7
TSTA3	"FX, P35B, SDR4E1"	ENSG00000104522	"Tissue specific transplantation antigen P35B"	Q13630	8	143612618-143618048	"Enzymes, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol			600000	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favourable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	9.4	12.0	7.0	9.5	10.1	16.3	10.2	6.1	13.8	8.6	18.7	8.4	16.6	24.8	8.4	9.9	28.0	7.7	23.7	15.7	8.1	7.8	11.7	40.0	8.9	16.5	6.8	8.1	9.7	60.1	6.4	14.2	21.9	12.2	13.9	14.9	9.5	35.4	14.2	16.8	28.4	20.2	6.9	4.7	11.3	35.5	24.6	5.6	14.7	13.0	17.8	24.8	9.8	10.4	18.7	25.6	17.7	21.0	28.1	26.9	20.5	17.5	12.8	6.5	19.3	5.4	5.2	12.0	14.6	14.3	10.4	7.8	15.7	18.8	7.7	14.3	10.3	12.6	9.7	19.8	4.7	19.9	14.1	11.4	22.7	18.1	11.1	7.6	13.0	6.5	10.2	7.0	25.0	16.8	12.6	11.2	7.8	53.3	9.9	11.5	8.8	17.6	11.3	4.9	23.7	20.9	17.6	13.3	10.4	10.0	19.7	14.6	25.0	11.1	14.1	6.9	27.4	8.2	14.0	8.4	6.0	5.6	10.6	17.4	10.3	10.5	15.9	17.7	21.0	21.0	21.2	16.1	22.7	22.6	18.0	18.7	16.9	18.7	16.3	28.1	16.3	25.6	26.9	20.5	7.0	10.1	6.1	13.8	8.1	7.8	6.8	8.1	12.2	5.6
TSTD1	KAT	ENSG00000215845	"Thiosulfate sulfurtransferase like domain containing 1"	Q8NFU3	1	161037631-161038990	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.4;SK-BR-3: 52.8;T-47d: 51.0;U-266/70: 59.6;U-266/84: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"olfactory region: 8.2"	"Low region specificity"	"Detected in many"			"HPA006518, HPA006655"	Approved		Approved	"Cytosol,Cytoplasmic bodies"				"Cytosol, Cytoplasmic bodies"		"HPA006518: , HPA006655: AB_10600919"	"unprognostic (6.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.88e-3)"	9.1	19.9	14.8	15.4	29.8	13.1	24.2	3.6	13.9	10.1	18.1	4.4	45.4	12.2	4.2	34.7	23.3	21.8	16.0	14.4	12.2	8.1	28.4	26.0	19.2	14.6	4.1	13.2	15.0	62.2	27.7	32.9	10.1	6.3	26.0	12.8	11.9	79.8	46.0	9.2	18.7	16.5	5.6	1.9	10.4	14.1	15.0	5.5	20.4	61.3	19.5	27.1	12.3	11.0	77.0	30.9	55.0	14.8	42.1	58.7	31.9	21.4	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	21.2	4.6	12.9	0.0	19.9	0.0	8.5	0.0	17.7	16.0	2.4	8.1	0.0	2.3	8.0	0.1	0.1	5.3	0.0	0.9	2.9	0.0	25.1	2.5	37.4	21.6	0.1	0.1	0.1	7.1	0.0	33.0	18.4	6.0	13.0	7.0	0.0	52.8	0.1	51.0	0.1	0.1	0.0	8.0	0.1	0.9	59.6	41.9	4.6	0.0	0.0	0.0	55.0	3.6	51.2	36.3	10.5	34.8	75.8	47.8	40.2	10.9	77.0	54.7	45.9	51.6	42.1	14.8	30.9	58.7	31.9	14.8	29.8	3.6	13.9	12.2	8.1	4.1	13.2	6.3	5.5
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243680-43288259	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 20.8;SH-SY5Y: 7.9"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA031735: , HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	1.1	3.9	12.4	1.3	12.9	0.9	1.0	14.9	28.9	1.0	1.4	8.2	0.0	4.6	1.0	1.0	1.0	1.1	1.4	1.3	10.3	7.5	1.7	3.5	1.1	1.2	7.1	12.5	1.0	1.4	1.6	7.7	1.0	9.0	1.3	1.3	0.7	1.0	1.2	1.0	1.0	6.8	1.1	6.2	1.2	1.3	2.3	8.3	0.0	1.0	0.0	1.3	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	20.8	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.4	12.9	14.9	21.7	10.3	7.5	7.1	12.5	9.0	8.3
TTC1	TPR1	ENSG00000113312	"Tetratricopeptide repeat domain 1"	Q99614	5	160009113-160065543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036557, HPA057502"	Approved		Enhanced	Cytosol				Cytosol		"HPA036557: AB_10670112, HPA057502: "	"unprognostic (4.34e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.16e-2)"	25.3	28.0	44.4	21.0	36.0	14.3	25.4	31.4	44.9	21.7	25.2	25.4	16.8	16.9	21.3	38.4	24.8	21.0	16.6	33.9	41.7	42.9	31.3	27.7	20.5	26.9	48.9	33.9	23.7	16.0	25.7	23.9	22.0	56.7	22.0	29.4	15.9	23.7	25.1	50.5	21.6	20.6	26.7	37.4	25.2	19.7	20.3	26.6	27.4	26.8	20.0	33.5	25.9	18.0	46.0	38.4	54.2	41.3	43.2	45.3	52.8	24.5	25.7	19.2	32.1	22.9	16.5	21.8	27.6	24.6	30.4	36.2	36.0	28.7	25.3	54.1	23.6	19.5	25.5	37.8	49.1	46.7	27.1	22.6	20.3	25.8	32.4	37.4	19.0	15.4	25.1	26.8	22.5	36.4	21.5	25.2	34.6	19.2	27.1	29.5	21.8	26.3	26.3	27.0	27.8	38.4	23.1	15.9	17.9	19.1	22.9	50.9	36.2	36.4	25.5	20.3	17.5	18.0	42.4	18.2	33.1	24.5	28.1	42.8	26.2	47.0	39.1	52.4	32.4	41.3	40.4	46.0	38.4	37.6	38.4	40.6	35.6	39.4	54.2	43.2	39.0	34.1	45.3	52.8	44.4	36.0	31.4	44.9	41.7	42.9	48.9	33.9	56.7	26.6
TTC17	FLJ10890	ENSG00000052841	"Tetratricopeptide repeat domain 17"	Q96AE7	11	43358932-43494933	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038508	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA038508: AB_10671744"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.01e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (4.75e-6)"	"unprognostic (1.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.54e-2)"	12.7	13.6	16.3	15.8	18.4	6.8	21.2	21.1	17.0	12.7	10.7	9.1	21.1	10.9	15.0	13.9	11.5	17.7	11.5	10.5	12.8	7.4	12.0	19.9	20.4	19.8	21.7	11.3	26.6	47.7	20.5	20.8	15.0	15.4	13.8	12.0	10.6	20.7	11.7	12.1	10.9	14.0	17.7	12.9	11.9	16.4	12.3	17.3	11.1	19.5	9.1	11.1	12.8	12.5	22.4	23.3	24.5	29.0	20.4	23.1	21.1	5.7	12.0	12.6	19.8	31.8	26.5	8.9	14.1	18.9	11.8	14.3	8.3	8.6	12.3	14.2	14.1	12.3	8.8	9.2	14.3	9.4	11.6	9.4	7.7	8.1	39.4	14.0	12.1	24.5	28.6	8.6	27.9	11.7	13.5	10.5	11.9	7.0	10.3	8.1	18.8	10.4	9.7	13.4	14.2	15.0	8.6	6.7	16.1	10.9	29.3	17.6	27.5	16.0	15.6	17.0	7.5	19.0	20.2	20.7	16.6	11.8	10.9	8.5	18.0	22.3	28.3	23.8	21.0	29.0	21.9	22.4	22.6	19.7	21.9	20.7	23.1	21.0	24.5	20.4	24.7	23.3	20.3	21.1	16.3	18.4	21.1	17.0	12.8	7.4	21.7	11.3	15.4	17.3
TTC23	"FLJ12572, HCC-8"	ENSG00000103852	"Tetratricopeptide repeat domain 23"	Q5W5X9	15	99136323-99251223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039806, HPA040369"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039806: AB_10793921, HPA040369: AB_10795381"	"prognostic favourable (3.17e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.40e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.56e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.23e-1)"	9.5	10.7	6.0	6.1	8.6	1.0	9.7	5.4	7.5	13.2	15.5	12.2	11.9	3.7	20.3	9.9	10.7	10.6	10.4	11.9	7.7	4.7	10.6	8.2	8.1	3.0	9.8	7.5	17.5	11.7	10.7	10.2	10.0	10.5	13.7	8.7	14.0	8.4	12.0	7.8	8.6	6.4	12.3	15.7	5.2	8.7	16.2	9.0	5.1	14.1	7.7	5.0	13.0	11.4	0.5	2.4	3.8	1.3	2.0	0.5	0.1	6.7	7.1	10.9	12.5	13.0	14.7	4.6	8.4	10.3	9.0	10.2	6.1	11.9	1.7	17.0	9.5	13.2	3.5	8.3	9.8	2.2	11.6	7.2	12.4	4.7	7.6	1.6	0.5	10.4	7.5	7.1	6.8	15.1	5.5	1.0	8.4	4.0	5.7	1.8	5.9	4.9	1.8	14.2	2.5	7.3	9.1	4.7	2.1	11.1	4.5	10.2	7.5	7.5	9.9	11.4	6.9	7.6	10.7	6.0	8.1	2.3	10.3	0.5	6.7	3.8	0.5	0.6	0.3	1.3	0.3	0.4	0.4	0.5	2.4	0.5	0.3	0.3	1.8	2.0	0.5	1.9	0.4	0.1	6.0	8.6	5.4	7.5	7.7	4.7	9.8	7.5	10.5	9.0
TTC26	"dyf-13, DYF13, FLJ12571, IFT56"	ENSG00000105948	"Tetratricopeptide repeat domain 26"	A0AVF1	7	139133744-139191986	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036338, HPA036339"	Enhanced		Approved	"Nuclear speckles,Intermediate filaments,Cytosol"				"Nuclear speckles, Intermediate filaments, Cytosol"		"HPA036338: AB_10673351, HPA036339: AB_10673386"	"unprognostic (3.40e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.56e-1)"	3.5	6.5	6.9	2.5	8.1	3.3	5.6	6.9	8.3	6.1	3.1	4.4	7.4	1.3	6.6	7.6	3.1	20.9	4.5	3.5	5.7	5.1	8.3	1.9	5.1	2.8	2.7	4.8	8.8	3.2	13.0	20.1	3.8	8.4	5.6	2.8	5.4	3.6	5.5	2.3	3.2	2.2	4.6	2.7	2.6	3.1	17.4	3.9	3.8	7.3	2.8	3.1	3.7	3.9	3.6	2.5	5.3	1.5	1.6	2.3	0.9	11.3	8.6	7.6	9.0	9.5	11.1	3.8	5.5	5.8	9.1	9.3	5.5	8.2	2.5	9.3	4.3	5.7	8.5	6.5	13.3	7.1	7.3	3.1	6.9	4.7	4.7	8.8	2.1	6.3	5.9	13.6	6.2	6.7	6.8	1.6	7.2	10.7	14.9	10.3	7.6	7.6	5.2	9.0	4.0	7.9	3.4	11.2	8.0	13.7	5.8	7.8	7.0	4.7	4.6	8.5	7.4	7.7	10.2	3.7	4.6	1.9	14.9	4.3	9.9	1.2	0.5	1.2	2.1	0.5	1.1	3.6	1.5	1.4	1.1	2.4	2.3	1.7	5.3	1.6	1.5	2.5	1.0	0.9	6.9	8.1	6.9	8.3	5.7	5.1	2.7	4.8	8.4	3.9
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: "	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	22.9	22.1	34.0	18.7	36.5	12.0	23.4	39.2	40.0	34.9	20.6	15.9	26.7	13.0	21.6	33.3	15.3	19.5	19.0	21.5	29.1	16.5	21.4	17.0	15.4	14.3	17.7	27.5	34.5	25.8	27.4	50.4	15.2	34.7	28.9	19.9	16.1	24.5	25.4	21.6	16.1	16.8	21.6	21.7	13.6	21.3	19.5	19.9	19.7	35.4	11.1	15.1	23.3	18.9	10.6	12.8	4.8	5.7	9.1	18.6	3.8	21.4	7.6	35.7	6.7	34.5	50.2	12.4	23.6	29.4	10.7	14.5	10.1	10.8	18.5	8.2	39.5	7.0	10.7	14.5	15.1	19.6	7.7	37.4	11.5	13.1	12.6	20.8	12.1	25.9	9.0	10.8	9.7	15.8	22.5	21.8	20.0	16.6	20.2	5.4	10.1	13.0	27.1	17.1	9.7	12.4	16.6	27.3	20.8	29.3	16.8	15.2	19.0	8.2	20.5	15.3	6.1	18.7	8.8	21.9	15.7	18.5	25.2	20.9	11.5	2.9	4.4	4.8	9.1	4.8	13.6	9.5	10.6	12.3	7.9	10.6	18.6	11.3	0.7	9.1	5.7	12.8	7.2	3.8	34.0	36.5	39.2	40.0	29.1	16.5	17.7	27.5	34.7	19.9
TTC31	FLJ12788	ENSG00000115282	"Tetratricopeptide repeat domain 31"	Q49AM3	2	74483073-74494886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041783	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA041783: AB_10794306"	"unprognostic (2.38e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (6.70e-4)"	"unprognostic (2.64e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.56e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.83e-2)"	"prognostic favourable (2.49e-4)"	9.2	8.9	7.4	12.3	11.7	11.5	8.6	13.8	9.3	9.0	15.7	8.6	5.3	10.5	11.6	9.4	8.7	7.9	14.5	7.4	8.9	3.7	9.9	23.6	8.2	10.4	10.4	7.7	9.7	13.4	13.2	10.0	13.7	8.3	8.0	9.5	10.5	8.1	7.5	6.5	11.1	16.2	9.3	7.0	13.6	11.6	8.6	12.2	11.5	7.7	9.7	11.5	10.6	8.5	9.3	9.7	8.1	10.2	7.5	9.0	7.8	10.9	10.0	6.5	3.4	3.8	11.2	7.6	6.1	8.5	11.1	7.7	8.4	8.2	15.5	4.9	4.8	8.0	6.0	6.6	5.5	17.0	6.2	16.5	8.9	14.5	7.4	6.7	10.9	8.1	8.9	9.5	5.9	7.5	11.0	6.6	6.9	10.2	9.9	3.9	4.0	4.9	9.8	17.1	7.3	6.1	8.1	3.2	12.0	5.7	9.0	6.2	6.7	3.8	13.8	7.6	12.8	4.7	9.0	9.7	7.8	10.1	9.5	7.7	7.1	6.4	10.2	8.1	8.4	10.2	9.0	9.3	6.5	8.0	9.7	7.3	6.3	6.8	1.4	7.5	10.2	5.7	8.3	7.8	7.4	11.7	13.8	9.3	8.9	3.7	10.4	7.7	8.3	12.2
TTC37	"KIAA0372, THES"	ENSG00000198677	"Tetratricopeptide repeat domain 37"	Q6PGP7	5	95463895-95555007	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037905	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037905: AB_10673034"	"unprognostic (5.99e-2)"	"unprognostic (7.65e-3)"	"prognostic favourable (2.62e-4)"	"unprognostic (8.48e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.30e-3)"	"unprognostic (6.88e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.98e-2)"	"unprognostic (7.90e-3)"	29.6	21.8	18.9	16.1	19.4	6.9	19.2	35.7	37.9	21.1	19.7	8.2	20.7	15.6	17.3	15.5	27.5	14.8	13.7	17.5	20.2	14.1	28.2	25.2	17.1	13.8	21.5	21.5	21.3	22.2	40.2	42.1	20.7	26.5	21.1	16.8	6.6	16.8	17.4	33.1	23.9	22.7	21.5	29.8	16.0	18.8	9.1	25.0	25.2	19.7	23.5	15.3	28.1	16.1	10.3	14.8	3.5	7.4	8.2	12.0	3.7	12.4	13.3	16.9	5.8	28.3	38.6	15.1	23.7	19.3	15.5	23.4	14.1	9.1	22.0	15.7	22.6	12.3	21.3	28.7	26.1	12.8	17.4	14.7	27.0	9.3	24.3	9.5	10.7	25.6	14.8	19.7	27.7	24.5	11.5	14.5	29.2	7.1	12.4	7.7	9.5	11.3	10.6	23.6	23.1	17.2	9.8	21.2	16.6	19.6	9.7	21.7	15.1	8.2	33.6	21.2	12.2	16.7	18.2	14.0	17.6	20.5	21.5	14.1	27.2	3.5	6.0	2.1	9.9	7.4	12.0	9.6	9.7	8.0	7.2	10.3	10.0	10.4	0.2	8.2	6.7	14.8	8.8	3.7	18.9	19.4	35.7	37.9	20.2	14.1	21.5	21.5	26.5	25.0
TTC38	FLJ20699	ENSG00000075234	"Tetratricopeptide repeat domain 38"	Q5R3I4	22	46267961-46294008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 59.8;liver: 92.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 36.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.1;NK-cells: 13.5;T-cells: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029302	Approved		Approved	Cytosol			19000	Cytosol		"HPA029302: AB_10601704"	"unprognostic (7.78e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.92e-3)"	"prognostic favourable (3.21e-6)"	"unprognostic (8.34e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.72e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.02e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.97e-1)"	"unprognostic (8.33e-2)"	10.5	8.1	3.8	8.8	5.0	16.1	14.0	3.9	4.4	5.5	31.6	5.5	6.2	31.2	6.6	5.0	6.7	5.9	15.0	10.9	3.8	3.3	47.2	92.8	5.3	5.0	6.0	2.2	10.0	19.8	3.0	5.9	3.1	5.3	8.7	12.9	7.5	10.4	6.9	8.6	3.9	59.8	5.2	3.9	8.4	9.1	2.5	5.5	1.0	8.2	4.7	4.2	5.3	5.8	0.9	4.0	10.1	4.3	13.5	36.0	13.4	5.6	6.2	7.9	16.5	7.5	6.5	8.0	8.3	5.4	9.0	7.1	10.1	4.1	0.0	5.3	8.4	5.1	7.9	6.6	3.3	12.6	17.8	7.4	14.0	34.9	10.4	4.1	29.1	11.1	3.5	4.1	4.7	7.5	5.4	9.3	5.7	5.5	0.1	12.9	6.0	6.2	0.0	3.8	3.7	6.1	6.5	1.4	11.2	11.4	7.8	6.1	12.5	8.3	8.8	6.5	7.1	4.9	5.2	7.3	4.3	0.8	4.3	6.4	6.6	10.1	4.3	8.0	36.0	4.1	3.9	0.9	3.5	16.0	4.0	0.7	1.5	15.4	2.9	13.5	3.0	1.6	1.6	13.4	3.8	5.0	3.9	4.4	3.8	3.3	6.0	2.2	5.3	5.5
TTF2	"HuF2, ZGRF6"	ENSG00000116830	"Transcription termination factor 2"	Q9UNY4	1	117060303-117107453	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005776, HPA070762"	Approved		Supported	Cytosol				Cytosol		"HPA005776: AB_1080416, HPA070762: "	"unprognostic (1.82e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.01e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.41e-3)"	"unprognostic (5.27e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.34e-3)"	"unprognostic (1.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.65e-2)"	5.7	9.4	5.4	8.5	8.4	6.6	6.0	0.9	5.2	5.9	7.0	8.4	2.6	6.0	5.9	2.3	9.8	4.5	3.9	5.8	4.6	3.8	3.9	3.1	4.7	11.5	12.0	2.1	5.5	5.5	6.7	10.7	4.9	7.2	5.0	8.1	4.2	6.5	3.6	8.4	6.9	5.7	6.8	7.7	6.8	5.4	6.3	8.0	25.1	5.2	7.8	17.8	6.4	6.5	3.7	5.9	3.2	6.3	5.3	6.1	2.5	12.5	4.6	9.4	13.2	3.7	3.3	11.7	6.7	3.2	9.9	8.8	6.5	2.2	15.3	10.5	4.4	13.1	16.5	8.7	15.4	11.7	11.7	13.0	9.0	8.2	2.7	19.0	15.0	3.7	3.3	7.3	13.7	6.7	10.0	14.0	7.5	19.2	12.6	11.8	14.6	9.4	18.2	34.6	6.7	6.0	5.7	8.0	3.3	10.1	10.1	3.8	5.5	7.8	6.8	6.3	13.4	14.7	14.6	6.4	5.5	18.8	4.2	14.4	25.2	1.8	5.2	3.2	3.0	6.3	2.9	3.7	3.5	4.7	5.9	3.5	3.6	4.1	0.9	5.3	3.6	3.3	6.1	2.5	5.4	8.4	0.9	5.2	4.6	3.8	12.0	2.1	7.2	8.0
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavourable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.7	1.1	3.5	13.6	15.5	9.6	22.7	27.8	10.9	10.2	19.8	12.1	6.6	17.4	21.2	9.5	31.7	18.0	17.1	18.3	10.7	8.9	0.0	21.5	12.0	0.4	1.0	15.9	10.2	12.8	20.0	20.5	19.3	9.9	12.3	15.6	14.2	9.7	11.0	43.9	8.2	5.7	8.6	16.6	9.7	9.1	9.9	5.6	9.3	16.4	5.3	10.2	10.2	6.6	24.8	4.6	15.5	11.0	3.6	20.1	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187133	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"			2100000	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: "	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	7.3	13.8	7.2	14.7	8.3	14.0	11.2	13.6	12.3	10.9	21.5	5.5	8.9	15.0	7.1	8.7	46.3	9.0	36.0	6.9	7.3	7.1	8.4	19.4	5.3	9.2	6.5	5.9	16.5	29.8	4.4	7.0	6.8	7.1	9.4	12.1	7.0	13.5	7.9	5.5	16.4	13.9	5.9	4.0	9.7	20.7	18.3	5.3	10.7	7.6	23.7	23.5	8.3	15.2	3.5	3.8	1.3	4.7	4.3	5.6	3.3	31.5	13.3	5.4	13.3	8.3	5.7	17.5	10.4	3.7	10.0	5.2	21.6	18.0	30.4	12.6	8.6	22.5	22.4	19.0	2.5	3.8	35.6	7.4	21.4	18.5	13.0	33.4	7.7	9.0	23.2	11.9	12.8	10.5	45.8	7.2	4.6	29.3	23.2	18.1	19.6	13.3	23.6	18.6	43.7	8.4	10.4	16.5	6.8	22.1	32.4	11.7	12.7	14.9	10.0	6.7	9.4	12.8	14.4	12.2	15.0	22.5	7.6	17.2	9.0	0.0	4.7	0.7	5.6	2.4	5.5	3.5	5.5	4.1	3.8	2.7	5.5	3.7	1.3	4.3	3.1	3.3	3.5	3.3	7.2	8.3	13.6	12.3	7.3	7.1	6.5	5.9	7.1	5.3
TTLL5	KIAA0998	ENSG00000119685	"Tubulin tyrosine ligase like 5"	Q6EMB2	14	75633625-75955078	"Disease related genes, Predicted intracellular proteins"	Transcription	Ligase	"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032128	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA032128: AB_10600835"	"unprognostic (7.35e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.21e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.15e-2)"	5.9	6.5	7.6	5.9	11.1	10.1	7.4	12.0	10.4	8.0	6.5	18.0	6.4	4.9	11.8	7.7	8.1	11.8	6.7	6.8	7.9	7.1	6.6	4.4	6.6	5.0	10.1	6.9	8.1	5.8	13.2	9.5	7.6	13.9	7.4	7.6	8.2	7.7	7.5	5.2	7.2	4.8	8.9	15.8	4.2	6.0	51.1	10.5	10.1	8.1	5.5	7.3	7.1	7.1	3.8	5.7	12.4	3.8	3.4	5.1	2.3	14.0	10.3	9.1	9.4	7.1	11.2	8.4	8.3	10.1	10.0	12.9	6.3	13.2	4.0	4.6	8.7	13.4	7.8	13.7	19.0	4.7	4.7	7.8	10.8	6.9	6.1	5.6	7.5	8.5	6.8	12.5	14.0	21.4	4.4	6.7	9.9	19.6	9.5	7.7	6.4	10.6	5.9	12.7	5.4	9.6	13.9	12.0	7.6	17.6	12.8	4.4	17.6	6.2	24.2	13.4	11.9	11.8	7.7	5.7	8.1	9.2	13.5	6.5	8.8	12.4	3.5	2.7	4.6	3.3	4.0	3.8	4.2	4.5	5.1	3.5	5.1	4.7	3.8	3.4	3.8	5.7	3.4	2.3	7.6	11.1	12.0	10.4	7.9	7.1	10.1	6.9	13.9	10.5
TTPAL	"C20orf121, dJ179M20.3"	ENSG00000124120	"Alpha tocopherol transfer protein like"	Q9BTX7	20	44475886-44494603	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 39.6;HSkMC: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046957, HPA066532"	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA046957: AB_10959741, HPA066532: "	"unprognostic (8.71e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (3.47e-5)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (8.09e-5)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.93e-2)"	9.5	6.2	6.3	7.2	8.3	9.1	7.6	6.5	13.1	8.2	4.6	4.8	5.1	4.3	6.3	9.2	7.0	6.9	5.3	4.2	5.8	7.9	5.7	32.0	4.0	9.7	5.9	11.5	6.6	7.6	11.1	12.8	5.0	9.8	6.4	5.0	6.4	6.2	7.3	3.8	14.7	5.3	6.6	3.6	5.7	5.5	6.4	3.0	5.8	9.3	5.5	9.2	5.9	7.9	5.9	3.1	4.2	3.5	7.9	7.6	3.4	8.5	4.5	3.5	6.1	39.6	15.4	3.4	9.3	13.0	9.0	7.8	16.5	5.2	5.3	8.0	8.6	8.5	4.4	14.6	9.8	5.5	2.0	2.5	4.6	4.8	11.0	3.7	6.0	34.1	9.6	8.9	15.0	3.0	3.2	5.6	7.2	9.8	3.6	2.4	4.1	7.5	1.1	3.7	2.9	3.5	6.2	7.7	3.6	12.9	5.7	5.7	6.2	2.4	3.1	20.3	8.1	6.0	8.0	8.4	5.7	5.8	9.8	2.7	5.9	0.7	1.6	2.6	6.7	3.2	7.1	5.9	5.7	6.7	1.7	5.8	5.1	7.6	4.2	7.9	3.5	3.1	5.7	3.4	6.3	8.3	6.5	13.1	5.8	7.9	5.9	11.5	9.8	3.0
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859482-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (1.92e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (2.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (1.00e-5)"	"unprognostic (2.86e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (6.06e-4)"	"unprognostic (4.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.83e-2)"	8.7	8.0	9.3	8.1	13.8	6.8	12.4	19.9	12.2	12.3	11.2	13.5	16.6	6.7	13.6	16.4	18.2	10.0	8.3	8.4	8.9	7.2	8.5	9.3	8.8	10.2	16.1	8.5	16.3	13.2	10.4	18.7	7.2	12.3	12.3	8.2	11.7	11.4	12.2	9.9	11.6	7.5	9.3	13.4	9.3	9.6	9.2	16.4	16.2	15.5	10.3	13.8	14.1	13.0	10.1	8.8	14.1	7.6	8.1	17.6	6.9	5.9	8.1	6.4	6.7	3.6	2.6	5.4	4.6	2.7	6.1	5.1	8.8	3.9	5.4	7.9	1.0	5.0	8.9	2.8	5.9	3.1	10.9	6.3	6.9	10.4	1.9	3.7	3.4	1.4	4.4	5.3	2.0	4.8	13.5	3.8	2.1	41.9	7.6	4.3	5.6	3.6	8.2	9.4	8.4	2.4	2.7	6.0	3.6	3.3	2.6	3.2	6.3	3.6	1.5	4.4	9.8	3.1	5.0	4.4	6.6	8.2	2.1	4.3	3.9	5.6	7.6	14.1	10.9	5.0	12.4	10.1	13.5	11.5	5.2	8.6	17.6	14.2	8.2	8.1	5.3	8.8	14.1	6.9	9.3	13.8	19.9	12.2	8.9	7.2	16.1	8.5	12.3	16.4
TUBGCP5	"GCP5, KIAA1899"	ENSG00000275835	"Tubulin gamma complex associated protein 5"	Q96RT8	15	22983192-23039673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039366, HPA040366"	Supported		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA039366: AB_10673243, HPA040366: "	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.53e-3)"	5.1	5.7	5.7	5.1	8.4	5.5	7.3	4.0	10.4	7.9	4.6	6.0	4.6	4.2	7.4	8.7	5.9	4.9	4.7	6.6	7.7		6.3	6.8	5.6	5.5	6.0	11.0	5.0	10.0	10.2	6.3	4.8	12.9	7.5	5.3	5.3	4.0	7.4	14.5	7.3	3.0	9.3	10.0	4.8	5.3	12.9	5.9	5.4	8.6	7.0	6.1	4.6	0.8	5.3	4.0	1.5	3.3	5.4	7.6	2.5	12.1	12.9	15.3	9.0	11.8	7.7	8.8	15.2	16.8	16.8	14.6	9.8	5.8	9.2	6.5	13.9	12.3	10.0	11.8	14.1	14.2	4.0	16.6	13.0	5.2	3.9	16.9	7.4	12.6	4.5	11.2	10.4	10.0	11.7	15.0	10.6	8.0	11.3	7.3	9.0	11.8	14.0	16.8	1.8	9.7	19.0	5.2	8.9	12.4	8.7	7.9	14.1	7.9	8.6	11.6	7.6	8.9	22.5	11.8	11.8	24.9	15.2	11.2	10.8	0.2	2.3	0.9	4.5	3.3	4.6	3.7	6.7	7.2	3.6	5.3	6.0	7.6	1.5	5.4	3.3	4.0	5.4	2.5										
TUSC2	"C3orf11, FUS1, PAP, PDAP2"	ENSG00000114383	"Tumor suppressor candidate 2"	O75896	3	50320027-50328251	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030116			Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA030116: AB_10602253"	"unprognostic (1.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.99e-2)"	"prognostic favourable (8.70e-7)"	"unprognostic (9.22e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-3)"	13.4	16.3	28.5	12.2	27.2	9.2	15.1	18.9	38.1	11.9	15.9	11.1	13.9	11.1	10.3	26.2	10.8	18.6	15.5	22.0	26.4	25.8	18.9	18.0	13.5	13.2	26.2	17.0	12.0	15.3	21.3	12.3	15.3	27.3	13.2	15.0	12.2	13.5	17.0	29.9	8.8	12.1	12.3	13.2	14.2	13.9	15.2	8.1	12.0	21.1	15.0	17.2	9.9	8.5	19.5	20.4	26.3	17.3	17.1	22.0	22.9	12.0	10.0	14.1	15.3	15.6	8.1	15.5	9.9	13.3	18.7	15.9	17.6	11.1	20.6	10.8	9.1	7.8	17.1	12.8	16.4	12.1	15.8	10.1	9.4	18.9	13.7	17.8	17.8	8.8	20.8	18.7	9.3	19.2	12.2	9.9	10.7	9.2	18.6	22.9	19.2	14.5	6.5	6.8	16.8	18.7	13.1	7.5	15.6	7.2	12.9	14.2	12.3	21.8	15.1	5.6	13.7	12.7	19.8	24.5	38.0	14.4	12.5	11.9	8.8	10.2	17.3	26.3	20.4	15.3	20.4	19.4	18.1	21.2	11.3	19.5	20.9	22.0	24.5	17.1	13.9	20.4	19.5	22.9	28.5	27.2	18.9	38.1	26.4	25.8	26.2	17.0	27.3	8.1
TUT1	"FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase"	ENSG00000149016	"Terminal uridylyl transferase 1, U6 snRNA-specific"	Q9H6E5	11	62575045-62592177	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA069055, HPA071838"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA069055: , HPA071838: "	"unprognostic (3.81e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavourable (9.51e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-3)"	10.9	12.1	10.7	9.9	13.6	7.8	12.9	13.5	13.3	10.5	8.7	15.9	13.0	12.9	11.5	10.8	10.0	16.9	13.7	10.7	13.6	8.3	12.2	22.7	9.6	18.1	15.5	9.5	14.5	26.2	15.5	16.2	12.3	13.0	13.9	6.2	11.9	16.4	11.9	20.5	13.9	11.7	10.2	11.4	14.6	12.5	18.6	13.2	17.1	14.0	8.8	13.6	11.5	9.8	13.1	9.4	6.6	7.3	9.8	16.0	7.2	7.2	9.1	6.3	8.8	7.7	4.4	8.2	7.8	4.8	6.6	5.8	8.2	14.2	11.6	18.1	3.8	13.7	11.6	9.1	3.4	8.9	6.1	11.9	9.3	7.7	8.6	8.4	5.4	6.2	9.8	8.3	12.6	6.3	17.8	12.0	5.6	15.9	11.9	17.9	7.2	11.2	13.4	10.1	28.1	6.1	4.2	10.5	14.7	6.0	11.3	9.7	15.8	8.2	5.7	7.5	6.8	8.7	5.9	20.9	18.3	14.2	8.8	6.7	6.2	5.9	5.9	6.6	10.5	7.3	14.6	9.8	9.9	8.4	7.8	13.1	16.0	12.5	3.6	9.8	5.3	9.4	8.9	7.2	10.7	13.6	13.5	13.3	13.6	8.3	15.5	9.5	13.0	13.2
TWF1	"A6, PTK9"	ENSG00000151239	"Twinfilin actin binding protein 1"	Q12792	12	43793723-43806375	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018116	Approved		Supported	Cytosol				Cytosol		"HPA018116: AB_1855899"	"unprognostic (3.06e-1)"	"unprognostic (1.95e-2)"	"prognostic favourable (8.29e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.51e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.62e-1)"	14.2	15.8	15.1	11.0	15.8	11.8	20.4	7.8	13.5	17.9	19.7	8.5	33.1	20.5	13.3	15.4	39.5	13.8	14.8	6.7	14.9	11.9	17.6	31.3	12.6	13.7	16.1	9.6	15.7	21.0	8.8	23.5	14.0	14.6	14.6	20.5	4.6	14.8	32.1	3.5	10.7	24.1	16.0	15.7	10.0	16.9	9.7	12.7	7.1	25.0	19.1	9.6	18.3	19.4	7.8	5.4	10.1	5.2	14.7	8.7	4.1	26.6	19.9	10.4	12.6	27.1	31.4	25.4	37.6	30.9	30.5	23.1	31.9	37.5	7.2	35.0	35.8	18.2	14.2	26.7	43.4	2.5	16.6	6.7	16.9	15.0	22.2	7.6	8.7	21.4	21.8	31.6	35.4	26.5	7.2	8.2	47.2	14.2	3.6	5.3	6.3	32.8	3.1	11.7	8.1	40.3	33.5	7.7	11.5	31.2	28.4	27.0	26.5	7.6	25.4	37.7	25.1	30.1	31.0	7.2	7.0	9.9	34.6	19.8	14.2	10.1	3.3	6.7	6.7	4.9	7.6	7.8	8.1	8.3	5.4	3.9	8.1	8.7	5.4	14.7	5.2	3.4	8.0	4.1	15.1	15.8	7.8	13.5	14.9	11.9	16.1	9.6	14.6	12.7
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"		6600000	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	13.0	8.9	8.3	6.9	8.5	2.9	17.3	5.0	6.2	21.9	17.4	9.3	56.2	4.7	33.0	21.5	19.0	14.4	16.4	9.2	8.4	7.1	19.8	4.8	12.6	6.6	11.0	6.1	20.4	4.4	12.7	11.4	10.7	9.1	26.5	10.2	10.6	9.4	34.8	6.1	7.6	8.6	36.0	12.3	9.4	12.0	13.0	8.1	4.3	20.5	8.7	6.8	26.0	17.9	3.3	7.8	7.5	4.1	4.1	7.5	3.1	14.8	5.4	15.6	7.7	30.8	27.9	7.2	28.4	35.4	15.6	22.5	5.7	19.6	2.1	14.4	37.5	5.2	15.2	11.2	28.9	5.8	4.3	3.8	4.6	2.8	27.4	2.7	8.0	28.2	9.2	13.1	6.3	24.2	5.8	3.9	40.0	4.5	3.0	3.4	5.1	4.4	5.3	16.0	1.3	17.7	19.9	2.0	5.4	22.3	6.2	6.0	7.0	6.5	20.0	28.7	14.4	26.9	17.7	5.8	5.1	4.0	17.6	3.9	10.1	7.5	4.1	5.8	6.7	2.2	4.4	3.3	3.2	6.8	7.8	2.8	3.8	7.5	2.0	4.1	0.7	7.8	1.4	3.1	8.3	8.5	5.0	6.2	8.4	7.1	11.0	6.1	9.1	8.1
TXLNA	DKFZp451J0118	ENSG00000084652	"Taxilin alpha"	P40222	1	32179686-32198285	"Cancer-related genes, Predicted intracellular proteins"	Exocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045383, HPA072477"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA045383: AB_10967649, HPA072477: "	"prognostic favourable (6.24e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.04e-2)"	"prognostic favourable (5.53e-4)"	"prognostic unfavourable (1.57e-6)"	"unprognostic (3.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.25e-3)"	"prognostic favourable (8.69e-5)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (7.21e-7)"	"unprognostic (3.94e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	22.5	29.4	20.2	19.4	27.5	14.0	17.9	23.2	26.4	20.3	23.7	17.0	23.4	16.6	30.4	24.7	24.2	25.0	24.6	16.4	18.5	13.9	20.9	44.8	19.0	19.9	25.6	13.4	26.5	23.6	31.5	35.9	19.3	21.8	24.6	18.5	20.8	23.9	23.3	16.5	31.0	18.9	28.3	19.9	23.5	21.2	38.4	22.9	17.0	22.8	18.8	26.0	19.3	23.5	8.0	14.3	8.4	12.2	14.2	13.9	9.0	19.7	16.9	17.7	19.8	22.9	30.3	14.3	28.3	22.5	27.4	26.3	18.8	21.5	22.6	11.5	27.4	22.4	24.0	18.6	25.0	25.8	18.6	35.7	24.6	24.6	24.4	25.9	28.4	30.3	25.0	28.9	13.7	21.6	14.5	23.4	22.3	10.9	18.9	16.7	25.7	15.6	22.3	26.8	19.9	18.7	25.2	18.5	19.1	29.3	18.6	30.0	17.2	15.8	22.4	29.0	25.1	38.2	36.0	35.0	27.0	20.5	30.0	35.4	26.7	8.4	9.0	4.5	13.9	9.7	11.9	7.3	9.6	10.3	6.9	8.0	8.4	9.1	1.3	14.2	12.2	14.3	7.0	9.0	20.2	27.5	23.2	26.4	18.5	13.9	25.6	13.4	21.8	22.9
TXLNG	"CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX"	ENSG00000086712	"Taxilin gamma"	Q9NUQ3	X	16786427-16844519	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000297, HPA000841"	Approved		Approved	Cytosol				Cytosol		"HPA000297: AB_1078590, HPA000841: AB_1078589"	"unprognostic (2.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavourable (6.33e-6)"	"unprognostic (2.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.00e-3)"	16.2	20.1	14.4	13.5	17.5	14.9	14.0	24.9	19.9	13.2	11.1	5.6	13.0	9.9	12.0	8.4	8.4	12.0	9.1	6.9	12.4	10.1	9.4	9.6	9.2	13.8	11.8	10.1	21.1	10.3	13.9	20.1	6.9	12.8	8.6	7.5	5.4	8.4	17.2	17.3	7.4	8.6	10.3	11.2	8.8	8.9	7.1	17.4	6.0	12.8	5.5	13.5	13.6	23.8	6.5	3.4	1.6	3.0	4.3	7.4	3.4	11.9	7.4	7.2	12.7	13.2	7.2	3.8	4.8	4.6	5.5	5.4	10.4	7.1	25.2	12.2	2.6	7.8	24.6	15.7	9.9	7.6	30.0	9.0	10.3	6.6	5.5	13.3	6.4	4.3	7.7	12.8	23.1	6.9	17.2	7.5	4.2	7.1	12.2	7.4	21.5	8.8	8.5	9.8	20.8	4.4	6.0	11.7	8.5	11.1	10.6	8.8	12.9	5.5	3.4	3.5	4.6	12.1	8.2	7.9	12.0	25.5	4.4	8.8	3.5	1.0	3.0	1.6	5.3	2.2	6.7	6.1	5.7	6.0	3.3	6.5	6.9	7.4	1.1	4.3	2.5	3.4	5.8	3.4	14.4	17.5	24.9	19.9	12.4	10.1	11.8	10.1	12.8	17.4
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243811-110256640	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 447.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 127.1;granulocytes: 104.5"	"Low region specificity"	"Detected in all"							"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"		25000000	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favourable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	23.6	16.7	26.6	18.2	16.9	35.8	25.9	10.8	19.7	30.8	57.9	7.7	17.5	40.7	15.5	20.4	162.3	27.5	22.2	11.7	20.9	19.0	65.8	69.4	39.0	19.4	21.3	14.1	18.2	22.0	5.3	8.0	41.2	28.7	15.5	50.6	8.0	50.2	16.3	16.0	26.3	58.9	21.9	17.6	19.8	26.3	9.2	7.0	40.0	18.9	447.3	82.0	31.3	27.1	12.8	127.1	104.5	25.1	14.2	26.0	18.8	61.9	85.2	23.1	25.5	58.3	76.0	34.0	75.5	70.5	52.6	40.1	55.3	74.8	55.3	32.5	69.7	140.2	32.9	100.6	51.7	81.9	73.0	27.7	79.9	95.6	66.7	68.7	84.6	53.9	66.4	77.0	58.3	46.2	46.5	53.3	71.9	50.2	57.2	103.1	49.1	104.0	24.0	78.3	64.4	67.3	44.0	50.3	18.0	81.4	66.2	51.2	63.5	47.6	55.4	54.3	35.1	101.8	93.5	27.0	76.2	47.0	78.8	60.0	75.3	32.2	25.1	104.5	14.5	15.1	13.9	12.8	20.5	17.4	37.1	5.6	7.7	11.5	99.7	14.2	9.6	127.1	26.0	18.8	26.6	16.9	10.8	19.7	20.9	19.0	21.3	14.1	28.7	7.0
TXNDC11	EFP1	ENSG00000153066	"Thioredoxin domain containing 11"	Q6PKC3	16	11679080-11742878	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041174, HPA041390"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041174: AB_10794191, HPA041390: AB_10796670"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.82e-3)"	"prognostic favourable (2.12e-5)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.34e-2)"	12.5	12.5	6.1	10.9	8.1	24.1	12.3	12.8	9.9	12.7	20.8	8.3	13.2	19.2	12.9	16.0	12.6	12.7	17.5	11.4	7.3	4.4	21.2	47.2	22.4	21.3	7.4	4.4	13.9	22.9	28.6	11.4	15.0	7.1	13.2	15.4	18.6	24.1	14.3	23.2	9.9	27.4	7.8	5.0	23.6	17.6	5.6	6.7	15.9	28.6	11.6	33.2	15.0	10.2	5.7	3.6	9.6	3.3	7.8	9.2	3.5	8.7	6.1	2.8	3.9	7.7	6.5	5.0	8.7	11.9	8.0	10.3	3.0	14.0	22.1	14.7	10.9	7.9	3.5	7.3	6.6	9.8	4.6	4.7	7.0	14.7	11.4	6.8	9.5	4.9	8.3	8.9	14.2	10.0	7.1	28.5	7.0	7.9	5.3	2.6	3.7	3.1	6.9	5.8	47.3	9.1	4.7	4.0	3.8	17.0	13.3	9.2	8.1	9.5	10.3	3.7	4.3	17.4	5.0	38.9	21.2	13.3	7.9	8.7	6.2	4.9	3.3	9.6	2.7	2.5	6.6	5.7	4.9	6.0	3.6	4.9	4.8	3.1	1.0	7.8	2.8	2.8	9.2	3.5	6.1	8.1	12.8	9.9	7.3	4.4	7.4	4.4	7.1	6.7
TXNDC9	APACD	ENSG00000115514	"Thioredoxin domain containing 9"	O14530	2	99318982-99340702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031844, HPA031845, HPA031846"	Approved		Enhanced	Cytosol				Cytosol		"HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916"	"unprognostic (3.63e-3)"	"unprognostic (4.26e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (4.31e-4)"	"prognostic unfavourable (9.63e-7)"	"unprognostic (2.06e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	29.2	20.7	16.8	17.8	19.4	13.0	25.9	20.1	25.3	23.4	21.1	13.8	14.9	15.2	19.0	23.9	28.8	15.8	15.7	23.9	18.1	20.8	42.9	33.3	17.0	22.3	19.0	13.9	20.4	15.1	13.3	27.6	33.9	27.3	19.5	23.3	9.3	19.4	15.3	22.8	16.2	21.6	21.4	22.1	32.3	16.7	14.9	17.5	39.6	21.2	28.1	27.8	20.4	18.3	32.6	28.9	45.2	36.7	35.2	41.8	40.2	25.4	8.2	21.1	10.3	20.4	20.7	22.8	29.3	27.1	31.0	30.3	22.6	19.7	19.2	23.6	25.7	18.5	19.1	30.4	36.8	14.0	16.3	20.8	11.7	25.8	19.7	24.9	15.5	18.9	27.4	26.1	19.4	35.4	23.8	18.0	36.3	12.9	14.6	21.8	15.4	22.6	10.9	19.2	18.5	43.9	19.7	13.1	10.7	14.0	19.7	31.0	22.6	20.1	24.3	22.9	22.3	14.1	20.6	7.5	11.4	23.2	18.7	25.9	20.7	45.2	27.6	28.2	29.1	28.5	36.3	32.6	34.7	32.9	28.9	26.0	32.9	32.8	26.8	35.2	36.7	28.8	41.8	40.2	16.8	19.4	20.1	25.3	18.1	20.8	19.0	13.9	27.3	17.5
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996600	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 110.2;HSkMC: 146.6;hTCEpi: 74.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	127.7	10.6	4.1	17.0	4.6	10.5	73.6	2.5	6.0	45.9	49.8	16.1	25.0	6.3	39.3	22.8	41.0	20.3	20.4	55.3	4.8		34.8	11.7	52.3	82.6	6.5	4.2	34.1	25.8	9.3	20.2	19.1	8.3	47.4	16.1	18.8	18.5	19.5	97.0	15.3	27.7	34.6	9.2	39.0	13.6	23.1	6.0	29.0	85.3	16.0	41.5	52.5	32.3	64.9	35.5	134.9	58.3	65.3	90.0	132.5	6.0	0.0	1.4	0.1	33.5	110.2	3.3	7.2	14.5	6.5	9.0	3.8	8.2	1.7	42.9	1.9	1.6	1.4	13.7	17.6	7.9	0.7	4.9	2.2	3.5	1.5	20.1	10.3	146.6	74.7	13.3	23.5	2.5	19.5	13.5	3.3	8.2	3.3	19.3	4.0	5.4	3.0	12.1	52.3	17.1	13.4	6.9	11.2	31.1	9.0	24.6	3.2	28.8	6.1	18.2	1.1	34.0	11.8	19.0	18.1	1.5	4.4	9.3	9.5	94.7	53.3	123.0	90.0	58.3	83.1	58.8	76.5	79.9	35.5	64.9	76.0	80.3	134.9	65.3	49.9	16.7	70.6	132.5										
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597208-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol			1500000	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favourable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	20.5	31.9	27.9	17.8	30.0	34.0	24.4	20.6	34.5	22.5	20.1	21.5	17.3	20.1	22.1	33.8	29.6	18.0	19.8	37.2	27.7	28.5	28.0	38.5	16.4	21.7	27.7	22.8	26.1	34.3	21.5	23.3	26.8	32.1	23.1	21.6	17.6	22.4	20.9	64.4	17.6	21.1	26.5	23.4	20.4	24.0	19.3	21.1	22.3	96.0	27.7	23.3	27.7	18.9	22.2	29.9	39.0	35.3	23.4	23.0	30.9	24.8	24.5	33.3	34.2	28.9	42.4	23.6	29.7	30.5	38.3	32.5	21.8	24.5	27.0	26.5	32.2	31.0	31.4	26.8	39.7	27.5	14.4	37.0	20.5	40.7	33.9	53.8	24.2	32.1	27.8	36.0	33.1	30.8	27.0	45.4	38.7	23.8	31.1	35.2	24.1	26.4	25.5	22.4	46.9	44.7	38.8	27.6	25.2	16.8	23.7	28.0	25.8	28.9	24.4	40.3	21.3	14.0	28.8	44.1	47.2	42.2	26.3	41.3	29.4	39.0	35.3	25.3	15.9	29.6	21.7	22.2	19.7	20.8	29.9	19.3	19.4	19.6	26.5	23.4	27.9	25.5	23.0	30.9	27.9	30.0	20.6	34.5	27.7	28.5	27.7	22.8	32.1	21.1
TXNL4A	"DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD"	ENSG00000141759	"Thioredoxin like 4A"	P83876	18	79970811-80033949	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"		Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041324			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA041324: "	"unprognostic (7.56e-2)"	"unprognostic (1.06e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	28.2	35.8	57.2	27.7	43.9	36.7	30.2	21.7	43.4	22.0	29.4	30.7	22.9	23.9	15.8	38.9	26.5	21.0	21.8	33.5	47.9	42.7	29.0	42.5	18.4	35.1	52.6	25.4	14.1	64.9	22.1	38.4	23.2	32.7	21.1	25.2	24.0	46.8	20.5	35.5	26.6	25.1	19.0	37.7	26.9	23.2	41.6	20.8	40.2	28.8	26.8	32.2	23.5	16.9	12.7	25.0	8.4	9.6	11.3	12.7	4.4	21.5	29.0	25.9	24.6	21.2	22.4	23.0	23.5	19.0	31.9	29.0	27.0	15.4	26.3	8.8	22.4	18.4	31.1	27.3	21.1	30.7	39.5	18.9	44.1	63.4	27.1	54.0	30.9	20.8	24.2	22.7	29.1	30.0	16.5	38.4	22.2	39.0	38.3	36.6	20.2	63.0	23.4	17.3	54.2	31.3	34.2	39.7	28.9	11.6	34.6	42.8	17.0	32.2	14.1	28.2	34.6	12.8	28.6	17.1	64.0	43.2	26.4	41.1	25.8	8.4	8.4	6.8	12.2	9.6	8.4	12.3	10.0	9.6	11.4	12.7	10.2	11.9	6.8	11.3	9.5	25.0	12.7	4.4	57.2	43.9	21.7	43.4	47.9	42.7	52.6	25.4	32.7	20.8
TXNL4B	"Dim2, DLP, FLJ20511"	ENSG00000140830	"Thioredoxin like 4B"	Q9NX01	16	72044289-72094431	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065865			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA065865: "	"unprognostic (1.45e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	11.1	10.0	14.1	11.5	16.3	15.6	12.3	18.6	17.0	11.0	11.7	18.5	10.4	12.8	10.2	10.3	12.2	13.3	11.2	9.3	13.2	12.2	9.8	20.8	8.8	13.0	20.9	13.6	27.8	12.6	11.0	19.9	9.4	13.7	9.8	10.8	9.8	10.7	10.3	11.3	10.1	10.4	8.7	17.2	10.0	10.0	18.9	15.3	14.0	10.9	6.0	11.9	8.6	13.7	10.8	9.4	18.3	14.2	5.0	13.7	9.9	6.8	10.3	5.7	7.7	4.2	5.0	12.7	9.0	7.4	15.9	12.0	10.5	6.4	10.1	6.6	4.6	9.3	10.1	5.3	12.4	5.0	9.5	9.3	7.9	15.8	9.0	11.0	8.1	5.2	3.7	14.0	13.2	6.7	22.3	6.1	7.5	13.1	13.2	9.6	10.3	9.6	13.6	7.2	13.5	5.8	5.2	13.0	11.3	8.5	4.0	11.7	9.2	7.0	6.4	7.6	11.1	6.3	8.4	12.1	19.5	41.9	8.5	7.4	7.5	18.3	9.8	12.9	9.2	10.9	13.7	10.8	9.5	7.8	8.5	9.0	13.1	12.7	13.9	5.0	14.2	9.4	10.5	9.9	14.1	16.3	18.6	17.0	13.2	12.2	20.9	13.6	13.7	15.3
TXNRD2	"TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941992	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Supported	Mitochondria,Cytosol			410000	Mitochondria	Cytosol	"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favourable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	9.8	30.2	8.5	8.3	10.1	11.6	7.4	19.0	15.0	8.3	10.3	9.0	7.6	9.2	11.9	12.3	8.8	8.4	13.0	22.6	8.3	7.5	13.9	40.9	10.8	8.4	7.8	9.7	11.9	13.0	9.9	9.9	14.0	7.1	17.9	4.5	10.0	15.2	8.8	16.5	6.0	10.2	5.4	5.6	11.2	14.6	10.5	6.8	4.9	12.6	9.2	10.5	7.5	7.9	4.8	9.1	5.8	12.1	4.8	4.9	4.9	6.3	13.2	1.2	5.1	2.4	3.4	3.0	6.1	7.2	11.1	8.2	12.2	6.6	3.5	14.9	6.4	11.3	6.1	8.4	4.2	6.7	15.1	5.9	10.5	7.2	4.6	6.6	2.9	3.3	6.4	5.7	4.8	31.4	32.8	6.0	8.6	15.4	2.2	9.9	6.1	9.4	3.4	29.3	3.2	6.7	6.9	6.5	5.7	10.5	13.8	7.0	11.2	9.0	17.4	8.1	48.8	6.7	12.8	6.0	4.4	2.2	7.8	5.1	10.2	3.2	12.1	5.8	4.3	9.2	3.3	4.8	3.8	3.9	9.1	3.6	4.9	4.0	1.3	4.8	8.7	3.4	2.4	4.9	8.5	10.1	19.0	15.0	8.3	7.5	7.8	9.7	7.1	6.8
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB020802: , HPA036109: "	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favourable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	13.7	3.5	4.5	7.1	8.4	12.7	2.3	6.1	5.5	5.0	7.1	6.3	7.8	0.0	7.8	8.4	5.5	5.6	6.3	6.3	0.0	4.1	1.6	3.3	4.8	7.2	5.5	0.5	11.6	5.5	1.7	11.6	3.6	3.3	0.0	8.0	9.9	1.1	3.0	6.4	2.7	0.4	3.9	2.2	5.3	6.9	7.8	4.8	17.4	5.1	8.8	7.0	2.1	6.0	6.1	1.5	8.3	2.8	3.6	1.5	0.0	3.3	1.9	5.2	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380676	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol				Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favourable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favourable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favourable (4.16e-4)"	16.8	19.0	22.9	36.0	22.6	49.4	17.5	24.4	23.9	17.8	19.4	26.7	13.9	20.0	19.3	20.2	15.0	16.8	21.8	17.0	18.3	14.0	24.0	34.4	27.5	31.5	24.7	17.4	20.0	21.3	19.0	24.8	13.9	19.1	21.1	18.6	21.6	24.4	15.4	15.6	24.4	23.8	16.7	17.9	47.9	18.5	6.4	22.8	33.9	20.9	13.5	34.7	16.7	15.1	5.8	15.8	22.9	13.4	5.3	9.1	7.3	8.5	12.5	7.5	11.7	10.0	14.1	7.2	11.7	12.0	14.9	16.4	9.6	5.7	13.0	13.8	13.1	8.6	9.0	13.8	7.9	22.9	14.0	24.0	24.9	23.5	15.6	10.1	27.7	13.6	9.8	16.9	10.0	14.4	10.1	36.4	13.1	26.9	14.8	62.3	2.4	21.9	14.8	6.4	13.3	12.1	27.6	7.0	8.7	11.5	12.1	8.4	6.7	17.2	12.2	20.1	7.2	23.1	13.7	30.0	23.3	11.9	10.0	21.1	11.2	6.6	13.4	17.0	9.1	10.2	5.9	5.6	5.5	8.1	15.8	5.8	3.8	5.1	22.9	5.3	9.7	9.0	6.8	7.3	22.9	22.6	24.4	23.9	18.3	14.0	24.7	17.4	19.1	22.8
TYSND1	"MGC34695, NET41"	ENSG00000156521	"Trypsin domain containing 1"	Q2T9J0	10	70137981-70146676	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;PC-3: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030304	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA030304: AB_10670560"	"unprognostic (4.75e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	15.2	8.2	4.7	7.0	6.8	3.0	8.0	6.7	7.3	6.0	6.7	5.9	6.9	10.1	5.3	8.4	13.9	5.4	5.2	3.5	3.7	2.8	7.4	7.4	3.5	7.2	3.7	3.6	5.6	9.0	3.3	4.5	4.7	3.5	6.9	2.7	6.9	8.0	5.7	5.3	12.5	8.5	4.8	4.7	9.0	8.2	40.7	3.4	6.2	8.5	6.6	10.1	6.5	7.6	6.1	1.4	1.2	1.6	2.9	6.3	2.3	9.4	6.7	0.5	4.0	0.7	0.6	2.4	1.2	0.8	1.4	1.3	4.3	6.0	8.4	4.0	0.3	17.7	0.7	2.6	0.3	5.3	6.0	0.5	1.9	2.1	1.6	0.7	0.0	1.2	5.1	1.2	2.1	1.0	0.0	2.6	0.6	4.2	3.2	3.5	2.2	27.2	5.6	1.6	3.7	0.6	1.6	4.9	2.5	4.1	9.3	3.6	6.0	0.7	1.7	1.6	1.1	3.0	5.3	9.6	5.8	4.1	1.9	3.6	1.2	0.0	1.3	1.2	6.3	1.6	4.1	5.1	3.7	4.9	1.4	6.1	5.3	4.4	0.4	2.9	1.1	1.0	4.0	2.3	4.7	6.8	6.7	7.3	3.7	2.8	3.7	3.6	3.5	3.4
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	16.5	19.7	13.7	13.5	17.7	11.9	18.3	15.0	19.9	20.4	17.7	7.5	13.7	9.5	21.0	15.2	20.6	16.4	10.0	21.1	11.1	12.9	20.4	17.0	11.3	14.3	16.2	17.2	30.0	14.4	22.2	34.3	13.5	17.0	20.7	12.3	8.6	13.8	15.7	12.3	10.5	10.9	24.7	15.6	16.0	14.8	12.3	18.1	12.3	23.5	14.3	16.9	23.5	33.3	9.7	9.0	6.0	8.0	13.6	13.9	5.2	8.4	7.1	12.4	8.8	14.1	15.4	18.8	14.6	13.4	14.0	12.3	15.1	7.2	22.3	13.4	12.6	6.9	14.1	16.9	17.6	13.8	12.2	17.5	21.8	29.2	9.2	34.9	11.3	11.7	17.1	17.8	17.3	12.4	30.3	17.1	17.9	7.2	17.0	11.7	32.8	16.7	16.1	25.8	10.0	12.0	11.1	9.6	8.2	6.9	19.1	22.4	10.4	12.8	8.0	6.2	17.0	16.8	17.5	9.9	17.9	15.6	13.9	12.7	17.8	6.0	6.0	1.6	10.3	8.0	9.9	9.7	9.1	9.3	9.0	8.8	13.2	13.9	0.5	13.6	5.9	8.7	8.4	5.2	13.7	17.7	15.0	19.9	11.1	12.9	16.2	17.2	17.0	18.1
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.0"	"Cell line enhanced"	"Detected in many"		"BJ: 61.3;BJ hTERT+: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 2.2;intermediate monocyte: 4.3;memory B-cell: 1.2;myeloid DC: 2.0;naive B-cell: 3.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	11	"B-cells: 3.4;dendritic cells: 2.0;monocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041412: AB_10966708, HPA043503: "	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (1.03e-4)"	21.7	8.9	4.7	8.6	8.1	0.4	25.9	2.9	5.8	15.4	14.1	8.4	22.8	10.6	17.2	22.3	15.6	10.5	15.7	18.0	6.1	4.2	16.4	8.2	23.7	7.5	9.0	4.6	17.5	8.6	8.2	6.5	13.7	9.6	15.5	7.6	26.7	18.8	26.9	68.0	10.1	16.9	11.4	14.9	15.7	8.4	10.1	7.1	1.0	18.6	32.4	5.3	9.9	13.5	3.4	2.0	0.2	4.3	0.1	0.3	0.7	10.4	8.6	3.8	5.1	7.8	33.8	0.0	61.3	37.5	16.1	13.9	14.4	15.5	7.2	16.9	15.2	12.1	8.7	4.8	20.3	0.0	3.8	4.0	6.7	3.0	10.2	0.1	1.5	15.9	2.7	9.5	7.2	17.0	1.0	0.0	19.9	3.4	0.0	0.6	3.2	4.5	0.0	28.0	0.0	7.8	3.5	1.0	1.9	11.6	1.8	12.3	3.4	1.2	32.6	0.9	6.5	5.2	9.7	0.6	2.1	0.0	8.1	1.1	6.9	0.2	2.2	0.0	0.0	4.3	0.0	1.2	0.1	0.0	2.0	3.4	0.3	0.1	0.2	0.1	2.9	0.1	0.0	0.7	4.7	8.1	2.9	5.8	6.1	4.2	9.0	4.6	9.6	7.1
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 105.7;U-251 MG: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			19000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	38.4	18.5	7.0	17.4	9.8	17.2	24.8	9.0	13.4	16.1	26.9	5.7	45.7	17.2	10.9	19.4	23.6	15.7	18.3	22.5	7.7	7.8	11.0	67.1	16.0	7.4	6.6	8.9	20.4	31.4	5.1	16.0	21.5	9.1	13.9	26.9	7.8	43.9	62.5	19.4	12.4	33.4	28.8	7.1	8.1	23.0	37.7	3.7	5.6	12.4	13.5	15.3	24.4	16.7	8.3	5.6	8.1	1.6	6.2	16.1	4.8	29.9	2.1	6.0	4.8	29.2	23.4	4.1	44.1	16.2	34.0	27.8	5.7	14.1	1.1	9.9	33.8	5.2	6.7	12.8	56.1	4.7	10.1	5.3	6.9	11.1	13.7	9.0	3.6	10.8	6.1	37.3	105.7	20.8	29.9	12.4	45.4	5.5	5.2	5.8	4.4	9.8	4.7	11.7	14.6	5.3	3.5	6.4	6.7	19.2	12.0	10.2	5.9	10.3	35.3	17.2	15.8	43.2	68.8	20.8	7.3	9.9	9.8	4.2	10.8	1.0	1.6	8.1	13.0	1.6	16.1	8.3	7.9	13.3	3.4	6.5	7.6	9.5	1.6	6.2	0.8	5.6	3.9	4.8	7.0	9.8	9.0	13.4	7.7	7.8	6.6	8.9	9.1	3.7
UAP1L1		ENSG00000197355	"UDP-N-acetylglucosamine pyrophosphorylase 1 like 1"	Q3KQV9	9	137077501-137084539	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044356	Approved		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"HPA044356: AB_10959902"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.80e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.65e-2)"	"prognostic favourable (5.23e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.64e-3)"	10.5	14.7	13.6	9.8	20.6	5.0	16.3	3.4	17.5	13.0	8.8	22.1	8.6	10.0	7.3	9.7	5.9	5.8	9.4	11.3	14.7	8.1	12.5	3.1	11.6	12.2	24.9	9.3	3.9	10.5	8.5	14.7	10.9	14.2	12.8	6.7	14.1	15.2	10.9	2.5	9.0	9.4	6.6	13.5	20.3	10.8	3.5	29.1	1.4	13.3	4.9	10.3	11.4	13.9	2.1	1.8	0.6	3.7	0.3	3.0	1.2	0.4	2.8	0.0	7.6	13.1	6.1	2.2	3.8	10.1	10.9	7.6	5.5	1.3	1.7	2.3	3.9	5.8	14.2	0.9	2.2	4.6	1.3	3.7	4.2	5.2	29.2	0.0	15.4	4.5	1.0	6.2	5.1	8.5	1.1	8.7	7.3	6.2	0.3	3.8	1.2	4.0	6.0	0.1	5.3	4.3	0.5	4.5	2.8	0.9	21.3	8.6	11.5	10.3	6.7	19.7	4.3	13.7	1.8	9.5	13.6	3.7	17.1	4.0	5.6	0.4	3.7	0.1	0.8	2.0	3.0	2.1	0.4	1.3	1.8	1.0	1.0	1.3	0.6	0.3	0.0	1.1	1.7	1.2	13.6	20.6	3.4	17.5	14.7	8.1	24.9	9.3	14.2	29.1
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"			9600	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: , HPA065335: "	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	19.1	25.3	29.7	22.2	31.0	53.7	26.8	30.9	31.4	20.3	19.7	31.3	15.9	16.1	22.8	25.4	25.4	19.5	18.4	38.2	23.8	22.7	24.7	17.6	19.3	28.7	37.5	21.2	20.4	15.1	17.9	28.0	27.8	40.8	22.6	22.6	21.8	28.0	20.4	25.0	27.6	21.9	24.0	30.2	27.8	17.3	13.5	31.9	28.4	18.2	17.2	31.0	22.9	20.4	18.9	22.3	35.6	27.8	20.2	22.2	26.0	26.8	11.4	28.1	17.1	26.3	34.9	21.7	24.1	27.3	26.3	26.5	14.1	19.0	20.5	7.0	25.9	15.5	21.6	27.6	30.0	37.3	13.7	27.7	21.5	14.2	20.3	27.1	23.3	27.4	18.5	24.8	20.8	33.8	11.4	17.6	34.6	9.6	17.8	18.3	24.9	9.8	13.9	20.8	18.8	41.9	34.4	12.1	16.9	25.4	18.5	20.6	12.6	26.7	25.6	20.0	17.6	25.9	33.4	20.2	32.3	24.4	20.5	30.2	25.4	34.7	25.4	35.6	14.3	27.8	16.1	18.9	18.9	17.6	22.3	16.0	17.9	18.0	24.4	20.2	27.7	11.4	22.2	26.0	29.7	31.0	30.9	31.4	23.8	22.7	37.5	21.2	40.8	31.9
UBA5	"FLJ23251, UBE1DC1"	ENSG00000081307	"Ubiquitin like modifier activating enzyme 5"	Q9GZZ9	3	132654446-132678097	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017235	Uncertain		Enhanced	Vesicles,Cytosol				Cytosol	Vesicles	"HPA017235: AB_1858507"	"unprognostic (4.34e-3)"	"unprognostic (6.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	14.8	30.3	17.8	12.3	19.8	13.2	17.4	17.9	26.2	14.5	15.0	10.5	27.8	16.2	13.4	24.2	15.1	13.3	12.7	21.2	15.3	16.3	22.7	29.8	13.7	14.8	16.0	25.0	15.1	41.4	29.3	32.7	18.1	21.2	18.8	16.7	11.7	37.8	33.5	32.5	15.7	17.9	14.6	13.6	18.9	18.5	15.3	12.7	17.9	23.5	17.5	17.4	15.1	12.5	11.1	14.1	5.0	6.6	18.9	15.0	7.9	27.0	10.1	17.8	14.6	12.6	14.4	18.7	23.4	24.2	14.7	17.1	18.3	10.1	21.6	17.2	16.9	16.5	17.6	18.4	21.9	20.5	7.5	26.2	16.3	20.5	12.5	32.1	15.4	12.5	10.9	14.0	21.1	16.5	16.3	32.0	16.4	24.0	17.7	12.1	16.2	9.7	15.5	15.6	40.9	13.5	21.0	17.2	15.5	13.7	13.8	19.8	16.6	16.3	14.8	15.6	15.3	7.5	12.2	30.3	20.3	40.0	17.8	11.7	13.9	4.1	5.1	5.0	9.6	5.8	11.6	11.1	10.8	15.0	11.8	6.9	12.9	12.8	1.1	18.9	6.6	14.1	10.7	7.9	17.8	19.8	17.9	26.2	15.3	16.3	16.0	25.0	21.2	12.7
UBA52	"CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40"	ENSG00000221983	"Ubiquitin A-52 residue ribosomal protein fusion product 1"	P62987	19	18571730-18577550	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041344, HPA049132, HPA056624"	Supported		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA041344: , HPA049132: , HPA056624: "	"unprognostic (1.98e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	84.7	73.8	71.1	76.4	76.5	167.0	101.5	32.8	71.1	83.2	73.0	48.7	67.8	47.7	79.0	93.2	102.7	78.8	82.0	85.9	58.2	50.2	74.1	135.5	67.7	182.7	64.0	59.0	150.3	225.2	56.5	62.8	71.6	55.5	75.8	74.0	51.6	96.0	75.2	191.4	104.6	68.0	91.9	72.0	101.1	75.5	89.5	52.1	121.2	97.6	131.7	145.1	99.9	161.7	200.5	157.0	75.1	132.4	109.7	205.0	246.6	104.6	83.7	62.9	104.8	163.3	155.4	155.9	80.9	112.4	134.4	107.3	151.5	98.2	151.9	83.7	133.3	71.0	121.5	143.8	127.2	40.7	189.8	83.1	130.1	170.8	119.0	180.2	106.5	179.8	196.8	92.1	134.0	134.6	131.4	210.6	114.6	175.3	143.9	161.7	140.7	181.3	119.1	62.8	173.8	129.5	159.2	82.0	99.2	58.7	142.4	140.2	63.1	233.3	99.9	67.5	56.4	142.0	142.9	129.7	172.1	150.3	91.8	204.8	91.3	50.7	132.4	69.8	119.4	107.2	162.2	200.5	178.5	142.6	147.6	199.1	205.0	165.6	75.1	109.7	96.1	157.0	138.5	246.6	71.1	76.5	32.8	71.1	58.2	50.2	64.0	59.0	55.5	52.1
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	16.8	12.6	14.1	14.1	16.6	22.7	13.0	18.0	16.0	17.0	10.5	14.6	7.0	12.2	16.7	10.0	20.5	9.9	12.4	9.5	12.0	12.0	10.2	16.4	14.5	17.3	18.7	11.2	14.3	10.9	17.4	44.8	18.5	17.7	12.7	13.2	7.5	13.7	10.4	10.1	12.6	15.3	13.4	20.7	16.9	13.9	14.6	18.6	27.1	12.3	13.3	19.9	15.7	19.5	5.6	5.1	9.3	4.0	9.7	5.8	1.9	14.8	8.3	13.8	10.8	6.8	8.1	9.3	30.8	12.1	14.1	16.5	8.7	20.1	18.8	11.0	12.6	8.8	14.2	15.3	21.3	21.6	4.0	12.0	14.7	8.1	5.8	21.1	9.2	5.7	4.9	18.2	11.1	12.4	28.6	11.2	16.6	5.6	21.9	4.8	8.1	10.1	13.0	28.3	6.9	11.5	16.9	6.7	8.5	17.4	12.4	5.8	8.2	5.7	17.9	13.1	14.7	10.6	13.4	8.1	6.3	19.0	23.3	5.9	12.5	9.3	3.0	4.6	4.4	3.9	4.8	5.6	5.1	5.8	3.7	5.2	3.9	4.5	2.2	9.7	4.0	5.1	4.2	1.9	14.1	16.6	18.0	16.0	12.0	12.0	18.7	11.2	17.7	18.6
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805207-49813946	"Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 22.3;HEL: 20.8;HMC-1: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol			1400000	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: "	"prognostic favourable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.48e-4)"	11.3	12.1	6.8	22.0	7.5	16.0	11.5	2.0	6.7	10.8	12.7	14.4	25.4	19.6	17.2	31.6	17.7	12.9	33.1	9.1	6.7	3.9	15.9	11.9	18.8	28.2	6.0	6.2	19.1	9.5	1.4	8.4	8.9	9.4	18.5	12.1	14.2	24.5	34.2	3.3	9.0	25.5	11.3	7.7	35.9	13.2	3.4	5.9	20.4	17.8	18.4	23.5	12.6	13.1	12.4	14.3	24.8	21.7	11.1	11.8	13.0	4.3	0.0	0.3	0.1	12.0	12.7	1.3	2.3	10.4	16.7	22.3	0.0	9.1	0.1	1.8	8.5	2.4	0.0	4.1	1.4	11.1	0.0	20.8	0.2	1.3	8.9	1.9	40.6	19.5	0.2	6.5	0.4	8.3	0.0	1.3	3.8	0.1	4.2	5.1	0.0	0.4	5.4	0.4	0.7	3.4	8.4	0.0	0.3	2.8	4.1	1.4	0.4	13.8	3.7	3.3	0.4	1.4	0.9	0.0	0.0	0.1	9.1	7.4	0.7	13.9	14.7	24.8	11.8	21.7	10.3	12.3	10.8	10.5	14.3	12.4	9.9	8.9	4.6	11.1	17.2	5.2	10.6	13.0	6.8	7.5	2.0	6.7	6.7	3.9	6.0	6.2	9.4	5.9
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961380	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 113.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 59.3;K-562: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"			54000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favourable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	7.6	5.7	12.4	5.8	13.4	27.1	6.2	10.9	12.7	6.1	11.0	8.0	6.8	9.9	6.2	10.3	10.0	9.4	5.1	22.2	11.0	8.6	8.8	7.6	6.4	5.8	11.6	7.4	7.8	6.7	6.9	6.6	9.3	8.7	7.4	7.8	7.7	9.2	9.2	113.2	15.7	9.6	9.3	10.1	5.7	6.1	10.9	7.8	3.9	6.1	21.9	9.0	7.6	8.3	3.2	9.7	5.1	18.8	2.2	3.6	4.0	8.9	10.5	7.5	10.8	5.6	6.6	14.0	7.9	6.7	9.8	7.9	14.5	11.5	10.8	7.6	6.4	30.7	10.4	9.1	4.4	59.3	9.8	9.0	18.9	8.1	5.9	11.7	8.7	6.2	12.0	6.2	6.0	8.1	75.2	8.8	7.7	18.5	9.6	12.1	17.7	17.9	10.8	14.1	14.3	7.0	5.8	11.6	12.8	11.4	10.3	8.0	8.7	12.7	6.6	5.6	8.4	6.6	9.7	5.1	9.6	12.9	10.3	10.7	7.6	3.4	11.3	5.1	3.1	17.2	3.3	3.2	3.6	2.1	9.7	2.0	1.9	2.2	2.5	2.2	18.8	1.0	2.7	4.0	12.4	13.4	10.9	12.7	11.0	8.6	11.6	7.4	8.7	7.8
UBAC2	"FLJ30548, PHGDHL1, RP11-178C10.1"	ENSG00000134882	"UBA domain containing 2"	Q8NBM4	13	99200774-99386434	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013448	Approved		Approved	Cytosol				Cytosol		"HPA013448: AB_1855301"	"unprognostic (7.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.26e-2)"	16.7	15.6	9.1	15.6	10.4	11.0	24.2	8.2	13.9	14.6	14.6	10.0	18.3	16.7	17.2	17.1	29.6	18.1	15.4	15.5	11.0	7.6	15.1	20.0	20.6	36.5	8.2	10.1	15.1	25.5	11.8	9.5	22.1	9.8	11.1	14.6	11.9	19.5	13.7	26.9	26.3	17.6	13.8	11.7	13.4	14.9	24.8	8.1	21.6	20.6	17.3	24.5	17.2	15.8	25.3	23.9	24.7	23.1	31.3	37.5	31.8	13.3	8.4	6.3	9.2	16.2	17.6	15.4	6.9	24.9	12.7	9.9	8.1	28.9	5.6	12.4	10.6	12.2	9.2	12.0	7.3	9.4	9.1	9.2	4.5	5.0	13.7	11.6	7.1	13.6	15.0	7.3	23.0	11.1	8.0	2.9	10.3	3.5	8.7	2.9	7.9	6.6	7.0	5.6	4.0	8.7	6.8	6.8	10.2	5.8	17.3	10.1	11.6	37.2	7.9	5.0	4.9	5.1	7.6	3.9	3.3	1.9	10.8	17.8	9.7	20.8	23.1	17.3	27.3	22.1	37.5	19.6	23.4	27.3	18.6	25.3	32.7	32.2	24.7	31.3	21.2	23.9	15.1	31.8	9.1	10.4	8.2	13.9	11.0	7.6	8.2	10.1	9.8	8.1
UBALD1	FAM100A	ENSG00000153443	"UBA like domain containing 1"	Q8TB05	16	4608883-4615027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066771	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA066771: "	"unprognostic (7.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.63e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-2)"	23.0	16.7	20.5	17.9	25.0	37.5	11.9	32.4	39.2	12.1	19.3	15.1	11.7	23.7	20.4	11.0	15.0	13.9	12.4	14.8	20.9	14.2	19.6	32.9	15.7	13.8	12.0	22.2	14.8	27.2	9.0	12.1	27.9	16.9	18.9	5.3	13.6	19.4	18.1	38.3	16.7	19.5	14.2	11.5	23.9	25.9	13.2	13.0	9.9	17.3	11.3	11.6	17.8	12.8	1.9	2.8	11.3	4.5	1.5	2.6	1.5	5.4	15.7	3.7	5.9	2.5	3.3	16.8	8.2	3.4	3.2	4.6	7.7	6.4	8.1	9.2	2.5	15.0	2.4	8.4	0.9	17.0	23.9	7.6	16.4	11.9	5.2	4.7	13.0	4.6	6.3	4.9	2.4	3.4	11.4	8.5	1.2	26.8	7.8	25.7	14.0	13.9	11.3	4.6	26.2	2.8	7.9	10.9	10.0	9.7	15.0	12.9	9.6	7.7	10.0	6.5	7.3	25.8	5.3	16.6	13.3	9.1	2.6	6.4	3.3	1.3	2.3	11.3	2.5	3.5	1.6	1.9	2.0	2.6	2.8	1.8	2.1	2.2	3.9	1.5	4.5	1.8	2.4	1.5	20.5	25.0	32.4	39.2	20.9	14.2	12.0	22.2	16.9	13.0
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favourable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	26.4	34.6	25.7	17.5	25.0	81.9	28.6	29.1	29.5	24.2	26.0	26.5	14.5	16.6	25.3	20.0	40.5	20.4	22.9	34.4	24.0	23.6	25.6	38.6	27.7	17.3	27.0	20.0	26.8	20.7	26.7	19.2	26.8	25.5	20.4	19.0	21.5	19.4	24.3	62.3	22.6	24.6	26.4	26.3	21.4	20.9	33.5	26.0	17.2	23.6	22.1	25.4	29.2	29.5	10.5	17.8	45.9	19.6	17.4	26.5	19.2	20.7	11.6	13.5	14.7	25.0	15.5	11.4	16.6	23.4	18.7	25.5	12.7	8.7	14.5	7.5	24.9	10.7	18.7	26.1	18.0	20.9	8.4	13.0	26.2	13.1	22.8	14.4	17.3	19.1	43.4	22.1	29.1	20.6	9.9	14.6	17.4	8.7	13.2	20.1	14.6	17.5	12.0	9.6	8.4	40.0	13.8	7.7	10.8	18.5	19.3	8.5	9.4	14.3	14.7	9.6	14.9	14.3	15.4	7.2	9.0	15.3	19.3	11.7	28.2	9.0	19.6	24.1	15.4	17.1	26.5	10.5	15.5	16.1	17.8	8.8	15.1	12.3	45.9	17.4	14.5	9.9	19.1	19.2	25.7	25.0	29.1	29.5	24.0	23.6	27.0	20.0	25.5	26.0
UBAP2	"bA176F3.5, FLJ22435, KIAA1491"	ENSG00000137073	"Ubiquitin associated protein 2"	Q5T6F2	9	33921693-34048949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021684	Approved		Approved	Cytosol				Cytosol		"HPA021684: AB_2211887"	"unprognostic (2.71e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavourable (3.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"prognostic favourable (8.59e-4)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-3)"	"prognostic favourable (1.95e-4)"	"unprognostic (8.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.77e-2)"	13.0	23.8	11.8	13.9	12.8	17.0	11.6	15.1	14.5	11.6	11.9	12.8	9.4	10.0	18.6	10.8	16.8	10.7	10.5	11.5	10.4	8.6	12.7	9.5	11.6	11.0	8.4	10.7	15.2	13.5	13.4	18.2	18.3	11.5	12.7	14.4	12.3	17.6	11.7	38.1	18.4	9.7	12.2	10.6	10.4	12.0	27.5	11.5	24.7	15.4	21.0	19.2	11.6	13.6	4.7	6.8	4.7	10.5	7.5	8.2	3.3	17.9	16.6	12.0	15.1	11.9	10.5	14.5	14.5	9.0	15.0	14.6	22.5	9.6	21.0	4.6	12.0	10.5	20.2	15.9	16.8	15.4	9.9	11.7	21.2	24.5	9.8	26.3	18.8	9.8	13.5	19.0	13.2	12.0	16.0	17.4	13.5	12.0	19.5	44.7	12.8	13.1	15.1	7.4	13.3	14.5	13.6	12.4	8.6	17.1	14.0	4.2	12.4	11.8	14.0	8.9	12.1	10.5	16.0	6.7	14.0	22.5	9.8	10.1	22.1	2.6	4.3	4.7	3.9	5.2	8.2	4.7	4.8	5.4	5.0	2.5	4.3	5.8	2.6	7.5	10.5	6.8	5.3	3.3	11.8	12.8	15.1	14.5	10.4	8.6	8.4	10.7	11.5	11.5
UBAP2L	"KIAA0144, NICE-4"	ENSG00000143569	"Ubiquitin associated protein 2 like"	Q14157	1	154220179-154271510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035068	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA035068: AB_10696366"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (4.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (5.10e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.96e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (7.40e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-1)"	33.8	33.0	39.1	34.8	47.5	32.7	32.3	34.3	46.6	31.2	31.3	32.9	25.5	20.6	40.6	30.3	36.1	34.8	28.3	36.9	38.3	25.2	26.7	23.9	35.1	34.1	26.5	39.5	42.7	25.0	42.1	40.6	43.9	30.5	29.2	25.8	31.2	31.8	32.8	53.2	36.8	25.3	36.6	30.2	30.5	27.4	37.5	30.2	34.6	33.8	26.6	38.5	37.9	32.4	18.3	24.3	17.6	26.5	24.6	20.6	18.3	42.7	41.3	40.5	31.9	28.9	33.1	34.8	49.3	35.7	44.8	31.2	44.3	33.3	53.5	51.3	41.3	37.2	53.0	36.3	39.5	47.1	45.4	57.9	42.8	36.9	27.2	60.3	34.3	31.4	15.9	40.5	25.9	35.4	52.6	26.0	35.2	46.6	47.0	22.6	75.3	39.2	33.8	32.0	47.2	28.0	50.1	41.3	50.0	56.7	53.4	21.5	53.6	41.8	56.8	27.8	29.5	34.1	46.8	57.0	61.3	72.8	29.9	33.1	41.5	8.8	19.2	13.2	17.5	25.1	19.1	15.6	16.4	15.7	24.3	18.3	19.1	20.6	17.6	24.6	26.5	11.4	14.7	18.3	39.1	47.5	34.3	46.6	38.3	25.2	26.5	39.5	30.5	30.2
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (2.27e-3)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	32.5	27.5	17.3	14.6	30.3	37.4	16.2	33.8	30.2	40.3	38.3	14.2	22.4	25.8	34.4	37.2	23.5	24.7	17.9	38.9	35.8	14.6	11.4	22.0	12.7	27.8	28.5	19.6	25.5	25.6	38.6	16.8	27.9	14.0	23.1	45.6	34.5	43.9	26.9	28.8	31.1	22.4	18.4	24.0	32.5	21.4	13.3	13.7	45.0	20.7	24.6	18.0	24.9	27.2	25.9	11.6	51.1	38.1	22.4	36.4	25.3	27.5	36.1	20.2	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	36.2	9.6	20.0	19.0	17.5	18.9	32.3	27.3	14.4	17.6	21.0	28.9	24.4	19.8	33.0	17.4	14.5	15.1	20.2	19.2	31.4	16.3	10.9	26.5	31.0	20.5	12.9	22.4	16.2	27.5	15.9	13.5	15.0	19.9	36.0	15.8	21.2	20.4	34.1	8.6	9.1	20.6	22.0	27.6	15.7	28.1	27.0	21.1	21.4	10.1	47.4	21.8	35.6	29.7	20.5	14.3	27.5	29.8	30.1	41.2	27.9	23.1	24.4	20.3	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 130.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: , HPA054975: "	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	3.1	2.3	0.4	24.0	0.9	25.1	4.3	0.4	0.7	3.8	9.5	0.4	0.8	7.8	2.0	2.6	25.6	0.6	3.2	2.8	0.5	0.4	2.1	2.1	4.6	15.6	0.6	0.5	1.2	1.3	0.0	0.6	12.6	0.9	1.3	11.7	0.7	3.7	0.6	1.0	8.3	10.0	3.5	1.2	11.6	7.0	15.3	0.5	130.8	0.8	17.6	26.3	2.8	7.8	1.2	0.9	2.7	0.6	2.4	10.0	4.2	39.2	28.8	52.0	24.9	1.4	3.2	29.9	31.2	15.8	51.4	36.9	94.6	45.4	41.6	30.6	14.8	38.8	0.2	33.4	52.5	17.7	27.4	12.8	22.1	24.8	0.4	18.3	32.2	1.0	3.6	34.8	34.1	25.0	0.2	35.4	42.3	64.6	30.2	5.2	31.2	69.0	32.1	47.1	0.2	17.3	13.6	30.0	25.0	49.1	36.0	19.7	36.3	27.0	9.1	46.1	40.3	31.3	60.3	11.2	0.3	46.4	28.0	13.1	43.7	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.2	2.3	0.9	0.2	0.2	0.1	2.7	2.4	0.6	0.5	10.0	4.2	0.4	0.9	0.4	0.7	0.5	0.4	0.6	0.5	0.9	0.5
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334975-58370753	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 74.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	8.2	10.6	8.1	10.0	7.9	17.1	7.5	7.7	9.0	6.3	7.3	5.5	4.8	4.7	8.5	5.5	8.2	5.5	6.4	25.6	7.6	7.2	5.5	5.4	7.0	13.7	8.1	6.7	5.9	4.8	5.3	7.4	6.8	7.4	6.5	7.9	3.5	6.4	5.0	74.9	4.6	5.8	8.8	8.4	11.0	5.6	3.2	8.4	5.5	6.0	25.1	7.1	9.5	10.0	3.7	7.2	41.0	13.7	2.8	3.5	7.1	10.6	5.8	10.8	13.9	22.2	17.9	7.0	7.0	12.0	8.1	11.9	11.7	9.2	0.0	11.1	10.5	9.7	20.9	10.2	11.4	11.0	12.3	2.8	2.1	6.7	14.6	8.4	6.8	20.7	11.5	8.4	15.7	16.1	5.5	4.5	10.9	3.3	9.0	9.4	13.2	9.1	7.6	9.8	5.9	12.1	6.2	8.2	11.0	13.8	23.3	11.2	8.5	5.7	12.9	3.1	10.9	10.6	7.7	11.5	8.9	9.4	9.8	17.5	3.5	2.8	13.7	6.2	2.4	9.5	2.8	3.3	2.9	3.0	7.2	3.7	3.0	2.3	41.0	2.8	7.9	3.0	3.5	7.1	8.1	7.9	7.7	9.0	7.6	7.2	8.1	6.7	7.4	8.4
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628433	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favourable (5.09e-5)"	"prognostic favourable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavourable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavourable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	35.6	25.0	41.2	31.5	39.9	44.2	35.9	31.9	49.6	43.9	50.4	35.5	31.5	22.2	35.5	52.2	44.8	47.6	27.1	34.8	39.5	40.5	37.2	39.5	34.8	55.6	40.5	36.1	35.3	41.7	23.8	35.3	33.6	35.9	30.8	46.4	30.7	30.5	37.9	80.6	33.2	37.4	39.3	41.9	41.3	29.1	68.0	29.3	71.0	34.4	31.2	64.5	42.2	36.1	34.3	39.3	40.8	23.0	22.5	41.7	19.5	36.5	24.4	42.8	29.9	28.9	37.1	27.4	38.7	36.2	45.6	53.4	62.8	34.8	52.3	51.0	39.9	23.2	42.0	65.2	61.1	33.7	24.5	29.6	27.0	36.0	56.6	28.9	26.4	29.1	33.7	45.2	67.7	48.6	25.6	44.8	42.2	36.7	44.6	41.2	23.5	26.6	34.0	44.5	37.8	47.9	43.3	39.0	25.8	33.8	43.5	61.4	27.2	25.7	31.8	34.8	19.4	28.9	47.2	32.2	52.3	73.3	24.9	47.7	27.7	14.8	20.9	40.8	22.6	18.8	24.7	34.1	32.7	31.7	23.4	34.3	41.7	35.2	34.5	22.5	23.0	39.3	40.0	19.5	41.2	39.9	31.9	49.6	39.5	40.5	40.5	36.1	35.9	29.3
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favourable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	67.2	70.6	39.1	52.7	44.6	132.7	70.4	36.9	50.9	45.5	51.8	37.5	38.4	49.3	46.3	39.1	63.2	45.7	47.5	72.5	37.3	39.5	63.0	91.9	67.5	68.1	43.4	36.9	60.6	53.4	42.8	49.1	66.5	45.2	49.6	48.5	38.4	46.7	43.3	91.1	53.2	58.9	48.4	44.4	68.2	49.5	40.0	42.2	88.8	66.3	55.4	61.4	74.6	81.4	24.7	31.2	118.0	36.2	29.7	33.2	50.9	52.5	30.1	50.3	40.6	53.7	77.6	43.3	53.6	71.4	47.8	45.2	45.2	75.1	56.4	35.1	54.3	30.2	53.6	71.9	65.9	52.3	27.0	51.3	31.0	36.8	56.4	72.1	44.2	58.9	45.6	52.7	73.9	62.0	64.4	57.6	63.6	42.5	105.7	41.1	36.4	30.2	55.8	49.4	40.7	48.2	50.3	50.8	42.8	32.9	84.5	60.4	35.1	42.7	56.9	50.1	42.9	32.8	48.6	51.1	65.8	86.2	53.4	40.2	53.7	71.1	35.9	54.6	25.1	36.1	33.2	24.7	31.8	29.6	31.2	20.1	32.6	29.7	118.0	29.7	36.2	21.5	32.6	50.9	39.1	44.6	36.9	50.9	37.3	39.5	43.4	36.9	45.2	42.2
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926438-43956136	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.6"	"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favourable (4.86e-4)"	"prognostic favourable (5.77e-4)"	"prognostic favourable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	10.1	13.1	14.7	5.0	13.3	4.5	9.1	13.8	17.4	8.8	7.6	11.4	7.9	5.3	7.5	11.2	8.0	9.0	7.2	23.8	14.2	10.0	12.7	15.3	8.4	5.3	12.1	9.4	7.9	17.4	8.7	6.9	5.9	11.9	8.7	6.2	8.1	10.6	9.1	48.6	9.4	5.3	10.3	12.8	7.3	6.5	5.1	6.1	2.7	9.6	16.1	5.7	7.7	6.5	10.7	11.8	12.9	20.5	7.7	14.0	6.7	3.7	3.2	1.9	8.9	9.2	3.7	1.5	1.9	4.6	2.4	3.1	1.7	4.5	3.7	5.2	4.9	4.3	2.5	2.0	3.6	8.1	4.1	3.9	4.9	4.3	3.4	8.5	8.0	2.9	4.3	2.7	4.1	2.9	4.3	7.6	3.2	2.4	5.0	4.9	4.3	4.1	3.1	2.7	5.6	5.0	4.6	7.3	24.7	3.9	7.9	2.9	3.9	2.6	2.5	1.6	4.9	3.3	5.4	11.0	8.2	1.8	4.7	11.2	8.7	6.3	11.7	12.9	9.3	18.4	9.5	10.3	11.6	10.5	11.8	10.7	14.0	11.5	1.1	7.7	20.5	10.2	9.4	6.7	14.7	13.3	13.8	17.4	14.2	10.0	12.1	9.4	11.9	6.1
UBE2F	NCE2	ENSG00000184182	"Ubiquitin conjugating enzyme E2 F (putative)"	Q969M7	2	237966827-238042782	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037444	Approved		Approved	Cytosol				Cytosol		"HPA037444: AB_10672491"	"unprognostic (1.73e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.59e-7)"	"unprognostic (2.04e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.51e-1)"	14.5	18.4	21.3	13.6	17.6	19.9	17.2	12.2	19.8	16.7	15.8	17.7	12.3	13.6	14.7	32.2	25.0	11.0	16.3	34.6	20.2	21.6	14.6	24.1	12.9	26.4	23.4	10.1	10.4	62.8	16.3	13.2	22.2	24.2	14.9	19.6	11.4	15.3	18.2	32.1	10.3	17.9	20.2	20.2	14.6	15.1	13.9	16.8	15.8	32.9	17.4	17.7	18.7	16.4	10.9	23.1	35.6	30.0	39.9	29.1	24.6	13.7	7.9	18.1	18.5	23.6	28.8	25.6	13.0	18.6	14.7	15.1	8.6	8.8	7.1	4.7	29.0	11.7	20.5	28.2	22.9	10.8	8.0	9.8	10.0	27.9	29.7	4.1	23.1	16.5	46.6	19.3	29.5	25.9	29.8	4.6	26.5	20.6	11.1	18.0	19.9	12.0	13.5	12.0	12.7	22.1	5.8	12.1	18.1	15.2	11.5	23.9	10.4	17.1	16.1	16.2	14.2	18.3	13.9	5.7	4.4	13.9	19.2	12.5	11.9	35.6	21.0	25.2	29.1	27.6	11.5	10.9	19.9	17.6	18.6	10.1	18.6	18.8	15.6	39.9	30.0	23.1	20.5	24.6	21.3	17.6	12.2	19.8	20.2	21.6	23.4	10.1	24.2	16.8
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045681: , HPA050551: "	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	10.8	11.1	12.6	17.8	13.5	14.3	11.2	11.6	15.3	13.0	19.4	17.8	8.9	11.9	13.3	8.5	27.4	9.2	9.7	26.9	13.5	11.2	14.6	17.7	8.9	18.7	15.2	9.7	9.1	17.1	12.0	6.0	11.4	14.5	14.0	13.3	8.8	11.9	12.0	95.6	14.1	16.6	14.6	19.4	15.0	11.9	11.8	13.6	21.3	12.5	20.7	23.3	17.7	16.5	23.7	13.1	24.4	11.5	20.5	20.6	13.1	21.2	23.0	21.5	15.7	17.6	18.7	30.7	20.7	16.7	19.8	17.4	15.8	10.9	33.3	21.8	20.3	23.0	26.7	19.2	31.9	17.5	21.8	12.4	12.2	18.0	17.3	18.0	23.6	15.9	28.8	18.7	27.3	26.4	21.8	36.1	16.2	9.5	22.9	16.6	23.7	12.0	29.8	11.4	30.4	23.0	14.0	9.3	17.4	19.5	17.0	16.1	16.7	11.8	19.8	19.9	15.2	23.2	23.1	14.0	16.4	47.1	15.3	16.9	15.2	8.1	10.3	24.4	15.4	10.8	20.6	23.7	20.1	20.1	13.1	15.5	20.2	20.5	18.6	20.5	11.5	9.6	18.3	13.1	12.6	13.5	11.6	15.3	13.5	11.2	15.2	9.7	14.5	13.6
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698044-39782792	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Supported	"Intermediate filaments,Actin filaments,Cytosol"			150000	Cytosol	"Intermediate filaments, Actin filaments"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	27.2	21.8	27.0	21.2	27.6	17.3	21.6	38.6	40.7	17.0	33.2	11.8	14.1	29.1	19.9	18.5	29.9	14.9	18.5	28.1	27.7	26.8	26.6	44.5	17.1	17.9	24.1	26.4	16.9	15.8	18.9	26.9	29.8	25.2	19.7	24.0	13.4	18.4	17.3	31.8	22.0	24.6	18.8	19.2	16.9	29.3	16.0	15.9	21.3	23.6	19.7	18.8	22.8	20.4	17.6	23.7	20.6	19.9	10.9	14.1	8.9	23.8	24.5	13.2	12.5	8.3	7.8	22.5	32.9	7.0	8.8	9.3	37.0	24.6	29.8	29.0	9.2	10.1	25.4	14.3	14.2	20.0	18.2	38.6	24.8	32.0	10.4	41.4	21.9	7.3	16.2	12.4	13.4	11.5	39.2	10.7	9.1	23.1	28.9	23.0	17.6	18.7	17.1	39.7	11.2	12.3	33.3	27.4	12.1	24.6	9.3	14.7	12.0	13.9	31.5	13.8	29.3	16.4	30.2	15.2	44.3	32.8	7.2	26.6	16.1	13.9	16.6	20.6	13.5	14.3	12.7	17.6	14.1	12.6	16.6	12.5	10.7	12.0	13.3	10.9	19.9	23.7	13.7	8.9	27.0	27.6	38.6	37.7	27.7	26.8	24.1	26.4	25.2	15.9
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol			8800000	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: "	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	27.8	34.9	34.8	23.5	29.6	31.3	24.9	25.5	36.9	25.9	27.7	38.4	22.8	26.4	25.6	29.2	38.0	26.9	23.0	33.0	30.7	30.8	27.4	36.0	23.5	32.5	34.3	33.1	24.3	23.9	24.3	21.7	30.1	36.9	27.5	31.7	29.3	30.6	26.7	43.5	23.9	34.4	33.1	36.2	28.5	25.1	35.7	22.6	25.3	25.0	32.4	33.9	28.4	22.2	34.7	49.9	46.1	45.8	34.6	46.9	54.9	24.4	14.1	20.7	16.1	22.6	20.2	11.9	20.6	23.6	26.6	25.3	16.0	11.8	23.1	10.4	27.3	21.0	27.5	22.4	26.5	23.0	29.7	26.7	13.8	19.1	15.1	38.1	19.3	17.8	19.6	19.2	14.0	29.8	107.9	12.4	28.6	18.0	19.8	27.6	15.2	14.9	16.2	31.1	6.3	24.9	19.7	18.6	13.8	16.4	20.7	18.9	12.9	21.1	21.3	18.8	24.2	15.9	21.0	12.1	19.5	21.1	25.5	17.7	17.8	30.8	40.4	46.1	41.4	45.8	38.8	34.7	39.6	44.2	49.9	31.2	34.5	41.6	34.2	34.6	37.6	48.4	46.9	54.9	34.8	29.6	25.5	36.9	30.7	30.8	34.3	33.1	36.9	22.6
UBE2L5	UBE2L5P	ENSG00000236444	"Ubiquitin conjugating enzyme E2 L5"		13	30422488-30428616	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	9	"testis: 31.5"	"Low cell line specificity"	"Detected in some"			"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in single"			"HPA045609, HPA062415"	Approved		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: "	"unprognostic (2.09e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.50e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.44e-2)"	"unprognostic (8.75e-2)"	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.7		0.3	0.2	0.2	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	31.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	1.9	2.7	3.6	1.9	2.0	2.8	0.6	0.3	1.2	1.6	0.6	0.6	0.6	1.1	0.6	0.4	0.2	0.0	3.0	1.4	0.5	1.3	0.6	0.8	0.4	1.1	2.4	0.6	0.4	0.8	0.2	0.2	0.7	1.5	0.2	0.3	0.6	0.2	0.9	0.7	1.3	0.3	0.0	1.6	2.5	1.3	0.2	0.4	0.6	0.4	0.9	1.5	1.2	0.3	0.4	0.1	1.8	0.6	2.4	0.0	0.7	0.5	0.7	1.1	1.5	0.3	1.6	1.0	0.9	0.4	1.8	1.1	1.9	1.4	3.6	1.2	3.2	1.5	1.6	1.5	1.7	1.4	2.0	2.7	1.9	1.6	1.9	2.0	2.8										
UBE2L6	UBCH8	ENSG00000156587	"Ubiquitin conjugating enzyme E2 L6"	O14933	11	57551656-57568284	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003328, CAB073407"	Enhanced		Approved	Cytosol			34000	Cytosol		"CAB073407: , HPA003328: AB_1858539"	"prognostic favourable (6.75e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.42e-2)"	31.1	31.0	32.0	34.1	28.6	30.4	40.4	18.2	25.6	23.3	19.1	17.0	17.1	19.0	21.9	30.0	19.9	28.6	27.4	18.4	23.5	27.4	28.3	55.1	50.5	45.0	28.9	20.4	27.1	21.8	17.9	18.5	21.7	25.8	26.0	18.8	18.7	42.8	22.2	10.1	15.9	23.5	28.3	23.6	47.9	21.4	7.7	23.6	44.0	33.6	15.1	34.4	33.0	49.0	49.2	53.6	113.6	83.4	61.2	66.4	112.6	8.7	4.4	14.9	4.7	31.6	39.4	1.6	5.1	30.4	45.1	58.7	1.6	22.8	28.0	18.0	15.5	7.0	6.4	16.8	9.6	25.5	0.2	27.6	0.0	6.2	58.6	6.3	9.1	42.1	3.9	21.1	5.8	14.2	1.2	19.4	8.1	11.1	42.5	15.2	3.9	5.6	37.6	9.1	19.2	12.1	9.8	0.3	7.8	10.2	0.8	22.3	11.2	3.2	5.2	9.4	3.3	7.1	1.6	26.5	26.7	0.5	26.3	16.0	2.0	56.7	71.6	62.5	51.2	83.4	56.4	49.2	53.4	53.4	53.6	39.7	46.5	48.8	113.6	61.2	68.3	34.0	66.4	112.6	32.0	28.6	18.2	25.6	23.5	27.4	28.9	20.4	25.8	23.6
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558960	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	18.1	26.0	51.8	16.3	38.9	32.1	13.6	28.4	52.4	15.2	20.4	17.0	20.5	17.8	17.3	19.6	24.9	19.3	17.4	43.2	35.1	33.9	19.6	19.1	16.5	18.1	32.1	30.5	19.4	20.2	25.9	22.8	32.0	26.4	18.4	16.7	15.0	20.9	22.6	61.9	19.2	15.9	19.2	19.8	18.5	17.9	31.8	16.1	32.7	22.2	21.2	19.9	18.2	23.5	3.8	7.6	10.9	4.3	1.8	3.8	2.1	21.1	38.6	19.6	18.6	10.5	12.5	14.3	22.1	19.5	16.0	13.8	23.3	16.5	22.3	16.7	15.6	13.9	21.7	21.8	12.0	25.3	131.9	32.4	24.8	15.1	25.6	29.3	25.7	13.3	17.1	24.4	29.0	19.2	15.7	28.2	21.2	21.7	23.3	26.6	12.4	33.8	21.8	16.3	28.6	18.4	26.7	34.4	28.2	19.1	23.4	20.6	14.1	26.9	14.4	50.2	10.2	15.7	39.1	34.1	51.6	23.9	31.9	26.0	32.7	6.8	4.3	4.1	3.5	2.8	2.7	3.4	3.8	3.7	3.1	3.8	3.7	2.5	10.9	1.8	2.7	7.6	3.1	2.1	51.8	38.9	28.4	52.4	35.1	33.9	32.1	30.5	26.4	16.1
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908369-48929056	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favourable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	27.1	40.6	29.2	27.7	37.0	22.2	28.8	34.4	50.2	33.7	28.9	59.9	45.1	26.6	36.2	49.5	37.2	36.0	28.0	28.7	30.5	29.2	32.1	25.6	29.2	30.9	46.6	28.0	32.5	29.5	36.6	28.0	35.0	39.7	32.9	32.5	28.4	33.3	43.2	24.1	35.9	30.5	39.1	32.7	36.6	29.4	22.4	43.4	29.4	39.8	22.2	44.2	28.8	32.2	12.8	10.1	11.0	14.5	7.4	13.1	8.6	24.8	30.9	11.6	11.0	29.5	28.7	15.9	27.3	33.5	32.7	31.6	38.5	21.6	20.3	39.2	33.4	16.2	14.5	25.5	41.8	67.1	15.8	18.3	20.4	23.9	34.2	13.0	19.8	24.4	28.3	26.6	34.6	23.9	13.4	26.5	35.1	39.8	14.0	12.9	10.8	27.0	11.3	29.6	11.5	25.6	24.5	12.0	18.2	18.5	10.0	18.6	27.6	10.3	28.1	49.0	23.7	16.0	22.2	20.2	19.2	12.0	24.0	9.5	21.2	6.5	11.0	8.1	13.1	14.5	10.7	9.4	11.4	13.0	8.0	12.8	11.1	12.0	11.0	7.4	13.0	10.1	11.5	8.6	29.2	37.0	34.4	50.2	30.5	29.2	46.6	28.0	39.7	43.4
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	19.3	19.4	20.3	23.1	25.0	17.8	20.2	30.0	25.1	21.7	19.9	14.3	19.8	14.1	21.0	22.1	19.8	18.5	17.2	24.0	22.2	20.8	20.2	24.6	19.7	23.1	19.1	19.5	23.0	17.2	26.1	24.6	20.1	20.9	20.6	17.9	13.3	19.3	21.5	70.2	18.4	18.8	21.2	19.9	18.8	16.9	26.4	16.4	36.4	25.0	26.6	19.5	19.9	26.6	15.6	11.9	11.6	14.8	21.1	16.0	5.7	19.3	10.9	27.6	16.4	16.1	19.2	13.6	29.8	18.7	21.1	19.2	25.3	9.7	34.7	22.6	22.2	17.9	34.9	21.0	25.8	17.9	11.7	28.8	18.4	14.9	24.2	34.7	21.3	22.6	19.8	19.9	25.5	16.5	29.0	24.8	33.1	10.5	28.7	10.1	17.9	15.9	29.5	41.2	15.3	19.1	30.4	28.3	21.4	24.1	26.2	34.2	21.4	19.6	21.2	37.0	30.6	17.7	21.7	28.4	33.5	46.8	21.2	18.9	19.2	8.6	8.7	11.6	13.3	7.6	15.2	12.0	14.0	15.9	11.9	15.6	16.0	14.2	2.0	21.1	14.8	11.1	10.1	5.7	20.3	25.0	30.0	25.1	22.2	20.8	19.1	19.5	20.9	16.4
UBL4A	"DXS254E, GDX, GET5, MDY2, TMA24, UBL4"	ENSG00000102178	"Ubiquitin like 4A"	P11441	X	154483717-154486670	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003617	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA003617: AB_1080450"	"unprognostic (2.75e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.50e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-2)"	11.5	15.3	14.1	7.3	16.0	6.6	12.4	11.9	28.2	11.7	12.2	8.7	11.0	12.2	10.2	13.8	14.0	10.9	10.5	26.5	14.1	11.0	10.6	13.7	10.9	12.1	11.2	16.9	11.2	25.4	11.3	8.3	9.4	13.6	15.4	9.0	8.0	18.8	15.7	59.2	13.3	9.3	14.8	8.6	9.8	10.9	4.3	6.1	8.2	12.2	20.6	11.7	14.9	10.4	10.1	9.9	32.9	10.0	14.3	22.9	17.9	28.8	18.2	5.5	14.9	11.6	11.5	18.3	12.9	9.3	13.3	14.3	18.1	11.5	22.3	38.9	11.7	11.2	27.2	14.1	7.4	14.6	17.3	15.9	17.4	10.6	14.3	18.8	17.3	9.0	16.9	8.9	15.4	9.5	17.5	11.1	10.8	23.9	17.0	18.8	6.3	30.5	15.2	16.3	23.5	11.3	12.5	10.5	15.9	7.2	23.8	20.6	11.0	14.3	9.5	13.6	15.4	21.8	26.8	22.5	21.7	39.6	14.3	32.6	15.7	32.9	10.0	9.6	16.5	8.5	22.9	10.1	15.4	17.3	9.9	8.3	13.3	14.9	3.4	14.3	7.1	5.8	15.0	17.9	14.1	16.0	11.9	28.2	14.1	11.0	11.2	16.9	13.6	6.1
UBL7	"BMSC-UbP, MGC14421"	ENSG00000138629	"Ubiquitin like 7"	Q96S82	15	74445977-74461182	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040423, HPA041897"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040423: AB_10673442, HPA041897: "	"unprognostic (4.21e-2)"	"prognostic favourable (6.37e-5)"	"unprognostic (2.93e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.43e-2)"	14.4	18.0	30.0	16.6	31.8	16.4	17.0	20.8	58.4	20.7	19.4	22.7	15.2	18.2	17.9	19.6	18.4	22.0	15.9	27.6	29.0	21.1	18.6	17.2	16.4	23.1	26.8	26.1	18.4	21.4	30.2	14.3	18.9	33.0	17.5	20.7	15.0	19.8	21.4	45.5	23.0	16.1	23.0	28.3	22.5	18.5	34.8	16.1	36.9	28.2	18.6	34.9	17.7	14.4	26.6	75.5	32.8	28.7	25.8	31.6	23.1	11.5	12.6	20.5	27.5	21.5	28.3	13.8	18.7	23.0	24.6	30.5	15.3	16.8	16.9	20.2	23.0	18.8	57.0	25.4	23.5	22.3	34.8	22.1	21.0	27.5	20.7	13.7	19.1	21.6	23.1	20.4	28.2	20.4	18.9	25.4	24.9	15.8	16.9	21.3	49.0	15.4	18.3	16.1	37.7	21.1	13.5	20.2	40.0	18.3	17.3	25.0	18.3	22.9	11.9	22.8	13.5	11.4	23.2	25.6	48.7	18.8	14.8	25.0	19.6	13.6	26.2	28.5	18.8	28.7	17.9	26.6	18.9	19.5	35.1	26.4	18.5	21.8	32.8	25.8	25.7	75.5	31.6	23.1	30.0	31.8	20.8	58.4	29.0	21.1	26.8	26.1	33.0	16.1
UBQLN1	"DA41, DSK2, PLIC-1, XDRP1"	ENSG00000135018	"Ubiquilin 1"	Q9UMX0	9	83659963-83708203	"Plasma proteins, Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037256, HPA054143"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB037256: AB_1858556, HPA054143: "	"unprognostic (4.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.07e-5)"	"unprognostic (3.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.29e-2)"	26.8	33.9	27.2	26.2	38.7	41.1	38.1	35.0	42.2	24.9	24.4	21.2	27.8	21.9	29.1	22.2	30.5	21.4	21.0	34.5	28.9	32.1	31.6	40.8	23.3	25.8	30.0	27.8	21.5	28.1	36.0	29.5	30.4	37.2	26.5	23.7	15.2	23.8	28.9	79.1	27.8	27.6	26.9	33.9	28.6	23.1	22.9	23.3	59.8	25.7	16.2	34.8	24.8	27.3	16.0	19.2	23.4	25.0	24.7	18.8	14.9	43.5	40.3	29.6	22.9	24.7	26.3	49.1	40.7	36.1	43.3	32.9	16.5	31.1	43.3	26.3	34.0	50.1	41.0	28.9	45.1	22.8	19.1	26.5	31.0	25.6	32.6	32.1	29.2	21.8	36.4	36.5	50.8	32.3	28.6	31.0	35.3	25.8	44.9	17.8	38.8	37.0	33.4	33.2	22.6	28.2	19.0	26.8	29.9	37.6	37.9	29.1	18.9	23.4	32.0	27.7	25.9	45.8	40.7	43.5	61.4	21.2	41.2	23.7	33.5	23.4	17.1	17.6	16.6	25.0	16.2	16.0	14.5	15.2	19.2	15.5	14.7	16.0	18.5	24.7	23.1	8.2	18.8	14.9	27.2	38.7	35.0	38.7	28.9	32.1	30.0	27.8	37.2	23.3
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563639-56567868	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"			200000	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.4	20.8	27.0	13.9	40.7	9.4	16.2	34.9	35.3	17.3	13.6	17.8	15.0	11.1	17.0	16.7	18.1	18.2	14.5	20.8	26.2	28.6	13.9	18.9	14.0	16.4	21.2	26.6	27.0	10.6	25.5	18.3	15.6	20.8	21.1	12.5	13.3	13.7	21.5	24.6	13.5	11.6	18.7	18.8	13.9	12.9	5.4	16.7	18.0	20.9	10.9	17.7	16.4	14.1	5.5	10.9	25.0	19.4	12.1	20.4	10.9	18.8	14.1	14.1	16.5	32.5	20.8	8.9	15.3	18.2	11.5	12.8	7.8	8.9	14.5	16.7	18.0	11.1	26.9	17.0	13.9	22.3	16.2	5.8	19.4	8.3	17.1	11.4	12.9	19.3	21.7	15.4	13.6	10.0	6.8	16.0	18.1	8.8	14.6	10.0	11.7	16.8	13.2	18.3	13.6	23.2	14.8	17.5	16.4	22.0	9.8	8.9	16.4	8.5	11.2	12.2	12.5	17.6	9.2	6.1	7.4	10.0	13.7	12.1	10.3	25.0	14.1	14.1	9.9	19.3	11.1	5.1	15.1	11.5	10.9	5.5	20.4	12.2	12.4	12.1	19.4	3.9	14.1	10.9	27.0	40.7	34.9	35.3	26.2	28.6	21.2	26.6	20.8	16.7
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074506-19210276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	24.4	25.4	22.4	29.0	25.4	58.3	23.7	28.5	32.5	22.4	28.5	26.3	31.5	18.2	34.0	32.5	22.7	20.3	27.3	20.5	23.3	15.9	25.5	29.7	31.2	20.3	21.0	20.9	35.5	21.0	40.9	31.4	28.4	25.0	30.7	20.5	30.6	24.7	27.1	55.9	69.0	25.5	39.3	20.2	26.5	30.2	41.1	21.6	37.7	26.1	17.3	25.9	43.4	29.0	4.6	9.1	18.3	18.5	2.7	3.4	4.6	22.9	23.2	21.0	15.5	39.3	20.3	18.2	17.9	18.9	19.5	17.8	37.0	19.8	13.9	16.8	23.6	15.7	16.4	17.8	18.3	11.5	14.5	31.7	22.4	24.1	27.7	19.4	21.1	18.1	22.9	39.7	38.3	21.3	21.6	12.9	18.5	16.4	9.1	23.7	17.0	13.1	12.8	16.4	11.6	17.6	13.5	14.9	14.8	21.2	12.2	15.2	8.4	15.3	33.0	22.9	14.3	27.1	20.0	15.3	9.2	16.1	15.7	30.0	19.4	18.3	18.5	2.9	3.4	3.8	2.9	4.6	3.0	1.9	9.1	2.9	2.7	2.5	9.8	2.7	1.3	4.3	2.1	4.6	22.4	25.4	28.5	32.5	23.3	15.9	21.0	20.9	25.0	21.6
UBR5	"DD5, EDD, EDD1, HYD, KIAA0896"	ENSG00000104517	"Ubiquitin protein ligase E3 component n-recognin 5"	O95071	8	102253012-102412841	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053688			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053688: "	"unprognostic (3.79e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.54e-3)"	"unprognostic (8.29e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.45e-1)"	27.0	16.7	27.1	29.5	31.7	30.3	29.2	40.8	32.8	24.9	25.0	19.1	21.1	14.4	26.8	24.0	23.8	22.0	17.6	22.7	25.5	15.3	17.9	17.0	24.2	29.6	21.9	20.6	29.7	22.2	32.4	25.5	25.0	23.6	20.2	17.1	19.7	22.9	21.8	39.9	29.7	22.4	29.3	17.5	21.9	21.1	39.7	28.3	37.9	20.3	15.9	27.0	27.5	28.6	5.0	4.0	6.3	5.5	2.4	7.1	2.1	23.2	10.4	20.2	10.3	19.9	20.3	18.6	17.6	15.6	13.8	12.1	10.4	15.7	46.4	15.2	16.5	14.2	17.2	15.3	19.4	20.0	8.4	38.7	14.2	18.7	17.7	12.0	21.4	23.2	15.3	14.2	24.8	16.5	18.6	26.4	13.5	21.0	30.5	14.4	15.2	11.8	17.8	11.9	22.0	12.6	22.9	14.9	12.4	12.3	12.0	12.2	19.2	12.8	16.5	14.7	17.2	13.2	12.2	14.1	13.6	47.7	14.6	18.8	11.9	3.1	3.4	5.0	5.6	3.4	5.6	5.0	6.0	5.9	4.0	3.9	4.8	7.1	6.3	2.4	5.5	3.6	7.1	2.1	27.1	31.7	40.8	32.8	25.5	15.3	21.9	20.6	23.6	28.3
UBTD1	FLJ11807	ENSG00000165886	"Ubiquitin domain containing 1"	Q9HAC8	10	97498868-97571209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.5;neutrophil: 8.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034825	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA034825: AB_10602254"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (5.54e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.66e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.78e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.50e-3)"	16.0	5.6	7.7	7.3	7.1	10.2	20.5	5.1	9.0	11.5	4.6	5.8	9.7	2.9	6.6	13.9	8.1	8.3	9.0	23.8	6.8	6.5	15.6	11.2	26.0	8.3	9.1	4.8	8.9	12.9	3.1	7.8	5.3	6.4	6.5	1.5	8.9	10.7	10.8	24.2	22.7	2.5	7.0	6.7	5.3	4.1	30.3	5.7	1.0	12.9	10.9	4.4	10.3	8.6	0.3	1.7	8.5	3.4	0.0	0.4	0.5	9.0	9.0	2.4	11.9	10.1	9.6	2.8	10.4	15.3	11.2	8.6	6.0	7.9	1.1	12.7	7.0	10.9	2.4	13.9	1.5	2.8	4.7	1.1	2.8	7.5	14.6	1.0	3.1	13.1	4.7	12.2	3.0	17.8	0.6	1.7	7.1	4.3	0.4	9.2	3.9	16.6	0.9	4.2	1.0	8.6	3.4	0.8	2.5	4.7	2.9	13.4	10.8	6.8	19.1	14.2	8.7	14.8	13.5	2.2	2.5	0.4	12.0	6.2	7.4	1.3	3.4	7.5	0.2	0.8	0.2	0.3	0.1	0.0	1.7	0.0	0.1	0.0	8.5	0.0	0.9	1.2	0.4	0.5	7.7	7.1	5.1	8.1	6.8	6.5	9.1	4.8	6.4	5.7
UBXN11	"SOC, SOCI, UBXD5"	ENSG00000158062	"UBX domain protein 11"	Q5T124	1	26281328-26318363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 32.4;intermediate monocyte: 28.1;myeloid DC: 16.6;non-classical monocyte: 22.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 16.6;monocytes: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028600, HPA031357"	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA028600: AB_10604001, HPA031357: "	"unprognostic (1.78e-3)"	"prognostic favourable (2.54e-5)"	"unprognostic (8.18e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (2.53e-1)"	"prognostic favourable (4.90e-4)"	"prognostic unfavourable (5.90e-6)"	"unprognostic (8.41e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.59e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-2)"	5.4	7.6	16.6	10.2	25.7	18.9	5.6	7.0	21.5	8.6	4.6	7.9	9.0	4.2	6.7	23.8	4.3	35.4	8.4	5.9	17.0	15.0	9.3	3.7	12.0	8.2	9.8	12.3	9.7	8.2	8.4	18.3	5.2	12.7	5.4	3.5	13.6	8.3	8.3	6.2	6.0	4.4	5.0	5.6	11.7	4.8	27.4	8.5	6.2	15.7	2.7	5.7	6.1	3.9	5.3	16.6	2.4	32.4	1.9	5.7	13.2	17.1	7.8	3.9	7.8	2.8	2.1	13.5	3.8	6.0	10.7	7.8	3.0	15.3	10.1	5.8	2.4	9.4	2.4	6.2	2.7	5.0	9.2	1.7	11.1	7.4	5.1	7.3	3.4	3.3	6.7	18.0	4.6	2.9	6.5	7.0	3.6	7.7	4.1	3.5	7.8	6.0	8.6	2.8	9.0	5.9	2.5	18.4	4.4	9.5	8.9	6.6	6.9	7.1	2.8	6.2	9.3	9.2	5.7	6.7	18.8	11.4	7.6	10.1	5.0	0.7	32.4	1.5	3.4	28.1	4.1	4.4	5.0	3.9	16.6	5.3	5.7	3.6	2.4	1.9	22.5	2.5	4.1	13.2	16.6	25.7	7.0	21.5	17.0	15.0	9.8	12.3	12.7	8.5
UBXN6	"UBXD1, UBXDC2"	ENSG00000167671	"UBX domain protein 6"	Q9BZV1	19	4444999-4457822	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040906, HPA041313, HPA061872"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: "	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.50e-2)"	"prognostic favourable (5.68e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.48e-1)"	"prognostic favourable (6.95e-4)"	"unprognostic (3.93e-2)"	"prognostic favourable (2.78e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.79e-1)"	29.1	47.7	29.0	20.0	38.0	38.4	22.9	30.5	45.9	21.0	21.8	12.4	42.3	26.2	23.3	45.9	26.3	24.9	35.6	35.1	29.7	21.8	29.2	37.6	23.4	26.6	25.4	30.5	35.1	45.3	18.9	35.6	22.9	23.3	23.7	8.1	20.8	42.1	46.7	72.0	25.4	28.9	30.3	21.7	22.2	22.8	41.5	18.4	11.9	38.8	42.2	12.0	26.9	22.5	7.4	13.6	12.9	10.3	3.6	8.7	6.1	21.0	14.9	7.1	15.4	18.1	22.6	10.8	21.6	25.8	15.8	16.8	9.2	17.8	9.4	19.7	21.2	12.3	5.5	16.5	5.8	16.5	11.9	7.9	15.8	12.1	29.8	9.8	15.8	20.5	21.9	12.3	12.0	19.2	16.1	25.7	11.6	13.3	19.5	16.7	11.5	13.0	9.0	10.2	22.2	14.9	13.2	20.8	30.2	12.1	12.5	35.0	14.8	16.1	23.0	21.0	16.2	44.6	14.1	57.7	22.7	9.4	40.2	18.5	18.6	8.5	9.2	12.9	5.5	10.3	8.7	6.8	6.5	7.3	8.9	7.4	7.7	6.1	9.1	3.6	6.0	13.6	6.9	6.1	29.0	38.0	30.5	45.9	29.7	21.8	25.4	30.5	23.3	18.4
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 225.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 97.1;SCLC-21H: 96.9;U-251 MG: 88.7;U-266/84: 85.5;U-87 MG: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.6"	"Lineage enriched"	"Detected in single"	37	"B-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol			440000	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (1.93e-4)"	8.2	40.2	52.4	8.9	65.1	2.0	3.1	17.5	225.8	4.5	6.3	11.5	0.0	5.5	6.0	1.8	2.7	5.7	6.5	5.4	53.4	97.4	14.0	2.0	2.7	6.5	62.0	57.1	15.4	6.3	1.8	30.5	2.7	100.6	5.3	4.7	6.0	3.0	4.4	7.5	2.7	8.6	5.2	38.6	2.3	2.8	8.0	8.3	0.0	3.9	0.0	4.5	5.6	2.8	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	55.0	11.4	0.0	1.5	1.9	0.0	57.6	29.7	20.4	20.6	11.1	0.0	0.0	97.1	29.3	0.1	21.0	0.0	8.3	0.1	8.6	0.0	0.3	0.0	44.0	0.0	0.0	10.6	0.2	16.3	0.0	0.1	0.0	0.2	10.8	0.0	0.0	0.9	32.9	62.2	0.0	24.4	0.0	30.8	0.0	96.9	60.9	0.3	0.2	0.1	0.0	0.4	0.3	1.3	0.4	0.0	88.7	45.5	85.5	0.2	94.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	52.4	65.1	17.5	92.6	53.4	97.4	62.0	57.1	100.6	8.3
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol			490000	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavourable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	13.7	39.1	23.6	11.9	37.6	17.4	21.4	17.5	18.7	10.6	21.2	11.4	12.8	12.8	9.0	40.5	37.7	8.1	12.4	15.5	20.6	12.6	20.7	36.8	10.3	12.2	18.2	13.5	7.7	20.8	9.5	28.9	26.3	14.7	12.4	25.0	6.1	24.0	14.9	31.7	28.8	15.0	16.9	13.3	15.3	14.5	24.6	18.6	18.9	28.1	29.8	20.2	16.0	16.2	17.4	46.0	15.8	43.5	20.5	23.4	17.3	53.2	8.9	7.8	5.4	14.6	17.4	22.5	20.2	20.0	26.3	29.5	49.3	25.9	27.6	14.6	21.2	29.4	18.2	49.0	40.0	14.7	15.9	17.4	14.8	31.5	21.1	41.5	13.1	15.5	34.1	20.5	33.1	25.6	19.0	7.9	39.5	19.2	16.8	27.2	11.6	26.9	13.5	12.6	18.1	30.9	21.7	23.5	6.9	11.5	22.4	9.3	12.9	11.8	19.8	11.5	13.7	12.2	26.9	11.1	12.3	32.1	23.2	45.0	8.2	15.6	24.1	15.8	10.9	43.5	14.2	17.4	19.9	15.5	33.6	16.0	19.8	18.3	5.4	20.5	36.2	46.0	23.4	17.3	23.6	37.6	17.5	18.7	20.6	12.6	18.2	13.5	14.7	18.6
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000281-74009435	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 99.6"	"Cell line enriched"	"Detected in many"	4	"HDLM-2: 17.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010771: AB_261839, HPA072225: "	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	0.9	0.2	0.2	0.3	0.2	0.6	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	1.0	0.2	99.6	0.3	0.2	0.2	0.2	0.5	0.1	0.6	0.2	0.2	0.6	6.4	0.8	0.2	0.2	0.8	0.1	0.7	0.3	0.2	2.1	0.4	0.2	2.0	2.0	1.7	0.8	0.4	0.4	0.5	0.5	0.5	0.3	0.5	0.4	1.0	0.3	0.4	2.2	0.8	0.4	0.8	17.8	0.7	0.4	2.4	0.2	0.6	1.2	1.7	0.5	1.4	1.3	0.1	0.6	0.5	1.4	0.7	1.2	0.8	1.6	1.0	1.4	1.6	4.2	0.6	1.1	0.6	1.2	1.2	0.5	0.9	0.7	0.2	1.1	0.4	0.3	1.4	0.6	1.2	1.6	1.7	0.8	0.3	1.1	0.6	0.0	0.3	0.7	2.1	0.1	0.9	0.0	1.5	1.8	0.0	0.8	0.6	1.2	0.1	0.2	0.0	0.1	0.4	0.4	0.2	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favourable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	17.3	15.0	13.3	11.6	12.9	5.5	20.8	9.7	13.3	17.1	18.2	16.4	12.9	15.1	15.0	16.3	17.8	12.6	13.0	13.2	13.1	12.1	21.8	17.2	13.3	12.3	15.6	10.9	13.8	11.8	19.1	14.2	16.2	15.5	17.9	20.0	11.4	14.8	13.9	20.4	20.2	15.9	18.3	23.0	12.5	13.4	10.0	15.0	14.3	15.2	11.8	11.5	16.5	13.5	5.2	7.1	11.1	8.5	8.7	7.6	3.8	9.1	11.0	5.2	5.0	17.1	15.3	5.1	10.0	14.1	13.3	12.8	4.6	2.6	2.8	5.6	11.7	14.2	4.7	10.2	15.2	8.3	6.2	4.0	5.2	5.0	7.6	6.3	6.2	10.5	11.0	6.4	9.2	12.3	3.0	2.8	16.9	6.9	0.2	2.1	1.4	11.4	1.0	12.2	3.5	16.0	14.5	2.2	4.7	11.0	14.1	8.7	11.2	3.8	9.2	12.3	6.5	20.3	9.8	0.6	6.2	0.6	10.6	5.0	12.5	6.9	8.3	5.0	7.6	8.5	7.1	4.5	5.5	6.1	5.5	5.2	3.6	4.7	11.1	8.7	6.6	7.1	3.8	3.8	13.3	12.9	9.7	13.3	13.1	12.1	15.6	10.9	15.5	15.0
UFC1	HSPC155	ENSG00000143222	"Ubiquitin-fold modifier conjugating enzyme 1"	Q9Y3C8	1	161152776-161158856	"Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027481, HPA028722"	Enhanced		Approved	"Nuclear speckles,Cytosol"			180000	"Nuclear speckles"	Cytosol	"HPA027481: AB_10599850, HPA028722: AB_10601674"	"unprognostic (2.16e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (2.62e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.22e-2)"	34.2	38.6	52.6	25.4	54.7	35.1	45.6	21.1	41.8	35.4	37.3	27.8	47.7	36.9	31.5	57.2	40.6	69.9	40.8	36.0	42.5	45.9	56.1	55.2	32.0	29.8	46.3	35.6	48.7	85.5	39.3	40.6	54.2	34.4	44.0	46.8	29.2	63.6	40.3	34.3	36.1	48.6	35.8	34.4	39.1	39.1	22.2	33.9	38.9	50.2	38.9	38.9	37.9	33.4	41.1	43.6	22.4	33.0	40.9	54.1	48.0	22.8	21.2	18.7	23.5	25.1	40.4	39.5	23.3	27.5	22.3	19.8	27.7	46.9	31.8	39.2	32.4	11.9	15.6	22.4	16.6	27.0	43.0	19.4	31.5	33.2	24.9	42.6	49.4	34.4	36.3	27.8	19.2	38.8	32.1	23.3	28.4	27.6	19.7	39.0	34.4	23.3	24.2	13.6	44.2	43.2	27.9	21.6	34.3	20.3	67.5	26.8	25.8	79.4	29.0	16.6	16.2	15.9	34.0	40.6	51.9	28.7	26.3	27.2	21.0	22.4	32.8	20.4	39.0	33.0	47.2	41.1	41.8	41.5	40.4	31.0	36.7	39.5	6.0	40.9	24.0	43.6	54.1	48.0	52.6	54.7	21.1	41.8	42.5	45.9	46.3	35.6	34.4	33.9
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449910-19479215	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 130.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	27.8	28.0	22.7	24.3	38.0	38.7	23.9	25.3	30.4	21.1	28.9	23.3	24.7	21.7	32.8	40.3	31.6	21.3	21.7	35.6	21.9	22.9	28.0	46.6	24.6	34.8	44.3	15.9	22.4	34.7	22.5	22.6	31.6	33.0	21.7	27.7	21.9	26.7	24.4	57.9	27.3	24.7	28.3	39.7	26.7	26.2	31.8	29.9	37.8	27.8	26.9	31.7	23.9	23.7	27.7	35.3	53.5	42.8	31.1	67.6	37.5	31.4	22.9	19.6	29.6	16.1	11.3	15.1	26.0	26.0	36.0	33.4	25.4	13.7	22.0	20.3	21.8	27.3	22.9	22.8	31.5	40.5	24.2	23.2	16.2	20.0	15.3	36.8	31.7	10.4	23.5	30.7	15.1	28.9	130.1	42.5	21.9	45.7	23.6	22.5	14.0	19.5	28.7	46.3	8.5	22.1	29.7	16.1	18.1	20.4	22.2	20.4	13.3	17.7	31.3	30.5	41.4	25.3	27.9	18.2	36.1	28.7	25.6	18.8	27.7	39.8	29.0	47.8	36.1	42.8	34.7	27.7	41.6	37.3	25.5	23.9	35.9	35.1	53.5	31.1	41.1	35.3	67.6	37.5	22.7	38.0	25.3	30.4	21.9	22.9	44.3	15.9	33.0	29.9
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399540-185425985	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favourable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	15.8	20.3	12.5	10.3	14.9	4.1	18.7	11.3	20.3	17.3	17.4	16.3	17.0	11.0	19.4	17.4	20.1	17.3	13.5	24.2	11.4	11.7	28.1	19.2	13.2	11.6	14.6	11.3	30.5	20.1	18.3	22.8	12.3	17.0	18.4	12.6	13.7	14.4	20.3	40.8	16.6	13.6	16.9	20.2	14.2	17.3	23.7	14.6	15.8	23.5	19.2	12.2	20.8	13.3	15.6	13.0	5.5	7.9	13.9	17.9	8.2	12.0	7.4	20.8	15.0	18.8	19.6	11.5	12.5	12.7	15.0	14.2	12.4	15.5	12.2	5.8	15.1	9.6	16.1	20.3	15.6	13.0	9.4	6.4	7.2	11.2	20.8	9.7	8.0	11.5	15.9	13.1	13.6	24.0	16.3	24.6	19.4	7.3	13.0	7.3	5.4	10.7	12.9	8.2	14.6	14.4	7.0	12.4	11.6	7.8	12.7	15.2	9.8	6.9	13.9	6.3	11.1	4.3	9.7	22.4	8.6	5.8	20.3	6.1	15.9	5.5	7.9	5.4	16.3	6.8	17.1	15.6	16.5	17.6	9.8	11.0	17.8	17.9	0.4	13.9	6.6	13.0	14.0	8.2	12.5	14.9	11.3	20.3	11.4	11.7	14.6	11.3	17.0	14.6
UGGT1	"HUGT1, UGCGL1"	ENSG00000136731	"UDP-glucose glycoprotein glucosyltransferase 1"	Q9NYU2	2	128091200-128195677	"Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012761, HPA015127"	Enhanced		Uncertain	Cytosol			3800000	Cytosol		"HPA012761: AB_1858597, HPA015127: AB_1858596"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.05e-2)"	"prognostic unfavourable (6.37e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-3)"	13.7	14.7	7.6	16.4	10.2	23.8	11.3	10.7	10.8	12.7	15.2	10.0	21.1	11.4	12.3	26.3	13.1	10.6	11.3	13.0	7.7	7.9	13.7	33.4	13.9	14.6	11.0	5.7	10.4	44.1	13.4	11.2	22.1	9.1	11.7	13.5	9.7	15.5	20.5	19.3	11.1	17.4	8.9	9.0	16.1	13.0	9.9	9.5	24.3	13.8	6.4	15.7	11.4	11.0	6.3	7.4	8.8	6.2	4.7	5.9	2.8	16.2	5.7	10.9	23.4	14.4	11.5	16.6	18.8	8.2	6.3	5.7	12.6	12.1	23.1	7.5	13.8	12.1	8.3	8.2	12.9	14.6	4.0	20.3	7.5	38.4	14.3	27.1	12.8	8.4	6.5	12.7	11.6	14.6	13.0	12.6	13.3	11.4	10.9	15.6	19.3	5.9	9.0	10.4	9.8	11.7	12.1	5.7	8.6	13.0	17.8	11.0	7.0	19.2	20.1	17.4	11.9	9.9	13.4	13.2	18.3	10.7	14.8	14.9	16.0	7.1	6.2	5.4	5.9	6.0	5.8	4.0	4.8	5.3	4.5	6.3	4.1	5.9	8.8	4.7	5.7	7.4	3.8	2.8	7.6	10.2	10.7	10.8	7.7	7.9	11.0	5.7	9.1	9.5
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951010-36001028	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 44.0;liver: 47.7"	"Cell line enriched"	"Detected in single"	42	"RH-30: 24.7"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA047697: , HPA056290: "				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	5.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	44.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.2	0.1	6.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.2	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035017-36071358	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;T-47d: 5.7;THP-1: 12.9"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: "	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.1	1.1	0.1	0.0	0.2	6.4	1.6	0.1	0.6	0.1	0.1	0.5	0.4	0.0	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.6	5.6	0.8	0.1	0.0	0.5	0.0	0.2	0.0	0.0	1.7	0.2	2.0	0.6	0.0	2.9	0.1	0.0	0.1	14.4	0.1	0.0	0.3	1.4	0.1	13.2	0.0	37.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.4	5.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	4.0	0.0	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.6	0.5	0.0	2.0	0.0
UHRF1BP1	"C6orf107, dJ349A12.1, FLJ20302, ICBP90"	ENSG00000065060	"UHRF1 binding protein 1"	Q6BDS2	6	34792015-34883138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032099, HPA032100"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA032099: AB_10696057, HPA032100: AB_10671087"	"unprognostic (2.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (3.58e-2)"	"unprognostic (4.39e-3)"	"unprognostic (9.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.24e-2)"	7.6	9.3	7.6	7.6	8.2	18.7	6.7	18.5	10.9	4.8	5.9	7.1	4.7	5.1	5.5	4.4	6.0	5.3	4.5	13.7	6.1	5.8	6.1	10.9	8.0	6.9	5.5	6.8	6.6	13.1	15.1	9.5	8.1	7.7	6.0	6.3	6.8	8.6	5.1	22.2	4.9	5.5	6.4	7.6	6.8	7.2	22.5	5.5	8.5	9.4	3.2	6.8	5.9	10.8	1.5	1.2	1.1	4.5	1.4	1.3	0.8	8.3	6.0	5.4	17.4	2.8	2.1	9.7	4.9	3.3	4.8	6.8	11.9	2.2	12.6	5.4	5.1	6.4	19.5	2.8	6.6	6.5	6.3	11.2	5.8	9.9	11.6	10.1	7.0	4.7	8.2	3.8	8.2	6.0	18.7	5.0	2.1	8.0	7.8	6.6	2.4	4.2	4.7	8.6	7.6	6.5	7.8	6.5	6.6	12.4	6.5	16.6	12.4	13.3	3.7	2.4	8.8	3.7	5.4	7.5	11.7	8.1	1.3	14.2	5.9	0.5	1.2	1.1	1.3	1.7	1.3	1.3	1.2	1.3	1.2	1.5	0.6	1.0	0.7	1.4	4.5	0.5	0.4	0.8	7.6	8.2	18.5	10.9	6.1	5.8	5.5	6.8	7.7	5.5
UHRF1BP1L	KIAA0701	ENSG00000111647	"UHRF1 binding protein 1 like"	A0JNW5	12	100028455-100142848	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039671, HPA075150"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA039671: AB_10794201, HPA075150: "	"unprognostic (4.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.94e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-2)"	14.9	13.9	15.9	11.4	19.9	31.9	10.8	16.9	26.0	9.5	10.0	8.7	5.3	9.9	9.3	8.8	10.2	8.0	10.6	10.4	18.0	13.7	14.7	28.0	10.6	9.7	14.8	12.0	11.1	4.7	21.5	15.3	13.7	22.6	11.1	9.6	6.9	8.7	11.2	26.2	8.4	11.1	11.2	13.7	11.8	9.0	15.2	9.8	10.0	13.0	8.1	8.1	16.7	8.4	3.8	8.4	22.9	8.4	3.7	3.7	3.4	11.3	12.4	6.9	7.1	10.7	15.2	13.8	17.7	17.9	14.4	10.5	9.1	3.9	9.8	4.6	18.1	4.4	12.9	6.0	14.0	26.1	6.3	6.6	9.9	10.6	9.9	12.3	10.8	8.6	5.1	17.2	12.0	10.0	5.2	10.3	14.0	6.3	7.9	10.7	11.9	11.3	9.0	12.3	9.7	7.3	20.1	11.8	7.3	13.5	15.5	5.2	13.9	14.2	7.9	15.9	8.5	13.7	12.4	12.2	20.8	13.8	8.0	9.4	9.6	12.5	7.6	4.9	2.6	8.4	3.7	3.8	2.9	2.9	8.4	3.4	2.5	3.0	22.9	3.7	6.8	5.1	3.2	3.4	15.9	19.9	16.9	26.0	18.0	13.7	14.8	12.0	22.6	9.8
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149964007-149973710	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.9;lung: 9.7;testis: 10.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 23.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: "	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.7	0.6	2.0	0.4	0.6	0.5	0.5	13.9	1.5	0.4	0.7	0.2	0.0	0.4	0.5	0.5	0.8	0.9	0.5	1.2	1.5	0.3	1.2	0.9	9.7	0.2	0.3	0.0	1.2	0.4	0.6	0.6	1.3	1.0	0.8	0.4	0.5	1.0	0.2	1.6	0.6	0.3	0.3	1.2	0.3	0.9	10.5	0.2	0.2	3.8	0.6	0.5	0.7	4.9	0.7	0.1	0.9	1.8	0.3	3.5	0.3	2.7	1.3	2.7	1.4	2.7	7.9	2.8	3.7	1.1	1.7	2.9	1.8	3.2	2.8	2.9	12.8	2.7	23.7	4.6	4.4	12.4	3.9	0.2	0.9	0.0	14.0	0.1	1.0	8.6	5.8	11.7	3.1	2.4	2.3	0.0	4.1	3.3	2.9	0.0	1.0	4.3	1.2	2.4	0.4	5.0	2.1	0.9	0.3	5.4	3.4	0.8	2.7	5.5	1.9	1.3	2.3	5.2	3.2	0.4	0.4	2.5	8.2	4.1	3.4	0.1	0.2	0.1	2.4	1.3	3.5	0.7	1.2	2.8	0.1	0.2	0.7	1.2	0.9	0.3	1.8	0.0	1.9	0.3	2.0	0.6	13.9	1.5	1.5	0.3	0.3	0.0	1.0	0.2
ULK1	"ATG1, ATG1A"	ENSG00000177169	"Unc-51 like autophagy activating kinase 1"	O75385	12	131894651-131923167	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9;plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063990			Approved	Cytosol				Cytosol		"HPA063990: "	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.21e-3)"	"unprognostic (8.01e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.04e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.03e-2)"	"unprognostic (9.09e-3)"	"unprognostic (8.19e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.16e-1)"	10.9	18.6	14.6	9.2	49.6	33.2	8.9	24.0	24.4	14.4	11.8	6.9	13.3	11.7	16.5	10.7	9.8	10.6	16.2	17.4	11.5	8.3	9.0	15.8	9.0	8.3	7.9	12.0	18.2	59.6	13.8	23.8	17.2	11.6	13.4	4.0	13.9	18.1	13.4	33.4	24.3	11.5	10.2	5.4	16.5	11.4	11.4	11.4	13.8	10.7	9.6	6.5	12.1	10.9	0.6	6.4	6.9	1.7	0.2	0.8	0.6	5.1	16.6	7.7	9.6	3.5	2.8	10.5	8.2	5.9	3.5	2.8	3.6	5.3	1.4	8.6	5.7	5.1	1.7	3.2	1.0	5.5	10.0	3.4	13.6	4.8	6.5	2.5	7.6	5.2	9.0	3.9	1.6	4.3	4.5	4.1	2.3	11.7	15.3	14.5	8.5	15.9	11.6	2.8	6.8	2.0	6.4	19.6	10.8	8.7	9.0	4.5	13.7	16.8	8.2	8.4	5.0	14.6	3.7	18.3	6.6	1.8	14.2	4.3	9.6	0.2	1.7	2.3	0.8	0.7	0.2	0.1	0.7	0.7	0.3	0.6	0.5	0.5	6.9	0.2	0.7	6.4	0.5	0.6	14.6	49.6	24.0	24.4	11.5	8.3	7.9	12.0	11.6	11.4
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	4.3	4.8	5.1	4.7	8.3	10.3	4.2	4.3	5.4	11.9	2.8	5.9	6.0	2.1	10.7	10.9	2.8	12.3	3.1	13.1	5.2	3.0	5.4	3.4	5.5	4.2	3.1	4.2	4.5	3.6	13.5	19.7	9.0	5.8	4.4	2.8	6.7	4.2	4.5	1.4	3.5	3.3	5.1	5.7	4.4	3.4	27.5	3.4	6.3	7.1	1.7	8.4	4.0	6.0	6.4	5.1	10.7	6.3	2.6	10.3	5.2	7.2	1.7	2.6	3.0	1.1	1.7	4.5	2.5	2.6	3.0	2.6	0.9	2.1	8.4	1.4	5.7	3.7	3.2	1.9	2.8	1.1	0.9	1.6	5.3	2.8	3.9	5.5	1.7	1.6	2.2	14.7	3.0	2.1	1.8	7.0	2.2	5.8	6.9	4.4	3.2	3.0	1.5	8.4	3.7	6.4	7.0	1.3	9.7	2.5	1.2	2.0	2.9	1.8	6.1	1.9	2.2	13.0	2.0	4.2	7.9	3.5	10.8	5.8	2.3	5.7	5.8	5.8	8.0	6.3	6.5	5.6	8.6	7.2	5.1	6.4	6.5	9.2	10.7	2.6	3.2	4.6	10.3	5.2	5.1	8.3	4.3	5.4	5.2	3.0	3.1	4.2	5.8	3.4
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730366-124749273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Supported	Cytosol				Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	8.4	12.2	4.9	6.8	6.8	4.8	8.0	9.3	7.6	5.9	9.1	8.5	5.2	8.4	6.8	6.7	13.2	8.2	6.6	3.6	4.0	3.9	9.6	20.7	5.2	10.1	7.3	3.6	8.9	19.0	9.5	9.3	11.6	4.7	6.4	7.1	6.4	8.9	4.0	10.9	9.5	8.5	5.5	5.9	9.8	8.3	6.8	6.2	10.6	7.4	12.0	9.3	7.8	6.4	16.6	13.1	4.6	9.8	10.2	13.0	7.9	1.4	4.3	5.0	2.0	3.0	3.4	5.2	7.4	2.3	3.1	2.6	3.7	2.0	3.8	8.2	2.9	8.3	7.0	2.4	5.0	4.3	4.0	7.7	2.8	2.6	2.6	8.0	5.9	3.8	2.3	1.9	3.9	1.4	3.5	1.8	2.3	3.3	9.9	1.5	10.9	2.8	6.5	5.9	3.1	2.5	2.4	4.0	2.6	11.1	4.0	4.1	4.0	3.0	14.2	2.5	5.0	6.8	2.9	7.4	10.1	10.3	2.8	3.3	2.5	4.5	9.0	4.6	12.5	9.8	12.1	13.7	8.9	11.3	13.1	16.6	13.0	10.4	0.6	10.2	8.0	9.7	10.3	7.9	4.9	6.8	9.3	5.7	4.0	3.9	7.3	3.6	4.7	6.2
UNC119B	"MGC5139, POC7B"	ENSG00000175970	"Unc-119 lipid binding chaperone B"	A6NIH7	12	120710435-120723640	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077812	Enhanced		Approved	"Cytokinetic bridge,Mitotic spindle,Mitochondria,Cytosol"				"Cytokinetic bridge, Mitotic spindle"	"Mitochondria, Cytosol"	"HPA077812: "	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.26e-4)"	"unprognostic (9.35e-2)"	"prognostic favourable (6.69e-10)"	"unprognostic (2.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.42e-2)"	12.7	33.5	18.1	9.2	18.6	9.5	16.3	17.0	17.2	16.0	12.1	15.0	18.7	8.6	20.7	15.0	11.6	42.8	14.9	13.2	18.9	19.7	27.1	14.7	14.0	9.3	14.2	16.0	33.7	17.1	40.8	25.8	13.4	20.4	18.4	12.3	14.6	14.1	23.8	6.7	13.6	11.4	17.5	15.5	13.4	14.5	21.9	15.2	16.1	38.6	7.3	13.7	12.1	16.3	2.1	2.5	2.1	5.8	2.5	4.0	1.4	11.4	11.2	23.4	19.9	23.4	17.4	19.8	14.3	16.8	16.3	7.4	13.4	4.8	11.7	5.7	16.0	12.3	24.6	16.0	16.9	9.0	12.5	5.4	8.3	8.3	15.9	14.8	8.6	13.7	16.6	12.1	18.8	18.4	13.1	1.3	13.7	10.1	13.5	12.1	28.8	13.9	16.2	15.5	6.0	19.5	24.2	14.1	17.7	34.3	6.8	11.7	26.7	10.2	11.4	15.2	10.4	6.5	9.6	9.4	8.2	7.2	18.1	7.5	16.5	0.2	1.1	1.3	3.3	0.6	2.1	1.8	3.0	3.8	1.2	2.1	4.0	3.2	2.1	2.5	5.8	2.5	2.8	1.4	18.1	18.6	17.0	17.2	18.9	19.7	14.2	16.0	20.4	15.2
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.1"	"Cell line enhanced"	"Detected in many"		"HEL: 55.1;HMC-1: 57.1;SK-BR-3: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"	"Low region specificity"	"Detected in many"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol			14000000	Cytosol	Vesicles	"HPA067117: , HPA073525: "	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	4.5	3.3	2.9	17.1	5.2	31.3	4.5	4.1	3.1	5.2	5.2	2.8	1.4	4.5	3.8	1.8	11.5	5.2	8.7	13.0	1.8	1.6	2.6	4.9	30.1	24.9	4.5	1.6	8.7	5.5	0.3	5.3	67.1	3.2	3.1	2.6	2.6	8.0	3.9	3.2	3.0	7.6	2.8	3.7	33.8	7.2	2.2	3.3	23.6	2.4	9.3	24.7	7.0	8.2	4.0	6.9	24.8	13.6	8.2	11.5	7.9	8.3	3.2	0.0	0.0	0.1	0.2	10.4	0.0	0.0	0.0	0.0	8.0	18.8	0.7	10.0	0.0	2.9	0.0	0.5	0.0	0.1	0.1	55.1	24.4	5.1	0.9	20.9	57.1	0.1	0.4	0.1	0.5	3.7	19.0	0.2	0.0	14.2	22.1	10.5	0.2	0.4	7.1	0.2	0.3	0.3	3.3	0.0	15.3	3.6	39.1	0.2	10.5	11.9	10.4	0.1	14.8	0.1	0.0	0.3	1.3	0.8	0.1	6.7	0.0	24.8	8.0	16.4	11.5	9.4	10.4	4.0	6.7	8.1	6.9	2.2	5.3	6.9	22.4	8.2	13.6	4.0	6.0	7.9	2.9	5.2	4.1	3.1	1.8	1.6	4.5	1.6	3.2	3.3
UNC45A	"GC-UNC45, SMAP-1"	ENSG00000140553	"Unc-45 myosin chaperone A"	Q9H3U1	15	90930180-90954093	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039228	Approved		Supported	"Nuclear speckles,Cytosol"			21000000	"Nuclear speckles"	Cytosol	"HPA039228: "	"unprognostic (1.46e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-3)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.85e-2)"	"prognostic favourable (7.46e-7)"	"unprognostic (9.30e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-2)"	19.1	21.0	10.1	14.4	10.1	11.9	20.6	21.8	14.6	20.3	27.6	10.7	23.2	13.0	29.7	15.5	24.9	20.4	24.8	12.8	9.5	7.3	16.2	15.9	15.2	13.2	11.9	12.3	22.1	19.4	25.8	14.1	22.8	11.5	23.8	10.9	15.3	20.2	29.6	6.9	26.6	16.9	35.8	9.7	15.7	22.4	18.4	10.8	18.0	20.8	12.6	16.9	33.2	30.4	10.1	12.0	12.1	11.9	10.8	14.5	9.8	15.1	30.9	12.8	11.1	35.1	16.3	11.4	17.2	14.9	23.5	18.9	24.6	20.1	17.9	23.2	21.7	33.7	21.7	22.2	11.1	19.8	31.6	34.5	32.3	17.6	19.9	8.5	23.5	20.1	27.2	23.0	16.9	31.8	15.2	14.7	17.6	24.4	10.9	7.3	17.3	15.7	21.8	19.5	19.0	16.0	36.1	18.1	16.4	23.2	23.2	21.5	21.0	17.7	31.3	20.1	14.5	16.9	18.0	14.1	19.5	8.4	19.7	20.0	20.4	12.1	9.0	5.4	14.5	8.3	14.0	10.1	11.9	11.2	12.0	8.3	10.0	9.1	1.8	10.8	11.9	10.7	10.5	9.8	10.1	10.1	21.8	14.6	9.5	7.3	11.9	12.3	11.5	10.8
UNC45B	"CMYA4, UNC45"	ENSG00000141161	"Unc-45 myosin chaperone B"	Q8IWX7	17	35147817-35189345	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2"	"Group enriched"	"Detected in some"	11	"BEWO: 4.6;HSkMC: 6.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.9;testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017861			Supported	Cytosol				Cytosol		"HPA017861: AB_1847012"	"unprognostic (7.17e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.49e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.13e-6)"	"unprognostic (6.77e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	0.3	48.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.2	62.5	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.2	23.2	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	0.2	2.9	0.0	0.7	1.8	0.0	0.0	0.4	2.0	0.2	0.3	0.3	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNC5A	"KIAA1976, UNC5H1"	ENSG00000113763	"Unc-5 netrin receptor A"	Q6ZN44	5	176810477-176880898	"Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 11.9;brain: 35.3"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 43.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.8;eosinophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.8"	"Group enriched"	"Detected in all"	4	"amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1"	"Low region specificity"	"Detected in all"			HPA071450			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA071450: "	"unprognostic (5.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.18e-3)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.66e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.07e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.77e-5)"	"unprognostic (6.39e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.17e-2)"	0.9	11.9	10.5	1.1	11.1	1.2	1.4	35.3	30.9	1.1	0.7	0.4	0.0	1.3	0.8	0.9	0.7	1.5	1.0	0.7	7.6	4.6	0.7	0.7	0.9	1.7	1.6	12.6	0.9	3.2	0.6	5.1	0.6	2.1	0.8	0.7	0.3	0.9	0.7	0.6	0.7	0.9	0.8	0.8	0.6	1.2	1.3	0.5	0.0	0.8	0.0	0.7	0.9	0.2	0.0	0.0	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	1.2	5.0	0.0	43.3	1.9	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.3	1.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	10.5	11.1	35.3	22.2	7.6	4.6	1.6	12.6	2.1	0.5
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097574-109110992	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol				Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	16.3	44.1	17.0	19.4	17.0	10.0	22.8	10.5	14.4	13.5	20.3	10.2	21.4	12.6	11.8	10.8	22.5	11.8	11.0	15.4	13.5	13.1	20.4	23.3	7.1	12.1	19.6	12.2	12.3	12.7	17.3	8.9	18.6	12.0	12.9	22.1	10.7	16.6	19.7	29.1	22.5	13.5	11.0	19.7	13.2	12.3	35.6	9.8	35.1	25.1	19.8	19.0	11.5	14.4	9.8	3.9	5.8	3.0	8.7	19.5	7.9	20.0	20.6	19.8	18.0	33.1	9.5	19.0	11.9	8.1	18.8	14.4	16.3	13.8	26.3	17.9	10.6	12.7	21.9	12.3	18.3	22.3	40.7	25.7	11.9	27.6	4.9	38.2	15.9	8.5	11.3	9.0	5.0	13.5	20.8	8.8	12.6	25.0	35.1	45.1	35.3	31.8	32.3	29.9	22.4	11.7	25.3	28.3	15.7	21.3	18.4	10.3	34.2	17.9	6.9	16.3	14.6	10.7	16.4	17.2	37.0	50.0	12.4	25.7	19.8	5.8	1.5	2.7	13.4	3.0	19.5	9.8	15.9	15.5	3.9	9.2	10.3	11.5	0.0	8.7	3.0	2.8	14.0	7.9	17.0	17.0	10.5	14.4	13.5	13.1	19.6	12.2	12.0	9.8
UNK	"KIAA1753, ZC3H5, ZC3HDC5"	ENSG00000132478	"Unkempt family zinc finger"	Q9C0B0	17	75784771-75825799	"Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023636, HPA027962"	Uncertain		Supported	"Cytosol,Cytoplasmic bodies"				"Cytosol, Cytoplasmic bodies"		"HPA023636: AB_10601774, HPA027962: AB_10611522"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.04e-3)"	"unprognostic (9.51e-2)"	"prognostic favourable (2.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.73e-2)"	"unprognostic (9.78e-2)"	"prognostic favourable (6.58e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-2)"	11.6	11.7	13.0	17.8	14.6	13.9	15.5	19.5	14.5	17.8	11.2	15.0	17.6	12.5	18.7	16.1	13.5	17.0	15.4	10.6	13.0	8.7	12.3	11.8	18.4	17.6	14.5	14.3	24.5	18.2	18.5	20.7	13.4	11.2	15.6	6.8	22.2	19.6	16.3	15.0	25.1	13.7	14.3	9.7	21.2	12.9	22.1	16.4	15.6	17.5	8.2	16.1	13.8	15.2	2.8	1.9	0.4	1.1	1.3	2.3	1.5	6.3	10.2	11.4	9.6	3.6	3.4	9.3	4.3	4.6	4.8	5.9	3.7	7.4	13.7	3.7	4.6	5.9	5.7	5.1	2.2	7.0	18.8	8.5	8.2	7.9	4.9	6.5	10.9	6.7	3.1	4.1	4.5	6.3	4.4	6.8	3.8	12.7	14.5	9.0	4.9	6.8	15.4	11.4	6.9	4.5	6.9	10.6	20.7	5.6	7.8	15.0	9.5	10.1	4.5	11.5	6.3	5.0	5.5	11.8	3.4	7.5	8.3	4.2	7.0	0.3	1.1	0.4	2.3	0.7	2.3	1.1	1.3	1.4	0.7	2.8	2.1	2.0	0.4	1.3	0.9	1.9	1.3	1.5	13.0	14.6	19.5	14.5	13.0	8.7	14.5	14.3	11.2	16.4
UNKL	"C16orf28, FLJ23360, ZC3H5L, ZC3HDC5L"	ENSG00000059145	"Unkempt family like zinc finger"	Q9H9P5	16	1363205-1414751	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA055801, HPA073949"	Uncertain		Supported	Cytosol				Cytosol		"HPA055801: , HPA073949: "	"unprognostic (5.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-3)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.55e-1)"	9.6	10.0	14.0	10.4	12.9	12.1	10.1	27.9	16.3	10.5	7.3	9.3	10.2	11.0	15.2	7.9	6.0	11.0	5.0	5.7	12.2	4.5	6.3	4.8	9.1	11.7	9.2	8.3	18.9	10.1	6.5	7.2	9.0	10.1	10.5	4.4	9.3	12.3	12.7	14.4	10.5	10.6	7.2	5.6	14.3	9.9	8.4	11.7	11.0	11.7	7.0	7.6	10.8	9.3	1.9	3.2	7.6	2.1	2.4	3.7	1.3	3.4	9.0	2.0	5.1	1.8	2.0	16.0	8.5	2.6	2.5	2.0	6.6	7.3	1.3	18.2	3.0	6.2	2.6	0.8	1.7	15.6	7.7	2.3	9.2	5.9	1.2	1.2	5.5	2.5	1.2	3.7	1.6	4.3	7.1	4.8	1.1	5.2	3.8	4.1	5.7	10.1	10.1	1.9	9.2	1.4	0.7	6.9	4.1	4.4	3.2	0.6	5.0	2.1	3.8	5.3	7.7	4.4	3.6	10.2	5.6	6.0	4.3	2.9	5.9	5.7	2.1	4.5	3.7	0.7	2.1	1.5	1.5	0.9	0.7	1.9	2.8	1.4	7.6	2.4	0.7	3.2	1.6	1.3	14.0	12.9	27.9	16.3	12.2	4.5	9.2	8.3	10.1	11.7
UPF2	"DKFZP434D222, KIAA1408, RENT2, smg-3"	ENSG00000151461	"UPF2, regulator of nonsense mediated mRNA decay"	Q9HAU5	10	11920022-12043170	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067008			Supported	"Cytosol,Cytoplasmic bodies"				Cytosol	"Cytoplasmic bodies"	"HPA067008: "	"unprognostic (1.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.48e-2)"	15.8	8.7	12.9	18.9	18.1	19.2	13.4	19.7	14.2	22.5	25.5	8.1	14.6	10.2	15.8	14.2	17.2	11.7	9.2	12.7	13.8	11.9	14.5	20.2	12.8	17.8	13.6	10.0	17.8	14.1	20.1	22.3	18.1	13.4	24.5	13.8	7.4	12.2	20.0	33.5	14.5	19.2	19.8	19.3	20.1	12.0	19.4	17.5	28.8	23.0	16.0	17.7	25.5	13.5	7.9	8.4	21.8	3.2	3.7	4.2	1.2	19.0	12.1	10.4	12.9	7.9	10.2	11.8	14.9	6.9	10.7	12.9	11.3	15.6	27.4	5.1	12.4	16.0	14.9	13.5	15.4	17.2	8.6	32.8	9.9	10.3	9.0	14.7	22.2	7.6	10.6	13.5	9.2	13.0	19.4	14.1	12.2	9.3	18.2	8.7	9.9	6.5	16.1	12.5	13.5	10.2	7.7	6.8	7.3	11.8	12.7	12.8	15.4	19.9	13.8	8.4	17.7	17.2	11.3	13.0	10.2	22.7	13.5	14.4	6.6	8.3	3.2	7.1	3.3	3.0	3.2	7.3	3.8	3.4	2.1	7.9	4.2	3.4	21.8	3.7	2.0	8.4	2.7	1.2	12.9	18.1	19.7	14.2	13.8	11.9	13.6	10.0	13.4	17.5
UPF3A	"HUPF3A, RENT3A, UPF3"	ENSG00000169062	"UPF3A, regulator of nonsense mediated mRNA decay"	Q9H1J1	13	114281584-114305817	"Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018325, HPA061316"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA018325: AB_1858638, HPA061316: "	"unprognostic (9.08e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.44e-1)"	"prognostic favourable (7.09e-5)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (3.71e-4)"	11.3	16.3	16.9	10.9	20.2	11.9	10.9	32.8	21.9	10.4	9.9	18.6	13.0	13.8	13.1	12.3	10.1	13.2	9.2	7.1	16.1	14.9	11.0	7.5	9.2	12.0	20.2	16.0	12.7	15.4	8.1	12.8	8.5	17.2	12.1	8.7	10.0	11.9	16.1	16.1	11.9	11.9	10.2	23.6	11.8	11.2	34.5	16.7	10.7	24.0	7.4	7.9	11.2	9.3	11.7	15.6	4.1	5.5	11.1	9.5	4.3	23.0	6.8	15.1	13.5	7.2	12.7	9.7	17.9	12.9	11.5	12.9	10.3	8.2	22.7	5.2	8.2	12.5	7.4	5.9	14.5	16.6	14.6	19.5	19.4	11.3	12.6	33.9	8.8	8.5	12.3	7.7	9.0	9.1	11.9	10.6	11.4	7.0	13.8	9.1	20.1	6.8	18.0	8.5	13.2	10.2	7.4	17.2	19.0	14.2	22.0	12.8	16.3	30.4	11.6	12.2	20.5	6.6	11.1	23.1	16.0	31.4	22.5	19.5	10.0	1.9	5.5	4.1	6.8	4.4	5.3	11.7	7.1	7.0	6.0	9.1	7.4	6.7	0.8	11.1	5.1	15.6	9.5	4.3	16.9	20.2	32.8	21.9	16.1	14.9	20.2	16.0	17.2	16.7
UPF3B	"HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B, regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: , HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavourable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavourable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.7	10.3	19.4	11.5	21.9	14.5	10.8	34.1	24.0	10.2	13.0	9.3	12.8	14.2	14.6	13.5	13.0	8.8	8.4	7.8	16.9	17.5	10.0	12.4	9.0	17.2	16.5	21.7	14.8	8.7	14.3	26.7	10.5	17.2	12.4	13.2	9.1	9.7	14.4	14.5	18.6	11.1	14.2	21.7	12.9	9.9	15.0	21.0	9.9	12.5	11.5	18.3	12.6	12.9	17.5	10.0	7.1	5.9	7.9	8.1	2.7	11.6	7.1	14.8	12.0	6.7	4.4	9.5	11.3	6.3	8.8	7.8	13.3	8.4	21.1	9.6	4.7	11.2	19.1	6.7	11.3	12.0	14.0	19.5	23.5	6.9	7.7	21.1	9.7	3.8	5.1	15.1	18.5	8.2	18.8	17.6	7.3	14.2	14.8	26.5	28.5	19.4	14.5	16.9	15.4	7.2	5.9	19.7	13.6	23.0	9.3	16.8	4.9	12.3	7.1	9.2	7.1	14.7	23.8	9.7	10.8	28.5	7.4	31.0	10.7	7.1	5.3	6.8	7.5	5.1	5.7	13.8	7.0	5.9	3.8	17.5	7.6	8.1	5.9	7.9	5.9	10.0	7.8	2.7	19.4	21.9	34.1	24.0	16.9	17.5	16.5	21.7	17.2	21.0
UQCC3	"C11orf83, UNQ655"	ENSG00000204922	"Ubiquinol-cytochrome c reductase complex assembly factor 3"	Q6UW78	11	62670273-62673687	"Disease related genes, Predicted membrane proteins"	"ATP synthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046851	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA046851: "	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (2.55e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.70e-3)"	"unprognostic (7.84e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.36e-1)"	10.0	13.4	8.9	11.4	8.5	10.6	14.7	8.7	9.9	7.3	15.4	4.7	19.7	16.5	7.3	8.5	14.5	6.5	12.4	13.2	8.0	8.7	10.7	13.4	5.6	8.3	8.5	8.7	9.5	15.4	5.3	7.6	6.2	7.7	12.3	4.9	7.1	22.9	14.1	27.8	8.6	14.8	6.0	6.2	9.6	12.2	5.7	5.4	6.4	13.5	12.3	9.1	8.0	18.1	23.7	21.2	15.2	20.8	14.0	19.4	15.5	11.8	24.1	3.5	5.5	2.2	2.2	3.0	4.7	1.6	3.6	3.5	14.1	10.4	7.7	9.8	1.6	11.8	3.4	5.5	1.1	3.9	12.5	4.4	12.7	9.0	3.0	7.0	3.5	2.1	4.7	3.1	3.6	2.7	9.3	5.6	1.9	36.3	6.8	17.3	3.9	13.7	7.9	5.4	13.7	2.7	5.9	7.2	7.3	5.2	19.1	7.0	18.2	6.6	3.5	7.8	9.1	8.1	10.5	8.7	4.7	7.9	6.4	6.1	5.6	9.1	20.8	15.2	18.1	14.4	17.1	23.5	18.0	15.9	15.8	23.7	16.6	13.3	8.9	14.0	12.7	21.2	19.4	15.5	8.9	8.5	8.7	9.9	8.0	8.7	8.5	8.7	7.7	5.4
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.7"	"Cell line enhanced"	"Detected in all"		"PC-3: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria,Cytosol			1300000	Mitochondria	Cytosol	"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favourable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	18.1	13.7	11.1	9.8	12.5	9.4	11.8	12.5	20.5	11.0	33.7	6.9	10.4	20.0	9.1	9.7	15.8	12.4	10.8	66.7	10.8	11.2	23.0	30.5	7.7	9.3	13.3	13.5	6.3	14.4	20.4	7.8	11.5	13.3	12.5	12.3	7.8	19.5	21.9	172.7	14.0	20.9	12.0	8.7	8.4	23.0	18.4	7.4	9.4	9.1	39.9	9.8	10.3	9.1	23.3	52.7	28.1	57.8	15.1	22.0	74.3	10.0	16.2	5.9	3.6	8.7	8.0	26.7	18.5	15.0	15.4	14.0	25.2	3.0	25.9	11.7	8.3	9.7	7.4	21.5	2.8	15.4	35.5	26.6	14.1	27.4	17.3	16.7	11.5	11.0	24.4	10.5	17.2	15.2	14.3	1.7	9.3	17.4	12.0	19.1	14.8	64.6	8.2	15.7	21.2	15.9	11.0	6.3	11.2	25.1	3.0	14.8	6.4	2.6	15.3	4.3	16.3	13.4	19.1	15.8	13.9	15.0	9.4	19.3	13.7	17.6	57.8	28.1	18.9	56.9	17.9	23.3	18.9	19.0	52.7	18.6	17.1	16.4	14.1	15.1	48.5	21.0	22.0	74.3	11.1	12.5	12.5	20.5	10.8	11.2	13.3	13.5	13.3	7.4
URGCP	"DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4"	ENSG00000106608	"Upregulator of cell proliferation"	Q8TCY9	7	43875894-43926411	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019879, HPA020134, HPA029468"	Approved		Supported	Cytosol				Cytosol		"HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.23e-3)"	"unprognostic (3.71e-1)"	"prognostic favourable (1.90e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.69e-3)"	13.7	27.1	18.5	13.4	21.4	8.6	13.4	28.3	29.5	15.8	18.2	18.6	14.8	22.2	18.3	15.1	13.8	15.6	11.6	19.3	18.3	15.9	20.4	21.3	12.1	9.5	13.8	19.5	21.6	18.4	22.5	22.1	14.4	17.9	17.7	19.6	19.8	18.4	17.1	26.8	17.4	21.0	19.1	10.9	13.8	12.8	7.0	17.2	8.3	14.6	7.9	12.5	15.0	12.3	6.1	9.8	5.8	7.5	2.6	11.9	6.1	13.8	13.0	5.2	16.8	14.3	13.2	5.1	15.4	30.6	18.8	19.2	10.8	11.4	8.3	8.8	16.5	22.5	14.8	12.4	18.5	15.6	8.5	5.6	12.9	9.3	15.2	8.7	10.8	10.1	15.3	14.8	14.4	9.3	14.1	6.5	12.5	10.6	9.0	7.4	9.9	12.3	12.7	7.2	11.4	17.9	14.2	13.8	23.3	17.4	26.0	8.1	13.2	10.5	8.6	10.6	4.7	11.8	12.8	17.9	25.9	10.4	12.3	13.7	20.1	2.6	4.5	5.8	9.0	7.3	9.9	6.1	9.6	11.9	9.8	5.6	10.6	9.3	0.5	2.6	7.5	1.5	9.6	6.1	18.5	21.4	28.3	29.5	18.3	15.9	13.8	19.5	17.9	17.2
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1, prefoldin like chaperone"	O94763	19	29923644-30016608	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA071709: "	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	16.4	21.2	19.7	15.9	21.5	17.8	21.0	21.7	19.8	18.4	18.0	18.9	16.6	12.9	19.7	19.4	20.5	17.7	14.2	17.5	19.2	16.5	16.6	22.9	13.0	20.7	22.7	15.4	26.3	21.8	21.8	28.8	15.0	21.1	22.6	18.8	12.7	16.7	18.5	45.0	25.3	17.7	15.7	28.3	18.7	14.0	69.2	22.8	21.0	32.1	14.5	20.3	18.6	17.2	6.6	3.1	3.8	2.5	3.7	6.2	1.4	22.6	30.9	14.5	22.5	10.3	15.1	24.5	14.8	12.6	10.9	12.5	16.2	15.0	35.3	29.5	17.2	16.1	30.7	19.0	24.8	24.5	17.5	32.1	15.3	20.9	15.0	30.8	13.8	13.2	26.1	9.4	35.7	8.0	38.0	9.9	13.6	19.4	20.1	13.0	13.5	9.5	19.9	26.9	14.2	7.2	26.9	23.4	18.4	17.0	20.6	21.7	8.5	19.5	10.5	26.9	23.9	13.1	22.4	27.5	29.6	23.9	13.2	27.2	16.1	3.8	2.4	3.2	5.7	2.5	4.8	3.5	5.1	5.8	2.0	6.6	6.2	6.1	0.3	3.7	2.3	3.1	3.8	1.4	19.7	21.5	21.7	19.8	19.2	16.5	22.7	15.4	21.1	22.8
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45012147-45015575	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol			5200000	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: "	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	20.7	50.2	23.1	12.2	26.2	67.5	20.7	14.2	28.6	17.7	24.2	16.5	25.9	11.2	27.8	22.6	17.8	20.8	17.4	34.0	21.1	20.3	29.6	58.1	14.3	14.8	21.6	22.9	27.4	18.4	35.9	17.6	25.8	16.2	19.2	12.3	24.3	45.6	19.2	28.8	12.1	13.2	22.9	18.9	16.6	15.0	16.3	11.5	17.2	26.3	23.6	16.0	15.0	13.0	25.7	48.6	20.6	36.3	26.0	27.4	35.6	12.5	8.2	13.2	17.3	22.8	21.5	6.4	15.3	39.6	32.3	24.9	11.8	6.6	8.9	16.2	23.2	6.5	25.1	29.9	22.5	7.9	26.4	46.0	19.0	39.1	26.6	14.0	8.6	22.3	19.0	30.8	25.0	41.4	79.8	9.8	30.8	10.5	9.5	12.1	20.5	29.1	14.4	19.6	12.9	28.1	10.6	14.1	11.1	16.8	12.6	25.9	9.9	14.7	26.8	18.4	14.4	6.3	24.7	10.2	10.9	7.5	28.8	21.3	9.2	17.6	36.3	20.6	19.7	25.8	20.0	25.7	23.8	19.2	48.6	23.7	22.3	20.3	6.6	26.0	15.5	32.4	27.4	35.6	23.1	26.2	14.2	28.6	21.1	20.3	21.6	22.9	16.2	11.5
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823248	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol			15000	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	13.8	16.1	48.6	9.0	46.6	33.2	13.9	12.8	35.3	8.9	11.4	15.7	12.8	13.2	9.3	41.2	10.5	11.3	11.5	31.4	36.9	20.4	22.6	25.5	10.0	16.8	22.7	23.4	14.5	14.1	14.4	12.0	7.9	20.0	12.9	12.4	14.0	18.1	14.0	45.6	9.8	12.0	13.0	12.5	11.7	12.5	13.8	13.8	10.8	16.4	14.4	12.7	9.4	6.3	17.3	27.1	2.4	15.6	24.7	21.3	17.8	17.4	18.9	13.8	30.7	18.5	18.8	18.6	22.6	39.1	15.9	15.9	8.2	21.3	24.4	10.6	28.0	10.0	8.0	16.1	15.0	30.1	15.2	51.8	10.7	13.5	26.1	21.8	12.2	23.5	9.2	11.1	29.8	14.5	8.9	23.2	26.5	20.8	19.1	24.6	15.0	19.8	13.5	15.3	14.5	20.8	10.9	10.8	18.6	22.6	17.4	30.7	15.6	20.8	14.4	21.1	7.9	16.2	19.1	21.4	15.5	16.6	29.4	8.9	10.0	2.4	15.6	2.2	16.1	15.4	18.5	15.7	16.0	20.4	27.1	17.3	21.3	16.3	1.2	24.7	14.6	12.9	14.2	17.8	48.6	46.6	12.8	35.3	36.9	20.4	22.7	23.4	20.0	13.8
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.0;intestine: 57.0;kidney: 22.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 35.2;HeLa: 12.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favourable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.1	0.1	1.6	4.3	7.1	0.0	0.0	0.8	3.3	0.1	23.8	6.2	0.0	40.5	0.0	6.3	0.0	1.3	26.0	0.3	5.0	2.3	22.1	0.4	0.0	0.0	4.8	1.9	0.3	2.1	0.0	5.2	0.0	3.5	0.1	20.7	1.8	0.0	0.1	0.0	0.0	57.0	0.9	10.2	0.0	11.5	0.2	3.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	35.2	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	7.1	0.8	2.3	5.0	2.3	4.8	1.9	3.5	3.6
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699978-84779922	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 105.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favourable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	13.9	18.8	16.0	24.2	19.0	13.4	14.4	24.4	20.4	15.9	18.1	15.6	8.4	16.1	20.2	10.4	19.7	18.2	12.0	16.4	19.3	15.1	16.4	20.7	13.7	18.8	19.7	17.4	18.5	17.1	35.8	15.0	23.5	16.2	15.0	15.6	17.9	15.3	17.8	47.0	17.0	17.5	20.2	16.3	16.0	15.0	15.5	16.2	20.4	17.6	15.7	20.9	19.7	15.8	7.2	10.4	105.5	8.6	7.7	17.3	10.0	13.6	18.9	18.4	22.8	6.8	11.6	24.9	13.5	14.3	22.9	12.6	26.6	11.9	23.7	15.7	14.1	15.7	25.5	21.5	30.5	9.6	13.4	13.6	8.9	17.6	9.0	20.2	8.3	7.3	16.6	23.9	27.7	17.5	37.1	5.2	15.8	28.6	20.9	9.8	22.1	12.8	27.2	10.1	11.2	14.4	11.1	17.2	10.1	32.3	10.5	9.1	24.1	12.9	12.8	15.9	12.7	8.0	12.8	8.7	12.1	60.1	10.3	13.0	16.3	2.5	8.6	1.6	5.7	7.0	6.8	7.2	17.3	6.3	10.4	6.7	9.9	6.0	105.5	7.7	6.3	3.5	6.1	10.0	16.0	19.0	24.4	20.4	19.3	15.1	19.7	17.4	16.2	16.2
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179652755-179789401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.8;skeletal muscle: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"MAIT T-cell: 15.4"	"Lineage enriched"	"Detected in many"	8	"T-cells: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (3.06e-4)"	6.4	7.5	2.0	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2.0	2.3	2.3	3.4	6.0	2.5	2.1	2.1	7.2	3.0	3.3	9.8	1.9	3.0	3.0	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2.0	1.9	0.0	0.4	0.0	15.4	0.7	12.3	5.3	10.1	7.7	4.6	6.4	4.9	7.3	8.4	10.8	9.1	7.8	4.4	15.3	8.2	8.8	0.9	11.3	4.4	12.9	36.2	4.8	4.0	8.0	7.3	3.3	11.2	0.0	6.8	1.6	8.4	10.7	8.6	1.9	19.8	8.9	8.1	6.8	2.0	7.8	4.8	11.7	10.0	12.5	7.3	3.5	5.7	7.4	7.0	9.4	4.2	16.2	8.1	9.3	13.0	10.4	11.1	28.1	9.6	8.0	31.4	6.0	7.6	12.1	0.0	0.2	0.0	1.3	0.4	15.4	2.0	1.3	2.9	1.5	0.6	1.0	1.0	0.0	0.0	0.4	1.9	0.6	0.7	2.0	2.8	2.9	4.1	2.0	2.3	2.1	2.1	3.0	1.3
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	Cytosol			1400000	Cytosol		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (7.81e-5)"	"prognostic unfavourable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favourable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	24.8	24.2	25.9	20.7	32.1	19.4	21.7	21.7	28.4	16.5	17.1	17.9	19.1	13.4	19.4	24.3	25.3	14.7	14.4	23.3	22.1	27.6	23.2	24.4	15.8	21.9	22.6	28.8	16.2	16.2	22.3	18.0	25.1	29.2	29.9	19.4	14.5	16.7	20.5	53.3	15.7	12.9	23.9	22.1	15.4	15.6	17.2	16.5	19.5	20.1	25.4	28.6	17.8	17.8	13.1	15.2	7.7	15.2	23.0	21.2	11.0	26.8	22.1	18.8	19.1	18.7	18.7	33.7	35.3	19.4	36.0	33.6	28.7	14.4	39.9	27.0	28.9	15.1	37.1	27.0	41.1	11.3	18.3	22.5	14.8	22.5	18.7	55.2	21.6	14.9	20.9	36.7	21.1	27.6	31.0	29.7	35.4	21.8	30.8	15.1	18.4	26.0	25.7	24.7	29.1	26.6	23.3	22.0	18.5	36.6	17.7	15.0	17.3	14.9	31.2	42.3	32.0	38.8	50.0	19.6	35.6	39.7	24.4	23.0	26.3	5.0	10.7	7.7	17.8	15.2	21.2	13.1	17.7	18.4	15.2	10.1	17.5	16.9	0.8	23.0	11.4	11.1	16.7	11.0	25.9	32.1	21.7	27.1	22.1	27.6	22.6	28.8	29.2	16.5
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 68.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Enhanced	Cytosol			280000	Cytosol		"HPA006237: AB_1080502, HPA006428: , HPA071014: "	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavourable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	23.1	16.8	11.5	22.5	11.9	88.9	17.8	21.1	15.7	14.5	14.5	5.2	11.9	11.4	12.7	12.4	16.1	14.1	11.2	15.2	9.6	6.2	13.8	20.4	23.8	26.2	11.6	9.4	22.5	15.8	18.9	22.5	31.0	14.9	12.4	13.8	7.6	16.2	10.7	28.5	23.0	19.7	16.3	16.2	35.6	14.3	20.0	11.0	33.1	14.1	15.4	18.9	18.4	17.9	5.7	6.0	68.5	14.2	3.3	12.1	4.8	9.3	8.8	8.8	7.6	13.9	16.3	15.7	15.2	13.5	13.5	12.1	8.8	9.4	10.0	8.7	13.0	10.2	11.7	13.2	15.8	11.0	7.2	13.7	7.5	6.7	13.5	21.7	33.4	11.8	13.8	15.9	14.2	15.9	44.4	19.4	12.4	10.4	12.9	11.0	12.9	13.0	8.3	9.3	16.1	12.5	10.8	11.1	5.3	17.6	11.2	8.6	14.7	13.0	19.0	10.5	10.5	16.3	9.4	9.2	10.2	11.4	12.0	17.7	11.8	27.2	14.2	13.8	3.4	7.3	3.5	5.7	4.6	3.2	4.9	4.7	5.9	3.5	68.5	3.3	5.8	6.0	12.1	4.8	11.5	11.9	21.1	15.7	9.6	6.2	11.6	9.4	14.9	11.0
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	25.4	21.7	24.4	27.4	24.2	20.4	22.8	32.4	23.1	24.2	24.3	13.5	23.6	20.4	22.6	28.2	27.1	19.4	17.0	23.8	23.8	22.6	28.4	34.0	16.8	20.7	25.8	19.5	27.3	23.6	31.6	41.6	45.9	25.3	26.0	22.3	13.3	20.6	28.8	35.8	16.1	33.2	26.2	28.6	29.1	20.8	20.1	25.3	37.6	28.4	25.6	25.5	30.8	17.1	30.9	23.5	21.2	20.5	19.9	26.2	10.1	21.8	8.7	13.9	12.5	9.9	16.3	13.1	21.3	14.2	14.8	14.1	10.9	14.2	22.3	6.5	20.4	10.0	17.2	15.5	19.4	21.3	18.3	29.7	10.6	12.1	14.7	29.1	16.5	13.9	16.4	19.3	17.8	14.2	24.4	39.4	17.1	10.0	17.9	10.6	14.8	11.3	12.0	34.3	25.5	12.2	15.8	15.1	16.1	13.8	22.1	18.7	15.2	20.0	14.2	17.3	21.6	15.9	21.9	33.7	46.2	23.4	18.1	21.2	17.2	21.2	16.2	20.9	25.4	16.1	19.8	26.4	23.9	22.8	14.9	30.9	26.2	24.8	15.5	19.9	20.5	23.5	24.5	10.1	24.4	24.2	32.4	23.1	23.8	22.6	25.8	19.5	25.3	25.3
USP18		ENSG00000184979	"Ubiquitin specific peptidase 18"	Q9UMW8	22	18149899-18177397	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 48.0;BJ hTERT+ SV40 Large T+ RasG12V: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA044768	Uncertain		Approved	Cytosol				Cytosol		"HPA044768: AB_10963697"	"unprognostic (2.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.38e-2)"	20.4	6.4	4.8	13.0	4.8	6.3	15.4	1.9	5.5	5.3	6.3	5.6	3.2	5.2	6.1	9.5	6.0	6.5	7.1	5.4	4.4	4.6	8.8	20.9	14.0	15.9	4.3	4.8	4.9	4.2	3.8	7.8	7.6	4.7	4.8	3.9	5.7	11.7	2.3	9.7	4.2	15.5	4.5	4.1	10.6	6.4	10.6	4.0	22.4	10.6	2.9	7.7	4.3	6.9	4.1	2.9	6.6	8.8	11.0	11.0	4.8	3.7	3.7	1.1	4.8	4.9	3.6	4.9	1.9	4.5	48.0	52.3	0.6	5.2	0.0	2.9	1.0	1.3	5.6	1.6	1.6	16.4	7.8	7.2	0.5	6.8	0.5	1.7	6.9	1.6	0.6	3.4	0.0	10.6	0.3	0.4	0.4	6.3	8.3	4.2	3.4	2.9	3.3	7.5	0.0	0.9	3.1	4.0	3.2	2.3	3.9	17.8	2.6	1.7	17.4	0.3	0.9	1.1	1.9	0.9	11.2	0.0	4.3	4.3	2.7	2.7	3.2	6.6	7.8	8.8	10.0	4.1	6.7	10.1	1.6	2.7	7.9	8.8	0.5	11.0	6.6	2.9	11.0	4.8	4.8	4.8	1.9	4.0	4.4	4.6	4.3	4.8	4.7	4.0
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381726	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 79.9"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favourable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	3.1	4.8	6.9	1.4	12.2	1.5	1.6	12.6	16.1	2.5	5.9	10.0	0.0	7.9	2.6	6.4	5.9	7.0	2.2	26.8	5.7	3.1	29.7	10.6	2.2	0.7	5.7	6.2	2.9	10.1	18.4	7.6	1.3	6.7	2.3	3.9	19.1	3.2	2.4	79.9	4.6	11.7	4.2	3.8	0.8	2.7	36.1	8.8	0.0	2.2	25.2	1.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	3.4	0.3	0.5	1.9	0.1	0.1	0.7	0.4	0.2	0.0	0.3	3.6	0.5	5.9	1.1	0.6	0.6	4.7	1.7	0.1	4.2	0.6	1.7	2.5	7.3	1.6	0.0	1.6	0.6	0.3	0.4	1.2	0.3	8.2	0.5	1.0	2.4	0.0	0.4	0.9	0.7	0.0	1.3	0.8	2.7	0.2	7.2	2.2	2.0	1.6	0.4	5.3	3.6	0.0	0.0	0.9	0.5	0.5	34.4	7.6	0.1	0.0	1.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.3	0.3	6.9	12.2	12.6	16.1	5.7	3.1	5.7	6.2	6.7	8.8
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881838	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 30.4;MOLT-4: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favourable (8.01e-4)"	"prognostic unfavourable (2.48e-4)"	"prognostic favourable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favourable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favourable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	7.8	13.2	10.5	15.2	14.6	24.4	8.5	23.0	19.6	13.2	12.1	12.7	10.2	9.7	13.3	6.2	9.3	11.6	12.5	8.8	10.5	13.7	8.0	7.3	9.1	19.6	9.6	16.1	16.8	12.9	11.5	19.0	8.0	11.9	14.9	6.1	10.8	13.7	17.2	10.2	14.0	11.8	20.0	8.8	14.6	10.2	14.0	8.8	51.5	19.3	4.2	15.3	15.6	10.0	3.8	2.4	4.8	1.7	9.0	10.7	5.4	3.0	2.9	5.2	7.0	6.8	5.8	7.4	4.9	4.1	3.7	2.6	2.4	3.3	4.1	4.2	4.7	7.6	3.1	3.5	1.5	22.2	4.1	7.6	8.0	1.6	4.8	7.1	5.7	5.1	5.1	4.9	3.7	4.0	30.4	5.1	2.2	8.0	27.8	16.9	4.1	7.0	4.7	5.8	7.0	2.9	3.3	1.1	5.8	5.7	7.2	4.6	7.5	10.0	5.9	4.1	1.9	5.5	3.2	5.1	7.4	2.9	8.2	9.4	3.8	1.0	1.7	4.8	8.6	1.4	9.3	3.7	8.8	8.3	2.4	3.8	10.4	8.9	2.8	9.0	1.3	2.1	10.7	5.4	10.5	14.6	23.0	19.6	10.5	13.7	9.6	16.1	11.9	8.8
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favourable (3.35e-5)"	11.8	16.4	22.1	12.8	21.2	15.3	19.1	23.6	24.8	18.1	16.1	25.5	14.0	15.5	19.7	14.6	18.3	33.3	14.1	13.7	20.9	12.1	15.4	10.6	14.0	16.7	26.4	14.1	28.3	19.0	24.4	17.2	15.2	20.5	18.1	13.1	17.1	19.0	25.3	19.4	23.5	15.4	15.1	17.0	18.7	16.0	17.0	22.9	16.0	24.5	9.6	15.6	17.9	19.2	14.1	12.0	18.3	11.1	13.4	17.2	10.7	7.4	12.8	16.9	16.3	13.5	11.3	10.4	5.5	9.0	15.2	11.9	11.8	14.7	9.7	9.5	6.8	12.9	10.9	10.7	8.4	18.5	18.3	11.6	18.5	9.2	9.7	10.3	8.7	9.5	14.4	10.4	15.0	10.7	17.1	13.6	9.6	13.7	18.2	16.2	15.8	16.3	17.3	5.6	16.3	8.9	8.9	15.4	19.8	10.3	10.8	8.3	23.8	16.6	6.2	10.9	9.7	7.6	9.4	27.5	21.3	14.4	10.0	8.9	9.8	13.0	11.1	18.3	14.9	7.1	17.2	12.8	13.8	15.4	12.0	14.1	16.0	14.6	9.6	13.4	7.7	12.0	13.3	10.7	22.1	21.2	23.6	24.8	20.9	12.1	26.4	14.1	20.5	22.9
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215113	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 46.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: "	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavourable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	12.3	7.6	7.5	12.1	8.8	30.1	10.6	20.1	8.5	7.8	10.2	6.8	10.6	5.0	10.1	7.0	7.7	6.9	7.0	14.7	7.9	6.4	10.4	9.3	7.6	12.7	8.0	5.6	10.9	7.3	15.5	16.9	5.8	6.9	7.6	8.5	5.1	9.7	10.7	46.0	8.9	8.7	7.3	6.2	10.9	7.8	4.9	8.7	16.4	7.4	11.5	12.7	9.7	13.7	6.0	10.5	5.9	2.2	3.8	4.5	1.1	17.8	9.8	12.3	6.7	16.1	14.1	14.2	7.9	10.0	11.4	11.9	14.0	6.3	14.3	8.8	14.6	14.5	16.3	13.3	17.9	15.0	9.9	28.7	21.5	16.3	9.6	19.7	22.3	12.3	11.9	17.3	19.7	10.3	26.4	6.0	15.2	4.2	11.9	10.5	18.1	11.9	12.3	15.7	6.2	19.8	12.1	10.9	7.6	13.5	9.7	11.8	6.7	9.8	13.9	10.4	10.1	12.5	12.6	7.6	5.7	18.8	9.9	16.5	9.3	5.9	2.0	2.5	4.5	1.8	2.8	4.8	3.5	3.5	1.8	6.0	3.2	4.2	2.3	3.8	2.2	10.5	1.9	1.1	7.5	8.8	20.1	8.5	7.9	6.4	8.0	5.6	6.9	8.7
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol				Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	14.9	8.5	11.0	14.2	15.5	12.4	28.7	11.3	11.1	17.5	11.8	6.6	17.8	6.5	20.7	14.5	12.6	10.6	10.1	17.8	9.9	5.8	12.9	10.4	22.1	14.8	7.6	7.1	14.5	8.2	8.1	8.4	17.7	7.7	12.9	8.6	7.8	11.4	13.6	56.3	8.3	12.3	19.2	7.3	11.6	9.0	26.1	7.5	16.5	10.5	14.6	9.6	13.8	18.1	3.1	2.8	5.8	2.9	2.3	7.2	1.6	13.0	9.9	9.4	1.4	17.3	25.9	11.0	9.4	9.4	7.0	8.9	8.6	7.5	14.1	13.9	14.8	7.0	7.2	12.4	9.7	14.0	8.2	11.5	10.5	6.6	28.8	15.2	5.3	16.8	15.2	11.3	32.7	24.5	14.8	26.6	12.6	5.4	17.3	2.9	11.5	8.8	13.2	8.7	10.7	19.0	3.5	2.0	5.6	13.4	11.4	8.7	6.1	8.9	23.3	10.9	7.1	11.4	5.2	7.8	4.7	11.2	7.1	6.8	8.0	0.0	2.9	3.6	4.0	2.8	4.4	3.1	3.4	7.2	2.5	2.2	3.2	4.8	5.8	2.3	2.5	2.8	4.4	1.6	11.0	15.5	11.3	11.1	9.9	5.8	7.6	7.1	7.7	7.5
USP31	KIAA1203	ENSG00000103404	"Ubiquitin specific peptidase 31"	Q70CQ4	16	23061406-23149270	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006937	Uncertain		Approved	Cytosol				Cytosol		"HPA006937: AB_1080523"	"unprognostic (6.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (5.59e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-3)"	6.3	5.3	11.2	4.0	16.6	7.1	8.7	12.7	16.5	10.9	4.9	19.7	2.6	3.7	15.3	7.7	9.3	6.5	4.1	11.0	9.0	6.3	6.2	7.7	7.3	3.6	24.6	8.1	3.7	6.3	20.6	10.4	7.4	17.4	9.6	4.9	2.8	6.0	8.5	10.9	15.9	3.4	14.2	14.8	2.8	3.5	20.7	19.3	1.7	4.2	2.4	4.9	13.4	9.5	0.5	0.8	0.6	1.3	0.1	2.1	0.2	9.4	10.0	2.9	4.0	5.3	4.1	2.7	3.3	3.0	4.3	5.1	6.3	5.8	3.2	3.5	4.1	12.5	7.1	12.9	7.1	2.3	2.9	1.3	5.8	13.2	6.6	3.3	3.6	3.5	11.2	7.9	18.3	7.6	3.8	9.9	5.8	6.5	1.6	2.7	5.7	3.1	7.9	8.1	6.3	6.4	14.2	7.7	5.0	5.1	10.2	2.9	4.1	7.3	4.4	8.7	6.4	4.4	8.9	3.3	5.4	3.4	6.2	4.4	3.4	0.1	0.7	0.6	0.8	0.3	2.1	0.1	0.7	1.5	0.8	0.5	0.8	0.8	0.1	0.1	1.3	0.2	1.3	0.2	11.2	16.6	12.7	16.5	9.0	6.3	24.6	8.1	17.4	19.3
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60179094-60422470	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 28.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 28.4;granulocytes: 13.5"									HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA044365: "	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	9.5	13.9	17.3	10.8	19.5	20.6	10.9	14.6	20.3	8.0	8.5	18.9	7.9	7.2	8.2	5.4	13.1	7.4	9.1	11.1	14.7	12.2	15.5	19.7	12.5	8.6	18.8	14.3	7.4	8.5	17.3	11.4	9.8	19.2	8.7	8.9	11.6	8.2	9.0	23.0	12.2	7.2	9.8	16.5	12.1	8.1	58.4	18.1	7.3	15.6	7.9	8.5	8.8	8.5	1.4	28.4	13.5	2.1	0.6	1.1	0.9	10.9	12.5	6.6	10.6	16.8	15.8	6.3	9.0	13.5	11.7	15.1	6.5	7.1	6.8	7.5	16.5	5.8	11.3	12.4	20.7	5.1	5.0	13.5	9.9	7.1	16.8	10.7	12.4	14.8	9.1	15.8	14.6	12.8	13.7	5.6	14.5	60.4	10.8	7.6	7.8	6.0	5.2	17.6	4.1	12.3	8.0	4.7	7.0	7.4	2.2	11.5	9.2	14.9	10.8	17.9	18.7	11.2	8.3	5.8	11.0	6.3	8.9	8.4	11.6	4.3	2.1	7.2	1.0	1.8	0.7	1.4	0.7	0.8	4.1	1.1	0.5	1.0	13.5	0.6	2.0	28.4	1.1	0.9	17.3	19.5	14.6	20.3	14.7	12.2	18.8	14.3	19.2	18.1
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223830	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.3"	"Cell line enhanced"	"Detected in all"		"U-266/84: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: , HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favourable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	7.7	7.8	6.6	6.6	6.5	19.1	8.3	7.4	7.8	7.9	12.1	8.6	8.8	8.8	8.3	7.1	8.6	7.1	7.6	12.5	6.6	5.3	9.3	15.2	12.7	11.1	10.3	5.1	6.3	8.8	10.0	6.2	11.4	5.9	6.6	6.6	7.1	7.2	7.0	45.3	8.9	13.2	6.5	10.8	10.6	7.4	7.5	8.2	22.6	8.6	10.2	8.4	7.8	8.8	6.3	8.1	12.5	5.7	12.3	9.9	5.0	4.7	4.5	4.0	6.8	5.2	5.2	2.9	7.6	7.4	7.0	6.0	12.9	7.0	5.9	5.4	6.4	3.8	9.3	7.5	5.8	14.4	6.0	5.4	5.3	2.7	7.2	10.9	5.4	6.3	6.9	7.2	5.8	7.0	11.7	18.5	4.7	7.5	14.2	2.0	3.6	8.7	9.4	5.9	5.6	4.5	5.5	8.1	7.3	5.9	10.3	6.6	6.3	4.1	8.3	6.5	5.3	5.6	7.9	20.7	35.1	10.7	6.6	8.4	5.4	12.5	5.4	11.7	7.5	5.7	9.6	6.3	6.6	6.5	8.1	5.7	6.7	5.7	5.4	12.3	5.7	3.5	9.9	5.0	6.6	6.5	7.4	7.7	6.6	5.3	10.3	5.1	5.9	8.2
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277831-49340712	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favourable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favourable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	22.1	18.4	21.4	22.4	29.3	41.4	23.1	30.3	32.5	20.7	20.1	26.8	16.9	16.1	23.6	20.9	23.5	19.3	17.5	22.8	22.2	18.0	20.2	18.5	25.7	25.5	20.2	17.5	23.6	17.1	23.6	19.7	22.1	24.3	20.9	21.9	23.6	19.1	21.3	25.7	27.6	19.4	25.9	20.4	30.6	17.7	25.0	19.7	36.8	21.2	14.1	42.4	22.1	22.0	17.0	24.1	59.4	27.3	21.5	18.6	22.2	6.2	7.2	10.1	13.4	18.7	20.1	6.8	17.2	15.3	22.3	20.1	7.7	15.9	12.2	6.8	25.0	8.5	13.4	24.4	20.8	18.8	4.0	27.0	14.4	8.5	27.4	14.2	15.6	20.6	10.7	24.4	20.1	25.7	9.4	19.4	20.6	10.7	16.8	24.2	8.5	12.7	6.9	6.3	10.6	17.5	13.1	8.4	11.2	12.5	8.8	6.3	6.1	22.9	22.8	15.0	8.2	18.7	10.0	15.5	7.5	17.8	13.5	22.6	17.2	18.0	27.3	30.0	16.9	22.1	18.6	17.0	17.6	16.9	24.1	14.1	17.1	15.0	59.4	21.5	24.4	9.6	18.6	22.2	21.4	29.3	30.3	32.5	22.2	18.0	20.2	17.5	24.3	19.7
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432379-99521728	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	9.8	9.1	8.5	10.2	12.2	7.2	9.0	28.4	11.6	9.0	9.7	8.6	8.9	13.7	15.7	9.6	10.0	8.1	11.9	11.5	7.7	8.5	12.2	9.0	7.1	12.7	9.8	8.0	10.7	9.6	10.2	21.7	9.6	15.0	9.9	13.1	7.9	9.8	8.4	14.6	11.8	12.4	10.8	10.6	9.9	8.9	5.7	9.4	7.1	10.7	10.4	9.5	8.8	15.0	8.6	5.1	3.7	2.5	2.6	6.2	1.4	4.1	3.0	5.9	8.3	10.9	10.4	6.2	7.2	8.1	7.6	10.8	6.1	4.6	11.1	5.4	7.3	5.6	9.0	7.2	10.5	8.7	8.6	10.8	5.9	4.8	8.4	10.0	6.2	11.1	5.7	6.8	11.6	11.2	26.0	11.0	7.1	3.9	3.2	9.5	9.5	6.4	4.7	4.4	6.2	10.5	4.9	8.3	6.8	5.1	6.8	5.3	3.6	4.9	11.2	4.2	5.3	6.1	11.0	4.7	4.3	20.3	7.2	9.5	7.4	3.7	2.0	0.6	4.9	1.3	6.2	7.4	4.2	5.6	3.5	8.6	3.0	2.9	0.5	2.6	2.5	5.1	3.5	1.4	8.5	12.2	28.4	11.6	7.7	8.5	9.8	8.0	15.0	9.4
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavourable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	20.1	38.8	18.6	28.9	30.9	30.9	22.1	48.2	27.5	19.9	18.4	25.6	15.4	17.6	21.3	17.6	19.0	17.4	20.5	17.8	16.9	15.8	15.5	18.3	18.3	26.2	26.6	22.5	27.0	19.8	24.6	35.4	23.1	26.8	21.6	22.0	22.1	24.5	16.3	17.0	23.9	22.2	22.2	19.7	29.1	26.2	15.8	23.6	25.8	23.9	14.0	29.0	19.8	21.0	13.7	10.5	33.7	9.6	5.6	11.2	5.6	14.6	7.0	16.5	11.9	14.3	17.7	16.3	18.5	12.6	12.4	16.5	6.4	15.0	16.5	12.5	16.7	13.6	20.3	14.9	18.9	16.0	13.9	35.3	26.1	11.6	12.8	17.7	18.9	14.3	12.9	12.6	14.1	36.6	27.7	46.8	15.2	7.3	14.6	23.0	10.4	12.6	20.6	16.6	19.3	14.3	12.4	20.1	12.5	17.4	16.0	41.8	8.2	21.4	25.9	13.4	11.1	16.4	10.7	37.5	26.6	16.4	12.9	22.0	19.7	33.7	9.6	16.7	6.4	4.6	7.6	13.7	9.5	9.5	10.5	12.8	11.2	7.0	8.9	5.6	5.0	7.7	10.1	5.6	18.6	30.9	48.2	27.5	16.9	15.8	26.6	22.5	26.8	23.6
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852128-6866632	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol			820000	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	18.6	28.7	23.1	17.8	32.6	13.6	12.9	24.6	50.9	15.9	21.5	26.8	13.8	17.6	22.3	12.8	27.7	19.1	14.7	22.4	23.9	28.6	14.9	24.8	14.4	18.6	23.6	33.2	14.4	13.2	29.7	19.6	21.7	36.8	19.5	16.1	11.6	14.1	22.7	41.2	33.5	18.1	25.3	23.6	14.1	15.9	30.9	18.7	22.8	19.2	20.4	19.9	21.3	16.0	10.8	18.6	5.3	16.6	10.8	17.1	16.6	25.3	39.7	26.7	30.2	18.2	16.8	34.1	27.6	21.2	33.0	24.1	37.5	25.2	30.7	14.5	28.6	22.4	29.3	27.4	21.2	57.5	24.8	28.1	31.9	20.3	14.2	25.4	29.6	16.9	15.9	28.5	19.8	28.2	24.1	12.3	27.2	27.8	38.1	12.6	52.0	16.8	30.0	34.8	21.2	18.8	24.7	14.7	29.7	18.8	28.7	12.0	11.5	20.8	27.3	28.0	33.9	21.3	34.3	14.9	34.2	46.7	31.2	16.2	27.2	2.3	12.3	5.3	17.1	16.6	16.1	10.8	15.2	14.4	18.6	10.0	14.6	14.8	0.9	10.8	14.7	13.6	12.9	16.6	23.1	32.6	24.6	50.9	23.9	28.6	23.6	33.2	36.8	18.7
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 34.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4;naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favourable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favourable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	0.6	2.7	2.0	0.3	2.9	0.1	0.9	2.3	1.8	1.4	0.6			0.0	1.8	34.1	0.2	3.4	0.3	1.0	1.8	3.7	2.2	0.5	0.7	0.4	1.6		4.1	0.8	3.6	1.8	1.3		1.3	0.3		0.3	1.5	0.0	0.5	0.5	1.1	1.4	0.9	0.3	1.3			3.2		0.5	0.7	0.5	0.9	0.0	2.4	0.0	0.6	2.4	0.1	0.0	0.9	5.7	1.7	2.9	1.5	0.0	0.9	0.5	1.1	1.3	1.8	0.8	0.0	6.9	1.2	0.3	1.5	0.6	1.8	1.8	0.1	1.5	0.3	0.0	1.2	3.5	0.3	5.9	0.1	0.6	0.0	0.4	4.4	4.4	0.9	3.8	3.4	1.8	7.2	0.3	4.9	1.1	2.2	1.4	0.2	0.0	1.1	1.6	0.2	5.4	1.4	1.8	0.3	2.3	3.1	0.6	0.2	7.0	2.7	1.4	1.5	2.0	1.5	0.0	0.0	2.4	0.3	0.0	0.0	0.6	0.6	0.0	0.0	0.9	2.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1										
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514419	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA050215: "	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favourable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	19.4	21.9	21.0	20.6	20.6	21.6	18.1	27.3	21.6	21.4	23.9	13.8	19.5	20.2	22.1	17.4	22.3	17.4	15.5	17.4	19.7	18.2	28.2	26.4	17.0	25.4	21.8	15.2	21.9	16.7	42.6	43.2	29.1	29.7	16.7	18.9	10.7	19.9	17.9	24.3	17.8	32.1	19.2	29.3	30.3	17.7	27.5	26.1	28.9	24.1	12.7	20.9	22.3	18.4	16.7	10.6	38.1	15.1	9.5	11.9	6.9	11.0	15.9	8.9	15.7	16.3	18.3	12.4	15.9	18.9	15.5	18.4	10.6	7.3	11.7	12.3	18.2	21.5	12.2	11.9	18.4	10.2	8.1	21.6	14.8	10.9	16.8	14.4	14.6	14.2	14.3	13.7	23.3	15.0	12.3	14.2	14.5	22.7	9.2	5.7	10.2	7.3	8.4	16.6	17.5	14.7	26.1	11.4	10.4	16.8	25.1	20.8	13.7	17.7	17.0	16.1	9.1	49.6	21.0	11.1	23.1	12.9	12.9	29.2	15.5	38.1	13.3	22.4	11.1	12.4	10.7	16.5	11.4	11.1	10.6	16.7	11.9	10.7	22.7	9.5	15.1	9.9	8.5	6.9	21.0	20.6	27.3	21.6	19.7	18.2	21.8	15.2	29.7	26.1
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A, small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA047217: , HPA054023: "	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavourable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	15.1	11.4	8.2	13.3	11.2	10.2	15.8	12.7	13.8	13.3	13.4	8.4	8.5	8.5	17.6	13.9	16.9	13.9	9.0	10.0	7.1	7.2	13.2	14.9	10.7	14.8	7.6	9.8	17.4	22.7	13.1	13.8	12.5	10.6	13.5	14.7	8.6	13.2	10.6	19.6	11.8	11.0	15.3	7.7	16.1	13.3	4.3	7.7	20.7	12.4	16.3	19.5	16.0	13.5	11.1	11.8	16.2	14.3	15.5	14.6	7.7	14.2	15.9	8.6	22.5	14.4	14.7	14.4	15.8	12.1	15.9	12.7	16.2	14.1	33.8	31.9	11.4	18.3	34.2	17.2	19.6	11.2	17.0	19.3	13.6	12.3	16.3	27.2	14.8	18.0	15.2	21.6	22.9	12.5	19.1	10.6	13.7	23.4	19.6	20.8	17.8	17.9	15.4	12.9	23.1	11.0	10.9	9.0	23.6	9.0	16.6	18.6	8.9	15.9	10.8	7.0	9.2	19.6	30.3	13.3	15.4	30.1	10.6	33.8	15.8	16.2	8.0	4.0	12.7	14.3	14.6	11.1	10.7	11.8	11.8	10.9	13.5	12.4	1.0	15.5	12.0	9.4	14.4	7.7	8.2	11.2	12.7	13.8	7.1	7.2	7.6	9.8	10.6	7.7
UTP14C	"2700066J21Rik, KIAA0266"	ENSG00000253797	"UTP14C, small subunit processome component"	Q5TAP6	13	52024691-52033600	"Predicted intracellular proteins"	"Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA047217: , HPA054023: "	"unprognostic (7.89e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.47e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (7.35e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.46e-5)"	"unprognostic (2.44e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.04e-2)"	4.8	4.8	5.3	3.4	5.9	0.5	6.2	6.6	5.9	6.8	5.3			4.6	6.7	4.6	3.6	5.2	3.9	5.5	5.1	5.2	8.0	7.9	4.5	3.5	5.5		6.1	5.8	8.9	4.8	6.6		7.1	5.9		5.7	5.5	5.3	2.9	4.5	5.3	6.2	4.4	5.7	2.3			9.1		3.8	4.6	4.2	4.1	5.8	6.7	4.8	3.5	6.8	3.1	4.3	6.9	14.3	11.2	14.7	10.6	11.0	12.4	9.7	8.4	7.8	6.8	9.1	10.6	3.4	11.8	10.1	12.6	6.9	11.2	10.8	9.0	20.4	4.9	6.6	10.0	18.1	14.2	9.3	13.2	6.4	12.6	6.9	11.8	5.4	12.6	3.2	11.0	10.1	13.0	5.0	10.9	10.0	4.6	14.3	7.0	4.7	9.6	7.4	11.1	8.5	10.0	14.4	10.4	7.8	8.2	8.7	8.5	5.5	7.9	12.9	4.2	6.8	14.6	6.7	3.7	5.4	4.6	4.8	3.9	3.0	4.9	3.7	4.4	4.1	6.8	6.7	2.4	3.5	3.9	5.8	5.2	3.1										
VAC14	"ArPIKfyve, FLJ10305, TAX1BP2"	ENSG00000103043	"Vac14, PIKFYVE complex component"	Q08AM6	16	70687439-70801161	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027766, HPA075382"	Approved		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA027766: AB_1848651, HPA075382: "	"unprognostic (9.25e-2)"	"prognostic favourable (8.33e-5)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.26e-1)"	"prognostic favourable (1.56e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-1)"	26.3	26.6	22.9	22.8	21.8	16.3	17.4	15.6	34.9	17.9	18.4	27.0	18.5	19.8	18.8	15.8	21.0	20.9	17.0	22.2	22.9	23.5	25.7	27.1	20.1	34.9	22.3	20.8	19.2	27.8	33.7	21.4	20.1	25.8	17.9	14.1	22.9	24.3	19.4	23.3	24.6	21.6	19.2	22.2	29.0	20.0	21.7	20.6	31.2	26.0	16.3	22.9	21.0	16.3	5.5	9.7	6.6	5.9	3.7	5.5	1.9	11.2	11.2	9.5	10.6	13.8	10.1	14.5	8.2	13.0	15.7	7.3	13.8	18.3	14.5	10.7	9.8	14.3	12.4	13.3	7.4	4.4	13.0	7.3	8.5	17.0	35.7	12.5	15.4	16.7	14.0	23.2	21.2	14.9	12.8	6.6	13.7	16.3	11.6	20.9	16.7	10.6	14.0	6.9	21.4	7.5	7.8	11.3	12.3	27.2	8.3	18.7	12.3	11.8	11.8	20.9	12.0	13.3	8.8	9.5	11.6	27.8	34.9	11.2	9.5	1.3	4.8	6.6	2.9	5.9	2.5	4.0	3.7	5.5	9.7	5.5	3.5	3.1	1.6	3.7	5.4	5.1	2.3	1.9	22.9	21.8	15.6	34.9	22.9	23.5	22.3	20.8	25.8	20.6
VARS	VARS2	ENSG00000204394	"Valyl-tRNA synthetase"	P26640	6	31777518-31795953	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 24.8;U-266/84: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol			23000	Cytosol		"HPA046710: "	"unprognostic (1.86e-2)"	"prognostic unfavourable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (1.86e-4)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	11.7	11.4	8.9	12.0	9.5	9.1	18.3	7.6	14.0	8.1	11.3	7.3	5.0	12.8	13.5	6.7	14.2	10.2	8.1	9.5	6.4	6.8	9.5	22.7	11.5	24.2	8.3	9.7	9.6	19.2	15.6	15.0	8.5	8.6	7.7	9.4	6.1	9.1	5.9	30.6	14.3	10.3	13.2	8.7	14.4	15.2	40.6	7.5	10.9	8.2	13.2	11.8	9.7	8.5	1.6	1.5	0.6	1.2	2.4	1.0	0.9	2.2	2.0	3.1	6.3	3.5	2.8	8.5	8.6	2.6	6.5	3.9	2.6	1.4	7.6	10.7	5.4	2.4	10.0	6.6	3.9	5.5	14.2	3.7	5.1	6.0	4.6	15.0	12.4	4.2	2.4	2.6	6.0	3.2	10.4	10.3	4.2	3.4	6.8	0.7	6.0	4.2	8.8	1.6	24.8	5.0	2.8	3.9	1.4	0.7	8.5	3.7	5.2	6.0	1.1	4.5	4.2	6.0	14.2	14.8	25.4	6.2	3.3	3.0	5.0	0.0	0.6	0.6	1.0	1.2	1.0	1.6	0.6	0.4	1.1	1.1	0.8	0.8	0.0	2.4	1.0	1.5	0.6	0.9	8.9	9.5	7.6	14.0	6.4	6.8	8.3	9.7	8.6	7.5
VASH2	FLJ12505	ENSG00000143494	"Vasohibin 2"	Q86V25	1	212950520-212992037	"Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.2"	"Cell line enhanced"	"Detected in some"		"AF22: 9.4;AN3-CA: 11.5;NTERA-2: 18.0;RH-30: 53.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045820			Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA045820: "	"unprognostic (2.22e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-5)"	"unprognostic (1.95e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.81e-4)"	3.1	0.7	2.6	5.8	6.0	1.4	3.7	1.1	4.8	3.3	1.4	0.1	1.0	1.3	4.2	3.8	7.8	1.5	4.9	2.8	1.5	1.8	1.1	0.8	2.2	3.8	1.2	1.7	1.8	0.8	1.8	7.7	1.4	3.6	7.7	1.2	5.7	1.6	1.6	1.6	1.2	2.0	3.5	1.1	2.1	1.3	23.2	1.1	9.7	1.2	3.1	3.7	2.9	6.3	0.2	3.2	0.0	0.0	0.0	0.4	0.0	0.1	0.6	9.4	11.5	0.1	0.0	1.5	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.1	0.0	0.0	3.8	0.0	0.4	7.5	1.4	0.7	0.5	0.5	0.0	0.0	0.1	1.5	0.0	0.5	0.0	0.1	0.0	2.3	0.7	0.1	4.8	0.6	18.0	1.4	2.8	53.0	0.4	0.0	0.7	2.2	3.4	1.2	0.1	0.1	1.7	0.3	0.0	0.4	1.1	0.2	0.5	1.3	2.2	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	3.2	0.4	0.0	2.6	6.0	1.1	4.8	1.5	1.8	1.2	1.7	3.6	1.1
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788530-77980107	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.3;brain: 47.1;retina: 32.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.2;BJ hTERT+: 27.1;fHDF/TERT166: 14.8;NTERA-2: 31.9;U-87 MG: 33.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol				Cytosol		"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.1	57.3	7.9	3.0	41.3	1.2	1.0	28.4	20.1	1.3	3.4	5.7	0.0	2.4	1.8	6.3	2.0	1.4	3.8	12.7	3.8	47.1	5.3	1.4	0.9	1.0	8.4	12.7	0.9	2.1	0.6	1.5	2.0	27.2	0.8	5.2	32.1	0.9	1.0	0.6	0.6	3.1	2.6	15.4	0.7	1.7	2.1	5.8	0.0	2.0	0.0	2.4	1.4	0.4	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	3.2	0.0	0.0	1.1	27.1	0.3	0.2	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	31.9	0.0	0.7	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.4	0.0	0.0	7.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	41.3	28.4	9.1	3.8	47.1	8.4	12.7	27.2	5.8
VAV1	VAV	ENSG00000141968	"Vav guanine nucleotide exchange factor 1"	P15498	19	6772714-6857366	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.7;bone marrow: 25.7;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 30.9;Karpas-707: 35.3;MOLT-4: 33.5;REH: 22.2;THP-1: 26.0;U-266/84: 25.6;U-937: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001864	Enhanced		Approved	Cytosol			30000	Cytosol		"HPA001864: AB_1858722"	"unprognostic (2.93e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.28e-1)"	5.1	3.0	3.1	19.0	5.6	25.7	2.3	0.7	2.2	1.7	3.5	4.0	0.3	2.8	1.9	2.6	2.6	2.6	3.1	3.3	2.5	3.0	2.7	2.6	8.5	25.1	5.3	1.2	2.0	1.5	5.2	1.8	4.4	3.5	3.2	3.7	2.3	5.8	1.1	0.8	1.4	10.7	2.6	8.7	37.1	2.5	1.5	4.8	43.1	2.0	1.2	20.0	6.1	2.4	9.3	10.5	25.7	22.8	11.5	14.7	10.5	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	15.2	4.6	0.0	0.0	0.0	0.0	0.0	6.4	0.5	18.3	0.0	0.0	0.0	17.8	30.9	0.0	0.0	0.0	0.0	0.0	0.6	35.3	0.0	2.5	33.5	10.2	0.0	0.0	22.2	0.0	12.0	0.6	0.0	0.0	0.0	0.0	5.1	0.0	2.2	26.0	0.0	0.0	0.4	0.0	0.0	21.2	25.6	17.2	0.0	28.1	0.0	0.9	11.5	11.9	14.7	18.8	10.5	9.3	10.7	12.7	10.5	9.2	11.8	10.6	25.7	11.5	22.8	9.0	8.5	10.5	3.1	5.6	0.7	2.2	2.5	3.0	5.3	1.2	3.5	4.8
VBP1	"PFD3, PFDN3"	ENSG00000155959	"VHL binding protein 1"	P61758	X	155197007-155239817	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006260, HPA023230"	Approved		Supported	Vesicles,Cytosol				Cytosol	Vesicles	"CAB006260: AB_425740, HPA023230: AB_1858727"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.80e-1)"	17.3	19.2	37.8	15.5	28.0	24.5	18.4	26.1	32.5	14.9	16.9	20.6	12.5	12.8	14.9	16.3	17.8	13.8	13.3	35.9	35.4	36.8	22.9	17.4	13.0	21.0	40.9	25.6	15.3	11.8	18.3	22.0	16.9	33.9	18.2	19.2	10.1	11.1	15.6	50.5	10.9	14.3	16.4	46.0	13.9	12.5	8.7	22.9	21.0	18.4	25.6	22.0	16.9	12.8	15.0	18.4	37.0	12.6	13.8	21.6	15.7	35.1	12.7	27.7	18.4	11.5	15.9	8.0	17.5	13.6	23.1	36.2	15.1	18.1	45.3	37.5	14.7	13.9	40.1	16.4	30.0	23.8	28.1	19.0	20.1	11.8	13.7	30.6	15.0	11.8	19.6	19.2	24.3	21.2	37.1	27.0	25.9	14.6	28.8	27.4	16.0	27.4	24.8	22.0	26.5	20.0	16.1	30.1	18.3	12.0	14.2	19.3	12.1	23.7	12.3	18.5	22.9	31.3	43.1	30.5	44.2	79.2	16.4	38.0	22.6	8.5	11.6	37.0	14.4	12.6	16.5	15.0	16.9	17.2	18.4	11.8	19.6	20.7	13.6	13.8	10.4	15.1	21.6	15.7	37.8	28.0	26.1	31.9	35.4	36.8	40.9	25.6	33.9	22.9
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol			110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favourable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favourable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	17.4	42.3	40.1	43.6	30.7	24.5	19.9	38.9	37.6	26.6	22.3	26.6	27.6	27.0	43.5	19.5	54.3	20.6	20.8	40.1	25.4	21.8	53.7	37.0	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	18.5	15.9	44.4	20.2	26.1	17.9	29.4	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2
VCPKMT	"C14orf138, METTL21D, VCP-KMT"	ENSG00000100483	"Valosin containing protein lysine methyltransferase"	Q9H867	14	50108632-50116600	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001146, HPA076561"	Uncertain		Supported	Cytosol				Cytosol		"HPA001146: AB_1845558, HPA076561: "	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.97e-2)"	"prognostic favourable (2.40e-4)"	"unprognostic (8.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.90e-2)"	"prognostic unfavourable (4.75e-4)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.27e-2)"	5.2	7.6	7.6	9.5	16.9	12.6	6.0	15.3	14.0	6.3	5.8	6.3	3.7	5.4	9.8	8.3	10.5	5.8	7.1	4.6	9.9	7.1	6.2	6.9	5.7	10.9	7.1	6.3	5.1	6.3	6.2	8.6	4.8	12.0	5.0	5.4	4.5	5.1	5.4	4.8	8.1	5.9	8.6	5.7	9.2	7.0	11.0	7.4	10.6	7.4	5.2	12.5	7.9	6.1	17.1	3.8	6.1	3.1	8.0	8.4	3.4	4.1	4.8	4.1	5.6	3.0	3.6	5.0	4.3	4.7	4.9	3.7	2.7	5.2	13.7	3.0	3.1	8.8	5.4	7.6	5.0	6.7	3.5	2.5	2.1	3.2	4.5	7.0	3.8	2.5	4.4	5.2	5.6	5.9	3.2	6.0	3.7	5.8	14.1	7.0	4.3	7.8	9.8	8.3	3.6	6.2	6.5	7.5	9.0	6.5	1.9	7.4	4.7	6.4	1.7	8.0	6.3	2.8	4.6	5.7	11.5	5.3	2.8	6.2	3.9	6.1	2.0	0.0	6.5	3.1	7.6	17.1	6.3	7.8	2.5	14.5	7.5	8.4	0.6	8.0	1.4	3.8	5.2	3.4	7.6	16.9	15.3	14.0	9.9	7.1	7.1	6.3	12.0	7.4
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.1;parathyroid gland: 45.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 22.7;HDLM-2: 32.0;U-937: 31.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0"	"Region enhanced"	"Detected in single"		"olfactory region: 2.5"	"Low region specificity"	"Detected in some"			"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"				Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: , HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favourable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.0	9.2	0.2	10.0	0.3	2.5	7.8	0.3	0.6	3.5	40.9	0.4	4.1	21.2	1.2	7.7	10.2	1.1	10.7	1.5	0.5	0.3	13.0	0.6	8.3	3.8	0.5	0.1	1.3	6.5	45.8	11.7	4.4	0.6	2.1	12.6	0.4	4.9	2.8	5.3	15.2	57.1	1.2	1.5	3.1	2.6	1.5	0.2	2.0	1.9	9.4	8.2	4.0	5.2	0.7	5.7	7.5	7.0	0.2	0.8	1.2	5.4	0.9	0.0	0.0	4.7	6.9	0.1	6.7	3.4	5.7	5.0	4.0	4.6	1.4	7.3	4.6	10.2	0.2	22.7	2.7	32.0	1.6	2.4	1.3	0.3	3.5	4.8	7.7	9.3	10.6	6.3	10.4	0.4	0.7	1.5	2.6	3.7	0.1	2.3	0.0	7.4	0.1	0.0	3.5	5.2	5.5	2.6	0.1	5.7	16.5	2.0	18.6	2.7	0.4	11.0	2.9	3.2	3.8	0.9	0.0	1.2	3.4	31.4	2.7	0.2	3.7	2.1	0.0	7.0	0.1	0.7	0.3	0.0	5.7	0.1	0.1	0.0	7.5	0.2	6.9	0.6	0.8	1.2	0.2	0.3	0.3	0.6	0.5	0.3	0.5	0.1	0.6	0.2
VENTX	"HPX42B, VENTX2"	ENSG00000151650	"VENT homeobox"	O95231	10	133237404-133241929	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	24	"NB-4: 17.6;NTERA-2: 10.1"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 30.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 2.4;classical monocyte: 4.6;intermediate monocyte: 5.1;myeloid DC: 3.1;neutrophil: 1.8;non-classical monocyte: 3.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;granulocytes: 2.4;monocytes: 5.1"									HPA050955	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	Cytosol	"HPA050955: "	"unprognostic (9.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.70e-4)"	"unprognostic (4.22e-1)"	"unprognostic (2.51e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.14e-1)"	5.6	2.4	1.2	6.6	1.2	4.4	2.0	1.2	1.2	1.7	1.7	1.2	1.2	0.4	1.7	1.2	1.2	2.0	2.5	1.2	1.2	1.5	1.9	1.2	4.4	1.2	1.2	1.2	1.7	2.1	1.0	1.5	1.2	1.2	1.2	0.4	1.2	1.5	1.2	1.2	2.0	1.2	2.1	2.2	7.3	0.9	6.3	1.2	2.9	1.2	1.2	1.2	1.5	1.2	0.5	3.1	2.4	5.1	0.6	0.3	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	17.6	10.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	2.4	4.6	0.6	0.3	5.1	0.1	0.5	0.2	0.2	3.1	0.5	0.2	0.3	1.8	0.6	3.9	0.2	0.1	1.0	1.2	1.2	1.2	1.2	1.2	1.5	1.2	1.2	1.2	1.2
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 38.1;pituitary gland: 70.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;HUVEC TERT2: 64.8;TIME: 38.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 2.2;pons and medulla: 5.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favourable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.5	16.0	0.3	0.2	0.3	1.1	1.4	2.2	3.5	1.9	0.4	0.7	2.0	0.2	0.4	12.1	0.2	3.4	1.1	0.4	0.8	0.5	20.7	0.6	38.1	0.1	0.7	0.1	1.1	8.6	0.7	70.3	1.6	5.5	1.2	0.3	17.7	6.9	4.9	0.2	0.7	0.2	0.1	0.3	2.3	0.6	1.7	0.2	0.1	1.1	0.5	0.6	0.5	0.8	0.0	0.0	1.5	0.7	0.0	0.0	5.1	1.8	0.2	4.2	0.0	2.5	9.3	0.0	11.0	24.3	3.2	4.8	0.3	1.7	0.0	4.3	11.8	0.0	0.1	0.2	18.2	0.0	0.0	1.8	0.2	0.0	0.8	0.0	0.0	2.7	0.1	13.9	2.8	64.8	0.6	0.0	8.8	0.2	0.0	0.0	1.7	1.6	0.0	0.3	0.0	1.6	0.9	0.1	0.0	0.3	0.5	4.3	18.8	0.0	38.5	13.0	0.4	4.5	15.0	0.0	0.0	0.0	10.4	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.1	0.3	0.3	2.2	0.4	0.8	0.5	0.7	0.1	5.5	0.2
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302790	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavourable (1.93e-5)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	12.3	21.4	15.4	14.3	17.2	5.1	14.6	28.3	27.2	12.9	14.4	9.1	19.0	9.5	17.1	15.9	15.6	11.5	12.1	14.7	11.8	9.5	12.1	10.4	13.8	9.6	11.0	14.0	13.3	12.6	15.7	20.4	19.6	11.4	15.8	10.6	10.3	10.9	13.9	42.7	16.1	11.0	16.2	12.5	7.2	10.7	7.2	12.2	13.6	29.8	14.5	10.0	15.7	12.2	5.2	4.4	1.1	3.5	2.4	5.0	1.2	10.4	9.7	13.4	7.2	10.3	7.3	5.2	7.7	9.6	6.1	9.8	3.5	4.9	13.5	5.0	6.6	5.4	9.5	6.7	11.4	9.1	5.3	5.2	2.5	3.7	5.6	10.2	3.0	9.3	11.7	5.8	16.6	12.8	3.0	5.3	5.5	2.8	8.8	4.8	6.8	9.8	8.0	6.3	4.4	17.8	7.6	9.1	7.9	7.4	11.1	3.5	13.8	1.7	10.3	5.6	2.1	2.4	4.2	5.2	7.8	11.5	2.1	3.7	2.8	0.5	3.1	1.1	3.6	3.5	4.7	5.2	5.0	2.1	4.4	3.6	2.4	2.0	0.3	2.4	0.9	1.8	3.5	1.2	15.4	17.2	28.3	18.8	11.8	9.5	11.0	14.0	11.4	12.2
VGLL3	VGL-3	ENSG00000206538	"Vestigial like family member 3"	A8MV65	3	86876388-86991119	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 195.7"	"Cell line enriched"	"Detected in many"	4	"U-2197: 103.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054983	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA054983: "	"unprognostic (9.08e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.73e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.05e-1)"	22.5	1.0	0.5	3.4	0.5	0.2	8.6	0.2	0.3	6.3	6.2	0.4	3.3	0.6	8.2	7.8	6.1	5.2	6.8	4.3	1.0	0.7	1.8	0.6	16.1	3.6	0.6	0.3	10.6	2.7	0.7	0.4	195.7	0.8	8.0	1.6	2.8	1.9	3.1	7.5	4.0	2.1	11.9	0.8	2.4	2.9	8.0	0.3	0.1	3.4	1.9	1.0	12.2	9.2	1.1	0.6	2.3	0.5	0.8	0.7	0.1	1.5	2.5	13.9	0.0	18.6	23.2	0.2	9.6	6.7	8.2	10.3	2.9	0.6	0.0	0.0	15.0	1.3	0.9	0.9	11.3	5.4	0.0	0.7	0.9	0.0	8.5	0.1	0.0	17.7	1.5	12.0	5.4	1.2	0.0	0.0	10.2	0.0	0.1	0.0	0.2	0.0	0.0	18.4	0.0	0.0	1.6	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.5	18.3	2.7	103.9	0.3	0.0	0.0	0.0	3.4	0.0	0.7	2.3	0.5	0.7	0.4	0.3	0.4	0.5	0.5	0.3	0.2	1.1	0.6	0.7	2.0	0.8	0.4	0.6	0.5	0.1	0.5	0.5	0.2	0.3	1.0	0.7	0.6	0.3	0.8	0.3
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141008-10152220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005430, HPA031631, HPA031632"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005430: AB_2241850, HPA031631: , HPA031632: "	"prognostic unfavourable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	13.8	17.4	18.1	29.2	18.4	24.3	15.4	25.8	21.4	13.3	19.8	19.3	14.5	15.9	15.1	13.6	16.4	14.3	18.9	10.5	17.1	18.5	13.7	16.3	14.6	27.9	13.5	12.3	15.2	22.5	13.8	14.6	18.8	12.8	15.1	16.6	12.5	21.8	13.7	14.8	14.0	22.3	13.4	17.0	22.6	16.2	17.9	11.2	39.2	16.9	11.5	29.3	15.4	19.1	5.4	3.9	8.0	4.1	4.4	4.3	1.7	6.7	6.5	14.3	8.8	13.3	10.3	53.6	5.9	8.5	7.6	9.0	7.6	8.4	23.8	8.1	8.0	5.8	13.2	8.3	9.4	11.4	12.0	18.5	10.5	10.5	12.6	16.3	14.8	10.3	9.5	10.1	12.8	8.7	16.4	18.1	7.5	12.2	15.5	12.0	9.6	8.3	19.7	12.6	11.9	9.3	17.4	5.4	17.9	12.5	6.7	7.2	13.2	20.7	7.5	7.6	10.1	7.0	9.3	12.9	26.4	38.0	8.4	19.5	6.9	2.6	4.1	3.3	3.8	2.5	3.6	4.1	2.9	4.3	3.9	5.4	2.5	2.7	8.0	4.4	3.2	2.4	3.1	1.7	18.1	18.4	25.8	21.4	17.1	18.5	13.5	12.3	12.8	11.2
VPS11	"PEP5, RNF108"	ENSG00000160695	"VPS11, CORVET/HOPS core subunit"	Q9H270	11	119067692-119081978	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039020	Approved		Approved	Cytosol				Cytosol		"HPA039020: AB_10674847"	"unprognostic (6.97e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (1.44e-4)"	"unprognostic (4.07e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-1)"	6.2	7.3	5.3	5.3	10.2	10.2	6.5	5.6	16.3	6.7	4.6	11.3	4.5	4.8	6.6	6.9	5.1	8.2	5.6	5.5	4.7		6.3	3.4	6.2	7.4	5.7	7.9	8.6	6.5	12.5	8.3	8.4	9.4	6.6	5.2	8.6	5.8	7.5	5.5	7.5	4.6	7.5	3.2	6.3	4.4	5.2	5.4	9.3	8.6	3.4	6.7	6.0	0.9	9.8	17.8	15.7	15.2	12.8	14.3	12.0	5.7	5.7	6.6	4.8	13.3	12.5	6.7	6.9	9.5	9.1	9.0	9.3	10.7	7.9	10.2	13.4	9.5	8.1	9.5	7.2	8.2	5.6	17.5	7.1	9.7	17.4	10.1	11.0	13.5	10.6	13.8	7.2	11.4	12.5	12.8	10.6	14.0	7.8	9.3	2.9	10.6	9.2	9.1	5.2	8.6	11.8	4.8	8.1	8.4	11.0	7.6	17.1	8.7	10.1	8.8	3.7	3.7	5.1	6.0	5.4	7.0	5.9	12.7	7.5	15.7	15.2	12.8	13.2	11.6	14.3	9.8	11.5	12.5	17.8	9.8	10.8	13.1	3.0	12.8	14.5	7.6	12.9	12.0										
VPS13D	"FLJ10619, KIAA0453"	ENSG00000048707	"Vacuolar protein sorting 13 homolog D"	Q5THJ4	1	12230032-12512047	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027332, HPA051621"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA027332: , HPA051621: "	"unprognostic (2.97e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"prognostic favourable (7.42e-12)"	"unprognostic (5.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.31e-2)"	11.7	9.8	16.6	8.5	16.4	8.0	16.6	18.5	19.7	19.9	12.5	17.0	11.7	6.9	12.8	15.3	16.1	10.8	10.2	15.8	15.7	13.2	15.4	11.0	12.3	9.9	16.5	13.8	15.9	11.9	28.1	14.1	9.2	13.3	18.6	11.3	14.0	15.1	16.8	30.3	39.2	9.7	17.3	14.8	10.2	12.8	11.6	13.6	8.6	21.7	11.3	14.4	10.8	17.9	4.1	3.9	6.0	1.9	1.7	3.6	0.9	8.0	4.6	5.2	4.0	14.0	11.2	2.4	4.0	6.9	6.8	6.5	3.1	5.7	7.6	5.0	11.2	7.4	9.1	7.7	9.5	4.1	3.0	6.5	7.2	2.5	5.9	9.4	3.4	9.4	11.0	8.7	8.5	10.7	13.3	3.9	6.2	3.7	5.5	3.7	2.1	5.9	4.8	6.3	2.2	4.8	4.8	2.5	3.5	11.5	8.5	8.1	7.3	3.1	11.6	4.2	4.4	10.9	3.2	3.5	2.8	12.0	4.8	6.7	6.4	6.0	1.9	1.4	3.3	1.9	3.5	2.5	3.6	2.3	1.5	4.1	3.2	2.5	2.6	1.7	1.4	3.9	1.7	0.9	16.6	16.4	18.5	19.7	15.7	13.2	16.5	13.8	13.3	13.6
VPS29	"DC15, DC7, PEP11"	ENSG00000111237	"VPS29, retromer complex component"	Q9UBQ0	12	110491097-110502117	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039748	Uncertain		Supported	Vesicles,Cytosol			140000	"Vesicles, Cytosol"		"HPA039748: AB_10674426"	"unprognostic (9.46e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (2.79e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-2)"	"prognostic favourable (7.70e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (4.29e-3)"	39.2	34.9	35.6	28.5	38.5	44.4	32.6	23.0	46.6	30.3	38.0	24.4	29.5	33.6	31.5	50.4	51.2	29.0	27.5	35.9	31.5	30.9	62.2	51.2	31.3	33.1	32.8	27.8	27.6	31.4	18.3	31.4	34.5	46.6	41.6	43.5	27.3	34.1	40.6	64.0	25.2	36.2	47.3	28.9	43.1	34.9	17.0	23.8	29.8	38.3	32.9	38.0	51.5	27.4	40.5	67.4	52.7	79.9	41.7	46.0	72.1	31.2	30.7	29.2	20.8	32.9	32.7	23.1	29.7	31.1	30.0	27.2	30.7	27.4	29.0	31.3	29.4	29.9	38.6	27.5	31.5	34.3	30.9	35.4	38.7	25.2	28.7	42.2	31.1	21.5	23.5	25.4	28.1	52.4	33.8	27.2	53.7	15.7	33.0	60.0	16.7	39.5	22.1	29.9	40.7	49.9	46.6	31.5	16.7	33.7	30.0	37.2	40.7	32.7	29.4	26.1	17.2	36.0	34.6	18.6	25.9	34.1	30.4	40.4	27.7	43.9	57.6	52.7	31.9	73.2	35.1	40.5	40.7	37.3	67.4	31.4	37.4	36.8	38.5	41.7	79.9	45.3	46.0	72.1	35.6	38.5	23.0	46.6	31.5	30.9	32.8	27.8	46.6	23.8
VPS37A	"FLJ32642, HCRP1, PQBP2, SPG53"	ENSG00000155975	"VPS37A, ESCRT-I subunit"	Q8NEZ2	8	17246571-17302427	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024705, HPA024781"	Supported		Approved	Vesicles,Centrosome,Cytosol				Vesicles	"Centrosome, Cytosol"	"HPA024705: AB_10601776, HPA024781: AB_10602100"	"unprognostic (8.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.18e-1)"	23.5	21.3	15.1	13.5	15.6	12.8	22.1	23.1	18.1	21.3	23.5	15.8	16.4	18.6	19.1	15.1	22.7	13.3	15.5	34.4	15.8	14.9	23.3	25.9	18.4	14.4	16.6	10.4	21.7	15.8	34.2	20.8	31.6	16.1	20.0	16.2	20.7	15.2	22.7	41.8	16.5	27.3	24.4	20.2	16.4	14.9	27.7	14.6	17.3	18.0	16.4	14.8	27.6	22.7	10.1	11.7	25.0	15.2	20.6	15.5	11.4	7.0	11.7	10.2	8.9	22.6	18.0	11.1	25.3	21.5	23.4	20.2	7.8	6.9	6.1	13.8	20.2	7.0	11.4	11.1	27.7	6.2	3.4	11.2	5.9	8.3	26.5	4.3	10.6	17.5	21.6	21.6	22.2	16.6	8.2	15.8	24.6	4.8	13.1	11.1	10.1	6.1	6.4	11.4	7.2	19.6	9.8	12.2	6.5	10.1	10.1	15.6	6.6	9.1	14.1	14.1	7.2	20.2	13.2	5.0	10.2	7.1	16.1	8.3	14.4	25.0	15.2	13.5	12.9	11.3	15.5	9.9	12.4	12.3	11.7	10.1	11.6	13.8	15.9	20.6	10.0	10.8	11.4	11.4	15.1	15.6	23.1	18.1	15.8	14.9	16.6	10.4	16.1	14.6
VPS50	"CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L"	ENSG00000004766	"VPS50, EARP/GARPII complex subunit"	Q96JG6	7	93232340-93361121	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026679	Approved		Uncertain	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA026679: AB_1846135"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.97e-2)"	"prognostic unfavourable (7.21e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.69e-1)"	"unprognostic (5.17e-2)"	"prognostic favourable (1.35e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	15.9	16.3	16.4	15.3	24.2	6.9	21.6	26.1	28.3	13.0	16.0	9.9	13.3	11.5	17.7	17.5	15.7	11.9	10.4	12.6	19.8	16.0	20.0	12.1	13.2	15.3	16.4	22.2	15.4	13.5	23.9	30.8	12.8	26.7	14.3	18.5	7.5	15.0	14.2	18.7	16.8	12.8	14.8	15.9	15.5	14.1	13.8	19.2	15.8	15.8	14.0	15.3	14.2	12.9	5.5	10.4	4.2	8.1	5.2	11.2	4.3	11.0	6.7	8.6	13.4	16.2	11.6	8.7	10.5	9.0	10.9	12.0	9.4	13.0	9.8	11.9	9.0	9.6	12.9	10.0	15.2	11.5	9.0	18.4	13.0	5.9	9.9	9.4	10.1	9.8	11.6	13.2	13.3	14.1	14.5	12.8	14.5	11.0	8.8	8.4	6.0	9.4	7.0	11.4	13.4	10.1	8.9	6.2	13.3	12.1	26.8	10.7	9.2	7.0	12.7	15.9	9.4	29.0	10.7	7.0	15.5	11.9	11.7	9.2	12.6	4.2	7.0	3.4	6.2	8.1	11.2	5.5	6.9	7.6	10.4	5.5	5.5	7.4	1.7	5.2	4.8	5.1	8.1	4.3	16.4	24.2	26.1	28.3	19.8	16.0	16.4	22.2	26.7	19.2
VPS8	"FLJ32099, KIAA0804"	ENSG00000156931	"VPS8, CORVET complex subunit"	Q8N3P4	3	184812143-185052614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036871	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA036871: AB_10672103"	"unprognostic (4.36e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.97e-2)"	12.6	11.1	14.9	11.1	20.9	22.6	12.0	21.6	24.8	15.5	12.5	18.2	8.0	9.1	16.4	19.0	11.5	10.1	12.5	20.3	17.1	19.3	12.5	9.2	13.8	14.8	21.5	13.6	16.7	10.1	21.8	23.6	13.3	28.4	12.8	16.7	12.1	9.5	12.0	28.4	14.2	9.9	14.5	21.9	14.9	14.1	17.8	15.9	13.2	17.5	9.0	11.5	12.5	11.6	3.9	6.0	17.7	4.9	3.9	6.4	3.1	10.8	6.6	10.1	10.1	21.2	18.9	6.7	10.7	11.8	7.9	11.0	8.4	5.7	11.7	18.8	16.7	12.9	10.9	13.1	15.2	21.1	9.7	12.8	8.3	4.9	13.1	8.6	17.3	13.4	12.6	11.1	11.3	19.7	6.5	8.5	14.3	7.8	6.9	5.1	6.6	6.3	8.6	19.5	9.1	7.8	19.0	10.4	6.8	12.4	13.2	9.7	20.9	4.6	17.3	12.2	6.9	12.3	9.4	10.5	12.7	16.0	13.9	10.9	9.5	11.7	4.9	16.2	4.0	3.7	3.8	3.5	4.3	4.0	6.0	3.9	6.4	4.3	17.7	3.9	4.6	1.7	3.5	3.1	14.9	20.9	21.6	24.8	17.1	19.3	21.5	13.6	28.4	15.9
VPS9D1	"ATP-BL, C16orf7"	ENSG00000075399	"VPS9 domain containing 1"	Q9Y2B5	16	89707134-89720986	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	13	"neutrophil: 16.6"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007847, HPA023620"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA007847: AB_1845582, HPA023620: AB_1845583"	"unprognostic (7.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.63e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.37e-1)"	"prognostic favourable (2.91e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-3)"	8.6	15.4	16.1	19.2	17.9	14.2	5.3	22.7	30.6	6.7	7.1	13.3	8.8	16.6	7.1	7.2	17.0	7.0	9.3	11.0	17.2	16.3	11.7	15.0	8.2	10.4	12.6	24.1	6.4	12.2	16.5	17.6	6.8	17.6	7.9	4.9	10.2	15.3	8.4	12.8	12.6	13.0	6.2	9.3	15.7	10.3	13.5	10.6	1.7	9.3	7.5	7.7	8.5	7.6	0.2	0.2	16.6	0.6	0.1	0.4	0.1	4.5	6.9	7.7	8.2	7.8	7.7	6.5	8.5	8.7	7.3	3.6	6.0	10.2	4.7	5.5	9.2	10.5	0.6	4.8	2.1	4.2	11.8	3.3	5.9	7.2	5.9	1.9	8.1	8.4	4.4	8.8	2.0	5.0	8.4	2.9	4.8	20.6	3.5	7.3	2.9	7.9	8.8	6.4	2.8	5.8	7.2	6.5	6.9	10.8	4.1	8.6	18.2	8.2	7.9	9.6	12.1	7.7	5.0	13.4	4.2	4.1	13.9	5.1	7.9	1.2	0.6	0.3	0.2	0.4	0.0	0.2	0.1	0.1	0.2	0.2	0.4	0.2	16.6	0.1	0.2	0.0	0.2	0.1	16.1	17.9	22.7	30.6	17.2	16.3	12.6	24.1	17.6	10.6
VRK1		ENSG00000100749	"Vaccinia related kinase 1"	Q99986	14	96797304-96931722	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	6.0	4.4	7.1	9.8	17.1	39.0	8.7	8.6	10.2	6.1	7.8	4.4	4.1	5.2	5.9	5.7	9.4	6.9	3.3	6.0	7.4	6.5	6.2	4.3	4.5	18.3	6.9	6.1	5.9	3.7	3.8	5.1	7.1	6.7	5.3	9.1	4.1	4.8	4.1	4.3	6.4	6.9	5.4	6.1	15.7	6.7	33.3	6.9	33.0	4.9	6.1	18.4	5.9	5.7	20.8	13.5	20.1	9.5	28.5	22.3	12.5	15.7	9.1	22.5	10.0	2.7	5.0	14.0	11.9	9.3	19.1	19.0	10.8	15.6	40.1	8.1	7.0	17.5	21.0	15.5	26.3	22.8	11.3	25.0	6.0	11.1	2.9	48.0	15.7	2.7	2.8	14.4	10.6	13.2	21.2	25.4	16.4	18.0	38.1	20.7	14.4	17.3	35.7	39.4	13.6	8.7	16.2	15.9	9.0	10.5	10.8	8.0	12.3	19.0	7.1	8.7	7.8	15.0	11.9	13.3	15.7	38.8	13.6	21.0	10.3	20.1	7.6	14.5	15.1	9.3	18.4	20.3	17.6	18.5	9.9	20.8	19.1	19.3	4.5	28.5	9.5	13.5	22.3	12.5	7.1	17.1	8.6	10.2	7.4	6.5	6.9	6.1	6.7	6.9
VSIG1	MGC44287	ENSG00000101842	"V-set and immunoglobulin domain containing 1"	Q86XK7	X	108044970-108079184	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 29.5;stomach 1: 66.6;testis: 87.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.7;HUVEC TERT2: 11.6;PC-3: 3.9;TIME: 2.9"	"Group enriched"	"Detected in many"	17	"lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.7;T-reg: 11.2"	"Lineage enriched"	"Detected in many"	4	"T-cells: 11.7"	"Not detected"	"Not detected"							"HPA001445, HPA036310, HPA036311"	Enhanced		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350"	"unprognostic (4.33e-3)"	"unprognostic (4.60e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-3)"	0.1	0.0	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.3	0.8	0.1	0.3	0.1	0.2	0.2	0.0	29.5	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.0	1.3	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	66.6	87.4	0.1	0.1	0.1	0.1	0.4	1.5	0.1	2.6	0.1	0.6	0.1	0.2	11.7	2.5	0.2	1.0	0.0	0.2	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.3	0.4	1.0	0.1	1.9	11.6	0.1	0.3	0.0	0.4	0.4	0.3	0.4	3.9	0.3	0.0	0.0	0.7	1.0	0.2	0.1	0.2	0.2	0.6	0.1	0.0	2.9	0.3	0.9	0.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	1.0	0.0	3.7	2.6	7.7	3.3	0.0	1.0	11.7	5.4	0.4	0.2	0.1	0.1	11.2	2.5	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
VSIG10		ENSG00000176834	"V-set and immunoglobulin domain containing 10"	Q8N0Z9	12	118063593-118136026	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 60.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA062022	Enhanced		Approved	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA062022: "	"unprognostic (1.32e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.42e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-2)"	8.1	10.2	2.6	9.8	3.1	0.4	18.0	2.9	2.6	8.2	31.6	2.7	5.2	11.7	4.5	4.5	8.9	4.0	7.6	3.6	2.4	2.2	6.2	11.9	11.6	3.8	3.2	1.4	5.9	10.9	8.9	4.0	12.2	3.4	8.4	13.9	4.0	6.3	6.4	12.9	4.6	60.9	3.8	2.5	3.3	5.5	3.9	2.5	1.7	26.3	6.1	4.9	6.1	8.6	0.7	2.4	3.5	2.0	0.4	0.6	0.4	4.9	7.3	3.2	10.6	13.2	6.0	8.0	8.6	5.6	4.3	3.5	2.1	11.9	0.7	3.4	6.3	12.2	22.1	2.2	5.1	2.4	3.3	1.1	6.9	3.2	2.6	0.7	1.8	2.7	6.5	3.3	2.1	9.3	1.4	0.1	4.0	5.3	0.0	0.7	9.8	4.7	1.8	8.7	0.0	6.2	16.2	2.7	3.4	8.4	3.5	2.2	7.8	3.4	10.8	4.9	3.1	6.1	4.3	0.1	0.1	0.0	7.1	3.5	9.8	0.6	2.0	2.3	0.4	0.6	0.6	0.0	0.4	0.2	2.4	0.7	0.4	0.6	3.5	0.4	0.2	0.7	0.6	0.4	2.6	3.1	2.9	2.2	2.4	2.2	3.2	1.4	3.4	2.5
VSIG4	Z39IG	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.0;U-937: 2.7"	"Cancer enhanced"	"Detected in all"		"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	26	"classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 13.1;monocytes: 13.9"					"Low region specificity"	"Detected in many"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"			41000000	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	67.1	28.1	15.9	17.6	16.6	2.6	19.0	1.8	10.4	6.3	18.0	5.6	1.0	9.2	6.1	14.2	9.3	28.7	15.5	15.9	11.5	3.5	18.5	22.9	61.4	37.0	17.9	3.4	8.2	8.2	3.7	7.9	52.4	12.0	10.9	12.6	8.1	11.3	4.0	10.5	4.0	14.6	39.9	16.7	28.5	9.4	13.5	17.8	0.0	10.7	1.7	1.8	14.4	9.0	0.1	13.1	0.4	13.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.1	3.1	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.8	2.7	0.0	0.0	13.9	0.0	0.0	8.1	0.0	0.0	0.0	0.2	13.1	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.3	15.9	16.6	1.8	10.1	11.5	3.5	17.9	3.4	12.0	17.8
VSNL1	"HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1"	ENSG00000163032	"Visinin like 1"	P62760	2	17539126-17657018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 165.7"	"Group enriched"	"Detected in some"	5	"HaCaT: 43.2;Hep G2: 43.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053808			Approved	Cytosol				Cytosol		"HPA053808: "	"unprognostic (1.04e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (4.90e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.14e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.51e-2)"	1.4	13.6	36.5	1.7	48.8	1.2	3.9	91.6	165.7	1.8	3.0	3.3	0.0	1.3	1.7	1.2	18.0	1.9	1.3	17.5	34.8	27.9	2.0	10.5	2.4	1.2	19.9	66.1	2.8	1.7	1.2	0.2	3.4	64.0	3.0	3.6	0.1	3.2	1.5	1.7	5.2	1.3	1.6	7.1	1.3	1.7	1.5	1.4	0.0	1.5	3.1	4.1	2.3	3.4	0.1	0.7	0.2	0.1	0.1	0.5	0.1	0.2	0.0	0.5	7.8	0.9	1.3	0.0	0.0	0.0	0.0	0.2	0.1	4.7	0.0	0.0	0.0	43.2	0.3	1.5	0.0	0.0	0.2	0.0	0.0	43.6	0.0	0.0	0.1	0.3	2.3	0.0	1.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.1	3.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.5	0.1	0.2	0.1	0.1	0.7	0.0	0.1	36.5	48.8	91.6	138.6	34.8	27.9	19.9	66.1	64.0	1.4
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224689	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol			22000	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavourable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavourable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	18.8	19.5	20.5	15.5	28.2	17.2	20.6	25.0	39.3	17.2	22.0	18.5	9.6	24.2	16.0	17.1	31.4	17.9	14.9	21.2	19.8	20.3	24.9	29.9	13.5	19.3	20.1	20.7	15.3	15.6	16.3	21.7	30.5	30.7	16.8	26.3	11.2	19.4	13.5	48.6	20.9	32.7	17.0	24.0	20.8	14.6	12.9	18.2	33.6	18.0	24.3	24.0	18.4	19.7	29.0	30.9	58.6	38.1	30.9	30.1	36.1	18.1	15.6	25.5	39.0	22.5	24.8	17.6	41.1	24.6	37.7	36.1	26.3	14.2	29.6	27.9	36.8	23.2	27.1	28.1	52.3	20.0	23.8	32.1	16.7	31.4	16.6	49.7	18.6	20.4	32.9	37.6	24.4	24.1	29.7	14.9	31.5	26.4	32.2	25.9	19.1	17.9	29.7	20.4	18.0	29.0	20.1	26.7	20.8	23.1	17.8	20.6	19.3	33.9	17.4	17.0	23.7	28.4	29.5	14.7	25.4	33.7	11.1	27.8	25.8	58.6	31.0	49.5	23.5	38.1	30.1	29.0	26.8	27.4	30.9	26.6	29.8	29.9	19.1	30.9	37.4	19.0	25.7	36.1	20.5	28.2	25.0	39.3	19.8	20.3	20.1	20.7	30.7	18.2
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 24.4;testis: 51.9"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA036700: , HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.0	0.2	1.7	0.0	0.0	0.0	0.2	1.1	0.2	2.0	0.0	0.0	0.5	4.3	0.0	24.4	0.5	0.4	1.7	1.6	0.0	0.0	4.0	0.0	0.1	0.1	2.3	0.0	0.0	1.1	0.1	3.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	51.9	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.1	1.7	1.6	0.1	0.1	3.2	0.3
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.6;epididymis: 6.4;testis: 6.9"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 5.2"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"			Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: "	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	1.2	0.7	0.2	3.3	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	0.0	6.4	0.1	0.7	0.5	0.1	2.8	3.3	2.0	0.0	0.1	0.2	0.2	0.4	0.0	0.1	2.2	5.6	0.2	17.6	0.2	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.5	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.5	2.8	3.3	0.2	0.4	17.6	0.5
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;HeLa: 3.3;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"			"Plasma membrane, Cytosol"		"HPA046954: , HPA054262: "	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favourable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.4	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.1	0.5	0.7	0.3	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.3	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.0	0.2	3.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	2.0	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.4	1.2	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295424	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.8;ovary: 10.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6;Hep G2: 18.9;HSkMC: 11.1;REH: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"		1300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: , HPA043921: "	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.9	1.1	0.9	0.6	1.3	2.3	3.1	0.7	1.3	2.8	1.0	1.4	3.4	0.5	1.4	2.9	1.5	5.7	1.4	1.0	1.3	1.2	0.6	19.8	0.8	0.3	0.4	1.1	10.7	0.1	0.5	0.5	9.1	0.3	1.8	0.6	1.3	1.7	1.0	1.9	0.9	1.1	1.2	0.2	0.9	0.3	1.8	0.5	6.5	0.8	1.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.2	1.1	0.4	0.2	1.7	0.0	0.2	5.6	0.0	0.3	0.0	0.4	0.0	2.0	0.0	0.1	0.4	0.0	0.5	0.0	18.9	1.0	0.0	0.1	11.1	0.5	0.5	0.0	1.7	0.2	0.3	0.3	0.0	4.1	0.0	1.6	0.0	10.6	0.1	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.5	0.7	0.0	0.4	0.2	0.3	0.5	0.1	0.2	0.4	0.9	0.8	0.2	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.7	1.3	1.3	1.2	0.4	1.1	0.3	0.5
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 29.5"	"Cell line enhanced"	"Detected in many"		"K-562: 10.6;NTERA-2: 5.3;SCLC-21H: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA026619, HPA036044"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"			Cytosol	Nucleoplasm	"HPA026619: , HPA036044: "	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.4	0.5	1.6	0.3	2.7	2.3	2.3	0.4	2.3	0.8	0.9	0.0	0.9	0.2	0.7	4.9	0.8	1.5	0.7	4.1	0.8	0.5	0.7	0.5	0.7	0.2	0.4	0.5	0.5	0.9	0.0	29.5	0.3	0.5	1.5	0.3	0.1	5.7	5.5	0.4	0.6	0.6	0.2	0.4	0.5	2.0	0.6	0.0	0.1	6.2	0.0	1.3	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.5	0.0	0.3	1.7	0.0	2.0	0.7	0.8	0.4	3.0	0.2	0.0	0.0	0.4	2.1	1.9	0.6	3.9	2.2	3.5	4.7	0.0	0.0	1.0	2.3	0.1	0.3	0.0	1.2	0.8	10.6	0.0	0.0	1.2	0.0	0.0	5.3	0.6	0.0	0.0	1.6	0.0	1.3	8.5	1.3	0.0	1.7	0.0	0.0	1.1	0.1	0.0	1.0	0.0	0.8	3.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.9	0.1	1.6	2.7	0.4	2.3	0.8	0.5	0.4	0.5	0.5	0.0
WARS	"IFI53, IFP53"	ENSG00000140105	"Tryptophanyl-tRNA synthetase"	P23381	14	100333788-100376805	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.8;thyroid gland: 157.0"	"Cell line enhanced"	"Detected in all"		"HHSteC: 116.6;SK-MEL-30: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 131.2;non-classical monocyte: 142.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol			53000000	Cytosol		"HPA005573: , HPA018944: "	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favourable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	42.5	23.3	14.5	53.9	20.1	17.0	20.6	10.7	25.4	11.1	19.1	13.3	7.1	12.7	16.5	20.5	17.8	14.5	13.7	32.0	17.8	18.7	24.6	17.9	68.5	35.3	16.9	14.8	12.1	15.6	9.4	23.5	89.6	28.2	16.4	21.0	23.5	15.7	11.7	22.3	9.3	19.8	21.0	15.7	51.6	19.8	23.7	9.4	20.9	157.0	19.2	22.7	24.0	13.8	5.6	27.7	51.8	142.8	3.3	3.4	46.4	10.9	10.4	6.8	39.9	9.9	14.1	11.0	14.1	27.3	30.5	38.4	6.8	9.8	11.9	13.2	33.7	18.6	19.9	16.1	19.6	18.8	5.7	7.6	7.9	8.3	116.6	21.8	12.6	16.0	23.2	17.7	36.8	27.2	24.0	31.5	13.0	20.9	7.5	10.2	6.9	18.9	6.2	10.8	7.6	14.8	9.6	18.4	10.7	8.4	7.3	140.8	18.8	27.6	18.0	3.3	7.3	33.3	7.4	61.5	31.2	22.1	36.7	16.9	29.7	6.1	39.5	51.8	3.4	131.2	3.1	5.6	2.8	3.1	27.7	4.1	2.0	2.4	14.1	3.3	142.8	4.2	3.3	46.4	14.5	20.1	10.7	25.4	17.8	18.7	16.9	14.8	28.2	9.4
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"Wiskott-Aldrich syndrome"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 55.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;HMC-1: 45.7;MOLT-4: 19.4;NB-4: 21.1;RPMI-8226: 26.0;U-266/70: 24.2;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"			320000	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favourable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favourable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavourable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	7.6	4.0	4.9	28.9	7.8	30.7	3.3	2.0	5.1	2.7	4.4	5.9	0.5	4.8	2.4	5.6	3.7	4.5	4.4	3.0	4.6	4.1	4.1	5.0	12.6	29.9	7.6	1.3	2.6	2.2	0.7	2.6	5.4	6.0	3.2	3.2	3.5	5.4	1.9	1.4	2.2	14.3	3.7	12.8	55.9	4.1	1.7	7.3	53.2	2.8	1.4	33.2	5.8	2.5	2.1	3.5	20.3	5.3	2.1	3.2	2.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	21.3	0.0	0.0	0.7	0.0	0.0	0.0	12.2	0.1	18.8	0.2	0.0	0.2	9.6	45.7	0.0	0.0	0.0	0.0	0.0	0.2	13.1	0.0	2.1	19.4	21.1	0.1	0.1	16.9	0.0	26.0	0.0	0.0	0.1	0.2	0.3	0.2	0.2	0.1	19.2	0.1	0.0	0.1	0.3	0.0	24.2	11.8	14.9	0.1	24.4	0.0	1.8	4.6	20.3	3.0	5.0	2.2	1.8	2.3	2.5	3.5	2.1	2.1	2.3	18.1	2.1	5.3	1.8	3.2	2.0	4.9	7.8	2.0	5.1	4.6	4.1	7.6	1.3	6.0	7.3
WASF2	"SCAR2, WAVE2"	ENSG00000158195	"WAS protein family member 2"	Q9Y6W5	1	27404226-27490158	"Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022632, HPA045288"	Enhanced		Approved	"Plasma membrane,Cytosol"			470000	"Plasma membrane"	Cytosol	"CAB022632: , HPA045288: "	"unprognostic (9.58e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavourable (5.29e-8)"	"unprognostic (3.94e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (8.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.26e-2)"	36.9	23.3	22.0	23.8	30.0	30.0	28.6	13.6	24.0	31.9	28.8	33.2	13.2	15.7	36.9	16.0	55.3	28.8	22.3	20.5	22.8	13.1	20.2	11.6	29.4	31.1	32.5	12.6	38.8	24.0	21.3	14.8	29.7	23.2	26.4	23.3	22.2	25.6	26.1	11.4	35.1	26.7	42.9	31.5	34.0	26.4	20.7	32.7	32.3	21.6	22.2	35.2	39.1	30.3	18.9	21.8	36.9	38.4	8.5	12.9	16.8	24.1	11.6	26.9	24.4	19.6	25.7	15.6	19.7	18.4	21.8	19.7	10.0	26.1	16.8	19.1	30.8	19.4	21.7	32.4	26.2	23.5	13.6	36.6	20.5	11.8	26.5	29.2	21.2	23.5	35.4	23.7	44.4	27.3	29.1	8.7	29.5	8.7	21.7	13.5	21.7	17.8	45.5	33.1	17.1	15.6	13.7	13.4	14.8	34.4	15.4	25.8	12.8	17.8	35.7	18.1	18.8	37.5	15.5	18.0	23.7	22.5	21.4	36.3	20.3	14.8	23.3	18.5	12.9	29.1	10.5	14.1	10.2	8.9	14.8	18.9	10.7	8.1	36.9	8.5	38.4	21.8	10.2	16.8	22.0	30.0	13.6	24.0	22.8	13.1	32.5	12.6	23.2	32.7
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoli, Cytosol"	"HPA047844: , HPA060975: , HPA061022: "	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavourable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	24.0	21.0	15.8	31.4	19.3	24.7	27.1	22.5	18.3	19.1	21.2	16.2	12.6	19.4	22.8	15.3	15.7	15.5	14.4	42.9	17.6	13.9	26.1	12.1	20.7	20.2	15.3	15.8	22.5	14.0	21.2	27.0	17.7	22.0	16.7	23.0	13.1	17.5	16.5	15.5	19.2	21.3	16.8	14.6	27.4	16.2	9.4	14.8	27.0	21.4	9.8	20.2	18.4	27.4	6.6	9.0	11.7	13.9	9.0	12.5	8.8	10.9	5.3	9.1	10.6	37.1	20.8	7.4	12.9	27.4	19.2	20.6	12.4	16.5	9.7	8.1	19.2	12.0	13.1	10.9	19.0	9.2	9.5	6.9	10.7	12.4	25.9	11.7	12.0	21.3	13.7	21.0	13.3	14.5	11.2	9.8	23.1	7.8	6.4	19.2	7.4	25.2	9.8	13.2	5.7	13.2	12.7	3.1	9.8	12.0	11.2	17.2	13.8	8.1	21.3	9.8	8.3	27.8	10.6	10.1	20.1	8.3	21.6	21.6	3.9	1.2	10.7	11.7	12.0	13.9	12.5	6.6	10.2	11.0	9.0	6.5	10.2	7.4	5.1	9.0	8.2	5.3	10.4	8.8	15.8	19.3	22.5	18.3	17.6	13.9	15.3	15.8	22.0	14.8
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792961	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoli, Cytosol"	"HPA047844: , HPA060975: , HPA061022: "	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavourable (1.35e-5)"	"prognostic favourable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	17.2	15.8	10.0	33.6	15.7	30.1	27.2	24.9	17.1	16.7	15.8	10.7	15.9	12.2	18.3	17.0	12.3	13.2	13.6	23.2	14.2	10.2	20.6	12.8	17.3	14.8	16.0	8.4	20.2	10.1	22.7	16.5	13.4	16.2	13.4	18.5	13.0	15.3	24.0	17.1	14.8	17.0	15.8	14.0	15.5	12.5	10.1	15.3	19.4	14.9	13.2	14.6	19.3	14.8	10.7	11.4	17.2	20.3	12.2	13.4	11.6	11.1	12.0	9.8	11.1	25.5	22.6	5.9	13.1	21.6	15.5	14.9	7.3	10.9	9.2	8.9	19.3	10.1	10.9	6.0	15.6	8.5	9.1	9.5	14.9	5.6	27.1	9.5	11.8	21.3	14.6	16.8	12.6	15.9	15.1	7.3	19.0	5.8	6.3	16.4	7.1	1.8	7.9	14.4	4.7	11.5	17.5	4.8	10.8	15.2	7.7	18.4	10.4	9.6	26.7	8.1	8.7	21.3	8.7	10.3	15.9	9.1	11.4	22.9	4.3	12.5	16.9	11.0	13.0	18.2	12.5	10.7	10.8	13.4	11.4	9.6	10.8	9.7	17.2	12.2	20.3	8.4	10.1	11.6	10.0	15.7	24.9	17.1	14.2	10.2	16.0	8.4	16.2	15.3
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"Wiskott-Aldrich syndrome like"	O00401	7	123681935-123749067	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 44.3;U-2197: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favourable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	17.9	19.3	25.6	11.6	29.5	3.8	20.7	21.0	39.3	23.7	31.2	17.0	8.9	27.4	21.0	14.6	22.5	14.8	21.7	15.4	35.2	22.5	33.3	34.5	15.3	5.5	18.8	23.0	27.8	21.9	36.7	16.9	25.4	28.6	19.9	28.8	18.0	16.9	19.5	21.6	14.4	30.2	18.2	16.6	12.1	22.0	17.3	15.0	10.0	26.7	12.0	9.7	23.7	21.1	4.6	4.5	4.9	6.2	6.2	4.3	1.5	10.7	7.9	8.8	7.5	13.8	14.4	11.4	7.5	12.5	5.5	7.2	6.5	13.6	1.1	6.0	11.3	8.1	16.2	8.2	8.6	1.8	6.4	0.9	6.6	7.0	15.1	1.4	0.9	11.5	15.5	8.2	14.0	9.5	4.8	2.1	13.2	6.5	1.8	1.9	16.4	7.3	1.1	7.1	2.4	11.7	44.3	10.8	15.9	10.3	31.1	20.1	6.0	1.4	10.8	14.9	4.2	42.0	7.3	2.4	0.8	2.4	12.9	1.2	11.9	4.9	4.1	1.8	4.3	4.1	3.6	4.6	2.8	2.6	3.5	3.2	3.6	3.8	1.8	6.2	6.2	4.5	1.4	1.5	25.6	29.5	21.0	39.3	35.2	22.5	18.8	23.0	28.6	15.0
WBP1	WBP-1	ENSG00000239779	"WW domain binding protein 1"	Q96G27	2	74458329-74460891	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057067	Approved		Approved	Cytosol				Cytosol		"HPA057067: "	"unprognostic (5.94e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (6.05e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (6.83e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favourable (6.36e-4)"	17.6	23.5	37.6	12.6	34.8	15.1	18.1	12.1	27.5	22.4	14.9	34.4	23.6	15.9	19.2	26.1	19.0	31.0	20.6	21.2	30.9	22.7	23.0	26.4	15.4	15.5	28.6	17.2	27.6	35.9	27.7	22.1	15.4	20.8	29.8	10.2	32.1	49.1	25.5	15.3	19.7	15.8	16.4	25.2	14.7	17.9	10.6	17.0	40.5	36.0	17.2	17.6	18.7	19.2	19.2	30.3	15.3	18.5	21.5	24.0	16.5	6.1	29.2	17.8	20.1	22.8	17.5	13.4	6.6	12.3	6.6	5.4	15.2	11.7	6.0	11.8	15.1	9.1	7.2	17.1	6.4	23.6	17.0	8.4	13.8	21.3	14.5	3.0	8.3	24.5	18.2	8.8	13.1	13.1	3.3	21.5	16.7	41.6	10.3	7.7	12.7	15.6	10.4	20.0	9.0	17.5	26.0	10.5	26.3	8.8	14.6	18.1	19.5	8.1	8.1	16.0	13.2	6.2	6.4	32.8	11.4	7.0	17.2	7.9	14.1	15.3	18.5	12.2	18.1	14.2	15.9	19.2	16.0	17.6	19.4	18.8	22.4	19.4	13.0	21.5	12.0	30.3	24.0	16.5	37.6	34.8	12.1	27.5	30.9	22.7	28.6	17.2	20.8	17.0
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Approved	Nucleoplasm,Cytosol			870000	"Nucleoplasm, Cytosol"		"HPA065682: , HPA068819: "	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	37.4	50.4	59.5	22.8	79.8	29.9	22.6	62.5	119.3	24.3	20.4	75.2	15.0	27.0	22.9	19.7	25.7	36.6	26.4	51.6	58.7	56.4	32.0	48.7	31.9	22.3	62.1	56.2	41.8	35.7	36.8	24.5	23.0	110.8	32.2	17.2	40.3	55.5	33.6	47.1	28.2	25.9	23.0	55.6	30.5	27.4	28.5	44.3	10.6	26.8	15.7	21.5	24.5	18.3	14.9	11.1	63.5	25.5	11.2	15.1	16.8	26.5	30.9	11.7	13.8	24.0	24.0	15.3	8.6	27.2	19.9	24.8	15.4	27.2	13.8	22.1	12.2	16.0	12.2	26.1	18.4	10.1	23.5	25.4	18.8	24.9	49.5	10.4	43.5	26.5	25.0	23.5	33.1	38.6	17.0	41.8	16.0	27.1	21.6	21.6	9.9	20.5	14.9	23.3	25.6	29.0	16.5	19.6	30.6	15.1	26.3	41.9	35.4	26.2	22.1	20.4	18.0	19.7	13.6	38.7	27.7	10.3	57.1	9.8	14.4	42.8	16.7	56.0	11.6	20.5	12.9	14.9	13.0	11.7	11.1	12.0	12.6	10.3	63.5	11.2	25.5	8.6	15.1	16.8	59.5	79.8	62.5	119.3	58.7	56.4	62.1	56.2	110.8	44.3
WDCP	"C2orf44, FLJ21945"	ENSG00000163026	"WD repeat and coiled coil containing"	Q9H6R7	2	24029340-24049575	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041054	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041054: AB_10796566"	"unprognostic (1.07e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (5.14e-8)"	"unprognostic (7.69e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.00e-1)"	11.7	9.6	8.3	7.6	9.4	2.4	9.2	14.6	9.8	9.6	9.3	11.5	8.4	5.3	10.7	8.0	7.4	7.2	5.6	6.8	7.1	6.9	7.5	8.9	5.4	12.4	8.3	4.8	11.6	7.7	11.2	9.4	8.5	8.7	8.7	6.2	7.8	7.1	12.9	13.8	5.9	7.5	7.4	8.0	9.4	7.0	12.5	9.2	17.9	8.9	5.5	13.7	9.4	6.4	4.9	4.3	1.5	3.8	5.0	7.8	4.2	7.2	11.1	12.3	8.5	8.5	6.8	4.4	8.8	4.7	9.2	8.8	10.1	3.3	19.0	3.8	4.5	5.3	17.4	6.0	9.6	11.4	10.0	11.5	5.5	10.5	5.8	10.5	8.0	4.0	4.7	9.4	4.7	8.7	16.0	5.3	9.6	3.3	13.7	6.3	14.8	8.7	15.1	20.8	7.6	4.3	3.6	9.5	13.1	4.3	4.2	5.4	3.3	4.7	8.2	7.4	8.2	4.4	8.0	8.7	10.9	26.8	4.8	11.3	5.7	0.0	2.4	1.5	7.5	3.8	7.8	4.9	5.0	5.5	4.3	4.7	6.8	7.5	0.7	5.0	2.6	1.6	7.1	4.2	8.3	9.4	14.6	9.8	7.1	6.9	8.3	4.8	8.7	9.2
WDFY3	"ALFY, KIAA0993, ZFYVE25"	ENSG00000163625	"WD repeat and FYVE domain containing 3"	Q8IZQ1	4	84669610-84966391	"Disease related genes, Predicted intracellular proteins"	Autophagy	"Developmental protein"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	23	"dendritic cells: 1.1;granulocytes: 4.3;monocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042734, HPA048572"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"				Cytosol	"Nucleoli, Plasma membrane"	"HPA042734: , HPA048572: "	"unprognostic (7.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"prognostic favourable (3.64e-5)"	"prognostic unfavourable (9.35e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.95e-2)"	10.1	15.2	17.2	7.5	18.7	13.1	9.0	17.9	18.6	9.6	8.3	17.6	4.8	3.6	11.5	6.9	9.4	9.3	9.0	7.3	17.3	6.5	21.3	5.8	7.9	2.4	22.8	9.5	14.7	9.0	24.0	14.6	11.8	17.0	9.2	5.9	8.6	9.8	8.1	13.7	10.9	5.6	8.7	14.8	7.5	7.8	8.0	21.4	0.4	12.1	3.2	2.6	14.2	6.6	0.0	1.1	4.3	1.5	0.0	0.0	0.3	6.3	4.4	8.0	4.4	14.2	11.1	5.0	6.1	6.5	6.4	5.8	4.9	5.3	0.0	6.4	10.2	3.2	8.5	6.7	8.2	4.4	2.7	4.0	4.8	2.9	5.3	3.1	7.6	8.1	6.1	8.4	8.5	20.4	4.1	19.6	11.8	4.6	3.0	0.7	4.1	2.2	4.5	6.4	0.9	11.1	8.5	9.4	4.4	7.6	8.4	4.2	4.3	7.8	31.0	8.5	8.5	4.7	7.7	0.0	0.0	0.0	5.8	2.7	9.3	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	0.3	17.2	18.7	17.9	18.6	17.3	6.5	22.8	9.5	17.0	21.4
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.7;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 29.4;HDLM-2: 26.9;HL-60: 10.2;THP-1: 9.1;U-698: 12.5;U-937: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7"	"Group enriched"	"Detected in many"	7	"B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2"	"Low region specificity"	"Detected in many"							HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	2.7	1.5	3.6	31.2	5.4	8.6	1.5	0.9	2.7	1.2	1.6	5.2	0.0	1.1	1.2	1.5	1.5	1.5	2.6	1.4	3.1	1.9	1.7	1.2	9.4	20.8	5.3	0.6	1.1	1.1	0.2	1.1	0.8	3.7	1.2	1.5	1.2	5.7	0.4	0.9	2.0	10.2	1.3	7.3	19.1	1.6	1.5	4.4	4.1	1.6	0.9	26.6	3.0	1.2	12.5	19.7	6.2	1.7	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	3.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	12.1	0.0	0.0	1.7	0.0	0.0	1.6	0.0	8.9	0.0	0.1	6.7	12.5	0.0	0.0	6.2	0.0	0.8	19.7	0.0	0.6	3.6	5.4	0.9	2.7	3.1	1.9	5.3	0.6	3.7	4.4
WDR11	"BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15"	ENSG00000120008	"WD repeat domain 11"	Q9BZH6	10	120851175-120909524	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038980	Approved		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA038980: AB_10675955"	"unprognostic (8.98e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.84e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.80e-3)"	"prognostic favourable (5.04e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.38e-2)"	18.6	21.9	10.6	17.4	17.2	6.2	16.4	17.1	18.9	17.3	15.5	21.5	18.0	14.5	22.6	15.9	19.6	21.0	15.7	10.6	11.5	12.7	25.2	19.8	14.9	17.0	13.9	10.6	19.4	16.1	33.9	17.7	18.4	26.0	16.5	17.3	19.0	20.3	21.5	8.5	14.8	19.9	17.5	20.0	19.7	18.9	12.8	12.9	20.6	24.0	11.7	19.8	22.0	17.3	6.4	6.8	15.5	16.3	3.9	3.3	3.4	11.9	11.8	11.6	19.1	16.3	20.8	8.1	11.6	23.2	12.9	16.4	6.6	13.4	8.7	6.0	17.1	11.8	13.4	16.0	16.0	11.8	11.5	9.4	9.5	6.3	15.4	13.0	10.9	17.0	12.8	11.7	19.1	24.3	7.4	10.9	13.7	5.1	8.1	5.1	5.6	7.5	3.3	19.6	7.5	15.0	10.0	5.8	10.3	10.0	11.2	30.6	8.2	8.4	17.9	8.9	5.4	1.3	10.7	5.5	3.4	10.8	12.7	10.8	4.6	15.5	5.9	2.5	3.3	8.0	2.6	6.4	2.3	3.1	6.8	3.8	2.4	2.5	0.5	3.9	16.3	1.6	2.9	3.4	10.6	17.2	17.1	18.9	11.5	12.7	13.9	10.6	26.0	12.9
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874782-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	5.8	9.7	7.2	5.5	16.1	6.7	7.6	11.5	15.2	5.9	6.2	6.5	3.7	8.9	7.1	7.0	8.0	6.7	5.0	8.4	6.8	8.6	11.1	8.7	4.2	6.4	7.4	8.9	7.3	5.7	6.7	8.0	6.6	12.6	4.9	8.7	6.7	5.4	5.2	11.0	7.7	6.0	7.4	6.2	5.3	5.6	17.1	8.2	9.6	7.1	5.1	7.5	5.8	5.6	5.4	6.9	3.6	5.0	3.6	5.9	3.0	4.3	4.6	5.3	10.0	10.0	8.6	9.7	6.6	5.3	8.2	8.0	11.6	6.1	7.9	6.1	5.3	5.5	14.3	10.6	13.2	4.0	8.9	13.4	7.4	13.7	6.5	17.4	8.2	7.8	7.7	9.7	19.4	8.5	20.9	5.2	9.0	5.0	11.9	10.2	12.1	11.7	8.7	8.3	12.4	9.0	5.2	9.3	8.2	5.2	6.8	8.1	4.0	11.5	6.8	7.4	6.0	6.1	7.3	6.8	10.3	13.3	7.3	11.9	7.3	3.6	4.7	2.0	4.2	5.0	5.9	5.3	4.0	4.3	6.0	5.4	5.2	5.0	2.1	3.6	4.5	6.9	4.3	3.0	7.2	16.1	11.5	15.2	6.8	8.6	7.4	8.9	12.6	8.2
WDR24	"C16orf21, DKFZp434F054, JFP7"	ENSG00000127580	"WD repeat domain 24"	Q96S15	16	684622-690444	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039506	Approved		Supported	Vesicles,Cytosol				Vesicles	Cytosol	"HPA039506: AB_10795148"	"unprognostic (9.07e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.15e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.05e-1)"	"prognostic favourable (3.75e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	8.8	11.6	10.9	9.8	11.3	9.3	9.2	18.9	17.6	7.6	7.8	8.2	6.5	12.1	10.2	10.2	9.4	9.3	8.5	9.9	9.5	7.8	9.0	15.7	15.3	17.7	8.7	11.1	12.8	14.5	17.0	11.9	9.2	8.8	10.3	3.6	8.8	16.2	8.8	16.9	13.5	10.2	10.0	10.6	13.3	10.5	17.6	9.5	17.9	11.8	7.9	6.5	9.2	7.8	7.1	7.7	6.5	10.3	4.3	10.7	7.1	4.4	10.3	4.8	6.6	4.6	3.3	8.4	5.6	5.0	7.0	6.1	11.2	6.6	6.9	9.8	2.5	7.0	4.6	5.5	1.5	11.6	14.6	4.7	13.8	4.3	7.3	5.7	7.4	5.7	3.7	5.0	4.2	3.8	9.2	7.8	2.6	16.3	10.0	4.2	7.3	8.1	14.9	3.9	12.7	2.3	3.1	11.9	5.4	6.3	11.0	6.2	10.0	5.8	5.6	5.2	5.4	5.6	5.4	16.8	15.2	11.3	3.3	5.7	7.1	6.5	7.5	4.0	10.7	4.5	8.7	7.1	6.9	7.8	7.7	6.4	8.2	7.7	1.8	4.3	10.3	6.2	8.9	7.1	10.9	11.3	18.9	17.6	9.5	7.8	8.7	11.1	8.8	9.5
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385143-224437033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028539: AB_10669752, HPA061094: "	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavourable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	8.2	7.2	6.7	6.7	6.7	18.5	7.2	8.2	7.3	7.8	7.0	6.7	6.7	4.0	6.8	9.3	13.0	5.9	7.0	7.5	6.7	5.0	6.7	9.3	9.0	7.2	6.7	6.7	7.0	6.9	9.2	6.7	8.7	6.7	7.0	6.7	6.7	7.2	6.7	15.2	9.9	6.7	7.1	6.7	10.2	6.3	63.9	6.7	6.7	7.0	6.7	7.4	6.7	8.3	1.5	2.1	8.3	3.9	2.7	2.7	1.3	11.9	6.2	19.3	8.9	25.8	29.4	13.9	17.6	28.8	16.1	15.2	9.8	13.6	14.2	17.7	28.3	10.9	11.3	15.1	26.5	11.1	12.9	9.8	8.1	9.2	28.1	10.2	17.2	27.3	21.9	17.0	16.1	26.8	12.9	14.7	21.1	6.6	10.5	9.9	18.6	7.2	9.7	20.2	11.2	19.6	12.1	7.0	17.9	20.0	27.1	21.5	31.1	16.8	28.1	13.8	6.3	12.9	21.1	15.7	7.5	9.7	15.7	7.3	17.0	4.1	1.9	3.3	2.7	2.4	1.5	1.5	1.9	2.1	1.8	1.4	1.4	2.1	8.3	2.7	3.9	2.1	1.6	1.3	6.7	6.7	8.2	6.7	6.7	5.0	6.7	6.7	6.7	6.7
WDR31	FLJ35921	ENSG00000148225	"WD repeat domain 31"	Q8NA23	9	113313222-113340298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019340, HPA019347"	Approved		Approved	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA019340: AB_1858800, HPA019347: AB_2215267"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-3)"	"prognostic favourable (1.85e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (1.90e-9)"	"unprognostic (9.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-3)"	"unprognostic (8.50e-2)"	2.2	6.8	4.1	1.0	8.2	1.5	4.7	1.7	5.5	3.2	2.4	4.0	8.8	1.5	4.5	3.3	2.4	6.3	2.3	8.9	3.3	4.1	5.6	3.1	2.3	0.9	3.5	2.7	3.7	3.0	16.6	11.2	1.0	4.0	3.4	2.2	5.8	10.2	7.5	1.3	2.5	1.1	2.2	3.6	0.8	2.1	7.3	1.7	3.8	7.1	1.4	0.8	3.0	2.0	1.6	0.9	4.4	1.0	2.3	1.4	0.8	5.5	4.2	1.5	3.0	5.0	5.9	1.4	1.4	2.7	1.4	1.7	0.7	3.6	2.1	1.0	2.0	3.6	1.2	2.7	2.7	3.3	0.3	1.7	2.2	0.7	5.7	0.9	0.3	3.1	3.6	5.8	5.1	1.1	4.5	1.9	1.5	3.8	2.4	1.4	0.9	5.2	2.1	1.2	2.5	3.7	1.2	3.6	2.7	6.7	1.2	3.2	8.7	0.9	0.6	2.0	2.2	5.0	1.5	4.0	3.8	0.5	3.0	1.4	1.9	4.4	1.0	1.0	0.9	0.6	0.8	0.9	1.0	0.8	0.8	1.6	1.4	1.3	3.4	2.3	0.7	0.9	0.7	0.8	4.1	8.2	1.7	5.5	3.3	4.1	3.5	2.7	4.0	1.7
WDR34	"bA216B9.3, DIC5, FAP133, MGC20486"	ENSG00000119333	"WD repeat domain 34"	Q96EX3	9	128633661-128656787	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 19.1;naive B-cell: 25.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040764, HPA041091"	Approved		Approved	Cytosol				Cytosol		"HPA040764: AB_10795625, HPA041091: AB_10796237"	"unprognostic (1.45e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (2.55e-1)"	"prognostic favourable (7.01e-5)"	"unprognostic (2.27e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavourable (8.79e-4)"	"unprognostic (6.04e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.65e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-1)"	6.3	23.0	8.2	16.9	9.0	23.4	21.3	4.2	12.3	12.6	13.6	7.4	24.1	17.3	11.4	19.9	17.3	24.4	24.2	13.6	8.0	9.1	23.6	16.0	14.4	9.1	5.6	8.0	13.1	23.9	14.8	18.2	15.1	14.2	14.5	8.3	11.2	21.6	24.1	7.3	12.3	14.3	9.2	6.2	11.6	16.1	51.0	7.1	42.1	33.1	17.8	13.7	8.6	11.2	25.3	5.6	0.9	2.5	2.0	2.8	1.9	22.9	41.4	11.2	16.3	2.4	3.6	33.0	10.2	6.7	13.8	8.9	20.3	41.6	8.7	7.0	6.1	38.3	9.7	10.5	3.4	19.6	8.7	5.5	29.4	10.3	3.1	8.7	8.9	1.6	5.3	13.9	3.9	9.4	17.0	7.3	7.3	87.8	31.4	22.2	13.8	25.7	33.9	14.2	28.3	8.6	7.6	27.1	21.9	30.7	28.3	7.4	48.4	8.4	6.0	16.9	25.2	20.3	18.8	8.5	20.7	8.0	15.2	8.7	15.3	0.9	0.5	0.2	0.8	0.8	1.2	19.1	1.5	2.1	1.4	25.3	0.6	0.9	0.4	2.0	2.5	5.6	2.8	1.9	8.2	9.0	4.2	12.3	8.0	9.1	5.6	8.0	14.2	7.1
WDR4	"TRM82, TRMT82"	ENSG00000160193	"WD repeat domain 4"	P57081	21	42843094-42879568	"Predicted intracellular proteins"	"DNA damage, tRNA processing"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017381	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA017381: AB_1858807"	"unprognostic (3.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (5.48e-7)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.46e-2)"	9.1	9.3	8.4	14.2	8.4	12.1	7.5	9.3	11.1	7.6	7.2	6.7	6.5	10.7	12.5	5.1	17.4	8.2	8.1	6.1	8.3	4.9	7.3	12.2	7.8	18.2	8.9	8.4	9.7	22.0	6.9	8.4	8.9	8.5	7.0	7.0	6.8	11.8	8.4	13.1	10.2	7.5	7.4	6.6	11.7	7.3	10.9	9.6	10.1	9.3	11.3	17.0	8.5	11.1	7.5	9.1	0.2	8.8	4.4	5.5	4.4	14.4	20.4	5.5	7.8	3.3	3.6	13.2	8.4	3.0	7.1	4.6	20.4	7.5	24.2	4.9	6.0	8.1	18.9	10.7	5.1	7.8	18.0	24.3	21.3	17.2	5.8	14.9	6.1	2.0	4.7	9.7	7.1	9.3	29.3	9.0	6.2	12.1	15.4	8.5	13.7	20.0	16.9	3.3	23.9	5.4	8.9	12.9	8.4	8.8	13.1	4.2	8.6	11.6	6.8	11.1	7.4	5.1	16.8	12.4	8.6	19.6	5.4	23.8	13.0	0.0	5.4	0.2	3.5	8.8	4.7	7.5	4.7	4.3	9.1	7.2	4.8	4.9	0.0	4.4	5.0	4.4	5.5	4.4	8.4	8.4	9.3	11.1	8.3	4.9	8.9	8.4	8.5	9.6
WDR41	FLJ10904	ENSG00000164253	"WD repeat domain 41"	Q9HAD4	5	77425970-77620611	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043124	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA043124: AB_10793990"	"unprognostic (1.81e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.15e-3)"	"unprognostic (6.11e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.90e-3)"	16.2	12.8	18.8	13.1	21.7	17.3	16.2	19.5	23.3	15.1	12.6	17.7	9.4	9.4	13.3	13.3	20.6	17.5	12.2	16.9	18.8	17.5	15.8	14.8	14.0	13.9	21.4	20.0	9.4	21.3	14.4	15.8	11.4	28.9	12.0	13.8	11.5	13.7	12.0	19.7	12.8	11.2	19.2	23.3	12.5	11.5	26.6	19.8	8.1	23.1	12.9	16.6	13.5	13.6	8.9	24.8	24.0	18.1	15.8	5.7	7.3	6.7	11.6	16.4	23.9	17.1	24.4	12.9	21.5	23.3	10.2	18.9	10.6	11.4	20.5	9.9	20.3	8.8	12.3	29.4	11.0	24.7	14.1	8.2	13.6	9.1	26.2	17.3	20.4	15.5	37.9	11.5	25.2	16.3	8.1	22.4	16.5	14.5	9.1	11.1	6.1	4.6	21.9	22.4	14.4	11.1	5.7	9.6	11.8	18.4	11.6	17.9	11.5	21.7	14.2	13.8	11.2	7.6	15.7	20.4	16.5	36.7	18.9	7.8	23.0	11.4	14.0	24.0	5.7	16.3	5.5	8.9	3.4	5.1	24.8	5.4	2.3	4.2	6.8	15.8	18.1	11.1	2.6	7.3	18.8	21.7	19.5	23.3	18.8	17.5	21.4	20.0	28.9	19.8
WDR45B	"WDR45L, WIPI3"	ENSG00000141580	"WD repeat domain 45B"	Q5MNZ6	17	82614562-82648553	"Predicted intracellular proteins"	Autophagy		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017886			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA017886: AB_1858810"	"unprognostic (1.91e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-2)"	"prognostic unfavourable (2.98e-5)"	"unprognostic (1.23e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.93e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.02e-1)"	25.4	31.0	37.1	17.2	39.0	38.7	38.9	30.3	38.1	27.4	23.5	35.3	19.9	21.8	25.6	24.9	39.9	32.7	29.5	29.4	36.6	29.2	26.6	22.9	23.5	26.6	38.2	28.5	32.8	35.6	29.9	24.2	19.6	39.2	26.6	21.2	18.8	32.6	23.8	20.9	28.4	25.0	29.3	53.3	19.3	29.5	47.7	39.1	6.8	26.5	23.3	23.5	23.3	24.8	10.0	15.6	22.1	19.3	8.9	12.6	11.9	28.7	19.8	16.7	15.2	15.5	14.4	19.9	21.5	24.3	35.3	30.3	23.6	15.4	8.3	13.5	19.2	16.0	16.0	18.3	32.5	5.2	31.9	16.8	11.3	18.3	20.4	13.2	12.9	15.5	19.3	18.8	17.7	28.4	12.5	7.8	19.6	18.5	9.4	9.1	21.3	26.4	10.3	30.1	8.5	19.1	28.9	21.8	32.1	21.3	21.8	25.1	25.9	10.1	19.3	36.7	28.8	25.8	38.4	20.1	8.6	12.2	23.8	13.4	26.8	16.5	19.3	22.1	12.3	19.2	12.6	10.0	9.7	10.4	15.6	9.9	8.7	7.9	16.2	8.9	14.8	8.0	7.6	11.9	37.1	39.0	30.3	38.1	36.6	29.2	38.2	28.5	39.2	39.1
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 21.6;fallopian tube: 20.7"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;NTERA-2: 3.7;THP-1: 16.7;U-937: 8.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2"	"Group enriched"	"Detected in many"	24	"dendritic cells: 5.2;monocytes: 5.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA036225: AB_10696652, HPA036226: "	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.5	0.7	6.5	1.1	6.8	3.6	0.6	12.6	5.0	1.2	0.9	8.5	0.0	3.9	1.2	4.4	2.1	20.7	0.7	4.7	12.3	5.4	1.0	0.4	4.0	0.9	7.6	2.8	3.2	0.9	0.4	1.7	0.4	21.6	0.7	0.6	0.0	0.7	0.4	0.4	0.5	8.0	0.7	17.6	1.1	0.8	1.5	14.2	0.0	0.5	0.0	1.0	0.8	0.6	0.2	5.2	0.0	5.6	0.0	0.0	0.7	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.8	0.0	0.0	5.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	6.5	6.8	12.6	3.7	12.3	5.4	7.6	2.8	21.6	14.2
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavourable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	4.3	4.3	5.9	6.8	6.9	7.2	5.2	6.4	5.9	4.0	4.2	4.5	7.1	2.1	4.9	6.6	5.1	3.9	3.5	4.0	4.8	3.8	4.0	5.4	3.8	5.5	5.9	4.3	4.3	3.3	7.5	11.9	4.4	6.1	4.1	4.1	4.8	4.0	4.5	6.8	6.7	4.5	4.1	5.0	6.2	4.0	48.0	4.6	7.4	4.2	3.2	6.5	3.9	4.2	7.5	5.9	13.9	6.7	6.5	14.9	4.9	18.7	4.0	7.3	6.5	7.4	6.5	11.6	9.9	7.7	11.3	10.7	11.0	10.0	8.9	33.4	6.0	11.0	9.1	8.5	14.2	14.0	7.9	9.0	9.9	7.2	9.3	12.6	7.4	5.3	12.6	10.0	11.0	8.8	8.8	17.3	8.6	17.5	10.7	13.0	9.9	11.8	12.9	12.5	19.0	6.2	6.6	7.2	7.8	6.9	10.3	14.5	26.4	11.8	8.1	9.6	9.1	10.7	19.3	14.7	29.4	26.7	6.3	16.3	9.6	9.6	5.1	13.9	8.6	4.4	14.0	7.5	12.3	8.7	4.1	7.1	10.3	6.2	4.4	6.5	6.7	5.9	14.9	4.9	5.9	6.9	6.4	5.9	4.8	3.8	5.9	4.3	6.1	4.6
WDR54	FLJ12953	ENSG00000005448	"WD repeat domain 54"	Q9H977	2	74421678-74425755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 56.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043257, HPA053558"	Enhanced		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA043257: AB_10795981, HPA053558: AB_2682189"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.85e-2)"	4.8	6.3	9.4	5.4	17.0	5.0	4.8	8.4	15.4	7.0	3.9	6.0	10.5	3.0	7.0	7.8	3.1	56.8	7.2	3.4	9.9	11.6	7.9	1.4	8.1	8.6	4.8	13.0	8.4	5.4	21.3	16.0	5.4	7.8	5.0	3.7	10.5	3.9	9.0	1.5	3.5	3.9	6.8	3.5	7.7	5.7	27.6	3.7	20.6	5.8	2.5	8.9	6.2	4.0	12.6	23.1	2.3	5.3	13.2	18.7	10.0	15.9	29.6	14.5	12.6	5.3	9.9	4.5	8.1	16.8	21.5	19.9	2.5	12.6	14.2	8.5	9.1	13.7	10.2	36.5	18.8	10.7	6.3	6.9	16.3	1.6	5.4	10.9	5.7	4.4	10.4	21.7	11.3	11.1	2.8	16.8	11.8	24.7	17.2	11.5	11.1	11.2	14.8	16.4	29.7	18.8	8.0	25.3	19.7	6.4	5.8	9.4	9.4	5.2	5.5	11.0	19.4	11.8	18.1	18.4	9.2	3.6	32.5	6.7	8.0	2.3	4.2	0.3	16.2	5.3	16.3	12.6	18.7	17.4	14.1	11.1	13.2	12.8	0.3	13.2	4.5	23.1	17.5	10.0	9.4	17.0	8.4	15.4	9.9	11.6	4.8	13.0	7.8	3.7
WDR59	FLJ12270	ENSG00000103091	"WD repeat domain 59"	Q6PJI9	16	74871367-75000173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041084, HPA048218"	Approved		Approved	Cytosol				Cytosol		"HPA041084: AB_10793867, HPA048218: "	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.16e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (8.83e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.21e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.61e-2)"	10.1	16.8	24.2	13.5	27.4	14.7	15.2	29.0	27.6	14.4	13.6	23.8	17.4	13.7	19.9	23.4	15.2	14.9	13.7	16.2	22.3	17.6	17.5	31.3	11.5	12.3	24.7	19.1	23.3	15.1	30.3	28.7	17.9	22.9	15.0	15.4	13.6	15.5	14.5	22.9	21.9	15.9	16.2	19.7	15.0	14.5	14.0	30.6	17.7	22.4	7.3	16.2	13.0	15.0	3.5	1.6	1.5	1.6	2.0	7.6	1.0	8.4	13.1	15.2	14.5	12.0	10.9	12.9	5.4	9.5	11.7	13.4	17.6	15.0	11.8	6.0	10.0	13.6	12.0	12.9	16.7	7.1	12.9	15.2	8.4	28.4	7.3	10.9	18.5	12.6	10.6	14.1	13.5	12.0	22.3	5.9	5.5	24.9	16.7	19.6	12.1	5.4	16.9	6.7	9.8	12.6	7.6	9.3	10.3	15.5	9.1	6.9	13.7	9.7	10.4	7.3	11.3	8.3	4.6	11.4	15.4	25.9	13.0	7.7	7.9	1.3	1.5	1.4	2.4	0.8	7.6	3.5	4.2	3.4	0.9	2.6	2.8	3.1	1.5	2.0	1.6	1.6	1.9	1.0	24.2	27.4	29.0	27.6	22.3	17.6	24.7	19.1	22.9	30.6
WDR6		ENSG00000178252	"WD repeat domain 6"	Q9NNW5	3	49007062-49015953	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042622	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA042622: AB_10966784"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.97e-6)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.94e-2)"	"prognostic favourable (4.52e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	15.8	36.7	21.5	26.1	23.5	14.9	19.7	29.9	29.9	32.7	31.0	30.8	56.4	27.5	39.0	37.0	18.7	33.1	32.6	20.4	20.1	20.4	26.0	22.0	21.1	28.2	22.8	26.9	60.9	46.0	56.7	55.8	24.3	22.1	39.0	22.1	34.3	33.4	54.4	23.9	26.6	28.3	40.8	17.5	29.1	24.7	23.7	22.1	26.9	50.7	20.3	25.1	31.2	24.6	12.3	14.4	10.3	12.9	11.7	18.9	12.0	17.4	24.1	39.9	33.8	26.8	21.9	27.0	26.1	21.6	29.5	24.0	21.4	25.3	28.1	16.7	41.6	20.0	31.8	36.5	21.1	22.3	21.1	26.6	59.1	28.1	27.2	27.4	12.0	39.3	26.3	27.2	20.6	21.5	15.1	30.1	26.7	34.7	31.8	31.3	35.4	22.4	18.7	17.1	17.7	35.0	51.9	19.4	36.4	19.6	16.1	11.3	28.0	22.0	28.7	22.0	35.4	21.3	34.6	53.2	22.7	24.4	29.8	35.2	15.7	3.7	9.1	10.3	16.9	12.9	18.9	12.0	12.5	12.9	11.3	12.3	14.7	10.9	3.4	11.7	6.5	14.4	10.5	12.0	21.5	23.5	29.9	29.9	20.1	20.4	22.8	26.9	22.1	22.1
WDR61	REC14	ENSG00000140395	"WD repeat domain 61"	Q9GZS3	15	78277835-78299794	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039932, HPA040065"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039932: AB_10796336, HPA040065: AB_10793926"	"unprognostic (1.08e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.74e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.72e-2)"	"prognostic favourable (2.03e-10)"	"unprognostic (1.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.09e-2)"	23.8	34.3	23.5	17.2	31.2	29.6	34.5	25.2	32.1	24.3	22.0	27.6	22.7	20.3	24.2	69.4	25.9	27.4	19.6	23.1	23.7	28.2	34.2	28.2	22.4	18.7	26.8	23.1	20.7	30.7	22.4	37.7	27.7	30.8	27.4	25.7	24.9	28.1	23.1	26.3	29.9	18.5	23.6	27.8	18.6	20.9	38.5	20.9	26.9	32.5	30.1	24.6	19.1	20.3	21.9	45.2	11.1	32.4	22.7	25.2	28.7	9.2	23.6	18.6	19.2	18.4	17.0	14.1	14.1	15.9	18.0	17.7	22.5	16.9	17.8	17.7	16.1	19.7	39.5	17.1	14.9	11.5	31.0	14.3	21.8	21.7	16.1	22.1	16.1	13.1	13.2	7.0	6.0	20.3	26.2	20.0	23.5	28.9	19.3	21.5	13.7	19.0	17.9	14.1	21.7	20.9	28.8	26.0	14.2	19.3	21.8	77.1	14.0	30.5	12.1	14.1	16.7	10.1	24.3	17.2	25.9	25.2	20.5	35.9	28.1	11.1	31.6	10.5	21.5	32.4	23.2	21.9	21.6	22.3	45.2	16.9	23.0	25.2	2.6	22.7	26.3	24.2	23.5	28.7	23.5	31.2	25.2	32.1	23.7	28.2	26.8	23.1	30.8	20.9
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054881-36105106	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 25.6;testis: 88.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	9	"monocytes: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA043255: , HPA043639: "	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.5	0.2	0.2	3.3	0.4	4.3	0.6	0.4	0.5	0.4	0.5	0.4	0.4	0.4	0.4	0.8	1.0	0.2	0.5	5.5	0.5	0.2	0.5	0.3	0.5	1.4	0.2	0.2	0.4	0.2	0.0	0.3	0.7	0.4	0.3	0.3	0.3	0.6	0.2	25.6	1.4	0.7	0.4	0.5	1.1	0.3	88.4	0.3	10.3	0.2	1.3	3.0	0.3	0.7	0.1	0.1	0.0	3.7	0.0	0.3	0.2	10.7	21.5	8.4	7.7	0.5	0.7	4.2	9.3	4.4	13.0	11.7	11.2	4.2	14.0	6.4	4.9	3.7	7.8	3.0	7.7	8.8	5.5	9.5	12.2	7.2	0.1	10.3	14.3	0.2	0.2	9.8	3.9	3.2	12.2	19.2	6.5	13.4	18.0	6.2	4.6	4.5	15.1	7.8	5.6	1.9	4.9	9.4	4.8	7.6	8.7	1.5	5.9	7.5	2.6	13.0	12.8	9.8	15.4	9.3	11.6	16.6	5.2	9.9	14.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.3	0.2	0.2	0.4	0.4	0.5	0.5	0.2	0.2	0.2	0.4	0.3
WDR66	"CaM-IP4, MGC33630"	ENSG00000158023	"WD repeat domain 66"	Q8TBY9	12	121917862-122003927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 21.4;hTCEpi: 20.2;hTERT-HME1: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039902, HPA040005"	Supported		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039902: AB_10795236, HPA040005: AB_10795160"	"unprognostic (4.92e-3)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-3)"	"prognostic favourable (3.11e-4)"	"unprognostic (5.58e-3)"	"unprognostic (6.89e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	1.3	1.2	6.3	1.0	13.2	0.4	1.7	0.4	4.0	4.4	0.5	4.5	1.5	0.4	2.5	11.3	0.5	24.6	2.0	1.5	6.4	3.7	3.2	1.8	6.4	0.9	0.7	3.2	3.9	2.1	4.7	28.4	1.3	18.0	0.8	0.4	1.3	1.3	2.2	0.5	1.8	0.5	1.0	0.9	2.0	0.8	35.0	2.4	0.0	6.7	0.0	1.2	0.8	1.7	0.2	4.9	0.4	0.0	0.1	0.3	0.0	1.8	0.2	0.3	0.1	0.3	0.3	0.3	0.2	1.7	0.8	2.0	0.2	0.9	0.1	2.4	0.1	0.6	0.2	21.4	3.0	0.1	0.3	0.1	0.4	0.2	2.6	0.0	5.9	1.2	20.2	1.6	13.7	0.9	4.8	0.0	1.2	0.6	0.2	0.3	0.3	0.1	0.3	0.5	0.0	3.7	0.3	1.7	0.1	0.2	0.0	0.1	0.5	0.1	0.7	1.7	2.6	0.3	0.3	0.3	0.1	2.5	2.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.4	0.1	0.0	4.9	0.3	0.0	6.3	13.2	0.4	4.0	6.4	3.7	0.7	3.2	18.0	2.4
WDR7	"KIAA0541, TRAG"	ENSG00000091157	"WD repeat domain 7"	Q9Y4E6	18	56651343-57036606	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042074, HPA051057"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042074: , HPA051057: "	"unprognostic (1.03e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.05e-2)"	"prognostic favourable (1.13e-5)"	"unprognostic (4.80e-2)"	"unprognostic (4.52e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	8.0	11.3	14.2	7.9	21.2	9.1	6.8	16.7	34.0	7.5	7.7	11.9	6.1	6.0	7.1	8.1	6.6	6.4	7.7	8.8	17.3	17.9	7.9	10.4	7.2	9.5	14.4	16.4	6.6	6.2	15.6	19.0	6.9	21.1	11.1	7.4	7.9	6.1	8.8	10.5	5.7	6.1	8.3	12.5	8.3	6.9	6.2	12.1	13.2	13.1	4.0	8.2	7.4	6.3	4.5	6.3	9.2	8.7	7.4	9.0	3.2	3.8	6.5	7.5	4.1	11.8	6.9	1.9	7.7	6.6	6.4	7.6	2.6	2.4	10.7	3.1	6.9	4.2	7.5	6.1	8.0	12.4	4.6	10.1	5.3	2.3	7.1	15.2	12.9	5.8	5.1	8.5	5.7	7.9	4.8	14.9	7.8	3.8	10.5	4.5	3.2	4.3	4.7	5.7	5.2	4.9	7.0	9.7	4.8	5.5	2.7	3.6	4.1	4.3	6.9	9.1	4.6	2.7	4.1	15.0	11.1	11.8	7.5	7.7	6.1	7.2	5.0	9.2	6.6	7.6	8.2	4.4	7.5	6.7	6.3	4.5	7.9	7.2	4.6	7.4	8.7	3.0	9.0	3.2	14.2	21.2	16.7	23.7	17.3	17.9	14.4	16.4	21.1	12.1
WDR70	FLJ10233	ENSG00000082068	"WD repeat domain 70"	Q9NW82	5	37379212-37753435	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043064, HPA048149"	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA043064: , HPA048149: "	"unprognostic (2.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavourable (4.34e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.11e-2)"	17.5	13.4	15.4	21.9	22.8	16.3	17.7	30.9	21.1	15.7	16.3	12.0	16.9	10.4	19.6	13.5	15.0	15.6	10.0	13.0	15.8	8.7	11.2	11.8	13.0	18.8	16.2	13.0	18.6	13.9	12.6	14.4	14.0	17.9	13.2	14.3	7.9	15.6	14.4	36.3	17.2	13.3	16.2	18.3	14.0	13.9	12.7	16.5	13.9	13.2	8.4	15.1	17.4	15.7	12.7	15.8	12.6	17.5	11.1	10.3	7.1	9.0	6.0	12.0	15.1	12.1	12.0	16.3	11.6	10.9	13.4	11.4	9.8	9.5	14.8	6.9	11.2	8.4	9.9	10.6	15.0	14.1	12.3	11.2	18.3	6.8	9.1	18.7	10.0	11.5	8.2	10.2	14.2	11.0	13.9	6.2	8.3	6.1	12.0	9.2	8.2	10.7	13.9	29.9	15.1	6.8	10.8	10.3	9.7	38.3	8.5	8.4	11.2	11.9	12.5	12.2	11.7	11.9	9.1	8.3	12.3	17.2	8.2	16.8	10.1	6.2	14.5	12.6	8.8	17.5	9.7	11.4	10.3	9.5	15.3	12.7	10.2	9.8	3.5	11.1	15.8	15.8	9.8	7.1	15.4	22.8	30.9	21.1	15.8	8.7	16.2	13.0	17.9	16.5
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 68.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favourable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	11.2	16.5	10.0	17.3	16.2	5.9	9.7	8.5	18.1	9.8	10.9	14.3	5.7	9.5	13.9	15.7	19.0	68.6	15.7	16.6	9.9	10.8	13.6	19.2	9.9	16.8	12.1	9.6	14.6	14.0	15.1	11.7	12.1	15.8	12.6	16.6	10.3	16.4	13.4	27.2	8.9	11.1	13.0	7.9	16.5	14.5	12.9	9.3	19.3	9.9	23.2	22.7	19.1	11.0	24.9	25.7	6.2	17.7	26.7	16.1	11.9	20.4	18.0	17.2	14.1	10.4	6.1	23.9	15.5	8.3	23.8	15.7	26.4	7.7	35.0	15.2	13.2	14.9	31.0	29.8	28.8	13.9	24.3	20.8	21.0	37.9	11.7	21.3	35.6	7.4	21.3	23.3	15.0	15.8	27.8	9.3	23.0	25.9	27.3	11.2	33.8	30.2	27.4	27.1	13.4	21.1	36.4	14.2	10.3	13.6	17.2	12.3	13.8	14.7	11.5	13.2	26.6	25.6	32.9	7.7	9.6	31.5	16.7	24.0	38.7	6.2	11.6	2.9	13.9	17.7	15.5	24.9	15.1	15.5	25.7	21.6	16.1	15.0	1.7	26.7	15.5	16.1	12.5	11.9	10.0	16.2	8.5	18.1	9.9	10.8	12.1	9.6	15.8	9.3
WDR89	"C14orf150, MGC9907"	ENSG00000140006	"WD repeat domain 89"	Q96FK6	14	63597039-63641861	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000813	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA000813: AB_1078324"	"prognostic favourable (3.37e-4)"	"unprognostic (6.46e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.29e-1)"	13.2	12.6	11.5	11.6	13.4	4.6	13.7	19.3	18.8	12.5	10.3	9.5	7.4	8.0	14.6	11.5	10.5	11.9	8.6	8.1	11.0	10.7	14.8	16.1	9.1	17.8	15.7	11.6	15.0	14.0	16.2	16.3	12.9	12.3	12.0	12.1	8.3	8.7	8.4	13.2	10.8	8.9	10.5	11.8	13.8	8.5	8.6	14.4	21.0	16.9	7.6	17.0	11.6	10.2	7.0	4.3	0.6	3.6	8.4	14.0	4.9	25.2	11.0	13.8	7.3	8.3	9.1	19.6	10.2	5.6	10.3	11.5	7.8	11.9	24.5	8.4	3.0	11.7	16.8	9.9	18.3	15.8	9.6	16.7	6.9	9.7	10.5	21.1	11.5	8.2	12.9	11.8	17.7	10.0	13.5	13.6	7.7	12.6	17.6	12.0	12.3	21.9	13.1	13.9	13.7	11.4	9.8	11.7	9.6	10.9	11.7	7.7	13.5	11.5	6.9	12.5	11.9	8.1	12.1	7.9	5.9	15.0	5.6	15.6	8.8	0.0	2.5	0.3	8.2	2.5	10.5	7.0	8.7	7.5	4.3	6.9	14.0	12.1	0.6	8.4	3.6	2.8	8.7	4.9	11.5	13.4	19.3	18.8	11.0	10.7	15.7	11.6	12.3	14.4
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235793-159286799	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: "	"unprognostic (1.37e-2)"	"prognostic favourable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	10.3	14.2	9.7	6.6	12.7	10.9	14.8	18.9	14.0	10.3	8.5	8.9	10.6	5.8	9.8	22.1	11.1	11.8	9.9	11.5	9.7	10.6	27.7	8.2	10.7	16.1	11.5	7.0	16.4	15.5	19.4	23.8	15.7	9.2	11.3	9.2	16.0	11.8	8.7	7.7	8.2	7.7	9.9	9.5	10.5	9.0	7.7	10.2	8.5	22.2	6.1	9.2	10.0	15.0	9.8	10.3	2.8	9.3	16.2	13.0	6.2	6.6	4.9	4.5	7.1	8.2	9.5	15.3	5.2	10.2	9.5	16.7	10.7	10.8	8.8	5.5	7.8	4.0	12.6	4.7	13.4	3.4	10.5	9.1	5.7	10.7	10.0	7.7	12.6	5.5	17.6	11.6	9.6	7.8	12.0	6.7	8.9	6.8	5.5	14.2	6.1	10.7	8.7	6.6	4.8	10.9	9.5	8.4	5.5	5.4	7.0	12.0	5.4	13.5	3.2	6.7	5.0	9.4	4.9	3.4	5.7	8.1	11.9	9.6	4.2	2.7	9.3	2.8	13.0	7.0	9.8	9.8	5.2	8.1	10.3	8.9	6.3	7.4	0.6	16.2	6.3	9.7	2.6	6.2	9.7	12.7	18.9	14.0	9.7	10.6	11.5	7.0	9.2	10.2
WHAMM	"KIAA1971, WHAMM1, WHDC1"	ENSG00000156232	"WAS protein homolog associated with actin, golgi membranes and microtubules"	Q8TF30	15	82809628-82836108	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039690, HPA040231"	Supported		Supported	Cytosol				Cytosol		"HPA039690: AB_10795405, HPA040231: AB_10795361"	"unprognostic (7.98e-2)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.20e-2)"	10.6	6.6	7.9	9.8	11.7	44.5	10.1	14.0	9.5	8.7	8.8	11.2	7.7	8.8	8.5	6.7	10.2	7.3	6.6	7.4	10.1	5.3	9.5	11.4	10.7	9.6	10.7	8.0	10.9	9.3	16.7	7.9	8.9	13.9	10.1	8.2	7.6	9.3	7.5	23.3	12.0	10.6	12.0	12.3	11.9	8.3	5.5	14.3	8.3	9.6	6.6	11.0	11.1	13.1	3.2	2.4	5.0	1.6	5.8	3.2	0.9	4.0	4.1	2.6	3.9	8.4	5.9	4.4	5.7	5.7	6.2	6.2	2.7	7.4	8.8	7.1	5.2	9.0	7.9	4.5	4.1	2.9	4.5	5.0	4.7	4.0	8.6	3.6	6.0	5.8	6.2	3.0	6.2	4.4	4.5	11.6	6.2	3.1	3.0	5.2	1.1	2.5	4.4	5.6	2.4	10.8	16.4	2.5	2.0	8.7	5.8	5.8	3.9	7.7	7.0	8.3	2.9	5.5	6.4	12.6	7.1	4.3	5.9	5.0	5.2	5.0	1.6	1.3	3.2	1.1	2.9	2.6	3.1	2.4	1.0	3.2	2.9	2.9	3.6	5.8	1.1	2.4	2.4	0.9	7.9	11.7	14.0	9.5	10.1	5.3	10.7	8.0	13.9	14.3
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 44.5;Karpas-707: 64.1;U-266/70: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"			290000	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: "	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	20.6	7.3	10.5	47.0	14.4	23.2	21.6	2.1	9.2	17.1	16.5	20.2	6.6	8.7	14.3	11.4	10.3	9.8	17.2	12.0	14.6	10.5	9.0	7.8	22.6	55.7	21.1	5.6	8.7	4.7	5.7	4.2	15.6	10.9	10.6	10.7	10.5	10.5	11.7	4.0	7.3	21.3	13.8	44.2	55.5	9.9	4.5	14.9	42.9	11.4	8.9	51.7	22.8	15.3	12.3	8.2	52.7	12.9	17.8	25.0	15.3	0.1	1.4	3.4	0.0	8.7	15.4	3.5	6.4	5.5	2.5	4.0	0.3	0.2	44.5	1.9	9.6	0.1	0.5	0.0	3.4	30.1	0.8	23.4	5.8	0.0	3.3	19.5	37.0	6.4	1.0	5.9	0.5	5.6	0.6	64.1	7.5	0.0	21.6	17.9	4.0	0.2	18.6	1.4	8.3	2.3	0.1	0.5	7.1	0.0	1.8	3.8	0.0	9.5	4.3	8.8	2.4	6.3	6.1	51.2	31.3	23.3	13.3	13.4	24.2	12.1	10.8	26.2	25.0	11.9	21.0	12.3	16.8	24.5	8.2	10.3	13.8	18.1	52.7	17.8	12.9	3.6	18.7	15.3	10.5	14.4	2.1	9.2	14.6	10.5	21.1	5.6	10.9	14.9
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.5;ASC TERT1: 39.4;HHSteC: 49.6;HSkMC: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 25.0;eosinophil: 53.0"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favourable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	18.4	11.0	6.0	6.5	10.0	10.5	19.6	7.6	9.6	16.1	15.9	7.8	39.7	5.7	9.0	12.9	8.1	6.7	10.7	34.8	5.3	3.7	20.2	11.5	14.4	12.2	8.5	5.3	6.9	23.9	10.0	10.2	33.5	9.4	8.4	17.9	11.5	30.2	19.3	49.3	11.8	7.7	10.0	7.5	8.9	14.5	4.6	6.5	1.6	10.0	25.2	9.8	10.3	10.3	1.1	2.2	53.0	5.7	2.5	3.1	3.3	1.0	2.1	1.9	2.8	51.5	39.4	10.4	7.5	36.1	3.0	9.8	1.6	1.6	0.5	3.4	16.1	0.8	0.7	4.8	5.4	0.9	0.9	7.4	0.7	9.2	49.6	0.5	10.8	41.4	8.9	12.0	16.5	13.6	0.4	18.8	9.1	6.4	0.1	1.4	0.3	3.2	0.1	6.6	7.3	4.6	3.7	0.5	2.5	1.7	23.6	38.3	12.2	2.1	12.9	15.0	2.2	6.9	1.8	16.5	18.6	2.2	22.6	3.6	6.6	25.0	4.6	53.0	3.1	5.5	1.4	1.1	0.8	3.0	2.2	0.4	0.0	1.5	9.7	2.5	5.7	1.5	0.6	3.3	6.0	10.0	7.6	9.6	5.3	3.7	8.5	5.3	9.4	6.5
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190188-5233826	"Predicted intracellular proteins"	Autophagy		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favourable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favourable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	24.5	23.6	33.9	17.8	34.7	32.7	21.9	30.6	47.4	20.6	21.7	27.8	17.4	20.3	24.4	23.1	25.4	25.3	20.5	30.5	27.9	27.2	23.5	27.5	21.9	22.3	26.0	31.2	25.0	30.8	28.7	23.2	27.0	26.1	25.0	17.2	25.0	34.7	25.5	28.3	31.8	18.2	22.9	25.6	22.0	23.0	49.3	26.0	26.6	24.1	15.9	23.4	22.9	20.5	6.1	6.9	13.0	6.3	2.6	9.2	2.2	27.0	17.3	16.9	28.9	26.1	27.5	26.1	24.2	27.8	25.8	27.4	16.7	25.2	19.3	18.6	30.2	19.9	17.1	19.7	20.2	9.9	26.6	13.2	17.5	18.4	25.9	20.7	14.5	28.8	23.7	29.3	16.3	35.8	37.3	17.5	23.3	28.1	15.7	35.9	35.2	25.5	25.9	24.2	31.8	17.0	13.2	21.2	31.9	17.7	30.5	21.0	18.7	39.5	28.4	16.5	34.7	27.5	18.0	31.6	29.4	22.1	26.9	24.0	24.3	0.3	4.9	13.0	5.1	6.3	3.1	5.6	6.7	9.1	4.5	6.1	8.5	5.4	9.9	2.6	4.2	6.9	9.2	2.2	33.9	34.7	30.6	47.4	27.9	27.2	26.0	31.2	26.1	26.0
WISP1	"CCN4, WISP-1, WISP1-OT1, WISP1-UT1"	ENSG00000104415	"WNT1 inducible signaling pathway protein 1"	O95388	8	133191039-133231690	"Cancer-related genes, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HHSteC: 7.9;HSkMC: 44.5;hTEC/SVTERT24-B: 25.4;U-2197: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"olfactory region: 11.9"	"Not detected"	"Not detected"			"HPA007121, CAB012205"	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"			Cytosol		"CAB012205: , HPA007121: AB_1858844"	"unprognostic (7.77e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (7.52e-3)"	"unprognostic (2.55e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.67e-3)"	4.2	11.0	0.6	7.7	1.6	0.0	2.3	0.6	2.9	14.7	3.9	1.0	0.0	1.2	18.5	6.4	2.2	6.5	8.5	4.0	0.7	0.3	18.0	2.9	8.9	13.4	0.8	0.4	13.0	1.0	0.2	2.7	3.5	1.2	3.4	0.9	4.5	1.3	4.2	2.0	1.6	3.9	14.4	6.2	14.6	3.8	3.7	0.4	0.3	1.3	2.7	4.2	14.4	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	1.7	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	44.5	0.0	25.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	0.3	24.3	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	1.6	0.6	2.9	0.7	0.3	0.8	0.4	1.2	0.4
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls"	ENSG00000116729	"Wntless Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 71.8;ASC TERT1: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 10.0;neutrophil: 29.1"	"Group enriched"	"Detected in many"	46	"granulocytes: 29.1;monocytes: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA069520: "	"prognostic favourable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favourable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favourable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (3.51e-4)"	13.7	17.2	33.5	14.3	39.0	1.5	14.5	6.8	26.6	20.0	28.3	25.8	51.6	9.1	19.5	55.1	26.7	19.9	37.1	24.1	23.1	25.4	36.8	8.9	20.3	6.9	27.0	18.6	31.4	34.7	12.1	9.8	29.2	44.5	29.0	22.8	37.8	14.5	47.4	5.3	19.3	14.1	46.2	30.5	10.8	24.4	12.2	22.3	1.9	8.9	13.5	8.2	29.6	17.0	0.0	0.4	29.1	10.0	0.0	0.0	1.9	2.0	3.0	71.8	0.0	39.8	55.6	41.6	9.9	24.5	13.9	19.3	4.3	4.7	0.0	10.0	2.8	20.8	16.1	16.3	11.8	0.1	12.0	0.0	8.6	0.0	34.8	0.0	0.1	39.7	11.0	34.0	11.2	32.5	0.0	0.1	20.4	0.3	0.0	0.2	3.2	4.8	0.0	15.1	0.0	2.4	10.7	4.0	8.4	9.1	0.4	11.9	1.9	0.3	37.7	13.3	10.7	21.3	13.4	4.8	0.1	0.0	30.7	0.3	24.3	0.0	10.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.1	0.0	0.3	0.1	0.0	1.9	33.5	39.0	6.8	23.8	23.1	25.4	27.0	18.6	44.5	22.3
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752593-911452	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046541, HPA059157"	Enhanced		Supported	Cytosol				Cytosol		"HPA046541: , HPA059157: "	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	30.0	12.4	49.3	19.1	47.5	28.9	45.4	22.5	36.7	21.2	12.6	42.6	10.6	8.5	15.9	19.4	45.5	16.9	16.5	38.5	53.7	36.4	45.6	18.0	33.0	34.3	62.3	27.1	18.5	11.3	29.1	12.7	20.3	41.4	17.1	14.3	12.0	15.4	20.3	43.4	31.3	10.3	22.3	82.8	16.9	15.7	23.8	38.8	23.9	16.7	17.4	24.5	18.9	26.5	3.7	2.6	10.9	7.1	2.1	5.2	1.9	14.2	27.0	35.7	3.3	25.8	24.8	13.6	14.2	17.1	15.4	14.4	15.2	16.3	20.1	5.0	30.5	10.8	24.1	16.4	21.7	34.8	14.4	44.9	35.9	13.1	18.9	24.2	19.6	19.2	25.0	25.5	45.8	20.8	20.4	48.6	23.3	13.1	43.5	4.1	29.1	6.5	20.8	39.6	5.4	22.2	30.9	10.4	12.2	33.2	21.5	9.6	23.7	24.9	23.0	19.1	22.2	26.8	20.9	7.4	12.3	30.5	18.2	12.8	15.5	0.9	2.7	2.6	3.8	4.0	5.2	3.0	4.3	3.6	2.6	3.7	2.3	4.1	10.9	2.1	7.1	1.7	4.9	1.9	49.3	47.5	22.5	36.7	53.7	36.4	62.3	27.1	41.4	38.8
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.2;Hep G2: 18.4;SCLC-21H: 23.4"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol				Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.8	8.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	1.6	0.1	11.2	1.5	0.0	0.2	6.4	0.0	0.0	0.0	7.4	0.0	3.5	18.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	5.8	0.1	0.1	7.1	0.2	0.0	0.0	9.1	0.0	0.6	23.4	9.2	1.4	6.3	0.6	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0										
WNT11		ENSG00000085741	"Wnt family member 11"	O96014	11	76186325-76210736	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.9;breast: 24.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.3;CACO-2: 6.5;CAPAN-2: 9.7;EFO-21: 32.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 6.6"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 6.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050101, HPA063569"	Uncertain		Approved	Centrosome,Cytosol	"Secreted to extracellular matrix"			Cytosol	Centrosome	"HPA050101: , HPA063569: "	"prognostic favourable (5.97e-4)"	"unprognostic (9.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.87e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.09e-3)"	25.9	14.1	0.8	1.6	1.0	0.9	24.1	1.8	0.9	3.4	7.6	1.4	0.7	2.6	1.9	6.0	4.7	3.1	3.4	7.2	0.4	0.4	1.2	8.5	4.8	2.3	0.5	0.1	4.3	7.8	0.5	2.3	6.3	2.2	4.0	1.2	1.0	3.4	1.3	11.1	4.5	7.9	3.1	0.3	3.5	0.7	3.7	0.5	0.3	10.8	5.4	0.7	4.6	10.2	0.0	0.0	0.8	0.1	6.6	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.1	20.3	0.0	0.0	0.0	0.1	6.5	9.7	0.0	32.2	0.0	3.0	0.6	0.0	0.0	2.9	1.1	1.6	0.7	1.2	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	1.6	0.2	0.0	1.2	0.1	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.8	1.0	1.8	0.9	0.4	0.4	0.5	0.1	2.2	0.5
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: "	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	6.9	6.9	8.1	10.3	8.0	13.3	6.8	11.8	10.7	7.4	7.2	10.6	6.8	6.8	8.4	8.4	7.9	25.6	7.7	6.8	7.5	6.6	9.4	6.6	8.7	12.7	7.9	5.8	7.8	12.0	6.1	7.6	8.1	7.8	5.3	7.3	7.8	6.6	6.6	9.8	8.1	7.7	7.8	5.4	12.5	7.2	11.4	8.3	22.8	7.6	6.6	12.8	7.5	6.2	4.7	6.6	20.0	5.8	4.2	8.5	3.5	11.0	20.8	15.0	15.0	4.5	4.2	8.8	7.2	7.7	23.6	22.1	12.1	6.9	13.4	7.6	6.4	12.4	17.2	12.7	18.3	8.0	22.3	6.1	13.8	10.1	4.1	4.7	8.0	3.3	5.0	20.8	4.8	15.3	5.8	4.4	9.4	10.1	13.7	11.5	8.0	10.4	18.1	9.9	7.8	8.7	4.0	6.9	10.5	11.4	6.1	6.0	8.3	5.0	5.3	9.4	10.0	0.0	18.6	3.5	8.8	7.0	8.5	8.1	11.4	20.0	5.2	4.6	5.4	5.8	6.3	3.3	4.2	6.0	4.7	4.7	3.8	4.4	2.7	4.2	2.3	6.6	8.5	3.5	8.1	8.0	11.8	10.7	7.5	6.6	7.9	5.8	7.8	8.3
WWC3	"BM042, KIAA1280"	ENSG00000047644	"WWC family member 3"	Q9ULE0	X	10015562-10144478	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 56.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA039814	Uncertain		Approved	"Actin filaments,Cytosol"				Cytosol	"Actin filaments"	"HPA039814: AB_10674987"	"unprognostic (2.53e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (9.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (9.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.50e-2)"	10.2	13.2	8.9	9.8	12.6	5.3	10.3	13.7	10.1	10.0	13.1	18.2	56.9	4.5	11.6	22.0	12.4	8.9	10.8	15.4	10.0	7.2	7.2	3.9	21.0	12.5	13.1	6.4	18.7	9.4	9.9	6.7	25.7	10.6	11.3	5.6	12.6	9.0	44.4	7.6	12.3	10.8	13.2	9.4	11.8	11.2	6.9	11.8	6.2	12.2	8.1	10.2	10.2	18.1	6.6	0.7	12.3	1.0	2.7	6.9	2.1	6.7	7.7	9.4	3.1	3.9	5.6	8.9	3.8	6.7	2.3	2.6	1.0	7.1	0.7	0.0	5.1	3.5	2.1	4.0	1.9	5.0	0.7	1.5	5.0	0.7	8.5	0.0	2.4	3.6	8.4	5.8	6.2	10.9	0.1	9.2	5.6	13.9	1.6	0.4	8.8	2.7	4.9	0.4	2.9	2.2	3.5	1.0	2.6	4.7	6.1	4.1	53.9	0.5	14.5	6.8	0.1	10.0	4.2	7.5	5.0	2.5	4.1	2.5	10.0	4.1	1.0	0.2	6.9	0.8	6.0	2.4	3.4	5.1	0.5	6.6	3.2	3.8	12.3	2.7	0.8	0.7	1.6	2.1	8.9	12.6	13.7	10.1	10.0	7.2	13.1	6.4	10.6	11.8
WWOX	"FOR, SDR41C1, WOX1"	ENSG00000186153	"WW domain containing oxidoreductase"	Q9NZC7	16	78099413-79212667	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	Oxidoreductase	"Disease mutation, Epilepsy, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050992	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA050992: "	"prognostic unfavourable (9.07e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.50e-2)"	"prognostic favourable (4.49e-5)"	"unprognostic (3.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.77e-1)"	13.2	7.4	19.2	10.5	17.9	5.3	11.9	21.5	14.6	8.9	5.9	20.5	14.8	8.9	12.6	17.1	11.6	13.4	10.0	6.1	17.0	17.7	19.2	17.8	7.1	6.5	19.7	12.5	9.4	10.5	22.3	11.5	7.6	16.1	10.9	5.3	11.4	10.6	15.4	4.9	9.6	7.2	11.9	20.9	5.4	7.6	15.8	17.9	10.3	29.4	4.9	8.9	8.7	8.6	8.5	13.8	5.4	8.8	7.8	12.3	5.4	5.0	4.4	4.9	3.1	5.2	2.3	5.3	0.7	1.5	1.7	1.5	3.4	4.3	9.3	3.8	0.7	4.3	2.4	0.6	1.2	4.9	12.7	3.0	0.8	7.1	3.9	7.7	1.5	2.8	1.8	1.1	1.0	2.1	4.1	1.9	1.2	39.5	13.2	10.5	4.3	2.6	14.1	1.9	9.4	2.4	1.7	8.0	5.2	3.1	5.7	1.7	5.7	5.4	0.5	1.3	4.5	1.0	2.9	0.0	8.7	19.1	5.0	3.9	2.1	5.4	8.8	1.9	10.5	7.2	12.3	8.5	8.5	9.2	6.8	6.4	8.4	8.9	0.8	7.8	5.0	13.8	12.3	5.4	19.2	17.9	21.5	14.2	17.0	17.7	19.7	12.5	16.1	17.9
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342738-86478420	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favourable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	15.4	9.1	9.7	15.6	14.1	5.2	20.9	8.5	9.5	11.5	16.9	7.5	21.1	8.7	11.9	19.3	11.7	7.2	22.0	40.7	8.7	8.5	16.9	37.2	10.2	15.9	10.0	7.8	10.1	11.3	40.7	7.3	15.6	12.7	17.8	11.3	8.9	11.8	9.4	58.0	13.8	13.0	18.4	9.9	19.1	11.4	10.4	9.5	11.1	11.2	18.0	12.5	14.5	12.3	3.7	2.6	6.5	2.8	2.9	10.4	2.3	22.9	10.8	7.5	5.3	9.4	9.3	6.9	8.4	8.9	6.7	8.0	7.6	14.1	9.9	5.7	14.3	19.7	10.5	13.4	11.6	12.2	8.4	11.3	9.6	17.8	6.9	4.5	5.9	8.4	17.2	7.3	13.6	29.4	5.9	11.6	11.3	11.4	10.8	3.4	4.5	12.2	7.1	9.0	8.7	15.0	17.6	2.2	5.2	8.3	42.1	8.9	12.5	4.2	33.8	10.0	11.9	10.6	4.3	13.8	8.4	10.1	12.4	0.8	7.6	6.5	2.8	4.8	7.2	2.4	6.0	3.7	8.7	7.1	1.9	3.6	10.4	6.3	1.7	2.9	2.8	2.6	8.0	2.3	9.7	14.1	8.5	9.5	8.7	8.5	10.0	7.8	12.7	9.5
WWTR1	"DKFZp586I1419, TAZ"	ENSG00000018408	"WW domain containing transcription regulator 1"	Q9GZV5	3	149517235-149736714	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 59.8;SK-MEL-30: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6;memory CD8 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007415, CAB017483, CAB068248"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB017483: AB_2216639, CAB068248: , HPA007415: AB_1080602"	"unprognostic (1.85e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.01e-3)"	25.1	9.9	9.3	16.0	18.6	0.2	20.4	7.7	10.5	27.2	38.5	18.4	15.0	5.6	27.2	17.6	41.2	16.4	25.8	20.6	14.7	9.0	31.0	13.1	29.8	6.2	15.2	5.6	30.9	21.7	10.4	8.5	29.0	20.7	34.6	9.1	29.4	15.8	22.4	12.1	13.4	11.7	81.5	25.8	13.8	20.8	12.0	16.4	0.7	18.2	13.2	7.1	68.4	31.0	0.2	0.1	0.6	0.1	0.1	2.8	0.4	16.5	19.7	10.5	13.9	12.5	22.4	11.0	9.6	14.1	4.4	4.6	11.0	14.0	0.0	59.8	10.8	9.8	6.8	7.0	4.3	4.6	5.2	0.0	5.1	9.1	7.1	0.0	0.0	11.8	1.8	15.2	6.6	33.9	0.0	0.0	15.1	2.2	0.0	0.0	2.4	24.9	0.0	14.0	0.1	37.2	2.4	0.0	0.1	6.3	4.5	41.3	7.6	0.3	27.6	8.6	4.1	6.9	18.8	0.1	0.1	0.2	18.4	0.0	21.8	0.4	0.1	0.1	2.6	0.0	0.0	0.0	0.3	2.8	0.0	0.2	0.1	1.3	0.6	0.1	0.0	0.1	1.9	0.4	9.3	18.6	7.7	10.5	14.7	9.0	15.2	5.6	20.7	16.4
XIAP	"API3, BIRC4, hILP"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913979	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: "	"prognostic unfavourable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	17.4	14.4	20.0	18.1	20.2	12.0	15.9	21.3	18.9	17.2	19.4	14.5	22.9	16.1	17.4	17.0	18.9	12.6	14.7	15.7	18.9	22.1	19.8	19.4	16.5	15.5	18.8	14.6	13.9	19.7	36.6	26.1	18.2	15.9	15.6	16.8	16.9	14.6	22.9	21.5	14.2	23.4	17.0	19.0	15.8	16.2	7.0	12.3	13.9	24.3	11.4	14.0	15.4	20.5	5.7	4.3	11.1	3.9	3.3	5.5	1.9	11.5	9.9	7.8	6.7	9.2	11.9	10.2	12.6	9.4	6.9	5.9	4.4	13.6	10.8	18.7	10.7	4.3	11.5	7.9	12.7	11.2	6.3	7.3	8.3	6.7	11.7	13.2	15.2	8.2	12.3	11.4	14.7	9.5	11.5	12.5	13.3	12.0	7.3	6.4	6.4	7.8	7.9	9.1	11.4	10.4	16.8	5.3	7.7	17.2	10.0	10.1	6.1	6.5	11.7	0.3	4.7	20.6	14.0	10.5	10.5	12.0	14.2	9.4	8.7	11.1	2.6	3.5	5.0	2.3	4.7	4.6	3.8	5.5	1.4	5.7	4.4	3.0	8.2	3.3	3.9	4.3	2.5	1.9	20.0	20.2	21.3	18.9	18.9	22.1	18.8	14.6	15.9	12.3
XPNPEP1	"XPNPEP, XPNPEPL, XPNPEPL1"	ENSG00000108039	"X-prolyl aminopeptidase 1"	Q9NQW7	10	109864766-109923553	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025196, HPA030419, HPA030420, HPA030422"	Supported		Enhanced	Cytosol			760000	Cytosol		"CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783"	"unprognostic (3.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (8.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.18e-2)"	16.6	14.7	13.4	16.1	18.9	12.8	13.6	14.8	22.2	15.7	20.6	19.5	14.1	33.2	17.5	16.1	17.8	15.8	20.3	17.8	13.7	11.4	18.3	21.0	14.8	14.9	13.8	14.0	17.8	46.0	14.9	15.9	19.0	17.2	16.0	26.9	15.6	19.6	11.3	18.5	20.4	38.6	18.6	11.9	18.0	16.8	15.1	12.0	9.9	15.7	15.2	24.2	14.1	13.8	5.5	24.0	10.0	21.0	14.7	10.6	13.4	25.3	11.2	17.9	24.4	29.2	27.5	13.7	14.2	28.9	21.3	23.1	21.7	21.9	36.3	12.3	21.8	13.5	14.2	17.5	20.9	10.7	13.6	24.2	7.3	9.0	20.4	18.8	20.2	27.0	10.9	23.4	20.8	34.9	7.8	11.6	27.0	8.6	13.4	11.7	7.0	12.1	15.1	36.1	6.5	27.0	8.0	5.4	20.8	12.3	7.8	23.6	9.5	17.6	17.9	8.7	11.4	13.7	12.4	19.8	9.6	31.0	20.5	26.4	6.8	10.0	13.7	5.6	10.6	21.0	7.3	5.5	7.0	9.5	24.0	4.8	5.0	6.6	1.1	14.7	17.5	18.8	7.5	13.4	13.4	18.9	14.8	22.2	13.7	11.4	13.8	14.0	17.2	12.0
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738974-129769538	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 145.6;kidney: 49.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.2;ASC TERT1: 32.6;HSkMC: 16.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2"	"Group enriched"	"Detected in many"	7	"monocytes: 4.4;T-cells: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"		8900000	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	4.7	0.5	0.0	1.1	0.1	0.0	3.2	0.0	0.1	1.7	57.4	0.1	0.8	37.0	1.2	1.7	4.2	3.4	1.3	2.6	0.0	0.0	49.7	8.0	1.0	1.2	0.0	0.0	3.5	0.9	0.0	0.0	0.6	0.1	3.6	2.0	0.7	0.7	0.3	1.6	2.1	145.6	2.5	0.1	0.2	1.7	1.2	0.0	0.1	0.9	1.4	0.3	4.0	10.7	0.4	0.8	0.2	4.4	0.0	7.3	1.3	0.0	0.0	0.4	0.0	6.2	32.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.3	2.1	2.2	0.0	2.4	4.8	0.3	0.4	0.7	3.6	0.2	0.0	4.4	0.8	2.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
XPO1	"CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61477849-61538626	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"			170000	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: "	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavourable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	20.7	27.9	36.1	28.1	39.6	21.6	35.1	41.5	36.3	28.2	23.2	19.5	26.0	16.5	35.7	35.3	26.1	36.0	20.3	20.1	33.0	19.2	19.5	22.2	22.0	34.5	42.0	19.5	45.0	34.6	33.4	27.6	30.8	33.6	25.8	24.5	18.0	20.2	29.9	34.9	29.8	25.0	28.4	32.1	24.5	21.9	32.1	39.3	51.1	28.2	16.4	35.7	26.0	57.8	6.1	5.4	12.6	5.1	6.2	5.1	2.5	38.8	34.7	47.1	35.3	21.4	28.7	34.7	43.0	27.7	45.2	38.8	46.1	29.2	57.0	30.1	29.4	33.0	71.8	29.8	66.7	34.8	26.4	56.1	35.8	28.8	15.5	56.5	38.4	16.2	22.3	35.7	39.0	36.9	64.7	33.3	41.6	20.4	47.0	24.8	54.8	26.6	42.1	53.8	34.6	20.6	29.5	37.7	20.0	41.8	35.4	20.9	28.9	27.9	24.6	42.5	48.3	34.6	42.2	27.0	44.6	82.7	26.4	48.5	38.3	12.6	5.1	5.8	5.1	5.0	4.7	4.3	3.6	4.5	3.9	6.1	4.3	3.7	12.4	6.2	3.2	5.4	3.2	2.5	36.1	39.6	41.5	36.3	33.0	19.2	42.0	19.5	33.6	39.3
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA053768: "	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	8.9	6.6	4.9	6.9	9.6	10.9	7.9	13.6	11.1	7.5	6.7	11.6	7.9	5.0	11.4	5.9	7.5	7.3	4.9	12.8	6.1	5.3	6.9	6.1	7.7	8.6	8.0	5.3	9.0	7.8	8.1	12.9	6.8	10.2	7.3	7.6	10.7	7.4	7.4	47.3	8.2	7.2	8.2	8.3	8.6	6.7	7.9	8.0	14.3	8.4	6.3	12.3	7.8	7.3	3.1	2.7	3.1	6.0	3.1	4.0	1.2	6.6	5.0	8.3	7.9	4.0	7.1	8.6	7.6	5.6	9.0	7.5	10.2	8.4	14.7	4.1	7.3	11.0	19.1	10.3	16.8	10.0	5.5	23.3	6.3	6.9	6.1	20.4	7.6	6.9	6.5	9.1	17.3	10.8	11.0	4.9	8.5	5.5	9.7	9.0	9.4	4.7	10.8	13.7	6.1	6.3	8.1	9.5	6.6	6.5	9.5	7.8	5.6	11.2	8.9	6.4	5.0	7.8	10.8	3.2	4.8	12.2	3.1	13.1	9.5	3.1	2.0	2.1	3.4	2.3	4.0	3.1	2.9	2.9	2.7	2.6	3.6	3.5	0.0	3.1	6.0	2.0	2.7	1.2	4.9	9.6	13.6	11.1	6.1	5.3	8.0	5.3	10.2	8.0
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097979-28211920	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"neutrophil: 56.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (8.80e-4)"	18.4	14.1	24.3	32.0	25.0	47.9	17.7	16.0	30.6	12.4	17.7	30.4	9.9	13.4	13.5	12.0	16.8	14.1	14.9	9.6	27.5	23.9	13.3	19.1	20.6	54.6	25.6	16.9	15.3	13.2	22.0	18.0	25.9	21.7	14.1	17.0	16.3	19.4	13.1	8.3	18.8	18.3	16.3	23.8	50.4	14.8	28.9	19.8	37.1	18.0	7.8	31.8	17.2	13.2	5.2	2.6	56.4	4.4	2.7	6.5	2.0	28.4	20.4	18.0	19.3	12.5	19.9	20.7	35.2	31.9	41.3	41.8	28.6	20.4	20.2	30.4	32.0	18.6	42.7	27.0	50.2	45.5	26.5	22.1	28.8	31.8	29.6	30.8	24.9	15.6	20.1	36.6	36.3	23.7	40.2	10.2	27.9	31.9	37.0	36.8	30.5	19.5	34.8	21.4	33.5	15.3	14.5	35.2	19.1	17.4	29.1	15.4	20.9	20.4	25.1	34.9	23.4	29.7	29.3	23.9	30.2	30.0	26.6	32.2	29.4	4.7	2.7	8.4	4.1	3.0	4.4	5.2	4.7	4.4	2.0	3.9	5.2	6.5	56.4	2.7	4.4	2.6	3.8	2.0	24.3	25.0	16.0	30.6	27.5	23.9	25.6	16.9	21.7	19.8
XPOT	XPO3	ENSG00000184575	"Exportin for tRNA"	O43592	12	64404350-64451127	"Predicted intracellular proteins, Transporters"	Transport	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048067, HPA057602"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA048067: , HPA057602: "	"unprognostic (4.53e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavourable (1.81e-7)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavourable (2.41e-12)"	"unprognostic (2.72e-1)"	"unprognostic (3.68e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (5.79e-4)"	19.3	19.4	20.7	19.3	22.8	26.9	29.9	17.9	21.7	16.9	12.4	18.7	13.2	10.5	16.1	19.8	21.3	12.5	12.6	12.7	19.0	19.4	14.7	35.7	18.3	18.9	22.4	15.5	17.3	30.1	21.4	18.5	18.6	23.5	15.3	14.7	15.8	21.3	13.7	15.6	17.3	11.6	16.7	21.7	14.5	14.7	17.9	21.3	18.2	48.7	14.1	21.4	15.8	27.8	7.9	10.2	10.1	7.5	11.1	14.7	6.5	17.5	12.2	12.4	15.5	18.7	20.0	22.7	23.5	19.7	15.8	14.4	12.1	6.0	35.6	16.8	29.6	13.2	23.5	18.1	23.0	22.2	12.4	19.8	11.3	10.6	33.1	36.4	17.9	14.2	46.7	17.5	54.3	14.0	32.9	71.7	16.7	21.5	20.1	14.5	23.6	21.8	16.0	14.9	26.6	8.6	10.4	13.8	16.2	13.8	15.8	34.0	28.1	36.3	14.7	12.4	12.6	17.8	18.3	45.1	34.6	27.6	27.6	28.5	20.1	5.8	7.5	10.1	10.9	7.5	14.7	7.9	12.4	11.3	10.2	5.3	11.4	9.6	2.3	11.1	6.7	3.5	10.3	6.5	20.7	22.8	17.9	21.2	19.0	19.4	22.4	15.5	23.5	21.3
XRN1	SEP1	ENSG00000114127	"5'-3' exoribonuclease 1"	Q8IZH2	3	142306607-142448062	"Predicted intracellular proteins"		"DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035005, HPA035006"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035005: AB_10670695, HPA035006: AB_10672750"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (9.43e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.32e-2)"	16.5	12.4	9.9	16.2	15.5	24.4	15.9	23.8	15.7	15.7	17.5	7.5	12.4	14.7	15.2	14.2	13.4	11.5	11.0	10.1	8.4	6.8	9.6	21.7	15.9	16.1	11.7	9.0	17.4	13.2	17.4	26.5	23.6	10.7	12.5	13.0	8.2	14.4	13.3	21.2	17.2	25.0	14.4	15.2	16.2	11.7	11.8	10.9	30.8	12.9	10.8	15.3	15.0	15.2	7.4	6.1	18.3	4.7	4.3	8.4	2.5	9.8	1.9	4.5	3.8	5.0	8.4	2.7	4.6	6.2	6.0	7.4	1.7	2.9	3.9	4.8	6.1	3.8	4.0	2.3	9.2	9.9	3.1	5.8	3.3	1.5	4.4	5.8	5.9	6.6	2.7	4.3	5.6	5.3	3.8	9.4	5.4	1.9	5.0	3.0	1.4	2.1	4.1	57.1	4.9	2.9	5.0	2.6	3.3	8.3	4.5	3.5	5.5	4.5	7.3	4.2	2.3	4.8	3.9	13.5	6.9	6.3	3.9	3.1	3.6	18.3	4.7	12.2	8.3	4.2	5.8	7.4	6.4	7.4	2.3	6.0	8.4	5.8	17.2	4.3	4.0	6.1	4.6	2.5	9.9	15.5	23.8	15.7	8.4	6.8	11.7	9.0	10.7	10.9
XYLT2	"PXYLT2, XT-II"	ENSG00000015532	"Xylosyltransferase 2"	Q9H1B5	17	50346092-50363138	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 53.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016456			Approved	"Nuclear bodies,Cytosol"	"Secreted to blood"		990000	"Nuclear bodies"	Cytosol	"HPA016456: AB_1858907"	"unprognostic (1.52e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-2)"	6.9	8.5	5.8	11.3	10.6	4.1	7.4	10.3	10.9	10.7	9.2	5.4	15.8	10.0	9.6	12.2	8.5	10.4	14.9	9.4	5.3	4.8	9.2	6.1	6.1	10.2	4.7	8.8	11.8	13.5	9.1	5.8	9.0	5.4	12.1	3.9	13.1	12.7	11.7	7.9	15.6	6.9	17.0	3.8	8.4	53.4	5.8	3.7	10.2	9.5	6.7	10.4	11.7	9.0	5.3	4.9	6.6	4.0	7.8	7.8	4.3	9.7	12.5	3.4	2.8	4.8	4.7	8.9	9.1	8.4	8.2	9.3	13.2	7.4	5.1	23.2	8.2	7.5	1.1	12.8	1.7	25.2	8.9	11.4	3.8	5.7	6.6	3.6	6.2	6.4	7.9	6.6	3.1	7.0	2.0	4.3	5.4	12.7	6.6	4.9	3.1	8.8	3.3	10.0	4.2	4.6	5.1	1.8	4.3	6.1	5.8	9.6	27.6	3.5	8.2	18.8	9.6	10.2	8.1	23.4	10.7	1.7	19.8	5.8	5.1	6.6	4.0	3.2	5.9	2.8	6.3	2.9	5.9	7.8	4.9	5.3	6.0	5.3	4.7	7.8	2.5	3.4	5.2	4.3	5.8	10.6	10.3	10.9	5.3	4.8	4.7	8.8	5.4	3.7
YAE1D1	"C7orf36, GK003"	ENSG00000241127	"Yae1 domain containing 1"	Q9NRH1	7	39566376-39610320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019226, HPA031249"	Uncertain		Approved	Cytosol				Cytosol		"HPA019226: AB_1845759, HPA031249: "	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.30e-1)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-3)"	11.9	17.3	24.1	14.2	26.0	2.7	20.2	28.6	23.6	16.5	20.3	15.9	16.3	15.7	19.5	26.2	15.9	18.4	12.6	17.8	19.1	17.4	17.3	13.0	12.2	10.1	20.1	20.3	25.2	13.2	16.9	27.6	12.5	18.1	15.6	22.8	10.9	15.2	14.5	14.1	12.1	22.2	17.8	21.1	11.2	15.2	20.9	23.4	9.9	16.7	8.6	10.2	15.2	13.6	12.2	8.0	12.0	5.2	7.5	19.2	6.6	11.8	7.9	16.9	18.5	13.4	13.7	10.0	17.4	15.3	16.1	18.3	6.7	7.1	6.7	8.6	14.6	12.4	15.9	12.2	15.8	6.5	13.2	6.2	9.8	13.0	12.1	6.3	4.7	12.4	10.1	16.8	18.9	14.0	19.4	3.1	14.0	8.3	5.2	12.8	37.3	9.4	7.1	9.9	7.7	15.3	11.0	21.5	24.2	14.3	19.9	18.3	17.9	12.3	9.3	8.5	15.8	10.3	15.0	10.0	21.0	14.5	10.1	14.5	24.7	12.0	5.0	6.3	8.3	5.2	9.0	12.2	10.7	12.0	5.7	11.4	19.2	13.5	0.5	7.5	3.8	8.0	11.5	6.6	24.1	26.0	28.6	23.6	19.1	17.4	20.1	20.3	18.1	23.4
YARS	"tyrRS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase"	P54577	1	32775237-32818153	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol			230000	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavourable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (6.57e-4)"	16.6	36.3	22.8	22.8	40.6	17.4	13.9	26.6	43.1	14.6	17.5	16.3	22.4	17.1	14.2	15.5	24.1	14.4	11.2	15.5	24.9	28.3	14.1	29.6	21.3	23.2	24.9	27.4	21.2	54.8	19.3	13.9	17.5	26.7	12.7	21.9	11.2	23.5	25.7	27.3	16.5	14.9	22.7	22.7	14.6	25.9	20.9	26.0	15.2	30.0	16.8	29.6	17.0	28.0	9.9	17.8	20.9	13.4	36.5	24.3	17.1	28.3	14.8	15.7	37.7	19.5	22.5	16.7	29.4	24.3	24.1	30.8	17.6	19.6	51.7	11.7	30.5	16.7	47.7	34.6	38.2	21.7	18.9	47.3	22.5	16.6	64.2	37.3	28.7	22.2	43.0	38.1	97.1	24.4	52.2	54.8	20.7	14.7	41.8	20.5	28.5	20.6	36.7	15.0	43.5	17.3	14.2	30.3	18.6	16.0	18.8	54.1	18.8	40.7	19.8	14.7	26.2	29.8	24.2	44.3	47.1	48.3	36.7	52.1	40.3	20.9	12.7	6.6	24.3	13.4	23.9	9.9	14.5	22.3	17.8	8.1	10.8	16.5	3.0	36.5	12.4	10.2	15.6	17.1	22.8	40.6	26.6	43.1	24.9	28.3	24.9	27.4	26.7	26.0
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682427-42702349	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 128.1;testis: 426.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"		870000	Cytosol	Vesicles	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: "	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavourable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	47.5	20.6	15.6	36.4	18.4	57.6	35.2	13.7	14.4	27.9	44.5	21.2	20.1	25.6	35.1	36.4	40.0	25.6	32.5	57.8	15.2	12.3	33.1	38.1	35.3	49.8	17.6	13.2	30.2	36.7	9.4	12.2	26.1	15.5	32.0	33.1	31.1	26.6	23.0	128.1	22.5	27.1	50.0	21.0	47.9	33.2	426.5	15.9	53.2	31.4	64.1	37.2	39.4	41.0	23.5	26.9	21.8	40.5	11.6	23.0	10.6	91.5	54.0	86.5	86.7	84.3	76.3	77.1	67.6	63.0	94.0	73.8	74.0	85.6	116.2	70.9	67.8	55.5	97.4	102.6	93.4	62.0	90.3	118.6	107.3	94.9	68.0	159.2	88.9	70.2	88.4	93.8	116.2	77.7	123.3	50.7	87.5	57.7	179.8	155.0	195.0	73.0	108.8	155.5	125.6	93.1	67.8	119.7	84.4	66.3	89.8	126.2	29.9	317.1	60.6	66.8	114.0	90.5	137.5	74.3	93.1	132.3	63.2	119.4	70.8	4.3	18.1	21.8	16.3	37.8	19.9	23.5	19.5	15.8	26.9	20.1	16.8	17.2	3.3	11.6	40.5	20.9	23.0	10.6	15.6	18.4	13.7	14.4	15.2	12.3	17.6	13.2	15.5	15.9
YBX3	"CSDA, CSDA1, dbpA, ZONAB"	ENSG00000060138	"Y-box binding protein 3"	P16989	12	10699089-10723312	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 612.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034838	Approved		Supported	Cytosol			56000	Cytosol		"HPA034838: AB_10670980"	"unprognostic (1.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (6.17e-13)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.44e-1)"	23.8	5.0	3.0	6.4	6.0	11.2	15.9	2.1	4.6	12.4	14.3	2.0	3.7	3.2	8.5	14.7	25.0	8.4	6.7	91.6	3.2	1.7	7.6	6.5	17.2	6.8	5.5	0.8	17.2	20.6	1.3	8.1	9.5	6.2	12.4	5.3	6.2	12.9	6.8	612.6	29.9	5.0	14.9	5.8	8.6	9.5	30.2	4.1	4.5	18.5	54.2	12.0	27.2	24.6	9.5	4.5	1.0	5.7	0.9	2.3	1.4	17.7	15.6	7.0	22.8	29.2	54.2	51.2	27.8	23.7	23.8	22.4	27.3	43.1	17.4	9.3	22.1	34.1	29.9	57.9	20.7	0.1	53.7	14.4	22.0	16.6	36.5	25.9	1.6	62.5	75.2	22.1	72.7	54.7	19.4	0.0	25.5	19.0	21.3	22.3	70.6	12.8	12.0	32.0	19.7	32.3	23.6	8.7	0.0	21.1	21.0	25.8	6.0	20.4	35.7	16.3	45.9	17.4	31.2	0.1	5.7	2.0	22.5	0.0	17.5	0.0	5.7	0.0	0.7	5.4	0.0	1.6	0.0	2.1	4.5	9.5	0.1	2.3	1.0	0.9	3.0	0.2	0.1	1.4	3.0	6.0	2.1	4.6	3.2	1.7	5.5	0.8	6.2	4.1
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 14.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"			4300000	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	26.2	13.1	17.0	9.4	15.6	2.6	47.2	6.7	12.8	15.8	23.8	8.9	13.7	18.2	13.1	17.4	22.0	10.7	14.9	17.9	14.8	12.4	22.6	43.2	23.6	13.7	15.8	6.6	13.2	21.4	16.7	10.7	31.3	16.8	12.2	17.3	6.5	23.7	21.0	10.6	12.3	24.8	18.8	16.8	34.5	15.5	13.6	12.0	8.1	16.8	15.6	7.1	21.9	17.5	0.1	0.1	14.7	0.0	1.0	2.5	0.6	14.2	7.1	22.4	17.5	13.5	16.7	26.4	9.5	19.4	11.2	15.4	16.8	10.5	0.0	10.1	16.1	8.3	20.9	16.8	22.0	0.0	7.1	4.2	7.0	11.7	11.0	3.2	7.6	12.7	18.1	16.9	18.9	37.8	18.4	6.3	15.9	9.8	1.9	4.2	14.2	9.1	2.4	17.6	1.2	16.3	16.9	4.6	5.3	19.6	14.9	12.4	10.3	6.8	32.5	27.7	30.7	20.8	25.5	5.5	2.7	0.8	10.5	4.7	16.4	14.7	0.0	0.9	2.5	0.0	1.6	0.1	0.5	1.4	0.0	0.0	1.2	1.9	0.0	1.0	0.0	0.1	0.1	0.6	17.0	15.6	6.7	12.8	14.8	12.4	15.8	6.6	16.8	12.0
YKT6		ENSG00000106636	"YKT6 v-SNARE homolog"	O15498	7	44200968-44214294	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030817, HPA030818"	Approved		Approved	Mitochondria,Cytosol				Cytosol	Mitochondria	"HPA030817: AB_10599828, HPA030818: AB_10602102"	"unprognostic (1.25e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.30e-3)"	"unprognostic (7.80e-3)"	"unprognostic (7.45e-3)"	"prognostic unfavourable (4.64e-4)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.66e-3)"	26.5	21.9	35.1	21.4	30.6	31.1	23.1	19.0	32.2	21.8	27.6	26.5	27.9	21.1	21.0	32.6	31.1	16.0	16.8	22.3	34.9	33.5	24.4	17.3	19.6	25.7	36.1	24.0	14.3	51.2	29.7	21.6	25.7	26.8	21.3	26.7	18.3	39.1	24.6	29.1	21.8	21.7	27.1	31.4	20.5	24.9	27.3	25.1	22.2	21.0	23.4	26.3	17.5	15.5	7.7	11.1	15.7	12.8	7.2	12.4	6.3	22.5	23.9	20.1	28.1	25.3	22.2	16.6	45.6	35.0	25.6	26.0	25.1	18.7	21.6	20.6	44.8	27.9	24.5	30.2	32.7	26.0	23.5	12.6	17.7	15.7	31.7	26.7	23.1	20.7	29.6	31.2	33.4	30.8	29.1	16.0	33.9	23.4	19.9	29.7	49.1	40.0	21.9	18.2	18.6	21.1	19.1	23.6	46.4	21.7	34.7	24.7	27.3	27.6	35.2	27.5	34.1	27.1	50.2	42.7	47.1	32.1	37.4	23.7	53.8	5.9	11.2	15.7	7.8	12.8	11.0	6.9	9.2	12.4	10.3	7.7	8.8	8.6	9.5	7.2	12.1	11.1	9.4	6.3	35.1	30.6	19.0	32.2	34.9	33.5	36.1	24.0	26.8	25.1
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Unfolded protein response"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Cell line enhanced"	"Detected in many"		"HEL: 39.4;K-562: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			40000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	4.5	4.6	4.0	4.0	5.3	44.7	6.6	4.8	7.5	6.1	3.9	7.6	2.6	4.1	4.0	3.1	24.5	3.7	3.5	5.0	4.0	2.2	4.5	5.2	9.4	4.2	7.1	4.4	3.5	3.6	2.5	5.1	6.3	5.1	3.4	4.0	3.4	9.7	3.0	6.5	14.9	4.8	2.7	8.5	5.2	8.4	5.6	6.9	14.3	5.8	10.0	8.2	5.8	12.3	0.5	1.3	3.9	1.5	1.2	1.8	0.9	5.3	2.8	4.5	2.7	1.6	2.1	8.8	3.5	2.7	2.7	2.7	5.4	5.5	2.8	1.4	2.1	5.9	0.0	4.3	3.0	2.2	4.8	39.4	11.6	2.5	1.5	5.1	13.9	1.5	3.4	2.2	8.4	2.3	27.4	0.0	2.3	0.0	4.5	2.8	4.3	6.4	2.3	0.2	2.0	2.7	6.0	2.3	5.2	5.8	6.7	7.6	2.4	3.6	1.1	2.3	6.1	1.9	4.6	4.5	0.2	4.2	2.7	0.0	1.5	3.9	1.2	2.0	1.1	1.5	1.5	0.4	1.7	0.9	1.3	0.5	1.4	1.8	2.9	1.2	1.0	0.7	0.8	0.9	4.0	5.3	4.8	7.5	4.0	2.2	7.1	4.4	5.1	6.9
YPEL5	CGI-127	ENSG00000119801	"Yippee like 5"	P62699	2	30146941-30160533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042809	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA042809: "	"unprognostic (7.22e-3)"	"unprognostic (6.50e-3)"	"unprognostic (9.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.67e-3)"	29.6	32.5	39.0	20.1	38.2	164.9	32.9	34.2	52.9	31.2	34.6	20.7	38.2	19.4	28.7	40.9	35.1	25.6	30.8	26.1	38.1	39.5	40.5	29.8	31.9	30.5	35.3	32.5	30.0	23.4	24.6	26.0	48.1	36.4	33.8	22.2	33.1	28.7	47.6	27.7	26.1	29.1	36.8	30.6	29.6	27.2	31.4	18.3	34.2	39.0	20.6	28.2	40.1	25.2	21.3	35.0	72.4	31.9	12.5	21.6	30.9	10.0	5.5	12.1	5.9	34.3	33.3	10.3	14.2	44.0	8.3	12.8	4.5	10.4	5.9	9.7	28.6	5.4	2.8	14.5	11.7	26.2	5.4	3.1	2.5	7.3	29.3	1.0	7.3	34.3	29.5	15.6	20.1	15.6	4.3	10.6	22.2	5.2	3.2	7.2	6.7	6.6	1.9	16.3	5.6	27.6	19.5	4.9	14.9	7.2	7.0	17.6	7.8	5.8	20.4	22.4	8.6	6.1	3.9	25.3	9.9	7.9	16.0	2.8	9.0	41.7	19.6	43.1	13.6	21.8	13.5	21.3	16.6	15.9	18.2	17.4	16.0	14.1	72.4	12.5	31.9	35.0	21.6	30.9	39.0	38.2	34.2	52.9	38.1	39.5	35.3	32.5	36.4	18.3
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"				Cytosol	"Cytoplasmic bodies"	"HPA030063: , HPA054080: , HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	31.1	33.0	18.2	27.0	19.9	42.0	52.4	21.5	28.3	23.7	23.6	20.4	31.5	22.1	26.6	35.1	36.0	26.1	21.7	23.3	18.5	19.4	26.8	35.8	30.0	42.5	18.1	21.3	25.5	37.2	29.7	18.4	32.6	20.2	21.7	26.2	22.1	34.4	31.3	39.6	36.5	24.4	25.1	15.1	29.8	24.8	28.0	17.0	44.2	26.4	30.4	31.7	24.7	31.0	36.5	42.2	33.3	39.9	39.0	40.4	41.8	21.5	15.1	33.0	31.9	25.7	19.8	37.9	21.0	26.3	26.3	26.8	13.7	25.5	37.0	21.0	27.0	20.2	38.1	34.2	31.5	23.2	27.7	31.1	20.7	25.1	30.4	32.7	24.6	26.6	35.4	28.3	40.6	32.2	31.2	18.5	29.5	16.9	34.6	25.8	53.0	19.3	30.0	24.4	30.5	36.9	31.0	28.2	30.0	21.9	33.8	56.8	22.3	30.9	21.9	18.6	19.2	17.3	29.7	22.2	14.2	42.5	21.3	25.9	29.5	33.3	32.4	32.6	28.9	39.9	40.0	36.5	33.9	36.4	42.2	25.5	36.1	34.1	11.5	39.0	38.0	25.9	40.4	41.8	18.2	19.9	21.5	28.3	18.5	19.4	18.1	21.3	20.2	17.0
YTHDF3	FLJ31657	ENSG00000185728	"YTH N6-methyladenosine RNA binding protein 3"	Q7Z739	8	63168553-63212786	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048703			Approved	"Nuclear membrane,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear membrane, Cytosol"	"HPA048703: "	"unprognostic (1.06e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.65e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.11e-1)"	21.7	17.5	12.2	12.8	15.2	53.2	16.0	16.7	17.3	19.4	20.2	14.3	16.8	14.2	24.3	13.6	17.7	17.6	17.6	26.9	11.9	11.4	18.8	26.8	16.8	12.4	14.2	10.6	25.1	15.6	16.6	19.3	29.0	16.8	21.2	15.6	12.9	18.1	18.8	28.0	12.7	24.7	19.4	14.4	18.1	15.9	13.3	14.2	20.1	17.2	15.9	14.1	21.0	15.9	8.2	16.9	21.2	24.9	9.7	11.0	10.1	16.0	21.8	21.0	15.8	28.1	24.2	14.4	29.3	24.6	18.6	22.1	18.5	16.1	17.0	6.4	28.5	15.4	27.6	19.5	27.7	13.8	13.1	31.6	16.5	12.5	25.6	9.0	15.6	32.0	15.0	19.9	27.9	15.7	18.5	15.6	27.9	11.1	17.2	8.4	29.2	16.1	13.1	16.1	8.4	17.5	28.5	8.6	15.4	20.8	18.8	21.2	25.2	11.4	28.2	17.4	16.8	15.5	15.7	18.8	17.0	25.5	17.7	12.7	20.9	20.6	16.6	17.4	8.9	19.4	9.8	7.4	9.0	10.5	16.9	8.2	11.0	10.5	21.2	9.7	24.9	5.1	9.4	10.1	12.2	15.2	16.7	17.3	11.9	11.4	14.2	10.6	16.8	14.2
YWHAB	YWHAA	ENSG00000166913	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta"	P31946	20	44885676-44908532	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003759, HPA007925, HPA011212, HPA061603"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol			210000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: "	"prognostic unfavourable (9.18e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.06e-2)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (3.80e-1)"	"prognostic unfavourable (6.14e-4)"	"prognostic unfavourable (1.91e-6)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (8.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (2.52e-5)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.60e-3)"	"unprognostic (8.59e-2)"	39.3	38.6	65.5	39.4	79.2	28.6	33.0	60.1	87.9	34.0	47.5	27.7	28.7	37.9	35.2	26.4	48.1	30.2	29.6	40.3	68.7	63.4	47.3	36.5	37.4	46.8	49.8	76.2	25.8	18.9	41.1	18.4	36.7	50.1	31.4	53.4	22.9	30.7	43.2	28.3	38.4	39.3	43.3	38.4	53.7	36.7	16.8	33.6	48.2	36.1	31.8	60.2	41.2	34.9	30.9	41.9	37.3	58.4	26.8	43.5	26.6	51.8	39.3	31.7	30.4	52.8	46.7	43.0	47.2	46.0	58.2	51.1	81.8	58.8	55.4	49.5	62.3	55.2	44.7	87.8	69.6	21.2	27.3	41.2	34.6	48.5	35.0	66.7	39.9	36.5	65.7	45.6	58.9	58.2	44.4	26.8	59.7	61.3	52.0	55.0	29.9	61.2	40.9	46.0	43.0	62.3	58.0	33.9	36.1	80.0	85.6	55.1	62.3	64.2	66.0	90.5	46.5	51.0	48.0	17.9	32.6	50.8	66.1	44.7	46.0	34.8	40.1	34.4	29.7	52.2	30.2	30.9	37.7	36.3	41.9	28.6	30.8	36.6	37.3	26.8	58.4	26.5	43.5	26.6	65.5	79.2	60.1	87.9	68.7	63.4	49.8	76.2	50.1	33.6
YWHAE	FLJ45465	ENSG00000108953	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon"	P62258	17	1344272-1400378	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008445, CAB016200, CAB021109, CAB047350, HPA061603"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			160000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336, HPA061603: "	"unprognostic (1.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-2)"	"prognostic favourable (6.48e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-3)"	"unprognostic (8.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.94e-2)"	55.2	54.3	107.5	35.3	87.1	32.7	37.3	71.5	118.4	28.4	40.2	60.9	23.8	40.2	35.9	54.1	43.1	44.2	23.4	57.7	92.3	81.9	64.5	50.9	32.8	25.4	94.1	77.9	40.2	40.2	41.0	37.9	45.1	73.7	35.0	42.5	27.9	42.4	27.7	135.9	36.8	36.2	32.2	101.1	26.2	38.5	46.0	53.6	30.9	47.5	36.5	37.2	31.6	32.1	19.2	41.5	17.2	36.2	15.0	23.3	31.5	77.8	58.2	70.5	59.3	31.2	36.1	67.8	50.4	29.7	45.0	34.9	104.0	32.0	52.9	59.2	41.7	54.1	59.7	50.9	63.8	36.5	111.3	36.9	48.6	44.5	37.3	35.3	37.8	32.7	37.6	45.0	69.0	54.1	42.3	38.2	57.8	37.9	46.7	28.2	64.6	37.8	56.8	33.3	37.5	45.8	45.1	39.3	59.7	60.6	24.9	39.4	47.2	32.7	51.1	43.7	37.1	55.1	88.9	24.0	44.3	44.4	52.4	42.3	63.1	17.2	31.8	8.6	12.4	36.2	15.6	19.2	18.7	13.9	41.5	16.1	17.0	14.3	10.8	15.0	30.9	28.8	23.3	31.5	107.5	87.1	71.5	90.2	92.3	81.9	94.1	77.9	73.7	53.6
YWHAG	PPP1R170	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326794-76359031	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 117.8;skeletal muscle: 91.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013274, CAB018389, HPA026918, HPA061603"	Approved	Approved	Supported	Nucleoplasm,Nucleoli,Cytosol			160000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: "	"unprognostic (3.71e-2)"	"prognostic unfavourable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	52.4	31.2	46.3	17.7	54.6	7.3	17.2	36.2	117.8	13.4	14.2	13.3	4.6	14.4	15.0	7.0	18.6	9.0	17.0	33.1	50.2	56.2	15.9	22.0	12.9	12.1	45.9	49.8	13.3	18.0	14.8	7.8	16.6	74.6	14.7	14.0	8.6	10.0	13.3	91.8	11.7	12.5	20.2	22.8	12.7	11.2	8.9	13.5	6.8	8.8	13.8	14.3	14.7	13.2	3.1	5.9	3.2	5.0	1.1	3.3	1.7	37.1	46.7	41.4	52.5	42.4	24.5	18.7	43.2	21.4	26.8	29.2	29.3	40.0	52.4	14.9	38.3	34.8	51.8	47.7	37.8	35.5	22.6	49.6	32.0	32.5	38.7	60.5	48.6	26.8	45.8	31.3	64.9	42.6	68.1	59.3	40.0	35.0	43.2	44.7	45.9	32.8	50.7	41.9	57.9	42.1	25.4	22.2	61.7	47.9	61.4	30.6	42.7	36.7	44.9	52.4	30.5	46.4	57.7	19.7	36.9	80.7	47.1	57.3	55.8	3.2	5.0	1.1	2.1	4.6	3.3	3.1	2.4	2.6	5.2	1.8	1.8	2.0	1.1	1.1	3.8	5.9	2.0	1.7	46.3	54.6	36.2	88.9	50.2	56.2	45.9	49.8	74.6	13.5
YWHAH	YWHA1	ENSG00000128245	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta"	Q04917	22	31944461-31957603	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 154.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025918, HPA061603"	Uncertain		Approved	Nucleoli,Cytosol			130000000	Cytosol	Nucleoli	"CAB025918: , HPA061603: "	"unprognostic (3.77e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (1.59e-5)"	"unprognostic (8.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.81e-2)"	21.5	18.6	87.9	20.6	47.4	16.3	19.3	41.9	154.3	13.7	24.4	10.0	4.3	17.2	13.1	14.1	14.0	16.4	18.6	15.2	78.8	59.1	11.7	11.5	25.0	13.5	35.5	101.6	10.0	16.7	5.2	10.4	22.4	49.5	12.3	20.1	6.8	9.9	15.6	13.9	9.9	17.4	25.9	19.4	12.8	26.9	3.7	9.1	6.3	10.5	5.5	15.1	18.5	10.6	8.1	16.6	14.9	14.4	17.7	12.8	9.6	67.9	27.2	30.4	17.7	18.5	17.1	19.3	66.1	32.7	38.1	43.6	28.8	23.7	40.1	16.1	60.6	32.9	36.4	36.3	36.0	35.5	31.7	23.7	21.4	25.7	18.7	76.3	26.5	15.5	19.4	32.1	22.9	31.1	32.7	29.4	29.0	27.4	23.1	35.1	36.2	29.8	33.2	41.9	21.3	24.0	29.4	65.4	21.5	37.6	26.3	23.5	15.0	18.9	49.7	38.5	38.5	28.2	41.9	16.4	25.3	50.2	27.9	30.8	33.8	7.8	14.4	14.9	5.7	11.8	8.1	8.1	7.0	8.1	16.6	7.6	2.8	3.6	8.7	17.7	12.2	4.5	12.8	9.6	87.9	47.4	41.9	126.3	78.8	59.1	35.5	101.6	49.5	9.1
YWHAQ	"14-3-3, HS1"	ENSG00000134308	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta"	P27348	2	9583972-9631014	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA007925, CAB010286, HPA061603"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			120000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: "	"unprognostic (2.65e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (8.20e-4)"	"unprognostic (1.53e-1)"	"unprognostic (5.78e-3)"	"prognostic unfavourable (9.83e-6)"	"unprognostic (4.90e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.39e-3)"	40.5	47.3	77.8	32.1	60.8	48.0	50.8	88.5	82.5	52.2	44.0	82.5	25.0	37.9	60.5	48.2	57.6	45.3	40.0	68.5	73.7	76.2	45.9	37.2	35.0	38.2	74.3	54.8	55.9	64.4	39.2	39.0	39.3	69.8	54.2	44.1	31.2	38.9	48.8	17.6	33.3	36.5	57.9	72.2	29.8	36.9	44.3	63.5	58.8	45.4	56.7	43.3	47.7	46.3	31.5	30.9	24.8	28.9	51.4	58.4	60.9	42.7	64.5	58.5	56.5	46.1	63.8	55.0	58.8	57.9	61.8	51.9	48.5	37.7	55.4	30.7	84.2	40.3	64.9	64.1	79.8	136.3	52.8	51.8	42.1	51.8	35.3	49.8	31.4	43.1	37.7	67.4	44.0	69.3	50.8	33.5	75.9	29.8	88.2	50.9	99.3	74.4	64.6	75.9	67.8	68.0	38.3	55.7	94.4	53.5	55.5	42.5	34.5	25.7	63.1	77.7	55.1	67.2	89.6	34.2	46.8	73.1	66.4	52.1	64.4	17.1	22.2	24.8	47.8	28.9	58.4	31.5	45.1	50.8	30.9	28.8	24.7	39.9	6.8	51.4	27.2	15.7	43.1	60.9	77.8	60.8	88.5	69.0	73.7	76.2	74.3	54.8	69.8	63.5
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916525-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005065, HPA061603"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol			760000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB005065: AB_2218378, HPA061603: "	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavourable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (2.28e-5)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	54.6	40.9	89.9	51.8	104.6	70.8	39.6	55.8	117.7	52.4	69.6	38.7	25.3	47.4	43.5	37.6	141.8	38.3	51.9	29.1	81.7	67.0	44.1	32.9	40.7	60.0	50.1	66.7	46.4	27.5	37.8	25.2	69.0	78.2	42.5	70.3	31.7	55.2	47.2	19.7	63.0	71.4	53.5	43.8	56.3	51.5	34.1	31.5	89.4	46.0	74.9	83.2	53.6	70.2	58.6	57.2	129.4	77.9	57.0	78.4	104.9	138.9	67.6	129.0	37.0	32.1	40.8	63.9	65.3	85.0	88.5	86.2	47.0	91.2	62.5	70.9	103.7	60.5	81.1	93.1	134.8	55.3	32.0	59.0	51.2	30.4	42.3	24.6	67.7	37.8	126.9	73.1	116.5	79.4	67.0	61.3	75.6	50.5	101.6	43.7	43.6	70.9	43.3	37.6	42.9	85.1	78.5	72.2	51.5	49.7	49.3	103.4	71.4	29.1	64.6	44.9	65.9	54.1	58.5	39.1	46.4	76.7	74.3	46.5	183.7	129.4	45.0	81.2	69.1	66.5	70.3	58.6	59.0	66.5	57.2	48.0	44.8	56.4	74.6	57.0	77.9	35.4	78.4	104.9	89.9	104.6	55.8	117.7	81.7	67.0	50.1	66.7	78.2	31.5
Z83844.3		ENSG00000285304			22	37639693-37666932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.3"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA000757	Approved		Uncertain	Cytosol				Cytosol		"HPA000757: AB_1079951"																		2.4	0.1	1.8	12.3	2.7	8.5	1.0	2.4	3.5	3.7	7.5	2.0	0.9	8.4	1.3	2.0	11.6	1.9	2.4	1.0	1.5		0.3	1.0	3.7	8.2	1.7	1.5	2.5	0.9	2.8	0.0	6.0	1.8	3.5	5.7	1.4	4.4	2.8	0.0	2.2	12.5	2.6	2.5	13.4	1.6	0.9	2.4	10.5	0.3	10.4	16.3	4.6	2.0	1.6	3.6	0.1	2.7	1.7	2.6	1.5	9.1	1.6	5.3	3.3	1.5	4.6	5.8	2.7	8.4	10.1	10.6	7.4	2.3	6.7	1.1	3.0	8.0	5.7	13.8	3.2	6.9	5.1	14.0	0.2	7.4	3.0	21.3	19.2	5.4	6.6	11.8	1.1	0.6	4.0	5.0	0.4	11.2	0.9	2.0	5.4	1.3	8.7	3.6	5.4	1.1	3.2	3.0	5.5	0.7	3.5	6.1	4.6	10.7	1.2	1.5	5.5	0.7	0.0	9.1	3.4	6.1	3.5	14.7	10.1	0.0	2.7	0.1	2.2	1.3	1.8	1.6	1.4	2.1	3.6	0.9	2.6	1.6	0.0	1.7	2.7	2.2	2.5	1.5										
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595443	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 21.0;thyroid gland: 74.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 19.7;EFO-21: 13.7;HaCaT: 19.0;HBEC3-KT: 42.6;RPTEC TERT1: 28.4"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.4"	"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.0;T-cells: 2.5"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"				"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.1	0.9	1.4	0.0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0.0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0.0	0.4	4.0	0.1	0.1	0.0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21.0	74.5	7.5	7.4	0.2	6.2	4.0	0.0	0.1	0.0	0.5	2.5	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.1	13.7	0.0	19.0	0.0	42.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	3.6	0.6	0.3	0.0	4.0	1.9	2.5	0.1	0.5	0.0	0.0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364117-151391548	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	11.1	7.7	10.3	10.6	8.6	14.4	13.3	11.7	10.7	9.3	10.3	8.2	9.2	7.9	11.1	8.1	8.5	10.7	11.5	8.4	8.4	6.6	7.7	9.9	13.1	14.4	11.0	6.8	17.4	14.4	8.6	5.3	9.2	10.3	8.7	9.9	6.9	11.1	12.3	14.0	8.6	10.6	14.6	9.6	12.0	9.4	7.7	11.1	27.7	32.2	8.0	13.0	11.2	13.9	5.7	6.6	15.1	10.7	7.8	14.1	6.3	8.7	6.4	9.7	7.3	10.5	11.0	10.4	13.8	20.0	17.5	16.8	12.2	7.2	22.4	7.7	13.9	10.4	15.6	16.9	21.9	10.1	11.6	10.1	7.6	18.5	15.6	27.2	12.5	11.6	10.1	16.0	19.7	10.2	18.3	13.2	12.3	19.5	14.7	12.7	11.8	9.7	14.1	9.2	8.9	13.3	13.3	10.9	7.6	10.9	14.4	10.8	9.7	16.4	8.4	14.9	16.1	6.7	18.3	17.6	18.3	25.1	6.1	14.8	10.5	13.6	6.0	15.1	11.3	6.6	14.1	5.7	10.3	13.4	6.6	4.4	8.7	10.5	6.9	7.8	10.7	2.7	8.3	6.3	10.3	8.6	11.7	10.7	8.4	6.6	11.0	6.8	10.3	11.1
ZBTB33	"kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348"	ENSG00000177485	"Zinc finger and BTB domain containing 33"	Q86T24	X	120250752-120258398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000755, CAB001980, HPA005732"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166"	"unprognostic (9.14e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.59e-2)"	15.4	10.4	12.8	9.3	15.5	20.2	18.0	16.3	13.9	9.6	8.5	11.6	9.1	9.1	7.7	11.5	14.9	10.0	9.0	6.0	12.6	15.0	8.0	22.5	10.7	14.0	13.4	11.6	12.2	11.6	17.7	15.5	10.2	16.7	10.5	7.9	6.2	15.0	10.0	9.5	21.6	10.2	6.0	18.6	12.7	9.9	6.9	14.8	29.3	17.4	5.3	14.6	10.3	9.7	3.4	8.9	14.2	8.9	5.1	7.2	5.2	9.0	10.2	13.9	12.7	10.9	12.5	16.3	7.1	9.5	8.3	10.2	6.2	8.0	13.4	13.5	7.1	14.1	21.9	11.1	10.6	14.8	15.8	14.0	15.4	8.3	8.3	13.9	15.9	8.9	13.6	8.4	12.5	14.0	9.0	15.7	10.2	10.9	13.0	9.0	16.9	11.1	14.8	10.5	21.3	8.4	16.3	25.4	10.8	15.0	14.7	16.6	7.9	19.7	13.8	6.6	4.9	9.8	12.5	8.8	8.9	17.0	9.2	19.9	8.2	14.2	6.1	7.7	4.4	8.9	7.2	3.4	5.6	5.5	8.9	3.3	7.1	4.8	1.2	5.1	5.6	8.5	4.9	5.2	12.8	15.5	16.3	13.9	12.6	15.0	13.4	11.6	16.7	14.8
ZBTB37	"MGC2629, ZNF908"	ENSG00000185278	"Zinc finger and BTB domain containing 37"	Q5TC79	1	173868082-173903549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023438	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA023438: AB_1858954"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.96e-2)"	6.4	4.0	6.9	6.5	9.8	11.1	5.8	6.4	7.9	5.3	4.0	11.2	3.7	4.0	9.1	5.5	3.4	4.6	4.7	5.6	7.2	3.7	5.3	4.8	6.0	7.7	9.9	5.2	7.6	4.5	6.8	9.2	4.7	7.8	5.3	3.9	10.6	4.6	4.9	4.0	7.0	5.2	6.8	9.5	7.9	5.1	18.4	8.8	7.7	6.1	2.8	6.3	4.8	5.5	1.8	2.4	6.0	1.0	2.3	2.8	0.8	2.4	3.7	5.6	2.4	3.4	2.8	6.2	2.2	1.6	4.0	2.9	4.6	3.1	6.6	4.6	3.4	3.1	4.7	2.4	3.3	3.6	3.0	9.0	3.9	2.2	2.0	5.3	5.7	2.5	1.7	6.0	4.0	2.0	8.0	4.4	4.2	1.8	3.6	1.4	5.3	0.8	2.4	4.9	2.2	2.2	6.0	4.2	5.2	3.1	4.3	4.3	6.2	5.5	3.6	5.2	5.6	2.6	3.5	8.0	5.9	10.5	3.5	3.0	3.1	0.4	1.0	3.4	2.8	1.0	1.2	0.7	1.3	2.0	0.6	1.8	0.7	1.8	6.0	2.3	1.0	2.4	1.0	0.8	6.9	9.8	6.4	7.9	7.2	3.7	9.9	5.2	7.8	8.8
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: "	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favourable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	20.1	23.5	20.1	10.9	22.7	4.7	20.6	27.9	38.3	26.3	21.8	19.8	13.7	9.2	22.8	22.7	16.6	22.5	15.1	22.3	19.6	18.3	15.6	6.3	21.4	10.7	21.0	19.4	35.1	16.3	70.1	15.4	14.6	25.8	22.3	9.9	26.2	19.9	30.0	21.4	14.8	11.3	22.3	20.2	18.7	14.2	10.6	14.7	8.2	23.9	9.5	12.7	23.4	24.7	1.8	1.3	1.4	4.6	2.0	3.5	1.5	6.4	8.9	2.2	4.3	23.9	12.4	4.1	9.1	13.1	8.2	8.2	2.9	3.1	0.6	7.2	17.1	10.3	2.2	12.7	6.0	10.2	3.8	3.2	7.2	2.0	6.7	0.6	7.7	8.6	13.3	7.9	10.1	7.1	1.0	2.1	9.0	4.3	2.2	1.3	0.9	4.2	4.1	3.9	0.9	10.0	5.5	1.3	3.3	4.0	2.8	4.2	5.3	1.4	9.9	9.3	3.7	8.7	7.4	3.8	2.6	0.4	10.0	2.0	4.8	1.1	0.9	1.4	3.2	1.4	3.5	1.6	2.6	2.6	0.7	1.8	3.4	3.1	0.6	2.0	4.6	1.3	1.3	1.5	20.1	22.7	27.9	38.3	19.6	18.3	21.0	19.4	25.8	14.7
ZBTB41	"DKFZp686C06120, FLJ36199, FRBZ1, ZNF924"	ENSG00000177888	"Zinc finger and BTB domain containing 41"	Q5SVQ8	1	197153680-197200542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034841, HPA034842"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA034841: , HPA034842: AB_10669995"	"unprognostic (2.36e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.01e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.58e-1)"	2.6	3.8	4.1	1.8	4.0	0.2	5.9	10.8	5.0	4.5	2.2			2.1	3.2	3.8	2.4	2.8	3.2	2.3	4.0	4.7	4.3	3.3	2.3	2.4	4.2		5.9	2.9	5.6	3.8	2.2		3.3	2.5		2.9	2.6	3.3	2.4	1.8	2.2	4.8	3.0	3.2	2.6			6.4		2.2	3.1	2.1	1.5	1.4	1.7	0.7	1.8	2.2	0.7	7.2	4.1	5.5	4.4	8.7	13.2	4.4	4.4	7.3	4.7	4.4	2.6	6.1	2.7	6.4	10.0	6.0	3.8	3.8	7.4	2.3	2.2	2.2	5.5	2.4	7.7	4.3	2.1	5.4	10.1	4.7	8.2	3.1	5.0	3.3	11.9	3.5	3.2	2.4	2.1	1.5	2.2	7.6	4.8	5.7	4.1	7.8	6.9	7.9	13.9	8.3	10.6	3.3	5.2	9.2	5.4	7.2	5.7	3.7	1.9	2.9	4.3	1.6	12.7	1.7	0.7	0.4	1.2	0.4	2.2	1.5	1.6	1.6	1.4	1.4	2.2	2.0	0.0	1.8	0.6	0.7	1.0	0.7										
ZBTB45	"FLJ14486, ZNF499"	ENSG00000119574	"Zinc finger and BTB domain containing 45"	Q96K62	19	58513530-58538911	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035754	Uncertain		Approved	Cytosol				Cytosol		"HPA035754: AB_10603461"	"unprognostic (1.38e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.38e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.40e-1)"	15.3	11.1	11.8	12.0	13.4	11.1	10.2	15.1	24.9	15.2	10.9	13.5	11.4	14.6	14.9	8.7	11.6	12.5	10.3	10.0	12.6	10.0	9.8	7.7	11.0	10.1	10.3	8.5	16.6	13.9	9.1	8.8	10.9	11.2	14.5	4.7	13.2	21.5	11.0	21.0	17.2	14.7	11.8	7.3	13.3	14.6	7.5	9.2	15.8	15.9	9.1	14.4	13.5	10.5	7.9	8.7	13.2	11.3	7.0	9.8	5.5	10.4	15.1	3.9	6.2	4.0	3.3	4.7	5.5	2.3	1.4	1.4	2.9	7.0	16.6	8.4	3.2	6.5	2.0	4.9	0.6	10.8	27.0	8.8	7.6	3.6	2.4	5.3	5.7	3.1	3.6	2.3	2.0	2.9	7.8	0.8	2.3	7.6	8.7	5.7	5.7	13.1	6.8	2.4	10.1	3.1	10.1	12.7	8.8	4.2	11.8	3.0	18.4	3.8	5.4	6.7	2.9	2.2	5.5	19.4	13.6	8.6	7.8	2.2	4.2	9.2	6.7	13.2	8.1	10.2	9.8	6.1	5.8	7.7	7.2	7.9	7.1	5.0	5.9	7.0	11.3	8.7	5.1	5.5	11.8	13.4	15.1	24.9	12.6	10.0	10.3	8.5	11.2	9.2
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6580001-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favourable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	10.8	12.0	9.6	15.1	12.6	13.3	12.3	11.1	16.3	13.5	12.2	12.7	21.4	11.7	13.2	15.1	12.7	14.2	17.6	9.6	8.9	7.5	12.9	21.6	14.3	17.1	7.0	11.3	19.9	15.8	17.1	14.0	10.7	11.4	17.2	13.2	16.9	12.6	11.7	10.9	14.4	17.2	11.3	8.8	17.1	12.9	28.2	10.3	19.9	18.4	7.4	15.9	13.0	14.4	7.5	7.8	26.7	6.8	6.6	6.4	5.3	3.8	4.7	7.5	10.9	8.3	6.4	3.9	3.9	4.7	7.6	8.2	4.8	8.9	12.8	7.0	3.4	7.3	11.3	7.8	6.1	13.0	10.7	10.4	13.6	4.7	9.9	16.7	28.2	6.4	6.1	7.3	11.8	5.5	10.2	8.4	5.6	7.4	8.2	12.0	5.6	8.2	9.3	7.0	14.1	6.8	3.6	14.6	6.7	5.9	13.5	9.0	7.8	13.4	6.1	5.2	3.4	5.6	4.9	9.2	7.9	19.8	4.8	13.4	3.0	10.9	6.8	26.7	6.0	4.2	6.0	6.5	4.7	5.7	7.8	7.5	6.4	5.5	10.0	6.6	6.6	5.0	3.8	5.3	9.6	12.6	11.1	16.3	8.9	7.5	7.0	11.3	11.4	10.3
ZBTB49	"FLJ38559, ZNF509"	ENSG00000168826	"Zinc finger and BTB domain containing 49"	Q6ZSB9	4	4290251-4321786	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024450	Approved		Approved	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA024450: AB_1859311"	"unprognostic (4.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (5.24e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (1.76e-4)"	"unprognostic (5.54e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"prognostic favourable (2.88e-5)"	7.3	5.4	5.0	6.0	9.0	11.8	6.8	9.2	8.7	7.2	6.2	9.9	3.4	4.5	9.5	7.0	5.6	6.3	5.3	6.2	6.1	5.1	4.7	5.9	6.5	7.5	6.8	5.3	10.6	7.7	6.0	13.3	5.6	8.9	7.9	4.4	7.1	10.0	6.5	10.1	4.8	6.3	6.5	6.1	9.2	6.0	10.3	6.7	6.7	8.1	5.0	8.5	7.8	5.8	2.9	1.9	12.1	2.7	3.2	6.4	1.8	2.1	3.5	4.3	7.2	5.8	6.1	5.1	2.6	5.1	5.7	4.4	3.0	4.0	7.4	2.7	2.9	3.6	7.5	4.3	5.9	2.4	2.9	8.6	2.3	4.2	4.9	5.2	3.2	3.9	3.6	5.2	3.4	5.7	4.4	4.0	5.3	3.4	10.3	10.2	7.3	4.7	6.2	5.6	4.6	2.3	3.7	5.2	5.0	5.7	2.2	5.7	3.1	5.1	5.5	5.2	2.3	3.4	5.5	4.9	4.8	6.3	3.7	4.4	5.0	3.7	2.6	12.1	6.4	2.7	5.0	2.2	3.6	6.0	1.9	2.9	4.1	4.7	6.2	3.2	2.2	0.4	3.2	1.8	5.0	9.0	9.2	8.7	6.1	5.1	6.8	5.3	8.9	6.7
ZC2HC1A	"C8orf70, CGI-62, FAM164A"	ENSG00000104427	"Zinc finger C2HC-type containing 1A"	Q96GY0	8	78666047-78719765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 20.6;SK-BR-3: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.6;T-reg: 17.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024726	Approved		Approved	"Actin filaments,Cytosol"				Cytosol	"Actin filaments"	"HPA024726: AB_1846597"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.19e-7)"	"unprognostic (2.96e-1)"	"unprognostic (7.25e-2)"	"prognostic unfavourable (9.00e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.05e-3)"	7.6	6.2	16.1	6.1	21.2	2.0	14.3	23.6	20.0	12.7	8.0	8.4	6.7	3.3	19.7	9.1	11.5	19.5	10.0	8.1	16.5	15.7	8.3	2.9	12.6	5.1	11.9	22.6	23.6	4.9	26.1	26.1	11.4	25.8	12.8	7.8	5.0	7.5	10.9	4.2	43.1	5.8	13.1	13.8	5.9	5.8	8.6	11.0	1.5	19.8	4.2	8.4	11.0	12.1	5.1	3.3	20.6	8.1	0.6	17.7	1.5	2.4	3.0	5.6	4.6	12.1	12.7	2.4	6.7	4.5	3.4	4.3	0.8	4.3	4.1	2.8	6.8	2.0	3.3	3.7	5.0	13.4	2.1	0.4	2.8	2.4	7.2	0.6	1.3	9.1	6.4	2.7	8.3	4.6	0.7	20.6	7.1	2.3	0.8	1.2	1.4	4.8	0.0	7.2	0.8	5.0	5.2	2.2	8.8	5.3	38.6	7.3	1.0	0.1	3.8	10.6	4.4	4.8	3.3	5.1	5.2	2.7	5.0	0.0	4.0	20.6	3.9	0.1	0.1	4.1	0.0	5.1	4.0	0.2	3.3	3.3	1.2	0.4	0.1	0.6	8.1	0.2	17.7	1.5	16.1	21.2	23.6	20.0	16.5	15.7	11.9	22.6	25.8	11.0
ZC3H15	LEREPO4	ENSG00000065548	"Zinc finger CCCH-type containing 15"	Q8WU90	2	186486156-186509363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031099, HPA031100, HPA031101"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669"	"unprognostic (1.51e-1)"	"prognostic unfavourable (6.45e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (5.92e-2)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (1.48e-7)"	"unprognostic (9.08e-3)"	"unprognostic (4.95e-2)"	"prognostic favourable (3.98e-4)"	"prognostic unfavourable (9.75e-4)"	"unprognostic (5.72e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.45e-2)"	25.2	31.1	35.7	25.2	40.1	67.3	38.0	32.9	52.6	24.7	24.7	10.5	30.2	29.0	25.1	30.7	28.2	19.8	22.6	25.2	60.0	35.4	32.8	40.3	20.3	29.5	32.3	33.5	24.5	32.7	26.9	35.3	29.4	51.6	24.3	28.9	10.7	25.8	26.2	58.0	27.0	29.9	27.4	43.4	28.5	23.3	23.7	21.7	28.3	30.5	19.0	30.1	30.0	38.8	32.8	31.1	28.3	39.1	32.5	36.9	22.4	26.7	18.2	22.5	28.9	25.6	26.0	33.8	29.9	20.4	27.7	25.1	53.0	21.8	36.6	27.4	21.2	19.5	41.4	36.5	39.3	33.2	31.6	52.5	28.1	58.6	34.7	53.4	32.2	21.3	40.5	30.1	42.9	29.7	50.1	28.7	28.9	24.1	34.0	38.2	42.5	46.1	27.2	30.5	34.0	35.1	32.8	27.2	20.1	18.9	25.9	43.1	18.2	38.9	25.4	31.4	27.1	19.2	35.6	25.0	42.0	52.3	27.9	38.0	27.3	28.3	27.5	26.9	27.2	34.0	33.7	32.8	33.8	34.5	31.1	24.7	31.5	33.2	16.8	32.5	39.1	27.5	36.9	22.4	35.7	40.1	32.9	52.6	60.0	35.4	32.3	33.5	51.6	21.7
ZC3H4	"C19orf7, KIAA1064"	ENSG00000130749	"Zinc finger CCCH-type containing 4"	Q9UPT8	19	47064187-47113752	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040934, HPA041068"	Supported		Enhanced	Nucleoplasm,Cytosol			8500	Nucleoplasm	Cytosol	"HPA040934: AB_10795495, HPA041068: AB_10796567"	"unprognostic (8.02e-3)"	"unprognostic (3.68e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.90e-2)"	"prognostic favourable (2.23e-4)"	12.0	8.2	8.6	14.5	16.9	8.5	18.2	25.6	13.9	8.9	9.6	14.7	9.8	11.5	12.8	6.0	11.8	10.4	6.5	8.2	9.3	7.6	9.2	10.9	19.9	14.1	16.5	5.2	14.6	12.5	10.4	45.4	15.4	13.9	9.7	7.2	10.8	11.8	10.4	14.1	13.5	11.5	8.5	26.0	16.0	11.5	14.5	12.4	17.5	10.5	9.3	11.5	10.3	24.0	5.2	6.8	6.2	3.7	5.2	5.6	1.2	8.7	13.8	8.6	12.2	4.8	3.0	8.7	7.1	4.0	6.7	4.5	9.8	9.9	18.6	5.2	4.8	15.3	3.7	10.0	4.2	11.4	6.1	13.2	8.3	7.4	4.2	12.6	14.2	5.1	2.8	6.1	4.9	5.4	12.7	7.1	4.3	15.3	14.2	21.2	12.7	4.7	22.3	7.4	8.4	5.0	14.4	10.5	14.8	10.8	9.0	5.2	9.5	10.1	9.5	9.1	8.9	5.8	9.9	9.3	7.5	16.6	7.1	10.2	12.9	4.6	2.2	3.2	5.5	3.7	5.6	5.2	4.9	5.5	2.9	5.1	4.3	4.8	6.2	5.2	3.5	6.8	3.1	1.2	8.6	16.9	25.6	13.9	9.3	7.6	16.5	5.2	13.9	12.4
ZC3H7A	"FLJ20318, HSPC055, ZC3H7, ZC3HDC7"	ENSG00000122299	"Zinc finger CCCH-type containing 7A"	Q8IWR0	16	11750586-11797267	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040808, HPA059849"	Uncertain		Supported	Cytosol				Cytosol		"HPA040808: AB_10794150, HPA059849: "	"unprognostic (2.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.27e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.55e-2)"	22.9	19.6	18.3	16.6	18.8	27.3	21.2	25.6	19.1	19.2	18.4	18.4	21.4	14.2	24.4	17.0	13.5	19.2	17.5	15.8	16.9	11.9	19.4	18.0	23.6	21.7	19.0	16.6	25.5	21.3	25.4	20.2	21.3	16.8	20.8	16.5	23.1	22.6	22.5	32.9	15.1	19.1	25.6	18.1	23.3	17.9	8.9	19.3	32.9	23.5	13.5	21.8	20.7	17.1	12.8	10.5	16.0	23.5	17.5	19.2	7.1	13.3	6.9	24.2	13.1	17.0	17.0	9.7	21.5	21.5	16.4	20.1	7.6	11.7	18.7	13.5	25.4	8.6	13.6	20.8	23.6	14.7	15.5	8.0	14.0	12.7	24.1	18.4	17.7	19.1	11.6	15.3	29.0	20.4	13.1	16.9	23.5	10.4	13.9	9.3	14.2	6.3	20.3	13.5	13.3	15.3	10.4	18.6	14.8	17.3	16.8	21.4	12.2	12.1	19.2	19.1	11.7	25.7	14.4	13.6	10.2	27.8	14.0	13.8	49.0	12.3	10.7	16.0	12.5	14.4	17.1	12.8	16.1	13.3	10.5	12.2	19.2	13.4	13.3	17.5	23.5	8.4	19.0	7.1	18.3	18.8	25.6	19.1	16.9	11.9	19.0	16.6	16.8	19.3
ZC3H7B	"DKFZp434K0920, FLJ13787, KIAA1031, RoXaN"	ENSG00000100403	"Zinc finger CCCH-type containing 7B"	Q9UGR2	22	41301522-41360147	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001784	Uncertain		Uncertain	Cytosol				Cytosol		"HPA001784: AB_1080637"	"unprognostic (1.71e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.19e-1)"	"prognostic favourable (5.43e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-1)"	21.7	31.9	31.0	14.7	24.9	10.9	13.4	30.0	45.6	17.8	13.3	24.2	13.7	18.8	19.0	11.3	15.1	21.3	14.4	17.1	30.5	20.2	21.3	29.0	18.4	14.9	24.5	27.8	34.3	23.9	41.7	21.9	14.4	29.4	18.8	10.7	20.4	32.8	22.7	17.2	15.4	19.6	16.6	21.7	19.4	16.1	9.8	28.0	13.1	37.2	9.2	11.7	14.4	11.8	1.9	1.5	0.5	0.6	1.4	1.4	0.3	21.9	12.2	16.4	9.9	15.0	13.6	19.2	25.2	26.9	21.1	16.6	13.3	9.1	12.4	31.0	34.9	15.0	13.8	23.6	10.8	28.3	22.7	11.1	15.1	16.9	20.2	21.2	9.7	17.1	13.5	18.1	22.3	22.7	22.2	6.9	17.7	22.1	16.7	11.1	11.8	9.3	25.7	10.3	14.1	17.9	15.7	10.6	7.9	23.1	14.2	11.9	9.3	14.3	45.4	20.7	21.6	6.3	15.4	12.1	6.7	12.5	17.3	10.5	17.8	0.0	0.6	0.5	1.0	0.4	1.0	1.9	1.2	1.1	0.5	1.8	1.4	0.9	0.0	1.4	0.2	1.5	0.9	0.3	31.0	24.9	30.0	45.6	30.5	20.2	24.5	27.8	29.4	28.0
ZC3HAV1	"FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043520-139109719	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: "	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavourable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favourable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	14.3	14.8	6.8	19.8	6.6	52.6	13.8	1.6	5.6	11.2	11.5	6.7	10.8	6.9	10.0	10.9	14.2	9.5	10.4	7.0	5.4	7.2	11.2	13.1	17.2	44.4	7.5	4.0	10.6	11.0	9.8	11.4	8.5	8.6	11.2	10.2	9.3	16.9	11.5	3.8	9.5	14.8	10.8	9.0	22.6	9.6	7.8	6.9	43.9	18.2	8.8	26.1	10.8	29.0	16.3	7.0	28.8	11.9	15.6	27.9	11.8	11.4	14.2	2.0	11.8	18.7	18.0	8.6	13.0	10.0	22.7	23.4	10.1	14.9	10.1	12.2	20.7	13.0	15.8	15.4	12.9	17.9	5.9	20.0	14.4	12.5	10.8	23.2	18.6	18.3	9.9	25.8	5.8	16.9	16.9	11.3	9.7	10.8	19.1	27.1	8.0	8.6	22.7	7.1	9.7	15.6	14.5	3.6	7.5	20.0	14.1	17.3	8.2	14.5	21.2	4.8	7.1	13.2	10.7	8.7	9.1	23.7	10.9	21.7	11.4	28.8	8.2	11.9	19.4	10.6	24.6	14.3	27.9	23.5	6.4	16.3	27.3	26.4	22.1	15.6	11.9	7.0	24.2	11.8	6.8	6.6	1.6	5.6	5.4	7.2	7.5	4.0	8.6	6.9
ZC3HAV1L	"C7orf39, MGC14289"	ENSG00000146858	"Zinc finger CCCH-type containing, antiviral 1 like"	Q96H79	7	139025706-139036029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 10.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 10.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020386, HPA050741"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA020386: AB_2257412, HPA050741: "	"unprognostic (1.12e-1)"	"prognostic unfavourable (7.35e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-3)"	8.2	6.1	2.9	3.1	4.7	1.5	9.4	1.1	3.0	14.7	6.6	2.0	5.0	4.2	10.3	9.7	8.6	7.4	5.6	4.7	2.0	2.4	6.2	1.9	5.3	3.0	1.6	1.7	20.2	9.9	4.4	12.2	14.1	2.0	12.0	4.4	8.4	5.9	10.1	3.0	11.6	4.4	8.8	1.8	6.0	4.5	4.4	2.1	10.5	17.4	5.6	6.2	9.0	9.1	1.0	0.3	10.7	0.3	0.3	0.4	0.3	9.0	7.5	5.5	18.4	4.6	7.1	0.2	4.5	2.0	3.3	4.7	12.3	5.3	0.2	6.5	4.8	6.6	7.6	1.8	10.3	5.4	0.1	11.6	7.3	4.2	3.7	0.1	4.3	5.4	2.9	5.0	2.4	5.7	5.0	0.3	6.9	0.0	12.2	6.9	1.0	4.8	12.9	18.7	0.1	3.1	4.9	3.7	16.8	11.1	1.6	6.9	6.9	4.7	7.9	6.1	5.5	2.1	0.0	0.3	0.0	0.2	3.5	0.1	5.7	10.7	0.3	1.3	0.2	0.1	0.3	0.6	0.4	0.4	0.2	1.0	0.3	0.4	0.8	0.3	0.1	0.3	0.3	0.3	2.9	4.7	1.1	3.0	2.0	2.4	1.6	1.7	2.0	2.1
ZCCHC11	"KIAA0191, PAPD3, TUT4"	ENSG00000134744	"Zinc finger CCHC-type containing 11"	Q5TAX3	1	52408282-52553487	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavourable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	13.8	19.1	18.4	25.6	19.0	20.5	18.7	50.9	21.3	22.4	13.3	11.8	16.1	7.7	22.1	22.0	11.5	16.8	14.0	13.5	17.8	16.5	14.2	17.7	13.3	27.4	15.4	14.6	28.3	17.6	34.4	56.0	18.8	16.3	16.1	10.5	12.1	12.6	20.6	44.6	28.1	17.1	20.3	26.6	20.9	12.3	24.9	21.1	31.9	23.9	14.6	25.1	18.3	17.0	23.2	26.0	26.7	4.3	10.3	15.0	2.2	10.4	9.9	24.4	16.5	9.6	12.3	16.9	9.3	13.6	13.6	15.7	10.2	5.5	22.3	11.0	12.9	8.7	18.3	9.8	17.3	18.2	16.7	23.5	12.8	21.2	15.9	25.4	13.4	14.5	21.9	14.5	18.0	9.4	19.1	11.2	11.3	0.1	25.3	18.2	17.7	12.6	22.5	24.8	17.4	14.6	8.6	13.1	13.0	14.3	6.1	13.9	8.5	13.4	7.9	10.6	14.3	9.7	11.3	24.5	32.1	32.1	7.0	13.9	7.6	26.7	4.3	13.8	11.8	1.7	8.8	19.1	12.4	9.5	2.1	23.2	15.0	9.9	16.2	10.3	1.4	26.0	9.3	2.2	18.4	19.0	50.9	21.3	17.8	16.5	15.4	14.6	16.3	21.1
ZCCHC2	"C18orf49, FLJ20222, FLJ20281, KIAA1744"	ENSG00000141664	"Zinc finger CCHC-type containing 2"	Q9C0B9	18	62523007-62587709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 99.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040943	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA040943: AB_10795496"	"unprognostic (9.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	12.6	5.0	6.8	7.0	7.5	22.8	16.0	8.0	6.8	7.5	8.5	6.0	5.3	6.8	6.9	7.1	6.5	7.4	9.0	8.5	5.3	5.7	5.8	23.0	10.1	7.6	8.1	5.7	8.8	6.3	7.8	8.5	8.2	5.5	8.1	5.8	4.5	99.1	5.9	16.8	11.3	7.5	7.6	5.6	8.9	6.5	13.4	8.9	10.8	7.8	4.3	6.4	11.0	19.3	1.6	1.0	4.9	1.6	0.6	2.0	0.4	5.8	5.1	4.4	8.7	13.5	5.8	8.4	3.4	5.1	8.1	8.1	2.7	3.6	16.6	4.5	5.6	10.0	14.2	7.5	3.4	11.4	6.7	4.4	11.8	18.6	4.6	8.3	6.4	5.7	9.7	5.1	9.6	15.2	4.6	5.6	2.6	4.8	5.4	3.5	2.8	5.1	7.2	4.7	0.1	5.6	6.0	5.6	3.5	5.7	12.8	5.0	4.5	6.6	6.4	8.0	5.5	3.1	4.8	2.2	4.2	7.1	6.0	3.5	2.9	0.0	1.0	2.4	1.7	1.6	1.2	0.5	1.1	1.5	0.3	1.6	2.0	1.3	4.9	0.6	0.3	1.0	1.2	0.4	6.8	7.5	8.0	6.8	5.3	5.7	8.1	5.7	5.5	8.9
ZCCHC6	"FLJ13409, KIAA1711, PAPD6, TUT7"	ENSG00000083223	"Zinc finger CCHC-type containing 6"	Q5VYS8	9	86287733-86354454	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.1;monocytes: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	11.2	9.3	7.7	22.6	11.2	17.0	17.3	9.7	13.7	10.8	13.5	5.6	12.8	9.4	8.6	8.1	23.1	8.3	10.3	10.1	9.4	5.2	7.4	33.1	16.3	19.5	9.8	5.1	9.0	12.9	9.2	18.6	33.3	9.0	19.3	10.8	4.5	14.0	13.6	12.5	30.9	15.6	9.7	13.6	22.2	11.7	10.3	10.7	23.3	8.7	15.2	16.9	13.7	14.3	4.4	4.3	42.1	15.7	4.5	5.7	2.9	9.8	10.7	6.4	9.2	16.3	24.8	7.8	13.5	13.2	6.0	7.0	4.8	8.8	14.1	12.3	8.9	17.5	7.5	7.6	8.9	16.5	4.0	10.1	11.3	9.0	13.9	11.5	14.8	16.4	16.0	9.5	11.3	10.0	9.5	15.3	16.6	10.6	9.6	7.0	5.2	7.2	4.9	11.1	6.5	10.6	19.4	4.6	3.7	8.2	10.9	4.7	4.1	5.2	15.4	5.7	6.9	10.1	9.2	17.7	13.7	10.5	13.6	6.9	7.5	11.5	7.1	7.1	5.7	9.1	4.9	4.4	3.2	4.1	4.3	4.4	3.7	4.0	42.1	4.5	15.7	2.0	3.0	2.9	7.7	11.2	9.7	13.7	9.4	5.2	9.8	5.1	9.0	10.7
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120539-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	15.2	12.7	9.9	28.4	11.3	16.2	16.8	16.5	12.1	16.1	13.4	10.2	20.0	11.3	19.2	14.9	11.5	13.1	12.4	10.2	10.1	10.3	10.0	11.1	10.9	27.5	11.8	8.4	21.9	19.8	8.6	30.7	10.2	11.2	13.5	14.2	9.8	14.3	19.2	9.9	12.7	13.9	14.0	11.8	18.4	11.8	14.3	12.4	19.9	16.1	12.3	29.3	19.2	12.9	29.7	7.5	10.9	8.5	10.1	11.4	5.2	7.2	4.9	6.8	7.3	7.2	11.1	6.4	7.1	8.3	5.5	7.7	4.8	3.5	25.8	3.9	5.5	3.0	6.6	6.7	8.0	11.8	4.6	7.4	8.0	4.2	11.1	12.6	7.4	7.6	10.5	5.8	22.7	6.4	20.2	9.0	4.9	3.4	9.7	7.0	7.3	7.3	46.8	4.5	6.5	6.9	2.9	7.7	5.6	5.0	6.1	6.5	4.4	8.2	5.7	4.1	5.2	5.9	4.3	3.1	5.7	30.7	6.6	8.2	7.5	4.7	4.4	10.9	7.8	5.0	7.7	18.1	8.9	8.8	4.0	29.7	11.4	10.4	8.8	10.1	8.5	7.5	7.4	5.2	9.9	11.3	16.5	12.1	10.1	10.3	11.8	8.4	11.2	12.4
ZDBF2	"FLJ45338, KIAA1571, Slx9"	ENSG00000204186	"Zinc finger DBF-type containing 2"	Q9HCK1	2	206274663-206314428	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			"HPA039121, HPA050311"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039121: , HPA050311: "	"unprognostic (8.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.73e-3)"	"unprognostic (7.59e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.40e-1)"	4.4	12.0	8.6	3.5	26.9	2.2	4.2	14.7	12.7	5.4	3.7	2.1	5.1	2.0	7.2	6.1	3.1	5.1	4.4	4.5	8.9	8.3	4.9	3.6	3.2	3.8	3.7	10.8	14.8	8.3	5.6	20.9	7.5	9.0	4.7	2.6	3.8	3.7	5.3	5.4	3.9	3.0	5.1	4.0	4.2	3.4	5.4	3.1	2.5	6.5	2.9	3.3	3.7	3.5	0.7	0.5	0.3	0.0	0.3	1.4	0.2	1.9	0.3	6.6	1.2	2.2	1.9	9.3	1.9	2.2	0.9	1.4	1.0	1.5	0.1	0.9	2.3	0.5	4.2	1.4	1.7	2.3	3.9	0.0	3.7	0.2	2.9	2.0	4.2	2.0	2.4	1.6	3.9	2.4	0.3	2.6	2.8	0.3	0.5	0.0	8.9	1.9	0.0	6.9	0.0	1.1	1.0	3.4	8.2	3.3	0.0	2.7	0.2	0.0	3.6	0.8	3.2	0.7	1.5	6.0	1.5	0.3	4.6	0.0	2.2	0.3	0.0	0.0	0.3	0.0	0.9	0.5	1.0	0.6	0.0	0.7	1.1	0.7	0.0	0.3	0.0	0.5	1.4	0.2	8.6	26.9	14.7	12.7	8.9	8.3	3.7	10.8	9.0	3.1
ZDHHC1	"C16orf1, HSU90653, ZNF377"	ENSG00000159714	"Zinc finger DHHC-type containing 1"	Q8WTX9	16	67394419-67416833	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.4;ASC TERT1: 14.9;U-138 MG: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042531, HPA048659"	Uncertain		Approved	Cytosol				Cytosol		"HPA042531: , HPA048659: "	"unprognostic (8.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.05e-3)"	"prognostic favourable (1.25e-6)"	"unprognostic (1.68e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (2.17e-1)"	"prognostic favourable (1.55e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.63e-3)"	9.6	6.3	4.3	3.9	6.6	0.5	10.2	5.3	10.5	16.9	7.4	5.5	7.9	3.8	13.5	16.4	6.3	22.6	14.0	6.2	4.5	3.7	11.2	3.8	7.8	4.9	5.3	3.5	17.1	16.2	11.5	14.0	15.1	6.5	11.6	3.2	11.2	14.7	12.1	8.0	10.8	3.9	9.3	3.3	10.1	6.2	25.7	2.6	0.6	31.3	9.3	4.9	6.9	9.7	0.0	2.4	0.3	3.6	0.0	0.0	0.8	5.0	6.1	1.5	8.1	13.4	14.9	0.0	2.8	11.0	2.9	3.4	0.0	3.2	0.0	1.3	5.1	3.3	0.5	0.5	0.6	1.5	4.6	0.4	0.1	0.4	6.8	0.3	4.3	7.1	6.3	3.1	0.8	3.7	0.0	0.0	2.0	0.5	0.0	0.0	3.0	0.1	0.0	0.1	0.0	4.1	3.1	2.1	7.4	0.5	0.2	6.6	2.1	1.2	4.9	12.9	2.1	6.2	3.4	1.5	0.3	0.0	7.9	0.1	5.3	0.0	2.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.8	4.3	6.6	5.3	10.5	4.5	3.7	5.3	3.5	6.5	2.6
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type containing 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 5.6;K-562: 3.5;LHCN-M2: 3.9;MOLT-4: 4.1;NTERA-2: 3.7;RH-30: 5.7;RPTEC TERT1: 3.1;SH-SY5Y: 4.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003618	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686"	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	3.0	5.4	4.9	1.5	6.8	1.1	5.3	6.2	9.9	5.8	3.4	3.9	2.4	1.3	6.5	3.7	3.2	4.5	3.3	5.4	5.9	8.7	5.3	1.2	4.1	1.6	4.8	5.3	8.5	4.7	5.0	8.7	0.7	7.0	4.0	2.3	5.4	12.7	6.9	1.6	2.8	1.8	5.2	6.4	2.9	2.1	2.6	3.1	2.0	6.6	2.1	1.5	2.6	3.1	0.3	0.4	0.7	0.2	0.5	1.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	3.9	0.0	4.1	0.1	3.7	0.0	0.0	5.7	0.0	3.1	0.0	1.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.7	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.2	1.6	1.1	0.7	0.5	0.1	0.4	0.0	0.3	4.9	6.8	6.2	9.6	5.9	8.7	4.8	5.3	7.0	3.1
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type containing 16"	Q969W1	10	97446131-97457370	"Enzymes, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	12.0	13.7	15.9	10.8	17.3	6.4	17.9	17.6	24.6	17.1	17.9	15.6	18.1	15.1	15.5	21.2	17.6	11.5	14.4	18.1	13.2	11.0	23.3	37.4	20.8	11.1	10.9	13.0	15.1	22.5	21.8	15.4	30.7	10.5	16.0	18.9	18.1	28.5	14.1	20.7	14.0	15.7	17.6	8.5	13.2	19.4	16.4	10.8	14.7	19.6	15.4	16.1	15.1	20.0	9.3	14.2	9.4	10.4	13.0	12.0	5.8	21.4	25.2	16.8	20.7	26.9	18.5	17.6	23.6	31.5	27.3	26.1	19.6	19.2	18.9	27.3	34.5	25.3	21.1	33.4	24.4	18.7	24.5	12.0	17.7	18.6	21.6	14.3	17.7	20.6	22.1	31.9	23.0	28.0	9.6	14.4	34.5	20.5	21.6	19.6	13.7	21.9	14.8	17.1	17.4	23.1	9.9	8.2	11.7	14.4	14.9	12.8	19.7	14.0	17.1	17.2	16.0	11.1	27.6	13.8	22.3	11.6	19.9	22.2	9.0	0.3	9.8	9.4	7.0	10.4	8.0	8.2	12.0	11.1	14.2	9.3	9.9	9.8	0.5	13.0	10.4	10.9	9.4	5.8	15.9	17.3	17.6	24.6	13.2	11.0	10.9	13.0	10.5	10.8
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type containing 21"	Q8IVQ6	9	14611071-14693471	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA065254: "	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favourable (9.28e-6)"	6.5	10.8	15.9	7.9	16.8	4.2	11.6	29.0	22.6	7.8	8.5	9.3	3.8	12.2	9.8	11.7	14.4	7.5	6.7	9.0	13.8	10.4	9.4	4.8	9.2	11.1	9.4	16.5	10.0	8.4	11.5	22.2	7.8	14.8	10.0	9.9	6.6	8.3	7.4	7.7	15.7	12.6	7.7	9.9	9.5	7.9	7.3	9.7	4.7	11.3	9.9	10.7	7.7	11.3	5.2	1.4	0.5	0.8	2.8	1.7	0.6	5.3	2.7	5.4	3.5	0.9	1.0	4.2	6.8	2.1	2.4	2.8	1.3	2.5	5.3	1.7	4.8	3.5	3.7	2.2	3.5	10.6	2.9	22.5	6.0	2.6	2.9	3.9	7.5	1.8	5.2	2.8	1.8	14.2	1.8	0.6	4.3	2.9	0.9	3.8	3.8	5.2	0.0	2.6	2.6	7.6	5.9	3.3	8.9	3.1	3.9	2.1	4.9	6.5	10.1	1.8	2.7	1.7	6.2	2.2	4.1	0.0	3.7	0.2	1.8	0.5	0.4	0.1	1.2	0.8	1.3	5.2	1.2	1.1	0.2	3.5	0.8	1.2	0.0	2.8	0.6	1.4	1.7	0.6	15.9	16.8	29.0	22.6	13.8	10.4	9.4	16.5	14.8	9.7
ZDHHC24		ENSG00000174165	"Zinc finger DHHC-type containing 24"	Q6UX98	11	66520637-66546238	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016619	Approved		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA016619: AB_2288672"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.55e-3)"	"prognostic unfavourable (3.28e-4)"	"unprognostic (8.76e-2)"	"unprognostic (7.74e-3)"	"unprognostic (7.11e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.35e-1)"	11.7	17.4	10.5	10.3	12.8	14.1	12.3	5.7	15.5	7.7	8.3	13.8	10.8	9.1	9.4	17.0	12.2	9.0	11.3	9.9	10.7	11.8	17.3	13.4	11.1	20.4	12.8	10.3	6.5	19.4	22.6	9.6	13.7	9.3	11.4	7.7	10.0	12.4	13.1	7.9	13.2	9.4	7.1	10.0	16.0	12.4	9.9	10.5	11.7	17.7	7.9	13.4	10.0	7.8	5.8	17.2	2.4	5.5	6.6	7.2	4.6	4.8	7.8	2.6	6.7	6.4	5.3	6.5	4.1	3.5	3.3	2.3	6.8	7.9	1.4	11.2	3.5	12.0	1.9	3.6	2.3	7.0	4.9	3.0	3.8	4.2	6.0	3.0	7.5	6.3	6.5	2.7	3.9	5.5	4.3	4.4	4.1	10.6	5.8	8.5	5.1	6.7	7.5	5.4	9.1	4.0	3.9	3.6	5.7	6.6	6.9	11.3	9.5	2.5	8.5	7.6	2.4	8.8	3.0	6.5	2.0	2.0	6.6	1.4	8.2	2.4	5.5	1.0	6.2	4.8	5.7	5.4	5.0	7.2	6.3	5.8	3.0	5.4	2.4	6.6	4.4	17.2	5.1	4.6	10.5	12.8	5.7	15.5	10.7	11.8	12.8	10.3	9.3	10.5
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type containing 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavourable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	20.7	19.2	25.7	16.9	23.0	9.2	23.4	24.4	35.3	14.3	9.9	14.0	17.3	11.6	16.0	10.9	13.9	13.6	14.4	16.0	18.7	10.6	15.2	16.5	14.6	15.4	17.7	17.6	18.0	23.9	17.4	21.0	16.4	19.0	13.4	7.0	17.5	20.4	16.6	20.5	22.2	11.2	13.0	10.4	19.8	15.9	8.4	18.6	8.9	18.5	7.9	11.1	12.9	14.5	2.0	4.1	4.0	1.5	1.3	2.5	0.5	11.3	7.3	11.6	15.3	17.1	10.2	10.5	21.5	14.7	14.6	13.1	3.8	5.9	0.0	8.9	17.8	15.6	6.1	16.4	7.2	16.4	23.3	5.5	19.1	8.7	14.1	0.0	7.7	17.8	11.1	11.2	9.5	16.3	38.0	9.0	12.9	5.6	6.7	14.9	5.9	11.6	14.4	10.2	4.1	6.3	13.9	18.7	9.5	8.7	4.2	10.2	0.3	7.8	18.6	33.2	24.3	18.6	9.5	13.0	4.2	4.3	9.7	7.2	9.7	4.0	1.2	0.3	2.5	1.5	1.3	0.8	0.7	1.2	0.4	2.0	1.3	1.8	0.0	1.3	0.8	4.1	2.0	0.5	25.7	23.0	24.4	35.3	18.7	10.6	17.7	17.6	19.0	18.6
ZDHHC9	"CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type containing 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavourable (9.77e-5)"	"prognostic unfavourable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	18.2	7.3	16.7	6.7	24.7	3.2	14.2	7.8	33.9	14.1	14.7	78.3	5.1	21.1	8.4	8.4	9.8	7.9	10.4	7.4	24.1	15.2	25.4	27.0	15.6	3.0	24.9	13.9	8.0	17.4	19.6	7.1	11.5	28.4	13.4	17.3	3.8	13.2	8.3	7.4	19.7	22.2	10.4	32.7	2.4	12.8	2.8	25.3	1.2	9.6	5.7	4.3	10.8	9.4	4.6	7.8	2.6	6.8	3.4	7.6	3.3	15.2	8.0	11.5	23.2	39.9	31.4	9.4	15.1	17.3	7.2	9.1	12.6	19.9	0.5	25.8	16.0	10.3	13.0	15.1	10.5	0.8	8.1	3.0	8.4	16.6	15.8	2.0	5.5	34.1	24.7	11.8	17.6	13.6	3.3	6.1	11.7	13.3	2.9	3.8	6.2	13.9	2.7	7.4	9.0	10.5	8.5	9.1	7.7	4.3	22.3	7.0	9.5	3.4	11.1	7.4	2.5	17.3	12.1	5.7	4.1	1.8	13.3	8.4	3.7	0.0	3.3	2.6	4.8	2.9	6.1	4.6	5.8	4.7	3.7	2.7	7.6	4.3	0.0	3.4	6.8	7.8	2.5	3.3	16.7	24.7	7.8	33.9	24.1	15.2	24.9	13.9	28.4	25.3
ZEB2	"KIAA0569, SIP-1, SIP1, ZFHX1B"	ENSG00000169554	"Zinc finger E-box binding homeobox 2"	O60315	2	144364364-144524583	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 76.6"	"Cell line enhanced"	"Detected in many"		"HEL: 38.4;THP-1: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003456	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA003456: AB_10603840"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (6.04e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.32e-2)"	30.2	23.7	48.0	27.8	42.4	55.5	16.6	6.7	36.6	29.4	12.3	72.9	3.4	11.3	15.6	11.1	14.4	11.1	22.6	22.5	52.5	28.8	9.9	11.6	20.7	19.6	54.4	26.4	37.5	3.6	5.0	3.1	31.5	37.6	10.9	16.3	15.7	5.7	12.5	9.6	7.7	12.8	17.2	76.6	32.6	9.3	8.2	38.7	1.9	8.3	7.5	12.4	21.5	14.8	5.0	12.7	9.7	21.6	3.6	10.7	7.4	0.4	0.5	22.1	0.0	26.4	13.5	0.0	9.1	9.2	10.2	9.9	0.0	0.2	1.6	0.0	9.8	0.1	3.7	0.0	12.8	9.4	2.6	38.4	1.6	0.0	5.9	6.6	30.5	11.0	0.2	12.6	6.1	7.7	10.7	1.1	12.0	0.0	0.0	20.1	3.2	0.5	11.3	15.2	0.0	0.1	0.2	0.1	5.8	1.1	0.0	23.9	0.0	45.7	11.9	11.7	0.2	22.8	2.8	12.5	0.0	1.9	17.6	19.9	31.6	9.7	21.6	5.7	10.7	20.8	1.0	4.4	1.4	5.3	12.7	5.0	1.1	4.0	7.5	3.6	19.5	10.2	0.3	7.4	48.0	42.4	6.7	35.6	52.5	28.8	54.4	26.4	37.6	38.7
ZER1	"C9orf60, Hzyg, ZYG, ZYG11BL"	ENSG00000160445	"Zyg-11 related cell cycle regulator"	Q7Z7L7	9	128729786-128772414	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048464			Approved	Cytosol				Cytosol		"HPA048464: AB_2756306"	"unprognostic (1.37e-1)"	"prognostic favourable (1.18e-6)"	"unprognostic (9.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.65e-1)"	"unprognostic (4.90e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.69e-1)"	"prognostic favourable (5.15e-11)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.14e-1)"	15.4	17.1	36.0	9.7	32.0	12.0	12.5	28.0	45.3	15.9	18.2	19.7	11.3	27.4	16.7	12.3	23.8	21.9	14.4	29.9	27.0	28.5	15.7	11.1	16.5	10.4	19.9	34.2	22.1	22.0	24.1	18.2	13.1	29.1	20.6	11.0	14.7	21.9	22.2	40.3	17.4	25.3	14.0	13.5	12.5	14.1	25.8	18.8	16.9	19.0	8.5	9.3	17.9	12.6	5.0	5.7	15.8	5.8	5.5	7.7	4.9	8.7	9.6	6.4	8.7	19.2	13.3	17.6	8.4	14.5	11.7	9.6	8.6	9.9	5.4	9.5	14.7	19.1	7.0	12.5	4.9	10.7	9.3	3.7	17.0	6.3	15.0	5.4	10.4	16.4	18.9	11.8	8.4	9.9	6.6	11.8	7.9	33.1	10.2	6.1	6.4	12.4	9.3	8.5	20.4	8.7	11.8	12.4	9.4	14.1	18.2	9.6	26.5	6.5	11.1	9.7	4.3	12.3	5.0	14.9	13.9	4.2	14.2	3.3	7.0	10.9	3.7	10.0	5.6	5.6	7.7	3.8	5.8	7.2	3.9	5.0	6.5	5.9	15.8	5.5	5.8	5.7	5.3	4.9	36.0	32.0	28.0	45.3	27.0	28.5	19.9	34.2	29.1	18.8
ZFAND1	FLJ14007	ENSG00000104231	"Zinc finger AN1-type containing 1"	Q8TCF1	8	81701334-81732903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023383	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA023383: AB_1859008"	"unprognostic (6.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.74e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.04e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.36e-2)"	18.9	17.7	12.5	10.8	23.2	14.8	25.8	24.3	25.9	22.8	19.4	8.6	16.0	16.1	21.6	17.9	19.9	20.8	14.4	14.8	12.7	15.8	19.6	26.6	16.2	13.8	14.8	16.2	35.8	35.1	16.0	31.1	12.6	27.4	23.7	18.7	10.3	23.3	18.1	16.9	13.5	20.2	23.7	16.5	17.5	20.3	10.3	13.2	19.0	42.6	16.1	17.0	26.7	21.3	18.5	20.0	6.4	13.9	17.2	25.1	16.8	19.3	6.2	8.6	7.6	11.9	24.0	8.7	11.6	15.7	10.2	13.4	6.8	15.4	19.1	13.8	8.8	13.2	10.0	16.7	15.4	16.0	10.0	10.9	10.5	8.0	21.9	13.3	7.3	19.5	40.2	7.1	69.7	12.7	16.4	27.4	10.5	12.7	16.5	9.6	2.5	19.6	11.3	7.4	8.5	12.8	18.0	8.8	5.7	8.3	5.3	19.0	17.6	9.9	8.1	7.6	11.1	10.8	16.1	10.9	6.7	11.7	9.0	1.2	5.8	6.4	13.9	3.9	11.3	10.2	19.4	18.5	18.5	15.0	20.0	13.4	25.1	18.7	1.4	17.2	11.8	11.6	21.1	16.8	12.5	23.2	24.3	25.9	12.7	15.8	14.8	16.2	27.4	13.2
ZFAND2B	AIRAPL	ENSG00000158552	"Zinc finger AN1-type containing 2B"	Q8WV99	2	219195237-219209651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035159, HPA035160"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA035159: , HPA035160: AB_10670697"	"unprognostic (3.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.77e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (9.38e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.02e-2)"	13.4	12.9	16.4	14.6	16.9	23.8	13.5	22.3	24.6	14.8	30.0	20.2	15.9	30.5	15.3	14.2	22.2	13.1	22.2	11.6	16.2	13.3	20.0	28.5	15.2	27.3	18.8	17.9	14.1	29.1	18.6	18.0	22.2	15.6	14.7	18.5	11.3	17.3	14.2	15.9	23.4	34.7	24.5	17.5	22.6	21.8	9.5	13.9	23.0	30.0	12.9	19.3	14.7	16.6	29.1	20.5	36.6	27.8	30.7	32.5	25.4	10.4	7.1	8.2	11.5	8.7	9.2	11.4	10.6	12.5	15.3	15.2	16.0	9.0	8.5	11.3	18.1	7.2	7.6	13.5	12.2	13.1	11.8	19.4	11.8	13.8	17.9	10.3	22.5	7.6	29.7	15.1	36.0	10.2	11.3	24.2	14.9	18.1	17.0	21.7	4.2	8.2	10.6	4.9	14.6	14.5	8.9	17.9	8.1	5.1	8.7	11.8	7.4	21.9	10.8	15.5	14.5	17.8	15.1	10.0	3.2	15.3	15.2	20.5	12.0	17.7	21.7	28.6	32.1	27.8	28.0	25.4	29.3	31.3	16.4	29.1	26.7	32.5	36.6	30.7	21.9	20.5	30.2	25.4	16.4	16.9	22.3	24.6	16.2	13.3	18.8	17.9	15.6	13.9
ZFAND5	"ZA20D2, ZFAND5A, ZNF216"	ENSG00000107372	"Zinc finger AN1-type containing 5"	O76080	9	72351425-72365235	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.5"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018129	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018129: AB_1859012"	"unprognostic (1.97e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (4.43e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.03e-2)"	82.5	57.6	26.9	15.5	35.2	36.6	57.1	31.7	34.3	28.6	23.1	20.3	31.4	10.8	25.7	35.5	29.0	27.4	28.7	33.0	24.3	22.6	32.6	56.5	31.6	23.6	24.3	21.1	59.3	20.9	17.0	45.4	22.4	25.1	24.0	15.1	22.4	17.2	52.7	207.5	17.6	15.8	28.4	25.9	24.1	23.2	26.7	21.7	14.6	23.1	29.5	16.5	39.2	29.3	7.0	13.6	15.4	32.1	8.6	6.8	7.8	21.8	22.4	26.4	11.7	34.3	16.3	20.0	25.9	36.1	13.9	10.9	2.7	20.7	12.2	15.7	40.5	24.5	60.9	10.1	20.9	82.5	9.4	9.6	12.9	13.7	25.3	13.8	14.3	21.4	18.8	14.6	16.3	24.7	9.2	16.2	16.4	5.8	18.0	7.8	34.2	15.6	14.1	13.7	12.9	45.5	21.3	19.4	17.3	16.4	18.0	21.1	8.0	12.1	18.8	11.6	14.3	20.5	17.7	23.3	20.3	6.4	15.6	9.4	28.8	15.1	13.6	15.4	5.2	21.6	5.7	7.0	6.8	6.6	13.6	6.2	6.3	5.6	12.2	8.6	32.1	2.9	4.8	7.8	26.9	35.2	31.7	34.3	24.3	22.6	24.3	21.1	25.1	21.7
ZFP28	"KIAA1431, mkr5"	ENSG00000196867	"ZFP28 zinc finger protein"	Q8NHY6	19	56538948-56556810	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028879	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA028879: AB_10603841"	"unprognostic (5.02e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.32e-4)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-1)"	3.1	3.6	4.9	1.4	4.1	0.4	3.7	6.1	7.0	3.4	2.5			1.1	5.6	4.2	2.3	3.1	3.2	3.6	5.4	5.7	3.1	0.1	3.5	1.6	5.0		10.1	2.5	6.1	4.0	2.9		4.3	1.6		2.3	4.0	1.9	2.7	1.2	4.4	5.5	2.8	2.1	5.1			4.0		1.8	2.8	2.5	3.1	1.5	3.9	0.5	2.4	3.7	0.9	0.0	1.7	8.0	2.4	2.7	2.6	4.1	5.2	5.0	4.2	6.9	0.0	1.1	0.0	2.6	6.2	0.2	3.9	1.7	6.4	0.0	6.8	5.3	0.2	0.0	7.8	0.2	6.1	7.2	2.2	6.3	0.1	0.8	1.0	0.1	5.4	0.0	2.6	0.9	3.7	1.7	4.1	10.4	0.0	5.6	3.3	0.0	7.3	0.0	0.3	1.2	3.1	5.3	1.9	3.9	4.3	0.4	6.3	0.1	0.2	0.4	0.1	0.1	0.4	0.0	0.5	3.9	0.5	0.3	2.6	1.9	2.6	1.8	1.1	3.1	2.1	1.6	0.5	2.4	0.4	1.5	3.7	0.9										
ZFP3	"FLJ30726, ZNF752"	ENSG00000180787	"ZFP3 zinc finger protein"	Q96NJ6	17	5078248-5096374	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 7.4;SH-SY5Y: 7.6;SiHa: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053085, HPA057290"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA053085: , HPA057290: "	"unprognostic (3.71e-2)"	"prognostic favourable (5.68e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (3.05e-1)"	"prognostic favourable (1.38e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.33e-1)"	"prognostic favourable (1.07e-4)"	"unprognostic (4.89e-2)"	"prognostic favourable (7.69e-7)"	"unprognostic (8.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.29e-3)"	4.9	6.3	11.0	10.0	10.4	1.9	8.9	19.6	14.7	6.8	8.9	11.9	9.6	13.0	6.9	6.9	6.7	11.2	6.3	12.4	9.8	7.6	10.2	3.3	7.3	9.2	7.9	8.3	9.9	11.3	16.6	10.8	5.2	11.4	7.9	10.9	7.4	10.7	15.4	33.3	6.7	11.3	6.3	8.5	10.2	8.3	9.9	11.8	10.6	11.1	3.5	11.2	6.6	5.7	5.4	1.4	1.4	2.2	1.9	4.3	1.6	0.0	1.3	0.3	0.0	1.2	0.6	0.0	2.8	0.0	2.1	2.5	5.5	2.5	0.0	4.0	2.7	5.6	0.0	0.0	1.2	0.0	0.1	0.2	2.0	0.0	3.9	0.0	7.4	1.9	0.0	1.5	0.0	0.7	0.0	0.0	0.3	0.0	0.1	0.2	0.3	0.5	0.0	0.8	1.8	3.4	3.4	3.5	7.6	6.9	5.7	3.6	3.4	5.4	0.0	0.0	1.1	2.0	4.0	0.1	0.2	0.0	0.0	0.0	3.2	0.0	2.0	1.4	2.8	2.2	1.7	2.1	1.6	2.5	1.4	5.4	4.3	3.0	0.2	1.9	1.9	0.9	1.6	1.6	11.0	10.4	19.6	14.7	9.8	7.6	7.9	8.3	11.4	11.8
ZFP30	"KIAA0961, ZNF745"	ENSG00000120784	"ZFP30 zinc finger protein"	Q9Y2G7	19	37613749-37692337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030606	Uncertain		Approved	Cytosol				Cytosol		"HPA030606: AB_10602684"	"unprognostic (1.86e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.64e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (5.96e-2)"	"prognostic favourable (3.86e-4)"	"unprognostic (3.01e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-3)"	5.0	6.6	10.2	5.4	15.3	1.7	8.3	20.0	12.3	6.1	5.5	6.5	5.5	3.8	8.5	6.9	6.0	7.4	4.6	5.3	8.0	7.1	6.0	4.1	5.4	6.4	11.2	9.4	9.4	6.3	9.5	10.7	7.5	9.6	8.0	5.0	5.0	5.3	8.0	5.2	9.3	4.9	11.3	10.9	6.6	5.3	16.5	10.6	6.1	10.8	1.9	6.4	5.9	9.2	4.3	2.0	4.9	1.3	5.8	4.0	2.1	6.5	5.6	9.4	13.2	5.1	5.0	2.8	6.8	6.3	5.1	5.5	4.6	1.1	0.0	7.0	6.1	2.4	9.3	3.5	5.2	10.0	3.6	6.5	7.1	3.5	3.8	0.9	5.1	3.7	5.6	4.4	6.8	2.9	4.9	0.1	6.5	3.0	7.0	3.4	2.0	4.0	2.8	12.3	0.1	3.2	10.9	10.5	11.4	7.9	3.1	2.5	4.2	1.7	5.7	7.0	23.5	3.2	6.7	3.6	3.7	4.3	0.0	0.0	5.2	4.9	1.2	2.8	2.8	1.3	3.7	1.3	3.1	2.4	0.9	4.3	3.8	4.0	0.9	5.8	0.4	2.0	2.3	2.1	10.2	15.3	20.0	12.3	8.0	7.1	11.2	9.4	9.6	10.6
ZFP69B	"FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B"	ENSG00000187801	"ZFP69 zinc finger protein B"	Q9UJL9	1	40450102-40463718	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044289	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044289: AB_10962717"	"unprognostic (2.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.05e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-5)"	"unprognostic (1.64e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.89e-1)"	1.6	1.7	7.8	4.6	11.1	1.1	2.8	8.2	12.8	3.1	2.5	1.8	0.1	2.6	4.3	2.4	2.2	1.6	3.3	1.8	6.3	4.9	1.6	2.4	1.6	3.7	3.6	5.8	2.0	3.5	3.2	3.6	1.1	4.7	2.0	3.1	1.2	1.9	1.8	1.2	1.4	1.8	3.0	3.2	2.3	2.5	4.0	3.8	5.0	2.7	0.9	5.5	3.8	1.7	2.1	1.2	0.9	2.1	1.3	4.1	1.0	3.3	1.3	5.6	13.9	2.1	5.7	1.6	3.2	3.1	1.4	2.8	1.6	2.2	6.3	3.1	2.8	1.2	2.9	2.8	3.2	5.5	1.2	2.6	3.2	4.7	1.5	0.4	4.2	1.3	4.7	5.1	6.8	2.0	6.8	6.3	4.4	2.3	8.4	0.6	7.7	1.4	4.8	5.6	3.0	2.9	3.2	7.7	8.0	5.1	4.4	2.1	2.3	7.3	4.3	4.7	10.0	4.3	4.6	9.8	9.3	13.7	6.3	0.9	4.9	0.0	0.3	0.9	2.6	2.1	3.5	2.0	1.8	1.4	1.2	2.1	3.4	3.0	0.2	1.3	0.7	0.5	4.1	1.0	7.8	11.1	8.2	12.8	6.3	4.9	3.6	5.8	4.7	3.8
ZFP82	"KIAA1948, MGC45380, ZNF545"	ENSG00000181007	"ZFP82 zinc finger protein"	Q8N141	19	36383120-36418656	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051669, HPA060470"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA051669: , HPA060470: "	"unprognostic (1.52e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.14e-4)"	"unprognostic (9.63e-2)"	"unprognostic (9.17e-4)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.91e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.05e-1)"	4.3	5.0	9.8	8.8	9.3	1.5	8.7	15.0	13.9	9.9	5.2	5.3	2.4	2.4	9.1	12.4	2.7	9.0	5.4	7.3	8.5	9.7	5.5	1.8	4.9	7.8	8.3	6.3	13.8	2.7	8.0	10.1	7.0	8.3	7.4	3.3	3.6	4.1	6.8	2.1	2.2	3.6	7.8	6.8	6.3	3.1	6.4	8.7	9.3	10.8	1.6	8.6	5.8	6.9	9.6	3.1	1.1	1.1	4.7	9.2	2.9	0.0	2.6	8.4	8.8	2.9	3.8	2.8	3.4	4.3	7.0	9.1	1.6	1.2	7.4	5.8	4.1	0.2	0.0	0.9	8.9	6.9	4.2	6.6	1.9	2.1	6.7	0.0	5.8	5.8	1.3	5.0	1.5	3.2	0.0	0.0	6.8	0.0	11.5	0.0	7.9	1.5	9.7	5.8	2.2	3.5	4.2	0.1	8.7	0.0	0.5	5.5	1.6	5.1	0.4	2.5	4.4	4.5	5.8	5.1	3.5	11.4	0.0	0.0	5.4	0.0	0.9	1.1	6.0	1.1	6.0	9.6	5.9	6.8	2.7	9.0	9.2	8.1	0.1	4.7	1.1	3.1	3.6	2.9	9.8	9.3	15.0	13.9	8.5	9.7	8.3	6.3	8.3	8.7
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein"	Q96JP5	11	58579111-58621042	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA024037, CAB025417"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB025417: , HPA024037: AB_1859051"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	17.1	14.7	20.1	13.6	25.6	32.0	14.9	24.4	21.7	15.3	18.1	23.2	15.8	16.2	16.3	11.8	16.3	13.6	13.8	26.5	20.3	15.4	16.3	19.4	15.0	14.4	20.8	18.1	14.9	14.3	26.7	17.0	14.2	19.7	13.1	21.9	11.2	14.5	15.5	33.8	17.5	19.6	16.9	21.6	15.0	13.9	71.0	19.4	15.7	16.8	14.6	15.9	17.8	21.4	4.6	7.0	5.4	5.0	3.7	5.4	2.8	24.5	14.1	16.6	16.8	15.9	19.3	9.1	20.3	38.2	23.6	20.2	7.7	26.0	29.4	20.1	25.6	21.9	16.8	21.6	31.1	15.6	9.4	19.4	14.4	8.3	18.1	24.4	32.0	16.8	21.2	33.1	38.8	23.3	19.2	27.9	30.3	8.2	21.1	13.5	8.7	13.8	16.4	28.0	19.5	17.3	23.7	17.8	14.2	25.9	23.9	33.1	26.6	18.4	26.1	29.8	20.6	44.8	22.5	16.2	11.9	24.5	26.3	13.8	30.3	3.9	5.0	3.5	5.4	4.5	3.0	4.5	3.3	3.3	4.9	4.6	3.6	4.6	5.4	3.7	4.2	7.0	2.6	2.8	20.1	25.6	24.4	21.7	20.3	15.4	20.8	18.1	19.7	19.4
ZFPM1	"FOG, FOG1, ZC2HC11A, ZNF89A"	ENSG00000179588	"Zinc finger protein, FOG family member 1"	Q8IX07	16	88453317-88537016	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 30.4"	"Cell line enhanced"	"Detected in many"		"HEL: 14.3;K-562: 21.2"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 12.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046603	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA046603: "	"unprognostic (1.29e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.89e-2)"	"prognostic favourable (4.24e-4)"	4.3	3.7	3.7	7.9	2.9	12.0	2.2	6.8	3.3	2.9	11.2	1.6	4.7	18.5	3.8	4.5	2.8	3.7	30.4	4.7	3.9	3.0	2.7	15.2	5.4	5.5	2.7	1.9	7.3	24.5	1.5	5.6	1.8	2.1	7.0	1.7	7.7	6.9	7.3	2.2	3.8	15.4	1.5	2.1	12.7	21.5	12.7	0.8	15.7	3.8	1.4	9.4	4.8	2.2	0.3	0.6	1.5	0.3	0.6	1.3	0.3	1.1	2.8	2.1	4.5	0.4	0.1	9.2	3.0	0.4	1.0	0.3	9.1	1.1	4.4	2.3	0.4	7.1	0.1	2.5	0.2	3.4	1.9	14.3	5.6	7.9	1.7	0.8	4.8	1.0	1.6	1.0	0.3	1.0	21.2	0.3	0.8	5.4	5.0	5.2	1.4	2.5	1.4	1.0	2.1	1.0	3.6	6.0	9.9	3.7	0.2	2.9	2.3	2.3	3.6	3.8	2.5	1.7	0.6	1.0	0.7	0.4	1.1	1.7	3.7	0.0	0.1	1.5	0.9	0.2	0.2	0.1	0.4	1.3	0.2	0.3	0.3	0.5	0.9	0.6	0.3	0.6	0.1	0.3	3.7	2.9	6.8	3.3	3.9	3.0	2.7	1.9	2.1	0.8
ZFYVE16	"KIAA0305, PPP1R69"	ENSG00000039319	"Zinc finger FYVE-type containing 16"	Q7Z3T8	5	80408013-80479350	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035935, HPA035936"	Supported		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA035935: AB_10672076, HPA035936: AB_10669662"	"unprognostic (1.11e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.23e-2)"	10.7	11.9	11.0	10.1	28.9	6.1	11.6	14.9	19.2	21.2	9.0	33.2	7.7	6.7	17.0	6.6	9.6	9.7	14.6	17.6	11.7	9.5	13.1	13.3	11.6	6.8	25.7	16.8	16.8	7.1	13.4	15.0	16.5	37.3	11.5	8.4	9.0	8.6	9.3	12.7	6.4	8.7	12.8	26.9	11.2	8.4	11.7	21.2	3.8	12.6	4.6	5.8	12.8	10.8	2.5	2.3	17.3	3.9	2.4	1.5	0.3	5.6	6.7	11.9	11.5	7.2	7.5	8.0	8.8	7.6	7.9	10.7	4.9	6.6	3.9	6.4	7.2	5.9	8.5	7.2	8.7	2.5	5.6	4.2	9.1	5.5	6.1	1.2	3.2	8.2	4.0	6.6	6.3	9.0	4.1	6.1	8.5	7.2	2.7	1.2	2.8	3.1	5.7	24.8	4.1	6.8	11.1	4.5	10.4	12.6	6.0	41.5	8.4	3.9	7.9	4.8	5.5	7.3	7.3	1.8	3.5	3.9	6.3	3.9	10.6	11.5	3.7	1.8	1.5	2.3	0.8	2.5	0.7	1.3	1.4	2.5	0.6	0.7	17.3	2.4	3.9	2.3	0.8	0.3	11.0	28.9	14.9	19.2	11.7	9.5	25.7	16.8	37.3	21.2
ZFYVE27	"FLJ32919, SPG33"	ENSG00000155256	"Zinc finger FYVE-type containing 27"	Q5T4F4	10	97737121-97760907	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037523, HPA069876"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA037523: AB_10672351, HPA069876: "	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.38e-3)"	"prognostic favourable (7.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.26e-2)"	"prognostic favourable (7.80e-4)"	10.1	22.6	16.1	12.7	20.8	20.7	11.8	28.6	33.0	10.3	17.4	15.7	17.4	25.6	11.6	25.4	9.8	17.9	14.1	12.8	17.6	20.7	15.5	18.2	11.3	15.2	15.1	23.4	17.1	15.4	19.6	24.3	14.3	17.6	13.3	17.5	25.6	14.0	11.8	7.9	17.1	24.0	9.4	14.7	18.1	14.9	14.2	13.3	12.2	13.1	5.5	14.7	8.5	10.4	11.2	8.5	13.4	12.6	9.0	15.2	11.7	10.4	12.9	7.8	17.2	8.9	6.2	10.6	10.7	11.3	12.5	12.3	11.4	21.8	16.2	12.3	7.7	23.5	11.2	10.4	6.6	16.6	11.3	7.6	12.7	10.6	11.4	12.2	15.4	10.1	12.6	12.3	9.5	7.0	11.3	10.9	9.3	8.1	9.8	23.2	6.3	10.0	11.3	7.8	7.6	12.0	6.4	6.3	12.2	7.2	6.1	27.7	13.3	12.2	7.4	6.3	7.5	9.6	20.3	12.7	10.7	8.4	15.8	15.8	7.2	7.1	8.4	13.4	15.2	9.1	13.1	10.9	10.5	12.0	8.0	11.2	12.1	12.9	12.1	9.0	12.6	8.5	13.4	11.7	16.1	20.8	28.6	33.0	17.6	20.7	15.1	23.4	17.6	13.3
ZFYVE28	KIAA1643	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418663	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 63.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 11.0;NB-4: 11.9;U-266/70: 12.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: "	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favourable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	4.5	8.6	7.7	5.1	15.8	3.1	3.7	63.6	15.1	3.7	7.4	4.6	1.8	10.4	4.1	3.1	3.4	4.3	5.9	2.4	7.1	5.5	5.7	4.2	4.4	6.1	7.9	8.0	3.4	7.3	7.9	7.5	1.8	9.9	2.9	5.1	5.8	9.5	5.4	4.3	5.7	11.9	2.8	9.4	7.0	7.5	7.9	6.7	1.2	5.3	3.1	4.0	4.5	3.2	3.1	0.7	0.9	0.4	0.3	4.4	1.3	0.8	1.0	0.2	3.7	2.1	0.7	0.1	1.8	3.1	1.0	0.3	0.1	6.6	0.0	1.9	3.2	3.8	1.2	0.3	0.6	9.5	1.3	0.2	4.2	0.3	4.3	0.7	11.0	3.0	0.6	1.1	0.1	3.0	1.8	8.1	0.9	2.2	0.1	11.9	0.1	8.1	0.0	0.0	3.9	1.5	0.5	5.8	0.4	1.8	0.1	1.0	2.4	0.3	0.5	1.7	0.0	5.4	0.1	12.6	9.1	0.1	5.3	2.3	1.8	0.9	0.4	0.1	4.4	0.0	1.9	0.9	2.3	3.2	0.7	3.1	3.2	3.2	0.1	0.3	0.3	0.2	4.0	1.3	7.7	15.8	63.6	15.1	7.1	5.5	7.9	8.0	9.9	6.7
ZFYVE9	"MADHIP, PPP1R173, SARA, SMADIP"	ENSG00000157077	"Zinc finger FYVE-type containing 9"	O95405	1	52142094-52346686	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017702, HPA065852, HPA065862"	Approved		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB017702: AB_1128462, HPA065852: , HPA065862: "	"unprognostic (5.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.73e-2)"	10.2	10.0	13.6	3.8	18.4	1.0	13.0	28.4	27.7	15.5	8.0	9.5	10.1	6.8	14.1	9.1	10.8	12.2	8.1	10.4	13.8	15.7	15.2	10.7	11.3	4.1	13.8	15.8	19.5	16.9	32.3	14.6	7.4	18.7	13.6	9.9	9.6	9.8	13.8	25.5	12.3	7.4	13.3	11.6	4.2	8.6	14.9	8.0	1.5	19.5	8.8	4.2	10.9	13.8	0.4	0.0	0.0	0.0	0.2	2.1	0.4	9.8	4.7	6.8	8.6	16.6	15.0	11.1	8.0	11.1	9.6	11.1	5.4	0.8	0.0	5.0	11.4	3.6	12.0	13.0	14.8	0.0	8.1	2.8	5.4	6.5	11.0	2.5	1.7	10.0	14.7	8.4	19.1	13.9	4.3	1.8	12.8	2.2	3.5	1.8	8.8	8.3	3.1	11.6	0.9	5.5	22.1	5.7	5.8	9.0	7.7	10.4	3.5	3.3	12.8	9.7	3.9	7.4	4.8	2.5	1.5	1.2	6.9	3.1	3.9	0.0	0.0	0.0	0.3	0.0	2.1	0.3	1.6	0.4	0.0	0.4	1.3	0.7	0.0	0.2	0.0	0.0	0.0	0.4	13.6	18.4	28.4	27.7	13.8	15.7	13.8	15.8	18.7	8.0
ZGRF1	"C4orf21, FLJ11331"	ENSG00000138658	"Zinc finger GRF-type containing 1"	Q86YA3	4	112539333-112636995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA030704, HPA030706"	Uncertain		Approved	Cytosol				Cytosol		"HPA030704: , HPA030706: AB_10601784"	"unprognostic (8.48e-2)"	"unprognostic (6.17e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.83e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.72e-3)"	"unprognostic (7.60e-10)"	"unprognostic (3.45e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.02e-4)"	2.5	1.8	3.3	4.9	4.8	13.8	2.8	13.8	6.5	2.5	2.4	0.5	0.1	2.6	2.6	1.5	3.0	2.1	1.3	1.5	3.1	1.0	1.6	1.6	2.7	5.0	2.5	3.3	3.2	2.2	0.9	4.5	3.5	3.5	2.1	3.1	1.1	2.7	2.3	2.9	3.0	3.2	2.1	4.2	3.8	2.6	7.3	4.1	17.0	2.7	2.2	5.8	2.1	2.5	2.5	2.8	1.3	2.9	1.1	1.6	0.4	3.7	2.7	9.3	6.6	0.7	1.3	3.6	6.6	2.8	6.7	6.0	5.2	5.5	9.7	2.0	2.0	3.0	9.7	3.5	7.8	5.2	2.4	6.1	4.3	1.5	0.3	13.6	4.1	0.6	0.4	8.5	2.3	2.7	8.7	11.0	4.5	6.0	18.2	5.0	4.8	3.2	10.2	13.9	3.3	1.2	3.2	4.4	7.3	3.0	4.1	1.2	1.9	4.0	3.2	8.5	8.3	4.5	5.2	4.2	7.2	13.0	3.8	4.6	4.8	0.0	0.6	1.3	1.0	2.9	0.6	1.3	0.5	0.2	0.1	2.5	1.6	1.6	0.9	1.1	0.7	2.8	1.0	0.4	3.3	4.8	13.8	6.5	3.1	1.0	2.5	3.3	3.5	4.1
ZHX1-C8orf76		ENSG00000259305	"ZHX1-C8orf76 readthrough"	Q96EF9	8	123226189-123274284	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.49e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.64e-11)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-2)"	8.6	7.4	11.4	5.0	11.0	25.9	8.7	10.3	10.7	8.5	6.2	5.9	8.9	8.1	7.3	8.1	10.4	5.9	5.4	8.7	11.2	5.0	7.1	9.7	9.7	8.7	9.6	7.4	8.7	6.8	7.1	12.7	7.1	8.8	8.7	9.9	4.5	9.0	8.7	11.9	9.9	9.3	7.7	11.4	10.5	6.6	5.1	11.7	5.8	10.5	4.6	10.2	7.5	11.6	5.5	4.6	8.0	8.3	4.8	8.5	3.3	3.0	3.9	2.9	2.0	1.8	2.0	2.1	1.3	1.4	3.3	2.6	3.1	2.4	1.8	1.2	2.2	2.1	3.2	1.7	5.0	2.9	6.6	5.3	2.7	3.7	1.8	1.1	2.9	2.7	2.7	2.7	1.7	3.9	4.3	2.5	2.9	9.4	4.4	3.4	0.7	4.4	3.5	1.9	2.4	2.3	3.1	4.4	3.2	2.8	23.9	1.4	3.5	1.0	0.3	1.4	2.7	2.3	3.1	3.6	4.4	3.8	2.0	2.9	1.0	3.1	5.7	8.0	4.1	8.3	3.7	5.5	5.3	3.5	4.6	4.6	4.4	3.6	1.8	4.8	5.9	4.0	8.5	3.3	11.4	11.0	10.3	10.7	11.2	5.0	9.6	7.4	8.8	11.7
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406860	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 52.2"	"Cell line enhanced"	"Detected in some"		"AF22: 18.2;ASC diff: 5.2;MCF7: 5.2;SH-SY5Y: 5.5;U-2197: 4.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	18	"cerebellum: 52.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 118.4"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030194: "	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.2	0.0	0.2	0.0	0.4	0.0	0.0	52.2	7.9	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.0	0.0	0.0	3.7	3.5	0.5	0.0	1.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.2	0.0	5.2	2.1	3.9	1.9	0.4	0.2	0.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.2	0.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	0.0	0.0	2.5	0.0	0.0	0.0	1.3	0.0	4.3	1.9	0.0	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	52.2	0.4	0.3	0.8	0.3	0.4	2.9	0.3
ZIM2	ZNF656	ENSG00000269699	"Zinc finger imprinted 2"	Q9NZV7	19	56774552-56840729	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;ovary: 35.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.2;Hep G2: 9.6;NTERA-2: 2.8;RH-30: 2.9;U-2 OS: 2.0;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA071856			Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA071856: "	"unprognostic (9.01e-4)"				"unprognostic (8.77e-2)"		"unprognostic (5.09e-2)"			"unprognostic (4.60e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"		1.6	13.1	8.5	1.6	44.0	1.4	2.5	8.2	19.1	2.2	1.7	4.8	0.0	1.6	3.2	1.2	1.7	2.8	1.4	2.6	8.1	6.5	2.0	1.7	1.4	1.5	3.0	13.7	35.4	1.5	1.8	21.1	18.3	18.2	2.0	1.5	0.1	3.7	2.0	1.3	1.4	1.8	2.2	3.9	1.7	1.5	11.4	6.1	0.0	2.2	0.0	2.0	1.9	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.9	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	44.0	8.2	19.1	8.1	6.5	3.0	13.7	18.2	6.1
ZKSCAN7	"FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39"	ENSG00000196345	"Zinc finger with KRAB and SCAN domains 7"	Q9P0L1	3	44555193-44594173	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;NTERA-2: 5.1;SH-SY5Y: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048312, HPA049906, HPA071850"	Uncertain		Supported	"Nuclear speckles,Cytosol"				Cytosol	"Nuclear speckles"	"HPA048312: , HPA049906: , HPA071850: "	"unprognostic (3.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.17e-3)"	3.4	6.0	5.7	6.3	3.9	1.9	5.3	9.9	6.1	6.1	3.9	6.0	6.1	2.0	6.9	9.5	2.9	6.4	5.3	4.8	5.6	3.9	4.5	4.6	5.1	5.1	4.4	3.4	13.0	6.7	6.8	18.2	3.4	4.1	6.6	3.5	7.2	3.7	5.8	4.3	2.2	3.8	7.2	3.9	4.8	3.7	18.6	4.4	12.1	6.0	1.9	4.8	5.5	5.9	3.7	2.5	2.0	1.2	2.4	3.4	1.2	0.0	0.0	4.6	6.6	1.3	0.7	0.0	2.2	1.9	2.3	2.7	0.0	0.1	0.1	0.8	1.5	0.0	0.0	1.4	2.9	0.0	0.0	0.2	1.4	1.7	4.1	0.0	0.0	3.2	1.5	1.3	0.0	0.6	0.0	0.1	3.5	0.0	0.0	0.0	5.1	0.0	0.0	2.1	0.0	1.3	0.6	3.1	8.1	0.1	0.2	0.0	0.0	3.1	0.7	1.4	0.5	1.8	0.0	0.2	0.1	0.0	0.3	0.0	1.1	2.0	1.2	1.6	3.4	0.5	1.0	1.3	2.1	2.6	1.0	3.7	1.6	3.2	1.6	2.4	1.1	2.5	2.1	1.2	5.7	3.9	9.9	6.1	5.6	3.9	4.4	3.4	4.1	4.4
ZKSCAN8	"LD5-1, ZNF192, ZSCAN40"	ENSG00000198315	"Zinc finger with KRAB and SCAN domains 8"	Q15776	6	28141910-28159472	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003483	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003483: AB_1080686"	"unprognostic (2.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.94e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (2.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.80e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.33e-3)"	16.5	12.1	13.4	10.3	15.6	17.7	16.1	27.7	16.5	17.7	16.3	20.8	12.5	9.2	21.8	19.9	10.0	17.2	11.0	10.7	13.5	9.3	11.2	10.9	14.1	13.9	18.4	13.3	25.0	15.4	21.9	22.6	12.8	14.0	15.1	11.9	17.2	13.9	17.2	12.0	11.5	15.9	18.3	18.2	14.4	14.1	12.8	18.2	18.1	17.1	8.8	14.5	16.7	12.4	3.8	1.9	4.1	4.2	3.0	3.1	1.3	5.9	3.7	18.2	17.9	11.7	10.9	5.8	6.7	12.2	8.6	10.9	4.1	3.5	13.0	10.9	6.4	5.1	11.5	4.4	12.8	7.0	9.8	11.8	7.2	9.5	10.7	14.4	8.8	11.5	7.7	9.0	13.7	8.8	17.9	4.9	9.1	3.0	10.0	12.8	6.8	4.3	10.8	11.4	10.2	6.4	7.3	13.7	17.3	7.9	3.7	8.6	4.2	8.1	7.4	13.1	7.5	4.3	8.9	12.0	8.5	10.7	3.7	10.2	6.9	4.1	1.3	1.3	2.7	3.3	3.1	1.5	1.7	1.2	1.0	3.8	2.8	2.3	0.5	3.0	4.2	1.9	1.6	1.3	13.4	15.6	27.7	16.5	13.5	9.3	18.4	13.3	14.0	18.2
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258107-40294184	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved		Approved	"Golgi apparatus,Cytosol"			13000	Cytosol	"Golgi apparatus"	"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (6.34e-4)"	"unprognostic (2.71e-2)"	21.6	24.2	17.6	15.4	19.6	6.5	18.6	10.7	21.3	20.9	20.6	14.9	27.0	17.9	29.7	19.7	21.4	19.9	20.7	20.8	17.1	16.9	34.2	48.7	16.2	23.1	21.9	17.0	16.0	20.4	39.8	17.0	23.0	23.5	21.7	23.3	15.6	18.9	19.0	19.1	14.7	20.9	25.2	19.2	17.7	19.0	10.7	17.9	20.9	20.6	14.7	18.4	19.1	16.7	15.1	25.8	15.1	23.9	24.2	22.5	20.3	20.7	13.9	10.8	8.1	28.7	23.0	21.0	21.8	18.2	24.6	22.5	15.1	36.0	17.9	15.1	26.6	21.6	22.0	20.0	28.4	16.8	14.1	17.3	14.8	13.8	16.4	27.8	21.7	16.6	20.6	21.0	9.1	17.3	18.3	18.0	23.3	9.7	16.8	8.3	20.7	14.5	14.6	19.2	22.2	21.8	20.1	11.3	13.3	20.1	44.9	27.0	16.5	76.8	17.1	22.3	16.3	20.7	26.4	11.1	29.6	15.6	24.4	19.5	23.6	15.1	20.0	13.6	17.9	23.9	21.5	15.1	19.1	18.9	25.8	11.6	17.0	22.5	11.8	24.2	22.7	16.9	22.3	20.3	17.6	19.6	10.7	21.3	17.1	16.9	21.9	17.0	23.5	17.9
ZMYM4	"KIAA0425, MYM, ZNF198L3, ZNF262"	ENSG00000146463	"Zinc finger MYM-type containing 4"	Q5VZL5	1	35268967-35422058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051301, HPA054802"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA051301: , HPA054802: "	"unprognostic (8.95e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (9.75e-9)"	"unprognostic (9.76e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.21e-1)"	16.6	15.9	17.9	17.3	22.1	13.6	19.7	28.1	24.7	22.0	14.8	17.1	18.3	10.2	19.8	18.2	15.0	17.9	15.7	13.1	17.6	19.0	15.8	14.4	14.1	15.0	15.8	14.6	27.0	15.7	26.1	22.6	19.6	22.2	21.0	13.6	18.2	18.0	26.8	15.9	12.9	12.5	16.6	15.2	16.0	15.4	36.3	13.6	26.7	21.6	13.0	18.8	17.2	14.7	4.2	9.8	3.5	8.2	9.6	4.4	2.5	12.7	10.4	31.9	16.1	9.3	20.3	11.8	15.2	23.0	18.6	24.3	11.2	12.8	23.8	9.4	19.0	8.3	22.1	11.2	26.9	13.4	15.3	29.0	12.1	9.5	17.0	24.8	13.2	15.3	10.1	18.0	17.1	20.6	31.6	6.5	22.5	7.7	21.0	13.8	26.6	9.9	23.6	20.5	11.5	13.3	16.9	18.4	17.9	18.3	13.4	20.8	10.9	18.9	24.8	17.3	18.0	7.6	16.3	7.2	13.3	18.3	12.5	19.0	16.5	2.4	5.0	3.5	4.3	7.1	4.4	4.2	4.2	3.8	4.8	3.7	4.1	3.9	1.0	9.6	8.2	9.8	3.1	2.5	17.9	22.1	28.1	24.7	17.6	19.0	15.8	14.6	22.2	13.6
ZMYND10	"BLU, CILD22"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50346852	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 55.7;testis: 99.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 10.4;U-87 MG: 7.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035255			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favourable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.1	0.1	1.9	0.2	4.8	0.3	0.6	0.3	0.8	1.6	0.1	5.5	0.2	0.2	0.9	4.6	0.2	55.7	0.3	0.1	2.6	3.1	0.5	0.2	4.7	0.2	0.2	0.3	4.2	0.2	1.4	1.6	0.1	10.2	0.1	0.1	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.5	0.2	0.1	99.4	1.2	0.1	0.8	0.1	0.1	0.1	0.0	0.4	1.1	0.8	0.7	3.8	2.5	0.5	2.7	1.0	0.4	0.8	1.0	1.6	0.8	0.4	1.7	2.9	0.9	0.2	1.4	1.0	1.1	1.7	0.6	2.4	0.1	0.3	1.1	1.1	2.5	3.5	0.1	0.1	0.7	1.2	0.1	0.3	3.7	0.2	0.2	0.6	0.6	0.4	1.4	0.5	3.4	0.0	1.1	1.0	0.1	0.8	3.6	0.1	2.9	1.1	0.3	0.8	0.2	10.4	0.9	0.0	0.8	0.7	1.8	0.2	1.3	0.6	0.3	7.3	3.3	0.2	0.3	0.4	0.3	2.5	0.4	1.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.8	3.8	0.7	0.4	0.1	0.5	1.9	4.8	0.3	0.8	2.6	3.1	0.2	0.3	10.2	1.2
ZMYND15	DKFZp434N127	ENSG00000141497	"Zinc finger MYND-type containing 15"	Q9H091	17	4740015-4746119	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.6"	"Cell line enhanced"	"Detected in some"		"A-431: 5.0;CAPAN-2: 4.7;HaCaT: 3.9;T-47d: 3.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.1;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	11	"granulocytes: 1.1;monocytes: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023286			Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA023286: AB_1859076"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.62e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.49e-1)"	"unprognostic (6.72e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	3.6	1.6	2.3	2.9	2.0	0.9	2.0	0.7	2.7	1.3	1.0	5.1	1.4	5.2	1.8	4.5	1.2	1.5	3.8	3.8	3.6	1.8	2.4	3.5	6.1	4.9	3.7	1.7	0.9	4.7	12.5	1.8	1.5	3.4	1.9	1.0	4.2	3.8	2.7	0.4	1.8	3.9	1.2	4.8	6.2	2.4	25.6	2.9	0.7	1.4	0.7	0.8	1.6	0.9	0.0	0.1	1.1	1.5	0.0	0.0	0.2	5.0	0.8	0.0	2.4	0.0	0.2	0.4	0.1	1.4	1.3	3.0	2.3	4.7	0.0	0.1	0.0	3.9	0.9	0.4	0.1	0.5	1.7	0.0	0.5	1.2	0.8	0.0	1.4	0.2	0.6	0.2	0.2	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.6	0.0	0.1	1.4	1.6	2.3	3.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.2	2.3	2.0	0.7	2.7	3.6	1.8	3.7	1.7	3.4	2.9
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491123	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 64.8;skeletal muscle: 111.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 48.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: "	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	14.9	5.4	8.8	6.6	10.4	9.0	10.3	6.3	9.1	7.1	7.8	4.5	4.5	3.9	7.4	6.3	12.7	5.4	6.1	64.8	9.2	6.3	6.4	3.7	7.8	6.0	7.6	6.4	6.6	4.4	8.4	7.1	5.0	11.9	7.8	5.6	11.3	6.0	5.7	111.1	4.3	5.9	10.9	8.0	6.3	6.0	5.7	7.2	3.4	5.7	46.9	6.8	7.0	17.7	8.3	10.8	48.5	19.6	3.9	5.1	4.5	14.1	8.2	14.4	15.9	36.4	32.1	8.8	11.5	11.0	10.1	10.8	19.3	4.1	9.5	10.3	14.1	16.2	14.9	11.8	15.5	15.4	7.2	18.2	19.2	6.9	10.5	21.8	10.9	24.1	7.9	15.3	17.1	16.2	21.6	1.3	16.4	5.6	8.3	5.3	6.1	8.4	8.0	26.2	5.2	5.3	16.0	9.2	4.9	23.3	11.0	13.0	10.1	14.2	24.4	10.9	16.8	14.4	16.8	7.9	15.2	35.6	9.7	17.4	18.8	19.9	19.6	7.6	5.1	15.9	4.5	6.7	4.2	4.2	10.5	8.3	3.8	3.4	48.5	3.9	18.5	10.8	3.8	4.5	8.8	10.4	6.3	9.1	9.2	6.3	7.6	6.4	11.9	7.2
ZNF114	MGC17986	ENSG00000178150	"Zinc finger protein 114"	Q8NC26	19	48270102-48287608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 11.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;Hep G2: 19.6;NTERA-2: 10.2;REH: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA025019, HPA029553"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA025019: AB_1859080, HPA029553: AB_10603005"	"unprognostic (1.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.29e-4)"	"unprognostic (2.67e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.63e-1)"	1.5	1.0	3.7	2.2	2.7	2.1	1.2	1.2	3.3	2.3	0.6	2.1	1.0	0.9	2.4	2.4	1.3	1.9	1.5	1.7	3.7	4.6	1.6	0.5	1.4	1.9	2.6	0.8	1.2	5.3	4.2	1.6	7.5	2.1	3.1	0.4	2.5	3.7	1.3	3.7	3.7	0.7	1.4	3.5	1.6	0.7	1.6	1.7	1.0	11.5	0.5	1.1	1.3	5.7	2.6	3.5	5.4	0.7	2.0	0.6	0.4	2.7	4.2	5.1	0.5	0.3	0.0	16.7	0.5	0.0	1.5	2.1	1.5	4.3	0.1	4.9	0.3	5.5	7.0	0.3	1.8	0.0	0.4	0.6	1.3	19.6	1.6	2.6	0.5	0.3	0.5	0.8	0.1	0.3	0.7	0.4	0.3	7.9	0.2	8.3	10.2	0.9	10.4	0.0	0.3	0.2	2.3	2.0	2.4	2.7	0.0	2.9	1.1	4.9	0.7	0.8	1.7	1.5	0.5	0.4	0.1	0.1	0.2	1.4	0.8	3.3	0.7	0.9	0.5	0.6	0.3	0.9	0.6	0.4	1.7	2.6	0.5	0.4	5.4	2.0	0.7	3.5	0.2	0.4	3.7	2.7	1.2	3.3	3.7	4.6	2.6	0.8	2.1	1.7
ZNF117	"H-plk, HPF9"	ENSG00000152926	"Zinc finger protein 117"	Q03924	7	64971776-65006684	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 14.9;AN3-CA: 15.6;THP-1: 15.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"											HPA031148			Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"		"HPA031148: "	"unprognostic (1.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (7.10e-2)"	"prognostic unfavourable (2.17e-11)"	"unprognostic (1.08e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	11.1	13.2	1.3	3.4	1.5	2.1	7.1	2.1	3.7	3.1	2.1			0.5	4.2	6.5	5.2	2.8	5.6	2.7	1.1	1.3	2.3	0.9	3.9	2.6	1.0		5.0	2.1	2.4	4.0	5.3		2.8	2.2		3.6	2.4	0.6	4.2	1.6	2.8	1.3	3.4	1.8	5.3			3.4		2.6	2.5	4.5	1.0	0.7	6.2	1.9	0.9	0.6	0.2	1.2	0.1	14.9	15.6	5.7	2.6	8.4	3.2	0.8	0.8	1.6	0.6	6.4	5.5	2.7	1.6	1.0	1.7	0.4	1.8	1.6	1.5	2.5	0.4	3.0	0.5	0.0	1.5	3.3	0.6	0.6	0.6	2.5	10.1	3.7	3.7	2.7	5.6	5.7	6.3	0.2	7.4	1.0	1.1	2.0	2.4	2.3	12.7	1.6	0.7	0.7	2.8	15.8	7.4	4.5	0.5	2.7	2.0	2.5	4.7	2.9	1.6	7.1	2.7	0.4	0.6	1.0	0.6	1.9	0.6	1.0	0.4	0.4	0.7	1.0	0.4	0.4	6.2	0.9	0.5	0.7	0.5	0.2										
ZNF135	"pHZ-17, ZNF61, ZNF78L1"	ENSG00000176293	"Zinc finger protein 135"	P52742	19	58059239-58086310	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 6.2;HSkMC: 6.7;MOLT-4: 6.9;NTERA-2: 6.2;T-47d: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA006961	Approved		Approved	Cytosol				Cytosol		"HPA006961: AB_1080670"	"unprognostic (4.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-2)"	"unprognostic (9.18e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.34e-1)"	"prognostic favourable (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.25e-1)"	4.6	3.5	8.4	3.1	13.7	1.7	8.6	7.3	10.6	7.9	5.4	12.0	4.5	1.9	11.8	11.2	3.9	8.6	5.7	4.5	6.4	5.2	5.9	1.1	3.8	2.9	6.4	9.1	15.9	3.3	21.4	11.0	5.3	8.1	8.6	3.0	9.5	3.0	7.6	2.6	6.2	2.7	9.6	5.3	4.9	3.4	8.9	10.4	7.3	10.6	1.2	3.2	6.4	5.1	3.9	3.9	3.4	0.2	4.5	3.7	0.8	0.0	0.0	1.5	0.0	0.1	0.0	0.0	3.6	0.0	5.1	0.3	0.0	0.2	0.0	3.9	5.4	0.2	0.0	0.0	5.6	0.0	5.9	0.0	0.0	0.0	2.3	0.0	6.2	6.7	0.0	2.8	0.0	0.0	0.0	0.0	3.9	0.0	6.9	0.0	6.2	0.0	0.0	0.0	0.0	2.7	4.3	5.8	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	3.4	0.0	0.0	0.3	2.4	0.0	0.0	0.0	2.9	0.0	0.1	3.4	0.0	0.2	0.2	0.9	0.3	0.3	1.7	3.9	3.7	2.1	0.1	4.5	0.0	3.9	0.2	0.8	8.4	13.7	7.3	10.6	6.4	5.2	6.4	9.1	8.1	10.4
ZNF14	"GIOT-4, KOX6"	ENSG00000105708	"Zinc finger protein 14"	P17017	19	19710471-19733097	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA049863	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA049863: "	"unprognostic (1.04e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (7.96e-4)"	"unprognostic (1.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.55e-2)"	"prognostic favourable (8.09e-6)"	"unprognostic (1.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.05e-3)"	7.4	5.3	7.9	8.7	10.5	11.9	12.8	23.3	10.3	11.3	7.0	8.1	6.6	3.9	9.4	9.6	5.7	9.3	6.0	6.6	8.1	7.6	8.4	1.7	4.9	10.5	12.2	6.0	15.7	7.5	12.7	10.7	8.8	9.4	12.3	5.1	6.5	7.1	9.9	3.4	7.2	7.2	8.9	9.0	9.4	7.0	6.2	10.7	7.1	13.8	3.1	10.9	9.8	7.7	10.3	3.0	11.4	3.6	6.5	18.4	6.3	3.5	3.5	6.0	7.8	4.0	4.4	7.2	3.7	5.0	5.4	5.9	3.3	2.7	9.4	6.1	3.8	3.5	6.2	3.6	6.8	2.3	7.2	4.4	2.7	4.5	4.9	0.1	6.8	4.4	3.9	3.8	3.3	3.4	5.1	4.5	5.3	5.8	7.9	5.1	7.8	10.3	4.2	9.8	4.5	3.9	7.1	6.0	4.3	0.1	4.2	5.7	5.9	9.1	2.1	4.8	1.3	5.5	4.7	3.5	4.2	8.3	0.3	4.9	2.8	11.4	1.8	6.1	9.6	3.1	15.1	10.3	13.1	12.0	2.6	8.2	18.4	14.5	4.1	6.5	3.6	3.0	8.4	6.3	7.9	10.5	23.3	10.3	8.1	7.6	12.2	6.0	9.4	10.7
ZNF155	pHZ-96	ENSG00000204920	"Zinc finger protein 155"	Q12901	19	43967862-43998325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003220	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA003220: AB_1080675"	"unprognostic (2.71e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.98e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.57e-2)"	9.9	9.7	6.1	5.2	9.4	4.2	9.4	16.0	11.1	10.1	7.6	11.7	9.6	5.4	12.8	12.0	7.0	7.7	6.2	9.7	7.2	7.5	8.9	10.6	7.4	8.0	6.8	5.4	10.6	5.7	15.8	13.0	7.1	9.4	9.9	8.0	7.7	10.0	8.1	6.2	8.8	10.8	10.1	9.4	11.5	8.3	5.2	7.4	10.1	13.3	8.5	8.9	13.1	6.4	6.2	5.1	11.8	3.5	6.4	9.3	4.9	4.5	3.8	9.7	8.8	5.4	6.2	2.8	3.7	3.5	2.7	3.8	2.5	2.3	0.0	4.8	5.8	3.5	3.2	8.0	4.4	5.0	8.0	9.5	8.1	2.7	5.5	3.0	5.6	8.8	6.4	5.4	8.0	6.1	0.1	0.1	7.1	4.0	4.3	3.5	5.9	3.4	0.0	10.3	3.4	7.1	14.8	6.5	8.7	9.2	0.5	3.6	6.2	8.4	4.5	5.9	8.7	3.8	5.4	10.8	7.7	0.0	5.0	0.7	5.4	10.3	3.4	11.8	8.5	3.5	8.4	5.3	6.1	9.3	5.1	6.2	7.4	6.8	3.0	6.4	2.7	3.0	5.2	4.9	6.1	9.4	16.0	11.1	7.2	7.5	6.8	5.4	9.4	7.4
ZNF160	"F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18"	ENSG00000170949	"Zinc finger protein 160"	Q9HCG1	19	53066606-53103436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023599	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA023599: AB_2218442"	"unprognostic (1.18e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.90e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.65e-5)"	"unprognostic (5.20e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.71e-1)"	"prognostic favourable (2.67e-5)"	17.7	28.0	15.7	18.5	19.9	8.1	17.2	26.4	20.0	16.3	15.5	21.6	14.1	9.6	22.7	17.2	11.0	15.5	16.8	13.8	14.5	8.9	19.7	13.2	17.3	12.8	22.5	15.2	25.9	12.7	20.9	18.2	16.1	18.8	15.1	13.3	9.9	14.3	19.3	10.2	13.1	12.1	17.4	19.6	31.5	13.2	15.2	22.4	19.0	29.5	7.5	12.5	18.0	15.0	9.1	4.3	10.7	5.9	17.5	11.2	5.4	5.9	5.3	7.4	11.3	12.5	8.8	12.6	6.5	8.7	5.3	8.5	4.6	3.8	6.8	5.6	6.0	4.4	6.9	6.7	10.6	5.0	8.4	10.5	4.0	2.5	6.8	0.0	7.2	10.9	6.9	5.7	8.0	5.6	5.3	0.0	9.9	4.1	8.6	6.4	6.9	8.6	5.5	7.8	5.2	8.3	30.2	6.3	8.1	0.0	5.2	1.0	5.5	6.1	10.7	14.8	5.3	4.3	4.7	3.9	16.1	9.7	2.6	2.6	7.0	9.0	3.1	10.7	7.1	4.2	10.3	8.4	7.3	9.5	4.3	9.1	11.2	8.7	6.5	17.5	5.9	4.1	7.3	5.4	15.7	19.9	26.4	20.0	14.5	8.9	22.5	15.2	18.8	22.4
ZNF169	MGC51961	ENSG00000175787	"Zinc finger protein 169"	Q14929	9	94259311-94301454	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041769	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA041769: "	"unprognostic (1.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.27e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.45e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-4)"	4.5	4.2	6.5	8.5	10.9	5.9	7.8	12.7	13.5	7.4	6.7	8.3	4.4	5.6	7.7	8.7	4.1	7.5	5.7	4.6	8.6	5.7	5.5	3.2	5.0	11.0	9.8	8.5	9.4	5.2	5.9	4.9	4.3	8.2	6.6	11.1	5.8	7.2	5.6	8.6	10.0	8.6	6.6	7.1	10.6	8.1	4.3	9.5	10.5	8.0	5.0	10.0	6.9	6.5	9.5	4.5	6.1	6.9	6.7	9.1	3.4	4.0	3.5	4.0	7.0	1.9	5.0	4.5	1.4	2.8	3.1	3.3	2.4	6.0	9.7	2.0	2.3	8.0	8.2	3.7	4.2	5.5	8.8	6.8	8.0	4.5	2.9	10.3	7.0	4.3	4.1	2.6	4.2	3.9	6.1	3.0	3.9	3.9	4.7	5.7	6.5	4.3	4.2	2.8	3.2	2.8	3.6	4.1	4.9	2.8	4.9	2.0	3.1	4.5	4.2	2.9	3.7	3.6	3.1	5.2	1.9	2.0	2.7	6.8	2.7	3.2	6.5	6.1	5.5	6.9	6.9	6.3	6.2	3.9	4.5	9.5	6.7	9.1	5.6	6.7	5.0	4.2	6.5	3.4	6.5	10.9	12.7	13.5	8.6	5.7	9.8	8.5	8.2	9.5
ZNF174	ZSCAN8	ENSG00000103343	"Zinc finger protein 174"	Q15697	16	3401235-3409370	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009656	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"				Nucleoplasm	"Actin filaments, Cytosol"	"HPA009656: AB_1080679"	"unprognostic (4.33e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.94e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.06e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.83e-1)"	10.0	11.6	11.1	9.0	16.0	5.7	12.8	15.8	24.3	13.0	14.8	18.1	9.4	9.6	16.8	18.8	11.0	17.7	13.4	15.3	11.8	12.0	11.1	9.9	8.7	11.6	15.1	10.5	21.0	9.1	28.5	15.2	8.2	15.7	14.7	11.7	16.1	12.2	18.2	14.1	11.4	9.7	16.8	13.3	11.9	10.5	13.5	15.7	18.8	12.2	9.1	12.8	14.8	10.8	9.5	6.9	23.1	6.4	6.8	11.5	6.7	6.2	10.3	11.9	13.4	14.5	10.5	8.2	5.9	14.6	12.8	11.7	8.1	10.9	21.6	9.4	10.4	9.0	11.0	9.8	12.1	13.7	11.3	11.2	9.7	9.8	10.4	12.7	13.5	12.5	11.6	10.8	10.8	10.8	17.6	9.8	13.1	10.4	12.6	10.6	13.0	12.8	18.1	13.3	17.0	9.4	3.2	11.2	8.7	11.5	12.8	9.8	12.5	14.2	8.7	9.6	10.4	7.6	7.7	12.1	13.1	17.1	5.1	8.0	9.0	13.1	5.7	23.1	9.1	6.4	8.7	9.5	9.4	10.2	6.9	7.1	11.5	8.5	6.8	6.8	4.2	3.6	8.8	6.7	11.1	16.0	15.8	24.3	11.8	12.0	15.1	10.5	15.7	15.7
ZNF175	OTK18	ENSG00000105497	"Zinc finger protein 175"	Q9Y473	19	51571298-51592508	"Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 25.7;RT4: 23.4;TIME: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA002717	Uncertain		Supported	"Nucleoplasm,Intermediate filaments,Cytosol"				Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA002717: AB_1080681"	"unprognostic (9.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.33e-3)"	"unprognostic (9.94e-2)"	"unprognostic (6.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (3.50e-3)"	6.1	6.7	11.2	6.1	12.6	4.7	8.4	26.2	16.0	7.7	6.5	7.1	9.4	8.4	9.2	8.5	5.5	7.6	4.9	6.6	12.7	7.4	7.3	6.4	8.0	8.7	11.1	10.3	14.5	7.3	19.8	10.9	12.1	11.4	7.6	6.1	6.4	9.1	9.5	6.4	5.5	7.9	8.1	8.8	9.7	6.7	15.0	11.7	9.2	10.8	5.0	9.2	8.7	11.9	2.1	4.6	0.6	1.3	0.9	2.2	0.7	1.8	3.3	3.3	3.5	3.5	4.9	0.0	4.2	5.4	3.9	4.8	3.3	2.8	3.4	2.4	4.2	3.1	3.5	2.9	7.1	0.0	5.2	25.7	5.0	1.1	3.1	4.3	16.6	1.9	2.7	8.0	3.9	6.3	8.6	3.5	4.3	0.0	4.6	3.2	1.8	3.3	0.0	4.3	1.6	2.1	23.4	4.2	3.0	3.9	1.3	2.5	1.0	3.5	23.7	6.0	2.7	1.4	4.0	4.6	8.5	3.4	16.8	2.5	3.0	0.1	1.3	0.0	1.7	0.5	1.8	1.9	1.6	1.4	1.4	2.1	2.2	1.7	0.6	0.9	0.3	4.6	0.3	0.7	11.2	12.6	26.2	16.0	12.7	7.4	11.1	10.3	11.4	11.7
ZNF18	"HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38"	ENSG00000154957	"Zinc finger protein 18"	P17022	17	11977439-11997510	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006144	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA006144: AB_1080683"	"unprognostic (2.99e-3)"	"prognostic favourable (6.32e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"prognostic favourable (5.12e-6)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (1.52e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.53e-3)"	8.3	6.8	8.2	7.0	13.9	15.7	9.6	9.4	15.5	8.5	7.2	13.2	3.5	6.4	14.1	9.5	8.8	7.5	7.2	7.3	9.0	8.7	6.5	13.2	6.2	10.5	9.9	9.8	10.4	7.8	8.4	11.8	5.1	14.5	9.8	9.2	12.5	9.0	7.1	8.2	12.8	8.2	7.8	10.8	12.3	6.2	15.5	9.2	15.6	8.4	14.3	10.2	7.7	7.6	9.1	8.8	19.6	7.6	7.0	11.2	5.6	3.1	6.6	7.0	10.5	13.3	11.8	3.7	4.6	8.1	6.0	6.5	3.0	5.4	10.8	6.9	5.0	6.6	5.8	7.2	6.6	8.1	4.9	6.4	6.7	4.2	9.4	3.7	8.6	9.7	11.8	4.6	8.4	9.1	3.7	5.1	8.2	3.3	11.8	7.2	5.2	3.0	9.9	7.1	4.8	8.7	3.9	2.7	5.9	7.8	3.9	6.1	5.5	3.4	7.1	7.2	3.6	3.2	3.5	5.7	4.1	5.3	8.3	8.3	8.4	10.6	5.9	6.6	11.0	5.8	10.2	9.1	10.2	10.3	5.8	8.2	11.0	11.2	19.6	7.0	7.6	8.8	10.6	5.6	8.2	13.9	9.4	15.5	9.0	8.7	9.9	9.8	14.5	9.2
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.5;esophagus: 67.6"	"Cell line enhanced"	"Detected in many"		"A-431: 31.0;EFO-21: 36.9;HBEC3-KT: 25.6;PC-3: 22.7;TIME: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.6;monocytes: 13.9"					"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"			5400	"Plasma membrane, Cytosol"	"Actin filaments, Focal adhesion sites"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	3.9	1.7	1.8	2.0	3.2	0.8	1.8	2.7	2.0	14.3	1.8	1.4	10.7	0.0	3.8	93.5	67.6	3.1	2.0	1.9	1.7	0.8	2.0	1.1	3.3	3.1	2.1	1.1	1.2	0.9	0.1	2.3	4.0	1.7	4.2	0.3	1.3	10.1	28.1	1.5	9.9	1.2	1.4	1.2	3.7	0.8	1.9	2.0	1.2	3.9	1.4	6.6	2.1	22.8	0.4	3.8	21.6	13.9	0.2	0.6	10.2	31.0	6.6	0.6	0.4	0.8	1.0	1.4	1.5	0.1	3.9	0.5	0.2	9.4	0.4	36.9	2.3	4.4	0.9	25.6	15.9	0.3	0.6	2.0	2.7	1.0	1.8	0.1	0.1	0.7	18.4	0.4	15.1	19.7	0.1	0.3	0.1	7.3	0.1	0.1	0.4	22.7	0.1	0.1	0.2	2.0	2.9	0.2	2.1	0.0	5.9	0.9	6.0	0.6	60.4	0.2	13.4	0.7	1.1	0.3	0.2	0.2	0.4	2.2	0.4	21.6	13.9	5.7	0.5	12.9	0.3	0.4	0.4	0.6	3.8	0.3	0.6	0.3	9.5	0.2	10.2	2.5	0.5	10.2	1.8	3.2	2.7	2.0	1.7	0.8	2.1	1.1	1.7	2.0
ZNF195		ENSG00000005801	"Zinc finger protein 195"	O14628	11	3339261-3379222	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA030605	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030605: AB_10602686"	"unprognostic (2.30e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavourable (3.53e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavourable (4.24e-4)"	"prognostic unfavourable (7.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-2)"	"prognostic favourable (4.79e-7)"	12.2	11.3	14.0	13.2	18.8	15.0	20.9	28.0	22.7	13.4	15.4	19.6	10.8	13.5	13.4	25.3	10.8	12.6	11.1	9.6	15.2	16.9	16.4	14.6	12.7	16.5	16.9	10.5	10.6	16.0	8.8	20.8	9.9	22.5	16.4	19.4	9.3	13.2	9.7	13.0	13.5	14.0	11.3	15.4	19.5	13.3	6.9	20.0	25.8	15.9	8.6	15.9	13.1	12.9	13.6	12.2	9.9	9.2	13.0	19.1	8.2	7.9	8.7	15.0	18.2	5.3	6.6	22.0	8.2	7.0	8.7	11.0	9.1	14.9	13.0	5.1	5.4	11.2	16.6	9.9	12.7	6.3	13.9	9.7	8.6	9.1	6.8	15.9	14.4	8.3	9.6	7.2	12.3	10.9	16.9	8.5	9.5	6.4	18.8	12.6	34.9	8.8	16.6	9.2	6.6	13.8	18.8	25.1	24.9	9.0	11.3	7.4	5.6	14.2	7.7	4.2	8.0	7.4	7.2	7.7	10.9	20.6	4.2	11.8	7.3	1.9	8.4	9.9	12.0	9.2	15.2	13.6	14.8	14.6	12.2	12.7	14.0	15.6	1.4	13.0	7.7	10.7	19.1	8.2	14.0	18.8	28.0	22.7	15.2	16.9	16.9	10.5	22.5	20.0
ZNF2	"A1-5, Zfp661, ZNF661"	ENSG00000275111	"Zinc finger protein 2"	Q9BSG1	2	95165432-95184317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041358	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041358: AB_10795539"	"unprognostic (1.18e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.13e-3)"	"prognostic favourable (4.69e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	5.1	4.1	5.2	3.2	6.3	0.7	4.0	6.4	6.1	5.3	2.6	6.4	2.5	3.3	5.4	5.7	3.5	4.8	2.3	4.6	5.1		4.2	2.7	3.5	4.3	5.3	5.0	6.5	2.8	6.5	7.1	3.1	5.2	4.8	2.5	4.9	3.7	5.5	4.2	4.7	2.2	4.1	6.1	4.3	3.5	4.3	5.9	4.3	5.0	4.5	5.0	4.3	4.0	7.2	5.0	15.1	6.2	4.2	8.6	4.5	5.3	5.2	6.4	10.7	9.5	7.5	4.2	6.0	7.9	8.2	10.9	5.6	3.7	3.4	4.3	5.7	4.5	6.8	4.5	8.7	7.5	5.9	7.9	4.2	6.9	7.8	4.1	5.2	6.4	6.4	7.5	11.7	7.1	5.3	2.8	8.5	4.9	5.8	5.7	2.8	7.2	5.6	11.1	4.4	4.7	3.2	5.4	7.4	5.6	8.1	6.8	5.0	6.2	5.8	10.0	5.8	7.9	5.0	4.9	4.3	4.2	6.7	5.4	7.6	5.9	4.4	15.1	8.6	6.2	6.2	7.2	7.0	7.5	5.0	6.9	8.5	8.6	3.6	4.2	4.7	4.1	7.6	4.5										
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142805	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: "	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	5.7	8.2	9.0	6.0	10.3	6.0	5.7	10.8	16.7	5.0	6.2	14.6	4.7	9.3	7.5	5.1	8.4	6.8	6.0	9.1	9.5	7.7	4.4	2.4	6.3	8.8	7.1	9.3	10.3	12.1	8.7	7.3	4.1	9.1	6.5	2.5	6.8	17.4	5.9	11.1	16.9	11.2	6.8	7.6	7.5	6.9	20.1	8.0	7.5	9.2	4.7	5.4	7.1	5.8	4.8	3.2	3.5	2.5	4.0	4.7	1.8	3.3	10.6	4.7	11.2	4.6	3.8	5.9	6.2	2.5	3.3	3.8	3.4	7.0	4.1	6.1	4.0	8.2	2.2	6.8	1.3	8.5	8.2	2.9	11.7	6.6	8.8	7.0	7.6	3.7	8.5	4.6	1.7	2.4	7.4	9.2	2.1	14.5	6.5	8.6	8.1	8.1	8.8	5.5	7.5	2.6	2.3	9.8	8.5	9.3	5.6	4.4	7.3	12.1	6.0	6.7	6.1	7.5	4.3	5.2	4.8	6.3	2.7	9.3	5.1	0.0	1.6	3.4	3.7	2.5	3.2	2.7	3.6	2.4	1.6	4.8	4.7	3.4	3.5	4.0	1.9	3.2	2.0	1.8	9.0	10.3	10.8	16.7	9.5	7.7	7.1	9.3	9.1	8.0
ZNF23	"KOX16, Zfp612, ZNF359, ZNF612"	ENSG00000167377	"Zinc finger protein 23"	P17027	16	71447597-71463095	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023534	Uncertain		Approved	Cytosol				Cytosol		"HPA023534: AB_1859140"	"unprognostic (8.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.04e-2)"	7.1	5.5	8.5	6.3	11.5	5.6	7.7	16.4	14.3	6.7	8.1	5.1	4.6	5.5	9.3	14.9	6.1	10.3	5.2	6.0	11.6	9.6	7.6	6.5	8.7	9.5	11.3	13.9	11.4	6.1	11.1	19.5	5.5	11.4	8.4	7.6	8.4	6.4	8.0	7.4	8.5	6.4	11.4	8.8	8.2	6.0	8.7	9.6	5.4	10.2	7.0	9.5	7.4	7.3	4.6	4.2	1.7	3.6	4.0	4.9	1.8	4.6	4.0	10.2	7.4	5.8	5.4	6.3	11.3	8.4	7.6	5.5	5.3	5.2	10.0	3.1	7.4	3.5	6.0	6.7	6.8	2.4	4.3	5.5	3.9	4.0	5.8	10.1	3.9	6.4	5.2	7.8	13.7	2.3	8.2	3.0	7.1	10.9	4.0	4.8	8.7	3.7	2.7	3.1	3.1	5.3	4.0	8.2	8.7	3.7	2.7	3.0	3.6	4.7	9.5	15.8	4.4	4.3	7.4	5.3	6.2	14.2	12.0	4.2	8.7	1.7	1.8	1.2	4.5	3.6	3.9	3.0	2.5	4.9	2.5	4.6	4.9	3.8	0.0	4.0	2.0	4.2	4.1	1.8	8.5	11.5	16.4	14.3	11.6	9.6	11.3	13.9	11.4	9.6
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: "	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favourable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	6.7	5.2	6.5	6.7	9.5	2.0	7.4	14.3	11.1	6.6	8.2	11.1	7.8	4.5	8.9	10.1	5.5	9.9	5.5	5.9	7.3	5.4	6.6	6.3	6.3	7.0	9.8	5.7	14.3	10.0	3.8	8.7	6.2	8.7	7.6	5.9	6.5	8.8	6.4	7.7	5.5	6.3	8.5	6.2	6.9	7.2	7.5	10.7	6.4	8.0	5.4	6.1	6.3	6.2	11.8	7.4	1.9	2.1	5.4	7.8	3.9	5.5	4.2	6.9	7.0	2.5	1.1	3.7	2.7	1.4	2.7	3.8	6.5	1.4	11.2	3.4	1.0	3.8	4.8	2.8	1.6	4.4	7.3	1.9	9.7	5.8	3.6	0.0	3.4	2.0	3.0	2.9	2.6	1.9	9.4	4.2	3.3	2.7	9.5	3.9	13.5	4.6	8.2	4.4	7.5	2.3	0.8	7.2	4.7	5.4	2.2	4.4	1.1	2.8	3.2	2.7	4.6	2.1	5.3	5.6	8.8	2.8	7.0	0.3	4.5	1.4	2.1	1.9	4.7	1.9	5.5	11.8	5.2	6.2	4.0	11.0	7.8	7.2	0.1	5.4	1.2	7.4	4.2	3.9	6.5	9.5	14.3	11.1	7.3	5.4	9.8	5.7	8.7	10.7
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822607-76970727	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	5.7	5.2	7.0	9.1	11.2	10.8	10.0	15.3	11.0	7.2	5.8	7.3	6.7	5.0	7.6	7.1	5.6	7.6	6.3	5.1	8.3	5.7	4.7	4.3	6.4	6.2	8.3	3.5	11.3	7.1	12.2	8.9	5.6	7.3	6.2	4.1	5.4	6.6	12.6	5.7	9.9	5.5	5.8	6.5	5.5	5.8	16.6	10.6	10.4	6.5	1.9	10.0	6.2	12.7	9.0	4.6	5.9	3.4	3.0	5.4	1.2	4.3	5.8	8.2	6.0	6.3	6.1	3.7	3.4	4.7	5.4	4.3	4.1	4.1	6.2	1.7	4.4	8.0	5.7	4.8	4.6	6.5	5.7	5.9	6.7	4.8	3.9	9.4	6.8	6.0	5.2	5.1	7.9	5.4	5.6	5.2	5.4	4.1	11.4	5.2	4.5	4.6	7.3	8.5	4.1	4.0	6.8	4.7	4.9	6.1	3.7	4.2	4.4	6.6	5.6	9.3	3.7	2.5	5.0	3.5	4.9	8.0	6.2	5.2	6.9	1.1	3.4	5.9	5.4	2.9	5.2	9.0	4.0	3.7	2.2	8.1	4.6	4.8	3.7	3.0	2.7	4.6	3.9	1.2	7.0	11.2	15.3	11.0	8.3	5.7	8.3	3.5	7.3	10.6
ZNF260	"ozrf1, Zfp260"	ENSG00000254004	"Zinc finger protein 260"	Q3ZCT1	19	36510695-36528660	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028806	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028806: AB_10795285"	"unprognostic (1.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.89e-3)"	8.4	9.4	10.3	7.6	16.8	2.3	12.0	18.4	14.1	10.8	7.0	6.2	9.4	6.2	11.2	7.9	8.0	8.4	8.2	7.5	11.2	9.5	11.6	8.5	7.3	12.4	17.1	9.1	13.4	6.6	20.4	19.5	10.9	11.9	10.3	7.1	5.9	8.8	7.6	4.8	10.0	7.7	8.1	20.6	8.3	8.1	4.5	15.4	17.3	14.7	5.5	9.7	10.7	8.4	5.9	3.2	6.8	3.5	4.1	7.2	3.0	7.8	8.0	18.5	13.9	5.7	8.8	8.1	6.9	7.4	6.4	8.2	3.6	4.4	5.2	11.3	5.5	3.0	9.3	4.3	9.8	6.8	4.0	7.6	6.1	4.0	8.0	3.8	6.4	7.9	7.1	6.6	10.1	8.5	6.0	5.7	12.7	4.2	14.2	2.4	11.7	3.4	9.5	11.5	3.8	7.1	14.1	13.4	14.7	15.3	8.2	5.6	6.9	7.3	7.3	11.1	11.6	6.5	6.1	7.4	14.1	12.1	0.3	4.1	14.9	6.8	2.8	3.0	4.0	2.5	4.2	5.1	5.3	3.2	3.2	5.9	7.2	5.5	1.6	4.1	3.5	2.2	4.6	3.0	10.3	16.8	18.4	14.1	11.2	9.5	17.1	9.1	11.9	15.4
ZNF263	"FPM315, ZKSCAN12, ZSCAN44"	ENSG00000006194	"Zinc finger protein 263"	O14978	16	3263800-3301401	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035085, HPA035086"	Approved		Supported	"Nucleoplasm,Mitotic spindle,Cytosol"				Cytosol	"Nucleoplasm, Mitotic spindle"	"HPA035085: AB_10671099, HPA035086: AB_10603244"	"unprognostic (2.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.98e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.66e-1)"	28.3	17.8	21.5	16.9	25.7	15.0	23.3	26.4	23.5	21.9	19.2	18.1	14.0	13.8	30.4	23.4	15.4	24.2	17.6	14.6	15.7	14.2	16.9	17.1	18.5	20.4	20.3	18.1	30.7	23.0	36.4	24.8	20.1	16.8	21.8	16.8	20.2	19.5	21.1	15.8	22.7	18.2	18.6	14.0	23.6	20.5	17.3	16.5	18.9	20.1	14.5	28.8	20.2	27.6	6.6	5.5	9.6	5.0	6.7	9.2	3.3	8.4	11.0	13.2	19.1	10.5	13.9	17.1	11.7	18.0	14.1	15.3	12.0	13.4	31.3	12.2	15.0	10.8	17.8	11.9	14.2	17.2	17.8	14.2	14.7	11.5	12.3	21.0	17.5	16.0	24.9	12.8	18.8	12.0	16.0	21.4	11.5	11.7	19.3	16.2	24.5	9.5	31.5	13.3	24.6	9.8	8.5	19.1	20.0	12.8	13.9	14.2	15.3	25.2	12.4	14.9	14.4	11.0	10.9	22.9	24.2	37.8	5.8	10.6	10.5	2.1	3.9	9.6	6.0	4.2	6.9	4.5	7.3	8.0	5.5	6.6	9.2	6.8	5.0	6.7	5.0	4.6	4.9	3.3	21.5	25.7	26.4	23.5	15.7	14.2	20.3	18.1	16.8	16.5
ZNF268	HZF3	ENSG00000090612	"Zinc finger protein 268"	Q14587	12	133181409-133214831	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001794	Approved		Approved	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA001794: "	"unprognostic (7.65e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.63e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.59e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.53e-3)"	8.8	13.5	9.3	13.0	10.3	4.6	13.4	11.2	13.0	11.7	9.0	8.5	13.3	6.2	11.1	14.7	11.8	12.6	10.4	7.9	9.0	8.2	13.5	17.3	10.1	13.2	7.9	8.8	19.7	9.6	20.6	14.2	17.6	11.1	15.7	7.8	9.6	9.9	10.4	6.0	8.0	8.0	12.0	8.2	11.4	9.6	9.6	8.5	12.9	16.6	11.2	9.3	12.0	9.4	10.0	7.4	5.7	8.0	10.6	15.7	5.1	5.1	9.1	16.6	14.6	7.4	10.5	11.7	7.6	8.8	7.3	6.2	7.8	3.8	6.3	12.0	9.1	4.9	8.2	9.9	9.2	0.2	6.7	12.7	4.2	9.9	7.5	10.7	10.3	13.4	9.7	8.9	14.4	8.5	8.7	6.1	12.4	6.4	4.4	5.2	13.0	0.4	4.1	6.4	5.6	4.1	12.1	12.8	10.4	15.7	5.5	7.1	14.3	9.1	9.3	8.3	10.4	2.8	7.1	2.1	3.1	9.8	4.6	5.7	8.7	1.7	4.9	5.7	8.5	4.9	5.7	10.0	9.6	10.7	7.4	8.2	15.7	10.7	1.5	10.6	8.0	5.9	4.9	5.1	9.3	10.3	11.2	13.0	9.0	8.2	7.9	8.8	11.1	8.5
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740903	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.7	9.8	9.0	18.6	13.1	25.5	7.9	20.2	12.3	10.8	11.1	30.6	9.4	16.0	9.0	8.4	14.5	11.4	9.5	6.7	9.8	7.3	8.4	10.1	9.6	21.7	21.3	11.2	13.5	10.9	11.0	11.6	7.4	12.6	10.2	8.8	8.1	11.3	11.4	11.4	18.5	15.3	6.8	9.9	22.2	12.2	6.4	18.4	11.1	10.1	8.1	15.1	9.5	10.3	2.9	2.0	4.5	1.9	5.0	10.1	2.4	5.0	4.2	3.4	8.9	2.8	3.9	6.1	3.4	2.1	3.2	1.2	5.4	5.3	6.6	4.4	3.6	9.2	4.3	3.8	2.3	4.1	23.2	5.9	7.9	2.1	5.4	5.7	7.8	5.3	5.1	4.3	3.5	4.8	10.8	5.7	1.4	7.0	7.3	13.1	2.5	9.5	11.7	3.8	4.4	4.0	2.9	9.3	7.8	7.5	6.8	4.2	9.2	8.3	5.4	5.3	7.2	4.1	2.9	20.5	6.6	3.5	4.2	9.5	5.2	4.3	1.7	2.8	10.1	1.9	4.8	2.0	5.5	7.6	1.8	2.9	5.6	7.2	4.5	5.0	1.2	2.0	4.0	2.4	9.0	13.1	20.2	11.3	9.8	7.3	21.3	11.2	12.6	18.4
ZNF280D	"FLJ20086, SUHW4, ZNF634"	ENSG00000137871	"Zinc finger protein 280D"	Q6N043	15	56630181-56734086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA030233	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus, Centrosome"	"HPA030233: AB_10602590"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.72e-2)"	16.5	15.7	10.5	9.2	13.3	22.8	16.5	23.0	18.8	21.1	14.3	14.2	12.6	8.1	21.2	9.0	12.0	18.2	9.9	11.4	10.3	7.0	11.0	14.0	11.4	9.8	11.3	14.9	27.2	16.9	14.4	28.0	12.2	16.9	18.1	12.4	8.5	18.8	11.7	22.0	9.8	11.2	24.8	16.3	11.1	14.6	8.4	14.5	46.3	13.6	8.4	10.0	23.6	19.6	6.1	5.9	10.0	4.1	3.0	4.3	1.8	8.7	5.0	9.2	14.1	9.3	13.1	6.8	13.5	9.6	5.7	6.5	3.5	9.1	14.8	5.7	9.5	6.5	4.6	3.6	6.8	7.5	2.7	1.5	8.2	5.4	9.3	13.2	4.5	8.5	4.9	3.9	5.5	12.3	7.6	17.2	8.6	6.2	8.8	1.5	0.0	4.0	2.8	15.2	10.5	6.6	10.2	7.4	13.5	11.3	7.0	4.3	7.7	12.3	10.8	8.3	12.6	7.6	10.8	9.0	13.5	0.0	9.3	19.7	8.9	10.0	4.1	5.4	3.6	3.7	3.6	6.1	3.4	3.1	5.9	5.5	3.5	4.3	0.6	3.0	3.2	5.9	3.0	1.8	10.5	13.3	23.0	18.8	10.3	7.0	11.3	14.9	16.9	14.5
ZNF282	HUB1	ENSG00000170265	"Zinc finger protein 282"	Q9UDV7	7	149195485-149226248	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024374	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA024374: AB_1851322"	"unprognostic (1.79e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.11e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	13.6	11.7	12.6	12.7	11.5	17.5	13.1	20.7	18.1	19.1	16.1	16.6	16.8	17.7	17.9	14.1	17.9	17.2	18.1	12.5	10.2	8.4	12.4	14.4	12.3	11.2	10.8	11.8	18.5	26.6	12.2	12.3	24.9	10.8	21.4	7.8	13.3	17.8	15.8	20.7	19.5	14.5	15.1	8.9	15.2	14.6	6.4	12.9	14.2	14.1	16.3	12.7	17.0	13.8	3.9	2.4	3.5	1.8	1.8	3.4	1.0	11.5	11.5	6.8	16.2	6.0	7.1	10.0	10.6	7.8	9.4	9.4	10.5	12.7	11.7	16.0	6.6	12.9	7.9	10.1	3.6	17.6	28.1	9.8	7.5	8.8	8.9	12.3	11.1	8.1	13.7	9.0	9.9	9.7	18.8	9.2	5.0	13.6	25.8	18.2	21.9	14.5	16.9	6.6	16.2	5.1	11.2	15.4	14.8	11.7	14.2	9.7	9.1	12.0	12.1	13.4	3.0	16.0	15.3	13.3	7.9	8.7	11.2	10.7	11.4	0.0	1.8	3.5	2.1	1.5	2.3	0.9	2.7	2.1	1.0	3.9	1.4	1.8	1.8	1.8	1.7	2.4	3.4	1.0	12.6	11.5	20.7	18.1	10.2	8.4	10.8	11.8	10.8	12.9
ZNF286B	"ZNF286C, ZNF286L, ZNF590"	ENSG00000249459	"Zinc finger protein 286B"	P0CG31	17	18658429-18682262	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA068125	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA068125: "	"unprognostic (3.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.20e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.20e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	0.7	0.9	1.4	1.2	1.4	0.8	1.5	6.5	2.8	2.0	1.2			0.3	3.4	1.8	2.3	1.9	1.1	0.8	1.5	1.8	1.6	0.2	0.7	1.2	1.4		5.4	0.6	1.3	1.4	1.0		1.4	1.4		0.8	1.4	2.9	1.4	0.9	1.9	1.5	1.3	1.2	1.1			1.0		1.6	1.4	1.7	3.0	0.9	1.1	1.7	3.2	4.2	1.0	3.1	2.7	5.4	5.3	2.1	3.4	4.2	2.8	0.8	1.3	1.1	6.4	0.4	4.4	1.7	2.3	3.6	5.8	2.2	2.8	1.9	6.1	2.9	2.1	1.1	2.6	0.0	2.5	3.8	2.1	6.2	3.1	3.2	1.9	0.4	2.9	1.1	6.6	2.0	2.2	0.9	3.1	8.1	0.1	1.0	1.0	3.1	9.6	4.3	1.4	2.5	3.9	1.3	3.1	1.7	6.4	4.6	4.4	2.1	2.6	0.2	1.6	1.3	3.9	1.1	0.8	0.5	3.4	0.9	3.0	2.1	3.2	3.8	0.7	3.0	3.9	4.2	0.9	3.2	1.7	0.9	3.5	1.0										
ZNF30	"DKFZp686N19164, FLJ20562, KOX28"	ENSG00000168661	"Zinc finger protein 30"	P17039	19	34926903-34945170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA030400	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030400: AB_10603245"	"unprognostic (3.04e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.10e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.42e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-2)"	3.4	5.2	11.1	2.6	10.9	0.7	5.9	21.4	11.6	5.3	3.9	5.0	2.9	4.2	4.5	3.4	3.4	7.0	2.6	5.0	7.0	5.4	4.6	6.5	6.0	5.1	10.0	6.5	5.6	6.9	6.4	7.7	3.3	6.6	5.8	4.5	5.8	4.6	5.2	5.3	5.6	3.9	5.1	7.2	5.4	4.8	3.9	8.3	2.4	4.4	2.0	5.1	3.8	4.0	3.4	1.3	2.8	0.4	6.9	7.2	1.8	3.7	8.2	3.5	8.8	6.4	4.1	0.1	3.6	2.6	3.4	3.7	5.8	1.2	0.0	4.8	2.3	2.3	10.1	5.2	4.2	0.0	4.8	2.7	4.5	4.4	3.2	3.6	2.5	3.5	4.6	3.4	4.5	5.2	8.8	0.0	5.3	2.8	2.6	1.6	4.9	4.3	3.4	2.7	0.9	2.5	3.2	4.6	6.7	0.0	0.1	3.4	3.3	1.0	3.8	7.1	3.7	2.6	4.9	2.4	11.6	1.0	1.4	0.0	4.1	2.8	0.1	0.1	4.8	0.4	4.7	3.4	3.8	2.2	1.3	2.1	7.2	7.2	0.0	6.9	0.0	1.2	3.4	1.8	11.1	10.9	21.4	11.6	7.0	5.4	10.0	6.5	6.6	8.3
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369478	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 6.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.3	7.1	14.2	15.3	13.7	9.9	12.2	24.7	17.7	12.5	8.9	10.4	9.2	7.1	12.7	11.1	7.0	9.0	7.1	7.6	12.8	6.3	7.3	8.3	9.2	23.6	15.4	9.4	13.2	8.6	14.6	8.0	7.9	11.4	10.2	8.2	7.9	7.9	8.6	8.6	11.7	10.0	9.2	9.0	14.6	6.8	39.2	16.8	10.0	13.7	4.7	23.6	9.8	10.9	6.3	0.9	0.4	0.7	0.7	1.4	0.5	16.1	4.1	11.9	19.7	10.4	9.4	5.8	7.0	9.3	8.5	7.5	4.2	2.1	25.8	4.0	9.3	7.4	13.2	6.2	11.2	6.7	6.7	7.1	5.2	6.8	5.2	12.6	5.8	6.0	6.5	7.2	6.4	6.6	9.5	12.9	9.0	5.7	3.8	8.1	5.3	3.9	4.7	11.5	4.1	4.8	3.9	10.9	6.7	5.5	4.8	5.8	6.0	17.7	6.6	12.1	6.0	8.0	7.0	7.7	6.2	18.4	3.8	9.7	6.7	0.0	0.7	0.0	1.4	0.5	0.4	1.4	1.2	0.9	0.9	6.3	0.9	1.0	0.4	0.7	0.4	0.7	1.2	0.5	14.2	13.7	24.7	17.7	12.8	6.3	15.4	9.4	11.4	16.8
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: , HPA046692: "	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favourable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favourable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	8.8	9.7	7.7	5.4	10.9	0.4	10.1	10.6	15.4	13.1	8.6	7.9	9.5	6.9	12.7	10.8	6.8	9.2	11.5	13.3	8.4	6.9	9.5	7.0	7.9	6.7	8.8	7.0	14.8	6.9	15.0	18.0	8.6	11.8	12.3	8.6	8.6	8.2	15.5	7.7	5.0	7.9	9.7	10.7	8.7	7.6	8.2	12.5	4.3	13.6	6.7	7.2	11.8	8.4	11.2	7.9	10.5	11.2	17.6	11.4	4.9	5.7	4.4	17.3	19.8	11.4	15.2	6.2	7.7	10.2	10.8	13.1	8.5	3.6	7.0	18.6	6.7	7.3	12.8	5.0	13.5	10.8	11.6	12.3	5.7	8.3	12.9	0.0	11.2	9.3	17.7	7.1	8.1	9.3	14.1	7.5	11.8	3.3	8.6	10.3	5.0	5.3	9.7	12.2	9.9	6.7	9.2	14.0	14.8	9.2	8.7	16.2	8.1	8.0	9.2	18.0	7.2	7.3	7.8	7.9	15.8	6.7	3.9	2.0	18.1	3.3	8.7	10.5	11.4	7.4	8.3	11.2	5.8	7.4	7.0	10.5	6.8	9.9	8.3	17.6	11.2	7.9	4.4	4.9	7.7	10.9	10.6	15.4	8.4	6.9	8.8	7.0	11.8	12.5
ZNF324	"ZF5128, ZNF324A"	ENSG00000083812	"Zinc finger protein 324"	O75467	19	58467045-58475436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA039774	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA039774: AB_10673149"	"unprognostic (8.60e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (4.74e-5)"	"unprognostic (6.39e-2)"	"prognostic favourable (1.34e-7)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (3.56e-1)"	7.7	8.0	8.9	11.5	10.8	12.6	7.4	15.8	14.0	9.8	8.8	11.9	10.2	8.5	12.0	9.1	12.7	10.5	9.2	7.6	9.9	9.3	6.5	10.5	7.7	10.5	10.4	11.5	14.6	15.0	10.2	12.7	7.1	7.1	10.6	6.0	7.2	11.2	13.3	5.8	11.9	7.3	8.2	9.3	8.3	8.6	8.0	9.7	16.8	11.9	8.1	10.7	9.3	7.2	6.4	6.4	13.1	5.0	6.0	11.8	3.4	4.0	5.1	3.5	5.3	4.0	3.5	3.8	3.3	4.1	3.3	3.0	4.5	2.0	6.3	3.1	2.7	5.1	4.5	4.5	1.6	5.5	34.8	4.4	3.9	2.1	3.2	7.3	5.2	2.6	5.6	4.7	2.2	2.3	6.2	4.1	3.6	3.3	6.5	4.0	2.8	7.8	7.0	4.4	4.0	2.4	8.2	7.1	5.6	3.6	5.8	2.5	2.9	5.3	4.1	10.0	2.2	3.5	5.6	6.0	6.0	3.2	5.0	3.6	3.1	2.3	4.7	7.2	9.5	5.0	10.7	5.3	7.6	10.5	3.2	6.4	11.8	8.9	13.1	6.0	3.9	6.4	7.2	3.4	8.9	10.8	15.8	14.0	9.9	9.3	10.4	11.5	7.1	9.7
ZNF324B	FLJ45850	ENSG00000249471	"Zinc finger protein 324B"	Q6AW86	19	58451604-58457833	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"NK-cell: 8.3"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 8.3"									HPA023400	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023400: AB_1859195"	"unprognostic (2.75e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (2.83e-4)"	"unprognostic (5.58e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.94e-2)"	7.4	6.2	6.9	8.3	12.4	5.0	9.0	11.4	12.6	8.7	5.9	7.6	9.8	5.9	8.5	5.0	8.4	9.0	6.8	4.7	6.6	5.5	6.2	6.6	7.3	6.8	9.1	7.0	10.2	10.1	8.0	8.4	4.8	8.8	7.5	6.1	8.4	8.9	8.5	8.2	11.2	6.0	7.4	5.3	10.3	8.0	11.3	9.3	9.4	8.0	6.0	6.4	9.3	6.9	1.1	0.6	1.3	1.0	8.3	1.3	0.7	4.2	7.1	3.9	6.4	2.8	2.4	2.8	3.8	2.8	3.1	2.3	2.5	1.8	5.8	2.4	2.2	3.6	5.1	3.5	2.4	5.8	28.8	5.0	5.3	1.0	2.9	8.1	7.4	2.4	3.6	3.5	3.0	2.2	7.2	3.5	3.2	2.8	6.0	1.9	2.1	4.1	5.7	5.1	3.4	2.0	8.5	9.3	5.3	3.6	5.9	0.9	2.2	2.3	2.6	7.5	1.9	4.0	6.1	7.7	6.9	4.3	3.0	3.5	2.9	0.0	1.0	0.1	1.3	0.6	0.9	0.5	0.6	0.9	0.6	1.1	1.3	0.9	1.3	8.3	0.4	0.6	0.4	0.7	6.9	12.4	11.4	12.6	6.6	5.5	9.1	7.0	8.8	9.3
ZNF334	bA179N14.1	ENSG00000198185	"Zinc finger protein 334"	Q9HCZ1	20	46499630-46513559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 12.9;BEWO: 16.2;NTERA-2: 8.7;SCLC-21H: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.7;plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.6;NK-cells: 2.7"	"Low region specificity"	"Detected in all"							HPA050022	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA050022: "	"unprognostic (3.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.71e-3)"	3.1	7.3	11.1	2.2	14.3	1.9	9.5	18.2	12.0	6.4	2.6	8.1	11.5	2.9	9.2	13.4	2.4	12.1	5.8	2.1	9.8	7.8	6.8	4.1	4.7	2.1	5.8	6.9	22.5	7.5	2.9	20.4	7.0	11.5	12.8	3.5	7.0	6.8	10.0	1.5	3.0	3.8	4.9	7.6	3.1	7.0	8.3	8.8	2.7	10.8	1.7	1.8	5.2	4.5	0.4	3.6	0.2	0.5	2.7	0.1	0.1	0.0	0.0	12.9	0.1	0.9	0.1	16.2	1.1	0.1	1.0	0.1	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.2	0.5	0.0	2.7	4.1	0.1	4.6	3.5	0.1	0.0	4.2	0.0	1.1	0.0	0.1	2.7	0.0	0.1	0.0	0.0	7.3	8.7	1.1	0.0	0.0	0.0	3.5	3.1	10.8	6.1	0.0	0.3	0.2	0.0	3.6	0.0	0.1	5.9	0.1	0.0	1.0	5.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.2	0.2	0.1	0.0	0.1	2.7	0.0	3.6	0.0	0.1	11.1	14.3	18.2	12.0	9.8	7.8	5.8	6.9	11.5	8.8
ZNF34	KOX32	ENSG00000196378	"Zinc finger protein 34"	Q8IZ26	8	144773114-144787345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA053925, HPA060755, HPA066805"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA053925: , HPA060755: , HPA066805: "	"unprognostic (2.54e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	9.0	5.7	12.3	4.1	11.5	4.6	8.6	28.5	14.4	10.0	9.4	12.6	7.8	3.6	10.0	8.0	6.3	10.4	6.6	7.5	13.4	7.8	6.4	6.5	7.5	5.8	17.2	13.8	17.0	7.8	12.5	11.5	7.6	12.2	8.7	6.0	8.3	5.6	12.7	5.9	8.0	5.4	10.7	11.8	6.0	5.9	7.1	16.0	4.1	11.1	1.8	4.7	8.7	7.8	7.2	10.4	12.7	15.2	5.5	8.5	5.0	3.0	5.2	8.8	6.6	7.5	7.4	2.3	2.8	6.1	7.2	6.1	1.2	5.0	4.9	5.4	7.2	3.1	5.0	5.8	5.4	4.8	4.3	9.5	8.1	4.0	6.8	2.5	4.9	7.8	6.7	5.8	11.7	4.9	6.3	4.1	6.3	7.7	5.5	3.9	6.4	5.5	5.0	3.5	5.9	4.0	3.1	8.3	6.2	6.6	4.6	4.4	5.3	3.2	3.4	6.7	5.9	5.6	5.5	5.1	1.7	5.7	4.9	4.1	7.9	8.1	7.0	12.7	7.4	6.4	6.5	6.8	6.9	8.5	10.4	7.2	4.9	7.4	1.0	5.5	15.2	4.9	5.4	5.0	12.3	11.5	28.5	14.4	13.4	7.8	17.2	13.8	12.2	16.0
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178694605-178730702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: "	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favourable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavourable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	14.0	7.0	13.0	12.1	13.6	14.2	14.2	13.3	14.4	12.6	15.0	6.7	11.4	7.1	13.7	13.3	10.4	11.7	9.8	14.5	13.2	9.3	18.0	6.2	10.8	12.7	16.7	16.1	10.9	15.0	11.7	14.1	14.0	13.4	13.3	10.0	7.1	8.8	15.1	11.9	12.3	10.6	13.6	12.9	17.1	10.4	14.0	14.4	13.1	15.1	8.6	14.2	17.0	25.1	5.7	5.3	15.0	5.8	6.0	6.4	3.6	4.2	3.3	7.0	18.5	12.2	9.9	29.0	4.9	6.6	6.9	7.4	4.9	7.2	5.7	6.5	4.5	8.5	2.6	21.0	10.6	7.6	8.0	1.7	4.2	0.6	9.3	0.0	4.8	7.7	13.5	6.0	12.4	6.5	1.4	0.0	9.9	8.6	8.5	5.7	6.1	8.7	6.4	1.2	3.6	6.4	4.3	7.7	8.4	6.2	7.1	9.5	5.8	8.4	5.0	7.8	5.1	4.4	4.2	1.9	3.9	3.6	0.2	1.3	9.7	4.4	5.8	14.5	5.1	3.8	6.4	5.7	4.6	5.7	5.3	3.6	5.3	3.8	15.0	6.0	3.9	1.9	4.1	3.6	13.0	13.6	13.3	14.4	13.2	9.3	16.7	16.1	13.4	14.4
ZNF354C	KID3	ENSG00000177932	"Zinc finger protein 354C"	Q86Y25	5	179060415-179083537	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030904	Uncertain		Supported	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"HPA030904: AB_10603842"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.56e-4)"	"unprognostic (4.76e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.83e-1)"	6.4	4.9	6.6	4.6	7.9	1.2	8.2	12.9	8.9	9.3	7.4	7.7	6.5	2.6	10.6	4.1	5.6	7.8	5.4	5.6	7.7	3.4	4.6	3.0	6.6	6.5	9.4	5.3	15.0	5.3	3.4	3.5	6.5	6.7	9.0	3.5	5.7	4.3	7.3	5.5	4.1	5.1	8.8	5.7	6.4	5.3	4.5	9.3	5.5	9.8	3.1	6.8	6.5	10.5	1.3	0.9	0.8	2.0	1.5	3.3	1.5	0.8	1.2	9.6	15.5	5.1	8.2	0.0	4.3	3.8	4.8	5.5	0.0	1.9	0.0	5.2	4.7	3.0	0.0	1.5	9.2	0.0	0.1	0.0	0.4	0.0	4.8	0.0	2.2	6.1	1.4	4.8	0.0	2.3	0.1	0.0	5.7	0.5	8.8	0.0	6.9	0.0	0.0	0.0	0.0	1.8	0.3	6.0	10.0	6.9	0.1	4.6	4.0	3.6	2.8	0.0	6.5	4.2	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.8	0.5	0.5	2.2	0.9	2.2	1.3	2.9	2.0	0.9	1.3	3.3	2.8	0.0	1.5	2.0	0.1	1.7	1.5	6.6	7.9	12.9	8.4	7.7	3.4	9.4	5.3	6.7	9.3
ZNF385A	"DKFZp586G1122, Hzf, ZFP385, ZNF385"	ENSG00000161642	"Zinc finger protein 385A"	Q96PM9	12	54369133-54391298	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 81.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.8;HBEC3-KT: 27.4;HEL: 34.4;hTCEpi: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 16.6;monocytes: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039799			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039799: AB_10795117"	"unprognostic (8.56e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (5.20e-4)"	"unprognostic (6.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (9.75e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.07e-3)"	23.7	4.3	23.6	16.3	27.3	16.8	7.9	13.2	32.5	7.9	5.7	12.8	2.3	4.8	3.2	10.7	28.1	6.2	8.9	4.3	18.4	22.6	2.3	3.8	11.6	8.9	31.8	15.4	2.0	2.0	13.8	8.5	12.6	19.4	10.3	5.4	35.5	8.9	10.1	5.9	81.6	5.7	8.7	16.4	13.9	4.4	2.1	16.1	5.5	18.1	21.9	21.9	25.8	14.9	0.8	16.6	1.6	16.8	0.0	0.2	6.6	0.8	3.4	5.2	6.5	6.0	4.0	14.3	0.6	2.6	2.7	2.3	6.9	2.5	1.9	2.3	1.4	28.8	1.9	27.4	0.9	1.8	2.7	34.4	2.2	1.3	2.7	0.5	24.1	3.5	30.9	3.0	7.7	1.6	16.5	0.1	1.2	15.3	1.6	4.9	2.9	2.7	6.1	0.4	6.7	2.1	22.5	2.3	10.4	0.2	19.5	1.4	23.0	14.4	1.7	1.5	3.4	1.7	1.7	0.5	0.1	1.6	6.1	1.6	3.8	1.6	15.3	0.0	0.0	16.8	0.0	0.6	0.0	0.0	16.6	0.8	0.0	0.2	1.2	0.0	11.9	1.6	0.0	6.6	23.6	27.3	13.2	32.5	18.4	22.6	31.8	15.4	19.4	16.1
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99486519-99500324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favourable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favourable (1.09e-4)"	11.3	8.3	10.0	11.5	11.8	77.5	12.2	16.4	13.2	10.8	10.9	11.7	8.8	10.7	11.0	7.7	12.2	11.2	9.3	10.4	7.9	6.2	9.4	9.5	12.6	12.2	11.2	6.6	14.3	12.0	7.9	16.2	8.4	9.7	13.0	9.1	10.1	10.1	9.0	14.8	13.6	13.5	9.1	9.1	19.1	10.9	9.5	11.0	15.6	11.4	8.8	17.5	11.9	11.6	17.6	22.3	31.6	17.0	24.3	29.3	17.0	7.7	7.7	5.2	10.9	8.1	5.6	10.3	6.6	8.8	7.7	7.5	8.1	8.5	9.2	9.5	6.8	7.5	7.0	8.4	7.6	6.7	9.2	9.1	9.1	8.9	6.5	12.9	15.9	7.3	7.3	7.5	8.0	8.7	13.0	18.5	7.0	14.5	13.3	21.2	11.6	9.2	7.6	5.7	16.1	8.3	11.1	6.2	12.9	7.7	18.7	12.4	4.8	16.1	9.1	9.3	9.4	13.4	8.2	15.2	15.9	15.0	6.6	13.1	9.8	31.6	14.3	24.1	23.1	17.0	24.2	17.6	23.6	25.0	15.6	17.2	29.3	23.1	26.3	24.3	16.7	22.3	25.2	17.0	10.0	11.8	16.4	13.2	7.9	6.2	11.2	6.6	9.7	11.0
ZNF395	"DKFZp434K1210, HDBP2, PBF, PRF-1"	ENSG00000186918	"Zinc finger protein 395"	Q9H8N7	8	28345585-28402701	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049382, HPA076275"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA049382: , HPA076275: "	"unprognostic (1.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (9.35e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (5.71e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.42e-2)"	17.4	10.7	10.0	13.3	10.9	18.6	19.0	7.4	10.1	16.8	22.5	9.7	13.4	12.1	12.0	11.9	27.2	16.9	14.1	15.0	10.4	5.4	13.1	19.5	11.3	18.0	9.0	6.8	33.8	27.8	9.8	9.5	19.6	7.6	22.1	8.3	13.7	21.7	11.1	13.8	23.2	16.3	13.8	8.8	11.9	14.2	12.3	10.8	9.6	18.2	10.2	25.3	27.5	27.6	13.7	6.4	10.6	4.2	3.3	7.2	2.1	48.7	7.0	6.7	18.4	5.1	7.5	19.3	6.0	10.5	4.8	11.5	11.1	8.6	23.3	20.7	9.3	10.6	6.0	14.7	9.5	3.8	4.7	5.8	1.4	2.2	5.3	2.3	2.5	13.0	20.3	0.8	12.7	2.5	5.9	5.2	6.7	8.3	10.9	7.5	10.4	8.2	10.7	7.2	7.7	11.2	9.7	18.5	19.2	1.5	3.7	9.6	7.3	5.8	0.7	10.3	12.5	5.5	2.5	6.4	3.3	15.3	27.1	4.8	9.0	6.7	4.2	10.6	4.8	0.8	4.6	10.0	5.6	5.6	1.6	13.7	7.2	4.9	1.8	3.3	0.6	6.4	2.1	2.1	10.0	10.9	7.4	10.1	10.4	5.4	9.0	6.8	7.6	10.8
ZNF397	"MGC13250, ZNF47, ZSCAN15"	ENSG00000186812	"Zinc finger protein 397"	Q8NF99	18	35241030-35267133	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026087	Uncertain		Approved	"Nucleoli,Plasma membrane,Microtubules,Cytosol"				"Nucleoli, Plasma membrane, Cytosol"	Microtubules	"HPA026087: AB_1859243"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (9.44e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.09e-3)"	15.1	17.7	20.3	16.8	31.1	5.7	20.6	23.9	26.4	16.2	15.0	27.9	16.7	13.3	22.7	16.5	13.4	15.2	12.9	14.6	20.2	13.8	14.9	12.7	13.6	18.8	34.8	19.3	23.6	17.1	25.3	24.8	14.7	25.6	18.4	18.0	13.8	17.5	16.3	15.0	17.2	15.9	18.9	30.5	19.0	16.7	11.9	35.1	22.0	20.2	8.3	19.2	17.3	16.8	13.3	8.1	12.4	9.4	4.8	9.4	2.2	2.9	5.8	13.8	12.5	15.3	13.0	6.6	6.1	6.1	3.0	4.0	2.1	4.2	15.1	5.5	4.8	8.1	8.9	6.6	4.3	9.5	5.5	0.6	7.6	6.1	5.1	7.2	5.5	5.8	9.0	3.6	10.6	1.9	8.8	10.6	7.8	6.4	12.1	5.6	11.9	2.3	12.8	4.0	10.7	6.3	7.9	15.0	12.9	9.9	5.3	5.9	9.2	5.4	3.0	10.2	5.7	3.4	2.7	17.2	6.4	8.8	9.0	5.1	9.6	9.4	5.1	8.4	6.6	8.0	4.8	10.3	6.3	5.3	3.6	13.3	9.4	6.5	12.4	4.8	9.4	8.1	3.2	2.2	20.3	31.1	23.9	26.4	20.2	13.8	34.8	19.3	25.6	35.1
ZNF408	FLJ12827	ENSG00000175213	"Zinc finger protein 408"	Q9H9D4	11	46700818-46705912	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017892	Uncertain		Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA017892: AB_1859248"	"unprognostic (7.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (6.59e-5)"	"unprognostic (3.01e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.99e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-2)"	7.5	5.8	6.6	7.9	7.8	20.8	10.4	11.9	8.4	9.3	11.4	6.9	5.8	8.6	9.9	4.3	9.7	8.1	8.6	8.8	6.6	5.3	6.2	14.8	5.6	10.7	7.4	3.7	9.6	16.4	4.2	6.6	11.7	4.9	9.6	5.0	6.6	13.8	8.0	11.3	11.3	8.2	6.1	8.4	9.2	8.9	13.1	6.5	14.2	10.8	6.6	9.9	10.4	13.0	11.9	9.9	10.0	11.1	7.6	14.6	9.3	4.0	9.9	4.7	8.3	5.9	5.1	12.1	5.4	7.7	11.2	8.4	8.9	4.6	6.5	5.1	6.6	10.5	5.8	10.8	4.0	4.9	12.0	6.1	6.4	10.6	11.1	6.7	8.9	10.3	10.6	5.7	8.0	5.5	9.5	5.8	4.6	13.2	7.7	12.8	19.2	12.1	8.6	7.0	9.9	5.8	10.8	6.6	8.6	10.7	13.5	8.5	11.8	11.1	6.2	11.1	7.3	9.1	10.8	8.3	7.2	9.5	7.2	7.3	8.9	5.2	10.4	10.0	12.7	11.1	9.7	9.3	12.0	14.6	9.9	11.9	13.7	10.4	9.6	7.6	8.1	7.7	10.7	9.3	6.6	7.8	11.9	8.4	6.6	5.3	7.4	3.7	4.9	6.5
ZNF414	"MGC15716, Zfp414"	ENSG00000133250	"Zinc finger protein 414"	Q96IQ9	19	8509678-8514164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053769	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053769: "	"unprognostic (7.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.26e-3)"	"prognostic favourable (4.17e-4)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.67e-6)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.29e-2)"	"prognostic favourable (4.59e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (8.71e-4)"	16.6	16.2	14.3	13.6	22.7	20.8	10.6	17.6	28.6	13.2	10.9	22.4	5.6	21.4	16.6	10.0	11.6	11.6	9.7	9.9	14.1	11.4	12.0	13.1	10.7	15.8	15.5	14.8	16.7	13.7	9.2	15.3	14.0	17.3	15.8	4.6	13.4	20.5	14.1	23.6	25.5	16.6	7.7	12.5	22.8	19.1	13.6	20.3	19.9	15.7	6.1	13.5	11.8	12.3	3.0	3.4	5.4	2.1	2.5	2.7	1.2	5.4	4.7	2.6	4.1	0.7	1.6	5.7	4.1	1.6	2.7	2.5	4.1	2.7	7.5	12.0	1.3	7.6	0.8	3.4	0.4	6.7	18.9	4.7	4.3	4.9	3.7	4.1	6.4	3.0	2.5	2.2	0.8	1.1	6.2	11.1	1.7	6.7	9.2	23.9	7.7	13.4	10.8	1.3	7.5	1.9	4.5	8.9	13.9	4.5	3.5	3.7	6.6	4.8	4.3	8.0	4.1	11.6	5.3	16.2	6.7	5.9	6.4	3.5	4.3	3.0	1.6	0.8	1.8	1.4	1.0	2.5	2.7	2.7	1.6	3.0	2.6	2.6	5.4	2.5	2.1	3.4	1.4	1.2	14.3	22.7	17.6	28.6	14.1	11.4	15.5	14.8	17.3	20.3
ZNF416	FLJ20557	ENSG00000083817	"Zinc finger protein 416"	Q9BWM5	19	57571566-57578927	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA063318			Approved	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA063318: "	"unprognostic (1.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.57e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.37e-2)"	"prognostic favourable (1.20e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-1)"	6.1	6.8	7.0	5.1	10.7	5.0	8.7	13.0	10.7	6.8	6.1	7.0	5.9	3.2	6.9	9.5	8.9	8.2	4.4	6.1	6.5	5.3	6.1	4.6	6.7	7.1	5.3	8.6	10.9	3.9	8.7	7.0	6.6	5.8	6.7	4.9	7.0	6.3	7.6	6.6	13.5	4.8	8.2	3.8	6.3	4.9	9.3	8.1	12.8	8.8	4.8	9.1	7.7	6.9	9.7	4.4	1.9	2.8	9.5	9.4	4.3	3.2	3.2	6.9	5.4	4.2	6.0	4.6	3.3	6.0	6.5	4.2	2.3	1.7	2.2	2.5	4.2	1.2	4.0	5.6	8.1	3.5	16.1	5.3	3.6	1.8	7.5	4.7	3.5	6.0	5.9	4.1	8.7	4.5	0.7	1.8	8.7	1.3	9.8	2.2	8.0	6.0	4.9	10.2	4.8	4.5	7.0	4.9	5.6	5.9	3.1	3.0	2.8	5.7	3.3	7.1	3.4	2.3	4.9	5.7	9.3	6.1	1.6	3.1	4.3	1.1	2.8	1.9	4.8	2.1	8.9	7.4	6.8	7.2	4.4	9.7	9.4	6.8	0.9	9.5	1.8	3.9	3.1	4.3	7.0	10.7	13.0	10.7	6.5	5.3	5.3	8.6	5.8	8.1
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369442	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.9;HSkMC: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	14.5	18.6	10.1	4.7	13.0	2.9	12.9	13.6	15.8	10.7	8.7	11.8	8.6	6.3	15.1	17.5	18.4	10.2	11.2	11.7	9.9	6.1	6.7	4.3	7.8	5.6	12.9	9.6	20.3	8.1	11.6	6.5	8.5	11.3	12.1	6.9	6.3	16.9	13.4	7.2	15.6	6.1	12.7	12.6	8.0	6.8	10.4	10.0	5.7	12.3	9.7	8.0	12.5	11.2	1.6	2.8	1.6	2.1	6.6	2.3	1.6	2.7	1.7	6.4	3.4	7.2	14.9	3.0	2.4	3.4	3.2	3.8	1.0	2.4	1.8	2.8	3.5	3.4	11.3	4.3	3.5	2.3	2.4	2.0	3.6	1.6	2.9	0.8	1.4	27.2	6.1	2.7	3.2	4.6	2.4	1.3	3.4	1.3	2.0	1.5	0.2	2.8	2.7	2.7	1.8	2.6	7.1	2.9	3.7	7.0	3.6	2.7	2.0	1.0	3.6	2.8	2.1	2.2	1.4	2.1	2.5	1.6	2.2	1.6	2.2	0.0	1.8	1.6	2.0	2.1	2.0	1.3	1.4	2.1	2.8	1.6	2.3	2.0	1.3	6.6	2.0	0.4	2.2	1.6	10.1	13.0	13.6	15.8	9.9	6.1	12.9	9.6	11.3	10.0
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.1;HUVEC TERT2: 14.3;U-937: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	21.8	5.8	9.8	10.0	10.2	7.9	9.7	11.8	9.9	10.6	12.9	13.0	2.6	6.2	22.6	11.3	8.3	10.2	9.2	13.8	9.3	6.2	6.2	8.6	12.0	7.1	10.1	6.6	10.2	4.5	6.6	17.3	6.4	9.6	9.0	6.9	7.7	9.5	9.6	29.1	8.9	7.6	14.3	8.6	13.6	8.3	10.1	11.9	7.7	15.8	8.7	5.2	10.5	12.1	3.1	3.1	14.1	7.8	3.8	3.9	3.5	2.7	2.7	2.4	2.1	14.1	9.9	1.3	2.2	3.2	3.4	4.3	0.1	3.3	3.7	2.6	3.8	0.7	1.2	1.6	4.9	8.5	0.9	1.6	1.5	0.1	7.9	1.2	1.7	4.7	2.9	4.9	2.8	14.3	3.1	2.6	4.7	2.0	4.2	7.1	0.2	1.1	1.9	3.4	2.1	4.8	0.7	1.7	1.9	1.1	0.4	1.5	1.1	12.0	5.9	1.6	2.7	4.6	2.7	0.6	1.0	0.0	3.1	18.8	1.1	1.4	7.8	3.3	2.3	7.4	1.7	1.2	1.8	3.0	2.4	3.1	3.6	2.0	14.1	3.8	4.4	3.1	3.9	3.5	9.8	10.2	11.8	9.9	9.3	6.2	10.1	6.6	9.6	11.9
ZNF44	"KOX7, ZNF504, ZNF55, ZNF58"	ENSG00000197857	"Zinc finger protein 44"	P15621	19	12224686-12294887	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003146	Supported		Approved	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA003146: AB_1080723"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.63e-2)"	"prognostic favourable (8.74e-4)"	"unprognostic (8.39e-2)"	"prognostic favourable (7.54e-4)"	"unprognostic (5.65e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.56e-3)"	"unprognostic (7.30e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.69e-2)"	"prognostic favourable (9.21e-6)"	10.5	8.4	9.6	7.3	13.1	20.2	13.6	19.3	9.8	9.8	11.6	7.9	20.8	8.2	9.6	13.2	10.3	9.5	8.1	7.0	8.5	4.6	11.7	15.2	9.6	9.6	12.2	6.9	15.9	11.1	8.7	12.1	7.0	9.4	11.1	13.0	9.1	9.2	18.1	17.3	15.4	11.1	14.1	11.6	13.9	9.6	13.8	12.8	6.5	11.3	6.5	10.5	10.7	10.8	4.7	3.1	15.1	3.0	11.5	9.5	3.5	3.5	1.0	2.7	4.8	2.7	2.7	11.8	5.2	2.3	8.2	7.3	4.8	2.0	3.6	6.4	4.9	3.8	3.5	3.6	7.1	0.0	3.2	3.4	4.7	12.7	3.8	0.0	9.2	2.9	5.6	5.0	6.5	3.2	2.2	0.7	5.2	3.7	5.2	5.9	2.7	6.1	3.5	6.1	4.4	4.9	8.5	3.1	3.7	6.5	2.5	1.6	5.4	5.7	3.7	9.9	2.6	9.6	4.4	7.6	9.5	3.4	0.2	3.1	2.9	9.8	1.6	15.1	8.0	3.0	9.4	4.7	8.6	8.6	1.4	3.2	9.5	9.2	5.3	11.5	3.0	3.1	5.7	3.5	9.6	13.1	19.3	9.8	8.5	4.6	12.2	6.9	9.4	12.8
ZNF445	"ZKSCAN15, ZNF168, ZSCAN47"	ENSG00000185219	"Zinc finger protein 445"	P59923	3	44431720-44477670	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006678	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA006678: AB_10603329"	"unprognostic (7.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.05e-1)"	6.8	6.4	8.3	6.4	10.9	4.5	7.5	16.5	10.9	8.6	7.1	11.7	8.0	5.1	13.6	7.7	5.2	8.3	6.1	6.3	7.7	7.0	6.3	7.5	6.7	6.6	11.3	10.5	13.0	7.6	16.1	13.9	7.1	7.9	8.6	6.6	9.9	8.1	8.2	11.2	8.2	5.7	12.3	6.6	7.0	7.3	6.5	8.9	14.2	6.9	4.8	8.1	6.7	8.2	1.1	1.1	4.1	2.5	1.9	1.5	0.5	2.5	2.9	9.1	7.1	5.1	5.2	4.1	3.5	2.9	5.3	5.3	4.4	2.2	4.5	2.2	3.5	2.1	6.1	2.3	6.4	4.9	2.3	8.3	5.9	4.3	3.2	10.4	7.0	3.6	3.0	5.9	3.7	3.7	6.4	3.4	4.2	1.6	9.9	7.1	6.1	2.6	4.4	5.7	2.2	2.8	5.2	4.5	5.6	5.4	2.8	1.4	5.2	4.6	4.4	7.5	6.6	4.5	4.4	2.7	2.0	3.8	2.7	5.2	4.5	2.7	1.3	2.3	1.2	0.8	1.1	0.7	0.9	0.9	0.9	1.1	1.5	1.1	4.1	1.9	2.5	1.1	0.4	0.5	8.3	10.9	16.5	10.9	7.7	7.0	11.3	10.5	7.9	8.9
ZNF449	"FLJ23614, ZSCAN19"	ENSG00000173275	"Zinc finger protein 449"	Q6P9G9	X	135344796-135363152	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018079	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA018079: AB_1859277"	"unprognostic (5.51e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.61e-2)"	"unprognostic (4.22e-2)"	13.7	15.8	5.3	6.7	10.4	1.9	11.6	7.5	10.8	10.1	7.2	6.0	4.8	5.0	14.0	10.9	7.5	6.0	8.6	8.3	5.0	6.1	6.1	5.0	7.3	5.8	6.3	9.6	9.7	16.1	12.5	9.8	11.0	12.2	9.6	5.5	6.6	8.6	7.5	7.6	5.8	5.3	12.4	5.0	9.5	7.6	4.8	4.7	5.3	10.6	4.6	6.4	12.1	8.9	1.5	2.6	3.6	6.6	5.6	5.7	2.2	2.8	4.2	8.5	7.0	7.8	15.6	4.2	5.6	4.3	3.6	8.8	1.4	3.9	1.7	7.3	4.4	3.3	6.0	2.5	5.8	2.4	5.0	2.4	4.1	2.1	5.9	1.9	3.6	5.9	7.5	3.0	9.0	6.8	2.3	2.0	10.2	1.6	2.4	2.1	2.9	4.6	2.0	5.7	2.7	5.3	1.7	2.0	5.1	1.3	4.1	4.2	3.0	2.1	6.6	8.3	3.1	5.6	4.9	1.6	1.9	1.4	3.3	3.2	5.3	1.7	2.7	3.6	3.0	3.4	5.7	1.5	2.7	4.1	2.6	1.1	2.6	2.6	0.6	5.6	6.6	1.5	2.4	2.2	5.3	10.4	7.5	10.8	5.0	6.1	6.3	9.6	12.2	4.7
ZNF484	"BA526D8.4, FLJ33884"	ENSG00000127081	"Zinc finger protein 484"	Q5JVG2	9	92845031-92878038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA028973	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028973: AB_10610703"	"unprognostic (5.52e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.84e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.77e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.51e-1)"	6.5	6.6	9.9	5.4	14.6	10.1	6.5	33.0	13.9	7.7	4.8	7.8	4.7	3.7	7.0	5.3	4.2	6.2	4.7	4.9	11.7	7.0	7.3	5.2	5.8	6.6	12.5	7.1	9.1	4.5	12.1	14.0	7.9	12.6	7.0	5.2	4.6	5.0	6.3	3.7	4.2	5.0	6.2	17.1	7.7	6.0	4.8	13.5	2.8	9.0	1.9	7.9	7.3	5.8	5.6	2.5	5.3	3.5	4.5	7.4	3.0	4.0	5.0	6.6	4.2	3.4	4.2	0.0	3.3	5.4	6.0	6.5	1.6	3.1	3.5	3.0	2.7	6.7	4.8	5.0	6.3	5.6	2.1	3.0	4.0	3.3	5.3	2.5	5.5	4.7	3.8	6.5	6.9	5.1	3.2	14.2	6.4	4.1	3.6	1.1	5.4	2.5	3.0	8.0	2.6	3.2	4.6	4.6	4.1	5.9	1.7	3.3	0.4	2.0	5.5	5.4	5.1	2.8	2.4	5.4	2.7	2.1	3.5	2.0	4.2	1.4	2.5	5.3	5.3	3.5	6.5	3.7	5.4	4.4	2.2	5.6	7.4	6.7	1.4	4.5	3.1	2.5	4.4	3.0	9.9	14.6	33.0	13.9	11.7	7.0	12.5	7.1	12.6	13.5
ZNF487	"KRBO1, ZNF487P"	ENSG00000243660	"Zinc finger protein 487"	B1APH4	10	43436841-43483179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 32.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA037820			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA037820: AB_10697083"	"unprognostic (1.97e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.97e-4)"	"unprognostic (5.85e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.92e-2)"	4.1	2.7	4.8	2.7	5.3	5.1	3.9	11.1	9.1	4.6	3.5	3.3	2.2	3.3	5.1	3.1	2.8	7.9	4.9	3.2	6.6	5.0	3.3	3.1	4.0	2.9	5.6	7.4	6.1	2.3	3.7	6.9	2.6	11.2	3.3	2.7	4.0	2.5	4.0	1.7	3.3	3.5	4.2	8.1	3.1	3.0	32.1	6.4	4.3	4.4	2.0	2.9	4.3	3.4	3.2	5.1	13.9	3.9	3.5	4.7	2.6	2.4	2.3	2.9	3.0	3.6	7.2	0.7	4.0	6.9	3.7	4.0	3.6	6.6	6.2	0.7	4.7	3.9	0.9	1.5	4.6	0.6	1.5	1.9	0.6	2.0	4.5	1.9	2.8	7.2	3.4	6.0	4.6	1.3	1.0	1.2	2.7	4.1	3.9	1.6	0.8	2.5	2.0	1.0	2.4	8.3	2.6	2.8	1.9	3.4	2.0	2.2	3.1	2.3	2.0	3.4	2.4	1.9	1.1	0.5	1.6	6.7	8.2	2.7	1.3	2.5	3.9	5.8	4.7	2.8	4.0	2.8	3.5	4.3	5.1	3.2	3.0	3.6	13.9	3.5	1.5	3.9	1.8	2.6	4.8	5.3	11.1	9.1	6.6	5.0	5.6	7.4	11.2	6.4
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384273	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 29.7;intestine: 25.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 23.1;HDLM-2: 33.5;RT4: 18.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA035957: AB_10672234, HPA035958: "	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.4	0.4	5.7	0.4	18.5	0.3	1.2	2.9	14.2	0.5	3.2	17.0	0.0	25.8	0.5	2.3	0.9	0.5	0.6	0.4	15.1		1.1	0.3	0.5	0.3	19.8	6.0	0.7	0.3	0.3	0.0	4.1	21.4	0.6	1.1	0.0	0.6	0.4	0.3	2.2	12.5	0.4	29.7	0.3	0.6	1.2	12.8	0.0	0.3	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	6.7	1.1	0.3	0.0	0.0	0.1	0.2	0.3	0.4	0.4	2.6	6.2	0.1	0.4	0.0	23.1	0.6	2.5	0.3	33.5	0.7	0.1	0.7	0.2	0.0	0.0	0.3	0.0	6.1	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.1	1.7	0.6	0.0	2.9	0.0	0.1	18.6	5.5	1.0	1.6	0.2	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZNF500	"KIAA0557, ZKSCAN18, ZSCAN50"	ENSG00000103199	"Zinc finger protein 500"	O60304	16	4748239-4767624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA035498, HPA057963"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA035498: AB_10602356, HPA057963: "	"unprognostic (3.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.10e-2)"	"prognostic favourable (3.41e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.19e-2)"	8.1	6.4	10.2	9.4	7.5	5.9	8.1	13.8	11.4	10.3	8.0	11.7	11.5	8.4	12.2	10.9	6.2	8.9	10.4	6.0	6.2	5.1	6.0	5.2	7.2	12.5	6.6	9.4	13.9	8.5	9.1	8.0	6.7	6.6	9.3	5.3	10.6	11.3	14.9	7.5	8.5	7.5	7.5	5.4	11.4	7.7	7.2	8.4	9.9	9.2	7.1	8.3	9.2	8.4	5.3	6.5	3.4	2.5	3.0	4.9	2.1	2.0	8.4	2.8	7.3	3.3	3.0	12.8	6.1	6.7	7.6	5.2	3.7	4.0	4.4	5.3	3.3	4.7	5.8	3.2	5.6	3.2	8.8	3.6	10.6	4.9	4.7	2.5	4.0	3.5	7.8	3.4	6.5	4.3	5.3	7.0	3.0	4.6	5.2	4.4	3.6	3.0	9.3	6.7	8.7	2.5	2.4	10.4	6.8	5.2	7.9	2.3	5.1	4.1	4.8	7.2	5.5	8.0	2.9	6.7	4.5	3.9	2.2	2.1	4.5	2.3	2.5	3.4	3.9	2.4	3.3	4.9	2.5	3.0	1.4	5.3	4.2	4.9	2.9	3.0	1.7	6.5	3.9	2.1	10.2	7.5	13.8	11.4	6.2	5.1	6.6	9.4	6.6	8.4
ZNF503	"FLJ45745, MGC2555, Nlz2"	ENSG00000165655	"Zinc finger protein 503"	Q96F45	10	75397830-75401906	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 38.2;PC-3: 49.5;U-87 MG: 15.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.6;myeloid DC: 1.4"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.4;monocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026848	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA026848: AB_10610704"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.63e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.63e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavourable (3.50e-4)"	"prognostic favourable (1.97e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	9.4	23.1	2.3	6.2	7.2	2.2	14.1	0.8	4.7	47.8	10.2	3.0	20.8	9.0	28.1	15.1	27.8	14.1	15.3	5.8	3.4	3.0	22.1	5.7	16.5	2.6	4.8	1.5	38.1	19.4	4.0	3.0	4.8	7.5	21.3	2.5	18.5	6.4	50.7	2.9	3.2	6.6	10.1	8.0	7.6	9.4	7.3	2.9	0.5	7.7	8.5	3.7	14.4	25.0	0.0	1.4	0.0	1.6	0.0	0.0	0.1	1.7	1.6	0.3	2.1	3.6	2.4	0.5	1.5	0.9	0.6	0.5	2.4	6.8	0.0	4.5	1.5	3.1	0.2	1.6	0.4	0.0	38.2	0.0	4.1	7.9	2.9	1.9	4.3	6.5	1.6	1.2	0.7	0.1	0.0	0.0	0.8	0.8	0.0	6.0	0.0	49.5	0.0	1.9	0.0	0.9	1.3	1.4	1.7	2.8	0.2	8.2	0.3	1.3	1.2	5.0	5.6	10.3	4.2	0.0	0.0	0.0	15.4	8.8	3.9	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.3	7.2	0.8	3.6	3.4	3.0	4.8	1.5	7.5	2.9
ZNF507	KIAA1084	ENSG00000168813	"Zinc finger protein 507"	Q8TCN5	19	32345594-32387667	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030964, HPA049728"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA030964: AB_10670562, HPA049728: "	"unprognostic (3.39e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.28e-3)"	"unprognostic (7.24e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.46e-2)"	10.9	8.7	11.3	16.0	13.1	13.5	12.0	18.4	16.4	12.0	11.4	9.0	10.2	10.0	12.4	9.8	9.6	12.2	10.3	10.1	9.4	8.1	9.0	11.1	8.2	10.5	12.3	10.3	18.6	10.9	13.6	15.7	16.9	11.1	10.7	9.9	6.8	11.0	9.6	21.0	8.6	14.7	11.9	12.9	9.6	9.7	28.3	13.0	17.1	18.7	10.0	10.5	11.0	20.1	4.0	0.4	2.3	1.4	2.0	4.7	1.4	9.1	18.2	13.6	8.4	8.9	14.0	11.0	8.2	8.1	7.6	8.5	10.5	7.2	13.6	10.2	7.9	5.3	19.8	10.2	14.7	10.5	17.9	13.9	8.8	7.1	10.7	11.6	7.6	8.8	7.8	9.7	15.8	10.2	20.5	11.0	8.0	5.7	12.4	3.8	14.6	5.8	13.0	15.8	5.5	4.6	10.2	11.2	9.7	10.9	7.4	9.0	5.8	8.4	10.8	12.2	13.1	7.1	10.6	10.7	12.4	14.1	8.6	8.6	11.0	0.4	0.1	2.3	4.1	0.0	4.7	2.5	3.1	2.8	0.0	4.0	4.2	3.4	2.0	2.0	1.4	0.4	2.4	1.4	11.3	13.1	18.4	16.4	9.4	8.1	12.3	10.3	11.1	13.0
ZNF516	"HsT287, KIAA0222"	ENSG00000101493	"Zinc finger protein 516"	Q92618	18	76358190-76495190	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015792	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA015792: AB_1859314"	"prognostic favourable (7.09e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (2.63e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.29e-2)"	"prognostic favourable (7.96e-4)"	"unprognostic (5.87e-2)"	"prognostic favourable (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	4.2	5.4	8.3	5.7	9.9	15.1	4.7	2.0	4.8	20.8	5.9	4.5	18.6	4.1	25.2	8.0	6.3	15.8	3.9	3.5	5.1	2.9	3.4	5.1	5.0	4.2	4.7	3.9	17.0	4.6	8.7	10.8	2.6	6.4	7.3	1.8	13.1	6.4	13.3	8.6	6.3	4.1	9.1	3.3	6.3	4.5	18.6	4.6	3.0	4.8	4.0	4.9	8.0	10.9	0.4	1.6	12.2	2.2	1.0	0.6	0.4	1.4	1.7	12.2	16.0	3.6	5.4	1.5	9.2	7.7	2.0	3.7	3.4	5.6	7.9	1.9	9.8	3.3	6.6	8.8	1.4	0.0	5.2	0.7	0.0	7.4	8.9	5.2	5.3	10.2	4.0	4.2	4.4	2.2	0.0	0.0	2.0	3.2	0.1	9.3	6.1	0.4	3.4	1.2	4.1	3.2	6.9	12.2	7.6	0.1	0.0	9.9	2.0	21.2	1.5	4.6	8.0	0.1	0.9	0.0	0.2	6.1	2.7	3.7	11.8	2.7	2.2	3.0	0.1	1.5	0.6	0.1	0.2	0.1	1.6	0.4	0.6	0.3	12.2	1.0	1.6	1.0	0.0	0.4	8.3	9.9	2.0	4.8	5.1	2.9	4.7	3.9	6.4	4.6
ZNF528	KIAA1827	ENSG00000167555	"Zinc finger protein 528"	Q3MIS6	19	52397849-52418412	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 24.3;U-266/84: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA065435			Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA065435: "	"unprognostic (1.90e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.26e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-3)"	9.8	11.7	16.6	8.9	20.2	5.8	12.2	21.1	21.4	12.4	9.1	15.7	7.9	5.5	15.3	21.7	10.0	15.6	11.4	11.4	15.3	11.2	11.1	5.2	9.3	9.3	17.5	11.4	21.3	6.4	12.7	21.0	10.9	15.3	13.4	10.0	13.3	12.8	12.1	7.6	12.6	7.5	9.8	15.6	11.8	10.0	13.8	22.0	8.2	19.9	5.1	11.5	12.6	10.8	10.5	8.4	10.6	5.0	16.5	12.7	3.4	0.1	0.0	2.9	17.5	6.8	8.4	7.4	6.5	10.8	4.0	9.0	0.2	3.2	0.1	1.6	8.0	2.0	0.0	4.3	5.1	0.0	4.8	2.7	1.0	1.6	10.0	0.1	7.4	8.5	7.5	4.4	0.0	9.5	1.7	0.3	5.8	0.1	9.8	1.4	7.6	4.6	0.1	11.8	3.1	4.9	24.3	12.2	10.1	0.0	0.5	4.1	11.7	1.5	10.9	7.0	8.1	2.7	8.8	0.3	30.6	5.9	3.5	0.1	10.8	7.1	5.0	10.6	6.7	4.7	12.7	7.3	8.1	10.0	5.0	10.5	8.0	7.1	1.4	16.5	5.0	8.4	8.9	3.4	16.6	20.2	21.1	21.4	15.3	11.2	17.5	11.4	15.3	22.0
ZNF540	DKFZp547B0714	ENSG00000171817	"Zinc finger protein 540"	Q8NDQ6	19	37551406-37614097	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"pituitary gland: 30.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA003444	Supported		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA003444: AB_1080732"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-4)"	"unprognostic (4.24e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.88e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (8.08e-2)"	"unprognostic (8.33e-5)"	2.8	9.3	8.6	3.9	29.9	1.2	6.0	23.7	16.7	5.8	4.4	5.0	5.3	3.9	6.0	9.4	3.0	4.2	3.6	9.1	8.6	12.1	6.3	2.6	5.0	6.3	9.0	9.1	13.8	3.8	13.3	30.7	2.3	11.0	7.1	3.6	9.0	6.1	8.9	2.9	6.0	4.5	3.8	7.9	6.3	4.6	11.5	9.5	2.7	14.4	3.1	6.0	3.4	4.0	3.1	0.3	1.2	0.1	3.0	7.1	1.8	0.4	0.0	2.7	2.7	6.9	4.1	0.2	1.0	0.9	1.1	2.1	0.2	0.0	1.2	0.3	2.4	1.0	1.8	0.9	0.9	3.7	2.7	1.0	1.2	0.0	1.8	1.2	2.0	1.9	2.5	0.7	0.0	0.1	0.4	0.0	1.6	0.1	1.7	0.7	0.9	0.5	1.4	1.6	0.8	0.6	0.4	2.8	3.1	1.0	0.3	0.3	1.3	0.7	0.0	1.0	3.1	1.2	0.9	3.7	2.0	2.6	0.0	0.4	0.6	0.0	0.0	1.2	3.9	0.1	3.9	2.9	4.1	4.4	0.1	3.1	6.8	7.1	0.2	3.0	0.0	0.3	4.2	1.8	8.6	29.9	23.7	16.7	8.6	12.1	9.0	9.1	11.0	9.5
ZNF541	DKFZp434I1930	ENSG00000118156	"Zinc finger protein 541"	Q9H0D2	19	47520685-47555856	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 17.7"	"Group enriched"	"Detected in some"	5	"HEL: 3.1;SiHa: 10.0;U-87 MG: 3.5"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.7"					"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058541, HPA076453"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA058541: , HPA076453: "	"unprognostic (4.49e-2)"	"prognostic favourable (2.94e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.92e-5)"	"unprognostic (7.98e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-2)"	1.2	2.6	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.4			0.1	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.9	0.0	0.1	0.1	0.0		2.2	0.0	0.0	0.4	0.3		0.0	0.0		0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.5	0.0	17.7			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.1	0.0	0.5	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	1.0	0.2	0.2	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0										
ZNF546	"MGC43537, ZNF49"	ENSG00000187187	"Zinc finger protein 546"	Q86UE3	19	39984134-40021041	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA030838			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030838: AB_10603332"	"unprognostic (4.38e-6)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.58e-5)"	4.1	5.1	5.0	3.7	7.1	2.5	4.7	7.9	6.6	4.2	3.6	7.6	7.3	2.0	6.3	3.8	2.8	5.7	2.9	4.9	4.7	3.8	4.8	5.5	3.2	3.8	7.9	4.4	7.3	3.7	6.5	8.5	3.1	6.8	4.6	2.7	5.2	2.9	6.1	5.6	3.8	3.4	5.3	8.3	5.4	3.1	20.8	7.9	6.6	6.0	2.8	4.4	3.6	3.3	2.7	2.8	2.6	2.4	2.5	4.7	1.2	0.2	4.6	2.0	2.6	4.7	3.4	0.3	1.8	2.8	2.2	3.0	0.2	0.6	2.5	2.1	1.6	0.2	1.0	0.3	3.3	2.6	3.3	3.2	3.2	1.7	2.5	3.2	2.2	2.7	2.0	1.3	3.5	2.8	4.0	6.1	2.3	0.6	1.5	0.7	0.7	0.5	1.8	1.7	1.2	1.1	0.4	1.4	1.5	1.0	0.2	1.8	0.9	1.4	1.1	0.7	1.5	0.3	1.4	4.6	4.4	0.5	1.7	1.3	1.4	1.6	1.5	2.6	3.7	2.4	2.5	2.7	2.4	2.2	2.8	2.4	4.7	4.1	1.1	2.5	1.2	0.7	3.0	1.2	5.0	7.1	7.9	6.6	4.7	3.8	7.9	4.4	6.8	7.9
ZNF549	FLJ34917	ENSG00000121406	"Zinc finger protein 549"	Q6P9A3	19	57527325-57557542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 13.4"	"Group enriched"	"Detected in all"	4	"B-cells: 4.7;NK-cells: 13.4;T-cells: 5.8"									HPA039511	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA039511: AB_10671998"	"unprognostic (6.27e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.01e-4)"	"unprognostic (4.03e-3)"	"unprognostic (2.51e-8)"	"unprognostic (2.88e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.89e-3)"	"unprognostic (9.11e-3)"	4.7	6.2	7.3	11.8	11.0	5.9	9.3	18.8	10.3	5.2	5.8	8.0	4.0	3.6	7.2	7.7	3.9	8.0	6.9	5.4	9.0	6.2	5.6	2.6	7.6	8.8	9.5	7.0	11.2	4.5	12.5	13.8	6.9	7.0	8.3	4.4	6.5	5.6	6.7	5.4	7.3	6.1	7.3	10.6	9.9	5.2	7.2	8.5	11.2	9.1	3.0	9.7	6.5	11.6	4.7	1.8	1.8	1.2	13.4	5.8	2.1	1.3	1.8	7.2	6.0	2.2	1.8	1.7	3.4	4.1	3.3	16.3	1.9	1.3	2.0	2.4	3.1	0.8	2.3	4.9	5.5	0.2	13.4	9.1	1.4	2.7	3.1	7.5	6.4	3.2	3.8	3.4	4.7	2.1	0.1	0.3	6.0	0.8	8.4	3.2	6.2	4.8	6.0	6.0	4.1	1.3	3.5	3.0	5.3	0.1	0.5	3.9	4.1	5.9	1.7	6.4	4.4	0.3	4.9	3.4	9.9	6.3	1.1	2.6	5.8	0.7	1.0	1.8	3.0	0.8	4.1	2.7	4.1	4.6	1.8	4.7	5.8	3.7	0.8	13.4	1.2	1.6	2.4	2.1	7.3	11.0	18.8	10.3	9.0	6.2	9.5	7.0	7.0	8.5
ZNF557	MGC4054	ENSG00000130544	"Zinc finger protein 557"	Q8N988	19	7069444-7087968	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003151, HPA029291"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				"Nucleoplasm, Intermediate filaments"	Cytosol	"HPA003151: AB_1859344, HPA029291: AB_10602357"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (5.29e-2)"	"prognostic favourable (5.70e-4)"	"unprognostic (2.56e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (1.32e-1)"	"prognostic favourable (2.62e-4)"	"unprognostic (2.51e-2)"	"unprognostic (2.51e-2)"	"prognostic favourable (1.51e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.81e-3)"	6.8	9.2	7.2	8.1	9.4	13.1	8.5	12.4	9.9	7.0	6.5	11.1	7.2	5.1	9.5	7.7	8.7	8.5	6.0	5.5	5.9	5.6	6.9	10.3	6.8	9.7	7.6	8.1	9.8	9.0	7.0	12.9	6.7	9.2	7.5	6.4	7.2	9.2	10.5	5.3	7.2	7.6	7.6	6.7	11.7	8.0	8.4	9.8	21.7	9.0	4.0	11.3	7.0	7.1	10.7	11.1	9.3	6.7	13.7	11.5	4.0	3.6	4.4	4.0	8.2	6.3	4.6	3.3	3.8	4.9	5.1	6.8	5.0	2.5	7.0	6.8	4.7	4.9	7.9	5.1	4.8	9.0	4.8	10.1	7.8	2.6	4.4	10.1	10.8	6.1	5.9	5.5	7.5	4.7	4.1	12.6	7.4	5.3	7.8	3.1	3.9	6.2	5.5	6.0	4.2	3.2	9.4	4.7	5.8	5.7	4.2	4.4	3.5	6.2	6.9	4.4	3.2	8.5	4.1	12.0	9.2	6.7	4.8	5.4	3.4	9.3	6.7	8.6	9.5	5.5	10.6	7.6	10.3	8.6	7.2	10.7	11.5	9.6	7.4	13.7	5.2	11.1	9.3	4.0	7.2	9.4	12.4	9.9	5.9	5.6	7.6	8.1	9.2	9.8
ZNF559	MGC13105	ENSG00000188321	"Zinc finger protein 559"	Q9BR84	19	9323772-9351162	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA059632, HPA065485"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA059632: , HPA065485: "	"unprognostic (1.35e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-3)"	"prognostic favourable (6.99e-4)"	"unprognostic (7.28e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	9.3	11.1	17.7	8.4	16.2	2.7	14.1	39.5	16.1	13.6	10.4	17.2	11.4	5.1	18.8	18.8	5.9	17.3	8.2	11.9	14.2	8.2	11.2	7.5	10.4	11.8	17.6	15.5	24.0	7.6	22.1	29.2	9.8	16.2	13.6	9.3	11.2	8.3	11.4	3.3	8.7	9.8	16.3	16.2	14.9	8.8	13.7	19.8	10.7	14.0	3.4	10.3	10.2	11.3	12.5	5.3	18.9	4.3	14.2	15.8	6.2	8.6	4.6	9.2	11.2	5.4	4.9	2.4	5.3	10.9	8.0	6.8	2.3	1.0	7.1	6.3	7.7	3.1	5.5	5.0	10.1	11.3	7.5	9.5	7.7	3.1	9.7	8.4	10.5	10.4	9.0	9.0	11.1	6.6	7.0	25.0	5.0	0.0	11.3	26.4	15.0	7.8	5.5	11.2	9.5	4.8	12.2	10.5	8.8	10.3	1.7	12.4	7.4	6.4	5.5	14.6	3.3	11.9	8.0	2.0	0.0	6.9	2.6	5.3	9.1	18.9	3.4	7.5	9.1	3.2	12.0	11.9	9.6	9.6	5.3	12.5	15.8	12.7	1.9	14.2	4.3	4.4	8.4	6.2	17.7	16.2	39.5	16.1	14.2	8.2	17.6	15.5	16.2	19.8
ZNF567	MGC45586	ENSG00000189042	"Zinc finger protein 567"	Q8N184	19	36687612-36727701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023937	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023937: AB_1859351"	"unprognostic (4.39e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.03e-2)"	5.9	7.0	6.3	6.7	6.9	5.0	10.2	12.2	10.2	8.0	6.3	4.7	6.6	3.8	9.2	7.5	7.8	7.0	5.5	5.3	7.7	6.0	6.0	7.7	5.8	8.6	7.1	2.3	8.4	4.9	10.4	15.8	13.0	8.0	9.3	5.0	5.1	7.3	12.1	7.4	5.6	5.5	9.7	9.1	7.2	5.5	14.2	9.6	9.0	8.3	3.3	8.2	6.6	7.5	8.8	3.9	7.0	2.3	7.9	8.2	3.0	6.7	5.3	9.8	8.7	5.6	5.5	9.3	5.0	7.7	5.7	9.2	3.0	2.4	4.3	6.1	4.5	1.8	9.0	5.2	7.8	8.4	4.6	8.1	5.9	2.9	5.2	10.2	6.2	8.6	6.3	5.4	10.6	6.6	3.1	2.3	6.8	4.2	13.1	3.9	9.4	4.3	6.5	13.5	6.1	3.7	10.4	7.3	7.9	9.3	4.6	4.9	5.9	6.9	4.1	7.6	7.7	3.8	5.6	8.8	7.3	14.3	0.0	4.1	6.6	5.7	2.3	7.0	7.7	2.0	6.3	7.3	8.2	7.1	3.9	8.8	8.2	8.2	1.3	7.9	2.0	2.7	6.6	3.0	6.3	6.9	12.2	10.2	7.7	6.0	7.1	2.3	8.0	9.6
ZNF573	FLJ30921	ENSG00000189144	"Zinc finger protein 573"	Q86YE8	19	37735833-37817300	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042776	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"HPA042776: AB_10961399"	"unprognostic (3.79e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.60e-2)"	6.2	6.4	7.3	4.2	8.6	7.2	7.6	14.1	9.5	6.3	4.6	8.6	5.2	4.3	7.5	10.8	4.8	5.0	6.8	5.3	5.8	4.1	5.3	4.2	6.0	4.1	10.0	5.7	8.4	6.8	6.7	11.7	5.7	6.2	5.5	4.9	5.9	6.4	5.6	5.3	7.8	5.3	6.9	6.8	5.3	7.5	10.0	9.5	4.5	9.8	4.0	6.2	7.4	6.2	6.3	3.3	3.3	2.6	3.6	5.7	1.0	1.0	3.6	2.8	2.4	1.4	3.4	1.2	2.3	2.7	0.9	2.2	3.5	2.8	3.5	2.3	2.1	2.2	2.8	3.8	3.4	1.8	1.9	4.0	5.4	1.8	1.4	3.3	2.6	3.0	1.4	4.8	2.1	2.8	1.8	1.6	0.7	1.4	2.7	2.0	4.5	0.4	2.8	5.7	1.1	0.2	1.6	3.7	3.7	4.6	1.5	0.4	3.5	3.1	1.0	3.2	3.3	2.8	3.8	4.2	5.3	5.7	0.8	0.4	2.6	3.2	1.0	3.3	4.2	1.2	3.4	3.4	3.5	4.5	1.9	6.3	5.7	4.4	0.4	3.6	2.6	3.3	2.0	1.0	7.3	8.6	14.1	9.5	5.8	4.1	10.0	5.7	6.2	9.5
ZNF575	FLJ32567	ENSG00000176472	"Zinc finger protein 575"	Q86XF7	19	43525497-43536130	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051865	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA051865: "	"unprognostic (1.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.53e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.87e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.75e-1)"	8.8	3.9	10.5	3.8	10.0	2.5	3.2	12.3	13.5	4.9	13.8	6.8	2.9	5.6	4.7	4.0	2.4	3.6	4.6	3.6	6.6	4.2	3.9	3.2	3.6	3.9	5.4	6.2	6.3	2.3	3.0	5.2	2.0	6.7	5.5	7.1	5.1	5.0	4.1	12.9	4.8	6.4	3.4	6.0	5.8	4.7	1.9	6.5	2.4	3.3	2.3	4.2	3.5	3.7	3.0	1.9	0.8	0.9	7.0	4.4	1.3	2.9	2.6	0.6	0.8	4.0	3.3	0.2	1.9	1.2	0.7	1.0	0.6	1.1	0.6	1.3	1.4	1.6	0.1	0.3	0.3	4.1	0.5	2.2	0.9	0.5	0.9	0.9	2.7	1.9	1.1	1.0	0.2	0.6	0.8	4.1	1.2	1.9	11.6	0.3	0.2	1.3	6.3	0.0	1.5	0.7	1.7	0.6	1.0	1.5	1.9	1.9	0.5	1.0	2.0	3.7	2.5	0.8	1.4	2.2	3.1	1.7	2.3	2.6	3.8	0.1	0.9	0.6	3.0	0.5	1.2	1.5	2.8	2.9	1.3	3.0	4.4	3.2	0.8	7.0	0.3	1.9	2.3	1.3	10.5	10.0	12.3	13.5	6.6	4.2	5.4	6.2	6.7	6.5
ZNF582	FLJ30927	ENSG00000018869	"Zinc finger protein 582"	Q96NG8	19	56375846-56393545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028858	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA028858: AB_10603247"	"unprognostic (1.19e-3)"	"unprognostic (9.86e-4)"	"unprognostic (3.88e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.02e-7)"	"unprognostic (3.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.00e-3)"	4.8	8.7	7.7	4.7	8.9	2.7	6.3	9.4	9.0	4.7	4.9	7.8	3.6	2.3	7.9	13.5	4.8	6.1	6.4	8.0	8.2	7.1	5.9	4.8	5.2	8.0	9.6	3.9	10.2	4.0	7.5	11.4	5.4	8.9	8.4	2.7	4.4	4.1	5.5	3.5	5.6	3.3	5.5	7.7	7.2	3.4	8.9	13.1	7.8	13.8	2.2	3.7	5.4	5.9	5.9	3.4	5.9	3.3	11.0	6.5	2.8	0.0	1.0	5.9	1.2	1.5	1.5	0.0	2.4	2.5	1.6	1.2	0.0	0.3	0.0	1.6	1.3	0.0	0.7	0.3	1.2	0.0	23.8	5.7	0.0	0.4	2.5	1.5	4.6	5.3	1.3	1.0	0.0	0.9	1.3	0.0	0.9	0.0	3.3	3.6	3.3	0.0	1.5	2.0	2.1	1.3	3.3	0.0	3.9	0.0	0.8	0.0	2.7	3.1	1.0	3.1	6.3	0.8	3.2	5.1	5.5	3.6	0.2	0.3	1.7	4.3	2.2	5.9	4.4	3.3	6.5	5.9	5.2	4.4	3.3	4.3	3.8	4.8	0.5	11.0	2.4	3.4	1.6	2.8	7.7	8.9	9.4	9.0	8.2	7.1	9.6	3.9	8.9	13.1
ZNF583	FLJ31030	ENSG00000198440	"Zinc finger protein 583"	Q96ND8	19	56397966-56436035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023805, HPA023957"	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023805: , HPA023957: "	"unprognostic (9.89e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	7.2	5.9	7.9	3.9	9.3	2.3	4.7	11.6	12.4	5.6	4.6	5.6	3.7	3.2	6.1	5.5	3.6	5.8	5.4	5.0	7.7	7.3	6.6	5.9	6.6	4.5	7.5	6.3	11.2	5.9	7.3	8.4	4.7	8.3	6.0	3.5	3.3	2.6	4.7	4.8	2.1	3.1	6.2	7.6	5.4	3.9	15.8	7.6	5.0	7.9	2.1	4.1	4.4	5.7	6.3	3.5	9.4	4.7	9.2	7.4	2.8	0.0	1.9	4.6	0.0	3.3	2.6	0.0	5.7	5.8	2.6	2.2	0.2	0.6	4.3	2.8	5.2	0.2	1.8	1.8	2.9	2.0	10.0	5.6	0.0	1.0	3.7	4.6	5.1	3.7	2.8	3.8	1.9	2.6	2.1	1.6	8.6	0.0	5.7	1.6	1.1	1.9	2.9	8.8	3.2	2.1	4.2	2.6	4.0	0.0	0.5	1.5	2.9	6.0	1.7	13.8	3.7	2.6	11.2	5.9	10.8	6.7	0.3	1.2	4.9	9.4	2.2	4.7	4.9	3.2	7.2	6.3	4.0	4.5	2.5	5.5	7.4	4.4	1.0	9.2	4.7	3.5	4.9	2.8	7.9	9.3	11.6	12.4	7.7	7.3	7.5	6.3	8.3	7.6
ZNF598	"FLJ00086, HEL2"	ENSG00000167962	"Zinc finger protein 598"		16	1997654-2009823	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041760, HPA041896"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041760: AB_10794787, HPA041896: AB_10796464"	"unprognostic (9.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.81e-2)"	8.4	6.1	4.1	9.1	9.4	14.3	13.9	10.6	9.5	8.3	7.7	8.8	4.7	9.9	8.7	4.0	10.0	7.1	4.8	5.6	5.2	4.1	5.9	12.2	7.8	9.1	4.2	7.1	9.8	24.8	6.5	12.9	8.1	6.4	8.9	3.2	6.8	15.6	7.3	12.9	15.3	9.9	9.5	2.9	11.8	12.4	10.1	6.1	10.0	7.7	10.6	12.5	6.8	7.6	1.8	3.2	0.6	0.9	1.2	1.7	0.5	9.9	12.8	3.3	7.9	3.0	4.1	9.5	7.4	3.8	4.9	3.9	13.9	6.0	9.9	9.3	4.8	11.7	5.4	9.2	1.3	14.1	30.8	7.7	13.6	7.6	13.5	12.3	8.8	4.5	12.6	7.8	15.1	5.3	17.3	15.5	2.5	17.1	11.7	19.1	9.6	15.6	26.7	6.5	23.1	2.4	3.6	15.8	12.9	7.5	9.3	12.0	6.5	20.6	8.6	10.5	12.5	9.0	13.9	17.4	15.4	13.0	4.5	11.8	9.6	0.6	0.6	0.2	1.2	0.7	1.7	1.1	1.2	0.9	0.7	1.8	1.1	1.6	0.4	1.2	0.9	3.2	0.3	0.5	4.1	9.4	10.6	9.5	5.2	4.1	4.2	7.1	6.4	6.1
ZNF599	FLJ30663	ENSG00000153896	"Zinc finger protein 599"	Q96NL3	19	34758076-34773229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014701	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA014701: AB_1859371"	"unprognostic (3.52e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.35e-3)"	"unprognostic (9.20e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.12e-3)"	5.9	8.1	10.0	5.2	12.5	2.4	8.5	16.8	8.0	10.1	6.5	11.7	5.8	4.5	12.2	21.4	4.4	14.1	6.5	5.8	10.3	6.8	9.7	4.9	6.0	5.7	10.5	5.7	11.4	5.7	14.3	13.2	6.0	8.1	10.4	5.5	11.6	7.4	9.5	5.5	8.0	5.4	7.1	8.1	6.5	5.9	19.9	11.2	10.4	13.2	6.0	6.2	6.4	7.2	4.3	3.8	6.4	4.8	5.7	6.7	2.9	5.3	2.7	5.9	5.5	6.6	8.9	3.2	2.0	5.5	4.9	5.8	2.3	3.6	0.6	5.7	3.7	2.8	3.9	2.5	6.1	0.6	4.9	4.1	5.4	6.6	5.0	0.9	4.7	8.0	3.7	2.2	2.3	5.6	6.9	0.5	7.6	2.1	10.3	4.3	2.6	0.2	5.6	5.6	3.3	6.1	1.3	7.1	10.1	6.6	1.2	3.9	3.5	0.5	3.0	4.9	5.5	3.6	2.1	6.2	6.7	0.5	3.0	0.1	4.6	3.1	1.1	6.4	6.1	2.5	4.0	2.0	6.5	3.5	1.7	4.3	6.7	5.9	0.6	5.7	4.8	3.8	4.9	2.9	10.0	12.5	16.8	8.0	10.3	6.8	10.5	5.7	8.1	11.2
ZNF609	KIAA0295	ENSG00000180357	"Zinc finger protein 609"	O15014	15	64460742-64686068	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040742, HPA040832"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040742: AB_10963581, HPA040832: AB_10960400"	"unprognostic (2.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	11.1	11.2	14.5	14.5	12.6	7.3	11.4	17.1	15.1	17.9	14.2	16.2	19.1	12.1	18.7	8.4	10.2	15.7	14.0	10.9	12.3	10.4	9.1	10.2	13.9	11.3	10.9	11.0	29.9	11.6	18.1	11.6	16.3	10.9	15.2	11.4	14.6	12.6	22.8	9.2	11.9	11.2	16.1	12.7	12.9	11.4	28.9	13.6	21.4	12.4	4.5	12.1	15.6	28.4	1.2	2.8	3.2	1.7	4.0	3.0	0.5	6.1	15.5	16.7	6.4	6.4	8.2	5.7	8.0	10.7	10.0	10.2	9.5	9.7	10.5	6.7	9.4	13.1	24.4	11.0	10.6	12.1	5.2	19.1	8.9	4.6	11.9	11.0	12.8	8.3	10.1	10.5	20.8	18.6	30.0	6.8	8.2	5.5	8.5	4.7	12.6	4.3	7.8	15.2	5.5	7.3	11.0	13.6	10.4	10.9	12.5	7.5	6.1	7.7	18.5	9.4	15.1	4.8	9.9	7.6	8.6	9.5	5.8	12.0	7.6	3.2	1.7	1.9	2.3	0.7	1.6	0.7	1.3	1.6	0.6	1.2	3.0	3.0	2.1	4.0	0.8	2.8	0.8	0.5	14.5	12.6	17.1	15.1	12.3	10.4	10.9	11.0	10.9	13.6
ZNF614	FLJ21941	ENSG00000142556	"Zinc finger protein 614"	Q8N883	19	52012765-52030240	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021197	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA021197: AB_1859380"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.15e-3)"	7.7	7.1	9.9	5.6	9.4	10.1	10.1	15.6	12.5	9.2	7.3	6.6	5.8	4.5	9.5	7.3	6.3	8.8	6.0	7.0	7.9	8.5	6.9	4.7	6.3	8.2	9.3	7.1	14.0	5.1	6.5	13.7	14.2	9.7	16.4	5.5	5.5	5.4	8.9	11.1	7.6	6.3	8.9	13.5	9.7	5.8	13.8	10.7	18.2	14.3	5.1	7.5	8.5	9.6	6.0	5.5	4.3	5.9	9.6	8.1	3.2	3.8	2.8	7.3	9.5	5.2	5.9	1.0	5.1	3.7	4.8	5.9	3.7	2.2	9.6	2.9	4.4	1.7	10.8	6.9	7.2	2.6	15.4	14.5	5.2	7.3	4.3	3.0	7.4	4.5	3.8	4.9	6.9	5.6	7.7	2.2	6.4	1.5	12.4	6.0	8.4	5.2	8.3	14.1	7.9	4.9	9.8	9.8	5.9	3.1	3.9	3.2	5.2	7.6	5.7	4.8	6.6	2.7	6.1	4.4	6.8	14.8	4.5	4.2	6.2	4.3	4.3	3.0	6.5	5.9	7.8	6.0	5.7	6.1	5.5	6.0	8.1	5.3	3.3	9.6	4.5	3.1	5.9	3.2	9.9	9.4	15.6	12.5	7.9	8.5	9.3	7.1	9.7	10.7
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA036514: , HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	14.3	10.8	18.3	12.1	19.4	28.8	14.8	20.5	20.3	12.6	19.5	14.5	9.5	15.5	14.4	16.9	13.6	13.2	12.3	38.6	13.8	14.6	14.8	18.8	12.8	14.5	16.8	15.5	15.1	45.9	12.5	15.0	16.0	17.2	13.1	19.8	10.9	17.5	12.8	29.0	18.6	19.6	12.6	12.8	12.4	15.9	14.1	17.3	14.0	16.7	11.9	15.4	13.7	14.9	50.4	45.6	55.4	45.9	39.1	56.9	47.2	11.0	24.2	7.6	15.6	18.6	15.9	27.6	19.9	15.1	16.3	20.8	28.7	10.3	13.0	26.9	15.7	14.6	12.2	15.5	13.1	17.4	16.5	11.8	42.9	20.5	26.8	22.9	14.2	24.5	19.7	15.1	14.3	11.3	15.9	12.9	17.8	18.6	12.0	22.4	13.4	23.9	9.5	9.2	11.0	15.0	16.6	10.5	11.8	27.8	20.9	32.2	11.6	17.8	15.4	18.2	13.9	17.6	12.6	18.6	16.6	18.1	15.8	19.9	12.6	45.2	41.6	52.9	49.1	43.4	51.2	50.4	49.5	53.7	45.6	47.0	56.9	47.7	55.4	39.1	45.9	37.0	50.1	47.2	18.3	19.4	20.5	20.3	13.8	14.6	16.8	15.5	17.2	17.3
ZNF630	"BC037316, dJ54B20.2, FLJ20573, MGC138344"	ENSG00000221994	"Zinc finger protein 630"	Q2M218	X	47983356-48071658	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001053, HPA068130"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA001053: , HPA068130: "	"unprognostic (1.03e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.83e-2)"	"unprognostic (9.06e-3)"	"unprognostic (8.68e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.51e-5)"	4.0	5.2	5.3	6.4	9.0	2.1	6.7	8.8	8.5	7.0	5.4	5.9	11.3	3.5	6.3	7.5	5.0	4.8	5.8	5.9	6.0	4.6	5.2	3.0	5.0	5.4	12.3	5.8	11.2	8.3	11.9	10.1	4.9	8.8	8.4	6.2	6.4	6.1	6.9	2.3	4.0	4.2	7.5	7.3	4.8	6.8	1.8	10.1	1.0	9.3	1.5	3.6	8.4	13.7	2.6	3.8	5.8	1.9	1.5	2.8	2.0	1.4	1.1	0.3	0.0	0.1	0.1	0.0	1.9	0.6	1.0	0.9	3.3	5.4	0.1	1.0	2.0	2.3	0.0	1.0	1.3	0.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	1.3	5.7	3.2	0.0	1.0	0.0	5.4	3.6	5.7	0.0	0.0	2.1	1.6	0.7	1.3	0.0	2.5	3.0	3.2	2.6	7.1	4.8	2.1	5.7	1.4	1.2	0.0	2.6	2.5	0.0	0.0	4.7	0.0	0.0	0.1	4.5	5.8	1.9	4.8	2.2	1.0	2.4	2.6	2.0	2.0	3.8	1.8	2.5	2.8	2.1	1.5	0.6	0.9	1.1	2.0	5.3	9.0	8.8	8.5	6.0	4.6	12.3	5.8	8.8	10.1
ZNF646	KIAA0296	ENSG00000167395	"Zinc finger protein 646"	O15015	16	31074422-31084196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042364, HPA066468"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042364: AB_10794796, HPA066468: "	"unprognostic (1.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.66e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavourable (1.28e-6)"	"unprognostic (3.23e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	9.8	6.4	5.9	10.4	7.6	13.4	7.3	12.2	7.8	10.2	6.8	10.4	8.2	10.6	9.8	6.8	7.5	8.6	7.6	5.9	6.8	5.5	6.9	6.1	13.5	11.3	10.6	5.6	10.3	8.2	10.1	9.4	8.0	7.2	7.9	4.9	5.8	9.8	14.2	12.4	10.6	9.6	6.5	7.4	12.9	9.1	36.1	9.2	24.7	7.7	5.2	11.5	7.8	10.8	4.0	5.2	19.8	3.7	3.4	4.3	1.5	6.1	12.9	8.5	6.6	6.1	4.8	11.2	6.8	7.2	8.2	7.6	9.4	5.9	12.1	10.9	5.8	8.3	7.0	7.4	3.2	13.8	6.6	8.9	11.5	7.8	6.3	11.5	14.0	6.1	6.8	8.8	5.1	4.9	14.1	7.1	6.2	9.8	12.7	7.9	11.5	6.7	20.4	16.6	12.1	2.6	5.9	12.4	12.5	7.8	8.3	4.1	6.9	10.1	9.9	10.4	5.9	6.9	6.3	11.9	10.9	12.3	9.4	12.5	8.1	5.9	3.7	9.4	4.3	3.3	2.2	3.3	2.0	1.7	3.5	4.0	2.2	2.5	19.8	3.4	2.1	5.2	2.0	1.5	5.9	7.6	12.2	7.8	6.8	5.5	10.6	5.6	7.2	9.2
ZNF660	FLJ36870	ENSG00000144792	"Zinc finger protein 660"	Q6AZW8	3	44578223-44599694	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;HEL: 5.5;NTERA-2: 8.6;RH-30: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"myeloid DC: 1.1;naive B-cell: 1.3;NK-cell: 1.6;plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"B-cells: 1.3;dendritic cells: 3.7;NK-cells: 1.6"					"Low region specificity"	"Detected in all"			HPA029705	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"		"HPA029705: AB_10602592"	"unprognostic (5.43e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.87e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.94e-2)"	3.1	3.1	3.5	3.0	5.9	3.5	3.0	10.3	7.2	7.6	3.8	3.8	4.4	1.3	7.9	5.2	2.2	5.2	3.6	2.9	4.4	3.8	2.5	1.3	2.9	4.2	5.7	6.2	11.3	2.6	6.3	11.5	3.7	6.0	5.7	2.2	5.5	2.1	4.7	2.3	2.1	2.7	5.9	6.4	3.4	2.7	4.4	4.7	1.8	4.7	0.8	3.1	4.1	4.1	1.3	3.7	0.4	0.4	1.6	0.3	0.2	0.0	0.0	5.6	1.4	0.1	0.0	0.8	0.6	1.4	0.8	0.8	0.0	0.0	0.1	1.2	0.5	0.0	1.8	0.0	1.1	0.0	0.0	5.5	0.4	0.8	1.3	0.1	0.0	2.3	0.1	2.0	0.0	1.3	0.0	0.3	2.9	0.0	0.0	3.2	8.6	0.0	0.1	5.7	0.0	0.1	0.3	1.4	3.8	0.0	0.0	0.1	0.1	2.1	0.4	1.6	1.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.2	0.1	0.1	0.2	0.2	0.3	1.1	1.3	0.2	0.2	0.2	1.6	0.0	3.7	0.0	0.2	3.5	5.9	10.3	7.2	4.4	3.8	5.7	6.2	6.0	4.7
ZNF670	MGC12466	ENSG00000277462	"Zinc finger protein 670"	Q9BS34	1	247036784-247078755	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003142	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003142: AB_1859404"	"unprognostic (2.11e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.05e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-2)"	3.5	2.2	3.1	2.9	5.5	0.7	6.2	12.0	6.1	4.1	2.6	3.2	0.0	2.8	5.7	3.4	1.9	3.7	3.8	2.5	4.5		3.9	3.0	4.0	3.4	1.8	1.3	5.5	2.8	3.1	1.3	1.4	4.0	3.4	3.5	2.5	1.9	3.1	1.6	2.6	2.4	4.3	2.9	3.1	3.3	4.8	2.7	5.4	3.7	3.0	4.7	4.2	1.0	6.6	4.1	1.7	2.3	2.8	6.5	2.3	3.7	2.7	7.7	9.5	1.9	3.4	17.9	4.9	3.3	5.8	5.8	3.2	4.0	6.1	8.1	3.0	3.2	8.5	3.8	11.0	4.6	1.0	5.4	1.8	4.8	1.7	6.8	3.3	1.9	3.9	3.8	7.3	3.7	7.8	2.7	5.8	1.5	7.9	3.3	14.4	4.8	8.2	9.6	5.8	3.5	8.3	8.9	8.1	6.8	2.7	3.8	2.8	14.2	2.3	3.5	4.1	2.6	5.4	5.2	9.8	12.5	1.3	4.9	4.5	0.0	2.0	1.7	4.4	2.3	2.3	6.6	4.1	4.6	4.1	5.9	6.5	4.9	0.2	2.8	1.4	2.3	3.0	2.3										
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoli	"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	9.0	7.6	8.2	6.6	16.2	7.1	8.8	19.4	10.8	9.3	7.2	6.7	7.1	5.4	9.2	6.2	6.1	7.7	7.4	7.4	8.9	6.3	6.4	5.3	7.8	9.8	12.7	8.2	9.9	12.6	7.2	19.4	9.7	8.9	10.6	10.8	4.6	7.6	6.3	6.2	5.2	6.6	7.5	14.2	9.5	7.6	8.7	15.5	12.0	12.7	5.1	9.1	8.2	9.4	6.6	3.2	7.1	1.1	2.2	3.2	1.5	2.0	3.2	11.8	13.4	1.4	3.4	7.1	2.7	2.7	4.0	4.3	2.5	2.5	8.2	7.1	1.2	3.9	6.9	1.8	6.7	3.4	13.2	3.9	2.5	1.6	2.6	6.5	10.5	2.9	3.3	2.4	5.3	3.8	9.7	13.0	4.4	1.7	9.0	2.3	10.3	5.4	7.0	7.6	3.2	3.0	6.4	5.0	9.8	4.1	4.8	2.0	6.7	8.3	2.5	5.1	4.8	4.5	5.5	4.2	9.5	9.0	2.1	1.2	5.2	7.1	1.1	1.3	2.5	0.3	3.0	6.6	2.5	1.4	2.1	4.5	2.2	3.2	0.2	2.2	0.7	3.2	2.7	1.5	8.2	16.2	19.4	10.8	8.9	6.3	12.7	8.2	8.9	15.5
ZNF684	MGC27466	ENSG00000117010	"Zinc finger protein 684"	Q5T5D7	1	40531561-40548169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059153	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA059153: "	"unprognostic (4.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.67e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.10e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.96e-2)"	"prognostic favourable (4.89e-10)"	"unprognostic (4.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.52e-2)"	3.6	6.4	4.1	2.9	8.9	8.2	4.2	5.8	7.4	3.6	3.8	2.3	5.4	3.2	3.6	4.3	3.2	3.1	3.4	10.6	4.4	3.3	18.3	20.8	3.4	4.4	9.8	3.6	3.8	5.4	2.5	4.6	2.1	5.4	5.1	4.8	1.6	3.5	4.1	4.4	4.1	3.4	3.2	5.9	5.1	4.2	4.3	7.8	6.4	5.6	4.1	3.5	3.1	2.7	6.0	3.9	7.0	7.7	3.5	5.9	2.4	2.1	0.7	2.7	3.7	2.5	3.7	1.6	2.0	1.9	2.3	4.0	1.3	2.8	3.7	1.6	1.2	2.7	2.7	1.9	3.8	3.2	4.6	4.0	2.5	3.5	1.3	4.3	4.4	2.5	0.8	2.9	1.1	3.6	2.1	5.5	3.4	0.6	6.3	5.0	6.7	2.3	2.9	8.2	2.6	3.6	1.9	2.0	3.5	3.6	3.6	4.0	1.5	27.5	2.1	2.4	5.1	2.3	3.9	4.7	3.3	4.3	2.1	4.6	3.7	7.0	4.0	1.9	5.9	7.7	3.2	6.0	4.2	3.6	2.4	3.5	2.8	5.5	2.3	3.5	4.1	3.9	4.7	2.4	4.1	8.9	5.8	7.4	4.4	3.3	9.8	3.6	5.4	7.8
ZNF70	"Cos17, MGC48959"	ENSG00000187792	"Zinc finger protein 70"	Q9UC06	22	23738678-23751092	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018821	Uncertain		Supported	Cytosol				Cytosol		"HPA018821: AB_1859423"	"unprognostic (3.17e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.69e-2)"	5.5	5.0	8.4	7.6	8.5	5.5	5.5	14.3	10.3	7.5	5.5	8.2	10.7	3.4	7.8	8.7	3.6	7.4	5.9	6.3	8.6	3.8	4.1	3.0	4.7	4.9	7.1	5.7	15.3	6.5	10.1	6.2	4.5	7.1	5.9	4.8	9.0	7.2	8.4	9.1	4.3	5.1	7.0	4.9	5.2	5.1	4.7	10.9	3.9	6.7	1.1	5.6	5.8	5.4	1.5	1.6	4.2	1.0	2.0	1.2	0.4	1.9	2.5	4.7	4.9	7.1	3.4	1.6	1.8	3.6	4.0	5.8	2.4	1.3	2.7	1.2	3.8	2.1	3.3	2.3	5.2	1.8	3.0	5.2	4.4	2.1	4.3	4.6	4.5	3.3	1.6	5.5	4.6	3.2	1.8	3.9	3.0	2.7	2.7	2.3	1.2	1.1	11.2	4.5	0.6	1.4	2.6	2.7	3.3	2.6	3.4	2.0	1.7	2.2	4.2	4.6	5.7	3.0	2.0	4.1	0.7	2.6	4.0	2.2	3.8	4.2	1.0	0.9	1.0	0.8	0.6	0.8	1.0	0.6	0.5	1.5	1.1	1.2	3.2	2.0	0.8	1.6	0.4	0.4	8.4	8.5	14.3	10.3	8.6	3.8	7.1	5.7	7.1	10.9
ZNF720		ENSG00000197302	"Zinc finger protein 720"	Q7Z2F6	16	31713229-31794869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA041570	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA041570: AB_10795126"	"unprognostic (5.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-3)"	"unprognostic (8.72e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.47e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-2)"	15.1	15.8	11.1	13.7	11.8	9.9	12.7	16.8	17.6	14.3	12.4	11.3	17.7	7.2	11.7	17.4	16.4	12.8	10.3	10.1	11.1	15.1	14.2	11.6	10.7	17.5	15.5	11.0	9.6	12.9	13.4	24.5	19.4	15.5	14.5	14.0	11.4	13.9	17.7	10.3	17.3	10.1	13.2	14.3	18.4	14.1	13.7	15.9	16.6	19.2	11.0	18.1	14.6	11.6	14.4	8.9	23.0	5.5	12.8	14.2	5.0	10.2	7.2	9.0	7.9	7.9	12.0	8.7	11.0	7.2	5.4	7.2	5.2	11.0	5.0	19.4	3.7	7.2	8.8	4.2	8.0	22.2	4.6	2.7	3.9	14.8	11.8	5.9	15.3	8.1	11.8	3.7	5.4	10.1	9.2	6.6	5.8	16.6	6.0	7.8	8.8	5.7	11.4	4.0	7.8	6.1	6.5	4.1	6.1	11.1	5.0	9.8	9.6	11.7	6.5	3.9	3.1	7.8	3.3	11.0	12.0	14.3	3.5	9.1	6.1	13.9	4.8	23.0	14.2	5.4	10.6	13.7	10.0	12.7	5.2	14.4	9.3	11.7	6.3	12.8	5.5	8.9	12.2	5.0	11.1	11.8	16.8	17.6	11.1	15.1	15.5	11.0	15.5	15.9
ZNF721	KIAA1982	ENSG00000182903	"Zinc finger protein 721"	Q8TF20	4	425815-499156	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA065313			Approved	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA065313: "	"unprognostic (2.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-3)"	"prognostic favourable (2.76e-4)"	16.1	15.3	20.9	17.2	24.5	20.8	24.7	42.3	25.6	17.7	13.9	15.9	15.4	13.4	17.2	19.3	15.4	20.4	13.5	12.1	19.4	15.3	16.1	16.3	16.4	26.9	24.6	22.8	21.5	19.2	21.1	39.2	13.1	20.7	16.5	16.4	13.9	16.1	15.0	14.5	23.5	16.0	17.5	22.1	18.3	16.2	17.7	23.9	20.3	22.5	12.7	27.8	19.0	16.7	15.1	9.5	11.3	7.8	11.5	20.8	6.5	8.8	5.8	11.2	13.9	8.4	11.2	7.0	8.2	7.2	9.1	8.2	8.5	9.1	15.1	8.8	7.8	5.8	11.6	10.0	12.1	5.3	13.6	26.3	6.0	5.8	7.9	10.9	1.7	10.2	8.8	10.2	14.8	8.9	15.3	10.9	12.5	8.7	18.1	17.9	17.4	12.2	14.8	16.3	8.4	9.4	12.4	16.6	10.6	10.7	6.0	9.9	11.5	11.8	11.4	8.3	2.9	6.3	14.1	12.5	11.8	36.8	6.2	3.1	7.4	7.0	7.8	11.3	12.0	7.6	11.9	15.1	13.1	11.5	7.6	15.1	20.8	16.0	11.1	11.5	6.7	9.5	14.6	6.5	20.9	24.5	42.3	25.6	19.4	15.3	24.6	22.8	20.7	23.9
ZNF747	MGC2474	ENSG00000169955	"Zinc finger protein 747"	Q9BV97	16	30530367-30535347	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003203, HPA069173"	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA003203: AB_1080753, HPA069173: "	"unprognostic (3.82e-2)"	"prognostic favourable (6.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.66e-2)"	"prognostic favourable (4.46e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.01e-1)"	12.5	10.5	11.0	8.9	12.4	5.7	10.3	13.1	19.4	14.1	11.3	18.5	6.3	9.6	14.3	10.3	8.9	11.8	10.5	13.2	10.3	8.9	11.4	17.0	8.4	9.3	11.5	8.0	13.2	15.5	23.1	10.4	6.2	10.6	14.6	9.2	13.6	11.2	15.3	14.1	11.0	10.5	11.8	9.4	11.4	10.2	12.4	13.3	18.2	11.8	6.7	9.0	12.8	8.8	8.8	8.1	9.0	4.8	6.6	8.9	4.1	3.8	3.7	1.2	6.1	4.9	4.3	6.2	3.2	4.8	4.6	4.5	2.2	4.9	8.3	2.2	3.8	5.7	2.8	4.0	2.0	9.8	6.2	7.2	4.0	3.4	5.4	3.3	10.3	4.9	5.1	3.7	5.8	3.0	2.0	7.2	3.2	4.2	14.8	4.6	7.2	2.5	17.7	0.4	7.6	4.0	2.0	8.6	7.6	4.8	3.2	3.5	6.2	6.6	2.4	5.9	2.7	4.6	0.1	13.7	9.6	4.7	1.2	5.1	6.9	9.0	4.8	6.4	4.5	2.6	5.2	7.4	5.1	5.2	6.0	8.8	8.9	6.6	2.7	6.6	2.4	8.1	3.8	4.1	11.0	12.4	13.1	19.4	10.3	8.9	11.5	8.0	10.6	13.3
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favourable (1.18e-4)"	"prognostic favourable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	9.2	20.0	16.0	14.6	18.4	8.5	11.3	27.2	17.8	11.4	11.5	18.1	14.5	11.9	12.5	18.5	10.4	13.7	12.7	20.8	14.8	9.6	14.1	13.0	10.6	15.0	15.3	12.3	19.5	13.9	19.5	31.4	19.7	16.9	15.6	10.2	21.8	16.0	16.6	45.1	10.5	13.1	10.6	13.6	18.3	12.2	19.9	16.4	12.6	24.0	10.3	14.6	12.4	11.0	10.5	7.4	5.4	9.3	9.3	16.0	8.8	6.6	6.1	13.5	14.9	5.7	8.8	9.7	5.7	9.7	9.7	7.7	4.5	8.9	14.4	8.5	8.6	3.8	11.3	8.7	5.7	21.5	17.0	13.8	9.3	7.2	11.4	7.0	8.2	10.7	5.5	11.2	10.5	8.8	10.2	15.3	8.7	14.5	11.6	8.1	6.6	5.9	11.3	7.0	13.3	8.7	9.3	21.1	7.8	7.0	8.9	17.2	13.4	22.6	6.7	6.8	5.9	4.6	8.2	15.4	10.7	13.5	5.9	11.0	17.9	3.8	6.6	5.4	16.0	8.6	12.7	10.0	11.7	11.3	7.4	10.5	12.5	13.0	2.0	9.3	9.3	3.7	9.0	8.8	16.0	18.4	27.2	17.8	14.8	9.6	15.3	12.3	16.9	16.4
ZNF764	MGC13138	ENSG00000169951	"Zinc finger protein 764"	Q96H86	16	30553764-30558498	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003203	Uncertain		Approved	Cytosol				Cytosol		"HPA003203: AB_1080753"	"unprognostic (9.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.47e-2)"	"prognostic favourable (6.84e-4)"	"unprognostic (6.62e-2)"	"unprognostic (9.75e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.64e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.05e-1)"	9.4	9.0	12.0	8.0	9.9	9.8	7.4	19.5	11.3	9.4	8.7	10.0	9.7	13.0	10.6	4.4	7.1	9.5	10.8	9.7	10.5	6.1	8.1	11.2	6.8	11.3	10.6	7.4	12.5	8.9	10.6	12.5	6.1	9.9	9.7	8.4	8.3	7.9	7.1	9.4	6.8	11.7	6.4	5.9	11.1	14.0	11.3	10.4	14.9	7.6	6.1	8.1	7.5	7.6	4.1	3.1	6.2	2.7	10.8	6.3	2.5	3.0	3.5	7.3	7.0	3.2	3.2	4.3	3.8	3.2	3.8	2.9	2.8	2.9	5.5	4.6	2.2	4.3	3.9	2.5	3.0	6.0	10.2	3.6	4.3	5.3	3.8	3.5	5.9	2.5	3.2	3.1	4.2	3.4	6.8	6.5	3.4	6.7	9.8	5.6	4.3	4.9	13.4	3.1	7.2	3.1	1.5	14.1	10.8	2.6	6.1	3.6	5.4	6.4	3.0	5.0	2.8	2.8	3.8	8.7	6.0	4.7	3.7	5.0	7.1	3.4	2.1	6.2	4.9	2.6	6.3	2.9	4.9	5.9	2.7	4.1	5.1	4.8	2.1	10.8	2.7	3.1	3.1	2.5	12.0	9.9	19.5	11.3	10.5	6.1	10.6	7.4	9.9	10.4
ZNF772	DKFZp686I1569	ENSG00000197128	"Zinc finger protein 772"	Q68DY9	19	57466663-57477570	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA031312	Uncertain		Approved	Cytosol				Cytosol		"HPA031312: AB_10603941"	"unprognostic (2.30e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.01e-2)"	"prognostic favourable (1.02e-6)"	"unprognostic (7.99e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-2)"	3.4	8.3	11.0	2.5	14.5	2.2	7.9	21.2	11.8	5.4	3.9	8.1	3.9	3.0	3.9	9.5	4.8	8.8	4.2	10.3	9.3	6.9	6.9	4.1	4.8	5.0	8.9	10.2	10.6	4.6	18.9	19.2	6.9	8.0	7.6	2.6	8.6	6.2	7.1	15.7	6.8	3.7	4.0	6.4	7.6	4.0	5.8	9.6	7.4	14.9	3.0	6.3	5.2	3.6	7.6	3.3	2.2	2.4	3.4	4.4	1.9	2.2	1.6	9.0	3.7	2.5	5.2	4.0	3.8	4.7	6.1	21.3	0.5	2.3	0.2	2.9	3.2	0.2	1.9	5.0	7.6	0.0	13.7	7.0	0.8	2.3	3.2	0.8	7.5	4.3	2.1	4.2	8.6	4.5	2.1	1.4	5.6	1.6	0.9	1.7	5.5	4.2	1.9	11.4	7.0	2.9	5.4	9.5	5.8	0.1	2.1	2.8	6.1	4.4	2.1	5.8	3.8	1.3	3.9	8.9	15.3	2.5	1.3	0.2	5.6	0.3	2.4	2.2	0.8	1.8	2.9	4.3	2.2	0.9	3.3	7.6	4.4	2.3	1.2	3.4	1.7	1.6	0.6	1.9	11.0	14.5	21.2	11.8	9.3	6.9	8.9	10.2	8.0	9.6
ZNF774	MGC75360	ENSG00000196391	"Zinc finger protein 774"	Q6NX45	15	90352245-90369146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA030839, HPA030840"	Uncertain		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"HPA030839: , HPA030840: AB_10602691"	"unprognostic (1.11e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.89e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.82e-2)"	1.5	5.1	5.8	3.6	8.6	1.6	5.7	14.0	8.7	5.0	7.5	4.1	0.0	3.9	5.5	7.3	2.8	5.3	5.1	4.2	4.8	5.4	2.6	2.9	2.1	1.2	3.9	5.9	2.3	6.5	7.1	5.7	1.3	9.4	4.3	12.4	3.0	6.8	10.3	11.9	5.3	3.5	3.3	3.1	1.3	4.6	8.2	4.7	3.8	4.9	3.1	1.7	3.9	3.5	2.0	1.9	4.2	1.1	2.7	1.3	0.4	2.3	1.1	3.1	3.4	1.3	0.7	7.1	1.5	2.4	1.8	2.3	3.7	2.8	0.9	2.8	1.7	3.5	3.0	5.0	1.8	1.7	6.0	2.4	11.3	1.7	2.3	1.4	2.0	0.7	6.1	2.7	2.6	3.1	2.7	1.2	3.0	2.3	1.9	1.3	0.9	3.6	1.8	2.6	0.7	3.7	6.3	6.9	2.9	2.8	4.4	1.2	2.9	0.4	1.6	2.1	1.9	1.7	3.0	7.4	5.0	0.6	3.3	3.9	0.9	3.6	1.1	2.2	1.0	0.5	0.7	0.9	0.8	1.3	1.9	2.0	1.0	0.9	4.2	2.7	0.6	1.2	0.5	0.4	5.8	8.6	14.0	8.6	4.8	5.4	3.9	5.9	9.4	4.7
ZNF776	FLJ38288	ENSG00000152443	"Zinc finger protein 776"	Q68DI1	19	57746796-57758159	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA046653, HPA068553"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046653: AB_10961126, HPA068553: "	"unprognostic (6.73e-2)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (3.99e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.86e-2)"	5.8	9.8	14.0	10.8	15.9	19.4	12.2	34.9	15.2	9.4	8.6	7.9	17.3	8.4	8.2	29.9	7.8	10.3	6.9	9.8	11.0	9.5	10.7	9.5	8.6	11.0	10.7	8.9	12.4	7.1	17.0	18.8	10.2	12.8	11.9	9.3	9.6	10.8	13.4	11.4	8.6	8.7	7.3	9.6	11.6	10.0	8.7	15.0	19.3	14.5	6.0	10.7	10.7	8.0	4.2	2.5	11.1	2.4	7.5	4.3	2.1	4.6	3.9	12.5	8.3	2.1	6.4	5.4	3.7	6.5	6.5	4.3	2.3	5.0	5.2	3.4	3.3	3.0	6.5	6.4	10.4	4.9	23.8	7.1	9.2	2.6	4.7	3.9	5.7	7.3	5.4	4.3	4.7	5.0	4.7	3.8	8.4	2.0	12.8	3.7	7.3	8.2	8.3	9.5	5.9	4.8	14.7	14.3	10.3	6.8	5.7	4.0	5.8	5.6	4.5	7.0	3.8	0.6	5.5	10.6	11.8	8.7	4.2	3.7	5.7	7.9	2.4	11.1	1.8	1.7	3.9	3.5	2.8	3.4	2.2	4.2	4.3	3.2	6.2	7.5	2.1	2.5	2.3	2.1	14.0	15.9	34.9	15.2	11.0	9.5	10.7	8.9	12.8	15.0
ZNF783	DKFZp667J212	ENSG00000204946	"Zinc finger family member 783"	Q6ZMS7	7	149262171-149297302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA020375	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA020375: AB_1859453"	"unprognostic (3.17e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.29e-2)"	"prognostic unfavourable (2.24e-7)"	"unprognostic (2.49e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"prognostic favourable (4.11e-4)"	10.1	8.1	11.4	14.4	14.9	6.5	15.1	14.3	15.8	11.5	9.4	15.4	9.9	10.0	13.1	11.2	8.2	13.0	11.0	7.2	11.6	7.7	8.5	4.6	8.6	16.1	13.1	18.4	17.2	11.2	9.4	10.2	7.2	12.5	13.0	9.7	12.2	9.3	13.5	11.6	12.6	12.2	20.1	15.4	17.7	9.1	9.2	12.5	2.9	11.8	6.2	15.0	9.9	16.1	3.8	2.7	0.5	4.5	1.5	3.2	1.1	3.3	3.4	5.7	4.1	3.8	7.2	5.4	2.2	1.1	5.0	2.2	5.4	6.4	11.6	5.6	3.5	2.2	4.0	4.2	2.2	3.1	3.6	7.4	7.5	1.1	8.7	4.8	9.3	7.5	8.8	4.5	5.6	3.3	5.9	5.9	4.1	7.2	7.2	7.5	12.8	4.7	1.6	0.5	10.1	5.6	5.7	4.6	9.6	8.5	4.0	5.7	4.4	9.8	5.0	4.0	0.9	2.2	4.7	9.2	5.8	0.1	5.7	1.7	8.7	0.3	1.1	0.5	3.2	2.2	2.5	2.3	2.0	2.0	1.3	3.8	2.7	2.2	0.4	1.5	4.5	2.7	1.2	1.1	11.4	14.9	14.3	15.8	11.6	7.7	13.1	18.4	12.5	12.5
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favourable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favourable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favourable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favourable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	9.9	11.0	7.6	6.7	7.8	6.7	8.1	18.3	8.5	9.2	9.6	10.3	6.9	5.6	12.9	10.4	7.0	9.4	5.6	6.8	6.8	5.3	6.8	9.5	6.8	8.3	7.5	5.2	9.1	9.5	13.2	11.8	8.1	8.4	11.2	8.2	10.7	12.2	8.3	13.2	8.7	7.7	8.3	6.1	10.2	8.8	21.1	8.6	12.8	8.5	4.8	10.5	13.3	9.9	8.5	7.5	7.4	6.0	9.4	11.8	4.9	2.2	4.5	6.0	3.6	6.8	4.0	16.9	5.6	6.8	6.7	7.7	4.8	2.1	4.8	2.3	4.1	7.0	4.5	6.8	5.3	4.8	2.9	3.3	7.3	5.3	8.0	7.8	5.3	4.0	7.7	8.3	6.7	6.9	5.6	7.2	6.3	4.9	6.1	2.9	4.8	5.8	5.1	8.4	6.8	2.8	3.3	6.9	4.6	10.6	5.5	3.2	7.2	4.5	4.8	4.3	3.9	4.2	4.3	9.8	20.8	6.2	5.5	2.4	7.1	3.3	4.9	7.4	9.3	6.0	10.6	7.4	6.4	11.8	7.0	8.5	8.4	9.1	6.5	9.4	4.0	7.5	7.9	4.9	7.6	7.8	18.3	8.5	6.8	5.3	7.5	5.2	8.4	8.6
ZNF793		ENSG00000188227	"Zinc finger protein 793"	Q6ZN11	19	37506939-37548762	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.4;RT4: 9.7;U-266/70: 16.9;U-266/84: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA034781	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA034781: AB_10602784"	"unprognostic (4.80e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.12e-3)"	3.1	7.7	12.5	4.9	11.9	2.1	6.4	22.1	14.0	6.4	4.2	12.8	4.6	3.0	9.3	6.9	5.2	6.7	4.6	6.8	10.3	8.0	6.2	1.1	3.3	5.6	8.3	10.0	14.1	4.0	15.7	18.4	4.5	11.2	7.5	6.0	8.1	3.6	5.8	3.7	10.7	3.6	6.1	10.1	5.6	5.3	12.3	9.6	2.1	11.0	3.2	4.9	4.9	5.7	4.0	2.1	7.2	1.6	4.0	2.8	1.4	0.1	0.2	4.2	11.4	0.9	0.9	0.2	3.3	0.2	0.7	0.3	0.2	1.3	2.9	5.5	1.7	0.4	0.3	2.8	0.3	0.8	4.2	0.3	0.4	0.3	2.1	0.2	2.6	3.4	2.5	0.6	0.1	0.1	0.1	0.5	0.5	3.2	0.3	0.4	6.9	0.3	0.1	0.1	0.6	2.8	9.7	3.1	6.7	0.2	0.2	0.0	6.4	0.3	0.4	0.1	1.8	0.2	3.2	16.9	11.3	0.2	0.0	0.2	0.5	7.2	1.6	1.2	1.5	0.6	2.3	2.0	2.8	2.5	1.2	4.0	1.9	2.4	4.2	4.0	0.6	2.1	2.2	1.4	12.5	11.9	22.1	14.0	10.3	8.0	8.3	10.0	11.2	9.6
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023090: AB_1859457, HPA052194: "	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	17.5	11.2	10.8	14.4	11.7	61.7	18.7	18.6	12.7	11.9	11.9	6.3	12.8	10.3	14.6	10.4	15.4	13.5	11.6	9.5	10.2	5.9	8.9	14.4	16.5	20.7	13.5	9.2	15.2	15.3	16.2	18.6	10.8	12.6	10.5	10.5	7.1	15.1	16.1	14.9	22.7	14.8	11.5	15.7	15.2	13.1	19.1	12.8	22.4	12.7	10.9	13.8	14.4	15.5	14.2	12.0	16.9	6.8	18.9	17.2	5.9	8.9	4.7	5.5	9.6	8.0	10.7	5.3	8.7	10.3	9.0	8.7	4.3	8.6	15.3	5.4	8.2	6.6	9.0	9.3	12.4	13.4	5.3	9.8	4.8	4.0	10.1	13.4	18.9	9.1	8.6	9.9	13.4	9.5	12.1	15.8	9.7	6.8	14.8	9.7	4.6	6.2	9.2	7.8	10.1	6.6	11.3	7.9	8.3	8.6	34.1	11.1	4.0	9.2	10.2	15.1	4.8	9.9	10.2	18.9	8.3	22.1	11.2	12.3	12.5	16.9	6.8	10.1	13.3	6.3	14.0	12.0	10.0	13.5	7.0	14.2	16.4	17.2	6.0	18.9	6.6	12.0	13.8	5.9	10.8	11.7	18.6	12.7	10.2	5.9	13.5	9.2	12.6	12.8
ZNF852		ENSG00000178917	"Zinc finger protein 852"	Q6ZMS4	3	44498970-44510636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA048312, HPA049885, HPA071850"	Uncertain		Approved	Cytosol				Cytosol		"HPA048312: , HPA049885: , HPA071850: "	"unprognostic (2.64e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.62e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.11e-2)"	3.8	4.0	5.0	4.7	5.4	3.1	4.7	12.9	6.9	4.6	4.0	3.2	4.6	3.6	5.2	3.7	3.6	4.2	3.1	3.3	4.8	2.1	4.0	3.7	4.8	4.8	5.5	3.9	6.4	10.3	9.0	13.5	4.7	5.4	5.6	5.8	4.2	8.8	4.6	2.9	4.6	5.4	7.0	4.7	5.1	6.0	2.9	4.6	7.1	4.4	2.5	6.3	5.0	6.1	2.4	2.7	1.4	1.3	0.7	1.8	0.4	0.8	1.5	3.5	6.1	0.8	2.1	2.5	1.0	1.3	1.6	2.8	1.9	1.0	3.0	0.7	1.0	0.9	3.9	0.9	2.4	2.4	1.8	2.7	5.9	1.5	1.5	3.0	5.4	0.8	1.9	2.5	0.8	1.5	3.3	1.6	1.7	0.2	2.5	2.5	1.9	0.7	1.3	3.6	1.4	1.1	3.0	3.0	2.2	1.8	0.8	0.8	1.9	2.8	1.8	2.3	2.4	1.3	1.0	2.5	1.5	1.5	0.8	2.2	1.4	0.0	0.6	1.4	0.6	1.3	1.0	2.4	1.1	0.7	0.5	1.6	1.0	1.8	0.9	0.7	0.3	2.7	0.1	0.4	5.0	5.4	12.9	6.9	4.8	2.1	5.5	3.9	5.4	4.6
ZRANB1	TRABID	ENSG00000019995	"Zinc finger RANBP2-type containing 1"	Q9UGI0	10	124942123-124988189	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029239, HPA029240, HPA029241"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205"	"unprognostic (2.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.53e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-2)"	5.1	9.3	4.9	1.9	4.7	7.9	5.3	11.9	6.0	6.3	5.2			1.4	5.9	5.2	4.1	4.4	3.6	7.3	4.6	4.0	4.2	10.4	4.2	2.5	4.4		8.6	3.1	7.1	3.9	3.9		4.6	3.3		3.4	5.8	18.0	5.2	3.0	6.3	3.8	2.8	3.6	7.7			3.8		3.9	4.2	4.8	3.4	1.4	4.6	1.1	3.8	4.4	0.8	7.7	4.4	9.5	6.9	14.8	12.5	4.0	7.6	20.8	14.5	16.9	6.6	6.1	8.1	5.7	9.6	5.6	12.0	5.6	19.6	8.6	5.9	4.6	5.1	7.1	31.6	6.9	3.5	13.8	16.5	10.6	22.8	9.1	0.6	6.7	7.8	6.1	8.1	6.0	3.4	4.8	7.0	6.7	3.6	6.4	5.6	4.8	8.1	6.4	5.0	8.4	5.5	5.9	6.7	6.2	6.4	5.1	9.4	7.2	6.2	9.4	7.0	4.9	3.0	2.1	1.1	3.0	2.2	0.4	1.9	2.4	2.6	2.2	0.9	3.4	4.4	3.3	4.6	3.8	0.5	1.4	2.2	0.8										
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006637	Approved		Approved	Microtubules,Cytosol				Cytosol	Microtubules	"HPA006637: AB_1080646"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	6.4	5.5	8.0	7.4	8.6	3.7	11.4	12.1	9.0	8.1	7.2	5.7	6.9	4.9	9.4	7.6	4.6	7.3	4.6	4.7	7.2	5.0	6.0	3.8	5.7	8.3	5.0	3.9	11.4	9.0	10.1	14.1	7.0	7.6	8.9	6.0	4.8	6.9	9.9	2.8	4.5	6.6	7.5	5.1	7.2	5.8	9.5	6.9	11.5	10.3	3.7	7.7	9.4	10.2	6.1	2.2	5.2	1.7	3.9	4.5	1.9	5.3	1.7	8.1	0.1	4.3	3.3	5.8	3.7	5.1	5.6	7.8	1.2	2.0	5.1	7.0	2.5	2.4	0.0	4.5	5.8	0.0	6.6	7.4	5.3	3.7	3.9	2.6	1.9	4.4	4.3	5.6	10.2	1.5	10.9	1.2	3.5	0.6	0.0	5.9	5.1	0.9	8.9	7.4	1.3	4.2	3.5	10.0	10.2	1.9	4.4	6.3	1.7	6.6	1.5	2.2	4.8	1.7	2.9	3.2	3.3	1.0	2.0	0.7	3.4	5.2	1.6	3.3	3.6	1.0	3.4	4.3	2.7	4.2	2.2	6.1	4.5	3.8	0.5	3.9	1.7	2.0	2.1	1.9	8.0	8.6	12.1	9.0	7.2	5.0	5.0	3.9	7.6	6.9
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 36.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favourable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favourable (4.16e-5)"	9.8	7.6	5.2	7.2	7.4	9.7	15.0	5.9	6.3	7.3	6.2	5.8	9.0	4.1	9.5	8.4	3.4	5.3	8.2	8.2	4.8	4.7	9.1	10.1	4.5	8.0	6.2	5.0	10.2	36.9	6.9	6.3	2.8	5.1	7.1	4.3	6.7	12.4	5.1	9.5	3.4	5.5	9.0	5.1	8.1	8.5	12.0	6.0	24.4	6.3	3.9	6.9	6.5	9.7	7.1	10.5	10.0	12.2	9.0	12.1	6.4	1.7	9.8	7.7	12.7	4.5	3.0	6.7	1.9	5.3	4.1	5.5	7.5	4.0	3.6	5.4	3.0	4.3	6.5	3.7	3.6	7.4	10.0	4.6	5.7	15.8	3.9	2.9	3.7	4.5	4.5	5.2	5.0	12.1	6.1	2.9	4.9	4.8	13.4	6.8	14.1	5.8	14.0	4.4	6.8	4.3	12.5	10.8	19.1	5.9	3.3	9.1	6.8	8.2	7.9	5.0	9.6	2.4	2.4	5.0	6.6	12.1	3.3	6.8	3.1	10.0	9.6	8.3	10.9	10.5	5.4	7.1	9.2	8.2	10.5	7.1	7.6	8.2	5.4	9.0	12.2	10.2	12.1	6.4	5.2	7.4	5.9	6.3	4.8	4.7	6.2	5.0	5.1	6.0
ZSCAN22	"HKR2, ZNF50"	ENSG00000182318	"Zinc finger and SCAN domain containing 22"	P10073	19	58327019-58342332	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006471	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA006471: AB_2221026"	"unprognostic (5.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.00e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.07e-1)"	4.8	5.6	4.1	8.5	6.1	3.0	10.8	9.3	6.2	6.7	4.8	4.7	9.3	5.1	5.7	4.2	6.1	4.6	3.5	4.9	4.3	4.1	4.2	7.7	4.8	4.8	9.7	3.7	7.8	7.3	9.4	9.1	5.3	6.8	5.1	4.3	2.7	7.0	9.2	6.1	8.1	5.2	5.6	3.9	5.2	5.5	5.7	6.2	8.0	6.5	4.3	6.4	4.6	5.3	3.2	3.0	2.7	2.3	3.2	5.6	2.3	2.8	5.2	2.8	4.3	3.4	2.0	3.1	2.4	1.2	1.5	1.4	2.7	2.0	2.3	1.6	2.0	2.2	4.0	2.7	1.6	3.5	17.8	4.8	4.8	2.5	2.7	3.8	5.0	2.4	2.7	3.3	3.5	2.2	4.8	4.4	2.6	2.3	1.9	1.8	2.4	5.8	2.6	4.4	3.9	1.6	3.8	4.5	3.2	3.5	4.9	2.2	2.3	2.6	2.0	8.1	2.4	2.0	4.1	4.4	6.0	1.7	3.2	2.7	2.8	0.3	2.1	2.7	5.6	1.8	3.9	2.6	3.3	4.6	3.0	3.2	2.9	2.9	0.7	3.2	2.3	1.4	2.6	2.3	4.1	6.1	9.3	6.2	4.3	4.1	9.7	3.7	6.8	6.2
ZSCAN30	"ZNF397OS, ZNF917"	ENSG00000186814	"Zinc finger and SCAN domain containing 30"	Q86W11	18	35251058-35290245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA007289	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA007289: AB_1079726"	"unprognostic (6.02e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-3)"	"unprognostic (7.02e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.44e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.36e-1)"	9.4	14.4	11.8	9.2	19.1	7.9	12.2	23.0	19.9	9.4	8.9	20.9	9.8	10.1	14.2	13.9	6.7	10.3	10.4	16.4	12.2	10.6	12.1	8.7	10.3	12.4	11.8	12.8	10.7	9.7	19.8	27.3	9.6	14.7	11.1	8.4	12.8	9.2	9.4	15.4	11.7	12.8	9.4	15.0	12.1	10.0	10.5	15.0	13.0	15.2	6.8	9.4	8.6	8.2	7.7	5.4	4.8	1.9	4.0	5.6	2.5	4.4	1.2	10.1	13.3	6.8	13.5	6.9	8.6	11.6	5.0	9.9	3.6	5.5	8.0	5.7	9.1	3.1	4.7	9.0	13.7	8.1	2.7	5.2	5.7	2.5	7.1	4.4	5.2	8.7	7.1	13.5	11.5	9.2	8.4	9.6	13.1	2.0	6.4	7.4	6.5	4.2	9.5	3.4	5.8	7.6	3.0	14.2	7.4	8.5	2.7	3.6	4.2	5.9	11.4	18.1	3.9	2.8	3.4	17.1	7.3	7.1	13.7	4.9	10.2	2.4	1.3	4.4	4.6	1.6	3.0	5.3	4.2	2.7	2.2	7.7	5.0	5.6	4.8	4.0	1.9	5.4	3.7	2.5	11.8	19.1	23.0	19.9	12.2	10.6	11.8	12.8	14.7	15.0
ZSCAN31	"ZNF310P, ZNF323"	ENSG00000235109	"Zinc finger and SCAN domain containing 31"	Q96LW9	6	28324693-28356271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 21.3;TIME: 16.0;U-2 OS: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 13.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.4"					"Low region specificity"	"Detected in all"			HPA007124	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA007124: AB_1080703"	"unprognostic (1.11e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.10e-2)"	"prognostic favourable (2.19e-5)"	"unprognostic (8.43e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	5.2	4.0	11.3	2.2	12.1	3.5	11.2	36.4	27.6	8.0	9.9	3.6	5.9	3.2	16.3	8.4	9.9	6.8	15.5	6.4	8.0	3.8	5.2	4.5	8.7	1.9	16.7	5.6	17.7	8.1	4.8	8.3	2.3	14.9	7.1	5.1	3.5	6.5	8.3	7.0	11.0	3.5	10.7	21.9	2.1	13.3	18.4	11.8	0.6	21.0	5.6	3.1	7.3	6.9	1.5	2.0	13.4	0.3	1.4	1.5	0.3	1.0	1.4	2.2	10.1	0.3	0.5	3.2	0.4	0.6	0.5	0.4	1.2	15.3	0.2	21.3	0.7	3.2	1.1	0.9	0.3	1.8	0.9	3.5	7.9	2.3	0.9	7.1	4.4	0.3	8.5	0.6	0.9	14.6	3.8	2.7	2.2	1.4	1.2	1.7	0.7	6.3	3.1	2.0	1.8	1.5	1.2	7.1	2.0	13.6	8.8	2.0	4.4	2.4	16.0	3.3	26.0	0.7	1.1	1.1	1.6	0.2	0.4	3.4	0.7	13.4	0.3	0.6	1.5	0.2	1.3	1.5	1.2	1.2	0.3	1.3	1.0	1.5	0.3	1.4	0.3	2.0	0.2	0.3	11.3	12.1	36.4	27.6	8.0	3.8	16.7	5.6	14.9	11.8
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041147: , HPA046751: "	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	11.3	13.8	7.3	7.6	11.4	10.2	7.8	17.2	15.7	7.3	8.5	10.4	5.6	8.8	10.1	7.8	9.3	9.3	10.1	9.8	7.5	7.7	12.8	11.3	6.9	9.5	6.9	8.5	12.6	14.1	10.0	11.4	12.2	6.3	10.3	7.7	14.1	10.4	8.1	27.3	12.3	10.6	9.1	8.1	12.2	8.7	9.0	9.5	16.1	11.5	9.8	13.3	9.6	7.0	5.4	4.4	6.9	3.7	1.2	5.3	1.4	6.3	8.0	6.0	7.2	10.9	6.4	6.1	4.3	5.7	10.0	9.2	18.2	7.5	7.6	13.2	6.3	15.3	9.7	12.3	7.5	2.9	5.7	9.9	10.0	12.4	6.7	8.0	10.2	9.1	10.4	8.3	8.0	7.7	8.7	6.1	5.7	19.2	9.0	6.6	3.3	9.0	6.9	8.7	5.3	6.4	9.4	8.0	5.1	15.1	22.3	5.1	13.2	6.0	6.3	10.9	6.8	5.8	6.3	6.1	4.3	7.7	8.6	6.3	5.5	3.8	2.9	6.9	1.0	3.7	0.7	5.4	3.7	1.6	1.6	5.1	5.3	4.7	3.1	1.2	3.5	4.4	3.0	1.4	7.3	11.4	17.2	15.7	7.5	7.7	6.9	8.5	6.3	9.5
ZSWIM3	"C20orf164, dJ337O18.7, PPP1R174"	ENSG00000132801	"Zinc finger SWIM-type containing 3"	Q96MP5	20	45857617-45879122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055692, HPA060508"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"				Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA055692: , HPA060508: "	"prognostic unfavourable (9.32e-5)"	"unprognostic (8.53e-2)"	"unprognostic (3.55e-1)"	"prognostic unfavourable (4.21e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.77e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.72e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.13e-2)"	5.1	9.6	8.3	5.6	8.2	2.2	5.7	15.2	9.6	6.1	6.7	6.3	5.2	7.4	6.7	8.9	5.9	6.8	5.4	6.0	7.3	7.2	5.6	7.0	5.9	9.3	6.2	7.4	9.0	5.0	6.9	9.5	5.3	6.7	6.1	7.3	9.4	5.4	5.4	3.9	6.7	7.4	5.5	6.0	10.5	5.8	9.5	6.3	13.7	5.9	2.9	11.2	6.1	4.7	4.3	3.8	3.2	8.5	3.3	6.3	2.1	2.1	1.7	5.3	3.0	6.5	4.6	3.1	3.3	4.0	6.1	6.1	7.3	3.3	6.6	11.5	2.8	3.5	7.6	3.5	4.6	4.0	3.2	6.4	3.3	4.7	7.9	3.6	8.7	4.2	4.0	4.6	2.9	5.2	5.8	3.2	4.6	10.5	4.9	7.1	2.0	7.2	4.9	4.9	4.8	1.7	1.3	7.0	3.5	5.3	6.2	4.2	3.0	9.4	5.1	6.2	2.0	2.3	2.0	6.9	3.6	4.2	5.2	4.3	2.0	2.1	2.3	3.2	3.0	3.2	6.3	4.3	3.3	4.2	3.8	3.6	3.2	4.3	1.7	3.3	8.5	2.3	4.9	2.1	8.3	8.2	15.2	9.6	7.3	7.2	6.2	7.4	6.7	6.3
ZSWIM6	KIAA1577	ENSG00000130449	"Zinc finger SWIM-type containing 6"	Q9HCJ5	5	61332273-61546170	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA035938	Uncertain		Approved	Cytosol				Cytosol		"HPA035938: AB_10672077"	"unprognostic (2.22e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.99e-1)"	14.1	10.0	14.4	14.9	22.9	6.3	8.8	13.1	18.0	9.0	15.8	40.1	8.2	10.4	9.2	10.3	12.6	10.2	17.0	7.1	15.0	12.2	8.0	13.6	17.4	9.4	25.2	10.6	11.5	12.6	19.4	9.7	13.6	20.4	12.5	19.1	17.7	10.3	12.1	5.2	8.2	12.4	11.1	19.4	11.6	17.2	12.5	25.9	11.2	10.4	5.9	8.7	10.4	11.8	1.2	3.4	4.4	3.2	0.9	0.9	0.5	3.2	4.3	19.9	1.4	4.3	7.9	1.6	4.3	3.9	4.8	7.5	1.7	5.2	0.8	3.8	5.4	2.8	4.4	5.3	6.8	13.4	4.1	1.6	8.3	0.9	5.7	1.0	2.3	5.7	3.9	11.4	9.8	11.8	0.4	16.3	19.7	2.3	0.8	2.0	3.0	3.2	6.3	5.8	23.7	7.9	4.2	4.0	6.4	10.2	0.6	3.9	1.7	4.2	16.4	4.0	5.2	5.6	6.1	2.9	0.4	1.7	6.2	1.2	8.5	1.5	3.1	1.2	0.2	2.4	0.9	0.6	0.3	0.4	1.5	1.2	0.4	0.3	4.4	0.9	3.2	3.4	0.4	0.5	14.4	22.9	13.1	18.0	15.0	12.2	25.2	10.6	20.4	25.9
ZSWIM7	SWS1	ENSG00000214941	"Zinc finger SWIM-type containing 7"	Q19AV6	17	15976560-15999717	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054681	Uncertain		Uncertain	Cytosol				Cytosol		"HPA054681: "	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.58e-1)"	"prognostic favourable (3.54e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (1.70e-1)"	10.0	16.2	14.3	11.5	21.7	7.0	21.5	9.8	28.7	9.4	10.3	9.8	13.8	13.2	11.5	14.2	11.6	11.2	8.8	18.7	17.4	13.8	15.2	14.4	13.6	13.8	16.9	12.2	14.3	13.9	8.6	15.5	10.2	16.5	9.6	9.1	9.9	14.0	13.1	49.2	13.8	9.3	11.2	22.1	12.2	10.5	10.8	12.1	6.2	12.1	8.4	7.3	11.4	11.2	17.2	26.0	15.2	17.2	10.0	12.6	12.2	10.6	15.7	8.5	19.7	3.4	3.3	9.9	7.2	2.8	7.7	5.7	2.9	3.1	5.2	6.5	7.9	3.5	2.7	5.8	3.7	5.3	9.6	5.8	7.3	6.0	8.2	4.7	9.8	7.9	10.4	4.2	7.3	9.8	3.6	2.8	3.9	14.6	16.0	11.1	5.1	9.3	10.3	20.9	8.0	6.9	5.9	2.9	12.5	11.2	11.3	7.2	8.1	1.2	13.8	12.6	4.3	3.3	6.2	1.4	3.8	5.9	10.7	5.9	10.6	15.2	17.2	7.0	8.9	16.1	9.3	17.2	10.4	8.5	26.0	14.3	12.6	12.0	1.0	10.0	11.3	16.1	7.5	12.2	14.3	21.7	9.8	28.7	17.4	13.8	16.9	12.2	16.5	12.1
ZSWIM8	"4832404P21Rik, KIAA0913"	ENSG00000214655	"Zinc finger SWIM-type containing 8"	A7E2V4	10	73785582-73801797	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041244	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041244: AB_10794269"	"unprognostic (8.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-2)"	"prognostic favourable (5.61e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.52e-1)"	22.5	30.2	27.1	17.7	27.9	35.3	20.6	29.8	32.4	21.7	27.2	38.1	29.7	25.6	25.5	43.3	33.1	19.9	24.9	19.8	25.9	20.4	28.8	43.1	22.3	20.9	34.0	24.9	26.4	23.3	39.0	50.0	28.1	28.6	29.9	17.8	29.8	30.3	28.9	19.5	48.2	34.8	27.9	20.0	36.8	21.8	29.1	37.0	22.7	30.1	15.9	22.2	21.7	24.0	3.5	6.6	9.0	4.2	1.9	5.7	1.7	5.8	10.0	12.5	20.6	29.9	14.4	7.3	7.5	21.0	10.8	13.0	8.8	4.9	3.3	5.4	12.4	9.1	4.4	8.9	5.4	5.3	9.2	4.7	10.6	11.6	22.6	3.2	18.4	23.3	16.0	13.4	15.7	12.6	6.5	6.5	12.3	8.9	4.8	9.7	3.7	31.6	5.9	5.9	1.9	15.3	12.6	3.0	13.7	6.2	18.7	10.6	12.4	6.8	12.6	12.2	7.2	5.4	7.6	16.6	8.9	2.1	13.1	4.8	6.1	4.3	4.1	3.2	5.7	2.7	3.3	3.5	2.6	2.4	3.2	2.7	1.1	3.7	9.0	1.9	4.2	6.6	3.2	1.7	27.1	27.9	29.8	32.4	25.9	20.4	34.0	24.9	28.6	37.0
ZUFSP	"C6orf113, dJ412I7.3"	ENSG00000153975	"Zinc finger with UFM1 specific peptidase domain"	Q96AP4	6	116635618-116668794	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044426	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044426: AB_10960887"	"unprognostic (2.28e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (3.27e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.92e-3)"	8.0	8.4	8.8	9.7	14.1	19.0	9.7	18.8	14.4	7.2	10.3	7.3	5.1	16.5	7.3	7.3	11.0	6.7	9.0	5.4	10.5	8.7	9.3	11.9	10.2	12.8	14.3	8.0	5.6	9.7	6.0	18.1	8.5	11.3	8.6	9.8	5.2	8.2	7.3	6.2	10.3	13.5	6.8	10.5	12.3	8.4	9.5	11.5	15.4	7.6	7.5	13.9	8.9	8.2	11.1	11.1	17.3	11.5	9.2	12.6	7.1	4.4	4.4	10.4	18.7	6.0	8.0	7.5	10.0	9.5	10.0	11.9	7.4	5.2	16.2	8.3	6.2	7.5	11.7	6.9	13.4	9.5	12.1	12.3	6.3	13.5	9.3	14.6	15.2	7.0	11.7	7.8	13.9	8.7	22.0	8.5	13.0	7.0	7.3	11.2	7.4	4.8	9.7	8.7	6.8	10.9	4.7	8.7	9.8	6.9	6.1	6.1	3.7	11.4	6.9	6.3	4.3	3.6	8.7	7.7	9.9	16.4	5.7	8.9	9.2	17.3	8.5	8.4	8.4	9.9	9.7	11.1	9.3	9.5	11.1	10.3	10.7	7.8	3.3	9.2	11.5	7.9	12.6	7.1	8.8	14.1	18.8	14.4	10.5	8.7	14.3	8.0	11.3	11.5
ZW10	KNTC1AP	ENSG00000086827	"Zw10 kinetochore protein"	O43264	11	113733187-113773811	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011565, HPA051253, HPA055410"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809"	"unprognostic (4.33e-3)"	"unprognostic (6.65e-2)"	"prognostic favourable (2.70e-4)"	"unprognostic (3.12e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (7.44e-2)"	"unprognostic (8.01e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.57e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-3)"	11.8	11.4	9.0	10.4	13.5	10.7	15.2	19.8	15.2	12.5	11.4	11.2	8.6	7.8	14.0	10.5	17.2	8.9	8.0	10.3	9.9	7.6	12.2	19.6	9.6	11.7	10.3	9.9	11.9	16.8	14.9	14.4	10.4	17.0	11.4	14.3	7.9	15.2	11.0	24.1	22.9	10.7	12.2	12.5	11.7	12.0	25.0	10.9	18.6	9.4	12.4	15.8	11.8	13.1	8.3	12.3	8.6	13.2	7.3	11.8	7.2	12.0	7.7	15.8	11.1	10.3	10.7	9.2	13.6	11.5	17.2	17.5	19.9	22.3	15.1	17.9	13.6	16.9	19.9	17.0	24.6	10.4	8.2	16.0	6.8	12.2	10.9	15.5	9.8	9.1	11.1	18.3	14.9	17.7	18.3	5.6	18.0	6.2	14.9	10.7	10.0	15.3	14.0	16.5	17.0	11.4	11.6	6.3	7.5	15.4	12.8	5.7	23.6	9.1	9.9	14.4	23.1	7.9	15.0	3.3	5.5	16.0	4.7	20.0	16.7	7.4	9.5	8.6	8.8	13.2	11.8	8.3	8.3	7.6	12.3	7.2	7.9	9.4	2.7	7.3	11.1	3.6	7.3	7.2	9.0	13.5	19.8	15.2	9.9	7.6	10.3	9.9	17.0	10.9
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357228-56361275	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.6;testis: 37.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 15.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	1.7	3.5	3.4	14.6	3.1	18.4	3.0	0.9	2.8	3.3	9.4	1.3	2.1	6.8	2.0	4.5	14.1	1.1	6.3	1.6	2.7	1.8	4.6	2.9	2.6	12.8	2.4	3.4	1.7	2.8	2.8	1.9	7.3	1.9	1.8	11.8	1.5	4.2	1.4	0.9	5.2	8.8	3.1	2.5	9.0	6.2	37.1	0.7	35.6	1.9	12.7	17.2	3.1	4.6	1.6	1.3	0.6	2.6	2.9	15.2	3.0	39.5	31.5	22.4	24.9	1.6	2.3	18.3	29.2	22.1	35.3	32.1	55.6	23.7	20.4	11.1	10.0	20.4	31.5	22.0	33.0	51.7	16.4	20.3	25.3	25.7	0.1	33.4	27.3	1.0	1.4	32.8	13.5	17.7	27.4	25.0	31.0	31.9	29.5	21.2	15.9	38.9	30.2	43.6	10.8	11.0	17.7	20.8	12.8	27.6	62.8	7.3	40.7	32.7	9.6	15.5	39.8	15.9	44.5	22.1	10.6	35.4	21.8	42.1	19.4	0.0	0.7	0.6	2.2	2.6	0.3	1.6	5.3	3.6	1.3	0.3	6.4	3.6	0.0	2.9	2.0	1.0	15.2	3.0	3.4	3.1	0.9	2.8	2.7	1.8	2.4	3.4	1.9	0.7